FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Yu, J
   Yang, HY
   Li, K
   Lei, JM
   Zhou, LQ
   Huang, C
AF Yu, Jian
   Yang, Hongye
   Li, Kang
   Lei, Jinmei
   Zhou, Liqun
   Huang, Cui
TI A novel application of nanohydroxyapatite/mesoporous silica biocomposite
   on treating dentin hypersensitivity: An in vitro study
SO JOURNAL OF DENTISTRY
LA English
DT Article
DE Dentin hypersensitivity; Mesoporous silica; Hydroxyapatite; Dentinal
   tubule; Microtensile bond strength
ID MESOPOROUS SILICA; DESENSITIZING AGENTS; TUBULE OCCLUSION;
   DRUG-DELIVERY; CITRIC-ACID; HYDROXYAPATITE; CALCIUM; NANOPARTICLES;
   PERMEABILITY; BIOMATERIAL
AB Objectives: To fabricate a nanohydroxyapatite/mesoporous silica nanoparticle (nHAp@MSN) biocomposite and investigate its effectiveness on dentinal tubule occlusion, acid-resistant stability, and microtensile bond strength (MTBS).
   Methods: The nHAp@MSN biocomposite was synthesized and characterized by X-ray diffraction (XRD), Fourier transform infrared (FT-IR) spectroscopy, N-2 adsorption-desorption isotherms, field-emission scanning electron microscopy (FESEM), and high-resolution transmission electron microscopy (HRTEM). Thirty-two simulated sensitive dentin discs were prepared and randomly divided into four groups according to the following treatments (n = 8 each): Group 1, no treatment; Group 2, NovaMin, 15 s x 2; Group 3, MSN, 15 s x 2; Group 4, nHAp@MSN, 15 s x 2. Then, four discs per group were post-treated with 6 wt.% citric acid challenge to test their acid-resistant stability. The effects on dentinal tubule occlusion were observed by FESEM. A self-etch adhesive (G-Bond) was applied to evaluate the MTBS. The cytotoxicity was detected using the Cell Counting Kit-8 (CCK-8) assay.
   Results: Results revealed that the nHAp@MSN biocomposite was successfully fabricated. nHAp@MSN could effectively occlude the dentinal tubules, and the intratubular crystals were tightly associated with the tubular wall. After citric acid attack, nHAp@MSN exhibited the highest acid-resistant stability among the four groups. Moreover, no significant difference in MTBS was noted among the four groups (P > 0.05). CCK-8 assay identified that nHAp@MSN induced no more than 20% cell death even at the highest concentration of 640 mu g/mL.
   Conclusions: The application of the nHAp@MSN biocomposite resulted in efficient dentinal tubule occlusion, acid-resistant stability, and did not compromise immediate bond strength between dentin and self-etch adhesive system. Clinical significance: The nHAp@MSN biocomposite indicates enormous potential as a new strategy for relieving dentin hypersensitivity. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Huang, Cui] Wuhan Univ, State Key Lab Breeding Base Bas Sci Stomatol Hube, Wuhan 430079, Peoples R China.
   [Huang, Cui] Wuhan Univ, Key Lab Oral Biomed, Minist Educ, Sch & Hosp Stomatol, Wuhan 430079, Peoples R China.
RP Huang, C (reprint author), Wuhan Univ, State Key Lab Breeding Base Bas Sci Stomatol Hube, Wuhan 430079, Peoples R China.; Huang, C (reprint author), Wuhan Univ, Key Lab Oral Biomed, Minist Educ, Sch & Hosp Stomatol, Wuhan 430079, Peoples R China.
EM huangcui@whu.edu.cn
FU National Natural Science Foundation of China [81371191]; Fundamental
   Research Funds for the Central Universities [2042015kf1052]
FX This work was financially supported by the National Natural Science
   Foundation of China (No. 81371191) and the Fundamental Research Funds
   for the Central Universities (2042015kf1052).
CR Adebayo OA, 2008, J DENT, V36, P1013, DOI 10.1016/j.jdent.2008.08.011
   Al-Kady AS, 2011, EUR J PHARM BIOPHARM, V77, P66, DOI 10.1016/j.ejpb.2010.10.007
   Andrade GF, 2014, J MATER SCI-MATER M, V25, P2527, DOI 10.1007/s10856-014-5273-6
   Anunziata OA, 2009, MATERIALS, V2, P1508, DOI 10.3390/ma2041508
   Barbour ME, 2003, EUR J ORAL SCI, V111, P428, DOI 10.1034/j.1600-0722.2003.00059.x
   Besinis A, 2012, DENT MATER, V28, P1012, DOI 10.1016/j.dental.2012.05.007
   BRANNSTROM M, 1963, J AM DENT ASSOC, V66, P366
   Burrow MF, 1996, DENT MATER, V12, P302, DOI 10.1016/S0109-5641(96)80038-8
   Chiang YC, 2010, J DENT RES, V89, P236, DOI 10.1177/0022034509357148
   Chiang YC, 2014, ACS NANO, V8, P12502, DOI 10.1021/nn5053487
   Diaz A, 2006, ACTA BIOMATER, V2, P173, DOI 10.1016/j.actbio.2005.12.006
   DOWELL P, 1983, J CLIN PERIODONTOL, V10, P341, DOI 10.1111/j.1600-051X.1983.tb01283.x
   Fu CH, 2013, BIOMATERIALS, V34, P2565, DOI 10.1016/j.biomaterials.2012.12.043
   Fujita K, 2011, J DENT RES, V90, P607, DOI 10.1177/0022034510397837
   Gillam DG, 1999, ENDOD DENT TRAUMATOL, V15, P198
   Hannig M, 2012, Adv Dent Res, V24, P53, DOI 10.1177/0022034512450446
   Hao XH, 2015, ACS NANO, V9, P9614, DOI 10.1021/nn507485j
   Holland GR, 1997, J CLIN PERIODONTOL, V24, P808, DOI 10.1111/j.1600-051X.1997.tb01194.x
   Huang S, 2011, CARIES RES, V45, P460, DOI 10.1159/000331207
   ISHIKAWA K, 1994, J DENT RES, V73, P1197, DOI 10.1177/00220345940730061101
   Kimura Y, 2000, J CLIN PERIODONTOL, V27, P715, DOI 10.1034/j.1600-051x.2000.027010715.x
   Lee BS, 2005, DENT MATER, V21, P511, DOI 10.1016/j.dental.2004.08.002
   Marshall SJ, 2010, DENT MATER, V26, pE11, DOI 10.1016/j.dental.2009.11.157
   PASHLEY DH, 1994, ARCH ORAL BIOL, V39, pS73, DOI 10.1016/0003-9969(94)90191-0
   Pei DD, 2013, EUR J ORAL SCI, V121, P204, DOI 10.1111/eos.12047
   Prati C, 2003, J PERIODONTOL, V74, P428, DOI 10.1902/jop.2003.74.4.428
   Reis C, 2008, DENT MATER, V24, P1608, DOI 10.1016/j.dental.2008.03.027
   Schafer F, 2009, INT DENT J, V59, P321, DOI 10.1922/IDJ_2499Schafer04
   Schmidlin PR, 2013, CLIN ORAL INVEST, V17, pS55, DOI 10.1007/s00784-012-0912-0
   Shi XT, 2008, J MATER SCI-MATER M, V19, P2933, DOI 10.1007/s10856-008-3424-3
   Singal P, 2005, J PERIODONTOL, V76, P351, DOI 10.1902/jop.2005.76.3.351
   Sousa A, 2008, ACTA BIOMATER, V4, P671, DOI 10.1016/j.actbio.2007.11.003
   Tang FQ, 2012, ADV MATER, V24, P1504, DOI 10.1002/adma.201104763
   Tschoppe P, 2011, J DENT, V39, P430, DOI 10.1016/j.jdent.2011.03.008
   Van Meerbeek B, 2011, DENT MATER, V27, P17, DOI 10.1016/j.dental.2010.10.023
   Wang ZJ, 2015, AM J DENT, V28, P128
   Wang ZJ, 2010, J DENT, V38, P400, DOI 10.1016/j.jdent.2010.01.007
   Wiegand A, 2007, J DENT, V35, P21, DOI 10.1016/j.jdent.2006.04.002
   Xu Z, 2008, J DENT, V36, P1005, DOI 10.1016/j.jdent.2008.08.007
   Yang HY, 2014, J DENT, V42, P1115, DOI 10.1016/j.jdent.2014.03.018
   Yang HY, 2013, AM J DENT, V26, P137
   Yang PP, 2011, J MATER CHEM, V21, P5505, DOI 10.1039/c0jm03878d
   Yoshihara K, 2010, ACTA BIOMATER, V6, P3573, DOI 10.1016/j.actbio.2010.03.024
   Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548
NR 44
TC 6
Z9 6
U1 8
U2 39
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0300-5712
EI 1879-176X
J9 J DENT
JI J. Dent.
PD JUL
PY 2016
VL 50
BP 21
EP 29
DI 10.1016/j.jdent.2016.04.005
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DO7PZ
UT WOS:000377975800003
PM 27101767
DA 2018-10-19
ER

PT J
AU ten Harkel, B
   Koopsen, J
   van Putten, SM
   van Veen, H
   Picavet, DI
   de Vries, TJ
   Bank, RA
   Everts, V
AF ten Harkel, Bas
   Koopsen, Jelle
   van Putten, Sander M.
   van Veen, Henk
   Picavet, Daisy I.
   de Vries, Teun J.
   Bank, Ruud A.
   Everts, Vincent
TI Ultrastructural aspects of foreign body giant cells generated on
   different substrates
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE Foreign body giant cell; FBGC; Biomaterial; Collagen; Sealing zone;
   Cross-linking
ID DERMAL SHEEP COLLAGEN; CROSS-LINKING; BIOMATERIALS; DEGRADATION; FUSION
AB Implantation of biomaterials into the body, e.g. for tissue engineering purposes, induces a material dependent inflammatory response called the foreign body reaction (FBR). A hallmark feature of this response is the formation of large multinucleated cells: foreign body giant cells (FBGCs). Biomaterials like cross-linked and non-cross-linked collagen often induce the formation of FBGCs. It is unknown whether different biomaterials result in the formation of different FBGCs. To investigate this, we implanted cross linked and non-cross-linked dermal sheep collagen subcutaneously in mice. After 21 days the implanted material was collected and prepared for ultrastructural analysis. More FBGCs formed on and between implants of cross-linked collagen compared to non-cross-linked material. The ultrastructural aspects of the FBGCs present on the two types of implants proved to be similar. On both materials, they formed long slender protrusions on the basolateral membrane, they were very rich in mitochondria, contained numerous nuclei, and showed signs of the presence of a clear zone facing the implanted material. Similar clear zones, that resemble osteoclastic features, were also seen in FBGCs generated in vitro on bone slices, but these cells did not form a ruffled border. However, similarities in ultrastructure such as the occurrence of slender protrusions and high mitochondrion content were also found in the FBGCs generated in vitro. These data indicate that FBGCs formed on different substrates share many morphological characteristics. The formation of long finger-like protrusions seemed typical for the FBGCs, in vivo as well as in vitro, however the function of these structures needs further analysis. (C) 2016 Elsevier Inc. All rights reserved.
C1 [ten Harkel, Bas; Koopsen, Jelle; Everts, Vincent] Univ Amsterdam, Dept Oral Cell Biol, Acad Ctr Dent Amsterdam ACTA, MOVE Res Inst Amsterdam, Gustav Mahlerlaan 3004, NL-1081 BT Amsterdam, Netherlands.
   [ten Harkel, Bas; Koopsen, Jelle; de Vries, Teun J.; Everts, Vincent] Vrije Univ Amsterdam, Gustav Mahlerlaan 3004, NL-1081 BT Amsterdam, Netherlands.
   [Koopsen, Jelle] AUC, Sci Pk 113, NL-1098 XG Amsterdam, Netherlands.
   [van Putten, Sander M.; Bank, Ruud A.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.
   [van Veen, Henk; Picavet, Daisy I.] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, Core Facil Cellular Imaging, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.
   [de Vries, Teun J.] Univ Amsterdam, Dept Periodontol, Acad Ctr Dent Amsterdam ACTA, MOVE Res Inst Amsterdam, Gustav Mahlerlaan 3004, NL-1081 BT Amsterdam, Netherlands.
RP ten Harkel, B (reprint author), Univ Amsterdam, Dept Oral Cell Biol, Acad Ctr Dent Amsterdam ACTA, MOVE Res Inst Amsterdam, Gustav Mahlerlaan 3004, NL-1081 BT Amsterdam, Netherlands.; ten Harkel, B (reprint author), Vrije Univ Amsterdam, Gustav Mahlerlaan 3004, NL-1081 BT Amsterdam, Netherlands.
EM b.t.harkel@acta.nl
OI de Vries, Teun/0000-0001-6464-5172; Koopsen, Jelle/0000-0002-5723-6933
FU Dutch government to The Netherlands Institute for Regenerative Medicine
   (NIRM) [1672802]
FX This work was supported by a grant from the Dutch government to The
   Netherlands Institute for Regenerative Medicine (NIRM, grant No.
   1672802).
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Chen E.H., 2011, CURRENT TOPICS MEMBR, P235
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P429
   Davison NL, 2014, BIOMATERIALS, V35, P7441, DOI 10.1016/j.biomaterials.2014.05.048
   Delgado LM, 2015, TISSUE ENG PART B-RE, V21, P298, DOI [10.1089/ten.teb.2014.0290, 10.1089/ten.TEB.2014.0290]
   Goodman SB, 2013, BIOMATERIALS, V34, P3174, DOI 10.1016/j.biomaterials.2013.01.074
   Jarman-Smith ML, 2004, J MATER SCI-MATER M, V15, P925, DOI 10.1023/B:JMSM.0000036281.47596.cc
   Khouw I.M., 1999, J BIOMED MATER RES, V50, P259
   McNally AK, 2015, J BIOMED MATER RES A, V103, P1380, DOI 10.1002/jbm.a.35280
   Miyamoto Takeshi, 2011, Keio Journal of Medicine, V60, P101
   Ramshaw JAM, 2009, J MATER SCI-MATER M, V20, P3, DOI 10.1007/s10856-008-3415-4
   ten Harkel B., 2015, PLOS ONE, V10, P1
   van Putten SM, 2013, ACTA BIOMATER, V9, P6502, DOI 10.1016/j.actbio.2013.01.022
   VANDERLAAN JS, 1991, INT J ARTIF ORGANS, V14, P661
   VANWACHEM PB, 1991, BIOMATERIALS, V12, P215, DOI 10.1016/0142-9612(91)90203-M
   VIGNERY A, 1989, J HISTOCHEM CYTOCHEM, V37, P1265, DOI 10.1177/37.8.2546991
   Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050615
   Ye QS, 2011, BIOMATERIALS, V32, P1339, DOI 10.1016/j.biomaterials.2010.09.076
NR 20
TC 1
Z9 1
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD JUL
PY 2016
VL 195
IS 1
BP 31
EP 40
DI 10.1016/j.jsb.2016.04.016
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA DO4ET
UT WOS:000377735300004
PM 27155321
DA 2018-10-19
ER

PT J
AU Passos, MF
   Dias, DRC
   Bastos, GNT
   Jardini, AL
   Benatti, ACB
   Dias, CGBT
   Maciel, R
AF Passos, M. F.
   Dias, D. R. C.
   Bastos, G. N. T.
   Jardini, A. L.
   Benatti, A. C. B.
   Dias, C. G. B. T.
   Maciel Filho, R.
TI pHEMA hydrogels Synthesis, kinetics and in vitro tests
SO JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY
LA English
DT Article
DE pHEMA; Hydrogel; Biomaterial; Calorimetry; Kinetic; In vitro tests
ID POLY(2-HYDROXYETHYL METHACRYLATE) PHEMA; CHEMICAL-VAPOR-DEPOSITION;
   HYALURONIC-ACID; 2-HYDROXYETHYL METHACRYLATE; GRAFT-COPOLYMERIZATION;
   CONTACT-LENS; POLYMERIZATION; NANOCOMPOSITES; DERIVATIVES; DELIVERY
AB Hydrogels of poly (2-hydroxyethyl methacrylate) (pHEMA) are suitable materials for medical applications. Synthesis, structural characterization, kinetic, physical properties and cell viability of these materials are reported in this article. The system was conducted via free radical polymerization in the absence of solvents or cross-linking agents. Hydrogels were obtained with excellent dimensional stability and high thermal stability (738 K), glass transition temperature of approximately 375 K and a degree of swelling of 66 +/- A 4 % in ethanol. The conversion of C=C double bond of the monomer 2-hydroxyethyl methacrylate was confirmed by Fourier transform infrared spectroscopy. Results showed dense and rough morphologies in the pHEMA, presence of high molecular interactions and good resistance to various organic solvents. In vitro tests showed excellent cell viability. The materials did not display cytotoxicity, and cells proliferated and adhered at a satisfactory rate on the hydrogel. These materials have great potential for biomedical application.
   pHEMA hydrogels are materials receiving great attention among researchers due to their ease of synthesis and biomedical application. This article demonstrates a new method of obtaining pHEMA hydrogels by bulk polymerization, in a single processing step and without the use of cross-linking agents. A kinetic study was evaluated, and the results of in vitro tests showed good cell proliferation.
   [GRAPHICS]
   .
C1 [Passos, M. F.; Jardini, A. L.; Benatti, A. C. B.; Maciel Filho, R.] Univ Estadual Campinas, Natl Inst Biofabricat, Sch Chem Engn, Campinas, SP, Brazil.
   [Dias, D. R. C.; Bastos, G. N. T.] Fed Univ Para, Neuroinflammat Lab, Inst Biol Sci, BR-66059 Belem, PA, Brazil.
   [Dias, C. G. B. T.] Fed Univ Para, Sch Mech Engn, Ecocomposites Lab, BR-66059 Belem, PA, Brazil.
RP Passos, MF (reprint author), Univ Estadual Campinas, Natl Inst Biofabricat, Sch Chem Engn, Campinas, SP, Brazil.
EM marcelepassos2004@yahoo.com.br
RI Jardini, Andre Luiz/N-9963-2016
OI Jardini, Andre Luiz/0000-0002-9381-9335; Bueno Benatti, Ana
   Carolina/0000-0002-3510-8439; Passos, Marcele/0000-0002-5616-2127
FU Sao Paulo Research Foundation (FAPESP) [2008/57860-3, 2011/18525-7];
   National Institute of Science and Technology in Biofabrication
   (BIOFABRIS); National Council of Technological and Scientific
   Development (CNPq) [573661/2008-1]
FX The authors gratefully acknowledge the Sao Paulo Research Foundation
   (FAPESP) (FAPESP Process 2008/57860-3 and 2011/18525-7), the National
   Institute of Science and Technology in Biofabrication (BIOFABRIS) and
   the National Council of Technological and Scientific Development (CNPq)
   (Process 573661/2008-1) for financial support.
CR Achilias DS, 2014, J THERM ANAL CALORIM, V116, P1379, DOI 10.1007/s10973-013-3633-y
   Achilias DS, 2010, J THERM ANAL CALORIM, V102, P451, DOI 10.1007/s10973-010-0935-1
   Bach LG, 2012, APPL SURF SCI, V253, P2816
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   Canevarolo JR SV, 2002, CIENCIA POLIMEROS TE, P56
   Canevarolo JR SV, 2002, CIENCIA POLIMEROS TE, P82
   Casimiro MH, 2013, MATER CHEM PHYS, V138, P11, DOI 10.1016/j.matchemphys.2012.11.061
   Chan K, 2005, LANGMUIR, V21, P8930, DOI 10.1021/la051004q
   Garcia-Moreno I, 2005, J PHYS CHEM B, V109, P21618, DOI 10.1021/jp058076a
   He CL, 2011, APPL SURF SCI, V258, P755, DOI 10.1016/j.apsusc.2011.08.074
   Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010
   Holmes RL, 2011, POLYMER, V20, P4471
   Hsieh YC, 2010, AEROSOL AIR QUAL RES, V10, P212, DOI 10.4209/aaqr.2009.08.0053
   Huang CW, 1997, J POLYM SCI POL CHEM, V35, P1873
   Jiang YJ, 2014, BIOMATERIALS, V35, P4969, DOI 10.1016/j.biomaterials.2014.03.001
   Kodama Y, 2014, RADIAT PHYS CHEM, V94, P98, DOI 10.1016/j.radphyschem.2013.07.016
   Nguyen MK, 2014, PROG POLYM SCI, V39, P1235, DOI 10.1016/j.progpolymsci.2013.12.001
   Morita S, 2004, VIB SPECTROSC, V35, P15, DOI 10.1016/j.vibspec.2003.11.020
   Morita S, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00010
   Morita S, 2009, VIB SPECTROSC, V51, P28, DOI 10.1016/j.vibspec.2008.09.008
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nogueira N, 2012, J COLLOID INTERF SCI, V385, P202, DOI 10.1016/j.jcis.2012.06.015
   Palumbo FS, 2015, CARBOHYD POLYM, V122, P408, DOI 10.1016/j.carbpol.2014.11.002
   Passos MF, 2015, CHEM ENGINEER TRANS, V43, P1459, DOI 10.3303/CET1543244
   Patel A, 2011, J BIOACT COMPAT POL, V26, P114, DOI 10.1177/0883911511398713
   Prestwich GD, 1998, J CONTROL RELEASE, V53, P93, DOI 10.1016/S0168-3659(97)00242-3
   Rantuch P., 2014, EUROPEAN J ENV SAFET, V2, P12
   Rezaei SM, 2011, POLYM TEST, V30, P69, DOI 10.1016/j.polymertesting.2010.07.013
   Ribeiro A, 2011, BIOMACROMOLECULES, V12, P701, DOI 10.1021/bm101562v
   Salmieri S, 2015, IND CROP PROD, V70, P64, DOI 10.1016/j.indcrop.2015.02.056
   Sbirrazzuoli N, 2002, THERMOCHIM ACTA, V388, P289, DOI 10.1016/S0040-6031(02)00053-9
   Silvestri B, 2009, J BIOMED MATER RES B, V89B, P369, DOI 10.1002/jbm.b.31225
   Singh A, 2015, CONTACT LENS ANTERIO, V38, P79, DOI 10.1016/j.clae.2014.09.002
   Sun YM, 1997, BIOMATERIALS, V18, P527, DOI 10.1016/S0142-9612(96)00166-4
   Sun YW, 2014, APPL SURF SCI, V320, P818, DOI 10.1016/j.apsusc.2014.09.085
   Tang Q, 2011, CURR APPL PHYS, V11, P945, DOI 10.1016/j.cap.2010.12.035
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
NR 37
TC 6
Z9 6
U1 8
U2 53
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-6150
EI 1572-8943
J9 J THERM ANAL CALORIM
JI J. Therm. Anal. Calorim.
PD JUL
PY 2016
VL 125
IS 1
BP 361
EP 368
DI 10.1007/s10973-016-5329-6
PG 8
WC Thermodynamics; Chemistry, Analytical; Chemistry, Physical
SC Thermodynamics; Chemistry
GA DO4YG
UT WOS:000377790200035
DA 2018-10-19
ER

PT J
AU Rossi, AM
   Saidel, WM
   Gravante, CJ
   Sayers, CW
   Shain, DH
AF Rossi, Anthony M.
   Saidel, William M.
   Gravante, Christopher J.
   Sayers, Charlene W.
   Shain, Daniel H.
TI Mechanics of cocoon secretion in a segmented worm (Annelida:
   Hirudinidae)
SO MICRON
LA English
DT Article
DE Clitellate; Reproduction; Biomaterial; Egg case; Operculum; Granule
ID THEROMYZON-TESSULATUM ANNELIDA; AQUATIC LEECH; GLOSSIPHONIIDAE;
   OLIGOCHAETA; ULTRASTRUCTURE; MEMBRANE
AB Clitellate annelids (e.g., segmented earthworms, leeches) secrete proteinaceous cocoons into which eggs are deposited. The process of cocoon production is characterized by the coordinated release of micro granules from secretory cells positioned asymmetrically within the clitellum. Collectively, these assemble into a tubular cocoon sheath that is sealed at either end by globular opercula. By transmission electron microscopy (TEM), we show here that granules destined to the cocoon operculum in the leech, Erpodbdella obscura, display a series of concentric rings surrounding a structureless core with dimensions approximating a single nanoglobule found in the operculum. Upon their channeling to the surface through narrow tubules, granules are secreted into the cocoon lumen where they appear to fragment upon contact with the operculum matrix. The distribution of partial concentric ring structures throughout the operculum suggests that granular fusion causes dynamic fragmentation of outer surface material, which thereafter integrates into operculum nanoglobules and cavities. Other granules within the same secretory cell display a punctate pattern and likely fuse with the cocoon sheath prior to crystallization. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Rossi, Anthony M.; Saidel, William M.; Gravante, Christopher J.; Sayers, Charlene W.; Shain, Daniel H.] Rutgers State Univ, Dept Biol, 315 Penn St, Camden, NJ 08102 USA.
   [Rossi, Anthony M.] NYU, Dept Biol, 100 Washington Sq East, New York, NY 10003 USA.
RP Shain, DH (reprint author), Rutgers State Univ, Dept Biol, 315 Penn St, Camden, NJ 08102 USA.
EM dshain@camden.rutgers.edu
OI Rossi, Anthony/0000-0001-9345-7939
FU NSF [DBI-0216233]
FX Supported by NSF grant DBI-0216233 to DHS.
CR Brumpt E, 1900, MEM SOC ZOOL FR, VXIII, P286
   Coleman J, 2008, J MORPHOL, V269, P812, DOI 10.1002/jmor.10624
   Dimitriu C, 2004, MICRON, V35, P281, DOI 10.1016/j.micron.2003.10.049
   Hess R.T., 1974, TISSUE CELL, V5, P503
   Hirao Y. h., 1965, Journal of the Faculty of Science Hokkaido University Zoology, V15, P625
   KNIGHT DP, 1974, COMP BIOCHEM PHYSIOL, V47, P871, DOI 10.1016/0300-9629(74)90462-9
   Lang SA, 2012, AM MIDL NAT, V167, P384, DOI 10.1674/0003-0031-167.2.384
   Marotta R, 2007, J STRUCT BIOL, V158, P336, DOI 10.1016/j.jsb.2006.12.009
   Mason TA, 2005, AM MIDL NAT, V154, P78, DOI 10.1674/0003-0031(2005)154[0078:CDAHIT]2.0.CO;2
   Mason TA, 2004, FEBS LETT, V561, P167, DOI 10.1016/S0014-5793(04)00167-X
   MORRIS GM, 1983, J MORPHOL, V177, P41, DOI 10.1002/jmor.1051770104
   RICHARDS KS, 1977, J ZOOL, V183, P161
   Rossi AM, 2013, J MORPHOL, V274, P940, DOI 10.1002/jmor.20150
   SAWYER RT, 1984, ZOOL J LINN SOC-LOND, V80, P303, DOI 10.1111/j.1096-3642.1984.tb01980.x
   Sayers CW, 2009, TISSUE CELL, V41, P35, DOI 10.1016/j.tice.2008.05.003
   Sheehan DC, 1980, THEORY PRACTICE HIST
   SUZUTANI C, 1977, Journal of the Faculty of Science Hokkaido University Series VI Zoology, V21, P1
   SUZUTANISHIOTA C, 1980, J MORPHOL, V164, P25, DOI 10.1002/jmor.1051640103
   WILKIALIS J, 1980, J ZOOL, V192, P421
NR 19
TC 2
Z9 2
U1 1
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-4328
J9 MICRON
JI Micron
PD JUL
PY 2016
VL 86
BP 30
EP 35
DI 10.1016/j.micron.2016.04.004
PG 6
WC Microscopy
SC Microscopy
GA DO5JZ
UT WOS:000377820700003
PM 27129037
OA Other Gold
DA 2018-10-19
ER

PT J
AU Park, HJ
   Min, KD
   Lee, MC
   Kim, SH
   Lee, OJ
   Ju, HW
   Moon, BM
   Lee, JM
   Park, YR
   Kim, DW
   Jeong, JY
   Park, CH
AF Park, Hyun Jung
   Min, Kyung Dan
   Lee, Min Chae
   Kim, Soo Hyeon
   Lee, Ok Joo
   Ju, Hyung Woo
   Moon, Bo Mi
   Lee, Jung Min
   Park, Ye Ri
   Kim, Dong Wook
   Jeong, Ju Yeon
   Park, Chan Hum
TI Fabrication of 3D porous SF/-TCP hybrid scaffolds for bone tissue
   reconstruction
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE -TCP; silk fibroin; bio-ceramic; tissue engineering; bone regeneration
ID CALVARIAL DEFECT MODEL; SILK FIBROIN; COMPOSITE SCAFFOLD; IONIC GELS;
   IN-VITRO; CELLS; BIOCOMPATIBILITY; BIOMATERIALS; REGENERATION
AB Bio-ceramic is a biomaterial actively studied in the field of bone tissue engineering. But, only certain ceramic materials can resolve the corrosion problem and possess the biological affinity of conventional metal biomaterials. Therefore, the recent development of composites of hybrid composites and polymers has been widely studied. In this study, we aimed to select the best scaffold of silk fibroin and -TCP hybrid for bone tissue engineering. We fabricated three groups of scaffold such as SF (silk fibroin scaffold), GS (silk fibroin/small granule size of -TCP scaffold) and GM (silk fibroin/medium granule size of -TCP scaffold), and we compared the characteristics of each group. During characterization of the scaffold, we used scanning electron microscopy (SEM) and a Fourier transform infrared spectroscopy (FTIR) for structural analysis. We compared the physiological properties of the scaffold regarding the swelling ratio, water uptake and porosity. To evaluate the mechanical properties, we examined the compressive strength of the scaffold. During in vitro testing, we evaluated cell attachment and cell proliferation (CCK-8). Finally, we confirmed in vivo new bone regeneration from the implanted scaffolds using histological staining and micro-CT. From these evaluations, the fabricated scaffold demonstrated high porosity with good inter-pore connectivity, showed good biocompatibility and high compressive strength and modulus. In particular, the present study indicates that the GM scaffold using -TCP accelerates new bone regeneration of implanted scaffolds. Accordingly, our scaffold is expected to act a useful application in the field of bone tissue engineering. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 1779-1787, 2016.
C1 [Park, Hyun Jung; Lee, Min Chae; Kim, Soo Hyeon; Lee, Ok Joo; Ju, Hyung Woo; Moon, Bo Mi; Lee, Jung Min; Park, Ye Ri; Kim, Dong Wook; Jeong, Ju Yeon; Park, Chan Hum] Hallym Univ, Nanobio Regenerat Med Inst, Gangwon 200702, South Korea.
   [Park, Chan Hum] Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Gangwon 200704, South Korea.
   [Min, Kyung Dan] CGbio Corp, Inst Res & Dev, Songnam, South Korea.
RP Park, CH (reprint author), Hallym Univ, Nanobio Regenerat Med Inst, Gangwon 200702, South Korea.; Park, CH (reprint author), Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Gangwon 200704, South Korea.
EM hlpch@paran.com
RI Park, Chan Hum/C-6848-2016
FU Hallym University Research Fund; Ministry for Food, Agriculture,
   Forestry and Fisheries, Republic of Korea [Bio-industry Technology
   Development (1120 07-05-4-SB010)]
FX Contract grant sponsor: Hallym University Research Fund; Contract grant
   sponsor: Ministry for Food, Agriculture, Forestry and Fisheries,
   Republic of Korea; contract grant number: Bio-industry Technology
   Development (1120 07-05-4-SB010)
CR Cao H, 2010, BONE, V46, P386, DOI 10.1016/j.bone.2009.09.031
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Develioglu H, 2009, DENT MATER J, V28, P396, DOI 10.4012/dmj.28.396
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Hui Fan J, 2014, BIOMED RES INT, V2014
   Ju HW, 2014, J BIOMED MATER RES A, V102, P2713, DOI 10.1002/jbm.a.34947
   Kim SH, 2015, J BIOACT COMPAT POL, V30, P178, DOI 10.1177/0883911514566015
   Lee JH, 2013, J MATER SCI-MATER M, V24, P2117, DOI 10.1007/s10856-013-4967-5
   Lee Y, 1997, J MEMBRANE SCI, V130, P149, DOI 10.1016/S0376-7388(97)00017-3
   Lou T, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-014-5366-2
   Misch CE, 1999, J ORAL MAXIL SURG, V57, P700, DOI 10.1016/S0278-2391(99)90437-8
   Mobini S, 2013, J MED BIOL ENG, V33, P207, DOI 10.5405/jmbe.1065
   Mohd Al Amin Muhamad N, 2009, J NUCL RELATED TECHN, V6, P1
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Park CH., 2014, J BIOMED MAT RES A
   Park HJ, 2015, INT J BIOL MACROMOL, V78, P215, DOI 10.1016/j.ijbiomac.2015.03.064
   RICKA J, 1984, MACROMOLECULES, V17, P2916, DOI 10.1021/ma00142a081
   Salinas AJ, 2013, BIOMATER SCI-UK, V1, P40, DOI 10.1039/c2bm00071g
   Spicer PP, 2012, NAT PROTOC, V7, P1918, DOI 10.1038/nprot.2012.113
   TANAKA T, 1980, PHYS REV LETT, V45, P1636, DOI 10.1103/PhysRevLett.45.1636
   Tang X, 2009, J BIOMED MATER RES A, V91A, P166, DOI 10.1002/jbm.a.32212
   Umoh JU, 2009, PHYS MED BIOL, V54, P2147, DOI 10.1088/0031-9155/54/7/020
   Wang J, 1999, CALCIFIED TISSUE INT, V65, P486, DOI 10.1007/s002239900737
   Weinand C, 2006, BONE, V38, P555, DOI 10.1016/j.bone.2005.10.016
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   유경훈, 2010, [Journal of Life Science, 생명과학회지], V20, P1207
NR 26
TC 5
Z9 5
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2016
VL 104
IS 7
BP 1779
EP 1787
DI 10.1002/jbm.a.35711
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DO1FW
UT WOS:000377524900022
PM 26999521
DA 2018-10-19
ER

PT J
AU Lotfi, G
   Shokrgozar, MA
   Mofid, R
   Abbas, FM
   Ghanavati, F
   Baghban, AA
   Yavari, SK
   Pajoumshariati, S
AF Lotfi, Ghogha
   Shokrgozar, Mohammad Ali
   Mofid, Rasoul
   Abbas, Fatemeh Mashhadi
   Ghanavati, Farzin
   Baghban, Alireza Akbarzadeh
   Yavari, Seyedeh Kimia
   Pajoumshariati, Seyedramin
TI Biological Evaluation (In Vitro and In Vivo) of Bilayered Collagenous
   Coated (Nano Electrospun and Solid Wall) Chitosan Membrane for
   Periodontal Guided Bone Regeneration
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Chitosan; Collagen; Electrospun nanofiber; Solid wall; MSC
   differentiation; Guided bone regeneration membrane
ID MARROW STROMAL CELLS; OSTEOBLAST DIFFERENTIATION; OSTEOGENIC
   DIFFERENTIATION; TRANSCRIPTION FACTOR; EXTRACELLULAR-MATRIX; TISSUE
   REGENERATION; EXPRESSION; DEFECTS; RATS; COMPOSITES
AB The application of barrier membranes in guided bone regeneration (GBR) has become a commonly used surgical technique in periodontal research. The objectives of this study were to evaluate the in vitro biocompatibility and osteogenic differentiation of mesenchymal stem cells (MSCs) on two different collagenous coatings (nano electrospun fibrous vs. solid wall) of bilayered collagen/chitosan membrane and their histological evaluation on bone regeneration in rabbit calvarial defects. It was found that chitosan-nano electrospun collagen (CNC) membranes had higher proliferation/metabolic activity compared to the chitosan-collagen (CC) and pristine chitosan membranes. The qRT-PCR analysis demonstrated the CNC membranes induced significant expression of osteogenic genes (Osteocalcin, RUNX2 and Col-alpha 1) in MSCs. Moreover, higher calcium content and alkaline phosphatase activity of MSCs were observed compared to the other groups. Histologic and histomorphometric evaluations were performed on the uncovered (negative control) as well as covered calvarial defects of ten adult white rabbits with different membranes (CNC, CC, BioGide (BG, positive control)) at 1 and 2 months after surgery. More bone formation was detected in the defects covered with CNC and BG membranes than those covered by CC and the negative control. No inflammation and residual biomaterial particles were observed on the membrane surface or in the surrounding tissues in the surgical areas. These results suggest that bilayer CNC membrane can have the potential for use as a GBR membrane material facilitating bone formation.
C1 [Lotfi, Ghogha; Mofid, Rasoul; Ghanavati, Farzin] Shahid Beheshti Univ Med Sci, Dent Res Ctr, Tehran, Iran.
   [Lotfi, Ghogha; Mofid, Rasoul] Shahid Beheshti Univ Med Sci, Sch Dent, Dept Periodontol, Tehran, Iran.
   [Shokrgozar, Mohammad Ali; Yavari, Seyedeh Kimia] Pasteur Inst Iran, Natl Cell Bank Iran, Tehran, Iran.
   [Abbas, Fatemeh Mashhadi] Shahid Beheshti Univ Med Sci, Dept Pathol, Tehran, Iran.
   [Baghban, Alireza Akbarzadeh] Shahid Beheshti Univ Med Sci, Sch Rehabil Sci, Prote Res Ctr, Dept Basic Sci, Tehran, Iran.
   [Pajoumshariati, Seyedramin] Shahid Beheshti Univ, Med Plants & Drugs Res Inst, Dept Chem Engn, Tehran 1983963113, Iran.
   [Pajoumshariati, Seyedramin] Univ S Carolina, Dept Chem Engn, Columbia, SC 29208 USA.
RP Pajoumshariati, S (reprint author), Univ S Carolina, Dept Chem Engn, Columbia, SC 29208 USA.
EM pajoumsh@cec.sc.edu
RI shokrgozar, mohammad ali/L-4149-2017
OI shokrgozar, mohammad ali/0000-0001-5123-4155; Mashhadi Abbas,
   Fatemeh/0000-0002-8711-2843
FU Dental Research Center, Shahid Beheshti University of Medical Sciences,
   Tehran, Iran
FX This work was supported by research grant from Dental Research Center,
   Shahid Beheshti University of Medical Sciences, Tehran, Iran. The
   authors thank Dr. Davood Sharifi, an animal researcher at the faculty of
   Veterinary Medicine of Tehran University, for his assistance in the
   study.
CR Allori AC, 2008, TISSUE ENG PART B-RE, V14, P275, DOI 10.1089/ten.teb.2008.0083
   Arpornmaeklong P, 2008, INT J ORAL MAX SURG, V37, P357, DOI 10.1016/j.ijom.2007.11.014
   Arpornmaeklong P, 2007, INT J ORAL MAX SURG, V36, P328, DOI 10.1016/j.ijom.2006.09.023
   Borges GJ, 2009, CLIN ORAL IMPLAN RES, V20, P1105, DOI 10.1111/j.1600-0501.2009.01731.x
   Bottino MC, 2012, DENT MATER, V28, P703, DOI 10.1016/j.dental.2012.04.022
   Bottino MC, 2011, ACTA BIOMATER, V7, P216, DOI 10.1016/j.actbio.2010.08.019
   Boynuegri D, 2009, J BIOMED MATER RES B, V90B, P461, DOI 10.1002/jbm.b.31307
   Bumgardner JD, 2007, IMPLANT DENT, V16, P66, DOI 10.1097/ID.0b013e3180312011
   BUSER D, 1999, PERIODONTOLOGY, P151
   Buser D., 1994, GUIDED BONE REGENERA
   Cai YZ, 2010, J BIOMED MATER RES A, V95A, P49, DOI 10.1002/jbm.a.32816
   Chen JP, 2008, COLLOID SURFACE A, V313, P183, DOI 10.1016/j.colsurfa.2007.04.129
   Chen VJ, 2006, BIOMATERIALS, V27, P3973, DOI 10.1016/j.biomaterials.2006.02.043
   Chen ZG, 2010, ACTA BIOMATER, V6, P372, DOI 10.1016/j.actbio.2009.07.024
   Chen ZG, 2008, CARBOHYD POLYM, V72, P410, DOI 10.1016/j.carbpol.2007.09.018
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0
   Dupoirieux L, 2001, INT J ORAL MAX SURG, V30, P58, DOI 10.1054/ijom.2000.0011
   Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369
   FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843
   Gomes PS, 2011, LAB ANIM-UK, V45, P14, DOI 10.1258/la.2010.010085
   Jayaraman K, 2004, J NANOSCI NANOTECHNO, V4, P52, DOI 10.1166/jnn.2004.078
   Jung UW, 2007, BIOMED MATER, V2, pS101, DOI 10.1088/1748-6041/2/3/S03
   Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15
   Klokkevold PR, 1996, J PERIODONTOL, V67, P1170, DOI 10.1902/jop.1996.67.11.1170
   Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958
   Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Kung S, 2011, J PERIODONTAL RES, V46, P126, DOI 10.1111/j.1600-0765.2010.01322.x
   Kuo SM, 2006, J BIOMED MATER RES A, V76A, P408, DOI 10.1002/jbm.a.30534
   Li XM, 2005, POLYM INT, V54, P1034, DOI [10.1002/pi.1804, 10.1002/pi.l804]
   Liao S, 2005, BIOMATERIALS, V26, P7564, DOI 10.1016/j.biomaterials.2005.05.050
   Long MW, 2001, BLOOD CELL MOL DIS, V27, P677, DOI 10.1006/bcmd.2001.0431
   Malette W.G., 1986, CHITIN NATURE TECHNO, P435
   Mathews S, 2011, CELL PROLIFERAT, V44, P537, DOI 10.1111/j.1365-2184.2011.00788.x
   Newman MG, 2011, CARRANZAS CLIN PERIO
   Pajoumshariati S, 2016, ANN BIOMED ENG, V44, P1808, DOI 10.1007/s10439-015-1478-1
   Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030
   Park YJ, 2006, BIOTECHNOL APPL BIOC, V43, P17, DOI 10.1042/BA20050075
   Retzepi M, 2010, CLIN ORAL IMPLAN RES, V21, P567, DOI 10.1111/j.1600-0501.2010.01922.x
   Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011
   Sell SA, 2009, ADV DRUG DELIVER REV, V61, P1007, DOI 10.1016/j.addr.2009.07.012
   Shin SY, 2005, J PERIODONTOL, V76, P1778, DOI 10.1902/jop.2005.76.10.1778
   Sionkowska A, 2004, BIOMATERIALS, V25, P795, DOI 10.1016/S0142-9612(03)00595-7
   Song JH, 2007, J BIOMED MATER RES B, V83B, P248, DOI 10.1002/jbm.b.30790
   Spector JA, 2001, PLAST RECONSTR SURG, V107, P124, DOI 10.1097/00006534-200101000-00018
   Temenoff JS, 2004, J BIOMED MATER RES A, V70A, P235, DOI 10.1002/jbm.a.30064
   Teng SH, 2008, J BIOMED MATER RES B, V87B, P132, DOI 10.1002/jbm.b.31082
   Thein-Han WW, 2008, MATER SCI TECH-LOND, V24, P1062, DOI 10.1179/174328408X341753
   Thirunavukkarasu K, 2000, J BIOL CHEM, V275, P25163, DOI 10.1074/jbc.M000322200
   Timnak A, 2011, J MATER SCI-MATER M, V22, P1555, DOI 10.1007/s10856-011-4316-5
   Woo KM, 2007, BIOMATERIALS, V28, P335, DOI 10.1016/j.biomaterials.2006.06.013
   XIANMIAO C, 2009, MAT SCI ENG C, V29, P29, DOI DOI 10.1016/J.MSEC.2008.05.008
   Young M. F., 2003, Osteoporosis International, V14, P35
   Zhang C, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-37
   Zhu JX, 2001, HISTOCHEM J, V33, P25, DOI 10.1023/A:1017587712914
NR 56
TC 4
Z9 4
U1 5
U2 49
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUL
PY 2016
VL 44
IS 7
BP 2132
EP 2144
DI 10.1007/s10439-015-1516-z
PG 13
WC Engineering, Biomedical
SC Engineering
GA DN9YW
UT WOS:000377437600004
PM 26586588
DA 2018-10-19
ER

PT J
AU Stevenson, G
   Rehman, S
   Draper, E
   Hernandez-Nava, E
   Hunt, J
   Haycock, JW
AF Stevenson, G.
   Rehman, S.
   Draper, E.
   Hernandez-Nava, E.
   Hunt, J.
   Haycock, J. W.
TI Combining 3D human in vitro methods for a 3Rs evaluation of novel
   titanium surfaces in orthopaedic applications
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE additive manufacturing; in vitro test; osteoblast; plasma spraying;
   surface topography; titanium alloy
ID BIOACTIVE GLASS SCAFFOLD; HUMAN OSTEOBLASTS; HYDROXYAPATITE COATINGS;
   BIOLOGICAL RESPONSE; NODULE FORMATION; BONE INGROWTH; IMPLANTS; CELLS;
   MINERALIZATION; ALLOY
AB In this study, we report on a group of complementary human osteoblast in vitro test methods for the preclinical evaluation of 3D porous titanium surfaces. The surfaces were prepared by additive manufacturing (electron beam melting [EBM]) and plasma spraying, allowing the creation of complex lattice surface geometries. Physical properties of the surfaces were characterized by SEM and profilometry and 3D in vitro cell culture using human osteoblasts. Primary human osteoblast cells were found to elicit greater differences between titanium sample surfaces than an MG63 osteoblast-like cell line, particularly in terms of cell survival. Surface morphology was associated with higher osteoblast metabolic activity and mineralization on rougher titanium plasma spray coated surfaces than smoother surfaces. Differences in osteoblast survival and metabolic activity on titanium lattice structures were also found, despite analogous surface morphology at the cellular level. 3D confocal microscopy identified osteoblast organization within complex titanium surface geometries, adhesion, spreading, and alignment to the biomaterial strut geometries. Mineralized nodule formation throughout the lattice structures was also observed, and indicative of early markers of bone in-growth on such materials. Testing methods such as those presented are not traditionally considered by medical device manufacturers, but we suggest have value as an increasingly vital tool in efficiently translating pre-clinical studies, especially in balance with current regulatory practice, commercial demands, the 3Rs, and the relative merits of in vitro and in vivo studies. Biotechnol. Bioeng. 2016;113: 1586-1599. (c) 2015 The Authors. Biotechnology and Bioengineering Published by Wiley Periodicals, Inc.
C1 [Stevenson, G.; Rehman, S.; Draper, E.] JRI Orthopaed Ltd, Sheffield, S Yorkshire, England.
   [Hernandez-Nava, E.; Hunt, J.] Univ Sheffield, Mercury Ctr, Sheffield S3 7HQ, S Yorkshire, England.
   [Haycock, J. W.] Univ Sheffield, Dept Mat Sci & Engn, Sheffield S3 7HQ, S Yorkshire, England.
RP Haycock, JW (reprint author), Univ Sheffield, Dept Mat Sci & Engn, Sheffield S3 7HQ, S Yorkshire, England.
EM j.w.haycock@sheffield.ac.uk
OI Hernandez-Nava, Everth/0000-0002-6414-3313
FU JRI Orthopaedics Ltd.; Innovate U.K.; EPSRC; BBSRC; Department of Health
   through the Knowledge Transfer Partnership Scheme, U.K. [KTP008411]
FX Contract grant sponsor: JRI Orthopaedics Ltd.; Contract grant sponsor:
   Innovate U.K. (formerly the Technology Strategy Board); Contract grant
   sponsor: EPSRC; Contract grant sponsor: BBSRC; Contract grant sponsor:
   Department of Health through the Knowledge Transfer Partnership Scheme,
   U.K.; Contract grant number: KTP008411
CR Balani K, 2007, BIOMATERIALS, V28, P618, DOI 10.1016/j.biomaterials.2006.09.013
   Biemond JE, 2011, J MATER SCI-MATER M, V22, P917, DOI 10.1007/s10856-011-4256-0
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Chang YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095590
   DAVID A, 1995, ARCH ORTHOP TRAUM SU, V114, P112, DOI 10.1007/BF00422838
   Eitel E, 2013, FUTURE ADDITIVE MANU
   Georgakoudi I, 2008, TISSUE ENG PART B-RE, V14, P321, DOI 10.1089/ten.teb.2008.0248
   Gittens RA, 2011, BIOMATERIALS, V32, P3395, DOI 10.1016/j.biomaterials.2011.01.029
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   Grigoriou V, 2005, J BIOL CHEM, V280, P1733, DOI 10.1074/jbc.M402550200
   Hearnden V, 2011, METHODS MOL BIOL, V695, P41, DOI 10.1007/978-1-60761-984-0_3
   Heinl P, 2007, ADV ENG MATER, V9, P360, DOI 10.1002/adem.200700025
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Jones JR, 2007, BIOMATERIALS, V28, P1653, DOI 10.1016/j.biomaterials.2006.11.022
   Kienapfel H, 1999, J ARTHROPLASTY, V14, P355, DOI 10.1016/S0883-5403(99)90063-3
   Levine B, 2008, ADV ENG MATER, V10, P788, DOI 10.1002/adem.200800215
   Madhankumar A, 2014, J MATER SCI, V49, P4067, DOI 10.1007/s10853-014-8094-6
   McLaughlin JR, 2011, J ARTHROPLASTY, V26, P9, DOI 10.1016/j.arth.2009.11.021
   Murr LE, 2012, INT J BIOMATER, V2012, DOI DOI 10.1155/2012/245727
   NC3Rs, 2014, CTR REPL REF RED AN
   NJR, 2014, NAT JOINT REG STAT
   Northgate, 2014, COMPL PROT PAT SUPP
   Parthasarathy J, 2010, J MECH BEHAV BIOMED, V3, P249, DOI 10.1016/j.jmbbm.2009.10.006
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   Russell WMS, 1959, PRINCIPLES HUMANE EX
   Sammons RL, 2011, SURFACE MODIFICATION, P365
   Schmidt C, 2001, J BIOMED MATER RES, V54, P209, DOI 10.1002/1097-4636(200102)54:2<209::AID-JBM7>3.0.CO;2-7
   Stubinger S, 2013, J BIOMED MATER RES B, V101, P1154, DOI 10.1002/jbm.b.32925
   Tan F, 2011, BIOTECHNOL BIOENG, V108, P454, DOI 10.1002/bit.22955
   Thomsen P, 2009, J BIOMED MATER RES B, V90B, P35, DOI 10.1002/jbm.b.31250
   van Noort R, 2012, DENT MATER, V28, P3, DOI 10.1016/j.dental.2011.10.014
   Wang YH, 2006, BIOTECHNOL PROGR, V22, P1697, DOI 10.1021/bp060274b
   Yazici H, 2013, ACTA BIOMATER, V9, P5341, DOI 10.1016/j.actbio.2012.11.004
   Yeung WK, 2013, J BIOMED MATER RES B, V101B, P939, DOI 10.1002/jbm.b.32899
NR 34
TC 4
Z9 4
U1 1
U2 34
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
EI 1097-0290
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD JUL
PY 2016
VL 113
IS 7
BP 1586
EP 1599
DI 10.1002/bit.25919
PG 14
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DO1HA
UT WOS:000377527900021
PM 26702609
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Zhong, QW
   Li, WH
   Su, XP
   Li, G
   Zhou, Y
   Kundu, SC
   Yao, JM
   Cai, YR
AF Zhong, Qiwei
   Li, Wenhua
   Su, Xiuping
   Li, Geng
   Zhou, Ying
   Kundu, Subhas C.
   Yao, Juming
   Cai, Yurong
TI Degradation pattern of porous CaCO3 and hydroxyapatite microspheres in
   vitro and in vivo for potential application in bone tissue engineering
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Hydroxyapatite; Microspheres; Degradation; Injectable composite; Bone
   tissue engineering
ID CALCIUM-PHOSPHATE CEMENT; MESENCHYMAL STEM-CELLS; OSTEOGENIC
   DIFFERENTIATION; MECHANICAL-PROPERTIES; TRICALCIUM PHOSPHATE;
   GROWTH-FACTORS; SILK SERICIN; COMPOSITE; DELIVERY; REGENERATION
AB Despite superior clinical handling, excellent biocompatibility, biodegradation property of calcium phosphate needs to be improved to coincide with the rate of new bone formation. In this study, spherical CaCO3 are fabricated in the presence of the silk sericin and then transformed into porous hydroxyapatite (HAP) microspheres via hydrothermal method. The degradation behavior of obtained CaCO3, HAP and their mixture is first investigated in vitro. The result demonstrates that the weight loss of HAP microspheres are almost 24.3% after immersing in pH 7.40 Tris-HCl buffer solution for 12 weeks, which is far slower than that of spherical CaCO3 (97.5%). The degradation speed of the mixtures depends on the proportion of CaCO3 and HAP. The mixture with higher content of CaCO3 possesses a quicker degradation speed. The obtained CaCO3 and HAP microspheres are injected into subcutaneous tissue of ICR mice with the assistance of sodium alginate. The result in vivo also shows an obvious difference of degradation speed between the obtained CaCO3 and HAP microspheres, implying it is feasible to modulate the degradation property of the mixture through changing the proportion of CaCO3 and HAP The good cytocompatibility of the two kinds of microspheres is proved and a mild inflammation response is observed only at early stage of implantation. The job offers a simple method to modify the degradation properties of biomaterial for potential use in bone tissue engineering. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Zhong, Qiwei; Li, Wenhua; Su, Xiuping; Li, Geng; Zhou, Ying; Yao, Juming; Cai, Yurong] Zhejiang Sci Tech Univ, Key Lab Adv Text Mat & Mfg Technol, Natl Engn Lab Text Fiber Mat & Proc Technol, Minist Educ,Coll Mat & Text, Hangzhou 310018, Peoples R China.
   [Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Cai, YR (reprint author), Zhejiang Sci Tech Univ, Key Lab Adv Text Mat & Mfg Technol, Natl Engn Lab Text Fiber Mat & Proc Technol, Minist Educ,Coll Mat & Text, Hangzhou 310018, Peoples R China.
EM caiyr@zstu.edu.cn
RI Yao, Juming/N-7886-2014
OI Kundu, Subhas C./0000-0002-7170-2291
FU National Natural Science Foundation of China [51202219, 51372226];
   Zhejiang Provincial Natural Science Foundation of China [LY16E020013];
   Zhejiang Top Priority Discipline of Textile Science and Engineering
FX The authors acknowledge the support of National Natural Science
   Foundation of China (51202219 and 51372226), Zhejiang Provincial Natural
   Science Foundation of China (LY16E020013) and Zhejiang Top Priority
   Discipline of Textile Science and Engineering. SCK is grateful for the
   hospitality provided during his short visit to the laboratory of College
   of Materials and Textiles, Zhejiang Sci-Tech University.
CR He FP, 2012, J BIOMED MATER RES A, V100A, P3239, DOI 10.1002/jbm.a.34265
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Kasuya A, 2012, J ORTHOP RES, V30, P1103, DOI 10.1002/jor.22044
   Kovtun A, 2015, ACTA BIOMATER, V12, P242, DOI 10.1016/j.actbio.2014.10.034
   Kundu B, 2014, PROG POLYM SCI, V39, P251, DOI 10.1016/j.progpolymsci.2013.09.002
   Kurashina K, 2002, BIOMATERIALS, V23, P407, DOI 10.1016/S0142-9612(01)00119-3
   Liao HH, 2000, BIOMATERIALS, V21, P457, DOI 10.1016/S0142-9612(99)00184-2
   Lin HR, 2004, J BIOMED MATER RES B, V71B, P52, DOI 10.1002/b.30065
   Lin LZ, 2014, MATER LETT, V126, P154, DOI 10.1016/j.matlet.2014.04.028
   Link DP, 2009, J BIOMED MATER RES A, V90A, P372, DOI 10.1002/jbm.a.32091
   Liu J, 2013, MATER LETT, V110, P221, DOI 10.1016/j.matlet.2013.08.021
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Miao TX, 2014, J CONTROL RELEASE, V192, P57, DOI 10.1016/j.jconrel.2014.06.029
   Monchau F, 2002, BIOMOL ENG, V19, P143, DOI 10.1016/S1389-0344(02)00023-0
   Murakami K, 2010, BIOMATERIALS, V31, P83, DOI 10.1016/j.biomaterials.2009.09.031
   Ni P, 2014, BIOMATERIALS, V35, P236, DOI 10.1016/j.biomaterials.2013.10.016
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Nilsson M, 2004, J BONE JOINT SURG BR, V86B, P120, DOI 10.1302/0301-620X.86B1.14040
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   POUMARAT G, 1993, BIOMATERIALS, V14, P337, DOI 10.1016/0142-9612(93)90051-3
   Ribeiro CC, 2004, BIOMATERIALS, V25, P4363, DOI 10.1016/j.biomaterials.2003.11.028
   Ruhe PQ, 2006, TISSUE ENG, V12, P789, DOI 10.1089/ten.2006.12.789
   Santo VE, 2013, TISSUE ENG PART B-RE, V19, P308, DOI [10.1089/ten.teb.2012.0138, 10.1089/ten.TEB.2012.0138]
   Sui C, 2013, CRYST GROWTH DES, V13, P3201, DOI 10.1021/cg400595s
   Sun XQ, 2013, BIOMATERIALS, V34, P4971, DOI 10.1016/j.biomaterials.2013.03.015
   Tan RW, 2010, POLYM DEGRAD STABIL, V95, P1736, DOI 10.1016/j.polymdegradstab.2010.05.015
   Ventura M, 2014, BIOMATERIALS, V35, P2227, DOI 10.1016/j.biomaterials.2013.11.084
   Walsh WR, 2003, J ORTHOP RES, V21, P655, DOI 10.1016/S0736-0266(03)00012-3
   Wang YY, 2010, POLYM DEGRAD STABIL, V95, P207, DOI 10.1016/j.polymdegradstab.2009.11.023
   Wu J, 2013, MINI-REV MED CHEM, V13, P1501
   Xie CM, 2014, ACS APPL MATER INTER, V6, P8580, DOI 10.1021/am501428e
   Xu HHK, 2005, BIOMATERIALS, V26, P1337, DOI 10.1016/j.biomaterials.2004.04.043
   Yang MY, 2014, BIOMACROMOLECULES, V15, P1185, DOI 10.1021/bm401740x
   Zhang J, 2010, ACTA BIOMATER, V6, P445, DOI 10.1016/j.actbio.2009.07.001
   Zhi H., 2009, BIOMED MATER, V4
NR 35
TC 8
Z9 10
U1 12
U2 70
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JUL 1
PY 2016
VL 143
BP 56
EP 63
DI 10.1016/j.colsurfb.2016.03.020
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA DM9OZ
UT WOS:000376696900007
PM 26998866
DA 2018-10-19
ER

PT J
AU Wang, XW
   Hu, HW
   Wang, WY
   Lee, KI
   Gao, C
   He, L
   Wang, YF
   Lai, CL
   Fei, B
   Xin, JH
AF Wang, Xiaowen
   Hu, Huawen
   Wang, Wenyi
   Lee, Ka I.
   Gao, Chang
   He, Liang
   Wang, Yuanfeng
   Lai, Chuilin
   Fei, Bin
   Xin, John H.
TI Antibacterial modification of an injectable, biodegradable,
   non-cytotoxic block copolymer-based physical gel with body
   temperature-stimulated sol-gel transition and controlled drug release
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Antibacterial modification; MPEG-PCL-DMA-PCL-mPEG block copolymers;
   Sol-gel-sol transition; Crystallinity; Amphiphilic balance
ID PEG-PCL-PEG; THERMOSENSITIVE HYDROGEL; BIOMEDICAL APPLICATIONS;
   MOLECULAR-WEIGHT; CLICK CHEMISTRY; MICELLES; GRAPHENE; COMPOSITE;
   CYCLODEXTRIN; FLUORESCENCE
AB Biomaterials are being extensively used in various biomedical fields; however, they are readily infected with microorganisms, thus posing a serious threat to the public health care. We herein presented a facile route to the antibacterial modification of an important A-B-A type biomaterial using poly (ethylene glycol) methyl ether (mPEG)-poly(epsilon-caprolactone) (PCL)-mPEG as a typical model. Inexpensive, commercial bis(2-hydroxyethyl) methylammonium chloride (DMA) was adopted as an antibacterial unit. The effective synthesis of the antibacterial copolymer mPEG-PCL-similar to similar to similar to-PCL-mPEG (where similar to similar to similar to denotes the segment with DMA units) was well confirmed by FTIR and H-1 NMR spectra. At an appropriate modification extent, the DMA unit could render the copolymer mPEG-PCL-similar to similar to similar to-PCL-mPEG highly antibacterial, but did not largely alter its fascinating intrinsic properties including the thermosensitivity (e.g., the body temperature-induced sol-gel transition), non-cytotoxicity, and controlled drug release. A detailed study on the sol-gel-sol transition behavior of different copolymers showed that an appropriate extent of modification with DMA retained a sol-gel-sol transition, despite the fact that a too high extent caused a loss of sol-gel-sol transition. The hydrophilic and hydrophobic balance between mPEG and PCL was most likely broken upon a high extent of quaternization due to a large disturbance effect of DMA units at a large quantity (as evidenced by the heavily depressed PCL segment crystallinity), and thus the micelle aggregation mechanism for the gel formation could not work anymore, along with the loss of the thermosensitivity. The work presented here is highly expected to be generalized for synthesis of various block copolymers with immunity to microorganisms. Light may also be shed on understanding the phase transition behavior of various multiblock copolymers. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Wang, Xiaowen; Hu, Huawen; Wang, Wenyi; Lee, Ka I.; Gao, Chang; He, Liang; Wang, Yuanfeng; Lai, Chuilin; Fei, Bin; Xin, John H.] Hong Kong Polytech Univ, Inst Text & Clothing, Nanotechnol Ctr, Hong Kong, Hong Kong, Peoples R China.
RP Fei, B; Xin, JH (reprint author), Hong Kong Polytech Univ, Inst Text & Clothing, Nanotechnol Ctr, Hong Kong, Hong Kong, Peoples R China.
EM tcxinjh@polyu.edu.hk
RI fei, bin/A-9594-2009
OI fei, bin/0000-0002-4274-1873; Wang, Yuanfeng/0000-0002-1167-804X; XIN,
   John Haozhong/0000-0001-9965-7421
FU Research Grants Council of the Hong Kong SAR Government [PolyU 5316/10E]
FX We greatly appreciate the PolyU 5316/10E funding from Research Grants
   Council of the Hong Kong SAR Government.
CR Alexander A, 2013, J CONTROL RELEASE, V172, P715, DOI 10.1016/j.jconrel.2013.10.006
   Anzai R, 2015, COLLOID SURFACE B, V127, P292, DOI 10.1016/j.colsurfb.2015.01.028
   Cai MT, 2015, COLLOID SURFACE B, V126, P1, DOI 10.1016/j.colsurfb.2014.12.005
   Chen L, 2015, MACROMOLECULES, V48, P3662, DOI 10.1021/acs.macromol.5b00168
   Chen L, 2014, MACROMOLECULES, V47, P5895, DOI 10.1021/ma501110p
   Cui C, 2015, COLLOID SURFACE B, V129, P137, DOI 10.1016/j.colsurfb.2015.03.040
   Du H, 2014, POLYM CHEM-UK, V5, P4002, DOI 10.1039/c4py00030g
   Ferruti P, 2003, BIOMACROMOLECULES, V4, P181, DOI 10.1021/bm020115q
   Gong CY, 2013, J BIOMED NANOTECHNOL, V9, P1984, DOI 10.1166/jbn.2013.1754
   Gong CY, 2009, J BIOMED MATER RES B, V91B, P26, DOI 10.1002/jbm.b.31370
   Gong CY, 2009, INT J PHARM, V365, P89, DOI 10.1016/j.ijpharm.2008.08.027
   Gou QH, 2015, COLLOID SURFACE B, V126, P26, DOI 10.1016/j.colsurfb.2014.12.012
   Han Q, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5556-6
   Hu HW, 2013, CHEMPLUSCHEM, V78, P1483, DOI 10.1002/cplu.201300124
   Hu HW, 2015, NANO RES, V8, P3992, DOI 10.1007/s12274-015-0902-z
   Hu HW, 2015, CHEM COMMUN, V51, P16699, DOI 10.1039/c5cc05826k
   Hu HW, 2015, J MATER CHEM A, V3, P11157, DOI 10.1039/c5ta00753d
   Hu HW, 2015, APPL CATAL A-GEN, V492, P1, DOI 10.1016/j.apcata.2014.11.041
   Hu HW, 2014, J MATER CHEM A, V2, P11319, DOI 10.1039/c4ta01620c
   Hu HW, 2014, MOLECULES, V19, P7459, DOI 10.3390/molecules19067459
   Hu HW, 2014, NANO RES, V7, P418, DOI 10.1007/s12274-014-0408-0
   Hu HW, 2013, CARBOHYD POLYM, V91, P305, DOI 10.1016/j.carbpol.2012.08.038
   Hu YX, 2015, NANO RES, V8, P611, DOI 10.1007/s12274-015-0732-z
   Hwang MJ, 2005, BIOMACROMOLECULES, V6, P885, DOI 10.1021/bm049347a
   Khodaverdi E, 2015, AAPS PHARMSCITECH, V16, P140, DOI 10.1208/s12249-014-0198-4
   Li F, 2013, J DENT RES, V92, P932, DOI 10.1177/0022034513502053
   Li YL, 2014, POLYMERS-BASEL, V6, P634, DOI 10.3390/polym6030634
   Liu S, 2015, CHEM COMMUN, V51, P5218, DOI 10.1039/c4cc09568e
   Liu X, 2012, POLYM CHEM-UK, V3, P2082, DOI 10.1039/c2py20170d
   Ni P, 2014, BIOMATERIALS, V35, P236, DOI 10.1016/j.biomaterials.2013.10.016
   Ott C, 2011, POLYM CHEM-UK, V2, P2782, DOI 10.1039/c1py00412c
   Ramimoghadam D, 2015, COLLOID SURFACE B, V133, P388, DOI 10.1016/j.colsurfb.2015.02.003
   Sarker B, 2014, J MATER CHEM B, V2, P1470, DOI 10.1039/c3tb21509a
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Shen LL, 2015, NANO RES, V8, P491, DOI 10.1007/s12274-014-0651-4
   Sim H. J., 2015, J MAT CHEM B
   Smeets NMB, 2014, CHEM COMMUN, V50, P3306, DOI 10.1039/c3cc48514e
   Sun YN, 2015, CHEM COMMUN, V51, P8512, DOI 10.1039/c4cc10094h
   Tang ZC, 2015, CHEM COMMUN, V51, P14263, DOI 10.1039/c5cc05652g
   Tang ZC, 2015, CHEM COMMUN, V51, P10099, DOI 10.1039/c5cc02659h
   Thomas V, 2009, J BIOMAT SCI-POLYM E, V20, P2129, DOI 10.1163/156856209X410102
   Vercelino R, 2013, J MATER SCI-MATER M, V24, P2157, DOI 10.1007/s10856-013-4973-7
   Vermonden T, 2012, CHEM REV, V112, P2853, DOI 10.1021/cr200157d
   Wang XW, 2015, CATAL COMMUN, V72, P81, DOI 10.1016/j.catcom.2015.09.014
   Wang XW, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/12/125027
   Wu QJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13553
   Xiao LP, 2014, POLYM CHEM-UK, V5, P2231, DOI 10.1039/c3py01476b
   Yim SL, 2014, CHEM COMMUN, V50, P3064, DOI 10.1039/c3cc49323g
NR 48
TC 6
Z9 6
U1 13
U2 118
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JUL 1
PY 2016
VL 143
BP 342
EP 351
DI 10.1016/j.colsurfb.2016.02.008
PG 10
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA DM9OZ
UT WOS:000376696900041
PM 27022875
DA 2018-10-19
ER

PT J
AU Ibarra, V
   Appel, AA
   Anastasio, MA
   Opara, EC
   Brey, EM
AF Ibarra, Veronica
   Appel, Alyssa A.
   Anastasio, Mark A.
   Opara, Emmanuel C.
   Brey, Eric M.
TI This paper is a winner in the Undergraduate category for the SFB awards:
   Evaluation of the tissue response to alginate encapsulated islets in an
   omentum pouch model
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE X-ray phase contrast; alginate; biomaterial stability; inflammatory
   response; macrophages
ID MULTIPLE-IMAGE RADIOGRAPHY; LONG-TERM FUNCTION; MACROPHAGE PHENOTYPE;
   REGENERATIVE MEDICINE; RAT PANCREAS; PIG ISLETS; SCAFFOLDS;
   MICROCAPSULES; BIOCOMPATIBILITY; IMPLEMENTATION
AB Islet transplantation is currently in clinical use as a treatment for type I diabetes, but donor shortages and long-term immunosuppression limit broad application. Alginate microcapsules coated with poly-l-ornithine can be used to encapsulate islets in an environment that allows diffusion of glucose, insulin, nutrients, and waste products while inhibiting cells and antibodies. While clinical trials are ongoing using islets encapsulated in alginate microbeads, there are concerns in regards to long-term stability. Evaluation of the local tissue response following implantation provides insight into the underlying mechanisms contributing to biomaterial failure, which can be used to the design of new material strategies. Macrophages play an important role in driving the response. In this study, the stability of alginate microbeads coated with PLO containing islets transplanted in the omentum pouch model was investigated. Biomaterial structure and the inflammatory response were characterized by X-ray phase contrast (XPC) CT imaging, histology, and immunostaining. XPC allowed evaluation of microbead 3D structure and identification of failed and stable microbeads. A robust inflammatory response characterized by high cell density and the presence of pro-inflammatory macrophages was found around the failed grafts. The results obtained provide insight into the local tissue response and possible failure mechanisms for alginate microbeads. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 1581-1590, 2016.
C1 [Ibarra, Veronica; Appel, Alyssa A.; Brey, Eric M.] IIT, Dept Biomed Engn, Chicago, IL 60616 USA.
   [Anastasio, Mark A.] Washington Univ, Dept Biomed Engn, St Louis, MO USA.
   [Opara, Emmanuel C.] Wake Forest Inst Regenerat Med, Winston Salem, NC USA.
   [Brey, Eric M.] Vet Affairs Edward Hines Jr Hosp, Res Serv, Ines, IL USA.
RP Brey, EM (reprint author), IIT, Dept Biomed Engn, Chicago, IL 60616 USA.; Brey, EM (reprint author), Vet Affairs Edward Hines Jr Hosp, Res Serv, Ines, IL USA.
EM brey@iit.edu
FU National Science Foundation [CBET-1263994, EEC-1157041, EEC-1461215];
   Veterans Administration [5 I01 BX000418-06]; Armour College of
   Engineering RD program
FX Contract grant sponsor: National Science Foundation; contract grant
   numbers: CBET-1263994, EEC-1157041, EEC-1461215; Contract grant sponsor:
   Veterans Administration; contract grant number: 5 I01 BX000418-06;
   Contract grant sponsor: Armour College of Engineering R&D program
CR Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   Appel AA, 2015, BIOTECHNOL BIOENG, V112, P612, DOI 10.1002/bit.25467
   Appel AA, 2012, TISSUE ENG PART C-ME, V18, P859, DOI [10.1089/ten.tec.2012.0123, 10.1089/ten.TEC.2012.0123]
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Bartneck M, 2012, BIOMATERIALS, V33, P4136, DOI 10.1016/j.biomaterials.2012.02.050
   Brankov JG, 2006, MED PHYS, V33, P278, DOI 10.1118/1.2150788
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Capone SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062032
   Chou CY, 2007, PHYS MED BIOL, V52, P1923, DOI 10.1088/0031-9155/52/7/011
   Darrabie MD, 2005, BIOMATERIALS, V26, P6846, DOI 10.1016/j.biomaterials.2005.05.009
   Dufrane D, 2006, TRANSPLANTATION, V81, P1345, DOI 10.1097/01.tp.0000208610.75997.20
   Field J, 1996, TRANSPLANTATION, V61, P1554, DOI 10.1097/00007890-199605270-00026
   Garg K, 2013, BIOMATERIALS, V34, P4439, DOI 10.1016/j.biomaterials.2013.02.065
   Hillberg AL, 2013, J BIOMED MATER RES B, V101B, P258, DOI 10.1002/jbm.b.32835
   Khanna O, 2010, J BIOMED MATER RES A, V95A, P632, DOI 10.1002/jbm.a.32883
   King A, 2001, J BIOMED MATER RES, V57, P374, DOI 10.1002/1097-4636(20011205)57:3<374::AID-JBM1180>3.0.CO;2-L
   Kollmer M, 2016, TISSUE ENG PART B-RE, V22, P34, DOI 10.1089/ten.teb.2015.0140
   LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35
   McQuilling JP, 2011, TRANSPL P, V43, P3262, DOI 10.1016/j.transproceed.2011.10.030
   Mokarram N, 2012, BIOMATERIALS, V33, P8793, DOI 10.1016/j.biomaterials.2012.08.050
   Moya ML, 2012, J MATER SCI-MATER M, V23, P903, DOI 10.1007/s10856-012-4575-9
   Opara EC, 2010, J INVEST MED, V58, P831, DOI 10.231/JIM.0b013e3181ed3807
   Pareta R, 2014, PANCREAS, V43, P605, DOI 10.1097/MPA.0000000000000107
   Pareta RA, 2013, PATHOBIOLOGY, V80, P194, DOI 10.1159/000345873
   Ponce S, 2006, BIOMATERIALS, V27, P4831, DOI 10.1016/j.biomaterials.2006.05.014
   Robitaille R, 2005, BIOMATERIALS, V26, P4119, DOI 10.1016/j.biomaterials.2004.10.028
   Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012
   Sun JC, 2013, MATERIALS, V6, P1285, DOI 10.3390/ma6041285
   Sun YL, 1996, J CLIN INVEST, V98, P1417, DOI 10.1172/JCI118929
   Tam SK, 2011, ACTA BIOMATER, V7, P1683, DOI 10.1016/j.actbio.2010.12.006
   Uludag H, 2000, ADV DRUG DELIVER REV, V42, P29, DOI 10.1016/S0169-409X(00)00053-3
   Umashankar PR, 2013, J BIOMED MATER RES A, V101, P2202, DOI 10.1002/jbm.a.34535
   Wernick MN, 2003, PHYS MED BIOL, V48, P3875, DOI 10.1088/0031-9155/48/23/006
   Zakrzewski JL, 2014, NAT BIOTECHNOL, V32, P786, DOI 10.1038/nbt.2960
   Zhong Z, 2000, NUCL INSTRUM METH A, V450, P556, DOI 10.1016/S0168-9002(00)00308-9
   Zhu HT, 2015, J ZHEJIANG UNIV-SC B, V16, P329, DOI 10.1631/jzus.B1400310
NR 36
TC 5
Z9 5
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2016
VL 104
IS 7
BP 1581
EP 1590
DI 10.1002/jbm.a.35769
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DO1FW
UT WOS:000377524900002
PM 27144389
OA Green Accepted, Bronze
DA 2018-10-19
ER

PT J
AU Srinivasan, K
   Naula, DP
   Mijares, DQ
   Janal, MN
   LeGeros, RZ
   Zhang, Y
AF Srinivasan, Kritika
   Naula, Diana P.
   Mijares, Dindo Q.
   Janal, Malvin N.
   LeGeros, Racquel Z.
   Zhang, Yu
TI Preservation and promotion of bone formation in the mandible as a
   response to a novel calcium-phosphate based biomaterial in mineral
   deficiency induced low bone mass male versus female rats
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE calcium phosphate biomaterial; mineral deficiency; peak bone mass;
   animal studies; bone mu CT; microradiography
ID POSTMENOPAUSAL WOMEN; COMPUTED-TOMOGRAPHY; CORTICAL BONE;
   MECHANICAL-PROPERTIES; TRICALCIUM PHOSPHATE; OSTEOPOROSIS THERAPY;
   BODY-COMPOSITION; RESIDUAL RIDGE; DENSITY; ZINC
AB Calcium and other trace mineral supplements have previously demonstrated to safely improve bone quality. We hypothesize that our novel calcium-phosphate based biomaterial (SBM) preserves and promotes mandibular bone formation in male and female rats on mineral deficient diet (MD). Sixty Sprague-Dawley rats were randomly assigned to receive one of three diets (n=10): basic diet (BD), MD or mineral deficient diet with 2% SBM. Rats were sacrificed after 6 months. Micro-computed tomography (mu CT) was used to evaluate bone volume and 3D-microarchitecture while microradiography (Faxitron) was used to measure bone mineral density from different sections of the mandible. Results showed that bone quality varied with region, gender and diet. MD reduced bone mineral density (BMD) and volume and increased porosity. SBM preserved BMD and bone mineral content (BMC) in the alveolar bone and condyle in both genders. In the alveolar crest and mandibular body, while preserving more bone in males, SBM also significantly supplemented female bone. Results indicate that mineral deficiency leads to low bone mass in skeletally immature rats, comparatively more in males. Furthermore, SBM administered as a dietary supplement was effective in preventing mandibular bone loss in all subjects. This study suggests that the SBM preparation has potential use in minimizing low peak bone mass induced by mineral deficiency and related bone loss irrespective of gender. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 1622-1632, 2016.
C1 [Srinivasan, Kritika; Naula, Diana P.; Mijares, Dindo Q.; LeGeros, Racquel Z.; Zhang, Yu] NYU, Coll Dent, Dept Biomat & Biomimet, 433 First Ave, New York, NY 10010 USA.
   [Janal, Malvin N.] NYU, Coll Dent, Dept Epidemiol & Hlth Promot, 380 Second Ave,Suite 301, New York, NY 10010 USA.
RP Zhang, Y (reprint author), NYU, Coll Dent, Dept Biomat & Biomimet, 433 First Ave, New York, NY 10010 USA.
EM yz21@nyu.edu
FU NIH/NIAMS [R01 AR056208]; NIH/NIDCR [2R01 DE017925]
FX Contract grant sponsor: NIH/NIAMS; contract grant number: R01 AR056208;
   Contract grant sponsor: NIH/NIDCR; contract grant number: 2R01 DE017925
CR [Anonymous], 2000, NIH CONSENSUS STATE, V17, P1
   Bagi CM, 2006, BONE, V38, P136, DOI 10.1016/j.bone.2005.07.028
   Bailey CA, 2008, P NUTR SOC, V67, P9, DOI 10.1017/S0029665108005971
   Becker W, 2000, J PERIODONTOL, V71, P625, DOI 10.1902/jop.2000.71.4.625
   Bischoff-Ferrari HA, 2007, AM J CLIN NUTR, V86, P1780
   Body JJ, 2011, ACTA CLIN BELG, V66, P443, DOI 10.2143/ACB.66.6.2062612
   Bollen AM, 2000, ORAL SURG ORAL MED O, V90, P518, DOI 10.1067/moe.2000.107802
   Bonjour JP, 2009, SALUD PUBLICA MEXICO, V51, pS5
   BONJOUR JP, 1994, OSTEOPOROSIS INT, V4, P7
   Bradney M, 1998, J BONE MINER RES, V13, P1814, DOI 10.1359/jbmr.1998.13.12.1814
   Chou AHK, 2009, KEY ENG MAT, V396-398, P653, DOI 10.4028/www.scientific.net/KEM.396-398.653
   Cilotti A, 2009, CLIN CASES MINER BON, V6, P229
   COLDITZ GA, 1990, JAMA-J AM MED ASSOC, V264, P2648, DOI 10.1001/jama.264.20.2648
   Ebeling PR, 2008, NEW ENGL J MED, V358, P1474, DOI 10.1056/NEJMcp0707217
   Erdogan O, 2007, ORAL SURG ORAL MED O, V104, P738, DOI 10.1016/j.tripleo.2007.04.008
   Faulkner RA, 2003, MED SCI SPORT EXER, V35, P513, DOI 10.1249/01.MSS.0000053724.33480.8B
   Fawell J. K, 2006, FLUORIDE DRINKING WA
   FELSON DT, 1993, NEW ENGL J MED, V329, P1141, DOI 10.1056/NEJM199310143291601
   Heaney RP, 2000, J AM COLL NUTR, V19, p83S, DOI 10.1080/07315724.2000.10718088
   Ho-Pham LT, 2014, J CLIN ENDOCR METAB, V99, P30, DOI 10.1210/jc.2013-3190
   Holahan CM, 2008, INT J ORAL MAX IMPL, V23, P905
   Houari S, 2014, J BONE MINER RES, V29, P1446, DOI 10.1002/jbmr.2153
   Ijuin M, 2002, MATURITAS, V43, P239, DOI 10.1016/S0378-5122(02)00273-6
   Jee W. S. S., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P193
   KRIBBS PJ, 1983, J PROSTHET DENT, V50, P719, DOI 10.1016/0022-3913(83)90215-9
   Laib A, 2000, MED BIOL ENG COMPUT, V38, P326, DOI 10.1007/BF02347054
   Lee YK, 2008, KEY ENG MATER, V377, P43, DOI 10.4028/www.scientific.net/KEM.377.43
   LeGeros R Z, 1991, Monogr Oral Sci, V15, P1
   LeGeros RZ, 1971, ADV XRAY ANALYSIS, V14, P57
   Li XJJW, 1992, CELLS MATERIALS S, V1, P25
   Liu CC, 2015, J BONE MINER RES, V30, P670, DOI 10.1002/jbmr.2382
   Mardon J, 2009, PEDIATR RES, V66, P513, DOI 10.1203/PDR.0b013e3181b9b4bb
   Mary Bath-Balogh MJF, 2011, ILLUSTRATED DENTAL E
   Mijares D, 2012, ARCH ORAL BIOL, V57, P1264, DOI 10.1016/j.archoralbio.2012.02.021
   Mijares DQ, 2010, SYNTHETIC BONE MINER
   Moyer-Mileur L, 2001, J CLIN DENSITOM, V4, P313, DOI 10.1385/JCD:4:4:313
   Nakada H, 2013, KEY ENG MATER, V529-530, P341, DOI 10.4028/www.scientific.net/KEM.529-530.341
   Nakada H, 2011, J HARD TISSUE BIOL, V20, P107
   National Osteoporosis Foundation, 2014, 54 MILL AM AFF OST L
   Nielsen FH, 2011, BRIT J NUTR, V106, P1872, DOI 10.1017/S0007114511002352
   Nieves JW, 2005, J BONE MINER RES, V20, P529, DOI 10.1359/JBMR.041005
   Nilsson M, 2012, J BONE MINER RES, V27, P1206, DOI 10.1002/jbmr.1549
   Otsuka M, 2008, J PHARM SCI-US, V97, P421, DOI 10.1002/jps.21131
   Reid IR, 2002, BONE, V31, P547, DOI 10.1016/S8756-3282(02)00864-5
   Rude RK, 2004, J NUTR BIOCHEM, V15, P710, DOI 10.1016/j.jnutbio.2004.08.001
   Sader MS, 2009, J MATER SCI-MATER M, V20, P521, DOI 10.1007/s10856-008-3610-3
   Sakae T, 2013, KEY ENG MATER, V529-530, P337, DOI 10.4028/www.scientific.net/KEM.529-530.337
   SCHAPIRA D, 1991, CELLS MATERIALS S, V1, P181
   Sengupta P., 2011, BIOMED INT, V2, P81
   Singhal S, 2012, GERODONTOLOGY, V29, pE1059, DOI 10.1111/j.1741-2358.2011.00610.x
   Sirimaharaj Wimon, 2008, Journal of the Medical Association of Thailand, V91, P868
   Stoch SA, 2008, CLIN PHARMACOL THER, V83, P172, DOI 10.1038/sj.clpt.6100450
   Suresh E, 2014, RHEUMATOLOGY, V53, P19, DOI 10.1093/rheumatology/ket236
   Taketa T, 2008, J BONE MINER METAB, V26, P143, DOI 10.1007/s00774-007-0808-2
   Teo JCM, 2007, MAT SCI ENG C-BIO S, V27, P333, DOI 10.1016/j.msec.2006.05.003
   Tokudome Y, 2009, J BIOMED MATER RES B, V90B, P229, DOI 10.1002/jbm.b.31277
   Vlasiadis KZ, 2008, MATURITAS, V59, P226, DOI 10.1016/j.maturitas.2008.01.006
   Weat R, 1987, HDB CHEM PHYS, P88
   Weaver CM, 2008, ASIA PAC J CLIN NUTR, V17, P135
   Wells G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004523.pub3
   Whitaker M, 2012, NEW ENGL J MED, V366, P2048, DOI 10.1056/NEJMp1202619
   Wright NC, 2014, J BONE MINER RES, V29, P2520, DOI 10.1002/jbmr.2269
   Yamada Y, 2008, J BIOMED MATER RES A, V84A, P344, DOI 10.1002/jbm.a.31265
   YAMAGUCHI M, 1986, RES EXP MED, V186, P337, DOI 10.1007/BF01852099
   Yamaguchi M, 2010, MOL CELL BIOCHEM, V338, P241, DOI 10.1007/s11010-009-0358-0
   Ye D, 1994, J W CHINA U MED SCI, V25, P414
   Young D, 2001, OSTEOPOROSIS INT, V12, P506, DOI 10.1007/s001980170097
   Zix J, 2011, SWISS MED WEEKLY, P141
NR 68
TC 1
Z9 1
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2016
VL 104
IS 7
BP 1622
EP 1632
DI 10.1002/jbm.a.35691
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DO1FW
UT WOS:000377524900006
PM 26914814
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Li, R
   Pavuluri, S
   Bruggeman, K
   Long, BM
   Parnell, AJ
   Martel, A
   Parnell, SR
   Pfeffer, FM
   Dennison, AJC
   Nicholas, KR
   Barrow, CJ
   Nisbet, DR
   Williams, RJ
AF Li, Rui
   Pavuluri, Sivapriya
   Bruggeman, Kiara
   Long, Benjamin M.
   Parnell, Andrew J.
   Martel, Anne
   Parnell, Steven R.
   Pfeffer, Frederick M.
   Dennison, Andrew J. C.
   Nicholas, Kevin R.
   Barrow, Colin J.
   Nisbet, David R.
   Williams, Richard J.
TI Coassembled nanostructured bioscaffold reduces the expression of
   proinflammatory cytokines to induce apoptosis in epithelial cancer cells
SO NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE
LA English
DT Article
DE Bionanotechnology; Self-assembly; Cancer; Supramolecular materials;
   Hydrogels; Tissue engineering
ID NF-KAPPA-B; TUMOR PROGRESSION; DRUG-DELIVERY; SELF; CARCINOMA;
   INFLAMMATION; FIBROBLASTS; HYDROGELS; INHIBITION; MOLECULES
AB The local inflammatory environment of the cell promotes the growth of epithelial cancers. Therefore, controlling inflammation locally using a material in a sustained, non-steroidal fashion can effectively kill malignant cells without significant damage to surrounding healthy cells. A promising class of materials for such applications is the nanostructured scaffolds formed by epitope presenting minimalist self-assembled peptides; these are bioactive on a cellular length scale, while presenting as an easily handled hydrogel. Here, we show that the assembly process can distribute an anti- inflammatory polysaccharide, fucoidan, localized to the nanofibers within the scaffold to create a biomaterial for cancer therapy. We show that it supports healthy cells, while inducing apoptosis in cancerous epithelial cells, as demonstrated by the significant down-regulation of gene and protein expression pathways associated with epithelial cancer progression. Our findings highlight an innovative material approach with potential applications in local epithelial cancer immunotherapy and drug delivery. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Li, Rui; Pavuluri, Sivapriya; Long, Benjamin M.; Pfeffer, Frederick M.; Nicholas, Kevin R.; Barrow, Colin J.; Williams, Richard J.] Deakin Univ, Ctr Chem & Biotechnol, Waurn Ponds, Australia.
   [Bruggeman, Kiara; Nisbet, David R.] Australian Natl Univ, Res Sch Engn, Canberra, ACT, Australia.
   [Parnell, Andrew J.] Univ Sheffield, Dept Phys & Astron, Sheffield S10 2TN, S Yorkshire, England.
   [Martel, Anne; Dennison, Andrew J. C.] Inst Laue Langevin, Grenoble, France.
   [Parnell, Steven R.] Indiana Univ, LENS, Bloomington, IN USA.
   [Li, Rui] Chinese Acad Trop Agr Sci, Coconut Res Inst, Wenchang, Hainan, Peoples R China.
   [Pavuluri, Sivapriya; Nicholas, Kevin R.] Deakin Univ, Sch Med, Waurn Ponds, Vic, Australia.
   [Williams, Richard J.] RMIT Univ, Sch Aerosp Mech & Mfg Engn, Melbourne, Vic, Australia.
   [Williams, Richard J.] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic, Australia.
   [Dennison, Andrew J. C.] TU Berlin, Inst Chem, Berlin, Germany.
RP Williams, RJ (reprint author), RMIT Univ, Sch Aerosp Mech & Mfg Engn, Melbourne, Vic, Australia.; Williams, RJ (reprint author), RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic, Australia.
EM Richard.Williams@RMIT.edu.au
RI Parnell, Andrew/F-8969-2011; Pfeffer, Frederick/E-1710-2011; Parnell,
   Steven/J-4574-2013
OI Parnell, Andrew/0000-0001-8606-8644; Pfeffer,
   Frederick/0000-0002-5441-6437; Nisbet, David/0000-0002-1343-0769; Long,
   Benjamin/0000-0002-3248-8851
FU Australian Research Council (ARC) Discovery Project [DP130103131]; ARC
   [LE110100141]; NHMRC Career Development Fellowship [APP1050684]; Alfred
   Deakin Research Fellowship; Australian Microscopy and Microanalysis
   Research Facility (AMMRF); Swedish Research Council VR; Institut
   Laue-Langevin user access programme [8-03-826]
FX This work was funded by an Australian Research Council (ARC) Discovery
   Project (DP130103131). N.M.R. instrumentation was provided through ARC
   funding (LE110100141). D.R.N. was supported by an NHMRC Career
   Development Fellowship (APP1050684). R.J.W. was supported via an Alfred
   Deakin Research Fellowship. Access to the facilities of the Centre for
   Advanced Microscopy (CAM) with funding through the Australian Microscopy
   and Microanalysis Research Facility (AMMRF) is gratefully acknowledged.
   A.J.C.D. was supported by the Swedish Research Council VR. Preliminary
   SANS measurements were performed at the Low Energy Neutron Source,
   Indiana. Access to the D33 instrument was provided by the Institut
   Laue-Langevin user access programme (8-03-826).
CR Adams DJ, 2009, SOFT MATTER, V5, P1856, DOI 10.1039/b901556f
   Bhuniya S, 2006, TETRAHEDRON LETT, V47, P7153, DOI 10.1016/j.tetlet.2006.08.002
   Boekhoven J, 2012, ADV MAT
   Cheng G, 2010, LANGMUIR, V26, P4990, DOI 10.1021/la903678e
   Conde J, 2010, ADV FUNCT MAT
   Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322
   Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077
   Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X
   Dewhurst R, 2008, MEAS SCI TECHNOL, V19, DOI 10.1088/0957-0233/19/2/020101
   Dias PF, 2005, CANCER CHEMOTH PHARM, V56, P436, DOI 10.1007/s00280-004-0995-7
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025
   Hamill KJ, 2012, J INVEST DERMATOL, V132, P448, DOI 10.1038/jid.2011.297
   Hirst AR, 2010, NAT CHEM, V2, P1089, DOI 10.1038/NCHEM.861
   Javid N, 2013, BIOMACROMOLECULES, V14, P4368, DOI 10.1021/bm401319c
   Jones MK, 1999, NAT MED, V5, P1418
   Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877
   Kim EJ, 2005, BMC GASTROENTEROL, V10, P96
   Kline SR, 2006, J APPL CRYSTALLOGR, V39, P895, DOI 10.1107/S0021889806035059
   Ko SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055795
   Kuang Y, 2013, RSC ADV, V3, P7704, DOI 10.1039/c3ra41523f
   Li R, 2015, RSC ADV, V5, P301, DOI 10.1039/c4ra13266a
   Lin A, 2003, SEMINARS CANC BIOL, P107
   Lirdprapamongkol K., 2010, AM J APPL SCI, V7, P1038
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Modepalli VN, 2014, BIOPOLYMERS, V102, P197, DOI 10.1002/bip.22469
   Morris KL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2499
   Murakami K, 2010, BIOMATERIALS, V31, P83, DOI 10.1016/j.biomaterials.2009.09.031
   Nakano Y, 1999, JPN J CANCER RES, V90, P858, DOI 10.1111/j.1349-7006.1999.tb00827.x
   Nisbet DR, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-011-0002-x
   Olumi AF, 2006, CANCER RES, V59, P5002
   Park HY, 2014, MOLECULES, V19, P5981, DOI 10.3390/molecules19055981
   Patel MK, 2002, THROMB HAEMOSTASIS, V87, P149
   Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394
   Raeburn J, 2015, CHEM COMMUN, V51, P5170, DOI 10.1039/c4cc08626k
   Rao SK, 2010, J BIOL CHEM, V285, P32512, DOI 10.1074/jbc.M110.150490
   Reuter S, 1999, ANN NY ACAD SCI, V1171, P436
   RHEINWALD JG, 1981, CANCER RES, V41, P1657
   Rodriguez A., 2015, NANO RES, P1
   Rodriguez AL, 2014, J MATER CHEM B, V2, P7771, DOI 10.1039/c4tb01391c
   Rodriguez AL, 2013, SOFT MATTER, V9, P3915, DOI 10.1039/c3sm27758e
   Sayes CM, 2006, TOXICOL SCI, V92, P174, DOI 10.1093/toxsci/kfj197
   Sezer AD, 2007, AAPS PHARMSCITECH, V8, DOI 10.1208/pt0802039
   Smith AM, 2008, ADV MATER, V20, P37, DOI 10.1002/adma.200701221
   Tao JQ, 2014, TUMOR BIOL, V35, P4389, DOI 10.1007/s13277-013-1578-1
   Waseem A, 2010, ORAL ONCOL, V46, P536, DOI 10.1016/j.oraloncology.2010.03.022
   Whitesides GM, 2002, P NATL ACAD SCI USA, V99, P4769, DOI 10.1073/pnas.082065899
   Williams RJ, 2013, AUST J CHEM, V66, P572, DOI 10.1071/CH12557
   Williams RJ, 2011, BIOMATERIALS, V32, P5304, DOI 10.1016/j.biomaterials.2011.03.078
   Williams RJ, 2009, NAT NANOTECHNOL, V4, P19, DOI [10.1038/nnano.2008.378, 10.1038/NNANO.2008.378]
   Wolinsky JB, 2012, J CONTROL RELEASE, V159, P14, DOI 10.1016/j.jconrel.2011.11.031
   Worthington P, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00092
   Yallapu MM, 2011, DRUG DISCOV TODAY, V16, P457, DOI 10.1016/j.drudis.2011.03.004
   Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914
   Yang ZM, 2009, CHEM COMMUN, V35, P4414
   Yu C, 2013, TISSUE ENG PART C-ME, V19, P829, DOI [10.1089/ten.tec.2012.0693, 10.1089/ten.TEC.2012.0693]
   Zhao F, 2009, CHEM SOC REV, V38, P883, DOI 10.1039/b806410p
   Zhou M, 2009, BIOMATERIALS, V30, P2523, DOI 10.1016/j.biomaterials.2009.01.010
   Zhu C, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/692549
NR 62
TC 11
Z9 11
U1 6
U2 38
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1549-9634
EI 1549-9642
J9 NANOMED-NANOTECHNOL
JI Nanomed.-Nanotechnol. Biol. Med.
PD JUL
PY 2016
VL 12
IS 5
BP 1397
EP 1407
DI 10.1016/j.nano.2016.01.009
PG 11
WC Nanoscience & Nanotechnology; Medicine, Research & Experimental
SC Science & Technology - Other Topics; Research & Experimental Medicine
GA DN9OM
UT WOS:000377409100023
PM 26961467
DA 2018-10-19
ER

PT J
AU Avigo, C
   Flori, A
   Armanetti, P
   Di Lascio, N
   Kusmic, C
   Jose, J
   Losi, P
   Soldani, G
   Faita, F
   Menichetti, L
AF Avigo, Cinzia
   Flori, Alessandra
   Armanetti, Paolo
   Di Lascio, Nicole
   Kusmic, Claudia
   Jose, Jithin
   Losi, Paola
   Soldani, Giorgio
   Faita, Francesco
   Menichetti, Luca
TI Strategies for non-invasive imaging of polymeric biomaterial in vascular
   tissue engineering and regenerative medicine using ultrasound and
   photoacoustic techniques
SO POLYMER INTERNATIONAL
LA English
DT Review
DE molecular imaging; ultrasound; photoacustic imaging; regenerative
   medicine; vascular tissue engineering
ID MICRO-ULTRASOUND; CELL THERAPY; LIVING MICE; NANOPARTICLES;
   ANGIOGENESIS; TOMOGRAPHY; SCAFFOLDS; DISEASE; DACRON
AB The ability of new polymeric materials to provide excellent biomechanical properties expanded their potential for biomedical applications enormously. The use of non-invasive imaging modalities could provide crucial information to monitor the efficacy/effectiveness/efficiency of the new materials employed in regenerative' approaches, including scaffolds, hydrogels, self-assembling materials and nanosized structures. The assessment of the morpho-functional and metabolic changes of treated or implanted tissues, the visualization of sites of drug delivery and the real-time check of the in vivo efficacy of therapeutics could be achieved by non-invasive micro- and macro-imaging techniques. The macro- and nano-requirements of these new materials and their behaviour in vivo can be investigated using standard approaches such as computed tomography, MRI and ultrasound techniques and the emerging photoacoustic imaging. This paper presents recent advancements of ultrasonography and the novel photoacoustic technique to monitor the morpho-functional parameters of synthetic polymeric scaffolds and conduits in experimental models. (c) 2016 Society of Chemical Industry
C1 [Avigo, Cinzia; Flori, Alessandra; Armanetti, Paolo; Di Lascio, Nicole; Kusmic, Claudia; Jose, Jithin; Losi, Paola; Soldani, Giorgio; Faita, Francesco; Menichetti, Luca] CNR, Inst Clin Physiol, Via G Moruzzi 1, I-56124 Pisa, Italy.
RP Menichetti, L (reprint author), CNR, Inst Clin Physiol, Via G Moruzzi 1, I-56124 Pisa, Italy.
EM luca.menichetti@ifc.cnr.it
RI Jose, Jithin/F-3412-2017
OI Jose, Jithin/0000-0002-8389-5596; Di Lascio, Nicole/0000-0003-0826-3465;
   Menichetti, Luca/0000-0002-3293-9616
CR Abdulhannan P, 2012, BRIT MED BULL, V104, P21, DOI 10.1093/bmb/lds027
   Agarwal A, 2007, J APPL PHYS, V102, DOI 10.1063/1.2777127
   Appel AA, 2013, BIOMATERIALS, V34, P6615, DOI 10.1016/j.biomaterials.2013.05.033
   Avigo C, 2015, PROC SPIE, V9323, DOI 10.1117/12.2077942
   Beard P, 2011, INTERFACE FOCUS, V1, P602, DOI 10.1098/rsfs.2011.0028
   Byrom MJ, 2010, J VASC SURG, V52, P176, DOI 10.1016/j.jvs.2009.10.080
   Cai X, 2013, MATER TODAY, V16, P67, DOI 10.1016/j.mattod.2013.03.007
   Cai X, 2012, TISSUE ENG PART C-ME, V18, P310, DOI [10.1089/ten.tec.2011.0519, 10.1089/ten.TEC.2011.0519]
   Chen HB, 2015, BIOMED RES INT, DOI 10.1155/2015/757101
   Chen YS, 2011, NANO LETT, V11, P348, DOI 10.1021/nl1042006
   Deshpande N, 2010, ANGIOGENESIS, V13, P175, DOI 10.1007/s10456-010-9175-z
   Di Lascio N, 2015, PROC SPIE, V9323, DOI 10.1117/12.2077947
   El-Brolossy TA, 2008, EUR PHYS J-SPEC TOP, V153, P361, DOI 10.1140/epjst/e2008-00462-0
   Enomoto S, 2010, J VASC SURG, V51, P155, DOI 10.1016/j.jvs.2009.09.005
   Foster FS, 2011, INTERFACE FOCUS, V1, P576, DOI 10.1098/rsfs.2011.0037
   Gnyawali SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122327
   Hu S, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3281673
   Iwai S, 2005, ANN THORAC SURG, V80, P1821, DOI 10.1016/j.athoracsur.2005.03.139
   Jokerst JV, 2012, ACS NANO, V6, P5920, DOI 10.1021/nn302042y
   Kim K, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2743752
   Lao YQ, 2008, PHYS MED BIOL, V53, P4203, DOI 10.1088/0031-9155/53/15/013
   Lee PC, 2008, OPT EXPRESS, V16, P18605
   Leong-Poi H, 2009, CARDIOVASC RES, V84, P190, DOI 10.1093/cvr/cvp248
   Lepidi S, 2006, EUR J VASC ENDOVASC, V32, P411, DOI 10.1016/j.ejvs.2006.02.012
   Li K, 2014, CHEM SOC REV, V43, P6570, DOI 10.1039/c4cs00014e
   Mallidi S, 2009, P SOC PHOTO-OPT INS
   Martinoli C, 1998, EUR J RADIOL, V27, pS133, DOI 10.1016/S0720-048X(98)00054-0
   Needles A, 2013, IEEE T ULTRASON FERR, V60, P888, DOI 10.1109/TUFFC.2013.2646
   Nguyen PK, 2014, CELL STEM CELL, V14, P431, DOI 10.1016/j.stem.2014.03.009
   Povsic TJ, 2016, CURR CARDIOL REP, V18, DOI 10.1007/s11886-015-0693-6
   Pu KY, 2014, NAT NANOTECHNOL, V9, P233, DOI [10.1038/nnano.2013.302, 10.1038/NNANO.2013.302]
   Rapoport N, 2007, J NATL CANCER I, V99, P1095, DOI 10.1093/jnci/dim043
   Ravi S, 2010, REGEN MED, V5, P107, DOI 10.2217/RME.09.77
   Ravi S, 2009, VASCULAR, V17, pS45, DOI 10.2310/6670.2008.00084
   Rissanen TT, 2008, JACC-CARDIOVASC IMAG, V1, P83, DOI 10.1016/j.jcmg.2007.10.009
   Roll Stephanie, 2008, BMC Surg, V8, P22, DOI 10.1186/1471-2482-8-22
   Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3
   SHUMTIM D, 1999, ANN THORAC SURG, V68, P2305
   Takagi H, 2010, J VASC SURG, V52, P232, DOI 10.1016/j.jvs.2010.02.010
   Talukdar Y, 2014, TISSUE ENG PART C-ME, V20, P440, DOI [10.1089/ten.tec.2013.0203, 10.1089/ten.TEC.2013.0203]
   Upputuri PK, 2015, BIOMED RES INT, DOI 10.1155/2015/783983
   van Det RJ, 2009, EUR J VASC ENDOVASC, V37, P457, DOI 10.1016/j.ejvs.2008.11.041
   Wang LV, 2009, NAT PHOTONICS, V3, P503, DOI 10.1038/NPHOTON.2009.157
   Wang XD, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2192804
   Welch AJ, 2011, OPTICAL THERMAL RESPONSE OF LASER-IRRADIATED TISSUE, SECOND EDITION, P1, DOI 10.1007/978-90-481-8831-4
   Wu D, 2014, INT J MOL SCI, V15, P23616, DOI 10.3390/ijms151223616
   Xiang LZ, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2437752
   Yang HW, 2013, BIOMATERIALS, V34, P5651, DOI 10.1016/j.biomaterials.2013.03.085
   Yang SH, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2749185
   Yang S, 2007, MED PHYS, V34, P3294, DOI 10.1118/1.2757088
NR 50
TC 5
Z9 5
U1 3
U2 35
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0959-8103
EI 1097-0126
J9 POLYM INT
JI Polym. Int.
PD JUL
PY 2016
VL 65
IS 7
BP 734
EP 740
DI 10.1002/pi.5113
PG 7
WC Polymer Science
SC Polymer Science
GA DO0WV
UT WOS:000377500300002
DA 2018-10-19
ER

PT J
AU Zanin, H
   Rodrigues, BVM
   Neto, WAR
   Bretas, RES
   Da-Silva, NS
   Marciano, FR
   Lobo, AO
AF Zanin, Hudson
   Manzolli Rodrigues, Bruno Vinicius
   Ribeiro Neto, Wilson Alves
   Suman Bretas, Rosario Elida
   Da-Silva, Newton Soares
   Marciano, Fernanda Roberta
   Lobo, Anderson Oliveira
TI High loading of graphene oxide/multi-walled carbon nanotubes into PDLLA:
   A route towards the design of osteoconductive, bactericidal and
   non-immunogenic 3D porous scaffolds
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Polymers; Biomaterials; Nanostructures; Chemical synthesis;
   Electrochemical properties; Composites materials
ID IN-VIVO; POLY(LACTIC ACID); RELEASE CHARACTERISTICS; CELL VIABILITY;
   BONE; COMPOSITE; POLYMERS; OXIDE; OSTEOBLASTS; SURFACE
AB We have prepared a novel 3D porous biomaterial combining poly (DL-lactic acid) (PDLLA) and graphene and multi-walled carbon nanotubes oxides (MWCNTO-GO) composite. PDLLA as control and a high loading of PDLLA/MWCNTO-GO (50/50 w/w) bioscaffolds were prepared and functionalized. MWCNTs were exfoliated to form MWCNTO-GO by oxygen plasma etching. The later was also applied to enhance the scaffolds wettability, attaching oxygen-containing groups on their surfaces. This approach produced a porous architecture observed by scanning electron microscopy and semi-quantified by electrochemical analysis. The later also indicated a notable increase on the conductivity of PDLLA/MWCNTO-GO scaffold compared to MWCNTO-GO free PDLLA (about 5 orders of magnitudes at low frequencies). Thermogravimetric analysis showed that the MWCNTO-GO acted protecting the PDLLA matrix, enhancing its thermal stability. The PDLLA/MWCNTO-GO scaffolds had significant cellular adhesion, did not present cytotoxicity effect, besides reduced bactericidal proliferation and produced mineralized tissues in SBF media. The metallic MWCNTO-GO powder held together by PDLLA polymer opens a whole new branch of applications, including bioelectroanalyses, drug delivery systems and tissue engineering. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Zanin, Hudson; Manzolli Rodrigues, Bruno Vinicius; Marciano, Fernanda Roberta; Lobo, Anderson Oliveira] Univ Vale Paraiba, Inst Res & Dev, Lab Biomed Nanotechnol NANOBIO, Av Shishima Hifumi 2911, BR-12244000 Sao Jose Dos Campos, SP, Brazil.
   [Zanin, Hudson] Univ Vale Paraiba, Inst Res & Dev, Lab Energy Storage & Supply ES&S, Av Shishima Hifumi 2911, BR-12244000 Sao Jose Dos Campos, SP, Brazil.
   [Ribeiro Neto, Wilson Alves; Suman Bretas, Rosario Elida] Univ Fed Sao Carlos, Dept Mat Engn, Rodovia Washington Luis,Km 235,SP-310, Sao Carlos, SP, Brazil.
   [Da-Silva, Newton Soares] Univ Vale Paraiba, Lab Cell Biol & Tissue, Inst Res & Dev, Av Shishima Hifumi 2911, BR-12244000 Sao Jose Dos Campos, SP, Brazil.
RP Lobo, AO (reprint author), Univ Vale Paraiba, Inst Res & Dev, Lab Biomed Nanotechnol NANOBIO, Av Shishima Hifumi 2911, BR-12244000 Sao Jose Dos Campos, SP, Brazil.
EM aolobo@pq.cnpq.br
RI Rodrigues, Bruno/P-5905-2014; Lobo, Anderson/B-2893-2011
OI Lobo, Anderson/0000-0002-2544-0438; Soares da Silva,
   Newton/0000-0001-6452-9278
FU Sao Paulo Research Foundation (FAPESP) [2011/17877-7, 2011/20345-7,
   2013/20054-8, 2014/02163-7, 2015/01259-3]; National Council for
   Scientific and Technological Development (CNPq) [202439/2012-7,
   474090/2013-2]; Brazilian Innovation Agency (FINEP) [0113042800];
   Coordination for the Improvement of Higher Education Personnel (CAPES)
   [88887.095044/2015-00]; FAPESP [2015/08523-8]
FX The authors would like to thank Sao Paulo Research Foundation (FAPESP,
   grants 2011/17877-7, 2011/20345-7, 2013/20054-8, 2014/02163-7 and
   2015/01259-3), National Council for Scientific and Technological
   Development (CNPq grants 202439/2012-7 and 474090/2013-2), Brazilian
   Innovation Agency (FINEP) (Grant 0113042800) and Coordination for the
   Improvement of Higher Education Personnel (CAPES, 88887.095044/2015-00)
   for financial support. B. V. M. R. would also like to thank FAPESP for
   the post-doctoral fellowship (2015/08523-8).
CR An X., 2013, J NANOMATER, V2013, P7
   Barrere F, 2002, BIOMATERIALS, V23, P1921, DOI 10.1016/S0142-9612(01)00318-0
   Bodamyali T, 1998, BIOCHEM BIOPH RES CO, V250, P458, DOI 10.1006/bbrc.1998.9243
   Bushinsky DA, 1996, AM J PHYSIOL-RENAL, V271, pF216
   Cai X, 2012, CHEM-ASIAN J, V7, P1664, DOI 10.1002/asia.201200045
   Cameron RE, 2008, WOODHEAD PUBL MATER, P43, DOI 10.1533/9781845695033.2.43
   Cho M, 2001, AM J PHYSIOL-HEART C, V280, pH2357
   Domun N, 2015, NANOSCALE, V7, P10294, DOI 10.1039/c5nr01354b
   Fredericks DC, 2007, SPINE, V32, P174, DOI 10.1097/01.brs.0000251363.77027.49
   FUKADA E, 1957, J PHYS SOC JPN, V12, P1158, DOI 10.1143/JPSJ.12.1158
   Garlotta D., J POLYM ENV, V9, P63
   Gong YH, 2007, ACTA BIOMATER, V3, P531, DOI 10.1016/j.actbio.2006.12.008
   Goswami J, 2013, EXPRESS POLYM LETT, V7, P767, DOI 10.3144/expresspolymlett.2013.74
   Grinet MAVM, 2014, J MATER CHEM B, V2, P1196, DOI 10.1039/c3tb21525c
   Han HS, 2014, J NANOSCI NANOTECHNO, V14, P4050, DOI 10.1166/jnn.2014.8258
   Hasegawa S, 2005, J BIOMED MATER RES A, V75A, P567, DOI 10.1002/jbm.a.30460
   He LM, 2013, CARBON, V56, P224, DOI 10.1016/j.carbon.2013.01.025
   Heidemann W, 2001, BIOMATERIALS, V22, P2371, DOI 10.1016/S0142-9612(00)00424-5
   Hidalgo IA, 2013, MOL CELL BIOMECH, V10, P85
   Hollanda LM, 2014, MAT SCI ENG C-MATER, V39, P288, DOI 10.1016/j.msec.2014.03.002
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hwang Y, 2013, COMPOS PART A-APPL S, V55, P195, DOI 10.1016/j.compositesa.2013.08.010
   Ivnitski D, 2008, SMALL, V4, P357, DOI 10.1002/smll.200700725
   Jiang X., 2010, CHEM STRUCTURE POLYL, P67, DOI DOI 10.1002/9780470649848.CH6
   Jin C, 2014, BIOL TRACE ELEM RES, V159, P393, DOI 10.1007/s12011-014-0027-3
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kazufumi K., 2009, SMART MATER STRUCT, V18
   Kim IS, 2006, BBA-MOL CELL RES, V1763, P907, DOI 10.1016/j.bbamcr.2006.06.007
   Kingston C, 2014, CARBON, V68, P33, DOI 10.1016/j.carbon.2013.11.042
   Kobashi K, 2008, SENSOR ACTUAT B-CHEM, V134, P787, DOI 10.1016/j.snb.2008.06.035
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kokubo T, 1998, ACTA MATER, V46, P2519, DOI 10.1016/S1359-6454(98)80036-0
   Kumar B, 2012, SENSOR ACTUAT B-CHEM, V161, P621, DOI 10.1016/j.snb.2011.10.077
   Lasprilla AJR, 2012, BIOTECHNOL ADV, V30, P321, DOI 10.1016/j.biotechadv.2011.06.019
   Li JJ, 2010, MAT SCI ENG C-MATER, V30, P795, DOI 10.1016/j.msec.2010.03.011
   Li RJ, 2015, INT J CLIN EXP PATHO, V8, P8057
   Lim HN, 2012, J NON-CRYST SOLIDS, V358, P525, DOI 10.1016/j.jnoncrysol.2011.11.007
   Lin H, 2015, TISSUE ENG PT A, V21, pS197
   Lobo AO, 2012, MATER LETT, V70, P89, DOI 10.1016/j.matlet.2011.11.071
   Mazaheri M, 2014, APPL SURF SCI, V301, P456, DOI 10.1016/j.apsusc.2014.02.099
   Menaa F, 2015, J TISSUE ENG REGEN M, V9, P1321, DOI 10.1002/term.1910
   Okamoto M, 2013, PROG POLYM SCI, V38, P1487, DOI 10.1016/j.progpolymsci.2013.06.001
   Oliveira J.E., 2013, ADV MATER SCI ENG, V2013, P14
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   Palmre V, 2012, CARBON, V50, P4351, DOI 10.1016/j.carbon.2012.04.071
   Pandey H, 2011, NANOSCALE, V3, P4104, DOI 10.1039/c1nr10661a
   Penel G, 1998, CALCIFIED TISSUE INT, V63, P475, DOI 10.1007/s002239900561
   Prasertsung I, 2010, INT J BIOL MACROMOL, V46, P72, DOI 10.1016/j.ijbiomac.2009.11.001
   Quan H, 2012, POLYMER, V53, P4547, DOI 10.1016/j.polymer.2012.07.061
   Ramos SC, 2010, DIAM RELAT MATER, V19, P752, DOI 10.1016/j.diamond.2010.01.044
   Rasal RM, 2010, MACROMOL MATER ENG, V295, P204, DOI 10.1002/mame.200900195
   Rey C, 2007, MATERIALWISS WERKST, V38, P996, DOI 10.1002/mawe.200700229
   Neto WAR, 2012, POLYM DEGRAD STABIL, V97, P2037, DOI 10.1016/j.polymdegradstab.2012.03.048
   Rodrigues BVM, 2016, MAT SCI ENG C-MATER, V59, P782, DOI 10.1016/j.msec.2015.10.075
   Saligheh O, 2013, J POLYM RES, V20, DOI 10.1007/s10965-012-0065-5
   SCHAKENRAAD JM, 1988, CELL BIOPHYS, V13, P75, DOI 10.1007/BF02797367
   Sharifi E, 2016, MAT SCI ENG C-MATER, V59, P533, DOI 10.1016/j.msec.2015.09.037
   Shi GX, 2008, BIOMATERIALS, V29, P3792, DOI 10.1016/j.biomaterials.2008.06.010
   Siqueira IAWB, 2015, ACS APPL MATER INTER, V7, P9385, DOI 10.1021/acsami.5b01066
   Sirivisoot S, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/29/295101
   Supronowicz PR, 2002, J BIOMED MATER RES, V59, P499, DOI 10.1002/jbm.10015
   Tang ZH, 2013, CARBON, V64, P487, DOI 10.1016/j.carbon.2013.07.103
   Tawakkal ISMA, 2014, J FOOD SCI, V79, pR1477, DOI 10.1111/1750-3841.12534
   Tsai HC, 2013, INT J NANOMED, V8, P4427, DOI 10.2147/IJN.S53636
   Ud-Din S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124502
   VANOSS CJ, 1986, J COLLOID INTERF SCI, V111, P378, DOI 10.1016/0021-9797(86)90041-X
   Wang HY, 2009, ACTA BIOMATER, V5, P279, DOI 10.1016/j.actbio.2008.07.017
   Wang K, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9751-6
   Wepasnick KA, 2011, CARBON, V49, P24, DOI 10.1016/j.carbon.2010.08.034
   Wu CS, 2007, POLYMER, V48, P4449, DOI 10.1016/j.polymer.2007.06.004
   Wu S, 2015, MATER LETT, V161, P716, DOI 10.1016/j.matlet.2015.09.065
   Yaszemski M J, 2003, TISSUE ENG NOVEL DEL
   Yoon IS, 2015, INT J PHARMACEUT, V488, P70, DOI 10.1016/j.ijpharm.2015.04.046
   Zanin H, 2015, NANOSCALE, V7, P10218, DOI 10.1039/c4nr07317g
   Zanin H, 2014, J ELECTROCHEM SOC, V161, pH290, DOI 10.1149/2.011405jes
   Zanin H, 2014, ACS APPL MATER INTER, V6, P990, DOI 10.1021/am4044344
   Zheng XT, 2009, J BIOMED MATER RES B, V91B, P181, DOI 10.1002/jbm.b.31388
   Zou B, 2012, J BIOMED MATER RES A, V100A, P1407, DOI 10.1002/jbm.a.34079
NR 79
TC 4
Z9 4
U1 7
U2 55
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
EI 1879-3312
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD JUL 1
PY 2016
VL 177
BP 56
EP 66
DI 10.1016/j.matchemphys.2016.03.040
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA DM9OK
UT WOS:000376695400009
DA 2018-10-19
ER

PT J
AU Velasco-Ortega, E
   Alfonso-Rodriguez, CA
   Monsalve-Guil, L
   Espana-Lopez, A
   Jimenez-Guerra, A
   Garzon, I
   Alaminos, M
   Gil, FJ
AF Velasco-Ortega, E.
   Alfonso-Rodriguez, C. A.
   Monsalve-Guil, L.
   Espana-Lopez, A.
   Jimenez-Guerra, A.
   Garzon, I.
   Alaminos, M.
   Gil, F. J.
TI Relevant aspects in the surface properties in titanium dental implants
   for the cellular viability
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Roughness treatments; Titanium; Wettability; Surface free energy;
   Cellular behavior; Bone index contact
ID OSTEOBLAST-LIKE CELLS; IN-VITRO; BIOMATERIAL SURFACES; FIBROBLAST
   ADHESION; SOLID-SURFACES; ROUGHNESS; PROLIFERATION; DIFFERENTIATION;
   MATRIX; CYTOTOXICITY
AB Roughness and topographical features are the most relevant of the surface properties for a dental implant for its osseointegration. For that reason, we studied the four surfaces more used in titanium dental implants: machined, sandblasted, acid etching and sandblasted plus acid etching. The roughness and wettability (contact angle and surface free energy) was studied by means 3D-interferometric microscope and sessile drop method. Normal human gingival fibroblasts (HGF) were obtained from small oral mucosa biopsies and were used for cell cultures. To analyze cell integrity, we first quantified the total amount of DNA and LDH released from dead cells to the culture medium. Then, LIVE/DEAD assay was used as a combined method assessing cell integrity and metabolism. All experiments were carried out on each cell type cultured on each Ti material for 24 h, 48 h and 72 h. To evaluate the in vivo cell adhesion capability of each Ti surface, the four types of discs were grafted subcutaneously in 5 Wistar rats. Sandblasted surfaces were significantly rougher than acid etching and machined. Wettability and surface free energy decrease when the roughness increases in sand blasted samples. This fact favors the protein adsorption. The DNA released by cells cultured on the four Ti surfaces did not differ from that of positive control cells (p> 0.05). The number of cells per area was significantly lower (p < 0.05) in the sand-blasted surface than in the machined and surface for both cell types (7 +/- 2 cells for HGF and 10 +/- 5 cells for SAOS-2). The surface of the machined-type discs grafted in vivo had a very small area occupied by cells and/or connective tissue (3.5%), whereas 36.6% of the sandblasted plus acid etching surface, 75.9% of sandblasted discs and 59.6% of acid etching discs was covered with cells and connective tissue. Cells cultured on rougher surfaces tended to exhibit attributes of more differentiated osteoblasts than cells cultured on smoother surfaces. These surface properties justify that the sandblasted implants is able to significantly increase bone contact and bone growth with very good osseointegration results in vivo. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Velasco-Ortega, E.; Monsalve-Guil, L.; Espana-Lopez, A.; Jimenez-Guerra, A.] Univ Seville, Fac Dent, Dept Stomatol, Seville, Spain.
   [Alfonso-Rodriguez, C. A.; Garzon, I.; Alaminos, M.] Univ Granada, Fac Med & Dent, Dept Histol, Tissue Engn Grp, Granada, Spain.
   [Gil, F. J.] Univ Politecn Cataluna, Dept Ciencia Mat & Ingn Met, ETSEIB, Biomat Biomech & Tissue Engn Res Grp, Barcelona, Spain.
   [Gil, F. J.] Univ Int Catalunya, Sch Dent, Immaculada 22, Barcelona, Spain.
RP Gil, FJ (reprint author), Univ Int Catalunya, Sch Dent, Immaculada 22, Barcelona, Spain.
EM Xavier.gil@uic.cat
RI Velasco-Ortega, Eugenio/J-5714-2017; ALAMINOS, MIGUEL/N-9960-2016; Gil,
   Fernando/P-4258-2014
OI Velasco-Ortega, Eugenio/0000-0002-0228-484X; ALAMINOS,
   MIGUEL/0000-0003-4876-2672; Gil, Fernando/0000-0001-9816-8618
FU Spanish Government [MAT 2012-30706]
FX The authors are grateful to Spanish Government for the CICYT (Ministerio
   Economia y Competitividad) project MAT 2012-30706.
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Martin-Piedra MA, 2013, CYTOTHERAPY, V15, P507, DOI 10.1016/j.jcyt.2012.11.017
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Aparicio C, 2007, J BIOMED MATER RES A, V82A, P521, DOI 10.1002/jbm.a.31164
   Aparicio C, 2011, MAT SCI ENG C-MATER, V31, P320, DOI 10.1016/j.msec.2010.09.018
   Aparicio C, 2002, J MATER SCI-MATER M, V13, P1105, DOI 10.1023/A:1021173500990
   Bagno A, 2004, J MATER SCI-MATER M, V15, P935, DOI 10.1023/B:JMSM.0000042679.28493.7f
   Bigerelle M, 2005, J BIOMED MATER RES A, V72A, P36, DOI 10.1002/jbm.a.30212
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Buser D., 2001, TITANIUM MED, P875
   Oliveira AC, 2014, EXP BIOL MED, V239, P71, DOI 10.1177/1535370213503274
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Donath K., 1989, J ORAL PATHOL, V11, P318
   Drelich J, 1997, POL J CHEM, V71, P525
   Eisenbarth E, 2002, BIOMOL ENG, V19, P233, DOI 10.1016/S1389-0344(02)00028-X
   Feller L, 2015, BIOMED RES INT, DOI 10.1155/2015/171945
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   GOOD RJ, 1992, J ADHES SCI TECHNOL, V6, P1269, DOI 10.1163/156856192X00629
   Guillem-Marti J, 2013, CLIN ORAL IMPLAN RES, V24, P770, DOI 10.1111/j.1600-0501.2012.02451.x
   Jayaraman M, 2004, BIOMATERIALS, V25, P625, DOI 10.1016/S0142-9612(03)00571-4
   Kardos TB, 2014, J ORAL IMPLANTOL, V40, P294, DOI 10.1563/AAID-JOI-D-11-00249
   Kim H, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025011
   Lange R, 2002, BIOMOL ENG, V19, P255, DOI 10.1016/S1389-0344(02)00047-3
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Li D., 2006, J BIOMED MATER RES A, V76, P323
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Morra M, 1997, J BIOMAT SCI-POLYM E, V9, P55, DOI 10.1163/156856297X00263
   Ogler O. E., 2015, DENT CLIN N AM, P505
   Pegueroles M, 2008, SURF COAT TECH, V202, P3470, DOI 10.1016/j.surfcoat.2007.12.021
   Pegueroles M, 2010, ACTA BIOMATER, V6, P291, DOI 10.1016/j.actbio.2009.07.030
   Piattelli A, 1998, INT J ORAL MAX IMPL, V13, P805
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Richards RG, 1996, INJURY, V27, P38
   Schwartz Z, 1996, J BIOMED MATER RES, V30, P145
   Sheng YJ, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2804425
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Stoddart MJ, 2011, METHODS MOL BIOL, V740, P1, DOI 10.1007/978-1-61779-108-6_1
   Velasco-Ortega E, 2010, MUTAT RES-GEN TOX EN, V702, P17, DOI 10.1016/j.mrgentox.2010.06.013
   Vijayaraghavan Vasantha, 2012, J Indian Prosthodont Soc, V12, P201, DOI 10.1007/s13191-012-0139-4
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wang XX, 2001, J BIOMED MATER RES, V54, P172, DOI 10.1002/1097-4636(200102)54:2<172::AID-JBM3>3.0.CO;2-#
   Wennerberg A, 2000, INT J ORAL MAX IMPL, V15, P331
   Wennerberg A, 2010, INT J ORAL MAX IMPL, V25, P63
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024
   Wieland M, 2000, WEAR, V237, P231, DOI 10.1016/S0043-1648(99)00347-6
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yeo IS, 2008, J BIOMED MATER RES B, V87B, P303, DOI 10.1002/jbm.b.31104
NR 51
TC 16
Z9 17
U1 2
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUL 1
PY 2016
VL 64
BP 1
EP 10
DI 10.1016/j.msec.2016.03.049
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA DM7NQ
UT WOS:000376547700001
PM 27127022
DA 2018-10-19
ER

PT J
AU Ye, CR
   Wang, Y
   Su, H
   Yang, P
   Huang, N
   Maitz, MF
   Zhao, AS
AF Ye, Changrong
   Wang, Yan
   Su, Hong
   Yang, Ping
   Huang, Nan
   Maitz, Manfred F.
   Zhao, Anshan
TI Construction of a fucoidan/laminin functional multilayer to direction
   vascular cell fate and promotion hemocompatibility
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Fucoidan; Laminin; Anticoagulation; Cardiovascular implants; Endothelial
   cells; Smooth muscle cells
ID BIOMATERIAL SURFACES; EXTRACELLULAR-MATRIX; IN-VITRO;
   ENDOTHELIALIZATION; HEPARIN; FIBRONECTIN; ADSORPTION; MICROENVIRONMENT;
   ANTICOAGULANT; ANGIOGENESIS
AB Surface biofunctional modification of cardiovascular stents is a versatile approach to reduce the adverse effects after implantation. In this work, a novel multifunctional coating was fabricated by coimmobilization of the sulfated polysaccharide of brown algae fucoidan and laminin to biomimic the vascular intimal conditions in order to support rapid endothelialization, prevent restenosis and improve hemocompatibility. The surface properties of the coating such as hydrophilicity, bonding density of biomolecules and stability were evaluated and optimized. According to the biocompatibility tests, the fucoidan/laminin multilayer coated surface displayed less platelet adhesion with favorable anticoagulant property. In addition, the fucoidan/laminin complex showed function to selectively regulate vascular cells growth behavior. The proliferation of endothelial cells (ECs) on the fucoidan/laminin biofunctional coating was significantly promoted. For the smooth muscle cells (SMC5), inhibitory effects on cell adhesion and proliferation were observed. In conclusion, the fucoidan/laminin biofunctional coating was successfully fabricated with desirable anticoagulant and endothelialization properties which show a promising application in the vascular devices such as vascular stents or grafts surface modification. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Ye, Changrong; Wang, Yan; Su, Hong; Yang, Ping; Huang, Nan; Zhao, Anshan] Southwest Jiaotong Univ, Dept Mat Sci & Engn, Minist Educ, Key Lab Adv Mat Technol, Chengdu 610031, Peoples R China.
   [Maitz, Manfred F.] Max Bergmann Ctr Biomat Dresden, Leibniz Inst Polymer Res Dresden, D-01069 Dresden, Germany.
RP Zhao, AS (reprint author), Southwest Jiaotong Univ, Dept Mat Sci & Engn, Minist Educ, Key Lab Adv Mat Technol, Chengdu 610031, Peoples R China.
RI Maitz, Manfred/E-6749-2010; Umlauf, Ursula/D-3356-2014
OI Maitz, Manfred/0000-0002-0671-048X; 
FU National Natural Science Foundation of China [81330031, 81401522]; Key
   Basic Research Program [2011CB606204]
FX The authors gratefully acknowledge the assistance from Dr Ansha Zhao,
   Xiaohua Zhu, Xin Li and Guoneng Xue, the financial support of National
   Natural Science Foundation of China (81330031, 81401522), Key Basic
   Research Program (2011CB606204).
CR Avci-Adali M, 2008, BIOMATERIALS, V29, P3936, DOI 10.1016/j.biomaterials.2008.07.002
   Bachelet L, 2009, BBA-GEN SUBJECTS, V1790, P141, DOI 10.1016/j.bbagen.2008.10.008
   Baddour LM, 2011, J AM DENT ASSOC, V142, P159, DOI 10.14219/jada.archive.2011.0058
   Beamish JA, 2009, BIOMATERIALS, V30, P6286, DOI 10.1016/j.biomaterials.2009.08.004
   Boisson-Vidal C, 2000, DRUG DEVELOP RES, V51, P216, DOI 10.1002/ddr.2
   Brown BN, 2014, TRANSL RES, V163, P268, DOI 10.1016/j.trsl.2013.11.003
   Durig J, 1997, THROMB RES, V85, P479, DOI 10.1016/S0049-3848(97)00037-6
   Giraux JL, 1998, EUR J CELL BIOL, V77, P352, DOI 10.1016/S0171-9335(98)80094-0
   Gu Z, 2010, BIOMATERIALS, V31, P5455, DOI 10.1016/j.biomaterials.2010.03.050
   Hamerli P, 2003, BIOMATERIALS, V24, P3989, DOI 10.1016/S0142-9612(03)00312-0
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u
   Kwak JY, 2014, MAR DRUGS, V12, P851, DOI 10.3390/md12020851
   Lee JH, 2015, STEM CELLS, V33, P1939, DOI 10.1002/stem.1973
   Li GC, 2011, BIOMATERIALS, V32, P4691, DOI 10.1016/j.biomaterials.2011.03.025
   Liu P, 2015, MAT SCI ENG C-MATER, V55, P1, DOI 10.1016/j.msec.2015.05.047
   Lord MS, 2006, BIOMATERIALS, V27, P4856, DOI 10.1016/j.biomaterials.2006.05.037
   Mahapatro A, 2015, MAT SCI ENG C-MATER, V55, P227, DOI 10.1016/j.msec.2015.05.018
   Matou S, 2002, THROMB RES, V106, P213, DOI 10.1016/S0049-3848(02)00136-6
   Mitchell MJ, 2015, BIOMATERIALS, V56, P179, DOI 10.1016/j.biomaterials.2015.03.045
   Molino PJ, 2012, LANGMUIR, V28, P8433, DOI 10.1021/la300692y
   Mustafa A, 2015, INT J CARDIOL, V201, P648, DOI 10.1016/j.ijcard.2014.12.118
   Park HY, 2011, FOOD CHEM TOXICOL, V49, P1745, DOI 10.1016/j.fct.2011.04.020
   Qi PK, 2013, SURF COAT TECH, V233, P80, DOI 10.1016/j.surfcoat.2013.02.008
   Schopka S, 2010, MATERIALS, V3, P638, DOI 10.3390/ma3010638
   Suri CR, 1996, BIOSENS BIOELECTRON, V11, P1199, DOI 10.1016/0956-5663(96)88084-5
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   von der Mark K, 2013, PROG MATER SCI, V58, P327, DOI 10.1016/j.pmatsci.2012.09.002
   Wang J, 2014, APPL SURF SCI, V317, P776, DOI 10.1016/j.apsusc.2014.07.129
   Wang J, 2010, INT J BIOL MACROMOL, V46, P6, DOI 10.1016/j.ijbiomac.2009.10.015
   Wang X, 2013, BIOMATERIALS, V34, P2865, DOI 10.1016/j.biomaterials.2013.01.021
   Wang X, 2014, APPL SURF SCI, V320, P871, DOI 10.1016/j.apsusc.2014.09.004
   Yang ZL, 2012, BIOMATERIALS, V33, P6615, DOI 10.1016/j.biomaterials.2012.06.055
   Zhang MC, 2014, PATHOL RES PRACT, V210, P1026, DOI 10.1016/j.prp.2014.04.004
NR 33
TC 3
Z9 3
U1 2
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUL 1
PY 2016
VL 64
BP 236
EP 242
DI 10.1016/j.msec.2016.03.070
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA DM7NQ
UT WOS:000376547700028
PM 27127049
DA 2018-10-19
ER

PT J
AU Iqbal, Y
   Bae, H
   Rhee, I
   Hong, S
AF Iqbal, Yousaf
   Bae, Hongsub
   Rhee, Ilsu
   Hong, Sungwook
TI Magnetic heating of silica-coated manganese ferrite nanoparticles
SO JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
LA English
DT Article
DE Magnetic heating; Manganese ferrite nanoparticles; Silica coating;
   Magnetic hyperthermia
ID IRON-OXIDE NANOPARTICLES; TARGETED DRUG-DELIVERY; MRI CONTRAST AGENTS;
   SOL-GEL METHOD; COMPOSITE NANOPARTICLES; PHOTOCATALYTIC SHELL; FE3O4
   NANOPARTICLES; BIOMATERIAL SYSTEM; HYPERTHERMIA; CHITOSAN
AB Manganese ferrite nanoparticles were synthesized using the reverse micelle method; these particles were then coated with silica. The silica-coated nanoparticles were spherical in shape, with an average diameter of 14 nm. The inverse spinel crystalline structure was observed through X-ray diffraction patterns. The coating status of silica on the surface of the nanoparticles was confirmed with a Fourier transform infrared spectrometer. The superparamagnetic properties were revealed by the zero coercive force in the hysteresis curve. Controllable heating at a fixed temperature of 42 degrees C was achieved by changing either the concentration of nanoparticles in the aqueous solution or the intensity of the alternating magnetic field. We found that at a fixed field strength of 5.5 kA/m, the 2.6 mg/ml sample showed a saturation temperature of 42 degrees C for magnetic hyperthermia. On the other hand, at a fixed concentration of 3.6 mg/ml, a field intensity of 4.57 Wm satisfied the required temperature of 42 degrees C. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Iqbal, Yousaf; Bae, Hongsub; Rhee, Ilsu] Kyungpook Natl Univ, Dept Phys, Taegu 702701, South Korea.
   [Hong, Sungwook] Daegu Univ, Div Sci Educ, Gyongsan 712714, South Korea.
RP Rhee, I (reprint author), Kyungpook Natl Univ, Dept Phys, Taegu 702701, South Korea.
EM ilrhee@knu.ac.kr
FU National Research Foundation of Korea [2010-0021315]
FX This work was supported by the National Research Foundation of Korea
   (2010-0021315).
CR Ahmad T, 2015, J MAGN MAGN MATER, V381, P151, DOI 10.1016/j.jmmm.2014.12.077
   Ahmad T, 2013, J KOREAN PHYS SOC, V62, P1696, DOI 10.3938/jkps.62.1696
   Ahmad T, 2012, J NANOSCI NANOTECHNO, V12, P5132, DOI 10.1166/jnn.2012.6368
   Ahmad T, 2012, CURR APPL PHYS, V12, P969, DOI 10.1016/j.cap.2011.12.020
   Ahmad T, 2010, J KOREAN PHYS SOC, V57, P1545, DOI 10.3938/jkps.57.1545
   Aslibeiki B, 2012, J MAGN MAGN MATER, V324, P154, DOI 10.1016/j.jmmm.2011.07.057
   Bruni S, 1999, NANOSTRUCT MATER, V11, P573, DOI 10.1016/S0965-9773(99)00335-9
   Carta D, 2008, PHYS CHEM CHEM PHYS, V10, P3108, DOI 10.1039/b800359a
   Chen LY, 2010, J ALLOY COMPD, V497, P221, DOI 10.1016/j.jallcom.2010.03.016
   Depan D., 2013, J BIOMED RES, V2934, P2934
   Do Kim K, 2007, J IND ENG CHEM, V13, P1137
   Dobson J, 2006, DRUG DEVELOP RES, V67, P55, DOI 10.1002/ddr.20067
   Guerrero-Martinez A, 2010, ADV MATER, V22, P1182, DOI 10.1002/adma.200901263
   Hergt R, 2006, J PHYS-CONDENS MAT, V18, pS2919, DOI 10.1088/0953-8984/18/38/S26
   Hong S, 2010, J KOREAN PHYS SOC, V56, P868, DOI 10.3938/jkps.56.868
   Huang HS, 2013, INT J NANOMED, V8, P2521, DOI 10.2147/IJN.S43770
   Iqbal Y., 2015, NEW PHYS SAE MULLI, V65, P147
   Jordan A, 1999, J MAGN MAGN MATER, V194, P185, DOI 10.1016/S0304-8853(98)00558-7
   Jung YI, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-43
   KLIBANOV AL, 1990, FEBS LETT, V268, P235, DOI 10.1016/0014-5793(90)81016-H
   Lewandowska-Lancucka J, 2014, J ALLOY COMPD, V586, P45, DOI 10.1016/j.jallcom.2013.10.039
   McBain SC, 2008, INT J NANOMED, V3, P169
   Misra RDK, 2008, MATER SCI TECH-LOND, V24, P1011, DOI 10.1179/174328408X341690
   Misra RDK, 2011, NANOPLATFORM-BASED MOLECULAR IMAGING, P709
   Misra RDK, 2010, MATER TECHNOL, V25, P118, DOI 10.1179/175355510X12723642365241
   Mojic B, 2012, CERAM INT, V38, P6635, DOI 10.1016/j.ceramint.2012.05.050
   Na HB, 2009, ADV MATER, V21, P2133, DOI 10.1002/adma.200802366
   Nica V, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/20/204115
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rhee Iisu, 2015, New Physics: Sae Mulli, V65, P411, DOI 10.3938/NPSM.65.411
   Rosensweig RE, 2002, J MAGN MAGN MATER, V252, P370, DOI 10.1016/S0304-8853(02)00706-0
   Sahoo B, 2014, J COLLOID INTERF SCI, V431, P31, DOI 10.1016/j.jcis.2014.06.003
   Senpan A, 2009, ACS NANO, V3, P3917, DOI 10.1021/nn900819y
   Wang WW, 2010, MATER LETT, V64, P840, DOI 10.1016/j.matlet.2010.01.034
   Xu W, 2012, PHYS CHEM CHEM PHYS, V14, P12687, DOI 10.1039/c2cp41357d
   Yoo MK, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/94740
NR 38
TC 13
Z9 13
U1 1
U2 109
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-8853
EI 1873-4766
J9 J MAGN MAGN MATER
JI J. Magn. Magn. Mater.
PD JUL 1
PY 2016
VL 409
BP 80
EP 86
DI 10.1016/j.jmmm.2016.02.078
PG 7
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA DG8GF
UT WOS:000372320300014
DA 2018-10-19
ER

PT J
AU Atanasov, PA
   Stankova, NE
   Nedyalkov, NN
   Fukata, N
   Hirsch, D
   Rauschenbach, B
   Amoruso, S
   Wang, X
   Kolev, KN
   Valova, EI
   Georgieva, JS
   Armyanov, SA
AF Atanasov, P. A.
   Stankova, N. E.
   Nedyalkov, N. N.
   Fukata, N.
   Hirsch, D.
   Rauschenbach, B.
   Amoruso, S.
   Wang, X.
   Kolev, K. N.
   Valova, E. I.
   Georgieva, J. S.
   Armyanov, St. A.
TI Fs-laser processing of medical grade polydimethylsiloxane (PDMS)
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT Symposium CC on Laser and Plasma Processing for Advanced Applications in
   Material Science held during the Annual Spring Meeting of the
   European-Materials-Research-Society (E-MRS)
CY MAY 11-15, 2015
CL Lille, FRANCE
SP European Mat Res Soc
DE PDMS-elastomer; IR; VIS and UV fs-laser processing; mu-Raman
   spectrometry; AFM and SEM analyses; Metallization
ID SILICONE-RUBBER; POLY(DIMETHYLSILOXANE); IRRADIATION; FABRICATION
AB Medical grade polydimethylsiloxane (PDMS) elastomer is a biomaterial widely used in medicine and high-tech devices, e.g. MEMS and NEMS. In this work, we report an experimental investigation on femtosecond laser processing of PDMS-elastomer with near infrared (NIR), visible (VIS) and ultraviolet (UV) pulses. High definition trenches are produced by varying processing parameters as laser wavelength, pulse duration, fluence, scanning speed and overlap of the subsequent pulses. The sample surface morphology and chemical composition are investigated by Laser Microscopy, SEM and Raman spectroscopy, addressing the effects of the various processing parameters through comparison with the native materials characteristics. For all the laser pulse wavelengths used, the produced tracks are successfully metalized with Ni via electro-less plating method. We observe a negligible influence of the time interval elapsed between laser treatment and metallization process. Our experimental findings suggest promising perspectives of femtosecond laser pulses in micro- and nano-fabrication of hi-tech PDMS devices. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Atanasov, P. A.; Stankova, N. E.; Nedyalkov, N. N.] Bulgarian Acad Sci, Inst Elect, 72 Tsaridradsko Shose Blvd, Sofia 1784, Bulgaria.
   [Fukata, N.] Natl Inst Mat Sci, Int Ctr Mat NanoArchitecton MANA, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.
   [Hirsch, D.; Rauschenbach, B.] Leibniz Inst Surface Modificat IOM, Permoserstr 15, D-04318 Leipzig, Germany.
   [Amoruso, S.; Wang, X.] Univ Naples Federico II, Dipartmento Fis, Via Cintia, I-80126 Naples, Italy.
   [Amoruso, S.; Wang, X.] Complesso Univ Monte S Angelo, CNR SPIN, Via Cintia, I-80126 Naples, Italy.
   [Kolev, K. N.; Valova, E. I.; Georgieva, J. S.; Armyanov, St. A.] Bulgarian Acad Sci, Rostislaw Kaischew Inst Phys Chem, Acad G Bonchev Str,Block 11, Sofia 1113, Bulgaria.
RP Atanasov, PA (reprint author), Bulgarian Acad Sci, Inst Elect, 72 Tsaridradsko Shose Blvd, Sofia 1784, Bulgaria.
EM paatanas@ie.bas.bg
RI amoruso, salvatore/E-3941-2012; WANG, Xuan/F-1243-2011
OI amoruso, salvatore/0000-0002-1011-3215; WANG, Xuan/0000-0002-0830-0898
CR [Anonymous], 2009, CURR OPIN SOLID STAT, P1
   [Anonymous], 2004, SIL COMP SIL SIL
   Atanasov PA, 2014, J APPL PHYS, V116, DOI 10.1063/1.4887812
   Curtis J M, 2004, BIOMATERIALS SCI
   Dicara C, 2003, P SOC PHOTO-OPT INS, V5147, P255, DOI 10.1117/12.537694
   Dupas-Bruzek C, 2009, APPL SURF SCI, V255, P8715, DOI 10.1016/j.apsusc.2009.06.025
   Ferrari AC, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.121405
   Ferrari AC, 2007, SOLID STATE COMMUN, V143, P47, DOI 10.1016/j.ssc.2007.03.052
   Graubner VM, 2002, APPL SURF SCI, V197, P786, DOI 10.1016/S0169-4332(02)00415-4
   Guo L, 2013, IEEE T BIOMED CIRC S, V7, P1, DOI 10.1109/TBCAS.2012.2192932
   HajjHassan M, 2008, SENSORS-BASEL, V8, P6704, DOI 10.3390/s8106704
   Hassler C, 2011, J POLYM SCI POL PHYS, V49, P18, DOI 10.1002/polb.22169
   Hermanson G T, 1992, IMMOBILIZED AFFINITY, P454
   Lacour SP, 2010, MED BIOL ENG COMPUT, V48, P945, DOI 10.1007/s11517-010-0644-8
   Laude L, 2008, US Patent, Patent No. [US 2008/ 10305320 A1, 200810305320]
   Laude L D, 1997, US Patent No, Patent No. 5599592
   Makamba H, 2003, ELECTROPHORESIS, V24, P3607, DOI 10.1002/elps.200305627
   McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C
   Okoshi M, 2005, OPT LETT, V30, P2730, DOI 10.1364/OL.30.002730
   Palma C, 1999, APPL SURF SCI, V138, P24, DOI 10.1016/S0169-4332(98)00382-1
   Stankova NE, 2015, APPL SURF SCI, V336, P321, DOI 10.1016/j.apsusc.2014.12.121
NR 21
TC 9
Z9 9
U1 1
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD JUN 30
PY 2016
VL 374
BP 229
EP 234
DI 10.1016/j.apsusc.2015.11.175
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA DL9BV
UT WOS:000375937300036
DA 2018-10-19
ER

PT J
AU Burke, KA
   Brenckle, MA
   Kaplan, DL
   Omenetto, FG
AF Burke, Kelly A.
   Brenckle, Mark A.
   Kaplan, David L.
   Omenetto, Fiorenzo G.
TI Evaluation of the Spectral Response of Functionalized Silk Inverse Opals
   as Colorimetric Immunosensors
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE silk fibroin; immunosensor; inverse opal; biopolymer; antibody; antigen;
   biosensor; photonic crystals
ID SURFACE-PLASMON RESONANCE; QUARTZ-CRYSTAL MICROBALANCE;
   MONOCLONAL-ANTIBODIES; FIBROIN; BIOSENSOR; STERILIZATION; SENSORS;
   BIOMATERIAL; PROTEINS; ADHESIVE
AB Regenerated silk fibroin is a high molecular weight protein obtained by purifying the cocoons of the Expose to domesticated silkworm, Bombyx mori. This report exploits the analyte aqueous processing and tunable beta sheet secondary structure of regenerated silk to produce nanostructures (i.e., inverse opals) that can be used as colorimetric immunosensors. Such sensors would enable direct detection of antigens by changes in reflectance spectra induced by binding events within the nanostructure. Silk inverse opals were prepared by solution casting and annealing in a humidified atmosphere to render the silk insoluble. Next, antigen sensing capabilities were imparted to silk through a three step synthesis: coupling of avidin to silk surfaces, coupling of biotin to antibodies, and lastly antibody attachment to silk through avidin biotin interactions. Varying the antibody enables detection of different antigens, as demonstrated using different protein antigens: antibodies, red fluorescent protein, and the beta subunit of cholera toxin. Antigen binding to sensors induces a red shift in the opal reflectance spectra, while sensors not exposed to antigen showed either no shift or a slight blue shift. This work constitutes a first step for the design of biopolymer-based optical systems that could directly detect antigens using commercially available reagents and environmentally friendly chemistries.
C1 [Burke, Kelly A.; Brenckle, Mark A.; Kaplan, David L.; Omenetto, Fiorenzo G.] Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
   [Omenetto, Fiorenzo G.] Tufts Univ, Dept Phys, 4 Colby St, Medford, MA 02155 USA.
   [Burke, Kelly A.] Univ Connecticut, Dept Chem & Biomol Engn, Storrs, CT 06269 USA.
   [Burke, Kelly A.] Univ Connecticut, Polymer Program, Storrs, CT 06269 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.; Omenetto, FG (reprint author), 4 Colby St,Sci & Technol Ctr Room 229, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu; fiorenzo.omenetto@tufts.edu
FU Air Force Office of Scientific Research [FA9550-14-1-0015, 32 CFR 168a];
   National Institutes of Health [NIH P41 EB002520]; Ruth Kirschstein
   Postdoctoral Fellowship [F32-DK093194]; Department of Defense
FX The authors wish to thank the Air Force Office of Scientific Research
   (FA9550-14-1-0015), as well as the National Institutes of Health for
   funding support in the form of the Tissue Engineering Resource Center
   (NIH P41 EB002520) and a Ruth Kirschstein Postdoctoral Fellowship
   awarded to K.A.B. (F32-DK093194). M.A.B. would like to acknowledge
   support from the Department of Defense, Air Force Office of Scientific
   Research in the form of a National Defense Science and Engineering
   Graduate (NDSEG) Fellowship, 32 CFR 168a.
CR Amsden JJ, 2009, OPT EXPRESS, V17, P21271, DOI 10.1364/OE.17.021271
   Arugula MA, 2014, MEAS SCI TECHNOL, V25, DOI 10.1088/0957-0233/25/3/032001
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Boriskina SV, 2010, OPT EXPRESS, V18, P14568, DOI 10.1364/OE.18.014568
   Burke KA, 2016, BIOMACROMOLECULES, V17, P237, DOI 10.1021/acs.biomac.5b01330
   Byrne B, 2009, SENSORS-BASEL, V9, P4407, DOI 10.3390/s90604407
   Cheng CI, 2012, CHEM SOC REV, V41, P1947, DOI 10.1039/c1cs15168a
   Conroy PJ, 2009, SEMIN CELL DEV BIOL, V20, P10, DOI 10.1016/j.semcdb.2009.01.010
   Cronin-Golomb M, 2012, J POLYM SCI POL PHYS, V50, P257, DOI 10.1002/polb.23003
   de Moraes MA, 2014, J BIOMED MATER RES B, V102, P869, DOI 10.1002/jbm.b.33069
   Diao YY, 2013, ADV FUNCT MATER, V23, P5373, DOI 10.1002/adfm.201203672
   Gil ES, 2014, MACROMOL BIOSCI, V14, P257, DOI 10.1002/mabi.201300321
   Gonzalez M, 1999, BIOMOL ENG, V16, P67, DOI 10.1016/S1050-3862(99)00041-8
   Hao RZ, 2009, BIOSENS BIOELECTRON, V24, P1330, DOI 10.1016/j.bios.2008.07.071
   Healy DA, 2007, TRENDS BIOTECHNOL, V25, P125, DOI 10.1016/j.tibtech.2007.01.004
   Hock B, 1997, ANAL CHIM ACTA, V347, P177, DOI 10.1016/S0003-2670(97)00167-0
   Hofmann S, 2014, ACTA BIOMATER, V10, P308, DOI 10.1016/j.actbio.2013.08.035
   Homola J, 2008, CHEM REV, V108, P462, DOI 10.1021/cr068107d
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hu X, 2013, ADV FUNCT MATER, V23, P3875, DOI 10.1002/adfm.201202685
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Justino CIL, 2015, TRAC-TREND ANAL CHEM, V68, P2, DOI 10.1016/j.trac.2015.03.006
   KARLSSON R, 1991, J IMMUNOL METHODS, V145, P229, DOI 10.1016/0022-1759(91)90331-9
   Kim S, 2013, OPT EXPRESS, V21, P8897, DOI 10.1364/OE.21.008897
   Kim S, 2012, NAT PHOTONICS, V6, P817, DOI [10.1038/NPHOTON.2012.264, 10.1038/nphoton.2012.264]
   Kuralay F, 2011, TALANTA, V85, P1330, DOI 10.1016/j.talanta.2011.06.012
   Kurland NE, 2013, ADV MATER, V25, P6207, DOI 10.1002/adma.201302823
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Lee SY, 2010, P NATL ACAD SCI USA, V107, P12086, DOI 10.1073/pnas.1002849107
   Lu Q, 2011, ACTA BIOMATER, V7, P2782, DOI 10.1016/j.actbio.2011.03.001
   Luong JHT, 2008, BIOTECHNOL ADV, V26, P492, DOI 10.1016/j.biotechadv.2008.05.007
   Mayer KM, 2008, ACS NANO, V2, P687, DOI 10.1021/nn7003734
   Miller PR, 2012, TALANTA, V88, P739, DOI 10.1016/j.talanta.2011.11.046
   Mondia JP, 2010, ADV MATER, V22, P4596, DOI 10.1002/adma.201001238
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   Pal RK, 2015, ACS APPL MATER INTER, V7, P8809, DOI 10.1021/acsami.5b01380
   Piliarik M, 2010, BIOSENS BIOELECTRON, V26, P1656, DOI 10.1016/j.bios.2010.08.063
   Pohanka M, 2007, SENSORS-BASEL, V7, P341, DOI 10.3390/s7030341
   Rnjak-Kovacina J, 2015, MACROMOL BIOSCI, V15, P861, DOI 10.1002/mabi.201500013
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Serban MA, 2010, BIOMACROMOLECULES, V11, P3406, DOI 10.1021/bm100925s
   Shen ZH, 2007, ANAL CHEM, V79, P2312, DOI 10.1021/ac061986j
   Shukla AA, 2007, J CHROMATOGR B, V848, P28, DOI 10.1016/j.jchromb.2006.09.026
   Shukla AA, 2010, TRENDS BIOTECHNOL, V28, P253, DOI 10.1016/j.tibtech.2010.02.001
   Swinerd VM, 2007, SOFT MATTER, V3, P1377, DOI 10.1039/b711975e
   Tao H, 2012, P NATL ACAD SCI USA, V109, P19584, DOI 10.1073/pnas.1209056109
   Tao H, 2012, ADV MATER, V24, P1067, DOI 10.1002/adma.201103814
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XQ, 2011, MACROMOL BIOSCI, V11, P100, DOI 10.1002/mabi.201000173
   Wang X, 2014, TRENDS ENVIRON ANAL, V2, P25, DOI 10.1016/j.teac.2014.04.001
   Wang YT, 2010, SENSOR ACTUAT B-CHEM, V146, P381, DOI 10.1016/j.snb.2010.02.032
   WILCHEK M, 1988, ANAL BIOCHEM, V171, P1, DOI 10.1016/0003-2697(88)90120-0
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 53
TC 9
Z9 9
U1 16
U2 61
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JUN 29
PY 2016
VL 8
IS 25
BP 16218
EP 16226
DI 10.1021/acsami.6b02215
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DQ1UB
UT WOS:000378984800041
PM 27322909
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Zilm, ME
   Chen, L
   Sharma, V
   McDannald, A
   Jain, M
   Ramprasad, R
   Wei, M
AF Zilm, M. E.
   Chen, L.
   Sharma, V.
   McDannald, A.
   Jain, M.
   Ramprasad, R.
   Wei, M.
TI Hydroxyapatite substituted by transition metals: experiment and theory
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Article
ID IRON-OXIDE NANOPARTICLES; CALCIUM-HYDROXYAPATITE; DOPED HYDROXYAPATITE;
   DFT; STRONTIUM; MANGANESE; DENSITY; BONE; EPR; CERAMICS
AB Bioceramics are versatile materials for hard tissue engineering. Hydroxyapatite (HA) is a widely studied biomaterial for bone grafting and tissue engineering applications. The crystal structure of HA allows for a wide range of substitutions, which allows for tailoring materials properties. Transition metals and lanthanides are of interest since substitution in HA can result in magnetic properties. In this study, experimental results were compared to theoretical calculations of HA substituted with a transition metal. Calculation of a 10 atomic percent substitution of a transition metal ion Mn2+, Fe2+, and Co2+ substituted HA samples lead to magnetic moments of 5, 4, and 3 Bohr magnetons, respectively. Hydroxyapatite substituted by transition metals (MHA) was fabricated through an ion exchange procedure and characterized with X-ray diffraction, Fourier transform infra-red spectroscopy (FTIR), X-ray photoelectron spectroscopy, and vibrating sample magnetometer, and results were compared to theoretical calculations. All the substitutions resulted in phase-pure M(2+)HA with lattice parameters and FTIR spectra in good agreement with calculations. Magnetic measurements revealed that the substitution of Mn2+ has the greatest effect on the magnetic properties of HA followed by the substitution of Fe2+ and then Co2+. The present work underlines the power of synergistic theoretical-experimental work in guiding the rational design of materials.
C1 [Zilm, M. E.; Chen, L.; Sharma, V.; McDannald, A.; Ramprasad, R.; Wei, M.] Univ Connecticut, Dept Mat Sci & Engn, Storrs, CT 06269 USA.
   [Jain, M.] Univ Connecticut, Dept Phys, Storrs, CT USA.
RP Wei, M (reprint author), Univ Connecticut, Dept Mat Sci & Engn, Storrs, CT 06269 USA.
EM meiwei@engr.uconn.edu
OI sharma, vinit/0000-0002-0577-5716
FU NSF [CBET-1133883, CBET-1347130, DMR 1310149]; NSF GK-12 program
   [0947869]
FX The authors would like to thank NSF grants (CBET-1133883 and
   CBET-1347130) and NSF GK-12 program (0947869) for their support. For
   magnetic measurements, author MJ acknowledges the support of NSF grant
   DMR 1310149.
CR Astala R, 2006, CHEM MATER, V18, P413, DOI 10.1021/cm051989x
   Astala R, 2005, CHEM MATER, V17, P4125, DOI 10.1021/cm050523b
   Bae YJ, 2008, BIOL TRACE ELEM RES, V124, P28, DOI 10.1007/s12011-008-8119-6
   Bhat SS, 2014, CRYST GROWTH DES, V14, P3131, DOI 10.1021/cg5004269
   Biktagirov T, 2014, J PHYS CHEM A, V118, P1519, DOI 10.1021/jp410900m
   Boanini E, 2010, ACTA BIOMATER, V6, P1882, DOI 10.1016/j.actbio.2009.12.041
   BORODKO YG, 1976, CHEM PHYS LETT, V42, P264, DOI 10.1016/0009-2614(76)80360-0
   Bose S, 2013, TRENDS BIOTECHNOL, V31, P594, DOI 10.1016/j.tibtech.2013.06.005
   Briggs D., 1983, PRACTICAL SURFACE AN
   Chandra VS, 2012, ACS APPL MATER INTER, V4, P1200, DOI 10.1021/am300140q
   Chappell HF, 2007, J MATER SCI-MATER M, V18, P829, DOI 10.1007/s10856-006-0001-5
   de Leeuw NH, 2002, PHYS CHEM CHEM PHYS, V4, P3865, DOI 10.1039/b203114k
   Ellis DE, 2006, PHYS CHEM CHEM PHYS, V8, P967, DOI 10.1039/b509254j
   Fiorentini V, 1996, J PHYS-CONDENS MAT, V8, P6525, DOI 10.1088/0953-8984/8/36/005
   Gafurov M, 2015, PHYS CHEM CHEM PHYS, V17, P20331, DOI 10.1039/c5cp01986a
   Gafurov M, 2014, APPL MAGN RESON, V45, P1189, DOI 10.1007/s00723-014-0572-0
   Issa B, 2013, INT J MOL SCI, V14, P21266, DOI 10.3390/ijms141121266
   Jiang M, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.224107
   Khachani M, 2010, APPL CATAL A-GEN, V388, P113, DOI 10.1016/j.apcata.2010.08.043
   Kramer E, 2014, CERAM INT, V40, P13471, DOI 10.1016/j.ceramint.2014.05.072
   Kramer ER, 2013, J MATER SCI, V48, P665, DOI 10.1007/s10853-012-6779-2
   Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169
   Landi E, 2003, J EUR CERAM SOC, V23, P2931, DOI 10.1016/S0955-2219(03)00304-2
   Larson A. C., 2000, LOS ALAMOS NATL LAB, P86
   Laurencin D, 2011, BIOMATERIALS, V32, P1826, DOI 10.1016/j.biomaterials.2010.11.017
   Li Y, 2012, J MATER SCI, V47, P754, DOI 10.1007/s10853-011-5851-7
   Lindsay D, 2011, NAT CHEM, V3, P494, DOI 10.1038/nchem.1053
   Ma XY, 2008, BIOMATERIALS, V29, P257, DOI 10.1016/j.biomaterials.2007.10.001
   Matsunaga K, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.014102
   Mayer I, 2010, J INORG BIOCHEM, V104, P1107, DOI 10.1016/j.jinorgbio.2010.06.009
   MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188
   Na HB, 2009, ADV MATER, V21, P2133, DOI 10.1002/adma.200802366
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   Panseri S, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-32
   Patel N, 2002, J MATER SCI-MATER M, V13, P1199, DOI 10.1023/A:1021114710076
   Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
   POSNER AS, 1958, ACTA CRYSTALLOGR, V11, P308, DOI 10.1107/S0365110X58000815
   Rico H, 2000, EUR J OBSTET GYN R B, V90, P97, DOI 10.1016/S0301-2115(99)00223-7
   Rulis P, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.155104
   Soenen SJH, 2011, BIOMATERIALS, V32, P195, DOI 10.1016/j.biomaterials.2010.08.075
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Terra J, 2010, PHYS CHEM CHEM PHYS, V12, P15490, DOI 10.1039/c0cp01032d
   Terra J, 2009, PHYS CHEM CHEM PHYS, V11, P568, DOI 10.1039/b802841a
   Toby BH, 2001, J APPL CRYSTALLOGR, V34, P210, DOI 10.1107/S0021889801002242
   Veiseh O, 2010, ADV DRUG DELIVER REV, V62, P284, DOI 10.1016/j.addr.2009.11.002
   Veselinovic L, 2010, J APPL CRYSTALLOGR, V43, P320, DOI 10.1107/S0021889809051395
   Webster TJ, 2004, BIOMATERIALS, V25, P2111, DOI 10.1016/j.biomaterials.2003.09.001
   Williams R. J. P., 1968, ROY I CHEM REV, V1, P13
   Xu HY, 2011, BIOMATERIALS, V32, P9758, DOI 10.1016/j.biomaterials.2011.08.076
   Xue WC, 2006, J BIOMED MATER RES A, V79A, P804, DOI 10.1002/jbm.a.30815
   Yin SX, 2010, PHYS CHEM CHEM PHYS, V12, P156, DOI 10.1039/b915171k
   Zeglinski J, 2012, PHYS CHEM CHEM PHYS, V14, P3435, DOI 10.1039/c2cp23163h
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
   Zhu WH, 2004, CHEM PHYS LETT, V396, P38, DOI 10.1016/j.cplett.2004.08.006
   Zilm ME, 2014, J MATER CHEM B, V2, P7176, DOI 10.1039/c4tb00925h
NR 55
TC 14
Z9 14
U1 3
U2 45
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
EI 1463-9084
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PD JUN 28
PY 2016
VL 18
IS 24
BP 16457
EP 16465
DI 10.1039/c6cp00474a
PG 9
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA DS8TS
UT WOS:000381056500047
PM 27264723
DA 2018-10-19
ER

PT J
AU Knaack, GL
   McHail, DG
   Borda, G
   Koo, B
   Peixoto, N
   Cogan, SF
   Dumas, TC
   Pancrazio, JJ
AF Knaack, Gretchen L.
   McHail, Daniel G.
   Borda, German
   Koo, Beomseo
   Peixoto, Nathalia
   Cogan, Stuart F.
   Dumas, Theodore C.
   Pancrazio, Joseph J.
TI In vivo Characterization of Amorphous Silicon Carbide As a Biomaterial
   for Chronic Neural Interfaces
SO FRONTIERS IN NEUROSCIENCE
LA English
DT Article
DE amorphous silicon carbide; neuroprosthetic device; neural electrode;
   foreign body response; neuroinflammatory response; in vivo models
ID CENTRAL-NERVOUS-SYSTEM; BRAIN-TISSUE; MICROELECTRODE ARRAYS;
   CEREBRAL-CORTEX; DEVICES; RESPONSES; IMPLANTS; STENT
AB Implantable microelectrode arrays (MEAs) offer clinical promise for prosthetic devices by enabling restoration of communication and control of artificial limbs. While proof-of-concept recordings from MEAs have been promising, work in animal models demonstrates that the obtained signals degrade over time. Both material robustness and tissue response are acknowledged to have a role in device lifetime. Amorphous Silicon carbide (a-SiC), a robust material that is corrosion resistant, has emerged as an alternative encapsulation layer for implantable devices. We systematically examined the impact of a-SiC coating on Si probes by immunohistochemical characterization of key markers implicated in tissue-device response. After implantation, we performed device capture immunohistochemical labeling of neurons, astrocytes, and activated microglia/macrophages after 4 and 8 weeks of implantation. Neuron loss and microglia activation were similar between Si and a-SiC coated probes, while tissue implanted with a-SiC displayed a reduction in astrocytes adjacent to the probe. These results suggest that a-SiC has a similar biocompatibility profile as Si, and may be suitable for implantable MEA applications as a hermetic coating to prevent material degradation.
C1 [Knaack, Gretchen L.; McHail, Daniel G.; Dumas, Theodore C.] George Mason Univ, Krasnow Inst Adv Study, Dept Mol Neurosci, Fairfax, VA 22030 USA.
   [Knaack, Gretchen L.; Pancrazio, Joseph J.] Quantitat Sci Solut, Arlington, VA USA.
   [Borda, German; Koo, Beomseo] George Mason Univ, Dept Bioengn, Fairfax, VA 22030 USA.
   [Peixoto, Nathalia] George Mason Univ, Dept Elect & Comp Engn, Fairfax, VA 22030 USA.
   [Cogan, Stuart F.; Pancrazio, Joseph J.] Univ Texas Dallas, Dept Bioengn, Richardson, TX 75083 USA.
RP Pancrazio, JJ (reprint author), Quantitat Sci Solut, Arlington, VA USA.; Pancrazio, JJ (reprint author), Univ Texas Dallas, Dept Bioengn, Richardson, TX 75083 USA.
EM joseph.pancrazio@utdallas.edu
FU Defense Advanced Research Projects Agency (DARPA) MTO under the Space
   and Naval Warfare Systems Center, Pacific Grant [N66001-12-1-4026]
FX We are grateful to Dr. William Shain (University of Washington, Seattle,
   WA, USA) for sharing the device capture histology method and Dr. Jeffrey
   Capadona (Case Western Reserve University and Louis Stokes Cleveland VA
   Medical Center, Cleveland 011, USA) for providing custom software for
   image analysis. This work was sponsored by the Defense Advanced Research
   Projects Agency (DARPA) MTO under the auspices of Dr. Jack Judy through
   the Space and Naval Warfare Systems Center, Pacific Grant/Contract No.
   N66001-12-1-4026 (to JP). The sponsor did not have a role in the design,
   analysis, or writing of the study.
CR ALEXANDER GB, 1954, J PHYS CHEM-US, V58, P453, DOI 10.1021/j150516a002
   Amon M, 1996, J MATER SCI-MATER M, V7, P273, DOI 10.1007/BF00058566
   Azemi E, 2011, BIOMATERIALS, V32, P681, DOI 10.1016/j.biomaterials.2010.09.033
   Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371
   Barrese JC, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/2/026003
   Barrese JC, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/6/066014
   Bertrand OF, 1998, J AM COLL CARDIOL, V32, P562, DOI 10.1016/S0735-1097(98)00289-7
   Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020
   Bjornsson CS, 2006, J NEURAL ENG, V3, P196, DOI 10.1088/1741-2560/3/3/002
   Cogan SF, 2003, J BIOMED MATER RES A, V67A, P856, DOI 10.1002/jbm.a.10152
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Frewin CL, 2011, IEEE ENG MED BIO, P2957, DOI 10.1109/IEMBS.2011.6090582
   Hamm CW, 2003, CATHETER CARDIO INTE, V60, P375, DOI 10.1002/ccd.10656
   Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970
   Hsu JM, 2007, THIN SOLID FILMS, V516, P34, DOI 10.1016/j.tsf.2007.04.050
   Iliescu C, 2008, SENSOR ACTUAT B-CHEM, V129, P404, DOI 10.1016/j.snb.2007.08.043
   Jansson D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-104
   Kandel E, 2000, PRINCIPLES NEUROSCIE
   Kane SR, 2013, IEEE T BIO-MED ENG, V60, P2153, DOI 10.1109/TBME.2013.2248152
   Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009
   Kim YT, 2004, BIOMATERIALS, V25, P2229, DOI 10.1016/j.biomaterials.2003.09.010
   Kozai TDY, 2012, NAT MATER, V11, P1065, DOI [10.1038/NMAT3468, 10.1038/nmat3468]
   Kozai TDY, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/6/066001
   Liu X, 1999, IEEE Trans Rehabil Eng, V7, P315
   McConnell GC, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055005
   Nguyen JK, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056014
   Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015
   Potter KA, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046020
   Prasad A, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/5/056015
   Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265
   Rousche PJ, 1998, J NEUROSCI METH, V82, P1, DOI 10.1016/S0165-0270(98)00031-4
   SELLA C, 1993, SURF COAT TECH, V60, P577, DOI 10.1016/0257-8972(93)90156-I
   Skaper SD, 2012, FASEB J, V26, P3103, DOI 10.1096/fj.11-197194
   STENSAAS SS, 1976, ACTA NEUROPATHOL, V35, P187
   Stice P, 2007, J NEURAL ENG, V4, P42, DOI 10.1088/1741-2560/4/2/005
   Stice P, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046004
   Szarowski DH, 2003, BRAIN RES, V983, P23, DOI 10.1016/S0006-8993(03)03023-3
   Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983
   Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996
   Williams JC, 1999, BRAIN RES PROTOC, V4, P303, DOI 10.1016/S1385-299X(99)00034-3
   Winslow BD, 2010, BIOMATERIALS, V31, P1558, DOI 10.1016/j.biomaterials.2009.11.049
   Woolley AJ, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026007
   Woolley AJ, 2011, J NEUROSCI METH, V201, P67, DOI 10.1016/j.jneumeth.2011.07.012
   Zorman C. A., 2009, SILICON CARBIDE MAT
NR 44
TC 5
Z9 5
U1 2
U2 13
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1662-453X
J9 FRONT NEUROSCI-SWITZ
JI Front. Neurosci.
PD JUN 28
PY 2016
VL 10
AR 301
DI 10.3389/fnins.2016.00301
PG 12
WC Neurosciences
SC Neurosciences & Neurology
GA DQ7NS
UT WOS:000379395000001
PM 27445672
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Datta, SS
   Steinberg, AP
   Ismagilov, RF
AF Datta, Sujit S.
   Steinberg, Asher Preska
   Ismagilov, Rustem F.
TI Polymers in the gut compress the colonic mucus hydrogel
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE hydrogel; biophysics; biomaterials; polymers; mucus
ID HOST-MICROBIAL INTERACTIONS; POLYETHYLENE-GLYCOL; POLY(ETHYLENE GLYCOL);
   POLY(ACRYLIC ACID); LIGHT-SCATTERING; IN-VIVO;
   POLY(N-ISOPROPYLACRYLAMIDE) GEL; AUREOBASIDIUM-PULLULANS;
   PSEUDOMONAS-AERUGINOSA; INTRINSIC-VISCOSITY
AB Colonic mucus is a key biological hydrogel that protects the gut from infection and physical damage and mediates host-microbe interactions and drug delivery. However, little is known about how its structure is influenced by materials it comes into contact with regularly. For example, the gut abounds in polymers such as dietary fibers or administered therapeutics, yet whether such polymers interact with the mucus hydrogel, and if so, how, remains unclear. Although several biological processes have been identified as potential regulators of mucus structure, the polymeric composition of the gut environment has been ignored. Here, we demonstrate that gut polymers do in fact regulate mucus hydrogel structure, and that polymer-mucus interactions can be described using a thermodynamic model based on Flory-Huggins solution theory. We found that both dietary and therapeutic polymers dramatically compressed murine colonic mucus ex vivo and in vivo. This behavior depended strongly on both polymer concentration and molecular weight, in agreement with the predictions of our thermodynamic model. Moreover, exposure to polymer-rich luminal fluid from germ-free mice strongly compressed the mucus hydrogel, whereas exposure to luminal fluid from specific-pathogen-free mice-whose microbiota degrade gut polymers-did not; this suggests that gut microbes modulate mucus structure by degrading polymers. These findings highlight the role of mucus as a responsive biomaterial, and reveal a mechanism of mucus restructuring that must be integrated into the design and interpretation of studies involving therapeutic polymers, dietary fibers, and fiber-degrading gut microbes.
C1 [Datta, Sujit S.; Steinberg, Asher Preska; Ismagilov, Rustem F.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.
   [Ismagilov, Rustem F.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.
RP Ismagilov, RF (reprint author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.; Ismagilov, RF (reprint author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.
EM rustem.admin@caltech.edu
OI Datta, Sujit/0000-0003-2400-1561
FU Defense Advanced Research Projects Agency Biological Robustness in
   Complex Settings [HR0011-15-C-0093]; National Science Foundation (NSF)
   Emerging Frontiers in Research and Innovation Award [1137089]; NSF
   Graduate Research Fellowship [DGE-1144469]
FX We thank Said Bogatyrev, Andres Collazo, Elaine Hsiao, Julia Kornfield,
   Octavio Mondragon-Palomino, Ahmad Omar, Alexandre Persat, David Tirrell,
   Zhen-Gang Wang, and David Weitz for useful discussions; the Beckman
   Institute Biological Imaging Facility, the Broad Animal Facility, and
   the Church Animal Facility for experimental resources; the veterinary
   technicians at the California Institute of Technology for experimental
   assistance; Jennifer R. Keeffe for assistance with dynamic light
   scattering measurements; Dorothy Pan for assistance with gel permeation
   chromatography measurements; and Natasha Shelby for contributions to
   writing and editing this manuscript. This work was supported in part by
   Defense Advanced Research Projects Agency Biological Robustness in
   Complex Settings Contract HR0011-15-C-0093, National Science Foundation
   (NSF) Emerging Frontiers in Research and Innovation Award Grant 1137089,
   and NSF Graduate Research Fellowship DGE-1144469 (to A.P.S.).
CR ADACHI H, 1982, POLYM J, V14, P985, DOI 10.1295/polymj.14.985
   Aksoy N, 2002, TURK J MED SCI, V32, P373
   Ambort D, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a014159
   Ambort D, 2012, P NATL ACAD SCI USA, V109, P5645, DOI 10.1073/pnas.1120269109
   American Veterinary Medical Association, 2013, AVMA GUID EUTH AN 20
   Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922
   BANSIL R, 1995, ANNU REV PHYSIOL, V57, P635, DOI 10.1146/annurev.ph.57.030195.003223
   Barcelo A, 2000, GUT, V46, P218, DOI 10.1136/gut.46.2.218
   BEDNAR B, 1984, MACROMOLECULES, V17, P1634, DOI 10.1021/ma00138a037
   Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902
   BOYER RF, 1945, J CHEM PHYS, V13, P363, DOI 10.1063/1.1724050
   Brandup J, 1975, POLYM HDB
   BROCHARD F, 1981, J PHYS-PARIS, V42, P505, DOI 10.1051/jphys:01981004203050500
   Brownlee IA, 2003, P NUTR SOC, V62, P245, DOI 10.1079/PNS2003206
   BULIGA GS, 1987, INT J BIOL MACROMOL, V9, P71, DOI 10.1016/0141-8130(87)90029-8
   Button B, 2012, SCIENCE, V337, P937, DOI 10.1126/science.1223012
   Cai L., 2012, THESIS
   CHEN HL, 1982, MACROMOLECULES, V15, P1445, DOI 10.1021/ma00233a047
   Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008
   DEVANAND K, 1991, MACROMOLECULES, V24, P5943, DOI 10.1021/ma00022a008
   DiPalma JA, 2000, AM J GASTROENTEROL, V95, P446
   DIPALMA JA, 1989, AM J GASTROENTEROL, V84, P1008
   Dobrynin AV, 2005, PROG POLYM SCI, V30, P1049, DOI 10.1016/j.progpolymsci.2005.07.006
   Dondi F, 2012, THEORETICAL ADV CHRO
   Engevik MA, 2015, AM J PHYSIOL-GASTR L, V308, pG510, DOI 10.1152/ajpgi.00091.2014
   Fischer J, 2008, J PHYS CHEM B, V112, P13561, DOI 10.1021/jp805770q
   Flory P. J, 1953, PRINCIPLES POLYM CHE
   Georgiades P, 2014, BIOPOLYMERS, V101, P366, DOI 10.1002/bip.22372
   Gustafsson JK, 2012, AM J PHYSIOL-GASTR L, V302, pG430, DOI [10.1152/ajpgi.00405.2011., 10.1152/ajpgi.00405.2011]
   Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054
   Heneghan J, 2012, GERMFREE RES BIOL EF
   Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259
   HOVERSTAD T, 1986, J NUTR, V116, P1772
   ISHIDAO T, 1993, MACROMOLECULES, V26, P7361, DOI 10.1021/ma00078a036
   ISHIDAO T, 1995, FLUID PHASE EQUILIBR, V104, P119, DOI 10.1016/0378-3812(94)02643-F
   ITO T, 1989, BIOPHYS J, V56, P707, DOI 10.1016/S0006-3495(89)82717-1
   Jakobsson HE, 2015, EMBO REP, V16, P164, DOI 10.15252/embr.201439263
   JENTOFT N, 1990, TRENDS BIOCHEM SCI, V15, P291, DOI 10.1016/0968-0004(90)90014-3
   Johansson MEV, 2015, CELL HOST MICROBE, V18, P582, DOI 10.1016/j.chom.2015.10.007
   Johansson MEV, 2014, GUT, V63, P281, DOI 10.1136/gutjnl-2012-303207
   Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107
   Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238
   Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105
   KATO T, 1984, MACROMOLECULES, V17, P1726, DOI 10.1021/ma00139a016
   Kawaguchi S, 1997, POLYMER, V38, P2885, DOI 10.1016/S0032-3861(96)00859-2
   Kayaman N, 1997, POLYM GELS NETW, V5, P167, DOI 10.1016/S0966-7822(96)00039-1
   Khanvilkar K, 2001, ADV DRUG DELIVER REV, V48, P173, DOI 10.1016/S0169-409X(01)00115-6
   KIEFER J, 1993, COLLOID POLYM SCI, V271, P253, DOI 10.1007/BF00652365
   Kienberger F., 2000, Single Molecules, V1, P123, DOI 10.1002/1438-5171(200006)1:2<123::AID-SIMO123>3.3.CO;2-V
   Kim JH, 2000, BIOTECHNOL LETT, V22, P987, DOI 10.1023/A:1005681019573
   Kobayashi K, 2002, GUT, V51, P169, DOI 10.1136/gut.51.2.169
   Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104
   Lai SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004294
   Lai SK, 2009, ADV DRUG DELIVER REV, V61, P86, DOI 10.1016/j.addr.2008.09.012
   Lazaridou A, 2002, ENZYME MICROB TECH, V31, P122, DOI 10.1016/S0141-0229(02)00082-0
   Lentle RG, 2011, PHYS PROCESSES DIGES, P232
   Li H, 2009, SMART HYDROGEL MODELLING, P1, DOI 10.1007/978-3-642-02368-2
   Li H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9292
   Lidell ME, 2006, P NATL ACAD SCI USA, V103, P9298, DOI 10.1073/pnas.0600623103
   Lieleg O, 2010, BIOPHYS J, V98, P1782, DOI 10.1016/j.bpj.2010.01.012
   LOESCHE WJ, 1969, J BACTERIOL, V99, P520
   Lotfy S, 2009, INT J BIOL MACROMOL, V44, P57, DOI 10.1016/j.ijbiomac.2008.10.002
   Macfarlane S, 2006, ALIMENT PHARM THERAP, V24, P701, DOI 10.1111/j.1365-2036.2006.03042.x
   Maisel K, 2015, J CONTROL RELEASE, V209, P280, DOI 10.1016/j.jconrel.2015.04.040
   Matsui H, 2006, P NATL ACAD SCI USA, V103, P18131, DOI 10.1073/pnas.0606428103
   Mestecky J, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P1
   MIJNLIEFF PF, 1978, J POLYM SCI POL PHYS, V16, P245, DOI 10.1002/pol.1978.180160206
   MIKKELSEN A, 1985, BIOPOLYMERS, V24, P1683, DOI 10.1002/bip.360240904
   MOMII T, 1989, MACROMOLECULES, V22, P1384, DOI 10.1021/ma00193a063
   NISHI S, 1985, MACROMOLECULES, V18, P1519, DOI 10.1021/ma00150a001
   Olmsted SS, 2001, BIOPHYS J, V81, P1930, DOI 10.1016/S0006-3495(01)75844-4
   Pal S, 2010, INT J BIOL MACROMOL, V47, P623, DOI 10.1016/j.ijbiomac.2010.08.009
   Perez-Vilar J, 2007, AM J RESP CELL MOL, V36, P183, DOI 10.1165/rcmb.2006-0291TR
   PHILIPPOVA OE, 1994, MACROMOLECULES, V27, P2398, DOI 10.1021/ma00087a006
   Philippova OE, 2013, MACROMOLECULES, V46, P9359, DOI 10.1021/ma401945z
   Poon W. C. K., 2006, SOFT CONDENSED MATTE
   Prasitnok K, 2013, PHYS CHEM CHEM PHYS, V15, P17093, DOI 10.1039/c3cp52958d
   Quillin ML, 2000, ACTA CRYSTALLOGR D, V56, P791, DOI 10.1107/S090744490000679X
   Raynal BDE, 2003, J BIOL CHEM, V278, P28703, DOI 10.1074/jbc.M304632200
   RUBINSTEIN M, 1994, PHYS REV LETT, V73, P2776, DOI 10.1103/PhysRevLett.73.2776
   Rubinstein M., 2003, POLYM PHYS
   Saunders BR, 1997, MACROMOLECULES, V30, P482, DOI 10.1021/ma961277f
   SELLERS LA, 1991, BIOCHIM BIOPHYS ACTA, V1115, P174, DOI 10.1016/0304-4165(91)90027-E
   Sheehan JK, 2000, BIOCHEM J, V347, P37, DOI 10.1042/0264-6021:3470037
   Shimotoyodome A, 2001, DIGEST DIS SCI, V46, P1482, DOI 10.1023/A:1010644021888
   SHOGREN R, 1989, BIOCHEMISTRY-US, V28, P5525, DOI 10.1021/bi00439a029
   Sing CE, 2013, MACROMOLECULES, V46, P5053, DOI 10.1021/ma400372p
   Sobota JA, 2006, MOL BIOL CELL, V17, P5038, DOI 10.1091/mbc.E06-07-0626
   Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051
   SPIRO RG, 1970, ANNU REV BIOCHEM, V39, P599, DOI 10.1146/annurev.bi.39.070170.003123
   Stephen A. M., 2006, FOOD POLYSACCHARIDES
   Sun JL, 2010, MOLECULES, V15, P5162, DOI 10.3390/molecules15085162
   Szycher M., 1991, HIGH PERFORMANCE BIO
   TANFORD C, 1961, PHYS CHEM MACROMOLEC
   Valentine MT, 2004, BIOPHYS J, V86, P4004, DOI 10.1529/biophysj.103.037812
   VASILEVSKAYA VV, 1992, MACROMOLECULES, V25, P384, DOI 10.1021/ma00027a059
   Verdugo P., 2012, COLD SPRING HARB PER, V2
   Wang YY, 2008, ANGEW CHEM INT EDIT, V47, P9726, DOI 10.1002/anie.200803526
   Waters DJ, 2010, MACROMOLECULES, V43, P6861, DOI 10.1021/ma101070s
   White DR, 2003, J CHROMATOGR A, V997, P79, DOI 10.1016/S0021-9673(03)00626-5
   Wiley B. J., 1993, Journal of Environmental Polymer Degradation, V1, P3, DOI 10.1007/BF01457648
   Wu LC, 2004, GASTROENTEROLOGY, V126, P488, DOI 10.1053/j.gastro.2003.11.011
   Ziebacz N, 2011, SOFT MATTER, V7, P7181, DOI 10.1039/c0sm01357a
   Zindl CL, 2013, P NATL ACAD SCI USA, V110, P12768, DOI 10.1073/pnas.1300318110
NR 104
TC 6
Z9 6
U1 3
U2 23
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUN 28
PY 2016
VL 113
IS 26
BP 7041
EP 7046
DI 10.1073/pnas.1602789113
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DQ2LI
UT WOS:000379033400038
PM 27303035
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Han, FY
   Thurecht, KJ
   Whittaker, AK
   Smith, MT
AF Han, Felicity Y.
   Thurecht, Kristofer J.
   Whittaker, Andrew K.
   Smith, Maree T.
TI Bioerodable PLGA-Based Microparticles for Producing Sustained-Release
   Drug Formulations and Strategies for Improving Drug Loading
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Review
DE PLGA microparticles; drug delivery system; hydrophilic molecule;
   biodegradation mechanisms; tuneable release; microfluidics;
   supercritical carbon dioxide; hydrogel template
ID SUPERCRITICAL CARBON-DIOXIDE; DOUBLE-WALLED MICROSPHERES; HYDROGEL
   TEMPLATE METHOD; DOUBLE EMULSION METHOD; ONE-STEP FABRICATION; IN-VITRO
   EVALUATION; WATER-SOLUBLE DRUG; GLYCOLIC ACID PLGA; DELIVERY-SYSTEMS;
   SOLVENT EXTRACTION/EVAPORATION
AB Poly(lactic-co-glycolic acid) (PLGA) is the most widely used biomaterial for microencapsulation and prolonged delivery of therapeutic drugs, proteins and antigens. PLGA has excellent biodegradability and biocompatibility and is generally recognized as safe by international regulatory agencies including the United States Food and Drug Administration and the European Medicines Agency. The physicochemical properties of PLGA may be varied systematically by changing the ratio of lactic acid to glycolic acid. This in turn alters the release rate of microencapsulated therapeutic molecules from PLGA microparticle formulations. The obstacles hindering more widespread use of PLGA for producing sustained-release formulations for clinical use include low drug loading, particularly of hydrophilic small molecules, high initial burst release and/or poor formulation stability. In this review, we address strategies aimed at overcoming these challenges. These include use of low temperature double-emulsion methods to increase drug-loading by producing PLGA particles with a small volume for the inner water phase and a suitable pH of the external phase. Newer strategies for producing PLGA particles with high drug loading and the desired sustained -release profiles include fabrication of multi layered microparticles, nanoparticles-in-microparticles, use of hydrogel templates, as well as coaxial electrospray, microfluidics, and supercritical carbon dioxide methods. Another recent strategy with promise for producing particles with well-controlled and reproducible sustained -release profiles involves complexation of PLGA with additives such as polyethylene glycol, poly(ortho esters), chitosan, alginate, caffeic acid, hyaluronic acid, and silicon dioxide.
C1 [Han, Felicity Y.; Smith, Maree T.] Univ Queensland, Ctr Integrated Preclin Drug Dev, Brisbane, Qld, Australia.
   [Thurecht, Kristofer J.; Whittaker, Andrew K.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia.
   [Thurecht, Kristofer J.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia.
   [Thurecht, Kristofer J.; Whittaker, Andrew K.] ARC Ctr Excellence Convergent BioNano Sci & Techn, Brisbane, Qld, Australia.
   [Smith, Maree T.] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia.
RP Smith, MT (reprint author), Univ Queensland, Ctr Integrated Preclin Drug Dev, Brisbane, Qld, Australia.; Smith, MT (reprint author), Univ Queensland, Sch Pharm, Brisbane, Qld, Australia.
EM maree.smith@uq.edu.au
FU National Health and Medical Research Council (NHMRC) [APP1107723]
FX FH is supported by a postdoctoral fellowship funded by a National Health
   and Medical Research Council (NHMRC) grant, APP1107723.
CR Abulateefeh SR, 2016, AAPS PHARMSCITECH, V17, P891, DOI 10.1208/s12249-015-0413-y
   Acharya G, 2010, J CONTROL RELEASE, V146, P201, DOI 10.1016/j.jconrel.2010.03.024
   Acharya G, 2010, J CONTROL RELEASE, V141, P314, DOI 10.1016/j.jconrel.2009.09.032
   Anderson JM, 2012, ADV DRUG DELIVER REV, V64, P72, DOI 10.1016/j.addr.2012.09.004
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   Ansari T., 2012, ELIXIR PHARM, V47, P8821
   Barrow WW, 2004, CURR PHARM DESIGN, V10, P3275, DOI 10.2174/1381612043383197
   Baxendale A, 2011, INT J PHARMACEUT, V413, P147, DOI 10.1016/j.ijpharm.2011.04.053
   BODMEIER R, 1988, INT J PHARM, V43, P179, DOI 10.1016/0378-5173(88)90073-7
   Budisa Nediljko, 2014, Life-Basel, V4, P331, DOI 10.3390/life4030331
   Cai CF, 2009, J MICROENCAPSUL, V26, P334, DOI 10.1080/02652040802354707
   Chaisri Wasana, 2009, Current Drug Delivery, V6, P69
   Champeau M, 2015, J CONTROL RELEASE, V209, P248, DOI 10.1016/j.jconrel.2015.05.002
   Chaudhari KR, 2010, J MICROENCAPSUL, V27, P303, DOI 10.3109/02652040903191818
   Chemmunique, 1980, THE HLB SYST
   Cho DID, 2015, J MICROELECTROMECH S, V24, P10, DOI 10.1109/JMEMS.2014.2368071
   COHEN S, 1991, PHARMACEUT RES, V8, P713, DOI 10.1023/A:1015841715384
   Curley J, 1996, ANESTHESIOLOGY, V84, P1401, DOI 10.1097/00000542-199606000-00017
   Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043
   Dawes GJS, 2009, J MATER SCI-MATER M, V20, P1089, DOI 10.1007/s10856-008-3666-0
   Della Porta G, 2013, J BIOMAT SCI-POLYM E, V24, P1831, DOI 10.1080/09205063.2013.807457
   deMello AJ, 2006, NATURE, V442, P394, DOI 10.1038/nature05062
   Dhanda DS, 2013, J CONTROL RELEASE, V168, P239, DOI 10.1016/j.jconrel.2013.03.027
   Draheim C, 2015, PHARM RES-DORDR, V32, P2609, DOI 10.1007/s11095-015-1647-9
   Dunne M, 2000, BIOMATERIALS, V21, P1659, DOI 10.1016/S0142-9612(00)00040-5
   Engineer C, 2010, TRENDS BIOMATER ARTI, V24, P131, DOI DOI 10.1016/J.CHERD.2010.06.013
   Falco N, 2012, IND ENG CHEM RES, V51, P8616, DOI 10.1021/ie300482n
   Feng SB, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41943
   Feng SS, 2007, NANOMEDICINE-UK, V2, P333, DOI 10.2217/17435889.2.3.333
   Fredenberg S, 2011, INT J PHARMACEUT, V415, P34, DOI 10.1016/j.ijpharm.2011.05.049
   Freiberg S, 2004, INT J PHARM, V282, P1, DOI 10.1016/j.ijpharm.2004.04.013
   Freitas S, 2005, J CONTROL RELEASE, V102, P313, DOI 10.1016/j.jconrel.2004.10.015
   Fu X, 2005, J MICROENCAPSUL, V22, P705, DOI 10.1080/02652040500162196
   Gasparini G, 2010, COLLOID SURFACE B, V75, P557, DOI 10.1016/j.colsurfb.2009.09.035
   Govender T, 1999, J CONTROL RELEASE, V57, P171, DOI 10.1016/S0168-3659(98)00116-3
   Graves RA, 2004, INT J PHARMACEUT, V270, P251, DOI 10.1016/j.ijpharm.2003.10.019
   Han FY, 2015, J PHARM SCI-US, V104, P2334, DOI 10.1002/jps.24497
   Hillery AM, 2005, DRUG DELIVERY TARGET
   Houchin ML, 2009, J APPL POLYM SCI, V114, P2848, DOI 10.1002/app.30813
   Howdle SM, 2001, CHEM COMMUN, P109, DOI 10.1039/b008188o
   Huang Y, 2014, LANGMUIR, V30, P7304, DOI 10.1021/la5011488
   Hung LH, 2010, LAB CHIP, V10, P1820, DOI 10.1039/c002866e
   Hwisa N. T., 2013, VRI BIOL MED CHEM, V1, P8, DOI [10.14259/bmc.v1i1.29, DOI 10.14259/BMC.V1I1.29]
   Ito F, 2011, COLLOID SURFACE A, V384, P368, DOI 10.1016/j.colsurfa.2011.04.017
   Jordan F, 2010, J CONTROL RELEASE, V141, P153, DOI 10.1016/j.jconrel.2009.09.013
   Joung Yoon Ki, 2011, [Biomaterials Research, 생체재료학회지], V15, P78
   Kamaly N, 2016, CHEM REV, V116, P2602, DOI 10.1021/acs.chemrev.5b00346
   Kapoor DN, 2015, THER DELIV, V6, P41, DOI [10.4155/tde.14.91, 10.4155/TDE.14.91]
   Kim HK, 2006, J CONTROL RELEASE, V112, P167, DOI 10.1016/j.jconrel.2006.02.004
   Klose D, 2008, INT J PHARMACEUT, V354, P95, DOI 10.1016/j.ijpharm.2007.10.030
   Klose D, 2006, INT J PHARMACEUT, V314, P198, DOI 10.1016/j.ijpharm.2005.07.031
   Koushik K, 2004, PHARM RES-DORDR, V21, P524, DOI 10.1023/B:PHAM.0000019308.25479.a4
   LANGER R, 1986, CHEMTECH, V16, P108
   Lee YS, 2013, EUR J PHARM BIOPHARM, V83, P168, DOI 10.1016/j.ejpb.2012.10.016
   Lee YH, 2011, COLLOID SURFACE B, V82, P104, DOI 10.1016/j.colsurfb.2010.08.022
   Leo E, 2004, INT J PHARM, V278, P133, DOI 10.1016/j.ijpharm.2004.03.002
   Leon RAL, 2015, PART PART SYST CHAR, V32, P567, DOI 10.1002/ppsc.201400229
   Li WX, 2015, RSC ADV, V5, P23181, DOI 10.1039/c4ra17153e
   Liggins RT, 2004, INFLAMM RES, V53, P363, DOI 10.1007/s00011-004-1273-1
   Lim MPA, 2013, BIOMATER SCI-UK, V1, P486, DOI 10.1039/c3bm00175j
   Lu Y, 2014, INT J PHARMACEUT, V461, P258, DOI 10.1016/j.ijpharm.2013.11.058
   Mahboubian A, 2010, IRAN J PHARM RES, V9, P369
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   Malavia N, 2015, INVEST OPHTH VIS SCI, V56
   Mao SR, 2007, INT J PHARM, V334, P137, DOI 10.1016/j.ijpharm.2006.10.036
   Na XM, 2012, ACS MACRO LETT, V1, P697, DOI 10.1021/mz200222d
   Nafissi-Varcheh N, 2011, IRAN J PHARM RES, V10, P203
   Nan KH, 2014, ACTA BIOMATER, V10, P3505, DOI 10.1016/j.actbio.2014.04.024
   Navaei A, 2014, DRUG DEV IND PHARM, V40, P701, DOI 10.3109/03639045.2013.777734
   Nie ZH, 2006, J AM CHEM SOC, V128, P9408, DOI 10.1021/ja060882n
   Nijsen JFW, 2002, CURR MED CHEM, V9, P73, DOI 10.2174/0929867023371454
   Park KM, 2014, FOOD CHEM, V161, P53, DOI 10.1016/j.foodchem.2014.03.125
   Reinhold SE, 2013, MACROMOL BIOSCI, V13, P1700, DOI 10.1002/mabi.201300323
   Riahi R, 2015, CURR OPIN CHEM ENG, V7, P101, DOI 10.1016/j.coche.2014.12.001
   Sanna V, 2015, INT J BIOL MACROMOL, V72, P531, DOI 10.1016/j.ijbiomac.2014.08.053
   Selmin Francesca, 2015, J Funct Biomater, V6, P1, DOI 10.3390/jfb6010001
   SHAH SS, 1992, J CONTROL RELEASE, V18, P261, DOI 10.1016/0168-3659(92)90171-M
   Shi M, 2003, J CONTROL RELEASE, V89, P167, DOI 10.1016/S0168-3659(02)00493-5
   Siegel SJ, 2006, EUR J PHARM BIOPHARM, V64, P287, DOI 10.1016/j.wjpb.2006.06.009
   Siepmann J, 2004, J CONTROL RELEASE, V96, P123, DOI 10.1016/j.jconrel.2004.01.011
   Sosnik A, 2015, ADV COLLOID INTERFAC, V223, P40, DOI 10.1016/j.cis.2015.05.003
   Syrett JA, 2010, POLYM CHEM-UK, V1, P978, DOI 10.1039/c0py00104j
   Thote AJ, 2005, NANOMED-NANOTECHNOL, V1, P85, DOI 10.1016/j.nano.2004.12.001
   Varde NK, 2004, EXPERT OPIN BIOL TH, V4, P35, DOI 10.1517/eobt.4.1.35.25256
   Viry L, 2012, J MATER CHEM, V22, P11347, DOI 10.1039/c2jm31069d
   Wan F, 2016, INT J PHARMACEUT, V498, P82, DOI 10.1016/j.ijpharm.2015.12.025
   Wang H, 2015, BIOMATERIALS, V72, P74, DOI 10.1016/j.biomaterials.2015.08.048
   Wang J, 2002, J CONTROL RELEASE, V82, P289, DOI 10.1016/S0168-3659(02)00137-2
   Xie H, 2012, LANGMUIR, V28, P4459, DOI 10.1021/la2042185
   Xu QB, 2009, SMALL, V5, P1575, DOI 10.1002/smll.200801855
   Yang YY, 2000, J CONTROL RELEASE, V69, P81, DOI 10.1016/S0168-3659(00)00291-1
   Yuan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132609
   Yun-Seok R., 2010, PHARM TECH S, V2010, P1
   Zamani M, 2014, INT J PHARMACEUT, V473, P134, DOI 10.1016/j.ijpharm.2014.07.006
   Zhang LL, 2012, EXPERT REV MED DEVIC, V9, P595, DOI [10.1586/erd.12.58, 10.1586/ERD.12.58]
   Zhang Y, 2013, ADV DRUG DELIVER REV, V65, P104, DOI 10.1016/j.addr.2012.10.003
   Zheng CH, 2010, DRUG DELIV, V17, P77, DOI 10.3109/10717540903509001
   Zheng W, 2009, INT J PHARMACEUT, V374, P90, DOI 10.1016/j.ijpharm.2009.03.015
NR 98
TC 29
Z9 33
U1 20
U2 175
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD JUN 28
PY 2016
VL 7
AR 185
DI 10.3389/fphar.2016.00185
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DP7OI
UT WOS:000378688300001
PM 27445821
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Rossi, B
   Campia, P
   Merlini, L
   Brasca, M
   Pastori, N
   Farris, S
   Melone, L
   Punta, C
   Galante, YM
AF Rossi, Bianca
   Campia, Paola
   Merlini, Luca
   Brasca, Milena
   Pastori, Nadia
   Farris, Stefano
   Melone, Lucio
   Punta, Carlo
   Galante, Yves M.
TI An aerogel obtained from chemo-enzymatically oxidized fenugreek
   galactomannans as a versatile delivery system
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Galactomannans; Fenugreek; Laccase oxidation; Aerogel; Lysozyme;
   Delivery system
ID GALACTOSE-CONTAINING POLYSACCHARIDES; TEMPO-MEDIATED OXIDATION;
   ANTIBACTERIAL ACTIVITY; SELECTIVE OXIDATION; FTIR SPECTROSCOPY; GREEN
   CHEMISTRY; GUAR GUM; CELLULOSE; OXIDASE; LACCASE
AB We describe a new aerogel obtained from laccase-oxidized galactomannans of the leguminous plant fenugreek (Trigonella foenum-graecum) and suggest its potential practical use.
   Laccase/TEMPO oxidation of fenugreek in aqueous solution caused a viscosity increase of over 15-fold. A structured, elastic, stable hydrogel was generated, due to formation of carbonyl groups from primary OH of galactose side units and subsequent establishment of hemiacetalic bonds with available free hydroxyl groups.
   Upon lyophilization of this hydrogel, a water-insoluble aerogel was obtained (EOLFG), capable of up taking aqueous or organic solvents over 20 times its own weight. The material was characterized by scanning electron microscopy, FT-IR, elemental analysis and C-13 CP-MAS NMR spectroscopy and its mechanical properties were investigated.
   To test the EOLFG as a delivery system, the anti-microbial enzyme lysozyme was used as model active principle. Lysozyme was added before or after formation of the aerogel, entrapped or absorbed in the gel, retained and released in active form, as proven by its hydrolytic glycosidase activity on lyophilized Micrococcus lysodeikticus cells wall peptidoglycans.
   This new biomaterial, composed of a chemo-enzymatically modified plant polysaccharide, might represent a versatile, biocompatible "delivery system" of active principles in food and non-food products. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Rossi, Bianca; Merlini, Luca; Galante, Yves M.] CNR, Ist Chim Riconoscimento Mol, Via Mario Bianco 9, I-20131 Milan, Italy.
   [Campia, Paola; Brasca, Milena] CNR, Ist Sci Prod Alimentari, Via Celoria 2, I-20131 Milan, Italy.
   [Pastori, Nadia; Melone, Lucio; Punta, Carlo] Politecn Milan, Dept Chem Mat & Chem Engn G Natta, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy.
   [Pastori, Nadia; Melone, Lucio; Punta, Carlo] Politecn Milan, Local Unit INSTM, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy.
   [Melone, Lucio] Univ E Campus, Via Isimbardi 10, I-22060 Novedrate, Como, Italy.
   [Farris, Stefano] Univ Milan, Dept Food Environm & Nutr Sci, DeFENS, PackLAB,Unimi Food Packaging Lab, ViaCeloria 2, I-20133 Milan, Italy.
RP Galante, YM (reprint author), CNR, Ist Chim Riconoscimento Mol, Via Mario Bianco 9, I-20131 Milan, Italy.; Melone, L; Punta, C (reprint author), Politecn Milan, Dept Chem Mat & Chem Engn G Natta, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy.; Melone, L; Punta, C (reprint author), Politecn Milan, Local Unit INSTM, Piazza Leonardo da Vinci 32, I-20133 Milan, Italy.; Melone, L (reprint author), Univ E Campus, Via Isimbardi 10, I-22060 Novedrate, Como, Italy.
EM bianca.rossi@polimi.it; paola.campia@ispa.cnr.it;
   luca.merlini@icrm.cnr.it; milena.brasca@ispa.cnr.it;
   nadia.pastori@polimi.it; stefano.farris@unimi.it;
   lucio.melone@polimi.it; carlo.punta@polimi.it; yves.galante@icrm.cnr.it
RI Brasca, Milena/C-4049-2009; Farris, Stefano/J-3257-2016; Punta,
   Carlo/C-2657-2008
OI Brasca, Milena/0000-0002-8821-0787; Punta, Carlo/0000-0002-7239-9554;
   Merlini, Luca/0000-0002-9856-1185; Farris, Stefano/0000-0002-6423-8443
FU program Suschem Lombardia: prodotti e processi chimici sostenibili per
   l'industria lombarda. Accordo Quadro Regione Lombardia-CNR [18096/RCC];
   Cariplo Foundation [2014-0478]; MIUR (PRIN) [2010PFLRJR_005]
FX This project was supported by the program Suschem Lombardia: prodotti e
   processi chimici sostenibili per l'industria lombarda. Accordo Quadro
   Regione Lombardia-CNR, 16/07/2012 (protocol no. 18096/RCC), by Cariplo
   Foundation (grant 2014-0478) and by MIUR (PRIN 2010-2011, PROxi project
   2010PFLRJR_005).
CR Abidi N, 2014, CARBOHYD POLYM, V100, P9, DOI 10.1016/j.carbpol.2013.01.074
   Alcalde M, 2006, TRENDS BIOTECHNOL, V24, P281, DOI 10.1016/j.tibtech.2005.04.002
   Avila M, 2014, INT J FOOD MICROBIOL, V172, P70, DOI 10.1016/j.ijfoodmicro.2013.12.002
   Baldaro E, 2012, COLOR TECHNOL, V128, P315, DOI 10.1111/j.1478-4408.2012.00382.x
   Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117
   Bragd PL, 2004, TOP CATAL, V27, P49, DOI 10.1023/B:TOCA.0000013540.69309.46
   Brasca M, 2013, MOLECULES, V18, P6008, DOI 10.3390/molecules18056008
   Brummer Y, 2003, FOOD HYDROCOLLOID, V17, P229, DOI 10.1016/S0268-005X(02)00054-1
   Carrillo W, 2014, J FOOD PROTECT, V77, P1732, DOI 10.4315/0362-028X.JFP-14-009
   Chen WS, 2011, SOFT MATTER, V7, P10360, DOI 10.1039/c1sm06179h
   Cheng HN, 2012, POLYMERS-BASEL, V4, P1311, DOI 10.3390/polym4021311
   Cheng Y, 2002, MACROMOLECULES, V35, P10155, DOI 10.1021/ma020887e
   Cheroni S, 2010, ENZYME MICROB TECH, V47, P348, DOI 10.1016/j.enzmictec.2010.08.001
   Crescenzi V, 2004, BIOMACROMOLECULES, V5, P537, DOI 10.1021/bm034387k
   Daas PJH, 2002, J AGR FOOD CHEM, V50, P4282, DOI 10.1021/jf011399t
   Daas PJH, 2000, CARBOHYD RES, V329, P609, DOI 10.1016/S0008-6215(00)00209-3
   Daniel JR, 1994, ULLMANNS ENCY IND A, VA25, P1
   Delagrave S, 2001, PROTEIN ENG, V14, P261, DOI 10.1093/protein/14.4.261
   Delagrave S, 2002, US Patent, Patent No. [6.498.026 B2, 6498026]
   Delattre C, 2015, CARBOHYD POLYM, V116, P34, DOI 10.1016/j.carbpol.2014.04.054
   Deszczynski M, 2003, CARBOHYD POLYM, V53, P85, DOI 10.1016/S0144-8617(02)00327-2
   Ding B, 2008, CARBOHYD RES, V343, P3112, DOI 10.1016/j.carres.2008.09.005
   Donnelly MJ, 1999, METH BIOTEC, V10, P79
   Elboutachfaiti R, 2011, CARBOHYD POLYM, V84, P1, DOI 10.1016/j.carbpol.2010.10.063
   Fabbrini M, 2002, J MOL CATAL B-ENZYM, V16, P231, DOI 10.1016/S1381-1177(01)00067-4
   FROLLINI E, 1995, CARBOHYD POLYM, V27, P129, DOI 10.1016/0144-8617(95)00021-X
   Galante YA, 2003, CURR ORG CHEM, V7, P1399, DOI 10.2174/1385272033486468
   Ghafar A, 2015, EUR POLYM J, V71, P171, DOI 10.1016/j.eurpolymj.2015.07.046
   HALL LD, 1980, CARBOHYD RES, V81, pC10, DOI 10.1016/S0008-6215(00)85669-4
   Jetten J.M., 2000, WO Patent, Patent No. [00/50463, 0050463]
   Kulys J, 2005, J MOL CATAL B-ENZYM, V37, P79, DOI 10.1016/j.molcatb.2005.09.010
   Lavazza M, 2011, J BIOTECHNOL, V156, P108, DOI 10.1016/j.jbiotec.2011.08.029
   Leppanen AS, 2010, CARBOHYD RES, V345, P2610, DOI 10.1016/j.carres.2010.09.026
   Li Shuang, 2012, Comput Struct Biotechnol J, V2, pe201209017, DOI 10.5936/csbj.201209017
   Liyanage S, 2015, IND CROP PROD, V74, P388, DOI 10.1016/j.indcrop.2015.05.013
   Marzorati M, 2005, GREEN CHEM, V7, P310, DOI 10.1039/b416668j
   Mathur MK, 2011, IND GALACTOMANNAN PO
   MCCLEARY BV, 1985, CARBOHYD RES, V139, P237
   Melone L, 2013, J PHOTOCH PHOTOBIO A, V261, P53, DOI 10.1016/j.jphotochem.2013.04.004
   Merlini L, 2015, J BIOTECHNOL, V198, P31, DOI 10.1016/j.jbiotec.2015.01.023
   Mikkonen KS, 2014, RSC ADV, V4, P11884, DOI 10.1039/c3ra47440b
   Mitrus M., 2009, THERMOPLASTIC STARCH, P1
   Morozova OV, 2007, APPL BIOCHEM MICRO+, V43, P523, DOI 10.1134/S0003683807050055
   Murlidhar Meghwal, 2012, Journal of Food Processing and Technology, V3, P181
   Murthy P. S., 2010, U.S. Patent, Patent No. [7,815,946, 7815946]
   Narain R., 2011, ENG CARBOHYDRATE BAS
   Nestl BM, 2011, CURR OPIN CHEM BIOL, V15, P187, DOI 10.1016/j.cbpa.2010.11.019
   NIKUPAAVOLA ML, 1988, BIOCHEM J, V254, P877, DOI 10.1042/bj2540877
   Olsson AM, 2004, CARBOHYD RES, V339, P813, DOI 10.1016/j.carres.2004.01.005
   Parikka K, 2015, J MOL CATAL B-ENZYM, V120, P47, DOI 10.1016/j.molcatb.2015.06.006
   Parikka K, 2012, BIOMACROMOLECULES, V13, P2418, DOI 10.1021/bm300679a
   Parikka K, 2010, J AGR FOOD CHEM, V58, P262, DOI 10.1021/jf902930t
   Parikka K, 2009, CARBOHYD RES, V344, P14, DOI 10.1016/j.carres.2008.08.020
   Prajapati VD, 2013, INT J BIOL MACROMOL, V60, P83, DOI 10.1016/j.ijbiomac.2013.05.017
   Riva S, 2006, TRENDS BIOTECHNOL, V24, P219, DOI 10.1016/j.tibtech.2006.03.006
   Rodgers CJ, 2010, TRENDS BIOTECHNOL, V28, P63, DOI 10.1016/j.tibtech.2009.11.001
   Silvetti T, 2010, J I BREWING, V116, P33, DOI 10.1002/j.2050-0416.2010.tb00395.x
   Sittikijyothin W, 2005, CARBOHYD POLYM, V59, P339, DOI 10.1016/j.carbpol.2004.10.005
   Takahashi H, 2011, J FOOD PROTECT, V74, P994, DOI 10.4315/0362-028X.JFP-10-406
   Tavernier ML, 2008, CARBOHYD RES, V343, P2687, DOI 10.1016/j.carres.2008.06.002
   Tiwari BK, 2009, J AGR FOOD CHEM, V57, P5987, DOI 10.1021/jf900668n
   Viikari L., 1999, WO Patent, Patent No. [99/23240, 9923240]
   Viikari L., 1999, WO Patent, Patent No. [99/23117, 923117]
   Wei YX, 2015, J FOOD ENG, V166, P21, DOI 10.1016/j.jfoodeng.2015.05.015
   Witayakran S, 2009, ADV SYNTH CATAL, V351, P1187, DOI 10.1002/adsc.200800775
   Yoshitomi T, 2012, ACTA BIOMATER, V8, P1323, DOI 10.1016/j.actbio.2011.11.029
   Yoshitomi T, 2011, BIOMATERIALS, V32, P8021, DOI 10.1016/j.biomaterials.2011.07.014
NR 67
TC 8
Z9 8
U1 5
U2 74
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JUN 25
PY 2016
VL 144
BP 353
EP 361
DI 10.1016/j.carbpol.2016.02.007
PG 9
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA DI9NX
UT WOS:000373830700042
PM 27083827
OA Green Published
DA 2018-10-19
ER

PT J
AU Gu, Q
   Tomaskovic-Crook, E
   Lozano, R
   Chen, Y
   Kapsa, RM
   Zhou, Q
   Wallace, GG
   Crook, JM
AF Gu, Qi
   Tomaskovic-Crook, Eva
   Lozano, Rodrigo
   Chen, Yu
   Kapsa, Robert M.
   Zhou, Qi
   Wallace, Gordon G.
   Crook, Jeremy M.
TI Functional 3D Neural Mini-Tissues from Printed Gel-Based Bioink and
   Human Neural Stem Cells
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE 3D bioprinting; 3D human neural tissue; cell encapsulation; human stem
   cells; polysaccharide bioink
ID MAGNETIC-RESONANCE ELASTOGRAPHY; BIOMEDICAL APPLICATIONS; BRAIN;
   ENCAPSULATION; CONSTRUCTS; NEURONS
AB Direct-write printing of stem cells within biomaterials presents an opportunity to engineer tissue for in vitro modeling and regenerative medicine. Here, a first example of constructing neural tissue by printing human neural stem cells that are differentiated in situ to functional neurons and supporting neuroglia is reported. The supporting biomaterial incorporates a novel clinically relevant polysaccharide-based bioink comprising alginate, carboxymethyl-chitosan, and agarose. The printed bioink rapidly gels by stable cross-linking to form a porous 3D scaffold encapsulating stem cells for in situ expansion and differentiation. Differentiated neurons form synaptic contacts, establish networks, are spontaneously active, show a bicuculline-induced increased calcium response, and are predominantly gamma-aminobutyric acid expressing. The 3D tissues will facilitate investigation of human neural development, function, and disease, and may be adaptable for engineering other 3D tissues from different stem cell types.
C1 [Gu, Qi; Tomaskovic-Crook, Eva; Lozano, Rodrigo; Chen, Yu; Kapsa, Robert M.; Wallace, Gordon G.; Crook, Jeremy M.] Univ Wollongong, AIIM Facil, ARC Ctr Excellence Elect Sci, Intelligent Polymer Res Inst, Innovation Campus,Squires Way, Fairy Meadow, NSW 2519, Australia.
   [Gu, Qi; Zhou, Qi] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.
   [Tomaskovic-Crook, Eva; Crook, Jeremy M.] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia.
   [Kapsa, Robert M.] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia.
   [Crook, Jeremy M.] Univ Melbourne, St Vincents Hosp, Dept Surg, Fitzroy, Vic 3065, Australia.
RP Wallace, GG; Crook, JM (reprint author), Univ Wollongong, AIIM Facil, ARC Ctr Excellence Elect Sci, Intelligent Polymer Res Inst, Innovation Campus,Squires Way, Fairy Meadow, NSW 2519, Australia.; Crook, JM (reprint author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia.; Crook, JM (reprint author), Univ Melbourne, St Vincents Hosp, Dept Surg, Fitzroy, Vic 3065, Australia.
EM gwallace@uow.edu.au; jcrook@uow.edu.au
RI Wallace, Gordon/H-1123-2011
OI Wallace, Gordon/0000-0002-0381-7273; Crook, Jeremy/0000-0002-6415-1639;
   Tomaskovic-Crook, Eva/0000-0002-7818-9013
FU Australian Research Council (ARC) Centre of Excellence Scheme
   [CE140100012]; Australian National Fabrication Facility (ANFF)-Materials
   Node; ARC through an ARC Laureate Fellowship [FL110100196]; Consejo
   Nacional de Ciencia y Tecnologia (CONACYT, Mexico); National Basic
   Research Program of China [2012CBA01300]
FX J.M.C., G.G.W., Q.Z., and R.K. conceived the study. J.M.C., Q.G., and
   E.T.C. planned and/or executed experiments. R.L. and Y.C. provided
   technical support and guidance with data interpretation for diffusion
   studies and SEM, respectively. J.M.C. wrote the paper with contributions
   from Q.G. and E.T.C. All authors commented on the paper. J.M.C. and
   G.G.W. supervised all aspects of the work. The authors wish to
   acknowledge funding from the Australian Research Council (ARC) Centre of
   Excellence Scheme (CE140100012), the use of facilities at the University
   of Wollongong Electron Microscopy Centre, support of the Australian
   National Fabrication Facility (ANFF)-Materials Node, and assistance
   provided by Dr. Johnson Chung with bioink and gel characterization, Dr.
   Xiao Liu and Dr. Zhilian Yue with bioprinting, Mr. Aaron Waters with
   COMSOL modeling, and Dr. Kerry Gilmore for critically reviewing the
   paper. Prof. Gordon Wallace acknowledges the support of the ARC through
   an ARC Laureate Fellowship (FL110100196), and Mr. Rodrigo Lozano
   acknowledges the support of the Consejo Nacional de Ciencia y Tecnologia
   (CONACYT, Mexico). Professor Qi Zhou acknowledges the support of the
   National Basic Research Program of China (2012CBA01300). The
   acknowledgements section of this article was changed on 22.06.2016.
CR Ahearne M., 2008, TOPICS TISSUE ENG, P1
   Billiet T, 2014, BIOMATERIALS, V35, P49, DOI 10.1016/j.biomaterials.2013.09.078
   CARMAN PC, 1954, PROC R SOC LON SER-A, V222, P109, DOI 10.1098/rspa.1954.0056
   Cave JW, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00016
   Chueh BH, 2010, BIOMED MICRODEVICES, V12, P145, DOI 10.1007/s10544-009-9369-6
   Chung JHY, 2013, BIOMATER SCI-UK, V1, P763, DOI 10.1039/c3bm00012e
   Cohen DL, 2011, TISSUE ENG PART C-ME, V17, P239, DOI [10.1089/ten.tec.2010.0093, 10.1089/ten.TEC.2010.0093]
   Crank J, 1975, MATH DIFFUSION
   Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254
   Jeon O, 2013, ADV FUNCT MATER, V23, P4765, DOI 10.1002/adfm.201300529
   Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Li RH, 1996, BIOTECHNOL BIOENG, V50, P365, DOI 10.1002/(SICI)1097-0290(19960520)50:4<365::AID-BIT3>3.0.CO;2-J
   Lozano R, 2015, BIOMATERIALS, V67, P264, DOI 10.1016/j.biomaterials.2015.07.022
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Ouyang LL, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/4/044101
   Pati F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4935
   Patrulea V, 2015, EUR J PHARM BIOPHARM, V97, P417, DOI 10.1016/j.ejpb.2015.08.004
   Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684
   RADOMSKI MW, 1990, P NATL ACAD SCI USA, V87, P10043, DOI 10.1073/pnas.87.24.10043
   Rutz AL, 2015, ADV MATER, V27, P1607, DOI 10.1002/adma.201405076
   Shin SR, 2012, ACS NANO, V6, P362, DOI 10.1021/nn203711s
   Sivashankari PR, 2016, INT J BIOL MACROMOL, V93, P1382, DOI 10.1016/j.ijbiomac.2016.02.043
   Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027
   Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657
   Upadhyaya L, 2013, CARBOHYD POLYM, V91, P452, DOI 10.1016/j.carbpol.2012.07.076
   WEINSTEIN DE, 1991, J CELL BIOL, V112, P1205, DOI 10.1083/jcb.112.6.1205
   Xu ZNS, 2013, J ULTRAS MED, V32, P485, DOI 10.7863/jum.2013.32.3.485
NR 28
TC 43
Z9 44
U1 17
U2 132
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JUN 22
PY 2016
VL 5
IS 12
BP 1429
EP 1438
DI 10.1002/adhm.201600095
PG 10
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA DQ9SU
UT WOS:000379550400006
PM 27028356
OA Bronze
DA 2018-10-19
ER

PT J
AU Glynn, JJ
   Hinds, MT
AF Glynn, Jeremy J.
   Hinds, Monica T.
TI Bioactive Anti-Thrombotic Modification of Decellularized Matrix for
   Vascular Applications
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE coagulation; decellularized biomaterial; heparin; platelets;
   thrombomodulin
ID SMALL-INTESTINAL SUBMUCOSA; ACTIVATED PROTEIN-C; NEOINTIMAL HYPERPLASIA;
   IN-VITRO; GRAFTS; HEPARIN; MODEL; VALVE; THROMBOSIS; HEMOCOMPATIBILITY
AB The decellularized matrix derived from porcine small intestinal submucosa (SIS) is a widely used biomaterial being investigated for numerous applications. Currently, thrombus deposition and neointimal hyperplasia have limited the use of SIS in some vascular applications. To limit these detrimental processes, this work applies bioactive, endothelial-inspired properties to the material. SIS is modified with the endothelial cell membrane protein thrombomodulin and the glycosaminoglycan heparin to facilitate protein C activation and anticoagulant activity, respectively. Modifying SIS with thrombomodulin alone enables robust activated protein C (APC) generation, and thrombomodulin activity is maintained after prolonged exposure to fluid shear and blood plasma. Heparin-modified SIS has a potent anticoagulant activity. When both modifications are applied sequentially, SIS modified first with thrombomodulin then with heparin retains the full activity of each individual modification. Tubular SIS devices are connected to a baboon arteriovenous shunt to quantify thrombus deposition on these materials. After being exposed to flowing whole blood for 60 min, SIS devices modified first with thrombomodulin then with heparin have significantly less platelet accumulation compared to unmodified SIS devices. These studies demonstrate that modifying SIS with thrombomodulin and heparin confers APC generation and anticoagulant activity that results in reduced thrombogenesis.
C1 [Glynn, Jeremy J.; Hinds, Monica T.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Mail Code CH13B,3303 SW Bond Ave, Portland, OR 97239 USA.
RP Hinds, MT (reprint author), Oregon Hlth & Sci Univ, Dept Biomed Engn, Mail Code CH13B,3303 SW Bond Ave, Portland, OR 97239 USA.
EM hindsm@ohsu.edu
OI Glynn, Jeremy/0000-0003-1961-9121
FU National Science Foundation [DGE-0925180]; American Heart Association
   Predoctoral Fellowship [14PRE20380042]; NIH [R01HL103728, OD011092]
FX The authors gratefully acknowledge the technical support provided by
   Jennifer Greisel. Additionally, the authors appreciate the donation of
   SIS from Cook Biotech, and financial support from the National Science
   Foundation Graduate Research Fellowship DGE-0925180, the American Heart
   Association Predoctoral Fellowship 14PRE20380042, as well as funding
   from NIH Grant R01HL103728. Operation of the Oregon National Primate
   Research Center was supported by NIH grant OD011092. These sponsors did
   not have any involvement in designing or performing the experiments or
   in writing the manuscript.
CR Anderson DEJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115163
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Begovac PC, 2003, EUR J VASC ENDOVASC, V25, P432, DOI 10.1053/ejvs.2002.1909
   Cutiongco MFA, 2015, ACTA BIOMATER, V25, P97, DOI 10.1016/j.actbio.2015.07.039
   Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S
   Fallon AM, 2014, J THORAC CARDIOV SUR, V148, P333, DOI 10.1016/j.jtcvs.2013.10.048
   Gasper PM, 2012, P NATL ACAD SCI USA, V109, P21216, DOI 10.1073/pnas.1218414109
   Glynn JJ, 2016, J BIOMED MATER RES B, V104, P1610, DOI 10.1002/jbm.b.33507
   Glynn JJ, 2015, ACTA BIOMATER, V14, P96, DOI 10.1016/j.actbio.2014.11.038
   Glynn JJ, 2015, TISSUE ENG PT A, V21, P174, DOI [10.1089/ten.tea.2014.0032, 10.1089/ten.TEA.2014.0032]
   Griffin JH, 2007, J THROMB HAEMOST, V5, P73, DOI 10.1111/j.1538-7836.2007.02491.x
   Griffin JH, 2015, BLOOD, V125, P2898, DOI 10.1182/blood-2015-02-355974
   Hanson SR, 1998, AM HEART J, V135, pS132, DOI 10.1016/S0002-8703(98)70241-8
   HANSON SR, 1985, ARTERIOSCLEROSIS, V5, P595, DOI 10.1161/01.ATV.5.6.595
   HANSON SR, 1980, J LAB CLIN MED, V95, P289
   Hinds MT, 2008, J BIOMED MATER RES A, V86A, P804, DOI 10.1002/jbm.a.31672
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Kocsis JF, 2000, J LONG-TERM EFF MED, V10, P19
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   Li JM, 2004, J VASC SURG, V39, P1074, DOI 10.1016/j.jvs.2003.12.030
   Lin PH, 2004, J VASC SURG, V39, P1322, DOI 10.1016/j.jvs.2004.01.046
   Lukovic D, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5580-6
   Mann KG, 2009, HAMOSTASEOLOGIE, V29, P7
   Mann KG, 2003, ARTERIOSCL THROM VAS, V23, P17, DOI 10.1161/01.ATV.0000046238.23903.FC
   Matheny RG, 2000, J HEART VALVE DIS, V9, P769
   Matsusaki M, 2008, J BIOMED MATER RES A, V84A, P1, DOI 10.1002/jbm.a.31460
   Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004
   Pavcnik D, 2002, J VASC SURG, V35, P598, DOI 10.1067/mva.2002.118825
   Pavcnik D, 2008, VASC MED, V13, P75, DOI 10.1177/1358863X07083474
   Pavcnik D, 2009, CARDIOVASC INTER RAD, V32, P106, DOI 10.1007/s00270-008-9449-7
   Quint C, 2011, P NATL ACAD SCI USA, V108, P9214, DOI 10.1073/pnas.1019506108
   Qureshi SH, 2009, BIOCHEMISTRY-US, V48, P8261, DOI 10.1021/bi900921t
   Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x
   Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8
   SANDUSKY GE, 1992, AM J PATHOL, V140, P317
   Smith RJ, 2015, BIOMATERIALS, V51, P303, DOI 10.1016/j.biomaterials.2015.02.025
   Toyota N, 2002, J VASC INTERV RADIOL, V13, P489, DOI 10.1016/S1051-0443(07)61529-2
   van Oeveren W, 2002, ARTIF ORGANS, V26, P506, DOI 10.1046/j.1525-1594.2002.06872.x
   Vartanian KB, 2008, BIOCHEM BIOPH RES CO, V371, P787, DOI 10.1016/j.bbrc.2008.04.167
   Weitz JI, 1997, NEW ENGL J MED, V337, P688, DOI 10.1056/NEJM199709043371007
   Wissink MJB, 2001, BIOMATERIALS, V22, P151, DOI 10.1016/S0142-9612(00)00164-2
   Wong G, 2008, J VASC SURG, V47, P608, DOI 10.1016/j.jvs.2007.11.025
NR 43
TC 3
Z9 3
U1 2
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JUN 22
PY 2016
VL 5
IS 12
BP 1439
EP 1446
DI 10.1002/adhm.201600020
PG 8
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA DQ9SU
UT WOS:000379550400007
PM 27072858
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Razafiarison, T
   Silvan, U
   Meier, D
   Snedeker, JG
AF Razafiarison, Tojo
   Silvan, Unai
   Meier, Daniela
   Snedeker, Jess G.
TI Surface-Driven Collagen Self-Assembly Affects Early Osteogenic Stem Cell
   Signaling
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE collagen monomer; hydrophobicity; nanotopographical cue;
   polydimethylsiloxane; stem cell
ID SUBSTRATE STIFFNESS AFFECTS; FOCAL ADHESION KINASE; SUPRAMOLECULAR
   ORGANIZATION; EXTRACELLULAR-MATRIX; DIFFERENTIATION;
   POLYDIMETHYLSILOXANE; BEHAVIOR; POLY(DIMETHYLSILOXANE); FIBRONECTIN;
   INTERPLAY
AB This study reports how extracellular matrix (ECM) ligand self-assembly on biomaterial surfaces and the resulting nanoscale architecture can drive stem cell behavior. To isolate the biological effects of surface wettability on protein deposition, folding, and ligand activity, a polydimethylsiloxane (PDMS)-based platform was developed and characterized with the ability to tune wettability of elastomeric substrates with otherwise equivalent topology, ligand loading, and mechanical properties. Using this platform, markedly different assembly of covalently bound type I collagen monomers was observed depending on wettability, with hydrophobic substrates yielding a relatively rough layer of collagen aggregates compared to a smooth collagen layer on more hydrophilic substrates. Cellular and molecular investigations with human bone marrow stromal cells revealed higher osteogenic differentiation and upregulation of focal adhesion-related components on the resulting smooth collagen layer coated substrates. The initial collagen assembly driven by the PDMS surface directly affected 11 integrin/discoidin domain receptor 1 signaling, activation of the extracellular signal-regulated kinase/mitogen activated protein kinase pathway, and ultimately markers of osteogenic stem cell differentiation. We demonstrate for the first time that surface-driven ligand assembly on material surfaces, even on materials with otherwise identical starting topographies and mechanical properties, can dominate the biomaterial surface-driven cell response.
C1 [Razafiarison, Tojo; Silvan, Unai; Meier, Daniela; Snedeker, Jess G.] Univ Zurich, Balgrist Univ Hosp, Dept Orthoped, Lengghalde 5, CH-8008 Zurich, Switzerland.
   [Razafiarison, Tojo; Silvan, Unai; Snedeker, Jess G.] Swiss Fed Inst Technol, Lab Orthoped Biomech, Lengghalde 5, CH-8008 Zurich, Switzerland.
RP Snedeker, JG (reprint author), Univ Zurich, Balgrist Univ Hosp, Dept Orthoped, Lengghalde 5, CH-8008 Zurich, Switzerland.
EM snedeker@ethz.ch
RI Snedeker, Jess/C-2105-2009
OI Snedeker, Jess/0000-0002-8115-0275; Silvan, Unai/0000-0003-0757-3621
FU Swiss National Science Foundation [31003A-138221]
FX This work was generously supported by the Swiss National Science
   Foundation (Grant No. 31003A-138221). The authors thank Stefania
   Wunderli for protocols for RT-PCR and Barbara Schar for her help
   designing Figure 1. All figures in this manuscript were exchanged for
   versions of higher resolution on 22.06.2016.
CR Arshi A, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/2/025003
   Ataollahi F, 2015, J BIOMED MATER RES A, V103, P2203, DOI 10.1002/jbm.a.35186
   Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004
   Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6
   Bartalena G, 2012, SOFT MATTER, V8, P673, DOI 10.1039/c1sm06250f
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Benoit DSW, 2007, BIOMATERIALS, V28, P66, DOI 10.1016/j.biomaterials.2006.08.033
   Bhadriraju K, 2009, BIOMATERIALS, V30, P6687, DOI 10.1016/j.biomaterials.2009.08.036
   Brown XQ, 2005, BIOMATERIALS, V26, P3123, DOI 10.1016/j.biomaterials.2004.08.009
   Carter EM, 2009, CURR OPIN PEDIATR, V21, P46, DOI 10.1097/MOP.0b013e32832185c5
   Chen WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083394
   Choi H, 2014, EXP DERMATOL, V23, P172, DOI 10.1111/exd.12343
   Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359
   Dowling DP, 2011, J BIOMATER APPL, V26, P327, DOI 10.1177/0885328210372148
   Dupont-Gillain CC, 2005, COLLOID SURFACE B, V43, P179, DOI 10.1016/j.colsurfb.2004.12.022
   Dupont-Gillain CC, 2004, J MATER SCI-MATER M, V15, P347, DOI 10.1023/B:JMSM.0000021100.71256.29
   Eddington DT, 2006, SENSOR ACTUAT B-CHEM, V114, P170, DOI 10.1016/j.snb.2005.04.037
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Eroshenko N, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-7
   Evans ND, 2009, EUR CELLS MATER, V18, P1
   Frith JE, 2012, J CELL SCI, V125, P317, DOI 10.1242/jcs.087916
   Fuard D, 2008, MICROELECTRON ENG, V85, P1289, DOI 10.1016/j.mee.2008.02.004
   Gutekunst SB, 2014, BEILSTEIN J NANOTECH, V5, P1393, DOI 10.3762/bjnano.5.152
   Harjanto D, 2010, ORG BIOMOL CHEM, V8, P299, DOI 10.1039/b913064k
   Hoemann CD, 2009, PATHOL BIOL, V57, P318, DOI 10.1016/j.patbio.2008.06.004
   KADLER K, 1994, PROTEIN PROFILE, V1, P519
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Kim MS, 2007, TISSUE ENG, V13, P2095, DOI 10.1089/ten.2006.0062
   Kuddannaya S, 2013, ACS APPL MATER INTER, V5, P9777, DOI 10.1021/am402903e
   Kulangara K, 2012, BIOMATERIALS, V33, P4998, DOI 10.1016/j.biomaterials.2012.03.053
   Li BJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02425
   Li JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03910
   Lund A W, 2009, Open Stem Cell J, V1, P40
   MacQueen L, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0179
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Coelho NM, 2010, EUR CELLS MATER, V19, P262, DOI 10.22203/eCM.v019a25
   Narayanan B, 2014, LANGMUIR, V30, P1343, DOI 10.1021/la4043364
   Palchesko RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051499
   Park JY, 2010, BIOCHIP J, V4, P230, DOI 10.1007/s13206-010-4311-9
   Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370
   Prauzner-Bechcicki S, 2015, J MECH BEHAV BIOMED, V41, P13, DOI 10.1016/j.jmbbm.2014.09.020
   Rosa AL, 2014, J CELL BIOCHEM, V115, P540, DOI 10.1002/jcb.24688
   Ruiz PA, 2011, J BIOL CHEM, V286, P12912, DOI 10.1074/jbc.M110.143693
   Salasznyk RM, 2007, EXP CELL RES, V313, P22, DOI 10.1016/j.yexcr.2006.09.013
   Schaap-Oziemlak AM, 2014, RSC ADV, V4, P53307, DOI 10.1039/c4ra07915a
   Seo JH, 2013, ACTA BIOMATER, V9, P5493, DOI 10.1016/j.actbio.2012.10.015
   Sharma RI, 2010, BIOMATERIALS, V31, P7695, DOI 10.1016/j.biomaterials.2010.06.046
   Shi YL, 2013, MOL MED REP, V7, P419, DOI 10.3892/mmr.2012.1213
   Stalder G. K. A. F., 2006, COLLOID SURF A, V286, P92
   Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309
   Taubenberger AV, 2010, BIOMATERIALS, V31, P2827, DOI 10.1016/j.biomaterials.2009.12.051
   Toworfe GK, 2004, J BIOMED MATER RES A, V71A, P449, DOI 10.1002/jbm.a.30164
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Tsai KS, 2010, J BIOMED MATER RES A, V94A, P673, DOI 10.1002/jbm.a.32693
   Valamehr B, 2008, P NATL ACAD SCI USA, V105, P14459, DOI 10.1073/pnas.0807235105
   Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9
   Wang CZ, 2006, MOL BIOL CELL, V17, P2839, DOI 10.1091/mbc.E05-11-1068
   Wang PY, 2012, ACTA BIOMATER, V8, P519, DOI 10.1016/j.actbio.2011.09.030
   Wen JH, 2014, NAT MATER, V13, P979, DOI [10.1038/NMAT4051, 10.1038/nmat4051]
   Wu CC, 2011, SURF COAT TECH, V205, P3182, DOI 10.1016/j.surfcoat.2010.11.036
   Wu M, 2014, COLLOID SURFACE B, V116, P700, DOI 10.1016/j.colsurfb.2013.11.010
   Xie J, 2014, ACTA BIOMATER, V10, P2463, DOI 10.1016/j.actbio.2014.01.031
   Xu HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052209
   Yao MJ, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/2/025012
   Yao X, 2013, BIOMATERIALS, V34, P9001, DOI 10.1016/j.biomaterials.2013.08.013
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Zhang WJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02332
NR 67
TC 7
Z9 7
U1 5
U2 34
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JUN 22
PY 2016
VL 5
IS 12
BP 1481
EP 1492
DI 10.1002/adhm.201600128
PG 12
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA DQ9SU
UT WOS:000379550400011
PM 27125602
DA 2018-10-19
ER

PT J
AU Ventre, M
   Netti, PA
AF Ventre, Maurizio
   Netti, Paolo A.
TI Engineering Cell Instructive Materials To Control Cell Fate and
   Functions through Material Cues and Surface Patterning
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE adhesion; cytoskeleton; topography; material stiffness; patterning;
   differentiation
ID MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX; FOCAL ADHESIONS;
   NANOSCALE; DIFFERENTIATION; SUBSTRATE; BIOMATERIALS; MIGRATION; LINEAGE;
   TISSUE
AB Mastering the interaction between cells and extracellular environment is a fundamental prerequisite in order to engineer functional biomaterial interfaces able to instruct cells with specific commands. Such advanced biomaterials might find relevant application in prosthesis design, tissue engineering, diagnostics and stem cell biology. Because of the highly complex, dynamic, and multifaceted context, a thorough understanding of the cell-material crosstalk has not been achieved yet; however, a variety of material features including biological cues, topography, and mechanical properties have been proved to impact the strength and the nature of the cell-material interaction, eventually affecting cell fate and functions. Although the nature of these three signals may appear very different, they are equated by their participation in the same materialcytoskeleton crosstalk pathway as they regulate cell adhesion events. In this work we present recent and relevant findings on the material-induced cell responses, with a particular emphasis on how the presentation of biochemical/biophysical signals modulates cell behavior. Finally, we summarize and discuss the literature data to draw out unifying elements concerning cell recognition of and reaction to signals displayed by material surfaces.
C1 [Netti, Paolo A.] Univ Naples Federico II, Dept Chem Mat & Ind Prod Engn, Ple Tecchio 80, I-80125 Naples, Italy.
   Univ Naples Federico II, Interdisciplinary Res Ctr Biomat, Ple Tecchio 80, I-80125 Naples, Italy.
   Ist Italiano Tecnol, Ctr Adv Biomat Hlth Care CRIB, Lgo Barsanti & Matteucci 53, I-80125 Naples, Italy.
RP Netti, PA (reprint author), Univ Naples Federico II, Dept Chem Mat & Ind Prod Engn, Ple Tecchio 80, I-80125 Naples, Italy.
EM nettipa@unina.it
OI NETTI, PAOLO/0000-0002-2435-7181
CR Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Bacharouche J, 2013, ACS NANO, V7, P3457, DOI 10.1021/nn400356p
   Battista E, 2015, BIOMATERIALS, V45, P72, DOI 10.1016/j.biomaterials.2014.12.012
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Biela SA, 2009, ACTA BIOMATER, V5, P2460, DOI 10.1016/j.actbio.2009.04.003
   Bierbaum Susanne, 2012, Biomatter, V2, P132, DOI 10.4161/biom.20921
   Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009
   Cameron AR, 2011, BIOMATERIALS, V32, P5979, DOI 10.1016/j.biomaterials.2011.04.003
   Causa F, 2010, LANGMUIR, V26, P9875, DOI 10.1021/la100207q
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chowdhury F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015655
   Christman KL, 2008, J AM CHEM SOC, V130, P16585, DOI 10.1021/ja803676r
   Comoglio PM, 2003, CURR OPIN CELL BIOL, V15, P565, DOI 10.1016/S0955-0674(03)00096-6
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2014, NAT MATER, V13, P558, DOI [10.1038/NMAT3980, 10.1038/nmat3980]
   del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912
   Diez M, 2011, ADV ENG MATER, V13, pB395, DOI 10.1002/adem.201080122
   Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Fusco S, 2015, ACTA BIOMATER, V23, P63, DOI 10.1016/j.actbio.2015.05.008
   Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033
   George PA, 2009, BIOMATERIALS, V30, P4732, DOI 10.1016/j.biomaterials.2009.05.039
   Gerecht S, 2007, BIOMATERIALS, V28, P4068, DOI 10.1016/j.biomaterials.2007.05.027
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Glass R, 2003, NANOTECHNOLOGY, V14, P1153, DOI 10.1088/0957-4484/14/10/314
   Guarnieri D, 2010, ACTA BIOMATER, V6, P2532, DOI 10.1016/j.actbio.2009.12.050
   Guillemette MD, 2009, INTEGR BIOL, V1, P196, DOI 10.1039/b820208g
   Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792
   HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736
   Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Iannone M, 2015, NANO LETT, V15, P1517, DOI 10.1021/nl503737k
   Jansen KA, 2015, BBA-MOL CELL RES, V1853, P3043, DOI 10.1016/j.bbamcr.2015.05.007
   Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107
   Kim DH, 2009, BIOMATERIALS, V30, P5433, DOI 10.1016/j.biomaterials.2009.06.042
   Lamers E, 2010, EUR CELLS MATER, V20, P329
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Li Y, 2011, BIOPHYS J, V100, P1902, DOI 10.1016/j.bpj.2011.03.008
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166
   Mason B., 2012, ENG BIOMATERIALS REG, P19, DOI DOI 10.1007/978-1-4614-1080-5_2
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   Natale CF, 2014, BIOMATERIALS, V35, P2743, DOI 10.1016/j.biomaterials.2013.12.023
   Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019
   Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957
   Peng R, 2011, BIOMATERIALS, V32, P8048, DOI 10.1016/j.biomaterials.2011.07.035
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661
   Raynor JE, 2009, BIOINTERPHASES, V4, pFA3, DOI 10.1116/1.3089252
   Rianna C, 2015, ACS APPL MATER INTER, V7, P16984, DOI 10.1021/acsami.5b02080
   Schvartzman M, 2011, NANO LETT, V11, P1306, DOI 10.1021/nl104378f
   Shahal T, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0023-0
   Smith JT, 2004, LANGMUIR, V20, P8279, DOI 10.1021/la0489763
   Ventre M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0687
   Ventre M, 2012, J R SOC INTERFACE, V9, P2017, DOI 10.1098/rsif.2012.0308
   Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594
   Wu JD, 2012, INTERFACE FOCUS, V2, P337, DOI 10.1098/rsfs.2011.0124
   Yao X, 2013, BIOMATERIALS, V34, P930, DOI 10.1016/j.biomaterials.2012.10.052
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Zhernenkov M, 2015, ACS APPL MATER INTER, V7, P11857, DOI 10.1021/acsami.5b01453
NR 74
TC 23
Z9 23
U1 3
U2 50
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JUN 22
PY 2016
VL 8
IS 24
SI SI
BP 14896
EP 14908
DI 10.1021/acsami.5b08658
PG 13
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DP6CP
UT WOS:000378584800002
PM 26693600
DA 2018-10-19
ER

PT J
AU Modulevsky, DJ
   Cuerrier, CM
   Pelling, AE
AF Modulevsky, Daniel J.
   Cuerrier, Charles M.
   Pelling, Andrew E.
TI Biocompatibility of Subcutaneously Implanted Plant-Derived Cellulose
   Biomaterials
SO PLOS ONE
LA English
DT Article
ID 3D CELL-CULTURE; IN-VIVO BIOCOMPATIBILITY; BACTERIAL CELLULOSE;
   MECHANICAL-PROPERTIES; RESORBABLE BIOMATERIALS; BIOMEDICAL APPLICATIONS;
   REGENERATIVE MEDICINE; ELECTROSPUN SCAFFOLDS; DECELLULARIZED MATRIX;
   EXTRACELLULAR-MATRIX
AB There is intense interest in developing novel biomaterials which support the invasion and proliferation of living cells for potential applications in tissue engineering and regenerative medicine. Decellularization of existing tissues have formed the basis of one major approach to producing 3D scaffolds for such purposes. In this study, we utilize the native hypanthium tissue of apples and a simple preparation methodology to create implantable cellulose scaffolds. To examine biocompatibility, scaffolds were subcutaneously implanted in wild-type, immunocompetent mice (males and females; 6-9 weeks old). Following the implantation, the scaffolds were resected at 1, 4 and 8 weeks and processed for histological analysis (H&E, Masson's Trichrome, anti-CD31 and anti-CD45 antibodies). Histological analysis revealed a characteristic foreign body response to the scaffold 1 week post-implantation. However, the immune response was observed to gradually disappear by 8 weeks post-implantation. By 8 weeks, there was no immune response in the surrounding dermis tissue and active fibroblast migration within the cellulose scaffold was observed. This was concomitant with the deposition of a new collagen extracellular matrix. Furthermore, active blood vessel formation within the scaffold was observed throughout the period of study indicating the pro-angiogenic properties of the native scaffolds. Finally, while the scaffolds retain much of their original shape they do undergo a slow deformation over the 8-week length of the study. Taken together, our results demonstrate that native cellulose scaffolds are biocompatible and exhibit promising potential as a surgical biomaterial.
C1 [Modulevsky, Daniel J.; Cuerrier, Charles M.; Pelling, Andrew E.] Univ Ottawa, Ctr Interdisciplinary NanoPhys, Ottawa, ON, Canada.
   [Modulevsky, Daniel J.; Pelling, Andrew E.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada.
   [Cuerrier, Charles M.; Pelling, Andrew E.] Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada.
   [Pelling, Andrew E.] Univ Ottawa, Inst Sci Soc & Policy, Ottawa, ON, Canada.
   [Pelling, Andrew E.] Univ Western Australia, Sch Anat Physiol & Human Biol, SymbioticA, Perth, WA 6009, Australia.
RP Pelling, AE (reprint author), Univ Ottawa, Ctr Interdisciplinary NanoPhys, Ottawa, ON, Canada.; Pelling, AE (reprint author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.; Pelling, AE (reprint author), Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada.; Pelling, AE (reprint author), Univ Ottawa, Inst Sci Soc & Policy, Ottawa, ON, Canada.; Pelling, AE (reprint author), Univ Western Australia, Sch Anat Physiol & Human Biol, SymbioticA, Perth, WA 6009, Australia.
EM a@pellinglab.net
FU Natural Sciences and Engineering Resource Council (NSERC) Discovery
   Grant [RGPIN-2014-04978]; University of Ottawa Faculty Development Fund;
   "Fonds de Recherche du Quebec - Sante" (FRQS); Canada Research Chairs
   Program [950-229071]
FX This study was funded by a Natural Sciences and Engineering Resource
   Council (NSERC) Discovery Grant (#RGPIN-2014-04978) and the University
   of Ottawa Faculty Development Fund. D.J.M. was supported by a graduate
   student fellowship from the "Fonds de Recherche du Quebec - Sante"
   (FRQS). C.M.C. was supported by a postdoctoral training award from the
   "Fonds de Recherche du Quebec - Sante" (FRQS). A.E.P. would like to
   acknowledge generous support from the Canada Research Chairs Program
   (#950-229071). The funders had no role in study design, datacollection
   and analysis, decision to publish, or preparation of the manuscript.
CR Abou Neel EA, 2014, J DENT, V42, P915, DOI 10.1016/j.jdent.2014.05.008
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Andrade FK, 2013, J BIOACT COMPAT POL, V28, P97, DOI 10.1177/0883911512467643
   Andrade FK, 2011, J BIOMED MATER RES A, V98A, P554, DOI 10.1002/jbm.a.33148
   [Anonymous], WHY ORG EYE TISS DON
   [Anonymous], 2011, COMPR BIOM ONL VERS, V1
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Anseth KS, 2012, DYNAMIC MICROENVIRON, V4, P1
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Badylak SF, 2011, ANN REV
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Bae H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003688
   Bagno A, 2004, J MATER SCI-MATER M, V15, P935, DOI 10.1023/B:JMSM.0000042679.28493.7f
   Bai F, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015007
   Baker BM, 2008, BIOMATERIALS, V29, P2348, DOI 10.1016/j.biomaterials.2008.01.032
   Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001
   Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067
   Baptista PM, 2009, IEEE ENG MED BIO, P6526, DOI 10.1109/IEMBS.2009.5333145
   BEGUIN P, 1994, FEMS MICROBIOL REV, V13, P25, DOI 10.1016/0168-6445(94)90099-X
   Behravesh E, 1999, CLIN ORTHOP RELAT R, pS118
   Bhardwaj N, 2015, MACROMOL BIOSCI, V15, P153, DOI 10.1002/mabi.201400335
   Bhattacharya M, 2012, J CONTROL RELEASE, V164, P291, DOI 10.1016/j.jconrel.2012.06.039
   Blakeney BA, 2011, BIOMATERIALS, V32, P1583, DOI 10.1016/j.biomaterials.2010.10.056
   Bohner M, 2010, MATER TODAY, V13, P24, DOI 10.1016/S1369-7021(10)70014-6
   Brown EE, 2013, BIOMACROMOLECULES, V14, P1063, DOI 10.1021/bm3019467
   Campoli G, 2013, MATER DESIGN, V49, P957, DOI 10.1016/j.matdes.2013.01.071
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   Cervantes TM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0413
   Chang HI, 2011, REGENERATIVE MEDICINE AND TISSUE ENGINEERING - CELLS AND BIOMATERIALS, P569
   Chen QZ, 2013, PROG POLYM SCI, V38, P584, DOI 10.1016/j.progpolymsci.2012.05.003
   Cornwell Kevin G, 2009, Clin Podiatr Med Surg, V26, P507, DOI 10.1016/j.cpm.2009.08.001
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   de Guzman RC, 2011, BIOMATERIALS, V32, P8205, DOI 10.1016/j.biomaterials.2011.07.054
   Derda R, 2009, P NATL ACAD SCI USA, V106, P18457, DOI 10.1073/pnas.0910666106
   Dong WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep18266
   Dugan JM, 2013, NANOMEDICINE-UK, V8, P287, DOI [10.2217/NNM.12.211, 10.2217/nnm.12.211]
   Dugan JM, 2013, ACTA BIOMATER, V9, P4707, DOI 10.1016/j.actbio.2012.08.050
   Entcheva E, 2004, BIOMATERIALS, V25, P5753, DOI 10.1016/j.biomaterials.2004.01.024
   Tischer PCSF, 2010, BIOMACROMOLECULES, V11, P1217, DOI 10.1021/bm901383a
   Gibson LJ, 2012, J R SOC INTERFACE, V9, P2749, DOI 10.1098/rsif.2012.0341
   Gottenbos B, 2002, J MATER SCI-MATER M, V13, P717, DOI 10.1023/A:1016175502756
   Gu L, 2016, NAT REV CANCER, V16, P56, DOI 10.1038/nrc.2015.3
   Guillaume O, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-015-5648-3
   Guyette JP, 2016, CIRC RES, V118, P56, DOI 10.1161/CIRCRESAHA.115.306874
   Hattori N, 2014, MOVEMENT DISORD, V29, P185, DOI 10.1002/mds.25740
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Hsu SH, 2015, WOUND REPAIR REGEN, V23, P57, DOI 10.1111/wrr.12239
   ISHIHARA K, 1995, J BIOMED MATER RES, V29, P181, DOI 10.1002/jbm.820290207
   ISHIHARA K, 1992, BIOMATERIALS, V13, P145, DOI 10.1016/0142-9612(92)90062-S
   Isogai N, 2004, TISSUE ENG, V10, P673, DOI 10.1089/1076327041348527
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   Kar M, 2016, BIOMATERIALS, V77, P186, DOI 10.1016/j.biomaterials.2015.11.018
   Kim MS, 2007, BIOMATERIALS, V28, P5137, DOI 10.1016/j.biomaterials.2007.08.014
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Lee Daniel K, 2007, J Foot Ankle Surg, V46, P451, DOI 10.1053/j.jfas.2007.05.007
   Lee J-S, 2014, BIOFABRICATION, V6
   Lemons J E, 1986, J Arthroplasty, V1, P143
   Liao HT, 2015, PLAST RECONSTR SURG, V135, p313E, DOI 10.1097/PRS.0000000000001105
   Lin N, 2014, EUR POLYM J, V59, P302, DOI 10.1016/j.eurpolymj.2014.07.025
   Lu Y, 2014, TAPPI J, V13, P47
   Lv S, 2010, NATURE, V465, P69, DOI 10.1038/nature09024
   Mannoor MS, 2013, NANO LETT, V13, P2634, DOI 10.1021/nl4007744
   Mao AS, 2015, P NATL ACAD SCI USA, V112, P14452, DOI 10.1073/pnas.1508520112
   Maurer MM, 2015, MATERIALS, V8, P2794, DOI 10.3390/ma8052794
   McBane JE, 2011, BIOMATERIALS, V32, P6034, DOI 10.1016/j.biomaterials.2011.04.048
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179
   MIYAMOTO T, 1989, J BIOMED MATER RES, V23, P125, DOI 10.1002/jbm.820230110
   Modulevsky DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097835
   MOTEGI K, 1984, J MAXILLOFAC SURG, V12, P21, DOI 10.1016/S0301-0503(84)80205-2
   Nakayama KH, 2010, TISSUE ENG PT A, V16, P2207, DOI [10.1089/ten.tea.2009.0602, 10.1089/ten.TEA.2009.0602]
   Neumeister MW, 2006, PLAST RECONSTR SURG, V117, P116, DOI 10.1097/01.prs.0000195071.01699.ce
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nimeskern L, 2013, J MECH BEHAV BIOMED, V22, P12, DOI 10.1016/j.jmbbm.2013.03.005
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Onuki Yoshinori, 2008, J Diabetes Sci Technol, V2, P1003
   Orlando G, 2011, TRANSPLANTATION, V91, P1310, DOI 10.1097/TP.0b013e318219ebb5
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Page H, 2013, CELL TISSUE RES, V352, P123, DOI 10.1007/s00441-012-1441-5
   Pashuck ET, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002717
   Pertile RAN, 2012, J BIOMAT SCI-POLYM E, V23, P1339, DOI 10.1163/092050611X581516
   Phipps MC, 2012, BIOMATERIALS, V33, P524, DOI 10.1016/j.biomaterials.2011.09.080
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Pomerantseva I, 2016, TISSUE ENG PT A, V22, P197, DOI [10.1089/ten.tea.2015.0173, 10.1089/ten.TEA.2015.0173]
   Puschmann TB, 2013, GLIA, V61, P432, DOI 10.1002/glia.22446
   Rai R, 2011, MAT SCI ENG R, V72, P29, DOI 10.1016/j.mser.2010.11.002
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Raya-Rivera A, 2011, LANCET, V377, P1175, DOI 10.1016/S0140-6736(10)62354-9
   Raya-Rivera AM, 2014, LANCET, V384, P329, DOI 10.1016/S0140-6736(14)60542-0
   Ren X, 2015, NAT BIOTECHNOL, V33, P1097, DOI 10.1038/nbt.3354
   Rickert D, 2003, CLIN HEMORHEOL MICRO, V28, P175
   Saini M, 2015, WORLD J CLIN CASES, V3, P52, DOI 10.12998/wjcc.v3.i1.52
   Salzberg CA, 2006, ANN PLAS SURG, V57, P1, DOI 10.1097/01.sap.0000214873.13102.9f
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Schumann DA, 2009, CELLULOSE, V16, P877, DOI 10.1007/s10570-008-9264-y
   Shieh SJ, 2004, BIOMATERIALS, V25, P1545, DOI 10.1016/S0142-9612(03)00501-5
   Shue Li, 2012, Biomatter, V2, P271, DOI 10.4161/biom.22948
   Sieminski AL, 2000, BIOMATERIALS, V21, P2233, DOI 10.1016/S0142-9612(00)00149-6
   Sittinger M, 1996, BIOMATERIALS, V17, P237, DOI 10.1016/0142-9612(96)85561-X
   Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005
   Soto-Gutierrez A, 2011, TISSUE ENG PART C-ME, V17, P677, DOI 10.1089/ten.tec.2010.0698
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Sterling JA, 2014, CURR OSTEOPOROS REP, V12, P48, DOI 10.1007/s11914-014-0187-2
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Takebe T, 2013, NATURE, V499, P481, DOI 10.1038/nature12271
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Torres Fernando G, 2012, J Funct Biomater, V3, P864, DOI 10.3390/jfb3040864
   Trindade R, 2016, CLIN IMPLANT DENT R, V18, P192, DOI 10.1111/cid.12274
   Wang X., 2013, ADV BIOMATER SCI APP, P112, DOI DOI 10.5772/53461
   WATANABE K, 1993, CYTOTECHNOLOGY, V13, P107, DOI 10.1007/BF00749937
   Xiao X, 2015, SCI REP-UK, V5, DOI 10.1038/srep09409
   Xu JW, 2005, PLAST RECONSTR SURG, V115, P1633, DOI 10.1097/01.PRS.0000161465.21513.5D
   Zhao RG, 2011, ACTA BIOMATER, V7, P1220, DOI 10.1016/j.actbio.2010.11.004
   Zhou LB, 2011, TISSUE ENG PT A, V17, P1573, DOI 10.1089/ten.tea.2010.0627
NR 117
TC 15
Z9 15
U1 5
U2 35
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 21
PY 2016
VL 11
IS 6
AR e0157894
DI 10.1371/journal.pone.0157894
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DP0WU
UT WOS:000378212400059
PM 27328066
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Jastrzebska, K
   Felcyn, E
   Kozak, M
   Szybowicz, M
   Buchwald, T
   Pietralik, Z
   Jesionowski, T
   Mackiewicz, A
   Dams-Kozlowska, H
AF Jastrzebska, Katarzyna
   Felcyn, Edyta
   Kozak, Maciej
   Szybowicz, Miroslaw
   Buchwald, Tomasz
   Pietralik, Zuzanna
   Jesionowski, Teofil
   Mackiewicz, Andrzej
   Dams-Kozlowska, Hanna
TI The method of purifying bioengineered spider silk determines the silk
   sphere properties
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PROTEIN SECONDARY STRUCTURE; HUMAN CYSTATIN-C; NEPHILA-CLAVIPES;
   DRUG-DELIVERY; DRAGLINE SILK; FIBROIN; MICROSPHERES; RELEASE; FIBER;
   NANOPARTICLES
AB Bioengineered spider silks are a biomaterial with great potential for applications in biomedicine. They are biocompatible, biodegradable and can self-assemble into films, hydrogels, scaffolds, fibers, capsules and spheres. A novel, tag-free, bioengineered spider silk named MS2(9x) was constructed. It is a 9-mer of the consensus motif derived from MaSp2-the spidroin of Nephila clavipes dragline silk. Thermal and acidic extraction methods were used to purify MS2(9x). Both purification protocols gave a similar quantity and quality of soluble silk; however, they differed in the secondary structure and zeta potential value. Spheres made of these purified variants differed with regard to critical features such as particle size, morphology, zeta potential and drug loading. Independent of the purification method, neither variant of the MS2(9x) spheres was cytotoxic, which confirmed that both methods can be used for biomedical applications. However, this study highlights the impact that the applied purification method has on the further biomaterial properties.
C1 [Jastrzebska, Katarzyna; Mackiewicz, Andrzej; Dams-Kozlowska, Hanna] Poznan Univ Med Sci, Chair Med Biotechnol, PL-61688 Poznan, Poland.
   [Jastrzebska, Katarzyna] Adam Mickiewicz Univ, NanoBioMed Ctr, PL-61614 Poznan, Poland.
   [Felcyn, Edyta; Mackiewicz, Andrzej] BioContract Sp Zoo, PL-61051 Poznan, Poland.
   [Kozak, Maciej; Pietralik, Zuzanna] Adam Mickiewicz Univ, Dept Macromol Phys, PL-61614 Poznan, Poland.
   [Kozak, Maciej] Adam Mickiewicz Univ, Joint Lab SAXS Studies, PL-61614 Poznan, Poland.
   [Szybowicz, Miroslaw; Buchwald, Tomasz] Poznan Univ Tech, Fac Tech Phys, PL-60965 Poznan, Poland.
   [Jesionowski, Teofil] Poznan Univ Tech, Inst Chem Technol & Engn, Fac Chem Technol, PL-60965 Poznan, Poland.
   [Mackiewicz, Andrzej; Dams-Kozlowska, Hanna] Greater Poland Canc Ctr, Dept Diagnost & Canc Immunol, PL-61688 Poznan, Poland.
RP Dams-Kozlowska, H (reprint author), Poznan Univ Med Sci, Chair Med Biotechnol, PL-61688 Poznan, Poland.; Dams-Kozlowska, H (reprint author), Greater Poland Canc Ctr, Dept Diagnost & Canc Immunol, PL-61688 Poznan, Poland.
EM hanna.dams-kozlowska@wco.pl
RI Szybowicz, Miroslaw/H-6283-2013; Jesionowski, Teofil/N-1623-2014;
   Buchwald, Tomasz/B-3356-2014
OI Szybowicz, Miroslaw/0000-0001-8933-571X; Buchwald,
   Tomasz/0000-0003-1837-402X; Dams-Kozlowska, Hanna/0000-0003-2349-419X
FU HARMONIA3 grant from the National Science Centre (Poland)
   [2012/06/M/ST4/00036]; National Science Centre, Poland
   [2014/15/B/NZ7/00903]; International PhD Projects Programme Foundation
   for Polish Science within the European Regional Development Fund
FX KJ was supported by the International PhD Projects Programme Foundation
   for Polish Science operated within the Innovative Economy Operational
   Programme (IE OP) 2007-2013 within the European Regional Development
   Fund. MK and ZP were partially supported by HARMONIA3 grant (Project No.
   2012/06/M/ST4/00036) from the National Science Centre (Poland). The
   project was partially supported by grant from The National Science
   Centre, Poland (2014/15/B/NZ7/00903).
CR Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Blum C, 2012, BIONANOSCIENCE, V2, P67, DOI 10.1007/s12668-012-0036-7
   Breslauer DN, 2010, BIOMACROMOLECULES, V11, P643, DOI 10.1021/bm901209u
   Brooks AE, 2005, BIOMACROMOLECULES, V6, P3095, DOI 10.1021/bm050421e
   Chen MJ, 2012, J BIOMED MATER RES A, V100A, P203, DOI 10.1002/jbm.a.33265
   Dams-Kozlowska H, 2013, J BIOMED MATER RES A, V101, P456, DOI 10.1002/jbm.a.34353
   Florczak A, 2014, BIOMACROMOLECULES, V15, P2971, DOI 10.1021/bm500591p
   GATENBY AA, 1990, TRENDS BIOTECHNOL, V8, P354, DOI 10.1016/0167-7799(90)90224-L
   Germershaus O, 2014, BIOMATERIALS, V35, P3427, DOI 10.1016/j.biomaterials.2013.12.083
   Hagn F, 2012, J PEPT SCI, V18, P357, DOI 10.1002/psc.2417
   Hedhammar M, 2008, BIOCHEMISTRY-US, V47, P3407, DOI 10.1021/bi702432y
   Heim M, 2010, CHEM SOC REV, V39, P156, DOI 10.1039/b813273a
   Hijirida DH, 1996, BIOPHYS J, V71, P3442, DOI 10.1016/S0006-3495(96)79539-5
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188
   Jansson R, 2014, BIOMACROMOLECULES, V15, P1696, DOI 10.1021/bm500114e
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Kundu J, 2010, INT J PHARMACEUT, V388, P242, DOI 10.1016/j.ijpharm.2009.12.052
   Lammel A, 2008, CHEMSUSCHEM, V1, P413, DOI 10.1002/cssc.200800030
   Lammel A, 2011, BIOMATERIALS, V32, P2233, DOI 10.1016/j.biomaterials.2010.11.060
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lefevre T, 2007, BIOMACROMOLECULES, V8, P2342, DOI 10.1021/bm7005517
   Lefevre T, 2007, BIOPHYS J, V92, P2885, DOI 10.1529/biophysj.106.100339
   Mello CM, 2004, BIOMACROMOLECULES, V5, P1849, DOI 10.1021/bm049815g
   Milanova D, 2011, ELECTROPHORESIS, V32, P3286, DOI 10.1002/elps.201100210
   Ostner G, 2013, J BIOL CHEM, V288, P16438, DOI 10.1074/jbc.M113.469593
   Rabotyagova OS, 2009, BIOMACROMOLECULES, V10, P229, DOI 10.1021/bm800930x
   Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105
   Rising A, 2014, ACTA BIOMATER, V10, P1627, DOI 10.1016/j.actbio.2013.09.030
   Rising A, 2011, CELL MOL LIFE SCI, V68, P169, DOI 10.1007/s00018-010-0462-z
   Schacht K, 2014, CURR OPIN BIOTECH, V29, P62, DOI 10.1016/j.copbio.2014.02.015
   Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14
   Seib FP, 2013, ADV HEALTHC MATER, V2, P1606, DOI 10.1002/adhm.201300034
   Slotta UK, 2008, ANGEW CHEM INT EDIT, V47, P4592, DOI 10.1002/anie.200800683
   Spiess K, 2010, MACROMOL BIOSCI, V10, P998, DOI 10.1002/mabi.201000071
   Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879
   Tokareva O, 2013, MICROB BIOTECHNOL, V6, P651, DOI 10.1111/1751-7915.12081
   Wahlbom M, 2007, J BIOL CHEM, V282, P18318, DOI 10.1074/jbc.M611368200
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853
NR 44
TC 9
Z9 9
U1 2
U2 31
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 17
PY 2016
VL 6
AR 28106
DI 10.1038/srep28106
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DO8NW
UT WOS:000378041300001
PM 27312998
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Zheng, K
   Chen, Y
   Huang, WW
   Lin, YN
   Kaplan, DL
   Fan, YM
AF Zheng, Ke
   Chen, Ying
   Huang, Wenwen
   Lin, Yinan
   Kaplan, David L.
   Fan, Yimin
TI Chemically Functionalized Silk for Human Bone Marrow-Derived Mesenchymal
   Stem Cells Proliferation and Differentiation
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE silk fibroin; oxidation; carboxyl groups; serine; mesenchymal stern
   cells
ID TEMPO-MEDIATED OXIDATION; OSTEOGENIC-DIFFERENTIATION; BIOMATERIAL
   SCAFFOLDS; FIBROIN FILMS; STROMAL CELLS; SPIDER SILK; IN-VITRO;
   PROTEINS; FIBERS; HYDROXYAPATITE
AB To produce biocompatible, mechanically robust, and conductive materials for bone tissue engineering, chemical oxidation using sodium hyprochlorite (NaClO) was utilized to introduce carboxyl groups onto silk fibroin (SF). A final carboxyl content of 1.09 mM/g SF was obtained, corresponding to similar to 47% of the primary hydroxymethyl groups on the silk. Interestingly, both infrared (IR) spectroscopy and circular dichroism (CD) spectra demonstrated that the resulting oxidized silk (OxSF) self-assembled into beta-sheet structures under aqueous conditions and this contributed to the mechanical properties of the as-prepared silk-based scaffolds and the mineralized OxSF scaffolds (M-OxSF). The OxSF scaffolds had a compressive modulus of 211 +/- 75 KPa in the hydrated state, 10 times higher than that of the SF scaffolds, and the modulus of the M-OxSF scaffolds was increased to 758 +/- 189 KPa. Human bone marrow-derived mesenchymal stem cells (hMSCs) grown on the scaffolds during osteogenesis showed that the OxSF scaffolds supported the proliferation and differentiation of hMSCs in vitro.
C1 [Zheng, Ke; Fan, Yimin] Nanjing Forestry Univ, Coll Chem Engn, Jiangsu Key Lab Biomass Based Green Fuel & Chem, Nanjing 210037, Jiangsu, Peoples R China.
   [Zheng, Ke; Chen, Ying; Huang, Wenwen; Lin, Yinan; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
RP Fan, YM (reprint author), Nanjing Forestry Univ, Coll Chem Engn, Jiangsu Key Lab Biomass Based Green Fuel & Chem, Nanjing 210037, Jiangsu, Peoples R China.; Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.com; fanyimin@njfu.edu.cn
RI Huang, Wenwen/H-5352-2018
OI Huang, Wenwen/0000-0001-8175-9083
FU National Forestry Public Welfare Industry Research Project [201304609];
   Foundation for Innovation Training of Graduate Student of Jiangsu
   Province [KYZZ15_0250]; National Natural Science Foundation of China
   [31100426]; Specialized Research Fund for the Doctoral Program of the
   Higher Education of China [20133204110008]; Priority Academic Program
   Development of Jiangsu Higher Education Institutions (PAPD)
FX This research was supported by the National Forestry Public Welfare
   Industry Research Project (No. 201304609), the Foundation for Innovation
   Training of Graduate Student of Jiangsu Province (No. KYZZ15_0250), the
   National Natural Science Foundation of China (No. 31100426), the
   Specialized Research Fund for the Doctoral Program of the Higher
   Education of China (No. 20133204110008) and the Priority Academic
   Program Development of Jiangsu Higher Education Institutions (PAPD).
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   An B, 2011, BIOMACROMOLECULES, V12, P2375, DOI 10.1021/bm200463e
   Bai LQ, 2008, APPL SURF SCI, V254, P2988, DOI 10.1016/j.apsusc.2007.10.049
   BAKER RWR, 1947, BIOCHEM J, V41, P337, DOI 10.1042/bj0410337
   Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058
   Boyd R N, 1992, ORGANIC CHEM
   BROWN CH, 1950, Q J MICROSC SCI, V91, P331
   CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015
   Correia C, 2012, ACTA BIOMATER, V8, P2483, DOI 10.1016/j.actbio.2012.03.019
   Fan YM, 2009, CARBOHYD POLYM, V77, P832, DOI 10.1016/j.carbpol.2009.03.008
   Forsyth WR, 2002, PROTEINS, V48, P388, DOI 10.1002/prot.10174
   Gholipourmalekabadi M, 2015, BIOTECHNOL APPL BIOC, V62, P441, DOI 10.1002/bab.1285
   Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x
   HAZAN A, 1975, COMP BIOCHEM PHYS B, V51, P457, DOI 10.1016/0305-0491(75)90038-3
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   Hu YH, 2002, J BIOMED MATER RES, V59, P563, DOI 10.1002/jbm.1269
   Jiang J, 2013, BIOTECHNOL LETT, V35, P657, DOI 10.1007/s10529-012-1121-2
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jones GL, 2009, BIOMATERIALS, V30, P5376, DOI 10.1016/j.biomaterials.2009.07.028
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kenney JM, 2002, EUR J BIOCHEM, V269, P4159, DOI 10.1046/j.1432-1033.2002.03112.x
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   KREJCHI MT, 1994, SCIENCE, V265, P1427, DOI 10.1126/science.8073284
   Kundu B, 2014, PROG POLYM SCI, V39, P251, DOI 10.1016/j.progpolymsci.2013.09.002
   Lee YJ, 2013, BIOMATERIALS, V34, P5059, DOI 10.1016/j.biomaterials.2013.03.051
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Lin LX, 2015, J BIOSCI BIOENG, V119, P591, DOI 10.1016/j.jbiosc.2014.10.009
   Ling SJ, 2011, BIOMACROMOLECULES, V12, P3344, DOI 10.1021/bm2006032
   Lu Q, 2010, MACROMOL BIOSCI, V10, P289, DOI 10.1002/mabi.200900258
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Mieszawska AJ, 2010, BIOMATERIALS, V31, P8902, DOI 10.1016/j.biomaterials.2010.07.109
   Mobini S, 2013, J BIOMED MATER RES A, V101, P2392, DOI 10.1002/jbm.a.34537
   Mou ZL, 2013, MATER LETT, V105, P189, DOI 10.1016/j.matlet.2013.03.130
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Rockwood DN, 2011, ACTA BIOMATER, V7, P144, DOI 10.1016/j.actbio.2010.07.020
   Romero IS, 2013, ACS APPL MATER INTER, V5, P553, DOI 10.1021/am301844c
   Saito T, 2004, BIOMACROMOLECULES, V5, P1983, DOI 10.1021/bm0497769
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Surmenev RA, 2014, ACTA BIOMATER, V10, P557, DOI 10.1016/j.actbio.2013.10.036
   Takeuchi A, 2005, J ROY SOC INTERFACE, V2, P373, DOI 10.1098/rsif.2005.0052
   Thimm BW, 2011, ACTA BIOMATER, V7, P2218, DOI 10.1016/j.actbio.2011.02.004
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wenk E, 2010, BIOMATERIALS, V31, P1403, DOI 10.1016/j.biomaterials.2009.11.006
   Wongpanit P, 2007, EUR POLYM J, V43, P4123, DOI 10.1016/j.eurpolymj.2007.07.004
   Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875
   Yoo CR, 2008, INT J BIOL MACROMOL, V42, P324, DOI 10.1016/j.ijbiomac.2007.12.004
   Zhang WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102371
   Zhang WJ, 2014, EUR CELLS MATER, V27, P1
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 56
TC 6
Z9 6
U1 7
U2 51
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JUN 15
PY 2016
VL 8
IS 23
BP 14406
EP 14413
DI 10.1021/acsami.6b03518
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DP0QT
UT WOS:000378195000015
PM 27177120
DA 2018-10-19
ER

PT J
AU Ashokkumar, M
   Chipara, AC
   Narayanan, NT
   Anumary, A
   Sruthi, R
   Thanikaivelan, P
   Vajtai, R
   Mani, SA
   Ajayan, PM
AF Ashokkumar, Meiyazhagan
   Chipara, Alin Cristian
   Narayanan, Narayanan Tharangattu
   Anumary, Ayyappan
   Sruthi, Radhakrishnan
   Thanikaivelan, Palanisamy
   Vajtai, Robert
   Mani, Sendurai A.
   Ajayan, Pulickel M.
TI Three-Dimensional Porous Sponges from Collagen Biowastes
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE collagen; skin wastes; porous sponge; environmental applications; cell
   viability
ID IRON-OXIDE NANOPARTICLES; CARBON NANOTUBES; CROSS-LINKING; SCAFFOLDS;
   FIBERS; OIL; BIOMATERIAL; CHROMIUM; DELIVERY; WASTE
AB Three-dimensional, functional, and porous scaffolds can find applications in a variety of fields. Here we report the synthesis of hierarchical and interconnected porous sponges using a simple freeze-drying technique, employing collagen extracted from animal skin wastes and superparamagnetic iron oxide nanoparticles. The ultralightweight, high-surface-area sponges exhibit excellent mechanical stability and enhanced absorption of organic contaminants such as oils and dye molecules. Additionally, these biocomposite sponges display significant cellular biocompatibility, which opens new prospects in biomedical uses. The approach highlights innovative ways of transforming biowastes into advanced hybrid materials using simple and scalable synthesis techniques.
C1 [Ashokkumar, Meiyazhagan; Chipara, Alin Cristian; Anumary, Ayyappan; Sruthi, Radhakrishnan; Vajtai, Robert; Ajayan, Pulickel M.] Rice Univ, Dept Mat Sci & NanoEngn, Houston, TX 77005 USA.
   [Narayanan, Narayanan Tharangattu] Ctr Interdisciplinary Sci TCIS, Tata Inst Fundamental Res, Hyderabad 500075, Andhra Pradesh, India.
   [Anumary, Ayyappan; Thanikaivelan, Palanisamy] CSIR, Adv Mat Lab, Ctr Leather Apparel & Accessories Dev CLAD, Cent Leather Res Inst, Chennai 600020, Tamil Nadu, India.
   [Mani, Sendurai A.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA.
RP Ashokkumar, M; Ajayan, PM (reprint author), Rice Univ, Dept Mat Sci & NanoEngn, Houston, TX 77005 USA.
EM ma37@rice.edu; ajayan@rice.edu
RI Mani, Sendurai/A-7244-2009
OI Mani, Sendurai/0000-0002-5918-4276; Meiyazhagan,
   AshokKumar/0000-0002-9765-4347
FU USIEF, India; Air Force Office of Scientific Research [AFOSR
   FA9550-13-1-0084]; Fred L. Hartley Family Foundation; CSIR, India under
   ZERIS Project [CSC0103]
FX M.A. thanks USIEF, India for the Fulbright-Doctoral and Professional
   Research (DPR) Fellowship, Air Force Office of Scientific Research,
   (Grant No. AFOSR FA9550-13-1-0084), and Fred L. Hartley Family
   Foundation for financial assistance. P.T. is grateful for financial
   support from CSIR, India under ZERIS Project (CSC0103).
CR Alliraja C, 2015, RSC ADV, V5, P20939, DOI 10.1039/c4ra16181e
   Anderson ML, 2003, NANO LETT, V3, P1321, DOI 10.1021/nl034543t
   Anumary A, 2013, SOFT MATER, V11, P181, DOI 10.1080/1539445X.2012.617634
   Ashokkumar M, 2012, CARBON, V50, P5574, DOI 10.1016/j.carbon.2012.08.006
   Chen GP, 2000, ADV MATER, V12, P455, DOI 10.1002/(SICI)1521-4095(200003)12:6<455::AID-ADMA455>3.0.CO;2-C
   Choi SJ, 2011, ACS APPL MATER INTER, V3, P4552, DOI 10.1021/am201352w
   Covington AD, 1997, CHEM SOC REV, V26, P111, DOI 10.1039/cs9972600111
   DAMINK LHHO, 1995, J BIOMED MATER RES, V29, P149, DOI 10.1002/jbm.820290203
   Deng DH, 2008, LANGMUIR, V24, P368, DOI 10.1021/la702831m
   Faivre D, 2010, NAT NANOTECHNOL, V5, P562, DOI 10.1038/nnano.2010.159
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gelinsky M, 2008, CHEM ENG J, V137, P84, DOI 10.1016/j.cej.2007.09.029
   Gough JE, 2002, J BIOMED MATER RES, V61, P121, DOI 10.1002/jbm.10145
   Gui XC, 2010, ADV MATER, V22, P617, DOI 10.1002/adma.200902986
   Hirata E, 2009, J BIOMED MATER RES B, V90B, P629, DOI 10.1002/jbm.b.31327
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Kinneberg K. R. C., 2011, THESIS
   LAKES R, 1993, NATURE, V361, P511, DOI 10.1038/361511a0
   Laurent S, 2014, EXPERT OPIN DRUG DEL, V11, P1449, DOI 10.1517/17425247.2014.924501
   Lee CK, 2009, ANGEW CHEM INT EDIT, V48, P5116, DOI 10.1002/anie.200804788
   Lee SB, 2004, BIOMATERIALS, V25, P2309, DOI 10.1016/j.biomaterials.2003.09.016
   Meiyazhagan A, 2015, MATER CHEM PHYS, V157, P8, DOI 10.1016/j.matchemphys.2015.03.005
   Moura FCC, 2009, APPL CATAL B-ENVIRON, V90, P436, DOI 10.1016/j.apcatb.2009.04.003
   Munster S, 2013, P NATL ACAD SCI USA, V110, P12197, DOI 10.1073/pnas.1222787110
   Munoz JA, 2002, ENVIRON SCI TECHNOL, V36, P3405, DOI 10.1021/es020017c
   Narayanan TN, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/5/055607
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   PETITE H, 1990, J BIOMED MATER RES, V24, P179, DOI 10.1002/jbm.820240205
   Ramay HR, 2003, BIOMATERIALS, V24, P3293, DOI 10.1016/S0142-9612(03)00171-6
   Shakespeare P, 2001, BURNS, V27, P517, DOI 10.1016/S0305-4179(01)00017-1
   Sheu MT, 2001, BIOMATERIALS, V22, P1713, DOI 10.1016/S0142-9612(00)00315-X
   Shi B., 2000, PLANT POLYPHENOLS, P73
   Sreeram KJ, 2003, RESOUR CONSERV RECY, V38, P185, DOI 10.1016/S0921-3449(02)00151-9
   Svagan AJ, 2008, ADV MATER, V20, P1263, DOI 10.1002/adma.200701215
   Thanikaivelan P, 2012, SCI REP-UK, V2, DOI 10.1038/srep00230
   Usha R, 2000, THERMOCHIM ACTA, V356, P59, DOI 10.1016/S0040-6031(00)00518-9
   Wang S, 2011, J MATER SCI-MATER M, V22, P1195, DOI 10.1007/s10856-011-4297-4
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   Yannas I., 1995, ELECT ENG HDB, P1619
NR 40
TC 7
Z9 7
U1 1
U2 33
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JUN 15
PY 2016
VL 8
IS 23
BP 14836
EP 14844
DI 10.1021/acsami.6b04582
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DP0QT
UT WOS:000378195000065
PM 27219483
DA 2018-10-19
ER

PT J
AU Stipniece, L
   Salma-Ancane, K
   Rjabovs, V
   Juhnevica, I
   Turks, M
   Narkevica, I
   Berzina-Cimdina, L
AF Stipniece, Liga
   Salma-Ancane, Kristine
   Rjabovs, Vitalijs
   Juhnevica, Inna
   Turks, Maris
   Narkevica, Inga
   Berzina-Cimdina, Liga
TI Development of functionalized hydroxyapatiteipoly(vinyl alcohol)
   composites
SO JOURNAL OF CRYSTAL GROWTH
LA English
DT Article
DE Microgranules; In situ synthesis; Spray drying; Hydroxyapatite;
   Poly(vinyl alcohol)
ID POLY(VINYL ALCOHOL); CELLULOSE NANOCRYSTALS; BIOCOMPOSITE SCAFFOLDS;
   MECHANICAL-PROPERTIES; POLYVINYL-ALCOHOL; DRUG-DELIVERY; BIOMATERIAL;
   TEMPERATURE; HYDROGEL; ACID
AB Based on the well-known pharmaceutical excipient potential of poly(vinyl alcohol) (PVA) and clinical success of hydroxyapatite (HAp), the objective of this work was to fabricate functionalized composite microgranules. PVA was modified with succinic anhydride to introduce carboxyl groups (-COOH), respectively, by reaction between the-OH groups of PVA and succinic anhydride, for attachment of drug molecules. For the first time, the functionalized composite microgranules containing HAp/PVA in the ratio of 1:1 were prepared through in situ precipitation of HAp in modified PVA aqueous solutions followed by spray drying of obtained suspensions. The microgranules were characterized by Fourier transform infrared spectroscopy (FT-IR), X-ray diffraction (XRD), field emission scanning electron microscopy (FE-SEM), and differential scanning calorimetry (DSC). The presence of -COOH groups was verified by FT-IR, and the amount of functional groups added to PVA molecules (averaging 15 mol%) was determined by nuclear magnetic resonance spectroscopy (NMR). DSC results showed that modification with -COOH groups slightly decreased the thermal stability of PVA. FT-IR and XRD analysis confirmed that the resulting composites contain mainly nanocrystalline HAp and PVA. Moreover, the images taken by FE-SEM revealed that the microgranules consisted of nanosized HAp crystallites homogenously embedded in the PVA matrix. DSC measurements indicated that decomposition mechanism of the HAp/PVA differs from that of pure PVA and occurs at lower temperatures. However, the presence of HAp had minor influence on the thermal decomposition of the PVA modified with succinic anhydride. The investigation of composite microgranules confirmed interaction and integration between the HAp and PVA. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Stipniece, Liga; Salma-Ancane, Kristine; Narkevica, Inga; Berzina-Cimdina, Liga] Riga Tech Univ, Inst Gen Chem Engn, Fac Mat Sci & Appl Chem, Rudolfs Cimdins Riga Biomat Innovat & Dev Ctr RTU, Pulka 3, LV-1007 Riga, Latvia.
   [Rjabovs, Vitalijs; Turks, Maris] Riga Tech Univ, Inst Technol Organ Chem, Fac Mat Sci & Appl Chem, Paula Valdena 3-7, LV-1048 Riga, Latvia.
   [Juhnevica, Inna] Riga Tech Univ, Fac Mat Sci & Appl Chem, Inst Silicate Mat, Paula Valdena 3-7, LV-1048 Riga, Latvia.
RP Stipniece, L (reprint author), Riga Tech Univ, Inst Gen Chem Engn, Fac Mat Sci & Appl Chem, Rudolfs Cimdins Riga Biomat Innovat & Dev Ctr RTU, Pulka 3, LV-1007 Riga, Latvia.
EM liga.stipniece@rtu.lv
OI Rjabovs, Vitalijs/0000-0003-4302-7804; Stipniece,
   Liga/0000-0001-5472-7684
FU European Social Fund within the project "Involvement of new scientist
   group for synergistic investigation to development of nanostructured
   composite materials for bone tissue regeneration"
   [2013/0007/1DP/1.1.1.2.0/13/APIA/VIAA/024]
FX This work has been supported by European Social Fund within the project
   "Involvement of new scientist group for synergistic investigation to
   development of nanostructured composite materials for bone tissue
   regeneration" No. 2013/0007/1DP/1.1.1.2.0/13/APIA/VIAA/024.
CR Abal-hay A., 2014, CERAM INT, V40, P4995
   Alves MH, 2011, MACROMOL BIOSCI, V11, P1293, DOI 10.1002/mabi.201100145
   Baker MI, 2012, J BIOMED MATER RES B, V100B, P1451, DOI 10.1002/jbm.b.32694
   Balgova Z, 2013, CENT EUR J CHEM, V11, P1403, DOI 10.2478/s11532-013-0283-7
   Cai X, 2009, ACTA BIOMATER, V5, P2693, DOI 10.1016/j.actbio.2009.03.005
   Cannan RK, 1938, J AM CHEM SOC, V60, P2314, DOI 10.1021/ja01277a012
   Chua CK, 2004, J MATER SCI-MATER M, V15, P1113, DOI 10.1023/B:JMSM.0000046393.81449.a5
   Chung YS, 2007, J APPL POLYM SCI, V104, P3240, DOI 10.1002/app.25949
   Costa Vilma Conceição, 2007, Mat. Res., V10, P21, DOI 10.1590/S1516-14392007000100006
   Dhandayuthapani B, 2011, INT J POLYM SCI, DOI 10.1155/2011/290602
   Dinga B., 2005, POLYMER, V45, P1895
   Drouet C, 2013, BIOMED RES INT, DOI 10.1155/2013/490946
   DUNCAN R, 1994, CLIN PHARMACOKINET, V27, P290, DOI 10.2165/00003088-199427040-00004
   Fundueanu G, 2010, ACTA BIOMATER, V6, P3899, DOI 10.1016/j.actbio.2010.04.026
   Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931
   Guirguis OW, 2012, NAT SCI, V4, P57, DOI DOI 10.4236/NS.2012.41009
   Han XZ, 2009, DESALINATION, V240, P21, DOI 10.1016/j.desal.2008.01.047
   Hayami T, 2007, MATER LETT, V61, P2667, DOI 10.1016/j.matlet.2006.10.019
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Iqbal N, 2012, CURR APPL PHYS, V12, P755, DOI 10.1016/j.cap.2011.11.003
   Kumar A, 2014, CELLULOSE, V21, P3409, DOI 10.1007/s10570-014-0339-7
   Kumar A, 2014, MATER LETT, V129, P61, DOI 10.1016/j.matlet.2014.05.038
   Lin XY, 2004, MATER LETT, V58, P3569, DOI 10.1016/j.matlet.2004.06.044
   Mansur HS, 2008, MAT SCI ENG C-BIO S, V28, P539, DOI 10.1016/j.msec.2007.10.088
   Pan YS, 2009, WEAR, V266, P699, DOI 10.1016/j.wear.2008.08.012
   Parrish B, 2005, J AM CHEM SOC, V127, P7404, DOI 10.1021/ja050310n
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Raj M. Sundar, 2013, INDIAN J SCI TECH S5, V6, pS4653
   Roche KJ, 2015, J CRYST GROWTH, V409, P80, DOI 10.1016/j.jcrysgro.2014.10.002
   Sadjadi MS, 2010, MATER CHEM PHYS, V124, P217, DOI 10.1016/j.matchemphys.2010.06.022
   Sanchez-Chaves M, 1998, POLYMER, V39, P2751, DOI 10.1016/S0032-3861(97)00601-0
   Singh A, 2012, B MATER SCI, V35, P1031, DOI 10.1007/s12034-012-0384-5
   Stipniece L, 2014, CERAM INT, V40, P3261, DOI 10.1016/j.ceramint.2013.09.110
   Tang CY, 2009, CERAM INT, V35, P2171, DOI 10.1016/j.ceramint.2008.11.028
   Tsetsekou A, 2014, MAT SCI ENG C-MATER, V43, P555, DOI 10.1016/j.msec.2014.07.011
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Zhou ZF, 2007, J APPL POLYM SCI, V103, P848, DOI 10.1002/app.25190
NR 37
TC 5
Z9 5
U1 6
U2 50
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-0248
EI 1873-5002
J9 J CRYST GROWTH
JI J. Cryst. Growth
PD JUN 15
PY 2016
VL 444
BP 14
EP 20
DI 10.1016/j.jcrysgro.2016.03.029
PG 7
WC Crystallography; Materials Science, Multidisciplinary; Physics, Applied
SC Crystallography; Materials Science; Physics
GA DM6EO
UT WOS:000376443600003
DA 2018-10-19
ER

PT J
AU Castano, IM
   Curtin, CM
   Duffy, GP
   O'Brien, FJ
AF Castano, Irene Mencia
   Curtin, Caroline M.
   Duffy, Garry P.
   O'Brien, Fergal J.
TI Next generation bone tissue engineering: non-viral miR-133a inhibition
   using collagen-nanohydroxyapatite scaffolds rapidly enhances
   osteogenesis
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; OSTEOBLAST DIFFERENTIATION; POSITIVE REGULATION;
   ADIPOSE-TISSUE; DELIVERY; REGENERATION; TRANSFECTION; DEFECTS; MIRNAS;
   REPAIR
AB Bone grafts are the second most transplanted materials worldwide at a global cost to healthcare systems valued over $30 billion every year. The influence of microRNAs in the regenerative capacity of stem cells offers vast therapeutic potential towards bone grafting; however their efficient delivery to the target site remains a major challenge. This study describes how the functionalisation of porous collagen-nanohydroxyapatite (nHA) scaffolds with miR-133a inhibiting complexes, delivered using non-viral nHA particles, enhanced human mesenchymal stem cell-mediated osteogenesis through the novel focus on a key activator of osteogenesis, Runx2. This study showed enhanced Runx2 and osteocalcin expression, as well as increased alkaline phosphatase activity and calcium deposition, thus demonstrating a further enhanced therapeutic potential of a biomaterial previously optimised for bone repair applications. The promising features of this platform offer potential for a myriad of applications beyond bone repair and tissue engineering, thus presenting a new paradigm for microRNA-based therapeutics.
C1 [Castano, Irene Mencia; Curtin, Caroline M.; Duffy, Garry P.; O'Brien, Fergal J.] RCSI, Dept Anat, Tissue Engn Res Grp, 123 St Stephens Green, Dublin 2, Ireland.
   [Castano, Irene Mencia; Curtin, Caroline M.; Duffy, Garry P.; O'Brien, Fergal J.] Coll Green, TCD, Trinity Ctr Bioengn, Dublin 2, Ireland.
   [Castano, Irene Mencia; Curtin, Caroline M.; Duffy, Garry P.; O'Brien, Fergal J.] RCSI, Adv Mat & Bioengn Res AMBER Ctr, Dublin 2, Ireland.
   [Castano, Irene Mencia; Curtin, Caroline M.; Duffy, Garry P.; O'Brien, Fergal J.] TCD, Dublin 2, Ireland.
RP O'Brien, FJ (reprint author), RCSI, Dept Anat, Tissue Engn Res Grp, 123 St Stephens Green, Dublin 2, Ireland.; O'Brien, FJ (reprint author), Coll Green, TCD, Trinity Ctr Bioengn, Dublin 2, Ireland.; O'Brien, FJ (reprint author), RCSI, Adv Mat & Bioengn Res AMBER Ctr, Dublin 2, Ireland.; O'Brien, FJ (reprint author), TCD, Dublin 2, Ireland.
EM fjobrien@rcsi.ie
RI O'Brien, Fergal/F-9485-2011
OI O'Brien, Fergal/0000-0003-2030-8005; Duffy, Garry/0000-0002-4994-9511
FU BioAT; European Regional Development Fund (ERDF); European Union
   Structural Funds Programme; European Research Council (ERC) Grant
   [239685]
FX This work was supported by the BioAT funding bodies PRTL (Programme for
   Research in Third Level Institutions) Cycle 5 and European Regional
   Development Fund (ERDF), part of the European Union Structural Funds
   Programme 2007-2013. Support funding also included the European Research
   Council (ERC) Grant Agreement no. 239685. The authors are thankful to
   Integra LifeSciences Corporation for providing the collagen for the
   scaffold synthesis, Ms. Georgina Shaw and Dr. J. Mary Murphy at NUI
   Galway for kindly providing hMSCs.
CR Beavers KR, 2015, ADV DRUG DELIVER REV, V88, P123, DOI 10.1016/j.addr.2014.12.006
   Castano IM, 2015, J CONTROL RELEASE, V200, P42, DOI 10.1016/j.jconrel.2014.12.034
   Clark EA, 2014, STEM CELLS, V32, P1074, DOI 10.1002/stem.1623
   Cunniffe GM, 2010, J BIOMED MATER RES A, V95A, P1142, DOI 10.1002/jbm.a.32931
   Cunniffe GM, 2010, J MATER SCI-MATER M, V21, P2293, DOI 10.1007/s10856-009-3964-1
   Curtin CM, 2015, ADV HEALTHC MATER, V4, P223, DOI 10.1002/adhm.201400397
   Curtin CM, 2012, ADV MATER, V24, P749, DOI 10.1002/adma.201103828
   Deng Y, 2014, EUR CELLS MATER, V27, P13, DOI 10.22203/eCM.v027a02
   Deng Y, 2013, BIOMATERIALS, V34, P6717, DOI 10.1016/j.biomaterials.2013.05.042
   Duffy GP, 2009, TISSUE ENG PT A, V15, P2459, DOI [10.1089/ten.tea.2008.0341, 10.1089/ten.TEA.2008.0341]
   Elmore J. C., 2010, MARKET TECHNOLOGY RE
   Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455
   Gleeson JP, 2010, EUR CELLS MATER, V20, P218
   Gordeladze JO, 2010, ILAR J, V51, P42, DOI 10.1093/ilar.51.1.42
   Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267
   Hassan MQ, 2012, J BIOL CHEM, V287, P42084, DOI 10.1074/jbc.M112.377515
   Hu R, 2010, EXPERT OPIN THER TAR, V14, P1109, DOI 10.1517/14728222.2010.512916
   James EN, 2014, ACTA BIOMATER, V10, P3571, DOI 10.1016/j.actbio.2014.04.026
   Jensen ED, 2010, BIOFACTORS, V36, P25, DOI 10.1002/biof.72
   Kim KM, 2014, CURR OPIN PHARMACOL, V16, P133, DOI 10.1016/j.coph.2014.05.001
   Kim YJ, 2009, J BONE MINER RES, V24, P816, DOI 10.1359/JBMR.081230
   Kwong FNK, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2436
   Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832
   Li JG, 2014, ADV MATER, V26, P8217, DOI 10.1002/adma.201403877
   Li Y, 2013, BIOMATERIALS, V34, P5048, DOI 10.1016/j.biomaterials.2013.03.052
   Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105
   Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200
   Liao XB, 2013, ENDOCRINOLOGY, V154, P3344, DOI 10.1210/en.2012-2236
   Liao YH, 2014, BIOMATERIALS, V35, P4901, DOI 10.1016/j.biomaterials.2014.02.055
   Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315
   Mariner P. D., 2011, J TISSUE ENG REGEN M, V6, P314
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nguyen MK, 2014, BIOMATERIALS, V35, P6278, DOI 10.1016/j.biomaterials.2014.04.048
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Pedraza CE, 2008, BIOMATERIALS, V29, P3384, DOI 10.1016/j.biomaterials.2008.04.043
   Qureshi AT, 2013, BIOMATERIALS, V34, P7799, DOI 10.1016/j.biomaterials.2013.07.004
   Raftery RM, 2016, ADV MATER, V28, P5447, DOI 10.1002/adma.201505088
   Schoolmeesters A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005605
   Sriram M, 2015, INT J BIOL MACROMOL, V74, P404, DOI 10.1016/j.ijbiomac.2014.12.034
   Tierney E. G., 2011, J CONTROL RELEASE, V158, P304
   Wu KM, 2013, ACS APPL MATER INTER, V5, P2733, DOI 10.1021/am400374c
   Yang XC, 2008, TISSUE ENG PT A, V14, P71, DOI 10.1089/ten.a.2007.0102
NR 42
TC 17
Z9 18
U1 2
U2 17
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 14
PY 2016
VL 6
AR 27941
DI 10.1038/srep27941
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DO5NM
UT WOS:000377829800001
PM 27297802
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Vishali, S
   Rashmi, P
   Karthikeyan, R
AF Vishali, S.
   Rashmi, P.
   Karthikeyan, R.
TI Evaluation of wasted biomaterial, crab shells (Portunus sanguinolentus),
   as a coagulant, in paint effluent treatment
SO DESALINATION AND WATER TREATMENT
LA English
DT Article
DE Portunus sanguinolentus; Crab shell; Paint effluent; Coagulation; Eluate
ID ELECTROCHEMICAL TREATMENT; INDUSTRIAL EFFLUENTS; AQUEOUS-SOLUTIONS;
   WATER; CHITOSAN; BIOSORPTION; REMOVAL; PARTICLES; ALUMINUM; CHITIN
AB The ability of the wasted biomaterial crab shells, Portunus sanguinolentus, as a coagulant, in the treatment of simulated water-based paint industry effluent was evaluated. The treatment process was conducted in conventional jar test. The FTIR spectrum values endorse the existence of chitosan in P. sanguinolentus. The leverage of variables such as time (min), eluent type (deionized water, NaCl, and BaCl2), eluent concentration (1-5N), coagulant dose (1-6g), coagulant volume (20-100mL), initial pH (5-10), and initial concentration (3,100, 4,224, 5,650, 6,258, and 7,693mg/L named as sample number 1-5, respectively) were investigated in terms of color, chemical oxygen demand, and turbidity. The optimized value of the above-mentioned variables were examined and the values are 20min of slow mixing, 15min of settling course, 3N NaCl as an eluent, and 100mL of 3g crab shells eluate to treat 1L of effluent under basic pH. The maximum removal efficiency was identified for higher initial concentration effluent, sample 5. The results were compared with conventional coagulant alum and ferric chloride from previous studies. The wasted biomaterial crab shells could act as propitious surrogate for conventional coagulants.
C1 [Vishali, S.; Rashmi, P.] SRM Univ, Dept Chem Engn, Madras 603203, Tamil Nadu, India.
   [Karthikeyan, R.] AAMEC, Kovilvenni 614403, Thanjavur, India.
RP Vishali, S (reprint author), SRM Univ, Dept Chem Engn, Madras 603203, Tamil Nadu, India.
EM meet.vishali@gmail.com; rashmi_p30@yahoo.com; drrkarthi@yahoo.com
CR Ahmad AL, 2011, CHEM ENG J, V173, P879, DOI 10.1016/j.cej.2011.07.070
   Ahmad A. L., 2006, CHEM ENG J, P9
   Akyol A, 2012, DESALINATION, V285, P91, DOI 10.1016/j.desal.2011.09.039
   APHA, 1995, STAND METH EX WAST W
   Bolat Y, 2010, PAK VET J, V30, P227
   Brugnerotto J, 2001, POLYMER, V42, P3569, DOI 10.1016/S0032-3861(00)00713-8
   Chi FH, 2006, J POLYM ENVIRON, V14, P411, DOI 10.1007/s10924-006-0027-2
   Dahiya S, 2008, BIORESOURCE TECHNOL, V99, P179, DOI 10.1016/j.biortech.2006.11.011
   Flaten TP, 2001, BRAIN RES BULL, V55, P187, DOI 10.1016/S0361-9230(01)00459-2
   George T. S., 2011, WORLD J SCI TECHNOL, V1, P3
   Korbahti BK, 2007, J HAZARD MATER, V148, P83, DOI 10.1016/j.jhazmat.2007.02.005
   Korbahti BK, 2009, CHEM ENG J, V148, P444, DOI 10.1016/j.cej.2008.09.019
   Kumar R, 2013, CHEM ENG J, V226, P377, DOI 10.1016/j.cej.2013.04.063
   Meyssami B, 2005, BIORESOURCE TECHNOL, V96, P303, DOI 10.1016/j.biortech.2004.04.014
   Palpandi C., 2009, INT J MED MED SCI, V5, P198
   Patel H, 2012, J SAUDI CHEM SOC, V16, P131, DOI 10.1016/j.jscs.2010.12.003
   Rizzo L, 2008, SEP PURIF TECHNOL, V62, P79, DOI 10.1016/j.seppur.2007.12.020
   Sciban M. B., 2006, APTEFF, V37, P1
   Sciban M, 2009, BIORESOURCE TECHNOL, V100, P6639, DOI 10.1016/j.biortech.2009.06.047
   Shazly M. A. E. L., 2010, AM EURASIAN J AGR EN, V8, P597
   Shuguang L., 2007, J HAZARD MATER, V149, P208
   Verma AK, 2012, J ENVIRON MANAGE, V93, P154, DOI 10.1016/j.jenvman.2011.09.012
   Vijayaraghavan K, 2005, J HAZARD MATER, V119, P251, DOI 10.1016/j.jhazmat.2004.12.017
   Vijayaraghavan K, 2011, DESALINATION, V266, P195, DOI 10.1016/j.desal.2010.08.026
   Vijayaraghavan K, 2010, CHEM ENG J, V163, P337, DOI 10.1016/j.cej.2010.08.012
   Vishali S, 2014, SEP SCI TECHNOL, V49, P2510, DOI 10.1080/01496395.2014.931098
   Vishali S., 2014, DESALIN WATER TREAT, DOI [10.1080/19443994.2014.945487, DOI 10.1080/19443994.2014.945487]
   Yin CY, 2010, PROCESS BIOCHEM, V45, P1437, DOI 10.1016/j.procbio.2010.05.030
   Zemmouri H, 2012, PROCEDIA ENGINEER, V33, P254, DOI 10.1016/j.proeng.2012.01.1202
NR 29
TC 6
Z9 6
U1 0
U2 16
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1944-3994
EI 1944-3986
J9 DESALIN WATER TREAT
JI Desalin. Water Treat.
PD JUN 14
PY 2016
VL 57
IS 28
BP 13157
EP 13165
DI 10.1080/19443994.2015.1055812
PG 9
WC Engineering, Chemical; Water Resources
SC Engineering; Water Resources
GA DG1GH
UT WOS:000371813600025
DA 2018-10-19
ER

PT J
AU Izquierdo, J
   Gonzalez-Marrero, MB
   Bozorg, M
   Fernandez-Perez, BM
   Vasconcelos, HC
   Santana, JJ
   Souto, RM
AF Izquierdo, J.
   Gonzalez-Marrero, M. B.
   Bozorg, M.
   Fernandez-Perez, B. M.
   Vasconcelos, H. C.
   Santana, J. J.
   Souto, R. M.
TI Multiscale electrochemical analysis of the corrosion of titanium and
   nitinol for implant applications
SO ELECTROCHIMICA ACTA
LA English
DT Article
DE Ti alloys; corrosion resistance; passive layers; potentiodynamic
   polarization; scanning electrochemical microscopy; biomaterials
ID SIMULATED PHYSIOLOGICAL SOLUTIONS; SHAPE-MEMORY ALLOYS; BIOMEDICAL
   APPLICATIONS; PITTING CORROSION; METALLIC BIOMATERIALS; LOCALIZED
   CORROSION; HYDROGEN-PEROXIDE; CHLORIDE SOLUTION; PRECURSOR SITES; ZRTI
   ALLOYS
AB Surface electrochemical activity of titanium and nitinol biomaterials in naturally aerated Ringer's physiological solution was investigated using potentiodynamic polarization and scanning electrochemical microscopy (SECM) techniques. SECM was operated in feedback and redox competition modes as a function of potential applied to the substrate. The kinetics of the electron transfer rate on both materials was characterized by mathematical modelling of the Z-approach curves monitored under feedback conditions. The rate constant values greatly depended on the characteristics of the passive layers formed over the metals under potentiostatic control. A more insulating film was found on nitinol when biased at low polarizations, resulting in smaller tip current increments during tip approach to the investigated surface under positive feedback and competition operation modes. However, at higher anodic polarizations, nitinol passive layers experience breakdown, and therefore tip current values reflect the release of metal cations from the biomaterial surface. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Izquierdo, J.; Gonzalez-Marrero, M. B.; Bozorg, M.; Fernandez-Perez, B. M.; Souto, R. M.] Univ La Laguna, Dept Chem, POB 456, E-38200 Tenerife, Canary Islands, Spain.
   [Izquierdo, J.; Souto, R. M.] Univ La Laguna, Inst Mat Sci & Nanotechnol, POB 456, E-38200 Tenerife, Canary Islands, Spain.
   [Vasconcelos, H. C.] Azores Univ, Dept Technol Sci & Dev, P-9501801 Ponta Delgada, Sao Miguel, Portugal.
   [Santana, J. J.] Univ Las Palmas Gran Canaria, Dept Proc Engn, E-35017 Las Palmas Gran Canaria, Canary Islands, Spain.
RP Souto, RM (reprint author), Univ La Laguna, Dept Chem, POB 456, E-38200 Tenerife, Canary Islands, Spain.
EM rsouto@ull.es
RI Santana Rodriguez, Juan Jose/C-4040-2008
OI Santana Rodriguez, Juan Jose/0000-0002-3030-2195; /0000-0001-5935-870X;
   Izquierdo Perez, Javier/0000-0003-3287-9403; Souto, Ricardo
   M./0000-0001-9429-5513
FU Spanish Ministry of Economy and Competitiveness (MINECO, Madrid, Spain)
   [CTQ2012-36787]; European Regional Development Fund (Brussels, Belgium)
   [CTQ2012-36787]; Spanish Ministry of Education (Programa de Formacion de
   Personal Investigador, Madrid, Spain); Obra Social La Caixa - Fundacion
   Cajacanarias (Santa Cruz de Tenerife, Spain)
FX This work was supported by the Spanish Ministry of Economy and
   Competitiveness (MINECO, Madrid, Spain), jointly with the European
   Regional Development Fund (Brussels, Belgium), under Grant
   CTQ2012-36787. The award of Research Training Grants to J.I. by the
   Spanish Ministry of Education (Programa de Formacion de Personal
   Investigador, Madrid, Spain), and to B.M.F.-P. by Obra Social La Caixa -
   Fundacion Cajacanarias (Santa Cruz de Tenerife, Spain) are greatly
   acknowledged.
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Alkhateeb E, 2005, J BIOMED MATER RES A, V75A, P934, DOI 10.1002/jbm.a.30508
   Alves VA, 2009, CORROS SCI, V51, P2473, DOI 10.1016/j.corsci.2009.06.035
   Assis S.L.d., 2006, ELECTROCHIM ACTA, V51, P1815, DOI DOI 10.1016/J.ELECTACTA.2005.02.121
   Azumi K, 2001, CORROS SCI, V43, P533, DOI 10.1016/S0010-938X(00)00105-0
   Bard A. J, 2012, SCANNING ELECTROCHEM
   Bard A.J., 2001, ELECTROCHEMICAL METH
   BASAME SB, 1995, J PHYS CHEM-US, V99, P16430, DOI 10.1021/j100044a034
   Basame SB, 1998, J PHYS CHEM B, V102, P9812, DOI 10.1021/jp982088x
   Bolat G, 2013, ELECTROCHIM ACTA, V113, P470, DOI 10.1016/j.electacta.2013.09.116
   Bolat G, 2013, ELECTROCHIM ACTA, V88, P447, DOI 10.1016/j.electacta.2012.10.026
   Bolz A, 1996, TEX HEART I J, V23, P162
   Burstein GT, 2005, BIOMATERIALS, V26, P245, DOI 10.1016/j.biomaterials.2004.02.023
   Carroll WM, 2003, J BIOMED MATER RES A, V67A, P1123, DOI 10.1002/jbm.a.10099
   CASILLAS N, 1994, J ELECTROCHEM SOC, V141, P636, DOI 10.1149/1.2054783
   CASILLAS N, 1993, J ELECTROCHEM SOC, V140, pL142, DOI 10.1149/1.2220897
   Chan CW, 2012, CORROS SCI, V56, P158, DOI 10.1016/j.corsci.2011.11.020
   Chelariu R, 2014, ELECTROCHIM ACTA, V137, P280, DOI 10.1016/j.electacta.2014.06.021
   Cheng XL, 2005, BIOMATERIALS, V26, P7350, DOI 10.1016/j.biomaterials.2005.05.047
   Ciurescu G, 2012, INT J ELECTROCHEM SC, V7, P7404
   Cornut R, 2008, J ELECTROANAL CHEM, V621, P178, DOI 10.1016/j.jelechem.2007.09.021
   Es-Souni M, 2005, ANAL BIOANAL CHEM, V381, P557, DOI 10.1007/s00216-004-2888-3
   Fan F.-R. F., 2012, SCANNING ELECTROCHEM
   Garfias-Mesias LF, 1998, J ELECTROCHEM SOC, V145, P2005, DOI 10.1149/1.1838590
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Hallab NJ, 2003, J BIOMED MATER RES A, V65A, P311, DOI 10.1002/jbm.a.10429
   HOAR TP, 1966, PROC R SOC LON SER-A, V294, P486, DOI 10.1098/rspa.1966.0220
   Huang WM, 2013, ADV DRUG DELIVER REV, V65, P515, DOI 10.1016/j.addr.2012.06.004
   Izquierdo J, 2014, J ELECTROANAL CHEM, V728, P148, DOI 10.1016/j.jelechem.2014.06.009
   Izquierdo J, 2014, APPL SURF SCI, V313, P259, DOI 10.1016/j.apsusc.2014.05.201
   Izquierdo J, 2014, ELECTROCHIM ACTA, V134, P167, DOI 10.1016/j.electacta.2014.04.161
   Izquierdo J, 2012, PROG ORG COAT, V74, P526, DOI 10.1016/j.porgcoat.2012.01.019
   Izquierdo J, 2010, ELECTROCHIM ACTA, V55, P8791, DOI 10.1016/j.electacta.2010.08.020
   Lamaka S. V., 2010, MICROSCOPY SCI TECHN, V3, P2162
   Li YH, 2014, MATERIALS, V7, P1709, DOI 10.3390/ma7031709
   Maho A, 2014, ELECTROCHIM ACTA, V116, P78, DOI 10.1016/j.electacta.2013.11.008
   Mansfeld F., 1993, 26 SOL SCHLUMB, V4, P41
   Milosev I, 2012, MAT SCI ENG C-MATER, V32, P1068, DOI 10.1016/j.msec.2011.08.022
   Milosev I, 2012, MAT SCI ENG C-MATER, V32, P1087, DOI 10.1016/j.msec.2011.11.007
   Niinomi M, 2012, ACTA BIOMATER, V8, P3888, DOI 10.1016/j.actbio.2012.06.037
   Pan J, 1996, J BIOMED MATER RES, V30, P393
   PAN J, 1994, J BIOMED MATER RES, V28, P113, DOI 10.1002/jbm.820280115
   Pan J., 1996, THESIS ROYAL I TECHN
   Pourbaix M, 1966, ATLAS ELECTROCHEMICA
   Pust SE, 2007, J ELECTROCHEM SOC, V154, pC508, DOI 10.1149/1.2754080
   Pust SE, 2007, ADV MATER, V19, P878, DOI 10.1002/adma.200601446
   Rajan GP, 2005, J BIOMED MATER RES B, V72B, P305, DOI 10.1002/jbm.b.30165
   Rosalbino F, 2011, J MATER SCI-MATER M, V22, P1293, DOI 10.1007/s10856-011-4301-z
   Ruhlig D, 2008, ANALYST, V133, P1700, DOI 10.1039/b804718a
   Santana JJ, 2010, ELECTROCHIM ACTA, V55, P4488, DOI 10.1016/j.electacta.2010.02.091
   Schiff N, 2002, BIOMATERIALS, V23, P1995, DOI 10.1016/S0142-9612(01)00328-3
   Schulte A, 2004, MAT SCI ENG A-STRUCT, V378, P523, DOI 10.1016/j.msea.2003.10.354
   Schulte A., 2002, Materials Science Forum, V394-395, P145
   Shabalovskaya SA, 2009, BIOMATERIALS, V30, P3662, DOI 10.1016/j.biomaterials.2009.03.034
   Shih CC, 2005, J BIOMED MATER RES A, V74A, P325, DOI 10.1002/ibm.a.30255
   Wallinder D, 1999, CORROS SCI, V41, P275
   Wang BL, 2009, MATER CORROS, V60, P330, DOI 10.1002/maco.200805120
   Yang P, 2004, SURF COAT TECH, V177, P747, DOI 10.1016/j.surfcoat.2003.08.016
   Yeum B., 2001, ELECTROCHEMICAL IMPE
   Zhu RK, 2008, ANAL CHEM, V80, P1437, DOI 10.1021/ac701796u
   Zhu RK, 2007, CHEM MATER, V19, P2533, DOI 10.1021/cm070023d
NR 61
TC 5
Z9 5
U1 5
U2 33
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0013-4686
EI 1873-3859
J9 ELECTROCHIM ACTA
JI Electrochim. Acta
PD JUN 10
PY 2016
VL 203
BP 366
EP 378
DI 10.1016/j.electacta.2016.01.146
PG 13
WC Electrochemistry
SC Electrochemistry
GA DM1UV
UT WOS:000376133200041
DA 2018-10-19
ER

PT J
AU Oprych, KM
   Whitby, RLD
   Mikhalovsky, SV
   Tomlins, P
   Adu, J
AF Oprych, Karen M.
   Whitby, Raymond L. D.
   Mikhalovsky, Sergey V.
   Tomlins, Paul
   Adu, Jimi
TI Repairing Peripheral Nerves: Is there a Role for Carbon Nanotubes?
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE carbon nanotubes; nerve regeneration; nerve repair conduits; neurons;
   tissue scaffold
ID ELECTRICAL-STIMULATION PROMOTES; CONDUCTIVE POLYPYRROLE/CHITOSAN
   POLYMERS; ENHANCE NEURITE OUTGROWTH; ROOT GANGLIA NEURONS; NEURAL
   STEM-CELLS; IN-VITRO; AXON REGENERATION; NERVOUS-SYSTEM; SCIATIC-NERVE;
   GROWTH-FACTOR
AB Peripheral nerve injury continues to be a major global health problem that can result in debilitating neurological deficits and neuropathic pain. Current state-of-the-art treatment involves reforming the damaged nerve pathway using a nerve autograft. Engineered nerve repair conduits can provide an alternative to the nerve autograft avoiding the inevitable tissue damage caused at the graft donor site. Commercially available nerve repair conduits are currently only considered suitable for repairing small nerve lesions; the design and performance of engineered conduits requires significant improvements to enable their use for repairing larger nerve defects. Carbon nanotubes (CNTs) are an emerging novel material for biomedical applications currently being developed for a range of therapeutic technologies including scaffolds for engineering and interfacing with neurological tissues. CNTs possess a unique set of physicochemical properties that could be useful within nerve repair conduits. This progress report aims to evaluate and consolidate the current literature pertinent to CNTs as a biomaterial for supporting peripheral nerve regeneration. The report is presented in the context of the state-of-the-art in nerve repair conduit design; outlining how CNTs may enhance the performance of next generation peripheral nerve repair conduits.
C1 [Oprych, Karen M.] UCL, Inst Neurol, Dept Brain Repair & Rehabil, Queen Sq, London WC1N 3BG, England.
   [Whitby, Raymond L. D.; Mikhalovsky, Sergey V.] Nazarbayev Univ, Sch Engn, Astana 010000, Kazakhstan.
   [Mikhalovsky, Sergey V.; Adu, Jimi] Univ Brighton, Sch Pharm & Biomol Sci, Brighton BN2 4GJ, E Sussex, England.
RP Oprych, KM (reprint author), UCL, Inst Neurol, Dept Brain Repair & Rehabil, Queen Sq, London WC1N 3BG, England.; Adu, J (reprint author), Univ Brighton, Sch Pharm & Biomol Sci, Brighton BN2 4GJ, E Sussex, England.
EM k.gladwin@ucl.ac.uk; j.adu@brighton.ac.uk
FU University of Brighton; National Physical Laboratory; Engineering and
   Physical Sciences Research Council [GR/T18387/01]; University College
   London/University College London Hospitals Biomedical Research Center -
   National Institute for Health Research
FX This work was supported by funds from the following organizations:
   University of Brighton, the National Physical Laboratory, Engineering
   and Physical Sciences Research Council (GR/T18387/01) and University
   College London/University College London Hospitals Biomedical Research
   Center which receives funding from the National Institute for Health
   Research.
CR Abu-Rub MT, 2011, SOFT MATTER, V7, P2770, DOI 10.1039/c0sm01062f
   Agarwal S, 2010, LANGMUIR, V26, P2244, DOI 10.1021/la9048743
   Ahn HS, 2015, ACTA BIOMATER, V13, P324, DOI 10.1016/j.actbio.2014.11.026
   Al-Jamal KT, 2011, P NATL ACAD SCI USA, V108, P10952, DOI 10.1073/pnas.1100930108
   Al-Majed AA, 2004, CELL MOL NEUROBIOL, V24, P379, DOI 10.1023/B:CEMN.0000022770.66463.f7
   Al-Majed AA, 2000, J NEUROSCI, V20, P2602
   Anava S, 2009, BIOPHYS J, V96, P1661, DOI 10.1016/j.bpj.2008.10.058
   Arslantunali D, 2014, J BIOMED MATER RES A, V102, P828, DOI 10.1002/jbm.a.34727
   Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021
   Ayutsede J, 2006, BIOMACROMOLECULES, V7, P208, DOI 10.1021/bm0505888
   Bardi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080964
   Bareket-Keren Lilach, 2012, Front Neural Circuits, V6, P122, DOI 10.3389/fncir.2012.00122
   Beduer A, 2012, LANGMUIR, V28, P17363, DOI 10.1021/la304278n
   Bell JHA, 2012, TISSUE ENG PART B-RE, V18, P116, DOI [10.1089/ten.teb.2011.0498, 10.1089/ten.TEB.2011.0498]
   Belyanskaya L, 2009, NEUROTOXICOLOGY, V30, P702, DOI 10.1016/j.neuro.2009.05.005
   Bhattacharyya S, 2008, BIOMACROMOLECULES, V9, P505, DOI 10.1021/bm7009976
   Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400
   Borgens RB, 1999, J NEUROTRAUM, V16, P639, DOI 10.1089/neu.1999.16.639
   Borgens RB, 1999, NEUROSCIENCE, V91, P251, DOI 10.1016/S0306-4522(98)00584-3
   Bremus-Koebberling EA, 2012, J LASER APPL, V24, DOI 10.2351/1.4730804
   Brooks DN, 2012, MICROSURG, V32, P1, DOI 10.1002/micr.20975
   Brushart T.M., 2011, NERVE REPAIR
   Cai D, 2005, NAT METHODS, V2, P449, DOI 10.1038/NMETH761
   CARBONETTO S, 1987, J NEUROSCI, V7, P610
   Chae SY, 2003, CHEM MATER, V15, P3326, DOI 10.1021/cm030171d
   Chao T, 2013, ANN NEUROL, V73, P210, DOI 10.1002/ana.23781
   Chen MB, 2006, ANN PLAS SURG, V57, P462, DOI 10.1097/01.sap.0000237577.07219.b6
   Chen YS, 2011, BIOMEDICINE-TAIWAN, V1, P33, DOI 10.1016/j.biomed.2011.10.006
   Chen YY, 2005, J NEUROPATH EXP NEUR, V64, P613, DOI 10.1097/01.jnen.0000171650.94341.46
   Chew SY, 2007, ADV FUNCT MATER, V17, P1288, DOI 10.1002/adfm.200600441
   Cho YN, 2010, J BIOMED MATER RES A, V95A, P510, DOI 10.1002/jbm.a.32841
   Collins PC, 2001, SCIENCE, V292, P706, DOI 10.1126/science.1058782
   Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285
   de Winter F, 2013, EUR J PHARMACOL, V719, P145, DOI 10.1016/j.ejphar.2013.04.057
   Deister C, 2007, J BIOMAT SCI-POLYM E, V18, P983, DOI 10.1163/156856207781494377
   Edwards SL, 2009, BIOMATERIALS, V30, P1725, DOI 10.1016/j.biomaterials.2008.12.031
   Eggers R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071076
   English AW, 2007, DEV NEUROBIOL, V67, P158, DOI 10.1002/neu.20339
   Esawi AMK, 2007, MATER DESIGN, V28, P2394, DOI 10.1016/j.matdes.2006.09.022
   Fan L, 2012, NANO LETT, V12, P3668, DOI 10.1021/nl301428w
   FORDHOLEVINSKI T, 1986, DEV BRAIN RES, V28, P121, DOI 10.1016/0165-3806(86)90071-4
   Gabay T, 2005, PHYSICA A, V350, P611, DOI 10.1016/j.physa.2004.11.007
   Gaillard C, 2011, J PEPT SCI, V17, P139, DOI 10.1002/psc.1290
   Galvan-Garcia P, 2007, J BIOMAT SCI-POLYM E, V18, P1245, DOI 10.1163/156856207782177891
   Gattazzo F., 2014, J BIOMED MAT RES B
   Georgiou M, 2013, BIOMATERIALS, V34, P7335, DOI 10.1016/j.biomaterials.2013.06.025
   Ghasemi-Mobarakeh L, 2011, J TISSUE ENG REGEN M, V5, pE17, DOI 10.1002/term.383
   Gheith MK, 2006, ADV MATER, V18, P2975, DOI 10.1002/adma.200600878
   Gheith MK, 2005, ADV MATER, V17, P2663, DOI 10.1002/adma.200500366
   GhoshMitra S, 2012, ADV DRUG DELIVER REV, V64, P110, DOI 10.1016/j.addr.2011.12.013
   Gladwin KM, 2013, ADV HEALTHC MATER, V2, P728, DOI 10.1002/adhm.201200233
   Gordon T, 2008, NEUROL RES, V30, P1012, DOI 10.1179/174313208X362488
   Gordon T, 2010, EXP NEUROL, V223, P192, DOI 10.1016/j.expneurol.2009.09.020
   Haastert K, 2006, NEUROBIOL DIS, V21, P138, DOI 10.1016/j.nbd.2005.06.020
   Haastert-Talini K., 2011, NEUROTRAUMA, V28, P661
   Hall S, 2005, J BONE JOINT SURG BR, V87B, P1309, DOI 10.1302/0301-620X.87B10.16700
   Hanein Y, 2010, PHYS STATUS SOLIDI B, V247, P2635, DOI 10.1002/pssb.201000109
   Heath CA, 1998, TRENDS BIOTECHNOL, V16, P163, DOI 10.1016/S0167-7799(97)01165-7
   Heister E, 2009, CARBON, V47, P2152, DOI 10.1016/j.carbon.2009.03.057
   Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351
   Hrkach J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003651
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   Hu H, 2005, J PHYS CHEM B, V109, P4285, DOI 10.1021/jp0441137
   Huang JH, 2010, J BIOMED MATER RES A, V93A, P164, DOI 10.1002/jbm.a.32511
   Huang YC, 2011, J BIOMED MATER RES A, V99A, P86, DOI 10.1002/jbm.a.33164
   Huang YJ, 2012, SMALL, V8, P2869, DOI 10.1002/smll.201200715
   Hwang JY, 2013, NANOSCALE, V5, P487, DOI 10.1039/c2nr31581e
   Jang MJ, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/23/235102
   Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009
   Jin GZ, 2011, NEUROSCI LETT, V501, P10, DOI 10.1016/j.neulet.2011.06.023
   Johansson F, 2006, BIOMATERIALS, V27, P1251, DOI [10.1016/j.biomaterials.2005.07.047, 10.1016/j.niomaterials.2005.07.047]
   Kabiri M, 2012, BIOTECHNOL LETT, V34, P1357, DOI 10.1007/s10529-012-0889-4
   Kagan VE, 2010, NAT NANOTECHNOL, V5, P354, DOI [10.1038/NNANO.2010.44, 10.1038/nnano.2010.44]
   Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059
   Kateb B, 2007, NEUROIMAGE, V37, pS9, DOI 10.1016/j.neuroimage.2007.03.078
   Keefer EW, 2008, NAT NANOTECHNOL, V3, P434, DOI 10.1038/nnano.2008.174
   Kehoe S, 2012, INJURY, V43, P553, DOI 10.1016/j.injury.2010.12.030
   Kim JA, 2012, INTEGR BIOL-UK, V4, P587, DOI 10.1039/c2ib20017a
   Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014
   Konofaos P, 2013, J RECONSTR MICROSURG, V29, P149, DOI 10.1055/s-0032-1333316
   Kotchey GP, 2013, ADV DRUG DELIVER REV, V65, P1921, DOI 10.1016/j.addr.2013.07.007
   Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6
   Lahiri D, 2009, ACS APPL MATER INTER, V1, P2470, DOI 10.1021/am900423q
   Landers J, 2014, ADV HEALTHC MATER, V3, P1745, DOI 10.1002/adhm.201400042
   Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9
   Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042
   Lee YS, 2011, POLYMERS-BASEL, V3, P413, DOI 10.3390/polym3010413
   LEIN PJ, 1989, DEV BIOL, V136, P330, DOI 10.1016/0012-1606(89)90260-1
   LEMMON V, 1992, J NEUROSCI, V12, P818
   Lewitus DY, 2011, ADV FUNCT MATER, V21, P2624, DOI 10.1002/adfm.201002429
   Li GN, 2008, TISSUE ENG PT B-REV, V14, P33, DOI 10.1089/teb.2007.0181
   LIESI P, 1985, EMBO J, V4, P2505, DOI 10.1002/j.1460-2075.1985.tb03963.x
   Lin MY, 2013, HAND CLIN, V29, P331, DOI 10.1016/j.hcl.2013.04.003
   Liopo AV, 2006, J NANOSCI NANOTECHNO, V6, P1365, DOI 10.1166/jnn.2006.155
   Liu J, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/19/195101
   Liu Z, 2008, P NATL ACAD SCI USA, V105, P1410, DOI 10.1073/pnas.0707654105
   Liu Z, 2009, NANO RES, V2, P85, DOI 10.1007/s12274-009-9009-8
   Lovat V, 2005, NANO LETT, V5, P1107, DOI 10.1021/nl050637m
   Lu Y, 2010, BIOMATERIALS, V31, P5169, DOI 10.1016/j.biomaterials.2010.03.022
   LUNDBORG G, 1982, EXP NEUROL, V76, P361, DOI 10.1016/0014-4886(82)90215-1
   Ma HY, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/2/025701
   MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386
   MacDonald RA, 2008, ACTA BIOMATER, V4, P1583, DOI 10.1016/j.actbio.2008.07.005
   Malarkey EB, 2008, NANO LETT, V8, P3538, DOI 10.1021/nl8017912
   Malarkey EB, 2009, NANO LETT, V9, P264, DOI 10.1021/nl802855c
   Mason MRJ, 2011, CURR GENE THER, V11, P75
   Matsumoto K, 2000, BRAIN RES, V868, P315, DOI 10.1016/S0006-8993(00)02207-1
   Matsumoto K, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/11/115101
   Matsumoto K, 2007, J BIOSCI BIOENG, V103, P216, DOI 10.1263/jbb.103.216
   Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175
   Mazzatenta A, 2007, J NEUROSCI, V27, P6931, DOI 10.1523/JNEUROSCI.1051-07.2007
   McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004
   MCCAIG CD, 1986, J PHYSIOL-LONDON, V375, P55, DOI 10.1113/jphysiol.1986.sp016105
   McCullen SD, 2007, MACROMOLECULES, V40, P997, DOI 10.1021/ma061735c
   Meng L, 2013, SMALL, V9, P1786, DOI 10.1002/smll.201201388
   Menorca RMG, 2013, HAND CLIN, V29, P317, DOI 10.1016/j.hcl.2013.04.002
   MERLE M, 1989, MICROSURG, V10, P130, DOI 10.1002/micr.1920100213
   Mikael PE, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/3/035001
   Mottaghitalab F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074417
   Nguyen QT, 2002, NAT NEUROSCI, V5, P861, DOI 10.1038/nn905
   Ni YC, 2005, J NANOSCI NANOTECHNO, V5, P1707, DOI 10.1166/jnn.2005.189
   Nimmagadda A, 2006, J BIOMED MATER RES A, V76A, P614, DOI 10.1002/jbm.a.30577
   NURCOMBE V, 1992, PHARMACOL THERAPEUT, V56, P247, DOI 10.1016/0163-7258(92)90019-V
   Owens CM, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/4/045007
   Pan LL, 2012, COLLOID SURFACE B, V93, P226, DOI 10.1016/j.colsurfb.2012.01.011
   Pantarotto D, 2004, ANGEW CHEM INT EDIT, V43, P5242, DOI 10.1002/anie.200460437
   PATEL N, 1982, J NEUROSCI, V2, P483
   Podesta JE, 2009, SMALL, V5, P1176, DOI 10.1002/smll.200801572
   Qi FY, 2013, BIOMATERIALS, V34, P1799, DOI 10.1016/j.biomaterials.2012.11.042
   Raivich G, 2007, BRAIN RES REV, V53, P287, DOI 10.1016/j.brainresrev.2006.09.005
   Ren JF, 2012, BIOMATERIALS, V33, P3324, DOI 10.1016/j.biomaterials.2012.01.025
   Richardson JA, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046015
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rivers TJ, 2002, ADV FUNCT MATER, V12, P33, DOI 10.1002/1616-3028(20020101)12:1<33::AID-ADFM33>3.0.CO;2-E
   Roberts MJ, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/036013
   ROGERS SL, 1983, DEV BIOL, V98, P212, DOI 10.1016/0012-1606(83)90350-0
   Romano NH, 2015, ACTA BIOMATER, V11, P48, DOI 10.1016/j.actbio.2014.10.008
   RUEGG UT, 1984, NEUROSCI LETT, V49, P319, DOI 10.1016/0304-3940(84)90309-4
   Ruiter GCW, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E5
   Russier J, 2011, NANOSCALE, V3, P893, DOI 10.1039/c0nr00779j
   Saeed K, 2007, J APPL POLYM SCI, V104, P1957, DOI 10.1002/app.25901
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02516
   Schlosshauer B, 2006, NEUROSURGERY, V59, P740, DOI 10.1227/01.NEU.0000235197.36789.42
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Shapiro S, 2005, J NEUROSURG-SPINE, V2, P3, DOI 10.3171/spi.2005.2.1.0003
   Shi JJ, 2010, NANO LETT, V10, P3223, DOI 10.1021/nl102184c
   Shi XF, 2008, J BIOMED MATER RES A, V86A, P813, DOI 10.1002/jbm.a.31671
   Shi XF, 2006, BIOMACROMOLECULES, V7, P2237, DOI 10.1021/bm060391v
   Shin MK, 2008, SENSOR ACTUAT B-CHEM, V134, P122, DOI 10.1016/j.snb.2008.04.021
   Shin SR, 2012, ACS NANO, V6, P362, DOI 10.1021/nn203711s
   Shokrgozar MA, 2011, J BIOMED NANOTECHNOL, V7, P276, DOI 10.1166/jbn.2011.1284
   Shoval Asaf, 2009, Front Neuroeng, V2, P4, DOI 10.3389/neuro.16.004.2009
   Singh R, 2006, P NATL ACAD SCI USA, V103, P3357, DOI 10.1073/pnas.0509009103
   Singh S, 2003, ADV FUNCT MATER, V13, P868, DOI 10.1002/adfm.200304411
   Song M, 2007, ANN BIOMED ENG, V35, P1812, DOI 10.1007/s10439-007-9348-0
   Sorkin R, 2006, J NEURAL ENG, V3, P95, DOI 10.1088/1741-2560/3/2/003
   Sorkin R, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/1/015101
   Szynkaruk M, 2013, TISSUE ENG PART B-RE, V19, P83, DOI [10.1089/ten.TEB.2012.0275, 10.1089/ten.teb.2012.0275]
   Tan W, 2010, IEEE T NANOBIOSCI, V9, P111, DOI 10.1109/TNB.2010.2043367
   Tannemaat MR, 2008, EUR J NEUROSCI, V28, P1467, DOI 10.1111/j.1460-9568.2008.06452.x
   Tasis D, 2006, CHEM REV, V106, P1105, DOI 10.1021/cr050569o
   Thompson BC, 2009, CARBON, V47, P1282, DOI 10.1016/j.carbon.2009.01.013
   TOMASELLI KJ, 1987, J CELL BIOL, V105, P2347, DOI 10.1083/jcb.105.5.2347
   Tonge DA, 1997, EXP NEUROL, V146, P81, DOI 10.1006/exnr.1997.6498
   Tosun Z, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/6/066002
   VALENTINI RF, 1992, BIOMATERIALS, V13, P183, DOI 10.1016/0142-9612(92)90069-Z
   Varro P, 2013, ACTA BIOL HUNG, V64, P137, DOI 10.1556/ABiol.64.2013.2.1
   Vitale F, 2015, ACS NANO, V9, P4465, DOI 10.1021/acsnano.5b01060
   Voge CM, 2008, J BIOMED MATER RES A, V86A, P269, DOI 10.1002/jbm.a.32029
   Wang AJ, 2007, BIOTECHNOL LETT, V29, P1697, DOI 10.1007/s10529-007-9460-0
   WANG GY, 1992, BRAIN RES, V570, P116, DOI 10.1016/0006-8993(92)90571-P
   Wang HB, 2010, ACTA BIOMATER, V6, P2970, DOI 10.1016/j.actbio.2010.02.020
   Wang K, 2006, NANO LETT, V6, P2043, DOI 10.1021/nl061241t
   Wang SF, 2005, BIOMACROMOLECULES, V6, P3067, DOI 10.1021/bm050378v
   Wang SF, 2010, INT J POLYM SCI, DOI 10.1155/2010/138686
   Wang XD, 2004, J BIOMED MATER RES A, V68A, P411, DOI 10.1002/jbm.a.20065
   Webster TJ, 2004, NANOTECHNOLOGY, V15, P48, DOI 10.1088/0957-4484/15/1/009
   Weigel S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050714
   Wen XJ, 2006, J BIOMED MATER RES A, V76A, P626, DOI 10.1002/jbm.a.30520
   Wong BS, 2013, ADV DRUG DELIVER REV, V65, P1964, DOI 10.1016/j.addr.2013.08.005
   Wood M, 2006, BIOELECTROMAGNETICS, V27, P328, DOI 10.1002/bem.20214
   Wood MD, 2009, ACTA BIOMATER, V5, P959, DOI 10.1016/j.actbio.2008.11.008
   Wu D, 2012, NEUROSCI LETT, V507, P72, DOI 10.1016/j.neulet.2011.11.056
   Xie JW, 2010, NANOSCALE, V2, P35, DOI 10.1039/b9nr00243j
   Xie JW, 2009, ADV FUNCT MATER, V19, P2312, DOI 10.1002/adfm.200801904
   Xie JW, 2009, ACS NANO, V3, P1151, DOI 10.1021/nn900070z
   Xie JN, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/10/105101
   Xie JN, 2006, SMART MATER STRUCT, V15, pN85, DOI 10.1088/0964-1726/15/4/N02
   Xu HX, 2014, BIOMATERIALS, V35, P225, DOI 10.1016/j.biomaterials.2013.10.002
   Yang ST, 2007, J PHYS CHEM C, V111, P17761, DOI 10.1021/jp070712c
   Yildirim ED, 2008, J BIOMED MATER RES B, V87B, P406, DOI 10.1002/jbm.b.31118
   Yu WW, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/16/165102
   Zhang RF, 2013, ACS NANO, V7, P6156, DOI 10.1021/nn401995z
   Zhang X, 2005, SENSOR ACTUAT B-CHEM, V106, P843, DOI 10.1016/j.snb.2004.10.039
   Zhang Z, 2007, ARTIF ORGANS, V31, P13, DOI 10.1111/j.1525-1594.2007.00335.x
   Zhao M, 1999, P NATL ACAD SCI USA, V96, P4942, DOI 10.1073/pnas.96.9.4942
   Zhao XC, 2012, ENVIRON INT, V40, P244, DOI 10.1016/j.envint.2011.12.003
   Zhao Y, 2011, J PHYS CHEM A, V115, P9536, DOI 10.1021/jp112324d
   Zhou HH, 2013, ACTA BIOMATER, V9, P6439, DOI 10.1016/j.actbio.2013.01.042
   Zhu W, 2014, NANOMEDICINE-UK, V9, P859, DOI [10.2217/nnm.14.36, 10.2217/NNM.14.36]
NR 201
TC 7
Z9 7
U1 1
U2 47
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JUN 8
PY 2016
VL 5
IS 11
BP 1253
EP 1271
DI 10.1002/adhm.201500864
PG 19
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA DP6XE
UT WOS:000378642100001
PM 27027923
OA Other Gold
DA 2018-10-19
ER

PT J
AU Domingues, RMA
   Chiera, S
   Gershovich, P
   Motta, A
   Reis, RL
   Gomes, ME
AF Domingues, Rui M. A.
   Chiera, Silvia
   Gershovich, Pavel
   Motta, Antonella
   Reis, Rui L.
   Gomes, Manuela E.
TI Enhancing the Biomechanical Performance of Anisotropic Nanofibrous
   Scaffolds in Tendon Tissue Engineering: Reinforcement with Cellulose
   Nanocrystals
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE anisotropic alignment; cellulose nanocrystals; mechanical properties;
   nanofibrous scaffolds; tendon tissue engineering
ID STEM-CELL DIFFERENTIATION; MECHANICAL-PROPERTIES; IN-VIVO; TENOGENIC
   DIFFERENTIATION; HUMAN MSCS; NANOCOMPOSITE; DEGRADATION; ALIGNMENT;
   CHITOSAN; REPAIR
AB Anisotropically aligned electrospun nanofibrous scaffolds based on natural/synthetic polymer blends have been established as a reasonable compromise between biological and biomechanical performance for tendon tissue engineering (TE) strategies. However, the limited tensile properties of these biomaterials restrict their application in this field due to the load-bearing nature of tendon/ligament tissues. Herein, the use of cellulose nanocrystals (CNCs) as reinforcing nanofillers in aligned electrospun scaffolds based on a natural/synthetic polymer blend matrix, poly-epsilon-caprolactone/chitosan (PCL/CHT) is reported. The incorporation of small amounts of CNCs (up to 3 wt%) into tendon mimetic nanofiber bundles has a remarkable biomaterial-toughing effect (85% +/- 5%, p < 0.0002) and raises the scaffolds mechanical properties to tendon/ligament relevant range (sigma = 39.3 +/- 1.9 MPa and E = 540.5 +/- 83.7 MPa, p < 0.0001). Aligned PCL/CHT/CNC nanocomposite fibrous scaffolds meet not only the mechanical requirements for tendon TE applications but also provide tendon mimetic extracellular matrix (ECM) topographic cues, a key feature for maintaining tendon cell's morphology and behavior. The strategy proposed here may be extended to other anisotropic aligned nanofibrous scaffolds based on natural/synthetic polymer blends and enable the full exploitation of the advantages provided by their tendon mimetic fibrous structures in tendon TE.
C1 [Domingues, Rui M. A.; Gershovich, Pavel; Reis, Rui L.; Gomes, Manuela E.] Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, Avepk Parque Ciencia & Tecnol, P-4805017 Barco, Guimaraes, Portugal.
   [Domingues, Rui M. A.; Gershovich, Pavel; Reis, Rui L.; Gomes, Manuela E.] ICVS 3Bs PT Associate Lab, Braga, Portugal.
   [Chiera, Silvia; Motta, Antonella] Univ Trento, Dept Ind Engn, I-38123 Trento, Italy.
   [Chiera, Silvia; Motta, Antonella] Univ Trento, Biotech Res Ctr, I-38123 Trento, Italy.
   [Chiera, Silvia; Motta, Antonella] European Inst Excellence Tissue Engn & Regenerat, I-38123 Trento, Italy.
RP Gomes, ME (reprint author), Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, Avepk Parque Ciencia & Tecnol, P-4805017 Barco, Guimaraes, Portugal.; Gomes, ME (reprint author), ICVS 3Bs PT Associate Lab, Braga, Portugal.
EM megomes@dep.uminho.pt
RI Gomes, Manuela/B-6282-2009; Reis, Rui L./A-8938-2008; Domingues,
   Rui/G-3893-2011; Group, 3Bs/E-4374-2012
OI Gomes, Manuela/0000-0002-2036-6291; Reis, Rui L./0000-0002-4295-6129;
   Domingues, Rui/0000-0002-3654-9906; Group, 3Bs/0000-0002-5195-3456;
   Motta, Antonella/0000-0003-4893-6863; Chiera, Silvia/0000-0003-0920-6577
FU North Portugal Regional Operational Programme (ON.2 - O Novo Norte)
   under the National Strategic Reference Framework (NSRF), through the
   European Regional Development Fund (ERDF)
   [RL1-ABMR-NORTE-01-0124-FEDER-000016]; Project POLARIS - EU-FP7
   [REGPOT-2012-2013-1-316331]
FX The authors acknowledge the financial support from the Project
   RL1-ABMR-NORTE-01-0124-FEDER-000016 cofinanced by North Portugal
   Regional Operational Programme (ON.2 - O Novo Norte), under the National
   Strategic Reference Framework (NSRF), through the European Regional
   Development Fund (ERDF) and from Project POLARIS financed by EU-FP7
   (REGPOT-2012-2013-1-316331).
CR Araki J, 2013, SOFT MATTER, V9, P4125, DOI 10.1039/c3sm27514k
   Ayres C, 2006, BIOMATERIALS, V27, P5524, DOI 10.1016/j.biomaterials.2006.06.014
   Barber J, 2011, TISSUE ENG PART A, V19, P1265
   Bosworth LA, 2013, J MATER SCI-MATER M, V24, P1605, DOI 10.1007/s10856-013-4911-8
   Chen HS, 2013, CELL TRANSPLANT, V22, P677, DOI 10.3727/096368912X655118
   Cooper A, 2010, J MATER CHEM, V20, P8904, DOI 10.1039/c0jm01841d
   Domingues R. M. A., 2015, TENDON REGENERATION, P259
   Domingues RMA, 2015, BIOCONJUGATE CHEM, V26, P1571, DOI 10.1021/acs.bioconjchem.5b00209
   Domingues RMA, 2014, BIOMACROMOLECULES, V15, P2327, DOI 10.1021/bm500524s
   Gaspar D, 2015, ADV DRUG DELIVER REV, V84, P240, DOI 10.1016/j.addr.2014.11.023
   Habibi Y, 2008, J MATER CHEM, V18, P5002, DOI 10.1039/b809212e
   Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w
   He X, 2014, BIOMACROMOLECULES, V15, P618, DOI 10.1021/bm401656a
   Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x
   Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004
   Kishore V, 2012, BIOMATERIALS, V33, P2137, DOI 10.1016/j.biomaterials.2011.11.066
   LaCroix AS, 2013, J APPL PHYSIOL, V115, P43, DOI 10.1152/japplphysiol.01449.2012
   Lee J, 2012, MACROMOL RES, V20, P76, DOI 10.1007/s13233-012-0008-3
   Leung M, 2013, J MATER CHEM B, V1, P6516, DOI 10.1039/c3tb20825g
   Lin N, 2009, J APPL POLYM SCI, V113, P3417, DOI 10.1002/app.30308
   Liu CF, 2011, TISSUE ENG PART B-RE, V17, P165, DOI [10.1089/ten.TEB.2010.0662, 10.1089/ten.teb.2010.0662]
   Lomas A., 2015, TENDON REGENERATION, P225
   Lomas A. J., 2015, ADV DRUG DEL REV, V85, P257
   McNeilly CM, 1996, J ANAT, V189, P593
   Mo YF, 2015, COLLOID SURFACE B, V132, P177, DOI 10.1016/j.colsurfb.2015.05.029
   Moffat K. L., 2008, TISSUE ENG PART A, V15, P115
   Moon RJ, 2011, CHEM SOC REV, V40, P3941, DOI 10.1039/c0cs00108b
   Pooyan P, 2013, POLYMER, V54, P2105, DOI 10.1016/j.polymer.2013.01.030
   Ralphs JR, 2002, MATRIX BIOL, V21, P67, DOI 10.1016/S0945-053X(01)00179-2
   Raspanti M, 2002, ARCH HISTOL CYTOL, V65, P37, DOI 10.1679/aohc.65.37
   Richardson SH, 2007, MOL CELL BIOL, V27, P6218, DOI 10.1128/MCB.00261-07
   Roman M., 2015, Industrial Biotechnology, V11, P25
   Roozbahani F, 2013, J NANOMATER, DOI 10.1155/2013/641502
   Scherrer P., 1918, GOTTINGER NACHRICHTE, V2, P98
   Schiele NR, 2015, J ORTHOP RES, V33, P874, DOI 10.1002/jor.22880
   Sheng LB, 2014, J MACROMOL SCI B, V53, P820, DOI 10.1080/00222348.2013.861311
   Shi QF, 2012, CARBOHYD POLYM, V90, P301, DOI 10.1016/j.carbpol.2012.05.042
   Signini R, 1999, POLYM BULL, V42, P159, DOI 10.1007/s002890050448
   Subramony SD, 2013, BIOMATERIALS, V34, P1942, DOI 10.1016/j.biomaterials.2012.11.012
   Sun HF, 2006, BIOMATERIALS, V27, P1735, DOI 10.1016/j.biomaterials.2005.09.019
   van den Berg O, 2007, BIOMACROMOLECULES, V8, P1353, DOI 10.1021/bm061104q
   Van der Schueren L, 2012, CARBOHYD POLYM, V88, P1221, DOI 10.1016/j.carbpol.2012.01.085
   Wanasekara N. D., 2015, J MATER SCI, V51, P218
   Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011
   Wang XF, 2013, PROG MATER SCI, V58, P1173, DOI 10.1016/j.pmatsci.2013.05.001
   Wong SC, 2008, POLYMER, V49, P4713, DOI 10.1016/j.polymer.2008.08.022
   Xu Y, 2014, BIOMATERIALS, V35, P2760, DOI 10.1016/j.biomaterials.2013.12.042
   Yang X, 2013, BIOMACROMOLECULES, V14, P4447, DOI 10.1021/bm401364z
   Yin Z, 2010, BIOMATERIALS, V31, P2163, DOI 10.1016/j.biomaterials.2009.11.083
   Younesi M, 2014, ADV FUNCT MATER, V24, P5762, DOI 10.1002/adfm.201400828
   Zhou CJ, 2013, ACS APPL MATER INTER, V5, P3847, DOI 10.1021/am4005072
   Zhu J, 2010, BIOMATERIALS, V31, P6952, DOI 10.1016/j.biomaterials.2010.05.058
   Zoppe JO, 2009, ACS APPL MATER INTER, V1, P1996, DOI 10.1021/am9003705
NR 53
TC 14
Z9 14
U1 8
U2 69
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD JUN 8
PY 2016
VL 5
IS 11
BP 1364
EP 1375
DI 10.1002/adhm.201501048
PG 12
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA DP6XE
UT WOS:000378642100011
PM 27059281
DA 2018-10-19
ER

PT J
AU Zhu, BW
   Wang, H
   Leow, WR
   Cai, YR
   Loh, XJ
   Han, MY
   Chen, XD
AF Zhu, Bowen
   Wang, Hong
   Leow, Wan Ru
   Cai, Yurong
   Loh, Xian Jun
   Han, Ming-Yong
   Chen, Xiaodong
TI Silk Fibroin for Flexible Electronic Devices
SO ADVANCED MATERIALS
LA English
DT Review
ID FIELD-EFFECT TRANSISTORS; THIN-FILM TRANSISTORS; 25TH ANNIVERSARY
   ARTICLE; RESISTIVE SWITCHING MEMORIES; STRETCHABLE ELECTRONICS;
   EPIDERMAL ELECTRONICS; TRANSIENT ELECTRONICS; ORGANIC ELECTRONICS;
   MEMRISTIVE DEVICES; ENERGY HARVESTERS
AB Flexible electronic devices are necessary for applications involving unconventional interfaces, such as soft and curved biological systems, in which traditional silicon-based electronics would confront a mechanical mismatch. Biological polymers offer new opportunities for flexible electronic devices by virtue of their biocompatibility, environmental benignity, and sustainability, as well as low cost. As an intriguing and abundant biomaterial, silk offers exquisite mechanical, optical, and electrical properties that are advantageous toward the development of next-generation biocompatible electronic devices. The utilization of silk fibroin is emphasized as both passive and active components in flexible electronic devices. The employment of biocompatible and biosustainable silk materials revolutionizes state-of-the-art electronic devices and systems that currently rely on conventional semiconductor technologies. Advances in silk-based electronic devices would open new avenues for employing biomaterials in the design and integration of high-performance biointegrated electronics for future applications in consumer electronics, computing technologies, and biomedical diagnosis, as well as human-machine interfaces.
C1 [Zhu, Bowen; Wang, Hong; Leow, Wan Ru; Cai, Yurong; Chen, Xiaodong] Nanyang Technol Univ, Sch Mat Sci & Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
   [Loh, Xian Jun; Han, Ming-Yong] ASTAR, Inst Mat Res & Engn, 3 Res Link, Singapore 117602, Singapore.
RP Chen, XD (reprint author), Nanyang Technol Univ, Sch Mat Sci & Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
EM chenxd@ntu.edu.sg
RI Wang, Hong/I-9598-2017; Chen, Xiaodong/A-4537-2009
OI Wang, Hong/0000-0002-0213-3523; Chen, Xiaodong/0000-0002-3312-1664; Loh,
   Xian Jun/0000-0001-8118-6502
FU National Research Foundation, Prime Minister's Office, Singapore, under
   its Competitive Research Programme Funding Scheme [NRF-CRP13-2014-02];
   National Research Foundation, Prime Minister's Office, Singapore, under
   its Competitive Research Programme Funding Scheme (CREATE Progamme on
   Nanomaterials for Energy and Water Management); NTU-A*STAR Silicon
   Technologies Center of Excellence [11235100003]
FX The authors thank the financial support from the National Research
   Foundation, Prime Minister's Office, Singapore, under its Competitive
   Research Programme Funding Scheme (NRF-CRP13-2014-02 and CREATE Progamme
   on Nanomaterials for Energy and Water Management), and NTU-A*STAR
   Silicon Technologies Center of Excellence under the program grant No.
   11235100003.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arico AS, 2005, NAT MATER, V4, P366, DOI 10.1038/nmat1368
   Barr MC, 2011, ADV MATER, V23, P3500, DOI 10.1002/adma.201101263
   Baude PF, 2003, APPL PHYS LETT, V82, P3964, DOI 10.1063/1.1579554
   Bauer S, 2014, ADV MATER, V26, P149, DOI 10.1002/adma.201303349
   Bettinger CJ, 2007, ADV MATER, V19, P2847, DOI 10.1002/adma.200602487
   Bettinger CJ, 2010, POLYM INT, V59, P563, DOI 10.1002/pi.2827
   Bettinger CJ, 2010, ADV MATER, V22, P651, DOI 10.1002/adma.200902322
   Biswal M, 2013, ENERG ENVIRON SCI, V6, P1249, DOI 10.1039/c3ee22325f
   Bourzac K, 2015, NATURE, V519, pS4, DOI 10.1038/519S4a
   Cabana J, 2010, ADV MATER, V22, pE170, DOI 10.1002/adma.201000717
   Cao Q, 2009, ADV MATER, V21, P29, DOI 10.1002/adma.200801995
   Capelli R, 2011, ORG ELECTRON, V12, P1146, DOI 10.1016/j.orgel.2011.04.005
   Chang JW, 2011, ADV MATER, V23, P4077, DOI 10.1002/adma.201102124
   Cheng Y., 2014, J R SOC INTERFACE, V11, P8
   Choi Y, 2013, FIBER POLYM, V14, P2006, DOI 10.1007/s12221-013-2006-2
   Currie HA, 2011, ADV FUNCT MATER, V21, P2889, DOI 10.1002/adfm.201100249
   Dagdeviren C, 2013, SMALL, V9, P3398, DOI 10.1002/smll.201300146
   Eder F, 2004, APPL PHYS LETT, V84, P2673, DOI 10.1063/1.1690870
   Fei X, 2013, BIOMACROMOLECULES, V14, P4483, DOI 10.1021/bm4014149
   Fei X, 2013, NANOSCALE, V5, P7991, DOI 10.1039/c3nr01872e
   Fei X, 2013, J MATER CHEM B, V1, P213, DOI 10.1039/c2tb0001/b
   Forrest SR, 2004, NATURE, V428, P911, DOI 10.1038/nature02498
   Franklin AD, 2015, SCIENCE, V349, DOI 10.1126/science.aab2750
   Gelinck GH, 2004, NAT MATER, V3, P106, DOI 10.1038/nmat1061
   Gogurla N, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/34/345202
   Hagen JA, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2197973
   Hamedi M, 2007, NAT MATER, V6, P357, DOI [10.1038/nmat1884, 10.1038/nma11884]
   Hammock ML, 2013, ADV MATER, V25, P5997, DOI 10.1002/adma.201302240
   He YD, 2011, ADV MATER, V23, P5502, DOI 10.1002/adma.201103592
   Hota MK, 2012, ADV FUNCT MATER, V22, P4493, DOI 10.1002/adfm.201200073
   Hou JH, 2015, ACS NANO, V9, P2556, DOI 10.1021/nn506394r
   Hsieh CY, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4813075
   Hu X, 2012, MATER TODAY, V15, P208, DOI 10.1016/S1369-7021(12)70091-3
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Huang X, 2014, SMALL, V10, P3083, DOI 10.1002/smll.201400483
   Hubler A, 2011, ADV ENERGY MATER, V1, P1018, DOI 10.1002/aenm.201100394
   Hwang SW, 2015, ADV MATER, V27, P47, DOI 10.1002/adma.201403051
   Hwang SW, 2014, ADV MATER, V26, P1992, DOI 10.1002/adma.201304821
   Hwang SW, 2013, ADV FUNCT MATER, V23, P4087, DOI 10.1002/adfm.201300127
   Hwang SW, 2013, ADV MATER, V25, P3526, DOI 10.1002/adma.201300920
   Hwang SW, 2012, SCIENCE, V337, P1640, DOI 10.1126/science.1226325
   Irimia-Vladu M, 2014, CHEM SOC REV, V43, P588, DOI 10.1039/c3cs60235d
   Irimia-Vladu M, 2012, MATER TODAY, V15, P340, DOI 10.1016/S1369-7021(12)70139-6
   Irimia-Vladu M, 2011, J MATER CHEM, V21, P1350, DOI 10.1039/c0jm02444a
   Irimia-Vladu M, 2010, ADV FUNCT MATER, V20, P4069, DOI 10.1002/adfm.201001031
   Itaka K, 2006, ADV MATER, V18, P1713, DOI 10.1002/adma.200502752
   Jang KI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5779
   Jeong HM, 2011, NANO LETT, V11, P2472, DOI 10.1021/nl2009058
   Jeong JW, 2013, ADV MATER, V25, P6839, DOI 10.1002/adma.201301921
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Jung MW, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/28/285302
   Kaltenbrunner M, 2013, NATURE, V499, P458, DOI 10.1038/nature12314
   Kang SK, 2014, ADV FUNCT MATER, V24, P4427, DOI 10.1002/adfm.201304293
   Karakawa M, 2007, MACROMOL RAPID COMM, V28, P1479, DOI 10.1002/marc.200700186
   Kharlampieva E, 2010, ACS NANO, V4, P7053, DOI 10.1021/nn102456w
   Kharlampieva E, 2010, ADV FUNCT MATER, V20, P840, DOI 10.1002/adfm.200901774
   Kim BJ, 2013, SMALL, V9, P3784, DOI 10.1002/smll.201300522
   Kim C, 2007, SCIENCE, V318, P76, DOI 10.1126/science.1146458
   Kim DH, 2008, SCIENCE, V320, P507, DOI 10.1126/science.1154367
   Kim DH, 2012, MRS BULL, V37, P226, DOI 10.1557/mrs.2012.36
   Kim DH, 2011, SCIENCE, V333, P838, DOI 10.1126/science.1206157
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/nmat2745, 10.1038/NMAT2745]
   Kim DH, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3238552
   Kim J., 2014, NAT COMMUN, V5
   Kim J, 2015, SMALL, V11, P906, DOI 10.1002/smll.201402495
   Kim KD, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2213010
   Kim S, 2014, NAT NANOTECHNOL, V9, P306, DOI [10.1038/nnano.2014.47, 10.1038/NNANO.2014.47]
   Kim TI, 2013, SCIENCE, V340, P211, DOI 10.1126/science.1232437
   Kim YJ, 2007, CARBON, V45, P2116, DOI 10.1016/j.carbon.2007.05.026
   Klauk H, 2010, CHEM SOC REV, V39, P2643, DOI 10.1039/b909902f
   Ko Y, 2011, ACS NANO, V5, P9918, DOI 10.1021/nn2036939
   Koh LD, 2015, PROG POLYM SCI, V46, P86, DOI 10.1016/j.progpolymsci.2015.02.001
   Kundu SC, 2008, PROG POLYM SCI, V33, P998, DOI 10.1016/j.progpolymsci.2008.08.002
   Kurland NE, 2013, ADV MATER, V25, P6207, DOI 10.1002/adma.201302823
   Kwon DH, 2010, NAT NANOTECHNOL, V5, P148, DOI [10.1038/NNANO.2009.456, 10.1038/nnano.2009.456]
   Liang B, 2014, NANOSCALE, V6, P4264, DOI 10.1039/c3nr06057h
   Lin DM, 2012, ADV MATER, V24, P6088, DOI 10.1002/adma.201201888
   Liu LL, 2014, ADV MATER, V26, P4855, DOI 10.1002/adma.201401513
   Liu Q, 2012, ADV MATER, V24, P1844, DOI 10.1002/adma.201104104
   Liu YQ, 2014, ACS APPL MATER INTER, V6, P20670, DOI 10.1021/am504163r
   Maiti UN, 2014, ADV MATER, V26, P40, DOI 10.1002/adma.201303265
   Mannoor MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1767
   Mannsfeld SCB, 2010, NAT MATER, V9, P859, DOI [10.1038/nmat2834, 10.1038/NMAT2834]
   McEvoy MA, 2015, SCIENCE, V347, DOI 10.1126/science.1261689
   Meng FB, 2014, SMALL, V10, P277, DOI 10.1002/smll.201300810
   Meng FB, 2011, SMALL, V7, P3016, DOI 10.1002/smll.201101494
   Mukherjee C, 2013, PHYS STATUS SOLIDI A, V210, P1797, DOI 10.1002/pssa.201329109
   Muller C, 2011, ADV MATER, V23, P898, DOI 10.1002/adma.201003601
   Muskovich M, 2012, ADV HEALTHC MATER, V1, P248, DOI 10.1002/adhm.201200071
   Niu ZQ, 2013, ADV MATER, V25, P4035, DOI 10.1002/adma.201301332
   Niu ZQ, 2013, ADV MATER, V25, P1058, DOI 10.1002/adma.201204003
   Nogi M, 2008, ADV MATER, V20, P1849, DOI 10.1002/adma.200702559
   Nomura K, 2004, NATURE, V432, P488, DOI 10.1038/nature03090
   Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Pang C., 2014, ADV MATER, V27, P634
   Park J, 2004, APPL PHYS LETT, V85, P3283, DOI 10.1063/1.1805703
   Pereira RFP, 2015, MACROMOL MATER ENG, V300, P1171, DOI 10.1002/mame.201400276
   Qi DP, 2015, ADV MATER, V27, P3145, DOI 10.1002/adma.201405807
   Qi N, 2015, RSC ADV, V5, P50878, DOI 10.1039/c5ra03501e
   Qian WJ, 2014, ENERG ENVIRON SCI, V7, P379, DOI 10.1039/c3ee43111h
   Qie L, 2012, ADV MATER, V24, P2047, DOI 10.1002/adma.201104634
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383
   Sahu V, 2015, ELECTROCHIM ACTA, V160, P244, DOI 10.1016/j.electacta.2015.02.019
   Sawa A, 2008, MATER TODAY, V11, P28, DOI 10.1016/S1369-7021(08)70119-6
   Schwartz G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2832
   Sekitani T, 2008, SCIENCE, V321, P1468, DOI 10.1126/science.1160309
   Sekitani T, 2010, ADV MATER, V22, P2228, DOI 10.1002/adma.200904054
   Sheng WQ, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/11/115603
   Shi LL, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4862198
   Siegel AC, 2010, ADV FUNCT MATER, V20, P28, DOI 10.1002/adfm.200901363
   Siegel AC, 2009, LAB CHIP, V9, P2775, DOI 10.1039/b905832j
   Simon P, 2008, NAT MATER, V7, P845, DOI 10.1038/nmat2297
   Sirringhaus H, 1999, NATURE, V401, P685, DOI 10.1038/44359
   Sokolov A. N., 2011, ACCOUNTS CHEM RES, V45, P361
   Someya T, 2004, P NATL ACAD SCI USA, V101, P9966, DOI 10.1073/pnas.0401918101
   Stadler P, 2007, ORG ELECTRON, V8, P648, DOI 10.1016/j.orgel.2007.05.003
   Street RA, 2009, ADV MATER, V21, P2007, DOI 10.1002/adma.200803211
   Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932
   Sun XN, 2010, J MATER CHEM, V20, P2599, DOI 10.1039/b921449f
   Tang YX, 2015, CHEM SOC REV, V44, P5926, DOI 10.1039/c4cs00442f
   Tang-Schomer MD, 2014, ADV FUNCT MATER, V24, P1938, DOI 10.1002/adfm.201303196
   Tansil NC, 2012, ADV MATER, V24, P1388, DOI 10.1002/adma.201104118
   Tansil NC, 2011, ADV MATER, V23, P1463, DOI 10.1002/adma.201003860
   Tao H, 2014, P NATL ACAD SCI USA, V111, P17385, DOI 10.1073/pnas.1407743111
   Tao H, 2012, ADV MATER, V24, P2824, DOI 10.1002/adma.201104477
   Tao H, 2012, ADV MATER, V24, P1067, DOI 10.1002/adma.201103814
   Tao H, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3486157
   Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644
   Thompson SE, 2006, MATER TODAY, V9, P20, DOI 10.1016/S1369-7021(06)71539-5
   Tobjork D, 2011, ADV MATER, V23, P1935, DOI 10.1002/adma.201004692
   Tsai CL, 2012, ORG ELECTRON, V13, P3315, DOI 10.1016/j.orgel.2012.10.007
   Tsai LS, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4841595
   Uenuma M, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/21/215201
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Veres J, 2004, CHEM MATER, V16, P4543, DOI 10.1021/cm049598q
   Wang CH, 2011, ADV MATER, V23, P1630, DOI 10.1002/adma.201004071
   Wang H, 2015, ADV MATER, V27, P7670, DOI 10.1002/adma.201405728
   Wang H, 2015, ADV FUNCT MATER, V25, P3825, DOI 10.1002/adfm.201501389
   Wang H, 2013, ADV MATER, V25, P5498, DOI 10.1002/adma.201301983
   Wang H, 2014, ADV MATER, V26, P3638, DOI 10.1002/adma.201305682
   Wang H, 2013, ACS NANO, V7, P5131, DOI 10.1021/nn400731g
   Wang JC, 2012, J MATER CHEM, V22, P23710, DOI 10.1039/c2jm34066f
   Wang T, 2012, ADV FUNCT MATER, V22, P435, DOI 10.1002/adfm.201101011
   Wang T, 2011, CRYST GROWTH DES, V11, P2164, DOI 10.1021/cg101410u
   Wang XW, 2014, ADV MATER, V26, P1336, DOI 10.1002/adma.201304248
   Wang Y, 2014, ORG ELECTRON, V15, P3476, DOI 10.1016/j.orgel.2014.09.042
   Waser R, 2007, NAT MATER, V6, P833, DOI 10.1038/nmat2023
   Waser R, 2009, ADV MATER, V21, P2632, DOI 10.1002/adma.200900375
   Webb RC, 2013, NAT MATER, V12, P938, DOI [10.1038/nmat3755, 10.1038/NMAT3755]
   Wen YG, 2011, CHEM REV, V111, P3358, DOI 10.1021/cr1001904
   Xu XJ, 2012, ADV FUNCT MATER, V22, P4139, DOI 10.1002/adfm.201200316
   Yang JJS, 2013, NAT NANOTECHNOL, V8, P13, DOI [10.1038/nnano.2012.240, 10.1038/NNANO.2012.240]
   Yang YC, 2013, NANOSCALE, V5, P10076, DOI 10.1039/c3nr03472k
   Yao HB, 2014, ADV MATER, V26, P163, DOI 10.1002/adma.201303470
   Yin GF, 2011, J COLLOID INTERF SCI, V363, P393, DOI 10.1016/j.jcis.2011.07.009
   Yin L, 2014, ADV FUNCT MATER, V24, P645, DOI 10.1002/adfm.201301847
   Yin SY, 2013, ADV FUNCT MATER, V23, P2972, DOI 10.1002/adfm.201203491
   Yoon MH, 2005, J AM CHEM SOC, V127, P10388, DOI 10.1021/JA052488f
   You XQ, 2014, SENSOR ACTUAT B-CHEM, V202, P1357, DOI 10.1016/j.snb.2014.04.079
   Yumusak C, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3278592
   Yun YS, 2014, MACROMOL RES, V22, P509, DOI 10.1007/s13233-014-2071-4
   Yun YS, 2013, ADV MATER, V25, P1993, DOI 10.1002/adma.201204692
   Zang Y., 2015, NAT COMMUN, V6
   Zhai YP, 2011, ADV MATER, V23, P4828, DOI 10.1002/adma.201100984
   Zhang LL, 2009, CHEM SOC REV, V38, P2520, DOI 10.1039/b813846j
   Zhang XL, 2013, ACTA BIOMATER, V9, P6974, DOI 10.1016/j.actbio.2013.03.004
   Zheng GY, 2013, MRS BULL, V38, P320, DOI 10.1557/mrs.2013.59
   Zhu BW, 2014, SMALL, V10, P3625, DOI 10.1002/smll.201401207
   Zhu XJ, 2012, ADV MATER, V24, P3941, DOI 10.1002/adma.201201506
   Zhu YW, 2011, SCIENCE, V332, P1537, DOI 10.1126/science.1200770
   Zschieschang U, 2011, ADV MATER, V23, P654, DOI 10.1002/adma.201003374
NR 175
TC 87
Z9 88
U1 75
U2 434
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD JUN 8
PY 2016
VL 28
IS 22
SI SI
BP 4250
EP 4265
DI 10.1002/adma.201504276
PG 16
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA DN5PV
UT WOS:000377123500006
PM 26684370
DA 2018-10-19
ER

PT J
AU Safonov, VG
AF Safonov, Vladimir G.
TI Beaver trapping in Russia and Belarus and problems of resources
   management
SO RUSSIAN JOURNAL OF THERIOLOGY
LA English
DT Article
DE Eurasian beaver; North American beaver; population dynamics; trapping
   regulation; management; ecosystem; Russia; Belarus
AB In the Soviet Union experimental kill trapping (removal trapping) of Eurasian beaver began in 1960 in the Kirov region, and since 1963 the limited kill trapping was also permitted throughout Russia and Belarus. Regular trapping allowed obtaining large amounts of biomaterial, which significantly widened our knowledge on the general population ecology of beavers and on their behaviour during the under-ice period when observation is limited. The current decrease in demand for furs requires the realization of scientifically sound measures for beaver management based on ecological priorities.
C1 [Safonov, Vladimir G.] Russian Res Inst Game Management & Fur Farming, Dept Anim Ecol, Preobrazhenskaya Str 79, Kirov 610000, Russia.
RP Safonov, VG (reprint author), Russian Res Inst Game Management & Fur Farming, Dept Anim Ecol, Preobrazhenskaya Str 79, Kirov 610000, Russia.
EM safonov.vniioz@mail.ru
CR BARABASH-NIKIFOROV I. I., 1961, TR KHOPERSK GOS ZAPOVEDNIKA, V5, P3
   Borodina M.A., 1960, T OKSKOGO GOSZAPOVED, V3, P41
   BOYCE MS, 1981, J APPL ECOL, V18, P749, DOI 10.2307/2402366
   Danilov PI, 2015, RUSS J ECOL+, V46, P272, DOI 10.1134/S1067413615030029
   Danilov P. I., 2007, BEAVERS RUSSIAN EURO
   Durka W, 2005, MOL ECOL, V14, P3843, DOI 10.1111/j.1365-294X.2005.02704.x
   Emelyanov A. V., 2012, SYSTEM RES ECOLOGY R
   Halley D, 2012, BALT FOR, V18, P168
   Helgen K.M., 2005, MAMMALS SPECIES WORL, V2, P842
   Khlyap L. A., 2011, Russian Journal of Biological Invasions, V2, P293, DOI 10.1134/S2075111711040059
   Korth William W., 2001, Journal of Mammalian Evolution, V8, P279, DOI 10.1023/A:1014468732231
   Kudryashov V.S., 1980, BIOL OSNOVY OKHOTNIC, P45
   Larson J.S., 1983, Acta Zoologica Fennica, P91
   Lavrov L. S., 1983, ACTA ZOOL FENN, V174, P87
   Lavsund S., 1977, 26 I SCOGSZ SKOGSH, P8
   Litvinov V.F., 2012, POPULATION ECOLOGY B
   MILISHNIKOV AN, 1994, GENETIKA+, V30, P529
   Milishnikov AN, 2001, RUSS J GENET+, V37, P108, DOI 10.1023/A:1009039113581
   Nitsche K.-A., 2003, MOEGLICHKEITEN MASSN
   Nolet BA, 1998, BIOL CONSERV, V83, P165, DOI 10.1016/S0006-3207(97)00066-9
   NOVAK M, 1987, WILD FURBEARER MANAG, P283
   Odum E. P., 1975, FUNDAMENTALS ECOLOGY
   Oleynikov A. Yu., 2013, RUSSIAN J BIOL INVAS, V4, P180
   Owens R., 1968, FOREST FARMER, V28, P12
   PARSONS G, 1978, NEW YORK FISH GAME J, V25, P23
   SAFONOV V. G., 1966, BYUL MOSK OBSHCHEST ISPYT PRIR OTD BIOL, V71, P5
   SAFONOV V. G., 1964, SB NAUCH TEKH INFORM VSES NAUCH ISSLED DJST ZHIVOTN SYR YA PUSHNINY, V10, P42
   Safonov V.G., 1971, T KIROVSKOGO SELSKOK, V28, P25
   Safonov V.G., 1965, SBORNIK NAUCHNO TEKH, V12, P26
   Safonov V.G., 1962, OKHOTA OKHOTNICHYE K, P24
   Safonov V.G., 1962, SBORNIK NAUCHNO TEKH, V4, P3
   Saveljev A.P., 2003, THESIS
   Senn H, 2014, EVOL APPL, V7, P645, DOI 10.1111/eva.12162
   Vostokov E.K., 2014, BEAVER IN BELARUS
   [Зарубин Б.Е. Zarubin B.E.], 2015, [Аграрная наука Евро-Северо-Востока, Agrarnaya nauka Evro-Severo-Vostoka], P70
   Zarubin B.E., 2015, BEAV GEN VAR LANDSC, P72
   Zharkov I.V., 1968, THESIS
   Zurowski W., 1983, Acta Zoologica Fennica, P85
NR 38
TC 0
Z9 0
U1 1
U2 3
PU KMK SCIENTIFIC PRESS LTD, MOSCOW STATE UNIV
PI MOSCOW
PA ZOOLOGICAL MUSEUM, BOLSHAYA NIKITSKAYA STREET 6, MOSCOW, 00000, RUSSIA
SN 1682-3559
J9 RUSS J THERIOL
JI Russ. J. Theriol.
PD JUN 6
PY 2016
VL 15
IS 1
BP 2
EP 7
PG 6
WC Zoology
SC Zoology
GA DO3LQ
UT WOS:000377683500002
DA 2018-10-19
ER

PT J
AU Ozmen, Y
AF Ozmen, Yilmaz
TI Si3N4 as a biomaterial and its tribo-characterization under water
   lubrication
SO LUBRICATION SCIENCE
LA English
DT Article
DE silicon nitride; water lubrication; biomaterial; total joint
   replacements; friction; wear
ID TOTAL HIP-ARTHROPLASTY; SILICON-NITRIDE; JOINT REPLACEMENTS;
   LOW-FRICTION; WEAR; CERAMICS; IMPLANTS; ALUMINA; LAYER; MICROSTRUCTURE
AB Hip implant wear is recognised as the main cause of hip implant failure therefore has been widely investigated both experimentally and clinically, demonstrating the coexistence of abrasive, adhesive, fatigue and corrosive wear. Many clinical in vivo and bulk material wear rate data from published literature have been presented for non-oxide ceramic implants. Several studies have shown that the coefficient of friction of self-mated silicon nitride in water decreases from an initially high value to about 0.002 after a certain run-in period. Since the worn surfaces become extremely smooth, the low friction is attributed to the initiation of hydrodynamic lubrication by a thin water film at the interface. The possibility of mixed lubrication, i.e. hydrodynamic lubrication by water and boundary lubrication due to the presence of colloidal silica on the wearing surfaces, has also been proposed.
   Influence of load, speed and surface roughness on the duration of the run-in period of silicon nitride under water lubrication was investigated in this study. The results confirmed that a low coefficient of friction is obtained following a run-in period when a wear scar of sufficient size is developed to reduce the contact stress. The run-in period, during which the coefficient of friction is fairly high, is shorter for smoother surfaces and at higher loads and speeds. The striations that appeared to be associated with the high-friction spikes can be formed as a result of surface film breakdown. Although the results are consistent with the proposed mechanisms of hydrodynamic lubrication or mixed lubrication, it is proposed that the low-friction behaviour may also be related to fundamental interactions between two hard and elastically deforming surfaces covered with hydrogen-terminated oxide films. Copyright (C) 2016 John Wiley & Sons, Ltd.
C1 [Ozmen, Yilmaz] Pamukkale Univ, Dept Biomed Engn, TR-20070 Denizli, Turkey.
RP Ozmen, Y (reprint author), Pamukkale Univ, Dept Biomed Engn, TR-20070 Denizli, Turkey.
EM yilmaz.ozmen@gmail.com
FU DARPA
FX The author is grateful to Dr. Said Jahanmir, who guided and supported
   this project, for his enthusiastic encouragement and his tremendous
   contribution to tribology. The tribochemically polished disks were
   supplied by Professor T.E. Fischer at Stevens Institute of Technology.
   This project was supported by DARPA.
CR Adachi K, 2000, WEAR, V245, P84, DOI 10.1016/S0043-1648(00)00468-3
   AKAZAWA M, 1988, WEAR, V124, P123, DOI 10.1016/0043-1648(88)90239-6
   Bal BS, 2012, ACTA BIOMATER, V8, P2889, DOI 10.1016/j.actbio.2012.04.031
   Bal BS, 2008, J BIOMED MATER RES B, V87B, P447, DOI 10.1002/jbm.b.31123
   Bal BS, 2009, J ARTHROPLASTY, V24, P110, DOI 10.1016/j.arth.2008.01.300
   Bal BS, 2011, ADV CERAMICS ELECT M, DOI [10.5772/19381, DOI 10.5772/19381.ISBN:978-953-307-350-7]
   Buford A, 2004, MATER DESIGN, V25, P385, DOI 10.1016/j.matdes.2003.11.010
   Chen CY, 2013, TRIBOL LETT, V51, P127, DOI 10.1007/s11249-013-0153-7
   Chen CY, 2012, APPL PHYS A-MATER, V107, P345, DOI 10.1007/s00339-012-6822-9
   Chen M, 2002, TRIBOL INT, V35, P129, DOI 10.1016/S0301-679X(01)00105-0
   Ferreira V, 2012, WEAR, V296, P656, DOI 10.1016/j.wear.2012.07.030
   FISCHER TE, 1985, WEAR, V105, P29, DOI 10.1016/0043-1648(85)90004-3
   Hah SR, 1995, TRIBOCHEMICAL FINISH, V4
   Hanawa T, 2004, MAT SCI ENG C-BIO S, V24, P745, DOI 10.1016/j.msec.2004.08.018
   HOWLETT CR, 1989, CLIN ORTHOP RELAT R, P293
   Huang W, 2011, WEAR, V270, P682, DOI 10.1016/j.wear.2011.01.033
   Jahanmir S, 2004, TRIBOL LETT, V17, P409, DOI 10.1023/B:TRIL.0000044489.44053.be
   Jahanmir S, 2002, P I MECH ENG J-J ENG, V216, P371, DOI 10.1243/135065002762355307
   JAHANMIR S, 1988, TRIBOL T, V31, P32, DOI 10.1080/10402008808981795
   Kato K, 2002, WEAR, V253, P1097, DOI 10.1016/S0043-1648(02)00240-5
   Kotzar G, 2002, BIOMATERIALS, V23, P2737, DOI 10.1016/S0142-9612(02)00007-8
   Kristensen BW, 2001, BRAIN RES, V896, P1, DOI 10.1016/S0006-8993(00)03304-7
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Laarz E, 2000, J AM CERAM SOC, V83, P2394
   Landgraeber S, 2008, BIOMATERIALS, V29, P3444, DOI 10.1016/j.biomaterials.2008.04.044
   LaVan DA, 2003, NAT BIOTECHNOL, V21, P1184, DOI 10.1038/nbt876
   Litwin W, 2015, TRIBOL INT, V82, P153, DOI 10.1016/j.triboint.2014.10.002
   Ma LR, 2012, CHINESE SCI BULL, V57, P2062, DOI 10.1007/s11434-012-5031-4
   Mattei L, 2011, TRIBOL INT, V44, P532, DOI 10.1016/j.triboint.2010.06.010
   Mazzocchi M, 2008, J MATER SCI-MATER M, V19, P2881, DOI 10.1007/s10856-008-3417-2
   Muratov VA, 1998, TRIBOL INT, V31, P601, DOI 10.1016/S0301-679X(98)00081-4
   Neumann A, 2006, OTOLARYNG HEAD NECK, V134, P923, DOI 10.1016/j.otohns.2006.01.022
   Neumann A, 2006, HNO, V54, P937, DOI 10.1007/s00106-006-1397-4
   Neumann A, 2004, LARYNGO RHINO OTOL, V83, P845, DOI 10.1055/s-2004-825739
   Oloffson J., 2011, THESIS, P66
   Olofsson Johanna, 2012, Biomatter, V2, P94, DOI 10.4161/biom.20710
   Pettersson M, 2013, J MECH BEHAV BIOMED, V25, P41, DOI 10.1016/j.jmbbm.2013.05.002
   Rahaman MN, 2007, J AM CERAM SOC, V90, P1965, DOI 10.1111/j.1551-2916.2007.01725.x
   Ratoi M, 1999, TRIBOL T, V42, P479, DOI 10.1080/10402009908982244
   Saito T, 2001, WEAR, V247, P223, DOI 10.1016/S0043-1648(00)00539-1
   Sargeant A, 2006, MATER DESIGN, V27, P287, DOI 10.1016/j.matdes.2004.10.028
   Sargeant A, 2007, MATER DESIGN, V28, P155, DOI 10.1016/j.matdes.2005.05.018
   SASAKI S, 1989, WEAR, V134, P185, DOI 10.1016/0043-1648(89)90068-9
   Silva CCG, 2004, MAT SCI ENG C-BIO S, V24, P643, DOI 10.1016/j.msec.2004.08.007
   Sonntag R, 2012, ACTA BIOMATER, V8, P2434, DOI 10.1016/j.actbio.2012.03.029
   Sorrell CC, 2004, T 7 WORLD BIOM C
   Takadoum J, 1998, J EUR CERAM SOC, V18, P553, DOI 10.1016/S0955-2219(97)00157-X
   Tokoro M, 2009, WEAR, V267, P2167, DOI 10.1016/j.wear.2009.04.009
   Wong PL, 2003, TRIBOL LETT, V14, P197, DOI 10.1023/A:1022320531293
   Xu JG, 2000, WEAR, V245, P61, DOI 10.1016/S0043-1648(00)00466-X
   Xu JG, 1997, WEAR, V205, P55, DOI 10.1016/S0043-1648(96)07283-3
   Zhou YS, 1997, WEAR, V210, P171, DOI 10.1016/S0043-1648(97)00066-5
   Zhou YS, 1997, MAT SCI ENG C-BIOMIM, V5, P125, DOI 10.1016/S0928-4931(97)00032-5
NR 53
TC 3
Z9 3
U1 0
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0954-0075
EI 1557-6833
J9 LUBR SCI
JI Lubr. Sci.
PD JUN
PY 2016
VL 28
IS 4
BP 243
EP 254
DI 10.1002/ls.1329
PG 12
WC Engineering, Chemical; Engineering, Mechanical
SC Engineering
GA DW5XZ
UT WOS:000383722300004
DA 2018-10-19
ER

PT J
AU Banlunara, W
   Songsiripadapboon, S
   Jiemsirilers, S
   Saravari, O
   Kashima, DP
   Thunyakitpisal, N
   Brikshavana, P
   Srisuwan, P
   Rupunt, T
   Thunyakitpisal, P
AF Banlunara, Wijit
   Songsiripadapboon, Siriporn
   Jiemsirilers, Sirithan
   Saravari, Onusa
   Kashima, Dujreutai Pongkao
   Thunyakitpisal, Nonglax
   Brikshavana, Pasakorn
   Srisuwan, Phanitnan
   Rupunt, Thitima
   Thunyakitpisal, Pasutha
TI Pulp-dentin Complex Response to RU-HBM1, a Novel Resin Modified Glass
   Ionomer Cement Prototype, in Deep Cavity Preparation of Porcine Teeth
SO THAI JOURNAL OF VETERINARY MEDICINE
LA English
DT Article
DE animal study; biocompatibility; histopathology; reactionary dentin; RMGI
ID REACTIONARY DENTINOGENESIS; CALCIUM HYDROXIDE; BIOCOMPATIBILITY; LINERS
AB The objective of this study was to evaluate the response of the pulp-dentin complex to Research Unit-Herbal Medicine, Biomaterial and Material 1 (RU-HBM1), a resin-modified glass ionomer (RMGI) cement prototype, in deep cavity of porcine teeth compared with commercial RMGIs. Six 14-week-old pigs were used in this study. Deep class V cavity was created on the buccal surface of canine, premolar, and molar teeth. The teeth were randomly lined with the design cement bases: RU-HBM1, Vitrebond (TM) (VB), or GC-Gold Label Light-Cured Universal Restorative (GC). After that, the cavity walls were treated with 30% phosphoric acid and washed. Then, a bonding agent was applied and the cavities were restored using light-cured resin-based material (Filtek (TM) Z250XT, 3M ESPE). The teeth were extracted at 7, 30, and 70 days post-operation, sectioned and stained for histopathological evaluation. Data were collected and analyzed using SPSS program. It was found that the RU-HBM1, VB, and GC groups had no inflammatory reaction at all time points of observation except one sample in the VB group had mild reaction at day 7. Reactionary dentin formation was detected in all groups at 30 and 70 days post-treatment. Normal pulp tissue pattern and cellular organization were observed in all groups at all time points of observation. There was no significant difference in the overall histopathological scores of the RU-HBM1, VB, and GC groups at all time points of evaluation (p>0.05). In condusion, RU-HBM1, a novel resin-modified glass ionomer cement prototype, is biocompatible for deep cavity prepared in intact teeth.
C1 [Banlunara, Wijit] Chulalongkorn Univ, Dept Pathol, Fac Vet Sci, Bangkok 10330, Thailand.
   [Banlunara, Wijit; Songsiripadapboon, Siriporn; Jiemsirilers, Sirithan; Kashima, Dujreutai Pongkao; Thunyakitpisal, Nonglax; Srisuwan, Phanitnan; Rupunt, Thitima; Thunyakitpisal, Pasutha] Chulalongkorn Univ, Res Unit Herbal Med Biomat & Mat Dent Treatment, Bangkok 10330, Thailand.
   [Songsiripadapboon, Siriporn] Chulalongkorn Univ, Fac Dent, Dept Pediat Dent, Bangkok 10330, Thailand.
   [Jiemsirilers, Sirithan; Saravari, Onusa; Kashima, Dujreutai Pongkao] Chulalongkorn Univ, Dept Mat Sci, Fac Sci, Bangkok 10330, Thailand.
   [Brikshavana, Pasakorn] Chulalongkorn Univ, Dept Surg, Fac Vet Sci, Bangkok 10330, Thailand.
   [Thunyakitpisal, Pasutha] Chulalongkorn Univ, Fac Dent, Dept Anat, Bangkok 10330, Thailand.
RP Thunyakitpisal, P (reprint author), Chulalongkorn Univ, Res Unit Herbal Med Biomat & Mat Dent Treatment, Bangkok 10330, Thailand.; Thunyakitpisal, P (reprint author), Chulalongkorn Univ, Fac Dent, Dept Anat, Bangkok 10330, Thailand.
EM pthunyak@yahoo.com
FU Thai Government Research Fund; National Research University Project,
   Office of Higher Education Commission [WCU-030-AM-57]
FX We would like to thank Professor Visaka Limwong, Associate Professor Dr.
   Dolly Methatharathip, and Dr. Kevin Tompkins for their valuable
   suggestions. This project was supported by Thai Government Research Fund
   and National Research University Project, Office of Higher Education
   Commission (WCU-030-AM-57).
CR Costa CAD, 2007, J BIOMED MATER RES B, V81B, P175, DOI 10.1002/jbm.b.30651
   Bleicher F, 2014, EXP CELL RES, V325, P65, DOI 10.1016/j.yexcr.2013.12.012
   Couve E, 2014, J DENT RES, V93, P788, DOI 10.1177/0022034514539507
   Croll Theodore P, 2002, Pediatr Dent, V24, P423
   Darvell B. W., 2009, MAT SCI DENT, P214
   de Souza Costa CA, 2003, DENT MATER, V19, P739
   Costa CAD, 2006, DENT MATER, V22, P954, DOI 10.1016/j.dental.2005.10.007
   Duque C, 2006, J ORAL REHABIL, V33, P452, DOI 10.1111/j.1365-2842.2005.01585.x
   Faraco Junior Italo Medeiros, 2004, Braz. Dent. J., V15, P104, DOI 10.1590/S0103-64402004000200004
   Ibarra-Montano E. L., 2015, J APPL SOLUTION CHEM, V4, P7
   Khoroushi M, 2012, OPER DENT, V37, P54, DOI 10.2341/11-137-L
   Kruthkul K, 2012, VALUE CREATION MED D
   Leites AB, 2011, OPER DENT, V36, P448, DOI 10.2341/10-321-L
   Mickenautsch S, 2010, DENT MATER, V26, P761, DOI 10.1016/j.dental.2010.03.021
   MITRA SB, 1994, DENT MATER, V10, P78, DOI 10.1016/0109-5641(94)90044-2
   MOUNT GJ, 1994, OPER DENT, V19, P82
   Mousavinasab Majid, 2008, J Calif Dent Assoc, V36, P51
   Nicholson JW, 2008, DENT MATER, V24, P1702, DOI 10.1016/j.dental.2008.04.005
   Pameijer Cornelis H, 2015, J Clin Dent, V26, P23
   Shayegan A, 2009, DENT TRAUMATOL, V25, P413, DOI 10.1111/j.1600-9657.2009.00799.x
   Shen C., 2013, PHILIPS SCI DENT MAT, P307
   Shimada Y, 2004, OPER DENT, V29, P23
   Tarim B, 1998, QUINTESSENCE INT, V29, P535
   Thunyakitpisal P., 2015, JDAT, V65, P189
   Uzzaman MA, 2005, DENT MATER J, V24, P178
   Volk J, 2009, DENT MATER, V25, P1556, DOI 10.1016/j.dental.2009.07.009
   Watana J. C., 2002, RESTORATIVE DENT MAT, P125
   Yano J, 2011, J APPL ORAL SCI, V19, P218, DOI 10.1590/S1678-77572011000300007
NR 28
TC 0
Z9 0
U1 0
U2 2
PU CHULALONGKORN UNIV
PI BANGKOK
PA FAC VETERINARY SCI, HENRI DUNANT RD, BANGKOK, 10330, THAILAND
SN 0125-6491
J9 THAI J VET MED
JI Thai J. Vet. Med.
PD JUN
PY 2016
VL 46
IS 2
BP 185
EP 193
PG 9
WC Veterinary Sciences
SC Veterinary Sciences
GA EB2NJ
UT WOS:000387198800001
DA 2018-10-19
ER

PT J
AU Chang, TJ
   Wang, LB
   Zhao, KX
   Ge, Y
   He, M
   Li, G
AF Chang, Tianjun
   Wang, Libo
   Zhao, Kexu
   Ge, Yu
   He, Meng
   Li, Gang
TI Duplex Identification of Staphylococcus aureus by Aptamer and Gold
   Nanoparticles
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE Aptamer; Gold Nanoparticle; Biomaterial; Pathogenic Bacterium; Molecular
   Recognition
ID COLORIMETRIC DETECTION; RAPID DETECTION; BACTERIA; AGGREGATION;
   APTASENSORS; PATHOGENS; SELECTION; PROTEINS; PROGRESS; LIGANDS
AB Staphylococcus aureus is the top common pathogen causing infections and food poisoning. Identification of S. aureus is crucial for the disease diagnosis and regulation of food hygiene. Herein, we report an aptamer-AuNPs based method for duplex identification of S. aureus. Using AuNPs as an indicator, SA23, an aptamer against S. aureus, can well identify its target from Escherichia coli, Listeria monocytogenes and Pseudomonas aeruginosa. Furthermore, we find citrate-coated AuNPs can strongly bind to S. aureus, but not bind to Salmonella enterica and Proteus mirabilis, which leads to different color changes in salt solution. This colorimetric response is capable of distinguishing S. aureus from S. enteritidis and P. mirabilis. Thus, using the aptasensor and AuNPs together, S. aureus can be accurately identified from the common pathogens. This duplex identification system is a promising platform for simple visual identification of S. aureus. Additionally, in the aptasensing process, bacteria are incubated with aptamers and then be removed before the aptamers adding to AuNPs, which may avoid the interactions between bacteria and AuNPs. This strategy can be potentially applied in principle to detect other cells by AuNPs-based aptasensors.
C1 [Chang, Tianjun; Zhao, Kexu; Ge, Yu; He, Meng; Li, Gang] Henan Polytech Univ, Inst Resources & Environm, Jiaozuo 454000, Peoples R China.
   [Wang, Libo] Henan Polytech Univ, Inst Mat Sci & Engn, Jiaozuo 454000, Peoples R China.
RP Chang, TJ; Li, G (reprint author), Henan Polytech Univ, Inst Resources & Environm, Jiaozuo 454000, Peoples R China.
RI Chang, Tianjun/F-4460-2016
OI Chang, Tianjun/0000-0003-2030-9868
FU Henan Polytechnic University [B2013-068]
FX We gratefully acknowledge the financial support from the Doctoral
   Program of Henan Polytechnic University (Grant Numbers B2013-068). We
   also thank Dr. Dongyan Li for the helpful discussion.
CR Bing T, 2010, BIOSENS BIOELECTRON, V25, P1487, DOI 10.1016/j.bios.2009.11.003
   Cao XX, 2009, NUCLEIC ACIDS RES, V37, P4621, DOI 10.1093/nar/gkp489
   Chang TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062348
   Cheng JC, 2006, CLIN CHEM, V52, P1997, DOI 10.1373/clinchem.2006.069286
   Cho EJ, 2009, ANNU REV ANAL CHEM, V2, P241, DOI 10.1146/annurev.anchem.1.031207.112851
   DIRIENZO JM, 1978, ANNU REV BIOCHEM, V47, P481, DOI 10.1146/annurev.bi.47.070178.002405
   ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0
   GRABAR KC, 1995, ANAL CHEM, V67, P735, DOI 10.1021/ac00100a008
   Hayden SC, 2012, J AM CHEM SOC, V134, P6920, DOI 10.1021/ja301167y
   He XX, 2014, J BIOMED NANOTECHNOL, V10, P1359, DOI 10.1166/jbn.2014.1828
   Hennekinne JA, 2012, FEMS MICROBIOL REV, V36, P815, DOI 10.1111/j.1574-6976.2011.00311.x
   Iliuk AB, 2011, ANAL CHEM, V83, P4440, DOI 10.1021/ac201057w
   Li HX, 2004, P NATL ACAD SCI USA, V101, P14036, DOI 10.1073/pnas.0406115101
   Li ZX, 2014, J NANOSCI NANOTECHNO, V14, P905, DOI 10.1166/jnn.2014.8743
   Lin MH, 2013, ADV MATER, V25, P3490, DOI 10.1002/adma.201301333
   Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806
   Mei HC, 2012, ANAL CHEM, V84, P7323, DOI 10.1021/ac300281u
   Nakayama T, 2014, BIOSENS BIOELECTRON, V60, P175, DOI 10.1016/j.bios.2014.03.074
   Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174
   Niu KL, 2014, J NANOSCI NANOTECHNO, V14, P5151, DOI 10.1166/jnn.2014.8703
   Paniel N, 2013, METHODS, V64, P229, DOI 10.1016/j.ymeth.2013.07.001
   Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103
   Shen SF, 2011, J BIOMED NANOTECHNOL, V7, P691, DOI 10.1166/jbn.2011.1329
   Sung YJ, 2013, BIOSENS BIOELECTRON, V43, P432, DOI 10.1016/j.bios.2012.12.052
   Torres-Chavolla E, 2009, BIOSENS BIOELECTRON, V24, P3175, DOI 10.1016/j.bios.2008.11.010
   TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121
   Velasco V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097617
   Verma MS, 2014, BIOSENS BIOELECTRON, V61, P386, DOI 10.1016/j.bios.2014.05.045
   Wang S, 2014, ANAL CHEM, V86, P8261, DOI 10.1021/ac501657g
   Wu WH, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-658
   Xi ZJ, 2014, J BIOMED NANOTECHNOL, V10, P3043, DOI 10.1166/jbn.2014.1979
   Zhang SY, 2014, ACS APPL MATER INTER, V6, P21184, DOI 10.1021/am506112u
   Zhao W, 2008, CHEMBIOCHEM, V9, P2363, DOI 10.1002/cbic.200800282
NR 33
TC 9
Z9 10
U1 4
U2 39
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
EI 1533-4899
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD JUN
PY 2016
VL 16
IS 6
BP 5513
EP 5519
DI 10.1166/jnn.2016.11656
PG 7
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA DZ8MG
UT WOS:000386123900011
PM 27427591
DA 2018-10-19
ER

PT J
AU Dong, JM
   Yu, HF
   Xiao, XY
   Li, Y
   Wu, CY
   Wen, J
   Tan, YS
   Chang, CG
   Zheng, WX
AF Dong Jinmei
   Yu Hongfa
   Xiao Xueying
   Li Ying
   Wu Chengyou
   Wen Jing
   Tan Yongshan
   Chang Chenggong
   Zheng Weixin
TI Effects of Calcination Temperature of Boron-Containing Magnesium Oxide
   Raw Materials on Properties of Magnesium Phosphate Cement as a
   Biomaterial
SO JOURNAL OF WUHAN UNIVERSITY OF TECHNOLOGY-MATERIALS SCIENCE EDITION
LA English
DT Article
DE magnesium phosphate bone cement; boron-containing magnesium oxide;
   calcination temperature
ID RAPID REPAIR; CONCRETE; CERAMICS; ADHESIVE; STRENGTH; BINDER
AB A new magnesium phosphate bone cement (MPBC) was prepared as a byproduct of boron-containing magnesium oxide (B-MgO) after extracting Li2CO3 from salt lakes. We analyzed the elementary composition of the B-MgO raw materials and the effects of calcination temperature on the performance of MPBC. The phase composition and microstructure of the B-MgO raw materials and the hydration products (KMgPO4 center dot 6H(2)O) of MPBC were analyzed by X-ray diffraction and scanning electron microscopy. The results showed that ionic impurities and the levels of toxic elements were sufficiently low in B-MgO raw materials to meet the medical requirements for MgO (Chinese Pharmacopeia, 2010 Edition) and for hydroxyapatite surgical implants (GB23101.1-2008). The temperature of B-MgO calcination had a marked influence on the hydration and hardening of MPBC pastes. Increasing calcination temperature prolonged the time required for the MPBC slurry to set, significantly decreased the hydration temperature, and prolonged the time required to reach the highest hydration temperature. However, the compressive strength of hardened MPBC did not increase with higher calcination temperatures. In the 900-1 000 degrees C temperature range, the hardened MPBC had a higher compressive strength. Imaging analysis suggested that the setting time and the highest hydration temperature of MPBC pastes were dependent on the size and crystal morphology of the B-MgO materials. The production and microstructure compactness of KMgPO4 center dot 6H(2)O, the main hydration product, determined the compressive strength.
C1 [Dong Jinmei; Yu Hongfa; Xiao Xueying; Li Ying; Wu Chengyou; Wen Jing; Tan Yongshan; Chang Chenggong; Zheng Weixin] Chinese Acad Sci, Qinghai Inst Salt Lakes, Xining 810008, Peoples R China.
   [Yu Hongfa] Qinghai Univ, Civil Engn Inst, Xining 810016, Peoples R China.
   [Yu Hongfa] Nanjing Univ Aeronaut & Astronaut, Dept Civil Engn, Nanjing 210016, Peoples R China.
RP Yu, HF (reprint author), Chinese Acad Sci, Qinghai Inst Salt Lakes, Xining 810008, Peoples R China.; Yu, HF (reprint author), Qinghai Univ, Civil Engn Inst, Xining 810016, Peoples R China.; Yu, HF (reprint author), Nanjing Univ Aeronaut & Astronaut, Dept Civil Engn, Nanjing 210016, Peoples R China.
EM dongda839@163.com; yuhongfa@nuaa.edu.cn
FU National Natural Science Foundation of China [21276264]; Qinghai
   Province Science and Technology Department [2013-G-208]
FX Funded by the National Natural Science Foundation of China (No.21276264)
   and the Qinghai Province Science and Technology
   Department(No.2013-G-208)
CR Bruker, 2006, BRUK AXS 2006
   EUBANK WR, 1951, J AM CERAM SOC, V34, P225, DOI 10.1111/j.1151-2916.1951.tb11644.x
   Fang H S, 2009, GB2310112008ISO
   Gulotta LV, 2008, AM J SPORT MED, V36, P1290, DOI 10.1177/0363546508314396
   Jiang Q Y, 2011, J WUHAN UNIV TECHNOL, V23, P32
   Mestres G, 2011, ACTA BIOMATER, V7, P1853, DOI 10.1016/j.actbio.2010.12.008
   Moseke C, 2011, J MATER SCI-MATER M, V22, P2591, DOI 10.1007/s10856-011-4442-0
   Soudee E, 2002, CEMENT CONCRETE RES, V32, P153, DOI 10.1016/S0008-8846(01)00647-0
   State Pharmacopoeia Commission, 2010, PHARM PEOPL REP CH 2
   Wagh AS, 2003, J AM CERAM SOC, V86, P1838, DOI 10.1111/j.1151-2916.2003.tb03569.x
   Wang AJ, 2013, MAT SCI ENG C-MATER, V33, P5058, DOI 10.1016/j.msec.2013.08.031
   Waselau M, 2007, AM J VET RES, V68, P370, DOI 10.2460/ajvr.68.4.370
   Wu F, 2008, ACTA BIOMATER, V4, P1873, DOI 10.1016/j.actbio.2008.06.020
   Yang Q, 2000, MATER STRUCT, V33, P229, DOI 10.1007/BF02479332
   Yang QB, 2002, CEMENT CONCRETE RES, V32, P165, DOI 10.1016/S0008-8846(01)00651-2
   Yang QB, 1999, CEMENT CONCRETE RES, V29, P389, DOI 10.1016/S0008-8846(98)00230-0
NR 16
TC 2
Z9 2
U1 2
U2 17
PU JOURNAL WUHAN UNIV TECHNOLOGY
PI WUHAN
PA WUHAN UNIV TECHNOLOGY, WUHAN 430070, PEOPLES R CHINA
SN 1000-2413
EI 1993-0437
J9 J WUHAN UNIV TECHNOL
JI J. Wuhan Univ. Technol.-Mat. Sci. Edit.
PD JUN
PY 2016
VL 31
IS 3
BP 671
EP 676
DI 10.1007/s11595-016-1427-3
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA DY3YF
UT WOS:000385033600032
DA 2018-10-19
ER

PT J
AU Dordevic, L
   Najman, S
   Vasiljevic, P
   Miljkovic, M
   Ignjatovic, N
   Uskokovic, D
   Plavsic, M
AF Dordevic, Ljubisa
   Najman, Stevo
   Vasiljevic, Perica
   Miljkovic, Miroslav
   Ignjatovic, Nenad
   Uskokovic, Dragan
   Plavsic, Milenko
TI SCANNING ELECTRON MICROSCOPY ANALYSIS OF CHANGES OF
   HYDROXIAPATITE/POLY-L-LACTIDE WITH DIFFERENT MOLECULAR WEIGHT OF PLLA
   AFTER INTRAPERITONEAL IMPLANTATION
SO ACTA VETERINARIA-BEOGRAD
LA English
DT Article
DE calcium hydroxiapatite; poly-L-lactide; implant; mouse; peritoneum;
   collagen; SEM
ID COMPOSITE BIOMATERIALS; HAP/PLLA COMPOSITE; BONE; REGENERATION;
   SCAFFOLDS
AB Implantation of a biomaterial is one of the important trends in solving the problem of bone tissue loss. Calcium hydroxiapatite (HAp), as the most representative bone component is a serious candidate for such implantations. The synthetic polymer poly-L-lactide (PLLA) in HAp/PLLA is often used as a polymeric material, with a role in the substitution of bone tissue collagen fibers. Fibers of PLLA may strengthen HAp and its good bioresorption provides space for tissue remodeling. Differences in porosity, microstructure, compressive consistency as well as bioresorbility of HAp/PLLA may be achieved by using PLLA with different molecular weights. In this study HAp/PLLA composites with PLLA of different molecular weights (50,000; 160,000 and 430,000) were implanted in mouse peritoneum in order to examine the influence of the molecular weight of PLLA on morphology changes. Microstructural changes of biomaterial (HAp/PLLA) surface were analyzed one week, three weeks and four months after their implantation using Scanning Electron Microscopy. The results showed a significant difference in tissue reactions on the applied biocomposites, depending on their molecular weight. The most intense proliferation of cells was induced by HAp/PLLA 50,000 compared to HAp/PLLA 430,000 and HAp/PLLA 160,000. In the vicinity of HAp/PLLA 430,000 abundant erythrocytes were observed. The differences in biological reactions on the examined biocomposites are significant for their practical applications. HAp/PLLA composite biomaterials of different types and resorption rates require specific designing and programming to become suitable for particular purposes in an organism.
C1 [Dordevic, Ljubisa; Vasiljevic, Perica] Univ Nis, Fac Sci & Math, Dept Biol Ecol, Nish, Serbia.
   [Najman, Stevo; Miljkovic, Miroslav] Univ Nis, Sci Res Ctr Biomed, Fac Med, Nish, Serbia.
   [Ignjatovic, Nenad; Uskokovic, Dragan] Serbian Acad Arts & Sci, Inst Tech Sci, Belgrade, Serbia.
   [Plavsic, Milenko] Natl Acad Engn Serbia, Belgrade, Serbia.
RP Dordevic, L (reprint author), Univ Nis, Fac Sci & Math, Dept Biol Ecol, Nish, Serbia.
EM ljupce@pmf.ni.ac.rs
RI Ignjatovic, Nenad/C-4489-2008; Uskokovic, Dragan/B-4129-2008
OI Ignjatovic, Nenad/0000-0002-5749-094X; Uskokovic,
   Dragan/0000-0002-0421-4968; Vasiljevic, Perica/0000-0003-0006-7187
FU Ministry of Education, Science and Technological Development of Republic
   of Serbia [III 41017, III 45004]
FX This study was supported by the Ministry of Education, Science and
   Technological Development of Republic of Serbia, Project Grants III
   41017 and III 45004.
CR Angelova N, 1999, TRENDS BIOTECHNOL, V17, P409, DOI 10.1016/S0167-7799(99)01356-6
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Gao CD, 2014, INT J MOL SCI, V15, P4714, DOI 10.3390/ijms15034714
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Ignjatovic N, 2001, BIOMATERIALS, V22, P571, DOI 10.1016/S0142-9612(00)00215-5
   Keating JF, 2001, J BONE JOINT SURG BR, V83B, P3, DOI 10.1302/0301-620X.83B1.11952
   KURASHINA K, 1995, BIOMATERIALS, V16, P119, DOI 10.1016/0142-9612(95)98273-H
   Lazic Z, 2014, ACTA VET-BEOGRAD, V64, P477, DOI 10.2478/acve-2014-0045
   MainilVarlet P, 1997, J BIOMED MATER RES, V36, P360, DOI 10.1002/(SICI)1097-4636(19970905)36:3<360::AID-JBM11>3.0.CO;2-I
   Mansourizadeh F, 2013, MOL BIOL RES COMMUN, V2, P1
   Najman S, 2004, BIO-MED MATER ENG, V14, P61
   Najman S., 2003, FACTA U, V10, P131
   Nejati E, 2009, MAT SCI ENG C-BIO S, V29, P942, DOI 10.1016/j.msec.2008.07.038
   Persson M, 2014, COLLOID SURFACE B, V121, P409, DOI 10.1016/j.colsurfb.2014.06.029
   Podlaha J, 2014, ACTA VET-BEOGRAD, V64, P426, DOI 10.2478/acve-2014-0040
   Ripamonti U, 1996, MRS BULL, V21, P36
   Wang Z, 2016, SCI REPORTS, V9, P20770
   Yanagida H, 2011, J ARTIF ORGANS, V14, P331, DOI 10.1007/s10047-011-0594-4
NR 18
TC 0
Z9 0
U1 0
U2 6
PU DE GRUYTER OPEN LTD
PI WARSAW
PA BOGUMILA ZUGA 32A ST, 01-811 WARSAW, POLAND
SN 0567-8315
EI 1820-7448
J9 ACTA VET-BEOGRAD
JI Acta Vet.-Beogr.
PD JUN
PY 2016
VL 66
IS 2
BP 234
EP 244
DI 10.1515/acve-2016-0020
PG 11
WC Veterinary Sciences
SC Veterinary Sciences
GA DY0ER
UT WOS:000384770600008
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Ricklin, D
   Lambris, JD
AF Ricklin, Daniel
   Lambris, John D.
TI New milestones ahead in complement-targeted therapy
SO SEMINARS IN IMMUNOLOGY
LA English
DT Review
DE Complement; Inflammation; Therapeutics; Immune modulation
ID PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; C3 INHIBITOR CP40; ALTERNATIVE
   PATHWAY; FACTOR-H; IN-VITRO; PHARMACOKINETIC PROPERTIES; BIOMATERIAL
   SURFACES; RHEUMATOID-ARTHRITIS; MACULAR DEGENERATION; CONVERTASE
   INHIBITOR
AB The complement system is a powerful effector arm of innate immunity that typically confers protection from microbial intruders and accumulating debris. In many clinical situations, however, the defensive functions of complement can turn against host cells and induce or exacerbate immune, inflammatory, and degenerative conditions. Although the value of inhibiting complement in a therapeutic context has long been recognized, bringing complement-targeted drugs into clinical use has proved challenging. This important milestone was finally reached a decade ago, yet the clinical availability of complement inhibitors has remained limited. Still, the positive long-term experience with complement drugs and their proven effectiveness in various diseases has reinvigorated interest and confidence in this approach. Indeed, a broad variety of clinical candidates that act at almost any level of the complement activation cascade are currently in clinical development, with several of them being evaluated in phase 2 and phase 3 trials. With antibody-related drugs dominating the panel of clinical candidates, the emergence of novel small-molecule, peptide, protein, and oligonucleotide-based inhibitors offers new options for drug targeting and administration. Whereas all the currently approved and many of the proposed indications for complement-targeted inhibitors belong to the rare disease spectrum, these drugs are increasingly being evaluated for more prevalent conditions. Fortunately, the growing experience from preclinical and clinical use of therapeutic complement inhibitors has enabled a more evidence-based assessment of suitable targets and rewarding indications as well as related technical and safety considerations. This review highlights recent concepts and developments in complement-targeted drug discovery, provides an overview of current and emerging treatment options, and discusses the new milestones ahead on the way to the next generation of clinically available complement therapeutics. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Ricklin, Daniel; Lambris, John D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
RP Ricklin, D; Lambris, JD (reprint author), Univ Penn, Perelman Sch Med, Stellar Chance Labs 401, 422 Curie Blvd, Philadelphia, PA 19104 USA.
EM ricklin@upenn.edu; lambris@upenn.edu
FU National Institutes of Health [AI068730, AI030040]; National Science
   Foundation [1423304]; European Community's Seventh Framework Programme
   (DIREKT) [602699]
FX We thank Dr. Deborah McClellan for her excellent editorial assistance.
   This work was supported by grants for the National Institutes of Health
   (AI068730, AI030040) and the National Science Foundation (1423304) and
   by funding from the European Community's Seventh Framework Programme,
   under grant agreement number 602699 (DIREKT).
CR Abdel-Magid AF, 2012, ACS MED CHEM LETT, V3, P781, DOI 10.1021/ml300233n
   Abe T, 2012, J IMMUNOL, V189, P5442, DOI 10.4049/jimmunol.1202339
   Anderson K., 2016, ARVO ANN M SEATTL WA
   BAKER BR, 1969, J MED CHEM, V12, P408, DOI 10.1021/jm00303a016
   Barratt-Due A, 2013, J IMMUNOL, V191, P819, DOI 10.4049/jimmunol.1201909
   Barratt-Due A, 2012, IMMUNOBIOLOGY, V217, P1047, DOI 10.1016/j.imbio.2012.07.019
   Berends ETM, 2015, MOL IMMUNOL, V65, P328, DOI 10.1016/j.molimm.2015.01.020
   Biglarnia AR, 2015, ADV EXP MED BIOL, V865, P211, DOI 10.1007/978-3-319-18603-0_13
   Boross P., 2016, ALT C 2016 INN HOST
   Brennan F.H., 2016, SEMIN IMMUNOL
   Brennan FH, 2015, J NEUROSCI, V35, P6517, DOI 10.1523/JNEUROSCI.5218-14.2015
   Cagliani R., 2016, MOL ECOL
   Chehoud C, 2013, P NATL ACAD SCI USA, V110, P15061, DOI 10.1073/pnas.1307855110
   Chen S, 2011, AM J TRANSPLANT, V11, P2057, DOI 10.1111/j.1600-6143.2011.03646.x
   Cooper DKC, 2015, INT J SURG, V23, P211, DOI 10.1016/j.ijsu.2015.06.068
   Coyle D, 2014, MED DECIS MAKING, V34, P1016, DOI 10.1177/0272989X14539731
   Crowley M., 2016, ARVO 2016 ANN M SEAT
   DeAngelis RA, 2012, IMMUNOBIOLOGY, V217, P1097, DOI 10.1016/j.imbio.2012.07.012
   DeZern AE, 2014, EXP HEMATOL, V42, P857, DOI 10.1016/j.exphem.2014.06.007
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   Flohr S., 2014, [No title captured], Patent No. [W02014002052 (A1), 2014002052]
   Fonseca MI, 2009, J IMMUNOL, V183, P1375, DOI 10.4049/jimmunol.0901005
   Fremeaux-Bacchi V, 2015, KIDNEY INT, V88, P967, DOI 10.1038/ki.2015.253
   Fridkis-Hareli M, 2011, BLOOD, V118, P4705, DOI 10.1182/blood-2011-06-359646
   Gavriilaki E., 2015, BLOOD, V126, P275
   Georgoutsou-Spyridonos M, 2015, J IMMUNOL, V195, P3946, DOI 10.4049/jimmunol.1500966
   Grossman T.R., 2015, IMMUNOBIOLOGY
   Grossman T.R., 2015, ANTISENSE THERAPIES
   Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102
   Hajishengallis G, 2015, ADV EXP MED BIOL, V865, P57, DOI 10.1007/978-3-319-18603-0_4
   Hajishengallis G, 2013, SEMIN IMMUNOL, V25, P65, DOI 10.1016/j.smim.2013.04.004
   Hamad OA, 2015, THROMB HAEMOSTASIS, V114, P1207, DOI 10.1160/TH15-02-0162
   Harris CL, 2012, TRENDS IMMUNOL, V33, P513, DOI 10.1016/j.it.2012.06.001
   Hebecker M, 2013, J IMMUNOL, V191, P912, DOI 10.4049/jimmunol.1300269
   Hepburn NJ, 2007, J BIOL CHEM, V282, P8292, DOI 10.1074/jbc.M609858200
   Hillmen P, 2016, AM J HEMATOL, V91, pE16, DOI 10.1002/ajh.24280
   Hillmen P, 2013, BRIT J HAEMATOL, V162, P62, DOI 10.1111/bjh.12347
   Hoehlig K, 2013, MOL THER, V21, P2236, DOI 10.1038/mt.2013.178
   Holers M, 2012, IMMUNOBIOLOGY, V217, P1210, DOI 10.1016/j.imbio.2012.08.232
   Holers V.M., 2015, IMMUNOBIOLOGY
   Holers VM, 2013, ADV EXP MED BIOL, V735, P137, DOI 10.1007/978-1-4614-4118-2_9
   Hovland A, 2015, ATHEROSCLEROSIS, V241, P480, DOI 10.1016/j.atherosclerosis.2015.05.038
   Huang YJ, 2014, CHEMMEDCHEM, V9, P2223, DOI 10.1002/cmdc.201402212
   Huber-Lang M, 2013, SEMIN IMMUNOL, V25, P73, DOI 10.1016/j.smim.2013.05.006
   Johnson L., 2016, ANT FAB TREATM AG RE
   Jore MM, 2016, NAT STRUCT MOL BIOL, V23, P378, DOI 10.1038/nsmb.3196
   Katschke KJ, 2012, J BIOL CHEM, V287, P12886, DOI 10.1074/jbc.M112.345082
   Katschke KJ, 2009, J BIOL CHEM, V284, P10473, DOI 10.1074/jbc.M809106200
   Kolev M, 2014, NAT REV IMMUNOL, V14, P811, DOI 10.1038/nri3761
   Lachmann PJ, 2016, CLIN EXP IMMUNOL, V183, P150, DOI 10.1111/cei.12714
   Lachmann PJ, 2009, SCAND J IMMUNOL, V69, P471, DOI 10.1111/j.1365-3083.2009.02258.x
   Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439
   Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824
   Loschi M., 2015, AM J HEMATOL
   Loyet KM, 2014, J PHARMACOL EXP THER, V351, P527, DOI 10.1124/jpet.114.215921
   Macedo ACL, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00055
   Maekawa T., 2016, J CLIN PERIODONTOL
   Maekawa T, 2014, J IMMUNOL, V192, P6020, DOI 10.4049/jimmunol.1400569
   Mamidi S, 2015, IMMUNOBIOLOGY
   Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655
   Marsh JE, 2001, ARCH IMMUNOL THER EX, V49, pS41
   Mastellos DC, 2015, EUR J CLIN INVEST, V45, P423, DOI 10.1111/eci.12419
   Mastellos DC, 2014, EXPERT REV HEMATOL, V7, P583, DOI 10.1586/17474086.2014.953926
   Melis JPM, 2015, MOL IMMUNOL, V67, P117, DOI 10.1016/j.molimm.2015.01.028
   Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262
   Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257
   Mojcik CF, 2004, ANN RHEUM DIS, V63, P301
   Morgan BP, 2015, NAT REV DRUG DISCOV, V14, P857, DOI 10.1038/nrd4657
   Morgan BP, 2015, EXPERT REV CLIN IMMU, V11, P1109, DOI 10.1586/1744666X.2015.1074039
   Muller-Eberhard H J, 1968, Adv Immunol, V8, P1, DOI 10.1016/S0065-2776(08)60464-2
   Najaan N., SUBCUTANEOUSLY ADM I
   Nester CM, 2015, MOL IMMUNOL, V67, P31, DOI 10.1016/j.molimm.2015.03.246
   Nester CM, 2013, CURR OPIN PEDIATR, V25, P225, DOI 10.1097/MOP.0b013e32835df4a3
   Nilsson PH, 2013, BIOMATERIALS, V34, P985, DOI 10.1016/j.biomaterials.2012.10.040
   Nishimura J, 2014, NEW ENGL J MED, V370, P632, DOI 10.1056/NEJMoa1311084
   Nordmaj MA, 2015, FASEB J, V29, P4945, DOI 10.1096/fj.15-277103
   Noris M, 2012, NAT REV NEPHROL, V8, P622, DOI 10.1038/nrneph.2012.195
   Paixao-Cavalcante D, 2014, J IMMUNOL, V192, P4844, DOI 10.4049/jimmunol.1303131
   Patel H, 2006, J AM SOC NEPHROL, V17, P1102, DOI 10.1681/ASN.200610116
   Pio R, 2013, SEMIN IMMUNOL, V25, P54, DOI 10.1016/j.smim.2013.04.001
   Qu HC, 2013, IMMUNOBIOLOGY, V218, P496, DOI 10.1016/j.imbio.2012.06.003
   Qu H, 2009, MOL IMMUNOL, V47, P185, DOI 10.1016/j.molimm.2009.08.032
   Rafail S, 2015, J IMMUNOL, V194, P1285, DOI 10.4049/jimmunol.1402354
   Regillo C.D., 2013, 117 ANN AAO M NEW OR
   Reis ES, 2015, CLIN IMMUNOL, V161, P225, DOI 10.1016/j.clim.2015.08.009
   Reis ES, 2015, IMMUNOBIOLOGY, V220, P476, DOI 10.1016/j.imbio.2014.10.026
   Ricklin D., 2016, NATURE REV NEPHROLOG
   Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342
   Ricklin D, 2016, IMMUNOBIOLOGY, V221, P740, DOI 10.1016/j.imbio.2015.06.012
   Ricklin D, 2013, J IMMUNOL, V190, P3839, DOI 10.4049/jimmunol.1203200
   Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487
   Ricklin D, 2013, ADV EXP MED BIOL, V735, P1, DOI 10.1007/978-1-4614-4118-2_1
   Ricklin D, 2012, IMMUNOBIOLOGY, V217, P1057, DOI 10.1016/j.imbio.2012.07.016
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   Risitano A.M., 2016, AM J HEMATOL
   Risitano A.M., 2015, ASH 57 ANN M EXP ORL
   Risitano AM, 2014, BLOOD, V123, P2094, DOI 10.1182/blood-2013-11-536573
   de Cordoba SR, 2012, IMMUNOBIOLOGY, V217, P1034, DOI 10.1016/j.imbio.2012.07.021
   Roguska M, 2014, INVEST OPHTH VIS SCI, V55
   Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344
   Ruseva MM, 2015, P NATL ACAD SCI USA, V112, P14319, DOI 10.1073/pnas.1513698112
   Sacks SH, 2012, NAT REV IMMUNOL, V12, P431, DOI 10.1038/nri3225
   Sahelijo L, 2015, BLOOD, V126, P4777
   Sahu A, 2000, IMMUNOPHARMACOLOGY, V49, P133, DOI 10.1016/S0162-3109(00)80299-4
   Schmidt CQ, 2016, IMMUNOBIOLOGY, V221, P503, DOI 10.1016/j.imbio.2015.12.009
   Schmidt CQ, 2013, J IMMUNOL, V190, P5712, DOI 10.4049/jimmunol.1203548
   Scott D., 2015, IMMUNOBIOLOGY
   Silasi-Mansat R., 2015, J CELL MOL MED
   Silasi-Mansat R, 2010, BLOOD, V116, P1002, DOI 10.1182/blood-2010-02-269746
   SR E., 2006, J IMMUNOL, V63, P155
   Szebeni J, 2014, MOL IMMUNOL, V61, P163, DOI 10.1016/j.molimm.2014.06.038
   Taylor RP, 2014, METHODS, V65, P18, DOI 10.1016/j.ymeth.2013.07.027
   Vadrevu SK, 2014, CANCER RES, V74, P3454, DOI 10.1158/0008-5472.CAN-14-0157
   van der Veen S, 2014, INFECT IMMUN, V82, P1157, DOI 10.1128/IAI.01183-13
   van Lookeren Campagne M., 2015, IMMUNOBIOLOGY
   Vergunst CE, 2007, RHEUMATOLOGY, V46, P1773, DOI 10.1093/rheumatology/kem222
   Vogel CW, 2014, MOL IMMUNOL, V61, P191, DOI 10.1016/j.molimm.2014.06.035
   Wang JX, 2016, CLIN IMMUNOL, V162, P37, DOI 10.1016/j.clim.2015.11.002
   Woodruff TM, 2011, MOL IMMUNOL, V48, P1631, DOI 10.1016/j.molimm.2011.04.014
   Wu MA, 2016, EXPERT OPIN PHARMACO, V17, P27, DOI 10.1517/14656566.2016.1104300
   Wu YQ, 2011, J IMMUNOL, V186, P4269, DOI 10.4049/jimmunol.1003802
   Xiao F, 2016, BRIT J PHARMACOL, V173, P575, DOI 10.1111/bph.13388
   Zeerleder S, 2011, SEMIN THROMB HEMOST, V37, P362, DOI 10.1055/s-0031-1276585
   Zhang YZ, 2015, IMMUNOBIOLOGY, V220, P993, DOI 10.1016/j.imbio.2015.04.001
   Zhang YZ, 2013, J AM SOC NEPHROL, V24, P1820, DOI 10.1681/ASN.2013010045
   Zipfel PF, 2015, MOL IMMUNOL, V67, P21, DOI 10.1016/j.molimm.2015.03.012
NR 126
TC 25
Z9 25
U1 0
U2 11
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1044-5323
J9 SEMIN IMMUNOL
JI Semin. Immunol.
PD JUN
PY 2016
VL 28
IS 3
BP 208
EP 222
DI 10.1016/j.smim.2016.06.001
PG 15
WC Immunology
SC Immunology
GA DT9TQ
UT WOS:000381845600002
PM 27321574
OA Green Accepted, Other Gold
DA 2018-10-19
ER

PT J
AU Ekdahl, KN
   Huang, S
   Nilsson, B
   Teramura, Y
AF Ekdahl, Kristina N.
   Huang, Shan
   Nilsson, Bo
   Teramura, Yuji
TI Complement inhibition in biomaterial- and biosurface-induced
   thromboinflammation
SO SEMINARS IN IMMUNOLOGY
LA English
DT Review
DE Biomaterials; Coagulation; Complement; Inflammation; Platelets;
   Therapeutic medicine
ID CONTACT ACTIVATION; HUMAN BLOOD; TISSUE FACTOR; ENDOTHELIAL-CELLS;
   FACTOR-XII; FACTOR-H; ISLET TRANSPLANTATION; ALTERNATIVE PATHWAY;
   PROTEIN ADSORPTION; PLATELET-ADHESION
AB Therapeutic medicine today includes a vast number of procedures involving the use of biomaterials, transplantation of therapeutic cells or cell clusters, as well as of solid organs. These treatment modalities are obviously of great benefit to the patient, but also present a great challenge to the innate immune system, since they involve direct exposure of non-biological materials, cells of non-hematological origin as well as endothelial cells, damaged by ischemia-perfusion in solid organs to proteins and cells in the blood. The result of such an exposure may be an inappropriate activation of the complement and contact/kallikrein systems, which produce mediators capable of triggering the platelets and PMNs and monocytes, which can ultimately result in thrombotic and inflammatory (i.e., a thrombo-inflammatory) response to the treatment modality. In this concept review, we give an overview of the mechanisms of recognition within the innate immunity system, with the aim to identify suitable points for intervention. Finally, we discuss emerging and promising techniques for surface modification of biomaterials and cells with specific inhibitors in order to diminish thromboinflammation and improve clinical outcome. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Ekdahl, Kristina N.; Nilsson, Bo; Teramura, Yuji] Uppsala Univ, Rudbeck Lab C5 3, Dept Immunol Genet & Pathol IGP, SE-75185 Uppsala, Sweden.
   [Ekdahl, Kristina N.; Huang, Shan] Linnaeus Univ, Linnaeus Ctr Biomat Chem, SE-39182 Kalmar, Sweden.
   [Teramura, Yuji] Univ Tokyo, Dept Bioengn, Bunkyo Ku, 7-3-1Hongo, Tokyo 1138656, Japan.
RP Teramura, Y (reprint author), Uppsala Univ, Rudbeck Lab C5 3, Dept Immunol Genet & Pathol IGP, SE-75185 Uppsala, Sweden.
EM teramura@bioeng.t.u-tokyo.ac.jp
RI Nilsson Ekdahl, Kristina/B-5301-2012; Nilsson, Bo/B-3102-2012
OI Nilsson, Bo/0000-0003-0057-2730
FU Swedish Research Council (VR) [2013-65X-05647-34-4]; European
   Community's Seventh Framework Programme (DIRECT) [602699]; Swedish
   Foundation for International Cooperation in Research and Higher
   Education (STINT); Bilateral Joint Research Projects (Japan-Sweden) of
   the Japan Society for the Promotion of Science (JSPS); Linnus University
FX We thank Dr. Deborah McClellan for excellent editorial assistance. This
   work was supported by grant 2013-65X-05647-34-4 from the Swedish
   Research Council (VR), the European Community's Seventh Framework
   Programme under the grant agreement no 602699 (DIRECT), the Swedish
   Foundation for International Cooperation in Research and Higher
   Education (STINT), the Bilateral Joint Research Projects (Japan-Sweden)
   of the Japan Society for the Promotion of Science (JSPS), and faculty
   grants from the Linnus University.
CR Andersson J, 2006, J BIOMED MATER RES A, V76A, P25, DOI 10.1002/jbm.a.30377
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   Andersson J, 2001, BIOMATERIALS, V22, P2435, DOI 10.1016/S0142-9612(00)00431-2
   Arnebrant T, 1995, ACS SYM SER, V602, P239
   Asif S., 2016, ACTA BIOMATER
   Back J, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4399
   Back J, 2010, BIOCHEM BIOPH RES CO, V391, P11, DOI 10.1016/j.bbrc.2009.10.123
   Back J, 2009, BIOMATERIALS, V30, P6573, DOI 10.1016/j.biomaterials.2009.07.052
   Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907
   Bennet W, 2000, TRANSPLANTATION, V69, P711
   Biglarnia AR, 2011, TRANSPL INT, V24, pE61, DOI 10.1111/j.1432-2277.2011.01290.x
   Blitz A, 2014, ANN CARDIOTHORAC SUR, V3, P450, DOI 10.3978/j.issn.2225-319X.2014.09.10
   Brass LF, 2003, CHEST, V124, p18S, DOI 10.1378/chest.124.3_suppl.18S
   Cattaneo M, 1999, ARTERIOSCL THROM VAS, V19, P2281, DOI 10.1161/01.ATV.19.10.2281
   Cavalli A, 2010, MINERVA UROL NEFROL, V62, P1
   Christensen K, 2001, BIOMATERIALS, V22, P349, DOI 10.1016/S0142-9612(00)00190-3
   Colman R., 2006, CONTACT ACTIVATION K
   DEAGOSTINI A, 1984, J CLIN INVEST, V73, P1542, DOI 10.1172/JCI111360
   Dobo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020036
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507
   Engberg AE, 2015, BIOMATERIALS, V36, P55, DOI 10.1016/j.biomaterials.2014.09.011
   Engberg AE, 2011, J BIOMED MATER RES A, V97A, P74, DOI 10.1002/jbm.a.33030
   Engberg AE, 2009, BIOMATERIALS, V30, P2653, DOI 10.1016/j.biomaterials.2009.01.001
   Golias Ch, 2007, Hippokratia, V11, P124
   Gustafson EK, 2011, TRANSPLANTATION, V91, P632, DOI 10.1097/TP.0b013e31820ae459
   Hamad OA, 2008, J THROMB HAEMOST, V6, P1413, DOI 10.1111/j.1538-7836.2008.03034.x
   Hamad O.A., 2015, THROMB HAEMOST, V2015
   Hamad OA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012889
   Hamad OA, 2010, J IMMUNOL, V184, P2686, DOI 10.4049/jimmunol.0902810
   Hess K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035690
   HESSING M, 1990, J IMMUNOL, V144, P204
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   Huang S, 2016, BIOMATERIALS, V77, P111, DOI 10.1016/j.biomaterials.2015.10.067
   Ikeda K, 1997, THROMB HAEMOSTASIS, V77, P394
   ISHIHARA K, 1992, J BIOMED MATER RES, V26, P1543, DOI 10.1002/jbm.820261202
   Ishihara K, 1999, BIOMATERIALS, V20, P1553, DOI 10.1016/S0142-9612(98)00206-3
   Iwasaki Y, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/6/064101
   Joseph K, 2001, THROMB HAEMOSTASIS, V85, P119
   Kozarcanin H., 2015, J THROMB HAEMOST
   Krarup A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000623
   Krarup A, 2008, BBA-PROTEINS PROTEOM, V1784, P1294, DOI 10.1016/j.bbapap.2008.03.020
   Mandi F., 2002, BLOOD, V99, P3585, DOI DOI 10.1182/BL00D.V99.10.3585
   Marcus AJ, 1997, J CLIN INVEST, V99, P1351, DOI 10.1172/JCI119294
   Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006
   Miyamoto T, 2011, CURR OPIN NEPHROL HY, V20, P662, DOI 10.1097/MNH.0b013e32834ad504
   Moberg L, 2002, LANCET, V360, P2039, DOI 10.1016/S0140-6736(02)12020-4
   Moll G, 2012, STEM CELLS, V30, P1565, DOI 10.1002/stem.1111
   Moll G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021703
   Murakami Y, 2005, J BIOMAT SCI-POLYM E, V16, P381, DOI 10.1163/1568562053654095
   Murphy DA, 2015, TRANSFUS MED REV, V29, P90, DOI 10.1016/j.tmrv.2014.12.001
   Nagahashi K, 2015, COLLOID SURFACE B, V134, P384, DOI 10.1016/j.colsurfb.2015.07.040
   Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nilsson B, 2010, TRENDS IMMUNOL, V31, P32, DOI 10.1016/j.it.2009.09.005
   Nilsson PH, 2013, BIOMATERIALS, V34, P985, DOI 10.1016/j.biomaterials.2012.10.040
   Nilsson PH, 2010, BIOMATERIALS, V31, P4484, DOI 10.1016/j.biomaterials.2010.02.036
   NILSSON UR, 1993, MOL IMMUNOL, V30, P211, DOI 10.1016/0161-5890(93)90050-L
   Osterud B., 2012, FRONT BIOSCI, V1, P289
   Punjabi Prakash P, 2013, Glob Cardiol Sci Pract, V2013, P249, DOI 10.5339/gcsp.2013.32
   Ricklin D, 2013, J IMMUNOL, V190, P3839, DOI 10.4049/jimmunol.1203200
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   Ritis K, 2006, J IMMUNOL, V177, P4794, DOI 10.4049/jimmunol.177.7.4794
   Schmidt CQ, 2008, CLIN EXP IMMUNOL, V151, P14, DOI 10.1111/j.1365-2249.2007.03553.x
   Serruto D, 2010, NAT REV MICROBIOL, V8, P393, DOI 10.1038/nrmicro2366
   Simard T, 2014, CAN J CARDIOL, V30, P35, DOI 10.1016/j.cjca.2013.09.012
   SIMS PJ, 1991, IMMUNOL TODAY, V12, P338, DOI 10.1016/0167-5699(91)90012-I
   Singh A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055852
   Snyder TA, 2007, J BIOMED MATER RES A, V81A, P85, DOI 10.1002/jbm.a.31006
   Tedesco F, 1997, J EXP MED, V185, P1619, DOI 10.1084/jem.185.9.1619
   Tengvall P, 1997, J BIOMED MATER RES, V35, P81, DOI 10.1002/(SICI)1097-4636(199704)35:1<81::AID-JBM8>3.0.CO;2-I
   Teramura Y, 2007, BIOMATERIALS, V28, P4818, DOI 10.1016/j.biomaterials.2007.07.050
   Teramura Y, 2010, SOFT MATTER, V6, P1081, DOI 10.1039/b913621e
   Tillou X, 2010, KIDNEY INT, V78, P152, DOI 10.1038/ki.2010.75
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   Wettero J, 2001, J BIOMED MATER RES, V57, P550, DOI 10.1002/1097-4636(20011215)57:4<550::AID-JBM1201>3.0.CO;2-T
   Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755
   Wu YQ, 2011, J IMMUNOL, V186, P4269, DOI 10.4049/jimmunol.1003802
   Zhuo R, 2007, BIOMATERIALS, V28, P4355, DOI 10.1016/j.biomaterials.2007.06.019
NR 81
TC 4
Z9 4
U1 1
U2 16
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1044-5323
J9 SEMIN IMMUNOL
JI Semin. Immunol.
PD JUN
PY 2016
VL 28
IS 3
BP 268
EP 277
DI 10.1016/j.smim.2016.04.006
PG 10
WC Immunology
SC Immunology
GA DT9TQ
UT WOS:000381845600007
PM 27211838
DA 2018-10-19
ER

PT J
AU Girard, J
   Joset, N
   Crochet, A
   Tan, M
   Holzheu, A
   Brunetto, PS
   Fromm, KM
AF Girard, Jerome
   Joset, Nathalie
   Crochet, Aurelien
   Tan, Milene
   Holzheu, Anja
   Brunetto, Priscilla S.
   Fromm, Katharina M.
TI Synthesis of New Polyether Ether Ketone Derivatives with Silver Binding
   Site and Coordination Compounds of Their Monomers with Different Silver
   Salts
SO POLYMERS
LA English
DT Article
DE PEEK; antimicrobial polymer coating; silver coordination polymer
ID IMPLANT; BENZOPHENONE; REPLACEMENT; COMPOSITES; POLYMERS; MATRIX; STATE;
   PEEK
AB Polyether ether ketone (PEEK) is a well-known polymer used for implants and devices, especially spinal ones. To overcome the biomaterial related infection risks, 4-4-difluorobenzophenone, the famous PEEK monomer, was modified in order to introduce binding sites for silver ions, which are well known for their antimicrobial activity. The complexation of these new monomers with different silver salts was studied. Crystal structures of different intermediates were obtained with a linear coordination between two pyridine groups and the silver ions in all cases. The mechanical and thermal properties of different new polymers were characterized. The synthesized PEEKN5 polymers showed similar properties than the PEEK ones whereas the PEEKN7 polymers showed similar thermal properties but the mechanical properties are not as good as the ones of PEEK. To improve these properties, these polymers were complexed with silver nitrate in order to cross-link with silver ions. The presence of ionic silver in the polymer was then confirmed by thermogravimetric analysis (TGA) and X-ray powder diffraction (XRPD). Finally, a silver-based antimicrobial compound was successfully coated on the surface of PEEKN5.
C1 [Girard, Jerome; Joset, Nathalie; Tan, Milene; Holzheu, Anja; Brunetto, Priscilla S.; Fromm, Katharina M.] Univ Fribourg, Dept Chem, Chemin Musee 9, CH-1700 Fribourg, Switzerland.
   [Crochet, Aurelien] Univ Fribourg, Dept Phys, Fribourg Ctr Nanomat, FriMat, Chemin Musee 3, CH-1700 Fribourg, Switzerland.
RP Fromm, KM (reprint author), Univ Fribourg, Dept Chem, Chemin Musee 9, CH-1700 Fribourg, Switzerland.
EM jerome.girard@outlook.com; nathalie.joset@givaudan.com;
   aurelien.crochet@unifr.ch; milene.tan@unifr.ch; anja.holzheu@unifr.ch;
   priscilla.brunetto@unifr.ch; katharina.fromm@unifr.ch
OI Crochet, Aurelien/0000-0002-4763-2764
FU Swiss National Science Foundation; University of Fribourg; Fribourg
   Center for Nanomaterials (FriMat)
FX The authors thank Sandeep Kumar and the Adolphe Merkle Institute for DMA
   measurement. The Swiss National Science Foundation, the University of
   Fribourg, and Fribourg Center for Nanomaterials (FriMat) for financial
   and technical support.
CR Barton AJ, 1996, J BIOMED MATER RES, V30, P403, DOI 10.1002/(SICI)1097-4636(199603)30:3<403::AID-JBM15>3.0.CO;2-K
   BLANC E, 1991, J APPL CRYSTALLOGR, V24, P1035, DOI 10.1107/S002188989100835X
   Brunetto PS, 2011, MATERIALS, V4, P355, DOI 10.3390/ma4020355
   Burla MC, 2005, J APPL CRYSTALLOGR, V38, P381, DOI 10.1107/S002188980403225X
   Corvelli AA, 1999, J MATER SCI, V34, P2421, DOI 10.1023/A:1004562732460
   COSIER J, 1986, J APPL CRYSTALLOGR, V19, P105, DOI 10.1107/S0021889886089835
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Diez-Pascual AM, 2011, MATER CHEM PHYS, V130, P126, DOI 10.1016/j.matchemphys.2011.06.019
   Eckhardt S, 2013, CHEM REV, V113, P4708, DOI 10.1021/cr300288v
   ETTER MC, 1990, ACCOUNTS CHEM RES, V23, P120, DOI 10.1021/ar00172a005
   Fromm KM, 2013, APPL ORGANOMET CHEM, V27, P683, DOI 10.1002/aoc.3047
   Fromm KM, 2011, NAT CHEM, V3, P178, DOI 10.1038/nchem.970
   Girard J, 2013, CR CHIM, V16, P550, DOI 10.1016/j.crci.2013.04.010
   Gordon O, 2010, ANTIMICROB AGENTS CH, V54, P4208, DOI 10.1128/AAC.01830-09
   Gors H. G., 1989, U. S. Patent, Patent No. [4814508 A, 4814508]
   Govaert L., 2003, PLYMEREN KETEN KUNST
   HOFFMANN R, 1970, J PHYS CHEM-US, V74, P415, DOI 10.1021/j100697a030
   JOHANSSON M, 1993, J POLYM SCI POL CHEM, V31, P619, DOI 10.1002/pola.1993.080310304
   Kamm O, 1922, ORG SYNTH, V2, P5
   Lai YH, 2007, MAT SCI ENG A-STRUCT, V458, P158, DOI 10.1016/j.msea.2007.01.085
   MAGINN SJ, 1994, ACTA CRYSTALLOGR C, V50, P254, DOI 10.1107/S0108270193007437
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   Papilloud S, 2002, FOOD ADDIT CONTAM, V19, P168, DOI 10.1080/02652030110084800
   PAULIK F, 1985, THERMOCHIM ACTA, V92, P787, DOI 10.1016/0040-6031(85)85995-5
   SEFERIS JC, 1986, POLYM COMPOSITE, V7, P158, DOI 10.1002/pc.750070305
   Sheldrick G. M., 1997, SHELX 97
   Slenters TV, 2010, MATERIALS, V3, P3407, DOI 10.3390/ma3053407
   Staniland P. A., 1986, Patent No. [EP0184458 A2, 0184458]
   Steiner T, 2002, ANGEW CHEM INT EDIT, V41, P48, DOI 10.1002/1521-3773(20020104)41:1<48::AID-ANIE48>3.0.CO;2-U
   Varisco M, 2014, CHEMMEDCHEM, V9, P1221, DOI 10.1002/cmdc.201400072
   Vaudaux P, 2001, J ANTIMICROB CHEMOTH, V47, P163, DOI 10.1093/jac/47.2.163
   Wei J, 2010, POLYM ADVAN TECHNOL, V21, P656, DOI 10.1002/pat.1486
   WEIKERT RJ, 1991, J MED CHEM, V34, P1630, DOI 10.1021/jm00109a015
   Wu LL, 2011, CHEM-EUR J, V17, P4774, DOI 10.1002/chem.201003631
NR 34
TC 1
Z9 1
U1 4
U2 29
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2073-4360
J9 POLYMERS-BASEL
JI Polymers
PD JUN
PY 2016
VL 8
IS 6
DI 10.3390/polym8060208
PG 16
WC Polymer Science
SC Polymer Science
GA DR4GV
UT WOS:000379860500006
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Wen, B
   Kuhn, L
   Charles, L
   Pendrys, D
   Shafer, D
   Freilich, M
AF Wen, Bo
   Kuhn, Liisa
   Charles, Lyndon
   Pendrys, David
   Shafer, David
   Freilich, Martin
TI Comparison of bone morphogenetic protein-2 delivery systems to induce
   supracrestal bone guided by titanium implants in the rabbit mandible
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterial scaffold; BMP-2; dental implant; vertical supracrestal bone
   growth
ID GROWTH; AUGMENTATION; MATRIX; MODEL; RAT; REGENERATION; MODULATION;
   MINIPIG; BMP-2; DOG
AB Objective: To compare the ability of three non-glycosylated/rhBMP-2 (BMP-2) delivery systems to induce supracrestal bone.
   Material and methods: Thirty-six custom SLActive dental implants were partially embedded in transverse orientation into the posterior mandibles of 18 adult rabbits with the head of the implant located 3 mm supracrestal. Delivery of BMP-2 (30 mu g) from the following materials was studied: (1) Ti implant + BMP-2 with hydroxyapatite (HA)-coated collagen (Col/HA) scaffold, (2) Ti implant with Col/HA infused with PEG hydrogel + BMP-2, or (3) Ti implant with HA/beta-TCP/PEG hydrogel scaffold + BMP-2. Scaffolds were secured with a metal "umbrella." Non-BMP-2 contralateral controls were included. MicroCT imaging and histological analysis was performed after 10 weeks to assess new supracrestal bone formation. in vitro BMP-2 release studies were conducted.
   Results: All treatment groups displayed new supracrestal bone formation. Ti + BMP-2 with Col/HA (3.0 +/- 0.2 mm) and Ti with Col/HA/PEG hydrogel I BMP-2 (2.7 +/- 0.4 mm) had significantly greater (P < 0.05) outcomes than without BMP-2. Maximum bone volume occurred in the Ti implant with HA/beta-TCP/PEG hydrogel scaffold BMP-2 group.
   Conclusions: The use of an implant system composed of a partially inserted Ti implant, adjacent scaffold and scaffold stabilizer resulted in the formation of new supracrestal bone across all test groups with and without BMP-2. Delivery of BMP-2 directly from the Ti implant increased bone height, BIC and bone volume as compared to no BMP-2 when a Col/HA was used, but did not improve performance of the HA/beta-TCP/PEG scaffold.
C1 [Wen, Bo] Nanjing Univ, Dept Oral & Maxillofacial Surg, Div Implant Dent, Affiliated Stomatol Hosp,Med Sch, Nanjing, Jiangsu, Peoples R China.
   [Kuhn, Liisa; Charles, Lyndon; Pendrys, David; Freilich, Martin] Univ Connecticut, Sch Dent Med, Dept Reconstruct Sci, Ctr Regenerat Med & Skeletal Dev, Farmington, CT 06032 USA.
   [Shafer, David] Univ Connecticut, Sch Dent Med, Dept Craniofacial Sci, Div Oral & Maxillofacial Surg, Farmington, CT 06032 USA.
RP Freilich, M (reprint author), Univ Connecticut, Sch Dent Med, Dept Reconstruct Sci, 263 Farmington Ave, Farmington, CT 06032 USA.
EM freilich@uchc.edu
FU Institut Straumann AG, Basel, Switzerland
FX This study was supported by a grant from Institut Straumann AG, Basel,
   Switzerland. Experimental titanium implants, scaffold stabilizing
   devices and PEG hydrogel scaffolds were also provided by Institut
   Straumann. The authors greatly appreciate the assistance and
   professional expertise of Dr. Michel Hard, Mr. Marcel Obrecht and Dr.
   Aart Molenberg. We thank Ms. Denise Ortiz for her assistance in
   conducting biostatistical analysis and manuscript preparation. We also
   thank Dr. Peter Hotschansky of the Hans-Knoll-Institut, Jena, Germany
   for the gift of ng/rhBMP-2.
CR Catros S, 2013, INT J ORAL MAX IMPL, V28, P432, DOI 10.11607/jomi.2782
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Donos N, 2002, CLIN ORAL IMPLAN RES, V13, P175, DOI 10.1034/j.1600-0501.2002.130208.x
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   Fittkau MH, 2005, BIOMATERIALS, V26, P167, DOI 10.1016/j.biomaterials.2004.02.012
   Freilich M, 2008, BONE, V43, P781, DOI 10.1016/j.bone.2008.05.021
   Freilich M, 2012, CLIN ORAL IMPLAN RES, V23, P751, DOI 10.1111/j.1600-0501.2011.02199.x
   Freilich M, 2009, CLIN ORAL IMPLAN RES, V20, P201, DOI 10.1111/j.1600-0501.2008.01615.x
   Hall J, 2007, J CLIN PERIODONTOL, V34, P444, DOI 10.1111/j.1600-051X.2007.01064.x
   Jung RE, 2008, CLIN ORAL IMPLAN RES, V19, P188, DOI 10.1111/j.1600-0501.2007.01431.x
   Jung RE, 2007, CLIN ORAL IMPLAN RES, V18, P319, DOI 10.1111/j.1600-0501.2007.01342.x
   Leknes KN, 2008, CLIN ORAL IMPLAN RES, V19, P1027, DOI 10.1111/j.1600-0501.2008.01567.x
   Lutolf MP, 2001, BIOCONJUGATE CHEM, V12, P1051, DOI 10.1021/bc015519e
   Nicolau P, 2013, CLIN IMPLANT DENT R, V15, P600, DOI 10.1111/j.1708-8208.2011.00418.x
   Rengachary Setti S, 2002, Neurosurg Focus, V13, pe2
   Roos-Jansaker AM, 2002, CLIN ORAL IMPLAN RES, V13, P455, DOI 10.1034/j.1600-0501.2002.130502.x
   Sachse A, 2005, BONE, V37, P699, DOI 10.1016/j.bone.2005.06.011
   SAMPATH TK, 1990, J BIOL CHEM, V265, P13198
   Schmitt JM, 1999, J ORTHOPAED RES, V17, P269, DOI 10.1002/jor.1100170217
   Schmoekel H, 2004, J ORTHOPAED RES, V22, P376, DOI 10.1016/S0736-0266(03)00188-8
   Schwarz F, 2007, CLIN ORAL INVEST, V11, P245, DOI 10.1007/s00784-007-0110-7
   Seeherman H, 2002, SPINE, V27, pS16, DOI 10.1097/01.BRS.0000020728.34131.03
   Simion M, 1994, Int J Periodontics Restorative Dent, V14, P496
   Vasak C, 2014, CLIN ORAL IMPLAN RES, V25, P1378, DOI 10.1111/clr.12277
   Wen B, 2011, J BIOMED MATER RES B, V97B, P315, DOI 10.1002/jbm.b.31817
   Wikesjo UME, 2008, J CLIN PERIODONTOL, V35, P1001, DOI 10.1111/j.1600-051X.2008.01321.x
   Woo BH, 2001, PHARMACEUT RES, V18, P1747, DOI 10.1023/A:1013382832091
NR 27
TC 5
Z9 5
U1 1
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUN
PY 2016
VL 27
IS 6
BP 676
EP 685
DI 10.1111/clr.12645
PG 10
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA DR5BE
UT WOS:000379917200008
PM 26183057
DA 2018-10-19
ER

PT J
AU Choi, W
   Lee, S
   Kim, SH
   Jang, JH
AF Choi, Wuyong
   Lee, Slgirim
   Kim, Seung-Hyun
   Jang, Jae-Hyung
TI Polydopamine Inter-Fiber Networks: New Strategy for Producing Rigid,
   Sticky, 3D Fluffy Electrospun Fibrous Polycaprolactone Sponges
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE 3D fibers; delivery vehicles; electrospun fibers; polydopamine; tissue
   engineering scaffolds
ID ENGINEERING COMPLEX TISSUES; NANOFIBROUS SCAFFOLDS; STEM-CELLS; CELLULAR
   INFILTRATION; OXIDATIVE STRESS; DELIVERY; REGENERATION; HYDROGEL;
   SURFACES; COATINGS
AB Designing versatile 3D interfaces that can precisely represent a biological environment is a prerequisite for the creation of artificial tissue structures. To this end, electrospun fibrous sponges, precisely mimicking an extracellular matrix and providing highly porous interfaces, have capabilities that can function as versatile physical cues to regenerate various tissues. However, their intrinsic features, such as sheet-like, thin, and weak structures, limit the design of a number of uses in tissue engineering applications. Herein, a highly facile methodology capable of fabricating rigid, sticky, spatially expanded fluffy electrospun fibrous sponges is proposed. A bio-inspired adhesive material, poly(dopamine) (pDA), is employed as a key mediator to provide rigidity and stickiness to the 3D poly(e-caprolactone) (PCL) fibrous sponges, which are fabricated using a coaxial electrospinning with polystyrene followed by a selective leaching process. The iron ion induced oxidation of dopamine into pDA networks interwoven with PCL fibers results in significant increases in the rigidity of 3D fibrous sponges. Furthermore, the exposure of catecholamine groups on the fiber surfaces promotes the stable attachment of the sponges on wet organ surfaces and triggers the robust immobilization of biomolecules (e.g., proteins and gene vectors), demonstrating their potential for 3D scaffolds as well as drug delivery vehicles. Because fibrous structures are ubiquitous in the human body, these rigid, sticky, 3D fibrous sponges are good candidates for powerful biomaterial systems that functionally mimic a variety of tissue structures.
C1 [Choi, Wuyong; Lee, Slgirim; Kim, Seung-Hyun; Jang, Jae-Hyung] Yonsei Univ, Dept Chem & Biomol Engn, Seoul 120749, South Korea.
RP Jang, JH (reprint author), Yonsei Univ, Dept Chem & Biomol Engn, Seoul 120749, South Korea.
EM j-jang@yonsei.ac.kr
FU National Research Foundation of Korea (NRF) grant through the Active
   Polymer Center for Pattern Integration [2007-0056091]; Ministry of
   Science, ICT & Future Planning (MSIP) [NRF-2015R1A2A2A03003553]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant through the Active Polymer Center for Pattern Integration
   (2007-0056091) and NRF-2015R1A2A2A03003553 funded by the Ministry of
   Science, ICT & Future Planning (MSIP).
CR Blakeney BA, 2011, BIOMATERIALS, V32, P1583, DOI 10.1016/j.biomaterials.2010.10.056
   Bonino CA, 2012, SMALL, V8, P1928, DOI 10.1002/smll.201101791
   Bosworth LA, 2013, J MATER SCI-MATER M, V24, P1605, DOI 10.1007/s10856-013-4911-8
   Byun E, 2014, CHEM COMMUN, V50, P2869, DOI 10.1039/c3cc49043b
   Cheng Q, 2013, BIOMACROMOLECULES, V14, P1349, DOI 10.1021/bm302000n
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Holzwarth U, 2011, NAT NANOTECHNOL, V6, P534, DOI 10.1038/nnano.2011.145
   Howard D, 2008, J ANAT, V213, P66, DOI 10.1111/j.1469-7580.2008.00878.x
   Jang JH, 2011, MOL THER, V19, P667, DOI 10.1038/mt.2010.287
   Jiao YP, 2006, J APPL POLYM SCI, V101, P1515, DOI 10.1002/app.22291
   Jin G, 2015, ANGEW CHEM INT EDIT, V54, P7587, DOI 10.1002/anie.201502177
   Jin G, 2014, BIOMED MICRODEVICES, V16, P793, DOI 10.1007/s10544-014-9883-z
   Jones DC, 2000, J NEUROCHEM, V74, P2296, DOI 10.1046/j.1471-4159.2000.0742296.x
   Kim E, 2014, ACS APPL MATER INTER, V6, P8288, DOI 10.1021/am5011095
   Kim E, 2012, ANGEW CHEM INT EDIT, V51, P5598, DOI 10.1002/anie.201201495
   Kim K, 2015, BIOMATERIALS, V52, P161, DOI 10.1016/j.biomaterials.2015.02.010
   Kim TG, 2008, ACTA BIOMATER, V4, P1611, DOI 10.1016/j.actbio.2008.06.008
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222
   Lee S, 2014, ACS APPL MATER INTER, V6, P1082, DOI 10.1021/am404627r
   Leong MF, 2009, J BIOMED MATER RES A, V91A, P231, DOI 10.1002/jbm.a.32208
   Li L., 2014, BIOMATERIALS C, V37C, P218
   Liang D, 2007, ADV DRUG DELIVER REV, V59, P1392, DOI 10.1016/j.addr.2007.04.021
   Liu YD, 2014, ACTA BIOMATER, V10, P5074, DOI 10.1016/j.actbio.2014.08.036
   Lotharius J, 2001, ANN NEUROL, V49, P79, DOI 10.1002/1531-8249(200101)49:1<79::AID-ANA11>3.0.CO;2-D
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Navaei-Nigjeh M, 2014, J BIOMED MATER RES A, V102, P2533, DOI 10.1002/jbm.a.34921
   Nisbet DR, 2009, J BIOMATER APPL, V24, P7, DOI 10.1177/0885328208099086
   Park JP, 2015, CHEM MATER, V27, P105, DOI 10.1021/cm503425d
   Shabani I, 2012, BIOCHEM BIOPH RES CO, V423, P50, DOI 10.1016/j.bbrc.2012.05.069
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Sun B, 2012, NANOSCALE, V4, P2134, DOI 10.1039/c2nr11782g
   Wang YM, 2014, ACS APPL MATER INTER, V6, P2958, DOI 10.1021/am405556x
   Wittmer CR, 2011, ADV FUNCT MATER, V21, P4232, DOI 10.1002/adfm.201100755
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Zhang H, 2013, BIOMATERIALS, V34, P2202, DOI 10.1016/j.biomaterials.2012.12.005
   Zhong SP, 2012, TISSUE ENG PART B-RE, V18, P77, DOI 10.1089/ten.teb.2011.0390
NR 37
TC 6
Z9 6
U1 11
U2 88
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD JUN
PY 2016
VL 16
IS 6
BP 824
EP 835
DI 10.1002/mabi.201500375
PG 12
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA DR5AM
UT WOS:000379915300004
PM 26855375
DA 2018-10-19
ER

PT J
AU Wisotzki, EI
   Friedrich, RP
   Weidt, A
   Alexiou, C
   Mayr, SG
   Zink, M
AF Wisotzki, Emilia I.
   Friedrich, Ralf P.
   Weidt, Astrid
   Alexiou, Christoph
   Mayr, Stefan G.
   Zink, Mareike
TI Cellular Response to Reagent-Free Electron-Irradiated Gelatin Hydrogels
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE crosslinking; cytotoxicity; electron irradiation; gelatin; hydrogels
ID CROSS-LINKING; FUNCTIONAL-GROUPS; FLOW-CYTOMETRY; GAMMA-RAYS; COLLAGEN;
   APOPTOSIS; CELLS; SUBSTRATE; STIFFNESS; GLUTARALDEHYDE
AB As a biomaterial, it is well established that gelatin exhibits low cytotoxicity and can promote cellular growth. However, to circumvent the potential toxicity of chemical crosslinkers, reagent-free crosslinking methods such as electron irradiation are highly desirable. While high energy irradiation has been shown to exhibit precise control over the degree of crosslinking, these hydrogels have not been thoroughly investigated for biocompatibility and degradability. Here, NIH 3T3 murine fibroblasts are seeded onto irradiated gelatin hydrogels to examine the hydrogel's influence on cellular viability and morphology. The average projected area of cells seeded onto the hydrogels increases with irradiation dose, which correlates with an increase in the hydrogel's shear modulus up to 10 kPa. Cells on these hydrogels are highly viable and exhibits normal cell cycles, particularly when compared to those grown on glutaraldehyde crosslinked gelatin hydrogels. However, proliferation is reduced on both types of crosslinked samples. To mimic the response of the hydrogels in physiological conditions, degradability is monitored in simulated body fluid to reveal strongly dose-dependent degradation times. Overall, given the low cytotoxicity, influence on cellular morphology and variability in degradation times of the electron irradiated gelatin hydrogels, there is significant potential for application in areas ranging from regenerative medicine to mechanobiology.
C1 [Wisotzki, Emilia I.; Mayr, Stefan G.] Leibniz Inst Surface Modificat IOM, Permoserstr 15, D-04318 Leipzig, Germany.
   [Wisotzki, Emilia I.; Weidt, Astrid; Mayr, Stefan G.; Zink, Mareike] Univ Leipzig, Fac Phys & Earth Sci, Linnestr 5, D-04103 Leipzig, Germany.
   [Friedrich, Ralf P.; Alexiou, Christoph] Univ Hosp Erlangen, SEON, Else Kroner Fresenius Stiftung Professorship, ENT Clin, Erlangen, Germany.
RP Wisotzki, EI; Mayr, SG (reprint author), Leibniz Inst Surface Modificat IOM, Permoserstr 15, D-04318 Leipzig, Germany.; Wisotzki, EI; Mayr, SG (reprint author), Univ Leipzig, Fac Phys & Earth Sci, Linnestr 5, D-04103 Leipzig, Germany.; Friedrich, RP (reprint author), Univ Hosp Erlangen, SEON, Else Kroner Fresenius Stiftung Professorship, ENT Clin, Erlangen, Germany.
EM emilia.wisotzki@iom-leipzig.de; ralf.friedrich@uk-erlangen.de;
   stefan.mayr@iom-leipzig.de
RI Friedrich, Ralf/R-2580-2016; Zink, Mareike/D-8454-2016
OI Zink, Mareike/0000-0002-3603-3483
FU European Union; Free State of Saxony [SAB 100121467]; National Sciences
   and Engineering Research Council of Canada (NSERC) via a PGS D; Deutsche
   Forschungsgemeinschaft (DFG) [SPP 1681, AL 552/5, MA 2432/6]
FX The authors acknowledge Dr. U. Decker for his assistance with FTIR
   measurements, Dr. W. Knolle and R. Konecziey for electron irradiation,
   as well as F. Engert and B. Heyart for their contributions to this work.
   Grateful acknowledgement is given to Prof. J. A. Kas, as part of this
   work was performed within his labs. The project was funded in part by
   the European Union and the Free State of Saxony (SAB 100121467). Funding
   was also provided from the National Sciences and Engineering Research
   Council of Canada (NSERC) via a PGS D and the Deutsche
   Forschungsgemeinschaft (DFG) via Priority program SPP 1681
   "Feldgesteuerte Partikel-Matrix-Wechselwirkungen: Erzeugung,
   skalenubergreifende Modellierung und Anwendung magnetischer
   Hybrid-Materialien," grant numbers AL 552/5 and MA 2432/6.
CR Allenstein U, 2013, ACTA BIOMATER, V9, P5845, DOI 10.1016/j.actbio.2012.10.040
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Beal G. D., 1928, J AM PHARM ASSOC, V17, P261
   Bessho M, 2007, B CHEM SOC JPN, V80, P979, DOI 10.1246/bcsj.80.979
   Bhat R, 2009, FOOD CHEM, V113, P1160, DOI 10.1016/j.foodchem.2008.08.039
   Bohm I, 2006, ROFO-FORTSCHR RONTG, V178, P263, DOI 10.1055/s-2005-858791
   BORRAS A, 1972, AM J OPHTHALMOL, V73, P390, DOI 10.1016/0002-9394(72)90067-0
   Brodsky B., 2005, BIOPOLYMERS ONLINE
   Cataldo F., 2007, J RADIOANAL NUCL CH, V275, P125
   Chan TR, 2015, ACTA BIOMATER, V15, P164, DOI 10.1016/j.actbio.2015.01.005
   Demchenko A. P., 2012, Experimental Oncology, V34, P263
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dubruel P, 2007, BIOMACROMOLECULES, V8, P338, DOI 10.1021/bm0606869
   Friess W, 1996, BIOMATERIALS, V17, P2289, DOI 10.1016/0142-9612(96)00047-6
   HARRINGT.WF, 1970, BIOCHEMISTRY-US, V9, P3714, DOI 10.1021/bi00821a010
   HAUSCHKA SD, 1966, P NATL ACAD SCI USA, V55, P119, DOI 10.1073/pnas.55.1.119
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Jiang B, 2006, BIOMATERIALS, V27, P15, DOI 10.1016/j.biomaterials.2005.05.091
   Justice BA, 2009, DRUG DISCOV TODAY, V14, P102, DOI 10.1016/j.drudis.2008.11.006
   KOZLOV PV, 1983, POLYMER, V24, P651, DOI 10.1016/0032-3861(83)90001-0
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   MIYAZAWA T, 1958, J CHEM PHYS, V29, P611, DOI 10.1063/1.1744547
   Mohammadi H, 2014, BIOMATERIALS, V35, P1138, DOI 10.1016/j.biomaterials.2013.10.059
   Munoz LE, 2013, AUTOIMMUNITY, V46, P336, DOI 10.3109/08916934.2012.755960
   Paguirigan A, 2006, LAB CHIP, V6, P407, DOI 10.1039/b517524k
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   PEZRON I, 1990, J POLYM SCI POL PHYS, V28, P1823, DOI 10.1002/polb.1990.090281013
   Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11
   Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238
   SCHOR SL, 1979, J CELL SCI, V38, P267
   Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386
   Terao K, 2003, J BIOMAT SCI-POLYM E, V14, P1197, DOI 10.1163/156856203322553437
   TOMODA Y, 1961, J POLYM SCI, V54, P321, DOI 10.1002/pol.1961.1205416005
   Tsuda M., 1960, B SOC SCI PHOTOGR JP, V1960, P18
   van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R
   VANLUYN MJA, 1992, BIOMATERIALS, V13, P1017, DOI 10.1016/0142-9612(92)90153-F
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wisotzki EI, 2014, J MATER CHEM B, V2, P4297, DOI 10.1039/c4tb00429a
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
NR 41
TC 6
Z9 6
U1 0
U2 10
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD JUN
PY 2016
VL 16
IS 6
BP 914
EP 924
DI 10.1002/mabi.201500408
PG 11
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA DR5AM
UT WOS:000379915300012
PM 26937853
DA 2018-10-19
ER

PT J
AU Abe, T
   Iiyoshi, R
   Ito, K
   Takahashi, Y
   Sato, K
   Matsuzaka, A
   Sonoki, T
   Ito, Y
AF Abe, Tomomi
   Iiyoshi, Ryota
   Ito, Kyosuke
   Takahashi, Yutaka
   Sato, Kohei
   Matsuzaka, Atsushi
   Sonoki, Tomonori
   Ito, Yukihiro
TI Difference of saccharification yields between organs and growth stages
   in rice
SO PLANT BIOTECHNOLOGY
LA English
DT Article
DE Saccharification; straw; rice
ID ARABIDOPSIS-THALIANA; EXO-GLUCANASE; SWITCHGRASS; BIOFUELS; ETHANOL;
   TISSUE; STRAW; SUGAR
AB Saccharification is a key step in the efficient production of biofuels and biomaterials from cellulosic biomass. We examined saccharification yields from leaf blades, leaf sheaths and stems at several growth stages in rice. We found that saccharification yields were high before heading and reduced after heading in all three organs examined. Stems showed highest saccharification yields at all growth stages examined, and leaf blades showed lowest saccharification yields. Differences of saccharification yields between rice cultivars were also observed. Our results indicate that saccharification yields are different between rice organs. This suggests that the proportion of organs is one of the determinants of saccharification yields of rice straws, and thus it will be a breeding target for biofuel and biomaterial crops with high saccharification yields. Our results also suggest that the harvesting stage is critical for high saccharification yields.
C1 [Abe, Tomomi; Ito, Kyosuke; Takahashi, Yutaka; Matsuzaka, Atsushi; Ito, Yukihiro] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan.
   [Iiyoshi, Ryota; Sonoki, Tomonori] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori 0368560, Japan.
   [Sato, Kohei; Ito, Yukihiro] Tohoku Univ, Exploring Germinat & Growth Program Young Scienti, Sendai, Miyagi 9818555, Japan.
   [Takahashi, Yutaka] Northern Akita Reg Dev Bur, Kitaakita, Akita 0183393, Japan.
   [Sato, Kohei] Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan.
RP Ito, Y (reprint author), Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 9818555, Japan.; Ito, Y (reprint author), Tohoku Univ, Exploring Germinat & Growth Program Young Scienti, Sendai, Miyagi 9818555, Japan.
EM yukito@bios.tohoku.ac.jp
OI Sonoki, Tomonori/0000-0002-8671-2935
FU Japan Society for the Promotion of Science (JSPS) [23658003]; Japan
   Science and Technology Agency (JST)
FX This study was supported by a Grant-in-Aid for Challenging Exploratory
   Research (JSPS KAKENHI Grant Number 23658003) from the Japan Society for
   the Promotion of Science (JSPS) and Future Scientist Program from the
   Japan Science and Technology Agency (JST).
CR Alper H, 2009, NAT REV MICROBIOL, V7, P715, DOI 10.1038/nrmicro2186
   Berthet S, 2011, PLANT CELL, V23, P1124, DOI 10.1105/tpc.110.082792
   Bhandari HS, 2014, GCB BIOENERGY, V6, P26, DOI 10.1111/gcbb.12053
   Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316
   Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108
   Furukawa K, 2014, TRANSGENIC RES, V23, P531, DOI 10.1007/s11248-014-9786-z
   Furukawa T, 2013, J BIOSCI BIOENG, V116, P616, DOI 10.1016/j.jbiosc.2013.05.007
   Hendriks ATWM, 2009, BIORESOURCE TECHNOL, V100, P10, DOI 10.1016/j.biortech.2008.05.027
   Ishii T, 2001, PLANT PHYSIOL, V126, P1698, DOI 10.1104/pp.126.4.1698
   Nigorikawa M, 2012, RICE, DOI 10.1186/1939-8433-5-14
   Rancour DM, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00266
   Sainz MB, 2009, IN VITRO CELL DEV-PL, V45, P314, DOI 10.1007/s11627-009-9210-1
   Sato S, 2001, PLANT CELL PHYSIOL, V42, P251, DOI 10.1093/pcp/pce045
   Shen H, 2012, NEW PHYTOL, V193, P121, DOI 10.1111/j.1469-8137.2011.03922.x
   Sumiyoshi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078269
   Sumner JB, 1921, J BIOL CHEM, V47, P5
   Taylor LE, 2008, TRENDS BIOTECHNOL, V26, P413, DOI 10.1016/j.tibtech.2008.05.002
   Zhang H, 2014, GCB BIOENERGY, V6, P90, DOI 10.1111/gcbb.12060
NR 18
TC 0
Z9 0
U1 0
U2 3
PU JAPANESE SOC PLANT CELL & MOLECULAR BIOLOGY
PI NARA
PA NARA INST SCI & TECH, GRAD SCH BIOMEDICAL SCIENCES, NARA, 630-0101,
   JAPAN
SN 1342-4580
J9 PLANT BIOTECHNOL-NAR
JI Plant Biotechnol.
PD JUN
PY 2016
VL 33
IS 2
BP 105
EP +
DI 10.5511/plantbiotechnology.16.0502a
PG 7
WC Biotechnology & Applied Microbiology; Plant Sciences
SC Biotechnology & Applied Microbiology; Plant Sciences
GA DR5QV
UT WOS:000379958400006
OA Bronze
DA 2018-10-19
ER

PT J
AU Niespodziana, K
   Jurczyk, K
   Jurczyk, M
AF Niespodziana, K.
   Jurczyk, K.
   Jurczyk, M.
TI SYNTHESIS OF NITI BASED NANOCOMPOSITES REINFORCED BY HA ADDITION
SO ARCHIVES OF METALLURGY AND MATERIALS
LA English
DT Article
DE biomaterial; NiTi; hydroxyapatite; nanocomposite; mechanical alloying
ID ALLOY
AB NiTi alloy is well known for its unique properties, such as good ductility at room temperature, good corrosion resistance and also thermal shape memory effects. On the other hand hydroxyapatite has a combination of desirable properties, such as low density and excellent compatibility with the bone which used as ceramic reinforced phases can change the properties and thermal stability of the NiTi alloy.
   In this study, the NiTi alloy matrix shape memory composite reinforced by hydroxyapatite particles was successfully fabricated using mechanical alloying and powder metallurgical process. The structural evaluation of milled and heat treated powders was studied by X-ray diffraction, scanning electron microscopy and transmission electron microscopy. The differential scanning calorimetry was used to measure the phase transformation temperatures. The porosity, Vickers' hardness and corrosion resistance of the TiNi-HA composites were investigated. The results show that the increase of the weight ratio of hydroxyapatite causes increase the porosity and decrease the corrosion resistance. The fabricated NiTi alloy matrix composite possesses lower density and higher Vickers' hardness as the pure NiTi shape memory alloy, yet still exhibiting the shape memory effect.
C1 [Niespodziana, K.; Jurczyk, M.] Poznan Univ Tech, Inst Mat Sci & Engn, 5 M Sklodowska Curie Str, PL-60965 Poznan, Poland.
   [Jurczyk, K.] Poznan Univ Med Sci, Dept Conservat Dent & Periodontol, 70 Bukowska Str, PL-60812 Poznan, Poland.
RP Niespodziana, K (reprint author), Poznan Univ Tech, Inst Mat Sci & Engn, 5 M Sklodowska Curie Str, PL-60965 Poznan, Poland.
EM katarzyna.niespodziana@put.poznan.pl
RI Niespodziana, Kasia/N-7507-2013; Jurczyk, Mieczyslaw/F-8616-2014
OI Niespodziana, Kasia/0000-0001-9827-9879; Jurczyk,
   Mieczyslaw/0000-0001-5989-8298
CR BENJAMIN JS, 1976, SCI AM, V234, P40, DOI 10.1038/scientificamerican0576-40
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Jiang HJ, 2013, MATER LETT, V100, P74, DOI 10.1016/j.matlet.2013.02.113
   Kaczmarek M, 2014, J BIOMED MATER RES A, V102, P1316, DOI 10.1002/jbm.a.34808
   Neikov O.D., 2009, HDB NONFERROUS METAL
   Niespodziana K, 2010, MATER CHEM PHYS, V123, P160, DOI 10.1016/j.matchemphys.2010.03.076
   Wei ZG, 1998, J MATER SCI, V33, P3743, DOI 10.1023/A:1004692329247
   Wever DJ, 1997, BIOMATERIALS, V18, P1115, DOI 10.1016/S0142-9612(97)00041-0
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
NR 9
TC 0
Z9 0
U1 0
U2 7
PU POLSKA AKAD NAUK, POLISH ACAD SCIENCES, INST METALL & MATER SCI PAS
PI WARSZAWA
PA PL, 00-901 WARSZAWA, POLAND
SN 1733-3490
EI 2300-1909
J9 ARCH METALL MATER
JI Arch. Metall. Mater.
PD JUN
PY 2016
VL 61
IS 2
BP 577
EP 580
DI 10.1515/amm-2016-0098
PG 4
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA DQ9GR
UT WOS:000379518900017
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Basiaga, M
   Staszuk, M
   Walke, W
   Tanski, T
   Kajzer, W
AF Basiaga, M.
   Staszuk, M.
   Walke, W.
   Tanski, T.
   Kajzer, W.
TI POTENTIOSTATIC, POTENTIODYNAMIC AND IMPEDANCE STUDY OF TiO2 LAYERS
   DEPOSITED OF 316 LVM STEEL USED FOR CORONARY STENTS
SO ARCHIVES OF METALLURGY AND MATERIALS
LA English
DT Article
DE AISI 316LVM; TiO2 layer; ALD method; coronary stents; corrosion
   resistance
ID STAINLESS-STEEL; CORROSION-RESISTANCE; COATINGS
AB The objective of the study is assessment of suitability of the ALD method for application of a TiO2 layer on surface of 316LVM steel used for production of vessel stents. Selection of the appropriate process parameters for application of the layer affects its electrochemical properties, which largely determine resistance of the biomaterial to corrosion in the blood environment, thus affecting its hemocompatibility. To assess resistance of the AISI 316LVM steel with modified surface to corrosion, voltammetric and impedance measurements were conducted. The proposed variant of surface processing allows safe deformation of the TiO2 layer without its delamination.
C1 [Basiaga, M.; Walke, W.; Kajzer, W.] Silesian Tech Univ, Fac Biomed Engn, 40 Roosevelta Str, PL-41800 Zabrze, Poland.
   [Staszuk, M.; Tanski, T.] Silesian Tech Univ, Fac Mech Engn, 18a Konarskiego Str, PL-44100 Gliwice, Poland.
RP Basiaga, M (reprint author), Silesian Tech Univ, Fac Biomed Engn, 40 Roosevelta Str, PL-41800 Zabrze, Poland.
EM marcin.basiaga@polsl.pl
RI Tanski, Tomasz/F-8944-2014
OI Tanski, Tomasz/0000-0003-4024-1231; Staszuk, Marcin/0000-0003-3637-9713;
   Kajzer, Wojciech/0000-0001-9285-1272
FU National Science Centre [2014/13/D/ST8/03230]
FX The project was funded by the National Science Centre allocated on the
   basis of the decision No. 2014/13/D/ST8/03230.
CR Aarik L, 2013, THIN SOLID FILMS, V542, P100, DOI 10.1016/j.tsf.2013.06.074
   Basiaga M, 2016, MATERIALWISS WERKST, V47, P512, DOI 10.1002/mawe.201600527
   Basiaga M, 2016, MATER TEHNOL, V50, P153, DOI 10.17222/mit.2014.241
   Basiaga M, 2014, ADV INTELL SYST, V284, P411, DOI 10.1007/978-3-319-06596_39
   Kajzer A, 2015, ACTA BIOENG BIOMECH, V17, P35, DOI 10.5277/ABB-00140-2014-02
   Kiel M, 2010, ADV INTEL SOFT COMPU, V69, P447
   Kumagai H, 2011, J CRYST GROWTH, V314, P146, DOI 10.1016/j.jcrysgro.2010.12.003
   Lim BS, 2003, NAT MATER, V2, P749, DOI 10.1038/nmat1000
   Marin E, 2012, THIN SOLID FILMS, V522, P283, DOI 10.1016/j.tsf.2012.08.023
   Martin E., 2015, MATER CORROS, V66, P909
   Saleem MR, 2012, THIN SOLID FILMS, V520, P5442, DOI 10.1016/j.tsf.2012.04.008
   Shan CX, 2008, SURF COAT TECH, V202, P2399, DOI 10.1016/j.surfcoat.2007.08.066
   Walke W., INT C ADV COMP ENG E
   Walke W, 2014, ADV INTELL SYST, V284, P403, DOI 10.1007/978-3-319-06596_38
   Wang L, 2015, APPL SURF SCI, V340, P113, DOI 10.1016/j.apsusc.2015.02.191
NR 15
TC 0
Z9 0
U1 1
U2 4
PU POLSKA AKAD NAUK, POLISH ACAD SCIENCES, INST METALL & MATER SCI PAS
PI WARSZAWA
PA PL, 00-901 WARSZAWA, POLAND
SN 1733-3490
EI 2300-1909
J9 ARCH METALL MATER
JI Arch. Metall. Mater.
PD JUN
PY 2016
VL 61
IS 2
BP 821
EP 824
DI 10.1515/amm-2016-0138
PG 4
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA DQ9GR
UT WOS:000379518900057
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Affeld, K
   Schaller, J
   Wolken, T
   Krabatsch, T
   Kertzscher, U
AF Affeld, Klaus
   Schaller, Jens
   Woelken, Thies
   Krabatsch, Thomas
   Kertzscher, Ulrich
TI Role of flow for the deposition of platelets
SO BIOINTERPHASES
LA English
DT Article
ID STAGNATION POINT FLOW; SHEAR; TRANSPORT; ACCUMULATION; COATINGS;
   ADHESION; PUMPHEAD; THROMBUS; SURFACES; RATES
AB Implants inside the cardiovascular system are subjected to blood flow. Platelet deposition usually takes place, eventually leading to thrombus formation. Tests must be performed in order to select a suitable biomaterial, but no generally accepted test method exists for biomaterials in contact with blood. At a first glance, the flow appears to play only a minor role in the complex interaction between platelets and biomaterials. However, experiments and models have indeed demonstrated the importance of flow. Flow is the mechanism by which platelets are transported to the site of deposition, enabling deposition and forming the shape of a growing thrombus. This interaction is investigated here by means of two experimental models. The first model generates the simplest shear flow, the plane Couette flow. It serves to quantify the role of the shear rate. The second model, the stagnation point flow model, features a more complex shear flow. This model is used to understand the influence of a changing flow field along the wall over which the platelets travel. The platelet deposition is observed using the two experimental models, and a numerical model is developed to reproduce and simulate the experimental results. In the numerical model, the movement of platelets is computed with a combination of convective and stochastic movements due to diffusion. The combined motion brings some platelets close to the wall. The deposition of the platelet at the wall is modeled by a stochastic model. Probability determines whether the individual platelet deposits or flows onwards. This probability is the product of three different probabilities, which are the properties of the platelet, the wall, and the flow. The results of the models are compared with the experimental results and are used to understand the experiments. (C) 2016 American Vacuum Society.
C1 [Affeld, Klaus; Schaller, Jens; Woelken, Thies; Kertzscher, Ulrich] Charite Univ Med Berlin, Inst Lab Med Klin Chem & Pathobiochem, Lab Biofluidmech, Augustenburger Pl 1 Forum 4, D-13353 Berlin, Germany.
   [Krabatsch, Thomas] Deutsch Herzzentrum Berlin, DHZB, Augustenburger Pl 1, D-13353 Berlin, Germany.
RP Affeld, K (reprint author), Charite Univ Med Berlin, Inst Lab Med Klin Chem & Pathobiochem, Lab Biofluidmech, Augustenburger Pl 1 Forum 4, D-13353 Berlin, Germany.
EM Klaus.affeld@charite.de
FU German Research Foundation (DFG)
FX This work is funded by the German Research Foundation (DFG). The
   photograph of Fig. 1 was contributed by Friedrich Kaufmann (DHZB-German
   Heart Center Berlin). Rainer Haag and Tobias Becherer (Freie Universitat
   Berlin) developed the Polyglycerol coatings used for the experiments
   depicted in Fig. 15. Torsten Kragh (Department of Transfusion Medicine,
   Cell Therapeutics and Hemostasis, Medical Center of the University of
   Munich, Germany) performed the experiments with blood flowing over glass
   covered with collagen, with vWF, and with polyurethane, likewise in Fig.
   15.
CR AFFELD K, 1995, ARTIF ORGANS, V19, P597, DOI 10.1111/j.1525-1594.1995.tb02387.x
   Affeld K., 2014, BIOMED TECH, V59, ps11
   Affeld K, 2013, J BIOMECH, V46, P430, DOI 10.1016/j.jbiomech.2012.10.030
   Alston RP, 2005, BRIT J ANAESTH, V94, P699, DOI 10.1093/bja/aei128
   BALDAUF W, 1978, PATHOL RES PRACT, V163, P9, DOI 10.1016/S0344-0338(78)80107-1
   Bark DL, 2013, BIOPHYS J, V105, P502, DOI 10.1016/j.bpj.2013.05.049
   Bark DL, 2012, BIOTECHNOL BIOENG, V109, P2642, DOI 10.1002/bit.24537
   Becherer T, 2015, ANAL CHIM ACTA, V867, P47, DOI 10.1016/j.aca.2015.01.048
   Casa LDC, 2015, J VASC SURG, V61, P1068, DOI 10.1016/j.jvs.2014.12.050
   Dattilio Frank M, 2006, Neuropsychiatr Dis Treat, V2, P111
   Hoger K, 2013, EUR J PHARM BIOPHARM, V85, P756, DOI 10.1016/j.ejpb.2013.04.005
   Hund SJ, 2009, PHYS MED BIOL, V54, P6415, DOI 10.1088/0031-9155/54/20/024
   Jamiolkowski MA, 2015, J BIOMED MATER RES A, V103, P1303, DOI 10.1002/jbm.a.35202
   Jung F, 2013, CLIN HEMORHEOL MICRO, V53, P97, DOI 10.3233/CH-2012-1579
   Kragh T, 2015, MICROFLUID NANOFLUID, V19, P155, DOI 10.1007/s10404-015-1557-5
   PETSCHEK H, 1968, T AM SOC ART INT ORG, V14, P256
   Rastan AJ, 2006, INT J ARTIF ORGANS, V29, P1121
   Ruggeri ZM, 2006, BLOOD, V108, P1903, DOI 10.1182/blood-2006-04-011551
   Sorensen E. N., 2002, THESIS
   Stutz B, 2003, SCI AM, V289, P76, DOI 10.1038/scientificamerican0703-76
   TURITTO VT, 1975, T AM SOC ART INT ORG, V21, P593
   Virchow R., 1856, GESAMMELTE ABHANDLUN
   Wellnhofer E, 2010, ATHEROSCLEROSIS, V213, P475, DOI 10.1016/j.atherosclerosis.2010.09.007
   Wootton DM, 2001, ANN BIOMED ENG, V29, P321, DOI 10.1114/1.1359449
   ZYDNEY AL, 1988, PHYSICOCHEM HYDRODYN, V10, P77
NR 25
TC 0
Z9 0
U1 1
U2 10
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1934-8630
EI 1559-4106
J9 BIOINTERPHASES
JI Biointerphases
PD JUN
PY 2016
VL 11
IS 2
AR 029804
DI 10.1116/1.4944383
PG 9
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA DR0FF
UT WOS:000379582700049
PM 26984235
DA 2018-10-19
ER

PT J
AU Cornelius, RM
   Macri, J
   Cornelius, KM
   Brash, JL
AF Cornelius, Rena M.
   Macri, Joseph
   Cornelius, Katherine M.
   Brash, John L.
TI Lipoprotein interactions with a polyurethane and a polyethylene
   oxide-modified polyurethane at the plasma-material interface
SO BIOINTERPHASES
LA English
DT Article
ID AMPHIPHILIC TRIBLOCK COPOLYMERS; SURFACE MODIFYING ADDITIVES;
   APOLIPOPROTEIN-A-I; HIGH-DENSITY-LIPOPROTEIN; PEO-COPOLYMER/POLYURETHANE
   BLENDS; PROTEIN ADSORPTION; BIOMATERIAL SURFACES; PLATELET-ADHESION;
   POLYMER SURFACES; BLOOD-PLASMA
AB Lipoproteins [high density lipoprotein (HDL), low density lipoprotein (LDL), and very low density lipoprotein (VLDL)] are present in blood in relatively high concentrations, and, given their importance in cardiovascular disease, the interactions of these species with blood contacting biomaterials and their possible role in thrombogenesis is of interest. In the present communication, quantitative data on the adsorption of apolipoprotein AI, apolipoprotein AII (the main protein components of HDL), and apolipoprotein B (the main protein component of LDL and VLDL), as well as the lipoproteins themselves from plasma to a biomedical grade polyurethane (PU) with and without a copolymer additive that contains polyethylene oxide (PEO) segments, were investigated. Adsorption from some binary solutions was also studied. Significant quantities of the apolipoproteins were found to adsorb from plasma to the PU, while adsorption to the PEO material was more than 90% lower, demonstrating strong protein resistance of the latter material. In contrast, significant quantities of the lipoproteins were found to adsorb to the PEO as well as to the PU material. From these and previously published results, it is concluded that the protein layer formed on the PU surface from plasma (and by extension from blood) contains apolipoproteins and lipoproteins in addition to other plasma proteins; the layer formed on the PEO surface, however, appears to contain minimal quantities of plasma proteins (including free apolipoproteins) but significant quantities of lipoproteins. (C) 2016 American Vacuum Society.
C1 [Cornelius, Rena M.] McMaster Univ, Dept Chem Engn, 1280 Main St West, Hamilton, ON L8S 4L7, Canada.
   [Macri, Joseph] McMaster Univ, Dept Pathol & Mol Med, 1280 Main St West, Hamilton, ON L8S 4L7, Canada.
   [Cornelius, Katherine M.] McMaster Univ, Dept Biol, 1280 Main St West, Hamilton, ON L8S 4L7, Canada.
   [Brash, John L.] McMaster Univ, Dept Chem Engn, Sch Biomed Engn, 1280 Main St West, Hamilton, ON L8S 4L7, Canada.
RP Brash, JL (reprint author), McMaster Univ, Dept Chem Engn, Sch Biomed Engn, 1280 Main St West, Hamilton, ON L8S 4L7, Canada.
EM brashjl@mcmaster.ca
FU Natural Sciences and Engineering Research Council (NSERC) of Canada
FX Financial support from the Natural Sciences and Engineering Research
   Council (NSERC) of Canada is gratefully acknowledged.
CR Ajees AA, 2006, P NATL ACAD SCI USA, V103, P2126, DOI 10.1073/pnas.0506877103
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Capriotti AL, 2012, J PROTEOMICS, V75, P1924, DOI 10.1016/j.jprot.2012.01.003
   Cavigiolio G, 2010, J BIOL CHEM, V285, P18847, DOI 10.1074/jbc.M109.098434
   Cedervall T, 2007, ANGEW CHEM INT EDIT, V46, P5754, DOI 10.1002/anie.200700465
   Cornelius RM, 2015, LANGMUIR, V31, P12087, DOI 10.1021/acs.langmuir.5b02688
   Cornelius RM, 2011, J BIOMED MATER RES A, V99A, P109, DOI 10.1002/jbm.a.33169
   Cornelius RM, 2002, BIOMATERIALS, V23, P3583, DOI 10.1016/S0142-9612(02)00083-2
   Docter D, 2014, NAT PROTOC, V9, P2030, DOI 10.1038/nprot.2014.139
   Florentin M, 2008, CURR OPIN CARDIOL, V23, P370, DOI 10.1097/HCO.0b013e3283043806
   Frazier RA, 2000, BIOMATERIALS, V21, P957, DOI 10.1016/S0142-9612(99)00270-7
   Futamura K, 2008, LANGMUIR, V24, P10340, DOI 10.1021/la801017h
   Gossmann R, 2015, EUR J PHARM BIOPHARM, V93, P80, DOI 10.1016/j.ejpb.2015.03.021
   Graham I, 2007, ATHEROSCLEROSIS, V194, P1, DOI 10.1016/j.atherosclerosis.2007.08.024
   Gunkel G, 2013, J AM CHEM SOC, V135, P7047, DOI 10.1021/ja402126t
   He Y, 2008, LANGMUIR, V24, P10358, DOI 10.1021/la8013046
   Horbett T. A., 2012, ACS S SERIES, V1120
   Jansch M, 2012, INT J PHARMACEUT, V428, P125, DOI 10.1016/j.ijpharm.2012.01.060
   Jiang SY, 2010, ADV MATER, V22, P920, DOI 10.1002/adma.200901407
   Jin ZL, 2010, J BIOMED MATER RES A, V95A, P1223, DOI 10.1002/jbm.a.32935
   Johs A, 2006, J BIOL CHEM, V281, P19732, DOI 10.1074/jbc.M601688200
   Knetsch MLW, 2006, BIOMATERIALS, V27, P2813, DOI 10.1016/j.biomaterials.2005.12.025
   KNIGHT LC, 1981, THROMB HAEMOSTASIS, V46, P593
   Kumar S, 2013, CHEM COMMUN, V49, P90, DOI 10.1039/c2cc36284h
   Lazarovits J, 2015, CHEM COMMUN, V51, P2756, DOI 10.1039/c4cc07644c
   Liu XL, 2014, J MATER CHEM B, V2, P5718, DOI 10.1039/c4tb00881b
   Lyman D. J., 1971, THROMB DIATH HAEMO, V42, P109
   Morra M, 2000, J BIOMAT SCI-POLYM E, V11, P547, DOI 10.1163/156856200743869
   Pierce Chemical Company, 1993, IODO GEN IOD REAG
   Pollard RD, 2013, BIOCHEMISTRY-US, V52, P9470, DOI 10.1021/bi401080k
   Ren CL, 2008, J PHYS CHEM B, V112, P16238, DOI 10.1021/jp8080904
   Riedel T, 2013, LANGMUIR, V29, P3388, DOI 10.1021/la304886r
   Salvador-Morales C, 2006, MOL IMMUNOL, V43, P193, DOI 10.1016/j.molimm.2005.02.006
   Salvador-Morales C, 2009, BIOMATERIALS, V30, P2231, DOI 10.1016/j.biomaterials.2009.01.005
   Schottler S, 2016, NAT NANOTECHNOL, V11, P372, DOI [10.1038/NNANO.2015.330, 10.1038/nnano.2015.330]
   Sempf K, 2013, EUR J PHARM BIOPHARM, V85, P53, DOI 10.1016/j.ejpb.2012.11.030
   Tan J, 2008, J BIOMED MATER RES A, V85A, P862, DOI 10.1002/jbm.a.31548
   Tan J, 2008, J BIOMED MATER RES A, V85A, P873, DOI 10.1002/jbm.a.31554
   Tan J, 2008, J APPL POLYM SCI, V108, P1617, DOI 10.1002/app.27098
   Tan J, 2013, J BIOMAT SCI-POLYM E, V24, P497, DOI 10.1080/09205063.2012.690286
   Tan J, 2009, J BIOMED MATER RES A, V90A, P196, DOI 10.1002/jbm.a.32074
   Tenzer S, 2013, NAT NANOTECHNOL, V8, P772, DOI 10.1038/nnano.2013.181
   Tsai WB, 2002, J BIOMED MATER RES, V60, P348, DOI 10.1002/jbm.10048
   Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059
   Walkey CD, 2014, ACS NANO, V8, P2439, DOI 10.1021/nn406018q
   Wang LCH, 2006, J ETHNOPHARMACOL, V103, P103, DOI 10.1016/j.jep.2005.07.010
   Yang W, 2009, LANGMUIR, V25, P11911, DOI 10.1021/la9015788
   Zhang Z, 2008, BIOMACROMOLECULES, V9, P2686, DOI 10.1021/bm800407r
NR 49
TC 2
Z9 2
U1 6
U2 22
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1934-8630
EI 1559-4106
J9 BIOINTERPHASES
JI Biointerphases
PD JUN
PY 2016
VL 11
IS 2
AR 029810
DI 10.1116/1.4953867
PG 6
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA DR0FF
UT WOS:000379582700055
PM 27306077
DA 2018-10-19
ER

PT J
AU Hugoni, L
   Montano-Machado, V
   Yang, ML
   Pauthe, E
   Mantovani, D
   Santerre, JP
AF Hugoni, Ludivine
   Montano-Machado, Vanessa
   Yang, Meilin
   Pauthe, Emmanuel
   Mantovani, Diego
   Santerre, J. Paul
TI Fibronectin adsorption on surface-modified polyetherurethanes and their
   differentiated effect on specific blood elements related to inflammatory
   and clotting processes
SO BIOINTERPHASES
LA English
DT Article
ID HYDROPHOBIC IONIC POLYURETHANE; FOREIGN-BODY REACTION; MODIFYING
   MACROMOLECULES; PLASMA FIBRONECTIN; PLATELET-ADHESION; SEGMENTED
   POLYURETHANES; FIBRINOGEN ADSORPTION; PROTEIN ADSORPTION; CELL-ADHESION;
   IN-VITRO
AB After the introduction of a medical device into the body, adhesive proteins such as fibronectin (Fn) will adsorb to the surface of the biomaterial. Monocytes (MCs) will interact with these adsorbed proteins, and adopt either a proinflammatory and/or prowound healing phenotype, thereby influencing many blood interaction events including thrombogenesis. In this work, Fn adsorption as well as subsequent MC response and thrombus formation were investigated on two surfaces-modified polyetherurethanes (PEUs) using different surface modifiers: an anionic/dihydroxyl oligomeric (ADO) additive, known to enable cell adhesion, and a fluorinated polypropylene oxide oligomer (PPO), known to reduce platelet adhesion. Results indicated that at 24 h of MC culture, PEU-ADO and PEU-PPO promoted an anti-inflammatory character relative to the base PEU. Longer clotting times, based on a free hemoglobin assay, were also found on the two surface-modified PEUs relative to the native one, suggesting their potential for the reduction of thrombus formation. In presence of a Fn monolayer, the surface-modified PEUs conserved a lower thrombogenic character than the base PEU, and was however significantly decreased when compared to prior protein adsorption. Furthermore, Fn coatings increased the MC production levels of tumor necrosis factor-a and interleukin-10 at 24 h, while not affecting the anti-inflammatory effect of the modifications relative to the base PEU. This finding was most prominent on PEU-PPO, suggesting that the interaction of the adsorbed Fn with blood cells was different for the two additives. Hence, the results highlighted differentiating effects of Fn adsorption on specific blood activating processes related to inflammatory and thrombotic responses. (C) 2016 American Vacuum Society.
C1 [Hugoni, Ludivine; Montano-Machado, Vanessa; Mantovani, Diego] Univ Laval, Lab Biomat & Bioengn, Dept Min Met Mater Engn, CRC 1, Quebec City, PQ G1A 0V6, Canada.
   [Hugoni, Ludivine; Montano-Machado, Vanessa; Mantovani, Diego] CHU Quebec, Res Ctr, Quebec City, PQ G1A 0V6, Canada.
   [Hugoni, Ludivine; Montano-Machado, Vanessa; Pauthe, Emmanuel] Univ Cergy Pontoise, Lab ERRMECe, 2 Ave Adolphe Chauvin, F-95302 Cergy Pontoise, France.
   [Hugoni, Ludivine; Yang, Meilin; Santerre, J. Paul] Univ Toronto, Fac Dent, Toronto, ON M5G 1G6, Canada.
   [Santerre, J. Paul] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
RP Santerre, JP (reprint author), Univ Toronto, Fac Dent, Toronto, ON M5G 1G6, Canada.; Santerre, JP (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
EM paul.santerre@dentistry.utoronto.ca
OI Mantovani, Diego/0000-0001-9672-895X
FU NSERC CREATE Program in Regenerative Medicine; NSERC; CIHR; Fonds Samuel
   de Champlain; FQRS; FQRNT; CONACYT, Mexico; FRQ-Sante; FRQ-Nature et
   Technologies
FX L.H. was awarded with a M.Sc. Scholarship from NSERC CREATE Program in
   Regenerative Medicine (www.ncprm.ulaval.ca), NSERC, CIHR, Fonds Samuel
   de Champlain, FQRS, and FQRNT. V.M.M. was awarded with a Ph.D.
   Scholarship from CONACYT, Mexico. This work was partially supported by
   FRQ-Sante and FRQ-Nature et Technologies. The authors would like to
   thank Pascale Chevallier, Kyle Battiston and Lucie Levesque for their
   technical assistance, help, and guidance all along the project.
CR Alves CM, 2010, SOFT MATTER, V6, P4135, DOI 10.1039/c002972f
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Andrade J. D., 1985, SURFACE INTERFACIAL, P249
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Asanuma Y, 2013, COLLOID SURFACE B, V108, P239, DOI 10.1016/j.colsurfb.2013.02.042
   BAIER RE, 1972, B NEW YORK ACAD MED, V48, P257
   Battiston KG, 2012, BIOMATERIALS, V33, P8316, DOI 10.1016/j.biomaterials.2012.08.014
   Baujard-Lamotte L, 2008, COLLOID SURFACE B, V63, P129, DOI [10.1016/j.colsurfb.2007.11.015, 10.1016/j.coisurfb.2007.11.015]
   Bergkvist M, 2003, J BIOMED MATER RES A, V64A, P349, DOI 10.1002/jbm.a.10423
   BEVILACQUA MP, 1981, J EXP MED, V153, P42, DOI 10.1084/jem.153.1.42
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P457, DOI 10.1002/jbm.820260404
   Claiborne TE, 2012, EXPERT REV MED DEVIC, V9, P577, DOI [10.1586/ERD.12.51, 10.1586/erd.12.51]
   Dadsetan M, 2004, J BIOMED MATER RES A, V71A, P439, DOI 10.1002/jbm.a.30165
   DETTRE RH, 1965, J PHYS CHEM-US, V69, P1507, DOI 10.1021/j100889a012
   Ernsting MJ, 2007, J BIOMED MATER RES A, V83A, P759, DOI 10.1002/jbm.a.31370
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Galtayries A, 2006, SURF INTERFACE ANAL, V38, P186, DOI 10.1002/sia.2295
   Gretzer C, 2006, J BIOMAT SCI-POLYM E, V17, P669, DOI 10.1163/156856206777346340
   Guignot C, 2001, NUCL INSTRUM METH B, V185, P100, DOI 10.1016/S0168-583X(01)00850-3
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   Jahangir AR, 2002, J BIOMED MATER RES, V60, P135, DOI 10.1002/jbm.10033
   Kakkos SK, 2007, J VASC SURG, V45, P974, DOI 10.1016/j.jvs.2007.01.011
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Levi M, 2004, CIRCULATION, V109, P2698, DOI 10.1161/01.CIR.0000131660.51520.9A
   Lopez-Donaire ML, 2014, J APPL POLYM SCI, V131, DOI [10.1002/APP.40328, 10.1002/app.40328]
   MarcosFernandez A, 1997, MACROMOLECULES, V30, P3584, DOI 10.1021/ma9619039
   Marois Y, 2000, BIOCOMPATIBILITY POL
   Massa TM, 2007, J BIOMED MATER RES A, V81A, P178, DOI 10.1002/jbm.a.30936
   Mathieu E, 2014, J BIOMAT SCI-POLYM E, V25, P1159, DOI 10.1080/09205063.2014.923367
   McBane JE, 2011, BIOMATERIALS, V32, P3584, DOI 10.1016/j.biomaterials.2011.01.069
   McBane JE, 2009, J BIOMED MATER RES A, V91A, P1150, DOI 10.1002/jbm.a.32261
   McBane JE, 2009, BIOMATERIALS, V30, P5497, DOI 10.1016/j.biomaterials.2009.07.010
   McCloskey CB, 2002, MACROMOLECULES, V35, P924, DOI 10.1021/ma010283v
   Mickelson JK, 1996, J AM COLL CARDIOL, V28, P345, DOI 10.1016/0735-1097(96)00164-7
   Montano-Machado V, 2015, BIOMATTER, V5, DOI 10.4161/21592535.2014.979679
   Park HD, 2006, MACROMOL RES, V14, P73, DOI 10.1007/BF03219071
   Poulouin L, 1999, PROTEIN EXPRES PURIF, V17, P146, DOI 10.1006/prep.1999.1103
   Rampersad SN, 2012, SENSORS-BASEL, V12, P12347, DOI 10.3390/s120912347
   RINDER HM, 1991, BLOOD, V78, P1730
   Rumbaut RE, 2010, PLATELET VESSEL WALL
   RYU GH, 1995, ASAIO J, V41, pM384, DOI 10.1097/00002480-199507000-00036
   Scopelliti PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011862
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Sudhakaran PR, 2007, GLYCOCONJUGATE J, V24, P49, DOI 10.1007/s10719-006-9011-2
   Szycher M., 1999, SZYCHERS HDB POLYURE
   TAKAHARA A, 1991, J BIOMED MATER RES, V25, P1095, DOI 10.1002/jbm.820250905
   Tan DS, 2012, APPL SURF SCI, V258, P2697, DOI 10.1016/j.apsusc.2011.10.120
   Tang YW, 1996, J APPL POLYM SCI, V62, P1133, DOI 10.1002/(SICI)1097-4628(19961121)62:8<1133::AID-APP1>3.0.CO;2-J
   Tang YW, 1997, J BIOMED MATER RES, V35, P371, DOI 10.1002/(SICI)1097-4636(19970605)35:3<371::AID-JBM11>3.0.CO;2-I
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   THURLOW PJ, 1990, BRIT J HAEMATOL, V75, P549, DOI 10.1111/j.1365-2141.1990.tb07797.x
   TINGEY KG, 1991, LANGMUIR, V7, P2471, DOI 10.1021/la00059a013
   VANFURTH R, 1979, BLOOD, V54, P485
   Vanterpool FA, 2014, BIORESEARCH OPEN ACC, V3, P286, DOI 10.1089/biores.2014.0033
   Venkatraman S, 2008, PROG POLYM SCI, V33, P853, DOI 10.1016/j.progpolymsci.2008.07.001
   WANG CB, 1983, MACROMOLECULES, V16, P775, DOI 10.1021/ma00239a014
   Wang J, 2005, SURF COAT TECH, V196, P307, DOI 10.1016/j.surfcoat.2004.08.161
   Yang L, 2009, J BIOMED MATER RES A, V91A, P1089, DOI 10.1002/jbm.a.32331
   YASUDA H, 1991, LANGMUIR, V7, P2394, DOI 10.1021/la00058a070
   ZOGRAFI G, 1984, INT J PHARM, V22, P159, DOI 10.1016/0378-5173(84)90019-X
NR 61
TC 1
Z9 1
U1 0
U2 22
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1934-8630
EI 1559-4106
J9 BIOINTERPHASES
JI Biointerphases
PD JUN
PY 2016
VL 11
IS 2
AR 029809
DI 10.1116/1.4950887
PG 14
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA DR0FF
UT WOS:000379582700054
PM 27246517
DA 2018-10-19
ER

PT J
AU Modic, M
   Mozetic, M
AF Modic, Martina
   Mozetic, Miran
TI In vitro screening procedure for characterization of thrombogenic
   properties of plasma treated surfaces
SO BIOINTERPHASES
LA English
DT Article
ID B COLORIMETRIC ASSAY; PLATELET-ADHESION; BLOOD COMPATIBILITY; VASCULAR
   GRAFTS; SHAPE CHANGE; HEMOCOMPATIBILITY; BIOMATERIALS; COAGULATION;
   POLYETHYLENE; ACTIVATION
AB Estimation of thrombogenic surface properties is an important aspect of hemocompatibility studies. To improve our understanding of interaction between blood and biomaterial surfaces, there is a need to employ standardized methods that are both effective and efficient. This contribution details a systematic approach for the in vitro analysis of plasma modified polymer surfaces and human blood platelet interaction, following the recently introduced ISO 10933-4 guidelines. A holistic multistep process is presented that considers all aspects of testing procedure, including blood collection, platelet function testing, and incubation parameters, right through to a comparison and evaluation of the different methods and analysis available. In terms of detection and analysis, confocal light microscopy is shown to offer many advantages over the widely used scanning electron microscopy technique; this includes simpler, less-invasive sample preparation, and less time-consuming analysis procedure. On the other hand, as an alternative to microscopy techniques, toxicology sulforhodamine B based assay (TOX assay) was also evaluated. It has been shown that the assay could be used for rapid estimation of relative concentration of blood platelets on the surface of plasma treated materials, especially when samples do not allow the implementation of microscopy techniques. (C) 2016 American Vacuum Society.
C1 [Modic, Martina; Mozetic, Miran] Jozef Stefan Inst, Dept Surface Engn & Optoelect, Jamova Cesta 39, Ljubljana 1000, Slovenia.
RP Modic, M (reprint author), Jozef Stefan Inst, Dept Surface Engn & Optoelect, Jamova Cesta 39, Ljubljana 1000, Slovenia.
EM martina.modic@ijs.si
FU Slovenian Research Agency [L7-6782]
FX Financial support from the Slovenian Research Agency (Grant No. L7-6782)
   is gratefully acknowledged. Special thanks to Department of Hematology
   of the University Medical Centre Ljubljana for providing blood and
   equipment for assessing platelet function and especially Helena
   Podgornik and Tadej Pajic for their help and advice on the choice of
   used methods. The authors would also like to thank Rok Kostanjsek from
   Biotechnical Faculty from University of Ljubljana for SEM analysis.
CR ALLEN RD, 1979, J CELL BIOL, V83, P126, DOI 10.1083/jcb.83.1.126
   Barbucci R, 2002, BIOMATERIALS, V23, P1967, DOI 10.1016/S0142-9612(01)00323-4
   Briede JJ, 2003, J THROMB HAEMOST, V1, P559, DOI 10.1046/j.1538-7836.2003.00077.x
   Byrom MJ, 2013, ANN CARDIOTHORAC SUR, V2, P435, DOI 10.3978/j.issn.2225-319X.2013.05.04
   Choi JW, 2003, ANN CLIN LAB SCI, V33, P79
   Desmet T, 2009, BIOMACROMOLECULES, V10, P2351, DOI 10.1021/bm900186s
   Ferraz N, 2008, J MATER SCI-MATER M, V19, P3115, DOI 10.1007/s10856-008-3449-7
   Frank RD, 2000, J BIOMED MATER RES, V52, P374, DOI 10.1002/1097-4636(200011)52:2<374::AID-JBM18>3.3.CO;2-Q
   GOODMAN SL, 1989, J BIOMED MATER RES, V23, P105, DOI 10.1002/jbm.820230109
   Harrison P, 2005, BLOOD REV, V19, P111, DOI 10.1016/j.blre.2004.05.002
   Humpolicek P, 2015, COLLOID SURFACE B, V133, P278, DOI 10.1016/j.colsurfb.2015.06.008
   Iwasaki Y, 1996, J BIOMAT SCI-POLYM E, V8, P151, DOI 10.1163/156856296X00228
   Jing X, 2015, MAT SCI ENG C-MATER, V49, P40, DOI 10.1016/j.msec.2014.12.060
   Jung F, 2013, CLIN HEMORHEOL MICRO, V53, P97, DOI 10.3233/CH-2012-1579
   Junkar I, 2015, OPEN CHEM, V13, P490, DOI 10.1515/chem-2015-0061
   Junkar I, 2009, VACUUM, V84, P83, DOI 10.1016/j.vacuum.2009.04.011
   Lee JH, 1998, J BIOMED MATER RES, V41, P304, DOI 10.1002/(SICI)1097-4636(199808)41:2<304::AID-JBM16>3.0.CO;2-K
   Lippi G, 2012, SEMIN THROMB HEMOST, V38, P565, DOI 10.1055/s-0032-1315961
   Mackie I, 2013, INT J LAB HEMATOL, V35, P1, DOI 10.1111/ijlh.12004
   Massa TM, 2005, BIOMATERIALS, V26, P7367, DOI 10.1016/j.biomaterials.2005.05.063
   Morent R, 2011, PLASMA PROCESS POLYM, V8, P171, DOI 10.1002/ppap.201000153
   Mrowietz C, 2005, CLIN HEMORHEOL MICRO, V32, P89
   MURPHY S, 1971, J CLIN INVEST, V50, P370, DOI 10.1172/JCI106504
   Murugesan R, 2008, J APPL PHYS, V103, DOI 10.1063/1.2908200
   PACKHAM MA, 1988, P SOC EXP BIOL MED, V189, P261
   Papazisis KT, 1997, J IMMUNOL METHODS, V208, P151, DOI 10.1016/S0022-1759(97)00137-3
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Resmi KR, 2004, THROMB RES, V114, P121, DOI 10.1016/j.thromres.2004.05.014
   Roy RK, 2009, ACTA BIOMATER, V5, P249, DOI 10.1016/j.actbio.2008.07.031
   Savion N, 2006, PATHOPHYSIOL HAEMO T, V35, P83, DOI 10.1159/000093548
   Solouk A, 2011, BIOTECHNOL APPL BIOC, V58, P311, DOI 10.1002/bab.50
   Spijker HT, 2002, BIOMATERIALS, V23, P757, DOI 10.1016/S0142-9612(01)00181-8
   Stevens KN, 2009, ACS APPL MATER INTER, V1, P2049, DOI 10.1021/am900390h
   Stevens KNJ, 2009, BIOMATERIALS, V30, P3682, DOI 10.1016/j.biomaterials.2009.03.054
   Toes GJ, 1999, BIOMATERIALS, V20, P1951, DOI 10.1016/S0142-9612(99)00100-3
   Vasiljevic J, 2013, MATER TEHNOL, V47, P379
   Venkatraman S, 2008, PROG POLYM SCI, V33, P853, DOI 10.1016/j.progpolymsci.2008.07.001
   Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179
   Vroman L, 2008, COLLOID SURFACE B, V62, P1, DOI 10.1016/j.colsurfb.2007.11.017
   Wang J, 2005, SURF COAT TECH, V196, P307, DOI 10.1016/j.surfcoat.2004.08.161
NR 40
TC 0
Z9 0
U1 1
U2 4
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1934-8630
EI 1559-4106
J9 BIOINTERPHASES
JI Biointerphases
PD JUN
PY 2016
VL 11
IS 2
AR 029808
DI 10.1116/1.4948808
PG 9
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA DR0FF
UT WOS:000379582700053
PM 27154919
DA 2018-10-19
ER

PT J
AU Reviakine, I
   Braune, S
AF Reviakine, Ilya
   Braune, Steffen
TI Preface: In Focus Issue on Blood-Biomaterial Interactions
SO BIOINTERPHASES
LA English
DT Editorial Material
C1 [Reviakine, Ilya] Karlsruhe Inst Technol, Inst Funct Interfaces IFG, Hermann von Helmholtz Pl 1, D-76344 Eggenstein Leopoldshafen, Germany.
   [Reviakine, Ilya] Univ Washington, Dept Bioengn, Seattle, WA 98105 USA.
   [Braune, Steffen] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Dept Biointerface Engn, Kantstr 55, D-14513 Teltow, Germany.
RP Reviakine, I (reprint author), Karlsruhe Inst Technol, Inst Funct Interfaces IFG, Hermann von Helmholtz Pl 1, D-76344 Eggenstein Leopoldshafen, Germany.; Reviakine, I (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98105 USA.
RI Braune, Steffen/D-2315-2015; Reviakine, Ilya/B-2631-2013
OI Reviakine, Ilya/0000-0002-3448-5072
CR Blok SLJ, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4941850
   Cornelius RM, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4953867
   Farrugia BL, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4952450
   Ghanbari H, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4939036
   Gupta S, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4947047
   Jung F, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4938557
   Reviakine I, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4952652
   Szott LM, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4944586
   Tronic EH, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4943618
NR 9
TC 3
Z9 3
U1 2
U2 5
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1934-8630
EI 1559-4106
J9 BIOINTERPHASES
JI Biointerphases
PD JUN
PY 2016
VL 11
IS 2
AR 029501
DI 10.1116/1.4954646
PG 1
WC Biophysics; Materials Science, Biomaterials
SC Biophysics; Materials Science
GA DR0FF
UT WOS:000379582700039
PM 27936810
OA Other Gold
DA 2018-10-19
ER

PT J
AU Tang, JX
AF Tang, Jay X.
TI Measurements of fluid viscosity using a miniature ball drop device
SO REVIEW OF SCIENTIFIC INSTRUMENTS
LA English
DT Article
ID VISCOMETER; MICRORHEOLOGY
AB This paper describes measurement of fluid viscosity using a small ball drop device. It requires as little as 100 mu l of fluid. Each measurement can be performed in seconds. The experiment is designed to yield reliable viscosity values by operating at properly chosen tilt angles and with calibration using well-characterized Newtonian fluids such as mixtures of glycerol and water. It also yields dynamical viscosity of non-Newtonian fluids at moderate shear rates. The device is easy to assemble and it allows for the measurement of viscosity even when the fluid samples are too small to measure using most commercial viscometers or rheometers. Therefore, the technique is particularly useful in characterizing biological fluids such as solutions of proteins, DNA, and polymers frequently used in biomaterial applications. Published by AIP Publishing.
C1 [Tang, Jay X.] Brown Univ, Dept Phys, Providence, RI 02912 USA.
RP Tang, JX (reprint author), Brown Univ, Dept Phys, Providence, RI 02912 USA.
FU National Science Foundation's Fluid Physics program [CBET 1438033]
FX A number of undergraduate students in a freshman seminar course
   participated in the experiment. Mr. Dean Hudek of Physics Instructional
   Support designed the sample racks and provided valuable technical
   assistance. Other colleagues in the author's department, particularly
   Professor Humphrey Maris, offered helpful comments and proofread the
   manuscript. Funding by the National Science Foundation's Fluid Physics
   program (Award No. CBET 1438033) is gratefully acknowledged.
CR Addas KM, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.021503
   Almog Y, 1997, PHYS FLUIDS, V9, P16, DOI 10.1063/1.869158
   Ambari A., 1985, PHYS FLUIDS, V85, P1559
   Brizard M, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1851471
   CHO YI, 1984, J NON-NEWTON FLUID, V15, P61, DOI 10.1016/0377-0257(84)80028-2
   Crocker JC, 2000, PHYS REV LETT, V85, P888, DOI 10.1103/PhysRevLett.85.888
   FAXEN H, 1923, ARK MATEMATIK ASTRON, V17, P1
   GOLDMAN AJ, 1967, CHEM ENG SCI, V22, P637, DOI 10.1016/0009-2509(67)80047-2
   GOTTLIEB M, 1979, J NON-NEWTON FLUID, V6, P97, DOI 10.1016/0377-0257(79)87008-1
   Happel J., 1983, LOW REYNOLDS NUMBER, P318
   Larson R. G., 1999, STRUCTURE RHEOLOGY C
   Mason TG, 1997, PHYS REV LETT, V79, P3282, DOI 10.1103/PhysRevLett.79.3282
   McFarlane NL, 2010, LANGMUIR, V26, P13823, DOI 10.1021/la101907s
   PANIKER NV, 1972, J LAB CLIN MED, V80, P282
   POLLARD TD, 1982, METHOD CELL BIOL, V24, P301
   Srivastava N, 2005, ANAL CHEM, V77, P383, DOI 10.1021/ac0494681
   SWANK RL, 1954, REV SCI INSTRUM, V25, P1020, DOI 10.1063/1.1770901
   Tang JX, 1999, BIOPHYS J, V76, P2208, DOI 10.1016/S0006-3495(99)77376-5
   Tanner R. I., 1963, FLUID MECH, V17, P161
   Wagner O, 2001, BIOCHEM J, V355, P771, DOI 10.1042/bj3550771
   Yuan P., 2008, AM LAB, V40
NR 21
TC 2
Z9 2
U1 2
U2 8
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0034-6748
EI 1089-7623
J9 REV SCI INSTRUM
JI Rev. Sci. Instrum.
PD JUN
PY 2016
VL 87
IS 5
AR 054301
DI 10.1063/1.4948314
PG 8
WC Instruments & Instrumentation; Physics, Applied
SC Instruments & Instrumentation; Physics
GA DQ4QE
UT WOS:000379187600078
PM 27250443
OA Bronze
DA 2018-10-19
ER

PT J
AU Raman, R
   Clay, NE
   Sen, S
   Melhem, M
   Qin, E
   Kong, H
   Bashir, R
AF Raman, Ritu
   Clay, Nicholas E.
   Sen, Sanjeet
   Melhem, Molly
   Qin, Ellen
   Kong, Hyunjoon
   Bashir, Rashid
TI 3D printing enables separation of orthogonal functions within a hydrogel
   particle
SO BIOMEDICAL MICRODEVICES
LA English
DT Article
DE Hydrogel; Polyethylene glycol; Stereolithography; 3D printing;
   Biomaterial
ID STEREOLITHOGRAPHY; MICROPARTICLES; ANISOTROPY
AB Multifunctional particles with distinct physiochemical phases are required by a variety of applications in biomedical engineering, such as diagnostic imaging and targeted drug delivery. This motivates the development of a repeatable, efficient, and customizable approach to manufacturing particles with spatially segregated bioactive moieties. This study demonstrates a stereolithographic 3D printing approach for designing and fabricating large arrays of biphasic poly (ethylene glycol) diacrylate (PEGDA) gel particles. The fabrication parameters governing the physical and biochemical properties of multi-layered particles are thoroughly investigated, yielding a readily tunable approach to manufacturing customizable arrays of multifunctional particles. The advantage in spatially organizing functional epitopes is examined by loading superparamagnetic iron oxide nanoparticles (SPIONs) and bovine serum albumin (BSA) in separate layers of biphasic PEGDA gel particles and examining SPION-induced magnetic resonance (MR) contrast and BSA-release kinetics. Particles with spatial segregation of functional moieties have demonstrably higher MR contrast and BSA release. Overall, this study will contribute significant knowledge to the preparation of multifunctional particles for use as biomedical tools.
C1 [Raman, Ritu] Univ Illinois, Dept Mech Sci & Engn, 1206 W Green St, Urbana, IL 61801 USA.
   [Raman, Ritu; Bashir, Rashid] Univ Illinois, Micro & Nanotechnol Lab, 208 North Wright St, Urbana, IL 61801 USA.
   [Clay, Nicholas E.; Sen, Sanjeet; Qin, Ellen; Kong, Hyunjoon] Univ Illinois, Dept Chem & Biomol Engn, 600 South Mathews Ave, Urbana, IL 61801 USA.
   [Melhem, Molly; Bashir, Rashid] Univ Illinois, Dept Bioengn, 1270 Digital Comp Lab,MC-278, Urbana, IL 61801 USA.
RP Bashir, R (reprint author), Univ Illinois, Micro & Nanotechnol Lab, 208 North Wright St, Urbana, IL 61801 USA.; Bashir, R (reprint author), Univ Illinois, Dept Bioengn, 1270 Digital Comp Lab,MC-278, Urbana, IL 61801 USA.
EM rbashir@illinois.edu
FU National Science Foundation (NSF) Science and Technology Center EBICS
   [CBET-0939511]; National Institute of Health [1R01 HL109192]; NSF
   Graduate Research Fellowship [DGE-1144245]; NSF CMMB IGERT at UIUC
   [0965918]; Dow Graduate Fellowship
FX We acknowledge Boris Odintsov for his assistance in MR imaging. This
   work was funded by the National Science Foundation (NSF) Science and
   Technology Center EBICS (Grant CBET-0939511) and National Institute of
   Health (1R01 HL109192 to H.K). R.R was funded by an NSF Graduate
   Research Fellowship (Grant DGE-1144245) and NSF CMMB IGERT at UIUC
   (Grant 0965918). N.C. was funded by a Dow Graduate Fellowship.
CR Annabi N., 2013, ADV MAT
   Arcaute K, 2011, STEREOLITHOGRAPHY: MATERIALS, PROCESSES AND APPLICATIONS, P299, DOI 10.1007/978-0-387-92904-0_12
   Bartolo P. J., 2011, STEREOLITHOGRAPHY MA, P1
   Bhaskar S, 2010, SMALL, V6, P404, DOI 10.1002/smll.200901306
   Cha C, 2009, ADV FUNCT MATER, V19, P3056, DOI 10.1002/adfm.200900865
   Chan V, 2010, LAB CHIP, V10, P2062, DOI 10.1039/c004285d
   Jeong J. H, 2012, ADV MATER, V24, P58
   Jeong J. H., 2012, ADV MATER, V24, P1
   Kanesaraj Ramasamy R, 2015, ADV HEALTHC MATER, P1
   Lai MH, 2015, NANOSCALE, V7, P6737, DOI 10.1039/c5nr00736d
   Li B, 2016, ACS APPL MATER INTER, V8, P4158, DOI 10.1021/acsami.5b11883
   Melchels FPW, 2010, BIOMATERIALS, V31, P6121, DOI 10.1016/j.biomaterials.2010.04.050
   Neiman JAS, 2015, BIOTECHNOL BIOENG, V112, P777, DOI 10.1002/bit.25494
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Raman R., 2015, ESSENTIALS 3D BIOFAB, P89, DOI DOI 10.1016/B978-0-12-800972-7.00006-2
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Roh KH, 2005, NAT MATER, V4, P759, DOI 10.1038/nmat1486
   Shah B. R. K., 2009, ADV MATER, V729, P1949
   Shevchenko EV, 2008, ADV MATER, V20, P4323, DOI 10.1002/adma.200702994
   Stampfl J, 2011, STEREOLITHOGRAPHY: MATERIALS, PROCESSES AND APPLICATIONS, P161, DOI 10.1007/978-0-387-92904-0_7
   Yang SK, 2012, LAB CHIP, V12, P2097, DOI 10.1039/c2lc90046g
NR 21
TC 2
Z9 2
U1 1
U2 41
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
EI 1572-8781
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD JUN
PY 2016
VL 18
IS 3
AR 49
DI 10.1007/s10544-016-0068-9
PG 7
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA DP7PK
UT WOS:000378691100009
PM 27215416
DA 2018-10-19
ER

PT J
AU Galan-Marin, C
   Rivera-Gomez, C
   Garcia-Martinez, A
AF Galan-Marin, Carmen
   Rivera-Gomez, Carlos
   Garcia-Martinez, Antonio
TI Use of Natural-Fiber Bio-Composites in Construction versus Traditional
   Solutions: Operational and Embodied Energy Assessment
SO MATERIALS
LA English
DT Article
DE life cycle assessment; operational energy; embodied energy; natural
   composites; natural fibers; sustainability; load bearing walls
ID LIFE-CYCLE ENERGY; RESIDENTIAL BUILDINGS; EMISSIONS; REDUCTION; INDIA;
   NEED
AB During the last decades natural polymers have become more and more frequent to replace traditional inorganic stabilizers in building materials. The purpose of this research is to establish a comparison between the most conventional building material solutions for load-bearing walls and a type of biomaterial. This comparison will focus on load-bearing walls as used in a widespread type of twentieth century dwelling construction in Europe and still used in developing countries nowadays. To carry out this analysis, the structural and thermal insulation characteristics of different construction solutions are balanced. The tool used for this evaluation is the life cycle assessment throughout the whole lifespan of these buildings. This research aims to examine the environmental performance of each material assessed: fired clay brick masonry walls (BW), concrete block masonry walls (CW), and stabilized soil block masonry walls (SW) stabilized with natural fibers and alginates. These conventional and new materials are evaluated from the point of view of both operational and embodied energy.
C1 [Galan-Marin, Carmen; Rivera-Gomez, Carlos; Garcia-Martinez, Antonio] Univ Seville, Inst Architecture & Construct Sci, E-41012 Seville, Spain.
RP Galan-Marin, C (reprint author), Univ Seville, Inst Architecture & Construct Sci, E-41012 Seville, Spain.
EM cgalan@us.es; crivera@us.es; agarcia6@us.es
RI Galan-Marin, Carmen/M-9023-2014
OI Galan-Marin, Carmen/0000-0003-1929-3280
FU project PANEL of the Direccion General de Investigacion, Tecnologia y
   Empresa. Consejeria de Economia, Innovacion, Ciencia y Empleo., Junta de
   Andalucia [TEP-1988]
FX This research project and the costs to publish in open access have been
   partially funded by the TEP-1988 project PANEL of the 2012 call of the
   Direccion General de Investigacion, Tecnologia y Empresa. Consejeria de
   Economia, Innovacion, Ciencia y Empleo., Junta de Andalucia.
CR [Anonymous], ECOINVENT DAT
   [Anonymous], 2011, SPAHOUSEC PROJECT AN, P1
   Arena AP, 2003, BUILD ENVIRON, V38, P359, DOI 10.1016/S0360-1323(02)00056-2
   Asif M, 2007, BUILD ENVIRON, V42, P1391, DOI 10.1016/j.buildenv.2005.11.023
   Barber A., 2006, LIFE CYCLE ASSESSMEN
   Blengini GA, 2009, BUILD ENVIRON, V44, P319, DOI 10.1016/j.buildenv.2008.03.007
   Brown NWO, 2014, BUILD ENVIRON, V79, P46, DOI 10.1016/j.buildenv.2014.04.018
   Cabeza LF, 2014, RENEW SUST ENERG REV, V29, P394, DOI 10.1016/j.rser.2013.08.037
   Chen TY, 2001, ENERGY, V26, P323, DOI 10.1016/S0360-5442(01)00006-8
   Chung WS, 2009, APPL ENERG, V86, P1902, DOI 10.1016/j.apenergy.2009.02.001
   CIPECAD, 2015, CYPE ING S A
   CTE_DB-HE, COD TECN ED DOC BAS
   De Miranda F., INVENTARIO CICLO VID
   Devi LP, 2014, ENERG BUILDINGS, V80, P247, DOI 10.1016/j.enbuild.2014.05.034
   Eder P., 2009, 23775EN2009 EUR JRC
   Fitzmaurice R, 1958, MANUAL STABILISED SO
   Galan-Marin C, 2010, J BIOBASED MATER BIO, V4, P121, DOI 10.1166/jbmb.2010.1076
   Garcia-Martinez A., 2010, THESIS
   Guan L., 2015, PROCEDIA ENG, V121, P653
   Hendriks C.F., 2002, ADV BUILD TECHNOL, VII, P1399
   Huberman N, 2008, ENERG BUILDINGS, V40, P837, DOI 10.1016/j.enbuild.2007.06.002
   Ibn-Mohammed T, 2013, ENERG BUILDINGS, V66, P232, DOI 10.1016/j.enbuild.2013.07.026
   Iddon CR, 2013, ENERG BUILDINGS, V67, P479, DOI 10.1016/j.enbuild.2013.08.041
   ISO, 2006, 14044 ISO
   ISO (International Organization for Standardization), 2006, 14040 ISO
   Jollands M., 2014, ENERGY BUILD, V84, P33
   Kellenberger D., 2004, 7 SWISS CTR LIF CYCL
   Koesling M, 2015, ENERG BUILDINGS, V108, P330, DOI 10.1016/j.enbuild.2015.09.012
   Ortiz O, 2010, APPL ENERG, V87, P673, DOI 10.1016/j.apenergy.2009.08.002
   Ortiz O, 2009, BUILD ENVIRON, V44, P584, DOI 10.1016/j.buildenv.2008.05.004
   Praseeda KI, 2016, ENERG BUILDINGS, V110, P211, DOI 10.1016/j.enbuild.2015.09.072
   Resurreccion EP, 2012, BIORESOURCE TECHNOL, V126, P298, DOI 10.1016/j.biortech.2012.09.038
   Sartori I, 2007, ENERG BUILDINGS, V39, P249, DOI 10.1016/j.enbuild.2006.07.001
   Shukla A, 2009, RENEW ENERG, V34, P755, DOI 10.1016/j.renene.2008.04.002
   Stephan A, 2016, APPL ENERG, V161, P445, DOI 10.1016/j.apenergy.2015.10.023
   Stephan A, 2012, ENERG BUILDINGS, V55, P592, DOI 10.1016/j.enbuild.2012.09.008
   Thormark C, 2006, BUILD ENVIRON, V41, P1019, DOI 10.1016/j.buildenv.2005.04.026
   Thormark C, 2002, BUILD ENVIRON, V37, P429, DOI 10.1016/S0360-1323(01)00033-6
   Vazquez M., 2001, INF CONSTR, V52, P29
   Venkatarama R., 2003, ENERGY BUILD, V35, P129
   Walker P, 2000, P 6 INT SEM STRUCT M, P27
   WALKER PJ, 1995, CEMENT CONCRETE COMP, V17, P301, DOI 10.1016/0958-9465(95)00019-9
   Yildiz A, 2009, APPL ENERG, V86, P1939, DOI 10.1016/j.apenergy.2008.12.010
   Zhu JJ, 2013, HABITAT INT, V37, P148, DOI 10.1016/j.habitatint.2011.12.006
NR 44
TC 4
Z9 4
U1 3
U2 28
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD JUN
PY 2016
VL 9
IS 6
AR 465
DI 10.3390/ma9060465
PG 17
WC Materials Science, Multidisciplinary
SC Materials Science
GA DP6TB
UT WOS:000378630600064
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Rabadan-Ros, R
   Velasquez, PA
   Meseguer-Olmo, L
   De Aza, PN
AF Rabadan-Ros, Ruben
   Velasquez, Pablo A.
   Meseguer-Olmo, Luis
   De Aza, Piedad N.
TI Morphological and Structural Study of a Novel Porous Nurse's A Ceramic
   with Osteoconductive Properties for Tissue Engineering
SO MATERIALS
LA English
DT Article
DE bioceramics; calcium silicophosphate; scanning electron microscopy;
   mu-Raman spectroscopy; bone response; biocompatibility
ID ALPHA-TRICALCIUM PHOSPHATE; IN-VITRO; DICALCIUM SILICATE; BLOCK GRAFT;
   RAMAN; VIVO; TCP; PROLIFERATION; BIOCERAMICS; ADSORPTION
AB The characterization process of a new porous Nurse's A ceramic and the physico chemical nature of the remodeled interface between the implant and the surrounding bone were studied after in vivo implantation. Scaffolds were prepared by a solid-state reaction and implanted in New Zealand rabbits. Animals were sacrificed on days 15, 30, and 60. The porous biomaterial displayed biocompatible, bioresorbable, and osteoconductive capacity. The degradation processes of implants also encouraged osseous tissue ingrowths into the material's pores, and drastically changed the macro-and microstructure of the implants. After 60 healing days, the resorption rates were 52.62% +/- 1.12% for the ceramic and 47.38% +/- 1.24% for the residual biomaterial. The elemental analysis showed a gradual diffusion of the Ca and Si ions from the materials into the newly forming bone during the biomaterial's resorption process. The energy dispersive spectroscopy (EDS) analysis of the residual ceramic revealed some particle categories with different mean Ca/P ratios according to size, and indicated various resorption process stages. Since osteoconductive capacity was indicated for this material and bone ingrowth was possible, it could be applied to progressively substitute an implant.
C1 [Rabadan-Ros, Ruben] UCAM Univ Catolica San Antonio Murcia, Grp Invest Regenerac & Reparac Tejidos, Murcia 30107, Spain.
   [Velasquez, Pablo A.; De Aza, Piedad N.] Univ Miguel Hernandez, Inst Bioingn, Avda Univ S-N, Alicante 03202, Spain.
   [Meseguer-Olmo, Luis] UCAM Catholic Univ Murcia, Arrixaca Univ Hosp, Serv Orthopaed, Murcia 30120, Spain.
RP De Aza, PN (reprint author), Univ Miguel Hernandez, Inst Bioingn, Avda Univ S-N, Alicante 03202, Spain.
EM rubenrabadanros@gmail.com; pavelasquez@umh.es; lmeseguer.doc@gmail.com;
   piedad@umh.es
RI Velasquez, Pablo/O-5857-2015; De Aza, Piedad/A-7621-2015
OI Velasquez, Pablo/0000-0002-5142-4992; De Aza,
   Piedad/0000-0001-9316-4407; Rabadan-Ros, Ruben/0000-0003-2990-4620;
   Meseguer-Olmo, Luis/0000-0003-3858-8148
FU Spanish Ministry of Economy and Competitiveness (MINECO)
   [MAT2013-48426-C2-2-R]
FX Part of this work has been supported by Spanish Ministry of Economy and
   Competitiveness (MINECO) contract grant number: MAT2013-48426-C2-2-R.
CR Aguiar H, 2008, J NON-CRYST SOLIDS, V354, P5004, DOI 10.1016/j.jnoncrysol.2008.07.033
   Antonakos A, 2007, BIOMATERIALS, V28, P3043, DOI 10.1016/j.biomaterials.2007.02.028
   BAIER RE, 1977, ANN NY ACAD SCI, V283, P17, DOI 10.1111/j.1749-6632.1977.tb41750.x
   Beltrame F, 2005, BIOTECHNOL BIOENG, V92, P189, DOI 10.1002/bit.20591
   Bohner M, 2009, BIOMATERIALS, V30, P6403, DOI 10.1016/j.biomaterials.2009.08.007
   Bonino F, 2008, J RAMAN SPECTROSC, V39, P260, DOI 10.1002/jrs.1860
   BREEMHAAR W, 1984, BIOMATERIALS, V5, P269, DOI 10.1016/0142-9612(84)90071-1
   Calvo-Guirado J. L., 2015, CLIN ORAL IMPLAN RES, V26, P154
   Calvo-Guirado JL, 2014, CLIN ORAL IMPLAN RES, V25, P1228, DOI 10.1111/clr.12258
   CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   Carrodeguas RG, 2008, KEY ENG MATER, V361-363, P237
   Chevalier J, 2009, J EUR CERAM SOC, V29, P1245, DOI 10.1016/j.jeurceramsoc.2008.08.025
   De Aza P.N., 2016, CLIN ORAL IMPLANT RE
   De Aza PN, 2014, MATERIALS, V7, P2395, DOI 10.3390/ma7042395
   de Aza PN, 2013, MICROSC MICROANAL, V19, P1350, DOI 10.1017/S1431927613001864
   deAza PN, 1997, CHEM MATER, V9, P916, DOI 10.1021/cm9604266
   Garcia-Paez IH, 2014, J MECH BEHAV BIOMED, V30, P1, DOI 10.1016/j.jmbbm.2013.10.011
   Hadjicharalambous Chrystalleni, 2015, Front Bioeng Biotechnol, V3, P175, DOI 10.3389/fbioe.2015.00175
   Ibanez J, 2007, J RAMAN SPECTROSC, V38, P61, DOI 10.1002/jrs.1599
   Jugdaohsingh R, 2004, J BONE MINER RES, V19, P297, DOI 10.1359/JBMR.0301225
   KOCHWA S, 1977, ANN NY ACAD SCI, V283, P37, DOI 10.1111/j.1749-6632.1977.tb41751.x
   Kumar A., 2015, J APPL BIOMATER FUNC, V30, P1168
   Lazary A, 2007, BIOMATERIALS, V28, P393, DOI 10.1016/j.biomaterials.2006.09.002
   Lugo GJ, 2015, J EUR CERAM SOC, V35, P3693, DOI 10.1016/j.jeurceramsoc.2015.04.036
   Lugo GJ, 2016, CERAM INT, V42, P673, DOI 10.1016/j.ceramint.2015.08.164
   Martinez IM, 2012, MAT SCI ENG C-MATER, V32, P878, DOI 10.1016/j.msec.2012.02.006
   Martinez IM, 2011, CERAM INT, V37, P2527, DOI 10.1016/j.ceramint.2011.03.062
   Mate-Sanchez de Val J. E., 2016, CLIN ORAL IMPLANT RE
   de Val JEMS, 2012, J BIOMED MATER RES A, V100A, P3446, DOI 10.1002/jbm.a.34259
   de Val JEMS, 2012, CERAM INT, V38, P1563, DOI 10.1016/j.ceramint.2011.09.042
   Reid JW, 2006, BIOMATERIALS, V27, P2916, DOI 10.1016/j.biomaterials.2006.01.007
   Remy C, 1997, J AM CERAM SOC, V80, P413
   Ros-Tarraga P., 2016, MATERIALS
   Rubio V, 2011, J AM CERAM SOC, V94, P4459, DOI 10.1111/j.1551-2916.2011.04716.x
   Sayer M, 2003, BIOMATERIALS, V24, P369, DOI 10.1016/S0142-9612(02)00327-7
   SCHWARZ K, 1973, P NATL ACAD SCI USA, V70, P1608, DOI 10.1073/pnas.70.5.1608
   Serena S, 2015, CERAM INT, V41, P9411, DOI 10.1016/j.ceramint.2015.03.319
   Velasquez P, 2013, J BIOMED MATER RES A, V101, P1943, DOI 10.1002/jbm.a.34495
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
NR 39
TC 10
Z9 10
U1 1
U2 10
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD JUN
PY 2016
VL 9
IS 6
AR 474
DI 10.3390/ma9060474
PG 14
WC Materials Science, Multidisciplinary
SC Materials Science
GA DP6TB
UT WOS:000378630600073
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Recha-Sancho, L
   Moutos, FT
   Abella, J
   Guilak, F
   Semino, CE
AF Recha-Sancho, Lourdes
   Moutos, Franklin T.
   Abella, Jordi
   Guilak, Farshid
   Semino, Carlos E.
TI Dedifferentiated Human Articular Chondrocytes Redifferentiate to a
   Cartilage-Like Tissue Phenotype in a
   Poly(epsilon-Caprolactone)/Self-Assembling Peptide Composite Scaffold
SO MATERIALS
LA English
DT Article
DE cartilage tissue engineering; 3D cell culture; human chondrocytes; cell
   differentiation; biomimetic materials
ID MOUSE EMBRYONIC FIBROBLASTS; IN-VITRO; CHONDROGENIC PHENOTYPE;
   REGENERATIVE MEDICINE; WOVEN SCAFFOLDS; GENE-EXPRESSION; GELS AFFECTS;
   STEM-CELLS; MATRIX; HYDROGEL
AB Adult articular cartilage has a limited capacity for growth and regeneration and, with injury, new cellular or biomaterial-based therapeutic platforms are required to promote repair. Tissue engineering aims to produce cartilage-like tissues that recreate the complex mechanical and biological properties found in vivo. In this study, a unique composite scaffold was developed by infiltrating a three-dimensional (3D) woven microfiber poly (epsilon-caprolactone) (PCL) scaffold with the RAD16-I self-assembling nanofibers to obtain multi-scale functional and biomimetic tissue-engineered constructs. The scaffold was seeded with expanded dedifferentiated human articular chondrocytes and cultured for four weeks in control and chondrogenic growth conditions. The composite constructs were compared to control constructs obtained by culturing cells with 3D woven PCL scaffolds or RAD16-I independently. High viability and homogeneous cell distribution were observed in all three scaffolds used during the term of the culture. Moreover, gene and protein expression profiles revealed that chondrogenic markers were favored in the presence of RAD16-I peptide (PCL/RAD composite or alone) under chondrogenic induction conditions. Further, constructs displayed positive staining for toluidine blue, indicating the presence of synthesized proteoglycans. Finally, mechanical testing showed that constructs containing the PCL scaffold maintained the initial shape and viscoelastic behavior throughout the culture period, while constructs with RAD16-I scaffold alone contracted during culture time into a stiffer and compacted structure. Altogether, these results suggest that this new composite scaffold provides important mechanical requirements for a cartilage replacement, while providing a biomimetic microenvironment to re-establish the chondrogenic phenotype of human expanded articular chondrocytes.
C1 [Recha-Sancho, Lourdes; Semino, Carlos E.] Ramon Llull Univ, IQS Sch Engn, Bioengn Dept, Tissue Engn Lab, Via Augusta 390, Barcelona 08017, Spain.
   [Moutos, Franklin T.; Guilak, Farshid] Cytex Therapeut Inc, Durham, NC 27705 USA.
   [Guilak, Farshid] Washington Univ, Dept Orthopaed Surg, St Louis, MO 63110 USA.
   [Guilak, Farshid] Shriners Hosp Children St Louis, St Louis, MO 63110 USA.
   [Abella, Jordi] Ramon Llull Univ, Inst Quim Sarria, Dept Analyt Chem, Via Augusta 390, Barcelona 08017, Spain.
RP Semino, CE (reprint author), Ramon Llull Univ, IQS Sch Engn, Bioengn Dept, Tissue Engn Lab, Via Augusta 390, Barcelona 08017, Spain.
EM lourdesrechas@iqs.url.edu; frank.moutos@cytextherapeutics.com;
   jordi.abella@iqs.url.edu; guilak@wustl.edu; carlos.semino@iqs.url.edu
OI Abella, Jordi/0000-0002-5854-7514; Guilak, Farshid/0000-0001-7380-0330
FU AO Foundation, Exploratory Research Collaborative Research Program Acute
   Cartilage Injury/lesion/defect (CRP ACI) under the project Bioactive and
   biomimetic scaffolds for cartilage regeneration (BIOCART); OSTEOCHON3D;
   NIH [AR50245, AR48852, AG15768, AR48182, AG46927]; ESF [2015FI_B2 00109]
FX This study was supported in part by grants from AO Foundation,
   Exploratory Research Collaborative Research Program Acute Cartilage
   Injury/lesion/defect (CRP ACI) under the project Bioactive and
   biomimetic scaffolds for cartilage regeneration (BIOCART) and
   OSTEOCHON3D and grants from the NIH (AR50245, AR48852, AG15768, AR48182,
   AG46927). We thank the SUR of DEC of Catalan Government and the ESF for
   the pre-doctoral fellowship 2015FI_B2 00109 to Lourdes Recha Sancho. We
   also thank the Materials Science Laboratory of IQS-School of Engineering
   for kindly helping us with the DMA analysis and Scientific and
   Technological Centers of Barcelona University for the scanning electron
   microscopy service. Finally, we thank Maria Pilar Armengol from the
   Genomic Unit of the IGTP for her help with the quantitative PCR.
CR Alemany-Ribes M, 2013, TISSUE ENG PT A, V19, P1665, DOI [10.1089/ten.tea.2012.0661, 10.1089/ten.TEA.2012.0661]
   Asnaghi MA, 2011, J APPL BIOMATER BIOM, V9, P73, DOI 10.5301/JABB.2011.8562
   Bauge C, 2014, AGING DIS, V5, P394, DOI 10.14336/AD.2014.0500394
   Bobick BE, 2009, BIRTH DEFECTS RES C, V87, P351, DOI 10.1002/bdrc.20167
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Bussmann B.M., 2013, J TISSUE ENG REGEN M
   Cals FLJ, 2012, J TISSUE ENG REGEN M, V6, P68, DOI 10.1002/term.399
   Castells-Sala C., 2013, J BIOCHIP TISSUE C S, V2, P1
   Chiang HS, 2009, J FORMOS MED ASSOC, V108, P87, DOI 10.1016/S0929-6646(09)60039-5
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Cucchiarini M, 2014, Eur Cell Mater, V27, P12
   Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008
   Darnell MC, 2013, BIOMATERIALS, V34, P8042, DOI 10.1016/j.biomaterials.2013.06.061
   Degano IR, 2009, BIOMATERIALS, V30, P1156, DOI 10.1016/j.biomaterials.2008.11.021
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fernandez-Muinos T, 2015, ACTA BIOMATER, V16, P35, DOI 10.1016/j.actbio.2015.01.008
   Fernandez-Muinos T, 2014, TISSUE ENG PT A, V20, P1145, DOI 10.1089/ten.tea.2013.0369
   Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303
   Garcia-Giralt N, 2008, J BIOMED MATER RES A, V85A, P1082, DOI 10.1002/jbm.a.31670
   Garreta E, 2006, TISSUE ENG, V12, P2215, DOI 10.1089/ten.2006.12.2215
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Genove E, 2009, J CELL MOL MED, V13, P3387, DOI 10.1111/j.1582-4934.2009.00970.x
   Girotto D, 2003, BIOMATERIALS, V24, P3265, DOI 10.1016/S0142-9612(03)00160-1
   Grad S, 2006, TISSUE ENG, V12, P3171, DOI 10.1089/ten.2006.12.3171
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Guilak F, 2014, J BIOMECH, V47, P1933, DOI 10.1016/j.jbiomech.2014.04.019
   Huang MH, 2006, J APPL POLYM SCI, V102, P1681, DOI 10.1002/app.24196
   Hunziker EB, 2015, OSTEOARTHR CARTILAGE, V23, P334, DOI 10.1016/j.joca.2014.12.011
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Johnstone B, 2013, EUR CELLS MATER, V25, P248, DOI 10.22203/eCM.v025a18
   Kim M, 2011, BIOMATERIALS, V32, P7883, DOI 10.1016/j.biomaterials.2011.07.015
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kock L, 2012, CELL TISSUE RES, V347, P613, DOI 10.1007/s00441-011-1243-1
   Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016
   LEFEBVRE V, 1990, BIOCHIM BIOPHYS ACTA, V1051, P266, DOI 10.1016/0167-4889(90)90132-W
   Li QY, 2016, BIOMATERIALS, V75, P37, DOI 10.1016/j.biomaterials.2015.10.011
   Liao IC, 2013, ADV FUNCT MATER, V23, P5833, DOI 10.1002/adfm.201300483
   Mari-Buye N, 2013, TISSUE ENG PT A, V19, P870, DOI [10.1089/ten.TEA.2012.0077, 10.1089/ten.tea.2012.0077]
   Matson JB, 2012, CHEM COMMUN, V48, P26, DOI 10.1039/c1cc15551b
   Miot S, 2005, BIOMATERIALS, V26, P2479, DOI 10.1016/j.biomaterials.2004.06.048
   Moutos FT, 2008, BIORHEOLOGY, V45, P501, DOI 10.3233/BIR-2008-0491
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Moutos FT, 2010, TISSUE ENG PT A, V16, P1291, DOI [10.1089/ten.tea.2009.0480, 10.1089/ten.TEA.2009.0480]
   Moutos FT, 2010, MACROMOL BIOSCI, V10, P1355, DOI 10.1002/mabi.201000124
   Nava M.M., 2012, BIOMED RES INT, V2012
   Nava MM, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/1/015012
   Quinatana L, 2009, TISSUE ENG PT A, V15, P45, DOI 10.1089/ten.tea.2007.0296
   Recha-Sancho L, 2016, J BIOMED MATER RES A, V104, P1694, DOI 10.1002/jbm.a.35699
   Rohner D, 2003, J BIOMED MATER RES B, V66B, P574, DOI 10.1002/jbm.b.10037
   Semino CE, 2008, J DENT RES, V87, P606, DOI 10.1177/154405910808700710
   Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997
   Semino CE, 2003, J BIOMED BIOTECHNOL, P164, DOI 10.1155/S1110724303208019
   Sieminski AL, 2008, J BIOMED MATER RES A, V87A, P494, DOI 10.1002/jbm.a.31785
   Sieminski AL, 2007, CELL BIOCHEM BIOPHYS, V49, P73, DOI 10.1007/s12013-007-0046-1
   Valonen PK, 2010, BIOMATERIALS, V31, P2193, DOI 10.1016/j.biomaterials.2009.11.092
   Wu Jonathan, 2010, Journal of Nanobiotechnology, V8, P29, DOI 10.1186/1477-3155-8-29
   Yoon DM, 2006, ADV EXP MED BIOL, V585, P67
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
NR 59
TC 5
Z9 5
U1 2
U2 12
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD JUN
PY 2016
VL 9
IS 6
AR 472
DI 10.3390/ma9060472
PG 18
WC Materials Science, Multidisciplinary
SC Materials Science
GA DP6TB
UT WOS:000378630600071
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Gazquez, GC
   Chen, HL
   Veldhuis, SA
   Solmaz, A
   Mota, C
   Boukamp, BA
   van Blitterswijk, CA
   ten Elshof, JE
   Moroni, L
AF Gazquez, Gerard Cadafalch
   Chen, Honglin
   Veldhuis, Sjoerd A.
   Solmaz, Alim
   Mota, Carlos
   Boukamp, Bernard A.
   van Blitterswijk, Clemens A.
   ten Elshof, Johan E.
   Moroni, Lorenzo
TI Flexible Yttrium-Stabilized Zirconia Nanofibers Offer Bioactive Cues for
   Osteogenic Differentiation of Human Mesenchymal Stromal Cells
SO ACS NANO
LA English
DT Article
DE flexible ceramic scaffolds; electrospinning ceramic; surface roughness;
   human mesenchymal stromal cells; osteogenic differentiation
ID STEM-CELLS; MECHANICAL-PROPERTIES; ROBUST FLEXIBILITY; BONE-FORMATION;
   SCAFFOLDS; ELECTROSPUN; TISSUE; HYDROXYAPATITE; BIOMATERIAL; CERAMICS
AB Currently, the main drawback of ceramic scaffolds used in hard tissue regeneration is their low mechanical strength. Stabilized zirconia, especially the tetragonal 3% yttrium-stabilized zirconia (YSZ) phase, has been considered as a bioinert ceramic material with high mechanical strength. In the present work, flexible nanofibrous YSZ scaffolds were prepared by electrospinning. The obtained scaffolds showed remarkable flexibility at the macroscopic scale, while retaining their stiffness at the microscopic scale. The surface nanoroughness of the scaffolds could be tailored by varying the heat treatment method. Our results demonstrate that the osteogenic differentiation and mineralization of seeded human mesenchymal stromal cells were supported by the nanofibrous YSZ scaffolds, in contrast to the well-known bioinert behavior of bulk YSZ. These findings highlight that flexible ceramic scaffolds are an appealing alternative to the current brittle ceramics for bone tissue regeneration applications.
C1 [Gazquez, Gerard Cadafalch; Veldhuis, Sjoerd A.; Solmaz, Alim; Boukamp, Bernard A.; ten Elshof, Johan E.] Univ Twente, Inorgan Mat Sci Grp, MESA Inst Nanotechnol, POB 217, NL-7500 AE Enschede, Netherlands.
   [Chen, Honglin; Mota, Carlos; van Blitterswijk, Clemens A.; Moroni, Lorenzo] MERLN Inst Technol Inspired Regenerat Med, Dept Complex Tissue Regenerat, NL-6200 MD Maastricht, Netherlands.
RP ten Elshof, JE (reprint author), Univ Twente, Inorgan Mat Sci Grp, MESA Inst Nanotechnol, POB 217, NL-7500 AE Enschede, Netherlands.; Moroni, L (reprint author), MERLN Inst Technol Inspired Regenerat Med, Dept Complex Tissue Regenerat, NL-6200 MD Maastricht, Netherlands.
EM j.e.tenelshof@utwente.nl; 1.moroni@maastrichtuniversity.nl
RI Moroni, Lorenzo/D-2826-2014
OI Moroni, Lorenzo/0000-0003-1298-6025; Mota, Carlos/0000-0001-5935-6245
FU China Council Scholarship programme [2011614016]; ADEM Programme; NCRR
   of the NIH [P40RR017447]
FX H.C. thanks the China Council Scholarship programme for financial
   support (grant no. 2011614016). G.C.G. thanks the ADEM Programme for
   financial support. Roy Visser is thanked for assistance in mechanical
   testing, and Aliaksei Vasilevich for help in calculating the cell areas.
   Some of the materials employed in this work were provided by the Texas
   A&M Health Science Center College of Medicine Institute for Regenerative
   Medicine at Scott & White through a grant from NCRR of the NIH (grant
   no. P40RR017447).
CR Adams JW, 1997, J AM CERAM SOC, V80, P903
   Azad AM, 2006, MATER LETT, V60, P67, DOI 10.1016/j.matlet.2005.07.085
   Best SM, 2008, J EUR CERAM SOC, V28, P1319, DOI 10.1016/j.jeurceramsoc.2007.12.001
   Biswas A, 2012, CERAM INT, V38, P883, DOI 10.1016/j.ceramint.2011.07.060
   Chaim R, 2004, J MATER SCI, V39, P3057, DOI 10.1023/B:JMSC.0000025832.93840.b0
   Champion E, 2013, ACTA BIOMATER, V9, P5855, DOI 10.1016/j.actbio.2012.11.029
   Chen HL, 2011, INT J NANOMED, V6, P453, DOI 10.2147/IJN.S17057
   Chen HL, 2011, INT J BIOL MACROMOL, V48, P13, DOI 10.1016/j.ijbiomac.2010.09.019
   Chen YC, 2014, RSC ADV, V4, P2756, DOI 10.1039/c3ra45043k
   Chuah YJ, 2015, ACTA BIOMATER, V23, P52, DOI 10.1016/j.actbio.2015.05.023
   Curtin CM, 2012, ADV MATER, V24, P749, DOI 10.1002/adma.201103828
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x
   Fernandes H, 2010, TISSUE ENG PT A, V16, P1693, DOI 10.1089/ten.TEA.2009.0341
   Gaharwar AK, 2013, ADV MATER, V25, P3329, DOI 10.1002/adma.201300584
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Gerstenfeld LC, 1996, J CELL BIOCHEM, V62, P1
   Goldstein A, 1999, J EUR CERAM SOC, V19, P2067, DOI 10.1016/S0955-2219(99)00020-5
   Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002
   Guo M, 2010, J PHYS CHEM C, V114, P916, DOI 10.1021/jp909672r
   Hing KA, 2005, J MATER SCI-MATER M, V16, P467, DOI 10.1007/s10856-005-6988-1
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim HW, 2006, ADV FUNCT MATER, V16, P1529, DOI 10.1002/adfm.200500750
   Kim HW, 2004, BIOMATERIALS, V25, P1279, DOI 10.1016/j.biomaterials.2003.07.003
   Kitagawa F, 2013, TISSUE ENG PART C-ME, V19, P438, DOI [10.1089/ten.tec.2012.0166, 10.1089/ten.TEC.2012.0166]
   Lee SH, 2005, MAT SCI ENG A-STRUCT, V398, P77, DOI 10.1016/j.msea.2005.03.014
   Mao X, 2012, RSC ADV, V2, P12216, DOI 10.1039/c2ra22086e
   McNamara LE, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/120623
   Meza LR, 2014, SCIENCE, V345, P1322, DOI 10.1126/science.1255908
   Nandakumar Anandkumar, 2013, Biomatter, V3, DOI 10.4161/biom.23705
   Nandakumar A, 2010, LANGMUIR, V26, P7380, DOI 10.1021/la904406b
   Park SJ, 2010, J SOL-GEL SCI TECHN, V54, P188, DOI 10.1007/s10971-010-2174-0
   Phinney DG, 1999, J CELL BIOCHEM, V75, P424, DOI 10.1002/(SICI)1097-4644(19991201)75:3<424::AID-JCB8>3.3.CO;2-#
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Polini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026211
   Pot SA, 2010, INVEST OPHTH VIS SCI, V51, P1373, DOI 10.1167/iovs.09-4074
   Ramesh S, 2008, CERAM INT, V34, P1603, DOI 10.1016/j.ceramint.2007.04.012
   Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107
   Si Y, 2014, NANOSCALE, V6, P2102, DOI 10.1039/c3nr05879d
   Sundaresan SG, 2007, J APPL PHYS, V101, DOI 10.1063/1.2717016
   Takeuchi K, 2005, J BIOMED MATER RES A, V72A, P296, DOI 10.1002/jbm.a.30227
   Tang MH, 2014, TISSUE ENG PT A, V20, P1295, DOI [10.1089/ten.tea.2013.0211, 10.1089/ten.TEA.2013.0211]
   Wade RJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7639
   Wang J, 2006, J AM CERAM SOC, V89, P1977, DOI 10.1111/j.1551-2916.2006.00976.x
   Wang RY, 2011, J MATER CHEM, V21, P19375, DOI 10.1039/c1jm13979g
   Watari S, 2012, BIOMATERIALS, V33, P128, DOI 10.1016/j.biomaterials.2011.09.058
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   Xi M, 2014, MATER LETT, V120, P219, DOI 10.1016/j.matlet.2014.01.110
   Xie ZP, 1999, J EUR CERAM SOC, V19, P381, DOI 10.1016/S0955-2219(98)00203-9
   Xu SY, 2006, NANOTECHNOLOGY, V17, P4497, DOI 10.1088/0957-4484/17/17/036
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
   Zakaria SM, 2013, TISSUE ENG PART B-RE, V19, P431, DOI [10.1089/ten.teb.2012.0624, 10.1089/ten.TEB.2012.0624]
   Zamani F, 2013, J MATER SCI-MATER M, V24, P1551, DOI 10.1007/s10856-013-4905-6
NR 55
TC 10
Z9 10
U1 10
U2 60
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD JUN
PY 2016
VL 10
IS 6
BP 5789
EP 5799
DI 10.1021/acsnano.5b08005
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA DQ1PU
UT WOS:000378973700022
PM 27294434
DA 2018-10-19
ER

PT J
AU Dinjaski, N
   Kaplan, DL
AF Dinjaski, Nina
   Kaplan, David L.
TI Recombinant protein blends: silk beyond natural design
SO CURRENT OPINION IN BIOTECHNOLOGY
LA English
DT Review
ID SPIDER DRAGLINE SILK; ELASTIN-LIKE PROTEIN; ESCHERICHIA-COLI;
   BIOMATERIALS; NANOPARTICLES; TROPOELASTIN; EXPRESSION; POLYMERS;
   COLLAGEN; CONSTRUCTION
AB Recombinant DNA technology and new material concepts are shaping future directions in biomaterial science for the design and production of the next-generation biomaterial platforms. Aside from conventionally used synthetic polymers, numerous natural biopolymers (e.g., silk, elastin, collagen, gelatin, alginate, cellulose, keratin, chitin, polyhydroxyalkanoates) have been investigated for properties and manipulation via bioengineering. Genetic engineering provides a path to increase structural and functional complexity of these biopolymers, and thereby expand the catalog of available biomaterials beyond that which exists in nature. In addition, the integration of experimental approaches with computational modeling to analyze sequence-structure-function relationships is starting to have an impact in the field by establishing predictive frameworks for determining material properties. Herein, we review advances in recombinant DNA mediated protein production and functionalization approaches, with a focus on hybrids or combinations of proteins; recombinant protein blends or 'ecombinamers'. We highlight the potential biomedical applications of fibrous protein recombinamers, such as Silk-Elastin Like Polypeptides (SELPs) and Silk-Bacterial Collagens (SBCs). We also discuss the possibility for the rationale design of fibrous proteins to build smart, stimuli-responsive biomaterials for diverse applications. We underline current limitations with production systems for these proteins and discuss the main trends in systems/synthetic biology that may improve recombinant fibrous protein design and production.
C1 [Dinjaski, Nina; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM David.Kaplan@tufts.edu
FU NIH [P41 EB002520]; AFOSR; NSF IGERT program
FX We thank the NIH (P41 EB002520), the AFOSR and the NSF IGERT program for
   support of this work.
CR An B., 2014, FRONT CHEM, V2, P1
   An B, 2013, BIOMATERIALS, V34, P402, DOI 10.1016/j.biomaterials.2012.09.085
   BEDELLHOGAN D, 1993, J BIOL CHEM, V268, P10345
   Bracalello A, 2011, BIOMACROMOLECULES, V12, P2957, DOI 10.1021/bm2005388
   CANDELAS GC, 1990, DEV BIOL, V140, P215, DOI 10.1016/0012-1606(90)90069-U
   Rodrikuez-Cabello JC, 2006, NANOMEDICINE-UK, V1, P267, DOI 10.2217/17435889.1.3.267
   Caves JM, 2010, BIOMATERIALS, V31, P7175, DOI 10.1016/j.biomaterials.2010.05.014
   Collins T, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-21
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   FAZIO MJ, 1988, J INVEST DERMATOL, V91, P458, DOI 10.1111/1523-1747.ep12476591
   Floss DM, 2010, TRENDS BIOTECHNOL, V28, P37, DOI 10.1016/j.tibtech.2009.10.004
   Gomes S, 2012, PROG POLYM SCI, V37, P1, DOI 10.1016/j.progpolymsci.2011.07.003
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Gronau G, 2012, BIOMATERIALS, V33, P8240, DOI 10.1016/j.biomaterials.2012.06.054
   Gyorgy A, 2015, BIOPHYS J, V109, P639, DOI 10.1016/j.bpj.2015.06.034
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Hossainy S, 2012, Methods and Compositions for Treating Tissue Using Silk Proteins, Patent No. [US 20130251764 A1, 20130251764]
   Hu XA, 2010, BIOMATERIALS, V31, P8121, DOI 10.1016/j.biomaterials.2010.07.044
   Huang J, 2007, BIOMATERIALS, V28, P2358, DOI 10.1016/j.biomaterials.2006.11.021
   Huemmerich D, 2004, CURR BIOL, V14, P2070, DOI 10.1016/j.cub.2004.11.005
   Hunag W, 2015, EXPERT OPIN DRUG DEL, V12, P779
   Kaplan DL, 2002, ADV DRUG DELIV REV, V54, P1131, DOI DOI 10.1016/S0169-409X(02)00061-3
   Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775
   Kumar VA, 2014, BIOMED MATER, V9, P1
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   LEHRACH H, 1978, P NATL ACAD SCI USA, V75, P5417, DOI 10.1073/pnas.75.11.5417
   Lin YA, 2014, LANGMUIR, V30, P4406, DOI 10.1021/la403559t
   Machado R, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-11
   MacKay JA, 2009, NAT MATER, V8, P993, DOI [10.1038/NMAT2569, 10.1038/nmat2569]
   MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M
   McDaniel JR, 2013, ANGEW CHEM INT EDIT, V52, P1683, DOI 10.1002/anie.201200899
   Megeed Z, 2002, ADV DRUG DELIVER REV, V54, P1075, DOI 10.1016/S0169-409X(02)00063-7
   Patwardhan SV, 2006, P NATL ACAD SCI USA, V103, P9428
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Qiu WG, 2010, BIOMACROMOLECULES, V11, P3219, DOI 10.1021/bm100469w
   Rabotyagova OS, 2009, BIOMACROMOLECULES, V10, P229, DOI 10.1021/bm800930x
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   SOBEL ME, 1978, J BIOL CHEM, V75, P5846
   Spiess K, 2010, MACROMOL BIOSCI, V10, P998, DOI 10.1002/mabi.201000071
   Tillinghast EK, 1977, J EXP ZOOL, V202, P2113
   Tokareva O, 2013, MICROB BIOTECHNOL, V6, P651, DOI 10.1111/1751-7915.12081
   Tokareva OS, 2014, J BIOMED MATER RES B, V103, P1390
   Wang Q, 2014, ADV FUNCT MATER, V24, P4303, DOI 10.1002/adfm.201304106
   Widmaier DM, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.62
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Xia X-X, 2011, BIOMACROMOLECULES, V12, P3844
   Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107
   Xu LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050227
NR 49
TC 16
Z9 16
U1 6
U2 83
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0958-1669
EI 1879-0429
J9 CURR OPIN BIOTECH
JI Curr. Opin. Biotechnol.
PD JUN
PY 2016
VL 39
BP 1
EP 7
DI 10.1016/j.copbio.2015.11.002
PG 7
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA DP5VI
UT WOS:000378565700003
PM 26686863
OA Other Gold
DA 2018-10-19
ER

PT J
AU Ning, RZ
   Wang, F
   Lin, L
AF Ning, Ruizhi
   Wang, Feng
   Lin, Ling
TI Biomaterial-based microfluidics for cell culture and analysis
SO TRAC-TRENDS IN ANALYTICAL CHEMISTRY
LA English
DT Review
DE Biomaterials; Microfluidic; Cell culture; Organ on chip; Cell
   observation; Cell analysis
ID ON-A-CHIP; IN-VITRO; MASS-SPECTROMETRY; STEM-CELLS; SURFACE
   MODIFICATION; CYTOTOXICITY ASSAY; PROTEIN ADSORPTION; SOFT LITHOGRAPHY;
   TUMOR-CELLS; FABRICATION
AB To make microfluidics more functional and sensitive for biological applications, biomaterials for chip organization and function are key factors that can be controlled. Biomaterials used in microfluidics were found to be more diverse, complicated, and integrated, which were gradually replaced with polymers. Previously, microfluidics involved chemical and biological microanalysis, including biomolecular analysis. We believe that biomaterial-based microplatforms will be used for cell culture and analysis in vitro in future, thus revolutionizing biology and medicine research and applications. In this review, we first describe commonly used biomaterials in microfluidic construction. Then, biomaterials for two-dimensional (2D) and three-dimensional (3D) cell culture on chip, as well as organ-on-chip mimicking, are elaborated. Finally, based on cell observation and analysis, biomaterials with higher sensitivity are selected. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Ning, Ruizhi; Wang, Feng; Lin, Ling] Beijing Univ Chem Technol, State Key Lab Chem Resource Engn, Beijing 100029, Peoples R China.
   [Lin, Ling] Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
RP Lin, L (reprint author), Beijing Univ Chem Technol, State Key Lab Chem Resource Engn, Beijing 100029, Peoples R China.; Lin, L (reprint author), Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
EM lin@icl.t.u-tokyo.ac.jp
FU National Natural Science Foundation of China [51125007]
FX This work was supported by National Natural Science Foundation of China
   (No. 51125007).
CR Agarwal A, 2013, LAB CHIP, V13, P3599, DOI 10.1039/c3lc50350j
   Alessandri K, 2013, P NATL ACAD SCI USA, V110, P14843, DOI 10.1073/pnas.1309482110
   Annabi N, 2013, LAB CHIP, V13, P3569, DOI 10.1039/c3lc50252j
   Bartalena G, 2012, SOFT MATTER, V8, P673, DOI 10.1039/c1sm06250f
   Battle KN, 2014, ANALYST, V139, P1355, DOI 10.1039/c3an02400h
   Biju V, 2014, CHEM SOC REV, V43, P744, DOI 10.1039/c3cs60273g
   Bodas D, 2007, SENSOR ACTUAT B-CHEM, V123, P368, DOI 10.1016/j.snb.2006.08.037
   Booth R, 2012, LAB CHIP, V12, P1784, DOI 10.1039/c2lc40094d
   Caron MMJ, 2012, OSTEOARTHR CARTILAGE, V20, P1170, DOI 10.1016/j.joca.2012.06.016
   Chandrasekaran S, 2011, BIOMATERIALS, V32, P7159, DOI 10.1016/j.biomaterials.2011.06.013
   Chen QS, 2013, SCI REP-UK, V3, DOI 10.1038/srep02433
   Chen QS, 2012, LAB CHIP, V12, P5180, DOI 10.1039/c2lc40858a
   Chung S, 2009, ADV MATER, V21, P4863, DOI 10.1002/adma.200901727
   Dochow S, 2013, ANAL BIOANAL CHEM, V405, P2743, DOI 10.1007/s00216-013-6726-3
   Ertl P, 2014, TRENDS BIOTECHNOL, V32, P245, DOI 10.1016/j.tibtech.2014.03.004
   Gao D, 2013, LAB CHIP, V13, P978, DOI 10.1039/c2lc41215b
   Gao D, 2012, ANAL CHEM, V84, P9230, DOI 10.1021/ac301966c
   Gao D, 2010, ANAL CHIM ACTA, V665, P7, DOI 10.1016/j.aca.2010.03.015
   He QH, 2013, ANAL CHEM, V85, P1327, DOI 10.1021/ac303138x
   He XW, 2014, TRAC-TREND ANAL CHEM, V53, P84, DOI 10.1016/j.trac.2013.09.013
   Henrich D, 2013, MEDIAT INFLAMM, DOI 10.1155/2013/364591
   Hong S, 2012, INTEGR BIOL-UK, V4, P374, DOI 10.1039/c2ib00166g
   Hua X, 2013, ANAL CHIM ACTA, V788, P135, DOI 10.1016/j.aca.2013.06.001
   Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302
   Jung YD, 2014, J MATER CHEM B, V2, P4922, DOI 10.1039/c4tb00476k
   Kang E, 2010, LAB CHIP, V10, P2651, DOI [10.1039/c0lc00005a, 10.1039/c01c00005a]
   Kim C, 2012, LAB CHIP, V12, P2942, DOI 10.1039/c2lc40182g
   Kothapalli CR, 2011, LAB CHIP, V11, P497, DOI [10.1039/c0lc00240b, 10.1039/c01c00240b]
   Kuddannaya S, 2013, ACS APPL MATER INTER, V5, P9777, DOI 10.1021/am402903e
   Larsen EKU, 2013, LAB CHIP, V13, P669, DOI 10.1039/c2lc40750g
   Lee JW, 2013, MOL BIOSYST, V9, P1004, DOI 10.1039/c2mb25431j
   Lee KH, 2014, J BIOMED MATER RES A, V102, P1164, DOI 10.1002/jbm.a.34772
   Lee SA, 2013, LAB CHIP, V13, P3529, DOI 10.1039/c3lc50197c
   Lei KF, 2014, BIOSENS BIOELECTRON, V51, P16, DOI 10.1016/j.bios.2013.07.031
   Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031
   Li Q, 2014, TRAC-TREND ANAL CHEM, V58, P130, DOI 10.1016/j.trac.2014.03.007
   Lin HK, 2010, CLIN CANCER RES, V16, P5011, DOI 10.1158/1078-0432.CCR-10-1105
   Lin L, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3623412
   Lin L, 2011, ANALYST, V136, P4260, DOI 10.1039/c1an15530j
   Liu CS, 2010, ANAL CHEM, V82, P9418, DOI 10.1021/ac102094r
   Liu F, 2014, MICROCHIM ACTA, V181, P663, DOI 10.1007/s00604-014-1171-3
   Liu JJ, 2012, SCI CHINA CHEM, V55, P494, DOI 10.1007/s11426-012-4538-5
   Liu TQ, 2014, BIOMATERIALS, V35, P6060, DOI 10.1016/j.biomaterials.2014.04.047
   Liu W, 2014, ANAL CHEM, V86, P7128, DOI 10.1021/ac501678q
   Luo Y, 2012, ANAL CHEM, V84, P6731, DOI 10.1021/ac301191j
   Mack PJ, 2009, J BIOL CHEM, V284, P8412, DOI 10.1074/jbc.M804524200
   Mo XJ, 2010, BIOMATERIALS, V31, P7455, DOI 10.1016/j.biomaterials.2010.06.020
   Mogi K, 2014, SENSOR ACTUAT B-CHEM, V201, P407, DOI 10.1016/j.snb.2014.05.047
   Mu X, 2014, ANAL CHEM, V86, P5338, DOI 10.1021/ac500247f
   O'Connor RS, 2012, J IMMUNOL, V189, P1330, DOI 10.4049/jimmunol.1102757
   Onoe H, 2013, NAT MATER, V12, P584, DOI [10.1038/NMAT3606, 10.1038/nmat3606]
   Ou JJ, 2009, LAB CHIP, V9, P1926, DOI 10.1039/b821438g
   Ozaydin-Ince G, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/1/016501
   Paguirigan AL, 2008, BIOESSAYS, V30, P811, DOI 10.1002/bies.20804
   Pei Y, 2013, CELLULOSE, V20, P1897, DOI 10.1007/s10570-013-9930-6
   Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234
   Rolland JP, 2004, J AM CHEM SOC, V126, P2322, DOI 10.1021/ja031657y
   Roy E, 2011, LAB CHIP, V11, P3193, DOI 10.1039/c1lc20251k
   Sapir Y, 2011, BIOMATERIALS, V32, P1838, DOI 10.1016/j.biomaterials.2010.11.008
   Schmidt S, 2010, ADV FUNCT MATER, V20, P3235, DOI 10.1002/adfm.201000730
   Seiffert S, 2010, SOFT MATTER, V6, P3184, DOI 10.1039/c0sm00071j
   Shin Y, 2012, NAT PROTOC, V7, P1247, DOI 10.1038/nprot.2012.051
   Sun GY, 2012, J MICROELECTROMECH S, V21, P1504, DOI 10.1109/JMEMS.2012.2211574
   Sun TL, 2011, ADV MATER, V23, pH57, DOI 10.1002/adma.201004326
   Sun TL, 2004, ANGEW CHEM INT EDIT, V43, P357, DOI 10.1002/anie.200352565
   Tanzi S, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/11/115008
   TERRY SC, 1979, IEEE T ELECTRON DEV, V26, P1880, DOI 10.1109/T-ED.1979.19791
   Vu TT, 2014, SENSOR ACTUAT B-CHEM, V196, P64, DOI 10.1016/j.snb.2014.01.085
   Thuo MM, 2014, CHEM MATER, V26, P4230, DOI 10.1021/cm501596s
   Tsougeni K, 2012, SENSOR ACTUAT B-CHEM, V161, P216, DOI 10.1016/j.snb.2011.10.022
   van Midwoud PM, 2012, ANAL CHEM, V84, P3938, DOI 10.1021/ac300771z
   Wang J, 2010, LAB CHIP, V10, P1993, DOI 10.1039/c003264f
   Weltin A, 2014, LAB CHIP, V14, P138, DOI 10.1039/c3lc50759a
   Wu DP, 2006, LAB CHIP, V6, P942, DOI 10.1039/b600765a
   Wu J, 2013, LAB CHIP, V13, P1948, DOI 10.1039/c3lc00041a
   Wu J, 2012, LAB CHIP, V12, P3474, DOI 10.1039/c2lc40502d
   Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/nmat3101, 10.1038/NMAT3101]
   Xiao Y, 2014, LAB CHIP, V14, P869, DOI 10.1039/c3lc51123e
   Yakovleva J, 2002, ANAL CHEM, V74, P2994, DOI 10.1021/ac015645b
   Yang DM, 2013, CHEM-EUR J, V19, P2685, DOI 10.1002/chem.201203634
   Yoshii Y, 2011, BIOMATERIALS, V32, P6052, DOI 10.1016/j.biomaterials.2011.04.076
   You JB, 2013, LAB CHIP, V13, P1266, DOI 10.1039/c2lc41266g
   Yu JH, 2011, LAB CHIP, V11, P1286, DOI 10.1039/c0lc00524j
   Zhang L, 2015, RSC ADV, V5, P5638, DOI 10.1039/c4ra15907a
   Zhang YD, 2014, SCI CHINA CHEM, V57, P442, DOI 10.1007/s11426-013-4960-3
   Zhang YR, 2011, ANAL CHEM, V83, P9651, DOI 10.1021/ac202517x
   Zheng CF, 2012, BIOMATERIALS, V33, P5603, DOI 10.1016/j.biomaterials.2012.04.044
   Zhou JW, 2010, ELECTROPHORESIS, V31, P2, DOI 10.1002/elps.200900475
NR 88
TC 9
Z9 11
U1 5
U2 47
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0165-9936
EI 1879-3142
J9 TRAC-TREND ANAL CHEM
JI Trac-Trends Anal. Chem.
PD JUN
PY 2016
VL 80
BP 255
EP 265
DI 10.1016/j.trac.2015.08.017
PG 11
WC Chemistry, Analytical
SC Chemistry
GA DP4EW
UT WOS:000378450000021
DA 2018-10-19
ER

PT J
AU Huang, CJ
   Zhao, LX
   Gu, J
   Nie, DK
   Chen, YN
   Zuo, H
   Huan, W
   Shi, JL
   Chen, J
   Shi, W
AF Huang, Chuanjun
   Zhao, Longxiang
   Gu, Jun
   Nie, Dekang
   Chen, Yinan
   Zuo, Hao
   Huan, Wei
   Shi, Jinlong
   Chen, Jian
   Shi, Wei
TI The migration and differentiation of hUC-MSCsCXCR4/GFP encapsulated in
   BDNF/chitosan scaffolds for brain tissue engineering
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE traumatic brain injury; hUC-MSCs; CXCR4/SDF-1 alpha axis; migration;
   neuronal differentiation
ID MESENCHYMAL STEM-CELLS; BONE-MARROW; IN-VITRO; INJURY; THERAPY;
   TRAFFICKING; EXPRESSION; MODEL; MICE
AB We previously developed a biomaterial scaffold that could effectively provide seed cells to a lesion cavity resulting from traumatic brain injury. However, we subsequently found that few transplanted human umbilical cord mesenchymal stem cells (hUC-MSCs) are able to migrate from the scaffold to the lesion boundary. Stromal derived-cell factor-1 alpha and its receptor chemokine (C-X-C motif) receptor (CXCR) 4 are chemotactic factors that control cell migration and stem cell recruitment to target areas. Given the low expression level of CXCR4 on the hUC-MSC membrane, lentiviral vectors were used to generate hUC-MSCs stably expressing CXCR4 fused to green fluorescent protein (GFP) (hUC-MSCsCXCR4/GFP). We constructed a scaffold in which recombinant human brain-derived neurotrophic factor (BDNF) was linked to chitosan scaffolds with the crosslinking agent genipin (CGB scaffold). The scaffold containing hUC-MSCsCXCR4/GFP was transplanted into the lesion cavity of a rat brain, providing exogenous hUC-MSCs to both lesion boundary and cavity. These results demonstrate a novel strategy for inducing tissue regeneration after traumatic brain injury.
C1 [Huang, Chuanjun; Zhao, Longxiang; Gu, Jun; Chen, Yinan; Zuo, Hao; Huan, Wei; Shi, Jinlong; Chen, Jian; Shi, Wei] Nantong Univ, Affiliated Hosp, Dept Neurosurg, Nantong, Peoples R China.
   [Nie, Dekang] Nantong Univ, Affiliated Hosp 4, Dept Neurosurg, YanCheng City Peoples Hosp 1, Yancheng, Peoples R China.
RP Shi, W (reprint author), Nantong Univ, Affiliated Hosp, Dept Neurosurg, Nantong, Peoples R China.
EM ntshiwei123@163.com
FU National Nature Science Foundation of China [81271368]; Natural Science
   Foundation of Jiangsu Province [BK2012654]
FX The authors thank the Surgical Comprehensive Laboratory at the
   Affiliated Hospital of Nantong University for technical assistance and
   equipment support. This work was supported by the National Nature
   Science Foundation of China (grant no. 81271368) and the Natural Science
   Foundation of Jiangsu Province (grant no. BK2012654).
CR Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A
   Brooke G, 2008, STEM CELLS DEV, V17, P929, DOI 10.1089/scd.2007.0156
   Cao ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082949
   Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075
   Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197
   Dazzi F, 2007, CURR OPIN ONCOL, V19, P650, DOI 10.1097/CCO.0b013e3282f0e116
   Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047
   Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102
   Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415
   Jiang QS, 2011, CHINESE MED J-PEKING, V124, P1540, DOI 10.3760/cma.j.issn.0366-6999.2011.10.019
   Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667
   Keilhoff G, 2006, CELL MOL NEUROBIOL, V26, P1235, DOI 10.1007/s10571-006-9029-9
   Kim Ju-Yeon, 2010, World J Stem Cells, V2, P34, DOI 10.4252/wjsc.v2.i2.34
   Lee JH, 2011, J NEUROL SCI, V300, P86, DOI 10.1016/j.jns.2010.09.025
   Liang J, 2013, NEUROSCI LETT, V532, P59, DOI 10.1016/j.neulet.2012.11.014
   Lim JY, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt79
   Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9
   Maegele M, 2008, MINIM INVASIV THER, V17, P119, DOI 10.1080/13645700801970087
   McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000
   Murphy JM, 2003, ARTHRITIS RHEUM, V48, P3464, DOI 10.1002/art.11365
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Qiu YY, 2012, CYTOTHERAPY, V14, P285, DOI 10.3109/14653249.2011.651532
   Qu C, 2012, BRAIN RES, V1371, P129
   Shi M, 2007, HAEMATOL-HEMATOL J, V92, P897, DOI 10.3324/haematol.10669
   Shi W, 2012, BIOMATERIALS, V33, P3119, DOI 10.1016/j.biomaterials.2012.01.009
   Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271
   Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood2004-09-3507
   Wang KZ, 2014, FLEX SERV MANUF J, V26, P387, DOI 10.1007/s10696-012-9153-4
NR 28
TC 2
Z9 2
U1 2
U2 8
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2016
VL 11
IS 3
DI 10.1088/1748-6041/11/3/035004
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DP0GQ
UT WOS:000378167700005
PM 27147644
OA Other Gold
DA 2018-10-19
ER

PT J
AU Im, BJ
   Lee, SC
   Lee, MH
   Leesungbok, R
   Ahn, SJ
   Kang, YG
   Lee, DY
   Yoon, JH
   Lee, SW
AF Im, Byung-Jin
   Lee, Sang Cheon
   Lee, Myung-Hyun
   Leesungbok, Richard
   Ahn, Su-Jin
   Kang, Yoon-Goo
   Lee, Do Yun
   Yoon, Joon-Ho
   Lee, Suk Won
TI Promotion of osteoblastic differentiation and osteogenic transcription
   factor expression on a microgroove titanium surface with immobilized
   fibronectin or bone sialoprotein II
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE microgrooves; matrix protein immobilization; fibronectin; bone
   sialoprotein II; osteoblastic differentiation; osteogenic transcription
   factors
ID HUMAN GINGIVAL FIBROBLASTS; HUMAN PRIMARY-CELLS; IN-VITRO;
   QUANTITATIVE-ANALYSIS; ETCHED MICROGROOVES; STEM-CELLS; SUBSTRATA;
   PROLIFERATION; PROTEINS; ADHESION
AB We demonstrate that a composite surface of microgroove titanium (Ti) with immobilized fibronectin (FN) or bone sialoprotein II (BSP2) promotes osteoblastic differentiation and osteogenic transcription factor expression in human bone marrow-derived mesenchymal stem cells (MSCs). Comparisons made between smooth microgrooves, microgrooves with silanization and microgrooves with matrix protein (FN or BSP2)-immobilization Ti surfaces revealed a significant promotion of in vitro osteogenic activity and osteoblastic differentiation at various timelines of culture. An even more significant increase was verified on microgrooves with a matrix protein-immobilization Ti surface in 28 d time-dependent gene expression of the main osteogenic transcription factors, such as ARF4, FRA1, RUNX2, and OSX. As a result, a synergestic effect regarding the promotion of osteogenic transcription factor expression and osteoblastic differentiation in the matrix protein-microgroove Ti composite surface was confirmed. From a multiple regression analysis using various timelines of osteogenic culture as independent variables, day 13 was verified as the most prominent influential timeline for the promotion of osteoblastic differentiation induced by the matrix protein-microgroove Ti composite surface. The FN-or BSP2-microgroove Ti composite surface resulting from silanization can strongly induce the promotion of osteoblastic differentiation in human MSCs. The proposed surface is expected to be useful in the development of a variety of osteogenic biomaterial surfaces.
C1 [Im, Byung-Jin] Kyung Hee Univ, Grad Sch, Dept Dent, Seoul 02447, South Korea.
   [Lee, Sang Cheon] Kyung Hee Univ, Dept Maxillofacial Biomed Engn, Seoul 02447, South Korea.
   [Lee, Sang Cheon] Kyung Hee Univ, Sch Dent, Inst Oral Biol, Seoul 02447, South Korea.
   [Lee, Myung-Hyun] Korea Inst Ceram Engn & Technol, Div Energy & Environm, Jinju 660031, Gyeongsangnam D, South Korea.
   [Leesungbok, Richard; Ahn, Su-Jin; Lee, Suk Won] Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Dept Biomat & Prosthodont, Inst Oral Biol,Sch Dent, Seoul 05278, South Korea.
   [Kang, Yoon-Goo] Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Inst Oral Biol, Sch Dent,Dept Orthodont, Seoul 05278, South Korea.
   [Lee, Do Yun] ED Dent Clin, Seoul 08310, South Korea.
   [Yoon, Joon-Ho] Ilsan Hosp, Natl Hlth Insurance Med Ctr, Dept Prosthodont, Goyang 10444, Gyeonggi Do, South Korea.
RP Lee, SW (reprint author), Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Dept Biomat & Prosthodont, Inst Oral Biol,Sch Dent, Seoul 05278, South Korea.
EM ysprosth@hanmail.net
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Education, Republic of Korea
   [NRF-2015R1D1A1A01057956]
FX This research was supported by the Basic Science Research Program
   through the National Research Foundation of Korea (NRF) funded by the
   Ministry of Education, Republic of Korea (NRF-2015R1D1A1A01057956).
CR Chatakun P, 2014, CELL MOL LIFE SCI, V71, P113, DOI 10.1007/s00018-013-1326-0
   CHEHROUDI B, 1992, CELL MATER, V2, P89
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   denBraber ET, 1996, BIOMATERIALS, V17, P2037, DOI 10.1016/0142-9612(96)00032-4
   Eferl R, 2004, EMBO J, V23, P2789, DOI 10.1038/sj.emboj.7600282
   ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102
   Fujisawa R, 2012, FRONT BIOSCI-LANDMRK, V17, P1891, DOI 10.2741/4026
   Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401
   Godoy-Gallardo M, 2016, MAT SCI ENG C-MATER, V59, P524, DOI 10.1016/j.msec.2015.10.051
   Hilbig H, 2007, EUR J MED RES, V12, P6
   Im BJ, 2012, ARCH ORAL BIOL, V57, P898, DOI 10.1016/j.archoralbio.2011.11.013
   Jimbo R, 2007, BIOMATERIALS, V28, P3469, DOI 10.1016/j.biomaterials.2007.04.029
   Kim SY, 2014, BIOMED RES INT, DOI 10.1155/2014/452175
   Kim SY, 2009, CLIN ORAL IMPLAN RES, V20, P262, DOI 10.1111/j.1600-0501.2008.01652.x
   Kim SE, 2010, TISSUE ENG REGEN MED, V7, P202
   Koo KT, 2014, CLIN ORAL IMPLAN RES, V25, P714, DOI 10.1111/clr.12131
   Lee MH, 2013, ARCH ORAL BIOL, V58, P59, DOI 10.1016/j.archoralbio.2012.05.010
   Lee MH, 2012, BIOMATERIALS, V33, P3216, DOI 10.1016/j.biomaterials.2012.01.034
   Lee MH, 2010, TISSUE ENG REGEN MED, V7, P501
   Lee MH, 2010, BIOMATERIALS, V31, P3804, DOI 10.1016/j.biomaterials.2010.01.117
   Lee S W, 2007, J KOREAN ACAD PROSTH, V45, P787
   Lee SW, 2015, COLLOID SURFACE B, V135, P565, DOI 10.1016/j.colsurfb.2015.08.011
   Lee SW, 2012, TISSUE ENG REGEN MED, V9, P75, DOI 10.1007/s13770-012-0020-x
   Lee SW, 2012, J ORAL IMPLANTOL, V38, P11, DOI 10.1563/AAID-JOI-D-09-00144.1
   Lee SW, 2009, CLIN ORAL IMPLAN RES, V20, P458, DOI 10.1111/j.1600-0501.2008.01671.x
   Lee SW, 2009, CLIN ORAL IMPLAN RES, V20, P56, DOI 10.1111/j.1600-0501.2008.01597.x
   Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001
   Malaval L, 2008, J EXP MED, V205, P1145, DOI 10.1084/jem.20071294
   Middleton CA, 2007, J BIOMED MATER RES A, V83A, P1032, DOI 10.1002/jbm.a.31382
   Mould AP, 1997, J BIOL CHEM, V272, P17283, DOI 10.1074/jbc.272.28.17283
   Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   O'Toole GC, 2004, J ORTHOPAED RES, V22, P641, DOI 10.1016/j.orthres.2003.09.005
   Park JA, 2010, J ADV PROSTHODONT, V2, P18, DOI [10.4047/jap.2010.2.1.18, 10.4047/jap.2010.2.18-24]
   Park SJ, 2015, J ADV PROSTHODONT, V7, P496, DOI 10.4047/jap.2015.7.6.496
   Perizzolo D, 2001, J BIOMED MATER RES, V56, P494, DOI 10.1002/1097-4636(20010915)56:4<494::AID-JBM1121>3.0.CO;2-X
   Qu J, 1996, Oral Dis, V2, P102
   Seo Jin-Ho, 2015, [The Journal of Korean Academy of Prosthodontics, 대한치과보철학회지], V53, P198, DOI 10.4047/jkap.2015.53.3.198
   Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7
NR 39
TC 0
Z9 0
U1 3
U2 9
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2016
VL 11
IS 3
DI 10.1088/1748-6041/11/3/035020
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DP0GQ
UT WOS:000378167700021
PM 27327854
DA 2018-10-19
ER

PT J
AU Kang, MH
   Jang, TS
   Jung, HD
   Kim, SM
   Kim, HE
   Koh, YH
   Song, J
AF Kang, Min-Ho
   Jang, Tae-Sik
   Jung, Hyun-Do
   Kim, Sae-Mi
   Kim, Hyoun-Ee
   Koh, Young-Hag
   Song, Juha
TI Poly(ether imide)-silica hybrid coatings for tunable corrosion behavior
   and improved biocompatibility of magnesium implants
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE hybrid coating; silica; biodegradation; corrosion resistance; magnesium;
   hard tissue engineering
ID IN-VIVO CORROSION; GUIDED BONE REGENERATION; ORTHOPEDIC APPLICATIONS;
   BIOMEDICAL APPLICATIONS; ALLOYS; HYDROXYAPATITE; RESISTANCE; VITRO;
   AZ31; MG
AB Magnesium (Mg) and its alloys have gained considerable attention as a promising biomaterial for bioresorbable orthopedic implants, but the corrosion behavior of Mg-based implants is still the major issue for clinical use. In order to improve the corrosion stability and implant-tissue interfaces of these implants, methods for coating Mg have been actively investigated. In this study, poly(ether imide) (PEI)silica hybrid material was coated on Mg, for the tunable degradation and enhanced biological behavior. Homogeneous PEI-silica hybrid materials with various silica contents were coated on Mg substrates without any cracks, where silica nanoparticles were well dispersed in the PEI matrix without significant particle agglomeration up the 30 vol% silica. The hybrid coatings maintained good adhesion strength of PEI to Mg. The corrosion rate of hybrid-coated Mg was increased along with the increment of the silica content, due to improved hydrophilicity of the hybrid coating layers. Moreover, the biocompatibility of the hybrid-coated Mg specimens was significantly improved, mainly due to the higher Mg ion concentrations associated with faster corrosion, compared to PEI-coated Mg. Therefore, PEI-silica hybrid systems have significant potential as a coating material of Mg for load-bearing orthopedic applications by providing tunable corrosion behavior and enhanced biological performance.
C1 [Kang, Min-Ho; Jang, Tae-Sik; Kim, Sae-Mi; Kim, Hyoun-Ee; Song, Juha] Seoul Natl Univ, Dept Mat Sci & Engn, Seoul 151742, South Korea.
   [Kim, Hyoun-Ee; Song, Juha] Seoul Natl Univ, Adv Inst Convergence Technol, Suwon 443270, South Korea.
   [Koh, Young-Hag] Korea Univ, Sch Biomed Engn, Seoul 136703, South Korea.
   [Jung, Hyun-Do] Korea Inst Ind Technol, Liquid Proc & Casting Technol R&D Grp, Inchon 406840, South Korea.
   [Song, Juha] Nanyang Technol Univ, Sch Chem & Biomed Engn, 70 Nanyang Dr, Singapore 637457, Singapore.
RP Song, J (reprint author), Seoul Natl Univ, Dept Mat Sci & Engn, Seoul 151742, South Korea.; Song, J (reprint author), Seoul Natl Univ, Adv Inst Convergence Technol, Suwon 443270, South Korea.; Song, J (reprint author), Nanyang Technol Univ, Sch Chem & Biomed Engn, 70 Nanyang Dr, Singapore 637457, Singapore.
EM songjuha@ntu.edu.sg
RI Song, Juha/P-1927-2017
OI Song, Juha/0000-0002-3503-680X
FU Young Researcher Program [2015R1C1A2A01056113]; National Research
   Foundation of Korea; Industrial Strategic Technology Development Program
   [10045329]; Ministry of Trade, Industry & Energy (MI, Korea)
FX This research was supported by the Young Researcher Program (Contract
   grant No. 2015R1C1A2A01056113), funded by National Research Foundation
   of Korea, Minister of Science, ICT and Future Planning (MSIP, Korea),
   and the Industrial Strategic Technology Development Program (Contract
   grant No. 10045329, Development of customized implant with porous
   structure for bone replacement), funded by the Ministry of Trade,
   Industry & Energy (MI, Korea).
CR Abdal-hay A, 2013, CERAM INT, V39, P183, DOI 10.1016/j.ceramint.2012.06.008
   Abdal-Hay A, 2012, APPL SURF SCI, V261, P536, DOI 10.1016/j.apsusc.2012.08.051
   Birbilis N, 2009, CORROS SCI, V51, P683, DOI 10.1016/j.corsci.2008.12.012
   Chen YJ, 2014, ACTA BIOMATER, V10, P4561, DOI 10.1016/j.actbio.2014.07.005
   Conceicao TF, 2010, CORROS SCI, V52, P2066, DOI 10.1016/j.corsci.2010.02.027
   da Conceicao TF, 2011, CORROS SCI, V53, P338, DOI 10.1016/j.corsci.2010.09.040
   Diez M, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-015-5643-8
   Du J, 2015, J BIOMECH, V48, P3486, DOI 10.1016/j.jbiomech.2015.05.014
   Garcia-Gareta E, 2015, BONE, V81, P112, DOI 10.1016/j.bone.2015.07.007
   Ghali E, 2013, J MATER ENG PERFORM, V22, P2875, DOI 10.1007/s11665-013-0730-9
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Hahn BD, 2011, SURF COAT TECH, V205, P3112, DOI 10.1016/j.surfcoat.2010.11.029
   Jang TS, 2012, J BIOMED MATER RES B, V100B, P321, DOI 10.1002/jbm.b.31952
   Jeong H, 2015, SURF COAT TECH, V284, P26, DOI 10.1016/j.surfcoat.2015.10.039
   Jo JH, 2013, J BIOMATER APPL, V28, P617, DOI 10.1177/0885328212468921
   Jo JH, 2012, J BIOMATER APPL, V27, P469, DOI 10.1177/0885328211412633
   Jo JH, 2011, J MATER SCI-MATER M, V22, P2437, DOI 10.1007/s10856-011-4431-3
   Johnson I, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/37/375103
   Jun SH, 2011, J MATER SCI-MATER M, V22, P2757, DOI 10.1007/s10856-011-4458-5
   Jun SH, 2010, ACTA BIOMATER, V6, P302, DOI 10.1016/j.actbio.2009.06.024
   Kim SM, 2014, J BIOMED MATER RES A, V102, P429, DOI 10.1002/jbm.a.34718
   Kim SB, 2013, J BIOMED MATER RES A, V101, P1708, DOI 10.1002/jbm.a.34474
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Lee EJ, 2009, BIOMATERIALS, V30, P743, DOI 10.1016/j.biomaterials.2008.10.025
   Pan YK, 2012, J BIOMED MATER RES B, V100B, P1574, DOI 10.1002/jbm.b.32726
   Pezzato L, 2015, APPL SURF SCI, V357, P1031, DOI 10.1016/j.apsusc.2015.09.107
   Razavi M, 2015, MAT SCI ENG C-MATER, V48, P21, DOI 10.1016/j.msec.2014.11.020
   Romero AI, 2011, J MATER SCI, V46, P4701, DOI 10.1007/s10853-011-5380-4
   Sanchez AHM, 2015, ACTA BIOMATER, V13, P16, DOI 10.1016/j.actbio.2014.11.048
   Scharnagl N, 2009, SURF COAT TECH, V203, P1423, DOI 10.1016/j.surfcoat.2008.11.018
   Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N
   Staiger M P, 2006, BIOMATERIALS, V27, P728
   Vojtech D, 2011, ACTA BIOMATER, V7, P3515, DOI 10.1016/j.actbio.2011.05.008
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Xu LP, 2012, COLLOID SURFACE B, V93, P67, DOI 10.1016/j.colsurfb.2011.12.009
   Zomorodian A, 2013, ACTA BIOMATER, V9, P8660, DOI 10.1016/j.actbio.2013.02.036
NR 37
TC 7
Z9 8
U1 2
U2 31
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2016
VL 11
IS 3
DI 10.1088/1748-6041/11/3/035003
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DP0GQ
UT WOS:000378167700004
PM 27147643
DA 2018-10-19
ER

PT J
AU Smink, AM
   de Haan, BJ
   Paredes-Juarez, GA
   Wolters, AHG
   Kuipers, J
   Giepmans, BNG
   Schwab, L
   Engelse, MA
   van Apeldoorn, AA
   de Koning, E
   Faas, MM
   de Vos, P
AF Smink, Alexandra M.
   de Haan, Bart J.
   Paredes-Juarez, Genaro A.
   Wolters, Anouk H. G.
   Kuipers, Jeroen
   Giepmans, Ben N. G.
   Schwab, Leendert
   Engelse, Marten A.
   van Apeldoorn, Aart A.
   de Koning, Eelco
   Faas, Marijke M.
   de Vos, Paul
TI Selection of polymers for application in scaffolds applicable for human
   pancreatic islet transplantation
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE type 1 diabetes; pancreatic islet transplantation; polymeric scaffold
ID CELL ENCAPSULATION; NERVE GUIDES; MESENCHYMAL TRANSITION;
   INSULIN-SECRETION; DIABETIC MICE; SITE; RAT; TISSUE; REGENERATION;
   IMPROVEMENT
AB The liver is currently the site for transplantation of islets in humans. This is not optimal for islets, but alternative sites in humans are not available. Polymeric scaffolds in surgically accessible areas are a solution. As human donors are rare, the polymers should not interfere with functional survival of human-islets. We applied a novel platform to test the adequacy of polymers for application in scaffolds for human-islet transplantation. Viability, functionality, and immune parameters were included to test poly(D, L-lactide-co-epsilon-caprolactone) (PDLLCL), poly(ethylene oxide terephthalate)/polybutylene terephthalate (PEOT/PBT) block copolymer, and polysulfone.
   The type of polymer influenced the functional survival of human islets. In islets cultured on PDLLCL the glucagon-producing alpha-cells and insulin-producing beta-cells contained more hormone granules than in islets in contact with PEOT/PBT or polysulfone. This was studied with ultrastructural analysis by electron microscopy (nanotomy) during 7 d of culture. PDLLCL was also associated with statistically significant lower release of double-stranded DNA (dsDNA, a so called danger-associate molecular pattern (DAMP)) from islets on PDLLCL when compared to the other polymers. DAMPs support undesired immune responses. Hydrophilicity of the polymers did not influence dsDNA release. Islets on PDLLCL also showed less cellular outgrowth. These outgrowing cells were mainly fibroblast and some beta-cells undergoing epithelial to mesenchymal cell transition. None of the polymers influenced the glucose-stimulated insulin secretion. As PDLLCL was associated with less release of DAMPs, it is a promising candidate for creating a scaffold for human islets. Our study demonstrates that for sensitive, rare cadaveric donor tissue such as pancreatic islets it might be necessary to first select materials that do not influence functionality before proposing the biomaterial for in vivo application. Our presented platform may facilitate this selection of biomaterials.
C1 [Smink, Alexandra M.; de Haan, Bart J.; Paredes-Juarez, Genaro A.; Faas, Marijke M.; de Vos, Paul] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Sect Immunoendocrinol, Hanzepl 1,EA11, NL-9700 GZ Groningen, Netherlands.
   [Wolters, Anouk H. G.; Kuipers, Jeroen; Giepmans, Ben N. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, NL-9700 GZ Groningen, Netherlands.
   [Schwab, Leendert] Polyganics, Groningen, Netherlands.
   [Engelse, Marten A.] Leiden Univ, Med Ctr, Lab Pancreat Islet Isolat, Leiden, Netherlands.
   [van Apeldoorn, Aart A.] Univ Twente, Fac Sci & Technol, Dept Dev BioEngn, POB 217, NL-7500 AE Enschede, Netherlands.
   [de Koning, Eelco] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands.
RP Smink, AM (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Sect Immunoendocrinol, Hanzepl 1,EA11, NL-9700 GZ Groningen, Netherlands.
EM A.M.SMINK@UMCG.NL
RI Giepmans, Ben/R-4564-2016; de Vos, Paul/A-3170-2013; Paredes,
   Genaro/R-6633-2016
OI Giepmans, Ben/0000-0001-5105-5915; Paredes, Genaro/0000-0002-6621-7830
FU ZonMW [91111.006]
FX This research is part of the Diabetes Cell Therapy Initiative (DCTI)
   (FES 2009 program, Dutch ministry of welfare and sports, and the Dutch
   diabetes research foundation). Nanotomy has been performed in the UMCG
   Microscopy and Imaging Center (UMIC), sponsored by ZonMW grant
   91111.006.
CR Aoki M, 1988, Nihon Naibunpi Gakkai Zasshi, V64, P109
   Balamurugan AN, 2014, AM J TRANSPLANT, V14, P2595, DOI 10.1111/ajt.12872
   Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063
   Bavamian S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041535
   Bertleff MJOE, 2005, J HAND SURG-AM, V30A, P513, DOI 10.1016/j.jhsa.2004.12.009
   Bhujbal SV, 2014, ADV DRUG DELIVER REV, V67-68, P142, DOI 10.1016/j.addr.2014.01.010
   Blomeier H, 2006, TRANSPLANTATION, V82, P452, DOI 10.1097/01.tp.0000231708.19937.21
   Buitinga M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064772
   Bulstra SK, 1996, J BONE JOINT SURG BR, V78B, P892, DOI 10.1302/0301-620X78B6.6806
   Cantarelli E, 2011, CURR DIABETES REP, V11, P364, DOI 10.1007/s11892-011-0216-9
   Carlsson PO, 2000, TRANSPLANTATION, V69, P761
   Chase LG, 2007, DIABETES, V56, P3, DOI 10.2337/db06-1165
   Cheung SC, 1997, TRANSPLANT P, V29, P2144, DOI 10.1016/S0041-1345(97)00266-2
   Daoud J, 2010, BIOMATERIALS, V31, P1676, DOI 10.1016/j.biomaterials.2009.11.057
   de Vos P, 2014, ADV DRUG DELIVER REV, V67-68, P15, DOI 10.1016/j.addr.2013.11.005
   Den Dunnen WFA, 1998, J MATER SCI-MATER M, V9, P811, DOI 10.1023/A:1008987910224
   DeVos P, 1996, DIABETES, V45, P1102, DOI 10.2337/diabetes.45.8.1102
   Dufour JM, 2005, TISSUE ENG, V11, P1323, DOI 10.1089/ten.2005.11.1323
   Eden D, 2015, DIABETOLOGIA, V58, P2563, DOI 10.1007/s00125-015-3729-y
   Evans ND, 2006, MATER TODAY, V9, P26, DOI 10.1016/S1369-7021(06)71740-0
   Figliuzzi M, 2005, BIOMATERIALS, V26, P5640, DOI 10.1016/j.biomaterials.2005.02.019
   FRITSCHY WM, 1991, TRANSPLANTATION, V52, P777, DOI 10.1097/00007890-199111000-00004
   Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968
   Hakim RM, 1996, KIDNEY INT, V50, P566, DOI 10.1038/ki.1996.350
   Harlan DM, 2009, DIABETES, V58, P2175, DOI 10.2337/db09-0476
   Hosseini-Tabatabaei A, 2015, TRANSPLANTATION, V99, P1341, DOI 10.1097/TP.0000000000000661
   Ichii H, 2005, AM J TRANSPLANT, V5, P1635, DOI 10.1111/j.1600-6143.2005.00913.x
   Ihm SH, 2006, DIABETES, V55, P1361, DOI 10.2337/005-1333
   Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003
   KAGAWA S, 1987, LIFE SCI, V41, P2241, DOI 10.1016/0024-3205(87)90522-4
   KAUFMAN DB, 1990, TRANSPLANTATION, V50, P385, DOI 10.1097/00007890-199009000-00006
   Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215
   Kuipers J, 2015, EXP CELL RES, V33, P202
   Kunstar A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0464
   Lembert N, 2005, CELL TRANSPLANT, V14, P97, DOI 10.3727/000000005783983232
   Lembert N, 2001, EXP CLIN ENDOCR DIAB, V109, P116, DOI 10.1055/s-2001-14828
   Luis AL, 2007, MICROSURG, V27, P125, DOI 10.1002/micr.20317
   Meek MF, 2008, ANN PLAS SURG, V60, P466, DOI 10.1097/SAP.0b013e31804d441c
   Meek MF, 2009, MICROSURG, V29, P473, DOI 10.1002/micr.20642
   Moberg L, 2002, LANCET, V360, P2039, DOI 10.1016/S0140-6736(02)12020-4
   Ouziel-Yahalom L, 2006, BIOCHEM BIOPH RES CO, V341, P291, DOI 10.1016/j.bbrc.2005.12.187
   Paredes-Juarez G A, 2015, SCI REP, V30, P14623
   Pepper AR, 2015, NAT BIOTECHNOL, V33, P518, DOI 10.1038/nbt.3211
   Ravelli RBG, 2013, SCI REP-UK, V3, DOI 10.1038/srep01804
   Rinastiti M, 2010, J DENT, V38, P29, DOI 10.1016/j.jdent.2009.08.009
   Rokstad AMA, 2014, ADV DRUG DELIVER REV, V67-68, P111, DOI 10.1016/j.addr.2013.07.010
   Sakkers RJB, 1998, J MATER SCI-MATER M, V9, P375, DOI 10.1023/A:1013227428530
   SCHNELL AH, 1988, CELL TISSUE RES, V252, P9
   Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267
   Shapiro AMJ, 2005, THER DRUG MONIT, V27, P35, DOI 10.1097/00007691-200502000-00008
   Smink AM, 2013, DIABETES, V62, P1357, DOI 10.2337/db12-1553
   Sokol E, 2015, J INVEST DERMATOL, V135, P1763, DOI 10.1038/jid.2015.109
   Stagner JI, 2007, J PANCREAS, V8, P628
   Svensson J, 2011, CELL TRANSPLANT, V20, P783, DOI 10.3727/096368910X536527
   Tanaka S, 2013, ENDOCR J, V60, P837, DOI 10.1507/endocrj.EJ13-0222
   Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835
   Uludag H, 2000, ADV DRUG DELIVER REV, V42, P29, DOI 10.1016/S0169-409X(00)00053-3
NR 57
TC 4
Z9 5
U1 3
U2 16
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2016
VL 11
IS 3
DI 10.1088/1748-6041/11/3/035006
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DP0GQ
UT WOS:000378167700007
PM 27173149
DA 2018-10-19
ER

PT J
AU Zhang, JJ
   Wang, J
   Zhang, H
   Lin, JH
   Ge, ZG
   Zou, XN
AF Zhang, Jingjing
   Wang, Justin
   Zhang, Hui
   Lin, Jianhao
   Ge, Zigang
   Zou, Xuenong
TI Macroporous interpenetrating network of polyethylene glycol (PEG) and
   gelatin for cartilage regeneration
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE articular cartilage; tissue engineering; interpenetrating network;
   mechanical property; macroporous hydrogel
ID POLY(ETHYLENE GLYCOL); ENGINEERED CARTILAGE; ARTICULAR-CARTILAGE;
   STEM-CELL; PORE-SIZE; HYDROGELS; TISSUE; MATRIX; SCAFFOLD; AGAROSE
AB Poor mechanical properties hinder the application of hydrogels in cartilage tissue engineering. In this study, macroporous interpenetrating network (IPN) hydrogels of gelatin and polyethylene glycol (PEG) were fabricated for use as a functional biomaterial to support chondrocyte culture. The IPN structure enhanced mechanical properties, while the macroporous structure facilitated cell-cell interactions. The hydrogels had pore sizes around 80 mu m with favorable interconnectivity, reduced volume swelling ratios, and nearly unchanged weight swelling ratios with increasing gelatin ratios. More significantly, the Young's modulus increased with increasing gelatin ratio, reaching a 5.3-fold increase (p < 0.01) in IPN-10% over that of the PEG group. Chondrocytes developed elongated and fibroblast morphologies with extensive cell-cell interaction throughout IPN hydrogels, compared with round, isolated aggregates in PEG hydrogels. The glycosaminoglycan (GAG) accumulation was significantly higher in IPN hydrogels than in PEG hydrogels at day 21 and day 28. Additionally, significantly higher gene expressions of collagen II (p < 0.01) and sox-9 (p < 0.01) were found in IPN-10% when compared with other groups. Overall, the macroporous IPN hydrogels showed strong tissue formation abilities and enhanced mechanical properties, demonstrating high potential as scaffolds for cartilage regeneration.
C1 [Zhang, Jingjing] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing 100700, Peoples R China.
   [Zhang, Jingjing; Zhang, Hui; Ge, Zigang] Peking Univ, Dept Biomed Engn, Coll Engn, Beijing 100871, Peoples R China.
   [Wang, Justin] Univ Calif Los Angeles, Dept Bioengn, Henry Samueli Sch Engn & Appl Sci, Los Angeles, CA 90024 USA.
   [Lin, Jianhao; Ge, Zigang] Peking Univ, Peoples Hosp, Arthrit Clin & Res Ctr, Beijing 100871, Peoples R China.
   [Zou, Xuenong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Spinal Surg, Orthopaed Res Inst, Guangzhou 510080, Guangdong, Peoples R China.
RP Zhang, JJ (reprint author), China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing 100700, Peoples R China.; Zhang, JJ (reprint author), Peking Univ, Dept Biomed Engn, Coll Engn, Beijing 100871, Peoples R China.
EM zjj4785@163.com; justinw555@ucla.edu; zhangh0424@qq.com;
   jianhao_lin@yahoo.com; gez@pku.edu.cn; zxnong@hotmail.com
RI GE, Zigang/E-3576-2010
OI GE, Zigang/0000-0002-5202-0973
FU National Basic Research Program of China grant (973 Program)
   [2012CB619100]; National Natural Science Foundation of China [81471800]
FX The authors would like to acknowledge the support from the National
   Basic Research Program of China grant (973 Program 2012CB619100) and the
   National Natural Science Foundation of China grant (81471800).
CR Betz MW, 2010, BIOMACROMOLECULES, V11, P1160, DOI 10.1021/bm100061z
   Bian LM, 2013, P NATL ACAD SCI USA, V110, P10117, DOI 10.1073/pnas.1214100110
   Cai W, 2014, MACROMOL MATER ENG, V299, P504
   Daniele MA, 2014, BIOMATERIALS, V35, P1845, DOI 10.1016/j.biomaterials.2013.11.009
   DeKosky BJ, 2010, TISSUE ENG PART C-ME, V16, P1533, DOI 10.1089/ten.tec.2009.0761
   Erickson IE, 2012, ACTA BIOMATER, V8, P3027, DOI 10.1016/j.actbio.2012.04.033
   Erickson IE, 2009, TISSUE ENG PT A, V15, P1041, DOI 10.1089/ten.tea.2008.0099
   Gao GF, 2015, BIOTECHNOL LETT, V37, P2349, DOI 10.1007/s10529-015-1921-2
   Gigout A, 2008, J BIOL CHEM, V283, P31522, DOI 10.1074/jbc.M804234200
   Huang AH, 2008, OSTEOARTHR CARTILAGE, V16, P1074, DOI 10.1016/j.joca.2008.02.005
   Ingavle GC, 2014, BIOMATERIALS, V35, P3558, DOI 10.1016/j.biomaterials.2014.01.002
   Ingber DE, 2003, J CELL SCI, V116, P1397, DOI 10.1242/jcs.00360
   Li C, 2012, J BIOMAT SCI-POLYM E, V23, P405, DOI 10.1163/092050610X551970
   Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048824
   Liao IC, 2013, ADV FUNCT MATER, V23, P5833, DOI 10.1002/adfm.201300483
   Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020
   Lim KS, 2013, BIOMATERIALS, V34, P7097, DOI 10.1016/j.biomaterials.2013.06.005
   Little CJ, 2011, TISSUE ENG PART B-RE, V17, P213, DOI [10.1089/ten.teb.2010.0572, 10.1089/ten.TEB.2010.0572]
   Margadant C, 2007, J CELL SCI, V120, P66, DOI 10.1242/jcs.03301
   Moon JJ, 2009, TISSUE ENG PT A, V15, P579, DOI 10.1089/ten.tea.2008.0196
   Moreira Teixeira L S, 2012, EUR CELLS MATER, V23, P387
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   Nicodemus GD, 2011, ACTA BIOMATER, V7, P492, DOI 10.1016/j.actbio.2010.08.021
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Qiu Y., 2003, AAPS PHARMSCITECH, V4, P406
   Rennerfeldt DA, 2013, BIOMATERIALS, V34, P8241, DOI 10.1016/j.biomaterials.2013.07.052
   Rnjak-Kovacina J, 2014, ADV FUNCT MATER, V24, P2188, DOI 10.1002/adfm.201302901
   Schuh E, 2010, TISSUE ENG PT A, V16, P1281, DOI 10.1089/ten.TEA.2009.0614
   Simonsson C, 2011, TOXICOL APPL PHARM, V252, P221, DOI 10.1016/j.taap.2011.02.010
   Sridhar BV, 2015, REGEN ENG TRANSL MED, V1, P11, DOI 10.1007/s40883-015-0002-3
   Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859
   Webber RE, 2007, MACROMOLECULES, V40, P2919, DOI 10.1021/ma062924y
   Wolf F, 2008, EUR CELLS MATER, V16, P92, DOI 10.22203/eCM.v016a10
   Yasuda K, 2009, MACROMOL BIOSCI, V9, P307, DOI 10.1002/mabi.200800223
   Zhang JJ, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/3/035016
   Zhang JJ, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/3/035011
   Zhang JJ, 2013, TISSUE ENG PT A, V19, P2166, DOI [10.1089/ten.tea.2012.0393, 10.1089/ten.TEA.2012.0393]
   Zhang Y, 2012, MACROMOL RAPID COMM, V33, P296, DOI 10.1002/marc.201100695
NR 41
TC 1
Z9 1
U1 6
U2 47
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD JUN
PY 2016
VL 11
IS 3
DI 10.1088/1748-6041/11/3/035014
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DP0GQ
UT WOS:000378167700015
PM 27305040
DA 2018-10-19
ER

PT J
AU Alt, V
   Cheung, WH
   Chow, SKH
   Thormann, U
   Cheung, ENM
   Lips, KS
   Schnettler, R
   Leung, KS
AF Alt, Volker
   Cheung, Wing Hoi
   Chow, Simon K. H.
   Thormann, Ulrich
   Cheung, Edmond N. M.
   Lips, Katrin S.
   Schnettler, Reinhard
   Leung, Kwok-Sui
TI Bone formation and degradation behavior of nanocrystalline
   hydroxyapatite with or without collagen-type 1 in osteoporotic bone
   defects - an experimental study in osteoporotic goats
SO INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
LA English
DT Article
DE Hydroxyapatite; Collagen; Osteoporosis; Degradation; Biomaterial
ID METAPHYSEAL DEFECTS; MODEL; FRACTURES; REGENERATION; SUBSTITUTES;
   OSTIM(R)
AB The intention of the current work is to assess new bone formation and degradation behavior of nanocrystalline hydroxyapatite with (HA/col-1) or without collagen-type I (HA) in osteoporotic metaphyseal bone defects in goats. After ovariectomy and special low-calcium diet for three months, 3 drill hole defects in the vertebrae of L3, L4, L5, 4 drill hole defects in the right and left iliac crest and 1 drill hole defect at the distal femur were created in three Chinese mountain goats with a total of 24 defects. The defects were either filled with one of the biomaterials or left empty (empty defect control group). After 42 days, the animals were euthanized and the samples were assessed for new bone formation using high-resolution peripheral quantitative computed tomography (HR-pQCT) and histomorphometry with 2 regions of interest. Detail histology, enzymehistochemistry and immunohistochemistry as well as connexin-43 in situ hybridization and transmission electron microscopy were carried out for evaluation of degradation behavior of the materials and cellular responses of the surrounding tissue in respect to the implants. HR-pQCT showed the highest BV/TV ratio (p = 0.008) and smallest trabecular spacing (p = 0.005) for HA compared to the other groups in the region of interest at the interface with 1 mm distance to the initially created defect. The HA/col-1 yielded the highest connectivity density (Conn.D) (p = 0.034) and the highest number of trabeculae (Tb.N) (p = 0.002) compared to the HA and the control group. Histomorphometric analysis for the core region of the initially created defect revealed a statistically higher new bone formation in the HA (p = 0.001) and HA/col-1 group (p = 0.001) compared to the empty defect group including all defect sites. This result was confirmed for site specific analysis with significant higher new bone formation for the HA group for vertebral defects compared to the empty defect group (p = 0.029). For the interface region, no statistically significant differences were found between the three groups (p = 0.08). Histology revealed a good biocompatibility without inflammatory reaction for the HA-and HA/col-1 implants with a higher fragmentation of the HA-implant compared to the HA/col-1 biomaterial and formation of new bone in the region between the biomaterial fragments by osteoblasts. Fragmentation was shown by transmission electron microscopy to be caused by multinuclear osteoclast-like cells with degradation of the implant via intracellular incorporation of degraded implant material particles. In conclusion, both nanoparticulate HA with and without collagen type-1 showed better new bone formation compared to untreated drill hole defects in metaphyseal regions of this osteoporotic Chinese mountain goat model with good biocompatibility. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Alt, Volker; Schnettler, Reinhard] Univ Hosp Giessen Marburg GmbH, Dept Trauma Surg, Campus Giessen, D-35385 Giessen, Germany.
   [Alt, Volker; Thormann, Ulrich; Lips, Katrin S.; Schnettler, Reinhard] Univ Giessen, Lab Expt Trauma Surg Giessen, D-35394 Giessen, Germany.
   [Cheung, Wing Hoi; Chow, Simon K. H.; Cheung, Edmond N. M.; Leung, Kwok-Sui] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.
RP Leung, KS (reprint author), Univ Hosp Giessen Marburg GmbH, Dept Trauma Surg Giessen, Campus Giessen,Rudolf Buchheim Str 7, D-35385 Giessen, Germany.
EM volker.alt@chiru.med.uni-giessen.de
RI Cheung, Wing Hoi/J-2150-2018; Chow, Simon/J-1554-2018
OI Cheung, Wing Hoi/0000-0003-3247-8255; Chow, Simon/0000-0003-1742-980X
FU Germany/Hong Kong Joint Research Scheme of the German Academic Research
   Service (Deutscher Akademischer Austauschdienst (DAAD)) - Federal
   Ministry of Education and Reserach of Germany (Bundesministeriums fur
   Bildung und Forschung (BMBF)) [G_HK009/07]
FX The study was sponsored by a travel grant from Germany/Hong Kong Joint
   Research Scheme (Ref: G_HK009/07) of the German Academic Research
   Service (Deutscher Akademischer Austauschdienst (DAAD)) funded by means
   of the Federal Ministry of Education and Reserach of Germany
   (Bundesministeriums fur Bildung und Forschung (BMBF)). The authors thank
   aap Biomaterials, Dieburg, Germany, for the provision of the OSTIM (R)
   and OSTIM (R) + collagen type-I implants.
CR Alt V, 2013, ACTA BIOMATER, V9, P7035, DOI 10.1016/j.actbio.2013.02.002
   Brandt J, 2010, J MATER SCI-MATER M, V21, P283, DOI 10.1007/s10856-009-3859-1
   Busenlechner D, 2008, BIOMATERIALS, V29, P3195, DOI 10.1016/j.biomaterials.2008.04.021
   Canuto RA, 2013, CLIN ORAL IMPLAN RES, V24, P42, DOI 10.1111/j.1600-0501.2011.02363.x
   Chris A.J., 2006, BIOMATERIALS, V27, P1110
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Huber FX, 2008, ZBL CHIR, V133, P577, DOI 10.1055/s-2008-1076873
   Huber FX, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-164
   Leung KS, 2006, J BIOMED MATER RES B, V78B, P153, DOI 10.1002/jbm.b.30467
   Leung KS, 2001, J BONE MINER RES, V16, P2348, DOI 10.1359/jbmr.2001.16.12.2348
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Siu WS, 2004, BONE, V35, P21, DOI 10.1016/j.bone.2004.03.014
   Spies CKG, 2009, ARCH ORTHOP TRAUM SU, V129, P979, DOI 10.1007/s00402-008-0705-8
   Tam KF, 2009, ULTRASOUND MED BIOL, V35, P1109, DOI 10.1016/j.ultrasmedbio.2009.01.001
   Taubenberger V, 2010, BIOMATERIALS, V31, P2827
   Thorwarth M, 2005, J ORAL MAXIL SURG, V63, P1626, DOI 10.1016/j.joms.2005.06.010
   Van Lieshout EMM, 2016, INJURY, V47, pS43, DOI 10.1016/S0020-1383(16)30011-0
   Zaffe D, 2011, J APPL BIOMATER BIOM, V9, P19, DOI 10.5301/JABB.2011.6450
NR 21
TC 6
Z9 6
U1 1
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0020-1383
EI 1879-0267
J9 INJURY
JI Injury-Int. J. Care Inj.
PD JUN
PY 2016
VL 47
SU 2
BP S58
EP S65
DI 10.1016/S0020-1383(16)47010-5
PG 8
WC Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery
SC General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery
GA DP2UK
UT WOS:000378348500010
PM 27338229
DA 2018-10-19
ER

PT J
AU Ozcan, B
   Bayrak, E
   Erisken, C
AF Ozcan, Burak
   Bayrak, Ece
   Erisken, Cevat
TI Characterization of Human Dental Pulp Tissue Under Oscillatory Shear and
   Compression
SO JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME
LA English
DT Article
DE tooth; pulp; regeneration; viscoelastic; compression; biomaterial
ID VISCOELASTIC PROPERTIES; ARTICULAR-CARTILAGE; CROSS-LINKING; STEM-CELLS;
   COLLAGEN; REGENERATION; REPAIR
AB Availability of material as well as biological properties of native tissues is critical for biomaterial design and synthesis for regenerative engineering. Until recently, selection of biomaterials and biomolecule carriers for dental pulp regeneration has been done randomly or based on experience mainly due to the absence of benchmark data for dental pulp tissue. This study, for the first time, characterizes the linear viscoelastic material functions and compressive properties of human dental pulp tissue harvested from wisdom teeth, under oscillatory shear and compression. The results revealed a gel-like behavior of the pulp tissue over the frequency range of 0.1-100 rps. Uniaxial compression tests generated peak normal stress and compressive modulus values of 39.1 +/- 20.4 kPa and 5.5 +/- 2.8 kPa, respectively. Taken collectively, the linear viscoelastic and uniaxial compressive properties of the human dental pulp tissue reported here should enable the better tailoring of biomaterials or biomolecule carriers to be employed in dental pulp regeneration.
C1 [Ozcan, Burak; Bayrak, Ece; Erisken, Cevat] TOBB Univ Econ & Technol, Dept Biomed Engn, Sogutozu Ave 43, TR-06560 Ankara, Turkey.
RP Erisken, C (reprint author), TOBB Univ Econ & Technol, Dept Biomed Engn, Sogutozu Ave 43, TR-06560 Ankara, Turkey.
EM cerisken@etu.edu.tr
RI Erisken, Cevat/P-7850-2014
OI Erisken, Cevat/0000-0002-6337-8022
CR AKIZUKI S, 1986, J ORTHOPAED RES, V4, P379, DOI 10.1002/jor.1100040401
   Aktas S, 2014, J RHEOL, V58, P513, DOI 10.1122/1.4866295
   Cameron AR, 2014, BIOMATERIALS, V35, P1857, DOI 10.1016/j.biomaterials.2013.11.023
   CHAMBON F, 1987, J RHEOL, V31, P683, DOI 10.1122/1.549955
   Couppe C, 2009, J APPL PHYSIOL, V107, P880, DOI 10.1152/japplphysiol.00291.2009
   de Aro AA, 2012, MICRON, V43, P205, DOI 10.1016/j.micron.2011.07.015
   Degirmenbasi N, 2006, COLLOID SURFACE B, V48, P42, DOI 10.1016/j.colsurfb.2006.01.002
   Erisken C, 2015, J ENDODONT, V41, P1711, DOI 10.1016/j.joen.2015.07.005
   Erisken C, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001884
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Goldberg M, 2004, CRIT REV ORAL BIOL M, V15, P13, DOI 10.1177/154411130401500103
   Hargreaves K. M., 2008, J ENDODONT, V34, P51, DOI DOI 10.1016/J.JOEN.2008.02.032
   Haus JM, 2007, J APPL PHYSIOL, V103, P2068, DOI 10.1152/japplphysiol.00670.2007
   HAYES WC, 1978, J BIOMECH, V11, P407, DOI 10.1016/0021-9290(78)90075-1
   Mintz BR, 2014, J BIOMED MATER RES A, V102, P2918, DOI 10.1002/jbm.a.34957
   Murray PE, 2007, J ENDODONT, V33, P377, DOI 10.1016/j.joen.2006.09.013
   Shen ZLL, 2011, BIOPHYS J, V100, P3008, DOI 10.1016/j.bpj.2011.04.052
   Sloan AJ, 2007, ORAL DIS, V13, P151, DOI 10.1111/j.1601-0825.2006.01346.x
   SPIRT AA, 1989, J ORTHOP RES, V7, P43, DOI 10.1002/jor.1100070107
   Yuan ZL, 2011, TISSUE ENG PART B-RE, V17, P373, DOI [10.1089/ten.TEB.2011.0041, 10.1089/ten.teb.2011.0041]
   ZHU WB, 1993, J ORTHOPAED RES, V11, P771, DOI 10.1002/jor.1100110602
NR 21
TC 2
Z9 2
U1 1
U2 5
PU ASME
PI NEW YORK
PA TWO PARK AVE, NEW YORK, NY 10016-5990 USA
SN 0148-0731
EI 1528-8951
J9 J BIOMECH ENG-T ASME
JI J. Biomech. Eng.-Trans. ASME
PD JUN
PY 2016
VL 138
IS 6
AR 061006
DI 10.1115/1.4033437
PG 5
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA DP1OO
UT WOS:000378259500006
PM 27093446
DA 2018-10-19
ER

PT J
AU Ahmed, N
   Schober, J
   Hill, L
   Zustiak, SP
AF Ahmed, Naveed
   Schober, Joseph
   Hill, Lindsay
   Zustiak, Silviya P.
TI Custom Multiwell Plate Design for Rapid Assembly of Photopatterned
   Hydrogels
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID 3-DIMENSIONAL MATRIX STIFFNESS; SUBSTRATE STIFFNESS; TOXINS; TISSUE;
   CELLS; RESPONSIVENESS; ELASTICITY; PLATFORMS; MODULUS; DRUGS
AB The extracellular matrix provides both mechanical support and biochemical cues that influence cellular behavior. Matrix stiffness, in particular, has been found to regulate cellular morphology, motility, proliferation, differentiation, and drug responses among other behaviors. Thus, biomaterial platforms that exhibit wide range of stiffness and are available in a semi high-throughput format such as a multiwell plate would be useful for elucidating cell-substrate relationships. Polyacrylamide (PA) gels have been widely used as cell platforms since they span a range of stiffness between 0.3 and 300 kPa in Young's modulus, which encompasses all soft tissues. However, PA gels are time consuming and labor intensive to prepare, and are not amenable to a multiwell plate format. In this study, we present a novel custom multiwell plate design that allows for a one-step stiffness assay assembly that reduces preparation time and labor intensity by several fold. Gel stiffness is controlled by ultraviolet light intensity and exposure time to achieve a wide stiffness range from a single gel precursor solution. The geometry of the gels is defined by a custom photomask and gel thickness is controlled by spacers. A multiwell plate upper structure is designed similar to a regular multiwell plate such that a gel fits in each well and cells and media are added on top. The upper structure design allows for adequate gas exchange and minimum evaporation. Comparison between cell behaviors seeded in the custom and a standard multiwell plate demonstrated the suitability of the design as a cell culture platform. In summary, we describe and validate a novel custom design for an easy and rapid assembly of photopolymerizable PA-based stiffness assay.
C1 [Ahmed, Naveed; Hill, Lindsay; Zustiak, Silviya P.] St Louis Univ, Dept Biomed Engn, 3507 Lindell Blvd, St Louis, MO 63103 USA.
   [Schober, Joseph] So Illinois Univ, Dept Pharm, Edwardsville, IL 62026 USA.
RP Zustiak, SP (reprint author), St Louis Univ, Dept Biomed Engn, 3507 Lindell Blvd, St Louis, MO 63103 USA.
EM szustiak@slu.edu
FU Saint Louis University
FX This work was funded by start-up funds provided to Dr. Zustiak by Saint
   Louis University as well as by a President's Research Fund (PRF) grant
   and Stroble Award in Health Sciences awarded to Dr. Zustiak by Saint
   Louis University.
CR Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Feng JT, 2013, CLIN HEMORHEOL MICRO, V55, P121, DOI 10.3233/CH-131696
   Gumuscu B, 2015, BIOMACROMOLECULES, V16, P3802, DOI 10.1021/acs.biomac.5b01104
   Herrick WG, 2013, BIOMACROMOLECULES, V14, P2294, DOI 10.1021/bm400418g
   Kloxin AM, 2010, BIOMATERIALS, V31, P1, DOI 10.1016/j.biomaterials.2009.09.025
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   LI Y, 1993, J APPL POLYM SCI, V50, P1107, DOI 10.1002/app.1993.070500619
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Mih JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019929
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Ramamoorthi K, 2014, CELL MOL BIOENG, V7, P278, DOI 10.1007/s12195-014-0326-y
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Semler EJ, 2005, BIOTECHNOL BIOENG, V89, P296, DOI 10.1002/bit.20328
   Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1
   Stoppie N, 2009, J BIOMED MATER RES A, V90A, P792, DOI 10.1002/jbm.a.32145
   Sunyer R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046107
   Syed S, 2015, JOVE-J VIS EXP, V97
   Tilghman RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012905
   Tokuda EY, 2014, BIOMATERIALS, V35, P4310, DOI 10.1016/j.biomaterials.2014.01.063
   Tse J. R., 2010, CURR PROTOC CELL BIO, V47, P10, DOI DOI 10.1002/0471143030.CB1016S47
   WEBER K, 1969, J BIOL CHEM, V244, P4406
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Young DA, 2013, BIOMATERIALS, V34, P8581, DOI 10.1016/j.biomaterials.2013.07.103
   Zustiak S., 2012, AICHE S P ANN FALL M
   Zustiak S., 2013, BIOTECHNOL BIOENG, V111, P396
   Zustiak S, 2014, BIOTECHNOL BIOENG, V111, P396, DOI 10.1002/bit.25097
   Zustiak SP, 2010, BIOMACROMOLECULES, V11, P1348, DOI 10.1021/bm100137q
   Zustiak SP, 2016, BIOTECHNOL BIOENG, V113, P443, DOI 10.1002/bit.25709
   Zustiak SP, 2015, MACROMOL BIOSCI, V15, P589, DOI 10.1002/mabi.201400507
NR 30
TC 1
Z9 1
U1 0
U2 7
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD JUN
PY 2016
VL 22
IS 6
BP 543
EP 551
DI 10.1089/ten.tec.2015.0522
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA DO8LJ
UT WOS:000378034600004
PM 27059131
DA 2018-10-19
ER

PT J
AU Denham, SLW
   Alexander, LF
   Robbin, ML
AF Denham, Stephanie LeeAnn Wilson
   Alexander, Lauren F.
   Robbin, Michelle L.
TI Contrast-Enhanced Ultrasound: Practical Review for the Assessment of
   Hepatic and Renal Lesions
SO ULTRASOUND QUARTERLY
LA English
DT Review
DE microbubble; contrast agents; contrast-enhanced ultrasound; ultrasound
ID FOCAL NODULAR HYPERPLASIA; MICROBUBBLE CONTRAST; DIAGNOSTIC PERFORMANCE;
   HOSPITALIZED-PATIENTS; INITIAL-EXPERIENCE; ACUTE MORTALITY;
   LIVER-LESIONS; UNITED-STATES; BLOOD-FLOW; AGENTS
AB The use of microbubble contrast greatly enhances the ability of ultrasound to delineate structures and therefore aid in diagnosis. Ultrasound microbubble contrast agents are composed of low-solubility gas encapsulated in a biomaterial shell. These agents use the physics of ultrasound imaging to effectively identify and characterize focal hepatic and renal lesions. Not only can contrast agents be used to evaluate multiple phases of lesion contrast enhancement, but ultrasound also allows for real-time study of enhancement patterns. The short half-life and intravascular location of the microbubbles allows for multiple, sequential administrations of contrast to observe enhancement of lesions in different sites. Furthermore, the ability to perform imaging without ionizing radiation and the lack of nephrotoxicity make contrast-enhanced ultrasound an ideal evaluation method for patients who need serial surveillance or in whom imaging options are severely limited because of renal insufficiency. These techniques are widely used in many countries for diagnostic radiological purposes; however, the lack of both Food and Drug Administration approval and reimbursement for noncardiac hospital-based imaging has delayed widespread use in the United States. Despite these limitations, continued research and innovations in ultrasound contrast make it essential to have a working knowledge of the typical enhancement patterns of frequently seen hepatic and renal lesions as these techniques offer an alternative option for contrast imaging.
C1 [Denham, Stephanie LeeAnn Wilson; Robbin, Michelle L.] Univ Alabama Birmingham, Dept Radiol, JTN 331,619 19th St S, Birmingham, AL 35249 USA.
   [Alexander, Lauren F.] Emory Univ Hosp, Dept Radiol & Imaging Sci, 1364 Clifton Rd NE, Atlanta, GA 30322 USA.
RP Denham, SLW (reprint author), Univ Alabama Birmingham, Dept Radiol, JTN 331,619 19th St S, Birmingham, AL 35249 USA.
EM ldenham@uabmc.edu
CR Ascenti G, 2007, RADIOLOGY, V243, P158, DOI 10.1148/radiol.2431051924
   Barr RG, 2014, RADIOLOGY, V271, P133, DOI 10.1148/radiol.13130161
   Barr RG, 2013, J ULTRAS MED, V32, P7
   Bhayana D, 2010, AM J ROENTGENOL, V194, P977, DOI 10.2214/AJR.09.3375
   BOSNIAK MA, 1986, RADIOLOGY, V158, P1
   Bosniak MA, 1997, AM J ROENTGENOL, V169, P819, DOI 10.2214/ajr.169.3.9275903
   Bosniak MA, 2012, RADIOLOGY, V262, P781, DOI 10.1148/radiol.11111595
   Brannigan M, 2004, RADIOGRAPHICS, V24, P921, DOI 10.1148/rg.244035158
   Burns Peter N, 2006, Ultrasound Q, V22, P5
   Burns PN, 2007, RADIOLOGY, V242, P162, DOI 10.1148/radiol.2421051006
   Burns PN, 2000, INVEST RADIOL, V35, P58, DOI 10.1097/00004424-200001000-00007
   Burns PN, 2005, DIAGNOSTIC ULTRASOUN, P55
   CARROLL BA, 1980, INVEST RADIOL, V15, P260, DOI 10.1097/00004424-198005000-00013
   CARROLL BA, 1982, RADIOLOGY, V143, P747, DOI 10.1148/radiology.143.3.7079504
   Claudon M, 2013, ULTRASCHALL MED, V34, P11, DOI 10.1055/s-0032-1325499
   Correas Jean-Michel, 2006, Ultrasound Q, V22, P53
   Correas JM, 2001, EUR RADIOL, V11, P1316, DOI 10.1007/s003300100940
   Cosgrove D, 2006, EUR J RADIOL, V60, P324, DOI 10.1016/j.ejrad.2006.06.022
   Exuzides A, 2010, JACC-CARDIOVASC IMAG, V3, P578, DOI 10.1016/j.jcmg.2010.04.006
   FEINSTEIN SB, 1984, J AM COLL CARDIOL, V3, P14, DOI 10.1016/S0735-1097(84)80424-6
   FEINSTEIN SB, 1984, J AM COLL CARDIOL, V4, P595, DOI 10.1016/S0735-1097(84)80107-2
   Gerst S, 2011, AM J ROENTGENOL, V197, P897, DOI 10.2214/AJR.10.6330
   Goldberg YH, 2012, CARDIOLOGY, V122, P119, DOI 10.1159/000338731
   Gramiak R, 1968, Invest Radiol, V3, P356
   GRAMIAK R, 1969, RADIOLOGY, V92, P939, DOI 10.1148/92.5.939
   Jakobsen JA, 2005, EUR RADIOL, V15, P941, DOI 10.1007/s00330-004-2601-0
   Jang HJ, 2007, RADIOLOGY, V244, P898, DOI 10.1148/radiol.2443061520
   Kaewlai R, 2012, AM J ROENTGENOL, V199, pW17, DOI 10.2214/AJR.11.8144
   Kim TK, 2008, AM J ROENTGENOL, V190, P58, DOI 10.2214/AJR.07.2493
   Main ML, 2007, J AM COLL CARDIOL, V50, P2434, DOI 10.1016/j.jacc.2007.11.006
   Main ML, 2012, CARDIOLOGY, V122, P248, DOI 10.1159/000341246
   Main ML, 2008, AM J CARDIOL, V102, P1742, DOI 10.1016/j.amjcard.2008.08.019
   McCullough PA, 2008, CRIT CARE MED, V36, pS204, DOI 10.1097/CCM.0b013e318168cdc3
   Morel DR, 2000, INVEST RADIOL, V35, P80, DOI 10.1097/00004424-200001000-00009
   Murphy-Lavallee J, 2007, J ULTRAS MED, V26, P1545, DOI 10.7863/jum.2007.26.11.1545
   Neugut AI, 2001, ARCH INTERN MED, V161, P15, DOI 10.1001/archinte.161.1.15
   Paspulati RM, 2006, RADIOL CLIN N AM, V44, P787, DOI 10.1016/j.rcl.2006.10.002
   Piscaglia F, 2006, ULTRASOUND MED BIOL, V32, P1369, DOI 10.1016/j.ultrasmedbio.2006.05.031
   Quaia E, 2007, RADIOL MED, V112, P473, DOI 10.1007/s11547-007-0157-1
   Quaia E, 2004, RADIOLOGY, V232, P420, DOI 10.1148/radiol.2322031401
   Quaia E, 2008, AM J ROENTGENOL, V191, P1239, DOI 10.2214/AJR.07.3546
   Quaia E, 2007, EUR RADIOL, V17, P1995, DOI 10.1007/s00330-007-0623-0
   Robbin ML, 2003, RADIOL CLIN N AM, V41, P963, DOI 10.1016/S0033-8389(03)00070-8
   Sutherland T, 2011, J CLIN ULTRASOUND, V39, P399, DOI 10.1002/jcu.20847
   ter Haar GR, 2002, EUR J RADIOL, V41, P217, DOI 10.1016/S0720-048X(01)00456-9
   Torzilli Guido, 2005, Expert Opin Drug Saf, V4, P399, DOI 10.1517/14740338.4.3.399
   WANLESS IR, 1985, HEPATOLOGY, V5, P1194, DOI 10.1002/hep.1840050622
   Wilson SR, 2000, RADIOLOGY, V215, P153, DOI 10.1148/radiology.215.1.r00ap08153
   Wilson SR, 2001, SEMIN LIVER DIS, V21, P147, DOI 10.1055/s-2001-15342
   Wilson SR, 2010, RADIOLOGY, V257, P24, DOI 10.1148/radiol.10091210
   Wilson SR, 2009, AM J ROENTGENOL, V193, P55, DOI 10.2214/AJR.09.2553
   Xu ZF, 2010, J ULTRAS MED, V29, P709, DOI 10.7863/jum.2010.29.5.709
NR 52
TC 3
Z9 3
U1 1
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0894-8771
EI 1536-0253
J9 ULTRASOUND Q
JI Ultrasound Q.
PD JUN
PY 2016
VL 32
IS 2
BP 116
EP 125
DI 10.1097/RUQ.0000000000000182
PG 10
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA DP3RR
UT WOS:000378413100004
PM 27233070
DA 2018-10-19
ER

PT J
AU Zhang, SW
   Guo, YC
   Dong, YL
   Wu, YS
   Cheng, L
   Wang, YY
   Xing, M
   Yuan, Q
AF Zhang, Shiwen
   Guo, Yuchen
   Dong, Yuliang
   Wu, Yunshu
   Cheng, Lei
   Wang, Yongyue
   Xing, Malcolm
   Yuan, Quan
TI A Novel Nanosilver/Nanosilica Hydrogel for Bone Regeneration in Infected
   Bone Defects
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE nanosilica; nanosilver hydrogel; bone defects; infection
ID SILVER NANOPARTICLES; NANOCRYSTALLINE SILVER; COMPOSITE SCAFFOLDS;
   CALVARIAL DEFECTS; MINERAL DENSITY; ANTIBACTERIAL; DELIVERY;
   NANOCOMPOSITES; BIOMATERIALS; MATRIX
AB Treating bone defects in the presence of infection is a formidable clinical challenge. The use of a biomaterial with the dual function of bone regeneration and infection control is a novel therapeutic approach to this problem. In this Study, we fabricated an innovative, dual-function biocomposite hydrogel containing nano silver and nanosilica (nAg/nSiO(2)) particles and evaluated, its characteristics using FT-IR, SEM, swelling ratio, and stiffness assays. The in vitro antibacterial analysis showed that this nAg/nSiO(2) hydrogel inhibited both Gram-positive and Gram-negative bacteria. In addition, this nontoxic material could promote osteogenic differentiation of rat bone marrow stromal cells (BMSCs). We then created infected bone defects in rat calvaria in order to evaluate the function of the hydrogel in vivo. The hydrogel demonstrated effective antibacterial ability while promoting bone regeneration in these defects. Our results indicate that this nAg/nSiO(2) hydrogel has the potential to both control infection and to promote bone healing in contaminated defects.
C1 [Zhang, Shiwen; Guo, Yuchen; Dong, Yuliang; Wu, Yunshu; Cheng, Lei; Wang, Yongyue; Yuan, Quan] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Peoples R China.
   [Zhang, Shiwen; Xing, Malcolm] Univ Manitoba, Fac Engn, Dept Mech Engn, Winnipeg, MB R3E 3P4, Canada.
   [Zhang, Shiwen; Xing, Malcolm] Univ Manitoba, Dept Biochem & Genet, Fac Med, Winnipeg, MB R3E 3P4, Canada.
   [Zhang, Shiwen; Xing, Malcolm] Univ Manitoba, Manitoba Inst Child Hlth, Winnipeg, MB R3E 3P4, Canada.
RP Yuan, Q (reprint author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610041, Peoples R China.; Xing, M (reprint author), Univ Manitoba, Fac Engn, Dept Mech Engn, Winnipeg, MB R3E 3P4, Canada.; Xing, M (reprint author), Univ Manitoba, Dept Biochem & Genet, Fac Med, Winnipeg, MB R3E 3P4, Canada.; Xing, M (reprint author), Univ Manitoba, Manitoba Inst Child Hlth, Winnipeg, MB R3E 3P4, Canada.
EM malcolm.xing@umanitoba.ca; yuanquan@scu.edu.cn
FU Program for New Century Excellent Talents in University [NCET-12-0379];
   National Natural Science Foundation of China [NSFC 81571001, 81371173];
   Sichuan Province Youth Fund [2013JQ0017]; State Key Laboratory of Oral
   Diseases
FX This study is supported by Program for New Century Excellent Talents in
   University (NCET-12-0379), National Natural Science Foundation of China
   (NSFC 81571001, 81371173), Sichuan Province Youth Fund (2013JQ0017), and
   open funding from State Key Laboratory of Oral Diseases. S.Z and Q.Y.
   thank Essential Scientific Editing for assistance in preparing the final
   manuscript
CR Anisha BS, 2013, INT J BIOL MACROMOL, V62, P310, DOI 10.1016/j.ijbiomac.2013.09.011
   Arcos D, 2010, ACTA BIOMATER, V6, P2874, DOI 10.1016/j.actbio.2010.02.012
   Beck GR, 2012, NANOMED-NANOTECHNOL, V8, P793, DOI 10.1016/j.nano.2011.11.003
   Besinis A, 2014, NANOTOXICOLOGY, V8, P1, DOI 10.3109/17435390.2012.742935
   Castillo PM, 2008, NANOMEDICINE-UK, V3, P627, DOI 10.2217/17435889.3.5.627
   Chaloupka K, 2010, TRENDS BIOTECHNOL, V28, P580, DOI 10.1016/j.tibtech.2010.07.006
   Chen XQ, 2005, J ORTHOP RES, V23, P816, DOI 10.1016/j.orthres.2005.01.009
   Chun C, 2009, BIOMATERIALS, V30, P6295, DOI 10.1016/j.biomaterials.2009.08.011
   Cousins BG, 2007, J APPL MICROBIOL, V102, P757, DOI 10.1111/j.1365-2672.2006.03124.x
   Depan D, 2011, ACTA BIOMATER, V7, P2163, DOI 10.1016/j.actbio.2011.01.029
   Diefenbeck M, 2006, INJURY, V37, P95, DOI 10.1016/j.injury.2006.04.015
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dorigato A, 2012, J POLYM ENVIRON, V20, P713, DOI 10.1007/s10924-012-0425-6
   Durao SFO, 2012, INT J ORAL MAX IMPL, V27, P1400
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Ferruti P, 2005, BIOMACROMOLECULES, V6, P2229, DOI 10.1021/bm050210+
   Gaharwar AK, 2013, MAT SCI ENG C-MATER, V33, P1800, DOI 10.1016/j.msec.2012.12.099
   Gomes PS, 2011, LAB ANIM-UK, V45, P14, DOI 10.1258/la.2010.010085
   Gong T, 2015, BONE RES, V3, DOI 10.1038/boneres.2015.29
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Hesaraki S, 2012, J BIOMED MATER RES B, V100B, P1627, DOI 10.1002/jbm.b.32731
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Jugdaohsingh R, 2007, J NUTR HEALTH AGING, V11, P99
   Jugdaohsingh R, 2004, J BONE MINER RES, V19, P297, DOI 10.1359/JBMR.0301225
   Kanellakopoulou K, 2000, DRUGS, V59, P1223, DOI 10.2165/00003495-200059060-00003
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Keeling JJ, 2008, J BONE JOINT SURG AM, V90A, P2643, DOI 10.2106/JBJS.G.01326
   Kluin OS, 2013, EXPERT OPIN DRUG DEL, V10, P341, DOI 10.1517/17425247.2013.751371
   Li JD, 2012, J BIOMAT SCI-POLYM E, V23, P81, DOI 10.1163/092050610X543159
   Madhumathi K, 2009, INT J BIOL MACROMOL, V45, P289, DOI 10.1016/j.ijbiomac.2009.06.009
   Marom R, 2005, J CELL PHYSIOL, V202, P41, DOI 10.1002/jcp.20109
   Mieszawska AJ, 2010, BIOMATERIALS, V31, P8902, DOI 10.1016/j.biomaterials.2010.07.109
   Miyaji F, 1998, J MATER SCI-MATER M, V9, P61, DOI 10.1023/A:1008886729050
   Mohan YM, 2007, POLYMER, V48, P158, DOI 10.1016/j.polymer.2006.10.045
   Mohan YM, 2010, J COLLOID INTERF SCI, V342, P73, DOI 10.1016/j.jcis.2009.10.008
   Montanaro L, 2011, INT J ARTIF ORGANS, V34, P781, DOI 10.5301/ijao.5000052
   Mourino V, 2010, J R SOC INTERFACE, V7, P209, DOI 10.1098/rsif.2009.0379
   Murphy CM, 2010, CELL ADHES MIGR, V4, P377, DOI 10.4161/cam.4.3.11747
   Murphy M, 2015, J NANOMATER, DOI 10.1155/2015/696918
   Nadworny PL, 2008, NANOMED-NANOTECHNOL, V4, P241, DOI 10.1016/j.nano.2008.04.006
   Nair MB, 2011, CURR OPIN BIOTECH, V22, P721, DOI 10.1016/j.copbio.2011.02.005
   Nandi SK, 2009, MAT SCI ENG C-MATER, V29, P2478, DOI 10.1016/j.msec.2009.07.014
   Raasch W, 2001, BRIT J PHARMACOL, V133, P755, DOI 10.1038/sj.bjp.0704153
   Sakamoto Y, 2014, NEUROL MED-CHIR, V54, P647, DOI 10.2176/nmc.oa.2013-0295
   Schexnailder P, 2009, COLLOID POLYM SCI, V287, P1, DOI 10.1007/s00396-008-1949-0
   Schneider Oliver D, 2011, Open Orthop J, V5, P63, DOI 10.2174/1874325001105010063
   Shi JB, 2012, J MATER CHEM, V22, P23952, DOI 10.1039/c2jm34862d
   Simchi A, 2011, NANOMED-NANOTECHNOL, V7, P22, DOI 10.1016/j.nano.2010.10.005
   Sivolella S., 2012, J NANOMATER, V12, P4873
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Srinivasan S, 2013, J BIOMED NANOTECHNOL, V9, P1803, DOI 10.1166/jbn.2013.1658
   Thomas V, 2007, J COLLOID INTERF SCI, V315, P389, DOI 10.1016/j.jcis.2007.06.068
   Tian Y, 2013, J MATER CHEM B, V1, P5264, DOI 10.1039/c3tb20544d
   Wang C, 2004, ADV MATER, V16, P1074, DOI 10.1002/adma.200306516
   Wenke JC, 2011, EXPERT OPIN DRUG DEL, V8, P1555, DOI 10.1517/17425247.2011.628655
   Wright JB, 2002, WOUND REPAIR REGEN, V10, P141, DOI 10.1046/j.1524-475X.2002.10308.x
   Wu CJ, 2010, MATERIALS, V3, P2986, DOI 10.3390/ma3052986
   Yang SB, 2012, SOFT MATTER, V8, P8981, DOI 10.1039/c2sm25123j
   Zhang JC, 2010, CLIN ORAL IMPLAN RES, V21, P321, DOI 10.1111/j.1600-0501.2009.01838.x
   Zhang SW, 2014, J BIOMATER TISS ENG, V4, P875, DOI 10.1166/jbt.2014.1269
   Zheng Z, 2010, BIOMATERIALS, V31, P9293, DOI 10.1016/j.biomaterials.2010.08.041
   Zhong C, 2010, ACTA BIOMATER, V6, P3908, DOI 10.1016/j.actbio.2010.04.011
   Zou H, 2008, CHEM REV, V108, P3893, DOI 10.1021/cr068035q
NR 64
TC 17
Z9 18
U1 4
U2 69
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JUN 1
PY 2016
VL 8
IS 21
BP 13242
EP 13250
DI 10.1021/acsami.6b01432
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DN5ZM
UT WOS:000377150400008
PM 27167643
DA 2018-10-19
ER

PT J
AU Wang, HY
   Hua, XW
   Jia, HR
   Li, CC
   Lin, FM
   Chen, Z
   Wu, FG
AF Wang, Hong-Yin
   Hua, Xian-Wu
   Jia, Hao-Ran
   Li, Chengcheng
   Lin, Fengming
   Chen, Zhan
   Wu, Fu-Gen
TI Universal Cell Surface Imaging for Mammalian, Fungal, and Bacterial
   Cells
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE cell surface-biomaterial interaction; bioimaging; glycol chitosan; cell
   surface engineering; electrostatic interaction
ID GRAM-STAINING TECHNIQUE; PLASMA-MEMBRANE; SACCHAROMYCES-CEREVISIAE;
   ANTIBACTERIAL AGENTS; ESCHERICHIA-COLI; DRUG-DELIVERY; YEAST; PEPTIDES;
   PROTEINS; POLYMERS
AB Because of the distinct surface structures of different cells (mammalian cells, fungi, and bacteria), surface labeling for these cells requires a variety of fluorescent dyes. Besides, fluorescent dyes (especially the commercial ones) for staining Gram-negative bacterial cell walls are still lacking. Herein, a conformation-adjustable glycol chitosan (GC) derivative (GC-PEG cholesterolFITC) with "all-in-one" property was developed to realize universal imaging for plasma membranes of mammalian cells (via hydrophobic interaction) and cell walls of fungal and bacterial cells (via electrostatic interaction). By comparing the different staining behaviors of GC-PEG cholesterol-FITC and three other analogs (GC-PEGFITC, GC-FITC, and cholesterol-PEG-FITC), we have elucidated the different roles the hydrophobic and electrostatic interactions play in the staining performance of these different cells. Such a simple, noncytotoxic, economic, and universal cell surface staining reagent will be very useful for investigating cell surface-related biological events and advancing cell surface engineering of various types of cells.
C1 [Wang, Hong-Yin; Hua, Xian-Wu; Jia, Hao-Ran; Li, Chengcheng; Lin, Fengming; Wu, Fu-Gen] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.
   [Chen, Zhan] Univ Michigan, Dept Chem, 930 North Univ Ave, Ann Arbor, MI 48109 USA.
RP Wu, FG (reprint author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.; Chen, Z (reprint author), Univ Michigan, Dept Chem, 930 North Univ Ave, Ann Arbor, MI 48109 USA.
EM zhanc@umich.edu; wufg@seu.edu.cn
RI Wu, Fu-Gen/B-1444-2009; Wang, Hong-Yin/C-1423-2014
OI Wu, Fu-Gen/0000-0003-1773-2868; Chen, Zhan/0000-0001-8687-8348
FU National High Technology Research & Development Program of China
   [2015AA020502]; National Natural Science Foundation of China [21303017];
   Natural Science Foundation of Jiangsu Province [KB20130601]; Fundamental
   Research Funds for the Central Universities [2242015R30016]; Six Talents
   Peak Project in Jiangsu Province [2015-SWYY-003]; Scientific Research
   Foundation of Graduate School of Southeast University [YBPY1508];
   Graduate Students' Scientific Research Innovation Project of Jiangsu
   Province Ordinary University [CXZZ13_0122]; University of Michigan
FX This work was supported by grants from the National High Technology
   Research & Development Program of China (2015AA020502), National Natural
   Science Foundation of China (21303017), Natural Science Foundation of
   Jiangsu Province (KB20130601), Fundamental Research Funds for the
   Central Universities (2242015R30016), Six Talents Peak Project in
   Jiangsu Province (2015-SWYY-003), Scientific Research Foundation of
   Graduate School of Southeast University (YBPY1508), and Graduate
   Students' Scientific Research Innovation Project of Jiangsu Province
   Ordinary University (CXZZ13_0122). Z.C. thanks the University of
   Michigan for supporting his sabbatical.
CR Aghamohammadzadeh S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103311
   AI-Saadi A., 2009, J PHYS CHEM C, V113, P15260
   Bai HT, 2015, ANGEW CHEM INT EDIT, V54, P13208, DOI 10.1002/anie.201504566
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Bazan SB, 2014, VACCINE, V32, P2591, DOI 10.1016/j.vaccine.2014.03.043
   Boileau AJ, 2010, J NEUROSCI, V30, P4895, DOI 10.1523/JNEUROSCI.5039-09.2010
   Bondar OV, 2012, ACTA NATURAE, V4, P78
   Bugg TDH, 2011, TRENDS BIOTECHNOL, V29, P167, DOI 10.1016/j.tibtech.2010.12.006
   Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119
   Chen WW, 2014, ANGEW CHEM INT EDIT, V53, P13734, DOI 10.1002/anie.201407606
   Chen XY, 2015, CHEM COMMUN, V51, P487, DOI 10.1039/c4cc08681c
   Dalla Pellegrina C., 2005, TOXICOL APPL PHARM, V207, P170, DOI 10.1016/j.taap.2005.01.001
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Emde B, 2014, EUR J HISTOCHEM, V58, P315, DOI 10.4081/ejh.2014.2448
   Ernst AM, 2013, FEBS LETT, V587, P1411, DOI 10.1016/j.febslet.2013.03.019
   Fishov I, 1999, MOL MICROBIOL, V32, P1166, DOI 10.1046/j.1365-2958.1999.01425.x
   Gao WW, 2015, J DRUG TARGET, V23, P619, DOI 10.3109/1061186X.2015.1052074
   Gauvin TJ, 2015, MOL BIOL CELL, V26, P467, DOI 10.1091/mbc.E14-07-1247
   Goldenberg NM, 2010, CANCER RES, V70, P1277, DOI 10.1158/0008-5472.CAN-09-2905
   GREENBERG ML, 1993, J MEMBRANE BIOL, V131, P115, DOI 10.1007/BF02791320
   Guttenplan SB, 2013, MOL MICROBIOL, V87, P211, DOI 10.1111/mmi.12103
   Harbers GM, 2007, CHEM MATER, V19, P4405, DOI 10.1021/cm070509u
   He H, 2015, BIOMACROMOLECULES, V16, P1390, DOI 10.1021/acs.biomac.5b00180
   Holm C, 2003, APPL ENVIRON MICROB, V69, P2857, DOI 10.1128/AEM.69.5.2857-2863.2003
   Jia HR, 2016, BIOCONJUGATE CHEM, V27, P782, DOI 10.1021/acs.bioconjchem.6b00003
   Jung SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116519
   KARSON EM, 1978, J BIOL CHEM, V253, P6484
   Kuo CW, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/s12951-014-0054-4
   Lopez-Garcia B, 2015, APPL MICROBIOL BIOT, V99, P8011, DOI 10.1007/s00253-015-6541-1
   MAEDA H, 1967, J BIOCHEM-TOKYO, V62, P276, DOI 10.1093/oxfordjournals.jbchem.a128660
   Makovitzki A, 2006, P NATL ACAD SCI USA, V103, P15997, DOI 10.1073/pnas.0606129103
   Master RN, 2013, ANN NY ACAD SCI, V1277, P1, DOI 10.1111/nyas.12022
   Maurya IK, 2011, PEPTIDES, V32, P1732, DOI 10.1016/j.peptides.2011.06.003
   Figueroa-Lopez AM, 2014, J BASIC MICROB, V54, pS125, DOI 10.1002/jobm.201200594
   Monteiro JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9055
   Munoz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054813
   Pereira P, 2013, MACROMOL BIOSCI, V13, P1369, DOI 10.1002/mabi.201300123
   Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023
   Rojas E, 2014, P NATL ACAD SCI USA, V111, P7807, DOI 10.1073/pnas.1402591111
   Salje J, 2011, MOL CELL, V43, P478, DOI 10.1016/j.molcel.2011.07.008
   SIZEMORE RK, 1990, APPL ENVIRON MICROB, V56, P2245
   Sun HL, 2015, BIOMACROMOLECULES, V16, P597, DOI 10.1021/bm501652d
   Tada R, 2013, CURR PHARM DESIGN, V19, P3738, DOI 10.2174/1381612811319200012
   Takeo M, 2015, J BIOMAT SCI-POLYM E, V26, P353, DOI 10.1080/09205063.2015.1007414
   Teramura Y, 2010, SOFT MATTER, V6, P1081, DOI 10.1039/b913621e
   Tobinaga K, 2014, J CONTROL RELEASE, V177, P27, DOI 10.1016/j.jconrel.2013.12.024
   Ursell TS, 2014, P NATL ACAD SCI USA, V111, pE1025, DOI 10.1073/pnas.1317174111
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1893
   VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779
   Wang HY, 2016, J MATER CHEM B, V4, P834, DOI 10.1039/c5tb02183a
   Wang HY, 2015, J MATER CHEM B, V3, P6165, DOI 10.1039/c5tb00930h
   Wang HY, 2015, ACS APPL MATER INTER, V7, P7082, DOI 10.1021/acsami.5b01214
   Wang W, 2012, NAT CHEM, V4, P846, DOI [10.1038/NCHEM.1434, 10.1038/nchem.1434]
   Wenzel M, 2014, P NATL ACAD SCI USA, V111, pE1409, DOI 10.1073/pnas.1319900111
   Yao X, 2013, ADV MATER, V25, P5257, DOI 10.1002/adma.201301762
   Yhee JY, 2014, J CONTROL RELEASE, V193, P202, DOI 10.1016/j.jconrel.2014.05.009
   Yoritsune K, 2013, FEBS LETT, V587, P917, DOI 10.1016/j.febslet.2013.02.016
   Yuan HX, 2014, ADV MATER, V26, P4333, DOI 10.1002/adma.201400636
   Zhao YY, 2010, J AM CHEM SOC, V132, P12349, DOI 10.1021/ja1028843
   Zhou XX, 2015, SCIENCE, V348, P574, DOI 10.1126/science.aaa1511
   Zhu CL, 2011, ADV MATER, V23, P4805, DOI 10.1002/adma.201102850
NR 61
TC 12
Z9 12
U1 6
U2 36
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD JUN
PY 2016
VL 2
IS 6
BP 987
EP 997
DI 10.1021/acsbiomaterials.6b00130
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA DO6WX
UT WOS:000377925300012
DA 2018-10-19
ER

PT J
AU Francis, NL
   Bennett, NK
   Halikere, A
   Pang, ZPP
   Moghe, PV
AF Francis, Nicola L.
   Bennett, Neal K.
   Halikere, Apoorva
   Pang, Zhiping P.
   Moghe, Prabhas V.
TI Self-Assembling Peptide Nanofiber Scaffolds for 3-D Reprogramming and
   Transplantation of Human Pluripotent Stem Cell-Derived Neurons
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE nanofiber; self-assembling peptide; neuronal reprogramming; brain
   transplantation; human induced pluripotent stem cell; neural tissue
   engineering
ID BRAIN EXTRACELLULAR-MATRIX; NEURAL PRECURSOR CELLS; COMPLEMENTARY
   OLIGOPEPTIDE; FUNCTIONAL-NEURONS; NEURITE OUTGROWTH; RAT-BRAIN;
   IN-VITRO; SURVIVAL; DEATH; LAMININ
AB While cell transplantation presents a potential strategy to treat the functional deficits of neurodegenerative diseases or central nervous system injuries, the poor survival rate of grafted cells in vivo is a major barrier to effective therapeutic treatment. In this study, we investigated the role of a peptide-based nanofibrous scaffold composed of the self assembling peptide RADA16-I to support the reprogramming and maturation of human neurons in vitro and to transplant these neurons in vivo. The induced human neurons were generated via the single transcriptional factor transduction of induced pluripotent stem cells (iPSCs), which are a promising cell source for regenerative therapies. These neurons encapsulated within RADA16-I scaffolds displayed robust neurite outgrowth and demonstrated high levels of functional activity in vitro compared to that of 2-D controls, as determined by live cell calcium imaging. When evaluated in vivo as a transplantation vehicle for adherent, functional networks of neurons, monodisperse RADA16-I microspheres significantly increased survival (over 100-fold greater) compared to the conventional transplantation of unsupported neurons in suspension. The scaffold-encapsulated neurons integrated well in vivo within the injection site, extending neurites several hundred microns long into the host brain tissue. Overall, these results suggest that this biomaterial platform can be used to successfully improve the outcome of cell transplantation and neuro-regenerative therapies.
C1 [Francis, Nicola L.; Bennett, Neal K.; Moghe, Prabhas V.] Rutgers State Univ, Dept Biomed Engn, 599 Taylor Rd, Piscataway, NJ 08854 USA.
   [Halikere, Apoorva; Pang, Zhiping P.] Rutgers Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, Dept Neurosci & Cell Biol, 89 French St, New Brunswick, NJ 08901 USA.
   [Moghe, Prabhas V.] Rutgers State Univ, Dept Chem & Biochem Engn, 98 Brett Rd, Piscataway, NJ 08854 USA.
RP Moghe, PV (reprint author), Rutgers State Univ, Dept Biomed Engn, 599 Taylor Rd, Piscataway, NJ 08854 USA.; Pang, ZPP (reprint author), Rutgers Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, Dept Neurosci & Cell Biol, 89 French St, New Brunswick, NJ 08901 USA.; Moghe, PV (reprint author), Rutgers State Univ, Dept Chem & Biochem Engn, 98 Brett Rd, Piscataway, NJ 08854 USA.
EM pangzh@rwjms.rutgers.edu; moghe@rutgers.edu
FU NIH [P41 EB001046, R21 NS095082, T32EB005583]; NSF-IGERT [0801620]
FX Research reported here was supported by NIH P41 EB001046, NIH R21
   NS095082, NIH T32EB005583, and NSF-IGERT grant 0801620. We gratefully
   acknowledge the RUCDR for the gift of the iPSC line used in this study
   and 3-D Matrix for the gift of the RADA16-I self-assembling peptide
   (PuraMatrix).
CR Bakshi A, 2005, BRAIN RES, V1065, P8, DOI 10.1016/j.brainres.2005.09.059
   Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74
   Bonneh-Barkay D, 2009, BRAIN PATHOL, V19, P573, DOI 10.1111/j.1750-3639.2008.00195.x
   Carlson AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10862
   Cheng TY, 2013, BIOMATERIALS, V34, P2005, DOI 10.1016/j.biomaterials.2012.11.043
   Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x
   Cooke MJ, 2010, SOFT MATTER, V6, P4988, DOI 10.1039/c0sm00448k
   Cordeiro KK, 2014, EUR J NEUROSCI, V39, P1474, DOI 10.1111/ejn.12541
   Cormier AR, 2013, ACS NANO, V7, P7562, DOI 10.1021/nn401562f
   Deister C, 2007, J BIOMAT SCI-POLYM E, V18, P983, DOI 10.1163/156856207781494377
   Einstein O, 2006, GLIA, V53, P449, DOI 10.1002/glia.20305
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   FORDHOLEVINSKI T, 1986, DEV BRAIN RES, V28, P121, DOI 10.1016/0165-3806(86)90071-4
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Gorman AM, 2008, J CELL MOL MED, V12, P2263, DOI 10.1111/j.1582-4934.2008.00402.x
   Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254
   Guo J, 2007, NANOMED-NANOTECHNOL, V3, P311, DOI 10.1016/j.nano.2007.09.003
   Guo JS, 2009, NANOMED-NANOTECHNOL, V5, P345, DOI 10.1016/j.nano.2008.12.001
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hwang Onyou, 2013, Exp Neurobiol, V22, P11, DOI 10.5607/en.2013.22.1.11
   Inoue H, 2011, CLIN PHARMACOL THER, V89, P655, DOI 10.1038/clpt.2011.38
   Liu WW, 2013, INTEGR BIOL-UK, V5, P1244, DOI 10.1039/c3ib40131f
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Marchionini DM, 2003, J COMP NEUROL, V464, P172, DOI 10.1002/cne.10785
   Nakaji-Hirabayashi T, 2013, BIOCONJUGATE CHEM, V24, P1798, DOI 10.1021/bc400005m
   Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202
   Phillips JB, 2005, TISSUE ENG, V11, P1611, DOI 10.1089/ten.2005.11.1611
   RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0
   Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489
   Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774
   Srinivasan P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099640
   Swindle-Reilly KE, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046007
   Takeuchi S, 2005, ADV MATER, V17, P1067, DOI 10.1002/adma.200401738
   Thonhoff JR, 2008, BRAIN RES, V1187, P42, DOI 10.1016/j.brainres.2007.10.046
   Tsuda Y, 2010, LANGMUIR, V26, P2645, DOI [10.1021/la902827y, 10.1021/la002827y]
   Uemura M, 2010, J NEUROSCI RES, V88, P542, DOI 10.1002/jnr.22223
   Vasita R, 2006, INT J NANOMED, V1, P15, DOI 10.2147/nano.2006.1.1.15
   Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797
   Yang YL, 2009, NANO TODAY, V4, P193, DOI 10.1016/j.nantod.2009.02.009
   Yla-Outinen L, 2014, J TISSUE ENG REGEN M, V8, P186, DOI 10.1002/term.1512
   Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102
   Yu LMY, 2008, MATER TODAY, V11, P36, DOI 10.1016/S1369-7021(08)70088-9
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029
   Zhang ZX, 2010, BIOTECHNOL BIOPROC E, V15, P545, DOI 10.1007/s12257-009-3076-2
NR 46
TC 12
Z9 12
U1 3
U2 27
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD JUN
PY 2016
VL 2
IS 6
BP 1030
EP 1038
DI 10.1021/acsbiomaterials.6b00156
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA DO6WX
UT WOS:000377925300017
DA 2018-10-19
ER

PT J
AU Kojima, K
   Vacanti, CA
AF Kojima, K.
   Vacanti, C. A.
TI Tissue Engineering in the Trachea (vol 297, pg 44, 2014)
SO ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY
   BIOLOGY
LA English
DT Correction
DE tissue engineering; stem cell; trachea
AB This review summarizes efforts to generate an autologous tissue-engineered trachea (TET) using various biomaterial or cell sources to make tracheal cartilage to form the structural components of a functional tracheal replacement. Biomechanical assessments of the TET showed that the cartilage stiffness was excellent in the nude models; however, the sheep autologous TET did not provide sufficient support and collapsed easily. As a result, tissue engineering technology is still far from allowing the functional recovery of patients who suffer from severe tracheal disease. On the other hand, there are several clinical reports seeding cells to decellularized tissue using tissue engineering techniques. However, the working mechanisms of the tissue-engineered trachea remain unclear. Nevertheless, we believe that the field of tissue engineering has great potential for surmounting these obstacles and allowing us to generate functional tracheal replacements in the near future. (C) 2013 Wiley Periodicals, Inc.
CR Kojima K, 2014, ANAT REC, V297, P44, DOI 10.1002/ar.22799
NR 1
TC 0
Z9 0
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-8486
EI 1932-8494
J9 ANAT REC
JI Anat. Rec.
PD JUN
PY 2016
VL 299
IS 6
BP 703
EP 703
DI 10.1002/ar.23343
PG 1
WC Anatomy & Morphology
SC Anatomy & Morphology
GA DO2RJ
UT WOS:000377627300001
OA Bronze
DA 2018-10-19
ER

PT J
AU Santo, VE
   Babo, P
   Amador, M
   Correia, C
   Cunha, B
   Coutinho, DF
   Neves, NM
   Mano, JF
   Reis, RL
   Gomes, ME
AF Santo, Vitor E.
   Babo, Pedro
   Amador, Miguel
   Correia, Claudia
   Cunha, Barbara
   Coutinho, Daniela F.
   Neves, Nuno M.
   Mano, Joao F.
   Reis, Rui L.
   Gomes, Manuela E.
TI Engineering Enriched Microenvironments with Gradients of Platelet Lysate
   in Hydrogel Fibers
SO BIOMACROMOLECULES
LA English
DT Article
ID CONTROLLED-RELEASE STRATEGIES; GELLAN GUM HYDROGELS; ADIPOSE STEM-CELLS;
   RICH PLASMA; OSTEOGENIC DIFFERENTIATION; GROWTH-FACTOR; IN-VITRO;
   CARTILAGE TISSUE; BONE; REGENERATION
AB Gradients of physical and chemical cues are characteristic of specific,tissue inicroerrvironments and contribute toward morphogenesis and tissue regeneration upon injury. Recentadvances on microfluiclics and hydrogel inanipulation raised the possibility of generating biomimetic biothaterials enriched with bioactive factors and encapsulating cells following designs specifically tailored for a target application. The novelty of this work relies on the combination of methacrylated gellan gum (MeGG) with platelet lysate (PL), aiming to generate novel advanced 3D PL-enriched photo-cross-linkable hydrogels and overcoming the lack of adhesion sites provided by the native MeGG hydrogels. This combination takes advantage of the availability, enriched growth factor composition, and potential autologous application of PL while simultaneouslypreserving the ability provided by MeGG to tailor mechanical properties, protein release kinetics, and shape of the construct according to the desired goal. Incorporation of PL in the hydrogels significantly improved cellular adhesion and viability in the constructs. The use of mitrolluidic tools allowed the design of a fiber-like hydrogel incorporating a gradient of PL along the length of the fiber. These spatial protein gradients led to the viability and cell number gradients caused by maintenance of human umbilical vein endothelial cells (HUVECs) survival in the fibers toward the PL-enriched sections in comparison with the nonloaded MeGG sections of the fibers. Altogether, we propose a proof of concept strategy to design a PL gradient biomaterial with potential in tissue engineering approaches and analysis of cell-microenvironment interactions.
C1 [Santo, Vitor E.; Babo, Pedro; Amador, Miguel; Coutinho, Daniela F.; Neves, Nuno M.; Mano, Joao F.; Reis, Rui L.; Gomes, Manuela E.] Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, AvePark, P-4806909 Taipas, Guimaraes, Portugal.
   [Santo, Vitor E.; Babo, Pedro; Amador, Miguel; Coutinho, Daniela F.; Neves, Nuno M.; Mano, Joao F.; Reis, Rui L.; Gomes, Manuela E.] ICVS 3Bs PT Govt Associate Lab, P-4710243 Braga, Portugal.
   [Santo, Vitor E.; Correia, Claudia; Cunha, Barbara] Inst Biol Expt & Tecnol, iBET, Apartado 12, P-2780901 Oeiras, Portugal.
RP Santo, VE; Gomes, ME (reprint author), Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, AvePark, P-4806909 Taipas, Guimaraes, Portugal.; Santo, VE; Gomes, ME (reprint author), ICVS 3Bs PT Govt Associate Lab, P-4710243 Braga, Portugal.
EM v.espirito.santo@ibet.pt; megomes@dep.uminho.pt
RI Neves, Nuno/B-4685-2008; Mano, Joao/A-4418-2009; Espirito Santo,
   Vitor/K-7668-2015; Reis, Rui L./A-8938-2008; Group, 3Bs/E-4374-2012;
   Gomes, Manuela/B-6282-2009
OI Neves, Nuno/0000-0003-3041-0687; Mano, Joao/0000-0002-2342-3765;
   Espirito Santo, Vitor/0000-0002-0854-0197; Reis, Rui
   L./0000-0002-4295-6129; Group, 3Bs/0000-0002-5195-3456; Gomes,
   Manuela/0000-0002-2036-6291; Babo, Pedro/0000-0003-4347-599X
FU Fundacao para a Ciencia e a Tecnologia (FCT) under project BIBS
   [PTDC/CVT/102972/2008]; FCT [SFRH/BPD/91072/2012, SFRH/BD/73403/2010]
FX The research leading to these results has received funding from Fundacao
   para a Ciencia e a Tecnologia (FCT) under project BIBS
   (PTDC/CVT/102972/2008). Vitor E. Santo acknowledges his FCT Post-Doc
   Fellowship SFRH/BPD/91072/2012 and Pedro S. Babo acknowledges his FCT
   Ph.D. Grant SFRH/BD/73403/2010.
CR Allazetta S, 2011, CHEM COMMUN, V47, P191, DOI 10.1039/c0cc02377a
   Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440
   Babo P, 2014, INFLAMMATION REGENER, V34
   Biswal D, 2008, BIOMED MICRODEVICES, V10, P213, DOI 10.1007/s10544-007-9127-6
   Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001
   Brennan MA, 2013, STEM CELL RES THER, V4, DOI [10.1186/scrt307, 10.1186/1757-6512-4-96]
   Lima AC, 2015, STEM CELL REV REP, V11, P161, DOI 10.1007/s12015-014-9548-6
   Chen FM, 2011, J CONTROL RELEASE, V149, P92, DOI 10.1016/j.jconrel.2010.10.021
   Chow LW, 2014, ADV HEALTHC MATER, V3, P1381, DOI 10.1002/adhm.201400032
   Chung BG, 2005, LAB CHIP, V5, P401, DOI 10.1039/b417651k
   Chung BG, 2012, LAB CHIP, V12, P45, DOI 10.1039/c1lc20859d
   Correia C, 2012, TISSUE ENG PT A, V18, P1979, DOI [10.1089/ten.tea.2012.0083, 10.1089/ten.TEA.2012.0083]
   Cosson S, 2009, ADV FUNCT MATER, V19, P3411, DOI 10.1002/adfm.200900968
   Coutinho DF, 2010, BIOMATERIALS, V31, P7494, DOI 10.1016/j.biomaterials.2010.06.035
   Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X
   Dinis TM, 2014, ACS APPL MATER INTER, V6, P16817, DOI 10.1021/am504159j
   Fekete N, 2012, CYTOTHERAPY, V14, P540, DOI 10.3109/14653249.2012.655420
   Gattazzo F, 2014, BBA-GEN SUBJECTS, V1840, P2506, DOI 10.1016/j.bbagen.2014.01.010
   Greiner AM, 2014, BIOMATERIALS, V35, P611, DOI 10.1016/j.biomaterials.2013.09.095
   Guo XL, 2012, BIOMACROMOLECULES, V13, P3262, DOI 10.1021/bm301029a
   Hamcerencu M, 2008, CARBOHYD POLYM, V71, P92, DOI 10.1016/j.carbpol.2007.05.021
   Han YL, 2014, DRUG DISCOV TODAY, V19, P763, DOI 10.1016/j.drudis.2014.01.015
   Huang NF, 2011, ANN BIOMED ENG, V39, P1201, DOI 10.1007/s10439-011-0297-2
   Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005
   Intini G, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-13
   Jeong GS, 2011, BIOMED MICRODEVICES, V13, P717, DOI 10.1007/s10544-011-9541-7
   Kamei K, 2015, BIOMED MICRODEVICES, V17, DOI 10.1007/s10544-015-9928-y
   Kharkar PM, 2013, CHEM SOC REV, V42, P7335, DOI 10.1039/c3cs60040h
   Kitagawa Y, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/3/035011
   Lacci Kathleen M., 2010, Yale Journal of Biology and Medicine, V83, P1
   Lee KH, 2014, J BIOMED MATER RES A, V102, P1164, DOI 10.1002/jbm.a.34772
   Li Q, 2003, MACROMOLECULES, V36, P2556, DOI 10.1021/ma021190w
   Mak M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020825
   Martineau I, 2004, BIOMATERIALS, V25, P4489, DOI 10.1016/j.biomaterials.2003.11.013
   Matsui M, 2012, ACTA BIOMATER, V8, P1792, DOI 10.1016/j.actbio.2012.01.016
   Mehta S, 2008, J ORTHOP TRAUMA, V22, P433, DOI 10.1097/BOT.0b013e31817e793f
   Messora MR, 2008, J PERIODONTAL RES, V43, P723, DOI 10.1111/j.1600-0765.2008.01084.x
   Metallo CM, 2007, BIOTECHNOL PROGR, V23, P18, DOI 10.1021/bp060350a
   Oliveira JT, 2010, TISSUE ENG PT A, V16, P343, DOI 10.1089/ten.TEA.2009.0117
   Oliveira JT, 2010, J ORTHOP RES, V28, P1193, DOI 10.1002/jor.21114
   Oliveira SM, 2016, ACTA BIOMATER, V32, P129, DOI 10.1016/j.actbio.2015.12.028
   Oliveira SM, 2015, BIOMATERIALS, V48, P56, DOI 10.1016/j.biomaterials.2015.01.020
   Park JY, 2009, STEM CELLS, V27, P2646, DOI 10.1002/stem.202
   Popa E, 2012, BIOTECHNOL APPL BIOC, V59, P132, DOI 10.1002/bab.1007
   Rada T, 2012, J TISSUE ENG REGEN M, V6, P1, DOI 10.1002/term.388
   Rada T, 2009, J TISSUE ENG REGEN M, V3, P158, DOI 10.1002/term.141
   Rada T, 2011, J TISSUE ENG REGEN M, V5, P655, DOI 10.1002/term.364
   Rada T, 2011, STEM CELL REV REP, V7, P64, DOI 10.1007/s12015-010-9147-0
   Sant S, 2010, CAN J CHEM ENG, V88, P899, DOI 10.1002/cjce.20411
   Santo VE, 2015, ACTA BIOMATER, V19, P56, DOI 10.1016/j.actbio.2015.03.015
   Santo VE, 2013, TISSUE ENG PART B-RE, V19, P327, DOI [10.1089/ten.teb.2012.0727, 10.1089/ten.TEB.2012.0727]
   Santo VE, 2013, TISSUE ENG PART B-RE, V19, P308, DOI [10.1089/ten.teb.2012.0138, 10.1089/ten.TEB.2012.0138]
   Santo VE, 2012, J CONTROL RELEASE, V162, P19, DOI 10.1016/j.jconrel.2012.06.001
   Santo VE, 2012, J TISSUE ENG REGEN M, V6, ps47, DOI 10.1002/term.1519
   Silva-Correia J, 2011, J TISSUE ENG REGEN M, V5, pE97, DOI 10.1002/term.363
   Silva-Correia J, 2013, ADV HEALTHC MATER, V2, P568, DOI 10.1002/adhm.201200256
   van Noort D, 2009, BIOTECHNOL PROGR, V25, P52, DOI [10.1021/bp.171, 10.1002/btpr.171]
   Verhulsel M, 2014, BIOMATERIALS, V35, P1816, DOI 10.1016/j.biomaterials.2013.11.021
   Vickerman V, 2008, LAB CHIP, V8, P1468, DOI 10.1039/b802395f
   Wade RJ, 2015, ADV MATER, V27, P1356, DOI 10.1002/adma.201404993
   Wang L, 2016, CLIM DYNAM, DOI [10.1007/s00382-016-3215-3, DOI 10.1007/S00382-016-3215-3]
NR 61
TC 7
Z9 7
U1 3
U2 37
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUN
PY 2016
VL 17
IS 6
BP 1985
EP 1997
DI 10.1021/acs.biomac.6b00150
PG 13
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA DO6WS
UT WOS:000377924800009
PM 27203709
DA 2018-10-19
ER

PT J
AU Atyabi, SM
   Sharifi, F
   Irani, S
   Zandi, M
   Mivehchi, H
   Nagheh, Z
AF Atyabi, Seyed Mohammad
   Sharifi, Fereshteh
   Irani, Shiva
   Zandi, Mojgan
   Mivehchi, Houri
   Nagheh, Zahra
TI Cell Attachment and Viability Study of PCL Nano-fiber Modified by Cold
   Atmospheric Plasma
SO CELL BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE Tissue engineering; Nano-fiber; Surface modification; Cold plasma
   atmospheric
ID SURFACE MODIFICATION; SCAFFOLDS; PROLIFERATION; NANOTECHNOLOGY; ACID;
   JET
AB The field of tissue engineering is an emerging discipline which applies the basic principles of life sciences and engineering to repair and restore living tissues and organs. The purpose of this study was to investigate the effect of cold and non-thermal plasma surface modification of poly (e-caprolactone) (PCL) scaffolds on fibroblast cell behavior. Nano-fiber PCL was fabricated through electro-spinning technique, and some fibers were then treated by cold and non-thermal plasma. The cell-biomaterial interactions were studied by culturing the fibroblast cells on nano-fiber PCL. Scaffold biocompatibility test was assessed using an inverted microscope. The growth and proliferation of fibroblast cells on nano-fiber PCL were analyzed by MTT viability assay. Cellular attachment on the nanofiber and their morphology were evaluated using scanning electron microscope. The result of cell culture showed that nano-fiber could support the cellular growth and proliferation by developing three-dimensional topography. The present study demonstrated that the nano-fiber surface modification with cold plasma sharply enhanced the fibroblast cell attachment. Thus, cold plasma surface modification greatly raised the bioactivity of scaffolds.
C1 [Atyabi, Seyed Mohammad] Pasteur Inst Iran, Dept Pilot Biotechnol, Tehran, Iran.
   [Sharifi, Fereshteh; Irani, Shiva; Nagheh, Zahra] Islamic Azad Univ, Sci & Res Branch, Dept Biol, Tehran, Iran.
   [Zandi, Mojgan; Mivehchi, Houri] Iran Polymer & Petrochem Inst, Dept Biomat, Tehran, Iran.
RP Irani, S (reprint author), Islamic Azad Univ, Sci & Res Branch, Dept Biol, Tehran, Iran.
EM shi_irani@yahoo.com
OI Irani, Shiva/0000-0002-4202-9931
CR Adams J. C., 2002, METHODS CELL BIOL ME
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Cheng C, 2006, SURF COAT TECH, V200, P6659, DOI 10.1016/j.surfcoat.2005.09.033
   Chung T., 2009, MAT SCI, V20, P379
   Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715
   Cunha C, 2011, NANOMED-NANOTECHNOL, V7, P50, DOI 10.1016/j.nano.2010.07.004
   Domingos M, 2013, ACTA BIOMATER, V9, P5997, DOI 10.1016/j.actbio.2012.12.031
   Gloria A, 2009, J APPL BIOMATER BIOM, V7, P141
   Hauser J, 2009, J MATER SCI-MATER M, V20, P2541, DOI 10.1007/s10856-009-3826-x
   Jha BS, 2011, ACTA BIOMATER, V7, P203, DOI 10.1016/j.actbio.2010.08.004
   Keck M., 2013, SKIN TISSUE ENG, V13, P13
   Kim H. N., 2012, ADV DRUG DELIVERY RE, V65, P389
   Kim MC, 2003, SURF COAT TECH, V171, P312, DOI 10.1016/S0257-8972(03)00292-5
   Kumar G, 2012, BIOMATERIALS, V33, P4022, DOI 10.1016/j.biomaterials.2012.02.048
   Kumbar SG, 2008, BIOMATERIALS, V29, P4100, DOI 10.1016/j.biomaterials.2008.06.028
   Lee HU, 2008, APPL SURF SCI, V254, P5700, DOI 10.1016/j.apsusc.2008.03.049
   Mahmod G., PLASMA PHYS
   Masao Y., 2009, ENG TECHNOLOGY, V58, P171
   Prabhakaran MP, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/45/455102
   Pramanik S, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/4/043002
   Renata A. N. P., 2010, CARBOHYD POLYM, V82, P692
   Santis RD, 2011, J APPL POLYM SCI, V122, P3599
   Sasmazel HT, 2009, NATO SCIENCE PEACE S, P533, DOI 10.1007/978-1-4020-9916-8_55
   Shashurin A, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3020223
   Shi JJ, 2010, NANO LETT, V10, P3223, DOI 10.1021/nl102184c
   Supp D., 2005, CLIN DERMATOL, V4, P203
   Vance RJ, 2004, BIOMATERIALS, V25, P2095, DOI 10.1016/j.biomaterials.2003.08.064
   Yildirim ED, 2008, PLASMA PROCESS POLYM, V5, P58, DOI 10.1002/ppap.200700041
   Yildirim ED, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/1/014109
   Zhu XL, 2008, BIOMACROMOLECULES, V9, P1795, DOI 10.1021/bm800476u
NR 30
TC 6
Z9 6
U1 0
U2 9
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1085-9195
EI 1559-0283
J9 CELL BIOCHEM BIOPHYS
JI Cell Biochem. Biophys.
PD JUN
PY 2016
VL 74
IS 2
BP 181
EP 190
DI 10.1007/s12013-015-0718-1
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA DO5NX
UT WOS:000377830900009
PM 27286857
DA 2018-10-19
ER

PT J
AU Alex, MJ
   Periasamy, P
   Mohan, K
   Sekar, S
   Prabha, KKS
   Venkatachalam, R
AF Alex, Martina Jenitha
   Periasamy, Prabu
   Mohan, Kalirajan
   Sekar, Sankar
   Prabha, Kavitha Kandiah Suriya
   Venkatachalam, Rajendran
TI In situ synthesised TiO2-chitosan-chondroitin 4-sulphate nanocomposites
   for bone implant applications
SO IET NANOBIOTECHNOLOGY
LA English
DT Article
DE titanium compounds; filled polymers; nanocomposites; bone; orthopaedics;
   biomedical materials; sol-gel processing; nanofabrication; particle
   size; swelling; microorganisms; cellular biophysics; nanomedicine;
   prosthetics; in situ synthesised TiO2-chitosan-chondroitin 4-sulphate
   nanocomposites; bone implant applications; artificial materials; in situ
   sol-gel method; particle size; swelling nature; antimicrobial nature;
   microorganisms; Staphylococcus aureus; Escherichia coli; cell viability;
   MG-63; biomaterial; size 30 nm to 50 nm; TiO2
ID TISSUE ENGINEERING APPLICATIONS; COMPOSITE SCAFFOLDS; GROWTH-FACTOR;
   CHITOSAN; NANOPARTICLES; FABRICATION; MEMBRANES; TITANIA; TIO2
AB The artificial materials for bone implant applications are gaining more importance in the recent years. The series titania-chitosan-chondroitin 4-sulphate nanocomposites of three different concentrations (2:1:x, where x- 0.125, 0.25, 0.5) have been synthesised by in situ sol-gel method and characterised by various techniques. The particle size of the nanocomposites ranges from 30-50 nm. The bioactivity, swelling nature, and the antimicrobial nature of the nanocomposites were investigated. The swelling ability and bioactivity of the composites is significantly greater and they possess high zone of inhibition against the microorganisms such as Staphylococcus aureus and Escherichia coli. The cell viability of the nanocomposites were evaluated by using MG-63 and observed the composites possess high cell viability at low concentration. The excellent bioactivity and biocompatibility makes these nanocomposites a promising biomaterial for bone implant applications.
C1 [Alex, Martina Jenitha; Periasamy, Prabu; Mohan, Kalirajan; Sekar, Sankar; Prabha, Kavitha Kandiah Suriya; Venkatachalam, Rajendran] KS Rangasamy Coll Technol, Ctr Nano Sci & Technol, Tiruchengode 637215, Tamil Nadu, India.
RP Periasamy, P (reprint author), KS Rangasamy Coll Technol, Ctr Nano Sci & Technol, Tiruchengode 637215, Tamil Nadu, India.
EM prabukrp@gmail.com
OI VENKATACHALAM, RAJENDRAN/0000-0001-9471-5311
CR Amin KAM, 2012, POLYMERS-BASEL, V4, P590, DOI 10.3390/polym4010590
   Bjornson A, 2005, AM J PHYSIOL-RENAL, V288, pF748, DOI 10.1152/ajprenal.00202.2004
   Hua D, 2007, T NONFERR METAL SOC, V17, pS700
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Di Vona ML, 2007, J MEMBRANE SCI, V296, P156, DOI 10.1016/j.memsci.2007.03.037
   Facca S, 2011, J BIOMED NANOTECHNOL, V7, P482, DOI 10.1166/jbn.2011.1311
   Fisher J. P., 2003, TOPICS TISSUE ENG, P1
   Ganza Gonzalez A., 1999, EUROPEAN J PHARM BIO, V48, P149, DOI [10.1016/S0939-6411(99)00040-5, DOI 10.1016/S0939-6411(99)00040-5]
   He JK, 2009, ACTA BIOMATER, V5, P453, DOI 10.1016/j.actbio.2008.07.002
   Ho MH, 2005, BIOMATERIALS, V26, P3197, DOI 10.1016/j.biomaterials.2004.08.032
   Iouv M, 2008, OSTEOARTHR CARTILAGE, V16, P14, DOI [10.1016/j.joca.2008.06.008, DOI 10.1016/J.JOCA.2008.06.008]
   Jayachandran V., 2012, INT J BIOL MACROMOL, V51, P1033, DOI [10.1016/j.ijbiomac.2012.08.020, DOI 10.1016/J.IJBIOMAC.2012.08.020]
   Jayakumar R, 2011, INT J BIOL MACROMOL, V49, P274, DOI 10.1016/j.ijbiomac.2011.04.020
   Jiang LY, 2008, CARBOHYD POLYM, V74, P680, DOI 10.1016/j.carbpol.2008.04.035
   Jing H., 2012, CARBOHYD POLYM, V90, P122, DOI [10.1016/j.carbpol.2012.04.068, DOI 10.1016/J.CARBPOL.2012.04.068]
   Joana M., 2012, ACTA BIOMATER, V8, P4173, DOI [10.1016/j.actbio.2012.06.040, DOI 10.1016/J.ACTBIO.2012.06.040]
   Kavitha K, 2013, CURR NANOSCI, V9, P308, DOI 10.2174/1573413711309030003
   Kavitha K, 2013, CARBOHYD POLYM, V93, P731, DOI 10.1016/j.carbpol.2012.12.031
   Kavya KC, 2012, J BIOMED NANOTECHNOL, V8, P149, DOI 10.1166/jbn.2012.1363
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Li Z., 2009, J MATER SCI-MATER M, V20, P949
   Lin YS, 2010, J BIOMED NANOTECHNOL, V6, P247, DOI 10.1166/jbn.2010.1122
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Luo YB, 2009, APPL SURF SCI, V255, P6795, DOI 10.1016/j.apsusc.2009.02.074
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Manero J M, 2002, Implant Dent, V11, P170, DOI 10.1097/00008505-200204000-00019
   Maria de la F, 2008, INVEST OPHTH VIS SCI, V49, P2016, DOI [10.1167/iovs.07-1077, DOI 10.1167/IOVS.07-1077]
   Markovic M, 2004, J RES NATL INST STAN, V109, P553, DOI 10.6028/jres.109.042
   Mi FL, 2006, J BIOMED MATER RES A, V76A, P1, DOI 10.1002/jbm.a.30298
   Morimoto M, 2001, BIOMACROMOLECULES, V2, P1133, DOI 10.1021/bm010063p
   Park YJ, 2000, J CONTROL RELEASE, V67, P385, DOI 10.1016/S0168-3659(00)00232-7
   Peter M, 2010, CARBOHYD POLYM, V80, P687, DOI 10.1016/j.carbpol.2009.11.050
   Ramalingam S, 2009, J SOLID STATE ELECTR, V13, P1777, DOI 10.1007/s10008-009-0870-x
   Singla AK, 2001, J PHARM PHARMACOL, V53, P1047, DOI 10.1211/0022357011776441
   Smriti Sharma Vivek P, 2009, J MATER SCI-MATER M, V20, P1427
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Vitor Santo E., 2010, J SUPERCRIT FLUID, V54, P320, DOI [10.1016/j.supflu.2010.05.021, DOI 10.1016/J.SUPFLU.2010.05.021]
   Williams D, 2004, MATER TODAY, V7, P24, DOI 10.1016/S1369-7021(04)00232-9
   Yang D, 2009, CHEM ENG SCI, V64, P3130, DOI 10.1016/j.ces.2009.03.042
   Yang WJ, 2009, J BIOMED NANOTECHNOL, V5, P591, DOI 10.1166/jbn.2009.1067
   Yeh MK, 2011, ACTA BIOMATER, V7, P3804, DOI 10.1016/j.actbio.2011.06.026
   Yen Lin C., 2007, BIOMATERIALS, V28, P2294, DOI [10.1016/j.biomaterials.2007.01.027, DOI 10.1016/J.BIOMATERIALS.2007.01.027]
   Yuan NY, 2008, DESALINATION, V234, P166, DOI 10.1016/j.desal.2007.09.083
NR 44
TC 3
Z9 3
U1 2
U2 14
PU INST ENGINEERING TECHNOLOGY-IET
PI HERTFORD
PA MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND
SN 1751-8741
EI 1751-875X
J9 IET NANOBIOTECHNOL
JI IET Nanobiotechnol.
PD JUN
PY 2016
VL 10
IS 3
BP 107
EP 113
DI 10.1049/iet-nbt.2015.0023
PG 7
WC Biochemical Research Methods; Nanoscience & Nanotechnology
SC Biochemistry & Molecular Biology; Science & Technology - Other Topics
GA DO5MA
UT WOS:000377826000002
PM 27256888
DA 2018-10-19
ER

PT J
AU Sen, DG
   Najjar, M
   Yimaz, B
   Levasseur, SM
   Kalessan, B
   Quaegebeur, JM
   Bacha, EA
AF Sen, Danielle Gottlieb
   Najjar, Marc
   Yimaz, Betul
   Levasseur, Stephanie M.
   Kalessan, Bindu
   Quaegebeur, Jan M.
   Bacha, Emile A.
TI Aiming to Preserve Pulmonary Valve Function in Tetralogy of Fallot
   Repair: Comparing a New Approach to Traditional Management
SO PEDIATRIC CARDIOLOGY
LA English
DT Article
DE Tetralogy of Fallot; Pulmonary valve; Valve-sparing repair; Transannular
   patch repair
ID RECONSTRUCTION; OUTCOMES; TERM
AB Pulmonary valve (PV) incompetence following transannular patch (TAP) repair of tetralogy of Fallot (TOF) results in long-term morbidity and mortality. Valve-sparing repairs have recently gained recognition; however, they may be associated with residual pulmonary stenosis (PS) in patients with small PV z scores. We sought to determine whether a repair that increases the PV annulus and augments the valve leaflet with a biomaterial would result in annular growth and in longer duration of valve competence compared with TAP. Eighty patients (median age 136 days, range 4-350) who underwent surgical repair of TOF between 2010 and 2014 were included in the study. Patients were divided into three groups based on the PV intervention: balloon dilation/valvotomy (n = 29), valve-sparing transannular repair (VSTAR) (n = 19) and TAP (n = 32). Intraoperative, early postoperative and midterm follow-up echocardiographic data (median 19 months, range 1-59) were obtained. The primary outcomes were the presence and severity of pulmonary regurgitation and/or PS. Compared with TAP, VSTAR patients demonstrated significantly less severe PR with 100 % freedom of severe PR immediately post-op (vs. 0 % in TAP), 60 % at 6 months and 20 % at 20 months. There were no differences in PS between VSTAR and TAP at follow-up. A subgroup analysis of the VSTAR group was performed. PV z scores were calculated and fit to a random effects model. Patient data fit the model closely, predicting a reproducible increase in valve annulus size over time. With better short-term and comparable midterm results, VSTAR may be appropriate for TOF repair in patients with small PV that would conventionally require a TAP.
C1 [Sen, Danielle Gottlieb; Najjar, Marc; Levasseur, Stephanie M.; Kalessan, Bindu; Quaegebeur, Jan M.; Bacha, Emile A.] Columbia Univ, Pediat Cardiac Surg, Morgan Stanley Childrens Hosp New York Presbyteri, New York, NY 10027 USA.
   [Sen, Danielle Gottlieb] New Orleans Childrens Hosp, Pediat Cardiac Surg, New Orleans, LA USA.
   [Yimaz, Betul] Columbia Univ, Morgan Stanley Childrens Hosp New York Presbyteri, Pediat Cardiol, New York, NY USA.
   [Yimaz, Betul] Texas Childrens Hosp, Pediat Cardiol, Houston, TX 77030 USA.
RP Bacha, EA (reprint author), Columbia Univ, Pediat Cardiac Surg, Morgan Stanley Childrens Hosp New York Presbyteri, New York, NY 10027 USA.
EM mn2594@cumc.columbia.edu; eb2709@cumc.columbia.edu
CR Anagnostopoulos P, 2007, J THORAC CARDIOV SUR, V133, P640, DOI 10.1016/j.jtcvs.2006.10.039
   Bacha Emile, 2012, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V15, P24, DOI 10.1053/j.pcsu.2012.01.006
   Bautista-Hernandez V, 2013, PEDIATR CARDIOL, V34, P918, DOI 10.1007/s00246-012-0574-3
   Brown JW, 2007, J THORAC CARDIOV SUR, V133, P1336, DOI 10.1016/j.jtcvs.2006.12.045
   Geva T, 2013, CIRCULATION, V128, P1855, DOI 10.1161/CIRCULATIONAHA.113.005878
   Horton KD, 2009, J AM SOC ECHOCARDIOG, V22, P776, DOI 10.1016/j.echo.2009.04.027
   Hua ZD, 2011, EUR J CARDIO-THORAC, V40, P1221, DOI 10.1016/j.ejcts.2011.02.035
   Ito H, 2013, INTERACT CARDIOV TH, V16, P802, DOI 10.1093/icvts/ivt095
   MURPHY JG, 1993, NEW ENGL J MED, V329, P593, DOI 10.1056/NEJM199308263290901
   Nath DS, 2010, ANN THORAC SURG, V90, P42, DOI 10.1016/j.athoracsur.2010.03.045
   Ngodgnamthaweesuk M, 2012, ASIAN CARDIOVASC THO, V21, P9
   Stewart RD, 2005, ANN THORAC SURG, V80, P1431, DOI 10.1016/j.athoracsur.2005.04.016
   Sung SC, 2003, ANN THORAC SURG, V75, P303, DOI 10.1016/S0003-4975(02)03926-7
   Valente AM, 2014, HEART, V100, P247, DOI 10.1136/heartjnl-2013-304958
NR 14
TC 10
Z9 10
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0172-0643
EI 1432-1971
J9 PEDIATR CARDIOL
JI Pediatr. Cardiol.
PD JUN
PY 2016
VL 37
IS 5
BP 818
EP 825
DI 10.1007/s00246-016-1355-1
PG 8
WC Cardiac & Cardiovascular Systems; Pediatrics
SC Cardiovascular System & Cardiology; Pediatrics
GA DO3ZX
UT WOS:000377722400003
PM 26921062
DA 2018-10-19
ER

PT J
AU Mariot, P
   Leeflang, MA
   Schaeffer, L
   Zhou, J
AF Mariot, P.
   Leeflang, M. A.
   Schaeffer, L.
   Zhou, J.
TI An investigation on the properties of injection-molded pure iron
   potentially for biodegradable stent application
SO POWDER TECHNOLOGY
LA English
DT Article
DE Iron; Biodegradable material; Metal injection molding; In vitro
   degradation; Corrosion
ID CONGENITAL HEART-DISEASE; FE-MN ALLOYS; CORONARY STENTS;
   MECHANICAL-PROPERTIES; POWDER-METALLURGY; MICRO-NANOPOWDER; POROUS
   TITANIUM; BEHAVIOR; MICROSTRUCTURE; CYTOTOXICITY
AB Metal injection molding (MIM) is a near-net-shape manufacturing process suitable for the production of small size and complex-shape components. As a cost-effective and flexible manufacturing method, it may have distinct advantages over other methods when it comes to the manufacturing of implantable medical devices. However, up till now, the potential for MIM to be employed in the commercial-scale manufacturing of implantable medical devices has been insufficiently exploited. In the present research, an attempt was made to produce porous pure iron, as a metallic degradable biomaterial potentially for stent application, via the MIM route. The effects of iron powder loading and sintering temperature on the porosity, microstructure, mechanical properties, surface properties and in vitro degradation behavior of MIM iron were investigated. The results obtained were compared to those of cast iron. It was found that the amount of porosity retained in the as-sintered specimens had a major effect on their surface and mechanical properties. MIM iron exhibited strengths between those of magnesium alloys and 316 L stainless steel and very high ductility-a specially required property of stent materials. Its degradation rates in Hank's solution were superior to the degradation rate of cast iron. Interestingly, the material made from the feedstock containing 66% of iron powder, above the critical powder loading, showed the highest elongation and a good in vitro degradation rate. In conclusion, MIM is a promising method to be developed as a new route to produce thin-wall tubes for biodegradable stents. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Mariot, P.; Schaeffer, L.] Univ Fed Rio Grande do Sul, Fac Engn, Lab Mech Transformat LdTM, Ave Bento Goncalves 9500,POB 15021, BR-91501970 Porto Alegre, RS, Brazil.
   [Leeflang, M. A.; Zhou, J.] Delft Univ Technol, Dept Biomech Engn, NL-2628 CD Delft, Netherlands.
RP Mariot, P (reprint author), Univ Fed Rio Grande do Sul, Fac Engn, Lab Mech Transformat LdTM, Ave Bento Goncalves 9500,POB 15021, BR-91501970 Porto Alegre, RS, Brazil.
EM paulo.mariot@ufrgs.br; m.a.leeflang@tudelft.nl; schaefer@ufrgs.br;
   J.Zhou@tudelft.nl
RI Zhou, Jie/J-3019-2012
OI Zhou, Jie/0000-0002-6484-9156; Leeflang, Marius
   Alexander/0000-0003-1702-7413
FU Coordination for the Improvement of Higher Education Personnel (CAPES);
   Brazilian government [CAPES/AUX 993/2009]
FX The research was supported by the Coordination for the Improvement of
   Higher Education Personnel (CAPES) and financed by the Brazilian
   government under the project number CAPES/AUX 993/2009.
CR Aggarwal G, 2007, INT J REFRACT MET H, V25, P226, DOI 10.1016/j.ijrmhm.2006.05.005
   [Anonymous], US Patent, Patent No. [US 8303642 B1, 8303642]
   Ashby DT, 2002, CATHETER CARDIO INTE, V56, P83, DOI 10.1002/ccd.10209
   *ASTM, 2001, ANN BOOK ASTM STAND
   ASTM, 2004, ANN BOOK ASTM STAND
   Banerjee D, 2013, ACTA MATER, V61, P844, DOI 10.1016/j.actamat.2012.10.043
   Bowen PK, 2013, MAT SCI ENG C-MATER, V33, P5064, DOI 10.1016/j.msec.2013.08.042
   Capek J, 2014, MAT SCI ENG C-MATER, V35, P21, DOI 10.1016/j.msec.2013.10.014
   Chen G, 2013, MAT SCI ENG A-STRUCT, V582, P117, DOI 10.1016/j.msea.2013.05.082
   Chen LJ, 2009, T NONFERR METAL SOC, V19, P1174, DOI 10.1016/S1003-6326(08)60424-0
   Chen XB, 2009, ACTA BIOMATER, V5, P2290, DOI 10.1016/j.actbio.2009.02.027
   Choi JP, 2015, POWDER TECHNOL, V279, P196, DOI 10.1016/j.powtec.2015.04.014
   Choi JP, 2014, POWDER TECHNOL, V253, P596, DOI 10.1016/j.powtec.2013.11.048
   Demangel C, 2012, MAT SCI ENG C-MATER, V32, P1919, DOI 10.1016/j.msec.2012.05.037
   Fagali NS, 2015, COLLOID SURFACE B, V128, P480, DOI 10.1016/j.colsurfb.2015.02.047
   Gu X., 2009, BIOMATERIALS, V9, P484
   Hausnerova B, 2011, NEW TRENDS AND DEVELOPMENTS IN AUTOMOTIVE SYSTEM ENGINEERING, P129
   Hermawan H, 2008, POWDER METALL, V51, P38, DOI 10.1179/174329008X284868
   Hermawan H, 2013, ACTA BIOMATER, V9, P8585, DOI 10.1016/j.actbio.2013.04.027
   Hermawan H, 2010, ACTA BIOMATER, V6, P1852, DOI 10.1016/j.actbio.2009.11.025
   Huan Z, 2012, APPL SURF SCI, V258, P5244, DOI 10.1016/j.apsusc.2012.02.002
   Huang HH, 2004, BIOMOL ENG, V21, P93, DOI 10.1016/j.bioeng.2004.05.001
   Kafkas F, 2014, J ALLOY COMPD, V617, P359, DOI 10.1016/j.jallcom.2014.07.168
   Kong X, 2012, J MATER PROCESS TECH, V212, P2173, DOI 10.1016/j.jmatprotec.2012.05.023
   Levesque J, 2008, ACTA BIOMATER, V4, P284, DOI 10.1016/j.actbio.2007.09.012
   Li YMM, 2007, J MATER PROCESS TECH, V183, P432, DOI 10.1016/j.jmatprotec.2006.10.039
   Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042
   Migliavacca F, 2005, MED ENG PHYS, V27, P13, DOI 10.1016/j.medengphy.2004.08.012
   Moravej M, 2010, ACTA BIOMATER, V6, P1726, DOI 10.1016/j.actbio.2010.01.010
   Moravej M, 2011, INT J MOL SCI, V12, P4250, DOI 10.3390/ijms12074250
   Mueller P.P., 2006, BIOMATERIALS, V27, P4955
   MULLINS CE, 1988, CIRCULATION, V77, P188, DOI 10.1161/01.CIR.77.1.188
   Okubo M, 2001, CURR OPIN CARDIOL, V16, P84, DOI 10.1097/00001573-200103000-00002
   OLAUGHLIN MP, 1991, CIRCULATION, V83, P1923, DOI 10.1161/01.CIR.83.6.1923
   PULEO DA, 1995, J APPL BIOMATER, V6, P109, DOI 10.1002/jab.770060205
   Shongwe MB, 2015, J ALLOY COMPD, V649, P824, DOI 10.1016/j.jallcom.2015.07.223
   Song B, 2014, OPT LASER TECHNOL, V56, P451, DOI 10.1016/j.optlastec.2013.09.017
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Suwaidi Jassim Al, 2000, JAMA (Journal of the American Medical Association), V284, P1828
   Waksman R, 2006, CATHETER CARDIOVASC, V68, P606
   Waksman Ron, 2006, J Interv Cardiol, V19, P414, DOI 10.1111/j.1540-8183.2006.00187.x
   Waksman R, 2007, CATHETER CARDIO INTE, V70, P407, DOI 10.1002/ccd.21176
   Yin HQ, 2008, J UNIV SCI TECHNOL B, V15, P480, DOI 10.1016/S1005-8850(08)60090-0
   Zhang EL, 2010, J MATER SCI-MATER M, V21, P2151, DOI 10.1007/s10856-010-4070-0
   Zhu SF, 2009, MAT SCI ENG C-BIO S, V29, P1589, DOI 10.1016/j.msec.2008.12.019
NR 45
TC 7
Z9 7
U1 3
U2 50
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0032-5910
EI 1873-328X
J9 POWDER TECHNOL
JI Powder Technol.
PD JUN
PY 2016
VL 294
BP 226
EP 235
DI 10.1016/j.powtec.2016.02.042
PG 10
WC Engineering, Chemical
SC Engineering
GA DO4BJ
UT WOS:000377726500024
DA 2018-10-19
ER

PT J
AU Berns, EJ
   Alvarez, Z
   Goldberger, JE
   Boekhoven, J
   Kessler, JA
   Kuhn, HG
   Stupp, SI
AF Berns, Eric J.
   Alvarez, Zaida
   Goldberger, Joshua E.
   Boekhoven, Job
   Kessler, John A.
   Kuhn, H. Georg
   Stupp, Samuel I.
TI A tenascin-C mimetic peptide amphiphile nanofiber gel promotes neurite
   outgrowth and cell migration of neurosphere-derived cells
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Self assembly; Tenascin-C mimetic peptide; Peptide amphiphile; Neurite
   growth; Cell migration
ID ALTERNATIVELY SPLICED REGION; SPINAL-CORD-INJURY; PROGENITOR CELLS;
   MONODOMAIN GELS; BETA-1-INTEGRINS; DIFFERENTIATION; BIOMATERIALS;
   GENERATION; SURFACES; NEURONS
AB Biomimetic materials that display natural bioactive signals derived from extracellular matrix molecules like laminin and fibronectin hold promise for promoting regeneration of the nervous system. In this work, we investigated a biomimetic peptide amphiphile (PA) presenting a peptide derived from the extracellular glycoprotein tenascin-C, known to promote neurite outgrowth through interaction with beta 1 integrin. The tenascin-C mimetic PA (TN-C PA) was found to self-assemble into supramolecular nanofibers and was incorporated through co-assembly into PA gels formed by highly aligned nanofibers. TN-C PA content in these gels increased the length and number of neurites produced from neurons differentiated from encapsulated P19 cells. Furthermore, gels containing TN-C PA were found to increase migration of cells out of neurospheres cultured on gel coatings. These bioactive gels could serve as artificial matrix therapies in regions of neuronal loss to guide neural stem cells and promote through biochemical cues neurite extension after differentiation. One example of an important target would be their use as biomaterial therapies in spinal cord injury.
   Statement of Significance
   Tenascin-C is an important extracellular matrix molecule in the nervous system and has been shown to play a role in regenerating the spinal cord after injury and guiding neural progenitor cells during brain development, however, minimal research has been reported exploring the use of biomimetic biomaterials of tenascin-C. In this work, we describe a selfassembling biomaterial system in which peptide amphiphiles present a peptide derived from tenascin-C that promotes neurite outgrowth. Encapsulation of neurons in hydrogels of aligned nanofibers formed by tenascin-C-mimetic peptide amphiphiles resulted in enhanced neurite outgrowth. Additionally, these peptide amphiphiles promoted migration of neural progenitor cells cultured on nanofiber coatings. Tenascin-C biomimetic biomaterials such as the one described here have significant potential in neuroregenerative medicine. (c) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Berns, Eric J.; Stupp, Samuel I.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
   [Alvarez, Zaida; Boekhoven, Job; Stupp, Samuel I.] Northwestern Univ, Simpson Querrey Inst BioNanotechnol, Chicago, IL 60611 USA.
   [Goldberger, Joshua E.; Stupp, Samuel I.] Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.
   [Kessler, John A.] Northwestern Univ, Dept Neurol, Chicago, IL 60611 USA.
   [Kuhn, H. Georg] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Ctr Brain Repair & Rehabil, S-41390 Gothenburg, Sweden.
   [Stupp, Samuel I.] Northwestern Univ, Dept Mat Sci & Engn, 2220 Campus Dr, Evanston, IL 60208 USA.
   [Stupp, Samuel I.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA.
   [Goldberger, Joshua E.] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA.
RP Stupp, SI (reprint author), Northwestern Univ, Dept Mat Sci & Engn, 2220 Campus Dr, Evanston, IL 60208 USA.
EM eric-berns@u.northwestern.edu; zaida.pinto@northwestern.edu;
   goldberger@chemistry.ohio-state.edu; job.boekhoven@northwestern.edu;
   jakessler@northwestern.edu; Georg.Kuhn@neuro.gu.se;
   s-stupp@northwestern.edu
RI Goldberger, Joshua/F-5484-2011; Stupp, Samuel/B-6737-2009; Goldberger,
   Joshua/N-8963-2016
OI Goldberger, Joshua/0000-0003-4284-604X; Goldberger,
   Joshua/0000-0003-4284-604X; Boekhoven, Job/0000-0002-9126-2430; Kuhn,
   Hans-Georg/0000-0003-4247-5613
FU National Institutes of Health/National Institute of Biomedical Imaging
   And Bioengineering [5R01EB003806-07]; Center for Regenerative
   Nanomedicine at the Simpson Querrey Institute for BioNanotechnology at
   Northwestern; National Institutes of Health [F32EB007131]; U.S. Army
   Research Office; U.S. Army Medical Research and Materiel Command;
   Department of Energy; Frederick S. Upton Foundation; Northwestern
   University; NCI CCSG [P30 CA060553]; U.S. DOE [DE-AC02-06CH11357]
FX This project was supported by National Institutes of Health/National
   Institute of Biomedical Imaging And Bioengineering Award Number
   5R01EB003806-07 and by the Center for Regenerative Nanomedicine at the
   Simpson Querrey Institute for BioNanotechnology at Northwestern. J.E.G.
   received postdoctoral support from the National Institutes of Health
   Award Number F32EB007131. Peptide synthesis was performed in the Peptide
   Synthesis Core Facility and cell culture was performed in the
   Nanomedicine Cleanroom of the Simpson Querrey Institute at Northwestern
   University. The U.S. Army Research Office, the U.S. Army Medical
   Research and Materiel Command, the Department of Energy, the Frederick
   S. Upton Foundation and Northwestern University provided funding to
   develop these facilities. Imaging was performed at the Northwestern
   University Center for Advanced Microscopy generously supported by NCI
   CCSG P30 CA060553 awarded to the Robert H Lurie Comprehensive Cancer
   Center. SEM was performed at the Electron Probe Instrumentation Center
   of the NUANCE Center at Northwestern University, which is supported by
   NSF-NSEC, NSF-MRSEC, Keck Foundation, the State of Illinois, and
   Northwestern University. Use of the Advanced Photon Source, an Office of
   Science User Facility operated for the U.S. Department of Energy (DOE)
   Office of Science by Argonne National Laboratory, was supported by the
   U.S. DOE under Contract No. DE-AC02-06CH11357. The authors acknowledge
   Tammy McGuire for isolation of neural progenitor cells and Dr. Steven
   Weigand for assistance with SAXS experiments.
CR Ahmed I, 2006, J BIOMED MATER RES A, V76A, P851, DOI 10.1002/jbm.a.30587
   Beniash E, 2005, ACTA BIOMATER, V1, P387, DOI 10.1016/j.actbio.2005.04.002
   Berns EJ, 2014, BIOMATERIALS, V35, P185, DOI 10.1016/j.biomaterials.2013.09.077
   Collier JH, 2011, BIOMATERIALS, V32, P4198, DOI 10.1016/j.biomaterials.2011.02.030
   Garcion E, 2004, DEVELOPMENT, V131, P3423, DOI 10.1242/dev.01202
   Goldberger JE, 2011, ANGEW CHEM INT EDIT, V50, P6292, DOI 10.1002/anie.201100202
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Jacques TS, 1998, DEVELOPMENT, V125, P3167
   Leone DP, 2005, J CELL SCI, V118, P2589, DOI 10.1242/jcs.02396
   MacPherson P., 1995, METHODS, V65, P1093
   Matson JB, 2011, CURR OPIN SOLID ST M, V15, P225, DOI 10.1016/j.cossms.2011.08.001
   Meiners S, 2001, J NEUROSCI, V21, P7215, DOI 10.1523/JNEUROSCI.21-18-07215.2001
   Mercado MLT, 2004, J NEUROSCI, V24, P238, DOI 10.1523/JNEUROSCI.4519-03.2004
   Pan LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104335
   Peramo A, 2006, LANGMUIR, V22, P3228, DOI 10.1021/la051166m
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Sever M, 2014, BIOMACROMOLECULES, V15, P4480, DOI 10.1021/bm501271x
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Thomas LB, 1996, GLIA, V17, P1
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A
   Webber MJ, 2010, J INTERN MED, V267, P71, DOI 10.1111/j.1365-2796.2009.02184.x
   Webber MJ, 2013, ISR J CHEM, V53, P530, DOI 10.1002/ijch.201300046
   Yu YM, 2011, NEUROSCIENCE, V183, P238, DOI 10.1016/j.neuroscience.2011.03.043
   Zhang SM, 2010, NAT MATER, V9, P594, DOI [10.1038/nmat2778, 10.1038/NMAT2778]
   Zhang Y, 1997, J NEUROSCI RES, V49, P433
NR 29
TC 14
Z9 14
U1 5
U2 58
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2016
VL 37
BP 50
EP 58
DI 10.1016/j.actbio.2016.04.010
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DN8FM
UT WOS:000377314600006
PM 27063496
OA Green Accepted, Other Gold
DA 2018-10-19
ER

PT J
AU Bishop, CJ
   Majewski, RL
   Guiriba, TRM
   Wilson, DR
   Bhise, NS
   Quinones-Hinojosa, A
   Green, JJ
AF Bishop, Corey J.
   Majewski, Rebecca L.
   Guiriba, Toni-Rose M.
   Wilson, David R.
   Bhise, Nupura S.
   Quinones-Hinojosa, Alfredo
   Green, Jordan J.
TI Quantification of cellular and nuclear uptake rates of polymeric gene
   delivery nanoparticles and DNA plasmids via flow cytometry
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Gene delivery; Nanoparticle; Polymer; Computational modeling; Brain
   cancer
ID POLY(BETA-AMINO ESTERS); MAMMALIAN-CELLS; STEM-CELLS; IN-VIVO; THERAPY;
   POLYETHYLENIMINE; EXPRESSION; VECTOR; BINDING; GLIOBLASTOMA
AB Non-viral, biomaterial-mediated gene delivery has the potential to treat many diseases, but is limited by low efficacy. Elucidating the bottlenecks of plasmid mass transfer can enable an improved understanding of biomaterial structure-function relationships, leading to next-generation rationally designed non-viral gene delivery vectors. As proof of principle, we transfected human primary glioblastoma cells using a poly(beta-amino ester) complexed with eGFP plasmid DNA. The polyplexes transfected 70.6 +/- 0.6% of the cells with 101 +/- 3% viability. The amount of DNA within the cytoplasm, nuclear envelope, and nuclei was assessed at multiple time points using fluorescent dye conjugated plasmid up to 24 h post-transfection using a quantitative multi-well plate-based flow cytometry assay. Conversion to plasmid counts and degradation kinetics were accounted for via quantitative PCR (plasmid degradation rate constants were determined to be 0.62 h(-1) and 0.084 h(-1) for fast and slow phases respectively). Quantitative cellular uptake, nuclear association, and nuclear uptake rate constants were determined by using a four-compartment first order mass-action model. The rate limiting step for these poly(beta-amino ester)/DNA polyplex nanoparticles was determined to be cellular uptake (7.5 x 10(-4)h(-1)) and only 0.1% of the added dose was taken up by the human brain cancer cells, whereas 12% of internalized DNA successfully entered the nucleus (the rate of nuclear internalization of nuclear associated plasmid was 1.1 h(-1)). We describe an efficient new method for assessing cellular and nuclear uptake rates of non-viral gene delivery nanoparticles using flow cytometry to improve understanding and design of polymeric gene delivery nanoparticles.
   Statement of Significance
   In this work, a quantitative high throughput flow cytometry-based assay and computational modeling approach was developed for assessing cellular and nuclear uptake rates of non-viral gene delivery nanoparticles. This method is significant as it can be used to elucidate structure-function relationships of gene delivery nanoparticles and improve their efficiency. This method was applied to a particular type of biodegradable polymer, a poly(beta-amino ester), that transfected human brain cancer cells with high efficacy and without cytotoxicity. A four-compartment first order mass-action kinetics model was found to model the experimental transport data well without requiring external fitting parameters. Quantitative rate constants were identified for the intracellular transport, including DNA degradation rate from polyplexes, cellular uptake rate, and nuclear uptake rate, with cellular uptake identified as the rate-limiting step. (c) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Bishop, Corey J.; Majewski, Rebecca L.; Wilson, David R.; Bhise, Nupura S.; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Translat Tissue Engn Ctr, Baltimore, MD 21231 USA.
   [Guiriba, Toni-Rose M.; Green, Jordan J.] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21231 USA.
   [Quinones-Hinojosa, Alfredo; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21231 USA.
   [Quinones-Hinojosa, Alfredo; Green, Jordan J.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA.
   [Green, Jordan J.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21231 USA.
RP Green, JJ (reprint author), 400 North Broadway Rm 5017, Baltimore, MD 21231 USA.
EM green@jhu.edu
FU NSF [GRF: DGE-0707427]; National Institutes of Health [R01EB016721,
   P30-EY001865]
FX CJB thanks the NSF for a GRF: DGE-0707427. This work was also supported
   in part by the National Institutes of Health (R01EB016721 and a Core
   Grant to the Wilmer Institute, P30-EY001865).
CR ALTON EWFW, 1993, NAT GENET, V5, P135, DOI 10.1038/ng1093-135
   Anderson DG, 2005, MOL THER, V11, P426, DOI 10.1016/j.ymthe.2004.11.015
   Banks GA, 2003, GENE THER, V10, P1766, DOI 10.1038/sj.gt.3302076
   Bishop CJ, 2015, CHEM COMMUN, V51, P12134, DOI 10.1039/c5cc04417k
   Bishop CJ, 2015, ACTA BIOMATER, V11, P393, DOI 10.1016/j.actbio.2014.09.020
   Bishop CJ, 2014, ANN BIOMED ENG, V42, P1557, DOI 10.1007/s10439-013-0932-1
   Bishop CJ, 2013, J AM CHEM SOC, V135, P6951, DOI 10.1021/ja4002376
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Carapuca E, 2007, MOL BIOTECHNOL, V37, P120, DOI 10.1007/s12033-007-0007-3
   Chen HH, 2009, NANO TODAY, V4, P125, DOI 10.1016/j.nantod.2009.02.008
   Cohen RN, 2009, J CONTROL RELEASE, V135, P166, DOI 10.1016/j.jconrel.2008.12.016
   Cooper S, 2003, CELL MOL LIFE SCI, V60, P1099, DOI 10.1007/s00018-003-2253-2
   Filareto A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2550
   Guerrero-Cazares H, 2009, METHODS MOL BIOL, V568, P73, DOI 10.1007/978-1-59745-280-9_6
   Howe S.J., 2008, J CLIN INVEST, V118, P3143
   James MB, 2000, MOL THER, V1, P339, DOI 10.1006/mthe.2000.0054
   Keeney M, 2013, ACS NANO, V7, P7241, DOI 10.1021/nn402657d
   Ketola TM, 2013, J PHYS CHEM B, V117, P10405, DOI 10.1021/jp404812a
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Millili PG, 2010, MICROSC RES TECHNIQ, V73, P866, DOI 10.1002/jemt.20839
   Mohyeldin A, 2012, CANCER J, V18, P82, DOI 10.1097/PPO.0b013e3182458b13
   Mullen PM, 2000, BBA-GEN SUBJECTS, V1523, P103, DOI 10.1016/S0304-4165(00)00104-5
   Murphy AM, 2013, TRANSL RES, V161, P339, DOI 10.1016/j.trsl.2012.11.003
   Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046
   Raucher D, 1999, J CELL BIOL, V144, P497, DOI 10.1083/jcb.144.3.497
   Sacramento CB, 2010, BRAZ J MED BIOL RES, V43, P722, DOI 10.1590/S0100-879X2010000800005
   Schaffer DV, 2000, BIOTECHNOL BIOENG, V67, P598, DOI 10.1002/(SICI)1097-0290(20000305)67:5<598::AID-BIT10>3.0.CO;2-G
   Shmueli RB, 2012, NANOMED-NANOTECHNOL, V8, P1200, DOI 10.1016/j.nano.2012.01.006
   Sunshine JC, 2012, MOL PHARMACEUT, V9, P3375, DOI 10.1021/mp3004176
   Sunshine JC, 2011, THER DELIV, V2, P493, DOI 10.4155/TDE.11.14
   Toyoda E, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-30
   Tzeng SY, 2011, BIOMATERIALS, V32, P5402, DOI 10.1016/j.biomaterials.2011.04.016
   Varga CM, 2005, GENE THER, V12, P1023, DOI 10.1038/sj.gt.3302495
   Varga CM, 2001, MOL THER, V4, P438, DOI 10.1006/mthe.2001.0475
   Zhou JB, 2012, NAT MATER, V11, P82, DOI [10.1038/NMAT3187, 10.1038/nmat3187]
   Zhou JY, 2007, PHARM RES, V24, P1079, DOI 10.1007/s11095-006-9229-5
NR 36
TC 18
Z9 18
U1 1
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2016
VL 37
BP 120
EP 130
DI 10.1016/j.actbio.2016.03.036
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DN8FM
UT WOS:000377314600013
PM 27019146
OA Green Accepted
DA 2018-10-19
ER

PT J
AU van Oirschot, BAJA
   Eman, RM
   Habibovic, P
   Leeuwenburgh, SCG
   Tahmasebi, Z
   Weinans, H
   Alblas, J
   Meijer, GJ
   Jansen, JA
   van den Beucken, JJJP
AF van Oirschot, Bart A. J. A.
   Eman, Rhandy M.
   Habibovic, Pamela
   Leeuwenburgh, Sander C. G.
   Tahmasebi, Zeinab
   Weinans, Harrie
   Alblas, Jacqueline
   Meijer, Gert J.
   Jansen, John A.
   van den Beucken, Jeroen J. J. P.
TI Osteophilic properties of bone implant surface modifications in a
   cassette model on a decorticated goat spinal transverse process
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Biomaterials; Titanium implant; Surface modifications; Calcium
   phosphate; Goat model
ID CALCIUM-PHOSPHATE COATINGS; IN-VIVO EVALUATION; PLASMA-SPRAYED
   HYDROXYAPATITE; POROUS METAL IMPLANTS; OCTACALCIUM PHOSPHATE; TITANIUM
   IMPLANTS; DENTAL IMPLANTS; ORAL IMPLANTS; HEALING RESPONSE; BIOACTIVE
   GLASS
AB This study comparatively evaluated the osteophilic capacity of 17 different surface modifications (i.e. fourteen different chemical modifications via ceramic coatings and three different physical modifications via surface roughness) for titanium (Ti) surfaces. All surface modifications were subjected to physicochemical analyses and immersion in simulated body fluid (SBF) for coating stability assessment. Subsequently, a bone conduction chamber cassette model on the goat transverse process was used for comparative in vivo analysis based on bone responses to these different surface modifications after twelve weeks. Histological and histomorphometrical analyses in terms of longitudinal bone-to-implant contact percentage (BIC%), relative bone area (BA%) were investigated within each individual channel and maximum bone height (BH). Characterization of the surface modifications showed significant differences in surface chemistry and surface roughness among the surface modifications. Generally, immersion of the coatings in SBF showed net uptake of calcium by thick coatings (>50 mu m; plasma-sprayed and biomimetic coatings) and no fluctuations in the SBF for thin coatings (<50 mu m). The histomorphometrical data set demonstrated that only plasma-sprayed CaP coatings performed superiorly regarding BIC%, BA % and BH compared to un-coated surfaces, irrespective of surface roughness of the latter. In conclusion, this study demonstrated that the deposition of plasma-sprayed CaP coating with high roughness significantly improves the osteophilic capacity of titanium surfaces in a chamber cassette model.
   Statement of Significance
   For the bone implant market, a large number of surface modifications are available on different types of (dental and orthopedic) bone implants. As the implant surface provides the interface at which the biomaterial interacts with the surrounding (bone) tissue, it is of utmost importance to know what surface modification has optimal osteophilic properties. In contrast to numerous earlier studies on bone implant surface modifications with limited number of comparison surfaces, the manuscript by van Oirschot et al. describes the data of in vivo experiments using a large animal model that allows for direct and simultaneous comparison of a large variety of surface modifications, which included both commercially available and experimental surface modifications for bone implants. These data clearly show the superiority of plasma-sprayed hydroxyapatite coatings regarding bone-to-implant contact, bone amount, and bone height. (c) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [van Oirschot, Bart A. J. A.; Leeuwenburgh, Sander C. G.; Jansen, John A.; van den Beucken, Jeroen J. J. P.] Radboudumc, Dept Biomat, Nijmegen, Netherlands.
   [Eman, Rhandy M.; Weinans, Harrie; Alblas, Jacqueline] Univ Med Ctr Utrecht, Dept Orthoped, Utrecht, Netherlands.
   [Habibovic, Pamela; Tahmasebi, Zeinab] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, POB 217, NL-7500 AE Enschede, Netherlands.
   [van Oirschot, Bart A. J. A.; Meijer, Gert J.; Jansen, John A.] Radboudumc, Dept Implantol & Periodontol, Nijmegen, Netherlands.
RP van den Beucken, JJJP (reprint author), Radboudumc, Biomat 309, Philips van Leijdenln 25, NL-6525 EX Nijmegen, Netherlands.
EM jeroen.vandenbeucken@radboudumc.nl
RI Meijer, G.J./H-8073-2014; Jansen, John/H-8055-2014; Leeuwenburgh,
   S.C.G./L-4483-2015; van den beucken, jeroen/N-2910-2013; van Oirschot,
   Bart/P-8203-2015
OI Leeuwenburgh, S.C.G./0000-0003-1471-6133; van den beucken,
   jeroen/0000-0002-0301-1966; Alblas, Jacqueline/0000-0002-2996-9697
FU Dutch Ministry of Economic Affairs, Agriculture and Innovation [P2.04
   BONE-IP]; ReumaFonds [LLP-12]
FX The authors would like to acknowledge Mr. Vincent Cuijpers for his
   assistance with histomorphometrical analyses, and Ms. Natasja van Dijk
   for her assistance with the histological sectioning. We would like to
   thank Editage (www.editage.com) for English language editing. This
   research forms part of the Project P2.04 BONE-IP of the research program
   of the BioMedical Materials institute, co-funded by the Dutch Ministry
   of Economic Affairs, Agriculture and Innovation.
CR Alghamdi HS, 2013, TISSUE ENG PART B-RE, V19, P233, DOI [10.1089/ten.TEB.2012.0400, 10.1089/ten.teb.2012.0400]
   Alghamdi HS, 2013, CLIN ORAL IMPLAN RES, V24, P475, DOI 10.1111/j.1600-0501.2011.02409.x
   Allen PF, 2003, CLIN ORAL IMPLAN RES, V14, P173, DOI 10.1034/j.1600-0501.2003.140206.x
   Barradas AMC, 2012, BIOMATERIALS, V33, P3205, DOI 10.1016/j.biomaterials.2012.01.020
   Barrere F, 2003, J BIOMED MATER RES B, V67B, P655, DOI 10.1002/jbm.b.10057
   Barrere F, 2003, J BIOMED MATER RES A, V66A, P779, DOI 10.1002/jbm.a.10454
   Barrere F, 2001, J MATER SCI-MATER M, V12, P529, DOI 10.1023/A:1011271713758
   Becktor JP, 2004, INT J ORAL MAX IMPL, V19, P107
   Berglundh T, 2007, CLIN ORAL IMPLAN RES, V18, P147, DOI 10.1111/j.1600-0501.2006.01309.x
   Bornstein MM, 2008, CLIN ORAL IMPLAN RES, V19, P233, DOI 10.1111/j.1600-0501.2007.01473.x
   Bosco R, 2013, SURF COAT TECH, V233, P91, DOI 10.1016/j.surfcoat.2013.02.039
   Botticelli D, 2004, J CLIN PERIODONTOL, V31, P820, DOI 10.1111/j.1600-051X.2004.00565.x
   Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Chai YC, 2012, ACTA BIOMATER, V8, P3876, DOI 10.1016/j.actbio.2012.07.002
   Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4
   Christenson EM, 2007, J ORTHOP RES, V25, P11, DOI 10.1002/jor.20305
   Cleries L, 2000, BIOMATERIALS, V21, P967, DOI 10.1016/S0142-9612(99)00240-9
   Daculsi G., 2003, J MAT SCI MAT MED, V14
   Davies John E, 2003, J Dent Educ, V67, P932
   de Jonge LT, 2008, PHARM RES-DORDR, V25, P2357, DOI 10.1007/s11095-008-9617-0
   de Jonge LT, 2009, ACTA BIOMATER, V5, P2773, DOI 10.1016/j.actbio.2009.03.019
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   Dekker RJ, 2005, BIOMATERIALS, V26, P5231, DOI 10.1016/j.biomaterials.2005.01.057
   Esposito M, 1998, EUR J ORAL SCI, V106, P527, DOI 10.1046/j.0909-8836..t01-2-.x
   Fini M, 2004, BIOMED PHARMACOTHER, V58, P487, DOI 10.1016/j.biopha.2004.08.016
   GarciaSanz FJ, 1997, J MATER SCI-MATER M, V8, P861, DOI 10.1023/A:1018549720873
   Gottlander M, 1997, CLIN ORAL IMPLAN RES, V8, P345, DOI 10.1034/j.1600-0501.1997.080501.x
   Habibovic P, 2004, J MATER SCI-MATER M, V15, P373, DOI 10.1023/B:JMSM.0000021104.42685.9f
   Habibovic P, 2005, BIOMATERIALS, V26, P23, DOI 10.1016/j.biomaterials.2004.02.026
   Habibovic P, 2002, J AM CERAM SOC, V85, P517
   Havelin LI, 2000, ACTA ORTHOP SCAND, V71, P337, DOI 10.1080/000164700317393321
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   Itthichaisri C, 2007, J BIOMED MATER RES A, V82A, P777, DOI 10.1002/jbm.a.31191
   JANSEN JA, 1991, J BIOMED MATER RES, V25, P973, DOI 10.1002/jbm.820250805
   JANSEN JA, 1993, J BIOMED MATER RES, V27, P603, DOI 10.1002/jbm.820270507
   Junker R, 2009, CLIN ORAL IMPLAN RES, V20, P185, DOI 10.1111/j.1600-0501.2009.01777.x
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kruyt MC, 2006, BIOMATERIALS, V27, P5099, DOI 10.1016/j.biomaterials.2006.05.048
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Leeuwenburgh SCG, 2004, BIOMATERIALS, V25, P641, DOI 10.1016/S0142-9612(03)00575-1
   Lekholm U, 1999, INT J ORAL MAX IMPL, V14, P639
   Lenth RV, 2007, J ANIM SCI, V85, pE24, DOI 10.2527/jas.2006-449
   Lew D., 1999, J ORAL MAXILLOFAC SU, V1096, P9
   Li YF, 2010, J ORTHOP RES, V28, P578, DOI 10.1002/jor.21050
   Lohmann CH, 2002, J BIOMED MATER RES, V62, P204, DOI 10.1002/jbm.10290
   Mohammadi S, 2004, INT J ORAL MAX IMPL, V19, P498
   Nijhuis AWG, 2010, MACROMOL BIOSCI, V10, P1316, DOI 10.1002/mabi.201000142
   Ostman PO, 2008, CLIN IMPLANT DENT R, V10, P71, DOI 10.1111/j.1708-8208.2007.00069.x
   Oliveira AL, 2007, J BIOMED MATER RES B, V83B, P258, DOI 10.1002/jbm.b.30791
   Ong JL, 2002, INT J ORAL MAX IMPL, V17, P581
   Saravanapavan P, 2004, BIO-MED MATER ENG, V14, P467
   Schaeken H. G., 1999, J BIOMED MATER RES, V28, P1477
   Schouten C, 2010, CLIN ORAL IMPLAN RES, V21, P414, DOI 10.1111/j.1600-0501.2009.01872.x
   Schouten C, 2009, BIOMATERIALS, V30, P6407, DOI 10.1016/j.biomaterials.2009.08.001
   Schwartz-Arad D, 2005, INT J ORAL MAX IMPL, V20, P238
   Shalabi MM, 2006, J DENT RES, V85, P496, DOI 10.1177/154405910608500603
   Siebers MC, 2007, CLIN ORAL IMPLAN RES, V18, P354, DOI 10.1111/j.1600-0501.2006.01314.x
   Sonoyama W, 2002, CLIN ORAL IMPLAN RES, V13, P359, DOI 10.1034/j.1600-0501.2002.130403.x
   ter Brugge PJ, 2002, BIOMATERIALS, V23, P3269, DOI 10.1016/S0142-9612(02)00085-6
   van Oirschot BAJA, 2014, CLIN ORAL IMPLAN RES, V25, P21, DOI 10.1111/clr.12060
   VANDERLUBBE HBM, 1988, STAIN TECHNOL, V63, P171, DOI 10.3109/10520298809107179
   Vercaigne S, 1998, J DENT RES, V77, P769
   WENNERBERG A, 1995, J MATER SCI-MATER M, V6, P302, DOI 10.1007/BF00120275
   Wheeler DL, 2001, J BIOMED MATER RES, V55, P603, DOI 10.1002/1097-4636(20010615)55:4<603::AID-JBM1054>3.0.CO;2-N
   Wilson CE, 2006, BIOMATERIALS, V27, P302, DOI 10.1016/j.biomaterials.2005.06.041
   Wolke JGC, 2005, KEY ENG MAT, V284-286, P187, DOI 10.4028/www.scientific.net/KEM.284-286.187
   Xiropaidis AV, 2005, CLIN ORAL IMPLAN RES, V16, P532, DOI 10.1111/j.1600-0501.2005.01126.x
   Xue WC, 2004, BIOMATERIALS, V25, P415, DOI 10.1016/S0142-9612(03)00545-3
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Yuan H., 2010, P NATL ACAD SCI US, V107, P13614
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
NR 73
TC 6
Z9 6
U1 3
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2016
VL 37
BP 195
EP 205
DI 10.1016/j.actbio.2016.03.037
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DN8FM
UT WOS:000377314600020
PM 27019145
DA 2018-10-19
ER

PT J
AU Song, KD
   Li, LY
   Yan, XY
   Zhang, Y
   Li, RP
   Wang, YW
   Wang, L
   Wang, H
   Liu, TQ
AF Song, Kedong
   Li, Liying
   Yan, Xinyu
   Zhang, Yu
   Li, Ruipeng
   Wang, Yiwei
   Wang, Ling
   Wang, Hong
   Liu, Tianqing
TI Fabrication and development of artificial osteochondral constructs based
   on cancellous bone/hydrogel hybrid scaffold
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; CARTILAGE REPAIR; BONE-MARROW; ENGINEERED
   CARTILAGE; DYNAMIC FABRICATION; SPINNER FLASK; ADIPOSE; DIFFERENTIATION;
   REGENERATION; DEFECTS
AB Using tissue engineering techniques, an artificial osteochondral construct was successfully fabricated to treat large osteochondral defects. In this study, porcine cancellous bones and chitosan/gelatin hydrogel scaffolds were used as substitutes to mimic bone and cartilage, respectively. The porosity and distribution of pore size in porcine bone was measured and the degradation ratio and swelling ratio for chitosan/gelatin hydrogel scaffolds was also determined in vitro. Surface morphology was analyzed with the scanning electron microscope (SEM). The physicochemical properties and the composition were tested by using an infrared instrument. A double layer composite scaffold was constructed via seeding adipose-derived stem cells (ADSCs) induced to chondrocytes and osteoblasts, followed by inoculation in cancellous bones and hydrogel scaffolds. Cell proliferation was assessed through Dead/Live staining and cellular activity was analyzed with IpWin5 software. Cell growth, adhesion and formation of extracellular matrix in composite scaffolds blank cancellous bones or hydrogel scaffolds were also analyzed. SEM analysis revealed a super porous internal structure of cancellous bone scaffolds and pore size was measured at an average of 410 +/- 59 mu m while porosity was recorded at 70.6 +/- 1.7 %. In the hydrogel scaffold, the average pore size was measured at 117 +/- 21 mu m and the porosity and swelling rate were recorded at 83.4 +/- 0.8 % and 362.0 +/- 2.4 %, respectively. Furthermore, the remaining hydrogel weighed 80.76 +/- 1.6 % of the original dry weight after hydration in PBS for 6 weeks. In summary, the cancellous bone and hydrogel composite scaffold is a promising biomaterial which shows an essential physical performance and strength with excellent osteochondral tissue interaction in situ. ADSCs are a suitable cell source for osteochondral composite reconstruction. Moreover, the bi-layered scaffold significantly enhanced cell proliferation compared to the cells seeded on either single scaffold. Therefore, a bi-layered composite scaffold is an appropriate candidate for fabrication of osteochondral tissue.
C1 [Song, Kedong; Li, Liying; Yan, Xinyu; Zhang, Yu; Li, Ruipeng; Wang, Ling; Liu, Tianqing] Dalian Univ Technol, Dalian R&D Ctr Stem Cell & Tissue Engn, State Key Lab Fine Chem, Dalian 116024, Peoples R China.
   [Wang, Yiwei] Univ Sydney, ANZAC Res Inst, Burns Res, Concord, NSW 2139, Australia.
   [Wang, Ling] Dalian Med Univ, Affiliated Hosp 1, Dept Oncol, Dalian 116011, Peoples R China.
   [Wang, Hong] Dalian Med Univ, Affiliated Hosp 1, Dept Orthopaed, Dalian 116011, Peoples R China.
RP Song, KD; Wang, L; Liu, TQ (reprint author), Dalian Univ Technol, Dalian R&D Ctr Stem Cell & Tissue Engn, State Key Lab Fine Chem, Dalian 116024, Peoples R China.; Wang, L (reprint author), Dalian Med Univ, Affiliated Hosp 1, Dept Oncol, Dalian 116011, Peoples R China.
EM Kedongsong@dlut.edu.cn; whwl@hotmail.com; liutq@dlut.edu.cn
FU Fok Ying Tung Education Foundation [132027]; National Science Foundation
   of China [31370991/31170945/81271719/81341060]; Joint Open Foundation of
   Natural Science Foundation of Liaoning; Shenyang National Laboratory for
   Materials Science [2015021017]; Fundamental Research Funds for the
   Central Universities, SRF for ROCS, SEM [DUT14YQ106/15GY47/16ZD210]
FX The present work was supported by Fok Ying Tung Education Foundation
   (132027), National Science Foundation of China
   (31370991/31170945/81271719/81341060), the Joint Open Foundation of
   Natural Science Foundation of Liaoning and Shenyang National Laboratory
   for Materials Science (2015021017) and the Fundamental Research Funds
   for the Central Universities (DUT14YQ106/15GY47/16ZD210), SRF for ROCS,
   SEM.
CR Abou-Khalil R, 2015, STEM CELLS, V33, P1501, DOI 10.1002/stem.1945
   Basad Erhan, 2007, Acta Orthop Traumatol Turc, V41 Suppl 2, P79
   Cao S, 2012, BEIJING BIOMED ENG, V31, P478
   Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001
   Cheng NC, 2012, BIOMATERIALS, V33, P1748, DOI 10.1016/j.biomaterials.2011.11.049
   Chia SL, 2006, TISSUE ENG, V12, P1945, DOI 10.1089/ten.2006.12.1945
   Chien KB, 2013, TISSUE ENG PART C-ME, V19, P417, DOI [10.1089/ten.tec.2012.0383, 10.1089/ten.TEC.2012.0383]
   Damm P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120438
   Enea D, 2015, KNEE, V22, P30, DOI 10.1016/j.knee.2014.10.003
   Faia-Torres AB, 2014, BIOMATERIALS, V35, P9023, DOI 10.1016/j.biomaterials.2014.07.015
   Fields AJ, 2012, SPINE, V37, pE1310, DOI 10.1097/BRS.0b013e318267bcfc
   Filardo G, 2013, ARTHROSCOPY, V29, P174, DOI 10.1016/j.arthro.2012.05.891
   Filova E, 2008, J BIOMED MATER RES B, V87B, P415, DOI 10.1002/jbm.b.31119
   Godzik J, 2015, J NEUROSURG-SPINE, V23, P144, DOI 10.3171/2014.12.SPINE14535
   Ho STB, 2010, TISSUE ENG PT A, V16, P1123, DOI 10.1089/ten.TEA.2009.0471
   Karaoz E, 2013, CYTOTHERAPY, V15, P557, DOI 10.1016/j.jcyt.2013.01.005
   Kawamura S, 1998, ACTA ORTHOP SCAND, V69, P56, DOI 10.3109/17453679809002358
   Khanarian NT, 2012, TISSUE ENG PT A, V18, P533, DOI [10.1089/ten.tea.2011.0279, 10.1089/ten.TEA.2011.0279]
   Lee AY, 2015, RES VET SCI, V100, P115, DOI 10.1016/j.rvsc.2015.03.010
   Lee JW, 2015, CURR PHARM DESIGN, V21, P1606, DOI 10.2174/1381612821666150115125324
   Link DP, 2013, J BIOMED MATER RES A, V101, P3059, DOI 10.1002/jbm.a.34614
   Liu H, 2005, TISSUE ENG, V11, P319, DOI 10.1089/ten.2005.11.319
   Liu X, 2014, ACTA BIOMATER, V10, P4484, DOI 10.1016/j.actbio.2014.06.027
   Lu TF, 2014, APPL BIOCHEM BIOTECH, V174, P719, DOI 10.1007/s12010-014-1128-3
   Luo ZW, 2015, BIOMATERIALS, V52, P463, DOI 10.1016/j.biomaterials.2015.01.001
   Mesimaki K, 2009, INT J ORAL MAX SURG, V38, P201, DOI 10.1016/j.ijom.2009.01.001
   Mohan N, 2011, TISSUE ENG PT A, V17, P2845, DOI 10.1089/ten.tea.2011.0135
   Nooeaid P, 2012, J CELL MOL MED, V16, P2247, DOI 10.1111/j.1582-4934.2012.01571.x
   Perdisa F, 2014, HISTOL HISTOPATHOL, V29, P805, DOI 10.14670/HH-29.805
   Qu XJ, 2013, BIOCHEM BIOPH RES CO, V439, P552, DOI 10.1016/j.bbrc.2013.09.005
   Ren YZ, 2015, MOL CELL BIOCHEM, V400, P135, DOI 10.1007/s11010-014-2269-y
   SAMS AE, 1995, OSTEOARTHR CARTILAGE, V3, P61, DOI 10.1016/S1063-4584(05)80038-X
   Schek RM, 2004, TISSUE ENG, V10, P1376, DOI 10.1089/ten.2004.10.1376
   Solchaga LA, 2000, J ORTHOP RES, V18, P773, DOI 10.1002/jor.1100180515
   Song KD, 2016, MAT SCI ENG C-MATER, V62, P787, DOI 10.1016/j.msec.2016.02.036
   Song KD, 2015, MAT SCI ENG C-MATER, V55, P384, DOI 10.1016/j.msec.2015.05.062
   Song KD, 2014, APPL BIOCHEM BIOTECH, V174, P1331, DOI 10.1007/s12010-014-1132-7
   Song KD, 2013, APPL BIOCHEM BIOTECH, V170, P459, DOI 10.1007/s12010-013-0210-6
   Song KD, 2013, MAT SCI ENG C-MATER, V33, P1506, DOI 10.1016/j.msec.2012.12.054
   Song KD, 2012, APPL BIOCHEM BIOTECH, V167, P2381, DOI 10.1007/s12010-012-9764-y
   Steinwachs MR, 2014, ARTHROSC TEC, V3, pE399, DOI 10.1016/j.eats.2014.02.011
   Sterodimas A, 2010, J PLAST RECONSTR AES, V63, P1886, DOI 10.1016/j.bjps.2009.10.028
   Strem Brian M., 2005, Keio Journal of Medicine, V54, P132, DOI 10.2302/kjm.54.132
   Tang C, 2014, TISSUE ENG PT A, V20, P2455, DOI [10.1089/ten.tea.2013.0464, 10.1089/ten.TEA.2013.0464]
   van der Kraan PM, 2012, OSTEOARTHR CARTILAGE, V20, P223, DOI 10.1016/j.joca.2011.12.003
   Wang F, 2008, BIONIC DESIGN INITIA
   Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488
NR 47
TC 6
Z9 6
U1 4
U2 48
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2016
VL 27
IS 6
AR 114
DI 10.1007/s10856-016-5722-5
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DN9BD
UT WOS:000377373200015
PM 27180235
DA 2018-10-19
ER

PT J
AU Chiang, YC
   Wang, YL
   Lin, PY
   Chen, YY
   Chien, CY
   Lin, HP
   Lin, CP
AF Chiang, Yu-Chih
   Wang, Yin-Lin
   Lin, Po-Yen
   Chen, Yen-Yi
   Chien, Chih-Yu
   Lin, Hong-Ping
   Lin, Chun-Pin
TI A mesoporous biomaterial for biomimetic crystallization in dentinal
   tubules without impairing the bonding of a self-etch resin to dentin
SO JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
LA English
DT Article
DE biomimetic; crystal growth; dentinal tubule; mesoporous materials;
   self-etch adhesive
ID POSTOPERATIVE SENSITIVITY; IN-VITRO; COMPOSITE RESTORATIONS; AMALGAM
   RESTORATIONS; DP-BIOGLASS; DEEP DENTIN; HYPERSENSITIVITY; SYSTEMS; CELLS
AB Background/Purpose: CaCO3@mesoporous silica reacted with phosphoric acid (denoted as CCMS-HP) enables the growth of calcium phosphate crystals in dentinal tubules. This study tested whether CCMS-HP could be used to form a biomimetic barrier on the exposed dentin for prevention of dentin sensitivity without impairing the bonding of Single Bond Universal (SBU) self-etch adhesive to the dentin.
   Methods: Twenty-four dentin disks were prepared and divided into three groups: (1) SBU group (n = 8), in which SBU self-etch adhesive was bonded to the dentin disk directly; (2) CCMS-HP group (n = 8), in which CCMS-HP was applied onto the dentin surface; and (3) CCMS-HP/SBU group (n = 8), in which the dentin surface was first treated with CCMS-HP and then boned by SBU. The permeation depth of crystals into the dentinal tubules was examined and measured with a scanning electron microscope. The shear bonding strength of SBU and CCMS-HP/SBU to dentin was also measured.
   Results: The mean crystal permeation depth was 35.8 +/- 6.9 mu m for the CCMS-HP/SBU group and 33.6 +/- 12.2 mu m for the CCMS-HP group; no significant difference was found between the two groups. Moreover, the mean shear bonding strength was 22.7 +/- 6.7 MPa for the CCMS-HP/SBU group and 23.3 +/- 7.0 MPa for the SBU group. There was also no significant difference between the two groups.
   Conclusion: CCMS-HP can be used to form a biomimetic barrier for prevention of dentin sensitivity because it neither impedes the bonding of SBU to dentin nor impairs the shear bonding strength between the SBU and dentin. Copyright (C) 2016, Formosan Medical Association. Published by Elsevier Taiwan LLC.
C1 [Chiang, Yu-Chih; Wang, Yin-Lin; Chen, Yen-Yi; Lin, Chun-Pin] Natl Taiwan Univ, Sch Dent, Grad Inst Clin Dent, Taipei 10764, Taiwan.
   [Chiang, Yu-Chih; Wang, Yin-Lin; Chen, Yen-Yi; Lin, Chun-Pin] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Taipei 10764, Taiwan.
   [Lin, Po-Yen] Natl Yang Ming Univ, Dept Dent, Sch Dent, Taipei 112, Taiwan.
   [Chien, Chih-Yu] Natl Taiwan Univ, Sch Dent, Grad Inst Oral Biol, Taipei 10764, Taiwan.
   [Lin, Hong-Ping] Natl Cheng Kung Univ, Dept Chem, Tainan 70101, Taiwan.
RP Lin, CP (reprint author), Natl Taiwan Univ Hosp, Dept Dent, 1 Chang Te St, Taipei 10048, Taiwan.
EM pinlin@ntu.edu.tw
FU National Science Council Taiwan [103-2314-B-002-111-MY2,
   NSC101-2314-B-002-098-MY2]; National Taiwan University Hospital
   [100-N1766]
FX This study was partly supported by the funding from the National Science
   Council Taiwan (103-2314-B-002-111-MY2 and NSC101-2314-B-002-098-MY2)
   and the National Taiwan University Hospital (100-N1766). The authors
   also wish to thank the staff of the Core Labs, Department of Medical
   Research, National Taiwan University Hospital, Taipei, Taiwan for
   technical support.
CR Al-Omari WM, 2006, OPER DENT, V31, P165, DOI 10.2341/05-8
   Briso ALF, 2007, OPER DENT, V32, P421, DOI 10.2341/06-141
   Chang HH, 2005, BIOMATERIALS, V26, P745, DOI 10.1016/j.biomaterials.2004.03.021
   Chiang YC, 2010, J DENT RES, V89, P236, DOI 10.1177/0022034509357148
   Chiang YC, 2014, ACS NANO, V8, P12502, DOI 10.1021/nn5053487
   Chiang YC, 2010, COMPOS SCI TECHNOL, V70, P989, DOI 10.1016/j.compscitech.2010.02.017
   Chiang YC, 2010, DENT MATER, V26, P223, DOI 10.1016/j.dental.2009.09.013
   Fok ASL, 2013, DENT MATER, V29, P1108, DOI 10.1016/j.dental.2013.08.198
   GAAFAR H, 1976, ORL J OTO-RHINO-LARY, V38, P350, DOI 10.1159/000275295
   Gordan VV, 1999, OPER DENT, V24, P377
   He CL, 2010, ADV FUNCT MATER, V20, P3568, DOI 10.1002/adfm.201000993
   ISHIKAWA K, 1994, J DENT RES, V73, P1462, DOI 10.1177/00220345940730081101
   Lee BS, 2007, DENT MATER J, V26, P52, DOI 10.4012/dmj.26.52
   Lee BS, 2015, J FORMOS MED ASSOC, V114, P339, DOI 10.1016/j.jfma.2012.12.009
   Lee BS, 2005, DENT MATER J, V24, P562, DOI 10.4012/dmj.24.562
   LeGeros RZ., 1991, MONOGR ORAL SCI
   Love RM, 2002, CRIT REV ORAL BIOL M, V13, P171, DOI 10.1177/154411130201300207
   Mahmoud SH, 2014, J ADHES DENT, V16, P285, DOI 10.3290/j.jad.a31939
   Moretto SG, 2013, J DENT, V41, P675, DOI 10.1016/j.jdent.2013.05.016
   Nakajima M, 1999, J DENT RES, V78, P1298, DOI 10.1177/00220345990780070301
   Pashley DH, 2011, DENT MATER, V27, P1, DOI 10.1016/j.dental.2010.10.016
   PASHLEY DH, 1994, ARCH ORAL BIOL, V39, pS73, DOI 10.1016/0003-9969(94)90191-0
   PASHLEY EL, 1993, DENT MATER, V9, P19, DOI 10.1016/0109-5641(93)90099-C
   Pegado Rafael Eduardo Fernandes, 2010, Eur J Dent, V4, P110
   Reis A, 2015, DENT MATER, V31, P1052, DOI 10.1016/j.dental.2015.06.001
   SEGURA A, 1993, J ORAL REHABIL, V20, P495, DOI 10.1111/j.1365-2842.1993.tb01636.x
   Tanase CE, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/025002
   THOMAS HF, 1984, J DENT RES, V63, P1064, DOI 10.1177/00220345840630081101
   van Dijken JWV, 2014, DENT MATER, V30, pE245, DOI 10.1016/j.dental.2014.05.028
   Yoshida Y, 2004, J DENT RES, V83, P454, DOI 10.1177/154405910408300604
   Zhang L, 2014, DENT MATER, V30, P1245, DOI 10.1016/j.dental.2014.08.362
NR 31
TC 2
Z9 3
U1 1
U2 18
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 0929-6646
EI 1876-0821
J9 J FORMOS MED ASSOC
JI J. Formos. Med. Assoc.
PD JUN
PY 2016
VL 115
IS 6
BP 455
EP 462
DI 10.1016/j.jfma.2016.01.005
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA DO2FK
UT WOS:000377595100011
PM 26860038
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Patel, A
   Xue, YF
   Mukundan, S
   Rohan, LC
   Sant, V
   Stolz, DB
   Sant, S
AF Patel, Akhil
   Xue, Yingfei
   Mukundan, Shilpaa
   Rohan, Lisa C.
   Sant, Vinayak
   Stolz, Donna B.
   Sant, Shilpa
TI Cell-Instructive Graphene-Containing Nanocomposites Induce
   Multinucleated Myotube Formation
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Graphene nanosheet; Myoblast differentiation; Electrospinning;
   Polycaprolactone; Cell-instructive scaffolds; Biologic-free
ID MESENCHYMAL STEM-CELLS; SKELETAL-MUSCLE DIFFERENTIATION; GROWTH-FACTOR;
   OSTEOGENIC DIFFERENTIATION; ELECTRICAL-CONDUCTIVITY; DEGRADATION
   PROPERTIES; MECHANICAL-PROPERTIES; TISSUE REGENERATION; COMPOSITE; OXIDE
AB Myoblast differentiation is a key step in myogenesis and has long been considered to be controlled mainly by biochemical cues such as growth factors. However, the tissue engineering approaches based on biochemical cues demonstrate low reproducibility as a precise spatial control over their bioactivity is challenging. Recently, substrate micro/nano-structure and electro-responsive properties are recognized for their important roles in myoblast differentiation. In this study, we hypothesized that engineering biophysical features such as nano/micro-fibrous structure and conductive properties into a single biomaterial scaffold will instruct the myoblasts to differentiate into multinucleated myotubes even in the absence of differentiation media. We fabricated nanocomposite scaffolds composed of conductive graphene nanosheets and polycaprolactone (PCL), a widely used biocompatible material. The resulting graphene-PCL scaffolds possess excellent conductivity due to graphene nanosheets and great processability, biodegradability and elastic mechanical properties conferred by PCL. Additionally, physicochemical and mechanical properties of nanocomposite scaffolds can be tuned by varying graphene concentration. Further, graphene-PCL nanocomposites and their 8-week degradation products exhibited remarkable cytocompatibility and promoted adhesion and proliferation of C2C12 mouse myoblast cells. Importantly, these nanocomposite scaffolds induced graphene concentration-dependent differentiation of C2C12 cells into multinucleated myotubes even in normal growth media suggesting their cell-instructive potential. Thus, graphene-PCL nanocomposite scaffolds can serve as a strategy to promote skeletal muscle regeneration without biochemical cues.
C1 [Patel, Akhil; Xue, Yingfei; Mukundan, Shilpaa; Rohan, Lisa C.; Sant, Vinayak; Sant, Shilpa] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA.
   [Stolz, Donna B.] Univ Pittsburgh, Sch Med, Ctr Biol Imaging, Pittsburgh, PA 15261 USA.
   [Stolz, Donna B.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA.
   [Stolz, Donna B.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA.
   [Sant, Shilpa] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
   [Sant, Shilpa] McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA.
RP Sant, S (reprint author), Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA.
EM shs149@pitt.edu
OI Xue, Yingfei/0000-0002-4551-3702; Patel, Akhil/0000-0001-8915-8995;
   Sant, Shilpa/0000-0002-2017-9584
FU Department of Pharmaceutical Sciences at University of Pittsburgh
FX The authors acknowledge Material Characterization Lab, University of
   Pittsburgh for access to contact angle goniometer and Dr. Tracy Cui lab
   for access to conductivity measurement. SS acknowledges financial
   support (start-up funds) from the Department of Pharmaceutical Sciences
   at University of Pittsburgh.
CR Ahadian S, 2015, BIOMATER SCI-UK, V3, P1449, DOI 10.1039/c5bm00215j
   Ahadian S, 2014, RSC ADV, V4, P9534, DOI 10.1039/c3ra46218h
   Ahmed WW, 2010, BIOMATERIALS, V31, P250, DOI 10.1016/j.biomaterials.2009.09.047
   Alzari V, 2011, J MATER CHEM, V21, P8727, DOI 10.1039/c1jm11076d
   Aryaei A, 2014, J BIOMED MATER RES A, V102, P3282, DOI 10.1002/jbm.a.34993
   Bajaj P., 2014, ADV HEALTHC MATER, V3, P949
   BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y
   Bentzinger C. F., 2012, COLD SPRING HARB PER, V4
   Bonderer LJ, 2008, SCIENCE, V319, P1069, DOI 10.1126/science.1148726
   Bridges Amanda W, 2008, J Diabetes Sci Technol, V2, P984
   Cezar CA, 2016, P NATL ACAD SCI USA, V113, P1534, DOI 10.1073/pnas.1517517113
   Chaudhuri B, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/1/015009
   Depan D, 2014, BIOMATER SCI-UK, V2, P1727, DOI 10.1039/c4bm00168k
   Ding X., 2015, ADV HEALTHC MAT
   Ferri P, 2009, J CELL BIOCHEM, V108, P1302, DOI 10.1002/jcb.22360
   Gaharwar AK, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/1/015001
   Gawlitta D, 2008, TISSUE ENG PT A, V14, P161, DOI 10.1089/ten.a.2007.0095
   Goenka S, 2014, J CONTROL RELEASE, V173, P75, DOI 10.1016/j.jconrel.2013.10.017
   Gutierrez J, 2010, MOL CELL BIOL, V30, P1634, DOI 10.1128/MCB.01164-09
   Han Y, 2013, ACTA BIOMATER, V9, P9107, DOI 10.1016/j.actbio.2013.06.022
   Hill E, 2006, P NATL ACAD SCI USA, V103, P2494, DOI 10.1073/pnas.0506004103
   Holloway JL, 2014, ACTA BIOMATER, V10, P3581, DOI 10.1016/j.actbio.2014.05.004
   Horsley V, 2004, CELLS TISSUES ORGANS, V176, P67, DOI 10.1159/000075028
   Juhas M, 2013, CURR OPIN BIOTECH, V24, P880, DOI 10.1016/j.copbio.2013.04.013
   Jun I, 2009, BIOMATERIALS, V30, P2038, DOI 10.1016/j.biomaterials.2008.12.063
   KREIDER BL, 1992, SCIENCE, V255, P1700, DOI 10.1126/science.1372755
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lawson MA, 2000, CELLS TISSUES ORGANS, V167, P130, DOI 10.1159/000016776
   Lee J, 2013, J MEMBRANE SCI, V448, P223, DOI 10.1016/j.memsci.2013.08.017
   LI L, 1992, GENE DEV, V6, P676, DOI 10.1101/gad.6.4.676
   Li YF, 2013, P NATL ACAD SCI USA, V110, P12295, DOI 10.1073/pnas.1222276110
   Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901
   Liu WJ, 2015, ACTA BIOMATER, V21, P217, DOI 10.1016/j.actbio.2015.04.012
   Luo Y, 2015, ACS APPL MATER INTER, V7, P6331, DOI 10.1021/acsami.5b00862
   Mukundan S, 2015, EUR POLYM J, V68, P21, DOI 10.1016/j.eurpolymj.2015.04.026
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nayak TR, 2011, ACS NANO, V5, P4670, DOI 10.1021/nn200500h
   OLSON EN, 1992, DEV BIOL, V154, P261, DOI 10.1016/0012-1606(92)90066-P
   Ostrovidov S, 2014, TISSUE ENG PART B-RE, V20, P403, DOI [10.1089/ten.teb.2013.0534, 10.1089/ten.TEB.2013.0534]
   Patel A., 2016, ACTA BIOMATER
   Pelipenko J, 2015, INT J PHARMACEUT, V484, P57, DOI 10.1016/j.ijpharm.2015.02.043
   Rossi CA, 2011, FASEB J, V25, P2296, DOI 10.1096/fj.10-174755
   Sant S., 2012, BIOMIMETIC APPROACHE, P471
   Sant S, 2013, ACTA BIOMATER, V9, P5963, DOI 10.1016/j.actbio.2012.11.014
   Santin M., 2013, BIOL RESPONS BIOMATE, V1, P43
   Sanz A, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/10/104209
   Sfeir C., 2014, ACTA BIOMATER
   Soliman S, 2011, J BIOMED MATER RES A, V96A, P566, DOI 10.1002/jbm.a.33010
   Stone V, 2009, CRIT REV TOXICOL, V39, P613, DOI 10.1080/10408440903120975
   Suk JW, 2010, ACS NANO, V4, P6557, DOI 10.1021/nn101781v
   Tomblyn S, 2015, J BIOMED MAT RES B
   Tong ZX, 2011, TISSUE ENG PT A, V17, P2773, DOI [10.1089/ten.tea.2011.0219, 10.1089/ten.TEA.2011.0219]
   Ventre M., 2016, ACS APPL MAT INTERFA
   Warren H, 2014, J POLYM SCI POL PHYS, V52, P864, DOI 10.1002/polb.23497
   Wu N, 2012, J MATER CHEM, V22, P17254, DOI 10.1039/c2jm33114d
   Xavier JR, 2015, ACS NANO, V9, P3109, DOI 10.1021/nn507488s
   Xu AX, 2015, MAT SCI ENG C-MATER, V48, P592, DOI 10.1016/j.msec.2014.12.061
   Xue YF, 2015, EUR POLYM J, V72, P163, DOI 10.1016/j.eurpolymj.2015.09.013
   Yan XR, 2010, J ELECTROSTAT, V68, P458, DOI 10.1016/j.elstat.2010.06.009
   Yang HS, 2016, ADV HEALTHC MATER, V5, P137, DOI 10.1002/adhm.201500003
   Zhang YB, 2010, ACS NANO, V4, P3181, DOI 10.1021/nn1007176
   Zhou TN, 2013, EXPRESS POLYM LETT, V7, P747, DOI 10.3144/expresspolymlett.2013.72
NR 62
TC 9
Z9 9
U1 2
U2 29
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUN
PY 2016
VL 44
IS 6
BP 2036
EP 2048
DI 10.1007/s10439-016-1586-6
PG 13
WC Engineering, Biomedical
SC Engineering
GA DN0RO
UT WOS:000376772000015
PM 26983841
DA 2018-10-19
ER

PT J
AU Gao, WW
   Zhang, Y
   Zhang, QZ
   Zhang, LF
AF Gao, Weiwei
   Zhang, Yue
   Zhang, Qiangzhe
   Zhang, Liangfang
TI Nanoparticle-Hydrogel: A Hybrid Biomaterial System for Localized Drug
   Delivery
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Nanomedicine; Nanoparticle; Hydrogel; Hybrid biomaterial; Drug delivery
ID RESISTANT STAPHYLOCOCCUS-AUREUS; BIODEGRADABLE COLLOIDAL GELS; ON-DEMAND
   DRUG; SPINAL-CORD; THERAPEUTIC APPLICATIONS; NANOCOMPOSITE HYDROGELS;
   POLYMERIC NANOPARTICLES; REGENERATIVE MEDICINE; COMBINATION THERAPY;
   CONTROLLED-RELEASE
AB Nanoparticles have offered a unique set of properties for drug delivery including high drug loading capacity, combinatorial delivery, controlled and sustained drug release, prolonged stability and lifetime, and targeted delivery. To further enhance therapeutic index, especially for localized application, nanoparticles have been increasingly combined with hydrogels to form a hybrid biomaterial system for controlled drug delivery. Herein, we review recent progresses in engineering such nanoparticle-hydrogel hybrid system (namely 'NP-gel') with a particular focus on its application for localized drug delivery. Specifically, we highlight four research areas where NP-gel has shown great promises, including (1) passively controlled drug release, (2) stimuli-responsive drug delivery, (3) site-specific drug delivery, and (4) detoxification. Overall, integrating therapeutic nanoparticles with hydrogel technologies creates a unique and robust hybrid biomaterial system that enables effective localized drug delivery.
C1 [Zhang, Liangfang] Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA.
   [Zhang, Liangfang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.
RP Zhang, LF (reprint author), Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA.; Zhang, LF (reprint author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.
EM zhang@ucsd.edu
FU National Science Foundation [DMR-1505699]; National Institute of
   Diabetes and Digestive and Kidney Diseases of the National Institutes of
   Health [R01DK095168]
FX This work is supported by the National Science Foundation Grant
   DMR-1505699 and the National Institute of Diabetes and Digestive and
   Kidney Diseases of the National Institutes of Health under Award Number
   R01DK095168.
CR Al Ghanami RC, 2010, SOFT MATTER, V6, P5037, DOI 10.1039/c0sm00059k
   Aryal S, 2011, MOL PHARMACEUT, V8, P1401, DOI 10.1021/mp200243k
   Baumann MD, 2010, BIOMATERIALS, V31, P7631, DOI 10.1016/j.biomaterials.2010.07.004
   Baumann MD, 2009, J CONTROL RELEASE, V138, P205, DOI 10.1016/j.jconrel.2009.05.009
   Bishop KJM, 2009, SMALL, V5, P1600, DOI 10.1002/smll.200900358
   Blanco E, 2015, NAT BIOTECHNOL, V33, P941, DOI 10.1038/nbt.3330
   Caccavo D, 2015, MOL PHARMACEUT, V12, P474, DOI 10.1021/mp500563n
   Chen ML, 2012, ACS NANO, V6, P4835, DOI 10.1021/nn300106t
   Cho EC, 2008, NANO LETT, V8, P168, DOI 10.1021/nl072346e
   Chvatal SA, 2008, BIOMATERIALS, V29, P1967, DOI 10.1016/j.biomaterials.2008.01.002
   Cometa S, 2013, J BIOACT COMPAT POL, V28, P508, DOI 10.1177/0883911513498960
   Conrado RJ, 2008, CURR OPIN BIOTECH, V19, P492, DOI 10.1016/j.copbio.2008.07.006
   Dang TT, 2013, BIOMATERIALS, V34, P5792, DOI 10.1016/j.biomaterials.2013.04.016
   Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614
   DeMuth PC, 2012, ACS NANO, V6, P8041, DOI 10.1021/nn302639r
   DeMuth PC, 2010, ADV MATER, V22, P4851, DOI 10.1002/adma.201001525
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055
   Fang RH, 2015, ADV DRUG DELIVER REV, V90, P69, DOI 10.1016/j.addr.2015.04.001
   Fang RH, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005386
   Fang Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02811
   Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m
   Fraylich MR, 2010, J COLLOID INTERF SCI, V344, P61, DOI 10.1016/j.jcis.2009.12.030
   Fuhrer R, 2009, SMALL, V5, P383, DOI 10.1002/smll.200801091
   Fullenkamp DE, 2012, BIOMATERIALS, V33, P3783, DOI 10.1016/j.biomaterials.2012.02.027
   Gao WW, 2014, WIRES NANOMED NANOBI, V6, P532, DOI 10.1002/wnan.1282
   Gao WW, 2014, ACS NANO, V8, P2900, DOI 10.1021/nn500110a
   Gao WW, 2010, MOL PHARMACEUT, V7, P1913, DOI 10.1021/mp100253e
   Gobin AM, 2007, NANO LETT, V7, P1929, DOI 10.1021/nl070610y
   Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591
   Gorwitz RJ, 2008, J INFECT DIS, V197, P179, DOI 10.1086/523767
   Gou ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4774
   Grzelczak M, 2010, ACS NANO, V4, P3591, DOI 10.1021/nn100869j
   Gu Z, 2013, ACS NANO, V7, P4194, DOI 10.1021/nn400630x
   Gulsen D, 2005, CURR EYE RES, V30, P1071, DOI 10.1080/02713680500346633
   Gupta P, 2002, DRUG DISCOV TODAY, V7, P569, DOI 10.1016/S1359-6446(02)02255-9
   HIGUCHI T, 1961, J PHARM SCI, V50, P874, DOI 10.1002/jps.2600501018
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Hoshino Y, 2012, P NATL ACAD SCI USA, V109, P33, DOI 10.1073/pnas.1112828109
   Hu CMJ, 2015, NATURE, V526, P118, DOI 10.1038/nature15373
   Hu CMJ, 2013, NAT NANOTECHNOL, V8, P933, DOI [10.1038/nnano.2013.254, 10.1038/NNANO.2013.254]
   Hu CMJ, 2013, NAT NANOTECHNOL, V8, P336, DOI [10.1038/nnano.2013.54, 10.1038/NNANO.2013.54]
   Hu CMJ, 2011, P NATL ACAD SCI USA, V108, P10980, DOI 10.1073/pnas.1106634108
   Hu K, 2015, ADV MATER, V27, P2507, DOI 10.1002/adma.201405757
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Ilg P, 2013, SOFT MATTER, V9, P3465, DOI 10.1039/c3sm27809c
   Jung HJ, 2013, J CONTROL RELEASE, V165, P82, DOI 10.1016/j.jconrel.2012.10.010
   Kapoor Y, 2008, J COLLOID INTERF SCI, V322, P624, DOI 10.1016/j.jcis.2008.02.028
   Kastrup CJ, 2012, P NATL ACAD SCI USA, V109, P21444, DOI 10.1073/pnas.1217972110
   Kolishetti N, 2010, P NATL ACAD SCI USA, V107, P17939, DOI 10.1073/pnas.1011368107
   Lang N, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006557
   Langer R, 2009, ADV MATER, V21, P3235, DOI 10.1002/adma.200902589
   Laroui H, 2010, GASTROENTEROLOGY, V138, P843, DOI 10.1053/j.gastro.2009.11.003
   Li F, 2011, ANGEW CHEM INT EDIT, V50, P360, DOI 10.1002/anie.201001451
   Li L, 2015, POLYM CHEM-UK, V6, P353, DOI 10.1039/c4py01415d
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   Liu TY, 2008, J CONTROL RELEASE, V126, P228, DOI 10.1016/j.jconrel.2007.12.006
   Liu Y, 2013, NAT NANOTECHNOL, V8, P187, DOI [10.1038/nnano.2012.264, 10.1038/NNANO.2012.264]
   Lobatto ME, 2011, NAT REV DRUG DISCOV, V10, P835, DOI 10.1038/nrd3578
   Ma L, 2013, ACS NANO, V7, P9518, DOI 10.1021/nn405674m
   Merino S, 2015, ACS NANO, V9, P4686, DOI 10.1021/acsnano.5b01433
   Messing R, 2011, MACROMOLECULES, V44, P2990, DOI 10.1021/ma102708b
   Mohan YM, 2007, POLYMER, V48, P158, DOI 10.1016/j.polymer.2006.10.045
   Morton SW, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005261
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   Ninh C, 2014, BIOMATER SCI-UK, V2, P766, DOI 10.1039/c3bm60321k
   Park CG, 2015, MACROMOL RES, V23, P882, DOI 10.1007/s13233-015-3115-0
   Patel RG, 2014, CELL MOL BIOENG, V7, P394, DOI 10.1007/s12195-014-0353-8
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Qu Y, 2015, NPG ASIA MATER, V7, DOI 10.1038/am.2015.83
   Ramer LM, 2005, SPINAL CORD, V43, P134, DOI 10.1038/sj.sc.3101715
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Rattanaruengsrikul V, 2012, J APPL POLYM SCI, V124, P1668, DOI 10.1002/app.35195
   Romero MI, 2001, J NEUROSCI, V21, P8408
   Roux R, 2013, MAT SCI ENG C-MATER, V33, P997, DOI 10.1016/j.msec.2012.12.002
   Saquing CD, 2009, SMALL, V5, P944, DOI 10.1002/smll.200801273
   Satarkar NS, 2008, J CONTROL RELEASE, V130, P246, DOI 10.1016/j.jconrel.2008.06.008
   Sattayasamitsathit S, 2014, SMALL, V10, P2830, DOI 10.1002/smll.201303646
   Schafer-Korting M, 2007, ADV DRUG DELIVER REV, V59, P427, DOI 10.1016/j.addr.2007.04.006
   Schexnailder P, 2009, COLLOID POLYM SCI, V287, P1, DOI 10.1007/s00396-008-1949-0
   Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020
   Schmid-Wendtner MH, 2006, SKIN PHARMACOL PHYS, V19, P296, DOI 10.1159/000094670
   Schoffelen S, 2012, SOFT MATTER, V8, P1736, DOI 10.1039/c1sm06452e
   Sekine Y, 2012, ADV HEALTHC MATER, V1, P722, DOI 10.1002/adhm.201200175
   Sethi M, 2014, NANOSCALE, V6, P2321, DOI 10.1039/c3nr05961h
   Shi JJ, 2011, ACCOUNTS CHEM RES, V44, P1123, DOI 10.1021/ar200054n
   Shi JJ, 2010, NANO LETT, V10, P3223, DOI 10.1021/nl102184c
   Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P139, DOI 10.1016/S0169-409X(01)00112-0
   Siepmann J, 2011, INT J PHARMACEUT, V418, P6, DOI 10.1016/j.ijpharm.2011.03.051
   Singer AJ, 2014, NEW ENGL J MED, V370, P1039, DOI 10.1056/NEJMra1212788
   Thomas V, 2009, J APPL POLYM SCI, V111, P934, DOI 10.1002/app.29018
   Timko BP, 2011, ANNU REV MATER RES, V41, P1, DOI 10.1146/annurev-matsci-062910-100359
   Wang AZ, 2012, ANNU REV MED, V63, P185, DOI 10.1146/annurev-med-040210-162544
   Wang F, 2015, ADV MATER, V27, P3437, DOI 10.1002/adma.201501071
   Wang HA, 2011, ADV MATER, V23, pH119, DOI 10.1002/adma.201003908
   Wang Q, 2008, ADV MATER, V20, P236, DOI 10.1002/adma.200702099
   Wang Q, 2013, TISSUE ENG PT A, V19, P2586, DOI [10.1089/ten.tea.2013.0075, 10.1089/ten.TEA.2013.0075]
   Wang Q, 2011, J BIOMED MATER RES A, V96A, P520, DOI 10.1002/jbm.a.33000
   Wang SG, 2012, THER DELIV, V3, P1155, DOI 10.4155/TDE.12.103
   Wang YL, 2013, J CONTROL RELEASE, V172, pE90, DOI 10.1016/j.jconrel.2013.08.182
   Wu Z, 2015, NANOSCALE, V7, P13680, DOI 10.1039/c5nr03730a
   Xia LW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3226
   Xiang YQ, 2007, EUR POLYM J, V43, P4178, DOI 10.1016/j.eurpolymj.2007.08.005
   Yan B, 2012, J AM CHEM SOC, V134, P16558, DOI 10.1021/ja308876j
   Yoon YM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13155
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Zhang JH, 2010, ADV MATER, V22, P4249, DOI 10.1002/adma.201000755
   Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580
   Zhang LF, 2015, ADV DRUG DELIVER REV, V90, P1, DOI 10.1016/j.addr.2015.07.010
   Zhang XB, 2011, NANO LETT, V11, P3239, DOI 10.1021/nl201503e
   Zhao XL, 2006, NEW J CHEM, V30, P915, DOI 10.1039/b601069e
   Zhao XH, 2011, P NATL ACAD SCI USA, V108, P67, DOI 10.1073/pnas.1007862108
   Zhu CH, 2012, ADV FUNCT MATER, V22, P4017, DOI 10.1002/adfm.201201020
   Zhu W, 2010, BIOMACROMOLECULES, V11, P3086, DOI 10.1021/bm100889j
NR 117
TC 23
Z9 23
U1 11
U2 140
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUN
PY 2016
VL 44
IS 6
BP 2049
EP 2061
DI 10.1007/s10439-016-1583-9
PG 13
WC Engineering, Biomedical
SC Engineering
GA DN0RO
UT WOS:000376772000016
PM 26951462
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Akhtar, N
   Rahman, MS
   Jamil, HM
   Arifuzzaman, M
   Miah, MM
   Asaduzzaman, SM
AF Akhtar, Naznin
   Rahman, Md. Shaifur
   Jamil, Hossen Mohammad
   Arifuzzaman, Md.
   Miah, M. M.
   Asaduzzaman, S. M.
TI Tissue banking in Bangladesh: 12 years of experience (2003-2014)
SO CELL AND TISSUE BANKING
LA English
DT Article
DE Tissue bank; Guidelines of tissue banking; Tissue allografts; Bone;
   Amniotic membrane; Bangladesh
ID ALLOGRAFT; KERATINOCYTES; SURGERY; BONE; TRANSPLANTATION
AB Tissue Banking and Biomaterial Research Unit (TBBRU), the only tissue bank of Bangladesh, has been established to create an available supply of human tissue allografts for transplantation in Bangladesh. Since its establishment in 2003, TBBRU strictly follows the guidelines of tissue banking setup by the International Atomic Energy Agency, the European Association of Tissue Banks and the American Association of Tissue Banks. Though started serving from earlier, regular supply of tissue allografts from this bank were documented at the end of 2006. From January 2007 to December 2014, 3747 bones and 5772 amniotic sacs were collected from live tissue donors. During this period, 59,489 cc bone allografts and 23,472 pieces of amniotic membrane allografts were processed. In the same period, 58,483 cc bone allografts and 20,786 pieces membrane were supplied to different hospitals throughout the country on the basis of demand. The outcomes of the concerted efforts of tissue banking professionals and physicians were the restoration of health and hope of 3662 patients during the last 8 years.
C1 [Akhtar, Naznin; Rahman, Md. Shaifur; Jamil, Hossen Mohammad; Arifuzzaman, Md.; Asaduzzaman, S. M.] AERE, TBBRU, Dhaka 1349, Bangladesh.
   [Miah, M. M.] Natl Inst Nucl Med & Allied Sci, BSMMU Campus, Dhaka 1000, Bangladesh.
RP Akhtar, N; Asaduzzaman, SM (reprint author), AERE, TBBRU, Dhaka 1349, Bangladesh.
EM nazmbiocu@yahoo.com; sikderasad@yahoo.com
OI Rahman, Md Shaifur/0000-0002-4306-6224; Jamil, Hossen
   Mohammad/0000-0001-8244-8607
FU Ministry of Science and Technology, People's Republic of Bangladesh;
   IAEA
FX We would like to thank Ministry of Science and Technology, People's
   Republic of Bangladesh and IAEA for providing the financial and
   technical support for the development of Tissue Banking and Biomaterial
   Research Unit, Bangladesh. We also like convey the heartiest thanks to
   Prof. Dr. Naiyyum Choudhury, Chairman, Bangladesh Atomic Energy
   Regulatory Authority, Dr. M. Serajul Islam, former Member, Bangladesh
   Atomic Energy commission and Mrs. Azizun Nessa, former Director of TBBRU
   for their support throughout the development of the tissue bank. We
   would like to give special thanks to the personnel of Cobalt-60 gamma
   source at AERE.
CR [Anonymous], 2006, 111372 ISO
   [Anonymous], 2006, 111371 ISO
   Armitage WJ, 2011, TRANSFUS MED HEMOTH, V38, P143, DOI 10.1159/000326632
   Baker Thomas F., 2005, Cell and Tissue Banking, V6, P271, DOI 10.1007/s10561-005-7364-6
   Braye F, 2000, MED BIOL ENG COMPUT, V38, P248, DOI 10.1007/BF02344784
   Chapovsky F, 2005, ARTHROSCOPY, V21, DOI 10.1016/j.arthro.2005.04.005
   Chen HJ, 2000, BRIT J OPHTHALMOL, V84, P826, DOI 10.1136/bjo.84.8.826
   Donati D, 2005, CURR ORTHOPAED, V19, P393, DOI 10.1016/j.cuor.2005.08.001
   Ehrler DM, 2000, CLIN ORTHOP RELAT R, P38
   Feilmeier MR, 2010, MIDDLE EAST AFR J OP, V17, P38, DOI 10.4103/0974-9233.61215
   Heng WL, 2013, CELL TISSUE BANK, V14, P187, DOI 10.1007/s10561-012-9310-8
   Judas F, 2005, TRANSPLANT P, V37, P2799, DOI 10.1016/j.transproceed.2005.05.004
   KUROYANAGI Y, 1993, ANN PLAS SURG, V31, P340, DOI 10.1097/00000637-199310000-00011
   Leon-Villapalos J, 2010, CELL TISSUE BANK, V11, P99, DOI 10.1007/s10561-009-9152-1
   Nather A, 2004, J Orthop Surg (Hong Kong), V12, P184
   Nguyen H, 2011, J ARTHROPLASTY, V26, P303, DOI 10.1016/j.arth.2010.03.032
   Pedraza JM, 2011, CELL SCI THER, V2, P105
   Plunkett MD, 1999, SEMIN THORAC CARDIOV, V2, P95
   Reardon MJ, 1997, CURR OPIN CARDIOL, V12, P114, DOI 10.1097/00001573-199703000-00005
   RONFARD V, 1991, BURNS, V17, P181, DOI 10.1016/0305-4179(91)90099-3
   Toteberg-Harms M, 2009, DEV OPHTHALMOL, V43, P105, DOI 10.1159/000223843
   Vajaradul Yongyudh, 2000, Cell and Tissue Banking, V1, P229, DOI 10.1023/A:1026542730541
   Vloemans AFPM, 2002, BURNS S1, V28, P16
   Zelen CM, 2014, WOUND MED, V4, P1
   Zwitser EW, 2012, CELL TISSUE BANK, V13, P63, DOI 10.1007/s10561-010-9230-4
NR 25
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1389-9333
EI 1573-6814
J9 CELL TISSUE BANK
JI Cell Tissue Banking
PD JUN
PY 2016
VL 17
IS 2
BP 189
EP 197
DI 10.1007/s10561-016-9549-6
PG 9
WC Cell Biology; Engineering, Biomedical
SC Cell Biology; Engineering
GA DN3UD
UT WOS:000376988400002
PM 26915083
DA 2018-10-19
ER

PT J
AU Ricklin, D
   Lambris, JD
AF Ricklin, Daniel
   Lambris, John D.
TI Therapeutic control of complement activation at the level of the central
   component C3
SO IMMUNOBIOLOGY
LA English
DT Article; Proceedings Paper
CT Meeting on Complement-Driver of Inflammation and Therapeutic Target in
   Diverse Diseases
CY FEB, 2015
CL Royal Soc, Chicheley, ENGLAND
HO Royal Soc
DE Complement; C3; Therapeutics; Convertase; Alternative pathway
ID PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; ANTI-FACTOR D; ALTERNATIVE PATHWAY;
   TISSUE-INJURY; PHARMACOKINETIC PROPERTIES; BIOMATERIAL SURFACES; MACULAR
   DEGENERATION; INHIBITOR COMPSTATIN; FACTOR-I; FACTOR-H
AB The increasing recognition of the complement system's association with diseases of the inflammatory spectrum and with biomaterial and transplant-related complications has generated growing interest in the therapeutic modulation of this innate immune cascade. As a central functional hub that largely drives the activation, amplification, and effector generation of the complement response, the plasma protein C3 has long been recognized as an attractive target. While pharmacological modulation of C3 activation may offer a powerful opportunity to interfere with or even prevent complement-driven pathologies, the development of C3 inhibitors has often been accompanied by concerns regarding the safety and feasibility of this approach. Although no C3-targeted inhibitors have thus far been approved for clinical use, several promising concepts and candidates have emerged in recent years. At the same time, experiences from preclinical development and clinical trials are slowly providing a more detailed picture of therapeutic complement inhibition at the level of C3. This review highlights the current therapeutic strategies to control C3 activation and discusses the possibilities and challenges on the road to bringing C3-targeted therapeutics to the clinic. (C) 2015 Elsevier GmbH. All rights reserved.
C1 [Ricklin, Daniel; Lambris, John D.] Univ Penn, Dept Pathol & Lab Med, 401 Stellar Chance,422 Curie Blvd, Philadelphia, PA 19104 USA.
RP Ricklin, D (reprint author), Univ Penn, Dept Pathol & Lab Med, 401 Stellar Chance,422 Curie Blvd, Philadelphia, PA 19104 USA.
EM ricklin@upenn.edu
FU NEI NIH HHS [R01 EY020633]; NIAID NIH HHS [P01 AI068730, N01 AI030040,
   R01 AI030040, R21 AI097805]
CR ALPER CA, 1967, J CLIN INVEST, V46, P2021, DOI 10.1172/JCI105691
   Atkinson C, 2005, J CLIN INVEST, V115, P2444, DOI 10.1172/JCI25208
   Bajic G, 2013, PROTEIN SCI, V22, P204, DOI 10.1002/pro.2200
   Baudino L, 2014, P NATL ACAD SCI USA, V111, P1503, DOI 10.1073/pnas.1316877111
   Berends ETM, 2015, MOL IMMUNOL, V65, P328, DOI 10.1016/j.molimm.2015.01.020
   Botto M, 2009, MOL IMMUNOL, V46, P2774, DOI 10.1016/j.molimm.2009.04.029
   Craik CS, 2011, BIOCHEM J, V435, P1, DOI 10.1042/BJ20100965
   DiLillo DJ, 2006, MOL IMMUNOL, V43, P1010, DOI 10.1016/j.molimm.2005.05.003
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821
   Fridkis-Hareli M, 2011, BLOOD, V118, P4705, DOI 10.1182/blood-2011-06-359646
   Grumach AS, 2014, MOL IMMUNOL, V61, P110, DOI 10.1016/j.molimm.2014.06.030
   Harboe M, 2004, CLIN EXP IMMUNOL, V138, P439, DOI 10.1111/j.1365-2249.2004.02627.x
   Harboe M, 2009, MOL IMMUNOL, V47, P373, DOI 10.1016/j.molimm.2009.09.005
   Hillmen P, 2013, BRIT J HAEMATOL, V162, P62, DOI 10.1111/bjh.12347
   Holers VM, 2013, ADV EXP MED BIOL, V735, P137, DOI 10.1007/978-1-4614-4118-2_9
   Holz FG, 2013, OPHTHALMOLOGICA, V230, P12
   Huang YJ, 2014, CHEMMEDCHEM, V9, P2223, DOI 10.1002/cmdc.201402212
   Janssen BJC, 2007, J BIOL CHEM, V282, P29241, DOI 10.1074/jbc.M704587200
   Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172
   Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005
   Katschke KJ, 2012, J BIOL CHEM, V287, P12886, DOI 10.1074/jbc.M112.345082
   Katschke KJ, 2009, J BIOL CHEM, V284, P10473, DOI 10.1074/jbc.M809106200
   Kimura Y, 2010, J CLIN INVEST, V120, P3545, DOI 10.1172/JCI41782
   Lachmann PJ, 2009, ADV IMMUNOL, V104, P115, DOI 10.1016/S0065-2776(08)04004-2
   Lay E, 2015, CLIN EXP IMMUNOL, V181, P314, DOI 10.1111/cei.12437
   Lazar HL, 2007, CIRCULATION, V116, pI83, DOI 10.1161/CIRCULATIONAHA.106.677914
   Lesher AM, 2013, MOL IMMUNOL, V56, P191, DOI 10.1016/j.molimm.2013.06.002
   Lesher AM, 2013, J AM SOC NEPHROL, V24, P53, DOI 10.1681/ASN.2012060570
   Li Jennifer S, 2006, Expert Rev Cardiovasc Ther, V4, P649, DOI 10.1586/14779072.4.5.649
   Loyet KM, 2014, J PHARMACOL EXP THER, V351, P527, DOI 10.1124/jpet.114.215921
   Maekawa T, 2014, J IMMUNOL, V192, P6020, DOI 10.4049/jimmunol.1400569
   Mastellos DC, 2015, EUR J CLIN INVEST, V45, P423, DOI 10.1111/eci.12419
   Mastellos DC, 2014, EXPERT REV HEMATOL, V7, P583, DOI 10.1586/17474086.2014.953926
   Medical Research Council, UK CLIN RES NETW STU
   Milder FJ, 2007, NAT STRUCT MOL BIOL, V14, P224, DOI 10.1038/nsmb1210
   Miwa T, 2013, J IMMUNOL, V190, P3552, DOI 10.4049/jimmunol.1202275
   Morgan B. P., 2014, 56 ASH ANN M EXP SAN
   Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277
   Nilsson PH, 2013, BIOMATERIALS, V34, P985, DOI 10.1016/j.biomaterials.2012.10.040
   Paixao-Cavalcante D, 2014, J IMMUNOL, V192, P4844, DOI 10.4049/jimmunol.1303131
   Pauly D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096371
   Qu HC, 2013, IMMUNOBIOLOGY, V218, P496, DOI 10.1016/j.imbio.2012.06.003
   Reis ES, 2015, IMMUNOBIOLOGY, V220, P476, DOI 10.1016/j.imbio.2014.10.026
   Reis ES, 2006, SCAND J IMMUNOL, V63, P155, DOI 10.1111/j.1365-3083.2006.01729.x
   Ricklin D, 2008, ADV EXP MED BIOL, V632, P273, DOI 10.1007/978-0-387-78952-1_20
   Ricklin D, 2013, J IMMUNOL, V190, P3839, DOI 10.4049/jimmunol.1203200
   Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487
   Ricklin D, 2013, ADV EXP MED BIOL, V735, P1, DOI 10.1007/978-1-4614-4118-2_1
   Ricklin D, 2012, IMMUNOBIOLOGY, V217, P1057, DOI 10.1016/j.imbio.2012.07.016
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   Risitano AM, 2014, BLOOD, V123, P2094, DOI 10.1182/blood-2013-11-536573
   Risitano AM, 2012, BLOOD, V119, P6307, DOI 10.1182/blood-2011-12-398792
   Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756
   Roversi P, 2011, P NATL ACAD SCI USA, V108, P12839, DOI 10.1073/pnas.1102167108
   Ruseva MM, 2013, J AM SOC NEPHROL, V24, P43, DOI 10.1681/ASN.2012060571
   Sacks S, 2013, ADV EXP MED BIOL, V735, P247, DOI 10.1007/978-1-4614-4118-2_17
   Sacks SH, 2012, NAT REV IMMUNOL, V12, P431, DOI 10.1038/nri3225
   Sahu A, 1996, J IMMUNOL, V157, P884
   Schmidt CQ, 2013, J IMMUNOL, V190, P5712, DOI 10.4049/jimmunol.1203548
   Scott D, 2016, IMMUNOBIOLOGY, V221, P719, DOI 10.1016/j.imbio.2015.05.001
   Vogel CW, 2014, MOL IMMUNOL, V61, P191, DOI 10.1016/j.molimm.2014.06.035
   Wiles J., 2014, 56 ASH ANN M EXP SAN
   Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755
   Wu YQ, 2011, J IMMUNOL, V186, P4269, DOI 10.4049/jimmunol.1003802
   Zhang YZ, 2015, IMMUNOBIOLOGY, V220, P993, DOI 10.1016/j.imbio.2015.04.001
NR 66
TC 14
Z9 14
U1 0
U2 3
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0171-2985
J9 IMMUNOBIOLOGY
JI Immunobiology
PD JUN
PY 2016
VL 221
IS 6
SI SI
BP 740
EP 746
DI 10.1016/j.imbio.2015.06.012
PG 7
WC Immunology
SC Immunology
GA DN7BP
UT WOS:000377230600008
PM 26101137
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Gao, ZH
   Hu, L
   Liu, GL
   Wei, FL
   Liu, Y
   Liu, ZH
   Fan, ZP
   Zhang, CM
   Wang, JS
   Wang, SL
AF Gao, Z. H.
   Hu, L.
   Liu, G. L.
   Wei, F. L.
   Liu, Y.
   Liu, Z. H.
   Fan, Z. P.
   Zhang, C. M.
   Wang, J. S.
   Wang, S. L.
TI Bio-Root and Implant-Based Restoration as a Tooth Replacement
   Alternative
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE tissue engineering; stem cell(s); dental implant(s); bioengineering;
   tooth regeneration/transplantation; biomaterial(s)
ID PERIODONTAL-LIGAMENT; DENTAL IMPLANT; PROXIMAL FEMUR; STEM-CELLS;
   REGENERATION; SWINE; THERAPY
AB We previously reported that dental stem cell-mediated bioengineered tooth root (bio-root) regeneration could restore tooth loss in a miniature pig model. As a potential new method for tooth restoration, it is essential to compare this method with the widely used commercial dental implant-based method of tooth restoration. Tooth loss models were created by extracting mandibular incisors from miniature pigs. Allogeneic periodontal ligament stem cells (PDLSCs) and dental pulp stem cells (DPSCs) were isolated and cultured. A PDLSC sheet was prepared by adding 20.0 mu g/mL vitamin C to the culture medium; in addition, a hydroxyapatite tricalcium phosphate (HA/TCP)/DPSC graft was fabricated and cultured in a 3-dimensional culture system. A total of 46 bio-root implantations and 9 dental implants were inserted, and crown restorations were performed 6 mo after implantation. Histological, radiological, biomechanical, and elemental analyses were used to evaluate and compare tissue-engineered bio-roots and dental implants to the natural tooth roots. After 6 mo, both computed tomography scans and histological examinations showed that root-like structures and dentin-like tissues had formed. Three months after crown restoration, clinical assessments revealed that tooth function was equivalent in the regenerated bio-root and the dental implant. Biomechanical testing showed that the bio-roots were similar to natural tooth roots in compressive strength, modulus of elasticity, and torsional force; however, these properties were significantly higher in the dental implants. Elemental analysis revealed a higher similarity in elemental composition between bio-roots and natural tooth roots than between bio-roots and dental implants. However, the dental implant success rate was 100% (9 of 9) and the bio-root success rate was only 22% (10 of 46). Taken together, we showed that an allogeneic HA/TCP/DPSC/PDLSC sheet could successfully build a bio-root with structure and function similar to the natural tooth root; however, tissue engineering procedures must be optimized further to improve the success rate.
C1 [Gao, Z. H.; Hu, L.; Liu, G. L.; Liu, Y.; Liu, Z. H.; Fan, Z. P.; Zhang, C. M.; Wang, J. S.; Wang, S. L.] Capital Med Univ, Sch Stomatol, Beijing Key Lab Tooth Regenerat & Funct Reconstru, Mol Lab Gene Therapy & Tooth Regenerat, Tian Tan Xi Li 4, Beijing 100050, Peoples R China.
   [Wei, F. L.] Shandong Univ, Shandong Prov Key Lab Oral Biomed, Dept Orthodont, Sch Stomatol, Jinan 250100, Peoples R China.
   [Wang, S. L.] Capital Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Beijing 100050, Peoples R China.
RP Wang, SL (reprint author), Capital Med Univ, Sch Stomatol, Beijing Key Lab Tooth Regenerat & Funct Reconstru, Mol Lab Gene Therapy & Tooth Regenerat, Tian Tan Xi Li 4, Beijing 100050, Peoples R China.
EM slwang@ccmu.edu.cn
FU Beijing Municipality Government [PXM2013_014 226_000055,
   PXM2015_014226_000116, PXM2015_014226_0 00055, PXM2015_014226_000052,
   PXM2014_014226_000048, PXM2014_014226_000013, PXM2014_014226_000053,
   Z1211 00005212004, PXM 2013_014226_000021, PXM2013_01422 6_07_000080,
   TJSHG201310025005]
FX This work was supported by grants from Beijing Municipality Government
   grants (Beijing Scholar Program-PXM2013_014 226_000055,
   PXM2015_014226_000116, PXM2015_014226_0 00055, PXM2015_014226_000052,
   PXM2014_014226_000048, PXM2014_014226_000013, PXM2014_014226_000053,
   Z1211 00005212004, PXM 2013_014226_000021, PXM2013_01422 6_07_000080,
   and TJSHG201310025005). The authors thank Dr. Songtao Shi (Department of
   Anatomy and Cell Biology School of Dental Medicine University of
   Pennsylvania, USA) for his insights and thoughtful input. The authors
   declare no potential conflicts of interest with respect to the
   authorship and/or publication of this article.
CR Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Daley GQ, 2008, CELL, V132, P544, DOI 10.1016/j.cell.2008.02.009
   Du J, 2014, J DENT RES, V93, P183, DOI 10.1177/0022034513513026
   Erhart S, 2011, INJURY, V42, P1322, DOI 10.1016/j.injury.2011.04.010
   Gault P, 2010, J CLIN PERIODONTOL, V37, P750, DOI 10.1111/j.1600-051X.2010.01588.x
   Giannobile WV, 2010, J CLIN PERIODONTOL, V37, P747, DOI 10.1111/j.1600-051X.2010.01589.x
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Ikeda E, 2009, P NATL ACAD SCI USA, V106, P13475, DOI 10.1073/pnas.0902944106
   Kroger H, 1998, CLIN ORTHOP RELAT R, P66
   Liu Y, 2008, STEM CELLS, V26, P1065, DOI 10.1634/stemcells.2007-0734
   Meijer GJ, 1997, J ORAL REHABIL, V24, P85, DOI 10.1046/j.1365-2842.1997.d01-264.x
   Piotrowski B, 2014, MAT SCI ENG C-MATER, V38, P151, DOI 10.1016/j.msec.2014.01.048
   Sahin S, 2002, J DENT, V30, P271, DOI 10.1016/S0300-5712(02)00065-9
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079
   Wang S, 2007, ORAL DIS, V13, P530, DOI 10.1111/j.1601-0825.2006.01337.x
   Wei FL, 2013, STEM CELLS DEV, V22, P1752, DOI 10.1089/scd.2012.0688
   Wei FL, 2012, J CELL PHYSIOL, V227, P3216, DOI 10.1002/jcp.24012
   Wikesjo Ulf M E, 2007, Oral Maxillofac Surg Clin North Am, V19, P535, DOI 10.1016/j.coms.2007.07.004
   Zaky SH, 2009, J DENT RES, V88, P1077, DOI 10.1177/0022034509349926
NR 20
TC 12
Z9 15
U1 0
U2 11
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD JUN
PY 2016
VL 95
IS 6
BP 642
EP 649
DI 10.1177/0022034516639260
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DN3XB
UT WOS:000376996400006
PM 26976131
DA 2018-10-19
ER

PT J
AU Li, Y
   Guo, T
   Zhang, Z
   Yao, Y
   Chang, S
   Nor, JE
   Clarkson, BH
   Ni, L
   Liu, J
AF Li, Y.
   Guo, T.
   Zhang, Z.
   Yao, Y.
   Chang, S.
   Nor, J. E.
   Clarkson, B. H.
   Ni, L.
   Liu, J.
TI Autophagy Modulates Cell Mineralization on Fluorapatite-Modified
   Scaffolds
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE osteogenesis; tissue engineering; stem cell(s); biomaterial(s); bone
   biology; cell differentiation
ID MESENCHYMAL STEM-CELLS; PROTEIN-DEGRADATION; DIFFERENTIATION; LYSOSOMES;
   CONJUGATE; SURFACES; FUSION
AB As a major intracellular degradation and recycling machinery, autophagy plays an important role in maintaining cellular homeostasis and remodeling during normal development. Our previous study showed that fluorapatite (FA) crystal-coated electrospun polycaprolactone (PCL) was capable of inducing differentiation and mineralization of human dental pulp stem cells. However, how autophagy changes and whether autophagy plays a vital role during these processes is still unknown. In this study, we seeded STEMPRO human adipose-derived stem cells (ASCs) on both PCL+FA and PCL scaffolds to investigate the osteogenic inductive ability of FA crystals and we observed the autophagy changes of these cells. Scanning electron microscopy and fluorescence microscopy images, along with DNA quantitation, showed that both PCL+FA and PCL scaffolds could sustain ASC growth but only the PCL+FA scaffold could sustain cell mineralization. This was confirmed by alkaline phosphatase activity and Alizarin red and Von Kossa staining results. The autophagy RT2 Profiler polymerase chain reaction array analysis showed many autophagy-related genes changes during ASC differentiation. Western blot analysis indicated that several autophagy-related proteins fluctuated during the procedure. Among them, the microtubule-associated protein 1 light chain 3 (LC3)-II protein changes of the ASCs grown on the 2- or 3-dimensional environments at 6 h, 12 h, 1 d, 3 d, 7 d, 14 d, and 21 d reached a peak value at day 7 during osteogenesis. At earlier stages (from day 0 to day 3), the addition of autophagy inhibitors (3-mathyladenine, bafilomycin A1, and NH4Cl) attenuated the expression of osteogenic related markers (osteopontin, alkaline phosphatase activity, Alizarin red, and Von Kossa) compared with the control group. All data indicated that autophagy played an important role in ASC differentiation on the PCL+FA scaffold. Inhibition of autophagy before day 3 strongly inhibited osteogenic differentiation and mineralization of ASCs in the 3-dimensional model. This observation further elucidates the mechanism of autophagy in mesenchymal stem cell osteogenic differentiation.
C1 [Li, Y.; Guo, T.; Zhang, Z.; Yao, Y.; Chang, S.; Nor, J. E.; Clarkson, B. H.; Liu, J.] Univ Michigan, Sch Dent, Dept Cariol Restorat Sci & Endodont, Ann Arbor, MI 48109 USA.
   [Li, Y.] Fourth Mil Med Univ, Dept Oral & Maxillofacial Surg, State Key Lab Mil Stomatol, Xian 710032, Shaanxi, Peoples R China.
   [Guo, T.] Nanjing Jinling Hosp, Dept Stomatol, Nanjing, Jiangsu, Peoples R China.
   [Ni, L.] Fourth Mil Med Univ, Sch Stomatol, Dept Operat Dent & Endodont, Xian 710032, Shaanxi, Peoples R China.
RP Ni, L (reprint author), Fourth Mil Med Univ, Sch Stomatol, Dept Operat Dent & Endodont, Xian 710032, Shaanxi, Peoples R China.; Liu, J (reprint author), Univ Michigan, Dept Cariol Restorat Sci & Endodont, 2310A Dent Sch,1011 N Univ Ave, Ann Arbor, MI 48109 USA.
EM nilx2007@gmail.com; junlc@umich.edu
FU Department of Cariology, Restorative Sciences, and Endodontics at the
   University of Michigan, School of Dentistry
FX This work was supported by the Department of Cariology, Restorative
   Sciences, and Endodontics at the University of Michigan, School of
   Dentistry. The authors declare no potential conflicts of interest with
   respect to the authorship and/or publication of this article.
CR Blommaart EFC, 1997, HISTOCHEM J, V29, P365, DOI 10.1023/A:1026486801018
   Fass E, 2006, J BIOL CHEM, V281, P36303, DOI 10.1074/jbc.M607031200
   Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082
   Guan JL, 2013, AUTOPHAGY, V9, P830, DOI 10.4161/auto.24132
   Guo T, 2014, J DENT RES, V93, P1290, DOI 10.1177/0022034514547914
   He H, 2003, J BIOL CHEM, V278, P29278, DOI 10.1074/jbc.M303800200
   Huang CP, 2009, LAB CHIP, V9, P1740, DOI 10.1039/b818401a
   Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114
   Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720
   Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845
   Liu F, 2013, J BONE MINER RES, V28, P2414, DOI 10.1002/jbmr.1971
   Liu J, 2012, BIOMATERIALS, V33, P5036, DOI 10.1016/j.biomaterials.2012.03.050
   Liu J, 2010, TISSUE ENG PT A, V16, P2977, DOI [10.1089/ten.tea.2009.0632, 10.1089/ten.TEA.2009.0632]
   Mann SS, 1996, J NEUROSCI RES, V43, P535, DOI 10.1002/(SICI)1097-4547(19960301)43:5<535::AID-JNR3>3.0.CO;2-J
   Mizushima N, 1998, NATURE, V395, P395
   Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381
   Mizushima N, 1999, EMBO J, V18, P3888, DOI 10.1093/emboj/18.14.3888
   Oliver L, 2012, STEM CELLS DEV, V21, P2779, DOI 10.1089/scd.2012.0124
   Pan HZ, 2013, EMBO MOL MED, V5, P327, DOI 10.1002/emmm.201201999
   Pantovic A, 2013, BONE, V52, P524, DOI 10.1016/j.bone.2012.10.024
   Salemi S, 2012, CELL RES, V22, P432, DOI 10.1038/cr.2011.200
   SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889
   SEGLEN PO, 1992, EXPERIENTIA, V48, P158, DOI 10.1007/BF01923509
   Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004
   Vessoni AT, 2012, STEM CELLS DEV, V21, P513, DOI 10.1089/scd.2011.0526
   Wang XD, 2012, TISSUE ENG PART C-ME, V18, P821, DOI [10.1089/ten.tec.2011.0624, 10.1089/ten.TEC.2011.0624]
   Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102
   Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854
NR 28
TC 4
Z9 4
U1 1
U2 15
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD JUN
PY 2016
VL 95
IS 6
BP 650
EP 656
DI 10.1177/0022034516636852
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DN3XB
UT WOS:000376996400007
PM 26961490
DA 2018-10-19
ER

PT J
AU Litvinov, RI
   Weisel, JW
AF Litvinov, Rustem I.
   Weisel, John W.
TI What Is the Biological and Clinical Relevance of Fibrin?
SO SEMINARS IN THROMBOSIS AND HEMOSTASIS
LA English
DT Article
DE fibrin; fibrinogen; hemostasis; thrombosis; afibrinogenemia;
   hypofibrinogenemia; dysfibrinogenemia
ID RESTRICTED MYH9 INACTIVATION; ACUTE MYOCARDIAL-INFARCTION; FACTOR-XIII;
   SOLUBLE FIBRIN; LIVER-DISEASE; D-DIMER; PLATELET ACTIVATION; MONOMER
   COMPLEX; CLOT FORMATION; HOST-DEFENSE
AB d As our knowledge of the structure and functions of fibrinogen and fibrin has increased tremendously, several key findings have given some people a superficial impression that the biological and clinical significance of these clotting proteins may be less than earlier thought. Most strikingly, studies of fibrinogen knockout mice demonstrated that many of these mice survive to weaning and beyond, suggesting that fibrin(ogen) may not be entirely necessary. Humans with afibrinogenemia also survive. Furthermore, in recent years, the major emphasis in the treatment of arterial thrombosis has been on inhibition of platelets, rather than fibrin. In contrast to the initially apparent conclusions from these results, it has become increasingly clear that fibrin is essential for hemostasis; is a key factor in thrombosis; and plays an important biological role in infection, inflammation, immunology, and wound healing. In addition, fibrinogen replacement therapy has become a preferred, major treatment for severe bleeding in trauma and surgery. Finally, fibrin is a unique biomaterial and is used as a sealant or glue, a matrix for cells, a scaffold for tissue engineering, and a carrier and/or a vector for targeted drug delivery.
C1 [Litvinov, Rustem I.; Weisel, John W.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.
RP Weisel, JW (reprint author), Univ Penn, 421 Curie Blvd,BRB 2-3,Room 1154, Philadelphia, PA 19104 USA.
EM weisel@mail.med.upenn.edu
RI Litvinov, Rustem/E-5291-2011
OI Litvinov, Rustem/0000-0003-0643-1496
FU NIH [HL090774, U01-HL116330]
FX The authors thank Dr. Lubica Rauova for careful reading of the
   manuscript and valuable suggestions. The work was supported by NIH
   grants HL090774 and U01-HL116330.
CR Ahmad E, 2015, INT J BIOL MACROMOL, V81, P121, DOI 10.1016/j.ijbiomac.2015.07.054
   Aleman MM, 2014, J CLIN INVEST, V124, P3590, DOI 10.1172/JCI75386
   Allen P, 2011, J TISSUE ENG REGEN M, V5, pE74, DOI 10.1002/term.389
   Ariens RAS, 2002, BLOOD, V100, P743, DOI 10.1182/blood.V100.3.743
   Bates SM, 2012, SEMIN THROMB HEMOST, V38, P673, DOI 10.1055/s-0032-1326782
   Bennett JS, 2001, ANN NY ACAD SCI, V936, P340
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Bhasin N, 2008, J VASC SURG, V48, P1497, DOI 10.1016/j.jvs.2008.07.010
   Bonk Ryan, 2009, J Extra Corpor Technol, V41, P157
   Bornikova L, 2011, J THROMB HAEMOST, V9, P1687, DOI 10.1111/j.1538-7836.2011.04424.x
   Brown AEX, 2009, SCIENCE, V325, P741, DOI 10.1126/science.1172484
   Byrnes JR, 2016, SEMIN THROMB HEMOST, V42, P445, DOI 10.1055/s-0036-1571343
   Byrnes JR, 2015, BLOOD, V126, P1940, DOI 10.1182/blood-2015-06-652263
   Carr ME, 2003, CELL BIOCHEM BIOPHYS, V38, P55, DOI 10.1385/CBB:38:1:55
   Casini A, 2015, J THROMB HAEMOST, V13, P909, DOI 10.1111/jth.12916
   Casini A, 2015, BLOOD, V125, P553, DOI 10.1182/blood-2014-06-582866
   Ciesienski KL, 2013, MOL PHARMACEUT, V10, P1100, DOI 10.1021/mp300610s
   Cines DB, 2014, BLOOD, V123, P1596, DOI 10.1182/blood-2013-08-523860
   Collet JP, 2006, ARTERIOSCL THROM VAS, V26, P2567, DOI 10.1161/01.ATV.0000241589.52950.4c
   Collet JP, 2002, CIRC RES, V90, P428, DOI 10.1161/hh0402.105095
   Cotovio M, 2008, J VET INTERN MED, V22, P1403, DOI 10.1111/j.1939-1676.2008.0178.x
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   de Moerloose P, 2013, SEMIN THROMB HEMOST, V39, P585, DOI 10.1055/s-0033-1349222
   de Moerloose P, 2009, SEMIN THROMB HEMOST, V35, P356, DOI 10.1055/s-0029-1225758
   Dear A, 2007, Haematologica, V92, pe111, DOI 10.3324/haematol.11837
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Drew AF, 2001, BLOOD, V97, P3691, DOI 10.1182/blood.V97.12.3691
   Eckly A, 2009, BLOOD, V113, P3182, DOI 10.1182/blood-2008-06-164061
   Ehrlicher A, 2011, NAT MATER, V10, P12, DOI 10.1038/nmat2928
   Flick MJ, 2007, J CLIN INVEST, V117, P3224, DOI 10.1172/JCI30134
   Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741
   FORRESTER JM, 1995, MED HIST, V39, P477, DOI 10.1017/S0025727300060385
   Fries D, 2010, BRIT J ANAESTH, V105, P116, DOI 10.1093/bja/aeq161
   Fries D, 2013, TRANSFUSION, V53, p91S, DOI 10.1111/trf.12041
   Fries D, 2009, CURR OPIN ANESTHESIO, V22, P267, DOI 10.1097/ACO.0b013e32832678d9
   Gazzeri Roberto, 2015, Surg Technol Int, V26, P364
   Goncalves NR, 2014, NEUROIMAGE, V97, P196, DOI 10.1016/j.neuroimage.2014.04.012
   Haas T, 2008, ANESTH ANALG, V106, P1360, DOI 10.1213/01.ane.0b013e3181684339
   Hamano A, 2002, CLIN CHIM ACTA, V318, P25, DOI 10.1016/S0009-8981(01)00779-3
   Hanss M, 2001, ANN NY ACAD SCI, V936, P89
   Ieko M, 2009, TOHOKU J EXP MED, V219, P25, DOI 10.1620/tjem.219.25
   Innerhofer P, 2013, INJURY, V44, P209, DOI 10.1016/j.injury.2012.08.047
   Itosaka H, 2009, NEUROPATHOLOGY, V29, P248, DOI 10.1111/j.1440-1789.2008.00971.x
   Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327
   Jarvis GE, 2003, BRIT J PHARMACOL, V138, P574, DOI 10.1038/sj.bjp.0705095
   Kabrhel C, 2010, ACAD EMERG MED, V17, P589, DOI 10.1111/j.1553-2712.2010.00765.x
   Kasahara K, 2013, BLOOD, V122, P3340, DOI 10.1182/blood-2013-04-491290
   Kasahara K, 2010, BLOOD, V115, P1277, DOI 10.1182/blood-2009-06-227645
   Kim OV, 2014, BIOMATERIALS, V35, P6739, DOI 10.1016/j.biomaterials.2014.04.056
   Ko YP, 2016, SEMIN THROMB HEMOST, V42, P408, DOI 10.1055/s-0036-1579635
   Kolodziej AF, 2012, BIOCONJUGATE CHEM, V23, P548, DOI 10.1021/bc200613e
   Kopec AK, 2016, SEMIN THROMB HEMOST, V42, P397, DOI 10.1055/s-0036-1579655
   Kunishima S, 2010, CURR OPIN HEMATOL, V17, P405, DOI 10.1097/MOH.0b013e32833c069c
   Kurniawan NA, 2014, J THROMB HAEMOST, V12, P1687, DOI 10.1111/jth.12705
   Lam WA, 2011, NAT MATER, V10, P61, DOI [10.1038/nmat2903, 10.1038/NMAT2903]
   Lassila R, 2016, SEMIN THROMB HEMOST, V42, P440, DOI 10.1055/s-0036-1572324
   Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599
   Leon C, 2007, BLOOD, V110, P3183, DOI 10.1182/blood-2007-03-080184
   Levi M, 2014, SEMIN THROMB HEMOST, V40, P874, DOI 10.1055/s-0034-1395155
   Liebeskind DS, 2011, STROKE, V42, P1237, DOI 10.1161/STROKEAHA.110.605576
   Lisman T, 2016, SEMIN THROMB HEMOST, V42, P389, DOI 10.1055/s-0036-1572327
   Lisman T, 2010, BLOOD, V116, P878, DOI 10.1182/blood-2010-02-261891
   Litvinov RI, 2016, J BIOL CHEM
   Macrae FL, 2016, SEMIN THROMB HEMOST, V42, P344, DOI 10.1055/s-0036-1572353
   Martineau Laurie, 2007, Angiogenesis, V10, P269, DOI 10.1007/s10456-007-9079-8
   MARTINEZ J, 1978, J CLIN INVEST, V61, P535, DOI 10.1172/JCI108964
   Martini J, 2014, TRANSFUSION, V54, P149, DOI 10.1111/trf.12241
   Martini J, 2013, CRIT CARE MED, V41, pE301, DOI 10.1097/CCM.0b013e31828a4520
   Mills JD, 2002, CIRCULATION, V106, P1938, DOI 10.1161/CIR.0000033221.73082.06
   Misaki T, 2008, J ORTHOP SCI, V13, P419, DOI 10.1007/s00776-008-1266-y
   Mosesson MW, 2007, THROMB HAEMOSTASIS, V98, P105, DOI 10.1160/Th07-04-0274
   Muszbek L, 2016, SEMIN THROMB HEMOST, V42, P429, DOI 10.1055/s-0036-1572326
   Muthard RW, 2012, ARTERIOSCL THROM VAS, V32, P2938, DOI 10.1161/ATVBAHA.112.300312
   Nair SA, 2008, ANGEW CHEM INT EDIT, V47, P4918, DOI 10.1002/anie.200800563
   Neerman-Arbez M, 2016, SEMIN THROMB HEMOST, V42, P344
   Neerman-Arbez M, 2016, SEMIN THROMB HEMOST, V42, P356, DOI 10.1055/s-0036-1571340
   Ono A, 2008, BLOOD, V112, P90, DOI 10.1182/blood-2007-12-127001
   Overoye-Chan K, 2008, J AM CHEM SOC, V130, P6025, DOI 10.1021/ja800834y
   PANZER S, 1993, HAEMOSTASIS, V23, P69
   Piechocka IK, 2010, BIOPHYS J, V98, P2281, DOI 10.1016/j.bpj.2010.01.040
   Pluta A, 2010, ADV MED SCI-POLAND, V55, P16, DOI 10.2478/v10039-010-0018-3
   Prasad JM, 2015, BLOOD, V126, P2047, DOI 10.1182/blood-2015-04-639849
   Riopel M, 2015, TISSUE ENG PART B-RE, V21, P34, DOI [10.1089/ten.TEB.2014.0188, 10.1089/ten.teb.2014.0188]
   Samama CM, 2016, SEMIN THROMB HEMOST, V42, P375, DOI 10.1055/s-0036-1572325
   Schroeder V, 2016, SEMIN THROMB HEMOST, V42, P422, DOI 10.1055/s-0036-1571341
   Scognamiglio F, 2015, J BIOMED MAT RES B, DOI 10.1002/jbm.b.33409
   Semeraro N, 2012, THROMB RES, V129, P290, DOI 10.1016/j.thromres.2011.10.013
   Shevchenko RV, 2010, J R SOC INTERFACE, V7, P229, DOI 10.1098/rsif.2009.0403
   Silvain J, 2011, J AM COLL CARDIOL, V57, P1359, DOI 10.1016/j.jacc.2010.09.077
   Skewis LR, 2014, CLIN CHEM, V60, P1174, DOI 10.1373/clinchem.2014.223735
   Stalker TJ, 2014, BLOOD, V124, P1824, DOI 10.1182/blood-2014-01-550319
   Stalker TJ, 2014, CURR OPIN HEMATOL, V21, P410, DOI 10.1097/MOH.0000000000000070
   Stalker TJ, 2013, BLOOD, V121, P1875, DOI 10.1182/blood-2012-09-457739
   SUH TT, 1995, GENE DEV, V9, P2020, DOI 10.1101/gad.9.16.2020
   Undas A, 2008, DIABETES CARE, V31, P1590, DOI 10.2337/dc08-0282
   Undas A, 2016, SEMIN THROMB HEMOST, V42, P381, DOI 10.1055/s-0036-1579636
   Undas A, 2010, THROMB RES, V125, P357, DOI 10.1016/j.thromres.2009.11.013
   Undas A, 2009, BLOOD, V114, P4272, DOI 10.1182/blood-2009-05-222380
   Undas A, 2009, STROKE, V40, P1499, DOI 10.1161/STROKEAHA.108.532812
   Velik-Salchner C, 2007, J THROMB HAEMOST, V5, P1019, DOI 10.1111/j.1538-7836.2007.02481.x
   Weisel JW, 2013, BLOOD, V121, P1712, DOI 10.1182/blood-2012-09-306639
   Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153
   Welsh JD, 2015, J THROMB HAEMOST, V13, P174
   Wufsus AR, 2015, BIOPHYS J, V108, P173, DOI 10.1016/j.bpj.2014.11.007
   Zabczyk M, 2015, INT J CARDIOL, V179, P186, DOI 10.1016/j.ijcard.2014.10.004
   Zhang YF, 2012, BLOOD, V119, P238, DOI 10.1182/blood-2011-06-358853
NR 106
TC 13
Z9 16
U1 4
U2 23
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 0094-6176
EI 1098-9064
J9 SEMIN THROMB HEMOST
JI Semin. Thromb. Hemost.
PD JUN
PY 2016
VL 42
IS 4
BP 333
EP 343
DI 10.1055/s-0036-1571342
PG 11
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA DN7AK
UT WOS:000377227500003
PM 27056152
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Vishwakarma, A
   Bhise, NS
   Evangelista, MB
   Rouwkema, J
   Dokmeci, MR
   Ghaemmaghami, AM
   Vrana, NE
   Khademhosseini, A
AF Vishwakarma, Ajaykumar
   Bhise, Nupura S.
   Evangelista, Marta B.
   Rouwkema, Jeroen
   Dokmeci, Mehmet R.
   Ghaemmaghami, Amir M.
   Vrana, Nihal Engin
   Khademhosseini, Ali
TI Engineering Immunomodulatory Biomaterials To Tune the Inflammatory
   Response
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
ID FOREIGN-BODY RESPONSE; MANNOSE RECEPTOR-ACTIVITY; IN-VITRO; MACROPHAGE
   ACTIVATION; SURFACE WETTABILITY; ADAPTIVE IMMUNITY; STEM-CELLS;
   ADHESION; PHENOTYPE; DEXAMETHASONE
AB Current state-of-the-art biomedical implants and tissue engineering methods promise technologies to improve or even restore the function of diseased organs. However, one of the biggest challenges to clinical success is the lack of functional integration. A series of cellular and molecular events following biomaterial implantation poses an important bottleneck for developing breakthrough solutions. With inflammation increasingly recognized as a crucial component influencing regeneration, immunomodulation or immuno-engineering has emerged as a potential solution to overcome this key challenge in regenerative medicine. We postulate possibilities to utilize biomaterial physicochemical modifications to modulate the host inflammatory response and develop strategies for effective biomaterial integration. Biomaterial-based immunomodulation strategies can significantly ameliorate the outcomes of medical implants and tissue engineering therapies.
C1 [Vishwakarma, Ajaykumar; Bhise, Nupura S.; Rouwkema, Jeroen; Dokmeci, Mehmet R.; Khademhosseini, Ali] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Biomat Innovat Res Ctr, Cambridge, MA 02115 USA.
   [Vishwakarma, Ajaykumar; Bhise, Nupura S.; Rouwkema, Jeroen; Dokmeci, Mehmet R.; Khademhosseini, Ali] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02319 USA.
   [Evangelista, Marta B.; Vrana, Nihal Engin] Protip Med, 8 Pl Hop, F-67000 Strasbourg, France.
   [Rouwkema, Jeroen] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Biomech Engn, POB 217, NL-7500 AE Enschede, Netherlands.
   [Ghaemmaghami, Amir M.] Univ Nottingham, Fac Med & Hlth Sci, Sch Life Sci, Div Immunol,Queens Med Ctr, Nottingham NG7 2UH, England.
   [Vrana, Nihal Engin] INSERM, UMR 1121, 11 Rue Humann, F-67085 Strasbourg, France.
   [Khademhosseini, Ali] Harvard Univ, Sch Med, Wyss Inst Biol Inspired Engn, Boston, MA 02155 USA.
   [Khademhosseini, Ali] Konkuk Univ, Dept Bioind Technol, Coll Anim Biosci & Technol, Seoul 143701, South Korea.
   [Khademhosseini, Ali] King Abdulaziz Univ, Dept Phys, Jeddah 21569, Saudi Arabia.
RP Khademhosseini, A (reprint author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Biomat Innovat Res Ctr, Cambridge, MA 02115 USA.; Khademhosseini, A (reprint author), MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02319 USA.; Khademhosseini, A (reprint author), Harvard Univ, Sch Med, Wyss Inst Biol Inspired Engn, Boston, MA 02155 USA.; Khademhosseini, A (reprint author), Konkuk Univ, Dept Bioind Technol, Coll Anim Biosci & Technol, Seoul 143701, South Korea.; Khademhosseini, A (reprint author), King Abdulaziz Univ, Dept Phys, Jeddah 21569, Saudi Arabia.
EM alik@bwh.harvard.edu
OI Rouwkema, Jeroen/0000-0001-9666-9064; Khademhosseini,
   Ali/0000-0001-6322-8852; Ghaemmaghami, Amir/0000-0003-3160-8759
FU European Commission [602694, 606624]; People Programme (Marie Curie
   Actions) under REA grant [622294]
FX This work has received funding from the European Commission 7th
   Framework Programme for research, technological development and
   demonstration under grant agreements 602694 (IMMODGEL) and 606624
   (NanoTi). J.R. was supported by the People Programme (Marie Curie
   Actions) under REA grant agreement 622294 (PreVascIn).
CR Alfarsi MA, 2014, J BIOMED MATER RES A, V102, P60, DOI 10.1002/jbm.a.34666
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Bitar D, 2015, WORLD J ORTHOP, V6, P172, DOI 10.5312/wjo.v6.i2.172
   Blaszykowski C, 2014, TRENDS BIOTECHNOL, V32, P61, DOI 10.1016/j.tibtech.2013.11.002
   Boehler RM, 2014, BIOTECHNOL BIOENG, V111, P1210, DOI 10.1002/bit.25175
   Boehler RM, 2011, BIOTECHNIQUES, V51, P239, DOI 10.2144/000113754
   Bridges Amanda W, 2008, J Diabetes Sci Technol, V2, P984
   Bridges AW, 2008, BIOMATERIALS, V29, P4605, DOI 10.1016/j.biomaterials.2008.08.015
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2
   Brown BN, 2013, ACTA BIOMATER, V9, P4948, DOI 10.1016/j.actbio.2012.10.025
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Cantu DA, 2012, STEM CELL TRANSL MED, V1, P740, DOI 10.5966/sctm.2012-0061
   Chang DT, 2009, J BIOMED MATER RES A, V91A, P1210, DOI 10.1002/jbm.a.32218
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Chen ZT, 2014, BIOMATERIALS, V35, P1507, DOI 10.1016/j.biomaterials.2013.11.014
   Collier TO, 2004, J BIOMED MATER RES A, V69A, P644, DOI 10.1002/jbm.a.30030
   CROSSLEY GH, 1995, CIRCULATION, V92, P2935, DOI 10.1161/01.CIR.92.10.2935
   Damanik FFR, 2014, SCI REP-UK, V4, DOI 10.1038/srep06325
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   Dimitrova M, 2007, ADV FUNCT MATER, V17, P233, DOI 10.1002/adfm.200600155
   Dohle E, 2014, EUR CELLS MATER, V27, P149, DOI 10.22203/eCM.v027a12
   Esche C, 2005, J INVEST DERMATOL, V125, P615, DOI 10.1111/j.0022-202X.2005.23841.x
   Gonzalez R, 2003, EXP NEUROL, V184, P456, DOI 10.1016/S0014-4886(03)00257-7
   GROTH T, 1994, BIOMATERIALS, V15, P423, DOI 10.1016/0142-9612(94)90220-8
   HENSON PM, 1971, J IMMUNOL, V107, P1535
   Hubbell JA, 2013, NAT MATER, V12, P963, DOI 10.1038/nmat3788
   Hume PS, 2012, BIOMATERIALS, V33, P3615, DOI 10.1016/j.biomaterials.2012.02.009
   Kajahn Jennifer, 2012, Biomatter, V2, P226, DOI 10.4161/biom.22855
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Kim DH, 2006, BIOMATERIALS, V27, P3031, DOI 10.1016/j.biomaterials.2005.12.021
   Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004
   Kim YK, 2014, ADV HEALTHC MATER, V3, P989, DOI 10.1002/adhm.201300532
   Koedam JA, 2002, MOL CELL ENDOCRINOL, V197, P35, DOI 10.1016/S0303-7207(02)00276-9
   Kou PM, 2012, BIOMATERIALS, V33, P1699, DOI 10.1016/j.biomaterials.2011.10.066
   Kruger P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004651
   Kusaka T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092634
   Lee S, 2011, ACTA BIOMATER, V7, P2337, DOI 10.1016/j.actbio.2011.01.006
   Li GC, 2011, CYTOKINE, V56, P208, DOI 10.1016/j.cyto.2011.06.020
   Lin CC, 2010, J CONTROL RELEASE, V142, P384, DOI 10.1016/j.jconrel.2009.11.022
   Lin CC, 2009, BIOMATERIALS, V30, P4907, DOI 10.1016/j.biomaterials.2009.05.083
   Lu J, 2015, ACTA BIOMATER, V16, P223, DOI 10.1016/j.actbio.2015.01.036
   Luo JC, 2004, EUR J PHARMACOL, V485, P275, DOI 10.1016/j.ejphar.2003.11.038
   MAEDA M, 1986, J BIOMED MATER RES, V20, P25, DOI 10.1002/jbm.820200104
   Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13
   MATLAGA BF, 1976, J BIOMED MATER RES, V10, P391, DOI 10.1002/jbm.820100308
   McNally AK, 1996, AM J PATHOL, V149, P975
   McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110
   Mercanzini A, 2010, J CONTROL RELEASE, V145, P196, DOI 10.1016/j.jconrel.2010.04.025
   Meyer U, 2005, Eur Cell Mater, V9, P39
   Mora-Solano C, 2014, J MATER CHEM B, V2, P2409, DOI 10.1039/c3tb21549k
   Mori R, 2008, J EXP MED, V205, P43, DOI 10.1084/jem.20071412
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Murphy SV, 2013, BIOESSAYS, V35, P163, DOI 10.1002/bies.201200062
   Neacsu P, 2014, INT J BIOCHEM CELL B, V55, P187, DOI 10.1016/j.biocel.2014.09.006
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Patil SD, 2007, J CONTROL RELEASE, V117, P68, DOI 10.1016/j.jconrel.2006.10.013
   Rajyalakshmi A, 2011, INT J NANOMED, V6, P1765, DOI 10.2147/IJN.S22763
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Rogers TH, 2010, BIOMATERIALS, V31, P594, DOI 10.1016/j.biomaterials.2009.09.077
   Rostam HM, 2015, BIOMATER SCI-UK, V3, P424, DOI 10.1039/c4bm00375f
   SALTHOUSE TN, 1984, J BIOMED MATER RES, V18, P395, DOI 10.1002/jbm.820180407
   Scharp DW, 2014, ADV DRUG DELIVER REV, V67-68, P35, DOI 10.1016/j.addr.2013.07.018
   Shen MC, 2002, J BIOMAT SCI-POLYM E, V13, P367, DOI 10.1163/156856202320253910
   Simms HH, 1997, ANN SURG, V225, P757, DOI 10.1097/00000658-199706000-00013
   STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287
   Swartzlander MD, 2015, BIOMATERIALS, V41, P79, DOI 10.1016/j.biomaterials.2014.11.020
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tsianakas A, 2012, IMMUNOBIOLOGY, V217, P329, DOI 10.1016/j.imbio.2011.10.002
   Udipl K., 2000, J BLOMED MAT RES, V51, P549
   Vegas AJ, 2016, NAT BIOTECHNOL, V34, P345, DOI 10.1038/nbt.3462
   Veiseh O, 2015, NAT MATER, V14, P643, DOI [10.1038/NMAT4290, 10.1038/nmat4290]
   Vishwakarma A., 2014, STEM CELL BIOL TISSU
   Vitte J, 2004, Eur Cell Mater, V7, P52
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wong TS, 2011, NATURE, V477, P443, DOI 10.1038/nature10447
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Zandstra J, 2014, EUR CELLS MATER, V28, P335, DOI 10.22203/eCM.v028a23
   Zaveri TD, 2010, BIOMATERIALS, V31, P2999, DOI 10.1016/j.biomaterials.2009.12.055
   Zelikin AN, 2010, ACS NANO, V4, P2494, DOI 10.1021/nn100634r
   Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580
   Zhong YH, 2007, BRAIN RES, V1148, P15, DOI 10.1016/j.brainres.2007.02.024
   Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008
NR 86
TC 48
Z9 49
U1 11
U2 70
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
EI 1879-3096
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD JUN
PY 2016
VL 34
IS 6
BP 470
EP 482
DI 10.1016/j.tibtech.2016.03.009
PG 13
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DN1NW
UT WOS:000376833700006
PM 27138899
DA 2018-10-19
ER

PT J
AU Barry, M
   Pearce, H
   Cross, L
   Tatullo, M
   Gaharwar, AK
AF Barry, Mikayla
   Pearce, Hannah
   Cross, Lauren
   Tatullo, Marco
   Gaharwar, Akhilesh K.
TI Advances in Nanotechnology for the Treatment of Osteoporosis
SO CURRENT OSTEOPOROSIS REPORTS
LA English
DT Review
DE Nanotechnology; Osteoporosis; Bioactive nanomaterials; Bone regeneration
ID MESENCHYMAL STEM-CELLS; MESOPOROUS BIOACTIVE NANOCARRIERS; OSTEOGENIC
   DIFFERENTIATION; NANOCOMPOSITE HYDROGELS; BIOMEDICAL APPLICATIONS;
   SILICA NANOPARTICLES; POSTMENOPAUSAL WOMEN; UNITED-STATES; BONE LOSS;
   SCAFFOLDS
AB Osteoporosis is a degenerative bone disease commonly related to aging. With an increase in life expectancies worldwide, the prevalence of the disease is expected to rise. Current clinical therapeutic treatments are not able to offer long-term solutions to counter the bone mass loss and the increased risk of fractures, which are the primary characteristics of the disease. However, the combination of bioactive nanomaterials within a biomaterial scaffold shows promise for the development of a localized, long-term treatment for those affected by osteoporosis. This review summarizes the unique characteristics of engineered nanoparticles that render them applicable for bone regeneration and recaps the current body of knowledge on nanomaterials with potential for osteoporosis treatment and bone regeneration. Specifically, we highlight new developments that are shaping this emerging field and evaluate applications of recently developed nanomaterials for osteoporosis treatment. Finally, we will identify promising new research directions in nanotechnology for bone regeneration.
C1 [Barry, Mikayla; Pearce, Hannah; Cross, Lauren; Gaharwar, Akhilesh K.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77841 USA.
   [Tatullo, Marco] Calabrodent Clin, Maxillofacial Unit, I-88900 Crotone, Italy.
   [Tatullo, Marco] Tecnol Res Inst, Regenerat Med Sect, I-88900 Crotone, Italy.
   [Gaharwar, Akhilesh K.] Texas A&M Univ, Dept Mat Sci & Engn, College Stn, TX 77841 USA.
   [Gaharwar, Akhilesh K.] Texas A&M Univ, Ctr Remote Hlth Technol & Syst, College Stn, TX 77843 USA.
RP Gaharwar, AK (reprint author), Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77841 USA.; Gaharwar, AK (reprint author), Texas A&M Univ, Dept Mat Sci & Engn, College Stn, TX 77841 USA.; Gaharwar, AK (reprint author), Texas A&M Univ, Ctr Remote Hlth Technol & Syst, College Stn, TX 77843 USA.
EM gaharwar@tamu.edu
OI Gaharwar, Akhilesh/0000-0002-0284-0201
CR Alghamdi HS, 2014, BIOMATERIALS, V35, P5482, DOI 10.1016/j.biomaterials.2014.03.069
   Bilezikian JP, 2009, AM J MED, V122, P14, DOI 10.1016/j.amjmed.2008.12.003
   Bosco R, 2015, APPL SURF SCI, V328, P516, DOI 10.1016/j.apsusc.2014.12.072
   Cao LY, 2014, BIOMATERIALS, V35, P684, DOI 10.1016/j.biomaterials.2013.10.005
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Carrow JK, 2015, MACROMOL CHEM PHYS, V216, P248, DOI 10.1002/macp.201400427
   Chimene D, 2015, ADV MATER, V27, P7261, DOI 10.1002/adma.201502422
   Crowder SW, 2013, NANOSCALE, V5, P4171, DOI 10.1039/c3nr00803g
   Diab DL, 2012, ENDOCRIN METAB CLIN, V41, P487, DOI 10.1016/j.ecl.2012.04.007
   Ehnert S, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-101
   Ehrlich PJ, 2002, OSTEOPOROSIS INT, V13, P688, DOI 10.1007/s001980200095
   El-Fiqi A, 2014, RSC ADV, V4, P4444, DOI 10.1039/c3ra45858j
   Felsenberg D, 2002, J BONE MINER RES, V17, P716
   Francis RM, 1999, CLIN ENDOCRINOL, V50, P411
   Fricain JC, 2013, BIOMATERIALS, V34, P2947, DOI 10.1016/j.biomaterials.2013.01.049
   Gaharwar AK, 2014, TISSUE ENG PT A, V20, P2088, DOI 10.1089/ten.tea.2013.0281
   Gaharwar AK, 2014, BIOTECHNOL BIOENG, V111, P441, DOI 10.1002/bit.25160
   Gaharwar AK, 2013, ADV MATER, V25, P3329, DOI 10.1002/adma.201300584
   Gaharwar AK, 2011, BIOMACROMOLECULES, V12, P1641, DOI 10.1021/bm200027z
   Hu Y, 2010, ADV MATER, V22, P4146, DOI 10.1002/adma.201000854
   Ignjatovic N, 2013, J MATER SCI-MATER M, V24, P343, DOI 10.1007/s10856-012-4793-1
   Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4
   Kang GF, 2012, J MATER CHEM, V22, P21740, DOI 10.1039/c2jm34370c
   Kang MS, 2015, ACTA BIOMATER, V16, P103, DOI 10.1016/j.actbio.2014.12.028
   Karunaratne D. N., 2010, J NATL SCI FOUND SRI, V35, P149
   Kerativitayanan P, 2015, ACTA BIOMATER, V26, P34, DOI 10.1016/j.actbio.2015.08.025
   Kerativitayanan P, 2015, ADV HEALTHC MATER, V4, P1600, DOI 10.1002/adhm.201500272
   Kim T-H, 2015, ACTA BIOMATER
   Lad SP, 2011, SPINE, V36, pE274, DOI 10.1097/BRS.0b013e3182055a6b
   LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201
   Lindsay R, 1997, LANCET, V350, P550, DOI 10.1016/S0140-6736(97)02342-8
   Liu Y, 2009, BIOMATERIALS, V30, P6276, DOI 10.1016/j.biomaterials.2009.08.003
   Lozano-Calderon SA, 2014, ORTHOP CLIN N AM, V45, P403, DOI 10.1016/j.ocl.2014.03.006
   Mackey PA, 2015, JNP-J NURSE PRACT, V11, P1011, DOI 10.1016/j.nurpra.2015.08.010
   Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024
   Nhiem T, 2011, ACTA BIOMATER, V7, P1298, DOI 10.1016/j.actbio.2010.10.004
   Ong KL, 2010, SPINE, V35, P1794, DOI 10.1097/BRS.0b013e3181ecf6e4
   PARFITT AM, 1987, AM J MED, V82, P68, DOI 10.1016/0002-9343(87)90274-9
   Rawat M, 2006, BIOL PHARM BULL, V29, P1790, DOI 10.1248/bpb.29.1790
   Riggs BL, 1998, J BONE MINER RES, V13, P763, DOI 10.1359/jbmr.1998.13.5.763
   Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508
   Saifullah B, 2014, INT J NANOMED, V9, P4749, DOI 10.2147/IJN.S63608
   Saravanan S, 2013, INT J BIOL MACROMOL, V62, P481, DOI 10.1016/j.ijbiomac.2013.09.034
   Schmidt GA, 2010, AM J HEALTH-SYST PH, V67, P994, DOI 10.2146/ajhp090506
   Sowjanya JA, 2013, COLLOID SURFACE B, V109, P294, DOI 10.1016/j.colsurfb.2013.04.006
   Thakur T, 2016, J BIOMED MATER RES A, V104, P879, DOI 10.1002/jbm.a.35621
   Tran PA, 2009, J MATER CHEM, V19, P2653, DOI 10.1039/b814334j
   Tripathi A, 2012, INT J BIOL MACROMOL, V50, P294, DOI 10.1016/j.ijbiomac.2011.11.013
   Webster TJ, 2001, ADV CHEM ENG, V27, P125
   Weitzmann MN, 2015, NANOMED-NANOTECHNOL, V11, P959, DOI 10.1016/j.nano.2015.01.013
   Xavier JR, 2015, ACS NANO, V9, P3109, DOI 10.1021/nn507488s
   Xu AX, 2015, MAT SCI ENG C-MATER, V48, P592, DOI 10.1016/j.msec.2014.12.061
   Zallone A, 2006, ANN NY ACAD SCI, V1068, P173, DOI 10.1196/annals.1346.019
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
NR 54
TC 5
Z9 5
U1 1
U2 21
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1544-2241
J9 CURR OSTEOPOROS REP
JI Curr. Osteoporos. Rep.
PD JUN
PY 2016
VL 14
IS 3
BP 87
EP 94
DI 10.1007/s11914-016-0306-3
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DM8CA
UT WOS:000376587000003
PM 27048473
DA 2018-10-19
ER

PT J
AU Leal, CV
   Martinez, DST
   Mas, BA
   Alves, OL
   Duek, EAR
AF Leal, C. V.
   Martinez, D. S. T.
   Mas, B. A.
   Alves, O. L.
   Duek, E. A. R.
TI Influence of purified multiwalled carbon nanotubes on the mechanical and
   morphological behavior in poly (L-lactic acid) matrix
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Poly (L-lactic acid); Carbon nanotubes; Nanocomposites;
   Cytocompatibility; Toxicity
ID OSTEOBLAST-LIKE CELLS; NONISOTHERMAL CRYSTALLIZATION; BIOMEDICAL
   APPLICATIONS; PLLA NANOCOMPOSITES; IMPACT TOUGHNESS; IN-SITU;
   COMPOSITES; ADHESION; SURFACE; BLENDS
AB Poly (L-latic acid) (PLLA) is a bioresorbable polymer widely used as a biomaterial, but its fragility can limit its use. An alternative is to produce polymer nanocomposites, which can enhance the mechanical properties of polymeric matrix, resulting in a material with differentiated properties. In this work, PLLA based nanocomposites containing 0.25, 0.5 and 1.0 wt% of purified multiwalled carbon nanotubes (p-MWCNTs) were prepared by the solvent casting method. The morphology and mechanical properties results show an improvement in strain at break for 0.25 and 0.5 wt% p-MWCNTs and an increase in stiffness and elastic modulus for all compositions. Nanocomposites presented a p-MWCNTs agglomeration; however, there was a good stress transfer between PLLA and p-MWCNTs, which was confirmed by the increase in the hardness and elastic modulus. Atomic force microscopy analysis indicated an increase in roughness after nanotube addition. The in vitro biological study showed that PLLA/p-MWCNTs nanocomposites are cytocompatible with osteoblasts cells. The capacity of PLLA nanocomposites to stimulate osteogenesis was investigated by alkaline phosphatase (ALP) activity assay. Higher ALP activity was found on osteoblasts cultured on nanocomposites with 0.25 and 0.5 wt% p-MWCNT compared to neat PLLA, confirming that PLLA cytocompatibility was improved on these compositions. Finally, our results showed that by a simple and inexpensive solvent casting method, it is possible to manufacture biofunctional nanocomposites devices with potential for orthopedic applications. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Leal, C. V.; Duek, E. A. R.] Univ Estadual Campinas, Fac Mech Engn, Dept Mat Engn, BR-13083860 Campinas, SP, Brazil.
   [Martinez, D. S. T.; Alves, O. L.] Univ Estadual Campinas, Inst Chem, Solid State Chem Lab, POB 6154, BR-13081970 Campinas, SP, Brazil.
   [Martinez, D. S. T.] Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Nanotechnol Natl Lab LNNano, BR-1308970 Campinas, SP, Brazil.
   [Mas, B. A.; Duek, E. A. R.] Pontifical Catholic Univ Sao Paulo PUCSP, Fac Med Sci, BR-18030095 Sorocaba, SP, Brazil.
RP Leal, CV (reprint author), Univ Estadual Campinas, Fac Mech Engn, Dept Mat Engn, BR-13083860 Campinas, SP, Brazil.
EM lealcv5@gmail.com
RI Martinez, Diego/K-8310-2012; LEAL, CLAUDENETE/S-8592-2018; Alves,
   Oswaldo/J-7124-2012
OI Martinez, Diego/0000-0002-0086-3055; LEAL,
   CLAUDENETE/0000-0002-2223-2297; Alves, Oswaldo/0000-0002-1518-2092
FU CNPq [402280/2013-0, 552120/2011-1]; FAPESP [2008/57867-8]
FX The authors are grateful to CNPq (402280/2013-0 and 552120/2011-1) and
   FAPESP (2008/57867-8) to financial support. DSTM and OLA thank the
   National Institute of Science, Technology and Innovation on Complex
   Functional Materials (INCT-Inomat), Brazilian Nanotubes Network (Rede
   Nanotubos), Brazilian Nanotoxicology Network (Rede Cigenanotox), and
   SisNANO/MCTI (NanoBioss Laboratory). CVL and EARD thank the LAMULT
   Laboratory/Institute of Physics Gleb Wataghin (University of Campinas)
   for AFM analysis.
CR Ajayan PM, 2007, NATURE, V447, P1066, DOI 10.1038/4471066a
   American Society for Testing and Materials-ASTM, 2012, D88212 ASTM
   Andrade NF, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1761-8
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Armentano I, 2010, POLYM DEGRAD STABIL, V95, P2126, DOI 10.1016/j.polymdegradstab.2010.06.007
   Bikiaris D, 2010, MATERIALS, V3, P2884, DOI 10.3390/ma3042884
   Bin T., 2011, THERMOCHIM ACTA, V525, P141, DOI DOI 10.1016/J.TCA.2011.08.003
   Blumenstein R, 2002, INT J ONCOL, V21, P447
   Bruzaud S, 2007, POLYM TEST, V26, P652, DOI 10.1016/j.polymertesting.2007.04.001
   Cassu SN, 2005, QUIM NOVA, V28, P255, DOI 10.1590/S0100-40422005000200017
   Chen K, 2007, J PHYS CHEM B, V111, P12685, DOI 10.1021/jp0759168
   Chrissafis K, 2008, J APPL POLYM SCI, V110, P1739, DOI 10.1002/app.28818
   Datsyuk V, 2008, CARBON, V46, P833, DOI 10.1016/j.carbon.2008.02.012
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dondero WE, 2006, J POLYM SCI POL PHYS, V44, P864, DOI 10.1002/POLB.20743
   Ellis SJ, 2010, CELL TISSUE RES, V339, P121, DOI 10.1007/s00441-009-0828-4
   Firkowska I, 2008, ADV FUNCT MATER, V18, P3765, DOI 10.1002/adfm.200800760
   Gamez-Perez J, 2011, J APPL POLYM SCI, V120, P896, DOI 10.1002/app.33191
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   He AH, 2004, POLYMER, V45, P8231, DOI 10.1016/j.polymer.2004.08.076
   He YS, 2014, RSC ADV, V4, P12857, DOI 10.1039/c4ra00718b
   Hickey DJ, 2015, ACTA BIOMATER, V14, P175, DOI 10.1016/j.actbio.2014.12.004
   Hirata E, 2012, APPL SURF SCI, V262, P24, DOI 10.1016/j.apsusc.2012.01.012
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Jain S, 2011, CHEM RES TOXICOL, V24, P2028, DOI 10.1021/tx2003728
   Jana RN, 2010, COMPOS PART A-APPL S, V41, P1524, DOI 10.1016/j.compositesa.2010.06.015
   Jancar J., 2003, HDB POLYPROPYLENE PO, P374
   Kroustalli AA, 2013, ANN BIOMED ENG, V41, P2655, DOI 10.1007/s10439-013-0860-0
   Lacerda L, 2008, NANOMEDICINE-UK, V3, P149, DOI 10.2217/17435889.3.2.149
   Lacerda L, 2008, ADV MATER, V20, P225, DOI 10.1002/adma.200702334
   Lahiri D, 2009, ACS APPL MATER INTER, V1, P2470, DOI 10.1021/am900423q
   Leal CV, 2015, QUIM NOVA, V38, P1153, DOI 10.5935/0100-4042.20150132
   Li JZ, 2015, POLYMER, V63, P179, DOI 10.1016/j.polymer.2015.02.049
   Li WX, 2014, CHEM ENG J, V237, P291, DOI 10.1016/j.cej.2013.10.034
   Li X., 2009, BIOMED MATER, V4, P1
   Lin CL, 2011, COLLOID SURFACE B, V83, P367, DOI 10.1016/j.colsurfb.2010.12.011
   Liu HZ, 2011, J POLYM SCI POL PHYS, V49, P1051, DOI 10.1002/polb.22283
   Mas BA, 2014, MATER RES-IBERO-AM J, V17, P1523, DOI 10.1590/1516-1439.269414
   Mirsalehi SA, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.42052
   Montesano S., 2013, ISRN TISSUE ENG, V2013, P1
   Motta Adriana C., 2006, Polímeros, V16, P26, DOI 10.1590/S0104-14282006000100008
   Mundra RV, 2014, CURR OPIN BIOTECH, V28, P25, DOI 10.1016/j.copbio.2013.10.012
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Ng KW, 2005, TISSUE ENG, V11, P182, DOI 10.1089/ten.2005.11.182
   Nielsen L.E., 1993, MECH PROPERTIES POLY
   Ornagui H.L., 2010, J APPL POLYM SCI, V118, P887
   Papageorgiou DG, 2014, THERMOCHIM ACTA, V590, P181, DOI 10.1016/j.tca.2014.06.030
   Papageorgiou GZ, 2010, THERMOCHIM ACTA, V511, P129, DOI 10.1016/j.tca.2010.08.004
   Park S. J., 2011, INTERFACE SCI COMPOS
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Perez E, 2013, COMPOS PART B-ENG, V52, P72, DOI 10.1016/j.compositesb.2013.03.035
   Pothan LA, 2003, COMPOS SCI TECHNOL, V63, P283, DOI 10.1016/S0266-3538(02)00254-3
   Ramontja J, 2009, MACROMOL MATER ENG, V294, P839, DOI 10.1002/mame.200900197
   Sahoo NG, 2010, PROG POLYM SCI, V35, P837, DOI 10.1016/j.progpolymsci.2010.03.002
   Schadler L, 2007, NAT MATER, V6, P257, DOI 10.1038/nmat1873
   Stefani D, 2011, J HAZARD MATER, V189, P391, DOI 10.1016/j.jhazmat.2011.02.050
   Tang ZB, 2012, J APPL POLYM SCI, V125, P1108, DOI 10.1002/app.34799
   Tavangarian F, 2012, CERAM INT, V38, P6075, DOI 10.1016/j.ceramint.2012.05.038
   Thostenson ET, 2001, COMPOS SCI TECHNOL, V61, P1899, DOI 10.1016/S0266-3538(01)00094-X
   Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   Turan D, 2011, J APPL POLYM SCI, V121, P1067, DOI 10.1002/app.33802
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   Vardharajula S, 2012, INT J NANOMED, V7, P5361, DOI 10.2147/IJN.S35832
   Wagner HD, 2004, MATER TODAY, V7, P38, DOI 10.1016/S1369-7021(04)00507-3
   Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016
   Wang HF, 2004, J NANOSCI NANOTECHNO, V4, P1019, DOI 10.1166/jnn.2004.146
   Wepasnick KA, 2011, CARBON, V49, P24, DOI 10.1016/j.carbon.2010.08.034
   Wu LP, 2013, POLYM CHEM-UK, V4, P4490, DOI 10.1039/c3py00668a
   Xiao Y, 2010, ACS APPL MATER INTER, V2, P3506, DOI 10.1021/am100692n
   Xu HS, 2009, J POLYM SCI POL PHYS, V47, P2341, DOI 10.1002/polb.21830
   Xu ZH, 2011, ACS APPL MATER INTER, V3, P3744, DOI 10.1021/am200932q
   Yan LA, 2011, NANOSCALE, V3, P362, DOI 10.1039/c0nr00647e
   Yang ST, 2012, THERANOSTICS, V2, P271, DOI 10.7150/thno.3618
   Yang Y.K., 2011, FUNCTIONALIZATION CA
   Yu HY, 2012, CARBOHYD POLYM, V89, P971, DOI 10.1016/j.carbpol.2012.04.053
   Zhang L, 2015, CHEM ENG J, V264, P538, DOI 10.1016/j.cej.2014.11.066
   Zhang QW, 2012, BIOMATERIALS, V33, P5067, DOI 10.1016/j.biomaterials.2012.03.063
   Zhao YY, 2009, COMPOS SCI TECHNOL, V69, P627, DOI 10.1016/j.compscitech.2008.12.008
NR 80
TC 3
Z9 3
U1 4
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD JUN
PY 2016
VL 59
BP 547
EP 560
DI 10.1016/j.jmbbm.2016.03.016
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DM9NV
UT WOS:000376693900048
PM 27038896
DA 2018-10-19
ER

PT J
AU Saito, Y
   Kamitakahara, H
   Takano, T
AF Saito, Yasuko
   Kamitakahara, Hiroshi
   Takano, Toshiyuki
TI Preparation of (ruthenium (II) complex)-bound cellulose derivative for
   photocurrent generation system
SO JOURNAL OF WOOD SCIENCE
LA English
DT Article
DE Cellulose; Langmuir Blodgett film; Photoelectro conversion;
   Photosensitizer; Ruthenium complex
ID LANGMUIR-BLODGETT-FILMS; PERFORMANCE; COMPLEXES; RUTHENIUM; RING; DYE
AB 6-0-[Acetylacetonato-bis(2,2'-bipyridine)ruthenium(II)]-2,3-di-0-myristyl cellulose (3) was prepared from 2,3-di-0-myristyl cellulose (1) by two reaction steps in 37.7 % total yield. The LB monolayer film of compound 3 was successfully deposited onto an indium tin oxide electrode by a vertical dipping method and showed photocurrent generation performance in the range of 400-600 nm. Compound 3 was expected as a complementary material of porphyrinbound cellulose derivative for biomaterial-based solar cells.
C1 [Saito, Yasuko; Kamitakahara, Hiroshi; Takano, Toshiyuki] Kyoto Univ, Grad Sch Agr, Div Forest & Biomat Sci, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.
RP Takano, T (reprint author), Kyoto Univ, Grad Sch Agr, Div Forest & Biomat Sci, Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.
EM takatmys@kais.kyoto-u.ac.jp
RI Kamitakahara, Hiroshi/L-6710-2018
OI Kamitakahara, Hiroshi/0000-0002-0130-1919
CR Burke A, 2007, CHEM COMMUN, P234, DOI 10.1039/b609266g
   Edgar KJ, 2001, PROG POLYM SCI, V26, P1605, DOI 10.1016/S0079-6700(01)00027-2
   EDGAR KJ, 1995, MACROMOLECULES, V28, P4122, DOI 10.1021/ma00116a011
   ElHendawy AM, 1997, POLYHEDRON, V16, P3039
   Kang H, 2012, POLYM INT, V62, P338
   Matsumi N, 2008, POLYM J, V40, P400, DOI 10.1295/polymj.PJ2007225
   Nasuno T, 2006, HOLZFORSCHUNG, V60, P201, DOI 10.1515/HF.2006.033
   Numata Y, 2013, CHEM LETT, V42, P1328, DOI 10.1246/cl.130701
   Saito Y, 2016, CARBOHYD RES, V421, P40, DOI 10.1016/j.carres.2015.12.002
   Saito Y, 2014, CELLULOSE, V21, P1885, DOI 10.1007/s10570-014-0176-8
   Saito Y, 2012, CELLULOSE, V19, P2105, DOI 10.1007/s10570-012-9772-7
   Sakakibara K, 2007, MACROMOL RAPID COMM, V28, P1270, DOI 10.1002/marc.200700130
   Sakakibara K, 2010, MACROMOL CHEM PHYS, V211, P2425, DOI 10.1002/macp.201000257
   SULLIVAN BP, 1978, INORG CHEM, V17, P3334, DOI 10.1021/ic50190a006
   Taniguchi T, 1997, CHEM LETT, P295, DOI 10.1246/cl.1997.295
   Vougioukalakis GC, 2011, COORDIN CHEM REV, V255, P2602, DOI 10.1016/j.ccr.2010.11.006
   Wallen SL, 1997, J CHEM SOC FARADAY T, V93, P2391, DOI 10.1039/a701851g
   Wondraczek H, 2011, CARBOHYD POLYM, V83, P1048, DOI 10.1016/j.carbpol.2010.10.014
   Yin JF, 2012, COORDIN CHEM REV, V256, P3008, DOI 10.1016/j.ccr.2012.06.022
   Yoshida Y, 2007, CELLULOSE, V14, P481, DOI 10.1007/s10570-007-9133-0
NR 20
TC 0
Z9 0
U1 1
U2 11
PU SPRINGER JAPAN KK
PI TOKYO
PA CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065,
   JAPAN
SN 1435-0211
EI 1611-4663
J9 J WOOD SCI
JI J. Wood Sci.
PD JUN
PY 2016
VL 62
IS 3
BP 270
EP 275
DI 10.1007/s10086-016-1550-y
PG 6
WC Forestry; Materials Science, Paper & Wood
SC Forestry; Materials Science
GA DM8ZT
UT WOS:000376653700007
DA 2018-10-19
ER

PT J
AU Wang, HL
   Ping, L
   Yu, Q
   Hui, Y
AF Wang Hailei
   Ping, Li
   Yu, Qin
   Hui, Yang
TI Removal of phenol in phenolic resin wastewater by a novel biomaterial:
   the Phanerochaete chrysosporium pellet containing chlamydospore-like
   cells
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE Phenol; Chlamydospore-like cell; Metagenomic analysis; Lignin
   peroxidase; Mn-dependent peroxidase
ID YEAST CANDIDA-TROPICALIS; FIXED-BED REACTOR; WHITE-ROT FUNGUS;
   IMMOBILIZED CELLS; FLUIDIZED-BED; DEGRADATION; BIODEGRADATION;
   PEROXIDASE; MICROORGANISMS; NANOPARTICLES
AB A novel biomaterial, the Phanerochaete chrysosporium pellet (CP) composed of chlamydospore-like cells (CLCs), was prepared and its potential in treating phenolic resin wastewater was evaluated. CP possesses higher phenol removal ability in contrast with mycelial pellets of P. chrysosporium, and CLC can be seen as the naturally immobilized enzymes. At shake-flask level, the ideal pH value, temperature, and inoculation quantity of CP for treatment of 1430 mg/l phenol wastewater were pH 4-6, 30 A degrees C, and 5.0 g/l, respectively, and the maximum specific removal rate, 41.1 mg phenol/g CP/h, was obtained in fixed bed reactor (FBR) when the flow rate of wastewater was 3.4 l/h. During the treatment, FBR harbored amounts of bacteria (135 genera) and eukaryotes, as analyzed by metagenomic sequencing. Bacterial pollution not only decreased reactor performance but also had a negative impact on reusability of CP. Hot water treatment (80-85 A degrees C) is effective to inhibit bacterial pollution, and heat resistance of CLC makes the repeated regrowing of CP be feasible. This work presents an innovative and low-cost biomaterial for phenol removal and will be helpful for the practical application of P. chrysosporium in wastewater treatment.
C1 [Wang Hailei; Ping, Li; Yu, Qin] Henan Normal Univ, Coll Life Sci, Xinxiang 453007, Peoples R China.
   [Wang Hailei] Univ Henan Prov, Key Lab Microorganisms & Funct Mol, Xinxiang 453007, Peoples R China.
   [Hui, Yang] Henan Med Coll, Dept Med, Xinzheng 451191, Peoples R China.
RP Wang, HL (reprint author), Henan Normal Univ, Coll Life Sci, Xinxiang 453007, Peoples R China.; Wang, HL (reprint author), Univ Henan Prov, Key Lab Microorganisms & Funct Mol, Xinxiang 453007, Peoples R China.
EM whl@htu.edu.cn
FU National Science Foundation of China [51008119]
FX This work is supported by the National Science Foundation of China (No.
   51008119).
CR Adav SS, 2007, BIOTECHNOL BIOENG, V96, P844, DOI 10.1002/bit.21148
   Ahmaruzzaman M, 2008, ADV COLLOID INTERFAC, V143, P48, DOI 10.1016/j.cis.2008.07.002
   Al-Khalid T, 2012, CRIT REV ENV SCI TEC, V42, P1631, DOI 10.1080/10643389.2011.569872
   Aloke KG, 2011, INT BIODETER BIODEGR, V65, P1052
   ANSELMO AM, 1985, BIOTECHNOL LETT, V7, P889, DOI 10.1007/BF01088011
   APHA, 1998, STANDARD METHODS EXA
   Bajaj M, 2008, BIORESOURCE TECHNOL, V99, P8376, DOI 10.1016/j.biortech.2008.02.057
   Banerjee A, 2011, INT BIODETER BIODEGR, V65, P1052, DOI 10.1016/j.ibiod.2011.04.011
   Bayer C, 2010, WATER SCI TECHNOL, V62, P915, DOI 10.2166/wst.2010.368
   Bayramoglu G, 2010, BIORESOURCE TECHNOL, V101, P6615, DOI 10.1016/j.biortech.2010.03.088
   Bayramoglu G, 2009, BIORESOURCE TECHNOL, V100, P2685, DOI 10.1016/j.biortech.2008.12.042
   Begerow D, 2010, APPL MICROBIOL BIOT, V87, P99, DOI 10.1007/s00253-010-2585-4
   Bergauer P, 2005, CHEMOSPHERE, V59, P909, DOI 10.1016/j.chemosphere.2004.11.011
   Bogan BW, 1996, APPL ENVIRON MICROB, V62, P1597
   Busca G, 2008, J HAZARD MATER, V160, P265, DOI 10.1016/j.jhazmat.2008.03.045
   Carbajo JB, 2010, BIODEGRADATION, V21, P603, DOI 10.1007/s10532-010-9328-1
   CARDOSO RB, 2009, PROCESS BIOCHEM, V44, P23
   Carter MR, 1993, SOIL SAMPLING METHOD
   Chen KC, 2002, ENZYME MICROB TECH, V31, P490, DOI 10.1016/S0141-0229(02)00148-5
   Daims H, 2007, APPL MICROBIOL BIOT, V75, P237, DOI 10.1007/s00253-007-0886-z
   Galindez-Mayer J, 2008, BIOCHEM ENG J, V38, P147, DOI 10.1016/j.bej.2007.06.011
   Gao DW, 2010, CRIT REV BIOTECHNOL, V30, P70, DOI 10.3109/07388550903427272
   Godjevargova T, 2000, PROCESS BIOCHEM, V35, P699, DOI 10.1016/S0032-9592(99)00131-4
   Gomez JL, 2006, ENZYME MICROB TECH, V39, P1016, DOI 10.1016/j.enzmictec.2006.02.008
   Gomez M, 2009, J HAZARD MATER, V169, P46, DOI 10.1016/j.jhazmat.2009.03.059
   Hannaford AM, 1999, J IND MICROBIOL BIOT, V22, P121, DOI 10.1038/sj.jim.2900617
   He LM, 2014, MICROB ECOL, V67, P951, DOI 10.1007/s00248-014-0393-6
   Jiang HL, 2006, ENVIRON SCI TECHNOL, V40, P6137, DOI 10.1021/es0609295
   Jiang LC, 2013, J BASIC MICROB, V53, P224, DOI 10.1002/jobm.201100460
   Karigar C, 2006, BIODEGRADATION, V17, P47, DOI 10.1007/s10532-005-3048-y
   KENNES C, 1994, J IND MICROBIOL, V13, P311, DOI 10.1007/BF01569733
   Kibret M, 2000, WATER RES, V34, P1127, DOI 10.1016/S0043-1354(99)00248-1
   Le TH, 2012, BIORESOURCE TECHNOL, V104, P795, DOI 10.1016/j.biortech.2011.10.064
   Leitao AL, 2007, INT BIODETER BIODEGR, V59, P220, DOI 10.1016/j.ibiod.2006.09.009
   Levy I, 2003, BIOTECHNOL BIOENG, V82, P223, DOI 10.1002/bit.10562
   Liu YJ, 2009, BIOCHEM ENG J, V44, P187, DOI 10.1016/j.bej.2008.12.001
   Lobo CC, 2014, WATER SA, V40, P125, DOI 10.4314/wsa.v40i1.15
   Lu DB, 2012, BIODEGRADATION, V23, P209, DOI 10.1007/s10532-011-9500-2
   Nikola L, 2011, J SERB CHEM SOC, V76, P513
   Polaert I, 2005, CHEM ENG SCI, V60, P6354, DOI 10.1016/j.ces.2005.01.030
   Rho D, 2001, BIOTECHNOL BIOENG, V73, P271, DOI 10.1002/bit.1060
   Couto SR, 2006, WORLD J MICROB BIOT, V22, P607, DOI 10.1007/s11274-005-9078-0
   Saitoh T, 2011, J HAZARD MATER, V185, P1369, DOI 10.1016/j.jhazmat.2010.10.057
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09
   Seetharam GB, 2003, WATER RES, V37, P436, DOI 10.1016/S0043-1354(02)00290-7
   Shao J, 2007, BIOTECHNOL LETT, V29, P901, DOI 10.1007/s10529-007-9329-2
   STGERMAIN G, 1996, IDENTIFYING FILAMENT
   Su C, 2012, APPL MICROBIOL BIOT, V93, P993, DOI 10.1007/s00253-011-3800-7
   TIEN M, 1983, SCIENCE, V221, P661, DOI 10.1126/science.221.4611.661
   Urek RO, 2005, PROCESS BIOCHEM, V40, P83, DOI 10.1016/j.procbio.2003.11.040
   Wang C, 2008, BIOMED ENVIRON SCI, V21, P474, DOI 10.1016/S0895-3988(09)60005-2
   Wang F, 2012, BIORESOURCE TECHNOL, V110, P120, DOI 10.1016/j.biortech.2012.01.184
   Wang HL, 2005, J ENVIRON SCI, V17, P421
   Wesenberg D, 2003, BIOTECHNOL ADV, V22, P161, DOI 10.1016/j.biotechadv.2003.08.011
   Wu CD, 2001, WATER RES, V35, P3927, DOI 10.1016/S0043-1354(01)00133-6
   Yang YN, 2004, BIORESOURCE TECHNOL, V92, P285, DOI 10.1016/j.biortech.2003.09.011
   Zaushitsyna O, 2013, TOP CATAL, V56, P339
   Zhai ZJ, 2012, J CHEM TECHNOL BIOT, V87, P105, DOI 10.1002/jctb.2689
   ZHOU DQ, 2002, ESSENTIAL MICROBIOLO
NR 59
TC 2
Z9 2
U1 1
U2 41
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7598
EI 1432-0614
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD JUN
PY 2016
VL 100
IS 11
BP 5153
EP 5164
DI 10.1007/s00253-016-7353-7
PG 12
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DM3OG
UT WOS:000376255200038
PM 26860939
DA 2018-10-19
ER

PT J
AU Gramanzini, M
   Gargiulo, S
   Zarone, F
   Megna, R
   Apicella, A
   Aversa, R
   Salvatore, M
   Mancini, M
   Sorrentino, R
   Brunetti, A
AF Gramanzini, Matteo
   Gargiulo, Sara
   Zarone, Fernando
   Megna, Rosario
   Apicella, Antonio
   Aversa, Raffaella
   Salvatore, Marco
   Mancini, Marcello
   Sorrentino, Roberto
   Brunetti, Arturo
TI Combined microcomputed tomography, biomechanical and histomorphometric
   analysis of the peri-implant bone: a pilot study in minipig model
SO DENTAL MATERIALS
LA English
DT Article
DE Dental implant; Insertion torque; Resonance frequency analysis; mu CT;
   Histomorphometry; Minipig model
ID RESONANCE FREQUENCY-ANALYSIS; SINGLE-TOOTH IMPLANTS; BRANEMARK SYSTEM
   IMPLANTS; DENTAL QUANTITATIVE CT; PRIMARY STABILITY; IN-VITRO; INSERTION
   TORQUE; ENDOSSEOUS IMPLANTS; TITANIUM IMPLANTS; TRABECULAR BONE
AB Objectives. To present a practical approach that combines biomechanical tests, microcomputed tomography (mu CT) and histomorphometry, providing quantitative results on bone structure and mechanical properties in a minipig model, in order to investigate the specific response to an innovative dental biomaterial.
   Methods. Titanium implants with innovative three-dimensional scaffolds were inserted in the tibias of 4 minipigs. Primary stability and osseointegration were investigated by means of insertion torque (IT) values, resonance frequency analysis (RFA), bone-to-implant contact (BIC), bone mineral density (BMD) and stereological measures of trabecular bone.
   Results. A significant positive correlation was found between IT and RFA (r = 0.980, p = 0.0001). BMD at the implant sites was 18% less than the reference values (p = 0.0156). Pefi-implant Tb.Th was 50% higher, while Tb.N was 50% lower than the reference zone (p <0.003) and they were negatively correlated (r = -0.897, p = 0.006).
   Significance. mu CT increases evaluation throughput and offers the possibility for qualitative three-dimensional recording of the bone-implant system as well as for non-destructive evaluation of bone architecture and mineral density, in combination with conventional analysis methods. The proposed multimodal approach allows to improve accuracy and reproducibility for peri-implant bone measurements and could support future investigations. (C) 2016 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Gramanzini, Matteo; Gargiulo, Sara; Megna, Rosario; Mancini, Marcello] CNR, Inst Biostruct & Bioimaging, Via T De Amicis 95, I-80145 Naples, Italy.
   [Gramanzini, Matteo; Gargiulo, Sara; Brunetti, Arturo] CEINGE Scarl, Via G Salvatore 486, I-80145 Naples, Italy.
   [Zarone, Fernando; Sorrentino, Roberto] Univ Naples Federico II, Sch Med, Dept Neurosci Reprod & Odontostomatol Sci, Via Pansini 5, I-80131 Naples, Italy.
   [Apicella, Antonio; Aversa, Raffaella; Sorrentino, Roberto] Univ Naples 2, Dept Architecture & Ind Design, I-81031 Borgo San Lorenzo, Aversa, Italy.
   [Salvatore, Marco] IRCCS SDN, Via E Gianturco 113, I-80143 Naples, Italy.
   [Brunetti, Arturo] Univ Naples Federico II, Dept Adv Med Sci, Via Pansini 5, I-80145 Naples, Italy.
RP Gramanzini, M (reprint author), CNR, Inst Biostruct & Bioimaging, Via T De Amicis 95, I-80145 Naples, Italy.
EM matteo.gramanzini@ibb.cnr.it; sara.gargiulo@ibb.cnr.it;
   fernandozarone@mac.com; rosario.megna@ibb.cnr.it;
   antonio.apicella@unina2.it; raffaella.aversa@unina2.it;
   marsalva@unina.it; marcello.mancini@ibb.cnr.it; errestino@libero.it;
   brunetti@unina.it
OI Megna, Rosario/0000-0002-5716-2137; Brunetti,
   Arturo/0000-0001-7057-3494; apicella, antonio/0000-0002-5365-6033;
   aversa, raffaella/0000-0003-0672-634X
CR Aerssens J, 1998, ENDOCRINOLOGY, V139, P663, DOI 10.1210/en.139.2.663
   Alm JJ, 2012, J ORTHOP RES, V30, P1019
   Alsaadi G, 2007, J CLIN PERIODONTOL, V34, P359, DOI 10.1111/j.1600-051X.2007.01047.x
   Aversa Raffaella, 2015, Advanced Materials Research, V1088, P487, DOI 10.4028/www.scientific.net/AMR.1088.487
   Aversa R, 2009, DENT MATER, V25, P678, DOI 10.1016/j.dental.2008.10.015
   Beddoe HA., 1978, CALCIF TISSUE RES, V25, P273
   Beer A, 2003, CLIN ORAL IMPLAN RES, V14, P616, DOI 10.1034/j.1600-0501.2003.00932.x
   Berglundh T, 2003, CLIN ORAL IMPLAN RES, V14, P251, DOI 10.1034/j.1600-0501.2003.00972.x
   Bilhan H, 2012, INT J DENT, V2012
   Calandriello Roberto, 2003, Clin Implant Dent Relat Res, V5 Suppl 1, P10, DOI 10.1111/j.1708-8208.2003.tb00011.x
   Cha JY, 2010, AM J ORTHOD DENTOFAC, V137, P73, DOI 10.1016/j.ajodo.2008.03.024
   COLIN SS, 2005, J APPL PHYSIOL, V99, P2369
   CURREY JD, 1995, BIOMATERIALS, V16, P1267, DOI 10.1016/0142-9612(95)98135-2
   da Cunha HA, 2004, INT J ORAL MAX IMPL, V19, P578
   Dagher M, 2014, IMPLANT DENT, V23, P672, DOI 10.1097/ID.0000000000000155
   Davison KS, 2006, SEMIN ARTHRITIS RHEU, V36, P22, DOI 10.1016/j.semarthrit.2006.04.002
   Degidi M, 2010, CLIN IMPLANT DENT R, V21, P213
   Degidi M, 2013, CLIN IMPLANT DENT R, V15, P637, DOI 10.1111/j.1708-8208.2011.00392.x
   Degidi M, 2009, CLIN ORAL IMPLAN RES, V20, P778, DOI 10.1111/j.1600-0501.2008.01599.x
   FELDKAMP LA, 1989, J BONE MINER RES, V4, P3, DOI 10.1002/jbmr.5650040103
   Franchi M, 2005, MICRON, V36, P665, DOI 10.1016/j.micron.2005.05.010
   Friberg B, 1999, Clin Implant Dent Relat Res, V1, P75, DOI 10.1111/j.1708-8208.1999.tb00095.x
   FRIBERG B, 1995, CLIN ORAL IMPLAN RES, V6, P213, DOI 10.1034/j.1600-0501.1995.060403.x
   FRIBERG B, 1995, CLIN ORAL IMPLAN RES, V6, P164, DOI 10.1034/j.1600-0501.1995.060305.x
   FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104
   Gahlert M, 2008, EUR CELLS MATER, V16, P34
   Homolka P, 2002, RADIOLOGY, V224, P247, DOI 10.1148/radiol.2241010948
   Horiuchi K, 2000, INT J ORAL MAX IMPL, V15, P824
   Hui E, 2001, Clin Implant Dent Relat Res, V3, P79, DOI 10.1111/j.1708-8208.2001.tb00235.x
   Huwiler MA, 2007, CLIN ORAL IMPLAN RES, V18, P275, DOI 10.1111/j.1600-0501.2007.01336.x
   Ito Y, 2008, CLIN ORAL IMPLAN RES, V19, P9, DOI 10.1111/j.1600-0501.2007.01419.x
   Johansson P, 1994, INT J ORAL MAXILLOF, V9, P279
   Joos U, 2006, INT J ORAL MAX SURG, V35, P783, DOI 10.1016/j.ijom.2006.03.013
   KRAGSTRUP J, 1989, BONE, V10, P421, DOI 10.1016/8756-3282(89)90073-2
   KUHN JL, 1990, J ORTHOPAED RES, V8, P833, DOI 10.1002/jor.1100080608
   LAIBLIN C, 1979, BERL MUNCH TIERARZTL, V92, P124
   Lorenzoni M, 2003, CLIN ORAL IMPLAN RES, V14, P180, DOI 10.1034/j.1600-0501.2003.140207.x
   Calvo-Guirado JL, 2014, CLIN ORAL IMPLAN RES, V25, P352, DOI 10.1111/clr.12134
   Majumdar S, 1998, BONE, V22, P445, DOI 10.1016/S8756-3282(98)00030-1
   Malo P, 2000, Clin Implant Dent Relat Res, V2, P138, DOI 10.1111/j.1708-8208.2000.tb00004.x
   Martinez-Gonzalez JM, 2005, ORAL SURG ORAL MED O, V99, P11, DOI 10.1016/j.tripleo.2004.02.068
   Martiniakova M, 2006, J FORENSIC SCI, V51, P1235, DOI 10.1111/j.1556-4029.2006.00260.x
   Meredith N, 1997, CLIN ORAL IMPLAN RES, V8, P226, DOI 10.1034/j.1600-0501.1997.080309.x
   Meredith N, 1997, CLIN ORAL IMPLAN RES, V8, P234, DOI 10.1034/j.1600-0501.1997.080310.x
   Meredith N, 1996, CLIN ORAL IMPLAN RES, V7, P261, DOI 10.1034/j.1600-0501.1996.070308.x
   Meredith N, 1998, INT J PROSTHODONT, V11, P491
   Meredith N, 1996, MED SCI RES, V24, P191
   Miyamoto I, 2005, BONE, V37, P776, DOI 10.1016/j.bone.2005.06.019
   MOSEKILDE L, 1993, BONE, V14, P379, DOI 10.1016/8756-3282(93)90167-9
   MOSEKILDE L, 1987, CALCIFIED TISSUE INT, V40, P318, DOI 10.1007/BF02556693
   Muller B, 2007, INT J MATER RES, V98, P613, DOI 10.3139/146.101507
   Natali AN, 2004, DENT MATER, V22, p[3, 9]
   Nazarian A, 2009, J BIOMECH, V42, P82, DOI 10.1016/j.jbiomech.2008.09.037
   Neugebauer J, 2006, J PERIODONTOL, V77, P152, DOI 10.1902/jop.2006.040360
   Nikellis I, 2004, INT J ORAL MAX IMPL, V19, P116
   Nkenke E, 2003, CLIN ORAL IMPLAN RES, V14, P601, DOI 10.1034/j.1600-0501.2003.00937.x
   O'Sullivan D, 2000, Clin Implant Dent Relat Res, V2, P85, DOI 10.1111/j.1708-8208.2000.tb00110.x
   Ostman PO, 2006, INT J PROSTHODONT, V19, P77
   Otsuka M, 2013, J BIOMED MATER RES B, V101B, P338, DOI 10.1002/jbm.b.32844
   Ottoni JMP, 2005, INT J ORAL MAX IMPL, V20, P769
   Panseri S, 2013, BONE, V56, P432, DOI 10.1016/j.bone.2013.07.015
   Park YS, 2005, CLIN ORAL IMPLAN RES, V16, P156, DOI 10.1111/j.1600-0501.2004.01083.x
   Rebaudi A, 2011, INT J ORAL MAX IMPL, V26, P1233
   Roberts W E, 1988, J Dent Educ, V52, P804
   ROBERTS WE, 1989, ANGLE ORTHOD, V59, P247
   Romanos GE, 2014, CLIN IMPLANT DENT R, V16, P89, DOI 10.1111/j.1708-8208.2012.00464.x
   Sakoh J, 2006, INT J ORAL MAX IMPL, V21, P560
   Salimov F, 2014, CLIN ORAL IMPLAN RES, V25, P1016, DOI 10.1111/clr.12219
   Scarano A, 2006, CLIN IMPLANT DENT R, V8, P218, DOI 10.1111/j.1708-8208.2006.00022.x
   Schiraldi C, 2004, BIOMATERIALS, V25, P3645, DOI 10.1016/j.biomaterials.2003.10.059
   Schliephake H, 2006, INT J ORAL MAX SURG, V35, P941, DOI 10.1016/j.ijom.2006.05.002
   SEDLIN ED, 1966, ACTA ORTHOP SCAND, V37, P29, DOI 10.3109/17453676608989401
   Sennerby L, 2008, PERIODONTOL 2000, V47, P51, DOI 10.1111/j.1600-0757.2008.00267.x
   Shalabi MM, 2006, CLIN ORAL IMPLAN RES, V17, P172, DOI 10.1111/j.1600-0501.2005.01202.x
   Stadlinger B, 2010, BR J ORAL MAXILLOFAC, V50, P74
   Swain MV, 2009, INT J ORAL SCI, V1, P177, DOI 10.4248/IJOS09031
   Thorwarth M, 2005, J ORAL MAXIL SURG, V63, P1626, DOI 10.1016/j.joms.2005.06.010
   Turkyilmaz I, 2006, J ORAL REHABIL, V33, P754, DOI 10.1111/j.1365-2842.2006.01631.x
   Turkyilmaz I., 2007, J CLIN PERIODONTOL, V34, P716, DOI DOI 10.1111/J.1600-051X.2007.01112.X
   Turkyilmaz Ilser, 2008, BMC Oral Health, V8, P32, DOI 10.1186/1472-6831-8-32
   Velasquez P, 2013, J BIOMED MATER RES A, V101, P1943, DOI 10.1002/jbm.a.34495
   Vozzi G, 2013, J BIOMED MAT RES A, p00A
   Wang S, 2007, ORAL DIS, V13, P530, DOI 10.1111/j.1601-0825.2006.01337.x
NR 83
TC 2
Z9 2
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
EI 1879-0097
J9 DENT MATER
JI Dent. Mater.
PD JUN
PY 2016
VL 32
IS 6
BP 794
EP 806
DI 10.1016/j.dental.2016.03.025
PG 13
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA DL8GZ
UT WOS:000375880500012
PM 27063459
DA 2018-10-19
ER

PT J
AU Liu, XM
   Yang, L
   Li, J
   Zhang, YM
   Xu, WJ
   Ren, Y
   Liu, BW
   Yang, BA
   Li, BX
AF Liu, Xiaoming
   Yang, Lin
   Li, Jing
   Zhang, Yuming
   Xu, Weijun
   Ren, Yan
   Liu, Biwang
   Yang, Biao
   Li, Baoxing
TI GS/DBM/PLA porous composite biomaterial for the treatment of infective
   femoral condyle defect in rats
SO EXPERIMENTAL AND THERAPEUTIC MEDICINE
LA English
DT Article
DE bone tissue engineering; infection; bone defect; composite biomaterial
ID DEMINERALIZED BONE-MATRIX; IN-VITRO; GRAFTING MATERIALS; RELEASE;
   REPAIR; REGENERATION; DELIVERY; CEMENT; BIOCOMPATIBILITY; MICROPARTICLES
AB A bone defect resulting from open bone trauma may easily become infected; however, the administration of efficacious systemic antibiotics cannot be performed at safe levels. Previous studies have investigated anti-infective biomaterials that incorporate into bone and facilitate the direct application of high-concentration local antibiotics. In the present study, the effect of a novel porous composite with gentamicin sulfate (GS) in treating infected femoral condyle defects was investigated using a rat model. A novel porous composite biomaterial was prepared based on a supercritical carbon dioxide fluid technique that combined GS, demineralized bone matrix (DBM) and polylactic acid (PLA). A rat femoral condyle fracture model of infection was established. The GS/DBM/PLA composite biomaterial was implanted and its physicochemical characteristics, biocompatibility and ability to facilitate repair of infected bone defect were assessed. The GS/DBM/PLA composite biomaterial maintained the antibiotic activity of GS, with good anti-compression strength, porosity and biocompatibility. The results of the animal experiments indicated that the GS/DBM/PLA composite biomaterial exerted marked anti-infective effects and facilitated bone defect repair, while simultaneously controlling infection. Porous GS/DBM/PLA is therefore a promising composite biomaterial for use in bone tissue engineering.
C1 [Liu, Xiaoming; Li, Baoxing] Southern Med Univ, Guangdong Prov Key Lab Med Biomech, Dept Human Anat, Guangzhou 510515, Guangdong, Peoples R China.
   [Liu, Xiaoming; Li, Jing; Zhang, Yuming; Xu, Weijun; Yang, Biao; Li, Baoxing] China Inst Radiat Protect, 102 Xuefu St, Taiyuan 030006, Shanxi, Peoples R China.
   [Yang, Lin] Zunyi Med Coll, Dept Human Anat, Zhuhai 519041, Guangdong, Peoples R China.
   [Ren, Yan] Shanxi Med Univ, Dept Med Imaging, Taiyuan 030001, Shanxi, Peoples R China.
   [Liu, Biwang] Shanxi Univ, Dept Tradit Chinese Med, Taiyuan 030001, Shanxi, Peoples R China.
RP Li, BX (reprint author), China Inst Radiat Protect, 102 Xuefu St, Taiyuan 030006, Shanxi, Peoples R China.
EM pplxmpp@163.com
FU Shenzhen Governmental Basic Research Grant [JCYJ20120617115010496];
   State Key Laboratory of Bioelectronics of Southeast University (Nanjing,
   China); Doctor Startup Foundation of Zunyi Medical College [F-746]
FX The present study was supported by a grant from the Shenzhen
   Governmental Basic Research Grant (no. JCYJ20120617115010496), the State
   Key Laboratory of Bioelectronics of Southeast University (Nanjing,
   China) and the Doctor Startup Foundation of Zunyi Medical College (no.
   F-746).
CR Agarwal A, 2015, J CLIN ORTHOP TRAUMA, V6, P72
   Ajiboye RM, 2015, EUR SPINE J, V24, P2567, DOI 10.1007/s00586-015-4117-5
   Ambrose CG, 2004, CLIN ORTHOP RELAT R, P293, DOI 10.1097/01.blo.0000126303.41711.a2
   Anal AK, 2005, INT J PHARM, V290, P45, DOI 10.1016/j.ijpharm.2004.11.015
   Bakhshalian N, 2013, INT J ORAL MAX IMPL, V28, P1655, DOI 10.11607/jomi .2833
   Bucholz RW, 2002, CLIN ORTHOP RELAT R, P44
   Buranapanitkit B, 2004, CLIN ORTHOP RELAT R, P244, DOI 10.1097/01.blo.0000130268.27024.c1
   Chen Zhi-Wen, 2008, Zhongguo Gu Shang, V21, P377
   Corden TJ, 2000, BIOMATERIALS, V21, P713, DOI 10.1016/S0142-9612(99)00236-7
   CRANE GM, 1995, NAT MED, V1, P1322, DOI 10.1038/nm1295-1322
   Fong N, 2013, J BIOMED MATER RES B, V101B, P310, DOI 10.1002/jbm.b.32841
   Garcia-Gareta E, 2015, BONE, V81, P112, DOI 10.1016/j.bone.2015.07.007
   Hautaamaki MP, 2008, ACTA ORTHOP, V79, P555, DOI 10.1080/17453670710015571
   Hile DD, 2000, J CONTROL RELEASE, V66, P177, DOI 10.1016/S0168-3659(99)00268-0
   Jimi E, 2012, INT J DENT, DOI 10.1155/2012/148261
   Li XD, 2001, J BONE JOINT SURG BR, V83B, P1063, DOI 10.1302/0301-620X.83B7.11271
   Li ZX, 2012, J BIOMED MATER RES A, V100A, P2537, DOI 10.1002/jbm.a.34185
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Link DP, 2006, BIOMATERIALS, V27, P4941, DOI 10.1016/j.biomaterials.2006.05.022
   Liu HH, 2010, J BIOMED MATER RES B, V95B, P36, DOI 10.1002/jbm.b.31680
   Makinen TJ, 2005, J ANTIMICROB CHEMOTH, V56, P1063, DOI 10.1093/jac/dki366
   Nofar M, 2013, POLYMER, V54, P2382, DOI 10.1016/j.polymer.2013.02.049
   Pandey M, 2013, INT J POLYM SCI, DOI 10.1155/2013/905471
   Porter NL, 2001, J BIOMED MATER RES, V56, P504, DOI 10.1002/1097-4636(20010915)56:4<504::AID-JBM1122>3.0.CO;2-J
   Quaglino P, 2013, GIORN ITAL DERMAT V, V148, P453
   Roberts TT, 2012, ORGANOGENESIS, V8, P114, DOI 10.4161/org.23306
   Silverman LD, 2007, J ORTHOP RES, V25, P23, DOI 10.1002/jor.20284
   Stiller M, 2014, BIOMATERIALS, V35, P3154, DOI 10.1016/j.biomaterials.2013.12.068
   Tavakol S, 2013, J CRANIOFAC SURG, V24, P2135, DOI 10.1097/SCS.0b013e3182a243d4
   Thomas DB, 2005, CLIN ORTHOP RELAT R, P366, DOI 10.1097/01.blo.0000181144.01306.b0
   Turner TM, 2005, CLIN ORTHOP RELAT R, P97, DOI 10.1097/01.blo.0000175127.37343.0d
   Lima CEVD, 2011, BRAZ ORAL RES, V25, P42, DOI 10.1590/S1806-83242011000100008
   Won YH, 2011, IMPLANT DENT, V20, P460, DOI 10.1097/ID.0b013e31823541e7
   Xu CX, 2010, J BIOMED MATER RES A, V95A, P495, DOI 10.1002/jbm.a.32877
   Yandrapu SK, 2013, MOL PHARMACEUT, V10, P4676, DOI 10.1021/mp400487f
   Yoshikawa T, 1998, BIO-MED MATER ENG, V8, P311
   Zhang HY, 2013, J MECH BEHAV BIOMED, V20, P209, DOI 10.1016/j.jmbbm.2013.01.001
   Zhang HY, 2013, J TRIBOL-T ASME, V135, DOI 10.1115/1.4023802
   Zhang Yu-min, 2006, Nan Fang Yi Ke Da Xue Xue Bao, V26, P1745
   Zheng JP, 2011, J MATER SCI-MATER M, V22, P1063, DOI 10.1007/s10856-011-4269-8
NR 40
TC 2
Z9 2
U1 4
U2 12
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-0981
EI 1792-1015
J9 EXP THER MED
JI Exp. Ther. Med.
PD JUN
PY 2016
VL 11
IS 6
BP 2107
EP 2116
DI 10.3892/etm.2016.3219
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DM2NA
UT WOS:000376182300005
OA Green Published
DA 2018-10-19
ER

PT J
AU Alvarez-Anorve, LI
   Gaugue, I
   Link, H
   Marcos-Viquez, J
   Diaz-Jimenez, DM
   Zonszein, S
   Bustos-Jaimes, I
   Schmitz-Afonso, I
   Calcagno, ML
   Plumbridge, J
AF Alvarez-Anorve, Laura I.
   Gaugue, Isabelle
   Link, Hannes
   Marcos-Viquez, Jorge
   Diaz-Jimenez, Dana M.
   Zonszein, Sergio
   Bustos-Jaimes, Ismael
   Schmitz-Afonso, Isabelle
   Calcagno, Mario L.
   Plumbridge, Jacqueline
TI Allosteric Activation of Escherichia coli Glucosamine-6-Phosphate
   Deaminase (NagB) In Vivo Justified by Intracellular Amino Sugar
   Metabolite Concentrations
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID GLUCOSAMINE 6-PHOSPHATE DEAMINASE; N-ACETYLGLUCOSAMINE; ADAPTER PROTEIN;
   SMALL RNA; KINETICS; ENZYME; MECHANISM; ISOMERASE; SITE; K-12
AB We have investigated the impact of growth on glucosamine (GlcN) and N-acetylglucosamine (GlcNAc) on cellular metabolism by quantifying glycolytic metabolites in Escherichia coli. Growth on GlcNAc increased intracellular pools of both GlcNAc6P and GlcN6P 10- to 20-fold compared to growth on glucose. Growth on GlcN produced a 100-fold increase in GlcN6P but only a slight increase in GlcNAc6P. Changes to the amounts of downstream glycolytic intermediates were minor compared to growth on glucose. The enzyme glucosamine-6P deaminase (NagB) is required for growth on both GlcN and GlcNAc. It is an allosteric enzyme in E. coli, displaying sigmoid kinetics with respect to its substrate, GlcN6P, and is allosterically activated by GlcNAc6P. The high concentration of GlcN6P, accompanied by the small increase in GlcNAc6P, drives E. coli NagB (NagB(Ec)) into its high activity state, as observed during growth on GlcN (L. I. Alvarez-Anorve, I. Bustos-Jaimes, M. L. Calcagno, and J. Plumbridge, J Bacteriol 191: 6401-6407, 2009, http://dx.doi.org/10.1128/JB.00633-09). The slight increase in GlcNAc6P during growth on GlcN is insufficient to displace NagC, the GlcNAc6P-responsive repressor of the nag genes, from its binding sites, so there is only a small increase in nagB expression. We replaced the gene for the allosteric NagB(Ec) enzyme with that of the nonallosteric, B. subtilis homologue, NagB(Bs). We detected no effects on growth rates or competitive fitness on glucose or the amino sugars, nor did we detect any effect on the concentrations of central metabolites, thus demonstrating the robustness of amino sugar metabolism and leaving open the question of the role of allostery in the regulation of NagB.
   IMPORTANCE
   Chitin, the polymer of N-acetylglucosamine, is an abundant biomaterial, and both glucosamine and N-acetylglucosamine are valuable nutrients for bacteria. The amino sugars are components of numerous essential macromolecules, including bacterial peptidoglycan and mammalian glycosaminoglycans. Controlling the biosynthetic and degradative pathways of amino sugar metabolism is important in all organisms to avoid loss of nitrogen and energy via a futile cycle of synthesis and breakdown. The enzyme glucosamine-6P deaminase (NagB) is central to this control, and N-acetylglucosamine-6P is the key signaling molecule regulating amino sugar utilization in Escherichia coli. Here, we investigate how the metabolic status of the bacteria impacts on the activity of NagB(Ec) and the N-acetylglucosamine-6P-sensitive transcriptional repressor, NagC.
C1 [Alvarez-Anorve, Laura I.; Gaugue, Isabelle; Plumbridge, Jacqueline] Univ Paris Diderot, Sorbonne Paris Cite, CNRS, UMR8261,Inst Biol Phys Chim, Paris, France.
   [Alvarez-Anorve, Laura I.; Marcos-Viquez, Jorge; Diaz-Jimenez, Dana M.; Zonszein, Sergio; Bustos-Jaimes, Ismael; Calcagno, Mario L.] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Lab Fisicoquim & Ingn Prot, Mexico City 04510, Cdmx, Mexico.
   [Link, Hannes] ETH, Inst Mol Syst Biol, Zurich, Switzerland.
   [Schmitz-Afonso, Isabelle] Univ Paris 11, ICSN CNRS UPR2301, LabEx CEBA, Inst Chim Subst Nat, Gif Sur Yvette, France.
   [Gaugue, Isabelle] Inst Curie, CNRS, INSERM, UMR 3215,U 934,Ctr Rech, F-75231 Paris, France.
   [Link, Hannes] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany.
   [Schmitz-Afonso, Isabelle] Univ Rouen, Normandie Univ, COBRA, CNRS,UMR6014,FR 3038,IRCOF, Mont St Aignan, France.
RP Plumbridge, J (reprint author), Univ Paris Diderot, Sorbonne Paris Cite, CNRS, UMR8261,Inst Biol Phys Chim, Paris, France.
EM jackie.plumbridge@ibpc.fr
RI Schmitz-Afonso, Isabelle/D-2168-2013
OI Schmitz-Afonso, Isabelle/0000-0003-0665-0074; Bustos-Jaimes,
   Ismael/0000-0003-3038-8141
FU DGAPA-PAPIIT-UNAM [IN206009, IN213312]; DGAPA-PASPA-UNAM; Agence
   Nationale de la Recherche (ANR) [ANR-09-BLAN 0399, ANR-11-LABX-0011-01];
   Consejo Nacional de Ciencia y Tecnologia (CONACYT) [99857-Q, 116074];
   Centre National de la Recherche Scientifique (CNRS)
FX This work, including the efforts of Mario Calcagno, was funded by
   DGAPA-PAPIIT-UNAM (IN206009 and IN213312). This work, including the
   efforts of Laura I. Alvarez-Anorve, was funded by DGAPA-PASPA-UNAM. This
   work, including the efforts of Jacqueline A. Plumbridge, was funded by
   Agence Nationale de la Recherche (ANR) (ANR-09-BLAN 0399 and
   ANR-11-LABX-0011-01). This work, including the efforts of Mario
   Calcagno, was funded by Consejo Nacional de Ciencia y Tecnologia
   (CONACYT) (99857-Q and 116074). This work, including the efforts of
   Jacqueline A. Plumbridge, was funded by Centre National de la Recherche
   Scientifique (CNRS).
CR ALTAMIRANO MM, 1994, EUR J BIOCHEM, V220, P409, DOI 10.1111/j.1432-1033.1994.tb18638.x
   Alvarez-Anorve LI, 2011, BBA-PROTEINS PROTEOM, V1814, P1846, DOI 10.1016/j.bbapap.2011.07.010
   Alvarez-Anorve LI, 2009, J BACTERIOL, V191, P6401, DOI 10.1128/JB.00633-09
   Alvarez-Anorve LI, 2005, J BACTERIOL, V187, P2974, DOI 10.1128/JB.187.9.2974-2982.2005
   Arreola R, 2003, FEBS LETT, V551, P63, DOI 10.1016/S0014-5793(03)00896-2
   Baba Tomoya, 2006, Mol Syst Biol, V2
   Bertin Y, 2013, ENVIRON MICROBIOL, V15, P610, DOI 10.1111/1462-2920.12019
   BLANGY D, 1968, J MOL BIOL, V31, P13, DOI 10.1016/0022-2836(68)90051-X
   Buescher JM, 2010, ANAL CHEM, V82, P4403, DOI 10.1021/ac100101d
   Bustos-Jaimes I, 2005, BIOCHEMISTRY-US, V44, P1127, DOI 10.1021/bi048514o
   Bustos-Jaimes I, 2002, J MOL BIOL, V319, P183, DOI 10.1016/S0022-2836(02)00096-7
   Bustos-Jaimes I, 2001, ARCH BIOCHEM BIOPHYS, V394, P156, DOI 10.1006/abbi.2001.2523
   CALCAGNO M, 1984, BIOCHIM BIOPHYS ACTA, V787, P165, DOI 10.1016/0167-4838(84)90076-1
   Cisneros DA, 2004, ARCH BIOCHEM BIOPHYS, V421, P77, DOI 10.1016/j.abb.2003.09.041
   Conway T, 2015, MICROBIOL SPECTR, V3, P3
   Cook P. F., 2007, ENZYME KINETICS MECH
   Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297
   Ferenci T, 2009, J BACTERIOL, V191, P4025, DOI 10.1128/JB.00118-09
   Gaugue I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063025
   Gopel Y, 2014, RNA BIOL, V11, P433, DOI 10.4161/rna.28301
   Gopel Y, 2013, GENE DEV, V27, P552, DOI 10.1101/gad.210112.112
   Horjales E, 1999, STRUCT FOLD DES, V7, P527, DOI 10.1016/S0969-2126(99)80069-0
   Kerfeld CA, 2010, ANNU REV MICROBIOL, V64, P391, DOI 10.1146/annurev.micro.112408.134211
   Kochanowski K, 2013, P NATL ACAD SCI USA, V110, P1130, DOI 10.1073/pnas.1202582110
   Lara-Gonzalez S, 2000, J MOL BIOL, V301, P219, DOI 10.1006/jmbi.2000.3937
   Lara-Lemus R, 1998, BBA-PROTEIN STRUCT M, V1388, P1, DOI 10.1016/S0167-4838(98)00141-1
   Lenski R E, 1991, Biotechnology, V15, P173
   Link H, 2013, NAT BIOTECHNOL, V31, P357, DOI 10.1038/nbt.2489
   Link H, 2012, METHOD MICROBIOL, V39, P127, DOI 10.1016/B978-0-08-099387-4.00005-3
   Liu C, 2008, J MOL BIOL, V379, P73, DOI 10.1016/j.jmb.2008.03.031
   Lopez PJ, 1999, MOL MICROBIOL, V33, P188, DOI 10.1046/j.1365-2958.1999.01465.x
   Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100
   MIDELFORT CF, 1977, BIOCHEMISTRY-US, V16, P1590, DOI 10.1021/bi00627a010
   MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6
   Montero-Moran GM, 2001, BIOCHEMISTRY-US, V40, P10187, DOI 10.1021/bi0105835
   NATARAJAN K, 1993, J BIOL CHEM, V268, P9206
   Oliva G, 1995, STRUCTURE, V3, P1323, DOI 10.1016/S0969-2126(01)00270-2
   Park JT, 2001, J BACTERIOL, V183, P3842, DOI 10.1128/JB.183.13.3842-3847.2001
   Plumbridge J, 1998, MOL MICROBIOL, V27, P369, DOI 10.1046/j.1365-2958.1998.00685.x
   PLUMBRIDGE JA, 1991, MOL MICROBIOL, V5, P2053, DOI 10.1111/j.1365-2958.1991.tb00828.x
   PLUMBRIDGE JA, 1990, J BACTERIOL, V172, P2728, DOI 10.1128/jb.172.5.2728-2735.1990
   Plumbridge J, 2009, J BACTERIOL, V191, P5641, DOI 10.1128/JB.00448-09
   Reaves ML, 2013, NATURE, V500, P237, DOI 10.1038/nature12445
   Steimle PA, 1997, MOL BIOCHEM PARASIT, V84, P149, DOI 10.1016/S0166-6851(96)02790-9
   Tanaka T, 2005, J BACTERIOL, V187, P7038, DOI 10.1128/JB.187.20.7038-7044.2005
   Vincent F, 2005, J BIOL CHEM, V280, P19649, DOI 10.1074/jbc.M502131200
   Volkmer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023126
   WHITE RJ, 1968, BIOCHEM J, V106, P847, DOI 10.1042/bj1060847
   Wiser MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126210
   Xu YF, 2012, NAT CHEM BIOL, V8, P562, DOI [10.1038/NCHEMBIO.941, 10.1038/nchembio.941]
   Yang C, 2006, J BIOL CHEM, V281, P29872, DOI 10.1074/jbc.M60505220
NR 51
TC 3
Z9 3
U1 3
U2 13
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD JUN
PY 2016
VL 198
IS 11
BP 1610
EP 1620
DI 10.1128/JB.00870-15
PG 11
WC Microbiology
SC Microbiology
GA DM2VN
UT WOS:000376206300009
PM 27002132
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Asdrubali, F
   Bianchi, F
   Cotana, F
   D'Alessandro, F
   Pertosa, M
   Pisello, AL
   Schiavoni, S
AF Asdrubali, F.
   Bianchi, F.
   Cotana, F.
   D'Alessandro, F.
   Pertosa, M.
   Pisello, A. L.
   Schiavoni, S.
TI Experimental thermo-acoustic characterization of innovative common reed
   bio-based panels for building envelope
SO BUILDING AND ENVIRONMENT
LA English
DT Article
DE Common reed; Thermal insulation panels; Innovative bio-based panels;
   Sound insulation; Energy efficiency in buildings; Biomaterial building
   panels
ID PHRAGMITES-COMMUNIS TRIN; LIFE-CYCLE ASSESSMENT; ENERGY ANALYSIS;
   PERFORMANCE; CALIBRATION; CARDBOARD; BIOMASS; MODEL; LCA
AB Natural and bio-based construction materials represent a promising solution for optimizing buildings' environmental sustainability. In this view, the paper presents the multipurpose experimental thermoacoustic characterization of common reed-based building panels. Different geometries, densities, humidity rates and stalk shapes were considered and tested by means of hot-plate, hot-box and impedance tube in-lab experimental benches. The thermal analysis showed that the geometry scarcely affects the thermal conductivity, which is around 0.05 W/mK and, therefore, comparable to other materials already commercialized for the same scope. On the other hand, the acoustic behavior is strongly affected by the stalk configuration, e.g. perpendicular, parallel or combined orientation with respect to the incident wave. In particular, the longitudinal stalk layout showed a significant sound absorption performance. The exhaustive experimental original characterization of such by-product, therefore, showed a very promising overall thermo-acoustic behavior. At the same time, for optimizing the panel field performance, the acoustic requirements should represent the panel design drivers, given the high sensitivity of the panel layout characteristics affecting the acoustic performance. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Asdrubali, F.; Bianchi, F.; Cotana, F.; D'Alessandro, F.; Pertosa, M.; Pisello, A. L.; Schiavoni, S.] Univ Perugia, CIRIAF Inter Univ Res Ctr Environm & Pollut Mauro, Via G Duranti 67, I-06125 Perugia, Italy.
   [Asdrubali, F.] Univ Rome Tre, Dept Engn, Via V Volterra 62, I-00146 Rome, Italy.
   [Cotana, F.; Pisello, A. L.] Univ Perugia, Dept Engn, Via G Duranti 93, I-06125 Perugia, Italy.
   [D'Alessandro, F.] Univ Perugia, Dept Civil & Environm Engn, Via G Duranti 93, I-06125 Perugia, Italy.
RP Pisello, AL (reprint author), Univ Perugia, CIRIAF Inter Univ Res Ctr Environm & Pollut Mauro, Via G Duranti 67, I-06125 Perugia, Italy.; Pisello, AL (reprint author), Univ Perugia, Dept Engn, Via G Duranti 93, I-06125 Perugia, Italy.
EM pisello@crbnet.it
OI D'Alessandro, Francesco/0000-0002-9867-7540; PISELLO, ANNA
   LAURA/0000-0002-4527-6444
FU CIRIAF program for UNESCO
FX The corresponding author acknowledgments are due to the "CIRIAF program
   for UNESCO" in the framework of the UNESCO Chair "Water Resources
   Management and Culture", for supporting her research.
CR Afram A, 2014, BUILD ENVIRON, V72, P343, DOI 10.1016/j.buildenv.2013.11.016
   Allirand JM, 1995, BIOMASS BIOENERG, V9, P441, DOI 10.1016/0961-9534(95)00042-9
   [Anonymous], 1999, 13005 ENV
   [Anonymous], 1991, 8302 ISO
   [Anonymous], 1994, 8990 ISO
   [Anonymous], 1998, 105342 ISO
   [Anonymous], 2009, C42309A ASTM INT
   Ascione F, 2015, ENERG BUILDINGS, V88, P78, DOI 10.1016/j.enbuild.2014.11.058
   Asdrubali F, 2016, BUILD ENVIRON, V95, P145, DOI 10.1016/j.buildenv.2015.09.003
   Asdrubali F, 2012, BUILD ACOUST, V19, P283, DOI 10.1260/1351-010X.19.4.283
   Asdrubali F, 2011, ENERG BUILDINGS, V43, P1618, DOI 10.1016/j.enbuild.2011.03.005
   Asdrubali F., 2008, P AC 08 PAR FRANC 29
   Asdrubali F, 2015, P 22 INT C SOUND VIB
   Asdrubali F., 2010, P ASME ATI UIT C THE
   Asdrubali F, 2015, SUSTAIN MATER TECHNO, V4, P1, DOI 10.1016/j.susmat.2015.05.002
   Azkorra Z, 2015, APPL ACOUST, V89, P46, DOI 10.1016/j.apacoust.2014.09.010
   Baldinelli G, 2014, APPL ENERG, V136, P250, DOI 10.1016/j.apenergy.2014.09.021
   Barreneche C, 2016, RENEW ENERG, V85, P281, DOI 10.1016/j.renene.2015.06.054
   Bevilacqua P, 2015, BUILD ENVIRON, V92, P305, DOI 10.1016/j.buildenv.2015.04.026
   Cabeza LF, 2014, RENEW SUST ENERG REV, V29, P394, DOI 10.1016/j.rser.2013.08.037
   Castaldo V.L., 2015, URBAN CLIM, V14
   Chilekwa V., 2006, P EUR 2006 TAMP FINL
   Cox T. J., 2009, ACOUSTIC ABSORBERS D
   D'Alessandro F, 2015, BUILD ENVIRON, V94, P913, DOI 10.1016/j.buildenv.2015.06.004
   D'Oca S, 2014, ENERGY RES SOC SCI, V3, P131, DOI 10.1016/j.erss.2014.07.015
   European Committee for Standardization, 2001, 12664 EN
   Fouquet M, 2015, BUILD ENVIRON, V90, P51, DOI 10.1016/j.buildenv.2015.03.022
   HASLAM SM, 1972, J ECOL, V60, P585, DOI 10.2307/2258363
   Kobbing JF, 2013, MIRES PEAT, V13
   Lansdown R. V., 2015, IUCN RED LIST THREAT
   Miljan M., 2014, MIRES PEAT, V13, P1
   Oldham DJ, 2011, APPL ACOUST, V72, P350, DOI 10.1016/j.apacoust.2010.12.009
   Rincon L, 2015, EARTHEN ARCHITECTURE: PAST, PRESENT AND FUTURE, P311
   Rosso F, 2014, SUSTAINABILITY-BASEL, V6, P5439, DOI 10.3390/su6085439
   Salata F, 2015, ENERG BUILDINGS, V99, P32, DOI 10.1016/j.enbuild.2015.04.010
   Secchi S, 2016, J BUILD ENG, V5, P1, DOI 10.1016/j.jobe.2015.10.005
   Synnefa A, 2007, ENERG BUILDINGS, V39, P1167, DOI [10.1016/j.enbuild.2007.01.004, 10.1016/j.enbuild.2006.01.004]
   Torgal FP, 2011, ECO-EFFICIENT CONSTRUCTION AND BUILDING MATERIALS, P1
   Trematerra A., 2013, J SUSTAINABLE ARCHIT, V3, P33, DOI DOI 10.5755/J01.SACE.3.4A708
   Venegas R, 2011, J ACOUST SOC AM, V130, P2765, DOI 10.1121/1.3644915
   Woodside W., 1957, ASTM217 SPEC PUB, P32
   Xu XQ, 2014, ENERG BUILDINGS, V68, P312, DOI 10.1016/j.enbuild.2013.09.017
   Yuan SZ, 2002, AM SOC TEST MATER, V1426, P221, DOI 10.1520/STP11015S
NR 43
TC 14
Z9 14
U1 3
U2 21
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-1323
EI 1873-684X
J9 BUILD ENVIRON
JI Build. Environ.
PD JUN
PY 2016
VL 102
BP 217
EP 229
DI 10.1016/j.buildenv.2016.03.022
PG 13
WC Construction & Building Technology; Engineering, Environmental;
   Engineering, Civil
SC Construction & Building Technology; Engineering
GA DL2XK
UT WOS:000375498300018
DA 2018-10-19
ER

PT J
AU Girerd, D
   Parratte, S
   Lunebourg, A
   Boureau, F
   Ollivier, M
   Pasquier, G
   Putman, S
   Migaud, H
   Argenson, JN
AF Girerd, D.
   Parratte, S.
   Lunebourg, A.
   Boureau, F.
   Ollivier, M.
   Pasquier, G.
   Putman, S.
   Migaud, H.
   Argenson, J. N.
TI Total knee arthroplasty revision with trabecular tantalum cones:
   Preliminary retrospective study of 51 patients from two centres with a
   minimal 2-year follow-up
SO ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH
LA English
DT Article
DE Revision; Total knee arthroplasty; Knee; Trabecular metal cones;
   Tantalum; Bone defect
ID TIBIAL BONE LOSS; STRUCTURAL ALLOGRAFT; METAPHYSEAL CONES; REPLACEMENT;
   BIOMATERIAL; VALIDATION; OUTCOMES; DEFECTS; STEMS; TKA
AB Background: Successful management of large bone defects is of crucial importance when performing revision total knee arthroplasty (TKA). Trabecular tantalum cones may improve prosthesis fixation via their potential for reconstructing a stable metaphyseal support. The objective of this study was to evaluate the clinical and radiological outcomes and the complications of tantalum cones in revision TKA.
   Hypothesis: Trabecular tantalum cones provide stable and durable metaphyseal reconstruction when used during revision TKA.
   Material and methods: Trabecular Metal (TM) cones (Zimmer, Warsaw, IN, USA) were used for 52 revision TKAs in 51 patients (mean age, 68 +/- 9 years) managed in two centres between 2008 and 2013. A rotating hinge prosthesis was chosen for 38 (73%) knees and a condylar constrained knee prosthesis for 14 (27%) knees, with 37 tibial and 34 femoral cones. The two most common reasons for revision surgery were aseptic loosening (n= 22, 42%) and infection (n=19, 37%). The bone loss was severe in most cases. At each centre, after a mean follow-up of 34 months (range, 24-52 months), two independent observers assessed the Knee Society Score (KSS), range of motion, mechanical axis, and osteo-integration for each patient.
   Results: Mean KSS increased from 46 preoperatively to 77 (P=0.001) at last follow-up and the mean KSS function from 39 to 57 (P=0.007). Mean range of motion improved from 93 degrees (45 degrees-120 degrees) to 110 (65 degrees-130 degrees) (P= 0.001). Mean postoperative mechanical axis was 180 degrees (172 degrees-190 degrees). Radiographic evaluation showed evidence of osteo-integration for all cones. Four revisions were performed for recurrence of infection but none for mechanical failure.
   Discussion: The findings of our study confirm the biomechanical and biological reliability of Trabecular Metal (TM) cones used to fill metaphyseal bone defects during revision TKA. Level of evidence: IV, retrospective therapeutic study. (C) 2016 Elsevier Masson SAS. All rights reserved.
C1 [Girerd, D.; Parratte, S.; Lunebourg, A.; Ollivier, M.; Argenson, J. N.] Univ Aix Marseille, Serv Chirurg Orthoped & Traumatol, Inst Mouvement & Appareil Locomoteur, Hop St Marguerite,CNRS,AMU,UMR 787, 270 Blvd St Marguerite, F-13009 Marseille, France.
   [Boureau, F.; Pasquier, G.; Putman, S.; Migaud, H.] Ctr Hosp Reg Univ, Serv Chirurg Orthoped & Traumatol, Ave Oscar Lambret, F-59037 Lille, France.
   [Boureau, F.; Pasquier, G.; Putman, S.; Migaud, H.] Univ Lille, Rue Paul Duez, F-59000 Lille, France.
RP Parratte, S (reprint author), Univ Aix Marseille, Serv Chirurg Orthoped & Traumatol, Inst Mouvement & Appareil Locomoteur, Hop St Marguerite,CNRS,AMU,UMR 787, 270 Blvd St Marguerite, F-13009 Marseille, France.
EM sebastien@parratte.fr
CR Bauman RD, 2009, CLIN ORTHOP RELAT R, V467, P818, DOI 10.1007/s11999-008-0679-4
   Beckmann NA, 2015, J ARTHROPLASTY, V30, P249, DOI 10.1016/j.arth.2014.09.016
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Boureau F, 2015, ORTHOP TRAUMATOL-SUR, V101, P251, DOI 10.1016/j.otsr.2014.11.020
   Dalury DF, 2013, J ARTHROPLASTY, V28, P120, DOI 10.1016/j.arth.2013.04.051
   Derome P, 2014, J ARTHROPLASTY, V29, P122, DOI 10.1016/j.arth.2013.04.033
   Engh GA, 1998, ORTHOP CLIN N AM, V29, P205, DOI 10.1016/S0030-5898(05)70319-9
   Engh GA, 2007, J BONE JOINT SURG AM, V89A, P2640, DOI 10.2106/JBJS.F00865
   Greidanus NV, 2011, J ARTHROPLASTY, V26, P615, DOI 10.1016/j.arth.2010.04.026
   Howard JL, 2011, J BONE JOINT SURG AM, V93A, P478, DOI 10.2106/JBJS.l.01322
   Huten D, 2013, ORTHOP TRAUMATOL-SUR, V99, pS22, DOI 10.1016/j.otsr.2012.11.009
   INSALL JN, 1989, CLIN ORTHOP RELAT R, P13
   Iorio R, 2008, J BONE JOINT SURG AM, V90A, P1598, DOI 10.2106/JBJS.H.00067
   Kamath AF, 2015, J BONE JOINT SURG AM, V97A, P216, DOI 10.2106/JBJS.N.00540
   Lachiewicz PF, 2012, CLIN ORTHOP RELAT R, V470, P199, DOI 10.1007/s11999-011-1888-9
   Long WJ, 2009, J ARTHROPLASTY, V24, P1086, DOI 10.1016/j.arth.2008.08.011
   Mabry TM, 2007, J ARTHROPLASTY, V22, P56, DOI 10.1016/j.arth.2007.02.008
   Meneghini RM, 2008, J BONE JOINT SURG AM, V90A, P78, DOI 10.2106/JBJS.F.01495
   Ornetti P, 2008, OSTEOARTHR CARTILAGE, V16, P423, DOI 10.1016/j.joca.2007.08.007
   Parratte S, 2007, VANCOMYCIN BONE CEME
   Rao BM, 2013, BONE JOINT J, V95B, P1069, DOI 10.1302/0301-620X.95B8.29194
   Schmitz HCR, 2013, J ARTHROPLASTY, V28, P1556, DOI 10.1016/j.arth.2013.01.028
   Shen C, 2014, J ARTHROPLASTY, V29, P127, DOI [10.1016/j.arth.2013.09.048, 10.1016/j.arth.2013.04.042]
   Singh JA, 2014, RHEUMATOLOGY, V53, P313, DOI 10.1093/rheumatology/ket325
   van Kempen RWTM, 2013, CLIN ORTHOP RELAT R, V471, P2296, DOI 10.1007/s11999-013-2940-8
   Villanueva-Martinez M, 2013, J ARTHROPLASTY, V28, P988, DOI 10.1016/j.arth.2012.09.003
   Vince KG, 2005, ORTHOPEDICS, V28, P999
   Whaley AL, 2003, J ARTHROPLASTY, V18, P592, DOI 10.1016/S0883-5403(03)00200-6
   Wood GC, 2009, CLIN ORTHOP RELAT R, V467, P810, DOI 10.1007/s11999-008-0621-9
NR 30
TC 8
Z9 8
U1 0
U2 2
PU ELSEVIER MASSON
PI MILANO
PA VIA PALEOCAPA 7, 20121 MILANO, ITALY
SN 1877-0568
J9 ORTHOP TRAUMATOL-SUR
JI Orthop. Traumatol.-Surg. Res.
PD JUN
PY 2016
VL 102
IS 4
BP 429
EP 433
DI 10.1016/j.otsr.2016.02.010
PG 5
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA DL4IQ
UT WOS:000375598100003
PM 27052939
OA Bronze
DA 2018-10-19
ER

PT J
AU Wong, ML
   Wong, JL
   Vapniarsky, N
   Griffiths, LG
AF Wong, Maelene L.
   Wong, Janelle L.
   Vapniarsky, Natalia
   Griffiths, Leigh G.
TI In vivo xenogeneic scaffold fate is determined by residual antigenicity
   and extracellular matrix preservation
SO BIOMATERIALS
LA English
DT Article
DE Antigen removal; Decellularization; Xenogeneic scaffold; Extracellular
   matrix; Vascular regenerative medicine; Immune response
ID PORCINE AORTIC-VALVE; SODIUM DODECYL-SULFATE; BOVINE PERICARDIUM;
   CELLULAR REPOPULATION; IMMUNE-RESPONSE; TISSUE; GLUTARALDEHYDE;
   CALCIFICATION; COLLAGEN; REMOVAL
AB The immunological potential of animal-derived tissues and organs is the critical hurdle to increasing their clinical implementation. Glutaraldehyde-fixation cross-links proteins in xenogeneic tissues (e.g., bovine pericardium) to delay immune rejection, but also compromises the regenerative potential of the resultant biomaterial. Unfixed xenogeneic biomaterials in which xenoantigenicity has been ameliorated and native extracellular matrix (ECM) architecture has been maintained have the potential to overcome limitations of current clinically utilized glutaraldehyde-fixed biomaterials. The objective of this work was to determine how residual antigenicity and ECM architecture preservation modulate recipient immune and regenerative responses towards unfixed bovine pericardium (BP) ECM scaffolds. Disruption of ECM architecture during scaffold generation, with either SDS-decellularization or glutaraldehyde-fixation, stimulated recipient foreign body response and resultant fibrotic encapsulation following leporine subpannicular implantation. Conversely, BP scaffolds subjected to stepwise removal of hydrophilic and lipophilic antigens using amidosulfobetaine-14 (ASB-14) maintained native ECM architecture and thereby avoided fibrotic encapsulation. Removal of hydrophilic and lipophilic antigens significantly decreased local and systemic graft-specific, adaptive immune responses and subsequent calcification of BP scaffolds compared to scaffolds undergoing hydrophile removal only. Critically, removal of antigenic components and preservation of ECM architecture with ASB-14 promoted full-thickness recipient non immune cellular repopulation of the BP scaffold. Further, unlike clinically utilized fixed BP, ASB-14-treated scaffolds fostered rapid intimal and medial vessel wall regeneration in a porcine carotid patch angioplasty model. This work highlights the importance of residual antigenicity and ECM architecture preservation in modulating recipient immune and regenerative responses towards xenogeneic biomaterial generation. (C) 2016 Published by Elsevier Ltd.
C1 [Wong, Maelene L.; Wong, Janelle L.; Griffiths, Leigh G.] Univ Calif Davis, Dept Vet Med & Epidemiol, One Shields Ave, Davis, CA 95616 USA.
   [Wong, Maelene L.; Vapniarsky, Natalia] Univ Calif Davis, Dept Biomed Engn, One Shields Ave, Davis, CA 95616 USA.
RP Griffiths, LG (reprint author), Univ Calif Davis, Dept Vet Med & Epidemiol, One Shields Ave, Davis, CA 95616 USA.
EM lggriffiths@ucdavis.edu
FU American Heart Association [11SDG4980023]; NIH [R01HL115205]
FX We thank James Cravotta and Dr. Boaz Arzi for rabbit surgery assistance;
   Dr. Kevin Grayson for pig surgery assistance; Dr. Clare E. Yellowley for
   facility access; Ms. Becky Horn for her polarized light microscopy
   assistance; and Ms. Alycia Cook for technical immunohistochemistry
   assistance. Funding support was received from the American Heart
   Association (11SDG4980023, LGG) and NIH (R01HL115205, LGG).
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Badylak SF, 2014, ANN BIOMED ENG, V42, P1517, DOI 10.1007/s10439-013-0963-7
   Bayrak A, 2010, BIOMATERIALS, V31, P3793, DOI 10.1016/j.biomaterials.2010.01.120
   Brown B. V., 2009, MANUAL CENTRAL AM DI, V1, P1
   Cascalho M, 2001, IMMUNITY, V14, P437, DOI 10.1016/S1074-7613(01)00124-8
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Dohmen PM, 2009, ANN THORAC CARDIOVAS, V15, P362
   Galili U, 2001, BIOCHIMIE, V83, P557, DOI 10.1016/S0300-9084(01)01294-9
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   Goncalves AC, 2005, J HEART VALVE DIS, V14, P212
   Gratzer PF, 2006, TISSUE ENG, V12, P2975, DOI 10.1089/ten.2006.12.2975
   Harrison RD, 2005, J BIOMED MATER RES A, V75A, P841, DOI 10.1002/jbm.a.30486
   HENRIQUEZ M, 1994, MACROMOLECULES, V27, P6834, DOI 10.1021/ma00101a023
   Ho KJ, 2012, J VASC SURG, V55, P708, DOI 10.1016/j.jvs.2011.10.007
   Hulsmann J, 2012, XENOTRANSPLANTATION, V19, P286, DOI 10.1111/j.1399-3089.2012.00719.x
   Human P, 2001, ANN THORAC SURG, V71, pS385, DOI 10.1016/S0003-4975(01)02492-4
   JANEWAY C, 2001, IMMUNOBIOLOGY
   Junge K, 2012, LANGENBECK ARCH SURG, V397, P255, DOI 10.1007/s00423-011-0780-0
   Kasimir MT, 2005, THROMB HAEMOSTASIS, V94, P562, DOI 10.1160/TH05-01-0025
   Kim KM, 1999, AM J PATHOL, V154, P843, DOI 10.1016/S0002-9440(10)65331-X
   Kim MS, 2015, EUR J CARDIO-THORAC, V48, P392, DOI 10.1093/ejcts/ezu501
   Krejci J., 2007, International Journal of Cosmetic Science, V29, P121, DOI 10.1111/j.1467-2494.2007.00368.x
   LEVY RJ, 1983, AM J PATHOL, V113, P143
   LEVY RJ, 1986, AM J PATHOL, V122, P71
   Li X, 2011, ANN VASC SURG, V25, P561, DOI 10.1016/j.avsg.2010.11.007
   Manji RA, 2006, CIRCULATION, V114, P318, DOI 10.1161/CIRCULATIONAHA.105.549311
   McMorrow IM, 1997, TRANSPLANTATION, V64, P501, DOI 10.1097/00007890-199708150-00021
   Nam Jinhae, 2012, Korean J Thorac Cardiovasc Surg, V45, P380, DOI 10.5090/kjtcs.2012.45.6.380
   Orenstein SB, 2012, J SURG RES, V176, P423, DOI 10.1016/j.jss.2011.09.031
   Park S, 2009, J KOREAN MED SCI, V24, P1126, DOI 10.3346/jkms.2009.24.6.1126
   Reing JE, 2010, BIOMATERIALS, V31, P8626, DOI 10.1016/j.biomaterials.2010.07.083
   Rodriguez KJ, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-29
   Samouillan V, 1999, J BIOMED MATER RES, V46, P531, DOI 10.1002/(SICI)1097-4636(19990915)46:4<531::AID-JBM11>3.0.CO;2-2
   Samouillan V, 2003, J BIOMED MATER RES A, V64A, P330, DOI 10.1002/jbm.a.10326
   Shinoka T, 1995, ANN THORAC SURG, V60, pS513, DOI 10.1016/0003-4975(95)00733-4
   Swartzlander MD, 2015, BIOMATERIALS, V41, P79, DOI 10.1016/j.biomaterials.2014.11.020
   TRIGLIA D, 1991, IN VITRO CELL DEV B, V27, P239
   Wong ML, 2013, ACTA BIOMATER, V9, P6492, DOI 10.1016/j.actbio.2012.12.034
   Wong ML, 2011, BIOMATERIALS, V32, P8129, DOI 10.1016/j.biomaterials.2011.07.030
   Wright GA, 2009, COMPARATIVE MED, V59, P266
   Xu H, 2009, TISSUE ENG PT A, V15, P1807, DOI 10.1089/ten.tea.2008.0384
   Yang YG, 2007, NAT REV IMMUNOL, V7, P519, DOI 10.1038/nri2099
NR 43
TC 14
Z9 15
U1 4
U2 41
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2016
VL 92
BP 1
EP 12
DI 10.1016/j.biomaterials.2016.03.024
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DL1BF
UT WOS:000375366200001
PM 27031928
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Pan, HT
   Zheng, QX
   Guo, XD
   Wu, YC
   Wu, B
AF Pan, Haitao
   Zheng, Qixin
   Guo, Xiaodong
   Wu, Yongchao
   Wu, Bin
TI Polydopamine-assisted BMP-2-derived peptides immobilization on
   biomimetic copolymer scaffold for enhanced bone induction in vitro and
   in vivo
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Polydopamine; BMP-2; Bone induction; Scaffold; Ectopic bone formation
ID STEM-CELLS; MORPHOGENETIC PROTEIN-2; ALKALINE-PHOSPHATASE; COMPOSITE
   SCAFFOLDS; HYDROXYAPATITE; REGENERATION; COATINGS; TITANIUM;
   OSTEOGENESIS; CONJUGATION
AB In this study, a polydopamine (pDA)-coated PLGA-[Asp-PEG]n scaffold was developed for sustained delivery of bone morphogenetic protein-2 (BMP-2)-derived peptide (designated as P24), and then used to address the hypothesis that P24 peptides delivered from the scaffolds could enhance bone induction in vitro and in vivo. We found pDA coating as compared with physical adsorption could more efficiently mediate the grafting of peptides onto polymer surfaces, and the release of P24 peptides from PLGA-[Asp-PEG]n-pDA-P24 was sustained for about 21 days, while a burst P24 release was observed in initial 4h and almost all peptides were released within 24 h in physisorbed PLGA-[Asp-PEG]n-P24 group. In vitro, significantly greater ALP activity and mRNA expressions of osteo-specific markers of rat-derived mesenchymal stem cells (rMSCs) were observed in the sustained delivery system than those in physisorbed PLGA-[Asp-PEG]n-P24 and unmodified PLGA-[Asp-PEG]n groups. In vivo, ectopic bone formation studies showed that the sustained delivery system could induce bone formation to a much greater extent than physisorbed PLGA-[Asp-PEG]n-P24. Meanwhile, there were no evidences of bone formation in non P24-loaded PLGA-[Asp-PEG]n. It is concluded that PLGA-[Asp-PEG]n-pDA-P24 biomaterial can delivery bioactive P24 peptides in a sustained manner, which can more efficiently promote osteogenic differentiation of rMSCs in vitro and induce ectopic bone formation in vivo, as compared with PLGA-[Asp-PEG]n-P24 delivering P24 in a burst manner. This pDA-coated PLGA-[Asp-PEG]n-pDA-P24 composite promises to be an excellent biomaterial for inducing bone regeneration. Moreover, pDA-mediated catechol functionalization can be an effective, simple technique for developing sustained delivery systems. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Pan, Haitao; Zheng, Qixin; Guo, Xiaodong; Wu, Yongchao; Wu, Bin] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthopaed, 1277 Jiefang Dadao, Wuhan 430022, Peoples R China.
RP Wu, B (reprint author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthopaed, 1277 Jiefang Dadao, Wuhan 430022, Peoples R China.
EM bin_wu@hust.edu.cn
FU National Natural Science Foundation of China [81000520, 81471271,
   30900292]
FX This research was supported by the National Natural Science Foundation
   of China (81000520, 81471271, 30900292).
CR Barradas AMC, 2011, EUR CELLS MATER, V21, P407, DOI 10.22203/eCM.v021a31
   Baylan N, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/4/045011
   Biazar E, 2015, ARTIF CELL NANOMED B, V43, P112, DOI 10.3109/21691401.2013.848874
   Cai YL, 2014, COLLOID SURFACE B, V116, P681, DOI 10.1016/j.colsurfb.2013.11.004
   Chien CY, 2013, ACS APPL MATER INTER, V5, P6975, DOI 10.1021/am401071f
   Duan ZX, 2007, J HUAZHONG UNIV SCI, V27, P179, DOI 10.1007/s11596-007-0219-6
   Duan ZX, 2008, J HUAZHONG U SCI-MED, V28, P426, DOI 10.1007/s11596-008-0411-3
   Fujisawa R, 1996, BBA-PROTEIN STRUCT M, V1292, P53, DOI 10.1016/0167-4838(95)00190-5
   Guo X., 2007, KEY ENG MATER, V334, P1261
   He XZ, 2012, LANGMUIR, V28, P5387, DOI 10.1021/la205005h
   Ho MH, 2006, MACROMOL BIOSCI, V6, P90, DOI 10.1002/mabi.200500130
   Jeon O, 2007, BIOMATERIALS, V28, P2763, DOI 10.1016/j.biomaterials.2007.02.023
   Kim J, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014107
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   King WJ, 2012, ADV DRUG DELIVER REV, V64, P1239, DOI 10.1016/j.addr.2012.03.004
   Ko E, 2013, BIOMACROMOLECULES, V14, P3202, DOI 10.1021/bm4008343
   Kopecki Z, 2011, J PATHOL, V225, P401, DOI 10.1002/path.2973
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222
   Lee YB, 2012, BIOMATERIALS, V33, P8343, DOI 10.1016/j.biomaterials.2012.08.011
   Lin ZY, 2010, J CONTROL RELEASE, V144, P190, DOI 10.1016/j.jconrel.2010.02.016
   Ma JL, 2014, STEM CELL TRANSL MED, V3, P98, DOI 10.5966/sctm.2013-0126
   Mesfin A, 2013, J BONE JOINT SURG AM, V95A, P1546, DOI 10.2106/JBJS.L.01730
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   Moore NM, 2011, ACTA BIOMATER, V7, P2091, DOI 10.1016/j.actbio.2011.01.019
   Nandi SK, 2010, INDIAN J MED RES, V132, P15
   Nijhuis AWG, 2013, TISSUE ENG PART C-ME, V19, P610, DOI [10.1089/ten.tec.2012.0313, 10.1089/ten.TEC.2012.0313]
   Nijhuis AG, 2014, J BIOMED MATER RES A, V102, P1102, DOI 10.1002/jbm.a.34776
   Pan HT, 2007, J PEPT SCI, V13, P154, DOI 10.1002/psc.826
   Pan HT, 2014, J BIOMED MATER RES A, V102, P2864, DOI 10.1002/jbm.a.34961
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Seo JP, 2014, VET RES COMMUN, V38, P73, DOI 10.1007/s11259-013-9587-5
   Sonnaert M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136875
   Srinivasan S, 2013, J BIOMED NANOTECHNOL, V9, P1803, DOI 10.1166/jbn.2013.1658
   Wu B, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044111
   Xie J., 2015, ACTA BIOMATER
   Yang K, 2012, BIOMATERIALS, V33, P6952, DOI 10.1016/j.biomaterials.2012.06.067
   Zhang WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102371
   Zhang X., 2013, J TISSUE ENG REGEN M
   Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047
NR 40
TC 12
Z9 13
U1 4
U2 111
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JUN 1
PY 2016
VL 142
BP 1
EP 9
DI 10.1016/j.colsurfb.2016.01.060
PG 9
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA DK8IE
UT WOS:000375169600001
PM 26924362
DA 2018-10-19
ER

PT J
AU Singh, R
   Kumar, M
   Bishnoi, NR
AF Singh, Rajesh
   Kumar, Mukesh
   Bishnoi, Narsi R.
TI Development of biomaterial for chromium(VI) detoxification using
   Aspergillus flavus system supported with iron
SO ECOLOGICAL ENGINEERING
LA English
DT Article
DE Aspergillus flavus; Biomaterial; Biotransformation; Hexavalent chromium;
   Biosorption
ID HEXAVALENT CHROMIUM; HEAVY-METALS; CHROMATE REDUCTION; FERROUS IRON;
   BIOSORPTION; REMOVAL; BACTERIA; BIOMASS; GROWTH; NIGER
AB This study was aimed to develop the growing Aspergillus flavus biomaterial for Cr(VI) transformation and removal from simulated wastewater. Fe2+ ions have significant implication as it enhanced both chromium removal as well as sticky nature of the biomaterial. The values of Delta, i.e. the differences between the frequencies v(as) and v(s) of carboxyl group 146.59, 139.27, 152.38 by Fe(II), Cr(VI) and mix metalsions (Fe(II) + Cr(VI)) inferred the carboxylate ions bidentate coordination. The highest value in case of mix metals ions (Fe(II) + Cr(VI)) inferred that carboxylate groups have coordinated to surface Fe3+ ions increasingly with greatest bridging character. Heat flow value 31.36 Jg(-1) and 51.02 Jg(-1) in Fe2+ and Cr(VI) amended material respectively indicated that extremely little amount of the free water content was sorbed. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Singh, Rajesh] Cent Univ Gujarat, Sch Environm & Sustainable Dev, Gandhinagar 382030, Gujarat, India.
   [Singh, Rajesh; Kumar, Mukesh; Bishnoi, Narsi R.] Guru Jambheshwar Univ Sci & Technol, Dept Environm Sci & Engn, Hisar 125001, Haryana, India.
RP Singh, R (reprint author), Cent Univ Gujarat, Sch Environm & Sustainable Dev, Gandhinagar 382030, Gujarat, India.
EM rajeshsnain@gmail.com
FU Council of Scientific and Industrial Research (CSIR), New Delhi
FX One of the authors Singh R. is grateful to Council of Scientific and
   Industrial Research (CSIR), New Delhi for awarding Senior Research
   Fellowship.
CR Ahluwalia SS, 2007, BIORESOURCE TECHNOL, V98, P2243, DOI 10.1016/j.biortech.2005.12.006
   Aksu Z, 2007, J HAZARD MATER, V145, P210, DOI 10.1016/j.jhazmat.2006.11.011
   [American Water Works Association(AWWA) Water Environment Federation (WEF) APHA (American Public Health Association)], 2005, STAND METH FORTH EX
   [Anonymous], 2001, PALEONTOLOGICAL STAT
   Babu BV, 2008, ADSORPTION, V14, P85, DOI 10.1007/s10450-007-9057-x
   Bai R.S., 2001, BIORESOURCE TECHNOL, V79, P73, DOI DOI 10.1016/S0960-8524(00)00107-3
   Bakradze Nugzar G, 2003, ScientificWorldJournal, V3, P432
   Contreras EM, 2011, WATER RES, V45, P3034, DOI 10.1016/j.watres.2011.03.011
   Couri S, 2003, BRAZ J MICROBIOL, V34, P16, DOI 10.1590/S1517-83822003000100005
   Donmez G, 2001, WATER RES, V35, P1425, DOI 10.1016/S0043-1354(00)00394-8
   Dossing LN, 2011, CHEM GEOL, V285, P157, DOI 10.1016/j.chemgeo.2011.04.005
   EARY LE, 1988, ENVIRON SCI TECHNOL, V22, P972, DOI 10.1021/es00173a018
   Elangovan R, 2009, BIOCHEM ENG J, V44, P174, DOI 10.1016/j.bej.2008.11.014
   Everitt B S, 1992, APPL MULTIVARIATE DA
   Gikas P, 2009, GLOBAL NEST J, V11, P325
   Hansel CM, 2003, GEOCHIM COSMOCHIM AC, V67, P401, DOI 10.1016/S0016-7037(02)01081-5
   Kapoor A, 1998, BIORESOURCE TECHNOL, V63, P109, DOI 10.1016/S0960-8524(97)00118-1
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mouedhen G, 2009, J HAZARD MATER, V168, P983, DOI 10.1016/j.jhazmat.2009.02.117
   Puzon GJ, 2005, ENVIRON SCI TECHNOL, V39, P2811, DOI 10.1021/es048967g
   Ribe V, 2012, WASTE MANAGE, V32, P1886, DOI 10.1016/j.wasman.2012.05.011
   Samuel J, 2012, IND ENG CHEM RES, V51, P3740, DOI 10.1021/ie201796s
   Sedlak DL, 1997, GEOCHIM COSMOCHIM AC, V61, P2185, DOI 10.1016/S0016-7037(97)00077-X
   Singh R, 2015, ECOL ENG, V75, P103, DOI 10.1016/j.ecoleng.2014.11.023
   Singh R, 2013, BIORESOURCE TECHNOL, V127, P49, DOI 10.1016/j.biortech.2012.09.056
   Tigini V, 2011, APPL MICROBIOL BIOT, V90, P343, DOI 10.1007/s00253-010-3010-8
   Trunfio G, 2010, IND ENG CHEM RES, V49, P12217, DOI 10.1021/ie101042a
   Viamajala S, 2008, BIOTECHNOL BIOENG, V101, P1150, DOI 10.1002/bit.22020
   Vijayaraghavan K, 2008, BIOTECHNOL ADV, V26, P266, DOI 10.1016/j.biotechadv.2008.02.002
   Wielinga B, 2001, ENVIRON SCI TECHNOL, V35, P522, DOI 10.1021/es001457b
   Xu L, 2011, J HAZARD MATER, V185, P1169, DOI 10.1016/j.jhazmat.2010.10.028
NR 31
TC 8
Z9 8
U1 1
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-8574
EI 1872-6992
J9 ECOL ENG
JI Ecol. Eng.
PD JUN
PY 2016
VL 91
BP 31
EP 40
DI 10.1016/j.ecoleng.2016.01.060
PG 10
WC Ecology; Engineering, Environmental; Environmental Sciences
SC Environmental Sciences & Ecology; Engineering
GA DK2TE
UT WOS:000374766500005
DA 2018-10-19
ER

PT J
AU Kumar, A
   Nune, KC
   Misra, RDK
AF Kumar, A.
   Nune, K. C.
   Misra, R. D. K.
TI Biological functionality of extracellular matrix-ornamented
   three-dimensional printed hydroxyapatite scaffolds
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE additive manufacturing; 3D printing; tissue engineering; ECM;
   cytocompatibility
ID MARROW STROMAL CELLS; TISSUE; ADHESION; ANGIOGENESIS; REGENERATION;
   REGULATOR; GROWTH; ORGANS; FATE
AB Three-dimensional (3D) printing is considered an ideally suitable method to fabricate patient specific implantable devices. The approach enabled to produce a porous scaffold with tailored physical, mechanical, and biological properties because of the flexibility to tune the scaffold architecture. The objective of the study described was to elucidate the determining role of cell-laid extracellular matrix (ECM) in impacting biological response. In this regard, to mimic the natural ECM environment or the attributes of the native tissue, a natural ECM analogue surface was produced on the 3D printed and sintered hydroxyapatite (HA) scaffold surface by the mineralized ECM of the osteoblast. This involved the growth of osteoblast on 3D printed scaffolds, followed by differentiation to deposit the mineralized ECM on the biomaterial surface. The cells were removed from the mineralized matrix using freeze-thaw cycles to obtain a decellularized extracellular matrix (dECM) on the biomaterial surface. Subsequently, seeding of osteoblast on dECM-ornamented HA scaffolds led to 3D growth with enhanced expression of prominent proteins, actin and vinculin. Based on preliminary observations of present study, it was underscored that HA scaffolds-ornamented with dECM provided an optimized microenvironment conducive to the growth of 3D structural tissue and favorably promoted biological functionality because of the availability of an environment that promoted cell-cell and cell-scaffold interaction. The primary advantage of dECM is that it enabled constructive remodeling and promoted the formation of tissue in lieu of less functional tissue. The study opens-up a new path for printing of 3D structures suitable to treat segmental bone defects. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 1343-1351, 2016.
C1 [Kumar, A.; Nune, K. C.; Misra, R. D. K.] Univ Texas El Paso, Dept Met Mat & Biomed Engn, 500 W Univ Ave, El Paso, TX 79968 USA.
RP Misra, RDK (reprint author), Univ Texas El Paso, Dept Met Mat & Biomed Engn, 500 W Univ Ave, El Paso, TX 79968 USA.
EM dmisra2@utep.edu
CR Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200
   Carisey A, 2011, EUR J CELL BIOL, V90, P157, DOI 10.1016/j.ejcb.2010.06.007
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   Craighead HG, 2001, CURR OPIN SOLID ST M, V5, P177, DOI 10.1016/S1359-0286(01)00005-5
   DeMali KA, 2004, TRENDS BIOCHEM SCI, V29, P565, DOI 10.1016/j.tibs.2004.09.001
   Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359
   Flynn LE, 2010, BIOMATERIALS, V31, P4715, DOI 10.1016/j.biomaterials.2010.02.046
   FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Klammert U, 2010, J CRANIO MAXILL SURG, V38, P565, DOI 10.1016/j.jcms.2010.01.009
   Kumar A, 2013, MICROSTRUCTURE DEV B
   Kumar A, 2016, J BIOMATER APPL, V30, P1168, DOI 10.1177/0885328215617058
   Kumar A, 2015, J BIOMED MATER RES A, V103, P791, DOI 10.1002/jbm.a.35198
   Kumar A, 2013, J BIOMED MATER RES A, V101, P2925, DOI 10.1002/jbm.a.34603
   Kumar A, 2013, ACTA MATER, V61, P5198, DOI 10.1016/j.actamat.2013.05.013
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Lodish H., 2000, MOL CELL BIOL, P154
   Maazouz Y, 2014, J MATER CHEM B, V2, P5378, DOI 10.1039/c4tb00438h
   Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038
   Murugan R, 2005, COMPOS SCI TECHNOL, V65, P2385, DOI 10.1016/j.compscitech.2005.07.022
   OSBORN JF, 1980, BIOMATERIALS, V1, P108, DOI 10.1016/0142-9612(80)90009-5
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   Pati F, 2015, BIOMATERIALS, V37, P230, DOI 10.1016/j.biomaterials.2014.10.012
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Pham QP, 2008, BIOMATERIALS, V29, P2729, DOI 10.1016/j.biomaterials.2008.02.025
   Pinney E, 2000, J CELL PHYSIOL, V183, P74, DOI 10.1002/(SICI)1097-4652(200004)183:1<74::AID-JCP9>3.0.CO;2-G
   Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k
   Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026
   RUOSLAHTI E, 1984, CANCER METAST REV, V3, P43, DOI 10.1007/BF00047692
   Seitz H, 2005, J BIOMED MATER RES B, V74B, P782, DOI 10.1002/jbm.b.30291
   Sellaro TL, 2010, TISSUE ENG PT A, V16, P1075, DOI [10.1089/ten.tea.2008.0587, 10.1089/ten.TEA.2008.0587]
   URIST MARSHALL R., 1967, CLIN ORTHOP RELATED RESIN COMPLICATIONS OF ORTHOPAEDIC SURGERY, V53, P243
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Wu YC, 2006, BIOMATERIALS, V27, P896, DOI 10.1016/j.biomaterials.2005.07.002
   Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/nmat3101, 10.1038/NMAT3101]
   Yarlagadda PKDV, 2005, BIO-MED MATER ENG, V15, P159
NR 45
TC 14
Z9 14
U1 0
U2 61
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN
PY 2016
VL 104
IS 6
BP 1343
EP 1351
DI 10.1002/jbm.a.35664
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DK7PC
UT WOS:000375117200003
PM 26799466
DA 2018-10-19
ER

PT J
AU Samorezov, JE
   Headley, EB
   Everett, CR
   Alsberg, E
AF Samorezov, Julia E.
   Headley, Emma B.
   Everett, Christopher R.
   Alsberg, Eben
TI Sustained presentation of BMP-2 enhances osteogenic differentiation of
   human adipose-derived stem cells in gelatin hydrogels
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bone tissue engineering; drug delivery; growth factor; gelatin
   methacrylate; biomaterials
ID BONE MORPHOGENETIC PROTEIN-2; GROWTH-FACTOR DELIVERY; UMBILICAL-CORD
   BLOOD; STROMAL CELLS; CONTROLLED-RELEASE; TISSUE; MARROW; MICROSPHERES;
   FATE; MICROPARTICLES
AB Human adipose-derived stem cells (hASCs) show great potential for healing bone defects. Bone morphogenetic protein-2 (BMP-2) has been reported to stimulate their osteogenic differentiation both in vitro and in vivo. Here, methacrylated gelatin (GelMA) hydrogels were evaluated as a system to deliver BMP-2 to encapsulated hASCs from two different donors, and BMP-2 delivered from the hydrogels was compared to BMP-2 presented exogenously in culture media. GelMA hydrogels were shown to provide sustained, localized presentation of BMP-2 due to electrostatic interactions between the growth factor and biomaterial after an initial burst release. Both donors exhibited similar responses to the loaded and exogenous growth factor; BMP-2 from the hydrogels had a statistically significant effect on hASC osteogenic differentiation compared to exogenous BMP-2. Expression of alkaline phosphatase was accelerated, and cells in hydrogels with loaded BMP-2 deposited more calcium at one, two, and four weeks than cells without BMP-2 or with the growth factor presented in the media. There were no statistically significant differences in calcium content between groups with 25, 50, or 100 mu g/mL loaded BMP-2, suggesting that using a lower growth factor dose may be as effective as a higher loading amount in this system. Taken together, these findings suggest that controlled delivery of BMP-2 from the GelMA enhances its osteogenic bioactivity compared to free growth factor presented in the media. Thus, the GelMA system is a promising biomaterial for BMP-2-mediated hASC osteogenesis. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 1387-1397, 2016.
C1 [Samorezov, Julia E.; Headley, Emma B.; Everett, Christopher R.; Alsberg, Eben] Case Western Reserve Univ, Dept Biomed Engn, 10900 Euclid Ave, Cleveland, OH 44106 USA.
   [Alsberg, Eben] Case Western Reserve Univ, Dept Orthopaed Surg, 10900 Euclid Ave, Cleveland, OH 44106 USA.
   [Alsberg, Eben] Case Western Reserve Univ, Natl Ctr Regenerat Med, Div Gen Med Sci, 10900 Euclid Ave, Cleveland, OH 44106 USA.
RP Alsberg, E (reprint author), Case Western Reserve Univ, Dept Biomed Engn, 10900 Euclid Ave, Cleveland, OH 44106 USA.; Alsberg, E (reprint author), Case Western Reserve Univ, Dept Orthopaed Surg, 10900 Euclid Ave, Cleveland, OH 44106 USA.; Alsberg, E (reprint author), Case Western Reserve Univ, Natl Ctr Regenerat Med, Div Gen Med Sci, 10900 Euclid Ave, Cleveland, OH 44106 USA.
EM eben.alsberg@case.edu
OI Alsberg, Eben/0000-0002-3487-4625
FU National Defense Science and Engineering Graduate Fellowship; National
   Science Foundation Graduate Fellowship [R01AR066193, R01AR063194]
FX Contract grant sponsor: National Defense Science and Engineering
   Graduate Fellowship and National Science Foundation Graduate Fellowship
   ( to JES); contract grant numbers: R01AR066193 and R01AR063194 ( to EA)
CR Barnes GL, 1999, J BONE MINER RES, V14, P1805, DOI 10.1359/jbmr.1999.14.11.1805
   Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x
   Benton JA, 2009, TISSUE ENG PT A, V15, P3221, DOI [10.1089/ten.tea.2008.0545, 10.1089/ten.TEA.2008.0545]
   Bieback K, 2007, BIOMEDICAL MAT ENG S, V18, pS71
   BOWENPOPE DF, 1984, BLOOD, V64, P458
   Bramono DS, 2012, BONE, V50, P954, DOI 10.1016/j.bone.2011.12.013
   Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006
   Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131
   Chatterjee K, 2010, BIOMATERIALS, V31, P5051, DOI 10.1016/j.biomaterials.2010.03.024
   Chen YC, 2012, ADV FUNCT MATER, V22, P2027, DOI 10.1002/adfm.201101662
   Dang PN, ACS BIOMATERIALS SCI
   Dubois SG, 2008, ISOLATION HUMAN ADIP, P69
   EDELMAN ER, 1993, P NATL ACAD SCI USA, V90, P1513, DOI 10.1073/pnas.90.4.1513
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Hou QP, 2008, J PHARM SCI-US, V97, P3972, DOI 10.1002/jps.21310
   Hu XH, 2009, MACROMOL BIOSCI, V9, P1194, DOI 10.1002/mabi.200900275
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Hutton DL, 2013, TISSUE ENG PT A, V19, P2076, DOI [10.1089/ten.tea.2012.0752, 10.1089/ten.TEA.2012.0752]
   Hwang CM, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/035003
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Jeon O, 2015, ADV MATER, V27, P2216, DOI 10.1002/adma.201405337
   Jeon O, 2011, J CONTROL RELEASE, V154, P258, DOI 10.1016/j.jconrel.2011.06.027
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Kim J, 2009, TISSUE ENG PART C-ME, V15, P583, DOI [10.1089/ten.tec.2008.0642, 10.1089/ten.TEC.2008.0642]
   Knippenberg M, 2006, BIOCHEM BIOPH RES CO, V342, P902, DOI 10.1016/j.bbrc.2006.02.052
   Kyllonen L, 2013, GROWTH FACTORS, V31, P141, DOI 10.3109/08977194.2013.817404
   Levi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011177
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   Nguyen MK, 2014, PROG POLYM SCI, V39, P1235, DOI 10.1016/j.progpolymsci.2013.12.001
   MOSSNER E, 1980, H-S Z PHYSIOL CHEM, V361, P543, DOI 10.1515/bchm2.1980.361.1.543
   Nguyen AH, 2015, ACTA BIOMATER, V13, P101, DOI 10.1016/j.actbio.2014.11.028
   Overman JR, 2013, TISSUE ENG PT A, V19, P571, DOI [10.1089/ten.tea.2012.0133, 10.1089/ten.TEA.2012.0133]
   Ovsianikov A, 2011, BIOMACROMOLECULES, V12, P851, DOI 10.1021/bm1015305
   Panetta NJ, 2010, PLAST RECONSTR SURG, V125, P483, DOI 10.1097/PRS.0b013e3181c82d75
   Patel ZS, 2008, ACTA BIOMATER, V4, P1126, DOI 10.1016/j.actbio.2008.04.002
   Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x
   Raisz LG, 1999, CLIN CHEM, V45, P1885
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Solorio LD, 2012, STEM CELL TRANSL MED, V1, P632, DOI 10.5966/sctm.2012-0039
   Solorio L, 2010, J TISSUE ENG REGEN M, V4, P514, DOI 10.1002/term.267
   Sutter M, 2007, J CONTROL RELEASE, V119, P301, DOI 10.1016/j.jconrel.2007.03.003
   Tayalia P, 2009, ADV MATER, V21, P3269, DOI 10.1002/adma.200900241
   Tirkkonen L, 2013, EUR CELLS MATER, V25, P144, DOI 10.22203/eCM.v025a10
   Van den Bulcke AI, 2000, BIOMACROMOLECULES, V1, P31, DOI 10.1021/bm990017d
   Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546
   Yamachika E, 2009, J BIOMED MATER RES A, V88A, P599, DOI 10.1002/jbm.a.31833
   Yamamoto M, 2001, J BIOMAT SCI-POLYM E, V12, P77, DOI 10.1163/156856201744461
   YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005
   Zanetti AS, 2013, J BIOMED MATER RES B, V101B, P187, DOI 10.1002/jbm.b.32817
   Zhu M, 2009, J TISSUE ENG REGEN M, V3, P290, DOI 10.1002/term.165
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
   Zuk P, 2011, CONNECT TISSUE RES, V52, P119, DOI 10.3109/03008207.2010.484515
NR 53
TC 6
Z9 6
U1 4
U2 30
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN
PY 2016
VL 104
IS 6
BP 1387
EP 1397
DI 10.1002/jbm.a.35668
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DK7PC
UT WOS:000375117200007
PM 26822338
DA 2018-10-19
ER

PT J
AU Mirsalehi, SA
   Sattari, M
   Khavandi, A
   Mirdamadi, S
   Naimi-Jamal, MR
AF Mirsalehi, Seyed A.
   Sattari, Mohammadali
   Khavandi, Alireza
   Mirdamadi, Shamsodin
   Naimi-Jamal, Mohammad R.
TI Tensile and biocompatibility properties of synthesized
   nano-hydroxyapatite reinforced ultrahigh molecular weight polyethylene
   nanocomposite
SO JOURNAL OF COMPOSITE MATERIALS
LA English
DT Article
DE Biocompatibility; biomaterials; mechanical properties; ultrahigh
   molecular weight polyethylene; nanocomposites
ID BETA-TRICALCIUM PHOSPHATE; HIGH-DENSITY POLYETHYLENE; IN-VITRO;
   BIOMEDICAL APPLICATIONS; EXTRACELLULAR CALCIUM; MECHANICAL-PROPERTIES;
   SLIDING WEAR; COMPOSITES; BONE; PROLIFERATION
AB Ultrahigh molecular weight polyethylene-based nanocomposites reinforced with nano-sized hydroxyapatite particles were fabricated using internal mixer and compression molding with different weight percent of the nano-hydroxyapatite. In this study, first, hydroxyapatite nanoparticles were synthesized by sol-gel. Then, the mechanical and biological properties of nanocomposites were studied by tensile test and proliferation and cell adhesion assays using MG-63 osteoblast cells, respectively. Results of the tensile test showed that incorporation of 50 wt% nano-hydroxyapatite led to a 345.64% and 57.58% increase in Young's modulus and yield strength (compared to the pure ultrahigh molecular weight polyethylene), respectively. The effect of the nano-hydroxyapatite powders on the MG-63 osteoblast cells behavior was compared to those of a composite (positive control) and a negative control samples. Scanning electron microscopy micrographs revealed that cell-biomaterial interaction was carried out on the surface of the nanocomposites with normal phenotypic shape. Results of MTT assay exhibited that all samples are biocompatible.
C1 [Mirsalehi, Seyed A.; Sattari, Mohammadali; Khavandi, Alireza] Iran Univ Sci & Technol, Sch Materials Sci & Engn, Composite Lab, Tehran 1684613114, Iran.
   [Mirdamadi, Shamsodin] Iran Univ Sci & Technol, CEHSAT, Sch Materials Engn, Tehran 1684613114, Iran.
   [Naimi-Jamal, Mohammad R.] Iran Univ Sci & Technol, Dept Chem, Res Lab Green Organ Synth & Polymers, Tehran 1684613114, Iran.
RP Khavandi, A (reprint author), Iran Univ Sci & Technol, Sch Materials Sci & Engn, Composite Lab, Tehran 1684613114, Iran.
EM khavandi@iust.ac.ir
RI Khavandi, Alireza/S-3732-2018; khavandi, alireza/S-6562-2018
OI Naimi-Jamal, Mohammad Reza/0000-0002-8305-7234
CR Abadi MBH, 2010, POLYM COMPOSITE, V31, P1745, DOI 10.1002/pc.20965
   Akhilesh K., 2011, NANOBIOMATERIALS HDB
   Anderson BC, 2002, BIOMATERIALS, V23, P1761, DOI 10.1016/S0142-9612(01)00301-5
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   Brandt J, 2010, J MATER SCI-MATER M, V21, P283, DOI 10.1007/s10856-009-3859-1
   Brown PW, 1994, HYDROXYAPATITE RELAT
   COOPER JR, 1993, WEAR, V162, P378, DOI 10.1016/0043-1648(93)90521-M
   Deville S, 2007, ACTA MATER, V55, P1965, DOI 10.1016/j.actamat.2006.11.003
   Dutt RT, 2003, J BIOMED MATER RES A, V67, P1228
   Ehara A, 2003, BIOMATERIALS, V24, P831, DOI 10.1016/S0142-9612(02)00411-8
   Ergun C, 2007, J BIOMED MATER RES A, V80A, P990, DOI 10.1002/jbm.a.30923
   Fang L, 2003, PROCESSING HA UHMWPE
   Fang LM, 2006, BIOMATERIALS, V27, P3701, DOI 10.1016/j.biomaterials.2006.02.023
   Fang LM, 2005, BIOMATERIALS, V26, P3471, DOI 10.1016/j.biomaterials.2004.09.022
   Gergely G, 2010, CENT EUR J CHEM, V8, P375, DOI 10.2478/s11532-010-0004-4
   Gul RM, 2004, POLYM ENG SCI, V44, P1848, DOI 10.1002/pen.20186
   Hashimoto M, 2003, KEY ENG MAT, V240-2, P415, DOI 10.4028/www.scientific.net/KEM.240-242.415
   Hashmi SAR, 2001, WEAR, V247, P9, DOI 10.1016/S0043-1648(00)00513-5
   Homaeigohar SSH, 2005, J BIOMED MATER RES A, V75A, P14, DOI 10.1002/jbm.a.30333
   Ji BH, 2004, J MECH PHYS SOLIDS, V52, P1963, DOI 10.1016/j.jmps.2004.03.006
   Kalantari SM, 2015, J MECH BEHAV BIOMED, V48, P183, DOI 10.1016/j.jmbbm.2015.04.015
   KANATANI M, 1991, BIOCHEM BIOPH RES CO, V181, P1425, DOI 10.1016/0006-291X(91)92098-5
   KNETS IV, 1993, MECH COMPOS MATER, V29, P181, DOI 10.1007/BF00696450
   Krzypow DJ, 2000, BIOMATERIALS, V21, P2081, DOI 10.1016/S0142-9612(00)00138-1
   Lawrence E. N., 1994, MECH PROPERTIES POLY
   Li W, 2014, POLYMER, V55, P1792, DOI 10.1016/j.polymer.2014.02.023
   LOZA J, 1995, BONE, V16, pS341
   Mirsalehi SA, 2015, J APPL POLYM SCI, V132
   Mirsalehi SA, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.42052
   Monchau F, 2002, BIOMOL ENG, V19, P143, DOI 10.1016/S1389-0344(02)00023-0
   Pan YS, 2010, J MATER ENG PERFORM, V19, P1037, DOI 10.1007/s11665-009-9569-5
   Perepechko I, 1981, INTRO POLYM PHYS
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Rigo ECS, 2004, MAT SCI ENG C-BIO S, V24, P647, DOI 10.1016/j.msec.2004.08.044
   Roy S, 2002, B MATER SCI, V25, P609, DOI 10.1007/BF02707893
   Ruan SL, 2003, POLYMER, V44, P5643, DOI 10.1016/S0032-3861(03)00628-1
   Sattari M, 2014, POLYM TEST, V38, P26, DOI 10.1016/j.polymertesting.2014.06.006
   Supova M, 2009, J MATER SCI-MATER M, V20, P1201, DOI 10.1007/s10856-009-3696-2
   Suzuki T, 2000, J BIOSCI BIOENG, V89, P18, DOI 10.1016/S1389-1723(00)88045-7
   Tong J, 2003, WEAR, V255, P734, DOI 10.1016/S0043-1648(03)00221-7
   Tourani H, 2013, POLYM COMPOSITE, V34, P1961, DOI 10.1002/pc.22603
   Wang M, 2001, BIOMATERIALS, V22, P1311, DOI 10.1016/S0142-9612(00)00283-0
   Wang M, 1998, BIOMATERIALS, V19, P2357, DOI 10.1016/S0142-9612(98)00154-9
   Wang M, 1998, J BIOMED MATER RES, V42, P577, DOI 10.1002/(SICI)1097-4636(19981215)42:4<577::AID-JBM14>3.0.CO;2-2
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Xie XL, 2003, BIOMATERIALS, V24, P1889, DOI 10.1016/S0142-9612(02)00610-5
   Yoshimura M, 1998, J MATER RES, V13, P796, DOI 10.1557/JMR.1998.0101
   Zhou JS, 2005, J APPL POLYM SCI, V96, P2336, DOI 10.1002/app.21534
NR 49
TC 3
Z9 3
U1 1
U2 17
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0021-9983
EI 1530-793X
J9 J COMPOS MATER
JI J. Compos Mater.
PD JUN
PY 2016
VL 50
IS 13
BP 1725
EP 1737
DI 10.1177/0021998315595711
PG 13
WC Materials Science, Composites
SC Materials Science
GA DK6BP
UT WOS:000375006200003
DA 2018-10-19
ER

PT J
AU Bociaga, D
   Jakubowski, W
   Komorowski, P
   Sobczyk-Guzenda, A
   Jedrzejczak, A
   Batory, D
   Olejnik, A
AF Bociaga, Dorota
   Jakubowski, Witold
   Komorowski, Piotr
   Sobczyk-Guzenda, Anna
   Jedrzejczak, Anna
   Batory, Damian
   Olejnik, Anna
TI Surface characterization and biological evaluation of
   silver-incorporated DLC coatings fabricated by hybrid RF PACVD/MS method
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Ag-DLC coatings; Antibacterial properties; Cell viability; Biomaterial;
   Biomedical applications
ID DIAMOND-LIKE CARBON; A-C-H; AMORPHOUS-CARBON; ESCHERICHIA-COLI;
   BACTERIAL ADHESION; IN-VITRO; ANTIBACTERIAL PROPERTIES; BIOMEDICAL
   APPLICATIONS; ANTIBIOTIC-RESISTANCE; MECHANICAL-PROPERTIES
AB Since the biological response of the body towards an implanted material is mainly governed by its surface properties, biomaterials are improved by various kinds of coatings. Their role is to provide good mechanical and biological characteristics, and exclude some disadvantages like post-implantation infections. This phenomenon may be reduced by introduction of silver as an antibacterial agent. This study evaluates the Ag-DLC films synthesized by the hybrid RF PACVD/MS method according to the patent number PL401955-A1 worked out inter alia by the authors. Such tests as XPS, SEM, EDS, AFM, FTIR, Raman and ICP-TOF-MS were used to determine surface properties of the coatings. The obtained results were correlated with the biological response estimated on the basis of cells viability assay (osteoblast cells line Saos-2) and bacterial colonization test (Escherichia coli strain DH5 alpha). Results showed that the hybrid RF PACVD/MS method allows one to get tight coating preventing the diffusion of harmful elements from the metallic substrate. Ag concentration increases with the growing power density, it occurs in metallic state, does not create chemical bonds and is evenly dispersed within the DLC matrix in the form of nanoscale silver clusters. Increasing silver content above 2 at.% improves bactericidal properties, but decreases cell viability (C) 2016 Elsevier B.V. All rights reserved.
C1 [Bociaga, Dorota; Jedrzejczak, Anna; Batory, Damian; Olejnik, Anna] Lodz Univ Technol, Inst Mat Sci & Engn, Div Biomed Engn & Funct Mat, 1-15 Stefanowskiego St, PL-90924 Lodz, Poland.
   [Jakubowski, Witold; Komorowski, Piotr] Lodz Univ Technol, Inst Mat Sci & Engn, Div Biophys, 1-15 Stefanowskiego St, PL-90924 Lodz, Poland.
   [Sobczyk-Guzenda, Anna] Lodz Univ Technol, Inst Mat Sci & Engn, Div Coatings Engn & Nonmetall Mat, 1-15 Stefanowskiego St, PL-90924 Lodz, Poland.
   [Komorowski, Piotr] BioNanoPk Labs Lodz Reg Pk Sci & Technol, 114-116 Dubois St, PL-93465 Lodz, Poland.
RP Bociaga, D (reprint author), Lodz Univ Technol, Inst Mat Sci & Engn, Div Biomed Engn & Funct Mat, 1-15 Stefanowskiego St, PL-90924 Lodz, Poland.
EM dorota.bociagal@gmail.com
RI Jakubowski, Witold/S-1137-2018; Sobczyk-Guzenda, Anna/T-2089-2018
OI Jakubowski, Witold/0000-0003-1751-609X; Sobczyk-Guzenda,
   Anna/0000-0003-1583-4238
FU National Centre for Research and Development
   [ERA-NET/MNT/CARSILA/1/2010]
FX This work was supported by the National Centre for Research and
   Development under grant no. ERA-NET/MNT/CARSILA/1/2010.
CR Allen M, 2001, J BIOMED MATER RES, V58, P319, DOI 10.1002/1097-4636(2001)58:3<319::AID-JBM1024>3.0.CO;2-F
   Almaguer-Flore A., 2011, IMPLANT DENT MOST PR, P263
   Baba K, 2013, VACUUM, V89, P179, DOI 10.1016/j.vacuum.2012.04.015
   Baba K, 2012, ADV MATER SCI ENG, DOI 10.1155/2012/536853
   Batory D, 2008, J MATER SCI, V43, P3385, DOI 10.1007/s10853-007-2393-0
   Batory D., 2014, PL401955A1
   Batory D, 2013, APPL SURF SCI, V275, P303, DOI 10.1016/j.apsusc.2012.12.088
   Bendavid A, 2007, DIAM RELAT MATER, V16, P1616, DOI 10.1016/j.diamond.2007.02.006
   Bociaga D, 2008, DIAM RELAT MATER, V17, P1410, DOI 10.1016/j.diamond.2008.02.014
   Bociaga D, 2015, APPL SURF SCI, V355, P388, DOI 10.1016/j.apsusc.2015.07.117
   Bociaga D, 2010, J NANOSCI NANOTECHNO, V10, P1191, DOI 10.1166/jnn.2010.1850
   Bruinink A, 2005, BIOMATERIALS, V26, P3487, DOI 10.1016/j.biomaterials.2004.09.030
   Bryers JD, 2008, BIOTECHNOL BIOENG, V100, P1, DOI 10.1002/bit.21838
   Camargo SS, 1998, DIAM RELAT MATER, V7, P1155, DOI 10.1016/S0925-9635(98)00165-4
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Casiraghi C, 2005, DIAM RELAT MATER, V14, P1098, DOI 10.1016/j.diamond.2004.10.030
   Casiraghi C., 2005, PHYS REV B, V72
   Chai F, 2008, ACTA BIOMATER, V4, P1369, DOI 10.1016/j.actbio.2008.04.011
   Chan YH, 2011, SURF COAT TECH, V206, P1037, DOI 10.1016/j.surfcoat.2011.07.034
   Charitidis CA, 2010, INT J REFRACT MET H, V28, P51, DOI 10.1016/j.ijrmhm.2009.08.003
   Chekan NM, 2009, DIAM RELAT MATER, V18, P1006, DOI 10.1016/j.diamond.2009.02.024
   Choi HW, 2008, DIAM RELAT MATER, V17, P252, DOI 10.1016/j.diamond.2007.12.034
   Choi HW, 2007, THIN SOLID FILMS, V516, P248, DOI 10.1016/j.tsf.2007.06.154
   Cousen PJ, 2012, CONTACT DERMATITIS, V66, P55, DOI 10.1111/j.1600-0536.2011.01970.x
   Cui JF, 2012, APPL SURF SCI, V258, P5025, DOI 10.1016/j.apsusc.2012.01.072
   Dearnaley G, 2005, SURF COAT TECH, V200, P2518, DOI 10.1016/j.surfcoat.2005.07.077
   Dhandapani VS, 2014, SURF COAT TECH, V240, P128, DOI 10.1016/j.surfcoat.2013.12.025
   Endrino JL, 2008, SURF COAT TECH, V202, P3675, DOI 10.1016/j.surfcoat.2008.01.011
   Endrino JL, 2010, IOP CONF SER-MAT SCI, V12, DOI 10.1088/1757-899X/12/1/012012
   Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095
   Francz G, 1999, SURF INTERFACE ANAL, V28, P3, DOI 10.1002/(SICI)1096-9918(199908)28:1<3::AID-SIA609>3.0.CO;2-U
   Ghosh T, 2015, FRONT LIFE SCI, V8, P47, DOI 10.1080/21553769.2014.952048
   Grabarczyk J., 2007, J ACHIEV MAT MANUF E, V1-2, P107
   Grill A, 1999, DIAM RELAT MATER, V8, P428, DOI 10.1016/S0925-9635(98)00262-3
   Hallab N, 2001, J BONE JOINT SURG AM, V83A, P428, DOI 10.2106/00004623-200103000-00017
   Hauert R, 2013, SURF COAT TECH, V233, P119, DOI 10.1016/j.surfcoat.2013.04.015
   Hauert R, 2003, DIAM RELAT MATER, V12, P583, DOI 10.1016/S0925-9635(03)00081-5
   Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011
   Hollinger MA, 1996, CRIT REV TOXICOL, V26, P255, DOI 10.3109/10408449609012524
   Ivask A, 2014, ACS NANO, V8, P374, DOI 10.1021/nn4044047
   Jakubowski W, 2008, ADV APPL CERAM, V107, P217, DOI 10.1179/174367608X263395
   Jakubowski W, 2004, DIAM RELAT MATER, V13, P1761, DOI 10.1016/j.diamond.2004.03.003
   Kierek-Pearscon K, 2005, ADV APPL MICROBIOL, V57, P79, DOI 10.1016/S0065-2164(05)57003-5
   Kwok SCH, 2007, DIAM RELAT MATER, V16, P1353, DOI 10.1016/j.diamond.2006.11.001
   Lackner J.M., 2010, MONATSH, V155, P528
   Lambert J. B., 1987, INTRO ORGANIC SPECTR
   Lan WC, 2013, CERAM INT, V39, P4099, DOI 10.1016/j.ceramint.2012.10.264
   Lara HH, 2010, WORLD J MICROB BIOT, V26, P615, DOI 10.1007/s11274-009-0211-3
   Lee W, 2014, BIOMETALS, V27, P1191, DOI 10.1007/s10534-014-9782-z
   Lee YH, 2014, BIOMATERIALS, V35, P4706, DOI 10.1016/j.biomaterials.2014.02.021
   Linder S, 2002, BIOMATERIALS, V23, P767, DOI 10.1016/S0142-9612(01)00182-X
   Love CA, 2013, TRIBOL INT, V63, P141, DOI 10.1016/j.triboint.2012.09.006
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   Manninen NK, 2013, SURF COAT TECH, V232, P440, DOI 10.1016/j.surfcoat.2013.05.048
   Manninen NK, 2015, SURF COAT TECH, V267, P90, DOI 10.1016/j.surfcoat.2014.12.029
   Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y
   Marciano FR, 2011, VACUUM, V85, P662, DOI 10.1016/j.vacuum.2010.07.017
   Marciano FR, 2009, DIAM RELAT MATER, V18, P1010, DOI 10.1016/j.diamond.2009.02.014
   Martinez-Gutierrez F, 2012, NANOMED-NANOTECHNOL, V8, P328, DOI 10.1016/j.nano.2011.06.014
   Mohanty M, 2002, BIOMOL ENG, V19, P125, DOI 10.1016/S1389-0344(02)00026-6
   Mohanty S, 2012, NANOMED-NANOTECHNOL, V8, P916, DOI 10.1016/j.nano.2011.11.007
   Morshed MM, 2003, J MATER PROCESS TECH, V143, P922, DOI 10.1016/j.jmatprotec.2003.10.003
   Morzyk-Ociepa B, 2003, SPECTROCHIM ACTA A, V59, P1247, DOI 10.1016/S1386-1425(02)00306-2
   Okazaki Y, 2004, BIOMATERIALS, V25, P5913, DOI 10.1016/j.biomaterials.2004.01.064
   Okpalugo TIT, 2004, BIOMATERIALS, V25, P239, DOI 10.1016/S0142-9612(03)00494-0
   Oktar FN, 2015, CURR TOP MED CHEM, V15, P1583
   Rai MK, 2012, J APPL MICROBIOL, V112, P841, DOI 10.1111/j.1365-2672.2012.05253.x
   Rams TE, 2014, CLIN ORAL IMPLAN RES, V25, P82, DOI 10.1111/clr.12160
   Ren DW, 2013, SURF COAT TECH, V226, P1, DOI 10.1016/j.surfcoat.2013.03.025
   Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0
   Saito T, 2005, DIAM RELAT MATER, V14, P1116, DOI 10.1016/j.diamond.2004.09.017
   Schembri MA, 2003, MOL MICROBIOL, V48, P253, DOI 10.1046/j.1365-2958.2003.03432.x
   Shanna R, 2008, THIN SOLID FILMS, V516, P5397, DOI 10.1016/j.tsf.2007.07.099
   Sheng XX, 2008, J COLLOID INTERF SCI, V321, P256, DOI 10.1016/j.jcis.2008.02.038
   SILVERSTEIN RM, 1991, SPECTROMETRIC IDENTI
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Song F, 2015, J DENT RES, V94, P1027, DOI 10.1177/0022034515587690
   Swieczko-Zurek B., 2008, ADV MAT SCI, V8, P179
   Takeno T, 2013, DIAM RELAT MATER, V39, P20, DOI 10.1016/j.diamond.2013.07.004
   Voggenreiter G, 2003, BIOMATERIALS, V24, P247, DOI 10.1016/S0142-9612(02)00312-5
   Wang CB, 2009, APPL SURF SCI, V256, P1431, DOI 10.1016/j.apsusc.2009.08.103
   Wang QZ, 2013, ELECTROCHIM ACTA, V112, P603, DOI 10.1016/j.electacta.2013.09.022
   Wu YX, 2013, APPL SURF SCI, V284, P165, DOI 10.1016/j.apsusc.2013.07.074
   Yamane K, 2013, CLIN ORAL IMPLAN RES, V24, P1310, DOI 10.1111/j.1600-0501.2012.02574.x
   Zimmerli W, 2006, BEST PRACT RES CL RH, V20, P1045, DOI 10.1016/j.berh.2006.08.003
   Zou CW, 2013, APPL SURF SCI, V286, P137, DOI 10.1016/j.apsusc.2013.09.036
NR 86
TC 13
Z9 13
U1 4
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUN 1
PY 2016
VL 63
BP 462
EP 474
DI 10.1016/j.msec.2016.03.013
PG 13
WC Materials Science, Biomaterials
SC Materials Science
GA DK4UW
UT WOS:000374916800052
PM 27040240
DA 2018-10-19
ER

PT J
AU Pollini, M
   Paladini, F
   Sannino, A
   Maffezzoli, A
AF Pollini, Mauro
   Paladini, Federica
   Sannino, Alessandro
   Maffezzoli, Alfonso
TI Development of hybrid cotton/hydrogel yarns with improved absorption
   properties for biomedical applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Textile; Hydrogel; Durability; Absorption; Hyperhidrosis; Biomaterial
ID GLASS-IONOMER CEMENTS; FOCAL HYPERHIDROSIS; COTTON FABRICS; HYDROGEL;
   TRANSMISSION; DIAGNOSIS; BEHAVIOR
AB Hyperhidrosis, or excessive sweating, is an overlooked and potentially disabling symptom, which is often seen in social anxiety disorder. In this work an innovative advanced textile material was developed for application in the management of excessive sweating, preparing a drying yarn providing improved comfort Hybrid cotton/hydrogel yarns were obtained by combining cotton with superabsorbent hydrogels through an optimization study focused on the achievement of the most promising product in terms of absorption properties and resistance to washings. Swelling and washing tests were performed using different hydrogels, and the effect of an additional crosslinking on the materials was also evaluated by testing different solutions containing Al3+ and Ca2+ ions. Scanning electron microscopy and infrared spectroscopy analyses were adopted to characterize morphology and chemical structure of the hydrogels undergoing different production processes. The biocompatibility of the hybrid fabrics was demonstrated by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide colorimetric assay (MTT) through the extract method. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Pollini, Mauro; Paladini, Federica; Sannino, Alessandro; Maffezzoli, Alfonso] Univ Salento, Dept Engn Innovat, Via Monteroni, I-73100 Lecce, Italy.
RP Paladini, F (reprint author), Univ Salento, Dept Engn Innovat, Via Monteroni, I-73100 Lecce, Italy.
EM federica.paladini@unisalento.it
CR Bechara FG, 2007, J AM ACAD DERMATOL, V57, P207, DOI 10.1016/j.jaad.2007.01.035
   Bozaci E, 2015, CARBOHYD POLYM, V134, P128, DOI 10.1016/j.carbpol.2015.07.036
   Brook IM, 1998, BIOMATERIALS, V19, P565, DOI 10.1016/S0142-9612(98)00138-0
   Celino A, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2013.00043
   Cina CS, 1999, QUAL LIFE RES, V8, P693, DOI 10.1023/A:1008968401068
   Das B, 2008, FIBER POLYM, V9, P225, DOI 10.1007/s12221-008-0036-y
   Das S, 2012, INDIAN J FIBRE TEXT, V37, P151
   Davidson JRT, 2002, PROG NEURO-PSYCHOPH, V26, P1327, DOI 10.1016/S0278-5846(02)00297-X
   Eisenach JH, 2005, MAYO CLIN PROC, V80, P657, DOI 10.4065/80.5.657
   Garside P, 2003, STUD CONSERV, V48, P269, DOI 10.1179/sic.2003.48.4.269
   Ghali K, 2002, INT J HEAT MASS TRAN, V45, P3703, DOI 10.1016/S0017-9310(02)00088-1
   Haghi AK, 2004, J THERM ANAL CALORIM, V76, P1035, DOI 10.1023/B:JTAN.0000032288.16502.d2
   Haider A, 2005, CAN MED ASSOC J, V172, P69, DOI 10.1503/cmaj.1040708
   Hornberger J, 2004, J AM ACAD DERMATOL, V51, P274, DOI 10.1016/j.jaad.2003.12.029
   Hu J., 2011, J CONTROL RELEASE
   Ibrahim I.K., 2015, INT J MAT CHEM PHYS, V1, P99
   Kaufmann H, 2003, CLIN AUTON RES, V13, P96, DOI 10.1007/s10286-003-0082-x
   Khalil-Abad MS, 2010, J COLLOID INTERF SCI, V351, P293, DOI 10.1016/j.jcis.2010.07.049
   Kohler R, 2006, MACROMOL SYMP, V244, P89, DOI 10.1002/masy.200651208
   Leung AKC, 1999, INT J DERMATOL, V38, P561, DOI 10.1046/j.1365-4362.1999.00609.x
   Micelli F, 2001, J MATER SCI-MATER M, V12, P151, DOI 10.1023/A:1008974128215
   Mijnhout GS, 2006, NETH J MED, V64, P326
   Noel F, 2012, INT J DERMATOL, V51, P647, DOI 10.1111/j.1365-4632.2011.05307.x
   Onofrei E, 2011, J ENG FIBER FABR, V6, P10
   Paladini F, 2015, MAT SCI ENG C-MATER, V52, P1, DOI 10.1016/j.msec.2015.03.035
   Paladini F, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40326
   Paladini F, 2013, J MATER SCI-MATER M, V24, P2461, DOI 10.1007/s10856-013-4986-2
   Pena MA, 2007, SEMIN CUTAN MED SURG, V26, P29, DOI 10.1016/j.sder.2006.12.004
   Pollini M, 2013, J COAT TECHNOL RES, V10, P239, DOI 10.1007/s11998-012-9439-1
   Sannino A, 2003, J BIOMED MATER RES A, V67A, P1016, DOI 10.1002/jbm.a.10149
   Schieman C., 2010, EXPERT REV DERMATOL, V5, P31
   Staneva D, 2015, APPL SURF SCI, V345, P72, DOI 10.1016/j.apsusc.2015.03.141
   Vorkamp T, 2010, SURG-J R COLL SURG E, V8, P287, DOI 10.1016/j.surge.2010.06.002
   Wheaton MG, 2011, J PSYCHOPATHOL BEHAV, V33, P393, DOI 10.1007/s10862-010-9211-8
   Yuranova T, 2006, J MOL CATAL A-CHEM, V244, P160, DOI 10.1016/j.molcata.2005.08.059
   Zimehl R, 2000, COLLOID SURFACE A, V163, P55, DOI 10.1016/S0927-7757(99)00430-6
NR 36
TC 7
Z9 8
U1 1
U2 45
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUN 1
PY 2016
VL 63
BP 563
EP 569
DI 10.1016/j.msec.2016.03.027
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA DK4UW
UT WOS:000374916800063
PM 27040251
DA 2018-10-19
ER

PT J
AU Mendes, MWD
   Agreda, CG
   Bressiani, AHA
   Bressiani, JC
AF Mendes, Marcio W. D.
   Agreda, Carola G.
   Bressiani, Ana H. A.
   Bressiani, Jose C.
TI A new titanium based alloy Ti-27Nb-13Zr produced by powder metallurgy
   with biomimetic coating for use as a biomaterial
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Titanium alloy; Ti-Nb-Zr; powder metallurgy; Young's modulus; Apatite
   coating
ID SN-NB ALLOY; MECHANICAL-PROPERTIES; ELASTIC-MODULUS; IN-VITRO; TI;
   TI-13NB-13ZR; IMPLANTS; VIVO; MICROSTRUCTURE; BIOACTIVITY
AB Titanium alloys are widely used in biomedical applications due to their excellent properties such as high strength, good corrosion resistance and biocompatibility. Titanium alloys with alloying elements such as Nb and Zr are biocompatible and have Young's modulus close to that of human bone. To increase the bioactivity of titanium alloy surfaces is used chemical treatment with NaOH followed by immersion in simulated body fluid (SBF). The purpose of this study was to produce the alloy Ti-27Nb-13Zr with low Young's modulus by powder metallurgy using powders produced by the HDH process. The formation of biomimetic coatings on samples immersed in SBF for 3, 7,11 and 15 days was evaluated. Characterization of the coating was performed by diffuse reflectance infrared Fourier transform spectroscopy (DRIFTS) and scanning electron microscope. The microstructure and composition of the alloy were determined using SEM and XRD, while the mechanical properties were evaluated by determining the elastic modulus and the Vickers microhardness. The sintered alloys were composed of of and 13 phases, equiaxed grains and with density around 97.8% of its theoretical density. The Vickers microhardness and elasticity modulus of the alloy were determined and their values indicate that this alloy can be used as a biomaterial. Analysis of the coating revealed the presence of calcium phosphate layers on samples immersed for >3 days in the SBF solution. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Mendes, Marcio W. D.; Agreda, Carola G.; Bressiani, Ana H. A.; Bressiani, Jose C.] Energy & Nucl Res Inst, Mat Sci & Technol Ctr, Ave Lineu Prestes 2242, BR-05508000 Sao Paulo, SP, Brazil.
RP Mendes, MWD (reprint author), Energy & Nucl Res Inst, Mat Sci & Technol Ctr, Ave Lineu Prestes 2242, BR-05508000 Sao Paulo, SP, Brazil.
EM mwdmendes@ipen.com
RI Mendes, Marcio/D-8786-2013; Bressiani, Ana/I-1402-2012
FU Capes; CNPq [307954/2013-7]; FAPESP [2008/57860-3]
FX The authors acknowledge the financial support of Capes (scholarship
   granted to M.W.D. Mendes and C. G. Agreda), CNPq (grant no
   307954/2013-7) and FAPESP (grant no 2008/57860-3).
CR Abdel-Hady M, 2006, SCRIPTA MATER, V55, P477, DOI 10.1016/j.scriptamat.2006.04.022
   Afonso CRM, 2007, MAT SCI ENG C-BIO S, V27, P908, DOI 10.1016/j.msec.2006.11.001
   Agreda CG, 2013, ADV SCI TECH, V86, P28, DOI 10.4028/www.scientific.net/AST.86.28
   Ahmed T, 1996, J MATER SCI, V31, P4267, DOI 10.1007/BF00356449
   Assis C.M., 2005, MAT RES, V8, P207
   Barriobero-Vila P, 2015, J ALLOY COMPD, V626, P330, DOI 10.1016/j.jallcom.2014.11.176
   Bottino MC, 2009, J BIOMED MATER RES A, V88A, P689, DOI 10.1002/jbm.a.31912
   Candioto KCG, 2006, INT J REFRACT MET H, V24, P413, DOI 10.1016/j.ijrmhm.2005.06.001
   Chen R., 2015, MAT SCI ENG R, V87, P1
   Chen YK, 2007, SURF COAT TECH, V202, P494, DOI 10.1016/j.surfcoat.2007.06.015
   Feng B, 2002, BIOMATERIALS, V23, P173, DOI 10.1016/S0142-9612(01)00093-X
   Gabriel SB, 2011, INT J REFRACT MET H, V29, P134, DOI 10.1016/j.ijrmhm.2010.09.006
   Gabriel SB, 2010, MATER RES-IBERO-AM J, V13, P333, DOI 10.1590/S1516-14392010000300009
   He G, 2005, MAT SCI ENG C-BIO S, V25, P290, DOI 10.1016/j.msec.2005.03.001
   Hirschhorn Joel S., 1976, INTRO POWDER METALLU
   Izman S., 2012, TITANIUM ALLOYS ACHI
   Kamitakahara M., 2007, BIOMED MATER, V2, pR 17
   Kim HM, 1997, J MATER SCI-MATER M, V8, P341, DOI 10.1023/A:1018524731409
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Lee K, 2015, ARCH METALL MATER, V60, P1371, DOI 10.1515/amm-2015-0133
   Lutjering G., 2007, TITANIUM
   Majumdar P, 2008, MAT SCI ENG A-STRUCT, V489, P419, DOI 10.1016/j.msea.2007.12.029
   Medeiros W.S., 2008, ARTIF ORGANS, V32, P277
   Muller FA, 2008, DENT MATER, V24, P50, DOI 10.1016/j.dental.2007.02.005
   Ng HP, 2010, MAT SCI ENG A-STRUCT, V527, P7017, DOI 10.1016/j.msea.2010.07.055
   Nouri A, 2010, ACTA BIOMATER, V6, P1630, DOI 10.1016/j.actbio.2009.10.005
   Nouri A, 2008, MAT SCI ENG A-STRUCT, V485, P562, DOI 10.1016/j.msea.2007.10.010
   Rao X., 2011, INT J REFRACT MET H, V29, P27
   Rigo ECS, 2004, MAT SCI ENG C-BIO S, V24, P647, DOI 10.1016/j.msec.2004.08.044
   Simka W, 2013, RSC ADV, V3, P11195, DOI 10.1039/c3ra23256e
   Suryanarayana C, 2001, PROG MATER SCI, V46, P1, DOI 10.1016/S0079-6425(99)00010-9
   Upadhyaya GS, 2002, POWDER METALLURGY TE
   Zhao DP, 2013, J MECH BEHAV BIOMED, V28, P171, DOI 10.1016/j.jmbbm.2013.08.013
NR 35
TC 16
Z9 16
U1 2
U2 59
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUN 1
PY 2016
VL 63
BP 671
EP 677
DI 10.1016/j.msec.2016.03.052
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA DK4UW
UT WOS:000374916800076
PM 27040264
DA 2018-10-19
ER

PT J
AU Wang, JY
   Chen, FL
   Liu, LW
   Qi, CX
   Wang, BJ
   Yan, XJ
   Huang, CY
   Hou, W
   Zhang, MQ
   Chen, Y
   Du, YA
AF Wang, Jingyu
   Chen, Fengling
   Liu, Longwei
   Qi, Chunxiao
   Wang, Bingjie
   Yan, Xiaojun
   Huang, Chenyu
   Hou, Wei
   Zhang, Michael Q.
   Chen, Yang
   Du, Yanan
TI Engineering EMT using 3D micro-scaffold to promote hepatic functions for
   drug hepatotoxicity evaluation
SO BIOMATERIALS
LA English
DT Article
DE EMT; 3D micro-scaffold; Hepatic functions; HDACs; Drug hepatotoxicity
   evaluation
ID EPITHELIAL-MESENCHYMAL TRANSITION; PRIMARY HUMAN HEPATOCYTES;
   GENE-EXPRESSION PATTERNS; BETA-INDUCED APOPTOSIS; EMBRYONIC STEM-CELLS;
   HEPARG CELLS; IN-VITRO; TRANSCRIPTIONAL REGULATION; CANCER CELLS;
   E-CADHERIN
AB Accompanied by decreased hepatic functions, epithelial-mesenchymal transition (EMT) was observed in two dimensional (2D) cultured hepatocytes with elongated morphology, loss of polarity and weakened cell-cell interaction, while upgrading to 3D culture has been considered as significant improvement of its 2D counterpart for hepatocyte maintenance. Here we hypothesize that 3D culture enhances hepatic functions through regulating the EMT status. Biomaterial-engineered EMT was achieved by culturing HepaRG as 3D spheroids (SP-3D) or 3D stretched cells (ST-3D) in non-adherent and adherent micro scaffold respectively. In SP-3D, constrained EMT of HepaRG, a hepatic stem cell line, as represented by increased epithelial markers and decreased mesenchymal markers, was echoed by improved hepatic functions. To investigate the relationship between EMT status and hepatic functions, time-series RNASeq and gene network analysis were used for comparing different cell culture models, which identified histone deacetylases (HDACs) as key mediating factors. Protein analysis confirmed that high HDAC activity was correlated with high expression of Cadherin-1 (CDH1) and hepatic function genes, which were decreased upon HDAC inhibitor treatment in SP-3D, suggesting HDACs may play positive role in regulating EMT and hepatic functions. To illustrate the application of 3D micro-scaffold culture in drug safety evaluation, hepatotoxicity and metabolism assays of two hepatotoxins (i.e. N-acetyl-p-aminophenol and Doxorubicin) were performed and SP-3D showed more biomimetic toxicity response, indicating regulation of EMT as a vital consideration in designing 3D hepatocyte culture configuration. (c) 2016 Elsevier Ltd. All rights reserved.
C1 [Wang, Jingyu; Qi, Chunxiao; Yan, Xiaojun; Du, Yanan] Tsinghua Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Sch Med, Dept Biomed Engn, Beijing 100084, Peoples R China.
   [Chen, Fengling; Zhang, Michael Q.; Chen, Yang] Tsinghua Univ, Bioinformat Div, MOE, Key Lab Bioinformat, Beijing 100084, Peoples R China.
   [Chen, Fengling; Zhang, Michael Q.; Chen, Yang] Tsinghua Univ, TNLIST, Dept Automat, Ctr Synthet & Syst Biol, Beijing 100084, Peoples R China.
   [Liu, Longwei; Wang, Bingjie] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.
   [Huang, Chenyu] Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Med Ctr, Dept Plast Reconstruct & Aesthet Surg, Beijing 102218, Peoples R China.
   [Hou, Wei] Tianjin Second Peoples Hosp, Tianjin 300192, Peoples R China.
   [Hou, Wei] Tianjin Inst Hepatol, Tianjin 300192, Peoples R China.
   [Du, Yanan] China Orthoped Regenerat Med Grp CORMed, Hangzhou 310058, Zhejiang, Peoples R China.
RP Du, YA (reprint author), Tsinghua Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Sch Med, Dept Biomed Engn, Beijing 100084, Peoples R China.; Chen, Y (reprint author), Tsinghua Univ, Bioinformat Div, MOE, Key Lab Bioinformat, Beijing 100084, Peoples R China.; Chen, Y (reprint author), Tsinghua Univ, TNLIST, Dept Automat, Ctr Synthet & Syst Biol, Beijing 100084, Peoples R China.
EM yc@tsinghua.edu.cn; duyanan@tsinghua.edu.cn
RI Huang, Chenyu/I-4410-2018
OI Huang, Chenyu/0000-0001-9521-5650
FU Natural Science Foundation of China [51273106, 81201474, 91019016,
   31361163004, 31301044]; National Basic Research Program of China
   [2012CB316503]; Beijing Municipal Natural Science Foundation [157142090]
FX We greatly thank Prof. Sen Song from Tsinghua University and Tao Yu for
   the help in construction of plasmid containing ALB promoter-EGFP
   sequence. We are grateful to Xiaohui Liu and Xueying Wang for the help
   in LC/MS-LC detection. We thank Qinghai Dai and Bokai Song for the help
   in imaging experiments and all Du-lab members for general help. This
   work is financially supported by Natural Science Foundation of China
   (Grant No: 51273106, 81201474, 91019016, 31361163004, 31301044),
   National Basic Research Program of China (Grant No: 2012CB316503) and
   Beijing Municipal Natural Science Foundation (Grant No: 157142090).
CR ALTER HJ, 1966, BLOOD-J HEMATOL, V27, P297
   Andersson TB, 2012, EXPERT OPIN DRUG MET, V8, P909, DOI 10.1517/17425255.2012.685159
   Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850
   Aninat C, 2006, DRUG METAB DISPOS, V34, P75, DOI 10.1124/dmd.105.006759
   [Anonymous], 2008, J Prev Med Public Health, V41, P208
   [Anonymous], 2008, J PREV MED PUBLIC HL, V41, P209
   Bovolenta LA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-405
   Chang TT, 2014, BIOMATERIALS, V35, P2162, DOI 10.1016/j.biomaterials.2013.11.063
   Chang TT, 2009, TISSUE ENG PT A, V15, P559, DOI 10.1089/ten.tea.2007.0434
   CSARDI G, 2006, INT J COMPLEX SYST, V1695, P1695, DOI DOI 10.1080/01621459.1951.10500769
   De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321
   Downing TL, 2013, NAT MATER, V12, P1154, DOI [10.1038/nmat3777, 10.1038/NMAT3777]
   DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112
   Aguilar-Olivos NE, 2015, MINI-REV MED CHEM, V15, P1187, DOI 10.2174/1389557515666150709115702
   Elaut G, 2007, J PHARMACOL EXP THER, V321, P400, DOI 10.1124/jpet.106.116202
   Elkayam T, 2006, TISSUE ENG, V12, P1357, DOI 10.1089/ten.2006.12.1357
   FARDEL O, 1992, EUR J BIOCHEM, V205, P847, DOI 10.1111/j.1432-1033.1992.tb16849.x
   Flom P. L., 2004, CONNECTIONS, V26, P62
   Franco DL, 2010, J CELL SCI, V123, P3467, DOI 10.1242/jcs.068692
   Gerets HHJ, 2012, CELL BIOL TOXICOL, V28, P69, DOI 10.1007/s10565-011-9208-4
   Godoy P, 2009, HEPATOLOGY, V49, P2031, DOI 10.1002/hep.22880
   Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699
   Guillouzo A, 2007, CHEM-BIOL INTERACT, V168, P66, DOI 10.1016/j.cbi.2006.12.003
   Gunness P, 2013, TOXICOL SCI, V133, P67, DOI 10.1093/toxsci/kft021
   Hewitt NJ, 2007, DRUG METAB REV, V39, P159, DOI 10.1080/03602530601093489
   Hoekstra R, 2013, DRUG METAB DISPOS, V41, P562, DOI 10.1124/dmd.112.049098
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Jain N, 2013, P NATL ACAD SCI USA, V110, P11349, DOI 10.1073/pnas.1300801110
   Kaimori A, 2010, HEPATOLOGY, V52, P1033, DOI 10.1002/hep.23765
   Kawada M, 1998, IN VITRO CELL DEV-AN, V34, P109
   Leite SB, 2012, TOXICOL SCI, V130, P106, DOI 10.1093/toxsci/kfs232
   Li XK, 2014, LAB CHIP, V14, P471, DOI 10.1039/c3lc51103k
   Li YQ, 2014, P NATL ACAD SCI USA, V111, P13511, DOI 10.1073/pnas.1411295111
   Lin RZ, 2006, CELL TISSUE RES, V324, P411, DOI 10.1007/s00441-005-0148-2
   Liu W, 2014, LAB CHIP, V14, P2614, DOI 10.1039/c4lc00081a
   Liu W, 2014, ACTA BIOMATER, V10, P1864, DOI 10.1016/j.actbio.2013.12.008
   Liu ZF, 2014, J CELL MOL MED, V18, P610, DOI 10.1111/jcmm.12209
   Lubberstedt M, 2011, J PHARMACOL TOXICOL, V63, P59, DOI 10.1016/j.vascn.2010.04.013
   Moreau A, 2008, MOL PHARM, V5, P35, DOI 10.1021/mp700103m
   Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346
   Nelson CM, 2008, J CELL BIOCHEM, V105, P25, DOI 10.1002/jcb.21821
   Ng S, 2006, TISSUE ENG, V12, P2181, DOI 10.1089/ten.2006.12.2181
   O'Connor JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083188
   Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078
   Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004
   Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131
   Pingale SG, 2013, J PHARMACEUTICS, DOI 10.1155/2013/437697
   Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892
   Ramdas NM, 2015, J MOL BIOL, V427, P695, DOI 10.1016/j.jmb.2014.09.008
   Rebelo SP, 2015, ARCH TOXICOL, V89, P1347, DOI 10.1007/s00204-014-1320-9
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Roy KR, 2010, CANCER CHEMOTH PHARM, V65, P903, DOI 10.1007/s00280-009-1097-3
   Schneider D, 2011, BBA-MOL CELL RES, V1813, P2099, DOI 10.1016/j.bbamcr.2011.07.016
   Schulze A, 2012, HEPATOLOGY, V55, P373, DOI 10.1002/hep.24707
   Takayama K, 2012, MOL THER, V20, P127, DOI 10.1038/mt.2011.234
   Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408
   Tobwala S, 2015, EXP BIOL MED, V240, P261, DOI 10.1177/1535370214549520
   Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016
   Treyer A, 2013, COMPR PHYSIOL, V3, P243, DOI 10.1002/cphy.c120009
   Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509
   Wei SC, 2015, NAT CELL BIOL, V17, P678, DOI 10.1038/ncb3157
   Xiong AM, 2008, TISSUE ENG PT A, V14, P995, DOI [10.1089/ten.tea.2007.0087, 10.1089/tea.2007.0087]
   Xu Z., 2013, EMERGING TRENDS CELL, P33
   Yan XJ, 2015, LAB CHIP, V15, P2634, DOI 10.1039/c5lc00313j
   Yao R, 2014, SMALL, V10, P4311, DOI 10.1002/smll.201401040
   Zhao S, 2014, BIOMACROMOLECULES, V15, P2521, DOI 10.1021/bm500388m
NR 66
TC 16
Z9 17
U1 3
U2 72
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2016
VL 91
BP 11
EP 22
DI 10.1016/j.biomaterials.2016.03.001
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DK0OK
UT WOS:000374611900002
PM 26994875
DA 2018-10-19
ER

PT J
AU Gilmour, AD
   Woolley, AJ
   Poole-Warren, LA
   Thomson, CE
   Green, RA
AF Gilmour, A. D.
   Woolley, A. J.
   Poole-Warren, L. A.
   Thomson, C. E.
   Green, R. A.
TI A critical review of cell culture strategies for modelling intracortical
   brain implant material reactions
SO BIOMATERIALS
LA English
DT Review
DE Cell culture; Intracortical implants; Central nervous system wound
   healing; Glial scar; In vitro model
ID CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY; FIBRILLARY ACIDIC PROTEIN;
   IN-VITRO MODEL; BIOMATERIAL SURFACE-CHEMISTRY; CHRONIC RECORDING
   FUNCTION; BLOOD-DERIVED MACROPHAGES; NEURAL STEM-CELLS; GLIAL SCAR;
   ELECTRICAL-STIMULATION
AB The capacity to predict in vivo responses to medical devices in humans currently relies greatly on implantation in animal models. Researchers have been striving to develop in vitro techniques that can overcome the limitations associated with in vivo approaches. This review focuses on a critical analysis of the major in vitro strategies being utilized in laboratories around the world to improve understanding of the biological performance of intracortical, brain-implanted microdevices. Of particular interest to the current review are in vitro models for studying cell responses to penetrating intracortical devices and their materials, such as electrode arrays used for brain computer interface (BCI) and deep brain stimulation electrode probes implanted through the cortex. A background on the neural interface challenge is presented, followed by discussion of relevant in vitro culture strategies and their advantages and disadvantages. Future development of 2D culture models that exhibit developmental changes capable of mimicking normal, postnatal development will form the basis for more complex accurate predictive models in the future. Although not within the scope of this review, innovations in 3D scaffold technologies and microfluidic constructs will further improve the utility of in vitro approaches. (c) 2016 Elsevier Ltd. All rights reserved.
C1 [Gilmour, A. D.; Woolley, A. J.; Poole-Warren, L. A.; Green, R. A.] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
   [Thomson, C. E.] Univ Alaska Fairbanks, Dept Vet Med, Fairbanks, AK 99775 USA.
   [Woolley, A. J.] Univ Western Sydney, Sydney, NSW, Australia.
RP Gilmour, AD (reprint author), Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
EM a.gilmour@unsw.edu.au
CR ABEMAYOR E, 1989, ENVIRON HEALTH PERSP, V80, P3, DOI 10.2307/3430727
   Achyuta AKH, 2010, MACROMOL BIOSCI, V10, P872, DOI 10.1002/mabi.200900451
   Adeeb N, 2014, BRAIN BEHAV, V4, P105, DOI 10.1002/brb3.207
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Aregueta-Robles U. A., 2014, FRONT NEUROENG, V7, P1
   Astashkina A, 2012, PHARMACOL THERAPEUT, V134, P82, DOI 10.1016/j.pharmthera.2012.01.001
   Ayoub AE, 2003, J NEUROSCI, V23, P7759
   Barnett SC, 2013, NEUROSCIENTIST, V19, P442, DOI 10.1177/1073858412465655
   Barrese JC, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/6/066014
   BELLAMKONDA R, 1995, J NEUROSCI RES, V41, P501, DOI 10.1002/jnr.490410409
   Benavente JJM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090189
   Berghaus LJ, 2010, COMP IMMUNOL MICROB, V33, P443, DOI 10.1016/j.cimid.2009.07.001
   BETHEA CL, 1987, MOL CELL ENDOCRINOL, V50, P211, DOI 10.1016/0303-7207(87)90019-0
   Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020
   Bjornsson CS, 2006, J NEURAL ENG, V3, P196, DOI 10.1088/1741-2560/3/3/002
   Blaise GA, 2005, TOXICOLOGY, V208, P177, DOI 10.1016/j.tox.2004.11.032
   Braune S, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-33
   Bridges Amanda W, 2008, J Diabetes Sci Technol, V2, P984
   BRISMAR T, 1995, GLIA, V15, P231, DOI 10.1002/glia.440150305
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Brodbeck WG, 2009, CURR OPIN HEMATOL, V16, P53, DOI 10.1097/MOH.0b013e32831ac52e
   Bronstein JM, 2011, ARCH NEUROL-CHICAGO, V68, P165, DOI 10.1001/archneurol.2010.260
   Bryers JD, 2012, BIOTECHNOL BIOENG, V109, P1898, DOI 10.1002/bit.24559
   Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034
   Busch SA, 2010, J NEUROSCI, V30, P255, DOI 10.1523/JNEUROSCI.3705-09.2010
   Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599
   CHAO CC, 1992, J IMMUNOL, V149, P2736
   Chen HuiLiang, 2005, Chinese Journal of Rabbit Farming, P22
   Chen L, 2004, BIOMACROMOLECULES, V5, P238, DOI 10.1021/bm0344102
   Choi NW, 2007, NAT MATER, V6, P908, DOI 10.1038/nmat2022
   Cogan SF, 2008, ANNU REV BIOMED ENG, V10, P275, DOI 10.1146/annurev.bioeng.10.061807.160518
   COOKSON MR, 1994, TOXICOL IN VITRO, V8, P351, DOI 10.1016/0887-2333(94)90156-2
   Craighead HG, 1998, BIOMED MICRODEVICES, V1, P49, DOI 10.1023/A:1009982306118
   Cullen DK, 2007, ANN BIOMED ENG, V35, P835, DOI 10.1007/s10439-007-9292-z
   Daud N. Mohd, 2014, J ORTHOP TRANSL, V2, P1
   De Faveri Sara, 2014, Front Neuroeng, V7, P7, DOI 10.3389/fneng.2014.00007
   DENISDONINI S, 1984, NATURE, V307, P641, DOI 10.1038/307641a0
   Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002
   Diemel LT, 2003, J NEUROSCI RES, V74, P858, DOI 10.1002/jnr.10837
   Dobolyi A, 2012, INT J MOL SCI, V13, P8219, DOI 10.3390/ijms13078219
   DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799
   Dunstan RW, 2011, TOXICOL PATHOL, V39, P988, DOI 10.1177/0192623311419163
   Ekdahl KN, 2011, ADV DRUG DELIVER REV, V63, P1042, DOI 10.1016/j.addr.2011.06.012
   ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x
   Ereifej ES, 2013, J NEUROSCI METH, V217, P17, DOI 10.1016/j.jneumeth.2013.04.023
   Ereifej ES, 2013, J BIOMED MATER RES A, V101, P1743, DOI 10.1002/jbm.a.34480
   Evans TA, 2014, EXP NEUROL, V254, P109, DOI 10.1016/j.expneurol.2014.01.013
   Fahmy GH, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00129
   Feldmann M., 2014, J BIOL METHODS, V1, P11
   Fennrich Stefan, 1996, Methods in Cell Science, V18, P283, DOI 10.1007/BF00127905
   Fernandez Eduardo, 2014, Front Neuroeng, V7, P24, DOI 10.3389/fneng.2014.00024
   Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195
   Filous AR, 2010, DEV NEUROBIOL, V70, P826, DOI 10.1002/dneu.20820
   Fini M, 2003, J Appl Biomater Biomech, V1, P155
   Fitch MT, 1999, J NEUROSCI, V19, P8182
   Fornasiero EF, 2014, NEUROMETHODS, V86, pVII
   Francis KR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.22
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Freshney I, 2001, CELL BIOL TOXICOL, V17, P213, DOI 10.1023/A:1012572930721
   Freshney R. I., 2005, CULTURE CELLS TISSUE
   Gao HM, 2002, J NEUROCHEM, V81, P1285, DOI 10.1046/j.1471-4159.2002.00928.x
   Gao J, 2006, P NATL ACAD SCI USA, V103, P16681, DOI 10.1073/pnas.0606237103
   GARCIAABREU J, 1995, J NEUROSCI RES, V40, P471, DOI 10.1002/jnr.490400406
   Geraghty R. J., 2014, BRIT J CANCER, V111, P1, DOI DOI 10.1038/BJC.2014.166
   Gilletti A, 2006, J NEURAL ENG, V3, P189, DOI 10.1088/1741-2560/3/3/001
   Gilmour AD, 2013, TOXICOL ENVIRON CHEM, V95, P1129, DOI 10.1080/02772248.2013.844429
   Goding JA, 2015, J MATER CHEM B, V3, P5058, DOI 10.1039/c5tb00384a
   Goldshmit Y, 2014, BRAIN BEHAV, V4, P187, DOI 10.1002/brb3.172
   Gottlieb DI, 2002, ANNU REV NEUROSCI, V25, P381, DOI 10.1146/annurev.neuro.25.112701.142904
   Green RA, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056017
   Green RA, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/1/016009
   Green RA, 2013, IEEE ENG MED BIO, P6957, DOI 10.1109/EMBC.2013.6611158
   Green RA, 2010, BIOMATERIALS, V31, P886, DOI 10.1016/j.biomaterials.2009.09.099
   Green RA, 2010, ACTA BIOMATER, V6, P63, DOI 10.1016/j.actbio.2009.06.030
   Green RA, 2009, BIOMATERIALS, V30, P3637, DOI 10.1016/j.biomaterials.2009.03.043
   Greene L.A., 1998, CULTURING NERVE CELL
   GREENE LA, 1982, DEV BIOL, V91, P305, DOI 10.1016/0012-1606(82)90037-9
   Gregg JM, 2014, EXP NEUROL, V253, P197
   Groothuis J, 2014, BRAIN STIMUL, V7, P1, DOI 10.1016/j.brs.2013.07.001
   Grotenhuis N, 2014, BRIT J SURG, V101, P983, DOI 10.1002/bjs.9523
   Guillemin GJ, 2004, J LEUKOCYTE BIOL, V75, P388, DOI 10.1189/jlb.0303114
   Gunasekera B, 2015, ACS CHEM NEUROSCI, V6, P68, DOI 10.1021/cn5002864
   Hamby ME, 2006, GLIA, V54, P566, DOI 10.1002/glia.20411
   Harris James P., 2013, Critical Reviews in Biomedical Engineering, V41, P435
   Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483
   He W, 2005, BIOMATERIALS, V26, P2983, DOI 10.1016/j.biomaterials.2004.08.021
   He W., 2014, INT J COMPUT INTEG M, P1, DOI DOI 10.1080/0951192X.2013.874595
   He YR, 2014, STROKE, V45, P2514, DOI 10.1161/STROKEAHA.114.005427
   Hetrick EM, 2007, BIOMATERIALS, V28, P4571, DOI 10.1016/j.biomaterials.2007.06.036
   Hewett JA, 2009, J NEUROCHEM, V110, P1717, DOI 10.1111/j.1471-4159.2009.06288.x
   Holecko MM, 2005, J NEURAL ENG, V2, P97, DOI 10.1088/1741-2560/2/4/005
   Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005
   Ignatius AA, 1996, BIOMATERIALS, V17, P831, DOI 10.1016/0142-9612(96)81421-9
   Ishikawa M, 1996, Mult Scler, V2, P91
   Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208
   John P. M. S., 1997, J NEUROSCI METH, V75, P171
   Kam L, 2002, BIOMATERIALS, V23, P511, DOI 10.1016/S0142-9612(01)00133-8
   Kam L, 1999, BIOMATERIALS, V20, P2343, DOI 10.1016/S0142-9612(99)00163-5
   Kang K, 2014, GLIA, V62, P1328, DOI 10.1002/glia.22684
   Karumbaiah L, 2013, BIOMATERIALS, V34, P8061, DOI 10.1016/j.biomaterials.2013.07.016
   Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5
   Keller PJ, 2015, NAT METHODS, V12, P27, DOI 10.1038/nmeth.3214
   KEMPERMANN G, 2006, ADULT NEUROGENESIS S
   Kerstetter A.E., 2012, ISOL CULT SPINAL COR, V814, P93
   Kim S, 2009, EUR J PHARM BIOPHARM, V71, P420, DOI 10.1016/j.ejpb.2008.09.021
   Kim YJ, 2000, BIOMATERIALS, V21, P121, DOI 10.1016/S0142-9612(99)00137-4
   Klapka N, 2006, J NEUROTRAUM, V23, P422, DOI 10.1089/neu.2006.23.422
   Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971
   Kozai TDY, 2012, NAT MATER, V11, P1065, DOI [10.1038/NMAT3468, 10.1038/nmat3468]
   Kozai TDY, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/6/066001
   Kunze A, 2011, BIOMATERIALS, V32, P2088, DOI 10.1016/j.biomaterials.2010.11.047
   Kyritsis N, 2014, TRENDS CELL BIOL, V24, P128, DOI 10.1016/j.tcb.2013.08.004
   LAPING NJ, 1994, BRAIN PATHOL, V4, P259, DOI 10.1111/j.1750-3639.1994.tb00841.x
   Leach Jennie B, 2010, Front Neuroeng, V2, P18, DOI 10.3389/neuro.16.018.2009
   Lebedev M, 2014, TRANSL NEUROSCI, V5, P99, DOI 10.2478/s13380-014-0212-z
   Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004
   Lee JY, 2015, RSC ADV, V5, P39228, DOI 10.1039/c5ra03294f
   Lee K, 2004, BIOSENS BIOELECTRON, V20, P404, DOI 10.1016/j.bios.2004.02.005
   Lee KK, 2004, J MICROMECH MICROENG, V14, P32, DOI 10.1088/0960-1317/14/1/305
   Leung BK, 2008, BIOMATERIALS, V29, P3289, DOI 10.1016/j.biomaterials.2008.03.045
   Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1
   Li XJ, 2012, BIOANALYSIS, V4, P1509, DOI [10.4155/bio.12.133, 10.4155/BIO.12.133]
   Liao LJ, 2008, P NATL ACAD SCI USA, V105, P15281, DOI 10.1073/pnas.0804678105
   Liu W, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-5
   Liu X, 2011, BIOMATERIALS, V32, P7309, DOI 10.1016/j.biomaterials.2011.06.047
   London A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00034
   Magrez A, 2006, NANO LETT, V6, P1121, DOI 10.1021/nl060162e
   Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601
   Maqsood MI, 2013, CELL BIOL INT, V37, P1038, DOI 10.1002/cbin.10137
   Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13
   Massia SP, 2004, J BIOMED MATER RES A, V68A, P177, DOI 10.1002/jbm.a.20009
   Matsutani S, 1997, GLIA, V20, P1, DOI 10.1002/(SICI)1098-1136(199705)20:1<1::AID-GLIA1>3.0.CO;2-E
   Matyash V, 2010, BRAIN RES REV, V63, P2, DOI 10.1016/j.brainresrev.2009.12.001
   MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890
   McConnell GC, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/056003
   MCKEON RJ, 1991, J NEUROSCI, V11, P3398
   Merrill DR, 2005, J NEUROSCI METH, V141, P171, DOI 10.1016/j.jneumeth.2004.10.020
   Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005
   Middeldorp J, 2010, DEVELOPMENT, V137, P313, DOI 10.1242/dev.041632
   Miyazaki I, 1999, NEUROCHEM RES, V24, P857, DOI 10.1023/A:1020953913490
   Morrison B, 2011, STUD MECHANOBIOL TIS, V3, P247, DOI 10.1007/8415_2011_79
   Mosser D.M., 2008, CURRENT PROTOCOLS IM, V83
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Naik P, 2012, J PHARM SCI-US, V101, P1337, DOI 10.1002/jps.23022
   Nash B, 2011, J NEUROSCI, V31, P13028, DOI 10.1523/JNEUROSCI.1449-11.2011
   Nash B, 2011, J ANAT, V219, P44, DOI 10.1111/j.1469-7580.2010.01330.x
   Ndubaku U, 2008, ACTA HISTOCHEM, V110, P182, DOI 10.1016/j.acthis.2007.10.003
   Nyga A, 2011, J CELL COMMUN SIGNAL, V5, P239, DOI 10.1007/s12079-011-0132-4
   Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207
   Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475
   Polikov VS, 2006, BIOMATERIALS, V27, P5368, DOI 10.1016/j.biomaterials.2006.06.018
   Polikov VS, 2009, J NEUROSCI METH, V181, P170, DOI 10.1016/j.jneumeth.2009.05.002
   Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015
   Poole-Warren LA, 2008, APPL SURF SCI, V255, P519, DOI 10.1016/j.apsusc.2008.06.062
   Potter SM, 2001, J NEUROSCI METH, V110, P17, DOI 10.1016/S0165-0270(01)00412-5
   Ravikumar M, 2014, BIOMATERIALS, V35, P8049, DOI 10.1016/j.biomaterials.2014.05.084
   Reilly JF, 1998, GLIA, V22, P202, DOI 10.1002/(SICI)1098-1136(199802)22:2<202::AID-GLIA11>3.0.CO;2-1
   Ren D, 2003, BRAIN RES BULL, V61, P547, DOI 10.1016/S0361-9230(03)00193-X
   Reuss B, 2003, J NEUROSCI, V23, P6404
   Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591
   ROSE TL, 1990, IEEE T BIO-MED ENG, V37, P1118, DOI 10.1109/10.61038
   ROUSCHE PJ, 1992, ANN BIOMED ENG, V20, P413, DOI 10.1007/BF02368133
   Saneinejad S, 1998, J BIOMED MATER RES, V42, P13, DOI 10.1002/(SICI)1097-4636(199810)42:1<13::AID-JBM3>3.0.CO;2-R
   Saura J, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-26
   Saxena T, 2013, BIOMATERIALS, V34, P4703, DOI 10.1016/j.biomaterials.2013.03.007
   Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010
   Schildge S., 2013, JOVE-J VIS EXP, V71, P1
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Schwartz AB, 2004, ANNU REV NEUROSCI, V27, P487, DOI 10.1146/annurev.neuro.27.070203.144233
   Schwarz DA, 2014, NAT METHODS, V11, P670, DOI [10.1038/NMETH.2936, 10.1038/nmeth.2936]
   Seymour JP, 2007, BIOMATERIALS, V28, P3594, DOI 10.1016/j.biomaterials.2007.03.024
   SHANNON RV, 1992, IEEE T BIO-MED ENG, V39, P424, DOI 10.1109/10.126616
   Shapiro LA, 2005, BRAIN RES, V1040, P81, DOI 10.1016/j.brainres.2005.01.098
   Shechter R, 2013, TRENDS MOL MED, V19, P135, DOI 10.1016/j.molmed.2012.11.007
   Shin S, 2007, STEM CELLS, V25, P1298, DOI 10.1634/stemcells.2006-0660
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Simons M, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020479
   Singh A, 2003, BIOMATERIALS, V24, P5083, DOI 10.1016/S0142-9612(03)00424-1
   Sivaraman KM, 2013, ADV HEALTHC MATER, V2, P591, DOI 10.1002/adhm.201200282
   SMETANA K, 1993, J MATER SCI-MATER M, V4, P526, DOI 10.1007/BF00120134
   Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8
   Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002
   Sommakia S., 2014, FRONT NEUROENG, V7, P1
   Sommakia S, 2014, CURR OPIN SOLID ST M, V18, P319, DOI 10.1016/j.cossms.2014.07.005
   Sorensen A, 2008, GLIA, V56, P750, DOI 10.1002/glia.20650
   Stacey G, 2001, CELL BIOL TOXICOL, V17, P319, DOI 10.1023/A:1012585300679
   Stroncek J. D., 2008, INDWELLING NEURAL IM, P1
   Suzuki T, 2012, EUR J NEUROSCI, V36, P3653, DOI 10.1111/j.1460-9568.2012.08280.x
   Thelin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016267
   Thomson CE, 2008, EUR J NEUROSCI, V28, P1518, DOI 10.1111/j.1460-9568.2008.06415.x
   Tresco Patrick A., 2011, Critical Reviews in Biomedical Engineering, V39, P29
   Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381
   Turner AMP, 2000, J BIOMED MATER RES, V51, P430, DOI 10.1002/1097-4636(20000905)51:3<430::AID-JBM18>3.0.CO;2-C
   Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983
   Unsworth CP, 2011, BIOMATERIALS, V32, P6541, DOI 10.1016/j.biomaterials.2011.05.041
   van de Kamp J., 2013, STEM CELLS INT, V2013, DOI DOI 10.1155/2013/892065
   van Duinen V, 2015, CURR OPIN BIOTECH, V35, P118, DOI 10.1016/j.copbio.2015.05.002
   van Oeveren W., 2013, SCIENTIFICA CAIRO, V2013, P1
   VERDERBER L, 1995, INVEST OPHTH VIS SCI, V36, P1137
   Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015
   VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A
   Wachs FP, 2006, J NEUROPATH EXP NEUR, V65, P358, DOI 10.1097/01.jnen.0000218444.53405.f0
   Wadhwa R, 2006, J CONTROL RELEASE, V110, P531, DOI 10.1016/j.jconrel.2005.10.027
   WAINWRIGHT MS, 1995, J NEUROSCI, V15, P676
   WALIVAARA B, 1994, BIOMATERIALS, V15, P827, DOI 10.1016/0142-9612(94)90038-8
   Wang MO, 2013, BIOMACROMOLECULES, V14, P1321, DOI 10.1021/bm301962f
   Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013
   Weng B, 2012, SYNTHETIC MET, V162, P1375, DOI 10.1016/j.synthmet.2012.05.022
   White RE, 2010, J COMP NEUROL, V518, P1370, DOI 10.1002/cne.22282
   Williams JC, 1999, BRAIN RES PROTOC, V4, P303, DOI 10.1016/S1385-299X(99)00034-3
   Williams JC, 2007, J NEURAL ENG, V4, P410, DOI 10.1088/1741-2560/4/4/007
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Winn SR, 2000, BIOMATERIALS, V21, P2413, DOI 10.1016/S0142-9612(00)00109-5
   Winslow BD, 2010, BIOMATERIALS, V31, P1558, DOI 10.1016/j.biomaterials.2009.11.049
   Woehrling EK, 2011, NEUROTOX RES, V19, P472, DOI 10.1007/s12640-010-9202-2
   Woolley AJ, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026007
   Woolley AJ, 2011, J NEUROSCI METH, V201, P67, DOI 10.1016/j.jneumeth.2011.07.012
   Wu VW, 1998, J NEUROSCI RES, V51, P675, DOI 10.1002/(SICI)1097-4547(19980315)51:6<675::AID-JNR2>3.0.CO;2-8
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Xu LY, 2015, BIOMATER SCI-UK, V3, P250, DOI [10.1039/c4bm00245h, 10.1039/C4BM00245H]
   Yang JY, 2005, ACTA BIOMATER, V1, P125, DOI 10.1016/j.actbio.2004.09.006
   Yue ZL, 2011, BIOMATERIALS, V32, P4714, DOI 10.1016/j.biomaterials.2011.03.032
   Zang R., 2012, INT J BIOTECHNOL WEL, V1, P31, DOI DOI 10.6000/1927-3037.2012.01.01.02.
   Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069
   Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005
   Zhang YT, 2010, GLIA, V58, P964, DOI 10.1002/glia.20978
   ZHAO QH, 1993, J BIOMED MATER RES, V27, P379, DOI 10.1002/jbm.820270311
   Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071
   Zimmerli W, 2014, J INTERN MED, V276, P111, DOI 10.1111/joim.12233
NR 231
TC 9
Z9 10
U1 6
U2 89
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2016
VL 91
BP 23
EP 43
DI 10.1016/j.biomaterials.2016.03.011
PG 21
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DK0OK
UT WOS:000374611900003
PM 26994876
DA 2018-10-19
ER

PT J
AU Rowland, CR
   Colucci, LA
   Guilak, F
AF Rowland, Christopher R.
   Colucci, Lina A.
   Guilak, Farshid
TI Fabrication of anatomically-shaped cartilage constructs using
   decellularized cartilage-derived matrix scaffolds
SO BIOMATERIALS
LA English
DT Article
DE Articular cartilage; Decellularization; Tissue engineering; Mesenchymal
   stem cell; Cell-mediated contraction; Ice-templating
ID MESENCHYMAL STEM-CELLS; COLLAGEN-GLYCOSAMINOGLYCAN SCAFFOLDS;
   ARTICULAR-CARTILAGE; EXTRACELLULAR-MATRIX; CROSS-LINKING; IN-VITRO;
   CHONDROGENIC DIFFERENTIATION; GAG SCAFFOLDS; PORE-SIZE; PROMOTE
   CHONDROGENESIS
AB The native extracellular matrix of cartilage contains entrapped growth factors as well as tissue-specific epitopes for cell-matrix interactions, which make it a potentially attractive biomaterial for cartilage tissue engineering. A limitation to this approach is that the native cartilage extracellular matrix possesses a pore size of only a few nanometers, which inhibits cellular infiltration. Efforts to increase the pore size of cartilage-derived matrix (CDM) scaffolds dramatically attenuate their mechanical properties, which makes them susceptible to cell-mediated contraction. In previous studies, we have demonstrated that collagen crosslinking techniques are capable of preventing cell-mediated contraction in CDM disks. In the current study, we investigated the effects of CDM concentration and pore architecture on the ability of CDM scaffolds to resist cell-mediated contraction. Increasing CDM concentration significantly increased scaffold mechanical properties, which played an important role in preventing contraction, and only the highest CDM concentration (11% wow) was able to retain the original scaffold dimensions. However, the increase in CDM concentration led to a concomitant decrease in porosity and pore size. Generating a temperature gradient during the freezing process resulted in unidirectional freezing, which aligned the formation of ice crystals during the freezing process and in turn produced aligned pores in CDM scaffolds. These aligned pores increased the pore size of CDM scaffolds at all CDM concentrations, and greatly facilitated infiltration by mesenchymal stem cells (MSCs). These methods were used to fabricate of anatomically-relevant CDM hemispheres. CDM hemispheres with aligned pores supported uniform MSC infiltration and matrix deposition. Furthermore, these CDM hemispheres retained their original architecture and did not contract, warp, curl, or splay throughout the entire 28-day culture period. These findings demonstrate that given the appropriate fabrication parameters, CDM scaffolds are capable of maintaining complex structures that support MSC chondrogenesis. (c) 2016 Elsevier Ltd. All rights reserved.
C1 [Rowland, Christopher R.; Colucci, Lina A.; Guilak, Farshid] Washington Univ, Dept Orthopaed Surg, 3210 McKinley Res Bldg, St Louis, MO 63110 USA.
   [Rowland, Christopher R.; Colucci, Lina A.; Guilak, Farshid] Washington Univ, Dept Dev Biol, St Louis, MO 63110 USA.
   [Rowland, Christopher R.; Colucci, Lina A.; Guilak, Farshid] Washington Univ, Dept Biomed Engn, St Louis, MO 63110 USA.
   [Rowland, Christopher R.; Colucci, Lina A.; Guilak, Farshid] St Louis Hosp, Shriners Hosp Children, 3210 McKinley Res Bldg, St Louis, MO 63110 USA.
RP Guilak, F (reprint author), Washington Univ, Dept Orthopaed Surg, 3210 McKinley Res Bldg, St Louis, MO 63110 USA.; Guilak, F (reprint author), St Louis Hosp, Shriners Hosp Children, 3210 McKinley Res Bldg, St Louis, MO 63110 USA.
EM guilak@wustl.edu
OI Rowland, Chris/0000-0003-0228-4054; Guilak, Farshid/0000-0001-7380-0330;
   /0000-0003-1264-3815
FU NIH [P01 CA47741, AR50245, AR48852, AG15768, AR48182, AG46927, OD01070];
   Collaborative Research Center, AO Foundation, Davos, Switzerland;
   Arthritis Foundation; Nancy Taylor Foundation for Chronic Diseases; Lord
   Foundation Grant through the Shared Materials Instrumentation Facility
   (SMIF)
FX We thank Dr. Nelson Chao for providing bone marrow (NIH grant P01
   CA47741), Dr. Brad Estes, Dr. Frank Moutos, and Steven Earp of the Pratt
   Student Shop for assistance in machining the hemisphere molds, and
   Katherine Glass and Jonathan Brunger for assistance with various aspects
   of the project. This work was supported in part by NIH grants AR50245,
   AR48852, AG15768, AR48182, AG46927, OD01070, the Collaborative Research
   Center, AO Foundation, Davos, Switzerland, the Arthritis Foundation, the
   Nancy Taylor Foundation for Chronic Diseases, and the Lord Foundation
   Grant through the Shared Materials Instrumentation Facility (SMIF).
CR Almeida HV, 2015, ADV HEALTHC MATER, V4, P1043, DOI 10.1002/adhm.201400687
   Almeida HV, 2014, ACTA BIOMATER, V10, P4400, DOI 10.1016/j.actbio.2014.05.030
   Benders KEM, 2014, CARTILAGE, V5, P221, DOI 10.1177/1947603514535245
   Bhumiratana S, 2014, P NATL ACAD SCI USA, V111, P6940, DOI 10.1073/pnas.1324050111
   Chang CH, 2014, J BIOMED MATER RES A, V102, P2248, DOI 10.1002/jbm.a.34897
   Chen CC, 2012, J ORTHOP RES, V30, P393, DOI 10.1002/jor.21541
   Cheng CW, 2014, BIOTECHNOL ADV, V32, P462, DOI 10.1016/j.biotechadv.2013.12.012
   Cheng NC, 2013, TISSUE ENG PT A, V19, P484, DOI [10.1089/ten.tea.2012.0384, 10.1089/ten.TEA.2012.0384]
   Cheng NC, 2011, REGEN MED, V6, P81, DOI [10.2217/rme.10.87, 10.2217/RME.10.87]
   Cheng NC, 2009, TISSUE ENG PT A, V15, P231, DOI 10.1089/ten.tea.2008.0253
   Corin KA, 2010, BIOMATERIALS, V31, P4835, DOI 10.1016/j.biomaterials.2010.01.149
   DAYAN D, 1989, HISTOCHEMISTRY, V93, P27, DOI 10.1007/BF00266843
   Deville S, 2007, ACTA MATER, V55, P1965, DOI 10.1016/j.actamat.2006.11.003
   Deville S, 2006, BIOMATERIALS, V27, P5480, DOI 10.1016/j.biomaterials.2006.06.028
   Deville S, 2010, MATERIALS, V3, P1913, DOI 10.3390/ma3031913
   Diekman BO, 2010, TISSUE ENG PT A, V16, P523, DOI [10.1089/ten.tea.2009.0398, 10.1089/ten.TEA.2009.0398]
   Ding M, 1999, J BIOMECH, V32, P323, DOI 10.1016/S0021-9290(98)00176-6
   Elder BD, 2009, BIOMATERIALS, V30, P3749, DOI 10.1016/j.biomaterials.2009.03.050
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Garrigues NW, 2014, J BIOMED MATER RES A, V102, P3998, DOI 10.1002/jbm.a.35068
   Geidobler R, 2013, EUR J PHARM BIOPHARM, V85, P214, DOI 10.1016/j.ejpb.2013.04.014
   Ghanavi P, 2012, CELL TISSUE RES, V347, P643, DOI 10.1007/s00441-012-1323-x
   Gong YY, 2011, BIOMATERIALS, V32, P2265, DOI 10.1016/j.biomaterials.2010.11.078
   Gutierrez MC, 2008, CHEM MATER, V20, P634, DOI 10.1021/cm702028z
   Han EH, 2008, CLIN ORTHOP RELAT R, V466, P1912, DOI 10.1007/s11999-008-0291-7
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI [10.1089/ten.tea.2010.0590, 10.1089/ten.TEA.2010.0590]
   Haugh MG, 2010, TISSUE ENG PART C-ME, V16, P887, DOI 10.1089/ten.TEC.2009.0422
   Huber M, 2000, INVEST RADIOL, V35, P573, DOI 10.1097/00004424-200010000-00003
   Huey DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027857
   Hung CT, 2003, J BIOMECH, V36, P1853, DOI 10.1016/S0021-9290(03)00213-6
   Jia SJ, 2012, J BIOSCI BIOENG, V113, P647, DOI 10.1016/j.jbiosc.2011.12.009
   JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772
   Kalson NS, 2010, INT J CLIN PRACT, V64, P1444, DOI 10.1111/j.1742-1241.2010.02420.x
   Kang HJ, 2014, J TISSUE ENG REGEN M, V8, P442, DOI 10.1002/term.1538
   Kheir E, 2011, J BIOMED MATER RES A, V99A, P283, DOI 10.1002/jbm.a.33171
   Korhonen RK, 2002, J BIOMECH, V35, P903, DOI 10.1016/S0021-9290(02)00052-0
   Lee CR, 2001, BIOMATERIALS, V22, P3145, DOI 10.1016/S0142-9612(01)00067-9
   Lu HX, 2010, BIOMATERIALS, V31, P5825, DOI 10.1016/j.biomaterials.2010.04.019
   MacBarb RF, 2014, TISSUE ENG PT A, V20, P3290, DOI [10.1089/ten.tea.2013.0694, 10.1089/ten.TEA.2013.0694]
   Madaghiele M, 2008, J BIOMED MATER RES A, V85A, P757, DOI 10.1002/jbm.a.31517
   Mandal BB, 2013, MACROMOL BIOSCI, V13, P48, DOI 10.1002/mabi.201200230
   Matsiko A, 2015, TISSUE ENG PT A, V21, P486, DOI [10.1089/ten.tea.2013.0545, 10.1089/ten.TEA.2013.0545]
   Moradi A, 2016, J BIOMED MATER RES A, V104, P245, DOI 10.1002/jbm.a.35561
   Moradi A, 2014, SCI TECHNOL ADV MAT, V15, DOI 10.1088/1468-6996/15/6/065001
   Moutos FT, 2010, MACROMOL BIOSCI, V10, P1355, DOI 10.1002/mabi.201000124
   Munch E, 2009, J AM CERAM SOC, V92, P1534, DOI 10.1111/j.1551-2916.2009.03087.x
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Pawelec KM, 2014, APPL PHYS REV, V1, DOI 10.1063/1.4871083
   Pawelec KM, 2014, MAT SCI ENG C-MATER, V37, P141, DOI 10.1016/j.msec.2014.01.009
   Peretti GM, 1998, J ORTHOPAED RES, V16, P89, DOI 10.1002/jor.1100160115
   Pfeiffer E, 2008, OSTEOARTHR CARTILAGE, V16, P1237, DOI 10.1016/j.joca.2008.02.014
   Philip D, 2005, STEM CELLS, V23, P288, DOI 10.1634/stemcells.2002.0109
   Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6
   Rosenzweig DH, 2012, ACTA BIOMATER, V8, P3333, DOI 10.1016/j.actbio.2012.05.032
   Rowland CR, 2013, BIOMATERIALS, V34, P5802, DOI 10.1016/j.biomaterials.2013.04.027
   Schwarz S, 2015, J TISSUE ENG REGEN M, V9, pE239, DOI 10.1002/term.1650
   Schwarz S, 2012, TISSUE ENG PT A, V18, P2195, DOI [10.1089/ten.tea.2011.0705, 10.1089/ten.TEA.2011.0705]
   Shin YS, 2014, INT J PEDIATR OTORHI, V78, P32, DOI 10.1016/j.ijporl.2013.10.014
   Solchaga LA, 2006, TISSUE ENG, V12, P1851, DOI 10.1089/ten.2006.12.1851
   Sung HW, 2003, J BIOMED MATER RES A, V64A, P427, DOI 10.1002/jbm.a.10346
   Sutherland AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121966
   Sutherland AJ, 2015, ADV HEALTHC MATER, V4, DOI 10.1002/adhm.201400165
   Torres DS, 2000, BIOMATERIALS, V21, P1607
   Utomo L, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/1/015010
   Vickers SM, 2006, TISSUE ENG, V12, P1345, DOI 10.1089/ten.2006.12.1345
   Vickers SM, 2010, J ORTHOP RES, V28, P1184, DOI 10.1002/jor.21113
   Wang ZJ, 2014, GENET MOL RES, V13, P4599, DOI 10.4238/2014.June.18.2
   Wu X, 2010, ACTA BIOMATER, V6, P1167, DOI 10.1016/j.actbio.2009.08.041
   Xue JX, 2012, BIOMATERIALS, V33, P5832, DOI 10.1016/j.biomaterials.2012.04.054
   Yang F, 2006, BIOMATERIALS, V27, P4923, DOI 10.1016/j.biomaterials.2006.05.028
   Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037
   Yang Q, 2011, CHINESE MED J-PEKING, V124, P3930, DOI 10.3760/cma.j.issn.0366-6999.2011.23.018
   Yang W, 2014, TRANSPL P, V46, P1247, DOI 10.1016/j.transproceed.2013.11.082
   Yang ZQ, 2010, TISSUE ENG PART C-ME, V16, P865, DOI [10.1089/ten.tec.2009.0444, 10.1089/ten.TEC.2009.0444]
   Zhang H, 2007, ADV MATER, V19, P1529, DOI 10.1002/adma.200700154
   Zhang YY, 2012, BIOMATERIALS, V33, P2926, DOI 10.1016/j.biomaterials.2012.01.006
   Zhao YH, 2013, CHINESE MED J-PEKING, V126, P3130, DOI 10.3760/cma.j.issn.0366-6999.20130212
NR 79
TC 23
Z9 25
U1 5
U2 87
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2016
VL 91
BP 57
EP 72
DI 10.1016/j.biomaterials.2016.03.012
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DK0OK
UT WOS:000374611900005
PM 26999455
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Ghuman, H
   Massensini, AR
   Donnelly, J
   Kim, SM
   Medberry, CJ
   Badylak, SF
   Modo, M
AF Ghuman, Harmanvir
   Massensini, Andre R.
   Donnelly, Julia
   Kim, Sung-Min
   Medberry, Christopher J.
   Badylak, Stephen F.
   Modo, Michel
TI ECM hydrogel for the treatment of stroke: Characterization of the host
   cell infiltrate
SO BIOMATERIALS
LA English
DT Article
DE Biomaterial; Delivery; Extracellular matrix; Injection; Magnetic
   resonance imaging; Stereotactic; Brain; Stroke; Hydrogel; Phenotypes;
   Neural progenitor; Macrophage
ID NEURAL STEM-CELLS; POLY(ETHYLENE GLYCOL)-BASED HYDROGELS; SOLUBILIZED
   EXTRACELLULAR-MATRIX; TERM BEHAVIORAL-ASSESSMENT; PORCINE
   URINARY-BLADDER; FOCAL CEREBRAL-ISCHEMIA; BIOLOGIC SCAFFOLDS; MACROPHAGE
   PHENOTYPE; IN-VIVO; REGENERATIVE MEDICINE
AB Brain tissue loss following stroke is irreversible with current treatment modalities. The use of an acellular extracellular matrix (ECM), formulated to produce a hydrogel in situ within the cavity formed by a stroke, was investigated as a method to replace necrotic debris and promote the infiltration of host brain cells. Based on magnetic resonance imaging measurements of lesion location and volume, different concentrations of ECM (0, 1, 2, 3, 4, 8 mg/mL) were injected at a volume equal to that of the cavity (14 days post stroke). Retention of ECM within the cavity occurred at concentrations >3 mg/mL. A significant cell infiltration into the ECM material in the lesion cavity occurred with an average of similar to 36,000 cells in the 8 mg/mL concentration within 24 h. An infiltration of cells with distances of >1500 mu m into the ECM hydrogel was observed, but the majority of cells were at the tissue/hydrogel boundary. Cells were typically of a microglia, macrophage, or neural and oligodendrocyte progenitor phenotype. At the 8 mg/mL concentration, similar to 60% of infiltrating cells were brain-derived phenotypes and 30% being infiltrating peripheral macrophages, polarizing toward an M2-like anti-inflammatory phenotype. These results suggest that an 8 mg/mL ECM concentration promotes a significant acute endogenous repair response that could potentially be exploited to treat stroke. (c) 2016 Elsevier Ltd. All rights reserved.
C1 [Ghuman, Harmanvir; Massensini, Andre R.; Medberry, Christopher J.; Badylak, Stephen F.; Modo, Michel] Univ Pittsburgh, McGowan Inst Regenerat Med, 3025 East Carson St, Pittsburgh, PA 15203 USA.
   [Ghuman, Harmanvir; Kim, Sung-Min; Medberry, Christopher J.; Badylak, Stephen F.; Modo, Michel] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15203 USA.
   [Massensini, Andre R.; Modo, Michel] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15203 USA.
   [Donnelly, Julia] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15203 USA.
   [Badylak, Stephen F.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15203 USA.
   [Massensini, Andre R.] Univ Fed Minas Gerais, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil.
RP Modo, M (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, 3025 East Carson St, Pittsburgh, PA 15203 USA.
EM modomm@upmc.edu
OI Modo, Michel/0000-0003-4436-735X; Ghuman, Harmanvir/0000-0002-9123-7796;
   Badylak, Stephen/0000-0003-3555-0689
FU Department of Health of the Commonwealth of Pennsylvania [4100061184];
   National Institute of Neurological Disorders and Stroke [R01NS08226];
   CAPES Foundation, Brazil; Vertex Pharmaceuticals
FX This study was funded by a seed grant from the Department of Health of
   the Commonwealth of Pennsylvania (4100061184) and the National Institute
   of Neurological Disorders and Stroke (R01NS08226). ARM was supported by
   a Fellowship from CAPES Foundation, Brazil. SFB and MM gratefully
   acknowledge support from Vertex Pharmaceuticals.
CR Agrawal V, 2010, P NATL ACAD SCI USA, V107, P3351, DOI 10.1073/pnas.0905851106
   Ashioti M, 2007, BRAIN RES, V1145, P177, DOI 10.1016/j.brainres.2007.01.111
   Aurand ER, 2014, STEM CELL RES, V12, P11, DOI 10.1016/j.scr.2013.09.013
   Aurand Emily R, 2012, J Funct Biomater, V3, P839, DOI 10.3390/jfb3040839
   Aurand ER, 2012, NEUROSCI RES, V72, P199, DOI 10.1016/j.neures.2011.12.005
   Badylak SF, 2014, ANN BIOMED ENG, V42, P1517, DOI 10.1007/s10439-013-0963-7
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Beattie AJ, 2009, TISSUE ENG PT A, V15, P1119, DOI 10.1089/ten.tea.2008.0162
   Bible E, 2012, BIOMATERIALS, V33, P2858, DOI 10.1016/j.biomaterials.2011.12.033
   Bible E, 2009, NAT PROTOC, V4, P1440, DOI 10.1038/nprot.2009.156
   Bible E, 2009, BIOMATERIALS, V30, P2985, DOI 10.1016/j.biomaterials.2009.02.012
   Bjugstad KB, 2010, J BIOMED MATER RES A, V95A, P79, DOI 10.1002/jbm.a.32809
   Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104
   Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904
   Bracher M, 2013, BIOMATERIALS, V34, P6797, DOI 10.1016/j.biomaterials.2013.05.057
   Brown BN, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00510
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Cheeran B, 2009, NEUROREHAB NEURAL RE, V23, P97, DOI 10.1177/1545968308326636
   Crapo PM, 2014, TISSUE ENG PT A, V20, P313, DOI [10.1089/ten.tea.2013.0186, 10.1089/ten.TEA.2013.0186]
   Crapo PM, 2012, BIOMATERIALS, V33, P3539, DOI 10.1016/j.biomaterials.2012.01.044
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Dalise S, 2014, ARCH ITAL BIOL, V152, P190, DOI 10.12871/00039829201442
   Dearth CL, 2016, ACTA BIOMATER, V31, P50, DOI 10.1016/j.actbio.2015.11.043
   Duncan K, 2015, BRAIN RES, V1623, P160, DOI 10.1016/j.brainres.2015.03.007
   Encarnacion A, 2011, J NEUROSCI METH, V196, P247, DOI 10.1016/j.jneumeth.2011.01.010
   Farnebo S, 2014, TISSUE ENG PT A, V20, P1550, DOI [10.1089/ten.tea.2013.0207, 10.1089/ten.TEA.2013.0207]
   Fournier E, 2003, BIOMATERIALS, V24, P3311, DOI 10.1016/S0142-9612(03)00161-3
   Freytes DO, 2008, BIOMATERIALS, V29, P1630, DOI 10.1016/j.biomaterials.2007.12.014
   Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Hosseini Y, 2015, INTEGR BIOL-UK, V7, P1432, DOI 10.1039/c5ib00207a
   Hsiao TW, 2015, BIOMATERIALS, V39, P124, DOI 10.1016/j.biomaterials.2014.10.062
   Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Leipzig ND, 2009, BIOMATERIALS, V30, P6867, DOI 10.1016/j.biomaterials.2009.09.002
   Ma Y., 2016, PROG NEUROBIOL
   Macaya DJ, 2013, BIOMATERIALS, V34, P3591, DOI 10.1016/j.biomaterials.2012.12.050
   Marcal H, 2012, REGEN MED, V7, P159, DOI [10.2217/RME.12.6, 10.2217/rme.12.6]
   Massensini AR, 2015, ACTA BIOMATER, V27, P116, DOI 10.1016/j.actbio.2015.08.040
   Mauney JR, 2015, ADV DRUG DELIVER REV, V82-83, P77, DOI 10.1016/j.addr.2014.10.016
   Medberry CJ, 2013, BIOMATERIALS, V34, P1033, DOI 10.1016/j.biomaterials.2012.10.062
   Meng FW, 2015, BIOMATERIALS, V46, P131, DOI 10.1016/j.biomaterials.2014.12.044
   Modo M, 2000, J NEUROSCI METH, V104, P99, DOI 10.1016/S0165-0270(00)00329-0
   Modo M, 2013, CURR OPIN NEUROL, V26, P626, DOI 10.1097/WCO.0000000000000031
   Modo Michel, 2009, J Exp Stroke Transl Med, V2, P52
   Mokarram N, 2012, BIOMATERIALS, V33, P8793, DOI 10.1016/j.biomaterials.2012.08.050
   Moreau F, 2012, STROKE, V43, P1837, DOI 10.1161/STROKEAHA.111.647859
   Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152
   Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751
   Piterina AV, 2009, INT J MOL SCI, V10, P4375, DOI 10.3390/ijms10104375
   Plantman S, 2013, BIOMED RES INT, DOI 10.1155/2013/981695
   Roll L, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00219
   Rossetti T., 2016, CELL TRANSPLANT
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Sicari BM, 2014, BIOMATERIALS, V35, P8605, DOI 10.1016/j.biomaterials.2014.06.060
   Simona BR, 2015, BIOMATER SCI-UK, V3, P586, DOI 10.1039/c4bm00416g
   Smith EJ, 2012, STEM CELLS, V30, P785, DOI 10.1002/stem.1024
   Stabenfeldt SE, 2010, TISSUE ENG PT A, V16, P3747, DOI [10.1089/ten.tea.2009.0837, 10.1089/ten.TEA.2009.0837]
   Stille M, 2013, J NEUROSCI METH, V219, P27, DOI 10.1016/j.jneumeth.2013.06.003
   Tate MC, 2002, CELL TRANSPLANT, V11, P283
   Taylor Z, 2004, J BIOMECH, V37, P1263, DOI 10.1016/j.jbiomech.2003.11.027
   Wolf MT, 2014, BIOMATERIALS, V35, P6838, DOI 10.1016/j.biomaterials.2014.04.115
NR 62
TC 23
Z9 26
U1 2
U2 59
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2016
VL 91
BP 166
EP 181
DI 10.1016/j.biomaterials.2016.03.014
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DK0OK
UT WOS:000374611900012
PM 27031811
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Chu, MQ
   Hai, WX
   Zhang, ZY
   Wo, FJ
   Wu, Q
   Zhang, ZF
   Shao, YX
   Zhang, D
   Jin, L
   Shi, DL
AF Chu, Maoquan
   Hai, Wangxi
   Zhang, Zheyu
   Wo, Fangjie
   Wu, Qiang
   Zhang, Zefei
   Shao, Yuxiang
   Zhang, Ding
   Jin, Lu
   Shi, Donglu
TI Melanin nanoparticles derived from a homology of medicine and food for
   sentinel lymph node mapping and photothermal in vivo cancer therapy
SO BIOMATERIALS
LA English
DT Article
DE Natural black sesame melanin; A homology of medicine and food;
   Sheet-like nanoparticles; Sentinel lymph node mapping; Cancer therapy
ID QUANTUM DOTS; INDOCYANINE GREEN; PHOTODYNAMIC THERAPY; BLUE-DYE;
   ANTIOXIDANT ACTIVITY; METHYLENE-BLUE; ISOSULFAN BLUE; SESAME; TEA;
   ANAPHYLAXIS
AB The use of non-toxic or low toxicity materials exhibiting dual functionality for use in sentinel lymph node (SLN) mapping and cancer therapy has attracted considerable attention during the past two decades. Herein, we report that the natural black sesame melanin (BSM) extracted from black sesame seeds (Sesamum indicum L.) shows exciting potential for SLN mapping and cancer photothermal therapy. Aqueous solutions of BSM under neutral and alkaline conditions can assemble into sheet-like nano particles ranging from 20 to 200 nm in size. The BSM nanoparticles were encapsulated by liposomes to improve their water solubility and the encapsulated and bare BSM nanoparticles were both non-toxic to cells. Furthermore, the liposome-encapsulated BSM nanoparticles (liposome-BSM) did not exhibit any long-term toxicity in mice. The liposome-BSM nanoparticles were subsequently used to passively target healthy and tumor-bearing mice SLNs, which were identified by the black color of the nanoparticles. BSM also strongly absorbed light in the near-infrared (NIR) range, which was rapidly converted to heat energy. Human esophagus carcinoma cells (Eca-109) were killed efficiently by liposome-BSM nanocomposites upon NIR laser irradiation. Furthermore, mouse tumor tissues grown from Eca-109 cells were seriously damaged by the photothermal effects of the liposome-BSM nanocomposites, with significant tumor growth suppression compared with controls. Given that BSM is a safe and nutritious biomaterial that can be easily obtained from black sesame seed, the results presented herein represent an important development in the use of natural biomaterials for clinical SLN mapping and cancer therapy. (c) 2016 Elsevier Ltd. All rights reserved.
C1 [Chu, Maoquan; Zhang, Zheyu; Wo, Fangjie; Wu, Qiang; Zhang, Zefei; Shao, Yuxiang; Zhang, Ding; Jin, Lu] Tongji Univ, Sch Life Sci & Technol, Shanghai East Hosp, Res Ctr Translat Med, Shanghai 200092, Peoples R China.
   [Hai, Wangxi] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200240, Peoples R China.
   [Shi, Donglu] Tongji Univ, Sch Med, Shanghai 200092, Peoples R China.
   [Shi, Donglu] Univ Cincinnati, Coll Engn & Appl Sci, Dept Mech & Mat Engn, Mat Sci & Engn Program, Cincinnati, OH 45221 USA.
RP Chu, MQ (reprint author), Tongji Univ, Sch Life Sci & Technol, Shanghai East Hosp, Res Ctr Translat Med, Shanghai 200092, Peoples R China.
EM mqchu98@tongji.edu.cn
FU National Natural Science Foundation of China [31370961]; Nanoscience
   Foundation of Shanghai [13NM1402000]; Program for New Century Excellent
   Talents in University [NCET-07-0618]
FX This work was supported in part by the National Natural Science
   Foundation of China (31370961), the Nanoscience Foundation of Shanghai
   (13NM1402000) and the Program for New Century Excellent Talents in
   University (No. NCET-07-0618).
CR Amr D, 2005, AM SURGEON, V71, P720
   [Anonymous], 2008, NAT REV UROL, V5, P67
   Ballou B, 2007, BIOCONJUGATE CHEM, V18, P389, DOI 10.1021/bc060261j
   Basu P, 2004, NAT BIOTECHNOL, V22, P263, DOI 10.1038/nbt0304-263
   Ben Othman S, 2015, FOOD CHEM, V175, P306, DOI 10.1016/j.foodchem.2014.11.155
   Bezu C, 2011, SURG ONCOL, V20, pE55, DOI 10.1016/j.suronc.2010.10.002
   Brisibe EA, 2009, FOOD CHEM, V115, P1240, DOI 10.1016/j.foodchem.2009.01.033
   Bronze-Uhle ES, 2013, J MOL STRUCT, V1047, P102, DOI 10.1016/j.molstruc.2013.04.061
   Cao YH, 1999, NATURE, V398, P381, DOI 10.1038/18793
   Catarci M, 1998, ANN SURG ONCOL, V5, P580, DOI 10.1007/BF02303825
   Cheng L, 2014, CHEM REV, V114, P10869, DOI 10.1021/cr400532z
   Chu MQ, 2013, BIOMATERIALS, V34, P4078, DOI 10.1016/j.biomaterials.2013.01.086
   Chu MQ, 2013, BIOMATERIALS, V34, P1820, DOI 10.1016/j.biomaterials.2012.11.027
   Chu MQ, 2012, BIOMATERIALS, V33, P7071, DOI 10.1016/j.biomaterials.2012.06.062
   Chung JE, 2014, NAT NANOTECHNOL, V9, P907, DOI [10.1038/NNANO.2014.208, 10.1038/nnano.2014.208]
   Eichler J, 2000, MED ENG PHYS, V22, P307, DOI 10.1016/S1350-4533(00)00037-0
   Erogbogbo F, 2011, ACS NANO, V5, P413, DOI 10.1021/nn1018945
   Garbisa S, 1999, NAT MED, V5, P1216, DOI 10.1038/15145
   Gray J, 2007, PHOTODIAGN PHOTODYN, V4, P151, DOI 10.1016/j.pdpdt.2007.04.003
   Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100
   Hong XM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7304
   Hsia SM, 2006, INT J IMPOT RES, V18, P264, DOI 10.1038/sj.ijir.3901405
   Hu A, 2015, SCI REP-UK, V5, DOI 10.1038/srep13429
   Huang XL, 2012, BIOMATERIALS, V33, P4370, DOI 10.1016/j.biomaterials.2012.02.060
   Jangjoo A, 2010, ACTA ONCOL, V49, P877, DOI 10.3109/02841861003769964
   Jankun J, 1997, NATURE, V387, P561, DOI 10.1038/42381
   Jaque D, 2014, NANOSCALE, V6, P9494, DOI 10.1039/c4nr00708e
   Jiang X., 2015, INT J ORAL MAXILLOFA
   Jiang XW, 2012, OR SURG OR MED OR PA, V113, P500, DOI 10.1016/j.oooo.2011.09.007
   Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282
   Kaur IP, 2000, MUTAT RES-GEN TOX EN, V470, P71, DOI 10.1016/S1383-5718(00)00096-6
   Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920
   Kobayashi H, 2007, NANO LETT, V7, P1711, DOI 10.1021/nl0707003
   Kuerer HM, 2001, SURGERY, V129, P119, DOI 10.1067/msy.2001.111212
   Leong SPL, 2000, ANN SURG ONCOL, V7, P361, DOI 10.1007/s10434-000-0361-x
   Levenback C, 2001, GYNECOL ONCOL, V83, P276, DOI 10.1006/gyno.2001.6374
   Li GD, 2011, NANOSCALE, V3, P3251, DOI 10.1039/c1nr10284b
   Li LB, 2010, PHOTODIAGN PHOTODYN, V7, P139, DOI 10.1016/j.pdpdt.2010.06.002
   Li WW, 2015, BIOMATERIALS, V45, P18, DOI 10.1016/j.biomaterials.2014.12.037
   Liao MY, 2012, CHEM COMMUN, V48, P5319, DOI 10.1039/c2cc31448g
   Liu Z, 2014, BIOMATERIALS, V35, P4099, DOI 10.1016/j.biomaterials.2014.01.053
   Lyew MA, 2000, ANESTHESIOLOGY, V93, P1145, DOI 10.1097/00000542-200010000-00041
   Ma Y, 2013, BIOMATERIALS, V34, P7706, DOI 10.1016/j.biomaterials.2013.07.007
   MCCULLOCH DG, 1994, PHYS REV B, V50, P5905, DOI 10.1103/PhysRevB.50.5905
   Mizumoto M, 2014, RADIOTHER ONCOL, V113, P54, DOI 10.1016/j.radonc.2014.08.015
   Moon HK, 2009, ACS NANO, V3, P3707, DOI 10.1021/nn900904h
   Muijs CT, 2010, RADIOTHER ONCOL, V97, P165, DOI 10.1016/j.radonc.2010.04.024
   NAMIKI M, 1995, FOOD REV INT, V11, P281, DOI 10.1080/87559129509541043
   Nandi I., 2015, BIOACTIVE CARBOHYDRA, V5, P129
   Ohnishi S, 2005, MOL IMAGING, V4, P172
   Ono E, 2006, P NATL ACAD SCI USA, V103, P10116, DOI 10.1073/pnas.0603865103
   Oomah S., 2010, ALLERGY ASTHMA CL IM, V6, P29
   Pan DPJ, 2010, BIOMATERIALS, V31, P4088, DOI 10.1016/j.biomaterials.2010.01.136
   Panzella L, 2012, J AGR FOOD CHEM, V60, P8895, DOI 10.1021/jf2053096
   Park SH, 2010, FOOD REV INT, V26, P103, DOI 10.1080/87559120903564464
   Pattison DJ, 2008, NAT CLIN PRACT RHEUM, V4, P590, DOI 10.1038/ncprheum0920
   Plante M, 2015, GYNECOL ONCOL, V137, P443, DOI 10.1016/j.ygyno.2015.03.004
   Pons T, 2010, ACS NANO, V4, P2531, DOI 10.1021/nn901421v
   Raaphorst G. P., 1990, INTRO PRACTICAL ASPE, P10
   Rodwell C, 2012, NAT REV CANCER, V12, DOI 10.1038/nrc3288
   Rzyman W, 2006, EJSO, V32, P462, DOI 10.1016/j.ejso.2006.01.005
   Salazar H, 2008, NAT NEUROSCI, V11, P255, DOI 10.1038/nn2056
   Shahidi F, 1997, J AM OIL CHEM SOC, V74, P143, DOI 10.1007/s11746-997-0159-0
   Shahidi F, 2006, FOOD CHEM, V99, P478, DOI 10.1016/j.foodchem.2005.08.009
   Sharker SM, 2015, BIOMATERIALS, V61, P229, DOI 10.1016/j.biomaterials.2015.05.040
   Soltesz EG, 2005, ANN THORAC SURG, V79, P269, DOI 10.1016/j.athoracsur.2004.06.055
   Song KH, 2009, NANO LETT, V9, P183, DOI 10.1021/nl802746w
   Storm F. K., 1992, ARCH SURG-CHICAGO, V127, P392
   Sun Y, 2011, BIOMATERIALS, V32, P2999, DOI 10.1016/j.biomaterials.2011.01.011
   Sunagawa Y., 2015, PHARM NUTR
   Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743
   Teknos D, 2008, J NATL MED ASSOC, V100, P1483, DOI 10.1016/S0027-9684(15)31552-2
   Thomas SN, 2014, BIOMATERIALS, V35, P814, DOI 10.1016/j.biomaterials.2013.10.003
   Toma Atsushi, 2002, Gan To Kagaku Ryoho, V29, P2291
   Vaijayanthimala V, 2012, BIOMATERIALS, V33, P7794, DOI 10.1016/j.biomaterials.2012.06.084
   Wahid FN, 2014, J PEDIAT SURG CASE R, V2, P117, DOI 10.1016/j.epsc.2014.02.009
   Wu YF, 2014, COMPLEMENT THER MED, V22, P40, DOI 10.1016/j.ctim.2013.12.010
   Xia L, 2014, BIOMATERIALS, V35, P4146, DOI 10.1016/j.biomaterials.2014.01.068
   Xin C, 2015, J BIOSCI BIOENG, V119, P446, DOI 10.1016/j.jbiosc.2014.09.009
   Xu L.P., 2006, THESIS JIANGNAN U
   Yang K, 2015, BIOMATERIALS, V38, P1, DOI 10.1016/j.biomaterials.2014.10.052
   Yang X, 2015, SCI REP-UK, V5, DOI 10.1038/srep10322
   Yuan A, 2013, J PHARM SCI-US, V102, P6, DOI 10.1002/jps.23356
   Zhang C, 2010, BIOMATERIALS, V31, P1911, DOI 10.1016/j.biomaterials.2009.11.061
   Zhang M, 2008, P NATL ACAD SCI USA, V105, P14773, DOI 10.1073/pnas.0801349105
NR 85
TC 11
Z9 13
U1 19
U2 155
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2016
VL 91
BP 182
EP 199
DI 10.1016/j.biomaterials.2016.03.018
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DK0OK
UT WOS:000374611900013
PM 27031812
DA 2018-10-19
ER

PT J
AU Zabost, E
   Liwinska, W
   Karbarz, M
   Kurek, E
   Lyp, M
   Donten, M
   Stojek, Z
AF Zabost, Ewelina
   Liwinska, Wioletta
   Karbarz, Marcin
   Kurek, Eliza
   Lyp, Marek
   Donten, Mikolaj
   Stojek, Zbigniew
TI Electrochemical examination of ability of dsDNA/PAM composites for
   storing and releasing of doxorubicin
SO BIOELECTROCHEMISTRY
LA English
DT Article
DE DNA electrooxidation; Doxorubicin; Drug delivery system; Polyacrylamide;
   Square wave voltammetry; Switching system
ID NUCLEIC-ACID BASES; DRUG-DELIVERY; SIRNA DELIVERY; DNA; HYDROGELS;
   NANOPARTICLES; TEMPERATURE; DENATURATION; POLYMER; SYSTEMS
AB Composites consisting of ss- and ds-DNA strands and polyacrylamide (PAM) hydrogel have been synthesized. DNA was entrapped non-covalently. The obtained DNA biomaterial exhibited a strong increase in.guanine and adenine anodic currents when temperature reached the physiological level. This increase was related to the unique oligonucleotide structural changes in the composite. The structural alterations in the PAM lattices were employed for the release of the drug accumulated in the composite. Doxorubicin (Dox) was selected as the drug; it was accumulated by intercalation to dsDNA and was slowly released from the dsDNA/PAM system by using a minor temperature increase (up to 40 divided by 45 degrees C) as it is routinely done in hyperthermia. The applied release temperature was either constant or oscillating. The binding strength, the rate of Dox release and the properties of the composite were examined using voltammetry, SEM and ICP-MS. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Zabost, Ewelina; Liwinska, Wioletta; Karbarz, Marcin; Kurek, Eliza; Donten, Mikolaj; Stojek, Zbigniew] Univ Warsaw, Fac Chem, Pasteura 1, PL-02093 Warsaw, Poland.
   [Lyp, Marek] Coll Rehabil, Kasprzaka 49, PL-01234 Warsaw, Poland.
RP Zabost, E (reprint author), Univ Warsaw, Fac Chem, Pasteura 1, PL-02093 Warsaw, Poland.
EM ezabost@chem.uw.edu.pl
FU NCN [2012/05/D/ST5/03464]
FX Support of this work by NCN grant no.: 2012/05/D/ST5/03464 is thankfully
   acknowledged.
CR Agarwal T, 2015, INT J BIOL MACROMOL, V75, P409, DOI 10.1016/j.ijbiomac.2014.12.052
   Baser B., 2010, J APPL POLYM SCI, V120, P1420
   Bird S.P., 2001, ANALYST, V136, P3410
   Campolongo MJ, 2011, J MATER CHEM, V21, P6113, DOI 10.1039/c0jm03854g
   Cheng W., 2015, SCI ENG C, V45, P600
   Costa D., 2010, ADV COLLOID INTERF S, V158, P94
   Costa D, 2010, COLLOID SURFACE A, V354, P28, DOI 10.1016/j.colsurfa.2009.08.009
   Fahlman RP, 2003, NANO LETT, V3, P1073, DOI 10.1021/nl034267i
   Gogoi M, 2014, NANOMEDICINE-UK, V9, P955, DOI [10.2217/NNM.13.90, 10.2217/nnm.13.90]
   Gu FX, 2007, NANO TODAY, V2, P14, DOI 10.1016/S1748-0132(07)70083-X
   Guo WW, 2014, ANGEW CHEM INT EDIT, V53, P10134, DOI 10.1002/anie.201405692
   Gyenes T, 2008, ACTA BIOMATER, V4, P733, DOI 10.1016/j.actbio.2007.12.004
   Hruby M, 2015, EUR POLYM J, V65, P82, DOI 10.1016/j.eurpolymj.2015.01.016
   Huang H., 2010, NANO, V25, P2892
   Huo H, 2015, J COLLOID INTERF SCI, V447, P8, DOI 10.1016/j.jcis.2015.01.043
   Hynek D, 2012, INT J ELECTROCHEM SC, V7, P34
   Islam M., 2015, J MATER CHEM B, V1, P1
   Jeffryes C, 2015, CURR OPIN BIOTECH, V33, P23, DOI 10.1016/j.copbio.2014.10.005
   Kaniewska K, 2013, RSC ADV, V3, P23816, DOI 10.1039/c3ra42405g
   Karbarz M, 2010, SOFT MATTER, V6, P1336, DOI 10.1039/b920809g
   Karbarz M, 2009, ELECTROCHEM COMMUN, V11, P1217, DOI 10.1016/j.elecom.2009.04.005
   Katas H, 2006, J CONTROL RELEASE, V115, P216, DOI 10.1016/j.jconrel.2006.07.021
   Kim JK, 2014, ARCH PHARM RES, V37, P60, DOI 10.1007/s12272-013-0280-6
   Kim SM, 2013, POLYMER, V54, P2138, DOI 10.1016/j.polymer.2013.02.014
   KREMER M, 1994, MACROMOLECULES, V27, P2965, DOI 10.1021/ma00089a012
   Lee J, 2012, NAT NANOTECHNOL, V7, P816, DOI [10.1038/nnano.2012.211, 10.1038/NNANO.2012.211]
   Liao WC, 2010, ELECTROPHORESIS, V31, P2813, DOI 10.1002/elps.201000081
   Liu JW, 2011, SOFT MATTER, V7, P6757, DOI 10.1039/c1sm05284e
   Lu S., 2013, J COLLOID INTERF SCI, V412, P50
   Mackiewicz M, 2015, J MATER CHEM B, V3, P7262, DOI 10.1039/c5tb00907c
   MCFADYEN WD, 1990, BIOCHIM BIOPHYS ACTA, V1048, P50, DOI 10.1016/0167-4781(90)90021-S
   Merino S, 2015, ACS NANO, V9, P4686, DOI 10.1021/acsnano.5b01433
   Mora L, 2009, J CONTROL RELEASE, V140, P69, DOI 10.1016/j.jconrel.2009.08.002
   Nowicka A.M., 2007, BIOELECTROCHEMISTRY, V71, P440
   Nowicka AM, 2011, PHYS CHEM CHEM PHYS, V13, P7500, DOI 10.1039/c0cp02667k
   Oliveira-Brett AM, 2002, TALANTA, V56, P959, DOI 10.1016/S0039-9140(01)00656-7
   Palecek E, 2005, PERSP BIOANAL, V1, P1
   PALECEK E, 1965, J MOL BIOL, V11, P839, DOI 10.1016/S0022-2836(65)80040-7
   Palecek E, 2012, CHEM REV, V112, P3427, DOI 10.1021/cr200303p
   Piedade JAP, 2002, BIOELECTROCHEMISTRY, V56, P81, DOI 10.1016/S1567-5394(02)00013-0
   POLTEV VI, 1991, J BIOMOL STRUCT DYN, V9, P101, DOI 10.1080/07391102.1991.10507896
   Privalova AM, 2015, J NANOSCI NANOTECHNO, V15, P4806, DOI 10.1166/jnn.2015.10508
   Qiaoling L., 2014, APTAMER CONJUGATED N
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Roberts A.G., 2013, METHOD MOL BIOL, V1054, P1
   Samain F, 2015, CURR OPIN CHEM BIOL, V26, P72, DOI 10.1016/j.cbpa.2015.02.009
   Sanson C, 2010, J CONTROL RELEASE, V147, P428, DOI 10.1016/j.jconrel.2010.07.123
   Shelkovsky VS, 2002, EUR PHYS J D, V20, P421, DOI 10.1140/epjd/e2002-00144-9
   Shim MS, 2013, ANGEW CHEM INT EDIT, V52, P6926, DOI 10.1002/anie.201209633
   Syed SN, 2013, J AM CHEM SOC, V135, P5399, DOI 10.1021/ja311873t
   Tsung-Hua J., 2008, RECENT PATENTS MAT S, V1, P29
   Varga N., 2015, MICROPOR MESOPOR MAT, V2013, P134
   Wang F, 2015, ANGEW CHEM INT EDIT, V54, P1098, DOI 10.1002/anie.201404652
   Wang J, 1998, BIOELECTROCH BIOENER, V45, P33, DOI 10.1016/S0302-4598(98)00075-0
   Xiong XL, 2013, MACROMOL RAPID COMM, V34, P1271, DOI 10.1002/marc.201300411
   Ye L, 2014, J MATER CHEM B, V2, P5746, DOI 10.1039/c4tb00719k
   Zabost E, 2014, ELECTROCHEM COMMUN, V42, P50, DOI 10.1016/j.elecom.2014.02.011
   Zabost E, 2012, PHYS CHEM CHEM PHYS, V14, P3408, DOI 10.1039/c2cp23824a
   Zabost E, 2009, PHYS CHEM CHEM PHYS, V11, P8933, DOI 10.1039/b906752c
   Zhu YY, 2015, J NANOSCI NANOTECHNO, V15, P4753, DOI 10.1166/jnn.2015.10298
   Zou H, 2015, J MATER CHEM B, V3, P260, DOI 10.1039/c4tb01518e
NR 61
TC 4
Z9 4
U1 2
U2 38
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1567-5394
EI 1878-562X
J9 BIOELECTROCHEMISTRY
JI Bioelectrochemistry
PD JUN
PY 2016
VL 109
BP 1
EP 8
DI 10.1016/j.bioelechem.2015.12.001
PG 8
WC Biochemistry & Molecular Biology; Biology; Biophysics; Electrochemistry
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Biophysics; Electrochemistry
GA DI3SI
UT WOS:000373418400001
PM 26764570
DA 2018-10-19
ER

PT J
AU Lim, PN
   Lam, RN
   Zheng, YF
   Thian, ES
AF Lim, P. N.
   Lam, R. N.
   Zheng, Y. F.
   Thian, E. S.
TI Magnesium-calcium/hydroxyapatite (Mg-Ca/HA) composites with enhanced
   bone differentiation properties for orthopedic applications
SO MATERIALS LETTERS
LA English
DT Article
DE Hydroxyapatite; Magnesium-calcium; Composites; Stem cells
ID IN-VITRO; OSTEOBLASTIC CELLS; ALLOYS; HYDROXYAPATITE; BEHAVIOR
AB Mg-1Ca/HA composites were produced by blending magnesium-calcium (1 wt%) (Mg-1Ca) alloys with 5, 10 and 15 wt% of hydroxyapatite (HA). Morphology, elemental and phase composition of Mg-1Ca/HA composites were examined. Biocompatibility assessments were also performed using an indirect contact method by culturing human adipose mesenchymal stem cells (hASCs) in the extracts of Mg-1Ca alloy, Mg-1Ca/HA composites and Dulbecco's modified eagle's medium. Mg-1Ca/HA composites could promote cell proliferation and at the same time, enhanced collagen type I (COL I) and osteocalcin (OCN) expressions of hASCs. Among the Mg-1Ca/HA composites, 10 wt% of HA is the optimum amount to be added into Mg-1Ca alloy for enhanced bioactivity, thus emerging as a potential biomaterial for orthopedic fixation. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Lim, P. N.; Lam, R. N.; Thian, E. S.] Natl Univ Singapore, Dept Mech Engn, 9 Engn Dr 1, Singapore 117576, Singapore.
   [Zheng, Y. F.] Peking Univ, Coll Engn, Dept Mat Sci & Engn, Beijing 100871, Peoples R China.
RP Thian, ES (reprint author), Natl Univ Singapore, Dept Mech Engn, 9 Engn Dr 1, Singapore 117576, Singapore.; Zheng, YF (reprint author), Peking Univ, Coll Engn, Dept Mat Sci & Engn, Beijing 100871, Peoples R China.
EM yfzheng@pku.edu.cn; mpetes@nus.edu.sg
RI Zheng, Yufeng/A-4146-2010
OI Zheng, Yufeng/0000-0002-7402-9979
FU Ministry of Education Academic Research Fund (Singapore)
   [MOE2013-T2-1-074]; National Basic Research Program of China (973
   Program) [2012CB619102]; National Science Fund for Distinguished Young
   Scholars [51225101]; National Natural Science Foundation of China
   [51431002, 31170909]; Beijing Municipal Science and Technology Project
   [Z141100002814008]
FX This work was supported by the Ministry of Education Academic Research
   Fund (Singapore) Project number MOE2013-T2-1-074, and the National Basic
   Research Program of China (973 Program) (Grant no. 2012CB619102),
   National Science Fund for Distinguished Young Scholars (Grant no.
   51225101), National Natural Science Foundation of China (Grant nos.
   51431002 and 31170909), Beijing Municipal Science and Technology Project
   (Z141100002814008).
CR Cha PR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02367
   Chua BW, 1999, COMPOS STRUCT, V47, P595, DOI 10.1016/S0263-8223(00)00031-3
   Dorozhkin Sergey V, 2010, J Funct Biomater, V1, P22, DOI 10.3390/jfb1010022
   Dou YN, 2014, PROG NAT SCI-MATER, V24, P433, DOI 10.1016/j.pnsc.2014.08.001
   Hott M, 1997, J BIOMED MATER RES, V37, P508, DOI 10.1002/(SICI)1097-4636(19971215)37:4<508::AID-JBM9>3.0.CO;2-P
   Landi E, 2008, J MATER SCI-MATER M, V19, P239, DOI 10.1007/s10856-006-0032-y
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Lim PN, 2014, ACS APPL MATER INTER, V6, P17082, DOI 10.1021/am504716g
   Lim PN, 2012, J BIOMED MATER RES B, V100B, P285, DOI 10.1002/jbm.b.31951
   Salahshoor M, 2012, MATERIALS, V5, P135, DOI 10.3390/ma5010135
   Shu R, 2003, J BIOMED MATER RES A, V67A, P1196, DOI 10.1002/jbm.a.20021
   Xu LP, 2009, BIOMATERIALS, V30, P1512, DOI 10.1016/j.biomaterials.2008.12.001
   Zheng YF, 2010, ACTA BIOMATER, V6, P1783, DOI 10.1016/j.actbio.2009.10.009
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 14
TC 10
Z9 10
U1 10
U2 56
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD JUN 1
PY 2016
VL 172
BP 193
EP 197
DI 10.1016/j.matlet.2016.03.005
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA DI1WU
UT WOS:000373288500048
DA 2018-10-19
ER

PT J
AU Lee, JW
   Soman, P
   Park, JH
   Chen, SC
   Cho, DW
AF Lee, Jin Woo
   Soman, Pranav
   Park, Jeong Hun
   Chen, Shaochen
   Cho, Dong-Woo
TI A Tubular Biomaterial Construct Exhibiting a Negative Poisson's Ratio
SO PLOS ONE
LA English
DT Article
ID SMALL-INTESTINAL SUBMUCOSA; VASCULAR GRAFTS; BIODEGRADABLE POLYMER;
   PULMONARY-ARTERY; AUXETIC BEHAVIOR; BLOOD-VESSEL; HOLY-GRAIL; IN-VITRO;
   GROWTH; MODEL
AB Developing functional small-diameter vascular grafts is an important objective in tissue engineering research. In this study, we address the problem of compliance mismatch by designing and developing a 3D tubular construct that has a negative Poisson's ratio v(xy) (NPR). NPR constructs have the unique ability to expand transversely when pulled axially, thereby resulting in a highly-compliant tubular construct. In this work, we used projection stereolithography to 3D-print a planar NPR sheet composed of photosensitive poly(ethylene) glycol diacrylate biomaterial. We used a step-lithography exposure and a stitch process to scale up the projection printing process, and used the cut-missing rib unit design to develop a centimeter-scale NPR sheet, which was rolled up to form a tubular construct. The constructs had Poisson's ratios of -0.6 <= -v(xy) <= -0.1. The NPR construct also supports higher cellular adhesion than does the construct that has positive v(xy). Our NPR design offers a significant advance in the development of highly-compliant vascular grafts.
C1 [Lee, Jin Woo] Gachon Univ, Sch Med, Dept Mol Med, 7-45 Songdo Dong, Inchon 406840, South Korea.
   [Soman, Pranav] Syracuse Univ, Dept Biomed & Chem Engn, 318 Browne Hall, Syracuse, NY 13244 USA.
   [Park, Jeong Hun; Cho, Dong-Woo] Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, San 31, Pohang 790781, Gyeongbuk, South Korea.
   [Chen, Shaochen] Univ Calif San Diego, Dept NanoEngn, 9500 Gilman Dr,Atkinson Hall,MC-0448, La Jolla, CA 92093 USA.
RP Cho, DW (reprint author), Pohang Univ Sci & Technol POSTECH, Dept Mech Engn, San 31, Pohang 790781, Gyeongbuk, South Korea.; Chen, SC (reprint author), Univ Calif San Diego, Dept NanoEngn, 9500 Gilman Dr,Atkinson Hall,MC-0448, La Jolla, CA 92093 USA.
EM chen168@eng.ucsd.edu; dwcho@postech.ac.kr
FU National Institutes of Health [EB012597, EB017876]; National Research
   Foundation of Korea (NRF) [2014R1A1A2A16054777, 2010-0018294]; Korea
   Health Industry Development Institute (KHIDI) [HI14C3228]
FX This study was supported by the National Institutes of Health (EB012597
   and EB017876, http://www.nih.gov/) to SC; National Research Foundation
   of Korea (NRF)(2014R1A1A2A16054777, http://www.nrf.re.kr/) to JWL;
   National Research Foundation of Korea (NRF) (2010-0018294,
   http://www.nrf.re.kr/) to D-WC; Korea Health Industry Development
   Institute (KHIDI) (HI14C3228, http://www.khidi.or.kr/) to JWL.; We
   greatly appreciate the financial support from National Institutes of
   Health (EB012597 and EB017876) to S.C, National Research Foundation
   (NRF) of Korea (No. 2014R1A1A2A16054777 & No. 2010-0018294) and the
   Korea Health Industry Development Institute (KHIDI) (HI14C3228). And We
   also appreciate the donation of human turbinate mesenchymal stromal
   cells from Prof. Sung-Won Kim (Seoul Saint Mary Hospital).
CR Association AH, 2003, BIOST FACTSH CARD PR
   Badylak SF, 1998, J BIOMAT SCI-POLYM E, V9, P863, DOI 10.1163/156856298X00208
   BASSIOUNY HS, 1992, J VASC SURG, V15, P708, DOI 10.1016/0741-5214(92)90019-5
   Buckmann T, 2012, ADV MATER, V24, P2710, DOI 10.1002/adma.201200584
   CANHAM PB, 1991, CONNECT TISSUE RES, V26, P121, DOI 10.3109/03008209109152168
   Chaouat M, 2006, BIOMATERIALS, V27, P5546, DOI 10.1016/j.biomaterials.2006.06.032
   Conte MS, 1998, FASEB J, V12, P43
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Dahl SLM, 2003, CELL TRANSPLANT, V12, P659, DOI 10.3727/000000003108747136
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Eisenstadt MM, 1971, INTRO MECH PROPERTIE
   EVANS KE, 1991, NATURE, V353, P124, DOI 10.1038/353124a0
   Fozdar DY, 2011, ADV FUNCT MATER, V21, P2712, DOI 10.1002/adfm.201002022
   Fozdar DY, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/21/215303
   Fung Y, 1993, BIOMECHANICS MECH PR, P321
   Gaspar N, 2005, ACTA MATER, V53, P2439, DOI 10.1016/j.actamat.2005.02.006
   Gibson L.J., 1997, CELLULAR SOLIDS STRU, P510
   GIBSON LJ, 1982, P ROY SOC LOND A MAT, V382, P25, DOI 10.1098/rspa.1982.0087
   GLAGOV S, 1979, ARTERY, V5, P295
   Hoerstrup SP, 2002, ANN THORAC SURG, V74, P46, DOI 10.1016/S0003-4975(02)03649-4
   Hoerstrup SP, 2001, EUR J CARDIO-THORAC, V20, P164, DOI 10.1016/S1010-7940(01)00706-0
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   Kakisis JD, 2005, J VASC SURG, V41, P349, DOI 10.1016/j.jvs.2004.12.026
   Kannan RY, 2005, BIOMATERIALS, V26, P1857, DOI 10.1016/j.biomaterials.2004.07.006
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   Kurane A, 2007, BIOMATERIALS, V28, P2830, DOI 10.1016/j.biomaterials.2007.02.031
   L'Heureux N, 1998, FASEB J, V12, P47
   Masters IG, 1996, COMPOS STRUCT, V35, P403, DOI 10.1016/S0263-8223(96)00054-2
   Mooney DT, 1996, BIOMATERIALS, V17, P115, DOI 10.1016/0142-9612(96)85756-5
   Ounpuu S, 2000, EUR HEART J, V21, P880, DOI 10.1053/euhj.1999.1880
   Perler BA, 1995, J VASC INTERV RADIOL, V6, pS111, DOI 10.1016/S1051-0443(95)71259-3
   Popov EP, 1990, ENG MECH SOLIDS, P82
   Rashid ST, 2004, BIOMATERIALS, V25, P1627, DOI 10.1016/S0142-9612(03)00522-2
   Robotin-Johnson MC, 1998, J THORAC CARDIOV SUR, V116, P805, DOI 10.1016/S0022-5223(98)00436-X
   SANDUSKY GE, 1992, AM J PATHOL, V140, P317
   Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717
   Shum-Tim D, 1999, ANN THORAC SURG, V68, P2298, DOI 10.1016/S0003-4975(99)01055-3
   Smith CW, 2000, ACTA MATER, V48, P4349, DOI 10.1016/S1359-6454(00)00269-X
   Soletti L, 2011, J BIOMED MATER RES A, V96A, P436, DOI 10.1002/jbm.a.32997
   Pranav S, 2012, BIOMATERIALS, V33, P7064, DOI 10.1016/j.biomaterials.2012.06.012
   Soman P, 2012, ACTA BIOMATER, V8, P2587, DOI 10.1016/j.actbio.2012.03.035
   Soman P, 2012, SOFT MATTER, V8, P4946, DOI 10.1039/c2sm07354d
   Sung HW, 1997, ARTIF ORGANS, V21, P50
   Teebken OE, 2002, EUR J VASC ENDOVASC, V23, P475, DOI 10.1006/ejvs.2002.1654
   Timmins LH, 2010, AM J PHYSIOL-HEART C, V298, pH1537, DOI 10.1152/ajpheart.00891.2009
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Wake MC, 1996, CELL TRANSPLANT, V5, P465, DOI 10.1016/0963-6897(96)00025-5
   Watanabe M, 2001, TISSUE ENG, V7, P429, DOI 10.1089/10763270152436481
   WOLINSKY H, 1964, CIRC RES, V14, P400, DOI 10.1161/01.RES.14.5.400
   Zund G, 1998, EUR J CARDIO-THORAC, V13, P160, DOI 10.1016/S1010-7940(97)00309-6
NR 51
TC 1
Z9 1
U1 1
U2 22
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 27
PY 2016
VL 11
IS 5
AR e0155681
DI 10.1371/journal.pone.0155681
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DN2GV
UT WOS:000376883000005
PM 27232181
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Abhyankar, VV
   Wu, MY
   Koh, CY
   Hatch, AV
AF Abhyankar, Vinay V.
   Wu, Meiye
   Koh, Chung-Yan
   Hatch, Anson V.
TI A Reversibly Sealed, Easy Access, Modular (SEAM) Microfluidic
   Architecture to Establish In Vitro Tissue Interfaces
SO PLOS ONE
LA English
DT Article
ID ORGANS-ON-CHIPS; PEPTIDE-AMPHIPHILE NANOFIBERS; CELL-CULTURE;
   EXTRACELLULAR-MATRIX; MOLECULAR-MECHANISMS; DRUG DISCOVERY; MEMBRANES;
   DEVICES; MICROFABRICATION; PURIFICATION
AB Microfluidic barrier tissue models have emerged as advanced in vitro tools to explore interactions with external stimuli such as drug candidates, pathogens, or toxins. However, the procedures required to establish and maintain these systems can be challenging to implement for end users, particularly those without significant in-house engineering expertise. Here we present a module-based approach that provides an easy-to-use workflow to establish, maintain, and analyze microscale tissue constructs. Our approach begins with a removable culture insert that is magnetically coupled, decoupled, and transferred between standalone, prefabricated microfluidic modules for simplified cell seeding, culture, and downstream analysis. The modular approach allows several options for perfusion including standard syringe pumps or integration with a self-contained gravity-fed module for simple cell maintenance. As proof of concept, we establish a culture of primary human microvascular endothelial cells (HMVEC) and report combined surface protein imaging and gene expression after controlled apical stimulation with the bacterial endotoxin lipopolysaccharide (LPS). We also demonstrate the feasibility of incorporating hydrated biomaterial interfaces into the microfluidic architecture by integrating an ultra-thin (<1 mu m), self-assembled hyaluronic acid/peptide amphiphile culture membrane with brain-specific Young's modulus (similar to 1kPa). To highlight the importance of including biomimetic interfaces into microscale models we report multi-tiered readouts from primary rat cortical cells cultured on the self-assembled membrane and compare a panel of mRNA targets with primary brain tissue signatures. We anticipate that the modular approach and simplified operational workflows presented here will enable a wide range of research groups to incorporate microfluidic barrier tissue models into their work.
C1 [Abhyankar, Vinay V.; Wu, Meiye; Koh, Chung-Yan; Hatch, Anson V.] Sandia Natl Labs, Dept Biotechnol & Bioengn, Livermore, CA 94551 USA.
   [Abhyankar, Vinay V.] Univ Texas Arlington, Res Inst, Biol Microsyst, Ft Worth, TX 76118 USA.
RP Abhyankar, VV; Hatch, AV (reprint author), Sandia Natl Labs, Dept Biotechnol & Bioengn, Livermore, CA 94551 USA.; Abhyankar, VV (reprint author), Univ Texas Arlington, Res Inst, Biol Microsyst, Ft Worth, TX 76118 USA.
EM vinay.abhyankar@gmail.com; ahatch@sandia.gov
OI Abhyankar, Vinay/0000-0002-8462-3920
FU Laboratory Directed Research and Development (LDRD) at Sandia National
   Laboratories; Defense Threat Reduction Agency Joint Science and
   Technology Office for Chemical and Biological Defense (IAA) [DTRA
   10027IA-3167]; NIAID [R01AI98853]; US Department of Energy
   [DE-AC04-94AL85000]
FX This work was funded under Laboratory Directed Research and Development
   (LDRD) at Sandia National Laboratories and by the Defense Threat
   Reduction Agency Joint Science and Technology Office for Chemical and
   Biological Defense (IAA number DTRA 10027IA-3167). CK was supported by
   NIAID grant R01AI98853. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.; Sandia National Laboratories is a multi-program laboratory
   operated by Sandia Corporation, a Lockheed Martin Company, for the US
   Department of Energy under contract DE-AC04-94AL85000. Illustrations
   contained vector art designed by Freepik. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abaci HE, 2015, LAB CHIP, V15, P882, DOI 10.1039/c4lc00999a
   Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824
   Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Beebe DJ, 2000, P NATL ACAD SCI USA, V97, P13488, DOI 10.1073/pnas.250273097
   Beniash E, 2005, ACTA BIOMATER, V1, P387, DOI 10.1016/j.actbio.2005.04.002
   Berry SM, 2014, INTEGR BIOL-UK, V6, P224, DOI 10.1039/c3ib40136g
   Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989
   Bhattacharya J, 2013, ANNU REV PHYSIOL, V75, P593, DOI 10.1146/annurev-physiol-030212-183756
   Bruggeman LA, 2012, CELL MOL BIOENG, V5, P194, DOI 10.1007/s12195-012-0221-3
   Capito RM, 2008, SCIENCE, V319, P1812, DOI 10.1126/science.1154586
   Carvajal D, 2010, SOFT MATTER, V6, P1816, DOI 10.1039/b923903k
   Chosewood LC, 2009, BIOSAFETY MICROBIOLO, Vxxii
   Chow LW, 2011, BIOMATERIALS, V32, P1574, DOI 10.1016/j.biomaterials.2010.10.048
   Delmas P, 2011, NAT REV NEUROSCI, V12, P139, DOI 10.1038/nrn2993
   Domansky K, 2013, LAB CHIP, V13, P3956, DOI 10.1039/c3lc50558h
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Engler A. J., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P335
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Esch MB, 2015, LAB CHIP, V15, P2269, DOI 10.1039/c5lc00237k
   Esch MB, 2014, ADV DRUG DELIVER REV, V69, P158, DOI 10.1016/j.addr.2013.12.003
   Esch MB, 2012, BIOMED MICRODEVICES, V14, P895, DOI 10.1007/s10544-012-9669-0
   Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303
   Frohlich EM, 2013, LAB CHIP, V13, P2311, DOI 10.1039/c3lc50199j
   Fuerstman MJ, 2007, LAB CHIP, V7, P1479, DOI 10.1039/b706549c
   Gaver DP, 1998, BIOPHYS J, V75, P721, DOI 10.1016/S0006-3495(98)77562-9
   Geetha T, 2013, J BIOL CHEM
   Ghaemmaghami AM, 2012, DRUG DISCOV TODAY, V17, P173, DOI 10.1016/j.drudis.2011.10.029
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Hatch AV, 2006, ANAL CHEM, V78, P4976, DOI 10.1021/ac0600454
   Herr AE, 2007, P NATL ACAD SCI USA, V104, P5268, DOI 10.1073/pnas.0607254104
   Hinsby AM, 2004, FRONT BIOSCI, V9, P2227, DOI 10.2741/1393
   Huh D, 2013, NAT PROTOC, V8, P2135, DOI 10.1038/nprot.2013.137
   Huh D, 2012, LAB CHIP, V12, P2156, DOI 10.1039/c2lc40089h
   Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005
   Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302
   Huynh J, 2013, CELL MOL BIOENG, V6
   Ismagilov RF, 2001, ANAL CHEM, V73, P5207, DOI 10.1021/ac010502a
   Kang E, 2013, ADV MATER, V25, P2167, DOI 10.1002/adma.201204619
   Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j
   Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717
   Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673
   Lin CC, 2010, JALA-J LAB AUTOM, V15, P253, DOI 10.1016/j.jala.2010.01.013
   Lu JT, 2007, BIOMATERIALS, V28, P1486, DOI 10.1016/j.biomaterials.2006.11.023
   Miller FD, 2001, NEURON, V32, P767, DOI 10.1016/S0896-6273(01)00529-3
   Miller JJ, 2015, J MICROMECHANICS MIC, V25
   NAKAYAMA M, 1995, J NEUROSCI, V15, P5238
   Nan L, 2014, LAB CHIP, V14, P1060, DOI 10.1039/c3lc51133b
   Rehfeldt F, 2007, ADV DRUG DELIVER REV, V59, P1329, DOI 10.1016/j.addr.2007.08.007
   Reichen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052246
   Richert L, 2004, BIOMACROMOLECULES, V5, P1908, DOI 10.1021/bm0498023
   Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489
   Soofi SS, 2009, J STRUCT BIOL, V167, P216, DOI 10.1016/j.jsb.2009.05.005
   Sung JH, 2010, LAB CHIP, V10, P446, DOI 10.1039/b917763a
   Temiz Y, 2015, MICROELECTRON ENG, V132, P156, DOI 10.1016/j.mee.2014.10.013
   Toepke MW, 2006, LAB CHIP, V6, P1484, DOI 10.1039/b612140c
   Van Heirstraeten L, 2014, LAB CHIP, V14, P1519, DOI 10.1039/c3lc51339d
   Verbist B, 2015, DRUG DISCOV TODAY, V20, P505, DOI 10.1016/j.drudis.2014.12.014
   Verhulsel M, 2014, BIOMATERIALS, V35, P1816, DOI 10.1016/j.biomaterials.2013.11.021
   Wang JD, 2012, ANN BIOMED ENG, V40, P1862, DOI 10.1007/s10439-012-0562-z
   Wang TW, 2009, ACTA BIOMATER, V5, P2371, DOI 10.1016/j.actbio.2009.03.033
   Zhang JH, 2002, NAT GENET, V30, P416, DOI 10.1038/ng859
   Zhang P, 2000, IMMUNOL REV, V173, P39, DOI 10.1034/j.1600-065X.2000.917306.x
   Zhu XY, 2004, ANALYST, V129, P1026, DOI 10.1039/b407623k
NR 65
TC 4
Z9 4
U1 3
U2 28
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 26
PY 2016
VL 11
IS 5
AR e0156341
DI 10.1371/journal.pone.0156341
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DN2GQ
UT WOS:000376882500118
PM 27227828
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Yue, W
   Yan, F
   Zhang, YL
   Liu, SL
   Hou, SP
   Mao, GC
   Liu, N
   Ji, Y
AF Yue, Wei
   Yan, Feng
   Zhang, Yue-Lin
   Liu, Shu-Ling
   Hou, Shu-Ping
   Mao, Guo-Chao
   Liu, Ning
   Ji, Yong
TI Differentiation of Rat Bone Marrow Mesenchymal Stem Cells Into
   Neuron-Like Cells In Vitro and Co-Cultured with Biological Scaffold as
   Transplantation Carrier
SO MEDICAL SCIENCE MONITOR
LA English
DT Article
DE Adult Stem Cells; Bone Marrow Cells; Tissue Engineering
ID TRAUMATIC BRAIN-INJURY; NERVE REGENERATION; CHITOSAN
AB Background: Autograft and allograft transplantation are used to prompt the regeneration of axons after nerve injury. However, the poor self-regeneration caused by the glial scar and growth inhibitory factors after neuronal necrosis limit the efficacy of these methods. The purpose of this study was to develop a new chitosan porous scaffold for cell seeding.
   Material/Methods: The bone marrow mesenchymal stem cells (BMSCs) and tissue-engineered biomaterial scaffold compound were constructed and co-cultured in vitro with the differentiated BMSCs of Wistar rats and chitosan scaffold in a 3D environment. The purity of the third-generation BMSCs culture was identified using flow cytometry and assessment of induced neuronal differentiation. The scaffolds were prepared by the freeze-drying method. The internal structure of scaffolds and the change of cells' growth and morphology were observed under a scanning electron microscope. The proliferation of cells was detected with the MTT method.
   Results: On day 5 there was a significant difference in the absorbance value of the experimental group (0.549 +/- 0.0256) and the control group (0.487 +/- 0.0357) (P>0.05); but on day 7 there was no significant difference in the proliferation of the experimental group (0.751 +/- 0.011) and the control group and (0.78 +/- 0.017) (P>0.05).
   Conclusions: Tissue engineering technology can provide a carrier for cells seeding and is expected to become an effective method for the regeneration and repair of nerve cells. Our study showed that chitosan porous scaffolds can be used for such purposes.
C1 [Yue, Wei; Liu, Shu-Ling; Ji, Yong] Tianjin Huanhu Hosp, Dept Neurol, Tianjin, Peoples R China.
   [Yan, Feng; Zhang, Yue-Lin; Mao, Guo-Chao] Xi An Jiao Tong Univ, Shanxi Prov Peoples Hosp, Affiliate Hosp 3, Dept Neurosurg, Xian 710049, Shaanxi, Peoples R China.
   [Hou, Shu-Ping] Tianjin Med Univ Gen Hosp, Dept Dermatovenereol, Tianjin, Peoples R China.
   [Liu, Ning] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Xian 710049, Shaanxi, Peoples R China.
RP Zhang, YL (reprint author), Xi An Jiao Tong Univ, Shanxi Prov Peoples Hosp, Affiliate Hosp 3, Dept Neurosurg, Xian 710049, Shaanxi, Peoples R China.
EM yuelinzhang111@163.com
CR Amado S, 2008, BIOMATERIALS, V29, P4409, DOI 10.1016/j.biomaterials.2008.07.043
   Andelic N, 2013, LANCET NEUROL, V12, P28, DOI [10.1016/S1474-4422(12)20294-6, 10.1016/S1474-4422(12)70294-6]
   Danilevicius P, 2015, APPL SURF SCI, V336, P2, DOI 10.1016/j.apsusc.2014.06.012
   Gulbake A, 2012, EXPERT OPIN DRUG DEL, V9, P713, DOI 10.1517/17425247.2012.682148
   Huang R, 2015, BIOMATERIALS, V53, P58, DOI 10.1016/j.biomaterials.2015.02.076
   Kong L, 2007, J BIOMATER APPL, V22, P223, DOI 10.1177/0885328206073706
   Kuroda S, 2011, J STEM CELLS REGEN, V7, P2
   Lee B.-Y., 2015, BIOMEDICAL PHYS ENG, V1
   Liu CZ, 2008, J BIOMED MATER RES B, V85B, P519, DOI 10.1002/jbm.b.30975
   Liu QF, 2015, PHARM RES-DORDR, V32, P22, DOI 10.1007/s11095-014-1441-0
   Nawrotek K, 2016, CARBOHYD POLYM, V136, P764, DOI 10.1016/j.carbpol.2015.09.105
   Rocamonde B, 2016, BRAIN INJURY, V10, P1
   Santander-Ortega MJ, 2011, COLLOID SURFACE B, V82, P571, DOI 10.1016/j.colsurfb.2010.10.019
   Shen Q, 2016, CELL PHYSIOL BIOCHEM, V38, P748, DOI 10.1159/000443031
   Shen ZS, 2015, RSC ADV, V5, P55640, DOI 10.1039/c5ra06835e
   Uchida H, 2016, STEM CELLS, V34, P160, DOI 10.1002/stem.2206
   Wang LC, 2014, MAR DRUGS, V12, P4984, DOI 10.3390/md12094984
   Wang W, 2008, J BIOMED MATER RES A, V84A, P557, DOI 10.1002/jbm.a.31536
   Yada RY, 2014, COMPR REV FOOD SCI F, V13, P730, DOI 10.1111/1541-4337.12076
NR 19
TC 1
Z9 2
U1 1
U2 9
PU INT SCIENTIFIC LITERATURE, INC
PI SMITHTOWN
PA 361 FOREST LANE, SMITHTOWN, NY 11787 USA
SN 1643-3750
J9 MED SCI MONITOR
JI Med. Sci. Monitor
PD MAY 26
PY 2016
VL 22
BP 1766
EP 1772
DI 10.12659/MSM.898441
PG 7
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DN0EU
UT WOS:000376738000001
PM 27225035
OA Green Published
DA 2018-10-19
ER

PT J
AU Kuppusamy, S
   Thavamani, P
   Megharaj, M
   Venkateswarlu, K
   Lee, YB
   Naidu, R
AF Kuppusamy, Saranya
   Thavamani, Palanisami
   Megharaj, Mallavarapu
   Venkateswarlu, Kadiyala
   Lee, Yong Bok
   Naidu, Ravi
TI Potential of Melaleuca diosmifolia as a novel, non-conventional and
   low-cost coagulating adsorbent for removing both cationic and anionic
   dyes
SO JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY
LA English
DT Article
DE Adsorption; Anionic dye; Cationic dyes; Coagulation; Melaleuca
   diosmifolia; Wastewater treatment
ID HEXAVALENT CHROMIUM REMOVAL; EFFECTIVE NATURAL COAGULANT;
   AQUEOUS-SOLUTION; MALACHITE GREEN; METHYLENE-BLUE; WATER-TREATMENT; SEED
   GUM; ADSORPTION; WASTE; KINETICS
AB The potential of dried twigs of Melaleuca diosmifolia as a novel biosorbent for removing three cationic dyes, methylene blue (MB), acridine orange (AO) and malachite green (MG), and an anionic dye, eriochrome black T (EB) was evaluated in a batch adsorption process. Notably, the biosorbent removed 77-99% of both cationic and anionic dyes in a wide ranging pH of 2-10, and the reactions were endothermic. The dye adsorption equilibria were rapidly attained within 3 h. The monolayer adsorption capacity of the sorbent added at 5 g L-1 was 119.05, 126.8, 116.28 and 94.34 mg g(-1) for MB, AO, MG and EB, respectively. The water extract obtained from the plant material induced fast decolourization of both categories of dyes followed by gradual flocculation, indicating its potential as a natural coagulant. Gas chromatographic analysis also indicated that the main electrostatic attraction between 1,8-cineole, 1-p-methene-8-thiol and furfural compounds of the biomaterial, and dye molecules resulted in the formation of initial supramolecular complexes which further progressed into strong aggregates, leading to precipitation of dye-biomaterial complexes. Subsequently, the overall complex mechanism of dye removal was confirmed to be a combined process of adsorption and coagulation. Consistent with the batch studies, using selected plant material in real environmental water samples also resulted in effective dye removal, highlighting its potential for use in wastewater treatment. (C) 2016 The Korean Society of Industrial and Engineering Chemistry. Published by Elsevier B.V. All rights reserved.
C1 [Kuppusamy, Saranya; Lee, Yong Bok] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju 660701, South Korea.
   [Kuppusamy, Saranya; Megharaj, Mallavarapu; Naidu, Ravi] Univ S Australia, Ctr Environm Risk Assessment & Remediat, Mawson Lakes, SA 5095, Australia.
   [Kuppusamy, Saranya; Thavamani, Palanisami; Megharaj, Mallavarapu; Naidu, Ravi] Cooperat Res Ctr Contaminat Assessment & Remediat, POB 486, Salisbury South, SA 5106, Australia.
   [Thavamani, Palanisami; Megharaj, Mallavarapu; Naidu, Ravi] Univ Newcastle, Fac Sci & Informat Technol, Global Ctr Environm Remediat, Callaghan, NSW 2308, Australia.
   [Venkateswarlu, Kadiyala] Sri Krishnadevaraya Univ, Dept Microbiol, Anantapur 515055, Andhra Pradesh, India.
RP Kuppusamy, S (reprint author), Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju 660701, South Korea.
EM saran.miles2go@gmail.com
RI Kuppusamy, Saranya/L-3912-2017; Mallavarapu, Megharaj/D-3408-2011
OI Kuppusamy, Saranya/0000-0002-6271-7475; Mallavarapu,
   Megharaj/0000-0002-6230-518X
FU Australian Government, University of South Australia (UniSA);
   Cooperative Research Centre for Contamination Assessment and Remediation
   of Environment (CRC CARE)
FX SK thank the Australian Government, University of South Australia
   (UniSA) and Cooperative Research Centre for Contamination Assessment and
   Remediation of Environment (CRC CARE) for the International Postgraduate
   Research Scholarship (IPRS) and CRC CARE top-up fellowship during PhD.
CR Bapr CA, 2006, J HAZARD MATER, V135, P232
   Barka N, 2011, J TAIWAN INST CHEM E, V42, P320, DOI 10.1016/j.jtice.2010.07.004
   Bazrafshan E., 2012, J BIOTECHNOL, V11, P16661
   Beach ES, 2011, CATAL SCI TECHNOL, V1, P437, DOI 10.1039/c0cy00070a
   Beltran-Heredia J, 2009, IND ENG CHEM RES, V48, P6512, DOI 10.1021/ie9004833
   Bhatti H. N., 2015, J ANIM PLANT SCI, V25, P248
   Cengiz S, 2008, BIORESOURCE TECHNOL, V99, P2357, DOI 10.1016/j.biortech.2007.05.011
   Duran C, 2011, J CHEM ENG DATA, V56, P2136, DOI 10.1021/je101204j
   El-Latif M.M.A., 2010, J AM SCI, V6, P267
   Hamdaoui O, 2008, CHEM ENG J, V143, P73, DOI 10.1016/j.cej.2007.12.018
   Jeon JR, 2009, CHEMOSPHERE, V77, P1090, DOI 10.1016/j.chemosphere.2009.08.036
   Kuppusamy S, 2016, PROCESS SAF ENVIRON, V100, P173, DOI 10.1016/j.psep.2016.01.009
   Kuppusamy S, 2016, IND CROP PROD, V83, P630, DOI 10.1016/j.indcrop.2015.12.060
   Kuppusamy S, 2016, WATER AIR SOIL POLL, V227, DOI 10.1007/s11270-016-2760-z
   Kuppusamy S, 2016, REV ENVIRON CONTAM T, V236, P117, DOI 10.1007/978-3-319-20013-2_2
   Kuppusamy S, 2016, REV ENVIRON CONTAM T, V236, P1, DOI 10.1007/978-3-319-20013-2_1
   Lakshmi UR, 2009, J ENVIRON MANAGE, V90, P710, DOI 10.1016/j.jenvman.2008.01.002
   Lata H, 2007, DYES PIGMENTS, V74, P653, DOI 10.1016/j.dyepig.2006.04.007
   Lee JW, 2006, DYES PIGMENTS, V69, P196, DOI 10.1016/j.dyepig.2005.03.008
   Leopoldini M, 2006, J AGR FOOD CHEM, V54, P3078, DOI [10.1021/jf053180a, 10.1021/jp053180a]
   Malik R, 2007, WASTE MANAGE, V27, P1129, DOI 10.1016/j.wasman.2006.06.009
   Mallampati R, 2012, RSC ADV, V2, P9914, DOI 10.1039/c2ra21108d
   Miller SM, 2008, ENVIRON SCI TECHNOL, V42, P4274, DOI 10.1021/es7025054
   Ozer A, 2007, J HAZARD MATER, V146, P262, DOI 10.1016/j.jhazmat.2006.12.016
   Royer B, 2009, J HAZARD MATER, V164, P1213, DOI 10.1016/j.jhazmat.2008.09.028
   Sadaf S, 2015, J TAIWAN INST CHEM E, V47, P160, DOI 10.1016/j.jtice.2014.10.001
   Safarik I, 2005, J MAGN MAGN MATER, V293, P371, DOI 10.1016/j.jmmm.2005.02.033
   Salleh MAM, 2011, DESALINATION, V280, P1, DOI 10.1016/j.desal.2011.07.019
   Sanchez-Martin J, 2010, CHEM ENG J, V165, P851, DOI 10.1016/j.cej.2010.10.030
   Sanghi R, 2002, GREEN CHEM, V4, P252, DOI 10.1039/b200067a
   Sanghi R, 2006, J ENVIRON MANAGE, V81, P36, DOI 10.1016/j.jenvman.2005.09.015
   Sharma P, 2010, DESALINATION, V259, P249, DOI 10.1016/j.desal.2010.03.044
   Sivaraj R, 2001, WASTE MANAGE, V21, P105, DOI 10.1016/S0956-053X(00)00076-3
   Sonawane GH, 2009, DESALINATION, V247, P430, DOI 10.1016/j.desal.2009.01.006
   Yagub MT, 2014, ADV COLLOID INTERFAC, V209, P172, DOI 10.1016/j.cis.2014.04.002
   Yan MQ, 2008, WATER RES, V42, P3361, DOI 10.1016/j.watres.2008.04.017
   Yani S, 2014, FUEL, V133, P341, DOI 10.1016/j.fuel.2014.05.030
NR 37
TC 9
Z9 10
U1 3
U2 14
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1226-086X
EI 1876-794X
J9 J IND ENG CHEM
JI J. Ind. Eng. Chem.
PD MAY 25
PY 2016
VL 37
BP 198
EP 207
DI 10.1016/j.jiec.2016.03.021
PG 10
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA DO4FL
UT WOS:000377737100027
DA 2018-10-19
ER

PT J
AU Nayyer, L
   Jell, G
   Esmaeili, A
   Birchall, M
   Seifalian, AM
AF Nayyer, Leila
   Jell, Gavin
   Esmaeili, Ali
   Birchall, Martin
   Seifalian, Alexander M.
TI A Biodesigned Nanocomposite Biomaterial for Auricular Cartilage
   Reconstruction
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE auricular cartilage; biomaterial; Medpor; nanocomposite scaffold;
   POSS-PCU
ID GROWTH-FACTOR-BETA; POROUS POLYETHYLENE IMPLANTS; IN-VITRO;
   PROTEIN-ADSORPTION; EAR RECONSTRUCTION; FIBROTIC RESPONSE; MODIFIED
   TITANIUM; WOUND REPAIR; SURFACE; MACROPHAGE
AB Current biomaterials for auricular replacement are associated with high rates of infection and extrusion. The development of new auricular biomaterials that mimic the mechanical properties of native tissue and promote desirable cellular interactions may prevent implant failure. A porous 3D nanocomposite scaffold (NS) based on POSS-PCU (polyhedral oligomeric silsesquioxane nanocage into polycarbonate based urea-urethane) is developed with an elastic modulus similar to native ear. In vitro biological interactions on this NS reveal greater protein adsorption, increased fibroblast adhesion, proliferation, and collagen production compared with Medpor (the current synthetic auricular implant). In vivo, the POSS-PCU with larger pores (NS2; 150-250 m) have greater tissue ingrowth (approximate to 5.8x and approximate to 1.4 x increase) than the POSS-PCU with smaller pores (NS1; 100-50 m) and when compared to Medpor (>100 m). The NS2 with the larger pores demonstrates a reduced fibrotic encapsulation compared with NS1 and Medpor (approximate to 4.1x and approximate to 1.6x, respectively; P < 0.05). Porosity also influences the amount of neovascularization within the implants, with no blood vessel observed in NS1 (12 weeks postimplantation). The lack of chronic inflammatory response for all materials may indicate that the elastic modulus and pore size of the implant scaffold could be important design considerations for influencing fibrotic responses to auricular and other soft tissue implants.
C1 [Nayyer, Leila; Jell, Gavin; Esmaeili, Ali; Seifalian, Alexander M.] UCL, Div Surg & Intervent Sci, Mortimer St, London WC1E 6BT, England.
   [Birchall, Martin] UCL, Ear Inst, Mortimer St, London WC1E 6BT, England.
   [Esmaeili, Ali; Seifalian, Alexander M.] Royal Free Hampstead NHS Trust Hosp, Dept Plast & Reconstruct Surg, London NW3 2QG, England.
RP Jell, G (reprint author), UCL, Div Surg & Intervent Sci, Mortimer St, London WC1E 6BT, England.
EM g.jell@ucl.ac.uk
RI Jell, Gavin/C-4893-2009
FU UCL Ear Institute; Royal Free Hospital; HMRC [X6243, 501724]; Medical
   Research Council [MR/K026453/1, G1001539]; National Institute for Health
   Research [NF-SI-0513-10089]
FX The authors acknowledge A. Darbyshire for polymer material synthesis.
   The authors would like to acknowledge the Northwick Park Hospital
   Institute for assistance in the in vivo histology and IHC staining
   works, T. Jorgensenat from Falmouth University for use of the 3D
   printing facilities, and M. Durran for assistance in the glass-mould
   design. This research was financially supported by a generous gift from
   Hana Thalova to UCL Ear Institute and the Royal Free Hospital charity
   with HMRC No: X6243 and project No: 501724;
   http://www.ucl.ac.uk/ear/research/microtia/gift. Requests for materials
   should be addressed to A.M.S. The authors declare no competing financial
   interests in relation to the content of this paper.
CR Ahmed M., 2013, J BIOMED MAT RES B
   Ahmed M, 2014, BIOMATERIALS, V35, P9033, DOI 10.1016/j.biomaterials.2014.07.008
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5
   Bai F, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015007
   Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x
   BERGHAUS A, 1985, ARCH OTOLARYNGOL, V111, P154
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brunner G, 2004, THROMB HAEMOSTASIS, V92, P253, DOI 10.1160/TH04-05-0324
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   Cenzi R, 2005, J CRANIOFAC SURG, V16, P526, DOI 10.1097/01.scs.0000168761.46700.dc
   Cha C, 2011, ACTA BIOMATER, V7, P3719, DOI 10.1016/j.actbio.2011.06.017
   Chaloupka K, 2011, BIOTECHNOL APPL BIOC, V58, P363, DOI 10.1002/bab.53
   Choritz L, 2010, INVEST OPHTH VIS SCI, V51, P4047, DOI 10.1167/iovs.09-4759
   Collier TO, 2002, J BIOMED MATER RES, V60, P487, DOI 10.1002/jbm.10043
   COX NH, 1987, Q J MED, V64, P661
   Davis P K, 1971, Br J Plast Surg, V24, P405, DOI 10.1016/S0007-1226(71)80099-1
   DIPIETRO LA, 1995, SHOCK, V4, P233, DOI 10.1097/00024382-199510000-00001
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8
   Gerlach RC, 2013, OR SURG OR MED OR PA, V115, pE44, DOI 10.1016/j.oooo.2012.05.020
   Goreham RV, 2013, RSC ADV, V3, P10309, DOI 10.1039/c3ra23193c
   Guduru D, 2011, INT J ARTIF ORGANS, V34, P963, DOI [10.5301/ijao.5000012, 10.5301/IJAO.5000012]
   Harris J, 1996, J MED GENET, V33, P809, DOI 10.1136/jmg.33.10.809
   Henriksen TF, 2005, ANN PLAS SURG, V54, P343, DOI 10.1097/01.sap.0000151459.07978.fa
   Henry JA, 2009, ACTA BIOMATER, V5, P29, DOI 10.1016/j.actbio.2008.08.020
   Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613
   Hohman MH, 2014, ANN OTO RHINOL LARYN, V123, P135, DOI 10.1177/0003489414523710
   Hu XF, 2013, TISSUE ENG PT A, V19, P1919, DOI [10.1089/ten.tea.2012.0218, 10.1089/ten.TEA.2012.0218]
   Jell G., 2009, FUNDAMENTALS TISSUE, P469
   Jiang L, 2014, SPINAL CORD, V52, P145, DOI 10.1038/sc.2013.132
   Johnson R, 1997, Biomed Sci Instrum, V34, P47
   Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7
   Kam KR, 2014, TISSUE ENG PT A, V20, P130, DOI [10.1089/ten.tea.2012.0772, 10.1089/ten.TEA.2012.0772]
   Kannan RY, 2006, BIOMATERIALS, V27, P1971, DOI 10.1016/j.biomaterials.2005.10.006
   Kao WYJ, 1999, BIOMATERIALS, V20, P2213, DOI 10.1016/S0142-9612(99)00152-0
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kopf BS, 2015, J BIOMED MATER RES A, V103, P2661, DOI 10.1002/jbm.a.35401
   Lavenus S, 2010, NANOMEDICINE-UK, V5, P937, DOI [10.2217/nnm.10.54, 10.2217/NNM.10.54]
   Le SJ, 2010, DIFFERENTIATION, V79, P232, DOI 10.1016/j.diff.2010.03.001
   Lee S, 2011, ACTA BIOMATER, V7, P2337, DOI 10.1016/j.actbio.2011.01.006
   Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249
   Li ZD, 2007, HEPATOLOGY, V46, P1246, DOI 10.1002/hep.21792
   Luquetti DV, 2011, BIRTH DEFECTS RES A, V91, P813, DOI 10.1002/bdra.20836
   MacDonald DE, 2002, BIOMATERIALS, V23, P1269, DOI 10.1016/S0142-9612(01)00317-9
   MERRITT K, 1979, J BIOMED MATER RES, V13, P101, DOI 10.1002/jbm.820130111
   MUSTOE TA, 1987, SCIENCE, V237, P1333, DOI 10.1126/science.2442813
   NAKAI H, 1979, BRIT J PLAST SURG, V32, P261, DOI 10.1016/0007-1226(79)90076-6
   Nayyer L, 2014, NANOMED-NANOTECHNOL, V10, P235, DOI 10.1016/j.nano.2013.06.006
   Neel H B 3rd, 1983, Arch Otolaryngol, V109, P427
   RAPALA K, 1991, EUR SURG RES, V23, P261, DOI 10.1159/000129163
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Reinisch JF, 2009, FACIAL PLAST SURG, V25, P181, DOI 10.1055/s-0029-1239448
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Romo T, 2009, ANN PLAS SURG, V62, P384, DOI 10.1097/SAP.0b013e31819fae51
   ROSEN HM, 1991, PLAST RECONSTR SURG, V88, P1076, DOI 10.1097/00006534-199112000-00020
   RUBIN PAD, 1994, OPHTHALMOLOGY, V101, P1697
   Sclafani AP, 1997, PLAST RECONSTR SURG, V99, P41, DOI 10.1097/00006534-199701000-00007
   SHANBHAG A, 1990, ANN PLAS SURG, V24, P32, DOI 10.1097/00000637-199001000-00006
   Shephard P, 2004, AM J PATHOL, V164, P2055, DOI 10.1016/S0002-9440(10)63764-9
   Silver JH, 1999, BIOMATERIALS, V20, P1533, DOI 10.1016/S0142-9612(98)00173-2
   Tinsley D. M., 1994, OPHTHALMOLOGY, V4, P77
   VANROYEN BJ, 1986, PLAST RECONSTR SURG, V78, P360, DOI 10.1097/00006534-198609000-00013
   Wang K, 2015, BIOMATERIALS, V54, P63, DOI 10.1016/j.biomaterials.2015.03.019
   Webster T. J., 2000, KEY ENG MATER, V192-1, P321
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Zhang Q, 2009, PLAST RECONSTR SURG, V123, P849, DOI 10.1097/PRS.0b013e318199f057
NR 69
TC 5
Z9 5
U1 3
U2 40
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD MAY 25
PY 2016
VL 5
IS 10
BP 1203
EP 1212
DI 10.1002/adhm.201500968
PG 10
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA DO1HE
UT WOS:000377528300012
PM 26992039
DA 2018-10-19
ER

PT J
AU Manchineella, S
   Thrivikraman, G
   Khanum, KK
   Ramamurthy, PC
   Basu, B
   Govindaraju, T
AF Manchineella, Shivaprasad
   Thrivikraman, Greeshma
   Khanum, Khadija K.
   Ramamurthy, Praveen C.
   Basu, Bikramjit
   Govindaraju, T.
TI Pigmented Silk Nanofibrous Composite for Skeletal Muscle Tissue
   Engineering
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE biomaterials; electroactive and antioxidant scaffolds; electrospinning;
   myogenesis; silk; melanin composite
ID OXIDATIVE STRESS; STEM-CELLS; IN-VITRO; BIOMEDICAL APPLICATIONS;
   CONDUCTIVE NANOFIBERS; DRUG-DELIVERY; FIBER MATS; DIFFERENTIATION;
   FIBROIN; SCAFFOLDS
AB Skeletal muscle tissue engineering (SMTE) employs designed biomaterial scaffolds for promoting myogenic differentiation of myoblasts to functional myotubes. Oxidative stress plays a significant role in the biocompatibility of biomaterials as well as in the fate of myoblasts during myogenesis and is also associated with pathological conditions such as myotonic dystrophy. The inherent electrical excitability of muscle cells inspired the use of electroactive scaffolds for SMTE. Conducting polymers attracted the attention of researchers for their use in muscle tissue engineering. However, poor biocompatibility, biodegradability and development of oxidative stress associated immunogenic response limits the extensive use of synthetic conducting polymers for SMTE. In order to address the limitations of synthetic polymers, intrinsically electroactive and antioxidant silk fibroin/melanin composite films and electrospun fiber mats were fabricated and evaluated as scaffolds for promoting myogenesis in vitro. Melanin incorporation modulated the thermal stability, electrical conductivity of scaffolds, fiber alignment in electrospun mats and imparted good antioxidant properties to the scaffolds. The composite electrospun scaffolds promoted myoblast assembly and differentiation into uniformly aligned high aspect ratio myotubes. The results highlight the significance of scaffold topography along with conductivity in promoting myogenesis and the potential application of silk nanofibrous composite as electoractive platform for SMTE.
C1 [Manchineella, Shivaprasad; Govindaraju, T.] Jawaharlal Nehru Ctr Adv Sci Res, Bioorgan Chem Lab, New Chem Unit, Bengaluru 560064, Karnataka, India.
   [Thrivikraman, Greeshma; Basu, Bikramjit] Indian Inst Sci, Mat Res Ctr, Lab Biomat, Bengaluru 560012, Karnataka, India.
   [Khanum, Khadija K.; Ramamurthy, Praveen C.] Indian Inst Sci, Dept Mat Engn, Organ Nano Elect Lab, Bengaluru 560012, Karnataka, India.
RP Govindaraju, T (reprint author), Jawaharlal Nehru Ctr Adv Sci Res, Bioorgan Chem Lab, New Chem Unit, Bengaluru 560064, Karnataka, India.
EM tgraju@jncasr.ac.in
RI T, Govindaraju/H-1471-2012; Manchineella, Shivaprasad/J-6726-2012
OI T, Govindaraju/0000-0002-9423-4275; Manchineella,
   Shivaprasad/0000-0002-8773-5426; T, Greeshma/0000-0002-0870-5369
FU JNCASR, the Department of Biotechnology (DBT), Government of India under
   Innovative Young Biotechnologist Award (IYBA) [BT/03/IYBA/2010];
   DST-SERB/health sciences, Government of India; Council of Scientific and
   Industrial Research (CSIR), India
FX S.M. and G.T. contributed equally to this work. The authors thank Prof.
   C. N. R. Rao, FRS, for his constant support and JNCASR, the Department
   of Biotechnology (DBT), Government of India, for a research grant
   (BT/03/IYBA/2010) under Innovative Young Biotechnologist Award (IYBA)
   2010. G.T. and B.B. greatly acknowledge the financial support from
   DST-SERB/health sciences, Government of India. The Council of Scientific
   and Industrial Research (CSIR), India, is greatly acknowledged for
   awarding research fellowship to S.M.
CR Amiraliyan N, 2010, POLYM SCI SER A+, V52, P407, DOI 10.1134/S0965545X10040097
   Angammana CJ, 2011, IEEE T IND APPL, V47, P1109, DOI 10.1109/TIA.2011.2127431
   Balint R, 2014, ACTA BIOMATER, V10, P2341, DOI 10.1016/j.actbio.2014.02.015
   Barbieri Elena, 2012, J Signal Transduct, V2012, P982794, DOI 10.1155/2012/982794
   Bettinger CJ, 2009, BIOMATERIALS, V30, P3050, DOI 10.1016/j.biomaterials.2009.02.018
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Bothma JP, 2008, ADV MATER, V20, P3539, DOI 10.1002/adma.200703141
   Broda CR, 2011, J BIOMED MATER RES A, V98A, P509, DOI 10.1002/jbm.a.33128
   Burattini S, 2004, EUR J HISTOCHEM, V48, P223
   Canton M, 2014, J MUSCLE RES CELL M, V35, P23, DOI 10.1007/s10974-014-9380-2
   Chen MC, 2013, ACTA BIOMATER, V9, P5562, DOI 10.1016/j.actbio.2012.10.024
   Chuysinuan P, 2012, ACS APPL MATER INTER, V4, P3031, DOI 10.1021/am300404v
   Cirilo G., 2012, ANTIOXIDANT POLYM SY
   d'Ischia M, 2015, PIGM CELL MELANOMA R, V28, P520, DOI 10.1111/pcmr.12393
   d'Ischia M, 2014, ACCOUNTS CHEM RES, V47, P3541, DOI 10.1021/ar500273y
   Das S, 2015, ACTA BIOMATER, V11, P233, DOI 10.1016/j.actbio.2014.09.023
   Essick EE, 2010, OXID MED CELL LONGEV, V3, P168, DOI 10.4161/oxim.3.3.12106
   Fitzmaurice SD, 2011, SKIN PHARMACOL PHYS, V24, P113, DOI 10.1159/000322643
   Hardy JG, 2015, MACROMOL RAPID COMM, V36, P1884, DOI 10.1002/marc.201500233
   He CL, 2014, J MATER CHEM B, V2, P7828, DOI 10.1039/c4tb01464b
   Higuchi A, 2013, CHEM REV, V113, P3297, DOI 10.1021/cr300426x
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Jain S, 2013, BIOMATERIALS, V34, P9252, DOI 10.1016/j.biomaterials.2013.08.057
   Ju KY, 2011, BIOMACROMOLECULES, V12, P625, DOI 10.1021/bm101281b
   Kai D, 2013, J MATER CHEM B, V1, P2305, DOI 10.1039/c3tb00151b
   Kasoju N, 2012, J BIOMED MATER RES B, V100B, P1854, DOI 10.1002/jbm.b.32753
   Khanum KK, 2015, RSC ADV, V5, P60419, DOI 10.1039/c5ra06468f
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/nmat2745, 10.1038/NMAT2745]
   Kim DW, 2015, BIOMATERIALS, V70, P48, DOI 10.1016/j.biomaterials.2015.08.025
   Kim E, 2014, BIOMACROMOLECULES, V15, P1653, DOI 10.1021/bm500026x
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim SH, 2015, J CONTROL RELEASE, V206, P101, DOI 10.1016/j.jconrel.2015.03.026
   Kim YJ, 2013, P NATL ACAD SCI USA, V110, P20912, DOI 10.1073/pnas.1314345110
   Ku SH, 2012, BIOMATERIALS, V33, P6098, DOI 10.1016/j.biomaterials.2012.05.018
   Kulkarni A, 2010, POLYM-PLAST TECHNOL, V49, P427, DOI 10.1080/03602550903414019
   Kundu B, 2014, PROG POLYM SCI, V39, P251, DOI 10.1016/j.progpolymsci.2013.09.002
   Kundu S., 2014, SILK BIOMATERIALS TI
   Lawson MA, 2000, CELLS TISSUES ORGANS, V167, P130, DOI 10.1159/000016776
   Li Z., 2013, ONE DIMENSIONAL NANO
   Liu WE, 2011, BIOMATERIALS, V32, P1796, DOI 10.1016/j.biomaterials.2010.11.029
   Matheson LA, 2004, J CELL PHYSIOL, V199, P8, DOI 10.1002/jcp.10412
   McCaig CD, 2005, PHYSIOL REV, V85, P943, DOI 10.1152/physrev.00020.2004
   MCGINNESS J, 1974, SCIENCE, V183, P853, DOI 10.1126/science.183.4127.853
   Meechaisue C, 2007, BIOMED MATER, V2, P181, DOI 10.1088/1748-6041/2/3/003
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Mitra J, 2013, CARBON, V65, P140, DOI 10.1016/j.carbon.2013.08.008
   Mostert AB, 2012, P NATL ACAD SCI USA, V109, P8943, DOI 10.1073/pnas.1119948109
   O'Brien F. J., 2006, MATER TODAY, V14, P88
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Parker ST, 2009, ADV MATER, V21, P2411, DOI 10.1002/adma.200801580
   Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89
   Poltawski L, 2009, PHYS THER REV, V14, P104, DOI 10.1179/174328809X405973
   Potter-Baker KA, 2015, ACS MACRO LETT, V4, P275, DOI 10.1021/mz500743a
   Qazi TH, 2015, BIOMATERIALS, V53, P502, DOI 10.1016/j.biomaterials.2015.02.110
   Qazi TH, 2014, BIOMATERIALS, V35, P9068, DOI 10.1016/j.biomaterials.2014.07.020
   Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Seib FP, 2013, ISR J CHEM, V53, P756, DOI 10.1002/ijch.201300083
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Sirivisoot S, 2011, INT J NANOMED, V6, P2483, DOI 10.2147/IJN.S24073
   Solano F., 2014, NEW J SCI, V2014, DOI [10. 1155/2014/498276, DOI 10.1155/2014/498276]
   Tansil NC, 2012, ADV MATER, V24, P1388, DOI 10.1002/adma.201104118
   Tao H, 2012, ADV MATER, V24, P2824, DOI 10.1002/adma.201104477
   Thrivikraman G, 2013, BIOMATERIALS, V34, P7073, DOI 10.1016/j.biomaterials.2013.05.076
   Uyar T, 2008, POLYMER, V49, P5336, DOI 10.1016/j.polymer.2008.09.025
   Vallejo-Giraldo C, 2014, DRUG DISCOV TODAY, V19, P88, DOI 10.1016/j.drudis.2013.07.022
   van Lith R, 2014, BIOMATERIALS, V35, P8113, DOI 10.1016/j.biomaterials.2014.06.004
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wattamwar PP, 2010, ADV FUNCT MATER, V20, P147, DOI 10.1002/adfm.200900839
   Wolf MT, 2015, ADV DRUG DELIVER REV, V84, P208, DOI 10.1016/j.addr.2014.08.011
   Xu JZ, 2014, COLLOID SURFACE B, V123, P907, DOI 10.1016/j.colsurfb.2014.10.041
   Zhang F, 2012, BIOMACROMOLECULES, V13, P798, DOI 10.1021/bm201719s
   Zhou J, 2014, ACS APPL MATER INTER, V6, P21813, DOI 10.1021/am502278b
NR 74
TC 16
Z9 17
U1 8
U2 66
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD MAY 25
PY 2016
VL 5
IS 10
BP 1222
EP 1232
DI 10.1002/adhm.201501066
PG 11
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA DO1HE
UT WOS:000377528300014
PM 27226037
DA 2018-10-19
ER

PT J
AU Zou, YW
   Qin, JB
   Huang, ZB
   Yin, GF
   Pu, XM
   He, D
AF Zou, Yuanwen
   Qin, Jiabang
   Huang, Zhongbing
   Yin, Guangfu
   Pu, Ximing
   He, Da
TI Fabrication of Aligned Conducting PPy-PLLA Fiber Films and Their
   Electrically Controlled Guidance and Orientation for Neurites
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE aligned conducting fibers; PPy-PLLA; electrical controlled guidance;
   neurites orientation; nerve regeneration
ID STIMULATING ELECTRODES; NERVE REGENERATION; BONE REGENERATION; GROWTH;
   POLYPYRROLE; NANOFIBERS; OUTGROWTH; POLYMER; BIOMATERIALS; EXTENSION
AB Electrically conductive biomaterial scaffolds have great potential in a neural tissue regeneration. In this work, an aligned conductive fibrous scaffold was prepared by electrospinning PLLA on rotating collector and chemical oxidation polymerization of pyrrole (PPy) codoped with poly(glutamic acid)/dodecyl benzenesulfonic acid sodium. The characterization results of composition, structure and mechanics of fiber films show that the existence of weak polar van der Waals' force between PPy coating and PLLA fibers. The resistivity of aligned rough PPy-PLLA fiber film (about 800 nm of fiber diameter) at the perpendicular and parallel directions is 0.971 and 0.874 Omega m, respectively. Aligned rough PPy-PLLA fiber film could guide the extension of 68% PC12 neurites along the direction of fiber axis. Under electrostimulation (ES) of 100, 200, and 400 mV/cm, median neurite lengths of differentiated PC12 on aligned fiber-films are 128, 149, and 141 pm, respectively. Furthermore, under ES of 100, 200, and 400 mV/cm, the alignment rate of neurite along the electropotential direction (angle between neurite and electropotential direction <= 10 degrees) on random fibers film are 17, 23, and 28%, respectively, and the alignment rate of neurites along the fiber axis (angle between neurite and fiber axis <= 10 degrees) on aligned fibers film reach to 76, 83, and 79%, respectively, indicating that the combination of ES and rough conducting aligned structure could adjust the alignment of cellular neurites along the direction of the fiber axis or electropotential.
C1 [Zou, Yuanwen; Qin, Jiabang; Huang, Zhongbing; Yin, Guangfu; Pu, Ximing; He, Da] Sichuan Univ, Coll Mat Sci & Engn, Chengdu 610065, Peoples R China.
RP Huang, ZB (reprint author), Sichuan Univ, Coll Mat Sci & Engn, Chengdu 610065, Peoples R China.
EM zbhuang@scu.edu.cn
FU National Natural Science Foundation of China [51273122, 51173120,
   51202151]
FX This work has been supported by the National Natural Science Foundation
   of China (Projects 51273122, 51173120, and 51202151).
CR Amillo S, 1995, MICROSURG, V16, P621, DOI 10.1002/micr.1920160908
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Boland ED, 2001, ABSTR PAP AM CHEM S, V222, pU344
   Burnette DT, 2008, DEV CELL, V15, P163, DOI 10.1016/j.devcel.2008.05.016
   Chang YJ, 2013, BBA-GEN SUBJECTS, V1830, P4130, DOI 10.1016/j.bbagen.2013.04.007
   Chougule M. A., 2011, SOFT NANOSCI LETT, V1, P6, DOI [10.4236/snl.2011.11002, DOI 10.4236/SNL.2011.11002]
   Cogan SF, 2008, ANNU REV BIOMED ENG, V10, P275, DOI 10.1146/annurev.bioeng.10.061807.160518
   Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631
   CRAGGS MD, 1986, MED BIOL ENG COMPUT, V24, P424, DOI 10.1007/BF02442699
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43
   Ghosh P, 2015, COLLOID SURFACE B, V125, P160, DOI 10.1016/j.colsurfb.2014.11.031
   Ghosh P, 2014, RSC ADV, V4, P19516, DOI 10.1039/c4ra01971g
   Gomez N, 2007, ADV FUNCT MATER, V17, P1645, DOI 10.1002/adfm.200600669
   Gomez N, 2007, J BIOMED MATER RES A, V81A, P135, DOI 10.1002/jbm.a.31047
   Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012
   Hsiao CW, 2013, BIOMATERIALS, V34, P1063, DOI 10.1016/j.biomaterials.2012.10.065
   Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6
   Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042
   Millesi H, 2000, HAND CLIN, V16, P73
   PATEL N, 1982, J NEUROSCI, V2, P483
   PATEL NB, 1984, J NEUROSCI, V4, P2939
   Rafique J, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2768871
   Sanghvi AB, 2005, NAT MATER, V4, P496, DOI 10.1038/nmat1397
   Schaefer AW, 2002, J CELL BIOL, V158, P139, DOI 10.1083/jcb.200203038
   SCHINDLER A, 1979, J POLYM SCI POL CHEM, V17, P2593, DOI 10.1002/pol.1979.170170831
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Song HK, 2006, BIOMATERIALS, V27, P473, DOI 10.1016/j.biomaterials.2005.06.030
   Suter DM, 2011, PROG NEUROBIOL, V94, P91, DOI 10.1016/j.pneurobio.2011.04.002
   Suter DM, 2000, J NEUROBIOL, V44, P97, DOI 10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.0.CO;2-U
   Weiland JD, 2002, IEEE T BIO-MED ENG, V49, P1574, DOI 10.1109/TBME.2002.805487
   Xie JW, 2009, ADV FUNCT MATER, V19, P2312, DOI 10.1002/adfm.200801904
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yu QZ, 2011, MATER SCI ENG B-ADV, V176, P913, DOI 10.1016/j.mseb.2011.05.017
   Zeng JW, 2013, COLLOID SURFACE B, V110, P450, DOI 10.1016/j.colsurfb.2013.05.012
   Zhang JM, 2005, MACROMOLECULES, V38, P8012, DOI 10.1021/ma051232r
NR 38
TC 13
Z9 15
U1 8
U2 75
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAY 25
PY 2016
VL 8
IS 20
BP 12576
EP 12582
DI 10.1021/acsami.6b00957
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DN1KX
UT WOS:000376825800002
PM 27172537
DA 2018-10-19
ER

PT J
AU Li, CY
   Chaung, W
   Mozayan, C
   Chabra, R
   Wang, P
   Narayan, RK
AF Li, Chunyan
   Chaung, Wayne
   Mozayan, Cameron
   Chabra, Ranjeev
   Wang, Ping
   Narayan, Raj K.
TI A New Approach for On-Demand Generation of Various Oxygen Tensions for
   In Vitro Hypoxia Models
SO PLOS ONE
LA English
DT Article
ID CELL-CULTURE; MICROFLUIDIC DEVICES; HYDROGEN-PEROXIDE; STEM-CELLS;
   GRADIENTS; INJURY; ALPHA; MICROENVIRONMENT; MACROPHAGES; ISCHEMIA
AB The development of in vitro disease models closely mimicking the functions of human disease has captured increasing attention in recent years. Oxygen tensions and gradients play essential roles in modulating biological systems in both physiologic and pathologic events. Thus, controlling oxygen tension is critical for mimicking physiologically relevant in vivo environments for cell, tissue and organ research. We present a new approach for on-demand generation of various oxygen tensions for in vitro hypoxia models. Proof-of-concept prototypes have been developed for conventional cell culture microplate by immobilizing a novel oxygen-consuming biomaterial on the 3D-printed insert. For the first time, rapid (similar to 3.8 minutes to reach 0.5% O-2 from 20.9% O-2) and precisely controlled oxygen tensions/gradients (2.68 mmHg per 50 mu m distance) were generated by exposing the biocompatible biomaterial to the different depth of cell culture media. In addition, changing the position of 3D-printed inserts with immobilized biomaterials relative to the cultured cells resulted in controllable and rapid changes in oxygen tensions (<130 seconds). Compared to the current technologies, our approach allows enhanced spatiotemporal resolution and accuracy of the oxygen tensions. Additionally, it does not interfere with the testing environment while maintaining ease of use. The elegance of oxygen tension manipulation introduced by our new approach will drastically improve control and lower the technological barrier of entry for hypoxia studies. Since the biomaterials can be immobilized in any devices, including microfluidic devices and 3D-printed tissues or organs, it will serve as the basis for a new generation of experimental models previously impossible or very difficult to implement.
C1 [Li, Chunyan; Chabra, Ranjeev; Narayan, Raj K.] Feinstein Inst Med Res, Cushing Neuromonitoring Lab, Manhasset, NY USA.
   [Li, Chunyan; Mozayan, Cameron; Narayan, Raj K.] Hofstra Northwell Sch Med, Dept Neurosurg, Manhasset, NY USA.
   [Chaung, Wayne; Wang, Ping] Feinstein Inst Med Res, Ctr Translat Res, Manhasset, NY USA.
RP Li, CY (reprint author), Feinstein Inst Med Res, Cushing Neuromonitoring Lab, Manhasset, NY USA.; Li, CY (reprint author), Hofstra Northwell Sch Med, Dept Neurosurg, Manhasset, NY USA.
EM cli11@nshs.edu
FU Department of Neurosurgery at Northwell Health; U.S. Department of
   Defense [W81XWH-10-1-0978]
FX This work was supported in part by the Department of Neurosurgery at
   Northwell Health and U.S. Department of Defense (W81XWH-10-1-0978). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Adler M, 2010, LAB CHIP, V10, P388, DOI 10.1039/b920401f
   Allen CB, 2001, AM J PHYSIOL-LUNG C, V281, pL1021
   Allen JW, 2003, BIOTECHNOL BIOENG, V82, P253, DOI 10.1002/bit.10569
   Au AK, 2014, LAB CHIP, V14, P1294, DOI 10.1039/c3lc51360b
   Benam KH, 2015, ANNU REV PATHOL-MECH, V10, P195, DOI 10.1146/annurev-pathol-012414-040418
   Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989
   Bickler PE, 2015, NEUROSCIENCE, V310, P306, DOI 10.1016/j.neuroscience.2015.09.021
   Brennan MD, 2014, LAB CHIP, V14, P4305, DOI 10.1039/c4lc00853g
   Byrne MB, 2014, TRENDS BIOTECHNOL, V32, P556, DOI 10.1016/j.tibtech.2014.09.006
   Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x
   Chang CW, 2014, LAB CHIP, V14, P3762, DOI 10.1039/c4lc00732h
   Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669
   Gross BC, 2014, ANAL CHEM, V86, P3240, DOI 10.1021/ac403397r
   Hopkins AM, 2015, PROG NEUROBIOL, V125, P1, DOI 10.1016/j.pneurobio.2014.11.003
   Huang QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061345
   Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005
   Hung SP, 2012, J ORTHOP RES, V30, P260, DOI 10.1002/jor.21517
   Lee WH, 2009, ARCH PHARM RES, V32, P421, DOI 10.1007/s12272-009-1316-9
   Lo JF, 2010, LAB CHIP, V10, P2394, DOI 10.1039/c004660d
   Martou G, 2006, J APPL PHYSIOL, V101, P1335, DOI 10.1152/japplphysiol.00278.2006
   Miksa M, 2007, MOL MED, V13, P553, DOI 10.2119/2007-00019.Miksa
   Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007
   Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706
   Mueller S, 2009, ADV MED SCI-POLAND, V54, P121, DOI 10.2478/v10039-009-0042-3
   Nistico R, 2008, BRIT J PHARMACOL, V153, P1022, DOI 10.1038/sj.bjp.0707587
   Peng CC, 2013, LAB CHIP, V13, P3239, DOI 10.1039/c3lc50388g
   Polinkovsky M, 2009, LAB CHIP, V9, P1073, DOI 10.1039/b816191g
   SCANNELL G, 1993, J SURG RES, V54, P281, DOI 10.1006/jsre.1993.1044
   Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021
   Skolimowski M, 2010, LAB CHIP, V10, P2162, DOI 10.1039/c003558k
   Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010
   Takeda N, 2010, GENE DEV, V24, P491, DOI 10.1101/gad.1881410
   Waldbaur A, 2011, ANAL METHODS-UK, V3, P2681, DOI 10.1039/c1ay05253e
   WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510
   Wang L, 2013, LAB CHIP, V13, P695, DOI [10.1039/c2lc40661f, 10.1039/C2LC40661F]
   Yu X, 2012, J MOL CELL CARDIOL, V53, P848, DOI 10.1016/j.yjmcc.2012.10.002
NR 36
TC 3
Z9 3
U1 1
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 24
PY 2016
VL 11
IS 5
AR e0155921
DI 10.1371/journal.pone.0155921
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DN2FY
UT WOS:000376880700028
PM 27219067
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Clifford, R
   Sparks, M
   Hosford, E
   Ong, A
   Richesson, D
   Fraser, S
   Kwak, Y
   Miller, S
   Julius, M
   McGann, P
   Lesho, E
AF Clifford, Robert
   Sparks, Michael
   Hosford, Eve
   Ong, Ana
   Richesson, Douglas
   Fraser, Susan
   Kwak, Yoon
   Miller, Sonia
   Julius, Michael
   McGann, Patrick
   Lesho, Emil
TI Correlating Cleaning Thoroughness with Effectiveness and Briefly
   Intervening to Affect Cleaning Outcomes: How Clean Is Cleaned?
SO PLOS ONE
LA English
DT Article
ID RESISTANT STAPHYLOCOCCUS-AUREUS; DISINFECTION TISSUE DISPENSERS;
   COMPARING SURFACE DISINFECTION; CARE-ASSOCIATED INFECTIONS;
   EVIDENCE-BASED DESIGN; HOSPITAL ROOM; CLINICAL-PRACTICE; OVERWEIGHT;
   PARADIGM; PITFALLS
AB Objectives
   The most efficient approach to monitoring and improving cleaning outcomes remains unresolved. We sought to extend the findings of a previous study by determining whether cleaning thoroughness (dye removal) correlates with cleaning efficacy (absence of molecular or cultivable biomaterial) and whether one brief educational intervention improves cleaning outcomes.
   Design
   Before-after trial.
   Setting
   Newly built community hospital.
   Intervention
   90 minute training refresher with surface-specific performance results.
   Methods
   Dye removal, measured by fluorescence, and biomaterial removal and acquisition, measured with culture and culture-independent PCR-based assays, were clandestinely assessed for eight consecutive months. At this midpoint, results were presented to the cleaning staff (intervention) and assessments continued for another eight consecutive months.
   Results
   1273 surfaces were sampled before and after terminal room cleaning. In the short-term, dye removal increased from 40.3% to 50.0% (not significant). For the entire study period, dye removal also improved but not significantly. After the intervention, the number of rooms testing positive for specific pathogenic species by culturing decreased from 55.6% to 36.6% (not significant), and those testing positive by PCR fell from 80.6% to 53.7%(P = 0.016). For nonspecific biomaterial on surfaces: a) removal of cultivable Gram-negatives (GN) trended toward improvement (P = 0.056); b) removal of any cultivable growth was unchanged but acquisition (detection of biomaterial on post-cleaned surfaces that were contaminant-free before cleaning) worsened (P = 0.017); c) removal of PCR-based detection of bacterial DNA improved (P = 0.046), but acquisition worsened (P = 0.003); d) cleaning thoroughness and efficacy were not correlated.
   Conclusion
   At this facility, a minor intervention or minimally more aggressive cleaning may reduce pathogen-specific contamination, but not without unintended consequences.
C1 [Clifford, Robert; Sparks, Michael; Hosford, Eve; Ong, Ana; Richesson, Douglas; Kwak, Yoon; Julius, Michael; McGann, Patrick; Lesho, Emil] Walter Reed Army Inst Res, Multidrug Resistant Organism Repository & Surveil, Silver Spring, MD USA.
   [Fraser, Susan; Miller, Sonia] Ft Belvoir Community Hosp, Dept Infect Dis & Infect Control, Ft Belvoir, VA USA.
RP Lesho, E (reprint author), Walter Reed Army Inst Res, Multidrug Resistant Organism Repository & Surveil, Silver Spring, MD USA.
EM carolinelesho@yahoo.com
OI Mc Gann, Patrick/0000-0003-1548-9438
FU U.S. Army Medical Command; Department of Defense Global Emerging
   Infection Surveillance and Response System
FX This work was funded by the U.S. Army Medical Command and the Department
   of Defense Global Emerging Infection Surveillance and Response System.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Baron RB, 2011, ARCH INTERN MED, V171, P321, DOI 10.1001/archinternmed.2011.5
   Bogusz A., 2013, Healthcare Infection, V18, P3, DOI 10.1071/HI12063
   Boyce JM, 2007, J HOSP INFECT, V65, P50, DOI 10.1016/S0195-6701(07)60015-2
   Carling PC, 2015, INFECT CONT HOSP EP, V36, P850, DOI 10.1017/ice.2015.84
   Carling PC, 2014, INFECT CONT HOSP EP, V35, P1349, DOI 10.1086/678424
   Caselli E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148857
   Clifford RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048558
   DHHS, 2013, NATIONAL ACTION PLAN
   Force USPST, 2009, ANN INTERN MED, V150, P551
   Guh H, ENVIRONMENTAL EVALUA
   Han JH, 2015, ANN INTERN MED, V163, P598, DOI 10.7326/M15-1192
   Kampf G, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-37
   Kupfahl C, 2015, INFECT CONT HOSP EP, V36, P1362, DOI 10.1017/ice.2015.176
   Lesho E, 2015, INFECT CONT HOSP EP, V36, P1130, DOI 10.1017/ice.2015.151
   Livorsi DJ, 2015, INFECT CONT HOSP EP, V36, P1335, DOI 10.1017/ice.2015.174
   Manian FA, 2011, INFECT CONT HOSP EP, V32, P667, DOI 10.1086/660357
   Mitchell BG, 2015, J HOSP INFECT, V91, P211, DOI 10.1016/j.jhin.2015.08.005
   Otter JA, 2011, J HOSP INFECT, V79, P189, DOI 10.1016/j.jhin.2011.04.028
   Overballe-Petersen S, 2013, P NATL ACAD SCI USA, V110, P19860, DOI 10.1073/pnas.1315278110
   Post RE, 2011, ARCH INTERN MED, V171, P316, DOI 10.1001/archinternmed.2010.549
   Rupp ME, 2013, INFECT CONT HOSP EP, V34, P100, DOI 10.1086/668779
   Sattar SA, 2010, AM J INFECT CONTROL, V38, pS34, DOI 10.1016/j.ajic.2010.04.207
   Septimus E, 2014, INFECT CONT HOSP EP, V35, P797, DOI [10.1086/676535, 10.1017/S0899823X00193808]
   Smith PW, 2014, INFECT CONT HOSP EP, V35, P564, DOI 10.1086/675839
   Stewart M, 2014, INFECT CONT HOSP EP, V35, P1505, DOI 10.1086/678595
   Vandini A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108598
   Zimring C, 2013, INFECT CONT HOSP EP, V34, P514, DOI 10.1086/670220
NR 27
TC 4
Z9 4
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 19
PY 2016
VL 11
IS 5
AR e0155779
DI 10.1371/journal.pone.0155779
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DM4BR
UT WOS:000376291100100
PM 27196635
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Farago, S
   Lucconi, G
   Perteghella, S
   Vigani, B
   Tripodo, G
   Sorrenti, M
   Catenacci, L
   Boschi, A
   Faustini, M
   Vigo, D
   Chlapanidas, T
   Marazzi, M
   Torre, ML
AF Farago, Silvio
   Lucconi, Giulia
   Perteghella, Sara
   Vigani, Barbara
   Tripodo, Giuseppe
   Sorrenti, Milena
   Catenacci, Laura
   Boschi, Alessandra
   Faustini, Massimo
   Vigo, Daniele
   Chlapanidas, Theodora
   Marazzi, Mario
   Torre, Maria Luisa
TI A dry powder formulation from silk fibroin microspheres as a topical
   auto-gelling device
SO PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
LA English
DT Article
DE Alginate; microparticles; poloxamer; polyethylene glycol; silk fibroin;
   spray-drying; wound healing
ID CONFORMATION TRANSITION KINETICS; DRUG-DELIVERY; HYALURONIC-ACID;
   BIOMATERIAL; TISSUE; SPECTROSCOPY; HYDROGELS; THERAPY; RELEASE; SPHERES
AB With the aim of establishing the formulation of a new hydrophilic auto-gelling medical device for biomedical applications, fibroin-based microspheres were prepared. The proposed microspheres were produced by a cost-effective and industrially scalable technique, such as the spray-drying. Spray-dried silk fibroin microspheres were obtained and the effects of different hydrophilic polymer on the process yield, microsphere morphology and conformation transition of fibroin were evaluated. The final auto-gelling formulations were obtained by adding calcium gluconate (as a calcium source for alginate crosslinking) to the prepared microspheres and tested by an in vitro gelling test. This study showed that the combination of fibroin with sodium alginate and poloxamer produced the most promising auto-gelling formulation for specific biomedical applications, such as the treatment of pressure ulcers.
C1 [Farago, Silvio; Boschi, Alessandra] Innovhub, Stn Sperimentali Ind, Silk Div, Milan, Italy.
   [Lucconi, Giulia; Perteghella, Sara; Vigani, Barbara; Tripodo, Giuseppe; Sorrenti, Milena; Catenacci, Laura; Chlapanidas, Theodora; Torre, Maria Luisa] Univ Pavia, Dept Drug Sci, Via Taramelli 12, I-27100 Pavia, Italy.
   [Faustini, Massimo; Vigo, Daniele] Univ Milan, Dept Vet Sci & Publ Hlth, Milan, Italy.
   [Marazzi, Mario] Osped Niguarda Ca Granda, Struttura Semplice Tissue Therapy, Milan, Italy.
RP Chlapanidas, T (reprint author), Univ Pavia, Dept Drug Sci, Via Taramelli 12, I-27100 Pavia, Italy.
EM theodora.chlapanidas@unipv.it
RI Tripodo, Giuseppe/C-7232-2011; faustini, massimo/K-6595-2017; VIGO,
   DANIELE/L-4868-2017
OI Tripodo, Giuseppe/0000-0001-5462-5629; faustini,
   massimo/0000-0003-2182-1003; VIGO, DANIELE/0000-0002-6292-4992; TORRE,
   MARIA LUISA/0000-0001-8062-6836; Perteghella, Sara/0000-0003-1128-7636
FU Eurostars project [E!5227]
FX This work was supported by Eurostars project application E!5227
   FIBROSPHERE. The authors thank Eng. Marzio Sorlini (SUPSI - University
   of Applied Sciences and Arts of Southern Switzerland, Innovative
   Technologies Department) for their precious support during all the steps
   of the research project.
CR Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Chen X, 2007, PROTEINS, V68, P223, DOI 10.1002/prot.21414
   Chlapanidas T, 2013, INT J IMMUNOPATH PH, V26, P43, DOI 10.1177/03946320130260S106
   Chlapanidas T, 2011, TISSUE ENG PT A, V17, P1725, DOI 10.1089/ten.tea.2010.0636
   Chlapanidas T, 2013, INT J BIOL MACROMOL, V58, P47, DOI 10.1016/j.ijbiomac.2013.03.054
   Chung TW, 2011, J TAIWAN INST CHEM E, V42, P592, DOI 10.1016/j.jtice.2010.11.003
   Dumortier G, 2006, PHARM RES, V23, P2709, DOI 10.1007/s11095-006-9104-4
   Dyakonov T, 2012, J DRUG DELIV, DOI 10.1155/2012/490514
   Fortunati D, 2014, AMINO ACIDS, V46, P1751, DOI 10.1007/s00726-014-1732-0
   Gaetani P, 2008, TISSUE ENG PT A, V14, P1415, DOI 10.1089/ten.tea.2007.0330
   Ghidoni I, 2008, CYTOTECHNOLOGY, V58, P49, DOI 10.1007/s10616-008-9161-0
   Hino Tomoaki, 2000, Pharmacy and Pharmacology Communications, V6, P335
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Innocente F, 2009, CIRCULATION, V120, pS37, DOI 10.1161/CIRCULATIONAHA.109.848242
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Ling SJ, 2012, MATER LETT, V81, P13, DOI 10.1016/j.matlet.2012.04.136
   Liu TL, 2010, J ZHEJIANG UNIV-SC B, V11, P10, DOI 10.1631/jzus.B0900163
   Lu SZ, 2009, BIOMACROMOLECULES, V10, P1032, DOI 10.1021/bm800956n
   Min SJ, 2012, J BIOMAT SCI-POLYM E, V23, P97, DOI 10.1163/092050610X543609
   Ming JF, 2014, POLYM ENG SCI, V54, P129, DOI 10.1002/pen.23542
   Mitropoulos AN, 2014, ADV MATER, V26, P1105, DOI 10.1002/adma.201304244
   Nottelet B, 2009, J BIOMED MATER RES A, V89A, P865, DOI 10.1002/jbm.a.32023
   Pajardi G, 2016, INT WOUND J, V13, P44, DOI 10.1111/iwj.12223
   Palumbo FS, 2006, CARBOHYD POLYM, V66, P379, DOI 10.1016/j.carbpol.2006.03.023
   Pitarresi G, 2007, EUR POLYM J, V43, P3953, DOI 10.1016/j.eurpolymj.2007.06.027
   Pitarresi G, 2006, BIOMACROMOLECULES, V7, P1302, DOI 10.1021/bm050697m
   Pritchard EM, 2011, EXPERT OPIN DRUG DEL, V8, P797, DOI 10.1517/17425247.2011.568936
   Pritchard EM, 2010, J CONTROL RELEASE, V144, P159, DOI 10.1016/j.jconrel.2010.01.035
   Qiang L, 2004, J MATER SCI-MATER M, V15, P1193, DOI 10.1007/s10856-004-5918-y
   Qin YM, 2008, POLYM ADVAN TECHNOL, V19, P6, DOI 10.1002/pat.960
   Qu J.Q., 2013, J BIOMATER NANOBIOTE, V4, P84
   Roche ET, 2014, BIOMATERIALS, V35, P6850, DOI 10.1016/j.biomaterials.2014.04.114
   Roh DH, 2006, J MATER SCI-MATER M, V17, P547, DOI 10.1007/s10856-006-8938-y
   Teuschl AH, 2014, ACTA BIOMATER, V10, P2506, DOI 10.1016/j.actbio.2014.02.012
   Tripodo G, 2012, MATER RES SOC SYMP P, V1403, P21, DOI 10.1557/opl.2012.223
   Tripodo G, 2011, MACROMOL SYMP, V309-310, P49, DOI 10.1002/masy.201100058
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Wenk E, 2011, J CONTROL RELEASE, V150, P128, DOI 10.1016/j.jconrel.2010.11.007
   Wischke C, 2011, MACROMOL BIOSCI, V11, P1637, DOI 10.1002/mabi.201100226
   Xie MK, 2013, J SURG RES, V184, P774, DOI 10.1016/j.jss.2013.04.016
   Yeo JH, 2003, EUR POLYM J, V39, P1195, DOI 10.1016/S0014-3057(02)00359-2
   Yoo MK, 2004, INT J BIOL MACROMOL, V34, P263, DOI 10.1016/j.ijbiomac.2004.06.002
NR 47
TC 4
Z9 4
U1 2
U2 54
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1083-7450
EI 1097-9867
J9 PHARM DEV TECHNOL
JI Pharm. Dev. Technol.
PD MAY 18
PY 2016
VL 21
IS 4
BP 453
EP 462
DI 10.3109/10837450.2015.1022784
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DG2XL
UT WOS:000371934000008
PM 25757645
DA 2018-10-19
ER

PT J
AU Garbayo, E
   Gavira, JJ
   de Yebenes, MG
   Pelacho, B
   Abizanda, G
   Lana, H
   Blanco-Prieto, MJ
   Prosper, F
AF Garbayo, Elisa
   Jose Gavira, Juan
   Garcia de Yebenes, Manuel
   Pelacho, Beatriz
   Abizanda, Gloria
   Lana, Hugo
   Jose Blanco-Prieto, Maria
   Prosper, Felipe
TI Catheter-based Intramyocardial Injection of FGF1 or NRG1-loaded MPs
   Improves Cardiac Function in a Preclinical Model of Ischemia-Reperfusion
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ELEVATION MYOCARDIAL-INFARCTION; FIBROBLAST GROWTH FACTOR-2;
   CORONARY-ARTERY-DISEASE; HEART-FAILURE; STEM-CELLS; PLGA MICROPARTICLES;
   DOUBLE-BLIND; SWINE MODEL; FACTOR-I; DELIVERY
AB Cardiovascular protein therapeutics such as neuregulin (NRG1) and acidic-fibroblast growth factor (FGF1) requires new formulation strategies that allow for sustained bioavailability of the drug in the infarcted myocardium. However, there is no FDA-approved injectable protein delivery platform due to translational concerns about biomaterial administration through cardiac catheters. We therefore sought to evaluate the efficacy of percutaneous intramyocardial injection of poly(lactic-co-glycolic acid) microparticles (MPs) loaded with NRG1 and FGF1 using the NOGA MYOSTAR injection catheter in a porcine model of ischemia-reperfusion. NRG1- and FGF1-loaded MPs were prepared using a multiple emulsion solvent-evaporation technique. Infarcted pigs were treated one week after ischemia-reperfusion with MPs containing NRG1, FGF1 or non-loaded MPs delivered via clinically-translatable percutaneous transendocardial-injection. Three months post-treatment, echocardiography indicated a significant improvement in systolic and diastolic cardiac function. Moreover, improvement in bipolar voltage and decrease in transmural infarct progression was demonstrated by electromechanical NOGA-mapping. Functional benefit was associated with an increase in myocardial vascularization and remodeling. These findings in a large animal model of ischemia-reperfusion demonstrate the feasibility and efficacy of using MPs as a delivery system for growth factors and provide strong evidence to move forward with clinical studies using therapeutic proteins combined with catheter-compatible biomaterials.
C1 [Garbayo, Elisa; Lana, Hugo; Jose Blanco-Prieto, Maria] Univ Navarra, Sch Pharm, Dept Pharm & Pharmaceut Technol, E-31080 Pamplona, Spain.
   [Garbayo, Elisa; Jose Gavira, Juan; Garcia de Yebenes, Manuel; Pelacho, Beatriz; Abizanda, Gloria; Lana, Hugo; Jose Blanco-Prieto, Maria; Prosper, Felipe] Inst Invest Sanitaria Navarra IDISNA, Pamplona, Spain.
   [Jose Gavira, Juan; Garcia de Yebenes, Manuel; Pelacho, Beatriz; Abizanda, Gloria; Prosper, Felipe] Univ Navarra Clin, Hematol Cardiol & Cell Therapy, Pamplona, Spain.
   [Jose Gavira, Juan; Garcia de Yebenes, Manuel; Pelacho, Beatriz; Abizanda, Gloria; Prosper, Felipe] Univ Navarra, Fdn Appl Med Res, E-31080 Pamplona, Spain.
RP Blanco-Prieto, MJ (reprint author), Univ Navarra, Sch Pharm, Dept Pharm & Pharmaceut Technol, E-31080 Pamplona, Spain.; Blanco-Prieto, MJ; Prosper, F (reprint author), Inst Invest Sanitaria Navarra IDISNA, Pamplona, Spain.
EM mjblanco@unav.es; fprosper@unav.es
RI Garbayo, Elisa/V-1740-2017; Prosper, Felipe/H-6859-2017
OI Garbayo, Elisa/0000-0003-2049-4143; Prosper, Felipe/0000-0001-6115-8790;
   Blanco-prieto, Maria J/0000-0003-0710-899X
FU Spanish Ministry of Sciences and Innovations [JCI-2011-10737]; Spanish
   Ministry of Economy and Competitiveness [SAF2013-42528-R]; Instituto de
   Salud Carlos III (ISCIII) [PI10/01621, PI13/02144, CP09/00333,
   ISCIII-RETIC RD12/0019/0031, PLE2009-0116]; EU FPVII program (INELPY);
   UTE project CIMA
FX We acknowledge the technical assistance of Hanspeter Fischer and Stijn
   Kramer with NOGA mapping procedures and analysis. The study was funded
   through the support from the Spanish Ministry of Sciences and
   Innovations (JCI-2011-10737), Spanish Ministry of Economy and
   Competitiveness (SAF2013-42528-R), the Instituto de Salud Carlos III
   (ISCIII) PI10/01621, PI13/02144, CP09/00333 and ISCIII-RETIC
   RD12/0019/0031, PLE2009-0116 and INNPACTO Procardio, the EU FPVII
   program (INELPY), and the "UTE project CIMA".
CR Abizaid A, 2010, CIRC-CARDIOVASC INTE, V3, P384, DOI 10.1161/CIRCINTERVENTIONS.109.891192
   Arana M, 2014, BIOMATERIALS, V35, P143, DOI 10.1016/j.biomaterials.2013.09.083
   Awada H. K., 2015, BIOMATERIALS, V82, P94
   Beohar N, 2010, J AM COLL CARDIOL, V56, P1287, DOI 10.1016/j.jacc.2010.05.039
   Bergmann MW, 2011, EUR J HEART FAIL, V13, P560, DOI 10.1093/eurjhf/hfr002
   Callans DJ, 1999, CIRCULATION, V100, P1744, DOI 10.1161/01.CIR.100.16.1744
   Chang MY, 2013, J CONTROL RELEASE, V170, P287, DOI 10.1016/j.jconrel.2013.04.022
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Eckhouse SR, 2014, SCI TRANSL MED, V6, P223
   Emmert MY, 2013, BIOMATERIALS, V34, P2428, DOI 10.1016/j.biomaterials.2012.12.021
   Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103
   Formiga FR, 2013, EUR J PHARM BIOPHARM, V85, P665, DOI 10.1016/j.ejpb.2013.02.017
   Formiga FR, 2014, J CONTROL RELEASE, V173, P132, DOI 10.1016/j.jconrel.2013.10.034
   Formiga FR, 2010, J CONTROL RELEASE, V147, P30, DOI 10.1016/j.jconrel.2010.07.097
   Galindo CL, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000773
   Garbern JC, 2011, BIOMATERIALS, V32, P2407, DOI 10.1016/j.biomaterials.2010.11.075
   Goodfriend AC, 2015, J BIOMED MATER RES A, V103, P1761, DOI 10.1002/jbm.a.35313
   Guo HD, 2012, BIOCHEM BIOPH RES CO, V424, P105, DOI 10.1016/j.bbrc.2012.06.080
   Gyongyosi M, 2011, NAT REV CARDIOL, V8, P393, DOI 10.1038/nrcardio.2011.64
   Hastings CL, 2015, ADV DRUG DELIVER REV, V84, P85, DOI 10.1016/j.addr.2014.08.006
   Henry TD, 2003, CIRCULATION, V107, P1359, DOI 10.1161/01.CIR.0000061911.47710.8A
   Itoh N, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00247
   Jabbour A, 2011, EUR J HEART FAIL, V13, P83, DOI 10.1093/eurjhf/hfq152
   Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0
   Gavira JJ, 2010, EUR HEART J, V31, P1013, DOI 10.1093/eurheartj/ehp342
   Kerut EK, 2004, ECHOCARDIOGR-J CARD, V21, P439, DOI 10.1111/j.0742-2822.2004.04003.x
   Krause K, 2009, HEART, V95, P1145, DOI 10.1136/hrt.2008.155077
   Lam MT, 2012, EXPERT REV CARDIOVAS, V10, P1039, DOI [10.1586/erc.12.99, 10.1586/ERC.12.99]
   Lichtman J.H., 2014, CIRCULATION, V131, pe29, DOI DOI 10.1161/CIR.0000000000000152
   Lin Y., 2012, LASER OPTOELECTRONIC, V4, P109
   Lin YD, 2010, CIRCULATION, V122, pS132, DOI 10.1161/CIRCULATIONAHA.110.939512
   Liu XF, 2006, J AM COLL CARDIOL, V48, P1438, DOI 10.1016/j.jacc.2006.05.057
   Mazo M, 2012, CELL TRANSPLANT, V21, P2723, DOI 10.3727/096368912X638847
   Meller J, 1979, Adv Intern Med, V24, P331
   Menasche P, 2009, CIRCULATION, V119, P2735, DOI 10.1161/CIRCULATIONAHA.108.812693
   Minguell Jose J, 2011, Acute Card Care, V13, P40, DOI 10.3109/17482941.2010.551134
   Nagaoka K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132451
   Odiete O, 2012, CIRC RES, V111, P1376, DOI 10.1161/CIRCRESAHA.112.267286
   Onuma Y, 2011, CIRC J, V75, P509, DOI 10.1253/circj.CJ-10-1135
   Palmen M, 2004, J AM COLL CARDIOL, V44, P1113, DOI 10.1016/j.jacc.2004.05.067
   Pascual-Gil S, 2015, J CONTROL RELEASE, V220, P388, DOI 10.1016/j.jconrel.2015.10.058
   Pavo N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113245
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Ripa RS, 2006, CIRCULATION, V113, P1983, DOI 10.1161/CIRCULATIONAHA.105.610469
   Rupert CE, 2015, BIOMARK INSIGHTS, V10, P1, DOI [10.4137/BMIMI.S20061, 10.4137/BMI.S20061]
   Segers VFM, 2011, CIRC RES, V109, P910, DOI 10.1161/CIRCRESAHA.111.249052
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Simon-Yarza T, 2013, INT J PHARMACEUT, V454, P784, DOI 10.1016/j.ijpharm.2013.04.015
   Simons M, 2002, CIRCULATION, V105, P788, DOI 10.1161/hc0802.104407
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Smits PC, 2003, J AM COLL CARDIOL, V42, P2063, DOI 10.1016/j.jacc.2003.06.017
   Udelson JE, 2000, CIRCULATION, V102, P1605, DOI 10.1161/01.CIR.102.14.1605
   Voors AA, 2010, EUR HEART J, V31, P2593, DOI 10.1093/eurheartj/ehq304
   Vu TD, 2015, BIOMATERIALS, V45, P27, DOI 10.1016/j.biomaterials.2014.12.013
   Weidemann F, 2002, AM J PHYSIOL-HEART C, V283, pH792, DOI 10.1152/ajpheart.00025.2002
   Wolf T, 2001, J AM COLL CARDIOL, V37, P1590, DOI 10.1016/S0735-1097(01)01209-8
   Yutzey KE, 2015, NATURE, V520, P445, DOI 10.1038/520445a
   Zhang H., 2014, BLOOD, V1
   Zohlnhofer Dietlind, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS106, DOI 10.1038/ncpcardio0745
NR 59
TC 10
Z9 10
U1 4
U2 12
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 17
PY 2016
VL 6
AR 25932
DI 10.1038/srep25932
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DL8PP
UT WOS:000375904200001
PM 27184924
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Bodenberger, N
   Paul, P
   Kubiczek, D
   Walther, P
   Gottschalk, KE
   Rosenau, F
AF Bodenberger, Nicholas
   Paul, Patrick
   Kubiczek, Dennis
   Walther, Paul
   Gottschalk, Kay-Eberhard
   Rosenau, Frank
TI A Novel Cheap and Easy to Handle Protein Hydrogel for 3D Cell Culture
   Applications: A High Stability Matrix with Tunable Elasticity and Cell
   Adhesion Properties
SO CHEMISTRYSELECT
LA English
DT Article
DE Biomaterial; cell adhesion; tunable elasticity; AFM; cancer cell
ID HUMAN SERUM-ALBUMIN; CLICK CHEMISTRY; CROSS-LINKING; STEM-CELLS;
   CHONDROGENIC DIFFERENTIATION; INJECTABLE HYDROGEL; BINDING-SPECIFICITY;
   ALGINATE HYDROGELS; DRUG-DELIVERY; SCAFFOLDS
AB Modern hydrogels have a high potential for cell culture applications due to their ability to form 3D architectures resembling the natural environment of the cell. A new cheap, robust and cell compatible hydrogel consisting of chemically crosslinked human serum albumin is presented. The protein gels polymerize within minutes, have high pH and temperature stabilities and combine biocompatibility and biodegradability. Pore size and elasticity were investigated by atomic force microscopy and revealed an adjustable elasticity. Pore sizes were investigated using cryo-scanning electron microscopy. To evaluate biocompatibility, hydrogels were incubated with human breast cancer cells and adenocarcinomic human alveolar basal epithelial cells under 2D and 3D conditions and both cell lines showed high survival rates. All results indicate the versatility of the new material to be used as a simple, robust system with high mechanical and chemical stability and a broad range of possible applications.
C1 [Bodenberger, Nicholas; Kubiczek, Dennis; Rosenau, Frank] Univ Ulm, Fac Nat Sci, Ctr Pharmaceut, Albert Einstein Allee 11, D-89069 Ulm, Germany.
   [Paul, Patrick; Gottschalk, Kay-Eberhard] Univ Ulm, Fac Nat Sci, Inst Expt Phys, Albert Einstein Allee 11, D-89069 Ulm, Germany.
   [Walther, Paul] Univ Ulm, Cent Facil Elect Microscopy, Albert Einstein Allee 11, D-89069 Ulm, Germany.
RP Rosenau, F (reprint author), Univ Ulm, Fac Nat Sci, Ctr Pharmaceut, Albert Einstein Allee 11, D-89069 Ulm, Germany.
EM frank.rosenau@uni-ulm.de
FU Baden-Wurttemberg Stiftung
FX Nicholas Bodenberger thanks the Baden-Wurttemberg Stiftung for funding
   his work and supporting the project. Special thanks go to Cornelia
   Lee-Thedieck and Annamarija Raic for inspiring discussions.
CR Ahmed EM, 2015, J ADV RES, V6, P105, DOI 10.1016/j.jare.2013.07.006
   Annabi N, 2010, TISSUE ENG PART B-RE, V16, P371, DOI [10.1089/ten.teb.2009.0639, 10.1089/ten.TEB.2009.0639]
   Balakrishnan B, 2005, BIOMATERIALS, V26, P3941, DOI 10.1016/j.biomaterials.2004.10.005
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Bellis SL, 2011, BIOMATERIALS, V32, P4205, DOI 10.1016/j.biomaterials.2011.02.029
   Calvert P, 2009, ADV MATER, V21, P743, DOI 10.1002/adma.200800534
   Chung C, 2012, BIOMACROMOLECULES, V13, P3912, DOI 10.1021/bm3015279
   Crescenzi V, 2007, BIOMACROMOLECULES, V8, P1844, DOI 10.1021/bm0700800
   Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044
   De Boisseson MR, 2004, J COLLOID INTERF SCI, V273, P131, DOI 10.1016/j.jcis.2003.12.064
   Dimitriadis EK, 2002, BIOPHYS J, V82, P2798, DOI 10.1016/S0006-3495(02)75620-8
   Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075
   Gil ES, 2004, PROG POLYM SCI, V29, P1173, DOI 10.1016/j.progpolymsci.2004.08.003
   Hirose M, 2010, MAT SCI ENG C-MATER, V30, P664, DOI 10.1016/j.msec.2010.02.020
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Hong SM, 2015, ADV MATER, V27, P4035, DOI [10.1002/adma.201570182, 10.1002/adma.201501099]
   Hoshikawa A, 2006, TISSUE ENG, V12, P2333, DOI 10.1089/ten.2006.12.2333
   Huang HZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059482
   Jirasek A, 2006, PHYS MED BIOL, V51, P1891, DOI 10.1088/0031-9155/51/7/018
   Komatsu T, 2004, BBA-GEN SUBJECTS, V1675, P21, DOI 10.1016/j.bbagen.2004.08.010
   Li XY, 2012, BIOTECHNOL PROGR, V28, P856, DOI 10.1002/btpr.1526
   Li Yuting, 2015, ScientificWorldJournal, V2015, P685690, DOI 10.1155/2015/685690
   Lin ST, 2014, SOFT MATTER, V10, P7519, DOI 10.1039/c4sm01039f
   Lu SY, 2011, SOFT MATTER, V7, P10763, DOI 10.1039/c1sm06053h
   Ludwig T, 2008, PFLUG ARCH EUR J PHY, V456, P29, DOI 10.1007/s00424-007-0398-9
   Missirlis D, 2014, BIOMACROMOLECULES, V15, P195, DOI 10.1021/bm4014827
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Nwe K, 2009, CANCER BIOTHER RADIO, V24, P289, DOI 10.1089/cbr.2008.0626
   Parikka K, 2012, FOOD HYDROCOLLOID, V26, P212, DOI 10.1016/j.foodhyd.2011.05.012
   Park H, 2009, BIOMACROMOLECULES, V10, P541, DOI 10.1021/bm801197m
   Patenaude M, 2014, BIOMACROMOLECULES, V15, P781, DOI 10.1021/bm401615d
   PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294
   PRICE JS, 1975, J BACTERIOL, V124, P1574
   Purcell BP, 2014, NAT MATER, V13, P653, DOI [10.1038/nmat3922, 10.1038/NMAT3922]
   Raic A, 2014, BIOMATERIALS, V35, P929, DOI 10.1016/j.biomaterials.2013.10.038
   Raja STK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15977
   Ross AM, 2012, SMALL, V8, P336, DOI 10.1002/smll.201100934
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Satya Prakash S., 2010, INT J NANOMED, P525
   Sawicki LA, 2014, BIOMATER SCI-UK, V2, P1612, DOI 10.1039/c4bm00187g
   Sung KE, 2009, BIOMATERIALS, V30, P4833, DOI 10.1016/j.biomaterials.2009.05.043
   Tada D, 2005, J BIOSCI BIOENG, V100, P551, DOI 10.1263/hbb.100.551
   Tanaka H, 2004, J CELL BIOCHEM, V93, P454, DOI 10.1002/jcb.20171
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Walther P, 2003, J MICROSC-OXFORD, V212, P34, DOI 10.1046/j.1365-2818.2003.01236.x
   Yamashita S, 2014, RADIAT PHYS CHEM, V101, P53, DOI 10.1016/j.radphyschem.2014.04.004
   Yang F, 2014, INT J MOL SCI, V15, P3580, DOI 10.3390/ijms15033580
   Yu F, 2014, POLYM CHEM-UK, V5, P1082, DOI 10.1039/c3py00869j
   Zhu JM, 2011, EXPERT REV MED DEVIC, V8, P607, DOI [10.1586/ERD.11.27, 10.1586/erd.11.27]
NR 50
TC 3
Z9 3
U1 0
U2 14
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 2365-6549
J9 CHEMISTRYSELECT
JI ChemistrySelect
PD MAY 16
PY 2016
VL 1
IS 7
BP 1353
EP 1360
DI 10.1002/slct.201600206
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA EM6DJ
UT WOS:000395402700008
DA 2018-10-19
ER

PT J
AU Feyen, DAM
   Gaetani, R
   Deddens, J
   van Keulen, D
   van Opbergen, C
   Poldervaart, M
   Alblas, J
   Chamuleau, S
   van Laake, LW
   Doevendans, PA
   Sluijter, JPG
AF Feyen, Dries A. M.
   Gaetani, Roberto
   Deddens, Janine
   van Keulen, Danielle
   van Opbergen, Chantal
   Poldervaart, Michelle
   Alblas, Jacqueline
   Chamuleau, Steven
   van Laake, Linda W.
   Doevendans, Pieter A.
   Sluijter, Joost P. G.
TI Gelatin Microspheres as Vehicle for Cardiac Progenitor Cells Delivery to
   the Myocardium
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID STEM-CELLS; INTRACORONARY INJECTION; EXTRACELLULAR-MATRIX; MOUSE MODEL;
   INFARCTION; HEART; TRANSPLANTATION; HYDROGEL; DIFFERENTIATION;
   CARDIOMYOCYTES
AB Inadequate cell retention and survival in cardiac stem cell therapy seems to be reducing the therapeutic effect of the injected stem cells. In order to ameliorate their regenerative effects, various biomaterials are being investigated for their potential supportive properties. Here, gelatin microspheres (MS) are utilized as microcarriers to improve the delivery and therapeutic efficacy of cardiac progenitor cells (CPCs) in the ischemic myocardium. The gelatin MS, generated from a water-in-oil emulsion, are able to accommodate the attachment of CPCs, thereby maintaining their cardiogenic potential. In a mouse model of myocardial infarction, we demonstrated the ability of these microcarriers to substantially enhance cell engraftment in the myocardium as indicated by bioluminescent imaging and histological analysis. However, despite an observed tenfold increase in CPC numbers in the myocardium, echocardiography, and histology reveals that mice treated with MS-CPCs show marginal improvement in cardiac function compared to CPCs only. Overall, a straightforward and translational approach is developed to increase the retention of stem cells in the ischemic myocardium. Even though the current biomaterial setup with CPCs as cell source does not translate into improved therapeutic action, coupling this developed technology with stem cell-derived cardiomyocytes can lead to an effective remuscularization therapy.
C1 [Feyen, Dries A. M.; Gaetani, Roberto; Deddens, Janine; van Keulen, Danielle; van Opbergen, Chantal; Chamuleau, Steven; van Laake, Linda W.; Doevendans, Pieter A.; Sluijter, Joost P. G.] Univ Med Ctr Utrecht, Dept Cardiol DH&L, NL-3584 CX Utrecht, Netherlands.
   [Gaetani, Roberto] Univ Roma La Sapienza, Inst Pasteur, Cenci Bolognetti Fdn, Dept Mol Med, I-00161 Rome, Italy.
   [Poldervaart, Michelle; Alblas, Jacqueline] Univ Med Ctr Utrecht, Dept Orthoped, NL-3584 CX Utrecht, Netherlands.
   [Doevendans, Pieter A.; Sluijter, Joost P. G.] Interuniv Cardiol Inst Netherlands, NL-3511 EP Utrecht, Netherlands.
   [Sluijter, Joost P. G.] Univ Med Ctr Utrecht, Expt Cardiol Lab, Dept Cardiol DH&L, Heidelberglaan 100,Room G03-642, NL-3584 CX Utrecht, Netherlands.
RP Sluijter, JPG (reprint author), Univ Med Ctr Utrecht, Dept Cardiol DH&L, NL-3584 CX Utrecht, Netherlands.; Sluijter, JPG (reprint author), Interuniv Cardiol Inst Netherlands, NL-3511 EP Utrecht, Netherlands.; Sluijter, JPG (reprint author), Univ Med Ctr Utrecht, Expt Cardiol Lab, Dept Cardiol DH&L, Heidelberglaan 100,Room G03-642, NL-3584 CX Utrecht, Netherlands.
EM j.sluijter@umcutrecht.nl
OI Alblas, Jacqueline/0000-0002-2996-9697; Sluijter,
   Joost/0000-0003-2088-9102
FU Project SMARTCARE of the BioMedical Materials institute [P1.04]; Dutch
   Ministry of Economic Affairs, Agriculture and Innovation; Netherlands
   CardioVascular Research Initiative (CVON): The Dutch Heart Foundation,
   Dutch Federation of University Medical Centers; Netherlands Organization
   for Health Research and Development; Royal Netherlands Academy of
   Sciences; HLSU grant "cardiac microtissues"
FX D.A.M.F. and R.G. contributed equally to this work. This research forms
   part of the Project P1.04 SMARTCARE of the BioMedical Materials
   institute, co-funded by the Dutch Ministry of Economic Affairs,
   Agriculture and Innovation and the Netherlands CardioVascular Research
   Initiative (CVON): The Dutch Heart Foundation, Dutch Federation of
   University Medical Centers, the Netherlands Organization for Health
   Research and Development, and the Royal Netherlands Academy of Sciences.
   Financial support via a HLSU grant "cardiac microtissues" is
   appreciated.
CR Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Danoviz ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012077
   Ellison GM, 2011, J AM COLL CARDIOL, V58, P977, DOI 10.1016/j.jacc.2011.05.013
   Feyen D, 2013, CARDIOVASC RES, V99, P83, DOI 10.1093/cvr/cvt078
   Hirt MN, 2014, CIRC RES, V114, P354, DOI 10.1161/CIRCRESAHA.114.300522
   Hoshino K, 2006, GENE THER, V13, P1320, DOI 10.1038/sj.gt.3302793
   Ivaska J, 2000, CELL MOL LIFE SCI, V57, P16, DOI 10.1007/s000180050496
   Iwakura A, 2006, CIRCULATION, V113, P1605, DOI 10.1161/CIRCULATIONAHA.105.553925
   Kofidis T, 2005, CIRCULATION, V112, pI173, DOI 10.1161/CIRCULATIONAHA.104.526178
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Liu J, 2011, J CELL MOL MED, V15, P1474, DOI 10.1111/j.1582-4934.2010.01104.x
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   NEWTON JM, 1977, J PHARM PHARMACOL, V29, P294, DOI 10.1111/j.2042-7158.1977.tb11315.x
   Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B
   Poldervaart MT, 2014, J CONTROL RELEASE, V184, P58, DOI 10.1016/j.jconrel.2014.04.007
   Poldervaart MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072610
   Ptaszek LM, 2012, LANCET, V379, P933, DOI 10.1016/S0140-6736(12)60075-0
   Radisic M, 2013, MAYO CLIN PROC, V88, P884, DOI 10.1016/j.mayocp.2013.05.003
   Rane AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021571
   Sasajima T, 1997, ARTIF ORGANS, V21, P287
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434
   Sluijter JPG, 2004, J VASC RES, V41, P546, DOI 10.1159/000081972
   Smits AM, 2009, NAT PROTOC, V4, P232, DOI 10.1038/nprot.2008.229
   Smits AM, 2009, CARDIOVASC RES, V83, P527, DOI 10.1093/cvr/cvp146
   Spinale FG, 2002, CIRC RES, V90, P520, DOI 10.1161/01.RES.0000013290.12884.A3
   Steingen C, 2008, J MOL CELL CARDIOL, V44, P1072, DOI 10.1016/j.yjmcc.2008.03.010
   Terrovitis J, 2009, J AM COLL CARDIOL, V54, P1619, DOI 10.1016/j.jacc.2009.04.097
   Tous E, 2011, J CARDIOVASC TRANSL, V4, P528, DOI 10.1007/s12265-011-9291-1
   van Laake LW, 2007, NAT PROTOC, V2, P2551, DOI 10.1038/nprot.2007.371
   van Mil A, 2013, J MOL MED, V91, P1001, DOI 10.1007/s00109-013-1017-1
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wall ST, 2010, J BIOMED MATER RES A, V95A, P1055, DOI 10.1002/jbm.a.32904
   Wang T, 2009, ACTA BIOMATER, V5, P2939, DOI 10.1016/j.actbio.2009.04.040
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Zheng Y, 2005, BONE MARROW TRANSPL, V35, P137, DOI 10.1038/sj.bmt.1704751
NR 37
TC 9
Z9 9
U1 0
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD MAY 11
PY 2016
VL 5
IS 9
BP 1071
EP 1079
DI 10.1002/adhm.201500861
PG 9
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA DO1HB
UT WOS:000377528000009
PM 26913710
DA 2018-10-19
ER

PT J
AU Wu, CT
   Xia, LG
   Han, PP
   Mao, LX
   Wang, JC
   Zhai, D
   Fang, B
   Chang, J
   Xiao, Y
AF Wu, Chengtie
   Xia, Lunguo
   Han, Pingping
   Mao, Lixia
   Wang, Jiacheng
   Zhai, Dong
   Fang, Bing
   Chang, Jiang
   Xiao, Yin
TI Europium-Containing Mesoporous Bioactive Glass Scaffolds for Stimulating
   in Vitro and in Vivo Osteogenesis
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE Eu-containing mesoporous bioactive glass; scaffolds; bone tissue
   engineering; biolabeling; bone regeneration
ID PRO-ANGIOGENIC PROPERTIES; MARROW STROMAL CELLS; HYDROXYAPATITE
   NANOPARTICLES; DOPED HYDROXYAPATITE; HYDROXIDE NANORODS;
   GENE-EXPRESSION; HYALURONIC-ACID; DRUG-DELIVERY; STEM-CELLS; BONE
AB Bone tissue engineering offers a possible strategy for regenerating large bone defects, in which how to design beneficial scaffolds for accelerating bone formation remains significantly challenging. Europium, as an important rare earth element, has been used as a solid-state lighting material. However, there are few reports on whether Eu can be used for labeling bone tissue engineering scaffolds, and its biological effect on bone cells and bone tissue regeneration is unknown. In this study, we incorporated Eu into mesoporous bioactive glass (Eu-MBG) scaffolds by an in situ cotemplate method to achieve a bifunctional biomaterial with biolabeling and bone regeneration. The prepared Eu-MBG scaffolds have highly interconnective large pores (300-500 pm), a high specific surface area (140-290 m(2)/g), and well-ordered mesopores (5 nm) as well as uniformly distributed Eu. The incorporation of 2-5 mol % Eu into MBG scaffolds gives them a luminescent property. The in vitro degradation of Eu-MBG scaffolds has a functional effect on the change of the luminescence intensity. In addition, Eu-MBG can be used for labeling bone marrow stromal cells (BMSCs) in vitro and still presents a distinct luminescence signal in deep bone tissues in vivo to label new bone tissue via release of Eu ions. Furthermore, the incorporation of different contents of Eu (1, 2, and 5 mol %) into MBG scaffolds significantly enhances the osteogenic gene expression of BMSCs in the scaffolds. The Eu- and Si-containing ionic products released from Eu-MBG scaffolds distinctly promote the osteogenic differentiation of BMSCs. Critically sized femur defects in ovariectomized (OVX) rats are created to simulate an osteoporotic phenotype. The results show that Eu-MBG scaffolds significantly stimulate new bone formation in osteoporotic bone defects when compared to MBG scaffolds alone and Eu may be involved in the acceleration of bone regeneration in OVX rats. Our study for the first time reports that the incorporation of the rare earth element Eu into bioscaffolds has the ability to accelerate bone regeneration in vivo, and thus, the prepared Eu-MBG scaffolds possess bifunctional properties with biolabeling and bone regeneration.
C1 [Wu, Chengtie; Wang, Jiacheng; Zhai, Dong; Chang, Jiang] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
   [Xia, Lunguo; Mao, Lixia; Fang, Bing] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9,Ctr Craniofacial Orthodont, Dept Oral & Craniomaxillofacial Sci, Shanghai 200011, Peoples R China.
   [Han, Pingping; Xiao, Yin] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia.
RP Wu, CT; Chang, J (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.; Fang, B (reprint author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9,Ctr Craniofacial Orthodont, Dept Oral & Craniomaxillofacial Sci, Shanghai 200011, Peoples R China.
EM chengtiewu@mail.sic.ac.cn; braces_dr@hotmail.com; jchang@mail.sic.ac.acn
OI Xiao, Yin/0000-0003-1785-3491; Han, Pingping/0000-0001-7546-1635
FU Recruitment Program of Global Young Talent, China; National High
   Technology Research and Development Program of China (863 Program)
   [SS2015AA020302]; Natural Science Foundation of China [31370963,
   81190132]; Program of Shanghai Outstanding Academic Leaders
   [15XD1503900]; Key Research Program of the Chinese Academy of Sciences
   [KGZD-EW-T06]
FX We acknowledge the support of the Recruitment Program of Global Young
   Talent, China (C.W.), the National High Technology Research and
   Development Program of China (863 Program, Grant SS2015AA020302), the
   Natural Science Foundation of China (Grants 31370963 and 81190132), the
   Program of Shanghai Outstanding Academic Leaders (Grant 15XD1503900),
   and the Key Research Program of the Chinese Academy of Sciences (Grant
   KGZD-EW-T06).
CR [Anonymous], 2009, 1099352009 ISO
   Barta CA, 2007, DALTON T, P5019, DOI 10.1039/b705123a
   Bunzli JCG, 2010, CHEM REV, V110, P2729, DOI 10.1021/cr900362e
   Chen F, 2012, BIOMATERIALS, V33, P6447, DOI 10.1016/j.biomaterials.2012.05.059
   Chen F, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-67
   De Jong WH, 2008, BIOMATERIALS, V29, P1912, DOI 10.1016/j.biomaterials.2007.12.037
   DENHOLLANDER W, 1991, BIOMATERIALS, V12, P569, DOI 10.1016/0142-9612(91)90053-D
   Dillip GR, 2014, J PHYS CHEM SOLIDS, V75, P8, DOI 10.1016/j.jpcs.2013.07.008
   Fan Y, 2011, J COLLOID INTERF SCI, V357, P280, DOI 10.1016/j.jcis.2011.01.109
   Fan Y, 2009, J PHYS CHEM C, V113, P7826, DOI 10.1021/jp900515x
   Gbureck U, 2007, ADV FUNCT MATER, V17, P3940, DOI 10.1002/adfm.200700019
   Gerhardt LC, 2011, BIOMATERIALS, V32, P4096, DOI 10.1016/j.biomaterials.2011.02.032
   Ghosh S, 2008, ADV FUNCT MATER, V18, P1883, DOI 10.1002/adfm.200800040
   Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021
   Guo BL, 2015, REGEN BIOMATER, V2, P47, DOI 10.1093/rb/rbu016
   Han PP, 2014, BIOMATER SCI-UK, V2, P1230, DOI 10.1039/c4bm00111g
   Han YC, 2010, CURR NANOSCI, V6, P178, DOI 10.2174/157341310790945632
   Hayashi H, 1988, Nihon Shishubyo Gakkai Kaishi, V30, P1
   Hench LL, 2010, J R SOC INTERFACE, V7, pS379, DOI 10.1098/rsif.2010.0151.focus
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hou ZY, 2011, ADV FUNCT MATER, V21, P2356, DOI 10.1002/adfm.201100193
   Kim K, 2008, ACTA BIOMATER, V4, P783, DOI 10.1016/j.actbio.2008.02.010
   Kim TG, 2012, ADV FUNCT MATER, V22, P2446, DOI 10.1002/adfm.201103083
   Lee KH, 2013, J AM CERAM SOC, V96, P503, DOI 10.1111/jace.12057
   Li B, 2009, BIOMATERIALS, V30, P6768, DOI 10.1016/j.biomaterials.2009.08.038
   Li G, 2015, ADV APPL CERAM, V114, P164, DOI 10.1179/1743676114Y.0000000210
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Martin JR, 2014, BIOMATERIALS, V35, P3766, DOI 10.1016/j.biomaterials.2014.01.026
   Martins AM, 2009, TISSUE ENG PT A, V15, P1953, DOI 10.1089/ten.tea.2008.0023
   Mathews S, 2011, BIOCHEM BIOPH RES CO, V414, P270, DOI 10.1016/j.bbrc.2011.09.071
   Mawani Y, 2014, J INORG BIOCHEM, V132, P52, DOI 10.1016/j.jinorgbio.2013.12.004
   Mawani Y, 2013, DALTON T, V42, P5999, DOI 10.1039/c2dt32373g
   Mendonca G, 2009, INT J ORAL MAX IMPL, V24, P205
   Miao GH, 2014, J SOL-GEL SCI TECHN, V69, P250, DOI 10.1007/s10971-013-3209-0
   Mordon S, 1998, MICROVASC RES, V55, P146, DOI 10.1006/mvre.1998.2068
   Park JK, 2011, ADV FUNCT MATER, V21, P2906, DOI 10.1002/adfm.201100612
   Patra CR, 2008, ADV MATER, V20, P753, DOI 10.1002/adma.200701611
   Patra CR, 2009, TOXICOL APPL PHARM, V240, P88, DOI 10.1016/j.taap.2009.07.009
   Salinas AJ, 2011, ACTA BIOMATER, V7, P3452, DOI 10.1016/j.actbio.2011.05.033
   Shaat SKK, 2014, J ALLOY COMPD, V587, P600, DOI 10.1016/j.jallcom.2013.11.001
   Shruti S, 2013, ACTA BIOMATER, V9, P4836, DOI 10.1016/j.actbio.2012.09.024
   Stambouli W, 2013, J LUMIN, V138, P201, DOI 10.1016/j.jlumin.2013.01.019
   Sui BY, 2014, ACS APPL MATER INTER, V6, P3528, DOI 10.1021/am4056886
   Tapec R, 2002, J NANOSCI NANOTECHNO, V2, P405, DOI 10.1166/jnn.2002.114
   Wang YF, 2016, REGEN BIOMATER, V3, P33, DOI 10.1093/rb/rbv025
   Wennerberg A, 2011, INT J ORAL MAX IMPL, V26, P1161
   Wu CT, 2015, CARBON, V93, P116, DOI 10.1016/j.carbon.2015.04.048
   Wu CT, 2014, J CONTROL RELEASE, V193, P282, DOI 10.1016/j.jconrel.2014.04.026
   Wu CT, 2014, ACS APPL MATER INTER, V6, P4264, DOI 10.1021/am4060035
   Wu CT, 2013, ACTA BIOMATER, V9, P9159, DOI 10.1016/j.actbio.2013.06.026
   Wu CT, 2013, BIOMATERIALS, V34, P422, DOI 10.1016/j.biomaterials.2012.09.066
   Wu CT, 2012, J MATER CHEM, V22, P12288, DOI 10.1039/c2jm30566f
   Wu CT, 2012, BIOMATERIALS, V33, P2076, DOI 10.1016/j.biomaterials.2011.11.042
   Wu CT, 2011, ACTA BIOMATER, V7, P3563, DOI 10.1016/j.actbio.2011.06.028
   Wu CT, 2011, BIOMATERIALS, V32, P7068, DOI 10.1016/j.biomaterials.2011.06.009
   Wu CT, 2010, BIOMATERIALS, V31, P3429, DOI 10.1016/j.biomaterials.2010.01.061
   Wu Y, 2014, ADV FUNCT MATER, V24, P4473, DOI 10.1002/adfm.201304304
   Xia LG, 2014, BIOMATERIALS, V35, P8514, DOI 10.1016/j.biomaterials.2014.06.028
   Yang PP, 2008, BIOMATERIALS, V29, P4341, DOI 10.1016/j.biomaterials.2008.07.042
   Yang PP, 2012, CHEM SOC REV, V41, P3679, DOI 10.1039/c2cs15308d
   Zhang HB, 2014, TISSUE ENG PART B-RE, V20, P492, DOI [10.1089/ten.teb.2013.0452, 10.1089/ten.TEB.2013.0452]
NR 61
TC 11
Z9 11
U1 15
U2 128
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAY 11
PY 2016
VL 8
IS 18
BP 11342
EP 11354
DI 10.1021/acsami.6b03100
PG 13
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DL3GA
UT WOS:000375521000020
PM 27096527
DA 2018-10-19
ER

PT J
AU Maleki, H
   Rai, A
   Pinto, S
   Evangelista, M
   Cardoso, RMS
   Paulo, C
   Carvalheiro, T
   Paiva, A
   Imani, M
   Simchi, A
   Duraes, L
   Portugal, A
   Ferreira, L
AF Maleki, Hajar
   Rai, Akhilesh
   Pinto, Sandra
   Evangelista, Marta
   Cardoso, Renato M. S.
   Paulo, Cristiana
   Carvalheiro, Tiago
   Paiva, Artur
   Imani, Mohammad
   Simchi, Abdolreza
   Duraes, Luisa
   Portugal, Antonio
   Ferreira, Lino
TI High Antimicrobial Activity and Low Human Cell Cytotoxicity of
   Core-Shell Magnetic Nanoparticles Functionalized with an Antimicrobial
   Peptide
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE antimicrobial peptide; cecropin melittin; magnetic nanoparticles;
   core-shell nanoparticles; human cell biocompatibility
ID IRON-OXIDE NANOPARTICLES; AMPHIPATHIC PEPTIDES; GOLD NANOPARTICLES;
   ANTIBACTERIAL; SELECTIVITY; CARBOXYFLUORESCEIN; MECHANISMS; MEMBRANES;
   MELITTIN; DELIVERY
AB Superparamagnetic iron oxide nanoparticles (SPIONs) functionalized with antimicrobial agents are promising infection-targeted therapeutic platforms when coupled with external magnetic stimuli. These antimicrobial nanoparticles (NPs) may offer advantages in fighting intracellular pathogens as well as biomaterial-associated infections. This requires the development of NPs with high antimicrobial activity without interfering with the biology of mammalian cells. Here, we report the preparation of biocompatible antimicrobial SPION@gold core-shell NPs based on covalent immobilization of the antimicrobial peptide (AMP) cecropin melittin (CM) (the conjugate is named AMP-NP). The minimal inhibitory concentration (MIC) of the AMP-NP for Escherichia coli was 0.4 mu g/mL, 10-times lower than the MIC of soluble CM. The antimicrobial activity of CM depends on the length of the spacer between the CM and the NP. AMP-NPs are taken up by endothelial (between 60 and 170 pg of NPs per cell) and macrophage (between 18 and 36 pg of NPs per cell) cells and accumulate preferentially in endolysosomes. These NPs have no significant cytotoxic and pro-inflammatory activities for concentrations up to 200 mu g/mL (at least 100 times higher than the MIC of soluble CM). Our results in membrane models suggest that the selectivity of AMP-NPs for bacteria and not eukaryotic membranes is due to their membrane compositions. The AMP-NPs developed here open new opportunities for infection-site targeting.
C1 [Maleki, Hajar; Duraes, Luisa; Portugal, Antonio] Univ Coimbra, Dept Chem Engn, CIEPQPF, P-3030790 Coimbra, Portugal.
   [Rai, Akhilesh; Pinto, Sandra; Evangelista, Marta; Cardoso, Renato M. S.; Paulo, Cristiana; Ferreira, Lino] Biocant Biotechnol Innovat Ctr, P-3060197 Cantanhede, Portugal.
   [Rai, Akhilesh; Pinto, Sandra; Evangelista, Marta; Cardoso, Renato M. S.; Paulo, Cristiana; Ferreira, Lino] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal.
   [Carvalheiro, Tiago; Paiva, Artur] Portuguese Inst Blood & Transplantat, Blood & Transplantat Ctr Coimbra, P-3041861 Coimbra, Portugal.
   [Imani, Mohammad] Iran Polymer & Petrochem Inst, Novel Drug Delivery Syst Dept, Tehran 1311514977, Iran.
   [Simchi, Abdolreza] Sharif Univ Technol, Dept Mat Sci & Engn, Tehran 1136511155, Iran.
   [Simchi, Abdolreza] Sharif Univ Technol, Inst Nanosci & Nanotechnol, Tehran 1136511155, Iran.
   [Paiva, Artur] Univ Hosp Coimbra, Pathol Serv, Flow Cytometry Unit, P-3001301 Coimbra, Portugal.
RP Ferreira, L (reprint author), Biocant Biotechnol Innovat Ctr, P-3060197 Cantanhede, Portugal.; Ferreira, L (reprint author), Univ Coimbra, CNC Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal.
EM lino@biocant.pt
RI Duraes, Luisa/B-5176-2012; maleki, hajar/A-9926-2016
OI Duraes, Luisa/0000-0003-3336-2449; maleki, hajar/0000-0002-2813-4700;
   Carvalheiro, Tiago/0000-0002-3187-2288; Rai,
   Akhilesh/0000-0001-5352-5415; Portugal, Antonio/0000-0002-7520-4767;
   ferreira, lino/0000-0001-8985-9302; Paiva, Artur/0000-0002-6562-5859
FU FEDER through the Program COMPETE; Portuguese fund through FCT
   [PTDC/Qui-Qui/105000/2008]; COMPETE [Centro-07-ST24-FEDER-002008]; FCT
   [SFRH/BPD/73211/2010]
FX This work was funded by FEDER through the Program COMPETE and by
   Portuguese fund through FCT in the context of the project
   PTDC/Qui-Qui/105000/2008. The work was also funded by COMPETE in the
   context of the project "Stem cell based platforms for Regenerative and
   Therapeutic Medicine" (Centro-07-ST24-FEDER-002008). A.R. wishes to
   thank FCT for a BPD fellowship (SFRH/BPD/73211/2010).
CR Armstead AL, 2011, INT J NANOMED, V6, P3281, DOI 10.2147/IJN.S27285
   Arruebo M, 2007, NANO TODAY, V2, P22, DOI 10.1016/S1748-0132(07)70084-1
   Aslam M, 2004, J MATER CHEM, V14, P1795, DOI 10.1039/b402823f
   BARBET J, 1984, BIOCHIM BIOPHYS ACTA, V772, P347, DOI 10.1016/0005-2736(84)90152-4
   Bhargava K, 2004, BIOPHYS J, V86, P329, DOI 10.1016/S0006-3495(04)74108-9
   Bini RA, 2012, J MAGN MAGN MATER, V324, P534, DOI 10.1016/j.jmmm.2011.08.035
   Boal AK, 2004, CHEM MATER, V16, P3252, DOI 10.1021/cm0495865
   Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x
   Briones E, 2008, J CONTROL RELEASE, V125, P210, DOI 10.1016/j.jconrel.2007.10.027
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Cho EC, 2011, NAT NANOTECHNOL, V6, P385, DOI [10.1038/nnano.2011.58, 10.1038/NNANO.2011.58]
   Corot C, 2006, ADV DRUG DELIVER REV, V58, P1471, DOI 10.1016/j.addr.2006.09.013
   Ferreira L., 2007, Medical Devices and Coatings with Non-Leaching Antimicrobial Peptides, Patent No. [W02007095393 A2, 2007095393, WO 2007095393 A2]
   Gabriel M, 2006, BIOCONJUGATE CHEM, V17, P548, DOI 10.1021/bc050091v
   Glukhov E, 2005, J BIOL CHEM, V280, P33960, DOI 10.1074/jbc.M507042200
   Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267
   Hashizaki K, 2006, CHEM PHARM BULL, V54, P80, DOI 10.1248/cpb.54.80
   Hopp L., 1995, PERSPECT RESP NURS, V6, P8
   Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146
   KATSU T, 1989, BIOCHIM BIOPHYS ACTA, V983, P135, DOI 10.1016/0005-2736(89)90226-5
   Khdary NH, 2014, RSC ADV, V4, P50114, DOI 10.1039/c4ra09341k
   Kumar CSSR, 2010, J PHYS CHEM LETT, V1, P3141, DOI 10.1021/jz101202a
   LEE CCY, 1979, ANAL BIOCHEM, V94, P60, DOI 10.1016/0003-2697(79)90790-5
   Lee WR, 2005, J AM CHEM SOC, V127, P16090, DOI 10.1021/ja053659j
   Lyon JL, 2004, NANO LETT, V4, P719, DOI 10.1021/nl035253f
   Maleki H, 2012, J MAGN MAGN MATER, V324, P3997, DOI 10.1016/j.jmmm.2012.06.045
   MATSUZAKI K, 1995, BIOCHEMISTRY-US, V34, P3423, DOI 10.1021/bi00010a034
   McHenry AJ, 2012, BBA-BIOMEMBRANES, V1818, P3019, DOI 10.1016/j.bbamem.2012.07.021
   MERRIFIELD RB, 1995, P NATL ACAD SCI USA, V92, P3449, DOI 10.1073/pnas.92.8.3449
   Pedrosa J, 2015, MATER CHEM PHYS, V163, P88, DOI 10.1016/j.matchemphys.2015.07.018
   Robinson I, 2010, NANOSCALE, V2, P2624, DOI 10.1039/c0nr00621a
   Skerlavaj B, 1999, FEBS LETT, V463, P58, DOI 10.1016/S0014-5793(99)01600-2
   STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0
   Subbiandoss G, 2012, ACTA BIOMATER, V8, P2047, DOI 10.1016/j.actbio.2012.03.002
   Taylor EN, 2009, INT J NANOMED, V4, P145
   Teply BA, 2008, BIOMATERIALS, V29, P1216, DOI 10.1016/j.biomaterials.2007.11.018
   Tiozzo E, 1998, BIOCHEM BIOPH RES CO, V249, P202, DOI 10.1006/bbrc.1998.9114
   Vestal CR, 2002, J AM CHEM SOC, V124, P14312, DOI 10.1021/ja0274709
   Wang YQ, 2009, NANOSCALE RES LETT, V4, P684, DOI 10.1007/s11671-009-9298-6
   Yilmaz A, 2013, EUR HEART J, V34, P462, DOI 10.1093/eurheartj/ehs366
   Yount NY, 2009, P NATL ACAD SCI USA, V106, P14972, DOI 10.1073/pnas.0904465106
   Zhao Y, 2005, J AM CHEM SOC, V127, P7328, DOI 10.1021/ja050432f
   Ziegler A, 2008, ADV DRUG DELIVER REV, V60, P580, DOI 10.1016/j.addr.2007.10.005
NR 43
TC 17
Z9 17
U1 7
U2 60
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAY 11
PY 2016
VL 8
IS 18
BP 11366
EP 11378
DI 10.1021/acsami.6b03355
PG 13
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DL3GA
UT WOS:000375521000022
PM 27074633
DA 2018-10-19
ER

PT J
AU Al-Ta'ii, HMJ
   Amin, YM
   Periasamy, V
AF Al-Ta'ii, Hassan Maktuff Jaber
   Amin, Yusoff Mohd
   Periasamy, Vengadesh
TI Humidity influenced capacitance and resistance of an Al/DNA/Al Schottky
   diode irradiated by alpha particles
SO SCIENTIFIC REPORTS
LA English
DT Article
ID VOLTAGE CHARACTERISTICS; NANOMEMBRANE DIODES; PLASTIC SUBSTRATE;
   CHARGE-TRANSPORT; THIN-FILM; DNA; SENSORS; HYPERSENSITIVITY;
   FABRICATION; EXTRACTION
AB Deoxyribonucleic acid or DNA based sensors, especially as humidity and alpha particle sensors have become quite popular in recent times due to flexible and highly optimizable nature of this fundamental biomaterial. Application of DNA electronics allow for more sensitive, accurate and effective sensors to be developed and fabricated. In this work, we examined the effect of different humidity conditions on the capacitive and resistive response of Aluminum (Al)/DNA/Al Schottky barrier structure when bombarded by time-dependent dosages of alpha particles. Based on current-voltage profiles, which demonstrated rectifying behaviours, Schottky diode parameters such as ideality factor, barrier height and series resistance was calculated. Results observed generally pointed towards a decrease in the resistance value from the pristine to the radiated structures. It was also demonstrated that under the effect of humidity, the capacitance of the DNA thin film increased from 0.05894 to 92.736 nF, with rising relative humidity level. We also observed the occurrence of the hypersensitivity phenomena after alpha irradiation between 2 to 4 min by observing a drop in the series resistance, crucial in the study of DNA damage and repair mechanisms. These observations may also suggest the exciting possibility of utilizing Al/DNA/Al Schottky diodes as potentially sensitive humidity sensors.
C1 [Al-Ta'ii, Hassan Maktuff Jaber; Periasamy, Vengadesh] Univ Malaya, Dept Phys, Low Dimens Mat Res Ctr, Fac Sci, Kuala Lumpur 50603, Malaysia.
   [Al-Ta'ii, Hassan Maktuff Jaber] Univ Al Muthanna, Dept Phys, Fac Sci, Samawah 66001, Iraq.
   [Amin, Yusoff Mohd] Univ Malaya, Dept Phys, Fac Sci, Kuala Lumpur 50603, Malaysia.
RP Al-Ta'ii, HMJ; Periasamy, V (reprint author), Univ Malaya, Dept Phys, Low Dimens Mat Res Ctr, Fac Sci, Kuala Lumpur 50603, Malaysia.; Al-Ta'ii, HMJ (reprint author), Univ Al Muthanna, Dept Phys, Fac Sci, Samawah 66001, Iraq.
EM hassankirkukly@gmail.com; vengadeshp@um.edu.my
RI PERIASAMY, VENGADESH/B-9993-2010
FU FRGS [FP004-2013A]; UMRG [RG321-15AFR]; Ministry of Higher Education and
   Scientific Research of Iraq;  [PG202-2014B]
FX Financial assistance provided by the PG202-2014B, FRGS (FP004-2013A) and
   UMRG (RG321-15AFR) grants are greatly appreciated. The first author
   would like to thank the Ministry of Higher Education and Scientific
   Research of Iraq for the financial assistance provided for his PhD
   study.
CR Ahmad Z, 2008, PHYSICA E, V41, P18, DOI 10.1016/j.physe.2008.05.018
   Ahmad Z, 2013, SENSORS-BASEL, V13, P3615, DOI 10.3390/s130303615
   Al-Ta'ii H., 2015, PLOS ONE, V11
   Al-Ta'ii H. M. J., 2015, J APPL PHYS, V118
   Armitage NP, 2004, PHYS STATUS SOLIDI B, V241, P69, DOI 10.1002/pssb.200303603
   Aydogan S, 2008, MAT SCI SEMICON PROC, V11, P53, DOI 10.1016/j.mssp.2008.11.004
   Aziz F., 2012, MEAS SCI TECHNOL, V23
   Azmer MI, 2015, MEASUREMENT, V61, P180, DOI 10.1016/j.measurement.2014.10.048
   Bi H., 2013, SCI REP, V3, P1
   Bonea A, 2012, J OPTOELECTRON ADV M, V14, P511
   Cerreta A, 2013, EUR POLYM J, V49, P1916, DOI 10.1016/j.eurpolymj.2013.03.026
   Chani MTS, 2012, PHYSICA E, V45, P77, DOI 10.1016/j.physe.2012.07.012
   Chen HJ, 2010, SENSOR ACTUAT B-CHEM, V150, P487, DOI [10.1016/jsob.2010.07.038, 10.1016/j.snb.2010.07.038]
   Chen W.-C., 2014, J PHYS D, V47
   CHEUNG SK, 1986, APPL PHYS LETT, V49, P85, DOI 10.1063/1.97359
   CHIU SM, 1982, BIOCHIM BIOPHYS ACTA, V699, P15, DOI 10.1016/0167-4781(82)90166-X
   Cubero OF, 1999, PLANT SYST EVOL, V216, P243, DOI 10.1007/BF01084401
   Cvetkovic NV, 2012, MICROELECTRON ENG, V100, P47, DOI 10.1016/j.mee.2012.07.110
   Farag AAM, 2011, SYNTHETIC MET, V161, P32, DOI 10.1016/j.synthmet.2010.10.030
   Farahani H, 2014, SENSORS-BASEL, V14, P7881, DOI 10.3390/s140507881
   Gupta RK, 2012, SOL ENERGY, V86, P1539, DOI 10.1016/j.solener.2012.02.015
   Ha DH, 2002, CHEM PHYS LETT, V355, P405, DOI 10.1016/S0009-2614(02)00142-2
   Hassan M, 2009, J RAFIDEN SCI, V20, P113
   Hibbett D., 2013, FORENSIC D N A MINIP
   Huang JR, 2007, SENSOR ACTUAT A-PHYS, V133, P467, DOI 10.1016/j.sna.2006.04.020
   Imtiaj A., 2011, Micologia Aplicada International, V23, P1
   Jo YS, 2003, J KOREAN PHYS SOC, V43, P909
   Joiner MC, 1996, MUTAT RES-FUND MOL M, V358, P171, DOI 10.1016/S0027-5107(96)00118-2
   Karatas S, 2004, VACUUM, V74, P45, DOI 10.1016/j.vacuum.2003.11.006
   Karimov K.S., 2012, J SEMICOND, V33
   Karimov K. S., 2015, CHINESE PHYS B, V24
   Kleine-Ostmann T., 2006, APPL PHYS LETT, P88
   Knapp F. R., 2016, RADIOPHARMACEUTICALS, p[3, 40]
   KULWICKI BM, 1991, J AM CERAM SOC, V74, P697, DOI 10.1111/j.1151-2916.1991.tb06911.x
   Kumemura M, 2007, CHEMPHYSCHEM, V8, P1875, DOI 10.1002/cphc.200700268
   Leveritt III J. M., 2009, J CHEM PHYS, V131
   Li Y, 2004, TALANTA, V62, P707, DOI 10.1016/j.talanta.2003.09.011
   Lin CY, 2011, ORG ELECTRON, V12, P1777, DOI 10.1016/j.orgel.2011.07.006
   Ma DL, 2014, ACCOUNTS CHEM RES, V47, P3614, DOI 10.1021/ar500310z
   Maeda M, 2008, J RADIAT RES, V49, P171, DOI 10.1269/jrr.07093
   MASUDA H, 1995, SCIENCE, V268, P1466, DOI 10.1126/science.268.5216.1466
   Mogera U., 2014, SCI REP, V4, P1
   Otsuka Y, 2002, JPN J APPL PHYS 1, V41, P891, DOI 10.1143/JJAP.41.891
   Paul A, 2013, IEEE SENS J, V13, P1806, DOI 10.1109/JSEN.2012.2234451
   Qin GX, 2013, IEEE ELECTR DEVICE L, V34, P160, DOI 10.1109/LED.2012.2228464
   Ramaprasad AT, 2010, SENSOR ACTUAT B-CHEM, V148, P117, DOI 10.1016/j.snb.2010.05.044
   Reddy VR, 2011, J ALLOY COMPD, V509, P8001, DOI 10.1016/j.jallcom.2011.05.055
   Rittersma ZM, 2002, SENSOR ACTUAT A-PHYS, V96, P196, DOI 10.1016/S0924-4247(01)00788-9
   Seo JH, 2013, MICROELECTRON ENG, V110, P40, DOI 10.1016/j.mee.2013.05.001
   Steckl AJ, 2007, NAT PHOTONICS, V1, P3, DOI 10.1038/nphoton.2006.56
   Stetter JR, 2003, J ELECTROCHEM SOC, V150, pS11, DOI 10.1149/1.1539051
   Sze S. M., 2006, PHYS SEMICONDUCTOR D
   Tabata H, 2003, SYNTHETIC MET, V133, P469, DOI 10.1016/S0379-6779(02)00386-7
   Taniguchi M, 2003, JPN J APPL PHYS 1, V42, P6629, DOI 10.1143/JJAP.42.6629
   TRAVERSA E, 1995, SENSOR ACTUAT B-CHEM, V23, P135, DOI 10.1016/0925-4005(94)01268-M
   Tugluoglu N, 2012, CURR APPL PHYS, V12, P1529, DOI 10.1016/j.cap.2012.04.027
   Tuukkanen S., 2005, APPL PHYS LETT, V87
   Varghese OK, 2003, J NANOSCI NANOTECHNO, V3, P277, DOI 10.1166/jnn.2003.158
   Wang SR, 2013, SENSOR ACTUAT B-CHEM, V182, P467, DOI 10.1016/j.snb.2013.03.042
   Yamada M, 2008, POLYM J, V40, P327, DOI 10.1295/polymj.PJ2007215
   Yamahata C, 2008, BIOPHYS J, V94, P63, DOI 10.1529/biophysj.107.115980
   Yaworski B., 1968, HDB PHYS
   Zhang YY, 2008, SENSOR ACTUAT B-CHEM, V135, P317, DOI 10.1016/j.snb.2008.08.042
NR 63
TC 6
Z9 6
U1 1
U2 13
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 10
PY 2016
VL 6
AR 25519
DI 10.1038/srep25519
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DL2AY
UT WOS:000375436100001
PM 27160654
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Golberg, K
   Emuna, N
   Vinod, TP
   van Moppes, D
   Marks, RS
   Arad, SM
   Kushmaro, A
AF Golberg, Karina
   Emuna, Noa
   Vinod, T. P.
   van Moppes, Dorit
   Marks, Robert S.
   Arad, Shoshana Malis
   Kushmaro, Ariel
TI Novel Anti-Adhesive Biomaterial Patches: Preventing Biofilm with Metal
   Complex Films (MCF) Derived from a Microalgal Polysaccharide
SO ADVANCED MATERIALS INTERFACES
LA English
DT Article
ID PSEUDOMONAS-AERUGINOSA; SWARMING MOTILITY; STREPTOCOCCUS-MUTANS;
   ANTIMICROBIAL ACTIVITY; VIRULENCE FACTORS; STAINLESS-STEEL; RED
   MICROALGAE; BACTERIAL; INHIBITION; NANOPARTICLES
AB Biofilm matrices formed by irreversibly surface-anchored bacteria cause significant economic damage in the industrial and biomedical environments. The ubiquity of biofilms promotes increased investment in the development of technologies that will impede bacteria-surface association. Certain surface topographical fabrications may aid in preventing colonization. Herein, algalsecreted polysaccharide (Ps) biomaterial patches and metal complex films (MCF) are examined for their anti-Acinetobacter baumannii and anti-Pseudomonas aeruginosa biofilm properties. Ps moderately reduces biofilm formation; the Cu-MCF coating has significant anti-biofim activity while Zn-MCF had no effect. A mechanistic examination of these effects shows a two-fold greater coverage of the anti-adhesive surface of Cu-MCF than that of the control due to the induction of swarming motility, thus impeding bacterial transformation to the irreversibly attached state. Chemical compositions of the coatings and the interactions between coating components are examined using X-ray photoelectron spectroscopy (XPS) and Fourier transform infrared (FTIR) spectrometry. Cu-MCF surface morphology comprises protruding needle-like structures up to 100 nm in height that are lacking in both the Ps and the Zn-MCF. Their presence in an aqueous solution is yet unproven and role in preventing their bacterial attachment open to speculation. The present study highlights the need to generate novel biomaterials that integrate naturally occurring anti-adhesive polymers with specific metal ions to improve the chemical, physical and biological properties of these anti-adhesive surfaces. Cu-MCF complexes fabricated with thermal and pressure stability to prevent metal ion leakage hold promise for a broad spectrum of industrial and medical anti-biofilm applications.
C1 [Golberg, Karina; Emuna, Noa; van Moppes, Dorit; Marks, Robert S.; Arad, Shoshana Malis; Kushmaro, Ariel] Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, POB 653, IL-8410501 Beer Sheva, Israel.
   [Vinod, T. P.] Ben Gurion Univ Negev, Dept Chem, IL-8410501 Beer Sheva, Israel.
   [Marks, Robert S.; Kushmaro, Ariel] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.
   [Marks, Robert S.; Kushmaro, Ariel] Ben Gurion Univ Negev, Ilse Katz Ctr Meso & Nanoscale Sci & Technol, POB 653, IL-8410501 Beer Sheva, Israel.
RP Kushmaro, A (reprint author), Ben Gurion Univ Negev, Avram & Stella Goldstein Goren Dept Biotechnol En, POB 653, IL-8410501 Beer Sheva, Israel.
EM arielkus@bgu.ac.il
OI T. P., Vinod/0000-0001-5815-5230
FU Singapore National Research Foundation under the CREATE program:
   Nanomaterials for Energy and Water Management; Levi Eshkol scholarship
   from the Israeli Ministry of Science and Technology; Shimona Geresh
   award
FX This work was supported by the Singapore National Research Foundation
   under the CREATE program: Nanomaterials for Energy and Water Management;
   a Levi Eshkol scholarship from the Israeli Ministry of Science and
   Technology and Shimona Geresh award. The authors also thank Bar
   Piglanski and Juergen Jopp for technical support.
CR ALLISON C, 1992, INFECT IMMUN, V60, P4740
   [Anonymous], 2012, NIST XRAY PHOT SPECT
   Arad S, 2006, LANGMUIR, V22, P7313, DOI 10.1021/la060600x
   Asuri P, 2007, SMALL, V3, P50, DOI 10.1002/smll.200600312
   Atkinson S, 2009, J R SOC INTERFACE, V6, P959, DOI 10.1098/rsif.2009.0203
   Beamson G., 1993, SURF INTERFACE ANAL, V20, P267
   Bearinger JP, 2003, NAT MATER, V2, P259, DOI 10.1038/nmat851
   Bendaoud M, 2011, J BACTERIOL, V193, P3879, DOI 10.1128/JB.00311-11
   Birkenhauer E, 2014, JOVE-J VIS EXP, DOI 10.3791/52327
   Boles BR, 2005, MOL MICROBIOL, V57, P1210, DOI 10.1111/j.1365-2958.2005.04743.x
   Bosch TCG, 2013, ANNU REV MICROBIOL, V67, P499, DOI 10.1146/annurev-micro-092412-155626
   Braithwaite RA, 2005, ADV MAR BIOL, V47, P215
   Brochardt SA, 2001, APPL ENVIRON MICROB, V67, P3174
   Caiazza NC, 2004, J BACTERIOL, V186, P4476, DOI 10.1128/JB.186.14.4476-4485.2004
   Carte Brad K., 1993, Current Opinion in Biotechnology, V4, P275, DOI 10.1016/0958-1669(93)90095-E
   CERVANTES C, 1994, FEMS MICROBIOL REV, V14, P121
   Christensen BB, 1999, METHOD ENZYMOL, V310, P20
   Cloete TE, 2001, WATER SA, V27, P21
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   de la Fuente-Nunez C, 2012, ANTIMICROB AGENTS CH, V56, P2696, DOI 10.1128/AAC.00064-12
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Efimenko K, 2009, ACS APPL MATER INTER, V1, P1031, DOI 10.1021/am9000562
   Eshed M, 2014, ADV FUNCT MATER, V24, P1382, DOI 10.1002/adfm.201302425
   Eshed M, 2012, LANGMUIR, V28, P12288, DOI 10.1021/la301432a
   Falagas ME, 2007, INT J ANTIMICROB AG, V29, P630, DOI 10.1016/j.ijantimicag.2006.12.012
   Faundez G, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-19
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415
   Francolini I, 2010, FEMS IMMUNOL MED MIC, V59, P227, DOI 10.1111/j.1574-695X.2010.00665.x
   Fraser GM, 1999, CURR OPIN MICROBIOL, V2, P630, DOI 10.1016/S1369-5274(99)00033-8
   Gaddy JA, 2009, FUTURE MICROBIOL, V4, P273, DOI 10.2217/FMB.09.5
   Gao GZ, 2011, BIOMATERIALS, V32, P3899, DOI 10.1016/j.biomaterials.2011.02.013
   GERESH S, 1991, BIORESOURCE TECHNOL, V38, P195, DOI 10.1016/0960-8524(91)90154-C
   Giesbers M, 2013, LANGMUIR, V29, P4782, DOI 10.1021/la400445s
   Givskov M, 1996, J BACTERIOL, V178, P6618, DOI 10.1128/jb.178.22.6618-6622.1996
   Hattori T, 1998, J NAT PROD, V61, P823, DOI 10.1021/np970527y
   Hentzer M, 2002, MICROBIOL-SGM, V148, P87, DOI 10.1099/00221287-148-1-87
   Hofmann S., 2013, AUGER XRAY PHOTOELEC
   Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011
   Huleihel M, 2001, J APPL PHYCOL, V13, P127, DOI 10.1023/A:1011178225912
   INGRAM LO, 1990, CRIT REV BIOTECHNOL, V9, P305
   Jayaraman A, 2008, ANNU REV BIOMED ENG, V10, P145, DOI 10.1146/annurev.bioeng.10.061807.160536
   Jiang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018514
   Kielemoes J, 2001, LETT APPL MICROBIOL, V33, P148, DOI 10.1046/j.1472-765X.2001.00967.x
   Kim JS, 2007, BIOTECHNOL BIOPROC E, V12, P308, DOI 10.1007/BF02931109
   Leal MC, 2013, TRENDS BIOTECHNOL, V31, P555, DOI 10.1016/j.tibtech.2013.06.004
   Lee SY, 2007, POLYM ADVAN TECHNOL, V18, P562, DOI 10.1002/pat.918
   LIPPERT B, 1992, BIOMETALS, V5, P195, DOI 10.1007/BF01061218
   Loke MF, 2007, FEMS IMMUNOL MED MIC, V50, P231, DOI 10.1111/j.1574-695X.2007.00248.x
   LOPEZ GP, 1991, SURF INTERFACE ANAL, V17, P267, DOI 10.1002/sia.740170508
   Lutay N, 2011, APPL BIOCHEM BIOTECH, V164, P1, DOI 10.1007/s12010-010-9109-7
   Lynch AS, 2008, ANNU REV MED, V59, P415, DOI 10.1146/annurev.med.59.110106.132000
   Mansouri J, 2010, J MATER CHEM, V20, P4567, DOI 10.1039/b926440j
   Matsui MS, 2003, APPL BIOCHEM BIOTECH, V104, P13, DOI 10.1385/ABAB:104:1:13
   Merritt JH, 2007, J BACTERIOL, V189, P8154, DOI 10.1128/JB.00585-07
   Nabet A, 1997, APPL SPECTROSC, V51, P466, DOI 10.1366/0003702971940701
   Neal AL, 2008, ECOTOXICOLOGY, V17, P362, DOI 10.1007/s10646-008-0217-x
   Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730, DOI 10.1007/s002530051457
   Nikolic GS, 2008, RUSS J COORD CHEM+, V34, P322, DOI 10.1134/S1070328408050023
   Nikolic G. S., 2011, NEW ANAL APPROACHES, P15
   O'Loughlin CT, 2013, P NATL ACAD SCI USA, V110, P17981, DOI 10.1073/pnas.1316981110
   O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49
   Overhage J, 2008, J BACTERIOL, V190, P2671, DOI 10.1128/JB.01659-07
   Qin ZQ, 2009, MICROBIOL-SGM, V155, P2148, DOI 10.1099/mic.0.028001-0
   RAMUS J, 1972, J PHYCOL, V8, P97, DOI 10.1111/j.0022-3646.1972.00097.x
   Ren D, 2002, LETT APPL MICROBIOL, V34, P293, DOI 10.1046/j.1472-765x.2002.01087.x
   Rendueles O, 2013, ENVIRON MICROBIOL, V15, P334, DOI 10.1111/j.1462-2920.2012.02810.x
   Rozalski A, 1997, MICROBIOL MOL BIOL R, V61, P65
   RUGGIERI MR, 1987, J UROLOGY, V138, P423, DOI 10.1016/S0022-5347(17)43177-6
   Ruparelia JP, 2008, ACTA BIOMATER, V4, P707, DOI 10.1016/j.actbio.2007.11.006
   Saeki Yoji, 1994, Bulletin of Tokyo Dental College, V35, P9
   Sayem S M Abu, 2011, Microb Cell Fact, V10, P74, DOI 10.1186/1475-2859-10-74
   Schultz MP, 2011, BIOFOULING, V27, P87, DOI 10.1080/08927014.2010.542809
   Schumacher JF, 2007, BIOFOULING, V23, P55, DOI 10.1080/08927010601136957
   Shrout JD, 2006, MOL MICROBIOL, V62, P1264, DOI 10.1111/j.1365-2958.2006.05421.x
   Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3
   Tannin-Spitz T, 2005, J APPL PHYCOL, V17, P215, DOI 10.1007/s10811-005-0679-7
   Tenke P, 2004, INT J ANTIMICROB AG, V23, pS67, DOI 10.1016/j.ijantimicag.2003.12.007
   Valle J, 2006, P NATL ACAD SCI USA, V103, P12558, DOI 10.1073/pnas.0605399103
   Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004
   Wai SN, 1998, APPL ENVIRON MICROB, V64, P3648
   Wu C, 2013, J APPL MICROBIOL, V115, P30, DOI 10.1111/jam.12197
   Yano A, 2012, ARCH ORAL BIOL, V57, P711, DOI 10.1016/j.archoralbio.2012.01.001
NR 82
TC 2
Z9 2
U1 6
U2 31
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2196-7350
J9 ADV MATER INTERFACES
JI Adv. Mater. Interfaces
PD MAY 6
PY 2016
VL 3
IS 9
AR 1500486
DI 10.1002/admi.201500486
PG 11
WC Chemistry, Multidisciplinary; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA DQ0JN
UT WOS:000378885300002
DA 2018-10-19
ER

PT J
AU Dragostin, OM
   Samal, SK
   Dash, M
   Lupascu, F
   Panzariu, A
   Tuchilus, C
   Ghetu, N
   Danciu, M
   Dubruel, P
   Pieptu, D
   Vasile, C
   Tatia, R
   Profire, L
AF Dragostin, Oana Maria
   Samal, Sangram Keshari
   Dash, Mamoni
   Lupascu, Florentina
   Panzariu, Andreea
   Tuchilus, Cristina
   Ghetu, Nicolae
   Danciu, Mihai
   Dubruel, Peter
   Pieptu, Dragos
   Vasile, Cornelia
   Tatia, Rodica
   Profire, Lenuta
TI New antimicrobial chitosan derivatives for wound dressing applications
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Chitosan derivative; Membrane; Biomaterial; Healing activity
ID ANTIBACTERIAL ACTIVITY; COMPOSITE SPONGES; SURFACE-ENERGY;
   CELL-ADHESION; WATER; SULFONAMIDES; WETTABILITY; TECHNOLOGY; POLYMERS;
   CHITIN
AB Chitosan is a non-toxic, biocompatible, biodegradable natural cationic polymer known for its low imunogenicity, antimicrobial, antioxidant effects and wound-healing activity. To improve its therapeutic potential, new chitosan-sulfonamide derivatives have been designed to develop new wound dressing biomaterials. The structural, morphological and physico-chemical properties of synthesized chitosan derivatives were analyzed by FT-IR, H-1 NMR spectroscopy, scanning electron microscopy, swelling ability and porosity. Antimicrobial, in vivo testing and biodegradation behavior have been also performed. The chitosan derivative membranes showed improved swelling and biodegradation rate, which are important characteristics required for the wound healing process. The antimicrobial assay evidenced that chitosan-based sulfadiazine, sulfadimethoxine and sulfamethoxazole derivatives were the most active. The MTT assay showed that some of chitosan derivatives are nontoxic. Furthermore, the in vivo study on burn wound model induced in Wistar rats demonstrated an improved healing effect and enhanced epithelialization of chitosan-sulfonamide derivatives compared to neat chitosan. The obtained results strongly recommend the use of some of the newly developed chitosan derivatives as antimicrobial wound dressing biomaterials. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Dragostin, Oana Maria; Lupascu, Florentina; Panzariu, Andreea; Profire, Lenuta] Univ Med & Pharm Grigore T Popa Iasi, Dept Pharmaceut Chem, Fac Pharm, 16 Univ St, Iasi 700115, Romania.
   [Samal, Sangram Keshari] Univ Ghent, Ctr Nano & Biophoton, Lab Gen Biochem & Phys Pharm, Ottergemsesteenweg 460, B-9000 Ghent, Belgium.
   [Dash, Mamoni; Dubruel, Peter] Univ Ghent, Polymer Chem & Biomat Res Grp, Krijgslaan 281,S4 Bis, B-9000 Ghent, Belgium.
   [Tuchilus, Cristina] Univ Med & Pharm Grigore T Popa Iasi, Dept Microbiol, Fac Med, 16 Univ St, Iasi 700115, Romania.
   [Ghetu, Nicolae; Pieptu, Dragos] Univ Med & Pharm Grigore T Popa Iasi, Dept Plast Surg, Fac Med, 16 Univ St, Iasi 700115, Romania.
   [Danciu, Mihai] Univ Med & Pharm Grigore T Popa Iasi, Dept Morphopathol, Fac Med, 16 Univ St, Iasi 700115, Romania.
   [Vasile, Cornelia] Petni Poni Inst Macromol Chem, Dept Phys Chem Polymers, 41A Grigore Ghica Voda Alley, Iasi 700487, Romania.
   [Tatia, Rodica] Natl Inst Res & Dev Biol Sci, 296 Splaiul Independentei, Bucharest 060031, Romania.
RP Profire, L (reprint author), Univ Med & Pharm Grigore T Popa Iasi, Dept Pharmaceut Chem, Fac Pharm, 16 Univ St, Iasi 700115, Romania.
EM lenuta.profire@umfiasi.ro
RI Dash, Mamoni/H-5450-2013; Pieptu, Dragos/N-3173-2017; Danciu,
   Mihai/N-5012-2016; Profire, Lenuta/H-4514-2016
OI Dash, Mamoni/0000-0001-6930-6495; Pieptu, Dragos/0000-0001-8742-7581; 
FU POSDRU [159/1.5/S/136893]; Romanian National Authority for Scientific
   Research, CNCS-UEFISCDI [PN-II-ID-PCE-2011-3-0906]; Romanian UEFISCDI
   [164/2012 BIONANOMED]
FX The research was funded by POSDRU grant no. 159/1.5/S/136893 grant with
   title "Parteneriat strategic pentru cresterea calitatii cercetarii
   stiintifice din universitatile medicale prin acordarea de burse
   doctorale si postdoctorale-DocMed.Net_2.0" (partially) and by a grant of
   the Romanian National Authority for Scientific Research, CNCS-UEFISCDI,
   project number PN-II-ID-PCE-2011-3-0906". The authors thank also to
   Romanian UEFISCDI for the financial support given through the research
   project 164/2012 BIONANOMED.
CR Aider M, 2010, LWT-FOOD SCI TECHNOL, V43, P837, DOI 10.1016/j.lwt.2010.01.021
   Anisha BS, 2013, CARBOHYD POLYM, V92, P1470, DOI 10.1016/j.carbpol.2012.10.058
   Arpornmaeklong P, 2008, INT J ORAL MAX SURG, V37, P357, DOI 10.1016/j.ijom.2007.11.014
   Avadi MR, 2004, EUR POLYM J, V40, P1355, DOI 10.1016/j.europolymj.2004.02.015
   Baran ET, 2012, MAT SCI ENG C-MATER, V32, P1314, DOI 10.1016/j.msec.2012.02.015
   Batista MKS, 2006, CARBOHYD POLYM, V64, P299, DOI 10.1016/j.carbpol.2005.11.040
   Clinical Laboratory Standards Institute, 2012, 22 INF S, V32
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   Dias AMA, 2013, J SUPERCRIT FLUID, V74, P34, DOI 10.1016/j.supflu.2012.12.007
   Dragostin O. M., 2015, CARBOHYDRATE P UNPUB
   Dutta PK, 2002, J MACROMOL SCI-POL R, VC42, P307, DOI 10.1081/MC-120006451
   European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), 2000, CLIN MICROBIOL INFEC, V6, P509
   Feng YW, 2011, CARBOHYD POLYM, V83, P1169, DOI 10.1016/j.carbpol.2010.09.026
   Gallaher CM, 2000, J NUTR, V130, P2753
   Gethin G. T., 2007, WOUNDS UK, V3, P52
   Giri TK, 2012, ACTA PHARM SIN B, V2, P439, DOI 10.1016/j.apsb.2012.07.004
   Gomes JRB, 2005, TETRAHEDRON, V61, P2705, DOI 10.1016/j.tet.2005.01.034
   Gupta A, 2009, WATER RES, V43, P3862, DOI 10.1016/j.watres.2009.05.040
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Ignatova M, 2013, MACROMOL BIOSCI, V13, P860, DOI 10.1002/mabi.201300058
   Jones V, 2006, BRIT MED J, V332, P777, DOI 10.1136/bmj.332.7544.777
   Kolodynska D, 2012, CHEM ENG J, V179, P33, DOI 10.1016/j.cej.2011.10.028
   Kremer E, 2006, J INORG BIOCHEM, V100, P1167, DOI 10.1016/j.jinorgbio.2006.01.042
   Kumar PTS, 2012, ACS APPL MATER INTER, V4, P2618, DOI 10.1021/am300292v
   Kumirska J, 2011, POLYMERS-BASEL, V3, P1875, DOI 10.3390/polym3041875
   Lin YC, 2009, ACTA BIOMATER, V5, P2591, DOI 10.1016/j.actbio.2009.03.038
   Liu X, 2011, ADV POLYM SCI, V244, P81, DOI 10.1007/12_2011_118
   Lonnroth Emma Christin, 2005, Int J Occup Saf Ergon, V11, P131
   Ma GP, 2008, CARBOHYD POLYM, V74, P121, DOI 10.1016/j.carbpol.2008.01.028
   Mallick S, 2012, ACS APPL MATER INTER, V4, P1313, DOI 10.1021/am201586w
   Martins AF, 2014, INT J MOL SCI, V15, P20800, DOI 10.3390/ijms151120800
   Mazyala E. J, 2008, THESIS U STELLENBOSC
   O'Brien F. J., 2005, EFFECT PORE SIZE CEL
   Okamoto Y, 2003, CARBOHYD POLYM, V53, P337, DOI 10.1016/S0144-8617(03)00076-6
   Ozturk E, 2006, J APPL POLYM SCI, V101, P1602, DOI 10.1002/app.23563
   Paul W., 2004, TRENDS BIOMATERIALS, V18, P18
   Pillai CKS, 2009, PROG POLYM SCI, V34, P641, DOI 10.1016/j.progpolymsci.2009.04.001
   Rotta J, 2009, MAT SCI ENG C-BIO S, V29, P619, DOI 10.1016/j.msec.2008.10.032
   Samal SK, 2014, RSC ADV, V4, P53547, DOI 10.1039/c4ra10070k
   Samal SK, 2014, MACROMOL BIOSCI, V14, P991, DOI 10.1002/mabi.201300513
   Samal SK, 2012, CHEM SOC REV, V41, P7147, DOI 10.1039/c2cs35094g
   Sashiwa H, 2003, MACROMOL BIOSCI, V3, P231, DOI 10.1002/mabi.200390029
   Shabalovskaya SA, 2013, MAT SCI ENG C-MATER, V33, P127, DOI 10.1016/j.msec.2012.08.018
   Sionkowska A, 2013, J MOL LIQ, V178, P5, DOI 10.1016/j.molliq.2012.10.042
   Wang JP, 2009, WATER RES, V43, P5267, DOI 10.1016/j.watres.2009.08.040
   Xie YJ, 2007, CARBOHYD POLYM, V69, P142, DOI 10.1016/j.carbpol.2006.09.010
   Yang CY, 2010, EUR CELLS MATER, V20, P415
   Yang JM, 2008, MAT SCI ENG C-BIO S, V28, P150, DOI 10.1016/j.msec.2007.01.011
   Yang TC, 2005, INT J FOOD MICROBIOL, V97, P237, DOI 10.1016/S0168-1605(03)00083-7
   Zahid H. C., 2009, TRANSITION METAL CHE, V34, P153
   Zhong Z., 2007, CARBOHYD RES, V343, P566
NR 51
TC 27
Z9 27
U1 6
U2 248
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD MAY 5
PY 2016
VL 141
BP 28
EP 40
DI 10.1016/j.carbpol.2015.12.078
PG 13
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA DD5JT
UT WOS:000369960400004
PM 26876993
DA 2018-10-19
ER

PT J
AU Nieto-Suarez, M
   Lopez-Quintela, MA
   Lazzari, M
AF Nieto-Suarez, Marina
   Arturo Lopez-Quintela, M.
   Lazzari, Massimo
TI Preparation and characterization of crosslinked chitosan/gelatin
   scaffolds by ice segregation induced self-assembly
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Chitosan; Gelatin; Hydrogel; Scaffold; Unidirectional freezing;
   Biomaterial
ID BIOMEDICAL APPLICATIONS; GELATIN SCAFFOLDS; CONTROLLED-RELEASE;
   COMPOSITE FILMS; DRUG-DELIVERY; HYDROGELS; CHITIN; LINKING; MORPHOLOGY;
   GELS
AB Chitosan and gelatin are biodegradable and biocompatible polymers which may be used in the preparation of 3D scaffolds with applications in biomedicine. Chitosan/gelatin scaffolds crosslinked with glutaraldehyde were prepared by ice segregation induced self-assembly (ISISA); a unidirectional freezing at -196 degrees C followed freeze-drying to produce macroporous materials with a well-patterned structure. This process may be included within the green chemistry by the preparation of the porous structures without using organic solvents, moreover is a versatile, non-difficult and cheap process.
   The scaffolds prepared by ISISA were characterized by scanning electron microscopy, attenuated total reflectance Fourier transform infrared spectroscopy, thermal gravimetric analysis, differential scanning calorimetry, and their stability was evaluated by degree swelling and degradation tests. The scaffolds present properties as high porosity, high degree swelling and good stability which make them suitable of applications as biomaterials. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Nieto-Suarez, Marina; Lazzari, Massimo] Univ Santiago de Compostela, Ctr Res Biol Chem & Mol Mat CIQUS, Campus Vida, Santiago De Compostela 15782, Spain.
   [Nieto-Suarez, Marina; Arturo Lopez-Quintela, M.] Univ Santiago de Compostela, Dept Phys Chem, Fac Chem, Santiago De Compostela 15782, Spain.
RP Nieto-Suarez, M (reprint author), Univ Santiago de Compostela, Ctr Res Biol Chem & Mol Mat CIQUS, Campus Vida, Santiago De Compostela 15782, Spain.; Nieto-Suarez, M (reprint author), Univ Santiago de Compostela, Dept Phys Chem, Fac Chem, Santiago De Compostela 15782, Spain.
EM m.nieto@usc.es
RI lazzari, massimo/E-8799-2013
OI lazzari, massimo/0000-0003-1300-6711; Lopez-Quintela, M.
   Arturo/0000-0002-4842-8028
FU Xunta de Galicia [GRC2013-044]
FX This research work was supported by the Xunta de Galicia through grant
   GRC2013-044. M.N.S. thanks to the Xunta de Galicia for "Isidro Parga
   Pondal" research contract. The authors also thank Manuel Gomez (Optics
   Faculty-USC) for measurements of the mechanical properties
CR Alizadeh M, 2013, MAT SCI ENG C-MATER, V33, P3958, DOI 10.1016/j.msec.2013.05.039
   Attawia MA, 1999, J BIOMED MATER RES, V48, P322, DOI 10.1002/(SICI)1097-4636(1999)48:3<322::AID-JBM17>3.0.CO;2-U
   Avetta P, 2014, J MATER CHEM B, V2, P5287, DOI 10.1039/c4tb00236a
   Balakrishnan B, 2011, CHEM REV, V111, P4453, DOI 10.1021/cr100123h
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Chiono V, 2008, J MATER SCI-MATER M, V19, P889, DOI 10.1007/s10856-007-3212-5
   Choi YS, 2001, J MATER SCI-MATER M, V12, P67, DOI 10.1023/A:1026765321117
   Contri RV, 2014, MAT SCI ENG C-MATER, V42, P234, DOI 10.1016/j.msec.2014.05.001
   Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937
   Farris S, 2010, J AGR FOOD CHEM, V58, P998, DOI 10.1021/jf9031603
   Ferrer ML, 2006, CHEM MATER, V18, P554, DOI 10.1021/cm052087z
   Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x
   Garcia MA, 2006, STARCH-STARKE, V58, P453, DOI 10.1002/star.200500484
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Gutierrez MC, 2007, ADV FUNCT MATER, V17, P3505, DOI 10.1002/adfm.200700093
   Gutierrez MC, 2007, CHEM MATER, V19, P1968, DOI 10.1021/cm062882s
   Gutierrez MC, 2006, ADV MATER, V18, P1137, DOI 10.1002/adma.200502550
   Guvendiren M, 2012, SOFT MATTER, V8, P260, DOI 10.1039/c1sm06513k
   Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010
   Hopkins AM, 2013, ADV FUNCT MATER, V23, P5140, DOI 10.1002/adfm.201300435
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Ikeda T, 2014, BIOMED RES INT, V2014, DOI [10.1155/2014/786892, DOI 10.1155/2014/786892]
   Jayakumar R, 2010, CARBOHYD POLYM, V82, P227, DOI 10.1016/j.carbpol.2010.04.074
   Kim H, 2011, J BIOMED MATER RES A, V97A, P395, DOI 10.1002/jbm.a.33070
   Kuijpers AJ, 2000, J BIOMAT SCI-POLYM E, V11, P225, DOI 10.1163/156856200743670
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Kurita K, 2000, CARBOHYD POLYM, V42, P19, DOI 10.1016/S0144-8617(99)00127-7
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lopez-Perez PM, 2010, J MATER CHEM, V20, P483, DOI 10.1039/b911854c
   Monteiro OAC, 1999, INT J BIOL MACROMOL, V26, P119, DOI 10.1016/S0141-8130(99)00068-9
   Mukai SR, 2005, CARBON, V43, P1563, DOI 10.1016/j.carbon.2004.12.029
   Mukai SR, 2003, MICROPOR MESOPOR MAT, V63, P43, DOI 10.1016/S1387-1811(03)00430-X
   Muzzarelli RAA, 2012, CARBOHYD POLYM, V87, P995, DOI 10.1016/j.carbpol.2011.09.063
   Muzzarelli RAA, 2011, CARBOHYD POLYM, V83, P1433, DOI 10.1016/j.carbpol.2010.10.044
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   Nieto M, 2010, SOFT MATTER, V6, P3533, DOI 10.1039/c0sm00079e
   Olad A, 2014, CERAM INT, V40, P10061, DOI 10.1016/j.ceramint.2014.04.010
   Ostrowska-Czubenko J, 2009, CARBOHYD POLYM, V77, P590, DOI 10.1016/j.carbpol.2009.01.036
   Pal K, 2007, J MATER SCI-MATER M, V18, P1889, DOI 10.1007/s10856-007-3061-2
   Pawlak A, 2003, THERMOCHIM ACTA, V396, P153, DOI 10.1016/S0040-6031(02)00523-3
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Pillai CKS, 2009, PROG POLYM SCI, V34, P641, DOI 10.1016/j.progpolymsci.2009.04.001
   Pradal C, 2011, J MATER CHEM, V21, P2330, DOI 10.1039/c0jm03080e
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   RATNER BD, 1976, ACS SYM SER, P1
   Rigozzi S, 2013, J BIOMECH, V46, P813, DOI 10.1016/j.jbiomech.2012.11.017
   Rinaudo M, 2008, POLYM INT, V57, P397, DOI 10.1002/pi.2378
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Sarem M, 2013, CARBOHYD POLYM, V93, P635, DOI 10.1016/j.carbpol.2012.11.099
   She B., 2008, POLYM DEGRADATION ST, V93, P1316
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Smitha B, 2005, EUR POLYM J, V41, P1859, DOI 10.1016/j.eurpolymj.2005.02.018
   Suwanchawalit C, 2009, J MATER CHEM, V19, P8478, DOI 10.1039/b912698h
   Tseng HJ, 2013, J TISSUE ENG REGEN M, V7, P20, DOI 10.1002/term.492
   Verma V, 2007, BIOTECHNOL BIOENG, V96, P392, DOI 10.1002/bit.21111
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Wu X, 2010, ACTA BIOMATER, V6, P1167, DOI 10.1016/j.actbio.2009.08.041
   Yan L. P., 2010, J BIOMEDICAL MAT R A, V2, P465
   Yeul VS, 2013, J POLYM ENVIRON, V21, P606, DOI 10.1007/s10924-012-0458-x
NR 62
TC 28
Z9 28
U1 7
U2 215
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD MAY 5
PY 2016
VL 141
BP 175
EP 183
DI 10.1016/j.carbpol.2015.12.064
PG 9
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA DD5JT
UT WOS:000369960400021
PM 26877010
DA 2018-10-19
ER

PT J
AU He, XL
   Zhang, J
   Wang, WB
   Xuan, WP
   Wang, XZ
   Zhang, QL
   Smith, CG
   Luo, JK
AF He, Xingli
   Zhang, Jian
   Wang, Wenbo
   Xuan, Weipeng
   Wang, Xiaozhi
   Zhang, Qilong
   Smith, Charles G.
   Luo, Jikui
TI Transient Resistive Switching Devices Made from Egg Albumen Dielectrics
   and Dissolvable Electrodes
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE egg albumen; proteins; memristors; bipolar switch; dissolvability
ID NONVOLATILE MEMORY; GOLD NANOPARTICLES; CHICKEN ALBUMIN; PROTEIN;
   TRANSISTOR; NANODEVICES; MEMRISTOR; FILMS; ZNO
AB Egg albumen as the dielectric, and dissolvable Mg and W as the top and bottom electrodes are used to fabricate water-soluble memristors. 4 X 4 cross-bar configuration memristor devices show a bipolar resistive switching, behavior with a high to low resistance ratio in the range of 1 X 10(2) to 1 X 10(4), higher than most other biomaterial-based memristors, and a retention time over 10(4) s without any sign of deterioration, demonstrating its high stability and reliability. Metal filaments accompanied by hopping conduction are believed to be responsible for the switching behavior of the memory devices. The Mg and W electrodes, and albumen film all can be dissolved in water within 72 h, showing their transient characteristics. This work demonstrates a new way to fabricate biocompatible and dissolvable electronic devices by using cheap, abundant, and 100% natural materials for the forthcoming bioelectronics era as well as for environmental sensors when the Internet of things takes off.
C1 [He, Xingli; Wang, Wenbo; Xuan, Weipeng; Wang, Xiaozhi; Luo, Jikui] Zhejiang Univ, Coll Informat Sci & Elect Engn, Hangzhou 310027, Zhejiang, Peoples R China.
   [Zhang, Jian; Zhang, Qilong] Zhejiang Univ, Dept Mat Sci & Engn, Hangzhou 310027, Zhejiang, Peoples R China.
   [He, Xingli] Fujian Univ Technol, Coll Informat Sci & Engn, Fuzhou 350118, Peoples R China.
   [He, Xingli; Smith, Charles G.] Univ Cambridge, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England.
   [Luo, Jikui] Univ Bolton, Inst Mat Res & Innovat, Deane Rd, Bolton BL3 5AB, England.
RP Wang, XZ; Luo, JK (reprint author), Zhejiang Univ, Coll Informat Sci & Elect Engn, Hangzhou 310027, Zhejiang, Peoples R China.; Luo, JK (reprint author), Univ Bolton, Inst Mat Res & Innovat, Deane Rd, Bolton BL3 5AB, England.
EM xw224@zju.edu.cn; jl2@bolton.ac.uk
FU NSFC [61274037, 61301046]; Research Fund for the Doctoral Program of
   Higher Education of China [20120101110031, 20120101110054]
FX This work was supported by NSFC (Grants 61274037 and 61301046), and
   Research Fund for the Doctoral Program of Higher Education of China
   (Grants 20120101110031 and 20120101110054). The authors also acknowledge
   the Innovation Platform of Micro/Nanodevices and Integration System,
   Zhejiang University.
CR BORSOOK H, 1953, ADV PROTEIN CHEM, V8, P127, DOI 10.1016/S0065-3233(08)60092-3
   Byun JY, 2013, LAB CHIP, V13, P886, DOI 10.1039/c2lc41137g
   Chang JW, 2011, ADV MATER, V23, P4077, DOI 10.1002/adma.201102124
   Chang YC, 2014, ACS APPL MATER INTER, V6, P5413, DOI 10.1021/am500815n
   Chen C, 2012, J APPL PHYS, V111, DOI 10.1063/1.3672811
   Chen G, 2012, ADV MATER, V24, P3515, DOI 10.1002/adma.201201595
   Chen IT, 2013, SCI REP-UK, V3, DOI 10.1038/srep01505
   Chen Y. C., 2015, SCI REP, V5, P10022
   Chen YS, 2012, NAT NANOTECHNOL, V7, P197, DOI [10.1038/nnano.2012.7, 10.1038/NNANO.2012.7]
   Dagdeviren C, 2013, SMALL, V9, P3398, DOI 10.1002/smll.201300146
   de la Rica R, 2010, CHEM SOC REV, V39, P3499, DOI 10.1039/b917574c
   Fujisaki Y, 2014, ADV FUNCT MATER, V24, P1657, DOI 10.1002/adfm.201303024
   GRINBERG AA, 1989, IEEE T ELECTRON DEV, V36, P1162, DOI 10.1109/16.24363
   Hota MK, 2012, ADV FUNCT MATER, V22, P4493, DOI 10.1002/adfm.201200073
   Hubbard RE, 2010, ENCY LIFE SCI ELS, DOI [10. 1002/9780470015902. a0003011. pub2, DOI 10.1002/9780470015902.A0003011.PUB2, 10.1002/9780470015902.a0003011.pub2]
   Hung YC, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3671153
   Hwang SW, 2014, ACS NANO, V8, P5843, DOI 10.1021/nn500847g
   Hwang SW, 2013, ADV FUNCT MATER, V23, P4087, DOI 10.1002/adfm.201300127
   Hwang SW, 2012, SCIENCE, V337, P1640, DOI 10.1126/science.1226325
   Irimia-Vladu M, 2010, ORG ELECTRON, V11, P1974, DOI 10.1016/j.orgel.2010.09.007
   Jeong DS, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/7/076502
   Kiy M, 2002, APPL PHYS LETT, V80, P1198, DOI 10.1063/1.1449527
   Lin ZF, 2014, LAB CHIP, V14, P2505, DOI 10.1039/c4lc00223g
   Mandal B, 2014, RSC ADV, V4, P13854, DOI 10.1039/c3ra45997g
   Meng FB, 2014, SMALL, V10, P277, DOI 10.1002/smll.201300810
   Meng FB, 2011, SMALL, V7, P3016, DOI 10.1002/smll.201101494
   Mohanty N, 2008, NANO LETT, V8, P4469, DOI 10.1021/nl802412n
   Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920
   Petsko G. A., 2004, PROTEIN STRUCTURE FU
   Puskas J. E., 2013, INTRO POLYM CHEM
   Sela M., 1959, BIOCHIM BIOPHYS ACTA, V36, P417
   Wang H, 2013, ADV MATER, V25, P5498, DOI 10.1002/adma.201301983
   Xu D, 1997, PROTEIN ENG, V10, P999, DOI 10.1093/protein/10.9.999
   Yang JJ, 2008, NAT NANOTECHNOL, V3, P429, DOI 10.1038/nnano.2008.160
   Yang YC, 2009, NANO LETT, V9, P1636, DOI 10.1021/nl900006g
   Yin L, 2014, ADV FUNCT MATER, V24, P645, DOI 10.1002/adfm.201301847
   Zhang J, 2014, APPL PHYS A-MATER, V116, P663, DOI 10.1007/s00339-014-8324-4
   Zhang J, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4774400
   Zhu HL, 2013, ENERG ENVIRON SCI, V6, P2105, DOI 10.1039/c3ee40492g
NR 39
TC 30
Z9 30
U1 11
U2 73
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAY 4
PY 2016
VL 8
IS 17
BP 10954
EP 10960
DI 10.1021/acsami.5b10414
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DL3FX
UT WOS:000375520700036
PM 27052437
DA 2018-10-19
ER

PT J
AU Luvizuto, ER
   Tangl, S
   Dobsak, T
   Reich, K
   Gruber, R
   Sonoda, CK
   Okamoto, R
AF Luvizuto, Eloa R.
   Tangl, Stefan
   Dobsak, Toni
   Reich, Karoline
   Gruber, Reinhard
   Sonoda, Celso K.
   Okamoto, Roberta
TI Effect of recombinant PDGF-BB on bone formation in the presence of
   beta-tricalcium phosphate and bovine bone mineral matrix: a pilot study
   in rat calvarial defects
SO BMC ORAL HEALTH
LA English
DT Article
DE Bone substitutes; Bone formation; Bone regeneration; Bone augmentation;
   Platelet-derived growth factor-BB; Rat calvaria defects; beta-tricalcium
   phosphate; Demineralized bovine bone mineral; Histomorphometry; Graft
   consolidation
ID GROWTH-FACTOR-BB; VERTICAL RIDGE AUGMENTATION; CLINICAL-APPLICATIONS;
   RHPDGF-BB; BLOCK; MODEL; BIOLOGY
AB Background: Supplementation of bone substitutes with recombinant platelet-derived growth factor-BB (PDGF-BB) can enhance bone regeneration. The aim of the study was to evaluate the effect of PDGF-BB on bone formation in the presence of beta-tricalcium phosphate and bovine bone mineral matrix in a rat calvaria defect model.
   Methods: The authors examined 5 mm rat calvarial defects treated with beta-tricalcium phosphate (TCP) or demineralized bovine bone mineral (DBBM) with and without 0.3 mg/ml recombinant PDGF-BB. Calvaria defects were randomly divided into the following treatment groups (n = 5); TCP; TCP plus PDGF-BB; DBBM; DBBM plus PDGF-BB; and untreated empty control. After 45 days, bone formation was evaluated by histomorphometry and fluorescence microscopy.
   Results: The authors report that the area of newly formed bone was similar between the empty controls and the two bone substitutes, TCP and DBBM. Supplementation of TCP and DBBM with PDGF-BB had no significant impact on bone formation. Fluorochrome staining revealed no visible changes in the pattern of bone formation in defects filled with TCP and DBBM, irrespective of PDGF-BB. Furthermore, supplementation with PDGF-BB did not influence biomaterial degradation.
   Conclusions: The authors concluded that PDGF-BB had no impact on bone formation and degradation of bone substitutes in the respective rodent models. Thus, possible beneficial effects of PDGF-BB may require other model situations.
C1 [Luvizuto, Eloa R.; Sonoda, Celso K.] Univ Estadual Paulista, UNESP, Aracatuba Dent Sch, Dept Surg, Sao Paulo, Brazil.
   [Luvizuto, Eloa R.; Sonoda, Celso K.] Univ Estadual Paulista, UNESP, Aracatuba Dent Sch, Integrated Clin, Sao Paulo, Brazil.
   [Tangl, Stefan; Dobsak, Toni; Reich, Karoline] Med Univ Vienna, Div Oral Surg, Karl Donath Lab Hard Tissue & Biomat Res, Vienna, Austria.
   [Tangl, Stefan; Dobsak, Toni; Reich, Karoline] Austrian Cluster Tissue Regenerat, Vienna, Austria.
   [Gruber, Reinhard] Univ Bern, Sch Dent Med, Dept Prevent Restorat & Pediat Dent, Bern, Switzerland.
   [Gruber, Reinhard] Med Univ Vienna, Dept Oral Biol, Vienna, Austria.
   [Okamoto, Roberta] Univ Estadual Paulista, UNESP, Aracatuba Dent Sch, Dept Anat, Sao Paulo, Brazil.
RP Gruber, R (reprint author), Univ Bern, Sch Dent Med, Dept Prevent Restorat & Pediat Dent, Bern, Switzerland.; Gruber, R (reprint author), Med Univ Vienna, Dept Oral Biol, Vienna, Austria.
EM reinhard.gruber@meduniwien.ac.at
OI Gruber, Reinhard/0000-0001-5400-9009; Tangl, Stefan/0000-0002-9023-4745
FU FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)
   [2012/15181-8]
FX This research was supported by FAPESP (Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo) project number 2012/15181-8.
CR Al-Zube L, 2009, J ORTHOP RES, V27, P1074, DOI 10.1002/jor.20842
   Choo T, 2013, CLIN ORAL IMPLAN RES, V24, P158, DOI 10.1111/j.1600-0501.2011.02345.x
   Christersson A, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-015-0174-z
   Daniels TR, FOOT ANKLE INT
   Graham S, 2009, EXPERT OPIN INV DRUG, V18, P1633, DOI 10.1517/13543780903241607
   Hollinger JO, 2008, J BONE JOINT SURG AM, V90A, P48, DOI 10.2106/JBJS.G.01231
   Hollinger JO, 2008, J ORTHOP RES, V26, P83, DOI 10.1002/jor.20453
   Kaigler D, 2011, EXPERT OPIN BIOL TH, V11, P375, DOI 10.1517/14712598.2011.554814
   Khojasteh A, 2014, J BIOMED MATER RES B, V102, P1771, DOI 10.1002/jbm.b.33156
   Lee YM, J PERIODONTOL
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Lioubavina-Hack N, J CLIN PERIODONTOL
   Luvizuto ER, 2011, BIOMATERIALS, V32, P3855, DOI 10.1016/j.biomaterials.2011.01.076
   Moore DC, 2009, J BONE JOINT SURG AM, V91A, P1973, DOI 10.2106/JBJS.H.00540
   Nevins ML, 2014, INT J PERIODONT REST, V34, P157, DOI 10.11607/prd.1743
   Okamoto T, 1994, Braz Dent J, V5, P85
   Polo-Corrales L, 2014, J NANOSCI NANOTECHNO, V14, P15, DOI 10.1166/jnn.2014.9127
   Simion M, 2006, INT J PERIODONT REST, V26, P415
   Simion M, 2009, INT J PERIODONT REST, V29, P245
   Tsuchiya N, 2014, J ORAL SCI, V56, P23, DOI 10.2334/josnusd.56.23
   Xu L, 2012, J MATER SCI-MATER M, V23, P1073, DOI 10.1007/s10856-012-4558-x
NR 21
TC 0
Z9 0
U1 0
U2 3
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6831
J9 BMC ORAL HEALTH
JI BMC Oral Health
PD MAY 4
PY 2016
VL 16
AR 52
DI 10.1186/s12903-016-0210-3
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DL7FX
UT WOS:000375807100001
PM 27145819
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Hulsen, DJW
   Geurts, J
   van Gestel, NAP
   van Rietbergen, B
   Arts, JJ
AF Hulsen, D. J. W.
   Geurts, J.
   van Gestel, N. A. P.
   van Rietbergen, B.
   Arts, J. J.
TI Mechanical behaviour of Bioactive Glass granules and morselized
   cancellous bone allograft in load bearing defects
SO JOURNAL OF BIOMECHANICS
LA English
DT Article
DE Bioactive Glass; Bone allograft; Mechanical behaviour; Load-bearing
   defects; Confined compression
ID FRONTAL-SINUS OBLITERATION; CALCIUM-PHOSPHATE CEMENT; TIBIAL PLATEAU
   FRACTURE; CHRONIC OTITIS-MEDIA; IN-VITRO; CHRONIC OSTEOMYELITIS; GRAFT
   SUBSTITUTES; AUTOGENOUS BONE; AUTOLOGOUS BONE; HUMAN OSTEOBLASTS
AB Bioactive Glass (BAG) granules are osteoconductive and possess unique antibacterial properties for a synthetic biomaterial. To assess the applicability of BAG granules in load-bearing defects, the aim was to compare mechanical behaviour of graft layers consisting of BAG granules and morselized cancellous bone allograft in different volume mixtures under clinically relevant conditions.
   The graft layers were mechanically tested, using two mechanical testing modalities with simulated physiological loading conditions: highly controllable confined compression tests (CCT) and more clinically realistic in situ compression tests (ISCT) in cadaveric porcine bone defects. Graft layer impaction strain, residual strain, aggregate modulus, and creep strain were determined in CCT. Graft layer porosity was determined using micro computed tomography. The ISCT was used to determine graft layer subsidence in bone environment.
   ANOVA showed significant differences (p < 0.001) between different graft layer compositions. True strains absolutely decreased for increasing BAG content: impaction strain -0.92 (allograft) to -0.39 (BAG), residual strain -0.12 to -0.01, and creep strain -0.09 to 0.00 respectively. Aggregate modulus increased with increasing BAG content from 116 to 653 MPa. Porosity ranged from 66% (pure allograft) to 15% (pure BAG). Subsidence was highest for allograft, and remarkably low for a 1:1 BAG-allograft volume mixture.
   Both BAG granules and allograft morsels as stand-alone materials exhibit suboptimal mechanical behaviour for load-bearing purpose. BAG granules are difficult to handle and less porous, whereas allograft subsides and creeps. A 1:1 volume mixture of BAG and allograft is therefore proposed as the best graft material in load-bearing defects. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Hulsen, D. J. W.; Geurts, J.; Arts, J. J.] Maastricht Univ, Med Ctr, Res Sch CAPHRI, Dept Orthopaed Surg, NL-6200 MD Maastricht, Netherlands.
   [Hulsen, D. J. W.; van Gestel, N. A. P.; van Rietbergen, B.; Arts, J. J.] Eindhoven Univ Technol, Fac Biomed Engn, Dept Orthopaed Biomech, POB 513, NL-5600 MB Eindhoven, Netherlands.
   [Hulsen, D. J. W.] Jeroen Bosch Ziekenhuis, MICT Dept, Shertogenbosch, Netherlands.
   [van Gestel, N. A. P.] Eindhoven Univ Technol, Inst Complex Mol Syst, POB 513, NL-5600 MB Eindhoven, Netherlands.
RP Hulsen, DJW (reprint author), Maastricht Univ, Med Ctr, Dept Orthopaed Surg, POB 5800, NL-6202 AZ Maastricht, Netherlands.
EM d.hulsen@jbz.nl
OI Arts, Jacobus/0000-0002-2947-8564; van Gestel,
   Nicole/0000-0003-0162-490X
FU BonAlive Biomaterials Ltd.
FX The Radboudumc orthopaedic department (Nijmegen, Netherlands) is kindly
   acknowledged for lending the test setup. This research was sponsored in
   kind (materials) by BonAlive Biomaterials Ltd.
CR Aitasalo K, 2000, KEY ENG MAT, V192-1, P877
   Aitasalo K, 2001, J ORAL MAXIL SURG, V59, P1390, DOI 10.1053/joms.2001.27524
   Andersson O. H., 1992, NEW TRENDS BONE GRAF, P127
   ANDERSSON OH, 1990, J NON-CRYST SOLIDS, V119, P290, DOI 10.1016/0022-3093(90)90301-2
   ANDERSSON OH, 1990, J MATER SCI-MATER M, V1, P219, DOI 10.1007/BF00701080
   ANDERSSON OH, 1991, J BIOMED MATER RES, V25, P1019, DOI 10.1002/jbm.820250808
   Arts JJC, 2005, P I MECH ENG H, V219, P257, DOI 10.1243/095441105X34266
   Benoit Benoit, 2009, J Orthop Surg Res, V4, P37, DOI 10.1186/1749-799X-4-37
   Blom AW, 2002, P I MECH ENG H, V216, P265, DOI 10.1243/09544110260138754
   Brodt MD, 1998, J ORTHOPAED RES, V16, P43, DOI 10.1002/jor.1100160108
   Conejero JA, 2007, J CRANIOFAC SURG, V18, P1290, DOI 10.1097/scs.0b013e3180f610c7
   Coraca-Huber DC, 2014, J ORTHOP RES, V32, P175, DOI 10.1002/jor.22463
   Drago L, 2014, FUTURE MICROBIOL, V9, P593, DOI 10.2217/fmb.14.20
   Drago L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-584
   Eldridge JDJ, 1997, J ARTHROPLASTY, V12, P535, DOI 10.1016/S0883-5403(97)90176-5
   Frantzen J, 2011, J SPINAL DISORD TECH, V24, P455, DOI 10.1097/BSD.0b013e31822a20c6
   Fu Q, 2011, MAT SCI ENG C-MATER, V31, P1245, DOI 10.1016/j.msec.2011.04.022
   Gergely I, 2014, ACTA MICROBIOL IMM H, V61, P145, DOI 10.1556/AMicr.61.2014.2.5
   Giesen EBW, 2001, J BIOMECH, V34, P799, DOI 10.1016/S0021-9290(01)00030-6
   Gough JE, 2004, J BIOMED MATER RES A, V68A, P640, DOI 10.1002/jbm.a.20075
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   Gunn JM, 2013, ACTA ODONTOL SCAND, V71, P1238, DOI 10.3109/00016357.2012.757642
   Heikkila JT, 2011, J MATER SCI-MATER M, V22, P1073, DOI 10.1007/s10856-011-4272-0
   HEIKKILA JT, 1993, ACTA ORTHOP SCAND, V64, P678, DOI 10.3109/17453679308994597
   HEIKKILA JT, 1995, ACTA ORTHOP SCAND, V66, P463, DOI 10.3109/17453679508995588
   Keaveny T. M., 2003, STANDARD HDB BIOMEDI, V8, p[1, 23]
   Lepparanta O, 2008, J MATER SCI-MATER M, V19, P547, DOI 10.1007/s10856-007-3018-5
   Lindfors NC, 2010, BONE, V47, P212, DOI 10.1016/j.bone.2010.05.030
   Lindfors NC, 2010, J BIOMED MATER RES B, V94B, P157, DOI 10.1002/jbm.b.31636
   Lindfors NC, 2009, J BIOMED MATER RES B, V90B, P131, DOI 10.1002/jbm.b.31263
   Loty C, 2001, J BONE MINER RES, V16, P231, DOI 10.1359/jbmr.2001.16.2.231
   MATSUDA T, 1987, BIOMATERIALS, V8, P275, DOI 10.1016/0142-9612(87)90115-3
   McAndrew J, 2013, IRISH J MED SCI, V182, P509, DOI 10.1007/s11845-012-0895-5
   McDonald E, 2011, J ORTHOP TRAUMA, V25, P90, DOI 10.1097/BOT.0b013e3181e3e28f
   Munukka E, 2008, J MATER SCI-MATER M, V19, P27, DOI 10.1007/s10856-007-3143-1
   Peltola M, 1998, HEAD NECK-J SCI SPEC, V20, P315, DOI 10.1002/(SICI)1097-0347(199807)20:4<315::AID-HED6>3.0.CO;2-1
   Peltola M, 2006, HEAD NECK-J SCI SPEC, V28, P834, DOI 10.1002/hed.20436
   Peltola MJ, 2008, J ORAL MAXIL SURG, V66, P1699, DOI 10.1016/j.joms.2007.11.020
   Rantakokko J, 2012, SCAND J SURG, V101, P66, DOI 10.1177/145749691210100113
   Romano CL, 2014, BONE JOINT J, V96B, P845, DOI 10.1302/0301-620X.96B6.33014
   Sanzana ES, 2014, J BIOMED MATER RES A, V102, P1767, DOI 10.1002/jbm.a.34845
   Sarin J, 2012, ANN OTO RHINOL LARYN, V121, P563, DOI 10.1177/000348941212100901
   Silvola JT, 2012, OTOLARYNG HEAD NECK, V147, P119, DOI 10.1177/0194599812438168
   Stoor P, 2010, ANN OTO RHINOL LARYN, V119, P377, DOI 10.1177/000348941011900603
   Turunen T, 2004, CLIN ORAL IMPLAN RES, V15, P135, DOI 10.1111/j.1600-0501.2004.00989.x
   van Gestel NAP, 2015, BIOMED RES INT, DOI 10.1155/2015/684826
   Veitch SW, 2010, J TRAUMA, V68, P980, DOI 10.1097/TA.0b013e3181b16e3d
   Verdonschot N, 2001, J BIOMED MATER RES, V58, P599, DOI 10.1002/jbm.1058
   VROUWENVELDER WCA, 1992, BIOMATERIALS, V13, P382, DOI 10.1016/0142-9612(92)90044-O
   VROUWENVELDER WCA, 1993, J BIOMED MATER RES, V27, P465, DOI 10.1002/jbm.820270407
   Walschot LHB, 2010, J BIOMED MATER RES B, V95B, P131, DOI 10.1002/jbm.b.31692
   Waselau M., 2012, J TISSUE ENG, V23
   Welch RD, 2003, J BONE JOINT SURG AM, V85A, P222, DOI 10.2106/00004623-200302000-00007
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yeni YN, 2001, J BIOMECH, V34, P1649, DOI 10.1016/S0021-9290(01)00155-5
   Yetkinler DN, 2001, J ORTHOP TRAUMA, V15, P197, DOI 10.1097/00005131-200103000-00009
   Zhang D, 2010, J BIOMED MATER RES A, V93A, P475, DOI 10.1002/jbm.a.32564
   Zhou Z. H., 2010, Journal of Medical Engineering & Technology, V34, P285, DOI 10.3109/03091901003753041
NR 60
TC 2
Z9 2
U1 2
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0021-9290
EI 1873-2380
J9 J BIOMECH
JI J. Biomech.
PD MAY 3
PY 2016
VL 49
IS 7
BP 1121
EP 1127
DI 10.1016/j.jbiomech.2016.02.047
PG 7
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA DM0RB
UT WOS:000376052400019
PM 26972764
DA 2018-10-19
ER

PT J
AU Lassenberger, A
   Bixner, O
   Gruenewald, T
   Lichtenegger, H
   Zirbs, R
   Reimhult, E
AF Lassenberger, Andrea
   Bixner, Oliver
   Gruenewald, Tilman
   Lichtenegger, Helga
   Zirbs, Ronald
   Reimhult, Erik
TI Evaluation of High-Yield Purification Methods on Monodisperse
   PEG-Grafted Iron Oxide Nanoparticles
SO LANGMUIR
LA English
DT Article
ID CORE-SHELL NANOPARTICLES; MAGNETIC NANOPARTICLES; POLYETHYLENE-GLYCOL;
   BIOMEDICAL APPLICATIONS; HYDRODYNAMIC RADIUS; FUNCTIONALIZATION;
   PEGYLATION; THERAPY; DESIGN; FE3O4
AB Fundamental research on nanoparticle (NP) interactions and development of next-generation biomedical NP applications relies on synthesis of monodisperse, functional, coreshell nanoparticles free of residual dispersants with truly homogeneous and controlled physical properties. Still, synthesis and purification of e.g. such superparamagnetic iron oxide NPs remain a challenge. Comparing the success of different methods is marred by the sensitivity of analysis methods to the purity of the product. We synthesize monodisperse, oleic acid (OA)-capped, Fe3O4 NPs in the superparamagnetic size range (310 nm). Ligand exchange of OA for poly(ethylene glycol) (PEG) was performed with the PEG irreversibly grafted to the NP surface by a nitrodopamine (NDA) anchor. Four different methods were investigated to remove excess ligands and residual OA: membrane centrifugation, dialysis, size exclusion chromatography, and precipitation combined with magnetic decantation. Infrared spectroscopy and thermogravimetric analysis were used to determine the purity of samples after each purification step. Importantly, only magnetic decantation yielded pure NPs at high yields with sufficient grafting density for biomedical applications (similar to 1 NDA-PEG(5 kDa)/nm(2), irrespective of size). The purified NPs withstand challenging tests such as temperature cycling in serum and long-term storage in biological buffers. Dynamic light scattering, transmission electron microscopy, and small-angle X-ray scattering show stability over at least 4 months also in serum. The successful synthesis and purification route is compatible with any conceivable functionalization for biomedical or biomaterial applications of PEGylated Fe3O4 NPs.
C1 [Lassenberger, Andrea; Bixner, Oliver; Zirbs, Ronald; Reimhult, Erik] Univ Nat Resources & Life Sci, Inst Biol Inspired Mat, Dept Nanobiotechnol, Muthgasse 11, A-1190 Vienna, Austria.
   [Gruenewald, Tilman; Lichtenegger, Helga] Inst Phys & Mat Sci, Dept Mat Sci & Proc Engn, Peter Jordan Str 82, A-1190 Vienna, Austria.
RP Reimhult, E (reprint author), Univ Nat Resources & Life Sci, Inst Biol Inspired Mat, Dept Nanobiotechnol, Muthgasse 11, A-1190 Vienna, Austria.
EM Erik.reimhult@boku.ac.at
RI Reimhult, Erik/C-6011-2013; Grunewald, Tilman A./I-5453-2018
OI Reimhult, Erik/0000-0003-1417-5576; Grunewald, Tilman
   A./0000-0002-5621-605X
FU European Research Council under the European Union's Seventh Framework
   Programme/ERC [310034]; BMWFW IGS BioNanoTech
FX The research leading to these results received funding from the European
   Research Council under the European Union's Seventh Framework Programme
   (FP/2007-2013)/ERC Grant Agreement no. 310034 and BMWFW IGS BioNanoTech.
CR Amstad E, 2011, NANOSCALE, V3, P2819, DOI 10.1039/c1nr10173k
   Amstad E, 2009, NANO LETT, V9, P4042, DOI 10.1021/nl902212q
   Bixner O, 2015, LANGMUIR, V31, P9198, DOI 10.1021/acs.langmuir.5b01833
   Boni A, 2015, NANOSCALE, V7, P7307, DOI 10.1039/c5nr01148e
   Boyer C, 2010, NPG ASIA MATER, V2, P23, DOI 10.1038/asiamat.2010.6
   Bronstein LM, 2007, CHEM MATER, V19, P3624, DOI 10.1021/cm062948j
   Burda C, 2005, CHEM REV, V105, P1025, DOI 10.1021/cr030063a
   Cornard JP, 2005, CHEM PHYS, V309, P239, DOI 10.1016/j.chemphys.2004.09.020
   Davis K, 2014, LANGMUIR, V30, P10918, DOI 10.1021/la502204g
   El-Faham A, 2009, CHEM-EUR J, V15, P9404, DOI 10.1002/chem.200900615
   FINGER LW, 1986, PHYS CHEM MINER, V13, P215, DOI 10.1007/BF00308271
   Frey NA, 2009, CHEM SOC REV, V38, P2532, DOI 10.1039/b815548h
   Gillich T, 2013, ACS NANO, V7, P316, DOI 10.1021/nn304045q
   Grunewald TA, 2015, CHEM MATER, V27, P4763, DOI 10.1021/acs.chemmater.5b01488
   Halbreich A, 1998, BIOCHIMIE, V80, P379, DOI 10.1016/S0300-9084(00)80006-1
   Hong RY, 2008, BIOCHEM ENG J, V42, P290, DOI 10.1016/j.bej.2008.07.009
   Hyeon T, 2001, J AM CHEM SOC, V123, P12798, DOI 10.1021/ja016812s
   Jokerst JV, 2011, NANOMEDICINE-UK, V6, P715, DOI [10.2217/nnm.11.19, 10.2217/NNM.11.19]
   Jun YW, 2008, ANGEW CHEM INT EDIT, V47, P5122, DOI 10.1002/anie.200701674
   Kang SM, 2009, MACROMOL RES, V17, P259, DOI 10.1007/BF03218689
   Lacava LM, 2001, BIOPHYS J, V80, P2483, DOI 10.1016/S0006-3495(01)76217-0
   Lak A, 2013, NANOSCALE, V5, P11447, DOI 10.1039/c3nr02197a
   Lattuada M, 2007, LANGMUIR, V23, P2158, DOI 10.1021/la062092x
   Lee H, 2008, BIOPHYS J, V95, P1590, DOI 10.1529/biophysj.108.133025
   Lewin M, 2000, NAT BIOTECHNOL, V18, P410
   Linegar KL, 2010, COLLOID J+, V72, P279, DOI 10.1134/S1061933X10020195
   Ling DS, 2013, SMALL, V9, P1450, DOI 10.1002/smll.201202111
   Liu DF, 2011, ADV FUNCT MATER, V21, P1498, DOI 10.1002/adfm.201001658
   Lu AH, 2007, ANGEW CHEM INT EDIT, V46, P1222, DOI 10.1002/anie.200602866
   McCarthy JR, 2008, ADV DRUG DELIVER REV, V60, P1241, DOI 10.1016/j.addr.2008.03.014
   Mondini S, 2012, NANOSCALE, V4, P5356, DOI 10.1039/c2nr31276j
   Na HB, 2012, ACS NANO, V6, P389, DOI 10.1021/nn203735b
   Namdeo M, 2008, J NANOSCI NANOTECHNO, V8, P3247, DOI 10.1166/jnn.2008.399
   NAPOLITANO A, 1992, TETRAHEDRON, V48, P8515, DOI 10.1016/S0040-4020(01)86599-6
   Pankhurst Q. A., 2009, J PHYS D, V42
   Park J, 2007, ANGEW CHEM INT EDIT, V46, P4630, DOI 10.1002/anie.200603148
   Pittet MJ, 2006, NAT PROTOC, V1, P73, DOI 10.1038/nprot.2006.11
   Roonasi P, 2009, APPL SURF SCI, V255, P5891, DOI 10.1016/j.apsusc.2009.01.031
   Sahoo Y, 2001, LANGMUIR, V17, P7907, DOI 10.1021/la010703+
   Saville SL, 2012, J MATER CHEM, V22, P24909, DOI 10.1039/c2jm34902g
   Stone RC, 2014, J MATER CHEM B, V2, P4789, DOI 10.1039/c4tb00198b
   Tassa C, 2011, ACCOUNTS CHEM RES, V44, P842, DOI 10.1021/ar200084x
   WEISSLEDER R, 1990, RADIOLOGY, V175, P489, DOI 10.1148/radiology.175.2.2326474
   WEISSLEDER R, 1987, AM J ROENTGENOL, V149, P723, DOI 10.2214/ajr.149.4.723
   Xie J, 2007, ADV MATER, V19, P3163, DOI 10.1002/adma.200701975
   Ziebacz N, 2011, SOFT MATTER, V7, P7181, DOI 10.1039/c0sm01357a
   Zirbs R, 2015, NANOSCALE, V7, P11216, DOI 10.1039/c5nr02313k
NR 47
TC 12
Z9 12
U1 1
U2 54
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD MAY 3
PY 2016
VL 32
IS 17
BP 4259
EP 4269
DI 10.1021/acs.langmuir.6b00919
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA DL3FY
UT WOS:000375520800015
PM 27046133
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Li, LL
   Li, X
   Chen, L
   Sun, P
   Hao, N
   Jiang, B
AF Li, Lili
   Li, Xia
   Chen, Lu
   Sun, Peng
   Hao, Na
   Jiang, Bo
TI Morphology, proliferation, alignment, and new collagen synthesis of
   mesenchymal stem cells on a microgrooved collagen membrane
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE topographic cues; collagen; Microgrooves; oriented growth; MSC
ID TISSUE ENGINEERING SCAFFOLDS; OSTEOBLAST-LIKE CELLS; FIBRILLAR COLLAGEN;
   CONTACT GUIDANCE; THIN-FILMS; IN-VITRO; GROWTH; LAYERS; SUBSTRATA;
   DIFFERENTIATION
AB Abstract
   The topographic cues of the extracellular matrix may have significant effects upon cellular behavior, such as adhesion, spreading, migration, proliferation, differentiation, and in particular, morphology and orientation. In this study, we examined the effects of microgrooved collagen membrane (MCM) on mesenchymal stem cell (MSC) behavior. The MCM (9 mu m in periodicity, and 1-2 mu m in depth) was fabricated on an untreated (nonpolar) and smooth polystyrene substrate, based on the absorption and self-assembly properties of collagen on the polystyrene substrate. Methyl thiazolyl tetrazolium assay revealed that cell proliferation on the MCM was enhanced compared with the smooth collagen membrane at day 2. Qualitative observation of MSC behavior using confocal laser scanning microscopy and scanning electron microscopy showed that MSCs grew with a highly elongated morphology and were aligned strictly along the direction of the microgrooves. Additionally, scanning electron microscopy revealed the oriented cells produced a collagenous matrix on the MCM that had a preferential orientation, whereas the collagenous matrix produced by randomly oriented MSCs on the smooth collagen membrane was disorganized. Future studies should investigate the fabrication of oriented topographical substrates, based on the natural biomaterial collagen, to guide cell alignment and oriented growth along definite directions. These substrates may help produce aligned collagenous matrices that could have good potential for the production of tissue substitutes.
C1 [Li, Lili; Li, Xia; Chen, Lu; Sun, Peng; Hao, Na; Jiang, Bo] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
   [Sun, Peng] Sichuan Univ, Inst Nucl Sci & Technol, Key Lab Radiat Phys & Technol, Minist Educ, Chengdu 610064, Peoples R China.
RP Jiang, B (reprint author), Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
EM bjiang@scu.edu.cn
FU National Natural Science Foundation of China [81301934]
FX This work was supported by National Natural Science Foundation of China
   [grant number 81301934].
CR Alaerts JA, 2001, BIOMATERIALS, V22, P1635, DOI 10.1016/S0142-9612(00)00321-5
   Anene-Nzelu CG, 2013, LAB CHIP, V13, P4124, DOI 10.1039/c3lc50730k
   Bettinger CJ, 2006, BIOMATERIALS, V27, P2558, DOI 10.1016/j.biomaterials.2005.11.029
   Biran R, 2003, EXP NEUROL, V184, P141, DOI 10.1016/S0014-4886(03)00253-X
   Browne MM, 2004, SURF SCI, V553, P155, DOI 10.1016/j.susc.2004.01.046
   BRUNETTE DM, 1986, EXP CELL RES, V164, P11, DOI 10.1016/0014-4827(86)90450-7
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   Dupont-Gillain CC, 2004, PROG COLL POL SCI S, V128, P98
   Dupont-Gillain CC, 2005, COLLOID SURFACE B, V43, P179, DOI 10.1016/j.colsurfb.2004.12.022
   Dupont-Gillain CC, 2003, SURF SCI, V539, P145, DOI 10.1016/S0039-6028(03)00779-9
   Elliott JT, 2007, BIOMATERIALS, V28, P576, DOI 10.1016/j.biomaterials.2006.09.023
   Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6
   Gamboa JR, 2013, COLLOID SURFACE B, V104, P318, DOI 10.1016/j.colsurfb.2012.11.035
   Guo ZZ, 2015, J BIOMAT SCI-POLYM E, V26, P989, DOI 10.1080/09205063.2015.1065598
   Gurdak E, 2006, COLLOID SURFACE B, V52, P76, DOI 10.1016/j.colsurfb.2006.07.011
   Harrison RG, 1911, SCIENCE, V34, P279, DOI 10.1126/science.34.870.279
   He J, 2012, J BIOMED MATER RES A, V100A, P1706, DOI 10.1002/jbm.a.34121
   Huang NF, 2006, NANO LETT, V6, P537, DOI 10.1021/nl060060o
   Jacquemart I, 2004, J COLLOID INTERF SCI, V278, P63, DOI 10.1016/j.jcis.2004.05.040
   Lanfer B, 2009, BIOMATERIALS, V30, P5950, DOI 10.1016/j.biomaterials.2009.07.039
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   Meinel AJ, 2009, BIOMATERIALS, V30, P3058, DOI 10.1016/j.biomaterials.2009.01.054
   Murugan R, 2007, TISSUE ENG, V13, P1845, DOI 10.1089/ten.2006.0078
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Ricci JL, 2008, J BIOMED MATER RES A, V85A, P313, DOI 10.1002/jbm.a.31379
   Sang L, 2010, CARBOHYD POLYM, V82, P1264, DOI 10.1016/j.carbpol.2010.07.005
   Tan J, 2004, BIOMATERIALS, V25, P3593, DOI 10.1016/j.biomaterials.2003.10.034
   Vernon RB, 2005, BIOMATERIALS, V26, P3131, DOI 10.1016/j.biomateriasl.2004.08.011
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Walboomers XF, 1998, BIOMATERIALS, V19, P1861, DOI 10.1016/S0142-9612(98)00093-3
   Wang DY, 2007, J BIOMED MATER RES B, V80B, P447, DOI 10.1002/jbm.b.30616
   Wang JHC, 2000, J BIOMECH, V33, P729, DOI 10.1016/S0021-9290(00)00013-0
   Wang JHC, 2003, J BIOMECH, V36, P97, DOI 10.1016/S0021-9290(02)00233-6
   WEISS P, 1945, J EXP ZOOL, V100, P353, DOI 10.1002/jez.1401000305
   Whitehouse C, 2005, ANGEW CHEM INT EDIT, V44, P1965, DOI [10.1002/(ISSN)1521-3773, DOI 10.1002/(ISSN)1521-3773]
   Yang JY, 2009, J BIOMED MATER RES A, V90A, P629, DOI 10.1002/jbm.a.32130
   Zhou XT, 2012, ACS APPL MATER INTER, V4, P3888, DOI 10.1021/am301237j
   Zhu BS, 2005, TISSUE ENG, V11, P825, DOI 10.1089/ten.2005.11.825
   Zhu BS, 2004, BIOMATERIALS, V25, P4215, DOI 10.1016/j.biomaterials.2003.11.020
   Zuyderhoff EM, 2012, LANGMUIR, V28, P2007, DOI 10.1021/la203842q
NR 43
TC 1
Z9 1
U1 2
U2 25
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD MAY 2
PY 2016
VL 27
IS 7
BP 581
EP 598
DI 10.1080/09205063.2015.1136919
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA DH8AH
UT WOS:000373015000003
PM 26723935
DA 2018-10-19
ER

PT J
AU Vishwanath, V
   Pramanik, K
   Biswas, A
AF Vishwanath, Varshini
   Pramanik, Krishna
   Biswas, Amit
TI Optimization and evaluation of silk fibroin-chitosan freeze-dried porous
   scaffolds for cartilage tissue engineering application
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE silk fibroin; Tissue engineering; biocompatibility; chitosan; scaffolds;
   optimization
ID MESENCHYMAL STEM-CELLS; UMBILICAL-CORD BLOOD; NANOFIBROUS SCAFFOLD;
   BLEND SCAFFOLDS; REGENERATION; DIFFERENTIATION; ADHESION; DELIVERY; BONE
AB Silk fibroin/chitosan blend has been reported to be an attractive biomaterial that provides a 3D porous structure with controllable pore size and mechanical property suitable for tissue engineering applications. However, there is no systematic study for optimizing the ratio of silk fibroin (SF) and chitosan (CS) which seems to influence the scaffold property to a great extent. The present research, therefore, investigates the effect of blend ratio of SF and CS on scaffold property and establishes the optimum value of blend ratio. Among the various blends, the scaffolds with blend ratio of SF/CS (80:20) were found to be superior. The scaffold possesses pore size in the range 71-210 mu m and porosity of 82.2 +/- 1.3%. The compressive strength of the scaffold was measured as 190 +/- 0.2kPa. The cell supportive property of the scaffold in terms of cell attachment, cell viability, and proliferation was confirmed by cell culture study using mesenchymal stem cells derived from umbilical cord blood. Furthermore, the assessment of glycosaminoglycan secretion on the scaffolds indicates its potentiality toward cartilage tissue regeneration.
C1 [Vishwanath, Varshini; Pramanik, Krishna; Biswas, Amit] Natl Inst Technol, Dept Biotechnol & Med Engn, Rourkela, India.
RP Biswas, A (reprint author), Natl Inst Technol, Dept Biotechnol & Med Engn, Rourkela, India.
EM amitb79@nitrkl.ac.in
RI Biswas, Amit/O-7144-2017; Pramanik, Krishna/M-3729-2018
OI Pramanik, Krishna/0000-0002-5676-7740
FU Department of Biotechnology, Government of India [BT/01/COE/09/13]
FX This work was supported by the Department of Biotechnology, Government
   of India for providing research fellowship to one of the authors
   [Sanction order no.: BT/01/COE/09/13 Date: 09-06-2010].
CR Altman AM, 2010, ACTA BIOMATER, V6, P1388, DOI 10.1016/j.actbio.2009.10.034
   Altman AM, 2009, STEM CELLS, V27, P250, DOI 10.1634/stemcells.2008-0178
   Bhardwaj N, 2012, BIOMATERIALS, V33, P2848, DOI 10.1016/j.biomaterials.2011.12.028
   Bhardwaj N, 2011, BIOMATERIALS, V32, P5773, DOI 10.1016/j.biomaterials.2011.04.061
   Bhardwaj N, 2011, CARBOHYD POLYM, V85, P325, DOI 10.1016/j.carbpol.2011.02.027
   Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625
   Chen JP, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-170
   Chen X, 1997, J POLYM SCI POL PHYS, V35, P2293, DOI 10.1002/(SICI)1099-0488(199710)35:14<2293::AID-POLB9>3.0.CO;2-X
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Gobin AS, 2005, J BIOMED MATER RES A, V74A, P465, DOI 10.1002/jbm.a.30382
   Han KS, 2015, MACROMOL RES, V12, P1091
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hwang SH, 2014, TISSUE ENG REGEN MED, V11, P414, DOI 10.1007/s13770-014-4042-4
   Iwasa J, 2009, KNEE SURG SPORT TR A, V17, P561, DOI 10.1007/s00167-008-0663-2
   Kang SW, 2006, J BIOMAT SCI-POLYM E, V17, P925, DOI 10.1163/156856206777996862
   Kock L, 2012, CELL TISSUE RES, V347, P613, DOI 10.1007/s00441-011-1243-1
   Koga H, 2009, KNEE SURG SPORT TR A, V17, P1289, DOI 10.1007/s00167-009-0782-4
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016
   Luangbudnark W, 2012, SCI WORLD J, DOI 10.1100/2012/697201
   Lucia LA, 2009, NANOSCIENCE TECHNOLO, P297
   Mekala NK, 2012, TISSUE ENG REGEN MED, V9, P259, DOI 10.1007/s13770-012-0359-z
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Panda N, 2015, MAT SCI ENG C-MATER, V48, P521, DOI 10.1016/j.msec.2014.12.010
   Panda N, 2014, J BIOMAT SCI-POLYM E, V25, P1440, DOI 10.1080/09205063.2014.943548
   Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083
   Pati F, 2013, J BIOMED MATER RES A, V101, P2526, DOI 10.1002/jbm.a.34559
   Peter M, 2010, CARBOHYD POLYM, V80, P687, DOI 10.1016/j.carbpol.2009.11.050
   She Z-D, 2009, FRONT MAT SCI CHINA, V3, P241, DOI DOI 10.1007/S11706-009-0048-6
   She ZD, 2008, POLYM DEGRAD STABIL, V93, P1316, DOI 10.1016/j.polymdegradstab.2008.04.001
   Siddiqui N, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41534
   Siddiqui N, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.41025
   Vinatier C, 2009, CURR STEM CELL RES T, V4, P318, DOI 10.2174/157488809789649205
   Zang MQ, 2011, ACTA BIOMATER, V7, P3422, DOI 10.1016/j.actbio.2011.05.012
   Zeng SG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128658
   Zhang Q, 2014, ACTA BIOMATER, V10, P2005, DOI 10.1016/j.actbio.2013.12.042
NR 36
TC 11
Z9 11
U1 5
U2 43
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD MAY 2
PY 2016
VL 27
IS 7
BP 657
EP 674
DI 10.1080/09205063.2016.1148303
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA DH8AH
UT WOS:000373015000008
PM 26830046
DA 2018-10-19
ER

PT J
AU Tostanoski, LH
   Gosselin, EA
   Jewell, CM
AF Tostanoski, Lisa H.
   Gosselin, Emily A.
   Jewell, Christopher M.
TI Engineering Tolerance Using Biomaterials to Target and Control Antigen
   Presenting Cells
SO DISCOVERY MEDICINE
LA English
DT Article
ID REGULATORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS;
   TOLEROGENIC DENDRITIC CELLS; LYMPH-NODE MICROENVIRONMENT; NANOPARTICLE
   DELIVERY; TRANSPLANT TOLERANCE; ALLOGRAFT SURVIVAL; IMMUNE SIGNALS;
   INDUCTION; MICROPARTICLES
AB Autoimmune diseases occur when cells of the adaptive immune system incorrectly recognize and attack "self" tissues. Importantly, the proliferation and differentiation of these cells is triggered and controlled by interactions with antigen presenting cells (APCs), such as dendritic cells. Thus, modulating the signals transduced by APCs (e.g., cytokines, costimulatory surface proteins) has emerged as a promising strategy to promote tolerance for diseases such as multiple sclerosis, type 1 diabetes, and lupus. However, many approaches have been hindered by non-specific activity of immunosuppressive or immunoregulatory cues, following systemic administration of soluble factors via traditional injections routes (e.g., subcutaneous, intravenous). Biomaterials offer a unique opportunity to control the delivery of tolerogenic signals in vivo via properties such as controlled particle size, tunable release kinetics, and co-delivery of multiple classes of cargo. In this review, we highlight recent reports that exploit these properties of biomaterials to target APCs and promote tolerance via three strategies, i) passive or active targeting of particulate carriers to APCs, ii) biomaterial-mediated control over antigen localization and processing, and iii) targeted delivery of encapsulated or adsorbed immunomodulatory signals. These reports represent exciting advances toward the goal of more effective therapies for autoimmune diseases, without the broad suppressive effects associated with current clinically-approved therapies.
C1 [Tostanoski, Lisa H.; Gosselin, Emily A.; Jewell, Christopher M.] Univ Maryland, Fischell Dept Bioengn, 8228 Paint Branch Dr, College Pk, MD 20742 USA.
   [Jewell, Christopher M.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, 685 West Baltimore St, Baltimore, MD 21201 USA.
   [Jewell, Christopher M.] Marlene & Stewart Greenebaum Canc Ctr, 22 S Greene St, Baltimore, MD 21201 USA.
RP Jewell, CM (reprint author), Univ Maryland, Fischell Dept Bioengn, 8228 Paint Branch Dr, College Pk, MD 20742 USA.; Jewell, CM (reprint author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, 685 West Baltimore St, Baltimore, MD 21201 USA.; Jewell, CM (reprint author), Marlene & Stewart Greenebaum Canc Ctr, 22 S Greene St, Baltimore, MD 21201 USA.
EM cmjewell@umd.edu
OI Tostanoski, Lisa/0000-0001-9255-5684
FU National Multiple Sclerosis Society Award [RG-1501-02968, PP2103]; NSF
   CAREER Award [1351688]; Maryland Innovation Initiative; Damon Runyon
   Foundation [DRR3415]; Young Investigator of the Alliance for Cancer Gene
   Therapy [15051543]; Melanoma Research Alliance [348963]
FX This work was supported in part by the National Multiple Sclerosis
   Society Award # RG-1501-02968 and # PP2103, NSF CAREER Award # 1351688,
   and the Maryland Innovation Initiative. L.H.T. is a NSF Graduate Fellow
   (# DGE1322106). C.M.J. is a Damon Runyon-Rachleff Innovator supported by
   the Damon Runyon Foundation (# DRR3415), and a Young Investigator of the
   Alliance for Cancer Gene Therapy (# 15051543) and the Melanoma Research
   Alliance (# 348963).
CR Andorko JI, 2015, AAPS J, V17, P323, DOI 10.1208/s12248-014-9708-2
   Andorko JI, 2015, ACTA BIOMATER
   Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290
   Bluestone JA, 2015, J CLIN INVEST, V125, P2250, DOI 10.1172/JCI78089
   Bryant J, 2014, BIOMATERIALS, V35, P8887, DOI 10.1016/j.biomaterials.2014.06.044
   Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159
   Chalmers SA, 2015, DISCOV MED, V20, P43
   Chiu YC, 2015, ACS BIOMATER SCI ENG, V1, P1200, DOI 10.1021/acsbiomaterials.5b00375
   Dane KY, 2011, J CONTROL RELEASE, V156, P154, DOI 10.1016/j.jconrel.2011.08.009
   Foged C, 2005, INT J PHARM, V298, P315, DOI 10.1016/j.ijpharm.2005.03.035
   Gammon JM, 2015, J CONTROL RELEASE, V210, P169, DOI 10.1016/j.jconrel.2015.05.277
   Getts DR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007563
   Getts DR, 2012, NAT BIOTECHNOL, V30, P1217, DOI 10.1038/nbt.2434
   Griffith TS, 2011, IMMUNITY, V35, P456, DOI 10.1016/j.immuni.2011.08.011
   Grimm AJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15907
   Hlavaty KA, 2015, CLIN IMMUNOL, V160, P14, DOI 10.1016/j.clim.2015.03.013
   Hudalla GA, 2014, NAT MATER, V13, P829, DOI [10.1038/NMAT3998, 10.1038/nmat3998]
   Hunter Z, 2014, ACS NANO, V8, P2148, DOI 10.1021/nn405033r
   Irvine DJ, 2013, NAT MATER, V12, P978, DOI [10.1038/NMAT3775, 10.1038/nmat3775]
   Jewell CM, 2011, P NATL ACAD SCI USA, V108, P15745, DOI 10.1073/pnas.1105200108
   Jhunjhunwala S, 2009, J CONTROL RELEASE, V133, P191, DOI 10.1016/j.jconrel.2008.10.011
   Jones CH, 2015, DISCOV MED, V19, P447
   Kontos S, 2013, P NATL ACAD SCI USA, V110, pE60, DOI 10.1073/pnas.1216353110
   Kwon YJ, 2005, P NATL ACAD SCI USA, V102, P18264, DOI 10.1073/pnas.0509541102
   Lewis JS, 2015, CLIN IMMUNOL, V160, P90, DOI 10.1016/j.clim.2015.03.023
   Lewis JS, 2012, BIOMATERIALS, V33, P7221, DOI 10.1016/j.biomaterials.2012.06.049
   Liu HP, 2014, NATURE, V507, P519, DOI 10.1038/nature12978
   Look M, 2013, J CLIN INVEST, V123, P1741, DOI 10.1172/JCI65907
   Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432
   Lutterotti A, 2014, EXPERT OPIN INV DRUG, V23, P9, DOI 10.1517/13543784.2014.844788
   Maldonado RA, 2015, P NATL ACAD SCI USA, V112, pE156, DOI 10.1073/pnas.1408686111
   Maldonado RA, 2010, ADV IMMUNOL, V108, P111, DOI 10.1016/S0065-2776(10)08004_1
   Manicassamy S, 2011, IMMUNOL REV, V241, P206, DOI 10.1111/j.1600-065X.2011.01015.x
   Mankia K, 2015, DISCOV MED, V20, P129
   Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132
   Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588
   Northrup L, 2016, ADV DRUG DELIVER REV, V98, P86, DOI 10.1016/j.addr.2015.10.020
   Northrup L, 2014, AAPS J, V16, P1204, DOI 10.1208/s12248-014-9671-y
   Osorio F, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00535
   Peine KJ, 2014, MOL PHARMACEUT, V11, P828, DOI 10.1021/mp4005172
   Pereira BD, 2015, DISCOV MED, V20, P111
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Salmond RJ, 2011, EUR J IMMUNOL, V41, P2137, DOI 10.1002/eji.201141523
   Shao K, 2015, ACS NANO, V9, P16, DOI 10.1021/nn5062029
   Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106
   Shirali AC, 2011, AM J TRANSPLANT, V11, P2582, DOI 10.1111/j.1600-6143.2011.03725.x
   Singh A, 2014, ADV MATER, V26, P6530, DOI 10.1002/adma.201402105
   Soroosh P, 2013, J EXP MED, V210, P775, DOI 10.1084/jem.20121849
   Sunshine JC, 2014, BIOMATERIALS, V35, P269, DOI 10.1016/j.biomaterials.2013.09.050
   Sunshine JC, 2013, NANOMEDICINE-UK, V8, P1173, DOI [10.2217/NNM.13.98, 10.2217/nnm.13.98]
   Taner T, 2005, AM J TRANSPLANT, V5, P228, DOI 10.1046/j.1600-6143.2004.00673.x
   Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546
   Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015
   van Broekhoven CL, 2004, CANCER RES, V64, P4357, DOI 10.1158/0008-5472.CAN-04-0138
   Wang C, 2015, CELL, V163, DOI 10.1016/j.cell.2015.10.068
   Zhang PP, 2015, ACS NANO, V9, P6465, DOI 10.1021/acsnano.5b02153
NR 56
TC 11
Z9 12
U1 0
U2 6
PU DISCOVERY MEDICINE
PI TIMONIUM
PA 10 GERARD AVE, STE 201, TIMONIUM, MD 21093 USA
SN 1539-6509
EI 1944-7930
J9 DISCOV MED
JI Discov. Med.
PD MAY
PY 2016
VL 21
IS 117
BP 403
EP 410
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DX2JY
UT WOS:000384196200008
PM 27355336
DA 2018-10-19
ER

PT J
AU Sentineri, R
   Lombardi, T
   Celauro, A
   Stacchi, C
AF Sentineri, Rosario
   Lombardi, Teresa
   Celauro, Andrea
   Stacchi, Claudio
TI Nasal Floor Elevation with Transcrestal Hydrodynamic Approach Combined
   with Dental Implant Placement: A Case Report
SO INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY
LA English
DT Article
ID ANTERIOR MAXILLA; RECONSTRUCTION; AUGMENTATION
AB Severe atrophy of the anterior maxilla represents a major challenge for the clinician when planning an implant-supported rehabilitation. Several surgical options are available for augmenting bone volume in this area, including onlay or interpositional bone grafts, guided bone regeneration, distraction osteogenesis, and nasal floor augmentation. This case report describes a novel approach to nasal floor elevation using ultrasonic instruments to prepare the implant sites followed by transcrestal hydrodynamic nasal mucosa elevation and grafting with a collagenized xenogeneic biomaterial. This minimally invasive technique allowed for vertical augmentation of the atrophic anterior maxilla together with implant placement in a single-stage surgery.
C1 [Celauro, Andrea] Univ Genoa, Sch Dent, Dent, Genoa, Italy.
   [Stacchi, Claudio] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.
RP Stacchi, C (reprint author), Univ Trieste, Dept Odontol & Stomatol, Piazza Ospitale 1, I-34100 Trieste, Italy.
EM claudio@stacchi.it
OI STACCHI, CLAUDIO/0000-0003-4017-4980; Lombardi,
   Teresa/0000-0002-0334-6029
CR Adell R, 1985, TISSUE INTEGRATED PR, P226
   CAWOOD JI, 1988, INT J ORAL MAX SURG, V17, P232, DOI 10.1016/S0901-5027(88)80047-X
   Chiapasco M, 2009, INT J ORAL MAX IMPL, V24, P237
   El-Ghareeb M, 2012, J ORAL MAXIL SURG, V70, pE235, DOI 10.1016/j.joms.2011.09.032
   Gaggl A, 2005, INT J ORAL MAX SURG, V34, P37, DOI 10.1016/j.ijom.2004.03.008
   Garg A K, 1997, Dent Implantol Update, V8, P49
   Hising P, 2001, INT J ORAL MAX IMPL, V16, P90
   JENSEN J, 1994, J ORAL MAXIL SURG, V52, P210, DOI 10.1016/0278-2391(94)90283-6
   Keller E E, 1987, Int J Oral Maxillofac Implants, V2, P155
   Lorean A, 2014, INT J ORAL MAX IMPL, V29, P705, DOI 10.11607/jomi.3565
   Lundgren S, 1997, INT J ORAL MAX SURG, V26, P428, DOI 10.1016/S0901-5027(97)80007-0
   Mazor Z, 2012, CLIN IMPLANT DENT R, V14, P768, DOI 10.1111/j.1708-8208.2010.00312.x
   Merli M, 2013, INT J PERIODONT REST, V33, P129, DOI 10.11607/prd.1175
   Nystrom E, 2009, INT J ORAL MAX SURG, V38, P111, DOI 10.1016/j.ijom.2008.10.008
   Orsini G, 2011, INT J PERIODONT REST, V31, P535
   SAILER HF, 1989, J CRANIO MAXILL SURG, V17, P299, DOI 10.1016/S1010-5182(89)80057-5
   Schlee Markus, 2006, Implant Dent, V15, P334, DOI 10.1097/01.id.0000247859.86693.ef
   Sentineri R, 2011, J OSTEOL BIOMAT, V2, P69
   Stacchi C, 2013, CLIN IMPLANT DENT R, V15, P188, DOI 10.1111/j.1708-8208.2011.00341.x
   Troedhan A, 2014, J ORAL MAXILLOFAC SU, V72, p1503 e1
   Waldhorn Theodor, 2008, Schweiz Monatsschr Zahnmed, V118, P301
NR 21
TC 0
Z9 0
U1 0
U2 0
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0198-7569
EI 1945-3388
J9 INT J PERIODONT REST
JI Int. J. Periodontics Restor. Dent.
PD MAY-JUN
PY 2016
VL 36
IS 3
BP 357
EP 361
DI 10.11607/prd.2540
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DW7VX
UT WOS:000383862000008
PM 27100805
OA Bronze
DA 2018-10-19
ER

PT J
AU Istrate, B
   Mareci, D
   Munteanu, C
   Stanciu, S
   Crimu, CI
   Trinca, LC
   Kamel, E
AF Istrate, Bogdan
   Mareci, Daniel
   Munteanu, Corneliu
   Stanciu, Sergiu
   Crimu, Carmen-Iulia
   Trinca, Lucia Carmen
   Kamel, Earar
TI IN VITRO ELECTROCHEMICAL PROPERTIES OF BIODEGRADABLE YSZ-COATED MgCa
   ALLOY
SO ENVIRONMENTAL ENGINEERING AND MANAGEMENT JOURNAL
LA English
DT Article
DE EIS; MgCa alloy; plasma spraying; SEM; YSZ-coated
ID AZ91 MAGNESIUM ALLOY; LOW-POWER PLASMA; CORROSION BEHAVIOR; RINGERS
   SOLUTION; CA ALLOYS; BIOMATERIAL; RESISTANCE; COATINGS; ALBUMIN
AB Zirconia (ZrO2) as a ceramic biomaterial facilitates the osteoconductivity in new bone formation around implant. Surface characterization before and after electrochemical testing was performed used scanning electron microscopy (SEM). The electrochemical properties of the yttrium oxide stabilized zirconium oxide (YSZ) coated and uncoated MgCa sample with the open circuit potential at different immersion time in Ringer's solution were studied by electrochemical impedance spectroscopy (EIS). Equivalent circuits (ECs) were used to modeling EIS data, in order to characterize YSZ-coated and uncoated MgCa surface. The polarization resistance of the YSZ coated and uncoated MgCa decreases with the immersion time. However, after 2-days immersion in Ringer's solution the corrosion resistance presenteded bigger value for the uncoated (360 Omega cm(2)) than YSZ coated (140 Omega cm(2)) MgCa alloy. The present study, showed that electrochemical determinations can be a usefull tool to characterize such alloys. Knowledge of in vitro corrosion behaviour of these alloys may lead to a better undersanding of any biologically adverse effects in vivo.
C1 [Istrate, Bogdan; Munteanu, Corneliu; Crimu, Carmen-Iulia] Gheorghe Asachi Tech Univ Iasi, Fac Mech Engn, 43 D Mangeron St, Iasi 700050, Romania.
   [Mareci, Daniel] Gheorghe Asachi Tech Univ Iasi, Fac Chem Engn & Environm Protect, Iasi 700050, Romania.
   [Stanciu, Sergiu] Gheorghe Asachi Tech Univ Iasi, Fac Mat Sci & Engn, 41 D Mangeron St, Iasi 700050, Romania.
   [Trinca, Lucia Carmen] Ion Ionescu de la Brad Univ Agr Sci & Vet Med, Iasi 700490, Romania.
   [Kamel, Earar] Dunarea de Jos Univ Galati, Fac Med, Dent Med, Al I Cuza 35 St, Galati, Romania.
RP Munteanu, C (reprint author), Gheorghe Asachi Tech Univ Iasi, Fac Mech Engn, 43 D Mangeron St, Iasi 700050, Romania.
EM cornelmun@gmail.com
RI TRINCA, LUCIA CARMEN/F-5966-2011; Bogdan, Istrate/P-5182-2014
OI TRINCA, LUCIA CARMEN/0000-0001-7381-6658; Bogdan,
   Istrate/0000-0003-0817-3523
CR [Anonymous], 1999, G190 ASTM
   Bender S, 2007, MATER CORROS, V58, P977, DOI 10.1002/maco.200704091
   Bozzini B, 2011, J MATER SCI-MATER M, V22, P193, DOI 10.1007/s10856-010-4187-1
   Chen J, 2008, ELECTROCHEM COMMUN, V10, P577, DOI 10.1016/j.elecom.2008.01.027
   Crimu C, 2015, MATER CORROS, V66, P649, DOI 10.1002/maco.201407980
   Eliezer A, 2010, ADV MATER RES-SWITZ, V95, P17, DOI 10.4028/www.scientific.net/AMR.95.17
   Ghali E, 2004, J MATER ENG PERFORM, V13, P517, DOI 10.1361/10599490420665
   Gray JE, 2002, J ALLOY COMPD, V336, P88, DOI 10.1016/S0925-8388(01)01899-0
   Ilich JZ, 2000, J AM COLL NUTR, V19, P715, DOI 10.1080/07315724.2000.10718070
   Li N, 2013, J MATER SCI TECHNOL, V29, P489, DOI 10.1016/j.jmst.2013.02.005
   Li T, 2015, MATER CORROS, V66, P7, DOI 10.1002/maco.201307528
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liu CL, 2007, J MATER RES, V22, P1806, DOI 10.1557/JMR.2007.0241
   Liu XB, 2011, ELECTROCHIM ACTA, V56, P2582, DOI 10.1016/j.electacta.2010.12.030
   Mareci D, 2016, MAT SCI ENG C-MATER, V60, P402, DOI 10.1016/j.msec.2015.11.069
   Mareci D, 2010, ENVIRON ENG MANAG J, V9, P81
   Mareci D, 2009, ENVIRON ENG MANAG J, V8, P397
   Mareci D, 2009, ENVIRON ENG MANAG J, V8, P29, DOI 10.30638/eemj.2009.004
   Mareci D, 2008, ENVIRON ENG MANAG J, V7, P701, DOI 10.30638/eemj.2008.093
   Morks MF, 2006, MATER LETT, V60, P1049, DOI 10.1016/j.matlet.2005.10.073
   Morks MF, 2005, SURF COAT TECH, V199, P66, DOI 10.1016/j.surfcoat.2005.02.159
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Pompa L, 2015, MAT SCI ENG C-MATER, V49, P761, DOI 10.1016/j.msec.2015.01.017
   Popa MV, 2010, QUIM NOVA, V33, P1892, DOI 10.1590/S0100-40422010000900014
   Romas M, 2015, ENVIRON ENG MANAG J, V14, P2719
   Rosemann P, 2013, MATER CORROS, V64, P714, DOI 10.1002/maco.201206590
   Shaw B.A., 2003, CORROSION RESISTANCE
   Shi ZM, 2010, CORROS SCI, V52, P579, DOI 10.1016/j.corsci.2009.10.016
   Song GL, 2005, ADV ENG MATER, V7, P563, DOI 10.1002/adem.200500013
   Song YW, 2008, MATER LETT, V62, P3276, DOI 10.1016/j.matlet.2008.02.048
   Tie D, 2014, MATER CORROS, V65, P569, DOI 10.1002/maco.201206903
   Virtanen S, 2011, MATER SCI ENG B-ADV, V176, P1600, DOI 10.1016/j.mseb.2011.05.028
   Wang H, 2007, ADV ENG MATER, V9, P967, DOI 10.1002/adem.200700200
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   Xin YC, 2009, SURF COAT TECH, V203, P2554, DOI 10.1016/j.surfcoat.2009.02.074
   Zeng RC, 2006, T NONFERR METAL SOC, V16, pS763, DOI 10.1016/S1003-6326(06)60297-5
   Zeng RC, 2015, CORROS SCI, V96, P23, DOI 10.1016/j.corsci.2015.03.018
NR 38
TC 19
Z9 19
U1 0
U2 6
PU GH ASACHI TECHNICAL UNIV IASI
PI IASI
PA 71 MANGERON BLVD, IASI, 700050, ROMANIA
SN 1582-9596
EI 1843-3707
J9 ENVIRON ENG MANAG J
JI Environ. Eng. Manag. J.
PD MAY
PY 2016
VL 15
IS 5
BP 955
EP 963
PG 9
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA DT1WZ
UT WOS:000381274100002
DA 2018-10-19
ER

PT J
AU Rajabinejad, H
   Buciscanu, II
   Maier, SS
AF Rajabinejad, Hossein
   Buciscanu, Ingrid-Ioana
   Maier, Stelian-Sergiu
TI PRACTICAL WAYS OF EXTRACTING KERATIN FROM KERATINOUS WASTES AND
   BY-PRODUCTS: A REVIEW
SO ENVIRONMENTAL ENGINEERING AND MANAGEMENT JOURNAL
LA English
DT Article; Proceedings Paper
CT 6th International Conference on Biomaterials, Tissue Engineering and
   Medical Devices (BiomMed)
CY SEP 17-20, 2014
CL Constanta, ROMANIA
DE biopolymer; biomaterial; keratin solubilization; keratinous wastes;
   renewable resources
ID CARBOXYMETHYLATED FEATHER KERATINS; REGENERATED WOOL KERATIN;
   BACILLUS-PUMILUS A1; IONIC LIQUIDS; CHICKEN FEATHERS; HAIR KERATIN;
   AMINO-ACID; ENZYMATIC-HYDROLYSIS; ALKALINE-HYDROLYSIS; PROTEIN
   HYDROLYSATE
AB Renewable resources, biopolymers and bio-based materials are keywords of the sustainable development and environmental sustainability concepts. Biopolymers, the green alternatives to fossil fuel based polymers, have already found different feasible applications, from consumer goods to regenerative medicine. Keratin is the biopolymer contained in the skin derivatives and appendages and is one of the the proteins with the most sophisticated architecture nature could produce. It is found in huge quantities in materials regarded as by-products or wastes with negative environmental impact but with high potential, for which it is desirable to develop valorization solutions. The increased interest towards biopolymers and renewable resources determined a large body of research and practical work concerning keratin extraction from different sources and regeneration into useful products. It is the aim of this paper to review the conventional chemical pathways and environmentally friendly alternatives for keratin solubilization as it regards the mechanisms, process parameters, characteristics of the obtained keratin forms, environmental and economical aspects. Current and possible applications of the solubilized keratin forms are also shortly reviewed.
C1 [Rajabinejad, Hossein] Gheorghe Asachi Tech Univ Iasi, SMDTex Doctorate Programme, 67 Prof Dr Docent Dimitrie Mangeron Blvd, Iasi 700050, Romania.
   [Buciscanu, Ingrid-Ioana; Maier, Stelian-Sergiu] Gheorghe Asachi Tech Univ Iasi, Fac Text Leather & Ind Management, 71A Prof Dr Docent Dimitrie Mangeron Blvd, Iasi 700050, Romania.
RP Maier, SS (reprint author), Gheorghe Asachi Tech Univ Iasi, Fac Text Leather & Ind Management, 71A Prof Dr Docent Dimitrie Mangeron Blvd, Iasi 700050, Romania.
EM smaier@ch.tuiasi.ro
RI Buciscanu, Ingrid-Ioana/F-8711-2017
CR ALEXANDER P, 1950, BIOCHEM J, V46, P27, DOI 10.1042/bj0460027
   ALEXANDER P, 1950, NATURE, V166, P396, DOI 10.1038/166396a0
   Alexander P., 1952, Patent No. [No. 2622036, 2622036]
   ALEXANDER P, 1963, WOOL ITS CHEM PHYS
   Alibardi L, 2013, ANN ANAT, V195, P189, DOI 10.1016/j.aanat.2012.08.005
   Anker CA, 1972, US patent, Patent No. 3642498
   [Anonymous], 2007, United States Patent, Patent No. 7297342
   Arivithamani N, 2014, CLEAN TECHNOL ENVIR, V16, P1207, DOI 10.1007/s10098-014-0718-7
   BAILEY JL, 1959, J BIOL CHEM, V234, P1733
   Benson Heather A. E., 2005, Current Drug Delivery, V2, P23, DOI 10.2174/1567201052772915
   Blanchard C. R., 1999, US Pat, Patent No. [US5932552 A, 5932552, 5,932,552]
   Bragulla HH, 2009, J ANAT, V214, P516, DOI 10.1111/j.1469-7580.2009.01066.x
   BROWN CH, 1950, NATURE, V166, P439, DOI 10.1038/166439a0
   Burnett L., 2013, Patent No. [025940 A1, 025940]
   Cardamone JM, 2010, J MOL STRUCT, V969, P97, DOI 10.1016/j.molstruc.2010.01.048
   CASTINO F, 1974, HISTOCHEMISTRY, V39, P93, DOI 10.1007/BF02428555
   Cavello IA, 2013, PROCESS BIOCHEM, V48, P972, DOI 10.1016/j.procbio.2013.03.012
   Chen JY, 2014, MATERIALS, V7, P6158, DOI 10.3390/ma7096158
   Cilurzo F, 2013, POLYM ADVAN TECHNOL, V24, P1025, DOI 10.1002/pat.3168
   Cole R.D., 1967, METHOD ENZYMOL, V11, P206
   Converti A, 2015, ENVIRON ENG MANAG J, V14, P1231
   COOPERMAN ES, 1973, COSMET PERFUM, V88, P19
   CORFIELD MC, 1958, BIOCHEM J, V68, P348, DOI 10.1042/bj0680348
   Coulombe PA, 2013, ENCY BIOL CHEM, P665
   CREWTHER W. G. R. D. B. FRASER, 1965, ADVANCE PROTEIN CHEM, V20, P191, DOI 10.1016/S0065-3233(08)60390-3
   DALEV P, 1990, BIOTECHNOL LETT, V12, P71, DOI 10.1007/BF01028496
   de Guzman RC, 2011, BIOMATERIALS, V32, P8205, DOI 10.1016/j.biomaterials.2011.07.054
   DOUTHWAITE FJ, 1993, TEXT RES J, V63, P177, DOI 10.1177/004051759306300308
   EARLAND C, 1956, BIOCHIM BIOPHYS ACTA, V22, P405, DOI 10.1016/0006-3002(56)90048-8
   Erra P, 1997, TEXT RES J, V67, P397, DOI 10.1177/004051759706700602
   Eslahi N, 2013, PREP BIOCHEM BIOTECH, V43, P624, DOI 10.1080/10826068.2013.763826
   Fakhfakh N, 2013, J APPL MICROBIOL, V115, P424, DOI 10.1111/jam.12246
   Fakhfakh N, 2011, PROCESS BIOCHEM, V46, P1731, DOI 10.1016/j.procbio.2011.05.023
   FAN X, 2008, THESIS
   Fellahi S., 2014, J BIOPROCESSING BIOT, V4, P181, DOI [10.4172/2155-9821.1000181, DOI 10.4172/2155-9821.1000181]
   Feughelman M., 1997, MECH PROPERTIES STRU
   Fleischner A.M., 1989, US Patent, Patent No. 4818520
   FLORENCE TM, 1980, BIOCHEM J, V189, P507, DOI 10.1042/bj1890507
   Fontoura R, 2014, NEW BIOTECHNOL, V31, P506, DOI 10.1016/j.nbt.2014.07.002
   Fraser RDB, 2008, J STRUCT BIOL, V162, P1, DOI 10.1016/j.jsb.2008.01.011
   FUCHS E, 1983, CELL, V34, P332, DOI 10.1016/0092-8674(83)90367-7
   Fujii T., 2013, J BIOL MACROMOLECULE, V13, P92
   Gallstedt M., 2011, BIOPOLYMERS NEW MAT, P107
   Ghosh A, 2014, POLYM DEGRAD STABIL, V108, P108, DOI 10.1016/j.polymdegradstab.2014.06.007
   GILLESPIE J, 1961, BIOCHEM J, V79, P280, DOI 10.1042/bj0790280
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Gonzalez A, 2011, J FOOD ENG, V106, P331, DOI 10.1016/j.jfoodeng.2011.05.030
   Gousterova A, 2005, LETT APPL MICROBIOL, V40, P335, DOI 10.1111/j.1472-765X.2005.01692.x
   Gousterova A, 2003, BIOTECHNOL BIOTECHNO, V17, P140
   Gupta R, 2006, APPL MICROBIOL BIOT, V70, P21, DOI 10.1007/s00253-005-0239-8
   Hamasaki S, 2008, MAT SCI ENG C-BIO S, V28, P1250, DOI 10.1016/j.msec.2007.11.008
   HARRAP BS, 1964, BIOCHEM J, V92, P19, DOI 10.1042/bj0920019
   Hill P, 2010, BIOMATERIALS, V31, P585, DOI 10.1016/j.biomaterials.2009.09.076
   Hsiung D.Y., 1972, US Patent, Patent No. 3644084
   Ianelli M., 2011, MICROWAVE HEATING TO, P53
   Idris A, 2014, ACS SUSTAIN CHEM ENG, V2, P1888, DOI 10.1021/sc500229a
   Idris A, 2014, GREEN CHEM, V16, P2857, DOI 10.1039/c4gc00213j
   Idris A, 2013, GREEN CHEM, V15, P525, DOI 10.1039/c2gc36556a
   Ignatova Z, 1999, CAN J MICROBIOL, V45, P217, DOI 10.1139/cjm-45-3-217
   Istrate D, 2013, POLYM DEGRAD STABIL, V98, P542, DOI 10.1016/j.polymdegradstab.2012.12.001
   Jones LN, 2007, INT FIBER SCI TECHNO, V16, P331
   Kalbarg S.M., 2003, US Patent App, Patent No. 0175845
   Katoh K, 2004, BIOMATERIALS, V25, P2265, DOI 10.1016/j.biomaterials.2003.09.021
   Katritzky AR, 2003, MAGN RESON CHEM, V41, P37, DOI 10.1002/mrc.1110
   Kelly R.J., 2006, US Patent, Patent No. 7148327
   Kelly R.J., 2012, US Patent, Patent No. 8124735
   Kelly R.J., 2010, US Patent, Patent No. 7767756
   Ki CS, 2007, J MEMBRANE SCI, V302, P20, DOI 10.1016/j.memsci.2007.06.003
   Kilpelainen I, 2007, J AGR FOOD CHEM, V55, P9142, DOI 10.1021/jf071692e
   Kim WK, 2000, POULTRY SCI, V79, P528, DOI 10.1093/ps/79.4.528
   Kornillowicz-Kowalska T, 2011, WASTE MANAGE, V31, P1689, DOI 10.1016/j.wasman.2011.03.024
   Kornillowicz-Kowalska Teresa, 1997, Acta Mycologica, V32, P51
   Kreplak L, 2004, BIOPHYS J, V87, P640, DOI 10.1529/biophysj.103.036749
   KUNERT J, 1989, J BASIC MICROB, V29, P597, DOI 10.1002/jobm.3620290909
   Lane B.E., 2002, CONNECTIVE TISSUE AN, P329
   Lee SH, 2010, ACS SYM SER, V1038, P115
   LEE SJ, 2007, MANUAL BIOMATERIALS, P141
   Li JS, 2013, FOOD CHEM TOXICOL, V57, P338, DOI 10.1016/j.fct.2013.03.047
   Li R, 2013, J APPL POLYM SCI, V127, P2648, DOI 10.1002/app.37527
   Liu XY, 2011, MATER LETT, V65, P2489, DOI 10.1016/j.matlet.2011.05.017
   Maclaren J.A., 1981, WOOL SCI CHEM REACTI, P219
   Marmer WN, 2006, J AM LEATHER CHEM AS, V101, P408
   Meng ZJ, 2012, INT J BIOL MACROMOL, V51, P440, DOI 10.1016/j.ijbiomac.2012.05.030
   Mokrejs P., 2011, Rasayan Journal of Chemistry, V4, P728
   Mokrejs P, 2011, WASTE MANAGE RES, V29, P260, DOI 10.1177/0734242X10370378
   Moshy R.J., 1961, US Patent, Patent No. 2993794
   NACHTIGAL J, 1970, TEXT RES J, V40, P454, DOI 10.1177/004051757004000511
   NAGAI Y, 1970, AGR BIOL CHEM TOKYO, V34, P16, DOI 10.1080/00021369.1970.10859572
   NAGAI Y, 1970, AGR BIOL CHEM TOKYO, V34, P1676, DOI 10.1080/00021369.1970.10859823
   Nakamura A, 2002, BIOL PHARM BULL, V25, P569, DOI 10.1248/bpb.25.569
   Nakata R, 2015, J BIOSCI BIOENG, V120, P111, DOI 10.1016/j.jbiosc.2014.12.005
   NOISHIKI Y, 1982, KOBUNSHI RONBUNSHU, V39, P221, DOI 10.1295/koron.39.221
   Nomura Y, 2002, BIOSCI BIOTECH BIOCH, V66, P1382, DOI 10.1271/bbb.66.1382
   Nunez F, 2011, MICROCIRCULATION, V18, P663, DOI 10.1111/j.1549-8719.2011.00135.x
   O'DONNELL I. J., 1959, AUSTRALIAN JOUR BIOL SCI, V12, P294
   ODONNELL IJ, 1964, AUST J BIOL SCI, V17, P973, DOI 10.1071/BI9640973
   OERTEL RP, 1977, BIOPOLYMERS, V16, P2329, DOI 10.1002/bip.1977.360161017
   Ohba R, 2003, FOOD SCI TECHNOL RES, V9, P91, DOI 10.3136/fstr.9.91
   Onifade AA, 1998, BIORESOURCE TECHNOL, V66, P1, DOI 10.1016/S0960-8524(98)00033-9
   Ozaki Y, 2014, MAT SCI ENG C-MATER, V42, P146, DOI 10.1016/j.msec.2014.05.018
   Pasupuleti VK, 2010, PROTEIN HYDROLYSATES IN BIOTECHNOLOGY, P11, DOI 10.1007/978-1-4020-6674-0_2
   Plowman JE, 2003, J CHROMATOGR B, V787, P63, DOI 10.1016/S1570-0232(02)00211-8
   Poole AJ, 2011, J POLYM ENVIRON, V19, P995, DOI 10.1007/s10924-011-0365-6
   PRICE VH, 1967, J INVEST DERMATOL, V49, P297, DOI 10.1038/jid.1967.139
   Ramnani P, 2005, CAN J MICROBIOL, V51, P191, DOI 10.1139/W04-123
   Ramnani P, 2007, WORLD J MICROB BIOT, V23, P1537, DOI 10.1007/s11274-007-9398-3
   Reddy N, 2014, J CLEAN PROD, V65, P561, DOI 10.1016/j.jclepro.2013.09.046
   Reichl S, 2009, BIOMATERIALS, V30, P6854, DOI 10.1016/j.biomaterials.2009.08.051
   ROBBINS C, 1971, J SOC COSMET CHEM, V22, P339
   Robbins C.R., 2012, CHEM PHYS BEHAV HUMA, P205
   Rouette H.K., 2001, ENCY TEXTILE FINISHI, P2696
   Rouse JG, 2010, MATERIALS, V3, P999, DOI 10.3390/ma3020999
   Sahoo DK, 2012, APPL BIOCHEM BIOTECH, V167, P1040, DOI 10.1007/s12010-011-9527-1
   Sanderson W.R., 2002, HDB GREEN CHEM TECHN, P258
   Sando L, 2010, J BIOMED MATER RES A, V95A, P901, DOI 10.1002/jbm.a.32913
   SAVIGE WE, 1964, TETRAHEDRON LETT, P3289
   Schrooyen P.M., 2007, US Patent, Patent No. 7169896
   Schrooyen PMM, 2000, J AGR FOOD CHEM, V48, P4326, DOI 10.1021/jf9913155
   Schrooyen PMM, 2001, J AGR FOOD CHEM, V49, P221, DOI 10.1021/jf0004154
   Schrooyen PMM, 2001, J COLLOID INTERF SCI, V240, P30, DOI 10.1006/jcis.2001.7673
   Selmin Francesca, 2012, Results Pharma Sci, V2, P72, DOI 10.1016/j.rinphs.2012.10.001
   Shi B, 2003, J AM LEATHER CHEM AS, V98, P185
   Srinivasan B, 2010, J BIOMED MATER RES B, V92B, P5, DOI 10.1002/jbm.b.31483
   Sun P, 2009, J HAZARD MATER, V170, P786, DOI 10.1016/j.jhazmat.2009.05.034
   SWAN JM, 1961, AUST J CHEM, V14, P69, DOI 10.1071/CH9610069
   SWAN JM, 1957, NATURE, V180, P643, DOI 10.1038/180643a0
   Syed DG, 2009, BIORESOURCE TECHNOL, V100, P1868, DOI 10.1016/j.biortech.2008.09.047
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   TAKIUCHI I, 1983, Journal of Dermatology (Tokyo), V10, P327
   Tam J.P., 1992, US Patent, Patent No. 5144006
   Tanabe T, 2002, BIOMATERIALS, V23, P817, DOI 10.1016/S0142-9612(01)00187-9
   Tang L, 2012, EXP DERMATOL, V21, P458, DOI 10.1111/j.1600-0625.2012.01505.x
   THOMPSON EO, 1961, BIOCHIM BIOPHYS ACTA, V53, P447, DOI 10.1016/0006-3002(61)90471-1
   Tiwary E., 2012, J BIOPROCESS BIOTECH, V2, DOI [10.4172/2155-9821.100012\3, DOI 10.4172/2155-9821.1000123, 10.4172/2155-9821.1000123]
   Tonin C, 2006, BIOMACROMOLECULES, V7, P3499, DOI 10.1021/bm060597w
   Tsuda Y, 2014, ANIM SCI J, V85, P180, DOI 10.1111/asj.12093
   Van Dyke M.E., 2001, US Patent No, Patent No. 6316598
   VanDyke M.E., 2011, US Patent No, Patent No. 7892573
   VanDyke M.E., 2012, US Patent No, Patent No. 8258093
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Vasconcelos A, 2011, APPL MICROBIOL BIOT, V90, P445, DOI 10.1007/s00253-011-3135-4
   Vesela M, 2009, BIOTECHNOL BIOPROC E, V14, P84, DOI [10.1007/s12257-008-0083-7, 10.1007/S12257-008-0083-7]
   Wang X, 1997, POULTRY SCI, V76, P491, DOI 10.1093/ps/76.3.491
   Wang YX, 2012, PROCESS BIOCHEM, V47, P896, DOI 10.1016/j.procbio.2012.02.013
   WOLFRAM L J, 1970, Journal of the Society of Cosmetic Chemists, V21, P875
   Wolfram L.J., 1971, US Patent, No, Patent No. 3567363
   WOLFRAM LJ, 1966, TEXT RES J, V36, P947, DOI 10.1177/004051756603601102
   Wrzesniewska-Tosik K, 2007, FIBRES TEXT EAST EUR, V15, P106
   Xie HB, 2005, GREEN CHEM, V7, P606, DOI 10.1039/b502547h
   Xu HL, 2014, J MATER SCI, V49, P7513, DOI 10.1007/s10853-014-8457-z
   Xu SM, 2013, MAT SCI ENG C-MATER, V33, P648, DOI 10.1016/j.msec.2012.10.011
   Yamada M., 1994, US Patent, Patent No. 5276138
   YAMASHOJI S, 1979, AGR BIOL CHEM TOKYO, V43, P1505, DOI 10.1080/00021369.1979.10863656
   Yamauchi K, 1996, J BIOMED MATER RES, V31, P439, DOI 10.1002/(SICI)1097-4636(199608)31:4<439::AID-JBM1>3.0.CO;2-M
   Yang X, 2007, CHINESE SCI BULL, V52, P2876, DOI 10.1007/s11434-007-0418-3
   Yang X, 2009, J COLLOID INTERF SCI, V336, P756, DOI 10.1016/j.jcis.2009.04.050
   Yin J, 2007, BIOMACROMOLECULES, V8, P800, DOI 10.1021/bm060811g
   Yin XC, 2013, BIOMATER SCI-UK, V1, P528, DOI 10.1039/c3bm00158j
   Zhang J, 2013, POWDER TECHNOL, V246, P356, DOI 10.1016/j.powtec.2013.05.037
   Zhou LT, 2014, ENVIRON SCI POLLUT R, V21, P5730, DOI 10.1007/s11356-014-2513-8
   Zoccola M, 2015, WASTE BIOMASS VALORI, V6, P891, DOI 10.1007/s12649-015-9393-0
   Zoccola M, 2012, TEXT RES J, V82, P2006, DOI 10.1177/0040517512452948
   Zoccola M, 2009, J MOL STRUCT, V938, P35, DOI 10.1016/j.molstruc.2009.08.036
NR 163
TC 1
Z9 1
U1 4
U2 18
PU GH ASACHI TECHNICAL UNIV IASI
PI IASI
PA 71 MANGERON BLVD, IASI, 700050, ROMANIA
SN 1582-9596
EI 1843-3707
J9 ENVIRON ENG MANAG J
JI Environ. Eng. Manag. J.
PD MAY
PY 2016
VL 15
IS 5
BP 1131
EP 1147
PG 17
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA DT1WZ
UT WOS:000381274100024
DA 2018-10-19
ER

PT J
AU Deo, VK
   Kato, T
   Park, EY
AF Deo, Vipin Kumar
   Kato, Tatsuya
   Park, Enoch Y.
TI Virus-Like Particles Displaying Recombinant Short-Chain Fragment Region
   and Interleukin 2 for Targeting Colon Cancer Tumors and Attracting
   Macrophages
SO JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE bilayer; biomaterials; biotechnology; cancer chemotherapy; colon;
   nanoparticles; proteins; protein delivery; site-specific delivery;
   targeted drug delivery
ID ALPHA-RECEPTOR; DRUG-DELIVERY; FORCE-FIELD; GAG; IMMUNOTHERAPY;
   PLATFORM; UPDATE
AB Functionalized virus-like particles (VLPs) can target with specificity as drug delivery systems and can attract macrophages for the destruction of cancer cells. Here, the group antigen capsid protein from the Rous sarcoma virus was used to prepare VLPs, functionalized by displaying glycoleinositol phosphate-anchored recombinant single chain fragment variable (rscFv) and hemagglutinin transmembrane region anchored recombinant human interleukin-2 (rhIL2) (designated as VLP-rscFv-rhIL2s) in silkworms. The rscFv specifically binds the tumor-associated glycoprotein 72 that is expressed at the surface of colon cancer cells. VLP-rscFv-rhIL2 was affinity purified and had a smooth particle size with a diameter of 50 nm. Calcein-AM-packaged VLP-rscFv-rhIL2s successfully targeted cancer cells as a model for drug delivery system. VLP-rscFv-rhIL2 bound with colon cancer cells that attracted macrophages (human monocytic cell line-1 cells) in chemotaxis chamber assays compared with negative controls. The macrophages secreted tumor necrosis factor-a, a cytokine that is necessary to destroy cancer cells. These results demonstrate the potential of VLP-rscFv-rhIL2 as an intelligent nano biomaterial that is capable of attracting macrophages. (C) 2016 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.
C1 [Deo, Vipin Kumar] Shizuoka Univ, Coll Global Interdisciplinary Studies, Biotechnol Lab, Shizuoka 4228529, Japan.
   [Kato, Tatsuya; Park, Enoch Y.] Shizuoka Univ, Res Inst Green Sci & Technol, Biotechnol Lab, Shizuoka 4228529, Japan.
RP Park, EY (reprint author), Shizuoka Univ, Res Inst Green Sci & Technol, Biotechnol Lab, Shizuoka 4228529, Japan.
EM park.enoch@shizuoka.ac.jp
RI Kato, Tatsuya/E-3095-2010
OI Kato, Tatsuya/0000-0001-7990-2557
CR Bergstrom SE, 2013, IMMUNOLOGY, V140, P441, DOI 10.1111/imm.12154
   Bertrand N, 2014, ADV DRUG DELIVER REV, V66, P2, DOI 10.1016/j.addr.2013.11.009
   Boder ET, 2012, NATURE, V484, P463, DOI 10.1038/484463a
   Deo VK, 2015, MOL PHARMACEUT, V12, P839, DOI 10.1021/mp500860x
   Deo VK, 2014, PHARM RES-DORDR, V31, P2166, DOI 10.1007/s11095-014-1316-4
   Deo VK, 2013, J BIOTECHNOL, V165, P69, DOI 10.1016/j.jbiotec.2013.02.013
   Dwyer PJ, 2014, J PHYS CHEM A, V118, P11583, DOI 10.1021/jp506601e
   Goerner M, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-8
   Hank JA, 2009, CLIN CANCER RES, V15, P5923, DOI 10.1158/1078-0432.CCR-08-2963
   Kato T, 2015, PHARM RES-DORDR, V32, P3699, DOI 10.1007/s11095-015-1730-2
   Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q
   Lee S, 2011, CAMERON-CLEGG GOVERNMENT: COALITION POLITICS IN AN AGE OF AUSTERITY, P3
   Maksimenko A, 2014, ACS NANO, V8, P2018, DOI 10.1021/nn500517a
   Pokorski JK, 2011, MOL PHARMACEUT, V8, P29, DOI 10.1021/mp100225y
   Rao BM, 2003, PROTEIN ENG, V16, P1081, DOI 10.1093/protein/gzg111
   Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5
   SABZEVARI H, 1994, P NATL ACAD SCI USA, V91, P9626, DOI 10.1073/pnas.91.20.9626
   Shao K, 2015, ACS NANO, V9, P16, DOI 10.1021/nn5062029
   Sim GC, 2014, CYTOKINE GROWTH F R, V25, P377, DOI 10.1016/j.cytogfr.2014.07.018
   TANIGUCHI T, 1983, NATURE, V302, P305, DOI 10.1038/302305a0
   TEODORCZYKINJEYAN JA, 1992, CLIN EXP IMMUNOL, V90, P36
   Vazquez-Lombardi R, 2013, ANTIBODIES, V2, P426, DOI 10.3390/antib2030426
   Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893
   Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2
   Xiang Y, 1997, J VIROL, V71, P2083
   Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213
NR 26
TC 3
Z9 3
U1 1
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3549
EI 1520-6017
J9 J PHARM SCI-US
JI J. Pharm. Sci.
PD MAY
PY 2016
VL 105
IS 5
BP 1614
EP 1622
DI 10.1016/j.xphs.2016.02.011
PG 9
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA DT8TZ
UT WOS:000381769800005
PM 27037014
DA 2018-10-19
ER

PT J
AU Arias, SL
   Shetty, AR
   Senpan, A
   Echeverry-Rendon, M
   Reece, LM
   Allain, JP
AF Arias, Sandra L.
   Shetty, Akshath R.
   Senpan, Angana
   Echeverry-Rendon, Monica
   Reece, Lisa M.
   Allain, Jean Paul
TI Fabrication of a Functionalized Magnetic Bacterial Nanocellulose with
   Iron Oxide Nanoparticles
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Bioengineering; Issue 111; Gluconacetobacter xylinus; bacterial
   cellulose; iron oxide nanoparticles; blood vessel; biomaterial
ID BLOOD-VESSELS; CELLULOSE
AB In this study, bacterial nanocellulose (BNC) produced by the bacteria Gluconacetobacter xylinus is synthesized and impregnated in situ with iron oxide nanoparticles (IONP) (Fe3O4) to yield a magnetic bacterial nanocellulose (MBNC). The synthesis of MBNC is a precise and specifically designed multi-step process. Briefly, bacterial nanocellulose (BNC) pellicles are formed from preserved G. xylinus strain according to our experimental requirements of size and morphology. A solution of iron(III) chloride hexahydrate (FeCl3 center dot 6H(2)O) and iron(II) chloride tetrahydrate (FeCl2 center dot 4H(2)O) with a 2:1 molar ratio is prepared and diluted in deoxygenated high purity water. A BNC pellicle is then introduced in the vessel with the reactants. This mixture is stirred and heated at 80 degrees C in a silicon oil bath and ammonium hydroxide (14%) is then added by dropping to precipitate the ferrous ions into the BNC mesh. This last step allows forming in situ magnetite nanoparticles (Fe3O4) inside the bacterial nanocellulose mesh to confer magnetic properties to BNC pellicle. A toxicological assay was used to evaluate the biocompatibility of the BNC-IONP pellicle. Polyethylene glycol (PEG) was used to cover the IONPs in order to improve their biocompatibility. Scanning electron microscopy (SEM) images showed that the IONP were located preferentially in the fibril interlacing spaces of the BNC matrix, but some of them were also found along the BNC ribbons. Magnetic force microscope measurements performed on the MBNC detected the presence magnetic domains with high and weak intensity magnetic field, confirming the magnetic nature of the MBNC pellicle. Young's modulus values obtained in this work are also in a reasonable agreement with those reported for several blood vessels in previous studies.
C1 [Arias, Sandra L.; Allain, Jean Paul] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.
   [Shetty, Akshath R.; Allain, Jean Paul] Univ Illinois, Dept Nucl Plasma & Radiol Engn, Urbana, IL 61801 USA.
   [Senpan, Angana; Allain, Jean Paul] Univ Illinois, Micro & Nanotechnol Lab, Urbana, IL 61801 USA.
   [Echeverry-Rendon, Monica] Univ Antioquia, Program Study & Control Trop Dis PECET, Medellin, Antioquia, Colombia.
   [Reece, Lisa M.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.
   [Reece, Lisa M.] Univ Texas Med Branch, WHO Collaborating Ctr Vaccine Res Evaluat & Train, Galveston, TX 77555 USA.
   [Allain, Jean Paul] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA.
RP Allain, JP (reprint author), Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.; Allain, JP (reprint author), Univ Illinois, Dept Nucl Plasma & Radiol Engn, Urbana, IL 61801 USA.; Allain, JP (reprint author), Univ Illinois, Micro & Nanotechnol Lab, Urbana, IL 61801 USA.; Allain, JP (reprint author), Univ Illinois, Beckman Inst, Urbana, IL 61801 USA.
EM allain@illinois.edu
OI Allain, Jean Paul/0000-0003-1348-262X
FU Department of Defense [W81XWH-11-2-0067]
FX This work was funded by Department of Defense under contract No.
   W81XWH-11-2-0067
CR Azqueta A, 2013, ARCH TOXICOL, V87, P949, DOI 10.1007/s00204-013-1070-0
   Barud HS, 2015, J APPL PHYS, V117, DOI 10.1063/1.4917261
   Bodin A, 2007, BIOTECHNOL BIOENG, V97, P425, DOI 10.1002/bit.21314
   Cai Z, 2010, CELLULOSE, V17, P83, DOI 10.1007/s10570-009-9362-5
   Chan-Park MB, 2009, J BIOMED MATER RES A, V88A, P1104, DOI 10.1002/jbm.a.32318
   Fu LN, 2013, MAT SCI ENG C-MATER, V33, P2995, DOI 10.1016/j.msec.2013.03.026
   Illes E, 2015, J MAGN MAGN MATER, V380, P132, DOI 10.1016/j.jmmm.2014.10.146
   Karimi A, 2014, ARTERY RES, V8, P51, DOI 10.1016/j.artres.2014.02.001
   Martson M, 1999, BIOMATERIALS, V20, P1989, DOI 10.1016/S0142-9612(99)00094-0
   Olsson RT, 2010, NAT NANOTECHNOL, V5, P584, DOI [10.1038/NNANO.2010.155, 10.1038/nnano.2010.155]
   Saxena IM, 2013, PERSPECT NANOTECHNOL, P1
   Scherner M, 2014, J SURG RES, V189, P340, DOI 10.1016/j.jss.2014.02.011
   Torre B, 2011, SCI REP-UK, V1, DOI 10.1038/srep00202
   Torrisi V, 2014, BIOMACROMOLECULES, V15, P3171, DOI 10.1021/bm500832q
   Ulbricht J, 2014, BIOMATERIALS, V35, P4848, DOI 10.1016/j.biomaterials.2014.02.029
   Wu W, 2008, NANOSCALE RES LETT, V3, P397, DOI 10.1007/s11671-008-9174-9
   Zaborowska M, 2010, ACTA BIOMATER, V6, P2540, DOI 10.1016/j.actbio.2010.01.004
NR 17
TC 2
Z9 2
U1 3
U2 27
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD MAY
PY 2016
IS 111
AR e52951
DI 10.3791/52951
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DS0BJ
UT WOS:000380259900004
PM 27285589
OA Green Published
DA 2018-10-19
ER

PT J
AU Aires, MD
   Treter, J
   Braz, DC
   Krug, C
   Macedo, AJ
   Alves, C
AF Aires, Michelle de Medeiros
   Treter, Janine
   Braz, Danilo Cavalcante
   Krug, Cristiano
   Macedo, Alexandre Jose
   Alves Junior, Clodomiro
TI Influence of Oxynitrided Surface in the Production of a Less Susceptible
   Titanium Surface to Skin-Borne Bacterial Adhesion
SO ARTIFICIAL ORGANS
LA English
DT Article; Proceedings Paper
CT 12th International Conference on Pediatric Mechanical Circulatory
   Support Systems and Pediatric Cardiopulmonary Perfusion
CY MAY 18-21, 2016
CL Columbia Univ Med Ctr, New York Presbyterian, Vivian & Seymour Milstein
   Fa, New York, NY
HO Columbia Univ Med Ctr, New York Presbyterian, Vivian & Seymour Milstein Fa
DE Plasma; Staphylococcus epidermidis; Biofilm; Titanium
ID STAPHYLOCOCCAL ADHESION; COATINGS; BIOMATERIALS; INFECTIONS; TOPOGRAPHY;
   ROUGHNESS; BIOFILMS; BEHAVIOR
AB There is a growing quest for an ideal biomaterial that shows appropriate cellular response and is not susceptible to microbial adhesion. In this study, commercial grade II titanium was submitted to RF/DC plasma surface modification at 2.2 mbar, using gas mixtures of argon, nitrogen, and oxygen at proportions 4: 1: 2 and 4: 1: 3. The surfaces were physically and chemically characterized. In order to evaluate bacterial response, the surfaces were exposed to Staphylococcus epidermidis. Oxynitrided samples, although having a higher roughness as compared with untreated samples, exhibited lower bacterial growth. This observation is probably due to the formation of different crystalline phases of nitrides and oxides caused by plasma treatment. The surface with highest contact angle and highest surface tension showed lower bacterial adhesion. These results were confirmed by scanning electron microscopy. The role of nitrogen in reducing bacterial adhesion is clear when this material is compared with untreated titanium, on which only an oxide film is present.
C1 [Aires, Michelle de Medeiros; Braz, Danilo Cavalcante; Alves Junior, Clodomiro] Univ Fed Rio Grande do Norte, Lab Plasma, BR-59072970 Natal, RN, Brazil.
   [Treter, Janine; Macedo, Alexandre Jose] Univ Fed Rio Grande do Sul, Biofilms & Microbial Div Lab, Ctr Biotechnol, BR-90046900 Porto Alegre, RS, Brazil.
   [Treter, Janine; Macedo, Alexandre Jose] Univ Fed Rio Grande do Sul, Coll Pharm, BR-90046900 Porto Alegre, RS, Brazil.
   [Krug, Cristiano] Univ Fed Rio Grande do Sul, Inst Phys, BR-90046900 Porto Alegre, RS, Brazil.
RP Aires, MD (reprint author), Univ Fed Rio Grande do Norte, Lab Plasma, BR-59072970 Natal, RN, Brazil.
EM michellemaires@gmail.com
RI Alves Junior, Clodomiro/B-7578-2009
OI Alves Junior, Clodomiro/0000-0002-5547-5922
CR Antoci V, 2008, BIOMATERIALS, V29, P4684, DOI 10.1016/j.biomaterials.2008.08.016
   Araujo EA, 2010, QUIM NOVA, Vv, P1940
   BRIDGETT MJ, 1992, BIOMATERIALS, V13, P411, DOI 10.1016/0142-9612(92)90159-L
   Chandra J, 2005, APPL ENVIRON MICROB, V71, P8795, DOI 10.1128/AEM.71.12.8795-8801.2005
   Costa THC, 2008, MATERIA-BRAZIL, V13, P65, DOI 10.1590/S1517-70762008000100008
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008
   Deshmukh RR, 2003, MATER RES INNOV, V7, P283, DOI 10.1007/s10019-003-0265-z
   Gosheger G, 2004, BIOMATERIALS, V25, P5547, DOI 10.1016/j.biomaterials.2004.01.008
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Karunakaran E, 2011, APPL MICROBIOL BIOT, V90, P1869, DOI 10.1007/s00253-011-3293-4
   Kim WH, 2008, SURF INTERFACE ANAL, V40, P202, DOI 10.1002/sia.2809
   Koerner RJ, 2002, BIOMATERIALS, V23, P2835, DOI 10.1016/S0142-9612(01)00404-5
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Locatelli Claudete Inês, 2004, Arq. Bras. Oftalmol., V67, P241, DOI 10.1590/S0004-27492004000200011
   Lu X, 2004, BIOMATERIALS, V25, P1779, DOI 10.1016/j.biomaterials.2003.08.028
   Oner D, 2000, LANGMUIR, V16, P7777, DOI 10.1021/la000598o
   Otto Michael, 2009, NAT REV MICROBIOL, V7, P555
   Pascual A, 2002, CLIN MICROBIOL INFEC, V8, P256, DOI 10.1046/j.1469-0691.2002.00418.x
   Poortinga AT, 2001, BIOPHYS CHEM, V91, P273, DOI 10.1016/S0301-4622(01)00177-6
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Quirynen M, 1996, Int J Oral Maxillofac Implants, V11, P169
   Rino JP, 1999, PHYS REV B, V59, P6643, DOI 10.1103/PhysRevB.59.6643
   Sa JC, 2009, SURF COAT TECH, V203, P1765, DOI 10.1016/j.surfcoat.2008.12.017
   Sadiqali C, 2010, J APPL BIOMED, V8, P55
   SHIRKHANZADEH M, 1995, NANOSTRUCT MATER, V5, P33, DOI 10.1016/0965-9773(95)00006-Z
   Trentin DD, 2011, J ETHNOPHARMACOL, V137, P327, DOI 10.1016/j.jep.2011.05.030
   Treter J, 2011, SCI MICROBIAL PATHOG, V2, P693
   Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071
   Wall I, 2009, BONE, V45, P17, DOI 10.1016/j.bone.2009.03.662
   Whitehead KA, 2006, FOOD BIOPROD PROCESS, V84, P253, DOI 10.1205/fbp06035
   WHITEHEAD SA, 1995, J ORAL REHABIL, V22, P421, DOI 10.1111/j.1365-2842.1995.tb00795.x
   Windecker S, 2005, CIRCULATION, V111, P2617, DOI 10.1161/CIRCULASTIONAHA.104.486647
   Wu Y, 2011, BIOMATERIALS, V32, P951, DOI 10.1016/j.biomaterials.2010.10.001
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
NR 35
TC 4
Z9 4
U1 0
U2 6
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0160-564X
EI 1525-1594
J9 ARTIF ORGANS
JI Artif. Organs
PD MAY
PY 2016
VL 40
IS 5
BP 521
EP 526
DI 10.1111/aor.12581
PG 6
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA DP5MX
UT WOS:000378542800019
PM 26611366
DA 2018-10-19
ER

PT J
AU Maeda, NT
   Yoshimoto, M
   Allegrini, S
   Bressiani, AHD
AF Maeda, Nancy Tiaki
   Yoshimoto, Marcelo
   Allegrini Junior, Sergio
   de Almeida Bressiani, Ana Helena
TI Hydroxyapatite Dome for Bone Neoformation in Rabbit Tibia
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE bone neoformation; dome barrier; hydroxyapatite; osteoconduction
ID BETA-TRICALCIUM PHOSPHATE; FLUOROCHROME LABELS; SUBSTITUTES;
   REGENERATION; ALLOGRAFT; GRAFTS
AB Purpose: To evaluate supracortical bone neoformation with the use of hydroxyapatite (HA) hollow domes specially manufactured for osteogenesis promotion. Materials and Methods: Nine New Zealand rabbits were selected and 18 domes were placed, divided into three groups according to the iller: control (blood clot), vitamin complex, and particulate beta-tricalcium phosphate (beta-TCP). The healing period was 8 weeks, hence fluorescent markers were applied. After healing, the samples were embedded in resin to prepare slides for light and fluorescence microscopic evaluation of the amount of neoformed bone tissue. Energy dispersive spectroscopy was also used for chemical analysis of the material inside the domes. Results: The quality of neoformed bone tissue with active bone remodeling areas was observed. As a iller, beta-TCP showed higher bone formation (14.1%), better quality of neoformed bone tissue with organized structures, and an area of mineralized tissue in the dome. Bone neoformation inside the dome filled with blood clot confirmed the osteoconductive property of HA, as indicated by the migration of osteogenic cells from the blood clot, without the action of another biomaterial (mean area of bone formation for blood clot iller = 7.5%). Bone neoformation was not favored in samples filled with vitamin complex because of the difficulty of blood penetration through the material. Conclusion: HA domes performed well as a scaffold for bone neoformation over the cortical bone of rabbits, and this is based on maintenance of good stability and good integration with bone tissue. beta-TCP presented higher values of neoformed bone area compared with the blood clot. HA domes have osteoconductive properties, especially when filled with blood clot, because of the migration of osteogenic cells without action of any other biomaterial. In domes filled with vitamin complex, no bone formation was noted because of the absence of resorption.
C1 [Maeda, Nancy Tiaki] IPEN USP, Nucl & Energy Res Inst, Sao Paulo, SP, Brazil.
   [Yoshimoto, Marcelo; Allegrini Junior, Sergio] Univ Ibirapuera, Grad Masters Program Biodentistry, Sao Paulo, SP, Brazil.
   [Yoshimoto, Marcelo; Allegrini Junior, Sergio; de Almeida Bressiani, Ana Helena] IPEN USP, Nucl & Energy Res Inst, Dept Biomat, Sao Paulo, SP, Brazil.
RP Maeda, NT (reprint author), Av Prof Lineu Prestes,2242 Cidade Univ, BR-05508000 Sao Paulo, SP, Brazil.
EM nancymaeda@yahoo.com.br
RI Bressiani, Ana/I-1402-2012
CR Allegrini S, 2006, ANN ANAT, V188, P143, DOI 10.1016/j.aanat.2005.08.019
   Allegrini SJ, 2003, THESIS
   [Anonymous], 2009, 109935 ISO
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Beck TJ, 1997, THESIS
   BECKER W, 1994, J PERIODONTOL, V65, P1128, DOI 10.1902/jop.1994.65.12.1128
   Buser D, 2004, INT J ORAL MAX IMPL, V19, P43
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Horch HH, 2006, INT J ORAL MAX SURG, V35, P708, DOI 10.1016/j.ijom.2006.03.017
   ISO, 2012, ISO 10993 12 BIOL 12
   Jensen SS, 2009, INT J ORAL MAX IMPL, V24, P218
   Jensen SS, 2006, CLIN ORAL IMPLAN RES, V17, P237, DOI 10.1111/j.1600-0501.2005.01257.x
   KONIG JB, 2002, ANN ANAT, V184, P241
   LeGeros R Z, 1991, Monogr Oral Sci, V15, P1
   Lopes C. A. E, 2003, THESIS
   Maliska AM, 2013, SCANNING ELECT MICRO
   McAllister BS, 2007, J PERIODONTOL, V78, P377, DOI 10.1902/jop.2007.060048
   MELLONIG JT, 1992, J PERIODONTOL, V63, P979, DOI 10.1902/jop.1992.63.12.979
   NAGAHARA K, 1992, International Journal of Oral and Maxillofacial Implants, V7, P72
   Nasr HF, 1999, PERIODONTOL 2000, V19, P74, DOI 10.1111/j.1600-0757.1999.tb00148.x
   Nishimura I, 2004, CLIN ORAL IMPLAN RES, V15, P293, DOI 10.1111/j.1600-0501.2004.01001.x
   O'Brien FJ, 2002, J BIOMECH, V35, P523, DOI 10.1016/S0021-9290(01)00200-7
   Ribeiro C., 2003, THESIS
   Salles MB, 2007, THESIS
   Salles MB, 2001, THESIS
   Saska S, 2009, INT J ORAL MAX SURG, V38, P180, DOI 10.1016/j.ijom.2008.12.004
   Shermak MA, 1998, PLAST RECONSTR SURG, V102, P309, DOI 10.1097/00006534-199808000-00003
   Stevenson S, 1999, ORTHOP CLIN N AM, V30, P543, DOI 10.1016/S0030-5898(05)70107-3
   SUN TC, 1992, BONE, V13, P443, DOI 10.1016/8756-3282(92)90088-E
   van Gaalen SM, 2010, TISSUE ENG PART B-RE, V16, P209, DOI [10.1089/ten.teb.2009.0503, 10.1089/ten.TEB.2009.0503]
   Yoshimoto M, 2004, J ORAL MAXIL SURG, V62, P131, DOI 10.1016/j.joms.2004.03.011
   Zairopoulos GG, 2007, J PERIODONTOL, V78, P2216
   Zerbo IR, 2005, BIOMATERIALS, V26, P1445, DOI 10.1016/j.biomaterials.2004.05.003
   Zimmermann G, 2011, INJURY, V42, pS16, DOI 10.1016/j.injury.2011.06.199
NR 35
TC 0
Z9 0
U1 1
U2 5
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
EI 1942-4434
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD MAY-JUN
PY 2016
VL 31
IS 3
BP 571
EP 579
DI 10.11607/jomi.4412
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DP8JF
UT WOS:000378743600016
PM 27183066
OA Bronze
DA 2018-10-19
ER

PT J
AU Di Lorenzo, A
   Bloise, N
   Meneghini, S
   Sureda, A
   Tenore, GC
   Visai, L
   Arciola, CR
   Daglia, M
AF Di Lorenzo, Arianna
   Bloise, Nora
   Meneghini, Silvia
   Sureda, Antoni
   Tenore, Gian Carlo
   Visai, Livia
   Arciola, Carla Renata
   Daglia, Maria
TI Effect of Winemaking on the Composition of Red Wine as a Source of
   Polyphenols for Anti-Infective Biomaterials
SO MATERIALS
LA English
DT Article
DE red wine; winemaking process; metabolite profiling; polyphenols;
   anti-infective biomaterials
ID STREPTOCOCCUS-MUTANS; GALLIC ACID; ANTIBACTERIAL ACTIVITY; NATURAL
   ANTIOXIDANTS; PHENOLIC COMPOSITION; MICRO-OXYGENATION; ORAL
   STREPTOCOCCI; RESVERATROL; BIOFILM; GRAPES
AB Biomaterials releasing bactericides have currently become tools for thwarting medical device-associated infections. The ideal anti-infective biomaterial must counteract infection while safeguarding eukaryotic cell integrity. Red wine is a widely consumed beverage to which many biological properties are ascribed, including protective effects against oral infections and related bone (osteoarthritis, osteomyelitis, periprosthetic joint infections) and cardiovascular diseases. In this study, fifteen red wine samples derived from grapes native to the Oltrepo Pavese region (Italy), obtained from the winemaking processes of "Bonarda dell'Oltrepo Pavese" red wine, were analyzed alongside three samples obtained from marc pressing. Total polyphenol and monomeric anthocyanin contents were determined and metabolite profiling was conducted by means of a chromatographic analysis. Antibacterial activity of wine samples was evaluated against Streptococcus mutans, responsible for dental caries, Streptococcus salivarius, and Streptococcus pyogenes, two oral bacterial pathogens. Results highlighted the winemaking stages in which samples exhibit the highest content of polyphenols and the greatest antibacterial activity. Considering the global need for new weapons against bacterial infections and alternatives to conventional antibiotics, as well as the favorable bioactivities of polyphenols, results point to red wine as a source of antibacterial substances for developing new anti-infective biomaterials and coatings for biomedical devices.
C1 [Di Lorenzo, Arianna; Meneghini, Silvia; Daglia, Maria] Univ Pavia, Dept Drug Sci, Med Chem & Pharmaceut Technol Sect, Vle Taramelli 12, I-27100 Pavia, Italy.
   [Bloise, Nora; Visai, Livia] Univ Pavia, UdR INSTM, CHT, Dept Mol Med, Viale Taramelli 3-b, I-27100 Pavia, Italy.
   [Sureda, Antoni] Univ Balearic Isl, Res Grp Community Nutr & Oxidat Stress, E-07122 Palma De Mallorca, Balearic Island, Spain.
   [Sureda, Antoni] Univ Balearic Isl, CIBEROBN Physiopathol Obes & Nutr, E-07122 Palma De Mallorca, Balearic Island, Spain.
   [Tenore, Gian Carlo] Univ Naples Federico II, Dept Pharmaceut & Toxicol Chem, Via D Montesano 49, I-80131 Naples, Italy.
   [Visai, Livia] S Maugeri Fdn, IRCCS, Dept Occupat Med Toxicol & Environm Risks, Via S Boezio 28, I-27100 Pavia, Italy.
   [Arciola, Carla Renata] Rizzoli Orthopaed Inst, Res Unit Implant Infect, Via Barbiano 1-10, I-40136 Bologna, Italy.
   [Arciola, Carla Renata] Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, Via San Giacomo 14, I-40126 Bologna, Italy.
RP Daglia, M (reprint author), Univ Pavia, Dept Drug Sci, Med Chem & Pharmaceut Technol Sect, Vle Taramelli 12, I-27100 Pavia, Italy.; Arciola, CR (reprint author), Rizzoli Orthopaed Inst, Res Unit Implant Infect, Via Barbiano 1-10, I-40136 Bologna, Italy.; Arciola, CR (reprint author), Univ Bologna, Dept Expt Diagnost & Specialty Med DIMES, Via San Giacomo 14, I-40126 Bologna, Italy.
EM arianna.dilorenzo01@universitadipavia.it; nora.bloise@unipv.it;
   silvia.meneghini01@universitadipavia.it; tosugo@hotmail.com;
   gctenore@unina.it; livia.visai@unipv.it; carlarenata.arciola@ior.it;
   maria.daglia@unipv.it
RI Sureda Gomila, Antonio/L-7191-2014; Bloise, Nora/M-5699-2016
OI Sureda Gomila, Antonio/0000-0003-2101-616X; Bloise,
   Nora/0000-0002-6000-5036; Daglia, Maria/0000-0002-4870-7713; ,
   Antoni/0000-0001-8656-6838
FU project entitled "Esperienze di Riso e Vino nella terra dei Longobardi e
   dei Visconti" [11527-3/12/2014]; Spanish Ministry of Health, Social
   Services and Equality [CIBEROBN-CB12/03/30038]; "5 per mille" grants for
   Health Research
FX The research leading to these results has received funding from the
   project entitled "Esperienze di Riso e Vino nella terra dei Longobardi e
   dei Visconti" approved by Regione Lombardia (Dds n. 11527-3/12/2014).
   The authors would like to thank the vineyard "I Doria di Montalto"
   (Montalto Pavese, PV) and especially Daniele Manini for providing wine
   samples and giving us technical support for writing the Materials and
   Method Section, and Alessandra Leoni for the collection of wine samples.
   Antoni Sureda was supported by the Spanish Ministry of Health, Social
   Services and Equality (CIBEROBN-CB12/03/30038). Carla Renata Arciola
   acknowledges the financial contribution of "5 per mille" grants for
   Health Research to the Rizzoli Orthopedic Institute of Bologna.
CR Altiok D, 2010, J MATER SCI-MATER M, V21, P2227, DOI 10.1007/s10856-010-4065-x
   [Anonymous], 2009, M07A10 CLIN LAB STAN
   Baiano A., 2015, CRIT REV FOOD SCI NU
   Bandela V, 2015, J CLIN DIAGN RES, V9, pZE01, DOI 10.7860/JCDR/2015/14275.6874
   Baranac JM, 1997, J AGR FOOD CHEM, V45, P1694, DOI 10.1021/jf9606114
   da Silva ACB, 2008, BRAZ J MICROBIOL, V39, P648, DOI 10.1590/S1517-83822008000400009
   Borazan AA, 2013, FOOD CHEM, V138, P389, DOI 10.1016/j.foodchem.2012.10.099
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Carillo M., 2011, ELECTRON J BIOTECHN, V14, P7
   Castillo-Munoz N, 2007, J AGR FOOD CHEM, V55, P992, DOI 10.1021/jf062800k
   Choubey S, 2015, PHARM PAT ANAL, V4, P305, DOI [10.4155/PPA.15.14, 10.4155/ppa.15.14]
   Cote CD, 2015, NAT MED, V21, P498, DOI 10.1038/nm.3821
   Csiszar A, 2006, AM J PHYSIOL-HEART C, V291, pH1694, DOI 10.1152/ajpheart.00340.2006
   Daglia M, 2007, J AGR FOOD CHEM, V55, P5038, DOI 10.1021/jf070352q
   Daglia M, 2014, CURR PHARM BIOTECHNO, V15, P362, DOI 10.2174/138920101504140825120737
   Daglia M, 2012, CURR OPIN BIOTECH, V23, P174, DOI 10.1016/j.copbio.2011.08.007
   Moreira MD, 2011, J FOOD SCI, V76, pM54, DOI 10.1111/j.1750-3841.2010.01910.x
   Deng QA, 2011, J FOOD SCI, V76, pE309, DOI 10.1111/j.1750-3841.2011.02090.x
   Di Lorenzo A, 2016, MOL NUTR FOOD RES, V60, P566, DOI 10.1002/mnfr.201500567
   Duarte S, 2006, FEMS MICROBIOL LETT, V257, P50, DOI 10.1111/j.1574-6968.2006.00147.x
   Ehrlich GD, 2014, J APPL BIOMATER FUNC, V12, P13, DOI 10.5301/jabfm.5000203
   Escot S, 2001, AUST J GRAPE WINE R, V7, P153, DOI 10.1111/j.1755-0238.2001.tb00204.x
   Ferreira C, 2014, ANTIMICROB AGENTS CH, V58, P6197, DOI 10.1128/AAC.00093-14
   Frette XC, 2012, PLANTA MED, V78, P1281
   Ginjom IR, 2010, J AGR FOOD CHEM, V58, P10133, DOI 10.1021/jf100822n
   Giovinazzo G, 2015, PLANT FOOD HUM NUTR, V70, P454, DOI 10.1007/s11130-015-0518-1
   Gomez-Plaza E, 2011, FOOD CHEM, V125, P1131, DOI 10.1016/j.foodchem.2010.10.034
   Guo XF, 2012, MOLECULES, V17, P3794, DOI 10.3390/molecules17043794
   Haslam E, 1996, J NAT PROD, V59, P205, DOI 10.1021/np960040+
   Ivanova V, 2011, FOOD BIOPROCESS TECH, V4, P1512, DOI 10.1007/s11947-011-0566-y
   Cejudo-Bastante MJ, 2011, FOOD CHEM, V124, P727, DOI 10.1016/j.foodchem.2010.06.067
   KANNER J, 1994, J AGR FOOD CHEM, V42, P64, DOI 10.1021/jf00037a010
   Lachman J., 2009, INT J WINE RES, V101, P101
   Lagerweij MD, 2015, CURR ORAL HLTH REP, V2, P212
   Lee J, 2005, J AOAC INT, V88, P1269
   Leech MT, 2015, BEST PRACT RES CL RH, V29, P189, DOI 10.1016/j.berh.2015.03.001
   Leifert WR, 2008, NUTR RES, V28, P729, DOI 10.1016/j.nutres.2008.09.001
   Lemos JAC, 2005, CURR ISSUES MOL BIOL, V7, P95
   Leung E, 2011, B WORLD HEALTH ORGAN, V89, P390, DOI 10.2471/BLT.11.088435
   Lopez-Velez M, 2003, CRIT REV FOOD SCI, V43, P233, DOI 10.1080/10408690390826509
   Lupoae P, 2015, J OLEO SCI, V64, P1111, DOI 10.5650/jos.ess15023
   Malekinejad H, 2012, AVICENNA J PHYTOMEDI, V2, P188
   Marchese A, 2014, FOOD RES INT, V63, P182, DOI 10.1016/j.foodres.2014.01.036
   Mattivi F, 2002, ANN NY ACAD SCI, V957, P37, DOI 10.1111/j.1749-6632.2002.tb02904.x
   Mink PJ, 2007, AM J CLIN NUTR, V85, P895
   Moreno-Arribas MV, 2008, FOOD CHEM, V109, P149, DOI 10.1016/j.foodchem.2007.12.040
   Munoz-Gonzalez I, 2014, J AGR FOOD CHEM, V62, P4731, DOI 10.1021/jf501768p
   Nabavi SF, 2015, CURR MED CHEM, V22, P51
   Nabavi SF, 2015, CURR PHARM BIOTECHNO, V16, P891, DOI 10.2174/1389201016666150610160652
   Nabavi SF, 2015, NUTRIENTS, V7, P7729, DOI 10.3390/nu7095359
   Nabavi SM, 2015, FOOD CHEM, V173, P339, DOI 10.1016/j.foodchem.2014.10.042
   Nabavi SM, 2013, MOL CELL BIOCHEM, V372, P233, DOI 10.1007/s11010-012-1464-y
   Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011
   Percival RS, 2006, EUR J ORAL SCI, V114, P343, DOI 10.1111/j.1600-0722.2006.00386.x
   Pereira V, 2013, MOLECULES, V18, P2997, DOI 10.3390/molecules18032997
   Peroval C, 2002, J AGR FOOD CHEM, V50, P3977, DOI 10.1021/jf0116449
   Preserova J, 2015, J FOOD SCI TECH MYS, V52, P6405, DOI 10.1007/s13197-014-1644-8
   Ribereau-Gayon P., 1998, TRATTATO DI ENOLOGIA, VII
   Riihinen KR, 2014, FITOTERAPIA, V97, P78, DOI 10.1016/j.fitote.2014.05.012
   Sadat Sajadi Fatemeh, 2015, J Dent Res Dent Clin Dent Prospects, V9, P49, DOI 10.15171/joddd.2015.010
   Saini R, 2014, J FOOD SCI TECH MYS, V51, P3369, DOI 10.1007/s13197-012-0836-3
   SCALBERT A, 1991, PHYTOCHEMISTRY, V30, P3875, DOI 10.1016/0031-9422(91)83426-L
   Sileika TS, 2013, ANGEW CHEM INT EDIT, V52, P10766, DOI 10.1002/anie.201304922
   Soobrattee MA, 2006, BIOFACTORS, V27, P19, DOI 10.1002/biof.5520270103
   Vazquez ES, 2010, EUR FOOD RES TECHNOL, V231, P789, DOI 10.1007/s00217-010-1332-5
   Stauder M, 2010, J AGR FOOD CHEM, V58, P11662, DOI 10.1021/jf1031839
   Sun BS, 2011, J AGR FOOD CHEM, V59, P6550, DOI 10.1021/jf201383e
   van Loveren C, 2012, EUR J NUTR, V51, P15, DOI 10.1007/s00394-012-0323-7
   Zoellner H, 2011, SEMIN THROMB HEMOST, V37, P181, DOI 10.1055/s-0031-1273082
NR 69
TC 3
Z9 3
U1 3
U2 25
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAY
PY 2016
VL 9
IS 5
AR 316
DI 10.3390/ma9050316
PG 19
WC Materials Science, Multidisciplinary
SC Materials Science
GA DP6SG
UT WOS:000378628500011
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Edgar, L
   McNamara, K
   Wong, T
   Tamburrini, R
   Katari, R
   Orlando, G
AF Edgar, Lauren
   McNamara, Kyle
   Wong, Theresa
   Tamburrini, Riccardo
   Katari, Ravi
   Orlando, Giuseppe
TI Heterogeneity of Scaffold Biomaterials in Tissue Engineering
SO MATERIALS
LA English
DT Review
DE biomaterials; extracellular matrix scaffold; decellularized organs;
   natural polymer; synthetic polymer
ID MESENCHYMAL STEM-CELLS; REGENERATIVE MEDICINE APPROACH;
   GENTAMICIN-COLLAGEN SPONGE; HYALURONIC-ACID; BIOMEDICAL APPLICATIONS;
   CARTILAGE REGENERATION; ORGAN-TRANSPLANTATION; BIOLOGICAL-PROPERTIES;
   BONE REGENERATION; MATRIX SCAFFOLDS
AB Tissue engineering (TE) offers a potential solution for the shortage of transplantable organs and the need for novel methods of tissue repair. Methods of TE have advanced significantly in recent years, but there are challenges to using engineered tissues and organs including but not limited to: biocompatibility, immunogenicity, biodegradation, and toxicity. Analysis of biomaterials used as scaffolds may, however, elucidate how TE can be enhanced. Ideally, biomaterials should closely mimic the characteristics of desired organ, their function and their in vivo environments. A review of biomaterials used in TE highlighted natural polymers, synthetic polymers, and decellularized organs as sources of scaffolding. Studies of discarded organs supported that decellularization offers a remedy to reducing waste of donor organs, but does not yet provide an effective solution to organ demand because it has shown varied success in vivo depending on organ complexity and physiological requirements. Review of polymer-based scaffolds revealed that a composite scaffold formed by copolymerization is more effective than single polymer scaffolds because it allows copolymers to offset disadvantages a single polymer may possess. Selection of biomaterials for use in TE is essential for transplant success. There is not, however, a singular biomaterial that is universally optimal.
C1 [Edgar, Lauren; McNamara, Kyle; Wong, Theresa; Tamburrini, Riccardo; Katari, Ravi; Orlando, Giuseppe] Wake Forest Sch Med, 1 Med Ctr Blvd Winston Salem, Winston Salem, NC 27157 USA.
RP Orlando, G (reprint author), Wake Forest Sch Med, 1 Med Ctr Blvd Winston Salem, Winston Salem, NC 27157 USA.
EM laedgar@wakehealth.edu; kmcnamar@wakehealth.edu; twong@wakehealth.edu;
   rtamburr@wakehealth.edu; rkatari@wakehealth.edu; gorlando@wakehealth.edu
OI Edgar, Lauren/0000-0003-2923-7952; ORLANDO, GIUSEPPE/0000-0002-9584-6927
CR Ahn S, 2010, TISSUE ENG PART C-ME, V16, P813, DOI 10.1089/ten.tec.2009.0511
   Aladini F., 2016, J PEPT SCI
   Amiel GE, 2006, TISSUE ENG, V12, P2355, DOI 10.1089/ten.2006.12.2355
   Anisha BS, 2013, CARBOHYD POLYM, V92, P1470, DOI 10.1016/j.carbpol.2012.10.058
   Anitha A, 2009, CARBOHYD POLYM, V78, P672, DOI 10.1016/j.carbpol.2009.05.028
   Badylak SF, 2012, LANCET, V379, P943, DOI 10.1016/S0140-6736(12)60073-7
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Bao J, 2011, CELL TRANSPLANT, V20, P753, DOI 10.3727/096368910X536572
   Batchelder CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143849
   Bennett-Guerrero E, 2010, JAMA-J AM MED ASSOC, V304, P755, DOI 10.1001/jama.2010.1152
   Bhrany AD, 2006, TISSUE ENG, V12, P319, DOI 10.1089/ten.2006.12.319
   Bottcher-Haberzeth S, 2010, BURNS, V36, P450, DOI 10.1016/j.burns.2009.08.016
   Bogan S.L., 2016, J CELL BIOCH
   Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005
   Brown MB, 2005, J EUR ACAD DERMATOL, V19, P308, DOI 10.1111/j.1468-3083.2004.01180.x
   Caliari SR, 2011, BIOMATERIALS, V32, P8990, DOI 10.1016/j.biomaterials.2011.08.035
   Chahal S, 2015, RSC ADV, V5, P29497, DOI 10.1039/c4ra17087c
   Chen J, 2015, ACS APPL MATER INTER, V7, P28273, DOI 10.1021/acsami.5b10829
   Chen S, 2013, J MATER SCI, V48, P6567, DOI 10.1007/s10853-013-7453-z
   Chuang TH, 2009, TISSUE ENG PT A, V15, P2837, DOI [10.1089/ten.tea.2008.0394, 10.1089/ten.TEA.2008.0394]
   Claase MB, 2003, BIOMACROMOLECULES, V4, P57, DOI 10.1021/bm0256045
   Claase MB, 2003, J BIOMED MATER RES A, V64A, P291, DOI 10.1002/jbm.a.10418
   Connor RE, 2007, POLYM REV, V47, P9, DOI 10.1080/15583720601109552
   Cui L, 2009, BIOMATERIALS, V30, P2683, DOI 10.1016/j.biomaterials.2009.01.045
   Cullen LE, 2005, TREE PHYSIOL, V25, P563, DOI 10.1093/treephys/25.5.563
   Curran MP, 2010, DRUG AGING, V27, P925, DOI 10.2165/11205920-000000000-00000
   Dai WD, 2010, BIOMATERIALS, V31, P2141, DOI 10.1016/j.biomaterials.2009.11.070
   Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064
   Del Gaudio C, 2014, J BIOMED MATER RES A, V102, P2427, DOI 10.1002/jbm.a.34883
   Deng CM, 2007, CARBOHYD POLYM, V69, P583, DOI 10.1016/j.carbpol.2007.01.014
   Domingues R.M.A., 2016, ADV HEALTHC MAT
   dos Santos KSCR, 2006, INT J PHARMACEUT, V310, P37, DOI 10.1016/j.ijpharm.2005.11.019
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Durselen L, 2001, J BIOMED MATER RES, V58, P666, DOI 10.1002/jbm.1067
   Ekholm E, 2005, ACTA BIOMATER, V1, P535, DOI 10.1016/j.actbio.2005.05.003
   Entcheva E, 2004, BIOMATERIALS, V25, P5753, DOI 10.1016/j.biomaterials.2004.01.024
   Fan HB, 2006, BIOMATERIALS, V27, P4573, DOI 10.1016/j.biomaterials.2006.04.013
   Ferretti M, 2006, TISSUE ENG, V12, P2657, DOI 10.1089/ten.2006.12.2657
   Fishman JM, 2013, P NATL ACAD SCI USA, V110, P14360, DOI 10.1073/pnas.1213228110
   Fratzl P., 2008, STRUCTURE MECH
   Galler K M, 2011, Adv Dent Res, V23, P333, DOI 10.1177/0022034511405326
   Gifford S, 2015, REGEN MED, V10, P913, DOI 10.2217/rme.15.60
   Hou QP, 2004, J MATER CHEM, V14, P1915, DOI 10.1039/b401791a
   Hsieh FY, 2015, BIOMATERIALS, V71, P48, DOI 10.1016/j.biomaterials.2015.08.028
   Isogai N, 2005, J BIOMED MATER RES A, V74A, P408, DOI 10.1002/jbm.a.30343
   Jacobs IN, 2016, LARYNGOSCOPE, V126, pS5, DOI 10.1002/lary.25676
   Jastrzebska K, 2015, REP PRACT ONCOL RADI, V20, P87, DOI 10.1016/j.rpor.2014.11.010
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Kang HW, 2016, NAT BIOTECHNOL, V34, P312, DOI 10.1038/nbt.3413
   Katari R, 2014, NEPHRON EXP NEPHROL, V126, P119, DOI 10.1159/000360684
   Katari Ravi S, 2014, Adv Surg, V48, P137
   Kavanaugh TE, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-015-5654-5
   Keeley FW, 2002, PHILOS T R SOC B, V357, P185, DOI 10.1098/rstb.2001.1027
   Kew SJ, 2011, ACTA BIOMATER, V7, P3237, DOI 10.1016/j.actbio.2011.06.002
   Kim G, 2011, J MATER CHEM, V21, P6165, DOI 10.1039/c0jm03452e
   Kim J, 2008, INT J BIOL MACROMOL, V42, P41, DOI 10.1016/j.ijbiomac.2007.09.002
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   Kim KS, 2011, ACTA BIOMATER, V7, P666, DOI 10.1016/j.actbio.2010.09.030
   Kitahara H., 2016, INTERACT CARDIOVASC
   Kovalenko VI, 2010, RUSS CHEM REV+, V79, P231, DOI 10.1070/RC2010v079n03ABEH004065
   Kumar MS, 2010, J SURG RES, V158, P162, DOI 10.1016/j.jss.2008.07.006
   Kumbar SG, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/6/065005
   Kundu B, 2014, PROG POLYM SCI, V39, P251, DOI 10.1016/j.progpolymsci.2013.09.002
   Lai GJ, 2014, CARBOHYD POLYM, V111, P288, DOI 10.1016/j.carbpol.2014.04.094
   Hai LV, 2015, CELLULOSE, V22, P1789, DOI 10.1007/s10570-015-0633-z
   Leach JB, 2004, J BIOMED MATER RES A, V70A, P74, DOI 10.1002/jbm.a.30063
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Liao JF, 2014, J BIOMED NANOTECHNOL, V10, P3085, DOI 10.1166/jbn.2014.1934
   Liu XH, 2012, MACROMOL BIOSCI, V12, P911, DOI 10.1002/mabi.201100466
   Liu XH, 2011, NAT MATER, V10, P398, DOI [10.1038/NMAT2999, 10.1038/nmat2999]
   Lou T, 2013, INT J BIOL MACROMOL, V61, P353, DOI 10.1016/j.ijbiomac.2013.07.025
   Madhavan NK, 2010, BIORESOURCE TECHNOL, V101, P8493, DOI DOI 10.1016/J.BI0RTECH.2010.05.092
   Mahmood TA, 2006, J BIOMED MATER RES A, V79A, P216, DOI 10.1002/jbm.a.30830
   Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133
   Mazza G, 2015, SCI REP, V5
   Mendes SC, 2003, TISSUE ENG, V9, pS91, DOI 10.1089/10763270360697003
   Mirmalek-Sani A, 2013, BIOMATERIALS, V34, P5488
   Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7
   Muller FA, 2006, BIOMATERIALS, V27, P3955, DOI 10.1016/j.biomaterials.2006.02.031
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004
   Neves SC, 2011, BIOMATERIALS, V32, P1068, DOI 10.1016/j.biomaterials.2010.09.073
   Nichols JE, 2012, J CELL BIOCHEM, V113, P2185, DOI 10.1002/jcb.24112
   No HK, 2002, INT J FOOD MICROBIOL, V74, P65, DOI 10.1016/S0168-1605(01)00717-6
   Nukavarapu SP, 2008, BIOMACROMOLECULES, V9, P1818, DOI 10.1021/bm800031t
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   O'Neill JD, 2013, ANN THORAC SURG, V96, P1046, DOI 10.1016/j.athoracsur.2013.04.022
   Oerlemans AJM, 2014, REGEN MED, V9, P113, DOI [10.2217/RME.13.89, 10.2217/rme.13.89]
   Orabi H., 2013, SCI WORLD J, V2013
   Orlando G, 2013, ANN SURG, V258, P221, DOI 10.1097/SLA.0b013e31829c79cf
   Orlando G, 2013, BIOMATERIALS, V34, P5915, DOI 10.1016/j.biomaterials.2013.04.033
   Orlando G, 2013, GUT, V62, P774, DOI 10.1136/gutjnl-2011-301111
   Orlando G, 2012, ANN SURG, V255, P867, DOI 10.1097/SLA.0b013e318243a4db
   Orlando G, 2011, TRANSPLANTATION, V91, P1310, DOI 10.1097/TP.0b013e318219ebb5
   Orlando Giuseppe, 2011, Transpl Int, V24, P223, DOI 10.1111/j.1432-2277.2010.01182.x
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030
   Patterson J, 2010, BIOMATERIALS, V31, P6772, DOI 10.1016/j.biomaterials.2010.05.047
   Peloso A., 2015, ANN SURG
   Peloso A, 2015, TRANSPLANTATION, V99, P1807, DOI 10.1097/TP.0000000000000811
   Petrosyan A, 2015, CELLR4, V1, pe1401
   Polykandriotis E, 2010, J CELL MOL MED, V14, P2350, DOI 10.1111/j.1582-4934.2010.01169.x
   Rath S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141802
   Rhee SH, 2000, J MATER SCI-MATER M, V11, P449, DOI 10.1023/A:1008992009826
   Robertson MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090406
   Rolandi M, 2014, ADV COLLOID INTERFAC, V207, P216, DOI 10.1016/j.cis.2014.01.019
   Ryan AJ, 2015, BIOMATERIALS, V73, P296, DOI 10.1016/j.biomaterials.2015.09.003
   Saidi RF, 2012, WORLD J SURG, V36, P2909, DOI 10.1007/s00268-012-1748-0
   Salvatori M, 2015, XENOTRANSPLANTATION, V22, P1, DOI 10.1111/xen.12122
   Lopes MS, 2012, PROCEDIA ENGINEER, V42, P1402, DOI 10.1016/j.proeng.2012.07.534
   Scioli MG, 2016, J TISSUE ENG REGEN M
   Seeberger PH, 2003, CURR OPIN CHEM BIOL, V7, P715, DOI 10.1016/j.cbpa.2003.10.014
   Shin H, 2003, BIOMATERIALS, V24, P3201, DOI 10.1016/S0142-9612(03)00168-6
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   Singh N, 2016, NANOSCALE, V8, P8288, DOI 10.1039/c5nr06595j
   Smith MT, 2014, FEBS LETT, V588, P2755, DOI 10.1016/j.febslet.2014.05.062
   Song JJ, 2013, NAT MED, V19, P646, DOI 10.1038/nm.3154
   Soto-Gutierrez A, 2011, TISSUE ENG PART C-ME, V17, P677, DOI 10.1089/ten.tec.2010.0698
   Sreejalekshmi KG, 2011, J BIOMED MATER RES A, V96A, P477, DOI 10.1002/jbm.a.32980
   Steffens D, 2015, REGEN MED, V10, P975, DOI 10.2217/rme.15.58
   Sung HW, 1999, J BIOMED MATER RES, V46, P520
   Tan Aaron, 2013, Critical Reviews in Biomedical Engineering, V41, P495
   Tharanathan RN, 2003, CRIT REV FOOD SCI, V43, P61, DOI 10.1080/10408690390826455
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   Thurber AE, 2015, BIOMATERIALS, V71, P145, DOI 10.1016/j.biomaterials.2015.08.039
   Toh WS, 2012, BIOMATERIALS, V33, P3835, DOI 10.1016/j.biomaterials.2012.01.065
   Tokareva O, 2014, ACTA BIOMATER, V10, P1612, DOI 10.1016/j.actbio.2013.08.020
   Totonelli G, 2012, BIOMATERIALS, V33, P3401, DOI 10.1016/j.biomaterials.2012.01.012
   Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Vacanti CA, 2006, TISSUE ENG, V12, P1137, DOI 10.1089/ten.2006.12.1137
   Varga M, 2014, ARCH MED SCI, V10, P283, DOI 10.5114/aoms.2014.42580
   Veit G, 2006, J BIOL CHEM, V281, P3494, DOI 10.1074/jbc.M509333200
   Vellayappan MV, 2015, INT J NANOMED, V10, P2785, DOI 10.2147/IJN.S80121
   Visscher D.O., 2016, TISSUE ENG C
   Wan YZ, 2007, MAT SCI ENG C-BIO S, V27, P855, DOI 10.1016/j.msec.2006.10.002
   Weber FE, 2002, INT J ORAL MAX SURG, V31, P60, DOI 10.1054/ijom.2001.0154
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Xu YD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120244
   Yagi H, 2013, CELL TRANSPLANT, V22, P231, DOI 10.3727/096368912X654939
   Yahyaei H, 2016, MAT SCI ENG C-MATER, V61, P293, DOI 10.1016/j.msec.2015.12.048
   Zambon Joao Paulo, 2014, World J Nephrol, V3, P24, DOI 10.5527/wjn.v3.i3.24
   Zant E, 2016, ACTA BIOMATER, V31, P80, DOI 10.1016/j.actbio.2015.12.014
   Zhang KX, 2015, BIOMATERIALS, V71, P24, DOI 10.1016/j.biomaterials.2015.08.037
   Zhong SP, 2005, BIOMACROMOLECULES, V6, P2998, DOI 10.1021/bm050318p
   Zhou H, 2012, ACTA BIOMATER, V8, P1999, DOI 10.1016/j.actbio.2012.01.031
NR 148
TC 5
Z9 5
U1 3
U2 60
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAY
PY 2016
VL 9
IS 5
AR 332
DI 10.3390/ma9050332
PG 21
WC Materials Science, Multidisciplinary
SC Materials Science
GA DP6SG
UT WOS:000378628500027
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Gallo, J
   Panacek, A
   Prucek, R
   Kriegova, E
   Hradilova, S
   Hobza, M
   Holinka, M
AF Gallo, Jiri
   Panacek, Ales
   Prucek, Robert
   Kriegova, Eva
   Hradilova, Sarka
   Hobza, Martin
   Holinka, Martin
TI Silver Nanocoating Technology in the Prevention of Prosthetic Joint
   Infection
SO MATERIALS
LA English
DT Review
DE prosthetic joint infection; biomaterial-associated infection;
   anti-adhesive; anti-biofilm; antibacterial surface treatment; silver
   nanocoating; silver nanoparticles
ID ANTIBACTERIAL MULTILAYER FILMS; DOPED HYDROXYAPATITE COATINGS;
   ORTHOPEDIC BIOFILM INFECTIONS; SURGICAL SITE INFECTIONS; GRAM-NEGATIVE
   BACTERIA; IN-VITRO CYTOTOXICITY; HUMAN HEPATOMA-CELLS;
   PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI
AB Prosthetic joint infection (PJI) is a feared complication of total joint arthroplasty associated with increased morbidity and mortality. There is a growing body of evidence that bacterial colonization and biofilm formation are critical pathogenic events in PJI. Thus, the choice of biomaterials for implanted prostheses and their surface modifications may significantly influence the development of PJI. Currently, silver nanoparticle (AgNP) technology is receiving much interest in the field of orthopaedics for its antimicrobial properties and a strong anti-biofilm potential. The great advantage of AgNP surface modification is a minimal release of active substances into the surrounding tissue and a long period of effectiveness. As a result, a controlled release of AgNPs could ensure antibacterial protection throughout the life of the implant. Moreover, the antibacterial effect of AgNPs may be strengthened in combination with conventional antibiotics and other antimicrobial agents. Here, our main attention is devoted to general guidelines for the design of antibacterial biomaterials protected by AgNPs, its benefits, side effects and future perspectives in PJI prevention.
C1 [Gallo, Jiri; Hobza, Martin; Holinka, Martin] Palacky Univ, Fac Med & Dent, Dept Orthopaed, IP Pavlova 6, Olomouc 77900, Czech Republic.
   [Panacek, Ales; Prucek, Robert; Hradilova, Sarka] Palacky Univ, Reg Ctr Adv Technol & Mat, Slechtitelu 27, Olomouc 78371, Czech Republic.
   [Kriegova, Eva] Palacky Univ, Fac Med & Dent, Dept Immunol, Hnevotinska 3, Olomouc 77900, Czech Republic.
RP Gallo, J (reprint author), Palacky Univ, Fac Med & Dent, Dept Orthopaed, IP Pavlova 6, Olomouc 77900, Czech Republic.
EM jiri.gallo@volny.cz; ales.panacek@upol.cz; robert.prucek@upol.cz;
   eva.kriegova@email.cz; sarka.hradilova@upol.cz; martinhobza@gmail.com;
   mholinka@seznam.cz
OI Hobza, Martin/0000-0002-2208-6189; Holinka, Martin/0000-0001-9180-4458;
   Gallo, Jiri/0000-0002-7424-8653
FU Ministry of Health of the Czech Republic [AZV VES 15-27726A]
FX Funding was obtained from the Ministry of Health of the Czech Republic
   (AZV VES 15-27726A).
CR Afkhami F, 2015, J DENT, V43, P1573, DOI 10.1016/j.jdent.2015.08.012
   Agarwala M, 2014, J BIOMED MATER RES B, V102, P1223, DOI 10.1002/jbm.b.33106
   Aggarwal VK, 2014, J KNEE SURG, V27, P399, DOI 10.1055/s-0033-1364102
   Ahmed RA, 2014, APPL SURF SCI, V292, P390, DOI 10.1016/j.apsusc.2013.11.150
   Albers CE, 2013, NANOTOXICOLOGY, V7, P30, DOI 10.3109/17435390.2011.626538
   Perez-Diaz MA, 2015, MAT SCI ENG C-MATER, V55, P360, DOI 10.1016/j.msec.2015.05.036
   Albrecht MA, 2006, GREEN CHEM, V8, P417, DOI 10.1039/b517131h
   Albrekt AS, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-5
   Ali K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131178
   Alijanipour P, 2014, J KNEE SURG, V27, P251, DOI 10.1055/s-0034-1376332
   Ammons MCB, 2011, INT WOUND J, V8, P268, DOI 10.1111/j.1742-481X.2011.00781.x
   An YH, 1996, J HOSP INFECT, V33, P93, DOI 10.1016/S0195-6701(96)90094-8
   An YH, 1996, J ORTHOPAED RES, V14, P846, DOI 10.1002/jor.1100140526
   Ansari MA, 2014, J BASIC MICROB, V54, P688, DOI 10.1002/jobm.201300748
   Antoci V, 2007, CLIN ORTHOP RELAT R, P81, DOI 10.1097/BLO.0b013e3181123a50
   Antoci V, 2007, J ORTHOP RES, V25, P858, DOI 10.1002/jor.20348
   Antonelli M, 2012, J HOSP INFECT, V82, P101, DOI 10.1016/j.jhin.2012.07.010
   Arciola CR, 2015, ADV EXP MED BIOL, V830, P29, DOI 10.1007/978-3-319-11038-7_2
   Arora S, 2009, TOXICOL APPL PHARM, V236, P310, DOI 10.1016/j.taap.2009.02.020
   Asare N, 2012, TOXICOLOGY, V291, P65, DOI 10.1016/j.tox.2011.10.022
   AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w
   Funez AA, 2013, TOXICOL MECH METHOD, V23, P153, DOI 10.3109/15376516.2012.762081
   Bai L, 2015, APPL SURF SCI, V355, P32, DOI 10.1016/j.apsusc.2015.07.064
   Bai Y, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-015-5646-5
   Baker C, 2005, J NANOSCI NANOTECHNO, V5, P244, DOI 10.1166/jnn.2005.034
   Barros J, 2013, INT MICROBIOL, V16, P191, DOI 10.2436/20.1501.01.193
   Bedair H, 2015, CLIN ORTHOP RELAT R, V473, P2300, DOI 10.1007/s11999-015-4174-4
   Bellucci D, 2016, J BIOMED MATER RES A, V104, P1030, DOI 10.1002/jbm.a.35619
   Bemer P, 2014, J CLIN MICROBIOL, V52, P3583, DOI 10.1128/JCM.01459-14
   Benito N, 2014, J ORTHOP RES, V32, P633, DOI 10.1002/jor.22581
   Berend KR, 2013, CLIN ORTHOP RELAT R, V471, P510, DOI 10.1007/s11999-012-2595-x
   Bernthal NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012580
   Besinis A, 2014, NANOTOXICOLOGY, V8, P745, DOI 10.3109/17435390.2013.825343
   Birla SS, 2009, LETT APPL MICROBIOL, V48, P173, DOI 10.1111/j.1472-765X.2008.02510.x
   Bock RM, 2015, ACTA BIOMATER, V26, P318, DOI 10.1016/j.actbio.2015.08.014
   Braem A, 2015, COLLOID SURFACE B, V126, P481, DOI 10.1016/j.colsurfb.2014.12.054
   Brennan SA, 2015, BONE JOINT J, V97B, P582, DOI 10.1302/0301-620X.97B5.33336
   Brown AN, 2012, APPL ENVIRON MICROB, V78, P2768, DOI 10.1128/AEM.06513-11
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Busscher HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002440
   Cabiscol E, 2000, INT MICROBIOL, V3, P3, DOI DOI 10.2436/IM.V3I1.9235
   Campoccia D, 2012, INT J ARTIF ORGANS, V35, P800, DOI 10.5301/ijao.5000140
   Cao HL, 2011, BIOMATERIALS, V32, P693, DOI 10.1016/j.biomaterials.2010.09.066
   Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m
   Chagnot C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00303
   Chairuangkitti P, 2013, TOXICOL IN VITRO, V27, P330, DOI 10.1016/j.tiv.2012.08.021
   Chan ELK, 2015, CLIN COSMET INVESTIG, V7, P65, DOI 10.2147/CCIDE.S68874
   Chen CY, 2008, MATER LETT, V62, P3607, DOI 10.1016/j.matlet.2008.04.008
   Chen XN, 2012, EUR CELLS MATER, V24, P237, DOI 10.22203/eCM.v024a17
   Chen XY, 2013, SURF COAT TECH, V216, P158, DOI 10.1016/j.surfcoat.2012.11.049
   Chen Y, 2011, APPL ENVIRON MICROB, V77, P5065, DOI 10.1128/AEM.00502-11
   Cheng H, 2014, J BIOMED MATER RES A, V102, P3488, DOI 10.1002/jbm.a.35019
   Chennell P, 2013, INT J PHARMACEUT, V455, P298, DOI 10.1016/j.ijpharm.2013.07.014
   Choi O, 2008, ENVIRON SCI TECHNOL, V42, P4583, DOI 10.1021/es703238h
   Choi OY, 2010, WATER RES, V44, P6095, DOI 10.1016/j.watres.2010.06.069
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   Cipriano AF, 2014, J BIOMED NANOTECHNOL, V10, P2977, DOI 10.1166/jbn.2014.1927
   Corvec S, 2012, INT J ARTIF ORGANS, V35, P923, DOI 10.5301/ijao.5000168
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Costerton W, 2003, J CLIN INVEST, V112, P1466, DOI 10.1172/JCI200320365
   Cui L, 2013, ANAL CHEM, V85, P5436, DOI 10.1021/ac400245j
   De Angelis G, 2015, INFECTION, V43, P629, DOI 10.1007/s15010-015-0806-6
   De Giglio E, 2013, ANAL BIOANAL CHEM, V405, P805, DOI 10.1007/s00216-012-6293-z
   De Matteis V, 2015, NANOMED-NANOTECHNOL, V11, P731, DOI 10.1016/j.nano.2014.11.002
   Della Valle C, 2012, INT J ARTIF ORGANS, V35, P864, DOI 10.5301/ijao.5000161
   Dong W, 2013, J NANOSCI NANOTECHNO, V13, P6782, DOI 10.1166/jnn.2013.7757
   Drago L, 2014, CLIN ORTHOP RELAT R, V472, P3311, DOI 10.1007/s11999-014-3558-1
   Drake PL, 2005, ANN OCCUP HYG, V49, P575, DOI 10.1093/annhyg/mei019
   Durgalakshmi D, 2015, J NANOSCI NANOTECHNO, V15, P4285, DOI 10.1166/jnn.2015.9724
   Dziendzikowska K, 2012, J APPL TOXICOL, V32, P920, DOI 10.1002/jat.2758
   Ehrlich GD, 2005, CLIN ORTHOP RELAT R, P59, DOI 10.1097/01.blo.0000175125.60214.a4
   Eichenberger EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141436
   Elizabeth E, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/11/115101
   Nunez-Anita RE, 2014, INT J NANOMED, V9, P3999, DOI 10.2147/IJN.S63064
   Esfandiari N, 2014, J BIOMED MATER RES A, V102, P2625, DOI 10.1002/jbm.a.34934
   Eto S., 2015, J ARTHROPLAST
   Fabrega J, 2009, ENVIRON SCI TECHNOL, V43, P9004, DOI 10.1021/es901706j
   Fayaz AM, 2010, NANOMED-NANOTECHNOL, V6, P103, DOI 10.1016/j.nano.2009.04.006
   Filova E, 2015, INT J NANOMED, V10, P7145, DOI 10.2147/IJN.S87474
   Florschutz AV, 2015, J AM ACAD ORTHOP SUR, V23, pS8, DOI 10.5435/JAAOS-D-14-00447
   Follmann HDM, 2012, BIOMACROMOLECULES, V13, P3711, DOI 10.1021/bm3011962
   Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161
   Franci G, 2015, MOLECULES, V20, P8856, DOI 10.3390/molecules20058856
   Frankova J., 2016, J APPL BIOMATER FUNC
   Fu JH, 2006, J BIOMED MATER RES A, V79A, P665, DOI 10.1002/jbm.a.30819
   Fufa O, 2015, BIOINTERFACE RES APP, V5, P1011
   Funao H, 2016, SCI REP-UK, V6, DOI 10.1038/srep23238
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010
   Galandakova A., 2015, HUM EXP TOXICOL
   Gallo J, 2008, NEW MICROBIOL, V31, P97
   Gallo J, 2014, INT J MOL SCI, V15, P13849, DOI 10.3390/ijms150813849
   Gao A, 2014, BIOMATERIALS, V35, P4223, DOI 10.1016/j.biomaterials.2014.01.058
   Gardner AB, 2013, BIOMED RES INT, DOI 10.1155/2013/732182
   Garza-Ocanas L, 2010, METALLOMICS, V2, P204, DOI 10.1039/b916107d
   Gatin L, 2015, ORTHOP TRAUMATOL-SUR, V101, P851, DOI 10.1016/j.otsr.2015.08.007
   Getzlaf MA, 2016, J ORTHOP RES, V34, P177, DOI 10.1002/jor.23068
   Ghosh S, 2015, J NANOMATER, DOI 10.1155/2015/562938
   Ghosh S, 2012, INT J NANOMED, V7, P483, DOI 10.2147/IJN.S24793
   Glinel K, 2012, ACTA BIOMATER, V8, P1670, DOI 10.1016/j.actbio.2012.01.011
   Gottenbos B, 2003, BIOMATERIALS, V24, P2707, DOI 10.1016/S0142-9612(03)00083-8
   Grainger DW, 2013, BIOMATERIALS, V34, P9237, DOI 10.1016/j.biomaterials.2013.08.043
   GRISTINA AG, 1989, MED PROG TECHNOL, V14, P205
   Guimond-Lischer S, 2016, BIOINTERPHASES, V11, DOI 10.1116/1.4943225
   Gupta A, 1999, NAT MED, V5, P183, DOI 10.1038/5545
   HAEFELI C, 1984, J BACTERIOL, V158, P389
   Haenle M, 2011, J MATER SCI-MATER M, V22, P381, DOI 10.1007/s10856-010-4204-4
   Harrasser N, 2015, AMB EXPRESS, V5, DOI 10.1186/s13568-015-0162-z
   He T, 2010, J BIOMED MATER RES A, V95A, P454, DOI 10.1002/jbm.a.32872
   Hickok NJ, 2012, ADV DRUG DELIVER REV, V64, P1165, DOI 10.1016/j.addr.2012.03.015
   Higgins DM, 2009, AM J PATHOL, V175, P161, DOI 10.2353/ajpath.2009.080962
   Hizal F, 2015, ACS APPL MATER INTER, V7, P20304, DOI 10.1021/acsami.5b05947
   Hoene A., 2013, BIOMED MAT, V8
   Holinka J, 2013, BONE JOINT J, V95B, P678, DOI 10.1302/0301-620X.95B5.31216
   Holzapfel BM, 2013, ADV DRUG DELIVER REV, V65, P581, DOI 10.1016/j.addr.2012.07.009
   Hsiao IL, 2015, ENVIRON SCI TECHNOL, V49, P3813, DOI 10.1021/es504705p
   Hu H, 2012, ACTA BIOMATER, V8, P904, DOI 10.1016/j.actbio.2011.09.031
   Huang WJ, 2013, INT J BIOL MACROMOL, V53, P26, DOI 10.1016/j.ijbiomac.2012.10.024
   Humphreys H, 2012, J HOSP INFECT, V81, P71, DOI 10.1016/j.jhin.2012.03.007
   Huotari K, 2015, ACTA ORTHOP, V86, P321, DOI 10.3109/17453674.2015.1035173
   Hussain S.M., 2004, P 13 INT WORKSH IN V, P975
   Hwang IS, 2012, J MED MICROBIOL, V61, P1719, DOI 10.1099/jmm.0.047100-0
   Illingworth Kenneth David, 2013, J Bone Joint Surg Am, V95, pe50, DOI 10.2106/JBJS.L.00596
   Ionita D, 2011, J BIOSCI BIOENG, V112, P630, DOI 10.1016/j.jbiosc.2011.07.022
   Ivanova EP, 2010, LANGMUIR, V26, P1973, DOI 10.1021/la902623c
   Jaiswal S, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-014-5367-1
   Johansson H, 2013, TOXICOL IN VITRO, V27, P1163, DOI 10.1016/j.tiv.2012.05.019
   Johansson H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-399
   Kamath AF, 2015, J ARTHROPLASTY, V30, P1492, DOI 10.1016/j.arth.2015.03.035
   Kapadia BH, 2016, LANCET, V387, P386, DOI 10.1016/S0140-6736(14)61798-0
   Kasemets K, 2014, TOXICOL LETT, V229, pS193, DOI 10.1016/j.toxlet.2014.06.657
   Kawata K, 2009, ENVIRON SCI TECHNOL, V43, P6046, DOI 10.1021/es900754q
   Keller L, 2015, MATERIALS, V8, P6863, DOI 10.3390/ma8105342
   Ketabchi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092080
   Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001
   Kim S, 2009, TOXICOL IN VITRO, V23, P1076, DOI 10.1016/j.tiv.2009.06.001
   Knetsch MLW, 2011, POLYMERS-BASEL, V3, P340, DOI 10.3390/polym3010340
   Koseki H, 2013, INT J NANOMED, V8, P593, DOI 10.2147/IJN.S39201
   Kremer AN, 2012, J CLIN MICROBIOL, V50, P3249, DOI 10.1128/JCM.00885-12
   Kurtz SM, 2012, J ARTHROPLASTY, V27, P61, DOI 10.1016/j.arth.2012.02.022
   Kvitek L, 2008, J PHYS CHEM C, V112, P5825, DOI 10.1021/jp711616v
   Kwon HB, 2009, ANN DERMATOL, V21, P308, DOI 10.5021/ad.2009.21.3.308
   Lara HH, 2010, WORLD J MICROB BIOT, V26, P615, DOI 10.1007/s11274-009-0211-3
   Laverty G, 2013, FUTURE MICROBIOL, V8, P509, DOI [10.2217/FMB.13.7, 10.2217/fmb.13.7]
   Lemcke Johannes, 2012, Acta Neurochir Suppl, V114, P347, DOI 10.1007/978-3-7091-0956-4_67
   Lemire JA, 2013, NAT REV MICROBIOL, V11, P371, DOI 10.1038/nrmicro3028
   LewisOscar F, 2015, BIOFOULING, V31, P379, DOI 10.1080/08927014.2015.1048686
   Li BY, 2011, CLIN ORTHOP RELAT R, V469, P3262, DOI 10.1007/s11999-010-1690-0
   Li P, 2005, NANOTECHNOLOGY, V16, P1912, DOI 10.1088/0957-4484/16/9/082
   Li WR, 2011, BIOMETALS, V24, P135, DOI 10.1007/s10534-010-9381-6
   Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5
   Li XZ, 1997, J BACTERIOL, V179, P6127, DOI 10.1128/jb.179.19.6127-6132.1997
   Lindgren V, 2014, INFECT CONT HOSP EP, V35, P1491, DOI 10.1086/678600
   Liu JY, 2010, ACS NANO, V4, P6903, DOI 10.1021/nn102272n
   Liu W, 2010, NANOTOXICOLOGY, V4, P319, DOI 10.3109/17435390.2010.483745
   Liu Y., 2016, ACS NANO
   Liu YS, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/17/175501
   Loeschner K, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-18
   Lok CN, 2006, J PROTEOME RES, V5, P916, DOI 10.1021/pr0504079
   Ludecke C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084837
   Ma Z., 2015, INT ORTHOP
   Maoz G, 2015, CLIN ORTHOP RELAT R, V473, P453, DOI 10.1007/s11999-014-3780-x
   Markowska K, 2014, J MED MICROBIOL, V63, P849, DOI 10.1099/jmm.0.068833-0
   Martinez-Castanon GA, 2008, J NANOPART RES, V10, P1343, DOI 10.1007/s11051-008-9428-6
   Mastronardi E, 2014, SENSORS-BASEL, V14, P3156, DOI 10.3390/s140203156
   Mayr M, 2009, AM J KIDNEY DIS, V53, P890, DOI 10.1053/j.ajkd.2008.08.028
   McHugh SM, 2015, SURG-J R COLL SURG E, V13, P52, DOI 10.1016/j.surge.2014.10.003
   McMurray CL, 2015, J MED MICROBIOL, V64, P1489, DOI 10.1099/jmm.0.000182
   Mei SL, 2014, BIOMATERIALS, V35, P4255, DOI 10.1016/j.biomaterials.2014.02.005
   Mejia E, 2015, AORN J, V101, P213, DOI 10.1016/j.aorn.2014.03.017
   Min J, 2014, BIOMATERIALS, V35, P2507, DOI 10.1016/j.biomaterials.2013.12.009
   Mohanty S, 2012, NANOMED-NANOTECHNOL, V8, P916, DOI 10.1016/j.nano.2011.11.007
   Molleman B, 2015, LANGMUIR, V31, P13361, DOI 10.1021/acs.langmuir.5b03686
   Muhsin TM, 2014, WORLD J MICROB BIOT, V30, P2081, DOI 10.1007/s11274-014-1634-z
   Mukherjee SG, 2012, TOXICOL IN VITRO, V26, P238, DOI 10.1016/j.tiv.2011.12.004
   Muszanska AK, 2014, BIOMACROMOLECULES, V15, P2019, DOI 10.1021/bm500168s
   Naqvi SZH, 2013, INT J NANOMED, V8, DOI 10.2147/IJN.S49284
   Navratilova Z, 2012, TISSUE ANTIGENS, V80, P444, DOI 10.1111/tan.12001
   Necula BS, 2012, ACTA BIOMATER, V8, P4191, DOI 10.1016/j.actbio.2012.07.005
   Neoh KG, 2011, ACS APPL MATER INTER, V3, P2808, DOI 10.1021/am200646t
   Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2
   Nishitani K, 2015, J ORTHOP RES, V33, P1311, DOI 10.1002/jor.22907
   Norowski PA, 2011, IMPLANT DENT, V20, P56, DOI 10.1097/ID.0b013e3182087ac4
   Pajarinen J, 2014, J MATER CHEM B, V2, P7094, DOI [10.1039/c4tb01005a, 10.1039/C4TB01005A]
   Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06
   Palanisamy NK, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-2
   Panacek A., 2015, MOLECULES, V21
   Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h
   Panacek A, 2016, COLLOID SURFACE B, V142, P392, DOI 10.1016/j.colsurfb.2016.03.007
   Panacek A, 2013, COLLOID SURFACE B, V110, P191, DOI 10.1016/j.colsurfb.2013.04.031
   Pandit V, 2013, TISSUE ENG PT A, V19, P2452, DOI [10.1089/ten.tea.2012.0644, 10.1089/ten.TEA.2012.0644]
   Park EJ, 2010, TOXICOL IN VITRO, V24, P872, DOI 10.1016/j.tiv.2009.12.001
   Park MVDZ, 2011, BIOMATERIALS, V32, P9810, DOI 10.1016/j.biomaterials.2011.08.085
   Parvizi J, 2007, EXPERT REV MED DEVIC, V4, P55, DOI 10.1586/17434440.4.1.55
   Pauksch L, 2014, ACTA BIOMATER, V10, P439, DOI 10.1016/j.actbio.2013.09.037
   Peulen TO, 2011, ENVIRON SCI TECHNOL, V45, P3367, DOI 10.1021/es103450g
   Poncin-Epaillard F, 2013, MAT SCI ENG C-MATER, V33, P1152, DOI 10.1016/j.msec.2012.12.020
   Potara M, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/13/135101
   Qin H, 2014, BIOMATERIALS, V35, P9114, DOI 10.1016/j.biomaterials.2014.07.040
   Rajiv S, 2015, INT FORUM ALLERGY RH, V5, P283, DOI 10.1002/alr.21459
   Rapsch K, 2014, BIOCONJUGATE CHEM, V25, P308, DOI 10.1021/bc4004469
   Ratner B. D., 2013, BIOMATERIALS SCI INT, P259
   Ratner B. D., 2013, BIOMATERIALS SCI INT, P588
   Renoud P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039367
   Rezapoor M, 2015, J ARTHROPLASTY, V30, P902, DOI 10.1016/j.arth.2015.02.044
   Richtera L, 2015, MATERIALS, V8, P2994, DOI 10.3390/ma8062994
   Rizzello L, 2014, CHEM SOC REV, V43, P1501, DOI 10.1039/c3cs60218d
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Rodriguez-Cano A, 2014, SURF COAT TECH, V245, P66, DOI 10.1016/j.surfcoat.2014.02.041
   Rodriguez-Valencia C, 2013, J BIOMED MATER RES A, V101, P853, DOI 10.1002/jbm.a.34387
   Romano CL, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-015-0294-5
   Ruden S, 2009, ANTIMICROB AGENTS CH, V53, P3538, DOI 10.1128/AAC.01106-08
   Rujanapun N, 2015, TOXICOL IN VITRO, V29, P1982, DOI 10.1016/j.tiv.2015.08.005
   Saidin S, 2013, MAT SCI ENG C-MATER, V33, P4715, DOI 10.1016/j.msec.2013.07.026
   Saleh NB, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00677
   Sambale F., 2015, J NANOMATER
   Sathiyanarayanan G, 2013, COLLOID SURFACE B, V102, P13, DOI 10.1016/j.colsurfb.2012.07.032
   Scavone M, 2016, MATERIALS, V9, DOI 10.3390/ma9010037
   Scherr TD, 2014, METHODS MOL BIOL, V1106, P173, DOI 10.1007/978-1-62703-736-5_16
   Schlinkert P, 2015, J NANOBIOTECHNOL, V13, DOI 10.1186/s12951-014-0062-4
   Secinti KD, 2011, J CLIN NEUROSCI, V18, P391, DOI 10.1016/j.jocn.2010.06.022
   Shahbazzadeh D, 2011, IRAN J FISH SCI, V10, P487
   Shahverdi AR, 2007, NANOMED-NANOTECHNOL, V3, P168, DOI 10.1016/j.nano.2007.02.001
   Sharma VK, 2009, ADV COLLOID INTERFAC, V145, P83, DOI 10.1016/j.cis.2008.09.002
   Shchukin D, 2013, SCIENCE, V341, P1458, DOI 10.1126/science.1242895
   Shchukin DG, 2007, SMALL, V3, P926, DOI 10.1002/smll.200700064
   Shi YY, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-015-5634-9
   Shida T, 2013, INT J NANOMED, V8, P3955, DOI 10.2147/IJN.S51994
   Silver S, 2003, FEMS MICROBIOL REV, V27, P341, DOI 10.1016/S0168-6445(03)00047-0
   Silver S, 2006, J IND MICROBIOL BIOT, V33, P627, DOI 10.1007/s10295-006-0139-7
   Singh AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025029
   Singh R, 2013, INT J NANOMED, V8, P4277, DOI 10.2147/IJN.S48913
   Smekalova M, 2016, VET J, V209, P174, DOI 10.1016/j.tvjl.2015.10.032
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Spaan AN, 2013, ANNU REV MICROBIOL, V67, P629, DOI 10.1146/annurev-micro-092412-155746
   Stallard CP, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0031-0
   Stoehr LC, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-36
   Stoodley P., 2013, BIOMATERIALS SCI INT, P565
   Stoodley P, 2011, CURR ORTHOP PRACT, V22, P558, DOI 10.1097/BCO.0b013e318230efcf
   Sussman EM, 2015, J APPL TOXICOL, V35, P631, DOI 10.1002/jat.3104
   Taglietti A, 2014, BIOMATERIALS, V35, P1779, DOI 10.1016/j.biomaterials.2013.11.047
   Tan HL, 2013, INT J MOL SCI, V14, P1854, DOI 10.3390/ijms14011854
   Tande AJ, 2014, CLIN MICROBIOL REV, V27, P302, DOI 10.1128/CMR.00111-13
   Taraszkiewicz A, 2013, BIOMED RES INT, DOI 10.1155/2013/150653
   Thallinger B, 2013, BIOTECHNOL J, V8, P97, DOI 10.1002/biot.201200313
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Thomas R, 2015, J PHOTOCH PHOTOBIO B, V149, P68, DOI 10.1016/j.jphotobiol.2015.04.034
   Thornley Patrick, 2015, CMAJ Open, V3, pE338, DOI 10.9778/cmajo.20150012
   Tian B, 2016, J MECH BEHAV BIOMED, V61, P345, DOI 10.1016/j.jmbbm.2016.04.002
   Tian XH, 2013, INT J NANOMED, V8, P2129, DOI [10.2147/IJN.S47488, 10.2147/IJN.S45742]
   Tran Phong A, 2011, Int J Nanomedicine, V6, P1553, DOI 10.2147/IJN.S21729
   Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071
   Tsaras G, 2012, INFECT CONT HOSP EP, V33, P1207, DOI 10.1086/668421
   Tsuchiya H, 2012, J ORTHOP SCI, V17, P595, DOI 10.1007/s00776-012-0247-3
   Unosson E, 2015, ACTA BIOMATER, V11, P503, DOI 10.1016/j.actbio.2014.09.048
   van der Zande M, 2012, ACS NANO, V6, P7427, DOI 10.1021/nn302649p
   Vertelov GK, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/35/355707
   Vidlak D., 2016, INFECT IMMUN
   Voigt J, 2015, ANTIMICROB AGENTS CH, V59, P6696, DOI 10.1128/AAC.01331-15
   Wafa H, 2015, BONE JOINT J, V97B, P252, DOI 10.1302/0301-620X.97B2.34554
   Walter MS, 2014, DENT MATER, V30, P200, DOI 10.1016/j.dental.2013.11.006
   Wang JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082745
   Webster TJ, 2012, ACTA BIOMATER, V8, P4447, DOI 10.1016/j.actbio.2012.07.038
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Witso E, 2015, ACTA ORTHOP, V86, P277, DOI 10.3109/17453674.2015.1042320
   Wong CL, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00094
   Wu DM, 2014, J ENDODONT, V40, P285, DOI 10.1016/j.joen.2013.08.022
   Xie CM, 2014, ACS APPL MATER INTER, V6, P8580, DOI 10.1021/am501428e
   Xu HY, 2012, BIOMETALS, V25, P45, DOI 10.1007/s10534-011-9482-x
   Yang H, 2009, J APPL TOXICOL, V29, P69, DOI 10.1002/jat.1385
   Yazici H, 2016, ACS APPL MATER INTER, V8, P5070, DOI 10.1021/acsami.5b03697
   Yilmaz C, 2013, J BONE JOINT SURG AM, V95A, P117, DOI 10.2106/JBJS.K.01135
   Yu Q, 2015, ACTA BIOMATER, V16, P1, DOI 10.1016/j.actbio.2015.01.018
   Yu Q, 2013, ACS APPL MATER INTER, V5, P9295, DOI 10.1021/am4022279
   Yue C, 2015, EUR CELLS MATER, V29, P303, DOI 10.22203/eCM.v029a23
   Yue CX, 2015, J BIOMED MATER RES A, V103, P3590, DOI 10.1002/jbm.a.35502
   Yue CX, 2014, BIOMATERIALS, V35, P2580, DOI 10.1016/j.biomaterials.2013.12.036
   Zaborowska M., 2014, J BIOMED MAT RES B
   Zan XJ, 2010, BIOMACROMOLECULES, V11, P1082, DOI 10.1021/bm100048q
   Zhang M, 2016, ACS APPL MATER INTER, V8, P8834, DOI 10.1021/acsami.6b01396
   Zhang TL, 2014, YONSEI MED J, V55, P283, DOI 10.3349/ymj.2014.55.2.283
   Zhang XM, 2013, MAT SCI ENG C-MATER, V33, P2816, DOI 10.1016/j.msec.2013.03.010
   Zhao CJ, 2013, APPL SURF SCI, V280, P8, DOI 10.1016/j.apsusc.2013.04.057
   Zhao C, 2013, LANGMUIR, V29, P1517, DOI 10.1021/la304511s
   Zheng D, 2013, J COLLOID INTERF SCI, V406, P238, DOI 10.1016/j.jcis.2013.05.060
   Zhong X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146957
   Zhou B, 2014, COLLOID SURFACE B, V116, P432, DOI 10.1016/j.colsurfb.2014.01.016
   Zhou XD, 2015, GENE, V563, P76, DOI 10.1016/j.gene.2015.03.005
   Zhu H, 2014, CHEM COMMUN, V50, P3900, DOI 10.1039/c3cc47818a
   Zhu Y, 2015, J HOSP INFECT, V89, P82, DOI 10.1016/j.jhin.2014.10.008
   Zimmerli W, 2011, SEMIN IMMUNOPATHOL, V33, P295, DOI 10.1007/s00281-011-0275-7
   Zou J, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/s12951-014-0052-6
NR 291
TC 9
Z9 9
U1 4
U2 60
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAY
PY 2016
VL 9
IS 5
AR UNSP 337
DI 10.3390/ma9050337
PG 30
WC Materials Science, Multidisciplinary
SC Materials Science
GA DP6SG
UT WOS:000378628500032
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Pfeifer, CG
   Berner, A
   Koch, M
   Krutsch, W
   Kujat, R
   Angele, P
   Nerlich, M
   Zellner, J
AF Pfeifer, Christian G.
   Berner, Arne
   Koch, Matthias
   Krutsch, Werner
   Kujat, Richard
   Angele, Peter
   Nerlich, Michael
   Zellner, Johannes
TI Higher Ratios of Hyaluronic Acid Enhance Chondrogenic Differentiation of
   Human MSCs in a Hyaluronic Acid-Gelatin Composite Scaffold
SO MATERIALS
LA English
DT Article
DE composite scaffold; hyaluronic acid; gelatin; chondrogenesis; human
   mesenchymal stem cells
ID MESENCHYMAL STEM-CELLS; AUTOLOGOUS CHONDROCYTE IMPLANTATION;
   ARTICULAR-CARTILAGE REPAIR; PORE-SIZE; TISSUE; MATRIX; KNEE;
   TRANSPLANTATION; HYDROGELS; DEFECTS
AB Mesenchymal stem cells (MSCs) seeded on specific carrier materials are a promising source for the repair of traumatic cartilage injuries. The best supportive carrier material has not yet been determined. As natural components of cartilage's extracellular matrix, hyaluronic acid and collagen are the focus of biomaterial research. In order to optimize chondrogenic support, we investigated three different scaffold compositions of a hyaluronic acid (HA)-gelatin based biomaterial. Methods: Human MSCs (hMSCs) were seeded under vacuum on composite scaffolds of three different HA-gelatin ratios and cultured in chondrogenic medium for 21 days. Cell-scaffold constructs were assessed at different time points for cell viability, gene expression patterns, production of cartilage-specific extracellular matrix (ECM) and for (immuno-) histological appearance. The intrinsic transforming growth factor beta (TGF-beta) uptake of empty scaffolds was evaluated by determination of the TGF-beta concentrations in the medium over time. Results: No significant differences were found for cell seeding densities and cell viability. hMSCs seeded on scaffolds with higher ratios of HA showed better cartilage-like differentiation in all evaluated parameters. TGF-beta uptake did not differ between empty scaffolds. Conclusion: Higher ratios of HA support the chondrogenic differentiation of hMSCs seeded on a HA-gelatin composite scaffold.
C1 [Pfeifer, Christian G.; Berner, Arne; Koch, Matthias; Krutsch, Werner; Kujat, Richard; Angele, Peter; Nerlich, Michael; Zellner, Johannes] Univ Med CentreRegensburg, Dept Trauma Surg, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany.
   [Angele, Peter] Straubing Regensburg, Sporthopaedicum, Hildegard von Bingen Str 1, D-93053 Regensburg, Germany.
RP Pfeifer, CG (reprint author), Univ Med CentreRegensburg, Dept Trauma Surg, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany.
EM christian.pfeifer@ukr.de; arne.berner@ukr.de; matthias.koch@ukr.de;
   werner.krutsch@ukr.de; richard.kujat@ukr.de;
   peter.angele@sporthopaedicum.de; michael.nerlich@ukr.de;
   johannes.zellner@ukr.de
FU Clinic and Policlinic for Trauma Surgery, University Medical Center
   Regensburg
FX We want to highly acknowledge technical support of Daniela Drenkard.
   This study was funded by intramural funding of the Clinic and Policlinic
   for Trauma Surgery, University Medical Center Regensburg.
CR Al-Munajjed AA, 2008, J MATER SCI-MATER M, V19, P2859, DOI 10.1007/s10856-008-3422-5
   Angele P, 1999, TISSUE ENG, V5, P545, DOI 10.1089/ten.1999.5.545
   Angele P, 2008, J BIOMED MATER RES A, V85A, P445, DOI 10.1002/jbm.a.31480
   Angele P, 2009, J BIOMED MATER RES A, V91A, P416, DOI 10.1002/jbm.a.32236
   Basad E, 2010, KNEE SURG SPORT TR A, V18, P519, DOI 10.1007/s00167-009-1028-1
   BENEDETTI L, 1993, BIOMATERIALS, V14, P1154, DOI 10.1016/0142-9612(93)90160-4
   Bergemann C., 2015, INT J BIOMATER, V2015
   Bian LM, 2013, P NATL ACAD SCI USA, V110, P10117, DOI 10.1073/pnas.1214100110
   Bosserhoff AK, 2003, BIOMATERIALS, V24, P3229, DOI 10.1016/S0142-9612(03)00184-4
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Dienstknecht T, 2010, B EXP BIOL MED+, V150, P157, DOI 10.1007/s10517-010-1092-z
   Erickson IE, 2009, OSTEOARTHR CARTILAGE, V17, P1639, DOI 10.1016/j.joca.2009.07.003
   Erickson IE, 2012, ACTA BIOMATER, V8, P3027, DOI 10.1016/j.actbio.2012.04.033
   Filardo G, 2013, ARTHROSCOPY, V29, P174, DOI 10.1016/j.arthro.2012.05.891
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   Harris JD, 2011, OSTEOARTHR CARTILAGE, V19, P779, DOI 10.1016/j.joca.2011.02.010
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Johnstone B, 2013, EUR CELLS MATER, V25, P248, DOI 10.22203/eCM.v025a18
   Kim IL, 2015, TISSUE ENG PT A, V21, P2680, DOI 10.1089/ten.tea.2015.0150
   Kim IL, 2011, BIOMATERIALS, V32, P8771, DOI 10.1016/j.biomaterials.2011.08.073
   KUJAWA MJ, 1986, DEV BIOL, V114, P504, DOI 10.1016/0012-1606(86)90214-9
   Lisignoli G, 2006, J BIOMED MATER RES A, V77A, P497, DOI 10.1002/jbm.a.30632
   Matsiko A, 2015, TISSUE ENG PT A, V21, P486, DOI [10.1089/ten.tea.2013.0545, 10.1089/ten.TEA.2013.0545]
   Mithoefer K, 2009, AM J SPORT MED, V37, P2053, DOI 10.1177/0363546508328414
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   Mueller MB, 2008, ARTHRITIS RHEUM-US, V58, P1377, DOI 10.1002/art.23370
   Nejadnik H, 2010, AM J SPORT MED, V38, P1110, DOI 10.1177/0363546509359067
   Niemeyer P, 2008, AM J SPORT MED, V36, P2091, DOI 10.1177/0363546508322131
   Nuernberger S, 2011, BIOMATERIALS, V32, P1032, DOI 10.1016/j.biomaterials.2010.08.100
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Peterson L, 2003, J BONE JOINT SURG AM, V85A, P17, DOI 10.2106/00004623-200300002-00003
   Pietschmann MF, 2012, AM J SPORT MED, V40, P68, DOI 10.1177/0363546511424396
   Rutjes AWS, 2012, ANN INTERN MED, V157, P180, DOI 10.7326/0003-4819-157-3-201208070-00473
   Zellner J, 2015, ORTHOP RES REV, V7, P149, DOI 10.2147/ORR.S65569
   Zellner J, 2013, J BIOMED MATER RES B, V101, P1133, DOI 10.1002/jbm.b.32922
   Zellner J, 2010, J BIOMED MATER RES A, V94A, P1150, DOI 10.1002/jbm.a.32796
   Zhu H, 2006, STEM CELLS, V24, P928, DOI 10.1634/stemcells.2005-0186
NR 39
TC 5
Z9 5
U1 2
U2 8
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAY
PY 2016
VL 9
IS 5
AR 381
DI 10.3390/ma9050381
PG 15
WC Materials Science, Multidisciplinary
SC Materials Science
GA DP6SG
UT WOS:000378628500076
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Rokosz, K
   Hryniewicz, T
   Matysek, D
   Raaen, S
   Valicek, J
   Dudek, L
   Harnicarova, M
AF Rokosz, Krzysztof
   Hryniewicz, Tadeusz
   Matysek, Dalibor
   Raaen, Steinar
   Valicek, Jan
   Dudek, Lukasz
   Harnicarova, Marta
TI SEM, EDS and XPS Analysis of the Coatings Obtained on Titanium after
   Plasma Electrolytic Oxidation in Electrolytes Containing Copper Nitrate
SO MATERIALS
LA English
DT Article
DE titanium; plasma electrolytic oxidation (PEO); micro arc oxidation
   (MAO); copper nitrate; Scanning Electron Microscopy (SEM); Energy
   Dispersive X-ray Spectroscopy (EDS); X-ray Photoelectron Spectroscopy
   (XPS)
ID HIGH-CURRENT-DENSITY; MICRO-ARC OXIDATION; PURE TITANIUM;
   CORROSION-RESISTANCE; SURFACE MODIFICATION; STAINLESS-STEEL; SS
   BIOMATERIAL; ANTIBACTERIAL; CU; LAYERS
AB In the paper, the Scanning Electron Microscopy (SEM) with Energy Dispersive X-ray Spectroscopy (EDS) and X-ray Photoelectron Spectroscopy (XPS) results of the surface layer formed on pure titanium after plasma electrolytic oxidation (micro arc oxidation) at the voltage of 450 V are shown. As an electrolyte, the mixture of copper nitrate Cu(NO3)(2) (10-600 g/L) in concentrated phosphoric acid H3PO4 (98 g/mol) was used. The thickness of the obtained porous surface layer equals about 10 mu m, and it consists mainly of titanium phosphates and oxygen with embedded copper ions as a bactericidal agent. The maximum percent of copper in the PEO surface layer was equal to 12.2 +/- 0.7 wt % (7.6 +/- 0.5 at %), which is the best result that the authors obtained. The top surface layer of all obtained plasma electrolytic oxidation (PEO) coatings consisted most likely mainly of Ti-3(PO4)(4)center dot nH(3)PO(4) and Cu-3(PO4)(2)center dot nH(3)PO(4) with a small addition of CuP2, CuO and Cu2O.
C1 [Rokosz, Krzysztof; Hryniewicz, Tadeusz; Dudek, Lukasz] Koszalin Univ Technol, Fac Mech Engn, Div Surface Electrochem & Technol, Raclawicka 15-17, PL-75620 Koszalin, Poland.
   [Matysek, Dalibor] Koszalin Univ Technol, Fac Mech Engn, Div Surface Electrochem & Technol, Raclawicka 15-17, PL-75620 Koszalin, Poland.
   [Raaen, Steinar] VSB Tech Univ Ostrava, Fac Min & Geol, Inst Geol Engn, Ostrava 70833, Czech Republic.
   [Valicek, Jan; Harnicarova, Marta] Norwegian Univ Sci & Technol NTNU, Dept Phys, Realfagbygget E3-124,Hogskoleringen 5, NO-7491 Trondheim, Norway.
   [Valicek, Jan] VSB Tech Univ Ostrava, Fac Min & Geol, Inst Phys, Ostrava 70833, Czech Republic.
   [Valicek, Jan] VSB Tech Univ Ostrava, Fac Min & Geol, Inst Clean Technol Min & Utilizat Raw Mat Energy, Ostrava 70833, Czech Republic.
   VSB Tech Univ Ostrava, Fac Met & Mat Engn, Reg Mat Sci & Technol Ctr, Ostrava 70833, Czech Republic.
RP Hryniewicz, T (reprint author), Koszalin Univ Technol, Fac Mech Engn, Div Surface Electrochem & Technol, PL-75620 Koszalin, Poland.
EM rokosz@tu.koszalin.pl; Tadeusz.Hryniewicz@tu.koszalin.pl;
   dalibor.matysek@vsb.cz; steinar.raaen@ntnu.no; jan.valicek@vsb.cz;
   Lukasz.Dudek@tu.koszalin.pl; marta.harnicarova@vsb.cz
RI Dudek, Lukasz/R-3274-2016; Matysek, Dalibor/N-1737-2018
OI Matysek, Dalibor/0000-0002-1412-1079
FU Student Grant Competition (SGC) project [SP2016/94]; project of
   Institute of Clean Technologies for Mining and Utilization of Raw
   Materials for Energy Use [LO1406]; project Regional Materials Science
   and Technology Centre (RMTVC) [LO1203]
FX The plasma electrolytic oxidation (PEO) experiments on CP titanium Grade
   2 were performed at the Division of Surface Electrochemistry and
   Technology, Koszalin University of Technology, Poland. SEM and EDS were
   done at Vysoka skola banska-Technicka Univerzita Ostrava (VSB-TUO),
   Czech Republic; the research was elaborated partly in the framework of
   the project of Institute of Clean Technologies for Mining and
   Utilization of Raw Materials for Energy Use, Registration Number LO1406,
   the project Regional Materials Science and Technology Centre (RMTVC) No.
   LO1203 and Student Grant Competition (SGC) project SP2016/94. XPS
   studies were performed in the Department of Physics, Norges
   teknisk-naturvitenskapelige universitet (NTNU) Trondheim, Norway.
CR Aliasghari S, 2014, APPL SURF SCI, V316, P463, DOI 10.1016/j.apsusc.2014.08.037
   Baszkiewicz J, 2005, VACUUM, V78, P143, DOI 10.1016/j.vacuum.2005.01.017
   Biesinger MC, 2010, APPL SURF SCI, V257, P887, DOI 10.1016/j.apsusc.2010.07.086
   Hempel F, 2014, SURF COAT TECH, V256, P52, DOI 10.1016/j.surfcoat.2014.01.027
   Hryniewicz T, 2007, T I MET FINISH, V85, P325, DOI 10.1179/174591907X246537
   Hryniewicz T, 2012, APPL SURF SCI, V263, P357, DOI 10.1016/j.apsusc.2012.09.060
   Hryniewicz T, 2010, SURF COAT TECH, V204, P2583, DOI 10.1016/j.surfcoat.2010.02.005
   Hryniewicz T, 2015, MATERIALS, V8, P205, DOI 10.3390/ma8010205
   Hryniewicz T, 2014, FRONT MATER, DOI 10.3389/fmats.2014.00003
   Hryniewicz T, 2014, ANTI-CORROS METHOD M, V61, P57, DOI 10.1108/ACMM-03-2013-1249
   Hryniewicz T, 2012, MATER LETT, V83, P69, DOI 10.1016/j.matlet.2012.06.010
   Jelinek M, 2013, MAT SCI ENG C-MATER, V33, P1242, DOI 10.1016/j.msec.2012.12.018
   Krupa D, 2010, SURF COAT TECH, V205, P1743, DOI 10.1016/j.surfcoat.2010.05.015
   Laurindo CAH, 2014, MAT SCI ENG C-MATER, V37, P223, DOI 10.1016/j.msec.2014.01.006
   Mishra G, 2013, J ENVIRON CHEM ENG, V1, P1124, DOI 10.1016/j.jece.2013.08.031
   Park TE, 2013, SURF COAT TECH, V235, P706, DOI 10.1016/j.surfcoat.2013.08.051
   Rajendran A, 2014, RSC ADV, V4, P61444, DOI 10.1039/c4ra13107j
   Rokosz K., 2016, WORLD SCI NEWS, V35, P44
   Rokosz K, 2015, TEH VJESN, V22, P415, DOI 10.17559/TV-20140722110711
   Rokosz K, 2015, SURF INTERFACE ANAL, V47, P87, DOI 10.1002/sia.5676
   Rokosz K, 2014, TEH VJESN, V21, P799
   Rokosz K, 2014, TEH VJESN, V21, P533
   Rudnev VS, 2015, SURF COAT TECH, V269, P23, DOI 10.1016/j.surfcoat.2015.01.073
   Shin KR, 2011, J ALLOY COMPD, V509, pS478, DOI 10.1016/j.jallcom.2011.02.056
   Shin KR, 2010, MATER LETT, V64, P2714, DOI 10.1016/j.matlet.2010.08.069
   Simka W, 2013, ELECTROCHIM ACTA, V104, P518, DOI 10.1016/j.electacta.2012.10.130
   Simka W, 2011, ELECTROCHIM ACTA, V56, P8962, DOI 10.1016/j.electacta.2011.07.129
   Simka W, 2011, PRZEM CHEM, V90, P84
   Sowa M, 2013, ELECTROCHIM ACTA, V114, P627, DOI 10.1016/j.electacta.2013.10.047
   STATSOFT INC, 2011, STATISTICA DAT AN SO
   Stojadinovic S, 2013, APPL SURF SCI, V265, P226, DOI 10.1016/j.apsusc.2012.10.183
   Stojadinovic S, 2011, SURF COAT TECH, V206, P575, DOI 10.1016/j.surfcoat.2011.07.090
   Teker D, 2015, MAT SCI ENG C-MATER, V48, P579, DOI 10.1016/j.msec.2014.12.058
   Trujillo NA, 2012, MAT SCI ENG C-MATER, V32, P2135, DOI 10.1016/j.msec.2012.05.012
   Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071
   Wagner C.D., NIST XRAY PHOTOELECT
   Yao XH, 2014, APPL SURF SCI, V292, P944, DOI 10.1016/j.apsusc.2013.12.083
   Yu S, 2011, T NONFERR METAL SOC, V21, P573, DOI 10.1016/S1003-6326(11)60753-X
   Zhang W, 2008, APPL SURF SCI, V254, P5216, DOI 10.1016/j.apsusc.2008.02.047
   Zhang XY, 2012, APPL SURF SCI, V258, P10058, DOI 10.1016/j.apsusc.2012.06.074
   Zhu W, 2013, J MATER SCI TECHNOL, V29, P237, DOI 10.1016/j.jmst.2012.12.015
NR 41
TC 18
Z9 18
U1 4
U2 60
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAY
PY 2016
VL 9
IS 5
AR 318
DI 10.3390/ma9050318
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA DP6SG
UT WOS:000378628500013
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Ravindranathan, S
   Koppolu, BP
   Smith, SG
   Zaharoff, DA
AF Ravindranathan, Sruthi
   Koppolu, Bhanu Prasanth
   Smith, Sean G.
   Zaharoff, David A.
TI Effect of Chitosan Properties on Immunoreactivity
SO MARINE DRUGS
LA English
DT Article
DE chitosan; immunoreactivity; endotoxin; immune response
ID ORAL INSULIN DELIVERY; DENDRITIC CELLS; DRUG-DELIVERY; MEDIATED
   STIMULATION; DEACETYLATED CHITIN; MACROPHAGE FUNCTION; ACTIVATION;
   DERIVATIVES; SCAFFOLDS; BIOCOMPATIBILITY
AB Chitosan is a widely investigated biopolymer in drug and gene delivery, tissue engineering and vaccine development. However, the immune response to chitosan is not clearly understood due to contradicting results in literature regarding its immunoreactivity. Thus, in this study, we analyzed effects of various biochemical properties, namely degree of deacetylation (DDA), viscosity/polymer length and endotoxin levels, on immune responses by antigen presenting cells (APCs). Chitosan solutions from various sources were treated with mouse and human APCs (macrophages and/or dendritic cells) and the amount of tumor necrosis factor- (TNF-) released by the cells was used as an indicator of immunoreactivity. Our results indicate that only endotoxin content and not DDA or viscosity influenced chitosan-induced immune responses. Our data also indicate that low endotoxin chitosan (<0.01 EU/mg) ranging from 20 to 600 cP and 80% to 97% DDA is essentially inert. This study emphasizes the need for more complete characterization and purification of chitosan in preclinical studies in order for this valuable biomaterial to achieve widespread clinical application.
C1 [Ravindranathan, Sruthi; Koppolu, Bhanu Prasanth; Smith, Sean G.; Zaharoff, David A.] Univ Arkansas, Dept Biomed Engn, Fayetteville, AR 72701 USA.
RP Zaharoff, DA (reprint author), Univ Arkansas, Dept Biomed Engn, Fayetteville, AR 72701 USA.
EM ravindra@uark.edu; bkoppolu@uark.edu; sgs004@uark.edu; zaharoff@uark.edu
OI Ravindranathan, Sruthi/0000-0003-0451-7931
FU NCI NIH HHS [K22 CA131567, R15 CA176648, R01 CA172631]
CR Agnihotri SA, 2004, J CONTROL RELEASE, V100, P5, DOI 10.1016/j.jconrel.2004.08.010
   Al Rubeaan K, 2016, EXPERT OPIN DRUG DEL, V13, P223, DOI 10.1517/17425247.2016.1107543
   Azab AK, 2007, J BIOMED MATER RES A, V83A, P414, DOI 10.1002/jbm.a.31256
   Bao HQ, 2011, SMALL, V7, P1569, DOI 10.1002/smll.201100191
   Barbosa JN, 2010, J BIOMED MATER RES A, V93A, P20, DOI 10.1002/jbm.a.32499
   Bhardwaj N, 2012, BIOMATERIALS, V33, P2848, DOI 10.1016/j.biomaterials.2011.12.028
   Bueter CL, 2011, J BIOL CHEM, V286, P35447, DOI 10.1074/jbc.M111.274936
   Casettari L, 2014, J CONTROL RELEASE, V190, P189, DOI 10.1016/j.jconrel.2014.05.003
   Charernsriwilaiwat N, 2012, INT J PHARMACEUT, V427, P379, DOI 10.1016/j.ijpharm.2012.02.010
   Chen CL, 2008, BIOMATERIALS, V29, P2173, DOI 10.1016/j.biomaterials.2008.01.023
   Dai TH, 2011, EXPERT REV ANTI-INFE, V9, P857, DOI [10.1586/eri.11.59, 10.1586/ERI.11.59]
   Dang QF, 2016, CARBOHYD POLYM, V136, P516, DOI 10.1016/j.carbpol.2015.09.084
   Dang YB, 2011, CARBOHYD POLYM, V83, P1075, DOI 10.1016/j.carbpol.2010.08.071
   Feng J, 2004, BIOCHEM BIOPH RES CO, V317, P414, DOI 10.1016/j.bbrc.2004.03.048
   Gan Q, 2007, COLLOID SURFACE B, V59, P24, DOI 10.1016/j.colsurfb.2007.04.009
   Han YP, 2005, INT IMMUNOPHARMACOL, V5, P1533, DOI 10.1016/j.intimp.2005.04.015
   INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693
   Jana S, 2012, J MATER CHEM, V22, P6291, DOI [10.1039/C2JM16676C, 10.1039/c2jm16676c]
   Koppolu BP, 2014, BIOMATERIALS, V35, P4382, DOI 10.1016/j.biomaterials.2014.01.078
   Koppolu B, 2013, BIOMATERIALS, V34, P2359, DOI 10.1016/j.biomaterials.2012.11.066
   Kumar M, 2002, HUM GENE THER, V13, P1415, DOI 10.1089/10430340260185058
   Kweon DK, 2003, BIOMATERIALS, V24, P1595, DOI 10.1016/S0142-9612(02)00566-5
   Levengood SKL, 2014, J MATER CHEM B, V2, P3161, DOI 10.1039/c4tb00027g
   Lieder R, 2013, ACTA BIOMATER, V9, P4771, DOI 10.1016/j.actbio.2012.08.043
   Lih E, 2012, ACTA BIOMATER, V8, P3261, DOI 10.1016/j.actbio.2012.05.001
   Lu HD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084703
   Luo YC, 2014, INT J BIOL MACROMOL, V64, P353, DOI 10.1016/j.ijbiomac.2013.12.017
   Mao SR, 2004, INT J PHARM, V281, P45, DOI 10.1016/j.ijpharm.2004.05.019
   Mehrotra A, 2011, CHEM PHARM BULL, V59, P315, DOI 10.1248/cpb.59.315
   MORRISON DC, 1978, AM J PATHOL, V93, P526
   Moura LIF, 2014, ACTA BIOMATER, V10, P843, DOI 10.1016/j.actbio.2013.09.040
   Mukhopadhyay P, 2014, CARBOHYD POLYM, V112, P627, DOI 10.1016/j.carbpol.2014.06.045
   Nettles DL, 2002, TISSUE ENG, V8, P1009, DOI 10.1089/107632702320934100
   NISHIMURA K, 1986, VACCINE, V4, P151, DOI 10.1016/0264-410X(86)90002-2
   NISHIMURA K, 1987, VACCINE, V5, P136, DOI 10.1016/0264-410X(87)90061-2
   Park JH, 2010, ADV DRUG DELIVER REV, V62, P28, DOI 10.1016/j.addr.2009.10.003
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   Raftery R, 2013, MOLECULES, V18, P5611, DOI 10.3390/molecules18055611
   Risbud MV, 2000, J CONTROL RELEASE, V68, P23, DOI 10.1016/S0168-3659(00)00208-X
   Riva R, 2011, ADV POLYM SCI, V244, P19, DOI 10.1007/12_2011_137
   Ruel-Gariepy E, 2002, J CONTROL RELEASE, V82, P373, DOI 10.1016/S0168-3659(02)00146-3
   Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555
   Smith SG, 2015, CANCER IMMUNOL IMMUN, V64, P689, DOI 10.1007/s00262-015-1672-x
   SUZUKI K, 1984, MICROBIOL IMMUNOL, V28, P903, DOI 10.1111/j.1348-0421.1984.tb00746.x
   van der Lubben IM, 2001, EUR J PHARM SCI, V14, P201, DOI 10.1016/S0928-0987(01)00172-5
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Vasiliev YM, 2015, EXPERT REV VACCINES, V14, P37, DOI 10.1586/14760584.2015.956729
   Villiers C, 2009, MOL CELL PROTEOMICS, V8, P1252, DOI 10.1074/mcp.M800589-MCP200
   Vo JL, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.968001
   Wang BL, 2012, CARBOHYD POLYM, V90, P8, DOI 10.1016/j.carbpol.2012.03.080
   Yao WJ, 2013, MOL PHARMACEUT, V10, P2904, DOI 10.1021/mp4000053
   Yuan YL, 2011, MATERIALS, V4, P1399, DOI 10.3390/ma4081399
NR 52
TC 8
Z9 8
U1 1
U2 11
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1660-3397
J9 MAR DRUGS
JI Mar. Drugs
PD MAY
PY 2016
VL 14
IS 5
AR 91
DI 10.3390/md14050091
PG 12
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA DO7RV
UT WOS:000377981400010
PM 27187416
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Kadakia, PU
   Jain, E
   Hixon, KR
   Eberlin, CT
   Sell, SA
AF Kadakia, P. U.
   Jain, E.
   Hixon, K. R.
   Eberlin, C. T.
   Sell, S. A.
TI Sonication induced silk fibroin cryogels for tissue engineering
   applications
SO MATERIALS RESEARCH EXPRESS
LA English
DT Article
DE cryogel; silk fibroin; ultrasonication; tissue engineering; scaffold
ID BIOCOMPOSITE CRYOGELS; SCAFFOLDS; PROTEIN; BIOMATERIAL; TRANSITION;
   ULTRASOUND; MORPHOLOGY; BEHAVIOR; GELATION
AB In this study, we report a method to form macroporous silk fibroin (SF) scaffolds through a combination of ultrasonication followed by cryogelation at subzero temperatures. The resultant sonication induced SF cryogels encompassed larger pore sizes (151 +/- 56 mu m) and higher mechanical stability (127.15 +/- 24.71 kPa) than their hydrogel counterparts made at room temperature. Furthermore, the addition of dopants like Manuka honey and bone char in SF cryogels did not affect cryogel synthesis but decreased the pore size in a concentration dependent manner. With no crack propagation at 50% strain and promising stability under cyclic loads, mineralization and cellular infiltration potential were analyzed for bone tissue engineering purposes. Although the scaffolds showed limited mineralization, encouraging cellular infiltration results yield promise for other tissue engineering applications. The use of mild processing conditions, a simplistic procedure, and the lack of organic solvents or chemical cross-linkers renders the combination of sonication and cryogelation as an attractive fabrication technique for 3D SF macroporous scaffolds.
C1 [Kadakia, P. U.; Jain, E.; Hixon, K. R.; Eberlin, C. T.; Sell, S. A.] St Louis Univ, Dept Biomed Engn, St Louis, MO 63103 USA.
RP Sell, SA (reprint author), St Louis Univ, Dept Biomed Engn, St Louis, MO 63103 USA.
EM ssell@slu.edu
OI Hixon, Katherine/0000-0002-3094-5537
CR Ak F, 2013, BIOMACROMOLECULES, V14, P719, DOI 10.1021/bm3018033
   Bardelang D, 2008, J AM CHEM SOC, V130, P3313, DOI 10.1021/ja711342y
   Barthes J, 2014, BIOMED RES INT, DOI 10.1155/2014/921905
   Chen X, 2007, PROTEINS, V68, P223, DOI 10.1002/prot.21414
   Dragan ES, 2015, METHODS MOL BIOL, V1286, P239, DOI 10.1007/978-1-4939-2447-9_20
   Giesche H, 2006, PART PART SYST CHAR, V23, P9, DOI 10.1002/ppsc.200601009
   ISHIDA M, 1990, MACROMOLECULES, V23, P88, DOI 10.1021/ma00203a017
   Jain E, 2013, NAT PROTOC, V8, P821, DOI 10.1038/nprot.2013.027
   Jiang P, 2006, MATER LETT, V60, P919, DOI 10.1016/j.matlet.2005.10.056
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kathuria N, 2009, ACTA BIOMATER, V5, P406, DOI 10.1016/j.actbio.2008.07.009
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   Kim U J, 2005, BIOMATERIALS, V26, P2775, DOI DOI 10.1016/J.BIOMATERIALS.2004.07.044
   Kumar A, 2010, MATER TODAY, V13, P42, DOI 10.1016/S1369-7021(10)70202-9
   Kundu B, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/5/055003
   Kwon SM, 2009, J NANOSCI NANOTECHNO, V9, P7204, DOI 10.1166/jnn.2009.1616
   Li MZ, 2002, POLYM ADVAN TECHNOL, V13, P605, DOI 10.1002/pat.159
   Li MZ, 2001, J APPL POLYM SCI, V79, P2192, DOI 10.1002/1097-4628(20010321)79:12<2192::AID-APP1027>3.0.CO;2-0
   Lozinsky VI, 2001, BIOSEPARATION, V10, P163, DOI 10.1023/A:1016386902611
   Lu Q, 2011, ACTA BIOMATER, V7, P2394, DOI 10.1016/j.actbio.2011.02.032
   Lusby P E, 2002, J Wound Ostomy Continence Nurs, V29, P295, DOI 10.1067/mjw.2002.129073
   Mandal BB, 2008, MACROMOL BIOSCI, V8, P807, DOI 10.1002/mabi.200800113
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Mishra R, 2014, J COLLOID INTERF SCI, V431, P139, DOI 10.1016/j.jcis.2014.05.040
   Mishra R, 2011, J BIOMAT SCI-POLYM E, V22, P2107, DOI 10.1163/092050610X534230
   Mo CL, 2009, BIOMACROMOLECULES, V10, P2724, DOI 10.1021/bm900452u
   Mottaghitalab F, 2015, J CONTROL RELEASE, V215, P112, DOI 10.1016/j.jconrel.2015.07.031
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Oyane A, 2003, J BIOMED MATER RES A, V65, P188
   Paulusse JMJ, 2006, J POLYM SCI POL CHEM, V44, P5445, DOI 10.1002/pola.21646
   Rezaee A, 2009, B ENVIRON CONTAM TOX, V82, P732, DOI 10.1007/s00128-009-9690-z
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rnjak-Kovacina J, 2015, ACS BIOMATER SCI ENG, V1, P260, DOI 10.1021/ab500149p
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rodriguez Isaac A, 2013, Cells, V2, P244, DOI 10.3390/cells2020244
   Rodriguez IA, 2012, INT J BIOMATER, DOI 10.1155/2012/159484
   Samal SK, 2013, MACROMOL MATER ENG, V298, P1201, DOI 10.1002/mame.201200377
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Tretinnikov ON, 2001, LANGMUIR, V17, P7406, DOI 10.1021/la010791y
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   YOSHIMIZU H, 1990, J APPL POLYM SCI, V40, P127, DOI 10.1002/app.1990.070400111
   Yucel T, 2009, BIOPHYS J, V97, P2044, DOI 10.1016/j.bpj.2009.07.028
NR 45
TC 6
Z9 6
U1 6
U2 28
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 2053-1591
J9 MATER RES EXPRESS
JI Mater. Res. Express
PD MAY
PY 2016
VL 3
IS 5
AR 055401
DI 10.1088/2053-1591/3/5/055401
PG 15
WC Materials Science, Multidisciplinary
SC Materials Science
GA DO5GT
UT WOS:000377812300025
DA 2018-10-19
ER

PT J
AU Witherel, CE
   Graney, PL
   Freytes, DO
   Weingarten, MS
   Spiller, KL
AF Witherel, Claire E.
   Graney, Pamela L.
   Freytes, Donald O.
   Weingarten, Michael S.
   Spiller, Kara L.
TI Response of human macrophages to wound matrices in vitro
SO WOUND REPAIR AND REGENERATION
LA English
DT Article
ID CROSS-LINKING; SKIN WOUNDS; PHENOTYPE; SCAFFOLDS; CELLS;
   VASCULARIZATION; REGENERATION; SPONGES; REPAIR; MODEL
AB Chronic wounds remain a major burden to the global healthcare system. Myriad wound matrices are commercially available but their mechanisms of action are poorly understood. Recent studies have shown that macrophages are highly influenced by their microenvironment, but it is not known how different biomaterials affect this interaction. Here, it was hypothesized that human macrophages respond differently to changes in biomaterial properties in vitro with respect to phenotype, including pro-inflammatory M1, anti-inflammatory M2a, known for facilitating extracellular matrix deposition and proliferation, and M2c, which has recently been associated with tissue remodeling. Using multiple donors, it was found that collagen scaffolds cross-linked with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide and N-hydroxysuccinimide (EDC/NHS) promoted the least inflammatory phenotype in primary human macrophages compared with scaffolds cross-linked with formaldehyde or glutaraldehyde. Importantly, gene expression analysis trends were largely conserved between donors, especially TNFa (M1), CCL22 (M2a), and MRC1 (M2a). Then the response of primary and THP1 monocyte-derived macrophages to four commercially available wound matrices were comparedIntegra Dermal Regeneration Template (Integra), PriMatrix Dermal Repair Scaffold (PriMatrix), AlloMend Acellular Dermal Matrix (AlloMend), and Oasis Wound Matrix (Oasis). Gene expression trends were different between primary and THP1 monocyte-derived macrophages for all six genes analyzed in this study. Finally, the behavior of primary macrophages cultured onto the wound matrices over time was analyzed. Integra and Oasis caused down-regulation of M2a markers CCL22 and TIMP3. PriMatrix caused up-regulation of TNFa (M1) and CD163 (M2c) and down-regulation of CCL22 and TIMP3 (both M2a). AlloMend caused up-regulation in CD163 (M2c). Lastly, Oasis promoted the largest increase in the combinatorial M1/M2 score, defined as the sum of M1 genes divided by the sum of M2 genes. This preliminary study suggested that biomaterials influenced the wound microenvironment to affect macrophage phenotype.
C1 [Witherel, Claire E.; Graney, Pamela L.; Spiller, Kara L.] Drexel Univ, Sch Biomed Engn, Biomat & Regenerat Med Lab, Philadelphia, PA 19104 USA.
   [Freytes, Donald O.] New York Stem Cell Fdn, New York, NY USA.
   [Freytes, Donald O.] Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC 27599 USA.
   [Freytes, Donald O.] N Carolina State Univ, Raleigh, NC 27695 USA.
   [Weingarten, Michael S.] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA.
RP Spiller, KL (reprint author), Drexel Univ, Sch Biomed Engn, Biomat & Regenerat Med Lab, Philadelphia, PA 19104 USA.
EM spiller@drexel.edu
FU Integra LifeSciences
FX CEW would like to thank to Integra LifeSciences for their generous
   support via the Integra LifeSciences Doctoral Scholarship. Additionally,
   the authors would like to thank Justin Levrock for his technical
   assistance with SEM, and Bryan Vayda and Timothy Brockman for training
   and assistance with residual testing.
CR BORATYNSKI J, 1990, ANAL BIOCHEM, V184, P259, DOI 10.1016/0003-2697(90)90677-2
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI [10.1089/ten.tea.2010.0590, 10.1089/ten.TEA.2010.0590]
   Hermanson GT, 2013, BIOCONJUGATE TECHNIQUES, 3RD EDITION, P229, DOI 10.1016/B978-0-12-382239-0.00003-0
   Knipper JA, 2015, IMMUNITY, V43, P803, DOI 10.1016/j.immuni.2015.09.005
   Kuijpers AT, 1982, ANAL CHEM, V55, P391
   Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018
   Lei QP, 2004, J CHROMATOGR B, V813, P103, DOI 10.1016/j.jchromb.2004.09.015
   Lolmede K, 2009, J LEUKOCYTE BIOL, V85, P779, DOI 10.1189/jlb.0908579
   Mirza RE, 2013, DIABETES, V62, P2579, DOI 10.2337/db12-1450
   Moiemen NS, 2006, PLAST RECONSTR SURG, V117, p160S, DOI 10.1097/01.prs.0000222609.40461.68
   Nassiri S, 2015, J INVEST DERMATOL, V135, P1700, DOI 10.1038/jid.2015.30
   Neill JSA, 2013, AM J CLIN PATHOL, V140, P248, DOI 10.1309/AJCPMF3B9XJAKXKM
   Qin ZY, 2012, ATHEROSCLEROSIS, V221, P2, DOI 10.1016/j.atherosclerosis.2011.09.003
   Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x
   Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110
   Snyder DL, 2012, HCPR0610 US DEP HLTH
   Spiller KL, 2015, WOUND REPAIR REGEN, V23, pA40
   Spiller KL, 2015, BIOMATERIALS, V37, P194, DOI 10.1016/j.biomaterials.2014.10.017
   Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012
   Spiller KL, 2015, EXP CELL RES
   Tan GK, 2014, ACTA BIOMATER, V10, P2684, DOI 10.1016/j.actbio.2014.02.025
   Troidl C, 2013, CURR VASC PHARMACOL, V11, P5, DOI 10.2174/157016113804547629
   Ulubayram K, 2002, J BIOMAT SCI-POLYM E, V13, P1203, DOI 10.1163/156856202320892966
   Willenborg S, 2012, BLOOD, V120, P613, DOI 10.1182/blood-2012-01-403386
   Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354
   Xue J, 2015, NAT COMMUN, V6, P1
   Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006
   Ye QS, 2010, BIOMATERIALS, V31, P9192, DOI 10.1016/j.biomaterials.2010.08.049
NR 30
TC 12
Z9 12
U1 1
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1067-1927
EI 1524-475X
J9 WOUND REPAIR REGEN
JI Wound Repair Regen.
PD MAY-JUN
PY 2016
VL 24
IS 3
BP 514
EP 524
DI 10.1111/wrr.12423
PG 11
WC Cell Biology; Dermatology; Medicine, Research & Experimental; Surgery
SC Cell Biology; Dermatology; Research & Experimental Medicine; Surgery
GA DO0XA
UT WOS:000377500900005
PM 26874797
DA 2018-10-19
ER

PT J
AU Essoua, GGE
   Blanchet, P
   Landry, V
   Beauregard, R
AF Essoua, Gatien Geraud Essoua
   Blanchet, Pierre
   Landry, Veronic
   Beauregard, Robert
TI Pine Wood Treated with a Citric Acid and Glycerol Mixture: Biomaterial
   Performance Improved by a Bio-byproduct
SO BIORESOURCES
LA English
DT Article
DE Wood impregnation; Citric acid; Glycerol; Wood technical performance;
   Environmentally friendly treatment; By-product valorization
ID INFRARED-SPECTROSCOPY; CHEMICAL-REACTION; ROT FUNGI; BIODEGRADATION;
   STABILITY; COATINGS; PINASTER; DECAY; FTIR
AB Wood material is a good reservoir for biogenic carbon storage. The use of wood material for outdoor products such as siding in the building construction sector presents limits. These limits are bound to the nature of wood material (hygroscopic property and anatomical structure). They are responsible for the dimensional variation associated with moisture content variations. Fungal attacks and coating layers adhesion on wood surface, are other problems. This research investigated the feasibility of impregnation with environmentally friendly chemicals, i.e., a citric acid-glycerol mixture (CA-G). The anti-swelling efficiency (ASE), hardness, biodegradation, and coating adhesion tests were performed on softwood specimens. ASE results were up to 53%. The equilibrium moisture content of the treated specimens was less than half of the untreated ones. FTIR spectroscopy showed bands at 1720 to 1750 cm(-1), indicating the presence of ester bonds, and scanning electron microscopy images confirmed the polymerization and condensation of treatment solution inside the wood structure. Hardness and decay resistance were increased; however, treatment reduces coating adhesion. In conclusion, CA-G represents a promising eco-responsible solution for improving the technical performance of outdoor wood products.
C1 [Essoua, Gatien Geraud Essoua; Blanchet, Pierre; Landry, Veronic; Beauregard, Robert] Univ Laval, Dept Wood & Forest Sci, 2325 Rue Univ, Quebec City, PQ G1V 0A6, Canada.
   [Landry, Veronic] FPInnovat, G1P 4R4,319 Rue Franquet, Quebec City, PQ G1P 4R4, Canada.
RP Blanchet, P (reprint author), Univ Laval, Dept Wood & Forest Sci, 2325 Rue Univ, Quebec City, PQ G1V 0A6, Canada.
EM Pierre.Blanchet@sbf.ulaval.ca
RI Blanchet, Pierre/C-2455-2014; Landry, Veronic/S-6062-2017; Beauregard,
   Robert/S-3978-2016
OI Blanchet, Pierre/0000-0002-6348-0289; Beauregard,
   Robert/0000-0002-0781-7625
FU National Science and Engineering Research Council of Canada;
   FPInnovations [RDCPJ 386935]
FX The authors would like to acknowledge the National Science and
   Engineering Research Council of Canada and FPInnovations for funding
   this research (RDCPJ 386935).
CR American Society for Testing And Materials, 2014, D2395 ASTM
   Anand PM, 2011, NEW BIOTECHNOL, V1, P1, DOI DOI 10.1016/J.NBT.2011.05.010
   [Anonymous], 2009, D4541 ASTM
   [Anonymous], 2002, 4624 ISO
   [Anonymous], 2000, 1534 ISO
   [Anonymous], 2012, E10 AWPA
   Arnold M., 2010, PRAS 7 INT WOODC C R
   Barone JR, 2007, POLYM DEGRAD STABIL, V92, P859, DOI 10.1016/j.polymdegradstab.2007.01.030
   BENDER ML, 1960, CHEM REV, V60, P53, DOI 10.1021/cr60203a005
   Bodirlau R, 2009, ROM J PHYS, V54, P93
   Brioude Michel de Meireles, 2007, Mat. Res., V10, P335, DOI 10.1590/S1516-14392007000400003
   Budhavaram N. K., 2008, ASABE M PROV RI, DOI 10.13031/2013.24910
   Cai X., 2007, THESIS LAVAL U QUEBE
   Chang ST, 2001, POLYM DEGRAD STABIL, V71, P261, DOI 10.1016/S0141-3910(00)00171-3
   Essoua GGE, 2015, BIORESOURCES, V10, P6830
   GOLDSTEIN IS, 1959, IND ENG CHEM, V51, P1313, DOI 10.1021/ie50598a042
   Green W. D., 2006, FPTRN0303 USDA FOR S
   Guerrero P, 2015, J CLEAN PROD, V100, P179, DOI 10.1016/j.jclepro.2015.03.049
   Halpern JM, 2014, J BIOMED MATER RES A, V102, P1467, DOI 10.1002/jbm.a.34821
   Hasan M., 2012, P 6 EUR C WOOD MOD L, P63
   Hernandez RE, 2008, WOOD FIBER SCI, V40, P459
   Hill CAS, 2006, WOOD MODIFICATION CH, DOI [10.1002/0470021748, DOI 10.1002/0470021748]
   Holser RA, 2008, J BIOBASED MATER BIO, V2, P94, DOI 10.1166/jbmb.2008.205
   INOUE M, 1993, WOOD FIBER SCI, V25, P404
   Korkut S, 2008, BIORESOURCE TECHNOL, V99, P1861, DOI 10.1016/j.biortech.2007.03.038
   Li GY, 2011, CARBOHYD POLYM, V85, P560, DOI 10.1016/j.carbpol.2011.03.014
   Lukowsky D, 2002, HOLZ ROH WERKST, V60, P349, DOI 10.1007/s00107-002-0324-y
   Maminski M., 2011, 2 INT C ENV ENG APPL, P13
   Nelson G. L., 1995, ASTM SPECIAL TECHNIC, P513
   Nkeuwa WN, 2014, J COAT TECHNOL RES, V11, P283, DOI 10.1007/s11998-013-9551-x
   NORIMOTO M, 1992, WOOD FIBER SCI, V24, P25
   OWEN NL, 1989, APPL SPECTROSC, V43, P451, DOI 10.1366/0003702894202760
   Ozdemir T, 2015, ADV MATER SCI ENG, DOI 10.1155/2015/525496
   Pagliaro M, 2008, RSC GREEN CHEM SER, P1
   Pandey KK, 2003, INT BIODETER BIODEGR, V52, P151, DOI 10.1016/S0964-8305(03)00052-0
   Panshin AJ, 1964, TXB WOOD TECHNOLOGY
   Paukszta D, 2015, J COMPOS MATER, V49, P1369, DOI 10.1177/0021998314534096
   Podgorski L., 2010, IRG 41 ANN M BIARR F
   PRAMANICK D, 1988, POLYM BULL, V19, P365
   Ross Robert J., 2010, GTR190 USDA FOR SERV
   Rosu D, 2016, J CLEAN PROD, V112, P1175, DOI 10.1016/j.jclepro.2015.07.092
   Roussel C, 2001, HOLZFORSCHUNG, V55, P57, DOI 10.1515/HF.2001.009
   ROWELL RM, 1984, ADV CHEM SER, P175
   Sebe G, 2000, HOLZFORSCHUNG, V54, P474, DOI 10.1515/HF.2000.080
   Sebe G, 2004, HOLZFORSCHUNG, V58, P511, DOI 10.1515/HF.2004.078
   Shang J, 2013, BIORESOURCES, V8, P6066
   Siau JF, 1984, SPRINGER SERIES WOOD
   Teaca CA, 2013, BIORESOURCES, V8, P1478
   Trenkel-Amoroso J., 2008, THESIS OREGONS STATE
   URAKI Y, 1994, J WOOD CHEM TECHNOL, V14, P429, DOI 10.1080/02773819408003106
   Van Acker J., 1999, 9930206 IRGWP, DOI International Research Group on Wood Preservation
   Weaver J. W., 1960, Forest Products Journal, V10, P306
   Wen Z., 2012, NEW USES CRUDE GLYCE
   Westin M., 2004, 0440288 IRGWP
   Yang FX, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-13
   Yang Q, 2013, BIORESOURCES, V8, P487
   Yong F. L., 2010, WORLD ACAD SCI ENG T, V4, P67, DOI [10.1016/j.ibiod.2011.08.009, DOI 10.1016/J.IBIOD.2011.08.009]
NR 57
TC 4
Z9 4
U1 0
U2 21
PU NORTH CAROLINA STATE UNIV DEPT WOOD & PAPER SCI
PI RALEIGH
PA CAMPUS BOX 8005, RALEIGH, NC 27695-8005 USA
SN 1930-2126
J9 BIORESOURCES
JI BioResources
PD MAY
PY 2016
VL 11
IS 2
BP 3049
EP 3072
PG 24
WC Materials Science, Paper & Wood
SC Materials Science
GA DL6YT
UT WOS:000375786700009
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Hortensius, RA
   Harley, BAC
AF Hortensius, Rebecca A.
   Harley, Brendan A. C.
TI Naturally derived biomaterials for addressing inflammation in tissue
   regeneration
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Review
DE Chitosan; decellularized matrix; amniotic membrane; inflammation; tissue
   regeneration; biomaterial
ID COLLAGEN-GAG SCAFFOLDS; FETAL WOUND REPAIR; AMNIOTIC MEMBRANE
   TRANSPLANTATION; DECELLULARIZED PERICARDIAL BIOMATERIAL; OCULAR SURFACE
   RECONSTRUCTION; HEALING IN-VIVO; SCAR FORMATION; EXTRACELLULAR-MATRIX;
   CROSS-LINKING; GROWTH-FACTOR
AB Tissue regeneration strategies have traditionally relied on designing biomaterials that closely mimic features of the native extracellular matrix (ECM) as a means to potentially promote site-specific cellular behaviors. However, inflammation, while a necessary component of wound healing, can alter processes associated with successful tissue regeneration following an initial injury. These processes can be further magnified by the implantation of a biomaterial within the wound site. In addition to designing biomaterials to satisfy biocompatibility concerns as well as to replicate elements of the composition, structure, and mechanics of native tissue, we propose that ECM analogs should also include features that modulate the inflammatory response. Indeed, strategies that enhance, reduce, or even change the temporal phenotype of inflammatory processes have unique potential as future pro-regenerative analogs. Here, we review derivatives of three natural materials with intrinsic anti-inflammatory properties and discuss their potential to address the challenges of inflammation in tissue engineering and chronic wounds.
C1 [Hortensius, Rebecca A.] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.
   [Harley, Brendan A. C.] Univ Illinois, Dept Chem & Biol Engn, Urbana, IL 61801 USA.
   [Harley, Brendan A. C.] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA.
RP Hortensius, RA (reprint author), Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.
EM ralyons2@illinois.edu
FU NSF Graduate Research Fellowship [DGE 11-44245 FLLW]; University of
   Illinois Graduate Dissertation Fellowship; National Science Foundation
   [1105300]; National Institute of Arthritis and Musculoskeletal and Skin
   Diseases of the National Institutes of Health [R03 AR062811]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: The
   authors wish to acknowledge funding provided by the NSF Graduate
   Research Fellowship DGE 11-44245 FLLW (RAH), University of Illinois
   Graduate Dissertation Fellowship (RAH), the National Science Foundation
   under Grant No. 1105300 (BACH), and the National Institute of Arthritis
   and Musculoskeletal and Skin Diseases of the National Institutes of
   Health under Award Number R03 AR062811 (BACH).
CR ADZICK NS, 1994, ANN SURG, V220, P10, DOI 10.1097/00000658-199407000-00003
   Ariganello MB, 2011, BIOMATERIALS, V32, P439, DOI 10.1016/j.biomaterials.2010.09.004
   Ariganello MB, 2010, J BIOMED MATER RES A, V93A, P280, DOI 10.1002/jbm.a.32554
   ARMSTRONG JR, 1995, DEV BIOL, V169, P242, DOI 10.1006/dbio.1995.1141
   Azuara-Blanco A, 1999, BRIT J OPHTHALMOL, V83, P399, DOI 10.1136/bjo.83.4.399
   Azuma Kazuo, 2015, J Funct Biomater, V6, P33, DOI 10.3390/jfb6010033
   Badylak SF, 2014, ANN BIOMED ENG, V42, P1517, DOI 10.1007/s10439-013-0963-7
   Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950
   Beredjiklian PK, 2003, ANN BIOMED ENG, V31, P1143, DOI 10.1114/1.1616931
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Boucard N, 2007, BIOMATERIALS, V28, P3478, DOI 10.1016/j.biomaterials.2007.04.021
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Bruyere O, 2008, OSTEOARTHR CARTILAGE, V16, P254, DOI 10.1016/j.joca.2007.06.011
   Bullard KM, 2003, WORLD J SURG, V27, P54, DOI 10.1007/s00268-002-6737-2
   Bullers SJ, 2014, TISSUE ENG PT A, V20, P2390, DOI [10.1089/ten.tea.2013.0628, 10.1089/ten.TEA.2013.0628]
   Caliari SR, 2011, BIOMATERIALS, V32, P5330, DOI 10.1016/j.biomaterials.2011.04.021
   Cao HQ, 2010, J BIOMED MATER RES A, V93A, P1151, DOI 10.1002/jbm.a.32609
   Cass DL, 1997, J PEDIATR SURG, V32, P411, DOI 10.1016/S0022-3468(97)90593-5
   Chen HJ, 2000, BRIT J OPHTHALMOL, V84, P826, DOI 10.1136/bjo.84.8.826
   Chen Q, 2006, EUR J PHARMACOL, V541, P1, DOI 10.1016/j.ejphar.2006.03.044
   Chung MJ, 2012, INT IMMUNOPHARMACOL, V12, P453, DOI 10.1016/j.intimp.2011.12.027
   Colwell AS, 2006, PLAST RECONSTR SURG, V117, P2292, DOI 10.1097/01.prs.0000219340.47232.eb
   Colwell AS, 2005, ADV BIOCHEM ENG BIOT, V93, P83, DOI 10.1007/b99972
   Cooper LJ, 2005, CORNEA, V24, P722, DOI 10.1097/01.ico.0000154237.49112.29
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   Elsaesser AF, 2014, TISSUE ENG PT A, V20, P1668, DOI [10.1089/ten.tea.2013.0365, 10.1089/ten.TEA.2013.0365]
   Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701
   Fairbairn NG, 2014, J PLAST RECONSTR AES, V67, P662, DOI 10.1016/j.bjps.2014.01.031
   Farrell E, 2006, TISSUE ENG, V12, P459, DOI 10.1089/ten.2006.12.459
   Fishman JM, 2013, P NATL ACAD SCI USA, V110, P14360, DOI 10.1073/pnas.1213228110
   French KM, 2012, ACTA BIOMATER, V8, P4357, DOI 10.1016/j.actbio.2012.07.033
   Friedman AJ, 2013, J INVEST DERMATOL, V133, P1231, DOI 10.1038/jid.2012.399
   Gittes C, 2000, J PEDIATR SURG, V35, P872
   Gordon A, 2008, WOUND REPAIR REGEN, V16, P70, DOI 10.1111/j.1524-475X.2007.00326.x
   Harley BA, 2004, CELLS TISSUES ORGANS, V176, P153, DOI 10.1159/000075035
   Harley BA, 2007, BIOPHYS J, V93, P2911, DOI 10.1529/biophysj.106.095471
   Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598
   Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI [10.1089/ten.tea.2010.0590, 10.1089/ten.TEA.2010.0590]
   Holladay C, 2011, MOL THER, V19, P969, DOI 10.1038/mt.2010.311
   Holladay CA, 2012, BIOMATERIALS, V33, P1303, DOI 10.1016/j.biomaterials.2011.10.019
   Hortensius RA, 2016, J BIOMED MATER RES A, V104, P1332, DOI 10.1002/jbm.a.35663
   Hortensius RA, 2013, BIOMATERIALS, V34, P7645, DOI 10.1016/j.biomaterials.2013.06.056
   Hsu M, 2001, PLAST RECONSTR SURG, V107, P1787, DOI 10.1097/00006534-200106000-00023
   Hsu M, 2001, PLAST RECONSTR SURG, V107, P95
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Keane TJ, 2017, J BIOMED MATER RES B, V105, P291, DOI 10.1002/jbm.b.33556
   Kim H, 2013, ARCH PLAST SURG-APS, V40, P11, DOI 10.5999/aps.2013.40.1.11
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kim MM, 2006, FEBS LETT, V580, P2661, DOI 10.1016/j.febslet.2006.04.015
   Koch Holger, 2015, Front Bioeng Biotechnol, V3, P89, DOI 10.3389/fbioe.2015.00089
   Koob TJ, 2013, INT WOUND J, V10, P493, DOI 10.1111/iwj.12140
   Larson BJ, 2010, PLAST RECONSTR SURG, V126, P1172, DOI 10.1097/PRS.0b013e3181eae781
   Lee SH, 2009, BIOORG MED CHEM LETT, V19, P6655, DOI 10.1016/j.bmcl.2009.10.007
   Liechty KW, 1998, J SURG RES, V77, P80, DOI 10.1006/jsre.1998.5345
   Liechty KW, 2000, J PEDIATR SURG, V35, P866, DOI 10.1053/jpsu.2000.6868
   Liechty KW, 2000, CYTOKINE, V12, P671, DOI 10.1006/cyto.1999.0598
   LONGAKER MT, 1991, ANN SURG, V213, P292, DOI 10.1097/00000658-199104000-00003
   LONGAKER MT, 1994, ANN SURG, V219, P65, DOI 10.1097/00000658-199401000-00011
   LORENZ HP, 1993, ANN SURG, V217, P391, DOI 10.1097/00000658-199304000-00011
   LORENZ HP, 1992, DEVELOPMENT, V114, P253
   MALAK TM, 1993, PLACENTA, V14, P385, DOI 10.1016/S0143-4004(05)80460-6
   Mazza G, 2015, SCI REP-UK, V5, DOI 10.1038/srep13079
   McDade JK, 2013, ACTA BIOMATER, V9, P7191, DOI 10.1016/j.actbio.2013.02.021
   Medberry CJ, 2013, BIOMATERIALS, V34, P1033, DOI 10.1016/j.biomaterials.2012.10.062
   MERKEL JR, 1988, P SOC EXP BIOL MED, V187, P493
   MURPHY GF, 1990, LAB INVEST, V62, P305
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   Naik-Mathuria B, 2007, J PEDIATR SURG, V42, P166, DOI 10.1016/j.jpedsurg.2006.09.058
   Ngo DH, 2014, ADV FOOD NUTR RES, V73, P15, DOI 10.1016/B978-0-12-800268-1.00002-0
   Niknejad H, 2008, EUR CELLS MATER, V15, P88
   Novak ML, 2013, AM J PATHOL, V183, P1352, DOI 10.1016/j.ajpath.2013.06.034
   Nowocin AK, 2013, J TISSUE ENG REGEN M, V10, pE23
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Oliveira MI, 2012, EUR CELLS MATER, V24, P136, DOI 10.22203/eCM.v024a10
   Oliveira MI, 2012, EUR CELLS MATER, V24, P52
   Olutoye OO, 2005, PEDIATR RES, V58, P1290, DOI 10.1203/01.pdr.0000184326.01884.bc
   Olutoye OO, 1996, J PEDIATR SURG, V31, P91, DOI 10.1016/S0022-3468(96)90326-7
   Pangestuti R, 2011, INT J BIOL MACROMOL, V49, P599, DOI 10.1016/j.ijbiomac.2011.06.014
   Peranteau WH, 2008, J INVEST DERMATOL, V128, P1852, DOI 10.1038/sj.jid.5701232
   Pinkerton MC, 1942, LANCET, V1, P70
   PRUDDEN JF, 1970, AM J SURG, V119, P560, DOI 10.1016/0002-9610(70)90175-3
   Qiao Y, 2011, INT IMMUNOPHARMACOL, V11, P121, DOI 10.1016/j.intimp.2010.10.016
   Raghavan SS, 2012, TISSUE ENG PT A, V18, P796, DOI [10.1089/ten.tea.2011.0422, 10.1089/ten.TEA.2011.0422]
   Reing JE, 2009, TISSUE ENG PT A, V15, P605, DOI 10.1089/ten.tea.2007.0425
   Rhett JM, 2008, TRENDS BIOTECHNOL, V26, P173, DOI 10.1016/j.tibtech.2007.12.007
   Samandari MH, 2004, ORAL SURG ORAL MED O, V97, P574, DOI 10.1016/j.tripleo.2003.10.031
   SHAH M, 1994, J CELL SCI, V107, P1137
   Shukla SK, 2013, INT J BIOL MACROMOL, V59, P46, DOI 10.1016/j.ijbiomac.2013.04.043
   SOMASUND.K, 1970, J PATHOL, V100, P81, DOI 10.1002/path.1711000202
   Soo C, 2003, AM J PATHOL, V163, P2459, DOI 10.1016/S0002-9440(10)63601-2
   Spiller KL, 2015, BIOMATERIALS, V37, P194, DOI 10.1016/j.biomaterials.2014.10.017
   Taghiabadi E, 2015, CELL J, V16, P476
   Torres DS, 2000, BIOMATERIALS, V21, P1607
   TROENSEGAARDHANSEN E, 1950, LANCET, V258, P859
   Tseng SCG, 1998, ARCH OPHTHALMOL-CHIC, V116, P431, DOI 10.1001/archopht.116.4.431
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   Umashankar PR, 2013, J BIOMED MATER RES A, V101, P2202, DOI 10.1002/jbm.a.34535
   Wang QS, 2014, J BIOMED MATER RES A, V102, P4098, DOI 10.1002/jbm.a.35083
   Weisgerber DW, 2015, BIOMATER SCI-UK, V3, P533, DOI [10.1039/c4bm00397g, 10.1039/C4BM00397G]
   Willett NJ, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4476
   Wilshaw SP, 2006, TISSUE ENG, V12, P2117, DOI 10.1089/ten.2006.12.2117
   Xia WS, 2011, FOOD HYDROCOLLOID, V25, P170, DOI 10.1016/j.foodhyd.2010.03.003
   Xing Q, 2015, TISSUE ENG PART C-ME, V21, P77, DOI [10.1089/ten.tec.2013.0666, 10.1089/ten.TEC.2013.0666]
   Yannas I., 2001, TISSUE ORGAN REGENER
   Yannas IV, 2013, BIOMATERIALS, V34, P321, DOI 10.1016/j.biomaterials.2012.10.006
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Yousef M, 2012, PHARMACOL RES, V66, P66, DOI 10.1016/j.phrs.2012.03.013
   Yuan ZM, 2014, BIOMATER SCI-UK, V2, P502, DOI 10.1039/c3bm60198f
   Zgheib C, 2014, ADV WOUND CARE, V3, P344, DOI 10.1089/wound.2013.0456
   Zilla P, 2004, BIOTECHNOL APPL BIOC, V40, P57, DOI 10.1042/BA20030211
NR 111
TC 9
Z9 9
U1 2
U2 31
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD MAY
PY 2016
VL 241
IS 10
BP 1015
EP 1024
DI 10.1177/1535370216648022
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DN6PJ
UT WOS:000377197400001
PM 27190254
OA Green Accepted, Green Published
DA 2018-10-19
ER

PT J
AU Chow, LW
   Fischer, JF
AF Chow, Lesley W.
   Fischer, Jacob F.
TI Creating biomaterials with spatially organized functionality
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Review
DE Biomaterials; extracellular matrix; tissue engineering; regenerative
   medicine; translational; biomedical
ID PEPTIDE-AMPHIPHILE NANOFIBERS; CLICK-BASED HYDROGELS; STEM-CELL FATE;
   EXTRACELLULAR-MATRIX; REGENERATIVE MEDICINE; 3-DIMENSIONAL HYDROGELS;
   CARTILAGE REGENERATION; TISSUE CONSTRUCTS; FIBROUS SCAFFOLDS;
   MICROENVIRONMENTS
AB Biomaterials for tissue engineering provide scaffolds to support cells and guide tissue regeneration. Despite significant advances in biomaterials design and fabrication techniques, engineered tissue constructs remain functionally inferior to native tissues. This is largely due to the inability to recreate the complex and dynamic hierarchical organization of the extracellular matrix components, which is intimately linked to a tissue's biological function. This review discusses current state-of-the-art strategies to control the spatial presentation of physical and biochemical cues within a biomaterial to recapitulate native tissue organization and function.
C1 [Chow, Lesley W.] Lehigh Univ, Dept Mat Sci & Engn, Bethlehem, PA 18015 USA.
   [Chow, Lesley W.; Fischer, Jacob F.] Lehigh Univ, Bioengn Program, Bethlehem, PA 18015 USA.
RP Chow, LW (reprint author), Lehigh Univ, Dept Mat Sci & Engn, Bethlehem, PA 18015 USA.; Chow, LW (reprint author), Lehigh Univ, Bioengn Program, Bethlehem, PA 18015 USA.
EM lesley.chow@lehigh.edu
FU Lehigh University
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This work
   was supported by startup funds from Lehigh University. The authors have
   no other relevant affiliations or financial involvement with any
   organization or entity with a financial interest in or financial
   conflict with the subject matter or materials discussed in the
   manuscript. The authors acknowledge Dr E. Thomas Pashuck for useful
   discussions and editing the manuscript.
CR Abbah SA, 2015, ADV HEALTHC MATER, V4, P2488, DOI 10.1002/adhm.201500004
   Ahadian S, 2015, BIOCONJUGATE CHEM, V26, P1984, DOI 10.1021/acs.bioconjchem.5b00360
   Aizawa Y, 2010, ADV MATER, V22, P4831, DOI 10.1002/adma.201001855
   Azagarsamy MA, 2013, ACS MACRO LETT, V2, P5, DOI 10.1021/mz300585q
   Bae H, 2014, J TISSUE ENG REGEN M, V8, P1, DOI 10.1002/term.1494
   Bajaj P, 2014, ANNU REV BIOMED ENG, V16, P247, DOI 10.1146/annurev-bioeng-071813-105155
   Bandyopadhyay A, 2015, MRS BULL, V40, P108, DOI 10.1557/mrs.2015.3
   Bitton R, 2014, SMALL, V10, P500, DOI 10.1002/smll.201300254
   Boekhoven J, 2013, ANGEW CHEM INT EDIT, V52, P12077, DOI 10.1002/anie.201306278
   Bonzani IC, 2006, CURR OPIN CHEM BIOL, V10, P568, DOI 10.1016/j.cbpa.2006.09.009
   Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n
   Burdick JA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2271
   Caldwell DJ, 2013, ADV HEALTHC MATER, V2, P673, DOI 10.1002/adhm.201200346
   Caliari SR, 2015, ADV HEALTHC MATER, V4, P831, DOI 10.1002/adhm.201400809
   Caliari SR, 2014, ADV HEALTHC MATER, V3, P1086, DOI 10.1002/adhm.201300646
   Caliari SR, 2011, BIOMATERIALS, V32, P5330, DOI 10.1016/j.biomaterials.2011.04.021
   Capito RM, 2008, SCIENCE, V319, P1812, DOI 10.1126/science.1154586
   Carvajal D, 2010, SOFT MATTER, V6, P1816, DOI 10.1039/b923903k
   Charras G, 2014, NAT REV MOL CELL BIO, V15, P813, DOI 10.1038/nrm3897
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chow LW, 2014, ADV HEALTHC MATER, V3, P1381, DOI 10.1002/adhm.201400032
   Chow LW, 2011, BIOMATERIALS, V32, P1574, DOI 10.1016/j.biomaterials.2010.10.048
   Colosi C, 2016, ADV MATER, V28, P677, DOI 10.1002/adma.201503310
   Custodio CA, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0065-3
   Custodio CA, 2014, ADV HEALTHC MATER, V3, P797, DOI 10.1002/adhm.201300603
   Davey SK, 2015, TISSUE ENG PART C-ME, V21, P1188, DOI [10.1089/ten.tec.2015.0179, 10.1089/ten.TEC.2015.0179]
   DeForest CA, 2012, ANGEW CHEM INT EDIT, V51, P1816, DOI 10.1002/anie.201106463
   DeForest CA, 2011, NAT CHEM, V3, P925, DOI [10.1038/nchem.1174, 10.1038/NCHEM.1174]
   DeForest CA, 2010, CHEM MATER, V22, P4783, DOI 10.1021/cm101391y
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Gasiorowski JZ, 2011, BIOMACROMOLECULES, V12, P3549, DOI 10.1021/bm200763y
   Guven S, 2015, TRENDS BIOTECHNOL, V33, P269, DOI 10.1016/j.tibtech.2015.02.003
   Guvendiren M, 2013, ADV HEALTHC MATER, V2, P155, DOI 10.1002/adhm.201200105
   Harrison RH, 2015, ADV FUNCT MATER, V25, P5748, DOI 10.1002/adfm.201501277
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Highley CB, 2015, ADV MATER, V27, P5075, DOI 10.1002/adma.201501234
   Hinton TJ, 2015, SCI ADV, V1
   Hu J, 2014, PLOS ONE, V9
   Hudalla GA, 2014, NAT MATER, V13, P829, DOI [10.1038/NMAT3998, 10.1038/nmat3998]
   Huebsch N, 2015, NAT MATER, V14, P1269, DOI [10.1038/nmat4407, 10.1038/NMAT4407]
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Janson IA, 2015, J BIOMED MATER RES A, V103, P1246, DOI 10.1002/jbm.a.35254
   Jia XQ, 2009, MACROMOL BIOSCI, V9, P140, DOI 10.1002/mabi.200800284
   Kesti M, 2015, ADV FUNCT MATER, V25, P7397
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kidoaki A, 2008, J BIOTECHNOL, V133, P225, DOI 10.1016/j.jbiotec.2007.08.015
   Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062
   Kim J, 2016, ADV MATER, V28, P132, DOI 10.1002/adma.201503950
   Kyburz KA, 2015, ANN BIOMED ENG, V43, P489, DOI 10.1007/s10439-015-1297-4
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee TT, 2015, NAT MATER, V14, P352, DOI [10.1038/NMAT4157, 10.1038/nmat4157]
   Leong KF, 2008, J MECH BEHAV BIOMED, V1, P140, DOI 10.1016/j.jmbbm.2007.11.002
   Liu S, 2015, CHEM COMMUN, V51, P5218, DOI 10.1039/c4cc09568e
   Loo YH, 2015, NANO LETT, V15, P6919, DOI 10.1021/acs.nanolett.5b02859
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mandrycky C, 2016, BIOTECHNOL ADV, V34, P422, DOI 10.1016/j.biotechadv.2015.12.011
   Marklein RA, 2010, SOFT MATTER, V6, P136, DOI 10.1039/b916933d
   Matson JB, 2011, CURR OPIN SOLID ST M, V15, P225, DOI 10.1016/j.cossms.2011.08.001
   Matson JB, 2012, CHEM COMMUN, V48, P26, DOI 10.1039/c1cc15551b
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McClendon MT, 2012, BIOMATERIALS, V33, P5713, DOI 10.1016/j.biomaterials.2012.04.040
   McCullen SD, 2012, TISSUE ENG PT A, V18, P2073, DOI [10.1089/ten.tea.2011.0606, 10.1089/ten.TEA.2011.0606]
   Mosiewicz KA, 2013, NAT MATER, V12, P1071, DOI 10.1038/NMAT3766
   Mouw JK, 2014, NAT REV MOL CELL BIO, V15, P771, DOI 10.1038/nrm3902
   Nguyen LH, 2011, BIOMATERIALS, V32, P1
   Oliveira SM, 2015, BIOMATERIALS, V48, P56, DOI 10.1016/j.biomaterials.2015.01.020
   Pashuck ET, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002717
   Pati F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4935
   Pedron S, 2015, ADV MATER, V27, P1567, DOI 10.1002/adma.201404896
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197
   Rodell CB, 2015, BIOCONJUGATE CHEM, V26, P2279, DOI 10.1021/acs.bioconjchem.5b00483
   Seidi A, 2011, ACTA BIOMATER, V7, P1441, DOI 10.1016/j.actbio.2011.01.011
   Shukla A, 2016, ACS APPL MATER INTER, V8, P21883, DOI 10.1021/acsami.5b08978
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Steele JAM, 2014, ACTA BIOMATER, V10, P2065, DOI 10.1016/j.actbio.2013.12.030
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Sundararaghavan HG, 2011, BIOMACROMOLECULES, V12, P2344, DOI 10.1021/bm200415g
   Tang W, 2014, CHEM SOC REV, V43, P7013, DOI 10.1039/c4cs00139g
   Tayi AS, 2014, BIOMACROMOLECULES, V15, P1323, DOI 10.1021/bm401877s
   Tibbitt MW, 2015, P NATL ACAD SCI USA, V112, P14444, DOI 10.1073/pnas.1516247112
   Velichko YS, 2012, ADV FUNCT MATER, V22, P369, DOI 10.1002/adfm.201101538
   Wade RJ, 2015, ADV MATER, V27, P1356, DOI 10.1002/adma.201404993
   Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/nmat3101, 10.1038/NMAT3101]
   Zhang H, 2014, ACS MACRO LETT, V3, P727, DOI 10.1021/mz5002993
   Zhang SM, 2010, NAT MATER, V9, P594, DOI [10.1038/nmat2778, 10.1038/NMAT2778]
NR 91
TC 2
Z9 2
U1 0
U2 36
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD MAY
PY 2016
VL 241
IS 10
BP 1025
EP 1032
DI 10.1177/1535370216648023
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DN6PJ
UT WOS:000377197400002
PM 27190258
OA Green Published
DA 2018-10-19
ER

PT J
AU Tengood, JE
   Levy, RJ
   Stachelek, SJ
AF Tengood, Jillian E.
   Levy, Robert J.
   Stachelek, Stanley J.
TI The use of CD47-modified biomaterials to mitigate the immune response
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Review
DE CD47; signal regulatory protein alpha; biomaterials; inflammation
ID ALVEOLAR MACROPHAGE PHAGOCYTOSIS; HEMATOPOIETIC STEM-CELLS; FOREIGN-BODY
   REACTION; SURFACTANT PROTEIN-A; IN-VIVO; INFLAMMATORY RESPONSE;
   CARDIOPULMONARY BYPASS; SIRP-ALPHA; DENDRITIC CELLS; POLY(CARBONATE
   URETHANE)
AB Addressing the aberrant interactions between immune cells and biomaterials represents an unmet need in biomaterial research. Although progress has been made in the development of bioinert coatings, identifying and targeting relevant cellular and molecular pathways can provide additional therapeutic strategies to address this major healthcare concern. To that end, we describe the immune inhibitory motif, receptor-ligand pairing of signal regulatory protein alpha and its cognate ligand CD47 as a potential signaling pathway to enhance biocompatibility. The goals of this article are to detail the known roles of CD47-signal regulatory protein alpha signal transduction pathway and to describe how immobilized CD47 can be used to mitigate the immune response to biomaterials. Current applications of CD47-modified biomaterials will also be discussed herein.
C1 [Tengood, Jillian E.; Levy, Robert J.; Stachelek, Stanley J.] Childrens Hosp Philadelphia, Dept Pediat, Div Cardiol, Philadelphia, PA 19104 USA.
   [Tengood, Jillian E.; Levy, Robert J.; Stachelek, Stanley J.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.
RP Stachelek, SJ (reprint author), Childrens Hosp Philadelphia, Dept Pediat, Div Cardiol, Philadelphia, PA 19104 USA.; Stachelek, SJ (reprint author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.
EM stachelek@email.chop.edu
FU American Heart Association [14POST18830039]; NIH [R21 EB015612]; William
   J. Rashkind Endowment; Kibel Foundation; Erin's Fund of Children's
   Hospital of Philadelphia
FX Support for JTH is from the American Heart Association (14POST18830039).
   Support for SJS is from NIH R21 EB015612. Support for RJL is from the
   William J. Rashkind Endowment, Erin's Fund of the Children's Hospital of
   Philadelphia and The Kibel Foundation. The CD47 technology is licensed
   to SIRP Biological Coatings Inc. of which RJL and SJS are co-founders
   and equity shareholders.
CR Almeida CR, 2014, ACTA BIOMATER, V10, P613, DOI 10.1016/j.actbio.2013.10.035
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   Bajaj G, 2012, PLOS ONE, V7
   Bartoszewicz ZP, 1999, J NEUROCHEM, V72, P1688, DOI 10.1046/j.1471-4159.1999.721688.x
   Bellinger DC, 2003, J DEV BEHAV PEDIATR, V24, P169, DOI 10.1097/00004703-200306000-00007
   Bendszus M, 2002, ARCH NEUROL-CHICAGO, V59, P1090, DOI 10.1001/archneur.59.7.1090
   Brooke GP, 1998, EUR J IMMUNOL, V28, P1
   BRUCK SD, 1982, MED PROG TECHNOL, V9, P1
   Bruns H, 2015, CLIN CANCER RES, V21, P2075, DOI 10.1158/1078-0432.CCR-14-2696
   CAMPBELL IG, 1992, CANCER RES, V52, P5416
   Chao MP, 2011, CANCER RES, V71, P1374, DOI 10.1158/0008-5472.CAN-10-2238
   Christenson EM, 2006, J BIOMED MATER RES A, V76A, P480, DOI 10.1002/jbm.a.30506
   Christenson EM, 2004, J BIOMED MATER RES A, V70A, P245, DOI 10.1002/jbm.a.30067
   Dadsetan M, 2003, J CONTROL RELEASE, V93, P259, DOI 10.1016/j.jconrel.2003.08.010
   Edmunds LH, 1998, ANN THORAC SURG, V66, pS12, DOI 10.1016/S0003-4975(98)00967-9
   Edris B, 2012, P NATL ACAD SCI USA, V109, P6656, DOI 10.1073/pnas.1121629109
   Finley MJ, 2013, BIOMATERIALS, V34, P8640, DOI 10.1016/j.biomaterials.2013.07.088
   Finley MJ, 2012, BIOMATERIALS, V33, P5803, DOI 10.1016/j.biomaterials.2012.04.051
   Gao WW, 2013, ADV MATER, V25, P3549, DOI 10.1002/adma.201300638
   Gaynor J William, 2004, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V7, P133, DOI 10.1053/j.pcsu.2004.02.007
   Goda T, 2015, ACS APPL MATER INTER, V7, P27440, DOI 10.1021/acsami.5b09325
   Hagnerud S, 2006, J IMMUNOL, V176, P5772, DOI 10.4049/jimmunol.176.10.5772
   Hill GE, 1996, INT ANESTHESIOL CLIN, V34, P95, DOI 10.1097/00004311-199603420-00009
   Hogue CW, 2006, ANESTH ANALG, V103, P21, DOI 10.1213/01.ANE.0000220035.82989.79
   Hu CMJ, 2014, NANOSCALE, V6, P65, DOI 10.1039/c3nr05444f
   Hu CMJ, 2013, NANOSCALE, V5, P2664, DOI 10.1039/c3nr00015j
   Hu CMJ, 2011, P NATL ACAD SCI USA, V108, P10980, DOI 10.1073/pnas.1106634108
   INABA K, 1990, International Reviews of Immunology, V6, P197, DOI 10.3109/08830189009056630
   Isenberg JS, 2008, ARTERIOSCL THROM VAS, V28, P615, DOI 10.1161/ATVBAHA.107.158154
   Isenberg JS, 2007, J BIOL CHEM, V282, P15404, DOI 10.1074/jbc.M701638200
   Jakel A, 2010, IMMUNOBIOLOGY, V215, P551, DOI 10.1016/j.imbio.2009.09.005
   Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046
   Janssen WJ, 2008, AM J RESP CRIT CARE, V178, P158, DOI 10.1164/rccm.200711-1661OC
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jenney CR, 1999, J BIOMED MATER RES, V44, P206, DOI 10.1002/(SICI)1097-4636(199902)44:2<206::AID-JBM11>3.0.CO;2-D
   Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559
   Kim D, 2012, LEUKEMIA, V26, P2538, DOI 10.1038/leu.2012.141
   KRAAL G, 1992, INT REV CYTOL, V132, P31, DOI 10.1016/S0074-7696(08)62453-5
   Kyle DJT, 2015, BIOMATERIALS, V52, P88, DOI 10.1016/j.biomaterials.2015.02.003
   Landis Clive, 2007, J Extra Corpor Technol, V39, P281
   Levy JH, 2008, ANESTH ANALG, V106, P392, DOI [10.1213/ane.0b013e318160e0d, 10.1213/ane.0b013e3181602e0d]
   Levy JH, 2003, ANN THORAC SURG, V75, pS715, DOI 10.1016/S0003-4975(02)04701-X
   Li J, 2015, BIOMATERIALS, V47, P51, DOI 10.1016/j.biomaterials.2015.01.005
   Luther SA, 2002, J IMMUNOL, V169, P424, DOI 10.4049/jimmunol.169.1.424
   Maitz MF, 2010, J BIOMED MATER RES A, V94A, P905, DOI 10.1002/jbm.a.32780
   McCracken MN, 2015, CLIN CANCER RES, V21, P3597, DOI 10.1158/1078-0432.CCR-14-2520
   McGuinness J, 2008, SURG-J R COLL SURG E, V6, P162, DOI 10.1016/S1479-666X(08)80113-8
   Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588
   Narizhneva NV, 2005, FASEB J, V19, P1158, DOI 10.1096/fj.04-3310fje
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nygren H, 1997, J LAB CLIN MED, V129, P35, DOI 10.1016/S0022-2143(97)90159-1
   OKEREKE CS, 1995, TOXICOL LETT, V80, P61, DOI 10.1016/0378-4274(95)03334-H
   Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051
   Palaniyar N, 2003, ANN NY ACAD SCI, V1010, P471, DOI 10.1196/annals.1299.085
   Rebres RA, 2005, J CELL PHYSIOL, V205, P182, DOI 10.1002/jcp.20379
   ROBISON SH, 1994, ENVIRON MOL MUTAGEN, V23, P312, DOI 10.1002/em.2850230409
   Rodriguez PL, 2013, SCIENCE, V339, P971, DOI 10.1126/science.1229568
   Saito Y, 2010, BLOOD, V116, P3517, DOI 10.1182/blood-2010-03-277244
   Sato-Hashimoto M, 2011, J IMMUNOL, V187, P291, DOI 10.4049/jimmunol.1100528
   Saumet A, 2002, BIOCHEM J, V363, P473, DOI 10.1042/0264-6021:3630473
   Schagat TL, 2001, J IMMUNOL, V166, P2727, DOI 10.4049/jimmunol.166.4.2727
   SCHUBERT MA, 1995, J BIOMED MATER RES, V29, P337, DOI 10.1002/jbm.820290309
   Shahan TA, 1999, CANCER RES, V59, P4584
   Shinohara M, 2006, CANCER SCI, V97, P889, DOI 10.1111/j.1349-7006.2006.00245.x
   Slee JB, 2014, POLYMERS-BASEL, V6, P2526, DOI 10.3390/polym6102526
   Smadja DM, 2011, ARTERIOSCL THROM VAS, V31, P551, DOI 10.1161/ATVBAHA.110.220624
   Sperling C, 2004, BIOMATERIALS, V25, P5101, DOI 10.1016/j.biomaterials.2003.12.014
   Sperling C, 2007, BIOMATERIALS, V28, P3617, DOI 10.1016/j.biomaterials.2007.04.041
   Stachelek SJ, 2007, J BIOMED MATER RES A, V82A, P1004, DOI 10.1002/jbm.a.31215
   Stachelek SJ, 2011, BIOMATERIALS, V32, P4317, DOI 10.1016/j.biomaterials.2011.02.053
   Stachelek SJ, 2010, J BIOMED MATER RES A, V94A, P751, DOI 10.1002/jbm.a.32755
   Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x
   Stevens KNJ, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/29464
   STOKES K, 1990, Journal of Biomaterials Science Polymer Edition, V1, P207
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   Subramanian S, 2006, TRANSFUS CLIN BIOL, V13, P31, DOI 10.1016/j.tracli.2006.02.009
   Subramanian S, 2006, BLOOD, V107, P2548, DOI 10.1182/blood-2005-04-1463
   Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527
   Toutouzas K, 2013, CURR VASC PHARMACOL, V11, P379
   Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043
   Tsai RK, 2010, BLOOD CELL MOL DIS, V45, P67, DOI [10.1016/j.bcmd.2010.02.016, 10.1016/j.hcmd.2010.02.016]
   Ueda M, 2010, BIOMATERIALS, V31, P6394, DOI 10.1016/j.biomaterials.2010.05.006
   van den Berg TK, 2008, TRENDS IMMUNOL, V29, P203, DOI 10.1016/j.it.2008.02.004
   Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978
   Weber N, 2002, BIOMATERIALS, V23, P429, DOI 10.1016/S0142-9612(01)00122-3
   Wiggins MJ, 2001, J BIOMED MATER RES, V58, P302
   Wisniewski N, 2002, AM J PHYSIOL-ENDOC M, V282, pE1316, DOI 10.1152/ajpendo.00259.2001
   Wisniewski N, 2001, J BIOMED MATER RES, V57, P513, DOI 10.1002/1097-4636(20011215)57:4<513::AID-JBM1197>3.0.CO;2-E
   Yoo JW, 2010, CURR PHARM DESIGN, V16, P2298, DOI 10.2174/138161210791920496
   Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580
   ZUCKER MB, 1985, ARTERIOSCLEROSIS, V5, P2, DOI 10.1161/01.ATV.5.1.2
NR 92
TC 5
Z9 5
U1 2
U2 12
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD MAY
PY 2016
VL 241
IS 10
BP 1033
EP 1041
DI 10.1177/1535370216647130
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DN6PJ
UT WOS:000377197400003
PM 27190273
OA Green Published
DA 2018-10-19
ER

PT J
AU Garash, R
   Bajpai, A
   Marcinkiewicz, BM
   Spiller, KL
AF Garash, Reham
   Bajpai, Anamika
   Marcinkiewicz, Brandon M.
   Spiller, Kara L.
TI Drug delivery strategies to control macrophages for tissue repair and
   regeneration
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Review
DE Biomaterials; macrophage; drugs; wound; repair
ID FOREIGN-BODY RESPONSE; GIANT-CELL FORMATION; IN-VITRO; ANTIINFLAMMATORY
   MONOCYTES; LOCALIZED DELIVERY; ATHLETIC INJURIES; RECRUITMENT AGENT;
   BONE REGENERATION; DUAL RELEASE; SPINAL-CORD
AB Tissue repair and regeneration is a complex process. Our bodies have an excellent capacity to regenerate damaged tissues in many situations. However, tissue healing is impaired in injuries that exceed a critical size or are exacerbated by chronic inflammatory diseases like diabetes. In these instances, biomaterials and drug delivery strategies are often required to facilitate tissue regeneration by providing physical and biochemical cues. Inflammation is the body's response to injury. It is critical for wound healing and biomaterial integration and vascularization, as long as the timing is well controlled. For example, chronic inflammation is well known to impair healing in chronic wounds. In this review, we highlight the importance of a well-controlled inflammatory response, primarily mediated by macrophages in tissue repair and regeneration and discuss various strategies designed to promote regeneration by controlling macrophage behavior. These strategies include temporally controlled delivery of anti-inflammatory drugs, delivery of macrophages as cellular therapy, controlled release of cytokines that modulate macrophage phenotype, and the design of nanoparticles that exploit the inherent phagocytic behavior of macrophages. A clear outcome of this review is that a deeper understanding of the role and timing of complex macrophage phenotypes or activation states is required to fully harness their abilities with drug delivery strategies.
C1 [Garash, Reham; Bajpai, Anamika; Marcinkiewicz, Brandon M.; Spiller, Kara L.] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Biomat & Regenerat Med Lab, Philadelphia, PA 19104 USA.
RP Spiller, KL (reprint author), Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Biomat & Regenerat Med Lab, Philadelphia, PA 19104 USA.
EM Spiller@drexel.edu
FU NHLBI [1R01 HL130037-01]; Drexel-Coulter Translational Research
   Partnership
FX Work in the laboratory of KLS is supported by NHLBI 1R01 HL130037-01 and
   the Drexel-Coulter Translational Research Partnership.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075
   Awojoodu AO, 2013, P NATL ACAD SCI USA, V110, P13785, DOI 10.1073/pnas.1221309110
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   BAKKER D, 1988, BIOMATERIALS, V9, P14, DOI 10.1016/0142-9612(88)90064-6
   Bartneck M, 2010, ACS NANO, V4, P3073, DOI 10.1021/nn100262h
   Camacho N, 2015, LUBRICANTS, V3, P597, DOI 10.3390/lubricants3030597
   Champion JA, 2009, PHARM RES-DORD, V26, P244, DOI 10.1007/s11095-008-9626-z
   CHONN A, 1992, J BIOL CHEM, V267, P18759
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   Fijn R, 2003, PHARM WORLD SCI, V25, P138, DOI 10.1023/A:1024830213832
   Ghanaati S, 2011, BIOMATERIALS, V32, P8150, DOI 10.1016/j.biomaterials.2011.07.041
   Glass GE, 2011, P NATL ACAD SCI USA, V108, P1585, DOI 10.1073/pnas.1018501108
   Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110
   Harel-Adar T, 2011, P NATL ACAD SCI USA, V108, P1827, DOI 10.1073/pnas.1015623108
   He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065
   Hetrick EM, 2007, BIOMATERIALS, V28, P4571, DOI 10.1016/j.biomaterials.2007.06.036
   Hirose N, 2008, CELL TRANSPLANT, V17, P211, DOI 10.3727/000000008783906919
   Hisatome T, 2005, BIOMATERIALS, V26, P4550, DOI 10.1016/j.biomaterials.2004.11.032
   Hsu CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131643
   Huang HJ, 2008, ACS NANO, V2, P203, DOI 10.1021/nn7000867
   Ihn H, 2002, J IMMUNOL, V168, P1895, DOI 10.4049/jimmunol.168.4.1895
   Jetten N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102994
   Jones MK, 1999, NAT MED, V5, P1418
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   Keeler GD, 2015, ACTA BIOMATER, V12, P11, DOI 10.1016/j.actbio.2014.10.022
   Khallou-Laschet J, 2010, PLOS ONE, V5, pe8852
   Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009
   Kim YH, 2016, J BIOMED MATER RES A, V104, P942, DOI 10.1002/jbm.a.35635
   Kim YH, 2014, BIOMATERIALS, V35, P214, DOI 10.1016/j.biomaterials.2013.09.103
   Knipper JA, 2015, IMMUNITY, V43, P803, DOI 10.1016/j.immuni.2015.09.005
   Koh TJ, 2011, EXPERT REV MOL MED, V13, pe2
   Krieger JR, 2016, BIOMATERIALS, V77, P280, DOI 10.1016/j.biomaterials.2015.10.045
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Kzhyshkowska J, 2015, J LEUKOCYTE BIOL, V98, P953, DOI 10.1189/jlb.5VMR0415-166R
   Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018
   Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732
   Leor J, 2006, CIRCULATION, V114
   Li SX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061799
   Long J, 2002, J BONE JOINT SURG AM, V84A, P1763, DOI 10.2106/00004623-200210000-00004
   Lu JY, 2013, KIDNEY INT, V84, P745, DOI 10.1038/ki.2013.135
   MAHESHWARI RK, 1991, J CELL PHYSIOL, V146, P164, DOI 10.1002/jcp.1041460121
   Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201
   Mehallo CJ, 2006, CLIN J SPORT MED, V16, P170, DOI 10.1097/00042752-200603000-00015
   Meijer C, 2000, LIVER, V20, P66, DOI 10.1034/j.1600-0676.2000.020001066.x
   Milde R, 2015, CELL REP, V13, P1937, DOI 10.1016/j.celrep.2015.10.065
   Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248
   Mirza RE, 2014, DIABETES, V63, P1103, DOI 10.2337/db13-0927
   Mirza RE, 2013, DIABETES, V62, P2579, DOI 10.2337/db12-1450
   Mokarram N, 2012, BIOMATERIALS, V33, P8793, DOI 10.1016/j.biomaterials.2012.08.050
   Mosqueira VCF, 2001, BIOMATERIALS, V22, P2967, DOI 10.1016/S0142-9612(01)00043-6
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Mou Xiaodun, 2011, J Diabetes Sci Technol, V5, P619
   Nassiri S, 2015, TISSUE REGENERATION, P65
   Nassiri S, 2015, J INVEST DERMATOL, V135, P1700, DOI 10.1038/jid.2015.30
   Nichols AW, 2005, CLIN J SPORT MED, V15, P370
   Pajarinen J, 2015, J BIOMED MATER RES A, V103, P1339, DOI 10.1002/jbm.a.35278
   Pentecost A.E., 2016, MICROSCALE TECHNOLOG, P291
   Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118
   Pountos I, 2012, SCI WORLD J, DOI 10.1100/2012/606404
   Raggatt LJ, 2014, AM J PATHOL, V184, P3192, DOI 10.1016/j.ajpath.2014.08.017
   Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814
   Reeves ARD, 2015, BIOMATERIALS, V73, P272, DOI 10.1016/j.biomaterials.2015.09.027
   Rodriguez A, 2009, J BIOMED MATER RES A, V90A, P106, DOI 10.1002/jbm.a.32050
   Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107
   Rybalko V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145550
   Saito A, 2003, INT ARCH ALLERGY IMM, V132, P168, DOI 10.1159/000073718
   SATO N, 1990, J INVEST DERMATOL, V95, pS85, DOI 10.1111/1523-1747.ep12874809
   Schlundt C., 2015, BONE
   Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490
   Spiller K., 2014, ANN BIOMED ENG, V43, P616
   Spiller KL, 2015, WOUND REPAIR REGEN, V23, pA40
   Spiller KL, 2015, BIOMATERIALS, V37, P194, DOI 10.1016/j.biomaterials.2014.10.017
   Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012
   Spiller KL, 2015, EXP CELL RES
   Stevens KR, 2002, J BIOMAT SCI-POLYM E, V13, P1353, DOI 10.1163/15685620260449741
   Torihashi S, 2000, HISTOCHEM CELL BIOL, V113, P73, DOI 10.1007/s004180050009
   Vacanti NM, 2012, BIOMACROMOLECULES, V13, P3031, DOI 10.1021/bm300520u
   van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547
   Veiseh O, 2015, NAT MATER, V14, P643, DOI [10.1038/NMAT4290, 10.1038/nmat4290]
   Volpert OV, 1998, J EXP MED, V188, P1039, DOI 10.1084/jem.188.6.1039
   Wang Y, 2007, KIDNEY INT, V72, P290, DOI 10.1038/sj.ki.5002275
   Wood S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091574
   Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006
   Yu T, 2015, BIOMATERIALS REGENER, P17
   Yu T, 2016, J BIOMAT SCI-POLYM E, V27, P721, DOI 10.1080/09205063.2016.1155881
   Zuloff-Shani A, 2010, ARCH GERONTOL GERIAT, V51, P268, DOI 10.1016/j.archger.2009.11.015
NR 87
TC 13
Z9 14
U1 1
U2 29
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD MAY
PY 2016
VL 241
IS 10
BP 1054
EP 1063
DI 10.1177/1535370216649444
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DN6PJ
UT WOS:000377197400005
PM 27190256
OA Green Published
DA 2018-10-19
ER

PT J
AU Farhadi, SA
   Hudalla, GA
AF Farhadi, Shaheen A.
   Hudalla, Gregory A.
TI Engineering galectin-glycan interactions for immunotherapy and
   immunomodulation
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Review
DE Biomaterial; bionanoscience; engineering; immunology; immunobiology;
   glycan
ID TUMOR-INFILTRATING LYMPHOCYTES; GALACTOSIDE-BINDING LECTIN;
   T-CELL-ACTIVATION; EXTRACELLULAR-MATRIX; DENDRITIC CELLS; RECOGNITION
   RECEPTORS; SOLUBLE GALECTIN-1; PANCREATIC-CANCER; IMMUNE PRIVILEGE;
   APOPTOSIS
AB Galectins, a 15-member family of soluble carbohydrate-binding proteins, are receiving increasing interest as therapeutic targets for immunotherapy and immunomodulation due to their role as extracellular signals that regulate innate and adaptive immune cell phenotype and function. However, different galectins can have redundant, synergistic, or antagonistic signaling activity in normal immunological responses, such as resolution of inflammation and induction of antigen-specific tolerance. In addition, certain galectins can be hijacked to promote progression of immunopathologies, such as tumor immune privilege, metastasis, and viral infection, while others can inhibit these processes. Thus, eliciting a desired immunological outcome will likely necessitate therapeutics that can precisely enhance or inhibit particular galectin-glycan interactions. Multivalency is an important determinant of the affinity and specificity of natural galectin-glycan interactions, and is emerging as a key design element for therapeutics that can effectively manipulate galectin bioactivity. This minireview surveys current molecular and biomaterial engineering approaches to create therapeutics that can stabilize galectin multivalency or recapitulate natural glycan multivalency (i.e. the glycocluster effect). In particular, we highlight examples of using natural and engineered multivalent galectins for immunosuppression and immune tolerance, with a particular emphasis on treating autoimmune diseases or avoiding transplant rejection. In addition, we present examples of multivalent inhibitors of galectin-glycan interactions to maintain or restore T-cell function, with a particular emphasis on promoting antitumor immunity. Finally, we discuss emerging opportunities to further engineer galectin-glycan interactions for immunotherapy and immunomodulation.
C1 [Farhadi, Shaheen A.; Hudalla, Gregory A.] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.
RP Hudalla, GA (reprint author), Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.
EM ghudalla@bme.ufl.edu
FU National Science Foundation CAREER award [DMR-1455201]
FX This work was supported by a National Science Foundation CAREER award to
   G.A.H. (DMR-1455201).
CR Andre S, 2001, CHEMBIOCHEM, V2, P822, DOI 10.1002/1439-7633(20011105)2:11<822::AID-CBIC822>3.0.CO;2-W
   Auvynet C, 2013, GLYCOBIOLOGY, V23, P32, DOI 10.1093/glycob/cws128
   Banh A, 2011, CANCER RES, V71, P4423, DOI 10.1158/0008-5472.CAN-10-4157
   Baum LG, 2003, CLIN IMMUNOL, V109, P295, DOI 10.1016/j.clim.2003.08.003
   Beer MV, 2013, ADV HEALTHC MATER, V2, P306, DOI 10.1002/adhm.201200080
   Belardi B, 2012, J AM CHEM SOC, V134, P9549, DOI 10.1021/ja301694s
   Belitsky JM, 2007, CHEM BIOL, V14, P1140, DOI 10.1016/j.chembiol.2007.09.007
   Belo AI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065957
   Bernardi A, 2013, CHEM SOC REV, V42, P4709, DOI 10.1039/c2cs35408j
   Blanchard H, 2014, AUST J CHEM, V67, P1763, DOI 10.1071/CH14362
   Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680
   Blois SM, 2015, J REPROD IMMUNOL, V108, P33, DOI 10.1016/j.jri.2014.12.001
   Branson TR, 2013, CHEM SOC REV, V42, P4613, DOI 10.1039/c2cs35430f
   Cedeno-Laurent F, 2012, BLOOD, V119, P3534, DOI 10.1182/blood-2011-12-396457
   Cedeno-Laurent F, 2012, J IMMUNOL, V188, P3127, DOI 10.4049/jimmunol.1103433
   Cedeno-Laurent F, 2012, CLIN IMMUNOL, V142, P107, DOI 10.1016/j.clim.2011.09.011
   Cedeno-Laurent F, 2012, J INVEST DERMATOL, V132, P410, DOI 10.1038/jid.2011.335
   Cedeno-Laurent F, 2010, J IMMUNOL, V185, P4659, DOI 10.4049/jimmunol.1000715
   Chen HY, 2009, P NATL ACAD SCI USA, V106, P14496, DOI 10.1073/pnas.0903497106
   Chernyy ES, 2011, BIOCHEMISTRY-MOSCOW+, V76, P958, DOI 10.1134/S0006297911080128
   CHO MJ, 1995, J BIOL CHEM, V270, P5207, DOI 10.1074/jbc.270.10.5207
   Chung CD, 2000, J IMMUNOL, V165, P3722, DOI 10.4049/jimmunol.165.7.3722
   Collins BE, 2004, CURR OPIN CHEM BIOL, V8, P617, DOI 10.1016/j.cbpa.2004.10.004
   Compagno D, 2014, CURR MOL MED, V14, P630, DOI 10.2174/1566524014666140603101953
   Cooper DNW, 1999, GLYCOBIOLOGY, V9, P979, DOI 10.1093/glycob/9.10.979
   Cousin JM, 2015, BEILSTEIN J ORG CHEM, V11, P739, DOI 10.3762/bjoc.11.84
   Crocker PR., 2001, MAMMALIAN CARBOHYDRA
   Dahms NM, 2008, GLYCOBIOLOGY, V18, P664, DOI 10.1093/glycob/cwn061
   Dalotto-Moreno T, 2013, CANCER RES, V73, P1107, DOI 10.1158/0008-5472.CAN-12-2418
   Demotte N, 2014, CLIN CANCER RES, V20, P1823, DOI 10.1158/1078-0432.CCR-13-2459
   Demotte N, 2010, CANCER RES, V70, P7476, DOI 10.1158/0008-5472.CAN-10-0761
   Dettin L, 2003, BIOL REPROD, V68, P51, DOI 10.1095/biolreprod.102.006361
   Di Lella S, 2011, BIOCHEMISTRY-US, V50, P7842, DOI 10.1021/bi201121m
   Drickamer K, 2015, CURR OPIN STRUC BIOL, V34, P26, DOI 10.1016/j.sbi.2015.06.003
   Ebrahim AH, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.09.12
   Elola MT, 2015, BIOCHEM J, V469, P1, DOI 10.1042/BJ20150461
   Fettis MM, 2016, J MATER CHEM B, V4, P3054, DOI 10.1039/c5tb02446c
   Fontaniella B, 2004, PLANT PHYSIOL BIOCH, V42, P773, DOI 10.1016/j.plaphy.2004.09.003
   Fulcher JA, 2006, J IMMUNOL, V177, P216, DOI 10.4049/jimmunol.177.1.216
   Gauthier L, 2002, P NATL ACAD SCI USA, V99, P13014, DOI 10.1073/pnas.202323999
   Gauthier S, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-105
   Giudicelli V, 1997, GLYCOBIOLOGY, V7, pR8
   Grigorian A, 2009, IMMUNOL REV, V230, P232, DOI 10.1111/j.1600-065X.2009.00796.x
   He JL, 2004, J BIOL CHEM, V279, P4705, DOI 10.1074/jbc.M311183200
   Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364
   Horlacher T, 2010, CHEMBIOCHEM, V11, P1563, DOI 10.1002/cbic.201000020
   Huang ML, 2016, EXP BIOL MED, V241, P1042, DOI 10.1177/1535370216647811
   Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772
   Ishida K, 2003, OCUL IMMUNOL INFLAMM, V11, P91, DOI 10.1076/ocii.11.2.91.15914
   Ito K, 2012, CANCER METAST REV, V31, P763, DOI 10.1007/s10555-012-9388-2
   Ito K, 2012, CLIN EXP METASTAS, V29, P561, DOI 10.1007/s10585-012-9471-7
   Ito K, 2011, ANGIOGENESIS, V14, P293, DOI 10.1007/s10456-011-9213-5
   Kaltner H, 1998, ACTA ANAT, V161, P162
   Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]
   Kang CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15659
   Kouo T, 2015, CANCER IMMUNOL RES, V3, P412, DOI 10.1158/2326-6066.CIR-14-0150
   Kuwabara I, 1996, J IMMUNOL, V156, P3939
   Leppanen A, 2005, J BIOL CHEM, V280, P5549, DOI 10.1074/jbc.m412019200
   Liu FT, 2012, ANN NY ACAD SCI, V1253, P80, DOI 10.1111/j.1749-6632.2011.06386.x
   Liu SD, 2008, BLOOD, V112, P120, DOI 10.1182/blood-2007-09-114181
   Lundquist JJ, 2002, CHEM REV, V102, P555, DOI 10.1021/cr000418f
   Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737
   MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650
   Mascanfroni ID, 2011, INT IMMUNOPHARMACOL, V11, P833, DOI 10.1016/j.intimp.2011.01.021
   McDonald DM, 2015, FRONT CHEM, V3, DOI 10.3389/fchem.2015.00060
   Mercier S, 2008, VIROLOGY, V371, P121, DOI 10.1016/j.virol.2007.09.034
   Merlin J, 2011, ONCOGENE, V30, P2514, DOI 10.1038/onc.2010.631
   Michel AK, 2014, CHEMBIOCHEM, V15, P2106, DOI 10.1002/cbic.201402134
   Miller MC, 2009, BIOCHEM J, V421, P211, DOI 10.1042/BJ20090265
   Minko T, 2004, ADV DRUG DELIVER REV, V56, P491, DOI 10.1016/j.addr.2003.10.017
   Miura T, 2004, CELL DEATH DIFFER, V11, P1076, DOI 10.1038/sj.cdd.4401462
   Moiseeva EP, 2003, BBA-GEN SUBJECTS, V1619, P125, DOI 10.1016/S0304-4165(02)00447-6
   Morelli L, 2011, EUR J ORG CHEM, P5723, DOI 10.1002/ejoc.201100296
   Motran CC, 2008, EUR J IMMUNOL, V38, P3015, DOI 10.1002/eji.200838295
   Nabi IR, 2015, J CELL SCI, V128, P2213, DOI 10.1242/jcs.151159
   Nelson A, 2004, J AM CHEM SOC, V126, P11914, DOI 10.1021/ja0491073
   Nishi N, 2008, GLYCOBIOLOGY, V18, P1065, DOI 10.1093/glycob/cwn089
   Norling LV, 2009, J ENDOCRINOL, V201, P169, DOI 10.1677/JOE-08-0512
   Panjwani N, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.09.09
   PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0
   Perone MJ, 2009, J IMMUNOL, V182, P2641, DOI 10.4049/jimmunol.0800839
   Rabinovich G, 1999, J EXP MED, V190, P385, DOI 10.1084/jem.190.3.385
   Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536
   Restuccia A, 2016, J MATER CHEM B, V4, P1569, DOI 10.1039/c5tb01780g
   Restuccia A, 2015, CELL MOL BIOENG, V8, P471, DOI 10.1007/s12195-015-0399-2
   Rubinstein N, 2004, CANCER CELL, V5, P241, DOI 10.1016/S1535-6108(04)00024-8
   Ruvolo PP, 2015, BIOCHIM BIOPHYS ACTA, V1863, P562
   Santucci L, 2003, GASTROENTEROLOGY, V124, P1381, DOI 10.1016/S0016-5085(03)00267-1
   Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122
   St-Pierre C, 2012, ANTIMICROB AGENTS CH, V56, P154, DOI 10.1128/AAC.05595-11
   St-Pierre C, 2011, J VIROL, V85, P11742, DOI 10.1128/JVI.05351-11
   Stannard KA, 2010, CANCER LETT, V299, P95, DOI 10.1016/j.canlet.2010.08.005
   Starossom SC, 2012, IMMUNITY, V37, P249, DOI 10.1016/j.immuni.2012.05.023
   Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200
   Stowell SR, 2015, METHODS MOL BIOL, V1207, P51, DOI 10.1007/978-1-4939-1396-1_3
   Stowell SR, 2009, J BIOL CHEM, V284, P4989, DOI 10.1074/jbc.M808925200
   Tandon R, 2014, AIDS RES HUM RETROV, V30, P654, DOI [10.1089/aid.2014.0004, 10.1089/AID.2014.0004]
   Tang D, 2015, TUMOR BIOL, V36, P5617, DOI 10.1007/s13277-015-3233-5
   Thiemann S, 2016, ANNU REV IMMUNOL, V34, P91
   Thiemann S, 2015, J BIOL CHEM, V290, P22662, DOI 10.1074/jbc.M115.644799
   Thijssen VL, 2014, GLYCOBIOLOGY, V24, P915, DOI 10.1093/glycob/cwu048
   Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1489
   Toscano MA, 2006, J IMMUNOL, V176, P6323, DOI 10.4049/jimmunol.176.10.6323
   van der Leij J, 2007, MOL IMMUNOL, V44, P506, DOI 10.1016/j.molimm.2006.02.011
   Vasta GR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00199
   Vasta GR, 2012, ADV EXP MED BIOL, V946, P21, DOI 10.1007/978-1-4614-0106-3_2
   Vella M, 2015, EXPERT OPIN BIOL TH, V15, P529, DOI 10.1517/14712598.2015.993375
   Vespa GNR, 1999, J IMMUNOL, V162, P799
   Weisman A, 2015, ADV DRUG DELIVER REV, V90, P81, DOI 10.1016/j.addr.2015.05.011
   Xu GS, 2010, INT IMMUNOPHARMACOL, V10, P643, DOI 10.1016/j.intimp.2010.03.001
   Yamamoto K, 2009, BIOL PHARM BULL, V32, P767, DOI 10.1248/bpb.32.767
   Yan XB, 2015, BIOMACROMOLECULES, V16, P1827, DOI 10.1021/acs.biomac.5b00413
NR 112
TC 4
Z9 4
U1 1
U2 25
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD MAY
PY 2016
VL 241
IS 10
BP 1074
EP 1083
DI 10.1177/1535370216650055
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DN6PJ
UT WOS:000377197400007
PM 27229902
OA Green Published
DA 2018-10-19
ER

PT J
AU Ogle, ME
   Segar, CE
   Sridhar, S
   Botchwey, EA
AF Ogle, Molly E.
   Segar, Claire E.
   Sridhar, Sraeyes
   Botchwey, Edward A.
TI Monocytes and macrophages in tissue repair: Implications for
   immunoregenerative biomaterial design
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Review
DE Monocyte; macrophage; biomaterial; regeneration; wound healing;
   inflammation
ID SKELETAL-MUSCLE INJURY; POLY(ETHYLENE GLYCOL)-BASED HYDROGELS; ACUTE
   MYOCARDIAL-INFARCTION; COLLATERAL ARTERY GROWTH; FOREIGN-BODY REACTION;
   VIVO HOST RESPONSE; IN-VIVO; CIRCULATING MONOCYTES; RESIDENT
   MACROPHAGES; ANTIINFLAMMATORY MONOCYTES
AB Monocytes and macrophages play a critical role in tissue development, homeostasis, and injury repair. These innate immune cells participate in guiding vascular remodeling, stimulation of local stem and progenitor cells, and structural repair of tissues such as muscle and bone. Therefore, there is a great interest in harnessing this powerful endogenous cell source for therapeutic regeneration through immunoregenerative biomaterial engineering. These materials seek to harness specific subpopulations of monocytes/macrophages to promote repair by influencing their recruitment, positioning, differentiation, and function within a damaged tissue. Monocyte and macrophage phenotypes span a continuum of inflammatory (M1) to anti-inflammatory or pro-regenerative cells (M2), and their heterogeneous functions are highly dependent on microenvironmental cues within the injury niche. Increasing evidence suggests that division of labor among subpopulations of monocytes and macrophages could allow for harnessing regenerative functions over inflammatory functions of myeloid cells; however, the complex balance between necessary functions of inflammatory versus regenerative myeloid cells remains to be fully elucidated. Historically, biomaterial-based therapies for promoting tissue regeneration were designed to minimize the host inflammatory response; although, recent appreciation for the roles that innate immune cells play in tissue repair and material integration has shifted this paradigm. A number of opportunities exist to exploit known signaling systems of specific populations of monocytes/macrophages to promote repair and to better understand the biological and pathological roles of myeloid cells. This review seeks to outline the characteristics of distinct populations of monocytes and macrophages, identify the role of these cells within diverse tissue injury niches, and offer design criteria for immunoregenerative biomaterials given the intrinsic inflammatory response to their implantation.
C1 [Ogle, Molly E.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   Emory Univ, Atlanta, GA 30332 USA.
RP Ogle, ME (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
EM molly.ogle@bme.gatech.edu
FU NIH [5R01AR056445]; American Heart Association [15PRE25090024]; P.E.O.
   Scholar Award
FX This work was supported by NIH 5R01AR056445, American Heart Association
   Grant 15PRE25090024 (CES), and P.E.O. Scholar Award (CES).
CR Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354
   Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075
   Arnold L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9972
   Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883
   Avraham-Davidi I, 2013, J EXP MED, V210, P2611, DOI 10.1084/jem.20120690
   Awojoodu AO, 2014, BLOOD, V124, P1941, DOI 10.1182/blood-2014-01-543652
   Awojoodu AO, 2013, P NATL ACAD SCI USA, V110, P13785, DOI 10.1073/pnas.1221309110
   Bai F, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015007
   Bartneck M, 2012, BIOMATERIALS, V33, P4136, DOI 10.1016/j.biomaterials.2012.02.050
   Bergmann CE, 2006, J LEUKOCYTE BIOL, V80, P59, DOI 10.1189/jlb.0206087
   Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Cao HQ, 2010, J BIOMED MATER RES A, V93A, P1151, DOI 10.1002/jbm.a.32609
   Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010
   Champagne CM, 2002, BONE, V30, P26, DOI 10.1016/S8756-3282(01)00638-X
   Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103
   Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Cho SW, 2014, P NATL ACAD SCI USA, V111, P1545, DOI 10.1073/pnas.1315153111
   Collison JL, 2015, J IMMUNOL, V195, P1162, DOI 10.4049/jimmunol.1401806
   Crane MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086660
   Dal-Secco D, 2015, J EXP MED, V212, P447, DOI 10.1084/jem.20141539
   Deng B, 2012, J IMMUNOL, V189, P3669, DOI 10.4049/jimmunol.1103180
   Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249
   Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019
   Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832
   Fereol S, 2006, CELL MOTIL CYTOSKEL, V63, P321, DOI 10.1002/cm.20130
   Garg K, 2013, BIOMATERIALS, V34, P4439, DOI 10.1016/j.biomaterials.2013.02.065
   Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419
   Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2
   Getts DR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007563
   Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324
   Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110
   Goncalves R, 2011, J EXP MED, V208, P1253, DOI 10.1084/jem.20101751
   Goodman SB, 2007, BIOMATERIALS, V28, P5044, DOI 10.1016/j.biomaterials.2007.06.035
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Gref R, 2000, COLLOID SURFACE B, V18, P301, DOI 10.1016/S0927-7765(99)00156-3
   Griffith CK, 2005, TISSUE ENG, V11, P257, DOI 10.1089/ten.2005.11.257
   Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036
   Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063
   Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004
   Heil M, 2004, CIRC RES, V94, P671, DOI 10.1161/01.RES.0000122041.73808.B5
   Heil M, 2002, AM J PHYSIOL-HEART C, V283, pH2411, DOI 10.1152/ajpheart.01098.2001
   Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638
   Hoefer IE, 2004, CIRC RES, V94, P1179, DOI 10.1161/01.RES.0000126922.18222.F0
   Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011
   Hoffman AS, 2013, ADV DRUG DELIVER REV, V65, P10, DOI 10.1016/j.addr.2012.11.004
   Hsu CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131643
   Ito WD, 1997, CIRC RES, V80, P829
   Jay SM, 2010, BIOMATERIALS, V31, P3054, DOI 10.1016/j.biomaterials.2010.01.014
   Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999
   Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Knipper JA, 2015, IMMUNITY, V43, P803, DOI 10.1016/j.immuni.2015.09.005
   Krieger JR, 2016, BIOMATERIALS, V77, P280, DOI 10.1016/j.biomaterials.2015.10.045
   Kusaka T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092634
   Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018
   Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111
   Lee TT, 2015, NAT MATER, V14, P352, DOI [10.1038/NMAT4157, 10.1038/nmat4157]
   Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009
   Li L, 2012, J BIOL CHEM, V287, P25353, DOI 10.1074/jbc.M112.349126
   Lu HY, 2011, FASEB J, V25, P358, DOI 10.1096/fj.10-171579
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Lynn AD, 2011, ACTA BIOMATER, V7, P123, DOI 10.1016/j.actbio.2010.07.033
   Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Majmudar MD, 2013, CIRCULATION, V127, P2038, DOI 10.1161/CIRCULATIONAHA.112.000116
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303
   McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110
   Melgar-Lesmes P, 2015, J HEPATOL, V63, P917, DOI 10.1016/j.jhep.2015.05.011
   Mokarram N, 2012, BIOMATERIALS, V33, P8793, DOI 10.1016/j.biomaterials.2012.08.050
   Moldovan NI, 2000, CIRC RES, V87, P378
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   MUTSAERS SE, 1988, J LEUKOCYTE BIOL, V44, P17
   Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885
   Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346
   Nassiri S, 2015, J INVEST DERMATOL, V135, P1700, DOI 10.1038/jid.2015.30
   Nickerson MM, 2009, ANGIOGENESIS, V12, P355, DOI 10.1007/s10456-009-9157-1
   Ogle ME, 2014, ACTA BIOMATER, V10, P4704, DOI 10.1016/j.actbio.2014.08.007
   Padmanabhan J, 2014, ACS NANO, V8, P4366, DOI 10.1021/nn501874q
   PASSLICK B, 1989, BLOOD, V74, P2527
   Patel NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041024
   Patterson J, 2011, BIOMATERIALS, V32, P1301, DOI 10.1016/j.biomaterials.2010.10.016
   Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989
   Phelps EA, 2013, BIOMATERIALS, V34, P4602, DOI 10.1016/j.biomaterials.2013.03.012
   Pinto AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036814
   Raggatt LJ, 2014, AM J PATHOL, V184, P3192, DOI 10.1016/j.ajpath.2014.08.017
   Reeves ARD, 2015, BIOMATERIALS, V73, P272, DOI 10.1016/j.biomaterials.2015.09.027
   Rettig L, 2010, BLOOD, V115, P4533, DOI 10.1182/blood-2009-11-247817
   Riedel T, 2013, LANGMUIR, V29, P3388, DOI 10.1021/la304886r
   Ruparelia N, 2015, EUR HEART J, V36, P1923, DOI 10.1093/eurheartj/ehv195
   Rzeniewicz K, 2015, P NATL ACAD SCI USA, V112, pE1461, DOI 10.1073/pnas.1417100112
   Saclier M, 2013, STEM CELLS, V31, P384, DOI 10.1002/stem.1288
   Sanders JE, 2000, J BIOMED MATER RES, V52, P231, DOI 10.1002/1097-4636(200010)52:1<231::AID-JBM29>3.0.CO;2-E
   Schlundt C, 2018, BONE, V106, P78, DOI 10.1016/j.bone.2015.10.019
   Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070
   Sinder BP, 2015, J BONE MINER RES, V30, P2140, DOI 10.1002/jbmr.2735
   Sironi M, 2006, J LEUKOCYTE BIOL, V80, P342, DOI 10.1189/jlb.1005586
   Slaney CY, 2011, IMMUNOL CELL BIOL, V89, P7, DOI 10.1038/icb.2010.110
   Spiller KL, 2016, EXP CELL RES, V347, P1, DOI 10.1016/j.yexcr.2015.10.017
   Spiller KL, 2015, BIOMATERIALS, V37, P194, DOI 10.1016/j.biomaterials.2014.10.017
   Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012
   Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160
   Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410
   Swartzlander MD, 2015, BIOMATERIALS, V41, P26, DOI 10.1016/j.biomaterials.2014.11.026
   Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202
   TABATA Y, 1988, BIOMATERIALS, V9, P356, DOI 10.1016/0142-9612(88)90033-6
   Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549
   Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244
   van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547
   VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415
   Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011
   Veiseh O, 2015, NAT MATER, V14, P643, DOI [10.1038/NMAT4290, 10.1038/nmat4290]
   Vi L, 2015, J BONE MINER RES, V30, P1090, DOI 10.1002/jbmr.2422
   Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534
   Wolf MT, 2014, BIOMATERIALS, V35, P6838, DOI 10.1016/j.biomaterials.2014.04.115
   Wu Andy C, 2013, Bonekey Rep, V2, P373, DOI 10.1038/bonekey.2013.107
   Xie H, 2014, NAT MED, V20, P1270, DOI 10.1038/nm.3668
   Xing ZQ, 2010, DIS MODEL MECH, V3, P451, DOI 10.1242/dmm.003186
   Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001
   Yrlid U, 2006, J IMMUNOL, V176, P4155, DOI 10.4049/jimmunol.176.7.4155
   Zhao WM, 2016, FASEB J, V30, P380, DOI 10.1096/fj.14-270090
NR 126
TC 47
Z9 49
U1 9
U2 38
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD MAY
PY 2016
VL 241
IS 10
BP 1084
EP 1097
DI 10.1177/1535370216650293
PG 14
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DN6PJ
UT WOS:000377197400008
PM 27229903
OA Green Published, Green Accepted
DA 2018-10-19
ER

PT J
AU Lewis, JS
   Allen, RP
AF Lewis, Jamal S.
   Allen, Riley P.
TI An introduction to biomaterial-based strategies for curbing autoimmunity
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Review
DE Immuno-engineering; biomaterials; autoimmune disease; particulate;
   immunotherapy; tolerogenic
ID REGULATORY T-CELLS; TOLEROGENIC DENDRITIC CELLS; PLASMA-PROTEIN
   ADSORPTION; INFLAMMATORY-DISEASES; NEGATIVE SELECTION;
   CROSS-PRESENTATION; POLYMER PARTICLES; IMMUNE-SYSTEM; LYMPH-NODES;
   EX-VIVO
AB Recently, scientists have made significant progress in the development of immunotherapeutics that correct aberrant, autoimmune responses. Yet, concerns about the safety, efficacy, and wide scale applicability continue to hinder use of contemporary, immunology-based strategies. There is a clear need for therapies that finely control molecular and cellular elements of the immune system. Biomaterial engineers have taken up this challenge to develop therapeutics with selective spatial and temporal control of immune cells. In this review, we introduce the immunology of autoimmune disorders, survey the current therapeutic strategies for autoimmune diseases, and highlight the ongoing research efforts to engineer the immune system using biomaterials, for positive therapeutic outcomes in treatment of autoimmune disorders.
C1 [Lewis, Jamal S.; Allen, Riley P.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.
RP Lewis, JS (reprint author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.
EM jamlewis@ucdavis.edu
FU National Institutes of Health [R43DK100132]
FX JSL gratefully acknowledges the grant support from the National
   Institutes of Health (award - R43DK100132).
CR Aarvak T, 2000, RHEUMATOLOGY, V39, P513, DOI 10.1093/rheumatology/39.5.513
   Andrews S., 2010, BLOOD, V115, P4
   Azar ST, 1999, CLIN DIAGN LAB IMMUN, V6, P306
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156
   Brunstein CG, 2011, BLOOD, V117, P1061, DOI 10.1182/blood-2010-07-293795
   Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407
   Butoescu N, 2009, BIOMATERIALS, V30, P1772, DOI 10.1016/j.biomaterials.2008.12.017
   Candon S, 2004, J IMMUNOL, V172, P2917, DOI 10.4049/jimmunol.172.5.2917
   Castro JE, 1996, IMMUNITY, V5, P617, DOI 10.1016/S1074-7613(00)80275-7
   Champion JA, 2009, PHARM RES-DORD, V26, P244, DOI 10.1007/s11095-008-9626-z
   Charlton B, 1995, CURR OPIN IMMUNOL, V7, P793, DOI 10.1016/0952-7915(95)80050-6
   Chatenoud L, 2007, NAT REV IMMUNOL, V7, P622, DOI 10.1038/nri2134
   Chen CR, 2003, J CLIN INVEST, V111, P1897, DOI 10.1172/JCI200317069
   De Temmerman ML, 2011, DRUG DISCOV TODAY, V16, P569, DOI 10.1016/j.drudis.2011.04.006
   Dinarello CA, 2003, VACCINE, V21, pS24, DOI 10.1016/S0264-410X(03)00196-8
   Forrester JV, 2008, MUCOSAL IMMUNOL, V1, P372, DOI 10.1038/mi.2008.27
   Giannoukakis N, 2013, IMMUNOTHERAPY-UK, V5, P569, DOI [10.2217/IMT.13.50, 10.2217/imt.13.50]
   Giannoukakis N, 2011, DIABETES CARE, V34, P2026, DOI 10.2337/dc11-0472
   Gref R, 2000, COLLOID SURFACE B, V18, P301, DOI 10.1016/S0927-7765(99)00156-3
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   Horwitz DA, 2004, SEMIN IMMUNOL, V16, P135, DOI 10.1016/j.smim.2003.12.009
   IMBACH P, 1990, AM J PEDIAT HEMATOL, V12, P134
   Jewell CM, 2011, P NATL ACAD SCI USA, V108, P15745, DOI 10.1073/pnas.1105200108
   Jiang WL, 2005, ADV DRUG DELIVER REV, V57, P391, DOI 10.1016/j.addr.2004.09.003
   Jilek S, 2004, PHARM RES, V21, P8
   Kamradt T, 2001, NEW ENGL J MED, V344, P655, DOI 10.1056/NEJM200103013440907
   Kang ZH, 2013, NAT NEUROSCI, V16, P1401, DOI 10.1038/nn.3505
   Keselowsky BG, 2011, HUM VACCINES, V7, P37, DOI 10.4161/hv.7.1.12916
   Kourtis IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061646
   Lacasse FX, 1998, PHARMACEUT RES, V15, P312, DOI 10.1023/A:1011935222652
   Lapadula G, 2014, INT J IMMUNOPATH PH, V27, P33, DOI 10.1177/03946320140270S103
   Lewis JS, 2014, J MATER CHEM B, V2, P2562, DOI 10.1039/c3tb21460e
   Lewis JS, 2014, MRS BULL, V39, P25, DOI 10.1557/mrs.2013.310
   Lewis JS, 2012, BIOMATERIALS, V33, P7221, DOI 10.1016/j.biomaterials.2012.06.049
   Liu Y, 2013, J MATER CHEM B, V1, P3888, DOI 10.1039/c3tb20383b
   Longhi MS, 2004, J HEPATOL, V41, P31, DOI 10.1016/j.hep.2004.03.008
   Look M, 2013, J CLIN INVEST, V123, P1741, DOI 10.1172/JCI65907
   Maddur MS, 2012, AM J PATHOL, V181, P8, DOI 10.1016/j.ajpath.2012.03.044
   Marek-Trzonkowska N, 2012, DIABETES CARE, V35, P1817, DOI 10.2337/dc12-0038
   Mccarthy DP, 2012, METHOD MOL BIOL, V900, P1
   Munier S, 2005, COLLOID SURFACE B, V43, P163, DOI 10.1016/j.colsurfb.2005.05.001
   Munir H, 2015, STEM CELLS DEV, V24, P2091, DOI 10.1089/scd.2015.0008
   Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173
   Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983
   Neoh KG, 2011, POLYM CHEM-UK, V2, P747, DOI 10.1039/c0py00266f
   Noack M, 2014, AUTOIMMUN REV, V13, P668, DOI 10.1016/j.autrev.2013.12.004
   NOSSAL GJV, 1994, CELL, V76, P229, DOI 10.1016/0092-8674(94)90331-X
   O'Shea JJ, 2014, CELL, V157, P227, DOI 10.1016/j.cell.2014.03.010
   Ostrov BE, 2015, IMMUNOL INVEST, V44, P777, DOI 10.3109/08820139.2015.1093912
   Osuji N, 2005, LEUKEMIA LYMPHOMA, V46, P723, DOI 10.1080/10428190500052156
   Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261
   Patterson H, 2014, CLIN EXP IMMUNOL, V176, P1, DOI 10.1111/cei.12248
   Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297
   Reddy ST, 2006, J CONTROL RELEASE, V112, P26, DOI 10.1016/j.jconrel.2006.01.006
   Rouse M, 2013, IMMUNOBIOLOGY, V218, P674, DOI 10.1016/j.imbio.2012.08.269
   Sheng Y, 2009, BIOMATERIALS, V30, P2340, DOI 10.1016/j.biomaterials.2008.12.070
   Shu S, 2006, CANCER METAST REV, V25, P233, DOI 10.1007/s10555-006-8503-7
   Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040
   Suwandi JS, 2015, CLIN EXP RHEUMATOL, V33, pS97
   Suzuki K, 2009, J EXP MED, V206, P1485, DOI 10.1084/jem.20090209
   Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139
   Tran KK, 2009, BIOMATERIALS, V30, P1356, DOI 10.1016/j.biomaterials.2008.11.034
   Tsai SE, 2010, IMMUNITY, V32, P568, DOI 10.1016/j.immuni.2010.03.015
   Virgolini L, 2004, BIOMED PHARMACOTHER, V58, P299, DOI 10.1016/j.biopha.2004.04.006
   von Boehmer H, 2009, EUR J IMMUNOL, V39, P2313, DOI 10.1002/eji.200939575
   VONBOEHMER H, 1988, ANNU REV IMMUNOL, V6, P309, DOI 10.1146/annurev.immunol.6.1.309
   Vrolix K, 2010, AUTOIMMUNITY, V43, P380, DOI 10.3109/08916930903518073
   Waeckerle-Men Y, 2004, J IMMUNOL METHODS, V287, P109, DOI 10.1016/j.jim.2004.01.010
   Wang NX, 2012, BIOTECHNOL BIOENG, V109, P1835, DOI 10.1002/bit.24431
   Yang YW, 2008, BIOMATERIALS, V29, P2516, DOI 10.1016/j.biomaterials.2008.02.015
   Yarkoni Y, 2010, IMMUNOL REV, V237, P249, DOI 10.1111/j.1600-065X.2010.00936.x
   Yoo JW, 2011, NAT REV DRUG DISCOV, V10, P521, DOI 10.1038/nrd3499
   Yoon YM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13155
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
   Zhang X, 2013, J IMMUNOL, V191, P5867, DOI 10.4049/jimmunol.1301926
NR 76
TC 3
Z9 4
U1 0
U2 12
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD MAY
PY 2016
VL 241
IS 10
BP 1107
EP 1115
DI 10.1177/1535370216650294
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DN6PJ
UT WOS:000377197400010
PM 27229905
OA Green Published
DA 2018-10-19
ER

PT J
AU Mewhort, HEM
   Turnbull, JD
   Satriano, A
   Chow, K
   Flewitt, JA
   Andrei, AC
   Guzzardi, DG
   Svystonyuk, DA
   White, JA
   Fedak, PWM
AF Mewhort, Holly E. M.
   Turnbull, Jeannine D.
   Satriano, Alessandro
   Chow, Kelvin
   Flewitt, Jacqueline A.
   Andrei, Adin-Cristian
   Guzzardi, David G.
   Svystonyuk, Daniyil A.
   White, James A.
   Fedak, Paul W. M.
TI Epicardial infarct repair with bioinductive extracellular matrix
   promotes vasculogenesis and myocardial recovery
SO JOURNAL OF HEART AND LUNG TRANSPLANTATION
LA English
DT Article
DE heart failure; myocardial infarction; extracellular matrix;
   angiogenesis; cardiac MRI; ischemia-reperfusion
ID PARACRINE MECHANISM; HEART-DISEASE; CELL; REGENERATION; SCAFFOLD;
   INJURY; ECM
AB BACKGROUND: Infarcted myocardium can remodel after successful reperfusion, resulting in left ventricular dilation and heart failure. Epicardial infarct repair (EIR) using a bioinductive extracellular matrix (ECM) biomaterial is a novel surgical approach to promote endogenous myocardial repair and functional recovery after myocardial infarction. Using a pre-clinical porcine model of coronary ischemia-reperfusion, we assessed the effects of EIR on regional functional recovery, safety, and possible mechanisms of benefit.
   METHODS: An ECM biomaterial (CorMatrix ECM) was applied to the epicardium after 75 minutes of coronary ischemia in a porcine model. Following ischemia-reperfusion injury, animals were randomly assigned in 2:1 fashion to EIR (n = 8) or sham treatment (n = 4). Serial cardiac magnetic resonance imaging was performed on normal (n = 4) and study animals at baseline (1 week) and 6 weeks after treatment. Myocardial function and tissue characteristics were assessed.
   RESULTS: Functional myocardial recovery was significantly increased by EIR compared with sham treatment (change in regional myocardial contraction at 6 weeks, 28.6 +/- 14.0% vs 4.2 +/- 13.5% wall thickening, p < 0.05). Animals receiving EIR had reduced adhesions compared with animals receiving sham treatment (1.44 +/- 0.51 vs 3.08 +/- 0.89, p < 0.05). Myocardial fibrosis was not increased, and EIR did not cause myocardial constriction, as left ventricular compliance by passive pressure distention at matched volumes was similar between groups (13.9 +/- 4.0 mm Hg in EIR group vs 16.0 +/- 5.2 mm Hg in sham group, p = 0.61). Animals receiving EIR showed evidence of vasculogenesis in the region of functional recovery.
   CONCLUSIONS: In addition to the beneficial effects of successful reperfusion, EIR using a bioinductive ECM enhances myocardial repair and functional recovery. Clinical translation of EIR early after myocardial infarction as an adjunct to surgical revascularization may be warranted in the future. (C) 2016 The Authors. Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation. All rights reserved.
C1 [Mewhort, Holly E. M.; Turnbull, Jeannine D.; Guzzardi, David G.; Svystonyuk, Daniyil A.; Fedak, Paul W. M.] Univ Calgary, Div Cardiac Surg, Calgary, AB, Canada.
   [Satriano, Alessandro; Flewitt, Jacqueline A.; White, James A.] Univ Calgary, Dept Cardiac Sci, Stephenson Cardiovasc MR Ctr, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada.
   [Chow, Kelvin] Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada.
   [Andrei, Adin-Cristian; Fedak, Paul W. M.] Northwestern Univ, Bluhin Cardiovasc Inst, Chicago, IL 60611 USA.
RP Fedak, PWM (reprint author), C880,1403-29 St NW, Calgary, AB T2N 2T9, Canada.
EM paul.fedak@gmail.com
OI Fedak, Paul/0000-0003-0658-9381; Andrei,
   Adin-Cristian/0000-0001-8129-3981
FU Alberta Innovates [201201075]
CR Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Baicu CF, 2003, AM J PHYSIOL-HEART C, V284, pH122, DOI 10.1152/ajpheart.00233.2002
   Balmer GM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5054
   Bayomy AF, 2012, LIFE SCI, V91, P823, DOI 10.1016/j.lfs.2012.08.034
   Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000
   Bock-Marquette I, 2009, J MOL CELL CARDIOL, V46, P728, DOI 10.1016/j.yjmcc.2009.01.017
   Burkhoff D, 2005, AM J PHYSIOL-HEART C, V289, pH501, DOI 10.1152/ajpheart.00138.2005
   Chow K, 2014, MAGN RESON MED, V71, P2082, DOI 10.1002/mrm.24878
   Daly KA, 2009, TISSUE ENG PT A, V15, P3877, DOI [10.1089/ten.tea.2009.0089, 10.1089/ten.TEA.2009.0089]
   Fazel S, 2005, J THORAC CARDIOV SUR, V130, P1310, DOI 10.1016/j.jtcvs.2005.07.012
   Fedak PWM, 2012, CIRC-HEART FAIL, V5, P349, DOI 10.1161/CIRCHEARTFAILURE.111.965889
   Fedak PWM, 2010, CARDIOVASC RES, V87, P8, DOI 10.1093/cvr/cvq124
   Fedak PWM, 2005, J THORAC CARDIOV SUR, V130, P1430, DOI 10.1016/j.jtcvs.2005.05.055
   Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f
   Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003
   Konertz WF, 2003, ANN THORAC SURG, V76, P1270, DOI 10.1016/S0003-4975(03)00733-1
   Mercer SE, 2013, DEV BIOL, V382, P457, DOI 10.1016/j.ydbio.2013.08.002
   Mewhort HEM, 2014, J THORAC CARDIOV SUR, V147, P1650, DOI 10.1016/j.jtcvs.2013.08.005
   Morita M, 2011, ANN THORAC SURG, V92, P617, DOI 10.1016/j.athoracsur.2011.04.051
   Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Satriano A, 2015, J BIOMECH, V48, P354, DOI 10.1016/j.jbiomech.2014.11.016
   Scholl FG, 2010, WORLD J PEDIATR CONG, V1, P132, DOI 10.1177/2150135110362092
   Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383
   Smart N, 2012, FUTUR CARDIOL, V8, P53, DOI [10.2217/fca.11.87, 10.2217/FCA.11.87]
   Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188
   van Wijk B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044692
   Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327
   Walther T, 2002, CIRCULATION S1, V106, pI23
   Witt RG, 2013, EUR J CARDIO-THORAC, V44, P72, DOI 10.1093/ejcts/ezs638
   Zaidi AH, 2014, J THORAC CARDIOVASC, V148, pe1
   Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529
NR 33
TC 4
Z9 4
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1053-2498
EI 1557-3117
J9 J HEART LUNG TRANSPL
JI J. Heart Lung Transplant.
PD MAY
PY 2016
VL 35
IS 5
BP 661
EP 670
DI 10.1016/j.healun.2016.01.012
PG 10
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery;
   Transplantation
SC Cardiovascular System & Cardiology; Respiratory System; Surgery;
   Transplantation
GA DN3HB
UT WOS:000376951900018
PM 26987597
OA Other Gold
DA 2018-10-19
ER

PT J
AU Diculescu, VC
   Chiorcea-Paquim, AM
   Oliveira-Brett, AM
AF Diculescu, Victor Constantin
   Chiorcea-Paquim, Ana-Maria
   Oliveira-Brett, Ana Maria
TI Applications of a DNA-electrochemical biosensor
SO TRAC-TRENDS IN ANALYTICAL CHEMISTRY
LA English
DT Review
DE DNA-electrochemical biosensor; Voltammetry; G-quadruplex; DNA oxidative
   damage; Protein; Drug; Metal ion; Pollutant; Free radical; Radiation
ID ATOMIC-FORCE MICROSCOPY; IN-SITU EVALUATION; DOPED DIAMOND ELECTRODE;
   GLASSY-CARBON ELECTRODE; VOLTAMMETRIC CHARACTERIZATION; OXIDATIVE
   DAMAGE; NUCLEIC-ACIDS; QUADRUPLEX NANOSTRUCTURES; PYROLYTIC-GRAPHITE;
   ANODIC VOLTAMMETRY
AB As carrier of genetic information, DNA is one of the most important intracellular targets that undergo modification and damage upon interaction with endogenous and exogenous factors. DNA is an excellent biomaterial for the construction of new devices, in nanotechnology and biosensor technology, for evaluation of DNA interaction with a broad range of chemical compounds and biomolecules, essential from a biological and a medical point of view.
   This review discusses recent advances on the design and applications of DNA-electrochemical biosensors that use DNA direct electrochemistry as a detection platform. AFM and voltammetric characterization of new bottom up immobilisation procedures of self-assembled nanostructures based on DNA single- and double-stranded, G-quadruplex, and i-motif configurations are presented, relevant for the development of new DNA-electrochemical biosensor devices. The applications of DNA-electrochemical biosensors, for the label-free detection of interactions with proteins, pharmaceutical compounds, metal ions and metal complexes, pollutants, free radicals, and electromagnetic radiation, were revisited. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Diculescu, Victor Constantin; Chiorcea-Paquim, Ana-Maria; Oliveira-Brett, Ana Maria] Univ Coimbra, Dept Chem, P-3000 Coimbra, Portugal.
RP Oliveira-Brett, AM (reprint author), Univ Coimbra, Dept Chem, P-3000 Coimbra, Portugal.
EM brett@ci.uc.pt
RI Diculescu, Victor/D-4132-2012; Chiorcea Paquim, Ana Maria/F-5036-2013
OI Diculescu, Victor/0000-0003-0719-8016; Chiorcea Paquim, Ana
   Maria/0000-0002-0605-5147
FU Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BPD/92726/2013,
   PTDC/SAU-BMA/118531/2010, PTDC/QEQ-MED/0586/2012,
   PTDC/DTP-FTO/0191/2012]; CEMUC-R (Research Unit 285); FEDER funds
   through the program COMPETE - Programa Operacional Factores de
   Competitividade; European Community Fund FEDER
FX Financial support from Fundacao para a Ciencia e a Tecnologia (FCT),
   grant SFRH/BPD/92726/2013 (A.-M. Chiorcea-Paquim), projects
   PTDC/SAU-BMA/118531/2010, PTDC/QEQ-MED/0586/2012,
   PTDC/DTP-FTO/0191/2012, and CEMUC-R (Research Unit 285), (co-financed by
   the European Community Fund FEDER), and FEDER funds through the program
   COMPETE - Programa Operacional Factores de Competitividade, is
   gratefully acknowledged.
CR Aydogdu G, 2014, SENSOR ACTUAT B-CHEM, V197, P211, DOI 10.1016/j.snb.2014.02.083
   Babula P, 2012, INT J ELECTROCHEM SC, V7, P7349
   BRABEC V, 1978, J ELECTROANAL CHEM, V88, P373, DOI 10.1016/S0022-0728(78)80125-9
   Brett AMO, 2005, BIOELECTROCHEMISTRY, V67, P181, DOI 10.1016/j.bioelechem.2004.06.008
   Brett AMO, 2005, BIOELECTROCHEMISTRY, V66, P117, DOI 10.1016/j.bioelechem.2004.05.009
   Brett AMO, 1997, J ELECTROANAL CHEM, V429, P95
   Chiorcea AM, 2004, BIOELECTROCHEMISTRY, V63, P229, DOI 10.1016/j.bioelechem.2003.09.029
   Paquim AMC, 2006, BIOPHYS CHEM, V121, P131, DOI 10.1016/j.bpc.2005.12.017
   Chiorcea-Paquim AM, 2009, ELECTROCHIM ACTA, V54, P1978, DOI 10.1016/j.electacta.2008.07.032
   Chiorcea-Paquim AM, 2006, ANAL CHEM, V78, P8256, DOI 10.1021/ac061040+
   Chiorcea-Paquim AM, 2013, GUANINE QUARTETS: STRUCTURE AND APPLICATION, P100, DOI 10.1039/9781849736954-00100
   Chiorcea-Paquim AM, 2015, ANAL CHEM, V87, P6141, DOI 10.1021/acs.analchem.5b00743
   Chiorcea-Paquim AM, 2014, ELECTROCHEM COMMUN, V45, P71, DOI 10.1016/j.elecom.2014.05.019
   Chiorcea-Paquim AM, 2014, ELECTROCHIM ACTA, V126, P162, DOI 10.1016/j.electacta.2013.07.150
   Chiorcea-Paquim AM, 2013, ELECTROCHIM ACTA, V110, P599, DOI 10.1016/j.electacta.2013.03.103
   Chiorcea-Paquim AM, 2013, PHYS CHEM CHEM PHYS, V15, P9117, DOI 10.1039/c3cp50866h
   Diculescu VC, 2006, ELECTROANAL, V18, P1963, DOI 10.1002/elan.200603602
   Corduneanu O, 2010, ANAL CHEM, V82, P1245, DOI 10.1021/ac902127d
   Corduneanu O, 2009, TALANTA, V77, P1843, DOI 10.1016/j.talanta.2008.10.046
   de Vasconcellos MC, 2016, J ELECTROANAL CHEM, V765, P168, DOI 10.1016/j.jelechem.2015.09.040
   Del Carlo M, 2012, BIOSENS BIOELECTRON, V31, P270, DOI 10.1016/j.bios.2011.10.030
   Deppman A, 2004, BRAZ J PHYS, V34, P958, DOI 10.1590/S0103-97332004000500068
   Diculescu VC, 2005, SENSORS-BASEL, V5, P377, DOI 10.3390/s5060377
   Diculescu VC, 2016, BIOELECTROCHEMISTRY, V107, P50, DOI 10.1016/j.bioelechem.2015.10.004
   Diculescu VC, 2013, BIOSENSORS AND CANCER, P187
   Diculescu VC, 2010, J NUCLEIC ACIDS, DOI 10.4061/2010/841932
   Diculescu VC, 2011, J ELECTROANAL CHEM, V656, P159, DOI 10.1016/j.jelechem.2010.11.037
   Dogan-Topal B, 2014, SENSOR ACTUAT B-CHEM, V194, P185, DOI 10.1016/j.snb.2013.12.088
   Enache TA, 2009, ELECTROCHEM COMMUN, V11, P1342, DOI 10.1016/j.elecom.2009.04.017
   Fojta M, 2000, BIOSENS BIOELECTRON, V15, P107, DOI 10.1016/S0956-5663(00)00070-1
   Hlavata L, 2015, MICROCHIM ACTA, V182, P1715, DOI 10.1007/s00604-015-1502-z
   Hlavata L, 2012, ELECTROCHIM ACTA, V71, P134, DOI 10.1016/j.electacta.2012.03.119
   Jalalvand AR, 2015, INT J BIOL MACROMOL, V79, P1004, DOI 10.1016/j.ijbiomac.2015.05.047
   Kara HES, 2014, BIOELECTROCHEMISTRY, V99, P17, DOI 10.1016/j.bioelechem.2014.06.002
   Katz E, 2005, PERSP BIOANAL, V1, P195, DOI 10.1016/S1871-0069(05)01005-0
   Kurbanoglu S, 2015, ELECTROCHIM ACTA, V169, P233, DOI 10.1016/j.electacta.2015.04.087
   Kuzin Y, 2015, ELECTROANAL, V27, P2800, DOI 10.1002/elan.201500312
   Lopes IC, 2012, ANALYST, V137, P1904, DOI 10.1039/c2an16017j
   Oliveira A.M., 2003, LANGMUIR, V19, P3830
   Oliveira A.M., 2003, ELECTROCHEM COMMUN, V5, P178
   Oliveira A.M. Brett, 2007, COMPREHENSIVE ANAL C, P413
   Oliveira SCB, 2008, BIOELECTROCHEMISTRY, V72, P53, DOI 10.1016/j.bioelechem.2007.11.004
   Oliveira SCB, 2009, BIOELECTROCHEMISTRY, V76, P201, DOI 10.1016/j.bioelechem.2009.03.003
   Oliveira SCB, 2012, LANGMUIR, V28, P4896, DOI 10.1021/la300070x
   Oliveira SCB, 2010, ANAL BIOANAL CHEM, V398, P1633, DOI 10.1007/s00216-010-4051-7
   Oliveira SCB, 2010, ELECTROCHIM ACTA, V55, P4599, DOI 10.1016/j.electacta.2010.03.016
   Oliveira SCB, 2010, J ELECTROANAL CHEM, V648, P60, DOI 10.1016/j.jelechem.2010.06.020
   Oliveira-Brett AM, 2006, MED ENG PHYS, V28, P963, DOI 10.1016/j.medengphy.2006.05.009
   Oliveira-Brett A. M., 2006, ENCY SENSORS, V3, P301
   Oliveira-Brett AM, 2004, BIOELECTROCHEMISTRY, V64, P143, DOI 10.1016/j.bioelechem.2004.05.002
   Oliveira-Brett AM, 2004, BIOELECTROCHEMISTRY, V64, P133, DOI 10.1016/j.bioelechem.2004.05.003
   Oliveira-Brett AM, 2002, J ELECTROANAL CHEM, V538, P267, DOI 10.1016/S0022-0728(02)00944-0
   Oliveira-Brett AM, 2002, TALANTA, V56, P959, DOI 10.1016/S0039-9140(01)00656-7
   Oliveira-Brett AM, 2004, ANAL BIOCHEM, V332, P321, DOI 10.1016/j.ab.2004.06.021
   OLIVEIRABRETT AM, 1999, COMPREHENSIVE CHEM K, V37, P91
   Palecek E, 2002, TALANTA, V56, P809, DOI 10.1016/S0039-9140(01)00649-X
   Palecek E, 2012, CHEM REV, V112, P3427, DOI 10.1021/cr200303p
   Paquim AMC, 2004, BIOSENS BIOELECTRON, V20, P933, DOI 10.1016/j.bios.2004.06.018
   Paquim AMC, 2006, ELECTROCHIM ACTA, V51, P5037, DOI 10.1016/j.electacta.2006.03.041
   Piedade JAP, 2006, ANAL BIOCHEM, V355, P39, DOI 10.1016/j.ab.2006.05.022
   Piedade JAP, 2002, BIOELECTROCHEMISTRY, V56, P81, DOI 10.1016/S1567-5394(02)00013-0
   Pontinha ADR, 2013, BIOELECTROCHEMISTRY, V89, P50, DOI 10.1016/j.bioelechem.2012.08.005
   Qiu YY, 2011, J HAZARD MATER, V190, P480, DOI 10.1016/j.jhazmat.2011.03.071
   Pontinha ADR, 2014, ANAL CHEM, V86, P5851, DOI 10.1021/ac500624z
   Pontinha ADR, 2011, PHYS CHEM CHEM PHYS, V13, P5227, DOI 10.1039/c0cp02377a
   Santarino IB, 2014, ELECTROANAL, V26, P1304, DOI 10.1002/elan.201300488
   Santos PVF, 2012, ELECTROANAL, V24, P547, DOI 10.1002/elan.201100516
   Soleymani L., 2009, ANGEW CHEM, V121, P8609, DOI DOI 10.1002/ANGE.200902439
   Soleymani L, 2009, NAT NANOTECHNOL, V4, P844, DOI [10.1038/nnano.2009.276, 10.1038/NNANO.2009.276]
   Tang WW, 2014, TALANTA, V127, P262, DOI 10.1016/j.talanta.2014.03.069
   Tome LIN, 2015, ANAL CHIM ACTA, V898, P28, DOI 10.1016/j.aca.2015.09.049
   Vacek J, 2007, ELECTROANAL, V19, P2093, DOI 10.1002/elan.200703917
   Vacek J, 2013, CHEM-BIOL INTERACT, V205, P173, DOI 10.1016/j.cbi.2013.07.006
NR 73
TC 28
Z9 28
U1 16
U2 107
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0165-9936
EI 1879-3142
J9 TRAC-TREND ANAL CHEM
JI Trac-Trends Anal. Chem.
PD MAY
PY 2016
VL 79
SI SI
BP 23
EP 36
DI 10.1016/j.trac.2016.01.019
PG 14
WC Chemistry, Analytical
SC Chemistry
GA DM9RR
UT WOS:000376703900004
DA 2018-10-19
ER

PT J
AU Nor, FM
   Lee, HY
   Lim, JY
   Kurniawan, D
AF Nor, Fethma M.
   Lee, Ho Yong
   Lim, Joong Yeon
   Kurniawan, Denni
TI Strain rate and temperature effects on elastic properties of
   polycaprolactone/starch composite
SO E-POLYMERS
LA English
DT Article
DE composite; mechanical properties; strain rate; temperature
ID SCAFFOLDS; DESIGN; DEFORMATION; FABRICATION; POLYMERS; BEHAVIOR; STRESS;
   BLENDS; BONE
AB Composite of polycaprolactone (PCL) and starch is a potential biomaterial for tissue engineering scaffolds. During implantation, its mechanical properties might be compromised considering the various strain rates it is subjected to and that human body temperature is close to polycaprolactone's melting temperature. This study aims at revealing the effect of strain rate and temperature to the elastic properties of polycaprolactone-starch composite. Tensile test at strain rates of 5, 0.1, and 0.01 mm/min at ambient and body temperatures were performed. It was revealed that strain rate as well as temperature readily have significant effects on the composite's elastic properties. Such effects have similar trends with that of PCL homopolymer which is used as the composite's matrix. Further analysis on the consequence of the finding was performed by applying the behavior to a finite element model of a porous scaffold and it was found that the discrepancy in elastic properties throughout the construct is even greater.
C1 [Nor, Fethma M.; Lee, Ho Yong; Lim, Joong Yeon; Kurniawan, Denni] Dongguk Univ, Dept Mech Robot & Energy Engn, Seoul, South Korea.
   [Kurniawan, Denni] Univ Teknol Malaysia, Fac Mech Engn, Skudai, Malaysia.
RP Kurniawan, D (reprint author), Dongguk Univ, Dept Mech Robot & Energy Engn, Seoul, South Korea.; Kurniawan, D (reprint author), Univ Teknol Malaysia, Fac Mech Engn, Skudai, Malaysia.
EM denni@utm.my
RI Kurniawan, Denni/C-2703-2008
OI Kurniawan, Denni/0000-0002-4179-0454
FU Dongguk University, Korea; Universiti Teknologi Malaysia
FX Financial supports from the Dongguk University, Korea, as well as
   Universiti Teknologi Malaysia through this collaborative work are
   gratefully acknowledged.
CR Avella M, 2000, POLYMER, V41, P3875, DOI 10.1016/S0032-3861(99)00663-1
   Baas E, 2010, J BIOMECH, V43, P733, DOI 10.1016/j.jbiomech.2009.10.016
   Boyce MC, 2000, POLYMER, V41, P2183, DOI 10.1016/S0032-3861(99)00406-1
   Chen TT, 2015, E-POLYMERS, V15, P3, DOI 10.1515/epoly-2014-0158
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   Ghavimi SAA, 2015, POLYM TEST, V43, P94, DOI 10.1016/j.polymertesting.2015.02.012
   Hobeika S, 2000, MACROMOLECULES, V33, P1827, DOI 10.1021/ma9910484
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   KOENIG MF, 1995, POLYMER, V36, P1877, DOI 10.1016/0032-3861(95)90934-T
   Kurniawan D, 2011, P I MECH ENG H, V225, P1015, DOI 10.1177/0954411911413059
   Kweon DK, 2004, J APPL POLYM SCI, V92, P1716, DOI 10.1002/app.20130
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lu Z, 2002, SOLID MECH APPL, V87, P41
   Nor FM, 2012, P I MECH ENG H, V226, P693, DOI 10.1177/0954411912452988
   Ohashi F, 2002, POLYM ENG SCI, V42, P1046, DOI 10.1002/pen.11011
   Rajagopalan S, 2006, MED IMAGE ANAL, V10, P693, DOI 10.1016/j.media.2006.06.001
   Richeton J, 2006, INT J SOLIDS STRUCT, V43, P2318, DOI 10.1016/j.ijsolstr.2005.06.040
   Sanz-Herrera JA, 2010, J BIOMECH, V43, P2480, DOI 10.1016/j.jbiomech.2010.05.027
   Schuckert KH, 2009, TISSUE ENG PT A, V15, P493, DOI 10.1089/ten.tea.2008.0033
   Shapiro JM, 2014, ACTA MECH SINICA-PRC, V30, P7, DOI 10.1007/s10409-014-0025-x
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Yeong WY, 2010, ACTA BIOMATER, V6, P2028, DOI 10.1016/j.actbio.2009.12.033
NR 23
TC 0
Z9 0
U1 1
U2 16
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 1618-7229
J9 E-POLYMERS
JI e-Polymers
PD MAY
PY 2016
VL 16
IS 3
BP 217
EP 223
DI 10.1515/epoly-2015-0261
PG 7
WC Polymer Science
SC Polymer Science
GA DM7CX
UT WOS:000376513000006
DA 2018-10-19
ER

PT J
AU Chung, EJ
AF Chung, Eun Ji
TI Targeting and therapeutic peptides in nanomedicine for atherosclerosis
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Review
DE Peptides; nanoparticles; atherosclerosis; micelles; inflammation;
   biomaterial
ID DENSITY-LIPOPROTEIN NANOPARTICLES; APOLIPOPROTEIN-A-I; VASCULAR
   INFLAMMATION; AMPHIPHILE MICELLES; ANTITUMOR-ACTIVITY; CONTRAST AGENTS;
   VIVO EFFICACY; DISEASE; CHOLESTEROL; DELIVERY
AB Peptides in atherosclerosis nanomedicine provide structural, targeting, and therapeutic functionality and can assist in overcoming delivery barriers of traditional pharmaceuticals. Moreover, their inherent biocompatibility and biodegradability make them especially attractive as materials intended for use in vivo. In this review, an overview of nanoparticle-associated targeting and therapeutic peptides for atherosclerosis is provided, including peptides designed for cellular targets such as endothelial cells, monocytes, and macrophages as well as for plaque components such as collagen and fibrin. An emphasis is placed on recent advances in multimodal strategies and a discussion on current challenges and barriers for clinical applicability is presented.
C1 [Chung, Eun Ji] Univ So Calif, Los Angeles, CA 90089 USA.
RP Chung, EJ (reprint author), Univ So Calif, Los Angeles, CA 90089 USA.
EM eunchung@usc.edu
FU University of Southern California, National Heart, Lung, and Blood
   Institute (NHLBI) [K99HL124279]; Chicago Biomedical Consortium
   Postdoctoral Research Grant
FX The author would like to acknowledge the financial support from the
   University of Southern California, National Heart, Lung, and Blood
   Institute (NHLBI), K99HL124279, and the Chicago Biomedical Consortium
   Postdoctoral Research Grant.
CR American Heart Association, 2014, WHAT IS CARD DIS
   Bandeira-Melo C, 2005, J PHARMACOL EXP THER, V313, P1416, DOI 10.1124/jpet.104.080473
   Bentzon JF, 2010, CURR OPIN LIPIDOL, V21, P434, DOI 10.1097/MOL.0b013e32833ded6a
   Bruckman MA, 2014, NANO LETT, V14, P1551, DOI 10.1021/nl404816m
   Chacko AM, 2011, CURR OPIN COLLOID IN, V16, P215, DOI 10.1016/j.cocis.2011.01.008
   Chamberlain AM, 2008, BLOOD, V112, P2675, DOI 10.1182/blood-2008-05-157412
   Chen W, 2013, JACC-CARDIOVASC IMAG, V6, P373, DOI 10.1016/j.jcmg.2012.06.016
   Chen W, 2008, CONTRAST MEDIA MOL I, V3, P233, DOI 10.1002/cmmi.257
   Chung EJ, 2014, J CELL SCI THER, V5, P181, DOI DOI 10.4172/2157-7013.1000181
   Chung EJ, 2015, ADV HEALTHC MATER, V4, P2408, DOI 10.1002/adhm.201500126
   Chung EJ, 2015, ADV HEALTHC MATER, V4, DOI 10.1002/adhm.201400336
   Chung EJ, 2014, BIOMATERIALS, V35, P1249, DOI 10.1016/j.biomaterials.2013.10.064
   Cormode DP, 2009, BIOCONJUGATE CHEM, V20, P937, DOI 10.1021/bc800520d
   Damiano MG, 2013, ADV DRUG DELIVER REV, V65, P649, DOI 10.1016/j.addr.2012.07.013
   Eraso LH, 2011, VASC MED, V16, P145, DOI 10.1177/1358863X10392474
   Fang Y, 2012, ARTERIOSCL THROM VAS, V32, P979, DOI 10.1161/ATVBAHA.111.244053
   Fredman G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1065
   Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80
   Howard MD, 2014, ANNU REV PHARMACOL, V54, P205, DOI 10.1146/annurev-pharmtox-011613-140002
   Jonas A, 2008, N COMP BIOC, P485, DOI 10.1016/B978-044453219-0.50019-2
   Kamaly N, 2013, P NATL ACAD SCI USA, V110, P6506, DOI 10.1073/pnas.1303377110
   Kanwar RK, 2012, NANOMEDICINE-UK, V7, P899, DOI [10.2217/nnm.12.57, 10.2217/NNM.12.57]
   Kashiwagi M, 2010, ATHEROSCLEROSIS, V212, P171, DOI 10.1016/j.atherosclerosis.2010.05.004
   Kelly KA, 2005, CIRC RES, V96, P327, DOI 10.1161/01.RES.0000155722.17881.dd
   Kelly KA, 2006, MOL IMAGING BIOL, V8, P201, DOI 10.1007/s11307-006-0043-6
   Kheirolomoom A, 2015, ACS NANO, V9, P8885, DOI 10.1021/acsnano.5b02611
   Kuo CH, 2014, J MATER CHEM B, V2, P8142, DOI 10.1039/c4tb00977k
   Kusunose J, 2014, J DRUG TARGET, V22, P48, DOI 10.3109/1061186X.2013.837468
   Kusunose J, 2013, ANN BIOMED ENG, V41, P89, DOI 10.1007/s10439-012-0634-0
   La M, 2001, FASEB J, V15, P2247, DOI 10.1096/fj.01-0196com
   Laakkonen P, 2004, P NATL ACAD SCI USA, V101, P9381, DOI 10.1073/pnas.0403317101
   Lee GY, 2011, J CONTROL RELEASE, V155, P211, DOI 10.1016/j.jconrel.2011.07.010
   Lewis DR, 2011, WIRES NANOMED NANOBI, V3, P400, DOI 10.1002/wnan.145
   Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353
   Lobatto ME, 2011, NAT REV DRUG DISCOV, V10, P835, DOI 10.1038/nrd3578
   Luehmann HP, 2014, J NUCL MED, V55, P629, DOI 10.2967/jnumed.113.132001
   Marrache S, 2013, P NATL ACAD SCI USA, V110, P9445, DOI 10.1073/pnas.1301929110
   Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399
   Michalska M, 2012, ARTERIOSCL THROM VAS, V32, P2350, DOI 10.1161/ATVBAHA.112.255224
   Mlinar LB, 2014, BIOMATERIALS, V35, P8678, DOI 10.1016/j.biomaterials.2014.06.054
   Moghimi SM, 2005, FASEB J, V19, P311, DOI 10.1096/fj.04-2747rev
   Nahrendorf M, 2006, CIRCULATION, V114, P1504, DOI 10.1161/CIRCULATIONAHA.106.646380
   Nahrendorf M, 2009, ARTERIOSCL THROM VAS, V29, P1444, DOI 10.1161/ATVBAHA.109.193086
   Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123
   National Heart Lung Blood Institute, 2015, WHAT IS ATH
   Navab M, 2006, NAT CLIN PRACT CARD, V3, P540, DOI 10.1038/ncpcardio0661
   Pan H, 2013, FASEB J, V27, P255, DOI 10.1096/fj.12-218081
   Park Y, 2008, J CONTROL RELEASE, V128, P217, DOI 10.1016/j.jconrel.2008.03.019
   Peters D, 2009, P NATL ACAD SCI USA, V106, P9815, DOI 10.1073/pnas.0903369106
   Psarros C, 2012, MATURITAS, V73, P52, DOI 10.1016/j.maturitas.2011.12.014
   Raha S, 2011, WIRES NANOMED NANOBI, V3, P269, DOI 10.1002/wnan.121
   Redwine LS, 1999, CLIN IMMUNOL, V93, P124, DOI 10.1006/clim.1999.4771
   Schiener M, 2014, TRENDS MOL MED, V20, P271, DOI 10.1016/j.molmed.2013.12.001
   Southworth R, 2009, NANOMED-NANOTECHNOL, V5, P359, DOI 10.1016/j.nano.2008.12.002
   Srinivasan R, 2010, J BIOMED MATER RES A, V93A, P1004, DOI 10.1002/jbm.a.32549
   Staff MC, 1998, ARTERIOSCLEROSIS
   Starmans LWE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119257
   Starmans LWE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057335
   Swirski FK, 2006, P NATL ACAD SCI USA, V103, P10340, DOI 10.1073/pnas.0604260103
   Tang J, 2012, CURR CARDIOVASC IMAG, V5, P19, DOI 10.1007/s12410-011-9120-6
   Uchida M, 2011, ACS NANO, V5, P2493, DOI 10.1021/nn102863y
   UZIELY B, 1995, J CLIN ONCOL, V13, P1777, DOI 10.1200/JCO.1995.13.7.1777
   Webber MJ, 2010, J INTERN MED, V267, P71, DOI 10.1111/j.1365-2796.2009.02184.x
   Westein E, 2013, DRUG DEVELOP RES, V74, P460, DOI 10.1002/ddr.21103
   Wickline SA, 2007, J MAGN RESON IMAGING, V25, P667, DOI 10.1002/jmri.20866
   Wilson HM, 2010, J CELL MOL MED, V14, P2055, DOI 10.1111/j.1582-4934.2010.01121.x
   WILSON PWF, 1988, ARTERIOSCLEROSIS, V8, P737, DOI 10.1161/01.ATV.8.6.737
   Zhao YN, 2014, J LIPID RES, V55, P2053, DOI 10.1194/jlr.M049262
   Zhao YN, 2013, J AM CHEM SOC, V135, P13414, DOI 10.1021/ja404714a
NR 69
TC 8
Z9 9
U1 2
U2 24
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD MAY
PY 2016
VL 241
IS 9
BP 891
EP 898
DI 10.1177/1535370216640940
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DM5JA
UT WOS:000376383300002
PM 27022138
OA Green Published, Green Accepted
DA 2018-10-19
ER

PT J
AU Farris, E
   Brown, DM
   Ramer-Tait, AE
   Pannier, AK
AF Farris, Eric
   Brown, Deborah M.
   Ramer-Tait, Amanda E.
   Pannier, Angela K.
TI Micro- and nanoparticulates for DNA vaccine delivery
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Review
DE DNA vaccine; biomaterials; transfection; vaccination; oral delivery
ID MUCOSAL ANTIBODY-RESPONSES; B SURFACE-ANTIGEN; GENE DELIVERY; PLASMID
   DNA; CHITOSAN NANOPARTICLES; IMMUNE-RESPONSE; HEPATITIS-B; IN-VIVO;
   IMMUNOLOGICAL EFFECTIVENESS; POLYMERIC NANOPARTICLES
AB DNA vaccination has emerged as a promising alternative to traditional protein-based vaccines for the induction of protective immune responses. DNA vaccines offer several advantages over traditional vaccines, including increased stability, rapid and inexpensive production, and flexibility to produce vaccines for a wide variety of infectious diseases. However, the immunogenicity of DNA vaccines delivered as naked plasmid DNA is often weak due to degradation of the DNA by nucleases and inefficient delivery to immune cells. Therefore, biomaterial-based delivery systems based on micro- and nanoparticles that encapsulate plasmid DNA represent the most promising strategy for DNA vaccine delivery. Microparticulate delivery systems allow for passive targeting to antigen presenting cells through size exclusion and can allow for sustained presentation of DNA to cells through degradation and release of encapsulated vaccines. In contrast, nanoparticle encapsulation leads to increased internalization, overall greater transfection efficiency, and the ability to increase uptake across mucosal surfaces. Moreover, selection of the appropriate biomaterial can lead to increased immune stimulation and activation through triggering innate immune response receptors and target DNA to professional antigen presenting cells. Finally, the selection of materials with the appropriate properties to achieve efficient delivery through administration routes conducive to high patient compliance and capable of generating systemic and local (i.e. mucosal) immunity can lead to more effective humoral and cellular protective immune responses. In this review, we discuss the development of novel biomaterial-based delivery systems to enhance the delivery of DNA vaccines through various routes of administration and their implications for generating immune responses.
C1 [Farris, Eric; Pannier, Angela K.] Univ Nebraska, Dept Biol Syst Engn, Lincoln, NE 68588 USA.
   [Brown, Deborah M.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.
   [Brown, Deborah M.] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68588 USA.
   [Ramer-Tait, Amanda E.] Univ Nebraska, Dept Food Sci & Technol, Lincoln, NE 68588 USA.
   [Pannier, Angela K.] Univ Nebraska, Nebraska Ctr Mat & Nanosci, Lincoln, NE 68588 USA.
   [Pannier, Angela K.] Univ Nebraska, Ctr Nanohybrid Funct Mat, Lincoln, NE 68588 USA.
   [Pannier, Angela K.] Univ Nebraska, Med Ctr, Mary & Dick Holland Regenerat Med Program, 600 S 42nd St, Omaha, NE 68198 USA.
RP Pannier, AK (reprint author), Univ Nebraska, Dept Biol Syst Engn, Lincoln, NE 68588 USA.; Pannier, AK (reprint author), Univ Nebraska, Nebraska Ctr Mat & Nanosci, Lincoln, NE 68588 USA.; Pannier, AK (reprint author), Univ Nebraska, Ctr Nanohybrid Funct Mat, Lincoln, NE 68588 USA.; Pannier, AK (reprint author), Univ Nebraska, Med Ctr, Mary & Dick Holland Regenerat Med Program, 600 S 42nd St, Omaha, NE 68198 USA.
EM apannier2@unl.edu
OI Ramer-Tait, Amanda/0000-0003-0950-7548
FU Nebraska Research Initiative; University of Nebraska-Lincoln Tobacco
   Settlement Funds; National Science Foundation [CBET-1254415]; Center for
   Nanohybrid Functional Materials (NSF) [EPS-1004094]; American Heart
   Association [10SDG2640217]; University of Nebraska Foundation (Layman
   Funds); National Institute of General Medical Sciences of the National
   Institutes of Health [P20GM104320]; Crohn's and Colitis Foundation of
   America [3578]; Nebraska Corn Board; UNL Research Council
   Interdisciplinary Seed Grant; UNL Research Council-Tobacco Settlement
   Funds Biomedical Seed Grant; USDA CSREES-Nebraska [NEB-21-146,
   NEB-26-211]
FX The Nebraska Research Initiative, University of Nebraska-Lincoln Tobacco
   Settlement Funds, National Science Foundation (CBET-1254415), Center for
   Nanohybrid Functional Materials (NSF EPS-1004094), American Heart
   Association (#10SDG2640217), the University of Nebraska Foundation
   (Layman Funds), National Institute of General Medical Sciences of the
   National Institutes of Health (P20GM104320), the Crohn's and Colitis
   Foundation of America (#3578), and the Nebraska Corn Board, UNL Research
   Council Interdisciplinary Seed Grant, UNL Research Council-Tobacco
   Settlement Funds Biomedical Seed Grant and USDA CSREES-Nebraska
   [NEB-21-146 and NEB-26-211] are acknowledged for funding this work.
CR Anderson RJ, 2007, VACCINE, V25, pB24, DOI 10.1016/j.vaccine.2007.05.030
   Asthana GS, 2014, BIOMED RES INT, V17
   Barbon CM, 2010, VACCINE, V28, P7852, DOI 10.1016/j.vaccine.2010.09.078
   Beloor J, 2015, SMALL, V11, P2069, DOI 10.1002/smll.201402933
   Bhavsar MD, 2008, AAPS PHARMSCITECH, V9, P288, DOI 10.1208/s12249-007-9021-9
   Bhowmik T, 2012, J DRUG TARGET, V20, P364, DOI 10.3109/1061186X.2012.662686
   Bivas-Benita M, 2003, INT J PHARM, V266, P17, DOI 10.1016/S0378-5173(03)00377-6
   Bueter CL, 2011, J BIOL CHEM, V286, P35447, DOI 10.1074/jbc.M111.274936
   Carvalho JA, 2010, EXPERT REV VACCINES, V9, P175, DOI 10.1586/ERV.09.158
   Chai DF, 2014, HUM VACC IMMUNOTHER, V10, P1284, DOI 10.4161/hv.28333
   Channarong S, 2011, AAPS PHARMSCITECH, V12, P192, DOI 10.1208/s12249-010-9559-9
   Chen K, 2010, IMMUNITY, V33, P479, DOI 10.1016/j.immuni.2010.09.013
   Csaba N, 2009, INT J PHARMACEUT, V382, P205, DOI 10.1016/j.ijpharm.2009.07.028
   Deering RP, 2014, EXPERT OPIN DRUG DEL, V11, P885, DOI 10.1517/17425247.2014.901308
   DeMuth PC, 2013, NAT MATER, V12, P367, DOI [10.1038/nmat3550, 10.1038/NMAT3550]
   Doroud D, 2011, J CONTROL RELEASE, V153, P154, DOI 10.1016/j.jconrel.2011.04.011
   Dudhani AR, 2010, CARBOHYD POLYM, V81, P243, DOI 10.1016/j.carbpol.2010.02.026
   Eratalay A, 2010, J MICROENCAPSUL, V27, P48, DOI 10.3109/02652040902937666
   FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413
   Forrest ML, 2003, BIOCONJUGATE CHEM, V14, P934, DOI 10.1021/bc034014g
   Gao SS, 2013, VACCINE, V31, P5754, DOI 10.1016/j.vaccine.2013.08.053
   Glenn Gregory M, 2003, Expert Rev Vaccines, V2, P253, DOI 10.1586/14760584.2.2.253
   Gold MJ, 2016, EUR J IMMUNOL, V46, P122, DOI 10.1002/eji.201545628
   Hashida M, 1998, J CONTROL RELEASE, V53, P301, DOI 10.1016/S0168-3659(97)00263-0
   Hong XY, 2013, DRUG DES DEV THER, V7, P945, DOI 10.2147/DDDT.S44401
   Hu Y, 2015, POLYM CHEM-UK, V6, P373, DOI 10.1039/c4py01394h
   Ingolotti M, 2010, EXPERT REV VACCINES, V9, P747, DOI [10.1586/erv.10.57, 10.1586/ERV.10.57]
   Jain S, 2005, IMMUNOL LETT, V101, P41, DOI 10.1016/j.imlet.2005.04.002
   Jiang HL, 2008, BIOMATERIALS, V29, P1931, DOI 10.1016/j.biomaterials.2007.12.025
   Jones DH, 1997, VACCINE, V15, P814, DOI 10.1016/S0264-410X(96)00266-6
   Josefsberg JO, 2012, BIOTECHNOL BIOENG, V109, P1443, DOI 10.1002/bit.24493
   Kim NW, 2014, J CONTROL RELEASE, V179, P11, DOI 10.1016/j.jconrel.2014.01.016
   Kim Sae-Hae, 2012, Immune Netw, V12, P165, DOI 10.4110/in.2012.12.5.165
   Kim TH, 2006, MOL CANCER THER, V5, P1723, DOI 10.1158/1535-7163.MCT-06-0540
   Kim YC, 2013, J CONTROL RELEASE, V172, P579, DOI 10.1016/j.jconrel.2013.04.016
   Kines RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120797
   Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439
   Koping-Hoggard M, 2001, GENE THER, V8, P1108, DOI 10.1038/sj.gt.3301492
   Kumru OS, 2014, BIOLOGICALS, V42, P237, DOI 10.1016/j.biologicals.2014.05.007
   Kurisawa M, 2000, J CONTROL RELEASE, V69, P127, DOI 10.1016/S0168-3659(00)00297-2
   Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432
   Langer B, 2013, BIOLISTIC DNA DELIVE, P371
   Layek B, 2015, J CONTROL RELEASE, V207, P143, DOI 10.1016/j.jconrel.2015.04.014
   Lee D, 2006, J NANOSCI NANOTECHNO, V6, P2860, DOI 10.1166/jnn.2006.465
   Lee PW, 2010, BIOMATERIALS, V31, P2425, DOI 10.1016/j.biomaterials.2009.11.100
   Levine MM, 2011, VACCINE, V29, pD116, DOI 10.1016/j.vaccine.2011.11.090
   Li A, 2011, BIOMATERIALS, V32, P469, DOI 10.1016/j.biomaterials.2010.08.107
   Liu MA, 2011, IMMUNOL REV, V239, P62, DOI 10.1111/j.1600-065X.2010.00980.x
   Liu WG, 2003, BIOCONJUGATE CHEM, V14, P782, DOI 10.1021/bc020051g
   Liu XM, 2005, BIOMATERIALS, V26, P109, DOI 10.1016/j.biomaterials.2004.02.013
   Lonez C, 2014, NANOMED-NANOTECHNOL, V10, P775, DOI 10.1016/j.nano.2013.12.003
   Lu HD, 2011, INT J PHARMACEUT, V420, P358, DOI 10.1016/j.ijpharm.2011.08.046
   Luo YC, 2012, J AGR FOOD CHEM, V60, P836, DOI 10.1021/jf204194z
   Lynn DM, 2000, J AM CHEM SOC, V122, P10761, DOI 10.1021/ja0015388
   Matijevic M, 2011, CELL IMMUNOL, V270, P62, DOI 10.1016/j.cellimm.2011.04.005
   Mehta SK, 2011, COLLOID SURFACE A, V375, P219, DOI 10.1016/j.colsurfa.2010.12.014
   Nanda RK, 2014, BIOLOGICALS, V42, P153, DOI 10.1016/j.biologicals.2014.01.002
   Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777
   Nguyen DN, 2009, ADV MATER, V21, P847, DOI 10.1002/adma.200801478
   O'Hagan DT, 2004, IMMUNOL REV, V199, P191, DOI 10.1111/j.0105-2896.2004.00153.x
   O'Neill MJ, 2011, DRUG DISCOV TODAY, V16, P203, DOI 10.1016/j.drudis.2011.01.003
   Oliveira CR, 2012, SCI WORLD J, DOI 10.1100/2012/938457
   Page DT, 2001, DRUG DISCOV TODAY, V6, P92, DOI 10.1016/S1359-6446(00)01600-7
   Parris N, 2005, J AGR FOOD CHEM, V53, P4788, DOI 10.1021/jf040492p
   Peng YX, 2015, J NANOSCI NANOTECHNO, V15, P2619, DOI 10.1166/jnn.2015.9252
   Perche F, 2011, NANOMED-NANOTECHNOL, V7, P445, DOI 10.1016/j.nano.2010.12.010
   Prabha S, 2002, INT J PHARM, V244, P105, DOI 10.1016/S0378-5173(02)00315-0
   Reddy KS, 2012, J GENE MED, V14, P348, DOI 10.1002/jgm.2622
   Regier MC, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-44
   Sadeghi AMM, 2008, EUR J PHARM BIOPHARM, V70, P270, DOI 10.1016/j.ejpb.2008.03.004
   Sawaengsak C, 2014, INT J PHARMACEUT, V473, P113, DOI 10.1016/j.ijpharm.2014.07.005
   Shuaibu MN, 2011, VACCINE, V29, P3239, DOI 10.1016/j.vaccine.2011.02.033
   Singh M, 2000, P NATL ACAD SCI USA, V97, P811, DOI 10.1073/pnas.97.2.811
   Srinivas R, 2012, BIOMATERIALS, V33, P6220, DOI 10.1016/j.biomaterials.2012.05.006
   Stachyra A, 2014, ACTA BIOCHIM POL, V61, P515
   Tahamtan A, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0069-z
   Tang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055077
   Umthong S, 2015, J MICROBIOL BIOTECHN, V25, P526, DOI 10.4014/jmb.1408.08007
   Uto Tomofumi, 2013, Results Immunol, V3, P1, DOI 10.1016/j.rinim.2012.11.002
   VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703
   Vangasseri DP, 2006, MOL MEMBR BIOL, V23, P385, DOI 10.1080/09687860600790537
   Walters AA, 2015, J PHARM PHARMACOL, V67, P400, DOI 10.1111/jphp.12367
   Wang DA, 2010, VACCINE, V28, P3134, DOI 10.1016/j.vaccine.2010.02.058
   Wang HJ, 2005, J CONTROL RELEASE, V105, P120, DOI 10.1016/j.jconrel.2005.03.014
   Wang J, 2014, BIOMATERIALS, V35, P466, DOI 10.1016/j.biomaterials.2013.09.060
   Xu W, 2004, VACCINE, V22, P3603, DOI 10.1016/j.vaccine.2004.03.033
   Yang B, 2014, HUM VACC IMMUNOTHER, V10, P3153, DOI 10.4161/21645515.2014.980686
   Yao WJ, 2013, MOL PHARMACEUT, V10, P2904, DOI 10.1021/mp4000053
   Ye T, 2014, VACCINE, V32, P4457, DOI 10.1016/j.vaccine.2014.06.050
   Zhang J, 2013, BIOMATERIALS, V34, P3667, DOI 10.1016/j.biomaterials.2013.01.079
   Zhang YQ, 2014, FOOD CHEM, V142, P269, DOI 10.1016/j.foodchem.2013.07.058
   Zhao K, 2011, VACCINE, V29, P8549, DOI 10.1016/j.vaccine.2011.09.029
   Zhao K, 2010, J MICROENCAPSUL, V27, P178, DOI 10.3109/02652040903059239
NR 93
TC 10
Z9 11
U1 3
U2 38
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD MAY
PY 2016
VL 241
IS 9
BP 919
EP 929
DI 10.1177/1535370216643771
PG 11
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DM5JA
UT WOS:000376383300005
PM 27048557
OA Green Published
DA 2018-10-19
ER

PT J
AU Rosch, JC
   Hollmann, EK
   Lippmann, ES
AF Rosch, Jonah C.
   Hollmann, Emma K.
   Lippmann, Ethan S.
TI In vitro selection technologies to enhance biomaterial functionality
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Review
DE Biomaterial; in vitro selection; biomedical engineering; phage; aptamer;
   peptides
ID SPINAL-CORD-INJURY; ENDOTHELIAL GROWTH-FACTOR; MESENCHYMAL STEM-CELLS;
   CONTROLLED PROTEIN RELEASE; PHAGE DISPLAY LIBRARY; TISSUE ENGINEERING
   SCAFFOLDS; SCIATIC-NERVE REGENERATION; HIGH-AFFINITY APTAMERS;
   RECEPTOR-BINDING; EXPONENTIAL ENRICHMENT
AB Cells make decisions and fate choices based in part on cues they receive from their external environment. Factors that affect the interpretation of these cues include the soluble proteins that are present at any given time, the cell surface receptors that are available to bind these proteins, and the relative affinities of the soluble proteins for their cognate receptors. Researchers have identified many of the biological motifs responsible for the high-affinity interactions between proteins and their receptors, and subsequently incorporated these motifs into biomaterials to elicit control over cell behavior. Common modes of control include localized sequestration of proteins to improve bioavailability and direct inhibition or activation of a receptor by an immobilized peptide or protein. However, naturally occurring biological motifs often possess promiscuous affinity for multiple proteins and receptors or lack programmable actuation in response to dynamic stimuli, thereby limiting the amount of control they can exert over cellular decisions. These natural motifs only represent a small fraction of the biological diversity that can be assayed by in vitro selection strategies, and the discovery of "artificial'' motifs with varying affinity, specificity, and functionality could greatly expand the repertoire of engineered biomaterial properties. This minireview provides a brief summary of classical and emerging techniques in peptide phage display and nucleic acid aptamer selections and discusses prospective applications in the areas of cell adhesion, angiogenesis, neural regeneration, and immune modulation.
C1 [Rosch, Jonah C.; Hollmann, Emma K.; Lippmann, Ethan S.] Vanderbilt Univ, Dept Chem & Biomol Engn, 221 Kirkland Hall, Nashville, TN 37235 USA.
RP Lippmann, ES (reprint author), Vanderbilt Univ, Dept Chem & Biomol Engn, 221 Kirkland Hall, Nashville, TN 37235 USA.
EM ethan.s.lippmann@vanderbilt.edu
FU College of Engineering at Vanderbilt University
FX The authors are grateful for financial support from the College of
   Engineering at Vanderbilt University.
CR Ahmad KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027051
   Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Baird GS, 2010, AM J CLIN PATHOL, V134, P529, DOI 10.1309/AJCPFU4CG2WGJJKS
   Battig MR, 2014, BIOMATERIALS, V35, P8040, DOI 10.1016/j.biomaterials.2014.06.001
   Battig MR, 2012, J AM CHEM SOC, V134, P12410, DOI 10.1021/ja305238a
   Belair DG, 2014, CHEM COMMUN, V50, P15651, DOI 10.1039/c4cc04317k
   Boehler RM, 2014, BIOTECHNOL BIOENG, V111, P1210, DOI 10.1002/bit.25175
   Boehler RM, 2011, BIOTECHNIQUES, V51, P239, DOI 10.2144/000113754
   Brammer LA, 2008, ANAL BIOCHEM, V373, P88, DOI 10.1016/j.ab.2007.10.015
   Briquez PS, 2015, ADV WOUND CARE, V4, P479, DOI 10.1089/wound.2014.0603
   Brudno Y, 2014, P NATL ACAD SCI USA, V111, P12722, DOI 10.1073/pnas.1413027111
   Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034
   Cao LZ, 2012, P NATL ACAD SCI USA, V109, P7251, DOI 10.1073/pnas.1118088109
   Charras G, 2014, NAT REV MOL CELL BIO, V15, P813, DOI 10.1038/nrm3897
   Chen NC, 2012, BIOMATERIALS, V33, P1353, DOI 10.1016/j.biomaterials.2011.10.062
   Cho M, 2010, P NATL ACAD SCI USA, V107, P15373, DOI 10.1073/pnas.1009331107
   COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913
   DeForest CA, 2015, NAT MATER, V14, P523, DOI [10.1038/nmat4219, 10.1038/NMAT4219]
   DeForest CA, 2012, ANGEW CHEM INT EDIT, V51, P1816, DOI 10.1002/anie.201106463
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Deng Y, 2013, ACTA BIOMATER, V9, P8840, DOI 10.1016/j.actbio.2013.07.017
   Derda R, 2010, ANGEW CHEM INT EDIT, V49, P5301, DOI 10.1002/anie.201001143
   Derda R, 2010, J AM CHEM SOC, V132, P1289, DOI 10.1021/ja906089g
   Donaghue IE, 2014, J CONTROL RELEASE, V190, P219, DOI 10.1016/j.jconrel.2014.05.040
   Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081
   Ehrlich M, 2012, FEBS LETT, V586, P1885, DOI 10.1016/j.febslet.2012.01.040
   Ehrlich M, 2011, CELL SIGNAL, V23, P1424, DOI 10.1016/j.cellsig.2011.04.004
   ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0
   Ezquerro IJ, 2003, CYTOKINE, V22, P12, DOI 10.1016/S1043-4666(03)00101-7
   Fairbrother WJ, 1998, BIOCHEMISTRY-US, V37, P17754, DOI 10.1021/bi981931e
   Fan TH, 2011, SOFT MATTER, V7, P9326, DOI 10.1039/c1sm05802a
   Fleming JC, 2008, EXP NEUROL, V214, P147, DOI 10.1016/j.expneurol.2008.04.024
   Gaddes ER, 2015, BIOMACROMOLECULES, V16, P1382, DOI 10.1021/acs.biomac.5b00165
   Germeroth L, 2003, THROMB HAEMOSTASIS, V90, P501
   Ghivizzani SC, 1998, P NATL ACAD SCI USA, V95, P4613, DOI 10.1073/pnas.95.8.4613
   Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004
   Gopinath SCB, 2007, ANAL BIOANAL CHEM, V387, P171, DOI 10.1007/s00216-006-0826-2
   Gower RM, 2014, BIOMATERIALS, V35, P2024, DOI 10.1016/j.biomaterials.2013.11.036
   Gupta S, 2014, J BIOL CHEM, V289, P8706, DOI 10.1074/jbc.M113.532580
   Hayashi G, 2007, J AM CHEM SOC, V129, P8678, DOI 10.1021/ja071298x
   Hermida N, 2009, CARDIOVASC RES, V81, P601, DOI 10.1093/cvr/cvn315
   Hetian Lei, 2002, Journal of Biological Chemistry, V277, P43137, DOI 10.1074/jbc.M203103200
   Huang CJ, 2010, BIOSENS BIOELECTRON, V25, P1761, DOI 10.1016/j.bios.2009.12.029
   Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896
   Hynes NE, 2013, NAT REV MOL CELL BIO, V14, P393, DOI 10.1038/nrm3581
   Impellitteri NA, 2012, BIOMATERIALS, V33, P3475, DOI 10.1016/j.biomaterials.2012.01.032
   JELLINEK D, 1994, BIOCHEMISTRY-US, V33, P10450, DOI 10.1021/bi00200a028
   Jing M, 2013, ANAL CHEM, V85, P10761, DOI 10.1021/ac401875h
   Johnson PJ, 2010, SOFT MATTER, V6, P5127, DOI 10.1039/c0sm00173b
   Johnson PJ, 2010, J BIOMED MATER RES A, V92A, P152, DOI 10.1002/jbm.a.32343
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   Kim MJ, 2013, BIOMATERIALS, V34, P7236, DOI 10.1016/j.biomaterials.2013.06.019
   Klim JR, 2010, NAT METHODS, V7, P989, DOI 10.1038/NMETH.1532
   KOIVUNEN E, 1994, J CELL BIOL, V124, P373, DOI 10.1083/jcb.124.3.373
   KOIVUNEN E, 1993, J BIOL CHEM, V268, P20205
   Kricker JA, 2003, ENDOCRINOLOGY, V144, P2807, DOI 10.1210/en.2002-221086
   Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9
   Lee JS, 2010, ACTA BIOMATER, V6, P21, DOI 10.1016/j.actbio.2009.08.003
   Lee ST, 2010, BIOMATERIALS, V31, P1219, DOI 10.1016/j.biomaterials.2009.10.054
   Li LL, 2014, P NATL ACAD SCI USA, V111, P17099, DOI 10.1073/pnas.1420105111
   Li LY, 2011, P NATL ACAD SCI USA, V108, P11745, DOI 10.1073/pnas.1101454108
   Li LY, 2010, MOL BIOSYST, V6, P2392, DOI 10.1039/c0mb00115e
   Li SH, 2015, SCI REP-UK, V5, DOI 10.1038/srep14297
   Li SH, 2015, ANGEW CHEM INT EDIT, V54, P5957, DOI 10.1002/anie.201500397
   Li SH, 2013, BIOMATERIALS, V34, P460, DOI 10.1016/j.biomaterials.2012.09.040
   Lin CC, 2009, ADV FUNCT MATER, V19, P2325, DOI 10.1002/adfm.200900107
   Lin CC, 2009, BIOMATERIALS, V30, P4907, DOI 10.1016/j.biomaterials.2009.05.083
   LINDAHL U, 1978, ANNU REV BIOCHEM, V47, P385, DOI 10.1146/annurev.bi.47.070178.002125
   Liu MZ, 2010, BIOORG MED CHEM LETT, V20, P2964, DOI 10.1016/j.bmcl.2010.02.109
   Lou XH, 2009, P NATL ACAD SCI USA, V106, P2989, DOI 10.1073/pnas.0813135106
   Madl CM, 2014, BIOMACROMOLECULES, V15, P445, DOI 10.1021/bm401726u
   Manz BN, 2010, NAT REV MOL CELL BIO, V11, P342, DOI 10.1038/nrm2883
   Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663
   Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110
   Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614
   Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282
   Martino MM, 2009, BIOMATERIALS, V30, P1089, DOI 10.1016/j.biomaterials.2008.10.047
   Martino MM, 2015, FRONT BIOENG BIOTECH, V3, P1
   Matochko WL, 2012, METHODS, V58, P47, DOI 10.1016/j.ymeth.2012.07.006
   McCall JD, 2012, DRUG DELIV TRANSL RE, V2, P305, DOI 10.1007/s13346-012-0090-2
   McCreedy DA, 2014, BIOMATER SCI-UK, V2, P1672, DOI 10.1039/c4bm00106k
   Meyer C, 2014, RNA BIOL, V11, P57, DOI 10.4161/rna.27447
   Miller T, 2014, ACTA BIOMATER, V10, P1705, DOI 10.1016/j.actbio.2013.09.039
   Mittelberger F, 2015, RNA BIOL, V12, P1043, DOI 10.1080/15476286.2015.1079681
   MOORADIAN DL, 1989, J CELL BIOCHEM, V41, P189, DOI 10.1002/jcb.240410404
   Mosiewicz KA, 2013, NAT MATER, V12, P1071, DOI 10.1038/NMAT3766
   Mothe AJ, 2013, BIOMATERIALS, V34, P3775, DOI 10.1016/j.biomaterials.2013.02.002
   Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043
   Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355
   Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685
   Ouellet E, 2015, BIOTECHNOL BIOENG, V112, P1506, DOI 10.1002/bit.25581
   Ozer A, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.34
   Palomo J, 2015, CYTOKINE, V76, P25, DOI 10.1016/j.cyto.2015.06.017
   PASQUALINI R, 1995, J CELL BIOL, V130, P1189, DOI 10.1083/jcb.130.5.1189
   Pedersen RO, 2013, BIOMACROMOLECULES, V14, P4157, DOI 10.1021/bm4011722
   Piossek C, 1999, J BIOL CHEM, V274, P5612, DOI 10.1074/jbc.274.9.5612
   Qian JR, 2009, ANAL CHEM, V81, P5490, DOI 10.1021/ac900759k
   Rebollo IR, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku940
   Richards E, 2014, BIOMACROMOLECULES, V15, P4561, DOI 10.1021/bm501347s
   Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556
   Sacchi V, 2014, P NATL ACAD SCI USA, V111, P6952, DOI 10.1073/pnas.1404605111
   Sahni A, 1998, J BIOL CHEM, V273, P7554, DOI 10.1074/jbc.273.13.7554
   Sahni V, 2010, NAT REV NEUROL, V6, P363, DOI 10.1038/nrneurol.2010.73
   Sahni V, 2010, J NEUROSCI, V30, P1839, DOI 10.1523/JNEUROSCI.4459-09.2010
   Saito A, 2003, BBA-PROTEINS PROTEOM, V1651, P60, DOI 10.1016/S1570-9639(03)00235-8
   Sakiyama SE, 1999, FASEB J, V13, P2214
   Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035
   Sandvig A, 2004, GLIA, V46, P225, DOI 10.1002/glia.10315
   SHAW JP, 1991, NUCLEIC ACIDS RES, V19, P747, DOI 10.1093/nar/19.4.747
   Soontornworajit B, 2011, BIOMATERIALS, V32, P6839, DOI 10.1016/j.biomaterials.2011.05.074
   Soontornworajit B, 2010, BIOMACROMOLECULES, V11, P2724, DOI [10.1021/bm1007741, 10.1021/bm100774t]
   Soontornworajit B, 2010, SOFT MATTER, V6, P4255, DOI 10.1039/c0sm00206b
   Soontornworajit B, 2010, CHEM COMMUN, V46, P1857, DOI 10.1039/b924909e
   Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001
   't Hoen P.A., 2012, ANAL BIOCHEM, V421, P622, DOI DOI 10.1016/J.AB.2011.11.005
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121
   Ullman CG, 2011, BRIEF FUNCT GENOMICS, V10, P125, DOI 10.1093/bfgp/elr010
   Vaught JD, 2010, J AM CHEM SOC, V132, P4141, DOI 10.1021/ja908035g
   Vodnik M, 2011, MOLECULES, V16, P790, DOI 10.3390/molecules16010790
   Wang JP, 2014, ANGEW CHEM INT EDIT, V53, P4796, DOI 10.1002/anie.201309334
   Wang JP, 2011, P NATL ACAD SCI USA, V108, P6909, DOI 10.1073/pnas.1014753108
   Wilems TS, 2015, ACTA BIOMATER, V28, P23, DOI 10.1016/j.actbio.2015.09.018
   Willerth SM, 2007, J BIOMED MATER RES A, V80A, P13, DOI 10.1002/jbm.a.30844
   Wirkner M, 2011, CHEMBIOCHEM, V12, P2623, DOI 10.1002/cbic.201100437
   Wood MD, 2009, ACTA BIOMATER, V5, P959, DOI 10.1016/j.actbio.2008.11.008
   Wrighton PJ, 2014, P NATL ACAD SCI USA, V111, P18126, DOI 10.1073/pnas.1409525111
   YAYON A, 1993, P NATL ACAD SCI USA, V90, P10643, DOI 10.1073/pnas.90.22.10643
   You MX, 2014, J AM CHEM SOC, V136, P1256, DOI 10.1021/ja4114903
   Yuen WW, 2010, P NATL ACAD SCI USA, V107, P17933, DOI 10.1073/pnas.1001192107
   Yufa R, 2015, ANAL CHEM, V87, P1411, DOI 10.1021/ac5044187
   Zeisberg M, 2013, AM J PHYSIOL-CELL PH, V304, pC216, DOI 10.1152/ajpcell.00328.2012
   Zhang WY, 2012, ANAL CHEM, V84, P350, DOI 10.1021/ac2026942
   Zhang ZY, 2012, J AM CHEM SOC, V134, P15716, DOI 10.1021/ja307717w
   Zhu Z, 2014, ANAL CHEM, V86, P5881, DOI 10.1021/ac501423g
NR 137
TC 3
Z9 3
U1 1
U2 33
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD MAY
PY 2016
VL 241
IS 9
BP 962
EP 971
DI 10.1177/1535370216647182
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DM5JA
UT WOS:000376383300009
PM 27188514
OA Green Published
DA 2018-10-19
ER

PT J
AU Cao, S
   Wang, Y
   Cao, L
   Wang, Y
   Lin, BP
   Lan, W
   Cao, BC
AF Cao, Shuai
   Wang, Ye
   Cao, Lin
   Wang, Yu
   Lin, Bingpeng
   Lan, Wei
   Cao, Baocheng
TI Preparation and antimicrobial assay of ceramic brackets coated with TiO2
   thin films
SO KOREAN JOURNAL OF ORTHODONTICS
LA English
DT Article
DE Biomaterial science; Esthetics; Ceramic brackets; Antibacterial
ID SOL-GEL METHOD; PHOTOCATALYTIC TITANIUM-OXIDE; STAINLESS-STEEL;
   ANTIBACTERIAL PROPERTIES; IN-VITRO; LACTOBACILLUS-ACIDOPHILUS;
   ORTHODONTIC TREATMENT; BIOCOMPATIBILITY; NANOCOMPOSITE; NANOPARTICLES
AB Objective: Different methods have been utilized to prevent enamel demineralization and other complications during orthodontic treatment.-However, none of these methods can offer long-lasting and effective prevention of orthodontic complications or interventions after complications occur. Considering the photocatalytic effect of TiO2 on organic compounds, we hoped to synthesize a novel bracket with a TiO2 thin film to develop a photocatalytic antimicrobial effect. Methods: The sol-gel dip coating method was used to prepare TiO2 thin films on ceramic bracket surfaces. Twenty groups of samples were composed according to the experimental parameters. Crystalline structure and surface morphology were characterized by X-ray diffraction and scanning electron microscopy, respectively; film thickness was examined with a surface ellipsometer. The photocatalytic properties under ultraviolet (UV) light irradiation were analyzed by evaluating the degradation ratio of methylene blue (MB) at a certain time. Antibacterial activities of selected thin films were also tested against Lactobacillus acidophilus and Candida albicans. Results: Films with 5 coating layers annealed at 700 degrees C showed the greatest photocatalytic activity in terms of MB decomposition under UV light irradiation. TiO2 thin films with 5 coating layers annealed at 700 degrees C exhibited the greatest antimicrobial activity under UV-A light irradiation. Conclusions: These results provide promising guidance in prevention of demineralization by increasing antimicrobial activities of film coated brackets.
C1 [Cao, Shuai; Wang, Ye; Cao, Lin; Wang, Yu; Lin, Bingpeng; Cao, Baocheng] Lanzhou Univ, Sch Dent, Dept Orthodont, Lanzhou 730000, Peoples R China.
   [Lan, Wei] Lanzhou Univ, Sch Phys Sci & Technol, Dept Phys, Lanzhou 730000, Peoples R China.
RP Cao, BC (reprint author), Lanzhou Univ, Sch Dent, Dept Orthodont, Lanzhou 730000, Peoples R China.
EM caobch@lzu.edu.cn
FU Natural Science Foundation of Gansu Province [1208RJZA236, 1208RJZA199];
   Beijing research program [D121100001812002]
FX The authors would like to acknowledge the financial support provided by
   the Natural Science Foundation of Gansu Province (No. 1208RJZA236; No.
   1208RJZA199), Beijing research program (No. D121100001812002).
CR Akpan UG, 2010, APPL CATAL A-GEN, V375, P1, DOI 10.1016/j.apcata.2009.12.023
   BALASUBRAMANIAN K, 1993, APPL OPTICS, V32, P5594, DOI 10.1364/AO.32.005594
   Barrocas B, 2013, APPL SURF SCI, V264, P111, DOI 10.1016/j.apsusc.2012.09.136
   Bishara S E, 1997, Semin Orthod, V3, P178, DOI 10.1016/S1073-8746(97)80068-0
   Calderon-Moreno JM, 2014, CERAM INT, V40, P2209, DOI 10.1016/j.ceramint.2013.07.139
   Cao S, 2014, APPL SURF SCI, V309, P119, DOI 10.1016/j.apsusc.2014.04.198
   CHATTERJEE R, 1979, ARCH ORAL BIOL, V24, P97, DOI 10.1016/0003-9969(79)90056-6
   Chen Y, 2011, ARCH ORAL BIOL, V56, P16, DOI 10.1016/j.archoralbio.2010.08.006
   Chen YJ, 2006, APPL CATAL B-ENVIRON, V69, P24, DOI 10.1016/j.apcatb.2006.05.002
   Choi JY, 2007, J BIOMED MATER RES B, V80B, P353, DOI 10.1002/jbm.b.30604
   Chun MJ, 2007, ANGLE ORTHOD, V77, P483, DOI 10.2319/052406-211
   Cui CX, 2005, MATER LETT, V59, P3144, DOI 10.1016/j.matlet.2005.05.037
   Eissaa OE, 2013, TANTA DENT J, V10, P86, DOI DOI 10.1016/J.TDJ.2013.08.007
   ELIADES T, 1994, AM J ORTHOD DENTOFAC, V105, P10, DOI 10.1016/S0889-5406(94)70094-X
   Fu T, 2012, VACUUM, V86, P1402, DOI 10.1016/j.vacuum.2012.01.017
   FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0
   Ghamsari MS, 2008, MATER LETT, V62, P361, DOI 10.1016/j.matlet.2007.05.053
   GORELICK L, 1982, AM J ORTHOD DENTOFAC, V81, P93, DOI 10.1016/0002-9416(82)90032-X
   Hou Y.-Q., 2003, APPL SURF SCI, V218, P98
   Kaplan R, 2016, APPL CATAL B-ENVIRON, V181, P465, DOI 10.1016/j.apcatb.2015.08.027
   Karunakaran C, 2011, MAT SCI SEMICON PROC, V14, P133, DOI 10.1016/j.mssp.2011.01.017
   Kumar AM, 2013, CERAM INT, V39, P5639, DOI 10.1016/j.ceramint.2012.12.080
   Lee H, 2012, PROG ORG COAT, V74, P758, DOI 10.1016/j.porgcoat.2011.09.024
   Malengreaux CM, 2012, CHEM ENG J, V195, P347, DOI 10.1016/j.cej.2012.04.076
   Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094
   Mattsson A, 2013, J SOLID STATE CHEM, V199, P212, DOI 10.1016/j.jssc.2012.12.018
   Mechiakh R, 2007, OPT MATER, V30, P645, DOI 10.1016/j.optmat.2007.02.047
   Nakaruk A, 2010, J SOL-GEL SCI TECHN, V55, P328, DOI 10.1007/s10971-010-2257-y
   Nejand BA, 2011, APPL SURF SCI, V257, P10434, DOI 10.1016/j.apsusc.2011.06.124
   Ogaard B., 2008, SEMIN ORTHOD, V14, P183, DOI DOI 10.1053/J.SODO.2008.03.003
   Ozyildiz F, 2010, BIOTECHNOL BIOPROC E, V15, P680
   Poma AM, 2010, J BIOTECHNOL, V150, pS466, DOI 10.1016/j.jbiotec.2010.09.691
   Pomoni K, 2008, J NON-CRYST SOLIDS, V354, P4448, DOI 10.1016/j.jnoncrysol.2008.06.069
   Richter AE, 2011, AM J ORTHOD DENTOFAC, V139, P657, DOI 10.1016/j.ajodo.2009.06.037
   Sayilkan F, 2009, J HAZARD MATER, V162, P1309, DOI 10.1016/j.jhazmat.2008.06.043
   SCHEIE AA, 1984, SCAND J DENT RES, V92, P211
   Shah AG, 2011, ANGLE ORTHOD, V81, P1028, DOI 10.2319/021111-101.1
   Sharma SK, 2009, J ALLOY COMPD, V471, P244, DOI 10.1016/j.jallcom.2008.03.058
   Singh P, 2010, PHYSICA B, V405, P1258, DOI 10.1016/j.physb.2009.11.061
   Tavares CJ, 2008, THIN SOLID FILMS, V517, P1161, DOI 10.1016/j.tsf.2008.06.024
   Tufekci E, 2011, ANGLE ORTHOD, V81, P206, DOI 10.2319/051710-262.1
   Wang HF, 2011, J MATER SCI TECHNOL, V27, P309, DOI 10.1016/S1005-0302(11)60067-4
   Wang XM, 2012, APPL SURF SCI, V258, P8241, DOI 10.1016/j.apsusc.2012.05.028
   Zhou L., 2009, MATER CHEM PHYS, V117, P522
NR 44
TC 1
Z9 1
U1 0
U2 15
PU KOREAN ASSOC ORTHODONTISTS
PI SEOUL
PA 603 TRAPALACE II, 1327 SEOCHO-DONG, SEOCHO-GU, SEOUL, 137-070, SOUTH
   KOREA
SN 2234-7518
EI 2005-372X
J9 KOREAN J ORTHOD
JI Korean J. Orthod.
PD MAY
PY 2016
VL 46
IS 3
BP 146
EP 154
DI 10.4041/kjod.2016.46.3.146
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DM9VI
UT WOS:000376713400004
PM 27226960
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Safronova, TV
   Knot'ko, AV
   Shatalova, TB
   Evdokimov, PV
   Putlyaev, VI
   Kostin, MS
AF Safronova, T. V.
   Knot'ko, A. V.
   Shatalova, T. B.
   Evdokimov, P. V.
   Putlyaev, V. I.
   Kostin, M. S.
TI Calcium Phosphate Ceramic Based on Powder Synthesized From a
   Mixed-Anionic Solution
SO GLASS AND CERAMICS
LA English
DT Article
DE brushite; monetite; amorphous calcium pyrophosphate; ceramic;
   thermo-hydrolysis; calcium pyrophosphate; tricalcium phosphate;
   biomaterial
ID HYDROPHOSPHATE; ACETATE
AB Ceramic based on calcium phosphates is obtained from powders synthesized from water solutions of calcium nitrate, ammonium hydrophosphate, and ammonium pyrophosphate as well as from a mixed-anionic solution containing simultaneously ammonium pyro- and orthophosphate in the molar ratio (NH4)(2)HPO4/(NH4)(4)P2O7 = 1. The ceramic obtained contains biocompatible bioresorbable phases and can be used to make implants used in regenerative methods for the treatment of bone tissue defects. This represents the first time synthesis from mixed-anionic solutions is used to obtain powders of calcium phosphates with significant quantities of each anion.
C1 [Safronova, T. V.; Knot'ko, A. V.; Shatalova, T. B.; Evdokimov, P. V.; Putlyaev, V. I.; Kostin, M. S.] Moscow MV Lomonosov State Univ, Moscow, Russia.
RP Safronova, TV (reprint author), Moscow MV Lomonosov State Univ, Moscow, Russia.
EM t3470641@yandex.ru
RI Safronova, Tatiana/D-7285-2012; Shatalova, Tatiana/T-2059-2017
OI Safronova, Tatiana/0000-0002-9799-5029; Shatalova,
   Tatiana/0000-0002-4304-8624
FU Russian Science Foundation [15-19-00103]
FX The research was supported by the Russian Science Foundation under Grant
   No. 15-19-00103.
CR EANES ED, 1970, CALC TISS RES, V5, P133, DOI 10.1007/BF02017543
   Gibson IR, 2002, J MATER SCI-MATER M, V13, P685, DOI 10.1023/A:1015793927364
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   Kannan S, 2006, J AM CERAM SOC, V89, P2757, DOI 10.1111/j.1551-2916.2006.01158.x
   Koutsoukos P. G., 2000, P 2 INT C PHOSPH REC, P12
   Miao SD, 2006, KEY ENG MAT, V309-311, P565, DOI 10.4028/www.scientific.net/KEM.309-311.565
   Pietak AM, 2007, BIOMATERIALS, V28, P4023, DOI 10.1016/j.biomaterials.2007.05.003
   RAJENDRAN S, 1988, J MATER SCI, V23, P1805, DOI 10.1007/BF01115724
   Safronova TV, 2007, GLASS CERAM+, V64, P102, DOI 10.1007/s10717-007-0027-2
   Safronova TV, 2013, NANOSYST-PHYS CHEM M, V4, P24
   Safronova TV, 2013, GLASS CERAM+, V70, P65, DOI 10.1007/s10717-013-9510-0
   Safronova TV, 2011, GLASS CERAM+, V68, P131, DOI 10.1007/s10717-011-9338-4
   Safronova T. V., 2015, IAN SSSR NEORG MATER, V51, P1269
   Safronova T. V., 2013, STEKLO KERAM, P34
   Safronova TV, 2013, PROCESS APPL CERAM, V7, P9, DOI 10.2298/PAC1301009S
   Safronova TV, 2009, CENT EUR J CHEM, V7, P184, DOI 10.2478/s11532-009-0016-0
NR 16
TC 4
Z9 4
U1 1
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0361-7610
EI 1573-8515
J9 GLASS CERAM+
JI Glass Ceram.
PD MAY
PY 2016
VL 73
IS 1-2
BP 25
EP 31
DI 10.1007/s10717-016-9819-6
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA DM1GN
UT WOS:000376093500007
DA 2018-10-19
ER

PT J
AU Ramanathan, M
   Patil, MS
   Epur, R
   Kumta, PN
AF Ramanathan, Madhumati
   Patil, Mitali S.
   Epur, Rigved
   Kumta, Prashant N.
TI Tartrate Resistant Acid Phosphatase Assisted Degradation of Single-Wall
   Carbon Nanotubes (SWCNTs)
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE carbon nanotubes; biodegradation; tartrate resistant acid phosphatase;
   bone marker
ID BIOMEDICAL APPLICATIONS; CRYSTAL-STRUCTURES; IN-VIVO; BONE; COMPOSITES;
   IMPLANTS; PROLIFERATION; OSTEOBLASTS; SCIENCE
AB In this study, we explored the capability of tartrate resistant acid phosphatase (TRAcP), a bone resorption marker, to degrade carboxylated single-walled carbon nano tubes (C-SWCNTs). Optical observations and Raman and high-resolution transmission electron microscopy studies show that the enzyme contributes to the degradation of C-SWCNTs, although the degradation is not complete. Molecular modeling implemented to investigate the binding sites for carboxylated and pristine SWCNTs to TRAcP elucidate the varying proximity of SWCNTs to the binuclear iron active site and the active site residues of TRAcP, which is clearly dependent upon the degree of carboxylation introduced into the SWCNT model. The modeling results presented provide justification to the propensity of TRAcP to degrade the C-SWCNTs alluding to the possibility of C-SWCNTs to be used as a potential degradable biomaterial for use in therapeutic applications of mineralized tissue related conditions.
C1 [Ramanathan, Madhumati; Patil, Mitali S.; Kumta, Prashant N.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, 3700 OHara St, Pittsburgh, PA 15261 USA.
   [Epur, Rigved; Kumta, Prashant N.] Univ Pittsburgh, Swanson Sch Engn, Dept Mech Engn & Mat Sci, 3700 OHara St, Pittsburgh, PA 15261 USA.
   [Kumta, Prashant N.] Univ Pittsburgh, Swanson Sch Engn, Dept Chem & Petr Engn, 3700 OHara St, Pittsburgh, PA 15261 USA.
   [Kumta, Prashant N.] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, 3501 Terrace St, Pittsburgh, PA USA.
RP Kumta, PN (reprint author), Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, 3700 OHara St, Pittsburgh, PA 15261 USA.; Kumta, PN (reprint author), Univ Pittsburgh, Swanson Sch Engn, Dept Mech Engn & Mat Sci, 3700 OHara St, Pittsburgh, PA 15261 USA.; Kumta, PN (reprint author), Univ Pittsburgh, Swanson Sch Engn, Dept Chem & Petr Engn, 3700 OHara St, Pittsburgh, PA 15261 USA.
EM pkumta@pitt.edu
FU NSF-ERC [EEC-0812348]; Swanson School of Engineering, University of
   Pittsburgh; NSF-CBET [0933153]
FX The authors acknowledge the partial financial assistance of NSF-ERC
   Grant EEC-0812348 in supporting this work. The authors also acknowledge
   the financial support of the Swanson School of Engineering, University
   of Pittsburgh, whereas P.N.K. acknowledges the Edward R. Weidlein Chair
   Professorship, the Center for Complex Engineered Multifunctional
   Materials (CCEMM) of the Swanson School of Engineering, and NSF-CBET
   Grant 0933153 for support of use of equipment and accessories needed for
   this research.
CR Allen BL, 2009, J AM CHEM SOC, V131, P17194, DOI 10.1021/ja9083623
   Balani K, 2007, BIOMATERIALS, V28, P618, DOI 10.1016/j.biomaterials.2006.09.013
   Bianco A, 2005, CHEM COMMUN, P571, DOI 10.1039/b410943k
   BURSTONE MS, 1959, J HISTOCHEM CYTOCHEM, V7, P39, DOI 10.1177/7.1.39
   Ciombor Deborah McK, 2005, Foot Ankle Clin, V10, P579, DOI 10.1016/j.fcl.2005.06.006
   Coleman JN, 2006, CARBON, V44, P1624, DOI 10.1016/j.carbon.2006.02.038
   Giannona S, 2007, J NANOSCI NANOTECHNO, V7, P1679, DOI 10.1166/jnn.2007.454
   Harrison BS, 2007, BIOMATERIALS, V28, P344, DOI 10.1016/j.biomaterials.2006.07.044
   Herrera-Herrera AV, 2012, ANAL CHIM ACTA, V734, P1, DOI 10.1016/j.aca.2012.04.035
   Kagan VE, 2010, NAT NANOTECHNOL, V5, P354, DOI [10.1038/NNANO.2010.44, 10.1038/nnano.2010.44]
   Klabunde T, 1996, J MOL BIOL, V259, P737, DOI 10.1006/jmbi.1996.0354
   Kraus T, 2012, ACTA BIOMATER, V8, P1230, DOI 10.1016/j.actbio.2011.11.008
   Lacerda L, 2006, ADV DRUG DELIVER REV, V58, P1460, DOI 10.1016/j.addr.2006.09.015
   Newman P, 2013, NANOMED-NANOTECHNOL, V9, P1139, DOI 10.1016/j.nano.2013.06.001
   Oddie GW, 2000, BONE, V27, P575, DOI 10.1016/S8756-3282(00)00368-9
   Pan LL, 2012, COLLOID SURFACE B, V93, P226, DOI 10.1016/j.colsurfb.2012.01.011
   Roldo M, 2013, ANNU REP PROG CHEM C, V109, P10, DOI 10.1039/c3pc90010j
   Sinha N, 2005, IEEE T NANOBIOSCI, V4, P180, DOI 10.1109/TNB.2005.850478
   Sirivisoot S, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/29/295101
   Sitharaman B, 2008, BONE, V43, P362, DOI 10.1016/j.bone.2008.04.013
   Strater N, 2005, J MOL BIOL, V351, P233, DOI 10.1016/j.jmb.2005.04.014
   Supronowicz PR, 2002, J BIOMED MATER RES, V59, P499, DOI 10.1002/jbm.10015
   Thostenson ET, 2001, COMPOS SCI TECHNOL, V61, P1899, DOI 10.1016/S0266-3538(01)00094-X
   Tian FR, 2006, TOXICOL IN VITRO, V20, P1202, DOI 10.1016/j.tiv.2006.03.008
   Trojanowicz M, 2006, TRAC-TREND ANAL CHEM, V25, P480, DOI 10.1016/j.trac.2005.11.008
   Wang J, 2005, ELECTROANAL, V17, P7, DOI 10.1002/elan.200403113
   Webster TJ, 2011, NANOTECHNOLOGY ENABLED IN SITU SENSORS FOR MONITORING HEALTH, P1, DOI 10.1007/978-1-4419-7291-0
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Wong HM, 2010, BIOMATERIALS, V31, P2084, DOI 10.1016/j.biomaterials.2009.11.111
   Yang WR, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/41/412001
   Zanello LP, 2006, NANO LETT, V6, P562, DOI 10.1021/nl051861e
NR 31
TC 1
Z9 1
U1 1
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD MAY
PY 2016
VL 2
IS 5
BP 712
EP 721
DI 10.1021/acsbiomaterials.5b00462
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA DL8LN
UT WOS:000375893600002
DA 2018-10-19
ER

PT J
AU Huyer, LD
   Zhang, BY
   Korolj, A
   Montgomery, M
   Drecun, S
   Conant, G
   Zhao, YM
   Reis, L
   Radisic, M
AF Huyer, Locke Davenport
   Zhang, Boyan
   Korolj, Anastasia
   Montgomery, Miles
   Drecun, Stasja
   Conant, Genevieve
   Zhao, Yimu
   Reis, Lewis
   Radisic, Milica
TI Highly Elastic and Moldable Polyester Biomaterial for Cardiac Tissue
   Engineering Applications
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE elastomer; regenerative medicine; tunable properties; biodegradable;
   microfabrication; cross-linkable
ID VENTRICULAR FREE-WALL; CONTRACTILE FUNCTION; MYOCARDIUM; ELASTOMERS;
   STIFFNESS; MEDICINE; SCAFFOLD; STRAIN
AB Polyester biomaterials are used in tissue engineering as scaffolds for implantation of tissues developed in vitro. An ideal biodegradable elastomer for cardiac tissue engineering exhibits a relatively low Young's modulus, with high elongation and tensile strength. Here we describe a novel polyester biomaterial that exhibits improved elastic properties for cardiac tissue engineering applications. We synthesized poly(octamethylene maleate (anhydride) 1,2,4-butanetricarboxylate) (124 polymer) prepolymer gel in a one-step polycondensation reaction. The prepolymer was then molded as desired and exposed to ultraviolet (UV) light to produce a cross-linked elastomer. 124 polymer exhibited highly elastic properties under aqueous conditions that were tunable according to the UV light exposure, monomer composition, and porosity of the cured elastomer. Its elastomeric properties fell within the range of adult heart myocardium, but they could also be optimized for higher elasticity for weaker immature constructs. The polymer showed relatively stable degradation characteristics, both hydrolytically and in a cellular environment, suggesting maintenance of material properties as a scaffold support for potential tissue implants. When assessed for cell interaction, this polymer supported rat cardiac cell attachment in vitro as well as comparable acute in vivo host response when compared to poly(L-lactic acid) control. This suggests the potential applicability of this material as an elastomer for cardiac tissue engineered constructs.
C1 [Huyer, Locke Davenport; Zhang, Boyan; Korolj, Anastasia; Montgomery, Miles; Conant, Genevieve; Zhao, Yimu; Reis, Lewis; Radisic, Milica] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.
   [Huyer, Locke Davenport; Zhang, Boyan; Korolj, Anastasia; Montgomery, Miles; Conant, Genevieve; Reis, Lewis; Radisic, Milica] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
   [Drecun, Stasja] Univ Toronto, Human Biol, Toronto, ON, Canada.
RP Radisic, M (reprint author), Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.; Radisic, M (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
EM m.radisic@utoronto.ca
FU NSERC Steacie Fellowship; Canadian Institutes of Health Research (CIHR)
   [MOP-126027, MOP-137107]; NSERC Discovery Grant [RGPIN 326982-10];
   National Institutes of Health [2R01 HL076485]; Canadian Foundation for
   Innovation [19119]; Ontario Research Fund; CIHR Canadian Graduate
   Scholarships Masters; NSERC Vanier Graduate Scholarships; Ontario
   Graduate Scholarships
FX This work is funded by the NSERC Steacie Fellowship to M.R, Canadian
   Institutes of Health Research (CIHR) Operating Grants (MOP-126027 and
   MOP-137107), NSERC Discovery Grant (RGPIN 326982-10), and National
   Institutes of Health Grant 2R01 HL076485. The authors acknowledge the
   Canadian Foundation for Innovation, Project 19119, and the Ontario
   Research Fund for funding of the Centre for Spectroscopic Investigation
   of Complex Organic Molecules and Polymers. L.D.H. is supported by CIHR
   Canadian Graduate Scholarships Masters. M.M. is supported by NSERC
   Vanier Graduate Scholarships. G.C. is supported by Ontario Graduate
   Scholarships.
CR Arias V, 2014, BIOMACROMOLECULES, V15, P391, DOI 10.1021/bm401667b
   Bouten CVC, 2011, ADV DRUG DELIVER REV, V63, P221, DOI 10.1016/j.addr.2011.01.007
   Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3
   Chen QZ, 2013, PROG POLYM SCI, V38, P584, DOI 10.1016/j.progpolymsci.2012.05.003
   CHUONG CJ, 1991, AM J PHYSIOL, V260, pH1224
   Coirault C, 1998, J APPL PHYSIOL, V85, P1762
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Gupta B, 2007, PROG POLYM SCI, V32, P455, DOI 10.1016/j.progpolymsci.2007.01.005
   Hoshi RA, 2009, ADV MATER, V21, P188, DOI 10.1002/adma.200801132
   Huyer LD, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/3/034004
   Jawad H, 2008, BRIT MED BULL, V87, P31, DOI 10.1093/bmb/ldn026
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Marsano A, 2010, BIOTECHNOL PROGR, V26, P1382, DOI 10.1002/btpr.435
   MASSEY V, 1953, BIOCHEM J, V55, P172, DOI 10.1042/bj0550172
   Montgomery D.C., 2011, ENG STAT
   Montgomery M, 2014, J CARDIOVASC PHARM T, V19, P382, DOI 10.1177/1074248414528576
   Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF
   Nijst CLE, 2007, BIOMACROMOLECULES, V8, P3067, DOI 10.1021/bm070423u
   Nunes SS, 2013, NAT METHODS, V10, P781, DOI [10.1038/nmeth.2524, 10.1038/NMETH.2524]
   Omens JH, 1998, PROG BIOPHYS MOL BIO, V69, P559, DOI 10.1016/S0079-6107(98)00025-X
   Park H, 2005, IN VITRO CELL DEV-AN, V41, P188
   Radisic M, 2007, PHILOS T R SOC B, V362, P1357, DOI 10.1098/rstb.2007.2121
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Rappaport D, 2006, ULTRASOUND MED BIOL, V32, P1181, DOI 10.1016/j.ultrasmedbio.2006.05.005
   Reis LA, 2016, J TISSUE ENG REGEN M, V10, P11, DOI 10.1002/term.1944
   SACKS MS, 1993, J BIOMECH ENG-T ASME, V115, P202, DOI 10.1115/1.2894122
   Tran RT, 2010, SOFT MATTER, V6, P2449, DOI 10.1039/c001605e
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Weis SM, 2000, CIRC RES, V87, P663, DOI 10.1161/01.RES.87.8.663
   Zhang BY, 2016, NAT MATER, V15, P669, DOI [10.1038/NMAT4570, 10.1038/nmat4570]
   Zhang BY, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500423
   Zhao YM, 2014, CAN J CARDIOL, V30, P1307, DOI 10.1016/j.cjca.2014.08.027
NR 33
TC 17
Z9 17
U1 5
U2 47
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD MAY
PY 2016
VL 2
IS 5
BP 780
EP 788
DI 10.1021/acsbiomaterials.5b00525
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA DL8LN
UT WOS:000375893600009
DA 2018-10-19
ER

PT J
AU Wang, W
   Dang, M
   Zhang, ZP
   Hu, J
   Eyster, TW
   Ni, LX
   Ma, PX
AF Wang, Wei
   Dang, Ming
   Zhang, Zhanpeng
   Hu, Jiang
   Eyster, Thomas W.
   Ni, Longxing
   Ma, Peter X.
TI Dentin regeneration by stem cells of apical papilla on injectable
   nanofibrous microspheres and stimulated by controlled BMP-2 release
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Stem cells of apical papilla (SCAP); Nanofibrous microspheres (NF-MS);
   Odontogenic differentiation; Bone morphogenetic protein-2 (BMP-2);
   Controlled delivery
ID BONE MORPHOGENETIC PROTEIN-2; IN-VIVO; ODONTOGENIC DIFFERENTIATION;
   OSTEOGENIC DIFFERENTIATION; AMPUTATED PULP; PDGF-BB; TISSUE; SCAFFOLDS;
   DELIVERY; MICROCARRIERS
AB The aim of this study was to investigate the effects of PLLA nanofibrous microspheres (NF-MS) as a cell delivery carrier in combination with controlled release of BMP-2 from PLGA microspheres on the induction of odontogenic differentiation of human stem cells of apical papilla (SCAP). Injectable NF-MS, which mimic the physical architecture of collagen fibers on the nano scale, were fabricated by combining thermally-induced phase separation techniques with an emulsification process. SCAP cultured in a mono layer or cultured on NF-MS in spinner flasks were treated with 100 ng/ml BMP-2 in vitro. Odontogenic differentiation was characterized by measuring alkaline phosphatase activity, odontogenic gene expression levels, calcium content, and dentin sialophosphoprotein accumulation. The results demonstrated that BMP-2 enhanced human SCAP odontogenic differentiation both in monolayer culture and on 3D NF-MS in spinner flask culture in vitro. We also developed and tested a system combining NF-MS with controlled BMP-2 release for dentin regeneration in vivo. The results indicate that controlled release of BMP-2 promoted more mineralization and osteodentin formation compared to a BSA-releasing control in a dose-dependent and time-dependent manner. In summary, the NF-MS combined with controlled release of BMP-2 provides an excellent microenvironment for SCAP to regenerate dentin tissue.
   Statement of Significance
   Tooth lesion and loss affect masticatory efficiency, speaking function, facial aesthetics and even psychological health. Current treatments depend on "inert" restorative materials, which do not have the healing capacity and may lead to the failure of the restorations over a long term. The aim of this study was to develop an injectable biomaterial and desired growth factor delivery system to support stem cells for mineralized dental tissue regeneration. The study showed that novel injectable and biodegradable nanofibrous microspheres and controlled release of BMP-2 synergistically induce the odontogenic differentiation of human stem cells from the apical papilla and mineralized tissue regeneration, demonstrating the potential of living dental tissue repair. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Wang, Wei; Hu, Jiang; Eyster, Thomas W.; Ma, Peter X.] Univ Michigan, Dept Biol & Mat Sci, 1011 North Univ Ave,Room 2211, Ann Arbor, MI 48109 USA.
   [Wang, Wei; Ni, Longxing] Fourth Mil Med Univ, Sch Stomatol, Dept Operat Dent & Endodont, State Key Lab Mil Stomatol, Xian 710032, Peoples R China.
   [Dang, Ming; Ma, Peter X.] Univ Michigan, Macromol Sci & Engn Ctr, Ann Arbor, MI 48109 USA.
   [Zhang, Zhanpeng; Ma, Peter X.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Ma, Peter X.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.
RP Ma, PX (reprint author), Univ Michigan, Dept Biol & Mat Sci, 1011 North Univ Ave,Room 2211, Ann Arbor, MI 48109 USA.; Ni, LX (reprint author), Fourth Mil Med Univ, Sch Stomatol, Dept Operat Dent & Endodont, State Key Lab Mil Stomatol, Xian 710032, Peoples R China.
EM Longxing_Ni@hotmail.com; mapx@umich.edu
FU US NIH [NIDCR DE022327, DE015384]; US DOD [W81XWH-12-2-0008]; US NSF
   [DMR-1206575]; NSF of China (NSFC) [31500786]; Chinese Scholarship
   Council
FX This study was conducted in the Polymeric Biomaterials and Tissue
   Engineering Laboratory at the University of Michigan with the financial
   support from the US NIH (NIDCR DE022327 and DE015384: PXM), US DOD
   (W81XWH-12-2-0008: PXM), US NSF (DMR-1206575: PXM), and NSF of China
   (NSFC No 31500786: WW). WW was partially supported by a fellowship from
   the Chinese Scholarship Council to conduct research at the University of
   Michigan under the joint advisement of PXM and LN.
CR Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   Boerckel JD, 2011, BIOMATERIALS, V32, P5241, DOI 10.1016/j.biomaterials.2011.03.063
   Casagrande L, 2010, J DENT RES, V89, P603, DOI 10.1177/0022034510364487
   Dreifke MB, 2013, J BIOMED MATER RES A, V101, P2436, DOI 10.1002/jbm.a.34521
   Fang JJ, 2014, ACTA BIOMATER, V10, P276, DOI 10.1016/j.actbio.2013.09.002
   Francisco AT, 2013, BIOMATERIALS, V34, P7381, DOI 10.1016/j.biomaterials.2013.06.038
   Friedlander LT, 2009, INT ENDOD J, V42, P955, DOI 10.1111/j.1365-2591.2009.01622.x
   Goldberg M, 2001, Adv Dent Res, V15, P91
   Gupte MJ, 2012, J DENT RES, V91, P227, DOI 10.1177/0022034511417441
   Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867
   Huang GTJ, 2010, TISSUE ENG PT A, V16, P605, DOI [10.1089/ten.tea.2009.0518, 10.1089/ten.TEA.2009.0518]
   Huang GTJ, 2009, REGEN MED, V4, P697, DOI 10.2217/RME.09.45
   Iohara K, 2004, J DENT RES, V83, P590, DOI 10.1177/154405910408300802
   Jayasuriya AC, 2010, J BIOMED MATER RES A, V93A, P1280, DOI 10.1002/jbm.a.32623
   Jin QM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001729
   Kirker-Head CA, 2000, ADV DRUG DELIVER REV, V43, P65, DOI 10.1016/S0169-409X(00)00078-8
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Li G, 2005, J ORTHOP RES, V23, P680, DOI 10.1016/j.orthres.2004.12.005
   Liu XH, 2011, NAT MATER, V10, P398, DOI [10.1038/NMAT2999, 10.1038/nmat2999]
   Lovelace TW, 2011, J ENDODONT, V37, P133, DOI 10.1016/j.joen.2010.10.009
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Malda J, 2006, TRENDS BIOTECHNOL, V24, P299, DOI 10.1016/j.tibtech.2006.04.009
   Martin Y, 2011, TISSUE ENG PART B-RE, V17, P71, DOI [10.1089/ten.teb.2010.0559, 10.1089/ten.TEB.2010.0559]
   Mckay WF, 2007, INT ORTHOP, V31, P729, DOI 10.1007/s00264-007-0418-6
   NAKASHIMA M, 1994, ARCH ORAL BIOL, V39, P1085, DOI 10.1016/0003-9969(94)90062-0
   Nakashima M, 2003, NAT BIOTECHNOL, V21, P1025, DOI 10.1038/nbt864
   NAKASHIMA M, 1994, DEV BIOL, V162, P18, DOI 10.1006/dbio.1994.1063
   Nakashima M, 2005, CYTOKINE GROWTH F R, V16, P369, DOI 10.1016/j.cytogfr.2005.02.011
   NAKASHIMA M, 1994, J DENT RES, V73, P1515, DOI 10.1177/00220345940730090601
   Rao Subramaniam M, 2013, N Am J Med Sci, V5, P161, DOI 10.4103/1947-2714.109175
   Saito T, 2004, J ENDODONT, V30, P205, DOI 10.1097/00004770-200404000-00005
   Smith LA, 2009, TISSUE ENG PT A, V15, P1855, DOI 10.1089/ten.tea.2008.0227
   Smith LA, 2009, BIOMATERIALS, V30, P2516, DOI 10.1016/j.biomaterials.2009.01.009
   Sonoyama W, 2008, J ENDODONT, V34, P166, DOI 10.1016/j.joen.2007.11.021
   Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079
   Tasli PN, 2014, APPL BIOCHEM BIOTECH, V172, P3016, DOI 10.1007/s12010-013-0706-0
   Thomadakis G, 1999, EUR J ORAL SCI, V107, P368, DOI 10.1046/j.0909-8836.1999.eos107508.x
   Wang J, 2011, BIOMATERIALS, V32, P7822, DOI 10.1016/j.biomaterials.2011.04.034
   Wang J, 2010, ACTA BIOMATER, V6, P3856, DOI 10.1016/j.actbio.2010.04.009
   Wei GB, 2004, BIOMATERIALS, V25, P345, DOI 10.1016/S0142-9612(03)00528-3
   Wei GB, 2006, J CONTROL RELEASE, V112, P103, DOI 10.1016/j.jconrel.2006.01.011
   Wei GB, 2007, BIOMATERIALS, V28, P2087, DOI 10.1016/j.biomaterials.2006.12.028
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Woo KM, 2007, BIOMATERIALS, V28, P335, DOI 10.1016/j.biomaterials.2006.06.013
   Woo KM, 2009, TISSUE ENG PT A, V15, P2155, DOI 10.1089/ten.tea.2008.0433
   Wozney JM, 1998, CLIN ORTHOP RELAT R, P26
   YANG LJ, 1993, CLIN ORTHOP RELAT R, P305
   Zhao M, 2002, J BONE MINER RES, V17, P1441, DOI 10.1359/jbmr.2002.17.8.1441
   Zheng LQ, 2011, BIOMATERIALS, V32, P7053, DOI [10.1016/j.biomaterials.2011.06.094, 10.1016/j.biomaterials.2011.06.004]
NR 49
TC 17
Z9 17
U1 6
U2 62
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2016
VL 36
BP 63
EP 72
DI 10.1016/j.actbio.2016.03.015
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DL8JJ
UT WOS:000375888000005
PM 26971664
OA Other Gold, Green Accepted
DA 2018-10-19
ER

PT J
AU Bilem, I
   Chevallier, P
   Plawinski, L
   Sone, ED
   Durrieu, MC
   Laroche, G
AF Bilem, I.
   Chevallier, P.
   Plawinski, L.
   Sone, E. D.
   Durrieu, M. C.
   Laroche, G.
TI RGD and BMP-2 mimetic peptide crosstalk enhances osteogenic commitment
   of human bone marrow stem cells
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Stem cells; Biomimetic materials; Bone tissue engineering; Mimetic
   peptides; Surface modification
ID OSTEOBLAST DIFFERENTIATION; MORPHOGENETIC PROTEIN-2; IN-VIVO;
   SURFACE-DENSITY; GROWTH-FACTORS; STROMAL CELLS; BIOMATERIALS; ADHESION;
   MATRIX; SCAFFOLDS
AB Human bone marrow mesenchymal stem cells (hBMSCs) commitment and differentiation are dictated by bioactive molecules sequestered within their Extra Cellular Matrix (ECM). One common approach to mimic the physiological environment is to functionalize biomaterial surfaces with ECM-derived peptides able to recruit stem cells and trigger their linage-specific differentiation. The objective of this work was to investigate the effect of RGD and BMP-2 ligands crosstalk and density on the extent of hBMSCs osteogenic commitment, without recourse to differentiation medium. RGD peptide promotes cell adhesion via cell transmembrane integrin receptors, while BMP-2 peptide, corresponding to residues 73-92 of Bone Morphogenetic Protein-2, was shown to induce hBMSCs osteoblast differentiation. The immobilization of peptides on aminated glass was ascertained by X-ray Photoelectron Spectroscopy (XPS), the density of grafted peptides was quantified by fluorescence microscopy and the surface roughness was evaluated using Atomic Force Microscopy (AFM). The osteogenic commitment of hBMSCs cultured on RGD and/or BMP-2 surfaces was characterized by immunohistochemistry using STRO-1 as specific stem cells marker and Runx-2 as an earlier osteogenic marker. Biological results showed that the osteogenic commitment of hBMSCs was enhanced on bifunctionalized surfaces as compared to surfaces containing BMP-2, while on RGD surfaces cells mainly preserved their sternness character. These results demonstrated that RGD and BMP-2 mimetic peptides act synergistically to enhance hBMSCs osteogenesis without supplementing the media with osteogenic factors. These findings contribute to the development of biomimetic materials, allowing a deeper understanding of signaling pathways that govern the transition of stem cells towards the osteoblastic lineage.
   Statement of Significance
   For a long time, scientists thought that the differentiation of Mesenchymal Stem Cells (MSCs) into bone cells was dictated by growth factors. This manuscript shed light on other ligands that play a crucial role in regulating MSCs fate. In concrete terms, it was demonstrated that the osteoinductive effect of BMP-2 peptide is 2 folds improved in the presence of adhesive RGD peptide. Compared to previous works highlighting this synergistic cooperation between RGD and BMP-2 peptides, the main strength of this work lies to the use of primitive human cells (hMSCs) and well-defined biomimetic material surfaces (controlled surface roughness and peptide densities). This work provides valuable insights to develop custom-designed in vitro cell culture models, capable of targeting the desired cell response. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Bilem, I.; Chevallier, P.; Laroche, G.] Univ Laval, Dept Genie Mines Met & Mat, Ctr Rech Mat Avances, Lab Ingn Surface, 1065 Ave Med, Quebec City, PQ G1V 0A6, Canada.
   [Bilem, I.; Chevallier, P.; Laroche, G.] Univ Quebec, Ctr Rech Ctr Hosp, Hop St Francois dAssise, 10 Rue Espinay, Quebec City, PQ G1L 3L5, Canada.
   [Plawinski, L.; Durrieu, M. C.] Univ Bordeaux, CNRS, CBMN, Inst Chem & Biol Membranes & Nanoobjects,UMR5248, Bordeaux Inp, France.
   [Sone, E. D.] Univ Toronto, Dept Mat Sci & Engn, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   [Sone, E. D.] Univ Toronto, Fac Dent, Toronto, ON M5S 3G9, Canada.
RP Laroche, G (reprint author), Univ Laval, Dept Genie Mines Met & Mat, Ctr Rech Mat Avances, Lab Ingn Surface, 1065 Ave Med, Quebec City, PQ G1V 0A6, Canada.; Durrieu, MC (reprint author), Univ Bordeaux, CNRS, CBMN, Inst Chem & Biol Membranes & Nanoobjects,UMR5248, Bordeaux Inp, France.
EM Ibrahim.bilem.1@ulaval.ca; Pascale.Chevallier@crchudequebec.ulaval.ca;
   l.plawinski@cbmn.u-bordeaux.fr; eli.sone@utoronto.ca;
   marie-christine.durrieu@inserm.fr; Gaetan.Laroche@gmn.ulaval.ca
RI DURRIEU, Marie-Christine/I-4358-2016
OI DURRIEU, Marie-Christine/0000-0003-0583-9289
FU NSERC - Canada CREATE Program of Regenerative Medecine (NCPRM); National
   Research and Engineering Research Council of Canada
FX I. Bilem acknowledges funding from the NSERC - Canada CREATE Program of
   Regenerative Medecine (NCPRM). The authors also express their gratitude
   to Andree-Anne Guay-Begin for her assistance for XPS analyses. This
   research was supported by the National Research and Engineering Research
   Council of Canada (G.L.).
CR Amini Ami R., 2012, Critical Reviews in Biomedical Engineering, V40, P363
   Banwell EF, 2009, NAT MATER, V8, P596, DOI [10.1038/nmat2479, 10.1038/NMAT2479]
   BAYLINK DJ, 1993, J BONE MINER RES, V8, pS565
   Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607
   Boivin MC, 2013, J BIOMED MATER RES A, V101, P694, DOI 10.1002/jbm.a.34367
   Bucci-Sabattini V, 2010, ORAL SURG ORAL MED O, V109, P217, DOI 10.1016/j.tripleo.2009.09.007
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Burkus JK, 2004, ORTHOPEDICS, V27, P723
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Chen WQ, 2012, ACS NANO, V6, P4094, DOI 10.1021/nn3004923
   Chevallier P, 2001, J PHYS CHEM B, V105, P12490, DOI 10.1021/jp011607k
   Chollet C, 2012, MACROMOL BIOSCI, V12, P1648, DOI 10.1002/mabi.201200167
   Collier JH, 2011, BIOMATERIALS, V32, P4198, DOI 10.1016/j.biomaterials.2011.02.030
   Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328
   Elmengaard B, 2005, BIOMATERIALS, V26, P3521, DOI 10.1016/j.biomaterials.2004.09.039
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x
   Gauvreau V, 2004, BIOCONJUGATE CHEM, V15, P1146, DOI 10.1021/bc049858u
   Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   He XZ, 2008, LANGMUIR, V24, P12508, DOI 10.1021/la802447v
   Hoesli CA, 2014, BIOMATERIALS, V35, P879, DOI 10.1016/j.biomaterials.2013.09.076
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Hsiong SX, 2009, TISSUE ENG PT A, V15, P263, DOI 10.1089/ten.tea.2007.0411
   Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641
   Jun JH, 2010, J BIOL CHEM, V285, P36410, DOI 10.1074/jbc.M110.142307
   Jung JP, 2009, BIOMATERIALS, V30, P2400, DOI 10.1016/j.biomaterials.2009.01.033
   Kim Y, 2014, BIOMATER SCI-UK, V2, P1110, DOI 10.1039/c3bm60333d
   Knippenberg M, 2006, BIOCHEM BIOPH RES CO, V342, P902, DOI 10.1016/j.bbrc.2006.02.052
   Koepsel JT, 2012, J MATER CHEM, V22, P19474, DOI 10.1039/c2jm32242k
   Lai CF, 2005, J BONE MINER RES, V20, P330, DOI 10.1359/JBMR.041013
   Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mante Francis K, 2004, J Oral Implantol, V30, P343, DOI 10.1563/0.667.1
   Mata A, 2010, BIOMATERIALS, V31, P6004, DOI 10.1016/j.biomaterials.2010.04.013
   Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200
   Miyazono K, 1999, BONE, V25, P91, DOI 10.1016/S8756-3282(99)00113-1
   Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009
   Moon JH, 1996, LANGMUIR, V12, P4621, DOI 10.1021/la9604339
   Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005
   Moore NM, 2011, ACTA BIOMATER, V7, P2091, DOI 10.1016/j.actbio.2011.01.019
   Narayanan K, 2004, J BIOL CHEM, V279, P44294, DOI 10.1074/jbc.M403511200
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Pallu S, 2003, PEPTIDES, V24, P1349, DOI 10.1016/j.peptides.2003.09.003
   Papathanasiou I, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3805
   Park JS, 2010, BIOMATERIALS, V31, P6239, DOI 10.1016/j.biomaterials.2010.05.002
   Porte-Durrieu MC, 2004, BIOMATERIALS, V25, P4837, DOI 10.1016/j.biomaterials.2003.11.037
   Porte-Durrieu MC, 1999, J BIOMED MATER RES, V46, P368
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   Sabbatier G., 2015, MACROMOL BIOSCI
   Saito A, 2003, BBA-PROTEINS PROTEOM, V1651, P60, DOI 10.1016/S1570-9639(03)00235-8
   Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307
   Secchi AG, 2007, J BIOMED MATER RES A, V83A, P577, DOI 10.1002/jbm.a.31007
   Senta H, 2009, CYTOKINE GROWTH F R, V20, P213, DOI 10.1016/j.cytogfr.2009.05.006
   Su JL, 2010, J BIOL CHEM, V285, P31325, DOI 10.1074/jbc.M109.087122
   Suzawa M, 2002, J BONE MINER RES, V17, P240, DOI 10.1359/jbmr.2002.17.2.240
   Suzuki Y, 2000, J BIOMED MATER RES, V50, P405, DOI 10.1002/(SICI)1097-4636(20000605)50:3<405::AID-JBM15>3.0.CO;2-Z
   Takahashi Y, 2005, BIOMATERIALS, V26, P4856, DOI 10.1016/j.biomaterials.2005.01.012
   Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309
   Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Vallieres K, 2007, LANGMUIR, V23, P9745, DOI 10.1021/la701323q
   van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910
   Wan Mei, 2005, Biochemical and Biophysical Research Communications, V328, P651, DOI 10.1016/j.bbrc.2004.11.067
   Weber D, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-6
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zhang HN, 2009, BIOMATERIALS, V30, P4063, DOI 10.1016/j.biomaterials.2009.04.015
   Zhou M, 2009, BIOMATERIALS, V30, P2523, DOI 10.1016/j.biomaterials.2009.01.010
   Zouani OF, 2013, BIOL OPEN, V2, P872, DOI 10.1242/bio.20134986
   Zouani OF, 2010, BIOMATERIALS, V31, P8245, DOI 10.1016/j.biomaterials.2010.07.042
NR 71
TC 14
Z9 16
U1 8
U2 78
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2016
VL 36
BP 132
EP 142
DI 10.1016/j.actbio.2016.03.032
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DL8JJ
UT WOS:000375888000011
PM 27000551
DA 2018-10-19
ER

PT J
AU Patil, PS
   Fountas-Davis, N
   Huang, H
   Evancho-Chapman, MM
   Fulton, JA
   Shriver, LP
   Leipzig, ND
AF Patil, Pritam S.
   Fountas-Davis, Natalie
   Huang, He
   Evancho-Chapman, M. Michelle
   Fulton, Judith A.
   Shriver, Leah P.
   Leipzig, Nic D.
TI Fluorinated methacrylamide chitosan hydrogels enhance collagen synthesis
   in wound healing through increased oxygen availability
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Chitosan; Perfluorocarbons; Oxygen delivery; Metabolomics; Wound healing
ID NITRIC-OXIDE SYNTHASE; TISSUE SURVIVAL; DRUG-DELIVERY; CELL-CULTURE;
   IN-VIVO; METABOLISM; ARGININE; METABOLOMICS; MACROPHAGES; THERAPY
AB In this study, methacrylamide chitosan modified with perfluorocarbon chains (MACF) is used as the base material to construct hydrogel dressings for treating dermal wounds. MACF hydrogels saturated with oxygen (+O-2) are examined for their ability to deliver and sustain oxygen, degrade in a biological environment, and promote wound healing in an animal model. The emerging technique of metabolomics is used to understand how MACF + O-2 hydrogel dressings improve wound healing. Results indicate that MACF treatment facilitates oxygen transport rate that is two orders of magnitude greater than base MAC hydro gels. MACF hydrogel dressings are next tested in an in vivo splinted rat excisional wound healing model. Histological analysis reveals that MACF + O-2 dressings improve re-epithelialization (p < 0.0001) and synthesis of collagen over controls (p < 0.01). Analysis of endogenous metabolites in the wounds using global metabolomics demonstrates that MACF + O-2 dressings promotes a regenerative metabolic process directed toward hydroxyproline and collagen synthesis, with confirmation of metabolite levels within this pathway. The results of this study confirm that increased oxygen delivery through the application of MACF + O-2 hydrogels enhances wound healing and metabolomics analyses provides a powerful tool to assess wound healing physiology.
   Statement of Significance
   This work presents the first application of a novel class of oxygen delivering biomaterials (methacrylamide chitosan modified with perfluorocarbon chains (MACF)) as a hydrogel wound dressing. This manuscript also contains strong focus on the biochemical benefits of MACF dressings on underlying mechanisms vital to successful wound healing. In this vein, this manuscript presents the application of applied metabolomics (tandem mass spectroscopy) to uncover biomaterial interactions with wound healing mechanisms. We believe the approaches described in this manuscript will be of great interest to biomedical scientists and particularly to researchers studying wound healing, metabolomics, applied biomaterials and regenerative medicine. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Patil, Pritam S.; Fountas-Davis, Natalie; Leipzig, Nic D.] Univ Akron, Dept Chem & Biomol Engn, 200 East Buchtel Common, Akron, OH 44325 USA.
   [Huang, He; Shriver, Leah P.] Univ Akron, Dept Chem, Akron, OH 44325 USA.
   [Evancho-Chapman, M. Michelle] Summa Akron City Hosp, Akron, OH 44304 USA.
   [Fulton, Judith A.] Akron Gen Med Ctr, Akron, OH 44307 USA.
RP Leipzig, ND (reprint author), Univ Akron, Dept Chem & Biomol Engn, 200 East Buchtel Common, Akron, OH 44325 USA.
EM nl21@uakron.edu
FU National Institute of General Medical Sciences of the National
   Institutes of Health [R15GM104851]; AB SCIEX Young Investigator Award
FX We would like to acknowledge funding from the National Institute of
   General Medical Sciences of the National Institutes of Health under
   award number R15GM104851 to PSP, NFD, JF and NDL. We would also like to
   acknowledge support from AB SCIEX Young Investigator Award, to LPS.
   Parag Joshi is acknowledged for assistance with histology and
   accompanying analyses. We want to thank Jack Gillespie for glasswork and
   Frank Pelc for regular troubleshooting and setup, Bethany Noble for her
   help and expertise in animal care, Karen Day at the University of Akron
   Vivarium for her expertise and guidance, and Kelly Bondor for assistance
   with dermal fibroblast isolation and culture. Also, we want to thank
   Carla Giai and Nick Callow for help with the oxygen sensors and
   experimental setup and Dr. William Landis for use of histology
   equipment. Finally, we would like to thank group members Hang Li,
   Aleesha McCormick, Trevor Ham, and Ashley Wilkinson for assistance with
   analyses.
CR ABERCROMBIE M, 1954, J EMBRYOL EXP MORPH, V2, P264
   Arieli Y, 2014, RESP PHYSIOL NEUROBI, V197, P29, DOI 10.1016/j.resp.2014.03.006
   BENNER P, 1984, NOVICE EXPERT
   Benton HP, 2015, ANAL CHEM, V87, P884, DOI 10.1021/ac5025649
   Bo Y, 2014, TOXICOL MECH METHOD, V24, P461, DOI 10.3109/15376516.2014.939321
   Borisov SM, 2008, ANAL CHEM, V80, P9435, DOI 10.1021/ac801521v
   Carlson MA, 2003, J SURG RES, V110, P304, DOI 10.1006/jsre.2002.6602
   Castro CI, 2010, ARTIF ORGANS, V34, P622, DOI 10.1111/j.1525-1594.2009.00944.x
   Chen SC, 2004, J CONTROL RELEASE, V96, P285, DOI 10.1016/j.jconrel.2004.02.002
   DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9
   Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108
   Dreifke MB, 2015, MAT SCI ENG C-MATER, V48, P651, DOI 10.1016/j.msec.2014.12.068
   El-Gayar S, 2003, J IMMUNOL, V171, P4561, DOI 10.4049/jimmunol.171.9.4561
   Fonder MA, 2008, J AM ACAD DERMATOL, V58, P185, DOI 10.1016/j.jaad.2007.08.048
   Gajendrareddy PK, 2005, BRAIN BEHAV IMMUN, V19, P217, DOI 10.1016/j.bbi.2004.09.003
   German JB, 2005, METABOLOMICS, V1, P3, DOI 10.1007/s11306-005-1102-8
   Ghosh K, 2006, TISSUE ENG, V12, P601, DOI 10.1089/ten.2006.12.601
   Gordillo GM, 2013, ADV WOUND CARE, V2, P1, DOI 10.1089/wound.2012.0367
   Gordillo GM, 2009, INT J LOW EXTR WOUND, V8, P105, DOI 10.1177/1534734609335149
   Gordillo GM, 2003, AM J SURG, V186, P259, DOI 10.1016/S0002-9610(03)00211-3
   Gorres KL, 2010, CRIT REV BIOCHEM MOL, V45, P106, DOI 10.3109/10409231003627991
   Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125
   HAMAGUCHI K, 1960, J BIOCHEM-TOKYO, V48, P351, DOI 10.1093/oxfordjournals.jbchem.a127179
   HANKIEWICZ J, 1974, CLIN CHIM ACTA, V57, P205, DOI 10.1016/0009-8981(74)90398-2
   Harrison BS, 2007, BIOMATERIALS, V28, P4628, DOI 10.1016/j.biomaterials.2007.07.003
   HECKER M, 1995, FEBS LETT, V359, P251, DOI 10.1016/0014-5793(95)00039-C
   Igwegbe I, 2015, ADV SKIN WOUND CARE, V28, P206, DOI 10.1097/01.ASW.0000462327.30245.ae
   Kalkhof S, 2014, BIOMED RES INT, DOI 10.1155/2014/934848
   Ladizinsky D, 2010, WOUNDS, V22, P294
   LATTES A, 1994, ARTIF CELL BLOOD SUB, V22, P1007, DOI 10.3109/10731199409138798
   Li H, 2013, J CHROMATOGR A, V1275, P9, DOI 10.1016/j.chroma.2012.12.023
   Li ZQ, 2012, BIOMATERIALS, V33, P5914, DOI 10.1016/j.biomaterials.2012.05.012
   Lin Li-Chen, 2006, J Nurs Res, V14, P219
   Lowe KC, 1998, TRENDS BIOTECHNOL, V16, P272, DOI 10.1016/S0167-7799(98)01205-0
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Meyer A, 2012, BIOTECHNOL PROGR, V28, P171, DOI 10.1002/btpr.712
   Mirza RE, 2015, J PATHOL, V236, P433, DOI 10.1002/path.4548
   Oh SH, 2009, BIOMATERIALS, V30, P757, DOI 10.1016/j.biomaterials.2008.09.065
   Otto GP, 2012, CRIT CARE, V16, DOI 10.1186/cc11205
   Phang JM, 2015, CURR OPIN CLIN NUTR, V18, P71, DOI 10.1097/MCO.0000000000000121
   Pilarek M, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-50
   Poon L, 2014, CARBOHYD POLYM, V109, P92, DOI 10.1016/j.carbpol.2014.02.086
   Pusateri AE, 2003, J TRAUMA, V54, P177, DOI 10.1097/01.TA.0000032512.04647.C6
   Quan TH, 2013, J INVEST DERMATOL, V133, P658, DOI 10.1038/jid.2012.364
   Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532
   Riess JG, 2006, ARTIF CELL BLOOD SUB, V34, P567, DOI 10.1080/10731190600973824
   Ruiz Matute A. I., 2013, Food Hydrocolloids, V33, P245
   Schaper S.J. W., 2007, HEART PHYSL PATHOPHY
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Schreml S, 2010, BRIT J DERMATOL, V163, P257, DOI 10.1111/j.1365-2133.2010.09804.x
   Sen CK, 2009, WOUND REPAIR REGEN, V17, P1, DOI 10.1111/j.1524-475X.2008.00436.x
   Shavaleev NM, 2006, INORG CHEM, V45, P9410, DOI 10.1021/ic061283k
   Singh DK, 2000, J MACROMOL SCI R M C, VC40, P69, DOI 10.1081/MC-100100579
   Sood A, 2014, ADV WOUND CARE, V3, P511, DOI 10.1089/wound.2012.0401
   Sood RF, 2015, WOUND REPAIR REGEN, V23, P423, DOI 10.1111/wrr.12299
   Togami K, 2015, BIOL PHARM BULL, V38, P270, DOI 10.1248/bpb.b14-00659
   Tzafriri AR, 2005, CLIN CANCER RES, V11, P826
   Wang JP, 2011, ACS APPL MATER INTER, V3, P67, DOI 10.1021/am100862h
   Ward CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072485
   Wijekoon A, 2013, ACTA BIOMATER, V9, P5653, DOI 10.1016/j.actbio.2012.10.034
   Wu D., 2011, JOVE-J VIS EXP, P2899
   Zhao X., 2015, ADV HEALTHCARE MAT, V5
NR 62
TC 6
Z9 6
U1 7
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2016
VL 36
BP 164
EP 174
DI 10.1016/j.actbio.2016.03.022
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DL8JJ
UT WOS:000375888000014
PM 27000552
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Crichton, ML
   Archer-Jones, C
   Meliga, S
   Edwards, G
   Martin, D
   Huang, H
   Kendall, MAF
AF Crichton, Michael L.
   Archer-Jones, Cameron
   Meliga, Stefano
   Edwards, Grant
   Martin, Darren
   Huang, Han
   Kendall, Mark A. F.
TI Characterising the material properties at the interface between skin and
   a skin vaccination microprojection device
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Skin; Microneedles; Material testing; Material strength; Puncture
ID POLYMER MICRONEEDLES; DRUG-DELIVERY; STRUCTURAL-CHARACTERIZATION;
   FABRICATION; STRENGTH
AB The rapid emergence of micro-devices for biomedical applications over the past two decades has introduced new challenges for the materials used in the devices. Devices like microneedles and the Nanopatch, require sufficient strength to puncture skin often with sharp-slender micro-scale profiles, while maintaining mechanical integrity. For these technologies we sought to address two important questions: 1) On the scale at which the device operates, what forces are required to puncture the skin? And 2) What loads can the projections/microneedles withstand prior to failure. First, we used custom fabricated nanoindentation micro-probes to puncture skin at the micrometre scale, and show that puncture forces are 0.25-1.75 mN for fresh mouse skin, in agreement with finite element simulations for our device. Then, we used two methods to perform strength tests of Nanopatch projections with varied aspect ratios. The first method used a nanoindenter to apply a force directly on the top or on the side of individual silicon projections (110 ism in length, 10 Ism base radius), to measure the force of fracture. Our second method used an Instron to fracture full rows of projections and characterise a range of projection designs (with the method verified against previous nanoindentation experiments). Finally, we used Cryo-Scanning Electron Microscopy to visualise projections in situ in the skin to confirm the behaviour we quantified, qualitatively.
   Statement of Significance
   Micro-device development has proliferated in the past decade, including devices that interact with tissues for biomedical outcomes. The field of microneedles for vaccine delivery to skin has opened new material challenges both in understanding tissue material properties and device material. In this work we characterise both the biomaterial properties of skin and the material properties of our microprojection vaccine delivery device. This study directly measures the micro-scale puncture properties of skin, whilst demonstrating clearly how these relate to device design. This will be of strong interest to those in the field of biomedical microdevices. This includes work in the field of wearable and semi implantable devices, which will require clear understanding of tissue behaviour and material characterisation. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Crichton, Michael L.; Archer-Jones, Cameron; Meliga, Stefano; Edwards, Grant; Martin, Darren; Kendall, Mark A. F.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.
   [Crichton, Michael L.; Kendall, Mark A. F.] Univ Queensland, ARC Ctr Excellence Convergent Bionano Sci & Techn, Brisbane, Qld 4072, Australia.
   [Huang, Han] Univ Queensland, Sch Mech & Min Engn, Brisbane, Qld 4072, Australia.
   [Kendall, Mark A. F.] Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld 4102, Australia.
   [Kendall, Mark A. F.] Univ Queensland, Fac Med & Biomed Sci, Royal Brisbane & Womens Hosp, Herston, Qld 4006, Australia.
RP Kendall, MAF (reprint author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.
EM m.kendall@uq.edu.au
RI Kendall, Mark/M-4122-2017
OI Martin, Darren/0000-0002-8537-6765; Crichton,
   Michael/0000-0002-3683-802X
FU Queensland state Nirap grant; ARC Future Fellowship; University of
   Queensland Endeavour IPRS
FX We thank all members of Prof Kendall, Prof Martin and Prof Huang's
   groups at the University of Queensland. This work is funded by a
   Queensland state Nirap grant, an ARC Future Fellowship and a University
   of Queensland Endeavour IPRS. We thank Hysitron for providing a
   nanoindenter probe mount and the Queensland University of Technology
   AMMRF node for FIB assistance. This work was performed in part at the
   Queensland Node of the Australian National Fabrication Facility. A
   company established under the National Collaborative Research
   Infrastructure Strategy to provide nano and microfabrication facilities
   for Australia's researchers.
CR Chu LY, 2010, J PHARM SCI-US, V99, P4228, DOI 10.1002/jps.22140
   Crichton ML, 2013, BIOMATERIALS, V34, P2087, DOI 10.1016/j.biomaterials.2012.11.035
   Crichton ML, 2011, BIOMATERIALS, V32, P4670, DOI 10.1016/j.biomaterials.2011.03.012
   Crichton ML, 2010, BIOMATERIALS, V31, P4562, DOI 10.1016/j.biomaterials.2010.02.022
   Davis SP, 2004, J BIOMECH, V37, P1155, DOI 10.1016/j.jbiomech.2003.12.010
   Fernando GJP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010266
   Fischer-Cripps A., 2004, NANOINDENTATION
   Hirobe S, 2015, BIOMATERIALS, V57, P50, DOI 10.1016/j.biomaterials.2015.04.007
   Jenkins D., 2012, RSC ADV
   Kendall M, 2004, J BIOMECH, V37, P1733, DOI 10.1016/j.jbiomech.2004.01.032
   Kendall MAF, 2007, BIOMATERIALS, V28, P4968, DOI 10.1016/j.biomaterials.2007.08.006
   Khanna P, 2010, PROCEDIA ENGINEER, V5, P977, DOI 10.1016/j.proeng.2010.09.272
   Li CG, 2015, LAB CHIP, V15, P382, DOI 10.1039/c4lc00937a
   Loizidou EZ, 2015, EUR J PHARM BIOPHARM, V89, P224, DOI 10.1016/j.ejpb.2014.11.023
   McNeilly CL, 2014, J CONTROL RELEASE, V196, P252, DOI 10.1016/j.jconrel.2014.09.028
   Meliga S. C., 2012, 7 AUSTR C APPL MECH, P331
   Meliga SC, 2013, J MULTIDISCIPL ENG, V10, P173
   Mukundan V., 2009, J MICROELECTROMECHAN, V18, P405, DOI DOI 10.1109/JMEMS.2009.2039697
   O'Mahony C, 2014, BIOMED MICRODEVICES, V16, P333, DOI 10.1007/s10544-014-9836-6
   Park JH, 2006, PHARM RES, V23, P1008, DOI 10.1007/s11095-006-0028-9
   Park JH, 2005, J CONTROL RELEASE, V104, P51, DOI 10.1016/j.jconrel.2005.02.002
   Prow TW, 2010, SMALL, V6, P1776, DOI 10.1002/smll.201000331
   Raja WK, 2013, SMALL, V9, P3704, DOI 10.1002/smll.201202075
   SMITH WG, 1988, COMPUT STRUCT, V28, P677, DOI 10.1016/0045-7949(88)90011-9
   Suwito W, 1999, J APPL PHYS, V85, P3519, DOI 10.1063/1.369711
   WILDNAUER RH, 1971, J INVEST DERMATOL, V56, P72, DOI 10.1111/1523-1747.ep12292018
NR 26
TC 4
Z9 4
U1 0
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2016
VL 36
BP 186
EP 194
DI 10.1016/j.actbio.2016.02.039
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DL8JJ
UT WOS:000375888000016
PM 26956913
DA 2018-10-19
ER

PT J
AU Stefani, I
   Cooper-White, JJ
AF Stefani, I.
   Cooper-White, J. J.
TI Development of an in-process UV-crosslinked, electrospun PCL/aPLA-co-TMC
   composite polymer for tubular tissue engineering applications
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Electrospinning; Core-shell structured fibres; In-situ crosslinking;
   Vascular scaffold; Tissue engineering
ID MESENCHYMAL STEM-CELLS; SMOOTH-MUSCLE-CELLS; VASCULAR GRAFTS;
   POLY(TRIMETHYLENE CARBONATE-CO-L-LACTIDE); NANOFIBROUS SCAFFOLDS;
   MECHANICAL-PROPERTIES; ELASTOMERIC SCAFFOLD; POLYCAPROLACTONE; VITRO;
   RESPONSES
AB Cardiovascular diseases remain the largest cause of death worldwide, and half of these deaths are the result of failure of the vascular system. Tissue engineering promises to provide new, and potentially more effective therapeutic strategies to replace damaged or degenerated vessels with functional vessels. However, these engineered vessels have substantial performance criteria, including vessel-like tubular shape, structure and mechanical property slate. Further, whether implanted without or with prior in vitro culture, such tubular scaffolds must provide a suitable environment for cell adhesion and growth and be of sufficient porosity to permit cell colonization. This study investigates the fabrication of slowly degradable, composite tubular polymer scaffolds made from polycaprolactone (PCL) and acrylated L-lactide-co-trimethylene carbonate (aPLA-co-TMC). The addition of acrylate groups permits the 'in-process' formation of crosslinks between aPLA-co-TMC chains during electrospinning of the composite system, exemplifying a novel process to produce multicomponent, elastomeric electrospun polymer scaffolds. Although PCL and aPLA-co-TMC were miscible in a co-solvent, a criteria for electrospinning, due to thermodynamic incompatibility of the two polymers as melts, solvent evaporation during electrospinning drove phase separation of these two systems, producing 'core-shell' fibres, with the core being composed of PCL, and the shell of crosslinked elastomeric aPLA-co-TMC. The resulting elastic fibrous scaffolds displayed burst pressures and suture retention strengths comparable with human arteries. Cytocompatibility testing with human mesenchymal stem cells confirmed adhesion to, and proliferation on the three-dimensional fibrous network, as well as alignment with highly-organized fibres. This new processing methodology and resulting mechanically-robust composite scaffolds hold significant promise for tubular tissue engineering applications.
   Statement of Significance
   Autologous small diameter blood vessel grafts are unsuitable solutions for vessel repair. Engineered solutions such as tubular biomaterial scaffolds however have substantial performance criteria to meet, including vessel-like tubular shape, structure and mechanical property slate. We detail herein an innovative methodology to co-electrospin and 'in-process' crosslink composite mixtures of Poly( caprolactone) and a newly synthesised acrylated-Poly(lactide-co-trimethylene-carbonate) to create elastomeric, core shell nanofibrous porous scaffolds in a one-step process. This novel composite system can be used to make aligned scaffolds that encourage stem cell adhesion, growth and morphological control, and produce robust tubular scaffolds of tunable internal diameter and wall thickness that possess mechanical properties approaching those of native vessels, ideal for future applications in the field of vessel tissue engineering. (C) Crown Copyright 2016 Published by Elsevier Ltd. on behalf of Acta Materialia Inc. All rights reserved.
C1 [Stefani, I.] Politecn Milan, Giulio Natta Dept Chem Mat & Chem Engn, I-20133 Milan, Italy.
   [Stefani, I.; Cooper-White, J. J.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Tissue Engn & Microfluid Lab, Brisbane, Qld 4072, Australia.
   [Cooper-White, J. J.] Univ Queensland, Sch Chem Engn, Brisbane, Qld 4072, Australia.
   [Cooper-White, J. J.] CSIRO, Biomed Mfg, Mfg Flagship, Clayton, Vic 3169, Australia.
RP Cooper-White, JJ (reprint author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld 4072, Australia.
EM i.stefani@uq.edu.au; j.cooperwhite@uq.edu.au
RI Stefani, Ilaria/B-6392-2015
OI Stefani, Ilaria/0000-0003-3648-8688; Cooper-White,
   Justin/0000-0002-1920-8229
FU Australian Research Council [DP140104217]; Australian Institute for
   Bioengineering and Nanotechnology
FX We also would like to acknowledge the funding provided by the Australian
   Research Council (grant ID: DP140104217) and the Australian Institute
   for Bioengineering and Nanotechnology.
CR Agarwal S, 2010, MACROMOL RAPID COMM, V31, P1317, DOI 10.1002/marc.201000021
   Agarwal S, 2009, ADV MATER, V21, P3343, DOI 10.1002/adma.200803092
   Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559
   Alwan A., 2011, WHO LIB CATALOGUING, V2, P161
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Camarero-Espinosa S., 2015, BIOMATERIALS, V74, P42
   Catto V, 2014, ISRN VASC MED, V2014, P1, DOI [10.1155/2014/923030, DOI 10.1155/2014/923030]
   Catto V, 2015, MAT SCI ENG C-MATER, V54, P101, DOI 10.1016/j.msec.2015.05.003
   Cipitria A, 2011, J MATER CHEM, V21, P9419, DOI 10.1039/c0jm04502k
   Cleary MA, 2012, TRENDS MOL MED, V18, P394, DOI 10.1016/j.molmed.2012.04.013
   Conklin B.S., 2002, MED ENG PHYS, V24, P10
   Couet F, 2007, MACROMOL BIOSCI, V7, P701, DOI 10.1002/mabi.200700002
   Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003
   Dahlin RL, 2011, TISSUE ENG PART B-RE, V17, P349, DOI [10.1089/ten.teb.2011.0238, 10.1089/ten.TEB.2011.0238]
   Dargaville BL, 2013, ACTA BIOMATER, V9, P6885, DOI 10.1016/j.actbio.2013.02.009
   Dargaville BL, 2011, BIOMACROMOLECULES, V12, P3856, DOI 10.1021/bm201291e
   Elnakady YA, 2015, SCI ADV MATER, V7, P407, DOI 10.1166/sam.2015.2252
   Ercolani E, 2015, J TISSUE ENG REGEN M, V9, P861, DOI 10.1002/term.1697
   Hasan A, 2014, ACTA BIOMATER, V10, P11, DOI 10.1016/j.actbio.2013.08.022
   Huang AH, 2014, CELL MOL LIFE SCI, V71, P2103, DOI 10.1007/s00018-013-1546-3
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Ichim TE, 2010, CELL IMMUNOL, V260, P75, DOI 10.1016/j.cellimm.2009.10.006
   James R, 2011, METHODS MOL BIOL, V726, P243, DOI 10.1007/978-1-61779-052-2_16
   Kamoun E.A., 2014, ARAB J CHEM
   KOENIG MF, 1995, POLYMER, V36, P1877, DOI 10.1016/0032-3861(95)90934-T
   Konig G, 2009, BIOMATERIALS, V30, P1542, DOI 10.1016/j.biomaterials.2008.11.011
   Lin-Vien D., 1991, HDB INFRARED RAMAN C
   Liu S.Q., 1998, J BIOMCHEM ENG, V120, P8
   Pashneh-Tala S., 2015, TISSUE ENG B
   Patra S, 2013, J BIOMATER TISS ENG, V3, P289, DOI 10.1166/jbt.2013.1087
   Pellegata A.F., 2013, BIOMED RES INT
   Prichard HL, 2011, J CARDIOVASC TRANSL, V4, P674, DOI 10.1007/s12265-011-9306-y
   Rathore A, 2012, WIRES NANOMED NANOBI, V4, P257, DOI 10.1002/wnan.1166
   Salacinski HJ, 2001, J BIOMATER APPL, V15, P241, DOI 10.1106/NA5T-J57A-JTDD-FD04
   Sarkar S, 2005, ACTA BIOMATER, V1, P93, DOI 10.1016/j.actbio.2004.08.003
   Seifu DG, 2013, NAT REV CARDIOL, V10, P410, DOI 10.1038/nrcardio.2013.77
   Stewart SFC, 2004, ANN BIOMED ENG, V32, P991, DOI 10.1023/B:ABME.0000032462.56207.65
   Subbiah T, 2005, J APPL POLYM SCI, V96, P557, DOI 10.1002/app.21481
   Van Landuyt KL, 2015, DENT MATER, V31, P916, DOI 10.1016/j.dental.2015.04.016
   Wenddorff J.H., 2012, ELECTROSPINNING MAT
   Zaniboni A, 2015, AM J PHYSIOL-CELL PH, V309, pC320, DOI 10.1152/ajpcell.00049.2015
NR 41
TC 10
Z9 11
U1 12
U2 123
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2016
VL 36
BP 231
EP 240
DI 10.1016/j.actbio.2016.03.013
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DL8JJ
UT WOS:000375888000020
PM 26969522
DA 2018-10-19
ER

PT J
AU Li, JY
   Zhai, D
   Lv, F
   Yu, QQ
   Ma, HS
   Yin, JB
   Yi, ZF
   Liu, MY
   Chang, J
   Wu, CT
AF Li, Jinyan
   Zhai, Dong
   Lv, Fang
   Yu, Qingqing
   Ma, Hongshi
   Yin, Jinbo
   Yi, Zhengfang
   Liu, Mingyao
   Chang, Jiang
   Wu, Chengtie
TI Preparation of copper-containing bioactive glass/eggshell membrane
   nanocomposites for improving angiogenesis, antibacterial activity and
   wound healing
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Wound healing; Copper-containing bioactive glass; Nanocoating;
   Angiogenesis; Antibacterial activity
ID PULSED-LASER DEPOSITION; EGGSHELL MEMBRANE; GLASS SCAFFOLDS;
   CELL-ADHESION; ION RELEASE; IN-VITRO; NANOPARTICLES; REGENERATION;
   BIOMATERIAL; CAPACITY
AB Effectively stimulating angiogenesis and avoiding wound infection are great challenges in wound care management. Designing new healing dressings with requisite angiogenic capacity and antibacterial performance is of particular significance. In order to achieve this aim, we prepared a copper (Cu)-containing bioactive glass nanocoating (40-50 nm) with uniform nanostructure on natural eggshell membrane (Cu-BG/ESM) by the pulsed laser deposition (PLD) technique. The surface physicochemical properties including hydrophilicity and hardness of ESM were significantly improved after depositing Cu-BG nanocoatings. Meanwhile, 5Cu-BG/ESM films containing 5 mol% Cu stimulated proangiogenesis by improving vascular endothelial growth factor (VEGF) and hypoxia-inducible factor (HIF)-1 alpha protein secretion as well as angiogenesis-related gene expression (VEGF, VEGF receptor 2 (KDR) and endothelial nitric oxide (eNos)) of human umbilical vein endothelial cells (HUVECs). When used to treat full-thickness skin defects in mice, 5Cu-BG/ESM films enhanced the healing quality as confirmed by the significantly improved angiogenesis (as indicated by CD31 expression) and formation of continuous and uniform epidermis layer in vivo. Furthermore, 5Cu-BG/ESM films could maintain a sustained release of Cu2+ ions and distinctly inhibited the viability of bacteria (Escherichia coli). The results indicate that Cu2+ ions released from Cu-BG/ESM nanocomposite films play an important role for improving both angiogenesis and antibacterial activity and the prepared nanocomposite films combined Cu-containing BG nanocoatings with ESM are a promising biomaterial for wound healing application.
   Statement of Significance
   Designing new healing dressings with requisite angiogenic capacity and antibacterial performance is of particular significance in wound care management. In our study, we successfully prepared copper containing bioactive glass/eggshell membrane (Cu-BG/ESM) nanocomposites with uniform bioactive glass nanocoatings by using pulsed laser deposition (PLD) technology. Due to the deposited Cu-BG nanocoatings on the surface of ESM, Cu-BG/ESM nanocomposites possessed significantly improved physicochemical and biological properties, including surface hydrophilicity, hardness, antibacterial ability, angiogenesis rate in vitro and wound healing quality in vivo as compared to pure ESM and BG/ESM films. Our study showed that prepared nanocoatings on Cu-BG/ESM nanocomposites offer a beneficial carrier for sustained release of Cu2+ ions which played a key role for improving both angiogenesis and antibacterial activity. The prepared nanocomposites combined Cu-containing BG nanocoatings with ESM are a promising biomaterial for wound healing application. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Li, Jinyan; Zhai, Dong; Yu, Qingqing; Ma, Hongshi; Chang, Jiang; Wu, Chengtie] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
   [Lv, Fang; Yi, Zhengfang; Liu, Mingyao] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China.
   [Lv, Fang; Yi, Zhengfang; Liu, Mingyao] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China.
   [Yin, Jinbo] Shanghai Univ, Dept Polymer Mat, 333 Nanchen Rd, Shanghai 200444, Peoples R China.
RP Wu, CT (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.; Yi, ZF (reprint author), E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China.; Yi, ZF (reprint author), E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China.
EM zfyi@bio.ecnu.edu.cn; chengtiewu@mail.sic.ac.cn
FU Recruitment Program of Global Young Talent, China; National High
   Technology Research and Development Program of China (863 Program)
   [SS2015AA020302]; Natural Science Foundation of China [31370963,
   81190132, 81272463]; Program of Shanghai Outstanding Academic Leaders
   [15XD1503900]; Chinese Academy of Sciences [KGZD-EW-T06]
FX Funding for this study was provided by the Recruitment Program of Global
   Young Talent, China (Dr. Wu), the National High Technology Research and
   Development Program of China (863 Program, SS2015AA020302), Natural
   Science Foundation of China (Grant 31370963, 81190132, 81272463),
   Program of Shanghai Outstanding Academic Leaders (15XD1503900) and Key
   Research Program of Chinese Academy of Sciences (Grant KGZD-EW-T06).
   Authors thank for Prof. Renkui Zheng's assistance for preparing PLD
   nanocoatings.
CR Aguirre A, 2012, EUR CELLS MATER, V24, P90, DOI 10.22203/eCM.v024a07
   Ahlborn G, 2006, J FOOD PROTECT, V69, P729, DOI 10.4315/0362-028X-69.4.729
   Bonilla JJA, 2015, WORLD J MICROB BIOT, V31, P1801, DOI 10.1007/s11274-015-1933-z
   Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   Balaz M, 2014, ACTA BIOMATER, V10, P3827, DOI 10.1016/j.actbio.2014.03.020
   Barralet J, 2009, TISSUE ENG PT A, V15, P1601, DOI 10.1089/ten.tea.2007.0370
   Cai H, 2015, J MATER CHEM C, V3, P5307, DOI 10.1039/c5tc00475f
   Chatterjee AK, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/13/135101
   Devi PS, 2012, RSC ADV, V2, P11578, DOI 10.1039/c2ra21053c
   Eisenhawer B, 2013, NANO LETT, V13, P873, DOI 10.1021/nl3033075
   Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121
   Gorustovich AA, 2010, TISSUE ENG PART B-RE, V16, P199, DOI [10.1089/ten.teb.2009.0416, 10.1089/ten.TEB.2009.0416]
   Goyal A, 2014, J ALLOY COMPD, V583, P214, DOI 10.1016/j.jallcom.2013.08.115
   Grzybowski J, 1999, INT J PHARM, V184, P179, DOI 10.1016/S0378-5173(99)00064-2
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Haider A, 2015, ADV MATER SCI ENG, DOI 10.1155/2015/165257
   Harper D., 2014, SURGERY, V32, P445
   Huang Y, 2015, J MATER SCI, V50, P1688, DOI 10.1007/s10853-014-8730-1
   Jaiswal S, 2012, COLLOID SURFACE B, V94, P170, DOI 10.1016/j.colsurfb.2012.01.035
   Kaur G, 2014, J BIOMED MATER RES A, V102, P254, DOI 10.1002/jbm.a.34690
   Ku SH, 2010, BIOMATERIALS, V31, P2535, DOI 10.1016/j.biomaterials.2009.12.020
   Laurencin CT, 2014, DRUG DISCOV TODAY, V19, P794, DOI 10.1016/j.drudis.2014.01.012
   Law AYS, 2013, MOL CELL ENDOCRINOL, V374, P73, DOI 10.1016/j.mce.2013.04.024
   Li Z, 2013, BIOMATERIALS, V34, P7616, DOI 10.1016/j.biomaterials.2013.06.059
   Lin C, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/4/045017
   Liu AX, 2008, ACTA BIOMATER, V4, P1005, DOI 10.1016/j.actbio.2008.02.013
   Matsumoto S, 2013, PRS-GLOB OPEN, V1, DOI 10.1097/GOX.0b013e3182a88787
   Miguez-Pacheco V, 2015, ACTA BIOMATER, V13, P1, DOI 10.1016/j.actbio.2014.11.004
   Park K, 2012, KOREAN J FOOD SCI AN, V32, P308, DOI 10.5851/kosfa.2012.32.3.308
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Rossi Ana Cláudia, 2014, Int. J. Odontostomat., V8, P289, DOI 10.4067/S0718-381X2014000200023
   Seo CH, 2011, BIOMATERIALS, V32, P9568, DOI 10.1016/j.biomaterials.2011.08.077
   Shevchenko RV, 2010, J R SOC INTERFACE, V7, P229, DOI 10.1098/rsif.2009.0403
   Tan Q, 2014, J TISSUE ENG REGEN M, V8, P195, DOI 10.1002/term.1513
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Valarmathi MT, 2009, BIOMATERIALS, V30, P1098, DOI 10.1016/j.biomaterials.2008.10.044
   Wu CT, 2013, BIOMATERIALS, V34, P422, DOI 10.1016/j.biomaterials.2012.09.066
   Wu CT, 2012, BIOMATERIALS, V33, P2076, DOI 10.1016/j.biomaterials.2011.11.042
   Xu H, 2015, NANOSCALE, V7, P18446, DOI 10.1039/c5nr04802h
   Yang HS, 2011, EXP MOL MED, V43, P622, DOI 10.3858/emm.2011.43.11.070
   Yildirimer L, 2012, TRENDS BIOTECHNOL, V30, P638, DOI 10.1016/j.tibtech.2012.08.004
   Zhai WY, 2012, ACTA BIOMATER, V8, P341, DOI 10.1016/j.actbio.2011.09.008
   Zhang FB, 2014, J CRYST GROWTH, V387, P96, DOI 10.1016/j.jcrysgro.2013.11.022
   Zhao SC, 2015, ACTA BIOMATER, V14, P185, DOI 10.1016/j.actbio.2014.12.010
NR 44
TC 39
Z9 39
U1 20
U2 168
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2016
VL 36
BP 254
EP 266
DI 10.1016/j.actbio.2016.03.011
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DL8JJ
UT WOS:000375888000022
PM 26965395
DA 2018-10-19
ER

PT J
AU Fuoco, C
   Cannata, S
   Gargioli, C
AF Fuoco, Claudia
   Cannata, Stefano
   Gargioli, Cesare
TI Could a functional artificial skeletal muscle be useful in muscle
   wasting?
SO CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
LA English
DT Review
DE biomaterial scaffold; muscle tissue wasting; myogenic stem; progenitor
   cells; skeletal muscle tissue engineering
ID IN-VIVO; EXTRACELLULAR-MATRIX; STEM-CELLS; ELECTRICAL-STIMULATION;
   DYSTROPHIC MUSCLE; ENGINEERED MUSCLE; SATELLITE CELL; TISSUE;
   REGENERATION; DIFFERENTIATION
AB Purpose of reviewRegardless of the underlying cause, skeletal muscle wasting is detrimental for a person's life quality, leading to impaired strength, locomotion, and physiological activity. Here, we propose a series of studies presenting tissue engineering-based approaches to reconstruct artificial muscle in vitro and in vivo.Recent findingsSkeletal muscle tissue engineering is attracting more and more attention from scientists, clinicians, patients, and media, thanks to the promising results obtained in the last decade with animal models of muscle wasting. The use of novel and refined biomimetic scaffolds mimicking three-dimensional muscle environment, thus supporting cell survival and differentiation, in combination with well characterized myogenic stem/progenitor cells, revealed the noteworthy potential of these technologies for creating artificial skeletal muscle tissue. In vitro, the production of three-dimensional muscle structures offer the possibility to generate a drug-screening platform for patient-specific pharmacological treatment, opening new frontiers in the development of new compounds with specific therapeutic actions. In vivo, three-dimensional artificial muscle biomimetic constructs offer the possibility to replace, in part or entirely, wasted muscle by means of straight reconstruction and/or by enhancing endogenous regeneration.SummaryReports of tissue engineering approaches for artificial muscle building appeared in large numbers in the specialized press lately, advocating the suitability of this technology for human application upon scaling up and a near future applicability for medical care of muscle wasting.Video abstracthttp://links.lww.com/COCN/A9
C1 [Fuoco, Claudia; Cannata, Stefano; Gargioli, Cesare] Univ Roma Tor Vergata, Dept Biol, Via Ric Sci Snc, I-00133 Rome, Italy.
RP Gargioli, C (reprint author), Univ Roma Tor Vergata, Dept Biol, Via Ric Sci Snc, I-00133 Rome, Italy.
EM cesare.gargioli@uniroma2.it
FU European Research Council [N322749 DEPTH]; Uncovering Excellence Grant
   [MDESMPLAT]
FX This work has been supported by grants from: the European Research
   Council [N322749 DEPTH] and Uncovering Excellence Grant 2014
   [MDESMPLAT].
CR Alexakis C, 2007, AM J PHYSIOL-CELL PH, V293, pC661, DOI 10.1152/ajpcell.00061.2007
   Badylak Stephen F, 2015, Acta Biomater, V23 Suppl, pS17, DOI 10.1016/j.actbio.2015.07.016
   Bentzinger CF, 2013, EMBO REP, V14, P1062, DOI 10.1038/embor.2013.182
   Birbrair A, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00245
   Biressi S, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00140
   Carosio S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01420
   Cezar CA, 2015, ADV DRUG DELIVER REV, V84, P188, DOI 10.1016/j.addr.2014.09.008
   Christ GJ, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00053
   Cittadella Vigodarzere G, 2014, FRONT PHYSIOL, V5, P421
   Corona BT, 2012, TISSUE ENG PT A, V18, P1213, DOI [10.1089/ten.tea.2011.0614, 10.1089/ten.TEA.2011.0614]
   Cossu G, 2015, EMBO MOL MED, V7, P1513, DOI 10.15252/emmm.201505636
   Costamagna D, 2015, CURR GENE THER, V15, P348, DOI 10.2174/1566523215666150630121024
   De Lisio M, 2015, J APPL PHYSIOL, V119, P900, DOI 10.1152/japplphysiol.01112.2014
   Flaibani M, 2009, TISSUE ENG PT A, V15, P2447, DOI 10.1089/ten.tea.2008.0301
   Fuoco C, 2015, EMBO MOL MED, V7, P411, DOI 10.15252/emmm.201404062
   Fuoco C, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00203
   Fuoco C, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-24
   Gargioli C, 2008, NAT MED, V14, P973, DOI 10.1038/nm.1852
   Grasman JM, 2015, ACTA BIOMATER, V25, P2, DOI 10.1016/j.actbio.2015.07.038
   Grogan BF, 2011, J AM ACAD ORTHOP SUR, V19, pS35, DOI 10.5435/00124635-201102001-00007
   Handschin C, 2015, ADV DRUG DELIVER REV, V82-83, P168, DOI 10.1016/j.addr.2014.10.021
   Heher P, 2015, ACTA BIOMATER, V24, P251, DOI 10.1016/j.actbio.2015.06.033
   Hurd SA, 2015, BIOMATERIALS, V49, P9, DOI 10.1016/j.biomaterials.2015.01.027
   Ito A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04781
   Juhas M, 2016, METHODS, V99, P81, DOI 10.1016/j.ymeth.2015.10.002
   Juhas M, 2014, P NATL ACAD SCI USA, V111, P5508, DOI 10.1073/pnas.1402723111
   Kajbafzadeh AM, 2016, ANN BIOMED ENG, V44, P1773, DOI 10.1007/s10439-015-1468-3
   Karbalaeikhani A, 2015, ARCH BONE JT SURG-AB, V3, P193
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Liao H, 2009, TISSUE ENG PART B-RE, V15, P319, DOI 10.1089/ten.teb.2009.0092
   Londono R, 2015, ANN BIOMED ENG, V43, P577, DOI 10.1007/s10439-014-1103-8
   Madden L, 2015, ELIFE, V4, DOI 10.7554/eLife.04885
   Merritt EK, 2010, TISSUE ENG PT A, V16, P1395, DOI [10.1089/ten.tea.2009.0226, 10.1089/ten.TEA.2009.0226]
   Ostrovidov S, 2015, STEM CELL REV REP, V11, P866, DOI 10.1007/s12015-015-9618-4
   Ostrovidov S, 2014, BIOMATERIALS, V35, P6268, DOI 10.1016/j.biomaterials.2014.04.021
   Parmar N, 2014, REGEN MED, V9, P831, DOI [10.2217/RME.14.56, 10.2217/rme.14.56]
   Piccoli M, 2015, BIOMATERIALS, V74, P1
   Pinheiro CHJ, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00141
   Porzionato A, 2015, INT J MOL SCI, V16, P14808, DOI 10.3390/ijms160714808
   Qazi TH, 2015, BIOMATERIALS, V53, P502, DOI 10.1016/j.biomaterials.2015.02.110
   Rizzi Roberto, 2012, Muscles Ligaments Tendons J, V2, P230
   Rossi CA, 2011, FASEB J, V25, P2296, DOI 10.1096/fj.10-174755
   Salcedo L, 2014, STEM CELL TRANSL MED, V3, P760, DOI 10.5966/sctm.2013-0157
   Shandalov Y, 2015, METHODS, V84, P70, DOI 10.1016/j.ymeth.2015.03.021
   Sicari BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008085
   Tidball JG, 2011, COMPR PHYSIOL, V1, P2029, DOI 10.1002/cphy.c100092
   Wood LK, 2014, J APPL PHYSIOL, V117, P363, DOI 10.1152/japplphysiol.00256.2014
NR 47
TC 3
Z9 3
U1 2
U2 25
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1363-1950
EI 1473-6519
J9 CURR OPIN CLIN NUTR
JI Curr. Opin. Clin. Nutr. Metab. Care
PD MAY
PY 2016
VL 19
IS 3
BP 182
EP 187
DI 10.1097/MCO.0000000000000271
PG 6
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA DK2KR
UT WOS:000374743900003
PM 26910194
DA 2018-10-19
ER

PT J
AU Chew, BH
   Lange, D
AF Chew, Ben H.
   Lange, Dirk
TI Advances in ureteral stent development
SO CURRENT OPINION IN UROLOGY
LA English
DT Review
DE biomaterial; stent; ureter; urolithiasis
ID QUALITY-OF-LIFE; EXPERIENCE; MORBIDITY; REMOVAL; METAL
AB Purpose of review
   Ureteral stents are commonly used in urology, but there is no perfect ureteral stent. This review documents developing ureteral technologies and strategies over the past 2 years. This area has some progressive advances in the foreseeable future.
   Recent findings
   Publications from 2014 and 2015 from a PubMed search with the words 'ureter' and 'stent' in the title were reviewed. Topics that affected patient symptoms from stents include selecting the proper length of stent, patient education regarding stent symptoms, and how the stent is removed. Stent extraction strings have been studied and not increased the incidence of infection or pain. There have been several publications examining antirefluxing ureteral stents that reduced vesicoureteral reflux during micturition and infection of transplanted kidneys. Other novel methods of removing a stent include new biodegradable ureteral stents and metal beads attached to the stent used in tandem with a magnetic catheter. Several new metal and mesh stents were described for use in patients with malignant ureteral obstruction. Last, new stent coatings with antimicrobial peptides have also been described.
   Summary
   The search continues for the perfect stent and there has been promising progress over the past 2 years.
C1 [Chew, Ben H.; Lange, Dirk] Univ British Columbia, Dept Urol Sci, Level 6,2775 Laurel St, Vancouver, BC V5Z 1M9, Canada.
RP Chew, BH (reprint author), Univ British Columbia, Dept Urol Sci, Level 6,2775 Laurel St, Vancouver, BC V5Z 1M9, Canada.
EM ben.chew@ubc.ca
FU Boston Scientific Corporation; Cook Medical; ADVA-Tec/Poly-Med Inc.;
   Urotech
FX B.H.C. is a consultant for the following companies: ADVA-Tec/Poly-Med
   Inc., Bard Medical, Boston Scientific Corporation, Cook Medical, and
   Olympus Medical. He is also a lecturer/instructor for Boston Scientific
   Corporation, Cook Medical, and Olympus Medical. D.L. is a consultant for
   the following companies: Bard Medical, Boston Scientific Corporation,
   Cook Medical, and Urotech. Both authors received financial/study grants
   from Boston Scientific Corporation, Cook Medical, ADVA-Tec/Poly-Med
   Inc., and Urotech.
CR Abt D, 2015, INT J UROL, V22, P679, DOI 10.1111/iju.12782
   Abt D, 2015, KOREAN J UROL, V56, P370, DOI 10.4111/kju.2015.56.5.370
   Acelam PA, 2015, RES REP UROL, V7, P117, DOI 10.2147/RRU.S87860
   Althaus AB, 2015, J UROLOGY, V193, P2011, DOI 10.1016/j.juro.2014.12.087
   Ay N, 2015, INT J CLIN EXP MED, V8, P16340
   Barnes KT, 2014, BJU INT, V113, P605, DOI 10.1111/bju.12541
   Barros AA, 2015, INT J PHARMACEUT, V495, P651, DOI 10.1016/j.ijpharm.2015.08.040
   Barros AA, 2015, J BIOMED MATER RES B, V103, P608, DOI 10.1002/jbm.b.33237
   Bourdoumis A, 2014, J ENDOUROL, V28, P96, DOI 10.1089/end.2013.0332
   Chow PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135566
   Chow PM, 2014, J ENDOUROL, V28, P729, DOI 10.1089/end.2013.0792
   Chung HH, 2014, CARDIOVASC INTER RAD, V37, P463, DOI 10.1007/s00270-013-0675-2
   Elsamra SE, 2015, INT J UROL, V22, P629, DOI 10.1111/iju.12795
   Gultekinoglu M, 2015, ACTA BIOMATER, V21, P44, DOI 10.1016/j.actbio.2015.03.037
   Kim HW, 2015, J ENDOUROL
   Loh-Doyle JC, 2015, J ENDOUROL, V29, P35, DOI 10.1089/end.2014.0402
   Soria F, 2015, UROLOGY, V86, P417, DOI 10.1016/j.urology.2015.05.020
   Vogt B, 2015, WORLD J UROL, V33, P1061, DOI 10.1007/s00345-014-1394-2
   Wang J, 2014, UROLOGY, V84, P960, DOI 10.1016/j.urology.2014.06.024
   Yu K, 2015, ACS APPL MAT INTERFA
NR 20
TC 4
Z9 5
U1 1
U2 18
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0963-0643
EI 1473-6586
J9 CURR OPIN UROL
JI Curr. Opin. Urol.
PD MAY
PY 2016
VL 26
IS 3
BP 277
EP 282
DI 10.1097/MOU.0000000000000275
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA DK2SE
UT WOS:000374763900011
PM 26840739
DA 2018-10-19
ER

PT J
AU Wiacek, AE
   Terpilowski, K
   Jurak, M
   Worzakowska, M
AF Wiacek, Agnieszka Ewa
   Terpilowski, Konrad
   Jurak, Malgorzata
   Worzakowska, Marta
TI Effect of low-temperature plasma on chitosan-coated PEEK polymer
   characteristics
SO EUROPEAN POLYMER JOURNAL
LA English
DT Article
DE Polyetheretherketone; Low-temperature plasma; Chitosan film; Contact
   angle; Apparent surface energy; Wettability
ID SURFACE FREE-ENERGY; VAN-DER-WAALS; THERMAL-DECOMPOSITION;
   MOLECULAR-WEIGHT; BIOMATERIALS; WETTABILITY; PYROLYSIS; MECHANISM;
   ADHESION; FIBERS
AB Low-temperature plasma effect on changes of physicochemical properties of plastic polymer polyetheretherketone (PEEK) was investigated. Despite extensive use of PEEK, information about adhesion to this polymer is limited. The adhesive and energetic properties of biomaterial and after chitosan modification were studied by contact angles measurements and surface free energy evaluation using the acid-base LWAB theory and contact angle hysteresis (CAH) model. Modification by chitosan can enhance antibacterial properties, native haemostatic and the polymer biocompatibility. Plasma modification led to variation in surface chemistry and morphology determined by an optical profilometer. After air/nitrogen plasma treatment a relatively hydrophobic character of PEEK was changed into more hydrophilic, significant differences in the wettability of sample were observed. Though, practically no differences in thermal and mechanical properties were noticed. The profilometer pictures showed an increase in the surface roughness of plasma modified PEEK due to the formation of additional polar groups with oxygen and nitrogen on the surface. Plasma treated polyetheretherketone surfaces had better adhesive features. Novel and stable chitosan-coated PEEK biomaterials were prepared applicable for different industries, mainly pharmacy and reconstructive medicine. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Wiacek, Agnieszka Ewa; Terpilowski, Konrad; Jurak, Malgorzata] Marie Curie Sklodowska Univ, Dept Interfacial Phenomena, Fac Chem, PL-20031 Lublin, Poland.
   [Worzakowska, Marta] Marie Curie Sklodowska Univ, Dept Polymer Chem, Fac Chem, Lublin, Poland.
RP Wiacek, AE (reprint author), Marie Curie Sklodowska Univ, Dept Interfacial Phenomena, Fac Chem, PL-20031 Lublin, Poland.
EM a.wiacek@poczta.umcs.lublin.pl
OI Terpilowski, Konrad/0000-0002-8078-3644
FU European Regional Development Fund [POIG.02.01.00-06-024/09]; Marie
   Curie Initial Training Network "Complex Wetting Phenomena" [607861]
FX The research was carried out with the equipment purchased thanks to the
   financial support of the European Regional Development Fund in the
   framework of the Polish Innovation Economy Operational Program (contract
   no. POIG.02.01.00-06-024/09 Center of Functional Nanomaterials)
   www.cnf.umcs.lublin.pl.; Support from Marie Curie Initial Training
   Network "Complex Wetting Phenomena" (Project number 607861) is highly
   appreciated.
CR [Anonymous], 2005, THERMAL ANAL POLYMER, V53
   Awaja F, 2009, PROG POLYM SCI, V34, P948, DOI 10.1016/j.progpolymsci.2009.04.007
   Bismarck A, 2008, POLYM ENG SCI, V48, P1971, DOI 10.1002/pen.21103
   Chibowski E, 2003, ADV COLLOID INTERFAC, V103, P149, DOI 10.1016/S0001-8686(02)00093-3
   Dash M., 2011, PROGR POLYM SCI, V26, P981
   Denes FS, 2004, PROG POLYM SCI, V29, P815, DOI 10.1016/j.progpolymsci.2004.05.001
   Ding Z, 2004, BIOMATERIALS, V25, P1059, DOI 10.1016/S0142-9612(03)00615-X
   Dodane V, 1998, PHARM SCI TECHNOL TO, V1, P246, DOI 10.1016/S1461-5347(98)00059-5
   Furuike T, 2015, FIBERS, V3, P380, DOI 10.3390/fib3040380
   Gil'man AB, 2003, HIGH ENERG CHEM+, V37, P17, DOI 10.1023/A:1021957425359
   HAY JN, 1987, POLYMER, V28, P2047, DOI 10.1016/0032-3861(87)90039-5
   Hegemann D, 2003, NUCL INSTRUM METH B, V208, P281, DOI 10.1016/S0168-583X(03)00644-X
   Hegemann D., 2001, Plasmas and Polymers, V6, P221, DOI 10.1023/A:1014461932094
   Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410
   Huang M, 2004, PHARM RES, V21, P344, DOI 10.1023/B:PHAM.0000016249.52831.a5
   Kaminska A, 2002, EUR POLYM J, V38, P1915, DOI 10.1016/S0014-3057(02)00059-9
   Kuo MC, 2005, MATER CHEM PHYS, V90, P185, DOI 10.1016/j.matchemphys.2004.10.009
   Lommatzsch U., 2007, PLASMA PROCESS POLYM, V4, P1041
   Mark H.F., 1985, ENCY POLYM SCI ENG, V1, P490
   Mi F.-L., 2003, BIOMATERIALS, V24, P5035
   Miao JJ, 2012, LANGMUIR, V28, P4396, DOI 10.1021/la3000137
   Murari A, 2003, VACUUM, V72, P327, DOI 10.1016/j.vacuum.2003.08.011
   Nair KCM, 2001, COMPOS SCI TECHNOL, V61, P2519
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Patel P, 2010, POLYM DEGRAD STABIL, V95, P709, DOI 10.1016/j.polymdegradstab.2010.01.024
   Patela P., 2010, POLYM DEGRAD STABIL, V96, P12
   Perng LH, 1999, POLYMER, V40, P7321, DOI 10.1016/S0032-3861(99)00006-3
   Rochford ETJ, 2014, COLLOID SURFACE B, V113, P213, DOI 10.1016/j.colsurfb.2013.09.012
   Slepicka P, 2013, EXPRESS POLYM LETT, V7, P535, DOI 10.3144/expresspolymlett.2013.50
   Steen ML, 2001, CHEM MATER, V13, P2749, DOI 10.1021/cm010452q
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tokura S, 1997, MACROMOL SYMP, V120, P1, DOI 10.1002/masy.19971200103
   Tsai CJ, 1997, RAPID COMMUN MASS SP, V11, P1987, DOI 10.1002/(SICI)1097-0231(199712)11:18<1987::AID-RCM100>3.0.CO;2-Q
   Udpa N, 2013, TISSUE ENG PT A, V19, P2713, DOI [10.1089/ten.tea.2012.0739, 10.1089/ten.TEA.2012.0739]
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   VANOSS CJ, 1993, COLLOID SURFACE A, V78, P1, DOI 10.1016/0927-7757(93)80308-2
   VANOSS CJ, 1986, J COLLOID INTERF SCI, V111, P378, DOI 10.1016/0021-9797(86)90041-X
   VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006
   Wang XH, 2006, J BIOACT COMPAT POL, V21, P39, DOI 10.1177/0883911506060201
   Wiacek AE, 2016, POLYM TEST, V50, P325, DOI 10.1016/j.polymertesting.2016.01.020
   Wiacek AE, 2015, COLLOID SURFACE A, V480, P351, DOI 10.1016/j.colsurfa.2015.01.085
   Wiacek AE, 2015, FOOD HYDROCOLLOID, V48, P228, DOI 10.1016/j.foodhyd.2015.02.005
   Williams TS, 2013, REV ADHES ADHES, V1, P46, DOI 10.7569/RAA.2013.097302
   Zhang SN, 2011, COLLOID SURFACE A, V374, P88, DOI 10.1016/j.colsurfa.2010.11.013
NR 44
TC 10
Z9 10
U1 8
U2 61
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0014-3057
EI 1873-1945
J9 EUR POLYM J
JI Eur. Polym. J.
PD MAY
PY 2016
VL 78
BP 1
EP 13
DI 10.1016/j.eurpolymj.2016.02.024
PG 13
WC Polymer Science
SC Polymer Science
GA DL3CK
UT WOS:000375511600001
DA 2018-10-19
ER

PT J
AU Pieretti, EF
   das Neves, MDM
AF Pieretti, Eurico Felix
   Martins das Neves, Mauricio David
TI Influence of Laser Marks on the Electrochemical Behaviour of the ASTM
   F139 Stainless Steel for Biomedical Application
SO INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE
LA English
DT Article
DE Biomedical engineering; biointerfaces; laser engraving; electrochemistry
ID CORROSION-RESISTANCE; PITTING CORROSION; SURFACE-ROUGHNESS; OXIDE-FILMS;
   ALBUMIN
AB The aim of this work is to evaluate the effect of a laser marking technique on the microstructure and chemical composition at the surface of the ASTM F139 stainless steel and the influence of the surface modifications on its corrosion resistance. This is one of the most frequently used biomaterial for prosthesis manufacture. The laser effect on the corrosion resistance has been evaluated by electrochemical techniques, specifically electrochemical impedance spectroscopy. It was found that the laser marking reduces the corrosion resistance by modification of the microstructure and surface chemical composition affecting the surface passive layer, comparatively to the unmarked material. The surface and chemical composition was analyzed by scanning electron microscope coupled to a high-resolution field emission gun (SEM-FEG) and transmission electron microscopy (TEM) with microanalysis. TEM in areas affected by laser engraving showed a very high density of dislocations suggesting the presence of residual stresses induced by laser, decreasing the corrosion resistance of the stainless steel. Aluminum and silicon oxide inclusions were conveyed into the surface exposed to the corrosive electrolyte by melting the metallic matrix surrounding them during the incidence of the laser beam. The corrosive attack of this stainless steel matrix surrounding the oxide inclusions creates micro crevices, promoting pitting corrosion. This is the mechanism proposed to explain the increased susceptibility to localized corrosion associated to the areas affected by the laser marking process.
C1 [Pieretti, Eurico Felix; Martins das Neves, Mauricio David] Inst Pesquisas Energet & Nucl IPEN CNEN, Ave Prof Lineu Prestes 2242,Cidade Univ, BR-05422970 Sao Paulo, SP, Brazil.
RP Pieretti, EF (reprint author), Inst Pesquisas Energet & Nucl IPEN CNEN, Ave Prof Lineu Prestes 2242,Cidade Univ, BR-05422970 Sao Paulo, SP, Brazil.
EM efpieretti@usp.br
OI Neves, Mauricio/0000-0002-1304-2117
FU CNPq [350798/2014-1, 459565/2013-3]
FX The authors acknowledge CNPq for the financial support, under grant
   number Process: 350798/2014-1, Project: 459565/2013-3; the Instituto de
   Ortopedia e Traumatologia of the Hospital das Clinicas da Faculdade de
   Medicina da Universidade de Sao Paulo and Dr. I. Costa, PhD.
CR Anderson J. M., 2001, MAT RES, V31, P81
   Asteman H, 2002, OXID MET, V57, P193, DOI 10.1023/A:1014877600235
   BLACK J, 1984, BIOMATERIALS, V5, P11, DOI 10.1016/0142-9612(84)90061-9
   Cheng XQ, 2009, INT J MIN MET MATER, V16, P170, DOI 10.1016/S1674-4799(09)60029-7
   Da Cunha Belo M, 1999, ELECTROCHIM ACTA, V44, P2473
   Dowling NJE, 1999, CORROSION, V55, P187, DOI 10.5006/1.3283979
   Hakiki NE, 2000, CORROS SCI, V42, P687, DOI 10.1016/S0010-938X(99)00082-7
   Hong T, 1997, CORROS SCI, V39, P1665, DOI 10.1016/S0010-938X(97)00072-3
   Leone C., 2010, J MAT PROC TEC, V210, P1293
   Mudali UK, 2002, CORROS SCI, V44, P2183, DOI 10.1016/S0010-938X(02)00035-5
   Okasaki Y., 2002, BIOMATERIALS, V23, P2071
   Patrikar RA, 2004, APPL SURF SCI, V228, P213, DOI 10.1016/j.apsusc.2004.01.010
   Pieretti EF, 2014, INT J ELECTROCHEM SC, V9, P3828
   Pieretti EF, 2014, ELECTROCHIM ACTA, V124, P150, DOI 10.1016/j.electacta.2013.10.137
   Pieretti EF, 2014, INT J ELECTROCHEM SC, V9, P2435
   Pieretti EF, 2015, INT J ELECTROCHEM SC, V10, P1221
   Pieretti EF, 2013, ELECTROCHIM ACTA, V114, P838, DOI 10.1016/j.electacta.2013.05.101
   Pourbaix M., 1963, CORROS SCI, V3, P239
   Punckt C, 2004, SCIENCE, V305, P1133, DOI 10.1126/science.1101358
   Qi J, 2003, J MATER PROCESS TECH, V139, P273, DOI 10.1016/S0924-0136(03)00234-6
   SCHMUKI P, 1995, J ELECTROCHEM SOC, V142, P1705, DOI 10.1149/1.2048644
   Shahryari A, 2008, MAT SCI ENG C-BIO S, V28, P94, DOI 10.1016/j.msec.2007.09.002
   Shih CC, 2004, CORROS SCI, V46, P427, DOI 10.1016/S0010-938X(03)00148-3
   Virtanen S, 2008, ACTA BIOMATER, V4, P468, DOI 10.1016/j.actbio.2007.12.003
NR 24
TC 6
Z9 6
U1 1
U2 16
PU ESG
PI BELGRADE
PA BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA
SN 1452-3981
J9 INT J ELECTROCHEM SC
JI Int. J. Electrochem. Sci.
PD MAY
PY 2016
VL 11
IS 5
BP 3532
EP 3541
PG 10
WC Electrochemistry
SC Electrochemistry
GA DL6LG
UT WOS:000375750100021
DA 2018-10-19
ER

PT J
AU Sarmiento-Bustos, E
   Rodriguez-Diaz, RA
   Colin, J
   Molina-Ocampo, A
   Gaona-Jimenez, S
   Bahena-Medina, LA
AF Sarmiento-Bustos, E.
   Rodriguez-Diaz, R. A.
   Colin, J.
   Molina-Ocampo, A.
   Gaona-Jimenez, S.
   Bahena-Medina, L. A.
TI Optimized In-vitro Corrosion Assessment of a FeAl intermetallic Compound
   Modified with Ag in Artificial Human Media
SO INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE
LA English
DT Article
DE Corrosion; Fe-Al alloy; Hanks' solution; biomaterial; noise;
   polarization curve
ID IRON ALUMINIDE INTERMETALLICS; RAY PHOTOELECTRON-SPECTROSCOPY;
   PHYSIOLOGICAL SOLUTION; METALLIC BIOMATERIALS; BEHAVIOR; ALLOY; NI; CR
AB This article presents an assessment about the effect of the addition of silver on the corrosion performance of the intermetallic alloy Fe40Al (at. %) in a biomimetic environment that simulates the biological human body fluid. In the present work, an in-vitro corrosion assessment of Fe40Al based alloys was performed, since the electrochemical parameters of Fe40Al and Fe40Al2.5Ag alloys were compared. According to the polarization curves, the corrosion current density of Fe40Al2.5Ag alloy resulted minor than that of binary Fe40Al alloy; however, according to the measurements of the linear polarization resistance, the current density of the ternary alloy resulted higher than that of the binary FeAl based alloy. This behavior is ascribed to the enhancement of the protective character of the Al-oxide layer of the Fe40Al aluminide, while the exposed time in the Hanks' solution had elapsed.
C1 [Sarmiento-Bustos, E.] Univ Tecnol Emiliano Zapata Estado Morelos, Ave Univ Tecnol 1, Emiliano Zapata 62760, Morelos, Mexico.
   [Rodriguez-Diaz, R. A.; Gaona-Jimenez, S.; Bahena-Medina, L. A.] Univ Politecn Estado Morelos, Blvd Cuauhnahuac 566, Jiutepec 62574, Morelos, Mexico.
   [Colin, J.] Univ Autonoma Estado Morelos, Fac Ciencias Quim & Ingn, Ave Univ 1001, Cuernavaca 62209, Morelos, Mexico.
   [Rodriguez-Diaz, R. A.; Molina-Ocampo, A.] Univ Autonoma Estado Morelos, Ctr Invest Ingn & Ciencias Aplicada IICBA, Ave Univ 1001, Cuernavaca 62209, Morelos, Mexico.
RP Rodriguez-Diaz, RA (reprint author), Univ Politecn Estado Morelos, Blvd Cuauhnahuac 566, Jiutepec 62574, Morelos, Mexico.; Rodriguez-Diaz, RA (reprint author), Univ Autonoma Estado Morelos, Ctr Invest Ingn & Ciencias Aplicada IICBA, Ave Univ 1001, Cuernavaca 62209, Morelos, Mexico.
EM rdiaz.unam@gmail.com
FU PRODEP; CONACyT
FX The authors express their gratitude to PRODEP and CONACyT for their
   financial support provided for the development and accomplishment of
   this research.
CR Arenas MA, 2000, BR CORROS J, V35, P1
   Arrieta-Gonzalez CD, 2011, INT J ELECTROCHEM SC, V6, P4016
   Castaneda IE, 2011, INT J ELECTROCHEM SC, V6, P404
   Chaturvedi T P, 2009, Indian J Dent Res, V20, P91
   Chen QZ, 2015, MAT SCI ENG R, V87, P1, DOI 10.1016/j.mser.2014.10.001
   Concha-Guzman L., 2015, OMNIASCIENCE MONOGRA
   Hanawa T, 2002, SCI TECHNOL ADV MAT, V3, P289, DOI 10.1016/S1468-6996(02)00028-1
   Huape-Padilla E, 2015, INT J ELECTROCHEM SC, V10, P2141
   Jez M, 2014, J SOLID STATE ELECTR, V18, P1635, DOI 10.1007/s10008-014-2387-1
   Kubaschewski O., 2013, IRON BINARY PHASE DI
   [Luo Lin 骆琳], 2014, [硅酸盐学报, Journal of the Chinese Ceramic Society], V42, P574
   Mansfeld F, 2009, J SOLID STATE ELECTR, V13, P515, DOI 10.1007/s10008-008-0652-x
   McCabe J. F., 2008, APPL DENT MAT
   Menchaca-Campos C., 2013, RECENT PATENTS CORRO, V3, P12
   Milosev I, 2000, BIOMATERIALS, V21, P2103, DOI 10.1016/S0142-9612(00)00145-9
   Milosev I, 2000, J BIOMED MATER RES, V52, P404, DOI 10.1002/1097-4636(200011)52:2<404::AID-JBM22>3.0.CO;2-Z
   Okamoto H, 2010, PHASE DIAGRAMS BINAR
   POURBAIX M, 1984, BIOMATERIALS, V5, P122, DOI 10.1016/0142-9612(84)90046-2
   Pourbaix M., 2012, LECT ELECTROCHEMICAL
   Ramirez-Arteaga MA, 2014, INT J ELECTROCHEM SC, V9, P161
   Rodriguez-Diaz RA, 2013, INT J ELECTROCHEM SC, V8, P958
   Rosalbino F, 2014, CORROS SCI, V85, P394, DOI 10.1016/j.corsci.2014.04.054
   Senderowski C, 2015, MATERIALS, V8, P1108, DOI 10.3390/ma8031108
   Upadhyay D, 2006, MAT SCI ENG A-STRUCT, V432, P1, DOI 10.1016/j.msea.2006.05.003
   Zaid B, 2008, CORROS SCI, V50, P1841, DOI 10.1016/j.corsci.2008.03.006
   Zamanzade M, 2016, MAT SCI ENG A-STRUCT, V652, P370, DOI 10.1016/j.msea.2015.11.088
   Zamanzade M, 2016, CRYSTALS, V6, DOI 10.3390/cryst6010010
   Zamanzade M, 2014, ACTA MATER, V69, P210, DOI 10.1016/j.actamat.2014.01.042
   Zamanzade M, 2014, CORROS SCI, V78, P223, DOI 10.1016/j.corsci.2013.10.002
   Zarkevich N. A., 2003, PHYS REV B, V67
NR 30
TC 0
Z9 0
U1 0
U2 5
PU ESG
PI BELGRADE
PA BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA
SN 1452-3981
J9 INT J ELECTROCHEM SC
JI Int. J. Electrochem. Sci.
PD MAY
PY 2016
VL 11
IS 5
BP 4136
EP 4148
PG 13
WC Electrochemistry
SC Electrochemistry
GA DL6LG
UT WOS:000375750100069
DA 2018-10-19
ER

PT J
AU Muhonen, V
   Salonius, E
   Haaparanta, AM
   Jarvinen, E
   Paatela, T
   Meller, A
   Hannula, M
   Bjorkman, M
   Pyhalto, T
   Ella, V
   Vasara, A
   Toyras, J
   Kellomaki, M
   Kiviranta, I
AF Muhonen, Virpi
   Salonius, Eve
   Haaparanta, Anne-Marie
   Jarvinen, Elina
   Paatela, Teemu
   Meller, Anna
   Hannula, Markus
   Bjorkman, Mimmi
   Pyhalto, Tuomo
   Ella, Ville
   Vasara, Anna
   Toyras, Juha
   Kellomaki, Minna
   Kiviranta, Ilkka
TI Articular Cartilage Repair With Recombinant Human Type II
   Collagen/Polylactide Scaffold in a Preliminary Porcine Study
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
DE cartilage repair; recombinant type II collagen; polylactide; scaffold;
   ACI
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; MESENCHYMAL STEM-CELLS;
   OSTEOCHONDRAL DEFECTS; SUBCHONDRAL BONE; COLLAGEN GEL; IMAGE-ANALYSIS;
   KNEE; MODEL; LESIONS; RABBIT
AB The purpose of this study was to investigate the potential of a novel recombinant human type II collagen/polylactide scaffold (rhCo-PLA) in the repair of full-thickness cartilage lesions with autologous chondrocyte implantation technique (ACI). The forming repair tissue was compared to spontaneous healing (spontaneous) and repair with a commercial porcine type I/III collagen membrane (pCo). Domestic pigs (4-month-old, n = 20) were randomized into three study groups and a circular full-thickness chondral lesion with a diameter of 8 mm was created in the right medial femoral condyle. After 3 weeks, the chondral lesions were repaired with either rhCo-PLA or pCo together with autologous chondrocytes, or the lesion was only debrided and left untreated for spontaneous repair. The repair tissue was evaluated 4 months after the second operation. Hyaline cartilage formed most frequently in the rhCo-PLA treatment group. Biomechanically, there was a trend that both treatment groups resulted in better repair tissue than spontaneous healing. Adverse subchondral bone reactions developed less frequently in the spontaneous group (40%) and the rhCo-PLA treated group (50%) than in the pCo control group (100%). However, no statistically significant differences were found between the groups. The novel rhCo-PLA biomaterial showed promising results in this proof-of-concept study, but further studies will be needed in order to determine its effectiveness in articular cartilage repair. (C) 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.
C1 [Muhonen, Virpi; Salonius, Eve; Jarvinen, Elina; Paatela, Teemu; Vasara, Anna; Kiviranta, Ilkka] Univ Helsinki, Dept Orthopaed & Traumatol, Helsinki, Finland.
   [Haaparanta, Anne-Marie; Hannula, Markus; Ella, Ville; Kellomaki, Minna] Tampere Univ Technol, Dept Elect & Commun Engn, FIN-33101 Tampere, Finland.
   [Haaparanta, Anne-Marie; Hannula, Markus; Ella, Ville; Kellomaki, Minna] BioMediTech, Tampere, Finland.
   [Paatela, Teemu; Pyhalto, Tuomo; Vasara, Anna; Kiviranta, Ilkka] Helsinki Univ Hosp, Dept Orthopaed & Traumatol, Helsinki, Finland.
   [Meller, Anna] Univ Helsinki, Lab Anim Ctr, Helsinki, Finland.
   [Bjorkman, Mimmi; Toyras, Juha] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland.
   [Toyras, Juha] Kuopio Univ Hosp, Dept Clin Neurophysiol, SF-70210 Kuopio, Finland.
RP Salonius, E (reprint author), Univ Helsinki, Dept Orthopaed & Traumatol, Helsinki, Finland.
EM eve.salonius@helsinki.fi
OI Kellomaki, Minna/0000-0003-4321-1820; Hannula, Markus Ilkka
   Juhana/0000-0002-4485-8004; Paatela, Teemu/0000-0002-6389-051X
FU Finnish Funding Agency for Innovation (Tekes) [40091/09, 40113/13]
FX Grant sponsor: Finnish Funding Agency for Innovation (Tekes); Grant
   numbers: 40091/09, 40113/13.
CR Ahsan T, 1999, OSTEOARTHR CARTILAGE, V7, P29, DOI 10.1053/joca.1998.0160
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Bentley G, 2003, J BONE JOINT SURG BR, V85B, P223, DOI 10.1302/0301-620X.85B2.13543
   Biant LC, 2014, AM J SPORT MED, V42, P2178, DOI 10.1177/0363546514539345
   Bos PK, 2001, OSTEOARTHR CARTILAGE, V9, P382, DOI 10.1053/joca.2000.0399
   Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P58, DOI 10.2106/00004623-200300002-00008
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Crawford DC, 2009, AM J SPORT MED, V37, P1334, DOI 10.1177/0363546509333011
   de Vries-van Melle ML, 2014, TISSUE ENG PT A, V20, P23, DOI [10.1089/ten.tea.2013.0080, 10.1089/ten.TEA.2013.0080]
   Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023
   Haaparanta AM, 2008, J APPL BIOMATER BIOM, V6, P89
   Haaparanta AM, 2014, J MATER SCI-MATER M, V25, P1129, DOI 10.1007/s10856-013-5129-5
   Harris JD, 2010, J BONE JOINT SURG AM, V92A, P2220, DOI 10.2106/JBJS.J.00049
   Heiskanen A, 2007, STEM CELLS, V25, P197, DOI 10.1634/stemcells.2006-0444
   Hurtig MB, 2011, CARTILAGE, V2, P137, DOI 10.1177/1947603511401905
   Jones CW, 2008, J ORTHOP RES, V26, P292, DOI 10.1002/jor.20502
   Julkunen P, 2007, J BIOMECH, V40, P1862, DOI 10.1016/j.jbiomech.2006.07.026
   Kon E, 2011, AM J SPORT MED, V39, P1668, DOI 10.1177/0363546511404675
   Korhonen RK, 2003, J BIOMECH, V36, P1373, DOI 10.1016/S0021-9290(03)00069-1
   Kosiur JR, 2014, J BONE JOINT SURG AM, V96A, DOI 10.2106/JBJS.M.01041
   Laasanen MS, 2006, OSTEOARTHR CARTILAGE, V14, P258, DOI 10.1016/j.joca.2005.09.011
   Lansman S, 2006, J CRANIOFAC SURG, V17, P1121
   Mainil-Varlet P, 2003, J BONE JOINT SURG AM, V85A, P45, DOI 10.2106/00004623-200300002-00007
   Makela JTA, 2012, OSTEOARTHR CARTILAGE, V20, P1268, DOI 10.1016/j.joca.2012.07.016
   Niemeyer P, 2014, INT ORTHOP, V38, P2065, DOI 10.1007/s00264-014-2368-0
   Nooeaid P, 2012, J CELL MOL MED, V16, P2247, DOI 10.1111/j.1582-4934.2012.01571.x
   Orth P, 2013, EUR CELLS MATER, V25, P299, DOI 10.22203/eCM.v025a21
   Parenteau BR, 2011, ACTA BIOMATER, V7, P3757, DOI [10.1016/j.actbio.2011.06.020, DOI 10.1016/J.ACTBIO.2011.06.020]
   Pulkkinen HJ, 2013, OSTEOARTHR CARTILAGE, V21, P481, DOI 10.1016/j.joca.2012.12.004
   Pulkkinen HJ, 2010, OSTEOARTHR CARTILAGE, V18, P1077, DOI 10.1016/j.joca.2010.05.004
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schneider U, 2011, AM J SPORT MED, V39, P2558, DOI 10.1177/0363546511423369
   Scranton PE, 2001, FOOT ANKLE INT, V22, P380, DOI 10.1177/107110070102200504
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   Sharma B, 2013, SCI TRANSL MED, V5, P167, DOI DOI 10.1126/SCITRANSLMED.3004838
   Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.y,the.2004.02.012
   Spiller KL, 2011, TISSUE ENG PART B-RE, V17, P281, DOI [10.1089/ten.TEB.2011.0077, 10.1089/ten.teb.2011.0077]
   Swindle M., 2007, SWINE LAB SURG ANEST
   Tew SR, 2000, ARTHRITIS RHEUM-US, V43, P215, DOI 10.1002/1529-0131(200001)43:1<215::AID-ANR26>3.0.CO;2-X
   Vanlauwe J, 2011, AM J SPORT MED, V39, P2566, DOI 10.1177/0363546511422220
   Vasara AI, 2006, OSTEOARTHR CARTILAGE, V14, P1066, DOI 10.1016/j.joca.2006.04.003
   Vasara AI, 2004, CALCIFIED TISSUE INT, V74, P107, DOI 10.1007/s00223-002-2153-8
   Vasiliadis HS, 2010, AM J SPORT MED, V38, P943, DOI 10.1177/0363546509358266
   WAKITANI S, 1989, J BONE JOINT SURG BR, V71, P74
NR 44
TC 4
Z9 4
U1 1
U2 10
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0736-0266
EI 1554-527X
J9 J ORTHOP RES
JI J. Orthop. Res.
PD MAY
PY 2016
VL 34
IS 5
BP 745
EP 753
DI 10.1002/jor.23099
PG 9
WC Orthopedics
SC Orthopedics
GA DL4JX
UT WOS:000375602200003
PM 26573959
OA Bronze
DA 2018-10-19
ER

PT J
AU Illien-Junger, S
   Sedaghatpour, DD
   Laudier, DM
   Hecht, AC
   Qureshi, SA
   Iatridis, JC
AF Illien-Juenger, Svenja
   Sedaghatpour, Dillon D.
   Laudier, Damien M.
   Hecht, Andrew C.
   Qureshi, Sheeraz A.
   Iatridis, James C.
TI Development of a bovine decellularized extracellular matrix-biomaterial
   for nucleus pulposus regeneration
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
DE intervertebral disc; decellularization; nucleus pulposus replacement;
   extracellular matrix biomaterial; tissue engineering
ID MESENCHYMAL STEM-CELLS; INTERVERTEBRAL DISC DEGENERATION; IN-VITRO;
   REPAIR; TRANSPLANTATION; SCAFFOLDS; THERAPIES; HYDROGELS; DISEASES;
   SURGERY
AB Painful intervertebral disc (IVD) degeneration is a common cause for spinal surgery. There is a clinical need to develop injectable biomaterials capable of promoting IVD regeneration, yet many available biomaterials do not mimic the native extracellular matrix (ECM) or promote matrix production. This study aimed to develop a decellularized injectable bovine ECM material that maintains structural and compositional features of native tissue and promotes nucleus pulposus (NP) cell (NPC) and mesenchymal stem cell (MSC) adaption. Injectable decellularized ECM constructs were created using 3 NP tissue decellularization methods (con.A: sodium deoxycholate, con.B: sodium deoxycholate & sodium dodecyl sulfate, con.C: sodium deoxycholate, sodium dodecyl sulfate & TritonX-100) and evaluated for protein, microstructure, and for cell adaptation in 21 day human NPC and MSC culture experiments. Con.A was most efficient at DNA depletion, preserved best collagen microstructure and content, and maintained the highest glycosaminoglycan (GAG) content. NPCs in decellularized constructs of con.A&B demonstrated newly synthesized GAG production, which was apparent from halos of GAG staining surrounding seeded NPCs. Con.A also promoted MSC adaption with high cell viability and ECM production. The injectable decellularized NP biomaterial that used sodium deoxycholate without additional decellularization steps maintained native NP tissue structure and composition closest to natural ECM and promoted cellular adaptation of NP cells and MSCs. This natural decellularized biomaterial warrants further investigation for its potential as an injectable cell seeded supplement to augment NP replacement biomaterials and deliver NPCs or MSCs. (c) 2015 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 34:876-888, 2016.
C1 [Illien-Juenger, Svenja; Sedaghatpour, Dillon D.; Laudier, Damien M.; Hecht, Andrew C.; Qureshi, Sheeraz A.; Iatridis, James C.] Icahn Sch Med Mt Sinai, Leni & Peter W May Dept Orthopaed, New York, NY 10029 USA.
RP Illien-Junger, S (reprint author), Icahn Sch Med Mt Sinai, Leni & Peter W May Dept Orthopaed, New York, NY 10029 USA.
EM Svenja.illien-junger@mssm.edu
OI Illien-Junger, Svenja/0000-0001-9895-0693; Iatridis,
   James/0000-0002-2186-0590
FU National Institute of Arthritis and Musculoskeletal and Skin Diseases of
   the National Institutes of Health [R01 AR057397]; AO Exploratory
   Research Board of AO Foundation
FX Grant sponsor: National Institute of Arthritis and Musculoskeletal and
   Skin Diseases of the National Institutes of Health; Grant number: R01
   AR057397; Grant sponsor: AO Exploratory Research Board of AO Foundation.
CR Abbott RD, 2012, J ORTHOP RES, V30, P482, DOI 10.1002/jor.21534
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Bosnakovski D, 2006, BIOTECHNOL BIOENG, V93, P1152, DOI 10.1002/bit.20828
   Boubriak OA, 2013, J ANAT, V222, P341, DOI 10.1111/joa.12022
   Chan LKY, 2013, ACTA BIOMATER, V9, P5262, DOI 10.1016/j.actbio.2012.09.005
   Chan SCW, 2013, SPINE J, V13, P273, DOI 10.1016/j.spinee.2012.12.007
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Fakouri B, 2015, CLIN ORTHOP RELAT R, V473, P1957, DOI 10.1007/s11999-014-3904-3
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Feng GJ, 2012, TISSUE ENG PT A, V18, P2231, DOI [10.1089/ten.tea.2011.0747, 10.1089/ten.TEA.2011.0747]
   Fitzpatrick J. C., 2010, INT J BIOMATER, V2010, DOI [10.1155/2010/620503, DOI 10.1155/2010/620503]
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Guillaume O, 2015, J BIOMATER APPL, V29, P1230, DOI 10.1177/0885328214557905
   HANLEY EN, 1989, J BONE JOINT SURG AM, V71A, P719, DOI 10.2106/00004623-198971050-00013
   Hu JQ, 2015, MOL MED REP, V12, P5701, DOI 10.3892/mmr.2015.4139
   Huang YC, 2014, NAT REV RHEUMATOL, V10, P561, DOI 10.1038/nrrheum.2014.91
   Hudson KD, 2013, CURR OPIN BIOTECH, V24, P872, DOI 10.1016/j.copbio.2013.04.012
   Iatridis JC, 2013, SPINE J, V13, P243, DOI 10.1016/j.spinee.2012.12.002
   Jiang WC, 2014, BIOMATERIALS, V35, P3607, DOI 10.1016/j.biomaterials.2014.01.024
   Kim CH, 2013, SPINE, V38, P581, DOI 10.1097/BRS.0b013e318274f9a7
   Kirzner Yakira, 2012, J Long Term Eff Med Implants, V22, P73
   Laudier D, 2007, J ORTHOP RES, V25, P390, DOI 10.1002/jor.20304
   Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223
   Li H, 2013, CELLS TISSUES ORGANS, V198, P266, DOI 10.1159/000356505
   Loupasis GA, 1999, SPINE, V24, P2313, DOI 10.1097/00007632-199911150-00005
   Martin BI, 2007, SPINE, V32, P382, DOI 10.1097/01.brs.0000254104.55716.46
   Mern DS, 2014, J TISSUE ENG REGEN M, V8, P925, DOI 10.1002/term.1583
   Mochida J, 2015, EUR CELLS MATER, V29, P202, DOI 10.22203/eCM.v029a15
   Price AP, 2015, TISSUE ENG PART C-ME, V21, P94, DOI [10.1089/ten.tec.2013.0756, 10.1089/ten.TEC.2013.0756]
   Reing JE, 2010, BIOMATERIALS, V31, P8626, DOI 10.1016/j.biomaterials.2010.07.083
   Sakai D, 2015, NAT REV RHEUMATOL, V11, P243, DOI 10.1038/nrrheum.2015.13
   Sanchez PL, 2015, BIOMATERIALS, V61, P279, DOI 10.1016/j.biomaterials.2015.04.056
   Scarritt Michelle E, 2015, Front Bioeng Biotechnol, V3, P43, DOI 10.3389/fbioe.2015.00043
   Schwarz S, 2012, TISSUE ENG PT A, V18, P2195, DOI [10.1089/ten.tea.2011.0705, 10.1089/ten.TEA.2011.0705]
   Song JJ, 2013, NAT MED, V19, P646, DOI 10.1038/nm.3154
   Stapleton TW, 2008, TISSUE ENG PT A, V14, P505, DOI 10.1089/tea.2007.0233
   Teebken OE, 2009, EUR J VASC ENDOVASC, V37, P92, DOI 10.1016/j.ejvs.2008.10.012
   Thomas JD, 2010, ACTA BIOMATER, V6, P1319, DOI 10.1016/j.actbio.2009.10.024
   Vavken P, 2009, J ORTHOP RES, V27, P1612, DOI 10.1002/jor.20932
   Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2
   Wang Z, 2015, GENE, V564, P1, DOI 10.1016/j.gene.2015.03.022
   Watanabe T, 2010, J ORTHOP RES, V28, P623, DOI 10.1002/jor.21036
   Weymann A, 2015, ARTIF ORGANS, V39, P1024, DOI 10.1111/aor.12481
   Wuertz K, 2009, BIOCHEM BIOPH RES CO, V379, P824, DOI 10.1016/j.bbrc.2008.12.145
   Xu HG, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087726, 10.1371/journal.pone.0086723]
   Yang SH, 2008, SPINE, V33, P1951, DOI 10.1097/BRS.0b013e31817e6974
   Yang XL, 2009, EUR SPINE J, V18, P1564, DOI 10.1007/s00586-009-1092-8
NR 47
TC 11
Z9 11
U1 3
U2 26
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0736-0266
EI 1554-527X
J9 J ORTHOP RES
JI J. Orthop. Res.
PD MAY
PY 2016
VL 34
IS 5
BP 876
EP 888
DI 10.1002/jor.23088
PG 13
WC Orthopedics
SC Orthopedics
GA DL4JX
UT WOS:000375602200017
PM 26509556
OA Bronze, Green Accepted
DA 2018-10-19
ER

PT J
AU Manferdini, C
   Cavallo, C
   Grigolo, B
   Fiorini, M
   Nicoletti, A
   Gabusi, E
   Zini, N
   Pressato, D
   Facchini, A
   Lisignoli, G
AF Manferdini, C.
   Cavallo, C.
   Grigolo, B.
   Fiorini, M.
   Nicoletti, A.
   Gabusi, E.
   Zini, N.
   Pressato, D.
   Facchini, A.
   Lisignoli, G.
TI Specific inductive potential of a novel nanocomposite biomimetic
   biomaterial for osteochondral tissue regeneration
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE biomimetic materials; composite; mesenchymal stromal cells; osteogenic
   differentiation; chondrogenic differentiation; osteochondral lesions
ID 1,4-BUTANEDIOL DIGLYCIDYL ETHER; MARROW STROMAL CELLS; COMPOSITE
   MULTILAYERED BIOMATERIAL; MESENCHYMAL STEM-CELLS; DERMAL SHEEP COLLAGEN;
   CROSS-LINKING; CHONDROGENIC DIFFERENTIATION; BILAYERED SCAFFOLD; BONE;
   DESIGN
AB Osteochondral lesions require treatment to restore the biology and functionality of the joint. A novel nanostructured biomimetic gradient scaffold was developed to mimic the biochemical and biophysical properties of the different layers of native osteochondral structure. The present results show that the scaffold presents important physicochemical characteristics and can support the growth and differentiation of mesenchymal stromal cells (h-MSCs), which adhere and penetrate into the cartilaginous and bony layers. H-MSCs grown in chondrogenic or osteogenic medium decreased their proliferation during days 14-52 on both scaffold layers and in medium without inducing factors used as controls. Both chondrogenic and osteogenic differentiation of h-MSCs occurred from day 28 and were increased on day 52, but not in the control medium. Safranin O staining and collagen type II and proteoglycans immunostaining confirmed that chondrogenic differentiation was specifically induced only in the cartilaginous layer. Conversely, von Kossa staining, osteocalcin and osteopontin immunostaining confirmed that osteogenic differentiation occurred on both layers. This study shows the specific potential of each layer of the biomimetic scaffold to induce chondrogenic or osteogenic differentiation of h-MSCs. These processes depended mainly on the media used but not the biomaterial itself, suggesting that the local milieu is fundamental for guiding cell differentiation. Copyright (c) 2013 John Wiley & Sons, Ltd.
C1 [Manferdini, C.; Grigolo, B.; Facchini, A.; Lisignoli, G.] Ist Ortoped Rizzoli, SC Lab Immunoreumatol & Rigeneraz Tissutale, Bologna, Italy.
   [Manferdini, C.; Cavallo, C.; Grigolo, B.; Gabusi, E.; Facchini, A.; Lisignoli, G.] Ist Ortoped Rizzoli, Lab RAMSES, Bologna, Italy.
   [Fiorini, M.; Nicoletti, A.; Pressato, D.] Fin Ceram Faenza SpA, Faenza, RA, Italy.
   [Zini, N.] CNR IGM, IOR, Bologna, Italy.
   [Facchini, A.] Univ Bologna, Dipartimento Med Interna & Gastroenterol, I-40126 Bologna, Italy.
RP Lisignoli, G (reprint author), SC Lab Immunoreumatol & Rigeneraz Tissutale, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM gina.lisignoli@ior.it
RI Grigolo, Brunella/J-5417-2016
OI Grigolo, Brunella/0000-0002-3990-6745; manferdini,
   cristina/0000-0002-6648-6061; ZINI, NICOLETTA/0000-0002-4442-7079;
   Cavallo, Carola/0000-0002-2913-856X
FU Rizzoli Orthopaedic Institute; MIUR; RFO University of Bologna
FX Funding for the study was provided by Rizzoli Orthopaedic Institute
   (Ricerca Corrente and 'Cinque per mille'), MIUR and the RFO University
   of Bologna.
CR AHMED SA, 1994, J IMMUNOL METHODS, V170, P211
   Barker MK, 2001, RHEUMATOLOGY, V40, P274, DOI 10.1093/rheumatology/40.3.274
   CAVALLARO JF, 1994, BIOTECHNOL BIOENG, V43, P781, DOI 10.1002/bit.260430813
   Chen WC, 2013, J TISSUE ENG REGEN M, V7, P665, DOI 10.1002/term.1463
   Erisken C, 2011, TISSUE ENG PT A, V17, P1239, DOI [10.1089/ten.tea.2009.0693, 10.1089/ten.TEA.2009.0693]
   Grigolo B, 2011, J BIOL REGUL HOMEOST, V25, P3
   Hench L.L., 2002, FUTURE STRATEGIES TI, P3
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Kim HW, 2005, J BIOMED MATER RES A, V75A, P629, DOI 10.1002/jbm.a.30463
   Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kon E, 2010, J ORTHOP RES, V28, P116, DOI 10.1002/jor.20958
   Kon E, 2009, KNEE SURG SPORT TR A, V17, P1312, DOI 10.1007/s00167-009-0819-8
   Kon E, 2008, SPORTS MED ARTHROSC, V16, P221, DOI 10.1097/JSA.0b013e31818cdbc5
   Li J, 2009, TISSUE ENG PT A, V15, P2481, DOI 10.1089/ten.TEA.2008.0463
   Lisignoli G, 2005, BIOMATERIALS, V26, P5677, DOI 10.1016/j.biomaterials.2005.02.031
   Lisignoli G, 2002, BIOMATERIALS, V23, P1043, DOI 10.1016/S0142-9612(01)00216-2
   Lozano LF, 2003, J MATER SCI, V38, P4777, DOI 10.1023/A:1027483220584
   Manferdini C, 2010, BIOMATERIALS, V31, P3986, DOI 10.1016/j.biomaterials.2010.01.148
   Nicoletti A, 2013, J MATER SCI-MATER M, V24, P17, DOI 10.1007/s10856-012-4782-4
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Qu D, 2011, J BIOMED MATER RES B, V96B, P9, DOI 10.1002/jbm.b.31697
   Roveri N, 2003, MAT SCI ENG C-BIO S, V23, P441, DOI 10.1016/S0928-4931(02)00318-1
   Tampieri A, 2006, Patent No. [WO 2006/092718, 2006092718]
   Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008
   Tampieri A, 2008, KEY ENG MATER, V361-363, P927, DOI 10.4028/www.scientific.net/KEM.361-363.927
   Tampieri A, 2011, TRENDS BIOTECHNOL, V29, P526, DOI 10.1016/j.tibtech.2011.04.011
   Venugopal B, 2012, J BIOMED MATER RES A, V100A, P1427, DOI 10.1002/jbm.a.34082
   Wang JL, 2012, J BIOMED MATER RES A, V100A, P1438, DOI 10.1002/jbm.a.34081
   Whang K, 1999, TISSUE ENG, V5, P35, DOI 10.1089/ten.1999.5.35
   Yuan T, 2010, BIOTECHNOL PROGR, V26, P1749, DOI 10.1002/btpr.484
   Zeeman R, 1999, J BIOMED MATER RES, V46, P424, DOI 10.1002/(SICI)1097-4636(19990905)46:3<424::AID-JBM16>3.0.CO;2-R
   Zeeman R, 2000, J BIOMED MATER RES, V51, P541, DOI 10.1002/1097-4636(20000915)51:4<541::AID-JBM1>3.0.CO;2-P
   Zhang Z., 2012, J SOC LEATHER TECHNO, V90, P23
NR 35
TC 6
Z9 6
U1 0
U2 13
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD MAY
PY 2016
VL 10
IS 5
BP 374
EP 391
DI 10.1002/term.1723
PG 18
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA DL8BT
UT WOS:000375865100004
PM 23495253
DA 2018-10-19
ER

PT J
AU Stach, S
   Sapota, W
   Wrobel, Z
   Talu, S
AF Stach, Sebastian
   Sapota, Wiktoria
   Wrobel, Zygmunt
   Talu, Stefan
TI Assessment of Possibilities of Ceramic Biomaterial Fracture Surface
   Reconstruction Using Laser Confocal Microscopy and Long Working Distance
   Objective Lenses
SO MICROSCOPY RESEARCH AND TECHNIQUE
LA English
DT Article
DE confocal microscopy; fracture; long working distance; stereometry;
   surface morphology
ID SCANNING MICROSCOPY
AB A numerical description of fracture is an important step in the search of the correlation between specific micromechanisms of decohesion and material characteristics designated with the use of fracture mechanics methods. This issue is essential for the proper orientation of the search for basic relationships between chemical composition, technology, structure, and properties of materials. It often happens that fracture surfaces are well developed, which can significantly hinder or even prevent the measurement and reconstruction of the tested material surface geometry. In this article, comparative measurements of a biomaterial surface were performed using laser confocal microscopy. To this end, short working distance lenses dedicated to a focused UV laser beam and long working distance objective lenses were used. The article includes a quantitative comparative analysis and interpretation of the obtained results. (C) 2016 Wiley Periodicals, Inc.
C1 [Stach, Sebastian; Sapota, Wiktoria; Wrobel, Zygmunt] Univ Silesia, Dept Biomed Comp Syst, Inst Informat, Fac Comp Sci & Mat Sci, PL-41205 Sosnowiec, Poland.
   [Talu, Stefan] Tech Univ Cluj Napoca, Fac Mech Engn, Dept AET, Discipline Descript Geometry & Engn Graph, 103-105 B Dul Muncii St, Cluj Napoca 400641, Cluj, Romania.
RP Talu, S (reprint author), Tech Univ Cluj Napoca, Fac Mech Engn, Dept AET, Discipline Descript Geometry & Engn Graph, 103-105 B Dul Muncii St, Cluj Napoca 400641, Cluj, Romania.
EM stefan_ta@yahoo.com
OI Stach, Sebastian/0000-0001-7054-700X
CR BRUTKOWSKI W, 2013, KOSMOS, V62, P171
   Conn PM, 2010, TECHNIQUES CONFOCAL
   Cwajna J, 2001, MATER CHARACT, V46, P183, DOI 10.1016/S1044-5803(01)00122-X
   Davidson M.W., 2002, ENCY IMAGING SCI TEC, P1106
   Dudek A, 2011, ARCH METALL MATER, V56, P135, DOI 10.2478/v10172-011-0015-y
   Freiman SW, 2012, FRACTURE BRITTLE MAT, DOI [10.1002/9781118147757.ch6, DOI 10.1002/9781118147757.CH6]
   I.S.O, 2016, 2517822012 ISO
   Kelsall RW, 2009, NANOTECHNOLOGIES
   Moore D. R., 2001, ESIS PUBLICATION, V28
   Paddock SW, 2000, MOL BIOTECHNOL, V16, P127, DOI 10.1385/MB:16:2:127
   Pawlus P., 2006, SURFACE TOPOGRAPHY M
   PLUTA M, 1982, OPTICAL MICROSCOPY
   Price RL, 2011, BASIC CONFOCAL MICROSCOPY, P181, DOI 10.1007/978-0-387-78175-4_9
   Quinn GD, 2007, NIST SPECIAL PUBLICA, V960-16
   Quinn GD, 2008, MICROSC ANAL, V22, P21
   Ren F, 2005, INT J APPL CERAM TEC, V2, P200, DOI 10.1111/j.1744-7402.2005.02022.x
   Stach S, 2011, KEY ENG MATER, V465, P271, DOI 10.4028/www.scientific.net/KEM.465.271
   Stach S, 2009, MATER CHARACT, V60, P1151, DOI 10.1016/j.matchar.2009.02.013
   Synak R, 2013, ELECT INFORM TECHNOL, V54, P46
   Szczotok A, 2005, MATER SCI-POLAND, V23, P559
   Talu Stefan, 2015, MICRO NANOSCALE CHAR
   YAO N, 2005, HDB MICROSCOPY NANOT
NR 22
TC 1
Z9 1
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1059-910X
EI 1097-0029
J9 MICROSC RES TECHNIQ
JI Microsc. Res. Tech.
PD MAY
PY 2016
VL 79
IS 5
BP 385
EP 392
DI 10.1002/jemt.22641
PG 8
WC Anatomy & Morphology; Biology; Microscopy
SC Anatomy & Morphology; Life Sciences & Biomedicine - Other Topics;
   Microscopy
GA DJ9RR
UT WOS:000374551100006
PM 26918261
DA 2018-10-19
ER

PT J
AU Lappalainen, OP
   Haapea, M
   Serpi, R
   Lehtonen, S
   Ylikontiola, L
   Korpi, J
   Serlo, W
   Sandor, GKB
AF Lappalainen, Olli-Pekka
   Haapea, Marianne
   Serpi, Raisa
   Lehtonen, Siri
   Ylikontiola, Leena
   Korpi, Jarkko
   Serlo, Willy
   Sandor, George K. B.
TI Iron-labeled adipose stem cells and neovascularization in rabbit
   calvarial critical-sized defects
SO ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY
LA English
DT Article
ID IN-VIVO; BONE REGENERATION; OXIDE; TRACKING; NANOPARTICLES;
   ANGIOGENESIS; MODEL; MRI
AB Objective. The aim of this study was to evaluate the presence of iron-labeled adipose stem cells at the 2-week time point and vascular changes at the 2-week and 6-week time points using two different types of scaffolds.
   Study Design. This study included 22 White New Zealand adult male rabbits. In six rabbits, full-thickness calvarial criticalsized defects were filled with autogenous adipose stem cells labeled with iron oxide seeded onto two scaffolds, namely, solid bioactive glass (BAG) or porous tricalcium phosphate granules (TCP) used on reciprocal sides of the skull. Eleven rabbits were implanted with adipose stem celleseeded scaffolds without iron labeling for analysis of vascular changes. Five defects were left empty as negative control defects. The specimens were analyzed histologically at the 2-week and 6-week time points.
   Results. The TCP group showed significantly more vascularity compared with the BAG group. A greater number of labeled stem cells were identified in the TCP group compared with the BAG group, but the difference was not statistically significant.
   Conclusions. This study revealed the differences in stem cell distribution and revascularization of the calvarial defect, which may be biomaterial dependent.
C1 [Lappalainen, Olli-Pekka] Univ Oulu, Med Res Ctr, Res Grp Tissue Engn, Oral & Maxillofacial Surg, Oulu, Finland.
   [Haapea, Marianne] Oulu Univ Hosp, Dept Radiol, Oulu, Finland.
   [Serpi, Raisa] Univ Oulu, Fac Biochem & Mol Med, Oulu Ctr Cell Matrix Res, Bioctr Oulu, Oulu, Finland.
   [Lehtonen, Siri] Univ Oulu, Dept Internal Med, Resp Res Unit, Dept Anat & Cell Biol,Canc Res & Translat Med Res, Kajaanintie 50, SF-90220 Oulu, Finland.
   [Lehtonen, Siri] Oulu Univ Hosp, Med Res Ctr, Oulu, Finland.
   [Ylikontiola, Leena; Korpi, Jarkko] Oulu Univ Hosp, Cleft Lip & Palate Program, Oulu, Finland.
   [Ylikontiola, Leena; Korpi, Jarkko] Univ Oulu, Med Res Ctr, Oulu, Finland.
   [Serlo, Willy] Univ Oulu, Oulu Univ Hosp, Med Res Ctr,PEDEGO Res Ctr, Pediat Surg,Dept Children & Adolescents,Div Pedia, Oulu, Finland.
   [Sandor, George K. B.] Univ Oulu, Med Res Ctr, Tissue Engn & Oral & Maxillofacial Surg, Oulu, Finland.
   [Sandor, George K. B.] Oulu Univ Hosp, Oulu, Finland.
   [Sandor, George K. B.] Univ Tampere, Inst Biosci & Med Technol, BioMediTech, Res, FIN-33101 Tampere, Finland.
RP Sandor, GKB (reprint author), Univ Oulu, Dept Oral & Maxillofacial Surg, POB 5281, FIN-90014 Oulu, Finland.
EM sandor_george@hotmail.com
OI Haapea, Marianne/0000-0002-3989-9354; Serpi, Raisa/0000-0002-8207-4673
FU Finnish Medical Association Duodecim, Helsinki, Finland; Emil Aaltonen
   Foundation, Tampere, Finland; Pohjois-Pohjanmaan Sairaanhoitopiiri
   (Northern Ostrobothnia Hospital District); Stiftelsen Alma and K.A.
   Snellman Foundation, Oulu, Finland; ITI Foundation (ITI) [619-2009]
FX This study was generously funded by the Finnish Medical Association
   Duodecim, Helsinki, Finland; the Emil Aaltonen Foundation, Tampere,
   Finland; the VTR grant funds from the Pohjois-Pohjanmaan
   Sairaanhoitopiiri (Northern Ostrobothnia Hospital District), the
   Stiftelsen Alma and K.A. Snellman Foundation, Oulu, Finland; and by the
   ITI Foundation (ITI Grant number 619-2009).
CR Alestalo K, 2015, SCAND CARDIOVASC J, V49, P82, DOI 10.3109/14017431.2015.1018311
   Amsalem Y, 2007, CIRCULATION, V116, pI38, DOI 10.1161/CIRCULATIONAHA.106.680231
   Bai F, 2010, TISSUE ENG PT A, V16, P3791, DOI 10.1089/ten.TEA.2010.0148
   Balakumaran A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011462
   Banyard DA, 2015, PLAST RECONSTR SURG, V135, P1740, DOI 10.1097/PRS.0000000000001272
   Beaumont M, 2010, NMR BIOMED, V23, P48, DOI 10.1002/nbm.1425
   BERGGREN A, 1982, J BONE JOINT SURG AM, V64, P73, DOI 10.2106/00004623-198264010-00012
   Clokie CML, 2002, J CRANIOFAC SURG, V13, P111, DOI 10.1097/00001665-200201000-00026
   Delgado-Ruiz RA, 2015, CLIN ORAL IMPLANTS R
   Fok TCO, 2008, ORAL SURG ORAL MED O, V105, P417, DOI 10.1016/j.tripleo.2007.07.015
   Hansen L, 2014, SCAND J CLIN LAB INV, V74, P437, DOI 10.3109/00365513.2014.900698
   Hauger O, 2006, RADIOLOGY, V238, P200, DOI 10.1148/radiol.2381041668
   Hussain SM, 2005, TOXICOL IN VITRO, V19, P975, DOI 10.1016/j.tiv.2005.06.034
   Ittrich H, 2007, J MAGN RESON IMAGING, V25, P1179, DOI 10.1002/jmri.20925
   Jan Ahmed M A, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, P144, DOI 10.1016/j.tripleo.2005.08.032
   Korchinski DJ, 2015, MAGN RESON INSIGHTS, V8, P15, DOI 10.4137/MRI.S23557
   LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X
   Leucht P, 2015, J AM ACAD ORTHOP SUR, V23, P67, DOI 10.5435/JAAOS-23-01-67
   Mesimaki K, 2009, INT J ORAL MAX SURG, V38, P201, DOI 10.1016/j.ijom.2009.01.001
   Ohnishi S, 2007, INT J HEMATOL, V86, P17, DOI 10.1532/IJH97.07041
   Piitulainen JM, 2015, WORLD NEUROSURG, V83, P708, DOI 10.1016/j.wneu.2015.01.014
   Politi LS, 2007, STEM CELLS, V25, P2583, DOI 10.1634/stemcells.2007-0037
   Sandor GK, 2014, STEM CELL TRANSL MED, V3, P530, DOI 10.5966/sctm.2013-0173
   Sandor GK, 2013, J ORAL MAXIL SURG, V71, P938, DOI 10.1016/j.joms.2012.11.014
   Schwarz F, 2015, J NEUROSURG, V25, P1
   Shen WB, 2015, CELL TRANSPL
   Singh N, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.5358
   Valimaki VV, 2006, SCAND J SURG, V95, P95
   von der Haar K, 2015, APPL MICROBIOL BIOT, V99, P9907, DOI 10.1007/s00253-015-6965-7
   Wolff J, 2015, IMPLANT DENT, V24, P552, DOI 10.1097/ID.0000000000000320
   Xiao X, 2015, SCI REP-UK, V5, DOI 10.1038/srep09409
   Yamahara K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001666
   Yu M, 2012, INT J MOL SCI, V13, P5554, DOI 10.3390/ijms13055554
NR 33
TC 1
Z9 1
U1 4
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 2212-4403
EI 1528-395X
J9 OR SURG OR MED OR PA
JI Oral Surg. Oral Med. Oral Pathol. Oral Radiol.
PD MAY
PY 2016
VL 121
IS 5
BP E104
EP E110
DI 10.1016/j.oooo.2016.01.006
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DL4LN
UT WOS:000375608100002
PM 27017402
DA 2018-10-19
ER

PT J
AU Filip, D
   Macocinschi, D
   Paslaru, E
   Tuchilus, CG
   Vlad, S
AF Filip, Daniela
   Macocinschi, Doina
   Paslaru, Elena
   Tuchilus, Cristina G.
   Vlad, Stelian
TI Surface characterization and antimicrobial properties of sodium
   deoxycholate-based poly(ester ether)urethane ionomer biomaterials
SO REACTIVE & FUNCTIONAL POLYMERS
LA English
DT Article
DE Polyurethane ionomers; Sodium deoxycholate; Biomaterial; Surface
   characterization; Antibacterial
ID CONTACT-ANGLE; BIOMEDICAL APPLICATIONS; BLOOD COMPATIBILITY; BILE-SALTS;
   ACID; POLYMERS; SORPTION; ENERGY; BIOCOMPATIBILITY; POLYURETHANES
AB New sodium deoxycholate-based poly( ester ether)urethane ionomers have been obtained for the development of biomedical materials. Wettability, surface tension parameters, surface morphology, roughness, water sorption and/or desorption properties, and antimicrobial efficiency were determined for the obtained polyurethane biomembranes. Contact angle analysis evidenced that the synthesized polyurethane ionomers are hydrophilic due to orientation and amount of ionic bile salt moieties towards surface. The values of interfacial tension demonstrate biocompatible qualities for these polyurethanes. SEM microphotographs show that the resulted morphologies of polyurethane ionomers are different due to the diverse polyether co-soft segments which determine the supramolecular architecture, ionic interactions between bile salt moiety and polyether segments. AFM images evidence lamellar arrangement at the sub-micron scale and the nanophase separated morphology for these polyurethanes. The estimated moisture diffusion coefficients are dependent on a range of moisture transport mechanisms in the porous membranes and the moisture content of the polyurethanes. The monolayer sorption and average pore size values were estimated by applying BET and GAB models. GAB model could not be applied in the case of high water uptake polyurethane samples. The synthesized biocidal polyurethanes are effective at inactivation of tested bacteria: Staphylococcus aureus, Sarcina lutea, Escherichia coli, except Pseudomonas aeruginosa. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Filip, Daniela; Macocinschi, Doina; Paslaru, Elena; Vlad, Stelian] Petru Poni Inst Macromol Chem, Aleea Gr Ghica Voda 41A, Iasi 700487, Romania.
   [Tuchilus, Cristina G.] Gr T Popa Univ Med & Pharm, Fac Med, Dept Microbiol, 16 Univ St, Iasi 700115, Romania.
RP Filip, D (reprint author), Petru Poni Inst Macromol Chem, Aleea Gr Ghica Voda 41A, Iasi 700487, Romania.
EM dare67ro@yahoo.com
RI Paslaru, Elena/O-4402-2014; Vlad, Stelian/C-3430-2011
OI Paslaru, Elena/0000-0003-1409-9913; Vlad, Stelian/0000-0002-5895-438X
FU Unitatea Executiva pentru Finantarea Invatamantului Superior, a
   Cercetarii, Dezvoltarii si Inovarii-UEFISCDI [BIONANOMED 164/2012]
FX The authors gratefully acknowledge the financial support given by
   Unitatea Executiva pentru Finantarea Invatamantului Superior, a
   Cercetarii, Dezvoltarii si Inovarii-UEFISCDI through research project
   BIONANOMED 164/2012.
CR ANDERSON RB, 1946, J AM CHEM SOC, V68, P686, DOI 10.1021/ja01208a049
   Arslan N, 2006, J STORED PROD RES, V42, P112, DOI 10.1016/j.jspr.2005.01.001
   Balik CM, 1996, MACROMOLECULES, V29, P3025, DOI 10.1021/ma9509467
   Brunauer S, 1940, J AM CHEM SOC, V62, P1723, DOI 10.1021/ja01864a025
   Chen SF, 2010, POLYMER, V51, P5283, DOI 10.1016/j.polymer.2010.08.022
   Clinical and Laboratory Standards Institute, 2014, M100S20 CLSI
   Crank J, 1975, MATH DIFFUSION
   De Boer J. H., 1968, DYNAMICAL CHARACTER
   Diamond T, 1991, HPB Surg, V4, P81, DOI 10.1155/1991/48672
   Faibish RS, 2002, J COLLOID INTERF SCI, V256, P341, DOI 10.1006/jcis.2002.8612
   Filip D, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2710-x
   Filip D, 2016, J APPL POLYM SCI, V133, DOI 10.1002/app.42921
   Gautrot JE, 2006, ANGEW CHEM INT EDIT, V45, P6872, DOI 10.1002/anie.200602096
   Gonzalez-Paz RJ, 2013, REACT FUNCT POLYM, V73, P690, DOI 10.1016/j.reactfunctpolym.2013.02.005
   Gouin S, 2000, MACROMOLECULES, V33, P5379, DOI 10.1021/ma991364i
   Grassy F., 2000, POLYM SURFACES PHYS
   Guggenheim E. A, 1966, APPL STAT MECH
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Herrera-Gomez A, 2001, J APPL PHYS, V89, P5431, DOI 10.1063/1.1365427
   Janvier F, 2013, J MECH BEHAV BIOMED, V18, P100, DOI 10.1016/j.jmbbm.2012.11.008
   Jiang GC, 2010, REACT FUNCT POLYM, V70, P175, DOI 10.1016/j.reactfunctpolym.2009.11.010
   Kalble D. H., 1969, J ADHESION, V1, P102
   Korley LTJ, 2006, POLYMER, V47, P3073, DOI 10.1016/j.polymer.2006.02.093
   Kwok SCH, 2005, DIAM RELAT MATER, V14, P78, DOI 10.1016/j.diamond.2004.07.019
   Lelah MD, 1993, POLYURETHANES MED
   Liu J, 2011, POLYMER, V52, P4619, DOI 10.1016/j.polymer.2011.08.001
   Macocinschi D, 2015, J BIOACT COMPAT POL, V30, P509, DOI 10.1177/0883911515581508
   Macocinschi D, 2009, J MATER SCI-MATER M, V20, P775, DOI 10.1007/s10856-008-3626-8
   MARSHALL SE, 1987, J MED VET MYCOL, V25, P307
   MAURYA KK, 1992, J MATER SCI, V27, P6357, DOI 10.1007/BF00576285
   Melia E., 2005, POLYM PREPR, V46, P166
   Menzies KL, 2010, OPTOMETRY VISION SCI, V87, P387, DOI 10.1097/OPX.0b013e3181da863e
   Merritt ME, 2009, J MED MICROBIOL, V58, P1533, DOI 10.1099/jmm.0.014092-0
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Plank H., 1987, PROGR BIOMEDICAL ENG, V3
   Rankl M, 2003, COLLOID SURFACE B, V30, P177, DOI 10.1016/S0927-7765(03)00085-7
   RUCKENSTEIN E, 1986, BIOMATERIALS, V7, P403, DOI 10.1016/0142-9612(86)90028-1
   RUCKENSTEIN E, 1984, J COLLOID INTERF SCI, V101, P436, DOI 10.1016/0021-9797(84)90055-9
   Silver JH, 1999, BIOMATERIALS, V20, P1533, DOI 10.1016/S0142-9612(98)00173-2
   Skopinska-Wisniewska J, 2009, APPL SURF SCI, V255, P8286, DOI 10.1016/j.apsusc.2009.05.127
   Straube J., 2006, MOISTURE MAT
   SUNG JY, 1993, DIGEST DIS SCI, V38, P2104, DOI 10.1007/BF01297092
   Timmermann EO, 2003, COLLOID SURFACE A, V220, P235, DOI 10.1016/S0927-7757(03)00059-1
   Van Oss C. J., 1994, INTERFACIAL FORCES A
   VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006
   VANOSS CJ, 1988, LANGMUIR, V4, P884, DOI 10.1021/la00082a018
   Vermette P, 2001, TISSUE ENG INTELLIGE, V6
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Xu H, 2013, PROG ORG COAT, V76, P924, DOI 10.1016/j.porgcoat.2013.02.013
   Yuan Y., 2013, SURFACE SCI TECHNIQU, V51, DOI DOI 10.1007/978-3-642-34243-11
   Zhang JW, 2009, SCI CHINA SER B, V52, P849, DOI 10.1007/s11426-009-0124-x
   Zuluaga F, 1999, POLYM BULL, V42, P41, DOI 10.1007/s002890050432
NR 52
TC 7
Z9 8
U1 1
U2 31
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1381-5148
EI 1873-166X
J9 REACT FUNCT POLYM
JI React. Funct. Polym.
PD MAY
PY 2016
VL 102
BP 70
EP 81
DI 10.1016/j.reactfunctpolym.2016.02.011
PG 12
WC Chemistry, Applied; Engineering, Chemical; Polymer Science
SC Chemistry; Engineering; Polymer Science
GA DL6GI
UT WOS:000375737300010
DA 2018-10-19
ER

PT J
AU Klotz, BJ
   Gawlitta, D
   Rosenberg, AJWP
   Malda, J
   Melchels, FPW
AF Klotz, Barbara J.
   Gawlitta, Debby
   Rosenberg, Antoine J. W. P.
   Malda, Jos
   Melchels, Ferry P. W.
TI Gelatin-Methacryloyl Hydrogels: Towards Biofabrication-Based Tissue
   Repair
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
ID MESENCHYMAL STEM-CELLS; GROWTH-FACTOR RELEASE; CROSS-LINKING; BIOMEDICAL
   APPLICATIONS; CARTILAGE CONSTRUCTS; DELIVERY VEHICLE; AQUEOUS-SOLUTION;
   LADEN HYDROGELS; FABRICATION; PHOTOPOLYMERIZATION
AB Research over the past decade on the cell-biomaterial interface has shifted to the third dimension. Besides mimicking the native extracellular environment by 3D cell culture, hydrogels offer the possibility to generate well-defined 3D biofabricated tissue analogs. In this context, gelatin-methacryloyl (gelMA) hydrogels have recently gained increased attention. This interest is sparked by the combination of the inherent bioactivity of gelatin and the physicochemical tailorability of photo-crosslinkable hydrogels. GeIMA is a versatile matrix that can be used to engineer tissue analogs ranging from vasculature to cartilage and bone. Convergence of biological and biofabrication approaches is necessary to progress from merely proving cell functionality or construct shape fidelity towards regenerating tissues. GeIMA has a critical pioneering role in this process and could be used to accelerate the development of clinically relevant applications.
C1 [Klotz, Barbara J.; Gawlitta, Debby; Rosenberg, Antoine J. W. P.] Univ Med Ctr Utrecht, Dept Oral & Maxillofacial Surg & Special Dent Car, PO 85500, NL-3508 GA Utrecht, Netherlands.
   [Malda, Jos; Melchels, Ferry P. W.] Univ Med Ctr Utrecht, Dept Orthopaed, POB 85500, NL-3508 GA Utrecht, Netherlands.
   [Malda, Jos] Univ Utrecht, Fac Vet Med, Dept Equine Sci, Yalelaan 112, NL-3584 CM Utrecht, Netherlands.
   [Melchels, Ferry P. W.] Heriot Watt Univ, Inst Biol Chem Biophys & Bioengn, Sch Engn & Phys Sci, Edinburgh EH14 4AS, Midlothian, Scotland.
RP Malda, J (reprint author), Univ Med Ctr Utrecht, Dept Orthopaed, POB 85500, NL-3508 GA Utrecht, Netherlands.; Malda, J (reprint author), Univ Utrecht, Fac Vet Med, Dept Equine Sci, Yalelaan 112, NL-3584 CM Utrecht, Netherlands.
EM j.malda@umcutrecht.nl
OI Malda, Jos/0000-0002-9241-7676
FU Dutch Arthritis Foundation; European Community's Seventh Framework
   Programme (FP7) [309962]; European Research Council [647426]; ReumaFonds
   [LLP-12]
FX The authors' research work is supported by the Dutch Arthritis
   Foundation; the European Community's Seventh Framework Programme
   (FP7/2007-2013) under grant agreement 309962 (HydroZONES); and the
   European Research Council under grant agreement 647426 (3D-JOINT).
CR Amini AA, 2012, J BIOACT COMPAT POL, V27, P342, DOI 10.1177/0883911512444713
   Babin H, 2001, FOOD HYDROCOLLOID, V15, P271, DOI 10.1016/S0268-005X(01)00025-X
   Benton JA, 2009, TISSUE ENG PT A, V15, P3221, DOI [10.1089/ten.tea.2008.0545, 10.1089/ten.TEA.2008.0545]
   Bertassoni LE, 2014, LAB CHIP, V14, P2202, DOI 10.1039/c4lc00030g
   Bertassoni LE, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/024105
   Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2
   Billiet T, 2013, MACROMOL BIOSCI, V13, P1531, DOI 10.1002/mabi.201300143
   Billiet T, 2014, BIOMATERIALS, V35, P49, DOI 10.1016/j.biomaterials.2013.09.078
   Boere KWM, 2014, ACTA BIOMATER, V10, P2602, DOI 10.1016/j.actbio.2014.02.041
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Cha CY, 2014, BIOMATER SCI-UK, V2, P703, DOI 10.1039/c3bm60210a
   Chen PY, 2014, ACTA BIOMATER, V10, P912, DOI 10.1016/j.actbio.2013.11.009
   Chen YC, 2012, ADV FUNCT MATER, V22, P2027, DOI 10.1002/adfm.201101662
   Chuang CH, 2015, ACTA BIOMATER, V19, P85, DOI 10.1016/j.actbio.2015.02.024
   Croes M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132781
   Daniele MA, 2014, BIOMATERIALS, V35, P1845, DOI 10.1016/j.biomaterials.2013.11.009
   Das S, 2015, ACTA BIOMATER, V11, P233, DOI 10.1016/j.actbio.2014.09.023
   Djagny KB, 2001, CRIT REV FOOD SCI, V41, P481, DOI 10.1080/20014091091904
   Ehrbar M, 2007, BIOMATERIALS, V28, P3856, DOI 10.1016/j.biomaterials.2007.03.027
   Elzoghby AO, 2013, J CONTROL RELEASE, V172, P1075, DOI 10.1016/j.jconrel.2013.09.019
   Evans CH, 2011, TISSUE ENG PART B-RE, V17, P437, DOI [10.1089/ten.teb.2011.0228, 10.1089/ten.TEB.2011.0228]
   Farris S, 2009, TRENDS FOOD SCI TECH, V20, P316, DOI 10.1016/j.tifs.2009.04.003
   Fedorovich NE, 2009, BIOMATERIALS, V30, P344, DOI 10.1016/j.biomaterials.2008.09.037
   Gevaert E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105171
   Gevaert E, 2014, MACROMOL BIOSCI, V14, P419, DOI 10.1002/mabi.201300320
   Gomez-Guillen MC, 2011, FOOD HYDROCOLLOID, V25, P1813, DOI 10.1016/j.foodhyd.2011.02.007
   Gorgleva S., 2011, COLLAGEN VS GELATINE
   Groll J, 2016, BIOFABRICATION, V8, DOI 10.1088/1758-5090/8/1/013001
   HABEEB AFS, 1966, ANAL BIOCHEM, V14, P328, DOI 10.1016/0003-2697(66)90275-2
   Heino J, 2009, INT J BIOCHEM CELL B, V41, P341, DOI 10.1016/j.biocel.2008.08.021
   Henrikson K. J., 2014, SPINE J, V14, pS173
   Hoch E, 2013, J MATER CHEM B, V1, P5675, DOI 10.1039/c3tb20745e
   Hoshikawa A, 2006, TISSUE ENG, V12, P2333, DOI 10.1089/ten.2006.12.2333
   Huber B, 2016, J BIOMATER APPL, V30, P699, DOI 10.1177/0885328215587450
   Hutson CB, 2011, TISSUE ENG PT A, V17, P1713, DOI [10.1089/ten.TEA.2010.0666, 10.1089/ten.tea.2010.0666]
   Jung J., 2014, E-POLYMERS, V14, P161
   Jung J, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4880375
   Kolesky DB, 2014, ADV MATER, V26, P3124, DOI 10.1002/adma.201305506
   Koshy ST, 2014, BIOMATERIALS, V35, P2477, DOI 10.1016/j.biomaterials.2013.11.044
   Lai JY, 2010, BIOMACROMOLECULES, V11, P1387, DOI 10.1021/bm100213f
   Lee SH, 2014, ADV FUNCT MATER, V24, P6771, DOI 10.1002/adfm.201401110
   Lee Y, 2014, J MATER CHEM B, V2, P7712, DOI 10.1039/c4tb01111b
   Lee Y, 2013, J MATER CHEM B, V1, P2407, DOI [10.1039/c3tb00578j, 10.1039/C3TB00578J]
   Leijten J, 2015, ADV DRUG DELIVER REV, V84, P30, DOI 10.1016/j.addr.2014.10.025
   Levato R, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/3/035020
   Levett PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113216
   Levett PA, 2014, J BIOMED MATER RES A, V102, P2544, DOI 10.1002/jbm.a.34924
   Levett PA, 2014, ACTA BIOMATER, V10, P214, DOI 10.1016/j.actbio.2013.10.005
   Li YH, 2015, ADV FUNCT MATER, V25, P5999, DOI 10.1002/adfm.201502018
   Li Z, 2015, ACTA BIOMATER, V13, P88, DOI 10.1016/j.actbio.2014.11.002
   Lin H, 2014, TISSUE ENG PT A, V20, P2402, DOI [10.1089/ten.tea.2013.0642, 10.1089/ten.TEA.2013.0642]
   Lin RZ, 2013, BIOMATERIALS, V34, P6785, DOI 10.1016/j.biomaterials.2013.05.060
   Liu MY, 2014, J PHYS CHEM A, V118, P8701, DOI 10.1021/jp506099n
   Malda J, 2013, ADV MATER, V25, P5011, DOI 10.1002/adma.201302042
   Mazaki T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04457
   Melchels FPW, 2014, J MATER CHEM B, V2, P2282, DOI 10.1039/c3tb21280g
   Mironi-Harpaz I, 2012, ACTA BIOMATER, V8, P1838, DOI 10.1016/j.actbio.2011.12.034
   Munoz Z, 2014, BIOMATER SCI-UK, V2, P1063, DOI 10.1039/c4bm00070f
   Nguyen AH, 2015, ACTA BIOMATER, V13, P101, DOI 10.1016/j.actbio.2014.11.028
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   Occhetta P., 2014, J BIOMED MATER RES A, V103, P2109
   Ovsianikov A, 2014, LANGMUIR, V30, P3787, DOI 10.1021/la402346z
   Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236
   Park KM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5075
   Reddy N, 2015, TRENDS BIOTECHNOL, V33, P362, DOI 10.1016/j.tibtech.2015.03.008
   Santoro M, 2014, J CONTROL RELEASE, V190, P210, DOI 10.1016/j.jconrel.2014.04.014
   Schuurman W, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/2/021001
   Schuurman W, 2013, MACROMOL BIOSCI, V13, P551, DOI 10.1002/mabi.201200471
   Shi XT, 2015, ADV FUNCT MATER, V25, P2250, DOI 10.1002/adfm.201404531
   Shin SR, 2011, ACS NANO, V6, P362
   Shin SR, 2013, ADV MATER, V25, P6385, DOI 10.1002/adma.201301082
   Shin SR, 2013, ACS NANO, V7, P2369, DOI 10.1021/nn305559j
   Sirova M, 2014, J BIOMED MATER RES A, V102, P1982, DOI 10.1002/jbm.a.34873
   Sisson K, 2009, BIOMACROMOLECULES, V10, P1675, DOI 10.1021/bm900036s
   Soman P, 2013, BIOTECHNOL BIOENG, V110, P3038, DOI 10.1002/bit.24957
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   Van den Bulcke AI, 2000, BIOMACROMOLECULES, V1, P31, DOI 10.1021/bm990017d
   Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546
   Visser J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7933
   Visser J, 2015, BIOMATERIALS, V37, P174, DOI 10.1016/j.biomaterials.2014.10.020
   Visser J, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/3/035007
   Wang CM, 2011, J BIOMED MATER RES B, V97B, P58, DOI 10.1002/jbm.b.31786
   Wang H, 2014, J MATER SCI-MATER M, V25, P2173, DOI 10.1007/s10856-014-5261-x
   Wang LS, 2012, ACTA BIOMATER, V8, P1826, DOI 10.1016/j.actbio.2012.02.002
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Xiao WQ, 2011, ACTA BIOMATER, V7, P2384, DOI 10.1016/j.actbio.2011.01.016
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Yue K, 2015, BIOMATERIALS, V73, P254, DOI 10.1016/j.biomaterials.2015.08.045
   Zhou L, 2014, RSC ADV, V4, P21997, DOI 10.1039/c4ra02271h
   Zuo YC, 2015, ACS APPL MATER INTER, V7, P10386, DOI 10.1021/acsami.5b01433
   Zuo YC, 2012, CHEM COMMUN, V48, P3170, DOI 10.1039/c2cc16744a
NR 93
TC 72
Z9 72
U1 42
U2 153
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD MAY
PY 2016
VL 34
IS 5
BP 394
EP 407
DI 10.1016/j.tibtech.2016.01.002
PG 14
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DL7HD
UT WOS:000375810800008
PM 26867787
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Skwarek, E
   Janusz, W
   Gun'ko, VM
   Pakhlov, EM
   Zarko, VI
   Gdula, K
AF Skwarek, E.
   Janusz, W.
   Gun'ko, V. M.
   Pakhlov, E. M.
   Zarko, V. I.
   Gdula, K.
TI Characteristics of surface and electrochemical properties of composites
   with fumed metal oxides and hydroxyapatite
SO ADSORPTION-JOURNAL OF THE INTERNATIONAL ADSORPTION SOCIETY
LA English
DT Article; Proceedings Paper
CT 9th International Symposium on Surface Heterogeneity Effects in
   Adsorption and Catalysis on Solids (ISSHAC)
CY JUL 17-23, 2015
CL Wroclaw, POLAND
DE Surface; Hydroxyapatite; Fumed oxides; Composites; pH(p0zc) i pH(IEP)
ID ZERO CHARGE; PHOTOCATALYST; ALUMINA; POINT; IONS
AB Hydroxyapatite composite is a very important biomaterial, which can be applied in various life areas. Hydroxyapatite and its composites with fumed oxides ST20, AST1, Al2O3, A90, and A300 were prepared and studied using X-ray diffraction, Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy adsorption, potentiometric titration, quasi-elastic light scattering and zeta potential measurements. The values of pH(pzc) (the point of zero charge) and pH(IEP) (the isoelectric point) characteristic of the electrical double layer depend on the type of the fumed oxide matrix. Comparative studies of hydroxyapatite, fumed oxides and composites by adsorption and desorption of nitrogen, scanning electron microscopy and FTIR showed that in most cases composites have properties intermediate between hydroxyapatite and the oxides taken for the synthesis.
C1 [Skwarek, E.; Janusz, W.; Gdula, K.] Marie Curie Sklodowska Univ, Fac Chem, Maria Curie Sklodowska Sq 5, PL-20031 Lublin, Poland.
   [Gun'ko, V. M.; Pakhlov, E. M.; Zarko, V. I.] Chuiko Inst Surface Chem, Kiev 17 Naumov Str, UA-03164 Kiev, Ukraine.
RP Skwarek, E (reprint author), Marie Curie Sklodowska Univ, Fac Chem, Maria Curie Sklodowska Sq 5, PL-20031 Lublin, Poland.
EM ewunias@hektor.umcs.lublin.pl
OI Gun'ko, Vladimir/0000-0001-6333-3441; Pakhlov,
   Evgeniy/0000-0002-3103-0742
CR BELL LC, 1973, J COLLOID INTERF SCI, V42, P250, DOI 10.1016/0021-9797(73)90288-9
   Champion E, 1996, J MATER SCI-MATER M, V7, P125, DOI 10.1007/BF00058724
   Chen Y, 2006, CARBON, V44, P37, DOI 10.1016/j.carbon.2005.07.011
   Gregg S. L., 1982, ADSORPTION SURFACE A
   Gun'ko VM, 2007, APPL SURF SCI, V253, P3215, DOI 10.1016/j.apsusc.2006.07.013
   Gun'ko VM, 2009, POWDER TECHNOL, V195, P245, DOI 10.1016/j.powtec.2009.06.005
   Gun'ko V. M., 2013, NUCL MAGNETIC RESONA
   Gun'ko VM, 2014, APPL SURF SCI, V307, P444, DOI [10.1016/j.apsusc.2014.04.55, 10.1016/j.apsusc.2014.04.055]
   Hench L. L., 1993, INTRO BIOCERAMICS, P139
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Holst JR, 2010, ADV MATER, V22, P5212, DOI 10.1002/adma.201002440
   Hu AM, 2007, J MOL CATAL A-CHEM, V267, P79, DOI 10.1016/j.molcata.2006.11.038
   Janusz W, 2008, POL J CHEM, V82, P57
   Kim S, 2002, J MATER SCI-MATER M, V13, P307, DOI 10.1023/A:1014019103240
   Kiselev AV, 1975, INFRARED SPECTRA SUR
   Narasaraju TSB, 1996, J MATER SCI, V31, P1, DOI 10.1007/BF00355120
   NISHIKAWA H, 1994, B CHEM SOC JPN, V67, P2454, DOI 10.1246/bcsj.67.2454
   Nonami T, 2004, CATAL TODAY, V96, P113, DOI 10.1016/j.cattod.2004.06.112
   Skwarek E, 2014, J RADIOANAL NUCL CH, V299, P2027, DOI 10.1007/s10967-013-2825-z
   Smiciklas ID, 2000, SEP PURIF TECHNOL, V18, P185, DOI 10.1016/S1383-5866(99)00066-0
   Suzuki S, 1998, J MATER SCI LETT, V17, P381, DOI 10.1023/A:1006526915828
NR 21
TC 2
Z9 2
U1 0
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0929-5607
EI 1572-8757
J9 ADSORPTION
JI Adsorpt.-J. Int. Adsorpt. Soc.
PD MAY
PY 2016
VL 22
IS 4-6
BP 725
EP 734
DI 10.1007/s10450-016-9770-4
PG 10
WC Chemistry, Physical; Engineering, Chemical
SC Chemistry; Engineering
GA DJ7EP
UT WOS:000374375000034
OA Other Gold
DA 2018-10-19
ER

PT J
AU Bruzauskaite, I
   Bironaite, D
   Bagdonas, E
   Bernotiene, E
AF Bruzauskaite, Ieva
   Bironaite, Daiva
   Bagdonas, Edvardas
   Bernotiene, Eiva
TI Scaffolds and cells for tissue regeneration: different scaffold pore
   sizes-different cell effects
SO CYTOTECHNOLOGY
LA English
DT Review
DE Scaffold; Pore size; Tissue regeneration; Stem cells
ID MESENCHYMAL STEM-CELLS; IN-VITRO; POLY(L-LACTIC ACID); NANOFIBROUS
   SCAFFOLDS; POLYMERIC SCAFFOLDS; MATRIX DEPOSITION; HUMAN FIBROBLASTS;
   POROUS MEMBRANES; BONE-FORMATION; GROWTH
AB During the last decade biomaterial sciences and tissue engineering have become new scientific fields supplying rising demand of regenerative therapy. Tissue engineering requires consolidation of a broad knowledge of cell biology and modern biotechnology investigating biocompatibility of materials and their application for the reconstruction of damaged organs and tissues. Stem cell-based tissue regeneration started from the direct cell transplantation into damaged tissues or blood vessels. However, it is difficult to track transplanted cells and keep them in one particular place of diseased organ. Recently, new technologies such as cultivation of stem cell on the scaffolds and subsequently their implantation into injured tissue have been extensively developed. Successful tissue regeneration requires scaffolds with particular mechanical stability or biodegradability, appropriate size, surface roughness and porosity to provide a suitable microenvironment for the sufficient cell-cell interaction, cell migration, proliferation and differentiation. Further functioning of implanted cells highly depends on the scaffold pore sizes that play an essential role in nutrient and oxygen diffusion and waste removal. In addition, pore sizes strongly influence cell adhesion, cell-cell interaction and cell transmigration across the membrane depending on the various purposes of tissue regeneration. Therefore, this review will highlight contemporary tendencies in application of non-degradable scaffolds and stem cells in regenerative medicine with a particular focus on the pore sizes significantly affecting final recover of diseased organs.
C1 [Bruzauskaite, Ieva; Bagdonas, Edvardas; Bernotiene, Eiva] State Res Inst, Ctr Innovat Med, Dept Regenerat Med, Zygimantu 9, LT-01102 Vilnius, Lithuania.
   [Bironaite, Daiva] State Res Inst, Ctr Innovat Med, Dept Stem Cell Biol, Zygimantu 9, LT-01102 Vilnius, Lithuania.
RP Bironaite, D (reprint author), State Res Inst, Ctr Innovat Med, Dept Stem Cell Biol, Zygimantu 9, LT-01102 Vilnius, Lithuania.
EM daibironai@gmail.com
FU EU project "Biocardiostim" [VP1-3.1-SMM-10-V-02-029]
FX This work was supported by EU project "Biocardiostim" (No.
   VP1-3.1-SMM-10-V-02-029).
CR Aarvold A, 2013, J BIOMED MATER RES A, V101, P3431, DOI 10.1002/jbm.a.34646
   Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Akay G, 2004, BIOMATERIALS, V25, P3991, DOI 10.1016/j.biomaterials.2003.10.086
   Akino K, 2008, INT J DERMATOL, V47, P1112, DOI 10.1111/j.1365-4632.2008.03380.x
   Akram KM, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-9
   ASHMAN A, 1977, J PROSTHET DENT, V37, P657, DOI 10.1016/0022-3913(77)90216-5
   Atala A, 2012, J PEDIATR SURG, V47, P17, DOI 10.1016/j.jpedsurg.2011.10.013
   BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0
   Blakeney BA, 2011, BIOMATERIALS, V32, P1583, DOI 10.1016/j.biomaterials.2010.10.056
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Boyd AS, 2012, STEM CELLS, V30, P797, DOI 10.1002/stem.1066
   Bozkurt A, 2009, BIOMATERIALS, V30, P169, DOI 10.1016/j.biomaterials.2008.09.017
   BRAUNWALD E, 1991, AM J CARDIOL, V68, pD1
   Chang HI, 2011, REGENERATIVE MEDICINE AND TISSUE ENGINEERING - CELLS AND BIOMATERIALS, P569
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   de Sousa EB, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt501
   Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x
   Fitton JH, 1998, J BIOMED MATER RES, V42, P245
   Fukano Y, 2010, J BIOMED MATER RES A, V94A, P1172, DOI 10.1002/jbm.a.32798
   Goldner JS, 2006, BIOMATERIALS, V27, P460, DOI 10.1016/j.biomaterials.2005.06.035
   GRINNELL F, 1982, METHOD ENZYMOL, V82, P499
   Haniffa MA, 2007, J IMMUNOL, V179, P1595, DOI 10.4049/jimmunol.179.3.1595
   Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598
   Hatano K, 1999, BONE, V25, P439, DOI 10.1016/S8756-3282(99)00192-1
   Hausner T, 2007, ACTA NEUROCHIR SUPPL, V100, P69
   Hong JK, 2015, INT J NANOMED, V10, DOI 10.2147/IJN.S73096
   Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Jurga M, 2011, BIOMATERIALS, V32, P3423, DOI 10.1016/j.biomaterials.2011.01.049
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kawaguchi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014297
   Kim MY, 2014, J MEMBRANE SCI, V452, P460, DOI 10.1016/j.memsci.2013.11.034
   Kim S, 2007, STEM CELLS, V25, P2601, DOI 10.1634/stemcells.2006-0814
   Koo Min-Ah, 2014, Biomater Res, V18, P7, DOI 10.1186/2055-7124-18-7
   Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002
   Lee IC, 2009, J BIOMED MATER RES A, V91A, P929, DOI 10.1002/jbm.a.32309
   Lee M, 2008, J BIOMED MATER RES A, V87A, P1010, DOI 10.1002/jbm.a.31816
   Lee SJ, 2004, BIOMATERIALS, V25, P4699, DOI 10.1016/j.biomaterials.2003.11.034
   Li Dong-jie, 2011, Zhonghua Yi Xue Za Zhi, V91, P699
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Liang D, 2007, ADV DRUG DELIVER REV, V59, P1392, DOI 10.1016/j.addr.2007.04.021
   Lim SH, 2009, ADV DRUG DELIVER REV, V61, P1084, DOI 10.1016/j.addr.2009.07.011
   Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111566
   Liu WH, 2000, IN VITRO CELL DEV-AN, V36, P476
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Liu XH, 2005, J BIOMED NANOTECHNOL, V1, P54, DOI 10.1166/jbn.2005.013
   Lu QJ, 2004, BIOMATERIALS, V25, P5227, DOI 10.1016/j.biomaterials.2003.12.019
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Mahoney MJ, 2005, BIOMATERIALS, V26, P771, DOI 10.1016/j.biomaterials.2004.03.015
   Marshall A. J., 2004, ACS POLYM PREPR, V45, P100
   Matsiko A, 2015, TISSUE ENG PT A, V21, P486, DOI [10.1089/ten.tea.2013.0545, 10.1089/ten.TEA.2013.0545]
   McHugh KJ, 2013, J MATER SCI-MATER M, V24, P1659, DOI 10.1007/s10856-013-4934-1
   Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nain AS, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2372694
   Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   O'Brien Fergal J, 2007, Technol Health Care, V15, P3
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Owen SC, 2010, J BIOMED MATER RES A, V94A, P1321, DOI 10.1002/jbm.a.32834
   Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0
   Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075
   Paramonov SE, 2006, J AM CHEM SOC, V128, P7291, DOI 10.1021/ja060573x
   Pawar K, 2011, ACTA BIOMATER, V7, P2826, DOI 10.1016/j.actbio.2011.04.006
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Peyton SR, 2011, BIOTECHNOL BIOENG, V108, P1181, DOI 10.1002/bit.23027
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   Rosen MR, 2004, CARDIOVASC RES, V64, P12, DOI 10.1016/j.cardiores.2004.05.012
   Roufosse CA, 2004, INT J BIOCHEM CELL B, V36, P585, DOI 10.1016/j.biocel.2003.10.007
   SAUNDERS KB, 1992, IN VITRO CELL DEV-AN, V28A, P521
   Seale P, 2000, DEV BIOL, V218, P115, DOI 10.1006/dbio.1999.9565
   Sha'ban Munirah, 2008, J Orthop Surg Res, V3, P17, DOI 10.1186/1749-799X-3-17
   Smith IO, 2009, WIRES NANOMED NANOBI, V1, P226, DOI 10.1002/wnan.026
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tao SL, 2007, NANO LETT, V7, P1463, DOI 10.1021/nl0700346
   Tienen TG, 2006, AM J SPORT MED, V34, P64, DOI 10.1177/0363546505280905
   TUCKER SP, 1992, EUR J CELL BIOL, V58, P280
   Vagaska B, 2010, PHYSIOL RES, V59, P309
   VERFAILLIE CM, 1992, BLOOD, V79, P2821
   Wang HJ, 2005, J BIOMED MATER RES A, V74A, P523, DOI 10.1002/jbm.a.30232
   Wang YW, 2007, BIOMATERIALS, V28, P4619, DOI 10.1016/j.biomaterials.2007.07.006
   Wang YW, 2009, EUR J PHARM SCI, V37, P387, DOI 10.1016/j.ejps.2009.03.010
   Wang YY, 2014, BIOMATERIALS, V35, P8960, DOI 10.1016/j.biomaterials.2014.07.011
   Wenceslau CV, 2013, PLURIPOTENT STEM CEL, P39, DOI [10.5772/54372, DOI 10.5772/54372]
   Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Woo KM, 2007, BIOMATERIALS, V28, P335, DOI 10.1016/j.biomaterials.2006.06.013
   Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007
   Xi JY, 2010, FASEB J, V24, P2739, DOI 10.1096/fj.09-145177
   Yan XL, 2012, BREAST CANCER RES TR, V132, P153, DOI 10.1007/s10549-011-1577-0
   Yang F, 2004, J BIOMAT SCI-POLYM E, V15, P1483, DOI 10.1163/1568562042459733
   Yang J, 2002, J BIOMED MATER RES, V62, P438, DOI 10.1002/jbm.10318
   Yang YL, 2010, BIOMATERIALS, V31, P5678, DOI 10.1016/j.biomaterials.2010.03.039
   YANNAS I V, 1992, Clinical Materials, V9, P179, DOI 10.1016/0267-6605(92)90098-E
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Yuan N, 2014, NEURAL REGEN RES, V9, P1014, DOI 10.4103/1673-5374.133160
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
   Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367
   Zhang YF, 2010, ACTA BIOMATER, V6, P3021, DOI 10.1016/j.actbio.2010.02.030
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 105
TC 23
Z9 23
U1 3
U2 81
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-9069
EI 1573-0778
J9 CYTOTECHNOLOGY
JI Cytotechnology
PD MAY
PY 2016
VL 68
IS 3
BP 355
EP 369
DI 10.1007/s10616-015-9895-4
PG 15
WC Biotechnology & Applied Microbiology; Cell Biology
SC Biotechnology & Applied Microbiology; Cell Biology
GA DK5QC
UT WOS:000374973700001
PM 26091616
OA Green Published
DA 2018-10-19
ER

PT J
AU Gong, Y
   Han, GT
   Zhang, YM
   Zhang, JF
   Jiang, W
   Tao, XW
   Gao, SC
AF Gong, Ying
   Han, Guang Ting
   Zhang, Yuan Ming
   Zhang, Jin Feng
   Jiang, Wei
   Tao, Xiao Wei
   Gao, Sheng Chuan
TI Preparation of alginate membrane for tissue engineering
SO JOURNAL OF POLYMER ENGINEERING
LA English
DT Article
DE alginate; freeze drying; membrane; tissue engineering
ID BIOMATERIAL SCAFFOLDS; TECHNOLOGY; CHITOSAN; FILMS
AB Sodium alginate was provided with good processibility according to physical and chemical characterization of itself. Alginate scaffold has been used for preparation of soft or hard tissue engineering, but the structure of the scaffold needs to be improved for better performance for skin tissue engineering. In this study, highly porous alginate membrane was formed with ionic crosslinking. High molecular weight (M-w = 3.0 x 10(5)) alginate showed the best film-forming property. Therefore, the appropriate molecular weight should be selected for improving its performance. With freeze-drying technology and pre-freezing at -10 degrees C, we have built the honeycomb materials (porosity = 92.06%). Changing the pre-freezing temperature can regulate pore structure to some extent. With the increased dosage of sodium alginate, the porosity and the pore size of the materials were reduced, whereas tensile strength and elongation at break increased. Water absorption performance of the materials was good. The above studies lay a foundation for construction of skin tissue engineering scaffold.
C1 [Gong, Ying; Han, Guang Ting; Zhang, Yuan Ming; Tao, Xiao Wei; Gao, Sheng Chuan] Qingdao Univ, Lab New Fiber Mat & Modern Text, Growing Base State Key Lab, Qingdao 266071, Peoples R China.
   [Gong, Ying] Qingdao Univ, Coll Med, Inst Translat Med, Qingdao 266071, Peoples R China.
   [Zhang, Jin Feng] Qingdao Univ, Songshan Hosp, Dept Surg, Qingdao 266071, Peoples R China.
   [Jiang, Wei] Qingdao Univ, Coll Text, Qingdao 266071, Peoples R China.
RP Han, GT (reprint author), Qingdao Univ, Lab New Fiber Mat & Modern Text, Growing Base State Key Lab, Qingdao 266071, Peoples R China.
EM kychgt@qdu.edu.cn
FU National Natural Science Foundation of China [51373083]; Natural Science
   Foundation of Shandong Province, China [ZR2012EMZ002]
FX The work was funded by a grant from the National Natural Science
   Foundation of China (51373083) and the Natural Science Foundation of
   Shandong Province, China (ZR2012EMZ002).
CR ALSHAMKHANI A, 1995, J BIOACT COMPAT POL, V10, P4, DOI 10.1177/088391159501000102
   [Anonymous], 1995, PLAST DET TENS PRO 3
   BERSTED BH, 1990, J APPL POLYM SCI, V39, P499, DOI 10.1002/app.1990.070390302
   Butler MF, 2002, CRYST GROWTH DES, V2, P541, DOI 10.1021/cg02559le
   Chhatbar MU, 2012, SOFT MATTER, V8, P1837, DOI 10.1039/c2sm06947d
   Gaserod O, 1998, BIOMATERIALS, V19, P1815, DOI 10.1016/S0142-9612(98)00073-8
   Goh CH, 2012, CARBOHYD POLYM, V88, P1, DOI 10.1016/j.carbpol.2011.11.012
   Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Khan F, 2013, MACROMOL BIOSCI, V13, P395, DOI 10.1002/mabi.201200409
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   Ma GP, 2014, NEW J CHEM, V38, P1211, DOI 10.1039/c3nj00701d
   Pereira RF, 2013, CARBOHYD POLYM, V98, P311, DOI 10.1016/j.carbpol.2013.05.076
   Ribeiro CC, 2004, BIOMATERIALS, V25, P4363, DOI 10.1016/j.biomaterials.2003.11.028
   Speakman J. B., 1944, J SOC DYERS COLOUR, V60, P264
   Tong QY, 2013, INT J FOOD SCI TECH, V48, P870, DOI 10.1111/ijfs.12039
   Wang CC, 2011, BIOMATERIALS, V32, P7118, DOI 10.1016/j.biomaterials.2011.06.018
   Weng SY, 2013, J THERM ANAL CALORIM, V113, P1603, DOI 10.1007/s10973-013-3092-5
NR 19
TC 4
Z9 4
U1 3
U2 20
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0334-6447
EI 2191-0340
J9 J POLYM ENG
JI J. Polym. Eng.
PD MAY
PY 2016
VL 36
IS 4
BP 363
EP 370
DI 10.1515/polyeng-2015-0065
PG 8
WC Polymer Science
SC Polymer Science
GA DK8WX
UT WOS:000375210600002
OA Bronze
DA 2018-10-19
ER

PT J
AU Sealy, C
AF Sealy, Cordelia
TI Seaweed makes super-tough biomaterial
SO MATERIALS TODAY
LA English
DT News Item
CR Daemi H, 2016, BIOMATERIALS, V84, P54, DOI 10.1016/j.biomaterials.2016.01.025
NR 1
TC 1
Z9 1
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1369-7021
EI 1873-4103
J9 MATER TODAY
JI Mater. Today
PD MAY
PY 2016
VL 19
IS 4
BP 187
EP 187
PG 1
WC Materials Science, Multidisciplinary
SC Materials Science
GA DK8PF
UT WOS:000375188500008
OA Other Gold
DA 2018-10-19
ER

PT J
AU Glass, KA
   Rowland, CR
   Ettyreddy, AR
   Brunger, JM
   Huynh, NPT
   Gersbach, CA
   Guilak, F
AF Glass, Katherine A.
   Rowland, Christopher R.
   Ettyreddy, Adarsh R.
   Brunger, Jonathan M.
   Huynh, Nguyen P. T.
   Gersbach, Charles A.
   Guilak, Farshid
TI Biomaterial-Mediated Lentiviral Delivery of Anti-Inflammatory Genes in
   Cartilage-Derived Matrix Hemispheres
SO MOLECULAR THERAPY
LA English
DT Meeting Abstract
CT 19th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy
   (ASGCT)
CY MAY 04-07, 2016
CL Washington, DC
SP Amer Soc Gene & Cell Therapy
C1 [Glass, Katherine A.; Ettyreddy, Adarsh R.; Brunger, Jonathan M.; Huynh, Nguyen P. T.; Gersbach, Charles A.; Guilak, Farshid] Duke Univ, Biomed Engn, Durham, NC USA.
   [Rowland, Christopher R.; Guilak, Farshid] Washington Univ, Shriners Hosp, Orthopaed Res, St Louis, MO USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1525-0016
EI 1525-0024
J9 MOL THER
JI Mol. Ther.
PD MAY
PY 2016
VL 24
SU 1
MA 502
BP S199
EP S200
DI 10.1016/S1525-0016(16)33311-1
PG 2
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA DK9PT
UT WOS:000375264200496
OA Other Gold
DA 2018-10-19
ER

PT J
AU Koolen, PGL
   Haas, D
   Kim, K
   Fox, S
   Ibrahim, AMS
   Kim, P
   Kaplan, DL
   Lin, SJ
AF Koolen, Pieter G. L.
   Haas, Dylan
   Kim, Kuylhee
   Fox, Sharon
   Ibrahim, Ahmed M. S.
   Kim, Peter
   Kaplan, David L.
   Lin, Samuel J.
TI Increased Osteoid Formation in BMP-2-Loaded Silk-Based Screws
SO PLASTIC AND RECONSTRUCTIVE SURGERY
LA English
DT Article
ID BONE MORPHOGENETIC PROTEIN-2; INTERNAL-FIXATION; BIOMATERIAL SCAFFOLDS;
   BIOABSORBABLE PLATES; MANDIBULAR FRACTURES; ABSORBABLE PLATES;
   RESORBABLE PLATES; BOMBYX-MORI; IN-VITRO; FIBROIN
AB Background: Resorbable osteosynthesis systems are used to treat craniofacial fractures. However, conventional synthetic polyester materials are potentially associated with inflammatory reaction and negative host response and may result in incomplete bone remodeling. The authors have developed a resorbable silk fibroin-based osteosynthesis system and propose that silk screws loaded with bone morphogenetic protein-2 (BMP-2) may exhibit biocompatibility and promote bone remodeling.
   Methods: Resorbable silk screws were prepared and loaded with BMP-2. The BMP-2-loaded and nonloaded silk screws were inserted into the distal femora in 15 Sprague-Dawley rats by self-tapping, similar to conventional metal systems. Animals were euthanized after 1, 3, and 6 months. The femora were explanted at the designated time points, dissected for histologic evaluation, and compared regarding osteoid formation and inflammatory response.
   Results: Increasing organization of newly formed bone tissue was observed over time in both groups. No appreciable difference in inflammation was noted between the BMP-2-loaded and nonloaded silk screws. Notably, mineralized collagen around the periphery of the screw appears to be greatest and more organized in the BMP-2-loaded samples. There was greater recruitment of osteoclasts and osteoblasts around the perimeter of the BMP-2-loaded screws at 3 and 6 months.
   Conclusions: The BMP-2-loaded silk-based fixation device in this study exhibited characteristics comparable to the current nonloaded silk screws with regard to integration and biocompatibility. However, functionalization of silk screws with BMP-2 appeared to allow for more organized collagen and osteoid deposition after 3 and 6 months and may increase the potential of successful remodeling.
C1 Harvard Univ, Sch Med, Div Plast Surg, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Dept Pathol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.
   Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Lin, SJ (reprint author), 110 Francis St,Suite 5A, Boston, MA 02215 USA.; Kaplan, DL (reprint author), 4 Colby St,Room 251, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu; sjlin@bidmc.harvard.edu
RI Chen, Austin/N-3879-2017
FU National Institutes of Health/National Institute of Arthritis and
   Musculoskeletal and Skin Diseases [1R01AR068048-01]; Plastic Surgery
   Foundation National Endowment Research Grant
FX This study is supported in part by National Institutes of
   Health/National Institute of Arthritis and Musculoskeletal and Skin
   Diseases grant 1R01AR068048-01 and a Plastic Surgery Foundation National
   Endowment Research Grant. The authors thank Chunmei Li for her
   assistance with Figure 1.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   American Society of Plastic Surgeons, 2013 REC PLAST SURG
   Bonewald LF, 2003, CALCIFIED TISSUE INT, V72, P537, DOI 10.1007/s00223-002-1057-y
   BOS RRM, 1991, BIOMATERIALS, V12, P32, DOI 10.1016/0142-9612(91)90128-W
   BOS RRM, 1987, J ORAL MAXIL SURG, V45, P751, DOI 10.1016/0278-2391(87)90194-7
   BOS RRM, 1989, INT J ORAL MAX SURG, V18, P365, DOI 10.1016/S0901-5027(89)80035-9
   Bostman OM, 2005, J BONE JOINT SURG BR, V87B, P1575, DOI 10.1302/0301-620X.87B11.16520
   BOSTMAN OM, 1991, J BONE JOINT SURG AM, V73A, P148
   Bozic KJ, 2001, J HAND SURG-AM, V26A, P755, DOI 10.1053/jhsu.2001.24145
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Cordewener FW, 2000, TISSUE ENG, V6, P413, DOI 10.1089/107632700418119
   Dumont C, 2007, J HAND SURG-AM, V32A, P491, DOI 10.1016/j.jhsa.2007.02.005
   Eppley BL, 2005, J ORAL MAXIL SURG, V63, P385, DOI 10.1016/j.joms.2004.11.011
   Fedorowicz Z, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006204.pub2
   Gerlach K L, 2000, Mund Kiefer Gesichtschir, V4 Suppl 1, pS91
   Gilardino MS, 2009, CRANIOMAX TRAUM REC, V2, P49, DOI [10.1055/s-0029-1202591.ISSN1943-3875, 10.1055/s-0029-1202591]
   Goriainov V, 2014, ACTA BIOMATER, V10, P4043, DOI 10.1016/j.actbio.2014.06.004
   IIZUKA T, 1992, INT J ORAL MAX SURG, V21, P65, DOI 10.1016/S0901-5027(05)80533-8
   Imola M J, 2001, Arch Facial Plast Surg, V3, P79, DOI 10.1001/archfaci.3.2.79
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Kakudo N, 2006, WOUND REPAIR REGEN, V14, P336, DOI 10.1111/j.1743-6109.2006.00129.x
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kim KH, 2005, J BIOTECHNOL, V120, P327, DOI 10.1016/j.jbiotec.2005.06.033
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim YK, 2002, PLAST RECONSTR SURG, V110, P25, DOI 10.1097/00006534-200207000-00006
   Kirker-Head C, 2007, BONE, V41, P247, DOI 10.1016/j.bone.2007.04.186
   Kosaka M, 2003, J CRANIO MAXILL SURG, V31, P15, DOI 10.1016/S1010-5182(02)00162-2
   Kumar AV, 1997, J CRANIOFAC SURG, V8, P97, DOI 10.1097/00001665-199703000-00006
   Larsen MW, 2005, AM J SPORT MED, V33, P68, DOI 10.1177/0363546504265927
   Lee JM, 2013, JAMA OTOLARYNGOL, V139, P629, DOI 10.1001/jamaoto.2013.3044
   LEENSLAG JW, 1987, BIOMATERIALS, V8, P311, DOI 10.1016/0142-9612(87)90121-9
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Lionelli GT, 2002, ANN PLAS SURG, V49, P202, DOI 10.1097/00000637-200208000-00015
   Lu Q, 2010, MACROMOL BIOSCI, V10, P359, DOI 10.1002/mabi.200900388
   Lu SZ, 2009, BIOMACROMOLECULES, V10, P1032, DOI 10.1021/bm800956n
   Mohamed-Hashem I K, 2000, J Orthod, V27, P198, DOI 10.1093/ortho/27.2.198
   Neumann A, 2009, Laryngorhinootologie, V88 Suppl 1, pS48, DOI 10.1055/s-0028-1119515
   Numata K, 2010, BIOMATERIALS, V31, P2926, DOI 10.1016/j.biomaterials.2009.12.026
   Park CH, 2011, ARCH OTOLARYNGOL, V137, P125, DOI 10.1001/archoto.2010.241
   Perrone GS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4385
   Pietrzak William S, 2002, J Foot Ankle Surg, V41, P379
   Pritchard EM, 2011, BIOMATERIALS, V32, P909, DOI 10.1016/j.biomaterials.2010.09.055
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rokkanen PU, 2000, BIOMATERIALS, V21, P2607, DOI 10.1016/S0142-9612(00)00128-9
   Rovati LC, 1997, J CRANIOFAC SURG, V8, P323, DOI 10.1097/00001665-199707000-00016
   ROZEMA FR, 1990, INT J ORAL MAX SURG, V19, P374, DOI 10.1016/S0901-5027(05)80086-4
   Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004
   Schmidt BL, 1998, J ORAL MAXIL SURG, V56, P184, DOI 10.1016/S0278-2391(98)90865-5
   Schubert R, FRACTURE HEALING
   Shen Y, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/1/015015
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Stuck BA, 2011, HNO, V59, P1088, DOI 10.1007/s00106-011-2386-9
   Suuronen R, 2000, J Craniomaxillofac Trauma, V6, P19
   Tripathi Nalini, 2013, Natl J Maxillofac Surg, V4, P181, DOI 10.4103/0975-5950.127648
   van Bakelen NB, 2013, J DENT RES, V92, P1100, DOI 10.1177/0022034513508953
   Varghai D, 2011, J CRANIOFAC SURG, V22, P543, DOI 10.1097/SCS.0b013e318208ba49
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Waris E, 2003, CLIN ORTHOP RELAT R, P310, DOI 10.1097/01.blo.0000063789.32430.c6
   Yang LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067449
   Zhang JE, 2012, P NATL ACAD SCI USA, V109, P11981, DOI 10.1073/pnas.1206210109
   Zhang JW, 2012, J TRAUMA ACUTE CARE, V72, pE106, DOI 10.1097/TA.0b013e3182231811
   Zhou L, 2005, J PHYS CHEM B, V109, P16937, DOI 10.1021/jp050883m
NR 65
TC 0
Z9 0
U1 5
U2 21
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0032-1052
EI 1529-4242
J9 PLAST RECONSTR SURG
JI Plast. Reconstr. Surg.
PD MAY
PY 2016
VL 137
IS 5
BP 808E
EP 817E
DI 10.1097/PRS.0000000000002080
PG 10
WC Surgery
SC Surgery
GA DK8OL
UT WOS:000375186400006
PM 27119943
DA 2018-10-19
ER

PT J
AU Eghtedari, Y
   Richardson, A
   Mai, K
   Heng, B
   Guillemin, GJ
   Wakefield, D
   Di Girolamo, N
AF Eghtedari, Yas
   Richardson, Alexander
   Mai, Kelly
   Heng, Benjamin
   Guillemin, Gilles J.
   Wakefield, Denis
   Di Girolamo, Nick
TI Keratin 14 Expression in Epithelial Progenitor Cells of the Developing
   Human Cornea
SO STEM CELLS AND DEVELOPMENT
LA English
DT Article
ID ALPHA-V-INTEGRINS; STEM-CELLS; OCULAR SURFACE; LIMBAL EPITHELIUM;
   SELF-RENEWAL; TRANSPLANTATION; NICHE; ABSENCE; DIFFERENTIATION;
   PARKINSONS
AB A healthy and transparent cornea is essential for exquisite vision. During adulthood, its epithelium is constantly replenished through the activity of its stem cells (SCs). Precisely when these cells develop and their distribution across the ocular surface remain incompletely characterized in man. We postulated that the human fetal cornea harbors SCs that can be identified with keratin (K) 14 and v-integrin, two markers we and others previously used to identify their adult counterparts. Immunofluorescence, cell culture, quantitative real-time polymerase chain reaction (qRT-PCR), and colony-forming assays were performed on fetal and adult biomaterial to locate progenitors and establish their phenotypic and functional properties. K14 was used to map the spatiotemporal distribution of precursor cell activity across the developing cornea, divulging a dynamic pattern of vertical and horizontal consolidated expression with increasing gestational age. K14 was coexpressed with v-integrin in fetal and adult corneas and cultured corneolimbal epithelium, and colony-forming efficiency (an indicator of SC activity) was similar in cells from both sources. Finally, fetal cells were adherent, grew well, and maintained a K14 phenotype on contact lenses, a substrate we previously used to deliver cells to patients with blinding corneal disease. This study provides valuable insights into the development of the cornea, including the formation of the SC repository, the distribution of these cells across the ocular surface, and a preliminary attempt at harnessing, phenotyping, and functionally characterizing these cells. Future studies will focus on isolating fetal SCs to determine their utility as an alternative cell therapy for patients suffering from corneal blindness.
C1 [Eghtedari, Yas; Richardson, Alexander; Mai, Kelly; Wakefield, Denis; Di Girolamo, Nick] Univ New S Wales, Sch Med Sci, Ocular Dis Res Grp, Sydney, NSW 2052, Australia.
   [Heng, Benjamin; Guillemin, Gilles J.] Macquarie Univ, Neuroinflammat Grp, Fac Med & Hlth Sci, Sydney, NSW 2109, Australia.
RP Di Girolamo, N (reprint author), Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia.
EM n.digirolamo@unsw.edu.au
OI Heng, Ruiwen Benjamin/0000-0002-0247-2920; Guillemin,
   Gilles/0000-0001-8105-4470
FU University of New South Wales
FX Grant sponsorship: University of New South Wales. The authors thank Mr.
   Raj Devasahayam at the Lions NSW Eye Bank for providing the donor human
   adult corneas.
CR Abbott A, 2014, NATURE, V510, P195, DOI 10.1038/510195a
   Banting FG, 1922, CAN MED ASSOC J, V7, P141
   Barnard Z, 2001, CLIN EXP OPHTHALMOL, V29, P138, DOI 10.1046/j.1442-9071.2001.00394.x
   Baylis O, 2011, J CELL BIOCHEM, V112, P993, DOI 10.1002/jcb.23028
   Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012
   Bobba S, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0009-1
   Cattavarayane S, 2015, BMC CELL BIOL, V16, DOI 10.1186/s12860-015-0051-y
   CHUNG EH, 1992, INVEST OPHTH VIS SCI, V33, P2199
   CINTRON C, 1983, INVEST OPHTH VIS SCI, V24, P543
   Collinson JM, 2002, DEV DYNAM, V224, P432, DOI 10.1002/dvdy.10124
   DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0
   Davies SB, 2009, STEM CELLS, V27, P2781, DOI 10.1002/stem.209
   Di Girolamo N, 2015, STEM CELLS, V33, P157, DOI 10.1002/stem.1769
   Girolamo N, 2015, PROG RETIN EYE RES, V48, P203, DOI 10.1016/j.preteyeres.2015.04.002
   Di Girolamo N, 2009, TRANSPLANTATION, V87, P1571, DOI 10.1097/TP.0b013e3181a4bbf2
   Dua HS, 2005, BRIT J OPHTHALMOL, V89, P529, DOI 10.1136/bjo.2004.049742
   Duke-Elder S, 1963, SYSTEM OPHTHALMOLO 1, P137
   EBATO B, 1988, INVEST OPHTH VIS SCI, V29, P1533
   Echevarria TJ, 2011, INVEST OPHTH VIS SCI, V52, P8138, DOI 10.1167/iovs.11-8140
   Graw J, 2010, CURR TOP DEV BIOL, V90, P343, DOI 10.1016/S0070-2153(10)90010-0
   Hay ED, 1980, DEV VERTEBRATE CORNE
   Hayashi R, 2008, BIOCHEM BIOPH RES CO, V367, P256, DOI 10.1016/j.bbrc.2007.12.077
   HUANG AJW, 1991, INVEST OPHTH VIS SCI, V32, P96
   Hunt JS, 2005, FASEB J, V19, P681, DOI 10.1096/fj.04-2078rev
   KURPAKUS MA, 1994, CURR EYE RES, V13, P805, DOI 10.3109/02713689409025135
   Li W, 2007, CELL RES, V17, P26, DOI 10.1038/sj.cr.7310137
   LLOYD C, 1995, J CELL BIOL, V129, P1329, DOI 10.1083/jcb.129.5.1329
   Mai K, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-20
   Mann I, 1964, DEV HUMAN EYE
   McCarty JH, 2008, AM J PATHOL, V172, P1740, DOI 10.2353/ajpath.2008.070700
   Molvaer RK, 2013, ACTA OPHTHALMOL, V91, P457, DOI 10.1111/j.1755-3768.2012.02446.x
   Moore KL, 2010, CLIN ORIENTED ANATOM, P889
   Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447
   Nieto-Miguel T, 2011, MOL VIS, V17, P2102
   Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720
   Ordonez P, 2013, STEM CELL RES, V11, P888, DOI 10.1016/j.scr.2013.05.013
   Pajoohesh-Ganji A, 2004, DEV DYNAM, V230, P518, DOI 10.1002/dvdy.20050
   Pajoohesh-Ganji A, 2016, DEV DYNAM, V245, P132, DOI [10.1002/DVDY.24365, 10.1002/dvdy.24365]
   Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955
   RODRIGUES M, 1987, DIFFERENTIATION, V34, P60, DOI 10.1111/j.1432-0436.1987.tb00051.x
   Sangwan VS, 2011, BRIT J OPHTHALMOL, V95, P1525, DOI 10.1136/bjophthalmol-2011-300352
   SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49
   Sehic Amer, 2015, J Funct Biomater, V6, P863, DOI 10.3390/jfb6030863
   Sevel D, 1988, T AM OPHTHAL SOC, V86, P178
   Shortt AJ, 2007, STEM CELLS, V25, P1402, DOI 10.1634/stemcells.2006-0580
   Shortt AJ, 2011, BRIT MED BULL, V100, P209, DOI 10.1093/bmb/ldr041
   Singh P, 2009, J INVEST DERMATOL, V129, P217, DOI 10.1038/jid.2008.201
   Tadeu AMB, 2013, DEVELOPMENT, V140, P3777, DOI 10.1242/dev.093948
   Thomas PB, 2007, MOL VIS, V13, P337
   Townsend W M, 1991, Trans Am Ophthalmol Soc, V89, P721
   Utheim TP, 2009, BRIT J OPHTHALMOL, V93, P980, DOI 10.1136/bjo.2008.149591
   Utheim Tor Paaske, 2013, Methods Mol Biol, V1014, P3, DOI 10.1007/978-1-62703-432-6_1
   Weis SM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006478
   Yeung AM, 2009, EXP EYE RES, V88, P1161, DOI 10.1016/j.exer.2008.12.014
   Zhang H, 2005, JPN J OPHTHALMOL, V49, P195, DOI 10.1007/s10384-004-0189-1
   Zhao XPC, 2006, INVEST OPHTH VIS SCI, V47, P4341, DOI 10.1167/iovs.05-1611
   ZIESKE JD, 1993, J CELL SCI, V106, P145
NR 57
TC 4
Z9 5
U1 0
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1547-3287
EI 1557-8534
J9 STEM CELLS DEV
JI Stem Cells Dev.
PD MAY 1
PY 2016
VL 25
IS 9
BP 699
EP 711
DI 10.1089/scd.2016.0039
PG 13
WC Cell & Tissue Engineering; Hematology; Medicine, Research &
   Experimental; Transplantation
SC Cell Biology; Hematology; Research & Experimental Medicine;
   Transplantation
GA DK3YT
UT WOS:000374854000004
PM 26956898
DA 2018-10-19
ER

PT J
AU Altman, D
   Hjern, F
   Zetterstrom, J
AF Altman, Daniel
   Hjern, Fredrik
   Zetterstrom, Jan
TI Transanal submucosal polyacrylamide gel injection treatment of anal
   incontinence: a randomized controlled trial
SO ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
LA English
DT Article
DE Anal incontinence; injection; polyacrylamide; randomized trial
ID PASSIVE FECAL INCONTINENCE; INJECTABLE BULKING AGENTS; FEMALE STRESS;
   MULTICENTER; HYDROGEL; EFFICACY; SAFETY
AB Introduction. The efficacious and safe use of transurethral injections of polyacrylamide hydrogel (Bulkamid (R)) in women with stress urinary incontinence suggests that it may be suitable also for treatment of anal incontinence. We aimed to determine the effectiveness and safety of polyacrylamide hydrogel when used as a transanal submucosal bulking agent in women with anal incontinence. Materials and methods. Thirty women with a diagnosis of anal incontinence and a Cleveland Clinic Incontinence Score (CCIS) > 10 were randomized to three different techniques of transanal submucosal injections using polyacrylamide hydrogel. Follow up was performed at 2, 6 and 12 months using CCIS and the Fecal Incontinence Quality of Life scale (FIQL). Results. In all, 29 of the 30 women completed the follow up. Approximately half of the women requested a re-injection at the 6-month visit. The overall CCIS improved significantly from baseline (14.7. SD 2.5) to 1 year (12.4. SD 3.1) (p = 0.003). There was a significant improvement with regard to the occurrence of loose fecal incontinence (p = 0.014) but not for solid fecal incontinence (p = 0.28). At 1 year the FIQL domains of coping-behavior, depression, and embarrassment showed significant improvements (p = 0.012, p = 0.007 and p = 0.007, respectively). We recorded no adverse events related either to the injection technique or the biomaterial. There were no significant differences between the treatment groups in either CCIS or FIQL scores. Conclusion. Transanal submucosal injection of polyacrylamide hydrogel resulted in a modest although significant overall improvement in anal incontinence symptom scores with corresponding improvements in several domains of quality of life, regardless of injection volume.
C1 [Altman, Daniel] Stockholm Urogynecol Clin, Kommendorsgatan 5, S-11448 Stockholm, Sweden.
   [Altman, Daniel; Zetterstrom, Jan] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, S-18288 Danderyd, Sweden.
   [Altman, Daniel] Univ Milano Bicocca, Dept Stat & Quantitat Methods, Milan, Italy.
   [Hjern, Fredrik] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Div Surg, S-18288 Danderyd, Sweden.
   [Zetterstrom, Jan] Sophiahemmet Hosp, Gynecol Clin, Stockholm, Sweden.
RP Altman, D (reprint author), Stockholm Urogynecol Clin, Kommendorsgatan 5, S-11448 Stockholm, Sweden.
EM daniel.altman@ki.se
FU Swedish Society of Medicine; Stockholm county council; Karolinska
   Institute
FX Grant from the Swedish Society of Medicine and the regional agreement on
   medical training and clinical research (ALF) between Stockholm county
   council and Karolinska Institute.
CR Abramov Y, 2005, OBSTET GYNECOL, V106, P726, DOI 10.1097/01.AOG.0000161367.65261.16
   Brown SR, 2013, COCHRANE DB SYST REV, V7
   Graf W, 2011, LANCET, V377, P997, DOI 10.1016/S0140-6736(10)62297-0
   HAADEM K, 1991, OBSTET GYNECOL, V78, P823
   Koh CE, 2013, TECH COLOPROCTOL, V17, P343, DOI 10.1007/s10151-013-1018-7
   Maeda Y, 2008, COLORECTAL DIS, V10, P268, DOI 10.1111/j.1463-1318.2007.01318.x
   Maeda Y, 2013, COCHRANE DB SYST REV, V28, P2
   MARCIO J, 1993, DIS COLON RECTUM, V36, P77
   Morris OJ, 2013, TECH COLOPROCTOL, V17, P517, DOI 10.1007/s10151-013-1000-4
   Omar M.I., 2013, COCHRANE DATE BASE S, P11, DOI DOI 10.1002/14651858.CD002116.PUB2]
   Pallua N, 2010, PLAST RECONSTR SURG, V125, P1797, DOI 10.1097/PRS.0b013e3181d18158
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236
   Sokol ER, 2014, J UROLOGY, V192, P843, DOI 10.1016/j.juro.2014.03.109
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Toozs-Hobson P, 2012, INT UROGYNECOL J, V23, P1373, DOI 10.1007/s00192-012-1761-8
   *WHO, 1992, INT CLASS DIS HLTH R
NR 16
TC 3
Z9 3
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0001-6349
EI 1600-0412
J9 ACTA OBSTET GYN SCAN
JI Acta Obstet. Gynecol. Scand.
PD MAY
PY 2016
VL 95
IS 5
BP 528
EP 533
DI 10.1111/aogs.12866
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DJ6UT
UT WOS:000374349400007
PM 26866933
DA 2018-10-19
ER

PT J
AU Zhou, HY
   Goss, M
   Hernandez, C
   Mansour, JM
   Exner, A
AF Zhou, Haoyan
   Goss, Monika
   Hernandez, Christopher
   Mansour, Joseph M.
   Exner, Agata
TI Validation of Ultrasound Elastography Imaging for Nondestructive
   Characterization of Stiffer Biomaterials
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Ultrasound elastography; Mechanical; Biomaterial characterization;
   Nondestructive; Noninvasive; Elasticity
ID ELASTIC PROPERTIES; BIOLOGICAL TISSUES; PLAQUE COMPONENTS;
   PROSTATE-CANCER; GOLD STANDARD; STIFFNESS; ADHESION; SOFT; PEPTIDE;
   SYSTEMS
AB Ultrasound elastography (UE) has been widely used as a "digital palpation" tool to characterize tissue mechanical properties in the clinic. UE benefits from the capability of noninvasively generating 2-D elasticity encoded maps. This spatial distribution of elasticity can be especially useful in the in vivo assessment of tissue engineering scaffolds and implantable drug delivery platforms. However, the detection limitations have not been fully characterized and thus its true potential has not been completely discovered. Characterization studies have focused primarily on the range of moduli corresponding to soft tissues, 20-600 kPa. However, polymeric biomaterials used in biomedical applications such as tissue scaffolds, stents, and implantable drug delivery devices can be much stiffer. In order to explore UE's potential to assess mechanical properties of biomaterials in a broader range of applications, this work investigated the detection limit of UE strain imaging beyond soft tissue range. To determine the detection limit, measurements using standard mechanical testing and UE on the same polydimethylsiloxane samples were compared and statistically evaluated. The broadest detection range found based on the current optimized setup is between 47 kPa and 4 MPa which exceeds the modulus of normal soft tissue suggesting the possibility of using this technique for stiffer materials' mechanical characterization. The detectable difference was found to be as low as 157 kPa depending on sample stiffness and experimental setup.
C1 [Zhou, Haoyan; Goss, Monika; Hernandez, Christopher] Case Western Reserve Univ, Dept Biomed Engn, 11100 Euclid Ave, Cleveland, OH 44106 USA.
   [Mansour, Joseph M.] Case Western Reserve Univ, Dept Mech & Aerosp Engn, 11100 Euclid Ave, Cleveland, OH 44106 USA.
   [Exner, Agata] Case Western Reserve Univ, Dept Radiol, 11100 Euclid Ave, Cleveland, OH 44106 USA.
RP Exner, A (reprint author), Case Western Reserve Univ, Dept Radiol, 11100 Euclid Ave, Cleveland, OH 44106 USA.
EM hxz143@case.edu; mag150@case.edu; cxh404@case.edu; Jmm12@case.edu;
   Agata.exner@case.edu
OI Exner, Agata/0000-0003-3913-7066; Hernandez,
   Christopher/0000-0003-0380-7136
FU National Institute of Biomedical Imaging and Bioengineering of the
   National Institutes of Health [R01EB016960, T32-EB007509]
FX This work was supported by the National Institute of Biomedical Imaging
   and Bioengineering of the National Institutes of Health under award
   numbers R01EB016960 and T32-EB007509. Views and opinions of, and
   endorsements by the author(s) do not reflect those of the National
   Institutes of Health. The authors would like to thank Dr. Bo Hu and Dr.
   Chen-yuan Chung for their help with statistical analysis and mechanical
   analysis respectively in this paper.
CR Ali MY, 2014, SOFT MATTER, V10, P8829, DOI 10.1039/c4sm01602e
   Ataollahi F, 2015, J BIOMED MATER RES A, V103, P2203, DOI 10.1002/jbm.a.35186
   de Korte CL, 2000, PHYS MED BIOL, V45, P1465, DOI 10.1088/0031-9155/45/6/305
   de Korte CL, 2000, CIRCULATION, V102, P617, DOI 10.1161/01.CIR.102.6.617
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Fromageau J, 2007, IEEE T ULTRASON FERR, V54, P498, DOI 10.1109/TUFFC.2007.273
   Fung YC, 1993, BIOMECHANICS MECH PR
   Giovannini M, 2006, ENDOSCOPY, V38, P344, DOI 10.1055/s-2006-925158
   Greenleaf JF, 2003, ANNU REV BIOMED ENG, V5, P57, DOI 10.1146/annurev.bioeng.5.040202.121623
   Griffin MA, 2004, J CELL SCI, V117, P5855, DOI 10.1242/jcs.01496
   Han Z, 2015, BIOCONJUGATE CHEM, V26, P830, DOI 10.1021/acs.bioconjchem.5b00178
   HATAKEYAMA T, 1995, THERMOCHIM ACTA, V253, P137, DOI 10.1016/0040-6031(94)02087-5
   Hoyt K, 2008, CANCER BIOMARK, V4, P213, DOI 10.3233/CBM-2008-44-505
   Huang S, 2005, CANCER CELL, V8, P175, DOI 10.1016/j.ccr.2005.08.009
   Kim K, 2008, ACTA BIOMATER, V4, P783, DOI 10.1016/j.actbio.2008.02.010
   Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392
   Krouskop TA, 1998, ULTRASONIC IMAGING, V20, P260, DOI 10.1177/016173469802000403
   LERNER RM, 1990, ULTRASOUND MED BIOL, V16, P231, DOI 10.1016/0301-5629(90)90002-T
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/NMAT2344, 10.1038/nmat2344]
   Ophir J, 1999, P I MECH ENG H, V213, P203, DOI 10.1243/0954411991534933
   OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W
   Oudry J, 2014, PHYS MED BIOL, V59, P5775, DOI 10.1088/0031-9155/59/19/5775
   Parker KJ, 2011, PHYS MED BIOL, V56, pR1, DOI 10.1088/0031-9155/56/1/R01
   Sarvazyan A, 2011, CURR MED IMAGING REV, V7, P255, DOI 10.2174/157340511798038684
   Sarvestani AS, 2007, BIOPOLYMERS, V85, P370, DOI 10.1002/bip.20659
   Selzer RH, 2001, ATHEROSCLEROSIS, V154, P185, DOI 10.1016/S0021-9150(00)00461-5
   Weber N, 2007, LANGMUIR, V23, P3298, DOI 10.1021/la060500r
   Yeh WC, 2002, ULTRASOUND MED BIOL, V28, P467, DOI 10.1016/S0301-5629(02)00489-1
   Yu J, 2013, BIOMATERIALS, V34, P2701, DOI 10.1016/j.biomaterials.2013.01.036
   Zhi H, 2007, J ULTRAS MED, V26, P807, DOI 10.7863/jum.2007.26.6.807
   Zhou HY, 2015, CURR DRUG TARGETS, V16, P672, DOI 10.2174/1389450115666141122211920
NR 33
TC 1
Z9 1
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAY
PY 2016
VL 44
IS 5
BP 1515
EP 1523
DI 10.1007/s10439-015-1448-7
PG 9
WC Engineering, Biomedical
SC Engineering
GA DK1IO
UT WOS:000374665900014
PM 26369634
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Batoni, G
   Maisetta, G
   Esin, S
AF Batoni, Giovanna
   Maisetta, Giuseppantonio
   Esin, Semih
TI Antimicrobial peptides and their interaction with biofilms of medically
   relevant bacteria
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
LA English
DT Review
DE Biofilm; Antimicrobial peptides; Extracellular DNA; Antibiofilm drugs;
   Biofilm matrix; Biofilm exopolysaccharides; Biofilm proteins
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; BIOMATERIAL-ASSOCIATED INFECTION;
   RESISTANT STAPHYLOCOCCUS-AUREUS; RECOMBINANT HUMAN DNASE;
   PSEUDOMONAS-AERUGINOSA BIOFILMS; QUORUM-SENSING INHIBITORS;
   EXTRACELLULAR DNA; CYSTIC-FIBROSIS; HEPCIDIN 20; IN-VITRO
AB Biofilm-associated infections represent one of the major threats of modern medicine. Biofilm-forming bacteria are encased in a complex mixture of extracellular polymeric substances (EPS) and acquire properties that render them highly tolerant to conventional antibiotics and host immune response. Therefore, there is a pressing demand of new drugs active against microbial biofilms. In this regard, antimicrobial peptides (AMPs) represent an option taken increasingly in consideration. After dissecting the peculiar biofilm features that may greatly affect the development of new antibiofilm drugs, the present article provides a general overview of the rationale behind the use of AMPs against biofilms of medically relevant bacteria and on the possible mechanisms of AMP-antibiofilm activity. An analysis of the interactions of AMPs with biofilm components, especially those constituting the EPS, and the obstacles and/or opportunities that may arise from such interactions in the development of new AMP-based antibiofilm strategies is also presented and discussed. This article is part of a Special Issue entitled: Antimicrobial Peptides edited by Karl Lohner and Kai Hilpert. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Batoni, Giovanna; Maisetta, Giuseppantonio; Esin, Semih] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy.
RP Batoni, G (reprint author), Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy.
EM giovanna.batoni@med.unipi.it
OI Batoni, Giovanna/0000-0002-4448-2385
FU University of Pisa
FX This work was supported by funds from the University of Pisa. We would
   like to thank Mariagrazia Di Luca for critical reading of the
   manuscript. This article is dedicated to the memory of our "Maestro"
   Professor Mario Campa who passed away in July 2014. We are very grateful
   to him for his teaching and constant support in science and everyday
   life.
CR Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x
   Alves D, 2014, BIOFOULING, V30, P483, DOI 10.1080/08927014.2014.889120
   Anderson J. M., 2013, BIOMATERIALS ASS INF, P119
   Anderson MJ, 2013, J MICROBIOL METH, V92, P201, DOI 10.1016/j.mimet.2012.12.003
   Arciola CR, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00007
   Baelo A, 2015, J CONTROL RELEASE, V209, P150, DOI 10.1016/j.jconrel.2015.04.028
   Barraud N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084220
   Batoni G, 2011, CURR MED CHEM, V18, P256, DOI 10.2174/092986711794088399
   Beloin C, 2014, CURR OPIN PHARMACOL, V18, P61, DOI 10.1016/j.coph.2014.09.005
   Benincasa M, 2009, J PEPT SCI, V15, P595, DOI 10.1002/psc.1142
   Bjarnsholt T, 2013, TRENDS MICROBIOL, V21, P466, DOI 10.1016/j.tim.2013.06.002
   Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011
   Boles BR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000052
   Brackman G, 2015, CURR PHARM DESIGN, V21, P5
   Brancatisano FL, 2011, J DENT RES, V90, P241, DOI 10.1177/0022034510385686
   Brancatisano FL, 2014, BIOFOULING, V30, P435, DOI 10.1080/08927014.2014.888062
   Brandelli A, 2012, MINI-REV MED CHEM, V12, P731, DOI 10.2174/138955712801264774
   BRANDT T, 1995, THORAX, V50, P880, DOI 10.1136/thx.50.8.880
   Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385
   Broekhuizen CAN, 2010, INFECT IMMUN, V78, P954, DOI 10.1128/IAI.00849-09
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098
   Brooks JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004292
   Bucki R, 2008, J ANTIMICROB CHEMOTH, V62, P329, DOI 10.1093/jac/dkn176
   Chan C, 2005, J PEPT RES, V65, P343, DOI 10.1111/j.1399-3011.2005.0217.X
   Chan C, 2004, J BIOL CHEM, V279, P38749, DOI 10.1074/jbc.M406044200
   Chauhan A, 2012, ANTIMICROB AGENTS CH, V56, P6310, DOI 10.1128/AAC.01606-12
   Chen X, 2011, APPL ENVIRON MICROB, V77, P4878, DOI 10.1128/AEM.02440-10
   Chennupati SK, 2009, AMJ RHINOL ALLERGY, V23, P46, DOI 10.2500/ajra.2009.23.3261
   Christensen LD, 2012, J ANTIMICROB CHEMOTH, V67, P1198, DOI 10.1093/jac/dks002
   Ciofu O, 2015, ADV DRUG DELIVER REV, V85, P7, DOI 10.1016/j.addr.2014.11.017
   Cirioni O, 2006, PEPTIDES, V27, P1210, DOI 10.1016/j.peptides.2005.10.007
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Costerton W, 2003, J CLIN INVEST, V112, P1466, DOI 10.1172/JCI200320365
   Cramton SE, 1999, INFECT IMMUN, V67, P5427
   Cramton SE, 2001, INFECT IMMUN, V69, P4079, DOI 10.1128/IAI.69.6.4079-4085.2001
   de Breij A, 2009, RES MICROBIOL, V160, P213, DOI 10.1016/j.resmic.2009.01.002
   de la Fuente-Nunez C, 2015, CHEM BIOL, V22, P196, DOI 10.1016/j.chembiol.2015.01.002
   de la Fuente-Nunez C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004152
   de la Fuente-Nunez C, 2012, ANTIMICROB AGENTS CH, V56, P2696, DOI 10.1128/AAC.00064-12
   Del Gaudio G, 2013, ANTIMICROB AGENTS CH, V57, P4314, DOI 10.1128/AAC.00904-13
   Di Luca M, 2015, BIOFOULING, V31, P193, DOI 10.1080/08927014.2015.1021340
   Di Luca M, 2014, PATHOG DIS, V70, P257, DOI 10.1111/2049-632X.12151
   Donelli G, 2007, ANTIMICROB AGENTS CH, V51, P2733, DOI 10.1128/AAC.01249-06
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Doroshenko N, 2014, ANTIMICROB AGENTS CH, V58, P7273, DOI 10.1128/AAC.03132-14
   Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002
   DUNNE WM, 1990, ANTIMICROB AGENTS CH, V34, P390, DOI 10.1128/AAC.34.3.390
   Duperthuy M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003620
   Ehlers S, 1999, FEMS IMMUNOL MED MIC, V23, P149, DOI 10.1111/j.1574-695X.1999.tb01234.x
   Esin S, 2015, J INNATE IMMUN, V7, P11, DOI 10.1159/000363321
   Feng XR, 2013, PEPTIDES, V49, P131, DOI 10.1016/j.peptides.2013.09.007
   Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56
   Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001
   Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415
   Foschiatti M, 2009, MOL MICROBIOL, V72, P1137, DOI 10.1111/j.1365-2958.2009.06707.x
   Francolini I, 2010, FEMS IMMUNOL MED MIC, V59, P227, DOI 10.1111/j.1574-695X.2010.00665.x
   Franklin MJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00167
   FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003
   Gao GZ, 2011, BIOMATERIALS, V32, P3899, DOI 10.1016/j.biomaterials.2011.02.013
   Gil C, 2014, INFECT IMMUN, V82, P1017, DOI 10.1128/IAI.01419-13
   Gloag ES, 2013, P NATL ACAD SCI USA, V110, P11541, DOI 10.1073/pnas.1218898110
   Gomes F, 2014, BIOFOULING, V30, P131, DOI 10.1080/08927014.2013.848858
   Haisma EM, 2014, ANTIMICROB AGENTS CH, V58, P4411, DOI 10.1128/AAC.02554-14
   Hall-Stoodley L, 2012, FEMS IMMUNOL MED MIC, V65, P127, DOI 10.1111/j.1574-695X.2012.00968.x
   Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x
   Haney EF, 2015, PEPTIDES, V71, P276, DOI 10.1016/j.peptides.2015.03.015
   Hanke ML, 2013, J IMMUNOL, V190, P2159, DOI 10.4049/jimmunol.1202348
   Hanke ML, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00062
   Hansen CR, 2008, J CYST FIBROS, V7, P523, DOI 10.1016/j.jcf.2008.06.009
   Herasimenka Y, 2005, PEPTIDES, V26, P1127, DOI 10.1016/j.peptides.2005.01.020
   Hocquellet A, 2012, PEPTIDES, V36, P303, DOI 10.1016/j.peptides.2012.06.001
   Hoiby N, 2015, CLIN MICROBIOL INFEC, V21, pS1, DOI 10.1016/j.cmi.2014.10.024
   Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011
   Jesaitis AJ, 2003, J IMMUNOL, V171, P4329, DOI 10.4049/jimmunol.171.8.4329
   Johnson L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-115
   Jones EA, 2013, J INNATE IMMUN, V5, P24, DOI 10.1159/000339961
   Jorge P, 2012, BIOFOULING, V28, P1033, DOI 10.1080/08927014.2012.728210
   Kaplan JB, 2012, MBIO, V3, DOI 10.1128/mBio.00198-12
   Kaplan JB, 2012, J ANTIBIOT, V65, P73, DOI 10.1038/ja.2011.113
   Kazemzadeh-Narbat M, 2013, BIOMATERIALS, V34, P5969, DOI 10.1016/j.biomaterials.2013.04.036
   Kogan G, 2006, FEMS MICROBIOL LETT, V255, P11, DOI 10.1111/j.1574-6968.2005.00043.x
   Kuo HH, 2007, CHEM BIOL DRUG DES, V69, P405, DOI 10.1111/j.1747-0285.2007.00518.x
   Kwakman PHS, 2006, ANTIMICROB AGENTS CH, V50, P3977, DOI 10.1128/AAC.00575-06
   Lebeaux D, 2014, J INFECT DIS, V210, P1357, DOI 10.1093/infdis/jiu286
   Lebeaux D, 2014, MICROBIOL MOL BIOL R, V78, P510, DOI 10.1128/MMBR.00013-14
   Leid JG, 2002, INFECT IMMUN, V70, P6339, DOI 10.1128/IAI.70.11.6339-6345.2002
   Lewenza S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00021
   Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557
   Lombardi L, 2015, MOLECULES, V20, P6319, DOI 10.3390/molecules20046319
   Lourenco A, 2014, PATHOG DIS, V70, P250, DOI 10.1111/2049-632X.12146
   Maccari G, 2015, METHODS MOL BIOL, V1268, P195, DOI 10.1007/978-1-4939-2285-7_9
   Maccari G, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003212
   Maisetta G, 2006, ANTIMICROB AGENTS CH, V50, P806, DOI 10.1128/AAC.50.2.806.809.2006
   Maisetta G, 2008, PEPTIDES, V29, P1, DOI 10.1016/j.peptides.2007.10.013
   Maisetta G, 2013, FEBS J, V280, P2842, DOI 10.1111/febs.12288
   Maisetta G, 2011, PEPTIDES, V32, P1073, DOI 10.1016/j.peptides.2011.02.003
   Maisetta G, 2010, PEPTIDES, V31, P1995, DOI 10.1016/j.peptides.2010.08.007
   Maisetta G, 2009, PEPTIDES, V30, P1622, DOI 10.1016/j.peptides.2009.06.004
   Mangoni ML, 2008, ANTIMICROB AGENTS CH, V52, P85, DOI 10.1128/AAC.00796-07
   Mangoni ML, 2009, BBA-BIOMEMBRANES, V1788, P1610, DOI 10.1016/j.bbamem.2009.04.021
   Mansour SC, 2015, J PEPT SCI, V21, P323, DOI 10.1002/psc.2708
   Mansour SC, 2014, TRENDS IMMUNOL, V35, P443, DOI 10.1016/j.it.2014.07.004
   Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006
   Menousek J, 2012, INT J ANTIMICROB AG, V39, P402, DOI 10.1016/j.ijantimicag.2012.02.003
   Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165
   Montanaro L, 2011, INT J ARTIF ORGANS, V34, P824, DOI 10.5301/ijao.5000051
   Mu HB, 2014, INT J MOL SCI, V15, P22296, DOI 10.3390/ijms151222296
   Mulcahy H, 2010, ENVIRON MICROBIOL, V12, P1621, DOI 10.1111/j.1462-2920.2010.02208.x
   Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213
   Nagant C, 2012, ANTIMICROB AGENTS CH, V56, P5698, DOI 10.1128/AAC.00918-12
   Naves P, 2010, J HOSP INFECT, V76, P165, DOI 10.1016/j.jhin.2010.05.011
   Okshevsky M, 2015, CURR OPIN BIOTECH, V33, P73, DOI 10.1016/j.copbio.2014.12.002
   Otto M, 2008, CURR TOP MICROBIOL, V322, P207
   Otto M, 2006, CURR TOP MICROBIOL, V306, P251
   Overhage J, 2008, INFECT IMMUN, V76, P4176, DOI 10.1128/IAI.00318-08
   Pamp S. J., 2007, BIOFILM MODE LIFE MA, P37
   Pamp SJ, 2008, MOL MICROBIOL, V68, P223, DOI 10.1111/j.1365-2958.2008.06152.x
   Parkins MD, 2015, J CYST FIBROS, V14, P293, DOI 10.1016/j.jcf.2015.03.012
   Pavithra D, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034003
   Peschel A, 2013, NAT REV MICROBIOL, V11, P667, DOI 10.1038/nrmicro3110
   Pimentel ND, 2014, INT J FOOD MICROBIOL, V190, P1, DOI 10.1016/j.ijfoodmicro.2014.08.004
   Piras AM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00372
   Pompilio A, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-145
   Prabhakara R, 2011, INFECT IMMUN, V79, P5010, DOI 10.1128/IAI.05571-11
   Rabin N, 2015, FUTURE MED CHEM, V7, P493, DOI [10.4155/FMC.15.6, 10.4155/fmc.15.6]
   Reffuveille F, 2014, ANTIMICROB AGENTS CH, V58, P5363, DOI 10.1128/AAC.03163-14
   Ribeiro SM, 2015, ANTIMICROB AGENTS CH, V59, P3906, DOI 10.1128/AAC.00092-15
   Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046
   Romling U, 2014, J INTERN MED, V276, P98, DOI 10.1111/joim.12242
   Morones-Ramirez JR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006276
   Sakuragi Y, 2007, J BACTERIOL, V189, P5383, DOI 10.1128/JB.00137-07
   Scherr TD, 2015, MBIO, V6, DOI 10.1128/mBio.01021-15
   SCHLESSINGER D, 1988, Clinical Microbiology Reviews, V1, P54
   Segev-Zarko L, 2015, BIOCHEM J, V468, P259, DOI 10.1042/BJ20141251
   Song ZJ, 2005, ANTIMICROB AGENTS CH, V49, P3868, DOI 10.1128/AAC.49.9.3868-3874.2005
   Speziale P, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00171
   Stark M, 2002, ANTIMICROB AGENTS CH, V46, P3585, DOI 10.1128/AAC.46.11.3585.3590.2002
   Steinstraesser L, 2002, ANTIMICROB AGENTS CH, V46, P1837, DOI 10.1128/AAC.46.6.1837-1844.2002
   Tavanti A, 2011, PEPTIDES, V32, P2484, DOI 10.1016/j.peptides.2011.10.012
   Tong SYC, 2015, CLIN MICROBIOL REV, V28, P603, DOI 10.1128/CMR.00134-14
   Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200
   Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1111/j.1462-5822.2004.00367.x
   Vuotto C, 2014, PATHOGENS, V3, P743, DOI 10.3390/pathogens3030743
   Wang R, 2011, J CLIN INVEST, V121, P238, DOI 10.1172/JCI42520
   Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004
   Weiner DJ, 2003, AM J RESP CELL MOL, V28, P738, DOI 10.1165/rcmb.2002-0191OC
   Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487
   Wickstrom C, 2008, ORAL MICROBIOL IMMUN, V23, P177, DOI 10.1111/j.1399-302X.2007.00407.x
   Wiens JR, 2014, MBIO, V5, DOI 10.1128/mBio.01010-13
   Wood LF, 2006, MOL MICROBIOL, V62, P412, DOI 10.1111/j.1365-2958.2006.05390.x
   Xu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098935
   Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2
   Yin LM, 2013, PROTEIN PEPTIDE LETT, V20, P843, DOI 10.2174/0929866511320080001
   Zaat SAJ, 2010, FUTURE MICROBIOL, V5, P1149, DOI [10.2217/fmb.10.89, 10.2217/FMB.10.89]
   Zhang A, 2013, SCI REP-UK, V3, DOI 10.1038/srep03364
   Zhu C, 2013, J SURG RES, V183, P204, DOI 10.1016/j.jss.2012.11.048
NR 157
TC 38
Z9 43
U1 8
U2 75
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2736
EI 0006-3002
J9 BBA-BIOMEMBRANES
JI Biochim. Biophys. Acta-Biomembr.
PD MAY
PY 2016
VL 1858
IS 5
SI SI
BP 1044
EP 1060
DI 10.1016/j.bbamem.2015.10.013
PG 17
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA DK0LF
UT WOS:000374603600015
PM 26525663
OA Bronze
DA 2018-10-19
ER

PT J
AU Reich, KM
   Huber, CD
   Heimel, P
   Ulm, C
   Redl, H
   Tangl, S
AF Reich, Karoline Maria
   Huber, Christian Domitian
   Heimel, Patrick
   Ulm, Christian
   Redl, Heinz
   Tangl, Stefan
TI A quantification of regenerated bone tissue in human sinus biopsies:
   influences of anatomical region, age and sex
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE age- and sex-dependency; bone quality; bone regeneration potential; bone
   substitute material; maxillary region; sinus augmentation
ID AUGMENTATION PROCEDURES; DENTAL IMPLANTS; OSTEOPOROSIS; GRAFTS; FLOOR;
   RIDGE; BIOMATERIALS; REDUCTION; FRACTURES; OUTCOMES
AB ObjectivesSinus augmentation is a standard procedure to increase vertical bone supply for dental implants in the atrophic posterior maxilla. Despite the longstanding application of this method, information about some basic factors that could potentially influence bone regeneration after sinus augmentation is rare. The objective of this study was therefore to quantify the impact of the maxillary region (premolar/molar) and patients' age and sex on bone regeneration after sinus grafting.
   Material and methodsSinus augmentation procedures were performed in 107 patients (66 female: 52.811.0years, 41 male: 50.611.3years). After 6 +/- 1months, 201 sinus biopsies were harvested and histomorphometrically analysed. Height (oldHt) and bone volume fraction of pristine bone (oldBV/TV), as well as the amount of new bone (newBV/TV) and bone-to-bone substitute contact (BBSC) in the augmentation area, were assessed.
   ResultsIn women, newBV/TV in the augmented sinus decreased significantly by 0.22 +/- 0.08% per year. In men, no similar trend was observed. There were strong influences of the maxillary region and the dimensions of the host bone. In the premolar region, newBV/TV was 23.1 +/- 7.9% and 25.1 +/- 10.1%; in the molar region, newBV/TV averaged 20.4 +/- 9.4% and 17.8 +/- 8.8% for women and men, respectively. The greater the thickness of the wall of the sinus floor (mainly in the former premolar region), the greater was the amount of new bone tissue formed in the spaces in-between bone substitute particles.
   ConclusionsThese empirical results derived from a large human sample, link factors that influence the quality of biomaterial integration to the known clinical risks for the success of dental implants.
C1 [Reich, Karoline Maria; Huber, Christian Domitian; Heimel, Patrick; Tangl, Stefan] Med Univ Vienna, Karl Donath Lab Hard Tissue & Biomat Res, Dept Oral Surg, Sensengasse 2a, A-1090 Vienna, Austria.
   [Reich, Karoline Maria; Huber, Christian Domitian; Redl, Heinz; Tangl, Stefan] Austrian Cluster Tissue Regenerat, Vienna, Austria.
   [Heimel, Patrick; Redl, Heinz] Trauma Res Ctr AUVA, Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria.
   [Ulm, Christian] Med Univ Vienna, Dept Oral Surg, A-1090 Vienna, Austria.
RP Tangl, S (reprint author), Med Univ Vienna, Karl Donath Lab Hard Tissue & Biomat Res, Dept Oral Surg, Sensengasse 2a, A-1090 Vienna, Austria.
EM stefan.tangl@meduniwien.ac.at
OI Tangl, Stefan/0000-0002-9023-4745
FU Baxter AG; Department of Oral Surgery, Medical University of Vienna
FX Histological specimens were collected from studies partially funded by
   Baxter AG.; The study was supported by the authors' institution
   (Department of Oral Surgery, Medical University of Vienna). No other
   external funding, apart from the support of the authors' institution,
   was available for this study.
CR Alsaadi G, 2007, J CLIN PERIODONTOL, V34, P610, DOI 10.1111/j.1600-051X.2007.01077.x
   ATWOOD DA, 1971, J PROSTHET DENT, V26, P266, DOI 10.1016/0022-3913(71)90069-2
   Avila-Ortiz G, 2012, CLIN ORAL IMPLAN RES, V23, P1082, DOI 10.1111/j.1600-0501.2011.02270.x
   Becktor JP, 2008, J ORAL MAXIL SURG, V66, P780, DOI 10.1016/j.joms.2007.11.008
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Browaeys H, 2007, CLIN IMPLANT DENT R, V9, P166, DOI 10.1111/j.1708-8208.2007.00050
   CAWOOD JI, 1988, INT J ORAL MAX SURG, V17, P232, DOI 10.1016/S0901-5027(88)80047-X
   Coulthard P, 2002, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003604
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Degidi M, 2007, IMPLANT DENT, V16, P317, DOI 10.1097/ID.0b013e3180de4c5f
   Donath K., 1988, PRAPARATOR, V34, P197
   Doundoulakis JH, 2003, J AM DENT ASSOC, V134, P1455, DOI 10.14219/jada.archive.2003.0073
   Erdogan O, 2007, ORAL SURG ORAL MED O, V104, P738, DOI 10.1016/j.tripleo.2007.04.008
   Esposito M, 2010, COCHRANE DB SYST REV, V3
   Esposito M, 2006, INT J ORAL MAX IMPL, V21, P696
   Farhat F. F., 2008, COMPENDIUM CONTINUIN, V29, P398
   FARHAT FF, 2008, COMPEND CONTIN ED DE, V29, P394
   Farhat Fred F, 2008, Compend Contin Educ Dent, V29, P388
   Fini M, 2004, BIOMED PHARMACOTHER, V58, P487, DOI 10.1016/j.biopha.2004.08.016
   Fini M, 1997, INT J ARTIF ORGANS, V20, P291
   Fuerst G, 2009, CLIN ORAL IMPLAN RES, V20, P135, DOI 10.1111/j.1600-0501.2008.01624.x
   Giannoudis P, 2007, INJURY, V38, pS90, DOI 10.1016/j.injury.2007.02.014
   GOLDMAN MJ, 1986, J PERIODONTOL, V57, P347, DOI 10.1902/jop.1986.57.6.347
   Grecchi F, 2009, J CRANIOFAC SURG, V20, P2205, DOI 10.1097/SCS.0b013e3181bf8487
   Gruber R, 2006, EXP GERONTOL, V41, P1080, DOI 10.1016/j.exger.2006.09.008
   Hildebrand H, 1994, Fortschr Kiefer Gesichtschir, V39, P34
   HIRAI T, 1993, J PROSTHET DENT, V69, P49, DOI 10.1016/0022-3913(93)90240-O
   HIRSCHFELD L, 1978, J PERIODONTOL, V49, P225, DOI 10.1902/jop.1978.49.5.225
   Johansson B, 2001, DENTOMAXILLOFAC RAD, V30, P157, DOI 10.1038/sj.dmfr.4600601
   Jokstad A., 2009, COCHRANE DATABASE SY
   Katz MH, 2011, MULTIVARIABLE ANAL P
   Kaufman Eliaz, 2003, J Esthet Restor Dent, V15, P272, DOI 10.1111/j.1708-8240.2003.tb00298.x
   McAllister BS, 2007, J PERIODONTOL, V78, P377, DOI 10.1902/jop.2007.060048
   McNamee R, 2005, OCCUP ENVIRON MED, V62, P500, DOI 10.1136/oem.2002.001115
   Nikolaou VS, 2009, INJURY, V40, P663, DOI 10.1016/j.injury.2008.10.035
   Parker MJ, 2007, CLIN ORTHOP RELAT R, P175, DOI 10.1097/BLO.0b013e3180325a42
   Pinherio J. C., 2000, MIXED EFFECTS MODELS
   Rosner B., 2010, FUNDAMENTALS BIOSTAT
   Scarano A, 2007, IMPLANT DENT, V16, P195, DOI 10.1097/ID.0b013e3180587ad8
   Schliephake H, 1997, J ORAL MAXIL SURG, V55, P1227, DOI 10.1016/S0278-2391(97)90173-7
   Sharan A, 2008, INT J ORAL MAX IMPL, V23, P48
   SILVER JJ, 1995, CLIN ORTHOP RELAT R, P10
   Solar P, 1998, Schweiz Monatsschr Zahnmed, V108, P871
   Strube P, 2008, BONE, V42, P758, DOI 10.1016/j.bone.2007.12.223
   Tsolaki IN, 2009, J PROSTHODONT, V18, P309, DOI 10.1111/j.1532-849X.2008.00433.x
   van den Bergh JPA, 2000, CLIN ORAL IMPLAN RES, V11, P256, DOI 10.1034/j.1600-0501.2000.011003256.x
   VONWOWERN N, 1992, J PROSTHET DENT, V67, P656, DOI 10.1016/0022-3913(92)90165-7
   Voss R, 1972, Dtsch Zahnarztl Z, V27, P377
   Yildirim M, 2001, INT J ORAL MAX IMPL, V16, P23
NR 49
TC 4
Z9 4
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD MAY
PY 2016
VL 27
IS 5
BP 583
EP 590
DI 10.1111/clr.12627
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA DK1UF
UT WOS:000374699200010
PM 26037688
DA 2018-10-19
ER

PT J
AU Lee, IK
   Lim, HC
   Lee, JS
   Hong, JY
   Choi, SH
   Jung, UW
AF Lee, In-Kyeong
   Lim, Hyun-Chang
   Lee, Jung-Seok
   Hong, Ji-Youn
   Choi, Seong-Ho
   Jung, Ui-Won
TI Layered approach with autogenous bone and bone substitute for ridge
   augmentation on implant dehiscence defects in dogs
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE animal study; autogenous bone graft; bone substitutes; dental implants;
   guided bone regeneration
ID PARTIALLY EDENTULOUS PATIENTS; BARRIER MEMBRANES; CLINICAL-TRIAL; BOVINE
   BONE; MAXILLA; REGENERATION; EXTRACTION; PLACEMENT; GRAFTS; SITES
AB ObjectivesThis study compared the efficacies of different layered approaches using autogenous bone and synthetic bone substitute for ridge augmentation on implant dehiscence defects in dogs.
   Materials and methodsRight mandibular second, third, and fourth premolars and the first molar were extracted, followed by standardized one-wall defect preparation in five dogs. After a healing period of 12weeks, three implants (Implantium((R))) were installed. Each of the three implant dehiscence defects was grafted with a different material as follows: (i) synthetic bone substitute combined with collagen (SBC; SBC group), (ii) inner autogenous bone layer and outer SBC layer (IAB group), and (iii) inner SBC layer and outer autogenous bone layer (OAB group). The grafted sites were covered with a resorbable collagen membrane. Quantitative and qualitative analyses of the subsequent bone regeneration were performed at 12weeks postoperatively.
   ResultsThe dome-like augmented shape was relatively well maintained in the IAB and OAB groups, while the graft particles in the SBC group were dispersed. The bone-to-implant contact values tended to be significantly higher in the OAB group (49.51%) than in the SBC (36.58%) group. The amounts of newly formed bone within an area designated as 1x3mm (widthxheight) from the implant platform in the IAB, OAB, and SBC groups were 35.59%, 28.10%, and 16.71%, respectively.
   ConclusionApplication of the layered approach using autogenous bone and synthetic biomaterial resulted in substantial new bone formation and volume maintenance on implant dehiscence defects, irrespective of the position of the autogenous bone layer.
C1 [Lee, In-Kyeong; Lee, Jung-Seok; Choi, Seong-Ho; Jung, Ui-Won] Yonsei Univ, Dept Periodontol, Res Inst Periodontal Regenerat, Coll Dent, 50-1 Yonsei Ro, Seoul 120752, South Korea.
   [Lim, Hyun-Chang; Hong, Ji-Youn] Kyung Hee Univ, Dept Periodontol, Sch Dent, Seoul, South Korea.
RP Jung, UW (reprint author), Yonsei Univ, Dept Periodontol, Res Inst Periodontal Regenerat, Coll Dent, 50-1 Yonsei Ro, Seoul 120752, South Korea.
EM drjew@yuhs.ac
OI Hong, Ji-Youn/0000-0003-1040-7077
FU Korea Health technology R&D Project, Ministry of Health & Welfare,
   Republic of Korea [A120822]
FX This study was supported by a grant from the Korea Health technology R&D
   Project, Ministry of Health & Welfare, Republic of Korea (A120822).
CR Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P645, DOI 10.1111/j.1600-051X.2005.00726.x
   Bashutski JD, 2007, IMPLANT DENT, V16, P340, DOI 10.1097/ID.0b013e318159ca05
   Brunner E, 2000, BIOMETRICAL J, V42, P663, DOI 10.1002/1521-4036(200010)42:6<663::AID-BIMJ663>3.0.CO;2-7
   Buser D, 2004, INT J ORAL MAX IMPL, V19, P43
   Buser D, 1995, Int J Periodontics Restorative Dent, V15, P10
   Buser D, 1998, CLIN ORAL IMPLAN RES, V9, P137, DOI 10.1034/j.1600-0501.1998.090301.x
   Buser D, 1996, J ORAL MAXIL SURG, V54, P420, DOI 10.1016/S0278-2391(96)90113-5
   Chae SW, 2015, J PERIODONTAL IMPLAN, V45, P23, DOI 10.5051/jpis.2015.45.1.23
   Choi JY, 2011, CLIN ORAL IMPLAN RES, V22, P343, DOI 10.1111/j.1600-0501.2010.01978.x
   Dasmah A, 2012, J CRANIO MAXILL SURG, V40, P654, DOI 10.1016/j.jcms.2011.10.032
   Davies John E, 2003, J Dent Educ, V67, P932
   DesSantis E., 2013, CLIN ORAL IMPLAN RES, V24, P77
   Donos N, 2008, J CLIN PERIODONTOL, V35, P173, DOI 10.1111/j.1600-051X.2008.01269.x
   Fu J. H., 2014, CLIN ORAL IMPLAN RES, V26, P1150
   Fu JH, 2014, CLIN ORAL IMPLAN RES, V25, P458, DOI 10.1111/clr.12171
   Fu JH, 2012, EUR J ORAL IMPLANTOL, V5, pS91
   Fugazzotto PA, 1997, INT J PERIODONT REST, V17, P293
   Hammerle CHF, 2002, J CLIN PERIODONTOL, V29, P226, DOI 10.1034/j.1600-051X.29.s3.14.x
   Jang HY, 2010, J ORAL MAXIL SURG, V68, P1859, DOI 10.1016/j.joms.2009.09.093
   Jensen SS, 2006, CLIN ORAL IMPLAN RES, V17, P237, DOI 10.1111/j.1600-0501.2005.01257.x
   Jung UW, 2007, CLIN ORAL IMPLAN RES, V18, P171, DOI 10.1111/j.1600-0501.2006.01310.x
   Mordenfeld A, 2014, CLIN ORAL IMPLAN RES, V25, P310, DOI 10.1111/clr.12143
   Oginuma T, 2012, OR SURG OR MED OR PA, V114, pS107, DOI 10.1016/j.oooo.2011.08.004
   VansAssche N., 2013, CLIN IMPLANT DENT R, V15, P558
   von See C, 2010, BRIT J ORAL MAX SURG, V48, P607, DOI 10.1016/j.bjoms.2009.09.012
   vonsArx T., 2006, CLIN ORAL IMPLAN RES, V17, P359
   Wang Hom-Lay, 2004, Int J Periodontics Restorative Dent, V24, P232
   Zerbo IR, 2003, CLIN ORAL IMPLAN RES, V14, P759, DOI 10.1046/j.0905-7161.2003.00967.x
NR 29
TC 5
Z9 5
U1 1
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD MAY
PY 2016
VL 27
IS 5
BP 622
EP 628
DI 10.1111/clr.12649
PG 7
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA DK1UF
UT WOS:000374699200016
PM 26109377
DA 2018-10-19
ER

PT J
AU Vaikkath, D
   Anitha, R
   Sumathy, B
   Nair, PD
AF Vaikkath, Dhanesh
   Anitha, Rakhi
   Sumathy, Babitha
   Nair, Prabha D.
TI A simple and effective method for making multipotent/multilineage
   scaffolds with hydrophilic nature without any postmodification/treatment
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Electrospinning; Blending; Scaffold modification; Tissue engineering;
   Hydrophilicity
ID CELL-ADHESION; SURFACE MODIFICATION; ENDOTHELIAL-CELLS;
   BLOCK-COPOLYMERS; NANOFIBER MESHES; STEM-CELLS; ELECTROSPUN; FIBERS;
   MEMBRANES; SILK
AB A number of biodegradable and bioresorbable materials, as well as scaffold designs, have been experimentally and/or clinically studied for tissue engineering of diverse tissue types. Cell material responses are strongly dependent on the properties of the scaffold material. In this study, scaffolds based on polycaprolactone (PCL) and PCL blended with a triblock copolymer, Polycaprolactone-polytetrahydrofuran-polycaprolactone (PCL-PTHF-PCL) at different ratios were fabricated by electrospinning. Blending and electrospinning of the triblock copolymer with PCL generated a super hydrophilic scaffold, the mechanical and biological properties of which varied with the concentration of the triblock copolymer. The hydrophilicity of the electrospun scaffolds was determined by measurement of water-air contact angle. Cellular response to the electrospun scaffolds was studied by seeding two types of cells, L929 fibroblast cell line and rat mesenchymal stem cells (RMSC). We observed that the super hydrophilicity of the material did not prevent cell adhesion, while the cell proliferation was low or negligible for scaffolds containing higher amount of PCL-PTHF-PCL. Chondrogenic differentiation of RMSC was found to be better on the PCL blend containing 10% (w/v) of PCL-PTHF-PCL than the bare PCL. Our studies indicate that the cellular response is dependent on the biomaterial composition and highlight the importance of tailoring the scaffold properties for applications in tissue engineering and regenerative medicine. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Vaikkath, Dhanesh; Anitha, Rakhi; Sumathy, Babitha; Nair, Prabha D.] Sree Chitra Tirunal Inst Med Sci & Technol, Div Tissue Engn & Regenerat Technol, Trivandrum, Kerala, India.
RP Nair, PD (reprint author), Sree Chitra Tirunal Inst Med Sci & Technol, Div Tissue Engn & Regenerat Technol, Trivandrum, Kerala, India.
EM dhaneshvaikkath@gmail.com; a.rakhi86@gmail.com; babisp2005@gmail.com;
   prabha@sctimst.ac.in
FU Department of Biotechnology, India (Indo-Danish grant); CSIR India
FX The authors acknowledge funding from Department of Biotechnology, India
   (Indo-Danish grant), RA acknowledges fellowship from CSIR India. The
   authors are grateful to the Director, Sree Chitra Tirunal Institute for
   Medical Sciences and Technology (SCTIMST), India for support and
   facilities.
CR Aloysious N, 2013, TISSUE ENG PART A, V20, P1508
   da Silva MLA, 2010, BIOMACROMOLECULES, V11, P3228, DOI 10.1021/bm100476r
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Bacakova L, 1996, BIOMATERIALS, V17, P1121
   Baek HS, 2008, SURF COAT TECH, V202, P5794, DOI 10.1016/j.surfcoat.2008.06.154
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Chen F, 2007, MAT SCI ENG C-BIO S, V27, P325, DOI 10.1016/j.msec.2006.05.004
   Cipitria A, 2011, J MATER CHEM, V21, P9419, DOI 10.1039/c0jm04502k
   Ding B, 2002, J POLYM SCI POL PHYS, V40, P1261, DOI 10.1002/polb.10191
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   Guarino V, 2011, J BIOACT COMPAT POL, V26, P144, DOI 10.1177/0883911511399410
   Hamid Q, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/3/034109
   Hardy JG, 2014, MACROMOL BIOSCI, V14, P936, DOI 10.1002/mabi.201400020
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   Huang ZM, 2004, POLYMER, V45, P5361, DOI 10.1016/j.polymer.2004.04.005
   Jacobsen S, 1999, POLYM ENG SCI, V39, P1303, DOI 10.1002/pen.11517
   Jia YT, 2006, J APPL POLYM SCI, V99, P1462, DOI 10.1002/app.22633
   Kim HS, 2005, MACROMOL SYMP, V224, P145, DOI 10.1002/masy.200550613
   Kim K, 2003, BIOMATERIALS, V24, P4977, DOI 10.1016/S0142-9612(03)00407-1
   Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Liu S, 2012, BIOMACROMOLECULES, V13, P3611, DOI 10.1021/bm301022p
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Ma ML, 2005, LANGMUIR, V21, P5549, DOI 10.1021/la047064y
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Martins A, 2009, SMALL, V5, P1195, DOI 10.1002/smll.200801648
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Mohan N, 2015, J BIOMED MATER RES A, V103, P3896, DOI 10.1002/jbm.a.35506
   Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269
   Singh N, 2013, BIOMACROMOLECULES, V14, P1287, DOI 10.1021/bm301762p
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   Son WK, 2004, POLYMER, V45, P2959, DOI 10.1016/j.polymer.2004.02.006
   SVORCIK V, 1995, J MATER CHEM, V5, P27, DOI 10.1039/jm9950500027
   Teng PT, 2013, POLYM ENG SCI, V53, P762, DOI 10.1002/pen.23317
   Tsai HA, 2012, BIOMACROMOLECULES, V13, P3483, DOI 10.1021/bm301074j
   Viswanathan P, 2015, BIOMACROMOLECULES, V16, P66, DOI 10.1021/bm500671j
   Wang SD, 2009, BIOMACROMOLECULES, V10, P2240, DOI 10.1021/bm900416b
   Winer JP, 2009, TISSUE ENG PT A, V15, P147, DOI 10.1089/ten.tea.2007.0388
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zhang D, 2013, BIOMATERIALS, V34, P3962, DOI 10.1016/j.biomaterials.2013.02.029
   Zhu YB, 2002, BIOMACROMOLECULES, V3, P1312, DOI 10.1021/bm020074y
   Zong XH, 2003, POLYMER, V44, P4959, DOI 10.1016/S0032-3861(03)00464-6
NR 42
TC 5
Z9 5
U1 5
U2 41
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAY 1
PY 2016
VL 141
BP 112
EP 119
DI 10.1016/j.colsurfb.2015.12.041
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA DJ4SH
UT WOS:000374197700014
PM 26848946
DA 2018-10-19
ER

PT J
AU Kim, J
AF Kim, Jinku
TI Study of the conformational change of adsorbed proteins on biomaterial
   surfaces using hydrogen-deuterium exchange with mass spectroscopy
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Protein adsorption; Conformational change; Biomaterials;
   Hydrogen/deuterium exchange; Mass spectrometry
ID SOLID-SURFACES; BIOMEDICAL POLYMERS; ADSORPTION; SPECTROMETRY;
   ACTIVATION; FIBRINOGEN; NANOPARTICLES; DESORPTION; STABILITY; FTIR/ATR
AB There is no doubt that protein adsorption plays a crucial role in determining biocompatibility of biomaterials. Despite the information of the identity and composition of blood plasma/serum proteins adsorbed on surfaces of biomaterials to understand which proteins are involved in blood/biomaterial interactions, it still does not provide information about the conformations and orientations of adsorbed protein, which are very important in determining biological responses to biomaterials. Therefore, our laboratory has developed an experimental technology to probe protein conformations on materials that is applicable to mixtures of proteins. Herein, the new application of hydrogen/deuterium (H/D) exchange combined with mass spectrometry was applied to determine conformational changes of adsorbed proteins at biomaterial surfaces. The results suggest that there may be a significant conformational change in adsorbed proteins at 'low' bulk concentrations that leads to a large change in the kinetics of H/D exchange as compared to 'high' bulk concentrations. This technique may eventually be useful for the study of the kinetics of protein conformational changes. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Kim, Jinku] Hongik Univ, Dept Bio & Chem Engn, 2639 Sejong Ro, Jochiwon Eup 339701, Sejong, South Korea.
RP Kim, J (reprint author), Hongik Univ, Dept Bio & Chem Engn, 2639 Sejong Ro, Jochiwon Eup 339701, Sejong, South Korea.
EM jinkukim@hongik.ac.kr
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Education [2013R1A1A4A01011185]; Hongik
   University Research Fund
FX This research was supported by Basic Science Research Program through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Education (2013R1A1A4A01011185). This work was supported by 2014
   Hongik University Research Fund. The author acknowledges Dr. Donald L.
   Elbert of the Biomedical Engineering Department at Washington University
   in St. Louis for his helpful discussion.
CR Anand G, 2010, LANGMUIR, V26, P10803, DOI 10.1021/la1006132
   ANDERSON JM, 1995, J BIOMAT SCI-POLYM E, V7, P159, DOI 10.1163/156856295X00670
   ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   ANDRADE JD, 1985, J BIOMED MATER RES, V19, P981, DOI 10.1002/jbm.820190910
   BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110
   BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079
   Beavis RC, 1996, METHOD ENZYMOL, V270, P519
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   Brash JL, 1991, BLOOD COMPATIBLE MAT, P3
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   CHENG SS, 1994, J COLLOID INTERF SCI, V162, P135, DOI 10.1006/jcis.1994.1018
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Clague MJ, 1998, BIOCHEM J, V336, P271, DOI 10.1042/bj3360271
   Cole MA, 2009, BIOMATERIALS, V30, P1827, DOI 10.1016/j.biomaterials.2008.12.026
   COURTNEY JM, 1993, IMMOBILISED MACROMOL, P175
   DEJARDIN P, 1995, LANGMUIR, V11, P4001, DOI 10.1021/la00010a061
   Englander SW, 1996, CURR OPIN STRUC BIOL, V6, P18, DOI 10.1016/S0959-440X(96)80090-X
   Feng L., 1995, J BIOMAT SCI-POLYM E, V7, P14
   Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589
   Forbes C. D., 1995, HAEMOSTASIS THROMBOS, P1301
   Ghaemmaghami S, 2000, P NATL ACAD SCI USA, V97, P8296, DOI 10.1073/pnas.140111397
   Ghaemmaghami S, 2001, NAT STRUCT BIOL, V8, P879, DOI 10.1038/nsb1001-879
   Hlady V, 1996, CURR OPIN BIOTECH, V7, P72, DOI 10.1016/S0958-1669(96)80098-X
   Hook F, 2008, ACS NANO, V2, P2428, DOI 10.1021/nn800800v
   Horbett TA, 1995, ACS SYM SER, V602, P1
   Hu WB, 2013, P NATL ACAD SCI USA, V110, P7684, DOI 10.1073/pnas.1305887110
   LU CF, 1994, J COLLOID INTERF SCI, V168, P152, DOI 10.1006/jcis.1994.1404
   LUNDSTROM I, 1985, PROG COLL POL SCI S, V70, P76
   Nadarajah A., 1995, ACS SYM SER, V602, P14
   NORDE W, 1992, COLLOID SURFACE, V66, P73, DOI 10.1016/0166-6622(92)80122-I
   Powell KD, 2002, J AM CHEM SOC, V124, P10256, DOI 10.1021/ja026574g
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   RATNER BD, 1993, J BIOMED MATER RES, V27, P283, DOI 10.1002/jbm.820270302
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Salzman E W, 1969, J Biomed Mater Res, V3, P69
   SCOTT C F, 1991, Journal of Biomaterials Science Polymer Edition, V2, P173
   Shrivastava S, 2012, NANO LETT, V12, P1583, DOI 10.1021/nl2044524
   SLACK SM, 1989, J COLLOID INTERF SCI, V133, P148, DOI 10.1016/0021-9797(89)90288-9
   Slack SM, 1995, ACS SYM SER, V602, P112
   Wang AL, 2014, J PHYS CHEM B, V118, P14148, DOI 10.1021/jp506506p
   WOJCIECHOWSKI P, 1986, J COLLOID INTERF SCI, V111, P455, DOI 10.1016/0021-9797(86)90048-2
   WOJCIECHOWSKI PW, 1990, J COLLOID INTERF SCI, V140, P239, DOI 10.1016/0021-9797(90)90339-P
   Xiao YM, 2015, PROTEIN SCI, V24, P1247, DOI 10.1002/pro.2680
   Yan XG, 2004, MOL CELL PROTEOMICS, V3, P10, DOI 10.1074/mcp.R300010-MCP200
   Zhu MM, 2003, J AM CHEM SOC, V125, P5252, DOI 10.1021/ja029460d
NR 45
TC 3
Z9 3
U1 1
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAY 1
PY 2016
VL 141
BP 513
EP 518
DI 10.1016/j.colsurfb.2016.02.023
PG 6
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA DJ4SH
UT WOS:000374197700060
PM 26896658
DA 2018-10-19
ER

PT J
AU Santamala, H
   Livingston, R
   Sixta, H
   Hummel, M
   Skrifvars, M
   Saarela, O
AF Santamala, H.
   Livingston, R.
   Sixta, H.
   Hummel, M.
   Skrifvars, M.
   Saarela, O.
TI Advantages of regenerated cellulose fibres as compared to flax fibres in
   the processability and mechanical performance of thermoset composites
SO COMPOSITES PART A-APPLIED SCIENCE AND MANUFACTURING
LA English
DT Article
DE Biocomposite; Cellulose; Interface/interphase; Electron microscopy
ID TENSILE PROPERTIES; EPOXY COMPOSITES; DEFORMATION; BEHAVIOR; WATER
AB Man-made cellulosic fibres (MMCFs) have attracted widespread interest as the next generation of fibre reinforced composite. However, most studies focused entirely on their performance on single fibre level and little attention has been paid to their behaviour on a larger application scale. In this study, MMCFs were utilized as reinforcement in unidirectionally (UD) manufactured thermoset composites and compared to several commercial UD flax fibre products. Specimens were prepared using a vacuum bag based resin infusion technique and the respective laminates characterized in terms of void fraction and mechanical properties. MMCF laminates had comparable or better mechanical performance when compared to flax fibre laminates. Failure mechanisms of MMCF laminates were noted to differ from those of flax-reinforced laminates. The results demonstrate the potential of MMCFs as a viable alternative to glass fibre for reinforcement on a larger scale of UD laminates. These results were utilized in the Biofore biomaterial demonstration vehicle. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Santamala, H.; Livingston, R.; Saarela, O.] Aalto Univ, Sch Engn, Dept Appl Mech, POB 14300, FI-00076 Aalto, Finland.
   [Sixta, H.; Hummel, M.] Aalto Univ, Sch Chem, Dept Forest Prod Technol, POB 16300, FI-00076 Aalto, Finland.
   [Skrifvars, M.] Univ Boras, Sch Engn, Allegatan 1, S-50190 Boras, Sweden.
RP Santamala, H (reprint author), Aalto Univ, Sch Engn, Dept Appl Mech, POB 14300, FI-00076 Aalto, Finland.
EM harri.santamala@aalto.fi
RI Sixta, Herbert/A-8071-2013; Saarela, Olli/G-2406-2013; Hummel,
   Michael/O-1526-2014
FU Finnish Funding Agency for Technology and Innovation, TEKES
   [392/31/2011]
FX This project was supported by the Finnish Funding Agency for Technology
   and Innovation, TEKES [project number 392/31/2011]. In addition, the
   following companies were involved in this project: AGCO Sisu Power Oy,
   AGCO Suomi Oy, BRP Finland Oy, Componeering Oy, Helsinki Metropolia
   University of Applied Sciences, Kemin Digipolis Oy, Kemi-Tornionlaakso
   Municipal Education and Training Consortium Lappia, Outokumpu Stainless
   Oy, Oy All-Plast Ab, Randax Oy, Rovaniemen Kehitys Oy, Ruukki Metals Oy,
   Sandvik Mining and Construction Oy, Tampere University of Technology,
   and UPM Oy.
CR Abdel-Halim ES, 2008, POLYM-PLAST TECHNOL, V47, P58, DOI 10.1080/03602550701580912
   Adusumalli R-B, 2010, J COMPOS MATER, V46, P359
   Alix S, 2009, BIORESOURCE TECHNOL, V100, P4742, DOI 10.1016/j.biortech.2009.04.067
   Baley C, 2006, MATER LETT, V60, P2984, DOI 10.1016/j.matlet.2006.02.028
   Bledzki AK, 1999, PROG POLYM SCI, V24, P221, DOI 10.1016/S0079-6700(98)00018-5
   Bourmaud A, 2013, IND CROP PROD, V44, P343, DOI 10.1016/j.indcrop.2012.11.031
   Charlet K, 2010, IND CROP PROD, V32, P220, DOI 10.1016/j.indcrop.2010.04.015
   Coroller G, 2013, COMPOS PART A-APPL S, V51, P62, DOI 10.1016/j.compositesa.2013.03.018
   de Weyenberg IV, 2006, COMPOS PART A-APPL S, V37, P1368, DOI DOI 10.1016/J.COMPOSITESA.2005.08.016
   Dittenber DB, 2012, COMPOS PART A-APPL S, V43, P1419, DOI 10.1016/j.compositesa.2011.11.019
   Duigou A. L., 2014, COMPOS PART A-APPL S, V65, P161
   Eichhorn SJ, 2003, POLYMER, V44, P5901, DOI 10.1016/S0032-3861(03)00540-8
   El Messiry M., 2013, ALEXANDRIA ENG J, V52, P301
   Faruk O, 2014, MACROMOL MATER ENG, V299, P9, DOI 10.1002/mame.201300008
   Gindl W, 2006, COMPOS SCI TECHNOL, V66, P2049, DOI 10.1016/j.compscitech.2005.12.019
   Gindl-Altmutter W, 2012, COMPOS SCI TECHNOL, V72, P1304, DOI 10.1016/j.compscitech.2012.05.011
   Graupner N, 2014, COMPOS PART A-APPL S, V63, P133, DOI 10.1016/j.compositesa.2014.04.011
   Gu H, 2009, MATER DESIGN, V30, P3931, DOI 10.1016/j.matdes.2009.01.035
   Gurit, 2016, PRIM 20 LV TECHN DAT
   Jiang GS, 2012, CARBOHYD POLYM, V87, P2012, DOI 10.1016/j.carbpol.2011.10.022
   Lee KY, 2012, COMPOS SCI TECHNOL, V72, P1479, DOI 10.1016/j.compscitech.2012.06.014
   Lefeuvre A, 2014, IND CROP PROD, V52, P762, DOI 10.1016/j.indcrop.2013.11.043
   Lefeuvre A, 2013, IND CROP PROD, V50, P400, DOI 10.1016/j.indcrop.2013.07.035
   Li Y, 2015, COMPOS PART A-APPL S, V72, P40, DOI 10.1016/j.compositesa.2015.01.029
   Livingston R, 2013, P SAMPE STUD C PAR
   Mishra HK, 2000, POLYM-PLAST TECHNOL, V39, P187, DOI 10.1081/PPT-100100023
   Morrison WH, 2000, IND CROP PROD, V12, P39, DOI 10.1016/S0926-6690(99)00044-8
   Northolt MG, 1985, LENZINGER BER, V59, P71
   Oksman K, 2001, J REINF PLAST COMP, V20, P621, DOI 10.1106/CA5A-6FAX-VJRB-80P0
   PAN N, 1993, TEXT RES J, V63, P565
   Pizzi A, 2009, IND CROP PROD, V30, P235, DOI 10.1016/j.indcrop.2009.03.013
   Porcher, 2013, GREENL MAT BROCH
   Roder T, 2009, LENZINGER BER, V87, P98
   Santamala H, 2013, P EC C BIRM
   Santamala H, 2016, CHEM COMPOSITI UNPUB
   Sgriccia N, 2008, COMPOS PART A-APPL S, V39, P1632, DOI 10.1016/j.compositesa.2008.07.007
   Shah DU, 2012, COMPOS SCI TECHNOL, V72, P1909, DOI 10.1016/j.compscitech.2012.08.005
   Doan TTL, 2012, COMPOS SCI TECHNOL, V72, P1160, DOI 10.1016/j.compscitech.2012.03.025
   Tsai SW, 1988, COMPOSITE DESIGN, P11
   Weyenberg IVde, 2003, COMPOS SCI TECHNOL, V63, P1241
   Zaman HU, 2010, FIBER POLYM, V11, P258, DOI 10.1007/s12221-010-0258-7
   Zhang W, 2005, CARBOHYD POLYM, V59, P173, DOI 10.1016/j.carbpol.2004.09.007
NR 42
TC 5
Z9 5
U1 0
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-835X
EI 1878-5840
J9 COMPOS PART A-APPL S
JI Compos. Pt. A-Appl. Sci. Manuf.
PD MAY
PY 2016
VL 84
BP 377
EP 385
DI 10.1016/j.compositesa.2016.02.011
PG 9
WC Engineering, Manufacturing; Materials Science, Composites
SC Engineering; Materials Science
GA DJ4SN
UT WOS:000374198400039
DA 2018-10-19
ER

PT J
AU Bezerra, RDS
   Morais, AIS
   Osajima, JA
   Nunes, LCC
   Silva, EC
AF Bezerra, Roosevelt D. S.
   Morais, Alan I. S.
   Osajima, Josy A.
   Nunes, Livio C. C.
   Silva Filho, Edson C.
TI Development of new phosphated cellulose for application as an efficient
   biomaterial for the incorporation/release of amitriptyline
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Phosphated cellulose; Amitriptyline; Adsorption; Desorption
ID AQUEOUS-SOLUTION; PHOSPHORYLATED CELLULOSE; BIOMEDICAL APPLICATIONS;
   BACTERIAL CELLULOSE; ACTIVATED CARBON; EQUILIBRIUM DATA; DYE ADSORPTION;
   REMOVAL; SORPTION; KINETICS
AB In the last years has increased the study about the using of natural biopolymers and theirs derivatives in the removal (adsorption/incorporation) of contaminats of medium aqueous, and theirs utilization in the desorption (release) de drugs. However, there not in the literature studies about the utilization of the cellulose and cellulose phosphate in the adsorption (incorporation)/desorption (release) of the drug amitriptyline (AMI). Therefore, in this study was accomplished the synthesized of the phosphated cellulose (PC) through the reaction of pure cellulose (C) with sodium trimetaphosphate (P) under-reflux, for 4 h and at 393 K. The efficiency of the reaction was observed by XRD, TG/DTG, P-31 NMR and EDS. The adsorption study for the AMI in aqueous medium was carried out by varying the time, pH, concentration, temperature and ionic strength. The results showed that the PC showed a greater adsorption capacity of AMI than pure cellulose, presenting an increase of about 102.72% in the adsorption capacity of the drug by cellulose after the phosphating reaction. In desorption of drug from the surface of biomaterials was performed by varying the pH and time, where it was observed that PC showed a maximum release of 40.98%+/- 0.31% at pH 7. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Bezerra, Roosevelt D. S.] Fed Inst Educ Sci & Technol Piaui, Teresina Cent Campus, BR-64000040 Teresina, PI, Brazil.
   [Morais, Alan I. S.; Osajima, Josy A.; Nunes, Livio C. C.; Silva Filho, Edson C.] Univ Fed Piaui, Interdisciplinary Lab Adv Mat LIMAV, BR-64049550 Teresina, PI, Brazil.
RP Silva, EC (reprint author), Univ Fed Piaui, Interdisciplinary Lab Adv Mat LIMAV, BR-64049550 Teresina, PI, Brazil.
EM edsonfilho@ufpi.edu.br
OI Nunes, Livio/0000-0002-1178-7940; Morais, Alan/0000-0002-6974-6455;
   Silva Filho, Edson/0000-0003-0988-2970
FU Coordination Support in Higher Education (CAPES); National Council for
   Scientific and Technological Development (CNPq); Foundation of Support
   to Research of Piaui (FAPEPI)
FX The authors thank to Coordination Support in Higher Education (CAPES),
   National Council for Scientific and Technological Development (CNPq) and
   the Foundation of Support to Research of Piaui (FAPEPI) for financial
   support. The Federal University of Piaui (UFPI) and Federal Institute of
   Piaui (IFPI), to provide work research conditions.
CR Ahmad MA, 2011, CHEM ENG J, V171, P510, DOI 10.1016/j.cej.2011.04.018
   Ahmad MA, 2011, CHEM ENG J, V170, P154, DOI 10.1016/j.cej.2011.03.045
   Alencar JM, 2014, CHEM ENG J, V236, P332, DOI 10.1016/j.cej.2013.09.091
   Alshehri SM, 2014, CHEM ENG J, V254, P181, DOI 10.1016/j.cej.2014.05.100
   Barud HS, 2007, J THERM ANAL CALORIM, V87, P815, DOI 10.1007/s10973-006-8170-5
   Bezerra RDS, 2014, J ENVIRON CHEM ENG, V2, P605, DOI 10.1016/j.jece.2013.10.016
   Bezerra RDS, 2014, MATERIALS, V7, P7907, DOI 10.3390/ma7127907
   Bhattacharyya KG, 2004, J HAZARD MATER, V113, P97, DOI 10.1016/j.jhazmat.2004.05.034
   Chang PH, 2014, J HAZARD MATER, V277, P44, DOI 10.1016/j.jhazmat.2013.12.004
   Chang YK, 2006, PROCESS BIOCHEM, V41, P1864, DOI 10.1016/j.procbio.2006.03.039
   Cheng L, 2015, CHEM ENG J, V264, P672, DOI 10.1016/j.cej.2014.12.003
   Cury BSF, 2008, REACT FUNCT POLYM, V68, P1200, DOI 10.1016/j.reactfunctpolym.2008.04.003
   Daud WRW, 2011, BIORESOURCES, V6, P1719
   Fathi MR, 2015, SPECTROCHIM ACTA A, V135, P364, DOI 10.1016/j.saa.2014.07.008
   Freundlich H M F, 1906, J PHYS CHEM, V57, P385
   Granja PL, 2001, J APPL POLYM SCI, V82, P3341
   Ho YS, 1998, PROCESS SAF ENVIRON, V76, P183, DOI 10.1205/095758298529326
   Jayakumar R, 2009, POLYM ENG SCI, V49, P844, DOI 10.1002/pen.21306
   Kyzas GZ, 2015, CHEM ENG J, V259, P438, DOI 10.1016/j.cej.2014.08.019
   Lack S, 2007, CARBOHYD RES, V342, P943, DOI 10.1016/j.carres.2007.01.011
   Lagergren S, 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Lv GC, 2013, J COLLOID INTERF SCI, V411, P198, DOI 10.1016/j.jcis.2013.08.026
   Manoi K, 2010, CARBOHYD POLYM, V81, P687, DOI 10.1016/j.carbpol.2010.03.042
   Monier M, 2014, INT J BIOL MACROMOL, V66, P125, DOI 10.1016/j.ijbiomac.2014.01.068
   Mucalo MR, 2009, COLLOID SURFACE B, V71, P52, DOI 10.1016/j.colsurfb.2009.01.004
   Nabais JMV, 2012, ADSORPT SCI TECHNOL, V30, P255, DOI 10.1260/0263-6174.30.3.255
   Oshima T, 2011, CARBOHYD POLYM, V83, P953, DOI 10.1016/j.carbpol.2010.09.005
   Real FJ, 2012, IND ENG CHEM RES, V51, P16209, DOI 10.1021/ie302470g
   Rungrodnimitchai S., 2014, J SCI WORLD, V2014, P1
   Saleh TA, 2015, CHEM ENG J, V269, P9, DOI 10.1016/j.cej.2015.01.083
   Sang Y, 2007, CARBOHYD POLYM, V67, P201, DOI 10.1016/j.carbpol.2006.05.009
   Santana S. A. A., 2010, J THERM ANAL CALORIM, V100, P315
   Sari A, 2007, J HAZARD MATER, V149, P283, DOI 10.1016/j.jhazmat.2007.03.078
   Silva LS, 2015, OPEN CHEM, V13, P801, DOI 10.1515/chem-2015-0079
   Silva LS, 2013, CHEM ENG J, V218, P89, DOI 10.1016/j.cej.2012.11.118
   Silva MMF, 2012, CHEM ENG J, V203, P259, DOI 10.1016/j.cej.2012.07.009
   Suflet DM, 2006, REACT FUNCT POLYM, V66, P1240, DOI 10.1016/j.reactfunctpolym.2006.03.006
   Temkin MJ, 1940, ACTA PHYSIOCHIM USSR
   Vieira AP, 2011, CHEM ENG J, V173, P334, DOI 10.1016/j.cej.2011.07.043
   Vieira AP, 2009, J HAZARD MATER, V166, P1272, DOI 10.1016/j.jhazmat.2008.12.043
   Wan Z, 2015, J COLLOID INTERF SCI, V443, P115, DOI 10.1016/j.jcis.2014.12.012
   Wanrosli WD, 2011, CARBOHYD POLYM, V84, P262, DOI 10.1016/j.carbpol.2010.11.032
   Weber W, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   Wijekoon KC, 2014, J MEMBRANE SCI, V453, P636, DOI 10.1016/j.memsci.2013.12.002
   Wijekoon KC, 2013, BIORESOURCE TECHNOL, V144, P247, DOI 10.1016/j.biortech.2013.06.097
   Yang M, 2014, AQUAT TOXICOL, V151, P68, DOI 10.1016/j.aquatox.2013.12.029
   Yilmaz MS, 2015, RES CHEM INTERMEDIAT, V41, P199, DOI 10.1007/s11164-013-1182-4
NR 48
TC 7
Z9 7
U1 5
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD MAY
PY 2016
VL 86
BP 362
EP 375
DI 10.1016/j.ijbiomac.2016.01.063
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA DJ4RT
UT WOS:000374196100045
PM 26812113
DA 2018-10-19
ER

PT J
AU Moore, LB
   Sawyer, AJ
   Saucier-Sawyer, J
   Saltzman, WM
   Kyriakides, TR
AF Moore, Laura Beth
   Sawyer, Andrew J.
   Saucier-Sawyer, Jennifer
   Saltzman, W. Mark
   Kyriakides, Themis R.
TI Nanoparticle delivery of miR-223 to attenuate macrophage fusion
SO BIOMATERIALS
LA English
DT Article
DE Nanoparticle; microRNA; Biomaterial; Macrophage fusion; Foreign body
   giant cell
ID FOREIGN-BODY RESPONSE; GIANT-CELL FORMATION; IN-VIVO; OSTEOCLAST
   DIFFERENTIATION; TARGETING RAC1; E-CADHERIN; MICRORNA; EXPRESSION;
   ACTIVATION; INHIBITION
AB The foreign body response (FBR) begins with injury acquired during implantation of a biomaterial (BM) and is detrimental due to the eventual encapsulation of the implant. Fusion of macrophages to form foreign body giant cells (FBGC), a hallmark of the FBR, is the consequence of a multistep mechanism induced by interleukin (IL)-4 that includes the acquisition of a fusion competent state and subsequent cytoskeletal rearrangements. However, the precise mechanism, regulation, and interplay among molecular mediators to generate FBGCs are insufficiently understood. Seeking novel mediators of fusion that might be regulated at the post-transcriptional level, we examined the role of microRNAs (miRs) in this process. A miR microarray was screened and identified miR-223 as a negative regulator of macrophage fusion. In addition, transfection of primary macrophages with a mir-223 mimic attenuated IL-4 induced fusion. Furthermore, miR-223 KO mice and mir-223 deficient cells displayed increased fusion in vivo and in vitro, respectively. Finally, we developed a method for in vivo delivery of miR-223 mimic utilizing PLGA nanoparticles, which inhibited FBGC formation in a biomaterial implant model. Our results identify miR-223 as a negative regulator of fusion and demonstrate miR-223 mimic-loaded nanoparticles as a therapeutic inhibitor of macrophage fusion. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Moore, Laura Beth] Yale Univ, Dept Genet, New Haven, CT 06520 USA.
   [Sawyer, Andrew J.; Kyriakides, Themis R.] Yale Univ, Dept Pathol, 10 Amistad Str 3010, New Haven, CT 06520 USA.
   [Saucier-Sawyer, Jennifer; Saltzman, W. Mark; Kyriakides, Themis R.] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA.
   [Moore, Laura Beth; Sawyer, Andrew J.; Kyriakides, Themis R.] Yale Univ, Interdept Program Vasc Biol & Therapeut, New Haven, CT 06520 USA.
RP Kyriakides, TR (reprint author), Yale Univ, Dept Pathol, 10 Amistad Str 3010, New Haven, CT 06520 USA.
EM themis.kyriakides@yale.edu
FU National Institutes of Health [GM-072194, T32HL007950-12, T32GM007223];
   CRISP [NSF MRSEC DMR 1119826]; NSF-GRFP [DGE-1122492]
FX This work was funded by National Institutes of Health Grants
   (GM-072194), CRISP (NSF MRSEC DMR 1119826), NSF-GRFP (L.B.M
   DGE-1122492), and National Institutes of Health Vascular Research
   Training Grants (T32HL007950-12; AJ.S) and (T32GM007223; L.B.M).
CR Agatheeswaran S, 2013, LEUKEMIA, V27, P1578, DOI 10.1038/leu.2012.339
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   Arner E, 2012, DIABETES, V61, P1986, DOI 10.2337/db11-1508
   Avula MN, 2013, BIOMATERIALS, V34, P9737, DOI 10.1016/j.biomaterials.2013.08.090
   Babar IA, 2012, P NATL ACAD SCI USA, V109, pE1695, DOI 10.1073/pnas.1201516109
   Brodbeck WG, 2009, CURR OPIN HEMATOL, V16, P53, DOI 10.1097/MOH.0b013e32831ac52e
   Chandorkar Y, 2015, BIOMACROMOLECULES, V16, P636, DOI 10.1021/bm5017282
   Cheng CJ, 2012, MOL PHARMACEUT, V9, P1481, DOI 10.1021/mp300081s
   Dadsetan M, 2003, J CONTROL RELEASE, V93, P259, DOI 10.1016/j.jconrel.2003.08.010
   Devalliere J, 2014, FASEB J, V28, P908, DOI 10.1096/fj.13-238527
   Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783
   Esau CC, 2008, METHODS, V44, P55, DOI 10.1016/j.ymeth.2007.11.001
   Helming L, 2007, IMMUNOBIOLOGY, V212, P785, DOI 10.1016/j.imbio.2007.09.012
   Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005
   Helming L, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159665
   Jay SM, 2007, AM J PATHOL, V171, P632, DOI 10.2353/ajpath.2007.061213
   Jay SM, 2010, J BIOMED MATER RES A, V93A, P189, DOI 10.1002/jbm.a.32513
   Kagiya T, 2013, J PERIODONTAL RES, V48, P373, DOI 10.1111/jre.12017
   Kawano S, 2011, ANN RHEUM DIS, V70, pI88, DOI 10.1136/ard.2010.138669
   Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Kyriakides TR, 2003, THROMB HAEMOSTASIS, V90, P986, DOI 10.1160/TH03-06-0399
   Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918
   Lin XJ, 2014, BIOMED REP, V2, P122, DOI 10.3892/br.2013.192
   Liu D, 2015, THROMB RES, V135, P146, DOI 10.1016/j.thromres.2014.10.027
   Look M, 2014, BIOMATERIALS, V35, P1089, DOI 10.1016/j.biomaterials.2013.10.046
   MacLauchlan S, 2009, J LEUKOCYTE BIOL, V85, P617, DOI 10.1189/jlb.1008588
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   McNally AK, 2011, ADV EXP MED BIOL, V713, P97, DOI 10.1007/978-94-007-0763-4_7
   Moore LB, 2015, ACTA BIOMATER, V11, P37, DOI 10.1016/j.actbio.2014.09.022
   Moreno JL, 2007, J LEUKOCYTE BIOL, V82, P1542, DOI 10.1189/jlb.0107058
   Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Roy S, 2011, PHYSIOL GENOMICS, V43, P557, DOI 10.1152/physiolgenomics.00160.2010
   Rutnam ZJ, 2013, MATRIX BIOL, V32, P74, DOI 10.1016/j.matbio.2012.11.003
   Sazani P, 2002, NAT BIOTECHNOL, V20, P1228, DOI 10.1038/nbt759
   Sissons JR, 2012, J IMMUNOL, V189, P23, DOI 10.4049/jimmunol.1102477
   Skokos EA, 2011, AM J PATHOL, V178, P2311, DOI 10.1016/j.ajpath.2011.01.045
   Steinbach JM, 2012, J CONTROL RELEASE, V162, P102, DOI 10.1016/j.jconrel.2012.06.008
   Su SC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9523
   Sugatani T, 2007, J CELL BIOCHEM, V101, P996, DOI 10.1002/jcb.21335
   Sun G, 2013, CANCER BIOTHER RADIO, V28, P327, DOI 10.1089/cbr.2012.1380
   Sun Q, 2014, PROSTATE, V74, P1613, DOI 10.1002/pros.22878
   Udpa N, 2013, TISSUE ENG PT A, V19, P2713, DOI [10.1089/ten.tea.2012.0739, 10.1089/ten.TEA.2012.0739]
   Van den Bossche J, 2009, BLOOD, V114, P4664, DOI 10.1182/blood-2009-05-221598
   Wang Y, 2013, J CONTROL RELEASE, V169, P341, DOI 10.1016/j.jconrel.2012.12.028
   Wu LF, 2011, FEBS LETT, V585, P1322, DOI 10.1016/j.febslet.2011.03.067
   Zhang Y, 2013, J CONTROL RELEASE, V172, P962, DOI 10.1016/j.jconrel.2013.09.015
NR 50
TC 7
Z9 8
U1 0
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2016
VL 89
BP 127
EP 135
DI 10.1016/j.biomaterials.2016.02.036
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DJ2YY
UT WOS:000374072500011
PM 26967647
OA Green Accepted, Other Gold
DA 2018-10-19
ER

PT J
AU Yigit, S
   Dinjaski, N
   Kaplan, DL
AF Yigit, Sezin
   Dinjaski, Nina
   Kaplan, David L.
TI Fibrous proteins: At the crossroads of genetic engineering and
   biotechnological applications
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Review
DE silk; elastin; collagen; recombinant proteins; fibrous proteins
ID ELASTIN-LIKE POLYPEPTIDE; SPIDER-SILK PROTEINS; RECOMBINANT HUMAN
   TROPOELASTIN; COLLAGEN-LIKE PROTEINS; YEAST PICHIA-PASTORIS; BOMBYX-MORI
   SILK; RECURSIVE DIRECTIONAL LIGATION; HUMAN PROLYL 4-HYDROXYLASE;
   EXPRESSED HUMAN ELASTIN; CLAVIPES DRAGLINE SILK
AB Fibrous proteins, such as silk, elastin and collagen are finding broad impact in biomaterial systems for a range of biomedical and industrial applications. Some of the key advantages of biosynthetic fibrous proteins compared to synthetic polymers include the tailorability of sequence, protein size, degradation pattern, and mechanical properties. Recombinant DNA production and precise control over genetic sequence of these proteins allows expansion and fine tuning of material properties to meet the needs for specific applications. We review current approaches in the design, cloning, and expression of fibrous proteins, with a focus on strategies utilized to meet the challenges of repetitive fibrous protein production. We discuss recent advances in understanding the fundamental basis of structure-function relationships and the designs that foster fibrous protein self-assembly towards predictable architectures and properties for a range of applications. We highlight the potential of functionalization through genetic engineering to design fibrous protein systems for biotechnological and biomedical applications. Biotechnol. Bioeng. 2016;113: 913-929. (c) 2015 Wiley Periodicals, Inc.
C1 [Yigit, Sezin; Dinjaski, Nina; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Yigit, Sezin] Tufts Univ, Dept Chem, Somerville, MA 02145 USA.
   [Dinjaski, Nina] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM David.Kaplan@Tufts.edu
FU NIH [P41 EB002520]; AFOSR; NSF IGERT
FX Contract grant sponsor: NIH; Contract grant number: P41 EB002520;
   Contract grant sponsor: AFOSR; Contract grant sponsor: NSF IGERT
CR Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.2755/jcmm010.003.18
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Amiram M, 2011, NAT MATER, V10, P141, DOI [10.1038/nmat2942, 10.1038/NMAT2942]
   Amruthwar SS, 2012, J MATER SCI-MATER M, V23, P2903, DOI 10.1007/s10856-012-4749-5
   An B, 2014, J BIOL CHEM, V289, P4941, DOI 10.1074/jbc.M113.530808
   An B, 2013, BIOMATERIALS, V34, P402, DOI 10.1016/j.biomaterials.2012.09.085
   Arai T, 2001, J APPL POLYM SCI, V80, P297, DOI 10.1002/1097-4628(20010411)80:2<297::AID-APP1099>3.3.CO;2-Q
   Arcidiacono S, 2002, MACROMOLECULES, V35, P1262, DOI 10.1021/ma011471o
   Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Asai D, 2012, BIOMATERIALS, V33, P5451, DOI 10.1016/j.biomaterials.2012.03.083
   Assal Y, 2013, BIOMATERIALS, V34, P3315, DOI 10.1016/j.biomaterials.2013.01.067
   Baek DH, 2007, FIBER POLYM, V8, P271, DOI 10.1007/BF02877269
   Bai LQ, 2008, APPL SURF SCI, V254, P2988, DOI 10.1016/j.apsusc.2007.10.049
   Bandiera A, 2014, BIOMACROMOLECULES, V15, P416, DOI 10.1021/bm401677n
   Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8
   Beck K, 2000, P NATL ACAD SCI USA, V97, P4273, DOI 10.1073/pnas.070050097
   BEDELLHOGAN D, 1993, J BIOL CHEM, V268, P10345
   BELLA J, 1995, STRUCTURE, V3, P893, DOI 10.1016/S0969-2126(01)00224-6
   Bellas E, 2012, MACROMOL BIOSCI, V12, P1627, DOI 10.1002/mabi.201200262
   Bellingham CM, 2001, BBA-PROTEIN STRUCT M, V1550, P6, DOI 10.1016/S0167-4838(01)00262-X
   BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874
   Bessa PC, 2010, J TISSUE ENG REGEN M, V4, P349, DOI 10.1002/term.245
   Betre H, 2006, J CONTROL RELEASE, V115, P175, DOI 10.1016/j.jconrel.2006.07.022
   Bhardwaj N, 2011, CARBOHYD POLYM, V85, P325, DOI 10.1016/j.carbpol.2011.02.027
   Boydston JA, 2005, J BACTERIOL, V187, P5310, DOI 10.1128/JB.187.15.5310-5317.2005
   Bozzini S, 2011, J MATER SCI-MATER M, V22, P2641, DOI 10.1007/s10856-011-4451-z
   Bracalello A, 2011, BIOMACROMOLECULES, V12, P2957, DOI 10.1021/bm2005388
   Bretscher LE, 2001, J AM CHEM SOC, V123, P777, DOI 10.1021/ja005542v
   Briggs AW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks624
   Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7
   Cai L, 2014, BIOMATER SCI-UK, V2, P757, DOI 10.1039/c3bm60293a
   Cai ZX, 2010, INT J MOL SCI, V11, P3529, DOI 10.3390/ijms11093529
   CANDELAS GC, 1990, DEV BIOL, V140, P215, DOI 10.1016/0012-1606(90)90069-U
   Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731
   Cappello J, 1998, J CONTROL RELEASE, V53, P105, DOI 10.1016/S0168-3659(97)00243-5
   CAPPELLO J, 1990, TRENDS BIOTECHNOL, V8, P309, DOI 10.1016/0167-7799(90)90207-E
   Caves JM, 2010, BIOMATERIALS, V31, P7175, DOI 10.1016/j.biomaterials.2010.05.014
   Chen GQ, 2009, CHEM SOC REV, V38, P2434, DOI 10.1039/b812677c
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Chiarini A, 2003, BIOMATERIALS, V24, P789, DOI 10.1016/S0142-9612(02)00417-9
   Chow D, 2008, MAT SCI ENG R, V62, P125, DOI 10.1016/j.mser.2008.04.004
   Ciofani G, 2014, MACROMOL BIOSCI, V14, P632, DOI 10.1002/mabi.201300361
   Costa RR, 2013, NANOMED-NANOTECHNOL, V9, P895, DOI 10.1016/j.nano.2013.01.013
   Costa RR, 2013, J PHYS CHEM B, V117, P6839, DOI 10.1021/jp4028518
   Cranford SW, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0148
   Dams-Kozlowska H, 2013, J BIOMED MATER RES A, V101, P456, DOI 10.1002/jbm.a.34353
   Dash BC, 2011, J CONTROL RELEASE, V152, P382, DOI 10.1016/j.jconrel.2011.03.006
   Dreher MR, 2008, J AM CHEM SOC, V130, P687, DOI 10.1021/ja0764862
   Eles PT, 2004, BIOMACROMOLECULES, V5, P661, DOI 10.1021/bm0342685
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   FAZIO MJ, 1988, J INVEST DERMATOL, V91, P458, DOI 10.1111/1523-1747.ep12476591
   Fukushima Y, 1998, BIOPOLYMERS, V45, P269, DOI 10.1002/(SICI)1097-0282(19980405)45:4<269::AID-BIP1>3.0.CO;2-J
   Gagner JE, 2014, ACTA BIOMATER, V10, P1542, DOI 10.1016/j.actbio.2013.10.001
   Garcia Y, 2009, TISSUE ENG PT A, V15, P887, DOI 10.1089/ten.tea.2008.0104
   Gasser B, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-11
   Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627
   GEDDIS AE, 1993, MATRIX, V13, P399, DOI 10.1016/S0934-8832(11)80045-4
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Girotti A, 2011, BIOTECHNOL J, V6, P1174, DOI 10.1002/biot.201100116
   GOLDBERG I, 1989, GENE, V80, P305, DOI 10.1016/0378-1119(89)90294-1
   Gomes SC, 2011, BIOMATERIALS, V32, P4255, DOI 10.1016/j.biomaterials.2011.02.040
   GRAY WR, 1973, NATURE, V246, P461, DOI 10.1038/246461a0
   Gronau G, 2012, BIOMATERIALS, V33, P8240, DOI 10.1016/j.biomaterials.2012.06.054
   Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Hiob MA, 2013, BIOMATERIALS, V34, P7584, DOI 10.1016/j.biomaterials.2013.06.036
   Hsueh YS, 2014, MAT SCI ENG C-MATER, V38, P119, DOI 10.1016/j.msec.2014.01.058
   Hu F, 2010, APPL BIOCHEM BIOTECH, V160, P2377, DOI 10.1007/s12010-009-8850-2
   Hu X, 2006, CELL MOL LIFE SCI, V63, P1986, DOI 10.1007/s00018-006-6090-y
   Hu XA, 2010, BIOMATERIALS, V31, P8121, DOI 10.1016/j.biomaterials.2010.07.044
   Huang L, 2000, MACROMOLECULES, V33, P2989, DOI 10.1021/ma991858f
   Huemmerich D, 2004, CURR BIOL, V14, P2070, DOI 10.1016/j.cub.2004.11.005
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   INDIK Z, 1990, ARCH BIOCHEM BIOPHYS, V280, P80, DOI 10.1016/0003-9861(90)90521-Y
   Islam MM, 2015, ACTA BIOMATER, V12, P70, DOI 10.1016/j.actbio.2014.10.035
   Ito H, 2006, J BIOMED MATER RES A, V76A, P551, DOI 10.1002/jbm.a.30551
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   John DCA, 1999, NAT BIOTECHNOL, V17, P385, DOI 10.1038/7945
   Jordan SW, 2007, BIOMATERIALS, V28, P1191, DOI 10.1016/j.biomaterials.2006.09.048
   Kaplan DL, 1998, POLYM DEGRAD STABIL, V59, P25, DOI 10.1016/S0141-3910(97)00000-1
   Kaufmann D, 2008, MACROMOL BIOSCI, V8, P577, DOI 10.1002/mabi.200700234
   Keane MA, 2009, CHEMSUSCHEM, V2, P207, DOI 10.1002/cssc.200900001
   Keeley FW, 2002, PHILOS T R SOC B, V357, P185, DOI 10.1098/rstb.2001.1027
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]
   Khadka DB, 2014, POLYMER, V55, P2163, DOI 10.1016/j.polymer.2014.03.012
   Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775
   Kim S, 2014, NAT NANOTECHNOL, V9, P306, DOI [10.1038/nnano.2014.47, 10.1038/NNANO.2014.47]
   Kim W, 2012, ACTA BIOMATER, V8, P2476, DOI 10.1016/j.actbio.2012.04.011
   KING RD, 1994, PROTEIN ENG, V7, P1295, DOI 10.1093/protein/7.11.1295
   Kinikoglu B, 2011, J MATER SCI-MATER M, V22, P1541, DOI 10.1007/s10856-011-4315-6
   Kolbe A, 2011, MACROMOL RAPID COMM, V32, P186, DOI 10.1002/marc.201000491
   Koria P, 2011, P NATL ACAD SCI USA, V108, P1034, DOI 10.1073/pnas.1009881108
   Krishna UM, 2012, ACTA BIOMATER, V8, P988, DOI 10.1016/j.actbio.2011.11.024
   Kumar VA, 2014, BIOMED MATER, V9, P1
   Kurihara H, 2005, BIOTECHNOL LETT, V27, P665, DOI 10.1007/s10529-005-4477-8
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   Lao UL, 2007, BIOMACROMOLECULES, V8, P3736, DOI 10.1021/bm700662n
   LAPIERE CM, 1971, P NATL ACAD SCI USA, V68, P3054, DOI 10.1073/pnas.68.12.3054
   Laurencin CT, 1996, BONE, V19, P93
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee KH, 2007, INT J BIOL MACROMOL, V41, P168, DOI 10.1016/j.ijbiomac.2007.01.011
   Lee S, 2011, ACTA BIOMATER, V7, P3868, DOI 10.1016/j.actbio.2011.06.035
   Lee TAT, 2000, ADV MATER, V12, P1105, DOI 10.1002/1521-4095(200008)12:15<1105::AID-ADMA1105>3.0.CO;2-1
   Lefevre T, 2007, BIOPHYS J, V92, P2885, DOI 10.1529/biophysj.106.100339
   LEHRACH H, 1978, P NATL ACAD SCI USA, V75, P5417, DOI 10.1073/pnas.75.11.5417
   Leong YK, 2014, J BIOTECHNOL, V180, P52, DOI 10.1016/j.jbiotec.2014.03.020
   Lewis RV, 1996, PROTEIN EXPRES PURIF, V7, P400, DOI 10.1006/prep.1996.0060
   Li L, 2013, ACS MACRO LETT, V2, P635, DOI 10.1021/mz4002194
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Li MZ, 2002, INT J BIOL MACROMOL, V30, P89, DOI 10.1016/S0141-8130(02)00007-7
   Liu HT, 2008, MATER LETT, V62, P1949, DOI 10.1016/j.matlet.2007.10.061
   Lu Q, 2012, BIOMACROMOLECULES, V13, P826, DOI 10.1021/bm201731e
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mamat U, 2008, MOL MICROBIOL, V67, P633, DOI 10.1111/j.1365-2958.2007.06074.x
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Marsano E, 2008, INT J BIOL MACROMOL, V43, P106, DOI 10.1016/j.ijbiomac.2008.03.009
   Martin L, 2010, SOFT MATTER, V6, P1121, DOI 10.1039/b923684h
   Martin L, 2009, BIOMACROMOLECULES, V10, P3015, DOI 10.1021/bm900560a
   MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M
   Massodi I, 2005, J CONTROL RELEASE, V108, P396, DOI 10.1016/j.jcornel.2005.08.007
   Massodi I, 2007, J DRUG TARGET, V15, P611, DOI 10.1080/10611860701502780
   Mayne R, 1993, CURR OPIN CELL BIOL, V5, P883, DOI 10.1016/0955-0674(93)90039-S
   McDaniel JR, 2013, ANGEW CHEM INT EDIT, V52, P1683, DOI 10.1002/anie.201200899
   McDaniel JR, 2010, BIOMACROMOLECULES, V11, P944, DOI 10.1021/bm901387t
   McGrath K. P., 1997, PROTEIN BASED MAT
   McHale MK, 2005, TISSUE ENG, V11, P1768, DOI 10.1089/ten.2005.11.1768
   MCPHERSON DT, 1992, BIOTECHNOL PROGR, V8, P347, DOI 10.1021/bp00016a012
   McPherson DT, 1996, PROTEIN EXPRES PURIF, V7, P51, DOI 10.1006/prep.1996.0008
   MCPHERSON JM, 1985, COLLAGEN REL RES, V5, P119
   Megeed Z, 2004, J CONTROL RELEASE, V94, P433, DOI 10.1016/j.jconrel.2003.10.027
   Mello CM, 2004, BIOMACROMOLECULES, V5, P1849, DOI 10.1021/bm049815g
   Meyer DE, 2002, BIOMACROMOLECULES, V3, P357, DOI 10.1021/bm015630n
   Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100
   Miao M, 2005, BIOCHEMISTRY-US, V44, P14367, DOI 10.1021/bi0510173
   Miao M, 2003, J BIOL CHEM, V278, P48553, DOI 10.1074/jbc.M308465200
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200
   Motriuk-Smith D, 2005, BIOMACROMOLECULES, V6, P3152, DOI 10.1021/bm050472b
   Myllyharju J, 2000, BIOCHEM SOC T, V28, P353, DOI 10.1042/0300-5127:0280353
   Nagae M, 2007, TISSUE ENG, V13, P147, DOI 10.1089/ten.2006.0042
   Nath N, 2003, ANAL CHEM, V75, P709, DOI 10.1021/ac0261855
   NICOL A, 1991, J VASC SURG, V13, P746, DOI 10.1016/0741-5214(91)90373-3
   Nivison-Smith L, 2010, ACTA BIOMATER, V6, P354, DOI 10.1016/j.actbio.2009.08.011
   Nokelainen M, 1998, MATRIX BIOL, V16, P329, DOI 10.1016/S0945-053X(98)90004-X
   Nokelainen M, 2001, YEAST, V18, P797, DOI 10.1002/yea.730
   Notbohm H, 1999, J BIOL CHEM, V274, P8988, DOI 10.1074/jbc.274.13.8988
   Nuhn H, 2008, BIOMACROMOLECULES, V9, P2755, DOI 10.1021/bm800784y
   Numata K, 2011, BIOCONJUGATE CHEM, V22, P1605, DOI 10.1021/bc200170u
   Numata K, 2010, ADV DRUG DELIVER REV, V62, P1497, DOI 10.1016/j.addr.2010.03.009
   Numata K, 2009, BIOMATERIALS, V30, P5775, DOI 10.1016/j.biomaterials.2009.06.028
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Osborne JL, 2008, ACTA BIOMATER, V4, P49, DOI 10.1016/j.actbio.2007.07.007
   Otero JM, 2010, BIOTECHNOL BIOENG, V105, P439, DOI 10.1002/bit.22592
   Park KE, 2006, INT J BIOL MACROMOL, V38, P165, DOI 10.1016/j.ijbiomac.2006.03.003
   Perret S, 2001, J BIOL CHEM, V276, P43693, DOI 10.1074/jbc.M105507200
   PIEZ KA, 1960, J BIOL CHEM, V235, P995
   Pinkas DM, 2011, ACS CHEM BIOL, V6, P320, DOI 10.1021/cb100298r
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Qiu WG, 2010, BIOMACROMOLECULES, V11, P3219, DOI 10.1021/bm100469w
   Rabotyagova OS, 2009, BIOMACROMOLECULES, V10, P229, DOI 10.1021/bm800930x
   Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105
   Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200
   Ricci G, 2006, DERMATOLOGY, V213, P224, DOI 10.1159/000095040
   Rising A, 2006, BIOMACROMOLECULES, V7, P3120, DOI 10.1021/bm060693x
   Rodgers UR, 2004, BIOCHIMIE, V86, P173, DOI 10.1016/j.biochi.2004.03.002
   Rueda F, 2014, APPL MICROBIOL BIOT, V98, P9229, DOI 10.1007/s00253-014-6008-9
   Sarangthem V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081891
   Sato F, 2006, CLIN BIOCHEM, V39, P746, DOI 10.1016/j.clinbiochem.2006.02.017
   Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14
   Scheller J, 2004, TRANSGENIC RES, V13, P51, DOI 10.1023/B:TRAG.0000017175.78809.7a
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Seib FP, 2012, BIOMATERIALS, V33, P8442, DOI 10.1016/j.biomaterials.2012.08.004
   Sionkowska A, 2011, PROG POLYM SCI, V36, P1254, DOI 10.1016/j.progpolymsci.2011.05.003
   SOBEL ME, 1978, P NATL ACAD SCI USA, V75, P5846, DOI 10.1073/pnas.75.12.5846
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Srokowski EM, 2014, J BIOMED MATER RES A, V102, P540, DOI 10.1002/jbm.a.34699
   Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y
   STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4
   STERNBERG MJE, 1977, J MOL BIOL, V115, P1, DOI 10.1016/0022-2836(77)90242-X
   Stone PJ, 2001, AM J RESP CELL MOL, V24, P733, DOI 10.1165/ajrcmb.24.6.4304
   Szela S, 2000, BIOMACROMOLECULES, V1, P534, DOI 10.1021/bm0055697
   Tang-Schomer MD, 2014, P NATL ACAD SCI USA, V111, P13811, DOI 10.1073/pnas.1324214111
   Tao H, 2014, P NATL ACAD SCI USA, V111, P17385, DOI 10.1073/pnas.1407743111
   Tejeda-Montes E, 2014, ACTA BIOMATER, V10, P134, DOI 10.1016/j.actbio.2013.09.001
   TILLET E, 1994, EUR J BIOCHEM, V221, P177, DOI 10.1111/j.1432-1033.1994.tb18727.x
   Tokareva O, 2013, MICROB BIOTECHNOL, V6, P651, DOI 10.1111/1751-7915.12081
   Toman PD, 2000, J BIOL CHEM, V275, P23303, DOI 10.1074/jbc.M002284200
   Trabbic-Carlson K, 2004, PROTEIN SCI, V13, P3274, DOI 10.1110/ps.04931604
   Traub W, 1971, Adv Protein Chem, V25, P243, DOI 10.1016/S0065-3233(08)60281-8
   Tsukada M, 2003, J APPL POLYM SCI, V89, P638, DOI 10.1002/app.11911
   URRY DW, 1992, PROG BIOPHYS MOL BIO, V57, P23, DOI 10.1016/0079-6107(92)90003-O
   URRY DW, 1974, BIOCHIM BIOPHYS ACTA, V371, P597, DOI 10.1016/0005-2795(74)90057-9
   Valluzzi R, 1999, J PHYS CHEM B, V103, P11382, DOI 10.1021/jp991363s
   Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vuorela A, 1997, EMBO J, V16, P6702, DOI 10.1093/emboj/16.22.6702
   Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111
   Wang E, 2013, NANO LETT, V13, P2826, DOI 10.1021/nl401088b
   Wang XY, 2006, MATER TODAY, V9, P44, DOI 10.1016/S1369-7021(06)71742-4
   Wang Y, 2014, CURR OPIN BIOTECH, V30, P59, DOI 10.1016/j.copbio.2014.06.001
   Waterhouse A, 2010, BIOMATERIALS, V31, P8332, DOI 10.1016/j.biomaterials.2010.07.062
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Werkmeister JA, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012002
   WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191
   Widmaier DM, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.62
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P12739, DOI 10.1021/bi001335w
   Wise SG, 2014, ACTA BIOMATER, V10, P1532, DOI 10.1016/j.actbio.2013.08.003
   Wise SG, 2011, ACTA BIOMATER, V7, P295, DOI 10.1016/j.actbio.2010.07.022
   Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017
   Wong Foo Po C, 2002, ADV DRUG DELIV REV, V54, P1131
   Wong Po Foo C, 2006, P NATL ACAD SCI USA, V103, P9428
   Wu WY, 2006, NAT PROTOC, V1, P2257, DOI 10.1038/nprot.2006.314
   Wu WJ, 1999, J BIOL CHEM, V274, P21719, DOI 10.1074/jbc.274.31.21719
   Xia XX, 2011, BIOMACROMOLECULES, V12, P3844, DOI 10.1021/bm201165h
   Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107
   Xiong AS, 2008, FEMS MICROBIOL REV, V32, P522, DOI 10.1111/j.1574-6976.2008.00109.x
   Xu CY, 2010, BIOMACROMOLECULES, V11, P348, DOI 10.1021/bm900894b
   Xu LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050227
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Xu X, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-69
   Yamauchi M, 2012, ESSAYS BIOCHEM, V52, P113, DOI [10.1042/bse0520113, 10.1042/BSE0520113]
   Yang CL, 2004, BIODRUGS, V18, P103, DOI 10.2165/00063030-200418020-00004
   Yang G, 2002, J MEMBRANE SCI, V210, P379, DOI 10.1016/S0376-7388(02)00419-2
   Yao JM, 2004, J BIOCHEM, V136, P643, DOI 10.1093/jb/mvh172
   Yigit S, 2014, MACROMOL BIOSCI, V14, P1291, DOI 10.1002/mabi.201400113
   Yoo CR, 2008, INT J BIOL MACROMOL, V42, P324, DOI 10.1016/j.ijbiomac.2007.12.004
   Yoo MK, 2004, INT J BIOL MACROMOL, V34, P263, DOI 10.1016/j.ijbiomac.2004.06.002
   Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134
   Yu ZX, 2014, J STRUCT BIOL, V186, P451, DOI 10.1016/j.jsb.2014.01.003
   Zhang YS, 2008, MOL BIOL REP, V35, P329, DOI 10.1007/s11033-007-9090-6
   Zhou YT, 2001, BIOMACROMOLECULES, V2, P111, DOI 10.1021/bm005598h
   Zhu ZH, 2008, J APPL POLYM SCI, V109, P2956, DOI 10.1002/app.28460
NR 237
TC 7
Z9 7
U1 5
U2 73
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
EI 1097-0290
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD MAY
PY 2016
VL 113
IS 5
BP 913
EP 929
DI 10.1002/bit.25820
PG 17
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DI4NN
UT WOS:000373476700001
PM 26332660
DA 2018-10-19
ER

PT J
AU Sharma, LA
   Ali, MA
   Love, RM
   Wilson, MJ
   Dias, GJ
AF Sharma, L. Ajay
   Ali, M. A.
   Love, R. M.
   Wilson, M. J.
   Dias, G. J.
TI Novel keratin preparation supports growth and differentiation of
   odontoblast-like cells
SO INTERNATIONAL ENDODONTIC JOURNAL
LA English
DT Article
DE bioactivity; hydrogel; odontoblasts; polymers; scaffold
ID PULP STEM-CELLS; DENTIN MATRIX PROTEIN-1; IN-VITRO; ODONTOGENIC
   DIFFERENTIATION; TOOTH-TISSUE; OVINE MODEL; SCAFFOLDS; PROLIFERATION;
   SPONGE; OSSEOINTEGRATION
AB AimTo fabricate a keratin hydrogel, characterize its functionality as a biomaterial and investigate the effects of keratin on growth and differentiation of odontoblast-like cells.
   MethodologyKeratins were extracted from sheep wool using a well-established technique. The extracted proteins were purified by dialysis, quantified by gel electrophoresis, mass spectrometry, amino acid analysis and inductively coupled mass spectrometry. The microstructure of the fabricated keratin hydrogels was studied by scanning electron microscopy, flow characteristics by rheometer, hydrolytic stability and cytocompatibility by Live/Dead((R)) cell assay. Furthermore, the influence of keratin on odontoblast-like cells (MDPC-23) was assessed to confirm their bioactivity at different dilutions. Cell proliferation was studied using alamarBlue((R)) assay and differentiation by alkaline phosphatase enzyme activity, alizarin red staining and calcium quantification, reverse transcription polymerase chain reaction (rt-PCR) and immunocytochemical staining for dentine matrix protein- 1 (DMP-1) expression. anova with Tukey's tests was performed for statistical comparison.
   ResultsThe characterized hydrogel was injectable with a highly porous architecture that underwent slow degradation, and its cytocompatibility was statistically equivalent to collagen hydrogel (P>0.05). Cell proliferation and differentiation were enhanced at the optimal keratin concentration of 0.1mgmL(-1). At this concentration, the influence of keratin on cell differentiation was demonstrated by marked elevation in alkaline phosphatase activity (P<0.05), calcium deposition (P<0.01), gene expression (P<0.01) and positive immunostaining for DMP-1.
   ConclusionThe presence of keratin enhanced odontoblast cell behaviour. Keratin hydrogels may be a potential scaffold for pulp-dentine regen-eration.
C1 [Sharma, L. Ajay; Wilson, M. J.; Dias, G. J.] Univ Otago, Dept Anat, Dunedin, New Zealand.
   [Ali, M. A.] Univ Otago, Dept Appl Sci, Dunedin, New Zealand.
   [Love, R. M.] Univ Otago, Dept Oral Rehabil, Dunedin, New Zealand.
RP Sharma, LA (reprint author), Univ Otago, Otago Sch Med Sci, Dept Anat, Dunedin, New Zealand.
EM ajala685@student.otago.ac.nz
OI Love, Robert/0000-0001-7262-2990; Wilson, Megan/0000-0003-3425-5071
FU New Zealand Dental association Research Fund; Maurice and Phyllis Paykel
   Trust
FX This research is supported by New Zealand Dental association Research
   Fund and The Maurice and Phyllis Paykel Trust. We wish to acknowledge
   the assistance of Dr Aladin Beckitt, Department of food Science,
   University of Otago, for his guidance during sample preparation. Our
   thanks to Professor Jacques E. Nor, University of Michigan, USA, for
   providing us with MDPC-23 cells. We like to thank Mr Andrew McNaughton,
   Otago Center for Confocal Microscopy, and Ms Liz Girwan, Otago Center
   for Electron Microscopy for their assistance in microscopy. Finally, Mr
   Robbie McPhee for his help with Fig. 1. We the authors of this
   manuscript declare that there is no potential conflict of interest with
   respect to the authorship and/or publication of this article.
CR Albuquerque MTP, 2014, J DENT RES, V93, P1222, DOI 10.1177/0022034514549809
   Alsanea R, 2011, J ENDODONT, V37, P1092, DOI 10.1016/j.joen.2011.05.019
   Baba O, 2004, MATRIX BIOL, V23, P371, DOI 10.1016/j.matnio.2004.07.008
   Dias GJ, 2010, J BIOMED MATER RES A, V95A, P1084, DOI 10.1002/jbm.a.32908
   Dias GJ, 2010, J BIOMED MATER RES A, V92A, P513, DOI 10.1002/jbm.a.32394
   Feng JQ, 2003, J DENT RES, V82, P776, DOI 10.1177/154405910308201003
   Galler K M, 2011, Adv Dent Res, V23, P333, DOI 10.1177/0022034511405326
   Galler KM, 2012, TISSUE ENG PT A, V18, P176, DOI [10.1089/ten.tea.2011.0222, 10.1089/ten.TEA.2011.0222]
   Goldberg M, 2011, Adv Dent Res, V23, P270, DOI 10.1177/0022034511405385
   Hanks CT, 1998, CONNECT TISSUE RES, V37, P233, DOI 10.3109/03008209809002442
   Hesse M, 2004, EUR J CELL BIOL, V83, P19, DOI 10.1078/0171-9335-00354
   Hill P, 2010, BIOMATERIALS, V31, P585, DOI 10.1016/j.biomaterials.2009.09.076
   Hill PS, 2011, TISSUE ENG PT A, V17, P1499, DOI 10.1089/ten.tea.2010.0184
   Huang George T-J, 2011, Front Biosci (Elite Ed), V3, P788, DOI 10.2741/e286
   Iohara K, 2009, REGEN MED, V4, P377, DOI 10.2217/RME.09.5
   Kelly RJ, 2012, United States patent US, Patent No. [8142807 B2, 8142807]
   Koehn H, 2010, J PROTEOME RES, V9, P2920, DOI 10.1021/pr901106m
   Kumar GS, 2014, ORBANS ORAL HISTOLOG, P93
   Nakashima M, 2011, Adv Dent Res, V23, P313, DOI 10.1177/0022034511405323
   Narayanan K, 2003, J BIOL CHEM, V278, P17500, DOI 10.1074/jbc.M212700200
   NOISHIKI Y, 1982, KOBUNSHI RONBUNSHU, V39, P221, DOI 10.1295/koron.39.221
   Orsini G, 2008, EUR J HISTOCHEM, V52, P215
   Plowman JE, 2003, J CHROMATOGR B, V787, P63, DOI 10.1016/S1570-0232(02)00211-8
   Prescott RS, 2008, J ENDODONT, V34, P421, DOI 10.1016/j.joen.2008.02.005
   Rouse JG, 2010, MATERIALS, V3, P999, DOI 10.3390/ma3020999
   Sando L, 2010, J BIOMED MATER RES A, V95A, P901, DOI 10.1002/jbm.a.32913
   Shui CX, 2001, J BONE MINER RES, V16, P731, DOI 10.1359/jbmr.2001.16.4.731
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   Sumita Y, 2006, BIOMATERIALS, V27, P3238, DOI 10.1016/j.biomaterials.2006.01.055
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   Tachibana A, 2006, J BIOSCI BIOENG, V102, P425, DOI 10.1263/jbb.102.425
   THOMAS H, 1986, INT J BIOL MACROMOL, V8, P258, DOI 10.1016/0141-8130(86)90038-3
   Verma V, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025007
   Wang J, 2011, BIOMATERIALS, V32, P7822, DOI 10.1016/j.biomaterials.2011.04.034
   Wang J, 2010, ACTA BIOMATER, V6, P3856, DOI 10.1016/j.actbio.2010.04.009
   Wang S, 2012, CELL TISSUE RES, V347, P795, DOI 10.1007/s00441-011-1295-2
   Yamauchi K, 1996, J BIOMED MATER RES, V31, P439, DOI 10.1002/(SICI)1097-4636(199608)31:4<439::AID-JBM1>3.0.CO;2-M
   Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200
   Zhang HM, 2012, TISSUE ENG PT A, V18, P677, DOI [10.1089/ten.tea.2011.0269, 10.1089/ten.TEA.2011.0269]
   Zhang WB, 2006, BIOMATERIALS, V27, P5658, DOI 10.1016/j.biomaterials.2006.07.013
   Zheng LQ, 2011, BIOMATERIALS, V32, P7053, DOI [10.1016/j.biomaterials.2011.06.094, 10.1016/j.biomaterials.2011.06.004]
NR 41
TC 6
Z9 6
U1 3
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0143-2885
EI 1365-2591
J9 INT ENDOD J
JI Int. Endod. J.
PD MAY
PY 2016
VL 49
IS 5
BP 471
EP 482
DI 10.1111/iej.12476
PG 12
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DJ0PS
UT WOS:000373907000007
PM 26016886
DA 2018-10-19
ER

PT J
AU Yuan, F
   Lin, LX
   Zhang, HH
   Huang, D
   Sun, YL
AF Yuan, Fang
   Lin, Long-Xiang
   Zhang, Hui-Hui
   Huang, Dan
   Sun, Yu-Long
TI Effect of carbodiimide-derivatized hyaluronic acid gelatin on preventing
   postsurgical intra-abdominal adhesion formation and promoting healing in
   a rat model
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE postsurgical intra-abdominal adhesion; hyaluronic acid; hydrogel;
   healing
ID CANINE MODEL; PERITONEAL ADHESIONS; EXTRASYNOVIAL TENDON; SODIUM
   HYALURONATE; RABBIT MODEL; IN-VIVO; REDUCTION; SURFACE; GEL;
   CARBOXYMETHYLCELLULOSE
AB Adhesions often occur after abdominal surgery. It could cause chronic pelvic pain, intestinal obstruction, and infertility. A hydrogel biomaterial, carbodiimide-derivatized hyaluronic acid gelatin (cd-HA gelatin), has been successfully used to reduce adhesion formation after flexor tendon grafting. This study investigated the efficacy of cd-HA gelatin in preventing postsurgical peritoneal adhesions in a rat model. The surgical traumas were created on the underlying muscle of the abdominal wall and the serosal layer of the cecum. The wounds were covered with or without cd-HA gelatin. Animals were euthanized at day 14 after surgery. Adhesion formation was assessed with adhesion degree and adhesion breaking strength. The healing of abdominal wall was evaluated with biomechanical testing and histological analysis. The adhesions occurred in all rats (n=12) without cd-HA gelatin treatment. The application of cd-HA gelatin significantly reduced the adhesion rate from 100% to 58%. The decrease of adhesion breaking strength also manifested that cd-HA gelatin could reduce postsurgical intra-abdominal adhesion formation. Moreover, it was found that cd-HA gelatin was a safe material and could promote tissue healing. The cd-HA gelatin hydrogel could reduce the formation of intra-abdominal adhesions without adversely effects on wound healing. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 1175-1181, 2016.
C1 [Yuan, Fang; Lin, Long-Xiang; Zhang, Hui-Hui; Huang, Dan; Sun, Yu-Long] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen 518055, Guangdong, Peoples R China.
RP Sun, YL (reprint author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen 518055, Guangdong, Peoples R China.
EM yl.sun@siat.ac.cn
FU Chinese Academy of Sciences and Shenzhen Research Programs
   [JCYJ20140417113430613, KQCX2015033117354153]
FX Contract grant sponsor: Chinese Academy of Sciences and Shenzhen
   Research Programs; contract grant numbers: JCYJ20140417113430613,
   KQCX2015033117354153
CR Attard JAP, 2007, CAN J SURG, V50, P291
   Becker JM, 1996, J AM COLL SURGEONS, V183, P297
   Belluco C, 2001, J SURG RES, V100, P217, DOI 10.1006/jsre.2001.6248
   Brunelli G, 2005, J ORTHOP RES, V23, P1377, DOI 10.1016/j.orthres.2005.05.001
   Buckenmaier CC, 1999, AM SURGEON, V65, P274
   Dijkstra FR, 2000, SCAND J GASTROENTERO, V35, P52
   Ergul Emre, 2008, Int J Surg, V6, P253, DOI 10.1016/j.ijsu.2007.05.010
   Gaffney J, 2010, MOL BIOSYST, V6, P437, DOI 10.1039/b910552m
   Hayashi M, 2004, KNEE SURG SPORT TR A, V12, P545, DOI 10.1007/s00167-004-0512-x
   Holmdahl L, 1999, LANCET, V353, P1456, DOI 10.1016/S0140-6736(99)90061-2
   Irkorucu O, 2009, CLINICS, V64, P143, DOI 10.1590/S1807-59322009000200012
   Johns DB, 1997, FERTIL STERIL, V68, P37, DOI 10.1016/S0015-0282(97)81472-0
   Lauder CIW, 2011, J SURG RES, V171, P877, DOI 10.1016/j.jss.2010.06.028
   Liakakos T, 2001, DIGEST SURG, V18, P260, DOI 10.1159/000050149
   Marana R, 1997, HUM REPROD, V12, P1935, DOI 10.1093/humrep/12.9.1935
   MAZUJI MK, 1964, ARCH SURG-CHICAGO, V89, P1011
   Morey-Mas MA, 2010, J ORAL MAXIL SURG, V68, P1069, DOI 10.1016/j.joms.2009.09.039
   Oh CH, 2011, CLIN ORTHOP SURG, V3, P55, DOI 10.4055/cios.2011.3.1.55
   Oncel M, 2003, DIS COLON RECTUM, V46, P187, DOI 10.1097/01.DCR.0000049342.17762.16
   Rao CM, 1996, BIOCHEM MOL BIOL INT, V40, P327
   Reijnen MMPJ, 2003, BRIT J SURG, V90, P533, DOI 10.1002/bjs.4141
   Riccio M, 2010, J HAND SURG-EUR VOL, V35E, P130, DOI 10.1177/1753193409342044
   ROONEY P, 1995, INT J CANCER, V60, P632, DOI 10.1002/ijc.2910600511
   Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261
   Sun YL, 2004, J ORTHOP RES, V22, P984, DOI 10.1016/j.orthres.2004.02.005
   Takagi K, 2013, INT J MED SCI, V10, P467, DOI 10.7150/ijms.5607
   Tanaka T, 2007, J HAND SURG-AM, V32A, P876, DOI 10.1016/j.jhsa.2007.03.007
   Tanaka T, 2006, J ORTHOP RES, V24, P1555, DOI 10.1002/jor.20205
   Toole BP, 2008, SEMIN CANCER BIOL, V18, P244, DOI 10.1016/j.semcancer.2008.03.009
   URMAN B, 1991, FERTIL STERIL, V56, P563
   Ward BC, 2011, J SURG RES, V165, P91, DOI 10.1016/j.jss.2009.09.015
   West DC, 1997, INT J BIOCHEM CELL B, V29, P201, DOI 10.1016/S1357-2725(96)00133-1
   Yoldemir T, 2002, FERTIL STERIL, V78, P335, DOI 10.1016/S0015-0282(02)03224-7
   Zhao C, 2006, J BONE JOINT SURG AM, V88A, P2181, DOI 10.2106/JBJS.E.00871
   Zhao CF, 2010, J BONE JOINT SURG AM, V92A, P2817, DOI 10.2106/JBJS.I.01148
NR 35
TC 9
Z9 9
U1 1
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2016
VL 104
IS 5
BP 1175
EP 1181
DI 10.1002/jbm.a.35653
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DI7YQ
UT WOS:000373718300013
PM 26749008
DA 2018-10-19
ER

PT J
AU Qi, FF
   Yoshida, T
   Koike, T
   Aizawa, H
   Shimane, T
   Li, YH
   Yamada, S
   Okabe, M
   Nikaido, T
   Kurita, H
AF Qi, Fangfang
   Yoshida, Toshiko
   Koike, Takeshi
   Aizawa, Hitoshi
   Shimane, Tetsu
   Li, Yinghui
   Yamada, Shinichi
   Okabe, Motonori
   Nikaido, Toshio
   Kurita, Hiroshi
TI Construction and characterization of human oral mucosa equivalent using
   hyper-dry amniotic membrane as a matrix
SO ARCHIVES OF ORAL BIOLOGY
LA English
DT Article
DE Oral keratinocytes; Hyper-dry amniotic membrane; Matrix; Oral mucosal
   equivalent; Reconstruction
ID EPITHELIAL-CELLS; STEM-CELLS; CULTURE; TRANSPLANTATION; REGENERATION;
   DIFFERENTIATION; RECONSTRUCTION; DEFECTS; SERUM; MODEL
AB Background: Human amniotic membrane(HAM) as a graft material has been used in various fields. Hyper dry amniotic membrane (HD-AM) is a novel dried amniotic membrane that is easy to handle and can be preserved at room temperature without time limitation. The purpose of this study was to investigate the useful properties of HD-AM in reconstruction of the oral mucosa.
   Methods: Human oral keratinocytes were isolated and seeded on HD-AM in serum-free culture system. Oral mucosa equivalent (OME) was developed and transplanted onto full-thickness wound on athymic mice. The wound healing was analyzed and the OME both before and after transplantation was analyzed with hematoxylin-eosin staining and immunohistochemicial staining for Cytokines 10 (CK10), Cytokines 16 (CK16), and Ivolucrin (IVL).
   Results: Oral keratinocytes spread and proliferated well on HD-AM. Two weeks after air-lifting, OME had formed with good differentiation and morphology. We confirmed immunohistochemically that the expression of CK10 was positive in all suprabasal layers, as was CK16 in the upper layers, while IVL was present in all cell layers. Three weeks after transplantation to athymic mice, the newly generated tissue had survived well with the smallest contraction. The epithelial cells of newly generated tissue expressed CK10 throughout in all suprabasal layers, IVL was mainly in the granular layer, and CK16 positive cells were observed in all spinous layer and granular layer but were not expressed in the mouse skin, all of which were similar to native gingival mucosa.
   Conclusions: The OME with HD-AM as a matrix revealed a good morphology and stable wound healing. This study demonstrates that HD-AM is a useful and feasible biomaterial for oral mucosa reconstruction. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Qi, Fangfang; Aizawa, Hitoshi; Shimane, Tetsu; Li, Yinghui; Yamada, Shinichi; Kurita, Hiroshi] Shinshu Univ, Dept Dent & Oral Surg, Sch Med, 3-1-1 Asahi, Matsumato 3908621, Japan.
   [Yoshida, Toshiko; Okabe, Motonori; Nikaido, Toshio] Toyama Univ, Dept Regenerat Med, Grad Sch Med & Pharmaceut Sci, 2630 Sugitani, Toyama 9300194, Japan.
   [Koike, Takeshi] Ina Cent Hosp, Dept Dent & Oral Surg, 1313-1 Koshiroukubo, Ina, Nagano 3968555, Japan.
RP Kurita, H (reprint author), Shinshu Univ, Dept Dent & Oral Surg, Sch Med, 3-1-1 Asahi, Matsumato 3908621, Japan.
EM hkurita@shinshu-u.ac.jp
CR Ahn KM, 2006, ARTIF ORGANS, V30, P411, DOI 10.1111/j.1525-1594.2006.00236.x
   AKLE CA, 1981, LANCET, V2, P1003
   Alaminos M, 2007, J TISSUE ENG REGEN M, V1, P350, DOI 10.1002/term.38
   Amemiya T, 2010, BIO-MED MATER ENG, V20, P37, DOI 10.3233/BME-2010-0613
   Arai N, 2012, J ORAL MAXIL SURG, V70, P2221, DOI 10.1016/j.joms.2011.09.033
   Atala A, 2003, CLIN PLAST SURG, V30, P649, DOI 10.1016/S0094-1298(03)00094-4
   DALE B A, 1990, Critical Reviews in Oral Biology and Medicine, V1, P167
   Gasparoni A, 2004, ARCH ORAL BIOL, V49, P653, DOI 10.1016/j.archoralbio.2004.02.010
   Gower RM, 2013, ADV WOUND CARE, V2, P100, DOI 10.1089/wound.2011.0325
   Horst M, 2013, BIOMATERIALS, V34, P1537, DOI 10.1016/j.biomaterials.2012.10.075
   Izumi K, 1999, J ORAL MAXIL SURG, V57, P571, DOI 10.1016/S0278-2391(99)90077-0
   Izumi K, 2000, J DENT RES, V79, P798, DOI 10.1177/00220345000790030301
   Ji SZ, 2011, BIOMATERIALS, V32, P7801, DOI 10.1016/j.biomaterials.2011.06.076
   Jin CZ, 2007, TISSUE ENG, V13, P693, DOI 10.1089/ten.2006.0184
   Kamiya K, 2005, EXP EYE RES, V80, P671, DOI 10.1016/j.exer.2004.11.018
   Kesting MR, 2009, J BIOMED MATER RES B, V90B, P930, DOI 10.1002/jbm.b.31365
   KIKKAWA Y, 1994, J BIOCHEM-TOKYO, V116, P862, DOI 10.1093/oxfordjournals.jbchem.a124608
   Koike T, 2011, ARCH ORAL BIOL, V56, P1170, DOI 10.1016/j.archoralbio.2011.04.009
   Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173
   Lee SH, 1997, AM J OPHTHALMOL, V123, P303, DOI 10.1016/S0002-9394(14)70125-4
   Lo V, 2009, INT J DERMATOL, V48, P935, DOI 10.1111/j.1365-4632.2009.04173.x
   Loeffelbein DJ, 2012, J BIOMED MATER RES B, V100B, P1245, DOI 10.1002/jbm.b.32689
   Mamede AC, 2012, CELL TISSUE RES, V349, P447, DOI 10.1007/s00441-012-1424-6
   Meller D, 1999, INVEST OPHTH VIS SCI, V40, P878
   Nikenjad H., 2008, EUROPEAN CELLS MAT, V29, P88
   Okabe M, 2014, J BIOMED MATER RES A, V102, P862, DOI 10.1002/jbm.a.34753
   Presland RB, 2000, CRIT REV ORAL BIOL M, V11, P383, DOI 10.1177/10454411000110040101
   Robinson WP, 2002, PRENATAL DIAG, V22, P1076, DOI 10.1002/pd.483
   Rohaina CM, 2014, TRANSL RES, V163, P200, DOI 10.1016/j.trsl.2013.11.004
   Rouabhia M, 2010, BIOMATERIALS, V31, P5798, DOI 10.1016/j.biomaterials.2010.04.004
   Shandadfar A, 2012, EXP EYE RES, V97, P1, DOI 10.1016/j.exer.2012.01.013
   Shi HF, 2014, J MECH BEHAV BIOMED, V29, P114, DOI 10.1016/j.jmbbm.2013.08.031
   Shimazaki J, 1998, BRIT J OPHTHALMOL, V82, P235, DOI 10.1136/bjo.82.3.235
   Terada M, 2012, J BIOMED MATER RES B, V100B, P1792, DOI 10.1002/jbm.b.32746
   Tesavibul N, 2001, CELL TISSUE BANK, V2, P31
   Toda A, 2007, J PHARMACOL SCI, V105, P215, DOI 10.1254/jphs.CP0070034
   Tsuno T., 2014, ORAL SURG ORAL MED O, V117, P83
   VANBAARE J, 1994, BURNS, V20, pS77, DOI 10.1016/0305-4179(94)90096-5
   von Versen-Hoeynck F, 2008, BIOLOGICALS, V36, P248, DOI 10.1016/j.biologicals.2008.02.001
   Wolbank S, 2009, J TISSUE ENG REGEN M, V3, P651, DOI 10.1002/term.207
   Yang LJ, 2009, J DERMATOL SCI, V56, P188, DOI 10.1016/j.jdermsci.2009.09.009
   Zhang YY, 2009, BIOMATERIALS, V30, P4021, DOI 10.1016/j.biomaterials.2009.04.005
NR 42
TC 1
Z9 3
U1 0
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0003-9969
EI 1879-1506
J9 ARCH ORAL BIOL
JI Arch. Oral Biol.
PD MAY
PY 2016
VL 65
BP 26
EP 34
DI 10.1016/j.archoralbio.2016.01.011
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DH4MH
UT WOS:000372759600004
PM 26845199
DA 2018-10-19
ER

PT J
AU Park, JH
   Jeong, J
   Moon, H
   Kim, C
   Kim, SJ
AF Park, Jeong Hoan
   Jeong, Joonsoo
   Moon, Hyowon
   Kim, Chaebin
   Kim, Sung June
TI Feasibility of LCP as an Encapsulating Material for Photodiode-Based
   Retinal Implants
SO IEEE PHOTONICS TECHNOLOGY LETTERS
LA English
DT Article
DE Photodiodes; microphotodiodes; long-term implantable transparent
   packaging; retinal implant; liquid crystal polymer (LCP)
ID CRYSTAL POLYMER LCP; PROSTHESIS; DEVICES
AB While retinal implants based on microphotodiode array (MPDA) could achieve great number of channels without an external camera, the absence of proper packaging technology of MPDA has limited their use in chronic implantation. Liquid crystal polymer (LCP) has gained increasing attention as a biomaterial for implantable devices due to its low water absorption rate and low permeability. In this letter, feasibility of LCP film as an encapsulation material of photodiode-based retinal prosthesis was explored. Optical property of LCP was measured to find the film thickness that can guarantee the light transmittance greater than 20%, which was achieved by developing the dry etching process of commercial LCP films to be less than 10 mu m. The minimum distinguishable line pitch of the thin LCP encapsulation evaluated by a custom setup with projected grating patterns on CMOS image sensor was 90 mu m, which could be equivalent to ideally 1200 channels in macular area of 10 mm(2).
C1 [Park, Jeong Hoan; Jeong, Joonsoo; Moon, Hyowon; Kim, Chaebin; Kim, Sung June] Seoul Natl Univ, Dept Elect & Comp Engn, Seoul 08826, South Korea.
   [Moon, Hyowon] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.
RP Kim, SJ (reprint author), Seoul Natl Univ, Dept Elect & Comp Engn, Seoul 08826, South Korea.
EM tteem920@snu.ac.kr; joonsoo.jeong@gmail.com; hwmoon88@gmail.com;
   chae.b.kim@gmail.com; kimsj@snu.ac.kr
FU National Research Foundation of Korea within the Ministry of Education,
   Science and Technology through the Public Welfare and Safety Research
   Program [NRF-2010-0020851]; Defense Acquisition Program Administration
   [UD140069ID]; College of Engineering and College of Dentistry Seoul
   National University; Inter-university Semiconductor Research Center at
   Seoul National University; Department of Electrical and Computer
   Engineering at Seoul National University through the Brain Korea 21 plus
   Project
FX This work was supported in part by the National Research Foundation of
   Korea within the Ministry of Education, Science and Technology through
   the Public Welfare and Safety Research Program under Grant
   NRF-2010-0020851, in part by the Defense Acquisition Program
   Administration through the Project entitled Control of Animal Brain
   using MEMS Chip under Grant UD140069ID, in part by College of
   Engineering and College of Dentistry Seoul National University through
   the engineering dentistry interdisciplinary research grant, in part by
   the Inter-university Semiconductor Research Center at Seoul National
   University, and in part by the Department of Electrical and Computer
   Engineering at Seoul National University through the Brain Korea 21 plus
   Project in 2015. (Corresponding author: Sung June Kim.)
CR [Anonymous], 2015, 883J MIL
   Bae SH, 2012, INVEST OPHTH VIS SCI, V53, P2653, DOI 10.1167/iovs.11-9341
   Boreman G. D., 2001, MODULATION TRANSFER, V4
   Borton DA, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026010
   Chen MJ, 2006, IEEE T MICROW THEORY, V54, P4009, DOI 10.1109/TMTT.2006.884639
   Chow AY, 2004, ARCH OPHTHALMOL-CHIC, V122, P460, DOI 10.1001/archopht.122.4.460
   Ge J, 2003, J POLYM SCI POL PHYS, V41, P623, DOI 10.1002/polb.10407
   Ghezzi D, 2013, NAT PHOTONICS, V7, P400, DOI [10.1038/NPHOTON.2013.34, 10.1038/nphoton.2013.34]
   Greenhouse H, 2011, HERMETICITY ELECT PA
   Humayun MS, 2012, OPHTHALMOLOGY, V119, P779, DOI 10.1016/j.ophtha.2011.09.028
   Jenkins F. A., 1957, FUNDAMENTALS OPTICS
   Jeong J., 2016, J NEURAL ENG, V13
   Jeong J, 2015, IEEE T BIO-MED ENG, V62, P982, DOI 10.1109/TBME.2014.2377197
   Jeong J, 2012, SENSOR MATER, V24, P189
   Jiang GQ, 2010, BIOL MED PHYS BIOMED, P27, DOI 10.1007/978-0-387-98120-8_2
   Kumar V., 2011, ADV APPL SCI RES, V2, P79
   Lee SW, 2011, IEEE T BIO-MED ENG, V58, DOI 10.1109/TBME.2011.2136341
   Peacock AJ, 2006, POLYM CHEM PROPERTIE
   Stingl K, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0077
   Zhou DC, 2013, ADV INTEL SYS RES, V44, P1
   Zrenner E, 1999, VISION RES, V39, P2555, DOI 10.1016/S0042-6989(98)00312-5
   Zrenner E., 2010, P ROY SOC LOND B BIO, V283, P1489
NR 22
TC 2
Z9 2
U1 0
U2 7
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 1041-1135
EI 1941-0174
J9 IEEE PHOTONIC TECH L
JI IEEE Photonics Technol. Lett.
PD MAY 1
PY 2016
VL 28
IS 9
BP 1018
EP 1021
DI 10.1109/LPT.2016.2523561
PG 4
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA DH9IL
UT WOS:000373109600022
DA 2018-10-19
ER

PT J
AU Lu, JW
   Zhao, YQ
   Niu, HZ
   Zhang, YS
   Du, YZ
   Zhang, W
   Huo, WT
AF Lu, Jinwen
   Zhao, Yongqing
   Niu, Hongzhi
   Zhang, Yusheng
   Du, Yuzhou
   Zhang, Wei
   Huo, Wangtu
TI Electrochemical corrosion behavior and elasticity properties of
   Ti-6Al-xFe alloys for biomedical applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Ti-6Al-xFe alloys; Microstructure; Corrosion resistance; Elasticity;
   Biomaterial application
ID TI-MO ALLOYS; SIMULATED PHYSIOLOGICAL ENVIRONMENT; FREE TITANIUM-ALLOYS;
   IMPEDANCE SPECTROSCOPY; MECHANICAL-PROPERTIES; IMPLANT MATERIALS;
   TI-24NB-4ZR-8SN ALLOY; TI-5CR-XFE ALLOYS; SALINE SOLUTION; BODY
   SOLUTIONS
AB The present study is to investigate the microstructural characteristics, electrochemical corrosion behavior and elasticity properties of Ti-6Al-xFe alloys with Fe addition for biomedical application, and Ti-6Al-4V alloy with two-phase (alpha + beta) microstructure is also studied as a comparison. Microstructural characterization reveals that the phase and crystal structure are sensitive to the Fe content. Ti-6Al alloy displays feather-like hexagonal a phase, and Ti-6Al-1Fe exhibits coarse lath structure of hexagonal alpha phase and a small amount of beta phase. Ti-6Al-2Fe and Ti-6Al-4Fe alloys are dominated by elongated, equiaxed alpha phase and retained beta phase, but the size of alpha phase particle in Ti-6Al-4Fe alloy is much smaller than that in Ti-6Al-2Fe alloy. The corrosion resistance of these alloys is determined in SBF solution at 37 degrees C. It is found that the alloys spontaneously form a passive oxide film on their surface after immersion for 500 s, and then they are stable for polarizations up to 0 V-SCE. In comparison with Ti-6Al and Ti-6Al-4V alloys, Ti-6Al-xFe alloys exhibit better corrosion resistance with lower anodic current densities, larger polarization resistances and higher open-circuit potentials. The passive layers show stable characteristics, and the wide frequency ranges displaying capacitive characteristics occur for high iron contents. Elasticity experiments are performed to evaluate the elasticity property at room temperature. Ti-6Al-4Fe alloy has the lowest Young's modulus (112 GPa) and exhibits the highest strength/modulus ratios as large as 8.6, which is similar to that of c.p. Ti (8.5). These characteristics of Ti-6Al-xFe alloys form the basis of a great potential to be used as biomedical implantation materials. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Lu, Jinwen; Zhao, Yongqing; Niu, Hongzhi; Zhang, Yusheng; Du, Yuzhou; Zhang, Wei; Huo, Wangtu] Northwest Inst Nonferrous Met Res, Adv Mat Res Cent, Xian 710016, Peoples R China.
RP Lu, JW; Zhao, YQ (reprint author), Northwest Inst Nonferrous Met Res, Adv Mat Res Cent, Xian 710016, Peoples R China.
EM lujwen@163.com; trc@c-nin.com
FU National Natural Science Foundation of China [51471136, 51301140,
   51271152]
FX This work was performed partially under the support of the National
   Natural Science Foundation of China (Grant Nos. 51471136, 51301140 and
   51271152).
CR Alves VA, 2009, CORROS SCI, V51, P2473, DOI 10.1016/j.corsci.2009.06.035
   Arrazola PJ, 2009, J MATER PROCESS TECH, V209, P2223, DOI 10.1016/j.jmatprotec.2008.06.020
   Assis S.L.d., 2006, ELECTROCHIM ACTA, V51, P1815, DOI DOI 10.1016/J.ELECTACTA.2005.02.121
   Atapour M, 2011, MAT SCI ENG C-MATER, V31, P885, DOI 10.1016/j.msec.2011.02.005
   Aziz-Kerrzo M, 2001, BIOMATERIALS, V22, P1531, DOI 10.1016/S0142-9612(00)00309-4
   Bai Y, 2013, MAT SCI ENG C-MATER, V33, P2159, DOI 10.1016/j.msec.2013.01.036
   Bai Y, 2012, APPL SURF SCI, V258, P4035, DOI 10.1016/j.apsusc.2011.12.096
   Biesiekierski A, 2014, MATER DESIGN, V59, P303, DOI 10.1016/j.matdes.2014.02.058
   Bolat G, 2013, ELECTROCHIM ACTA, V113, P470, DOI 10.1016/j.electacta.2013.09.116
   Buenconsejo PJS, 2009, ACTA MATER, V57, P2509, DOI 10.1016/j.actamat.2009.02.007
   Chelariu R, 2014, ELECTROCHIM ACTA, V137, P280, DOI 10.1016/j.electacta.2014.06.021
   Choubey A, 2004, J ALLOY COMPD, V381, P288, DOI 10.1016/j.jallcom.2004.03.096
   Cremasco A, 2008, ELECTROCHIM ACTA, V53, P4867, DOI 10.1016/j.electacta.2008.02.011
   Fekry AM, 2009, ELECTROCHIM ACTA, V54, P3480, DOI 10.1016/j.electacta.2008.12.060
   Fonseca C, 2001, CORROS SCI, V43, P547, DOI 10.1016/S0010-938X(00)00107-4
   Geetha M, 2004, CORROS SCI, V46, P877, DOI 10.1016/S0010-938X(03)00186-0
   Ho WF, 2009, J ALLOY COMPD, V472, P546, DOI 10.1016/j.jallcom.2008.05.015
   Ho WF, 2009, MAT SCI ENG C-BIO S, V29, P36, DOI 10.1016/j.msec.2008.05.004
   Hsu HC, 2010, MATER CHARACT, V61, P851, DOI 10.1016/j.matchar.2010.05.003
   Hsu HC, 2009, J ALLOY COMPD, V474, P578, DOI 10.1016/j.jallcom.2008.07.003
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kotoka R, 2015, J MATER SCI TECHNOL, V31, P873, DOI 10.1016/j.jmst.2015.07.020
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Leyens C, 2003, TITANIUM TITANIUM AL
   Lin DJ, 2002, BIOMATERIALS, V23, P1723, DOI 10.1016/S0142-9612(01)00233-2
   Lopez MF, 2003, ELECTROCHIM ACTA, V48, P1395, DOI 10.1016/S0013-4686(03)00006-9
   Mareci D, 2013, EUR J SCI THEOL, V9, P189
   Marino CE, 2001, CORROS SCI, V43, P1465, DOI 10.1016/S0010-938X(00)00162-1
   Milosev I, 2008, ELECTROCHIM ACTA, V53, P3547, DOI 10.1016/j.electacta.2007.12.041
   Milosev I, 2013, ELECTROCHIM ACTA, V99, P176, DOI 10.1016/j.electacta.2013.03.086
   Min XH, 2010, MAT SCI ENG A-STRUCT, V527, P5499, DOI 10.1016/j.msea.2010.06.016
   Min XH, 2008, MAT SCI ENG A-STRUCT, V497, P74, DOI 10.1016/j.msea.2008.06.018
   Mohan L, 2013, APPL SURF SCI, V282, P281, DOI 10.1016/j.apsusc.2013.05.120
   Okazaki Y, 2002, BIOMATERIALS, V23, P2071, DOI 10.1016/S0142-9612(01)00337-4
   Oliveira NTC, 2007, MAT SCI ENG A-STRUCT, V452, P727, DOI 10.1016/j.msea.2006.11.061
   Park YJ, 2013, J DENT, V41, P1251, DOI 10.1016/j.jdent.2013.09.003
   Pimenova NV, 2006, ELECTROCHIM ACTA, V51, P2042, DOI 10.1016/j.electacta.2005.07.024
   Popa MV, 2004, ELECTROCHIM ACTA, V49, P2113, DOI 10.1016/j.electacta.2003.12.036
   Pouilleau J, 1997, MAT SCI ENG B-SOLID, V47, P235, DOI 10.1016/S0921-5107(97)00043-3
   Shan DB, 2009, J MATER PROCESS TECH, V209, P5713, DOI 10.1016/j.jmatprotec.2009.05.034
   Silva HM, 2004, MAT SCI ENG C-BIO S, V24, P679, DOI 10.1016/j.msec.2004.08.051
   Tamilselvi S, 2007, MATER CORROS, V58, P113, DOI 10.1002/maco.200603979
   Tamilselvi S, 2006, ELECTROCHIM ACTA, V52, P839, DOI 10.1016/j.electacta.2006.06.018
   Tsao LC, 2015, MAT SCI ENG C-MATER, V46, P246, DOI 10.1016/j.msec.2014.10.037
   Tsao LC, 2012, CORROS SCI, V63, P393, DOI 10.1016/j.corsci.2012.06.015
   Wang BL, 2009, MATER CORROS, V60, P330, DOI 10.1002/maco.200805120
   Zheng YF, 2006, MAT SCI ENG A-STRUCT, V438, P891, DOI 10.1016/j.msea.2006.01.131
   Zhou YL, 2011, J ALLOY COMPD, V509, P6267, DOI 10.1016/j.jallcom.2011.03.045
NR 48
TC 13
Z9 13
U1 1
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2016
VL 62
BP 36
EP 44
DI 10.1016/j.msec.2016.01.019
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA DH4MC
UT WOS:000372759100005
PM 26952395
DA 2018-10-19
ER

PT J
AU Yin, RX
   Zhang, N
   Wu, WT
   Wang, KM
AF Yin, Ruixue
   Zhang, Nan
   Wu, Wentao
   Wang, Kemin
TI Poly(ethylene glycol)-grafted cyclic acetals based polymer networks with
   non-water-swellable, biodegradable and surface hydrophilic properties
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Cyclic acetals; Photopolymerization; Non-water-swellable; Pendent PEG
   chains
ID CELL ENCAPSULATION; DRUG-DELIVERY; HYDROGELS; BONE; PHOTOPOLYMERIZATION;
   SPECTROSCOPY; INITIATORS; CONVERSION
AB Cyclic acetals based biomaterial without acidic products during hydrolytic degradation is a promising candidate for tissue engineering applications; however, low hydrophilicity is still one limitation for its biomedical application. In this work, we aim to achieve non-water-swellable cyclic acetal networks with improved hydrophilicity and surface wettability by copolymerization of cyclic acetal units based monomer, 5-ethyl-5-(hydroxymethyl)-beta,beta-dimethyl-1, 3-dioxane-2-ethanol diacrylate (EHD) and methoxy poly(ethylene glycol) monoacrylate (mPEGA) under UV irradiation, to avoid swelling of conventional hydrogels which could limit their applicability in particular of the mechanical properties and geometry integrity. Various EHD/mPEGA networks were fabricated with different concentrations of mPEGA from 0 to 30%, and the results showed photopolymerization behavior, mechanical property and thermal stability could not be significantly affected by addition of mPEGA, while the surface hydrophilicity was dramatically improved with the increase of mPEGA and could achieve a water contact angle of 37 degrees with 30% mPEGA concentration. The obtained EHD/mPEGA network had comparative degradation rate to the PECA hydrogels reported previously, and WIT assay indicated it was biocompatible to L929 cells. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Yin, Ruixue] E China Univ Sci & Technol, Sch Mech & Power Engn, Complex & Intelligent Res Ctr, Shanghai 200237, Peoples R China.
   [Zhang, Nan; Wu, Wentao; Wang, Kemin] Changzhou Univ, Sch Mat Sci & Engn, Changzhou 213164, Peoples R China.
RP Yin, RX (reprint author), E China Univ Sci & Technol, Sch Mech & Power Engn, Complex & Intelligent Res Ctr, Shanghai 200237, Peoples R China.; Wang, KM (reprint author), Changzhou Univ, Sch Mat Sci & Engn, Changzhou 213164, Peoples R China.
EM qdruinyan@hotmail.com; kemin-wang@hotmail.com
FU National Natural Science Foundation of China [21304011]; priority
   academic program development of Jiangsu Higher Education Institutions;
   Fundamental Research Funds for the Central Universities [22A201514029]
FX The authors would like to thank the National Natural Science Foundation
   of China (21304011) and a project funded by the priority academic
   program development of Jiangsu Higher Education Institutions for its
   financial support, as well as the support of the Fundamental Research
   Funds for the Central Universities (22A201514029).
CR Balci M, 2010, POLYM BULL, V64, P691, DOI 10.1007/s00289-009-0211-3
   Betz MW, 2008, J BIOMED MATER RES A, V86A, P662, DOI 10.1002/jbm.a.31640
   Cai L, 2010, BIOMATERIALS, V31, P4457, DOI 10.1016/j.biomaterials.2010.02.020
   DECKER C, 1989, MACROMOLECULES, V22, P4455, DOI 10.1021/ma00202a013
   Dev A, 2010, CARBOHYD POLYM, V80, P833, DOI 10.1016/j.carbpol.2009.12.040
   Duncan R, 2006, ADV POLYM SCI, V192, P1, DOI 10.1007/12_037
   Erin E., 2008, PHARM RES, V25, P2348
   Falco E. E., 2007, J SURG RES, V149, P76
   Finne-Wistrand A, 2006, ANNU REV MATER RES, V36, P369, DOI 10.1146/annurev.matsci.36.032905.091005
   HAZER B, 1992, MAKROMOL CHEM, V193, P1081
   HAZER B, 1995, MACROMOL CHEM PHYSIC, V196, P1945, DOI 10.1002/macp.1995.021960614
   Hazer B, 2015, POLYM DEGRAD STABIL, V119, P159, DOI 10.1016/j.polymdegradstab.2015.04.024
   Hwang DK, 2009, J AM CHEM SOC, V131, P4499, DOI 10.1021/ja809256d
   JANMEY PA, 1994, J BIOL CHEM, V269, P32503
   Kaihara S, 2008, EUR J PHARM BIOPHARM, V68, P67, DOI 10.1016/j.ejpb.2007.05.019
   Kaihara S, 2007, MACROMOLECULES, V40, P7625, DOI 10.1021/ma071297p
   Kamata H, 2014, SCIENCE, V343, P873, DOI 10.1126/science.1247811
   Kutikov AB, 2013, ACTA BIOMATER, V9, P8354, DOI 10.1016/j.actbio.2013.06.013
   Lee S, 2015, ORG BIOMOL CHEM, V13, P8445, DOI 10.1039/c5ob01056j
   Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055
   Moreau JL, 2007, J BIOMED MATER RES A, V81A, P594, DOI 10.1002/jbm.a.31104
   Rao BS, 2008, PROG ORG COAT, V63, P416, DOI 10.1016/j.porgcoat.2008.07.001
   Scherzer T, 2005, POLYMER, V46, P7072, DOI 10.1016/j.polymer.2005.05.142
   Schlosser M, 2005, J BIOMED MATER RES A, V72A, P317, DOI 10.1002/jbm.a.30240
   Stansbury JW, 2001, DENT MATER, V17, P71, DOI 10.1016/S0109-5641(00)00062-2
   Starr B, 2001, POLYMER, V42, P8727, DOI 10.1016/S0032-3861(01)00300-7
   Tang MJ, 2015, POLYM CHEM-UK, V6, P6671, DOI 10.1039/c5py00734h
   Wang KM, 2013, MAT SCI ENG C-MATER, V33, P1261, DOI 10.1016/j.msec.2012.12.024
   Wang SF, 2015, ADV FUNCT MATER, V25, P2715, DOI 10.1002/adfm.201500105
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Wolf MT, 2015, ADV DRUG DELIVER REV, V84, P208, DOI 10.1016/j.addr.2014.08.011
   Yin RX, 2015, MAT SCI ENG C-MATER, V46, P239, DOI 10.1016/j.msec.2014.10.040
   Zhang H.B., 2014, TISSUE ENG PART B-RE, V5, P492
NR 33
TC 1
Z9 1
U1 5
U2 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2016
VL 62
BP 137
EP 143
DI 10.1016/j.msec.2016.01.038
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA DH4MC
UT WOS:000372759100017
PM 26952407
DA 2018-10-19
ER

PT J
AU Nakamura, M
   Hori, N
   Ando, H
   Namba, S
   Toyama, T
   Nishimiya, N
   Yamashita, K
AF Nakamura, Miho
   Hori, Naoko
   Ando, Hiroshi
   Namba, Saki
   Toyama, Takeshi
   Nishimiya, Nobuyuki
   Yamashita, Kimihiro
TI Surface free energy predominates in cell adhesion to hydroxyapatite
   through wettability
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Cell adhesion; Wettability; Surface free energy; Surface
   characteristics; Hydroxyapatite
ID ELECTRICALLY POLARIZED HYDROXYAPATITE; HUMAN OSTEOBLASTIC CELLS; INITIAL
   ATTACHMENT; CALCIUM-PHOSPHATE; BEHAVIOR; MINERALIZATION; CYTOSKELETAL;
   EXPRESSION; RESPONSES; COATINGS
AB The initial adhesion of cells to biomaterials is critical in the regulation of subsequent cell behaviors. The purpose of this study was to investigate a mechanism through which the surface wettability of biomaterials can be improved and determine the effects of biomaterial surface characteristics on cellular behaviors. We investigated the surface characteristics of various types of hydroxyapatite after sintering in different atmospheres and examined the effects of various surface characteristics on cell adhesion to study cell-biomaterial interactions. Sintering atmosphere affects the polarization capacity of hydroxyapatite by changing hydroxide ion content and grain size. Compared with hydroxyapatite sintered in air, hydroxyapatite sintered in saturated water vapor had a higher polarization capacity that increased surface free energy and improved wettability, which in turn accelerated cell adhesion. We determined the optimal conditions of hydroxyapatite polarization for the improvement of surface wettability and acceleration of cell adhesion. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Nakamura, Miho; Hori, Naoko; Namba, Saki; Yamashita, Kimihiro] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
   [Ando, Hiroshi; Namba, Saki; Toyama, Takeshi; Nishimiya, Nobuyuki] Nihon Univ, Dept Mat & Appl Chem, Chiyoda Ku, 1-5-1 Kanda Surugadai, Tokyo 1018308, Japan.
RP Nakamura, M (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo 1010062, Japan.
EM miho.bcr@tmd.ac.jp
RI Nakamura, Miho/T-3166-2017
FU Sumitomo Foundation [15K20472, 26670847]; Shiseido Female Researcher
   Science Grant; Murata Foundation
FX This study was supported in part by Grants-in-Aid for Young Scientists
   (B) (15K20472) and for Exploratory Research (26670847), Grant for Basic
   Science Research Projects from the Sumitomo Foundation, the Shiseido
   Female Researcher Science Grant and the Murata Foundation.
CR Advincula MC, 2006, BIOMATERIALS, V27, P2201, DOI 10.1016/j.biomaterials.2005.11.014
   Aronov D, 2007, J EUR CERAM SOC, V27, P4181, DOI 10.1016/j.jeurceramsoc.2007.02.121
   Bodhak S, 2009, ACTA BIOMATER, V5, P2178, DOI 10.1016/j.actbio.2009.02.023
   Champion E, 2013, ACTA BIOMATER, V9, P5855, DOI 10.1016/j.actbio.2012.11.029
   CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514
   Costa DO, 2013, BIOMATERIALS, V34, P7215, DOI 10.1016/j.biomaterials.2013.06.014
   Dasgupta S, 2013, MAT SCI ENG C-MATER, V33, P2846, DOI 10.1016/j.msec.2013.03.004
   FOWKES FM, 1963, J PHYS CHEM-US, V67, P2538, DOI 10.1021/j100806a008
   Goldstein C, 2010, J ORTHOP TRAUMA, V24, pS62, DOI 10.1097/BOT.0b013e3181cdde1b
   Hao L, 2005, J MATER SCI-MATER M, V16, P719, DOI 10.1007/s10856-005-2608-3
   Horiuchi N, 2012, J APPL PHYS, V112, DOI 10.1063/1.4754298
   Kim MS, 2007, TISSUE ENG, V13, P2095, DOI 10.1089/ten.2006.0062
   Kim SH, 2007, J BIOMAT SCI-POLYM E, V18, P609, DOI 10.1163/156856207780852514
   Kobayashi T, 2001, J BIOMED MATER RES, V57, P477, DOI 10.1002/1097-4636(20011215)57:4<477::AID-JBM1193>3.0.CO;2-5
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791
   Nakamura M, 2006, J BIOMED MATER RES A, V79A, P627, DOI 10.1002/jbm.a.30827
   Nakamura M, 2009, ACS APPL MATER INTER, V1, P2181, DOI 10.1021/am900341v
   Nakamura M, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/1/011001
   Nakamura M, 2010, J BIOMED MATER RES A, V92A, P783, DOI 10.1002/jbm.a.32404
   Nakamura S, 2001, J APPL PHYS, V89, P5386, DOI 10.1063/1.1357783
   Nakamura S, 2009, J MATER SCI-MATER M, V20, P99, DOI 10.1007/s10856-008-3546-7
   Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452
   Okumura A, 2001, BIOMATERIALS, V22, P2263, DOI 10.1016/S0142-9612(00)00415-4
   Redey SA, 2000, J BIOMED MATER RES, V50, P353, DOI 10.1002/(SICI)1097-4636(20000605)50:3<353::AID-JBM9>3.0.CO;2-C
   Rouahi M, 2006, BIOMATERIALS, V27, P2829, DOI 10.1016/j.biomaterials.2006.01.001
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   Thian ES, 2010, ACTA BIOMATER, V6, P750, DOI 10.1016/j.actbio.2009.08.012
   Wang YS, 2008, J BIOMED MATER RES A, V84A, P769, DOI 10.1002/jbm.a.31289
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   YAMASHITA K, 1995, J AM CERAM SOC, V78, P1191, DOI 10.1111/j.1151-2916.1995.tb08468.x
   Yang L, 2010, BIOMATERIALS, V31, P2976, DOI 10.1016/j.biomaterials.2010.01.002
NR 33
TC 9
Z9 9
U1 3
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2016
VL 62
BP 283
EP 292
DI 10.1016/j.msec.2016.01.037
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA DH4MC
UT WOS:000372759100035
PM 26952425
DA 2018-10-19
ER

PT J
AU Chen, YH
   Cheng, CH
   Chang, WJ
   Lin, YC
   Lin, FH
   Lin, JC
AF Chen, Yen-Hsuan
   Cheng, Chi-Hui
   Chang, Wan-Ju
   Lin, Yi-Ching
   Lin, Feng-Huei
   Lin, Jui-Che
TI Studies of magnetic alginate-based electrospun matrices crosslinked with
   different methods for potential hyperthermia treatment
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Alginate; Electrospinning; Magnetic electrospun mats; Hyperthermia;
   Magnetic nanoparticles
ID CHITOSAN NANOFIBER COMPOSITE; FE3O4 NANOPARTICLES; FIBERS; FABRICATION;
   ADHESION
AB The magnetic electrospun mats were lately established as an innovative biomaterial for hyperthermic cancer treatment. Unlike those surface-modified magnetic nanoparticles that may not firmly adhere onto the tumor for long-term duration, the magnetic mats with nanofibrous structure can promote cell adhesion and kill the tumor directly within an alternating magnetic field. However, most magnetic electrospun mats were fabricated using non-biodegradable polymers and organic solvents, causing the problems of removal after therapy and the suspected biotoxicity associated with residual solvent. Alginate (SA) was utilized in this investigation as the main material for electrospinning because of being biodegradable and water-soluble. The alginate-based electrospun mats were then treated by an ionic or a covalent crosslinking method, and then followed by chelation with Fe2+/Fe3+ for chemical coprecipitation of Fe3O4 magnetic nanoparticles. Significant less cytotoxicity was noted on both liquid extracts from the ionic-crosslinked (Fe3O4-SA/PEO) and covalent-crosslinked (Fe3O4-SA/PVA) magnetic electrospun mats as well as the surface of Fe3O4-SA/PVA. In vitro hyperthermia assay indicated that the covalent-crosslinked magnetic alginate-based mats reduced tumor cell viability greater than Fe3O4 nanoparticles. Such magnetic electrospun mats are of potential for hyperthermia treatment by endoscopic/surgical delivery as well as serving as a supplementary debridement treatment after surgical tumor removal. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Chen, Yen-Hsuan; Chang, Wan-Ju; Lin, Jui-Che] Natl Cheng Kung Univ, Dept Chem Engn, Tainan 70101, Taiwan.
   [Cheng, Chi-Hui] Chang Gung Mem Hosp, Div Pediat Nephrol, Dept Pediat, Taoyuan 33305, Taiwan.
   [Cheng, Chi-Hui] Chang Gung Univ, Coll Med, Taoyuan 33302, Taiwan.
   [Lin, Yi-Ching] Fooyin Univ, Gen Educ Ctr, Kaohsiung 83102, Taiwan.
   [Lin, Yi-Ching] Fooyin Univ, Dept Phys Therapy, Kaohsiung 83102, Taiwan.
   [Lin, Feng-Huei] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10051, Taiwan.
   [Lin, Jui-Che] Natl Cheng Kung Univ, Inst Oral Med, Coll Med, Tainan 70101, Taiwan.
RP Lin, JC (reprint author), Natl Cheng Kung Univ, Dept Chem Engn, Tainan 70101, Taiwan.
EM jclin@mail.ncku.edu.tw
FU Ministry of Science and Technology, Taiwan [NSC 98-2221-E-006-054-MY3,
   NSC 100-2221-E-006-128-MY2, NSC 102-2221-E-006-184-MY3, MOST
   103-2314-B-182-022-MY3]
FX The financial support from the Ministry of Science and Technology
   (formerly known as National Science Council), Taiwan under Grant NSC
   98-2221-E-006-054-MY3, NSC 100-2221-E-006-128-MY2, NSC
   102-2221-E-006-184-MY3, and MOST 103-2314-B-182-022-MY3 is gratefully
   appreciated.
CR Amarjargal A, 2013, EUR POLYM J, V49, P3796, DOI 10.1016/j.eurpolymj.2013.08.026
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Bhattarai N, 2006, ADV MATER, V18, P1463, DOI 10.1002/adma.200502537
   Bhattarai N, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/45/455601
   Bonino CA, 2011, CARBOHYD POLYM, V85, P111, DOI 10.1016/j.carbpol.2011.02.002
   Chen L, 2011, J BIOMED MATER RES A, V99A, P395, DOI 10.1002/jbm.a.33202
   Durmus Z, 2011, POLYHEDRON, V30, P322, DOI 10.1016/j.poly.2010.10.028
   Fang N, 2005, COLLOID SURFACE B, V42, P245, DOI 10.1016/j.colsurfb.2004.11.002
   Fouda MMG, 2013, CARBOHYD POLYM, V92, P1012, DOI 10.1016/j.carbpol.2012.10.047
   Ho YC, 2009, INT J PHARMACEUT, V376, P69, DOI 10.1016/j.ijpharm.2009.04.048
   Huang CB, 2012, ADV FUNCT MATER, V22, P2479, DOI 10.1002/adfm.201102171
   Jeong SI, 2010, MACROMOL BIOSCI, V10, P934, DOI 10.1002/mabi.201000046
   Kim YJ, 2013, ADV FUNCT MATER, V23, P5753, DOI 10.1002/adfm.201300746
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lin TC, 2013, J BIOMAT SCI-POLYM E, V24, P1152, DOI 10.1080/09205063.2012.743061
   Lin TC, 2012, ACTA BIOMATER, V8, P2704, DOI 10.1016/j.actbio.2012.03.045
   Mansur HS, 2008, MAT SCI ENG C-BIO S, V28, P539, DOI 10.1016/j.msec.2007.10.088
   Mincheva R, 2008, EUR POLYM J, V44, P615, DOI 10.1016/j.eurpolymj.2007.11.001
   Miraftab M, 2003, CARBOHYD POLYM, V53, P225, DOI 10.1016/S0144-8617(03)00108-5
   Morimune S, 2012, POLYM J, V44, P1056, DOI 10.1038/pj.2012.58
   Nie HR, 2008, BIOMACROMOLECULES, V9, P1362, DOI 10.1021/bm701349j
   Papageorgiou SK, 2010, CARBOHYD RES, V345, P469, DOI 10.1016/j.carres.2009.12.010
   Park CH, 2013, CERAM INT, V39, P9785, DOI 10.1016/j.ceramint.2013.05.042
   Pawar SN, 2012, BIOMATERIALS, V33, P3279, DOI 10.1016/j.biomaterials.2012.01.007
   Qi HX, 2006, BIOMACROMOLECULES, V7, P2327, DOI 10.1021/bm060264z
   Qin YM, 2008, POLYM INT, V57, P171, DOI 10.1002/pi.2296
   Savva I., 2013, BIOMACROMOLECULES, V14, P4436
   Sharma N, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/8/085707
   Sharma S, 2012, RSC ADV, V2, P5837, DOI 10.1039/c2ra00006g
   Song HH, 2014, MATER RES BULL, V53, P280, DOI 10.1016/j.materresbull.2014.02.026
   Stone R, 2013, J APPL POLYM SCI, V130, P1975, DOI 10.1002/app.39408
   Sun J, 2007, J BIOMED MATER RES A, V80A, P333, DOI 10.1002/jbm.a.30909
   Uyar T, 2009, EUR POLYM J, V45, P1032, DOI 10.1016/j.eurpolymj.2008.12.024
   Wang A, 2004, POLYMER, V45, P5505, DOI 10.1016/j.polymer.2004.06.013
   Wang B, 2010, J APPL POLYM SCI, V115, P1781, DOI 10.1002/app.31288
   Wang SH, 2010, MATER LETT, V64, P9, DOI 10.1016/j.matlet.2009.09.043
   Xin Y, 2009, J APPL PHYS, V105, DOI 10.1063/1.3116552
   Yang DZ, 2010, PLAST RUBBER COMPOS, V39, P6, DOI 10.1179/146580109X12540995045363
   Zhang CC, 2009, APPL PHYS A-MATER, V97, P281, DOI [10.1007/s00339-009-53789, 10.1007/s00339-009-5378-9]
   Zhang D, 2009, POLYMER, V50, P4189, DOI 10.1016/j.polymer.2009.06.062
   Zhong Y, 2015, J MAGN MAGN MATER, V380, P330, DOI 10.1016/j.jmmm.2014.09.069
NR 41
TC 4
Z9 4
U1 9
U2 75
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2016
VL 62
BP 338
EP 349
DI 10.1016/j.msec.2016.01.070
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA DH4MC
UT WOS:000372759100042
PM 26952432
DA 2018-10-19
ER

PT J
AU Ma, FC
   Chen, S
   Liu, P
   Geng, F
   Li, W
   Liu, XK
   He, DH
   Pan, D
AF Ma, Fengcang
   Chen, Sai
   Liu, Ping
   Geng, Fang
   Li, Wei
   Liu, Xinkuan
   He, Daihua
   Pan, Deng
TI Improvement of beta-TCP/PLLA biodegradable material by surface
   modification with stearic acid
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Tricalcium phosphate; Interfacial compatibility; Surface modification;
   Hydrophilicity; Mechanical properties
ID COMPOSITE FILMS; IN-VITRO; HYDROXYAPATITE; FILLER; WETTABILITY;
   SCAFFOLDS; RESPONSES
AB Poly-L-lactide (PLLA) is a biodegradable polymer and used widely. Incorporation of beta tricalcium phosphate (beta-TCP) into PLLA can enhance its osteoinductive properties. But the interfacial layer between beta-TCP particles with PLLA matrix is easy to be destroyed due to inferior interfacial compatibility of the organic/inorganic material. In this work, a method of beta-TCP surface modification with stearic acid was investigated to improve the beta-TCP/PLLA biomaterial. The effects of surface modification on the beta-TCP were investigated by FTIR, XPS, TGA and CA. It was found that the stearic acid reacted with beta-TCP and oxhydryl was formed during the surface modification. Hydrophilicity of untreated or modified beta-TCP/PLLA composite was increased by the addition of 10 wt% beta-TCP, but it decreased as the addition amount increased from 10 wt.% to 20 wt.%. Two models were suggested to describe the effect of beta-TCP concentration on CA of the composites. Mechanical properties of beta-TCP/PLLA composites were tested by bending and tensile tests. Fractures of the composites after mechanical test were observed by SEM. It was found that surface modification with stearic acid improved bending and tensile strengths of the beta-TCP/PLLA composites obviously. The SEM results indicated that surface modification decreased the probability of interface debonding between fillers and matrix under load. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Ma, Fengcang; Liu, Ping; Li, Wei; Liu, Xinkuan; He, Daihua; Pan, Deng] Univ Shanghai Sci & Technol, Sch Mat Sci & Engn, Shanghai 200093, Peoples R China.
   [Chen, Sai] Univ Shanghai Sci & Technol, Sch Mech Engn, Shanghai 200093, Peoples R China.
   [Geng, Fang] Shanghai MicroPort Orthoped Co Ltd Liabil, Shanghai 201318, Peoples R China.
RP Ma, FC (reprint author), Univ Shanghai Sci & Technol, Sch Mat Sci & Engn, Shanghai 200093, Peoples R China.
EM mafengcang@163.com
RI Pan, Deng/A-1090-2018
FU National Research Fund of Science and Technology Commission of Shanghai
   Municipality [09ZR1422100]; Fund of Science and Technology Commission of
   Shanghai Municipality [11441900501]; Innovation Research Fund of
   Shanghai Municipal Commission of Education [10YZ94]; Key Laboratory of
   Advanced Metal-based Electrical Power Materials
FX The authors would like to acknowledge the financial support provided by
   the National Research Fund of Science and Technology Commission of
   Shanghai Municipality under Grant No. 09ZR1422100, the Fund of Science
   and Technology Commission of Shanghai Municipality under Grant No.
   11441900501, the Innovation Research Fund of Shanghai Municipal
   Commission of Education under Grant No. 10YZ94 and Key Laboratory of
   Advanced Metal-based Electrical Power Materials.
CR Carmen K., 2003, BIOMATERIALS, V24, P967
   Cerrai P, 1999, J MATER SCI-MATER M, V10, P283, DOI 10.1023/A:1008905529461
   Daculsi G, 2011, BIOMATERIALS, V32, P3166, DOI 10.1016/j.biomaterials.2011.01.033
   Deb S, 1996, J MATER SCI-MATER M, V7, P191, DOI 10.1007/BF00119729
   DOYLE C, 1991, BIOMATERIALS, V12, P841, DOI 10.1016/0142-9612(91)90072-I
   Dupraz AMP, 1996, J MATER SCI-MATER M, V7, P731, DOI 10.1007/BF00121408
   Hu K, 2007, J BIOACT COMPAT POL, V22, P395, DOI 10.1177/0883911507079893
   Huang HH, 2008, J APPL POLYM SCI, V107, P3325, DOI 10.1002/app.24894
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Karnnet S, 2005, POLYM DEGRAD STABIL, V90, P106, DOI 10.1016/j.polymdegradstab.2005.02.016
   Kikuchi M, 2002, J BIOMED MATER RES, V62, P265, DOI 10.1002/jbm.10248
   Kobayashi S, 2010, COMPOS SCI TECHNOL, V70, P1820, DOI 10.1016/j.compscitech.2010.06.008
   Liao JG, 2009, CHINESE J INORG CHEM, V25, P1267
   Liao JG, 2015, PROG CHEM, V27, P220, DOI 10.7536/PC140810
   Liu Q, 1998, J BIOMED MATER RES, V40, P490, DOI 10.1002/(SICI)1097-4636(19980605)40:3<490::AID-JBM20>3.0.CO;2-M
   Liu Q, 1998, J MATER SCI-MATER M, V9, P23, DOI 10.1023/A:1008826410395
   Liu Q., 1996, J MATER SCI-MATER M, V7, P51
   Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016
   [Ma Ming 马铭], 2012, [影像科学与光化学, Imaging Science and Photochemistry], V30, P269
   Manoudis N.P., 2014, PROG ORG COAT, V77, P331
   Manoudis PN, 2008, LANGMUIR, V24, P11225, DOI 10.1021/la801817e
   Nie T.C., 2008, CHINA SURFACTANT DET, V8, P16
   Quan D.P., 2001, ACTA MAT COMPOS SIN, V18, P22
   Schutzius TM, 2012, NANOSCALE, V4, P5378, DOI 10.1039/c2nr30979c
   Setzer B, 2009, BIOMATERIALS, V30, P979, DOI 10.1016/j.biomaterials.2008.10.054
   Teo WE, 2011, ACTA BIOMATER, V7, P193, DOI 10.1016/j.actbio.2010.07.041
   Tiwari MK, 2010, ACS APPL MATER INTER, V2, P1114, DOI 10.1021/am900894n
   Vivet L, 2013, APPL SURF SCI, V287, P13, DOI 10.1016/j.apsusc.2013.09.042
   Yang MJ, 2012, J COLLOID INTERF SCI, V368, P603, DOI 10.1016/j.jcis.2011.11.037
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yu HX, 2003, J APPL POLYM SCI, V88, P2557, DOI 10.1002/app.12093
   Zhou JL, 1990, ACTA PHYS-CHIM SIN, V6, P629, DOI 10.3866/PKU.WHXB19900522
NR 32
TC 7
Z9 7
U1 2
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2016
VL 62
BP 407
EP 413
DI 10.1016/j.msec.2016.01.087
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA DH4MC
UT WOS:000372759100050
DA 2018-10-19
ER

PT J
AU Singh, AK
   Gajiwala, AL
   Rai, RK
   Khan, MP
   Singh, C
   Barbhuyan, T
   Vijayalakshmi, S
   Chattopadhyay, N
   Sinha, N
   Kumar, A
   Bellare, JR
AF Singh, Atul Kumar
   Gajiwala, Astrid Lobo
   Rai, Ratan Kumar
   Khan, Mohd. Parvez
   Singh, Chandan
   Barbhuyan, Tarun
   Vijayalakshmi, S.
   Chattopadhyay, Naibedya
   Sinha, Neeraj
   Kumar, Ashutosh
   Bellare, Jayesh R.
TI Cross-correlative 3D micro-structural investigation of human bone
   processed into bone allografts
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Human bone; Allograft; Solid state NMR; Scanning electron microscopy;
   Bone; Processing; MIMICS
ID CORTICAL BONE; GAMMA-IRRADIATION; OSTEOPROTEGERIN; OSTEOPOROSIS;
   SUBSTITUTE; INTERFACE; COLLAGEN; RANKL; CELLS; WATER
AB Bone allografts (BA) are a cost-effective and sustainable alternative in orthopedic practice as they provide a permanent solution for preserving skeletal architecture and function. Such BA however, must be processed to be disease free and immunologically safe as well as biologically and clinically useful. Here, we have demonstrated a processing protocol for bone allografts and investigated the micro-structural properties of bone collected from osteoporotic and normal human donor samples. In order to characterize BA at different microscopic levels, a combination of techniques such as Solid State Nuclear Magnetic Resonance (ssNMR), Scanning Electron Microscope (SEM), micro-computed tomography (mu CT) and Thermal Gravimetric Analysis (TGA) were used for delineating the ultra-structural property of bone. ssNMR revealed the extent of water, collagen fine structure and crystalline order in the bone. These were greatly perturbed in the bone taken from osteoporotic bone donor. Among the processing methods analyzed, pasteurization at 60 degrees C and radiation treatment appeared to substantially alter the bone integrity. SEM study showed a reduction in Ca/P ratio and non-uniform distribution of elements in osteoporotic bones. mu-CT and MIMICS (R) (Materialize Interactive Medical Image Control System) demonstrated that pasteurization and radiation treatment affects the BA morphology and cause a shift in the HU unit. However, the combination of all these processes restored all-important parameters that are critical for BA integrity and sustain ability. Cross-correlation between the various probes we used quantitatively demonstrated differences in morphological and micro-structural properties between BA taken from normal and osteoporotic human donor. Such details could also be instrumental in designing an appropriate bone scaffold. For the best restoration of bone microstructure and to be used as a biomaterial allograft, a step-wise processing method is recommended that preserves all critical parameters of bone, showing a significant advancements over currently existing methods. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Singh, Atul Kumar; Vijayalakshmi, S.; Bellare, Jayesh R.] Indian Inst Technol, Ctr Res Nanotechnol & Sci, Bombay 400076, Maharashtra, India.
   [Gajiwala, Astrid Lobo] Tata Mem Hosp, Tissue Bank, Bombay 400012, Maharashtra, India.
   [Rai, Ratan Kumar; Singh, Chandan; Sinha, Neeraj] Ctr Biomed Res, SGPGIMS Campus, Lucknow 226014, Uttar Pradesh, India.
   [Khan, Mohd. Parvez; Barbhuyan, Tarun; Chattopadhyay, Naibedya] CSIR Cent Drug Res Inst, Ctr Res Anabol Skeletal Targets Hlth & Illness AS, Div Endocrinol, Lucknow 226031, Uttar Pradesh, India.
   [Kumar, Ashutosh] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.
   [Bellare, Jayesh R.] Indian Inst Technol, Dept Chem Engn, Bombay 400076, Maharashtra, India.
RP Sinha, N (reprint author), Ctr Biomed Res, SGPGIMS Campus, Lucknow 226014, Uttar Pradesh, India.; Kumar, A (reprint author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.; Bellare, JR (reprint author), Indian Inst Technol, Dept Chem Engn, Bombay 400076, Maharashtra, India.
EM neerajcbmr@gmail.com; ashutoshk@iitb.ac.in; jb@iitb.ac.in
RI Rai, Ratan/N-6344-2018
OI Rai, Ratan/0000-0001-6015-5539; Singh, Chandan/0000-0001-8006-1329
FU Department of Science & Technology (DST), Government of India; CSIR
   [BSC0201]; DBT, India [BT/PR12700/BRB/10/719/2009,
   BT/PR3138/NNT/28/550/2011]; DST, India [SR/SO/BB/022/2012]; CSIR, India
   [37(1509)/11/EMRII]
FX The authors are grateful for the technical assistance provided by Ms.
   Urmila Samant and Ms. Cynthia D'Lima at the Tissue Bank, TMH, Mumbai,
   for processing the human bone samples according to the various
   protocols. The authors are also thankful to Sophisticated Analytical
   Instrument Facility (SAIF) and Centre for Research in Nanotechnology and
   Science (CRNTS), Indian Institute of Technology Bombay, Mumbai for the
   SEM and TGA Facility. We thank Rajan Singh, Nitin Sagar, Mayur Temgire
   and Rohit Teotia for helping in characterization. Atul Kumar Singh is
   supported by a fellowship DST-INSPIRE from the Department of Science &
   Technology (DST), Government of India. NC acknowledges funding from CSIR
   (BSC0201). NS acknowledge funding from DBT, India
   (BT/PR12700/BRB/10/719/2009). AK acknowledges funding from DST, India
   (SR/SO/BB/022/2012) and CSIR, India (37(1509)/11/EMRII). JRB
   acknowledges funding from DBT, India (BT/PR3138/NNT/28/550/2011).
CR [Anonymous], 2004, WHO TECHN REP SER, V924
   Baharuddin MY, 2014, BIOMED RES INT, DOI 10.1155/2014/692328
   Bezerra MC, 2005, BRAZ J MED BIOL RES, V38, P161, DOI 10.1590/S0100-879X2005000200004
   Board TN, 2006, J BONE JOINT SURG BR, V88B, P852, DOI 10.1302/0301-620X.88B7.17425
   Boskey AL, 2010, J DENT RES, V89, P1333, DOI 10.1177/0022034510377791
   Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141
   Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260
   CASSELLA JP, 1995, CALCIFIED TISSUE INT, V56, P118, DOI 10.1007/BF00296342
   Catanese J, 1999, J BIOMED MATER RES, V45, P327, DOI 10.1002/(SICI)1097-4636(19990615)45:4<327::AID-JBM7>3.0.CO;2-L
   Centers for Disease Control and Prevention, 2003, MMWR-MORBID MORTAL W, V52, p[273, 276]
   Cornu O, 2000, J ORTHOPAED RES, V18, P426, DOI 10.1002/jor.1100180314
   DANIELSEN CC, 1994, BONE, V15, P91, DOI 10.1016/8756-3282(94)90897-4
   Eastlund T, 2010, ESSENTIALS OF TISSUE BANKING, P167, DOI 10.1007/978-90-481-9142-0_11
   Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896
   Gajiwala A. Lobo, 2003, Cell and Tissue Banking, V4, P125
   Gardin C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132344
   Ireland Lyn, 2005, Cell and Tissue Banking, V6, P181, DOI 10.1007/s10561-005-7365-5
   Janicki P, 2011, INJURY, V42, pS77, DOI 10.1016/j.injury.2011.06.014
   Jones DH, 2002, ANN RHEUM DIS, V61, P32
   Kaflak-Hachulska A, 2003, CALCIFIED TISSUE INT, V73, P476, DOI 10.1007/s00223-002-2111-5
   Kaminski A, 2012, CELL TISSUE BANK, V13, P363, DOI 10.1007/s10561-012-9308-2
   Kothiwale SV, 2009, CELL TISSUE BANK, V10, P317, DOI 10.1007/s10561-009-9126-3
   LANDIS WJ, 1978, J ULTRA MOL STRUCT R, V63, P188, DOI 10.1016/S0022-5320(78)80074-4
   Lau ML, 2013, COMPOS PART B-ENG, V55, P447, DOI 10.1016/j.compositesb.2013.06.027
   Levitt M.H., 1990, ADV MAGN RESON, V14, P111
   McGilvray KC, 2011, CELL TISSUE BANK, V12, P89, DOI 10.1007/s10561-010-9170-z
   Moreau MF, 2000, BIOMATERIALS, V21, P369, DOI 10.1016/S0142-9612(99)00193-3
   Nguyen Huynh, 2007, Cell and Tissue Banking, V8, P93, DOI 10.1007/s10561-006-9020-1
   Nguyen H, 2011, J ARTHROPLASTY, V26, P303, DOI 10.1016/j.arth.2010.03.032
   Nyman JS, 2013, J MECH BEHAV BIOMED, V22, P136, DOI 10.1016/j.jmbbm.2012.08.013
   Oryan A, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-18
   Rai RK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083478
   Rai RK, 2011, J PHYS CHEM C, V115, P14219, DOI 10.1021/jp2025768
   Rutala WA, 2008, GUIDELINE DISINFECTI
   Sastry TP, 2007, CLIN BIOCHEM, V40, P907, DOI 10.1016/j.clinbiochem.2007.04.011
   Seeman E, 1997, J BONE MINER RES, V12, P509, DOI 10.1359/jbmr.1997.12.4.509
   Shah M., 2014, CELL TISSUE BANK, P1
   Singh C, 2013, SOLID STATE NUCL MAG, V54, P18, DOI 10.1016/j.ssnmr.2013.05.003
   Trivedi R, 2010, EXPERT OPIN INV DRUG, V19, P995, DOI 10.1517/13543784.2010.501077
   Tuan HS, 2005, COMPUT AIDED DESIGN, V37, P1151, DOI 10.1016/j.cad.2005.02.006
   Zhao WL, 2014, LANGMUIR, V30, P13283, DOI 10.1021/la503158p
   Zhu PZ, 2009, J AM CHEM SOC, V131, P17064, DOI 10.1021/ja9081028
   Zoricic S, 2002, ACTA MED OKAYAMA, V56, P121
NR 43
TC 3
Z9 4
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2016
VL 62
BP 574
EP 584
DI 10.1016/j.msec.2016.02.002
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA DH4MC
UT WOS:000372759100071
PM 26952461
DA 2018-10-19
ER

PT J
AU Kandimalla, R
   Kalita, S
   Choudhury, B
   Devi, D
   Kalita, D
   Kalita, K
   Dash, S
   Kotoky, J
AF Kandimalla, Raghuram
   Kalita, Sanjeeb
   Choudhury, Bhaswati
   Devi, Dipali
   Kalita, Dhaneswar
   Kalita, Kasturi
   Dash, Suvakanta
   Kotoky, Jibon
TI Fiber from ramie plant (Boehmeria nivea): A novel suture biomaterial
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Ramie plant fiber; Suture biomaterial; Biocompatible; Superficial
   wounds; BMSF
ID ASSAMA SILK FIBROIN; HEMOCOMPATIBILITY; BIOCOMPATIBILITY; NANOPARTICLES;
   MECHANISMS; RESISTANCE; CELLULOSE
AB The quest for developing an ideal suture material prompted our interest to develop a novel suture with advantageous characters to market available ones. From natural origin only silk, cotton and linen fibers are presently available in market as non-absorbable suture biomaterials. In this study, we have developed a novel, cost-effective, and biocompatible suture biomaterial from ramie plant, Boehmeria nivea fiber. Field emission scanning electron microscopy (FE-SEM), energy-dispersive X-ray spectroscopy (EDX), attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR) and thermo gravimetric analysis (TGA) results revealed the physicochemical properties of raw and degummed ramie fiber, where the former one showed desirable characteristics for suture preparation. The braided multifilament ramie suture prepared from degummed fiber exhibited excellent tensile strength. The suture found to be biocompatible towards human erythrocytes and nontoxic to mammalian cells. The fabricated ramie suture exhibited significant antibacterial activity against Escherichia coli, Bacillus subtilis and Staphylococcus aureus; which can be attributed to the inherent bacteriostatic ability of ramie plant fiber. In vivo wound closure efficacy was evaluated in adult male wister rats by suturing the superficial wound incisions. Within seven days of surgery the wound got completely healed leaving no rash and scar. The role of the ramie suture in complete wound healing was supported by the reduced levels of serum inflammatory mediators. Histopathology studies confirmed the wound healing ability of ramie suture, as rapid synthesis of collagen, connective tissue and other skin adnexal structures were observed within seven days of surgery. Tensile properties, biocompatibility and wound closure efficacy of the ramie suture were comparable with market available BMSF suture. The outcome of this study can drive tremendous possibility for the utilization of ramie plant fiber for various biomedical applications. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Kandimalla, Raghuram; Kalita, Sanjeeb; Choudhury, Bhaswati; Kotoky, Jibon] Inst Adv Study Sci & Technol, Drug Discovery Lab, Gauhati 781035, Assam, India.
   [Devi, Dipali] Inst Adv Study Sci & Technol, Seri Biotech Lab, Gauhati 781035, Assam, India.
   [Kalita, Dhaneswar] Govt Ayurved Coll & Hosp, Gauhati 781014, Assam, India.
   [Kalita, Kasturi] Hayat Hosp, Dept Pathol, Gauhati 781034, Assam, India.
   [Dash, Suvakanta] Girijananda Chowdhury Inst Pharmaceut Sci, Gauhati 781017, Assam, India.
RP Kotoky, J (reprint author), Inst Adv Study Sci & Technol, Drug Discovery Lab, Gauhati 781035, Assam, India.
EM jkotoky@gmail.com
OI Kandimalla, Raghuram/0000-0002-9202-4071
CR Achrai B, 2015, MAT SCI ENG C-MATER, V53, P128, DOI 10.1016/j.msec.2015.04.040
   [Anonymous], 2015, GLOB IND AN SIZ SHAR, P2015
   Brigida AIS, 2010, CARBOHYD POLYM, V79, P832, DOI 10.1016/j.carbpol.2009.10.005
   Celeste C., 2008, SELECTION SUTURE MAT, P194
   Chellamani K. P., 2013, J ACAD IND RES, V1, P778
   Choudhury AJ, 2016, SURGERY, V159, P539, DOI 10.1016/j.surg.2015.07.022
   Choudhury AJ, 2016, MAT SCI ENG C-MATER, V60, P475, DOI 10.1016/j.msec.2015.11.070
   Choudhury B., 2016, FRONT PHARM
   Gogoi D., 2013, BIOPOLYMERS, V101, P355
   Justinger C, 2009, SURGERY, V145, P330, DOI 10.1016/j.surg.2008.11.007
   Kalita S, 2016, MAT SCI ENG C-MATER, V61, P720, DOI 10.1016/j.msec.2015.12.078
   Kalita S, 2015, INT J NANOMED, V10, P2971, DOI 10.2147/IJN.S75023
   Kruger T. F., 2007, CLIN GYNAECOLOGY, P554
   Liu TM, 2015, GENE, V558, P131, DOI 10.1016/j.gene.2014.12.057
   Madbouly S., 2015, BIOBASED PLANT OIL P
   MANOR A, 1982, J PERIODONTOL, V53, P86, DOI 10.1902/jop.1982.53.2.86
   Poletto M, 2014, MATERIALS, V7, P6105, DOI 10.3390/ma7096105
   POSTLETHWAIT RW, 1975, ANN SURG, V181, P144
   Pudner R., 2005, WOUND HEALING SURG P, P53
   Reddy KO, 2009, MATER LETT, V63, P2390, DOI 10.1016/j.matlet.2009.08.035
   Rihova B, 1996, ADV DRUG DELIVER REV, V21, P157
   Rosa IM, 2010, COMPOS SCI TECHNOL, V71, P246
   Sen T, 2011, INT J INNOVATION MAN, V2, P192, DOI [DOI 10.7763/IJIMT.2011.V2.130, 10.7763/IJIMT.2011.V2.130]
   Seyfert UT, 2002, BIOMOL ENG, V19, P91, DOI 10.1016/S1389-0344(02)00015-1
   Singhal JP, 2002, BIOMATERIALS, V23, P1139, DOI 10.1016/S0142-9612(01)00228-9
   van Heerden J, 2005, SAMJ S AFR MED J, V95, P972
   Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531
   WALLACE WR, 1970, J ORAL SURG, V28, P739
   Wambua P, 2003, COMPOS SCI TECHNOL, V63, P1259, DOI 10.1016/S0266-3538(03)00096-4
   Wang JN, 2014, MAT SCI ENG C-MATER, V34, P429, DOI 10.1016/j.msec.2013.09.039
   Werner K, 2014, J ANAL APPL PYROL, V110, P130, DOI 10.1016/j.jaap.2014.08.013
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Xi LX, 2013, BIORESOURCES, V8, P6501
   Yang HP, 2006, ENERG FUEL, V20, P388, DOI 10.1021/ef0580117
NR 34
TC 15
Z9 16
U1 3
U2 41
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2016
VL 62
BP 816
EP 822
DI 10.1016/j.msec.2016.02.040
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA DH4MC
UT WOS:000372759100098
PM 26952488
DA 2018-10-19
ER

PT J
AU Krukiewicz, K
   Zak, JK
AF Krukiewicz, Katarzyna
   Zak, Jerzy K.
TI Biomaterial-based regional chemotherapy: Local anticancer drug delivery
   to enhance chemotherapy and minimize its side-effects
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Review
DE Regional chemotherapy; Local drug delivery; Anticancer implants; Drug
   carriers; Biomaterials
ID ELECTROCHEMICALLY CONTROLLED-RELEASE; POROUS SILICON NANOPARTICLES;
   RESPONSIVE DEXTRIN NANOGELS; REDUCED GRAPHENE OXIDE; IN-VITRO;
   CANCER-THERAPY; BREAST-CANCER; COLORECTAL-CANCER; SILK FILMS; BIOMEDICAL
   APPLICATIONS
AB Since the majority of anticancer pharmacological agents affect not only cancer tissue but also normal cells, chemotherapy is usually accompanied with severe side effects. Regional chemotherapy, as the alternative version of conventional treatment, leads to the enhancement of the therapeutic efficiency of anticancer drugs and, simultaneously, reduction of toxic effects to healthy tissues. This paper provides an insight into different approaches of local delivery of chemotherapeutics, such as the injection of anticancer agents directly into tumor tissue, the use of injectable in situ forming drug carriers or injectable platforms in a form of implants. The wide range of biomaterials used as reservoirs of anticancer drugs is described, i.e. poly(ethylene glycol) and its copolymers, polyurethanes, poly(lactic acid) and its copolymers, poly(epsilon-caprolactone), polyanhydrides, chitosan, cellulose, cyclodextrins, silk, conducting polymers, modified titanium surfaces, calcium phosphate based biomaterials, silicone and silica implants, as well as carbon nanotubes and graphene. To emphasize the applicability of regional chemotherapy in cancer treatment, the commercially available products approved by the relevant health agencies are presented. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Krukiewicz, Katarzyna; Zak, Jerzy K.] Silesian Tech Univ, Dept Phys Chem & Technol Polymers, M Strzody 9, PL-44100 Gliwice, Poland.
RP Krukiewicz, K (reprint author), Silesian Tech Univ, Dept Phys Chem & Technol Polymers, M Strzody 9, PL-44100 Gliwice, Poland.
EM katarzyna.krukiewicz@polsl.pl; jerzy.zak@polsl.pl
OI Krukiewicz, Katarzyna/0000-0003-0503-0906
CR Agarwal P, 2013, DRUG DISCOV TODAY, V18, P337, DOI 10.1016/j.drudis.2013.01.013
   Ahmed KK, 2014, IMMUNOL RES, V59, P220, DOI 10.1007/s12026-014-8537-9
   Aigner KR, 2011, INDUCTION CHEMOTHERAPY: INTEGRATED TREATMENT PROGRAMS FOR LOCALLY ADVANCED CANCERS, P1, DOI 10.1007/978-3-642-18173-3
   Akhavan O, 2014, J MATER CHEM B, V2, P3306, DOI 10.1039/c3tb21834a
   Akhavan O, 2013, SMALL, V9, P3593, DOI 10.1002/smll.201203106
   Akhavan O, 2012, BIOMATERIALS, V33, P8017, DOI 10.1016/j.biomaterials.2012.07.040
   Akhavan O, 2012, J MATER CHEM, V22, P13773, DOI 10.1039/c2jm31396k
   Alhmoud H, 2015, ADV FUNCT MATER, V25, P1137, DOI 10.1002/adfm.201403414
   Alizadeh N, 2014, ELECTROCHIM ACTA, V130, P488, DOI 10.1016/j.electacta.2014.03.055
   Ampollini L, 2010, EUR J CARDIO-THORAC, V37, P557, DOI 10.1016/j.ejcts.2009.08.012
   Anglin EJ, 2004, LANGMUIR, V20, P11264, DOI 10.1021/la048105t
   Anglin EJ, 2008, ADV DRUG DELIVER REV, V60, P1266, DOI 10.1016/j.addr.2008.03.017
   Aoki H., 1993, REP I MED DENT ENG, V27, P39
   Atta W, 2009, BIOMATERIALS, V30, P5352, DOI 10.1016/j.biomaterials.2009.06.040
   Attarwala Husain, 2010, J Nat Sci Biol Med, V1, P53, DOI 10.4103/0976-9668.71675
   Aw MS, 2012, POWDER TECHNOL, V223, P52, DOI 10.1016/j.powtec.2011.04.023
   Bai S, 2012, RSC ADV, V2, P64, DOI 10.1039/c1ra00260k
   Balint R, 2014, ACTA BIOMATER, V10, P2341, DOI 10.1016/j.actbio.2014.02.015
   Barrioni BR, 2015, MAT SCI ENG C-MATER, V52, P22, DOI 10.1016/j.msec.2015.03.027
   Barton-Burke M., 2002, CANC CHEMOTHERAPY CA
   Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9
   Bhattarai N, 2005, J CONTROL RELEASE, V103, P609, DOI 10.1016/j.jconrel.2004.12.019
   Bogaerts W, 2012, LASER PHOTONICS REV, V6, P47, DOI 10.1002/lpor.201100017
   Boncel S, 2013, J CONTROL RELEASE, V169, P126, DOI 10.1016/j.jconrel.2013.04.009
   Bos GW, 2004, EUR J PHARM SCI, V21, P561, DOI 10.1016/j.ejps.2003.12.007
   Byrne JD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3009951
   Cancer Research UK, 2014, WORLDW CANC INC STAT
   Celikoglu F, 2003, J PHARM PHARMACOL, V55, P1441, DOI 10.1211/0022357021936
   Celikoglu F, 2008, CANC THER, V6, P545
   Chai F, 2014, J BIOMED MATER RES B, V102, P1130, DOI 10.1002/jbm.b.33094
   Chang GT, 2011, J CONTROL RELEASE, V156, P21, DOI 10.1016/j.jconrel.2011.07.008
   Chau N. D. Quyen, 2015, BIOCH BIOPHYS RES CO
   Chen DQ, 2015, J CONTROL RELEASE, V210, P230, DOI 10.1016/j.jconrel.2015.04.021
   Chen H, 2016, ANTI-CANCER DRUG, V27, P118, DOI 10.1097/CAD.0000000000000290
   Chen MW, 2012, INT J NANOMED, V7, P4285, DOI 10.2147/IJN.S33083
   Chen XY, 2013, COLLOID SURFACE B, V103, P149, DOI 10.1016/j.colsurfb.2012.10.022
   Chen Y, 2011, REACT FUNCT POLYM, V71, P525, DOI 10.1016/j.reactfunctpolym.2011.01.010
   Cheng YL, 2013, BIOMATERIALS, V34, P10338, DOI 10.1016/j.biomaterials.2013.09.064
   Chitkara D, 2006, MACROMOL BIOSCI, V6, P977, DOI 10.1002/mabi.200600129
   Chiu B, 2014, BRIT J CANCER, V111, P708, DOI 10.1038/bjc.2014.324
   Cirillo G, 2013, EUR J PHARM SCI, V49, P359, DOI 10.1016/j.ejps.2013.04.008
   Comeau TB, 2001, SUPPORT CARE CANCER, V9, P575, DOI 10.1007/s005200100279
   Corrie P. G., 2008, MEDICINE, V36, P24, DOI DOI 10.1016/J.MPMED.2007.10.012
   Costa D, 2012, COLLOID SURFACE B, V92, P106, DOI 10.1016/j.colsurfb.2011.11.038
   Croisier F, 2013, EUR POLYM J, V49, P780, DOI 10.1016/j.eurpolymj.2012.12.009
   da Silva GR, 2010, POLYM DEGRAD STABIL, V95, P491, DOI 10.1016/j.polymdegradstab.2010.01.001
   Dang WB, 1996, J CONTROL RELEASE, V42, P83, DOI 10.1016/0168-3659(96)01371-5
   Daubine F, 2009, BIOMATERIALS, V30, P6367, DOI 10.1016/j.biomaterials.2009.08.002
   Dave K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115712
   De Souza R, 2010, DRUG DELIV, V17, P365, DOI 10.3109/10717541003762854
   Denmeade SR, 2002, NAT REV CANCER, V2, P389, DOI 10.1038/nrc801
   DeVita VT, 2008, CANCER RES, V68, P8643, DOI 10.1158/0008-5472.CAN-07-6611
   Dhanikula AB, 2004, AAPS J, V6
   Erdogar N, 2014, INT J PHARMACEUT, V471, P1, DOI 10.1016/j.ijpharm.2014.05.014
   Esrafilzadeh D, 2013, J CONTROL RELEASE, V169, P313, DOI 10.1016/j.jconrel.2013.01.022
   Fesler Mark J, 2010, Pharmacotherapy, V30, P540, DOI 10.1592/phco.30.5.540
   Foraker AB, 2003, PHARMACEUT RES, V20, P110, DOI 10.1023/A:1022211127890
   Fowler JE, 2000, J UROLOGY, V164, P730, DOI 10.1016/S0022-5347(05)67291-6
   Fung LK, 1997, ADV DRUG DELIVER REV, V26, P209, DOI 10.1016/S0169-409X(97)00036-7
   Gabouze N, 2006, VACUUM, V80, P986, DOI 10.1016/j.vacuum.2006.01.004
   Gilert Ariel, 2010, J Angiogenes Res, V2, P20, DOI 10.1186/2040-2384-2-20
   Goncalves C, 2010, MATERIALS, V3, P1420, DOI 10.3390/ma3021420
   GOODMAN LS, 1946, JAMA-J AM MED ASSOC, V132, P126, DOI 10.1001/jama.1946.02870380008004
   Gou ML, 2011, NANOSCALE, V3, P1558, DOI 10.1039/c0nr00758g
   Gou ML, 2009, J PHYS CHEM B, V113, P12928, DOI 10.1021/jp905781g
   Gradmann C, 2011, DYNAMIS, V31, P305, DOI 10.4321/s0211-95362011000200003
   Gulati K, 2012, INT J NANOMED, V7, P2069, DOI 10.2147/IJN.S29917
   Gustavsson B, 2015, CLIN COLORECTAL CANC, V14, P1, DOI 10.1016/j.clcc.2014.11.002
   Haidary SM, 2012, J NANOMATER, DOI 10.1155/2012/830503
   Han HD, 2008, INT J PHARM, V350, P27, DOI 10.1016/j.ijpharm.2007.08.014
   Han S, 2003, MACROMOLECULES, V36, P8312, DOI 10.1021/ma0347971
   Haupt S, 2006, EUR J PHARM SCI, V28, P204, DOI 10.1016/j.ejps.2006.02.001
   Hendricks BK, 2015, NEUROSURG FOCUS, V38, DOI 10.3171/2015.1.FOCUS14767
   Herrlich S, 2012, ADV DRUG DELIVER REV, V64, P1617, DOI 10.1016/j.addr.2012.02.003
   Hines DJ, 2011, BIOMACROMOLECULES, V12, P804, DOI 10.1021/bm101421r
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Hochhaus A, 2002, LEUKEMIA, V16, P1205, DOI 10.1038/sj.leu.2402575
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Hon NK, 2012, J BIOMED MATER RES A, V100A, P3416, DOI 10.1002/jbm.a.34294
   Hong YL, 2010, MAT SCI ENG R, V70, P225, DOI 10.1016/j.mser.2010.06.010
   Huggins C, 1941, ARCH SURG-CHICAGO, V43, P209, DOI 10.1001/archsurg.1941.01210140043004
   Huggins C., 1941, CANCER RES, P293
   Jain JP, 2008, J BIOMED MATER RES A, V84A, P740, DOI 10.1002/jbm.a.31456
   Jain JP, 2005, J CONTROL RELEASE, V103, P541, DOI 10.1016/j.jconrel.2004.12.021
   Jelonek K, 2013, POLIMERY-W, V58, P858
   Joshi VB, 2013, HUM VACC IMMUNOTHER, V9, P2584, DOI 10.4161/hv.26136
   Joshi VB, 2013, ACTA BIOMATER, V9, P5583, DOI 10.1016/j.actbio.2012.11.001
   Juratli TA, 2013, PHARMACOL THERAPEUT, V139, P341, DOI 10.1016/j.pharmthera.2013.05.003
   Kang SG, 2010, MACROMOL RES, V18, P680, DOI 10.1007/s13233-010-0715-6
   Katti DS, 2002, ADV DRUG DELIVER REV, V54, P933, DOI 10.1016/S0169-409X(02)00052-2
   Kazek-Kesik A, 2014, MAT SCI ENG C-MATER, V39, P259, DOI 10.1016/j.msec.2014.03.008
   Kempe S, 2012, J CONTROL RELEASE, V161, P668, DOI 10.1016/j.jconrel.2012.04.016
   Kemper EM, 2004, CANCER TREAT REV, V30, P415, DOI 10.1016/j.ctrv.2004.04.001
   Khang G, 2003, MACROMOL RES, V11, P207, DOI 10.1007/BF03218355
   Kim SH, 2011, BIOMATERIALS, V32, P5505, DOI 10.1016/j.biomaterials.2011.04.017
   Kim S, 2009, J BIOMED MATER RES B, V90B, P145, DOI 10.1002/jbm.b.31266
   KLEIN CPAT, 1983, J BIOMED MATER RES, V17, P769, DOI 10.1002/jbm.820170505
   Ko PJ, 2011, NANOSCI NANOTECH LET, V3, P612, DOI 10.1166/nnl.2011.1236
   Krasko MY, 2003, J POLYM SCI POL CHEM, V41, P1059, DOI 10.1002/pola.10651
   Krishnamurthy S, 2014, BIOMATERIALS, V35, P9177, DOI 10.1016/j.biomaterials.2014.07.018
   Krukiewicz K, 2015, MAT SCI ENG C-MATER, V54, P176, DOI 10.1016/j.msec.2015.05.017
   Krukiewicz K, 2015, ACTA BIOMATER, V19, P158, DOI 10.1016/j.actbio.2015.03.006
   Krukiewicz K, 2014, J MATER SCI, V49, P5738, DOI 10.1007/s10853-014-8292-2
   Krzakala A, 2013, ELECTROCHIM ACTA, V104, P407, DOI 10.1016/j.electacta.2012.07.075
   Kufe D. W., 2003, HOLLAND FREI CANC ME
   Kuwata Yoichiro, 1997, Kobe Journal of Medical Sciences, V43, P83
   Kyriakopoulou S, 2011, CURR NANOSCI, V7, P503, DOI 10.2174/157341311796196880
   Leal-Egana A, 2010, BIOTECHNOL APPL BIOC, V55, P155, DOI 10.1042/BA20090229
   Levitzki A, 2010, MOL ASPECTS MED, V31, P287, DOI 10.1016/j.mam.2010.04.001
   Lewis SL, 2013, MED SURG NURSING ASS
   Li MQ, 2015, ACTA BIOMATER, V18, P132, DOI 10.1016/j.actbio.2015.02.022
   Li RB, 2011, CARBON, V49, P1797, DOI 10.1016/j.carbon.2011.01.003
   Li X, 2000, BIOMED MICRODEVICES, V2, P265, DOI 10.1023/A:1009951121205
   Lipps B. V., 2010, PROGR CANC THERAPY T
   Liu DX, 2015, DRUG DELIV, V22, P136, DOI 10.3109/10717544.2013.870258
   Liu L, 2013, COLLOID SURFACE B, V106, P93, DOI 10.1016/j.colsurfb.2013.01.047
   Liu Mingsong, 2000, Zhonghua Jiehe He Huxi Zazhi, V23, P550
   Liu S, 2015, NANOMED-NANOTECHNOL, V11, P1047, DOI 10.1016/j.nano.2015.03.001
   Loftsson T, 2007, INT J PHARM, V329, P1, DOI 10.1016/j.ijpharm.2006.10.044
   Lohr M, 1998, GENE THER, V5, P1070, DOI 10.1038/sj.gt.3300671
   Lu Q, 2010, MACROMOL BIOSCI, V10, P359, DOI 10.1002/mabi.200900388
   Ma J, 2008, MOL CANCER THER, V7, P3670, DOI 10.1158/1535-7163.MCT-08-0715
   Manabe T, 2005, J BIOMED MATER RES B, V73B, P203, DOI 10.1002/jbm.b.30186
   Manchun S, 2015, CARBOHYD POLYM, V126, P222, DOI 10.1016/j.carbpol.2015.03.018
   Manchun S, 2014, CARBOHYD POLYM, V114, P78, DOI 10.1016/j.carbpol.2014.08.002
   McKnight JA, 2003, CLIN TECH SMALL AN P, V18, P67, DOI 10.1053/svms.2003.36617
   Mechnikov I., 1967, NOBEL PRIZE PHYSL ME
   Mkhabela V, 2015, INT J BIOL MACROMOL, V79, P186, DOI 10.1016/j.ijbiomac.2015.04.056
   Morrison WB, 2010, J VET INTERN MED, V24, P1249, DOI 10.1111/j.1939-1676.2010.0590.x
   Munoz S, 2015, MATER CHARACT, V108, P68, DOI 10.1016/j.matchar.2015.08.019
   Nalwa H. S., 2008, HDB ORGANIC ELECT PH
   Niemela E, 2015, EUR J PHARM BIOPHARM, V96, P11, DOI 10.1016/j.ejpb.2015.07.009
   NIMNI ME, 1972, BIOCHEM PHARMACOL, V21, P485, DOI 10.1016/0006-2952(72)90321-8
   Olbrich JM, 2012, J BIOMED MATER RES A, V100A, P2365, DOI 10.1002/jbm.a.34179
   Olson J. S., 2010, YALE J BIOL MED, V83, P50
   Olson J. S., 1989, HIST CANC ANNOTATED
   Onn A, 2014, LANCET ONCOL, V15, P124, DOI 10.1016/S1470-2045(14)70010-5
   Otani Y, 1996, JPN J CLIN ONCOL, V26, P476, DOI 10.1093/oxfordjournals.jjco.a023268
   Papac Rose J., 2001, Yale Journal of Biology and Medicine, V74, P391
   Pardun K, 2015, MAT SCI ENG C-MATER, V48, P337, DOI 10.1016/j.msec.2014.12.031
   Park JS, 2011, SMALL, V7, P2061, DOI 10.1002/smll.201100438
   Park JH, 2009, NAT MATER, V8, P331, DOI [10.1038/NMAT2398, 10.1038/nmat2398]
   Park SB, 2015, MAT SCI ENG C-MATER, V50, P64, DOI 10.1016/j.msec.2015.01.073
   Park YH, 2015, J IND ENG CHEM, V30, P190, DOI 10.1016/j.jiec.2015.05.021
   Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387
   Pereira AD, 2013, DRUG DELIV, V20, P168, DOI 10.3109/10717544.2013.801052
   Perla V, 2005, J BIOMED MATER RES A, V75A, P356, DOI 10.1002/jbm.a.30423
   Pourjavadi A, 2015, POLYMER, V76, P52, DOI 10.1016/j.polymer.2015.08.050
   Poursaid A, 2015, BIOMATERIALS, V57, P142, DOI 10.1016/j.biomaterials.2015.04.015
   Pradeepa M., 2011, P INT C BIOSC BIOCH
   Price P., 2008, TREATMENT CANC
   Qian W, 2015, BIOORG MED CHEM LETT, V25, P856, DOI 10.1016/j.bmcl.2014.12.072
   Radivojsa M, 2013, EUR J PHARM SCI, V50, P93, DOI 10.1016/j.ejps.2013.03.002
   Rahman R, 2014, THER DELIV, V5, P1243, DOI [10.4155/TDE.14.83c2014Future, 10.4155/tde.14.83]
   Renneberg Reinhard, 2007, Biotechnology Journal, V2, P1207, DOI 10.1002/biot.200790106
   Rivers TJ, 2002, ADV FUNCT MATER, V12, P33, DOI 10.1002/1616-3028(20020101)12:1<33::AID-ADFM33>3.0.CO;2-E
   Rockwell S, 1998, RADIAT RES, V150, pS157, DOI 10.2307/3579817
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rokhade AP, 2006, CARBOHYD POLYM, V65, P243, DOI 10.1016/j.carbpol.2006.01.013
   Saboktakin MR, 2011, INT J BIOL MACROMOL, V48, P747, DOI 10.1016/j.ijbiomac.2011.02.020
   del Burgo LS, 2014, NANOMED-NANOTECHNOL, V10, P905, DOI 10.1016/j.nano.2013.10.001
   Salonen J, 2005, J CONTROL RELEASE, V108, P362, DOI 10.1016/j.jconrel.2005.08.017
   Sandler AB, 2000, J CLIN ONCOL, V18, P122, DOI 10.1200/JCO.2000.18.1.122
   Sartor O, 2003, UROLOGY, V61, P25, DOI 10.1016/S0090-4295(02)02396-8
   SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0
   Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020
   Schwartz AL, 2000, CANCER PRACT, V8, P16, DOI 10.1046/j.1523-5394.2000.81003.x
   Schwendeman SP, 2014, J CONTROL RELEASE, V190, P240, DOI 10.1016/j.jconrel.2014.05.057
   Seib FP, 2015, ACTA BIOMATER, V20, P32, DOI 10.1016/j.actbio.2015.04.003
   Seib FP, 2013, ADV FUNCT MATER, V23, P58, DOI 10.1002/adfm.201201238
   Seib FP, 2012, BIOMATERIALS, V33, P8442, DOI 10.1016/j.biomaterials.2012.08.004
   Sellers WR, 1999, J CLIN INVEST, V104, P1655, DOI 10.1172/JCI9053
   Selvam S, 2015, COLLOID SURFACE B, V126, P35, DOI 10.1016/j.colsurfb.2014.11.043
   Shamaeli E, 2013, ELECTROCHIM ACTA, V114, P409, DOI 10.1016/j.electacta.2013.10.119
   Sharifi S, 2009, ACTA BIOMATER, V5, P1966, DOI 10.1016/j.actbio.2009.02.004
   Sheleg SV, 2002, J NEURO-ONCOL, V60, P53, DOI 10.1023/A:1020288015457
   Shikanov A, 2004, J BIOMED MATER RES A, V69A, P47, DOI 10.1002/jbm.a.20101
   Shimpi Shyam, 2005, Acta Pharmaceutica (Zagreb), V55, P139
   Skeel RT, 2011, HDB CANC CHEMOTHERAP
   Sridhar R, 2014, J BIOMAT SCI-POLYM E, V25, P985, DOI 10.1080/09205063.2014.917039
   Storm PB, 2002, J NEURO-ONCOL, V56, P209, DOI 10.1023/A:1015003232713
   Sugihara S, 2005, MACROMOLECULES, V38, P1919, DOI 10.1021/ma048409m
   Sullivan M. A., 2000, CARDIOVASC REV REP, V21, P89
   Sun CC, 2005, SUPPORT CARE CANCER, V13, P219, DOI 10.1007/s00520-004-0710-6
   Svirskis D, 2010, J CONTROL RELEASE, V146, P6, DOI 10.1016/j.jconrel.2010.03.023
   Tahara Y, 2001, J Orthop Sci, V6, P556, DOI 10.1007/s007760100012
   TAKAHASHI T, 1976, CANCER, V38, P1507, DOI 10.1002/1097-0142(197610)38:4<1507::AID-CNCR2820380411>3.0.CO;2-V
   Talamonti C, 2011, NUCL INSTRUM METH A, V658, P84, DOI 10.1016/j.nima.2011.05.044
   Tanaka Fumihiro, 2000, Current Pharmaceutical Biotechnology, V1, P137, DOI 10.2174/1389201003378979
   Tanzawa Y, 2011, J ORTHOP SCI, V16, P77, DOI 10.1007/s00776-011-0045-3
   ten Hagen TLM, 2003, TECHNOL CANCER RES T, V2, P195
   Tohnai I, 1998, ORAL ONCOL, V34, P387, DOI 10.1016/S1368-8375(98)00018-9
   Tosti A, 2005, BRIT J DERMATOL, V152, P1056, DOI 10.1111/J.1365-2133.2005.06469.x
   Tran P. A., 2009, MRS P, V1209
   Tran P, 2008, INT J NANOMED, V3, P391
   Tran PA, 2010, J BIOMED MATER RES A, V93A, P1417, DOI 10.1002/jbm.a.32631
   Truong VX, 2013, J MATER CHEM B, V1, P221, DOI 10.1039/c2tb00148a
   Tyler B, 2010, J NEUROSURG, V113, P210, DOI 10.3171/2009.11.JNS08162
   Tzur-Balter A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7208
   Tzur-Balter A, 2013, ACTA BIOMATER, V9, P6208, DOI 10.1016/j.actbio.2012.12.010
   UCHIDA A, 1992, J ORTHOPAED RES, V10, P440, DOI 10.1002/jor.1100100317
   UENO N, 1982, J BIOMED MATER RES, V16, P669, DOI 10.1002/jbm.820160514
   UHLIR A, 1956, AT&T TECH J, V35, P333, DOI 10.1002/j.1538-7305.1956.tb02385.x
   Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237
   Varan C, 2014, J INCL PHENOM MACRO, V80, P9, DOI 10.1007/s10847-014-0422-6
   Vashist SK, 2011, CARBON, V49, P4077, DOI 10.1016/j.carbon.2011.05.049
   Vellimana AK, 2013, J NEURO-ONCOL, V111, P229, DOI 10.1007/s11060-012-1014-1
   Venuganti VVK, 2015, NANOSCALE, V7, P3903, DOI 10.1039/c4nr05241b
   Wadhwa R, 2006, J CONTROL RELEASE, V110, P531, DOI 10.1016/j.jconrel.2005.10.027
   Wang J, 2014, BIOMATERIALS, V35, P3080, DOI 10.1016/j.biomaterials.2013.12.025
   Wang PP, 2002, ADV DRUG DELIVER REV, V54, P987, DOI 10.1016/S0169-409X(02)00054-6
   Wang ZH, 2015, COLLOID SURFACE B, V134, P40, DOI 10.1016/j.colsurfb.2015.06.031
   Weng LH, 2013, ACTA BIOMATER, V9, P8182, DOI 10.1016/j.actbio.2013.06.020
   Weng LH, 2013, ACTA BIOMATER, V9, P6823, DOI 10.1016/j.actbio.2013.02.017
   Wong BS, 2012, DRUG DELIV TRANSL RE, V2, P272, DOI 10.1007/s13346-012-0096-9
   Wozniak Anna, 2012, Przegl Lek, V69, P1079
   Wu WQ, 2014, MOL PHARMACEUT, V11, P3378, DOI 10.1021/mp500019p
   Xia B, 2015, RSC ADV, V5, P44660, DOI 10.1039/c5ra04843e
   Xia Q, 1999, J Tongji Med Univ, V19, P219
   Yang F, 2008, MED HYPOTHESES, V70, P765, DOI 10.1016/j.mehy.2007.07.045
   Yang K, 2012, BIOMATERIALS, V33, P2206, DOI 10.1016/j.biomaterials.2011.11.064
   Yang K, 2010, NANO LETT, V10, P3318, DOI 10.1021/nl100996u
   Yang WE, 2015, NANOSCALE RES LETT, V10, P1, DOI 10.1186/s11671-015-0849-8
   Yang XQ, 2008, POLYMER, V49, P3477, DOI 10.1016/j.polymer.2008.06.005
   Yasin MN, 2014, J CONTROL RELEASE, V196, P208, DOI 10.1016/j.jconrel.2014.09.030
   Yi H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-211
   Yoshida K, 2011, BIOCHEM PHARMACOL, V82, P1884, DOI 10.1016/j.bcp.2011.09.015
   Yu SY, 2014, RSC ADV, V4, P18171, DOI 10.1039/c4ra02113d
   Yuan HP, 1999, BIOMATERIALS, V20, P1799, DOI 10.1016/S0142-9612(99)00075-7
   Yucel T, 2014, J CONTROL RELEASE, V190, P381, DOI 10.1016/j.jconrel.2014.05.059
   Zaman MH, 2013, NAT REV CANCER, V13, P596, DOI 10.1038/nrc3564
   Zhao B, 2005, MACROMOLECULES, V38, P9509, DOI 10.1021/ma0514572
   Zhao HP, 2013, INT J PHARMACEUT, V450, P235, DOI 10.1016/j.ijpharm.2013.04.051
   Zia KM, 2015, INT J BIOL MACROMOL, V79, P377, DOI 10.1016/j.ijbiomac.2015.04.076
NR 234
TC 31
Z9 31
U1 9
U2 137
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2016
VL 62
BP 927
EP 942
DI 10.1016/j.msec.2016.01.063
PG 16
WC Materials Science, Biomaterials
SC Materials Science
GA DH4MC
UT WOS:000372759100110
PM 26952500
DA 2018-10-19
ER

PT J
AU Shah, FA
   Trobos, M
   Thomsen, P
   Palmquist, A
AF Shah, Furqan A.
   Trobos, Margarita
   Thomsen, Peter
   Palmquist, Anders
TI Commercially pure titanium (cp-Ti) versus titanium alloy (Ti6Al4V)
   materials as bone anchored implants - Is one truly better than the
   other?
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Review
DE Commercially pure titanium; Ti6Al4V; Bacterial adhesion;
   Osseointegration; Biomechanics; Bone; Implant
ID TRANSMISSION ELECTRON-MICROSCOPY; STAPHYLOCOCCUS-EPIDERMIDIS; DENTAL
   IMPLANTS; TISSUE INTEGRATION; METALLIC IMPLANTS; SURFACE-TREATMENT;
   ION-IMPLANTATION; CORTICAL BONE; OXIDE-FILMS; RABBIT
AB Commercially pure titanium (cp-Ti) and titanium alloys (typically Ti6Al4V) display excellent corrosion resistance and biocompatibility. Although the chemical composition and topography are considered important, the mechanical properties of the material and the loading conditions in the host have, conventionally, influenced material selection for different clinical applications: predominantly Ti6Al4V in orthopaedics while cp-Ti in dentistry. This paper attempts to address three important questions: (i) To what extent do the surface properties differ when cp-Ti and Ti6Al4V materials are manufactured with the same processing technique?, (ii) Does bone tissue respond differently to the two materials, and (iii) Do bacteria responsible for causing biomaterial-associated infections respond differently to the two materials? It is concluded that: (i) Machined cp-Ti and Ti6Al4V exhibit similar surface morphology, topography, phase composition and chemistry, (ii) Under experimental conditions, cp-Ti and Ti6Al4V demonstrate similar osseointegration and biomechanical anchorage, and (iii) Experiments in vitro fail to disclose differences between cp-Ti and Ti6Al4V to harbour Staphylococcus epidermidis growth. No clinical comparative studies exist which could determine if long-term, clinical differences exist between the two types of bulk materials. It is debatable whether cp-Ti or Ti6Al4V exhibit superiority over the other, and further comparative studies, particularly in a clinical setting, are required. (C) 2016 Elsevier B.V. All rights reserved.
C1 Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Biomat, Gothenburg, Sweden.
   BIOMATCELL VINN Excellence Ctr Biomat & Cell Ther, Gothenburg, Sweden.
RP Shah, FA (reprint author), Univ Gothenburg, Sahlgrenska Acad, Dept Biomat, Gothenburg, Sweden.
EM furqan.ali.shah@biomaterials.gu.se
RI Palmquist, Anders/D-2171-2014
OI Shah, Furqan Ali/0000-0002-9876-0467; Thomsen, Peter/0000-0003-3910-6665
FU Swedish Research Council [K2015-52X-09495-28-4]; BIOMATCELL VINN
   Excellence Center of Biomaterials and Cell Therapy; Region Vastra
   Gotaland, an ALF/LUA grant [ALFGBG-138721]; IngaBritt and Arne Lundberg
   Foundation; Dr. Felix Neubergh Foundation; Wilhelm and Martina Lundgren
   Foundation, Promobilia; Hjalmar Svensson Foundation; Materials Science
   Area of Advance at Chalmers and the Department of Biomaterials,
   University of Gothenburg
FX This study was supported by the Swedish Research Council (grant
   K2015-52X-09495-28-4), the BIOMATCELL VINN Excellence Center of
   Biomaterials and Cell Therapy, the Region Vastra Gotaland, an ALF/LUA
   grant (ALFGBG-138721), the IngaBritt and Arne Lundberg Foundation, the
   Dr. Felix Neubergh Foundation, the Wilhelm and Martina Lundgren
   Foundation, Promobilia, the Hjalmar Svensson Foundation, and the
   Materials Science Area of Advance at Chalmers and the Department of
   Biomaterials, University of Gothenburg. The sponsors were not involved
   in the study design, data acquisition, interpretation, writing and
   submission of the article. The authors declare no conflict of interest.
CR ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4
   Al-Nawas B, 2012, CLIN IMPLANT DENT R, V14, P896, DOI 10.1111/j.1708-8208.2010.00324.x
   [Anonymous], 2013, B26513AE1 ASTM
   ASK M, 1990, J MATER RES, V5, P1662, DOI 10.1557/JMR.1990.1662
   Barao VAR, 2014, J PERIODONTOL, V85, P1275, DOI 10.1902/jop.2014.130595
   BLUMENTHAL NC, 1989, J BIOMED MATER RES-A, V23, P13, DOI 10.1002/jbm.820231305
   Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   Brunette D. M., 2001, TITANIUM MED
   Carr AB, 2001, J PROSTHET DENT, V85, P276, DOI 10.1067/mpr.2001.114821
   Challa VSA, 2013, J BIOMED MATER RES A, V101, P2083, DOI 10.1002/jbm.a.34492
   de Maeztu MA, 2003, CLIN ORAL IMPLAN RES, V14, P57, DOI 10.1034/j.1600-0501.2003.140108.x
   de Peppo GM, 2012, SCI WORLD J, DOI 10.1100/2012/646417
   Dhert WJA, 1998, J BIOMED MATER RES, V41, P574, DOI 10.1002/(SICI)1097-4636(19980915)41:4<574::AID-JBM9>3.0.CO;2-9
   Esposito M., 2014, COCHRANE DB SYST REV, V7, DOI DOI 10.1002/14651858.CD003815
   Forsgren J, 2007, ACTA BIOMATER, V3, P980, DOI 10.1016/j.actbio.2007.03.006
   GABRIEL BL, 1994, BIOMATERIALS, V15, P628, DOI 10.1016/0142-9612(94)90214-3
   Giordano C, 2011, COLLOID SURFACE B, V88, P648, DOI 10.1016/j.colsurfb.2011.07.054
   Gittens RA, 2014, ACTA BIOMATER, V10, P2907, DOI 10.1016/j.actbio.2014.03.032
   Grandfield K, 2013, ULTRAMICROSCOPY, V127, P48, DOI 10.1016/j.ultramic.2012.07.007
   Ha KY, 2005, SPINE, V30, P38, DOI 10.1097/01.brs.0000147801.63304.8a
   Han CH, 1998, CLIN ORAL IMPLAN RES, V9, P1, DOI 10.1034/j.1600-0501.1998.090101.x
   Jarmar T, 2008, J BIOMED MATER RES A, V87A, P1003, DOI 10.1002/jbm.a.31856
   Jimbo R, 2015, CLIN IMPLANT DENT R, V17, pE670, DOI 10.1111/cid.12305
   JOHANSSON C, 1989, J BIOMED ENG, V11, P3, DOI 10.1016/0141-5425(89)90158-1
   Johansson CB, 2012, CLIN IMPLANT DENT R, V14, P603, DOI 10.1111/j.1708-8208.2010.00296.x
   Johansson CB, 1998, INT J ORAL MAX IMPL, V13, P315
   JOHANSSON CB, 1993, J MATER SCI-MATER M, V4, P132, DOI 10.1007/BF00120382
   JOHANSSON CB, 1992, J MATER SCI-MATER M, V3, P126, DOI 10.1007/BF00705280
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   KATSIKERIS N, 1987, INT J ORAL MAX SURG, V16, P473, DOI 10.1016/S0901-5027(87)80087-5
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Lin DJ, 2007, BIOMATERIALS, V28, P2582, DOI 10.1016/j.biomaterials.2007.02.005
   LINDER L, 1989, ACTA ORTHOP SCAND, V60, P129
   LINDER L, 1989, ACTA ORTHOP SCAND, V60, P135, DOI 10.3109/17453678909149240
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Mendes VC, 2007, BIOMATERIALS, V28, P4748, DOI 10.1016/j.biomaterials.2007.07.020
   Mendes VC, 2009, J BIOMED MATER RES A, V90A, P577, DOI 10.1002/jbm.a.32126
   Morais LS, 2007, ACTA BIOMATER, V3, P331, DOI 10.1016/j.actbio.2006.10.010
   Okazaki Y, 2001, BIOMATERIALS, V22, P599, DOI 10.1016/S0142-9612(00)00221-0
   Palmquist A, 2012, APPL SURF SCI, V258, P6485, DOI 10.1016/j.apsusc.2012.03.065
   Palmquist A, 2010, J BIOMED MATER RES A, V92A, P1476, DOI 10.1002/jbm.a.32439
   Palmquist A, 2009, J BIOMED MATER RES B, V91B, P309, DOI 10.1002/jbm.b.31404
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Rupp F, 2004, BIOMATERIALS, V25, P1429, DOI 10.1016/j.biomaterials.2003.08.015
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   Saulacic N, 2012, EUR CELLS MATER, V23, P273, DOI 10.22203/eCM.v023a21
   Schildhauer TA, 2006, J ORTHOP TRAUMA, V20, P476, DOI 10.1097/00005131-200608000-00005
   Sela MN, 2007, CLIN ORAL IMPLAN RES, V18, P630, DOI 10.1111/j.1600-0501.2007.01373.x
   Shah FA, 2015, ACS BIOMATER SCI ENG, V1, P305, DOI 10.1021/ab500127y
   Shah FA, 2014, NANOMED-NANOTECHNOL, V10, P1729, DOI 10.1016/j.nano.2014.05.015
   Shida T, 2013, INT J NANOMED, V8, P3955, DOI 10.2147/IJN.S51994
   Stenlund P, 2015, ACTA BIOMATER, V20, P165, DOI 10.1016/j.actbio.2015.03.038
   Stenport VF, 2008, CLIN IMPLANT DENT R, V10, P191, DOI 10.1111/j.1708-8208.2007.00077.x
   Svetina M, 2001, ACTA MATER, V49, P2169, DOI 10.1016/S1359-6454(01)00136-7
   Tawse-Smith A, 2001, Clin Implant Dent Relat Res, V3, P185, DOI 10.1111/j.1708-8208.2001.tb00140.x
   Tawse-Smith Andrew, 2002, Clin Implant Dent Relat Res, V4, P33, DOI 10.1111/j.1708-8208.2002.tb00149.x
   Textor M, 2001, ENG MAT SER, P171
   Thoma DS, 2011, J PERIODONTOL, V82, P1453, DOI 10.1902/jop.2010.100737
   Welsch G., 1993, MAT PROPERTIES HDB T
   Yoda I, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0234-2
NR 60
TC 30
Z9 30
U1 8
U2 62
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2016
VL 62
BP 960
EP 966
DI 10.1016/j.msec.2016.01.032
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA DH4MC
UT WOS:000372759100112
PM 26952502
DA 2018-10-19
ER

PT J
AU Lewallen, EA
   Jones, DL
   Dudakovic, A
   Thaler, R
   Paradise, CR
   Kremers, HM
   Abdel, MP
   Kakar, S
   Dietz, AB
   Cohen, RC
   Lewallen, DG
   van Wijnen, AJ
AF Lewallen, Eric A.
   Jones, Dakota L.
   Dudakovic, Amel
   Thaler, Roman
   Paradise, Christopher R.
   Kremers, Hilal M.
   Abdel, Matthew P.
   Kakar, Sanjeev
   Dietz, Allan B.
   Cohen, Robert C.
   Lewallen, David G.
   van Wijnen, Andre J.
TI Osteogenic potential of human adipose-tissue-derived mesenchymal stromal
   cells cultured on 3D-printed porous structured titanium
SO GENE
LA English
DT Article
DE Mesenchymal stem cell; Biomaterial; Gene expression; Extracellular
   matrix; Scanning electron microscopy
ID STEM-CELLS; UNITED-STATES; TANTALUM BIOMATERIAL; HUMAN OSTEOBLASTS;
   DIFFERENTIATION; SCAFFOLDS; PROLIFERATION; ARTHROPLASTY; VALIDATION;
   SURFACES
AB Integration of porous metal prosthetics, which restore form and function of irreversibly damaged joints, into remaining healthy bone is critical for implant success. We investigated the biological properties of adipose tissue-derived mesenchymal stromal/stem cells (AMSCs) and addressed their potential to alter the in vitro microenvironment of implants. We employed human AMSCs as a practical source for musculoskeletal applications because these cells can be obtained in large quantities, are multipotent, and have trophic paracrine functions. AMSCs were cultured on surgical-grade porous titanium disks as a model for orthopedic implants. We monitored cell/substrate attachment, cell proliferation, multipotency, and differentiation phenotypes of AMSCs upon osteogenic induction. High-resolution scanning electron microscopy and histology revealed that AMSCs adhere to the porous metallic surface. Compared to standard tissue culture plastic, AMSCs grown in the porous titanium micro environment showed differences in temporal expression for genes involved in cell cycle progression (CCNB2, HIST2H4), extracellular matrix production (COL1A1, COL3A1), mesenchymal lineage identity (ACTA2, CD248, CD44), osteoblastic transcription factors (DLX3, DLX5,1D3), and epigenetic regulators (EZH1, EZH2). We conclude that metal orthopedic implants can be effectively seeded with clinical-grade stem/stromal cells to create a preconditioned implant. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Lewallen, Eric A.; Jones, Dakota L.; Dudakovic, Amel; Thaler, Roman; Paradise, Christopher R.; Abdel, Matthew P.; Kakar, Sanjeev; Lewallen, David G.; van Wijnen, Andre J.] Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA.
   [Jones, Dakota L.; van Wijnen, Andre J.] Mayo Clin, Dept Biomed Engn & Physiol, Mayo Grad Sch, 200 First St SW, Rochester, MN 55905 USA.
   [Kremers, Hilal M.] Mayo Clin, Dept Hlth Sci Res, Coll Med, 200 First St SW, Rochester, MN 55905 USA.
   [Dietz, Allan B.] Mayo Clin, Dept Lab Med & Pathol, 200 First St SW, Rochester, MN 55905 USA.
   [Cohen, Robert C.] Stryker Orthoped, 325 Corp Dr, Mahwah, NJ 07430 USA.
   [van Wijnen, Andre J.] Mayo Clin, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA.
RP Lewallen, DG; van Wijnen, AJ (reprint author), Mayo Clin, Dept Orthoped Surg, 200 First St SW, Rochester, MN 55905 USA.
EM lewallen.david@mayo.edu; vanwijnen.andre@mayo.edu
OI Dietz, Allan/0000-0003-3410-9621
FU National Institute of Arthritis and Musculoskeletal and Skin Diseases
   [R01 AR049069, T32 AR56950, F32 AR066508]; Stryker; Pipeline Biomedical;
   Zimmer; Ketai Medical Devices
FX We thank members of the van Wijnen and Dietz Laboratories, especially
   Matthew Getzlaf and Darcie Radel, as well as Scott Riester, Emily
   Camilleri, and Janet Denbeigh, for stimulating discussions and/or
   assistance with reagents and procedures. The Biomaterials
   Characterization and Quantitative Histomorphometry Core Laboratory
   facility performed histological analysis, particularly Bob Brown and Jim
   Herrick. We are grateful to Scott Gamb and the Electron Microscopy Core
   facility for their assistance with acquiring scanning electron
   microscopy images. We thank the Reconstructive Research and Development
   group at Stryker Orthopedics, particularly Brent Mitchell, Dale Swarts,
   and Mark Gruczynski, for manufacturing biomaterials used in this study.
   Financial support for this work came from the National Institute of
   Arthritis and Musculoskeletal and Skin Diseases (R01 AR049069 to Andre
   van Wijnen; T32 AR56950 to Eric Lewallen; and F32 AR066508 to Amel
   Dudakovic). We also appreciate the generous philanthropic support of
   William H. and Karen J. Eby, and the charitable foundation in their
   names. The following author disclosures are provided regarding
   affiliations that may be perceived to bias the presentation of this
   work: ABD has commercial interest in Mill Creek Life Sciences, which
   manufactures the clinical-grade commercial platelet lysate product used
   for maintaining adipose-tissue-derived mesenchymal stem cells. RCC
   serves as the vice president and general manager of Reconstructive
   Research and Development, Stryker Orthopedics, 325 Corporate Drive,
   Mahwah, NJ 07430. DGL reports personal fees and other from Stryker,
   Pipeline Biomedical, Zimmer, and Ketai Medical Devices. In addition, DGL
   has patents on selected hip and knee implants with royalties paid by
   Zimmer and is employed part time as the Medical Director for the
   American Joint Replacement registry.
CR Benazzo F., 2013, J BIOMED MAT RES A
   Blanco JF, 2011, EUR SPINE J, V20, P353, DOI 10.1007/s00586-011-1901-8
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733
   Catauro M, 2014, MAT SCI ENG C-MATER, V45, P395, DOI 10.1016/j.msec.2014.09.007
   Chan CW, 2014, MAT SCI ENG C-MATER, V42, P254, DOI 10.1016/j.msec.2014.05.022
   Cohen R., 2013, BONE JOINT J ORT S34, V95, P267
   Crespo-Diaz R, 2011, CELL TRANSPLANT, V20, P797, DOI 10.3727/096368910X543376
   de Peppo GM, 2012, SCI WORLD J, DOI 10.1100/2012/646417
   Di Puccio F, 2015, WORLD J ORTHOP, V6, P77, DOI 10.5312/wjo.v6.i1.77
   Dudakovic A, 2015, J BIOL CHEM, V290, P27604, DOI 10.1074/jbc.M115.672345
   Dudakovic A, 2015, J CELL PHYSIOL, V230, P52, DOI 10.1002/jcp.24680
   Dudakovic A, 2014, J CELL BIOCHEM, V115, P1816, DOI 10.1002/jcb.24852
   Eirin A, 2014, GENE, V551, P55, DOI 10.1016/j.gene.2014.08.041
   Ercan B, 2010, BIOMATERIALS, V31, P3684, DOI 10.1016/j.biomaterials.2010.01.078
   Findlay DM, 2004, BIOMATERIALS, V25, P2215, DOI 10.1016/j.biomaterials.2003.09.005
   Gastaldi G, 2010, J BIOMED MATER RES A, V94A, P790, DOI 10.1002/jbm.a.32721
   Getzlaf M.A., 2015, J ORTHOP RES
   Gotman I, 2013, ACTA BIOMATER, V9, P8440, DOI 10.1016/j.actbio.2013.05.030
   Guasconi V, 2010, EPIGENETICS-US, V5, P704, DOI 10.4161/epi.5.8.13025
   Hirota M, 2015, MAT SCI ENG C-MATER, V49, P623, DOI 10.1016/j.msec.2015.01.006
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Kurtz SM, 2014, J BONE JOINT SURG AM, V96A, P624, DOI 10.2106/JBJS.M.00285
   Lehil MS, 2014, J ARTHROPLASTY, V29, P1915, DOI 10.1016/j.arth.2014.05.017
   Lewallen E. A., 2014, TISSUE ENG PART B-RE, V21, P218
   Lopa S, 2013, J BIOMED MATER RES A, V101, P3396, DOI 10.1002/jbm.a.34649
   Mader E. K., 2013, J TRANSL MED, V11, P1186
   Mahmoudifar N, 2013, BIOTECHNOL PROGR, V29, P176, DOI 10.1002/btpr.1663
   Murphy Matthew B, 2013, Exp Mol Med, V45, pe54, DOI 10.1038/emm.2013.94
   Nguyen L.C., 2014, J ARTHROPLAST
   Olivares-Navarrete R, 2015, BONE, V73, P208, DOI 10.1016/j.bone.2014.12.057
   Olivares-Navarrete R, 2010, BIOMATERIALS, V31, P2728, DOI 10.1016/j.biomaterials.2009.12.029
   Sagomonyants KB, 2011, J ORTHOP RES, V29, P609, DOI 10.1002/jor.21251
   Shen XK, 2015, COLLOID SURFACE B, V127, P221, DOI 10.1016/j.colsurfb.2015.01.048
   Welldon KJ, 2008, J BIOMED MATER RES A, V84A, P691, DOI 10.1002/jbm.a.31336
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 37
TC 6
Z9 7
U1 2
U2 60
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD MAY 1
PY 2016
VL 581
IS 2
BP 95
EP 106
DI 10.1016/j.gene.2016.01.015
PG 12
WC Genetics & Heredity
SC Genetics & Heredity
GA DG3DG
UT WOS:000371949100001
PM 26774799
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Sharma, A
   McQuillan, AJ
   Shibata, Y
   Sharma, LA
   Waddell, JN
   Duncan, WJ
AF Sharma, Ajay
   McQuillan, A. James
   Shibata, Yo
   Sharma, Lavanya A.
   Waddell, John Neil
   Duncan, Warwick John
TI Histomorphometric and histologic evaluation of titanium-zirconium
   (aTiZr) implants with anodized surfaces
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID OSTEOBLAST ADHESION; BONE RESPONSE; INTRABONY DEFECTS; DENTAL IMPLANTS;
   OXIDE-FILMS; OSSEOINTEGRATION; BIOMATERIAL; RESOLUTION; OXIDATION;
   TI6AL4V
AB The choice of implant surface has a significant influence on osseointegration. Modification of TiZr surface by anodization is reported to have the potential to modulate the osteoblast cell behaviour favouring more rapid bone formation. The aim of this study is to investigate the effect of anodizing the surface of TiZr discs with respect to osseointegration after four weeks implantation in sheep femurs. Titanium (Ti) and TiZr discs were anodized in an electrolyte containing DL-alpha-glycerophosphate and calcium acetate at 300 V. The surface characteristics were analyzed by scanning electron microscopy, electron dispersive spectroscopy, atomic force microscopy and goniometry. Forty implant discs with thickness of 1.5 and 10 mm diameter (10 of each-titanium, titanium-zirconium, anodized titanium and anodized titanium-zirconium) were placed in the femoral condyles of 10 sheep. Histomorphometric and histologic analysis were performed 4 weeks after implantation. The anodized implants displayed hydrophilic, porous, nano-to-micrometer scale roughened surfaces. Energy dispersive spectroscopy analysis revealed calcium and phosphorous incorporation into the surface of both titanium and titanium-zirconium after anodization. Histologically there was new bone apposition on all implanted discs, slightly more pronounced on anodised discs. The percentage bone-to-implant contact measurements of anodized implants were higher than machined/unmodified implants but there was no significant difference between the two groups with anodized surfaces (P > 0.05, n = 10). The present histomorphometric and histological findings confirm that surface modification of titanium-zirconium by anodization is similar to anodised titanium enhances early osseointegration compared to machined implant surfaces.
C1 [Sharma, Ajay; Waddell, John Neil; Duncan, Warwick John] Univ Otago, Sir John Walsh Res Inst, Fac Dent, 310 Great King St, Dunedin 9016, New Zealand.
   [McQuillan, A. James] Univ Otago, Dept Chem, POB 56, Dunedin, New Zealand.
   [Shibata, Yo] Showa Univ, Sch Dent, Dept Conservat Dent, Div Biomat & Engn, Tokyo 142, Japan.
   [Sharma, Lavanya A.] Univ Otago, Otago Sch Med Sci, Dunedin, New Zealand.
RP Sharma, A (reprint author), Univ Otago, Sir John Walsh Res Inst, Fac Dent, 310 Great King St, Dunedin 9016, New Zealand.
EM ajsharma.perio@gmail.com
RI Duncan, Warwick/S-2126-2016
OI Duncan, Warwick/0000-0002-5412-0089
FU Dentsply, Australia; Lottery Health Research Grant, New Zealand
FX This study was funded by Dentsply, Australia and Lottery Health Research
   Grant, New Zealand. We wish to acknowledge the assistance of Liz Girwan,
   Otago Centre for Electron Microscopy, University of Otago, for her
   assistance in the SEM. We wish to acknowledge the assistance of Andrew
   McNaughton, Otago Centre for Confocal Microscopy, University of Otago,
   for his assistance in the confocal microscopy. We acknowledge the
   assistance of Dave Mathews, Hercus Taieri Research Unit for his
   assistance in animal surgeries.
CR Barter S, 2012, CLIN ORAL IMPLAN RES, V23, P873, DOI 10.1111/j.1600-0501.2011.02231.x
   Berglundh T, 2003, CLIN ORAL IMPLAN RES, V14, P251, DOI 10.1034/j.1600-0501.2003.00972.x
   Bernhard N, 2009, FORUM IMPLANTOLOGICU, V5, P30
   Bornstein MM, 2008, CLIN ORAL IMPLAN RES, V19, P233, DOI 10.1111/j.1600-0501.2007.01473.x
   Botticelli D, 2004, J CLIN PERIODONTOL, V31, P309, DOI 10.1111/j.1600-051X.2004.00502.x
   Branemark P I, 1977, Scand J Plast Reconstr Surg Suppl, V16, P1
   Choi JY, 2011, CLIN ORAL IMPLAN RES, V22, P343, DOI 10.1111/j.1600-0501.2010.01978.x
   Colon G, 2006, J BIOMED MATER RES A, V78A, P595, DOI 10.1002/jbm.a.30789
   Davies John E, 2003, J Dent Educ, V67, P932
   Davies JE, 2007, BIOMATERIALS, V28, P5058, DOI 10.1016/j.biomaterials.2007.07.049
   Duncan Warwick J, 2008, Ann R Australas Coll Dent Surg, V19, P152
   Giavaresi G, 2003, BIOMATERIALS, V24, P1583, DOI 10.1016/S0142-9612(02)00548-3
   Gottlow J, 2012, CLIN IMPLANT DENT R, V14, P538, DOI 10.1111/j.1708-8208.2010.00289.x
   Gottlow J, 2012, CLIN IMPLANT DENT R, V14, pe204, DOI 10.1111/j.1708-8208.2012.00439.x
   Jokstad A, 2008, AUST DENT J, V53, pS89, DOI 10.1111/j.1834-7819.2008.00046.x
   Jung UW, 2005, CURR APPL PHYS, V5, P507, DOI 10.1016/j.cap.2005.01.021
   Kim CS, 2004, J PERIODONTOL, V75, P229, DOI 10.1902/jop.2004.75.2.229
   KOBAYASHI E, 1995, J BIOMED MATER RES, V29, P943, DOI 10.1002/jbm.820290805
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Littell RC, 1998, J ANIM SCI, V76, P1216
   Park IS, 2008, J BIOMED MATER RES B, V84B, P422, DOI 10.1002/jbm.b.30887
   Park IS, 2011, SURF INTERFACE ANAL, V43, P1030, DOI 10.1002/sia.3686
   Park JW, 2009, CLIN ORAL IMPLAN RES, V20, P684, DOI 10.1111/j.1600-0501.2009.01714.x
   Park KH, 2007, J ORAL REHABIL, V34, P517, DOI 10.1111/j.1365-2842.2006.01688.x
   Sharma A, 2015, J MATER SCI-MATER M, V26, P1
   Shibata Y, 2004, J DENT RES, V83, P115, DOI 10.1177/154405910408300206
   Sista S, 2011, J BIOMED MATER RES A, V97A, P27, DOI 10.1002/jbm.a.33013
   Suh JY, 2003, BIOMATERIALS, V24, P347, DOI 10.1016/S0142-9612(02)00325-3
   Sul YT, 2006, INT J PROSTHODONT, V19, P319
   Sul YT, 2005, BIOMATERIALS, V26, P6720, DOI 10.1016/j.biomaterials.2005.04.058
   Sul YT, 2003, BIOMATERIALS, V24, P3893, DOI 10.1016/S0142-9612(03)00261-8
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   Yao C, 2005, J BIOMED NANOTECHNOL, V1, P68, DOI 10.1166/jbn.2005.008
   Zhu XL, 2004, BIOMATERIALS, V25, P4087, DOI 10.1016/j.biomaterials.2003.11.011
   Zhu XL, 2001, BIOMATERIALS, V22, P2199, DOI 10.1016/S0142-9612(00)00394-X
NR 36
TC 0
Z9 0
U1 1
U2 15
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2016
VL 27
IS 5
AR 86
DI 10.1007/s10856-016-5695-4
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DG7JT
UT WOS:000372261300005
PM 26970768
DA 2018-10-19
ER

PT J
AU Wang, HJ
   Huang, JC
   Hou, L
   Miyazawa, T
   Wang, JY
AF Wang, Hua-Jie
   Huang, Jing-Chun
   Hou, Li
   Miyazawa, Teruo
   Wang, Jin-Ye
TI Prolongation of the degradation period and improvement of the
   angiogenesis of zein porous scaffolds in vivo
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MECHANICAL-PROPERTIES; LINOLEIC ACIDS; CORN PROTEIN; BIOCOMPATIBILITY;
   FILM
AB Zein porous scaffolds modified with fatty acids have shown great improvement in mechanical properties and good cell compatibility in vitro, indicating the potential application as a bone tissue engineering substitute. The present study was conducted to systematically investigate whether the addition of fatty acids affects the short-term (up to 12 weeks) and long-term (up to 1 year) behaviors of scaffolds in vivo, mainly focusing on changes in the degradation period and inflammatory responses. Throughout the implantation period, no abnormal signs occurred and zein porous scaffolds modified with oleic acid showed good tolerance in rabbits, characterized by the growth of relatively more blood vessels in the scaffolds and only a slight degree of fibrosis histology. Moreover, the degradation period was prolonged from 8 months to 1 year as compared to the control. These results affirmed further that zein could be used as a new kind of natural biomaterial suitable for bone tissue engineering.
C1 [Wang, Hua-Jie; Wang, Jin-Ye] Shanghai Jiao Tong Univ, Sch Biomed Engn, Dongchuan Rd, Shanghai 200240, Peoples R China.
   [Huang, Jing-Chun; Hou, Li] Shandong Qual Inspect Ctr Med Devices, Key Lab Biol Evaluat Med Devices, Jinan 250101, Shandong, Peoples R China.
   [Miyazawa, Teruo] Tohoku Univ, New Ind Creat Hatchery Ctr NICHe, Food Biotechnol Innovat Project, Sendai, Miyagi 9800845, Japan.
   [Wang, Hua-Jie] Zhongyuan Univ Technol, Ctr Adv Mat Res, Xinzheng Shuanghu Econ Dev Zone, 1 Huaihe Rd, Zhengzhou 451191, Peoples R China.
RP Wang, JY (reprint author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Dongchuan Rd, Shanghai 200240, Peoples R China.
EM jinyewang@sjtu.edu.cn
RI Wang, Jin-Ye/H-1450-2011
OI Wang, Jin-Ye/0000-0002-0937-1508
FU International S&T Cooperation Program of China [2012DFA30270,
   2015DFG32730]; Shanghai Municipal Science and Technology Commission
   [12JC1403400, 15540723900]
FX The authors gratefully acknowledge the financial support provided by the
   International S&T Cooperation Program of China (2012DFA30270,
   2015DFG32730), the Shanghai Municipal Science and Technology Commission
   (12JC1403400, 15540723900).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Burugapalli K, 2007, BIOMACROMOLECULES, V8, P3439, DOI 10.1021/bm700560k
   Chen GP, 2001, MAT SCI ENG C-BIO S, V17, P63, DOI 10.1016/S0928-4931(01)00338-1
   Chen PY, 2011, J MECH BEHAV BIOMED, V4, P961, DOI 10.1016/j.jmbbm.2011.02.006
   Cury-Boaventura MF, 2006, CLIN NUTR, V25, P1004, DOI 10.1016/j.clnu.2006.05.008
   Dong J, 2004, BIOMATERIALS, V25, P4691, DOI 10.1016/j.biomaterials.2003.10.084
   Gong SJ, 2006, BIOMATERIALS, V27, P3793, DOI 10.1016/j.biomaterials.2006.02.019
   Hatakeda K, 2008, INT J CHEM REACT ENG, V6, P65
   Jiang QR, 2010, ACTA BIOMATER, V6, P4042, DOI 10.1016/j.actbio.2010.04.024
   Lai HM, 1997, CEREAL CHEM, V74, P83, DOI 10.1094/CCHEM.1997.74.1.83
   Liu XM, 2005, BIOMATERIALS, V26, P109, DOI 10.1016/j.biomaterials.2004.02.013
   Santosa FXB, 1999, J AGR FOOD CHEM, V47, P2070, DOI 10.1021/jf981154p
   Shukla R, 2001, IND CROP PROD, V13, P171, DOI 10.1016/S0926-6690(00)00064-9
   Skotak M, 2008, BIOMACROMOLECULES, V9, P1902, DOI 10.1021/bm800158c
   Subramaniam S, 2016, BIOMATERIALS, V74, P99, DOI 10.1016/j.biomaterials.2015.09.044
   Taylor J, 2015, J BIOMED MATER RES A, V103, P2582, DOI 10.1002/jbm.a.35394
   Tu JW, 2009, BIOMATERIALS, V30, P4369, DOI 10.1016/j.biomaterials.2009.04.054
   Venkatesan J, 2015, INT J BIOL MACROMOL, V72, P269, DOI 10.1016/j.ijbiomac.2014.07.008
   Wang HJ, 2005, J CONTROL RELEASE, V105, P120, DOI 10.1016/j.jconrel.2005.03.014
   Wang HJ, 2007, BIOMATERIALS, V28, P3952, DOI 10.1016/j.biomaterials.2007.05.017
   Wang XJ, 2016, BIOMATERIALS, V83, P127, DOI 10.1016/j.biomaterials.2016.01.012
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
NR 22
TC 1
Z9 1
U1 1
U2 22
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2016
VL 27
IS 5
AR 92
DI 10.1007/s10856-016-5697-2
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DG7JT
UT WOS:000372261300011
PM 26979976
DA 2018-10-19
ER

PT J
AU Muiznieks, LD
   Miao, M
   Sitarz, EE
   Keeley, FW
AF Muiznieks, Lisa D.
   Miao, Ming
   Sitarz, Eva E.
   Keeley, Fred W.
TI Contribution of Domain 30 of Tropoelastin to Elastic Fiber Formation and
   Material Elasticity
SO BIOPOLYMERS
LA English
DT Article
DE elastin; elastic fibers; beta-sheet; entropic elasticity; biomaterial
   design
ID MECHANICAL-PROPERTIES; TERMINAL DOMAIN; PROLINE; POLYPEPTIDES; PROTEIN;
   SEQUENCE; SILKS; AGGREGATION; TOUGHNESS; STRENGTH
AB Elastin is a fibrous structural protein of the extracellular matrix that provides reversible elastic recoil to vertebrate tissues such as arterial vessels, lung, and skin. The elastin monomer, tropoelastin, contains a large proportion of intrinsically disordered and flexible hydrophobic sequences that collectively are responsible for the initial phase separation of monomers during assembly, and are essential for driving elastic recoil. While structural disorder of hydrophobic sequences is controlled by a high proline and glycine residue composition, hydrophobic domain 30 of human tropoelastin is atypically proline-poor, and forms beta-sheet amyloid-like fibrils as an individual peptide. We explored the contribution of confined regions of secondary structure at the location of domain 30 in human tropoelastin to fiber assembly and mechanical properties using a set of mutations designed to inhibit or enhance the propensity of b-sheet formation at this location. Our data support a dual role for confined beta-sheet secondary structure in domain 30 of tropoelastin in guiding the formation of fibers, and as a determinant of stiffness and viscoelastic properties of cross-linked materials. Together, these results suggest a mechanism for specificity in fiber assembly, and elucidate structure-function relationships for the rational design of elastomeric biomaterials with defined mechanical properties. (C) 2016 Wiley Periodicals, Inc.
C1 [Muiznieks, Lisa D.; Miao, Ming; Sitarz, Eva E.; Keeley, Fred W.] Hosp Sick Children, Mol Struct & Funct Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.
   [Keeley, Fred W.] Univ Toronto, Dept Biochem, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.
   [Keeley, Fred W.] Univ Toronto, Dept Pathol & Lab Med, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.
RP Keeley, FW (reprint author), Hosp Sick Children, Mol Struct & Funct Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.; Keeley, FW (reprint author), Univ Toronto, Dept Biochem, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.; Keeley, FW (reprint author), Univ Toronto, Dept Pathol & Lab Med, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.
EM fwk@sickkids.ca
FU Heart and Stroke Foundation of Canada [T6725]
FX Contract grant sponsor: Heart and Stroke Foundation of Canada,; Contract
   grant number: T6725 (to F.W.K.)
CR ANDERSEN SO, 1995, INSECT BIOCHEM MOLEC, V25, P153, DOI 10.1016/0965-1748(94)00052-J
   Baldock C, 2011, P NATL ACAD SCI USA, V108, P4322, DOI 10.1073/pnas.1014280108
   Bax DV, 2009, J BIOL CHEM, V284, P28616, DOI 10.1074/jbc.M109.017525
   Broekelmann TJ, 2008, MATRIX BIOL, V27, P631, DOI 10.1016/j.matbio.2008.06.001
   Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200
   BrownAugsburger P, 1996, BIOCHEM J, V318, P149, DOI 10.1042/bj3180149
   BROWNAUGSBURGER P, 1995, J BIOL CHEM, V270, P17778, DOI 10.1074/jbc.270.30.17778
   Dicko C, 2006, ADV PROTEIN CHEM, V73, P17, DOI 10.1016/S0065-3233(06)73002-9
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   Green E. M., 2014, BIOPOLYMERS, V103, P187
   Guerette PA, 2014, ACS NANO, V8, P7170, DOI 10.1021/nn502149u
   Holland GP, 2008, J AM CHEM SOC, V130, P9871, DOI 10.1021/ja8021208
   Keeley F. W, 2013, EVOLUTION EXTRACELLU, P73
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]
   Kozel BA, 2006, J CELL PHYSIOL, V207, P87, DOI 10.1002/jcp.20546
   Kozel BA, 2003, J BIOL CHEM, V278, P18491, DOI 10.1074/jbc.M212715200
   Le DHT, 2013, BIOMACROMOLECULES, V14, P1028, DOI 10.1021/bm301887m
   Liu Y, 2008, BIOMACROMOLECULES, V9, P116, DOI 10.1021/bm700877g
   Miao M, 2003, J BIOL CHEM, V278, P48553, DOI 10.1074/jbc.M308465200
   Miao M, 2013, BIOPOLYMERS, V99, P392, DOI 10.1002/bip.22192
   Miao M, 2009, MATRIX BIOL, V28, P432, DOI 10.1016/j.matbio.2009.07.003
   Muiznieks LD, 2015, BIOPOLYMERS, V103, P563, DOI 10.1002/bip.22663
   Muiznieks LD, 2014, MATRIX BIOL, V36, P39, DOI 10.1016/j.matbio.2014.03.008
   Muiznieks LD, 2010, J BIOL CHEM, V285, P39779, DOI 10.1074/jbc.M110.164467
   Nonaka R, 2014, BIOL PHARM BULL, V37, P698, DOI 10.1248/bpb.b13-00933
   Nova A, 2010, NANO LETT, V10, P2626, DOI 10.1021/nl101341w
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Rauscher S, 2006, STRUCTURE, V14, P1667, DOI 10.1016/j.str.2006.09.008
   Rauscher S, 2012, ADV EXP MED BIOL, V725, P159, DOI 10.1007/978-1-4614-0659-4_10
   Reichheld SE, 2014, J BIOL CHEM, V289, P10057, DOI 10.1074/jbc.M113.533893
   ROBSON P, 1993, J BIOL CHEM, V268, P1440
   Savage KN, 2008, J EXP BIOL, V211, P1937, DOI 10.1242/jeb.014217
   Tamburro AM, 2005, J BIOL CHEM, V280, P2682, DOI 10.1074/jbc.M411617200
   Vieth S, 2007, BIOPOLYMERS, V85, P199, DOI 10.1002/bip.20619
   Wise SG, 2005, J STRUCT BIOL, V149, P273, DOI 10.1016/j.jsb.2004.11.006
   Yeo GC, 2014, J BIOL CHEM, V289, P34815, DOI 10.1074/jbc.M114.606772
   Yeo GC, 2012, P NATL ACAD SCI USA, V109, P2878, DOI 10.1073/pnas.1111615108
NR 37
TC 4
Z9 5
U1 1
U2 39
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3525
EI 1097-0282
J9 BIOPOLYMERS
JI Biopolymers
PD MAY
PY 2016
VL 105
IS 5
BP 267
EP 275
DI 10.1002/bip.22804
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA DF9OG
UT WOS:000371690100003
PM 26763595
DA 2018-10-19
ER

PT J
AU Gregoric, M
   Suen, K
   Cheng, RC
   Kralj-Fiser, S
   Kuntner, M
AF Gregoric, Matjaz
   Suen, Klavdija
   Cheng, Ren-Chung
   Kralj-Fiser, Simona
   Kuntner, Matjaz
TI Spider behaviors include oral sexual encounters
SO SCIENTIFIC REPORTS
LA English
DT Article
ID SPERM COMPETITION; ARANEAE ARANEIDAE; NEPHILID SPIDERS; DROSOPHILA;
   EMASCULATION; COEVOLUTION; COPULATION; CAEROSTRIS; DIMORPHISM; EVOLUTION
AB Several clades of spiders whose females evolved giant sizes are known for extreme sexual behaviors such as sexual cannibalism, opportunistic mating, mate-binding, genital mutilation, plugging, and emasculation. However, these behaviors have only been tested in a handful of size dimorphic spiders. Here, we bring another lineage into the picture by reporting on sexual behavior of Darwin's bark spider, Caerostris darwini. This sexually size dimorphic Madagascan species is known for extreme web gigantism and for producing the world's toughest biomaterial. Our field and laboratory study uncovers a rich sexual repertoire that predictably involves cannibalism, genital mutilation, male preference for teneral females, and emasculation. Surprisingly, C. darwini males engage in oral sexual encounters, rarely reported outside mammals. Irrespective of female's age or mating status males salivate onto female genitalia pre-, during, and post-copulation. While its adaptive significance is elusive, oral sexual contact in spiders may signal male quality or reduce sperm competition.
C1 [Gregoric, Matjaz; Suen, Klavdija; Cheng, Ren-Chung; Kralj-Fiser, Simona; Kuntner, Matjaz] Slovenian Acad Sci & Arts, Inst Biol, Ctr Sci Res, Ljubljana, Slovenia.
   [Kuntner, Matjaz] Smithsonian Inst, Natl Museum Nat Hist, Dept Entomol, Washington, DC 20560 USA.
RP Gregoric, M (reprint author), Slovenian Acad Sci & Arts, Inst Biol, Ctr Sci Res, Ljubljana, Slovenia.
EM matjaz.gregoric@gmail.com
FU Slovenian Research Agency; Explorers Club
FX This work was funded by the Slovenian Research Agency and the Explorers
   Club. We thank the MICET crew in Antananarivo, S. L. Rahanitriniaina and
   H. Nono Rabarison for help in the field, and T. Celik and T. Lokovsek
   for analytical and lab help.
CR Agnarsson I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011234
   Andrade MCB, 1996, SCIENCE, V271, P70, DOI 10.1126/science.271.5245.70
   Arnqvist G, 2002, NATURE, V415, P787
   Arnqvist G, 2005, SEXUAL CONFLICT, P330
   Berendock B., 2003, THESIS HEINRICH HEIN
   Blanckenhorn WU, 2005, ETHOLOGY, V111, P977, DOI 10.1111/j.1439-0310.2005.01147.x
   CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0
   Cheng RC, 2015, EVOL BIOL, V42, P223, DOI 10.1007/s11692-015-9313-z
   DAVIES NB, 1983, NATURE, V302, P334, DOI 10.1038/302334a0
   Eberhard WG, 1996, FEMALE CONTROL SEXUA, P472
   Elgar MA, 2003, ANIM BEHAV, V66, P211, DOI 10.1006/anbe.2003.2189
   Elgar MA, 2000, P ROY SOC B-BIOL SCI, V267, P2439, DOI 10.1098/rspb.2000.1303
   Fairbairn D.J., 2007, SEX SIZE GENDER ROLE
   Foellmer Matthias W., 2007, P71
   Forster Lyn, 1995, Records of the Western Australian Museum Supplement, V52, P13
   Fromhage L, 2005, EVOLUTION, V59, P1400
   Gregoric M, 2015, J ARACHNOL, V43, P293, DOI 10.1636/0161-8202-43.3.293
   Gregoric M, 2015, ZOOL J LINN SOC-LOND, V175, P225, DOI 10.1111/zoj.12281
   Gregoric M, 2011, J ARACHNOL, V39, P287, DOI 10.1636/CB10-95.1
   HALL JC, 1979, GENETICS, V92, P437
   Higgins L, 2011, EVOL ECOL, V25, P1289, DOI 10.1007/s10682-011-9475-9
   Knoflach B, 2000, J NAT HIST, V34, P1639, DOI 10.1080/00222930050117530
   Kuntner M, 2009, J ZOOL, V277, P257, DOI 10.1111/j.1469-7998.2008.00533.x
   Kuntner M., 2014, FRONT ECOL EVOL, V2, P26, DOI [10.3389/fevo.2014.00026, DOI 10.3389/FEVO.2014.00026]
   Kuntner M, 2015, BEHAV ECOL SOCIOBIOL, V69, P117, DOI 10.1007/s00265-014-1824-6
   Kuntner M, 2015, BIOL REV, V90, P279, DOI 10.1111/brv.12109
   Kuntner M, 2012, J ARACHNOL, V40, P345, DOI 10.1636/B12-03.1
   Kuntner M, 2009, EVOLUTION, V63, P1451, DOI 10.1111/j.1558-5646.2009.00634.x
   Lee QQ, 2012, BIOL LETTERS, V8, P733, DOI 10.1098/rsbl.2012.0285
   Maruthupandian J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059743
   Rivera M. J., 1901, REV CHIL HIST NAT, V8, P161
   Robinson M.H., 1980, Pacific Insects Monograph, V36, P1
   Robinson M.H., 1973, Smithsonian Contributions to Zoology, VNo. 149, P1
   Schneider J. M., 2015, CRYPTIC FEMALE CHOIC
   Sergiel A, 2014, ZOO BIOL, V33, P349, DOI 10.1002/zoo.21137
   Tan M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007595
   WELBERGEN P, 1992, BEHAV GENET, V22, P113, DOI 10.1007/BF01066796
   Wilder SM, 2009, ANNU REV ECOL EVOL S, V40, P21, DOI 10.1146/annurev.ecolsys.110308.120238
   Yamamoto D, 2013, NAT REV NEUROSCI, V14, P681, DOI 10.1038/nrn3567
   Zhang SC, 2011, ANIM BEHAV, V82, P1299, DOI 10.1016/j.anbehav.2011.09.010
NR 40
TC 2
Z9 2
U1 0
U2 21
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 29
PY 2016
VL 6
AR 25128
DI 10.1038/srep25128
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DK8MI
UT WOS:000375180400001
PM 27126507
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Sun, J
   Deng, Y
   Li, JP
   Wang, G
   He, P
   Tian, SY
   Bu, XM
   Di, ZF
   Yang, SW
   Ding, GQ
   Xie, XM
AF Sun, Jing
   Deng, Yuan
   Li, Jipeng
   Wang, Gang
   He, Peng
   Tian, Suyun
   Bu, Xiuming
   Di, Zengfeng
   Yang, Siwei
   Ding, Guqiao
   Xie, Xiaoming
TI A New Graphene Derivative: Hydroxylated Graphene with Excellent
   Biocompatibility
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE graphene derivative; hydroxylated graphene; biomaterial; reversible;
   regeneration
ID QUANTUM DOTS; FUNCTIONALIZED GRAPHENE; GRAPHITE OXIDE;
   PHOTOLUMINESCENCE; DISPERSIONS; GRAPHANE
AB Graphene derivatives (such as graphene oxide and hydrogenated graphene) have been widely investigated because of their excellent properties. Here, we report large-scale (kilogram scale) synthesis of a new unique graphene derivative: hydroxylated graphene (G-OH). The exclusive existence form of oxygen-containing groups in G-OH is hydroxyl, which was verified by spectral characterization and quantitative halogenating reaction. It is very interesting that both the wettability and electrical conductivity show reversible change in halogenating and hydrolysis reaction cycles, which demonstrates the versatility of G-OH. Most importantly, the hydrophilicity and weak inductive nature of G-OH provides a well microenvironment for the cells adhesion and proliferation. On G-OH paper, rat adipose tissue-derived stromal cells exhibited a typical fibroblast-like shape with high rate of increase and survival after 3 day of incubation. This G-OH paper with good mechanical property is expected to be a new biomaterial for bone, vessel and skin regeneration.
C1 [Sun, Jing; Li, Jipeng; Wang, Gang; He, Peng; Tian, Suyun; Bu, Xiuming; Di, Zengfeng; Yang, Siwei; Ding, Guqiao; Xie, Xiaoming] Chinese Acad Sci, Shanghai Inst Microsyst & Informat Technol, State Key Lab Funct Mat Informat, Shanghai 20050, Peoples R China.
   [Deng, Yuan; Li, Jipeng] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Ophthalmol, Shanghai 20011, Peoples R China.
   [Tian, Suyun; Xie, Xiaoming] ShanghaiTech Univ, Sch Phys Sci & Technol, Shanghai 200031, Peoples R China.
   [Ding, Guqiao] Shanghai SIMBATT Energy Co, Shanghai 201821, Peoples R China.
RP Yang, SW; Ding, GQ (reprint author), Chinese Acad Sci, Shanghai Inst Microsyst & Informat Technol, State Key Lab Funct Mat Informat, Shanghai 20050, Peoples R China.; Ding, GQ (reprint author), Shanghai SIMBATT Energy Co, Shanghai 201821, Peoples R China.
EM yangsiwei@mail.sim.ac.cn; gqding@mail.sim.ac.cn
OI He, Peng/0000-0003-0606-8762; Yuan, Deng/0000-0001-8585-1178
FU National Science and Technology Major Project Fund [2011ZX02707];
   Chinese Academy of Sciences [XDA02040000]; Science and Technology
   Commission of Shanghai Municipality The Sailing Program [15YF1406800];
   National Natural Science Foundation of China [81501605]
FX This work was supported by The National Science and Technology Major
   Project Fund (2011ZX02707), The Chinese Academy of Sciences
   (XDA02040000), Science and Technology Commission of Shanghai
   Municipality The Sailing Program (15YF1406800), and The National Natural
   Science Foundation of China (81501605).
CR Dikin DA, 2007, NATURE, V448, P457, DOI 10.1038/nature06016
   Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g
   Elias DC, 2009, SCIENCE, V323, P610, DOI 10.1126/science.1167130
   He P, 2015, CHEM MATER, V27, P218, DOI 10.1021/cm503782p
   KIM KS, 1974, ANAL CHEM, V46, P197, DOI 10.1021/ac60338a037
   Li JH, 2015, J MATER CHEM B, V3, P1544, DOI 10.1039/c4tb01510j
   Li XB, 2014, CARBON, V78, P38, DOI 10.1016/j.carbon.2014.06.034
   Liao F, 2015, J MATER CHEM A, V3, P7568, DOI 10.1039/c5ta00675a
   Lin MM, 2015, MAT SCI ENG C-MATER, V50, P300, DOI 10.1016/j.msec.2015.01.086
   Lotya M, 2010, ACS NANO, V4, P3155, DOI 10.1021/nn1005304
   Pan HL, 2003, NANO LETT, V3, P29, DOI 10.1021/nl025856b
   Pumera M, 2013, CHEM SOC REV, V42, P5987, DOI 10.1039/c3cs60132c
   Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034
   Sun J, 2015, PART PART SYST CHAR, V32, P434, DOI 10.1002/ppsc.201400189
   Taherian F, 2013, LANGMUIR, V29, P1457, DOI 10.1021/la304645w
   Tian SY, 2015, RSC ADV, V5, P69854, DOI 10.1039/c5ra09388k
   Wang JZ, 2011, J AM CHEM SOC, V133, P8888, DOI 10.1021/ja203725d
   Yan L, 2012, J MATER CHEM, V22, P8367, DOI 10.1039/c2jm30961k
   Yang D, 2008, J MATER CHEM, V18, P350, DOI 10.1039/b713467c
   Yang SW, 2016, ANALYST, V141, P1052, DOI 10.1039/c5an02270c
   Yang SW, 2015, CHEM MATER, V27, P2004, DOI 10.1021/acs.chemmater.5b00112
   Yang SW, 2014, J MATER CHEM A, V2, P8660, DOI 10.1039/c4ta00860j
   Zhang P, 2003, SYNTHETIC COMMUN, V33, P2469, DOI 10.1081/SCC-120021836
   Zhou J, 2009, NANO LETT, V9, P3867, DOI 10.1021/nl9020733
   Zhu C, 2015, J MATER CHEM B, V3, P6871, DOI 10.1039/c5tb01093d
   Zhu C, 2015, J MATER CHEM C, V3, P8810, DOI 10.1039/c5tc01933h
   Zhu YW, 2010, ADV MATER, V22, P3906, DOI 10.1002/adma.201001068
NR 27
TC 16
Z9 16
U1 11
U2 104
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD APR 27
PY 2016
VL 8
IS 16
BP 10226
EP 10233
DI 10.1021/acsami.6b02032
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DK9IW
UT WOS:000375245100020
PM 27052945
DA 2018-10-19
ER

PT J
AU Mo, F
   Lin, BF
   Lai, FJ
   Xu, CH
   Zou, HZ
AF Mo, Fang
   Lin, Baofeng
   Lai, Fengjiao
   Xu, Chuanhui
   Zou, Haizhong
TI A Green Modified Microsphere of Chitosan Encapsulating Dimethyl Fumarate
   and Cross-Linked by Vanillin and Its Application for Litchi Preservation
SO INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH
LA English
DT Article
ID CONTROLLED-RELEASE; ANTIBACTERIAL ACTIVITY; AMBIENT-TEMPERATURE;
   BETA-CYCLODEXTRIN; DRUG-RELEASE; SHELF-LIFE; GEL BEADS; IN-VITRO;
   NANOPARTICLES; ANTIOXIDANT
AB A green sustained delivery biomaterial was prepared to encapsulate dimethyl fiimarate (DMF) by an emulsion cross-linking method for sustained release. The average size of the microspheres was 20-150 mu m. The highest encapsulation efficiency and loading efficiency were 85.7 and 13.2%, respectively. The release of DMF in phosphate buffer saline followed a Fickian diffusion. In addition, the results of inhibition zone showed that DMF-loaded microspheres exhibited antimicrobial and antifungal properties much better than those of CS microspheres. Furthermore, weight loss of treated fruit was reduced insignificantly, and storage time was extended with the stable quality of litchi as compared with that of the control group. Thus, the microspheres were synthesized successfully as a sustained delivery system for DMF, which might have broad prospect and development value in preservation of fruits and vegetables.
C1 [Mo, Fang; Lin, Baofeng; Lai, Fengjiao; Xu, Chuanhui; Zou, Haizhong] Guangxi Univ, Coll Chem & Chem Engn, Nanning 530004, Peoples R China.
RP Lin, BF (reprint author), Guangxi Univ, Coll Chem & Chem Engn, Nanning 530004, Peoples R China.
EM linbf941@gxu.edu.cn
FU National Natural Science Foundation of China [51263001]; Scientific
   Research Foundation of Guangxi University of China [XTZ140787]
FX This work was financially supported by National Natural Science
   Foundation of China under Grant No. 51263001 (to B.L.) and Scientific
   Research Foundation of Guangxi University of China. Contract grant
   sponsor: XTZ140787.
CR Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   Ding P, 2007, INT J BIOL MACROMOL, V41, P125, DOI 10.1016/j.ijbiomac.2006.12.008
   Ducamp-Collin MN, 2008, POSTHARVEST BIOL TEC, V49, P241, DOI 10.1016/j.postharvbio.2008.01.009
   Esmaeili F, 2007, NANOMED-NANOTECHNOL, V3, P161, DOI 10.1016/j.nano.2007.03.003
   Furst W, 2005, ANN THORAC SURG, V79, P1522, DOI 10.1016/j.athoracsur.2004.11.054
   Gandhi A, 2014, INT J BIOL MACROMOL, V67, P478, DOI 10.1016/j.ijbiomac.2014.04.019
   Gupta KC, 2006, CARBOHYD RES, V341, P744, DOI 10.1016/j.carres.2006.02.003
   Huang XM, 2005, POSTHARVEST BIOL TEC, V36, P177, DOI 10.1016/j.postharvbio.2004.12.005
   Hundre SY, 2015, FOOD CHEM, V174, P16, DOI 10.1016/j.foodchem.2014.11.016
   Jiang YM, 2003, J HORTIC SCI BIOTECH, V78, P437, DOI 10.1080/14620316.2003.11511645
   Kai YM, 2013, FLUID PHASE EQUILIBR, V344, P19, DOI 10.1016/j.fluid.2012.12.031
   Kalinin S, 2013, J NEUROIMMUNOL, V263, P13, DOI 10.1016/j.jneuroim.2013.07.007
   Karathanos VT, 2007, FOOD CHEM, V101, P652, DOI 10.1016/j.foodchem.2006.01.053
   Kong XY, 2010, CARBOHYD POLYM, V79, P170, DOI 10.1016/j.carbpol.2009.07.037
   Kooijman H, 2004, ACTA CRYSTALLOGR E, V60, pO917, DOI 10.1107/S1600536804010177
   Liang YS, 2012, POSTHARVEST BIOL TEC, V68, P72, DOI 10.1016/j.postharvbio.2012.02.005
   Lin BF, 2011, J FOOD ENG, V102, P94, DOI 10.1016/j.jfoodeng.2010.08.009
   Lopes SB, 2002, PHYS CHEM CHEM PHYS, V4, P1014, DOI 10.1039/b107232n
   Mangaraj S, 2012, POSTHARVEST BIOL TEC, V71, P1, DOI 10.1016/j.postharvbio.2012.04.007
   Mi FL, 1999, J APPL POLYM SCI, V74, P1868, DOI 10.1002/(SICI)1097-4628(19991114)74:7<1868::AID-APP32>3.0.CO;2-N
   Misra R, 2009, NANOMEDICINE-UK, V4, P519, DOI [10.2217/nnm.09.28, 10.2217/NNM.09.28]
   Mohamed Nadia Hussein, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P876
   Mourtzinos I, 2009, FOOD CHEM, V114, P791, DOI 10.1016/j.foodchem.2008.10.014
   Olesen T, 2004, POSTHARVEST BIOL TEC, V32, P135, DOI 10.1016/j.postharvbio.2003.10.009
   Prakash B, 2012, FOOD RES INT, V49, P201, DOI 10.1016/j.foodres.2012.08.020
   Rathna GVN, 2008, J MATER SCI-MATER M, V19, P2351, DOI 10.1007/s10856-007-3334-9
   RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6
   Rokhade AP, 2007, CARBOHYD POLYM, V69, P678, DOI 10.1016/j.carbpol.2007.02.008
   Sashikala S., 2014, SCHOLARS RES LIB PHA, V6, P90
   Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P139, DOI 10.1016/S0169-409X(01)00112-0
   Silva MD, 2010, QUIM NOVA, V33, P1868, DOI 10.1590/S0100-40422010000900009
   Sinha AK, 2008, INT J FOOD SCI NUTR, V59, P299, DOI 10.1080/09687630701539350
   Sivakami MS, 2013, INT J BIOL MACROMOL, V57, P204, DOI 10.1016/j.ijbiomac.2013.03.005
   Takka S, 1998, EUR J PHARM SCI, V6, P241, DOI 10.1016/S0928-0987(97)10005-7
   Tanuma H, 2010, CARBOHYD POLYM, V80, P260, DOI 10.1016/j.carbpol.2009.11.022
   Wang HC, 2010, PHYTOPATHOLOGY, V100, P522, DOI 10.1094/PHYTO-100-5-0522
   Wu H, 2015, FOOD CHEM, V175, P344, DOI 10.1016/j.foodchem.2014.11.149
   Zhang SY, 2014, LWT-FOOD SCI TECHNOL, V57, P749, DOI 10.1016/j.lwt.2014.02.046
NR 38
TC 3
Z9 3
U1 14
U2 51
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0888-5885
J9 IND ENG CHEM RES
JI Ind. Eng. Chem. Res.
PD APR 27
PY 2016
VL 55
IS 16
BP 4490
EP 4498
DI 10.1021/acs.iecr.6b00028
PG 9
WC Engineering, Chemical
SC Engineering
GA DK9IU
UT WOS:000375244900012
DA 2018-10-19
ER

PT J
AU Zhao, M
   Shi, Y
   He, MX
   Huang, XD
   Wang, Q
AF Zhao, Mi
   Shi, Yu
   He, Maoxian
   Huang, Xiande
   Wang, Qi
TI PfSMAD4 plays a role in biomineralization and can transduce bone
   morphogenetic protein-2 signals in the pearl oyster Pinctada fucata
SO BMC DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE SMAD4; Biomineralization; BMP signaling pathway; Pinctada fucata
ID TGF-BETA; NACRE FORMATION; MATRIX PROTEIN; CELL-MEMBRANE; SMAD4;
   EXPRESSION; GENE; DPP; NUCLEUS; PATHWAY
AB Background: Mollusca is the second largest phylum in nature. The shell of molluscs is a remarkable example of a natural composite biomaterial. Biomineralization and how it affects mollusks is a popular research topic. The BMP-2 signaling pathway plays a canonical role in biomineralization. SMAD4 is an intracellular transmitter in the BMP signaling pathway in mammals, and some genomic data show SMAD4's involvment in BMP signaling in invertbrates, but whether SMAD4 plays a conservative role in pearl oyster, Pinctada fucata, still need to be tested.
   Results: In this study, we identified a SMAD4 gene (hereafter designated PfSMAD4) in pearl oyster Pinctada fucata. Bioinformatics analysis of PfSMAD4 showed high identity with its orthologs. PfSMAD4 was located in the cytoplasm in immunofluorescence assays and analyses of PfSMAD4 mRNA in tissues and developmental stages showed high expression in ovaries and D-shaped larvae. An RNA interference experiment, performed by PfSMAD4 double-stranded RNA (dsRNA) injection, demonstrated inhibition not only of nacre growth but also organic sheet formation with a decrease in PfSMAD4 expression. A knockdown experiment using PfBMP2 dsRNA showed decreased PfBMP2 and PfSMAD4 mRNA and irregular crystallization of the nacreous layer using scanning electron microscopy. In co-transfection experiments, PfBMP2-transactivated reporter constructs contained PfSMAD4 promoter sequences.
   Conclusions: Our results suggest that PfSMAD4 plays a role in biomineralization and can transduce BMP signals in P. fucata. Our data provides important clues about the molecular mechanisms that regulate biomineralization in pearl oyster.
C1 [Zhao, Mi; Shi, Yu; He, Maoxian; Huang, Xiande; Wang, Qi] Chinese Acad Sci, South China Sea Inst Oceanol, CAS Key Lab Trop Marine Bioresources & Ecol, Guangzhou 510301, Guangdong, Peoples R China.
   [Zhao, Mi; Wang, Qi] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
RP He, MX (reprint author), Chinese Acad Sci, South China Sea Inst Oceanol, CAS Key Lab Trop Marine Bioresources & Ecol, Guangzhou 510301, Guangdong, Peoples R China.
EM hmx@scsio.ac.cn
FU National Natural Science Foundation of China [41376159]; National
   Science and technology program of China [2012AA10A410]; Marine Fishery
   Science and Technology Promotion Program of Guangdong Province, China
   [A201201A05, A201301A03]
FX This work was supported by the National Natural Science Foundation of
   China (41376159), the National Science and technology program of China
   (2012AA10A410) and the Marine Fishery Science and Technology Promotion
   Program of Guangdong Province, China (A201201A05, A201301A03).
CR Addadi L, 1997, NATURE, V389, P912, DOI 10.1038/40010
   Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809
   Attisano L, 2001, GENOME BIOL, V2
   Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023
   Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929
   Cho YD, 2010, J BIOL CHEM, V285, P36369, DOI 10.1074/jbc.M110.103093
   Das P, 1998, DEVELOPMENT, V125, P1519
   De Robertis EM, 2008, CELL, V132, P185, DOI 10.1016/j.cell.2008.01.003
   Eivers E, 2009, CYTOKINE GROWTH F R, V20, P357, DOI 10.1016/j.cytogfr.2009.10.017
   Evans AG, 2001, J MATER RES, V16, P2475, DOI 10.1557/JMR.2001.0339
   Fang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021860
   Funabara D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084706
   Gong NP, 2008, J STRUCT BIOL, V164, P33, DOI 10.1016/j.jsb.2008.05.009
   Hashimoto N, 2012, DEV BIOL, V366, P367, DOI 10.1016/j.ydbio.2012.04.010
   Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284
   Hohenstein P, 2003, GENE CHROMOSOME CANC, V36, P273, DOI 10.1002/gcc.10169
   Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3
   Jiao Y, 2012, BIOCHEM BIOPH RES CO, V425, P679, DOI 10.1016/j.bbrc.2012.07.099
   Kin K, 2009, DEV BIOL, V329, P152, DOI 10.1016/j.ydbio.2009.01.021
   Kobayashi A, 1999, DEV GROWTH DIFFER, V41, P419
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lazzereschi D, 2005, ONCOGENE, V24, P5344, DOI 10.1038/sj.onc.1208603
   Le Goff C, 2012, NAT GENET, V44, P85, DOI 10.1038/ng.1016
   Liu G, 2014, CHIN J OCEANOL LIMN, V32, P1224, DOI 10.1007/s00343-014-3360-7
   Luo YJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9301
   Maru D, 2004, ONCOGENE, V23, P859, DOI 10.1038/sj.onc.1207194
   Miyashita T., 2013, INT J ZOOLOGY, V2013
   Miyashita T, 2008, BIOSCI BIOTECH BIOCH, V72, P37, DOI 10.1271/bbb.70302
   Nederbragt AJ, 2002, DEV BIOL, V246, P341, DOI 10.1006/dbio.2002.0653
   Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011
   PADGETT RW, 1993, P NATL ACAD SCI USA, V90, P2905, DOI 10.1073/pnas.90.7.2905
   Pierreux CE, 2000, MOL CELL BIOL, V20, P9041, DOI 10.1128/MCB.20.23.9041-9054.2000
   Retting KN, 2009, DEVELOPMENT, V136, P1093, DOI 10.1242/dev.029926
   Samuel G, 2001, EVOL DEV, V3, P241, DOI 10.1046/j.1525-142x.2001.003004241.x
   Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X
   Shimizu K, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-15
   Shimizu K, 2011, DEV GENES EVOL, V221, P59, DOI 10.1007/s00427-011-0358-4
   Shioda T, 1998, P NATL ACAD SCI USA, V95, P9785, DOI 10.1073/pnas.95.17.9785
   Shrey K, 2009, BIOCHEM BIOPH RES CO, V386, P273, DOI 10.1016/j.bbrc.2009.06.018
   Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tan XH, 2007, J CELL SCI, V120, P2162, DOI 10.1242/jcs.003466
   Tao SJ, 2010, DEV GROWTH DIFFER, V52, P335, DOI 10.1111/j.1440-169X.2009.01163.x
   WADA K., 1972, BIOMINERALISATION, V6, P141
   Wang RZ, 2001, J MATER RES, V16, P2485, DOI 10.1557/JMR.2001.0340
   Warmflash A, 2012, P NATL ACAD SCI USA, V109, pE1947, DOI 10.1073/pnas.1207607109
   Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798
   Xiao YT, 2007, BIOCHEM BIOPH RES CO, V362, P550, DOI 10.1016/j.bbrc.2007.08.045
   Xu C, 2005, GENE, V357, P1, DOI 10.1016/j.gene.2005.06.017
   Yu XS, 2011, SCI CHINA LIFE SCI, V54, P220, DOI 10.1007/s11427-011-4136-3
   Zaidi SK, 2002, P NATL ACAD SCI USA, V99, P8048, DOI 10.1073/pnas.112664499
   Zentz F, 2001, MAR BIOTECHNOL, V3, P36, DOI 10.1007/s101260000042
   Zhang Y, 1997, CURR BIOL, V7, P270, DOI 10.1016/S0960-9822(06)00123-0
NR 53
TC 5
Z9 5
U1 0
U2 21
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-213X
J9 BMC DEV BIOL
JI BMC Dev. Biol.
PD APR 26
PY 2016
VL 16
AR 9
DI 10.1186/s12861-016-0110-4
PG 9
WC Developmental Biology
SC Developmental Biology
GA DK2IQ
UT WOS:000374738300001
PM 27113217
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Zhao, TF
   Chen, CQ
   Deng, ZC
AF Zhao, T. F.
   Chen, C. Q.
   Deng, Z. C.
TI Elastoplastic properties of transversely isotropic sintered metal fiber
   sheets
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE Metal fiber networks; Transversely isotropic; Elastoplastic properties;
   Uniaxial test; Tomography
ID X-RAY TOMOGRAPHY; MECHANICAL-BEHAVIOR; CELLULAR METALS; NETWORK;
   DEFORMATION; MODEL; ENHANCEMENT; PREDICTION
AB Sintering of layered metal fiber sheets produces a structured, tunable, paper-like material that holds promise for thermal and biomaterial applications. Particularly promising for these areas is a material system synthesized by the sequential-overlap method, which produces a networked, transversely isotropic open cell porous material. Engineering application of these materials has been limited due in part to uncertainty about their mechanical responses. Here, we present a comprehensive structural and mechanical characterization of these materials, and define a modeling framework suitable for engineering design. X-ray tomography revealed a layered structure with an isotropic fiber distribution within each layer. In-plane uniaxial compression and tension tests revealed a linear dependence of Young's modulus and yield strength upon relative fiber density. Out-of-plane tests, however, revealed much lower Young's modulus and strength, with quartic and cubic dependence upon relative density, respectively. Fiber fracture was the dominant mode of failure for tension within the "in-plane" directions of the fiber layers, and fiber decohesion was the dominant mode of failure for tension applied in the "out-of-plane" direction, normal to the layers. Models based upon dispersions of beams predicted both in plane and out-of-plane elastoplastic properties as a function of the relative density of fibers. These models provide a foundation for mechanical design with and optimization of these materials for a broad range of potential applications. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Zhao, T. F.; Deng, Z. C.] Northwestern Polytech Univ, Sch Mech Civil Engn & Architecture, Xian 710072, Peoples R China.
   [Chen, C. Q.] Tsinghua Univ, AML, Dept Engn Mech, Beijing 100084, Peoples R China.
   [Chen, C. Q.] Tsinghua Univ, AML, Ctr Nano & Micro Mech, Beijing 100084, Peoples R China.
   [Deng, Z. C.] Dalian Univ Technol, State Key Lab Struct Anal Ind Equipment, Dalian 116024, Peoples R China.
RP Chen, CQ (reprint author), Tsinghua Univ, AML, Dept Engn Mech, Beijing 100084, Peoples R China.; Chen, CQ (reprint author), Tsinghua Univ, AML, Ctr Nano & Micro Mech, Beijing 100084, Peoples R China.
EM chencq@tsinghua.edu.cn
RI Chen, Changqing/A-4380-2009
OI Chen, Changqing/0000-0002-1561-0798
FU National Natural Science Foundation of China [11402201, 11172239,
   11372252]; National Basic Research Program of China [2015CB351900];
   Fundamental Research Funds for the Central Universities
   [3102014JCQ01037]
FX This work is supported by the National Natural Science Foundation of
   China (Nos. 11402201, 11172239 and 11372252), the National Basic
   Research Program of China (No. 2015CB351900), and the Fundamental
   Research Funds for the Central Universities (No. 3102014JCQ01037). The
   authors are grateful to Prof. Guy Genin at Washington University at St.
   Louis for his insightful comments and help on re-shaping this paper.
CR Ashby M.F., 2000, METAL FOAMS DESIGN G
   Banhart J, 2001, PROG MATER SCI, V46, P559, DOI 10.1016/S0079-6425(00)00002-5
   Budynas RG, 1998, ADV STRENGTH APPL ST
   Chadwick C, 2010, FILTR SEPARAT, V47, P18, DOI 10.1016/S0015-1882(10)70260-3
   CHEN YL, 2015, J MECH PHYS SOLIDS, V84, P395
   Clyne TW, 2005, COMPOS SCI TECHNOL, V65, P2492, DOI 10.1016/j.compscitech.2005.05.037
   Delince M, 2004, ACTA MATER, V52, P1013, DOI 10.1016/j.actamat.2003.10.035
   Deshpande VS, 2001, J MECH PHYS SOLIDS, V49, P1747, DOI 10.1016/S0022-5096(01)00010-2
   DUCHEYNE P, 1978, J MATER SCI, V13, P2650, DOI 10.1007/BF00552695
   Franco A, 2006, EXP THERM FLUID SCI, V30, P263, DOI 10.1016/j.expthermflusci.2005.07.002
   Gibson L. G., 1997, CELLULAR SOLIDS STRU
   Gibson LJ, 2011, INTEGR COMP BIOL, V51, pE47
   Huang X, 2013, MAT SCI ENG A-STRUCT, V585, P297, DOI 10.1016/j.msea.2013.07.052
   JANSEN JA, 1992, BIOMATERIALS, V13, P959, DOI 10.1016/0142-9612(92)90121-4
   Jayanty S, 2011, PHYS STATUS SOLIDI B, V248, P73, DOI 10.1002/pssb.201083973
   Jiang GF, 2014, MATER DESIGN, V56, P241, DOI 10.1016/j.matdes.2013.11.019
   Jin MZ, 2013, J MECH PHYS SOLIDS, V61, P161, DOI 10.1016/j.jmps.2012.08.006
   Liu JG, 2004, J POWER SOURCES, V133, P175, DOI 10.1016/j.jpowsour.2004.02.009
   Liu P, 2009, MATER DESIGN, V30, P2264, DOI 10.1016/j.matdes.2008.09.007
   Liu Q, 2013, MAT SCI ENG A-STRUCT, V587, P36, DOI 10.1016/j.msea.2013.07.087
   Markaki AE, 2003, ACTA MATER, V51, P1351, DOI 10.1016/S1359-6454(02)00529-3
   Neelakantan S, 2014, ACTA MATER, V66, P326, DOI 10.1016/j.actamat.2013.11.020
   Neelakantan S, 2015, SCRIPTA MATER, V106, P30, DOI 10.1016/j.scriptamat.2015.04.028
   Peukert W, 1998, FILTR SEPARAT, V35, P461, DOI 10.1016/S0015-1882(98)80015-3
   Tan J. C., 2006, ADV ENG MATER, V8, P455
   Tatlier M, 2009, PHYS STATUS SOLIDI B, V246, P2018, DOI 10.1002/pssb.200982032
   Tsarouchas D, 2011, ACTA MATER, V59, P6989, DOI 10.1016/j.actamat.2011.07.051
   Veyhl C, 2012, INT J HEAT MASS TRAN, V55, P2440, DOI 10.1016/j.ijheatmasstransfer.2012.01.016
   Wadley HNG, 2006, PHILOS T ROY SOC A, V364, P31, DOI 10.1098/rsta.2005.1697
   Wan ZP, 2012, MAT SCI ENG A-STRUCT, V544, P33, DOI 10.1016/j.msea.2012.02.070
   Yuranov I, 2003, APPL CATAL B-ENVIRON, V43, P217, DOI 10.1016/S0926-3373(02)00304-1
   Zhao TF, 2014, MECH MATER, V70, P33, DOI 10.1016/j.mechmat.2013.11.007
   Zhou DW, 2005, INT J MECH SCI, V47, P775, DOI 10.1016/j.ijmensci.2004.10.013
   Zou C., 2007, J MATER SCI-MATER M, V19, P401
NR 34
TC 5
Z9 5
U1 2
U2 14
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
EI 1873-4936
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD APR 26
PY 2016
VL 662
BP 308
EP 319
DI 10.1016/j.msea.2016.03.085
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA DK8GD
UT WOS:000375164300036
DA 2018-10-19
ER

PT J
AU Chahal, S
   Hussain, FSJ
   Kumar, A
   Rasad, MSBA
   Yusoff, MM
AF Chahal, Sugandha
   Hussain, Fathima Shahitha Jahir
   Kumar, Anuj
   Rasad, Mohammad Syaiful Bahari Abdull
   Yusoff, Mashitah Mohd
TI Fabrication, characterization and in vitro biocompatibility of
   electrospun hydroxyethyl cellulose poly (vinyl) alcohol nanofibrous
   composite biomaterial for bone tissue engineering
SO CHEMICAL ENGINEERING SCIENCE
LA English
DT Article
DE Hydroxyethyl cellulose; Electrospinning; Thermo-mechanical properties;
   Bone tissue engineering
ID POLY(VINYL ALCOHOL); SCAFFOLDS; HYDROGELS; COLLAGEN; FIBERS;
   NANOCOMPOSITES; DESIGN; FILMS; WATER; PVA
AB Development of novel scaffold materials that mimic the extracellular matrix, architecturally and functionally, is becoming highly important to meet the demands of the advances in bone tissue engineering. This paper reports, the fabrication of natural polymer cellulose derived hydroxyethyl cellulose (HEC) based nanostructured scaffolds with uniform fiber morphology through electrospinning. Poly (vinyl alcohol) (PVA) was used as an ionic solvent for supporting the electrospinning of HEC. Scanning electron microscopy and ImageJ analysis revealed the formation of non-woven nanofibers with well-defined porous architecture. The interactions between HEC and PVA in the electrospun nanofibers were studied by differential scanning calorimetry, X-ray diffraction, dynamic mechanical analysis thermo-gravimetric analysis; Fourier transform-infrared spectroscopy, X-ray photoelectron spectroscopy and tensile test. The mechanical properties of scaffolds were significantly altered with different ratios of HEC/PVA. Further, the biocompatibility of HEC/PVA scaffolds was evaluated using human osteosarcoma cells. The SEM images revealed favorable cells attachment and spreading on the nanofibrous scaffolds and MTS assay showed increased cell proliferation after different time periods. Thus, these results indicate that HEC based nanofibrous scaffolds will be a promising candidate for bone tissue engineering. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Chahal, Sugandha; Hussain, Fathima Shahitha Jahir; Yusoff, Mashitah Mohd] Univ Malaysia Pahang, Fac Ind Sci & Technol, Kuantan 26070, Pahang, Malaysia.
   [Kumar, Anuj] Czech Tech Univ, Dept Bldg Struct, Fac Civil Engn, Thakurova 7, Prague 16629 6, Czech Republic.
   [Rasad, Mohammad Syaiful Bahari Abdull] IIUM, Kulliyyah Allied Hlth Sci, Dept Biomed Sci, Kuantan 25200, Pahang, Malaysia.
RP Chahal, S (reprint author), Univ Malaysia Pahang, Fac Ind Sci & Technol, Kuantan 26070, Pahang, Malaysia.
EM mlt.mony@gmail.com
OI Kumar, Anuj/0000-0001-6940-3850; Yusoff, Mashitah/0000-0003-4118-5307
FU Fundamental Research Grant Scheme (FRGS) [RDU100106]; Ministry of Higher
   Education, Malaysia
FX This work was supported by Fundamental Research Grant Scheme (FRGS)
   RDU100106, by Ministry of Higher Education, Malaysia. Authors
   acknowledge the support of Dr. Janez Kovac from Jozef Stefan Institute,
   Ljubljana, Slovenia for conducted the XPS analysis of prepared samples.
CR Abd El-Kader FH, 1999, J APPL POLYM SCI, V72, P1395, DOI 10.1002/(SICI)1097-4628(19990613)72:11<1395::AID-APP3>3.0.CO;2-8
   Agarwal S, 2009, ADV MATER, V21, P3343, DOI 10.1002/adma.200803092
   Ali IO, 2013, COLLOID SURFACE A, V436, P922, DOI 10.1016/j.colsurfa.2013.08.032
   Andrade G, 2006, BIOMED MATER, V1, P221, DOI 10.1088/1748-6041/1/4/008
   Asran AS, 2010, POLYMER, V51, P868, DOI 10.1016/j.polymer.2009.12.046
   Attia A., 2013, INT J ELECTROCHEM SC, V8, P5672
   Azizi Samir M.A.S., 2005, BIOMACROMOLECULES, V6, P612, DOI DOI 10.1021/BM0493685
   Barazzouk S, 2011, CELLULOSE, V18, P643, DOI 10.1007/s10570-011-9503-5
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Chahal S, 2015, RSC ADV, V5, P29497, DOI 10.1039/c4ra17087c
   Chahal S, 2014, BIO-MED MATER ENG, V24, P1537, DOI 10.3233/BME-140957
   Chen R, 2010, CARBOHYD POLYM, V81, P188, DOI 10.1016/j.carbpol.2010.02.012
   Coates J., 2000, INTERPRETATION INFRA, P10815
   Ding FY, 2014, NANOSCALE, V6, P9477, DOI 10.1039/c4nr02814g
   Domingues RMA, 2014, BIOMACROMOLECULES, V15, P2327, DOI 10.1021/bm500524s
   Elashmawi I.S., 2014, BR J APPL SCI TECHNO, V4, P4263
   Fratzl P, 2003, CURR OPIN COLLOID IN, V8, P32, DOI 10.1016/S1359-0294(03)00011-6
   Goonoo N, 2013, POLYM INT, V62, P523, DOI 10.1002/pi.4474
   Guirguis OW, 2012, NAT SCI, V4, P57, DOI DOI 10.4236/NS.2012.41009
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Hadano S, 2003, J APPL POLYM SCI, V90, P2059, DOI 10.1002/app.12807
   Heydarkhan-Hagvall S, 2008, BIOMATERIALS, V29, P2907, DOI 10.1016/j.biomaterials.2008.03.034
   Hing KA, 2005, J MATER SCI-MATER M, V16, P467, DOI 10.1007/s10856-005-6988-1
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Jianga T., 2015, PROG POLYM SCI
   Kanungo BP, 2008, ACTA BIOMATER, V4, P490, DOI 10.1016/j.actbio.2008.01.003
   Kmmerer K., 2011, CHEMOSPHERE, V82, P1387
   Kovacs T, 2010, NANOTOXICOLOGY, V4, P255, DOI 10.3109/17435391003628713
   Krumova M, 2000, POLYMER, V41, P9265, DOI 10.1016/S0032-3861(00)00287-1
   Lee JS, 2004, J APPL POLYM SCI, V93, P1638, DOI 10.1002/app.20602
   Li J, 1997, J APPL POLYM SCI, V65, P373
   Lin F, 2013, J POLYM ENVIRON, V21, P343, DOI 10.1007/s10924-012-0453-2
   Linde L., 1989, J BIOMECH, V22, P485
   Lu WJ, 2014, J MATER CHEM B, V2, P2369, DOI 10.1039/c3tb21478h
   Mallapragada SK, 1996, J POLYM SCI POL PHYS, V34, P1339, DOI 10.1002/(SICI)1099-0488(199605)34:7<1339::AID-POLB15>3.0.CO;2-B
   Martins A, 2007, NANOMEDICINE-UK, V2, P929, DOI 10.2217/17435889.2.6.929
   MORRILL T. C., 1994, IDENTIFICACAO ESPECT
   Nayar S, 2008, J MATER SCI-MATER M, V19, P301, DOI 10.1007/s10856-007-3129-z
   Park JC, 2010, POLYM J, V42, P273, DOI 10.1038/pj.2009.340
   PEPPAS NA, 1976, J APPL POLYM SCI, V20, P1457, DOI 10.1002/app.1976.070200604
   Poinern GE, 2009, ULTRASON SONOCHEM, V16, P469, DOI 10.1016/j.ultsonch.2009.01.007
   Qua EH, 2009, J APPL POLYM SCI, V113, P2238, DOI 10.1002/app.30116
   Rathna GVN, 2011, POLYM J, V43, P654, DOI 10.1038/pj.2011.34
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Ricciardi R, 2004, MACROMOLECULES, V37, P1921, DOI 10.1021/ma035663q
   Rodriguez K, 2011, ACS APPL MATER INTER, V3, P681, DOI 10.1021/am100972r
   ROHLMANN A, 1980, ARCH ORTHOP TRAUM SU, V97, P95, DOI 10.1007/BF00450930
   Rong C., 2010, CARBOHYD POLYM, V81, P188
   Rosic R, 2011, J DRUG DELIV SCI TEC, V21, P229, DOI 10.1016/S1773-2247(11)50031-0
   ROSKELLEY CD, 1995, CURR OPIN CELL BIOL, V7, P736, DOI 10.1016/0955-0674(95)80117-0
   Russo R, 2010, CARBOHYD POLYM, V82, P1061, DOI 10.1016/j.carbpol.2010.06.037
   Salamone J. C., 1998, CONCISE POLYM MAT EN, V1
   Sannino A, 2009, MATERIALS, V2, P353, DOI 10.3390/ma2020353
   Seliktar D, 2005, ANN NY ACAD SCI, V1047, P386, DOI 10.1196/annals.1341.034
   SELIM IZ, 1994, POLYM-PLAST TECHNOL, V33, P161, DOI 10.1080/03602559408015293
   Shakesheff KM, 1997, J COLLOID INTERF SCI, V185, P538, DOI 10.1006/jcis.1996.4637
   Sheeny K., 2014, J MATER CHEM B, V2, P3161
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Wallner EI, 1998, AM J PHYSIOL-RENAL, V275, pF467, DOI 10.1152/ajprenal.1998.275.4.F467
   Wenjing L., 2014, J MATER CHEM B, V2, P2369
   Wignall G.D., 1993, SCATTERING TECHNIQUE
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
   Yang C., 2008, BIODRUGS, V18, P490
   Zhang L, 2012, SOFT MATTER, V8, P10439, DOI 10.1039/c2sm26102b
   Zhang YZ, 2005, BIOMACROMOLECULES, V6, P2583, DOI 10.1021/bm050314k
   Zhang YZ, 2006, BIOMACROMOLECULES, V7, P1049, DOI 10.1021/bm050743i
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zohuriaan MJ, 2004, POLYM TEST, V23, P575, DOI 10.1016/j.polymertesting.2003.11.001
   Zulkifli FH, 2014, CARBOHYD POLYM, V114, P238, DOI 10.1016/j.carbpol.2014.08.019
NR 69
TC 16
Z9 17
U1 4
U2 86
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0009-2509
EI 1873-4405
J9 CHEM ENG SCI
JI Chem. Eng. Sci.
PD APR 22
PY 2016
VL 144
BP 17
EP 29
DI 10.1016/j.ces.2015.12.030
PG 13
WC Engineering, Chemical
SC Engineering
GA DF6NO
UT WOS:000371472700003
DA 2018-10-19
ER

PT J
AU Kalman, S
   Garbett, KA
   Janka, Z
   Mirnics, K
AF Kalman, S.
   Garbett, K. A.
   Janka, Z.
   Mirnics, K.
TI HUMAN DERMAL FIBROBLASTS IN PSYCHIATRY RESEARCH
SO NEUROSCIENCE
LA English
DT Review
DE dermal fibroblasts; schizophrenia; major depression; bipolar disorder;
   in vitro model; gene*environment interaction
ID PLURIPOTENT STEM-CELLS; MAJOR DEPRESSIVE DISORDER; CULTURED SKIN
   FIBROBLASTS; NAIVE 1ST-EPISODE SCHIZOPHRENIA; IMPAIRED GLUTATHIONE
   SYNTHESIS; DECREASED TYROSINE TRANSPORT; CATECHOL-O-METHYLTRANSFERASE;
   CIRCADIAN GENE-EXPRESSION; DEPENDENT PROTEIN-KINASE;
   AMINO-ACID-TRANSPORT
AB In order to decipher the disease etiology, progression and treatment of multifactorial human brain diseases we utilize a host of different experimental models. Recently, patient-derived human dermal fibroblast (HDF) cultures have re-emerged as promising in vitro functional system for examining various cellular, molecular, metabolic and (patho) physiological states and traits of psychiatric disorders. HDF studies serve as a powerful complement to postmortem and animal studies, and often appear to be informative about the altered homeostasis in neural tissue. Studies of HDFs from patients with schizophrenia (SZ), depression, bipolar disorder (BD), autism, attention deficit and hyperactivity disorder and other psychiatric disorders have significantly advanced our understanding of these devastating diseases. These reports unequivocally prove that signal transduction, redox homeostasis, circadian rhythms and gene*environment (G*E) interactions are all amenable for assessment by the HDF model. Furthermore, the reported findings suggest that this underutilized patient biomaterial, combined with modern molecular biology techniques, may have both diagnostic and prognostic value, including prediction of response to therapeutic agents. (C) 2016 IBRO. Published by Elsevier Ltd. All rights reserved.
C1 [Kalman, S.; Janka, Z.; Mirnics, K.] Univ Szeged, Dept Psychiat, 57 Kalvaria Sgt, H-6725 Szeged, Hungary.
   [Garbett, K. A.; Mirnics, K.] Vanderbilt Univ, Dept Psychiat, 8128 MRB 3,465 21st Ave, Nashville, TN 37232 USA.
RP Mirnics, K (reprint author), Vanderbilt Univ, Dept Psychiat, 8128 MRB 3,465 21st Ave, Nashville, TN 37232 USA.
EM kalmansara@gmail.com; krassimira.garbett@vanderbilt.edu;
   janka.zoltan@med.u-szeged.hu; karoly.mirnics@vanderbilt.edu
OI Mirnics, Karoly/0000-0002-5521-0254
FU NIMH [R01 MH079299]; Vanderbilt International Summer Research Academy
   (VISRA) scholarship; Vanderbilt International Scholar Short-Term Visit
   Fellowship
FX K.M.'s work was partially supported by R01 MH079299 (NIMH). S.K.'s work
   was partially supported by the Vanderbilt International Summer Research
   Academy (VISRA) scholarship and the Vanderbilt International Scholar
   Short-Term Visit Fellowship. We are grateful to Ms. Kelli Money for
   editing and providing insightful comments on the manuscript.
CR Akin D, 2004, NEUROPSYCHOPHARMACOL, V29, P2081, DOI 10.1038/sj.npp.1300505
   Akin D, 2005, INT J NEUROPSYCHOPH, V8, P5, DOI 10.1017/S146114570400478X
   ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7
   Auburger G, 2012, MOL NEUROBIOL, V46, P20, DOI 10.1007/s12035-012-8245-1
   Bae S, 2015, ACTA PHARMACEUT, V65, P331, DOI 10.1515/acph-2015-0025
   Bajpai A, 2014, J CLIN DIAGN RES, V8, pCC4, DOI 10.7860/JCDR/2014/10258.5292
   Bamne MN, 2013, BIPOLAR DISORD, V15, P694, DOI 10.1111/bdi.12095
   Batalla A, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.122
   BAYREUTHER K, 1991, MUTAT RES, V256, P233, DOI 10.1016/0921-8734(91)90014-3
   Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016
   Belinsky GS, 2014, STEM CELL RES, V12, P101, DOI 10.1016/j.scr.2013.09.014
   Benedetti F, 2008, NEUROSCI LETT, V445, P184, DOI 10.1016/j.neulet.2008.09.002
   Benito E, 2015, MOL NEUROBIOL, V51, P1071, DOI 10.1007/s12035-014-8772-z
   Berretta S, 2015, SCHIZOPHR RES, V167, P18, DOI 10.1016/j.schres.2014.12.040
   BERRETTINI WH, 1987, BIOL PSYCHIAT, V22, P1439, DOI 10.1016/0006-3223(87)90101-6
   Biran R, 1999, J BIOMED MATER RES, V46, P150, DOI 10.1002/(SICI)1097-4636(199908)46:2<150::AID-JBM3>3.3.CO;2-K
   Bongiovanni R, 2013, SCHIZOPHR RES, V150, P386, DOI 10.1016/j.schres.2013.08.041
   Borgmann-Winter K, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2014.141
   BREAKEFIELD XO, 1980, PSYCHIAT RES, V2, P307, DOI 10.1016/0165-1781(80)90022-0
   Brennand KJ, 2012, MOL PSYCHIATR, V17, P1239, DOI 10.1038/mp.2012.20
   Brennand KJ, 2014, BIOL PSYCHIAT, V75, P936, DOI 10.1016/j.biopsych.2013.10.025
   BRESLOW RE, 1985, BIOL PSYCHIAT, V20, P58, DOI 10.1016/0006-3223(85)90135-0
   Brown JA, 2015, MOL PSYCHIAT
   Brown JA, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0183-6
   Brown SA, 2005, PLOS BIOL, V3, P1813, DOI 10.1371/journal.pbio.0030338
   BRUINVELS J, 1988, PHARMACOPSYCHIATRY, V21, P28, DOI 10.1055/s-2007-1014642
   Cataldo AM, 2010, AM J PATHOL, V177, P575, DOI 10.2353/ajpath.2010.081068
   Cattane N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116686
   Catts VS, 2006, SCHIZOPHR RES, V84, P20, DOI 10.1016/j.schres.2006.03.016
   Chanda S, 2014, STEM CELL REP, V3, P282, DOI 10.1016/j.stemcr.2014.05.020
   Chen YW, 2015, NEUROPSYCH DIS TREAT, V11, DOI 10.2147/NDT.S81432
   Coffey EE, 2014, NEUROSCIENCE, V263, P111, DOI 10.1016/j.neuroscience.2014.01.001
   COHEN MR, 1987, PSYCHIAT RES, V21, P43, DOI 10.1016/0165-1781(87)90060-6
   COHEN MR, 1989, BIOL PSYCHIAT, V25, P239, DOI 10.1016/0006-3223(89)90170-4
   COHEN MR, 1986, BIOL PSYCHIAT, V21, P322, DOI 10.1016/0006-3223(86)90055-7
   Connolly GP, 1998, TRENDS PHARMACOL SCI, V19, P171, DOI 10.1016/S0165-6147(98)01202-4
   Cordero MD, 2009, TOXICOL APPL PHARM, V235, P329, DOI 10.1016/j.taap.2008.12.026
   Dage JL, 2014, PSYCHOPHARMACOLOGY, V231, P1105, DOI 10.1007/s00213-013-3384-2
   De Filippi L, 2007, CURR GENET, V52, P171, DOI 10.1007/s00294-007-0151-0
   Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI [10.1194/jlr.r400004, 10.1194/jlr.r400004-JLR200]
   Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799
   Do KQ, 2000, EUR J NEUROSCI, V12, P3721, DOI 10.1046/j.1460-9568.2000.00229.x
   Druzd D, 2014, SEMIN IMMUNOPATHOL, V36, P149, DOI 10.1007/s00281-013-0414-4
   Dwivedi Y, 2002, AM J PSYCHIAT, V159, P66, DOI 10.1176/appi.ajp.159.1.66
   Dwivedi Yogesh, 2008, Neuropsychiatr Dis Treat, V4, P161
   Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677
   Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612
   Evangelisti E, 2014, J ALZHEIMERS DIS, V41, P289, DOI 10.3233/JAD-131406
   Faissner A, 2010, BRAIN RES REV, V63, P26, DOI 10.1016/j.brainresrev.2010.01.001
   Fathi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022856
   FEKKES D, 1986, BIOL PSYCHIAT, V21, P951, DOI 10.1016/0006-3223(86)90269-6
   Fernell E, 2007, NEUROSCI LETT, V418, P82, DOI 10.1016/j.neulet.2007.03.004
   Feron F, 2013, METHODS MOL BIOL, V1059, P107, DOI 10.1007/978-1-62703-574-3_10
   Flyckt L, 2001, ARCH GEN PSYCHIAT, V58, P953, DOI 10.1001/archpsyc.58.10.953
   Forrest MP, 2014, TRENDS MOL MED, V20, P322, DOI 10.1016/j.molmed.2014.01.010
   Fournier M, 2014, SCHIZOPHRENIA BULL, V40, P973, DOI 10.1093/schbul/sbu053
   Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213
   Fullar A, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1272-3
   Garbett KA, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.14
   Garbett KA, 2015, BIOL PSYCHIAT, V77, P256, DOI 10.1016/j.biopsych.2014.05.015
   Garriock HA, 2010, BIOL PSYCHIAT, V67, P133, DOI 10.1016/j.biopsych.2009.08.029
   Gaspar L, 2014, EUR J NEUROSCI, V40, P2206, DOI 10.1111/ejn.12602
   Gasso P, 2014, J PSYCHIATR RES, V48, P94, DOI 10.1016/j.jpsychires.2013.09.017
   Gibson SA, 2012, J PSYCHIATR RES, V46, P1326, DOI 10.1016/j.jpsychires.2012.06.008
   GILLER E, 1984, PSYCHIAT RES, V12, P339, DOI 10.1016/0165-1781(84)90050-7
   GILLER EL, 1980, PSYCHIAT RES, V2, P187, DOI 10.1016/0165-1781(80)90076-1
   Gladkevich A, 2004, PROG NEURO-PSYCHOPH, V28, P559, DOI 10.1016/j.pnpbo.2004.01.009
   Glaros T, 2009, FRONT BIOSCI, V14, P3988, DOI 10.2735/3506
   Gomez G, 2000, J NEUROSCI RES, V62, P737, DOI 10.1002/1097-4547(20001201)62:5<737::AID-JNR14>3.0.CO;2-A
   Gong QY, 2015, BIOL PSYCHIAT, V77, P223, DOI 10.1016/j.biopsych.2014.08.009
   Greiner J F W, 2011, Eur Cell Mater, V22, P403
   GROSHONG R, 1978, ARCH GEN PSYCHIAT, V35, P1198
   Gundelfinger ED, 2010, EUR J NEUROSCI, V31, P2156, DOI 10.1111/j.1460-9568.2010.07253.x
   Gurung R, 2015, PSYCHOL MED, V45, P2461, DOI 10.1017/S0033291715000537
   Gysin R, 2007, P NATL ACAD SCI USA, V104, P16621, DOI 10.1073/pnas.0706778104
   Gysin R, 2011, ANTIOXID REDOX SIGN, V15, P2003, DOI 10.1089/ars.2010.3463
   Gysin R, 2009, BRAIN RES BULL, V79, P46, DOI 10.1016/j.brainresbull.2008.10.015
   Hanzelmann S, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0057-5
   HAGENFELDT L, 1987, LIFE SCI, V41, P2749, DOI 10.1016/0024-3205(87)90468-1
   Hayashi-Takagi A, 2014, BIOL PSYCHIAT, V75, P920, DOI 10.1016/j.biopsych.2013.09.035
   HITZEMANN R, 1988, PSYCHIAT RES, V24, P337, DOI 10.1016/0165-1781(88)90114-X
   Horvath S, 2015, BIOL PSYCHIAT, V77, P22, DOI 10.1016/j.biopsych.2014.01.001
   Horvath S, 2011, BIOL PSYCHIAT, V69, P157, DOI 10.1016/j.biopsych.2010.07.017
   Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107
   Huang HM, 2005, NEUROBIOL AGING, V26, P839, DOI 10.1016/j.neurobiolaging.2004.07.012
   Huard JMT, 1998, J COMP NEUROL, V400, P469
   Hung YY, 2014, PSYCHIAT RES, V220, P283, DOI 10.1016/j.psychres.2014.07.074
   Iafrati J, 2014, MOL PSYCHIATR, V19, P417, DOI 10.1038/mp.2013.66
   Iga JI, 2008, ANN MED, V40, P336, DOI 10.1080/07853890802082088
   Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821
   Jagannath A, 2013, CURR OPIN NEUROBIOL, V23, P888, DOI 10.1016/j.conb.2013.03.008
   Johansson AS, 2013, J PSYCHIATR RES, V47, P1815, DOI 10.1016/j.jpsychires.2013.08.008
   Johansson AS, 2011, J BIOL RHYTHM, V26, P541, DOI 10.1177/0748730411419775
   Johansson J, 2013, ADHD-ATTEND DEFICIT, V5, P267, DOI 10.1007/s12402-013-0103-0
   Johansson J, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-40
   Kaiser T, 2015, NAT MED, V21, P979, DOI 10.1038/nm.3935
   Kalman S, 2014, EXP CELL RES, V320, P343, DOI 10.1016/j.yexcr.2013.10.019
   Khandaker G. M., 2015, PSYCHOPHARMACOLOGY
   Kim DS, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00109
   Kirkpatrick B, 2008, SCHIZOPHRENIA BULL, V34, P1024, DOI 10.1093/schbul/sbm140
   Koch CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016679
   Krieger K, 1998, PHARMACOPSYCHIATRY, V31, P193, DOI 10.1055/s-2007-979326
   Kubben N, 2015, METHODS
   Kumari D, 2014, HUM MUTAT, V35, P1485, DOI 10.1002/humu.22699
   Kurian SM, 2011, MOL PSYCHIATR, V16, P37, DOI 10.1038/mp.2009.117
   Kyosseva SV, 2004, PROG NEURO-PSYCHOPH, V28, P997, DOI 10.1016/j.pnpbp.2004.05.017
   Lauth M, 2010, MOL PHARMACOL, V78, P486, DOI 10.1124/mol.110.066431
   Lee Kim Mai, 2015, World J Virol, V4, P42, DOI 10.5501/wjv.v4.i2.42
   Leeb C, 2014, J BIOL CHEM, V289, P4161, DOI 10.1074/jbc.M113.529271
   Lemons JM, 2010, PLOS BIOL, V8
   Leonard BE, 2007, NEUROCHEM RES, V32, P1749, DOI 10.1007/s11064-007-9385-y
   Liu JP, 2014, CLIN EXP PHARMACOL P, V41, P445, DOI 10.1111/1440-1681.12247
   Liu Y, 2013, NAT PROTOC, V8, P1670, DOI 10.1038/nprot.2013.106
   Logue MW, 2013, MOL PSYCHIATR, V18, P937, DOI 10.1038/mp.2012.113
   Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0
   Corrales NLL, 2012, GENE, V506, P377, DOI 10.1016/j.gene.2012.07.005
   Lu Pengfei, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a005058
   Lubbers BR, 2014, PROG BRAIN RES, V214, P263, DOI 10.1016/B978-0-444-63486-3.00012-8
   Lundgaard I, 2014, NEUROSCIENCE, V276, P161, DOI 10.1016/j.neuroscience.2013.10.050
   MAHADIK SP, 1994, SCHIZOPHR RES, V13, P239, DOI 10.1016/0920-9964(94)90048-5
   Mahadik SP, 1996, PROSTAG LEUKOTR ESS, V55, P65, DOI 10.1016/S0952-3278(96)90147-7
   MAHADIK SP, 1991, PSYCHIAT RES, V37, P309, DOI 10.1016/0165-1781(91)90066-X
   MAHADIK SP, 1994, PSYCHIAT RES, V53, P87, DOI 10.1016/0165-1781(94)90097-3
   Mahadik SP, 1996, PSYCHIAT RES, V63, P133, DOI 10.1016/0165-1781(96)02899-5
   Maier AB, 2007, AGING CELL, V6, P27, DOI 10.1111/j.1474-9726.2006.00263.x
   Manier DH, 2001, J AFFECT DISORDERS, V65, P275, DOI 10.1016/S0165-0327(00)00278-0
   Manier DH, 2000, J AFFECT DISORDERS, V61, P51, DOI 10.1016/S0165-0327(99)00190-1
   Martins-Taylor K, 2012, STEM CELLS, V30, P22, DOI 10.1002/stem.705
   Matigian NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002412
   McCarthy MJ, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.90
   McCarthy MJ, 2016, NEUROPHARMACOLOGY, V101, P439, DOI 10.1016/j.neuropharm.2015.10.017
   McCarthy MJ, 2013, ALCOHOL CLIN EXP RES, V37, P1304, DOI 10.1111/acer.12106
   McGlashan TH, 2011, SCHIZOPHRENIA BULL, V37, P1101, DOI 10.1093/schbul/sbr130
   MEISTER A, 1995, METHOD ENZYMOL, V252, P26
   Mertens J, 2015, CELL STEM CELL, pS1934
   Mirnics K, 2006, BIOL PSYCHIAT, V60, P163, DOI 10.1016/j.biopsych.2006.02.003
   Moore NH, 2009, J NEUROCHEM, V108, P891, DOI 10.1111/j.1471-4159.2008.05836.x
   Moreira PI, 2007, J ALZHEIMERS DIS, V12, P195
   Mossner R, 2000, NEUROCHEM INT, V36, P197, DOI 10.1016/S0197-0186(99)00122-9
   Muller N, 2012, ADV PROTEIN CHEM STR, V88, P49, DOI 10.1016/B978-0-12-398314-5.00003-9
   MUKHERJEE AB, 1987, J CLIN INVEST, V79, P1039, DOI 10.1172/JCI112916
   Munzer A, 2013, TOXINS, V5, P2227, DOI 10.3390/toxins5112227
   Musliner KL, 2015, PSYCHOL MED, V45, P1709, DOI 10.1017/S0033291714002839
   Naba A, 2015, MATRIX BIOL
   Naderi W, 2006, MECH AGEING DEV, V127, P25, DOI 10.1016/j.mad.2005.08.006
   NADI NS, 1984, NEW ENGL J MED, V311, P225, DOI 10.1056/NEJM198407263110404
   Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015
   Naydenov AV, 2007, ARCH GEN PSYCHIAT, V64, P555, DOI 10.1001/archpsyc.64.5.555
   Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647
   Nestor CE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0576-y
   Olsson E, 2006, NEUROSCI LETT, V393, P211, DOI 10.1016/j.neulet.2005.09.070
   Ovadia G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019955
   Pagani L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013376
   Palazzo E, 2012, J CELL PHYSIOL, V227, P1017, DOI 10.1002/jcp.22811
   Palotas A, 2002, PROG NEURO-PSYCHOPH, V26, P971, DOI 10.1016/S0278-5846(02)00214-2
   Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202
   Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041
   Penninx BWJH, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-129
   Persson ML, 2009, NEUROSCI LETT, V457, P49, DOI 10.1016/j.neulet.2009.03.095
   PETERSON C, 1986, P NATL ACAD SCI USA, V83, P2758, DOI 10.1073/pnas.83.8.2758
   Przybyla LM, 2013, STEM CELLS, V31, P1097, DOI 10.1002/stem.1360
   RAMCHAND CN, 1994, SCHIZOPHR RES, V13, P249, DOI 10.1016/0920-9964(94)90049-3
   Ramchand CN, 1996, PROSTAG LEUKOTR ESS, V55, P59, DOI 10.1016/S0952-3278(96)90146-5
   RAMCHAND CN, 1995, LIFE SCI, V56, P1639, DOI 10.1016/0024-3205(95)00131-O
   Ranjekar PK, 2003, PSYCHIAT RES, V121, P109, DOI 10.1016/S0165-1781(03)00220-8
   Reyazuddin M, 2014, INDIAN J PSYCHIAT, V56, P344, DOI 10.4103/0019-5545.146516
   Rieske P, 2005, DIFFERENTIATION, V73, P474, DOI 10.1111/j.1432-0436.2005.00050.x
   Rohani L, 2014, AGING CELL, V13, P2, DOI 10.1111/acel.12182
   Saini C, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00095
   Sanacora G, 2013, BIOL PSYCHIAT, V73, P1172, DOI 10.1016/j.biopsych.2013.03.032
   Santarelli S, 2014, EUR NEUROPSYCHOPHARM, V24, P907, DOI 10.1016/j.euroneuro.2014.02.002
   Sarnyai Z, 2011, INT REV NEUROBIOL, V101, P203, DOI 10.1016/B978-0-12-387718-5.00008-0
   Schmidt MJ, 2014, MOL PSYCHIATR, V19, P580, DOI 10.1038/mp.2013.167
   Schmidt MJ, 2012, DEV NEUROSCI-BASEL, V34, P152, DOI 10.1159/000336731
   Schmitt A, 2008, CLINICS, V63, P255, DOI 10.1590/S1807-59322008000200015
   Schmitt A, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00019
   Shahpasand K, 2012, J NEUROSCI, V32, P2430, DOI 10.1523/JNEUROSCI.5927-11.2012
   Shelton RC, 2011, MOL PSYCHIATR, V16, P751, DOI 10.1038/mp.2010.52
   Shelton RC, 1999, INT J NEUROPSYCHOPH, V2, P187, DOI 10.1017/S1461145799001509
   Shelton RC, 1996, AM J PSYCHIAT, V153, P1037
   Shivakumar V, 2014, ASIAN J PSYCHIATR, V10, P3, DOI 10.1016/j.ajp.2014.02.007
   Singh Vimal K, 2015, Front Cell Dev Biol, V3, P2, DOI 10.3389/fcell.2015.00002
   Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43
   Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019
   Song MK, 2013, STEM CELLS DEV, V22, P1551, DOI 10.1089/scd.2012.0556
   Sprenger A, 2010, MOL BIOSYST, V6, P1579, DOI 10.1039/c003962d
   Sugden K, 2010, J PSYCHOPHARMACOL, V24, P1253, DOI 10.1177/0269881108099690
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tang S, 2015, J MED CHEM
   Tatullo M, 2015, INT J IMMUNOPATHOL P
   Tigges J, 2014, MECH AGEING DEV, V138, P26, DOI 10.1016/j.mad.2014.03.004
   Toll A, 2015, WORLD J PSYCHIATR, V5, P154, DOI 10.5498/wjp.v5.i1.154
   Toouli CD, 2002, ONCOGENE, V21, P128, DOI 10.1038/sj.onc.1205014
   Tosic M, 2006, AM J HUM GENET, V79, P586, DOI 10.1086/507566
   Tourjman V, 2013, SCHIZOPHR RES, V151, P43, DOI 10.1016/j.schres.2013.10.011
   van Scheltinga AFT, 2013, NEUROSCIENTIST, V19, P479, DOI 10.1177/1073858412472399
   Vangipuram M, 2013, JOVE-J VIS EXP, DOI 10.3791/3779
   Waldera-Lupa DM, 2014, AGING-US, V6, P856, DOI 10.18632/aging.100698
   Walker E, 2008, ANNU REV CLIN PSYCHO, V4, P189, DOI 10.1146/annurev.clinpsy.4.022007.141248
   Wang L, 2010, J PROTEOME RES, V9, P521, DOI 10.1021/pr900867x
   WASSEF AA, 1992, PROG NEURO-PSYCHOPH, V16, P65, DOI 10.1016/0278-5846(92)90009-4
   Wolkowitz OM, 2010, DEPRESS ANXIETY, V27, P327, DOI 10.1002/da.20686
   Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542
   Yang S, 2009, MOL PSYCHIATR, V14, P143, DOI 10.1038/mp.2008.10
   Yao JK, 2006, DIS MARKERS, V22, P83, DOI 10.1155/2006/248387
   Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323
   Zeng H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011853
   Zhan L, 2011, NEUROPATH APPL NEURO, V37, P206, DOI 10.1111/j.1365-2990.2010.01128.x
NR 208
TC 6
Z9 6
U1 0
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0306-4522
EI 1873-7544
J9 NEUROSCIENCE
JI Neuroscience
PD APR 21
PY 2016
VL 320
BP 105
EP 121
DI 10.1016/j.neuroscience.2016.01.067
PG 17
WC Neurosciences
SC Neurosciences & Neurology
GA DG1NJ
UT WOS:000371834500010
PM 26855193
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Krasnov, GS
   Dmitriev, AA
   Melnikova, NV
   Zaretsky, AR
   Nasedkina, TV
   Zasedatelev, AS
   Senchenko, VN
   Kudryavtseva, AV
AF Krasnov, George S.
   Dmitriev, Alexey A.
   Melnikova, Nataliya V.
   Zaretsky, Andrew R.
   Nasedkina, Tatiana V.
   Zasedatelev, Alexander S.
   Senchenko, Vera N.
   Kudryavtseva, Anna V.
TI CrossHub: a tool for multi-way analysis of The Cancer Genome Atlas
   (TCGA) in the context of gene expression regulation mechanisms
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID CELL LUNG-CANCER; MICRORNA TARGET PREDICTION; FACTOR-BINDING SITES;
   TRANSCRIPTION FACTOR; MESSENGER-RNA; PROSTATE-CANCER; WIDE
   IDENTIFICATION; SIGNALING PATHWAY; NOTI-MICROARRAYS; GASTRIC-CANCER
AB The contribution of different mechanisms to the regulation of gene expression varies for different tissues and tumors. Complementation of predicted mRNA-miRNA and gene-transcription factor (TF) relationships with the results of expression correlation analyses derived for specific tumor types outlines the interactions with functional impact in the current biomaterial. We developed CrossHub software, which enables two-way identification of most possible TF-gene interactions: on the basis of ENCODE ChIP-Seq binding evidence or Jaspar prediction and co-expression according to the data of The Cancer Genome Atlas (TCGA) project, the largest cancer omics resource. Similarly, CrossHub identifies mRNA-miRNA pairs with predicted or validated binding sites (TargetScan, mirSVR, PicTar, DI-ANA microT, miRTarBase) and strong negative expression correlations. We observed partial consistency between ChIP-Seq or miRNA target predictions and gene-TF/miRNA co-expression, demonstrating a link between these indicators. Additionally, CrossHub expression-methylation correlation analysis can be used to identify hypermethylated CpG sites or regions with the greatest potential impact on gene expression. Thus, CrossHub is capable of outlining molecular portraits of a specific gene and determining the three most common sources of expression regulation: promoter/enhancer methylation, miRNA interference and TF-mediated activation or repression. CrossHub generates formatted Excel workbooks with the detailed results. CrossHub is freely available at https://sourceforge.net/projects/crosshub/.
C1 [Krasnov, George S.; Dmitriev, Alexey A.; Melnikova, Nataliya V.; Nasedkina, Tatiana V.; Zasedatelev, Alexander S.; Senchenko, Vera N.; Kudryavtseva, Anna V.] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow 119991, Russia.
   [Krasnov, George S.; Nasedkina, Tatiana V.; Zasedatelev, Alexander S.; Kudryavtseva, Anna V.] NN Blokhin Russian Canc Res Ctr, Moscow 115478, Russia.
   [Krasnov, George S.] Russian Acad Med Sci, Orekhovich Inst Biomed Chem, Moscow 119121, Russia.
   [Zaretsky, Andrew R.] Russian Acad Sci, MM Shemyakin Yu Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia.
RP Dmitriev, AA (reprint author), Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow 119991, Russia.
EM Alex_245@mail.ru
RI Kudryavtseva, Anna/C-9032-2014; Senchenko, Vera/C-8992-2014; Dmitriev,
   Alexey/D-6109-2011; Melnikova, Nataliya/E-5894-2014
OI Kudryavtseva, Anna/0000-0002-3722-8207; Senchenko,
   Vera/0000-0002-3119-515X; Dmitriev, Alexey/0000-0002-6827-9584;
   Melnikova, Nataliya/0000-0001-8083-3018
FU Russian Science Foundation [14-35-00107, 14-15-01083]
FX Development and testing of the modules related to DE, TF target
   predictions and correlation analysis was supported by the Russian
   Science Foundation grant no. 14-35-00107; Development and testing of
   miRNA target prediction and methylation modules was supported by the
   Russian Science Foundation grant no. 14-15-01083. Funding for open
   access charge: Funds of authors.
CR Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640
   Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90
   Bockmuhl Y, 2015, EPIGENETICS-US, V10, P247, DOI 10.1080/15592294.2015.1017199
   Braun R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055037
   Brodie SA, 2015, RESP MED, V109, P131, DOI 10.1016/j.rmed.2014.11.004
   Campa VM, 2014, ONCOTARGET, V5, P8173, DOI 10.18632/oncotarget.2303
   Cao LL, 2014, INT J CLIN EXP PATHO, V7, P5582
   Chen Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098293
   Cho S, 2013, NUCLEIC ACIDS RES, V41, pD252, DOI 10.1093/nar/gks1168
   Claus R, 2012, J CLIN ONCOL, V30, P2483, DOI 10.1200/JCO.2011.39.3090
   Cole C, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-28
   Consortium E. P, 2011, PLOS BIOL, V9, DOI DOI 10.1371/JOURNAL.PBIO.1001046
   Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003
   Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889
   Dellinger AE, 2014, CANCER INFORM, V13, P1, DOI 10.4137/CIN.S13634
   Dmitriev AA, 2012, EPIGENETICS-US, V7, P502, DOI 10.4161/epi.19801
   Dong YJ, 2014, CANCER MANAG RES, V6, P405, DOI 10.2147/CMAR.S35164
   Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247
   Dweep H, 2014, METHODS MOL BIOL, V1182, P289, DOI 10.1007/978-1-4939-1062-5_25
   Dweep H, 2013, CURR GENOMICS, V14, P127, DOI 10.2174/1389202911314020005
   Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002
   Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707
   Ekimler S, 2014, GENES-BASEL, V5, P671, DOI 10.3390/genes5030671
   Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906
   Everett LJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-337
   Fedorova MS, 2015, MOL BIOL+, V49, P608, DOI [10.1134/S0026893315040044, 10.7868/S0026898415040047]
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Gnad F, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S8-S5
   Gore J, 2015, ONCOTARGET, V6, P7504, DOI 10.18632/oncotarget.3233
   Gunaratne PH, 2010, METHODS MOL BIOL, V667, P297, DOI 10.1007/978-1-60761-811-9_20
   Guo Y, 2015, APOPTOSIS, V20, P1109, DOI 10.1007/s10495-015-1138-9
   Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071462
   Hafner M, 2012, METHODS, V58, P94, DOI 10.1016/j.ymeth.2012.08.006
   Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009
   Han SS, 2014, LUNG CANCER, V84, P229, DOI 10.1016/j.lungcan.2014.03.018
   Haoues M, 2014, CELL MICROBIOL, V16, P1378, DOI 10.1111/cmi.12298
   Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043
   Hoeth M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030982
   Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266
   Hu ZH, 2015, BIOCHIMIE, V109, P42, DOI 10.1016/j.biochi.2014.12.001
   Huhn D, 2015, ONCOGENE, V34, P3977, DOI 10.1038/onc.2014.329
   Kim YW, 2013, NEURO-ONCOLOGY, V15, P829, DOI 10.1093/neuonc/not024
   Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412
   Krasnov GS, 2013, EXPERT OPIN THER TAR, V17, P1221, DOI 10.1517/14728222.2013.833607
   Krasnov GS, 2013, EXPERT OPIN THER TAR, V17, P681, DOI 10.1517/14728222.2013.775253
   Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536
   Kudla G, 2011, P NATL ACAD SCI USA, V108, P10010, DOI 10.1073/pnas.1017386108
   Li J, 2015, LAB INVEST, V95, P1056, DOI 10.1038/labinvest.2015.76
   Li P, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0473-z
   Li ZG, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1516-2
   Lin SL, 2009, BIOMETRICS, V65, P9, DOI 10.1111/j.1541-0420.2008.01044.x
   Loginov VI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123369
   Mahdevar G, 2013, GENES GENET SYST, V88, P301, DOI 10.1266/ggs.88.301
   Maiese K, 2015, WORLD J DIABETES, V6, P217, DOI 10.4239/wjd.v6.i2.217
   Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292
   Marco A, 2009, BIOINFORMATICS, V25, P2473, DOI 10.1093/bioinformatics/btp462
   Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997
   Migliardi G, 2012, CLIN CANCER RES, V18, P2515, DOI 10.1158/1078-0432.CCR-11-2683
   Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252
   Nam S, 2008, NUCLEIC ACIDS RES, V36, pD159, DOI 10.1093/nar/gkm829
   Nile CJ, 2008, ARTHRITIS RHEUM, V58, P2686, DOI 10.1002/art.23758
   Pal B, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0585-0
   Peterson SM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00023
   Qin J, 2011, NUCLEIC ACIDS RES, V39, pW430, DOI 10.1093/nar/gkr332
   Qu Hongzhu, 2013, Genomics Proteomics & Bioinformatics, V11, P135, DOI 10.1016/j.gpb.2013.05.001
   Rao X, 2013, ONCOGENE, V32, P4519, DOI 10.1038/onc.2012.474
   Ricketts CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085621
   Saini V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041401
   Salgado MC, 2014, BBA-GENE REGUL MECH, V1839, P288, DOI 10.1016/j.bbagrm.2014.01.005
   Senchenko VN, 2013, EPIGENETICS-US, V8, P409, DOI 10.4161/epi.24233
   Slezak J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-148
   Smallwood A, 2012, GENOME RES, V22, P1426, DOI 10.1101/gr.124818.111
   Sridharan R, 2013, NAT CELL BIOL, V15, P872, DOI 10.1038/ncb2768
   Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577
   Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136
   Tsang JS, 2010, MOL CELL, V38, P140, DOI 10.1016/j.molcel.2010.03.007
   Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182
   Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403
   Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pD153, DOI 10.1093/nar/gku1215
   Wang ZM, 2015, HUM MUTAT, V36, P684, DOI 10.1002/humu.22799
   Wang ZQ, 2014, MED SCI MONITOR, V20, P1668, DOI 10.12659/MSM.892096
   Wilentzik R, 2015, NUCLEIC ACIDS RES, V43, pE74, DOI 10.1093/nar/gkv203
   Wong HKA, 2015, MOL THER, V23, P1234, DOI 10.1038/mt.2015.72
   Woo S, 2014, PROTEOMICS, V14, P2719, DOI 10.1002/pmic.201400206
   Xu XF, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0218-4
   Yamamizu K, 2013, STEM CELL REP, V1, P545, DOI 10.1016/j.stemcr.2013.10.006
   Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438
   Zhang X, 2010, PROSTATE, V70, P765, DOI 10.1002/pros.21109
   Zhao Q, 2015, BRIEF BIOINFORM, V16, P291, DOI 10.1093/bib/bbu003
   Zhu YT, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv129
NR 90
TC 14
Z9 15
U1 0
U2 14
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD APR 20
PY 2016
VL 44
IS 7
AR e62
DI 10.1093/nar/gkv1478
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DL7DM
UT WOS:000375800200002
PM 26773058
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Su, DH
   Jiang, LB
   Chen, X
   Dong, J
   Shao, ZZ
AF Su, Dihan
   Jiang, Libo
   Chen, Xin
   Dong, Jian
   Shao, Zhengzhong
TI Enhancing the Gelation and Bioactivity of Injectable Silk Fibroin
   Hydrogel with Laponite Nanoplatelets
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE reconstitute silk fibroin; clay; hybrid hydrogel; thixotropy; primary
   osteoblasts
ID MESENCHYMAL STEM-CELLS; TISSUE REGENERATION; BIOMATERIALS; CLAY;
   DIFFERENTIATION; SPECTROSCOPY; SCAFFOLD; PROTEIN; FTIR; MECHANISMS
AB Regenerated silk fibroin (RSF) of Bombyx mori silk fiber is a promising natural material for bone defect repair. However, a lack of specific integrin and growth factor for osteoinduction significantly hinders its application in this area. In this study, the role of Laponite nanoplatelet (LAP), a bioactive clay that can promote osteoblast growth, in the formation of RSF hydrogel, as well as the various properties of RSF/LAP hybrid hydrogel, was closely investigated. The results indicate that LAP could serve as a medium to accelerate hydrophobic interaction among the RSF molecules and a disruptor to limit the growth of beta-sheet domain during the gelation of RSF. Rheological measurement suggests that the RSF/LAP hydrogel is injectable as it displays thixotropy in the room temperature. Proliferation and differentiation results of the primary osteoblasts encapsulated in hydrogel show that RSF/LAP hydrogel can promote the cell proliferation and enhance the osteogenic differentiation. The transcript levels for alkaline phosphatase, osteocalcin, osteopontin, and collagen type I osteogenic markers obviously improve with RSF/LAP hydrogel compared to the controls at 14 days, especially with the higher contents of LAP. Overall, the results suggest that the RSF/LAP hydrogel have great potential to be utilized as an injectable biomaterial for irregular bone defect repair.
C1 [Su, Dihan; Chen, Xin; Shao, Zhengzhong] Fudan Univ, State Key Lab Mol Engn Polymers, Dept Macromol Sci, Shanghai 200433, Peoples R China.
   [Su, Dihan; Chen, Xin; Shao, Zhengzhong] Fudan Univ, Adv Mat Lab, Shanghai 200433, Peoples R China.
   [Jiang, Libo; Dong, Jian] Fudan Univ, Dept Orthopaed Surg, Zhongshan Hosp, State Key Lab Mol Engn Polymers, Shanghai 200032, Peoples R China.
RP Shao, ZZ (reprint author), Fudan Univ, State Key Lab Mol Engn Polymers, Dept Macromol Sci, Shanghai 200433, Peoples R China.; Shao, ZZ (reprint author), Fudan Univ, Adv Mat Lab, Shanghai 200433, Peoples R China.; Dong, J (reprint author), Fudan Univ, Dept Orthopaed Surg, Zhongshan Hosp, State Key Lab Mol Engn Polymers, Shanghai 200032, Peoples R China.
EM dong.jian@zs-hospital.sh.cn; zzshao@fudan.edu.cn
RI Chen, Xin/F-6802-2015
OI Chen, Xin/0000-0001-7706-4166
FU National Natural Science Foundation of China [21574024, 21274028,
   21574023, 81572629, 81372002]; National High Technology Research and
   Development Program of China (863 program) [2015AA033703]
FX This work was supported by the National Natural Science Foundation of
   China (No. 21574024, 21274028, 21574023, 81572629 and 81372002) and
   National High Technology Research and Development Program of China (863
   program) (2015AA033703). We thank Dr. Yuhong Yang and Dr. Jingrong Yao
   at Fudan University for their valuable suggestions and discussion and
   Ms. Yiming Zhong (Curtin University, Australia) for critical reading and
   editing the English.
CR Balnois E, 2003, LANGMUIR, V19, P6633, DOI 10.1021/la0340908
   Bhattacharjee P, 2015, BIOPOLYMERS, V103, P271, DOI 10.1002/bip.22594
   Bombonato-Prado KF, 2009, J BIOMED MATER RES A, V88A, P401, DOI 10.1002/jbm.a.31701
   Braux J, 2011, ACTA BIOMATER, V7, P2593, DOI 10.1016/j.actbio.2011.02.013
   Chen X, 2001, POLYMER, V42, P9969, DOI 10.1016/S0032-3861(01)00541-9
   Chen X, 2007, PROTEINS, V68, P223, DOI 10.1002/prot.21414
   Cheng C, 2008, ADV FUNCT MATER, V18, P2172, DOI 10.1002/adfm.200701130
   Chimene D, 2015, ADV MATER, V27, P7261, DOI 10.1002/adma.201502422
   Dang QQ, 2010, BIOMACROMOLECULES, V11, P1796, DOI 10.1021/bm1002398
   Dawson JI, 2013, ADV MATER, V25, P4069, DOI 10.1002/adma.201301034
   Gaharwar AK, 2013, ADV MATER, V25, P3329, DOI 10.1002/adma.201300584
   Gaharwar AK, 2011, ACTA BIOMATER, V7, P568, DOI 10.1016/j.actbio.2010.09.015
   Gaharwar AK, 2010, ADV FUNCT MATER, V20, P429, DOI 10.1002/adfm.200901606
   Guerette PA, 2014, ACS NANO, V8, P7170, DOI 10.1021/nn502149u
   Guo P, 2014, ORTHOP SURG, V6, P280, DOI 10.1111/os.12135
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Kim JH, 2014, INT J BIOL MACROMOL, V68, P158, DOI 10.1016/j.ijbiomac.2014.04.045
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kodama N, 2009, BONE, V44, P699, DOI 10.1016/j.bone.2008.12.017
   Li GY, 2001, EUR J BIOCHEM, V268, P6600, DOI 10.1046/j.0014-2956.2001.02614.x
   Li JJ, 2015, J MATER CHEM B, V3, P5361, DOI 10.1039/c5tb00353a
   Liff SM, 2007, NAT MATER, V6, P76, DOI 10.1038/nmat1798
   Ling SJ, 2011, BIOMACROMOLECULES, V12, P3344, DOI 10.1021/bm2006032
   Liu YX, 2014, BIOMATER SCI-UK, V2, P1338, DOI 10.1039/c4bm00214h
   MANDAIR APS, 1990, POLYHEDRON, V9, P517, DOI 10.1016/S0277-5387(00)86228-2
   Martel A, 2008, J AM CHEM SOC, V130, P17070, DOI 10.1021/ja806654t
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Mieszawska AJ, 2011, ACTA BIOMATER, V7, P3036, DOI 10.1016/j.actbio.2011.04.016
   Mieszawska AJ, 2010, BIOMATERIALS, V31, P8902, DOI 10.1016/j.biomaterials.2010.07.109
   Monti P, 2005, J MOL STRUCT, V744, P685, DOI 10.1016/j.molstruc.2004.10.083
   Negrete, 2004, LANGMUIR, V20, P1564
   Paulusse JMJ, 2006, J POLYM SCI POL CHEM, V44, P5445, DOI 10.1002/pola.21646
   Shalumon KT, 2015, ACS APPL MATER INTER, V7, P21170, DOI 10.1021/acsami.5b04962
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Taddei P, 2005, BIOPOLYMERS, V78, P249, DOI 10.1002/bip.20275
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang CM, 2010, ADV DRUG DELIVER REV, V62, P699, DOI 10.1016/j.addr.2010.02.001
   WANG FC, 1994, J POLYM SCI POL PHYS, V32, P1305, DOI 10.1002/polb.1994.090320801
   Wang Q, 2010, NATURE, V463, P339, DOI 10.1038/nature08693
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875
   Yang Y., 2006, ACTA CHIM SINICA, V16, P1730
   Yang YH, 2004, BIOMACROMOLECULES, V5, P773, DOI 10.1021/bm0343848
   Zhu HL, 2012, MAT SCI ENG C-MATER, V32, P822, DOI 10.1016/j.msec.2012.01.033
   Zhu ZH, 2009, MATER CHEM PHYS, V117, P430, DOI 10.1016/j.matchemphys.2009.06.028
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 48
TC 20
Z9 21
U1 13
U2 157
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD APR 20
PY 2016
VL 8
IS 15
BP 9619
EP 9628
DI 10.1021/acsami.6b00891
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DK3JD
UT WOS:000374812000011
PM 26989907
DA 2018-10-19
ER

PT J
AU Zeng, RC
   Cui, LY
   Jiang, K
   Liu, R
   Zhao, BD
   Zheng, YF
AF Zeng, Rong-Chang
   Cui, Lan-yue
   Jiang, Ke
   Liu, Rui
   Zhao, Bao-Dong
   Zheng, Yu-Feng
TI In Vitro Corrosion and Cytocompatibility of a Microarc Oxidation Coating
   and Poly(L-lactic acid) Composite Coating on Mg-1Li-1Ca Alloy for
   Orthopedic Implants
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE magnesium alloy; degradation; microarc oxidation; poly(L-lactic acid);
   biomaterial
ID PLASMA ELECTROLYTIC OXIDATION; MAGNESIUM ALLOYS; HYDROLYTIC DEGRADATION;
   POLY(LACTIC ACID); COATED MAGNESIUM; TISSUE-RESPONSE; MG ALLOY; FILM;
   RESISTANCE; BEHAVIOR
AB Manipulating the degradation rate of biomedical magnesium alloys poses a challenge. The characteristics of a microarc oxidation (MAO), prepared in phytic acid, and poly(L-lactic acid) (PLLA) composite coating, fabricated on a novel Mg-1Li-1Ca alloy, were studied through field emission scanning electron microscopy (FE-SEM), electron probe X-ray microanalysis (EPMA), energy dispersive X-ray spectroscopy (EDS) and X-ray diffraction (XRD). The corrosion behaviors of the samples were evaluated via hydrogen evolution, potentiodynamic polarization and electrochemical impedance spectroscopy in Hanks' solution. The results indicated that the MAO/PLLA composite coatings significantly enhanced the corrosion resistance of the Mg-1Li-1Ca alloy. MTT and ALP assays using MC3T3 osteoblasts indicated that the MAO/PLLA coatings greatly improved the cytocompatibility, and the morphology of the cells cultured on different samples exhibited good adhesion. Hemolysis tests showed that the composite coatings endowed the Mg-1Li-1Ca alloys with a low hemolysis ratio. The increased solution pH resulting from the corrosion of magnesium could be tailored by the degradation of PLLA. The degradation mechanism of the composite coatings was discussed. The MAO/PLLA composite coating may be appropriate for applications on degradable Mg-based orthopedic implants.
C1 [Zeng, Rong-Chang; Cui, Lan-yue; Jiang, Ke] Shandong Univ Sci & Technol, Coll Mat Sci & Engn, Qingdao 266590, Peoples R China.
   [Zeng, Rong-Chang; Cui, Lan-yue; Jiang, Ke] Shandong Univ Sci & Technol, State Key Lab Min Disaster Prevent & Control Shan, Qingdao 266590, Peoples R China.
   [Zeng, Rong-Chang; Cui, Lan-yue; Jiang, Ke] Shandong Univ Sci & Technol, Minist Sci & Technol, Qingdao 266590, Peoples R China.
   [Liu, Rui; Zhao, Bao-Dong] Qingdao Univ, Affiliated Hosp, Qingdao 266590, Peoples R China.
   [Zheng, Yu-Feng] Peking Univ, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.
   [Zheng, Yu-Feng] Peking Univ, Dept Mat Sci & Engn, Coll Engn, Beijing 100871, Peoples R China.
RP Zeng, RC (reprint author), Shandong Univ Sci & Technol, Coll Mat Sci & Engn, Qingdao 266590, Peoples R China.; Zeng, RC (reprint author), Shandong Univ Sci & Technol, State Key Lab Min Disaster Prevent & Control Shan, Qingdao 266590, Peoples R China.; Zeng, RC (reprint author), Shandong Univ Sci & Technol, Minist Sci & Technol, Qingdao 266590, Peoples R China.; Zhao, BD (reprint author), Qingdao Univ, Affiliated Hosp, Qingdao 266590, Peoples R China.
EM rczeng@foxmail.com; zbd315@sina.com
RI Zheng, Yufeng/A-4146-2010; Zeng, Rong-Chang/H-4154-2011
OI Zheng, Yufeng/0000-0002-7402-9979; Zeng, Rong-Chang/0000-0002-5945-3851
FU National Natural Science Foundation of China [51571134]; SDUST (Shandong
   University of Science and Technology) Research Fund [2014TDJH104]; Joint
   Innovative Centre for Safe and Effective Mining Technology and Equipment
   of Coal Resources, Shandong Province
FX This work was supported by the National Natural Science Foundation of
   China (51571134), SDUST (Shandong University of Science and Technology)
   Research Fund (2014TDJH104), Joint Innovative Centre for Safe and
   Effective Mining Technology and Equipment of Coal Resources, Shandong
   Province.
CR Abdal-hay A, 2013, COLLOID SURFACE A, V420, P37, DOI 10.1016/j.colsurfa.2012.12.009
   Abdal-hay A, 2013, CERAM INT, V39, P183, DOI 10.1016/j.ceramint.2012.06.008
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   Badar M, 2013, ACTA BIOMATER, V9, P7580, DOI 10.1016/j.actbio.2013.03.012
   Baino F, 2011, ACTA BIOMATER, V7, P3248, DOI 10.1016/j.actbio.2011.05.016
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   BURKERSRODA F, 2002, BIOMATERIALS, V23, P4221, DOI DOI 10.1016/S0142-9612(02)00170-9
   Chen Y, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/2/025005
   de Jong SJ, 2001, POLYMER, V42, P2795, DOI 10.1016/S0032-3861(00)00646-7
   Ding YF, 2014, J MATER CHEM B, V2, P1912, DOI 10.1039/c3tb21746a
   Fischerauer S.F., 2012, ACTA BIOMATER, V9, P5411
   Gao JC, 2006, T NONFERR METAL SOC, V16, P539, DOI 10.1016/S1003-6326(06)60094-0
   Gao Y, 2013, SURF COAT TECH, V234, P132, DOI 10.1016/j.surfcoat.2012.11.035
   Garlotta D, 2001, J POLYM ENVIRON, V9, P63, DOI 10.1023/A:1020200822435
   Gu XN, 2011, ACTA BIOMATER, V7, P1880, DOI 10.1016/j.actbio.2010.11.034
   Gu XN, 2014, FRONT MATER SCI, V8, P200, DOI 10.1007/s11706-014-0253-9
   Gu XN, 2010, BIOMATERIALS, V31, P1093, DOI 10.1016/j.biomaterials.2009.11.015
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Guo MQ, 2011, J MATER SCI-MATER M, V22, P1735, DOI 10.1007/s10856-011-4354-z
   Han XG, 2013, SURF COAT TECH, V228, pS164, DOI 10.1016/j.surfcoat.2012.06.053
   Ivanou DK, 2013, CORROS SCI, V73, P300, DOI 10.1016/j.corsci.2013.04.019
   Liang J, 2014, FRONT MATER SCI, V8, P307, DOI 10.1007/s11706-014-0250-z
   Liu GY, 2011, APPL SURF SCI, V257, P2051, DOI 10.1016/j.apsusc.2010.09.050
   Liu X, 2013, ACTA BIOMATER, V9, P8671, DOI 10.1016/j.actbio.2012.12.025
   Lu L, 1999, J BIOMED MATER RES, V46, P236, DOI 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F
   Lu P, 2011, J BIOMED MATER RES B, V96B, P101, DOI 10.1002/jbm.b.31744
   Narayanan TSNS, 2014, PROG MATER SCI, V60, P1, DOI 10.1016/j.pmatsci.2013.08.002
   Nemcova A, 2013, SURF COAT TECH, V232, P827, DOI 10.1016/j.surfcoat.2013.06.107
   Piemonte V, 2013, J POLYM ENVIRON, V21, P313, DOI 10.1007/s10924-012-0547-x
   Shu Y, 2011, J NANOMATER, DOI 10.1155/2011/423686
   Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N
   Song YW, 2012, CORROS SCI, V65, P322, DOI 10.1016/j.corsci.2012.08.037
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Takagishi Y, 2006, TISSUE ENG, V12, P927, DOI 10.1089/ten.2006.12.927
   Tokiwa Y, 2006, APPL MICROBIOL BIOT, V72, P244, DOI 10.1007/s00253-006-0488-1
   Tomihata K, 2001, J BIOMED MATER RES, V58, P511, DOI 10.1002/jbm.1048
   van der Elst M, 1999, BIOMATERIALS, V20, P121, DOI 10.1016/S0142-9612(98)00117-3
   van Nostrum CF, 2004, POLYMER, V45, P6779, DOI 10.1016/j.polymer.2004.08.001
   Vogt C, 2010, P 8 INT C MAGN ALL T, P1162
   Wei ZL, 2015, J BIOMED MATER RES B, V103, P342, DOI 10.1002/jbm.b.33208
   Witte F, 2007, J BIOMED MATER RES A, V81A, P748, DOI 10.1002/jbm.a.31170
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Wong HM, 2010, BIOMATERIALS, V31, P2084, DOI 10.1016/j.biomaterials.2009.11.111
   Xu LP, 2012, APPL SURF SCI, V258, P6353, DOI 10.1016/j.apsusc.2012.03.036
   Xu LP, 2012, COLLOID SURFACE B, V93, P67, DOI 10.1016/j.colsurfb.2011.12.009
   Yuan XY, 2001, J APPL POLYM SCI, V81, P251, DOI 10.1002/app.1436
   Zeng RC, 2006, T NONFERR METAL SOC, V16, pS763, DOI 10.1016/S1003-6326(06)60297-5
   Zeng RC, 2015, ACTA METALL SIN-ENGL, V28, P373, DOI 10.1007/s40195-015-0208-x
   Zeng RC, 2014, FRONT MATER SCI, V8, P343, DOI 10.1007/s11706-014-0264-6
   Zeng RC, 2014, CORROS SCI, V88, P452, DOI 10.1016/j.corsci.2014.08.007
   Zeng RC, 2014, FRONT MATER SCI, V8, P230, DOI 10.1007/s11706-014-0256-6
   Zeng RC, 2014, J MATER CHEM A, V2, P13049, DOI 10.1039/c4ta01341g
   Zeng RC, 2014, CORROS SCI, V79, P69, DOI 10.1016/j.corsci.2013.10.028
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
   Zeng RC, 2013, ACTA METALL SIN-ENGL, V26, P681, DOI 10.1007/S40195-013-0397-0
   Zeng RC, 2011, ACTA METALL SIN, V47, P1477, DOI 10.3724/SP.J.1037.2011.00325
   Zeng RC, 2011, SURF COAT TECH, V205, P3347, DOI 10.1016/j.surfcoat.2010.11.027
   Zhang F, 2014, SURF COAT TECH, V258, P1152, DOI 10.1016/j.surfcoat.2014.07.017
   Zhang J, 2013, COLLOID SURFACE B, V111, P179, DOI 10.1016/j.colsurfb.2013.05.040
   Zhang RF, 2010, CURR APPL PHYS, V10, P255, DOI 10.1016/j.cap.2009.06.008
   Zhang RF, 2009, APPL SURF SCI, V255, P7893, DOI 10.1016/j.apsusc.2009.04.145
   Zheng YF, 2014, MAT SCI ENG R, V77, P1, DOI 10.1016/j.mser.2014.01.001
   Zhou H, 2012, ACTA BIOMATER, V8, P1999, DOI 10.1016/j.actbio.2012.01.031
NR 66
TC 51
Z9 52
U1 14
U2 84
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD APR 20
PY 2016
VL 8
IS 15
BP 10014
EP 10028
DI 10.1021/acsami.6b00527
PG 15
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DK3JD
UT WOS:000374812000055
PM 27022831
DA 2018-10-19
ER

PT J
AU Deen, GR
   Mah, CH
AF Deen, G. Roshan
   Mah, Chin Hao
TI Influence of external stimuli on the network properties of cationic
   poly(N-acryloyl-N '-propyl piperazine) hydrogels
SO POLYMER
LA English
DT Article
DE Poly(amido-amine)s; Stimuli-responsive hydrogels; Dynamic swelling;
   State of water
ID N'-ETHYL PIPERAZINE; SWELLING BEHAVIOR; ACID) HYDROGELS; 2-HYDROXYETHYL
   METHACRYLATE; RESPONSIVE POLYMERS; DRUG-RELEASE; POLYVINYL-ALCOHOL)
   HYDROGELS; BIOMEDICAL APPLICATIONS; COPOLYMER HYDROGELS; SENSITIVE
   HYDROGELS
AB Stimuli-responsive cationic hydrogels based on N-acryloyl-N'-propyl piperazine (AcrNPP) crosslinked with N,N'-methylenebisacrylamide (Mba) and 1,4-butanedioldiacrylate (Bda) were prepared by UV lightinitiated free-radical polymerization in bulk. The effect of external stimuli and type of crosslinker on the equilibrium swelling behavior and dynamic swelling was investigated in detail in buffer solution of various pH and temperatures. The equilibrium swelling capacity of the gels was large in swelling medium at pH 3.0 than at pH 10.0 due to ionization of polymer network under acidic conditions. With increase in temperature from 25 degrees C to 45 degrees C, the gels exhibited negative temperature-responsive (thermo-shrinking/ thermophobic) behavior with negative activation energy for diffusion of water. The thermodynamic parameters such as Gibbs' free energy (Delta G), enthalpy (Delta H), and entropy (Delta S) for the swelling of gels as function of temperature were negative indicating an exothermic swelling process. Water (media) transport mechanism and diffusion process in thin rectangular gels was studied. At pH 3.0, the diffusion process was non-Fickian (anomalous) while at pH 10.0 it was quasi-Fickian. The transport mechanism was partly influenced by the type of crosslinker in the gel. The dynamic swelling data was analyzed using early-time, late-time and Etters diffusion models. From the equilibrium swelling studies the average molecular weight between crosslinks (M-c), the crosslink density (rho(c)), and the mesh size (xi) were determined. The Mc was large at pH 3.0 due to ionization of polymer and chain expansion. The experimental Mc was much larger than the theoretical Mc which implied that the gels were loosely crosslinked real networks. The mesh size of gels were between 447 and 786 angstrom in the swollen (ionized) state (pH 3.0), and between 100 and 231 angstrom in the collapsed (non-ionized) state (pH 10.0). The mesh size increased between three to four times during the pH-dependent swelling transition. The state of water in fully swollen hydrogels which influences many important biomaterial properties was determined by differential scanning calorimetry. The bound water content of gels increased linearly with increase in pH of the swelling medium while the unbound water decreased. These hydrogels have potential to be used as controlled drug delivery systems and sorbents for removal of pollutants from water. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Deen, G. Roshan; Mah, Chin Hao] Nanyang Technol Univ, Natl Inst Educ, Soft Mat Lab, Nat Sci & Sci Educ, 1 Nanyang Walk, Singapore 637616, Singapore.
RP Deen, GR (reprint author), Nanyang Technol Univ, Natl Inst Educ, Soft Mat Lab, Nat Sci & Sci Educ, 1 Nanyang Walk, Singapore 637616, Singapore.
EM Roshan.gulam@nie.edu.sg
RI GR, Roshan Deen/I-2625-2017
OI GR, Roshan Deen/0000-0001-8329-0880
FU Nanyang Technological University (NTU), National Institute of Education
   (NIE) [NIEAcRF RI6/12GRD]
FX GRD and MCH thank the Nanyang Technological University (NTU), National
   Institute of Education (NIE) for financial support under research grant
   NIEAcRF RI6/12GRD, and for the NTU higher degree research scholarship,
   respectively. Bo Ouyang is thanked for his help with the SEM.
CR Alarcon CDH, 2005, CHEM SOC REV, V34, P276, DOI 10.1039/b406727d
   Awasthi S, 2012, J APPL POLYM SCI, V124, P2348, DOI 10.1002/app.35288
   Bajpai SK, 2006, REACT FUNCT POLYM, V66, P431, DOI 10.1016/j.reactfunctpolym.2005.09.003
   Bangbose J.T., 2012, J CHEM CHEM ENG, V6, P272
   BRAZEL CS, 1995, MACROMOLECULES, V28, P8016, DOI 10.1021/ma00128a007
   Bueno VB, 2013, CARBOHYD POLYM, V92, P1091, DOI 10.1016/j.carbpol.2012.10.062
   Bulmus V, 2000, BIOCONJUGATE CHEM, V11, P78, DOI 10.1021/bc9901043
   Burmistrova A, 2011, POLYMERS-BASEL, V3, P1575, DOI 10.3390/polym3041575
   Cakal E, 2010, IND ENG CHEM RES, V49, P11741, DOI 10.1021/ie1007097
   Chang CH, 2010, BIOMACROMOLECULES, V11, P133, DOI 10.1021/bm900985h
   CHEN CM, 1992, ANGEW MAKROMOL CHEM, V196, P49, DOI 10.1002/apmc.1992.051960104
   Chen KS, 2005, MATER CHEM PHYS, V91, P484, DOI 10.1016/j.matchemphys.2004.12.037
   Crank J, 1975, MATH DIFFUSION
   Deen GR, 2008, J APPL POLYM SCI, V107, P1449, DOI 10.1002/app.27126
   Deen GR, 2006, POLYMER, V47, P5025, DOI 10.1016/j.polymer.2006.05.003
   Deen GR, 2012, IND ENG CHEM RES, V51, P13354, DOI 10.1021/ie301987m
   Deen GR, 2012, J POLYM SCI POL CHEM, V50, P3363, DOI 10.1002/pola.26124
   Deen GR, 2011, POLYM BULL, V66, P301, DOI 10.1007/s00289-010-0277-y
   Desai PN, 2010, BIOMACROMOLECULES, V11, P666, DOI 10.1021/bm901240g
   Ende M., 1995, REACT POLYM, V25, P127
   Etters J. N., 1980, TEXT CHEM COLOR, V12, P140
   Ferruti P, 2000, MACROMOLECULES, V33, P7793, DOI 10.1021/ma000378h
   Ferruti P, 2006, J POLYM SCI POL CHEM, V44, P2316, DOI 10.1002/pola.21349
   Ferruti P, 2002, MACROMOL RAPID COMM, V23, P332, DOI 10.1002/1521-3927(20020401)23:5/6<332::AID-MARC332>3.0.CO;2-I
   Ferruti P, 1998, MACROMOL CHEM PHYSIC, V199, P2565, DOI 10.1002/(SICI)1521-3935(19981101)199:11<2565::AID-MACP2565>3.0.CO;2-G
   FIRESTONE BA, 1988, POLYM COMMUN, V29, P204
   Flory P. J, 1953, PRINCIPLES POLYM CHE
   FRANK S, 1993, NATURE, V363, P334, DOI 10.1038/363334a0
   FRANSON NM, 1983, J APPL POLYM SCI, V28, P1299, DOI 10.1002/app.1983.070280404
   Galaev IY, 1999, TRENDS BIOTECHNOL, V17, P335, DOI 10.1016/S0167-7799(99)01345-1
   Galperin A, 2013, J BIOMED MATER RES A, V101, P775, DOI 10.1002/jbm.a.34380
   Gan LH, 2000, MACROMOLECULES, V33, P7893, DOI 10.1021/ma000928b
   Garg G, 2012, J APPL POLYM SCI, V124, P3721, DOI 10.1002/app.35369
   Geever LM, 2006, EUR POLYM J, V42, P69, DOI 10.1016/j.eurpolymj.2005.09.027
   Goda T, 2006, POLYMER, V47, P1390, DOI 10.1016/j.polymer.2005.12.043
   Gonzalez N, 2005, MACROMOLECULES, V38, P9298, DOI 10.1021/ma050939a
   GUDEMAN LF, 1995, J APPL POLYM SCI, V55, P919, DOI 10.1002/app.1995.070550610
   Gurdag G., 1010, IND ENG CHEM RES, V49, P12675
   Hill DJT, 2000, POLYMER, V41, P1287, DOI 10.1016/S0032-3861(99)00279-7
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   Hoffman A.S., 1990, J CONTROL RELEASE, V13, P153
   Hoffmann J, 1999, SENSOR ACTUAT A-PHYS, V77, P139, DOI 10.1016/S0924-4247(99)00080-1
   Ikeda-Fukazawa T, 2013, J POLYM SCI POL PHYS, V51, P1017, DOI 10.1002/polb.23305
   Kakinoki S, 2003, RADIAT PHYS CHEM, V67, P685, DOI 10.1016/S0969-806X(02)00401-2
   Karadag E, 2002, TURK J CHEM, V26, P863
   Karadag E, 1997, TURK J CHEM, V21, P151
   Kim W., 2002, J BIOMAT SCI-POLYM E, V13, P1271
   Kong SD, 2013, ACTA BIOMATER, V9, P5447, DOI 10.1016/j.actbio.2012.11.006
   Kurata K, 2004, J MACROMOL SCI PURE, VA41, P143, DOI 10.1081/MA-120027300
   LI Y, 1990, J CHEM PHYS, V92, P1365, DOI 10.1063/1.458148
   Maeda T, 2006, BIOMACROMOLECULES, V7, P545, DOI 10.1021/bm050829b
   Mansor B.A., 1994, POLYM INT, V33, P2732
   Mao ZW, 2007, BIOMATERIALS, V28, P4488, DOI 10.1016/j.biomaterials.2007.06.033
   Mathur AM, 1996, J MACROMOL SCI R M C, VC36, P405
   MATSUO ES, 1992, NATURE, V358, P482, DOI 10.1038/358482a0
   MAZICH KA, 1992, MACROMOLECULES, V25, P6929, DOI 10.1021/ma00051a032
   Mullarney MP, 2006, POLYMER, V47, P3845, DOI 10.1016/j.polymer.2006.03.096
   Okay O, 1999, POLYMER, V40, P4117, DOI 10.1016/S0032-3861(98)00640-5
   Peniche C, 1997, POLYMER, V38, P5977, DOI 10.1016/S0032-3861(96)01058-0
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   PEPPAS NA, 1977, J APPL POLYM SCI, V21, P1763, DOI 10.1002/app.1977.070210704
   PEPPAS NA, 1976, J POLYM SCI POL CHEM, V14, P441, DOI 10.1002/pol.1976.170140215
   Plunkett KN, 2004, LANGMUIR, V20, P6535, DOI 10.1021/la049453y
   Quintana JR, 1999, LANGMUIR, V15, P4728, DOI 10.1021/la980982+
   Richardson SCW, 2001, BIOMACROMOLECULES, V2, P1023, DOI 10.1021/bm010079f
   RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Roshan Deen G., 2015, ENCY BIOMEDICAL POLY, V2
   RUSCONI L, 1982, POLYMER, V23, P1233, DOI 10.1016/0032-3861(82)90385-8
   Schexnailder P, 2009, COLLOID POLYM SCI, V287, P1, DOI 10.1007/s00396-008-1949-0
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Shiaw G., 1994, POLYMER, V35, P4416
   Sperling L.H., 1981, INTERPENETRATING POL
   Suzuki A, 2001, J CHEM PHYS, V114, P5012, DOI 10.1063/1.1350576
   Takafuji M, 2004, CHEM MATER, V16, P1977, DOI 10.1021/cm030334y
   TANAKA T, 1981, SCI AM, V244, P124, DOI 10.1038/scientificamerican0181-124
   Thakur A, 2011, CHEM BIOCHEM ENG Q, V25, P181
   Unnikrishnan G, 1997, J POLYM SCI POL PHYS, V35, P725, DOI 10.1002/(SICI)1099-0488(19970415)35:5<725::AID-POLB1>3.0.CO;2-L
   Varghese S, 2001, J PHYS CHEM B, V105, P5368, DOI 10.1021/jp002310+
   Velasco D, 2008, J MATER SCI-MATER M, V19, P1453, DOI 10.1007/s10856-007-3315-z
   Verestiuc L, 2004, INT J PHARM, V269, P185, DOI 10.1016/j.ijpharm.2003.09.031
   Wang B, 2008, COLLOID SURFACE B, V64, P34, DOI 10.1016/j.colsurfb.2008.01.001
   Wilson AN, 2014, POLYMERS-BASEL, V6, P2451, DOI 10.3390/polym6092451
   Xu ZH, 1997, APPL SURF SCI, V120, P269, DOI 10.1016/S0169-4332(97)00234-1
   Yan X., 2014, CARB POLYM, V114, P530
   YAO KJ, 1994, J APPL POLYM SCI, V53, P1533, DOI 10.1002/app.1994.070531115
   YOSHIDA H, 1990, POLYMER, V31, P693, DOI 10.1016/0032-3861(90)90291-6
   YOSHIDA R, 1992, IND ENG CHEM RES, V31, P2339, DOI 10.1021/ie00010a013
   Zhang QM, 2002, NATURE, V419, P284, DOI 10.1038/nature01021
   Zhang XZ, 2004, BIOMATERIALS, V25, P3793, DOI 10.1016/j.biomaterials.2003.10.065
   Zhao YB, 2006, J APPL POLYM SCI, V102, P3857, DOI 10.1002/app.24877
NR 91
TC 5
Z9 5
U1 3
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
EI 1873-2291
J9 POLYMER
JI Polymer
PD APR 20
PY 2016
VL 89
BP 55
EP 68
DI 10.1016/j.polymer.2016.02.027
PG 14
WC Polymer Science
SC Polymer Science
GA DH0SD
UT WOS:000372493500007
DA 2018-10-19
ER

PT J
AU Yan, W
   Chen, C
   Wang, L
   Zhang, D
   Li, AJ
   Yao, Z
   Shi, LY
AF Yan, Wei
   Chen, Chang
   Wang, Ling
   Zhang, Dan
   Li, Ai-Jun
   Yao, Zheng
   Shi, Li-Yi
TI Facile and green synthesis of cellulose nanocrystal-supported gold
   nanoparticles with superior catalytic activity
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE One-pot; Green synthesis; Cellulose nanocrystals; Polyethylene glycol;
   Gold nanoparticles; 4-Nitrophenol
ID ACID-HYDROLYSIS; SURFACE; NANOCOMPOSITES; PERFORMANCE; REDUCTION;
   OXIDATION; PLATINUM; SILVER; OXIDE
AB The emphasis of science and technology shifts toward environmentally friendly and sustainable resources and processes. Herein, we report a facile, one-pot and green synthesis of biomaterial-supported gold nanoparticles (AuNPs) with superior catalytic activity. Cellulose nanocrystal (CNC)-supported AuNPs were prepared by heating the aqueous mixture of HAuC14, CNCs and polyethylene glycol, avoiding toxic chemicals, extreme condition and complicated procedure. The resultant CNC-supported AuNPs exhibited catalytic activities for the reduction of 4-nitrophenol by sodium borohydride. The maximum apparent rate constant reached 1.47 x 10(-2) s(-1), and the turnover frequency reached 641 h(-1). The superior catalytic performance can be ascribed to the large amount of highly dispersed AuNPs with few nanometers in size which are loaded on CNCs. About 90% of the AuNPs are smaller than 10 nm, and nearly 60% of the AuNPs are smaller than 5 nm. The synthesis is eco-friendly, facile and low-cost, thus has great potential for industrial and medical applications. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Yan, Wei; Chen, Chang; Wang, Ling; Yao, Zheng; Shi, Li-Yi] Shanghai Univ, Nano Sci & Technol Res Ctr, Shanghai 200444, Peoples R China.
   [Zhang, Dan] Shanghai Univ, Shanghai Inst Appl Math & Mech, Shanghai 200444, Peoples R China.
   [Zhang, Dan] Shanghai Key Lab Mech Energy Engn, Shanghai 200072, Peoples R China.
   [Li, Ai-Jun] Shanghai Univ, Res Ctr Composite Mat, Shanghai 200444, Peoples R China.
RP Shi, LY (reprint author), Shanghai Univ, Nano Sci & Technol Res Ctr, Shanghai 200444, Peoples R China.; Li, AJ (reprint author), Shanghai Univ, Res Ctr Composite Mat, Shanghai 200444, Peoples R China.
EM aljun.li@shu.edu.cn; shiliyi@shu.edu.cn
FU National Natural Science Foundation of China [11202124]; Doctoral Fund
   of Ministry of Education [20113108120019]; Shanghai Municipal Science
   and Technology Commission [13DZ229210-0]; Baoshan District Science and
   Technology Commission of Shanghai [bkw2013142]; Program for Professor of
   Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher
   Learning
FX The authors acknowledge the support of the National Natural Science
   Foundation of China (11202124); Doctoral Fund of Ministry of Education
   (20113108120019); Shanghai Municipal Science and Technology Commission
   with the funded project No.13DZ229210-0; Baoshan District Science and
   Technology Commission of Shanghai with the funded project No.bkw2013142;
   The Program for Professor of Special Appointment (Eastern Scholar) at
   Shanghai Institutions of Higher Learning.
CR Ahmad A, 2003, LANGMUIR, V19, P3550, DOI 10.1021/la026772l
   Bai W, 2009, CELLULOSE, V16, P455, DOI 10.1007/s10570-009-9277-1
   Barton DG, 2005, J PHYS CHEM B, V109, P2262, DOI 10.1021/jp048837u
   Bondeson D, 2006, CELLULOSE, V13, P171, DOI 10.1007/s10570-006-9061-4
   Campbell CT, 2011, FARADAY DISCUSS, V152, P227, DOI 10.1039/c1fd00033k
   Chang YC, 2009, J HAZARD MATER, V165, P664, DOI 10.1016/j.jhazmat.2008.10.034
   Chen L, 2015, ACS SUSTAIN CHEM ENG, V3, P978, DOI 10.1021/acssuschemeng.5b00110
   Corma A, 2008, CHEM SOC REV, V37, P2096, DOI 10.1039/b707314n
   Esumi K, 2000, LANGMUIR, V16, P2604, DOI 10.1021/1a991291w
   Goy-Lopez S., 2009, J PHYS CHEM B, V114, P66
   Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w
   Haruta M, 2002, CATTECH, V6, P102, DOI 10.1023/A:1020181423055
   Hu J, 2014, CHEM ENG J, V236, P1, DOI 10.1016/j.cej.2013.09.080
   Huang T, 2009, J PHYS CHEM C, V113, P13636, DOI 10.1021/jp903405y
   Jaramillo TF, 2003, J AM CHEM SOC, V125, P7148, DOI 10.1021/ja029800v
   Kim KS, 2006, J MATER CHEM, V16, P1315, DOI 10.1039/b601478j
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Koga H, 2010, CHEM COMMUN, V46, P8567, DOI 10.1039/c0cc02754e
   Kuroda K., 2009, J MOL CATAL-A CHEM, V298, P7
   Lam E, 2012, NANOSCALE, V4, P997, DOI 10.1039/c2nr11558a
   Li J, 2012, J MATER CHEM, V22, P8426, DOI 10.1039/c2jm16386a
   Liu Q, 2014, ADV MATER, V26, P7178, DOI 10.1002/adma.201402699
   Lukach A, 2015, LANGMUIR, V31, P5033, DOI 10.1021/acs.langmuir.5b00728
   Luo CC, 2005, J COLLOID INTERF SCI, V288, P444, DOI 10.1016/j.jcis.2005.03.005
   Ma CY, 2013, GREEN CHEM, V15, P1035, DOI 10.1039/c3gc36891b
   Mahmoud KA, 2013, ACS APPL MATER INTER, V5, P4978, DOI 10.1021/am4007534
   Mahmoud KA, 2009, ACS APPL MATER INTER, V1, P1383, DOI 10.1021/am900331d
   Maji SK, 2014, ACS APPL MATER INTER, V6, P13648, DOI 10.1021/am503110s
   Mitsudome T, 2013, GREEN CHEM, V15, P2636, DOI 10.1039/c3gc41360h
   Moon RJ, 2011, CHEM SOC REV, V40, P3941, DOI 10.1039/c0cs00108b
   Nadagouda MN, 2007, BIOMACROMOLECULES, V8, P2762, DOI 10.1021/bm700446p
   Nadagouda MN, 2014, ACS SUSTAIN CHEM ENG, V2, P1717, DOI 10.1021/sc500237k
   Otsuka H, 2012, ADV DRUG DELIVER REV, V64, P246, DOI 10.1016/j.addr.2012.09.022
   Pandey S, 2014, CARBOHYD POLYM, V113, P525, DOI 10.1016/j.carbpol.2014.07.047
   Peng BL, 2011, CAN J CHEM ENG, V89, P1191, DOI 10.1002/cjce.20554
   Primo A, 2011, PHYS CHEM CHEM PHYS, V13, P886, DOI 10.1039/c0cp00917b
   Raveendran P, 2003, J AM CHEM SOC, V125, P13940, DOI 10.1021/ja029267j
   Saha S, 2009, LANGMUIR, V26, P2885
   Sen IK, 2013, CARBOHYD POLYM, V91, P518, DOI 10.1016/j.carbpol.2012.08.058
   Seol S. K., 2013, J NANOMATERIALS
   Sharma NC, 2007, ENVIRON SCI TECHNOL, V41, P5137, DOI 10.1021/es062929a
   Stratakis M, 2012, CHEM REV, V112, P4469, DOI 10.1021/cr3000785
   Wang HT, 2013, ACS SUSTAIN CHEM ENG, V1, P746, DOI 10.1021/sc400048m
   Wang LC, 2008, J PHYS CHEM C, V112, P6981, DOI 10.1021/jp711333t
   Wu XD, 2014, ENVIRON-SCI NANO, V1, P71, DOI 10.1039/c3en00066d
   Zhang MM, 2007, POLYMER, V48, P1989, DOI 10.1016/j.polymer.2007.01.069
   Zhang N, 2011, J MATER CHEM, V21, P11080, DOI 10.1039/c1jm12539g
   Zhao HB, 2007, CARBOHYD POLYM, V68, P235, DOI 10.1016/j.carbpol.2006.12.013
NR 48
TC 14
Z9 14
U1 4
U2 97
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD APR 20
PY 2016
VL 140
BP 66
EP 73
DI 10.1016/j.carbpol.2015.12.049
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA DD5JA
UT WOS:000369958300010
PM 26876829
DA 2018-10-19
ER

PT J
AU Zhao, MX
   Zhu, BJ
AF Zhao, Mei-Xia
   Zhu, Bing-Jie
TI The Research and Applications of Quantum Dots as Nano-Carriers for
   Targeted Drug Delivery and Cancer Therapy
SO NANOSCALE RESEARCH LETTERS
LA English
DT Review
DE Quantum dots; Nano-medicine; Targeted drug delivery; Biomaterial
ID DOUBLE-STRANDED-RNA; GENE-FUNCTION; NANOPARTICLES; FOLATE; INTERFERENCE;
   THERAPEUTICS; NANOCARRIERS; DOXORUBICIN; DROSOPHILA; LIPOSOMES
AB Quantum dots (QDs), nano-carriers for drugs, can help realize the targeting of drugs, and improve the bioavailability of drugs in biological fields. And, a QD nano-carrier system for drugs has the potential to realize early detection, monitoring, and localized treatments of specific disease sites. In addition, QD nano-carrier systems for drugs can improve stability of drugs, lengthen circulation time in vivo, enhance targeted absorption, and improve the distribution and metabolism process of drugs in organization. So, the development of QD nano-carriers for drugs has become a hotspot in the fields of nano-drug research in recent years. In this paper, we review the advantages and applications of the QD nano-carriers for drugs in biological fields.
C1 [Zhao, Mei-Xia; Zhu, Bing-Jie] Henan Univ, Key Lab Nat Med & Immune Engn, Kaifeng 475004, Peoples R China.
RP Zhao, MX (reprint author), Henan Univ, Key Lab Nat Med & Immune Engn, Kaifeng 475004, Peoples R China.
EM zhaomeixia2011@henu.edu.cn
FU National Natural Science Foundation of China [U1204201, 21501044];
   Postdoctoral Science Foundation Funded Project of China [2012M511570];
   Department of Education Science and Technology Research Key Projects of
   Henan [13A150063, 16A150004]
FX This work was supported by the National Natural Science Foundation of
   China (Nos. U1204201, 21501044), the Postdoctoral Science Foundation
   Funded Project of China (No. 2012M511570), and the Department of
   Education Science and Technology Research Key Projects of Henan (No.
   13A150063, 16A150004).
CR Abbaspourrad A, 2013, LANGMUIR, V29, P12697, DOI 10.1021/la403064f
   Bagalkot V, 2007, NANO LETT, V7, P3065, DOI 10.1021/nl071546n
   Bagalkot V, 2011, ACS NANO, V5, P8131, DOI 10.1021/nn202772p
   Balaure PC, 2015, CURR TOP MED CHEM, V15, P1424
   Bartosova L, 2012, CURR MED CHEM, V19, P4671, DOI 10.2174/092986712803306358
   Biju V, 2010, BIOTECHNOL ADV, V28, P199, DOI 10.1016/j.biotechadv.2009.11.007
   Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3
   Briguglio I, 2015, EUR J MED CHEM, V97, P612, DOI 10.1016/j.ejmech.2014.09.089
   Chaudhury A, 2015, CURR PHARM BIOTECHNO, V16, P333, DOI 10.2174/1389201016666150118135107
   Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441
   Cukierman E, 2010, BIOCHEM PHARMACOL, V80, P762, DOI 10.1016/j.bcp.2010.04.020
   de Bono JS, 2010, NATURE, V467, P543, DOI 10.1038/nature09339
   Dhyani H, 2015, RSC ADV, V5, P45928, DOI 10.1039/c5ra07012k
   Gui RJ, 2014, ANAL CHEM, V86, P5211, DOI 10.1021/ac501293e
   Han JH, 2015, ANAL BIOANAL CHEM, V407, P5243, DOI 10.1007/s00216-015-8708-0
   Lee SJ, 2015, NANOSCALE RES LETT, V10, P1, DOI 10.1186/s11671-014-0706-1
   Li C, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-244
   Li X, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-401
   Loretz B, 2013, SAFETY ASPECTS ENG N, P279
   Lyashchova A, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-88
   Malhotra A, 2014, PHARMACOGENET GENOM, V24, P582, DOI 10.1097/FPC.0000000000000094
   Mansur AAP, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-0879-2
   Merkx M, 2013, BIOCHEM SOC T, V41, P1201, DOI 10.1042/BST20130128
   Misquitta L, 1999, P NATL ACAD SCI USA, V96, P1451, DOI 10.1073/pnas.96.4.1451
   Bustos ARM, 2015, ANAL CHIM ACTA, V879, P77, DOI 10.1016/j.aca.2015.03.015
   Oluwole DO, 2015, POLYHEDRON, V87, P8, DOI 10.1016/j.poly.2014.10.024
   Ozcan G, 2015, ADV DRUG DELIVER REV, V87, P108, DOI 10.1016/j.addr.2015.01.007
   Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653
   Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387
   ROMANO N, 1992, MOL MICROBIOL, V6, P3343, DOI 10.1111/j.1365-2958.1992.tb02202.x
   Rosenkranz D, 2015, RNA, V21, P911, DOI 10.1261/rna.048603.114
   Savva YA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3745
   Schneider RL, 2005, BIOORGAN MED CHEM, V13, P2799, DOI 10.1016/j.bmc.2005.02.025
   Shao D, 2015, BIOMATER SCI-UK, V3, P833, DOI 10.1039/c5bm00077g
   Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686
   Wang YC, 2015, BIOMATER SCI-UK, V3, P192, DOI 10.1039/c4bm00306c
   Wargelius A, 1999, BIOCHEM BIOPH RES CO, V263, P156, DOI 10.1006/bbrc.1999.1343
   Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016
   Win KY, 2015, SMALL, V11, P1197, DOI 10.1002/smll.201402073
   Wolfbeis OS, 2015, CHEM SOC REV, V44, P4743, DOI 10.1039/c4cs00392f
   Yoo HS, 2004, J CONTROL RELEASE, V100, P247, DOI 10.1016/j.jconrel.2004.08.017
   Yuan Y, 2014, BIOMATERIALS, V35, P7881, DOI 10.1016/j.biomaterials.2014.05.071
   Zhang G, 2015, ACS APPL MATER INTER, V7, P14192
   Zrazhevskiy P, 2010, CHEM SOC REV, V39, P4326, DOI 10.1039/b915139g
   Zrazhevskiy P, 2009, NANO TODAY, V4, P414, DOI 10.1016/j.nantod.2009.07.004
NR 45
TC 18
Z9 18
U1 5
U2 256
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1556-276X
J9 NANOSCALE RES LETT
JI Nanoscale Res. Lett.
PD APR 18
PY 2016
VL 11
AR 207
DI 10.1186/s11671-016-1394-9
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA DJ8PP
UT WOS:000374474700001
PM 27090658
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Bernhard, JC
   Vunjak-Novakovic, G
AF Bernhard, Jonathan C.
   Vunjak-Novakovic, Gordana
TI Should we use cells, biomaterials, or tissue engineering for cartilage
   regeneration?
SO STEM CELL RESEARCH & THERAPY
LA English
DT Review
DE Cartilage; Tissue engineering; Chondrocytes; Mesenchymal stem cells;
   Biomaterial; Bioreactor; Hydrogel; Implantation
ID PLURIPOTENT STEM-CELLS; AUTOLOGOUS CHONDROCYTE IMPLANTATION; IN-VITRO
   CHONDROGENESIS; ARTICULAR-CARTILAGE; HYDROSTATIC-PRESSURE; STROMAL
   CELLS; REPAIR; DIFFERENTIATION; COLLAGEN; SCAFFOLDS
AB For a long time, cartilage has been a major focus of the whole field of tissue engineering, both because of the constantly growing need for more effective options for joint repair and the expectation that this apparently simple tissue will be easy to engineer. After several decades, cartilage regeneration has proven to be anything but easy. With gratifying progress in our understanding of the factors governing cartilage development and function, and cell therapy being successfully used for several decades, there is still a lot to do. We lack reliable methods to generate durable articular cartilage that would resemble the original tissue lost to injury or disease. The question posed here is whether the answer would come from the methods using cells, biomaterials, or tissue engineering. We present a concise review of some of the most meritorious efforts in each area, and propose that the solution will most likely emerge from the ongoing attempts to recapitulate certain aspects of native cartilage development. While an ideal recipe for cartilage regeneration is yet to be formulated, we believe that it will contain cell, biomaterial, and tissue engineering approaches, blended into an effective method for seamless repair of articular cartilage.
C1 [Bernhard, Jonathan C.; Vunjak-Novakovic, Gordana] Columbia Univ, Dept Biomed Engn, 622 West 168th St,VC12-234, New York, NY 10032 USA.
   [Vunjak-Novakovic, Gordana] Columbia Univ, Dept Med, 622 West 168th St,VC12-234, New York, NY 10032 USA.
RP Vunjak-Novakovic, G (reprint author), Columbia Univ, Dept Biomed Engn, 622 West 168th St,VC12-234, New York, NY 10032 USA.; Vunjak-Novakovic, G (reprint author), Columbia Univ, Dept Med, 622 West 168th St,VC12-234, New York, NY 10032 USA.
EM gv2131@columbia.edu
FU NIDCR [DE016525]; NIBIB [EB002520]; NIAMS [AR061988, AR060361]; NSF
   (GRF)
FX The authors gratefully acknowledge the funding support of their work by
   NIDCR (grant DE016525), NIBIB (grant EB002520), NIAMS (grants AR061988
   and AR060361) and the NSF (GRF for JCB).
CR Allan KS, 2007, TISSUE ENG, V13, P167, DOI 10.1089/ten.2006.0081
   Arokoski JPA, 2000, SCAND J MED SCI SPOR, V10, P186, DOI 10.1034/j.1600-0838.2000.010004186.x
   Bae SE, 2010, J CONTROL RELEASE, V143, P23, DOI 10.1016/j.jconrel.2009.12.024
   Bhardwaj N, 2015, MACROMOL BIOSCI, V15, P153, DOI 10.1002/mabi.201400335
   Bhumiratana S, 2014, P NATL ACAD SCI USA, V111, P6940, DOI 10.1073/pnas.1324050111
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Caldwell KL, 2015, OSTEOARTHR CARTILAGE, V23, P351, DOI 10.1016/j.joca.2014.11.004
   Cohen DL, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/035004
   Craft AM, 2013, DEVELOPMENT, V140, P2597, DOI 10.1242/dev.087890
   Cucchiarini M, 2014, Eur Cell Mater, V27, P12
   Cui XF, 2012, TISSUE ENG PT A, V18, P1304, DOI [10.1089/ten.TEA.2011.0543, 10.1089/ten.tea.2011.0543]
   Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200
   Diekman BO, 2012, P NATL ACAD SCI USA, V109, P19172, DOI 10.1073/pnas.1210422109
   Elder BD, 2009, TISSUE ENG PART B-RE, V15, P43, DOI 10.1089/ten.teb.2008.0435
   Elisseeff J, 2005, Orthod Craniofac Res, V8, P150, DOI 10.1111/j.1601-6343.2005.00335.x
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Fedorovich NE, 2012, TISSUE ENG PART C-ME, V18, P33, DOI [10.1089/ten.tec.2011.0060, 10.1089/ten.TEC.2011.0060]
   Foss C, 2013, BIOMACROMOLECULES, V14, P38, DOI 10.1021/bm301174x
   Garg T, 2014, EXPERT OPIN DRUG DEL, V11, P767, DOI 10.1517/17425247.2014.891014
   Gawlitta D, 2012, TISSUE ENG PT A, V18, P1957, DOI [10.1089/ten.TEA.2011.0657, 10.1089/ten.tea.2011.0657]
   Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652
   GRANDE DA, 1989, J ORTHOP RES, V7, P208, DOI 10.1002/jor.1100070208
   Guilak F, 2006, ANN NY ACAD SCI, P498, DOI [10.1196/annals.1346.011, DOI 10.1196/ANNALS.1346.011]
   Hambly K, 2006, AM J SPORT MED, V34, P1020, DOI 10.1177/0363546505281918
   Hansen U, 2001, J BIOMECH, V34, P941, DOI 10.1016/S0021-9290(01)00050-1
   Hayes AJ, 2001, ANAT EMBRYOL, V203, P469, DOI 10.1007/s004290100178
   Heng BC, 2004, STEM CELLS, V22, P1152, DOI 10.1634/stemcells.2004-0062
   Hou QP, 2004, J MATER CHEM, V14, P1915, DOI 10.1039/b401791a
   Hu JC, 2006, TISSUE ENG, V12, P969, DOI 10.1089/ten.2006.12.969
   Huey DJ, 2012, SCIENCE, V338, P917, DOI 10.1126/science.1222454
   Klein TJ, 2009, TISSUE ENG PART B-RE, V15, P143, DOI [10.1089/ten.teb.2008.0563, 10.1089/ten.TEB.2008.0563]
   Knutsen G, 2007, J BONE JOINT SURG AM, V89A, P2105, DOI 10.2106/JBJS.G.00003
   Ko JY, 2014, BIOMATERIALS, V35, P3571, DOI 10.1016/j.biomaterials.2014.01.009
   Kyurkchiev Dobroslav, 2014, World J Stem Cells, V6, P552, DOI 10.4252/wjsc.v6.i5.552
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X
   Lee CR, 2001, BIOMATERIALS, V22, P3145, DOI 10.1016/S0142-9612(01)00067-9
   Li CH, 2011, TISSUE ENG PT A, V17, P777, DOI [10.1089/ten.tea.2010.0078, 10.1089/ten.TEA.2010.0078]
   Mabvuure N, 2012, CURR STEM CELL RES T, V7, P287, DOI 10.2174/157488812800793018
   Madry H, 2011, DTSCH ARZTEBL INT, V108, P669, DOI 10.3238/arztebl.2011.0669
   Mardones R, 2015, INT J STEM CELLS, V8, P48, DOI 10.15283/ijsc.2015.8.1.48
   Mauck RL, 2006, OSTEOARTHR CARTILAGE, V14, P179, DOI 10.1016/j.joca.2005.09.002
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   McMahon LA, 2008, ANN BIOMED ENG, V36, P185, DOI 10.1007/s10439-007-9416-5
   Melchels FPW, 2012, PROG POLYM SCI, V37, P1079, DOI 10.1016/j.progpolymsci.2011.11.007
   Mollon B, 2013, OSTEOARTHR CARTILAGE, V21, P1824, DOI 10.1016/j.joca.2013.08.024
   MUIR H, 1995, BIOESSAYS, V17, P1039, DOI 10.1002/bies.950171208
   Munarin F, 2012, J APPL BIOMATER FUNC, V10, P67, DOI 10.5301/JABFM.2012.9418
   Nagaya H, 1999, ANN RHEUM DIS, V58, P186, DOI 10.1136/ard.58.3.186
   Nejadnik H, 2010, AM J SPORT MED, V38, P1110, DOI 10.1177/0363546509359067
   Ogawa R, 2009, TISSUE ENG PT A, V15, P2937, DOI [10.1089/ten.tea.2008.0672, 10.1089/ten.TEA.2008.0672]
   PACIFICI M, 1991, EXP CELL RES, V192, P266, DOI 10.1016/0014-4827(91)90185-W
   Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083
   Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136
   Portner R, 2009, ADV BIOCHEM ENG BIOT, V112, P145, DOI [10.1007/10_2008_4, 10.1007/978-3-540-69357-4_7]
   Quarto N, 2012, P NATL ACAD SCI USA, V109, P215, DOI 10.1073/pnas.1113442109
   Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587
   Saito T, 2015, BIOMED RES-TOKYO, V36, P179, DOI 10.2220/biomedres.36.179
   Schulz RM, 2007, EUR BIOPHYS J BIOPHY, V36, P539, DOI 10.1007/s00249-007-0139-1
   Schuurman W, 2015, J TISSUE ENG REGEN M, V9, P669, DOI 10.1002/term.1638
   Shen Y, 2014, CURR STEM CELL RES T, V9, P254, DOI 10.2174/1574888X09666140213202700
   Shin H, 2004, J BIOMED MATER RES A, V69A, P535, DOI 10.1002/jbm.a.30027
   Spiller KL, 2011, TISSUE ENG PART B-RE, V17, P281, DOI [10.1089/ten.TEB.2011.0077, 10.1089/ten.teb.2011.0077]
   Steinert AF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2195
   Stoop R, 2008, INJURY, V39, pS77, DOI 10.1016/j.injury.2008.01.036
   Tognana E, 2005, OSTEOARTHR CARTILAGE, V13, P896, DOI 10.1016/j.joca.2005.05.003
   Toh WS, 2007, STEM CELLS, V25, P950, DOI 10.1634/stemcells.2006-0326
   Toh WS, 2010, BIOMATERIALS, V31, P6968, DOI 10.1016/j.biomaterials.2010.05.064
   Tuli R, 2004, TISSUE ENG, V10, P1169, DOI 10.1089/ten.2004.10.1169
   Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005
   Vonk LA, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0086-1
   Wakitani S, 1998, TISSUE ENG, V4, P429, DOI 10.1089/ten.1998.4.429
   Wakitani S, 2007, J TISSUE ENG REGEN M, V1, P74, DOI 10.1002/term.8
   Webber MJ, 2015, ANN BIOMED ENG, V43, P641, DOI 10.1007/s10439-014-1104-7
   Wei YY, 2012, EUR CELLS MATER, V23, P1
   Zscharnack M, 2009, CELLS TISSUES ORGANS, V190, P81, DOI 10.1159/000178024
NR 76
TC 42
Z9 44
U1 1
U2 59
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1757-6512
J9 STEM CELL RES THER
JI Stem Cell Res. Ther.
PD APR 18
PY 2016
VL 7
AR 56
DI 10.1186/s13287-016-0314-3
PG 9
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA DK1AZ
UT WOS:000374645600001
PM 27089917
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Huang, Y
   Qiao, HX
   Nian, XF
   Zhang, XJ
   Zhang, XY
   Song, GQ
   Xu, ZW
   Zhang, HL
   Han, SG
AF Huang, Yong
   Qiao, Haixia
   Nian, Xiaofeng
   Zhang, Xuejiao
   Zhang, Xiaoyun
   Song, Guiqin
   Xu, Zhiwei
   Zhang, Honglei
   Han, Shuguang
TI Improving the bioactivity and corrosion resistance properties of
   electrodeposited hydroxyapatite coating by dual doping of bivalent
   strontium and manganese ion
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE Hydroxyapatite coating; Strontium; Manganese; Corrosion resistance;
   Biocompatibility
ID CALCIUM-PHOSPHATE COATINGS; PULSED-LASER DEPOSITION; IN-VITRO;
   CARBON/CARBON COMPOSITES; SUBSTITUTED HYDROXYAPATITES; IMPLANT
   APPLICATIONS; BIOLOGICAL-PROPERTY; TIN COATINGS; TITANIUM;
   BIOCOMPATIBILITY
AB The key property in the preparation of a biomaterial is to facilitate the regeneration and/or replacement of injured organs and tissues. To obtain such a biomaterial, strontium and manganese co-substituted hydroxyapatite (SrMnHA) ceramic coatings on commercially pure titanium (CP-Ti) were successfully prepared by a cathodic electrodeposition method. The formation of SrMnHA coating was investigated using Fourier transform infrared spectroscopy, X-ray diffraction, scanning electron microscopy, energy dispersive X-ray analysis and inductively coupled plasma. Co-doping of Sr2+ and Mn2+ ions decreased hydroxyapatite unit cell volume and grain sizes. Obtained coatings were crack-free and dense, which led to the decrease in the corrosion current densities of CP-Ti in physiological solutions. The dissolution tests performed on SrMnHA resulted in the leaching of Sr2+ and Mn2+ at low levels. SrMnHAs have moderately hydrophilic surfaces with a contact angle of 23.8 degrees.Additionally, the MC3T3-E1 cells show better cell morphology, adhesion, spreading, proliferation and expression of alkaline phosphatase on SrMnHA than on HA. The excellent biocompatibility of SrMnHA is mainly attributed to a probable effect of a combination of good surface wettability and ion release (Sr2+ and Mn2+). Results suggest that SrMnHA composite-coated CP-Ti can be a potential candidate for orthopaedic applications. (C) 2016 Elsevier" B.V. All rights reserved,
C1 [Huang, Yong; Qiao, Haixia; Nian, Xiaofeng; Zhang, Xuejiao; Zhang, Xiaoyun; Song, Guiqin; Xu, Zhiwei] Hebei North Univ, Coll Lab Med, Zhangjiakou 075000, Peoples R China.
   [Huang, Yong; Han, Shuguang] Univ Elect Sci & Technol China, Inst Life Sci & Technol, Chengdu 610054, Peoples R China.
   [Zhang, Honglei] Hebei Univ, Coll Chem Environm Sci, Baoding 071000, Peoples R China.
RP Huang, Y; Zhang, XJ (reprint author), Hebei North Univ, Coll Lab Med, Zhangjiakou 075000, Peoples R China.
EM xfpang@aliyun.com; 527238610@qq.com
FU Key Project of Science and Technology of Hebei Colleges [ZD2015124];
   Natural Science Foundation of Hebei North University; High-level
   Scientific Research Foundation of Hebei North University
FX This work was supported by the Key Project of Science and Technology of
   Hebei Colleges (No. ZD2015124), the Natural Science Foundation of Hebei
   North University, and the High-level Scientific Research Foundation of
   Hebei North University.
CR Bae YJ, 2008, BIOL TRACE ELEM RES, V124, P28, DOI 10.1007/s12011-008-8119-6
   Bigi A, 2005, BIOMATERIALS, V26, P2381, DOI 10.1016/j.biomaterials.2004.07.057
   Bir F, 2012, APPL SURF SCI, V258, P7021, DOI 10.1016/j.apsusc.2012.03.158
   Boanini E, 2015, J COLLOID INTERF SCI, V448, P1, DOI 10.1016/j.jcis.2015.01.088
   Boyd AR, 2015, MAT SCI ENG C-MATER, V46, P290, DOI 10.1016/j.msec.2014.10.046
   Bracci B, 2009, J INORG BIOCHEM, V103, P1666, DOI 10.1016/j.jinorgbio.2009.09.009
   Brown EM, 2007, NAT CLIN PRACT ENDOC, V3, P122, DOI 10.1038/ncpendmet0388
   Brown EM, 2003, OSTEOPOROSIS INT, V14, pS25, DOI 10.1007/s00198-002-1343-6
   Capuccini C, 2009, J BIOMED MATER RES A, V89A, P594, DOI 10.1002/jbm.a.31975
   Chen HT, 2015, SURF COAT TECH, V276, P168, DOI 10.1016/j.surfcoat.2015.06.056
   Diesselberg M, 2004, SURF COAT TECH, V177, P399, DOI 10.1016/j.surfcoat.2003.09.015
   Eliaz N, 2011, J MATER SCI-MATER M, V22, P1741, DOI 10.1007/s10856-011-4355-y
   Eliaz N, 2009, ACTA BIOMATER, V5, P3178, DOI 10.1016/j.actbio.2009.04.005
   Gopi D, 2015, RSC ADV, V5, P36766, DOI 10.1039/c5ra04382d
   Gopi D, 2015, RSC ADV, V5, P27402, DOI 10.1039/c5ra03432a
   Gopi D, 2015, CERAM INT, V41, P5454, DOI 10.1016/j.ceramint.2014.12.114
   Gopi D, 2014, RSC ADV, V4, P34751, DOI 10.1039/c4ra04484c
   Gyorgy E, 2004, J BIOMED MATER RES A, V71A, P353, DOI 10.1002/jbm.a.30172
   Huang Y, 2015, RSC ADV, V5, P17076, DOI 10.1039/c4ra12118j
   Huang Y, 2013, APPL SURF SCI, V282, P456, DOI 10.1016/j.apsusc.2013.05.152
   Huang Y, 2013, APPL SURF SCI, V282, P583, DOI 10.1016/j.apsusc.2013.06.015
   Huang Y, 2013, J MATER SCI-MATER M, V24, P1853, DOI 10.1007/s10856-013-4955-9
   Kaygili O, 2015, MAT SCI ENG C-MATER, V55, P538, DOI 10.1016/j.msec.2015.05.081
   Kim HW, 2007, TISSUE ENG, V13, P965, DOI 10.1089/ten.2006.0299
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kulanthaivel S, 2015, CERAM INT, V41, P11323, DOI 10.1016/j.ceramint.2015.05.090
   Liu B., 2015, MAT SCI ENG C, V53, P322
   Liu B, 2015, MAT SCI ENG C-MATER, V47, P97, DOI 10.1016/j.msec.2014.11.038
   Malakauskaite-Petruleviciene M, 2015, CERAM INT, V41, P7421, DOI 10.1016/j.ceramint.2015.02.055
   Mayrhofer PH, 2002, THIN SOLID FILMS, V415, P151, DOI 10.1016/S0040-6090(02)00511-4
   McGehee DS, 1997, J PHYSIOL-LONDON, V502, P31, DOI 10.1111/j.1469-7793.1997.031bl.x
   Miola M, 2014, MAT SCI ENG C-MATER, V38, P107, DOI 10.1016/j.msec.2014.01.045
   Mohseni E, 2015, CERAM INT, V41, P14447, DOI 10.1016/j.ceramint.2015.07.081
   Mohseni E, 2014, INT J ADHES ADHES, V48, P238, DOI 10.1016/j.ijadhadh.2013.09.030
   Narayanan R, 2008, J BIOMED MATER RES B, V85B, P279, DOI 10.1002/jbm.b.30932
   Paluszkiewicz C, 2010, J MOL STRUCT, V976, P301, DOI 10.1016/j.molstruc.2010.04.001
   Park JW, 2011, APPL SURF SCI, V258, P977, DOI 10.1016/j.apsusc.2011.09.053
   Pei XB, 2014, APPL SURF SCI, V295, P71, DOI 10.1016/j.apsusc.2014.01.009
   Sima F, 2007, APPL SURF SCI, V254, P1155, DOI 10.1016/j.apsuse.2007.08.053
   Sumathi S, 2015, J CRYST GROWTH, V422, P36, DOI 10.1016/j.jcrysgro.2015.04.022
   Supova M, 2015, CERAM INT, V41, P9203, DOI 10.1016/j.ceramint.2015.03.316
   Surmenev RA, 2014, ACTA BIOMATER, V10, P557, DOI 10.1016/j.actbio.2013.10.036
   Surmeneva M. A., 2015, COLLOIDS SURF B
   Tang S, 2014, SURF COAT TECH, V251, P210, DOI 10.1016/j.surfcoat.2014.04.028
   Vahabzadeh S, 2015, ACTA BIOMATER, V17, P47, DOI 10.1016/j.actbio.2015.01.022
   Vasilescu C, 2011, CORROS SCI, V53, P992, DOI 10.1016/j.corsci.2010.11.033
   Wang Y, 2015, MATER DESIGN, V85, P640, DOI 10.1016/j.matdes.2015.07.086
   Yang SP, 2015, APPL SURF SCI, V346, P554, DOI 10.1016/j.apsusc.2015.03.190
   Zalnezhad E, 2012, INT J PRECIS ENG MAN, V13, P1453, DOI 10.1007/s12541-012-0191-3
   Zhang LL, 2014, CERAM INT, V40, P13123, DOI 10.1016/j.ceramint.2014.05.015
   Zhang LL, 2014, APPL SURF SCI, V313, P85, DOI 10.1016/j.apsusc.2014.05.144
   Zhao XN, 2012, APPL SURF SCI, V258, P5117, DOI 10.1016/j.apsusc.2012.01.144
   Zhou H, 2015, MAT SCI ENG C-MATER, V56, P174, DOI 10.1016/j.msec.2015.06.032
NR 53
TC 14
Z9 14
U1 8
U2 59
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD APR 15
PY 2016
VL 291
BP 205
EP 215
DI 10.1016/j.surfcoat.2016.02.042
PG 11
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA EE5ZH
UT WOS:000389687600023
DA 2018-10-19
ER

PT J
AU Barros, SM
   Whitaker, SK
   Sukthankar, P
   Avila, LA
   Gudlur, S
   Warner, M
   Beltrao, EIC
   Tomich, JM
AF Barros, Sheila M.
   Whitaker, Susan K.
   Sukthankar, Pinakin
   Avila, L. Adriana
   Gudlur, Sushanth
   Warner, Matt
   Beltrao, Eduardo I. C.
   Tomich, John M.
TI A review of solute encapsulating nanoparticles used as delivery systems
   with emphasis on branched amphipathic peptide capsules
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE BAPCs; Nanoparticle; Drug delivery; Self-assembly; Peptide bilayer
ID SOLID LIPID NANOPARTICLES; SURFACTANT-LIKE PEPTIDES; CONTROLLED
   DRUG-DELIVERY; ALPHA-PARTICLE THERAPY; CROSS-LINKED MICELLES;
   BLOCK-COPOLYMERS; DIBLOCK COPOLYMERS; POLYMERIC MICELLES; PHASE-I;
   CLINICAL-APPLICATIONS
AB Various strategies are being developed to improve delivery and increase the biological half-lives of pharmacological agents. To address these issues, drug delivery technologies rely on different nano-sized molecules including: lipid vesicles, viral capsids and nano-particles. Peptides are a constituent of many of these nanomaterials and overcome some limitations associated with lipid-based or viral delivery systems, such as tune-ability, stability, specificity, inflammation, and antigenicity. This review focuses on the evolution of bio-based drug delivery nanomaterials that self-assemble forming vesicles/capsules. While lipid vesicles are preeminent among the structures; peptide-based constructs are emerging, in particular peptide bilayer delimited capsules.
   The novel biomaterial-Branched Amphiphilic Peptide Capsules (BAPCs) display many desirable properties. These nano-spheres are comprised of two branched peptides-bis(FLIVI)-K-KKKK and bis(FLIVIGSII)-K-KKKK, designed to mimic diacyl-phosphoglycerides in molecular architecture. They undergo supramolecular self-assembly and form solvent-filled, bilayer delineated capsules with sizes ranging from 20 nm to 2 mu m depending on annealing temperatures and time. They are able to encapsulate different fluorescent dyes, therapeutic drugs, radionuclides and even small proteins. While sharing many properties with lipid vesicles, the BAPCs are much more robust. They have been analyzed for stability, size, cellular uptake and localization, intra-cellular retention and, bio-distribution both in culture and in vivo. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Barros, Sheila M.; Whitaker, Susan K.; Sukthankar, Pinakin; Avila, L. Adriana; Gudlur, Sushanth; Warner, Matt; Tomich, John M.] Kansas State Univ, Dept Biochem & Mol Biophys, 141 Chalmers Hall, Manhattan, KS 66506 USA.
   [Barros, Sheila M.; Beltrao, Eduardo I. C.] Fed Univ Pernambuco UFPE, Dept Biochem, BR-50670901 Recife, PE, Brazil.
   [Sukthankar, Pinakin] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.
   [Avila, L. Adriana] Auburn Univ, Dept Chem & Biochem, Auburn, AL 36849 USA.
   [Gudlur, Sushanth] Nanyang Technol Univ, CBSS, Singapore 637553, Singapore.
RP Tomich, JM (reprint author), Kansas State Univ, Dept Biochem & Mol Biophys, 141 Chalmers Hall, Manhattan, KS 66506 USA.
EM jtomich@ksu.edu
RI bagheri, amir/C-3274-2017
OI TOMICH, JOHN/0000-0001-7848-8307; Sukthankar,
   Pinakin/0000-0002-9043-5846
FU PHS-NIH grant [GM074096]; Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES) [PDSE - 99999.007690/2014-02]; Terry Johnson
   Cancer Center Innovation Award; Affilation: CAPES Foundation; Ministry
   of Education, Brasilia, Brazil [DF 70.040-020]
FX We thank Professor Jianhan Chen for carrying out the computer simulation
   that generated Fig. 16. This is publication 16-158-J from the Kansas
   Agricultural Experiment Station. Partial support for this project was
   provided by PHS-NIH grant # GM074096 and a Terry Johnson Cancer Center
   Innovation Award (to J.M.T), Scholarship award (to S. B.) from the
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
   Process number: PDSE - 99999.007690/2014-02, Affilation: CAPES
   Foundation, Ministry of Education, Brasilia-DF 70.040-020, Brazil and
   the Terry Johnson Cancer Center at Kansas State University for summer
   support (for P.S. and S.G.).
CR Adams DJ, 2008, BIOMACROMOLECULES, V9, P2997, DOI 10.1021/bm8006693
   Alexis F, 2008, UROL ONCOL-SEMIN ORI, V26, P74, DOI 10.1016/j.urolonc.2007.03.017
   Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833
   ALLEN TM, 1980, BIOCHIM BIOPHYS ACTA, V597, P418, DOI 10.1016/0005-2736(80)90118-2
   ALLEN TM, 1987, FEBS LETT, V223, P42, DOI 10.1016/0014-5793(87)80506-9
   Antunes FE, 2009, ADV COLLOID INTERFAC, V147-48, P18, DOI 10.1016/j.cis.2008.10.001
   Arnedo A, 2004, J CONTROL RELEASE, V94, P217, DOI 10.1016/j.jconrel.2003.10.009
   Au JLS, 2001, J CONTROL RELEASE, V74, P31, DOI 10.1016/S0168-3659(01)00308-X
   Bae Y, 2005, BIOCONJUGATE CHEM, V16, P122, DOI 10.1021/bc0498166
   Basel MT, 2011, ACS NANO, V5, P2162, DOI 10.1021/nn103362n
   BILTONEN RL, 1993, CHEM PHYS LIPIDS, V64, P129, DOI 10.1016/0009-3084(93)90062-8
   Blasi P, 2007, ADV DRUG DELIVER REV, V59, P454, DOI 10.1016/j.addr.2007.04.011
   Boas U, 2004, CHEM SOC REV, V33, P43, DOI 10.1039/b309043b
   Brayden David J., 2003, Drug Discovery Today, V8, P976, DOI 10.1016/S1359-6446(03)02874-5
   Butun V, 2006, REACT FUNCT POLYM, V66, P157, DOI 10.1016/j.reactfunctpolym.2005.07.021
   Cai GQ, 2011, ACTA BIOMATER, V7, P3729, DOI 10.1016/j.actbio.2011.06.027
   Carafa M, 2009, J LIPOSOME RES, V19, P332, DOI 10.3109/08982100903014994
   Carlmark A, 2009, CHEM SOC REV, V38, P352, DOI 10.1039/b711745k
   Chauhan AS, 2004, J DRUG TARGET, V12, P575, DOI 10.1080/10611860400010655
   Choucair A, 2003, J AM CHEM SOC, V125, P11993, DOI 10.1021/ja036667d
   Choucair A, 2003, EUR PHYS J E, V10, P37, DOI 10.1140/epje/e2003-00002-5
   Chuanoi S, 2014, BIOMACROMOLECULES, V15, P2389, DOI 10.1021/bm500127g
   Cloninger MJ, 2002, CURR OPIN CHEM BIOL, V6, P742, DOI 10.1016/S1367-5931(02)00400-3
   Couturier O, 2005, EUR J NUCL MED MOL I, V32, P601, DOI 10.1007/s00259-005-1803-2
   Cui H, 2007, SOFT MATTER, V3, P945, DOI 10.1039/b704194b
   Cullis P.R., 1992, J LIPOSOME RES, V2, P397
   Daful AG, 2012, LANGMUIR, V28, P3730, DOI 10.1021/la204132c
   Davis ME, 2009, MOL PHARMACEUT, V6, P659, DOI 10.1021/mp900015y
   Decuzzi P, 2009, PHARM RES-DORD, V26, P235, DOI 10.1007/s11095-008-9697-x
   Devalapally H, 2007, CANCER CHEMOTH PHARM, V59, P477, DOI 10.1007/s00280-006-0287-5
   dos Santos S., 2013, DRUG DELIVERY SYSTEM, P35
   Drummond CJ, 1999, CURR OPIN COLLOID IN, V4, P449, DOI 10.1016/S1359-0294(00)00020-0
   El-Sayed M, 2001, PHARM RES-DORDR, V18, P23, DOI 10.1023/A:1011066408283
   Elgqvist J., 2014, FRONT ONCOL, V3, P1
   ENGIN K, 1995, INT J HYPERTHER, V11, P211, DOI 10.3109/02656739509022457
   Erhardt R, 2003, J AM CHEM SOC, V125, P3260, DOI 10.1021/ja028982q
   Erhardt R, 2001, MACROMOLECULES, V34, P1069, DOI 10.1021/ma000670p
   Etheridge ML, 2013, NANOMED-NANOTECHNOL, V9, P1, DOI 10.1016/j.nano.2012.05.013
   Ewert K, 2005, ADV GENET, V53, P119, DOI 10.1016/S0065-2660(05)53005-0
   Fang JY, 2001, INT J PHARM, V219, P61, DOI 10.1016/S0378-5173(01)00627-5
   FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664
   Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566
   Fetterly GJ, 2003, AAPS PHARMSCI, V5
   FUHRHOP JH, 1993, J AM CHEM SOC, V115, P11036, DOI 10.1021/ja00076a090
   Gabizon AA, 2006, J LIPOSOME RES, V16, P175, DOI 10.1080/08982100600848769
   Gebhardt KE, 2008, J COLLOID INTERF SCI, V317, P70, DOI 10.1016/j.jcis.2007.09.048
   Gelderblom H, 2001, EUR J CANCER, V37, P1590, DOI 10.1016/S0959-8049(01)00171-X
   Gharpure KM, 2015, CLIN CANCER RES, V21, P3121, DOI 10.1158/1078-0432.CCR-14-1189
   Gmeiner WH, 2014, NANOTECHNOL REV, V3, P111, DOI 10.1515/ntrev-2013-0013
   Goldstein AS, 1997, CHEM PHYS LIPIDS, V88, P21, DOI 10.1016/S0009-3084(97)00042-X
   GRACIAA A, 1989, J PHYS CHEM-US, V93, P4167, DOI 10.1021/j100347a055
   Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105
   GROVE A, 1993, PROTEIN SCI, V2, P1918, DOI 10.1002/pro.5560021113
   Gudlur S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045374
   Guy V., 1975, French Patent, Patent No. [2315991-A1, 2315991]
   Hajduk DA, 1998, J PHYS CHEM B, V102, P4269, DOI 10.1021/jp973323z
   Hamman JH, 2005, BIODRUGS, V19, P165, DOI 10.2165/00063030-200519030-00003
   Hamoudeh M, 2008, ADV DRUG DELIVER REV, V60, P1329, DOI 10.1016/j.addr.2008.04.013
   Handjani R, 1989, U.S. Patent, Patent No. [4830857, US4830857A]
   HANDJANIVILA RM, 1979, INT J COSMETIC SCI, V1, P303, DOI 10.1111/j.1467-2494.1979.tb00224.x
   Hart Stephen L., 2005, Current Drug Delivery, V2, P423, DOI 10.2174/156720105774370230
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Henriksen G, 2004, NUCL MED BIOL, V31, P441, DOI 10.1016/j.nucmedbio.2003.11.004
   Hoarau D, 2004, PHARM RES, V21, P1783, DOI 10.1023/B:PHAM.0000045229.87844.21
   Holder SJ, 2011, POLYM CHEM-UK, V2, P1018, DOI 10.1039/c0py00379d
   Holowka EP, 2005, J AM CHEM SOC, V127, P12423, DOI 10.1021/ja053557t
   Hsiao MS, 2014, MACROMOLECULES, V47, P2361, DOI 10.1021/ma402429d
   Hu CJ, 1999, INT J PHARM, V185, P23, DOI 10.1016/S0378-5173(99)00122-2
   Hu HQ, 2014, SOFT MATTER, V10, P3867, DOI 10.1039/c3sm52607k
   Iatrou H, 2007, BIOMACROMOLECULES, V8, P2173, DOI 10.1021/bm070360f
   Ibrahim NK, 2002, CLIN CANCER RES, V8, P1038
   Immordino ML, 2006, INT J NANOMED, V1, P297
   ISHIKAWA M, 1991, J COLLOID INTERF SCI, V141, P10, DOI 10.1016/0021-9797(91)90297-L
   Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1
   IWAMOTO T, 1994, INT J PEPT PROT RES, V43, P597, DOI 10.1111/j.1399-3011.1994.tb00562.x
   Jeong WJ, 2014, BIOCONJUGATE CHEM, V25, P1996, DOI 10.1021/bc500367z
   Jevprasesphant R, 2003, INT J PHARM, V252, P263, DOI 10.1016/S0378-5173(02)00623-3
   Jiao DZ, 2012, ANGEW CHEM INT EDIT, V51, P9633, DOI 10.1002/anie.201202947
   Johnsson M, 2003, BIOPHYS J, V85, P3839, DOI 10.1016/S0006-3495(03)74798-5
   JOKELA P, 1987, J PHYS CHEM-US, V91, P3291, DOI 10.1021/j100296a037
   Jung SH, 2009, INT J PHARMACEUT, V382, P254, DOI 10.1016/j.ijpharm.2009.08.002
   KALER EW, 1989, SCIENCE, V245, P1371, DOI 10.1126/science.2781283
   Kar S, 2011, PROTEIN PEPTIDE LETT, V18, P886, DOI 10.2174/092986611796011428
   Karim KM, 2010, J ADV PHARM TECHNOL, V1, P374, DOI 10.4103/0110-5558.76435
   Kaur IP, 2008, J CONTROL RELEASE, V127, P97, DOI 10.1016/j.jconrel.2007.12.018
   Kayser O, 2005, CURR PHARM BIOTECHNO, V6, P3
   Kim BS, 2008, ACS NANO, V2, P386, DOI 10.1021/nn700408z
   Kim JK, 2014, ARCH PHARM RES, V37, P60, DOI 10.1007/s12272-013-0280-6
   Kim JS, 1995, J BIOL CHEM, V270, P31097, DOI 10.1074/jbc.270.52.31097
   Kim TY, 2004, CLIN CANCER RES, V10, P3708, DOI 10.1158/1078-0432.CCR-03-0655
   Kim YS, 2012, TUMOR BIOL, V33, P573, DOI 10.1007/s13277-011-0286-y
   Kirpotin DB, 2006, CANCER RES, V66, P6732, DOI 10.1158/0008-5472.CAN-05-4199
   Koo OM, 2005, NANOMED-NANOTECHNOL, V1, P193, DOI 10.1016/j.nano.2005.06.004
   Koo OM, 2005, NANOMED-NANOTECHNOL, V1, P77, DOI 10.1016/j.nano.2004.11.002
   Krishnadas A, 2003, PHARMACEUT RES, V20, P297, DOI 10.1023/A:1022243709003
   Kristl J, 2003, EUR J PHARM SCI, V19, P181, DOI 10.1016/S0928-0987(03)00104-0
   Kubik T, 2005, CURR PHARM BIOTECHNO, V6, P17
   Kwon GS, 2003, CRIT REV THER DRUG, V20, P357, DOI 10.1615/CritRevTherDrugCarrierSyst.v20.i5.20
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   LaVan DA, 2003, NAT BIOTECHNOL, V21, P1184, DOI 10.1038/nbt876
   Lavasanifar A, 2002, ADV DRUG DELIVER REV, V54, P169, DOI 10.1016/S0169-409X(02)00015-7
   Le Garrec D., 2004, AM J DRUG DELIV, V2, P15, DOI DOI 10.1175/9038(04)0002-1
   Le Meins JF, 2011, EUR PHYS J E, V34, DOI 10.1140/epje/i2011-11014-y
   Lee ES, 2005, J CONTROL RELEASE, V103, P405, DOI 10.1016/j.jconrel.2004.12.018
   Lee ES, 2003, J CONTROL RELEASE, V91, P103, DOI 10.1016/S0168-3659(03)00239-6
   Letchford K, 2007, EUR J PHARM BIOPHARM, V65, P259, DOI 10.1016/j.ejpb.2006.11.009
   Levine DH, 2008, METHODS, V46, P25, DOI 10.1016/j.ymeth.2008.05.006
   Li Y, 2000, PHARMACEUT RES, V17, P607, DOI 10.1023/A:1007529218802
   Li ZB, 2006, MACROMOLECULES, V39, P765, DOI 10.1021/ma052199b
   Loh XJ, 2014, CHEM COMMUN, V50, P3033, DOI 10.1039/c3cc49074b
   Mai YY, 2012, CHEM SOC REV, V41, P5969, DOI 10.1039/c2cs35115c
   Mainardes RM, 2004, CURR DRUG TARGETS, V5, P449, DOI 10.2174/1389450043345407
   Manconi M, 2006, INT J PHARM, V311, P11, DOI 10.1016/j.ijpharm.2005.11.045
   Marianecci C, 2014, ADV COLLOID INTERFAC, V205, P187, DOI 10.1016/j.cis.2013.11.018
   Marsden HR, 2011, CHEM SOC REV, V40, P1572, DOI 10.1039/c0cs00115e
   Matsumura Y, 2004, BRIT J CANCER, V91, P1775, DOI 10.1038/sj.bjc.6602204
   McDevitt MR, 1999, APPL RADIAT ISOTOPES, V50, P895, DOI 10.1016/S0969-8043(98)00151-1
   Meng FH, 2009, BIOMACROMOLECULES, V10, P197, DOI 10.1021/bm801127d
   Miederer M, 2008, ADV DRUG DELIVER REV, V60, P1371, DOI 10.1016/j.addr.2008.04.009
   Min KH, 2008, J CONTROL RELEASE, V127, P208, DOI 10.1016/j.jconrel.2008.01.013
   Mishra B, 2010, NANOMED-NANOTECHNOL, V6, P9, DOI 10.1016/j.nano.2009.04.008
   Mo XQ, 2008, BIOPHYS J, V94, P1807, DOI [10.1529/biophysj.107.118299, 10.1529/hiophysj.107.118299]
   Moghimi SM, 2003, PROG LIPID RES, V42, P463, DOI 10.1016/S0163-7827(03)00033-X
   Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173
   Moses MA, 2003, CANCER CELL, V4, P337, DOI 10.1016/S1535-6108(03)00276-9
   Mourya VK, 2009, J MATER SCI-MATER M, V20, P1057, DOI 10.1007/s10856-008-3659-z
   Muller RH, 2000, EUR J PHARM BIOPHARM, V50, P161, DOI 10.1016/S0939-6411(00)00087-4
   Nagai A, 2007, J NANOSCI NANOTECHNO, V7, P2246, DOI 10.1166/jnn.2007.647
   Needham D., 2000, MECHANOCHEMISTRY LIP
   Nigavekar SS, 2004, PHARM RES, V21, P476, DOI 10.1023/B:PHAM.0000019302.26097.cc
   Ning SH, 2011, SOFT MATTER, V7, P9394, DOI 10.1039/c1sm05814b
   Ojugo ASE, 1999, NMR BIOMED, V12, P495, DOI 10.1002/(SICI)1099-1492(199912)12:8<495::AID-NBM594>3.0.CO;2-K
   Patil YB, 2009, BIOMATERIALS, V30, P859, DOI 10.1016/j.biomaterials.2008.09.056
   Pawar R, 2004, EXPERT OPIN BIOL TH, V4, P1203, DOI 10.1517/14712598.4.8.1203
   Percec V, 2010, SCIENCE, V328, P1009, DOI 10.1126/science.1185547
   Pollock S, 2010, FASEB J, V24, P1866, DOI 10.1096/fj.09-145755
   PORTE G, 1983, J PHYS CHEM-US, V87, P3541, DOI 10.1021/j100241a036
   Pramod PS, 2015, NANOSCALE, V7, P6636, DOI 10.1039/c5nr00799b
   Pramod PS, 2014, NANOSCALE, V6, P11841, DOI 10.1039/c4nr03514c
   Prasad V, 2007, DRUG DELIV, V14, P75, DOI 10.1080/10717540600642431
   Quintana A, 2002, PHARM RES-DORDR, V19, P1310, DOI 10.1023/A:1020398624602
   Rad-Malekshahi M, 2015, J AM CHEM SOC, V137, P7775, DOI 10.1021/jacs.5b02919
   Rajagopal K, 2004, CURR OPIN STRUC BIOL, V14, P480, DOI 10.1016/j.sbi.2004.06.006
   Read ES, 2007, CHEM COMMUN, P3021, DOI 10.1039/b701217a
   Ropponen J, 2004, ORG LETT, V6, P2495, DOI 10.1021/ol049555f
   Rosen BM, 2009, CHEM REV, V109, P6275, DOI 10.1021/cr900157q
   Rughani RV, 2008, MRS BULL, V33, P530, DOI 10.1557/mrs2008.106
   Sagar GH, 2007, INDIAN J EXP BIOL, V45, P133
   Sahoo SK, 2007, NANOMED-NANOTECHNOL, V3, P20, DOI 10.1016/j.nano.2006.11.008
   Sallach RE, 2006, J AM CHEM SOC, V128, P12014, DOI 10.1021/ja0638509
   Samad Abdus, 2007, Current Drug Delivery, V4, P297, DOI 10.2174/156720107782151269
   Santoso S, 2002, NANO LETT, V2, P687, DOI [10.1021/nl025563i, 10.1021/n1025563i]
   Sartor Oliver, 2003, Curr Oncol Rep, V5, P258, DOI 10.1007/s11912-003-0119-2
   Shen HW, 1999, J AM CHEM SOC, V121, P2728, DOI 10.1021/ja983712m
   Shen XC, 2006, J NANOSCI NANOTECHNO, V6, P837, DOI 10.1166/jnn.2006.126
   Shi JJ, 2010, NANO LETT, V10, P3223, DOI 10.1021/nl102184c
   Sinaga A, 2007, BIOMACROMOLECULES, V8, P2801, DOI 10.1021/bm700491q
   Sofou S, 2004, J NUCL MED, V45, P253
   Sofou S, 2007, BIOCONJUGATE CHEM, V18, P2061, DOI 10.1021/bc070075t
   Srinivas G, 2004, NAT MATER, V3, P638, DOI 10.1038/nmat1185
   Sukthankar P, 2015, LANGMUIR, V31, P2946, DOI 10.1021/la504381y
   Sukthankar P, 2013, LANGMUIR, V29, P14648, DOI 10.1021/la403492n
   Sukthankar P, 2014, BBA-BIOMEMBRANES, V1838, P2296, DOI 10.1016/j.bbamem.2014.02.005
   Sun J, 2008, LANGMUIR, V24, P10099, DOI 10.1021/la8013877
   Takeuchi H, 1998, INT J PHARM, V164, P103, DOI 10.1016/S0378-5173(97)00404-3
   Takeuchi H, 2001, J CONTROL RELEASE, V75, P83, DOI 10.1016/S0168-3659(01)00368-6
   TANFORD C, 1980, HYDROPHOBIC EFFECT F
   Tanisaka H, 2008, BIOCONJUGATE CHEM, V19, P109, DOI 10.1021/bc7001665
   ten Tije AJ, 2003, CLIN PHARMACOKINET, V42, P665, DOI 10.2165/00003088-200342070-00005
   Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632
   Torchilin VP, 2001, BIOMATERIALS, V22, P3035, DOI 10.1016/S0142-9612(01)00050-3
   Trent A, 2011, SOFT MATTER, V7, P9572, DOI 10.1039/c1sm05862b
   Tripathi PK, 2002, PHARMAZIE, V57, P261
   Tsonchev S, 2004, NANO LETT, V4, P427, DOI 10.1021/nl0351439
   Tu RS, 2004, ADV DRUG DELIVER REV, V56, P1537, DOI 10.1016/j.addr.2003.10.047
   Uchegbu IF, 1998, INT J PHARM, V172, P33, DOI 10.1016/S0378-5173(98)00169-0
   van Hell AJ, 2007, BIOMACROMOLECULES, V8, P2753, DOI 10.1021/bm0704267
   van Hell AJ, 2010, J CONTROL RELEASE, V141, P347, DOI 10.1016/j.jconrel.2009.09.012
   Vanlerberghe G., 1978, PHYSICOCHIMIE COMPOS, P303
   Vauthey S, 2002, P NATL ACAD SCI USA, V99, P5355, DOI 10.1073/pnas.072089599
   Velichko YS, 2008, J PHYS CHEM B, V112, P2326, DOI 10.1021/jp074420n
   Verma A, 2008, NAT MATER, V7, P588, DOI 10.1038/nmat2202
   Voets IK, 2006, ANGEW CHEM INT EDIT, V45, P6673, DOI 10.1002/anie.200601000
   von Maltzahn G, 2003, LANGMUIR, V19, P4332, DOI 10.1021/la026526+
   Vonarbourg A, 2006, BIOMATERIALS, V27, P4356, DOI 10.1016/j.biomaterials.2006.03.039
   Wang L, 2009, COLLOID SURFACE B, V74, P284, DOI 10.1016/j.colsurfb.2009.07.032
   Warriner HE, 1996, SCIENCE, V271, P969, DOI 10.1126/science.271.5251.969
   Wissing SA, 2004, ADV DRUG DELIVER REV, V56, P1257, DOI 10.1016/j.addr.2003.12.002
   Wu H, 2013, BIOMATERIALS, V34, P1213, DOI 10.1016/j.biomaterials.2012.08.072
   Xu H, 2009, LANGMUIR, V25, P4115, DOI 10.1021/la802499n
   Yang SJ, 2006, SUPRAMOL CHEM, V18, P389, DOI 10.1080/10615800600658586
   Yasam VR, 2014, DRUG DELIV, V21, P243, DOI 10.3109/10717544.2013.841783
   YOSHIOKA T, 1994, INT J PHARM, V105, P1, DOI 10.1016/0378-5173(94)90228-3
   Yu K, 1998, MACROMOLECULES, V31, P3509, DOI 10.1021/ma971419l
   YU ZJ, 1993, J COLLOID INTERF SCI, V156, P325, DOI 10.1006/jcis.1993.1119
   Zara GP, 2002, J DRUG TARGET, V10, P327, DOI 10.1080/10611860290031868
   Zhang JA, 2005, EUR J PHARM BIOPHARM, V59, P177, DOI 10.1016/j.ejpb.2004.06.009
   Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
   Zhao XB, 2010, CHEM SOC REV, V39, P3480, DOI 10.1039/b915923c
   Zhao XB, 2009, SOFT MATTER, V5, P1630, DOI 10.1039/b807149g
   Zhivotovsky B, 1998, NATURE, V391, P449, DOI 10.1038/35060
NR 202
TC 7
Z9 7
U1 3
U2 52
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2016
VL 596
BP 22
EP 42
DI 10.1016/j.abb.2016.02.027
PG 21
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA DK0UE
UT WOS:000374626900003
PM 26926258
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Kobolak, J
   Dinnyes, A
   Memic, A
   Khademhosseini, A
   Mobasheri, A
AF Kobolak, Julianna
   Dinnyes, Andras
   Memic, Adnan
   Khademhosseini, Ali
   Mobasheri, Ali
TI Mesenchymal stem cells: Identification, phenotypic characterization,
   biological properties and potential for regenerative medicine through
   biomaterial micro-engineering of their niche
SO METHODS
LA English
DT Article
DE Mesenchymal stem cell (MSC); Regenerative medicine; CD markers;
   Micro-engineering; Stem cell niche; Biomaterials
ID MARROW STROMAL CELLS; HUMAN UMBILICAL-CORD; 3D CULTURE-SYSTEMS;
   BONE-MARROW; IN-VITRO; PROGENITOR CELLS; STEM/PROGENITOR CELLS;
   CLINICAL-APPLICATIONS; SELF-RENEWAL; DIFFERENTIATION
AB Mesenchymal stem cells (MSCs) are multipotent stem cells. Although they were originally identified in bone marrow and described as 'marrow stromal cells', they have since been identified in many other anatomical locations in the body. MSCs can be isolated from bone marrow, adipose tissue, umbilical cord and other tissues but the richest tissue source of MSCs is fat. Since they are adherent to plastic, they may be expanded in vitro. MSCs have a distinct morphology and express a specific set of CD (cluster of differentiation) molecules. The phenotypic pattern for the identification of MSCs cells requires expression of CD73, CD90, and CD105 and lack of CD34, CD45, and HLA-DR antigens. Under appropriate micro-environmental conditions MSCs can proliferate and give rise to other cell types. Therefore, they are ideally suited for the treatment of systemic inflammatory and autoimmune conditions. They have also been implicated as key players in regenerating injured tissue following injury and trauma. MSC populations isolated from adipose tissue may also contain regulatory T (Treg) cells, which have the capacity for modulating the immune system. The immunoregulatory and regenerative properties of MSCs make them ideal for use as therapeutic agents in vivo. In this paper we review the literature on the identification, phenotypic characterization and biological properties of MSCs and discuss their potential for applications in cell therapy and regenerative medicine. We also discuss strategies for biomaterial micro-engineering of the stem cell niche. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Kobolak, Julianna; Dinnyes, Andras] Biotalentum Ltd, H-2100 Godollo, Hungary.
   [Dinnyes, Andras] Szent Istvan Univ, H-2100 Godollo, Hungary.
   [Dinnyes, Andras] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, NL-3584 CL Utrecht, Netherlands.
   [Memic, Adnan] King Abdulaziz Univ, Ctr Nanotechnol, Jeddah 21589, Saudi Arabia.
   [Khademhosseini, Ali] Harvard Univ, Ctr Biomed Engn, Dept Med, Brigham & Womens Hosp,Med Sch, Cambridge, MA 02139 USA.
   [Khademhosseini, Ali] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Khademhosseini, Ali] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
   [Khademhosseini, Ali] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan.
   [Mobasheri, Ali] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 7XH, Surrey, England.
   [Mobasheri, Ali] Univ Nottingham, Arthrit Res UK Ctr Sport Exercise & Osteoarthrit, MRC, Arthrit Res UK Pain Ctr,Queens Med Ctr, Nottingham NG7 2UH, England.
   [Mobasheri, Ali] Univ Nottingham, Arthrit Res UK Ctr Musculoskeletal Ageing Res, Queens Med Ctr, Nottingham NG7 2UH, England.
   [Mobasheri, Ali] King Abdulaziz Univ, CEGMR, KFMRC, Fac Appl Med Sci, Jeddah 21589, Saudi Arabia.
RP Mobasheri, A (reprint author), Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 7XH, Surrey, England.
EM julianna.kobolak@biotalentum.hu; andras.dinnyes@biotalentum.hu;
   amemic@kau.edu.sa; akhademhosseini@rics.bwh.harvard.edu;
   a.mobasheri@surrey.ac.uk
RI Mobasheri, Ali/D-5770-2011; Memic, Adnan/I-6138-2013
OI Mobasheri, Ali/0000-0001-6261-1286; Memic, Adnan/0000-0003-4639-8168;
   Khademhosseini, Ali/0000-0001-6322-8852; Kobolak,
   Julianna/0000-0002-0986-9517; Dinnyes, Andras/0000-0003-3791-2583
CR Agarwal P, 2013, LAB CHIP, V13, P4525, DOI 10.1039/c3lc50678a
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Andreeva ER, 1998, TISSUE CELL, V30, P127, DOI 10.1016/S0040-8166(98)80014-1
   Arnhold S, 2007, GRAEF ARCH CLIN EXP, V245, P414, DOI 10.1007/s00417-006-0382-7
   Baharvand H, 2006, INT J DEV BIOL, V50, P645, DOI 10.1387/ijdb.052072hb
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Bruno S., 2015, IMMUNOL LETT
   Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131
   Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003
   Chen YS, 2012, STEM CELL TRANSL MED, V1, P83, DOI 10.5966/sctm.2011-0022
   Cook D, 2013, ADV EXP MED BIOL, V786, P213, DOI 10.1007/978-94-007-6621-1_12
   Cosson S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04462
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   De Bari C, 2001, ARTHRITIS RHEUM, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P
   Dennis JE, 1999, J BONE MINER RES, V14, P700, DOI 10.1359/jbmr.1999.14.5.700
   Dolatshahi-Pirouz A, 2014, SCI REP-UK, V4, DOI 10.1038/srep03896
   Dolatshahi-Pirouz Alireza, 2011, J Funct Biomater, V2, P88, DOI 10.3390/jfb2030088
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Duffy MM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt75
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x
   Fan CG, 2005, CELL TRANSPLANT, V14, P311, DOI 10.3727/000000005783983070
   Feng JF, 2011, P NATL ACAD SCI USA, V108, P6503, DOI 10.1073/pnas.1015449108
   FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009
   Fu XB, 2006, WOUND REPAIR REGEN, V14, P325, DOI 10.1111/j.1743-6109.2006.00128.x
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Haynesworth SE, 1996, J CELL PHYSIOL, V166, P585, DOI 10.1002/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.3.CO;2-7
   Hwang YS, 2009, P NATL ACAD SCI USA, V106, P16978, DOI 10.1073/pnas.0905550106
   Hynes K, 2014, STEM CELLS DEV, V23, P1084, DOI 10.1089/scd.2013.0111
   in 'tAnker PS, 2003, BLOOD, V102, P1548, DOI 10.1182/blood-2003-04-1291
   Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Kierszenbaum A, HISTOLOGY CELL BIOL
   Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116
   Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711
   Kuznetsov SA, 2001, J CELL BIOL, V153, P1133, DOI 10.1083/jcb.153.5.1133
   Lindroos B, 2011, STEM CELL REV REP, V7, P269, DOI 10.1007/s12015-010-9193-7
   Lund AW, 2009, TISSUE ENG PART B-RE, V15, P371, DOI [10.1089/ten.teb.2009.0270, 10.1089/ten.TEB.2009.0270]
   Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298
   Markert LD, 2009, STEM CELLS DEV, V18, P1331, DOI 10.1089/scd.2009.0114
   McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66
   Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932
   Memic A, 2014, ORGANOGENESIS, V10, P299, DOI 10.4161/org.29646
   Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34
   Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046
   Munoz-Elias G, 2004, J NEUROSCI, V24, P4585, DOI 10.1523/JNEUROSCI.5060-03.2004
   Nakagawa H, 2005, BRIT J DERMATOL, V153, P29, DOI 10.1111/j.1365-2133.2005.06554.x
   Nakashima M., 2013, ENDODONTIC TOPICS, V28, P38
   Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716
   Nery AA, 2013, CYTOM PART A, V83A, P48, DOI 10.1002/cyto.a.22205
   Nichol JW, 2009, SOFT MATTER, V5, P1312, DOI 10.1039/b814285h
   Noort WA, 2002, EXP HEMATOL, V30, P870, DOI 10.1016/S0301-472X(02)00820-2
   Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100
   Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Prasad VK, 2011, BIOL BLOOD MARROW TR, V17, P534, DOI 10.1016/j.bbmt.2010.04.014
   Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62
   Rasmusson I, 2006, EXP CELL RES, V312, P2169, DOI 10.1016/j.yexcr.2006.03.019
   Ratajczak MZ, 2015, LEUKEMIA, V29, P776, DOI 10.1038/leu.2014.346
   Riordan NH, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-29
   Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572
   Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307
   Schwartz RE, 2002, J CLIN INVEST, V109, P1291, DOI 10.1172/JCI200215182
   Slack JMW, 2000, SCIENCE, V287, P1431, DOI 10.1126/science.287.5457.1431
   Sommer L., 2006, ADV EXP MED BIOL, V589, P197
   Takahashi N, 1999, BIOCHEM BIOPH RES CO, V256, P449, DOI 10.1006/bbrc.1999.0252
   Tang DQ, 2004, DIABETES, V53, P1721, DOI 10.2337/diabetes.53.7.1721
   Tay CY, 2010, EXP CELL RES, V316, P1159, DOI 10.1016/j.yexcr.2010.02.010
   Tian XF, 2008, SCAND J CLIN LAB INV, V68, P58, DOI 10.1080/00365510701466416
   WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212
   Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013
   Wang SH, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-19
   Wang Y, 2007, J TISSUE ENG REGEN M, V1, P39, DOI 10.1002/term.6
   Williams JT, 1999, AM SURGEON, V65, P22
   Yang F, 2010, BIOMACROMOLECULES, V11, P1909, DOI 10.1021/bm100357t
   Ye Z, 2008, HEPATOB PANCREAT DIS, V7, P608
   Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004
   Young RG, 1998, J ORTHOPAED RES, V16, P406, DOI 10.1002/jor.1100160403
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 87
TC 34
Z9 36
U1 1
U2 41
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
EI 1095-9130
J9 METHODS
JI Methods
PD APR 15
PY 2016
VL 99
BP 62
EP 68
DI 10.1016/j.ymeth.2015.09.016
PG 7
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DJ8AX
UT WOS:000374435600008
PM 26384580
DA 2018-10-19
ER

PT J
AU Hu, JJ
   Hu, K
   Cheng, YY
AF Hu, Jingjing
   Hu, Ke
   Cheng, Yiyun
TI Tailoring the dendrimer core for efficient gene delivery
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Dendrimer; Core effect; Gene delivery; Flexibility; Hydrophobicity
ID DENDRON-BEARING LIPIDS; SMALL INTERFERING RNA; SURFACE-ENGINEERED
   DENDRIMERS; STAR-SHAPED POLYMER; SIRNA DELIVERY; IN-VITRO; PAMAM
   DENDRIMERS; DRUG-DELIVERY; POLYAMIDOAMINE DENDRIMERS; BIOMEDICAL
   APPLICATIONS
AB Dendrimers have been widely used as non-viral gene vectors due to well-defined chemical structures, high density of cationic charges and ease of surface modification. Although a large number of studies have reported the important roles of dendrimer architecture, component, generation and surface functionality in gene delivery, the effect of dendrimer core on this issue still remains unclear. Recent literatures suggest that a slight alternation in dendrimer core has a profound effect in the transfection efficacy and biocompatibility. In this review, we will discuss the transfection mechanism of dendrimers with different types of cores in respect of flexibility, hydrophobicity and functionality. We hope to open a possibility of designing efficient dendrimers for gene delivery by choosing a proper dendrimer core.
   Statement of Significance
   As a branch of researches on dendrimers and dendritic polymers, the design of biocompatible and high efficient polymeric gene carriers has attracted increasing attentions during these years. Although the effect of dendrimer generation, species, architecture and surface functionality on gene delivery have been widely reported, the effect of dendrimer core on this issue still remains unclear. Recent literatures suggest that a minor variation on the dendrimer core has a profound effect in the transfection efficacy and biocompatibility. This critical review summarized the dendrimers with different types of cores and discussed the transfection mechanism with particular focus on the flexibility, hydrophobicity, and functionality. It is hoped to provide a new insight to design efficient and safe dendrimer-based gene vectors by choosing a proper core.
   To the best of our knowledge, this is the first review on the effect of dendrimer core on gene delivery. The findings obtained in this filed are of central importance in the design of efficient polymeric gene vectors. This article will appeal a wide readership such as physical chemist, dendrimer chemist, biological chemist, pharmaceutical scientist, and biomaterial researchers. We hope that this review article can be published by Acta Biomaterialia, a top journal that publishes important reviews in the field of biomaterials science. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Hu, Jingjing; Cheng, Yiyun] E China Normal Univ, Shanghai Key Lab Regulatory Biol, Sch Life Sci, Shanghai 200241, Peoples R China.
   [Hu, Ke] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Gynecol & Obstet, Shanghai 200127, Peoples R China.
RP Cheng, YY (reprint author), E China Normal Univ, Shanghai Key Lab Regulatory Biol, Sch Life Sci, Shanghai 200241, Peoples R China.
EM yycheng@mail.ustc.edu.cn
FU National Natural Science Foundation of China [21322405, 21474030,
   21404020]; Shanghai Municipal Science and Technology Commission
   [148014518]
FX We take financial supports from the National Natural Science Foundation
   of China (No. 21322405, No. 21474030 and No. 21404020) and the Shanghai
   Municipal Science and Technology Commission (148014518) on this work.
CR Albertazzi L, 2012, BIOMACROMOLECULES, V13, P4089, DOI 10.1021/bm301384y
   Arima H, 2014, CURR TOP MED CHEM, V14, P465, DOI 10.2174/1568026613666131219123610
   Arima H, 2013, ADV DRUG DELIVER REV, V65, P1204, DOI 10.1016/j.addr.2013.04.001
   Auwarter W, 2015, NAT CHEM, V7, P105, DOI 10.1038/nchem.2159
   Bonnet V, 2015, DRUG DISCOV TODAY, V20, P1120, DOI 10.1016/j.drudis.2015.05.008
   Carter KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4546
   Chang H, 2014, BIOCONJUGATE CHEM, V25, P342, DOI 10.1021/bc400496u
   Cheng HH, 2000, GENETICA, V108, P53, DOI 10.1023/A:1004047902652
   Cheng YY, 2014, SOFT MATTER, V10, P2714, DOI 10.1039/c3sm53180e
   Cheng YY, 2011, CHEM SOC REV, V40, P2673, DOI 10.1039/c0cs00097c
   Deng JJ, 2011, J MATER CHEM, V21, P5273, DOI 10.1039/c0jm03030a
   Dufes C, 2005, ADV DRUG DELIVER REV, V57, P2177, DOI 10.1016/j.addr.2005.09.017
   Fan JQ, 2013, SMALL, V9, P613, DOI 10.1002/smll.201201456
   Ghobril C, 2013, ANGEW CHEM INT EDIT, V52, P14070, DOI 10.1002/anie.201308007
   Gray WD, 2013, BIOMACROMOLECULES, V14, P101, DOI 10.1021/bm301393z
   HAENSLER J, 1993, BIOCONJUGATE CHEM, V4, P372, DOI 10.1021/bc00023a012
   Hayashi Y, 2012, MOL PHARMACEUT, V9, P1645, DOI 10.1021/mp200654g
   He DS, 2015, MACROMOL BIOSCI, V15, P600, DOI 10.1002/mabi.201400524
   Hu JJ, 2012, CHEM REV, V112, P3856, DOI 10.1021/cr200333h
   Hung CH, 2015, J BIOMED MATER RES A, V103, P1595, DOI 10.1002/jbm.a.35299
   Jones SP, 2008, CHEM COMMUN, P4700, DOI 10.1039/b811852c
   Jones SP, 2011, MOL PHARMACEUT, V8, P416, DOI 10.1021/mp100260c
   Kala S, 2014, J MED CHEM, V57, P2634, DOI 10.1021/jm401907z
   Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]
   Kaneshiro TL, 2007, MOL PHARM, V4, P759, DOI 10.1021/mp070036z
   Kannan RM, 2014, J INTERN MED, V276, P579, DOI 10.1111/joim.12280
   Kesharwani P, 2015, DRUG DISCOV TODAY, V20, P536, DOI 10.1016/j.drudis.2014.12.012
   Khan OF, 2014, ANGEW CHEM INT EDIT, V53, P14397, DOI 10.1002/anie.201408221
   Kim T, 2004, BIOMACROMOLECULES, V5, P2487, DOI 10.1021/bm049563j
   Kono K, 2012, BIOCONJUGATE CHEM, V23, P871, DOI 10.1021/bc200368b
   Lachelt U, 2015, CHEM REV, V115, P11043, DOI 10.1021/cr5006793
   Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171
   Liang B, 2013, CARBOHYD POLYM, V94, P185, DOI 10.1016/j.carbpol.2012.12.070
   Lim J, 2012, ADV DRUG DELIVER REV, V64, P826, DOI 10.1016/j.addr.2012.03.008
   Liu HM, 2012, J AM CHEM SOC, V134, P17680, DOI 10.1021/ja307290j
   Liu QL, 2012, SMALL, V8, P2070, DOI 10.1002/smll.201200158
   Liu XX, 2009, CHEMMEDCHEM, V4, P1302, DOI 10.1002/cmdc.200900076
   Liu XX, 2014, BIOTECHNOL ADV, V32, P844, DOI 10.1016/j.biotechadv.2013.08.001
   Liu XX, 2012, MOL PHARMACEUT, V9, P470, DOI 10.1021/mp2006104
   Liu XX, 2011, BIOCONJUGATE CHEM, V22, P2461, DOI 10.1021/bc200275g
   Liu ZH, 2010, PROG POLYM SCI, V35, P1144, DOI 10.1016/j.progpolymsci.2010.04.007
   Luo K, 2014, BIOTECHNOL ADV, V32, P818, DOI 10.1016/j.biotechadv.2013.12.008
   Ma D, 2014, BIOMATERIALS, V35, P4357, DOI 10.1016/j.biomaterials.2014.01.070
   Ma D, 2013, MACROMOL BIOSCI, V13, P1221, DOI 10.1002/mabi.201300139
   Ma XP, 2009, J AM CHEM SOC, V131, P14795, DOI 10.1021/ja9037406
   Merkel OM, 2010, MOL PHARMACEUT, V7, P969, DOI 10.1021/mp100101s
   Merkel OM, 2009, BIOCONJUGATE CHEM, V20, P1799, DOI 10.1021/bc900243r
   NEWKOME GR, 1985, J ORG CHEM, V50, P2003, DOI 10.1021/jo00211a052
   Nishiyama N, 2005, NAT MATER, V4, P934, DOI 10.1038/nmat1524
   Nomoto T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4545
   Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775
   Posocco P, 2013, MOL PHARMACEUT, V10, P3262, DOI 10.1021/mp400329g
   Rodrigo AC, 2011, BIOMACROMOLECULES, V12, P1205, DOI 10.1021/bm1014987
   Somani S, 2014, NANOMEDICINE-UK, V9, P2403, DOI [10.2217/NNM.14.130, 10.2217/nnm.14.130]
   Stanwix H, 2012, NANOMEDICINE-UK, V7, P953, DOI [10.2217/nnm.12.81, 10.2217/NNM.12.81]
   Sun QH, 2014, ADV MATER, V26, P7615, DOI 10.1002/adma.201401554
   Svenson S, 2005, ADV DRUG DELIVER REV, V57, P2106, DOI 10.1016/j.addr.2005.09.018
   Takahashi T, 2005, BIOCONJUGATE CHEM, V16, P1160, DOI 10.1021/bc050012f
   Takahashi T, 2003, BIOCONJUGATE CHEM, V14, P764, DOI 10.1021/bc025663f
   Takahashi T, 2007, BIOCONJUGATE CHEM, V18, P1349, DOI 10.1021/bc060311k
   Tang JB, 2011, J CONTROL RELEASE, V152, pE89, DOI 10.1016/j.jconrel.2011.08.142
   Tang MX, 1996, BIOCONJUGATE CHEM, V7, P703, DOI 10.1021/bc9600630
   Tian WD, 2013, CHEM SOC REV, V42, P705, DOI 10.1039/c2cs35306g
   Tomalia DA, 2005, PROG POLYM SCI, V30, P294, DOI 10.1016/j.progpolymsci.2005.01.007
   Tomalia DA, 2012, DENDRIMERS, DENDRONS, AND DENDRITIC POLYMERS: DISCOVERY, APPLICATIONS, AND THE FUTURE, P1, DOI 10.1017/CBO9781139048859
   van Vlerken LE, 2007, PHARM RES, V24, P1405, DOI 10.1007/s11095-007-9284-6
   Wagner E., 2014, ADV GENET, P231
   Wang H, 2015, ANGEW CHEM INT EDIT, V54, P11647, DOI 10.1002/anie.201501461
   Wang H, 2012, J PHYS CHEM B, V116, P11217, DOI 10.1021/jp3062916
   Wang MM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4053
   Wang Y, 2014, ADV MATER, V26, P4163, DOI 10.1002/adma.201400323
   Watkins DM, 1997, LANGMUIR, V13, P3136, DOI 10.1021/la9620263
   Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742
   Yang JP, 2015, CHEM REV, V115, P5274, DOI 10.1021/cr500542t
   Ye MZ, 2013, J CONTROL RELEASE, V169, P239, DOI 10.1016/j.jconrel.2013.01.034
   Yin R, 2014, NANOMED-NANOTECHNOL, V10, P795, DOI 10.1016/j.nano.2013.11.014
   Yu TZ, 2012, ANGEW CHEM INT EDIT, V51, P8478, DOI 10.1002/anie.201203920
   Yuba E, 2012, J CONTROL RELEASE, V160, P552, DOI 10.1016/j.jconrel.2012.04.002
   Zhang XQ, 2005, BIOMACROMOLECULES, V6, P341, DOI 10.1021/bm040060n
   Zhang Y, 2013, BIOMACROMOLECULES, V14, P4289, DOI 10.1021/bm4011563
   Zhou JH, 2006, CHEM COMMUN, P2362, DOI 10.1039/b601381c
   Zhou JH, 2011, MOL THER, V19, P2228, DOI 10.1038/mt.2011.207
   Zhou ZX, 2014, NANOMEDICINE-UK, V9, P2387, DOI [10.2217/NNM.14.133, 10.2217/nnm.14.133]
   Zhou ZX, 2014, ANGEW CHEM INT EDIT, V53, P10949, DOI 10.1002/anie.201406442
NR 84
TC 22
Z9 23
U1 9
U2 131
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 15
PY 2016
VL 35
BP 1
EP 11
DI 10.1016/j.actbio.2016.02.031
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DK8FI
UT WOS:000375162200001
PM 26923528
DA 2018-10-19
ER

PT J
AU Sanchez-Rodriguez, SP
   Moran-Garcia, AD
   Bolonduro, O
   Dordick, JS
   Bustos-Jaimes, I
AF Paola Sanchez-Rodriguez, Sandra
   del Carmen Moran-Garcia, Areli
   Bolonduro, Olurotimi
   Dordick, Jonathan S.
   Bustos-Jaimes, Ismael
TI Enhanced assembly and colloidal stabilization of primate
   erythroparvovirus 1 virus-like particles for improved surface
   engineering
SO ACTA BIOMATERIALIA
LA English
DT Article
DE In vitro assembly; Virus-like particles; Nanobiotechnology; Fluorescent
   labeling; Nanoparticle stabilization; Parvovirus B19
ID HUMAN PARVOVIRUS B19; DRUG-DELIVERY; EMPTY CAPSIDS; PROTEIN;
   NANOPARTICLES; PLATFORM; DISPLAY; CELLS
AB Virus-like particles (VLPs) are the product of the self-assembly, either in vivo or in vitro, of structural components of viral capsids. These particles are excellent scaffolds for surface display of biomolecules that can be used in vaccine development and tissue-specific drug delivery. Surface engineering of VLPs requires structural stability and chemical reactivity. Herein, we report the enhanced assembly, colloidal stabilization and fluorescent labeling of primate erythroparvovirus 1 (PE1V), generally referred to as parvovirus B19. In vitro assembly of the VP2 protein of PE1V produces VLPs, which are prone to flocculate and hence undergo limited chemical modification by thiol-specific reagents like the fluorogenic monobromobimane (mBBr). We determined that the addition of 0.2 M L-arginine during the assembly process produced an increased yield of soluble VLPs with good dispersion stability. Fluorescent labeling of VLPs suspended in phosphate buffered saline (PBS) added with 0.2 M L-Arg was achieved in significantly shorter times than the flocculated VLPs assembled in only PBS buffer. Finally, to demonstrate the potential application of this approach, mBBr-labeled VLPs were successfully used to tag human hepatoma HepG2 cells. This new method for assembly and labeling PE1V VLPs eases its applications and provides insights on the manipulation of this biomaterial for further developments.
   Statement of Significance
   Application of virus-derived biomaterials sometimes requires surface modification for diverse purposes, including enhanced cell-specific interaction, the inclusion of luminescent probes for bioimaging, or the incorporation of catalytic properties for the production of enzyme nanocarriers. In this research, we reported for the first time the colloidal stabilization of the primate erythroparvovirus 1 (PE1V) virus like particles (VLPs). Also, we report the chemical modification of the natural Cys residues located on the surface of these VLPs with a fluorescent probe, as well as its application for tagging hepatoma cells in vitro. Keeping in mind that PE1V is a human pathogen, virus-host interactions already exist in human cells, and they can be exploited for therapeutic and research aims. This study will impact on the speed in which the scientific community will be able to manipulate PEIV VLPs for diverse purposes. Additionally, this study may provide insights on the colloidal properties of these VLPs as well as in the effect of different protein additives used for protein stabilization. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Paola Sanchez-Rodriguez, Sandra; Bolonduro, Olurotimi; Dordick, Jonathan S.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA.
   [Paola Sanchez-Rodriguez, Sandra; del Carmen Moran-Garcia, Areli; Bustos-Jaimes, Ismael] Univ Nacl Autonoma Mexico, Fac Med, Dept Biochem, Mexico City 04510, DF, Mexico.
   [Dordick, Jonathan S.] Rensselaer Polytech Inst, Dept Biomed Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
   [Dordick, Jonathan S.] Rensselaer Polytech Inst, Dept Biol, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
RP Bustos-Jaimes, I (reprint author), Univ Nacl Autonoma Mexico, Fac Med, Dept Biochem, Mexico City 04510, DF, Mexico.
EM ismaelb@unam.mx
OI Bustos-Jaimes, Ismael/0000-0003-3038-8141; Bolonduro,
   Olurotimi/0000-0002-3210-0650
FU Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico
   [CB-2010-01-151189]; Programa de Apoyo a Proyectos de Investigacion e
   Innovacion Tecnologica (PAPIIT), UNAM [IN215613]
FX This work was funded by Consejo Nacional de Ciencia y Tecnologia
   (CONACyT), Mexico (grant CB-2010-01-151189) and Programa de Apoyo a
   Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), UNAM
   (grant IN215613). The authors acknowledge technical support of Laura
   Alvarez-Anorve.
CR Anderson L.J., 1997, MONOGR VIROL, V20, P153
   BROWN CS, 1991, J VIROL, V65, P2702
   Gallinella G., 2013, ISRN VIROL, V2013
   GERSTEIN M, 1992, ACTA CRYSTALLOGR A, V48, P271, DOI 10.1107/S0108767391012680
   Gilbert L, 2005, BIOCHEM BIOPH RES CO, V331, P527, DOI 10.1016/j.bbrc.2005.03.208
   Huang RK, 2011, NANOMEDICINE-UK, V6, P55, DOI 10.2217/NNM.10.99
   ICTV, 2015, VIR TAX 2014 REL
   KAJIGAYA S, 1991, P NATL ACAD SCI USA, V88, P4646, DOI 10.1073/pnas.88.11.4646
   KAJIGAYA S, 1989, P NATL ACAD SCI USA, V86, P7601, DOI 10.1073/pnas.86.19.7601
   Kamerzell TJ, 2011, ADV DRUG DELIVER REV, V63, P1118, DOI 10.1016/j.addr.2011.07.006
   Kaufmann B, 2004, P NATL ACAD SCI USA, V101, P11628, DOI 10.1073/pnas.0402992101
   Klem MT, 2008, J MATER CHEM, V18, P3821, DOI 10.1039/b805778h
   KOSOWER NS, 1987, METHOD ENZYMOL, V143, P76
   Manchester M, 2006, ADV DRUG DELIVER REV, V58, P1505, DOI 10.1016/j.addr.2006.09.014
   Mead G, 2014, BIOCONJUGATE CHEM, V25, P1444, DOI 10.1021/bc500200t
   NELSON CA, 1971, J BIOL CHEM, V246, P3895
   Ohtake S, 2011, ADV DRUG DELIVER REV, V63, P1053, DOI 10.1016/j.addr.2011.06.011
   Sanchez-Rodriguez SP, 2015, MOL BIOTECHNOL, V57, P309, DOI 10.1007/s12033-014-9823-4
   Prasuhn DE, 2008, CHEM BIOL, V15, P513, DOI 10.1616/j.chembiol.2008.03.018
   Ratha A, 2008, PNAS, V106, P1760
   Ren Y, 2007, BIOCONJUGATE CHEM, V18, P836, DOI 10.1021/bc060361p
   RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49
   Sanchez-Rodriguez S. P., 2010, CURRENT CHEM BIOL, V4, P231
   Sanchez-Rodriguez SP, 2012, BIOCHIMIE, V94, P870, DOI 10.1016/j.biochi.2011.12.006
   Santillan-Uribe JS, 2015, VIRUS RES, V201, P1, DOI 10.1016/j.virusres.2015.02.011
   Stephanopoulos N, 2009, ANGEW CHEM INT EDIT, V48, P9498, DOI 10.1002/anie.200902727
   Tsumoto K, 2004, BIOTECHNOL PROGR, V20, P1301, DOI 10.1021/bp0498793
   Tsumoto K, 2003, PROTEIN EXPRES PURIF, V28, P1, DOI 10.1016/S1046-5928(02)00641-1
   Udit AK, 2010, CHEMBIOCHEM, V11, P481, DOI 10.1002/cbic.201000001
   Yoo JW, 2011, NAT REV DRUG DISCOV, V10, P521, DOI 10.1038/nrd3499
   Yuan W, 2001, VIROLOGY, V279, P546, DOI 10.1006/viro.2000.0734
   Zeltins A, 2013, MOL BIOTECHNOL, V53, P92, DOI 10.1007/s12033-012-9598-4
NR 32
TC 5
Z9 5
U1 1
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 15
PY 2016
VL 35
BP 206
EP 214
DI 10.1016/j.actbio.2016.02.024
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DK8FI
UT WOS:000375162200019
PM 26911883
DA 2018-10-19
ER

PT J
AU Shimizu, T
   Fujibayashi, S
   Yamaguchi, S
   Yamamoto, K
   Otsuki, B
   Takemoto, M
   Tsukanaka, M
   Kizuki, T
   Matsushita, T
   Kokubo, T
   Matsuda, S
AF Shimizu, Takayoshi
   Fujibayashi, Shunsuke
   Yamaguchi, Seiji
   Yamamoto, Koji
   Otsuki, Bungo
   Takemoto, Mitsuru
   Tsukanaka, Masako
   Kizuki, Takashi
   Matsushita, Tomiharu
   Kokubo, Tadashi
   Matsuda, Shuichi
TI Bioactivity of sol-gel-derived TiO2 coating on polyetheretherketone: In
   vitro and in vivo studies
SO ACTA BIOMATERIALIA
LA English
DT Article
DE PEEK; Bioactivity; TiO2; Sol-gel; Sandblast; O-2 plasma
ID TISSUE-REACTIONS; ACETABULAR CUPS; PEEK IMPLANTS; CELL-ADHESION;
   ETHER-KETONE; BONE; TITANIUM; SURFACE; FIXATION; OXIDE
AB A polyetheretherketone (PEEK) surface was modified using a sol-gel-derived TiO2 coating in order to confer bone-bonding ability. To enhance the bonding strength of the coating layer, pretreatment with either O-2 plasma or sandblasting was performed prior to sol-gel coating. Additionally, post-treatment with acid was carried out to confer apatite (calcium phosphate)-forming ability to the surface. Biomechanical and histological analyses performed using an in vivo rabbit tibia model showed that PEEK surfaces modified with sol-gel-derived TiO2 and acid post-treatment had better bone-bonding properties than uncoated PEEK surfaces. These modified surfaces also performed well in terms of their in vitro cell responses due to their modified surface chemistries and topographies. Although O-2 plasma or sandblasting treatment were, for the most part, equivocal in terms of performance, we conclude that sol-gel-derived TiO2 coating followed by acid post-treatment significantly improves the bone bonding ability of PEEK surfaces, thus rendering them optimal for their use in surgical implants.
   Statement of Significance
   The role of polyetheretherketone (PEEK) as an alternative biomaterial to conventional metallic implant materials has become increasingly important. However, its low bone bonding ability is yet to be resolved. This in vivo and in vitro investigation on the functionalization of PEEK surfaces highlights the utility of this material in clinical interventions that require implants, and may extend range of applications of PEEK. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Shimizu, Takayoshi; Fujibayashi, Shunsuke; Otsuki, Bungo; Takemoto, Mitsuru; Tsukanaka, Masako; Matsuda, Shuichi] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto 6068507, Japan.
   [Yamaguchi, Seiji; Kizuki, Takashi; Matsushita, Tomiharu; Kokubo, Tadashi] Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, 1200 Matsumoto, Kasugai, Aichi 4878501, Japan.
   [Yamamoto, Koji] Kyoto Univ, Res & Educ Unit Leaders Integrated Med Syst, Ctr Promot Interdisciplinary Educ & Res, Kyoto 6068507, Japan.
RP Shimizu, T (reprint author), Kyoto Univ, Dept Orthoped Surg, Grad Sch Med, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.
EM takayosh@kuhp.kyoto-u.ac.jp
OI Otsuki, Bungo/0000-0002-4749-7830; Matsuda, Shuichi/0000-0003-0802-1255
CR [Anonymous], 2014, 233172014 ISO
   [Anonymous], 1994, GUID DOC TEST ORTH I
   Areva S, 2004, J BIOMED MATER RES A, V70A, P169, DOI 10.1002/jbm.a.20120
   Bacakova L, 2004, PHYSIOL RES, V53, pS35
   Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004
   Barkarmo S, 2013, J BIOMED MATER RES A, V101, P465, DOI 10.1002/jbm.a.34358
   BUMA P, 1995, J ARTHROPLASTY, V10, P389, DOI 10.1016/S0883-5403(05)80190-1
   Devine DM, 2013, J BIOMED MATER RES B, V101B, P591, DOI 10.1002/jbm.b.32861
   FURLONG RJ, 1991, J BONE JOINT SURG BR, V73, P741
   Johansson P, 2014, INT J NANOMED, V9, P3903, DOI 10.2147/IJN.S60387
   Jones FH, 2001, SURF SCI REP, V42, P79
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Kizuki T, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-014-5359-1
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kokubo T, 2000, KEY ENG MAT, V192-1, P3
   Kokubo T, 2008, J MATER SCI-MATER M, V19, P695, DOI 10.1007/s10856-007-3103-9
   Krzak-Ros J, 2009, ACTA BIOENG BIOMECH, V11, P21
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Lau D., 2015, J NEUROSURG, P1
   Lau D, 2013, NEUROSURGERY, V72, P529, DOI 10.1227/NEU.0b013e318282a558
   Lee JH, 2013, ACTA BIOMATER, V9, P6177, DOI 10.1016/j.actbio.2012.11.030
   Lee TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111390
   Manley MT, 1998, J BONE JOINT SURG AM, V80A, P1175, DOI 10.2106/00004623-199808000-00011
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   Nemoto O, 2014, EUR SPINE J, V23, P2150, DOI 10.1007/s00586-014-3466-9
   NEO M, 1992, J BIOMED MATER RES, V26, P1419, DOI 10.1002/jbm.820261103
   Nishiguchi S, 2003, J BIOMED MATER RES A, V67A, P26, DOI 10.1002/jbm.a.10540
   Ochsenbein A, 2008, ACTA BIOMATER, V4, P1506, DOI 10.1016/j.actbio.2008.03.012
   Olivares-Navarrete R, 2015, SPINE, V40, P399, DOI 10.1097/BRS.0000000000000778
   Olivares-Navarrete R, 2012, SPINE J, V12, P265, DOI 10.1016/j.spinee.2012.02.002
   Patsi ME, 1998, J SOL-GEL SCI TECHN, V11, P55, DOI 10.1023/A:1008684815735
   Pattanayak DK, 2011, J MATER SCI-MATER M, V22, P1803, DOI 10.1007/s10856-011-4372-x
   Rokkum M, 2003, J BONE JOINT SURG BR, V85B, P440, DOI 10.1302/0301-620X.85B3.12834
   Saito T, 2011, ACTA BIOMATER, V7, P1558, DOI 10.1016/j.actbio.2010.11.018
   Schimmel J. J., 2012, J SPINAL DISORDERS T
   Toth JM, 2006, BIOMATERIALS, V27, P324, DOI 10.1016/j.biomaterials.2005.07.011
   Vadapalli S, 2006, SPINE, V31, P2189, DOI 10.1097/01.brs.0000232720.23748.ce
   Wu GM, 2009, SURF COAT TECH, V203, P2755, DOI 10.1016/j.surfcoat.2009.02.115
   Wu WJ, 2012, EUR SPINE J, V21, P1374, DOI 10.1007/s00586-011-2131-9
   Wu XM, 2012, INT J NANOMED, V7, P1215, DOI 10.2147/IJN.S28101
NR 41
TC 13
Z9 13
U1 5
U2 50
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 15
PY 2016
VL 35
BP 305
EP 317
DI 10.1016/j.actbio.2016.02.007
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DK8FI
UT WOS:000375162200028
PM 26861855
DA 2018-10-19
ER

PT J
AU Wetteland, CL
   Nguyen, NYT
   Liu, HN
AF Wetteland, Cheyann Lee
   Nhu-Y Thi Nguyen
   Liu, Huinan
TI Concentration-dependent behaviors of bone marrow derived mesenchymal
   stem cells and infectious bacteria toward magnesium oxide nanoparticles
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Magnesium oxide (MgO) nanoparticles; Bone marrow derived mesenchymal
   stem cells (BMSCs); Cytocompatibility; Viability; Bacteria; Escherichia
   coli (E. coli); Staphylococcus epidermidis (S. epidermidis)
ID ANTIBACTERIAL PROPERTIES; TRICALCIUM PHOSPHATE; MGO NANOPARTICLES;
   ESCHERICHIA-COLI; STROMAL CELLS; IN-VITRO; DEGRADATION; HYDROXYAPATITE;
   ALLOYS; DIFFERENTIATION
AB This article reports the quantitative relationship between the concentration of magnesium oxide (MgO) nanoparticles and its distinct biological activities towards mammalian cells and infectious bacteria for the first time. The effects of MgO nanoparticles on the viability of bone marrow derived mesenchymal stem cells (BMSCs) and infectious bacteria (both gram-negative Escherichia coli and gram-positive Staphylococcus epidermidis) showed a concentration-dependent behavior in vitro. The critical concentrations of MgO nanoparticles identified in this study provided valuable guidelines for biomaterial design toward potential clinical translation. BMSCs density increased significantly when cultured in 200 mu g/mL of MgO in comparison to the Cells Only control without MgO. The density of BMSCs decreased significantly after culture in the media with 500 mu g/mL or more of MgO. Concentrations at or above 1000 mu g mL of MgO resulted in complete BMSCs death. Quantification of colony forming units (CFU) revealed that the minimum bactericidal concentration (MBC) of MgO for E. coli and S. epidermidis was 1200 mu g/mL. The addition of MgO nanoparticles into the cultures increased the pH and Mg2+ ion concentration in the respective culture media, which might have played a role in the observed cell responses but not the main factors. E. coli and S. epidermidis still proliferated significantly at alkaline pH up to 10 or with supplemental Mg2+ dosages up to 50 mM, indicating bactericidal properties of MgO are beyond the effects of increased media pH and me ion concentrations. MgO nanoparticles at a concentration of 200 mu g/mL provided dual benefits of promoting BMSC proliferation while reducing bacterial adhesion, which should be further studied for potential medical implant applications. The use of free MgO nanoparticles yielded detrimental effects to BMSCs in concentrations above 300 mu g/mL. We recommend further study into MgO nanoparticle as a coating material or as a part of a composite.
   Statement of Significance
   This article reports the quantitative relationship between the concentration of magnesium oxide (MgO) nanoparticles and its distinct biological activities towards mammalian cells and infectious bacteria for the first time. The effects of MgO nanoparticles on the viability of bone marrow derived mesenchymal stem cells (BMSCs) and infectious bacteria (both gram-negative Escherichia coli and gram-positive Staphylococcus epidermidis) showed a concentration-dependent behavior in vitro. The critical concentrations of MgO nanoparticles identified in this study provided valuable guidelines for biomaterial design toward potential clinical translation. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Wetteland, Cheyann Lee; Liu, Huinan] Univ Calif Riverside, Dept Bioengn, 900 Univ Ave, Riverside, CA 92521 USA.
   [Nhu-Y Thi Nguyen; Liu, Huinan] Univ Calif Riverside, Dept Microbiol, Riverside, CA 92521 USA.
   [Liu, Huinan] Univ Calif Riverside, Mat Sci & Engn Program, Riverside, CA 92521 USA.
   [Liu, Huinan] Univ Calif Riverside, Stem Cell Ctr, Riverside, CA 92521 USA.
RP Liu, HN (reprint author), Univ Calif Riverside, Dept Bioengn, 900 Univ Ave, Riverside, CA 92521 USA.
EM huinan.liu@ucr.edu
FU U.S. National Science Foundation (NSF) [CBET 1512764]; Burroughs
   Wellcome Fund [1011235]; Hellman Faculty Fellowship; NIH SBIR program
   [6R43DE023287]; University of California (UC) Regents Faculty Fellowship
FX The authors thank the support from the U.S. National Science Foundation
   (NSF award CBET 1512764), the Burroughs Wellcome Fund (1011235), the
   Hellman Faculty Fellowship (HL), NIH SBIR program (6R43DE023287), and
   the University of California (UC) Regents Faculty Fellowship (HL). The
   authors appreciate the Central Facility for Advanced Microscopy and
   Microanalysis (CFAMM) for the use of SEM FEI XL30 and TEM at the
   University of California at Riverside. The authors also thank the
   undergraduate student researchers (Vannessa Guzman, Hakikat Gill, and
   Jimmy Tran) for their assistance with pH measurements and ImageJ
   analysis.
CR Al-Hazmi F, 2012, SUPERLATTICE MICROST, V52, P200, DOI 10.1016/j.spmi.2012.04.013
   Carpenter TO, 2006, J CLIN ENDOCR METAB, V91, P4866, DOI 10.1210/jc.2006-1391
   Cipriano A., 2014, ACTA BIOMATER
   Cipriano AF, 2015, ACTA BIOMATER, V12, P298, DOI 10.1016/j.actbio.2014.10.018
   Cremet L, 2012, J INFECTION, V64, P169, DOI 10.1016/j.jinf.2011.11.010
   Dong CX, 2011, MATER RES BULL, V46, P576, DOI 10.1016/j.materresbull.2010.12.023
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Fielding GA, 2014, J BIOMED MATER RES A, V102, P2417, DOI 10.1002/jbm.a.34909
   FRUHWIRTH O, 1985, SURF TECHNOL, V24, P301, DOI 10.1016/0376-4583(85)90080-9
   Goldstein DA, 1990, CLIN METHODS HIST PH
   Grayson WL, 2015, NAT REV ENDOCRINOL, V11, P140, DOI 10.1038/nrendo.2014.234
   Hickey DJ, 2015, ACTA BIOMATER, V14, P175, DOI 10.1016/j.actbio.2014.12.004
   Honda MJ, 2007, BIOMATERIALS, V28, P680, DOI 10.1016/j.biomaterials.2006.09.039
   Iskandar ME, 2013, J BIOMED MATER RES A, V101, P2340, DOI 10.1002/jbm.a.34530
   Ito T., 1985, J CHEM SOC F1, V81, P10
   Jahnen-Dechent W, 2012, CLIN KIDNEY J, V5, P3, DOI 10.1093/ndtplus/sfr163
   Khandaker M, 2013, J BIOMECH, V46, P1035, DOI 10.1016/j.jbiomech.2012.12.006
   Krishnamoorthy K, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1063-6
   Kum CH, 2014, SMALL, V10, P3783, DOI 10.1002/smll.201302880
   Lee JY, 2009, INTEGR BIOL, V1, P460, DOI 10.1039/b905757a
   Leung YH, 2014, SMALL, V10, P1171, DOI 10.1002/smll.201302434
   Lew DP, 1997, NEW ENGL J MED, V336, P999, DOI 10.1056/NEJM199704033361406
   Liao JH, 2011, J ORTHOP RES, V29, P1544, DOI 10.1002/jor.21436
   Liu H, 2007, BIOMATERIALS, V28, P354, DOI 10.1016/j.biomaterials.2006.08.049
   Liu HN, 2011, J BIOMED MATER RES A, V99A, P249, DOI 10.1002/jbm.a.33188
   Lock JY, 2014, J BIOMED MATER RES A, V102, P781, DOI 10.1002/jbm.a.34741
   Mejias JA, 1999, CHEM PHYS LETT, V314, P558, DOI 10.1016/S0009-2614(99)00909-4
   Montero M, 2009, BIOCHEM J, V424, P129, DOI 10.1042/BJ20090980
   Mueller WD, 2009, J BIOMED MATER RES A, V90A, P487, DOI 10.1002/jbm.a.32106
   Nygren Hakan, 2014, J Funct Biomater, V5, P158, DOI 10.3390/jfb5030158
   Patel MK, 2013, BIOSENS BIOELECTRON, V45, P181, DOI 10.1016/j.bios.2012.12.055
   Pourdanesh F, 2014, MAT SCI ENG C-MATER, V40, P382, DOI 10.1016/j.msec.2014.04.018
   Rude R, 1996, FLUIDS ELECTROLYTES, P421
   Sales VL, 2007, TISSUE ENG, V13, P525, DOI 10.1089/ten.2006.0128
   Sawai J, 2003, J MICROBIOL METH, V54, P177, DOI 10.1016/S0167-7012(03)00037-X
   Sawai J, 2000, WORLD J MICROB BIOT, V16, P187, DOI 10.1023/A:1008916209784
   Simchi A, 2011, NANOMED-NANOTECHNOL, V7, P22, DOI 10.1016/j.nano.2010.10.005
   Tarafder S., 2014, J BIOMED MAT RES B
   Tarafder S, 2013, J TISSUE ENG REGEN M, V7, P631, DOI 10.1002/term.555
   US Nanomaterials Research Inc., 2015, MAGN OX MGO NAN
   Vallet-Regi M., 1998, J MATER CHEM, V9, P4
   Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k
   Yamamoto O., 2000, NANO LETT, V6, P1794
   YANAGISAWA Y, 1981, J PHYS SOC JPN, V50, P209, DOI 10.1143/JPSJ.50.209
   Yoshizawa S, 2014, ACTA BIOMATER, V10, P2834, DOI 10.1016/j.actbio.2014.02.002
   Zheng YF, 2014, MAT SCI ENG R, V77, P1, DOI 10.1016/j.mser.2014.01.001
NR 46
TC 12
Z9 12
U1 2
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 15
PY 2016
VL 35
BP 341
EP 356
DI 10.1016/j.actbio.2016.02.032
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DK8FI
UT WOS:000375162200031
PM 26923529
OA Other Gold
DA 2018-10-19
ER

PT J
AU Sadtler, K
   Estrellas, K
   Allen, BW
   Wolf, MT
   Fan, HN
   Tam, AJ
   Patel, CH
   Luber, BS
   Wang, H
   Wagner, KR
   Powell, JD
   Housseau, F
   Pardoll, DM
   Elisseeff, JH
AF Sadtler, Kaitlyn
   Estrellas, Kenneth
   Allen, Brian W.
   Wolf, Matthew T.
   Fan, Hongni
   Tam, Ada J.
   Patel, Chirag H.
   Luber, Brandon S.
   Wang, Hao
   Wagner, Kathryn R.
   Powell, Jonathan D.
   Housseau, Franck
   Pardoll, Drew M.
   Elisseeff, Jennifer H.
TI Developing a pro-regenerative biomaterial scaffold microenvironment
   requires T helper 2 cells
SO SCIENCE
LA English
DT Article
ID TH2-RESTRICTED IMMUNE-RESPONSE; MUSCLE REGENERATION; SKELETAL-MUSCLE;
   EXTRACELLULAR-MATRIX; IN-VIVO; MACROPHAGE; EXPRESSION; VACCINES; INNATE;
   GROWTH
AB Immune-mediated tissue regeneration driven by a biomaterial scaffold is emerging as an innovative regenerative strategy to repair damaged tissues. We investigated how biomaterial scaffolds shape the immune microenvironment in traumatic muscle wounds to improve tissue regeneration. The scaffolds induced a pro-regenerative response, characterized by an mTOR/Rictor-dependent T helper 2 pathway that guides interleukin-4-dependent macrophage polarization, which is critical for functional muscle recovery. Manipulating the adaptive immune system using biomaterials engineering may support the development of therapies that promote both systemic and local pro-regenerative immune responses, ultimately stimulating tissue repair.
C1 [Sadtler, Kaitlyn; Estrellas, Kenneth; Allen, Brian W.; Wolf, Matthew T.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Translat Tissue Engn Ctr, Wilmer Eye Inst, Baltimore, MD 21287 USA.
   [Sadtler, Kaitlyn; Estrellas, Kenneth; Allen, Brian W.; Wolf, Matthew T.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21287 USA.
   [Fan, Hongni; Tam, Ada J.; Patel, Chirag H.; Powell, Jonathan D.; Housseau, Franck; Pardoll, Drew M.] Johns Hopkins Univ, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Sch Med, Baltimore, MD 21231 USA.
   [Luber, Brandon S.; Wang, Hao] Johns Hopkins Univ, Div Biostat & Bioinformat, Sidney Kimmel Comprehens Canc Ctr, Sch Med, Baltimore, MD 21231 USA.
   [Wagner, Kathryn R.] Kennedy Krieger Inst, Hugo W Moser Res Inst, Baltimore, MD 21205 USA.
   [Wagner, Kathryn R.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
   [Wagner, Kathryn R.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.
   [Sadtler, Kaitlyn; Estrellas, Kenneth; Allen, Brian W.; Wolf, Matthew T.; Fan, Hongni; Tam, Ada J.; Patel, Chirag H.; Luber, Brandon S.; Wang, Hao; Powell, Jonathan D.; Housseau, Franck; Pardoll, Drew M.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Sch Med, Bloomberg Kimmel Inst Canc Immunotherapy, Baltimore, MD USA.
RP Elisseeff, JH (reprint author), Johns Hopkins Univ, Translat Tissue Engn Ctr, Wilmer Eye Inst, Baltimore, MD 21287 USA.; Elisseeff, JH (reprint author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21287 USA.
EM jhe@jhu.edu
FU Maryland Stem Cell Research Fund (MSCRF) [113345]; Armed Forces
   Institute for Regenerative Medicine; U.S. Department of Defense
   [W81XWH-11-2-0022]; Jules Stein Professorship from the Research to
   Prevent Blindness Foundation; Hartwell Foundation; Cancer Center Core
   grant [P30CA006973]; National Institutes of Health [R01AI077610];
   Bloomberg-Kimmel Institute for Cancer Immunotherapy
FX The authors acknowledge the Sidney Kimmel Comprehensive Cancer Center
   Flow Cytometry Research Core and L. Blosser for their help on flow
   cytometric studies; A. Anderson for assistance with adipogenesis
   studies; S. Sommerfeld and X. Wang for assistance with the clinical
   product testing; A. Rittenbach for assistance with computed tomography
   imaging; M. de Palma for generous donation of the iBMM macrophage cell
   line; M. Swartz and the Swartz lab for assistance in the pilot studies
   and J.H.E. sabbatical hosting; A. Ewald for helpful discussions; and J.
   Schneck for critical review. The data presented in this manuscript are
   tabulated in the main paper and in the supplementary materials. K.S.,
   F.H., D.P., and J.H.E. are inventors on provisional patent application
   no. 48317-502P01US, filed by Johns Hopkins University (JHU) related to
   regenerative immunology. J.H.E. holds equity in Aegeria Soft Tissue, a
   company that has licensed JHU intellectual property not directly related
   to the materials used in this study but similar enough that it may
   benefit from the results. The conflict is being managed by the Johns
   Hopkins Office of Policy Coordination. This work was funded by the
   Maryland Stem Cell Research Fund (MSCRF), grant 113345; the Armed Forces
   Institute for Regenerative Medicine; and U.S. Department of Defense
   grant W81XWH-11-2-0022 (awarded to J.H.E.) and the Jules Stein
   Professorship from the Research to Prevent Blindness Foundation. M.T.W.
   was supported by a postdoctoral fellowship from the Hartwell Foundation.
   D.M.P., J.D.P., B.S.L. and H.W. were supported by Cancer Center Core
   grant P30CA006973. J.D.P. was supported by a grant from the National
   Institutes of Health, R01AI077610. J.D.P, J.H.E., and D.M.P acknowledge
   support from the Bloomberg-Kimmel Institute for Cancer Immunotherapy.
CR Ali OA, 2014, CANCER RES, V74, P1670, DOI 10.1158/0008-5472.CAN-13-0777
   Ali OA, 2013, ADV FUNCT MATER, V23, P4621, DOI 10.1002/adfm.201203859
   Allman AJ, 2002, TISSUE ENG, V8, P53, DOI 10.1089/107632702753503054
   Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   Arsic N, 2004, MOL THER, V10, P844, DOI 10.1016/j.ymthe.2004.08.007
   Beachley VZ, 2015, NAT METHODS, V12, P1197, DOI 10.1038/nmeth.3619
   Blackwell J, 2015, J PHYSIOL SCI, V65, P145, DOI 10.1007/s12576-014-0350-7
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Davis ME, 2013, J APPL PHYSIOL, V115, P884, DOI 10.1152/japplphysiol.00137.2013
   Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005
   Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018
   Frantz S, 2005, CIRC RES, V96, P15, DOI 10.1161/01.RES.0000153188.68898.ac
   Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476
   Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053
   Horsley V, 2003, CELL, V113, P483, DOI 10.1016/S0092-8674(03)00319-2
   Kim J, 2011, NANO TODAY, V6, P466, DOI 10.1016/j.nantod.2011.08.005
   LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K
   Mase Vincent J Jr, 2010, Orthopedics, V33, P511, DOI 10.3928/01477447-20100526-24
   Matzinger P, 2011, NAT REV IMMUNOL, V11, P221, DOI 10.1038/nri2940
   Mourkioti F, 2005, TRENDS IMMUNOL, V26, P535, DOI 10.1016/j.it.2005.08.002
   Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008
   Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839
   Otis JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092363
   Peng Y, 2007, J AUTOIMMUN, V29, P303, DOI 10.1016/j.jaut.2007.07.017
   Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100
   Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106
   Salmon-Ehr V, 2000, LAB INVEST, V80, P1337, DOI 10.1038/labinvest.3780141
   Sicari BM, 2014, SCI TRANSL MED, V6, P234, DOI DOI 10.1126/SCITRANSLMED.3008085
   Sicari BM, 2012, TISSUE ENG PT A, V18, P1941, DOI [10.1089/ten.TEA.2012.0475, 10.1089/ten.tea.2012.0475]
   Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034
NR 33
TC 87
Z9 90
U1 11
U2 99
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD APR 15
PY 2016
VL 352
IS 6283
BP 366
EP 370
DI 10.1126/science.aad9272
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DJ1UK
UT WOS:000373990100046
PM 27081073
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Sun, F
   Jiang, Y
   Xu, YF
   Shi, HC
   Zhang, SQ
   Liu, XC
   Pan, S
   Ye, G
   Zhang, WD
   Zhang, FB
   Zhong, CH
AF Sun, Fei
   Jiang, Yuan
   Xu, Yanfei
   Shi, Hongcan
   Zhang, Siquan
   Liu, Xingchen
   Pan, Shu
   Ye, Gang
   Zhang, Weidong
   Zhang, Fangbiao
   Zhong, Chonghao
TI Genipin cross-linked decellularized tracheal tubular matrix for tracheal
   tissue engineering applications
SO SCIENTIFIC REPORTS
LA English
DT Article
ID LINKING AGENT GENIPIN; IN-VIVO; BIOLOGICAL TISSUES; NITRIC-OXIDE; CELLS;
   REPLACEMENT; SCAFFOLD; AIRWAY; VITRO; BIOMATERIAL
AB Decellularization techniques have been widely used as an alternative strategy for organ reconstruction. This study investigated the mechanical, pro-angiogenic and in vivo biocompatibility properties of decellularized airway matrices cross-linked with genipin. New Zealand rabbit tracheae were decellularized and cross-linked with genipin, a naturally derived agent. The results demonstrated that, a significant (p < 0.05) increase in the secant modulus was computed for the cross-linked tracheae, compared to the decellularized samples. Angiogenic assays demonstrated that decellularized tracheal scaffolds and cross-linked tracheae treated with 1% genipin induce strong in vivo angiogenic responses (CAM analysis). Seven, 15 and 30 days after implantation, decreased (p < 0.01) inflammatory reactions were observed in the xenograft models for the genipin cross-linked tracheae matrices compared with control tracheae, and no increase in the IgM or IgG content was observed in rats. In conclusion, treatment with genipin improves the mechanical properties of decellularized airway matrices without altering the pro-angiogenic properties or eliciting an in vivo inflammatory response.
C1 [Sun, Fei; Shi, Hongcan; Zhang, Siquan; Liu, Xingchen; Pan, Shu; Ye, Gang; Zhang, Weidong; Zhang, Fangbiao; Zhong, Chonghao] Yangzhou Univ, Dept Cardiothorac Surg, Coll Clin Med, Yangzhou 225001, Jiangsu, Peoples R China.
   [Sun, Fei; Jiang, Yuan; Xu, Yanfei; Shi, Hongcan; Zhang, Siquan; Liu, Xingchen; Pan, Shu; Ye, Gang; Zhang, Weidong; Zhang, Fangbiao; Zhong, Chonghao] Yangzhou Univ, Coll Med, Yangzhou 225001, Jiangsu, Peoples R China.
   [Jiang, Yuan; Xu, Yanfei; Shi, Hongcan; Zhang, Siquan; Zhong, Chonghao] Jiangsu Key Lab Integrated Tradit Chinese & Weste, Yangzhou 225001, Jiangsu, Peoples R China.
RP Shi, HC (reprint author), Yangzhou Univ, Dept Cardiothorac Surg, Coll Clin Med, Yangzhou 225001, Jiangsu, Peoples R China.; Shi, HC (reprint author), Yangzhou Univ, Coll Med, Yangzhou 225001, Jiangsu, Peoples R China.; Shi, HC (reprint author), Jiangsu Key Lab Integrated Tradit Chinese & Weste, Yangzhou 225001, Jiangsu, Peoples R China.
EM shihongcan@hotmail.com
FU National Natural Science Foundation of China [81170014, 81370118]; Top
   Talent Support Program of Yangzhou University [201431]; Jiangsu
   Students' Innovation Training Program [201511117033Z]
FX This study was supported by the National Natural Science Foundation of
   China (no. 81170014, 81370118), the Top Talent Support Program of
   Yangzhou University (no. 201431) and Jiangsu Students' Innovation
   Training Program (201511117033Z).
CR Baiguera S, 2014, BIOMATERIALS, V35, P6344, DOI 10.1016/j.biomaterials.2014.04.070
   Baiguera S, 2012, J BIOMED MATER RES B, V100B, P1425, DOI 10.1002/jbm.b.32653
   Baiguera S, 2012, BIOMATERIALS, V33, P3662, DOI 10.1016/j.biomaterials.2012.01.064
   Baiguera S, 2011, EXPERT REV RESP MED, V5, P487, DOI [10.1586/ers.11.42, 10.1586/ERS.11.42]
   Baiguera S, 2010, BIOMATERIALS, V31, P8931, DOI 10.1016/j.biomaterials.2010.08.005
   Bhrany AD, 2008, J TISSUE ENG REGEN M, V2, P365, DOI 10.1002/term.105
   Chang Y, 2002, BIOMATERIALS, V23, P2447, DOI 10.1016/S0142-9612(01)00379-9
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Elliott MJ, 2012, LANCET, V380, P994, DOI 10.1016/S0140-6736(12)60737-5
   Englert C, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2202
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Go T, 2010, J THORAC CARDIOV SUR, V139, P437, DOI 10.1016/j.jtcvs.2009.10.002
   Gonfiotti A, 2014, LANCET, V383, P238, DOI 10.1016/S0140-6736(13)62033-4
   Haag J, 2012, BIOMATERIALS, V33, P780, DOI 10.1016/j.biomaterials.2011.10.008
   Hamilton NJ, 2015, AM J TRANSPLANT, V15, P2750, DOI 10.1111/ajt.13318
   Hoshiba T, 2010, EXPERT OPIN BIOL TH, V10, P1717, DOI 10.1517/14712598.2010.534079
   Jungebluth P, 2012, CLIN PHARMACOL THER, V91, P81, DOI 10.1038/clpt.2011.270
   Jungebluth P, 2009, J THORAC CARDIOV SUR, V138, P586, DOI 10.1016/j.jtcvs.2008.09.085
   Koo HJ, 2006, J ETHNOPHARMACOL, V103, P496, DOI 10.1016/j.jep.2005.08.011
   Laurance J, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1633
   Liang HC, 2003, J BIOMED MATER RES A, V65A, P271, DOI 10.1002/jbm.a.10476
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Ott LM, 2011, ANN BIOMED ENG, V39, P2091, DOI 10.1007/s10439-011-0318-1
   Partington L, 2013, ACTA BIOMATER, V9, P5251, DOI 10.1016/j.actbio.2012.10.004
   Reich MS, 2013, CELL TISSUE BANK, V14, P381, DOI 10.1007/s10561-012-9335-z
   Sun F, 2015, J BIOMED MATER RES A, V103, P1509, DOI 10.1002/jbm.a.35273
   Sung HW, 2003, J BIOMED MATER RES A, V64A, P427, DOI 10.1002/jbm.a.10346
   Sung HW, 2001, J BIOMED MATER RES, V55, P538, DOI 10.1002/1097-4636(20010615)55:4<538::AID-JBM1047>3.3.CO;2-U
   Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008
   Vogel G, 2013, SCIENCE, V340, P266, DOI 10.1126/science.340.6130.266
   Wang CM, 2011, J BIOMED MATER RES B, V97B, P58, DOI 10.1002/jbm.b.31786
   Wang GF, 2009, ACTA PHARMACOL SIN, V30, P589, DOI 10.1038/aps.2009.31
   Yamazaki M, 2008, EUR J PHARMACOL, V581, P255, DOI 10.1016/j.ejphar.2007.12.001
   Yao C, 2008, BIOMATERIALS, V29, P66, DOI 10.1016/j.biomaterials.2007.08.049
   Yu XX, 2010, J MATER SCI-MATER M, V21, P777, DOI 10.1007/s10856-009-3933-8
   Zang MQ, 2013, PLAST RECONSTR SURG, V132, p549E, DOI 10.1097/PRS.0b013e3182a013fc
   Zang MQ, 2012, PLAST RECONSTR SURG, V130, P532, DOI 10.1097/PRS.0b013e31825dc084
   Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010
NR 38
TC 5
Z9 4
U1 0
U2 18
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 15
PY 2016
VL 6
AR 24429
DI 10.1038/srep24429
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DJ4HR
UT WOS:000374166500001
PM 27080716
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Lee, S
   Maeda, H
   Obata, A
   Ueda, K
   Narushima, T
   Kasuga, T
AF Lee, Sungho
   Maeda, Hirotaka
   Obata, Akiko
   Ueda, Kyosuke
   Narushima, Takayuki
   Kasuga, Toshihiro
TI Structures and dissolution behaviors of MgO-CaO-P2O5-Nb2O5 glasses
SO JOURNAL OF NON-CRYSTALLINE SOLIDS
LA English
DT Article
DE Biomaterial; Phosphate invert glass; Magnesium; Calcium; Structure;
   Dissolution
ID PHOSPHATE INVERT GLASSES; BIOMEDICAL APPLICATIONS; OPTICAL-PROPERTIES;
   MAGNESIUM CONTENT; SYSTEM; ZINC; CRYSTALLIZATION; IONS; SOLUBILITY;
   CERAMICS
AB MgO-CaO-P2O5-Nb2O5 glasses with the substitution of MgO for CaO consisting predominantly of meta-, pyro-, and orthophosphate groups were prepared using a melt-quenching method, and their structures and dissolution behaviors were investigated. Magnesium in the metaphosphate compositions was shown to act as a modifier oxide and coordinate phosphate groups. Magnesium in the pyro- and/or orthophosphate compositions was shown to act as a network former and to form P-O-Mg bonds, which crosslink short phosphate groups. The chemical durability of the metaphosphate glasses increased with increasing the substitution of MgO for CaO because magnesium exhibits a larger field strength than calcium. However, the durability of the pyro- and/or orthophosphate glasses decreased with increasing the MgO content: P-O-Mg bonds weakened the glass network structure and induced hydrolysis. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Lee, Sungho; Maeda, Hirotaka; Obata, Akiko; Kasuga, Toshihiro] Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.
   [Ueda, Kyosuke; Narushima, Takayuki] Tohoku Univ, Grad Sch Engn, Dept Met Mat Sci & Mat Proc, Aoba Ku, 6-6-02 Aoba, Sendai, Miyagi 9808579, Japan.
RP Kasuga, T (reprint author), Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Gokiso Cho, Nagoya, Aichi 4668555, Japan.
EM kasuga.toshihiro@nitech.ac.jp
RI Lee, Sungho/T-1734-2017
OI Lee, Sungho/0000-0002-4367-9573
FU JSPS KAKENHI [25249094, 26289238, 267992]
FX This work was supported in part by JSPS KAKENHI Grant Numbers 25249094,
   26289238, and 267992.
CR ABE Y, 1976, J AM CERAM SOC, V59, P487, DOI 10.1111/j.1151-2916.1976.tb09414.x
   Brauer DS, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0647
   Brauer DS, 2010, J NON-CRYST SOLIDS, V356, P2626, DOI 10.1016/j.jnoncrysol.2010.03.022
   BROW RK, 1995, J NON-CRYST SOLIDS, V191, P45, DOI 10.1016/0022-3093(95)00289-8
   Brow RK, 2000, J NON-CRYST SOLIDS, V263, P1, DOI 10.1016/S0022-3093(99)00620-1
   DAY DE, 1976, J NON-CRYST SOLIDS, V21, P343, DOI 10.1016/0022-3093(76)90026-0
   Diba M, 2012, INT J APPL GLASS SCI, V3, P221, DOI 10.1111/j.2041-1294.2012.00095.x
   Dietzel A., 1942, Z ELEKTROCHEM, V48, P9, DOI DOI 10.1007/BF01519713
   DILMORE MF, 1978, J AM CERAM SOC, V61, P439, DOI 10.1111/j.1151-2916.1978.tb09355.x
   ELJAZOULI A, 1988, J SOLID STATE CHEM, V73, P433, DOI 10.1016/0022-4596(88)90129-6
   Fayon F, 2001, J NON-CRYST SOLIDS, V283, P88, DOI 10.1016/S0022-3093(01)00357-X
   Flambard A, 2008, J NON-CRYST SOLIDS, V354, P3540, DOI 10.1016/j.jnoncrysol.2008.03.017
   Franks K, 2002, J MATER SCI-MATER M, V13, P549, DOI 10.1023/A:1015122709576
   Hsu SM, 2012, J NON-CRYST SOLIDS, V358, P14, DOI 10.1016/j.jnoncrysol.2011.08.006
   Isard J. O., 1969, Journal of Non-Crystalline Solids, V1, P235, DOI 10.1016/0022-3093(69)90003-9
   JEHNG JM, 1991, CHEM MATER, V3, P100, DOI 10.1021/cm00013a025
   Karakassides MA, 2004, J NON-CRYST SOLIDS, V347, P69, DOI 10.1016/j.jnoncrysol.2004.08.111
   Kasuga Toshihiro, 2012, Phosphorus Research Bulletin, V26, P8
   Kasuga T, 2003, J AM CERAM SOC, V86, P1031, DOI 10.1111/j.1151-2916.2003.tb03415.x
   Kasuga T, 2003, BIOMATERIALS, V24, P283, DOI 10.1016/S0142-9612(02)00316-2
   Kasuga T, 2001, J AM CERAM SOC, V84, P450
   Kasuga T, 1999, J NON-CRYST SOLIDS, V243, P70, DOI 10.1016/S0022-3093(98)00820-5
   Khor SF, 2013, OPT MATER, V35, P629, DOI 10.1016/j.optmat.2012.10.013
   Lee IH, 2013, J NON-CRYST SOLIDS, V363, P57, DOI 10.1016/j.jnoncrysol.2012.11.036
   Lee S., 2010, BIOCERAM DEV APPL, V1
   Lee S., 2015, J NONCRYST SOLIDS A, V432A, P60
   Lee S, 2015, J CERAM SOC JPN, V123, P942, DOI 10.2109/jcersj2.123.942
   Lee S, 2015, J NON-CRYST SOLIDS, V426, P35, DOI 10.1016/j.jnoncrysol.2015.06.024
   Lee S, 2009, J CERAM SOC JPN, V117, P935, DOI 10.2109/jcersj2.117.935
   Maeda H, 2014, J CERAM SOC JPN, V122, P122, DOI 10.2109/jcersj2.122.122
   Mandlule A, 2014, J NON-CRYST SOLIDS, V392, P31, DOI 10.1016/j.jnoncrysol.2014.04.002
   Mazali IO, 2004, J MATER SCI, V39, P1987, DOI 10.1023/B:JMSC.0000017760.85512.60
   Morikawa H, 2013, J NON-CRYST SOLIDS, V380, P53, DOI 10.1016/j.jnoncrysol.2013.08.029
   Obata A, 2012, ACS APPL MATER INTER, V4, P5684, DOI 10.1021/am301614a
   Okuma T, 2001, NUTRITION, V17, P679, DOI 10.1016/S0899-9007(01)00551-2
   OUCHETTO M, 1991, PHYS CHEM GLASSES, V32, P22
   Saboori A, 2009, MAT SCI ENG C-BIO S, V29, P335, DOI 10.1016/j.msec.2008.07.004
   SALTZBERG MA, 1990, J AM CERAM SOC, V73, P2970, DOI 10.1111/j.1151-2916.1990.tb06703.x
   Smith CE, 2014, J NON-CRYST SOLIDS, V390, P51, DOI 10.1016/j.jnoncrysol.2014.02.010
   Swenson J, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.155507
   TAKEICHI M, 1972, EXP CELL RES, V74, P51, DOI 10.1016/0014-4827(72)90480-6
   Tylkowski M, 2013, J NON-CRYST SOLIDS, V376, P175, DOI 10.1016/j.jnoncrysol.2013.05.039
   Watts SJ, 2010, J NON-CRYST SOLIDS, V356, P517, DOI 10.1016/j.jnoncrysol.2009.04.074
   Wolf Federica I., 1999, Frontiers in Bioscience, V4, pd607, DOI 10.2741/Wolf
   Yamasaki Y, 2002, J BIOMED MATER RES, V62, P99, DOI 10.1002/jbm.10220
   Zhifang W., 1986, J NONCRYST SOLIDS, V84, P468
NR 46
TC 4
Z9 4
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-3093
EI 1873-4812
J9 J NON-CRYST SOLIDS
JI J. Non-Cryst. Solids
PD APR 15
PY 2016
VL 438
BP 18
EP 25
DI 10.1016/j.jnoncrysol.2016.02.006
PG 8
WC Materials Science, Ceramics; Materials Science, Multidisciplinary
SC Materials Science
GA DI5NG
UT WOS:000373545300004
DA 2018-10-19
ER

PT J
AU Afroze, JD
   Abden, MJ
   Alam, MS
   Bahadur, NM
   Gafur, MA
AF Afroze, J. D.
   Abden, M. J.
   Alam, M. S.
   Bahadur, N. M.
   Gafur, M. A.
TI Development of functionalized carbon nanotube reinforced hydroxyapatite
   magnetic nanocomposites
SO MATERIALS LETTERS
LA English
DT Article
DE Hydroxyapatite; Carbon nanotubes; In-situ fabrication; Nanocomposites;
   Magnetic properties
ID CALCIUM PHOSPHATES; DRUG; NANOPARTICLES; DELIVERY; MATRIX
AB An innovative and effective approach is introduced to functionalize multi-walled carbon nanotubes (f-MWCNTs) by in-situ chemical precipitation of hydroxyapatite (HA) to improve their magnetic properties. The HA/f-MWCNTs nanocomposites are obtained by pressureless sintering in vacuum atmosphere. The carboxyl functional group (-COOH) is introduced by an acid treatment on the MWCNT surface. Magnetic hysteresis measurement reveals that HA/f-MWCNTs nanocomposites exhibit excellent hard ferromagnetic properties with saturation magnetization (M-s) of 0.233 emu/g and coercivity (H-C) of 2985.53 Oe at room temperature. The maximum magnetic hysteresis loss of 0.44 kJ/m(3) induces an expected heat generation and it is expected that this nanocomposite has potential to be used as a biomaterial for hyperthermia treatment of bone cancer and other biomedical applications. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Afroze, J. D.; Alam, M. S.; Bahadur, N. M.] Noakhali Sci & Technol Univ, Dept Appl Chem & Chem Engn, Noakhali 3814, Bangladesh.
   [Abden, M. J.] Int Islamic Univ Chittagong, Dept Elect & Elect Engn, Chittagong 4203, Bangladesh.
   [Abden, M. J.; Gafur, M. A.] Bangladesh Council Sci & Ind Res, Dev Mat Tools & Biometall Implant, Dhaka 1205, Bangladesh.
RP Abden, MJ (reprint author), Int Islamic Univ Chittagong, Dept Elect & Elect Engn, Chittagong 4203, Bangladesh.
EM mjaynul@gmail.com
OI Abden, M./0000-0002-7724-3663
CR Ashokan A, 2010, BIOMATERIALS, V31, P2606, DOI 10.1016/j.biomaterials.2009.11.113
   Balani K, 2007, BIOMATERIALS, V28, P618, DOI 10.1016/j.biomaterials.2006.09.013
   Chen F, 2012, BIOMATERIALS, V33, P6447, DOI 10.1016/j.biomaterials.2012.05.059
   Cheng FY, 2010, CHEM COMMUN, V46, P3167, DOI 10.1039/b919172k
   Freitag R, 2012, BIOTECHNOL J, V7, P90, DOI 10.1002/biot.201100015
   Heidari F, 2015, CERAM INT, V41, P3094, DOI 10.1016/j.ceramint.2014.10.153
   Kozlova D, 2012, J MATER CHEM, V22, P396, DOI 10.1039/c1jm14683a
   Li AM, 2007, MATER LETT, V61, P1839, DOI 10.1016/j.matlet.2006.07.159
   Liu TY, 2005, J CONTROL RELEASE, V107, P112, DOI 10.1016/j.jconrel.2005.05.025
   Lu XY, 2012, APPL SURF SCI, V262, P110, DOI 10.1016/j.apsusc.2012.02.139
   Lu XF, 2015, MATER LETT, V161, P128, DOI 10.1016/j.matlet.2015.07.102
   Mohammad F., 2011, ADV DRUG DELIV REV, V63, P789
   Morrison CJ, 2011, BIOTECHNOL BIOENG, V108, P813, DOI 10.1002/bit.22971
   Neelgund GM, 2011, MAT SCI ENG C-MATER, V31, P1477, DOI 10.1016/j.msec.2011.06.001
   Padilla S, 2008, CHEM MATER, V20, P5942, DOI 10.1021/cm801626k
   Prato M, 2008, ACCOUNTS CHEM RES, V41, P60, DOI 10.1021/ar700089b
   Rege K, 2003, NANO LETT, V3, P829, DOI 10.1021/nl034131k
   Ruiz-Hernandez E, 2007, CHEM MATER, V19, P3455, DOI 10.1021/cm0705789
   Sahoo NG, 2010, PROG POLYM SCI, V35, P837, DOI 10.1016/j.progpolymsci.2010.03.002
   Singh RK, 2012, MATER LETT, V75, P130, DOI 10.1016/j.matlet.2012.01.129
   Son KD, 2012, MATER CHEM PHYS, V132, P1041, DOI 10.1016/j.matchemphys.2011.12.062
   Tseng CL, 2014, CERAM INT, V40, P5117, DOI 10.1016/j.ceramint.2013.09.137
   Uskokovic V, 2011, J BIOMED MATER RES B, V96B, P152, DOI 10.1002/jbm.b.31746
   Usui Y, 2008, SMALL, V4, P240, DOI 10.1002/smll.200700670
   Vallet-Regi M, 2004, PROG SOLID STATE CH, V32, P1, DOI 10.1016/j.progsolidstchem.2004.07.001
   Wu MY, 2013, CARBON, V51, P335, DOI 10.1016/j.carbon.2012.08.061
   Zhang HF, 2012, MATER LETT, V75, P26, DOI 10.1016/j.matlet.2012.01.110
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
NR 28
TC 5
Z9 5
U1 1
U2 46
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD APR 15
PY 2016
VL 169
BP 24
EP 27
DI 10.1016/j.matlet.2016.01.060
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA DE3MK
UT WOS:000370533300007
DA 2018-10-19
ER

PT J
AU Zhu, YQ
   Meng, QK
   Guo, S
   Qi, LC
   Xiao, WL
   Ping, DH
   Zhao, XQ
AF Zhu, Yongqi
   Meng, Qingkun
   Guo, Shun
   Qi, Lichun
   Xiao, Wenlong
   Ping, Dehai
   Zhao, Xinqing
TI Anomalous phase stability of surface and interior in a metastable
   Ti-Nb-Zr alloy
SO MATERIALS LETTERS
LA English
DT Article
DE Biomaterial; Metals and alloys; Phase transformation; Metastable phase
ID BETA-TITANIUM ALLOY; MARTENSITIC-TRANSFORMATION; OMEGA; SUPERELASTICITY;
   PRESSURE
AB The structural stability of beta phase is a key factor to determine the mechanical properties, such as strength and elastic modulus, of metastable beta-type titanium alloys. In the present study, we reported an anomalous phenomenon that the surface and the interior of quenched Ti-22Nb-9Zr (wt%) alloy exhibit quite different phase constitutions. It is indicated that abundant alpha '' martensite phase forms in the surficial region of less than 200 mu m in the specimen, while the interior consists of dominant beta phase together with a few omega phase. This interesting result might be of great significance for research and development of metastable beta titanium alloys with superior mechanical properties. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Zhu, Yongqi; Meng, Qingkun; Qi, Lichun; Xiao, Wenlong; Zhao, Xinqing] Beihang Univ, Sch Mat Sci & Engn, Beijing 100191, Peoples R China.
   [Guo, Shun] Jiangsu Univ, Inst Adv Mat, Zhenjiang 212013, Peoples R China.
   [Ping, Dehai] Dalian Jiaotong Univ, Sch Mat Sci & Engn, Dalian 116028, Peoples R China.
RP Xiao, WL; Zhao, XQ (reprint author), Beihang Univ, Sch Mat Sci & Engn, Beijing 100191, Peoples R China.
EM wlxiao@buaa.edu.cn; xinqing@buaa.edu.cn
RI Xiao, Wenlong/B-4765-2008; 赵, 新青/I-3313-2016
FU National Natural Science Foundation of China [51271010, 51471017,
   51431007]; National 973 Program of China [2012CB619403]
FX This work was supported by the National Natural Science Foundation of
   China (Grant nos. 51271010, 51471017 and 51431007) and the National 973
   Program of China (Grant no. 2012CB619403).
CR An YB, 2005, MATER LETT, V59, P2178, DOI 10.1016/j.matlet.2005.02.059
   Banerjee D, 2013, ACTA MATER, V61, P844, DOI 10.1016/j.actamat.2012.10.043
   Duerig T., 1980, TITANIUM 80 SCI TECH, P1503
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Guo S, 2014, MATER LETT, V133, P236, DOI 10.1016/j.matlet.2014.07.044
   Hennig RG, 2005, NAT MATER, V4, P129, DOI 10.1038/nmat1292
   KAUFMAN L, 1960, ACTA METALL MATER, V8, P270, DOI 10.1016/0001-6160(60)90193-0
   Kim HS, 2007, MAT SCI ENG A-STRUCT, V449, P322, DOI 10.1016/j.msea.2006.02.329
   Kim HY, 2006, ACTA MATER, V54, P2419, DOI 10.1016/j.actamat.2006.01.019
   KLOSTERMANN JA, 1964, ACTA METALL MATER, V12, P355, DOI 10.1016/0001-6160(64)90004-5
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MOFFAT DL, 1988, METALL TRANS A, V19, P1677, DOI 10.1007/BF02645135
   Odegard B. C., 1974, Metallography, V7, P129, DOI 10.1016/0026-0800(74)90002-0
   Ohmori Y, 2001, MAT SCI ENG A-STRUCT, V312, P182, DOI 10.1016/S0921-5093(00)01891-8
   Ping D., 2008, APPL PHYS LETT, V93
   Ping DH, 2006, SCRIPTA MATER, V54, P1305, DOI 10.1016/j.scriptamat.2005.12.022
   Saito T, 2003, SCIENCE, V300, P464, DOI 10.1126/science.1081957
   Straumal B, 2014, ARCH CIV MECH ENG, V14, P242, DOI 10.1016/j.acme.2013.07.002
   Straumal BB, 2015, ADV ENG MATER, V17, P1835, DOI 10.1002/adem.201500143
   Straumal BB, 2012, MATER LETT, V81, P225, DOI 10.1016/j.matlet.2012.04.153
   Sun F, 2011, J MECH BEHAV BIOMED, V4, P1864, DOI 10.1016/j.jmbbm.2011.06.003
   Sun F, 2010, SCRIPTA MATER, V63, P1053, DOI 10.1016/j.scriptamat.2010.07.042
   Tian YX, 2015, MATER LETT, V145, P283, DOI 10.1016/j.matlet.2015.01.126
   Wu SQ, 2013, J ALLOY COMPD, V577, pS423, DOI 10.1016/j.jallcom.2011.12.152
   Wu SQ, 2014, ACTA MATER, V62, P122, DOI 10.1016/j.actamat.2013.09.040
   Zhang DC, 2012, J MECH BEHAV BIOMED, V13, P156, DOI 10.1016/j.jmbbm.2012.04.017
NR 26
TC 1
Z9 1
U1 1
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD APR 15
PY 2016
VL 169
BP 210
EP 213
DI 10.1016/j.matlet.2016.01.145
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA DE3MK
UT WOS:000370533300053
DA 2018-10-19
ER

PT J
AU Huang, BL
   Yuan, Y
   Li, T
   Ding, S
   Zhang, WJ
   Gu, YT
   Liu, CS
AF Huang, Baolin
   Yuan, Yuan
   Li, Tong
   Ding, Sai
   Zhang, Wenjing
   Gu, Yuantong
   Liu, Changsheng
TI Facilitated receptor-recognition and enhanced bioactivity of bone
   morphogenetic protein-2 on magnesium-substituted hydroxyapatite surface
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MOLECULAR-DYNAMICS SIMULATION; BMP-2 DELIVERY; ADSORPTION; REGENERATION;
   SCAFFOLDS; RHBMP-2; DIFFERENTIATION; NANOPARTICLES; DESORPTION;
   CHEMISTRY
AB Biomaterial surface functionalized with bone morphogenetic protein-2 (BMP-2) is a promising approach to fabricating successful orthopedic implants/scaffolds. However, the bioactivity of BMP-2 on material surfaces is still far from satisfactory and the mechanism of related protein-surface interaction remains elusive. Based on the most widely used bone-implants/scaffolds material, hydroxyapatite (HAP), we developed a matrix of magnesium-substituted HAP (Mg-HAP, 2.2 at% substitution) to address these issues. Further, we investigated the adsorption dynamics, BMPRs-recruitment, and bioactivity of recombinant human BMP-2 (rhBMP-2) on the HAP and Mg-HAP surfaces. To elucidate the mechanism, molecular dynamic simulations were performed to calculate the preferred orientations, conformation changes, and cysteine-knot stabilities of adsorbed BMP-2 molecules. The results showed that rhBMP-2 on the Mg-HAP surface exhibited greater bioactivity, evidenced by more facilitated BMPRs-recognition and higher ALP activity than on the HAP surface. Moreover, molecular simulations indicated that BMP-2 favoured distinct side-on orientations on the HAP and Mg-HAP surfaces. Intriguingly, BMP-2 on the Mg-HAP surface largely preserved the active protein structure evidenced by more stable cysteine-knots than on the HAP surface. These findings explicitly clarify the mechanism of BMP-2-HAP/Mg-HAP interactions and highlight the promising application of Mg-HAP/BMP-2 matrixes in bone regeneration implants/scaffolds.
C1 [Huang, Baolin; Yuan, Yuan; Zhang, Wenjing; Liu, Changsheng] E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.
   [Huang, Baolin; Yuan, Yuan; Ding, Sai; Liu, Changsheng] E China Univ Sci & Technol, Key Lab Ultrafine Mat, Minist Educ, Shanghai 200237, Peoples R China.
   [Huang, Baolin; Li, Tong; Gu, Yuantong] Queensland Univ Technol, Sch Chem Phys & Mech Engn, 2 George St, Brisbane, Qld 4001, Australia.
   [Yuan, Yuan; Ding, Sai; Zhang, Wenjing; Liu, Changsheng] E China Univ Sci & Technol, Minist Educ, Engn Res Ctr Biomed Mat, Shanghai 200237, Peoples R China.
RP Yuan, Y; Liu, CS (reprint author), E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.; Yuan, Y; Liu, CS (reprint author), E China Univ Sci & Technol, Key Lab Ultrafine Mat, Minist Educ, Shanghai 200237, Peoples R China.; Gu, YT (reprint author), Queensland Univ Technol, Sch Chem Phys & Mech Engn, 2 George St, Brisbane, Qld 4001, Australia.; Yuan, Y; Liu, CS (reprint author), E China Univ Sci & Technol, Minist Educ, Engn Res Ctr Biomed Mat, Shanghai 200237, Peoples R China.
EM yyuan@eucst.eud.cn; yuantong.gu@qut.edu.au; liucs@ecust.edu.cn
RI GU, Yuantong/C-5033-2009
OI GU, Yuantong/0000-0002-2770-5014
FU National Basic Research Program of China (973 Program) [2012CB933600];
   National Natural Science Foundation of China [31070850, 31330028,
   31470924]; Program for New Century Excellent Talents in University
   [NCET-11-0640]; 111 project [B14018]; China Scholarship Council
   [201406740036]
FX The authors wish to express their gratitude for the financial support
   received from the National Basic Research Program of China (973 Program,
   No. 2012CB933600) and the National Natural Science Foundation of China
   (No. 31070850, 31330028 and 31470924). This study was also supported by
   the Program for New Century Excellent Talents in University (No.
   NCET-11-0640), 111 project (B14018), and China Scholarship Council (No.
   201406740036). The authors are grateful to the High Performance Computer
   resources provided by the Queensland University of Technology.
CR Axelrad TW, 2009, CYTOKINE GROWTH F R, V20, P481, DOI 10.1016/j.cytogfr.2009.10.003
   Boix T, 2005, J INORG BIOCHEM, V99, P1043, DOI 10.1016/j.jinorgbio.2005.01.011
   Cox SC, 2014, MAT SCI ENG C-MATER, V35, P106, DOI 10.1016/j.msec.2013.10.015
   Crouzier T, 2011, ADV MATER, V23, pH111, DOI 10.1002/adma.201004637
   Crouzier T, 2010, SMALL, V6, P651, DOI 10.1002/smll.200901728
   Ding HM, 2014, BIOMATERIALS, V35, P8703, DOI 10.1016/j.biomaterials.2014.06.033
   Dolatshahi-Pirouz A, 2009, LANGMUIR, V25, P2971, DOI 10.1021/la803142u
   Dong XL, 2011, MOL SIMULAT, V37, P1097, DOI 10.1080/08927022.2011.582108
   Dong XL, 2007, BIOPHYS J, V93, P750, DOI 10.1529/biophysj.106.103168
   Farzadi A, 2014, CERAM INT, V40, P6021, DOI 10.1016/j.ceramint.2013.11.051
   Guan JJ, 2015, RSC ADV, V5, P36175, DOI 10.1039/c5ra01487e
   Hartvig RA, 2011, LANGMUIR, V27, P2634, DOI 10.1021/la104720n
   Hernandez A, 2012, ACTA BIOMATER, V8, P781, DOI 10.1016/j.actbio.2011.10.008
   Hettiaratchi MH, 2014, BIOMATERIALS, V35, P7228, DOI 10.1016/j.biomaterials.2014.05.011
   Hu JL, 2010, BIOCONJUGATE CHEM, V21, P1762, DOI 10.1021/bc9005706
   Huang BL, 2015, ACTA BIOMATER, V27, P275, DOI 10.1016/j.actbio.2015.09.007
   Kashiwagi K, 2009, BIOMATERIALS, V30, P1166, DOI 10.1016/j.biomaterials.2008.10.040
   Keller S, 2004, NAT STRUCT MOL BIOL, V11, P481, DOI 10.1038/nsmb756
   Kim MJ, 2013, BIOMATERIALS, V34, P7236, DOI 10.1016/j.biomaterials.2013.06.019
   La WG, 2013, SMALL, V9, DOI 10.1002/smll.201300571
   Lai ZB, 2014, J MECH BEHAV BIOMED, V36, P12, DOI 10.1016/j.jmbbm.2014.04.002
   Laurencin D, 2011, BIOMATERIALS, V32, P1826, DOI 10.1016/j.biomaterials.2010.11.017
   Lee SS, 2013, BIOMATERIALS, V34, P452, DOI 10.1016/j.biomaterials.2012.10.005
   Lee WH, 2014, COLLOID SURFACE B, V122, P823, DOI 10.1016/j.colsurfb.2014.07.029
   Luca L, 2010, J CONTROL RELEASE, V147, P38, DOI 10.1016/j.jconrel.2010.06.011
   Mehta M, 2012, ADV DRUG DELIVER REV, V64, P1257, DOI 10.1016/j.addr.2012.05.006
   Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200
   Park J, 2012, SMALL, V8, P98, DOI 10.1002/smll.201100790
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Rude RK, 2004, J NUTR BIOCHEM, V15, P710, DOI 10.1016/j.jnutbio.2004.08.001
   Sawyer AA, 2009, BIOMATERIALS, V30, P2479, DOI 10.1016/j.biomaterials.2008.12.055
   Scheufler C, 1999, J MOL BIOL, V287, P103, DOI 10.1006/jmbi.1999.2590
   Schwab EH, 2015, NANO LETT, V15, P1526, DOI 10.1021/acs.nanolett.5b00315
   Shen JW, 2008, BIOMATERIALS, V29, P513, DOI 10.1016/j.biomaterials.2007.10.016
   Shepherd JH, 2012, J MATER SCI-MATER M, V23, P2335, DOI 10.1007/s10856-012-4598-2
   Shi PJ, 2013, ADV HEALTHC MATER, V2, P934, DOI 10.1002/adhm.201200281
   Shiels SM, 2012, J BIOMED MATER RES A, V100A, P3117, DOI 10.1002/jbm.a.34241
   Supova M, 2015, CERAM INT, V41, P9203, DOI 10.1016/j.ceramint.2015.03.316
   Tagaya M, 2011, LANGMUIR, V27, P7645, DOI 10.1021/la200621p
   Utesch T, 2011, LANGMUIR, V27, P13144, DOI 10.1021/la202489w
   Visser R, 2009, BIOMATERIALS, V30, P2032, DOI 10.1016/j.biomaterials.2008.12.046
   Wang KF, 2014, MATER LETT, V123, P191, DOI 10.1016/j.matlet.2014.02.089
   Wang XW, 2012, LANGMUIR, V28, P14642, DOI 10.1021/la303001j
   Zhang J, 2015, BIOMATERIALS, V53, P251, DOI 10.1016/j.biomaterials.2015.02.097
NR 44
TC 11
Z9 11
U1 2
U2 43
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 14
PY 2016
VL 6
AR 24323
DI 10.1038/srep24323
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DJ2PQ
UT WOS:000374047500001
PM 27075233
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Govindarajan, SR
   Xu, Y
   Swanson, JP
   Jain, T
   Lu, YF
   Choi, JW
   Joy, A
AF Govindarajan, Sudhanva R.
   Xu, Ying
   Swanson, John P.
   Jain, Tanmay
   Lu, Yanfeng
   Choi, Jae-Won
   Joy, Abraham
TI A Solvent and Initiator Free, Low-Modulus, Degradable Polyester Platform
   with Modular Functionality for Ambient-Temperature 3D Printing
SO MACROMOLECULES
LA English
DT Article
ID IN-VITRO; BIOMATERIALS; FABRICATION; SCAFFOLDS; HYDROGELS; POLYMERS;
   TISSUES; CONSTRUCTS; LIBRARY
AB 3D printing has enabled the design of biomaterials into intricate and customized scaffolds. However, current 3D printed biomaterial scaffolds have potential drawbacks due to residual monomers, free-radical initiators, solvents, or printing at elevated temperatures. This work describes a solvent, initiator, and monomer-free degradable polyester platform for room temperature 3D printing. Linoleic acid side chains derived from soybean oil lowers the T-g and prevents packing and entanglement, ensuring that G '' > G' during room temperature printing. Upon printing, cross-linking of pendant functionalized coumarin moieties fixes the-viscous filaments to elastomeric solids. Furthermore, the modular design of the polyester platform enables conjugation of ligands, as demonstrated by the conjugation of FITC to surface amines on the 3D printed scaffolds. This low modulus, printable polyester platform addresses several design challenges in 3D printing of functional biomaterials and could potentially be useful in many tissue engineering applications.
C1 [Govindarajan, Sudhanva R.; Xu, Ying; Swanson, John P.; Jain, Tanmay; Joy, Abraham] Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA.
   [Lu, Yanfeng; Choi, Jae-Won] Univ Akron, Dept Mech Engn, Akron, OH 44325 USA.
RP Joy, A (reprint author), Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA.
EM abraham@uakron.edu
OI Swanson, John/0000-0001-8820-7273
FU NSF [1352485]; Univ. Akron; ABIA
FX Part of this work was funded by an NSF grant (#1352485) to A.J. The
   authors thank the Univ. Akron and ABIA for a fellowship to ,S.R.G. We
   thank Steven Mankoci (Univ. of Akron, Polymer Science) for guidance with
   optical microscopy images and cell adhesion data. We also thank Erik
   Willett (Univ. of Akron, Polymer Science) for assistance with infrared
   spectroscopy.
CR Billiet T, 2014, BIOMATERIALS, V35, P49, DOI 10.1016/j.biomaterials.2013.09.078
   Bose S, 2013, MATER TODAY, V16, P496, DOI 10.1016/j.mattod.2013.11.017
   Cao Y, 2006, BIOMATERIALS, V27, P2854, DOI 10.1016/j.biomaterials.2005.12.015
   Choi JW, 2009, J MATER PROCESS TECH, V209, P5494, DOI 10.1016/j.jmatprotec.2009.05.004
   de Espinosa LM, 2011, EUR POLYM J, V47, P837, DOI 10.1016/j.eurpolymj.2010.11.020
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Duan B, 2013, J BIOMED MATER RES A, V101, P1255, DOI 10.1002/jbm.a.34420
   Fertier L, 2013, PROG POLYM SCI, V38, P932, DOI 10.1016/j.progpolymsci.2012.12.002
   Gokhale S, 2013, BIOMACROMOLECULES, V14, P2489, DOI 10.1021/bm400697u
   Highley CB, 2015, ADV MATER, V27, P5075, DOI 10.1002/adma.201501234
   Horvath L, 2015, SCI REP-UK, V5, DOI 10.1038/srep07974
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Huyck R H., 2007, J MACROMOL SCI CHEM, V45, P9
   Kolesky DB, 2014, ADV MATER, V26, P3124, DOI 10.1002/adma.201305506
   Kuznetsova N. A., 1992, RUSS CHEM REV, V61, P683
   Lu Y., 2015, BIOFABRICATION, V7
   Lu YF, 2015, J MECH SCI TECHNOL, V29, P5377, DOI 10.1007/s12206-015-1139-1
   Lu YF, 2013, J MECH SCI TECHNOL, V27, P2929, DOI 10.1007/s12206-013-0805-4
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Maddipatla MVSN, 2013, MACROMOLECULES, V46, P5133, DOI 10.1021/ma400584y
   Melchels FPW, 2010, BIOMATERIALS, V31, P6121, DOI 10.1016/j.biomaterials.2010.04.050
   Messmore BW, 2004, J AM CHEM SOC, V126, P14452, DOI 10.1021/ja049325w
   Miller JS, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001882
   Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034
   Rutz AL, 2015, ADV MATER, V27, P1607, DOI 10.1002/adma.201405076
   Sato E, 2013, PROG ORG COAT, V76, P1747, DOI 10.1016/j.porgcoat.2013.05.010
   Schacht K, 2015, ANGEW CHEM INT EDIT, V54, P2816, DOI 10.1002/anie.201409846
   Skardal A, 2015, ANN BIOMED ENG, V43, P730, DOI 10.1007/s10439-014-1207-1
   Song SJ, 2011, ARTIF ORGANS, V35, P1132, DOI 10.1111/j.1525-1594.2011.01377.x
   Swanson JP, 2015, MACROMOLECULES, V48, P3834, DOI 10.1021/acs.macromol.5b00585
   Wang MO, 2015, ADV MATER, V27, P138, DOI 10.1002/adma.201403943
   Wust Silke, 2011, J Funct Biomater, V2, P119, DOI 10.3390/jfb2030119
   Zopf DA, 2013, NEW ENGL J MED, V368, P2043, DOI 10.1056/NEJMc1206319
NR 36
TC 6
Z9 6
U1 4
U2 55
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
EI 1520-5835
J9 MACROMOLECULES
JI Macromolecules
PD APR 12
PY 2016
VL 49
IS 7
BP 2429
EP 2437
DI 10.1021/acs.macromol.5b02399
PG 9
WC Polymer Science
SC Polymer Science
GA DJ4RO
UT WOS:000374195600003
DA 2018-10-19
ER

PT J
AU Chang, CW
   Petrie, T
   Clark, A
   Lin, X
   Sondergaard, CS
   Griffiths, LG
AF Chang, Chia Wei
   Petrie, Tye
   Clark, Alycia
   Lin, Xin
   Sondergaard, Claus S.
   Griffiths, Leigh G.
TI Mesenchymal Stem Cell Seeding of Porcine Small Intestinal Submucosal
   Extracellular Matrix for Cardiovascular Applications
SO PLOS ONE
LA English
DT Article
ID MYOCARDIAL-INFARCTION; PARACRINE MECHANISMS; CLINICAL-TRIAL; REPAIR;
   HEART; TRANSPLANTATION; REGENERATION; SURGERY; GRAFTS; TISSUE
AB In this study, we investigate the translational potential of a novel combined construct using an FDA-approved decellularized porcine small intestinal submucosa extracellular matrix (SIS-ECM) seeded with human or porcine mesenchymal stem cells (MSCs) for cardiovascular indications. With the emerging success of individual component in various clinical applications, the combination of SIS-ECM with MSCs could provide additional therapeutic potential compared to individual components alone for cardiovascular repair. We tested the in vitro effects of MSC-seeding on SIS-ECM on resultant construct structure/function properties and MSC phenotypes. Additionally, we evaluated the ability of porcine MSCs to modulate recipient graft-specific response towards SIS-ECM in a porcine cardiac patch in vivo model. Specifically, we determined: 1) in vitro loading-capacity of human MSCs on SIS-ECM, 2) effect of cell seeding on SIS-ECM structure, compositions and mechanical properties, 3) effect of SIS-ECM seeding on human MSC phenotypes and differentiation potential, and 4) optimal orientation and dose of porcine MSCs seeded SIS-ECM for an in vivo cardiac application. In this study, histological structure, biochemical compositions and mechanical properties of the FDA-approved SIS-ECM biomaterial were retained following MSCs re-population in vitro. Similarly, the cellular phenotypes and differentiation potential of MSCs were preserved following seeding on SIS-ECM. In a porcine in vivo patch study, the presence of porcine MSCs on SIS-ECM significantly reduced adaptive T cell response regardless of cell dose and orientation compared to SIS-ECM alone. These findings substantiate the clinical translational potential of combined SIS-ECM seeded with MSCs as a promising therapeutic candidate for cardiac applications.
C1 [Chang, Chia Wei; Clark, Alycia; Griffiths, Leigh G.] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA.
   [Petrie, Tye; Lin, Xin; Sondergaard, Claus S.] Univ Calif Davis, Sch Med, Dept Surg, Sacramento, CA 95817 USA.
RP Griffiths, LG (reprint author), Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA.
EM lggriffiths@ucdavis.edu
FU California Institute for Regenerative Medicine (CIRM) [TR3-05626,
   TG2-01163]
FX This work was supported by funding from California Institute for
   Regenerative Medicine (CIRM): TR3-05626 (LGG and CSS) and TG2-01163
   (CWC).
CR Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Bank RA, 1997, J CHROMATOGR B, V703, P37, DOI 10.1016/S0378-4347(97)00391-5
   Boyd WD, 2010, HEART SURG FORUM, V13, pE311, DOI 10.1532/HSF98.20091184
   Caione P, 2006, PEDIATR SURG INT, V22, P593, DOI 10.1007/s00383-006-1705-9
   Caione P, 2012, PEDIATR SURG INT, V28, P421, DOI 10.1007/s00383-012-3063-0
   Chalajour F, 2012, ANN THORAC SURG, V93, P1311, DOI 10.1016/j.athoracsur.2011.08.055
   Du XF, 2012, INT J PEDIATR OTORHI, V76, P345, DOI DOI 10.1016/J.IJP0RL.2011.12.005
   Engelmayr GC, 2006, BIOMATERIALS, V27, P6083, DOI 10.1016/j.biomaterials.2006.07.045
   Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826
   Guide for the Care and the Use of Laboratory Animals, 1996, GUID CAR US LAB AN
   Hodde J P, 2005, J Wound Care, V14, P23
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Hodonsky C, 2015, ANN THORAC SURG, V99, P605, DOI 10.1016/j.athoracsur.2014.08.071
   Janis AD, 2012, J BIOMATER APPL, V26, P1013, DOI 10.1177/0885328210391688
   Katritsis DG, 2005, CATHETER CARDIO INTE, V65, P321, DOI 10.1002/ccd.20406
   Kini S, 2001, OBES SURG, V11, P469, DOI 10.1381/096089201321209350
   Lam MT, 2013, TISSUE ENG PT A, V19, P738, DOI [10.1089/ten.tea.2012.0480, 10.1089/ten.TEA.2012.0480]
   Li AH, 2014, CIRC RES, V114, P916, DOI 10.1161/CIRCRESAHA.114.302819
   Lin HK, 2014, TISSUE ENG PART B-RE, V20, P73, DOI 10.1089/ten.TEB.2013.0126
   Lin X, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0165-3
   Lopes MF, 2006, DIS ESOPHAGUS, V19, P254, DOI 10.1111/j.1442-2050.2006.00574.x
   Lopes MF, 2006, J INVEST SURG, V19, P105, DOI 10.1080/08941930600569621
   Makris EA, 2013, OSTEOARTHR CARTILAGE, V21, P634, DOI 10.1016/j.joca.2013.01.007
   McCready RA, 2005, J VASC SURG, V41, P782, DOI 10.1016/j.jvs.2005.02.035
   Mirotsou M, 2011, J MOL CELL CARDIOL, V50, P280, DOI 10.1016/j.yjmcc.2010.08.005
   Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042
   Murphy KD, 2008, J HAND SURG-AM, V33A, P1168, DOI 10.1016/j.jhsa.2008.02.003
   Niezgoda Jeffrey A, 2005, Adv Skin Wound Care, V18, P258, DOI 10.1097/00129334-200506000-00012
   Nihsen Edith S, 2008, Adv Skin Wound Care, V21, P479, DOI 10.1097/01.ASW.0000323561.14144.19
   Nihsen Edith S, 2007, Adv Skin Wound Care, V20, P541, DOI 10.1097/01.ASW.0000294756.97425.c9
   Palmer EM, 2002, TISSUE ENG, V8, P893, DOI 10.1089/10763270260424259
   Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   Quarti A, 2011, INTERACT CARDIOV TH, V13, P569, DOI 10.1510/icvts.2011.280016
   Ramaswamy S, 2010, BIOMATERIALS, V31, P1114, DOI 10.1016/j.biomaterials.2009.10.019
   Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005
   Rossetto VJV, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-39
   Scholl FG, 2010, WORLD J PEDIATR CONG, V1, P132, DOI 10.1177/2150135110362092
   Sharma AK, 2011, STEM CELLS, V29, P241, DOI 10.1002/stem.568
   Slachman FN, 2014, ANN THORAC SURG, V97, pE129, DOI 10.1016/j.athoracsur.2013.10.103
   Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C
   Taljaard M, 2010, AM HEART J, V159, P354, DOI 10.1016/j.ahj.2009.12.021
   Tang YL, 2005, ANN THORAC SURG, V80, P229, DOI 10.1016/j.athoracsur.2005.02.072
   Williams AR, 2011, CIRC RES, V108, P792, DOI 10.1161/CIRCRESAHA.111.242610
   Witt RG, 2013, EUR J CARDIO-THORAC, V44, P72, DOI 10.1093/ejcts/ezs638
   Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9
   Wong ML, 2011, BIOMATERIALS, V32, P8129, DOI 10.1016/j.biomaterials.2011.07.030
   Yanagawa B, 2013, INNOVATIONS, V8, P348, DOI 10.1097/IMI.0000000000000014
NR 48
TC 12
Z9 12
U1 2
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 12
PY 2016
VL 11
IS 4
AR e0153412
DI 10.1371/journal.pone.0153412
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DJ0NI
UT WOS:000373900700062
PM 27070546
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Fischer, KM
   Morgan, KY
   Hearon, K
   Sklaviadis, D
   Tochka, ZL
   Fenton, OS
   Anderson, DG
   Langer, R
   Freed, LE
AF Fischer, Kristin M.
   Morgan, Kathy Ye
   Hearon, Keith
   Sklaviadis, Demetra
   Tochka, Zachary L.
   Fenton, Owen S.
   Anderson, Daniel G.
   Langer, Robert
   Freed, Lisa E.
TI Poly(Limonene Thioether) Scaffold for Tissue Engineering
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
ID THIOL-ACRYLATE PHOTOPOLYMERS; POLY(GLYCEROL SEBACATE) PGS; CARDIAC
   TISSUE; BIOMEDICAL APPLICATIONS; DEGRADATION BEHAVIOR; D-LIMONENE;
   IN-VIVO; BIOMATERIALS; SUPPORT; BIOCOMPATIBILITY
AB A photocurable thiol-ene network polymer, poly(limonene thioether) (PLT32o), is synthesized, characterized, fabricated into tissue engineering scaffolds, and demonstrated in vitro and in vivo. Micromolded PLT32o grids exhibit compliant, elastomeric mechanical behavior similar to grids made of poly(glycerol sebacate) (PGS), an established biomaterial. Multilayered PL32o scaffolds with regular, geometrically defined pore architectures support heart cell seeding and culture in a manner similar to multilayered PGS scaffolds. Subcutaneous implantation of multilayered PLT32o scaffolds with cultured heart cells provides long-term 3D structural support and retains the exogenous cells, whereas PGS scaffolds lose both their structural integrity and the exogenous cells over 31 d in vivo. PLT32o membrane implants retain their dry mass, whereas PGS implants lose 70 percent of their dry mass by day 31. Macrophages are initially recruited to PLT32o and PGS membrane implants but are no longer present by day 31. Facile synthesis and processing in combination with the capability to support heart cells in vitro and in vivo suggest that PLT32o can offer advantages for tissue engineering applications where prolonged in vivo maintenance of 3D structural integrity and elastomeric mechanical behavior are required.
C1 [Fischer, Kristin M.; Morgan, Kathy Ye; Hearon, Keith; Sklaviadis, Demetra; Tochka, Zachary L.; Fenton, Owen S.; Anderson, Daniel G.; Langer, Robert; Freed, Lisa E.] MIT, Harvard Mit Div Hlth Sci & Technol, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.
   [Fischer, Kristin M.; Morgan, Kathy Ye; Hearon, Keith; Sklaviadis, Demetra; Tochka, Zachary L.; Fenton, Owen S.; Anderson, Daniel G.; Langer, Robert; Freed, Lisa E.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA.
   [Freed, Lisa E.] Mat Engn Div, Draper Cambridge, MA 02139 USA.
RP Freed, LE (reprint author), MIT, Harvard Mit Div Hlth Sci & Technol, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.; Freed, LE (reprint author), Mat Engn Div, Draper Cambridge, MA 02139 USA.
EM Lfreed@mit.edu
OI Freed, Lisa/0000-0002-0720-8432
FU NIH/NHLBI [R01-HL107503]; Chick fil-A, Inc.
FX This work was funded by NIH/NHLBI Grant R01-HL107503 (to L.E.F.) and a
   fellowship from Chick fil-A, Inc. (to K.H.). We are grateful to J. Yu
   and C. van der Ven for help with polymer synthesis, J. Coppeta for help
   with embossed molds, A. Spencer and D. Stone for help with laser
   cutting, A. Anselmo for help with contact angle studies, J. Haupt and M.
   Jamiel for help with in vivo studies, N. Watson at the Whitehead
   Institute for help with imaging, and R. T. Bronson and the Koch
   Institute Core Facility for help with histology.
CR Ameer GA, 2002, J ORTHOPAED RES, V20, P16, DOI 10.1016/S0736-0266(01)00074-2
   Artzi N, 2011, NAT MATER, V10, P704, DOI [10.1038/nmat3095, 10.1038/NMAT3095]
   Atluri P, 2013, HEART FAIL REV, V18, P55, DOI 10.1007/s10741-012-9312-4
   Bettinger CJ, 2009, J BIOMED MATER RES A, V91A, P1077, DOI 10.1002/jbm.a.32306
   Bian W., 2012, TISSUE ENG PART A, V18, P957
   Chen QZ, 2010, BIOMATERIALS, V31, P3885, DOI 10.1016/j.biomaterials.2010.01.108
   Chen QZ, 2013, PROG POLYM SCI, V38, P584, DOI 10.1016/j.progpolymsci.2012.05.003
   Christoforou N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065963
   Claudino M, 2014, POLYM CHEM-UK, V5, P3245, DOI 10.1039/c3py01302b
   Engelmayr GC, 2006, J BIOMECH, V39, P1819, DOI 10.1016/j.jbiomech.2005.05.020
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303
   Fulmer GR, 2010, ORGANOMETALLICS, V29, P2176, DOI 10.1021/om100106e
   Gilboa SM, 2010, CIRCULATION, V122, P2254, DOI 10.1161/CIRCULATIONAHA.110.947002
   Goodpaster T, 2008, J HISTOCHEM CYTOCHEM, V56, P347, DOI 10.1369/jhc.7A7287.2007
   Hearon K, 2015, ADV HEALTHC MATER, V4, P1386, DOI 10.1002/adhm.201500156
   Hearon K, 2014, ADV MATER, V26, P1552, DOI 10.1002/adma.201304370
   Holmes JW, 2005, ANNU REV BIOMED ENG, V7, P223, DOI 10.1146/annurev.bioeng.7.060804.100453
   Huyer LD, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/3/034004
   Ifkovits JL, 2009, ACS APPL MATER INTER, V1, P1878, DOI 10.1021/am900403k
   Jiang JY, 2015, RSC ADV, V5, P36036, DOI 10.1039/c5ra02220g
   Kerativitayanan P, 2015, ACTA BIOMATER, V26, P34, DOI 10.1016/j.actbio.2015.08.025
   Kolewe ME, 2013, ADV MATER, V25, P4459, DOI 10.1002/adma.201301016
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Mann DL, 2012, J THORAC CARDIOV SUR, V143, P1036, DOI 10.1016/j.jtcvs.2011.06.014
   Morgan KY, 2014, TISSUE ENG PT A, V20, P1654, DOI [10.1089/ten.tea.2013.0355, 10.1089/ten.TEA.2013.0355]
   Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152
   Neal RA, 2013, TISSUE ENG PT A, V19, P793, DOI 10.1089/ten.tea.2012.0330
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Nijst CLE, 2007, BIOMACROMOLECULES, V8, P3067, DOI 10.1021/bm070423u
   Oliva N, 2015, ADV HEALTHC MATER, V4, P1584, DOI 10.1002/adhm.201400778
   Papadaki M, 2001, AM J PHYSIOL-HEART C, V280, pH168
   Park H, 2011, BIOMATERIALS, V32, P1856, DOI 10.1016/j.biomaterials.2010.11.032
   Pomerantseva I, 2009, J BIOMED MATER RES A, V91A, P1038, DOI 10.1002/jbm.a.32327
   Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077
   Rai R, 2013, MAT SCI ENG C-MATER, V33, P3677, DOI 10.1016/j.msec.2013.04.058
   Rai R, 2012, PROG POLYM SCI, V37, P1051, DOI 10.1016/j.progpolymsci.2012.02.001
   Rydholm AE, 2005, BIOMATERIALS, V26, P4495, DOI 10.1016/j.biomaterials.2004.11.046
   Rydholm AE, 2008, J BIOMED MATER RES A, V86A, P23, DOI 10.1002/jbm.a.31526
   Sales VL, 2007, CIRCULATION, V116, pI55, DOI 10.1161/CIRCULATIONAHA.106.6806637
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Shamsi A, 2014, MICROSYST TECHNOL, V20, P1925, DOI 10.1007/s00542-013-2000-z
   Stuckey DJ, 2010, TISSUE ENG PT A, V16, P3395, DOI 10.1089/ten.TEA.2010.0213
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
   Vunjak-Noyakovic G, 2011, ANNU REV BIOMED ENG, V13, P245, DOI 10.1146/annurev-bioeng-071910-124701
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Williams DF, 2014, TISSUE ENG PT A, V20, P1129, DOI 10.1089/ten.tea.2013.0769
   Ye K. Yuan, 2011, JOVE-J VIS EXP, V55, P3251
   Ye XF, 2014, ADV MATER, V26, P7202, DOI 10.1002/adma.201403074
   Ye XF, 2013, BIOMATERIALS, V34, P10007, DOI 10.1016/j.biomaterials.2013.09.039
   Zhang BY, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500423
NR 53
TC 7
Z9 7
U1 3
U2 47
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD APR 6
PY 2016
VL 5
IS 7
BP 813
EP 821
DI 10.1002/adhm.201500892
PG 9
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA DJ3IL
UT WOS:000374098000008
PM 26890480
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Xiao, X
   Zhang, CB
   Liu, DJ
   Bai, WB
   Zhang, QH
   Xiang, Q
   Huang, YD
   Su, ZJ
AF Xiao, Xue di
   Zhang, Changbin
   Liu, Dajun
   Bai, Weibin
   Zhang, Qihao
   Xiang, Qi
   Huang, Yadong
   Su, Zhijian
TI Prevention of gastrointestinal lead poisoning using recombinant
   Lactococcus lactis expressing human metallothionein-I fusion protein
SO SCIENTIFIC REPORTS
LA English
DT Article
ID GLUTATHIONE-S-TRANSFERASE; LEYDIG TUMOR-CELLS; CHELATION-THERAPY; ACID
   BACTERIA; GROWTH-FACTOR; PURIFICATION; TOXICITY; CHILDREN; DELIVERY;
   STEROIDOGENESIS
AB Low-level lead poisoning is an insidious disease that affects millions of children worldwide, leading to biochemical and neurological dysfunctions. Blocking lead uptake via the gastrointestinal tract is an important prevention strategy. With this in mind, we constructed the recombinant Lactococcus lactis strain pGSMT/MG1363, which constitutively expressed the fusion protein glutathione S-transferase (GST)-small molecule ubiquitin-like modifier protein (SUMO)-metallothionein-I (GST-SUMO-MT). The thermodynamic data indicated that the average number of lead bound to a GST-SUMO-MT molecule was 3.655 and this binding reaction was a spontaneous, exothermic and entropy-increasing process. The total lead-binding capacity of pGSMT/MG1363 was 4.11 +/- 0.15 mg/g dry mass. Oral administration of pGSMT/MG1363 (1 x 10(10) Colony-Forming Units) to pubertal male rats that were also treated with 5 mg/kg of lead acetate daily significantly inhibited the increase of blood lead levels, the impairment of hepatic function and the decrease of testosterone concentration in the serum, which were all impaired in rats treated by lead acetate alone. Moreover, the administration of pGSMT/MG1363 for 6 weeks did not affect the serum concentration of calcium, magnesium, potassium or sodium ions. This study provides a convenient and economical biomaterial for preventing lead poisoning via the digestive tract.
C1 [Xiao, Xue di; Zhang, Changbin; Liu, Dajun; Huang, Yadong; Su, Zhijian] Jinan Univ, Dept Cell Biol, Coll Life Sci & Technol, Guangzhou 510632, Guangdong, Peoples R China.
   [Zhang, Qihao; Xiang, Qi; Su, Zhijian] Jinan Univ, Inst Biomed, Guangdong Prov Key Lab Bioengn Med, Guangzhou 510632, Guangdong, Peoples R China.
   [Zhang, Changbin] Guangdong Women & Children Hosp, Dept Clin Mol Diag, Guangzhou 510010, Guangdong, Peoples R China.
   [Bai, Weibin] Jinan Univ, Dept Food Sci & Engieering, Guangzhou 510632, Guangdong, Peoples R China.
RP Huang, YD; Su, ZJ (reprint author), Jinan Univ, Dept Cell Biol, Coll Life Sci & Technol, Guangzhou 510632, Guangdong, Peoples R China.; Su, ZJ (reprint author), Jinan Univ, Inst Biomed, Guangdong Prov Key Lab Bioengn Med, Guangzhou 510632, Guangdong, Peoples R China.
EM tydhuang@jnu.edu.cn; tjnuszj@jnu.edu.cn
FU Guangdong Provincial Department of Science and Technology
   [2009B080701090, 2012B091100168]; Science Foundation of Wenzhou in China
   [Y20090252]; Major Scientific and Technological Special Project of
   Administration of Ocean and Fisheries of Guangdong Province
   [A201301B09]; National High-tech R&D Program of China [2011AA100901];
   Guangdong Province Higher Vocational Colleges & Schools Pearl River
   Scholar Funded Scheme
FX This work was partially supported by grant of Guangdong Provincial
   Department of Science and Technology (No. 2009B080701090,
   2012B091100168), grant of the Science Foundation of Wenzhou in China
   (No. Y20090252), Major Scientific and Technological Special Project of
   Administration of Ocean and Fisheries of Guangdong Province
   (A201301B09), National High-tech R&D Program of China (2011AA100901) and
   Project Supported by Guangdong Province Higher Vocational Colleges &
   Schools Pearl River Scholar Funded Scheme (2012).
CR Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848
   CDC, 2010, GUID ID MAN LEAD EXP
   Centers for Disease Control and Prevention, 2015, NAT REP HUM EXP ENV
   Chu DY, 2000, THERMOCHIM ACTA, V352, P205, DOI 10.1016/S0040-6031(99)00468-2
   Dietrich KN, 2004, PEDIATRICS, V114, P19, DOI 10.1542/peds.114.1.19
   Flora Gagan, 2012, Interdiscip Toxicol, V5, P47, DOI 10.2478/v10102-012-0009-2
   Garcia-Leston J, 2010, ENVIRON INT, V36, P623, DOI 10.1016/j.envint.2010.04.011
   Ge R., 2007, LEYDIG CELL HLTH DIS, P55
   Ge RS, 2006, P NATL ACAD SCI USA, V103, P2719, DOI 10.1073/pnas.0507692103
   Ge RS, 1998, ENDOCRINOLOGY, V139, P3787, DOI 10.1210/en.139.9.3787
   Grandjean P, 2014, LANCET NEUROL, V13, P330, DOI 10.1016/S1474-4422(13)70278-3
   Guo JJ, 2013, REPRODUCTION, V145, P371, DOI 10.1530/REP-12-0465
   Halttunen T, 2007, INT J FOOD MICROBIOL, V114, P30, DOI 10.1016/j.ijfoodmicro.2006.10.040
   HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119
   Hong SH, 2001, PROTEIN EXPRES PURIF, V21, P243, DOI 10.1006/prep.2000.1372
   Huang YD, 2009, J PHARMACOL EXP THER, V329, P469, DOI 10.1124/jpet.108.149401
   Hunaiti AA, 2000, SCI TOTAL ENVIRON, V248, P45, DOI 10.1016/S0048-9697(99)00548-3
   Ignacak J., 1990, FOLIA MED CRACOV, V32, P111
   Jaroslawiecka A, 2014, MICROBIOL-SGM, V160, P12, DOI 10.1099/mic.0.070284-0
   KOPP SJ, 1988, ENVIRON HEALTH PERSP, V78, P91, DOI 10.2307/3430507
   Kosik-Bogacka DI, 2011, MED SCI MONITOR, V17, pBR16, DOI 10.12659/MSM.881323
   Liu H, 2014, J STEROID BIOCHEM, V144, P483, DOI 10.1016/j.jsbmb.2014.09.016
   LIU J, 1991, TOXICOL APPL PHARM, V107, P27, DOI 10.1016/0041-008X(91)90327-B
   Liu MY, 2003, ARCH ANDROLOGY, V49, P29, DOI 10.1080/01485010390129151
   Liu MY, 2001, LIFE SCI, V68, P849, DOI 10.1016/S0024-3205(00)00983-8
   MAIORINO RM, 1989, TOXICOL APPL PHARM, V97, P338, DOI 10.1016/0041-008X(89)90338-4
   McMichael AJ, 2000, B WORLD HEALTH ORGAN, V78, P1117
   Medina M, 2008, MICROBIOL IMMUNOL, V52, P399, DOI [10.1111/j.1348-0421.2008.00050.x, 10.1111/j.1348.0421.2008.00050.x]
   Meyer PA, 2003, INT J HYG ENVIR HEAL, V206, P363, DOI 10.1078/1438-4639-00232
   Miller A L, 1998, Altern Med Rev, V3, P199
   Muller Halima, 2013, F1000Res, V2, P250, DOI 10.12688/f1000research.2-250.v1
   Needleman H, 2004, ANNU REV MED, V55, P209, DOI 10.1146/annurev.med.55.091902.103653
   Ngu TT, 2009, IUBMB LIFE, V61, P438, DOI 10.1002/iub.182
   Nouaille Sebastien, 2003, Genet Mol Res, V2, P102
   Qu W, 2002, AM J PATHOL, V160, P1047, DOI 10.1016/S0002-9440(10)64925-5
   Rogan WJ, 2001, NEW ENGL J MED, V344, P1421, DOI 10.1056/NEJM200105103441902
   Rossi Enrico, 2008, Clin Biochem Rev, V29, P63
   Steidler L, 2003, NAT BIOTECHNOL, V21, P785, DOI 10.1038/nbt840
   Steidler L, 2006, ANN NY ACAD SCI, V1072, P176, DOI 10.1196/annals.1326.031
   Su ZJ, 2006, PROTEIN PEPTIDE LETT, V13, P785, DOI 10.2174/092986606777841280
   Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8
   Vasak M, 2005, J TRACE ELEM MED BIO, V19, P13, DOI 10.1016/j.jtemb.2005.03.003
   Waalkes MP, 2004, CANCER RES, V64, P7766, DOI 10.1158/0008-5472.CAN-04-2220
   Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840
   WHO (World Health Organization), 2010, CHILDH LEAD POIS
   Wright LS, 1998, TOXICOL SCI, V46, P254, DOI 10.1006/toxs.1998.2543
   Zhou YJ, 2000, BBA-GEN SUBJECTS, V1524, P87, DOI 10.1016/S0304-4165(00)00072-6
NR 47
TC 2
Z9 2
U1 1
U2 23
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 5
PY 2016
VL 6
AR 23716
DI 10.1038/srep23716
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DI3KC
UT WOS:000373396500001
PM 27045906
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Sharma, N
   Raj, T
   Jangra, KK
AF Sharma, Neeraj
   Raj, Tilak
   Jangra, Kamal Kumar
TI Microstructural Evaluation of NiTi-powder, Steatite, and Steel Balls
   After Different Milling Conditions
SO MATERIALS AND MANUFACTURING PROCESSES
LA English
DT Article
DE Biomaterial; Intermetallics; Microscopy; NiTi; Scanning; Steatite; XRD
ID SHAPE-MEMORY ALLOY; PROCESS PARAMETERS; TI; FABRICATION; IMPLANTS
AB The present research deals with the investigation of morphological characteristics after mechanical alloying of Ni-50 at. %Ti in a high-energy planetary ball mill at various milling times (i.e., 4, 8, 30, 40, 50, and 60h). Crystallite size was observed to be decreased with the increase of milling time, entire titanium fused in the nickel trellis, and results of intermetallic NiTi. The shape of particle also changed from lamella to globular. Steatite-ceramic and hardened balls were separately used for the ball milling. The observations of morphologies revealed that steatite balls are more durable and wear resistant as compared to steel ball. This research shows that ball milling with steatite-ceramic balls is a cost-effective, high purity, and productive step toward the formation of NiTi intermetallic compound with homogeneous composition and desired particle size.
C1 [Sharma, Neeraj; Raj, Tilak] YMCA Univ Sci & Technol, Dept Mech Engn, Faridabad 121006, India.
   [Jangra, Kamal Kumar] PEC Univ Technol, Dept Mech Engn, Chandigarh, India.
RP Sharma, N (reprint author), YMCA Univ Sci & Technol, Dept Mech Engn, Faridabad 121006, India.
EM neeraj.sharma@live.com
OI Sharma, Neeraj/0000-0002-6719-8379; Kumar, Kamal/0000-0002-4293-0068
CR Aghili SE, 2012, MATER MANUF PROCESS, V27, P467, DOI 10.1080/10426914.2011.585501
   Ashokkumar T, 2013, MATER MANUF PROCESS, V28, P670, DOI 10.1080/10426914.2012.727121
   Bormann T, 2012, J MATER ENG PERFORM, V21, P2519, DOI 10.1007/s11665-012-0318-9
   Da Silva EP, 1999, MATER LETT, V38, P341, DOI 10.1016/S0167-577X(98)00186-4
   Dashtbayazi M. R., 2007, MAT MANUFACTURING PR, V23, P37, DOI [10.1080/104269107001524485, DOI 10.1080/104269107001524485]
   Frenzel J, 2004, J ALLOY COMPD, V385, P214, DOI 10.1016/j.jallcom.2004.05.002
   Gibson I, 2010, ADDITIVE MANUFACTURING TECHNOLOGIES: RAPID PROTOTYPING TO DIRECT DIGITAL MANUFACTURING, P1, DOI 10.1007/978-1-4419-1120-9
   Koike M, 2011, J MATER PROCESS TECH, V211, P1400, DOI 10.1016/j.jmatprotec.2011.03.013
   Krishna BV, 2009, J BIOMED MATER RES B, V89B, P481, DOI 10.1002/jbm.b.31238
   McNaney JM, 2003, MECH MATER, V35, P969, DOI 10.1016/S0167-6636(02)00310-1
   Nazarian-Samani M, 2010, MATER LETT, V64, P309, DOI 10.1016/j.matlet.2009.10.070
   Otsuka K, 2005, PROG MATER SCI, V50, P511, DOI 10.1016/j.pmatsci.2004.10.001
   Sadrnezhaad SK, 2006, MATER MANUF PROCESS, V21, P727, DOI 10.1080/10426910600727882
   Shariat BS, 2013, ACTA MATER, V61, P3411, DOI 10.1016/j.actamat.2013.02.032
   Starosvetsky D, 2001, BIOMATERIALS, V22, P1853, DOI 10.1016/S0142-9612(00)00368-9
   Suryanarayana C, 2004, MECH ALLOYING MILLIN
   Tadeja K., 2014, APPL SURF SCI, V288, P727, DOI [10.1016/j.apsusc.2013.10.116, DOI 10.1016/J.APSUSC.2013.10.116]
   Tosun G, 2012, MATER MANUF PROCESS, V27, P1184, DOI 10.1080/10426914.2011.648692
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
NR 19
TC 9
Z9 9
U1 0
U2 26
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1042-6914
EI 1532-2475
J9 MATER MANUF PROCESS
JI Mater. Manuf. Process.
PD APR 3
PY 2016
VL 31
IS 5
BP 628
EP 632
DI 10.1080/10426914.2015.1004710
PG 5
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA CZ8GM
UT WOS:000367338200010
DA 2018-10-19
ER

PT J
AU Hathout, RM
   Omran, MK
AF Hathout, Rania M.
   Omran, Mohamed K.
TI Gelatin-based particulate systems in ocular drug delivery
SO PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
LA English
DT Review
DE Biomaterial; drug delivery; gelatin; ocular; particles
ID SITU GELLING SYSTEMS; TUMOR-BEARING MICE; IN-VITRO; BIODEGRADABLE
   NANOPARTICLES; INTRAARTICULAR DELIVERY; PENETRATION ENHANCERS;
   CATIONIZED GELATIN; 2-STEP DESOLVATION; CELL UPTAKE; MICROSPHERES
AB Despite all scientists efforts exerted over the past years, the ocular delivery of drugs remains a great challenge due to several barriers and hurdles faced by this kind of administration. The exploitation of gelatin that has a long history of safe use in pharmaceuticals and which is considered as a GRAS (Generally Regarded As Safe) material by the FDA was not fully achieved in this field. This review summarizes the recent studies and findings where gelatin-based micro- and nanoparticles were used for successful ocular delivery aiming at drawing the attention of researchers and scientists to this valuable biomaterial that has not been fully explored.
C1 [Hathout, Rania M.; Omran, Mohamed K.] Ain Shams Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, African Union St, Cairo 11566, Egypt.
RP Hathout, RM (reprint author), Ain Shams Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, African Union St, Cairo 11566, Egypt.
EM r_hathout@yahoo.com
OI Hathout, Rania/0000-0001-9153-4355
CR Abdel-Hafez SM, 2014, INT J BIOL MACROMOL, V64, P334, DOI 10.1016/j.ijbiomac.2013.11.041
   Abdelkader H, 2014, DRUG DELIV, V21, P87, DOI 10.3109/10717544.2013.838077
   Abdelkader H, 2012, INT J PHARMACEUT, V433, P142, DOI 10.1016/j.ijpharm.2012.05.011
   Abdelkader H, 2011, J PHARM SCI-US, V100, P1833, DOI 10.1002/jps.22422
   Achouri D, 2013, DRUG DEV IND PHARM, V39, P1599, DOI 10.3109/03639045.2012.736515
   Agarwal R, 2014, DRUG DELIV IN PRESS
   Akhter KF, 2012, J PHYS CHEM BIOPHY S, VS11
   Ali J, 2014, DRUG DELIV IN PRESS
   Araujo J, 2009, NANOMED-NANOTECHNOL, V5, P394, DOI 10.1016/j.nano.2009.02.003
   Azarmi S, 2006, J PHARM PHARM SCI, V9, P124
   Azimi Bahareh, 2014, Iranian Biomedical Journal, V18, P34, DOI 10.6091/ibj.12422.2013
   Balthasar S, 2005, BIOMATERIALS, V26, P2723, DOI 10.1016/j.biomaterials.2004.07.047
   Barbu E, 2006, J MATER CHEM, V16, P3439, DOI 10.1039/b605640g
   Bourges JL, 2006, ADV DRUG DELIVER REV, V58, P1182, DOI 10.1016/j.addr.2006.07.026
   Bourlais C L, 1998, Prog Retin Eye Res, V17, P33
   Bourquin C, 2008, J IMMUNOL, V181, P2990, DOI 10.4049/jimmunol.181.5.2990
   Bourquin C, 2010, J IMMUNOTHER, V33, P935, DOI 10.1097/CJI.0b013e3181f5dfa7
   Bucolo C, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00188
   Calvo P, 1996, J PHARM PHARMACOL, V48, P1147, DOI 10.1111/j.2042-7158.1996.tb03911.x
   Cascone MG, 2002, J MATER SCI-MATER M, V13, P523, DOI 10.1023/A:1014791327253
   Chan J, 2007, INT J PHARM, V328, P65, DOI 10.1016/j.ijpharm.2006.10.004
   Chan J, 2008, CLIN OPHTHALMOL, V2, P129
   Chi JL, 2014, RADIAT RES, V181, P416, DOI 10.1667/RR13539.1
   Coester C, 2006, EUR J PHARM BIOPHARM, V62, P306, DOI 10.1016/j.ejpb.2005.09.009
   Coester C, 2000, INT J PHARM, V196, P147, DOI 10.1016/S0378-5173(99)00409-3
   Coester CJ, 2000, J MICROENCAPSUL, V17, P187
   Contreras-Ruiz L, 2013, GENE THER, V20, P467, DOI 10.1038/gt.2012.56
   Dwivedi P, 2012, J DRUG TARGET, V20, P883, DOI 10.3109/1061186X.2012.725169
   Elbialy NS, 2013, J BIOMED NANOTECHNOL, V9, P2105, DOI 10.1166/jbn.2013.1711
   Elzoghby AO, 2013, J CONTROL RELEASE, V172, P1075, DOI 10.1016/j.jconrel.2013.09.019
   Elzoghby AO, 2012, J CONTROL RELEASE, V161, P38, DOI 10.1016/j.jconrel.2012.04.036
   Ethirajan A, 2008, BIOMACROMOLECULES, V9, P2383, DOI 10.1021/bm800377w
   Fraunhofer W, 2004, ANAL CHEM, V76, P1909, DOI 10.1021/ac0353031
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Fuchs S, 2012, J MICROENCAPSUL, V29, P615, DOI 10.3109/02652048.2012.668962
   Gan L, 2013, DRUG DISCOV TODAY, V18, P290, DOI 10.1016/j.drudis.2012.10.005
   Gratieri T, 2011, EUR J PHARM BIOPHARM, V79, P320, DOI 10.1016/j.ejpb.2011.05.006
   Gratieri T, 2010, EUR J PHARM BIOPHARM, V75, P186, DOI 10.1016/j.ejpb.2010.02.011
   Gregoriadis G, 2000, METHODS MOL MED, P137
   Guinedi AS, 2005, INT J PHARM, V306, P71, DOI 10.1016/j.ijpharm.2005.09.023
   Gunji S, 2013, SURGERY, V154, P991, DOI 10.1016/j.surg.2013.04.054
   Gupta AK, 2004, J CONTROL RELEASE, V95, P197, DOI 10.1016/j.jconrel.2003.11.006
   Hallaj-Nezhadi S, 2013, FUTURE ONCOL, V9, P1195, DOI [10.2217/fon.13.82, 10.2217/FON.13.82]
   Hathout RM, 2007, AAPS PHARMSCITECH, V8
   Ishikawa H, 2012, BIOMATERIALS, V33, P9097, DOI 10.1016/j.biomaterials.2012.08.032
   Januleviciene Ingrida, 2012, Pharmaceutics, V4, P243, DOI 10.3390/pharmaceutics4010243
   Jin Y, 2014, ACTA BIOMATER, V10, P3126, DOI 10.1016/j.actbio.2014.02.045
   Karthikeyan S., 2013, Biomedicine & Preventive Nutrition, V3, P64
   Kaur IP, 2002, DRUG DEV IND PHARM, V28, P353, DOI 10.1081/DDC-120002997
   Kawadkar J, 2013, J DRUG TARGET, V21, P200, DOI 10.3109/1061186X.2012.745549
   Kawadkar J, 2012, EUR J PHARM BIOPHARM, V81, P563, DOI 10.1016/j.ejpb.2012.04.018
   Khan SA, 2013, MACROMOL BIOSCI, V13, P455, DOI 10.1002/mabi.201200382
   Kim HW, 2005, J MATER SCI-MATER M, V16, P1105, DOI 10.1007/s10856-005-4714-7
   Klier J, 2012, PHARM RES-DORDR, V29, P1650, DOI 10.1007/s11095-012-0686-8
   Kommareddy S, 2007, J PHARM SCI-US, V96, P397, DOI 10.1002/jps.20813
   Zorzi GK, 2011, MOL PHARMACEUT, V8, P1783, DOI 10.1021/mp200155t
   Zorzi GK, 2011, MACROMOL BIOSCI, V11, P905, DOI 10.1002/mabi.201100005
   Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001
   Kuno N, 2011, POLYMERS-BASEL, V3, P193, DOI 10.3390/polym3010193
   Kuntworbe N, 2012, AAPS PHARMSCITECH, V13, P568, DOI 10.1208/s12249-012-9775-6
   Kuo WT, 2011, J NANOMATER, DOI 10.1155/2011/646538
   Lee EJ, 2011, J BIOMAT SCI-POLYM E, V22, P753, DOI 10.1163/092050610X492093
   Lee SJ, 2013, J CONTROL RELEASE, V172, P358, DOI 10.1016/j.jconrel.2013.09.002
   Leeuwenburgh SCG, 2010, BIOMACROMOLECULES, V11, P2653, DOI 10.1021/bm1006344
   LEUCUTA SE, 1989, INT J PHARM, V54, P71, DOI 10.1016/0378-5173(89)90167-1
   Li JK, 1997, J PHARM SCI-US, V86, P891, DOI 10.1021/js970084i
   Li JK, 1998, J MICROENCAPSUL, V15, P163, DOI 10.3109/02652049809006846
   Li LL, 2014, ACS NANO, V8, P4975, DOI 10.1021/nn501040h
   Loftssona T, 1999, ADV DRUG DELIVER REV, V36, P59, DOI 10.1016/S0169-409X(98)00055-6
   Lu Z, 2004, CLIN CANCER RES, V10, P7677, DOI 10.1158/1078-0432.CCR-04-1443
   Mahapatro A, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-55
   Manca ML, 2013, J PHARM PHARMACOL, V65, P1302, DOI 10.1111/jphp.12094
   Mansour M, 2008, DRUG DEV IND PHARM, V34, P744, DOI [10.1080/03639040801926030, 10.1080/03639040801926030 ]
   Mladenovska K, 2002, INT J PHARM, V242, P247, DOI 10.1016/S0378-5173(02)00167-9
   Mladenovska K, 2002, INT J PHARM, V242, P251, DOI 10.1016/S0378-5173(02)00168-0
   Mladenovska Kristina, 2003, Acta Pharmaceutica (Zagreb), V53, P187
   Mladenovskat K, 2002, MACEDONIAN PHARM B, V48, P9
   Mohanty B, 2005, J SURF SCI TECHNOL, V21, P149, DOI 10.18311/isst/2005/1995
   Morimoto K, 2000, J PHARM PHARMACOL, V52, P611, DOI 10.1211/0022357001774444
   Nahar M, 2008, NANOMED-NANOTECHNOL, V4, P252, DOI 10.1016/j.nano.2008.03.007
   Ofokansi K, 2010, EUR J PHARM BIOPHARM, V76, P1, DOI 10.1016/j.ejpb.2010.04.008
   Patel M, 2006, DRUG DELIV, V13, P323, DOI 10.1080/10717540500398175
   Patel M, 2013, EXPERT OPIN DRUG DEL, V10, P889, DOI 10.1517/17425247.2013.784742
   Peptu CA, 2010, J BIOACT COMPAT POL, V25, P98, DOI 10.1177/0883911509350262
   ROMANELLI L, 1994, LIFE SCI, V54, P877, DOI 10.1016/0024-3205(94)00624-5
   Rupenthal ID, 2011, MOL PHARMACEUT, V8, P2282, DOI 10.1021/mp200140e
   Rupenthal ID, 2011, INT J PHARMACEUT, V411, P69, DOI 10.1016/j.ijpharm.2011.03.042
   Sahoo SK, 2008, DRUG DISCOV TODAY, V13, P144, DOI 10.1016/j.drudis.2007.10.021
   Saravanan M, 2011, J DRUG TARGET, V19, P96, DOI 10.3109/10611861003733979
   Solorio L, 2010, J TISSUE ENG REGEN M, V4, P514, DOI 10.1002/term.267
   Sudheesh MS, 2011, DRUG DELIV, V18, P320, DOI 10.3109/10717544.2010.549525
   TANGLIU DDS, 1994, J PHARM SCI, V83, P85, DOI 10.1002/jps.2600830120
   Tseng CL, 2007, BIOMATERIALS, V28, P3996, DOI 10.1016/j.biomaterials.2007.05.006
   Tseng CL, 2013, J NANOMATER, V2013, P1
   Vandelli MA, 2001, INT J PHARM, V215, P175, DOI 10.1016/S0378-5173(00)00681-5
   Vandervoort J, 2004, EUR J PHARM BIOPHARM, V57, P251, DOI 10.1016/s0939-6411(03)00187-5
   Vega E, 2006, J PHARM SCI-US, V95, P2393, DOI 10.1002/jps.20685
   Vyas SP, 1998, PHARMAZIE, V53, P466
   Wang J, 2001, J CONTROL RELEASE, V73, P223, DOI 10.1016/S0168-3659(01)00288-7
   Won YW, 2008, J CONTROL RELEASE, V127, P154, DOI 10.1016/j.jconrel.2008.01.010
   Xu J, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-75
   Xu J, 2013, MOL PHARMACEUT, V10, P2031, DOI 10.1021/mp400054e
   Yasukawa T, 2004, PROG RETIN EYE RES, V23, P253, DOI 10.1016/j.preteyeres.2004.02.003
   Yewale C, 2013, EXPERT OPIN DRUG DEL, V10, P1429, DOI 10.1517/17425247.2013.805200
   Youngren SR, 2013, BIOMED RES INT, DOI 10.1155/2013/858946
   Youshia J, 2012, INT J NANOMED, V7, P2483, DOI 10.2147/IJN.S28307
   Zhang J, 2013, J MATER CHEM B, V1, P4388, DOI 10.1039/c3tb20391c
NR 107
TC 7
Z9 7
U1 3
U2 46
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1083-7450
EI 1097-9867
J9 PHARM DEV TECHNOL
JI Pharm. Dev. Technol.
PD APR 2
PY 2016
VL 21
IS 3
BP 379
EP 386
DI 10.3109/10837450.2014.999786
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DC5WF
UT WOS:000369290600015
PM 25567143
DA 2018-10-19
ER

PT J
AU Go, YY
   Kim, SE
   Cho, GJ
   Chae, SW
   Song, JJ
AF Go, Yoon Young
   Kim, Sung Eun
   Cho, Geum Joon
   Chae, Sung-Won
   Song, Jae-Jun
TI Promotion of osteogenic differentiation by amnion/chorion membrane
   extracts
SO JOURNAL OF APPLIED BIOMATERIALS & FUNCTIONAL MATERIALS
LA English
DT Article
DE Amnion/chorion membrane extracts; Amnion membrane extracts; Growth
   factors; Osteogenesis
ID HUMAN AMNIOTIC MEMBRANE; OSTEOBLAST DIFFERENTIATION; CELLS;
   OPHTHALMOLOGY; CYTOKINES; PROTEINS; MATRIX; REPAIR; MODEL; BURNS
AB Background: The amniotic membrane is a favorable biomaterial to apply in the field of tissue engineering because of its unique biological properties. Human amniotic membranes consist of 2-layered sheets containing numerous growth factors, cytokines and other bioactive substances.
   Methods: In this study, we explored the potential of amnion membrane extracts (AME) and amnion/chorion membrane extracts (A/CME) to promote osteogenic differentiation of osteoblast-like (MG-63) cells. MG-63 cells were cultured in osteogenic induction medium (OIM) with or without 100 mu g/mL of AME or A/CME. To determine the early and late differentiation of osteogenesis, alkaline phosphatase (ALP) activity and calcium deposition were measured at 3, 7, 10 and 24 days. Expression of specific genes associated with osteogenic differentiation, including osteocalcin (OCN), osteopontin (OPN), runt domain-containing transcription factor (Runx2) and osterix (OSX) was also determined.
   Results: In vitro experiments demonstrated that A/CME increased ALP activity, osteogenic gene expression and mineralization under osteogenic-inducing conditions. Notably, we found that A/CME contained growth factors related to osteogenesis, including fibroblast growth factors and transforming growth factors, which potentially promoted osteogenic differentiation of MG-63 cells to a greater extent than AME.
   Conclusions: These results indicate that A/CME is capable of providing growth factors and other substrates for osteogenic differentiation, which significantly increased the efficacy of osteogenesis in MG-63 cells. Taken together, the results of this study suggest that human A/CME is a promising biomaterial with therapeutic potential in bone regeneration applications.
C1 [Go, Yoon Young; Chae, Sung-Won; Song, Jae-Jun] Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.
   [Kim, Sung Eun] Korea Univ, Coll Med, Dept Orthoped Surg, Seoul, South Korea.
   [Kim, Sung Eun] Korea Univ, Coll Med, Rare Dis Inst, Seoul, South Korea.
   [Cho, Geum Joon] Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.
RP Song, JJ (reprint author), Korea Univ, Guro Hosp, Dept Otorhinolaryngol Head & Neck Surg, 80 Guro Dong, Seoul 152703, South Korea.
EM jjsong23@gmail.com
FU National Research Foundation of Korea (NRF) grant - Korea government
   (MSIP) [2012M2A2A6035679]
FX This work was supported by a National Research Foundation of Korea (NRF)
   grant funded by the Korea government (MSIP) (No. 2012M2A2A6035679).
CR AKLE CA, 1981, LANCET, V2, P1003
   Boc S F, 1985, J Foot Surg, V24, P236
   Branski LK, 2008, BURNS, V34, P393, DOI 10.1016/j.burns.2007.06.007
   Bruderer M, 2014, EUR CELLS MATER, V28, P269, DOI 10.22203/eCM.v028a19
   Cecen B, 2015, J APPL BIOMATER FUNC, V13, P10, DOI 10.5301/jabfm.5000182
   Chen YJ, 2012, BIOMATERIALS, V33, P455, DOI 10.1016/j.biomaterials.2011.09.065
   Cowles EA, 1998, CALCIFIED TISSUE INT, V62, P74, DOI 10.1007/s002239900397
   Dahinterova J, 1969, SB VED PR LEK FAK S, P513
   Dua HS, 2004, SURV OPHTHALMOL, V49, P51, DOI 10.1016/j.survophthal.2003.10.004
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Farea M, 2014, ARCH ORAL BIOL, V59, P1400, DOI 10.1016/j.archoralbio.2014.08.015
   FAULK WP, 1980, LANCET, V1, P1156
   Feng XM, 2014, DEV GROWTH DIFFER, V56, P615, DOI 10.1111/dgd.12179
   Fritsche A, 2013, J APPL BIOMATER FUNC, V11, P1, DOI 10.5301/JABFM.2012.9263
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   He H, 2008, INVEST OPHTH VIS SCI, V49, P4468, DOI 10.1167/iovs.08-1781
   Hughes FJ, 2006, PERIODONTOL 2000, V41, P48, DOI 10.1111/j.1600-0757.2006.00161.x
   Kimura A, 2014, J ORAL MAXIL SURG, V72, P2015, DOI 10.1016/j.joms.2014.03.014
   Koob TJ, 2015, J BIOMED MATER RES B, V103, P1133, DOI 10.1002/jbm.b.33265
   Kruse FE, 2007, BRIT J OPHTHALMOL, V91, P841, DOI 10.1136/bjo.2006.108134
   Lim S., 2015, CELL TISSUE RES, P1
   Lindenmair A, 2010, BIOMATERIALS, V31, P8659, DOI 10.1016/j.biomaterials.2010.07.090
   Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254
   Lopez-Valladares MJ, 2010, ACTA OPHTHALMOL, V88, pe211, DOI 10.1111/j.1755-3768.2010.01908.x
   Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200
   Mohammadi AA, 2013, BURNS, V39, P349, DOI 10.1016/j.burns.2012.07.010
   Moore EE, 2005, OSTEOARTHR CARTILAGE, V13, P623, DOI 10.1016/j.joca.2005.03.003
   Ornitz DM, 2015, GENE DEV, V29, P1463, DOI 10.1101/gad.266551.115
   Rahman I, 2009, EYE, V23, P1954, DOI 10.1038/eye.2008.410
   Russo A, 2012, CELL TISSUE BANK, V13, P353, DOI 10.1007/s10561-011-9261-5
   Sheridan RL, 2001, BURNS, V27, P92, DOI 10.1016/S0305-4179(00)00076-0
   SORSBY A, 1947, BRIT J OPHTHALMOL, V31, P409, DOI 10.1136/bjo.31.7.409
   Suzuki E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112566
   Woo HM, 2001, BRIT J OPHTHALMOL, V85, P345, DOI 10.1136/bjo.85.3.345
   Xiao XY, 2013, EXP EYE RES, V115, P31, DOI 10.1016/j.exer.2013.06.005
   Zelen CM, 2015, CLIN PODIATR MED SUR, V32, P135, DOI 10.1016/j.cpm.2014.09.002
NR 36
TC 7
Z9 7
U1 4
U2 7
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 2280-8000
J9 J APPL BIOMATER FUNC
JI J. Appl. Biomater. Funct. Mater.
PD APR-JUN
PY 2016
VL 14
IS 2
BP E171
EP E180
DI 10.5301/jabfm.5000264
PG 10
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA EC8IS
UT WOS:000388385600006
PM 27056480
DA 2018-10-19
ER

PT J
AU Drira, N
   Piras, A
   Rosa, A
   Porcedda, S
   Dhaouadia, H
AF Drira, Neila
   Piras, Alessandra
   Rosa, Antonella
   Porcedda, Silvia
   Dhaouadia, Hatem
TI Microalgae from domestic wastewater facilitys high rate algal pond:
   Lipids extraction, characterization and biodiesel production
SO BIORESOURCE TECHNOLOGY
LA English
DT Article
DE wastewater; biomass flocculation/coagulation; lipid extraction;
   biodiesel
ID CHEMICAL-COMPOSITION; MICROWAVE IRRADIATION; HARVESTING MICROALGAE;
   CHLORELLA-VULGARIS; WET MICROALGAE; FLOCCULATION; PH;
   TRANSESTERIFICATION; MAGNESIUM; TISSUES
AB In this study, the harvesting of a biomass from a high rate algal pond (HRAP) of a real-scale domestic wastewater treatment facility and its potential as a biomaterial for the production of biodiesel were investigated. Increasing the medium pH to 12 induced high flocculation efficiency of up to 96% of the biomass through both sweep flocculation and charge neutralization. Lipids extracted by ultrasounds from this biomass contained around 70% of fatty acids, with palmitic and stearic acids being the most abundant. The extract obtained by supercritical CO2 contained 86% of fatty acids. Both conventional solvents extracts contained only around 10% of unsaturated fats, whereas supercritical CO2 extract contained more than 40% of unsaturated fatty acids. This same biomass was also subject to direct extractive-transesterification in a microwave reactor to produce fatty acid methyl ester, also known as, raw biodiesel.
C1 [Drira, Neila; Dhaouadia, Hatem] Univ Monastir, Fac Sci, Dept Chim, UR Chim Appl & Environm, Bvd Environm, Monastir 5000, Tunisia.
   [Piras, Alessandra; Porcedda, Silvia] Univ Cagliari, Dipartimento Sci Chim & Geol, Citadella Univ Monserrato,SP 8 Monserrato,Sestu k, I-09042 Monserrato, CA, Italy.
   [Rosa, Antonella] Univ Cagliari, Dipartimento Sci Biomed, Citadella Univ Monserrato,SP 8 Monserrato,Sestu k, I-09042 Monserrato, CA, Italy.
RP Dhaouadia, H (reprint author), Univ Monastir, Fac Sci, Dept Chim, UR Chim Appl & Environm, Bvd Environm, Monastir 5000, Tunisia.
EM neiladrira@yahoo.fr; apiras@unica.it; anrosa@unica.it;
   porcedda@unica.it; hatem.dhaouadi@fsm.rnu.tn
OI PORCEDDA, SILVIA/0000-0002-1441-3979; Rosa,
   Antonella/0000-0003-0939-9364; PIRAS, Alessandra/0000-0002-7232-4966
CR Andrich G, 2005, EUR J LIPID SCI TECH, V107, P381, DOI 10.1002/ejlt.200501130
   Araujo GS, 2013, ULTRASON SONOCHEM, V20, P95, DOI 10.1016/j.ultsonch.2012.07.027
   Aresta M, 2005, ENVIRON CHEM LETT, V3, P136, DOI 10.1007/s10311-005-0020-3
   Baananou S, 2015, NAT PROD RES, V29, P999, DOI 10.1080/14786419.2014.965167
   Chen CY, 2011, BIORESOURCE TECHNOL, V102, P71, DOI 10.1016/j.biortech.2010.06.159
   Cheng J, 2014, BIORESOURCE TECHNOL, V170, P69, DOI 10.1016/j.biortech.2014.07.089
   Christenson L, 2011, BIOTECHNOL ADV, V29, P686, DOI 10.1016/j.biotechadv.2011.05.015
   DRIRA N, 2015, DESALIN WATER TREAT
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5
   Martinez-Guerra E, 2014, APPL ENERG, V129, P354, DOI 10.1016/j.apenergy.2014.04.112
   Matthieu V, 2008, J CHROMATOGR A, V57, P1196
   Maxia A, 2012, MYCOPATHOLOGIA, V174, P61, DOI 10.1007/s11046-011-9519-2
   McMillan JR, 2013, APPL ENERG, V103, P128, DOI 10.1016/j.apenergy.2012.09.020
   Metchafe L.D., 1966, ANAL CHEM, V38, P524
   Mnari A, 2007, FOOD CHEM, V100, P1393, DOI 10.1016/j.foodchem.2005.11.030
   Mubarak M, 2015, ALGAL RES, V7, P117, DOI 10.1016/j.algal.2014.10.008
   Patil PD, 2011, BIORESOURCE TECHNOL, V102, P118, DOI 10.1016/j.biortech.2010.06.031
   Piras A, 2013, IND CROP PROD, V46, P317, DOI 10.1016/j.indcrop.2013.02.013
   Pittman JK, 2011, BIORESOURCE TECHNOL, V102, P17, DOI 10.1016/j.biortech.2010.06.035
   Prescott G. W., 1964, KNOW FRESHWATER ALGA
   RODIER J, 1996, ANALYSE EAU
   Rosa A, 2012, FOOD CHEM TOXICOL, V50, P3799, DOI 10.1016/j.fct.2012.07.003
   Garcia-Perez JS, 2014, ALGAL RES, V3, P24, DOI 10.1016/j.algal.2013.11.016
   Schlesinger A, 2012, BIOTECHNOL ADV, V30, P1023, DOI 10.1016/j.biotechadv.2012.01.011
   Teo CL, 2014, BIORESOURCE TECHNOL, V171, P477, DOI 10.1016/j.biortech.2014.08.024
   TGOBANOGLOUS G, 2003, WASTEWATER ENG OVERV
   Vandamme D, 2013, TRENDS BIOTECHNOL, V31, P233, DOI 10.1016/j.tibtech.2012.12.005
   Vandamme D, 2012, BIORESOURCE TECHNOL, V105, P114, DOI 10.1016/j.biortech.2011.11.105
   Vandamme D, 2010, J APPL PHYCOL, V22, P525, DOI 10.1007/s10811-009-9488-8
   Wahidin S, 2014, ENERG CONVERS MANAGE, V84, P227, DOI 10.1016/j.enconman.2014.04.034
   Wahlen BD, 2011, BIORESOURCE TECHNOL, V102, P2724, DOI 10.1016/j.biortech.2010.11.026
   Wileman A, 2012, BIORESOURCE TECHNOL, V104, P432, DOI 10.1016/j.biortech.2011.11.027
   Wu JH, 2015, BIORESOURCE TECHNOL, V197, P495, DOI 10.1016/j.biortech.2015.08.094
   Wu ZC, 2012, BIORESOURCE TECHNOL, V110, P496, DOI 10.1016/j.biortech.2012.01.101
NR 35
TC 19
Z9 19
U1 4
U2 47
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-8524
EI 1873-2976
J9 BIORESOURCE TECHNOL
JI Bioresour. Technol.
PD APR
PY 2016
VL 206
BP 239
EP 244
DI 10.1016/j.biortech.2016.01.082
PG 6
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA DF3RB
UT WOS:000371262100038
PM 26866759
DA 2018-10-19
ER

PT J
AU de Leon, CC
   Rios, MJS
   Alamo, NF
   Berriel, CH
   Robles, OJ
AF Carreno de Leon, Carmen
   Solache Rios, Marcos Jose
   Flores Alamo, Nicolas
   Hernandez Berriel, Consuelo
   Juarez Robles, Olivia
TI Biosorption of lead (II) and chromium with zea mays rachis in aqueous
   solutions: characterization studies
SO AFINIDAD
LA English
DT Article
DE Biosorption; heavy metals; Zea mays
ID HEAVY-METAL IONS; ORANGE PEEL; WASTE; ADSORPTION; REMOVAL; CR(III);
   BIOSORBENT; SORPTION; BIOMASS; SYSTEMS
AB The aim of this study was to evaluate the adsorption of lead (II) and chromium from aqueous solutions by Zea mays rachis (ZMR). Experiments were performed in a batch system in triplicate, metals content was evaluated by atomic absorption. According to the characterization studies, the biomaterial was classified as mesoporous, with an average pore size of 6.16 nm and is stable up to 220 degrees C, it is composed mainly by lignocellulose. It was found that the adsorption of lead (II) and chromium on ZMR at pH of 5.0 is a process of chemisorption with removal percentages of 100 and 64.8 % respectively, Freundlich isotherm described the process for lead (II) (R-2 = 0.999) and the Langmuir isotherm for chromium (R-2 = 0.989). The results show that the ZMR is suitable for the removal of these two metals, although it is more favorable for Lead (II).
C1 [Carreno de Leon, Carmen; Flores Alamo, Nicolas; Hernandez Berriel, Consuelo; Juarez Robles, Olivia] Inst Tecnol Toluca, Div Estudios Posgrad & Invest, Ave Tecnol S-N Col Agr Buenavista, Metepec 52149, Mex, Mexico.
   [Solache Rios, Marcos Jose] Inst Nacl Invest Nucl, Dept Quim, Apdo Postal 18-1027, Mexico City 11801, DF, Mexico.
RP de Leon, CC (reprint author), Inst Tecnol Toluca, Div Estudios Posgrad & Invest, Ave Tecnol S-N Col Agr Buenavista, Metepec 52149, Mex, Mexico.
EM mcarcarleon@yahoo.com.mx
FU Professor Improvement Program (PRO-MEP) [ITTOL-PTC-006]
FX The authors thank Professor Improvement Program (PRO-MEP) for supporting
   this research with the Project: ITTOL-PTC-006 and ITToluca for the
   facilities provided to complete this work.
CR Acosta I, 2012, AV CIENC ING, V3, P1
   Ahmad H-B., 2010, CHEM ENG J, V160, P190, DOI DOI 10.1016/J.CEJ.2010.03.040
   Altun R. A., 2009, CHEM ENG J, V151, P255
   Aman T, 2008, COLLOID SURFACE B, V63, P116, DOI 10.1016/j.colsurfb.2007.11.013
   Bedoya M., 2010, BISTUA REV FACULTAD, V8, P21
   Garcia-Reyes RB, 2010, BIORESOURCE TECHNOL, V101, P8099, DOI 10.1016/j.biortech.2010.06.020
   Bertagnolli C, 2014, CHEM ENG J, V237, P362, DOI 10.1016/j.cej.2013.10.024
   Bhatnagar A, 2010, ADV COLLOID INTERFAC, V160, P1, DOI 10.1016/j.cis.2010.06.011
   Cimino G, 2000, WATER RES, V34, P2955, DOI 10.1016/S0043-1354(00)00048-8
   Febrianto J, 2009, J HAZARD MATER, V162, P616, DOI 10.1016/j.jhazmat.2008.06.042
   Fu FL, 2011, J ENVIRON MANAGE, V92, P407, DOI 10.1016/j.jenvman.2010.11.011
   Garcia-Mendieta A, 2012, DESALINATION, V284, P167, DOI 10.1016/j.desal.2011.08.052
   Garcia-Rosales G, 2010, J ENVIRON MANAGE, V91, P2079, DOI 10.1016/j.jenvman.2010.06.004
   Gregg S.J., 1982, ADSORPTION SURFACE A, P111
   Gun'ko VM, 2013, ADV COLLOID INTERFAC, V187, P1, DOI 10.1016/j.cis.2012.11.001
   Gupta S, 2009, CHEM ENG J, V150, P352, DOI 10.1016/j.cej.2009.01.013
   Ho YS, 2006, WATER RES, V40, P119, DOI 10.1016/j.watres.2005.10.040
   Ho YS, 2004, SCIENTOMETRICS, V59, P171
   Ho YS, 2000, SEPAR PURIF METHOD, V29, P189, DOI 10.1081/SPM-100100009
   Ho YS, 2006, J HAZARD MATER, V136, P681, DOI 10.1016/j.jhazmat.2005.12.043
   Inoue K, 2010, HYDROMETALLURGY, V104, P123, DOI 10.1016/j.hydromet.2010.05.005
   Iqbal MJ, 2013, ASIAN J CHEM, V25, P2099
   Jacques RA, 2007, SEP PURIF TECHNOL, V57, P193, DOI 10.1016/j.seppur.2007.01.018
   Jain M, 2009, J HAZARD MATER, V162, P365, DOI 10.1016/j.jhazmat.2008.05.048
   Kaczala F, 2009, BIORESOURCE TECHNOL, V100, P235, DOI 10.1016/j.biortech.2008.05.055
   Li X, 2008, COLLOID SURFACE A, V317, P512, DOI 10.1016/j.colsurfa.2007.11.031
   Lopez-Mesas M, 2011, CHEM ENG J, V174, P9, DOI 10.1016/j.cej.2011.07.026
   Pinzon-Bedoya ML, 2009, DYNA-COLOMBIA, V76, P95
   Lugo-Lugo V, 2012, J ENVIRON MANAGE, V112, P120, DOI 10.1016/j.jenvman.2012.07.009
   Malkoc E, 2007, SEP PURIF TECHNOL, V54, P291, DOI 10.1016/j.seppur.2006.09.017
   Martin-Lara M. A., 2008, THESIS
   Miretzky P, 2008, BIORESOURCE TECHNOL, V99, P1211, DOI 10.1016/j.biortech.2007.02.045
   Moore W.J., 1986, FISICOQUIMICA BASICA, P284
   Navarro B. S., 2013, QUIMICA AGRICOLA SUE, P15
   Paliwal R.L., 2001, MAIZ TROPICOS MEJORA, P1
   Park D, 2010, BIOTECHNOL BIOPROC E, V15, P86, DOI 10.1007/s12257-009-0199-4
   Perez M.A.B., 2010, BIOCH ENG J, V53, P2
   Qaiser S., 2007, JAL BIOTECH, V10, P1
   Saha BC, 1999, APPL BIOCHEM BIOTECH, V76, P65, DOI 10.1385/ABAB:76:2:65
   Sari A, 2008, CHEM ENG J, V144, P1, DOI 10.1016/j.cej.2007.12.020
   Slejko F. L., 1985, ADSORPTION TECHNOLOG, P23
   Smith J.M., 1990, INGENIERIA CINETICA, P385
   Sud D, 2008, BIORESOURCE TECHNOL, V99, P6017, DOI 10.1016/j.biortech.2007.11.064
   Tan GQ, 2010, J HAZARD MATER, V174, P740, DOI 10.1016/j.jhazmat.2009.09.114
   Tejeda-Tovar C., 2014, EDUCACION INGENIERIA, V9, P86
   Ullah I, 2013, ECOL ENG, V60, P99, DOI 10.1016/j.ecoleng.2013.07.028
   Uluozlu OD, 2008, BIORESOURCE TECHNOL, V99, P2972, DOI 10.1016/j.biortech.2007.06.052
   Venugopal V, 2011, CHEM ENG J, V174, P151, DOI 10.1016/j.cej.2011.08.068
   Wang JL, 2009, BIOTECHNOL ADV, V27, P195, DOI 10.1016/j.biotechadv.2008.11.002
   Yamakake K.T.A., 2010, MEMORIAS INVESTIGACI, P1
   Yong Liu, 2010, Carbohydrate Polymers, V81, P335
   Zezzi M.A., 2004, CHEMOSPHERE, V54, P987
   Zvinowanda CM, 2009, INT J ENVIRON SCI TE, V6, P425, DOI 10.1007/BF03326081
NR 53
TC 1
Z9 1
U1 0
U2 2
PU ASOC QUIMICOS
PI BARCELONA
PA INST QUIMICO SARRIA, VIA AUGUSTA, 390, 08017 BARCELONA, SPAIN
SN 0001-9704
J9 AFINIDAD
JI Afinidad
PD APR-JUN
PY 2016
VL 73
IS 574
BP 140
EP 147
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA DT1HQ
UT WOS:000381232700009
DA 2018-10-19
ER

PT J
AU Wang, G
   Wang, JJ
   Li, F
   To, SST
AF Wang, Gang
   Wang, Jun-Jie
   Li, Fei
   To, Shing-Shun Tony
TI Development and Evaluation of a Novel Drug Delivery: Pluronics/SDS Mixed
   Micelle Loaded With Myricetin In Vitro and In Vivo
SO JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE myricetin (MYR); F68/SDS; lipid-based micelles; Labrasol; brain tumor;
   bioavailability
ID SODIUM DODECYL-SULFATE; WATER-SOLUBLE DRUGS; BLOCK-COPOLYMER;
   INTESTINAL-ABSORPTION; MASS-SPECTROMETRY; GENE DELIVERY; ACIDIC PH;
   LABRASOL; RATS; PHOSPHATIDYLCHOLINE
AB This study is to prepare and evaluate Pluronics-modified mixed micelle (MM) to deliver polyphenolic myricetin (MYR) across the blood-brain barrier. MYR has been proven to be an effective anticancer agent against glioblastoma cells in our previous studies. However, the poor solubility of MYR limits its access to the brain. In this study, the feasibility of preparing lipid-based MM that combined sodium dodecyl sulphate (SDS) with Pluronic F68 (F68) and Labrasol was investigated. Furthermore, the nonionic surfactant coating technology for the protection of MYR against oxidation, and its attainment in oral bioavailability, was examined. On account of the altered biomaterial properties of F68/SDS-modified lipid-based micelles, myricetin-loaded mixed micelles (MYR-MMs) were prepared by solvent-vaporation method to self-assembly into MMs. The average size of MYR-MMs was 96.3 nm, with negatively charged potential and spherical in shape. The drug loading of MYR-MMs was high with the increased grafting ratio, the more prolonged drug release profile, and more effective killing glioblastoma cells in vitro. Moreover, MYR-MMs showed a higher preference for the brain than free MYR alone, suggesting the novel MMs loaded with MYR could promote absorption and increase relative bioavailability. Taken together, the F68/SDS-modified and Labrasol-modified lipid-based micelles may provide a promising method to deliver polyphenolic compounds across the brain to treat brain tumor. (C) 2016 American Pharmacists Association(R). Published by Elsevier Inc. All rights reserved.
C1 [Wang, Gang; Wang, Jun-Jie; Li, Fei] Jiangsu Univ, Shanghai Peoples Hosp 8, Dept Pharmaceut, Shanghai 200235, Peoples R China.
   [Wang, Jun-Jie] Hubei Univ Med, Coll Pharm, Shiyan City 442000, Hubei, Peoples R China.
   [To, Shing-Shun Tony] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, Hong Kong, Peoples R China.
RP Wang, G (reprint author), Jiangsu Univ, Shanghai Peoples Hosp 8, Dept Pharmaceut, Shanghai 200235, Peoples R China.
EM wangan139@163.com
OI Tony, TO/0000-0003-1244-439X
CR Anderson BC, 2001, J CONTROL RELEASE, V70, P157, DOI 10.1016/S0168-3659(00)00341-2
   Batrakova EV, 2008, J CONTROL RELEASE, V130, P98, DOI 10.1016/j.jconrel.2008.04.013
   Chiu WT, 2010, NEUROBIOL DIS, V37, P118, DOI 10.1016/j.nbd.2009.09.015
   Contal E., 2010, THESIS
   Dang Y, 2014, Drug Res (Stuttg), V64, P516, DOI 10.1055/s-0033-1363220
   de Vos P, 2009, BIOMATERIALS, V30, P2559, DOI 10.1016/j.biomaterials.2009.01.014
   Du LY, 2014, EXPERT OPIN DRUG MET, V10, P921, DOI 10.1517/17425255.2014.918954
   Duan RL, 2011, ACTA PHARMACOL SIN, V32, P108, DOI 10.1038/aps.2010.192
   Eaimtrakarn S, 2002, J DRUG TARGET, V10, P255, DOI 10.1080/10611860290022688
   Fueyo J, 1998, NEUROLOGY, V51, P1250, DOI 10.1212/WNL.51.5.1250
   Fusco S, 2006, J BIOACT COMPAT POL, V21, P149, DOI 10.1177/0883911506063207
   Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017
   Gill KK, 2014, J DRUG TARGET, V30, P1
   GRIFFITHS LA, 1972, BIOCHEM J, V130, P141, DOI 10.1042/bj1300141
   GUZMAN M, 1992, INT J PHARM, V80, P119, DOI 10.1016/0378-5173(92)90269-8
   Hu ZP, 2001, LIFE SCI, V69, P2899, DOI 10.1016/S0024-3205(01)01375-3
   Itoh K, 2003, CHEM PHARM BULL, V51, P171, DOI 10.1248/cpb.51.171
   Jang JH, 2014, CHEM PHARM BULL, V62, P328, DOI 10.1248/cpb.c13-00814
   Kabanov AV, 2002, J CONTROL RELEASE, V82, P189, DOI 10.1016/S0168-3659(02)00009-3
   Ko CH, 2005, MOL CANCER THER, V4, P281
   Lapenna S, 2009, J PHARM SCI-US, V98, P3666, DOI 10.1002/jps.21685
   Lee Y, 2010, SOFT MATTER, V6, P977, DOI 10.1039/b919944f
   Li M, 2005, J BIOMED NANOTECHNOL, V1, P190
   Licciardi M, 2010, INT J PHARMACEUT, V396, P219, DOI 10.1016/j.ijpharm.2010.06.021
   Lin YL, 2007, BIOL PHARM BULL, V30, P1301, DOI 10.1248/bpb.30.1301
   Liu M, 2010, INT J PHARMACEUT, V391, P292, DOI 10.1016/j.ijpharm.2010.03.001
   Liu SQ, 2007, BIOMATERIALS, V28, P1423, DOI 10.1016/j.biomaterials.2006.11.013
   Lucas-Abellan C, 2008, J AGR FOOD CHEM, V56, P255, DOI 10.1021/jf0720640
   Maronpot RR, 2015, FOOD ADDIT CONTAM A, V32, P1799, DOI 10.1080/19440049.2015.1084653
   Min KH, 2010, J CONTROL RELEASE, V144, P259, DOI 10.1016/j.jconrel.2010.02.024
   Nduom EK, 2012, NEUROSURG CLIN N AM, V23, P439, DOI 10.1016/j.nec.2012.04.006
   Pazos M, 2009, J AGR FOOD CHEM, V57, P5042, DOI 10.1021/jf900437m
   Prasad YVR, 2003, INT J PHARM, V250, P181, DOI 10.1016/S0378-5173(02)00544-6
   Ranganathan R, 2005, CHEM PHYS LIPIDS, V135, P93, DOI 10.1016/j.chemphyslip.2005.02.004
   Rupp C, 2010, INT J PHARMACEUT, V395, P272, DOI 10.1016/j.ijpharm.2010.05.025
   Sharma PK, 2008, COLLOID SURFACE B, V61, P53, DOI 10.1016/j.colsurfb.2007.07.002
   Shih YW, 2009, J AGR FOOD CHEM, V57, P3490, DOI 10.1021/jf900124r
   Siegelin MD, 2009, CANCER LETT, V283, P230, DOI 10.1016/j.canlet.2009.04.002
   Strickley RG, 2004, PHARM RES, V21, P201, DOI 10.1023/B:PHAM.0000016235.32639.23
   Varshosaz J, 2014, J LIPOSOME RES, V24, P191, DOI 10.3109/08982104.2013.868476
   Wang YJ, 2012, INT J PHARMACEUT, V434, P1, DOI 10.1016/j.ijpharm.2012.05.015
   Weng CJ, 2012, CANCER METAST REV, V31, P323, DOI 10.1007/s10555-012-9347-y
   Xu RR, 2013, FOOD CHEM, V138, P48, DOI 10.1016/j.foodchem.2012.09.102
   Yang CY, 2001, J MICROENCAPSUL, V18, P223
   Yang T, 2007, INT J PHARM, V338, P317, DOI 10.1016/j.ijpharm.2007.02.011
   Yao YS, 2014, PHARMAZIE, V69, P19
   Zhu YA, 2010, ARCH PHARM RES, V33, P911, DOI 10.1007/s12272-010-0614-6
NR 47
TC 12
Z9 13
U1 6
U2 30
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3549
EI 1520-6017
J9 J PHARM SCI-US
JI J. Pharm. Sci.
PD APR
PY 2016
VL 105
IS 4
BP 1535
EP 1543
DI 10.1016/j.xphs.2016.01.016
PG 9
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA DT8TX
UT WOS:000381769600023
PM 26947760
DA 2018-10-19
ER

PT J
AU Cavallo, C
   Desando, G
   Ferrari, A
   Zini, N
   Mariani, E
   Grigolo, B
AF Cavallo, C.
   Desando, G.
   Ferrari, A.
   Zini, N.
   Mariani, E.
   Grigolo, B.
TI HYALURONAN SCAFFOLD SUPPORTS OSTEOGENIC DIFFERENTIATION OF BONE MARROW
   CONCENTRATE CELLS
SO JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
LA English
DT Article
DE orthopaedics; bone; transplantation; biomaterial; cells; histochemistry
ID MESENCHYMAL STEM-CELLS; ARTICULAR-CARTILAGE REPAIR; CHONDRAL DEFECTS;
   MICROFRACTURE; TRANSPLANTATION; PROLIFERATION; REGENERATION;
   OSTEOBLASTS; INJECTION; LESIONS
AB Osteochondral lesions are considered a challenge for orthopedic surgeons. Currently, the treatments available are often unsatisfactory and unable to stimulate tissue regeneration. Tissue engineering offers a new therapeutic strategy, taking into account the role exerted by cells, biomaterial and growth factors in restoring tissue damage. In this light, Mesenchymal Stem Cells (MSCs) have been indicated as a fascinating tool for regenerative medicine thanks to their ability to differentiate into bone, cartilage and adipose tissue. However, in vitro-cultivation of MSCs could be associated with some risks such as de-differentiation/reprogramming, infection and contaminations of the cells. To overcome these shortcomings, a new approach is represented by the use of Bone Marrow Concentrate (BMC), that could allow the delivery of cells surrounded by their microenvironment in injured tissue. For this purpose, cells require a tridimensional scaffold that can support their adhesion, proliferation and differentiation. This study is focused on the potentiality of BMC seeded onto a hyaluronan-based scaffold (Hyaff-11) to differentiate into osteogenic lineage. This process depends on the specific interaction between cells derived from bone marrow (surrounded by their niche) and scaffold, that create an environment able to support the regeneration of damaged tissue. The data obtained from the present study demonstrate that BMC grown onto Hyaff-11 are able to differentiate toward osteogenic sense, producing specific osteogenic genes and matrix proteins.
C1 [Cavallo, C.; Desando, G.; Mariani, E.; Grigolo, B.] Rizzoli Orthoped Inst, SSD Lab RAMSES, Bologna, Italy.
   [Ferrari, A.] Rizzoli Orthoped Inst, Lab Musculoskeletal Cell Biol, Bologna, Italy.
   [Zini, N.] IGM CNR, Rizzoli Orthoped Inst, Bologna, Italy.
   [Mariani, E.; Grigolo, B.] Rizzoli Orthopaed Inst, SC Lab Immunorheumatol & Tissue Regenerat, Bologna, Italy.
   [Mariani, E.] Univ Bologna, Dept Med & Surg Sci, Bologna, Italy.
RP Grigolo, B (reprint author), Rizzoli Orthoped Inst, SSD Lab RAMSES, SC Lab Immunorheumatol & Tissue Regenerat, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM brunella.grigolo@ior.it
OI Cavallo, Carola/0000-0002-2913-856X
FU Progetto Regione Emilia-Romagna University
FX We thank Patrizia Rappini and Graziella Salmi for their assistance in
   the preparation of the manuscript and Luciano Pizzi for his technical
   assistance. We also thank Dr Elettra Pignotti for statistical analysis.
   This work was partially supported by grants from Progetto Regione
   Emilia-Romagna University 2010-2012 "Regenerative medicine of cartilage
   and bone".
CR AHMED SA, 1994, J IMMUNOL METHODS, V170, P211
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Blair H, 2007, ANN NY ACAD SCI, V116, P165
   BLANCO FJ, 1995, J IMMUNOL, V154, P4018
   Block JE, 2005, MED HYPOTHESES, V65, P740, DOI 10.1016/j.mehy.2005.04.026
   Brittberg M, 1999, CLIN ORTHOP RELAT R, pS147
   Buckwalter JA, 1998, ARTHRITIS RHEUM-US, V41, P1331, DOI 10.1002/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO;2-J
   Cavallo C, 2013, J BIOMED MATER RES A, V101, P1559, DOI 10.1002/jbm.a.34460
   Gan YK, 2008, BIOMATERIALS, V29, P3973, DOI 10.1016/j.biomaterials.2008.06.026
   Giannini S, 2009, CLIN ORTHOP RELAT R, V467, P3307, DOI 10.1007/s11999-009-0885-8
   Giannoudis PV, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(08)70003-2
   Herberts CA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-29
   Hernigou P, 2015, INT ORTHOP, V39, P1639, DOI 10.1007/s00264-015-2738-2
   Hisatome T, 2005, BIOMATERIALS, V26, P4550, DOI 10.1016/j.biomaterials.2004.11.032
   Hosseinkhani M, 2014, WORLD J PLAST SURG, V3, P3
   Jager M, 2009, CURR STEM CELL RES T, V4, P34, DOI 10.2174/157488809787169039
   Kacena MA, 2006, BONE, V39, P978, DOI 10.1016/j.bone.2006.05.019
   Kreuz PC, 2006, OSTEOARTHR CARTILAGE, V14, P1119, DOI 10.1016/j.joca.2006.05.003
   Lisignoli G, 2002, BIOMATERIALS, V23, P1043, DOI 10.1016/S0142-9612(01)00216-2
   MANKIN HJ, 1982, J BONE JOINT SURG AM, V64, P460, DOI 10.2106/00004623-198264030-00022
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   Marijanovic I, 2003, CROAT MED J, V44, P412
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Matsumoto T, 2010, J CELL PHYSIOL, V225, P291, DOI 10.1002/jcp.22223
   Murphy MB, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.94
   Ochi M, 2001, ARTIF ORGANS, V25, P172, DOI 10.1046/j.1525-1594.2001.025003172.x
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Rozen S, 2000, Methods Mol Biol, V132, P365
   Schroeder Tania M., 2005, Birth Defects Research, V75, P213, DOI 10.1002/bdrc.20043
   Shang XL, 2016, KNEE SURG SPORT TR A, V24, P1243, DOI 10.1007/s00167-015-3575-y
   Sharma L, 2016, OSTEOARTHR CARTILAGE, V24, P36, DOI 10.1016/j.joca.2015.07.026
   Solchaga LA, 2000, J ORTHOP RES, V18, P773, DOI 10.1002/jor.1100180515
   Steadman JR, 2001, CLIN ORTHOP RELAT R, pS362, DOI 10.1097/00003086-200110001-00033
   Velazquez OC, 2007, J VASC SURG, V45, p39A, DOI 10.1016/j.jvs.2007.02.068
   Yoo HS, 2005, BIOMATERIALS, V26, P1925, DOI 10.1016/j.biomaterials.2004.06.021
NR 35
TC 2
Z9 2
U1 0
U2 6
PU BIOLIFE SAS
PI SILVA MARINA (TE)
PA VIA S STEFANO 39 BIS, 64029 SILVA MARINA (TE), ITALY
SN 0393-974X
EI 1724-6083
J9 J BIOL REG HOMEOS AG
JI J. Biol. Regul. Homeost. Agents
PD APR-JUN
PY 2016
VL 30
IS 2
BP 409
EP 420
PG 12
WC Endocrinology & Metabolism; Immunology; Medicine, Research &
   Experimental; Physiology
SC Endocrinology & Metabolism; Immunology; Research & Experimental
   Medicine; Physiology
GA DR3IB
UT WOS:000379795800012
PM 27358127
DA 2018-10-19
ER

PT J
AU Garcia, JR
   Garcia, AJ
AF Garcia, Jose R.
   Garcia, Andres J.
TI Biomaterial-mediated strategies targeting vascularization for bone
   repair
SO DRUG DELIVERY AND TRANSLATIONAL RESEARCH
LA English
DT Article
DE Vascularization; Bone regeneration; Growth factor; Cell therapy; Tissue
   engineering
ID MESENCHYMAL STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; PLATELET-RICH PLASMA;
   TISSUE-ENGINEERED CONSTRUCTS; SIZED CALVARIAL DEFECTS; MARROW STROMAL
   CELLS; MORPHOGENETIC PROTEIN-2; PROGENITOR CELLS; IN-VITRO; GENE-THERAPY
AB Repair of non-healing bone defects through tissue engineering strategies remains a challenging feat in the clinic due to the aversive microenvironment surrounding the injured tissue. The vascular damage that occurs following a bone injury causes extreme ischemia and a loss of circulating cells that contribute to regeneration. Tissue-engineered constructs aimed at regenerating the injured bone suffer from complications based on the slow progression of endogenous vascular repair and often fail at bridging the bone defect. To that end, various strategies have been explored to increase blood vessel regeneration within defects to facilitate both tissue-engineered and natural repair processes. Developments that induce robust vascularization will need to consolidate various parameters including optimization of embedded therapeutics, scaffold characteristics, and successful integration between the construct and the biological tissue. This review provides an overview of current strategies as well as new developments in engineering biomaterials to induce reparation of a functional vascular supply in the context of bone repair.
C1 [Garcia, Jose R.; Garcia, Andres J.] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   [Garcia, Jose R.; Garcia, Andres J.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.; Garcia, AJ (reprint author), Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
FU National Institutes of Health (NIH) [R01-AR062368, R01-AR062920]; Cell
   and Tissue Engineering NIH Biotechnology Training Grant [T32-GM008433]
FX This work was supported by the National Institutes of Health (NIH)
   grants R01-AR062368 and R01-AR062920 (AJG). JRG was supported by the
   Cell and Tissue Engineering NIH Biotechnology Training Grant
   (T32-GM008433).
CR Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802
   Aronin CEP, 2010, BIOMATERIALS, V31, P6417, DOI 10.1016/j.biomaterials.2010.04.061
   Asahara T, 2011, STEM CELLS, V29, P1650, DOI 10.1002/stem.745
   Asahina Izumi, 1997, Journal of Medical and Dental Sciences, V44, P63
   Awojoodu AO, 2013, P NATL ACAD SCI USA, V110, P13785, DOI 10.1073/pnas.1221309110
   Baek WY, 2009, J BONE MINER RES, V24, P1055, DOI [10.1359/JBMR.081248, 10.1359/jbmr.081248]
   Bai K, 2010, J BIOMECH, V43, P1176, DOI 10.1016/j.jbiomech.2009.11.030
   Bai Y, 2013, INT IMMUNOPHARMACOL, V16, P214, DOI 10.1016/j.intimp.2013.04.001
   Baltzer AWA, 2000, GENE THER, V7, P734, DOI 10.1038/sj.gt.3301166
   Baltzer AWA, 1999, KNEE SURG SPORT TR A, V7, P197, DOI 10.1007/s001670050147
   Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023
   Becquart P, 2012, TISSUE ENG PT A, V18, P2084, DOI [10.1089/ten.tea.2011.0690, 10.1089/ten.TEA.2011.0690]
   Berner A, 2012, CELL TISSUE RES, V347, P501, DOI 10.1007/s00441-011-1184-8
   Bleich NK, 2012, ADV DRUG DELIVER REV, V64, P1320, DOI 10.1016/j.addr.2012.03.007
   Boerckel JD, 2011, P NATL ACAD SCI USA, V108, pE674, DOI 10.1073/pnas.1107019108
   Bulnheim U, 2014, J TISSUE ENG REGEN M, V8, P831, DOI 10.1002/term.1590
   Byers BA, 2006, J BIOMED MATER RES A, V76A, P646, DOI 10.1002/jbm.a.30549
   Byers BA, 2002, J BONE MINER RES, V17, P1931, DOI 10.1359/jbmr.2002.17.11.1931
   Camci-Unal G, 2013, POLYM INT, V62, P843, DOI 10.1002/pi.4502
   Cao L, 2012, J BIOMED MATER RES B, V100B, P1229, DOI 10.1002/jbm.b.32687
   Carlevaro MF, 2000, J CELL SCI, V113, P59
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075
   Chen D, 2004, FRONT BIOSCI, V9, P349, DOI 10.2741/1090
   Chen XF, 2010, TISSUE ENG PT A, V16, P585, DOI [10.1089/ten.tea.2009.0491, 10.1089/ten.TEA.2009.0491]
   Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314
   Cheng G, 2011, BLOOD, V118, P4740, DOI 10.1182/blood-2011-02-338426
   Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017
   Chevrier A, 2007, OSTEOARTHR CARTILAGE, V15, P316, DOI 10.1016/j.joca.2006.08.007
   Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206
   Cornejo A, 2012, TISSUE ENG PT A, V18, P1552, DOI [10.1089/ten.tea.2011.0515, 10.1089/ten.TEA.2011.0515]
   Dalby MJ, 2014, NAT MATER, V13, P558, DOI [10.1038/NMAT3980, 10.1038/nmat3980]
   Das A, 2014, J BIOMED MATER RES A, V102, P1210, DOI 10.1002/jbm.a.34779
   De la Riva B, 2010, J CONTROL RELEASE, V143, P45, DOI 10.1016/j.jconrel.2009.11.026
   Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545
   Degano IR, 2008, BIOMATERIALS, V29, P427, DOI 10.1016/j.biomaterials.2007.10.006
   Derubeis AR, 2004, ANN BIOMED ENG, V32, P160, DOI 10.1023/B:ABME.0000007800.89194.95
   Deschepper M, 2011, J CELL MOL MED, V15, P1505, DOI 10.1111/j.1582-4934.2010.01138.x
   Dong JD, 2009, ACTA PHARMACOL SIN, V30, P530, DOI 10.1038/aps.2009.40
   Duan CG, 2014, ARCH MED SCI, V10, P174, DOI 10.5114/aoms.2012.30950
   Dupont KM, 2010, P NATL ACAD SCI USA, V107, P3305, DOI 10.1073/pnas.0905444107
   Eman RM, 2014, STEM CELLS DEV
   Feng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082945
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Fittkau MH, 2005, BIOMATERIALS, V26, P167, DOI 10.1016/j.biomaterials.2004.02.012
   Forsythe JA, 1996, MOL CELL BIOL, V16, P4604
   Freeman I, 2008, BIOMATERIALS, V29, P3260, DOI 10.1016/j.biomaterials.2008.04.025
   Fujita M, 2004, BIOMATERIALS, V25, P699, DOI 10.1016/S0142-9612(03)00557-X
   Galas RJ, 2014, J CELL PHYSIOL, V229, P90, DOI 10.1002/jcp.24421
   Gao C, 2013, EUR CELLS MATER, V26, P195, DOI 10.22203/eCM.v026a14
   Garcia JR, 2014, NAT MATER, V13, P539, DOI 10.1038/nmat3996
   Geesink RGT, 1999, J BONE JOINT SURG BR, V81B, P710, DOI 10.1302/0301-620X.81B4.9311
   Geiger F, 2005, J BONE MINER RES, V20, P2028, DOI 10.1359/JBMR.050701
   Gerber HP, 1999, NAT MED, V5, P623
   Gershovich JG, 2013, TISSUE ENG PT A, V19, P2565, DOI [10.1089/ten.tea.2013.0256, 10.1089/ten.TEA.2013.0256]
   Geuze RE, 2010, TISSUE ENG PT A, V16, P3343, DOI [10.1089/ten.tea.2009.0774, 10.1089/ten.TEA.2009.0774]
   Geuze RE, 2012, TISSUE ENG PT A, V18, P2052, DOI [10.1089/ten.tea.2011.0560, 10.1089/ten.TEA.2011.0560]
   Ghajar CM, 2006, TISSUE ENG, V12, P2875, DOI 10.1089/ten.2006.12.2875
   Grainger SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022086
   Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009
   Harrison BS, 2007, BIOMATERIALS, V28, P4628, DOI 10.1016/j.biomaterials.2007.07.003
   He X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104323
   Hendrich C, 2009, ORTHOP REV, V1, P99, DOI 10.4081/or.2009.e32
   Hernandez A, 2012, J BIOMED MATER RES A, V100A, P2382, DOI 10.1002/jbm.a.34183
   Hettiaratchi MH, 2014, BIOMATERIALS, V35, P7228, DOI 10.1016/j.biomaterials.2014.05.011
   Hollinger JO, 1998, J BIOMED MATER RES, V43, P356, DOI 10.1002/(SICI)1097-4636(199824)43:4<356::AID-JBM3>3.0.CO;2-7
   Hu N, 2013, J CELL SCI, V126, P532, DOI 10.1242/jcs.114231
   Huang YC, 2005, GENE THER, V12, P418, DOI 10.1038/sj.gt.3302439
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   Hutmacher DW, 2005, GENE, V347, P1, DOI 10.1016/j.gene.2004.12.040
   Jacobs SA, 2013, IMMUNOL CELL BIOL, V91, P32, DOI 10.1038/icb.2012.64
   Jager M, 2011, J ORTHOP RES, V29, P173, DOI 10.1002/jor.21230
   Jo S, 2013, J BIOMED MATER RES A, V101, P892, DOI 10.1002/jbm.a.34354
   Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130
   Kang SH, 2014, CELL TISSUE RES, V355, P81, DOI 10.1007/s00441-013-1738-z
   Kang YQ, 2013, ACTA BIOMATER, V9, P4906, DOI 10.1016/j.actbio.2012.08.008
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763
   Karvinen H, 2011, GENE THER, V18, P1166, DOI 10.1038/gt.2011.66
   Kempen DHR, 2009, BIOMATERIALS, V30, P2816, DOI 10.1016/j.biomaterials.2009.01.031
   Khan OF, 2011, TRENDS BIOTECHNOL, V29, P379, DOI 10.1016/j.tibtech.2011.03.004
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   Kim YH, 2014, BIOMATERIALS, V35, P214, DOI 10.1016/j.biomaterials.2013.09.103
   Kirker-Head C, 2007, BONE, V41, P247, DOI 10.1016/j.bone.2007.04.186
   Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330
   Kitoh H, 2007, J PEDIATR ORTHOPED, V27, P629, DOI 10.1097/BPO.0b013e318093f523
   Kitoh H, 2007, BONE, V40, P522, DOI 10.1016/j.bone.2006.09.019
   Koob S, 2011, TISSUE ENG PT A, V17, P311, DOI 10.1089/ten.TEA.2010.0338
   Langenfeld EM, 2004, MOL CANCER RES, V2, P141
   Laranjeira MS, 2012, CELL PROLIFERAT, V45, P320, DOI 10.1111/j.1365-2184.2012.00822.x
   Leach JK, 2006, BIOMATERIALS, V27, P3249, DOI 10.1016/j.biomaterials.2006.01.033
   Lee JY, 2001, J BONE JOINT SURG AM, V83A, P1032, DOI 10.2106/00004623-200107000-00008
   Lee TT, 2014, NAT MAT
   Leslie-Barbick JE, 2009, J BIOMAT SCI-POLYM E, V20, P1763, DOI 10.1163/156856208X386381
   Levi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011177
   Li Q, 2013, ARCH MED RES, V44, P504, DOI 10.1016/j.arcmed.2013.09.009
   Li R, 2009, J ORTHOP RES, V27, P8, DOI 10.1002/jor.20658
   Lin GL, 2011, J CELL BIOCHEM, V112, P3491, DOI 10.1002/jcb.23287
   Liu SY, 2011, TISSUE ENG PT A, V17, P725, DOI [10.1089/ten.tea.2010.0331, 10.1089/ten.TEA.2010.0331]
   Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602
   Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x
   Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Ma JL, 2014, J BIOMED MATER RES A, V102, P1026, DOI 10.1002/jbm.a.34775
   Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009
   MAEDA T, 1994, J BIOCHEM, V115, P182, DOI 10.1093/oxfordjournals.jbchem.a124315
   Majumdar MK, 2001, J CELL PHYSIOL, V189, P275, DOI 10.1002/jcp.10025
   Mariner PD, 2013, J ORTHOP RES, V31, P401, DOI 10.1002/jor.22243
   Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663
   Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614
   MASSIA SP, 1992, J BIOL CHEM, V267, P14019
   McCall JD, 2012, DRUG DELIV TRANSL RE, V2, P305, DOI 10.1007/s13346-012-0090-2
   McCarthy I, 2006, J BONE JOINT SURG AM, V88A, P4, DOI 10.2106/JBJS.F.00890
   Mckay WF, 2007, INT ORTHOP, V31, P729, DOI 10.1007/s00264-007-0418-6
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   Moutsatsos IK, 2001, MOL THER, V3, P449, DOI 10.1006/mthe.2001.0291
   Nguyen EH, 2014, BIOMATERIALS, V35, P2149, DOI 10.1016/j.biomaterials.2013.11.054
   Nguyen TH, 2013, NAT CHEM, V5, P221, DOI [10.1038/nchem.1573, 10.1038/NCHEM.1573]
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   Oh SH, 2009, BIOMATERIALS, V30, P757, DOI 10.1016/j.biomaterials.2008.09.065
   Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702
   Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191
   Ono I, 2004, BIOMATERIALS, V25, P4709, DOI 10.1016/j.biomaterials.2003.11.038
   Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702
   Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377
   Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420
   Pang H, 2013, INT ORTHOP, V37, P753, DOI 10.1007/s00264-012-1751-y
   Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019
   Patterson J, 2010, BIOMATERIALS, V31, P6772, DOI 10.1016/j.biomaterials.2010.05.047
   Pedraza E, 2012, P NATL ACAD SCI USA, V109, P4245, DOI 10.1073/pnas.1113560109
   Percival CJ, 2013, DEV DYNAM, V242, P909, DOI 10.1002/dvdy.23992
   Phelps EA, 2013, BIOMATERIALS, V34, P4602, DOI 10.1016/j.biomaterials.2013.03.012
   Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107
   Ramirez-Fernandez MP, 2013, CLIN ORAL INVEST, V17, P147, DOI 10.1007/s00784-012-0684-6
   Portalska KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046842
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Raida M, 2005, J CANCER RES CLIN, V131, P741, DOI 10.1007/s00432-005-0024-1
   Rao RR, 2014, ACTA BIOMATER, V10, P3091, DOI 10.1016/j.actbio.2014.03.010
   Rao RR, 2013, CYTOTHERAPY, V15, P1309, DOI 10.1016/j.jcyt.2013.06.005
   Rao RR, 2012, ANGIOGENESIS, V15, P253, DOI 10.1007/s10456-012-9257-1
   Ravanti L, 2000, INT J MOL MED, V6, P391
   Ren LL, 2014, BONE, V64, P173, DOI 10.1016/j.bone.2014.04.011
   Resch T, 2012, STEM CELL REV REP, V8, P926, DOI 10.1007/s12015-011-9332-9
   Rihn JA, 2009, SPINE J, V9, P623, DOI 10.1016/j.spinee.2009.04.004
   Ross TD, 2013, CURR OPIN CELL BIOL, V25, P613, DOI 10.1016/j.ceb.2013.05.006
   Salimath AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050980
   Santos MI, 2010, MACROMOL BIOSCI, V10, P12, DOI 10.1002/mabi.200900107
   Santos MI, 2009, BIOMATERIALS, V30, P4407, DOI 10.1016/j.biomaterials.2009.05.004
   Seebach C, 2012, CELL TRANSPLANT, V21, P1667, DOI 10.3727/096368912X638937
   Seebach C, 2010, TISSUE ENG PT A, V16, P1961, DOI [10.1089/ten.tea.2009.0715, 10.1089/ten.TEA.2009.0715]
   Seebach E, 2014, ACTA BIOMATER, V10, P4730, DOI 10.1016/j.actbio.2014.07.017
   Sefcik LS, 2008, BIOMATERIALS, V29, P2869, DOI 10.1016/j.biomaterials.2008.03.017
   Sensebe L, 2010, VOX SANG, V98, P93, DOI 10.1111/j.1423-0410.2009.01227.x
   Shantsila E, 2007, J AM COLL CARDIOL, V49, P741, DOI 10.1016/j.jacc.2006.09.050
   Shekaran A, 2014, BIOMATERIALS, V35, P5453, DOI 10.1016/j.biomaterials.2014.03.055
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Shi YF, 2010, CELL RES, V20, P510, DOI 10.1038/cr.2010.44
   SORRELL JM, 1988, ANAT REC, V221, P730
   Steiner D, 2012, J ORTHOP RES, V30, P1682, DOI 10.1002/jor.22130
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Sun HC, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-41
   Taite LJ, 2008, J BIOMED MATER RES B, V84B, P108, DOI 10.1002/jbm.b.30850
   Tayalia P, 2009, ADV MATER, V21, P3269, DOI 10.1002/adma.200900241
   Tsigkou O, 2010, P NATL ACAD SCI USA, V107, P3311, DOI 10.1073/pnas.0905445107
   Tsumaki N, 2002, J BONE MINER RES, V17, P898, DOI 10.1359/jbmr.2002.17.5.898
   Usami K, 2009, J BIOMED MATER RES A, V90A, P730, DOI 10.1002/jbm.a.32142
   Valimaki VV, 2005, TISSUE ENG, V11, P387, DOI 10.1089/ten.2005.11.387
   Vila OF, 2014, ACTA BIOMATER, V10, P4377, DOI 10.1016/j.actbio.2014.05.028
   Wang H, 2005, ARTERIOSCL THROM VAS, V25, P1817, DOI 10.1161/01.ATV.0000175840.90510.a8
   Wang J, 2011, BIOCHEM BIOPH RES CO, V412, P143, DOI 10.1016/j.bbrc.2011.07.062
   Wernike E, 2010, EUR CELLS MATER, V19, P30
   Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215
   Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705
   Ye F, 2012, BLOOD, V119, P26, DOI 10.1182/blood-2011-04-292128
   Yoneda M, 2005, BIOMATERIALS, V26, P5145, DOI 10.1016/j.biomaterials.2005.01.054
   Young S, 2009, TISSUE ENG PT A, V15, P2347, DOI 10.1089/ten.tea.2008.0510
   Yourek G, 2010, REGEN MED, V5, P713, DOI [10.2217/rme.10.60, 10.2217/RME.10.60]
   Yu HY, 2008, J ORTHOP RES, V26, P1147, DOI 10.1002/jor.20609
   Zelzer E, 2004, DEVELOPMENT, V131, P2161, DOI 10.1242/dev.01053
   Zhang ZY, 2010, BIOMATERIALS, V31, P608, DOI 10.1016/j.biomaterials.2009.09.078
   Zieris A, 2010, BIOMATERIALS, V31, P7985, DOI 10.1016/j.biomaterials.2010.07.021
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
   Zou DH, 2011, STEM CELLS, V29, P1380, DOI 10.1002/stem.693
NR 185
TC 11
Z9 11
U1 3
U2 36
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2190-393X
EI 2190-3948
J9 DRUG DELIV TRANSL RE
JI Drug Deliv. Transl. Res.
PD APR
PY 2016
VL 6
IS 2
BP 77
EP 95
DI 10.1007/s13346-015-0236-0
PG 19
WC Instruments & Instrumentation; Medicine, Research & Experimental;
   Pharmacology & Pharmacy
SC Instruments & Instrumentation; Research & Experimental Medicine;
   Pharmacology & Pharmacy
GA DO9YX
UT WOS:000378145200002
PM 26014967
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Jeon, OH
   Elisseeff, J
AF Jeon, Ok Hee
   Elisseeff, Jennifer
TI Orthopedic tissue regeneration: cells, scaffolds, and small molecules
SO DRUG DELIVERY AND TRANSLATIONAL RESEARCH
LA English
DT Review
DE Osteoporosis; Osteoarthritis; Bone; Cartilage; Stemcells; Scaffolds;
   Small molecules
ID MESENCHYMAL STEM-CELLS; OSTEOARTHRITIS STRUCTURAL ARTHRITIS;
   DEGENERATIVE JOINT DISEASE; ENHANCES BONE REGENERATION;
   ARTICULAR-CARTILAGE DEFECT; IN-VITRO CHONDROGENESIS; PLATELET-RICH
   PLASMA; SUBCHONDRAL BONE; KNEE OSTEOARTHRITIS; STRONTIUM RANELATE
AB Orthopedic tissue regeneration would benefit the aging population or patients with degenerative bone and cartilage diseases, especially osteoporosis and osteoarthritis. Despite progress in surgical and pharmacological interventions, new regenerative approaches are needed to meet the challenge of creating bone and articular cartilage tissues that are not only structurally sound but also functional, primarily to maintain mechanical integrity in their high load-bearing environments. In this review, we discuss new advances made in exploiting the three classes of materials in bone and cartilage regenerative medicine-cells, biomaterial-based scaffolds, and small molecules-and their successes and challenges reported in the clinic. In particular, the focus will be on the development of tissue-engineered bone and cartilage ex vivo by combining stem cells with biomaterials, providing appropriate structural, compositional, and mechanical cues to restore damaged tissue function. In addition, using small molecules to locally promote regeneration will be discussed, with potential approaches that combine bone and cartilage targeted therapeutics for the orthopedic-related disease, especially osteoporosis and osteoarthritis.
C1 [Elisseeff, Jennifer] Johns Hopkins Univ, Translat Tissue Engn Ctr, Wilmer Eye Inst, 5031 Smith Bldg,400N Broadway, Baltimore, MD 21231 USA.
   Johns Hopkins Univ, Dept Biomed Engn, 5031 Smith Bldg,400N Broadway, Baltimore, MD 21231 USA.
RP Elisseeff, J (reprint author), Johns Hopkins Univ, Translat Tissue Engn Ctr, Wilmer Eye Inst, 5031 Smith Bldg,400N Broadway, Baltimore, MD 21231 USA.
EM jhe@jhu.edu
CR Amini Ami R., 2012, Critical Reviews in Biomedical Engineering, V40, P363
   AMIR G, 1992, J CLIN PATHOL, V45, P990, DOI 10.1136/jcp.45.11.990
   Arrigoni E, 2013, J ORTHOP SCI, V18, P331, DOI 10.1007/s00776-012-0349-y
   Ashhurst DE, 2004, MATRIX BIOL, V23, P15, DOI 10.1016/j.mathbio.2004.02.001
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   Bay-Jensen AC, 2010, RHEUMATOL INT, V30, P435, DOI 10.1007/s00296-009-1183-1
   Bellido M, 2011, OSTEOARTHR CARTILAGE, V19, P1228, DOI 10.1016/j.joca.2011.07.003
   Bellido M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3103
   Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058
   Bingham CO, 2006, ARTHRITIS RHEUM, V54, P3494, DOI 10.1002/art.22160
   Bone HG, 2015, OSTEOPOROSIS INT, V26, P699, DOI 10.1007/s00198-014-2944-6
   Boonen S, 2012, CURR OSTEOPOROS REP, V10, P73, DOI 10.1007/s11914-011-0085-9
   Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165
   Buckland-Wright JC, 2007, RHEUMATOLOGY, V46, P257, DOI 10.1093/rheumatology/kel213
   Burr DB, 2012, NAT REV RHEUMATOL, V8, P665, DOI 10.1038/nrrheum.2012.130
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Carbone LD, 2004, ARTHRITIS RHEUM, V50, P3516, DOI 10.1002/art.20627
   Centeno CJ, 2008, PAIN PHYSICIAN, V11, P343
   Chang JK, 2009, ARTHRITIS RHEUM, V60, P3049, DOI 10.1002/art.24843
   Chen GP, 2004, BIOCHEM BIOPH RES CO, V322, P50, DOI 10.1016/j.bbrc.2004.07.071
   Coleman RM, 2007, BIOMATERIALS, V28, P2077, DOI 10.1016/j.biomaterials.2007.01.010
   Connor JR, 2009, OSTEOARTHR CARTILAGE, V17, P1236, DOI 10.1016/j.joca.2009.03.015
   Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958
   de Peppo GM, 2013, P NATL ACAD SCI USA, V110, P8680, DOI 10.1073/pnas.1301190110
   Debnath T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120803
   Diekman BO, 2012, P NATL ACAD SCI USA, V109, P19172, DOI 10.1073/pnas.1210422109
   Dragoo JL, 2007, TISSUE ENG, V13, P1615, DOI 10.1089/ten.2006.0249
   Duan XJ, 2011, J CELL PHYSIOL, V226, P150, DOI 10.1002/jcp.22316
   Estes BT, 2006, ARTHRITIS RHEUM, V54, P1222, DOI 10.1002/art.21779
   Eswaramoorthy R, 2012, ACTA BIOMATER, V8, P2254, DOI 10.1016/j.actbio.2012.03.015
   Fan HB, 2006, J BIOMED MATER RES A, V77A, P785, DOI 10.1002/jbm.a.30647
   Favi PM, 2013, MAT SCI ENG C-MATER, V33, P1935, DOI 10.1016/j.msec.2012.12.100
   FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381
   Frohlich M, 2010, TISSUE ENG PT A, V16, P179, DOI 10.1089/ten.TEA.2009.0164
   Fu SZ, 2012, BIOMATERIALS, V33, P4801, DOI 10.1016/j.biomaterials.2012.03.040
   Fukunaga N, 2010, CELL REPROGRAM, V12, P369, DOI [10.1089/cell.2009.0097, 10.1089/cell.2009.0086]
   Gabbay JS, 2006, ANN PLAS SURG, V57, P89, DOI 10.1097/01.sap.0000205378.89052.d3
   Garnero P, 2008, OSTEOARTHR CARTILAGE, V16, P660, DOI 10.1016/j.joca.2007.10.002
   Gellynck K, 2013, BONE, V57, P405, DOI 10.1016/j.bone.2013.09.012
   Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121
   Giuliani N, 2013, STEM CELLS INT, DOI 10.1155/2013/312501
   Goldring MB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2592
   Grayson WL, 2015, NAT REV ENDOCRINOL, V11, P140, DOI 10.1038/nrendo.2014.234
   Grayson WL, 2011, BIOTECHNOL BIOENG, V108, P1159, DOI 10.1002/bit.23024
   Guzzo RM, 2013, J CELL BIOCHEM, V114, P480, DOI 10.1002/jcb.24388
   Hashemibeni B, 2014, IRAN J BASIC MED SCI, V17, P854
   Hayami T, 2004, ARTHRITIS RHEUM, V50, P1193, DOI 10.1002/art.20124
   Hayami T, 2012, BONE, V50, P1250, DOI 10.1016/j.bone.2012.03.025
   Henrotin Y, 2001, J BONE MINER RES, V16, P299, DOI 10.1359/jbmr.2001.16.2.299
   Hicok KC, 2004, TISSUE ENG, V10, P371, DOI 10.1089/107632704323061735
   Huang CYC, 2004, ANAT REC PART A, V278A, P428, DOI 10.1002/ar.a.20010
   Huebsch N, 2015, NAT MATER, V14, P1269, DOI [10.1038/nmat4407, 10.1038/NMAT4407]
   Huey DJ, 2012, SCIENCE, V338, P917, DOI 10.1126/science.1222454
   HUGHES DE, 1995, J BONE MINER RES, V10, P1478
   Hutton DL, 2014, CURR OPIN CHEM ENG, V3, P75, DOI 10.1016/j.coche.2013.12.002
   Hwang NS, 2007, J CELL PHYSIOL, V212, P281, DOI 10.1002/jcp.21052
   Hwang NS, 2006, TISSUE ENG, V12, P2695, DOI 10.1089/ten.2006.12.2695
   Hwang NS, 2006, STEM CELLS, V24, P284, DOI 10.1634/stemcells.2005-0024
   Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106
   Ignjatovic N, 2005, J MATER SCI-MATER M, V16, P621, DOI 10.1007/s10856-005-2532-6
   Im GI, 2005, OSTEOARTHR CARTILAGE, V13, P845, DOI 10.1016/j.joca.2005.05.005
   Indrawattana N, 2004, BIOCHEM BIOPH RES CO, V320, P914, DOI 10.1016/j.bbre.2004.06.029
   Ishii I, 2007, J BONE JOINT SURG BR, V89B, P693, DOI 10.1302/0301-620X.89B5.18450
   Ito T, 2013, J PHARM PHARMACOL, V65, P494, DOI 10.1111/jphp.12008
   Jin XB, 2007, BIOMATERIALS, V28, P2994, DOI 10.1016/j.biomaterials.2007.03.002
   Jo CH, 2014, STEM CELLS, V32, P1254, DOI 10.1002/stem.1634
   Johnson K, 2012, SCIENCE, V336, P717, DOI 10.1126/science.1215157
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kadri A, 2008, ARTHRITIS RHEUM, V58, P2379, DOI 10.1002/art.23638
   Kao CL, 2010, STEM CELLS DEV, V19, P247, DOI 10.1089/scd.2009.0186
   Kassem M, 1997, OSTEOPOROSIS INT, V7, P514, DOI 10.1007/BF02652556
   Kawate K, 2006, ARTIF ORGANS, V30, P960, DOI 10.1111/j.1525-1594.2006.00333.x
   Kim H. J., 2012, J TISSUE ENG, V3
   Kim HJ, 2009, J ORTHOP RES, V27, P612, DOI 10.1002/jor.20766
   Kim MJ, 2011, ARTHRITIS RHEUM-US, V63, P3010, DOI 10.1002/art.30488
   Kim YS, 2015, AM J SPORT MED, V43, P176, DOI 10.1177/0363546514554190
   Knippenberg M, 2006, BIOCHEM BIOPH RES CO, V342, P902, DOI 10.1016/j.bbrc.2006.02.052
   Ko JY, 2014, BIOMATERIALS, V35, P3571, DOI 10.1016/j.biomaterials.2014.01.009
   Koh YG, 2013, KNEE SURG SPORT TR A, V23, P1308
   Koh YG, 2014, AM J SPORT MED, V42, P1628, DOI 10.1177/0363546514529641
   Koh YG, 2014, ARTHROSCOPY, V30, P1453, DOI 10.1016/j.arthro.2014.05.036
   Koh YG, 2012, KNEE, V19, P902, DOI 10.1016/j.knee.2012.04.001
   Kramer J, 2000, MECH DEVELOP, V92, P193, DOI 10.1016/S0925-4773(99)00339-1
   Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008
   Kreuz PC, 2006, OSTEOARTHR CARTILAGE, V14, P1119, DOI 10.1016/j.joca.2006.05.003
   Kuroda R, 2007, OSTEOARTHR CARTILAGE, V15, P226, DOI 10.1016/j.joca.2006.08.008
   Langle D, 2014, ACS CHEM BIOL, V9, P57, DOI 10.1021/cb4008277
   Lampropoulou-Adamidou K, 2014, J ORTHOP RES, V32, P1646, DOI 10.1002/jor.22712
   Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016
   Levi B, 2012, P NATL ACAD SCI USA, V109, P20379, DOI 10.1073/pnas.1218052109
   Li F, 2010, J CELL BIOCHEM, V109, P643, DOI 10.1002/jcb.22440
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Liao HT, 2016, J TISSUE ENG REGEN M, V10, pE337, DOI 10.1002/term.1811
   Liechty WB, 2010, ANNU REV CHEM BIOMOL, V1, P149, DOI 10.1146/annurev-chembioeng-073009-100847
   Lock J, 2011, INT J NANOMED, V6, P2769, DOI 10.2147/IJN.S24493
   Lv Y, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-370
   Maas M, 2011, NANO LETT, V11, P1383, DOI 10.1021/nl200116d
   Mahmoudifar N, 2010, BIOMATERIALS, V31, P3858, DOI 10.1016/j.biomaterials.2010.01.090
   Makris EA, 2015, NAT REV RHEUMATOL, V11, P21, DOI 10.1038/nrrheum.2014.157
   Marino G, 2010, J MATER SCI-MATER M, V21, P353, DOI 10.1007/s10856-009-3840-z
   McDougall JJ, 2010, OSTEOARTHR CARTILAGE, V18, P1355, DOI 10.1016/j.joca.2010.07.014
   Merceron C, 2011, CELL TRANSPLANT, V20, P1575, DOI 10.3727/096368910X557191
   Mesimaki K, 2009, INT J ORAL MAX SURG, V38, P201, DOI 10.1016/j.ijom.2009.01.001
   Mwale F, 2010, TISSUE ENG PT A, V16, P3449, DOI 10.1089/ten.TEA.2010.0091
   Nakagawa T, 2009, ARTHRITIS RHEUM-US, V60, P3686, DOI 10.1002/art.27229
   Nejadnik H, 2015, STEM CELL REV REP, V11, P242, DOI 10.1007/s12015-014-9581-5
   Nejadnik H, 2010, AM J SPORT MED, V38, P1110, DOI 10.1177/0363546509359067
   Neogi T, 2009, ARTHRIT RHEUM-ARTHR, V61, P1539, DOI 10.1002/art.24824
   Nishii T, 2013, CLIN RHEUMATOL, V32, P1759, DOI 10.1007/s10067-013-2338-8
   Ogawa R, 2015, TISSUE ENG PT A, V21, P257, DOI [10.1089/ten.TEA.2013.0525, 10.1089/ten.tea.2013.0525]
   Orth P, 2014, OSTEOARTHR CARTILAGE, V22, P813, DOI 10.1016/j.joca.2014.03.010
   Pang YG, 2005, ARCH FACIAL PLAST S, V7, P7, DOI 10.1001/archfaci.7.1.7
   Parker AM, 2006, EXPERT OPIN BIOL TH, V6, P567, DOI 10.1517/14712598.6.6.567
   Pasquinelli G, 2008, J ANAT, V213, P520, DOI 10.1111/j.1469-7580.2008.00974.x
   Pelletier JP, 2013, ANN RHEUM DIS, V72, P250, DOI 10.1136/annrheumdis-2012-201710
   Petrie A.C.E., 2010, BIOMATERIALS, V31, P6417
   Van Pham P, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt277
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Qu ZW, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/6/065001
   Ragetly GR, 2010, ACTA BIOMATER, V6, P1430, DOI 10.1016/j.actbio.2009.10.040
   Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005
   Reginster JY, 2014, ANN RHEUM DIS, V73, pE8, DOI 10.1136/annrheumdis-2013-204194
   Reginster JY, 2012, OSTEOPOROSIS INT, V23, P1115, DOI 10.1007/s00198-011-1847-z
   Reichert JC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003720
   Rudnicki JA, 1997, DEV BIOL, V185, P104, DOI 10.1006/dbio.1997.8536
   Saito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074137
   Sampson ER, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002214
   Schmitt B, 2003, DIFFERENTIATION, V71, P567, DOI 10.1111/j.1432-0436.2003.07109003.x
   Schurigt U, 2008, ARTHRITIS RHEUM, V58, P422, DOI 10.1002/art.23224
   Shamsul BS, 2014, TISSUE CELL, V46, P152, DOI 10.1016/j.tice.2014.02.001
   Sharma B, 2007, PLAST RECONSTR SURG, V119, P112, DOI 10.1097/01.prs.0000236896.22479.52
   Shimizu S, 2007, ARTHRITIS RHEUM-US, V56, P3358, DOI 10.1002/art.22941
   Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio.753
   Spector TD, 2005, ARTHRITIS RES THER, V7, pR625, DOI 10.1186/ar1716
   Srinivasan S, 2012, AGEING RES REV, V11, P353, DOI 10.1016/j.arr.2011.12.007
   Stadelmann VA, 2008, EUR CELLS MATER, V16, P10, DOI 10.22203/eCM.v016a02
   Strassle BW, 2010, OSTEOARTHR CARTILAGE, V18, P1319, DOI 10.1016/j.joca.2010.06.007
   Sumanasinghe RD, 2006, TISSUE ENG, V12, P3459, DOI 10.1089/ten.2006.12.3459
   Sun N, 2010, CELL CYCLE, V9, P880, DOI 10.4161/cc.9.5.10827
   Takahashi D, 2009, ARTHRITIS RHEUM, V60, P2372, DOI 10.1002/art.24718
   Tang MH, 2014, TISSUE ENG PT A, V20, P1295, DOI [10.1089/ten.tea.2013.0211, 10.1089/ten.TEA.2013.0211]
   Tat SK, 2011, BONE, V49, P559, DOI 10.1016/j.bone.2011.06.005
   TheinHan WW, 2013, BONE RES, V1, P371, DOI 10.4248/BR201304008
   Uebersax L, 2008, J CONTROL RELEASE, V127, P12, DOI 10.1016/j.jconrel.2007.11.006
   Vicente LM, 2011, STEM CELLS DEV, V20, P1011, DOI DOI 10.1089/SCD.2010.0355
   Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504
   Wakitani S, 2004, CELL TRANSPLANT, V13, P595, DOI 10.3727/000000004783983747
   Wang HA, 2014, ACTA BIOMATER, V10, P508, DOI 10.1016/j.actbio.2013.08.036
   Wang X, 2013, INT ORTHOP, V37, P2491, DOI 10.1007/s00264-013-2059-2
   Warzecha J, 2006, J ORTHOP SCI, V11, P491, DOI 10.1007/s00776-006-1058-1
   Wei YY, 2012, EUR CELLS MATER, V23, P1
   Weir MD, 2010, ACTA BIOMATER, V6, P4118, DOI 10.1016/j.actbio.2010.04.029
   Wilke MM, 2007, J ORTHOP RES, V25, P913, DOI 10.1002/jor.20382
   Wu X, 2004, CHEM BIOL, V11, P1229, DOI 10.1016/j.chembiol.2004.06.010
   Wu X, 2002, J AM CHEM SOC, V124, P14520, DOI 10.1021/ja0283908
   Xu JP, 2008, TISSUE ENG PT A, V14, P667, DOI 10.1089/tea.2007.0272
   Xu Y, 2007, BIOCHEM BIOPH RES CO, V359, P311, DOI 10.1016/j.bbrc.2007.05.098
   Yamashita A, 2014, NATURE, V513, P507, DOI 10.1038/nature13775
   Yang F, 2009, ACTA BIOMATER, V5, P3295, DOI 10.1016/j.actbio.2009.05.023
   Yeon B, 2013, BIOMACROMOLECULES, V14, P3256, DOI 10.1021/bm400868j
   Yoon HH, 2012, TISSUE ENG PT A, V18, P1949, DOI [10.1089/ten.tea.2011.0647, 10.1089/ten.TEA.2011.0647]
   Yoon IS, 2011, J BIOSCI BIOENG, V112, P402, DOI 10.1016/j.jbiosc.2011.06.018
   Yoon YM, 2002, J BIOL CHEM, V277, P8412, DOI 10.1074/jbc.M110608200
   Yoshii T, 2014, J TISSUE ENG REGEN M, V8, P589, DOI 10.1002/term.1547
   Zaky SH, 2009, J DENT RES, V88, P1077, DOI 10.1177/0022034509349926
   Zhang KX, 2013, ACTA BIOMATER, V9, P7276, DOI 10.1016/j.actbio.2013.03.025
   Zhang ZY, 2009, STEM CELLS, V27, P126, DOI 10.1634/stemcells.2008-0456
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 169
TC 9
Z9 9
U1 4
U2 42
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2190-393X
EI 2190-3948
J9 DRUG DELIV TRANSL RE
JI Drug Deliv. Transl. Res.
PD APR
PY 2016
VL 6
IS 2
BP 105
EP 120
DI 10.1007/s13346-015-0266-7
PG 16
WC Instruments & Instrumentation; Medicine, Research & Experimental;
   Pharmacology & Pharmacy
SC Instruments & Instrumentation; Research & Experimental Medicine;
   Pharmacology & Pharmacy
GA DO9YX
UT WOS:000378145200004
PM 26625850
DA 2018-10-19
ER

PT J
AU Wen, C
   Kang, HM
   Shih, YRV
   Hwang, Y
   Varghese, S
AF Wen, Cai
   Kang, Heemin
   Shih, Yu-Ru V.
   Hwang, YongSung
   Varghese, Shyni
TI In vivo comparison of biomineralized scaffold-directed osteogenic
   differentiation of human embryonic and mesenchymal stem cells
SO DRUG DELIVERY AND TRANSLATIONAL RESEARCH
LA English
DT Article
DE Embryonic stem cells; Mesenchymal stem cells; In vivo osteogenic
   differentiation; Biomineralized scaffold; Bone tissue engineering;
   Calcium phosphate
ID BONE MORPHOGENETIC PROTEIN; CALCIUM-PHOSPHATE; MINERAL COATINGS;
   MATRICES; TISSUE; ANGIOGENESIS; REGENERATION; MECHANISMS; MORPHOLOGY;
   HYDROGELS
AB Human pluripotent stem cells such as embryonic stem cells (hESCs) and multipotent stem cells like mesenchymal stem cells (hMSCs) hold great promise as potential cell sources for bone tissue regeneration. Comparing the in vivo osteogenesis of hESCs and hMSCs by biomaterial-based cues provides insight into the differentiation kinetics of these cells as well as their potential to contribute to bone tissue repair in vivo. Here, we compared in vivo osteogenic differentiation of hESCs and hMSCs within osteoinductive calcium phosphate (CaP)-bearing biomineralized scaffolds that recapitulate a bone-specific mineral microenvironment. Both hESCs and hMSCs underwent osteogenic differentiation responding to the biomaterial-based instructive cues. Furthermore, hMSCs underwent earlier in vivo osteogenesis compared to hESCs, but both stem cell types acquired a similar osteogenic maturation by 8 weeks of implantation.
C1 [Wen, Cai] Southeast Univ, Sch Chem & Chem Engn, Sipailou 2, Nanjing 210096, Jiangsu, Peoples R China.
   [Kang, Heemin; Shih, Yu-Ru V.; Hwang, YongSung; Varghese, Shyni] Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr, La Jolla, CA 92093 USA.
RP Varghese, S (reprint author), Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr, La Jolla, CA 92093 USA.
EM svarghese@ucsd.edu
FU National Institutes of Health (NIH) [1 R01 AR063184-01A1]; Texas A&M
   University from the NIH [P40RR017447]
FX This work was supported by National Institutes of Health (NIH; Grant 1
   R01 AR063184-01A1). The hMSCs used in this study were provided by Texas
   A&M University from the NIH (Grant P40RR017447).
CR Ahn SE, 2006, BIOCHEM BIOPH RES CO, V340, P403, DOI 10.1016/j.bbrc.2005.12.020
   Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004
   Barradas AMC, 2012, BIOMATERIALS, V33, P3205, DOI 10.1016/j.biomaterials.2012.01.020
   Barradas AMC, 2011, EUR CELLS MATER, V21, P407, DOI 10.22203/eCM.v021a31
   Bilousova G, 2011, STEM CELLS, V29, P206, DOI 10.1002/stem.566
   Both SK, 2011, J TISSUE ENG REGEN M, V5, P180, DOI 10.1002/term.303
   Brey DM, 2011, BIOTECHNOL BIOENG, V108, P163, DOI 10.1002/bit.22925
   Cameron K, 2013, J BIOMED MATER RES A, V101, P13, DOI 10.1002/jbm.a.34261
   Chai YC, 2012, BIOMATERIALS, V33, P3127, DOI 10.1016/j.biomaterials.2012.01.015
   Chang CW, 2013, BIOMATERIALS, V34, P912, DOI 10.1016/j.biomaterials.2012.10.020
   Choi S, 2013, BIOTECHNOL J, V8, P496, DOI 10.1002/biot.201200204
   de Peppo GM, 2013, P NATL ACAD SCI USA, V110, P8680, DOI 10.1073/pnas.1301190110
   Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3
   Friedman MS, 2006, J CELL BIOCHEM, V98, P538, DOI 10.1002/jcb.20719
   Gamie Z, 2014, EXPERT OPIN BIOL TH, V14, P1611, DOI 10.1517/14712598.2014.945414
   Hwang NS, 2013, TISSUE ENG PT A, V19, P1723, DOI [10.1089/ten.tea.2013.0064, 10.1089/ten.TEA.2013.0064]
   Hwang NS, 2009, WIRES SYST BIOL MED, V1, P97, DOI [10.1002/wsbm.026, 10.1002/wsbm.26]
   Kaigler D, 2006, J BONE MINER RES, V21, P735, DOI 10.1359/JBMR.060120
   Kang H, 2015, BIOMACROMOLECULES, V16, P1050, DOI 10.1021/acs.biomac.5b00099
   Kang HM, 2014, ACTA BIOMATER, V10, P4961, DOI 10.1016/j.actbio.2014.08.010
   Kang HM, 2014, J MATER CHEM B, V2, P5676, DOI 10.1039/c4tb00714j
   Karp JM, 2006, STEM CELLS, V24, P835, DOI 10.1634/stemcells.2005-0383
   Kawaguchi J, 2005, BONE, V36, P758, DOI 10.1016/j.bone.2004.07.019
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Levi B, 2012, P NATL ACAD SCI USA, V109, P20379, DOI 10.1073/pnas.1218052109
   Lin S, 2011, PHARM RES-DORDR, V28, P1422, DOI 10.1007/s11095-011-0378-9
   Liu YL, 2004, TISSUE ENG, V10, P101, DOI 10.1089/107632704322791745
   Madl CM, 2014, BIOMACROMOLECULES, V15, P445, DOI 10.1021/bm401726u
   Marolt D, 2010, STEM CELL RES THER, V1, P1
   Marolt D, 2012, P NATL ACAD SCI USA, V109, P8705, DOI 10.1073/pnas.1201830109
   Muller P, 2008, J CELL MOL MED, V12, P281, DOI 10.1111/j.1582-4934.2007.00103.x
   Murphy WL, 2004, J DENT RES, V83, P204, DOI 10.1177/154405910408300304
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200
   Petrie TA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001002
   Phadke A, 2013, EUR CELLS MATER, V25, P114, DOI 10.22203/eCM.v025a08
   Phadke A, 2012, MACROMOL BIOSCI, V12, P1022, DOI 10.1002/mabi.201100289
   Phadke A, 2010, BIOMACROMOLECULES, V11, P2060, DOI 10.1021/bm100425p
   Seong JM, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/6/062001
   Shih YR, 2015, ACTA BIOMATER, V19, P1, DOI 10.1016/j.actbio.2015.03.017
   Shih YRV, 2014, P NATL ACAD SCI USA, V111, P990, DOI 10.1073/pnas.1321717111
   Shimko DA, 2004, TISSUE ENG, V10, P1386, DOI 10.1089/ten.2004.10.1386
   Suarez-Gonzalez D, 2012, ACTA BIOMATER, V8, P1117, DOI 10.1016/j.actbio.2011.11.028
   Suarez-Gonzalez D, 2012, BIOMATERIALS, V33, P713, DOI 10.1016/j.biomaterials.2011.09.095
   Varghese S, 2010, STEM CELLS, V28, P765, DOI 10.1002/stem.325
   Wen L, 2012, BIOCHEM BIOPH RES CO, V424, P439, DOI 10.1016/j.bbrc.2012.06.128
   Xiao X, 2015, SCI REP-UK, V5, DOI 10.1038/srep09409
   Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/NMAT3889, 10.1038/nmat3889]
   Yang H, 2014, J MATER CHEM B, V2, P4703, DOI 10.1039/c4tb00424h
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P717, DOI 10.1023/A:1008998817977
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
   Zhang C, 2009, SOFT MATTER, V5, P3831, DOI 10.1039/b912102a
NR 52
TC 6
Z9 6
U1 2
U2 13
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2190-393X
EI 2190-3948
J9 DRUG DELIV TRANSL RE
JI Drug Deliv. Transl. Res.
PD APR
PY 2016
VL 6
IS 2
BP 121
EP 131
DI 10.1007/s13346-015-0242-2
PG 11
WC Instruments & Instrumentation; Medicine, Research & Experimental;
   Pharmacology & Pharmacy
SC Instruments & Instrumentation; Research & Experimental Medicine;
   Pharmacology & Pharmacy
GA DO9YX
UT WOS:000378145200005
PM 26105532
DA 2018-10-19
ER

PT J
AU Cruz, RDAL
   Diniz, LGM
   Lisboa, HM
   Fook, MVL
AF Alves Leal Cruz, Rita de Cassia
   Marques Diniz, Luana Geovanna
   Lisboa, Hugo Miguel
   Lia Fook, Marcus Vinicius
TI Effect of different carboxylic acids as solvent on chitosan fibers
   production by wet spinning
SO MATERIA-RIO DE JANEIRO
LA English
DT Article
DE Biopolymers; Swelling; Mechanical Properties; Medical devices
AB Over the past decades, chitosan has been extensively investigated and used as a biomaterial due to a set of properties, such as biocompatibility, biodegradability and bioactivity. In the present work to produce the chitosan fibers was used the wet spinning technique and Two parameters, solvent and polymers concentration, were chosen as variables. For polymer concentration two concentrations were applied: 2%, 2.5%; and for solvents, three different acids were used: acetic, malic and lactic. Characterizations were carried out, using FTIR, Swelling Degree measurements, SEM and mechanical tests in terms of Traction. From the dimensional analysis of the fiber, different diameters where detected possibly due to steric effects cause by the presence of the acid. Other properties were also affected, revealing that as denser fibers are tend they have higher mechanical properties, and lesser tendency to swell. The fibers showed good potential for application as sutures.
C1 [Alves Leal Cruz, Rita de Cassia; Marques Diniz, Luana Geovanna; Lisboa, Hugo Miguel; Lia Fook, Marcus Vinicius] Univ Fed Campina Grande, Dept Mat Engn, CERTBIO, BR-58109970 Campina Grande, PB, Brazil.
RP Cruz, RDAL (reprint author), Univ Fed Campina Grande, Dept Mat Engn, CERTBIO, BR-58109970 Campina Grande, PB, Brazil.
EM ritaalvesleal@hotmail.com; luanamdiniz@gmail.com;
   hugom.lisboa80@gmail.com; marcus.fook@pq.cnpq.br
OI Vinicius Lia Fook, Marcus/0000-0002-8566-920X; Lisboa,
   Hugo/0000-0002-4722-0364
FU CAPES
FX The authors acknowledged the financial support given by CAPES.
CR ABNT. Associacao Brasileira de Normas Tecnicas, 2003, 13904 NBR ABNT
   [Anonymous], 2010, ANN BOOK ASTM STAND
   BENNETT RG, 1988, J AM ACAD DERMATOL, V18, P619, DOI 10.1016/S0190-9622(88)70083-3
   Ellis MJ, 2007, BIOTECHNOL BIOENG, V96, P177, DOI 10.1002/bit.21093
   Fambri L, 2006, MACROMOL SYMP, V234, P20, DOI 10.1002/masy.200650204
   FERREIRA M. L. G., 2005, REV BRASILEIRA CIENC, V12, P84
   HUAIZAN L. N., 2013, THESIS
   Jayakumar R, 2010, BIOTECHNOL ADV, V28, P142, DOI 10.1016/j.biotechadv.2009.11.001
   Knaul J, 1998, J APPL POLYM SCI, V69, P1435, DOI 10.1002/(SICI)1097-4628(19980815)69:7<1435::AID-APP19>3.0.CO;2-S
   Knaul JZ, 1999, J APPL POLYM SCI, V72, P1721, DOI 10.1002/(SICI)1097-4628(19990624)72:13<1721::AID-APP8>3.0.CO;2-V
   MELO K. G. P. C., 2009, THESIS
   Moncrieff RW, 1970, MAN MADE FIBRES, V5th
   Nwe N, 2009, MATERIALS, V2, P374, DOI 10.3390/ma2020374
   PAUL DR, 1968, J APPL POLYM SCI, V12, P383, DOI 10.1002/app.1968.070120301
   Ravi Kumar M. N. V., 1999, B MATER SCI, V22, P905
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Sardenberg Trajano, 2003, Acta ortop. bras., V11, P88, DOI 10.1590/S1413-78522003000200004
   TUZLAKOGLU K., 2007, THESIS
   Zheng H, 2001, J APPL POLYM SCI, V80, P2558, DOI 10.1002/app.1365
   ZIABICKI A, 1985, HIGH SPEED FIBER SPI
NR 20
TC 0
Z9 0
U1 2
U2 21
PU UNIV FED RIO DE JANEIRO, LAB HIDROGENIO
PI RIO DE JANEIRO RJ
PA CIDADE UNIV, ILHA DO FUNDAO, BLOCO I 2000, S L I 146, RIO DE JANEIRO RJ,
   CEP21941-972, BRAZIL
SN 1517-7076
J9 MATERIA-BRAZIL
JI Materia
PD APR-JUN
PY 2016
VL 21
IS 2
BP 525
EP 531
DI 10.1590/S1517-707620160002.0049
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA DO2IZ
UT WOS:000377604600024
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Lv, XM
   Liu, Y
   Wu, F
   Yuan, Y
   Luo, M
AF Lv, Xue-man
   Liu, Yan
   Wu, Fei
   Yuan, Yi
   Luo, Min
TI Human umbilical cord blood-derived stem cells and brain-derived
   neurotrophic factor protect injured optic nerve: viscoelasticity
   characterization
SO NEURAL REGENERATION RESEARCH
LA English
DT Article
DE nerve regeneration; optic nerve injury; human umbilical cord
   blood-derived stem cells; brain-derived neurotrophic factors; creep;
   histomorphology; stress relaxation; viscoelasticity; neural regeneration
ID REGENERATION
AB The optic nerve is a viscoelastic solid-like biomaterial. Its normal stress relaxation and creep properties enable the nerve to resist constant strain and protect it from injury. We hypothesized that stress relaxation and creep properties of the optic nerve change after injury. Moreover, human brain-derived neurotrophic factor or umbilical cord blood-derived stem cells may restore these changes to normal. To validate this hypothesis, a rabbit model of optic nerve injury was established using a clamp approach. At 7 days after injury, the vitreous body received a one-time injection of 50 mu g human brain-derived neurotrophic factor or 1 x 10(6) human umbilical cord blood-derived stem cells. At 30 days after injury, stress relaxation and creep properties of the optic nerve that received treatment had recovered greatly, with pathological changes in the injured optic nerve also noticeably improved. These results suggest that human brain-derived neurotrophic factor or umbilical cord blood-derived stem cell intervention promotes viscoelasticity recovery of injured optic nerves, and thereby contributes to nerve recovery.
C1 [Lv, Xue-man; Yuan, Yi] Jilin Univ, China Japan Union Hosp, Dept Ophthalmol, Changchun 130023, Jilin Province, Peoples R China.
   [Liu, Yan] Jilin Univ, China Japan Union Hosp, Dept Hand Surg, Changchun 130023, Jilin Province, Peoples R China.
   [Wu, Fei] Jilin Univ, Hosp 2, Dept Obstet & Gynaecol, Changchun 130023, Jilin Province, Peoples R China.
   [Luo, Min] Jilin Univ, China Japan Union Hosp, Dept Pain Management, Changchun 130023, Jilin Province, Peoples R China.
RP Yuan, Y (reprint author), Jilin Univ, China Japan Union Hosp, Dept Ophthalmol, Changchun 130023, Jilin Province, Peoples R China.
EM yuany@jlu.edu.cn
OI Yuan, Yi/0000-0002-7007-2857
FU High-Tech Research and Development Program of Jilin Province of China
   [20110492]
FX This study was supported by a grant from High-Tech Research and
   Development Program of Jilin Province of China, No. 20110492.
CR Bi YY, 2009, NEUROSCI RES, V65, P215, DOI 10.1016/j.neures.2009.07.008
   Bodanapally UK, 2013, J NEURO-OPHTHALMOL, V33, P128, DOI 10.1097/WNO.0b013e3182842553
   Chakraborty S K, 2014, Mymensingh Med J, V23, P614
   Chiu CT, 2013, PHARMACOL REV, V65, P105, DOI 10.1124/pr.111.005512
   Dagnelie G, 2012, CURR OPIN NEUROL, V25, P67, DOI 10.1097/WCO.0b013e32834f02c3
   Dahlmann-Noor A, 2010, CAN J OPHTHALMOL, V45, P333, DOI 10.3129/i10-077
   GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707
   Hollander A, 2012, INVEST OPHTH VIS SCI, V53, P3973, DOI 10.1167/iovs.11-8350
   Hou X, 2004, YANKE XINJINZHAN, V24, P247
   Hunsberger JG, 2013, AM J TRANSL RES, V5, P450
   Li YQ, 2015, YANKE XINJINZHAN, V35, P125
   Liu Y, 2009, ZHONGHUA CHUANGSHANG, V25, P456
   Lv Q, 2013, SHENJING SUNSHANG YU, V8, P414
   Ma HS, 2004, ZHONGGUO SHENGWU YIX, V23, P274
   Ma HS, 2000, YIYONG SHENGWU LIXUE, V15, P125
   Mar FM, 2014, EMBO REP, V15, P254, DOI 10.1002/embr.201337723
   Munemasa Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034810
   Schwartz M, 2004, BRAIN RES BULL, V62, P467, DOI 10.1016/S0361-9230(03)00076-5
   Yi JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054792
   Zhao TT, 2011, GRAEF ARCH CLIN EXP, V249, P1021, DOI 10.1007/s00417-011-1635-7
   Zrenner E, 2011, P ROY SOC B-BIOL SCI, V278, P1489, DOI 10.1098/rspb.2010.1747
NR 21
TC 1
Z9 1
U1 0
U2 1
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1673-5374
EI 1876-7958
J9 NEURAL REGEN RES
JI Neural Regen. Res.
PD APR
PY 2016
VL 11
IS 4
BP 652
EP 656
DI 10.4103/1673-5374.180753
PG 5
WC Cell Biology; Neurosciences
SC Cell Biology; Neurosciences & Neurology
GA DO1XF
UT WOS:000377572700033
PM 27212930
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Ma, HC
   Yang, GL
   Fu, YH
   Ma, C
   Dong, XL
   Zhang, XF
AF Ma, Hongchao
   Yang, Guoliang
   Fu, Yinghuan
   Ma, Chun
   Dong, Xiaoli
   Zhang, Xiufang
TI Preparation, Characterization and Photocatalytic Properties of BiPO4
   Decorated with Ag/AgBr
SO JOURNAL OF CHEMICAL ENGINEERING OF JAPAN
LA English
DT Article
DE Photodegradation; KN-R; Ag/AgBr Modification; BiPO4
ID VISIBLE-LIGHT PHOTOCATALYST; OH-RELATED DEFECTS; COMPOSITE
   NANOPARTICLES; MAGNETIC CORE; ANTIMICROBIAL ACTIVITY; BIOMATERIAL
   SYSTEM; DEGRADATION; ANATASE; SHELL; ZNO
AB The present study investigates rod-like BiPO4 prepared by a hydrothermal process using bismuth nitrate and sodium dihydrogen phosphate as raw materials. Herein, Ag-AgBr was deposited onto the surface of BiPO4 via a facile precipitation-photoreduction technique. The structure, morphology, composition and optical property of as-synthesized samples were characterized by XRD, SEM, TEM, XPS, DRS and PL techniques. The results showed that introduction of Ag-AgBr did not change the structure and morphology of BiPO4, but extended its optical absorption to visible region. Moreover, the introduction of Ag-AgBr shifted binding energy of elements of BiPO4 to lower values, which implied that a strong interaction exists between Ag-AgBr and BiPO4. The photocatalytic tests showed that the Ag/AgBr/BiPO4 composites possess higher photocatalytic activity for degradation of anthraquinone dye (reactive brilliant blue KN-R) under simulated sunlight, as compared to that of pure BiPO4. The improvement of photocatalytic activity for Ag/AgBr/BiPO4 composites could be ascribed to their good optical absorption and the synergistic action between Ag-AgBr and BiPO4 substrate (the synergistic action effectively retarded recombination of photogenerated carriers in hetero-structured Ag/AgBr/BiPO4).
C1 [Ma, Hongchao; Yang, Guoliang; Fu, Yinghuan; Ma, Chun; Dong, Xiaoli; Zhang, Xiufang] Dalian Polytech Univ, Sch Chem Engn & Mat, 1 Qinggongyuan, Dalian 116034, Peoples R China.
RP Dong, XL; Zhang, XF (reprint author), Dalian Polytech Univ, Sch Chem Engn & Mat, 1 Qinggongyuan, Dalian 116034, Peoples R China.
EM 345961232@qq.com; fuyinghuan@sina.com
FU National Natural Science Foundation of China [21476033]; Program for
   Liaoning Excellent Talents in University [LR2014013]; Cultivation
   Program for Excellent Talents of Science and Technology Department of
   Liaoning Province [201402610]
FX This work was supported by The National Natural Science Foundation of
   China (21476033), Program for Liaoning Excellent Talents in University
   (LR2014013) and Cultivation Program for Excellent Talents of Science and
   Technology Department of Liaoning Province (No. 201402610).
CR Afzal S, 2013, ACS APPL MATER INTER, V5, P4753, DOI 10.1021/am400002k
   Cao J, 2013, CHEM ENG J, V228, P482, DOI 10.1016/j.cej.2013.05.008
   Chekroun M. Z., 2012, J MOD PHYS, V3, P102
   Deng ZW, 2008, J PHYS CHEM B, V112, P16, DOI 10.1021/jp077662w
   Fulekar MH, 2014, RSC ADV, V4, P10097, DOI 10.1039/c3ra44488k
   Gao EP, 2013, NANOSCALE, V5, P11248, DOI 10.1039/c3nr03370h
   Hernandez-Alonso MD, 2009, ENERG ENVIRON SCI, V2, P1231, DOI 10.1039/b907933e
   Hu C, 2006, J PHYS CHEM B, V110, P4066, DOI 10.1021/jp0564400
   Hu C, 2010, J AM CHEM SOC, V132, P857, DOI 10.1021/ja907792d
   Ibhadon AO, 2013, CATALYSTS, V3, P189, DOI 10.3390/catal3010189
   Keane DA, 2014, CATAL SCI TECHNOL, V4, P1211, DOI 10.1039/c4cy00006d
   Kim HG, 2005, ANGEW CHEM INT EDIT, V44, P4585, DOI 10.1002/anie.200500064
   Ko SH, 2011, NANO LETT, V11, P666, DOI 10.1021/nl1037962
   Li KB, 2014, APPL SURF SCI, V320, P1, DOI 10.1016/j.apsusc.2014.09.060
   Liang CH, 2001, APPL PHYS LETT, V78, P3202, DOI 10.1063/1.1374498
   Liu YF, 2014, APPL CATAL B-ENVIRON, V147, P851, DOI 10.1016/j.apcatb.2013.09.050
   Lv YH, 2014, J MATER CHEM A, V2, P1174, DOI 10.1039/c3ta13841k
   Pan CS, 2012, APPL CATAL B-ENVIRON, V115, P314, DOI 10.1016/j.apcatb.2011.12.030
   Pan CS, 2012, ADV FUNCT MATER, V22, P1518, DOI 10.1002/adfm.201102306
   Pan CS, 2010, ENVIRON SCI TECHNOL, V44, P5570, DOI 10.1021/es101223n
   PAPP J, 1993, CHEM MATER, V5, P284, DOI 10.1021/cm00027a009
   Pawinrat P, 2009, CATAL COMMUN, V10, P1380, DOI 10.1016/j.catcom.2009.03.002
   Qi B, 2012, MATER CHEM PHYS, V135, P549, DOI 10.1016/j.matchemphys.2012.05.023
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Sclafani A, 1998, J PHOTOCH PHOTOBIO A, V113, P181, DOI 10.1016/S1010-6030(97)00319-5
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Wang DS, 2012, J MATER CHEM, V22, P4847, DOI 10.1039/c2jm14628b
   Wang DS, 2011, DESALINATION, V270, P174, DOI 10.1016/j.desal.2010.11.042
   Wang H, 2011, COMM COM INF SC, V136, P1
   Xu YG, 2013, COLLOID SURFACE A, V436, P474, DOI 10.1016/j.colsurfa.2013.06.005
   Yan TJ, 2013, CHEM ENG J, V232, P564, DOI 10.1016/j.cej.2013.08.021
   Yan X, 2015, APPL CATAL B-ENVIRON, V164, P297, DOI 10.1016/j.apcatb.2014.09.046
   Yu JH, 2003, ACCOUNTS CHEM RES, V36, P481, DOI 10.1021/ar0201557
   Zhang J, 2015, CATAL COMMUN, V59, P30, DOI 10.1016/j.catcom.2014.09.041
   Zhang SB, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.075205
NR 39
TC 2
Z9 2
U1 2
U2 62
PU SOC CHEMICAL ENG JAPAN
PI BUNKYO KU TOKYO
PA KYORITSU BUILDING 4-16-19 KOHINATA, BUNKYO KU TOKYO, 112, JAPAN
SN 0021-9592
J9 J CHEM ENG JPN
JI J. Chem. Eng. Jpn.
PD APR
PY 2016
VL 49
IS 4
BP 366
EP 371
DI 10.1252/jcej.15we064
PG 6
WC Engineering, Chemical
SC Engineering
GA DO1MB
UT WOS:000377541200008
DA 2018-10-19
ER

PT J
AU Christensen, BB
AF Christensen, Bjorn Borsoe
TI Autologous tissue transplantations for osteochondral repair
SO DANISH MEDICAL JOURNAL
LA English
DT Article
ID ARTICULAR-CARTILAGE REPAIR; 2-YEAR FOLLOW-UP; FULL-THICKNESS DEFECTS;
   CHARACTERIZED CHONDROCYTE IMPLANTATION; COMPOSITE MULTILAYERED
   BIOMATERIAL; PARTICULATED JUVENILE CARTILAGE; CONTINUOUS PASSIVE MOTION;
   CRUCIATE LIGAMENT INJURY; LARGE-VOLUME DEFECTS; QUALITY-OF-LIFE
C1 [Christensen, Bjorn Borsoe] Aarhus Univ Hosp, Orthoped Res Lab, Norrebrogade 44,Build 1A,1 Floor, Aarhus, Denmark.
RP Christensen, BB (reprint author), Aarhus Univ Hosp, Orthoped Res Lab, Norrebrogade 44,Build 1A,1 Floor, Aarhus, Denmark.
EM bjornbc@gmail.com
FU Novo Nordisk Foundation; Gigtforeningen; Danish Orthopaedic Society
   Foundation; Aarhus University
FX I would like to acknowledge The Novo Nordisk Foundation for providing
   financial support for study 1 and study 4, Gigtforeningen for the
   financial support of study 1, Danish Orthopaedic Society Foundation for
   sponsoring a number of international conferences and Aarhus University
   for general financial support.
CR Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716
   Adams SB, 2014, ARTHROSC TEC, V3, pE533, DOI 10.1016/j.eats.2014.06.004
   Adkisson HD, 2010, AM J SPORT MED, V38, P1324, DOI 10.1177/0363546510361950
   ALBRECHT FH, 1983, FORTSCHR MED, V101, P1650
   Anders S., 2008, MATRIX ASS AUTOLOGOU
   [Anonymous], 2015, ELLEGAARD GOTTINGEN
   Archer CW, 2003, INT J BIOCHEM CELL B, V35, P401, DOI 10.1016/S1357-2725(02)00301-1
   Aroen A, 2004, AM J SPORT MED, V32, P211, DOI 10.1177/0363546503259345
   Barber FA, 2011, ARTHROSCOPY, V27, P60, DOI 10.1016/j.arthro.2010.06.023
   Bartlett W, 2005, J BONE JOINT SURG BR, V87B, P640, DOI 10.1302/0301-620X.87B5.15905
   Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a
   Bekkers JEJ, 2009, OSTEOARTHR CARTILAGE, V17, P1434, DOI 10.1016/j.joca.2009.04.019
   Bekkers JEJ, 2013, AM J SPORT MED, V41, P1290, DOI 10.1177/0363546513483536
   Benthien JP, 2011, KNEE SURG SPORT TR A, V19, P543, DOI 10.1007/s00167-010-1271-5
   Bentley G, 2012, J BONE JOINT SURG BR, V94B, P504, DOI 10.1302/0301-620X.94B4.27495
   Berruto M, 2014, AM J SPORT MED, V42, P1607, DOI 10.1177/0363546514530292
   Boden BP, 1997, J AM ACAD ORTHOP SUR, V5, P47, DOI DOI 10.5435/00124635-199701000-00006
   Boenisch T., 2001, IMMUNOCHEMICAL STAIN
   Bonal D, 2016, ANN FOREST SCI, V73, P27, DOI 10.1007/s13595-015-0522-5
   Bonasia D. E., 2015, KNEE SURG SPORT TRAU
   Bonasia DE, 2011, AM J SPORT MED, V39, P2355, DOI 10.1177/0363546511417172
   Bonner Kevin F, 2010, J Knee Surg, V23, P109
   Boughanem J, 2011, AM J SPORT MED, V39, P2212, DOI 10.1177/0363546511416594
   Brandt KD, 2006, ANN RHEUM DIS, V65, P1261, DOI 10.1136/ard.2006.058347
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brittberg M, 2000, ICRS CARTILAGE INJUR
   Brittberg M., 2000, OSTEOLOGIE, V9, P17
   Brown TD, 2006, J ORTHOP TRAUMA, V20, P739, DOI 10.1097/01.bot.0000246468.80635.ef
   Buckwalter J A, 2014, Iowa Orthop J, V34, P44
   Burr DB, 2003, RHEUM DIS CLIN N AM, V29, P675, DOI 10.1016/S0889-857X(03)00061-9
   Cahill BR, 1995, J AM ACAD ORTHOP SUR, V3, P237
   Carmont MR, 2009, ARTHROSCOPY, V25, P810, DOI 10.1016/j.arthro.2009.01.023
   Chahal J, 2013, ARTHROSCOPY, V29, P575, DOI 10.1016/j.arthro.2012.12.002
   Christensen B. B., 2015, KNEE SURG SPORT TRAU
   Christensen Bjorn Borsoe, 2015, J Exp Orthop, V2, P13, DOI 10.1186/s40634-015-0031-3
   Christensen BB, 2015, CARTILAGE, V6, P166, DOI 10.1177/1947603515580983
   Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI [10.1089/ten.teb.2009.0452, 10.1089/ten.TEB.2009.0452]
   Coetzee JC, 2013, FOOT ANKLE INT, V34, P1205, DOI 10.1177/1071100713485739
   Cole BJ, 2011, AM J SPORT MED, V39, P1170, DOI 10.1177/0363546511399382
   CRAWFURD EJP, 1990, J BONE JOINT SURG BR, V72, P320
   Curl WW, 1997, ARTHROSCOPY, V13, P456, DOI 10.1016/S0749-8063(97)90124-9
   Dai Z, 2013, J INT MED RES, V41, P688, DOI 10.1177/0300060513476591
   DAINER R D, 1988, Arthroscopy, V4, P267, DOI 10.1016/S0749-8063(88)80042-2
   Davidson P. A., 2007, ARTHROSCOPY S, V23, pe22
   de Matos LL, 2010, BIOMARK INSIGHTS, V5, P9
   de Windt TS, 2013, AM J SPORT MED, V41, P1695, DOI 10.1177/0363546512473258
   DeGroot J, 1999, ARTHRITIS RHEUM, V42, P1003, DOI 10.1002/1529-0131(199905)42:5<1003::AID-ANR20>3.0.CO;2-K
   Delcogliano Marco, 2014, Joints, V2, P102
   Delcogliano M, 2014, KNEE SURG SPORT TR A, V22, P1260, DOI 10.1007/s00167-013-2717-3
   Dhollander AAM, 2012, ARTHROSCOPY, V28, P225, DOI 10.1016/j.arthro.2011.07.017
   Dillon CF, 2006, J RHEUMATOL, V33, P2271
   Dines JS, 2008, ARTHROSCOPY, V24, P62, DOI 10.1016/j.arthro.2007.07.025
   Eckstein F, 2006, J ANAT, V208, P491, DOI 10.1111/j.1469-7580.2006.00546.x
   Gelber PE, 2014, KNEE, V21, P827, DOI 10.1016/j.knee.2014.04.013
   England T. N., 2002, CONTROLLED TRIAL ART
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Eyre D, 2002, ARTHRITIS RES, V4, P30, DOI 10.1186/ar380
   Farr J., 2014, PRACT CLIN APPL, V14, P9
   Farr J, 2014, AM J SPORT MED, V42, P1417, DOI 10.1177/0363546514528671
   Farr J, 2011, CARTILAGE, V2, P346, DOI 10.1177/1947603511405838
   Farr J, 2012, J KNEE SURG, V25, P23, DOI 10.1055/s-0031-1299652
   Filardo G, 2014, OSTEOARTHR CARTILAGE, V22, P557, DOI 10.1016/j.joca.2014.01.004
   Filardo G, 2013, KNEE, V20, P570, DOI 10.1016/j.knee.2013.05.007
   Filardo G, 2014, INT ORTHOP, V38, P1905, DOI 10.1007/s00264-014-2322-1
   Filardo G, 2013, AM J SPORT MED, V41, P1786, DOI 10.1177/0363546513490658
   Foldager CB, 2015, CARTILAGE, V6, P123, DOI 10.1177/1947603514560655
   Foldager CB, 2014, CARTILAGE, V5, P123, DOI 10.1177/1947603513518217
   Foldager CB, 2013, DAN MED J, V60
   Fowler Donald E 3rd, 2009, J Knee Surg, V22, P372
   Fox AJS, 2009, SPORTS HEALTH, V1, P461, DOI 10.1177/1941738109350438
   Frisbie DD, 2006, VET COMP ORTHOPAED, V19, P142
   Frisbie DD, 2009, AM J SPORT MED, V37, p71S, DOI 10.1177/0363546509348478
   Gao Y., 2014, BIOMED RES INT, V2014
   Garcia EJ, 2010, J BONE JOINT SURG AM, V92A, P1774, DOI 10.2106/JBJS.I.01470
   Giza E, 2014, FOOT ANKLE INT, V35, P1087, DOI 10.1177/1071100714548704
   Gobbi A, 2005, KNEE SURG SPORT TR A, V13, P213, DOI 10.1007/s00167-004-0499-3
   Gobbi A., 2013, KNEE SURG SPORT TR A, P1986
   Goldring MB, 2006, BEST PRACT RES CL RH, V20, P1003, DOI 10.1016/j.berh.2006.06.003
   Gomoll AH, 2007, ORTHOPEDICS, V30, P487
   Gomoll AH, 2010, KNEE SURG SPORT TR A, V18, P434, DOI 10.1007/s00167-010-1072-x
   Gooding CR, 2006, KNEE, V13, P203, DOI 10.1016/j.knee.2006.02.011
   Goodman S, 2007, PLOS MED, V4, P773, DOI 10.1371/journal.pmed.0040168
   Gotterbarm T., 2008, MINIPIG MODEL EXPT C, P71
   Goyal D, 2013, ARTHROSCOPY, V29, P1579, DOI 10.1016/j.arthro.2013.05.027
   Grimm NL, 2014, CLIN SPORT MED, V33, P181, DOI 10.1016/j.csm.2013.11.006
   Gudas R, 2005, ARTHROSCOPY, V21, P1066, DOI 10.1016/j.arthro.2005.06.018
   Gudas R, 2012, AM J SPORT MED, V40, P2499, DOI 10.1177/0363546512458763
   Hambly K, 2008, AM J SPORT MED, V36, P1695, DOI 10.1177/0363546508317718
   Hangody L, 1998, ORTHOPEDICS, V21, P751
   Hangody L, 2003, J BONE JOINT SURG AM, V85A, P25, DOI 10.2106/00004623-200300002-00004
   Harman BD, 2006, AM J SPORT MED, V34, P913, DOI 10.1177/0363546505283257
   HART DJ, 1993, J RHEUMATOL, V20, P331
   Heir S, 2010, AM J SPORT MED, V38, P231, DOI 10.1177/0363546509352157
   Herberhold C, 1998, MAGNET RESON MED, V39, P843, DOI 10.1002/mrm.1910390522
   Higgins LD, 2007, JOINT BONE SPINE, V74, P594, DOI 10.1016/j.jbspin.2007.01.036
   Hindle P, 2014, KNEE SURG SPORT TR A, V22, P1235, DOI 10.1007/s00167-013-2493-0
   Hjelle K, 2002, ARTHROSCOPY, V18, P730, DOI 10.1053/jars.2002.32839
   Hoemann C, 2011, CARTILAGE, V2, P153, DOI 10.1177/1947603510397535
   Hootman JM, 2006, ARTHRITIS RHEUM, V54, P226, DOI 10.1002/art.21562
   HUGHSTON JC, 1984, J BONE JOINT SURG AM, V66A, P1340, DOI 10.2106/00004623-198466090-00003
   Hunter W, 1743, PHILOS T R SOC LOND, V470, P514, DOI DOI 10.1098/RSTL.1742.0079)
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Imhof H, 2000, INVEST RADIOL, V35, P581, DOI 10.1097/00004424-200010000-00004
   INDELICATO PA, 1985, CLIN ORTHOP RELAT R, P77
   Ioannidis J. P. a, 2005, PLOS MED, V2, P0696
   Jackson DW, 2001, J BONE JOINT SURG AM, V83A, P53, DOI 10.2106/00004623-200101000-00008
   Jacobs TW, 1996, J NATL CANCER I, V88, P1054, DOI 10.1093/jnci/88.15.1054
   Jay GD, 2014, MATRIX BIOL, V39, P17, DOI 10.1016/j.matbio.2014.08.008
   Jiang C., 2007, REPAIR PORCINE ARTIC, P1277
   JOHNSON L L, 1990, Arthroscopy, V6, P179, DOI 10.1016/0749-8063(90)90073-M
   Johnson LL, 2012, CARTILAGE, V3, P86, DOI 10.1177/1947603511413568
   Johnson LL, 2014, CARTILAGE, V5, P86, DOI 10.1177/1947603513518216
   JONES GM, 1971, J PHYSIOL-LONDON, V219, P729, DOI 10.1113/jphysiol.1971.sp009685
   Joshi N, 2012, AM J SPORT MED, V40, P1289, DOI 10.1177/0363546512441585
   Jurgensen I, 2002, ARTHROSCOPY, V18, P378, DOI 10.1053/jars.2002.32237
   Kaab MJ, 1998, J ANAT, V193, P23, DOI 10.1046/j.1469-7580.1998.19310023.x
   Kao YJ, 2011, PHYSICIAN SPORTSMED, V39, P60, DOI 10.3810/psm.2011.11.1940
   Karthikeyan S, 2012, AM J SPORT MED, V40, P2725, DOI 10.1177/0363546512465400
   Kessler JI, 2014, AM J SPORT MED, V42, P320, DOI 10.1177/0363546513510390
   Kilborn SH, 2002, CONTEMP TOP LAB ANIM, V41, P21
   Knutsen G, 2007, J BONE JOINT SURG AM, V89A, P2105, DOI 10.2106/JBJS.G.00003
   Kocher MS, 2006, AM J SPORT MED, V34, P1181, DOI 10.1177/0363546506290127
   Kocher MS, 2001, AM J SPORT MED, V29, P562, DOI 10.1177/03635465010290050701
   Kock NB, 2008, KNEE SURG SPORT TR A, V16, P461, DOI 10.1007/s00167-008-0494-1
   Kon E, 2014, KNEE SURG SPORT TR A, V22, P1452, DOI 10.1007/s00167-013-2467-2
   Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014
   Kon E., 2012, TREAT OSTEOCHONDRITI, V1, P1
   Kon E, 2014, J MATER SCI-MATER M, V25, P2437, DOI 10.1007/s10856-014-5188-2
   Kon E, 2014, J SPORT REHABIL, V23, P270, DOI [10.1123/JSR.2013-0054, 10.1123/jsr.2013-0054]
   Kon E, 2014, AM J SPORT MED, V42, P158, DOI 10.1177/0363546513505434
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kon E, 2009, KNEE SURG SPORT TR A, V17, P1312, DOI 10.1007/s00167-009-0819-8
   Kruse DL, 2012, J FOOT ANKLE SURG, V51, P218, DOI 10.1053/j.jfas.2011.10.027
   Krych AJ, 2012, J BONE JOINT SURG AM, V94A, P971, DOI 10.2106/JBJS.K.00815
   LEFKOE TP, 1993, J ORTHOP TRAUMA, V7, P458, DOI 10.1097/00005131-199310000-00009
   Lexer E, 1908, SURG GYNECOL OBSTET, V6, P601
   Leyh M, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0453-9
   Lim H. C., 2012, CLIN ORTHOP RELAT RE
   Lind M, 2008, CONNECT TISSUE RES, V49, P437, DOI 10.1080/03008200802325037
   LINDEN B, 1976, ACTA ORTHOP SCAND, V47, P664, DOI 10.3109/17453677608988756
   LINDEN B, 1977, J BONE JOINT SURG AM, V59, P769, DOI 10.2106/00004623-197759060-00010
   Liu H, 2013, AM J SPORT MED, V41, P2658, DOI 10.1177/0363546513502945
   Louisia S, 2003, KNEE SURG SPORT TR A, V11, P33, DOI 10.1007/s00167-002-0320-0
   Lu YL, 2006, J ORTHOP RES, V24, P1261, DOI 10.1002/jor.20135
   Magnusson PB, 1941, SURG GYNECOL OBSTET, V73, P1
   Mainil-Varlet P, 2001, OSTEOARTHR CARTILAGE, V9, pS6, DOI 10.1053/joca.2001.0438
   Mainil-Varlet P, 2010, AM J SPORT MED, V38, P880, DOI 10.1177/0363546509359068
   Makino A, 2005, AM J SPORT MED, V33, P1499, DOI 10.1177/0363546505274717
   Malinin T, 2000, OSTEOARTHR CARTILAGE, V8, P483, DOI 10.1053/joca.2000.0324
   Marlovits S, 2006, EUR J RADIOL, V57, P16, DOI 10.1016/j.ejrad.2005.08.007
   Marlovits S, 2004, EUR J RADIOL, V52, P310, DOI 10.1016/j.ejrad.2004.03.014
   Marmotti A, 2013, KNEE SURG SPORT TR A, V21, P1819, DOI 10.1007/s00167-012-2244-7
   Marmotti A, 2012, KNEE SURG SPORT TR A, V20, P2590, DOI 10.1007/s00167-012-1920-y
   Marmotti A, 2013, EUR CELLS MATER, V26, P15, DOI 10.22203/eCM.v026a02
   MARSHALL M, 1972, RES EXP MED, V157, P300, DOI 10.1007/BF01852074
   Matricali GA, 2010, ACTA ORTHOP BELG, V76, P669
   McCarthy H. S., 2015, CARTILAGE
   Messner K, 1996, ACTA ORTHOP SCAND, V67, P165, DOI 10.3109/17453679608994664
   Minas T, 2009, AM J SPORT MED, V37, P902, DOI 10.1177/0363546508330137
   Mitsuyama H, 2007, OSTEOARTHR CARTILAGE, V15, P559, DOI 10.1016/j.joca.2006.10.017
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   Nordenvall R, 2012, AM J SPORT MED, V40, P1808, DOI 10.1177/0363546512449306
   Nover A. B., 2015, LONG TERM STORAGE PR
   ODRISCOLL SW, 1988, J BONE JOINT SURG AM, V70A, P595, DOI 10.2106/00004623-198870040-00017
   Pace JM, 2003, MATRIX BIOL, V22, P3, DOI 10.1016/S0945-053X(03)00007-6
   Paget J., 1851, MON J MED SCI    SEP
   Pallante AL, 2012, AM J SPORT MED, V40, P1814, DOI 10.1177/0363546512449321
   Parkkari J, 2008, BRIT J SPORT MED, V42, P422, DOI 10.1136/bjsm.2008.046185
   Pascual-Garrido C, 2009, SPORTS HEALTH, V1, P326, DOI 10.1177/1941738109334216
   Pena E, 2007, COMPUT BIOL MED, V37, P376, DOI 10.1016/j.compbiomed.2006.04.004
   Pestka JM, 2012, AM J SPORT MED, V40, P325, DOI 10.1177/0363546511425651
   Petersen JP, 2008, J MATER SCI-MATER M, V19, P2029, DOI 10.1007/s10856-007-3291-3
   Peterson L, 2003, J BONE JOINT SURG AM, V85A, P17, DOI 10.2106/00004623-200300002-00003
   Peterson L, 2000, CLIN ORTHOP RELAT R, P212
   PINEDA S, 1992, ACTA ANAT, V143, P335
   PRIDIE KH, 1959, J BONE JOINT SURG BR, V41, P618
   Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1
   Prodromos CC, 2007, ARTHROSCOPY, V23, P1320, DOI 10.1016/j.arthro.2007.07.003
   Pufe T, 2004, MATRIX BIOL, V23, P267, DOI 10.1016/j.matbio.2004.06.003
   RADIN EL, 1986, CLIN ORTHOP RELAT R, P34
   Redman SN, 2004, OSTEOARTHR CARTILAGE, V12, P106, DOI 10.1016/j.joca.2002.12.001
   Rhee DK, 2005, J CLIN INVEST, V115, P622, DOI 10.1172/JCI200522263
   Riboh J. C., 2015, CURR REV MUSCULOSKEL
   RISPAT G, 1993, LAB ANIM, V27, P368, DOI 10.1258/002367793780745561
   Roos EM, 2009, AM J SPORT MED, V37, P1042, DOI 10.1177/0363546509334226
   Russell WMS B. K., 1992, PRINCIPLES HUMANE EX
   Sage A, 2009, AMJ RHINOL ALLERGY, V23, P486, DOI 10.2500/ajra.2009.23.3347
   Saithna A., 2008, BRIT ORTH ASS C
   Saris D, 2014, AM J SPORT MED, V42, P1384, DOI 10.1177/0363546514528093
   Saris DBF, 2008, AM J SPORT MED, V36, P235, DOI 10.1177/0363546507311095
   Saris DBF, 2009, AM J SPORT MED, V37, p10S, DOI 10.1177/0363546509350694
   Sasaki K, 2012, INT ORTHOP, V36, P2243, DOI 10.1007/s00264-012-1648-9
   Schlichting K, 2008, AM J SPORT MED, V36, P2379, DOI 10.1177/0363546508322899
   SCHUMACHER BL, 1994, ARCH BIOCHEM BIOPHYS, V311, P144, DOI 10.1006/abbi.1994.1219
   Sgaglione NA, 2009, ARTHROSCOPY, V25, P815, DOI 10.1016/j.arthro.2009.04.067
   Shortkroff S, 1996, BIOMATERIALS, V17, P147, DOI 10.1016/0142-9612(96)85759-0
   Simianer H, 2010, J PHARMACOL TOX MET, V62, P221, DOI 10.1016/j.vascn.2010.05.004
   Simonian PT, 1998, AM J SPORT MED, V26, P491, DOI 10.1177/03635465980260040201
   Skagen P. S., 2014, MICROSC RESEACH, V2, P67
   Smith GD, 2005, ARTHROSCOPY, V21, P1462, DOI 10.1016/j.arthro.2005.09.007
   Smolders JMN, 2010, ACTA ORTHOP BELG, V76, P208
   Solheim E., 2014, KNEE SURG SPORT TRAU
   Steadman JR, 2001, CLIN ORTHOP RELAT R, pS362, DOI 10.1097/00003086-200110001-00033
   Stevens HY, 2014, CARTILAGE, V5, P74, DOI 10.1177/1947603513515483
   Stone KR, 2014, KNEE, V21, P1145, DOI 10.1016/j.knee.2014.09.003
   Stone KR, 2006, ARTHROSCOPY, V22, P291, DOI 10.1016/j.arthro.2005.12.051
   Tampieri A, 2003, J BIOMED MATER RES A, V67A, P618, DOI 10.1002/jbm.a.10039
   Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008
   Tanner SM, 2007, AM J SPORT MED, V35, P1450, DOI 10.1177/0363546507301883
   Tew SR, 2000, ARTHRITIS RHEUM-US, V43, P215, DOI 10.1002/1529-0131(200001)43:1<215::AID-ANR26>3.0.CO;2-X
   Tompkins M, 2013, ARTHROSCOPY, V29, P1661, DOI 10.1016/j.arthro.2013.05.021
   Tower D. E., 2015, J FOOT ANKLE SURG
   Van den Borne MPJ, 2007, OSTEOARTHR CARTILAGE, V15, P1397, DOI 10.1016/j.joca.2007.05.005
   van Osch GJVM, 2009, J CELL MOL MED, V13, P792, DOI 10.1111/j.1582-4934.2009.00789.x
   Vanlauwe J, 2011, AM J SPORT MED, V39, P2566, DOI 10.1177/0363546511422220
   Vasara AI, 2005, CLIN ORTHOP RELAT R, P233, DOI 10.1097/01.blo.0000150567.00022.2e
   Verdonk P., 2015, BONE JOINT J B, V97-B, P318
   W. Zimmer Biomet, ZIMMER COM
   Widuchowski W, 2008, ACTA CHIR ORTHOP TR, V75, P382
   Widuchowski W, 2007, KNEE, V14, P177, DOI 10.1016/j.knee.2007.02.001
   Williams J S Jr, 1998, Am J Knee Surg, V11, P221
   Williams Riley J, 2008, Instr Course Lect, V57, P563
   Yaziji H, 2006, ADV ANAT PATHOL, V13, P238, DOI 10.1097/01.pap.0000213041.39070.2f
   Yoshida S, 1998, CLIN ORTHOP RELAT R, P162
   Zheng M.-H., 2007, MATRIX INDUCED AUTOL
   Zhou SD, 2004, ARTHRITIS RHEUM, V50, P3915, DOI 10.1002/art.20675
   Zimmer, DENOVO NT LONG DAT C
   Zingler C., 2015, OSTEOARTHR CARTILAGE, P5
NR 228
TC 4
Z9 4
U1 1
U2 2
PU DANISH MEDICAL ASSOC
PI COPENHAGEN
PA TRONDHJEMSGADE 9, DK-2100 COPENHAGEN, DENMARK
SN 2245-1919
J9 DAN MED J
JI Dan. Med. J.
PD APR
PY 2016
VL 63
IS 4
AR B5236
PG 27
WC Medicine, General & Internal
SC General & Internal Medicine
GA DN2TQ
UT WOS:000376916300012
DA 2018-10-19
ER

PT J
AU Lv, XG
   Li, Z
   Wang, HP
   Xu, YM
   Feng, C
AF Lv, XiangGuo
   Li, Zhe
   Wang, HuaPing
   Xu, YueMin
   Feng, Chao
TI The Application of Oxygen Generating Keratin/Silk Fibroin for Urethral
   Reconstruction: A Preliminary Study
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Keratin; Silk Fibroin; Oxygen Generating; Urethral Stricture; Tissue
   Engineering
ID TISSUE REGENERATION; CALCIUM PEROXIDE; SCAFFOLDS
AB The aim of this study is to assess the efficacy and feasibility of using oxygen generating keratin/silk fibroin for the urethroplasty in animal model. The scaffold were manufactured by blending the keratin, silk fibroin, gelatin and calcium peroxide (CPO) in certain concentration. The scanning electronic microscopy (SEM), MTT assay, oxygen releasing test were performed in order to evaluate the characters of scaffold in vitro. Then, the scaffold was used for repairing the urethral defection in rabbit model. The SEM showed typical core shell particles, embedded into the scaffold. The cytotoxicity assessments showed non-cytotoxicity of scaffold. The oxygen releasing test exhibited that scaffold could release oxygen for at least 2 weeks. Three months after implantation, the study group showed the patent urethra lumen by urthrography, while obvious fistula was noticed in the control group. In histological examination, intact epithelial layers, organized muscle bundles could be observed in the study group. However, only discontinuous epithelial layer was seen near the implanted area and no muscle bundles were revealed in the control group. At the end of 6 months, similar results were found in those groups. Our study demonstrated that oxygen generating keratin/silk fibroin scaffold could be a potential biomaterial for urethral reconstruction.
C1 [Lv, XiangGuo; Xu, YueMin; Feng, Chao] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Urol, Shanghai 200233, Peoples R China.
   [Li, Zhe; Wang, HuaPing] Donghua Univ, Coll Mat Sci & Engn, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai 210620, Peoples R China.
   [Xu, YueMin] Shanghai Eastern Urol Reconstruct & Repair Inst, Shanghai 200233, Peoples R China.
RP Feng, C (reprint author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Urol, Shanghai 200233, Peoples R China.
FU National Natural Science Foundation of China [81100488]
FX There is no direct financial interest. Supproted by National Natural
   Science Foundation of China (81100488).
CR Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Atala A, 2002, UROL CLIN N AM, V29, P485, DOI 10.1016/S0094-0143(02)00033-2
   BAKER AM, 1987, PLANT SOIL, V99, P357, DOI 10.1007/BF02370881
   Chandrasekharam V V S, 2013, Indian J Urol, V29, P48, DOI 10.4103/0970-1591.109984
   El-Kassaby AW, 2003, J UROLOGY, V169, P170, DOI 10.1016/S0022-5347(05)64060-8
   Hanh DN, 2005, ENVIRON TECHNOL, V26, P581, DOI 10.1080/09593332608618543
   Harrison BS, 2007, BIOMATERIALS, V28, P4628, DOI 10.1016/j.biomaterials.2007.07.003
   Jia WS, 2015, BIOMATERIALS, V69, P45, DOI 10.1016/j.biomaterials.2015.08.009
   Li C, 2013, UROLOGY, V81, P1075, DOI 10.1016/j.urology.2013.01.041
   Macedo A, 2012, CURR OPIN UROL, V22, P447, DOI 10.1097/MOU.0b013e328357bc62
   Villoldo GM, 2013, UROLOGY, V81, DOI 10.1016/j.urology.2013.02.023
   Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0
   Oh SH, 2009, BIOMATERIALS, V30, P757, DOI 10.1016/j.biomaterials.2008.09.065
   Orabi H, 2013, SCI WORLD J, DOI 10.1155/2013/154564
   Palminteri E, 2007, EUR UROL, V51, P1695, DOI 10.1016/j.eururo.2006.12.016
   Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077
   Sahoo S, 2010, J BIOMED MATER RES B, V95B, P19, DOI 10.1002/jbm.b.31678
   Simaioforidis V, 2013, TISSUE ENG PART B-RE, V19, P413, DOI [10.1089/ten.teb.2012.0737, 10.1089/ten.TEB.2012.0737]
   Tanabe T, 2002, BIOMATERIALS, V23, P817, DOI 10.1016/S0142-9612(01)00187-9
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Wang D, 2015, SPR GEOL, P1, DOI 10.1007/978-3-662-46557-8
NR 21
TC 1
Z9 1
U1 3
U2 17
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD APR
PY 2016
VL 6
IS 4
BP 295
EP 300
DI 10.1166/jbt.2016.1444
PG 6
WC Cell & Tissue Engineering
SC Cell Biology
GA DM5WH
UT WOS:000376420600006
DA 2018-10-19
ER

PT J
AU Zhou, CX
   Lei, FY
   Chodosh, J
   Paschalis, EI
AF Zhou, Chengxin
   Lei, Fengyang
   Chodosh, James
   Paschalis, Eleftherios I.
TI The Role of Titanium Surface Microtopography on Adhesion, Proliferation,
   Transformation, and Matrix Deposition of Corneal Cells
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Article
DE titanium; biocompatibility; implants; cornea; surface roughness;
   alpha-smooth muscle actin; collagen deposition
ID BOSTON TYPE-1 KERATOPROSTHESIS; IN-VITRO; DIFFERENTIATION; FIBROBLASTS;
   EXPRESSION; OUTCOMES; KINASE; MYOFIBROBLASTS; ENDOTHELIUM; TOPOGRAPHY
AB PURPOSE. Titanium (Ti) is an excellent implantable biomaterial that can be further enhanced by surface topography optimization. Despite numerous data from orthopedics and dentistry, the effect of Ti surface topography on ocular cells is still poorly understood. In light of the recent adaptation of Ti in the Boston Keratoprosthesis artificial cornea, we attempted to perform an extended evaluation of the effect of Ti surface topography on corneal cell adhesion, proliferation, cytotoxicity, transformation, and matrix deposition.
   METHODS. Different surface topographies were generated on medical grade Ti-6Al-4V-ELI (extra-low interstitial), with linearly increased roughness (polished to grit blasted). Biological response was evaluated in vitro using human corneal limbal epithelial (HCLE) cells, stromal fibroblasts (HCF), and endothelial cells (HCEnC).
   RESULTS. None of the Ti surface topographies caused cytotoxicity to any of the three corneal cell types. However, rough Ti surface inhibited HCLE and HCF cell adhesion and proliferation, while HCEnC proliferation was unaffected. Long-term experiments with HCF revealed that rough Ti surface with R-a (the arithmetic average of the profile height from the mean line) >= 1.15 mu m suppressed HCF focal adhesion kinase phosphorylation, changed fibroblast morphology, and caused less aligned and reduced deposition of collagen matrix as compared to smooth Ti (R-a <= 0.08 mu m). In the presence of transforming growth factor beta 1 (TGF beta 1) stimulation, rough Ti inhibited alpha-smooth muscle actin (alpha-SMA) expression and collagen deposition, leading to decreased myofibroblast transformation and disorganization of the collagen fibrils as compared to smooth Ti.
   CONCLUSIONS. This study suggests that Ti surface topography regulates corneal cell behavior in a tissue-dependent manner that varies across the corneal strata. Contrary to the accepted paradigm, smooth surface topography can enhance cell adhesion and proliferation and increase matrix deposition by corneal cells.
C1 [Paschalis, Eleftherios I.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol,Boston Keratoprosthesis Lab, 243 Charles St, Boston, MA 02114 USA.
   [Paschalis, Eleftherios I.] Harvard Univ, Sch Med, Schepens Eye Res Inst, 243 Charles St, Boston, MA 02114 USA.
   [Chodosh, James] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, 243 Charles St, Boston, MA 02114 USA.
RP Paschalis, EI (reprint author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol,Boston Keratoprosthesis Lab, 243 Charles St, Boston, MA 02114 USA.; Paschalis, EI (reprint author), Harvard Univ, Sch Med, Schepens Eye Res Inst, 243 Charles St, Boston, MA 02114 USA.; Chodosh, J (reprint author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, 243 Charles St, Boston, MA 02114 USA.
EM James_Chodosh@meei.harvard.edu; eleftherios_paschalis@meei.harvard.edu
OI Paschalis, Eleftherios/0000-0002-4544-4452
FU Boston Keratoprosthesis Research Fund; Massachusetts Eye and Ear;
   Eleanor and Miles Shore Fund
FX Supported by the Boston Keratoprosthesis Research Fund, Massachusetts
   Eye and Ear, and the Eleanor and Miles Shore Fund. All authors are
   full-time employees of Massachusetts Eye and Ear Infirmary, a nonprofit
   organization that is the manufacturer of the Boston Keratoprosthesis.
   The authors alone are responsible for the content and writing of the
   paper.
CR Aldave AJ, 2012, OPHTHALMOLOGY, V119, P1530, DOI 10.1016/j.ophtha.2012.02.015
   Ament JD, 2009, CORNEA, V28, P808, DOI 10.1097/ICO.0b013e31819670ac
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   Bachle M, 2004, CLIN ORAL IMPLAN RES, V15, P683, DOI 10.1111/j.1600-0501.2004.01054.x
   BIRK DE, 1990, J CELL SCI, V95, P649
   Bourne WM, 2003, EYE, V17, P912, DOI 10.1038/sj.eye.6700559
   Cheung JWC, 2014, BIOMATERIALS, V35, P10025, DOI 10.1016/j.biomaterials.2014.09.001
   Chew HF, 2009, CORNEA, V28, P989, DOI 10.1097/ICO.0b013e3181a186dc
   Ciralsky J, 2010, OCUL IMMUNOL INFLAMM, V18, P275, DOI 10.3109/09273941003682300
   Estevez M, 2015, J BIOMED MATER RES A, V103, P1659, DOI 10.1002/jbm.a.35293
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851
   Guo XQ, 2007, INVEST OPHTH VIS SCI, V48, P4050, DOI 10.1167/iovs.06-1216
   Hou JH, 2014, JAMA OPHTHALMOL, V132, P1133, DOI 10.1001/jamaophthalmol.2014.1959
   Jester JV, 1996, CORNEA, V15, P505
   Jester JV, 1997, CORNEA, V16, P177
   Jester JV, 1999, PROG RETIN EYE RES, V18, P311, DOI 10.1016/S1350-9462(98)00021-4
   Joyce NC, 1996, INVEST OPHTH VIS SCI, V37, P645
   Karamichos D, 2010, INVEST OPHTH VIS SCI, V51, P1382, DOI 10.1167/iovs.09-3860
   Kim A, 2010, INVEST OPHTH VIS SCI, V51, P864, DOI 10.1167/iovs.09-4200
   Kubo K, 2009, BIOMATERIALS, V30, P5319, DOI 10.1016/j.biomaterials.2009.06.021
   Lauer G, 2001, BIOMATERIALS, V22, P2799, DOI 10.1016/S0142-9612(01)00024-2
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Leask A, 2013, ADV WOUND CARE, V2, P247, DOI 10.1089/wound.2012.0363
   Liliensiek SJ, 2006, J BIOMED MATER RES A, V79A, P185, DOI 10.1002/jbm.a.30744
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Masur SK, 1999, INVEST OPHTH VIS SCI, V40, P904
   Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011
   Mol A, 2005, BIOMATERIALS, V26, P3113, DOI 10.1016/j.biomaterials.2004.08.007
   Mustafa K, 2001, CLIN ORAL IMPLAN RES, V12, P515, DOI 10.1034/j.1600-0501.2001.120513.x
   Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373
   Paschalis EI, 2014, TRANSL VIS SCI TECHN, V3, DOI 10.1167/tvst.3.5.4
   Paschalis EI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067404
   Paschalis EI, 2013, INVEST OPHTH VIS SCI, V54, P3863, DOI 10.1167/iovs.13-11714
   Phillips DL, 2014, CORNEA, V33, P905, DOI 10.1097/ICO.0000000000000204
   POSTLETHWAITE AE, 1978, P NATL ACAD SCI USA, V75, P871, DOI 10.1073/pnas.75.2.871
   Rani WD, 2012, ACTA BIOMATER, V8, P1976
   RATNER BD, 2001, ENG MAT SER, P1
   Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002
   Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2
   Schmedt T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051427
   Srikumaran D, 2014, OPHTHALMOLOGY, V121, P2159, DOI 10.1016/j.ophtha.2014.05.030
   Stacy RC, 2011, ARCH OPHTHALMOL-CHIC, V129, P310, DOI 10.1001/archophthalmol.2011.26
   Todani A, 2011, GRAEF ARCH CLIN EXP, V249, P1515, DOI 10.1007/s00417-011-1684-y
   Torricelli AAM, 2014, EXP EYE RES, V129, P151, DOI 10.1016/j.exer.2014.09.013
   Toutant M, 2002, MOL CELL BIOL, V22, P7731, DOI 10.1128/MCB.22.22.7731-7743.2002
   Tsukimura N, 2011, BIOMATERIALS, V32, P4358, DOI 10.1016/j.biomaterials.2011.03.001
   WARING GO, 1982, OPHTHALMOLOGY, V89, P531
   Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200
   Zambuzzi WF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095662
   Zimerman B, 2004, CELL MOTIL CYTOSKEL, V58, P143, DOI 10.1002/cm.20005
NR 51
TC 8
Z9 8
U1 5
U2 13
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD APR
PY 2016
VL 57
IS 4
BP 1927
EP 1938
DI 10.1167/iovs.15-18406
PG 12
WC Ophthalmology
SC Ophthalmology
GA DL8XY
UT WOS:000375926700053
PM 27092719
OA Other Gold
DA 2018-10-19
ER

PT J
AU Gholami, M
   Mhaede, M
   Pastorek, F
   Altenberger, I
   Hadzima, B
   Wollmann, M
   Wagner, L
AF Gholami, Mozghan
   Mhaede, Mansour
   Pastorek, Filip
   Altenberger, Igor
   Hadzima, Branislav
   Wollmann, Manfred
   Wagner, Lothar
TI Corrosion Behavior and Mechanical Properties of Ultrafine-Grained Pure
   Copper with Potential as a Biomaterial
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
ID SEVERE PLASTIC-DEFORMATION; SIMULATED UTERINE FLUID; ELECTROCHEMICAL
   IMPEDANCE SPECTROSCOPY; DENSITY POLYETHYLENE NANOCOMPOSITE;
   INTRAUTERINE-DEVICE; RELEASE BEHAVIOR; WORK FUNCTION; CUPRIC ION; BULK;
   MICROSTRUCTURE
AB This study aims to evaluate and compare the mechanical and corrosion resistance properties of ultrafine-grained (UFG) copper with that of coarse-grained (CG) copper microstructures. Ultrafine-grained microstructures are produced through severe plastic deformation using rotary swaging. Potentiodynamic polarization and electrochemical impedance tests are performed at 37 degrees C in Hank's solution as the simulated body fluid. The results reveal that the highly deformed UFG-materials not only show marked enhancement of the mechanical properties but also remarkable enhancement of corrosion resistance compared with that of the CG counterpart.
C1 [Gholami, Mozghan; Mhaede, Mansour; Wollmann, Manfred; Wagner, Lothar] Tech Univ Clausthal, Inst Mat Sci & Engn, D-38678 Clausthal Zellerfeld, Germany.
   [Mhaede, Mansour] Zagazig Univ, Fac Engn, Zagazig, Egypt.
   [Pastorek, Filip; Hadzima, Branislav] Univ Zilina, Fac Mech Engn, Dept Mat Engn, Zilina 01026, Slovakia.
   [Altenberger, Igor] Wieland Werke AG, Cent Lab, D-89079 Ulm, Germany.
RP Mhaede, M (reprint author), Tech Univ Clausthal, Inst Mat Sci & Engn, D-38678 Clausthal Zellerfeld, Germany.; Mhaede, M (reprint author), Zagazig Univ, Fac Engn, Zagazig, Egypt.
EM mansour.mhaede@yahoo.com
FU European Regional Development Fund; Slovak state budget by the project
   "Research Centre of the University of Zilina" [ITMS 26220220183]
FX We would like to acknowledge the financial support of European Regional
   Development Fund and Slovak state budget by the project "Research Centre
   of the University of Zilina," ITMS 26220220183 granted to F. Pastorek
   and B. Hadzima. We would also like to thank E. Mawaad for performing the
   X-Ray texture measurements.
CR Abdulstaar M, 2014, SURF COAT TECH, V254, P244, DOI 10.1016/j.surfcoat.2014.06.026
   Abdulstaar M, 2014, MATER DESIGN, V57, P325, DOI 10.1016/j.matdes.2014.01.005
   Abdulstaar MA, 2014, J MATER SCI, V49, P1138, DOI 10.1007/s10853-013-7792-9
   Abdulstaar MA, 2013, MAT SCI ENG A-STRUCT, V565, P351, DOI 10.1016/j.msea.2012.12.046
   Acciari HA, 2005, CORROS SCI, V47, P635, DOI 10.1016/j.corsci.2004.07.004
   Alexandrov IV, 1998, METALL MATER TRANS A, V29, P2253, DOI 10.1007/s11661-998-0103-4
   Altenberger I, 2014, IOP CONF SER-MAT SCI, V63, DOI 10.1088/1757-899X/63/1/012135
   Balakrishnan A, 2008, TRENDS BIOMATER ARTI, V22, P58
   Barbucci A, 2001, J ALLOY COMPD, V317, P607, DOI 10.1016/S0925-8388(00)01396-7
   Bastidas JM, 2000, CONTRACEPTION, V61, P395, DOI 10.1016/S0010-7824(00)00124-4
   Bastidas JM, 1997, BIOMATERIALS, V18, P247, DOI 10.1016/S0142-9612(96)00136-6
   BEAUNIER L, 1980, ELECTROCHIM ACTA, V25, P1239, DOI 10.1016/0013-4686(80)87127-1
   Beaunier L., 1982, J PHYS, V43, pC6
   Brandao L, 1998, SCRIPTA MATER, V39, P27, DOI 10.1016/S1359-6462(98)00123-7
   Cai SZ, 2007, J BIOMED MATER RES B, V80B, P220, DOI 10.1002/jbm.b.30587
   Cai SZ, 2005, BIOMATERIALS, V26, P2671, DOI 10.1016/j.biomaterials.2004.08.003
   Chiou CF, 2003, CONTRACEPTION, V68, P3, DOI 10.1016/S0010-7824(03)00078-7
   d'Arcangues C, 2007, CONTRACEPTION, V75, P2
   Gabrielli C., 1983, 00483 SOL INSTR
   Gao J., 2007, J REPROD CONTRACEPT, V18, P33
   Ghosh SK, 2006, J ALLOY COMPD, V426, P235, DOI 10.1016/j.jallcom.2005.12.094
   Gollapudi R., 2012, CORROS SCI, V62, P90
   Gollapudi S, 2012, CORROS SCI, V62, P90, DOI 10.1016/j.corsci.2012.04.040
   Gubicza J., 2007, MATER SCI FORUM, V567-568, P181
   Guo WY, 2009, MATER CHARACT, V60, P173, DOI 10.1016/j.matchar.2008.08.006
   Gutman E. M., 1994, MECHANOCHEMISTRY SOL
   Haanappel VAC, 2001, CORROSION, V57, P557, DOI 10.5006/1.3290382
   HALL EO, 1951, P PHYS SOC LOND B, V64, P747, DOI 10.1088/0370-1301/64/9/303
   Hughes DA, 2000, ACTA MATER, V48, P2985, DOI 10.1016/S1359-6454(00)00082-3
   Kang Y. C., 2008, CORROSION 2008
   Li W, 2005, APPL SURF SCI, V240, P388, DOI 10.1016/j.apsusc.2004.07.017
   Liang JY, 2008, CONTRACEPTION, V77, P299, DOI 10.1016/j.contraception.2007.12.005
   MANSFELD F, 1985, CORROSION, V41, P490, DOI 10.5006/1.3583832
   Miyamoto H, 2008, CORROS SCI, V50, P1215, DOI 10.1016/j.corsci.2008.01.024
   Mohamed MA, 2011, LONG TERM CONTRACEPT
   Mora N, 2002, BIOMATERIALS, V23, P667, DOI 10.1016/S0142-9612(01)00154-5
   O'Brien PA, 2008, CONTRACEPTION, V77, P318, DOI 10.1016/j.contraception.2007.12.011
   Palumbo G, 1999, MRS BULL, V24, P27
   PETCH NJ, 1953, J IRON STEEL I, V174, P25
   Ralston KD, 2010, CORROSION-US, V66, DOI 10.5006/1.3462912
   Saldana L, 2007, BIOMATERIALS, V28, P4343, DOI 10.1016/j.biomaterials.2007.06.015
   Scully J. C, 1990, FUNDAMENTALS CORROSI
   Song D, 2011, CORROS SCI, V53, P362, DOI 10.1016/j.corsci.2010.09.044
   Tamilselvi S, 2006, ELECTROCHIM ACTA, V52, P839, DOI 10.1016/j.electacta.2006.06.018
   Tao S, 2008, PHIL MAG LETT, V88, P137, DOI 10.1080/09500830701771939
   Torre F. D., 2004, ACTA MAT, V52, P4819, DOI DOI 10.1016/J.ACTAMAT.2004.06.040
   Trdan U, 2012, CORROS SCI, V59, P324, DOI 10.1016/j.corsci.2012.03.019
   Trussell J, 2007, CONTRACEPTIVE TECHNO, P747
   Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021
   Valiev RZ, 2002, J MATER RES, V17, P5, DOI 10.1557/JMR.2002.0002
   Valiev RZ, 2000, PROG MATER SCI, V45, P103, DOI 10.1016/S0079-6425(99)00007-9
   Vinogradov A, 1999, SCRIPTA MATER, V41, P319, DOI 10.1016/S1359-6462(99)00170-0
   Wang LP, 2007, ELECTROCHIM ACTA, V52, P4342, DOI 10.1016/j.electacta.2006.12.009
   Xia XP, 2011, J MATER SCI-MATER M, V22, P1773, DOI 10.1007/s10856-011-4347-y
   Xia XP, 2006, MATER CHEM PHYS, V95, P122, DOI 10.1016/j.matchemphys.2005.05.010
   Xu XX, 2013, J BIOMED MATER RES B, V101, P1428, DOI 10.1002/jbm.b.32962
   Xu XX, 2012, ACTA BIOMATER, V8, P886, DOI 10.1016/j.actbio.2011.10.018
   Xu XX, 2010, MATER LETT, V64, P524, DOI 10.1016/j.matlet.2009.11.065
   Yamasaki T, 2001, MAT SCI ENG A-STRUCT, V318, P122, DOI 10.1016/S0921-5093(01)01332-6
   Yin SB, 2005, MAT SCI ENG A-STRUCT, V394, P266, DOI 10.1016/j.msea.2004.11.054
   Yu J, 2008, CONTRACEPTION, V78, P319, DOI 10.1016/j.contraception.2008.05.008
   Zhang WW, 2012, ACTA BIOMATER, V8, P897, DOI 10.1016/j.actbio.2011.09.024
   Zhu JJ, 1999, ADV CONTRACEPT, V15, P179, DOI 10.1023/A:1006793231274
NR 63
TC 4
Z9 4
U1 3
U2 19
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1438-1656
EI 1527-2648
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD APR
PY 2016
VL 18
IS 4
BP 615
EP 623
DI 10.1002/adem.201500269
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA DJ9SL
UT WOS:000374553100020
DA 2018-10-19
ER

PT J
AU Hong, YQ
   Zhu, XK
   Wang, P
   Fu, HT
   Deng, C
   Cui, L
   Wang, Q
   Fan, XR
AF Hong, Yanqing
   Zhu, Xueke
   Wang, Ping
   Fu, Haitian
   Deng, Chao
   Cui, Li
   Wang, Qiang
   Fan, Xuerong
TI Tyrosinase-Mediated Construction of a Silk Fibroin/Elastin Nanofiber
   Bioscaffold
SO APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
LA English
DT Article
DE Tyrosinase; Silk fibroin; Elastin; Bioscaffold; Biocompatibility
ID CROSS-LINKING; FIBROIN FILMS; ELASTIN; CHITOSAN; DIFFERENTIATION;
   BIOMATERIAL; MOLECULES; SCAFFOLDS; HYDROGELS; COLLAGEN
AB Elastin has characteristics of elasticity, biological activity, and mechanical stability. In the present work, tyrosinase-mediated construction of a bioscaffold with silk fibroin and elastin was carried out, aiming at developing a novel medical biomaterial. The efficiency of enzymatic oxidation of silk fibroin and the covalent reaction between fibroin and elastin were examined by spectrophotometry, sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), and size exclusion chromatography (SEC). The properties of composite air-dried and nanofiber scaffolds were investigated. The results reveal that elastin was successfully bonded to silk fibroins, resulting in an increase in molecular weight of fibroin proteins. ATR-FTIR spectra indicated that tyrosinase treatment impacted the conformational structure of fibroin-based membrane. The thermal behaviors and mechanical properties of the tyrosinase-treated scaffolds were also improved compared with the untreated group. NIH/3T3 cells exhibited optimum densities when grown on the nanofiber scaffold, implying that the nanofiber scaffold has enhanced biocompatibility compared to the air-dried scaffold. A biological nanofiber scaffold constructed from tyrosinase-treated fibroin and elastin could potentially be utilized in biomedical applications.
C1 [Hong, Yanqing; Zhu, Xueke; Wang, Ping; Cui, Li; Wang, Qiang; Fan, Xuerong] Jiangnan Univ, Key Lab Sci & Technol Ecotext, Minist Educ, Wuxi 214122, Peoples R China.
   [Fu, Haitian] Jiangnan Univ, Sch Pharmaceut Sci, Wuxi 214122, Peoples R China.
   [Deng, Chao] Jiangnan Univ, Wuxi Med Sch, Wuxi 214122, Peoples R China.
RP Wang, P (reprint author), Jiangnan Univ, Key Lab Sci & Technol Ecotext, Minist Educ, Wuxi 214122, Peoples R China.
EM pwang@jiangnan.edu.cn
FU National Natural Science Foundation of China [51373071]; Program for New
   Century Excellent Talents in University [NCET-12-0883]
FX This work was financially supported by the National Natural Science
   Foundation of China (51373071) and Program for New Century Excellent
   Talents in University (NCET-12-0883).
CR Annabi N, 2009, BIOMATERIALS, V30, P1, DOI 10.1016/j.biomaterials.2008.09.031
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Debelle L, 1999, BIOCHIMIE, V81, P981, DOI 10.1016/S0300-9084(99)00221-7
   Du XJ, 2014, COLLOID SURFACE B, V122, P79, DOI 10.1016/j.colsurfb.2014.06.049
   Faccio G, 2012, PROCESS BIOCHEM, V47, P1749, DOI 10.1016/j.procbio.2012.08.018
   Fan SN, 2013, INT J BIOL MACROMOL, V56, P83, DOI 10.1016/j.ijbiomac.2013.01.033
   Freddi G, 2003, J BIOTECHNOL, V106, P101, DOI 10.1016/j.jbiotec.2003.09.006
   Freddi G, 2006, J BIOTECHNOL, V125, P281, DOI 10.1016/j.jbiotec.2006.03.003
   Hashimoto T, 2015, POLYM DEGRAD STABIL, V112, P20, DOI 10.1016/j.polymdegradstab.2014.12.007
   Hu X, 2007, THERMOCHIM ACTA, V461, P137, DOI 10.1016/j.tca.2006.12.011
   Imsombut T, 2010, POWDER TECHNOL, V203, P603, DOI 10.1016/j.powtec.2010.06.027
   ITO S, 1977, BIOCHEM J, V161, P499, DOI 10.1042/bj1610499
   Jus S, 2011, MAT SCI ENG C-MATER, V31, P1068, DOI 10.1016/j.msec.2011.03.007
   Jus S, 2008, ENZYME MICROB TECH, V42, P535, DOI 10.1016/j.enzmictec.2008.02.012
   Kang GD, 2004, FIBER POLYM, V5, P234, DOI 10.1007/BF02903006
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Kundu J, 2012, ACTA BIOMATER, V8, P1720, DOI 10.1016/j.actbio.2012.01.004
   Li XQ, 2015, J COLLOID INTERF SCI, V445, P312, DOI 10.1016/j.jcis.2014.12.084
   Meinel AJ, 2009, BIOMATERIALS, V30, P3058, DOI 10.1016/j.biomaterials.2009.01.054
   Miyamoto K, 2009, INT J BIOL MACROMOL, V45, P33, DOI 10.1016/j.ijbiomac.2009.03.014
   Monogioudi E, 2009, FOOD HYDROCOLLOID, V23, P2008, DOI 10.1016/j.foodhyd.2009.03.011
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Sampaio S, 2005, J BIOTECHNOL, V116, P21, DOI 10.1016/j.jbiotec.2004.10.003
   Sionkowska A, 2013, J MOL LIQ, V178, P5, DOI 10.1016/j.molliq.2012.10.042
   Sousa F., 2009, PROCESS BIOCHEM, V44, P309
   Vasconcelos A., 2012, ACTA BIOMAERIALIA, V18, P3049
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang JL, 2011, COLLOID SURFACE B, V85, P241, DOI 10.1016/j.colsurfb.2011.02.035
   Wang JN, 2014, MAT SCI ENG C-MATER, V34, P429, DOI 10.1016/j.msec.2013.09.039
   Wang P, 2014, ENG LIFE SCI, V14, P211, DOI 10.1002/elsc.201300008
   Wise SG, 2009, ADV PROTEIN CHEM STR, V78, P1, DOI [10.1016/S1876-1623(08)78001-5, 10.1016/S1876-1623(09)78001-5]
   Zhang YQ, 2005, J BIOTECHNOL, V120, P315, DOI 10.1016/j.jbiotec.2005.06.027
NR 33
TC 6
Z9 7
U1 5
U2 37
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0273-2289
EI 1559-0291
J9 APPL BIOCHEM BIOTECH
JI Appl. Biochem. Biotechnol.
PD APR
PY 2016
VL 178
IS 7
BP 1363
EP 1376
DI 10.1007/s12010-015-1952-0
PG 14
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA DL4NN
UT WOS:000375614500008
PM 26679706
DA 2018-10-19
ER

PT J
AU Cross, MC
   Toomey, RG
   Gallant, ND
AF Cross, Michael C.
   Toomey, Ryan G.
   Gallant, Nathan D.
TI Protein-surface interactions on stimuli-responsive polymeric
   biomaterials
SO BIOMEDICAL MATERIALS
LA English
DT Review
DE stimulus responsive materials; smart materials; protein adsorption; cell
   adhesion; poly(N-isopropylacrylamide) or PNIPAAm
ID POLY-N-ISOPROPYLACRYLAMIDE; SELF-ASSEMBLED MONOLAYERS; BOVINE
   SERUM-ALBUMIN; BIOMEDICAL APPLICATIONS; GRAFTING DENSITY;
   THERMOSENSITIVE-POLYMER; CONFORMATIONAL-CHANGES; ADSORPTION BEHAVIORS;
   CHAIN COLLAPSE; IN-VIVO
AB Responsive surfaces: a review of the dependence of protein adsorption on the reversible volume phase transition in stimuli-responsive polymers. Specifically addressed are a widely studied subset: thermoresponsive polymers. Findings are also generalizable to other materials which undergo a similarly reversible volume phase transition. As of 2015, over 100 000 articles have been published on stimuli-responsive polymers and many more on protein-biomaterial interactions. Significantly, fewer than 100 of these have focused specifically on protein interactions with stimuli-responsive polymers. These report a clear trend of increased protein adsorption in the collapsed state compared to the swollen state. This control over protein interactions makes stimuli-responsive polymers highly useful in biomedical applications such as wound repair scaffolds, on-demand drug delivery, and antifouling surfaces. Outstanding questions are whether the protein adsorption is reversible with the volume phase transition and whether there is a time-dependence. A clear understanding of protein interactions with stimuli-responsive polymers will advance theoretical models, experimental results, and biomedical applications.
C1 [Cross, Michael C.] Univ S Florida, Dept Phys, Tampa, FL 33620 USA.
   [Toomey, Ryan G.] Univ S Florida, Dept Chem & Biomed Engn, Tampa, FL 33620 USA.
   [Gallant, Nathan D.] Univ S Florida, Dept Mech Engn, 4202 East Fowler Ave,ENB118, Tampa, FL 33620 USA.
RP Gallant, ND (reprint author), Univ S Florida, Dept Mech Engn, 4202 East Fowler Ave,ENB118, Tampa, FL 33620 USA.
EM ngallant@usf.edu
OI Gallant, Nathan/0000-0001-6454-7660
CR Ahn SK, 2008, SOFT MATTER, V4, P1151, DOI 10.1039/b714376a
   Akintewe OO, 2015, ACTA BIOMATER, V11, P96, DOI 10.1016/j.actbio.2014.09.040
   Alarcon CDH, 2005, J MATER CHEM, V15, P2089, DOI 10.1039/b419142k
   Alarcon CDL, 2005, INT J PHARMACEUT, V295, P77, DOI 10.1016/j.ijpharm.2005.01.037
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Balamurugan S, 2005, J AM CHEM SOC, V127, P14548, DOI 10.1021/ja054156g
   Bostrom M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.168103
   Brouette N, 2012, EUR PHYS J-SPEC TOP, V213, P343, DOI 10.1140/epjst/e2012-01681-4
   Burkert S, 2010, LANGMUIR, V26, P1786, DOI 10.1021/la902505q
   Cao B, 2013, ADV HEALTHC MATER, V2, P1096, DOI 10.1002/adhm.201200359
   Carman ML, 2006, BIOFOULING, V22, P11, DOI 10.1080/08927010500484854
   Castellanos A, 2007, LANGMUIR, V23, P6391, DOI 10.1021/la700338p
   Cheney SM, 2014, UROLOGY, V83, P489, DOI 10.1016/j.urology.2013.10.005
   Cho EC, 2004, POLYMER, V45, P3195, DOI 10.1016/j.polymer.2004.02.052
   Choi S, 2013, BIOMACROMOLECULES, V14, P92, DOI 10.1021/bm301390q
   Cole MA, 2009, BIOMATERIALS, V30, P1827, DOI 10.1016/j.biomaterials.2008.12.026
   Costa D, 2013, J BIOMED MATER RES A, V101, P1210, DOI 10.1002/jbm.a.34416
   Demirel G, 2007, J POLYM RES, V14, P23, DOI 10.1007/s10965-006-9076-4
   Der A, 2007, J PHYS CHEM B, V111, P5344, DOI 10.1021/jp066206p
   Ding XB, 2000, J APPL POLYM SCI, V77, P2915, DOI 10.1002/1097-4628(20000923)77:13<2915::AID-APP14>3.3.CO;2-U
   DuPont SJ, 2010, SOFT MATTER, V6, P3876, DOI 10.1039/c0sm00021c
   Duracher D, 2000, LANGMUIR, V16, P9002, DOI 10.1021/la0004045
   Duracher D, 2004, POLYM INT, V53, P618, DOI 10.1002/pi.1441
   Ekici S, 2011, J MATER SCI, V46, P2843, DOI 10.1007/s10853-010-5158-0
   Elaissari A, 2001, J MAGN MAGN MATER, V225, P151, DOI 10.1016/S0304-8853(00)01244-0
   Ercole F, 2010, POLYM CHEM-UK, V1, P37, DOI 10.1039/b9py00300b
   Federici S, 2012, J COLLOID INTERF SCI, V375, P1, DOI 10.1016/j.jcis.2012.02.013
   Finch C, 2013, J COMPUT PHYS, V244, P212, DOI 10.1016/j.jcp.2012.07.034
   Fu Q, 2004, J AM CHEM SOC, V126, P8904, DOI 10.1021/ja047895q
   Gan DJ, 2002, MACROMOLECULES, V35, P9634, DOI 10.1021/ma021186k
   Ge X, 2009, J APPL POLYM SCI, V114, P1270, DOI 10.1002/app.30545
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Halperin A, 2011, MACROMOLECULES, V44, P6986, DOI 10.1021/ma201006h
   Halperin A, 2009, LANGMUIR, V25, P11621, DOI 10.1021/la9008569
   Hoffman AS, 2013, ADV DRUG DELIVER REV, V65, P10, DOI 10.1016/j.addr.2012.11.004
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, pS137
   Huang QL, 2013, BIOMATERIALS, V34, P434, DOI 10.1016/j.biomaterials.2012.09.073
   Huber DL, 2003, SCIENCE, V301, P352, DOI 10.1126/science.1080759
   Ivanov AE, 2006, J COLLOID INTERF SCI, V296, P538, DOI 10.1016/j.jcis.2005.09.064
   Janzen J, 2004, J BIOMAT SCI-POLYM E, V15, P1121, DOI 10.1163/1568562041753043
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Kanazawa R, 2012, SEP PURIF TECHNOL, V96, P26, DOI 10.1016/j.seppur.2012.05.016
   KAWAGUCHI H, 1992, COLLOID POLYM SCI, V270, P53, DOI 10.1007/BF00656929
   Kayitmazer AB, 2013, SOFT MATTER, V9, P2553, DOI 10.1039/c2sm27002a
   Kidoaki S, 2001, LANGMUIR, V17, P2402, DOI 10.1021/la001522v
   Kim J, 2012, TRENDS BIOTECHNOL, V30, P426, DOI 10.1016/j.tibtech.2012.04.003
   Kim J, 2010, NAT MATER, V9, P159, DOI [10.1038/NMAT2606, 10.1038/nmat2606]
   Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025
   Koetting MC, 2015, MAT SCI ENG R, V93, P1, DOI 10.1016/j.mser.2015.04.001
   Laird D, 2015, J BIOACT COMPAT POL, V30, P319, DOI 10.1177/0883911515570370
   Lee SC, 2013, ADV DRUG DELIVER REV, V65, P17, DOI 10.1016/j.addr.2012.07.015
   Li LY, 2005, J PHYS CHEM B, V109, P2934, DOI 10.1021/jp0473321
   Liu XJ, 2011, SOFT MATTER, V7, P515, DOI 10.1039/c0sm00682c
   Lo Nostro P, 2012, CHEM REV, V112, P2286, DOI 10.1021/cr200271j
   London N, 2014, J STRUCT BIOL, V185, P136, DOI 10.1016/j.jsb.2013.03.012
   Mano JF, 2008, ADV ENG MATER, V10, P515, DOI 10.1002/adem.200700355
   Meng J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02655
   Morisada S, 2011, IND ENG CHEM RES, V50, P12358, DOI 10.1021/ie200779w
   Mueller TKH, 2013, J CHROMATOGR A, V1285, P97, DOI 10.1016/j.chroma.2013.02.025
   Nagase K, 2011, J MATER CHEM, V21, P2590, DOI 10.1039/c0jm03453c
   Nagase K, 2011, BIOMATERIALS, V32, P619, DOI 10.1016/j.biomaterials.2010.09.012
   Noh H, 2007, BIOMATERIALS, V28, P405, DOI 10.1016/j.biomaterials.2006.09.006
   Nolan CM, 2005, BIOMACROMOLECULES, V6, P2032, DOI 10.1021/bm0500087
   Okamura A, 2008, J BIOSCI BIOENG, V105, P221, DOI 10.1263/jbb.105.221
   Okubo M, 1996, COLLOID POLYM SCI, V274, P112, DOI 10.1007/BF00663443
   Ozdural AR, 2004, J CHROMATOGR A, V1041, P77, DOI 10.1016/j.chroma.2004.05.009
   Penna MJ, 2014, J AM CHEM SOC, V136, P5323, DOI 10.1021/ja411796e
   Plunkett KN, 2006, LANGMUIR, V22, P4259, DOI 10.1021/la0531502
   Poplewska I, 2014, J CHROMATOGR A, V1324, P181, DOI 10.1016/j.chroma.2013.11.040
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   Rane A, 2010, J UROLOGY, V183, P1417, DOI 10.1016/j.juro.2009.12.023
   Reinicke S, 2010, SOFT MATTER, V6, P2760, DOI 10.1039/c000943a
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Sang LC, 2011, LANGMUIR, V27, P13828, DOI 10.1021/la202907f
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Sethuraman A, 2004, LANGMUIR, V20, P7779, DOI 10.1021/la049454q
   Shamim N, 2008, J COLLOID INTERF SCI, V320, P15, DOI 10.1016/j.jcis.2007.08.012
   Shamim N, 2006, J COLLOID INTERF SCI, V304, P1, DOI 10.1016/j.jcis.2006.08.047
   Shi XN, 2015, RSC ADV, V5, P41820, DOI 10.1039/c5ra04897d
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Silva CSO, 2006, BIOTECHNOL LETT, V28, P2019, DOI 10.1007/s10529-006-9188-2
   Sinha SR, 2015, GASTROENTEROLOGY, V149, P52, DOI 10.1053/j.gastro.2015.04.002
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   Song MM, 2011, COLLOID SURFACE B, V84, P477, DOI 10.1016/j.colsurfb.2011.02.002
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Sugiura S, 2009, BIOSENS BIOELECTRON, V24, P1135, DOI 10.1016/j.bios.2008.06.038
   Sun TL, 2004, ANGEW CHEM INT EDIT, V43, P357, DOI 10.1002/anie.200352565
   Tomatsu I, 2011, ADV DRUG DELIVER REV, V63, P1257, DOI 10.1016/j.addr.2011.06.009
   Trongsatitkul T, 2013, COLLOID SURFACE B, V103, P244, DOI 10.1016/j.colsurfb.2012.10.053
   Tziveleka LA, 2014, MACROMOL BIOSCI, V14, P131, DOI 10.1002/mabi.201300212
   Ulijn RV, 2006, J MATER CHEM, V16, P2217, DOI 10.1039/b601776m
   Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   Wang KF, 2012, INTERFACE FOCUS, V2, P259, DOI 10.1098/rsfs.2012.0012
   Wang ZM, 2013, BBA-GEN SUBJECTS, V1830, P5356, DOI 10.1016/j.bbagen.2013.06.032
   Ward MA, 2011, POLYMERS-BASEL, V3, P1215, DOI 10.3390/polym3031215
   Wertz CF, 2001, LANGMUIR, V17, P3006, DOI 10.1021/la0017781
   White EM, 2013, J POLYM SCI POL PHYS, V51, P1084, DOI 10.1002/polb.23312
   Wu JY, 2005, J CONTROL RELEASE, V102, P361, DOI 10.1016/j.jconrel.2004.10.008
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Xue CY, 2012, ADV FUNCT MATER, V22, P2394, DOI 10.1002/adfm.201103056
   Xue CY, 2011, LANGMUIR, V27, P8810, DOI 10.1021/la2001909
   Yamazaki A, 1999, BBA-BIOMEMBRANES, V1421, P103, DOI 10.1016/S0005-2736(99)00117-0
   Yang WK, 2014, ACS APPL MATER INTER, V6, P10146, DOI 10.1021/am501193b
   Yigit C, 2012, LANGMUIR, V28, P14373, DOI 10.1021/la303292z
   YOSHIDA R, 1995, NATURE, V374, P240, DOI 10.1038/374240a0
   You JO, 2015, BIOMATERIALS, V57, P22, DOI 10.1016/j.biomaterials.2015.04.011
   Yu Q, 2013, ACS APPL MATER INTER, V5, P9295, DOI 10.1021/am4022279
   Yu Q, 2011, RSC ADV, V1, P262, DOI 10.1039/c1ra00201e
   Yu Q, 2010, LANGMUIR, V26, P8582, DOI 10.1021/la904663m
   Yu Q, 2010, COLLOID SURFACE B, V76, P468, DOI 10.1016/j.colsurfb.2009.12.006
   Yuan L, 2011, MACROMOL BIOSCI, V11, P1031, DOI 10.1002/mabi.201000464
   Zagar TM, 2014, INT J HYPERTHER, V30, P285, DOI 10.3109/02656736.2014.936049
   Zhao TL, 2011, COLLOID SURFACE B, V85, P26, DOI 10.1016/j.colsurfb.2010.10.047
   Zhou SY, 2014, J MEMBRANE SCI, V450, P351, DOI 10.1016/j.memsci.2013.09.011
   Zhu MQ, 2006, J AM CHEM SOC, V128, P4303, DOI 10.1021/ja0567642
   Zhu X, 2012, NANOSCALE RES LETT, V7, P1
   Zhu Y., 2005, ANGEW CHEM, V117, P5213, DOI DOI 10.1002/ANGE.200501500
NR 120
TC 9
Z9 9
U1 5
U2 94
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD APR
PY 2016
VL 11
IS 2
AR 022002
DI 10.1088/1748-6041/11/2/022002
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DL3GY
UT WOS:000375523400004
PM 26942693
OA Other Gold
DA 2018-10-19
ER

PT J
AU Magin, CM
   Alge, DL
   Anseth, KS
AF Magin, Chelsea M.
   Alge, Daniel L.
   Anseth, Kristi S.
TI Bio-inspired 3D microenvironments: a new dimension in tissue engineering
SO BIOMEDICAL MATERIALS
LA English
DT Review
DE bio-inspired; 3D; tissue engineering; biomaterials; microfabrication
ID STEM-CELL FATE; POLY(ETHYLENE GLYCOL) HYDROGELS; TETRAZINE-NORBORNENE
   CHEMISTRY; CLICK-BASED HYDROGELS; INK-JET METHOD; EXTRACELLULAR-MATRIX;
   REGENERATIVE MEDICINE; GROWTH-FACTORS; PROJECTION STEREOLITHOGRAPHY;
   PHOTODEGRADABLE HYDROGELS
AB Biomaterial scaffolds have been a foundational element of the tissue engineering paradigm since the inception of the field. Over the years there has been a progressive move toward the rational design and fabrication of bio-inspired materials that mimic the composition as well as the architecture and 3D structure of tissues. In this review, we chronicle advances in the field that address key challenges in tissue engineering as well as some emerging applications. Specifically, a summary of the materials and chemistries used to engineer bio-inspired 3D matrices that mimic numerous aspects of the extracellular matrix is provided, along with an overview of bioprinting, an additive manufacturing approach, for the fabrication of engineered tissues with precisely controlled 3D structures and architectures. To emphasize the potential clinical impact of the bio-inspired paradigm in biomaterials engineering, some applications of bio-inspired matrices are discussed in the context of translational tissue engineering. However, focus is also given to recent advances in the use of engineered 3D cellular microenvironments for fundamental studies in cell biology, including photoresponsive systems that are shedding new light on how matrix properties influence cell phenotype and function. In an outlook for future work, the need for high-throughput methods both for screening and fabrication is highlighted. Finally, microscale organ-on-a-chip technologies are highlighted as a promising area for future investment in the application of bio-inspired microenvironments.
C1 [Magin, Chelsea M.] Sharklet Technol Inc, Aurora, CO USA.
   [Alge, Daniel L.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX USA.
   [Alge, Daniel L.] Texas A&M Univ, Dept Mat Sci & Engn, College Stn, TX USA.
   [Anseth, Kristi S.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.
   [Anseth, Kristi S.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA.
   [Anseth, Kristi S.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.
RP Magin, CM (reprint author), Sharklet Technol Inc, Aurora, CO USA.
EM cmagin@sharklet.com
OI Magin, Chelsea/0000-0002-6988-8584
FU National Science Foundation [DMR 1408955]; National Institutes of Health
   [R01 DE016523]
FX The authors acknowledge financial support to KSA from the National
   Science Foundation (DMR 1408955) and the National Institutes of Health
   (R01 DE016523).
CR Alge DL, 2013, BIOMACROMOLECULES, V14, P949, DOI 10.1021/bm4000508
   Anderson JM, 2011, ACS NANO, V5, P9463, DOI 10.1021/nn203247m
   Anderson SB, 2011, BIOMATERIALS, V32, P3564, DOI 10.1016/j.biomaterials.2011.01.064
   Andukuri A, 2013, TISSUE ENG PART C-ME, V19, P375, DOI [10.1089/ten.tec.2012.0312, 10.1089/ten.TEC.2012.0312]
   Atala A, 2004, REJUV RES, V7, P15, DOI 10.1089/154916804323105053
   Atala A, 2012, SCI TRANSL MED, V4
   Azagarsamy MA, 2013, ANGEW CHEM INT EDIT, V52, P13803, DOI 10.1002/anie.201308174
   Azagarsamy MA, 2013, ACS MACRO LETT, V2, P5, DOI 10.1021/mz300585q
   Baier Leach J., 2003, BIOTECHNOL BIOENG, V82, P578, DOI DOI 10.1002/BIT.10605
   Bajaj P, 2014, ANNU REV BIOMED ENG, V16, P247, DOI 10.1146/annurev-bioeng-071813-105155
   Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Benton G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123312
   Bhattacharjee T, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500655
   Bian LM, 2013, P NATL ACAD SCI USA, V110, P10117, DOI 10.1073/pnas.1214100110
   Boekhoven J, 2014, ADV MATER, V26, P1642, DOI 10.1002/adma.201304606
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   Bury MI, 2014, BIOMATERIALS, V35, P9311, DOI 10.1016/j.biomaterials.2014.07.057
   Caplan AI, 2013, MESENCHYMAL STROMAL, P79
   Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008
   Chaudhuri O, 2014, NAT MATER, V13, P970, DOI [10.1038/NMAT4009, 10.1038/nmat4009]
   Choi NY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-103
   Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800
   Clark ER, 1939, AM J ANAT, V64, P251, DOI 10.1002/aja.1000640203
   Collier JH, 2010, CHEM SOC REV, V39, P3413, DOI 10.1039/b914337h
   Conda-Sheridan M, 2014, CHEM COMMUN, V50, P13757, DOI 10.1039/c4cc06340f
   Cordeiro JV, 2013, NAT REV MOL CELL BIO, V14, P249, DOI 10.1038/nrm3541
   Cui XF, 2012, TISSUE ENG PT A, V18, P1304, DOI [10.1089/ten.TEA.2011.0543, 10.1089/ten.tea.2011.0543]
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Cushing MC, 2007, SCIENCE, V316, P1133, DOI 10.1126/science.1140171
   D'haeseleer P, 2013, INSTRUCTABLES
   Dave PC, 2014, NAT MATER, V13, P532, DOI 10.1038/nmat3997
   DeForest CA, 2015, NAT MATER, V14, P523, DOI [10.1038/nmat4219, 10.1038/NMAT4219]
   DeForest CA, 2012, ANGEW CHEM INT EDIT, V51, P1816, DOI 10.1002/anie.201106463
   DeForest CA, 2011, NAT CHEM, V3, P925, DOI [10.1038/nchem.1174, 10.1038/NCHEM.1174]
   DeForest CA, 2010, CHEM MATER, V22, P4783, DOI 10.1021/cm101391y
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Demirci U, 2007, LAB CHIP, V7, P1139, DOI 10.1039/b704965j
   Desai RM, 2015, BIOMATERIALS, V50, P30, DOI 10.1016/j.biomaterials.2015.01.048
   Dolatshahi-Pirouz A, 2014, SCI REP-UK, V4, DOI 10.1038/srep03896
   Duan B, 2013, J BIOMED MATER RES A, V101, P1255, DOI 10.1002/jbm.a.34420
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Eng G, 2013, P NATL ACAD SCI USA, V110, P4551, DOI 10.1073/pnas.1300569110
   Fairbanks BD, 2009, ADV MATER, V21, P5005, DOI 10.1002/adma.200901808
   Fang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075187
   Fedorovich NE, 2012, TISSUE ENG PART C-ME, V18, P33, DOI [10.1089/ten.tec.2011.0060, 10.1089/ten.TEC.2011.0060]
   Flaherty J, 2013, WIRED CONDE NAST
   Galler KM, 2012, TISSUE ENG PT A, V18, P176, DOI [10.1089/ten.tea.2011.0222, 10.1089/ten.TEA.2011.0222]
   Giannitelli SM, 2014, ACTA BIOMATER, V10, P580, DOI 10.1016/j.actbio.2013.10.024
   Griffin DR, 2013, BIOMACROMOLECULES, V14, P1199, DOI 10.1021/bm400169d
   Grover GN, 2012, BIOMACROMOLECULES, V13, P3013, DOI 10.1021/bm301346e
   Gutierrez JMP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6571
   Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792
   Hanjaya-Putra D, 2012, BIOMATERIALS, V33, P6123, DOI 10.1016/j.biomaterials.2012.05.027
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Hauser CAE, 2010, CHEM SOC REV, V39, P2780, DOI 10.1039/b921448h
   Highley CB, 2015, ADV MATER, V27, P5075, DOI 10.1002/adma.201501234
   Hockaday LA, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/3/035005
   Holland JD, 2013, CURR OPIN CELL BIOL, V25, P254, DOI 10.1016/j.ceb.2013.01.004
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Holloway JL, 2014, J CONTROL RELEASE, V191, P63, DOI 10.1016/j.jconrel.2014.05.053
   Hribar KC, 2015, LAB CHIP, V15, P2412, DOI 10.1039/c5lc00159e
   Hudalla GA, 2014, NAT MATER, V13, P829, DOI [10.1038/NMAT3998, 10.1038/nmat3998]
   Imamura Y, 2015, ONCOL REP, V33, P1837, DOI 10.3892/or.2015.3767
   Janson IA, 2015, J BIOMED MATER RES A, V103, P1246, DOI 10.1002/jbm.a.35254
   Jeon O, 2013, TISSUE ENG PT A, V19, P1424, DOI [10.1089/ten.tea.2012.0581, 10.1089/ten.TEA.2012.0581]
   Jha AK, 2015, BIOMATERIALS, V47, P1, DOI 10.1016/j.biomaterials.2014.12.043
   Joly Y, 2010, NAT BIOTECHNOL, V28, P417, DOI 10.1038/nbt0510-417
   Jung JP, 2008, BIOMATERIALS, V29, P2143, DOI 10.1016/j.biomaterials.2008.01.008
   Jung JP, 2010, BIOPOLYMERS, V94, P49, DOI 10.1002/bip.21326
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kinney MA, 2013, TRENDS BIOTECHNOL, V31, P78, DOI 10.1016/j.tibtech.2012.11.001
   Kirschner CM, 2014, WILEY-SOC BIOMAT SER, P77
   Kirschner CM, 2014, ADV HEALTHC MATER, V3, P649, DOI 10.1002/adhm.201300288
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kolesky DB, 2014, ADV MATER, V26, P3124, DOI 10.1002/adma.201305506
   Krupinski P, 2012, CURR OPIN GENET DEV, V22, P613, DOI 10.1016/j.gde.2012.08.006
   Kwak B, 2014, J CONTROL RELEASE, V194, P157, DOI 10.1016/j.jconrel.2014.08.027
   Lee HJ, 2015, ADV HEALTHC MATER, V4, P1359, DOI 10.1002/adhm.201500193
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee MP, 2015, SCI REP-UK, V5, DOI 10.1038/srep09875
   Lee SS, 2013, BIOMATERIALS, V34, P452, DOI 10.1016/j.biomaterials.2012.10.005
   Leight JL, 2015, P NATL ACAD SCI USA, V112, P5366, DOI 10.1073/pnas.1505662112
   Lin CC, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41563
   Lin CC, 2011, BIOMATERIALS, V32, P9685, DOI 10.1016/j.biomaterials.2011.08.083
   Lin F, 2013, BIOMACROMOLECULES, V14, P3749, DOI 10.1021/bm401133r
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Malda J, 2013, ADV MATER, V25, P5011, DOI 10.1002/adma.201302042
   Mariner PD, 2013, J ORTHOP RES, V31, P401, DOI 10.1002/jor.22243
   Marklein RA, 2010, SOFT MATTER, V6, P136, DOI 10.1039/b916933d
   Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663
   Masket S, J CATARACT REFRACT S, V40, P2057
   Matson JB, 2012, CHEM COMMUN, V48, P26, DOI 10.1039/c1cc15551b
   McCall JD, 2012, BIOMACROMOLECULES, V13, P2410, DOI 10.1021/bm300671s
   McKinnon DD, 2014, SOFT MATTER, V10, P9230, DOI 10.1039/c4sm01365d
   McKinnon DD, 2014, ADV MATER, V26, P865, DOI 10.1002/adma.201303680
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]
   Mohammed JS, 2009, ADV MATER, V21, P2361, DOI 10.1002/adma.200803785
   Mosiewicz KA, 2013, NAT MATER, V12, P1071, DOI 10.1038/NMAT3766
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Nam KH, 2015, JALA-J LAB AUTOM, V20, P201, DOI 10.1177/2211068214557813
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Nimmo CM, 2011, BIOCONJUGATE CHEM, V22, P2199, DOI 10.1021/bc200281k
   Nimmo CM, 2011, BIOMACROMOLECULES, V12, P824, DOI 10.1021/bm101446k
   O'Leary LER, 2011, NAT CHEM, V3, P821, DOI [10.1038/nchem.1123, 10.1038/NCHEM.1123]
   Oliveira MB, 2014, TRENDS BIOTECHNOL, V32, P627, DOI 10.1016/j.tibtech.2014.09.009
   Owen SC, 2013, LANGMUIR, V29, P7393, DOI 10.1021/la305000w
   Pardo L, 2003, LANGMUIR, V19, P1462, DOI 10.1021/la026171u
   PATHAK CP, 1992, J AM CHEM SOC, V114, P8311, DOI 10.1021/ja00047a065
   Pati F, 2015, NAT COMMUN, V5, P3935
   Pearce JM, 2012, SCIENCE, V337, P1303, DOI 10.1126/science.1228183
   Polizzotti BD, 2008, BIOMACROMOLECULES, V9, P1084, DOI 10.1021/bm7012636
   Qin X. -H., 2014, BIONANOMATERIALS, V15, P49, DOI [10.1515/bnm-2014-0008, DOI 10.1515/BNM-2014-0008]
   Ranga A, 2012, CURR OPIN CELL BIOL, V24, P236, DOI 10.1016/j.ceb.2012.01.006
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Rutz AL, 2015, ADV MATER, V27, P1607, DOI 10.1002/adma.201405076
   Schuurman W, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/2/021001
   Scott CM, 2015, LANGMUIR, V31, P6122, DOI 10.1021/acs.langmuir.5b00196
   Sharma B, 2013, SCI TRANSL MED, V5
   Shubin AD, 2015, TISSUE ENG PT A, V21, P1733, DOI [10.1089/ten.TEA.2014.0674, 10.1089/ten.tea.2014.0674]
   Siew CK, 2005, BIOMACROMOLECULES, V6, P963, DOI 10.1021/bm049341l
   Singh M, 2010, ADV MATER, V22, P673, DOI 10.1002/adma.200901141
   Skardal A, 2015, ACTA BIOMATER, V25, P24, DOI 10.1016/j.actbio.2015.07.030
   Skardal A, 2012, STEM CELL TRANSL MED, V1, P792, DOI 10.5966/sctm.2012-0088
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   Sridhar BV, 2015, ADV HEALTHC MATER, V4, P702, DOI 10.1002/adhm.201400695
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Taipale J, 1997, FASEB J, V11, P51
   Tao X., 2013, BIOFABRICATION, V5
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Tokuda EY, 2014, BIOMATERIALS, V35, P4310, DOI 10.1016/j.biomaterials.2014.01.063
   Tyler K. M., 2015, BIOFABRICATION, V7, DOI DOI 10.1088/1758-5090/7/3/035003
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Vila OF, 2014, ACTA BIOMATER, V10, P4377, DOI 10.1016/j.actbio.2014.05.028
   Vunjak-Novakovic G, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt369
   Wade RJ, 2012, MATER TODAY, V15, P454, DOI 10.1016/S1369-7021(12)70197-9
   Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231
   Wei SC, 2015, NAT CELL BIOL, V17, P678, DOI 10.1038/ncb3157
   Weigelt B, 2014, ADV DRUG DELIVER REV, V69, P42, DOI 10.1016/j.addr.2014.01.001
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Wu PH, 2014, P NATL ACAD SCI USA, V111, P3949, DOI 10.1073/pnas.1318967111
   Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/nmat3101, 10.1038/NMAT3101]
   Wylie RG, 2011, BIOMACROMOLECULES, V12, P3789, DOI 10.1021/bm201037j
   Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011
   Xu T, 2004, BIOTECHNOL BIOENG, V85, P29, DOI 10.1002/bit.10768
   Xu T, 2013, BIOMATERIALS, V34, P130, DOI 10.1016/j.biomaterials.2012.09.035
   Xu T, 2008, J MANUF SCI E-T ASME, V130, DOI 10.1115/1.2902857
   Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/NMAT3889, 10.1038/nmat3889]
   Zhang AP, 2012, ADV MATER, V24, P4266, DOI 10.1002/adma.201202024
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
   Zopf DA, 2013, NEW ENGL J MED, V368, P2043, DOI 10.1056/NEJMc1206319
NR 156
TC 25
Z9 25
U1 14
U2 170
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD APR
PY 2016
VL 11
IS 2
AR 022001
DI 10.1088/1748-6041/11/2/022001
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DL3GY
UT WOS:000375523400003
PM 26942469
OA Other Gold
DA 2018-10-19
ER

PT J
AU Parmaksiz, M
   Dogan, A
   Odabas, S
   Elcin, AE
   Elcin, YM
AF Parmaksiz, Mahmut
   Dogan, Arin
   Odabas, Sedat
   Elcin, A. Eser
   Elcin, Y. Murat
TI Clinical applications of decellularized extracellular matrices for
   tissue engineering and regenerative medicine
SO BIOMEDICAL MATERIALS
LA English
DT Review
DE decellularization; extracellular matrix (ECM); clinical applications;
   biomaterials; tissue engineering; regenerative medicine
ID ACELLULAR DERMAL MATRIX; SMALL-INTESTINAL SUBMUCOSA; TENDON AUGMENTATION
   GRAFTS; DEMINERALIZED BONE-MATRIX; STEM-CELL DIFFERENTIATION; PORCINE
   MEDIAL MENISCUS; ABDOMINAL-WALL DEFECTS; VOLUMETRIC MUSCLE LOSS; VENTRAL
   HERNIA REPAIR; ROTATOR-CUFF TEARS
AB Decellularization is the process of removing the cellular components from tissues or organs. It is a promising technology for obtaining a biomaterial with a highly preserved extracellular matrix (ECM), which may also act as a biological scaffold for tissue engineering and regenerative therapies. Decellularized products are gaining clinical importance and market space due to their ease of standardized production, constant availability for grafting and mechanical or biochemical superiority against competing clinical options, yielding clinical results ahead of the ones with autografts in some applications. Current drawbacks and limitations of traditional treatments and clinical applications can be overcome by using decellularized or acellular matrices. Several companies are leading the market with versatile acellular products designed for diverse use in the reconstruction of tissues and organs. This review describes ECM-based decellularized and acellular products that are currently in use for different branches of clinic.
C1 [Parmaksiz, Mahmut; Dogan, Arin; Odabas, Sedat; Elcin, A. Eser; Elcin, Y. Murat] Ankara Univ, Fac Sci, TR-06100 Ankara, Turkey.
   [Parmaksiz, Mahmut; Dogan, Arin; Odabas, Sedat; Elcin, A. Eser; Elcin, Y. Murat] Ankara Univ, Stem Cell Inst, Tissue Engn Biomat & Nanobiotechnol Lab, TR-06100 Ankara, Turkey.
   [Elcin, Y. Murat] Biovalda Hlth Technol Inc, Ankara, Turkey.
RP Elcin, AE; Elcin, YM (reprint author), Ankara Univ, Fac Sci, TR-06100 Ankara, Turkey.; Elcin, AE; Elcin, YM (reprint author), Ankara Univ, Stem Cell Inst, Tissue Engn Biomat & Nanobiotechnol Lab, TR-06100 Ankara, Turkey.; Elcin, YM (reprint author), Biovalda Hlth Technol Inc, Ankara, Turkey.
EM elcin@ankara.edu.tr; elcin@ankara.edu.tr
RI Dogan, Arin/L-6443-2015
OI Dogan, Arin/0000-0002-5362-5501; Elcin, Yasar Murat/0000-0003-1037-0825
CR Agarwal Chitra, 2015, J Indian Soc Periodontol, V19, P216, DOI 10.4103/0972-124X.149938
   Agrawal V, 2012, INT J SHOULDER SURG, V6, P36, DOI 10.4103/0973-6042.96992
   Akhyari P, 2011, TISSUE ENG PART C-ME, V17, P915, DOI [10.1089/ten.tec.2011.0210, 10.1089/ten.TEC.2011.0210]
   Albornoz CR, 2013, PLAST RECONSTR SURG, V131, P15, DOI 10.1097/PRS.0b013e3182729cde
   [Anonymous], 2010, A426 MEDTECH INS
   Ariganello MB, 2011, BIOMATERIALS, V32, P439, DOI 10.1016/j.biomaterials.2010.09.004
   Armitage S, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/376251
   Arunkalaivanan AS, 2003, INT UROGYNECOL J, V14, P17, DOI 10.1007/s00192-002-1000-9
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atala A, 2006, CURR OPIN PEDIATR, V18, P167, DOI 10.1097/01.mop.0000193294.94646.be
   Aurora A, 2007, J SHOULDER ELB SURG, V16, p171S, DOI 10.1016/j.jse.2007.03.008
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SF, 1998, J BIOMAT SCI-POLYM E, V9, P863, DOI 10.1163/156856298X00208
   Badylak SF, 2014, ANN BIOMED ENG, V42, P1517, DOI 10.1007/s10439-013-0963-7
   Badylak SF, 2012, LANCET, V379, P943, DOI 10.1016/S0140-6736(12)60073-7
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Baiguera S, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/398069
   Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067
   Barakat O, 2012, J SURG RES, V173, pE11, DOI 10.1016/j.jss.2011.09.033
   Barber FA, 2012, ARTHROSCOPY, V28, P8, DOI 10.1016/j.arthro.2011.06.038
   Barber FA, 2006, ARTHROSCOPY, V22, P534, DOI 10.1016/j.arthro.2005.12.021
   Bellows CF, 2007, AM J SURG, V194, P192, DOI 10.1016/j.amjsurg.2006.11.012
   Berg M, 2014, TISSUE ENG PT A, V20, P389, DOI [10.1089/ten.tea.2012.0514, 10.1089/ten.TEA.2012.0514]
   Bissell M J, 1987, Prog Clin Biol Res, V249, P251
   Breuing K, 2010, SURGERY, V148, P544, DOI 10.1016/j.surg.2010.01.008
   Bringman S, 2010, HERNIA, V14, P81, DOI 10.1007/s10029-009-0587-x
   Brown CN, 2010, ANN ROY COLL SURG, V92, P272, DOI 10.1308/003588410X12664192076296
   Brown JW, 2011, ANN THORAC SURG, V91, P416, DOI 10.1016/j.athoracsur.2010.10.069
   Burkhead WZ, 2007, SEMIN ARTHROPLASTY, V18, P11, DOI DOI 10.1053/J.SART.2006.11.017
   Byrne GW, 2012, CURR OPIN ORGAN TRAN, V17, P148, DOI 10.1097/MOT.0b013e3283509120
   Cartmell JS, 2000, J BIOMED MATER RES, V49, P134, DOI 10.1002/(SICI)1097-4636(200001)49:1<134::AID-JBM17>3.3.CO;2-4
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   Chen RN, 2004, BIOMATERIALS, V25, P2679, DOI 10.1016/j.biomaterials.2003.09.070
   Cheng A, 2012, CLIN PLAST SURG, V39, P167, DOI 10.1016/j.cps.2012.02.004
   Cheng CW, 2014, BIOTECHNOL ADV, V32, P462, DOI 10.1016/j.biotechadv.2013.12.012
   Choe JM, 2001, UROLOGY, V58, P482, DOI 10.1016/S0090-4295(01)01205-5
   Choi JS, 2010, BIOMATERIALS, V31, P6738, DOI 10.1016/j.biomaterials.2010.05.020
   Cornwell Kevin G, 2009, Clin Podiatr Med Surg, V26, P507, DOI 10.1016/j.cpm.2009.08.001
   Corona BT, 2014, TISSUE ENG PT A, V20, P705, DOI 10.1089/ten.TEA.2012.0761
   Cortiella J, 2010, TISSUE ENG PT A, V16, P2565, DOI 10.1089/ten.tea.2009.0730
   Dallenbach P, 2015, IN J WOMENS HEALTH, V7, P331, DOI 10.2147/IJWH.S71236
   Demirdogen B, 2010, GROWTH FACTORS, V28, P426, DOI 10.3109/08977194.2010.508456
   Dieterich M, 2013, GEBURTSH FRAUENHEILK, V73, P1100, DOI 10.1055/s-0033-1350930
   Dogan A, 2016, STEM CELL REV REP, V12, P202, DOI 10.1007/s12015-015-9641-5
   Edmunds D, 2014, MEDTECH, V360
   Eker HH, 2013, JAMA SURG, V148, P259, DOI 10.1001/jamasurg.2013.1466
   Elcin AE, 2006, TISSUE ENG, V12, P959, DOI 10.1089/ten.2006.12.959
   Elcin YM, 1999, ARTIF ORGANS, V23, P146, DOI 10.1046/j.1525-1594.1999.06222.x
   Elsalanty ME, 2009, CRANIOMAX TRAUM REC, V2, P125, DOI [10.1055/s-0029-1215875.ISSN1943-3875, 10.1055/s-0029-1215875]
   Emmert MY, 2014, ADV DRUG DELIVER REV, V69, P254, DOI 10.1016/j.addr.2013.12.004
   Ferzoco SJ, 2013, INT SURG, V98, P399, DOI 10.9738/INTSURG-D-12-00002.1
   Flynn LE, 2010, BIOMATERIALS, V31, P4715, DOI 10.1016/j.biomaterials.2010.02.046
   Frazer M, 2009, PELVIPERINEOLOGY, V28, P82
   Freytes DO, 2004, BIOMATERIALS, V25, P2353, DOI 10.1016/j.biomaterials.2003.09.015
   Frishman WH, 2013, J CARDIOVASC PHARM T, V18, P310, DOI 10.1177/1074248413484986
   Frohlich M, 2010, TISSUE ENG PT A, V16, P179, DOI 10.1089/ten.TEA.2009.0164
   Galvez-Monton C, 2013, REV ESP CARDIOL, V66, P391, DOI 10.1016/j.rec.2012.11.012
   Gerber B, 2009, ANN SURG, V249, P461, DOI 10.1097/SLA.0b013e31819a044f
   Ghazi B, 2011, ANN PLAS SURG, V66, P488, DOI 10.1097/SAP.0b013e31820d18db
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Golla D, 2014, INT SURG, V99, P235, DOI 10.9738/INTSURG-D-13-00170.1
   Grandi C, 2011, INT J MOL MED, V28, P315, DOI 10.3892/ijmm.2011.720
   Gruskin E, 2012, ADV DRUG DELIVER REV, V64, P1063, DOI 10.1016/j.addr.2012.06.008
   Hara H, 2011, CORNEA, V30, P371, DOI 10.1097/ICO.0b013e3181f237ef
   HAWKINS RJ, 1985, J BONE JOINT SURG AM, V67A, P1349, DOI 10.2106/00004623-198567090-00007
   Heinemeier KM, 2011, J MUSCULOSKEL NEURON, V11, P115
   Hodde J P, 2005, J Wound Care, V14, P23
   Holubec T, 2015, J CARDIAC SURG, V30, P145, DOI 10.1111/jocs.12494
   Hulsmann J, 2012, XENOTRANSPLANTATION, V19, P286, DOI 10.1111/j.1399-3089.2012.00719.x
   Inanc B, 2008, TISSUE ENG PT A, V14, P955, DOI [10.1089/ten.tea.2007.0213, 10.1089/tea.2007.0213]
   Inanc B, 2009, TISSUE ENG PT A, V15, P3427, DOI [10.1089/ten.tea.2008.0380, 10.1089/ten.TEA.2008.0380]
   Jeon MJ, 2007, YONSEI MED J, V48, P147, DOI 10.3349/ymj.2007.48.2.147
   Dalmau MJ, 2011, EUR J CARDIO-THORAC, V39, P844, DOI 10.1016/j.ejcts.2010.11.015
   Juhasz I, 2010, DERMATOL RES PRACT, V2010
   Keenan TDL, 2011, BRIT J OPHTHALMOL, V95, P468, DOI 10.1136/bjo.2010.182329
   Kim BS, 2004, J BIOMED MATER RES A, V68A, P201, DOI 10.1002/jbm.a.10045
   Kim H, 2006, AM J SURG, V192, P705, DOI 10.1016/j.amjsurg.2006.09.003
   Kobashi KC, 2003, J UROLOGY, V169, P2242, DOI 10.1097/01.ju.0000060119.43064.f6
   Kochupura PV, 2005, CIRCULATION, V112, pI144, DOI 10.1161/CIRCULATIONAHA.104.524355
   Lam MT, 2012, EXPERT REV CARDIOVAS, V10, P1039, DOI [10.1586/erc.12.99, 10.1586/ERC.12.99]
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee W, 2014, INT J OPHTHALMOL-CHI, V7, P587, DOI 10.3980/j.issn.2222-3959.2014.04.01
   Lepow BD, 2011, EXPERT REV DERMATOL, V6, P255
   Levenda AC, 2015, ADV ORTHOP SURG, V2015, DOI DOI 10.1155/2015/423949
   Liao JH, 2010, BIOMATERIALS, V31, P8911, DOI 10.1016/j.biomaterials.2010.07.110
   Lin CH, 2014, INT J ARTIF ORGANS, V37, P546, DOI 10.5301/ijao.5000344
   Liu LB, 2011, INT UROGYNECOL J, V22, P221, DOI 10.1007/s00192-010-1288-9
   Longo UG, 2010, BRIT MED BULL, V94, P165, DOI 10.1093/bmb/ldp051
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Makris EA, 2011, BIOMATERIALS, V32, P7411, DOI 10.1016/j.biomaterials.2011.06.037
   Mamaril Myrna Eileen, 2007, J Perianesth Nurs, V22, P184
   Mantovani F, 2003, EUR UROL, V44, P600, DOI 10.1016/S0302-2838(03)00212-4
   Marcos-Campos I, 2012, BIOMATERIALS, V33, P8329, DOI 10.1016/j.biomaterials.2012.08.013
   Markeson D, 2015, J TISSUE ENG REGEN M, V9, P649, DOI 10.1002/term.1841
   Mase Vincent J Jr, 2010, Orthopedics, V33, P511, DOI 10.3928/01477447-20100526-24
   McDevitt CA, 2003, J BIOMED MATER RES A, V67A, P637, DOI 10.1002/jbm.a.10144
   McGregor CGA, 2011, J THORAC CARDIOV SUR, V141, P269, DOI 10.1016/j.jtcvs.2010.08.064
   Moroni F, 2014, AM J STEM CELLS, V3, P1
   Morticelli L, 2013, J HEART VALVE DIS, V22, P340
   Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042
   Nazemi TM, 2007, INDIAN J UROL, V23, P153, DOI 10.4103/0970-1591.32067
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Olausson M, 2014, EBIOMEDICINE, V1, P72, DOI 10.1016/j.ebiom.2014.09.001
   Oryan A, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-18
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   Parmaksiz M, 2017, J TISSUE ENG REGEN M, V11, P1754, DOI 10.1002/term.2071
   Pereira T., 2013, ADV BIOMATERIALS SCI
   Perri G, 2012, EUR J CARDIO-THORAC, V41, P1320, DOI 10.1093/ejcts/ezr221
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Raghavan SS, 2012, TISSUE ENG PT A, V18, P796, DOI [10.1089/ten.tea.2011.0422, 10.1089/ten.TEA.2011.0422]
   Roth JS, 2015, HERNIA, V19, P247, DOI 10.1007/s10029-014-1245-5
   Rutkow IM, 2003, SURG CLIN N AM, V83, P1045, DOI 10.1016/S0039-6109(03)00132-4
   Sanchez PL, 2015, BIOMATERIALS, V61, P279, DOI 10.1016/j.biomaterials.2015.04.056
   Sarig U, 2012, TISSUE ENG PT A, V18, P2125, DOI [10.1089/ten.tea.2011.0586, 10.1089/ten.TEA.2011.0586]
   Sawkins MJ, 2013, ACTA BIOMATER, V9, P7865, DOI 10.1016/j.actbio.2013.04.029
   Schenke-Layland K, 2011, ADV DRUG DELIVER REV, V63, P195, DOI 10.1016/j.addr.2011.05.001
   Scholl FG, 2010, WORLD J PEDIATR CONG, V1, P132, DOI 10.1177/2150135110362092
   Sicari BM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008085
   Sicari BM, 2012, TISSUE ENG PT A, V18, P1941, DOI [10.1089/ten.TEA.2012.0475, 10.1089/ten.tea.2012.0475]
   Siddiqui NY, 2014, IN J WOMENS HEALTH, V6, P83, DOI 10.2147/IJWH.S54845
   Silverman R P, 2004, Hernia, V8, P336, DOI 10.1007/s10029-004-0241-6
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   Smart NJ, 2014, BIOL-TARGETS THER, V8, P83, DOI 10.2147/BTT.S46469
   Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005
   Soto-Gutierrez A, 2011, TISSUE ENG PART C-ME, V17, P677, DOI 10.1089/ten.tec.2010.0698
   Stapleton TW, 2008, TISSUE ENG PT A, V14, P505, DOI 10.1089/tea.2007.0233
   Stapleton TW, 2011, TISSUE ENG PT A, V17, P231, DOI [10.1089/ten.tea.2009.0807, 10.1089/ten.TEA.2009.0807]
   Stelly M, 2013, ANN THORAC SURG, V96, pE127, DOI 10.1016/j.athoracsur.2013.06.114
   Sundermann SH, 2015, INTERACT CARDIOV TH, V20, P10, DOI 10.1093/icvts/ivu310
   Taylor JB, 2010, INT J PERIODONT REST, V30, P513
   Tidball JG, 2011, COMPR PHYSIOL, V1, P2029, DOI 10.1002/cphy.c100092
   Tilkeridis K, 2014, WORLD J ORTHOP, V5, P30, DOI 10.5312/wjo.v5.i1.30
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Valdatta L, 2014, PLAST SURG INT, V2014
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   van den Heever JJ, 2013, CELL TISSUE BANK, V14, P53, DOI 10.1007/s10561-012-9299-z
   Vashi A V, 2014, J BIOMED MATER RES A, DOI [10.1002/jbma.35335, DOI 10.1002/JBMA.35335]
   Vekris MD, 2008, INJURY, V39, pS15, DOI 10.1016/j.injury.2008.06.008
   Vindigni V, 2004, PLAST RECONSTR SURG, V114, P1509, DOI 10.1097/01.PRS.0000138253.96709.E5
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Wainwright JM, 2010, THESIS U PITTSBURGH
   Wang JC, 2007, EUR SPINE J, V16, P1233, DOI 10.1007/s00586-006-0282-x
   Weichman KE, 2013, PLAST RECONSTR SURG, V132, P725, DOI 10.1097/PRS.0b013e31829fe35b
   Wilson Samantha L, 2013, J Funct Biomater, V4, P114, DOI 10.3390/jfb4030114
   Wolf MT, 2012, BIOMATERIALS, V33, P2916, DOI 10.1016/j.biomaterials.2011.12.055
   Woods T, 2005, BIOMATERIALS, V26, P7339, DOI 10.1016/j.biomaterials.2005.05.066
   World Health Organization, 2012, WORLD HLTH STAT
   Wu I, 2012, PLAST RECONSTR SURG, V129, P1247, DOI 10.1097/PRS.0b013e31824ec3dc
   Yanagawa B, 2013, INNOVATIONS, V8, P348, DOI 10.1097/IMI.0000000000000014
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
   Youngstrom DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064151
NR 154
TC 22
Z9 23
U1 8
U2 55
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD APR
PY 2016
VL 11
IS 2
AR 022003
DI 10.1088/1748-6041/11/2/022003
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DL3GY
UT WOS:000375523400005
PM 26989100
DA 2018-10-19
ER

PT J
AU Varoni, EM
   Altomare, L
   Cochis, A
   GhalayaniEsfahani, A
   Cigada, A
   Rimondini, L
   De Nardo, L
AF Varoni, Elena Maria
   Altomare, Lina
   Cochis, Andrea
   GhalayaniEsfahani, Arash
   Cigada, Alberto
   Rimondini, Lia
   De Nardo, Luigi
TI Hierarchic micro-patterned porous scaffolds via electrochemical
   replica-deposition enhance neo-vascularization
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE neovascularization; electrochemical deposition; chitosan; tissue
   engineering
ID IN-VITRO; BIOMATERIAL SCAFFOLDS; TISSUE; CHITOSAN; CELLS; ANGIOGENESIS
AB Neo-vascularization is a key factor in tissue regeneration within porous scaffolds. Here, we tested the hypothesis that micro-patterned scaffolds, with precisely-designed, open micro-channels, might help endothelial cells to produce int ra-scaffold vascular networks. Three series of micro-patterned scaffolds were produced via electrochemical replica-deposition of chitosan and cross-linking. All had regularly-oriented micro-channels (0 500 pm), which differed for the inter-channel spacing, at 600, 700, or 900 pm, respectively. Random-pore scaffolds, using the same technique, were taken as controls. Physical-mechanical characterization revealed high water uptake and favorable elastic mechanical behavior for all scaffolds, slightly reduced in the presence of cross-linking and enhanced with the 700 pm-spaced micro-pattern. At MTT assay, mouse endothelial cell viability was >90% at day 1,3 and 7, confirmed by visual examination with scanning electron microscopy (SEM). Intrascaffold cell density, at fluorescence analysis, was higher for the 600 Am-spaced and the 700 pm-spaced micro-patterns over the others. The 700 Am-spaced scaffold was selected for the in vivo testing, to be compared to the random-pore one. Neither type produced an inflammatory reaction; both showed excellent tissue ingrowth. Micro-patterned scaffolds enhanced neo-vascularization, demonstrated by immu nofluorescent, semi-quantitative analyses. These findings support the use of micro-patterned porous scaffolds, with adequately spaced micro-channels, to promote neo-vascularization.
C1 [Varoni, Elena Maria; Cochis, Andrea] Univ Milan, Dept Biomed Surg & Dent Sci, Via Beldiletto 1, Milan, MI, Italy.
   [Altomare, Lina; GhalayaniEsfahani, Arash; Cigada, Alberto; De Nardo, Luigi] Politecn Milan, Dept Chem Mat & Chem Engn G Natta, Piazza Leonardo da Vinci 32, I-20133 Milan, MI, Italy.
   [Altomare, Lina; Cigada, Alberto; De Nardo, Luigi] Politecn Milan, Consorzio Interuniv Nazl Sci & Tecnol Mat INSTM, Local Unit, Via Giusti 9, I-50121 Florence, FI, Italy.
   [Cochis, Andrea; Rimondini, Lia] Univ Piemonte Orientale, Dept Hlth Sci, Via Solaroli 17, Novara, NO, Italy.
   [Cochis, Andrea; Rimondini, Lia] Univ Piemonte Orientale, Local Unit, Consorzio Interuniv Nazl Sci & Tecnol Mat INSTM, Via Giusti 9, I-50121 Florence, FI, Italy.
RP Varoni, EM (reprint author), Univ Milan, Dept Biomed Surg & Dent Sci, Via Beldiletto 1, Milan, MI, Italy.
EM elena.varoni@unimi.it
OI Cochis, Andrea/0000-0003-2455-8239; ALTOMARE, LINA/0000-0001-9555-1291
FU MIUR through FIRB Futuro in Ricerca (Surface-associated selective
   transfection-SAST) [RBFR08XH0H]; Ministry of Education, University and
   Research (M.I.U.R., Rome, Italy) [PRIN 20102ZLNJ5_006]
FX LA and LDN thank MIUR for economic support through FIRB Futuro in
   Ricerca (Surface-associated selective transfection-SAST, RBFR08XH0H). AC
   thanks PRIN 2010-2011 (PRIN 20102ZLNJ5_006), by the Ministry of
   Education, University and Research (M.I.U.R., Rome, Italy) for financial
   support.
CR Altomare L, 2008, J APPL BIOMATER BIOM, V6, P132
   Altomare Lina, 2014, Biomatter, V4, DOI 10.4161/biom.29506
   Altomare L, 2012, MATER LETT, V78, P18, DOI 10.1016/j.matlet.2012.03.035
   Anitua E, 2010, ADV DRUG DELIVER REV, V62, P741, DOI 10.1016/j.addr.2010.01.001
   Bi L, 2011, J MATER SCI-MATER M, V22, P51, DOI 10.1007/s10856-010-4177-3
   Bloch K, 2010, ACTA BIOMATER, V6, P1200, DOI 10.1016/j.actbio.2009.08.022
   Cao Y, 2006, BIOMATERIALS, V27, P2854, DOI 10.1016/j.biomaterials.2005.12.015
   Chiu YC, 2011, BIOMATERIALS, V32, P6045, DOI 10.1016/j.biomaterials.2011.04.066
   Chrobak KM, 2006, MICROVASC RES, V71, P185, DOI 10.1016/j.mvr.2006.02.005
   De Nardo L, 2012, COATINGS FOR BIOMEDICAL APPLICATIONS, P106
   Dutta RC, 2009, BIOTECHNOL ADV, V27, P334, DOI 10.1016/j.biotechadv.2009.02.002
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Ju YM, 2010, BIOMATERIALS, V31, P4313, DOI 10.1016/j.biomaterials.2010.02.002
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kaully T, 2009, TISSUE ENG PART B-RE, V15, P159, DOI 10.1089/ten.teb.2008.0193
   Luo YX, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015005
   Mehdizadeh H, 2013, BIOMATERIALS, V34, P2875, DOI 10.1016/j.biomaterials.2012.12.047
   Nardo L. D., 2011, SMART MATER STRUCT, V20
   Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   Obokata H, 2011, NAT PROTOC, V6, P1053, DOI 10.1038/nprot.2011.356
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729
   Phelps EA, 2010, CURR OPIN BIOTECH, V21, P704, DOI 10.1016/j.copbio.2010.06.005
   Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Simchi A, 2009, MATER LETT, V63, P2253, DOI 10.1016/j.matlet.2009.07.046
   Snyder JE, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/1/015007
   Stegen S, 2015, BONE, V70, P19, DOI 10.1016/j.bone.2014.09.017
   Sukmana I, 2012, SCI WORLD J, DOI 10.1100/2012/201352
   Sun CH, 2012, MACROMOL BIOSCI, V12, P761, DOI 10.1002/mabi.201200004
   Tan JY, 2013, BIOMED MICRODEVICES, V15, P83, DOI 10.1007/s10544-012-9690-3
   Unger RE, 2010, BIOMATERIALS, V31, P6959, DOI 10.1016/j.biomaterials.2010.05.057
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
NR 35
TC 4
Z9 4
U1 3
U2 15
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD APR
PY 2016
VL 11
IS 2
AR 025018
DI 10.1088/1748-6041/11/2/025018
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DL3GY
UT WOS:000375523400023
PM 27099204
DA 2018-10-19
ER

PT J
AU DeHoog, E
   Doraiswamy, A
AF DeHoog, Edward
   Doraiswamy, Anand
TI Evaluation of loss in optical quality of multifocal intraocular lenses
   with glistenings
SO JOURNAL OF CATARACT AND REFRACTIVE SURGERY
LA English
DT Article
ID SURFACE LIGHT-SCATTERING; VISUAL FUNCTION; SCHEIMPFLUG PHOTOGRAPHY;
   LONG-TERM; EYES; PERFORMANCE; CATARACT; IMPACT; ACUITY; MODEL
AB PURPOSE: To study the impact of loss in optical quality from glistenings in diffractive multifocal intraocular lenses (IOLs) using ray tracing in a model eye.
   SETTING: Independent research laboratory, Irvine, California, USA.
   DESIGN: Experimental study.
   METHODS: A pseudophakic eye model was constructed in Zemax, an optical ray-tracing program, using the Arizona eye model as the basis. The Mie scattering theory was used to describe the intensity and direction of light as it scattered for a spherical particle immersed in a diffractive multifocal IOL. To evaluate the impact of glistening scatter, a more advanced eye model was constructed in Fred, a nonsequential optical ray-tracing software. An evaluation of scatter and modulation transfer function (MTF) was performed for a hydrophobic biomaterial with a refractive index of 1.54 for various sizes and densities of glistenings under mesopic conditions.
   RESULTS: As predicted by the Mie theory, the amount of scatter was a function of the change in the refractive index, size of the scatterer, and volume fraction of the scatterers. This modeling showed that an increase in density of glistenings can lead to a significant drop of MTF of the IOL. This effect was more pronounced in multifocal IOLs than in monofocal IOLs.
   CONCLUSIONS: Mathematical modeling showed that glistenings in multifocal IOLs lead to a reduction in MTF of the IOL and the pseudophakic eye. The relative loss of MTF in multifocal IOLs was more significant than in monofocal IOLs because of the nature of the design.
C1 [DeHoog, Edward] Opt Engn & Anal LLC, Irvine, CA USA.
RP Doraiswamy, A (reprint author), 508 Natoma St, San Francisco, CA 94103 USA.
EM andyswamy@gmail.com
CR Agbessi L, 2014, ANN M ASS RES VIS OP
   Auffarth GU, 2001, OPHTHALMOLOGE, V98, P127, DOI 10.1007/s003470170172
   Beheregaray S, 2014, J CATARACT REFR SURG, V40, P1147, DOI 10.1016/j.jcrs.2013.10.047
   Behndig A, 2009, J CATARACT REFR SURG, V35, P14, DOI 10.1016/j.jcrs.2008.08.040
   Bellucci Roberto, 2005, Curr Opin Ophthalmol, V16, P33, DOI 10.1097/00055735-200502000-00006
   Christiansen G, 2001, J CATARACT REFR SURG, V27, P728, DOI 10.1016/S0886-3350(00)00700-8
   Colin J, 2012, J CATARACT REFR SURG, V38, P1140, DOI 10.1016/j.jcrs.2012.01.031
   Costello MJ, 2007, INVEST OPHTH VIS SCI, V48, P303, DOI 10.1167/iovs.06-0480
   De Hoog E, 2014, J CATARACT REFR SURG, V40, P95, DOI 10.1016/j.jcrs.2013.10.018
   de Vries NE, 2013, J CATARACT REFR SURG, V39, P268, DOI 10.1016/j.jcrs.2012.12.002
   Dhaliwal DK, 1996, J CATARACT REFR SURG, V22, P452, DOI 10.1016/S0886-3350(96)80041-1
   Dogru M, 2000, J CATARACT REFR SURG, V26, P571, DOI 10.1016/S0886-3350(99)00342-9
   Gilliland KO, 2008, MOL VIS, V14, P572
   Goodman JW, 1996, INTRO FOURIER OPTICS, P267
   Goodman T, 2007, LIGHTING RES TECHNOL, V39, P365, DOI 10.1177/1477153507080930
   GREIVENKAMP JE, 1995, AM J OPHTHALMOL, V120, P227, DOI 10.1016/S0002-9394(14)72611-X
   Gunenc U, 2001, J CATARACT REFR SURG, V27, P1611, DOI 10.1016/S0886-3350(01)00995-6
   Harvey JE, 2013, OPT ENG, V52, DOI 10.1117/1.OE.52.7.073110
   Hayashi K, 2012, AM J OPHTHALMOL, V154, P240, DOI 10.1016/j.ajo.2012.03.011
   Henriksen BS, 2015, J CATARACT REFR SURG, V41, P1190, DOI 10.1016/j.jcrs.2014.09.051
   Iskander DR, 2006, OPTOMETRY VISION SCI, V83, P57, DOI 10.1097/01.opx.0000195563.82891.3b
   Klos KM, 1999, OPHTHALMIC RES, V31, P130, DOI 10.1159/000055524
   LANG A, 1993, J CATARACT REFR SURG, V19, P505, DOI 10.1016/S0886-3350(13)80615-3
   LANG AJ, 1993, J OPT SOC AM A, V10, P1600, DOI 10.1364/JOSAA.10.001600
   Marsack JD, 2004, J VISION, V4, P322, DOI 10.1167/4.4.8
   Matsushima H, 2009, J CATARACT REFR SURG, V35, P1927, DOI 10.1016/j.jcrs.2009.07.004
   Mitooka K, 1998, GANKA, V40, P1501
   Miyata A, 2004, J CATARACT REFR SURG, V30, P1768, DOI 10.1016/j.jcrs.2003.12.038
   Miyata Akira, 1997, Rinsho Ganka, V51, P729
   Miyata K, 2012, J CATARACT REFR SURG, V38, P221, DOI 10.1016/j.jcrs.2011.08.042
   Monestam E, 2011, ACTA OPHTHALMOL, V89, P724, DOI 10.1111/j.1755-3768.2009.01833.x
   Moreno-Montanes J, 2003, J CATARACT REFR SURG, V29, P1980, DOI 10.1016/S0886-3350(03)00136-6
   Nagata M, 2010, J CATARACT REFR SURG, V36, P2056, DOI 10.1016/j.jcrs.2010.06.064
   Nishihara H, 2003, J CATARACT REFR SURG, V29, P1385, DOI 10.1016/S0886-3350(02)01994-6
   Omar O, 1998, J CATARACT REFR SURG, V24, P107, DOI 10.1016/S0886-3350(98)80082-5
   Ong MD, 2012, J CATARACT REFR SURG, V38, P1833, DOI 10.1016/j.jcrs.2012.05.043
   Oshika T, 2001, BRIT J OPHTHALMOL, V85, P1034, DOI 10.1136/bjo.85.9.1034
   Schwiegerling J, 2004, FIELD GUIDE VISUAL O, P19
   Shiokawa Y, 2000, SHIKAKU NO KAGAKU, V21, P18
   STOVER JC, 1995, OPTICAL SCATTERING, P4
   Takahashi Y, 2015, J CATARACT REFR SURG, V41, P193, DOI 10.1016/j.jcrs.2014.10.021
   Tognetto D, 2002, J CATARACT REFR SURG, V28, P1211, DOI 10.1016/S0886-3350(02)01353-6
   Waite A, 2007, AM J OPHTHALMOL, V144, P143, DOI 10.1016/j.ajo.2007.03.015
   [王磊 WANG Lei], 2007, [测绘通报, Bulletin of Surveying and Mapping], P7
   Werner L, 2007, J CATARACT REFR SURG, V33, P713, DOI 10.1016/j.jcrs.2007.01.015
   Werner L, 2010, J CATARACT REFR SURG, V36, P1398, DOI 10.1016/j.jcrs.2010.06.003
   Xi L, 2014, INT J OPHTHALMOL-CHI, V7, P446, DOI 10.3980/j.issn.2222-3959.2014.03.11
   Yaguchi Shigeo, 2002, Nippon Ganka Gakkai Zasshi, V106, P109
   Yoshida S, 2000, NIHON GANNAI RENZU K, V14, P289
NR 49
TC 2
Z9 2
U1 0
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0886-3350
EI 1873-4502
J9 J CATARACT REFR SURG
JI J. Cataract. Refract. Surg.
PD APR
PY 2016
VL 42
IS 4
BP 606
EP 612
DI 10.1016/j.jcrs.2015.10.071
PG 7
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA DL3DW
UT WOS:000375515400016
PM 27113885
DA 2018-10-19
ER

PT J
AU Du, JK
   Chao, CY
   Jhong, YT
   Wu, CH
   Wu, JH
AF Du, Je-Kang
   Chao, Chih-Yeh
   Jhong, Yu-Ting
   Wu, Chung-Hao
   Wu, Ju-Hui
TI Effects of Cr2N Precipitation on the Antibacterial Properties of AISI
   430 Stainless Steel
SO METALS
LA English
DT Article
DE Cr2N precipitation; antibacterial behavior; ferritic type stainless
   steel; Escherichia coli
ID BIOMATERIALS; TEMPERATURE
AB Based on their mechanical properties and good corrosion resistance, some commercial Ni-Cr stainless steels have been widely applied as biomaterials, including the austenitic 304 stainless steel, the austenitic 316 stainless steel, the duplex 2205 stainless steel, and the ferritic 430 stainless steel. In order to reduce the occurrence of infections resulting from biomaterial implants, instruments, and medical devices, Cu2+ and Ag2+ ions have been added onto biomaterials for increasing the antibacterial properties, but they are known to damage biofilm. The occurrence of nanoparticles can also improve the antibacterial properties of biomaterials through various methods. In this study, we used Escherichia coli and analyzed the microstructures of American Iron and Steel Institute (AISI) 430 stainless steel with a 0.18 mass % N alloy element. During a lower temperature aging, the microstructure of the as-quenched specimen is essentially a ferrite and martensite duplex matrix with some Cr2N precipitates formed. Additionally, the antibacterial properties of the alloy for E. coli ranged from 3% to 60%, consistent with the presence of Cr2N precipitates. When aged at a lower temperature, which resulted in nano-Cr2N precipitation, the specimen possessed the highest antibacterial activity.
C1 [Du, Je-Kang] Kaohsiung Med Univ, Coll Dent Med, Sch Dent, Kaohsiung 80708, Taiwan.
   [Du, Je-Kang; Wu, Ju-Hui] Kaohsiung Med Univ Hosp, Dept Dent, Kaohsiung 80708, Taiwan.
   [Du, Je-Kang] Kaohsiung Med Univ, Coll Dent Med, Sch Dent, PhD Program, Kaohsiung 80708, Taiwan.
   [Chao, Chih-Yeh; Wu, Chung-Hao] Natl Pingtung Univ Sci & Technol, Dept Mech Engn, Pingtung 91201, Taiwan.
   [Jhong, Yu-Ting; Wu, Ju-Hui] Kaohsiung Med Univ, Coll Dent Med, Grad Inst Oral Hyg, Kaohsiung 80708, Taiwan.
   [Wu, Ju-Hui] Kaohsiung Med Univ, Coll Dent Med, Dept Oral Hyg, 100 Shih Chuan 1st Rd, Kaohsiung 80708, Taiwan.
RP Wu, JH (reprint author), Kaohsiung Med Univ Hosp, Dept Dent, Kaohsiung 80708, Taiwan.; Wu, JH (reprint author), Kaohsiung Med Univ, Coll Dent Med, Grad Inst Oral Hyg, Kaohsiung 80708, Taiwan.; Wu, JH (reprint author), Kaohsiung Med Univ, Coll Dent Med, Dept Oral Hyg, 100 Shih Chuan 1st Rd, Kaohsiung 80708, Taiwan.
EM dujekang@gmail.com; cychao@mail.npust.edu.tw;
   steelwillpower0130@gmail.com; richman720423@gmail.com;
   wujuhui1020@gmail.com
FU Ministry of Science and Technology, ROC [104-2314-B-037-057-MY2]
FX This work was partially funded by a grant from the Ministry of Science
   and Technology, ROC (104-2314-B-037-057-MY2).
CR Barrere F, 2008, MAT SCI ENG R, V59, P38, DOI 10.1016/j.mser.2007.12.001
   Chen QZ, 2015, MAT SCI ENG R, V87, P1, DOI 10.1016/j.mser.2014.10.001
   Chieh L.W., 2000, STUDY ANTIBACTERIAL
   Chin-Min C., 2010, STUDY ANTIBACTERIAL
   Chu PK, 2007, SURF COAT TECH, V201, P8076, DOI 10.1016/j.surfcoat.2005.12.053
   Diaz-Visurraga J, 2011, SCI MICROBIAL PATHOG, V3, P210
   Dong J., 2004, MAT REV, V18, P41
   Dunnill CWH, 2009, J PHOTOCH PHOTOBIO A, V207, P244, DOI 10.1016/j.jphotochem.2009.07.024
   Erneman J, 2004, ACTA MATER, V52, P4337, DOI 10.1016/j.actamat.2004.06.001
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gehrig LMB, 2011, AM J SURG, V202, P364, DOI 10.1016/j.amjsurg.2011.06.007
   Hajipour MJ, 2012, TRENDS BIOTECHNOL, V30, P499, DOI 10.1016/j.tibtech.2012.06.004
   Ju L.T., 2004, ANTIBACTERIAL INFLUE, P707
   Li MJ, 2015, J MATER SCI TECHNOL, V31, P243, DOI 10.1016/j.jmst.2014.11.016
   Lin Z.D., 2010, STUDY ANTIBACTERIAL
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Lu M.Q., 2005, METALL FUNCT MAT, V12, P10
   Lyndon JA, 2014, J CONTROL RELEASE, V179, P63, DOI 10.1016/j.jconrel.2014.01.026
   Mahapatro A, 2015, MAT SCI ENG C-MATER, V55, P227, DOI 10.1016/j.msec.2015.05.018
   Mola J, 2011, SCRIPTA MATER, V65, P834, DOI 10.1016/j.scriptamat.2011.07.041
   Nan L, 2008, J MATER SCI TECHNOL, V24, P197
   Newson T., 2003, STAINLESS STEEL HYGI
   Prasongsook Sombat, 2015, Journal of Animal Science and Technology, V57, P31, DOI 10.1186/s40781-015-0063-3
   Rana S., 2011, ADV BIOTECHNOL, V11, P21
   Ren L, 2013, J MATER SCI TECHNOL, V29, P1005, DOI 10.1016/j.jmst.2013.09.008
   Shen YZ, 2010, J NUCL MATER, V400, P94, DOI 10.1016/j.jnucmat.2010.02.016
   Shi F, 2008, J IRON STEEL RES INT, V15, P72, DOI 10.1016/S1006-706X(08)60270-8
   Society T.M.I., 1992, ASM HDB
   Sung JH, 2008, MAT SCI ENG A-STRUCT, V489, P38, DOI 10.1016/j.msea.2007.11.078
   Van Landeghem HP, 2012, J CRYST GROWTH, V341, P53, DOI 10.1016/j.jcrysgro.2011.12.056
   Yan Y., 2001, CHEM PROCESS, V7, P5
   Yang K., 2005, METALL FUNCT MAT, V12, P6
   Yang K, 2007, J MATER SCI TECHNOL, V23, P333
   Zeng Y.S., 2008, STUDY PROPERTIES ANT
   Zhang D, 2013, COLLOID SURFACE B, V105, P51, DOI 10.1016/j.colsurfb.2012.12.025
   Zhang W, 2015, APPL SURF SCI, V349, P327, DOI 10.1016/j.apsusc.2015.05.012
   Zou D.N., 2005, FOUNDRY TECHNOL, V26, P1009
NR 37
TC 2
Z9 2
U1 1
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2075-4701
J9 METALS-BASEL
JI Metals
PD APR
PY 2016
VL 6
IS 4
AR 73
DI 10.3390/met6040073
PG 9
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA DL8AG
UT WOS:000375861100003
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Nogami, M
   Kimura, T
   Seki, S
   Matsui, Y
   Yoshida, T
   Koike-Soko, C
   Okabe, M
   Motomura, H
   Gejo, R
   Nikaido, T
AF Nogami, Makiko
   Kimura, Tomoatsu
   Seki, Shoji
   Matsui, Yoshito
   Yoshida, Toshiko
   Koike-Soko, Chika
   Okabe, Motonori
   Motomura, Hiraku
   Gejo, Ryuichi
   Nikaido, Toshio
TI A Human Amnion-Derived Extracellular Matrix-Coated Cell-Free Scaffold
   for Cartilage Repair: In Vitro and In Vivo Studies
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; HUMAN FETAL MEMBRANES; ARTICULAR-CARTILAGE;
   BONE-MARROW; FOLLOW-UP; DEFECTS; COLLAGEN; TISSUE; KNEE; TRANSPLANTATION
AB Objective: Extracellular matrix (ECM) derived from human amniotic mesenchymal cells (HAMs) has various biological activities. In this study, we developed a novel HAM-derived ECM-coated polylactic-co-glycolic acid (ECM-PLGA) scaffold, examined its property on mesenchymal cells, and investigated its potential as a cell-free scaffold for cartilage repair.
   Materials and Methods: ECM-PLGA scaffolds were developed by inoculating HAM on a PLGA. After decellularization by irradiation, accumulated ECM was examined. Exogenous cell growth and differentiation of rat mesenchymal stem cells (MSCs) on the ECM-PLGA were analyzed in vitro by cell attachment/proliferation assay and reverse transcription-polymerase chain reaction. The cell-free ECM-PLGA scaffolds were implanted into osteochondral defects in the trochlear groove of rat knees. After 4, 12, or 24 weeks, the animals were sacrificed and the harvested tissues were examined histologically.
   Results: The ECM-PLGA contained ECM that mimicked natural amniotic stroma that contains type I collagen, fibronectin, hyaluronic acid, and chondroitin sulfates. The ECM-PLGA showed excellent properties of cell attachment and proliferation. MSCs inoculated on the ECM-PLGA scaffold showed accelerated type II collagen mRNA expression after 3 weeks in culture. The ECM-PLGA implanted into an osteochondral defect in rat knees induced gradual tissue regeneration and resulted in hyaline cartilage repair, which was better than that in the empty control group.
   Conclusion: These in vitro and in vivo experiments show that the cell-free scaffold composed of HAM-derived ECM and PLGA provides a favorable growth environment for MSCs and facilitates the cartilage repair process. The ECM-PLGA may become a "ready-made" biomaterial for cartilage repair therapy.
C1 [Nogami, Makiko; Kimura, Tomoatsu; Seki, Shoji; Matsui, Yoshito; Motomura, Hiraku; Gejo, Ryuichi] Toyama Univ, Fac Med & Pharmaceut Sci, Dept Orthopaed Surg, Sugitani 2630, Toyama 9300194, Japan.
   [Yoshida, Toshiko; Koike-Soko, Chika; Okabe, Motonori; Nikaido, Toshio] Toyama Univ, Fac Med & Pharmaceut Sci, Dept Regenerat Med, Toyama 930, Japan.
RP Nogami, M (reprint author), Toyama Univ, Fac Med & Pharmaceut Sci, Dept Orthopaed Surg, Sugitani 2630, Toyama 9300194, Japan.
EM makohna@hotmail.com
FU JSPS KAKENHI Grant [24390350]
FX We thank Etsuko Furuichi for sectioning the paraffin-embedded cartilage
   tissue. This work was supported by JSPS KAKENHI Grant Number 24390350.
CR Amer MI, 2010, J MINIM INVAS GYN, V17, P605, DOI 10.1016/j.jmig.2010.03.019
   Andrade AL, 2010, EUR J OPHTHALMOL, V20, P290
   Behrens P, 2006, KNEE, V13, P194, DOI 10.1016/j.knee.2006.02.012
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Derfoul A, 2007, OSTEOARTHR CARTILAGE, V15, P646, DOI 10.1016/j.joca.2007.01.014
   Diaz-Prado S, 2010, CELL TISSUE BANK, V11, P183, DOI 10.1007/s10561-009-9144-1
   Erggelet C, 2007, BIOMATERIALS, V28, P5570, DOI 10.1016/j.biomaterials.2007.09.005
   Garfias Y, 2011, IMMUNOL INVEST, V40, P183, DOI 10.3109/08820139.2010.532266
   Gobbi A, 2005, KNEE SURG SPORT TR A, V13, P213, DOI 10.1007/s00167-004-0499-3
   Guo QC, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/306083
   Hollander AP, 2006, TISSUE ENG, V12, P1787, DOI 10.1089/ten.2006.12.1787
   Katayama R, 2004, RHEUMATOLOGY, V43, P980, DOI 10.1093/rheumatology/keh240
   Kon E, 2015, ARTHROSCOPY, V31, P767, DOI 10.1016/j.arthro.2014.11.017
   Kon E, 2014, AM J SPORT MED, V42, P158, DOI 10.1177/0363546513505434
   Lisignoli G, 2005, BIOMATERIALS, V26, P5677, DOI 10.1016/j.biomaterials.2005.02.031
   Ma DHK, 2010, BIOMATERIALS, V31, P6647, DOI 10.1016/j.biomaterials.2010.05.034
   Ma ZW, 2005, BIOMATERIALS, V26, P1253, DOI 10.1016/j.biomaterials.2004.04.031
   MALAK TM, 1993, PLACENTA, V14, P385, DOI 10.1016/S0143-4004(05)80460-6
   Meinert M, 2001, AM J OBSTET GYNECOL, V184, P679, DOI 10.1067/mob.2001.110294
   Mimura T, 2008, OSTEOARTHR CARTILAGE, V16, P1083, DOI 10.1016/j.joca.2008.02.003
   Niknejad H, 2008, EUR CELLS MATER, V15, P88
   Nogami M, 2012, TRANSPLANTATION, V93, P1221, DOI 10.1097/TP.0b013e3182529b76
   Ochi M, 2002, J BONE JOINT SURG BR, V84B, P571, DOI 10.1302/0301-620X.84B4.11947
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Peng YY, 2010, J BIOMED MATER RES A, V93A, P1235, DOI 10.1002/jbm.a.32616
   PINEDA S, 1992, ACTA ANAT, V143, P335
   Schneider U, 2011, KNEE SURG SPORT TR A, V19, P2145, DOI 10.1007/s00167-011-1460-x
   Shi JJ, 2012, ORTHOPEDICS, V35, pE665, DOI 10.3928/01477447-20120426-20
   Siclari A, 2012, CLIN ORTHOP RELAT R, V470, P910, DOI 10.1007/s11999-011-2107-4
   Silini A, 2013, CURR STEM CELL RES T, V8, P6, DOI 10.2174/1574888X11308010003
   Stanish WD, 2013, J BONE JOINT SURG AM, V95A, P1640, DOI 10.2106/JBJS.L.01345
   Steadman JR, 2003, ARTHROSCOPY, V19, P477, DOI 10.1053/jars.2003.50112
   Teng Z, 2013, CELL TRANSPLANT, V22, P267, DOI 10.3727/096368912X655055
   Toda A, 2007, J PHARMACOL SCI, V105, P215, DOI 10.1254/jphs.CP0070034
   Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Wei JP, 2003, CELL TRANSPLANT, V12, P545, DOI 10.3727/000000003108747000
   Wylie JD, 2016, ARTHROSCOPY, V32, P386, DOI 10.1016/j.arthro.2015.07.025
   Yamanaka K, 2015, DENT MATER J, V34, P78, DOI 10.4012/dmj.2013-330
   Zantop T, 2009, ARTHROSCOPY, V25, P1354, DOI 10.1016/j.arthro.2009.04.077
NR 41
TC 6
Z9 7
U1 0
U2 11
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD APR
PY 2016
VL 22
IS 7-8
BP 680
EP 688
DI 10.1089/ten.tea.2015.0285
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA DK2RH
UT WOS:000374761600010
PM 27019057
DA 2018-10-19
ER

PT J
AU Duffy, C
   Venturato, A
   Callanan, A
   Lilienkampf, A
   Bradley, M
AF Duffy, Caiman
   Venturato, Andrea
   Callanan, Anthony
   Lilienkampf, Annamaria
   Bradley, Mark
TI Arrays of 3D double-network hydrogels for the high-throughput discovery
   of materials with enhanced physical and biological properties
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Hydrogel; Biomaterial; Microarray; High-throughput screening;
   Double-network; Polymer
ID EMBRYONIC STEM-CELLS; POLYMERS; CULTURE; BIOMATERIALS; SCAFFOLDS;
   SUBSTRATE; SURFACES; GROWTH; FATE
AB Synthetic hydrogels are attractive biomaterials due to their similarity to natural tissues and their chemical tunability, which can impart abilities to respond to environmental cues, e.g. temperature, pH and light. The mechanical properties of hydrogels can be enhanced by the generation of a double-network. Here, we report the development of an array platform that allows the macroscopic synthesis of up to 80 single- and double-network hydrogels on a single microscope slide. This new platform allows for the screening of hydrogels as 3D features in a high-throughput format with the added dimension of significant control over the compressive and tensile properties of the materials, thus widening their potential application. The platform is adaptable to allow different hydrogels to be generated, with the potential ability to tune and alter the first and second network, and represents an exciting tool in material and biomaterial discovery. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Duffy, Caiman; Venturato, Andrea; Lilienkampf, Annamaria; Bradley, Mark] Univ Edinburgh, EaStCHEM, Sch Chem, Joseph Black Bldg,West Mains Rd, Edinburgh EH9 3FJ, Midlothian, Scotland.
   [Callanan, Anthony] Univ Edinburgh, Inst Bioengn, Sch Engn, Faraday Bldg,Kings Bldg, Edinburgh EH9 3JL, Midlothian, Scotland.
RP Bradley, M (reprint author), Univ Edinburgh, EaStCHEM, Sch Chem, Joseph Black Bldg,West Mains Rd, Edinburgh EH9 3FJ, Midlothian, Scotland.
EM mark.bradley@ed.ac.uk
FU ERC [ERC-2013-ADG 340469 ADREEM]; HumEn project [FP7/2007-2013 -
   HEALTH-F4-2013-602889]
FX We thank the ERC (ERC-2013-ADG 340469 ADREEM) and the HumEn project
   (FP7/2007-2013 - HEALTH-F4-2013-602889) for funding, Dr Logan MacKay for
   helpful discussions on 3D printing, and PolyPico (Ireland) for their
   technical support and helpful advice.
CR Accardi MA, 2013, TISSUE ENG PT A, V19, P2300, DOI [10.1089/ten.tea.2012.0580, 10.1089/ten.TEA.2012.0580]
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Callanan A, 2014, J BIOMECH, V47, P1885, DOI 10.1016/j.jbiomech.2014.02.037
   Duffy CRE, 2014, BIOMATERIALS, V35, P5998, DOI 10.1016/j.biomaterials.2014.04.013
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907
   Hague M. A., 2012, POLYMER, V53, P1805, DOI DOI 10.1016/J.BIOMATERIALS.2014.03.035
   Hansen A, 2014, ADV HEALTHC MATER, V3, P848, DOI 10.1002/adhm.201300489
   Hansen A, 2011, BIOMATERIALS, V32, P7034, DOI 10.1016/j.biomaterials.2011.06.001
   Hay DC, 2011, STEM CELL RES, V6, P92, DOI 10.1016/j.scr.2010.12.002
   Hook AL, 2012, NAT BIOTECHNOL, V30, P868, DOI 10.1038/nbt.2316
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Mangani C., 2015, BIOMATER SCI, P1371
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   McCullen SD, 2012, TISSUE ENG PT A, V18, P2073, DOI [10.1089/ten.tea.2011.0606, 10.1089/ten.TEA.2011.0606]
   Mizomoto H., 2004, SYNTHESIS SCREENING
   Myung D, 2007, POLYMER, V48, P5376, DOI 10.1016/j.polymer.2007.06.070
   Pernagallo S, 2011, J MATER CHEM, V21, P96, DOI 10.1039/c0jm01987a
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Ronken S, 2013, BIOMECH MODEL MECHAN, V12, P243, DOI 10.1007/s10237-012-0395-6
   Steele JAM, 2014, ACTA BIOMATER, V10, P2065, DOI 10.1016/j.actbio.2013.12.030
   Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409
   Tare RS, 2009, BIOMATERIALS, V30, P1045, DOI 10.1016/j.biomaterials.2008.10.038
   Venkateswaran S, 2014, J MATER CHEM B, V2, P6723, DOI 10.1039/c4tb01129e
   Wu M, 2012, WATER RES, V46, P1715, DOI 10.1016/j.watres.2011.12.041
   Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/NMAT3889, 10.1038/nmat3889]
   Zhang R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2341
NR 28
TC 3
Z9 3
U1 4
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 1
PY 2016
VL 34
SI SI
BP 104
EP 112
DI 10.1016/j.actbio.2015.12.030
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DJ6YN
UT WOS:000374359200011
PM 26712601
DA 2018-10-19
ER

PT J
AU Liu, HJ
   Usprech, J
   Sun, Y
   Simmons, CA
AF Liu, Haijiao
   Usprech, Jenna
   Sun, Yu
   Simmons, Craig A.
TI A microfabricated platform with hydrogel arrays for 3D mechanical
   stimulation of cells
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Microdevice; Mechanical stimulation; Three-dimensional; Hydrogel;
   Mesenchymal stromal cell
ID VALVE INTERSTITIAL-CELLS; MESENCHYMAL STEM-CELLS; CONNECTIVE-TISSUE;
   CYCLIC STRETCH; STRAIN; GROWTH; DIFFERENTIATION; MECHANOBIOLOGY;
   CONSTRUCTS; MICROARRAY
AB Cellular microenvironments present cells with multiple stimuli, including not only soluble biochemical and insoluble matrix cues but also mechanical factors. Biomaterial array platforms have been used to combinatorially and efficiently probe and define two-dimensional (2D) and 3D microenvironmental cues to guide cell functions for tissue engineering applications. However, there are few examples of array platforms that include dynamic mechanical forces, particularly to enable stretching of 3D cell-seeded biomaterials, which is relevant to engineering connective and cardiovascular tissues. Here we present a deformable membrane platform that enables 3D dynamic mechanical stretch of arrayed biomaterial constructs. Cell-seeded polyethylene glycol norbornene (PEG-NB) hydrogels were bound to miniaturized deformable membranes via a thiol-ene reaction with off-stoichiometry thiol-ene based polydimethylsiloxane (OSTE-PDMS) as the membrane material. Bonding to OSTE-PDMS enabled the 3D hydrogel microconstructs to be cyclically deformed and stretched by the membrane. As a first demonstration, human mesenchymal stromal cells (MSCs) embedded in PEG-NB were stretched for several days. They were found to be viable, spread in the 3D hydrogels, and exhibited a contractile myofibroblast phenotype when exposed to dynamic 3D mechanical deformation. This platform, which is readily scalable to larger arrays, enables systematic interrogation of the relationships between combinations of 3D mechanobiological cues and cellular responses, and thus has the potential to identify strategies to predictably control the construction of functional engineered tissues.
   Statement of significance
   Current high-throughput biomaterial screening approaches fail to consider the effects of dynamic mechanical stimulation, despite its importance in a wide variety of regenerative medicine applications. To meet this need, we developed a deformable membrane platform that enables 3D dynamic stretch of arrayed biomaterial constructs. Our approach combines microtechnologies fabricated with offstoichiometry thiol-ene based polydimethylsiloxane membranes that can covalently bond cell-seeded polyethylene glycol norbornene 3D hydrogels, a model biomaterial with tunable adhesive, elastic and degradation characteristics. As a first demonstration, we show that human mesenchymal stromal cells embedded in hydrogels and subjected to dynamic mechanical stimulation undergo myofibroblast differentiation. This system is readily scaled up to larger arrays, and will enable systematic and efficient screening of combinations of 3D mechanobiological and biomaterial cues on cell fate and function. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Liu, Haijiao; Sun, Yu; Simmons, Craig A.] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON M5S 3G8, Canada.
   [Liu, Haijiao; Usprech, Jenna; Sun, Yu; Simmons, Craig A.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
RP Sun, Y; Simmons, CA (reprint author), Univ Toronto, Dept Mech & Ind Engn, Toronto, ON M5S 3G8, Canada.
EM sun@mie.utoronto.ca; simmons@mie.utoronto.ca
RI Liu, Haijiao/O-1561-2015
OI Liu, Haijiao/0000-0003-2529-516X; Sun, Yu/0000-0001-7895-0741; Simmons,
   Craig/0000-0001-7729-1772
FU NSERC CREATE Program in Microfluidic Applications and Training in
   Cardiovascular Health (MATCH); Canadian Institutes of Health Research
   [MOP-130481]; Canada Research Chair in Mechanobiology; Canada Research
   Chair in Micro and Nanoengineering Systems
FX The authors thank Oleg Chebotarev for helpful suggestions and
   acknowledge financial support from the NSERC CREATE Program in
   Microfluidic Applications and Training in Cardiovascular Health (MATCH)
   (H.L.), the Canadian Institutes of Health Research (MOP-130481), and the
   Canada Research Chairs in Mechanobiology (C.S.) and Micro and
   Nanoengineering Systems (Y.S.).
CR Atala A, 2011, BRIT MED BULL, V97, P81, DOI 10.1093/bmb/ldr003
   Burdick J. A., 2009, TISSUE ENG, V15
   Cardwell R. D., 2015, J BIOMECH ENG, V137, P1
   Chen JH, 2011, ARTERIOSCL THROM VAS, V31, P590, DOI 10.1161/ATVBAHA.110.220061
   Chen WLK, 2010, BIOMATERIALS, V31, P2489, DOI 10.1016/j.biomaterials.2009.12.002
   Cui YD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7333
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dolatshahi-Pirouz A, 2014, SCI REP-UK, V4, DOI 10.1038/srep03896
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fairbanks BD, 2009, ADV MATER, V21, P5005, DOI 10.1002/adma.200901808
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Hansen TD, 2014, BIOMATER SCI-UK, V2, P745, DOI [10.1039/C3BM60278H, 10.1039/c3bm60278h]
   Hoyle CE, 2004, J POLYM SCI POL CHEM, V42, P5301, DOI 10.1002/pola.20366
   Huang GY, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/4/042001
   Huang HYS, 2007, J BIOMECH ENG-T ASME, V129, P880, DOI 10.1115/1.2801670
   Ingber D., 2006, FASEB J, P811
   Ingber DE, 2006, INT J DEV BIOL, V50, P255, DOI 10.1387/ijdb.052044di
   Ireland R.G., 2015, STEM CELLS
   Kamotani Y, 2008, BIOMATERIALS, V29, P2646, DOI 10.1016/j.biomaterials.2008.02.019
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Kluge JA, 2011, ANN BIOMED ENG, V39, P1390, DOI 10.1007/s10439-010-0243-8
   Lau K, 2015, NAT CELL BIOL, V17, P569, DOI 10.1038/ncb3156
   Liu HJ, 2014, ACS NANO, V8, P3821, DOI 10.1021/nn500553z
   Liu HJ, 2014, CELL BIOCHEM BIOPHYS, V68, P241, DOI 10.1007/s12013-013-9702-9
   Liu HJ, 2013, J BIOMECH, V46, P1967, DOI 10.1016/j.jbiomech.2013.05.001
   MacQueen L, 2012, LAB CHIP, V12, P4178, DOI [10.1039/c21c40670e, 10.1039/c2lc40670e]
   Maul TM, 2011, BIOMECH MODEL MECHAN, V10, P939, DOI 10.1007/s10237-010-0285-8
   McCall JD, 2012, BIOMACROMOLECULES, V13, P2410, DOI 10.1021/bm300671s
   Mihic A, 2014, BIOMATERIALS, V35, P2798, DOI 10.1016/j.biomaterials.2013.12.052
   Moraes C, 2013, INTEGR BIOL-UK, V5, P673, DOI 10.1039/c3ib20254b
   Moraes C, 2011, INTEGR BIOL-UK, V3, P959, DOI 10.1039/c1ib00056j
   Moraes C, 2010, BIOMATERIALS, V31, P577, DOI 10.1016/j.biomaterials.2009.09.068
   Nagai Y, 2012, BIOMATERIALS, V33, P1044, DOI 10.1016/j.biomaterials.2011.10.049
   Nguyen EH, 2014, BIOMATERIALS, V35, P2149, DOI 10.1016/j.biomaterials.2013.11.054
   O'Cearbhaill ED, 2008, BIOMATERIALS, V29, P1610, DOI 10.1016/j.biomaterials.2007.11.042
   Pedersen JA, 2005, ANN BIOMED ENG, V33, P1469, DOI 10.1007/s10439-005-8159-4
   Quinlan A. M., 2011, PLOS ONE, V6
   Riehl BD, 2012, TISSUE ENG PART B-RE, V18, P288, DOI [10.1089/ten.teb.2011.0465, 10.1089/ten.TEB.2011.0465]
   Sacks MS, 2009, ANNU REV BIOMED ENG, V11, P289, DOI 10.1146/annurev-bioeng-061008-124903
   Simmons CS, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/5/054016
   Simmons CS, 2013, LAB CHIP, V13, P646, DOI 10.1039/c2lc41110e
   Sridhar BV, 2015, ADV HEALTHC MATER, V4, P702, DOI 10.1002/adhm.201400695
   Sui GD, 2006, ANAL CHEM, V78, P5543, DOI 10.1021/ac060605z
   Syedain ZH, 2008, P NATL ACAD SCI USA, V105, P6537, DOI 10.1073/pnas.0711217105
   Syedain ZH, 2009, BIOMATERIALS, V30, P4078, DOI 10.1016/j.biomaterials.2009.04.027
   Tobita K, 2006, AM J PHYSIOL-HEART C, V291, pH1829, DOI 10.1152/ajpheart.00205.2006
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z
   WILSON E, 1995, J CLIN INVEST, V96, P2364, DOI 10.1172/JCI118293
   Yarmush ML, 2009, ANNU REV BIOMED ENG, V11, P235, DOI 10.1146/annurev.bioeng.10.061807.160502
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
NR 51
TC 9
Z9 9
U1 10
U2 60
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 1
PY 2016
VL 34
SI SI
BP 113
EP 124
DI 10.1016/j.actbio.2015.11.054
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DJ6YN
UT WOS:000374359200012
PM 26646540
DA 2018-10-19
ER

PT J
AU Groen, N
   Guvendiren, M
   Rabitz, H
   Welsh, WJ
   Kohn, J
   de Boer, J
AF Groen, Nathalie
   Guvendiren, Murat
   Rabitz, Herschel
   Welsh, William J.
   Kohn, Joachim
   de Boer, Jan
TI Stepping into the omics era: Opportunities and challenges for
   biomaterials science and engineering
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Materiomics; Transcriptomics; Genomics; Combinatorial screening;
   Computational modeling; High-throughput experimentation; Converging
   omics fields
ID TYROSINE-DERIVED POLYCARBONATES; DIMENSIONAL MODEL REPRESENTATIONS;
   SINGLE-CELL TRANSCRIPTOMICS; MESENCHYMAL STROMAL CELLS; DIP-PEN
   NANOLITHOGRAPHY; IN-VITRO; BONE-FORMATION; STEM-CELLS; FIBRINOGEN
   ADSORPTION; GENE DELIVERY
AB The research paradigm in biomaterials science and engineering is evolving from using low-throughput and iterative experimental designs towards high-throughput experimental designs for materials optimization and the evaluation of materials properties. Computational science plays an important role in this transition. With the emergence of the omics approach in the biomaterials field, referred to as materiomics, high-throughput approaches hold the promise of tackling the complexity of materials and understanding correlations between material properties and their effects on complex biological systems. The intrinsic complexity of biological systems is an important factor that is often oversimplified when characterizing biological responses to materials and establishing property-activity relationships. Indeed, in vitro tests designed to predict in vivo performance of a given biomaterial are largely lacking as we are not able to capture the biological complexity of whole tissues in an in vitro model. In this opinion paper, we explain how we reached our opinion that converging genomics and materiomics into a new field would enable a significant acceleration of the development of new and improved medical devices. The use of computational modeling to correlate high-throughput gene expression profiling with high throughput combinatorial material design strategies would add power to the analysis of biological effects induced by material properties. We believe that this extra layer of complexity on top of high-throughput material experimentation is necessary to tackle the biological complexity and further advance the biomaterials field.
   Statement of Significance
   In this opinion paper, we postulate that converging genomics and materiomics into a new field would enable a significant acceleration of the development of new and improved medical devices. The use of computational modeling to correlate high-throughput gene expression profiling with high throughput combinatorial material design strategies would add power to the analysis of biological effects induced by material properties. We believe that this extra layer of complexity on top of high-throughput material experimentation is necessary to tackle the biological complexity and further advance the biomaterials field. (C) 2016 Published by Elsevier Ltd. on behalf of Acta Materialia Inc.
C1 [Groen, Nathalie; de Boer, Jan] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Tissue Regenerat, POB 217, NL-7500 AE Enschede, Netherlands.
   [Guvendiren, Murat; Kohn, Joachim] Rutgers State Univ, New Jersey Ctr Biomat, Piscataway, NJ USA.
   [Rabitz, Herschel] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.
   [Welsh, William J.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA.
   [Kohn, Joachim] Rutgers State Univ, New Jersey Ctr Biomat, Dept Chem & Chem Biol, Piscataway, NJ USA.
   [de Boer, Jan] Maastricht Univ, cBITE Lab, Merin Inst Technol Inspired Regenerat Med, NL-6200 MD Maastricht, Netherlands.
   [Groen, Nathalie] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands.
RP de Boer, J (reprint author), Maastricht Univ, cBITE Lab, Merin Inst Technol Inspired Regenerat Med, NL-6200 MD Maastricht, Netherlands.
EM n.groen@utwente.nl
FU BioMedical Materials Institute [P2.04 BONE-IP]; Dutch Ministry of
   Economic Affairs; National Institute of Biomedical Imaging and
   Bio-engineering [P41 EB001046]; Province of Limburg
FX This research forms part of the Project P2.04 BONE-IP of the research
   program of the BioMedical Materials Institute, co-funded by the Dutch
   Ministry of Economic Affairs (NG). JK was supported by the National
   Institute of Biomedical Imaging and Bio-engineering under the P41
   EB001046 program. JdB acknowledges the financial contribution of the
   Province of Limburg.
CR Algahtani M.S., 2014, J CONTROL RELEASE, V30, P00454
   Anderson DG, 2003, ANGEW CHEM INT EDIT, V42, P3153, DOI 10.1002/anie.200351244
   Autefage H, 2015, P NATL ACAD SCI USA, V112, P4280, DOI 10.1073/pnas.1419799112
   Bakal C, 2007, SCIENCE, V316, P1753, DOI 10.1126/science.1140324
   Baker BA, 2014, BIOMATERIALS, V35, P6716, DOI 10.1016/j.biomaterials.2014.04.075
   Barbieri D, 2010, EUR CELLS MATER, V19, P252, DOI 10.22203/eCM.v019a24
   Barradas AMC, 2013, INTEGR BIOL-UK, V5, P920, DOI 10.1039/c3ib40027a
   Barradas AMC, 2012, BIOMATERIALS, V33, P3205, DOI 10.1016/j.biomaterials.2012.01.020
   Boyan B. D., 2003, European Cells & Materials, V6, P22
   Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M
   Brocchini S, 1997, J AM CHEM SOC, V119, P4553, DOI 10.1021/ja970389z
   Carlier A, 2011, ACTA BIOMATER, V7, P3573, DOI 10.1016/j.actbio.2011.06.021
   Chen K.H., 2015, SCIENCE, V348, P9
   Dalby MJ, 2008, J R SOC INTERFACE, V5, P1055, DOI 10.1098/rsif.2008.0016
   Davison NL, 2014, EUR CELLS MATER, V27, P281, DOI 10.22203/eCM.v027a20
   Delawi D, 2013, TISSUE ENG PART C-ME, V19, P821, DOI [10.1089/ten.tec.2012.0576, 10.1089/ten.TEC.2012.0576]
   Doom J, 2013, BIOMATERIALS, V34, P3053, DOI DOI 10.1016/J.BI0MATERIALS.2012.12.037
   Eyckmans J, 2013, BIOMATERIALS, V34, P4612, DOI 10.1016/j.biomaterials.2013.03.011
   Green JJ, 2008, ACCOUNTS CHEM RES, V41, P749, DOI 10.1021/ar7002336
   Groen N, 2015, ADV HEALTHC MATER, V4, P1691, DOI 10.1002/adhm.201500171
   Grun D, 2014, NAT METHODS, V11, P637, DOI [10.1038/NMETH.2930, 10.1038/nmeth.2930]
   Gubskaya AV, 2007, POLYMER, V48, P5788, DOI 10.1016/j.polymer.2007.07.007
   Gubskaya AV, 2011, MACROMOL THEOR SIMUL, V20, P275, DOI 10.1002/mats.201000087
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Habibovic P, 2008, J ORTHOP RES, V26, P1363, DOI 10.1002/jor.20648
   Habibovic P, 2006, ADV EXP MED BIOL, V585, P327
   Harris N.K., 2006, BIOMATERIALS INFORM, P163
   Hayes MY, 2006, J PHYS CHEM A, V110, P264, DOI 10.1021/jp053197w
   Hulsman M, 2015, ACTA BIOMATER, V15, P29, DOI 10.1016/j.actbio.2014.12.019
   Johnson PA, 2010, J BIOMED MATER RES A, V93A, P505, DOI 10.1002/jbm.a.32544
   Jukes JM, 2008, P NATL ACAD SCI USA, V105, P6840, DOI 10.1073/pnas.0711662105
   Junker JP, 2015, MOL CELL, V58, P563, DOI 10.1016/j.molcel.2015.05.019
   Ke RQ, 2013, NAT METHODS, V10, P857, DOI 10.1038/nmeth.2563
   Kholodovych V, 2004, POLYMER, V45, P7367, DOI 10.1016/j.polymer.2004.09.002
   Kholodovych V, 2008, POLYMER, V49, P2435, DOI 10.1016/j.polymer.2008.03.032
   Kohn J, 2004, NAT MATER, V3, P745, DOI 10.1038/nmat1249
   Kohn J, 2007, BIOMATERIALS, V28, P4171, DOI 10.1016/j.biomaterials.2007.06.022
   Kumar G, 2011, BIOMATERIALS, V32, P9188, DOI 10.1016/j.biomaterials.2011.08.054
   Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044
   Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939
   Le Nihouannen D, 2005, BONE, V36, P1086, DOI 10.1016/j.bone.2005.02.017
   Le T, 2012, CHEM REV, V112, P2889, DOI 10.1021/cr200066h
   Lewitus D, 2011, ACTA BIOMATER, V7, P2483, DOI 10.1016/j.actbio.2011.02.027
   Li GY, 2015, J PHYS CHEM A, V119, P8237, DOI 10.1021/acs.jpca.5b04911
   Li GY, 2001, J PHYS CHEM A, V105, P7765, DOI 10.1021/jp010450t
   Lin NJ, 2007, ACTA BIOMATER, V3, P163, DOI 10.1016/j.actbio.2006.10.001
   Liu E, 2009, COMB CHEM HIGH T SCR, V12, P646, DOI 10.2174/138620709788923737
   Lovmand J, 2009, BIOMATERIALS, V30, P2015, DOI 10.1016/j.biomaterials.2008.12.081
   LOWE G, 1995, CHEM SOC REV, V24, P309, DOI 10.1039/cs9952400309
   Lyubimova A, 2013, NAT PROTOC, V8, P1743, DOI 10.1038/nprot.2013.109
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Mendes SC, 2004, J MATER SCI-MATER M, V15, P1123, DOI 10.1023/B:JMSM.0000046394.53153.21
   Mentink A, 2013, BIOMATERIALS, V34, P4592, DOI 10.1016/j.biomaterials.2013.03.001
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Mulari MTK, 2004, CALCIFIED TISSUE INT, V75, P253, DOI 10.1007/s00223-004-0172-3
   Murthy NS, 2010, POLYMER, V51, P3978, DOI 10.1016/j.polymer.2010.06.024
   Nur E. K. A., 2006, STEM CELLS, V24, P426, DOI DOI 10.1634/STEMCELLS.2005-0170)
   Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661
   Rabitz H, 1999, J MATH CHEM, V25, P197, DOI 10.1023/A:1019188517934
   Ripamonti U, 2008, J CELL MOL MED, V12, P2609, DOI 10.1111/j.1582-4934.2008.00312.x
   Rohrer SP, 1998, SCIENCE, V282, P737, DOI 10.1126/science.282.5389.737
   Roth EA, 2004, BIOMATERIALS, V25, P3707, DOI 10.1016/j.biomaterials.2003.10.052
   Ryan PL, 2001, P NATL ACAD SCI USA, V98, P4323, DOI 10.1073/pnas.071615398
   Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439
   Siddappa R, 2008, P NATL ACAD SCI USA, V105, P7281, DOI 10.1073/pnas.0711190105
   Simon CG, 2011, ADV MATER, V23, P369, DOI 10.1002/adma.201001763
   Simon CG, 2005, BIOMATERIALS, V26, P6906, DOI 10.1016/j.biomaterials.2005.04.050
   Smith JR, 2005, POLYMER, V46, P4296, DOI 10.1016/j.polymer.2005.03.012
   Smith JR, 2004, J CHEM INF COMP SCI, V44, P1088, DOI 10.1021/ci0499774
   Sung HJ, 2009, J CELL PHYSIOL, V218, P549, DOI 10.1002/jcp.21629
   Tan W, 2003, TISSUE ENG, V9, P255, DOI 10.1089/107632703764664729
   Tangpasuthadol V, 2000, BIOMATERIALS, V21, P2371, DOI 10.1016/S0142-9612(00)00104-6
   Taylor M, 2009, SURF INTERFACE ANAL, V41, P127, DOI 10.1002/sia.2969
   Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107
   Tsimbouri PM, 2013, BIOMATERIALS, V34, P2177, DOI 10.1016/j.biomaterials.2012.12.019
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   Unadkat HV, 2011, P NATL ACAD SCI USA, V108, P16565, DOI 10.1073/pnas.1109861108
   Urquhart AJ, 2008, ANAL CHEM, V80, P135, DOI 10.1021/ac071560k
   Van der Stok J, 2011, ACTA BIOMATER, V7, P739, DOI 10.1016/j.actbio.2010.07.035
   Wang WJ, 2013, LANGMUIR, V29, P11420, DOI 10.1021/la401268s
   Wilson DL, 2001, P NATL ACAD SCI USA, V98, P13660, DOI 10.1073/pnas.241323198
   Yang J, 2009, ADV MATER, V21, P300, DOI 10.1002/adma.200801942
   Yang Y, 2008, ADV MATER, V20, P2037, DOI 10.1002/adma.200702088
   Yin Z, 2013, NAT CELL BIOL, V15, P860, DOI 10.1038/ncb2764
   Zhang SG, 1999, BIOMATERIALS, V20, P1213, DOI 10.1016/S0142-9612(99)00014-9
NR 85
TC 9
Z9 9
U1 1
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR 1
PY 2016
VL 34
SI SI
BP 133
EP 142
DI 10.1016/j.actbio.2016.02.015
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DJ6YN
UT WOS:000374359200014
PM 26876875
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Aperador, W
   Duque, J
   Delgado, E
AF Aperador, W.
   Duque, J.
   Delgado, E.
TI Synthesis and Electrochemical Characterization a Coating of
   beta-Tricalcium Phosphate Deposited on Steel 316LVM
SO INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE
LA English
DT Article
DE tricalcium phosphate; Physical vapor deposition; Corrosion; Biomaterials
ID BONE-GRAFTS; TCP; BIOCERAMICS; BIOMATERIAL; SILICATE
AB Beta tricalcium phosphate thin films they were deposited on austenitic steel by means of a magnetron sputtering with r.f. (13.56 MHz) from tricalcium phosphate (TCP) which it was used as a sputtering target. In order to study the effect of the content of the coating; in the corrosion rate and electrochemical response function of time (0, 24, 196 and 720 hours) of the coated steels, corrosion rate is studied by polarization curves Tafel and the electrochemical response by electrochemical impedance spectroscopy, microstructural characterization was performed using scanning electron microscopy (SEM). Finding himself a decrease of 32% in the corrosion rate for the system evaluated to 720 hours. The ion exchange capacity indicates an increase in corrosion resistance.
C1 [Aperador, W.; Duque, J.; Delgado, E.] Univ Mil Nueva Granada, Sch Engn, Bogota, Colombia.
RP Aperador, W (reprint author), Univ Mil Nueva Granada, Sch Engn, Bogota, Colombia.
EM g.ing.materiales@gmail.com
FU Universidad Militar Nueva Granada [ING-1903-2015]
FX Thanks the financial support from the Universidad Militar Nueva Granada,
   contract number ING-1903-2015
CR Barber FA, 2013, ARTHROSCOPY, V29, P1834, DOI 10.1016/j.arthro.2013.08.004
   Bohner M, 2000, INJURY, V31, pS37
   Cabanas MV, 2009, EUR J PHARM SCI, V37, P249, DOI 10.1016/j.ejps.2009.02.011
   Carbajal L, 2012, J EUR CERAM SOC, V32, P569, DOI 10.1016/j.jeurceramsoc.2011.09.025
   Cattalini JP, 2013, PROCEDIA ENGINEER, V59, P78, DOI 10.1016/j.proeng.2013.05.096
   Clarke SA, 2007, BONE, V40, P939, DOI 10.1016/j.bone.2006.11.004
   Duncan J, 2014, ACTA BIOMATER, V10, P1443, DOI 10.1016/j.actbio.2013.11.014
   Elayaraja K, 2013, APPL SURF SCI, V274, P203, DOI 10.1016/j.apsusc.2013.03.016
   Kazek-Kesik A, 2014, ARCH CIV MECH ENG, V14, P671, DOI 10.1016/j.acme.2013.10.008
   Kurtulus G., 2011, MATER LETT, P2883
   Leadley S.R., 1997, BIOMATER SCI, P311
   Marques CF, 2016, CERAM INT, V42, P2706, DOI 10.1016/j.ceramint.2015.11.001
   Martinez IM, 2012, MATER CHARACT, V63, P47, DOI 10.1016/j.matchar.2011.10.013
   McEntire BJ, 2015, J EUR CERAM SOC, V35, P4327, DOI 10.1016/j.jeurceramsoc.2015.07.034
   Mina A, 2015, MATER CHEM PHYS, V160, P296, DOI 10.1016/j.matchemphys.2015.04.041
   Montazerolghaem M, 2015, MAT SCI ENG C-MATER, V52, P212, DOI 10.1016/j.msec.2015.03.038
   Nejadnik MR, 2014, BIOMATERIALS, V35, P6918, DOI 10.1016/j.biomaterials.2014.05.003
   Nolff MC, 2010, J CRANIO MAXILL SURG, V38, P38, DOI 10.1016/j.jcms.2009.07.010
   Piccirillo C, 2013, MAT SCI ENG C-MATER, V33, P103, DOI 10.1016/j.msec.2012.08.014
   Sanosh KP, 2010, CURR APPL PHYS, V10, P68, DOI 10.1016/j.cap.2009.04.014
   Shamsul BS, 2014, TISSUE CELL, V46, P152, DOI 10.1016/j.tice.2014.02.001
   Sowmya S, 2013, PROG POLYM SCI, V38, P1748, DOI 10.1016/j.progpolymsci.2013.05.005
   Vandecandelaere N, 2014, POWDER TECHNOL, V255, P3, DOI 10.1016/j.powtec.2013.09.015
   Varma HK, 2005, CERAM INT, V31, P109, DOI 10.1016/j.ceramint.2004.03.041
   Volkmer TM, 2013, POWDER TECHNOL, V235, P599, DOI 10.1016/j.powtec.2012.10.025
   Weijs WLJ, 2010, INT J ORAL MAX SURG, V39, P424, DOI 10.1016/j.ijom.2010.02.004
NR 26
TC 0
Z9 0
U1 0
U2 5
PU ESG
PI BELGRADE
PA BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA
SN 1452-3981
J9 INT J ELECTROCHEM SC
JI Int. J. Electrochem. Sci.
PD APR
PY 2016
VL 11
IS 4
BP 2945
EP 2953
PG 9
WC Electrochemistry
SC Electrochemistry
GA DL1LP
UT WOS:000375393900035
DA 2018-10-19
ER

PT J
AU Liu, SP
   Lin, CH
   Lin, SJ
   Fu, RH
   Huang, YC
   Chen, SY
   Lin, SZ
   Hsu, CY
   Shyu, WC
AF Liu, Shih-Ping
   Lin, Chen-Huan
   Lin, Shao-Ji
   Fu, Ru-Huei
   Huang, Yu-Chuen
   Chen, Shih-Yin
   Lin, Shinn-Zong
   Hsu, Chung Y.
   Shyu, Woei-Cherng
TI Electrospun Polyacrylonitrile-Based Nanofibers Maintain Embryonic Stem
   Cell Sternness via TGF-Beta Signaling
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Electrospun; PAN; Pluripotenct Stem Cells; Stemness; TGF-Beta
ID SILICATE COMPOSITES; MATS; CULTURE; SCAFFOLDS; MEMBRANES; NANOPARTICLES;
   PLURIPOTENCY; REGENERATION; SUPPORT
AB Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) are capable of self-renewal and differentiation into any cell type, thus making them the focus of many clinical application studies. Culturing ESCs on mouse embryonic fibroblast-derived and cell-based feeder layers to maintain pluripotency is a standard laboratory procedure. However, xenogeneic contamination and the large amount of time required for feeder cell preparation are two challenges that encourage the use of a murine-based feeder layer. A novel biomaterial is required to replace the current cell-based feeder system. Toward this goal, we applied a combination of biocompatible polyacrylonitrile (PAN) and electrospinning technology to establish a non-cell-based feeder layer. According to results from stem cell marker staining, scanning electron microscopy, and embryoid body formation tests, optimal ESC stemness and pluripotency were noted in three electrospun groups (2, 4, and 8 minutes), with the longer electrospinning times producing higher feeder-layer densities. KEGG pathway microarray results identified TGF-beta signaling as one of the major deregulatory pathways on electrospun-based feeder layers. Western blot data indicate significant increases in TGF-beta receptor II, phosphorylated Smad3, and Nanog protein levels in the 4- and 8-minute electrospun-based feeder layer groups compared to the non-feeder layer group. Combined, the data suggest that electrospun-based feeder layers are good candidates for maintaining ESC and iPSC pluripotency in clinical applications.
C1 [Liu, Shih-Ping; Lin, Chen-Huan; Fu, Ru-Huei; Lin, Shinn-Zong; Shyu, Woei-Cherng] China Med Univ Hosp, Ctr Neuropsychiat, Taichung 40402, Taiwan.
   [Liu, Shih-Ping; Lin, Shao-Ji] China Med Univ, Grad Inst Basic Med Sci, Taichung 40402, Taiwan.
   [Liu, Shih-Ping] Asia Univ, Dept Social Work, Taichung 41354, Taiwan.
   [Fu, Ru-Huei; Lin, Shinn-Zong; Shyu, Woei-Cherng] China Med Univ, Grad Inst Immunol, Taichung 40402, Taiwan.
   [Huang, Yu-Chuen; Chen, Shih-Yin] China Med Univ Hosp, Dept Med Res, Genet Ctr, Taichung 40402, Taiwan.
   [Huang, Yu-Chuen; Chen, Shih-Yin] China Med Univ, Grad Inst Chinese Med Sci, Coll Chinese Med, Taichung 40402, Taiwan.
   [Lin, Shinn-Zong] China Med Univ, Beigan Hosp, Dept Neurosurg, Yunlin 65152, Taiwan.
   [Hsu, Chung Y.] China Med Univ, Grad Inst Clin Med Sci, Taichung 40402, Taiwan.
RP Liu, SP; Shyu, WC (reprint author), China Med Univ Hosp, Ctr Neuropsychiat, Taichung 40402, Taiwan.; Liu, SP (reprint author), China Med Univ, Grad Inst Basic Med Sci, Taichung 40402, Taiwan.; Liu, SP (reprint author), Asia Univ, Dept Social Work, Taichung 41354, Taiwan.; Shyu, WC (reprint author), China Med Univ, Grad Inst Immunol, Taichung 40402, Taiwan.
EM spliu@mail.cmu.edu.tw; shyu9423@gmail.com
OI Hsu, Chung Y./0000-0002-5632-2733
FU Taiwan Ministry of Health and Welfare Clinical Trial and Research Center
   of Excellence [MOHW104-TDU-B-212-113002]; China Medical University
   Hospital [DMR-104-050]
FX This study is supported in part by Taiwan Ministry of Health and Welfare
   Clinical Trial and Research Center of Excellence
   (MOHW104-TDU-B-212-113002) and China Medical University Hospital
   (DMR-104-050).
CR Abbasi N, 2014, CELL J, V16, P245
   Chen M, 2013, LANGMUIR, V29, P11858, DOI 10.1021/la4017799
   Ding FY, 2014, NANOSCALE, V6, P9477, DOI 10.1039/c4nr02814g
   Gauthaman K, 2009, J CELL MOL MED, V13, P3475, DOI 10.1111/j.1582-4934.2009.00699.x
   Han B, 2014, J BIOMAT SCI-POLYM E, V25, P341, DOI 10.1080/09205063.2013.861169
   Hashemi SM, 2011, BIOMATERIALS, V32, P7363, DOI 10.1016/j.biomaterials.2011.06.048
   Heng BC, 2004, IN VITRO CELL DEV-AN, V40, P255
   Huang R, 2014, J BIOMED NANOTECHNOL, V10, P1346, DOI 10.1166/jbn.2014.1802
   Huang R, 2014, J BIOMED NANOTECHNOL, V10, P485, DOI 10.1166/jbn.2014.1716
   James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706
   Li W, 2014, CARBOHYD POLYM, V99, P218, DOI 10.1016/j.carbpol.2013.07.055
   Liu SP, 2014, STEM CELLS DEV, V23, P421, DOI 10.1089/scd.2013.0182
   Liu SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044024
   Lou T, 2014, J BIOMED NANOTECHNOL, V10, P1105, DOI 10.1166/jbn.2014.1793
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Manuel J, 2015, J BIOMED NANOTECHNOL, V11, P143, DOI 10.1166/jbn.2015.2028
   Mege JL, 1996, AM J KIDNEY DIS, V28, P395, DOI 10.1016/S0272-6386(96)90497-7
   Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353
   Nirmala R, 2013, J COLLOID INTERF SCI, V397, P65, DOI 10.1016/j.jcis.2013.01.057
   OUHIBI N, 1995, MOL REPROD DEV, V40, P311, DOI 10.1002/mrd.1080400307
   Park Kyung-Soon, 2011, Int J Stem Cells, V4, P18
   Peng HS, 2014, J MATER CHEM B, V2, P6435, DOI 10.1039/c4tb00344f
   Ribba L, 2014, J BIOMED NANOTECHNOL, V10, P3508, DOI 10.1166/jbn.2014.2046
   Sakaki-Yumoto M, 2013, BBA-GEN SUBJECTS, V1830, P2280, DOI 10.1016/j.bbagen.2012.08.008
   Saxena S, 2008, MOL REPROD DEV, V75, P1523, DOI 10.1002/mrd.20895
   Schmidt J. V., 2001, CURR PROTOC TOXICOL
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Truong YB, 2012, BIOMATERIALS, V33, P9198, DOI 10.1016/j.biomaterials.2012.09.012
   Truong YB, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/2/025005
   Xin SJ, 2014, J BIOMED NANOTECHNOL, V10, P803, DOI 10.1166/jbn.2014.1748
   Yun YP, 2014, J BIOMED NANOTECHNOL, V10, P1080, DOI 10.1166/jbn.2014.1819
NR 32
TC 6
Z9 6
U1 0
U2 6
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
EI 1550-7041
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD APR
PY 2016
VL 12
IS 4
BP 732
EP 742
DI 10.1166/jbn.2016.2201
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA DK3HP
UT WOS:000374808000013
PM 27301199
DA 2018-10-19
ER

PT J
AU Khalifa, A
   Chapin, K
   Abdelgawad, O
   Al Kom, S
   Anderson, J
   Akkus, O
   Hijaz, A
AF Khalifa, Ahmad
   Chapin, Katherine
   Abdelgawad, Osama
   Al Kom, Shebin
   Anderson, James
   Akkus, Ozan
   Hijaz, Adonis
TI BIOCOMPATIBILITY OF WOVEN COLLAGEN MESH AS A NOVEL BIOMATERIAL FOR
   FUTURE SLINGS.
SO JOURNAL OF UROLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Urological-Association (AUA)
CY MAY 06-10, 2016
CL San Diego, CA
SP Amer Urol Assoc
OI Akkus, Ozan/0000-0003-3523-3421
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5347
EI 1527-3792
J9 J UROLOGY
JI J. Urol.
PD APR
PY 2016
VL 195
IS 4
SU S
MA PD36-11
BP E853
EP E853
DI 10.1016/j.juro.2016.02.1116
PG 1
WC Urology & Nephrology
SC Urology & Nephrology
GA DL3NC
UT WOS:000375539500580
DA 2018-10-19
ER

PT J
AU Achatz, FP
   Kujat, R
   Pfeifer, CG
   Koch, M
   Nerlich, M
   Angele, P
   Zellner, J
AF Achatz, Felix P.
   Kujat, Richard
   Pfeifer, Christian G.
   Koch, Matthias
   Nerlich, Michael
   Angele, Peter
   Zellner, Johannes
TI In Vitro Testing of Scaffolds for Mesenchymal Stem Cell-Based Meniscus
   Tissue Engineering-Introducing a New Biocompatibility Scoring System
SO MATERIALS
LA English
DT Article
DE meniscus; polyurethane scaffold; composite scaffold; hyaluronic acid;
   collagen; gelatin; chondrogenesis; human mesenchymal stem cells;
   biocompatibility
ID POLYURETHANE SCAFFOLD; CLINICAL-OUTCOMES; FOLLOW-UP; REPAIR;
   MENISCECTOMY; KNEE; IMPLANT; DIFFERENTIATION; REGENERATION; PROGENITOR
AB A combination of mesenchymal stem cells (MSCs) and scaffolds seems to be a promising approach for meniscus repair. To facilitate the search for an appropriate scaffold material a reliable and objective in vitro testing system is essential. This paper introduces a new scoring for this purpose and analyzes a hyaluronic acid (HA) gelatin composite scaffold and a polyurethane scaffold in combination with MSCs for tissue engineering of meniscus. The pore quality and interconnectivity of pores of a HA gelatin composite scaffold and a polyurethane scaffold were analyzed by surface photography and Berliner-Blau-BSA-solution vacuum filling. Further the two scaffold materials were vacuum-filled with human MSCs and analyzed by histology and immunohistochemistry after 21 days in chondrogenic media to determine cell distribution and cell survival as well as proteoglycan production, collagen type I and II content. The polyurethane scaffold showed better results than the hyaluronic acid gelatin composite scaffold, with signs of central necrosis in the HA gelatin composite scaffolds. The polyurethane scaffold showed good porosity, excellent pore interconnectivity, good cell distribution and cell survival, as well as an extensive content of proteoglycans and collagen type II. The polyurethane scaffold seems to be a promising biomaterial for a mesenchymal stem cell-based tissue engineering approach for meniscal repair. The new score could be applied as a new standard for in vitro scaffold testing.
C1 [Achatz, Felix P.; Kujat, Richard; Pfeifer, Christian G.; Koch, Matthias; Nerlich, Michael; Angele, Peter; Zellner, Johannes] Univ Med Ctr Regensburg, Dept Trauma Surg, Franz Josef Str Allee 11, D-93053 Regensburg, Germany.
   [Angele, Peter] Sporthopaedicum Regensburg, Hildegard von Bingen Str 1, D-93053 Regensburg, Germany.
RP Zellner, J (reprint author), Univ Med Ctr Regensburg, Dept Trauma Surg, Franz Josef Str Allee 11, D-93053 Regensburg, Germany.
EM felix.achatz@googlemail.com; richard.kujat@ukr.de;
   christian.pfeifer@ukr.de; matthias.koch@ukr.de; michael.nerlich@ukr.de;
   peter.angele@ukr.de; johannes.zellner@ukr.de
OI Achatz, Felix Paul/0000-0001-6859-9070
FU Clinic and Policlinic for Trauma Surgery, University Medical Center
   Regensburg; Orteq
FX We want to highly acknowledge technical support of Daniela Drenkard.
   Further we want to thank Florian Zeman from the Center of clinical
   studies of the University of Regensburg for the evaluation of our score.
   This study was funded by intramural funding of the Clinic and Policlinic
   for Trauma Surgery, University Medical Center Regensburg and by Orteq.
CR Abrams GD, 2013, AM J SPORT MED, V41, P2333, DOI 10.1177/0363546513495641
   AHMED AM, 1983, J BIOMECH ENG-T ASME, V105, P216, DOI 10.1115/1.3138409
   Akgun U, 2008, KNEE SURG SPORT TR A, V16, P809, DOI 10.1007/s00167-008-0542-x
   Angele P, 1999, TISSUE ENG, V5, P545, DOI 10.1089/ten.1999.5.545
   Angele P., 2014, J EXP ORTOP, V1
   Angele P, 2008, J BIOMED MATER RES A, V85A, P445, DOI 10.1002/jbm.a.31480
   Bouyarmane H, 2014, ORTHOP TRAUMATOL-SUR, V100, P153, DOI 10.1016/j.otsr.2013.10.011
   Brindle T, 2001, J Athl Train, V36, P160
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Di Matteo Berardo, 2015, Open Orthop J, V9, P143, DOI 10.2174/1874325001509010143
   Efe T, 2012, KNEE SURG SPORT TR A, V20, P1822, DOI 10.1007/s00167-011-1779-3
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Hernigou P, 2014, INT ORTHOP, V38, P1855, DOI 10.1007/s00264-014-2318-x
   Hoben GM, 2006, SPORTS MED ARTHROSC, V14, P129, DOI 10.1097/00132585-200609000-00004
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   KIMURA M, 1995, CLIN ORTHOP RELAT R, P185
   Krampera Mauro, 2007, Blood Transfus, V5, P120, DOI 10.2450/2007.0029-07
   KUROSAWA H, 1980, CLIN ORTHOP RELAT R, P283
   LEVY IM, 1989, J BONE JOINT SURG AM, V71A, P401, DOI 10.2106/00004623-198971030-00014
   Liu CX, 2013, ARCH ORTHOP TRAUM SU, V133, P95, DOI 10.1007/s00402-012-1624-2
   Longo UG, 2013, KNEE SURG SPORT TR A, V21, P1569, DOI 10.1007/s00167-012-2142-z
   Maher Suzanne A, 2011, HSS J, V7, P157, DOI 10.1007/s11420-010-9188-6
   Makris EA, 2011, BIOMATERIALS, V32, P7411, DOI 10.1016/j.biomaterials.2011.06.037
   Matsiko A, 2015, TISSUE ENG PT A, V21, P486, DOI [10.1089/ten.tea.2013.0545, 10.1089/ten.TEA.2013.0545]
   McDermott ID, 2006, J BONE JOINT SURG BR, V88B, P1549, DOI 10.1302/0301-620X.88B12.18140
   Petty CA, 2011, ARTHROSCOPY, V27, P419, DOI 10.1016/j.arthro.2010.08.016
   RENSTROM P, 1990, CLIN SPORT MED, V9, P523
   Rodkey WG, 2008, J BONE JOINT SURG AM, V90A, P1413, DOI 10.2106/JBJS.G.00656
   Shemesh M, 2014, J MECH BEHAV BIOMED, V29, P42, DOI 10.1016/j.jmbbm.2013.08.021
   Stone KR, 1997, J BONE JOINT SURG AM, V79A, P1770, DOI 10.2106/00004623-199712000-00002
   Verdonk P, 2012, AM J SPORT MED, V40, P844, DOI 10.1177/0363546511433032
   Verdonk R., 2013, MENISCAL TRANSPLANTA
   Vrancken ACT, 2013, INT ORTHOP, V37, P291, DOI 10.1007/s00264-012-1682-7
   Welsing RTC, 2008, AM J SPORT MED, V36, P1978, DOI 10.1177/0363546508319900
   Zellner J., 2006, THESIS U REGENSBURG
   Zellner J, 2013, J BIOMED MATER RES B, V101, P1133, DOI 10.1002/jbm.b.32922
   Zellner J, 2010, J BIOMED MATER RES A, V94A, P1150, DOI 10.1002/jbm.a.32796
NR 38
TC 3
Z9 3
U1 1
U2 33
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD APR
PY 2016
VL 9
IS 4
AR 276
DI 10.3390/ma9040276
PG 14
WC Materials Science, Multidisciplinary
SC Materials Science
GA DK8EB
UT WOS:000375158900062
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Tozzi, G
   De Mori, A
   Oliveira, A
   Roldo, M
AF Tozzi, Gianluca
   De Mori, Arianna
   Oliveira, Antero
   Roldo, Marta
TI Composite Hydrogels for Bone Regeneration
SO MATERIALS
LA English
DT Review
DE biomaterials; regenerative medicine; hydrogels; bone regeneration;
   tissue engineering; mechanical properties; growth factors; statins;
   bisphosphonates; hydroxyapatite
ID MESENCHYMAL STEM-CELLS; EXFOLIATED DECIDUOUS TEETH; PROMOTE OSTEOGENIC
   DIFFERENTIATION; CALCIUM-PHOSPHATE CEMENT; GROWTH-FACTOR DELIVERY;
   MARROW STROMAL CELLS; ACID-BASED HYDROGELS; OF-THE-ART; HYALURONIC-ACID;
   IN-VITRO
AB Over the past few decades, bone related disorders have constantly increased. Among all pathological conditions, osteoporosis is one of the most common and often leads to bone fractures. This is a massive burden and it affects an estimated 3 million people only in the UK. Furthermore, as the population ages, numbers are due to increase. In this context, novel biomaterials for bone fracture regeneration are constantly under development. Typically, these materials aim at favoring optimal bone integration in the scaffold, up to complete bone regeneration; this approach to regenerative medicine is also known as tissue engineering (TE). Hydrogels are among the most promising biomaterials in TE applications: they are very flexible materials that allow a number of different properties to be targeted for different applications, through appropriate chemical modifications. The present review will focus on the strategies that have been developed for formulating hydrogels with ideal properties for bone regeneration applications. In particular, aspects related to the improvement of hydrogels' mechanical competence, controlled delivery of drugs and growth factors are treated in detail. It is hoped that this review can provide an exhaustive compendium of the main aspects in hydrogel related research and, therefore, stimulate future biomaterial development and applications.
C1 [Tozzi, Gianluca] Univ Portsmouth, Sch Engn, Anglesea Bldg,Anglesea Rd, Portsmouth PO1 3DJ, Hants, England.
   [De Mori, Arianna; Oliveira, Antero; Roldo, Marta] Univ Portsmouth, Sch Pharm & Biomed Sci, St Michaels Bldg,White Swan Rd, Portsmouth PO1 2DT, Hants, England.
RP Roldo, M (reprint author), Univ Portsmouth, Sch Pharm & Biomed Sci, St Michaels Bldg,White Swan Rd, Portsmouth PO1 2DT, Hants, England.
EM gianluca.tozzi@port.ac.uk; arianna.demori@port.ac.uk;
   antero.oliveira@port.ac.uk; marta.roldo@port.ac.uk
OI Roldo, Marta/0000-0003-2242-7761; Tozzi, Gianluca/0000-0002-3172-5720
FU University of Portsmouth (UK); Institute of Biomedical and Biomolecular
   Science
FX The authors wish to thank the University of Portsmouth (UK) and in
   particular the Institute of Biomedical and Biomolecular Science for
   financial support. Owain McClelland is acknowledged for his contribution
   to Section 2.1.
CR Ahmed EM, 2015, J ADV RES, V6, P105, DOI 10.1016/j.jare.2013.07.006
   Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Almeshaly H., 2015, J ORAL MAXILLOFAC SU
   Amini Ami R., 2012, Critical Reviews in Biomedical Engineering, V40, P363
   Baldini N, 2009, WOODHEAD PUBL MATER, P69, DOI 10.1533/9781845696610.1.69
   Banyard DA, 2015, J CELL MOL MED, V19, P21, DOI 10.1111/jcmm.12425
   Barba M., 2013, BIOMED RES INT, V2013
   Basha RY, 2015, MAT SCI ENG C-MATER, V57, P452, DOI 10.1016/j.msec.2015.07.016
   Bayer EA, 2015, J CONTROL RELEASE, V219, P129, DOI 10.1016/j.jconrel.2015.08.004
   Benoit DSW, 2006, BIOMATERIALS, V27, P6102, DOI 10.1016/j.biomaterials.2006.06.031
   Bhakta G, 2012, BIOMATERIALS, V33, P6113, DOI 10.1016/j.biomaterials.2012.05.030
   Bifulco M, 2014, EUR J INTERN MED, V25, pE95, DOI 10.1016/j.ejim.2014.08.006
   Blokhuis TJ, 2013, INJURY, V44, pS40, DOI 10.1016/S0020-1383(13)70009-3
   Braddock M., 2001, PHYSIOLOGY, V10, P208
   Bradley JD, 2007, J PERIODONTAL RES, V42, P267, DOI 10.1111/j.1600-0765.2006.00943.x
   Buckwalter J A, 1987, Instr Course Lect, V36, P27
   Byrne DP, 2007, BIOMATERIALS, V28, P5544, DOI 10.1016/j.biomaterials.2007.09.003
   Chang C, 2013, CARBOHYD POLYM, V91, P7, DOI 10.1016/j.carbpol.2012.07.070
   Chung YI, 2007, J CONTROL RELEASE, V121, P91, DOI 10.1016/j.jconrel.2007.05.029
   Chung YS, 2000, J CLIN ENDOCR METAB, V85, P1137, DOI 10.1210/jc.85.3.1137
   Costa-Pinto AR, 2011, TISSUE ENG PART B-RE, V17, P331, DOI 10.1089/ten.teb.2010.0704
   Coutinho DF, 2010, BIOMATERIALS, V31, P7494, DOI 10.1016/j.biomaterials.2010.06.035
   Crowder SW, 2013, NANOSCALE, V5, P4171, DOI 10.1039/c3nr00803g
   CURREY JD, 2002, BONES STRUCTURE MECH, P3
   D'Este M, 2013, ACTA BIOMATER, V9, P5421, DOI 10.1016/j.actbio.2012.11.022
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Deligkaris K, 2010, SENSOR ACTUAT B-CHEM, V147, P765, DOI 10.1016/j.snb.2010.03.083
   Dreifke MB, 2013, J BIOMED MATER RES A, V101, P2436, DOI 10.1002/jbm.a.34521
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dyondi D, 2013, INT J NANOMED, V8, P47, DOI 10.2147/IJN.S37953
   Elavarasu S, 2012, J PHARM BIOALLIED SC, V4, pS248, DOI 10.4103/0975-7406.100225
   Fathi MH, 2009, J MATER PROCESS TECH, V209, P1385, DOI 10.1016/j.jmatprotec.2008.03.051
   Fedorovich NE, 2007, TISSUE ENG, V13, P1905, DOI 10.1089/ten.2006.0175
   Gantar A, 2014, MAT SCI ENG C-MATER, V43, P27, DOI 10.1016/j.msec.2014.06.045
   Gao C, 2012, NANOSCALE, V4, P1948, DOI 10.1039/c2nr11757f
   Gao GF, 2015, BIOTECHNOL J, V10, P1568, DOI 10.1002/biot.201400635
   Gao NN, 2016, CHEM ENG J, V287, P20, DOI 10.1016/j.cej.2015.11.015
   Garcia-Gareta E, 2015, BONE, V81, P112, DOI 10.1016/j.bone.2015.07.007
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Geris L, 2009, PHILOS T R SOC A, V367, P2031, DOI 10.1098/rsta.2008.0293
   Giannotti S, 2013, CLIN CASES MINER BON, V10, P116, DOI 10.11138/ccmbm/2013.10.2.116
   Gigante A, 2008, EUR J HISTOCHEM, V52, P169
   Gomez-Barrena E, 2011, J CELL MOL MED, V15, P1266, DOI 10.1111/j.1582-4934.2011.01265.x
   Hak DJ, 2014, INJURY, V45, pS3, DOI 10.1016/j.injury.2014.04.002
   Hayden RS, 2014, ACTA BIOMATER, V10, P486, DOI 10.1016/j.actbio.2013.09.028
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Heo DN, 2014, J MATER CHEM B, V2, P1584, DOI 10.1039/c3tb21246g
   Hesse E, 2010, J BIOMED MATER RES A, V94A, P442, DOI 10.1002/jbm.a.32696
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Holzwarth JM, 2011, BIOMATERIALS, V32, P9622, DOI 10.1016/j.biomaterials.2011.09.009
   Homma Y, 2013, INJURY, V44, pS46, DOI 10.1016/S0020-1383(13)70011-1
   Hu JX, 2016, INT J BIOL MACROMOL, V82, P134, DOI 10.1016/j.ijbiomac.2015.09.077
   Hwang NS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002498
   Iolascon G, 2010, CLIN CASES MINER BON, V7, P19
   Jeon JH, 2008, J PERIODONTOL, V79, P1457, DOI [10.1902/jop.2008.080004, 10.1902/jop.2008.080004 ]
   Jimi E., 2012, INT J DENT, V2012
   Johnson AJW, 2011, ACTA BIOMATER, V7, P16, DOI 10.1016/j.actbio.2010.07.012
   Kettenberger U., 2015, J TISSUE ENG REGEN M, V37, P3428
   Khosla S, 2012, J CLIN ENDOCR METAB, V97, P2272, DOI 10.1210/jc.2012-1027
   Khoushab F, 2010, MAR DRUGS, V8, P1988, DOI 10.3390/md8071988
   Killion JA, 2013, MAT SCI ENG C-MATER, V33, P4203, DOI 10.1016/j.msec.2013.06.013
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   Kraehenbuehl TP, 2011, NAT METHODS, V8, P731, DOI 10.1038/nmeth.1671
   Krishnan V, 2013, J ADV PHARM TECHNOL, V4, P78, DOI 10.4103/2231-4040.111523
   Kumar RA, 2015, ACS APPL MATER INTER, V7, P9399, DOI 10.1021/acsami.5b02685
   Lacroix J, 2014, CHEM ENG J, V256, P9, DOI 10.1016/j.cej.2014.06.022
   Lalwani G, 2013, BIOMACROMOLECULES, V14, P900, DOI 10.1021/bm301995s
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LANYON LE, 1993, CALCIFIED TISSUE INT, V53, pS102, DOI 10.1007/BF01673415
   Lee SSS, 2015, ADV HEALTHC MATER, V4, DOI 10.1002/adhm.201400129
   Levi B, 2011, STEM CELLS, V29, P576, DOI 10.1002/stem.612
   Li XM, 2013, J BIOMED MATER RES A, V101, P2424, DOI 10.1002/jbm.a.34539
   Li YF, 2010, OSTEOPOROSIS INT, V21, P1889, DOI 10.1007/s00198-009-1140-6
   Li YJ, 2006, J BIOMED MATER RES A, V79A, P1, DOI 10.1002/jbm.a.30732
   Li ZS, 2010, BIOMATERIALS, V31, P404, DOI 10.1016/j.biomaterials.2009.09.070
   Li ZY, 2014, COLLOID SURFACE B, V123, P959, DOI 10.1016/j.colsurfb.2014.10.050
   Liu DD, 2010, CHINESE SCI BULL, V55, P1013, DOI 10.1007/s11434-010-0046-1
   Lu HF, 2012, BIOMATERIALS, V33, P2419, DOI 10.1016/j.biomaterials.2011.11.077
   Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177
   Luo Y, 2015, ACS APPL MATER INTER, V7, P6331, DOI 10.1021/acsami.5b00862
   Lyu CQ, 2015, ACS APPL MATER INTER, V7, P20245, DOI 10.1021/acsami.5b05802
   Madl CM, 2014, BIOMACROMOLECULES, V15, P445, DOI 10.1021/bm401726u
   Marzona L, 2009, CLIN CASES MINER BON, V6, P159
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946
   Renno ACM, 2010, HUM ANAT PHYSIOL, P93
   National Osteoporosis Society, 2014, LIF OST UNT STOR
   National Osteoporosis Society, 2011, 25 ANN REP FRAG FUT
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Nuttelman CR, 2004, J BIOMED MATER RES A, V68A, P773, DOI 10.1002/jbm.a.20112
   Office of the Surgeon General (US), 2004, BON HLTH OST REP SUR
   Ohno K, 2011, CURR MED CHEM, V18, P220, DOI 10.2174/092986711794088335
   Park JB, 2011, MED ORAL PATOL ORAL, V16, pE115, DOI 10.4317/medoral.16.e115
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Patrick AR, 2010, J CLIN ENDOCR METAB, V95, P3251, DOI 10.1210/jc.2009-2778
   Pietschmann P., 2003, RADIOLOGY OSTEOPOROS
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Posadowska U, 2015, INT J PHARMACEUT, V485, P31, DOI 10.1016/j.ijpharm.2015.03.003
   Prestwich GD, 1998, J CONTROL RELEASE, V53, P93, DOI 10.1016/S0168-3659(97)00242-3
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Reichert J.C., 2009, BIOMED MAT, V4
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Ribeiro M, 2015, EUR POLYM J, V67, P66, DOI 10.1016/j.eurpolymj.2015.03.056
   Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726
   Roldo M, 2013, ANNU REP PROG CHEM C, V109, P10, DOI 10.1039/c3pc90010j
   Rosenbaum D, 2013, NUTR METAB CARDIOVAS, V23, P871, DOI 10.1016/j.numecd.2012.04.012
   Russell RGG, 1999, OSTEOPOROSIS INT, V9, P66
   Salamon A, 2014, MATERIALS, V7, P1342, DOI 10.3390/ma7021342
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Saravanan S., 2016, INT J BIOL MACROMOL
   Sarker A, 2015, INT J BIOL MACROMOL, V81, P898, DOI 10.1016/j.ijbiomac.2015.09.029
   SATO M, 1991, J CLIN INVEST, V88, P2095, DOI 10.1172/JCI115539
   Scanlon V C, 2011, ESSENTIALS ANATOMY P
   Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589
   Seebach E, 2014, ACTA BIOMATER, V10, P4730, DOI 10.1016/j.actbio.2014.07.017
   Seo BB, 2015, J CONTROL RELEASE, V209, P67, DOI 10.1016/j.jconrel.2015.04.023
   Seo SJ, 2014, COMPOS SCI TECHNOL, V96, P31, DOI 10.1016/j.compscitech.2014.03.004
   Seyednejad H, 2012, BIOMATERIALS, V33, P4309, DOI 10.1016/j.biomaterials.2012.03.002
   Seyednejad H, 2011, ACTA BIOMATER, V7, P1999, DOI 10.1016/j.actbio.2011.01.018
   Shadjou N, 2015, MAT SCI ENG C-MATER, V55, P401, DOI 10.1016/j.msec.2015.05.027
   Sheikh Z, 2015, MATERIALS, V8, P5744, DOI 10.3390/ma8095273
   Sitharaman B, 2007, J BIOMAT SCI-POLYM E, V18, P655, DOI 10.1163/156856207781034133
   Sivashanmugam A, 2015, EUR POLYM J, V72, P543, DOI 10.1016/j.eurpolymj.2015.05.014
   Smith AM, 2007, J BIOMATER APPL, V22, P241, DOI 10.1177/0885328207076522
   Song CL, 2003, BIOCHEM BIOPH RES CO, V308, P458, DOI 10.1016/S0006-291X(03)01408-6
   Steck E, 2009, STEM CELLS DEV, V18, P969, DOI 10.1089/scd.2008.0213
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Su WT, 2015, MAT SCI ENG C-MATER, V52, P46, DOI 10.1016/j.msec.2015.03.025
   Su WT, 2015, MAT SCI ENG C-MATER, V46, P427, DOI 10.1016/j.msec.2014.10.076
   Sukul M, 2015, EUR POLYM J, V73, P308, DOI 10.1016/j.eurpolymj.2015.10.022
   Tanigo T, 2010, J CONTROL RELEASE, V143, P201, DOI 10.1016/j.jconrel.2009.12.027
   Tonelli FMP, 2012, INT J NANOMED, V7, P4511, DOI 10.2147/IJN.S33612
   Tousi NS, 2013, MAT SCI ENG C-MATER, V33, P2757, DOI 10.1016/j.msec.2013.02.044
   Ullah F, 2015, MAT SCI ENG C-MATER, V57, P414, DOI 10.1016/j.msec.2015.07.053
   Ulubayram K, 2002, J BIOMAT SCI-POLYM E, V13, P1203, DOI 10.1163/156856202320892966
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Verron E, 2010, BIOMATERIALS, V31, P7776, DOI 10.1016/j.biomaterials.2010.06.047
   Vieira H.P., 2013, INT ARCH MED, V6
   Wang JS, 2010, STEM CELLS DEV, V19, P1375, DOI 10.1089/scd.2009.0258
   Watanabe J, 2007, J BIOMED MATER RES A, V83A, P845, DOI 10.1002/jbm.a.31435
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Wu Chengtie, 2009, BONE TISSUE REGENERA, V2, P25
   Yan Q, 2015, J BIOMED MATER RES A, V103, P3580, DOI 10.1002/jbm.a.35499
   Yang XW, 2011, ANGEW CHEM INT EDIT, V50, P7325, DOI 10.1002/anie.201100723
   Yasmeen S, 2014, LANGMUIR, V30, P12977, DOI 10.1021/la503057w
   Yi CQ, 2010, ACS NANO, V4, P6439, DOI 10.1021/nn101373r
   Zhang JT, 2016, ACTA BIOMATER, V31, P326, DOI 10.1016/j.actbio.2015.11.055
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
   Zuo Y, 2010, ACTA BIOMATER, V6, P1238, DOI 10.1016/j.actbio.2009.10.036
   Zur Nieden N.I., 2015, ACS APPL MATER INTER, V7, P10599
NR 152
TC 17
Z9 18
U1 4
U2 84
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD APR
PY 2016
VL 9
IS 4
AR UNSP 267
DI 10.3390/ma9040267
PG 24
WC Materials Science, Multidisciplinary
SC Materials Science
GA DK8EB
UT WOS:000375158900053
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Yang, YW
   Wu, P
   Wang, QY
   Wu, H
   Liu, Y
   Deng, YW
   Zhou, YZ
   Shuai, CJ
AF Yang, Youwen
   Wu, Ping
   Wang, Qiyuan
   Wu, Hong
   Liu, Yong
   Deng, Youwen
   Zhou, Yuanzhuo
   Shuai, Cijun
TI The Enhancement of Mg Corrosion Resistance by Alloying Mn and
   Laser-Melting
SO MATERIALS
LA English
DT Article
DE corrosion resistance; Mg-Mn alloy; laser-melting; microstructure;
   mechanical properties
ID IN-VITRO CORROSION; MAGNESIUM ALLOYS; POWDER-METALLURGY; VIVO; BONE;
   SYSTEM; BIODEGRADATION; DEGRADATION; MANGANESE
AB Mg has been considered a promising biomaterial for bone implants. However, the poor corrosion resistance has become its main undesirable property. In this study, both alloying Mn and laser-melting were applied to enhance the Mg corrosion resistance. The corrosion resistance, mechanical properties, and microstructure of rapid laser-melted Mg-xMn (x = 0-3 wt %) alloys were investigated. The alloys were composed of dendrite grains, and the grains size decreased with increasing Mn. Moreover, Mn could dissolve and induce the crystal lattice distortion of the Mg matrix during the solidification process. Mn ranging from 0-2 wt % dissolved completely due to rapid laser solidification. As Mn contents further increased up to 3 wt %, a small amount of Mn was left undissolved. The compressive strength of Mg-Mn alloys increased first (up to 2 wt %) and then decreased with increasing Mn, while the hardness increased continuously. The refinement of grains and the increase in corrosion potential both made contributions to the enhancement of Mg corrosion resistance.
C1 [Yang, Youwen; Zhou, Yuanzhuo; Shuai, Cijun] Cent S Univ, State Key Lab High Performance Complex Mfg, Changsha 410083, Hunan, Peoples R China.
   [Wu, Ping] Xiangtan Univ, Coll Chem, Xiangtan 411105, Peoples R China.
   [Wang, Qiyuan; Deng, Youwen] Cent S Univ, Xiangya Hosp 2, Dept Emergency Med, Changsha 410083, Hunan, Peoples R China.
   [Wu, Hong; Liu, Yong; Shuai, Cijun] Cent S Univ, State Key Lab Powder Met, Changsha 410083, Hunan, Peoples R China.
RP Shuai, CJ (reprint author), Cent S Univ, State Key Lab High Performance Complex Mfg, Changsha 410083, Hunan, Peoples R China.; Shuai, CJ (reprint author), Cent S Univ, State Key Lab Powder Met, Changsha 410083, Hunan, Peoples R China.
EM yangyouwen@csu.edu.cn; pingwu@xtu.edu.cn; idletwo@gmail.com;
   hwucsu@csu.edu.cn; yonliu@csu.edu.cn; dengjunjiejj@csu.edu.cn;
   zyz420357155@csu.edu.cn; shuai@csu.edu.cn
FU Natural Science Foundation of China [51575537, 81572577, 81472058];
   Overseas, Hong Kong & Macao Scholars Collaborated Researching Fund of
   National Natural Science Foundation of China [81428018]; Hunan
   Provincial Natural Science Foundation of China [14JJ1006]; Open-End Fund
   for the Valuable and Precision Instruments of Central South University;
   Fundamental Research Funds for the Central Universities of Central South
   University
FX This work was supported by the following funds: (1) The Natural Science
   Foundation of China (51575537, 81572577, 81472058); (2) Overseas, Hong
   Kong & Macao Scholars Collaborated Researching Fund of National Natural
   Science Foundation of China (81428018); (3) the Hunan Provincial Natural
   Science Foundation of China (14JJ1006); (4) The Open-End Fund for the
   Valuable and Precision Instruments of Central South University; and (5)
   The Fundamental Research Funds for the Central Universities of Central
   South University.
CR [Anonymous], 2004, E804 ASTM
   Asgharzadeh H, 2014, J ALLOY COMPD, V586, pS95, DOI 10.1016/j.jallcom.2012.10.108
   Baker H., 1992, ASM HDB, V3
   Baril G, 2001, CORROS SCI, V43, P471, DOI 10.1016/S0010-938X(00)00095-0
   Chaya A, 2015, ACTA BIOMATER, V18, P262, DOI 10.1016/j.actbio.2015.02.010
   Gu XN, 2012, ACTA BIOMATER, V8, P2360, DOI 10.1016/j.actbio.2012.02.018
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Hornberger H, 2012, ACTA BIOMATER, V8, P2442, DOI 10.1016/j.actbio.2012.04.012
   Kraus T, 2012, ACTA BIOMATER, V8, P1230, DOI 10.1016/j.actbio.2011.11.008
   LEACH RM, 1969, ARCH BIOCHEM BIOPHYS, V133, P22, DOI 10.1016/0003-9861(69)90483-4
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liu YZ, 2013, PHYSIOL MEAS, V34, P1593, DOI 10.1088/0967-3334/34/12/1593
   MAKAR GL, 1993, INT MATER REV, V38, P138, DOI 10.1179/imr.1993.38.3.138
   Mora E, 2009, SCRIPTA MATER, V60, P776, DOI 10.1016/j.scriptamat.2009.01.012
   Nayak S, 2016, J MECH BEHAV BIOMED, V59, P57, DOI 10.1016/j.jmbbm.2015.12.010
   Ng CC, 2011, APPL SURF SCI, V257, P7447, DOI 10.1016/j.apsusc.2011.03.004
   Orlov D, 2011, ACTA MATER, V59, P6176, DOI 10.1016/j.actamat.2011.06.033
   Salahshoor M, 2012, MATERIALS, V5, P135, DOI 10.3390/ma5010135
   Shuai CJ, 2010, J BIOMED NANOTECHNOL, V6, P370, DOI 10.1166/jbn.2010.1139
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Sun Y, 2012, MATER DESIGN, V34, P58, DOI 10.1016/j.matdes.2011.07.058
   Vilaro T, 2012, MAT SCI ENG A-STRUCT, V534, P446, DOI 10.1016/j.msea.2011.11.092
   Xie DQ, 2013, CHIN OPT LETT, V11, DOI 10.3788/COL201311.111401
   Yu K, 2012, ACTA BIOMATER, V8, P2845, DOI 10.1016/j.actbio.2012.04.009
   Zhang EL, 2009, MAT SCI ENG C-BIO S, V29, P987, DOI 10.1016/j.msec.2008.08.024
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
   Zhou Y., 2007, ANAL METHODS MAT SCI
NR 27
TC 8
Z9 9
U1 6
U2 33
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD APR
PY 2016
VL 9
IS 4
AR 216
DI 10.3390/ma9040216
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA DK8EB
UT WOS:000375158900002
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Morena, F
   Argentati, C
   Calzoni, E
   Cordellini, M
   Emiliani, C
   D'Angelo, F
   Martino, S
AF Morena, Francesco
   Argentati, Chiara
   Calzoni, Eleonora
   Cordellini, Marino
   Emiliani, Carla
   D'Angelo, Francesco
   Martino, Sabata
TI Ex-Vivo Tissues Engineering Modeling for Reconstructive Surgery Using
   Human Adult Adipose Stem Cells and Polymeric Nanostructured Matrix
SO NANOMATERIALS
LA English
DT Article
DE adult mesenchymal stem cells isolation and culture; stem cells and
   biomaterial interaction; INTEGRA (R); regenerative medicine
ID REGENERATIVE MEDICINE; DIFFERENTIATION; FATE
AB The major challenge for stem cell translation regenerative medicine is the regeneration of damaged tissues by creating biological substitutes capable of recapitulating the missing function in the recipient host. Therefore, the current paradigm of tissue engineering strategies is the combination of a selected stem cell type, based on their capability to differentiate toward committed cell lineages, and a biomaterial, that, due to own characteristics (e.g., chemical, electric, mechanical property, nano-topography, and nanostructured molecular components), could serve as active scaffold to generate a bio-hybrid tissue/organ. Thus, effort has been made on the generation of in vitro tissue engineering modeling. Here, we present an in vitro model where human adipose stem cells isolated from lipoaspirate adipose tissue and breast adipose tissue, cultured on polymeric INTEGRA (R) Meshed Bilayer Wound Matrix (selected based on conventional clinical applications) are evaluated for their potential application for reconstructive surgery toward bone and adipose tissue. We demonstrated that human adipose stem cells isolated from lipoaspirate and breast tissue have similar stemness properties and are suitable for tissue engineering applications. Finally, the overall results highlighted lipoaspirate adipose tissue as a good source for the generation of adult adipose stem cells.
C1 [Morena, Francesco; Argentati, Chiara; Calzoni, Eleonora; Emiliani, Carla; D'Angelo, Francesco; Martino, Sabata] Univ Perugia, Dept Chem Biol & Biotechnol, Biochem & Mol Biol Unit, Via Giochetto, I-06122 Perugia, Italy.
   [Cordellini, Marino] ASL 1 Umbria, Unita Operat Chirurg Plast & Ricostrutt, I-06012 Citta Di Castello, Italy.
   [D'Angelo, Francesco] Angelantoni Life Sci, Localita Cimacolle 464, I-06056 Perugia, Italy.
RP Martino, S (reprint author), Univ Perugia, Dept Chem Biol & Biotechnol, Biochem & Mol Biol Unit, Via Giochetto, I-06122 Perugia, Italy.
EM effemorena@gmail.com; chiara.argentati89@gmail.com;
   eleonoracalzoni@gmail.com; marinocordellini@yahoo.it;
   carla.emiliani@unipg.it; francesco.dangelo@angelantoni.it;
   sabata.martino@unipg.it
RI Emiliani, Carla/G-3738-2010; bagheri, amir/C-3274-2017; Martino,
   Sabata/F-2309-2014
OI Emiliani, Carla/0000-0002-6368-1515; Martino, Sabata/0000-0002-3942-237X
CR Barba M, 2013, BIOMED RES INT, DOI 10.1155/2013/416391
   Chen LN, 2014, J CARDIOVASC TRANSL, V7, P651, DOI 10.1007/s12265-014-9585-1
   Chen WQ, 2014, NANO TODAY, V9, P759, DOI 10.1016/j.nantod.2014.12.002
   Childs P.G., 2015, ACTA BIOMATER
   D'Angelo F, 2010, EUR CELLS MATER, V20, P231
   D'Angelo F, 2012, BIOMACROMOLECULES, V13, P1350, DOI 10.1021/bm3000716
   D'Angelo Francesco, 2011, J Funct Biomater, V2, P67, DOI 10.3390/jfb2020067
   De Francesco F, 2015, TISSUE ENG PART B-RE, V21, P572, DOI [10.1089/ten.TEB.2014.0608, 10.1089/ten.teb.2014.0608]
   DeFatta Robert J, 2008, Facial Plast Surg Clin North Am, V16, P383, DOI 10.1016/j.fsc.2008.05.006
   Eun SC, 2014, J KOREAN MED SCI, V29, pS167, DOI 10.3346/jkms.2014.29.S3.S167
   Farouz Y, 2015, STEM CELLS, V33, P1021, DOI 10.1002/stem.1929
   Hao J, 2015, ACTA BIOMATER, V20, P1, DOI 10.1016/j.actbio.2015.04.008
   Katzengold R, 2016, J TISSUE VIABILITY, V25, P32, DOI 10.1016/j.jtv.2015.12.003
   Lin CS, 2010, HISTOL HISTOPATHOL, V25, P807, DOI 10.14670/HH-25.807
   Lizundia E, 2012, MACROMOL BIOSCI, V12, P870, DOI 10.1002/mabi.201200008
   Mandrycky C, 2015, BIOTECHNOL ADV
   Martino S, 2014, CURR PROTEOMICS, V11, P193, DOI 10.2174/157016461103140922164050
   Martino S, 2009, TISSUE ENG PT A, V15, P3139, DOI [10.1089/ten.tea.2008.0552, 10.1089/ten.TEA.2008.0552]
   Martino S, 2012, BIOTECHNOL ADV, V30, P338, DOI 10.1016/j.biotechadv.2011.06.015
   Martino S, 2011, INT J BIOCHEM CELL B, V43, P775, DOI 10.1016/j.biocel.2011.02.001
   Mattar P, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00560
   McMurray RJ, 2015, J TISSUE ENG REGEN M, V9, P528, DOI 10.1002/term.1957
   Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076
   Montespan F, 2014, J IMMUNOL RES, DOI 10.1155/2014/230346
   Morena F, 2014, ANAL CHEM, V86, P473, DOI 10.1021/ac4023555
   Murphy WL, 2014, NAT MATER, V13, P547, DOI [10.1038/NMAT3937, 10.1038/nmat3937]
   Narins RS, 2006, PLAST RECONSTR SURG, V118, p77S, DOI 10.1097/01.prs.0000234919.25096.67
   Pecanha R, 2012, J BONE JOINT SURG AM, V94A, P609, DOI 10.2106/JBJS.K.00351
   Perbellini F, 2015, STEM CELL TRANSL MED, V4, P1403, DOI 10.5966/sctm.2015-0024
   Philips BJ, 2014, WOUND REPAIR REGEN, V22, P11, DOI 10.1111/wrr.12164
   Santos LJ, 2015, TRENDS BIOTECHNOL, V33, P471, DOI 10.1016/j.tibtech.2015.06.006
   Tiribuzi R, 2012, CELL BIOCHEM FUNCT, V30, P61, DOI 10.1002/cbf.1819
   Tsimbouri Penelope M, 2015, J Funct Biomater, V6, P598, DOI 10.3390/jfb6030598
   Veronesi F, 2014, J BIOMED MATER RES A, V102, P2448, DOI 10.1002/jbm.a.34896
   Vunjak-Novakovic G., 2015, TISSUE ENG
   Xu Y, 2013, NAT MATER, V12, P1082, DOI 10.1038/nmat3821
   Yin XL, 2016, CELL STEM CELL, V18, P25, DOI 10.1016/j.stem.2015.12.005
   Yiou R., 2015, STEM CELLS, V34
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 39
TC 3
Z9 3
U1 1
U2 11
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2079-4991
J9 NANOMATERIALS-BASEL
JI Nanomaterials
PD APR
PY 2016
VL 6
IS 4
AR 57
DI 10.3390/nano6040057
PG 13
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DK8WH
UT WOS:000375208800003
PM 28335186
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Oshiro, JA
   Abucafy, MP
   Manaia, EB
   da Silva, BL
   Chiari-Andreo, BG
   Chiavacci, LA
AF Oshiro Junior, Joao Augusto
   Abucafy, Marina Paiva
   Manaia, Eloisa Berbel
   da Silva, Bruna Lallo
   Chiari-Andreo, Bruna Galdorfini
   Chiavacci, Leila Aparecida
TI Drug Delivery Systems Obtained from Silica Based Organic-Inorganic
   Hybrids
SO POLYMERS
LA English
DT Review
DE organic-inorganic materials; drug delivery systems; sol-gel process
ID SOL-GEL METHOD; MESOPOROUS SILICA; SYNTHETIC STRATEGIES;
   BLOCK-COPOLYMERS; NITRIC-OXIDE; IN-VITRO; RELEASE; MATRIX;
   NANOPARTICLES; BEHAVIOR
AB This is a review of hybrid materials based on silica as an inorganic phase used as drug delivery systems (DDS). Silica based DDS have shown effectivity when compared with traditional delivery systems. They present advantages such as: (a) ability to maintain the therapeutic range with minor variations; (b) prevention of local and systemic toxic effects; (c) plasma concentrations increase of substances with a short half-life; and (d) reduction of the number of daily doses, which may increase patient adherence to the treatment. These advantages occur due to the physical, chemical and optical properties of these materials. Therefore, we discuss the properties and characteristics of them and we present some applications, using different approaches of DDS to ensure therapeutic effectiveness and side effects reduction such as implantable biomaterial, film-forming materials, stimuli-responsive systems and others.
C1 [Oshiro Junior, Joao Augusto; Abucafy, Marina Paiva; Manaia, Eloisa Berbel; da Silva, Bruna Lallo; Chiari-Andreo, Bruna Galdorfini; Chiavacci, Leila Aparecida] Univ Estadual Paulista, UNESP, Fac Ciencias Farmaceut, Araraquara Jau Km 1, BR-14800903 Araraquara, Brazil.
   [Chiari-Andreo, Bruna Galdorfini] Ctr Univ Araraquara UNIARA, Dept Ciencias Biol & Saude, BR-14800903 Araraquara, Brazil.
RP Chiavacci, LA (reprint author), Univ Estadual Paulista, UNESP, Fac Ciencias Farmaceut, Araraquara Jau Km 1, BR-14800903 Araraquara, Brazil.
EM joaooshiro@yahoo.com.br; marina.abucafy@gmail.com;
   elobm_elo@yahoo.com.br; brunalallo@hotmail.com;
   brunagchiari@yahoo.com.br; leila@fcfar.unesp.br
RI Chiari-Andreo, Bruna/J-2648-2013; Manaia, Eloisa/I-7222-2017
OI Chiari-Andreo, Bruna/0000-0001-7959-0207; Manaia,
   Eloisa/0000-0001-6352-1602; Oshiro Junior, Joao
   Augusto/0000-0001-7247-1598
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Programa
   de Apoio ao Desenvolvimento Cientifico da Faculdade de Ciencias
   Farmaceuticas do Campus de Araraquara da UNESP (PADC/FCF-UNESP)
FX Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and
   Programa de Apoio ao Desenvolvimento Cientifico da Faculdade de Ciencias
   Farmaceuticas do Campus de Araraquara da UNESP (PADC/FCF-UNESP) for the
   financial support.
CR Allen C, 1999, COLLOID SURFACE B, V16, P3, DOI 10.1016/S0927-7765(99)00058-2
   Ariga K, 2007, COORDIN CHEM REV, V251, P2562, DOI 10.1016/j.ccr.2007.02.024
   Ariga K, 2016, ADV MATER, V28, P1251, DOI 10.1002/adma.201502545
   Ariga K, 2014, NEW J CHEM, V38, P5149, DOI 10.1039/c4nj00864b
   Belting M, 2005, ADV DRUG DELIVER REV, V57, P505, DOI 10.1016/j.addr.2004.10.004
   Benvenutti EV, 2009, QUIM NOVA, V32, P1926, DOI 10.1590/S0100-40422009000700039
   BRENNAN AB, 1991, POLYMER, V32, P733, DOI 10.1016/0032-3861(91)90488-5
   Bronich TK, 1999, COLLOID SURFACE B, V16, P243, DOI 10.1016/S0927-7765(99)00075-2
   Burkett CM, 2008, CHEM MATER, V20, P1312, DOI 10.1021/cm0716001
   Chavanpatil MD, 2006, INT J PHARM, V316, P86, DOI 10.1016/j.ijpharm.2006.02.038
   Colilla M, 2006, CHEM MATER, V18, P5676, DOI 10.1021/cm0612043
   Colilla M, 2010, MICROPOR MESOPOR MAT, V135, P51, DOI 10.1016/j.micromeso.2010.06.010
   Corma A, 2009, ANGEW CHEM INT EDIT, V48, P6247, DOI 10.1002/anie.200902208
   de Menezes EW, 2012, J COLLOID INTERF SCI, V378, P10, DOI 10.1016/j.jcis.2012.04.021
   Esteves ACC, 2004, QUIM NOVA, V27, P798, DOI 10.1590/S0100-40422004000500020
   Franken L, 2002, QUIM NOVA, V25, P563, DOI 10.1590/S0100-40422002000400010
   Franville AC, 2000, CHEM MATER, V12, P428, DOI 10.1021/cm9904739
   Gao CB, 2009, MICROPOR MESOPOR MAT, V122, P201, DOI 10.1016/j.micromeso.2009.03.002
   Gao SF, 2012, PLAST RUBBER COMPOS, V41, P13, DOI 10.1179/1743289811Y.0000000021
   Garcia O, 2008, ADV FUNCT MATER, V18, P2017, DOI 10.1002/adfm.200701395
   GIRARDREYDET E, 1994, MACROMOL CHEM PHYSIC, V195, P149, DOI 10.1002/macp.1994.021950112
   Gonzalez B, 2008, CHEM MATER, V20, P4826, DOI 10.1021/cm703568k
   Herculano R.D., 2013, MAT SCI APPL, V4, P683
   Herculano RD, 2011, MATER RES-IBERO-AM J, V14, P355, DOI 10.1590/S1516-14392011005000055
   Jose NM, 2005, QUIM NOVA, V28, P281, DOI 10.1590/S0100-40422005000200020
   Junior J.A.O., 2014, MATERIA, V19, P24
   Kabanov A. V., 2002, CRITICAL REV THERAPE, V19, P72
   Kabanov AV, 2002, J CONTROL RELEASE, V82, P189, DOI 10.1016/S0168-3659(02)00009-3
   Kwon GS, 2012, ADV DRUG DELIVER REV, V64, P237, DOI 10.1016/j.addr.2012.09.016
   Lin CX, 2009, MICROPOR MESOPOR MAT, V117, P213, DOI 10.1016/j.micromeso.2008.06.023
   Lin M, 2007, J PHARM SCI-US, V96, P1518, DOI 10.1002/jps.20809
   Lin ZQ, 2014, J CONTROL RELEASE, V174, P161, DOI 10.1016/j.jconrel.2013.10.026
   Loira-Pastoriza C, 2014, ADV DRUG DELIVER REV, V75, P81, DOI 10.1016/j.addr.2014.05.017
   Lopes L, 2012, RSC ADV, V2, P5629, DOI 10.1039/c2ra01216b
   Magdalena S., 2009, CURR NANOSCI, V5, P1
   Matejka L, 2004, POLYMER, V45, P3267, DOI 10.1016/j.polymer.2004.03.033
   Molina EF, 2014, J SOL-GEL SCI TECHN, V70, P317, DOI 10.1007/s10971-014-3300-1
   Molina EF, 2014, LANGMUIR, V30, P3857, DOI 10.1021/la404812e
   Molina EF, 2010, J PHYS CHEM B, V114, P3461, DOI 10.1021/jp9097638
   Munoz B, 2003, CHEM MATER, V15, P500, DOI 10.1021/cm021217q
   Nassar EJ, 2007, QUIM NOVA, V30, P1567, DOI 10.1590/S0100-40422007000700013
   NAVA E, 1995, J HYPERTENS, V13, pS39, DOI 10.1097/00004872-199508001-00007
   Nori A, 2005, ADV DRUG DELIVER REV, V57, P609, DOI 10.1016/j.addr.2004.10.006
   Ogoshi T, 2005, COMPOS INTERFACE, V11, P539, DOI 10.1163/1568554053148735
   Oh KT, 2004, J CONTROL RELEASE, V94, P411, DOI 10.1016/j.jcornel.2003.10.018
   Orilall MC, 2011, CHEM SOC REV, V40, P520, DOI 10.1039/c0cs00034e
   Oshiro-Junior J.A., 2015, INT J POLYM SCI
   Palm C, 2007, BBA-BIOMEMBRANES, V1768, P1769, DOI 10.1016/j.bbamem.2007.03.029
   Paredes M, 2014, J SOL-GEL SCI TECHN, V72, P233, DOI 10.1007/s10971-014-3314-8
   Patel NR, 2010, NANOMEDICINE-UK, V5, P1037, DOI 10.2217/NNM.10.68
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   PHILIPP G, 1984, J NON-CRYST SOLIDS, V63, P283, DOI 10.1016/0022-3093(84)90407-1
   Popat A, 2012, J MATER CHEM, V22, P11173, DOI 10.1039/c2jm30501a
   Radin S, 2002, BIOMATERIALS, V23, P3113, DOI 10.1016/S0142-9612(02)00051-0
   Rekondo A, 2007, POLYM DEGRAD STABIL, V92, P2173, DOI 10.1016/j.polymdegradstab.2007.01.034
   Russell RGG, 1999, BONE, V25, P97, DOI 10.1016/S8756-3282(99)00116-7
   Sanchez C, 2005, J MATER CHEM, V15, P3559, DOI 10.1039/b509097k
   Sanchez C., 2000, MOL CRYST LIQ CRYST, V354, P143
   Santilli CV, 2009, CHEM MATER, V21, P463, DOI 10.1021/cm801899u
   Scherer G.W., 1990, SOL GEL PHYS CHEMYST
   Schmolka I. R., 1991, POLYM CONTROLLED DRU, P189
   Schottner G, 2001, CHEM MATER, V13, P3422, DOI 10.1021/cm011060m
   Schroeder IZ, 2007, EUR J PHARM BIOPHARM, V65, P111, DOI 10.1016/j.ejpb.2006.07.015
   Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4
   Souza LK, 2013, COLLOID SURFACE B, V101, P156, DOI 10.1016/j.colsurfb.2012.06.009
   Torchilin VP, 2001, J CONTROL RELEASE, V73, P137, DOI 10.1016/S0168-3659(01)00299-1
   Vallet-Regi M, 2001, CHEM MATER, V13, P308, DOI 10.1021/cm0011559
   Vallet-Regi M, 2011, CHEM SOC REV, V40, P596, DOI 10.1039/c0cs00025f
   VASTA V, 1995, BIOCHEM BIOPH RES CO, V206, P878, DOI 10.1006/bbrc.1995.1125
   Vendruscolo CW, 2005, INT J PHARMACEUT, V296, P1, DOI 10.1016/j.ijpharm.2005.02.007
   Wan XJ, 2010, LANGMUIR, V26, P15574, DOI 10.1021/la102148x
   Wu J, 2007, BIOMATERIALS, V28, P2220, DOI 10.1016/j.biomaterials.2006.12.024
   Wu N, 2005, J CONTROL RELEASE, V102, P569, DOI 10.1016/j.jconrel.2004.11.002
   Xue JM, 2004, J CONTROL RELEASE, V98, P209, DOI 10.1016/j.jconrel.2004.04.023
   Zhang F, 2013, ENERG ENVIRON SCI, V6, P1623, DOI 10.1039/c3ee40509e
   Zhao YJ, 2009, EUR J PHARM BIOPHARM, V72, P521, DOI 10.1016/j.ejpb.2009.03.002
NR 76
TC 8
Z9 8
U1 4
U2 44
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 2073-4360
J9 POLYMERS-BASEL
JI Polymers
PD APR
PY 2016
VL 8
IS 4
AR 91
DI 10.3390/polym8040091
PG 14
WC Polymer Science
SC Polymer Science
GA DK8EL
UT WOS:000375159900004
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Kucharikova, S
   Gerits, E
   De Brucker, K
   Braem, A
   Ceh, K
   Majdic, G
   Spanic, T
   Pogorevc, E
   Verstraeten, N
   Tournu, H
   Delattin, N
   Impellizzeri, F
   Erdtmann, M
   Krona, A
   Lovenklev, M
   Knezevic, M
   Frohlich, M
   Vleugels, J
   Fauvart, M
   de Silva, WJ
   Vandamme, K
   Garcia-Forgas, J
   Cammue, BPA
   Michiels, J
   Van Dijck, P
   Thevissen, K
AF Kucharikova, Sona
   Gerits, Evelien
   De Brucker, Katrijn
   Braem, Annabel
   Ceh, Katerina
   Majdic, Gregor
   Spanic, Tanja
   Pogorevc, Estera
   Verstraeten, Natalie
   Tournu, Helene
   Delattin, Nicolas
   Impellizzeri, Frederic
   Erdtmann, Martin
   Krona, Annika
   Lovenklev, Maria
   Knezevic, Miomir
   Frohlich, Mirjam
   Vleugels, Jef
   Fauvart, Maarten
   de Silva, Wander Jose
   Vandamme, Katleen
   Garcia-Forgas, Jordi
   Cammue, Bruno P. A.
   Michiels, Jan
   Van Dijck, Patrick
   Thevissen, Karin
TI Covalent immobilization of antimicrobial agents on titanium prevents
   Staphylococcus aureus and Candida albicans colonization and biofilm
   formation
SO JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
LA English
DT Article
ID ORTHOPEDIC IMPLANTS; ESCHERICHIA-COLI; IN-VITRO; INFECTIONS;
   CASPOFUNGIN; EPIDERMIDIS; STRATEGIES; MANAGEMENT; DIAGNOSIS; SURFACES
AB Biofilm-associated implant infections represent a serious public health problem. Covalent immobilization of antimicrobial agents on titanium (Ti), thereby inhibiting biofilm formation of microbial pathogens, is a solution to this problem.
   Vancomycin (VAN) and caspofungin (CAS) were covalently bound on Ti substrates using an improved processing technique adapted to large-scale coating of implants. Resistance of the VAN-coated Ti (VAN-Ti) and CAS-coated Ti (CAS-Ti) substrates against in vitro biofilm formation of the bacterium Staphylococcus aureus and the fungal pathogen Candida albicans was determined by plate counting and visualized by confocal laser scanning microscopy. The efficacy of the coated Ti substrates was also tested in vivo using an adapted biomaterial-associated murine infection model in which control-Ti, VAN-Ti or CAS-Ti substrates were implanted subcutaneously and subsequently challenged with the respective pathogens. The osseointegration potential of VAN-Ti and CAS-Ti was examined in vitro using human bone marrow-derived stromal cells, and for VAN-Ti also in a rat osseointegration model.
   In vitro biofilm formation of S. aureus and C. albicans on VAN-Ti and CAS-Ti substrates, respectively, was significantly reduced compared with biofilm formation on control-Ti. In vivo, we observed over 99.9% reduction in biofilm formation of S. aureus on VAN-Ti substrates and 89% reduction in biofilm formation of C. albicans on CAS-Ti substrates, compared with control-Ti substrates. The coated substrates supported osseointegration in vitro and in vivo.
   These data demonstrate the clinical potential of covalently bound VAN and CAS on Ti to reduce microbial biofilm formation without jeopardizing osseointegration.
C1 [Kucharikova, Sona; Tournu, Helene; Van Dijck, Patrick] VIB, Dept Mol Microbiol, Kasteelpk Arenberg 31,Box 2438, B-3001 Leuven, Belgium.
   [Kucharikova, Sona; Tournu, Helene; Van Dijck, Patrick] Katholieke Univ Leuven, Lab Mol Cell Biol, Kasteelpk Arenberg 31,Box 2438, B-3001 Leuven, Belgium.
   [Gerits, Evelien; De Brucker, Katrijn; Verstraeten, Natalie; Delattin, Nicolas; Fauvart, Maarten; Cammue, Bruno P. A.; Michiels, Jan; Thevissen, Karin] Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Kasteelpk Arenberg 20,Box 2460, B-3001 Leuven, Belgium.
   [Braem, Annabel; Vleugels, Jef] Katholieke Univ Leuven, Dept Mat Engn MTM, Kasteelpk Arenberg 44,Box 2450, B-3001 Leuven, Belgium.
   [Ceh, Katerina; Majdic, Gregor; Spanic, Tanja; Pogorevc, Estera] Univ Ljubljana, Fac Vet, Ctr Anim Genom, Gerbiceva 60, Ljubljana 1000, Slovenia.
   [Impellizzeri, Frederic] Biotech Int, Allees Craponne 305, F-13300 Salon De Provence, France.
   [Erdtmann, Martin] Hemoteq AG, Adenauerstr 15, D-52146 Wurselen, Germany.
   [Krona, Annika; Lovenklev, Maria] SP Food & Biosci, Dept Struct & Mat Design, Box 5401, S-40229 Gothenburg, Sweden.
   [Knezevic, Miomir; Frohlich, Mirjam] Educell Doo, Prevale 9, Trzin 1236, Slovenia.
   [Frohlich, Mirjam] Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, Jamova 39, Ljubljana 1000, Slovenia.
   [de Silva, Wander Jose; Vandamme, Katleen] Katholieke Univ Leuven, Dept Oral Hlth Sci Biomat BIOMAT, Kapucijnenvoer 33,Box 7001, B-3000 Leuven, Belgium.
   [de Silva, Wander Jose] FOP UNICAMP, Dept Prosthodont & Periodontol, Av Limeira 901, BR-13414903 Piracicaba, SP, Brazil.
   [Garcia-Forgas, Jordi] Alhenia AG, Tafernstr 39, CH-5405 Dattwil, Switzerland.
   [Cammue, Bruno P. A.] VIB, Dept Plant Syst Biol, Technol Pk 927, B-9052 Ghent, Belgium.
RP Thevissen, K (reprint author), Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Kasteelpk Arenberg 20,Box 2460, B-3001 Leuven, Belgium.
EM karin.thevissen@biw.kuleuven.be
RI Fauvart, Maarten/B-1612-2010; Braem, Annabel/A-4343-2017; Michiels,
   Jan/F-1601-2010; Thevissen, Karin/B-7003-2015; Vleugels,
   Jozef/C-8262-2017
OI Fauvart, Maarten/0000-0002-6256-9193; Braem,
   Annabel/0000-0002-4890-0177; Michiels, Jan/0000-0001-5829-0897;
   Thevissen, Karin/0000-0003-0275-9072; Vleugels,
   Jozef/0000-0003-4432-4675; Silva, Wander Jose da/0000-0002-5613-5081;
   Verstraeten, Natalie/0000-0002-9548-4647
FU European Commission [278425]; FWO [G0B2515N, G047112N, WO.026.11N];
   Interuniversity Attraction Poles Programme; Belgian Science Policy
   Office; 'Industrial Research Fund' of KU Leuven [IOFm/05/022];
   'Bijzonder Onderzoeks Fonds' of KU Leuven [PDMK 11/089, PDMK 14/149];
   FWO
FX This work was supported by the European Commission's Seventh Framework
   Programme (FP7/2007-2013) under the grant agreement COATIM (project no
   278425), by grants from the FWO (G0B2515N, G047112N, WO.026.11N), and
   the Interuniversity Attraction Poles Programme initiated by the Belgian
   Science Policy Office. K. T. acknowledges the receipt of a mandate of
   the 'Industrial Research Fund' of KU Leuven (IOFm/05/022). S. K. and N.
   D. acknowledge the receipt of postdoctoral grants of the 'Bijzonder
   Onderzoeks Fonds' of KU Leuven (grant PDMK 11/089 and 14/149,
   respectively) S. K. acknowledges the receipt of an FWO postdoctoral
   research grant.
CR Adam B, 2002, J MED MICROBIOL, V51, P344, DOI 10.1099/0022-1317-51-4-344
   Antoci V, 2007, CLIN ORTHOP RELAT R, P81, DOI 10.1097/BLO.0b013e3181123a50
   Antoci V, 2007, J ORTHOP RES, V25, P858, DOI 10.1002/jor.20348
   Antoci V, 2008, BIOMATERIALS, V29, P4684, DOI 10.1016/j.biomaterials.2008.08.016
   Aslam S, 2008, CURR INFECT DIS REP, V11, P7, DOI DOI 10.1007/S11908-009-0002-X
   Bachmann SP, 2002, ANTIMICROB AGENTS CH, V46, P3591, DOI 10.1128/AAC.46.11.3591-3596.2002
   Botequim D, 2012, LANGMUIR, V28, P7646, DOI 10.1021/la300948n
   Burgers R, 2010, ACTA BIOMATER, V6, P2307, DOI 10.1016/j.actbio.2009.11.003
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6
   CARPINO LA, 1987, ACCOUNTS CHEM RES, V20, P401, DOI 10.1021/ar00143a003
   Cataldo MA, 2010, J INFECTION, V61, P443, DOI 10.1016/j.jinf.2010.09.033
   Chen M, 2013, INT J MOL SCI, V14, P18488, DOI 10.3390/ijms140918488
   Chen X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111579
   Chu Vivian H, 2005, Am J Med, V118, P1416
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Davidson H, 2015, J BIOMED MATER RES B, V103, P1381, DOI 10.1002/jbm.b.33310
   De Brucker K, 2015, ANTIMICROB AGENTS CH, V59, P3052, DOI 10.1128/AAC.04650-14
   Della Valle C, 2011, J BONE JOINT SURG AM, V93A, P1355, DOI 10.2106/JBJS.9314ebo
   Dettenkofer M, 2004, AM J INFECT CONTROL, V32, P84, DOI 10.1016/j.ajic.2003.07.006
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Dutronc H, 2010, SCAND J INFECT DIS, V42, P890, DOI 10.3109/00365548.2010.498023
   Falcone M, 2009, MEDICINE, V88, P160, DOI 10.1097/MD.0b013e3181a693f8
   Fernandes A, 2013, J CLIN DIAGN RES, V7, P219, DOI 10.7860/JCDR/2013/4533.2732
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010
   Garcia-Oltra E, 2011, REV ESP QUIM, V24, P37
   GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721
   Hariott NN, 2009, CANDIDA ALBICANS STA, V53, P3914
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Hoiby N, 2015, CLIN MICROBIOL INFEC, V21, pS1, DOI 10.1016/j.cmi.2014.10.024
   Jamsen E, 2010, ACTA ORTHOP, V81, P660, DOI 10.3109/17453674.2010.537805
   Johannsson B, 2009, DIAGN MICR INFEC DIS, V64, P76, DOI 10.1016/j.diagmicrobio.2009.01.005
   Jose B, 2005, CHEM BIOL, V12, P1041, DOI 10.1016/j.chembiol.2005.06.013
   Juodzbalys G, 2003, STOMATOLOGIJA BALTIC, V5, P101
   Moraes MN, 2013, REV MED MINAS GERAIS, V23, P99
   Moyad TF, 2008, ORTHOPEDICS, V31, P581, DOI 10.3928/01477447-20080601-22
   O'Neill AJ, 2010, LETT APPL MICROBIOL, V51, P358, DOI 10.1111/j.1472-765X.2010.02885.x
   Ricicova M, 2010, MICROBIOL-SGM, V156, P909, DOI 10.1099/mic.0.033530-0
   Riool M, 2014, ACTA BIOMATER, V10, P5202, DOI 10.1016/j.actbio.2014.08.012
   Sarkar S, 2014, ANTIMICROB AGENTS CH, V58, P1183, DOI 10.1128/AAC.01745-13
   Silverman BM, 2005, LANGMUIR, V21, P225, DOI 10.1021/la0482271
   Stewart S, 2012, J BONE JOINT SURG AM, V94A, P1406, DOI 10.2106/JBJS.K.00886
   Taddei EB, 2004, MAT SCI ENG C-BIO S, V24, P683, DOI 10.1016/j.msec.2004.08.011
   Toms AD, 2006, J BONE JOINT SURG BR, V88B, P149, DOI 10.1302/0301-620X.88B2.17058
   Trampuz A, 2006, CURR OPIN INFECT DIS, V19, P349, DOI 10.1097/01.qco.0000235161.85925.e8
   Uppuluri P, 2011, ANTIMICROB AGENTS CH, V55, P3591, DOI 10.1128/AAC.01701-10
NR 46
TC 18
Z9 18
U1 3
U2 17
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-7453
EI 1460-2091
J9 J ANTIMICROB CHEMOTH
JI J. Antimicrob. Chemother.
PD APR
PY 2016
VL 71
IS 4
BP 936
EP 945
DI 10.1093/jac/dkv437
PG 10
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA DJ5FP
UT WOS:000374232500014
PM 26702917
OA Bronze
DA 2018-10-19
ER

PT J
AU McCreedy, DA
   Margul, DJ
   Seidlits, SK
   Antane, JT
   Thomas, RJ
   Sissman, GM
   Boehler, RM
   Smith, DR
   Goldsmith, SW
   Kukushliev, TV
   Lamano, JB
   Vedia, BH
   He, T
   Shea, LD
AF McCreedy, Dylan A.
   Margul, Daniel J.
   Seidlits, Stephanie K.
   Antane, Jennifer T.
   Thomas, Ryan J.
   Sissman, Gillian M.
   Boehler, Ryan M.
   Smith, Dominique R.
   Goldsmith, Sam W.
   Kukushliev, Todor V.
   Lamano, Jonathan B.
   Vedia, Bansi H.
   He, Ting
   Shea, Lonnie D.
TI Semi-automated counting of axon regeneration in poly(lactide
   co-glycolide) spinal cord bridges
SO JOURNAL OF NEUROSCIENCE METHODS
LA English
DT Article
DE Spinal cord injury; Hessian filter; Myelination; Automated
   quantification
ID MULTIPLE-CHANNEL BRIDGES; NEURAL STEM-CELLS; RAT SCIATIC-NERVE;
   IMAGE-ANALYSIS; ADULT-RAT; INJURY; SCAFFOLDS; GROWTH; RECOVERY;
   MYELINATION
AB Background: Spinal cord injury (SCI) is a debilitating event with multiple mechanisms of degeneration leading to life-long paralysis. Biomaterial strategies, including bridges that span the injury and provide a pathway to reconnect severed regions of the spinal cord, can promote partial restoration of motor function following SO. Axon growth through the bridge is essential to characterizing regeneration, as recovery can occur via other mechanisms such as plasticity. Quantitative analysis of axons by manual counting of histological sections can be slow, which can limit the number of bridge designs evaluated. In this study, we report a semi-automated process to resolve axon numbers in histological sections, which allows for efficient analysis of large data sets.
   New method: Axon numbers were estimated in SCI cross-sections from animals implanted with poly(lactide co-glycolide) (PLG) bridges with multiple channels for guiding axons. Immunofluorescence images of histological sections were filtered using a Hessian-based approach prior to threshold detection to improve the signal-to-noise ratio and filter out background staining associated with PLG polymer.
   Results: Semi-automated counting successfully recapitulated average axon densities and myelination in a blinded PLG bridge implantation study.
   Comparison with existing methods: Axon counts obtained with the semi-automated technique correlated well with manual axon counts from blinded independent observers across sections with a wide range of total axons.
   Conclusions: This semi-automated detection of Hessian-filtered axons provides an accurate and significantly faster alternative to manual counting of axons for quantitative analysis of regeneration following SCI. (C) 2016 Elsevier B.V. All rights reserved.
C1 [McCreedy, Dylan A.; Margul, Daniel J.; Thomas, Ryan J.; Sissman, Gillian M.; Shea, Lonnie D.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Seidlits, Stephanie K.; Antane, Jennifer T.; Boehler, Ryan M.; Smith, Dominique R.; Goldsmith, Sam W.; Kukushliev, Todor V.; Lamano, Jonathan B.; Vedia, Bansi H.; He, Ting] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA.
   [Seidlits, Stephanie K.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA.
RP Shea, LD (reprint author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
EM ldshea@umich.edu
OI Margul, Daniel/0000-0002-0907-1839
FU National Institutes of Health [R01 EB005678]
FX The authors would like to acknowledge Dr. Bea Penalver for her expertise
   in data analysis and Dirk-Jan Kroon for online examples of Hessian-based
   filtering methods. The published work was funded by the National
   Institutes of Health (R01 EB005678).
CR AUER RN, 1994, J NEUROSCI METH, V51, P229, DOI 10.1016/0165-0270(94)90015-9
   Cheng H, 1996, SCIENCE, V273, P510, DOI 10.1126/science.273.5274.510
   DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034
   DeVivo MJ, 2012, SPINAL CORD, V50, P365, DOI 10.1038/sc.2011.178
   Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130
   Geller HM, 2002, EXP NEUROL, V174, P125, DOI 10.1006/exnr.2002.7865
   Gensel JC, 2010, J NEUROSCI METH, V190, P71, DOI 10.1016/j.jneumeth.2010.04.026
   Grider MH, 2006, J NEUROSCI METH, V155, P172, DOI 10.1016/j.jneumeth.2005.12.021
   Han QQ, 2009, TISSUE ENG PT A, V15, P2927, DOI [10.1089/ten.tea.2008.0506, 10.1089/ten.TEA.2008.0506]
   Hurtado A, 2006, BIOMATERIALS, V27, P430, DOI 10.1016/j.biomaterials.2005.07.014
   Isaacs J, 2014, J NEUROSCI METH, V233, P45, DOI 10.1016/j.jneumeth.2014.05.032
   Kaplan S, 2010, J NEUROSCI METH, V187, P90, DOI 10.1016/j.jneumeth.2010.01.001
   Kim CY, 2015, VET OPHTHALMOL, V19, P29
   King VR, 2003, EXP NEUROL, V182, P383, DOI 10.1016/S0014-4886(03)00033-5
   Koppes AN, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046002
   Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020
   McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1
   McGavern DB, 1999, J NEUROSCI RES, V58, P492, DOI 10.1002/(SICI)1097-4547(19991115)58:4<492::AID-JNR3>3.0.CO;2-P
   Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022
   Meijering E, 2010, CYTOM PART A, V77A, P693, DOI 10.1002/cyto.a.20895
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   National Spinal Cord Injury Statistical Center, 2013, J Spinal Cord Med, V36, P1, DOI 10.1179/1079026813Z.000000000136
   Novikov LN, 2002, BIOMATERIALS, V23, P3369, DOI 10.1016/S0142-9612(02)00037-6
   Pawar K, 2015, BIOMATERIALS, V65, P1, DOI 10.1016/j.biomaterials.2015.05.032
   Sakiyama-Elbert S, 2012, Handb Clin Neurol, V109, P575, DOI 10.1016/B978-0-444-52137-8.00036-X
   Sathyanesan A, 2012, J NEUROSCI METH, V206, P165, DOI 10.1016/j.jneumeth.2012.02.019
   Sato Y, 1998, Med Image Anal, V2, P143, DOI 10.1016/S1361-8415(98)80009-1
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Thomas AM, 2014, INTEGR BIOL-UK, V6, P694, DOI 10.1039/c4ib00009a
   Thomas AM, 2013, BIOMATERIALS, V34, P2213, DOI 10.1016/j.biomaterials.2012.12.002
   Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955
   Tsai EC, 2006, BIOMATERIALS, V27, P519, DOI 10.1016/j.biomaterials.2005.07.025
   Tuinstra HM, 2014, TISSUE ENG PT A, V20, P1027, DOI [10.1089/ten.tea.2013.0111, 10.1089/ten.TEA.2013.0111]
   Tuinstra HM, 2012, BIOMATERIALS, V33, P1618, DOI 10.1016/j.biomaterials.2011.11.002
   WILSON DH, 1984, PARAPLEGIA, V22, P230, DOI 10.1038/sc.1984.39
   Wong DY, 2008, J NEUROTRAUM, V25, P1027, DOI 10.1089/neu.2007.0473
   Yang Y, 2009, TISSUE ENG PT A, V15, P3283, DOI [10.1089/ten.tea.2009.0081, 10.1089/ten.TEA.2009.0081]
NR 39
TC 1
Z9 2
U1 2
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0165-0270
EI 1872-678X
J9 J NEUROSCI METH
JI J. Neurosci. Methods
PD APR 1
PY 2016
VL 263
BP 15
EP 22
DI 10.1016/j.jneumeth.2016.01.021
PG 8
WC Biochemical Research Methods; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA DJ4SY
UT WOS:000374199500003
PM 26820904
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Gharbi, A
   El Feki, H
   Oudadesse, H
AF Gharbi, Amina
   El Feki, Hafed
   Oudadesse, Hassane
TI Novel alkali borosilicate glasses: Preparation, structural investigation
   and thermal study
SO KOREAN JOURNAL OF CHEMICAL ENGINEERING
LA English
DT Article
DE Bioactive Glasses; Melting; Thermal Proprieties; Biomedical Applications
ID IN-VITRO EVALUATION; BIOACTIVE GLASSES; BORATE GLASSES;
   RAMAN-SPECTROSCOPY; IONIC TRANSPORT; SYSTEM; HYDROXYAPATITE; MECHANISMS;
   CONVERSION; ALUMINUM
AB Bioactive glasses are indicated for use as bone substitutes in orthopedic or dental surgery because of their high reactivity once in contact with the biological medium. Boron is known as a glass network former and an activator of the glasses bioactivity. In this work, bioactive glass was doped by 5, 10 and 20 wt% of B2O3 according to the melting process. Adding boron oxide with high content enhances glass materials' bioactivity. Likewise, thanks to their solubility, borate-containing bioactive glasses were fluently used as orthopedic implants. The aim of our study was to investigate of boron effect on the thermal characteristics of our bioactive glass to better understand their proprieties in order for use as bone biomaterial. The obtained results proved that the more the boron content in the glass network increases, the more the melting temperature decreases and the more the thermal stability increases.
C1 [Gharbi, Amina; Oudadesse, Hassane] Univ Rennes 1, ISCR, UMR CNRS 6226, 263 Av Gen Leclerc, F-35042 Rennes, France.
   [Gharbi, Amina; El Feki, Hafed] Fac Sci Sfax, Mat Sci & Environm Lab, Sfax 3018, Tunisia.
RP Oudadesse, H (reprint author), Univ Rennes 1, ISCR, UMR CNRS 6226, 263 Av Gen Leclerc, F-35042 Rennes, France.
EM hassane.oudadesse@univ-rennes1.fr
CR Agathopoulos S, 2006, J NON-CRYST SOLIDS, V352, P322, DOI 10.1016/j.jnoncrysol.2005.12.003
   ASAI K, 1982, T JPN I MET, V23, P571, DOI 10.2320/matertrans1960.23.571
   Azooz MA, 2008, INDIAN J PURE AP PHY, V46, P880
   Bardez I., 2004, THESIS U P M CURIE P, P71
   Barton J, 2004, VERRE SCI TECHNOLOGI
   Bray P. J., 1997, P 2 INT C BOR GLASS, P1
   Brown RF, 2009, J BIOMED MATER RES A, V88A, P392, DOI 10.1002/jbm.a.31679
   Flower G. L., 2014, PHYS SCI, V62, P315
   Fu HL, 2009, MAT SCI ENG C-MATER, V29, P2275, DOI 10.1016/j.msec.2009.05.013
   FURUKAWA T, 1981, J AM CERAM SOC, V64, P443, DOI 10.1111/j.1151-2916.1981.tb09893.x
   Gadet M.D., 2002, BIOL TRACE ELEM RES, V85, P23
   Girot A. L., 2011, J NONCRSYT SOLIDS, V357, P3322
   Grandjean A, 2006, J NON-CRYST SOLIDS, V352, P2731, DOI 10.1016/j.jnoncrysol.2006.03.058
   Hakki SS, 2010, J TRACE ELEM MED BIO, V24, P243, DOI 10.1016/j.jtemb.2010.03.003
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Huang WH, 2006, J MATER SCI-MATER M, V17, P583, DOI 10.1007/s10856-006-9220-z
   Jastrzebski W, 2011, SPECTROCHIM ACTA A, V79, P722, DOI 10.1016/j.saa.2010.08.044
   Jebahi Samira, 2013, Eur J Orthop Surg Traumatol, V23, P759, DOI 10.1007/s00590-012-1087-8
   Jones JR, 2013, ACTA BIOMATER, V9, P4457, DOI 10.1016/j.actbio.2012.08.023
   KAMITSOS EI, 1990, J NON-CRYST SOLIDS, V126, P52, DOI 10.1016/0022-3093(90)91023-K
   Kaur G, 2014, J BIOMED MATER RES A, V102, P254, DOI 10.1002/jbm.a.34690
   KROGHMOE J, 1965, PHYS CHEM GLASSES, V6, P46
   Kumar V, 2010, SOLID STATE IONICS, V181, P79, DOI 10.1016/j.ssi.2009.12.005
   Lee JH, 2006, J BIOMED MATER RES A, V77A, P362, DOI 10.1002/jbm.a.30594
   Lee SK, 2002, GEOCHIM COSMOCHIM AC, V66, P303, DOI 10.1016/S0016-7037(01)00775-X
   Linati L, 2005, J PHYS CHEM B, V109, P4989, DOI 10.1021/jp046631n
   Miyoshi H, 2004, J NON-CRYST SOLIDS, V345, P99, DOI 10.1016/j.jnoncrysol.2004.08.003
   Mohini GJ, 2013, APPL SURF SCI, V287, P46, DOI 10.1016/j.apsusc.2013.09.055
   Raguenet B., 2011, THESIS U MONTPELLIER, P170
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Rao K. J., 2002, STRUCTURAL CHEM GLAS
   Reddy MS, 2007, J ALLOY COMPD, V438, P41, DOI 10.1016/j.jallcom.2006.08.054
   Richet P, 2006, J NON-CRYST SOLIDS, V352, P3854, DOI 10.1016/j.jnoncrysol.2006.06.034
   Saranti A, 2006, J NON-CRYST SOLIDS, V352, P390, DOI 10.1016/j.jnoncrysol.2006.01.042
   Shelby J. E., 1997, ROYAL SOC CHEM, V91, P108
   Sitarz M, 2011, J NON-CRYST SOLIDS, V357, P1603, DOI 10.1016/j.jnoncrysol.2011.01.007
   Sitarz M, 2012, VIB SPECTROSC, V61, P72, DOI 10.1016/j.vibspec.2012.01.016
   Souquet JL, 1998, SOLID STATE IONICS, V105, P237, DOI 10.1016/S0167-2738(97)00470-0
   Torres FJ, 2004, J NON-CRYST SOLIDS, V347, P45, DOI 10.1016/j.jnoncrysol.2004.09.003
   Wers E, 2014, THERMOCHIM ACTA, V580, P79, DOI 10.1016/j.tca.2014.02.001
   Wers E, 2014, J THERM ANAL CALORIM, V115, P2137, DOI 10.1007/s10973-013-3280-3
   Yang XY, 2012, J NON-CRYST SOLIDS, V358, P1171, DOI 10.1016/j.jnoncrysol.2012.02.005
   Yano T, 2003, J NON-CRYST SOLIDS, V321, P137, DOI 10.1016/S0022-3093(03)00158-3
   Zhong J., 1986, J NONCRYST SOLIDS, V87, P226
NR 47
TC 3
Z9 3
U1 0
U2 18
PU KOREAN INSTITUTE CHEMICAL  ENGINEERS
PI SEOUL
PA F.5, 119, ANAM-RO, SEONGBUK-GU, SEOUL 136-075, SOUTH KOREA
SN 0256-1115
EI 1975-7220
J9 KOREAN J CHEM ENG
JI Korean J. Chem. Eng.
PD APR
PY 2016
VL 33
IS 4
BP 1456
EP 1461
DI 10.1007/s11814-015-0287-4
PG 6
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA DJ5RA
UT WOS:000374266300040
DA 2018-10-19
ER

PT J
AU Schacht, K
   Vogt, J
   Scheibel, T
AF Schacht, Kristin
   Vogt, Jessica
   Scheibel, Thomas
TI Foams Made of Engineered Recombinant Spider Silk Proteins as 3D
   Scaffolds for Cell Growth
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE recombinant spider silk proteins; salt leaching; foams; porous
   scaffolds; biomedical applications; tissue engineering
ID GLASS-CERAMIC SCAFFOLDS; FIBROIN SCAFFOLDS; IN-VITRO; ENZYMATIC
   DEGRADATION; MECHANICAL-PROPERTIES; STREPTOMYCES-GRISEUS; FILMS;
   BIOMATERIAL; PARTICLES; OPPORTUNITIES
AB Materials for tissue engineering have to be biocompatible and have to support cell adhesion, proliferation and differentiation. Additionally, in case of soft tissue engineering the mechanical properties have to accommodate that of the tissue with mechanical integrity until the artificial scaffold is replaced by natural extracellular matrix. In case of artificial 3D scaffolds, it is of critical importance to be able to tune the mechanical properties, the inner free volume (i.e., pore size) and degradation behavior of the employed biomaterial. Here, the potential of recombinant spider silk proteins was evaluated concerning their processing into and application as 3D scaffolds for soft tissue engineering. Highly porous foams made of the recombinant spider silk protein eADF4(C16) and a variant containing an RGD motif were fabricated by salt leaching yielding mechanically robust scaffolds. In contrast to other salt-leached silk scaffolds, the swelling behavior of these scaffolds was low, and the mechanical properties in the range of soft tissues. The pore size and porosity of the foams could be adjusted by the salt crystal size. Fibroblasts adhered and proliferated well in foams made of the spider silk RGD variant but not in the foams of the nonmodified one.
C1 [Schacht, Kristin; Vogt, Jessica; Scheibel, Thomas] Univ Bayreuth, Lehrstuhl Biomat, Univ Str 30, D-95447 Bayreuth, Germany.
   [Scheibel, Thomas] Univ Bayreuth, BZKG, Univ Str 30, D-95447 Bayreuth, Germany.
   [Scheibel, Thomas] Univ Bayreuth, Inst BioMakromol Biomac, Univ Str 30, D-95447 Bayreuth, Germany.
   [Scheibel, Thomas] Univ Bayreuth, BZMB, Univ Str 30, D-95447 Bayreuth, Germany.
   [Scheibel, Thomas] Univ Bayreuth, Bayreuther Mat Zentrum BayMAT, Univ Str 30, D-95447 Bayreuth, Germany.
   [Vogt, Jessica] RESORBA Med GmbH, Flachmoor 16, D-90475 Nurnberg, Germany.
RP Scheibel, T (reprint author), Univ Bayreuth, Lehrstuhl Biomat, Univ Str 30, D-95447 Bayreuth, Germany.; Scheibel, T (reprint author), Univ Bayreuth, BZKG, Univ Str 30, D-95447 Bayreuth, Germany.; Scheibel, T (reprint author), Univ Bayreuth, Inst BioMakromol Biomac, Univ Str 30, D-95447 Bayreuth, Germany.; Scheibel, T (reprint author), Univ Bayreuth, BZMB, Univ Str 30, D-95447 Bayreuth, Germany.; Scheibel, T (reprint author), Univ Bayreuth, Bayreuther Mat Zentrum BayMAT, Univ Str 30, D-95447 Bayreuth, Germany.
EM thomas.scheibel@bm.uni-bayreuth.de
RI Scheibel, Thomas/I-1170-2014
OI Scheibel, Thomas/0000-0002-0457-2423
FU Deutsche Forschungsgemeinschaft [SFB 840 TPA8]
FX We thank Dr. Hendrik Bargel for scanning electron microscopy, Prof. Dr.
   Gregor Lang for experimental help with tensile testing, Elena Doblhofer
   for experimental help with FTIR and FSD, and Aniela Heidebrecht for
   proof reading and discussions. The sintered 45S5 Bioglass (R) scaffolds,
   fabricated by the replication method, were produced at the Department of
   Biomaterials, University Erlangen-Nuremberg, supervised by Prof. Dr.
   Aldo R Boccaccini. The freeze-cast aluminum oxide
   (Al<INF>2</INF>O<INF>3</INF>) scaffolds were prepared at the Thayer
   School of Engineering at Dartmouth, supervised by Prof. Dr. Ulrike
   Wegst. This work was supported by the Deutsche Forschungsgemeinschaft
   (SFB 840 TPA8).
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   BAUER CA, 1974, EUR J BIOCHEM, V41, P45, DOI 10.1111/j.1432-1033.1974.tb03242.x
   BAUER CA, 1974, EUR J BIOCHEM, V45, P469, DOI 10.1111/j.1432-1033.1974.tb03571.x
   Bauer F, 2013, BIOMATER SCI-UK, V1, P1244, DOI 10.1039/c3bm60114e
   Brown J, 2015, ACTA BIOMATER, V11, P212, DOI 10.1016/j.actbio.2014.09.013
   Cappella B, 1999, SURF SCI REP, V34, P1, DOI 10.1016/S0167-5729(99)00003-5
   Chen QZ, 2008, J BIOMED MATER RES A, V84A, P1049, DOI 10.1002/jbm.a.31512
   Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025
   Deville S, 2007, ACTA MATER, V55, P1965, DOI 10.1016/j.actamat.2006.11.003
   Deville S, 2010, MATERIALS, V3, P1913, DOI 10.3390/ma3031913
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2009, SCIENCE, V324, P208, DOI 10.1126/science.1170107
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Hardy JG, 2008, POLYMER, V49, P4309, DOI 10.1016/j.polymer.2008.08.006
   Hedhammar M, 2008, BIOCHEMISTRY-US, V47, P3407, DOI 10.1021/bi702432y
   Hollinger JO, 1996, BIOMATERIALS, V17, P187, DOI 10.1016/0142-9612(96)85763-2
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hu YH, 2002, J BIOMED MATER RES, V59, P563, DOI 10.1002/jbm.1269
   Huemmerich D, 2006, APPL PHYS A-MATER, V82, P219, DOI 10.1007/s00339-005-3428-5
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   Janmey PA, 2009, CELL MOTIL CYTOSKEL, V66, P597, DOI 10.1002/cm.20382
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Leal-Egana A, 2012, J MATER CHEM, V22, P14330, DOI 10.1039/c2jm31174g
   Lee SB, 2004, BIOMATERIALS, V25, P2309, DOI 10.1016/j.biomaterials.2003.09.016
   Lewicka M, 2012, BIOMATERIALS, V33, P7712, DOI 10.1016/j.biomaterials.2012.07.021
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Liu HF, 2008, BIOMATERIALS, V29, P1443, DOI 10.1016/j.biomaterials.2007.11.023
   Lu Q, 2010, MACROMOL BIOSCI, V10, P289, DOI 10.1002/mabi.200900258
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lv Q, 2006, J MATER SCI-MATER M, V17, P1349, DOI 10.1007/s10856-006-0610-z
   Maquet V, 2000, LANGMUIR, V16, P10463, DOI 10.1021/la000654l
   Muller-Herrmann S, 2015, ACS BIOMATER SCI ENG, V1, P247, DOI 10.1021/ab500147u
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Neubauer MP, 2013, BIOMATER SCI-UK, V1, P1160, DOI 10.1039/c3bm60108k
   Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024
   Pritchard EM, 2011, BIOMATERIALS, V32, P909, DOI 10.1016/j.biomaterials.2010.09.055
   Rajkhowa R, 2010, MACROMOL BIOSCI, V10, P599, DOI 10.1002/mabi.200900358
   Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3
   Saez A, 2007, P NATL ACAD SCI USA, V104, P8281, DOI 10.1073/pnas.0702259104
   Schacht K, 2015, ANGEW CHEM INT EDIT, V54, P2816, DOI 10.1002/anie.201409846
   Schacht K, 2011, BIOMACROMOLECULES, V12, P2488, DOI 10.1021/bm200154k
   Slotta U, 2006, SUPRAMOL CHEM, V18, P465, DOI 10.1080/10610270600832042
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wegst UGK, 2010, PHILOS T R SOC A, V368, P2099, DOI 10.1098/rsta.2010.0014
   Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193
   Widhe M, 2013, BIOMATERIALS, V34, P8223, DOI 10.1016/j.biomaterials.2013.07.058
   Widhe M, 2010, BIOMATERIALS, V31, P9575, DOI 10.1016/j.biomaterials.2010.08.061
   Wohlrab S, 2012, BIOMATERIALS, V33, P6650, DOI 10.1016/j.biomaterials.2012.05.069
   WOLTERS GHJ, 1995, DIABETES, V44, P227, DOI 10.2337/diabetes.44.2.227
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Yao DY, 2012, BIOMACROMOLECULES, V13, P3723, DOI 10.1021/bm301197h
   Yoon BH, 2008, SCRIPTA MATER, V58, P537, DOI 10.1016/j.scriptamat.2007.11.006
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zhang XH, 2012, J MATER SCI-MATER M, V23, P315, DOI 10.1007/s10856-011-4476-3
   Zhao CX, 2011, INT J BIOL MACROMOL, V48, P249, DOI 10.1016/j.ijbiomac.2010.11.004
NR 61
TC 9
Z9 9
U1 5
U2 37
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD APR
PY 2016
VL 2
IS 4
BP 517
EP 525
DI 10.1021/acsbiomaterials.5b00483
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA DJ3CU
UT WOS:000374083200007
DA 2018-10-19
ER

PT J
AU Heiny, M
   Shastri, VP
AF Heiny, Markus
   Shastri, V. Prasad
TI Nanofibers of Elastin and Hydrophilic Segmented Polyurethane Solution
   Blends Show Enhanced Mechanical Properties through Intermolecular
   Protein-Polymer H Bonding
SO BIOMACROMOLECULES
LA English
DT Article
ID DRUG-DELIVERY VEHICLES; PEG BLOCK-COPOLYMERS; COLLAGEN NANOFIBERS;
   SECONDARY STRUCTURE; CIRCULAR-DICHROISM; FIBER FORMATION; SCAFFOLDS;
   SURFACES; BEHAVIOR; HELIX
AB Combining mechanical properties with enhanced cell interaction is highly desirable in a biomaterial. In this study, a new paradigm for enhancing the mechanical properties of segmented polyurethanes (SPUs) through solution blending with a biopolymer is presented. This noncovalent approach is based on the premise that molecular level blending of SPUs rich in hydrogen bonding (H bonding) domains with a biopolymer capable of H bonding will promote H-bond bridges between the components, leading to molecular annealing and modification of the physicochemical properties of the SPU. We demonstrate that by solution-blending solubilized elastin with a triblock copolymer-derived SPU, a 5-fold increase in tensile modulus of electrospun constructs of the SPU can be achieved, with concomitant enhancement in human endothelial cell attachment. Spectroscopic and calorimetric analysis confirm the role of H bonding in the enhancement, thus providing the impetus to further explore blending with biopolymers as a means of improving the property profiles of synthetic polymeric biomaterials.
C1 [Shastri, V. Prasad] Univ Freiburg, Inst Macromol Chem, Hermann Staudinger Haus,Stefan Meier Str 31, D-79104 Freiburg, Germany.
   Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Schanzlestr 18, D-79104 Freiburg, Germany.
RP Shastri, VP (reprint author), Univ Freiburg, Inst Macromol Chem, Hermann Staudinger Haus,Stefan Meier Str 31, D-79104 Freiburg, Germany.
EM prasad.shastri@gmail.com
FU Excellence Initiative of the German Federal and State Governments [EXC
   294]; University of Freiburg
FX We thank Vincent Ahmadi for the acquisition of SEM images and Melika
   Sarem for technical help with circular dichroism. This work was funded
   by the Excellence Initiative of the German Federal and State Governments
   (Grant EXC 294, Centre for Biological Signalling Studies) and the
   University of Freiburg.
CR Almine JF, 2010, CHEM SOC REV, V39, P3371, DOI 10.1039/b919452p
   [Anonymous], 2010, F284710 ASTM
   Beese AM, 2013, ACS NANO, V7, P3434, DOI 10.1021/nn400346r
   Chen HR, 2011, POLYMER, V52, P400, DOI 10.1016/j.polymer.2010.11.041
   Cohn D, 2005, BIOMATERIALS, V26, P2297, DOI 10.1016/j.biomaterials.2004.07.052
   Daamen WF, 2008, TISSUE ENG PT A, V14, P349, DOI 10.1089/tea.2007.0076
   DEBELLE L, 1995, J BIOL CHEM, V270, P26099, DOI 10.1074/jbc.270.44.26099
   Duca L, 2004, CRIT REV ONCOL HEMAT, V49, P235, DOI 10.1016/j.critrevonc.2003.09.007
   Forget A, 2013, P NATL ACAD SCI USA, V110, P12887, DOI 10.1073/pnas.1222880110
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   He Y, 2004, PROG POLYM SCI, V29, P1021, DOI 10.1016/j.progpolymsci.2004.07.002
   Jaeger R, 1996, MACROMOLECULES, V29, P7634, DOI 10.1021/ma9610673
   Kaminski AM, 1997, J COATING TECHNOL, V69, P115
   Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005
   Kim BS, 2008, ACS NANO, V2, P386, DOI 10.1021/nn700408z
   Lasprilla AJR, 2012, BIOTECHNOL ADV, V30, P321, DOI 10.1016/j.biotechadv.2011.06.019
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lee PJ, 2003, PHARMACEUT RES, V20, P264, DOI 10.1023/A:1022283423116
   Ling XY, 2006, J POLYM SCI POL PHYS, V44, P3200, DOI 10.1002/polb.20972
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   MATSUO S, 1972, MAKROMOLEKUL CHEM, V152, P203
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Najafabadi AH, 2014, ADV MATER, V26, P5823, DOI 10.1002/adma.201401537
   Nisha SK, 2014, J MATER CHEM C, V2, P2051, DOI 10.1039/c3tc32241f
   Paulsson M, 2002, J COLLOID INTERF SCI, V248, P194, DOI 10.1006/jcis.2001.8182
   Pino CJ, 2012, P NATL ACAD SCI USA, V109, P21283, DOI 10.1073/pnas.1200942109
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   Riley T, 2001, LANGMUIR, V17, P3168, DOI 10.1021/la001226i
   Rnjak-Kovacina J, 2011, BIOMATERIALS, V32, P6729, DOI 10.1016/j.biomaterials.2011.05.065
   ROBERT L, 1963, B SOC CHIM BIOL, V45, P1317
   Samouillan V, 1999, J BIOMED MATER RES, V46, P531, DOI 10.1002/(SICI)1097-4636(19990915)46:4<531::AID-JBM11>3.0.CO;2-2
   Sarem M, 2015, MRS BULL, V40, P490, DOI 10.1557/mrs.2015.116
   Scelsi A, 2015, RSC ADV, V5, P95007, DOI 10.1039/c5ra21182d
   Shenoy SL, 2005, POLYMER, V46, P3372, DOI 10.1016/j.polymer.2005.03.011
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Telemeco TA, 2005, ACTA BIOMATER, V1, P377, DOI 10.1016/j.actbio.2005.04.006
   Vasconcelos A, 2012, ACTA BIOMATER, V8, P3049, DOI 10.1016/j.actbio.2012.04.035
   Vasconcelos A, 2011, APPL MICROBIOL BIOT, V90, P445, DOI 10.1007/s00253-011-3135-4
   Walgers R, 1998, J AM CHEM SOC, V120, P5073, DOI 10.1021/ja973552z
   Wang P., 2010, PLOS ONE, V5
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yeo GC, 2015, ADV HEALTHC MATER, V4, P2530, DOI 10.1002/adhm.201400781
   Yilgor I, 2015, POLYMER, V58, pA1, DOI 10.1016/j.polymer.2014.12.014
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
NR 47
TC 3
Z9 4
U1 3
U2 43
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD APR
PY 2016
VL 17
IS 4
BP 1312
EP 1320
DI 10.1021/acs.biomac.5b01681
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA DJ3AL
UT WOS:000374076900008
PM 26940665
DA 2018-10-19
ER

PT J
AU Pichavant, L
   Carrie, H
   Nguyen, MN
   Plawinski, L
   Durrieu, MC
   Heroguez, V
AF Pichavant, Loic
   Carrie, Helene
   Minh Ngoc Nguyen
   Plawinski, Laurent
   Durrieu, Marie-Christine
   Heroguez, Valerie
TI Vancomycin Functionalized Nanoparticles for Bactericidal Biomaterial
   Surfaces
SO BIOMACROMOLECULES
LA English
DT Article
ID OPENING METATHESIS POLYMERIZATION; INFECTIONS; PARTICLES; DELIVERY;
   EPIDERMIDIS; IMPLANTS; BIOFILMS; TITANIUM; ADHESION; OXIDE)
AB In this paper, we describe a simple and powerful way to synthesize antibacterial biomaterials with applications as implants in orthopedic surgery. Such implants are obtained by covalently grafting onto the Ti90A16 V4 alloy surface with vancomycin-functionalized nanoparticles. Nanoparticles were produced by ring-opening metathesis polymerization of alpha-norbornenyl-omega-vancomycin poly(ethylene oxide) macromonomers. Vancomycin is an interesting candidate because of its use in the field of implant associated infection as it is a glycopeptide which acts on bacterial walls. As a consequence, vancomycin does not need to be released for it to be active. In the first part of this paper, the synthesis and the complete characterization of these materials are described. In a second part, the in vitro antibacterial behavior is analyzed and discussed.
C1 [Pichavant, Loic; Carrie, Helene; Minh Ngoc Nguyen; Heroguez, Valerie] Univ Bordeaux, CNRS UMR5629, Lab Chim Polymeres Organ, IPB ENSCBP, 16 Ave Pey Berland, F-33607 Pessac, France.
   [Pichavant, Loic; Carrie, Helene; Plawinski, Laurent; Durrieu, Marie-Christine] Univ Bordeaux, CNRS UMR5248, Inst Chim & Biol Membranes & Nanoobjets, INP Bordeaux, 2 Rue Robert Escarpit, F-33607 Pessac, France.
   [Minh Ngoc Nguyen] VNU Univ Sci, Fac Chem, 19 Le Thanh Tong, Hanoi, Vietnam.
RP Heroguez, V (reprint author), Univ Bordeaux, CNRS UMR5629, Lab Chim Polymeres Organ, IPB ENSCBP, 16 Ave Pey Berland, F-33607 Pessac, France.
EM heroguez@enscbp.fr
RI DURRIEU, Marie-Christine/I-4358-2016; Nguyen, Minh Ngoc/D-3459-2014
OI DURRIEU, Marie-Christine/0000-0003-0583-9289; Nguyen, Minh
   Ngoc/0000-0002-1876-9761; Helene, Carrie/0000-0003-3352-2940
FU SATT of Region Aquitaine (Aquitaine Science Transfert); GIS AMA
   (Advanced Materials in Aquitaine)
FX The authors thank The SATT of Region Aquitaine (Aquitaine Science
   Transfert) and the GIS AMA (Advanced Materials in Aquitaine) for
   providing financial support to this project. The authors also want to
   thank Drs. G. Amador and J. Caillon from the University of Nantes for
   providing the bacterial strains. Microscopy was done in the Bordeaux
   Imaging Center, a service unit of the CNRS-INSERM and Bordeaux
   University, member of the national infrastructure France BioImaging.
   Finally, the authors would like to thank Dr. Edgar Cao from the
   University of Waterloo for his English assistance.
CR Arimoto H, 1999, CHEM COMMUN, P1361, DOI 10.1039/a903529j
   Arimoto H, 2001, TETRAHEDRON LETT, V42, P3347, DOI 10.1016/S0040-4039(01)00429-4
   Bernard L, 2004, J ANTIMICROB CHEMOTH, V53, P127, DOI 10.1093/jac/dkh033
   Chemtob A, 2002, MACROMOLECULES, V35, P9262, DOI 10.1021/ma020871o
   Cloutier M, 2015, TRENDS BIOTECHNOL, V33, P637, DOI 10.1016/j.tibtech.2015.09.002
   Collette F, 2013, J POLYM SCI POL CHEM, V51, P176, DOI 10.1002/pola.26357
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Denis I, 2014, BIOMACROMOLECULES, V15, P4534, DOI 10.1021/bm501338r
   Greenwald R. B., 2009, U.S. Patent, Patent No. [2009/0221471 Al, 20090221471]
   Gueugnon F, 2013, BIOMACROMOLECULES, V14, P2396, DOI 10.1021/bm400516b
   Harris Llinos G, 2006, Injury, V37 Suppl 2, pS3, DOI 10.1016/j.injury.2006.04.003
   Heroguez V, 1996, MACROMOLECULES, V29, P4459, DOI 10.1021/ma951797v
   Lawson MC, 2007, CLIN ORTHOP RELAT R, P96, DOI 10.1097/BLO.0b013e3180986706
   Lawson MC, 2010, CLIN ORTHOP RELAT R, V468, P2081, DOI 10.1007/s11999-010-1266-z
   Lawson MC, 2009, BIOMACROMOLECULES, V10, P2221, DOI 10.1021/bm900410a
   Lu J, 2007, CHEM COMMUN, P251, DOI 10.1039/b613319c
   Nguyen MN, 2012, BIOMACROMOLECULES, V13, P896, DOI 10.1021/bm201812u
   Nitanai Y, 2009, J MOL BIOL, V385, P1422, DOI 10.1016/j.jmb.2008.10.026
   Ong KL, 2009, J ARTHROPLASTY, V24, P1137, DOI 10.1016/j.arth.2008.08.005
   Pearce C. M., 1995, J CHEM SOC P2, V1, P153
   Pedersen AB, 2010, ACTA ORTHOP, V81, P542, DOI 10.3109/17453674.2010.519908
   Pichavant L, 2012, J CONTROL RELEASE, V162, P373, DOI 10.1016/j.jconrel.2012.06.033
   Pichavant L, 2011, MACROMOLECULES, V44, P7879, DOI 10.1021/ma2015479
   Porte-Durrieu MC, 2004, BIOMATERIALS, V25, P4837, DOI 10.1016/j.biomaterials.2003.11.037
   Quemener D, 2005, POLYMER, V46, P1067, DOI 10.1016/j.polymer.2004.11.096
   SANDERSON PJ, 1991, J HOSP INFECT, V18, P367, DOI 10.1016/0195-6701(91)90043-8
   Yoshida O, 2011, MEDCHEMCOMM, V2, P278, DOI 10.1039/c0md00230e
   Yu Q, 2015, ACTA BIOMATER, V16, P1, DOI 10.1016/j.actbio.2015.01.018
NR 29
TC 16
Z9 16
U1 3
U2 31
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD APR
PY 2016
VL 17
IS 4
BP 1339
EP 1346
DI 10.1021/acs.biomac.5b01727
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA DJ3AL
UT WOS:000374076900011
PM 26938371
DA 2018-10-19
ER

PT J
AU Massey, CJ
   Suh, JD
   Tessema, B
   Gray, ST
   Singh, A
AF Massey, Conner J.
   Suh, Jeffrey D.
   Tessema, Belachew
   Gray, Stacey T.
   Singh, Ameet
TI Biomaterials in Rhinology
SO OTOLARYNGOLOGY-HEAD AND NECK SURGERY
LA English
DT Review
DE biomaterials; nasal packing; removable packing; absorbable packing;
   hemostasis; wound healing; drug-eluting stents; endoscopic sinus
   surgery; rhinology; chronic rhinosinusitis
ID ENDOSCOPIC SINUS SURGERY; RANDOMIZED CONTROLLED-TRIAL; MICROPOROUS
   POLYSACCHARIDE HEMOSPHERES; CARBOXY-METHYLATED CELLULOSE; MIDDLE MEATAL
   SPACER; NASAL PACKING; CHRONIC RHINOSINUSITIS; DOUBLE-BLIND; CHITOSAN
   GEL; FIBRIN GLUE
AB Introduction Many different kinds of rhinologic biomaterials, both nonabsorbable and absorbable, have been developed over the years to improve outcomes following endoscopic sinus surgery (ESS) for patients with chronic rhinosinusitis. In particular, these products have been designed to prevent postoperative bleeding, optimize the wound healing process, and reduce inflammation. This review evaluates the most recent evidence on biomaterials used in rhinology, focusing on these outcomes after ESS.
   Data Sources MEDLINE, Scopus, Google Scholar, and Clinicaltrials.gov.
   Review Methods A primary literature search based on the listed databases was performed with combinatorial search terms. Studies were considered for review if they met a set of inclusion and exclusion criteria.
   Conclusions Some products have performed better than others in clinical trials, although significant heterogeneity among studies does not allow for selection of a clearly superior biomaterial. While nonabsorbable biomaterials are still effective in achieving certain outcomes, newer, absorbable substances may be just as effective and avoid the morbidity associated with nasal packing removal. Steroid-eluting biomaterials have shown promising early results in reducing inflammation and promoting wound healing.
   Implications for Practice Certain absorbable biomaterials, such as chitosan gel and fibrin glue, have performed well with respect to postoperative hemostasis and wound healing, although they do not address mucosal inflammation. Steroid delivery systems may play an increasingly important role in reducing disease recurrence after ESS, although more studies are needed to assess long-term outcomes.
C1 [Massey, Conner J.; Singh, Ameet] George Washington Univ, Div Otolaryngol, 2300 M St NW,4th Floor, Washington, DC 20037 USA.
   [Suh, Jeffrey D.] Univ Calif Los Angeles, Dept Head & Neck Surg, Los Angeles, CA USA.
   [Tessema, Belachew] Univ Connecticut, Connecticut Sinus Ctr, Div Otolaryngol Head & Neck Surg, Farmington, CT USA.
   [Gray, Stacey T.] Harvard Univ, Sch Med, Massachusetts Eye & Ear Infirm, Dept Otol & Laryngol,Dept Otolaryngol, Boston, MA 02115 USA.
RP Singh, A (reprint author), George Washington Univ, Div Otolaryngol, 2300 M St NW,4th Floor, Washington, DC 20037 USA.
EM ameetsingh@alum.mit.edu
CR Akbari E, 2012, RHINOLOGY, V50, P306, DOI 10.4193/Rhino11.215
   Akiyama K, 2014, AURIS NASUS LARYNX, V41, P264, DOI [10.1016/j.an1.2013.10.009, 10.1016/j.anl.2013.10.009]
   Al-Shaikh S, 2014, J LARYNGOL OTOL, V128, P709, DOI 10.1017/S0022215114001303
   Antisdel JL, 2011, AM J RHINOL ALLERGY, V25, P268, DOI 10.2500/ajra.2011.25.3619
   Antisdel JL, 2009, OTOLARYNG HEAD NECK, V141, P353, DOI 10.1016/j.otohns.2009.06.078
   Berlucchi M, 2009, EUR ARCH OTO-RHINO-L, V266, P839, DOI 10.1007/s00405-008-0841-3
   Beyea JA, 2011, ANN OTO RHINOL LARYN, V120, P495, DOI 10.1177/000348941112000801
   Chandra RK, 2003, AM J RHINOL, V17, P51, DOI 10.1177/194589240301700109
   Chang EH, 2011, J OTOLARYNGOL-HEAD N, V40, pS14, DOI 10.2310/7070.2011.100099
   Cho KS, 2015, EUR ARCH OTO-RHINO-L, V272, P1699, DOI 10.1007/s00405-014-3264-3
   Cho KS, 2013, LARYNGOSCOPE, V123, P564, DOI 10.1002/lary.23643
   Cote DWJ, 2010, LARYNGOSCOPE, V120, P1269, DOI 10.1002/lary.20905
   Cruise AS, 2006, CLIN OTOLARYNGOL, V31, P25, DOI 10.1111/j.1749-4486.2006.01122.x
   Dubin MG, 2007, AM J RHINOL, V21, P483, DOI 10.2500/ajr.2007.21.3047
   Eliashar R, 2006, OTOLARYNG HEAD NECK, V134, P276, DOI 10.1016/j.otohns.2005.10.012
   Erkan AN, 2007, LARYNGOSCOPE, V117, P491, DOI 10.1097/MLG.0b013e31802dc5bc
   Franklin JH, 2007, AM J RHINOL, V21, P214, DOI 10.2500/ajr.2007.21.3011
   Frenkiel Saul, 2002, J Otolaryngol, V31 Suppl 1, pS41, DOI 10.2310/7070.2002.21296
   Gall RM, 2002, J OTOLARYNGOL, V31, P271, DOI 10.2310/7070.2002.29810
   Hu KH, 2008, INT J PEDIATR OTORHI, V72, P1535, DOI 10.1016/j.ijporl.2008.07.006
   HUGGINS S, 1969, EYE EAR NOSE THROAT, V48, P420
   Jameson M, 2006, AM J OTOLARYNG, V27, P86, DOI 10.1016/j.amjoto.2005.07.011
   Kastl KG, 2009, AMJ RHINOL ALLERGY, V23, P80, DOI 10.2500/ajra.2009.23.3267
   Kastl KG, 2009, EUR ARCH OTO-RHINO-L, V266, P1239, DOI 10.1007/s00405-008-0881-8
   Kim DW, 2012, AM J RHINOL ALLERGY, V26, pE147, DOI 10.2500/ajra.2012.26.3813
   Kimmelman CP, 2001, OTOLARYNG HEAD NECK, V125, P603, DOI 10.1067/mhn.2001.120229
   Leung RM, 2011, AM J RHINOL ALLERGY, V25, P401, DOI 10.2500/ajra.2011.25.3672
   Lipworth BJ, 2000, DRUG SAFETY, V23, P11, DOI 10.2165/00002018-200023010-00002
   Marple BF, 2012, OTOLARYNG HEAD NECK, V146, P1004, DOI 10.1177/0194599811435968
   Melis A, 2015, LARYNGOSCOPE, V125, P1067, DOI 10.1002/lary.25105
   Miller RS, 2003, OTOLARYNG HEAD NECK, V128, P862, DOI 10.1016/S0194-5998(03)00460-1
   Murr AH, 2011, INT FORUM ALLERGY RH, V1, P23, DOI 10.1002/alr.20020
   Poetker DM, 2010, OTOLARYNG CLIN N AM, V43, P753, DOI 10.1016/j.otc.2010.04.003
   Ramadan HH, 1999, LARYNGOSCOPE, V109, P27, DOI 10.1097/00005537-199901000-00006
   Rudmik L, 2012, INT FORUM ALLERGY RH, V2, P248, DOI 10.1002/alr.21011
   Shaw CKL, 2000, J LARYNGOL OTOL, V114, P506
   Shi RJ, 2013, AM J RHINOL ALLERGY, V27, P71, DOI 10.2500/ajra.2013.27.3833
   Shoman N, 2009, J OTOLARYNGOL-HEAD N, V38, P112, DOI 10.2310/7070.2008.OA0217
   Song KJ, 2013, CLIN OTOLARYNGOL, V38, P225, DOI 10.1111/coa.12117
   Stankiewicz JA, 2011, LARYNGOSCOPE, V121, P2684, DOI 10.1002/lary.21446
   STEVENS RW, 1951, AMA ARCH OTOLARYNGOL, V54, P191
   Szczygielski K, 2010, EUR ARCH OTO-RHINO-L, V267, P537, DOI 10.1007/s00405-009-1117-2
   Ha TN, 2013, INT FORUM ALLERGY RH, V3, P573, DOI 10.1002/alr.21136
   Thornton RS, 1996, ARCH OTOLARYNGOL, V122, P869
   Tom LWC, 1997, AM J RHINOL, V11, P229, DOI 10.2500/105065897781751884
   Vaiman M, 2005, ANN OTO RHINOL LARYN, V114, P237, DOI 10.1177/000348940511400313
   Valentine R, 2010, AMJ RHINOL ALLERGY, V24, P70, DOI 10.2500/ajra.2010.24.3422
   Verim A, 2014, LARYNGOSCOPE, V124, P1529, DOI 10.1002/lary.24543
   Weber RK, 2009, HEAD NECK SURG, V8
   Wee JH, 2012, EUR ARCH OTO-RHINO-L, V269, P897, DOI 10.1007/s00405-011-1768-7
   WILLIAMS DF, 1987, PROGR BIOMEDICAL ENG, V4
   Wormald PJ, 2006, AM J RHINOL, V20, P7, DOI 10.1177/194589240602000102
   Yu MS, 2014, AM J RHINOL ALLERGY, V28, P335, DOI 10.2500/ajra.2014.28.4047
NR 53
TC 4
Z9 4
U1 2
U2 11
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0194-5998
EI 1097-6817
J9 OTOLARYNG HEAD NECK
JI Otolaryngol. Head Neck Surg.
PD APR
PY 2016
VL 154
IS 4
BP 606
EP 617
DI 10.1177/0194599815627782
PG 12
WC Otorhinolaryngology; Surgery
SC Otorhinolaryngology; Surgery
GA DJ2FL
UT WOS:000374019100005
PM 26908551
DA 2018-10-19
ER

PT J
AU Zhou, X
   Chen, X
   Mao, TC
   Li, X
   Shi, XH
   Fan, DL
   Zhang, YM
AF Zhou, Xin
   Chen, Xing
   Mao, Tong-cun
   Li, Xiang
   Shi, Xiao-hua
   Fan, Dong-li
   Zhang, Yi-ming
TI Carbon Ion Implantation: A Good Method to Enhance the Biocompatibility
   of Silicone Rubber
SO PLASTIC AND RECONSTRUCTIVE SURGERY
LA English
DT Article
ID LENS EPITHELIAL-CELLS; FOREIGN-BODY REACTION; SMOOTH MUSCLE ACTIN;
   BACTERIAL ADHESION; BREAST IMPLANTS; CAPSULAR CONTRACTURE; SURFACE
   MODIFICATION; INFECTION; ALPHA; RECONSTRUCTION
AB Background: Silicone rubber and silicone rubber-based materials have been used as medical tissue implants in the field of plastic surgery for many years, but there are still some reports of adverse reactions to long-term implants. Earlier studies have shown that ion implantation could enhance the biocompatibility of biomaterials. However, whether ion implantation has a good effect on silicone rubber is unknown. Methods: Three types of carbon ion silicone rubber were obtained by implanting three doses of carbon ions. Then, the antibacterial adhesion properties and the in vivo host responses were evaluated. The antibacterial adhesion properties were examined by plate colony counting, fluorescence staining, and scanning electron microscopic observation. The host responses were evaluated by surveying inflammation and fiber capsule formation that developed after subcutaneous implantation in Sprague-Dawley rats for 7, 30, 90, and 180 days. In addition, the possible mechanism by which ion implantation enhanced the biocompatibility of the biomaterial was investigated and discussed. Results: Carbon ion silicone rubber exhibits less bacterial adhesion, less collagen deposition, and thinner and weaker tissue capsules. Immunohistochemical staining results for CD4, tumor necrosis factor-alpha, alpha-smooth muscle actin, and elastin showed the possible mechanism enhancing the biocompatibility of silicone rubber. These data indicate that carbon ion silicone rubber exhibits good antibacterial adhesion properties and triggers thinner and weaker tissue capsules. In addition, high surface roughness and high zeta potential may be the main factors that induce the unique biocompatibility of carbon ion silicone rubber. Conclusion: Ion implantation should be considered for further investigation and application, and carbon ion silicone rubber could be a better biomaterial to decrease silicone rubber-initiated complications.
C1 [Zhou, Xin; Chen, Xing; Mao, Tong-cun; Li, Xiang; Shi, Xiao-hua; Fan, Dong-li; Zhang, Yi-ming] Third Mil Med Univ, Xinqiao Hosp, Dept Plast & Cosmet Surg, Chongqing 400037, Peoples R China.
RP Fan, DL; Zhang, YM (reprint author), Third Mil Med Univ, Xinqiao Hosp, Dept Plast & Cosmet Surg, Chongqing 400037, Peoples R China.
EM fdltmmu@sina.com; zympla@sina.com
OI Fan, Dongli/0000-0003-4356-7181
FU National Natural Science Foundation of China [81372075, 81571918]; Third
   Military Medical University [2012XZH05]; grant for Scientific Personnel
   Innovation from Chongqing [cstc2013kjrc-qnrc10003]
FX This work was funded by grants from the National Natural Science
   Foundation of China (81372075 and 81571918), a grant for Transformation
   of Scientific and Technological Achievements from the Third Military
   Medical University (2012XZH05), and a grant for Scientific Personnel
   Innovation from Chongqing (cstc2013kjrc-qnrc10003).
CR Adams WP, 2006, PLAST RECONSTR SURG, V117, P30, DOI 10.1097/01.prs.0000185671.51993.7c
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Araco A, 2007, AESTHET PLAST SURG, V31, P325, DOI 10.1007/s00266-006-0156-y
   Bazaka K, 2011, ACTA BIOMATER, V7, P2015, DOI 10.1016/j.actbio.2010.12.024
   Bergmann PA, 2014, J PLAST RECONSTR AES, V67, P1364, DOI 10.1016/j.bjps.2014.05.040
   Cazacu M, 2009, J COMPOS MATER, V43, P2045, DOI 10.1177/0021998309340447
   Eltze E, 2003, J BIOMED MATER RES A, V64A, P12, DOI 10.1002/jbm.a.10342
   Erlich Mark A, 2003, Facial Plast Surg, V19, P325
   Fundeanu I, 2010, ACTA BIOMATER, V6, P4271, DOI 10.1016/j.actbio.2010.06.010
   Garcia CM, 2006, EXP EYE RES, V83, P999, DOI 10.1016/j.exer.2006.04.009
   Grellner W, 2002, FORENSIC SCI INT, V130, P90, DOI 10.1016/S0379-0738(02)00342-0
   Hori K, 2010, BIOCHEM ENG J, V48, P424, DOI 10.1016/j.bej.2009.11.014
   Joseph J, 2010, J MATER SCI-MATER M, V21, P1665, DOI 10.1007/s10856-010-4015-7
   Kaali P, 2010, POLYM DEGRAD STABIL, V95, P1456, DOI 10.1016/j.polymdegradstab.2010.06.024
   Knight MAF, 2004, PLAST RECONSTR SURG, V114, p26E, DOI 10.1097/01.PRS.0000132678.97041.53
   Lawrence EL, 2005, MED ENG PHYS, V27, P443, DOI 10.1016/j.medengphy.2004.12.013
   Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006
   Ling T, 2013, J MATER SCI-MATER M, V24, P2709, DOI 10.1007/s10856-013-5028-9
   Liu PS, 2013, MAT SCI ENG C-MATER, V33, P3865, DOI 10.1016/j.msec.2013.05.025
   Lugowski SJ, 2000, J TRACE ELEM MED BIO, V14, P31, DOI 10.1016/S0946-672X(00)80021-8
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Macadam SA, 2004, ANN PLAS SURG, V53, P420, DOI 10.1097/01.sap.0000130705.19174.d4
   Meije Y, 2014, J INFECTION, V68, P548, DOI 10.1016/j.jinf.2014.01.001
   Meretoja VV, 2010, J BIOMED MATER RES A, V95A, P269, DOI 10.1002/jbm.a.32829
   Moyer HR, 2014, PLAST RECONSTR SURG, V133, P214, DOI 10.1097/01.prs.0000437255.01199.42
   Nagamoto T, 2000, INVEST OPHTH VIS SCI, V41, P1122
   National Research Council (US), COMM UPD GUID CAR US
   O'Horo JC, 2014, CRIT CARE MED, V42, P1334, DOI 10.1097/CCM.0000000000000166
   Pajkos A, 2003, PLAST RECONSTR SURG, V111, P1605, DOI 10.1097/01.PRS.0000054768.14922.44
   Price C, 2002, J BIOMED MATER RES, V63, P122, DOI 10.1002/jbm.10094
   Rahman CV, 2014, J TISSUE ENG REGEN M, V8, P59, DOI 10.1002/term.1497
   Rohrich RJ, 2006, PLAST RECONSTR SURG, V118, p1S 2S
   Tsuji H, 2007, SURF COAT TECH, V201, P8123, DOI 10.1016/j.surfcoat.2006.01.074
   Tsuji H, 2004, APPL SURF SCI, V235, P182, DOI 10.1016/j.apsusc.2004.05.121
   Tsuji H, 2009, SURF COAT TECH, V203, P2562, DOI 10.1016/j.surfcoat.2009.02.076
   VANLOOSDRECHT MCM, 1989, MICROBIAL ECOL, V17, P1, DOI 10.1007/BF02025589
   VANLOOSDRECHT MCM, 1990, AQUAT SCI, V52, P103, DOI 10.1007/BF00878244
   Vasilev K, 2009, EXPERT REV MED DEVIC, V6, P553, DOI [10.1586/erd.09.36, 10.1586/ERD.09.36]
   Wang SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098320
   Wolfram Dolores, 2004, J Autoimmun, V23, P81
   Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277
NR 41
TC 3
Z9 3
U1 3
U2 21
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0032-1052
EI 1529-4242
J9 PLAST RECONSTR SURG
JI Plast. Reconstr. Surg.
PD APR
PY 2016
VL 137
IS 4
BP 690E
EP 699E
DI 10.1097/PRS.0000000000002022
PG 10
WC Surgery
SC Surgery
GA DI8VN
UT WOS:000373780400001
PM 27018697
DA 2018-10-19
ER

PT J
AU Nguyen, KV
   Holade, Y
   Minteer, SD
AF Khiem Van Nguyen
   Holade, Yaovi
   Minteer, Shelley D.
TI DNA Redox Hydrogels: Improving Mediated Enzymatic Bioelectrocatalysis
SO ACS CATALYSIS
LA English
DT Article
ID MODIFIED LINEAR POLY(ETHYLENIMINE); GLASSY-CARBON ELECTRODE;
   TOLUIDINE-BLUE; METHYLENE-BLUE; BIOFUEL CELLS; DEHYDROGENASE; GLUCOSE;
   FILM; ENZYMES; LIPIDS
AB We present the preparation of a redox DNA hydrogel for mediated bioelectrocatalysis of oxidoreductase enzymes for biosensor and biofuel cell applications. The noncovalent functionalization of DNA with redox molecules is achieved by intercalation of aromatic redox probes into the DNA double helix or electrostatic binding of redox-active tetraalkylammonium ions to phosphate groups on DNA. Prepared DNA redox hydrogels demonstrate the capability of mediating bioelectrocatalytic glucose oxidation by oxidoreductase enzymes. This is the first evidence that redox DNA hydrogels can replace redox polymer hydrogels for self-exchange based mediation for bioelectrocatalytic applications. This study contributes toward advances in the use of DNA, an emerging biomaterial, in enzymatic bioelectrocatalysis-based applications.
C1 [Khiem Van Nguyen; Holade, Yaovi; Minteer, Shelley D.] Univ Utah, Dept Chem, 315 S 1400 E Room 2020, Salt Lake City, UT 84112 USA.
   [Khiem Van Nguyen; Holade, Yaovi; Minteer, Shelley D.] Univ Utah, Dept Mat Sci & Engn, 315 S 1400 E Room 2020, Salt Lake City, UT 84112 USA.
   [Khiem Van Nguyen] Duy Tan Univ, Inst Res & Dev, Da Nan, Vietnam.
RP Minteer, SD (reprint author), Univ Utah, Dept Chem, 315 S 1400 E Room 2020, Salt Lake City, UT 84112 USA.; Minteer, SD (reprint author), Univ Utah, Dept Mat Sci & Engn, 315 S 1400 E Room 2020, Salt Lake City, UT 84112 USA.
EM minteer@chem.utah.edu
RI HOLADE, Yaovi/K-8582-2015; Minteer, Shelley/C-4751-2014
OI HOLADE, Yaovi/0000-0002-8806-568X; Minteer, Shelley/0000-0002-5788-2249
FU Air Force Office of Scientific Research
FX Financial support from the Air Force Office of Scientific Research is
   greatly acknowledged.
CR Abbott NL, 2005, J AM CHEM SOC, V127, P11576, DOI 10.1021/ja054038t
   Aytar BS, 2013, J AM CHEM SOC, V135, P9111, DOI 10.1021/ja403546b
   Balazs DA, 2011, J DRUG DELIV, DOI 10.1155/2011/326497
   Bardea A, 1997, J AM CHEM SOC, V119, P9114, DOI 10.1021/ja971192+
   BOGUSLAVSKY LI, 1995, BIOSENS BIOELECTRON, V10, P693, DOI 10.1016/0956-5663(95)96960-7
   Chen W, 2015, J AM CHEM SOC, V137, P12884, DOI 10.1021/jacs.5b05432
   Chi ZX, 2010, J HAZARD MATER, V175, P274, DOI 10.1016/j.jhazmat.2009.09.160
   Cooney MJ, 2008, ENERG ENVIRON SCI, V1, P320, DOI 10.1039/b809009b
   Deng-Kai Y., 2011, NAN C INEC 2011 IEEE, P1
   GREGG BA, 1990, ANAL CHEM, V62, P258, DOI 10.1021/ac00202a007
   Gu JY, 2002, ELECTROANAL, V14, P949, DOI 10.1002/1521-4109(200207)14:13<949::AID-ELAN949>3.0.CO;2-O
   Gu TT, 2013, MATER SCI FORUM, V750, P84, DOI 10.4028/www.scientific.net/MSF.750.84
   Heller A, 2006, CURR OPIN CHEM BIOL, V10, P664, DOI 10.1016/j.cbpa.2006.09.018
   Jiao K, 2005, ELECTROANAL, V17, P997, DOI 10.1002/elan.200403208
   Kelley SO, 1997, BIOCONJUGATE CHEM, V8, P31, DOI 10.1021/bc960070o
   Nguyen KV, 2015, CHEM COMMUN, V51, P13071, DOI 10.1039/c5cc04810a
   Merchant SA, 2009, LANGMUIR, V25, P7736, DOI 10.1021/la9004938
   Meredith MT, 2012, ANNU REV ANAL CHEM, V5, P157, DOI 10.1146/annurev-anchem-062011-143049
   Meredith MT, 2011, J ELECTROCHEM SOC, V158, pB166, DOI 10.1149/1.3505950
   Moore CM, 2004, BIOMACROMOLECULES, V5, P1241, DOI 10.1021/bm0345256
   Nafisi S, 2007, J MOL STRUCT, V827, P35, DOI 10.1016/j.molstruc.2006.05.004
   Periasamy AP, 2011, TALANTA, V83, P930, DOI 10.1016/j.talanta.2010.10.058
   SAJI T, 1985, J AM CHEM SOC, V107, P6865, DOI 10.1021/ja00310a020
   Sridharan Gokul, 2012, J Oral Maxillofac Pathol, V16, P251, DOI 10.4103/0973-029X.99081
   Yao YL, 2007, ELECTROCHIM ACTA, V53, P278, DOI 10.1016/j.electacta.2007.04.007
NR 25
TC 7
Z9 7
U1 1
U2 49
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2155-5435
J9 ACS CATAL
JI ACS Catal.
PD APR
PY 2016
VL 6
IS 4
BP 2603
EP 2607
DI 10.1021/acscatal.5b02699
PG 5
WC Chemistry, Physical
SC Chemistry
GA DI5FN
UT WOS:000373524400053
OA Bronze
DA 2018-10-19
ER

PT J
AU Liu, WQ
   Kang, N
   Dong, YL
   Guo, YC
   Zhao, D
   Zhang, SW
   Zhou, LY
   Seriwatanachai, D
   Liang, X
   Yuan, Q
AF Liu, Weiqing
   Kang, Ning
   Dong, Yuliang
   Guo, Yuchen
   Zhao, Dan
   Zhang, Shiwen
   Zhou, Liyan
   Seriwatanachai, Dutmanee
   Liang, Xing
   Yuan, Quan
TI Effect of Resorbable Collagen Plug on Bone Regeneration in Rat
   Critical-Size Defect Model
SO IMPLANT DENTISTRY
LA English
DT Article
DE animal model; bone substitute materials; bone defect repair
ID PARATHYROID-HORMONE 1-34; RICH PLASMA PREPARATION; MESENCHYMAL
   STEM-CELLS; CALVARIAL DEFECTS; MORPHOGENETIC PROTEIN-2; TISSUE
   REGENERATION; IN-VITRO; MATRIX; HYDROXYAPATITE; BIOMATERIAL
AB Objective: The purpose of this investigation was to examine the effect of resorbable collagen plug (RCP) on bone regeneration in rat calvarial critical-size defects. Methods: About 5-mm-diameter calvarial defects were created in forty 12-week-old male Sprague-Dawley rats and implanted with or without RCP. Animals were killed at 1, 2, 4, and 8 weeks postoperatively. After being killed, specimens were collected and subjected to micro-computed tomography (mu CT) and histological analysis. Results: The mu CT showed a significant increase of newly formed bone volume/tissue volume in RCP-implanted defect compared with controls at all designated time points. After 8 weeks, the defects implanted with RCP displayed almost complete closure. Hematoxylin and eosin staining of the decalcified sections confirmed these observations and evidenced active bone regeneration in the RCP group. In addition, Masson's trichrome staining demonstrated that RCP implantation accelerated the process of collagen maturation. Conclusions: The RCP enhances bone regeneration in rat critical-size cranial defects, which suggest it might be a desired material for bone defect repair.
C1 [Liu, Weiqing; Dong, Yuliang; Guo, Yuchen; Zhao, Dan; Zhang, Shiwen; Zhou, Liyan; Liang, Xing; Yuan, Quan] Sichuan Univ, West China Sch Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China.
   [Kang, Ning; Liang, Xing; Yuan, Quan] Sichuan Univ, West China Hosp Stomatol, Dent Implant Ctr, 14 Third Sect,Renmin Nan Rd, Chengdu 610041, Peoples R China.
   [Seriwatanachai, Dutmanee] Mahidol Univ, Fac Dent, Dept Oral Biol, Bangkok, Thailand.
RP Liang, X; Yuan, Q (reprint author), Sichuan Univ, West China Hosp Stomatol, Dent Implant Ctr, 14 Third Sect,Renmin Nan Rd, Chengdu 610041, Peoples R China.
EM xingliangdent@vip.163.com; yuanquan@scu.edu.cn
FU National Natural Science Foundation of China [NSFC 81371173]; New
   Century Excellent Talents in University [NCET-120379]; Sichuan Province
   Youth Fund [2013JQ0017]; Science and Technology Supporting Program from
   Provincial Technology Department [2013SZ0070]
FX This work was supported by grants from the National Natural Science
   Foundation of China (NSFC 81371173), New Century Excellent Talents in
   University (NCET-120379) and Sichuan Province Youth Fund (2013JQ0017) to
   Q. Yuan, Science and Technology Supporting Program from Provincial
   Technology Department (2013SZ0070) to X. Liang. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bateman JP, 2012, J PERIODONTAL RES, V47, P243, DOI 10.1111/j.1600-0765.2011.01428.x
   BAUER TW, 2000, CLIN ORTHOP RELAT R, V371, P10, DOI DOI 10.1097/00003086-200002000-00003
   Bosch C, 1998, J CRANIOFAC SURG, V9, P310, DOI 10.1097/00001665-199807000-00004
   Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Choi Jung-Yoo, 2010, J Periodontal Implant Sci, V40, P11, DOI 10.5051/jpis.2010.40.1.11
   CHOI SY, 1993, J PERIODONTOL, V64, P878, DOI 10.1902/jop.1993.64.9.878
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Gabrielian L, 2011, J NEUROTRAUM, V28, P2103, DOI 10.1089/neu.2011.1785
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Giannoudis PV, 2005, INJURY, V36, pS2, DOI 10.1016/j.injury.2005.10.006
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Gomes PS, 2011, LAB ANIM-UK, V45, P14, DOI 10.1258/la.2010.010085
   Han DK, 2005, J PERIODONTOL, V76, P2216, DOI 10.1902/jop.2005.76.12.2216
   Herberg S, 2014, TISSUE ENG PT A, V20, P1444, DOI [10.1089/ten.TEA.2013.0442, 10.1089/ten.tea.2013.0442]
   Hong SJ, 2006, BIOMATERIALS, V27, P3810, DOI 10.1016/j.biomaterials.2006.02.045
   Jensen SS, 2009, INT J ORAL MAX IMPL, V24, P218
   Jensen SS, 2005, INT J ORAL MAX IMPL, V20, P703
   Jimi E, 2012, INT J DENT, V2012, DOI DOI 10.1155/2012/148261]
   Keogh MB, 2010, CELL TISSUE RES, V340, P169, DOI 10.1007/s00441-010-0939-y
   Kigami R, 2013, IMPLANT DENT, V22, P422, DOI 10.1097/ID.0b013e31829d19f0
   Kisiel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071683
   Lee JH, 2014, TISSUE ENG PT A, V20, P2031, DOI 10.1089/ten.tea.2013.0282
   Levi B, 2011, STEM CELLS, V29, P1241, DOI 10.1002/stem.670
   Liu YH, 2013, BIOMATERIALS, V34, P9998, DOI 10.1016/j.biomaterials.2013.09.040
   Mardas N, 2008, CLIN ORAL IMPLAN RES, V19, P1010, DOI 10.1111/j.1600-0501.2008.01572.x
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   Pang EK, 2005, J PERIODONTOL, V76, P1526, DOI 10.1902/jop.2005.76.9.1526
   Pelaez M, 2014, J CLIN PERIODONTOL, V41, P827, DOI 10.1111/jcpe.12270
   Peterson LJ, 1996, ORAL SURG ORAL MED O, V82, P365
   Petrungaro Paul S, 2005, Implant Dent, V14, P139, DOI 10.1097/01.id.0000163805.98577.ab
   Poehling S, 2006, J PERIODONTOL, V77, P1582, DOI 10.1902/jop.2006.050328
   Pryor ME, 2005, J PERIODONTOL, V76, P1287, DOI 10.1902/jop.2005.76.8.1287
   Pryor ME, 2005, J CLIN PERIODONTOL, V32, P966, DOI 10.1111/j.1600-051X.2005.00772.x
   RIPAMONTI U, 1991, J ORAL MAXIL SURG, V49, P817, DOI 10.1016/0278-2391(91)90010-J
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Sigurdsson TJ, 1997, CLIN ORAL IMPLAN RES, V8, P367, DOI 10.1034/j.1600-0501.1997.080503.x
   Sohn Joo-Yeon, 2010, J Periodontal Implant Sci, V40, P180, DOI 10.5051/jpis.2010.40.4.180
   Spicer PP, 2012, NAT PROTOC, V7, P1918, DOI 10.1038/nprot.2012.113
   Stancoven BW, 2013, J PERIODONTAL RES, V48, P243, DOI 10.1111/jre.12001
   TAKAGI K, 1982, ANN SURG, V196, P100, DOI 10.1097/00000658-198207000-00020
   Vajgel A, 2014, CLIN ORAL IMPLAN RES, V25, P879, DOI 10.1111/clr.12194
   Vehof JWM, 2003, J BIOMED MATER RES A, V64A, P417, DOI 10.1002/jbm.a.10288
   Yoshikawa T, 1996, J BIOMED MATER RES, V32, P481
   Yun JI, 2010, J CLIN PERIODONTOL, V37, P419, DOI 10.1111/j.1600-051X.2010.01547.x
   Zhao H, 2015, NAT CELL BIOL, V17, P386, DOI 10.1038/ncb3139
NR 47
TC 3
Z9 3
U1 4
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1056-6163
J9 IMPLANT DENT
JI Implant Dent.
PD APR
PY 2016
VL 25
IS 2
BP 163
EP 170
DI 10.1097/ID.0000000000000396
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DI0YL
UT WOS:000373223100003
PM 26901636
DA 2018-10-19
ER

PT J
AU Wang, SF
   Ao, JF
   Lv, FJ
   Zhang, QR
   Jiao, TF
AF Wang, Sufeng
   Ao, Jingfen
   Lv, Fengjing
   Zhang, Qingrui
   Jiao, Tifeng
TI The enhanced antibacterial performance by the unique Artemia egg
   shell-supported nano-Ag composites
SO JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS
LA English
DT Article
DE Artemia egg shell; Ag; Composites; Antibacterial
ID WATER DISINFECTION; AQUEOUS-SOLUTION; WASTE-WATER; CHLORINE;
   INACTIVATION; NANOPARTICLES; BACTERIA; OZONE; LIGHT; RESIN
AB Sterilization in waters is a worldwide issue. Herein, we successfully fabricate a new composite biomaterial (denoted shell-Ag) by embedding Ag-0 nanoparticles onto the hierarchical porous structure of Artemia shell using the in-situ deposition method. The resultant shell-Ag exhibits effectively antibacterial activity for both gram-negative bacterium Escherichia coli and the gram-positive bacterium Staphylococcus aureus and the complete sterilization process can be well achieved within 240 min and 360 min, respectively. The bactericidal tests on E. coli and S. aureus show that the MIC (Minimum Inhibitory Concentration) value for both bacteria ranged from 0.32 to 0.62 g/L, and the MBC values (Minimum Bactericidal Concentration) is approximately between 2.5 and 5 g/L. Four cycles tests demonstrate that the shell-Ag also presents the satisfactory Ag slow-release capacity and lasting duration. All the results suggest that the composited shell-Ag is a promising candidate as antibacterial materials. (C) 2016 Taiwan Institute of Chemical Engineers. Published by Elsevier B.V. All rights reserved.
C1 [Wang, Sufeng; Ao, Jingfen; Lv, Fengjing; Zhang, Qingrui; Jiao, Tifeng] Yanshan Univ, Sch Environm & Chem Engn, Hebei Key Lab Appl Chem, 438 Hebei Ave, Qinhuangdao 066004, Peoples R China.
   [Wang, Sufeng; Jiao, Tifeng] Yanshan Univ, State Key Lab Metastable Mat Sci & Technol, 438 Hebei Ave, Qinhuangdao 066004, Peoples R China.
RP Wang, SF; Zhang, QR (reprint author), Yanshan Univ, Sch Environm & Chem Engn, Hebei Key Lab Appl Chem, 438 Hebei Ave, Qinhuangdao 066004, Peoples R China.; Wang, SF (reprint author), Yanshan Univ, State Key Lab Metastable Mat Sci & Technol, 438 Hebei Ave, Qinhuangdao 066004, Peoples R China.
EM sfwang@ysu.edu.cn; zhangqr@ysu.edu.cn
OI Jiao, Tifeng/0000-0003-1238-0277
FU National Natural Science Foundation of China [40830746, 41271102,
   51578476, 21473153]; Key Laboratory of Reservoir Aquatic Environment,
   Chongqing Institute of Green and Intelligent Technology, Chinese Academy
   of Science [RAE2014CE03B]
FX We greatly acknowledge the financial support from the National Natural
   Science Foundation of China (Grant nos. 40830746, 41271102, 51578476 and
   21473153). Key Laboratory of Reservoir Aquatic Environment, Chongqing
   Institute of Green and Intelligent Technology, Chinese Academy of
   Science (Grant no. RAE2014CE03B).
CR Akhavan O, 2011, J MATER CHEM, V21, P387, DOI 10.1039/c0jm02395g
   Akhavan O, 2010, SURF COAT TECH, V204, P3676, DOI 10.1016/j.surfcoat.2010.04.048
   Akhavan O, 2009, CURR APPL PHYS, V9, P1381, DOI 10.1016/j.cap.2009.03.003
   Akhavan O, 2009, J COLLOID INTERF SCI, V336, P117, DOI 10.1016/j.jcis.2009.03.018
   Balamurugan A, 2008, DENT MATER, V24, P1343, DOI 10.1016/j.dental.2008.02.015
   Chord F, 2011, J HOSP INFECT, V78, P163
   Gayan E, 2013, INNOV FOOD SCI EMERG, V19, P140, DOI 10.1016/j.ifset.2013.04.007
   Hassen A, 2000, BIORESOURCE TECHNOL, V72, P85, DOI 10.1016/S0960-8524(99)00086-3
   Helbling DE, 2007, WATER RES, V41, P4424, DOI 10.1016/j.watres.2007.06.006
   Hua GH, 2007, WATER RES, V41, P1667, DOI 10.1016/j.watres.2007.01.032
   Huang L, 2014, MAT SCI ENG C-MATER, V39, P325, DOI 10.1016/j.msec.2014.03.017
   Jyoti KK, 2004, BIOCHEM ENG J, V18, P9, DOI 10.1016/S1369-703X(03)00116-5
   Kawashita M, 2003, J BIOMED MATER RES A, V66A, P266, DOI 10.1002/jbm.a.10547
   Kawashita M, 2000, BIOMATERIALS, V21, P393, DOI 10.1016/S0142-9612(99)00201-X
   Kim BR, 2002, WATER RES, V36, P4433, DOI 10.1016/S0043-1354(02)00188-4
   Li D, 2013, J ENVIRON SCI-CHINA, V25, P1319, DOI 10.1016/S1001-0742(12)60176-4
   Liu Y, 2008, MICROPOR MESOPOR MAT, V114, P431, DOI 10.1016/j.micromeso.2008.01.032
   Mthombeni NH, 2012, J HAZARD MATER, V217, P133, DOI 10.1016/j.jhazmat.2012.03.004
   Nelson KY, 2013, ENVIRON SCI POLLUT R, V20, P5441, DOI 10.1007/s11356-013-1564-6
   Shang C, 2001, WATER RES, V35, P244, DOI 10.1016/S0043-1354(00)00248-7
   Silva GHR, 2010, BIORESOURCE TECHNOL, V101, P6981, DOI 10.1016/j.biortech.2010.04.022
   Tartanson MA, 2014, WATER RES, V63, P135, DOI 10.1016/j.watres.2014.06.019
   Wang SF, 2007, MICROSC RES TECHNIQ, V70, P663, DOI 10.1002/jemt.20451
   Wang SF, 2015, J NANOMATER, DOI 10.1155/2015/963012
   Xu ZW, 2014, ENVIRON SCI POLLUT R, V21, P6571, DOI 10.1007/s11356-014-2556-x
   Zhang QR, 2013, ENVIRON SCI TECHNOL, V47, P6536, DOI 10.1021/es400919t
NR 26
TC 0
Z9 0
U1 2
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-1070
EI 1876-1089
J9 J TAIWAN INST CHEM E
JI J. Taiwan Inst. Chem. Eng.
PD APR
PY 2016
VL 61
BP 336
EP 341
DI 10.1016/j.jtice.2015.12.025
PG 6
WC Engineering, Chemical
SC Engineering
GA DI3RY
UT WOS:000373417400040
DA 2018-10-19
ER

PT J
AU Halgand, B
   Clouet, J
   Smith, A
   Colombier, P
   Lesoeur, J
   Weiss, P
   Hamel, O
   Gauthier, O
   Guicheux, J
   Fusellier, M
AF Halgand, B.
   Clouet, J.
   Smith, A.
   Colombier, P.
   Lesoeur, J.
   Weiss, P.
   Hamel, O.
   Gauthier, O.
   Guicheux, J.
   Fusellier, M.
TI REGENERATIVE MEDICINE OF NUCLEUS PULPOSUS NICHE THROUGH
   BIOMATERIAL-ASSISTED TRANSPLANTATION OF ADIPOSE STROMAL CELL-DERIVED
   NUCLEOPULPOCYTES: PRELIMINARY EXPERIMENTS IN SHEEP
SO OSTEOARTHRITIS AND CARTILAGE
LA English
DT Meeting Abstract
CT World Congress of the Osteoarthritis-Research-Society-International
   (OARSI) on Osteoarthritis
CY MAR 31-APR 03, 2016
CL Amsterdam, NETHERLANDS
SP Osteoarthritis Res Soc Int
C1 [Halgand, B.; Clouet, J.; Smith, A.; Colombier, P.; Lesoeur, J.; Weiss, P.; Hamel, O.; Gauthier, O.; Guicheux, J.; Fusellier, M.] INSERM, UMRS791, LIOAD UFR Odontol Nantes, Nantes, France.
   [Clouet, J.] CHU Nantes, PHU11, Pharm Cent, UFR Sci Biol & Pharmaceut Nantes, F-44035 Nantes 01, France.
   [Gauthier, O.; Fusellier, M.] CRIP ONIRIS, Nantes, France.
RI Fusellier, Marion/P-1541-2014; HALGAND, Boris/P-1301-2014; Weiss,
   Pierre/P-1372-2014; guicheux, Jerome/F-7767-2013
OI HALGAND, Boris/0000-0003-2753-6123; Weiss, Pierre/0000-0002-6159-8590;
   guicheux, Jerome/0000-0003-2754-3024
NR 0
TC 0
Z9 0
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1063-4584
EI 1522-9653
J9 OSTEOARTHR CARTILAGE
JI Osteoarthritis Cartilage
PD APR
PY 2016
VL 24
SU S
MA 793
BP S464
EP S465
DI 10.1016/j.joca.2016.01.847
PG 2
WC Orthopedics; Rheumatology
SC Orthopedics; Rheumatology
GA DI5KW
UT WOS:000373538800823
OA Bronze
DA 2018-10-19
ER

PT J
AU Aamodt, JM
   Grainger, DW
AF Aamodt, Joseph M.
   Grainger, David W.
TI Extracellular matrix-based biomaterial scaffolds and the host response
SO BIOMATERIALS
LA English
DT Review
DE Decellularized; Implants; Integration; ECM; Protein scaffolds; Tissue
   engineering
ID FOREIGN-BODY REACTION; SMALL-INTESTINAL SUBMUCOSA; DECELLULARIZED
   ADIPOSE-TISSUE; STEM-CELL DIFFERENTIATION; DIAMETER VASCULAR GRAFTS;
   CROSS-LINKED COLLAGEN; PORCINE HEART-VALVES; CAGE IMPLANT SYSTEM;
   IN-VIVO; INJECTABLE COLLAGEN
AB Extracellular matrix (ECM) collectively represents a class of naturally derived proteinaceous biomaterials purified from harvested organs and tissues with increasing scientific focus and utility in tissue engineering and repair. This interest stems predominantly from the largely unproven concept that processed ECM biomaterials as natural tissue-derived matrices better integrate with host tissue than purely synthetic biomaterials. Nearly every tissue type has been decellularized and processed for re-use as tissue derived ECM protein implants and scaffolds. To date, however, little consensus exists for defining ECM compositions or sources that best constitute decellularized biomaterials that might better heal, integrate with host tissues and avoid the foreign body response (FBR). Metrics used to assess ECM performance in biomaterial implants are arbitrary and contextually specific by convention. Few comparisons for in vivo host responses to ECM implants from different sources are published. This review discusses current ECM derived biomaterials characterization methods including relationships between ECM material compositions from different sources, properties and host tissue response as implants. Relevant preclinical in vivo models are compared along with their associated advantages and limitations, and the current state of various metrics used to define material integration and biocompatibility are discussed. Commonly applied applications of these ECM-derived biomaterials as stand-alone implanted matrices and devices are compared with respect to host tissue responses. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Aamodt, Joseph M.; Grainger, David W.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
   [Grainger, David W.] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
RP Grainger, DW (reprint author), Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
EM david.grainger@utah.edu
OI Grainger, David/0000-0003-1506-7286
FU NIH [EB011879]
FX Authors acknowledge support from NIH grant EB011879.
CR Akhyari P, 2011, TISSUE ENG PART C-ME, V17, P915, DOI [10.1089/ten.tec.2011.0210, 10.1089/ten.TEC.2011.0210]
   ALBERTS A, 2008, MOL BIOL CELL
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Angius D, 2012, BIOMATERIALS, V33, P8034, DOI 10.1016/j.biomaterials.2012.07.056
   Ansaloni L, 2007, Hernia, V11, P321, DOI 10.1007/s10029-007-0225-4
   Ansaloni L, 2009, AM J SURG, V198, P303, DOI 10.1016/j.amjsurg.2008.09.021
   AUCHINCLOSS H, 1988, TRANSPLANTATION, V46, P1, DOI 10.1097/00007890-198807000-00001
   Aurora A, 2007, J SHOULDER ELB SURG, V16, p171S, DOI 10.1016/j.jse.2007.03.008
   Avula MN, 2014, ACTA BIOMATER, V10, P1856, DOI 10.1016/j.actbio.2013.12.056
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Badylak SF, 2014, ANN BIOMED ENG, V42, P1517, DOI 10.1007/s10439-013-0963-7
   Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6
   Bantscheff M, 2012, ANAL BIOANAL CHEM, V404, P939, DOI 10.1007/s00216-012-6203-4
   Barnes CA, 2011, BIOMATERIALS, V32, P137, DOI 10.1016/j.biomaterials.2010.09.007
   Bee YS, 2015, OPHTHAL PLAST RECONS, V31, P348, DOI 10.1097/IOP.0000000000000339
   BENICHOU G, 1992, J EXP MED, V175, P305, DOI 10.1084/jem.175.1.305
   Bernd O., 2008, ANAL CHIM ACTA, P71
   Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020
   Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018
   Blit PH, 2010, J BIOMED MATER RES A, V94A, P1226, DOI 10.1002/jbm.a.32804
   Boer U, 2011, BIOMATERIALS, V32, P9730, DOI 10.1016/j.biomaterials.2011.09.015
   Bras LED, 2010, J BIOMED MATER RES B, V95B, P239, DOI 10.1002/jbm.b.31704
   Bratlie KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010032
   BREIER G, 1992, DEVELOPMENT, V114, P521
   BROOKS N, 1982, J DERMATOL SURG ONC, V8, P111, DOI 10.1111/j.1524-4725.1982.tb00247.x
   Brown BN, 2011, TISSUE ENG PART C-ME, V17, P411, DOI [10.1089/ten.tec.2010.0342, 10.1089/ten.TEC.2010.0342]
   Brown BN, 2010, BIOMATERIALS, V31, P428, DOI 10.1016/j.biomaterials.2009.09.061
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Canavan HE, 2007, LANGMUIR, V23, P50, DOI 10.1021/la062330o
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Chau DYS, 2005, BIOMATERIALS, V26, P6518, DOI 10.1016/j.biomaterials.2005.04.017
   Chvapil M, 1968, J Biomed Mater Res, V2, P245, DOI 10.1002/jbm.820020208
   COLEMAN DL, 1974, J BIOMED MATER RES, V8, P199, DOI 10.1002/jbm.820080503
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   COOPERMAN L, 1984, J AM ACAD DERMATOL, V10, P638, DOI 10.1016/S0190-9622(84)80271-6
   Cortiella J, 2010, TISSUE ENG PT A, V16, P2565, DOI 10.1089/ten.tea.2009.0730
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Daly KA, 2012, TISSUE ENG PT A, V18, P1293, DOI [10.1089/ten.tea.2011.0597, 10.1089/ten.TEA.2011.0597]
   Deeken CR, 2012, ANN SURG, V255, P595, DOI 10.1097/SLA.0b013e3182445341
   Delgado LM, 2015, TISSUE ENG PART B-RE, V21, P298, DOI [10.1089/ten.teb.2014.0290, 10.1089/ten.TEB.2014.0290]
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dunne LW, 2014, BIOMATERIALS, V35, P4940, DOI 10.1016/j.biomaterials.2014.03.003
   Elder BD, 2009, BIOMATERIALS, V30, P3749, DOI 10.1016/j.biomaterials.2009.03.050
   Elman JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089882
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Flynn LE, 2010, BIOMATERIALS, V31, P4715, DOI 10.1016/j.biomaterials.2010.02.046
   Flynn L, 2007, BIOMATERIALS, V28, P3834, DOI 10.1016/j.biomaterials.2007.05.002
   Fortunati D, 2014, AMINO ACIDS, V46, P1751, DOI 10.1007/s00726-014-1732-0
   Franklin M E Jr, 2002, Hernia, V6, P171
   Franklin ME, 2008, SURG ENDOSC, V22, P1941, DOI 10.1007/s00464-008-0005-y
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   GALILI U, 1987, P NATL ACAD SCI USA, V84, P1369, DOI 10.1073/pnas.84.5.1369
   Gilbert TW, 2009, J SURG RES, V152, P135, DOI 10.1016/j.jss.2008.02.013
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Goh SK, 2013, BIOMATERIALS, V34, P6760, DOI 10.1016/j.biomaterials.2013.05.066
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Gorgieva S, 2011, COLLAGEN VS GELATINE
   Gorham S., 1991, COLLAGEN BIOMATERIAL, P55
   Gould DS, 1999, IMMUNOL TODAY, V20, P77, DOI 10.1016/S0167-5699(98)01394-2
   Grauss RW, 2005, EUR J CARDIO-THORAC, V27, P566, DOI 10.1016/j.ejcts.2004.12.052
   Griffiths LG, 2008, BIOMATERIALS, V29, P3514, DOI 10.1016/j.biomaterials.2008.05.006
   Gui LQ, 2009, TISSUE ENG PT A, V15, P2665, DOI [10.1089/ten.tea.2008.0526, 10.1089/ten.TEA.2008.0526]
   Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902
   Haile LA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125078
   HANKE CW, 1991, J AM ACAD DERMATOL, V25, P319, DOI 10.1016/0190-9622(91)70200-L
   Harbers DWG G. M., 2006, INTRO BIOMATERIALS
   Harbers G. M., 2005, CELL MAT INTERACTION
   He W, 2005, TISSUE ENG, V11, P1574, DOI 10.1089/ten.2005.11.1574
   Hemmi H, 2000, NATURE, V408, P740
   Hernandez P, 2006, MASS SPECTROM REV, V25, P235, DOI 10.1002/mas.20068
   Higgins DM, 2009, AM J PATHOL, V175, P161, DOI 10.2353/ajpath.2009.080962
   Higuchi A, 2013, CHEM REV, V113, P3297, DOI 10.1021/cr300426x
   Himms-Hagen J, 1999, CRIT REV CL LAB SCI, V36, P575, DOI 10.1080/10408369991239259
   Ho KLV, 2004, J UROLOGY, V171, P268, DOI 10.1097/01.ju.0000098680.60020.32
   Hoganson DM, 2010, BIOMATERIALS, V31, P6730, DOI 10.1016/j.biomaterials.2010.05.019
   Holt DJ, 2012, ADV DRUG DELIVER REV, V64, P1123, DOI 10.1016/j.addr.2012.04.002
   Holt DJ, 2010, BIOMATERIALS, V31, P9382, DOI 10.1016/j.biomaterials.2010.07.101
   Honda A, 2015, EXP ANIM TOKYO, V64, P31, DOI 10.1538/expanim.14-0034
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129
   Jones CF, 2009, ADV DRUG DELIVER REV, V61, P438, DOI 10.1016/j.addr.2009.03.005
   Jus S, 2011, MAT SCI ENG C-MATER, V31, P1068, DOI 10.1016/j.msec.2011.03.007
   KAMER FM, 1984, ARCH OTOLARYNGOL, V110, P93
   Karayel E, 2009, EUR J IMMUNOL, V39, P1929, DOI 10.1002/eji.200939344
   Karp G., 2010, CELL MOL BIOL CONCEP
   Kasimir MT, 2003, INT J ARTIF ORGANS, V26, P421
   KEEFE J, 1992, Clinical Materials, V9, P155, DOI 10.1016/0267-6605(92)90095-B
   Kenneth Ward W, 2008, J Diabetes Sci Technol, V2, P768
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   Kheir E, 2011, J BIOMED MATER RES A, V99A, P283, DOI 10.1002/jbm.a.33171
   Khouw IMSL, 2000, J BIOMED MATER RES, V50, P259, DOI 10.1002/(SICI)1097-4636(200005)50:2<259::AID-JBM21>3.0.CO;2-B
   Kidd KR, 2002, J BIOMED MATER RES, V59, P682, DOI 10.1002/jbm.10032
   Kim J, 2010, J BIOMED MATER RES A, V95A, P191, DOI 10.1002/jbm.a.32810
   Konstantinovic ML, 2005, BJOG-INT J OBSTET GY, V112, P1554, DOI 10.1111/j.1471-0528.2005.00688.x
   Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971
   Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Kyriakides TR, 1999, P NATL ACAD SCI USA, V96, P4449, DOI 10.1073/pnas.96.8.4449
   Kyriakides TR, 2003, THROMB HAEMOSTASIS, V90, P986, DOI 10.1160/TH03-06-0399
   Laschke M. W., 2011, EUR CELLS MATER, V22, P147
   Laschke MW, 2005, J BIOMED MATER RES A, V74A, P696, DOI 10.1002/jbm.a.30371
   Lee CY, 2007, J AM CHEM SOC, V129, P9429, DOI 10.1021/ja071879m
   Li QY, 2016, BIOMATERIALS, V75, P37, DOI 10.1016/j.biomaterials.2015.10.011
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Lopez-Soler RI, 2007, J SURG RES, V139, P1, DOI 10.1016/j.jss.2006.07.040
   Lu T.-Y., 2013, NAT COMMUN, P4
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Luttikhuizen DT, 2007, J TISSUE ENG REGEN M, V1, P398, DOI 10.1002/term.50
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Magalhaes PO, 2007, J PHARM PHARM SCI, V10, P388
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   MCPHERSON IM, 1986, J BIOMED MATER RES, V20, P93
   McPherson TB, 2000, TISSUE ENG, V6, P233, DOI 10.1089/10763270050044416
   Medberry CJ, 2012, J SURG RES, V173, P38, DOI 10.1016/j.jss.2010.08.035
   MERGENHAGEN SE, 1960, BIOCHIM BIOPHYS ACTA, V43, P563, DOI 10.1016/0006-3002(60)90488-1
   Mermoud A, 1999, J CATARACT REFR SURG, V25, P323, DOI 10.1016/S0886-3350(99)80079-0
   Mescher A. L., 2010, JUNQUEIRAS BASIC HIS
   Mooney JE, 2010, AM J PATHOL, V176, P369, DOI 10.2353/ajpath.2010.090545
   Nalepka JL, 2004, BIOTECHNIQUES, V37, P413, DOI 10.2144/04373ST06
   Nesvizhskii AI, 2010, J PROTEOMICS, V73, P2092, DOI 10.1016/j.jprot.2010.08.009
   Nie X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135073
   Niu G., 2013, J SCI APPL BIOMED, V1, P1
   Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047
   Onuki Yoshinori, 2008, J Diabetes Sci Technol, V2, P1003
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Parker David M, 2006, Curr Surg, V63, P255, DOI 10.1016/j.cursur.2006.05.003
   Parker MW, 2014, J CLIN INVEST, V124, P1622, DOI 10.1172/JCI71386
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Petter-Puchner AH, 2006, SURG ENDOSC, V20, P942, DOI 10.1007/s00464-005-0568-9
   Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Pullinger BD, 1942, J PATHOL BACTERIOL, V54, P341, DOI 10.1002/path.1700540308
   Ragab AA, 1999, J ORTHOPAED RES, V17, P803, DOI 10.1002/jor.1100170603
   Rammelt S, 2004, J ORTHOPAED RES, V22, P1025, DOI 10.1016/j.orthres.2004.02.011
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009
   Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017
   Roch T, 2014, CLIN HEMORHEOL MICRO, V57, P203, DOI 10.3233/CH-141831
   Rodriguez A, 2009, J BIOMED MATER RES A, V90A, P106, DOI 10.1002/jbm.a.32050
   Ronneberger B, 1996, J BIOMED MATER RES, V30, P31
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Rothamel D, 2005, CLIN ORAL IMPLAN RES, V16, P369, DOI 10.1111/j.1600-0501.2005.01108.x
   Rowland C. R., 2012, J LONG-TERM EFF MED, P22
   Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1595, DOI 10.1016/j.addr.2003.08.003
   Salmi J, 2009, PROTEOMICS, V9, P848, DOI 10.1002/pmic.200800517
   Sandor M, 2008, TISSUE ENG PT A, V14, P2021, DOI 10.1089/ten.tea.2007.0317
   SANDRIN MS, 1994, IMMUNOL REV, V141, P169, DOI 10.1111/j.1600-065X.1994.tb00877.x
   Schenke-Layland K, 2004, MATRIX BIOL, V23, P113, DOI 10.1016/j.matbio.2004.03.005
   Schenke-Layland K, 2003, J STRUCT BIOL, V143, P201, DOI 10.1016/j.jsb.2003.08.002
   Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307
   Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311
   Simon CG, 2015, J BIOMED MATER RES B, V103, P949, DOI 10.1002/jbm.b.33286
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   Sinani VA, 2003, NANO LETT, V3, P1177, DOI 10.1021/nl0255045
   Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x
   Stacey KJ, 1996, J IMMUNOL, V157, P2116
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Takahashi H, 2010, J CONTROL RELEASE, V147, P400, DOI 10.1016/j.jconrel.2010.08.019
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Thevenot PT, 2011, BIOMATERIALS, V32, P8394, DOI 10.1016/j.biomaterials.2011.07.084
   Ueno T, 2004, J GASTROINTEST SURG, V8, P109, DOI 10.1016/j.gassur.2003.09.025
   Umashankar PR, 2011, J BIOMED MATER RES A, V97A, P311, DOI 10.1002/jbm.a.33061
   Ung DY, 1999, J BIOMED MATER RES, V46, P324, DOI 10.1002/(SICI)1097-4636(19990905)46:3<324::AID-JBM3>3.0.CO;2-5
   UNGAR H, 1953, AM J PATHOL, V29, P963
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   van Tienen TG, 2002, BIOMATERIALS, V23, P1731, DOI 10.1016/S0142-9612(01)00280-0
   VAUGHAN HA, 1994, TRANSPLANTATION, V58, P879, DOI 10.1097/00007890-199410270-00003
   Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06
   Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025
   Welham NV, 2013, BIOMATERIALS, V34, P669, DOI 10.1016/j.biomaterials.2012.09.050
   Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8
   Whitlock PW, 2007, BIOMATERIALS, V28, P4321, DOI 10.1016/j.biomaterials.2007.05.029
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wolf MT, 2012, BIOMATERIALS, V33, P7028, DOI 10.1016/j.biomaterials.2012.06.051
   Wong ML, 2014, ACTA BIOMATER, V10, P1806, DOI 10.1016/j.actbio.2014.01.028
   Wong V. W., 2010, BIOMED RES INT
   Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050615
   Yu C, 2013, BIOMATERIALS, V34, P3290, DOI 10.1016/j.biomaterials.2013.01.056
   Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580
   Zheng MH, 2005, J BIOMED MATER RES B, V73B, P61, DOI 10.1002/jbm.b.30170
NR 197
TC 49
Z9 49
U1 14
U2 135
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2016
VL 86
BP 68
EP 82
DI 10.1016/j.biomaterials.2016.02.003
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DG9FE
UT WOS:000372387400007
PM 26890039
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Montufar, EB
   Horynova, M
   Casas-Luna, M
   Diaz-De-La-Torre, S
   Celko, L
   Klakurkova, L
   Spotz, Z
   Dieguez-Trejo, G
   Fohlerova, Z
   Dvorak, K
   Zikmund, T
   Kaiser, J
AF Montufar, Edgar B.
   Horynova, Miroslava
   Casas-Luna, Mariano
   Diaz-De-La-Torre, Sebastian
   Celko, Ladislav
   Klakurkova, Lenka
   Spotz, Zdenek
   Dieguez-Trejo, Guillermo
   Fohlerova, Zdenka
   Dvorak, Karel
   Zikmund, Tomas
   Kaiser, Jozef
TI Spark Plasma Sintering of Load-Bearing Iron-Carbon Nanotube-Tricalcium
   Phosphate CerMets for Orthopaedic Applications
SO JOM
LA English
DT Article
ID FUNCTIONALLY GRADED BIOMATERIAL; POWDER-METALLURGY METHOD; HARD-TISSUE
   REPLACEMENT; IN-VITRO; COMPOSITES; HYDROXYAPATITE; CALCIUM; VIVO;
   OSTEOBLASTS; BIOACTIVITY
AB Recently, ceramic-metallic composite materials (CerMets) have been investigated for orthopaedic applications with promising results. This first generation of bio-CerMets combine the bioactivity of hydroxyapatite with the mechanical stability of titanium to fabricate bioactive, tough and biomechanically more biocompatible osteosynthetic devices. Nonetheless, these first CerMets are not biodegradable materials and a second surgery is required to remove the implant after bone healing. The present work aims to develop the next generation bio-CerMets, which are potential biodegradable materials. The process to produce the new biodegradable CerMet consisted of mixing powder of soluble and osteoconductive alpha tricalcium phosphate with biocompatible and biodegradable iron with consolidation through spark plasma sintering (SPS). The microstructure, composition and mechanical strength of the new CerMet were studied by metallography, x-ray diffraction and diametral tensile strength tests, respectively. The results show that SPS produces CerMet with higher mechanical performance (120 MPa) than the ceramic component alone (29 MPa) and similar mechanical strength to the pure metallic component (129 MPa). Nonetheless, although a short sintering time (10 min) was used, partial transformation of the alpha tricalcium phosphate into its allotropic and slightly less soluble beta phase was observed. Cell adhesion tests show that osteoblasts are able to attach to the CerMet surface, presenting spread morphology regardless of the component of the material with which they are in contact. However, the degradation process restricted to the small volume of the cell culture well quickly reduces the osteoblast viability.
C1 [Montufar, Edgar B.; Horynova, Miroslava; Casas-Luna, Mariano; Celko, Ladislav; Klakurkova, Lenka; Spotz, Zdenek; Fohlerova, Zdenka; Zikmund, Tomas; Kaiser, Jozef] Brno Univ Technol, CEITEC BUT, Cent European Inst Technol, CS-61090 Brno, Czech Republic.
   [Diaz-De-La-Torre, Sebastian; Dieguez-Trejo, Guillermo] Ctr Invest & Innovac Tecnol CIITEC, Inst Politecn Nacl, Mexico City, DF, Mexico.
   [Dvorak, Karel] Brno Univ Technol, Fac Civil Engn, CS-61090 Brno, Czech Republic.
RP Montufar, EB (reprint author), Brno Univ Technol, CEITEC BUT, Cent European Inst Technol, CS-61090 Brno, Czech Republic.
EM eb.montufar@ceitec.vutbr.cz
RI Montufar, Edgar/F-8040-2016; DvoAAk, Karel/K-2385-2014; Kaiser,
   Jozef/D-6800-2012; Zikmund, Tomas/G-9491-2014; Fohlerova,
   Zdenka/A-6893-2013; Celko, Ladislav/D-6870-2012; Casas Luna,
   Mariano/J-4074-2018; Horynova, Miroslava/E-4346-2012
OI Montufar, Edgar/0000-0002-8122-4000; DvoAAk, Karel/0000-0003-2111-3357;
   Kaiser, Jozef/0000-0002-7397-125X; Fohlerova,
   Zdenka/0000-0002-1232-2301; Celko, Ladislav/0000-0003-0264-3483;
   Horynova, Miroslava/0000-0003-3856-789X
FU European Regional Development Fund [CZ.1.05/1.1.00/02.0068]; Conacyt-SNI
   [P. 1777000]
FX The authors acknowledge the financial support provided in the frame of
   the Project "CEITEC-Central European Institute of Technology''
   (CZ.1.05/1.1.00/02.0068) by European Regional Development Fund. Part of
   the work was carried out with the support of core facilities of research
   infrastructure CEITEC Nano of CEITEC-Brno University of Technology. SDT
   acknowledges to Conacyt-SNI (P. 1777000). Special thanks to Dr. M.
   Rampichova from Czech Technical University in Prague for supplying the
   cells for this work.
CR [Anonymous], 2010, F108804A ASTM
   [Anonymous], 2010, E40707 ASTM
   Arifin A, 2014, MATER DESIGN, V55, P165, DOI 10.1016/j.matdes.2013.09.045
   Bakshi SR, 2010, INT MATER REV, V55, P41, DOI 10.1179/095066009X12572530170543
   BERENBAUM R, 1959, BRIT J APPL PHYS, V10, P281, DOI 10.1088/0508-3443/10/6/307
   BOHNER M, 2000, INJURY, V31, pD37, DOI DOI 10.1016/S0020-1383(00)80022-4
   Bresciani Eduardo, 2004, J. Appl. Oral Sci., V12, P344, DOI 10.1590/S1678-77572004000400017
   Carrodeguas RG, 2011, ACTA BIOMATER, V7, P3536, DOI 10.1016/j.actbio.2011.06.019
   Cheng J, 2013, J BIOMED MATER RES B, V101B, P485, DOI 10.1002/jbm.b.32783
   Chu CL, 2006, MAT SCI ENG A-STRUCT, V429, P18, DOI 10.1016/j.msea.2006.03.099
   Chu CL, 2006, J MATER SCI-MATER M, V17, P245, DOI 10.1007/s10856-006-7310-6
   Chu CL, 2004, J MATER SCI-MATER M, V15, P665, DOI 10.1023/B:JMSM.0000030207.16887.f2
   Chu CL, 1999, MAT SCI ENG A-STRUCT, V271, P95, DOI 10.1016/S0921-5093(99)00152-5
   Elliott JC, 1994, STRUCTURE CHEM APATI, V18, P1
   ETTMAYER P, 1995, INT J REFRACT MET H, V13, P343, DOI 10.1016/0263-4368(95)00027-G
   Francis A, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5473-8
   Ginebra MP, 1999, J AM CERAM SOC, V82, P2808
   Hallab NJ, 2002, J BIOMED MATER RES, V60, P420, DOI 10.1002/jbm.10106
   Jafari S, 2015, JOM-US, V67, P1143, DOI 10.1007/s11837-015-1366-z
   Karrholm J, 2008, CLIN ORTHOP RELAT R, V466, P380, DOI 10.1007/s11999-007-0039-9
   Kirkland N. T., 2014, MAGNESIUM BIOMATERIA, P73
   Kumar A, 2013, ACTA MATER, V61, P5198, DOI 10.1016/j.actamat.2013.05.013
   LeGeros RZ, 2003, KEY ENG MAT, V240-2, P3, DOI 10.4028/www.scientific.net/KEM.240-242.3
   Marie J.P., 2010, BONE, V46, P571, DOI DOI 10.1016/J.BONE.2009.07.082
   Montufar EB, 2013, ACTA BIOMATER, V9, P6188, DOI 10.1016/j.actbio.2012.11.028
   Mulukutla M, 2010, JOM-US, V62, P65, DOI 10.1007/s11837-010-0090-y
   Ning CQ, 2008, ACTA BIOMATER, V4, P1944, DOI 10.1016/j.actbio.2008.04.015
   Ning CQ, 2002, BIOMATERIALS, V23, P2909, DOI 10.1016/S0142-9612(01)00419-7
   Orru R, 2009, MAT SCI ENG R, V63, P127, DOI 10.1016/j.mser.2008.09.003
   Procopio AT, 2003, J MATER SCI, V38, P3629, DOI 10.1023/A:1025681432260
   Rajabi A, 2015, MATER DESIGN, V67, P95, DOI 10.1016/j.matdes.2014.10.081
   Reindl A, 2014, J MATER SCI, V49, P8234, DOI 10.1007/s10853-014-8532-5
   Santos L.A., 1999, BONE, V25, p99S
   Schmittenbecher PP, 2013, EUR J TRAUMA EMERG S, V39, P345, DOI 10.1007/s00068-013-0286-2
   Shepherd JH, 2011, JOM-US, V63, P83, DOI 10.1007/s11837-011-0063-9
   Ulum MF, 2014, MAT SCI ENG C-MATER, V36, P336, DOI 10.1016/j.msec.2013.12.022
   Wang LJ, 2013, INT J REFRACT MET H, V39, P103, DOI 10.1016/j.ijrmhm.2013.01.017
   Zheng YF, 2014, MAT SCI ENG R, V77, P1, DOI 10.1016/j.mser.2014.01.001
   Zhou HJ, 2010, J MATER SCI-MATER M, V21, P2175, DOI 10.1007/s10856-010-4083-8
NR 39
TC 2
Z9 2
U1 4
U2 35
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1047-4838
EI 1543-1851
J9 JOM-US
JI JOM
PD APR
PY 2016
VL 68
IS 4
BP 1134
EP 1142
DI 10.1007/s11837-015-1806-9
PG 9
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Mineralogy; Mining & Mineral Processing
SC Materials Science; Metallurgy & Metallurgical Engineering; Mineralogy;
   Mining & Mineral Processing
GA DH9QQ
UT WOS:000373131200012
DA 2018-10-19
ER

PT J
AU Back, JH
   Cho, WJ
   Kim, JH
   Park, IK
   Kwon, SW
AF Back, Ja Hoon
   Cho, Wan Jin
   Kim, Jun Ho
   Park, Il Kyu
   Kwon, Sung Won
TI Application of hyaluronic acid/sodium alginate-based microparticles to
   prevent tissue adhesion in a rabbit model
SO SURGERY TODAY
LA English
DT Article
DE Adhesion prevention; Microparticle; Hyaluronic acid/sodium alginate;
   Rabbit model
ID POSTOPERATIVE ABDOMINAL ADHESIONS; LAPAROSCOPIC MYOMECTOMY; ACID;
   SURGERY; CARBOXYMETHYLCELLULOSE; REDUCTION; MEMBRANE; EFFICACY; GEL
AB Purpose Postsurgical adhesion formation is a concern in every field of surgery. We evaluated the efficacy of hyaluronic acid/sodium alginate-based microparticle anti-adhesive agents (MP) for the prevention of postsurgical adhesion formation in a standardized rabbit model.
   Method To evaluate the anti-adhesion effect, a uterusabdominal wall abrasion model was created in rabbits. On the surface of the injured uterus, an anti-adhesive agent, Interceed (R) or MP, was applied (positive control and study groups, respectively; n = 10 each). In another group of 10 animals, neither agent was applied (negative control group). The adhesion levels were graded 3 weeks after surgery. Acute and chronic toxicity was also evaluated.
   Results The grade of adhesion was significantly lower in the MP group than in the negative control and positive control groups. No evidence of acute or chronic toxicity induced by this material was found in blood and tissue analysis.
   Conclusion MP shows potential as an effective novel type of resorbable biomaterial to reduce postoperative adhesion. The easy placement and handling of this material make the MP powder attractive as a tissue adhesion barrier.
C1 [Back, Ja Hoon; Kwon, Sung Won] CHA Univ, CHA Bundang Med Ctr, Dept Surg, 59 Yatap Ro, Songnam 463712, Gyeonggi Do, South Korea.
   [Cho, Wan Jin; Kim, Jun Ho; Park, Il Kyu] Genewel Co Ltd, R&D Ctr, 37 Sagimakgol Ro 62 Beon Gil, Songnam 462738, Gyeonggi Do, South Korea.
RP Kwon, SW (reprint author), CHA Univ, CHA Bundang Med Ctr, Dept Surg, 59 Yatap Ro, Songnam 463712, Gyeonggi Do, South Korea.
EM wizard95@cha.ac.kr
OI Kwon, Sung Won/0000-0002-1610-5726
FU SMBA [08-1-14]
FX We received a research grant from SMBA (08-1-14).
CR Almeida O D Jr, 1997, J Am Assoc Gynecol Laparosc, V4, P587, DOI 10.1016/S1074-3804(05)80093-3
   Attard JAP, 2007, CAN J SURG, V50, P291
   Becker JM, 1996, J AM COLL SURGEONS, V183, P297
   Boland GM, 2006, J SURG RES, V132, P3, DOI 10.1016/j.jss.2005.12.002
   Bowersock TL, 1997, CONTROLLED DRUG DELI, P281
   De Iaco PA, 1998, FERTIL STERIL, V69, P318
   Dijkstra FR, 2000, SCAND J GASTROENTE S, V232, P52
   Falk K, 2001, BRIT J SURG, V88, P286, DOI 10.1046/j.1365-2168.2001.01647.x
   FRASER JRE, 1984, CLIN EXP PHARMACOL P, V11, P17, DOI 10.1111/j.1440-1681.1984.tb00235.x
   Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x
   Ishikawa K, 2013, SURG TODAY, V43, P412, DOI 10.1007/s00595-012-0249-y
   Kwon SW, 2006, J KOREAN SURG SOC, V71, P280
   Marana R, 2000, PERITONEAL SURG, P329
   MENZIES D, 1993, ANN ROY COLL SURG, V75, P147
   Miller RS, 2003, OTOLARYNG HEAD NECK, V128, P862, DOI 10.1016/S0194-5998(03)00460-1
   MOLL HD, 1992, AM J VET RES, V53, P1454
   Okabayashi K, 2014, SURG TODAY, V44, P405, DOI 10.1007/s00595-013-0591-8
   Parker MC, 2001, DIS COLON RECTUM, V44, P822, DOI 10.1007/BF02234701
   Pellicano M, 2003, FERTIL STERIL, V80, P441, DOI 10.1016/S0015-0282(03)00597-1
   Ray NF, 1998, J AM COLL SURGEONS, V186, P1, DOI 10.1016/S1072-7515(97)00127-0
   Rodgers KE, 1997, FERTIL STERIL, V67, P553, DOI 10.1016/S0015-0282(97)80085-4
   Shim HS, 2002, J KOREAN SURG SOC, V63, P179
   Shimizu A, 2014, SURG TODAY, V44, P314, DOI 10.1007/s00595-013-0530-8
   Takeuchi H, 2008, FERTIL STERIL, V89, P1247, DOI 10.1016/j.fertnstert.2007.05.021
   Tsujimoto H, 2014, SURG TODAY, V44, P391, DOI 10.1007/s00595-013-0608-3
   URMAN B, 1991, FERTIL STERIL, V56, P568
   Vrijland WW, 2002, ANN SURG, V235, P193, DOI 10.1097/00000658-200202000-00006
   YAACOBI Y, 1993, J SURG RES, V55, P422, DOI 10.1006/jsre.1993.1163
   Yang HY, 1997, J KOREAN SURG SOC, V52, P335
NR 29
TC 4
Z9 5
U1 0
U2 21
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0941-1291
EI 1436-2813
J9 SURG TODAY
JI Surg. Today
PD APR
PY 2016
VL 46
IS 4
BP 501
EP 508
DI 10.1007/s00595-015-1186-3
PG 8
WC Surgery
SC Surgery
GA DI0BH
UT WOS:000373159300016
PM 25990765
DA 2018-10-19
ER

PT J
AU Rediguieri, CF
   Pinto, TDA
   Bou-Chacra, NA
   Galante, R
   de Araujo, GLB
   Pedrosa, TD
   Maria-Engler, SS
   De Bank, PA
AF Rediguieri, Carolina Fracalossi
   Andreoli Pinto, Terezinha de Jesus
   Bou-Chacra, Nadia Araci
   Galante, Raquel
   Barros de Araujo, Gabriel Lima
   Pedrosa, Tatiana do Nascimento
   Maria-Engler, Silvya Stuchi
   De Bank, Paul A.
TI Ozone Gas as a Benign Sterilization Treatment for PLGA Nanofiber
   Scaffolds
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID STEM-CELLS; POLY(LACTIDE-CO-GLYCOLIDE) PLGA; BIOMEDICAL APPLICATIONS;
   REGENERATIVE MEDICINE; POLY(L-LACTIDE) PLLA; GAMMA-IRRADIATION; POROUS
   SCAFFOLDS; ELECTROSPUN PLGA; DIFFERENTIATION; FABRICATION
AB The use of electrospun nanofibers for tissue engineering and regenerative medicine applications is a growing trend as they provide improved support for cell proliferation and survival due, in part, to their morphology mimicking that of the extracellular matrix. Sterilization is a critical step in the fabrication process of implantable biomaterial scaffolds for clinical use, but many of the existing methods used to date can negatively affect scaffold properties and performance. Poly(lactic-co-glycolic acid) (PLGA) has been widely used as a biodegradable polymer for 3D scaffolds and can be significantly affected by current sterilization techniques. The aim of this study was to investigate pulsed ozone gas as an alternative method for sterilizing PLGA nanofibers. The morphology, mechanical properties, physicochemical properties, and response of cells to PLGA nanofiber scaffolds were assessed following different degrees of ozone gas sterilization. This treatment killed Geobacillus stearothermophilus spores, the most common biological indicator used for validation of sterilization processes. In addition, the method preserved all of the characteristics of nonsterilized PLGA nanofibers at all degrees of sterilization tested. These findings suggest that ozone gas can be applied as an alternative method for sterilizing electrospun PLGA nanofiber scaffolds without detrimental effects.
C1 [Rediguieri, Carolina Fracalossi; Andreoli Pinto, Terezinha de Jesus; Bou-Chacra, Nadia Araci; Galante, Raquel; Barros de Araujo, Gabriel Lima] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Farmacia, Sao Paulo, Brazil.
   [Rediguieri, Carolina Fracalossi] Agencia Nacl Vigilancia Santaria, Brasilia, DF, Brazil.
   [Galante, Raquel] Univ Lisbon, Inst Super Tecn, Ctr Quim Estrutural, P-1699 Lisbon, Portugal.
   [Pedrosa, Tatiana do Nascimento; Maria-Engler, Silvya Stuchi; De Bank, Paul A.] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Analises Clin & Toxicol, Sao Paulo, Brazil.
   [De Bank, Paul A.] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England.
   [De Bank, Paul A.] Univ Bath, Ctr Regenerat Med, Bath BA2 7AY, Avon, England.
RP De Bank, PA (reprint author), Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England.; De Bank, PA (reprint author), Univ Bath, Ctr Regenerat Med, Bath BA2 7AY, Avon, England.; Rediguieri, CF (reprint author), Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Farmacia, Av Prof Lineu Prestes,580-B13 Cidade Univ, BR-05508000 Sao Paulo, Brazil.
EM carolina.rediguieri@usp.br; p.debank@bath.ac.uk
RI GALANTE, RAQUEL/K-2512-2014; Maria-Engler, Silvya/K-5936-2016; Pinto,
   Terezinha/C-4777-2012
OI GALANTE, RAQUEL/0000-0001-8616-4775; Maria-Engler,
   Silvya/0000-0003-4771-6041; Araujo, Gabriel/0000-0001-7590-3587; do
   Nascimento Pedrosa, Tatiana/0000-0003-0009-1013; De Bank,
   Paul/0000-0002-5717-7486; Pinto, Terezinha de Jesus
   Andreoli/0000-0002-0238-8227; Rediguieri, Carolina/0000-0002-3088-4535
FU National Council of Technological and Scientific Development of Brazil
   [CNPq-248814/2013-3]; University of Sao Paulo; University of Bath Global
   Partner Research Scholarship Scheme
FX The authors would like to thank the National Council of Technological
   and Scientific Development of Brazil (CNPq-248814/2013-3), the
   University of Sao Paulo, and the University of Bath Global Partner
   Research Scholarship Scheme for funding this research. They gratefully
   acknowledge Mrs. Tais Cecchi (Brasil Ozonio) for the use of the ozone
   sterilizer, Mr William Capelupi (TA Instruments, Sao Paulo) for access
   to their laboratory facility in Sao Paulo, Mr Nick Waywell (Department
   of Mechanical Engineering, University of Bath) for advice on mechanical
   testing, and Dr Ursula Potter and Dr John Mitchels (Microscopy and
   Analysis Suite, University of Bath) for their help and advice with
   electron microscopy.
CR Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014
   Andrews KD, 2007, BIOMATERIALS, V28, P1014, DOI 10.1016/j.biomaterials.2006.10.014
   Asti A, 2014, INT J ARTIF ORGANS, V37, P187, DOI [10.5301/ijao.5000307, 10.530/ijao.5000307]
   Bailey NA, 2002, J APPL POLYM SCI, V86, P1868, DOI 10.1002/app.11109
   Beachley V, 2010, PROG POLYM SCI, V35, P868, DOI 10.1016/j.progpolymsci.2010.03.003
   Bilgin S, 2013, POLYMER, V54, P6665, DOI 10.1016/j.polymer.2013.10.019
   Bini TB, 2004, NANOTECHNOLOGY, V15, P1459, DOI 10.1088/0957-4484/15/11/014
   Blackwood KA, 2008, BIOMATERIALS, V29, P3091, DOI 10.1016/j.biomaterials.2008.03.037
   Bosworth LA, 2012, J POLYM SCI POL PHYS, V50, P870, DOI 10.1002/polb.23072
   Braghirolli DI, 2014, J BIOMED MATER RES B, V102, P700, DOI 10.1002/jbm.b.33049
   Cantara SI, 2012, BIOMATERIALS, V33, P8372, DOI 10.1016/j.biomaterials.2012.08.021
   Charpentier PA, 2006, APPL SURF SCI, V252, P6360, DOI 10.1016/j.apsusc.2005.09.064
   Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031
   Danmark S, 2011, ACTA BIOMATER, V7, P2035, DOI 10.1016/j.actbio.2011.02.011
   Dong YX, 2008, TISSUE ENG PT A, V14, P1321, DOI 10.1089/ten.tea.2007.0395
   Dufresne S, 2008, AM J INFECT CONTROL, V36, P291, DOI 10.1016/j.ajic.2007.06.006
   Full SM, 2015, J BIOMED MATER RES B, V103, P39, DOI 10.1002/jbm.b.33153
   GURLEY B, 1985, Journal of Parenteral Science and Technology, V39, P256
   Ho MH, 2007, MACROMOL BIOSCI, V7, P467, DOI 10.1002/mabi.200600241
   ISO, 2009, 149372009 ISO
   Ji W, 2011, PHARM RES-DORDR, V28, P1259, DOI 10.1007/s11095-010-0320-6
   Jia L, 2014, J BIOMATER APPL, V29, P364, DOI 10.1177/0885328214529002
   Jia L, 2013, MAT SCI ENG C-MATER, V33, P4640, DOI 10.1016/j.msec.2013.07.021
   Kai D, 2013, BIOTECHNOL J, V8, P59, DOI 10.1002/biot.201200249
   Kikkawa Y, 2013, J MATER CHEM A, V1, P4667, DOI 10.1039/c3ta01670f
   Kim TG, 2006, TISSUE ENG, V12, P221, DOI 10.1089/ten.2006.12.221
   Kwon JH, 2005, J BIOACT COMPAT POL, V20, P361, DOI 10.1177/0883911505055386
   Lee J. B., 2015, J NANOMATER, V2015
   Lee JJ, 2008, J BIOMAT SCI-POLYM E, V19, P1637, DOI 10.1163/156856208786440497
   Lee JB, 2010, MACROMOL RES, V18, P1195, DOI 10.1007/s13233-010-1206-5
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Lim SH, 2009, ADV DRUG DELIVER REV, V61, P1084, DOI 10.1016/j.addr.2009.07.011
   Loo JSC, 2005, BIOMATERIALS, V26, P1359, DOI 10.1016/j.biomaterials.2004.05.001
   Loo SCJ, 2004, POLYM DEGRAD STABIL, V83, P259, DOI 10.1016/S0141-3910(03)00271-4
   Meng ZX, 2013, MAT SCI ENG C-MATER, V33, P699, DOI 10.1016/j.msec.2012.10.021
   Mitchell SA, 2004, BIOMATERIALS, V25, P4079, DOI 10.1016/j.biomaterials.2003.11.010
   Moat J, 2009, CAN J MICROBIOL, V55, P928, DOI [10.1139/W09-046, 10.1139/w09-046]
   Montanari L, 1998, J CONTROL RELEASE, V56, P219, DOI 10.1016/S0168-3659(98)00082-0
   Morris GE, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/3/035014
   Pan Z, 2012, INTERFACE FOCUS, V2, P366, DOI 10.1098/rsfs.2011.0123
   Park J., 2013, INT J CONTROL AUTOM, V6, P73
   Pinto TJA, 2010, CONTROLE BIOL QUALID
   Prabhakaran MP, 2014, J BIOMED MATER RES B, V102, P447, DOI 10.1002/jbm.b.33022
   Pulikkot S, 2014, CELL PROLIFERAT, V47, P553, DOI 10.1111/cpr.12141
   Rouse JJ, 2007, INT J PHARM, V339, P112, DOI 10.1016/j.ijpharm.2007.02.026
   Sefat F, 2013, PROCEDIA ENGINEER, V59, P101, DOI 10.1016/j.proeng.2013.05.099
   Selim M, 2011, BJU INT, V107, P296, DOI 10.1111/j.1464-410X.2010.09310.x
   Sousa CS, 2011, REV ESC ENFERM USP, V45, P1238
   Subramanian A, 2012, ANN BIOMED ENG, V40, P2098, DOI 10.1007/s10439-012-0592-6
   Subramanian A, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/2/025004
   Suh H, 2001, BIOMATERIALS, V22, P219, DOI 10.1016/S0142-9612(00)00177-0
   Paragkumar NT, 2006, APPL SURF SCI, V253, P2758, DOI 10.1016/j.apsusc.2006.05.047
   Thorvaldsson A, 2008, BIOMACROMOLECULES, V9, P1044, DOI 10.1021/bm701225a
   US Food and Drug Administration, 2004, GUID IND STER DRUG P
   US Pharmacopeial Convention Inc, 2012, US PHARM NAT FORM US
   WHO, 2011, WHO TECH REP SER, V961, P1
   World Health Organization, 2014, INT PHARM
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yeatts AB, 2014, TISSUE ENG PT A, V20, P139, DOI [10.1089/ten.tea.2013.0168, 10.1089/ten.TEA.2013.0168]
   Yoo HS, 2009, ADV DRUG DELIVER REV, V61, P1033, DOI 10.1016/j.addr.2009.07.007
NR 60
TC 6
Z9 6
U1 0
U2 18
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD APR 1
PY 2016
VL 22
IS 4
BP 338
EP 347
DI 10.1089/ten.tec.2015.0298
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA DI1EA
UT WOS:000373237600005
PM 26757850
OA Green Published
DA 2018-10-19
ER

PT J
AU Thomas, D
   Thirumaran, A
   Mallard, B
   Chen, XZ
   Browne, S
   Wheatley, AM
   O'Brien, T
   Pandit, A
AF Thomas, Dilip
   Thirumaran, Arun
   Mallard, Beth
   Chen, Xizhe
   Browne, Shane
   Wheatley, Antony M.
   O'Brien, Timothy
   Pandit, Abhay
TI Variability in Endogenous Perfusion Recovery of Immunocompromised Mouse
   Models of Limb Ischemia
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID COLONY-FORMING CELLS; ENDOTHELIAL PROGENITOR CELLS; CIRCULATING
   ANGIOGENIC CELLS; FEMORAL-ARTERY OCCLUSION; MESENCHYMAL STEM-CELLS;
   ATHYMIC NUDE MICE; HINDLIMB ISCHEMIA; THERAPEUTIC ANGIOGENESIS;
   BLOOD-FLOW; MURINE MODEL
AB Immunocompromised hind limb ischemia (HLI) murine models are essential for preclinical evaluation of human cell-based therapy or biomaterial-based interventions. These models are used to generate proof of principle that the approach is effective and also regulatory preclinical data required for translation to the clinic. However, surgical variations in creation of HLI models reported in the literature introduce variability in the pathological manifestation of the model, in consequence affecting therapeutic endpoints. This study aims to compare the extent of vascular regeneration in HLI-induced immunocompromised murine models to obtain a stable and more reproducible injury model for testing. Athymic and Balb/C nude mice underwent HLI surgery with single and double ligation of femoral artery (FA). The recovery from surgery was observed over a period of 2 weeks with respect to ischemia reperfusion using laser Doppler and clinical signs of necrosis and ambulatory impairment. Double ligation of the FA results in a more severe response to ischemia in Balb/C with endogenous perfusion recovery up to 50% +/- 10% compared with 75% +/- 20% in athymic nude mice. Single iliac artery (IA) and FA lead to creation of mild ischemia compared with femoral artery-vein (FAV) pair ligation in Balb/C. Microcirculatory parameters indicate significantly lower capillary numbers (26 +/- 3/mm(2)) and functional capillary density (203 +/- 5 cm/cm(2)) in the FAV group. In this study, we demonstrate a reproducible, arterial double ligation in an immunocompromised Balb/C nude mouse model that exhibits characteristic pathological signs of ischemia with impaired endogenous recovery.
C1 [Thomas, Dilip; Thirumaran, Arun; Chen, Xizhe; O'Brien, Timothy] Natl Univ Ireland Galway, Regenerat Med Inst, Galway, Ireland.
   [Thomas, Dilip; Browne, Shane; O'Brien, Timothy; Pandit, Abhay] Natl Univ Ireland Galway, Ctr Res Med Devices CURAM, Galway, Ireland.
   [Mallard, Beth; Wheatley, Antony M.] Natl Univ Ireland Galway, Dept Physiol, Galway, Ireland.
RP Pandit, A (reprint author), Natl Univ Ireland Galway, Ctr Res Med Devices CURAM, Biomed Sci, Galway, Ireland.
EM abhay.pandit@nuigalway.ie
RI Pandit, Abhay/B-6187-2008; O'Brien, Timothy/N-7112-2014; Mallard,
   Beth/Q-2137-2016
OI Pandit, Abhay/0000-0002-6292-4933; O'Brien, Timothy/0000-0001-9028-5481;
   Mallard, Beth/0000-0002-0634-7916; Thomas, Dilip/0000-0001-7427-5523
FU Science Foundation Ireland [09/SRC/B1794]
FX This material is based on works supported by the Science Foundation
   Ireland under Grant No. 09/SRC/B1794. The authors would also like to
   thank Mr. Maciej Doczyk for his help with the graphic illustrations.
CR Annex BH, 2013, NAT REV CARDIOL, V10, P387, DOI 10.1038/nrcardio.2013.70
   Aranguren XL, 2011, CELL TRANSPLANT, V20, P259, DOI 10.3727/096368910X516592
   Bhardwaj RS, 1997, J MATER SCI-MATER M, V8, P737, DOI 10.1023/A:1018552326808
   Bosevski M, 2006, Prilozi, V27, P89
   Bouvard C, 2010, ARTERIOSCL THROM VAS, V30, P1569, DOI 10.1161/ATVBAHA.110.209163
   Chalothorn D, 2010, PHYSIOL GENOMICS, V42, P469, DOI 10.1152/physiolgenomics.00070.2010
   CHEERS C, 1975, J IMMUNOL, V115, P844
   Cho HH, 2009, CELL PHYSIOL BIOCHEM, V24, P511, DOI 10.1159/000257495
   Di Santo S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005643
   Fan WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045621
   Frey-Vasconcells J, 2012, STEM CELL TRANSL MED, V1, P353, DOI 10.5966/sctm.2012-0018
   GERSHWIN ME, 1975, CLIN IMMUNOL IMMUNOP, V4, P324, DOI 10.1016/0090-1229(75)90002-1
   Gottsater A, 2006, EUR J VASC ENDOVASC, V32, P478, DOI 10.1016/j.ejvs.2006.03.007
   Harada Y, 2013, BIOMED RES-TOKYO, V34, P23, DOI 10.2220/biomedres.34.23
   Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3
   Heil M, 2006, J CELL MOL MED, V10, P45, DOI 10.1111/j.1582-4934.2006.tb00290.x
   Hellingman AA, 2011, EUR J VASC ENDOVASC, V41, P418, DOI 10.1016/j.ejvs.2010.11.017
   Hellingman AA, 2010, EUR J VASC ENDOVASC, V40, P796, DOI 10.1016/j.ejvs.2010.07.009
   Heo SC, 2014, STEM CELLS, V32, P779, DOI 10.1002/stem.1578
   Herrler T, 2009, J VASC RES, V46, P333, DOI 10.1159/000189794
   Hoover-Plow JL, 2008, INFLAMM RES, V57, P457, DOI 10.1007/s00011-008-7062-5
   Ito WD, 1997, AM J PHYSIOL-HEART C, V273, pH1255
   Jaipersad AS, 2014, J AM COLL CARDIOL, V63, P1, DOI 10.1016/j.jacc.2013.09.019
   Kang Y, 2010, MICROVASC RES, V80, P310, DOI 10.1016/j.mvr.2010.05.006
   Kim JH, 2013, BIOMATERIALS, V34, P1657, DOI 10.1016/j.biomaterials.2012.11.008
   Kim MS, 2009, CIRCULATION, V120, P2240, DOI 10.1161/CIRCULATIONAHA.109.856815
   Kim MH, 2011, J MOL CELL CARDIOL, V51, P702, DOI 10.1016/j.yjmcc.2011.07.006
   Kochi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084047
   Koh YJ, 2011, ARTERIOSCL THROM VAS, V31, P1141, DOI 10.1161/ATVBAHA.110.218206
   Kuraitis D, 2011, J MOL CELL CARDIOL, V51, P187, DOI 10.1016/j.yjmcc.2011.04.011
   Kwon YW, 2013, BBA-MOL BASIS DIS, V1832, P2136, DOI 10.1016/j.bbadis.2013.08.002
   Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P705, DOI 10.1189/jlb.1105656
   Lee E. J., 2013, REGEN MED, V8, P293
   Leifheit-Nestler M, 2010, ARTERIOSCL THROM VAS, V30, P1398, DOI 10.1161/ATVBAHA.110.206086
   Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185
   Mabuchi A, 2009, MICROCIRCULATION, V16, P364, DOI 10.1080/10739680902796917
   Moon SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075224
   Moon SH, 2011, BIOMATERIALS, V32, P6445, DOI 10.1016/j.biomaterials.2011.05.026
   Mor F, 2004, J IMMUNOL, V172, P4618, DOI 10.4049/jimmunol.172.7.4618
   Patel AS, 2013, EMBO MOL MED, V5, P858, DOI 10.1002/emmm.201302752
   Rahnemai-Azar A, 2011, CYTOTHERAPY, V13, P179, DOI 10.3109/14653249.2010.515579
   Russ John C., 2000, PRACTICAL STEREOLOGY
   Sarlon G, 2012, J THROMB HAEMOST, V10, P38, DOI 10.1111/j.1538-7836.2011.04554.x
   SCHMIDSCHOENBEIN GW, 1977, MICROVASC RES, V14, P303, DOI 10.1016/0026-2862(77)90028-0
   Schwarz TM, 2012, ARTERIOSCL THROM VAS, V32, pE13, DOI 10.1161/ATVBAHA.111.239822
   Shireman PK, 2005, J SURG RES, V129, P242, DOI 10.1016/j.jss.2005.06.013
   Silvestre JS, 2008, CARDIOVASC RES, V78, P242, DOI 10.1093/cvr/cvn027
   Tang GL, 2005, J VASC SURG, V41, P312, DOI 10.1016/j.jvs.2004.11.012
   Tang ZCW, 2011, BIOMATERIALS, V32, P75, DOI 10.1016/j.biomaterials.2010.08.085
   Thomas D, 2014, BIOMATERIALS, V35, P8757, DOI 10.1016/j.biomaterials.2014.06.053
   van Luyn MJA, 1998, J BIOMED MATER RES, V39, P398
   Westvik TS, 2009, J VASC SURG, V49, P464, DOI 10.1016/j.jvs.2008.08.077
   Yang HN, 2012, BIOMATERIALS, V33, P8670, DOI 10.1016/j.biomaterials.2012.08.012
   Yang YG, 2008, J VASC SURG, V48, P1546, DOI 10.1016/j.jvs.2008.07.063
   Yoshida T, 2010, ARTERIOSCL THROM VAS, V30, P1300, DOI 10.1161/ATVBAHA.109.198994
   Yu JX, 2009, J VASC SURG, V50, P608, DOI 10.1016/j.jvs.2009.05.049
   Zbinden S, 2007, AM J PHYSIOL-HEART C, V292, pH1891, DOI 10.1152/ajpheart.00537.2006
   Zhou B, 2007, J CELL BIOCHEM, V102, P183, DOI 10.1002/jcb.21290
NR 58
TC 3
Z9 3
U1 0
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD APR 1
PY 2016
VL 22
IS 4
BP 370
EP 381
DI 10.1089/ten.tec.2015.0441
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA DI1EA
UT WOS:000373237600008
PM 26830861
DA 2018-10-19
ER

PT J
AU Jongedijk, E
   Cankar, K
   Buchhaupt, M
   Schrader, J
   Bouwmeester, H
   Beekwilder, J
AF Jongedijk, Esmer
   Cankar, Katarina
   Buchhaupt, Markus
   Schrader, Jens
   Bouwmeester, Harro
   Beekwilder, Jules
TI Biotechnological production of limonene in microorganisms
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Review
DE Limonene; Biomaterial; Monoterpene; Microbial production; Metabolic
   engineering; Toxicity
ID GERANYL DIPHOSPHATE SYNTHASE; PERFORMANCE LIQUID-CHROMATOGRAPHY;
   ESCHERICHIA-COLI; MONOTERPENE BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE;
   TERPENOID BIOSYNTHESIS; GLANDULAR TRICHOMES; FUNCTIONAL-ANALYSIS; CDNA
   ISOLATION; ESSENTIAL OILS
AB This mini review describes novel, biotechnology-based, ways of producing the monoterpene limonene. Limonene is applied in relatively highly priced products, such as fragrances, and also has applications with lower value but large production volume, such as biomaterials. Limonene is currently produced as a side product from the citrus juice industry, but the availability and quality are fluctuating and may be insufficient for novel bulk applications. Therefore, complementary microbial production of limonene would be interesting. Since limonene can be derivatized to high-value compounds, microbial platforms also have a great potential beyond just producing limonene. In this review, we discuss the ins and outs of microbial limonene production in comparison with plant-based and chemical production. Achievements and specific challenges for microbial production of limonene are discussed, especially in the light of bulk applications such as biomaterials.
C1 [Jongedijk, Esmer; Bouwmeester, Harro] Wageningen Univ, Lab Plant Physiol, Droevendaalsesteeg 1, NL-6708 PB Wageningen, Netherlands.
   [Cankar, Katarina; Beekwilder, Jules] Plant Res Int, POB 16, NL-6700 AA Wageningen, Netherlands.
   [Buchhaupt, Markus; Schrader, Jens] DECHEMA Res Inst, Biochem Engn, Theodor Heuss Allee 25, D-60486 Frankfurt, Germany.
RP Beekwilder, J (reprint author), Plant Res Int, POB 16, NL-6700 AA Wageningen, Netherlands.
EM jules.beekwilder@wur.nl
RI Beekwilder, Jules/A-6802-2011
OI Beekwilder, Jules/0000-0003-3238-4427; Buchhaupt,
   Markus/0000-0003-2720-5973; Bouwmeester, Harro/0000-0003-0907-2732
FU Dutch Ministry of Economic Affairs [KB-13-006-042]
FX This research was funded by the Dutch Ministry of Economic Affairs Grant
   KB-13-006-042.
CR Aharoni A, 2005, TRENDS PLANT SCI, V10, P594, DOI 10.1016/j.tplants.2005.10.005
   Aharoni Asaph, 2006, Phytochemistry Reviews, V5, P49, DOI 10.1007/s11101-005-3747-3
   Alonso-Gutierrez J, 2013, METAB ENG, V19, P33, DOI 10.1016/j.ymben.2013.05.004
   ANDREWS RE, 1980, APPL ENVIRON MICROB, V40, P301
   [Anonymous], 2015, DICTIONARY OF NATURA
   Banerjee A, 2014, NAT PROD REP, V31, P1043, DOI 10.1039/c3np70124g
   Barros MT, 2007, EUR J ORG CHEM, P1357, DOI 10.1002/ejoc.200600890
   Behrendorff JBYH, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-76
   Bouvier F, 2000, PLANT J, V24, P241, DOI 10.1046/j.1365-313x.2000.00875.x
   Bowen ER, 1975, FLORIDA STATE HORTIC, V7072, P304
   Brennan TCR, 2015, APPL ENVIRON MICROB, V81, P3316, DOI 10.1128/AEM.04144-14
   Brennan TCR, 2012, BIOTECHNOL BIOENG, V109, P2513, DOI 10.1002/bit.24536
   Burke C, 2002, ARCH BIOCHEM BIOPHYS, V405, P130, DOI 10.1016/S0003-9861(02)00335-1
   Carter OA, 2003, PHYTOCHEMISTRY, V64, P425, DOI 10.1016/S0031-9422(03)00204-8
   Chang TH, 2010, PLANT CELL, V22, P454, DOI 10.1105/tpc.109.071738
   Chubukov V, 2015, APPL ENVIRON MICROB, V81, P4690, DOI 10.1128/AEM.01102-15
   Cimmino S, 1999, J POLYM SCI POL PHYS, V37, P867, DOI 10.1002/(SICI)1099-0488(19990501)37:9<867::AID-POLB1>3.3.CO;2-O
   Ciriminna R, 2014, CHEM COMMUN, V50, P15288, DOI 10.1039/c4cc06147k
   Colonna M, 2011, GREEN CHEM, V13, P2543, DOI 10.1039/c1gc15400a
   Davies F.K, 2014, SYNTH BIOL, V2, P21, DOI DOI 10.3389/FBI0E.2014.00021
   DOLENCE JM, 1995, P NATL ACAD SCI USA, V92, P5008, DOI 10.1073/pnas.92.11.5008
   Duetz WA, 2003, APPL MICROBIOL BIOT, V61, P269, DOI 10.1007/s00253-003-1221-y
   Duetz WA, 2001, APPL ENVIRON MICROB, V67, P2829, DOI 10.1128/AEM.67.6.2829-2832.2001
   Dunlop MJ, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.21
   Effmert U, 2012, J CHEM ECOL, V38, P665, DOI 10.1007/s10886-012-0135-5
   Erhardt H, 2014, MICROBIOLOGYOPEN, V3, P316, DOI 10.1002/mbo3.163
   Firdaus M, 2011, MACROMOLECULES, V44, P7253, DOI 10.1021/ma201544e
   Fischer K, 2013, TERPENES REPLACING B
   Fischer MJC, 2011, BIOTECHNOL BIOENG, V108, P1883, DOI 10.1002/bit.23129
   FRIEDMAN L, 1971, SCIENCE, V172, P1044, DOI 10.1126/science.172.3987.1044
   FUJITA T, 1993, PHYTOCHEMISTRY, V34, P1545, DOI 10.1016/S0031-9422(00)90843-4
   George KW, 2015, ADV BIOCHEM ENG BIOT, V148, P355, DOI 10.1007/10_2014_288
   Giglio S, 2011, ENVIRON SCI TECHNOL, V45, P992, DOI 10.1021/es102992p
   Griffin S, 1999, J CHROMATOGR A, V864, P221, DOI 10.1016/S0021-9673(99)01009-2
   Gruchattka E, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-84
   Hanson CD, 1999, US Patent US, Patent No. 005977421
   Heddergott C, 2014, EUKARYOT CELL, V13, P1014, DOI 10.1128/EC.00074-14
   Hodges A., 2012, FE903 U FLOR I FOOD
   Hung R, 2013, FUNGAL ECOL, V6, P19, DOI 10.1016/j.funeco.2012.09.005
   Ignea C, 2014, ACS SYNTH BIOL, V3, P298, DOI 10.1021/sb400115e
   Inouye S, 2001, J ANTIMICROB CHEMOTH, V47, P565, DOI 10.1093/jac/47.5.565
   Jongedijk E, 2015, YEAST, V32, P159, DOI 10.1002/yea.3038
   Kang JH, 2014, PLANT PHYSIOL, V164, P80, DOI 10.1104/pp.113.230466
   KARLBERG AT, 1994, ARCH DERMATOL RES, V286, P97, DOI 10.1007/BF00370734
   Kirby J, 2009, ANNU REV PLANT BIOL, V60, P335, DOI 10.1146/annurev.arplant.043008.091955
   Kiyota H, 2014, J BIOTECHNOL, V185, P1, DOI 10.1016/j.jbiotec.2014.05.025
   Komatsu M, 2008, P NATL ACAD SCI USA, V105, P7422, DOI 10.1073/pnas.0802312105
   Landmann C, 2007, ARCH BIOCHEM BIOPHYS, V465, P417, DOI 10.1016/j.abb.2007.06.011
   Lange BM, 2013, PLANT BIOTECHNOL J, V11, P2, DOI 10.1111/j.1467-7652.2012.00737.x
   Lange BM, 2015, ADV BIOCHEM ENG BIOT, V148, P319, DOI 10.1007/10_2014_289
   Langeveld JWA, 2010, CROP SCI, V50, pS142, DOI 10.2135/cropsci2009.09.0529
   Leng CB, 2013, J PHYS CHEM A, V117, P10359, DOI 10.1021/jp403603z
   Lerin L, 2010, CIENCIA TECNOL ALIME, V30, P399, DOI 10.1590/S0101-20612010000200017
   Lucker J, 2002, EUR J BIOCHEM, V269, P3160, DOI 10.1046/j.1432-1033.2002.02985.x
   Lucker J, 2001, PLANT J, V27, P315, DOI 10.1046/j.1365-313x.2001.01097.x
   Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833
   McCoy M, 2015, CONCENTRATES, V93, P17
   Meganathan R, 2001, FEMS MICROBIOL LETT, V203, P131, DOI 10.1016/S0378-1097(01)00330-5
   Miller JA, 2011, ONCOL REV, V5, P31, DOI 10.1007/s12156-010-0066-8
   Mirata MA, 2009, PROCESS BIOCHEM, V44, P764, DOI 10.1016/j.procbio.2009.03.013
   Miziorko HM, 2011, ARCH BIOCHEM BIOPHYS, V505, P131, DOI 10.1016/j.abb.2010.09.028
   Narita K, 1999, J BIOCHEM-TOKYO, V126, P566, DOI 10.1093/oxfordjournals.jbchem.a022487
   Nichkova M, 2009, J AGR FOOD CHEM, V57, P5673, DOI 10.1021/jf900652a
   Ramos JL, 2015, FEMS MICROBIOL REV, V39, P555, DOI 10.1093/femsre/fuv006
   Reiling KK, 2004, BIOTECHNOL BIOENG, V87, P200, DOI 10.1002/bit.20128
   Renninger NS, 2008, US Patent, Patent No. [WO 2008133658, 2008133658]
   Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138
   Rumbold K, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-64
   Schilmiller AL, 2009, P NATL ACAD SCI USA, V106, P10865, DOI 10.1073/pnas.0904113106
   Segura A, 2012, CURR OPIN BIOTECH, V23, P415, DOI 10.1016/j.copbio.2011.11.015
   Serra S, 2005, TRENDS BIOTECHNOL, V23, P193, DOI 10.1016/j.tibtech.2005.02.003
   SIKKEMA J, 1994, J BIOL CHEM, V269, P8022
   Sokovic M, 2010, MOLECULES, V15, P7532, DOI 10.3390/molecules15117532
   Stuart Clark IVG, 1998, PERFUMER FLAVORIST, V33
   Swiezewska E, 2005, PROG LIPID RES, V44, P235, DOI 10.1016/j.plipres.2005.05.002
   Takami T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049004
   Thorp N, 2010, DIPENTENE
   Tissier A, 2012, PLANT J, V70, P51, DOI 10.1111/j.1365-313X.2012.04913.x
   Tracy NI, 2009, FUEL, V88, P2238, DOI 10.1016/j.fuel.2009.02.002
   Tranchida PQ, 2013, J CHROMATOGR A, V1305, P276, DOI 10.1016/j.chroma.2013.07.042
   Tripathi A. K., 2009, J PHARMACOGNOSY PHYT, V1, P52
   Turner G, 1999, PLANT PHYSIOL, V120, P879, DOI 10.1104/pp.120.3.879
   Turner GW, 2015, INT J PLANT SCI, V176, P643, DOI 10.1086/682054
   Turner GW, 2004, PLANT PHYSIOL, V136, P4215, DOI 10.1104/pp.104.050229
   URIBE S, 1990, J CHEM ECOL, V16, P1399, DOI 10.1007/BF01021035
   van Schie CCN, 2007, PLANT J, V52, P752, DOI 10.1111/j.1365-313X.2007.03273.x
   Vararu F, 2015, NOTULAE SCI BIOL, V7, DOI 10.15835/nsb.7.1.9545
   Vickers CE, 2014, PLANT CELL ENVIRON, V37, P1753, DOI 10.1111/pce.12316
   Voirin B, 1996, PHYTOCHEMISTRY, V43, P573, DOI 10.1016/0031-9422(96)00285-3
   Voo SS, 2012, PLANT PHYSIOL, V159, P81, DOI 10.1104/pp.112.194233
   Wang X, 2015, PLANT BIOTECHNOL J, V13, P137, DOI 10.1111/pbi.12343
   Wang Y, 2013, NEW PHYTOL, V197, P886, DOI 10.1111/nph.12063
   Weldon PJ, 2011, J CHEM ECOL, V37, P348, DOI 10.1007/s10886-011-9922-7
   Wilbon PA, 2013, MACROMOL RAPID COMM, V34, P8, DOI 10.1002/marc.201200513
   Willrodt C, 2014, BIOTECHNOL J, V9, P1000, DOI 10.1002/biot.201400023
   Zhang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075972
NR 96
TC 19
Z9 20
U1 4
U2 51
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7598
EI 1432-0614
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD APR
PY 2016
VL 100
IS 7
BP 2927
EP 2938
DI 10.1007/s00253-016-7337-7
PG 12
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DG7RS
UT WOS:000372282000001
PM 26915992
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Park, JC
   Oh, SY
   Lee, JS
   Park, SY
   Choi, EY
   Cho, KS
   Kim, CS
AF Park, Jung-Chul
   Oh, Sang-Yeob
   Lee, Jung-Seok
   Park, So-Yon
   Choi, Eun-Young
   Cho, Kyoo-Sung
   Kim, Chang-Sung
TI In vivo bone formation by human alveolar-bone-derived mesenchymal stem
   cells obtained during implant osteotomy using biphasic calcium phosphate
   ceramics or Bio-Oss as carriers
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE biphasic calcium phosphate; mesenchymal stem cell; osteogenic
   differentiation; regeneration
ID SINUS FLOOR AUGMENTATION; PERIODONTAL-LIGAMENT; OSTEOBLAST
   DIFFERENTIATION; VITRO; REGENERATION; PARTICLES; COLLAGEN; CULTURE;
   MATRIX; RAT
AB ObjectivesThe aim of this study was to evaluate HA coated with different ratios of TCP as a carrier for hABMSCs obtained during implant osteotomy in comparison to slowly-resorbing biomaterial, Bio-Oss, as a negative control, using in vitro and in vivo experiments.
   Materials and MethodsHuman ABMSCs (hABMSCs) harvested during implant osteotomy were transplanted using HA/TCP or Bio-Oss as carriers in a murine ectopic transplantation model (n=12). Pore size and cell affinity were evaluated in vitro. The area of newly formed bone was analyzed histometrically, the number of osteocytes was counted, and immunohistochemical staining was conducted against several markers of osteogenesis, including alkaline phosphatase (ALP), runt-related transcription factor 2 (RUNX-2), osteocalcin (OCN), and osteopontin (OPN). Osteoclast formation was evaluated by tartrate-resistant acid phosphatase staining.
   ResultsThe carrier materials had comparable pore sizes. The cell affinity assay resulted in a high proportion of cell adhesion (>90%) in all experimental groups. Substantial new bone and osteocyte formation was observed on both HA/TCP carriers, whereas it was minimal with Bio-Oss. Positive immunostaining for ALP, RUNX-2, OCN, and OPN was observed with HA/TCP, but only limited expression of osteogenic markers with Bio-Oss. Conversely, there was a minimal osteoclast presence with Bio-Oss, but a significant presence of osteoclasts with both HA/TCP carriers.
   ConclusionsBoth types of scaffolds, BCP and Bio-Oss, showed high stem cell-carrying potential, but the in vivo healing patterns of their complexes with hABMSC could be affected by the microenvironment on the surfaces of the scaffolds. (c) 2015 Wiley Periodicals, Inc.
C1 [Park, Jung-Chul; Oh, Sang-Yeob; Lee, Jung-Seok; Park, So-Yon; Choi, Eun-Young; Cho, Kyoo-Sung; Kim, Chang-Sung] Yonsei Univ, Res Inst Periodontal Regenerat, Dept Periodontol, Coll Dent, Seoul 120749, South Korea.
   [Kim, Chang-Sung] Yonsei Univ, Dept Appl Life Sci, Coll Dent, BK PLUS Project 21, Seoul 120749, South Korea.
RP Kim, CS (reprint author), Yonsei Univ, Res Inst Periodontal Regenerat, Dept Periodontol, Coll Dent, Seoul 120749, South Korea.; Kim, CS (reprint author), Yonsei Univ, Dept Appl Life Sci, Coll Dent, BK PLUS Project 21, Seoul 120749, South Korea.
EM dentall@yuhs.ac
FU National Research Foundation of Korea (NRF) [2012R1A2A4A01007124]; Bio &
   Medical Technology Development Program of National Research Foundation
   (NRF) [2012M3A9B2052521]
FX Contract grant sponsor: National Research Foundation of Korea (NRF);
   contract grant number: 2012R1A2A4A01007124; Contract grant sponsor: Bio
   & Medical Technology Development Program of the National Research
   Foundation (NRF); contract grant number: 2012M3A9B2052521
CR Araujo M, 2008, INT J PERIODONT REST, V28, P123
   Arinzeh TL, 2003, J BONE JOINT SURG AM, V85A, P1927, DOI 10.2106/00004623-200310000-00010
   Arinzeh TL, 2005, BIOMATERIALS, V26, P3631, DOI 10.1016/j.biomaterials.2004.09.035
   Bojic S, 2014, HISTOL HISTOPATHOL, V29, P699, DOI 10.14670/HH-29.699
   BUDKE H, 1994, MODERN PATHOL, V7, P860
   Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3
   Clausen C, 2006, CLIN ORAL IMPLAN RES, V17, P533, DOI 10.1111/j.1600-0501.2006.01254.X
   Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Duncan RL, 1998, SEMIN NEPHROL, V18, P178
   Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101
   Flanagan D, 2010, IMPLANT DENT, V19, P241, DOI 10.1097/ID.0b013e3181dc9852
   Han J, 2014, AUST DENT J, V59, P117, DOI 10.1111/adj.12100
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hofman S, 1999, BIOMATERIALS, V20, P1155, DOI 10.1016/S0142-9612(97)00082-3
   Hughes FJ, 2006, PERIODONTOL 2000, V41, P48, DOI 10.1111/j.1600-0757.2006.00161.x
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Jung IH, 2012, TISSUE ENG PT A, V18, P643, DOI [10.1089/ten.tea.2011.0164, 10.1089/ten.TEA.2011.0164]
   Kadiyala S, 1997, CELL TRANSPLANT, V6, P125, DOI 10.1016/S0963-6897(96)00279-5
   Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5
   Krampera M, 2006, BONE, V39, P678, DOI 10.1016/j.bone.2006.04.020
   Lee JS, 2015, CELL TRANSPLANT, V24, P1767, DOI 10.3727/096368914X684628
   Marklein RA, 2010, ADV MATER, V22, P175, DOI 10.1002/adma.200901055
   Mladenovic Z, 2013, CLIN ORAL IMPLAN RES, V24, P329, DOI 10.1111/j.1600-0501.2011.02334.x
   Mordenfeld A, 2010, CLIN ORAL IMPLAN RES, V21, P961, DOI 10.1111/j.1600-0501.2010.01939.x
   Nishimura M, 2012, INT J DENT, V2012
   Orsini G, 2005, J BIOMED MATER RES B, V74B, P448, DOI 10.1002/jbm.b.30196
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Paganelli C, 2006, J ORAL REHABIL, V33, P625, DOI 10.1111/j.1365-2842.2005.01594.x
   Park DS, 2015, STEM CELLS DEV, V24, P228, DOI 10.1089/scd.2014.0148
   Park JC, 2012, J CLIN PERIODONTOL, V39, P495, DOI 10.1111/j.1600-051X.2012.01865.x
   Park JC, 2011, J CLIN PERIODONTOL, V38, P721, DOI 10.1111/j.1600-051X.2011.01716.x
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   ROACH HI, 1994, CELL BIOL INT, V18, P617, DOI 10.1006/cbir.1994.1088
   Rossi F, 2015, J TISSUE ENG REGEN M, V9, P1093, DOI 10.1002/term.1827
   Saldana L, 2009, ACTA BIOMATER, V5, P1294, DOI 10.1016/j.actbio.2008.11.022
   Schopper C, 2005, J BIOMED MATER RES B, V74B, P458, DOI 10.1002/jbm.b.30199
   Schwartz C, 1999, J MATER SCI-MATER M, V10, P821, DOI 10.1023/A:1008944227417
   Song DS, 2011, J PERIODONTAL RES, V46, P193, DOI 10.1111/j.1600-0765.2010.01328.x
   Sun JS, 1997, J BIOMED MATER RES, V37, P324, DOI 10.1002/(SICI)1097-4636(19971205)37:3<324::AID-JBM3>3.0.CO;2-N
   Yu BH, 2014, J BIOMATER APPL, V29, P243, DOI 10.1177/0885328214521846
   Yu BH, 2014, J ORAL MAXIL SURG, V72, P1084, DOI 10.1016/j.joms.2013.12.024
NR 42
TC 2
Z9 2
U1 3
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2016
VL 104
IS 3
BP 515
EP 524
DI 10.1002/jbm.b.33416
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DG7XN
UT WOS:000372297100009
PM 25939881
DA 2018-10-19
ER

PT J
AU Weizbauer, A
   Kieke, M
   Rahim, MI
   Angrisani, GL
   Willbold, E
   Diekmann, J
   Florkemeier, T
   Windhagen, H
   Muller, PP
   Behrens, P
   Budde, S
AF Weizbauer, Andreas
   Kieke, Marc
   Rahim, Muhammad Imran
   Angrisani, Gian Luigi
   Willbold, Elmar
   Diekmann, Julia
   Floerkemeier, Thilo
   Windhagen, Henning
   Mueller, Peter Paul
   Behrens, Peter
   Budde, Stefan
TI Magnesium-containing layered double hydroxides as orthopaedic implant
   coating materials-An in vitro and in vivo study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE biomaterial; layered double hydroxides; magnesium hydroxide; surface
   coating; orthopaedic implants; osteoconductivity
ID OSTEOBLAST ADHESION; LDH NANOHYBRID; DRUG-DELIVERY; UNITED-STATES;
   HYDROXYAPATITE; BONE; ARTHROPLASTY; REVISION; TITANIUM; ALLOYS
AB The total hip arthroplasty is one of the most common artificial joint replacement procedures. Several different surface coatings have been shown to improve implant fixation by facilitating bone ingrowth and consequently enhancing the longevity of uncemented orthopaedic hip prostheses. In the present study, two different layered double hydroxides (LDHs), Mg-Fe- and Mg-Al-LDH, were investigated as potential magnesium (Mg)-containing coating materials for orthopaedic applications in comparison to Mg hydroxide (Mg(OH)(2)). In vitro direct cell compatibility tests were carried out using the murine fibroblast cell line NIH 3T3 and the mouse osteosarcoma cell line MG 63. The host response of bone tissue was evaluated in in vivo experiments with nine rabbits. Two cylindrical pellets (3 x 3 mm) were implanted into each femoral condyle of the left hind leg. The samples were analyzed histologically and with -computed tomography (-CT) 6 weeks after surgery. An in vitro cytotoxicity test determined that more cells grew on the LDH pellets than on the Mg(OH)(2)-pellets. The pH value and the Mg2+ content of the cell culture media were increased after incubation of the cells on the degradable samples. The in vivo tests demonstrated the formation of fibrous capsules around Mg(OH)(2) and Mg-Fe-LDH. In contrast, the host response of the Mg-Al-LDH samples indicated that this Mg-containing biomaterial is a potential candidate for implant coating. (c) 2015 Wiley Periodicals, Inc.
C1 [Weizbauer, Andreas; Willbold, Elmar; Diekmann, Julia; Floerkemeier, Thilo; Windhagen, Henning; Budde, Stefan] Hannover Med Sch, Lab Biomech & Biomat, Dept Orthopaed Surg, Anna von Borries Str 1, D-30625 Hannover, Germany.
   [Weizbauer, Andreas; Willbold, Elmar; Diekmann, Julia] Hannover Med Sch, CrossBIT, Ctr Biocompatibil & Implant Immunol, Dept Orthopaed Surg, Feodor Lynen Str 31, D-30625 Hannover, Germany.
   [Kieke, Marc; Behrens, Peter] Leibniz Univ Hannover, Inst Inorgan Chem, Callinstr 9, D-30167 Hannover, Germany.
   [Rahim, Muhammad Imran; Mueller, Peter Paul] Helmholtz Ctr Infect Res, Inhoffenstr 7, D-38123 Braunschweig, Germany.
   [Angrisani, Gian Luigi] Univ Hannover, Inst Mat Sci, Univ 2, D-30823 Garbsen, Germany.
RP Weizbauer, A (reprint author), Hannover Med Sch, Lab Biomech & Biomat, Dept Orthopaed Surg, Anna von Borries Str 1, D-30625 Hannover, Germany.; Weizbauer, A (reprint author), Hannover Med Sch, CrossBIT, Ctr Biocompatibil & Implant Immunol, Dept Orthopaed Surg, Feodor Lynen Str 31, D-30625 Hannover, Germany.
EM weizbauer.andreas@mh-hannover.de
OI Mueller, Peter/0000-0002-1209-7546
FU German Research Foundation (DFG) [SFB 599]
FX Contract grant sponsor: German Research Foundation (DFG); contract grant
   number: SFB 599
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Andia JBC, 1996, NEPHROL DIAL TRANSPL, V11, P69
   Badar M, 2015, J BIOMED MATER RES A, V103, P2141, DOI 10.1002/jbm.a.35358
   Bartsch I, 2014, ACTA BIOMATER, V10, P34, DOI 10.1016/j.actbio.2013.08.047
   Bosco R, 2012, COATINGS, V2, P95, DOI 10.3390/coatings2030095
   Choy JH, 2004, BIOMATERIALS, V25, P3059, DOI 10.1016/j.biomaterials.2003.09.083
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Feyerabend F, 2010, ACTA BIOMATER, V6, P1834, DOI 10.1016/j.actbio.2009.09.024
   Geesink RGT, 2002, CLIN ORTHOP RELAT R, P53, DOI 10.1097/00003086-200202000-00007
   Goodman SB, 2013, BIOMATERIALS, V34, P3174, DOI 10.1016/j.biomaterials.2013.01.074
   Hallab N, 2001, J BONE JOINT SURG AM, V83A, P428, DOI 10.2106/00004623-200103000-00017
   Hallab NJ, 2002, J BIOMED MATER RES, V60, P420, DOI 10.1002/jbm.10106
   Hesse D, 2013, J MATER SCI-MATER M, V24, P129, DOI 10.1007/s10856-012-4769-1
   Janning C, 2010, ACTA BIOMATER, V6, P1861, DOI 10.1016/j.actbio.2009.12.037
   Jiang YP, 2013, ACTA ORTHOP BELG, V79, P1
   JOHANSSON CB, 1992, J MATER SCI-MATER M, V3, P126, DOI 10.1007/BF00705280
   Khan AI, 2001, CHEM COMMUN, P2342, DOI 10.1039/b106465g
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Kurtz SM, 2009, J ARTHROPLASTY, V24, P195, DOI 10.1016/j.arth.2007.11.015
   Kwak SY, 2004, BIOMATERIALS, V25, P5995, DOI 10.1016/j.biomaterials.2004.01.056
   Kwak SY, 2002, SOLID STATE IONICS, V151, P229, DOI 10.1016/S0167-2738(02)00714-2
   Ladewig K, 2010, BIOMATERIALS, V31, P1821, DOI 10.1016/j.biomaterials.2009.10.058
   Ladewig K, 2009, EXPERT OPIN DRUG DEL, V6, P907, DOI 10.1517/17425240903130585
   Lang F, 2007, METHOD ENZYMOL, V428, P209, DOI 10.1016/S0076-6879(07)28011-5
   Lazarinis S, 2010, ACTA ORTHOP, V81, P53, DOI 10.3109/17453670903413178
   Li RW, 2014, J BIOMED MATER RES A, V102, P4346, DOI 10.1002/jbm.a.35111
   Lin JK, 2011, J MATER CHEM, V21, P5011, DOI 10.1039/e0jm03764h
   Morscher EW, 1998, J BONE JOINT SURG BR, V80B, P267, DOI 10.1302/0301-620X.80B2.8316
   Oh JM, 2006, J PHYS CHEM SOLIDS, V67, P1024, DOI 10.1016/j.jpcs.2006.01.033
   OLAKANMI O, 1994, J IMMUNOL, V153, P2691
   OONISHI H, 1989, J BONE JOINT SURG BR, V71, P213
   Ramires PA, 2001, BIOMATERIALS, V22, P1467, DOI 10.1016/S0142-9612(00)00269-6
   Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490
   Sjogren G, 2000, J PROSTHET DENT, V84, P229, DOI 10.1067/mpr.2000.107227
   Tonino AJ, 1999, J BONE JOINT SURG BR, V81B, P148, DOI 10.1302/0301-620X.81B1.8948
   Uan JY, 2010, J MATER CHEM, V20, P761, DOI 10.1039/b917177k
   Webster TJ, 2002, J BIOMED MATER RES, V59, P312, DOI 10.1002/jbm.1247
   Yamasaki Y, 2002, J BIOMED MATER RES, V62, P99, DOI 10.1002/jbm.10220
   Yang L, 2013, ACTA BIOMATER, V9, P8475, DOI 10.1016/j.actbio.2012.10.001
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 41
TC 6
Z9 6
U1 5
U2 57
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2016
VL 104
IS 3
BP 525
EP 531
DI 10.1002/jbm.b.33422
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DG7XN
UT WOS:000372297100010
PM 25939995
DA 2018-10-19
ER

PT J
AU Sun, B
   Liang, DD
   Li, XP
   Chen, P
AF Sun, Bai
   Liang, Dandan
   Li, Xiaoping
   Chen, Peng
TI Nonvolatile bio-memristor fabricated with natural bio-materials from
   spider silk
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN ELECTRONICS
LA English
DT Article
ID RESISTIVE SWITCHING MEMORY; FIELD-EFFECT TRANSISTORS;
   ELECTRON-TRANSPORT; PROTEIN; FILMS; DEVICES; BEHAVIOR; FIBROIN;
   NANOPARTICLES; INTERLAYERS
AB The employ of nontoxic biomaterials as the basic building blocks of electronic devices is of growing interest for biocompatible and environmentally friendly electronics. Herein the fabrication and characterization of natural biomaterials-based bio-memristors with Ag/Fibroin/Au/Si structure is demonstrated. We observed a significant bipolar resistive switching behavior in Ag/Fibroin/Au/Si structure at room temperature. The results suggested that the memory behavior originates from the formation and rupture of conductive filaments. This work reveals that fibroin from spider silk is a useful natural biomaterial for nonvolatile memory applications, suggesting that spider silk possesses the potential for sustainable electronics and data storage.
C1 [Sun, Bai; Liang, Dandan; Li, Xiaoping; Chen, Peng] Southwest Univ, Sch Phys Sci & Technol, Chongqing 400715, Peoples R China.
RP Chen, P (reprint author), Southwest Univ, Sch Phys Sci & Technol, Chongqing 400715, Peoples R China.
EM pchen@swu.edu.cn
RI Sun, Bai/P-7421-2018
OI Sun, Bai/0000-0002-5840-509X
FU National Nature Science Foundation of China [51372209]
FX This work was supported by the National Nature Science Foundation of
   China (Grant No. 51372209).
CR Ambrogio S, 2014, ADV MATER, V26, P3885, DOI 10.1002/adma.201306250
   Amdursky N, 2012, J AM CHEM SOC, V134, P18221, DOI 10.1021/ja308953q
   Breemen A., 2015, ADV FUNCT MATER, V25, P278
   Cao X, 2009, APPL PHYS A-MATER, V97, P883, DOI 10.1007/s00339-009-5351-7
   Chang JW, 2011, ADV MATER, V23, P4077, DOI 10.1002/adma.201102124
   Chen Y. C., 2015, SCI REP, V5, P10022
   Chen YS, 2012, NAT NANOTECHNOL, V7, P197, DOI [10.1038/nnano.2012.7, 10.1038/NNANO.2012.7]
   Gogurla N, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/34/345202
   HIROSE Y, 1976, J APPL PHYS, V47, P2767, DOI 10.1063/1.322942
   Hosseini NR, 2015, ACS NANO, V9, P419, DOI 10.1021/nn5055909
   Hota MK, 2012, ADV FUNCT MATER, V22, P4493, DOI 10.1002/adfm.201200073
   Hung YC, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3671153
   Hwang SW, 2013, ADV MATER, V25, P3526, DOI 10.1002/adma.201300920
   Khan MA, 2014, ADV FUNCT MATER, V24, P1372, DOI 10.1002/adfm.201302056
   Kim CH, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3098071
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/nmat2745, 10.1038/NMAT2745]
   Kim DK, 2013, J APPL PHYS, V114, DOI 10.1063/1.4816794
   Ko Y, 2011, ACS NANO, V5, P9918, DOI 10.1021/nn2036939
   Lin DM, 2012, ADV MATER, V24, P6088, DOI 10.1002/adma.201201888
   Liu DQ, 2013, ACS APPL MATER INTER, V5, P11258, DOI 10.1021/am403497y
   Meng FB, 2014, SMALL, V10, P277, DOI 10.1002/smll.201300810
   Meng FB, 2011, SMALL, V7, P3016, DOI 10.1002/smll.201101494
   Mentovich ED, 2009, NANO LETT, V9, P1296, DOI 10.1021/nl802694k
   Mukherjee C, 2013, PHYS STATUS SOLIDI A, V210, P1797, DOI 10.1002/pssa.201329109
   Park J, 2013, ADV MATER, V25, P6423, DOI 10.1002/adma.201303017
   Rajachidambaram JS, 2013, J VAC SCI TECHNOL B, V31, DOI 10.1116/1.4767124
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Ron I, 2010, J AM CHEM SOC, V132, P4131, DOI 10.1021/ja907328r
   Sun B, 2016, CHEM PHYS LETT, V643, P66, DOI 10.1016/j.cplett.2015.11.022
   Sun B, 2015, J MATER CHEM C, V3, P12149, DOI 10.1039/c5tc02732b
   Sun B, 2015, CHEM PHYS, V457, P28, DOI 10.1016/j.chemphys.2015.05.010
   Sun B, 2015, PHYS CHEM CHEM PHYS, V17, P6718, DOI 10.1039/c4cp04901b
   Sun B, 2014, CRYSTENGCOMM, V16, P9891, DOI 10.1039/c4ce01442a
   Sun B, 2014, CHEM PHYS LETT, V613, P100, DOI 10.1016/j.cplett.2014.08.071
   Sun YM, 2015, J PHYS CHEM C, V119, P19520, DOI 10.1021/acs.jpcc.5b05337
   Tao H, 2012, ADV MATER, V24, P2824, DOI 10.1002/adma.201104477
   Uenuma M, 2013, RSC ADV, V3, P18044, DOI 10.1039/c3ra42392a
   Vladu M.I., 2011, J MATER CHEM, V21, P1350
   Vladu M.I., 2012, MATER TODAY, V15, P340
   Wang H, 2015, ADV MATER, V27, P7670, DOI 10.1002/adma.201405728
   Wang H, 2015, ADV FUNCT MATER, V25, P3825, DOI 10.1002/adfm.201501389
   Wang H, 2013, ADV MATER, V25, P5498, DOI 10.1002/adma.201301983
   Wang L, 2015, J MATER SCI-MATER EL, V26, P4618, DOI 10.1007/s10854-015-2848-z
   Waser R, 2009, ADV MATER, V21, P2632, DOI 10.1002/adma.200900375
   Yang JJS, 2013, NAT NANOTECHNOL, V8, P13, DOI [10.1038/nnano.2012.240, 10.1038/NNANO.2012.240]
   Zalar P, 2011, J AM CHEM SOC, V133, P11010, DOI 10.1021/ja201868d
   Zhang Y, 2012, ADV MATER, V24, P4255, DOI 10.1002/adma.201201248
NR 47
TC 9
Z9 9
U1 9
U2 64
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4522
EI 1573-482X
J9 J MATER SCI-MATER EL
JI J. Mater. Sci.-Mater. Electron.
PD APR
PY 2016
VL 27
IS 4
BP 3957
EP 3962
DI 10.1007/s10854-015-4248-9
PG 6
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Engineering; Materials Science; Physics
GA DG6BG
UT WOS:000372166600110
DA 2018-10-19
ER

PT J
AU Li, XS
   Yuan, ZW
   Wei, XW
   Li, H
   Zhao, GF
   Miao, JN
   Wu, D
   Liu, B
   Cao, SY
   An, D
   Ma, W
   Zhang, H
   Wang, WL
   Wang, QS
   Gu, H
AF Li, Xiaoshuai
   Yuan, Zhengwei
   Wei, Xiaowei
   Li, Hui
   Zhao, Guifeng
   Miao, Jiaoning
   Wu, Di
   Liu, Bo
   Cao, Songying
   An, Dong
   Ma, Wei
   Zhang, Henan
   Wang, Weilin
   Wang, Qiushi
   Gu, Hui
TI Application potential of bone marrow mesenchymal stem cell (BMSCs) based
   tissue-engineering for spinal cord defect repair in rat fetuses with
   spina bifida aperta
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID NEURAL-TUBE DEFECTS; CHITOSAN-GELATIN SCAFFOLDS; IN-VITRO; STROMAL
   CELLS; FETAL RATS; NEURODEGENERATIVE DISEASES; MYELOMENINGOCELE REPAIR;
   ANORECTAL MALFORMATION; CLINICAL-EXPERIENCE; TRANSPLANTATION
AB Spina bifida aperta are complex congenital malformations resulting from failure of fusion in the spinal neural tube during embryogenesis. Despite surgical repair of the defect, most patients who survive with spina bifida aperta have a multiple system handicap due to neuron deficiency of the defective spinal cord. Tissue engineering has emerged as a novel treatment for replacement of lost tissue. This study evaluated the prenatal surgical approach of transplanting a chitosan-gelatin scaffold seeded with bone marrow mesenchymal stem cells (BMSCs) in the healing the defective spinal cord of rat fetuses with retinoic acid induced spina bifida aperta. Scaffold characterisation revealed the porous structure, organic and amorphous content. This biomaterial promoted the adhesion, spreading and in vitro viability of the BMSCs. After transplantation of the scaffold combined with BMSCs, the defective region of spinal cord in rat fetuses with spina bifida aperta at E20 decreased obviously under stereomicroscopy, and the skin defect almost closed in many fetuses. The transplanted BMSCs in chitosan-gelatin scaffold survived, grew and expressed markers of neural stem cells and neurons in the defective spinal cord. In addition, the biomaterial presented high biocompatibility and slow biodegradation in vivo. In conclusion, prenatal transplantation of the scaffold combined with BMSCs could treat spinal cord defect in fetuses with spina bifida aperta by the regeneration of neurons and repairmen of defective region.
C1 [Li, Xiaoshuai; Yuan, Zhengwei; Wei, Xiaowei; Li, Hui; Zhao, Guifeng; Miao, Jiaoning; Wu, Di; Liu, Bo; Cao, Songying; An, Dong; Ma, Wei; Zhang, Henan; Gu, Hui] China Med Univ, Shengjing Hosp, Key Lab, Hlth Minist Congenital Malformat, 36 Sanhao St, Shenyang 110004, Peoples R China.
   [Wang, Weilin] China Med Univ, Dept Pediat Surg, Shenyang 110001, Peoples R China.
   [Wang, Qiushi] China Med Univ, Shengjing Hosp, Dept Blood Transfus, Shenyang 110001, Peoples R China.
RP Yuan, ZW (reprint author), China Med Univ, Shengjing Hosp, Key Lab, Hlth Minist Congenital Malformat, 36 Sanhao St, Shenyang 110004, Peoples R China.
EM yuanzw@hotmail.com
FU National Natural Foundation of China [81370717, 81171072]; National
   Basic Research Program of China (973 Program) [2013CB945402]; Program
   for Liaoning Innovative Research Team in University [LT2013016]
FX This study was supported by the National Natural Foundation of China.
   (Grant Numbers: 81370717,81171072). National Basic Research Program of
   China (973 Program, No. 2013CB945402). Program for Liaoning Innovative
   Research Team in University (LT2013016).
CR Baniasadi H, 2015, INT J BIOL MACROMOL, V74, P360, DOI 10.1016/j.ijbiomac.2014.12.014
   Bhat S., 2012, BIOSCI BIOENG, DOI [10.1016/j.jbiosc.2012.07.005., DOI 10.1016/J.JBIOSC.2012.07.005]
   Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775
   Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131
   Chen X, 2006, MICROSURG, V26, P111, DOI 10.1002/micr.20184
   Cipriani P, 2007, ARTHRITIS RHEUM, V56, P1994, DOI 10.1002/art.22698
   Copp AJ, 2010, J PATHOL, V220, P217, DOI 10.1002/path.2643
   Danzer E, 2005, EXP NEUROL, V194, P467, DOI 10.1016/j.expneurol.2005.03.011
   Danzer E, 2009, J NEUROS-PEDIATR, V3, P141, DOI 10.3171/2008.10.PEDS08199
   Farmer DL, 2003, ARCH SURG-CHICAGO, V138, P872, DOI 10.1001/archsurg.138.8.872
   Fauza DO, 2008, SURGERY, V144, P367, DOI 10.1016/j.surg.2008.05.009
   Feng YP, 2014, NEURAL REGEN RES, V9, P1968, DOI 10.4103/1673-5374.145378
   George J., 2015, FRONT PHARMACOL, V10, P53
   Guan KP, 2009, BIRTH DEFECTS RES A, V85, P583, DOI 10.1002/bdra.20576
   Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Johnson MP, 2003, AM J OBSTET GYNECOL, V189, P482, DOI 10.1067/S0002-9378(03)00295-3
   Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001
   Keong LC, 2009, INT J MOL SCI, V10, P1300, DOI 10.3390/ijms10031300
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kohl T, 2006, FETAL DIAGN THER, V21, P185, DOI 10.1159/000089301
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Lawrence BJ, 2008, CELL ADHES MIGR, V2, P9, DOI 10.4161/cam.2.1.5884
   Le Trong I, 2003, ACTA CRYSTALLOGR D, V59, P828, DOI 10.1107/S0907444903004153
   Li H, 2014, CYTOTHERAPY, V16, P319, DOI 10.1016/j.jcyt.2013.10.005
   Li H, 2012, J CELL MOL MED, V16, P1606, DOI 10.1111/j.1582-4934.2011.01470.x
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Merianos D, 2008, BIOL BLOOD MARROW TR, V14, P729, DOI 10.1016/j.bbmt.2008.02.012
   Miranda SCCC, 2011, ARCH ORAL BIOL, V56, P1, DOI 10.1016/j.archoralbio.2010.08.018
   Mohamed KR, 2014, J ADV RES, V5, P201, DOI 10.1016/j.jare.2013.02.004
   Muench MO, 2005, BONE MARROW TRANSPL, V35, P537, DOI 10.1038/sj.bmt.1704811
   Norambuena GA, 2012, PEDIATR RES, V71, P452, DOI 10.1038/pr.2011.68
   Pathak S, 2009, ARCH DIS CHILD-FETAL, V94, pF384, DOI 10.1136/adc.2008.137919
   Pezeshki-Modaress M, 2014, J BIOMED MATER RES A, V102, P3908, DOI 10.1002/jbm.a.35054
   Pisati F, 2007, CELL TRANSPLANT, V16, P41, DOI 10.3727/000000007783464443
   Poras JR, 2015, J IMMUNOL METHODS, V420, P38, DOI 10.1016/j.jim.2015.03.013
   Prockop DJ, 2010, J CELL MOL MED, V14, P2190, DOI 10.1111/j.1582-4934.2010.01151.x
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   Romosan G, 2009, ULTRASOUND OBST GYN, V34, P526, DOI 10.1002/uog.6446
   Roybal JL, 2010, SEMIN FETAL NEONAT M, V15, P46, DOI 10.1016/j.siny.2009.05.005
   Shin M, 2004, TISSUE ENG, V10, P33, DOI 10.1089/107632704322791673
   Sutton LN, 2008, BEST PRACT RES CL OB, V22, P175, DOI 10.1016/j.bpobgyn.2007.07.004
   Torrente Y, 2008, CELL TRANSPLANT, V17, P1103, DOI 10.3727/096368908787236576
   Tseng HJ, 2013, J TISSUE ENG REGEN M, V7, P20, DOI 10.1002/term.492
   Tulipan N, 2003, PEDIATR NEUROSURG, V38, P27, DOI 10.1159/000067560
   Varum KM, 1997, CARBOHYD RES, V299, P99, DOI 10.1016/S0008-6215(96)00332-1
   Wang XH, 2003, BIOMATERIALS, V24, P3213, DOI 10.1016/S0142-9612(03)00170-4
   Xia WY, 2004, J BIOMED MATER RES B, V71B, P373, DOI 10.1002/jbm.b.30087
   Xiao Y, 2003, TISSUE ENG, V9, P1167, DOI 10.1089/10763270360728071
   Yin YJ, 2003, J BIOMED MATER RES A, V67A, P844, DOI 10.1002/jbm.a.10153
   Yuan ZW, 2003, J PEDIATR SURG, V38, P1383, DOI 10.1016/S0022-3468(03)00401-9
   Zambelli H, 2007, CHILD NERV SYST, V23, P39
   Zhu L, 2006, TISSUE ENG, V12, P423, DOI 10.1089/ten.2006.12.423
   Zhu L, 2008, FOOD NUTR BULL, V29, pS196, DOI 10.1177/15648265080292S123
NR 55
TC 6
Z9 6
U1 3
U2 18
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2016
VL 27
IS 4
AR 77
DI 10.1007/s10856-016-5684-7
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DG7JA
UT WOS:000372259400014
PM 26894267
OA Other Gold, Green Published
DA 2018-10-19
ER

PT J
AU Zhang, LG
AF Zhang, Lije Grace
TI Development of Biologically Inspired 3D Printed Biomaterial Scaffolds
   for Improved Stem Cell Differentiation
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Experimental Biology Meeting
CY APR 02-06, 2016
CL San Diego, CA
SP Amer Assoc Anatomists, Amer Physiol Soc, Amer Soc Biochem & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Nutr, Amer Soc Pharmacol & Expt Therapeut
C1 [Zhang, Lije Grace] George Washington Univ, Washington, DC USA.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2016
VL 30
SU 1
MA 87.3
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA FB9FC
UT WOS:000406444004307
DA 2018-10-19
ER

PT J
AU Zhang, LG
AF Zhang, Lije Grace
TI Development of Biologically Inspired 3D Printed Biomaterial Scaffolds
   for Improved Stem Cell Differentiation
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Experimental Biology Meeting
CY APR 02-06, 2016
CL San Diego, CA
SP Amer Assoc Anatomists, Amer Physiol Soc, Amer Soc Biochem & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Nutr, Amer Soc Pharmacol & Expt Therapeut
C1 [Zhang, Lije Grace] George Washington Univ, Washington, DC USA.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2016
VL 30
SU 1
MA 87.3
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA FB9FC
UT WOS:000406444001295
DA 2018-10-19
ER

PT J
AU Zhang, LG
AF Zhang, Lije Grace
TI Development of Biologically Inspired 3D Printed Biomaterial Scaffolds
   for Improved Stem Cell Differentiation
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Experimental Biology Meeting
CY APR 02-06, 2016
CL San Diego, CA
SP Amer Assoc Anatomists, Amer Physiol Soc, Amer Soc Biochem & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Nutr, Amer Soc Pharmacol & Expt Therapeut
C1 [Zhang, Lije Grace] George Washington Univ, Washington, DC USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2016
VL 30
SU 1
MA 87.3
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA FB9FC
UT WOS:000406444000521
DA 2018-10-19
ER

PT J
AU Chen, RX
   Willcox, MDP
   Ho, KKK
   Smyth, D
   Kumar, N
AF Chen, Renxun
   Willcox, Mark D. P.
   Ho, Kitty Ka Kit
   Smyth, Daniel
   Kumar, Naresh
TI Antimicrobial peptide melimine coating for titanium and its in vivo
   antibacterial activity in rodent subcutaneous infection models
SO BIOMATERIALS
LA English
DT Article
DE Antimicrobial peptides; Biomaterial; In vivo infection model;
   Pseudomonas; Staphylococcus
ID CENTRAL VENOUS CATHETERS; RESIDUAL ETHYLENE-OXIDE; CATIONIC-PEPTIDE;
   CONTACT-LENSES; PSEUDOMONAS-AERUGINOSA; MEDICAL DEVICES; SILVER; VITRO;
   PREVENTION; SURFACES
AB Implant-associated infections represent a significant health problem and financial burden on healthcare systems. Current strategies for the treatment or prevention of such infections are still inadequate and new strategies are needed in this era of antibiotic resistance. Melimine, a synthetic antimicrobial peptide with broad spectrum activity against bacteria, fungi and protozoa, has been shown to be a promising candidate for development as antimicrobial coating for biomedical devices and implants. In this study, the in vitro and in vivo antimicrobial activity of melimine-coated titanium was tested. The titanium surface was amine-functionalised with 3-aminopropyltriethoxysilane (APTES) followed by reaction with a bifunctional linker 4-(N-maleimidomethyl)cyclohexane-1-carboxylic 3-sulfo-n-hydroxysuccinimide ester (Sulfo-SMCC) to yield a maleimide functionalised surface. Melimine was then tethered to the surface via a thioether linkage through a Michael addition reaction of the cysteine at its N-terminus with the maleimide moiety. Melimine coating significantly reduced in vitro adhesion and biofilm formation of Pseudomonas aeruginosa by up to 62% and Staphylococcus aureus by up to 84% on the titanium substrates compared to the blank (p < 0.05). The activity was maintained after ethylene oxide gas sterilisation. The coating was also challenged in both mouse and rat subcutaneous infection models and was able to reduce the bacterial load by up to 2 log(10) compared to the uncoated surface (p < 0.05). Melimine coating is a promising candidate for development as a surface antimicrobial that can withstand industrial sterilisation while showing good biocompatibility. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Chen, Renxun; Ho, Kitty Ka Kit; Kumar, Naresh] Univ New S Wales, Sch Chem, Sydney, NSW, Australia.
   [Chen, Renxun; Willcox, Mark D. P.] Univ New S Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia.
   [Smyth, Daniel] Cochlear Ltd, Sydney, NSW, Australia.
RP Kumar, N (reprint author), Univ New S Wales, Sch Chem, Sydney, NSW, Australia.
EM n.kumar@unsw.edu.au
RI Chen, Renxun/G-7015-2014
OI Chen, Renxun/0000-0003-0828-9980
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Alves D, 2014, BIOFOULING, V30, P483, DOI 10.1080/08927014.2014.889120
   Barraud N, 2006, J BACTERIOL, V188, P7344, DOI 10.1128/JB.00779-06
   Belen Burcu, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2014-208490
   BONDE M, 1992, ANAL BIOCHEM, V200, P195, DOI 10.1016/0003-2697(92)90298-L
   Bong JJ, 2003, J CLIN PATHOL, V56, P731, DOI 10.1136/jcp.56.10.731
   Chen L, 2015, J PHARM SCI-US, V104, P731, DOI 10.1002/jps.24257
   Chen RX, 2012, ACTA BIOMATER, V8, P4371, DOI 10.1016/j.actbio.2012.07.029
   Chen RX, 2009, BIOFOULING, V25, P517, DOI 10.1080/08927010902954207
   Ciampi S, 2007, LANGMUIR, V23, P9320, DOI 10.1021/la701035g
   Cole N, 2010, INVEST OPHTH VIS SCI, V51, P390, DOI 10.1167/iovs.09-4068
   Darouiche R, 2007, INT J ARTIF ORGANS, V30, P820
   Darouiche RO, 2008, J ANTIMICROB CHEMOTH, V61, P651, DOI 10.1093/jac/dkn006
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Dettin M, 2009, J BIOMED MATER RES A, V90A, P35, DOI 10.1002/jbm.a.32064
   Duewelhenke N, 2007, ANTIMICROB AGENTS CH, V51, P54, DOI 10.1128/AAC.00729-05
   Dutta D, 2014, OPTOMETRY VISION SCI, V91, P570, DOI 10.1097/OPX.0000000000000232
   Dutta D, 2013, INVEST OPHTH VIS SCI, V54, P175, DOI 10.1167/iovs.12-10989
   Fraenkel D, 2006, CRIT CARE MED, V34, P668, DOI 10.1097/01.CCM.0000201404.05523.34
   Gao GZ, 2011, BIOMATERIALS, V32, P3899, DOI 10.1016/j.biomaterials.2011.02.013
   Ho KKK, 2010, BIOFOULING, V26, P913, DOI 10.1080/08927014.2010.531463
   Kirov SM, 2007, MICROBIOL-SGM, V153, P3264, DOI 10.1099/mic.0.2007/009092-0
   Knetsch MLW, 2011, POLYMERS-BASEL, V3, P340, DOI 10.3390/polym3010340
   Lam PK, 2004, BRIT J BIOMED SCI, V61, P125, DOI 10.1080/09674845.2004.11732656
   Listyo A, 2014, A A CASE REP, V2, P3, DOI 10.1097/ACC.0b013e3182a08ff1
   Lucas AD, 2003, J BIOMED MATER RES B, V66B, P548, DOI 10.1002/jbm.b.10036
   Madkour AE, 2009, LANGMUIR, V25, P1060, DOI 10.1021/la802953v
   Mansouri MD, 2012, ANTIMICROB AGENTS CH, V56, P2201, DOI 10.1128/AAC.05521-11
   Mendes GCC, 2007, AM J INFECT CONTROL, V35, P574, DOI 10.1016/j.ajic.2006.10.014
   Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009
   O'Neill J., 2014, ANTIMICROBIAL RESIST, P1
   POOTHULLIL J, 1975, ANN INTERN MED, V82, P58, DOI 10.7326/0003-4819-82-1-58
   Ramritu P, 2008, AM J INFECT CONTROL, V36, P104, DOI 10.1016/i.ajic.2007.02.012
   Rasul R, 2010, INT J ANTIMICROB AG, V35, P566, DOI 10.1016/j.ijantimicag.2010.02.005
   Salwiczek M, 2014, TRENDS BIOTECHNOL, V32, P82, DOI 10.1016/j.tibtech.2013.09.008
   Schierholz JM, 2001, J HOSP INFECT, V49, P87, DOI 10.1053/jhin.2001.1052
   SHERERTZ RJ, 1989, ANTIMICROB AGENTS CH, V33, P1174, DOI 10.1128/AAC.33.8.1174
   Siedenbiedel F, 2012, POLYMERS-BASEL, V4, P46, DOI 10.3390/polym4010046
   Tilmaciu CM, 2015, ACTA BIOMATER, V15, P266, DOI 10.1016/j.actbio.2014.12.020
   Willcox MDP, 2008, J APPL MICROBIOL, V105, P1817, DOI 10.1111/j.1365-2672.2008.03942.x
   WINDMUELLER HG, 1959, J BIOL CHEM, V234, P895
NR 41
TC 36
Z9 36
U1 21
U2 156
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2016
VL 85
BP 142
EP 151
DI 10.1016/j.biomaterials.2016.01.063
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DG1QA
UT WOS:000371841400012
PM 26871890
DA 2018-10-19
ER

PT J
AU Lv, XG
   Li, Z
   Chen, SY
   Xie, MK
   Huang, JW
   Peng, XF
   Yang, RX
   Wang, HP
   Xu, YM
   Feng, C
AF Lv, XiangGuo
   Li, Zhe
   Chen, ShiYan
   Xie, MinKai
   Huang, JianWen
   Peng, XuFeng
   Yang, RanXing
   Wang, HuaPing
   Xu, YueMin
   Feng, Chao
TI Structural and functional evaluation of oxygenating keratin/silk fibroin
   scaffold and initial assessment of their potential for urethral tissue
   engineering
SO BIOMATERIALS
LA English
DT Article
DE Silk fibroin; Keratin; Oxygen generation; Urinary tract; Tissue
   Engineering
ID SILK FIBROIN; IN-VITRO; CALCIUM HYDROXIDE; STEM-CELLS; RECONSTRUCTION;
   REGENERATION; PROTEINS; MATRICES; REPAIR; REPLACEMENT
AB In this study, we report a new type of oxygen-generating scaffold, composed of human keratin, silk, gelatin and calcium peroxide (CPO). After mixing the silk/keratin (60:40) with 2% gelatin and 20% CPO, the film demonstrated excellent mechanical properties, non-cytotoxicity and oxygen-generative ability. The detailed structure of scaffold was revealed by confocal laser and electronic scanning microscopy. The gelatin formed the network structure, which mixed with silk fibroin and keratin. The CPOs were embedded into scaffold. A shell core structure was formed in the CPO particles, in which the CPO was located in the core and the gelatin was mainly wrapped around the CPO. Furthermore, the oxygen release test showed that scaffold was able to steadily release high level of oxygen over two weeks in vitro. In addition, the anti-bacterial function was also proved in the scaffold. Films with CPO enhanced the repair in dog urethral defect models, resulting in patent urethra. Improved organized muscle bundles and epithelial layer were observed in animals treated with CPO films compared with those treated with non-CPO films. This study suggests that this biomaterial could be suitable for tissue engineered urinary tract reconstruction. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Lv, XiangGuo; Xie, MinKai; Huang, JianWen; Peng, XuFeng; Yang, RanXing; Xu, YueMin; Feng, Chao] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Urol, 600 Yi Shan Rd, Shanghai 200233, Peoples R China.
   [Li, Zhe; Chen, ShiYan; Wang, HuaPing] Donghua Univ, Coll Mat Sci & Engn, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai, Peoples R China.
   [Xu, YueMin] Shanghai Eastern Urol Reconstruct & Repair Inst, Shanghai, Peoples R China.
RP Feng, C (reprint author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Urol, 600 Yi Shan Rd, Shanghai 200233, Peoples R China.
EM fengchaomed@sina.com
FU National Natural Science Foundation of China [81170641, 81100488,
   81370795]; Department of Education for Post-graduate Event
   [20130073110021]
FX This study was supported by National Natural Science Foundation of China
   (81170641, 81100488 and 81370795). Fund from the Department of Education
   for Post-graduate Event (20130073110021).
CR Arlen AM, 2010, THESCIENTIFICWORLDJO, V10, P74, DOI 10.1100/tsw.2010.16
   Atala A, 2004, AM J TRANSPLANT, V4, P58, DOI 10.1111/j.1600-6135.2004.0346.x
   Atala A, 2003, CLIN PLAST SURG, V30, P649, DOI 10.1016/S0094-1298(03)00094-4
   Atala A, 2008, PEDIATR RES, V63, P569, DOI 10.1203/PDR.0b013e3181660639
   BAKER AM, 1987, PLANT SOIL, V99, P379, DOI 10.1007/BF02370883
   Bhardwaj N, 2015, INTEGR BIOL-UK, V7, P53, DOI 10.1039/c4ib00208c
   Chakravarthy MV, 2001, CELL MOL LIFE SCI, V58, P1150, DOI 10.1007/PL00000929
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   Ding J, 2014, UROL INT, V93, P454, DOI 10.1159/000360796
   Dorin RP, 2008, WORLD J UROL, V26, P323, DOI 10.1007/s00345-008-0316-6
   Dwivedi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111289
   Folin M., 1995, ANTHROPOL ANZ, P337
   FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745
   FU FN, 1994, APPL SPECTROSC, V48, P1432, DOI 10.1366/0003702944028065
   Fujii T, 2004, BIOL PHARM BULL, V27, P89, DOI 10.1248/bpb.27.89
   Fujii T, 2009, J BIOMED MATER RES B, V91B, P528, DOI 10.1002/jbm.b.31426
   Hanh DN, 2005, ENVIRON TECHNOL, V26, P581, DOI 10.1080/09593332608618543
   Harrison BS, 2007, BIOMATERIALS, V28, P4628, DOI 10.1016/j.biomaterials.2007.07.003
   HAYASHI A, 1983, AGR BIOL CHEM TOKYO, V47, P1711, DOI 10.1080/00021369.1983.10865852
   Horst M, 2013, BIOMATERIALS, V34, P1537, DOI 10.1016/j.biomaterials.2012.10.075
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Jetbumpenkul P, 2012, INT J BIOL MACROMOL, V50, P7, DOI 10.1016/j.ijbiomac.2011.08.028
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Love NR, 2013, NAT CELL BIOL, V15, P222, DOI 10.1038/ncb2659
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Mangera A, 2013, ASIAN J ANDROL, V15, P89, DOI 10.1038/aja.2012.91
   Mohammadi Zahed, 2012, Iran Endod J, V7, P115
   Nakamura A, 2002, BIOL PHARM BULL, V25, P569, DOI 10.1248/bpb.25.569
   Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0
   Oh SH, 2009, BIOMATERIALS, V30, P757, DOI 10.1016/j.biomaterials.2008.09.065
   Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077
   Seino M, 2015, ANTICANCER RES, V35, P85
   Selim M, 2011, BJU INT, V107, P296, DOI 10.1111/j.1464-410X.2010.09310.x
   Shim JH, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/3/034102
   Shokraneh A, 2014, DENT MATER J, V33, P733, DOI 10.4012/dmj.2014-090
   Simaioforidis V, 2013, TISSUE ENG PART B-RE, V19, P413, DOI [10.1089/ten.teb.2012.0737, 10.1089/ten.TEB.2012.0737]
   Siqueira JF, 1999, INT ENDOD J, V32, P361, DOI 10.1046/j.1365-2591.1999.00275.x
   Srinivasan B, 2010, J BIOMED MATER RES B, V92B, P5, DOI 10.1002/jbm.b.31483
   Stark G, 2005, J MEMBRANE BIOL, V205, P1, DOI 10.1007/s00232-005-0753-8
   Urciuolo F, 2012, METHODS MOL BIOL, V811, P223, DOI 10.1007/978-1-61779-388-2_15
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Wang S, 2012, CELL TISSUE RES, V347, P795, DOI 10.1007/s00441-011-1295-2
   Ward CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072485
   Xie MK, 2014, J SURG RES, V188, P1, DOI 10.1016/j.jss.2013.11.1102
   Xie MK, 2013, J SURG RES, V184, P774, DOI 10.1016/j.jss.2013.04.016
   Yamada H, 2001, MAT SCI ENG C-BIO S, V14, P41, DOI 10.1016/S0928-4931(01)00207-7
NR 47
TC 9
Z9 11
U1 5
U2 78
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2016
VL 84
BP 99
EP 110
DI 10.1016/j.biomaterials.2016.01.032
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF5BT
UT WOS:000371367500009
PM 26826299
DA 2018-10-19
ER

PT J
AU Michael, FM
   Khalid, M
   Ratnam, CT
   Chee, CY
   Rashmi, W
   Hoque, ME
AF Michael, Feven Mattews
   Khalid, M.
   Ratnam, C. T.
   Chee, Ching Yern
   Rashmi, W.
   Hoque, M. E.
TI Sono-synthesis of nanohydroxyapatite: Effects of process parameters
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Calcination; Nanohydroxyapatite; Precipitation; Ultrasonication; Thermal
   stability
ID HYDROXYAPATITE NANOPARTICLES; HYDROTHERMAL METHOD; NANOCRYSTALLINE
   HYDROXYAPATITE; NANOPHASE HYDROXYAPATITE; MECHANICAL-PROPERTIES;
   TEMPERATURE; PRECIPITATION; MORPHOLOGY; SCAFFOLDS; BIOMATERIAL
AB Hydroxyapatite (HA) [Ca-10(PO4)(6)(OH)(2)] is a bioactive ceramic with excellent osteoconductive properties. This characteristic helps HA to be integrated into the bone without provoking an immune reaction, thus making it a useful biocompatible material for load bearing bone implant. In this study, nanohydroxyapatite (NHA) was synthesised using a precipitation method assisted with ultrasonication. The process parameters such as ultrasonic time (t) (10-30 min), ultrasonic amplitude (A) (50-70%), solution temperature (T) (50-90 degrees C), and solution pH (7-9) were varied on the basis of single factor and their effects on NHA synthesis was investigated. Besides that, the effect of calcination on the NHA powder morphology was also studied by varying the calcination time (2, 4 and 6 h) and temperature (400, 800 and 1200 degrees C). The characterisations of the synthesised NHA powder were conducted using thermogravimetric analysis (TGA), field emission scanning electron microscope (FESEM), energy-dispersive X-ray spectroscopy (EDX), X-ray diffraction (XRD), Brunauer-Emmet-Teller (BET), transmission electron microscope (I EM), zeta-sizer and Fourier transform infrared spectroscopy (FTIR). It was found that nano-sized HA particles can be produced at optimum set of process parameters of t=25 min, T=90 degrees C, A=65%, and pH=8. Results revealed that the thermal stability, morphology and crystallinity of the NHA powder was further improved by calcinating the powder at optimum temperature and time of 800 degrees C and 2 h, respectively. (C) 2016 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Michael, Feven Mattews; Khalid, M.] Univ Nottingham, Fac Engn, Div Mfg & Ind Proc, Malaysia Campus, Semenyih 43500, Selangor, Malaysia.
   [Ratnam, C. T.] Agensi Nuklear Malaysia, Radiat Proc Technol Div, Bangi, Malaysia.
   [Chee, Ching Yern] Univ Malaya, Fac Engn, Dept Mech Engn, Kuala Lumpur 50603, Malaysia.
   [Rashmi, W.] Taylors Univ, Sch Engn, Energy Res Grp, Subang Jaya 47500, Selangor, Malaysia.
   [Hoque, M. E.] King Faisal Univ, Dept Biomed Engn, Al Hufuf, Al Ahsa, Saudi Arabia.
RP Khalid, M (reprint author), Univ Nottingham, Fac Engn, Div Mfg & Ind Proc, Malaysia Campus, Semenyih 43500, Selangor, Malaysia.
EM khalid.siddiqui@nottingham.edu.my
RI CHING, CHEE/D-6881-2011; Engineering, Faculty/I-7935-2015; engineering,
   @UM-2016/I-9329-2016; RATNAM, CHANTARA THEVY/K-1275-2012
OI CHING, CHEE/0000-0002-1611-1341; Engineering,
   Faculty/0000-0002-4848-7052; RATNAM, CHANTARA THEVY/0000-0002-3683-8548;
   Hoque, Md Enamul/0000-0003-0393-6771; Khalid,
   Mohammad/0000-0002-0265-4820
FU University of Nottingham, Malaysia campus [UNR30005]; Ministry of
   Education Malaysia [UM.C/625/1/HIR/MoE/52]
FX The authors would like to acknowledge the financial support provided by
   the University of Nottingham, Malaysia campus, research Grant (UNR30005)
   and High Impact Research MoE Grant (UM.C/625/1/HIR/MoE/52) from the
   Ministry of Education Malaysia.
CR Aminzare M, 2013, CERAM INT, V39, P2197, DOI 10.1016/j.ceramint.2012.09.023
   Cao LY, 2005, CERAM INT, V31, P1041, DOI 10.1016/j.ceramint.2004.11.002
   Cengiz B, 2008, COLLOID SURFACE A, V322, P29, DOI 10.1016/j.colsurfa.2008.02.011
   Chandrasekar A., 2013, INT J PHYS SCI, V8, P1639
   Cox SC, 2014, J MATER SCI-MATER M, V25, P37, DOI 10.1007/s10856-013-5042-y
   Eslami H, 2010, MATER SCI-POLAND, V28, P5
   Figueiredo M, 2010, CERAM INT, V36, P2383, DOI 10.1016/j.ceramint.2010.07.016
   Gaharwar AK, 2014, BIOTECHNOL BIOENG, V111, P441, DOI 10.1002/bit.25160
   Gopi D, 2008, SPECTROCHIM ACTA A, V70, P1243, DOI 10.1016/j.saa.2008.02.015
   Gross KA, 1998, J AM CERAM SOC, V81, P106
   Hogue M.E., 2013, J MAT SCI ENG, V2, P132
   Hoque M.E., 2014, INT J SCI ENG TECHNO, V3, P458
   Hutmacher DW, 2008, VIRTUAL PROTOTYPING & BIO MANUFACTURING IN MEDICAL APPLICATIONS, P261, DOI 10.1007/978-0-387-68831-2_12
   Lazic S, 2001, THERMOCHIM ACTA, V374, P13, DOI 10.1016/S0040-6031(01)00453-1
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Li XM, 2014, J BIOMED MATER RES A, V102, P1580, DOI 10.1002/jbm.a.34801
   Liu DM, 2002, BIOMATERIALS, V23, P1679, DOI 10.1016/S0142-9612(01)00295-2
   Liu HS, 1997, CERAM INT, V23, P19, DOI 10.1016/0272-8842(95)00135-2
   Liu JB, 2003, CERAM INT, V29, P629, DOI 10.1016/S0272-8842(02)00210-9
   Mobasherpour I, 2007, J ALLOY COMPD, V430, P330, DOI 10.1016/j.jallcom.2006.05.018
   Neira I. S., 2008, CRYSTAL GROWTH DESIG, V9, P466, DOI DOI 10.1021/CG800738A
   Pramanik S, 2007, CERAM INT, V33, P419, DOI 10.1016/j.ceramint.2005.10.025
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rhee SH, 2002, BIOMATERIALS, V23, P1147, DOI 10.1016/S0142-9612(01)00229-0
   Sadat-Shojai M, 2013, ACTA BIOMATER, V9, P7591, DOI 10.1016/j.actbio.2013.04.012
   Scalera F, 2013, CERAM INT, V39, P4839, DOI 10.1016/j.ceramint.2012.11.076
   Seema K, 2012, J MATER ENG PERFORM, V21, P1737, DOI 10.1007/s11665-011-0059-1
   Singh A, 2012, B MATER SCI, V35, P1031, DOI 10.1007/s12034-012-0384-5
   Song QZ, 2011, MATER RES BULL, V46, P1398, DOI 10.1016/j.materresbull.2011.05.015
   Wang PP, 2010, POWDER TECHNOL, V203, P315, DOI 10.1016/j.powtec.2010.05.023
   Yousefi A., 2014, J BIOMED MATER RES A, V103, P2460
   Zakaria SM, 2013, TISSUE ENG PART B-RE, V19, P431, DOI [10.1089/ten.teb.2012.0624, 10.1089/ten.TEB.2012.0624]
NR 32
TC 2
Z9 2
U1 1
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD APR
PY 2016
VL 42
IS 5
BP 6263
EP 6272
DI 10.1016/j.ceramint.2016.01.009
PG 10
WC Materials Science, Ceramics
SC Materials Science
GA DE8KI
UT WOS:000370884500079
DA 2018-10-19
ER

PT J
AU Cifuentes, SC
   Bensiamar, F
   Gallardo-Moreno, AM
   Osswald, TA
   Gonzalez-Carrasco, JL
   Benavente, R
   Gonzalez-Martin, ML
   Garcia-Rey, E
   Vilaboa, N
   Saldana, L
AF Cifuentes, Sandra C.
   Bensiamar, Fatima
   Gallardo-Moreno, Amparo M.
   Osswald, Tim A.
   Gonzalez-Carrasco, Jose L.
   Benavente, Rosario
   Gonzalez-Martin, Maria L.
   Garcia-Rey, Eduardo
   Vilaboa, Nuria
   Saldana, Laura
TI Incorporation of Mg particles into PDLLA regulates mesenchymal stem cell
   and macrophage responses
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE magnesium; polymer; composite; mesenchymal stem cell; macrophage
ID MAGNESIUM DEGRADATION-PRODUCTS; IN-VIVO CORROSION; L-LACTIC ACID; BONE
   REGENERATION; ALLOYS; DIFFERENTIATION; FIXATION; IMPLANTS; VITRO;
   BIOCOMPATIBILITY
AB In this work, we investigated a new approach to incorporate Mg particles within a PDLLA matrix using a solvent-free commercially available process. PDLLA/Mg composites were manufactured by injection moulding and the effects of Mg incorporated into PDLLA on MSC and macrophage responses were evaluated. Small amounts of Mg particles (1 wt %) do not cause thermal degradation of PDLLA, which retains its mechanical properties. PDLLA/Mg composites release hydrogen, alkaline products and Mg2+ ions without changing pH of culture media. Mg-containing materials provide a noncytotoxic environment that enhances MSC viability. Concentration of Mg2+ ions in extracts of MSCs increases with the increment of Mg content in the composites. Incorporation of Mg particles into PDLLA stimulates FN production, ALP activity, and VEGF secretion in MSCs, an effect mediated by degradation products dissolved from the composites. Degradation products of PDLLA induce an increase in MCP-1, RANTES, and MIP-1 secretion in macrophages while products of composites have minimal effect on these chemokines. Regulation of MSC behavior at the biomaterial's interface and macrophage-mediated inflammatory response to the degradation products is related to the incorporation of Mg in the composites. These findings suggest that including small amounts of Mg particles into polymeric devices can be a valuable strategy to promote osseointegration and reduce host inflammatory response. (c) 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 866-878, 2016.
C1 [Cifuentes, Sandra C.; Gonzalez-Carrasco, Jose L.] CSIC, Ctr Nacl Invest Met CENIM, Dept Met Fis, Avda Gregorio Del Amo 8, Madrid 28040, Spain.
   [Bensiamar, Fatima; Garcia-Rey, Eduardo; Vilaboa, Nuria; Saldana, Laura] Hosp Univ La Paz IdiPAZ, Grp Fisiopatol Osea & Biomat, Paseo Castellana 261, Madrid 28046, Spain.
   [Bensiamar, Fatima; Gallardo-Moreno, Amparo M.; Gonzalez-Carrasco, Jose L.; Gonzalez-Martin, Maria L.; Vilaboa, Nuria; Saldana, Laura] CIBER Bioingn Biomat & Nanomed CIBER BBN, Madrid, Spain.
   [Gallardo-Moreno, Amparo M.; Gonzalez-Martin, Maria L.] Univ Extremadura, Dept Fis Aplicada, Avda De Elvas S-N, Badajoz 06006, Spain.
   [Osswald, Tim A.] Univ Wisconsin, PEC, Dept Mech Engn, Madison, WI USA.
   [Benavente, Rosario] ICTP CSIC, Dept Quim Fis, Madrid, Spain.
   [Garcia-Rey, Eduardo] Hosp Univ La Paz IdiPAZ, Dept Cirugia Ortoped & Traumatol, Paseo Castellana 261, Madrid 28046, Spain.
RP Saldana, L (reprint author), Hosp Univ La Paz IdiPAZ, Grp Fisiopatol Osea & Biomat, Paseo Castellana 261, Madrid 28046, Spain.; Saldana, L (reprint author), CIBER Bioingn Biomat & Nanomed CIBER BBN, Madrid, Spain.
EM laura.saldana@salud.madrid.org
RI Benavente, Rosario/F-5034-2016; Garcia-Rey, Eduardo/M-2094-2017
OI Benavente, Rosario/0000-0003-0416-0151; Garcia-Rey,
   Eduardo/0000-0002-8378-8096; CIFUENTES CUELLAR, SANDRA
   CAROLINA/0000-0001-9779-369X; Saldana, Laura/0000-0003-3057-4649
FU Ministerio de Economia y Competitividad (MINECO, Spain)
   [MAT2012-37736-CO5-01-03-05, MAT2013-47972-C2-1-P]; Fondo de
   Investigaciones Sanitarias (FIS, Spain) [PI12/01698]; Comunidad Autonoma
   de Madrid (CAM, Spain) [S2013/MIT-2862]; FIS [CP11/00022]
FX Contract grant sponsor: Ministerio de Economia y Competitividad (MINECO,
   Spain); contract grant numbers: MAT2012-37736-CO5-01-03-05;
   MAT2013-47972-C2-1-P.; Contract grant sponsor: Fondo de Investigaciones
   Sanitarias (FIS, Spain); contract grant number: PI12/01698.; Contract
   grant sponsor: Comunidad Autonoma de Madrid (CAM, Spain); contract grant
   number: S2013/MIT-2862; Program I2.; Contract grant sponsor: FIS;
   contract grant number: CP11/00022.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   BOSTMAN OM, 2000, CLIN ORTHOPAEDICS, V371, P216
   Brown A, 2015, ACTA BIOMATER, V11, P543, DOI 10.1016/j.actbio.2014.09.008
   Castiglioni S, 2013, NUTRIENTS, V5, P3022, DOI 10.3390/nu5083022
   Cifuentes SC, 2012, MATER LETT, V74, P239, DOI 10.1016/j.matlet.2012.01.134
   Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206
   DesJong WH, 2005, BIOMATERIALS, V26, P1781
   Galli S, 2014, ACTA BIOMATER, V10, P5193, DOI 10.1016/j.actbio.2014.08.011
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Hallab NJ, 2002, J BIOMED MATER RES, V60, P420, DOI 10.1002/jbm.10106
   Hornberger H, 2012, ACTA BIOMATER, V8, P2442, DOI 10.1016/j.actbio.2012.04.012
   Jiang X., 2010, POLYLACTIC ACID SYNT, P69
   Kuhlmann J, 2013, ACTA BIOMATER, V9, P8714, DOI 10.1016/j.actbio.2012.10.008
   Leidi M, 2011, MAGNESIUM RES, V24, P1, DOI 10.1684/mrh.2011.0271
   Li RW, 2014, J BIOMED MATER RES A, V102, P4346, DOI 10.1002/jbm.a.35111
   Marumo K, 2006, J ORTHOP SCI, V11, P154, DOI 10.1007/s00776-005-0989-2
   Mau LP, 2012, IMPLANT DENT, V21, P171, DOI 10.1097/ID.0b013e31824eece1
   Motoyama T, 2007, POLYM DEGRAD STABIL, V92, P1350, DOI 10.1016/j.polymdegradstab.2007.03.014
   Netea MG, 2008, P NATL ACAD SCI USA, V105, P3515, DOI 10.1073/pnas.0712381105
   Park JW, 2012, CLIN ORAL IMPLAN RES, V23, P294, DOI 10.1111/j.1600-0501.2010.02144.x
   Razavi M, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5514-3
   Saldana L, 2006, J BIOMED MATER RES A, V77A, P220, DOI 10.1002/jbm.a.30599
   Seitz JM, 2014, J BIOMED MATER RES A, V102, P3744, DOI 10.1002/jbm.a.35023
   Sissi C, 2009, NUCLEIC ACIDS RES, V3, P702
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Sugimoto J, 2012, J IMMUNOL, V188, P6338, DOI 10.4049/jimmunol.1101765
   Sun H, 2014, BONE JOINT J, V96B, P548, DOI 10.1302/0301-620X.96B4.32171
   Valles G, 2015, BIOMATERIALS, V37, P124, DOI 10.1016/j.biomaterials.2014.10.028
   Wan P, 2014, COMPOS SCI TECHNOL, V98, P36, DOI 10.1016/j.compscitech.2014.04.011
   Wang JL, 2015, ACTA BIOMATER, V21, P237, DOI 10.1016/j.actbio.2015.04.011
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Wong HM, 2013, BIOMATERIALS, V34, P7016, DOI 10.1016/j.biomaterials.2013.05.062
   Yang CX, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/045005
   Yoshizawa S, 2014, ACTA BIOMATER, V10, P2834, DOI 10.1016/j.actbio.2014.02.002
   Zhai ZJ, 2014, BIOMATERIALS, V35, P6299, DOI 10.1016/j.biomaterials.2014.04.044
NR 37
TC 10
Z9 10
U1 1
U2 34
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2016
VL 104
IS 4
BP 866
EP 878
DI 10.1002/jbm.a.35625
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF5XB
UT WOS:000371425000006
PM 26662548
DA 2018-10-19
ER

PT J
AU Bischel, LL
   Coneski, PN
   Lundin, JG
   Wu, PK
   Giller, CB
   Wynne, J
   Ringeisen, BR
   Pirlo, RK
AF Bischel, Lauren L.
   Coneski, Peter N.
   Lundin, Jeffrey G.
   Wu, Peter K.
   Giller, Carl B.
   Wynne, James
   Ringeisen, Brad R.
   Pirlo, Russell K.
TI Electrospun gelatin biopapers as substrate for in vitro bilayer models
   of blood-brain barrier tissue
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE blood-brain barrier; electrospinning; gelatin; tissue engineering;
   biomaterial
ID MICROVASCULAR ENDOTHELIAL-CELLS; CROSS-LINKING METHODS; ASTROCYTES;
   DIFFERENTIATION; PERMEABILITY; VIVO; MORPHOLOGY; SCAFFOLDS; MIGRATION;
   TRANSPORT
AB Gaining a greater understanding of the blood-brain barrier (BBB) is critical for improvement in drug delivery, understanding pathologies that compromise the BBB, and developing therapies to protect the BBB. In vitro human tissue models are valuable tools for studying these issues. The standard in vitro BBB models use commercially available cell culture inserts to generate bilayer co-cultures of astrocytes and endothelial cells (EC). Electrospinning can be used to produce customized cell culture substrates with optimized material composition and mechanical properties with advantages over off-the-shelf materials. Electrospun gelatin is an ideal cell culture substrate because it is a natural polymer that can aid cell attachment and be modified and degraded by cells. Here, we have developed a method to produce cell culture inserts with electrospun gelatin biopaper membranes. The electrospun fiber diameter and cross-linking method were optimized for the growth of primary human endothelial cell and primary human astrocyte bilayer co-cultures to model human BBB tissue. BBB co-cultures on biopaper were characterized via cell morphology, trans-endothelial electrical resistance (TEER), and permeability to FITC-labeled dextran and compared to BBB co-cultures on standard cell culture inserts. Over longer culture periods (up to 21 days), cultures on the optimized electrospun gelatin biopapers were found to have improved TEER, decreased permeability, and permitted a smaller separation between co-cultured cells when compared to standard PET inserts. (c) 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 901-909, 2016.
C1 [Bischel, Lauren L.; Coneski, Peter N.; Pirlo, Russell K.] US Naval Res Lab, Bldg 207,Rm 241,4555 Overlook Ave SW, Washington, DC USA.
   [Lundin, Jeffrey G.; Wynne, James; Ringeisen, Brad R.; Pirlo, Russell K.] US Naval Res Lab, Div Chem, Washington, DC USA.
   [Wu, Peter K.] Southern Oregon Univ, Dept Phys, Ashland, OR USA.
   [Giller, Carl B.] US Naval Res Lab, Leidos, Washington, DC USA.
RP Pirlo, RK (reprint author), US Naval Res Lab, Bldg 207,Rm 241,4555 Overlook Ave SW, Washington, DC USA.
EM russell.pirlo@nrl.navy.mil
FU Chemical Biological Technologies Directorate, Department of Defense
   Chemical and Biological Defense program through the Defense Threat
   Reduction Agency (DTRA); American Society for Engineering Education
   [CB10011]
FX Contract grant sponsor: Chemical Biological Technologies Directorate,
   Department of Defense Chemical and Biological Defense program through
   the Defense Threat Reduction Agency (DTRA) and the American Society for
   Engineering Education; contract grant number: CB10011.
CR ARTURSSON P, 1990, J PHARM SCI, V79, P476, DOI 10.1002/jps.2600790604
   Baiguera S, 2009, J MATER SCI-MATER M, V21, P1353
   Berezowski V, 2012, INT J CELL BIOL, V2012
   Carlson EC, 2003, ANAT REC PART A, V271A, P332, DOI 10.1002/ar.a.10038
   Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368
   Chang JC, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/5/055002
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   DEHOUCK MP, 1990, J NEUROCHEM, V54, P1798, DOI 10.1111/j.1471-4159.1990.tb01236.x
   Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8
   Demeuse P, 2002, J NEUROSCI METH, V121, P21, DOI 10.1016/S0165-0270(02)00225-X
   Eigenmann DE, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-33
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Fromm M, 2009, MOL STRUCTURE FUNCTI
   Gaillard PJ, 2000, EUR J PHARM SCI, V12, P95, DOI 10.1016/S0928-0987(00)00152-4
   Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007
   Gnavi S, 2015, MAT SCI ENG C-MATER, V48, P620, DOI 10.1016/j.msec.2014.12.055
   Hajiali H, 2011, INT J NANOMED, P2133
   Hatherell K, 2011, J NEUROSCI METH, V199, P223, DOI 10.1016/j.jneumeth.2011.05.012
   Hawkins RA, 2006, J NUTR, V136, P218
   Hodgkinson T, 2014, J TISSUE ENG
   HURWITZ AA, 1993, BRAIN RES, V625, P238, DOI 10.1016/0006-8993(93)91064-Y
   Jalaja K, 2014, CARBOHYD POLYM, V114, P467, DOI 10.1016/j.carbpol.2014.08.023
   Jong AY, 2001, INFECT IMMUN, V69, P4536, DOI 10.1128/IAI.69.7.4536-4544.2001
   Kelley LC, 2014, J CELL BIOL, V204, P291, DOI 10.1083/jcb.201311112
   Kuntz M, 2014, J CEREBR BLOOD F MET, V34, P95, DOI 10.1038/jcbfm.2013.169
   Kuo YC, 2011, COLLOID SURFACE B, V86, P225, DOI 10.1016/j.colsurfb.2011.04.005
   Li GL, 2010, ANN BIOMED ENG, V38, P2499, DOI 10.1007/s10439-010-0023-5
   Lo CM, 1999, EXP CELL RES, V250, P576, DOI 10.1006/excr.1999.4538
   Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802
   Lowery JL, 2010, BIOMATERIALS, V31, P491, DOI 10.1016/j.biomaterials.2009.09.072
   Megard I, 2002, BRAIN RES, V927, P153, DOI 10.1016/S0006-8993(01)03337-6
   Morris GE, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/3/035014
   Ozeki M, 2005, J BIOMAT SCI-POLYM E, V16, P549, DOI 10.1163/1568562053783731
   Panzavolta S, 2011, ACTA BIOMATER, V7, P1702, DOI 10.1016/j.actbio.2010.11.021
   Qu J, 2013, J BIOMED MATER RES A, V101, P2667, DOI 10.1002/jbm.a.34551
   Ren YJ, 2013, ACTA BIOMATER, V9, P7727, DOI 10.1016/j.actbio.2013.04.034
   Schafer A, 2011, J VIROL, V85, P10682, DOI 10.1128/JVI.05032-11
   Sisson K, 2010, J BIOMED MATER RES A, V94A, P1312, DOI 10.1002/jbm.a.32756
   Sisson K, 2009, BIOMACROMOLECULES, V10, P1675, DOI 10.1021/bm900036s
   Soza G, 2005, INT J MED ROBOT COMP, V1, P87, DOI 10.1002/rcs.32
   Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065
   Whited BM, 2014, BIOTECHNOL BIOENG, V111, P184, DOI 10.1002/bit.24995
   Wolff A, 2015, J PHARM SCI, V1104, P2727
   Wuest DM, 2013, J NEUROSCI METH, V212, P211, DOI 10.1016/j.jneumeth.2012.10.016
   Xue Q, 2013, INT J BIOL SCI, V9, P174, DOI 10.7150/ijbs.5115
   Zhao L, 2008, J BIOMED MATER RES B, V87B, P26, DOI 10.1002/jbm.b.31060
NR 46
TC 5
Z9 5
U1 5
U2 47
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2016
VL 104
IS 4
BP 901
EP 909
DI 10.1002/jbm.a.35624
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF5XB
UT WOS:000371425000009
PM 26650896
DA 2018-10-19
ER

PT J
AU Ju, HW
   Lee, OJ
   Lee, JM
   Moon, BM
   Park, HJ
   Park, YR
   Lee, MC
   Kim, SH
   Chao, JR
   Ki, CS
   Park, CH
AF Ju, Hyung Woo
   Lee, Ok Joo
   Lee, Jung Min
   Moon, Bo Mi
   Park, Hyun Jung
   Park, Ye Ri
   Lee, Min Chae
   Kim, Soo Hyeon
   Chao, Janet Ren
   Ki, Chang Seok
   Park, Chan Hum
TI Wound healing effect of electrospun silk fibroin nanomatrix in
   burn-model
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Silk fibroin; Wound healing; Electrospinning
ID IN-VITRO; GROWTH-FACTOR; CELLS; RATS; SKIN; BIOMATERIALS; SCAFFOLDS;
   TISSUES; PROTEIN; FILMS
AB Silk fibroin has recently become an important biomaterial for tissue engineering application. In this study, silk fibroin nanomatrix was fabricated by electrospinning and evaluated as wound dressing material in a burn rat model. The wound size reduction, histological examination, and the quantification of transforming growth factor TGF-beta 1 and interleukin IL-1 alpha, 6, and 10 were measured to evaluate the healing effects. The silk fibroin nanomatrix treatment exhibited effective performance in decreasing the wound size and epithelialization. Histological finding also revealed that the deposition of collagen in the dermis was organized by covering the wound area in the silk fibroin nanomatrix treated group. The expression level of pro-inflammatory cytokine (IL-1 alpha) was significantly reduced in the injured skin following the silk fibroin nanomatrix treatment compared to the medical gauze (control) at 7 days after burn. Also, the expression level of TGF-beta 1 in the wound treated with silk fibroin nanomatrix peaked 21-days post-treatment whereas expression level of TGF-beta 1 was highest at day 7 in the gauze treated group. In conclusion, this data demonstrates that silk fibroin nanomatrix enhances the burn wound healing, suggesting it is a good candidate for burn wound treatment. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Ju, Hyung Woo; Lee, Ok Joo; Lee, Jung Min; Moon, Bo Mi; Park, Hyun Jung; Park, Ye Ri; Lee, Min Chae; Kim, Soo Hyeon; Park, Chan Hum] Hallym Univ, Nanobio Regenerat Med Inst, 1 Hallymdaehak Gil, Chunchon 200702, Gangwon Do, South Korea.
   [Chao, Janet Ren] George Washington Univ, Sch Med, Washington, DC 20037 USA.
   [Ki, Chang Seok] Indiana Univ Purdue Univ, Purdue Sch Engn, Dept Biomed Engn, Indianapolis, IN 46202 USA.
   [Park, Chan Hum] Hallym Univ, Sch Med, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, 77 Sakju Ro, Chunchon 200704, Gangwon Do, South Korea.
RP Park, CH (reprint author), Hallym Univ, Nanobio Regenerat Med Inst, 1 Hallymdaehak Gil, Chunchon 200702, Gangwon Do, South Korea.
EM hlpch@paran.com
FU Hallym university research fund; National Research Foundation of
   Korea(NRF) - Korea government(MSIP), Republic of Korea.
   [NRF-2015R1A4A1041631]
FX This work was supported by Hallym university research fund and the
   National Research Foundation of Korea(NRF) grant funded by the Korea
   government(MSIP) (NRF-2015R1A4A1041631), Republic of Korea.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arturson G, 1996, BURNS, V22, P255, DOI 10.1016/0305-4179(95)00153-0
   Aukhil I, 2000, PERIODONTOL 2000, V22, P44, DOI 10.1034/j.1600-0757.2000.2220104.x
   Baek HS, 2008, SURF COAT TECH, V202, P5794, DOI 10.1016/j.surfcoat.2008.06.154
   Chiarini A, 2003, BIOMATERIALS, V24, P789, DOI 10.1016/S0142-9612(02)00417-9
   Guang SY, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.42503
   Gurfinkel R, 2010, ACAD EMERG MED, V17, P514, DOI 10.1111/j.1553-2712.2010.00736.x
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Kim DW, 2011, J NEUROSURG, V114, P485, DOI 10.3171/2010.9.JNS091764
   Kim YS, 2010, J KOREAN MED SCI, V25, P589, DOI 10.3346/jkms.2010.25.4.589
   Lee JH, 2010, INT J TISSUE REGEN, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0015394
   Lee OJ, 2014, J BIOMED NANOTECHNOL, V10, P1294, DOI 10.1166/jbn.2014.1818
   Li MZ, 2002, INT J BIOL MACROMOL, V30, P89, DOI 10.1016/S0141-8130(02)00007-7
   Lu BY, 2010, BURNS, V36, P891, DOI 10.1016/j.burns.2009.12.001
   MALEFYT RD, 1991, J EXP MED, V174, P1209
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   Molan Peter C, 2002, Ostomy Wound Manage, V48, P28
   Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683
   Mori H, 2000, J Biotechnol, V74, P95
   Nall A. V., 1996, OTOLARYNGOLOGY, V122, P171
   PEJNOVIC N, 1995, ARCH SURG-CHICAGO, V130, P999
   ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167
   Roh DH, 2006, J MATER SCI-MATER M, V17, P547, DOI 10.1007/s10856-006-8938-y
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Schneider A, 2009, ACTA BIOMATER, V5, P2570, DOI 10.1016/j.actbio.2008.12.013
   Shan YH, 2015, INT J PHARMACEUT, V479, P291, DOI 10.1016/j.ijpharm.2014.12.067
   Shin YM, 2001, POLYMER, V42, P9955, DOI 10.1016/S0032-3861(01)00540-7
   Sigal LH, 2004, JCR-J CLIN RHEUMATOL, V10, P353, DOI 10.1097/01.rhu.0000147138.11053.e4
   Singer AJ, 2007, ACAD EMERG MED, V14, P1125, DOI 10.1197/j.aem.2007.07.012
   Singer AJ, 2000, ACAD EMERG MED, V7, P1, DOI 10.1111/j.1553-2712.2000.tb01881.x
   Srivastava CM, 2015, FIBER POLYM, V16, P1020, DOI 10.1007/s12221-015-1020-y
   Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Upadhyay NK, 2009, FOOD CHEM TOXICOL, V47, P1146, DOI 10.1016/j.fct.2009.02.002
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang RJ, 2000, WOUND REPAIR REGEN, V8, P128, DOI 10.1046/j.1524-475x.2000.00128.x
   Wharram SE, 2010, MACROMOL BIOSCI, V10, P246, DOI 10.1002/mabi.200900274
   Yeo JH, 2000, BIOL PHARM BULL, V23, P1220
   Zhang X, 2012, EXP THER MED, V3, P9, DOI 10.3892/etm.2011.367
   Zhang YQ, 2005, J BIOTECHNOL, V120, P315, DOI 10.1016/j.jbiotec.2005.06.027
NR 45
TC 27
Z9 27
U1 6
U2 93
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD APR
PY 2016
VL 85
BP 29
EP 39
DI 10.1016/j.ijbiomac.2015.12.055
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA DE8LF
UT WOS:000370886800005
PM 26718866
DA 2018-10-19
ER

PT J
AU Kim, SH
   Park, HS
   Lee, OJ
   Chao, JR
   Park, HJ
   Lee, JM
   Ju, HW
   Moon, BM
   Park, YR
   Song, JE
   Khang, G
   Park, CH
AF Kim, Soo Hyeon
   Park, Hae Sang
   Lee, Ok Joo
   Chao, Janet Ren
   Park, Hyun Jung
   Lee, Jung Min
   Ju, Hyung Woo
   Moon, Bo Mi
   Park, Ye Ri
   Song, Jeong Eun
   Khang, Gilson
   Park, Chan Hum
TI Fabrication of duck's feet collagen-silk hybrid biomaterial for tissue
   engineering
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Collagen; Duck's feet; Silk
ID FIBROIN; MEMBRANES; MATRIX
AB Collagen constituting the extracellular matrix has been widely used as biocompatible material for human use. In this study, we have selected duck's feet for extracting collagen. A simple method not utilizing harsh chemical had been employed to extract collagen from duck's feet. We fabricated duck's feet collagen/silk hybrid scaffold for the purpose of modifying the degradation rate of duck's feet collagen. This study suggests that extracted collagen from duck's feet is biocompatible and resembles collagen extracted from porcine which is commercially used. Duck's feet collagen is also economically feasible and it could therefore be a good candidate as a tissue engineering material. Further, addition of silk to fabricate a duck's feet collagen/silk hybrid scaffold could enhance the biostability of duck's feet collagen scaffold. Duck's feet collagen/silk scaffold increased the cell viability compared to silk alone. Animal studies also showed that duck's feet collagen/silk scaffold was more biocompatible than silk alone and more biostable than duck's feet or porcine collagen alone. Additionally, the results revealed that duck's feet collagen/silk hybrid scaffold had high porosity, cell infiltration and proliferation. We suggest that duck's feet collagen/silk hybrid scaffold could be used as a dermal substitution for full thickness skin defects. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Kim, Soo Hyeon; Park, Hae Sang; Lee, Ok Joo; Park, Hyun Jung; Lee, Jung Min; Ju, Hyung Woo; Moon, Bo Mi; Park, Ye Ri; Park, Chan Hum] Hallym Univ, Sch Med, Nanobio Regenerat Med Inst, Chunchon 200702, Gangwon Do, South Korea.
   [Park, Hae Sang; Park, Chan Hum] Hallym Univ, Sch Med, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, 77 Sakju Ro, Chunchon 200704, Gangwon Do, South Korea.
   [Chao, Janet Ren] George Washington Univ, Sch Med, Washington, DC 20037 USA.
   [Song, Jeong Eun; Khang, Gilson] Chonbuk Natl Univ, Dept BIN Fus Technol, Dept Polymer Nano Sci &Technol, 567 Baekje Daero, Jeonju 561756, South Korea.
   [Song, Jeong Eun; Khang, Gilson] Chonbuk Natl Univ, Polymer BIN Res Ctr, 567 Baekje Daero, Jeonju 561756, South Korea.
RP Park, CH (reprint author), Hallym Univ, Sch Med, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, 77 Sakju Ro, Chunchon 200704, Gangwon Do, South Korea.; Park, CH (reprint author), Hallym Univ, Nanobio Regenerat Med Inst, 1 Hallymdaehak Gil, Chunchon 200702, Gangwon Do, South Korea.
EM hlpch@paran.com
RI song, jeong eun/P-9106-2015; Park, Chan Hum/C-6848-2016
OI song, jeong eun/0000-0001-6879-7616; 
FU Hallym University Research Fund; Technology Commercialization Support
   Program, Ministry for Food, Agriculture, Forestry and Fisheries,
   Republic of Korea [814005-03-2-HD030]
FX This work was supported by a grant from Hallym University Research Fund
   and Technology Commercialization Support Program (814005-03-2-HD030),
   Ministry for Food, Agriculture, Forestry and Fisheries, Republic of
   Korea.
CR Bi FG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125900
   Bottcher-Haberzeth S, 2012, PEDIATR SURG INT, V28, P171, DOI 10.1007/s00383-011-2990-5
   Cha S.R., 2014, INT J TISSUE REGEN, V5, P84
   Chen GP, 2003, J BIOMED MATER RES A, V67A, P1170, DOI 10.1002/jbm.a.10164
   Hashim P., 2014, INT J BIOL FOOD VET, V8, P242
   Ko H.A., 2012, INT J TISSUE REGEN, V3, P103
   Lee OJ, 2014, J BIOMED NANOTECHNOL, V10, P1294, DOI 10.1166/jbn.2014.1818
   Lee OJ, 2012, J BIOMED MATER RES A, V100A, P2018, DOI 10.1002/jbm.a.33308
   Lee S.E., 2014, INT J TISSUE REGEN, V5, P103
   Liu DC, 2001, ASIAN AUSTRAL J ANIM, V14, P1638, DOI 10.5713/ajas.2001.1638
   Long K, 2015, J BIOMED MATER RES A, V103, P1159, DOI 10.1002/jbm.a.35268
   Muyonga JH, 2004, FOOD CHEM, V86, P325, DOI 10.1016/j.foodchem.2003.09.038
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Qiang L, 2004, J MATER SCI-MATER M, V15, P1193, DOI 10.1007/s10856-004-5918-y
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   Silva TH, 2014, MAR DRUGS, V12, P5881, DOI 10.3390/md12125881
   Sun Kai, 2015, Eur J Orthop Surg Traumatol, V25, P243, DOI 10.1007/s00590-014-1515-z
   Tang J, 2015, INT J ARTIF ORGANS, V38, P105, DOI 10.5301/ijao.5000392
   Wei GJ, 2015, INT UROL NEPHROL, V47, P95, DOI 10.1007/s11255-014-0854-3
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 20
TC 15
Z9 17
U1 1
U2 20
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD APR
PY 2016
VL 85
BP 442
EP 450
DI 10.1016/j.ijbiomac.2015.12.086
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA DE8LF
UT WOS:000370886800052
PM 26748068
DA 2018-10-19
ER

PT J
AU Lalhmunsiama
   Lalchhingpuii
   Nautiyal, BP
   Tiwari, D
   Choi, SI
   Kong, SH
   Lee, SM
AF Lalhmunsiama
   Lalchhingpuii
   Nautiyal, B. P.
   Tiwari, Diwakar
   Choi, S. I.
   Kong, Sung-Ho
   Lee, Seung-Mok
TI Silane grafted chitosan for the efficient remediation of aquatic
   environment contaminated with arsenic(V)
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE Hybrid biomaterials; Chitosan; Silane grafted chitosan; As(V); Column
   reactor
ID ACTIVATED CARBON; MESOPOROUS SILICA; AQUEOUS-SOLUTIONS; COPPER(II) IONS;
   HEAVY-METALS; WHEAT-STRAW; WASTE-WATER; DYE REMOVAL; ADSORPTION; BEADS
AB Hypothesis: Chitosan, naturally abundant biomaterial showed an insignificant affinity toward arsenate. The incorporation of organosilane could improve the physical and chemical properties of chitosan for the efficient removal of arsenate from aquatic environment.
   Experiment: The hybrid materials were obtained by grafting the natural biopolymer chitosan with 3mercaptopropyl trimethoxysilane (CHMS) and trimethoxy-octylsilane (CHTS). The hybrid materials along with bare chitosan were characterized with SEM EDX, FT-IR and BET specific surface area analyses and the solid materials were further employed in the efficient remediation of aqueous solutions contaminated with As(V) under batch and column reactor operations.
   Findings: The hybrid materials showed an extremely high percentage of As(V) removal compared to bare chitosan within a wide range of pH. As(V) was aggregated rapidly onto the solid surfaces and relatively high percent removal of As(V) was achieved in a wide range of As(V) initial concentrations. Moreover, As(V) was bound with, relatively, weaker forces and forming an 'outer sphere complexes' at the surface of solids. The presence of co-existing ions could not significantly affect the removal of As(V) from aqueous solutions. Furthermore, breakthrough data confirmed that these two hybrid materials possessed significantly high loading capacity of As(V) even under dynamic conditions. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Lalhmunsiama; Lee, Seung-Mok] Catholic Kwandong Univ, Dept Environm Engn, 522 Naegok Dong, Kangnung 210701, South Korea.
   [Lalchhingpuii; Tiwari, Diwakar] Mizoram Univ, Sch Phys Sci, Dept Chem, Aizawl 796004, India.
   [Nautiyal, B. P.] Mizoram Univ, Dept Hort Aromat & Med Plant, Aizawl 796004, India.
   [Choi, S. I.] Kwangwoon Univ, Dept Environm Engn, Seoul 139701, South Korea.
   [Kong, Sung-Ho] Hanyang Univ, Dept Chem Engn, Seoul 133791, South Korea.
RP Lee, SM (reprint author), Catholic Kwandong Univ, Dept Environm Engn, 522 Naegok Dong, Kangnung 210701, South Korea.; Kong, SH (reprint author), Hanyang Univ, Dept Chem Engn, Seoul 133791, South Korea.
EM shkong@hanyang.ac.kr; leesm@cku.ac.kr
FU Korea Ministry of Environment as "Converging technology project"
   [2013001450001]
FX This work was supported by the Korea Ministry of Environment as
   "Converging technology project" (Proposal No. 2013001450001).
CR Adak A, 2006, DYES PIGMENTS, V69, P245, DOI 10.1016/j.dyepig.2005.03.009
   BERTOLUZZA A, 1982, J NON-CRYST SOLIDS, V48, P117, DOI 10.1016/0022-3093(82)90250-2
   Boamah PO, 2015, ECOTOX ENVIRON SAFE, V116, P113, DOI 10.1016/j.ecoenv.2015.01.012
   Boddu VM, 2008, WATER RES, V42, P633, DOI 10.1016/j.watres.2007.08.014
   Cao CH, 2015, APPL SURF SCI, V333, P110, DOI 10.1016/j.apsusc.2015.02.002
   Chammui Y, 2014, CHEM ENG J, V240, P202, DOI 10.1016/j.cej.2013.11.083
   Chandra V, 2010, ACS NANO, V4, P3979, DOI 10.1021/nn1008897
   Chen CY, 2008, BIORESOURCE TECHNOL, V99, P7487, DOI 10.1016/j.biortech.2008.02.015
   Chuang CL, 2005, CHEMOSPHERE, V61, P478, DOI 10.1016/j.chemosphere.2005.03.012
   Crini G, 2008, PROG POLYM SCI, V33, P399, DOI 10.1016/j.progpolymsci.2007.11.001
   Dambies L, 2000, COLLOID SURFACE A, V170, P19, DOI 10.1016/S0927-7757(00)00484-2
   Dang VBH, 2009, BIORESOURCE TECHNOL, V100, P211, DOI 10.1016/j.biortech.2008.05.031
   Dominguez-Gonzalez R, 2014, TALANTA, V118, P262, DOI 10.1016/j.talanta.2013.10.029
   Elwakeel K. Z., 2013, INT J ENVIRON SCI TE, V11, P1051
   Foo KY, 2010, CHEM ENG J, V156, P2, DOI 10.1016/j.cej.2009.09.013
   Gong XJ, 2015, INT BIODETER BIODEGR, V102, P256, DOI 10.1016/j.ibiod.2015.01.007
   Gupta A, 2009, WATER RES, V43, P3862, DOI 10.1016/j.watres.2009.05.040
   HAYES KF, 1988, J COLLOID INTERF SCI, V125, P717, DOI 10.1016/0021-9797(88)90039-2
   Hossain MA, 2012, BIORESOURCE TECHNOL, V121, P386, DOI 10.1016/j.biortech.2012.06.119
   Hughes MF, 2002, TOXICOL LETT, V133, P1, DOI 10.1016/S0378-4274(02)00084-X
   Koonsom Titima, 2014, Environmental Engineering Research, V19, P241
   Lalhmunsiama, 2015, J ENVIRON RADIOACTIV, V147, P76
   Lalhmunsiama C. Lalhriatpuia, 2014, APPL SURF SCI, V321, P275
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Lee MY, 2005, INT J BIOL MACROMOL, V36, P152, DOI 10.1016/j.ijbiomac.2005.05.004
   Lee SM, 2015, CHEM ENG J, V270, P496, DOI 10.1016/j.cej.2015.02.053
   Lee SM, 2014, ENVIRON SCI POLLUT R, V21, P3686, DOI 10.1007/s11356-013-2310-9
   Li GL, 2013, J COLLOID INTERF SCI, V405, P164, DOI 10.1016/j.jcis.2013.05.055
   Li YR, 2010, J HAZARD MATER, V177, P131, DOI 10.1016/j.jhazmat.2009.12.006
   Machida M, 2012, APPL SURF SCI, V258, P7389, DOI 10.1016/j.apsusc.2012.04.042
   Mohan D, 2007, J HAZARD MATER, V142, P1, DOI 10.1016/j.jhazmat.2007.01.006
   Pontoni L, 2012, CARBOHYD RES, V356, P86, DOI 10.1016/j.carres.2012.03.042
   Rivera-Utrilla J, 2001, J CHEM TECHNOL BIOT, V76, P1209, DOI 10.1002/jctb.506
   Rossman TG, 2003, MUTAT RES-FUND MOL M, V533, P37, DOI 10.1016/j.mrfmmm.2003.07.009
   Rusmin R, 2015, APPL SURF SCI, V353, P363, DOI 10.1016/j.apsusc.2015.06.124
   Silva SS, 2005, J MATER CHEM, V15, P3952, DOI 10.1039/b505875a
   Thanhmingliana, 2014, RSC ADV, V4, P43921
   Thomas HC, 1944, J AM CHEM SOC, V66, P1664, DOI 10.1021/ja01238a017
   Tian Y, 2011, J HAZARD MATER, V193, P10, DOI 10.1016/j.jhazmat.2011.04.093
   TINWELL H, 1991, ENVIRON HEALTH PERSP, V95, P205, DOI 10.2307/3431125
   Tiwari Diwakar, 2014, Environmental Engineering Research, V19, P107, DOI 10.4491/eer.2014.19.1.107
   Tiwari D, 2012, CHEM ENG J, V204, P23, DOI 10.1016/j.cej.2012.07.086
   Vakili M, 2014, CARBOHYD POLYM, V113, P115, DOI 10.1016/j.carbpol.2014.07.007
   Vipin AK, 2014, CARBOHYD POLYM, V111, P477, DOI 10.1016/j.carbpol.2014.04.037
   Wang JL, 2014, BIORESOURCE TECHNOL, V160, P129, DOI 10.1016/j.biortech.2013.12.110
   WanNgah W. S., 2011, CARBOHYD POLYM, V83, P1446, DOI DOI 10.1016/J.CARBPOL.2010.11.004
   Yamani JS, 2012, WATER RES, V46, P4427, DOI 10.1016/j.watres.2012.06.004
   Yang T, 2012, ENVIRON SCI TECHNOL, V46, P2251, DOI 10.1021/es204034z
   Yokohira M, 2010, TOXICOL APPL PHARM, V246, P1, DOI 10.1016/j.taap.2010.04.013
   Zavareh S, 2015, CHEM ENG J, V273, P610, DOI 10.1016/j.cej.2015.03.112
NR 50
TC 7
Z9 9
U1 4
U2 53
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
EI 1095-7103
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD APR 1
PY 2016
VL 467
BP 203
EP 212
DI 10.1016/j.jcis.2016.01.019
PG 10
WC Chemistry, Physical
SC Chemistry
GA DE7QP
UT WOS:000370832100024
PM 26802278
DA 2018-10-19
ER

PT J
AU Cabrejos-Azama, J
   Alkhraisat, MH
   Rueda, C
   Torres, J
   Pintado, C
   Blanco, L
   Lopez-Cabarcos, E
AF Cabrejos-Azama, Jatsue
   Hamdan Alkhraisat, Mohammad
   Rueda, Carmen
   Torres, Jesus
   Pintado, Concepcion
   Blanco, Luis
   Lopez-Cabarcos, Enrique
TI Magnesium substitution in brushite cements: Efficacy of a new
   biomaterial loaded with vancomycin for the treatment of Staphylococcus
   aureus infections
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Drug delivery; Magnesium; Newberyite; Calcium phosphate cement;
   Vancomycin; Staphylococcus aureus
ID CALCIUM-PHOSPHATE CEMENT; CEFUROXIME-IMPREGNATED CEMENT; VERTICAL BONE
   AUGMENTATION; TOTAL KNEE ARTHROPLASTY; IN-VITRO; TRICALCIUM PHOSPHATE;
   RELEASE; OSTEOMYELITIS; SYSTEM; APATITE
AB Staphylococcus aureus is the most relevant pathogen associated with bone infection that sometimes appears after implant surgery, thus compromising a successful treatment. The aim of this work was to assess the effectiveness of brushite cements, doped with magnesium, as a new vancomycin carrier system against S. aureus infections. We performed an "in vitro" study to evaluate vancomycin release from the cements by measuring its antimicrobial activity against a strain of S. aureus. We have used two methods to load the cements with vancomycin: i) adsorption from a solution and ii) incorporation of the antibiotic into the solid phase during the cement synthesis. Furthermore, the compression strength of the loaded samples was measured to detect changes in the mechanical properties of the system.
   The "in vitro" study showed that the sustained release of vancomycin depends on the concentration of magnesium in the cement matrix. In addition, the standardized antibacterial assay revealed that the release of vancomycin from the cements may be helpful to prevent infections in bone regeneration procedures. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Cabrejos-Azama, Jatsue; Hamdan Alkhraisat, Mohammad; Rueda, Carmen; Lopez-Cabarcos, Enrique] UCM, Fac Farm, Dept Quim Fis 2, Madrid, Spain.
   [Cabrejos-Azama, Jatsue; Torres, Jesus; Blanco, Luis] UCM, Fac Odontol, Dept Estomatol 3, Madrid, Spain.
   [Pintado, Concepcion] UCM, Fac Farm, Dept Microbiol 2, Madrid, Spain.
RP Cabrejos-Azama, J (reprint author), UCM, Fac Farm, Dept Quim Fis 2, Madrid, Spain.
EM jacaza@farm.ucm.es
OI Alkhraisat, Mohammad/0000-0003-4422-4527; TORRES GARCIA DENCHE,
   JESUS/0000-0002-8310-9209
FU Spanish MINECO [MAT2014-55065R]; UCM-BSCH [911033]; EU COST Action
   [CM1101]
FX The authors acknowledge financial support from the Spanish MINECO grant
   (MAT2014-55065R), the UCM-BSCH grant to research group 911033, and the
   EU COST Action CM1101.
CR Alkhralsat MH, 2008, ACTA BIOMATER, V4, P664, DOI 10.1016/j.actbio.2007.12.001
   Barth RE, 2011, INT J ANTIMICROB AG, V38, P371, DOI 10.1016/j.ijantimicag.2011.03.008
   Bohner M, 1997, J PHARM SCI, V86, P565, DOI 10.1021/js960405a
   Bohner M, 2000, Injury, V31 Suppl 4, P37
   Bohner M, 2000, J PHARM SCI, V89, P1262, DOI 10.1002/1520-6017(200010)89:10<1262::AID-JPS4>3.3.CO;2-Z
   Cabrejos-Azama J, 2014, MAT SCI ENG C-MATER, V43, P403, DOI 10.1016/j.msec.2014.06.036
   Chilukuri DM, 2005, PHARM RES, V22, P563, DOI 10.1007/s11095-005-2492-z
   Chiu FY, 2001, J BONE JOINT SURG BR, V83B, P691, DOI 10.1302/0301-620X.83B5.11737
   Chiu FY, 2002, J BONE JOINT SURG AM, V84A, P759, DOI 10.2106/00004623-200205000-00009
   CORNELL CN, 1993, J ORTHOPAED RES, V11, P619, DOI 10.1002/jor.1100110502
   COSTANTINO PD, 1994, OTOLARYNG CLIN N AM, V27, P1037
   Creedon A, 1999, BRIT J NUTR, V82, P63, DOI 10.1017/S0007114599001130
   Driessens FCM, 1998, P I MECH ENG H, V212, P427, DOI 10.1243/0954411981534196
   Ehara A, 2003, BIOMATERIALS, V24, P831, DOI 10.1016/S0142-9612(02)00411-8
   Engesaeter LB, 2003, ACTA ORTHOP SCAND, V74, P644, DOI 10.1080/00016470310018135
   Ergun C, 2002, J BIOMED MATER RES, V59, P305, DOI 10.1002/jbm.1246
   Esteban J, 2011, EXPERT OPIN PHARMACO, V12, P899, DOI 10.1517/14656566.2011.543676
   Ferraris S, 2010, J APPL BIOMATER BIOM, V8, P166, DOI 10.5301/JABB.2010.6068
   Gay E.C., 2003, TRATADO CIRUGIA BUCA
   Generosi A, 2008, MATER RES BULL, V43, P561, DOI 10.1016/j.materresbull.2007.04.016
   Ginebra MP, 2006, BIOMATERIALS, V27, P2171, DOI 10.1016/j.biomaterials.2005.11.023
   Grover LM, 2005, J AM CERAM SOC, V88, P3096, DOI [10.1111/j.1551-2916.2005.00558.x, 10.1111/j.1551-2916.2005.00566.x]
   Hamanishi C, 1996, J BIOMED MATER RES, V33, P139, DOI 10.1002/(SICI)1097-4636(199623)33:3<139::AID-JBM3>3.0.CO;2-R
   Alkhraisat MH, 2010, ACTA BIOMATER, V6, P1522, DOI 10.1016/j.actbio.2009.10.043
   Alkhraisat MH, 2013, MAT SCI ENG C-MATER, V33, P475, DOI 10.1016/j.msec.2012.09.017
   Hou CH, 2009, BIOMATERIALS, V30, P4700, DOI 10.1016/j.biomaterials.2009.05.018
   Ji C, 2010, J KOREAN NEUROSURG S, V47, P180, DOI 10.3340/jkns.2010.47.3.180
   Joosten U, 2004, BIOMATERIALS, V25, P4287, DOI 10.1016/j.biomaterials.2003.10.083
   Kannan S, 2005, J SOLID STATE CHEM, V178, P3190, DOI 10.1016/j.jssc.2005.08.003
   Kim SR, 2003, BIOMATERIALS, V24, P1389, DOI 10.1016/S0142-9612(02)00523-9
   Lagier R, 2003, PATHOL RES PRACT, V199, P329, DOI 10.1078/0344-0338-00425
   Liu C, 2011, CLIN INFECT DIS, V52, pE18, DOI 10.1093/cid/ciq146
   Livingston T, 2002, J BIOMED MATER RES, V62, P1, DOI 10.1002/jbm.10157
   Maenz S, 2014, J MECH BEHAV BIOMED, V39, P328, DOI 10.1016/j.jmbbm.2014.07.028
   Mayer I, 1997, J INORG BIOCHEM, V66, P1, DOI 10.1016/S0162-0134(96)00145-6
   Miclau T, 2010, J ORTHOP TRAUMA, V24, P583, DOI 10.1097/BOT.0b013e3181eebf12
   MIRTCHI AA, 1989, BIOMATERIALS, V10, P475, DOI 10.1016/0142-9612(89)90089-6
   Mohamed W., 2014, EUR CELLS MATER, V23, P258
   Murphy WL, 2005, BIOMATERIALS, V26, P303, DOI 10.1016/j.biomaterials.2004.02.034
   Obadia L, 2003, BIOMATERIALS, V24, P1265, DOI 10.1016/S0142-9612(02)00446-5
   Rude RK, 1998, J BONE MINER RES, V13, P749, DOI 10.1359/jbmr.1998.13.4.749
   Rybak MJ, 2006, CLIN INFECT DIS, V42, pS35, DOI 10.1086/491712
   Scott CP, 2003, J BIOMED MATER RES B, V64B, P94, DOI 10.1002/jbm.b.10515
   Serre CM, 1998, J BIOMED MATER RES, V42, P626
   Simchi A, 2011, NANOMED-NANOTECHNOL, V7, P22, DOI 10.1016/j.nano.2010.10.005
   Soundrapandian C, 2007, CRIT REV THER DRUG, V24, P493, DOI 10.1615/CritRevTherDrugCarrierSyst.v24.i6.10
   Tamimi F, 2008, J BIOMED MATER RES A, V85A, P707, DOI 10.1002/jbm.a.31610
   Tamimi F, 2012, ACTA BIOMATER, V8, P474, DOI 10.1016/j.actbio.2011.08.005
   Tamimi F, 2009, BIOMATERIALS, V30, P208, DOI 10.1016/j.biomaterials.2008.09.032
   Marinno FT, 2007, J BIOMED MATER RES A, V81A, P93, DOI 10.1002/jbm.a.31014
   Thomazeau H, 1997, Chirurgie, V121, P663
   Tran PA, 2009, J MATER CHEM, V19, P2653, DOI 10.1039/b814334j
   United States Pharmacopeial Convention Inc, 2001, US PHARM 25 NAT FORM
   Wen CY, 2009, J BIOMED MATER RES B, V89B, P466, DOI 10.1002/jbm.b.31236
NR 54
TC 3
Z9 3
U1 3
U2 52
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2016
VL 61
BP 72
EP 78
DI 10.1016/j.msec.2015.10.092
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA DE0GR
UT WOS:000370303600011
PM 26838826
DA 2018-10-19
ER

PT J
AU Zhu, D
   Cheng, HH
   Li, JN
   Zhang, WW
   Shen, YY
   Chen, SJ
   Ge, ZC
   Chen, SG
AF Zhu, Dan
   Cheng, Honghao
   Li, Jianna
   Zhang, Wenwen
   Shen, Yuanyuan
   Chen, Shaojun
   Ge, Zaochuan
   Chen, Shiguo
TI Enhanced water-solubility and antibacterial activity of novel chitosan
   derivatives modified with quaternary phosphonium salt
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Chitosan; Quaternary phosphonium; Antibacterial; Water solubility
ID ANTIMICROBIAL ACTIVITY; DRUG-DELIVERY; GENE DELIVERY; NANOPARTICLES;
   NANOCOMPOSITES; SILVER
AB Chitosan (CS) has been widely recognized as an important biomaterial due to its good antimicrobial activity, biocompatibility and biodegradability. However, CS is insoluble in water in neutral and alkaline aqueous solution due to the linear aggregation of chain molecules and the formation of crystallinity. This is one of the key factors that limit its practical applications. Therefore, improving the solubility of CS in neutral and alkaline aqueous solution is a primary research direction for biomedical applications. In this paper, a reactive antibacterial compound (4-(2,5-Dioxo-pyrrolidin-1-yloxycarbonyl)-benzyl)-triphenyl-phosphonium bromide (NHS-QPS) was synthesized for chemical modification of CS, and a series of novel polymeric antimicrobial agents, N-quaternary phosphonium chitosan derivatives (N-QPCSxy, x = 1-2,y = 1-4) were obtained. The water solubilities and antibacterial activities of N-QPCSxy against Escherichia coli and Staphylococcus aureus were evaluated compare to CS. The water solubility of N-QPCSxy was all better than that of CS at neutral pH aqueous solution, particularly, N-QPCS14 can be soluble in water over the pH range of 3 to 12. The antibacterial activities of CS derivatives were improved by introducing quaternary phosphonium salt, and antibacterial activity of N-QPCSxy increases with degree of substitution. Overall, N-QPCS14 represents a novel antibacterial polymer material with good antibacterial activity, waters solubility and low cytotoxicity. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Zhu, Dan; Cheng, Honghao; Chen, Shaojun; Ge, Zaochuan; Chen, Shiguo] Shenzhen Univ, Coll Mat Sci & Engn, Nanshan Dist Key Lab Biopolymers & Safety Evaluat, Shenzhen 518060, Peoples R China.
   [Li, Jianna; Shen, Yuanyuan] Shenzhen Univ, Hlth Sci Ctr, Shenzhen 518060, Peoples R China.
   [Zhang, Wenwen] N Carolina State Univ, Raleigh, NC 27695 USA.
RP Chen, SG (reprint author), Shenzhen Univ, Coll Mat Sci & Engn, Nanshan Dist Key Lab Biopolymers & Safety Evaluat, Shenzhen 518060, Peoples R China.
EM csg@szu.edu.cn
RI chen, shiguo/J-3076-2014
OI chen, shiguo/0000-0002-5338-690X
FU Natural Science Foundation of China [51573097]; Natural Science
   Foundation of Guangdong Province [S2013010013056]; Science and
   Technology Project of Guangdong Province [2015A010105033]; Collaborative
   Innovation and Technology Project for Shenzhen-Hong Kong Innovation
   Circle of Shenzhen city [SGLH20120926161415782]; Science and Technology
   Project of Shenzhen City [JCYJ 20120613090936342]; Nanshan District Key
   lab for Biopolymers and safety evaluation [KC2014ZDZJ0001A]
FX We gratefully acknowledge financial support from the Natural Science
   Foundation of China (Grant 51573097), the Natural Science Foundation of
   Guangdong Province (Grant S2013010013056), the Science and Technology
   Project of Guangdong Province (Grant 2015A010105033), the Collaborative
   Innovation and Technology Project for Shenzhen-Hong Kong Innovation
   Circle of Shenzhen city (Grant SGLH20120926161415782), the Science and
   Technology Project of Shenzhen City (Grant JCYJ 20120613090936342), and
   Nanshan District Key lab for Biopolymers and safety evaluation (No.
   KC2014ZDZJ0001A).
CR Ambrogi V, 2014, J MATER CHEM B, V2, P6054, DOI 10.1039/c4tb00927d
   Anitha A, 2014, PROG POLYM SCI, V39, P1644, DOI 10.1016/j.progpolymsci.2014.02.008
   Cao CH, 2013, APPL SURF SCI, V271, P105, DOI 10.1016/j.apsusc.2013.01.135
   Casettari L, 2014, J CONTROL RELEASE, V190, P189, DOI 10.1016/j.jconrel.2014.05.003
   Chen SG, 2014, CHEM ENG J, V256, P238, DOI 10.1016/j.cej.2014.07.006
   Chen SG, 2012, J MATER CHEM, V22, P9092, DOI 10.1039/c2jm00063f
   Chen SG, 2011, ACS APPL MATER INTER, V3, P1154, DOI 10.1021/am101275d
   Chen SG, 2011, COLLOID SURFACE B, V85, P323, DOI 10.1016/j.colsurfb.2011.03.004
   Chen YZ, 2014, TETRAHEDRON, V70, P1748, DOI 10.1016/j.tet.2014.01.035
   Chivangkul T, 2014, CARBOHYD POLYM, V108, P224, DOI 10.1016/j.carbpol.2014.02.078
   Guo AJ, 2014, INT J BIOL MACROMOL, V67, P163, DOI 10.1016/j.ijbiomac.2014.03.024
   Hu LM, 2013, NANOSCALE, V5, P3103, DOI 10.1039/c3nr00338h
   Kuete V, 2008, J ETHNOPHARMACOL, V120, P17, DOI 10.1016/j.jep.2008.07.026
   Liang XF, 2013, LANGMUIR, V29, P8683, DOI 10.1021/la401166v
   Liong M, 2009, ADV MATER, V21, P1684, DOI 10.1002/adma.200802646
   Liu BJ, 2013, CHEM ENG J, V220, P412, DOI 10.1016/j.cej.2013.01.071
   Lu Y, 2014, BIOMATERIALS, V35, P1716, DOI 10.1016/j.biomaterials.2013.11.015
   Moura LIF, 2014, ACTA BIOMATER, V10, P843, DOI 10.1016/j.actbio.2013.09.040
   Regiel-Futyra A, 2015, ACS APPL MATER INTER, V7, P1087, DOI 10.1021/am508094e
   Ruparelia JP, 2008, ACTA BIOMATER, V4, P707, DOI 10.1016/j.actbio.2007.11.006
   Sahariah P, 2015, BIOMACROMOLECULES, V16, P1449, DOI 10.1021/acs.biomac.5b00163
   Shi BY, 2013, POLYM CHEM-UK, V4, P840, DOI 10.1039/c2py20494k
   Torabi S, 2016, MAT SCI ENG C-MATER, V59, P1, DOI 10.1016/j.msec.2015.09.096
   Wang L, 2011, INT J BIOL MACROMOL, V48, P375, DOI 10.1016/j.ijbiomac.2010.12.006
   Wen Y, 2015, MAT SCI ENG C-MATER, V48, P220, DOI 10.1016/j.msec.2014.11.066
   Wiarachai O, 2012, COLLOID SURFACE B, V92, P121, DOI 10.1016/j.colsurfb.2011.11.034
   Xu JK, 2015, BIOMATERIALS, V37, P395, DOI 10.1016/j.biomaterials.2014.10.024
   Yao DD, 2013, POLYMER, V54, P3485, DOI 10.1016/j.polymer.2013.05.005
   Zhang W, 2008, J APPL POLYM SCI, V108, P2958, DOI 10.1002/app.27610
   Zhang WW, 2015, J POLYM SCI POL CHEM, V53, P1594, DOI 10.1002/pola.27592
   Zhou PY, 2014, BIOMATERIALS, V35, P10033, DOI 10.1016/j.biomaterials.2014.09.009
   Zhuang PY, 2012, INT J BIOL MACROMOL, V50, P658, DOI 10.1016/j.ijbiomac.2012.01.026
NR 32
TC 40
Z9 41
U1 12
U2 117
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2016
VL 61
BP 79
EP 84
DI 10.1016/j.msec.2015.12.024
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA DE0GR
UT WOS:000370303600012
PM 26838827
DA 2018-10-19
ER

PT J
AU Naleway, SE
   Fickas, KC
   Maker, YN
   Meyers, MA
   McKittrick, J
AF Naleway, Steven E.
   Fickas, Kate C.
   Maker, Yajur N.
   Meyers, Marc A.
   McKittrick, Joanna
TI Reproducibility of ZrO2-based freeze casting for biomaterials
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Freeze casting; Bioinspired; Biomaterial; Statistical analysis;
   Reproducibility; Mechanical properties
ID POROUS ALUMINA; PRESSURELESS INFILTRATION; COMPOSITES; CERAMICS; TOUGH;
   FABRICATION; SCAFFOLDS
AB The processing technique of freeze casting has been intensely researched for its potential to create porous scaffold and infiltrated composite materials for biomedical implants and structural materials. However, in order for this technique to be employed medically or commercially, it must be able to reliably produce materials in great quantities with similar microstructures and properties. Here we investigate the reproducibility of the freeze casting process by independently fabricating three sets of eight ZrO2-epoxy composite scaffolds with the same processing conditions but varying solid loading (10, 15 and 20 vol.%). Statistical analyses (One-way ANOVA and Tukey's HSD tests) run upon measurements of the microstructural dimensions of these composite scaffold sets show that, while the majority of microstructures are similar, in all cases the composite scaffolds display statistically significant variability. In addition, composite scaffolds where mechanically compressed and statistically analyzed. Similar to the microstructures, almost all of their resultant properties displayed significant variability though most composite scaffolds were similar. These results suggest that additional research to improve control of the freeze casting technique is required before scaffolds and composite scaffolds can reliably be reproduced for commercial or medical applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Naleway, Steven E.; Meyers, Marc A.; McKittrick, Joanna] Univ Calif San Diego, Mat Sci & Engn Program, 9500 Gilman Dr, La Jolla, CA 92093 USA.
   [Fickas, Kate C.] Oregon State Univ, Dept Forest Ecosyst & Soc, 321 Richardson Hall, Corvallis, OR 97331 USA.
   [Maker, Yajur N.] Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr, La Jolla, CA 92093 USA.
   [Meyers, Marc A.; McKittrick, Joanna] Univ Calif San Diego, Dept Mech & Aerosp Engn, 9500 Gilman Dr, La Jolla, CA 92093 USA.
   [Meyers, Marc A.] Univ Calif San Diego, Dept NanoEngn, 9500 Gilman Dr, La Jolla, CA 92093 USA.
RP Naleway, SE (reprint author), Univ Calif San Diego, Mat Sci & Engn Program, 9500 Gilman Dr, La Jolla, CA 92093 USA.
EM snaleway@eng.ucsd.edu; kate.fickas@oregonstate.edu; ymaker@eng.ucsd.edu;
   mameyers@eng.ucsd.edu; jmckittrick@eng.ucsd.edu
RI Naleway, Steven/K-3497-2016; Meyers, Marc/A-2970-2016
OI Naleway, Steven/0000-0001-9413-0399; Meyers, Marc/0000-0003-1698-5396;
   McKittrick, Joanna/0000-0002-1442-3472
FU Multi-University Research Initiative through the Air Force Office of
   Scientific Research of the United States [AFOSR-FA9550-15-1-0009]
FX This work is supported by a Multi-University Research Initiative through
   the Air Force Office of Scientific Research of the United States
   (AFOSR-FA9550-15-1-0009). The authors wish to acknowledge Dr. Antoni
   Tomsia for generously introducing us to the freeze casting process and
   Michael B. Frank, Christopher F. Yu, Rachel Hsiong and Michael Ix for
   their help with the freeze casting process.
CR Albakry M, 2003, J DENT, V31, P181, DOI 10.1016/S0300-5712(03)00025-3
   Binner J, 2009, J EUR CERAM SOC, V29, P837, DOI 10.1016/j.jeurceramsoc.2008.07.034
   Bouville F, 2014, NAT MATER, V13, P508, DOI [10.1038/NMAT3915, 10.1038/nmat3915]
   Chen HM, 2014, CERAM INT, V40, P6293, DOI 10.1016/j.ceramint.2013.11.088
   CHUN KJ, 2014, J DENT BIOMECH, V5, P1
   Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937
   Deville S, 2008, ADV ENG MATER, V10, P155, DOI 10.1002/adem.200700270
   Deville S, 2007, ACTA MATER, V55, P1965, DOI 10.1016/j.actamat.2006.11.003
   Deville S, 2006, BIOMATERIALS, V27, P5480, DOI 10.1016/j.biomaterials.2006.06.028
   Deville S, 2013, J MATER RES, V28, P2202, DOI 10.1557/jmr.2013.105
   Deville S, 2010, MATERIALS, V3, P1913, DOI 10.3390/ma3031913
   Deville S, 2010, J AM CERAM SOC, V93, P2507, DOI 10.1111/j.1551-2916.2010.03840.x
   Deville S, 2009, J AM CERAM SOC, V92, P2489, DOI 10.1111/j.1551-2916.2009.03163.x
   Manhart J, 2000, J BIOMED MATER RES, V53, P353, DOI 10.1002/1097-4636(2000)53:4<353::AID-JBM9>3.0.CO;2-B
   Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865
   Munch E, 2009, J AM CERAM SOC, V92, P1534, DOI 10.1111/j.1551-2916.2009.03087.x
   Naleway SE, 2015, MATER DESIGN, V71, P62, DOI 10.1016/j.matdes.2015.01.010
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Porter M.M., 2014, THESIS U CALIFORNIA
   Porter MM, 2015, COMPOS STRUCT, V119, P174, DOI 10.1016/j.compstruct.2014.08.033
   Porter MM, 2014, AM CERAM SOC BULL, V93, P18
   Porter MM, 2013, JOM-US, V65, P720, DOI 10.1007/s11837-013-0606-3
   Porter MM, 2012, MAT SCI ENG A-STRUCT, V556, P741, DOI 10.1016/j.msea.2012.07.058
   Porter MM, 2013, ADV FUNCT MATER, V24, P1978
   Rao BS, 2001, J MATER RES, V16, P2906, DOI 10.1557/JMR.2001.0399
   Tabachnick B. G., 2013, USING MULTIVARIATE S
   Tang YF, 2014, J EUR CERAM SOC, V34, P4077, DOI 10.1016/j.jeurceramsoc.2014.05.040
   Wegst UGK, 2015, NAT MATER, V14, P23, DOI [10.1038/nmat4089, 10.1038/NMAT4089]
   Wegst UGK, 2010, PHILOS T R SOC A, V368, P2099, DOI 10.1098/rsta.2010.0014
   Xia ZM, 2013, ACTA BIOMATER, V9, P7308, DOI 10.1016/j.actbio.2013.03.038
NR 30
TC 20
Z9 21
U1 3
U2 37
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2016
VL 61
BP 105
EP 112
DI 10.1016/j.msec.2015.12.012
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA DE0GR
UT WOS:000370303600015
PM 26838830
OA Other Gold, Green Published
DA 2018-10-19
ER

PT J
AU Wers, E
   Lefeuvre, B
   Pellen-Mussi, P
   Novella, A
   Oudadesse, H
AF Wers, E.
   Lefeuvre, B.
   Pellen-Mussi, P.
   Novella, A.
   Oudadesse, H.
TI New method of synthesis and in vitro studies of a porous biomaterial
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biointerface; Surface; Bioglass; Hydroxyapatite; Porosity; Osteoblasts
ID DOPED BIOACTIVE GLASSES; THERMAL-BEHAVIOR; EXCESS ENTROPY; PART 1; BONE;
   SCAFFOLDS; CRYSTALLIZATION; CRYSTALS; DESIGN; MODEL
AB Biomaterials for bone reconstruction represent a widely studied area. In this paper, a new method of synthesis of a porous glass-ceramic obtained by thermal treatment is presented. The prepared biomaterial was characterized by X-ray diffraction (XRD), scanning electron microscopy (SEM), and induced couple plasma-optical emission spectroscopy (ICP-OES), mercury porosimetry and by the Archimedes method. In vitro evaluations in a simulated body fluid (SBF) and in contact with SaOS(2) human osteoblasts were also carried out. The porous glass-ceramic is composed of a total porous network of 60% suitable for body fluid and cell infiltration, with pore sizes varying from 60 nm to 143 mu m. The presence of two crystalline phases decreases the kinetic of bioactivity compared to an amorphous biomaterial (bioactive glass). A hydroxyapatite layer appears from 15 days of immersion on the surface and inside the pores, showing a biodegradation and a bioactivity in four steps. Cytotoxicity assessments present an increase of the cellular viability after 72 h proving the non-cytotoxic effect of the glass-ceramic. Thus, the results of these different studies indicate that the porous biomaterial may have a potential application for the bone regeneration. This paper also presents the novelty of this method. It is a rapid synthesis which combines simplicity and low cost. This represents an advantage for an eventual industrialization. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Wers, E.; Lefeuvre, B.; Oudadesse, H.] Univ Europeenne Bretagne, Univ Rennes 1, Equipe Chim Solide & Mat, UMR CNRS 6226,Sci Chim Rennes, 263 Ave Gen Leclerc, F-35042 Rennes, France.
   [Pellen-Mussi, P.; Novella, A.] Univ Europeenne Bretagne, Univ Rennes 1, Equipe Chim Solide & Mat, UMR CNRS 6226,Sci Chim Rennes, 2 Ave Prof Leon Bernard, F-35042 Rennes, France.
RP Wers, E (reprint author), Univ Europeenne Bretagne, Univ Rennes 1, Equipe Chim Solide & Mat, UMR CNRS 6226,Sci Chim Rennes, 263 Ave Gen Leclerc, F-35042 Rennes, France.
EM wers.eric@hotmail.com
CR Bohner M, 2009, BIOMATERIALS, V30, P2175, DOI 10.1016/j.biomaterials.2009.01.008
   BROWN WE, 1983, J DENT RES, V62, P672
   Clupper DC, 2003, J NON-CRYST SOLIDS, V318, P43, DOI 10.1016/S0022-3093(02)01857-4
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   Gao TJ, 1997, BIOMATERIALS, V18, P219, DOI 10.1016/S0142-9612(96)00133-0
   Gosh S.K., 2008, J BIOMED MATER RES B, V86, P217
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Huang LC, 2007, MAT SCI ENG A-STRUCT, V452, P326, DOI 10.1016/j.msea.2006.10.136
   Jones R. J., 2013, ACTA BIOMATER, V9, P4457
   Kaito T., 2000, J BIOMED MATER RES B, V78, P378
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Lefebvre L, 2007, ACTA MATER, V55, P3305, DOI 10.1016/j.actamat.2007.01.029
   Lefebvre L., 2007, THESIS INSA LYON
   Lin CC, 2005, J NON-CRYST SOLIDS, V351, P3195, DOI 10.1016/j.jnoncrysol.2005.08.020
   Motomiya M, 2007, EUR SPINE J, V16, P2215, DOI 10.1007/s00586-007-0501-0
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nandi SK, 2008, SMALL RUMINANT RES, V75, P144, DOI 10.1016/j.smallrumres.2007.09.006
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   OHSATO H, 1986, ACTA CRYSTALLOGR C, V42, P934, DOI 10.1107/S0108270186093940
   Oudadesse H, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/3/035006
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Roberts J.P., 1979, GLASS CERAM, P76
   Washburn EW, 1921, P NATL ACAD SCI USA, V7, P115, DOI 10.1073/pnas.7.4.115
   Wers E, 2014, J THERM ANAL CALORIM, V117, P579, DOI 10.1007/s10973-014-3731-5
   Wers E, 2014, THERMOCHIM ACTA, V580, P79, DOI 10.1016/j.tca.2014.02.001
   Wers E, 2014, J THERM ANAL CALORIM, V115, P2137, DOI 10.1007/s10973-013-3280-3
   Wucherer L, 2009, INT J APPL CERAM TEC, V6, P651, DOI 10.1111/j.1744-7402.2008.02303.x
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yoneda M, 2005, BIOMATERIALS, V26, P5145, DOI 10.1016/j.biomaterials.2005.01.054
   Yun HS, 2011, ACTA BIOMATER, V7, P2651, DOI 10.1016/j.actbio.2011.02.014
NR 36
TC 1
Z9 1
U1 1
U2 49
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2016
VL 61
BP 133
EP 142
DI 10.1016/j.msec.2015.12.022
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA DE0GR
UT WOS:000370303600018
PM 26838833
DA 2018-10-19
ER

PT J
AU Przekora, A
   Ginalska, G
AF Przekora, Agata
   Ginalska, Grazyna
TI In vitro evaluation of the risk of inflammatory response after
   chitosan/HA and chitosan/beta-1,3-glucan/HA bone scaffold implantation
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Reactive oxygen intermediates; Tumour necrosis factor-alpha; Protein
   adsorption; Fibrinogen; Biomaterial-induced inflammation; Bone tissue
   engineering
ID OSTEOBLAST ADHESION; THP-1 CELLS; DIFFERENTIATION; BIOMATERIALS;
   MACROPHAGES; COMPOSITES; RECOGNITION; ACTIVATION; CHEMISTRY; CURDLAN
AB The aim of the study was to evaluate in vitro the risk of inflammatory response induced by chitosan/hydroxyapatite (chit/HA) and novel chitosan/beta-1,3-glucan/hydroxyapatite (chit/glu/HA) bone scaffolds. The inflammatory response was assessed via measurement of proinflammatory cytokine and ROI production by human monocytes, macrophages, and osteoblasts stimulated with investigated scaffolds. Moreover, adsorption of human serum/plasma proteins to the tested materials was determined.
   Both biomaterials did not induce intracellular ROI generation by monocytes, macrophages, and osteoblasts and did not stimulate proinflammatory cytokine (IL-6 and TNF-alpha) production by inflammatory cells. Moreover, the chit/glu/HA material induced increased TNF-alpha production by osteoblasts that is believed to enhance osteogenic differentiation. Thus, it was demonstrated that chit/HA and chit/glu/HA scaffolds carry a low risk of biomaterial-induced inflammatory response and are promising materials as bone scaffolds for bone tissue engineering and regenerative medicine applications. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Przekora, Agata; Ginalska, Grazyna] Med Univ Lublin, Dept Biochem & Biotechnol, Chodzki 1, PL-20093 Lublin, Poland.
RP Przekora, A (reprint author), Med Univ Lublin, Dept Biochem & Biotechnol, Chodzki 1, PL-20093 Lublin, Poland.
EM agata.przekora@umlub.pl
OI Przekora-Kusmierz, Agata/0000-0002-6076-1309; Ginalska,
   Grazyna/0000-0002-9961-4226
FU Ministry of Science and Higher Education in Poland within Medical
   University of Lublin [DS2/15]
FX Financial assistance was provided by the Ministry of Science and Higher
   Education in Poland within DS2/15 project of Medical University of
   Lublin. The paper was developed using the equipment purchased within the
   agreement No. POPW.01.03.00-06-010/09-00 Operational Programme
   Development of Eastern Poland 2007-2013, Priority Axis I, Modern
   Economy, Operations 1.3. Innovations Promotion.
CR Abbas S, 2003, CYTOKINE, V22, P33, DOI 10.1016/S1043-4666(03)00106-6
   [Anonymous], 2009, 1099352009E ISO
   Baldwin L, 2008, CYTOKINE, V41, P217, DOI 10.1016/j.cyto.2007.11.015
   Brevig T, 2005, BIOMATERIALS, V26, P3039, DOI 10.1016/j.biomaterials.2004.09.006
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668
   Glass GE, 2011, P NATL ACAD SCI USA, V108, P1585, DOI 10.1073/pnas.1018501108
   Kataoka K, 2002, J BIOL CHEM, V277, P36825, DOI 10.1074/jbc.M206756200
   Li GC, 2011, CYTOKINE, V56, P208, DOI 10.1016/j.cyto.2011.06.020
   Lu ZF, 2012, STEM CELLS DEV, V21, P2420, DOI 10.1089/scd.2011.0589
   Przekora A., 2015, BIOMED MAT, V10
   Przekora A, 2016, MAT SCI ENG C-MATER, V58, P891, DOI 10.1016/j.msec.2015.09.046
   Przekora A, 2014, INT J BIOL MACROMOL, V70, P474, DOI 10.1016/j.ijbiomac.2014.07.035
   Przekora A, 2014, J BIOTECHNOL, V182, P46, DOI 10.1016/j.jbiotec.2014.04.022
   Przekora A, 2014, CENT EUR J BIOL, V9, P634, DOI 10.2478/s11535-014-0297-y
   Qin ZY, 2012, ATHEROSCLEROSIS, V221, P2, DOI 10.1016/j.atherosclerosis.2011.09.003
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Sidney LE, 2015, TISSUE ENG PT A, V21, P362, DOI [10.1089/ten.tea.2014.0100, 10.1089/ten.TEA.2014.0100]
   Sousa SR, 2008, J BIOMED MATER RES A, V84A, P281, DOI 10.1002/jbm.a.31201
   Sridharan R, 2015, MATER TODAY, V18, P313, DOI 10.1016/j.mattod.2015.01.019
   TANG L, 2000, BIOMATERIAL ENG DEVI, V1, P3
   Tang LP, 1998, J BIOMAT SCI-POLYM E, V9, P1257
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tukulula M, 2015, PHARM RES-DORDR, V32, P2713, DOI 10.1007/s11095-015-1655-9
   Ueda M, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt420
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Zhang RR, 2014, BIOMACROMOLECULES, V15, P1079, DOI 10.1021/bm500038g
NR 27
TC 13
Z9 13
U1 2
U2 32
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2016
VL 61
BP 355
EP 361
DI 10.1016/j.msec.2015.12.066
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA DE0GR
UT WOS:000370303600045
PM 26838861
DA 2018-10-19
ER

PT J
AU Gonzalez, M
   Merino, U
   Vargas, S
   Quintanilla, F
   Rodriguez, R
AF Gonzalez, Maykel
   Merino, Ulises
   Vargas, Susana
   Quintanilla, Francisco
   Rodriguez, Rogelio
TI Synthesis and characterization of a HAp-based biomarker with controlled
   drug release for breast cancer
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Breast cancer; Biomarkers; Drug controlled release; Implant; Cisplatin
ID CISPLATIN; HYDROXYAPATITE; CHEMOTHERAPY; ENHANCEMENT; SCAFFOLDS;
   DELIVERY; SPECTRA
AB A biocompatible hybrid porous polymer-ceramic material was synthesized to be used as a biomarker in the treatment of breast cancer. This device was equipped with the capacity to release medicaments locally in a controlled manner. The biomaterial was Hydroxyapatite(HAp)-based and had a controlled pore size and pore volume fraction. It was implemented externally using a sharp end and a pair of barbed rings placed opposite each other to prevent relative movement once implanted. The biomarker was impregnated with cis-diamine dichloride platinum (II) [Cl-2-Pt-(NH3)(2)]; the rate of release was obtained using inductively coupled plasma atomic emission spectroscopy (ICP-AES), and release occurred over the course of three months. Different release profiles were obtained as a function of the pore volume fraction. The biomaterial was characterized using scanning electron microscopy (SEM) and Raman spectroscopy. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Gonzalez, Maykel; Merino, Ulises; Vargas, Susana; Rodriguez, Rogelio] Univ Nacl Autonoma Mexico, Ctr Appl Phys & Adv Technol CFATA, Dept Mol Engn Mat, Blvd Juriquilla 3001, Santiago De Queretaro 76230, Queretaro, Mexico.
   [Merino, Ulises; Quintanilla, Francisco] UVM, Blvd Villas Meson 1000, Santiago De Queretaro 76320, Queretaro, Mexico.
RP Rodriguez, R (reprint author), Univ Nacl Autonoma Mexico, Ctr Appl Phys & Adv Technol CFATA, Dept Mol Engn Mat, Blvd Juriquilla 3001, Santiago De Queretaro 76230, Queretaro, Mexico.
EM rogelior@unam.mx
RI Rodriguez Talavera, Jose Rogelio/L-1709-2018
OI Rodriguez Talavera, Jose Rogelio/0000-0002-7455-2276; Gonzalez Torres,
   Maykel/0000-0003-3899-4410; VARGAS MUNOZ, SUSANA/0000-0001-9031-4182
FU DGAPA-CTIC (CONACYT-Mexico) [220224]
FX The authors wish to thank Carolina Munoz Tones and Alicia del Real Lopez
   for their technical assistance in the ICP-AES and SEM analysis. We are
   also indebted to Guillermo Vazquez Sanchez, Domingo Rangel, Blanca
   Huerta and Guadalupe Mendez for their technical assistance. This
   research was supported by DGAPA-CTIC (CONACYT-Mexico) (Grant # 220224).
CR Aebi Stefan, 2006, Breast, V15 Suppl 2, pS11, DOI 10.1016/S0960-9776(07)70010-3
   Arakawa Y, 2015, J INFECT CHEMOTHER, V21, P502, DOI 10.1016/j.jiac.2015.03.008
   Berners-Price S.J., 1992, J CHEM SOC CHEM COMM, P3
   Brostow W, 2008, J MATER RES, V23, P1587, DOI 10.1557/JMR.2008.0191
   Carr C, 2008, CURR ANAESTH CRIT CA, V19, P70, DOI DOI 10.1016/J.CACC2008.01.004
   Charrois GJR, 2004, BBA-BIOMEMBRANES, V1663, P167, DOI 10.1016/j.bbamem.2004.03.006
   Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025
   Duncan R, 2013, ADV DRUG DELIVER REV, V65, P60, DOI 10.1016/j.addr.2012.08.012
   Karlsson KH, 2008, J NON-CRYST SOLIDS, V354, P717, DOI 10.1016/j.jnoncrysol.2007.06.100
   Kozelka J, 2009, INORG CHIM ACTA, V362, P651, DOI 10.1016/j.ica.2008.04.024
   Li P, 2014, INT J PHARMACEUT, V477, P390, DOI 10.1016/j.ijpharm.2014.10.039
   Lin KL, 2013, CHEM ENG J, V222, P49, DOI 10.1016/j.cej.2013.02.037
   Michalska D, 2005, CHEM PHYS LETT, V403, P211, DOI 10.1016/j.cplett.2004.12.096
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   Peng JR, 2013, BIOMATERIALS, V34, P8726, DOI 10.1016/j.biomaterials.2013.07.092
   Sadat-Shojai M, 2013, ACTA BIOMATER, V9, P7591, DOI 10.1016/j.actbio.2013.04.012
   Sousa A, 2008, ACTA BIOMATER, V4, P671, DOI 10.1016/j.actbio.2007.11.003
   Surmenev RA, 2014, ACTA BIOMATER, V10, P557, DOI 10.1016/j.actbio.2013.10.036
   Truslow JG, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3576926
   Verweij J, 2000, EUR J CANCER, V36, P1479, DOI 10.1016/S0959-8049(00)00133-7
   Villacampa AI, 2000, J CRYST GROWTH, V211, P111, DOI 10.1016/S0022-0248(99)00793-9
   Will J, 2008, J MATER SCI-MATER M, V19, P2781, DOI 10.1007/s10856-007-3346-5
   Wysokinski R, 2007, CHEM PHYS, V333, P37, DOI 10.1016/j.chemphys.2007.01.002
   Zhu YF, 2015, PHARMACOL RES, V93, P36, DOI 10.1016/j.phrs.2014.12.006
NR 24
TC 11
Z9 11
U1 2
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2016
VL 61
BP 801
EP 808
DI 10.1016/j.msec.2016.01.015
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA DE0GR
UT WOS:000370303600095
PM 26838911
DA 2018-10-19
ER

PT J
AU Zhang, Y
   Du, XL
   Hu, D
   Zhang, J
   Zhou, Y
   Min, GQ
   Lang, MD
AF Zhang, Yan
   Du, Xiaolin
   Hu, Dan
   Zhang, Jing
   Zhou, Yan
   Min, Guoquan
   Lang, Meidong
TI Combined Chemical Groups and Topographical Nanopattern on the
   Poly(epsilon-Caprolactone) Surface for Regulating Human Foreskin
   Fibroblasts Behavior
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE poly(epsilon-caprolactone); surface chemistry; nanopattern;
   UV-nanoimprint; cell behaviors
ID MESENCHYMAL STEM-CELLS; LEAF-LIKE TOPOGRAPHY; SUBSTRATE TOPOGRAPHY;
   FUNCTIONAL-GROUPS; INTEGRIN BINDING; NANOWIRE ARRAYS; ADHESION;
   DIFFERENTIATION; CHEMISTRY; FABRICATION
AB Surface chemistry and substrate topography could contribute significantly to providing a biochemical and topographical cues for governing the fate of cells on the cell material interface. However, the synergies between these two properties have not been exploited extensively for biomaterial design. Herein, we achieved spatial-controlled patterning of chemical groups on the poly(epsilon-caprolactone) (PCL) surface by elegant UV-nanoimprint lithography (UN-NIL). The introduction of chemical groups on the PCL surface was developed by our newly 6-benzyloxycarbonylmethyl-epsilon-caprolactone (BCL) monomer, which not only solved the lack of functional groups along the PCL chain but also retained the original favorable properties of PCL materials. The synergetic effect of the chemical groups and nanopatterns on the human foreskin fibroblasts (HFFs) behaviors was evaluated in detail. The results revealed that the patterned functional PCL surfaces could induce enhanced cell adhesion and proliferation, further trigger changes in HFFs morphology, orientation and collagen secretion. Taken together, this study provided a method for straightforward fabrication of reactive PCL surfaces with topographic patterns by one-step process, and they would facilitate. PCL as potential candidate for cell cultivation and tissue engineering.
C1 [Zhang, Yan; Du, Xiaolin; Lang, Meidong] E China Univ Sci & Technol, Sch Mat Sci & Engn, Key Lab Ultrafine Mat, Minist Educ, 130 Meilong Rd, Shanghai 200237, Peoples R China.
   [Hu, Dan; Zhou, Yan] E China Univ Sci & Technol, Sch Bioengn, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.
   [Zhang, Yan; Zhang, Jing; Min, Guoquan] Shanghai Nanotechnol Promot Ctr, Shanghai 200237, Peoples R China.
RP Zhang, Y; Lang, MD (reprint author), E China Univ Sci & Technol, Sch Mat Sci & Engn, Key Lab Ultrafine Mat, Minist Educ, 130 Meilong Rd, Shanghai 200237, Peoples R China.; Zhang, Y (reprint author), Shanghai Nanotechnol Promot Ctr, Shanghai 200237, Peoples R China.
EM Zhang_yan@ecust.edu.cn; mdlang@ecust.edu.cn
OI Lang, Meidong/0000-0003-2053-9284
FU National Natural Science Foundation of China [21274039]; Shanghai
   Pujiang Program [14PJD014]; 111 Project [B14018]; Specialized Research
   Fund for the Doctoral Program of Higher Education [20130074110007]
FX Financial support from the National Natural Science Foundation of China
   (21274039), Shanghai Pujiang Program (14PJD014), 111 Project (B14018),
   and Specialized Research Fund for the Doctoral Program of Higher
   Education (20130074110007) are gratefully acknowledged.
CR Bi XP, 2014, ACTA BIOMATER, V10, P2814, DOI 10.1016/j.actbio.2014.02.018
   Britland S, 1996, EXP CELL RES, V228, P313, DOI 10.1006/excr.1996.0331
   Broderick AH, 2011, BIOMACROMOLECULES, V12, P1998, DOI 10.1021/bm200296a
   Buck ME, 2009, BIOMACROMOLECULES, V10, P1564, DOI 10.1021/bm9001552
   Chapman CAR, 2015, ACS APPL MATER INTER, V7, P7093, DOI 10.1021/acsami.5b00410
   Chastain SR, 2006, J BIOMED MATER RES A, V78A, P73, DOI 10.1002/jbm.a.30686
   Chen M, 2015, COLLOID SURFACE B, V134, P322, DOI 10.1016/j.colsurfb.2015.07.018
   Crouch AS, 2009, BIOMATERIALS, V30, P1560, DOI 10.1016/j.biomaterials.2008.11.041
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Di Cio S, 2016, ACTA BIOMATER, V30, P26, DOI 10.1016/j.actbio.2015.11.027
   Ding YH, 2015, ACTA BIOMATER, V15, P150, DOI 10.1016/j.actbio.2014.12.014
   Ebara M, 2014, POLYMER, V55, P5961, DOI 10.1016/j.polymer.2014.09.009
   Elsayed M, 2014, NANOMEDICINE-UK, V9, P349, DOI 10.2217/nnm.13.200
   Fox CB, 2015, NANO LETT, V15, P1540, DOI 10.1021/nl503872p
   Fredin NJ, 2009, BIOMACROMOLECULES, V10, P994, DOI 10.1021/bm900045c
   Fujita S, 2009, J R SOC INTERFACE, V6, pS269, DOI 10.1098/rsif.2008.0428.focus
   Groth T, 1996, BIOMATERIALS, V17, P1227, DOI 10.1016/0142-9612(96)84943-X
   Guo LJ, 2007, ADV MATER, V19, P495, DOI 10.1002/adma.200600882
   Jeon H, 2015, ACS APPL MATER INTER, V7, P4525, DOI 10.1021/acsami.5b00554
   Juarez-Moreno JA, 2015, APPL SURF SCI, V349, P763, DOI 10.1016/j.apsusc.2015.05.063
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062
   Kolind K, 2012, BIOMATERIALS, V33, P6626, DOI 10.1016/j.biomaterials.2012.05.070
   LaPointe VLS, 2013, ADV HEALTHC MATER, V2, P1644, DOI 10.1002/adhm.201200382
   Lee JY, 2004, J CONTROL RELEASE, V94, P323, DOI 10.1016/j.conrel.2003.10.012
   Li D, 2014, POLYM CHEM-UK, V5, P14, DOI 10.1039/c3py00739a
   Mahmud A, 2006, MACROMOLECULES, V39, P9419, DOI 10.1021/ma0613786
   Pinto LFV, 2011, LANGMUIR, V27, P6330, DOI 10.1021/la200422q
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Quere D, 2008, ANNU REV MATER RES, V38, P71, DOI 10.1146/annurev.matsci.38.060407.132434
   Shi XJ, 2012, LANGMUIR, V28, P17011, DOI 10.1021/la303042d
   Sreenivasan SV, 2011, COMPREHENSIVE NANOSCIENCE AND TECHNOLOGY, VOL 4: NANOFABRICATION AND DEVICES, P83
   Sun TL, 2004, ANGEW CHEM INT EDIT, V43, P357, DOI 10.1002/anie.200352565
   Tsai WB, 2009, ACTA BIOMATER, V5, P1442, DOI 10.1016/j.actbio.2009.01.002
   Wang HW, 2013, ACS APPL MATER INTER, V5, P1800, DOI 10.1021/am3031322
   Wang X, 2015, NANO LETT, V15, P1457, DOI 10.1021/nl5049862
   Wang X, 2013, BIOMATERIALS, V34, P2865, DOI 10.1016/j.biomaterials.2013.01.021
   Wang YY, 2013, ACS APPL MATER INTER, V5, P3816, DOI 10.1021/am400469g
   Wu YN, 2014, NANOMED-NANOTECHNOL, V10, P1507, DOI 10.1016/j.nano.2014.04.002
   Yang HS, 2014, BIOMATERIALS, V35, P1478, DOI 10.1016/j.biomaterials.2013.10.067
   Yang JY, 2009, J BIOMED MATER RES A, V90A, P629, DOI 10.1002/jbm.a.32130
   Yang K, 2013, ACS APPL MATER INTER, V5, P10529, DOI 10.1021/am402156f
   Yao X, 2013, ADV MATER, V25, P5257, DOI 10.1002/adma.201301762
   Yuan L, 2011, MACROMOL BIOSCI, V11, P1031, DOI 10.1002/mabi.201000464
   Zhang Y, 2014, J POLYM SCI POL CHEM, V52, P188, DOI 10.1002/pola.26987
   Zhang Y, 2012, J COLLOID INTERF SCI, V368, P64, DOI 10.1016/j.jcis.2011.11.010
   Zhao SC, 2015, J MATER CHEM B, V3, P1612, DOI 10.1039/c4tb01287a
   Zheng J, 2013, ACS APPL MATER INTER, V5, P5882, DOI 10.1021/am4017329
   Zheng J, 2010, COLLOID SURFACE B, V77, P234, DOI 10.1016/j.colsurfb.2010.01.032
   Zhu BS, 2005, TISSUE ENG, V11, P825, DOI 10.1089/ten.2005.11.825
   Zhu BS, 2004, BIOMATERIALS, V25, P4215, DOI 10.1016/j.biomaterials.2003.11.020
NR 52
TC 2
Z9 2
U1 4
U2 46
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAR 30
PY 2016
VL 8
IS 12
BP 7720
EP 7728
DI 10.1021/acsami.6b01361
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DI5DQ
UT WOS:000373519500013
PM 26950754
DA 2018-10-19
ER

PT J
AU de Viteria, VS
   Bayon, R
   Igartua, A
   Barandika, G
   Moreno, JE
   Peremarch, CPJ
   Perez, MM
AF Saenz de Viteria, V.
   Bayon, R.
   Igartua, A.
   Barandika, G.
   Esteban Moreno, J.
   Perez-Jorge Peremarch, C.
   Martinez Perez, M.
TI Structure, tribocorrosion and biocide characterization of Ca, P and I
   containing TiO2 coatings developed by plasma electrolytic oxidation
SO APPLIED SURFACE SCIENCE
LA English
DT Article
ID TITANIUM SURFACES; PURE TITANIUM; ALLOY; VITRO; BONE; ADHESION; TI6AL4V;
   OSSEOINTEGRATION; BIOMATERIALS; WETTABILITY
AB In hip joint implants, in particular in the stems, wear-corrosion effects can accelerate the degradation of the biomaterial. The lack of osseointegration and the risk of contracting implant-associated infections may be other reasons for a premature failure of the implant. In this work, TiO2 coatings have been developed by means of plasma electrolytic oxidation (PEO) technique in order to achieve wear-resistant hard coatings with osseointegration ability and biocide characteristics. During the PEO process, elements that favor cell growth, like Ca and P, were introduced into the coating. With the purpose of providing the coating with antibacterial properties iodine was added like biocide agent. The microstructure and chemical composition of the developed coatings were analyzed in order to see if the surface of the films was suitable for the cell attachment. The effect of wear-corrosion synergy was studied by means of tribocorrosion tests. Finally, the biocide capacity of iodine against Staphylococcus aureus and Staphylococcus epidermidis was analyzed through bacterial adhesion tests. High wear and corrosion resistance was shown in one of the developed coatings. The achieved surface microstructures seem to be appropriate to improve the osseointegration with proper pore size and porosity index. The antibacterial capacity of iodine was confirmed for S. epidermidis. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Saenz de Viteria, V.; Bayon, R.; Igartua, A.] IK4 Tekniker, Polo Tecnol Eibar, Calle Inaki Goenaga 5, Eibar 20600, Spain.
   [Barandika, G.] Univ Basque Country, UPV EHU, Fac Ciencia & Tecnol, Dept Quim Inorgan, Apartado 644, E-48080 Bilbao, Spain.
   [Esteban Moreno, J.; Perez-Jorge Peremarch, C.; Martinez Perez, M.] IIS Fdn Jimenez Diaz, Dept Clin Microbiol, Ave Reyes Catolicos 2, Madrid 28040, Spain.
RP de Viteria, VS (reprint author), IK4 Tekniker, Polo Tecnol Eibar, Calle Inaki Goenaga 5, Eibar 20600, Spain.
EM virginia.saenzdeviteri@tekniker.es
RI Barandika, Gotzone/N-2157-2014
OI Barandika, Gotzone/0000-0002-6771-6586
FU Basque Country; Spanish Ministry of Science and Innovation
   [CSD2008-0023]; Ministerio de Economia y Competitividad
   [MAT2013-42092-R]
FX The authors want to acknowledge to the Basque Country for the financial
   support, to the Spanish Ministry of Science and Innovation for the
   financial of FUNCOAT (CSD2008-0023), the EMAITEK Project, CONSOLIDER
   Project, and to the SGIker technical support (MEC, GV/EJ, European
   Social Found). This work has also been financially supported by the
   "Ministerio de Economia y Competitividad" (MAT2013-42092-R).
CR Aliasghari S, 2014, APPL SURF SCI, V316, P463, DOI 10.1016/j.apsusc.2014.08.037
   Alsaran A, 2011, SURF COAT TECH, V205, pS537, DOI 10.1016/j.surfcoat.2011.03.032
   [Anonymous], 2015, ASM MAT DAT SHEET
   Arenas MA, 2013, COLLOID SURFACE B, V105, P106, DOI 10.1016/j.colsurfb.2012.12.051
   Arrabal R, 2009, SURF COAT TECH, V203, P2207, DOI 10.1016/j.surfcoat.2009.02.011
   BASLE MF, 1993, CALCIFIED TISSUE INT, V53, P348, DOI 10.1007/BF01351842
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   Chandra A, 2011, J MECH BEHAV BIOMED, V4, P1990, DOI 10.1016/j.jmbbm.2011.06.018
   Contu F, 2004, ELECTROCHIM ACTA, V50, P33, DOI 10.1016/j.electacta.2004.07.024
   Diomidis N, 2012, ACTA BIOMATER, V8, P852, DOI 10.1016/j.actbio.2011.09.034
   Diomidis N, 2011, TRIBOL INT, V44, P1452, DOI 10.1016/j.triboint.2011.02.013
   Durdu S, 2014, CERAM INT, V40, P3627, DOI 10.1016/j.ceramint.2013.09.062
   Fazel M, 2015, APPL SURF SCI, V324, P751, DOI 10.1016/j.apsusc.2014.11.030
   Goriainov V, 2014, ACTA BIOMATER, V10, P4043, DOI 10.1016/j.actbio.2014.06.004
   Grinnell F, 1978, Int Rev Cytol, V53, P65
   Hailer NP, 2010, ACTA ORTHOP, V81, P34, DOI 10.3109/17453671003685400
   Hussein R. O., 2010, J PHYS D, V43
   Jaspard-Mecuson F, 2007, SURF COAT TECH, V201, P8677, DOI 10.1016/j.surfcoat.2006.09.005
   Junker R, 2009, CLIN ORAL IMPLAN RES, V20, P185, DOI 10.1111/j.1600-0501.2009.01777.x
   Khorasanian M, 2011, SURF COAT TECH, V206, P1495, DOI 10.1016/j.surfcoat.2011.09.038
   Kinnari TJ, 2008, J BIOMED MATER RES A, V86A, P760, DOI 10.1002/jbm.a.31643
   Knetsch MLW, 2011, POLYMERS-BASEL, V3, P340, DOI 10.3390/polym3010340
   Kotharu V, 2012, CERAM INT, V38, P731, DOI 10.1016/j.ceramint.2011.07.065
   Kulkarni M, 2015, COLLOID SURFACE B, V129, P47, DOI 10.1016/j.colsurfb.2015.03.024
   Kulkarni M, 2015, INT J NANOMED, V10, P1359, DOI 10.2147/IJN.S77492
   Kumar S, 2010, MAT SCI ENG C-MATER, V30, P921, DOI 10.1016/j.msec.2010.03.024
   Kuzyk PRT, 2011, INDIAN J ORTHOP, V45, P108, DOI 10.4103/0019-5413.77129
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   Mabboux F, 2004, COLLOID SURFACE B, V39, P199, DOI 10.1016/j.colsurfb.2004.08.002
   Manhabosco TM, 2011, CORROS SCI, V53, P1786, DOI 10.1016/j.corsci.2011.01.057
   MAXIAN SH, 1994, J BIOMED MATER RES, V28, P1311, DOI 10.1002/jbm.820281109
   Neoh KG, 2012, BIOMATERIALS, V33, P2813, DOI 10.1016/j.biomaterials.2012.01.018
   Neupane M. P., 2012, WORLD ACAD SCI ENG T, V6, P10
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Perez-Tanoira R., 2012, J BIOMED MATER RES A, V100, P4208
   Ravanetti F, 2010, ACTA BIOMATER, V6, P1014, DOI 10.1016/j.actbio.2009.09.022
   Segomotso B., 2012, APPL SURF SCI, V258, P3927
   Shin KR, 2014, APPL SURF SCI, V314, P221, DOI 10.1016/j.apsusc.2014.06.121
   Shirai T, 2011, ACTA BIOMATER, V7, P1928, DOI 10.1016/j.actbio.2010.11.036
   Sollazzo V, 2007, J CRANIOFAC SURG, V18, P806, DOI 10.1097/scs.0b013e3180a7728f
   Song HJ, 2009, J MATER PROCESS TECH, V209, P864, DOI 10.1016/j.jmatprotec.2008.02.055
   Temenoff J.S., 2008, BIOMATERIALS INTERSE
   Uchida M, 2003, J BIOMED MATER RES A, V64A, P164, DOI 10.1002/jbm.a.10414
   Vasilev K, 2009, EXPERT REV MED DEVIC, V6, P553, DOI [10.1586/erd.09.36, 10.1586/ERD.09.36]
   Wang HR, 2015, APPL SURF SCI, V356, P1234, DOI 10.1016/j.apsusc.2015.08.228
   Wang HY, 2014, MAT SCI ENG C-MATER, V42, P657, DOI 10.1016/j.msec.2014.06.005
   Williams S, 2003, P I MECH ENG H, V217, P147, DOI 10.1243/09544110360579367
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Yerokhin AL, 2000, SURF COAT TECH, V130, P195, DOI 10.1016/S0257-8972(00)00719-2
   Zhang EL, 2013, MAT SCI ENG C-MATER, V33, P4280, DOI 10.1016/j.msec.2013.06.016
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020
NR 51
TC 9
Z9 9
U1 8
U2 45
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAR 30
PY 2016
VL 367
BP 1
EP 10
DI 10.1016/j.apsusc.2016.01.145
PG 10
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA DH1BL
UT WOS:000372519300001
DA 2018-10-19
ER

PT J
AU Mosbahi, S
   Oudadesse, H
   Lefeuvre, B
   Barroug, A
   Elfeki, H
   Elfeki, A
   Roiland, C
   Keskes, H
AF Mosbahi, Siwar
   Oudadesse, Hassane
   Lefeuvre, Bertand
   Barroug, Allal
   Elfeki, Hafed
   Elfeki, Abdelfattah
   Roiland, Claire
   Keskes, Hassib
TI Risedronate adsorption on bioactive glass surface for applications as
   bone biomaterial
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Adsorption; Bisphosphonate; Bioactive glass; Risedronate; Spectroscopy
ID OSTEOPOROSIS; RAMAN; BISPHOSPHONATES; HYDROXYAPATITE; ALENDRONATE;
   DISORDERS; APATITE; WOMEN; ACID
AB The aim of the current work is to study the physicochemical interactions between bisphosphonates molecules, risedronate (RIS) and bioactive glass (46S6) after their association by adsorption phenomenon. To more understand the interaction processes of RIS with the 46S6 surface we have used complementary physicochemical techniques such as infrared (FTIR), Raman and nuclear magnetic resonance (NMR) spectroscopy. The obtained results suggest that risedronate adsorption corresponds to an ion substitution reaction with silicon ions occurring at the bioactive glass surface. Thus, a pure bioactive glass was synthesized and fully characterized comparing the solids after adsorption (46S6-XRIS obtained after the interaction of 46S6 and X% risedronate). Therefore, based on the spectroscopic results FTIR, Raman and MAS-NMR, it can be concluded that strong interactions have been established between RIS ions and 46S6 surface. In fact, FTIR and Raman spectroscopy illustrate the fixation of risedronate on the bioactive glass surface by the appearance of several bands characterizing risedronate. The P-31 MAS-NMR of the composite 46S6-XRIS show the presence of two species at a chemical shift of 15 and 19 ppm demonstrating thus the fixation of the RIS on 46S6 surface. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Mosbahi, Siwar; Oudadesse, Hassane; Lefeuvre, Bertand; Roiland, Claire] Univ Rennes 1, UMR CNRS 6226, Campus Beaulieu, F-35042 Rennes, France.
   [Mosbahi, Siwar; Keskes, Hassib] Sfax Fac Med, Orthopaed & Traumatol Lab, Sfax, Tunisia.
   [Elfeki, Hafed] Sfax Fac Sci, Sci Mat & Environm Lab, Sfax, Tunisia.
   [Elfeki, Abdelfattah] Sfax Fac Sci, Dept Life Sci, Anim Ecophysiol Lab, Sfax, Tunisia.
   [Barroug, Allal] Univ Cadi Ayyad, Fac Sci Semlalia, Marrakech, Morocco.
   [Barroug, Allal] CNRST, Rabat, Morocco.
RP Oudadesse, H (reprint author), Univ Rennes 1, UMR CNRS 6226, Campus Beaulieu, F-35042 Rennes, France.
EM hassane.oudadesse@univ-rennes1.fr
OI roiland, claire/0000-0001-9587-1340
CR Barroug A, 1998, J COLLOID INTERF SCI, V208, P147, DOI 10.1006/jcis.1998.5759
   Benaziz L, 2001, J COLLOID INTERF SCI, V238, P48, DOI 10.1006/jcis.2001.7450
   Brink M, 1997, J BIOMED MATER RES, V37, P114, DOI 10.1002/(SICI)1097-4636(199710)37:1<114::AID-JBM14>3.0.CO;2-G
   Bui XV, 2010, J AUST CERAM SOC, V46, P24
   Cohen S, 1999, ARTHRITIS RHEUM, V42, P2309, DOI 10.1002/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K
   Coleman RE, 2001, CANCER TREAT REV, V27, P165, DOI 10.1053/ctrv.2001.0210
   deGroen PC, 1996, NEW ENGL J MED, V335, P1016, DOI 10.1056/NEJM199610033351403
   Dietrich E., 2007, J BIOMED MAT, V10, P1002
   Errassifi F, 2014, J COLLOID INTERF SCI, V420, P101, DOI 10.1016/j.jcis.2014.01.017
   Ettinger B, 1998, AM J MANAG CARE, V4, P1377
   Fleisch H, 1998, ENDOCR REV, V19, P80, DOI 10.1210/er.19.1.80
   Fleisch HA, 1997, ANN MED, V29, P55, DOI 10.3109/07853899708998743
   Gonzalez P, 2003, J NON-CRYST SOLIDS, V320, P92, DOI 10.1016/S0022-3093(03)00013-9
   Hammami K, 2015, APPL SURF SCI, V353, P165, DOI 10.1016/j.apsusc.2015.06.068
   Handke M, 2003, J MOL STRUCT, V651, P39, DOI 10.1016/S0022-2860(03)00099-1
   Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344
   HENCH LL, 1994, BIOCERAMICS, V7, P3
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Hsi CS, 2007, J EUR CERAM SOC, V27, P3171, DOI 10.1016/j.jeurceramsoc.2006.11.081
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Jebahi S., 2014, BIOTECHNOL LETT, V36, P2571
   JOHNSSON M, 1991, CALCIFIED TISSUE INT, V49, P134, DOI 10.1007/BF02565136
   Josse S, 2005, BIOMATERIALS, V26, P2073, DOI 10.1016/j.biomaterials.2004.05.019
   Juillard A, 2010, BONE, V47, P895, DOI 10.1016/j.bone.2010.07.018
   Karlsson KH, 1998, GLASTECH BER-GLASS, V71, P141
   Kos J, 2011, MOLECULES, V16, P3740, DOI 10.3390/molecules16053740
   MacDonald S. A., 2000, J NONCRYST SOLIDS, V275, P275
   Mosbahi S., 2014, IJET, V3, P2277
   Mostafa A. M., 2013, BIOCERAM DEV APPL, V4, P1
   Oudadesse H, 2011, APPL SURF SCI, V257, P8587, DOI 10.1016/j.apsusc.2011.05.022
   Ouizat S., 2000, MAT RES B, V34, P2279, DOI DOI 10.1016/S0025-5408(00)00167-7
   Pascaud P., 2012, BIOMED MATER, V7, P1
   Redman-Furey N, 2005, J PHARM SCI-US, V94, P893, DOI 10.1002/jps.20308
   Reigstad O., 2011, J BIOMED MATER RES B, V19, P14
   Rosenqvist K, 2013, INT J PHARMACEUT, V452, P102, DOI 10.1016/j.ijpharm.2013.04.059
   Roussiere H, 2005, J MATER CHEM, V15, P3869, DOI 10.1039/b503680a
   Sitarz M., 1999, J MOL STRUCT, V511, P282
   Vallano PT, 2003, J CHROMATOGR B, V794, P23, DOI 10.1016/S1570-0232(03)00394-5
   Wers E, 2015, APPL SURF SCI, V353, P200, DOI 10.1016/j.apsusc.2015.06.146
   Xie XH, 2010, J MATER SCI-MATER M, V21, P2165, DOI 10.1007/s10856-010-4077-6
NR 40
TC 2
Z9 2
U1 0
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAR 30
PY 2016
VL 367
BP 205
EP 213
DI 10.1016/j.apsusc.2016.01.184
PG 9
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA DH1BL
UT WOS:000372519300027
DA 2018-10-19
ER

PT J
AU Zhao, Q
   Mahmood, W
   Zhu, YY
AF Zhao, Qing
   Mahmood, Wacias
   Zhu, Yanying
TI Synthesis of dittmarite/Mg(OH)(2) composite coating on AZ31 using
   hydrothermal treatment
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Hydrothermal method; Cytotoxicity; Magnesium alloy; Biomaterial;
   Dittmarite/magnesium hydroxide composite (DMC) coating
ID MAGNESIUM ALLOY; ELECTROCHEMICAL METHOD; CORROSION-RESISTANCE;
   THIN-FILMS; BONE; TEMPERATURE; PROTECTION; IMPLANTS; GROWTH; STENTS
AB In this work, we have used hydrothermal method for the synthesis of dittmarite/Mg(OH)(2) composite (DMC) layer on AZ31 alloy of magnesium. The synthesized coating was characterized by X-ray diffraction (XRD), field emission scanning electron microscopy (FESEM) and energy dispersive X-ray spectroscopy (EDS). In a test immersion into the Hank's mixture for 31 days, the synthesized coating inhibited corrosion of AZ31 significantly and the amorphous calcium apatite precursor deposited on the coating surface. In another tape test, we noticed strong adhesion between the coating and substrate that eventually concludes that the synthesized coating is hydrophilic and a promising candidate to be used in the absorbable implant materials. Besides, the cytotoxicity of the AZ31 alloy with DMC coating, grown under different conditions on L-929 cells in vitro was examined indirectly through the growth inhibition method (MTT assay). The cytotoxicity of the deposited coating lie between 0 similar to 1 that indicates it as a promising biomaterial. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Zhao, Qing; Mahmood, Wacias; Zhu, Yanying] Beijing Inst Technol, Sch Phys, Beijing 100081, Peoples R China.
RP Zhao, Q (reprint author), Beijing Inst Technol, Sch Phys, Beijing 100081, Peoples R China.
EM qzhaoyuping@bit.edu.cn
FU National Natural Science Foundation of China [11075077, 11275024];
   Ministry of Science and Technology, China [2013YQ03059503, 2014AA120101]
FX This work was supported by National Natural Science Foundation of China
   (11075077 and 11275024). Additional support was provided by the Ministry
   of Science and Technology, China (2013YQ03059503, 2014AA120101).
CR [Anonymous], 2004, G3172 ASTM
   Asl SKF, 2015, MATER CHEM PHYS, V161, P185, DOI 10.1016/j.matchemphys.2015.05.035
   Duygulu O, 2007, MATER SCI FORUM, V546-549, P421, DOI 10.4028/www.scientific.net/MSF.546-549.421
   Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Guo XX, 2009, LANGMUIR, V25, P9894, DOI 10.1021/la901012w
   Hu Y, 2008, J PHYS CHEM C, V112, P13037, DOI 10.1021/jp803726c
   Huse E.C., 1878, CHICAGO MED J EXAMIN, V37, P171
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P1071, DOI 10.1002/jbm.820290907
   Jeong H, 2015, SURF COAT TECH, V284, P26, DOI 10.1016/j.surfcoat.2015.10.039
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Mario CD, 2004, J INTERV CARDIOL, V17, P391, DOI DOI 10.1111/J0IC.2004.17.ISSUE-6
   MOHAJIT K K B, 1989, Biological Wastes, V30, P133
   Optrajanov B. S., 2002, J MOL STRUCT, V613, P7
   Peeters P, 2005, J ENDOVASC THER, V12, P1, DOI 10.1583/04-1349R.1
   Ren YF, 2015, MAT SCI ENG C-MATER, V49, P364, DOI 10.1016/j.msec.2015.01.046
   Shaw BA., 2003, ASM HDB A, P692
   Song SW, 2000, J AM CERAM SOC, V83, P2839
   Song YW, 2008, MATER LETT, V62, P3276, DOI 10.1016/j.matlet.2008.02.048
   Sreekanth D, 2012, MATER LETT, V68, P439, DOI 10.1016/j.matlet.2011.11.025
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Suchanek WL, 1998, J AM CERAM SOC, V81, P2864, DOI 10.1111/j.1151-2916.1998.tb02707.x
   Sun K, 2011, CHEM COMMUN, V47, P7776, DOI 10.1039/c1cc11397f
   Tian P, 2015, COLLOID SURFACE B, V128, P44, DOI 10.1016/j.colsurfb.2015.02.011
   Wang H, 2008, MATER LETT, V62, P2476, DOI 10.1016/j.matlet.2007.12.052
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Wu J, 2007, CHINESE J CHEM, V25, P72, DOI 10.1002/cjoc.200790020
   YOO SE, 1990, J AM CERAM SOC, V73, P2561, DOI 10.1111/j.1151-2916.1990.tb07637.x
   Yun H, 2008, APPL SURF SCI, V255, P2113, DOI 10.1016/j.apsusc.2008.06.194
   Zartner P, 2005, CATHETER CARDIO INTE, V66, P590, DOI 10.1002/ccd.20520
   Zberg B, 2009, NAT MATER, V8, P887, DOI [10.1038/NMAT2542, 10.1038/nmat2542]
   Zhu HL, 2007, SURF COAT TECH, V201, P5870, DOI 10.1016/j.surfcoat.2006.10.037
   Zhu YY, 2012, SURF COAT TECH, V206, P2961, DOI 10.1016/j.surfcoat.2011.12.029
   Zhu YY, 2011, APPL SURF SCI, V257, P6129, DOI 10.1016/j.apsusc.2011.02.017
   Zomorodian A, 2013, ACTA BIOMATER, V9, P8660, DOI 10.1016/j.actbio.2013.02.036
NR 37
TC 6
Z9 6
U1 4
U2 34
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAR 30
PY 2016
VL 367
BP 249
EP 258
DI 10.1016/j.apsusc.2016.01.055
PG 10
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA DH1BL
UT WOS:000372519300032
DA 2018-10-19
ER

PT J
AU Miles, KB
   Ball, RL
   Matthew, HWT
AF Miles, Kevin Barrett
   Ball, Rebecca Lee
   Matthew, Howard William Trevor
TI Chitosan films with improved tensile strength and toughness from
   N-acetyl-cysteine mediated disulfide bonds
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE N-acetyl-cysteine chitosan; Cyclical tensile properties; Disulfide
   bonds; Biomaterial mechanical properties; Biomaterial crystallinitya
ID IN-VIVO DEGRADATION; MECHANICAL-PROPERTIES; CRYSTAL-STRUCTURE; HYDROGEL;
   CHITIN; VITRO; SCAFFOLDS; DEACETYLATION; BIOMATERIALS; CONJUGATE
AB To improve the mechanical properties of chitosan (Ct) materials without the use of cytotoxic crosslinkers, disulfide cross-linkable Ct was synthesized by grafting N-acetyl-cysteine (NAC) to Ct using carbodiimide chemistry. Cast films of NAC-Ct conjugates were prepared with degrees of substitution (DS) of 0%, 6%, 15%, and 20%, and the disulfide bond formation was induced by increasing the reaction media pH to 11. The tensile strength, breaking strain, elastic moduli and toughness of disulfide cross-linked polymers were analyzed by monotonic tensile testing of hydrated NAC-Ct films. Crystallinity was determined via XRD. Results demonstrated that NAC incorporation and crosslinking in chitosan produced tougher polymer films with 4-fold higher tensile strength (10 MPa) and 6-fold greater elongation (365%), but reduced crystallinity, compared to unmodified chitosan. The resilience of NAC-Ct films was evaluated by cyclic testing, and results demonstrate that increasing NAC content produced a more resilient material that dissipated less energy when deformed. These improved mechanical properties broaden chitosan's applicability towards the construction of mechanically robust implantable scaffolds for tissue regeneration. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Miles, Kevin Barrett; Ball, Rebecca Lee; Matthew, Howard William Trevor] Wayne State Univ, Dept Chem Engn & Mat Sci, Detroit, MI 48202 USA.
RP Matthew, HWT (reprint author), Wayne State Univ, Dept Chem Engn & Mat Sci, 5050 Anthony Wayne Dr, Detroit, MI 48202 USA.
EM kbmiles@wayne.edu; rlball@andrew.cmu.edu; hmatthew@wayne.edu
OI Matthew, Howard/0000-0001-6033-9258
CR Abdou ES, 2008, BIORESOURCE TECHNOL, V99, P1359, DOI 10.1016/j.biortech.2007.01.051
   Amin AFMS, 2006, INT J PLASTICITY, V22, P1610, DOI 10.1016/j.ijplas.2005.09.005
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Bao DS, 2014, CARBOHYD POLYM, V110, P113, DOI 10.1016/j.carbpol.2014.03.095
   Cervera MF, 2004, CARBOHYD POLYM, V58, P401, DOI 10.1016/j.carbpol.2004.08.017
   Chang RJY, 2011, PROTEIN REV, V14, P1, DOI 10.1007/978-1-4419-7273-6
   Chen RH, 1996, CARBOHYD POLYM, V31, P141, DOI 10.1016/S0144-8617(96)00047-1
   Chupa JM, 2000, BIOMATERIALS, V21, P2315, DOI 10.1016/S0142-9612(00)00158-7
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   Gough JE, 2002, J BIOMED MATER RES, V61, P121, DOI 10.1002/jbm.10145
   Kim HJ, 2014, ACS NANO, V8, P2998, DOI 10.1021/nn5002968
   Lavertu M, 2003, J PHARMACEUT BIOMED, V32, P1149, DOI 10.1016/S0731-7085(03)00115-9
   Lima IS, 2004, THERMOCHIM ACTA, V421, P133, DOI 10.1016/j.tca.2004.03.012
   Ma XX, 2014, J MATER CHEM B, V2, P2749, DOI 10.1039/c3tb21842b
   Ma ZW, 2011, BIOMACROMOLECULES, V12, P3265, DOI 10.1021/bm2007218
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Mir S, 2011, CARBOHYD POLYM, V83, P414, DOI 10.1016/j.carbpol.2010.07.069
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   Okuyama K, 1997, MACROMOLECULES, V30, P5849, DOI 10.1021/ma970509n
   Onishi H, 1999, BIOMATERIALS, V20, P175, DOI 10.1016/S0142-9612(98)00159-8
   Prabaharan M, 2007, J BIOMED MATER RES B, V81B, P427, DOI 10.1002/jbm.b.30680
   Ravindran S, 2012, TISSUE ENG PT A, V18, P295, DOI [10.1089/ten.TEA.2011.0136, 10.1089/ten.tea.2011.0136]
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Schmitz T, 2008, INT J PHARMACEUT, V347, P79, DOI 10.1016/j.ijpharm.2007.06.040
   Shrestha A, 2012, ANTIMICROB AGENTS CH, V56, P4876, DOI 10.1128/AAC.00810-12
   Shu XZ, 2002, BIOMACROMOLECULES, V3, P1304, DOI 10.1021/bm025603c
   Spada C, 2002, CLIN CHEM LAB MED, V40, P452, DOI 10.1515/CCLM.2002.077
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Walton A. G., 1973, BIOPOLYMERS
   Wan Y, 2005, J MATER SCI-MATER M, V16, P1017, DOI 10.1007/s10856-005-4756-x
   Wan Y, 2003, J APPL POLYM SCI, V89, P306, DOI 10.1002/app.12090
   Wang T, 2004, POLYM INT, V53, P911, DOI 10.1002/pi.1461
   Wu ZM, 2009, EUR J PHARM SCI, V37, P198, DOI 10.1016/j.ejps.2009.01.010
   Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869
   YUI T, 1994, MACROMOLECULES, V27, P7601, DOI 10.1021/ma00104a014
   Zhang HW, 2011, BIOMACROMOLECULES, V12, P1428, DOI 10.1021/bm101192b
   Zhang YQ, 2005, CARBOHYD RES, V340, P1914, DOI 10.1016/j.carres.2005.05.005
   Zhang YF, 2007, BIOMATERIALS, V28, P1515, DOI 10.1016/j.biomaterials.2006.11.040
NR 40
TC 5
Z9 6
U1 6
U2 104
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD MAR 30
PY 2016
VL 139
BP 1
EP 9
DI 10.1016/j.carbpol.2015.11.052
PG 9
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA DA8ZZ
UT WOS:000368097200001
PM 26794940
DA 2018-10-19
ER

PT J
AU Lin, KF
   He, S
   Song, Y
   Wang, CM
   Gao, Y
   Li, JQ
   Tang, P
   Wang, Z
   Bi, L
   Pei, GX
AF Lin, Kai-Feng
   He, Shu
   Song, Yue
   Wang, Chun-Mei
   Gao, Yi
   Li, Jun-Qin
   Tang, Peng
   Wang, Zheng
   Bi, Long
   Pei, Guo-Xian
TI Low-Temperature Additive Manufacturing of Biomimic Three-Dimensional
   Hydroxyapatite/Collagen Scaffolds for Bone Regeneration
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE three-dimensional printing; collagen; hydroxyapatite; bone substitutes;
   tissue engineering
ID TISSUE ENGINEERING SCAFFOLDS; CALCIUM-PHOSPHATE; BIOMATERIAL SCAFFOLDS;
   MECHANICAL-PROPERTIES; COMPOSITE SCAFFOLDS; SUBSTITUTES; POROSITY;
   WETTABILITY; CARTILAGE; DELIVERY
AB Low-temperature additive manufacturing, (AM) holds promise for fabrication of-three-dimensional (3D) scaffolds containing bioactive molecules and/or drugs. Due to the strict technical limitations of current approaches, few materials are suitable for printing at low temperature. Here, a low-temperature robocasting method was employed to print: biomimic 3D scaffolds for bone regeneration using a routine collagen-hydroxyapatite (CHA) composite material, which is too viscous to be printed via normal 3D printing methods at low temperature. The CHA scaffolds had excellent 3D structure and maintained most raw material properties after printing. compared to nonprinted scaffolds, printed scaffolds promoted bone marrow stromal cell proliferation and improved osteogenic outcome in vitro. In a rabbit femoral condyle defect model, the interconnecting pores within the printed scaffolds facilitated cell penetration and mineralization before the scaffolds degraded and enhanced repair, compared-to nonprinted CHA scaffolds. Additionally, the optimal printing parameters for 3D CHA scaffolds were investigated; 600-mu m-diameter rods were optimal in terms of moderate mechanical strength and better repair outcome in vivo. This low-temperature robocasting method could enable-a variety of bioactive molecules to be incorporated into printed CHA materials and provides a method of bioprinting biomaterials without compromising their natural properties.
C1 [Lin, Kai-Feng; He, Shu; Song, Yue; Wang, Chun-Mei; Gao, Yi; Li, Jun-Qin; Tang, Peng; Wang, Zheng; Bi, Long; Pei, Guo-Xian] Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Peoples R China.
RP Bi, L; Pei, GX (reprint author), Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Peoples R China.
EM bilong@fmmu.edu.cn; nfperry@163.com
FU National Natural Science Foundation of China [81371982]
FX National Natural Science Foundation of China, grant number 81371982.
CR An B, 2016, ADV DRUG DELIVER REV, V97, P69, DOI 10.1016/j.addr.2015.11.013
   Bi L, 2011, J MATER SCI-MATER M, V22, P51, DOI 10.1007/s10856-010-4177-3
   Bose S, 2013, MATER TODAY, V16, P496, DOI 10.1016/j.mattod.2013.11.017
   Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005
   Butscher A, 2011, ACTA BIOMATER, V7, P907, DOI 10.1016/j.actbio.2010.09.039
   Campana V, 2014, J MATER SCI-MATER M, V25, P2445, DOI 10.1007/s10856-014-5240-2
   Cao H, 2010, BONE, V46, P386, DOI 10.1016/j.bone.2009.09.031
   Chen O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141201
   Forster Yvonne, 2012, Biomatter, V2, P149, DOI 10.4161/biom.21563
   Gbureck U, 2007, ADV FUNCT MATER, V17, P3940, DOI 10.1002/adfm.200700019
   Gleeson JP, 2010, EUR CELLS MATER, V20, P218
   Hao LJ, 2014, J MATER CHEM B, V2, P4794, DOI 10.1039/c4tb00597j
   Haugh MG, 2010, TISSUE ENG PART C-ME, V16, P887, DOI 10.1089/ten.TEC.2009.0422
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Inzana JA, 2014, BIOMATERIALS, V35, P4026, DOI 10.1016/j.biomaterials.2014.01.064
   Ishack S, 2017, J BIOMED MATER RES B, V105, P366, DOI 10.1002/jbm.b.33561
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016
   Kruger TE, 2013, SCI WORLD J, DOI 10.1155/2013/812718
   Kurien T, 2013, BONE JOINT J, V95B, P583, DOI 10.1302/0301-620X.95B5.30286
   Lee SB, 2005, BIOMATERIALS, V26, P1961, DOI 10.1016/j.biomaterials.2004.06.032
   Loh QL, 2013, TISSUE ENG PART B-RE, V19, P485, DOI [10.1089/ten.TEB.2012.0437, 10.1089/ten.teb.2012.0437]
   Miranda P, 2008, J BIOMED MATER RES A, V85A, P218, DOI 10.1002/jbm.a.31587
   Molladavoodi S, 2013, J MECH BEHAV BIOMED, V17, P186, DOI 10.1016/j.jmbbm.2012.08.021
   Moreau JL, 2009, J BIOMED MATER RES A, V91A, P605, DOI 10.1002/jbm.a.32248
   Murphy CM, 2014, ACTA BIOMATER, V10, P2250, DOI 10.1016/j.actbio.2014.01.016
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Muzzarelli RAA, 2015, MAR DRUGS, V13, P7314, DOI 10.3390/md13127068
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001
   Perez RA, 2013, J MATER SCI-MATER M, V24, P381, DOI 10.1007/s10856-012-4799-8
   Rupp F, 2014, ACTA BIOMATER, V10, P2894, DOI 10.1016/j.actbio.2014.02.040
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Sachlos E, 2008, ACTA BIOMATER, V4, P1322, DOI 10.1016/j.actbio.2008.03.016
   SACHS E, 1992, J ENG IND-T ASME, V114, P481
   Shue Li, 2012, Biomatter, V2, P271, DOI 10.4161/biom.22948
   Swetha M, 2010, INT J BIOL MACROMOL, V47, P1, DOI 10.1016/j.ijbiomac.2010.03.015
   Venkatesan J, 2014, J BIOMED NANOTECHNOL, V10, P3124, DOI 10.1166/jbn.2014.1893
   Vorndran E, 2010, ADV FUNCT MATER, V20, P1585, DOI 10.1002/adfm.200901759
   Wachiralarpphaithoon C, 2007, BIOMATERIALS, V28, P984, DOI 10.1016/j.biomaterials.2006.10.024
   Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06
   Wang DX, 2013, INT J NANOMED, V8, P1855, DOI 10.2147/IJN.S43706
   Wojtowicz AM, 2010, BIOMATERIALS, V31, P2574, DOI 10.1016/j.biomaterials.2009.12.008
   Wu LB, 2004, BIOMATERIALS, V25, P5821, DOI 10.1016/j.biomaterials.2004.01.038
   Yoshikawa H, 2009, J R SOC INTERFACE, V6, pS341, DOI 10.1098/rsif.2008.0425.focus
   Zeng Q, 2014, China Patent, Patent No. [CN 104325644 A, 104325644]
   Zeng Q, 2015, China Patent, Patent No. [CN 104826171 A, 104826171]
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
   Zhu YL, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/5/055009
NR 49
TC 26
Z9 27
U1 11
U2 144
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAR 23
PY 2016
VL 8
IS 11
BP 6905
EP 6916
DI 10.1021/acsami.6b00815
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DH7BQ
UT WOS:000372946600016
PM 26930140
DA 2018-10-19
ER

PT J
AU Tarchala, M
   Harvey, EJ
   Barralet, J
AF Tarchala, Magdalena
   Harvey, Edward J.
   Barralet, Jake
TI Biomaterial-Stabilized Soft Tissue Healing for Healing of Critical-Sized
   Bone Defects: the Masquelet Technique
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Review
ID INDUCED MEMBRANE TECHNIQUE; POLYLACTIDE MEMBRANES; NERVE REGENERATION;
   SEGMENTAL DEFECTS; OPEN FRACTURES; LONG BONES; RECONSTRUCTION; FUTURE;
   REPAIR; SHEEP
AB Critical-sized bone defects present a signifi cant burden to the medical community due to their challenging treatment. However, a successful limb-salvaging technique, the Masquelet Technique (MT), has significantly improved the prognosis of many segmental bone defects in helping to restore form and function. Although the Masquelet Technique has proven to be clinically effective, the physiology of the healing it induces is not well understood. Multiple modifiable factors have been implicated by various surgical and research teams, but no single factor has been proven to be critical to the success of the Masquelet Technique. In this review the most recent clinical and experimental evidence that supports and helps to decipher the traditional Masquelet, as well as the modifiable factors and their effect on the success of the technique are discussed. In addition, future developments for the integration of the traditional Masquelet Technique with the use of alternative biomaterials to increase the effectiveness and expand the clinical applicability of the Masquelet Technique are reviewed.
C1 [Tarchala, Magdalena; Harvey, Edward J.] McGill Univ, Ctr Hlth, Div Orthopaed Surg, Montreal, PQ H3G 1A4, Canada.
   [Barralet, Jake] McGill Univ, Fac Dent, Montreal, PQ H3A 0G4, Canada.
RP Harvey, EJ (reprint author), McGill Univ, Ctr Hlth, Div Orthopaed Surg, Montreal, PQ H3G 1A4, Canada.
EM edward.harvey@mcgill.ca
OI Barralet, jake/0000-0003-3543-6042; harvey, edward/0000-0003-3934-8920
CR AABOE M, 1995, BRIT J ORAL MAX SURG, V33, P312, DOI 10.1016/0266-4356(95)90045-4
   Accadbled F, 2013, ORTHOP TRAUMATOL-SUR, V99, P479, DOI 10.1016/j.otsr.2013.01.008
   Aho OM, 2013, J BONE JOINT SURG AM, V95A, P597, DOI 10.2106/JBJS.L.00310
   Aronson J, 1997, J BONE JOINT SURG AM, V79A, P1243, DOI 10.2106/00004623-199708000-00019
   Auregan J.-C., 2014, INT ORTHOP, V38, P9
   Bauer T. W., 2005, CLIN ORTHOP RELAT R, V371, P10
   Biau D. J., 2009, CLIN ORTHOP RELAT R, V2, P572
   Blair C., 2015, CASE REP ORTHOP, V19, P1
   Boccaccini AR, 2012, EXPERT REV MED DEVIC, V9, P457, DOI [10.1586/ERD.12.49, 10.1586/erd.12.49]
   Bosemark P, 2015, J ORTHOP RES, V33, P488, DOI 10.1002/jor.22815
   Bouis D, 2006, PHARMACOL RES, V53, P89, DOI 10.1016/j.phrs.2005.10.006
   BOYNE PJ, 1969, J AM DENT ASSOC, V78, P767, DOI 10.1016/S0002-8177(69)84023-7
   Breitbart A. S., 2006, GRABB SMITHS PLASTIC, P1
   Cawcutt KA, 2014, MAYO CLIN PROC, V89, P1572, DOI 10.1016/j.mayocp.2014.07.009
   Childs SG, 2005, ORTHOP NURS, V24, P295
   Chiu YC, 2011, BIOMATERIALS, V32, P6045, DOI 10.1016/j.biomaterials.2011.04.066
   Chotel F, 2012, ORTHOP TRAUMATOL-SUR, V98, P301, DOI 10.1016/j.otsr.2011.11.008
   Christou C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114122
   Cross WW, 2008, INDIAN J ORTHOP, V42, P377, DOI 10.4103/0019-5413.43373
   de Gauzy JS, 2012, ORTHOP TRAUMATOL-SUR, V98, P220, DOI 10.1016/j.otsr.2012.01.001
   de Mones E, 2015, ACTA BIOMATER, V19, P119, DOI 10.1016/j.actbio.2015.03.005
   Dimitriou R, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-81
   Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66
   Dugan TR, 2013, INJURY, V44, P1826, DOI 10.1016/j.injury.2013.03.018
   Gardner MJ, 2008, J ORTHOP TRAUMA, V22, P451, DOI 10.1097/BOT.0b013e318176b8d9
   Gerber A, 2002, INJURY, V33, P43, DOI 10.1016/S0020-1383(02)00132-8
   Giannoudis PV, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(08)70003-2
   Giannoudis PV, 2011, INJURY, V42, P591, DOI 10.1016/j.injury.2011.03.036
   Gottlow J., 2010, J JPN SOC PERIDONTOL, V35, P1
   Gouron R., 2013, ORTHOPAEDICA TRAUMAT, V7, P837
   Gouron R, 2017, J TISSUE ENG REGEN M, V11, P382, DOI 10.1002/term.1921
   Gugala Z, 2002, INJURY, V33, P71, DOI 10.1016/S0020-1383(02)00135-3
   Gugala Z, 2007, MACROMOL SYMP, V253, P147, DOI 10.1002/masy.200750722
   GUSTILO RB, 1976, J BONE JOINT SURG AM, V58, P453, DOI 10.2106/00004623-197658040-00004
   Hannink G, 2011, INJURY, V42, pS22, DOI 10.1016/j.injury.2011.06.008
   Henrich D, 2013, J TISSUE ENG REGENER
   Hirschi KK, 2002, ANN NY ACAD SCI, V961, P223, DOI 10.1111/j.1749-6632.2002.tb03090.x
   Huffman LK, 2009, FOOT ANKLE INT, V30, P895, DOI 10.3113/FAI.2009.0895
   HURLEY LA, 1959, J BONE JOINT SURG AM, V41, P1243, DOI 10.2106/00004623-195941070-00007
   Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821
   Javed A, 1999, J BONE MINER RES, V14, pS165
   Jung RE, 2011, CLIN ORAL IMPLAN RES, V22, P802, DOI 10.1111/j.1600-0501.2010.02068.x
   Kanczler J. M., 2008, EUR CELLS MATER, V29, P3105
   Karger C, 2012, ORTHOP TRAUMATOL-SUR, V98, P97, DOI 10.1016/j.otsr.2011.11.001
   Kenneth Ward W, 2008, J Diabetes Sci Technol, V2, P768
   Killion JA, 2013, MAT SCI ENG C-MATER, V33, P4203, DOI 10.1016/j.msec.2013.06.013
   Kinoshita Y., 2004, JMAJ, V47, P294
   Klaue K, 1995, REV CHIR ORTHOP S, V70, P109
   Klaue K, 2009, INJURY, V40, pS95, DOI 10.1016/j.injury.2009.10.043
   Kurobe H, 2012, STEM CELL TRANSL MED, V1, P566, DOI 10.5966/sctm.2012-0044
   Lasanianos NG, 2010, ORTHOP TRAUMA, V24, P149, DOI 10.1016/j.mporth.2009.10.003
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   LUNDBORG G, 1982, EXP NEUROL, V76, P361, DOI 10.1016/0014-4886(82)90215-1
   MADISON RD, 1987, EXP NEUROL, V95, P378, DOI 10.1016/0014-4886(87)90146-4
   Makridis KG, 2014, FOOT ANKLE SURG, V20, pE19, DOI 10.1016/j.fas.2013.11.006
   Marais LC, 2015, STRATEG TRAUMA LIMB, V10, P27, DOI 10.1007/s11751-015-0221-7
   Masquelet A C, 2000, Ann Chir Plast Esthet, V45, P346
   Masquelet AC, 2003, LANGENBECK ARCH SURG, V388, P344, DOI 10.1007/s00423-003-0379-1
   Masquelet AC, 2010, ORTHOP CLIN N AM, V41, P27, DOI 10.1016/j.ocl.2009.07.011
   McAllister BS, 2007, J PERIODONTOL, V78, P377, DOI 10.1902/jop.2007.060048
   Meinig RP, 2010, ORTHOP CLIN N AM, V41, P39, DOI 10.1016/j.ocl.2009.07.012
   Mekhail O. A., 2004, J TRAUMA ACUTE CARE, V56, P368
   Micev AJ, 2015, J HAND SURG-AM, V40, P593, DOI 10.1016/j.jhsa.2014.12.007
   Motsitsi NS, 2012, E CENT AFR J SURG, V17, P1
   Myeroff C, 2011, J BONE JOINT SURG AM, V93A, P2227, DOI 10.2106/JBJS.J.01513
   Najafpour A, 2013, INT J SURG, V11, P1010, DOI 10.1016/j.ijsu.2013.05.034
   O'Malley NT, 2012, ARCH ORTHOP TRAUM SU, V132, P245, DOI 10.1007/s00402-011-1417-z
   OGISO B, 1991, J CELL PHYSIOL, V146, P442, DOI 10.1002/jcp.1041460315
   OSTERMANN PAW, 1995, J BONE JOINT SURG BR, V77B, P93
   PATZAKIS MJ, 1989, CLIN ORTHOP RELAT R, P36
   Pelissier P, 2002, BRIT J PLAST SURG, V55, P596, DOI 10.1054/bjps.2002.3936
   PELISSIER P.H, 2006, J ORTHOP RES, V22, P73
   Precheur Harry V, 2007, Dent Clin North Am, V51, P729
   Retzepi M, 2010, CLIN ORAL IMPLAN RES, V21, P567, DOI 10.1111/j.1600-0501.2010.01922.x
   Santos MI, 2010, MACROMOL BIOSCI, V10, P12, DOI 10.1002/mabi.200900107
   Schenk R. K., 1994, HISTOLOGIC ULTRASTRU, P117
   SCHMID J, 1994, CLIN ORAL IMPLAN RES, V5, P125, DOI 10.1034/j.1600-0501.1994.050302.x
   Stevenson S, 1996, CLIN ORTHOP RELAT R, P66
   Suneelkumar C., 2008, J CONVERVATIVE DENT, V11, P1
   Toba T., 2004, JPN MED ASS J, V47, P282
   Uzel AP, 2010, ORTHOP TRAUMATOL-SUR, V96, P194, DOI [10.1016/j.rcot.2010.02.001, 10.1016/j.otsr.2009.10.017]
   Viateau V, 2006, VET SURG, V35, P445, DOI 10.1111/j.1532-950X.2006.00173.x
   WEILAND AJ, 1984, PLAST RECONSTR SURG, V74, P368, DOI 10.1097/00006534-198409000-00006
   Wiese A, 2010, ORTHOP CLIN N AM, V41, P1, DOI 10.1016/j.ocl.2009.07.003
   Wong TM, 2014, SCI WORLD J, V2014
   Woon CYL, 2010, J BONE JOINT SURG AM, V92A, P196, DOI [10.2106/JBJS.1.00273, 10.2106/JBJS.I.00273]
   Zadegan SA, 2015, FRONT SURG, V2, DOI 10.3389/fsurg.2015.00012
   Zalavras CG, 2004, CLIN ORTHOP RELAT R, P86, DOI 10.1097/01.blo.0000143571.18892.8d
   Zalavras CG, 2003, J AM ACAD ORTHOP SUR, V11, P212
   Zhou J., 2012, OSTEOGENESIS
NR 90
TC 6
Z9 6
U1 4
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD MAR 23
PY 2016
VL 5
IS 6
BP 630
EP 640
DI 10.1002/adhm.201500793
PG 11
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA DH9LA
UT WOS:000373116400001
PM 26855349
DA 2018-10-19
ER

PT J
AU Amoako, KA
   Sundaram, HS
   Suhaib, A
   Jiang, SY
   Cook, KE
AF Amoako, Kagya A.
   Sundaram, Harihara S.
   Suhaib, Ahmed
   Jiang, Shaoyi
   Cook, Keith E.
TI Multimodal, Biomaterial-Focused Anticoagulation via Superlow Fouling
   Zwitterionic Functional Groups Coupled with Anti-Platelet Nitric Oxide
   Release
SO ADVANCED MATERIALS INTERFACES
LA English
DT Article
DE anti-fouling coatings; blood-contacting surfaces; nitric oxide; platelet
   adsorption; zwitterionic polycarboxybetaine
ID SURFACE-CHEMISTRY; EXTRACORPOREAL-CIRCULATION; PROTEIN ADSORPTION;
   POLYMER; PLATELET; SILICONE; ADHESION; MODEL; ACCUMULATION; RESISTANCE
AB The functions of anti-fouling, zwitterionic polycarboxybetaine (pCB) coating, and anti-platelet nitric oxide (NO) release replicate key anticoagulant properties of the endothelium. The two approaches, only tested separately thus far, are paired on gas permeable polydimethylsiloxane (PDMS) membranes and evaluated for fibrinogen (Fg) and platelet adsorption. Uncoated (control) and pCB-coated PDMS separate sheep plasma (10(8) platelets per milliliter) and gas flow chambers within bioreactors used in this study, and either 100 or 0 ppm of NO/N-2 flows through the gas chamber so PDMS transfers NO into flowing plasma. Surface-adsorbed platelets are quantified using a lactate dehydrogenase assay after 8h plasma recirculation. Fg and platelet adsorption on pCB-coated PDMS are 10.40% +/- 3.0% of control (p < 0.01) and 23.3% +/- 7.4% (p < 0.01) of control, respectively. NO flux alone limits platelet adsorption to 79.0% +/- 5.0% (p < 0.05) of control. Together, NO and pCB reduce platelet adsorption to 6.90% +/- 1.30% of control (p < 0.001). The data suggest that pCB coating and NO act in concert to reduce platelet fouling at significantly higher levels than either pCB coating or NO release alone.
C1 [Amoako, Kagya A.] Univ New Haven, Tagliatela Coll Engn Biomed Engn, West Haven, CT 06516 USA.
   [Sundaram, Harihara S.; Jiang, Shaoyi] Dept Chem Engn, Seattle, WA USA.
   [Suhaib, Ahmed] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Cook, Keith E.] Carnegie Mellon Univ, Dept Biomed Engn, 700 Technol Dr, Pittsburgh, PA 15219 USA.
RP Amoako, KA (reprint author), Univ New Haven, Tagliatela Coll Engn Biomed Engn, West Haven, CT 06516 USA.; Cook, KE (reprint author), Carnegie Mellon Univ, Dept Biomed Engn, 700 Technol Dr, Pittsburgh, PA 15219 USA.
EM Kamoako@newhaven.edu; keicook@andrew.cmu.edu
FU NIH [R01 HL089043, NIH 5T32HL007853-15]
FX This work was supported by NIH grants R01 HL089043 and NIH
   5T32HL007853-15. The authors thank Jiang lab at the University of
   Washington, Chemical Engineering Department, for assisting with surface
   coatings. The authors also thank Dr. Robert Bartlett's Extracorporeal
   Life Support Laboratory at the University of Michigan for their
   assistance.
CR Amoako K. A., 2011, THESIS U MICHIGAN
   Amoako KA, 2013, J BIOMED MATER RES A, V101, P3511, DOI 10.1002/jbm.a.34655
   Amoako KA, 2012, ASAIO J, V58, P238, DOI 10.1097/MAT.0b013e31824abed5
   Amoako KA, 2011, ASAIO J, V57, P539, DOI 10.1097/MAT.0b013e31823b9692
   Anderson TH, 2010, ADV FUNCT MATER, V20, P4196, DOI 10.1002/adfm.201000932
   Campbell E J, 1994, ASAIO J, V40, pM853, DOI 10.1097/00002480-199407000-00118
   Chen SF, 2008, ADV MATER, V20, P335, DOI 10.1002/adma.200701164
   Cheng G, 2009, BIOMATERIALS, V30, P5234, DOI 10.1016/j.biomaterials.2009.05.058
   Davidson D, 1998, PEDIATRICS, V101, P325, DOI 10.1542/peds.101.3.325
   Demirkilic U, 2004, J BIOACT COMPAT POL, V19, P395, DOI 10.1177/0883911504046690
   Gao CL, 2010, BIOMATERIALS, V31, P1486, DOI 10.1016/j.biomaterials.2009.11.025
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Gupta S, 2014, ADV MATER INTERFACES, V1, DOI 10.1002/admi.201400012
   Howlett R, 1998, NATURE, V395, P625, DOI 10.1038/27019
   Jiang SY, 2010, ADV MATER, V22, P920, DOI 10.1002/adma.200901407
   Kang SM, 2012, ADV FUNCT MATER, V22, P2949, DOI 10.1002/adfm.201200177
   Kang SM, 2010, ANGEW CHEM INT EDIT, V49, P9401, DOI 10.1002/anie.201004693
   Ladd J, 2008, BIOMACROMOLECULES, V9, P1357, DOI 10.1021/bm701301s
   Lantvit SM, 2013, J BIOMED MATER RES A, V101, P3201, DOI 10.1002/jbm.a.34627
   Larson DF, 2000, PERFUSION-UK, V15, P13, DOI 10.1177/026765910001500103
   Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103
   Major TC, 2011, BIOMATERIALS, V32, P5957, DOI 10.1016/j.biomaterials.2011.03.036
   Major TC, 2010, BIOMATERIALS, V31, P2736, DOI 10.1016/j.biomaterials.2009.12.028
   Nakagawa TA, 1997, J PEDIATR-US, V131, P63, DOI 10.1016/S0022-3476(97)70125-2
   Palanzo DA, 2001, PERFUSION-UK, V16, P279, DOI 10.1177/026765910101600403
   PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0
   RAPOPORT RM, 1983, NATURE, V306, P174, DOI 10.1038/306174a0
   Roman A, 2004, J PEDIATR SURG, V39, P48, DOI 10.1053/S0022-3468(03)00676-6
   Sundaram HS, 2014, ADV MATER INTERFACES, V1, DOI 10.1002/admi.201400071
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Vaisocherova H, 2008, ANAL CHEM, V80, P7894, DOI 10.1021/ac8015888
   Waite JH, 2008, NAT MATER, V7, P8, DOI 10.1038/nmat2087
   Whelan DM, 2000, HEART, V83, P338, DOI 10.1136/heart.83.3.338
   Yang W, 2012, BIOMATERIALS, V33, P7945, DOI 10.1016/j.biomaterials.2012.07.035
   Yang W, 2011, BIOSENS BIOELECTRON, V26, P2454, DOI 10.1016/j.bios.2010.10.031
   Yoshinari N., 1999, ANESTH ANALG, V89, P573
   Zhang HP, 2002, BIOMATERIALS, V23, P1485, DOI 10.1016/S0142-9612(01)00274-5
   Zhang Z, 2008, BIOMACROMOLECULES, V9, P2686, DOI 10.1021/bm800407r
   Zhao H, 2006, J BIOL CHEM, V281, P26150, DOI 10.1074/jbc.M604357200
   Zhu YH, 2014, BIOMACROMOLECULES, V15, P1845, DOI 10.1021/bm500209a
NR 42
TC 8
Z9 8
U1 7
U2 60
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2196-7350
J9 ADV MATER INTERFACES
JI Adv. Mater. Interfaces
PD MAR 23
PY 2016
VL 3
IS 6
AR 1500646
DI 10.1002/admi.201500646
PG 9
WC Chemistry, Multidisciplinary; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA DH9XN
UT WOS:000373149400008
DA 2018-10-19
ER

PT J
AU Asadi-Eydivand, M
   Solati-Hashjin, M
   Shafiei, SS
   Mohammadi, S
   Hafezi, M
   Abu Osman, NA
AF Asadi-Eydivand, Mitra
   Solati-Hashjin, Mehran
   Shafiei, Seyedeh Sara
   Mohammadi, Sepideh
   Hafezi, Masoud
   Abu Osman, Noor Azuan
TI Structure, Properties, and In Vitro Behavior of Heat-Treated Calcium
   Sulfate Scaffolds Fabricated by 3D Printing
SO PLOS ONE
LA English
DT Article
ID 3-DIMENSIONAL SCAFFOLDS; ENGINEERING SCAFFOLDS; REGENERATIVE MEDICINE;
   MECHANICAL-PROPERTIES; BONE SCAFFOLDS; FILL DEFECTS; TISSUE; DESIGN;
   PHOSPHATE; BIOMATERIALS
AB The ability of inkjet-based 3D printing (3DP) to fabricate biocompatible ceramics has made it one of the most favorable techniques to generate bone tissue engineering (BTE) scaffolds. Calcium sulfates exhibit various beneficial characteristics, and they can be used as a promising biomaterial in BTE. However, low mechanical performance caused by the brittle character of ceramic materials is the main weakness of 3DP calcium sulfate scaffolds. Moreover, the presence of certain organic matters in the starting powder and binder solution causes products to have high toxicity levels. A post-processing treatment is usually employed to improve the physical, chemical, and biological behaviors of the printed scaffolds. In this study, the effects of heat treatment on the structural, mechanical, and physical characteristics of 3DP calcium sulfate prototypes were investigated. Different microscopy and spectroscopy methods were employed to characterize the printed prototypes. The in vitro cytotoxicity of the specimens was also evaluated before and after heat treatment. Results showed that the as-printed scaffolds and specimens heat treated at 300 degrees C exhibited severe toxicity in vitro but had almost adequate strength. By contrast, the specimens heat treated in the 500 degrees C-1000 degrees C temperature range, although non-toxic, had insufficient mechanical strength, which was mainly attributed to the exit of the organic binder before 500 degrees C and the absence of sufficient densification below 1000 degrees C. The sintering process was accelerated at temperatures higher than 1000 degrees C, resulting in higher compressive strength and less cytotoxicity. An anhydrous form of calcium sulfate was the only crystalline phase existing in the samples heated at 500 degrees C-1150 degrees C. The formation of calcium oxide caused by partial decomposition of calcium sulfate was observed in the specimens heat treated at temperatures higher than 1200 degrees C. Although considerable improvements in cell viability of heat-treated scaffolds were observed in this study, the mechanical properties were not significantly improved, requiring further investigations. However, the findings of this study give a better insight into the complex nature of the problem in the fabrication of synthetic bone grafts and scaffolds via post-fabrication treatment of 3DP calcium sulfate prototypes.
C1 [Asadi-Eydivand, Mitra; Hafezi, Masoud; Abu Osman, Noor Azuan] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.
   [Solati-Hashjin, Mehran; Mohammadi, Sepideh] Amirkabir Univ Technol, Biomed Engn Fac, Tehran 15914, Iran.
   [Solati-Hashjin, Mehran] Amirkabir Univ Technol, Biomat Ctr Excellence, Tehran 15914, Iran.
   [Shafiei, Seyedeh Sara] Natl Inst Genet Engn & Biotechnol, Stem Cell & Regenerat Med Grp, Tehran 14965161, Iran.
RP Abu Osman, NA (reprint author), Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.; Solati-Hashjin, M (reprint author), Amirkabir Univ Technol, Biomed Engn Fac, Tehran 15914, Iran.; Solati-Hashjin, M (reprint author), Amirkabir Univ Technol, Biomat Ctr Excellence, Tehran 15914, Iran.
EM solati@aut.ac.ir; azuan@um.edu.my
RI engineering, @UM-2016/I-9329-2016; Hafezi Ardakani, Masoud/K-3589-2013;
   Engineering, Faculty/I-7935-2015
OI Hafezi Ardakani, Masoud/0000-0002-7199-3180; Engineering,
   Faculty/0000-0002-4848-7052; Shafiei, Seyedeh Sara/0000-0002-4517-5969
FU University of Malaya [UM.C/HIR/MOHE/ENG/14 D000014-16001]
FX This study was supported by High Impact Research Grant
   UM.C/HIR/MOHE/ENG/14 D000014-16001 from the University of Malaya.
CR Aghajani F, 2004, DENT MATER J, V23, P373, DOI 10.4012/dmj.23.373
   Amini A. R., 2012, CRITICAL REV BIOMEDI, V40
   Asadi-Eydivand M, 2016, ROBOT CIM-INT MANUF, V37, P57, DOI 10.1016/j.rcim.2015.06.005
   Athanasiou KA, 2000, TISSUE ENG, V6, P361, DOI 10.1089/107632700418083
   Bateman J, 2005, J PERIODONTOL, V76, P1833, DOI 10.1902/jop.2005.76.11.1833
   Bergmann C, 2010, J EUR CERAM SOC, V30, P2563, DOI 10.1016/j.jeurceramsoc.2010.04.037
   Blom A, 2007, CURR ORTHOPAED, V21, P280, DOI 10.1016/j.cuor.2007.06.005
   Bohner M, 2011, ACTA BIOMATER, V7, P478, DOI 10.1016/j.actbio.2010.08.008
   Bose S, 2013, MATER TODAY, V16, P496, DOI 10.1016/j.mattod.2013.11.017
   Brand RA, 2012, CLIN ORTHOP RELAT R, V470, P3628, DOI 10.1007/s11999-012-2571-5
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Butscher A, 2011, ACTA BIOMATER, V7, P907, DOI 10.1016/j.actbio.2010.09.039
   Chen AA, 2007, BIOMEMS BIOMEDICAL N, P23
   Chia HN, 2015, J BIOL ENG, V9, DOI 10.1186/s13036-015-0001-4
   Doty HA, 2014, J MATER SCI-MATER M, V25, P1449, DOI 10.1007/s10856-014-5167-7
   Farzadi A, 2014, EFFECT LAYER THICKNE, DOI [10.1371/journal.pone.0108252, DOI 10.1371/JOURNAL.PONE.0108252]
   Farzadi A, 2015, CERAM INT, V41, P8320, DOI 10.1016/j.ceramint.2015.03.004
   Fereshteh Z, 2015, MAT SCI ENG C-MATER, V54, P50, DOI 10.1016/j.msec.2015.05.011
   Frascati J., 2007, THESIS U CENTRAL FLO
   Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042
   Gbureck U, 2007, ADV FUNCT MATER, V17, P3940, DOI 10.1002/adfm.200700019
   Gentile P, 2014, INT J MOL SCI, V15, P3640, DOI 10.3390/ijms15033640
   Guo BL, 2015, REGEN BIOMATER, V2, P47, DOI 10.1093/rb/rbu016
   Hollinger J. O., 2011, INTRO BIOMATERIALS
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Impens D., 2015, THESIS U WINDSOR
   Insights P., BONE REGENERATION CA
   Kameda T, 1998, BIOCHEM BIOPH RES CO, V245, P419, DOI 10.1006/bbrc.1998.8448
   Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2
   Kassim B, 2014, AUST DENT J, V59, P48, DOI 10.1111/adj.12098
   Khalyfa A, 2007, J MATER SCI-MATER M, V18, P909, DOI 10.1007/s10856-006-0073-2
   Lam CXF, 2002, MAT SCI ENG C-BIO S, V20, P49, DOI 10.1016/S0928-4931(02)00012-7
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Lichte P, 2011, INJURY, V42, P569, DOI 10.1016/j.injury.2011.03.033
   Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020
   Liu C, 2007, CHEM ENG RES DES, V85, P1051, DOI [10.1205/cherd06196, 10.1205/cherd061915]
   Mazzoli A, 2015, RAPID PROTOTYPING J, V21, P386, DOI 10.1108/RPJ-04-2013-0040
   Munch E, 2008, JOM-US, V60, P54, DOI 10.1007/s11837-008-0072-5
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nyan M, 2007, J PHARMACOL SCI, V104, P384, DOI 10.1254/jphs.SC0070184
   Park YB, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/5/055007
   Pattanayak DK, 2007, MAT SCI ENG C-BIO S, V27, P684, DOI 10.1016/j.msec.2006.06.021
   PELTIER LF, 1957, ANN SURG, V146, P61, DOI 10.1097/00000658-195707000-00007
   Pina S, 2015, ADV MATER, V27, P1143, DOI 10.1002/adma.201403354
   Polo-Corrales L, 2014, J NANOSCI NANOTECHNO, V14, P15, DOI 10.1166/jnn.2014.9127
   Rajzer I, 2014, MAT SCI ENG C-MATER, V44, P183, DOI 10.1016/j.msec.2014.08.017
   Rauschmann MA, 2005, BIOMATERIALS, V26, P2677, DOI 10.1016/j.biomaterials.2004.06.045
   Rauschmann M, 2010, EUR SPINE J, V19, P887, DOI 10.1007/s00586-010-1279-z
   Razak SIA, 2012, INT J BASIC APPL SCI, V12, P31
   Sadeghpour S, 2014, CERAM INT, V40, P16107, DOI 10.1016/j.ceramint.2014.07.039
   Sadiasa A, 2014, J BIOMAT SCI-POLYM E, V25, P150, DOI 10.1080/09205063.2013.846633
   Shen Y, 2014, ACS APPL MATER INTER, V6, P12177, DOI 10.1021/am501448t
   Sottosanti J, 1992, Compendium, V13, P226
   Suwanprateeb J, 2010, J MATER SCI-MATER M, V21, P419, DOI 10.1007/s10856-009-3883-1
   Swift W. M., 1976, DECOMPOSITION CALCIU
   Technology NIoSa, 2011, 2 PYRR INFR SPECTR
   Technology NIoSa, 2011, WAT INFR SPECTR
   Thomas MV, 2009, J BIOMED MATER RES B, V88B, P597, DOI 10.1002/jbm.b.31269
   Thomas MV, 2005, J LONG TERM EFFECTS, V15
   Trdnost VPDNN, 2013, MATER TEHNOL, V47, P781
   Utela B, 2008, J MANUFACTURING PROC, V10, P96, DOI DOI 10.1016/J.JMAPRO.2009.03.002
   Vorndran E, 2011, ADV APPL CERAM, V110, P476, DOI 10.1179/1743676111Y.0000000030
   Vorndran E, 2015, MRS BULL, V40, P127, DOI 10.1557/mrs.2015.326
   Wu SL, 2014, MAT SCI ENG R, V80, P1, DOI 10.1016/j.mser.2014.04.001
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   Zhou Z, 2012, ISRN BIOMATERIALS, P2013
   Zhou ZX, 2014, MAT SCI ENG C-MATER, V38, P1, DOI 10.1016/j.msec.2014.01.027
NR 68
TC 10
Z9 10
U1 5
U2 69
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 21
PY 2016
VL 11
IS 3
AR e0151216
DI 10.1371/journal.pone.0151216
PG 29
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DH3NW
UT WOS:000372694700027
PM 26999789
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Cui, Y
   Han, J
   Xiao, ZF
   Chen, T
   Wang, B
   Chen, B
   Liu, SM
   Han, SF
   Fang, YX
   Wei, JS
   Wang, XJ
   Ma, X
   Dai, JW
AF Cui, Yi
   Han, Jin
   Xiao, Zhifeng
   Chen, Tong
   Wang, Bin
   Chen, Bing
   Liu, Sumei
   Han, Sufang
   Fang, Yongxiang
   Wei, Jianshu
   Wang, Xiujie
   Ma, Xu
   Dai, Jianwu
TI The miR-20-Rest-Wnt signaling axis regulates neural progenitor cell
   differentiation
SO SCIENTIFIC REPORTS
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; STEM-CELL; NEURONAL DIFFERENTIATION;
   SELF-RENEWAL; MICRORNAS; SCAFFOLDS; PATHWAY; FATE; REST; PROLIFERATION
AB Increasing evidence suggests that three dimensional (3-D) cell cultures are an improvement over traditional two dimensional (2-D) cell cultures. Current researches have extensively focused on the study of utilizing biomaterial-based 3-D culture systems to study and direct stem-cell fate both in vitro and in vivo. Here in our study, we screened the differential expression patterns of miRNAs between 2-D cultured and 3-D cultured NPCs using microarray analysis. Among these differentially expressed miRNAs, miR-20 was found to increase during differentiation of NPCs. Specifically, the facilitative effect on neural differentiation of miR-20 is mediated, at least in part by directly target the Rest gene, which is essential for preventing neural differentiation and maintaining NPCs self-renewal. Furthermore, the expression of miR-20 was decreased when the WNT pathway was inhibited by knock down of beta-catenin or by exogenous Dkk protein, whereas it increased when the WNT pathway was activated by exogenous Wnt3a protein. Overall, miR-20, Rest and Wnt signaling are suggested to be involved in a regulatory circuit that can modulate the neural differention of NPCs. This novel regulatory circuit provides additional insight into how microRNAs interact with signaling molecules during neural differentiation of NPCs, allowing for fine-tuning of intricate cellular processes.
C1 [Cui, Yi; Ma, Xu] Natl Res Inst Family Planning, Reprod & Genet Ctr, Beijing 100081, Peoples R China.
   [Cui, Yi; Han, Jin; Xiao, Zhifeng; Wang, Bin; Chen, Bing; Liu, Sumei; Han, Sufang; Wei, Jianshu; Dai, Jianwu] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100190, Peoples R China.
   [Chen, Tong] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Chen, Tong; Wang, Xiujie] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China.
   [Fang, Yongxiang] CAAS, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Key Lab Vet Publ Hlth,Minist Agr, Lanzhou 730046, Peoples R China.
RP Ma, X (reprint author), Natl Res Inst Family Planning, Reprod & Genet Ctr, Beijing 100081, Peoples R China.; Dai, JW (reprint author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100190, Peoples R China.
EM genetic88@126.com; jwdai@genentics.ac.cn
FU Ministry of Science and Technology of China [2011CB965001]; National
   Science Foundation of China [30930032, 31200813]
FX This work was supported by the Ministry of Science and Technology of
   China (2011CB965001) and the National Science Foundation of China
   (30930032 and 31200813).
CR Akerblom M, 2014, NEUROSCIENTIST, V20, P235, DOI 10.1177/1073858413497265
   Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185
   Buxboim A, 2010, NAT METHODS, V7, P695, DOI 10.1038/nmeth0910-695
   Chen B, 2007, BIOMATERIALS, V28, P1027, DOI 10.1016/j.biomaterials.2006.10.013
   Cui Y, 2014, STEM CELLS DEV, V23, P393, DOI 10.1089/scd.2013.0342
   Cui Y, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-116
   Davis BN, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-18
   Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621
   Han J, 2008, MOL CELL NEUROSCI, V39, P118, DOI 10.1016/j.mcn.2008.06.003
   Han J, 2013, BIOMATERIALS, V34, P1921, DOI 10.1016/j.biomaterials.2012.11.063
   Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165
   Hubner R, 2010, BIOCHEM BIOPH RES CO, V400, P358, DOI 10.1016/j.bbrc.2010.08.066
   Jo J, 2011, BRIEF FUNCT GENOMICS, V10, P175, DOI 10.1093/bfgp/elr012
   Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3
   Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256
   Justice BA, 2009, DRUG DISCOV TODAY, V14, P102, DOI 10.1016/j.drudis.2008.11.006
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Lang MF, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00071
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Loh QL, 2013, TISSUE ENG PART B-RE, V19, P485, DOI [10.1089/ten.TEB.2012.0437, 10.1089/ten.teb.2012.0437]
   Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Mayer RP, 2005, J COLLOID INTERF SCI, V285, P781, DOI 10.1016/j.jcis.2004.11.067
   Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104
   Moyse E, 2008, CURR STEM CELL RES T, V3, P163, DOI 10.2174/157488808785740334
   Muroyama Y, 2004, BIOCHEM BIOPH RES CO, V313, P915, DOI 10.1016/j.bbrc.2003.12.023
   Nishihara S, 2003, BIOCHEM BIOPH RES CO, V311, P55, DOI 10.1016/j.bbrc.2003.09.158
   Pham JT, 2012, AM J STEM CELLS, V1, P182
   Qureshi IA, 2010, CELL CYCLE, V9, P4477, DOI 10.4161/cc.9.22.13973
   Shi YH, 2008, CRIT REV ONCOL HEMAT, V65, P43, DOI 10.1016/j.critrevonc.2007.06.004
   Su XH, 2004, MOL CELL BIOL, V24, P8018, DOI 10.1128/MCB.24.18.8018-8025.2004
   Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200
   Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174
   Threlfall RN, 2012, ORG BIOMOL CHEM, V10, P746, DOI 10.1039/c1ob06614e
   Votteler M, 2010, MACROMOL BIOSCI, V10, P1302, DOI 10.1002/mabi.201000102
   Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8
NR 38
TC 15
Z9 16
U1 2
U2 12
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 21
PY 2016
VL 6
AR 23300
DI 10.1038/srep23300
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DH0AK
UT WOS:000372444700001
PM 26996236
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Oh, DX
   Cha, YJ
   Nguyen, HL
   Je, HH
   Jho, YS
   Hwang, DS
   Yoon, DK
AF Oh, Dongyeop X.
   Cha, Yun Jeong
   Hoang-Linh Nguyen
   Je, Hwa Heon
   Jho, Yong Seok
   Hwang, Dong Soo
   Yoon, Dong Ki
TI Chiral nematic self-assembly of minimally surface damaged chitin
   nanofibrils and its load bearing functions
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MESOPOROUS SILICA; COMPOSITES; FILMS; CHITOSAN; COMPLEX; CUTICLE
AB Chitin is one of the most abundant biomaterials in nature, with 1010 tons produced annually as hierarchically organized nanofibril fillers to reinforce the exoskeletons of arthropods. This green and cheap biomaterial has attracted great attention due to its potential application to reinforce biomedical materials. Despite that, its practical use is limited since the extraction of chitin nanofibrils requires surface modification involving harsh chemical treatments, leading to difficulties in reproducing their natural prototypal hierarchical structure, i.e. chiral nematic phase. Here, we develop a chemical etching-free approach using calcium ions, called "natural way", to disintegrate the chitin nanofibrils while keeping the essential moiety for the self-assembly, ultimately resulting in the reproduction of chitin's natural chiral structure in a polymeric matrix. This chiral chitin nanostructure exceptionally toughens the composite. Our resultant chiral nematic phase of chitin materials can contribute to the understanding and use of the reinforcing strategy in nature.
C1 [Oh, Dongyeop X.] Korea Res Inst Chem Technol, Res Ctr Ind Chem Biotechnol, Ulsan 44429, South Korea.
   [Cha, Yun Jeong; Yoon, Dong Ki] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Taejon 305701, South Korea.
   [Cha, Yun Jeong; Yoon, Dong Ki] Korea Adv Inst Sci & Technol, KINC, Taejon 305701, South Korea.
   [Hoang-Linh Nguyen; Je, Hwa Heon; Hwang, Dong Soo] Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea.
   [Jho, Yong Seok] Pohang Univ Sci & Technol, Dept Phys, Pohang 790784, South Korea.
   [Jho, Yong Seok] Asia Pacific Ctr Theoret Phys, Pohang 790784, South Korea.
   [Hwang, Dong Soo] Pohang Univ Sci & Technol POSTECH, Sch Environm Sci & Engn, Pohang 790784, South Korea.
RP Yoon, DK (reprint author), Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Taejon 305701, South Korea.; Yoon, DK (reprint author), Korea Adv Inst Sci & Technol, KINC, Taejon 305701, South Korea.; Hwang, DS (reprint author), Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, Pohang 790784, South Korea.; Hwang, DS (reprint author), Pohang Univ Sci & Technol POSTECH, Sch Environm Sci & Engn, Pohang 790784, South Korea.
EM dshwang@postech.ac.kr; nandk@kaist.ac.kr
RI Yoon, Dong Ki/C-9670-2011
OI Yoon, Dong Ki/0000-0002-9383-8958; Oh, Dongyeop/0000-0003-3665-405X;
   Hwang, Dong Soo/0000-0002-2487-2255
FU National Research Foundation (NRF) - Korean Government (MSIP)
   [2014R1A2A2A01006724, C1ABA001-2011-0029960, 2015R1A1A1A05000986,
   2012M3A7B4049802]; Marine Biomaterials Research Centre - Ministry of
   Oceans and Fisheries, Korea [D11013214H480000110]
FX This work was supported by the grant from the National Research
   Foundation (NRF), funded by the Korean Government (MSIP)
   (2014R1A2A2A01006724, C1ABA001-2011-0029960, 2015R1A1A1A05000986 and
   2012M3A7B4049802). This work was also supported by the Marine
   Biomaterials Research Centre grant (D11013214H480000110) funded by the
   Ministry of Oceans and Fisheries, Korea.
CR Andersons J, 2004, COMPOS SCI TECHNOL, V64, P2139, DOI 10.1016/j.compscitech.2004.03.007
   Bar-On B., 2014, NAT COMMUN, V5, P1
   Capadona JR, 2008, SCIENCE, V319, P1370, DOI 10.1126/science.1153307
   COOK WJ, 1973, J AM CHEM SOC, V95, P6442, DOI 10.1021/ja00800a048
   Das P, 2012, BIOMACROMOLECULES, V13, P4205, DOI 10.1021/bm3014796
   Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937
   Erb RM, 2012, SCIENCE, V335, P199, DOI 10.1126/science.1210822
   Fernandez JG, 2013, ADV FUNCT MATER, V23, P4454, DOI 10.1002/adfm.201300053
   Gordon LM, 2011, NATURE, V469, P194, DOI 10.1038/nature09686
   Grunenfelder LK, 2014, ACTA BIOMATER, V10, P3997, DOI 10.1016/j.actbio.2014.03.022
   Gyliene O, 2002, WATER RES, V36, P4128, DOI 10.1016/S0043-1354(02)00105-7
   HOICZYK E, 1995, J BACTERIOL, V177, P2387, DOI 10.1128/jb.177.9.2387-2395.1995
   Ifuku S, 2010, CARBOHYD POLYM, V81, P134, DOI 10.1016/j.carbpol.2010.02.006
   Kato Y, 2004, CARBOHYD POLYM, V58, P421, DOI 10.1016/j.carbpol.2004.08.011
   Liu Q, 2014, ADV MATER, V26, P7178, DOI 10.1002/adma.201402699
   Majtan J, 2007, INT J BIOL MACROMOL, V40, P237, DOI 10.1016/j.ijbiomac.2006.07.010
   Miserez A, 2008, SCIENCE, V319, P1816, DOI 10.1126/science.1154117
   Nikolov S, 2010, ADV MATER, V22, P519, DOI 10.1002/adma.200902019
   Nishino T, 1999, J POLYM SCI POL PHYS, V37, P1191, DOI 10.1002/(SICI)1099-0488(19990601)37:11<1191::AID-POLB13>3.0.CO;2-H
   Park JH, 2014, CHEMPHYSCHEM, V15, P1477, DOI 10.1002/cphc.201400062
   Shopsowitz KE, 2010, NATURE, V468, P422, DOI 10.1038/nature09540
   Tamura H, 2006, CELLULOSE, V13, P357, DOI 10.1007/s10570-006-9058-z
   Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906
   TANIEWSKAOSINSKA S, 1984, J CHEM SOC FARAD T 1, V80, P1409, DOI 10.1039/f19848001409
   Nguyen TD, 2014, ADV OPT MATER, V2, P1031, DOI 10.1002/adom.201400279
   Nguyen TD, 2013, CHEM-EUR J, V19, P15148, DOI 10.1002/chem.201301929
   Vincent JFV, 2002, COMPOS PART A-APPL S, V33, P1311, DOI 10.1016/S1359-835X(02)00167-7
   Weaver JC, 2012, SCIENCE, V336, P1275, DOI 10.1126/science.1218764
   Zeng J. B., 2011, BIOMACROMOLECULES, V13, P1
   Zimmermann EA, 2013, NAT COMMUN, V4, P1
NR 30
TC 6
Z9 6
U1 2
U2 30
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 18
PY 2016
VL 6
AR 23245
DI 10.1038/srep23245
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DH0IR
UT WOS:000372468200003
PM 26988392
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Mozdzen, LC
   Rodgers, R
   Banks, JM
   Bailey, RC
   Harley, BAC
AF Mozdzen, Laura C.
   Rodgers, Ryan
   Banks, Jessica M.
   Bailey, Ryan C.
   Harley, Brendan A. C.
TI Increasing the strength and bioactivity of collagen scaffolds using
   customizable arrays of 3D-printed polymer fibers
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Composite CG scaffolds; Tunable mechanics; Tendon tissue engineering;
   Three-dimensional printing
ID GROWTH-FACTOR SUPPLEMENTATION; TENDON MECHANICAL-PROPERTIES; BOVINE
   TRABECULAR BONE; GAG SCAFFOLDS; GLYCOSAMINOGLYCAN SCAFFOLDS; TENOCYTE
   BIOACTIVITY; COMPOSITE SCAFFOLDS; PLANT STEMS; REGENERATION; MATRIX
AB Tendon is a highly aligned connective tissue which transmits force from muscle to bone. Each year, people in the US sustain more than 32 million tendon injuries. To mitigate poor functional outcomes due to scar formation, current surgical techniques rely heavily on autografts. Biomaterial platforms and tissue engineering methods offer an alternative approach to address these injuries. Scaffolds incorporating aligned structural features can promote expansion of adult tenocytes and mesenchymal stem cells capable of tenogenic differentiation. However, appropriate balance between scaffold bioactivity and mechanical strength of these constructs remains challenging. The high porosity required to facilitate cell infiltration, nutrient and oxygen biotransport within three-dimensional constructs typically results in insufficient biomechanical strength. Here we describe the use of three-dimensional printing techniques to create customizable arrays of acrylonitrile butadiene styrene (ABS) fibers that can be incorporated into a collagen scaffold under development for tendon repair. Notably, mechanical performance of scaffold fiber composites (elastic modulus, peak stress, strain at peak stress, and toughness) can be selectively manipulated by varying fiber-reinforcement geometry without affecting the native bioactivity of the collagen scaffold. Further, we report an approach to functionalize ABS fibers with activity-inducing growth factors via sequential oxygen plasma and carbodiimide crosslinking treatments. Together, we report an adaptable approach to control both mechanical strength and presence of biomolecular cues in a manner orthogonal to the architecture of the collagen scaffold itself.
   Statement of Significance
   Tendon injuries account for more than 32 million injuries each year in the US alone. Current techniques use allografts to mitigate poor functional outcomes, but are not ideal platforms to induce functional regeneration following injury. Tissue engineering approaches using biomaterial substrates have significant potential for addressing these defects. However, the high porosity required to facilitate cell infiltration and nutrient transport often dictates that the resultant biomaterials has insufficient biomechanical strength. Here we describe the use of three-dimensional printing techniques to generate customizable fiber arrays from ABS polymer that can be incorporated into a collagen scaffold under development for tendon repair applications. Notably, the mechanical performance of the fiber-scaffold composite can be defined by the fiber array independent of the bioactivity of the collagen scaffold design. Further, the fiber array provides a substrate for growth factor delivery to aid healing. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Mozdzen, Laura C.; Rodgers, Ryan; Harley, Brendan A. C.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.
   [Banks, Jessica M.; Bailey, Ryan C.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA.
   [Harley, Brendan A. C.] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA.
RP Harley, BAC (reprint author), Univ Illinois, Carl R Woese Inst Genom Biol, Dept Chem & Biomol Engn, 110 Roger Adams Lab,600 S Mathews Ave, Urbana, IL 61801 USA.
EM bharley@illinois.edu
OI Bailey, Ryan/0000-0003-1021-4267; Harley, Brendan/0000-0001-5458-154X
FU National Institute of Arthritis and Musculoskeletal and Skin Diseases of
   the National Institutes of Health [R21 AR063331]; National Science
   Foundation [0965918]; Support for Under-Represented Groups in
   Engineering (SURGE) Fellowship; DuPont Science and Engineering
   Fellowship; U.S. Department of Energy [DE-FG02-07ER46453,
   DE-FG02-07ER46471]
FX The authors would like to acknowledge Dr. Hyun Joon Kong (UIUC) for
   access to mechanical testing facilities, Dr. Sandra McMasters (SCS,
   UIUC) for preparation of culture media, Dr. Matthew Wheeler for
   providing pASCs, and Richard Graybill for assistance with oxygen plasma
   treatment. Research reported in this publication was supported by the
   National Institute of Arthritis and Musculoskeletal and Skin Diseases of
   the National Institutes of Health under Award Numbers R21 AR063331. LCM
   was partially funded via National Science Foundation Grant 0965918
   IGERT: Training the Next Generation of Researchers in Cellular &
   Molecular Mechanics and BioNanotechnology, as well as the Support for
   Under-Represented Groups in Engineering (SURGE) Fellowship and the
   DuPont Science and Engineering Fellowship. This research was carried out
   in part in the Frederick Seitz Materials Research Laboratory Central
   Facilities, University of Illinois, which are partially supported by the
   U.S. Department of Energy under Grants DE-FG02-07ER46453 and
   DE-FG02-07ER46471.
CR ABRAHAMS M, 1967, MED BIOL ENG, V5, P433, DOI 10.1007/BF02479137
   Alsop AT, 2014, ACTA BIOMATER, V10, P4715, DOI 10.1016/j.actbio.2014.07.002
   Baker BM, 2012, P NATL ACAD SCI USA, V109, P14176, DOI 10.1073/pnas.1206962109
   Banks JM, 2014, BIOMATERIALS, V35, P8951, DOI 10.1016/j.biomaterials.2014.07.012
   Caliari SR, 2015, ADV HEALTHC MATER, V4, P831, DOI 10.1002/adhm.201400809
   Caliari SR, 2014, J BIOMED MATER RES A, V102, P917, DOI 10.1002/jbm.a.35058
   Caliari SR, 2013, TISSUE ENG PT A, V19, P1100, DOI [10.1089/ten.TEA.2012.0497, 10.1089/ten.tea.2012.0497]
   Caliari SR, 2012, J MECH BEHAV BIOMED, V11, P27, DOI 10.1016/j.jmbbm.2011.12.004
   Caliari SR, 2011, BIOMATERIALS, V32, P8990, DOI 10.1016/j.biomaterials.2011.08.035
   Caliari SR, 2011, BIOMATERIALS, V32, P5330, DOI 10.1016/j.biomaterials.2011.04.021
   Capito RM, 2007, GENE THER, V14, P721, DOI 10.1038/sj.gt.3302918
   Chamberlain LJ, 1998, EXP NEUROL, V154, P315, DOI 10.1006/exnr.1998.6955
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Freyman TM, 2001, EXP CELL RES, V269, P140, DOI 10.1006/excr.2001.5302
   Galatz LM, 2006, J ORTHOP RES, V24, P541, DOI 10.1002/jor.20067
   Gibson L. J., 2010, CELLULAR MAT NATURE
   GIBSON LJ, 1995, P R SOC-MATH PHYS SC, V450, P141, DOI 10.1098/rspa.1995.0076
   Harley BA, 2007, BIOPHYS J, V93, P2911, DOI 10.1529/biophysj.106.095471
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1078, DOI 10.1002/jbm.a.32387
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1066, DOI 10.1002/jbm.a.32361
   Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598
   Hortensius RA, 2015, BIOMATER SCI-UK, V3, P645, DOI [10.1039/c5bm00033e, 10.1039/C5BM00033E]
   Hortensius RA, 2013, BIOMATERIALS, V34, P7645, DOI 10.1016/j.biomaterials.2013.06.056
   James R, 2008, J HAND SURG-AM, V33A, P102, DOI 10.1016/j.jhsa.2007.09.007
   Kanungo BP, 2008, ACTA BIOMATER, V4, P490, DOI 10.1016/j.actbio.2008.01.003
   KARAM GN, 1994, MAT SCI ENG C-BIOMIM, V2, P113, DOI 10.1016/0928-4931(94)90039-6
   Keays SL, 2007, AM J SPORT MED, V35, P729, DOI 10.1177/0363546506298277
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   Levingstone TJ, 2014, ACTA BIOMATER, V10, P1996, DOI 10.1016/j.actbio.2014.01.005
   Lichtwark GA, 2005, J EXP BIOL, V208, P4715, DOI 10.1242/jeb.01950
   Liu Y, 2008, TRENDS BIOTECHNOL, V26, P201, DOI 10.1016/j.tibtech.2008.01.003
   Lyons FG, 2014, CLIN ORTHOP RELAT R, V472, P1318, DOI 10.1007/s11999-013-3438-0
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Maganaris CN, 2000, J BIOMECH, V33, P1453, DOI 10.1016/S0021-9290(00)00099-3
   Maganaris CN, 1999, J PHYSIOL-LONDON, V521, P307, DOI 10.1111/j.1469-7793.1999.00307.x
   Martin TA, 2011, BIOMATERIALS, V32, P3949, DOI 10.1016/j.biomaterials.2011.02.018
   Mathew A.P., 2012, MACROMOLECULAR BIOSC
   McCoy RJ, 2013, STEM CELLS, V31, P2420, DOI 10.1002/stem.1482
   MICHEL MC, 1993, J BIOMECH, V26, P453, DOI 10.1016/0021-9290(93)90009-4
   Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7
   Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007
   Monaco E, 2009, OPEN TISSUE ENG REGE, P20, DOI DOI 10.2174/1875043500902010020
   Moore TLA, 2001, J BIOMECH ENG-T ASME, V123, P613, DOI 10.1115/1.1407828
   Mullen LM, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-014-5325-y
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   O'Brien Fergal J, 2007, Technol Health Care, V15, P3
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Quinlan E, 2015, BIOMATERIALS, V52, P358, DOI 10.1016/j.biomaterials.2015.02.006
   Serra T, 2013, ACTA BIOMATER, V9, P5521, DOI 10.1016/j.actbio.2012.10.041
   Speck T, 2011, ANNU REV MATER RES, V41, P169, DOI 10.1146/annurev-matsci-062910-100425
   Thorpe CT, 2010, EQUINE VET J, V42, P538, DOI 10.1111/j.2042-3306.2010.00175.x
   Thorpe CT, 2012, J R SOC INTERFACE, V9, P3108, DOI 10.1098/rsif.2012.0362
   Tierney CM, 2009, J BIOMED MATER RES A, V91A, P92, DOI 10.1002/jbm.a.32207
   Weisgerber DW, 2013, J MECH BEHAV BIOMED, V28, P26, DOI 10.1016/j.jmbbm.2013.07.016
   Weisgerber DW, 2015, BIOMATER SCI-UK, V3, P533, DOI [10.1039/c4bm00397g, 10.1039/C4BM00397G]
   Wopenka B, 2008, APPL SPECTROSC, V62, P1285, DOI 10.1366/000370208786822179
   Xu YH, 2008, CLIN ORTHOP RELAT R, V466, P1528, DOI 10.1007/s11999-008-0286-4
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
NR 61
TC 16
Z9 16
U1 3
U2 109
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 15
PY 2016
VL 33
BP 25
EP 33
DI 10.1016/j.actbio.2016.02.004
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DH3LO
UT WOS:000372688700003
PM 26850145
OA Other Gold, Green Accepted
DA 2018-10-19
ER

PT J
AU Kuang, R
   Zhang, ZP
   Jin, XB
   Hu, J
   Shi, ST
   Ni, LX
   Ma, PX
AF Kuang, Rong
   Zhang, Zhanpeng
   Jin, Xiaobing
   Hu, Jiang
   Shi, Songtao
   Ni, Longxing
   Ma, Peter X.
TI Nanofibrous spongy microspheres for the delivery of hypoxia-primed human
   dental pulp stem cells to regenerate vascularized dental pulp
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Regeneration; Stem cell; Dental pulp; Hypoxic; Biomaterial; Microcarrier
ID ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; ODONTOGENIC DIFFERENTIATION;
   INDUCIBLE FACTOR-1; SCAFFOLDS; ANGIOGENESIS; TEETH; HIF-1-ALPHA;
   ACTIVATION; LIVER
AB Dental pulp infection and necrosis are widespread diseases. Conventional endodontic treatments result in a devitalized and weakened tooth. In this work, we synthesized novel star-shaped polymer to self assemble into unique nanofibrous spongy microspheres (NF-SMS), which were used to carry human dental pulp stem cells (hDPSCs) into the pulp cavity to regenerate living dental pulp tissues. It was found that NF-SMS significantly enhanced hDPSCs attachment, proliferation, odontogenic differentiation and angiogenesis, as compared to control cell carriers. Additionally, NF-SMS promoted vascular endothelial growth factor (VEGF) expression of hDPSCs in a 3D hypoxic culture. Hypoxia-primed hDPSCs/NF-SMS complexes were injected into the cleaned pulp cavities of rabbit molars for subcutaneous implantation in mice. After 4 weeks, the hypoxia group significantly enhanced angiogenesis inside the pulp chamber and promoted the formation of ondontoblast-like cells lining along the dentin pulp interface, as compared to the control groups (hDPSCs alone group, NF-SMS alone group, and hDPSCsiNF-SMS group pre-cultured under normoxic conditions). Furthermore, in an in situ dental pulp repair model in rats, hypoxia-primed hDPSCsiNF-SMS were injected to fully fill the pulp cavity and regenerate pulp-like tissues with a rich vasculature and a histological structure similar to the native pulp.
   Statement of Significance
   Vascularization is key to the regeneration of many vital tissues. However, it is challenging to create a suitable microenvironment for stem cells to regenerate vascularized tissue structure. This manuscript reports a novel star-shaped block copolymer that self-assembles into unique nanofibrous spongy microspheres, which as an injectable scaffold recapitulate the cell cell and cell matrix interactions in development. Using a clinically-relevant surgical procedure and a hypoxic treatment, the nanofibrous spongy micro spheres were used to deliver stem cells and successfully regenerate dental pulp with a rich vasculature and a complex histologic structure similar to that of the native dental pulp. The novel microspheres can likely be used to regenerate many other vascularized tissues. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Kuang, Rong; Jin, Xiaobing; Hu, Jiang; Ma, Peter X.] Univ Michigan, Dept Biol & Mat Sci, 1011 North Univ Ave,Room 2211, Ann Arbor, MI 48109 USA.
   [Kuang, Rong; Ni, Longxing] Fourth Mil Med Univ, Sch Stomatol, Dept Operat Dent & Endodont, State Key Lab Mil Stomatol, Xian 710032, Peoples R China.
   [Zhang, Zhanpeng; Ma, Peter X.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Ma, Peter X.] Univ Michigan, Macromol Sci & Engn Ctr, Ann Arbor, MI 48109 USA.
   [Ma, Peter X.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.
   [Shi, Songtao] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, 240 S 40th St, Philadelphia, PA 19104 USA.
RP Ma, PX (reprint author), Univ Michigan, Dept Biol & Mat Sci, 1011 North Univ Ave,Room 2211, Ann Arbor, MI 48109 USA.; Ni, LX (reprint author), Fourth Mil Med Univ, Sch Stomatol, Dept Operat Dent & Endodont, State Key Lab Mil Stomatol, Xian 710032, Peoples R China.
EM nilx2007@gmail.com; mapx@umich.edu
RI Zhang, Zhanpeng/F-2272-2015
OI Zhang, Zhanpeng/0000-0002-6451-7004
FU NIH [NIDCR DE022327, DE015384, NHLBI HL114038]; DOD [W81XWH-12-2-0008];
   NSF [DMR-1206575]
FX The authors gratefully acknowledge financial support from the NIH (NIDCR
   DE022327, DE015384, and NHLBI HL114038: PXM), DOD (W81XWH-12-2-0008:
   PXM), and NSF (DMR-1206575: PXM).
CR Ahluwalia A, 2012, CURR MED CHEM, V19, P90, DOI 10.2174/092986712803413944
   Aranha AMF, 2010, J ENDODONT, V36, P1633, DOI 10.1016/j.joen.2010.05.013
   Atari M, 2012, J CELL SCI, V125, P3343, DOI 10.1242/jcs.096537
   Blaker JJ, 2005, ACTA BIOMATER, V1, P643, DOI 10.1016/j.actbio.2005.07.003
   Chen FP, 2010, ACTA BIOMATER, V6, P3199, DOI 10.1016/j.actbio.2010.02.049
   CVEK M, 1992, ENDOD DENT TRAUMATOL, V8, P45
   Dammaschke T, 2003, J ENDODONT, V29, P638, DOI 10.1097/00004770-200310000-00006
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   El-Backly RM, 2008, AUST ENDOD J, V34, P52, DOI 10.1111/j.1747-4477.2008.00139.x
   Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4
   Forsythe JA, 1996, MOL CELL BIOL, V16, P4604
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Huang AHC, 2009, J ENDODONT, V35, P673, DOI 10.1016/j.joen.2009.01.019
   Huang George T-J, 2011, Front Biosci (Elite Ed), V3, P788, DOI 10.2741/e286
   Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685
   Kuang R, 2015, ADV HEALTHC MATER, V4, P1993, DOI 10.1002/adhm.201500308
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562
   Liu XH, 2011, NAT MATER, V10, P398, DOI [10.1038/NMAT2999, 10.1038/nmat2999]
   Ma DD, 2012, J ENDODONT, V38, P796, DOI 10.1016/j.joen.2012.02.014
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958
   Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Nakashima M, 2003, NAT BIOTECHNOL, V21, P1025, DOI 10.1038/nbt864
   Nakashima M, 2009, CYTOKINE GROWTH F R, V20, P435, DOI 10.1016/j.cytogfr.2009.10.012
   Perry BC, 2008, TISSUE ENG PT C-METH, V14, P149, DOI 10.1089/ten.tec.2008.0031
   Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677
   Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6
   Sharp FR, 2004, NAT REV NEUROSCI, V5, P437, DOI 10.1038/nrn1408
   Sheta EA, 2001, ONCOGENE, V20, P7624, DOI 10.1038/sj.onc.1204972
   SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0
   Wang J, 2011, BIOMATERIALS, V32, P7822, DOI 10.1016/j.biomaterials.2011.04.034
   Wang J, 2010, ACTA BIOMATER, V6, P3856, DOI 10.1016/j.actbio.2010.04.009
   Yamakawa M, 2003, CIRC RES, V93, P664, DOI 10.1161/01.RES.0000093984.48643.D7
   Young CS, 2002, J DENT RES, V81, P695, DOI 10.1177/154405910208101008
   Yu CY, 2002, ARCH ORAL BIOL, V47, P529, DOI 10.1016/S0003-9969(02)00036-5
   Zhang Z., CELL CARRIERS MICROP
NR 41
TC 15
Z9 16
U1 4
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 15
PY 2016
VL 33
BP 225
EP 234
DI 10.1016/j.actbio.2016.01.032
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DH3LO
UT WOS:000372688700022
PM 26826529
OA Other Gold
DA 2018-10-19
ER

PT J
AU Torres, AM
   Matheny, JB
   Keaveny, TM
   Taylor, D
   Rimnac, CM
   Hernandez, CJ
AF Torres, Ashley M.
   Matheny, Jonathan B.
   Keaveny, Tony M.
   Taylor, David
   Rimnac, Clare M.
   Hernandez, Christopher J.
TI Material heterogeneity in cancellous bone promotes deformation recovery
   after mechanical failure
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE biomaterial; bone remodeling; fracture mechanics; advanced glycation end
   products; cellular solid
ID HUMAN CORTICAL BONE; AGE-RELATED-CHANGES; TRABECULAR BONE; NONENZYMATIC
   GLYCATION; FRACTURE CRITERIA; TOUGHNESS; MICRODAMAGE; STRENGTH; CRACKS;
   OSTEOPOROSIS
AB Many natural structures use a foam core and solid outer shell to achieve high strength and stiffness with relatively small amounts of mass. Biological foams, however, must also resist crack growth. The process of crack propagation within the struts of a foam is not well understood and is complicated by the foam microstructure. We demonstrate that in cancellous bone, the foam-like component of whole bones, damage propagation during cyclic loading is dictated not by local tissue stresses but by heterogeneity of material properties associated with increased ductility of strut surfaces. The increase in surface ductility is unexpected because it is the opposite pattern generated by surface treatments to increase fatigue life in man-made materials, which often result in reduced surface ductility. We show that the more ductile surfaces of cancellous bone are a result of reduced accumulation of advanced glycation end products compared with the strut interior. Damage is therefore likely to accumulate in strut centers making cancellous bone more tolerant of stress concentrations at strut surfaces. Hence, the structure is able to recover more deformation after failure and return to a closer approximation of its original shape. Increased recovery of deformation is a passive mechanism seen in biology for setting a broken bone that allows for a better approximation of initial shape during healing processes and is likely the most important mechanical function. Our findings suggest a previously unidentified biomimetic design strategy in which tissue level material heterogeneity in foams can be used to improve deformation recovery after failure.
C1 [Torres, Ashley M.; Matheny, Jonathan B.; Hernandez, Christopher J.] Cornell Univ, Meinig Sch Biomed Engn, Ithaca, NY 14853 USA.
   [Torres, Ashley M.; Matheny, Jonathan B.; Hernandez, Christopher J.] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.
   [Keaveny, Tony M.] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA.
   [Taylor, David] Trinity Coll Dublin, Dept Mech & Mfg Engn, Dublin 2, Ireland.
   [Rimnac, Clare M.] Case Western Reserve Univ, Dept Mech Engn, Cleveland, OH 44106 USA.
   [Hernandez, Christopher J.] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA.
RP Hernandez, CJ (reprint author), Cornell Univ, Meinig Sch Biomed Engn, Ithaca, NY 14853 USA.; Hernandez, CJ (reprint author), Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.; Hernandez, CJ (reprint author), Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA.
EM cjh275@cornell.edu
RI Hernandez, Christopher/B-5290-2009
OI Hernandez, Christopher/0000-0002-0712-6533; Rimnac,
   Clare/0000-0001-9981-8723; Matheny, Jonathan/0000-0003-4046-9615
FU National Institute of Arthritis and Musculoskeletal and Skin Diseases of
   the National Institutes of Health Award [AR057362]; National Institutes
   of Health (NIH) [8U42OD011158-22]; Cornell's National Science Foundation
   (NSF) [DGE-1144153]; NSF Graduate Research Fellowship Program (GRFP);
   NSF GRFP; Cornell Colman fellowship; NIH [S10RR025502]
FX We thank Christopher Chapa and Floor Lambers for assistance with
   specimen preparation. We thank Matthew Goff for assistance with finite
   element models. This work was supported by National Institute of
   Arthritis and Musculoskeletal and Skin Diseases of the National
   Institutes of Health Award AR057362 (principal investigator, C.J.H.). We
   acknowledge use of human vertebral bodies provided by the National
   Disease Research Interchange, with support from National Institutes of
   Health (NIH) Grant 8U42OD011158-22, Cornell's National Science
   Foundation (NSF) Grant DGE-1144153, NSF Graduate Research Fellowship
   Program (GRFP) (to A.M.T.), NSF GRFP (to J.B.M.), and a Cornell Colman
   fellowship (to A.M.T.). Imaging data were acquired in the Cornell
   Biotechnology Resource Center (BRC)-Imaging Facility using the shared,
   NIH-funded (S10RR025502) Zeiss LSM 710 Confocal.
CR Ager JW, 2006, J MATER RES, V21, P1878, DOI 10.1557/JMR.2006.0242
   Akkus O, 2000, J MATER SCI, V35, P6065, DOI 10.1023/A:1026719531300
   Akkus O, 2001, J ORTHOP RES, V19, P927, DOI 10.1016/S0736-0266(01)00004-3
   Bigley RF, 2008, BONE, V42, P212, DOI 10.1016/j.bone.2007.09.043
   Brennan O, 2009, J BIOMECH, V42, P498, DOI 10.1016/j.jbiomech.2008.11.032
   Burket JC, 2013, BONE, V52, P326, DOI 10.1016/j.bone.2012.10.018
   Busse B, 2013, SCI TRANSL MED, V5, P88
   Cook RB, 2009, J BIOMECH, V42, P2054, DOI 10.1016/j.jbiomech.2009.06.001
   Currey J. D., 2002, BONES STRUCTURE MECH
   Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805
   Dempster DM, 2000, J BONE MINER RES, V15, P20, DOI 10.1359/jbmr.2000.15.1.20
   Dowling N., 2007, MECH BEHAV MAT
   Eswaran SK, 2006, J BONE MINER RES, V21, P307, DOI 10.1359/JBMR.051027
   FYHRIE DP, 1994, BONE, V15, P105, DOI 10.1016/8756-3282(94)90900-8
   Gibson LJ, 2005, J BIOMECH, V38, P377, DOI 10.1016/j.jbiomech.2004.09.027
   Goff MG, 2014, J BIOMECH, V47, P3156, DOI 10.1016/j.jbiomech.2014.06.016
   Griffith JF, 2012, ENDOCRINE, V42, P39, DOI 10.1007/s12020-012-9691-2
   Hernandez CJ, 2008, BONE, V42, P1014, DOI 10.1016/j.bone.2008.02.001
   Hernandez CJ, 2014, BONE, V66, P205, DOI 10.1016/j.bone.2014.05.023
   Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116
   Keaveny TM, 1999, J ORTHOPAED RES, V17, P346, DOI 10.1002/jor.1100170308
   Koester KJ, 2008, NAT MATER, V7, P672, DOI 10.1038/nmat2221
   Kruzic JJ, 2006, J BIOMECH, V39, P968, DOI 10.1016/j.jbiomech.2005.01.025
   Launey ME, 2010, ANNU REV MATER RES, V40, P25, DOI 10.1146/annurev-matsci-070909-10442
   McNamara LM, 2006, J BIOMECH, V39, P734, DOI 10.1016/j.jbiomech.2004.12.027
   Meyers MA, 2013, SCIENCE, V339, P773, DOI 10.1126/science.1220854
   Meza LR, 2015, P NATL ACAD SCI USA, V112, P11502, DOI 10.1073/pnas.1509120112
   Nalla RK, 2005, J BIOMECH, V38, P1517, DOI 10.1016/j.jbiomech.2004.07.010
   Nalla RK, 2003, NAT MATER, V2, P164, DOI 10.1038/nmat832
   O'Brien FJ, 2002, J BIOMECH, V35, P523, DOI 10.1016/S0021-9290(01)00200-7
   Renders GAP, 2011, J BIOMECH, V44, P402, DOI 10.1016/j.jbiomech.2010.10.004
   Ritchie RO, 2009, PHYS TODAY, V62, P41, DOI 10.1063/1.3156332
   Slyfield CR, 2009, J MICROSC-OXFORD, V236, P52, DOI 10.1111/j.1365-2818.2009.03204.x
   Tang SY, 2010, BONE, V46, P148, DOI 10.1016/j.bone.2009.09.003
   Taylor D, 2007, THEORY CRITICAL DIST
   Taylor D, 2007, NAT MATER, V6, P263, DOI 10.1038/nmat1866
   Vashishth D, 2001, BONE, V28, P195, DOI 10.1016/S8756-3282(00)00434-8
   Wang X, 2002, BONE, V31, P1, DOI 10.1016/S8756-3282(01)00697-4
   Wegst UGK, 2015, NAT MATER, V14, P23, DOI [10.1038/nmat4089, 10.1038/NMAT4089]
   Willett TL, 2013, BONE, V52, P611, DOI 10.1016/j.bone.2012.11.014
   Zimmermann EA, 2011, P NATL ACAD SCI USA, V108, P14416, DOI 10.1073/pnas.1107966108
   Zioupos P, 1998, BONE, V22, P57, DOI 10.1016/S8756-3282(97)00228-7
NR 42
TC 10
Z9 10
U1 1
U2 28
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 15
PY 2016
VL 113
IS 11
BP 2892
EP 2897
DI 10.1073/pnas.1520539113
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DG4BF
UT WOS:000372014200044
PM 26929343
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Shakeri, H
   Arshadi, M
   Salvacion, JWL
AF Shakeri, H.
   Arshadi, M.
   Salvacion, J. W. L.
TI Removal of BTEX by using a surfactant - Bio originated composite
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE Biomaterial; BTEX; Adsorption; Surfactant; Anzali lagoon water
ID AQUEOUS-SOLUTIONS; CARBON NANOTUBES; ACTIVATED CARBON; M-XYLENE;
   ADSORPTION; SORPTION; TOLUENE; ETHYLBENZENE; MONTMORILLONITE;
   CLINOPTILOLITE
AB The application of ostrich bone waste-loaded a cationic surfactant (OBW-OH-CTABr) bioadsorbent for benzene, toluene, ethylbenzene and p-xylene (BTEX) removal from the synthetic and real waters have been studied, and the prepared biomaterials were studied by Fourier transform infrared (FTIR), X-ray diffraction (XRD), surface area measurements (BET), scanning electron microscopy (SEM), Energy dispersive X-ray spectroscopy (EDX) and point of zero (pH(PZC)). The immobilization of CTABr molecules on the framework of modified OBW showed good tendency to adsorb BTEX from aqueous solution. The exposure time to obtain equilibrium for maximum removal of BTEX was observed to be 60 min. The removal kinetics of BTEX has been evaluated in terms of pseudo-first- and-second-order kinetics, and the Freundlich and Langmuir isotherm models have also been utilized to the equilibrium removal data. The removal process was spontaneous and endothermic in nature and followed pseudo-second-order kinetic model. The immobilized CTABr showed high reusability because of its high adsorption efficiency after 12th cycles. The proposed low-cost bioadsorbent could also be utilized to adsorb BTEX from the real water (Anzali lagoon water). The OBW-OH-CTABr composite is indeed an attractive biomaterial for drinking water-based pollutants and act as an adsorbent for BTEX and oil spills especially in third world due to its low-cost preparation and regeneration and clean processing of the biomaterial with no byproducts after utilize. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Shakeri, H.; Salvacion, J. W. L.] Mapua Inst Technol, Muralla St Intramuros, Manila 1002, Philippines.
   [Arshadi, M.] Islamic Azad Univ, Shiraz Branch, Dept Chem, POB 71955-149, Shiraz, Fars, Iran.
RP Arshadi, M (reprint author), Islamic Azad Univ, Shiraz Branch, Dept Chem, POB 71955-149, Shiraz, Fars, Iran.
EM m-arshadi@ch.iut.ac.ir
RI Magpantay, Ramil/C-9089-2016
CR Arshadi M, 2015, RSC ADV, V5, P43290, DOI 10.1039/c5ra03191e
   Bowman S.R., 2000, NATURAL ZEOLITES 3 M, P287
   Bundschuh J, 2004, APPL GEOCHEM, V19, P231, DOI 10.1016/j.apgeochem.2003.09.009
   CASON R, 1977, Proceedings of the Oklahoma Academy of Science, V57, P116
   Chen W, 2007, ENVIRON SCI TECHNOL, V41, P8295, DOI 10.1021/es071230h
   Chin CJM, 2007, CARBON, V45, P1254, DOI 10.1016/j.carbon.2007.01.015
   ECKENFELDER WW, 1989, IND WATER POLLUTION
   Faby J.-A., 1998, DOCUMENT TECHNIQUE F, V11
   Fan JL, 2011, DESALINATION, V267, P139, DOI 10.1016/j.desal.2010.09.016
   Ghiaci M, 2008, J CHEM ENG DATA, V53, P2707, DOI 10.1021/je800532p
   Institute A.P., 2002, PRED WAT SOL ORG WSO
   ISHIKAWA T, 1989, LANGMUIR, V5, P140, DOI 10.1021/la00085a025
   Khan FI, 2000, J LOSS PREVENT PROC, V13, P527, DOI 10.1016/S0950-4230(00)00007-3
   Kim Sang-Hyoun, 2013, J POROUS MAT, P9690
   Li ZH, 1998, ENVIRON SCI TECHNOL, V32, P2278, DOI 10.1021/es971118r
   Li ZH, 2003, CLAY CLAY MINER, V51, P445, DOI 10.1346/CCMN.2003.0510411
   Li ZH, 1999, LANGMUIR, V15, P6438, DOI 10.1021/la981535x
   Liu B, 2011, MATER CHEM PHYS, V130, P1220, DOI 10.1016/j.matchemphys.2011.08.064
   Lu C, 2008, APPL SURF SCI, V254, P7035, DOI 10.1016/j.apsusc.2008.05.282
   McBride M. B., 1994, ENV CHEM SOILS
   MING DW, 1987, CLAY CLAY MINER, V35, P463, DOI 10.1346/CCMN.1987.0350607
   Nourmoradi H, 2012, CHEM ENG J, V191, P341, DOI 10.1016/j.cej.2012.03.029
   Peters F, 2000, THERMOCHIM ACTA, V361, P131, DOI 10.1016/S0040-6031(00)00554-2
   Ranganayaki M.D., 1999, SOUV CUM P NAT SEM P, P187
   Ribeiro TH, 2000, ENVIRON SCI TECHNOL, V34, P5201, DOI 10.1021/es991139g
   Royer B, 2010, J HAZARD MATER, V181, P366, DOI 10.1016/j.jhazmat.2010.05.019
   Su FS, 2010, COLLOID SURFACE A, V353, P83, DOI 10.1016/j.colsurfa.2009.10.025
   Tu A. T., 1986, SPECTROSCOPY BIOL SY, P47
   Wang XY, 2010, BIOMED ENVIRON SCI, V23, P473, DOI 10.1016/S0895-3988(11)60010-X
   WEBER WJ, 1991, WATER RES, V25, P499, DOI 10.1016/0043-1354(91)90125-A
   Wibowo N, 2007, J HAZARD MATER, V146, P237, DOI 10.1016/j.jhazmat.2006.12.011
   Yang R. T., 2003, ADSORBENTS FUNDAMENT
   Yu F, 2012, J AGR FOOD CHEM, V60, P12245, DOI 10.1021/jf304104z
   Yu F, 2011, J HAZARD MATER, V192, P1370, DOI 10.1016/j.jhazmat.2011.06.048
NR 34
TC 8
Z9 8
U1 0
U2 90
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
EI 1095-7103
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD MAR 15
PY 2016
VL 466
BP 186
EP 197
DI 10.1016/j.jcis.2015.12.019
PG 12
WC Chemistry, Physical
SC Chemistry
GA DC3KV
UT WOS:000369119100021
PM 26724701
DA 2018-10-19
ER

PT J
AU Valouma, A
   Verganelaki, A
   Maravelaki-Kalaitzaki, P
   Gidarakos, E
AF Valouma, Aikaterini
   Verganelaki, Anastasia
   Maravelaki-Kalaitzaki, Pagona
   Gidarakos, Evangelos
TI Chrysotile asbestos detoxification with a combined treatment of oxalic
   acid and silicates producing amorphous silica and biomaterial
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE Chrysotile asbestos; Oxalic acid; TEOS; Amorphous silica; Magnesium
   oxalate
ID THERMAL-DECOMPOSITION; TRADITIONAL CERAMICS; POWER ULTRASOUND; FIBERS;
   TEMPERATURE; WASTE
AB This study was primarily imposed by the ever increasing need for detoxification of asbestos and asbestos containing materials (ACM), with potential application onsite. The present work investigates potential detoxification of pure chrysotile (Chr) asbestos via a combined treatment of oxalic acid dihydrate (Oxac) (H2C2O4 center dot 2H(2)O) with silicates, such as tetraethoxysilane (TEOS) (SiH20C8O4) and pure water glass (WG) (potassium silicate) (K2SiO3). These reagents used in the experimental procedure, do not cause adverse effects on the environment and are cost effective. The results of FTIR, XRD, optical and scanning microscopy coupled with EDS analyses indicated that all of the applied treatments destructed the Chr structure and yielded silica of amorphous phase and the biomaterial glushinskite from the Oxac reacted with brucite [Mg(OH)(2)] layer. Each of the proposed formulations can be applied for the detoxification of asbestos, according to priorities related to the specific products of the recovery treatment. Therefore, Oxac acid leaching followed by the TEOS addition is preferred in cases of glushinskite recovery; TEOS treatment of asbestos with subsequent Oxac addition produced amorphous silica production; finally Oxac acid leaching followed by WG encapsulated the asbestos fibers and can be used in cases of onsite asbestos and ACM detoxification. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Valouma, Aikaterini; Gidarakos, Evangelos] Tech Univ Crete, Sch Environm Engn, Akrotiri Univ Campus, Khania 73100, Crete, Greece.
   [Verganelaki, Anastasia; Maravelaki-Kalaitzaki, Pagona] Tech Univ Crete, Sch Architectural Engn, Akrotiri Univ Campus, Khania 73100, Crete, Greece.
RP Gidarakos, E (reprint author), Tech Univ Crete, Sch Environm Engn, Akrotiri Univ Campus, Khania 73100, Crete, Greece.; Maravelaki-Kalaitzaki, P (reprint author), Tech Univ Crete, Sch Architectural Engn, Akrotiri Univ Campus, Khania 73100, Crete, Greece.
EM nmaravel@elci.tuc.gr; gidarako@mred.tuc.gr
CR Anastasiadou K, 2010, J HAZARD MATER, V179, P926, DOI 10.1016/j.jhazmat.2010.03.094
   Favero-Longo SE, 2005, J ENVIRON MONITOR, V7, P764, DOI 10.1039/b507569f
   Finley BL, 2012, CRIT REV TOXICOL, V42, P119, DOI 10.3109/10408444.2011.636028
   Fonseca MG, 2001, J COLLOID INTERF SCI, V240, P533, DOI 10.1006/jcis.2001.7663
   Gualtieri AF, 2000, J EUR CERAM SOC, V20, P1409, DOI 10.1016/S0955-2219(99)00290-3
   Gualtieri AF, 2000, J APPL POLYM SCI, V75, P713, DOI 10.1002/(SICI)1097-4628(20000131)75:5<713::AID-APP14>3.0.CO;2-D
   Gualtieri AF, 2008, J HAZARD MATER, V156, P260, DOI 10.1016/j.jhazmat.2007.12.016
   Gulumian M, 2005, J TOXICOL ENV HEAL B, V8, P453, DOI 10.1080/10937400590952547
   Habaue S, 2008, J APPL POLYM SCI, V110, P2891, DOI 10.1002/app.28899
   Jiang HM, 2006, IND ENG CHEM RES, V45, P8617, DOI 10.1021/ie0607550
   Kapridaki C, 2014, APPL CATAL B-ENVIRON, V156, P416, DOI 10.1016/j.apcatb.2014.03.042
   Koshi K., 2012, IND HLTH, V10, P16
   Lavkulich LM, 2014, J ENVIRON SCI HEAL A, V49, P617, DOI 10.1080/10934529.2014.865401
   Leonelli C, 2006, J HAZARD MATER, V135, P149, DOI 10.1016/j.jhazmat.2005.11.035
   MING DW, 1985, SOIL SCI SOC AM J, V49, P1303, DOI 10.2136/sssaj1985.03615995004900050046x
   Nam SN, 2014, J HAZARD MATER, V265, P151, DOI 10.1016/j.jhazmat.2013.11.004
   Norbet C, 2015, CURR PROBL DIAGN RAD, V44, P371, DOI 10.1067/j.cpradiol.2014.10.002
   Raloff J, 1998, SCI NEWS, V153, P5
   Rozalen M, 2013, CHEM GEOL, V352, P134, DOI 10.1016/j.chemgeo.2013.06.004
   Stanescu-Dumitru R., 2008, OALIB J, V4, P6
   Sugama T, 1998, IND ENG CHEM RES, V37, P79, DOI 10.1021/ie9702744
   Turci F, 2008, ULTRASON SONOCHEM, V15, P420, DOI 10.1016/j.ultsonch.2007.08.007
   Turci F, 2007, J ENVIRON MONITOR, V9, P1064, DOI 10.1039/b709571f
   Wypych F, 2003, J MATER CHEM, V13, P304, DOI 10.1039/b210370b
   Yamamoto T, 2014, WASTE MANAGE, V34, P536, DOI 10.1016/j.wasman.2013.11.008
NR 25
TC 8
Z9 8
U1 1
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
EI 1873-3336
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD MAR 15
PY 2016
VL 305
BP 164
EP 170
DI 10.1016/j.jhazmat.2015.11.036
PG 7
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA DC8DZ
UT WOS:000369451400019
PM 26685063
DA 2018-10-19
ER

PT J
AU Avula, M
   Jones, D
   Rao, AN
   McClain, D
   McGill, LD
   Grainger, DW
   Solzbacher, F
AF Avula, M.
   Jones, D.
   Rao, A. N.
   McClain, D.
   McGill, L. D.
   Grainger, D. W.
   Solzbacher, F.
TI Local release of masitinib alters in vivo implantable continuous glucose
   sensor performance
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE Foreign body response (FBR); Encapsulation; Mast cells (MC); Tyrosine
   kinase inhibitor (TKI); Local drug delivery; Subcutaneous murine
   implants
ID FOREIGN-BODY RESPONSE; ACUTE INFLAMMATORY RESPONSES; TYROSINE KINASE
   INHIBITOR; MAST-CELLS; BIOMATERIAL IMPLANTS; TISSUE-RESPONSE; MEDICAL
   DEVICES; NITRIC-OXIDE; BIOSENSORS; DELIVERY
AB Continuous glucose monitoring (CGM) sensors are often advocated as a clinical solution to improve longterm glycemic control in the context of diabetes. Subcutaneous sensor inflammatory response, fouling and fibrous encapsulation resulting from the host foreign body response (FBR) reduce sensor sensitivity to glucose, eventually resulting in sensor performance compromise and device failure. Several combination device strategies load CGM sensors with drug payloads that release locally to tissue sites to mitigate FBR-mediated sensor failure. In this study, the mast cell-targeting tyrosine kinase inhibitor, masitinib, was released from degradable polymer microspheres delivered from the surfaces of FDA-approved human commercial CGM needle-type implanted sensors in a rodent subcutaneous test bed. By targeting the mast cell c-Kit receptor and inhibiting mast cell activation and degranulation, local masitinib penetration around the CGM to several hundred microns sought to reduce sensor fibrosis to extend CGM functional lifetimes in subcutaneous sites. Drug-releasing and control CGM implants were compared in murine percutaneous implant sites for 21 days using direct-wire continuous glucose reporting. Drug-releasing implants exhibited no significant difference in CGM fibrosis at implant sites but showed relatively stable continuous sensor responses over the study period compared to blank microsphere control CGM implants. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Avula, M.; Grainger, D. W.; Solzbacher, F.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
   [Jones, D.; McClain, D.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA.
   [Rao, A. N.; Grainger, D. W.] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA.
   [McGill, L. D.] Univ Utah, Associated Reg & Univ Pathologist Labs, Salt Lake City, UT 84112 USA.
   [Solzbacher, F.] Univ Utah, Dept Elect & Comp Engn, Salt Lake City, UT 84112 USA.
RP Grainger, DW (reprint author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.
EM david.grainger@utah.edu
OI McClain, Don/0000-0002-3310-2359; Avula, Mahender/0000-0001-5287-8972
FU University of Utah Research Foundation [SEED (51003520)]; Technology
   Commercialization [51003517]
FX The authors acknowledge support from the University of Utah Research
   Foundation (SEED (51003520) and Technology Commercialization (51003517)
   grants). D. Sze, R. Caldwell, and P. Hogrebe (all Utah) are thanked for
   support and technical assistance. Dr. B. Feldman and B. Cho, (Abbott
   Diabetes Care, Alameda, USA) are thanked for generously providing the
   CGM sensors used in this study. Author F. Solzbacher has a financial
   interest in the company Blackrock Microsystems (USA) that develops and
   produces implantable neural interfaces and electrophysiological
   equipment and software, none of which is used in this study.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Avula MN, 2014, ACTA BIOMATER, V10, P1856, DOI 10.1016/j.actbio.2013.12.056
   Avula M.N., 2015, DRUG DEVICE IN PRESS
   Avula MN, 2013, BIOMATERIALS, V34, P9737, DOI 10.1016/j.biomaterials.2013.08.090
   Bhardwaj Upkar, 2007, J Diabetes Sci Technol, V1, P8
   Bode BW, 1999, DIABETES RES CLIN PR, V46, P183, DOI 10.1016/S0168-8227(99)00113-8
   Chase HP, 2001, PEDIATRICS, V107, P222, DOI 10.1542/peds.107.2.222
   Cobelli C, 2011, DIABETES, V60, P2672, DOI 10.2337/db11-0654
   Coster S, 2000, HEALTH TECHNOL ASSES, V12, P1
   Cunningham D. D., 2009, IN VIVO GLUCOSE SENS
   Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X
   Daneshian M, 2006, J IMMUNOL METHODS, V313, P169, DOI 10.1016/j.jim.2006.04.009
   Dubreuil P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007258
   Facchinetti Andrea, 2010, J Diabetes Sci Technol, V4, P4
   Feldman Ben, 2003, Diabetes Technol Ther, V5, P769, DOI 10.1089/152091503322526978
   Frost MC, 2002, CURR OPIN CHEM BIOL, V6, P633, DOI 10.1016/S1367-5931(02)00371-X
   Gerritsen M, 1999, NETH J MED, V54, P167, DOI 10.1016/S0300-2977(99)00006-6
   Gifford R, 2006, BIOMATERIALS, V27, P2587, DOI 10.1016/j.biomaterials.2005.11.033
   Godek M.L., 2009, IN VIVO GLUCOSE SENS, P29
   Golub JS, 2010, AM J PHYSIOL-HEART C, V298, pH1959, DOI 10.1152/ajpheart.00199.2009
   Helton Kristen L, 2011, J Diabetes Sci Technol, V5, P632
   Hetrick EM, 2007, BIOMATERIALS, V28, P4571, DOI 10.1016/j.biomaterials.2007.06.036
   Hickey T, 2002, BIOMATERIALS, V23, P1649, DOI 10.1016/S0142-9612(01)00291-5
   Hickey T, 2002, J BIOMED MATER RES, V61, P180, DOI 10.1002/jbm.10016
   Ju YM, 2010, J BIOMED MATER RES A, V93A, P200, DOI 10.1002/jbm.a.32512
   Jungheim K, 2001, DIABETES CARE, V24, P1696, DOI 10.2337/diacare.24.9.1696
   Klueh U, 2005, BIOMATERIALS, V26, P1155, DOI 10.1016/j.biomaterials.2004.04.017
   Klueh U., 2013, J BIOMEDICAL MAT R A
   Klueh U, 2006, DIABETES TECHNOL THE, V8, P402, DOI 10.1089/dia.2006.8.402
   Klueh U, 2010, BIOMATERIALS, V31, P4540, DOI 10.1016/j.biomaterials.2010.02.023
   Koschwanez HE, 2007, BIOMATERIALS, V28, P3687, DOI 10.1016/j.biomaterials.2007.03.034
   Krishnaswamy Guha, 2006, Methods Mol Biol, V315, P13
   Liao KC, 2008, BIOSENS BIOELECTRON, V23, P1458, DOI 10.1016/j.bios.2008.01.012
   Ludvigsson J, 2003, PEDIATRICS, V111, P933, DOI 10.1542/peds.111.5.933
   MILLER KM, 1989, J BIOMED MATER RES, V23, P1007, DOI 10.1002/jbm.820230904
   MURCH AR, 1982, J PATHOL, V137, P177, DOI 10.1002/path.1711370302
   Nablo BJ, 2005, BIOMATERIALS, V26, P6984, DOI 10.1016/j.biomaterials.2005.05.017
   Nichols SP, 2011, ANAL CHEM, V83, P1180, DOI 10.1021/ac103070t
   Nielsen JK, 2005, DIABETES, V54, P1635, DOI 10.2337/diabetes.54.6.1635
   Paul C, 2010, AM J HEMATOL, V85, P921, DOI 10.1002/ajh.21894
   Perez R, 2008, WOUNDS, V20, P3
   Reber L, 2006, EUR J PHARMACOL, V533, P327, DOI 10.1016/j.ejphar.2005.12.067
   Sung JY, 2009, BIOMATERIALS, V30, P622, DOI 10.1016/j.biomaterials.2008.09.052
   Tanenberg R, 2004, MAYO CLIN PROC, V79, P1521, DOI 10.4065/79.12.1521
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Thevenot PT, 2011, BIOMATERIALS, V32, P8394, DOI 10.1016/j.biomaterials.2011.07.084
   Ward W Kenneth, 2004, Diabetes Technol Ther, V6, P137, DOI 10.1089/152091504773731320
   Ward WK, 1999, ASAIO J, V45, P555, DOI 10.1097/00002480-199911000-00009
   Wilson G.S., 2010, IN VIVO GLUCOSE SENS, P1
   Wilson GS, 2005, BIOSENS BIOELECTRON, V20, P2388, DOI 10.1016/j.bios.2004.12.003
   Wilson GS, 2000, CHEM REV, V100, P2693, DOI 10.1021/cr990003y
   Wisniewski N, 2000, FRESEN J ANAL CHEM, V366, P611, DOI 10.1007/s002160051556
   Wisniewski N, 2000, COLLOID SURFACE B, V18, P197, DOI 10.1016/S0927-7765(99)00148-4
   Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031
   Zdolsek J, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-31
NR 55
TC 9
Z9 9
U1 3
U2 74
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
EI 1873-4235
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD MAR 15
PY 2016
VL 77
BP 149
EP 156
DI 10.1016/j.bios.2015.08.059
PG 8
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA CZ0AG
UT WOS:000366766900024
PM 26402593
DA 2018-10-19
ER

PT J
AU Fourel, L
   Valat, A
   Faurobert, E
   Guillot, R
   Bourrin-Reynard, I
   Ren, KF
   Lafanechere, L
   Planus, E
   Picart, C
   Albiges-Rizo, C
AF Fourel, Laure
   Valat, Anne
   Faurobert, Eva
   Guillot, Raphael
   Bourrin-Reynard, Ingrid
   Ren, Kefeng
   Lafanechere, Laurence
   Planus, Emmanuelle
   Picart, Catherine
   Albiges-Rizo, Corinne
TI beta 3 integrin-mediated spreading induced by matrix-bound BMP-2
   controls Smad signaling in a stiffness-independent manner
SO JOURNAL OF CELL BIOLOGY
LA English
DT Article
ID GROWTH-FACTOR RECEPTORS; MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX;
   OSTEOBLAST LINEAGE; C2C12 MYOBLASTS; SKELETAL-MUSCLE; RHO-GTPASES;
   DIFFERENTIATION; ACTIN; MIGRATION
AB Understanding how cells integrate multiple signaling pathways to achieve specific cell differentiation is a challenging question in cell biology. We have explored the physiological presentation of BMP-2 by using a biomaterial that harbors tunable mechanical properties to promote localized BMP-2 signaling. We show that matrix-bound BMP-2 is sufficient to induce beta 3 integrin-dependent C2C12 cell spreading by overriding the soft signal of the biomaterial and impacting actin organization and adhesion site dynamics. In turn, alpha v beta 3 integrin is required to mediate BMP-2 induced Smad signaling through a Cdc42-Src-FAK-ILK pathway. beta 3 integrin regulates a multistep process to control first BMP-2 receptor activity and second the inhibitory role of GSK3 on Smad signaling. Overall, our results show that BMP receptors and beta 3 integrin work together to control Smad signaling and tensional homeostasis, thereby coupling cell adhesion and fate commitment, two fundamental aspects of developmental biology and regenerative medicine.
C1 [Fourel, Laure; Valat, Anne; Faurobert, Eva; Bourrin-Reynard, Ingrid; Lafanechere, Laurence; Planus, Emmanuelle; Albiges-Rizo, Corinne] INSERM, Inst Albert Bonniot, U823, F-38042 Grenoble, France.
   [Fourel, Laure; Valat, Anne; Faurobert, Eva; Bourrin-Reynard, Ingrid; Planus, Emmanuelle; Albiges-Rizo, Corinne] CNRS, Equipe Rech Labellisee 5284, F-38042 Grenoble, France.
   [Fourel, Laure; Valat, Anne; Faurobert, Eva; Bourrin-Reynard, Ingrid; Lafanechere, Laurence; Planus, Emmanuelle; Albiges-Rizo, Corinne] Univ Grenoble Alpes, F-38041 Grenoble, France.
   [Fourel, Laure; Valat, Anne; Guillot, Raphael; Ren, Kefeng; Picart, Catherine] CNRS, UMR 5628, Lab Mat & Genie Phys, Inst Technol, F-38016 Grenoble, France.
RP Albiges-Rizo, C (reprint author), INSERM, Inst Albert Bonniot, U823, F-38042 Grenoble, France.; Albiges-Rizo, C (reprint author), CNRS, Equipe Rech Labellisee 5284, F-38042 Grenoble, France.; Albiges-Rizo, C (reprint author), Univ Grenoble Alpes, F-38041 Grenoble, France.; Picart, C (reprint author), CNRS, UMR 5628, Lab Mat & Genie Phys, Inst Technol, F-38016 Grenoble, France.
EM catherine.picart@grenoble-inp.fr; corinne.albiges-rizo@ujf-grenoble.fr
RI Lafanechere, Laurence/N-7474-2013
OI Lafanechere, Laurence/0000-0002-7902-7630
FU European Commission, FP7, via a European Research Council starting grant
   [GA 239370]; Institut Universitaire de France; Fondation pour la
   Recherche Medical; Ligue Contre le Cancer for Equipe labelisee Ligue
FX This work was supported by the European Commission, FP7, via a European
   Research Council starting grant to C. Picart (BIOMIM, GA 239370), by the
   Institut Universitaire de France (C. Picart), by the Fondation pour la
   Recherche Medical (C. Albiges-Rizo), and by the Ligue Contre le Cancer
   for Equipe labelisee Ligue 2014 (C. Albiges-Rizo). The groups of C.
   Picart and C. Albiges-Rizo belong to the Centre National de la Recherche
   Scientifique consortium CellTiss.
CR Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704
   Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811
   Biver E, 2014, MOL CELL ENDOCRINOL, V382, P120, DOI 10.1016/j.mce.2013.09.018
   Boudou T, 2011, MACROMOL BIOSCI, V11, P77, DOI 10.1002/mabi.201000301
   Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245
   Capdevila J, 2001, ANNU REV CELL DEV BI, V17, P87, DOI 10.1146/annurev.cellbio.17.1.87
   Chen TT, 2010, J CELL BIOL, V188, P595, DOI 10.1083/jcb.200906044
   Cheng SL, 1998, J BONE MINER RES, V13, P633, DOI 10.1359/jbmr.1998.13.4.633
   Cluzel C, 2005, J CELL BIOL, V171, P383, DOI 10.1083/jcb.200503017
   Comoglio PM, 2003, CURR OPIN CELL BIOL, V15, P565, DOI 10.1016/S0955-0674(03)00096-6
   Crouzier T, 2011, BIOMATERIALS, V32, P7543, DOI 10.1016/j.biomaterials.2011.06.062
   Crouzier T, 2011, ADV MATER, V23, pH111, DOI 10.1002/adma.201004637
   Crouzier T, 2009, SMALL, V5, P598, DOI 10.1002/smll.200800804
   Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g
   Delcommenne M, 1998, P NATL ACAD SCI USA, V95, P11211, DOI 10.1073/pnas.95.19.11211
   Dingal PCDP, 2015, NAT MATER, V14, P951, DOI [10.1038/NMAT4350, 10.1038/nmat4350]
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dopie J, 2012, P NATL ACAD SCI USA, V109, pE544, DOI 10.1073/pnas.1118880109
   Dudas M, 2004, MECH DEVELOP, V121, P173, DOI 10.1016/j.mod.2003.12.003
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320
   Foletta VC, 2003, J CELL BIOL, V162, P1089, DOI 10.1083/jcb.200212060
   Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027
   Gamell C, 2008, J CELL SCI, V121, P3960, DOI 10.1242/jcs.031286
   Gilbert PM, 2010, J CLIN INVEST, V120, P1535, DOI 10.1172/JCI39534
   Goldstein AM, 2005, MECH DEVELOP, V122, P821, DOI 10.1016/j.mod.2005.03.003
   Hanna S, 2013, CELL SIGNAL, V25, P1955, DOI 10.1016/j.cellsig.2013.04.009
   Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Ivaska J, 2011, ANNU REV CELL DEV BI, V27, P291, DOI 10.1146/annurev-cellbio-092910-154017
   KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755
   Katagiri T, 1997, EXP CELL RES, V230, P342, DOI 10.1006/excr.1996.3432
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   King WJ, 2012, ADV DRUG DELIVER REV, V64, P1239, DOI 10.1016/j.addr.2012.03.004
   Kopf J, 2014, BIOFACTORS, V40, P171, DOI 10.1002/biof.1137
   Krause U, 2010, P NATL ACAD SCI USA, V107, P4147, DOI 10.1073/pnas.0914360107
   Logeart-Avramoglou D, 2006, ANAL BIOCHEM, V349, P78, DOI 10.1016/j.ab.2005.10.030
   Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147
   Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166
   Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276
   Martino M. M., 2011, SCI TRANSL MED, V3, DOI DOI 10.1126/SCITRANSLMED.3002614
   Martino MM, 2014, SCIENCE, V343, P885, DOI 10.1126/science.1247663
   Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745
   Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051
   Mayer U, 2003, J BIOL CHEM, V278, P14587, DOI 10.1074/jbc.R200022200
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Munsie LN, 2012, J CELL SCI, V125, P3977, DOI 10.1242/jcs.097667
   Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200
   Ozeki N, 2007, BIOCHEM BIOPH RES CO, V353, P54, DOI 10.1016/j.bbrc.2006.11.110
   Pelish Henry E, 2006, Nat Chem Biol, V2, P39, DOI 10.1038/nchembio751
   Plotnikov SV, 2013, CURR OPIN CELL BIOL, V25, P619, DOI 10.1016/j.ceb.2013.06.003
   Prudent R, 2012, CANCER RES, V72, P4429, DOI 10.1158/0008-5472.CAN-11-3342
   Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003
   Ren KF, 2010, ACTA BIOMATER, V6, P4238, DOI 10.1016/j.actbio.2010.06.014
   Sailer MHM, 2005, J CELL SCI, V118, P5849, DOI 10.1242/jcs.02708
   Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006
   Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066
   Sen B, 2015, STEM CELLS, V33, P3065, DOI 10.1002/stem.2090
   Serrels B, 2007, NAT CELL BIOL, V9, P1046, DOI 10.1038/ncb1626
   Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007
   Song JF, 2014, P NATL ACAD SCI USA, V111, P7337, DOI 10.1073/pnas.1321764111
   Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104
   Tenney RM, 2009, CURR OPIN CELL BIOL, V21, P630, DOI 10.1016/j.ceb.2009.06.003
   Tomar A, 2010, DEV CELL, V18, P170, DOI 10.1016/j.devcel.2010.01.013
   Tomar A, 2009, CURR OPIN CELL BIOL, V21, P676, DOI 10.1016/j.ceb.2009.05.006
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Wang YK, 2012, STEM CELLS DEV, V21, P1176, DOI 10.1089/scd.2011.0293
   Yamamoto N, 1997, BIOCHEM BIOPH RES CO, V238, P574, DOI 10.1006/bbrc.1997.7325
   Yu PB, 2007, NAT CHEM BIOL, V4, P33, DOI DOI 10.1038/NCHEMBIO.2007.54
NR 70
TC 18
Z9 18
U1 6
U2 26
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0021-9525
EI 1540-8140
J9 J CELL BIOL
JI J. Cell Biol.
PD MAR 14
PY 2016
VL 212
IS 6
BP 693
EP 706
DI 10.1083/jcb.201508018
PG 14
WC Cell Biology
SC Cell Biology
GA DH3FC
UT WOS:000372671900011
PM 26953352
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Sudo, Y
   Nabae, Y
   Hayakawa, T
   Kakimoto, MA
AF Sudo, Yu
   Nabae, Yuta
   Hayakawa, Teruaki
   Kakimoto, Masa-Aki
TI Copolymer of hyperbranched polystyrene and poly(N-isopropylacrylamide)
   as a thermo-responsive biomaterial for cell sheet recovery
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Sudo, Yu; Nabae, Yuta; Hayakawa, Teruaki; Kakimoto, Masa-Aki] Tokyo Inst Technol, Organ & Polymer Mat, Meguro Ku, Tokyo, Japan.
EM sudo.y.ab@m.titech.ac.jp
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 13
PY 2016
VL 251
MA 57
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA VC1WR
UT WOS:000431905706536
DA 2018-10-19
ER

PT J
AU Cartwright, JHE
AF Cartwright, Julyan H. E.
TI Directed self-assembly, genomic assembly complexity and the formation of
   biological structure, or, what are the genes for nacre?
SO PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL
   AND ENGINEERING SCIENCES
LA English
DT Article
DE complexity; DNA; information; self-assembly; self-organization
AB Biology uses dynamical mechanisms of self-organization and self-assembly of materials, but it also choreographs and directs these processes. The difference between abiotic self-assembly and a biological process is rather like the difference between setting up and running an experiment to make a material remotely compared with doing it in one's own laboratory: with a remote experiment-say on the International Space Station-everything must be set up beforehand to let the experiment run 'hands off', but in the laboratory one can intervene at any point in a 'hands-on' approach. It is clear that the latter process, of directed self-assembly, can allow much more complicated experiments and produce far more complex structures than self-assembly alone. This control over self-assembly in biology is exercised at certain key waypoints along a trajectory and the process may be quantified in terms of the genomic assembly complexity of a biomaterial.
C1 [Cartwright, Julyan H. E.] Univ Granada, CSIC, Inst Andaluz Ciencias Tierra, Granada 18100, Spain.
   [Cartwright, Julyan H. E.] Univ Granada, Inst Carlos I de Fis Teor & Computac, E-18071 Granada, Spain.
RP Cartwright, JHE (reprint author), Univ Granada, CSIC, Inst Andaluz Ciencias Tierra, Granada 18100, Spain.; Cartwright, JHE (reprint author), Univ Granada, Inst Carlos I de Fis Teor & Computac, E-18071 Granada, Spain.
EM julyan.cartwright@csic.es
RI Cartwright, Julyan/C-1387-2016
OI Cartwright, Julyan/0000-0001-7392-0957
FU Spanish Ministerio de Ciencia e Innovacion [FIS2013-48444-C2-2-P]
FX This research was funded by project FIS2013-48444-C2-2-P of the Spanish
   Ministerio de Ciencia e Innovacion.
CR Beebe CW, 1906, BIRD ITS FORM FUNCTI
   Cartwright JHE, 2007, J R SOC INTERFACE, V4, P491, DOI 10.1098/rsif.2006.0188
   Cartwright JHE, 2012, PHILOS T R SOC A, V370, P2807, DOI 10.1098/rsta.2012.0106
   Cartwright JHE, 2009, P NATL ACAD SCI USA, V106, P10499, DOI 10.1073/pnas.0900867106
   Claverie JM, 2001, SCIENCE, V291, P1255, DOI 10.1126/science.1058969
   JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056
   MACKAY AL, 1986, COMPUT MATH APPL-B, V12, P803, DOI 10.1016/0898-1221(86)90426-8
   Takeuchi T, 2012, DNA RES, V19, P117, DOI 10.1093/dnares/dss005
NR 8
TC 2
Z9 2
U1 1
U2 8
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1364-503X
EI 1471-2962
J9 PHILOS T R SOC A
JI Philos. Trans. R. Soc. A-Math. Phys. Eng. Sci.
PD MAR 13
PY 2016
VL 374
IS 2063
AR 20150449
DI 10.1098/rsta.2015.0449
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DD1OE
UT WOS:000369690200021
PM 26857670
DA 2018-10-19
ER

PT J
AU Almaki, JH
   Nasiri, R
   Idris, A
   Majid, FAA
   Salouti, M
   Wong, TS
   Dabagh, S
   Marvibaigi, M
   Amini, N
AF Almaki, Javad Hamzehalipour
   Nasiri, Rozita
   Idris, Ani
   Majid, Fadzilah Adibah Abdul
   Salouti, Mojtaba
   Wong, Tet Soon
   Dabagh, Shadab
   Marvibaigi, Mohsen
   Amini, Neda
TI Synthesis, characterization and in vitro evaluation of exquisite
   targeting SPIONs-PEG-HER in HER2+human breast cancer cells
SO NANOTECHNOLOGY
LA English
DT Article
DE superparamagnetic; iron oxide nanoparticles; polyethylene glycol;
   herceptin; HER2+breast cancer
ID IRON-OXIDE NANOPARTICLES; BIOMEDICAL APPLICATIONS; MAGNETIC
   NANOPARTICLES; SUPERPARAMAGNETIC NANOPARTICLES; MAGHEMITE NANOPARTICLES;
   IMAGING AGENTS; HYPERTHERMIA; DELIVERY; THERAPY; DEXTRAN
AB A stable, biocompatible and exquisite SPIONs-PEG-HER targeting complex was developed. Initially synthesized superparamagnetic iron oxide nanoparticles (SPIONs) were silanized using 3-aminopropyltrimethoxysilane (APS) as the coupling agent in order to allow the covalent bonding of polyethylene glycol (PEG) to the SPIONs to improve the biocompatibility of the SPIONs. SPIONs-PEG were then conjugated with herceptin (HER) to permit the SPIONs-PEG-HER to target the specific receptors expressed over the surface of the HER2+ metastatic breast cancer cells. Each preparation step was physico-chemically analyzed and characterized by a number of analytical methods including AAS, FTIR spectroscopy, XRD, FESEM, TEM, DLS and VSM. The biocompatibility of SPIONs-PEG-HER was evaluated in vitro on HSF-1184 (human skin fibroblast cells), SK-BR-3 (human breast cancer cells, HER+), MDA-MB-231 (human breast cancer cells, HER-) and MDA-MB-468 (human breast cancer cells, HER-) cell lines by performing MTT and trypan blue assays. The hemolysis analysis results of the SPIONs-PEG-HER and SPIONs-PEG did not indicate any sign of lysis while in contact with erythrocytes. Additionally, there were no morphological changes seen in RBCs after incubation with SPIONs-PEG-HER and SPIONs-PEG under a light microscope. The qualitative and quantitative in vitro targeting studies confirmed the high level of SPION-PEG-HER binding to SK-BR-3 (HER2+ metastatic breast cancer cells). Thus, the results reflected that the SPIONs-PEG-HER can be chosen as a favorable biomaterial for biomedical applications, chiefly magnetic hyperthermia, in the future.
C1 [Almaki, Javad Hamzehalipour; Nasiri, Rozita; Idris, Ani; Majid, Fadzilah Adibah Abdul; Wong, Tet Soon] Univ Teknol Malaysia, Fac Chem Engn, Dept Bioproc Engn, Johor Baharu 81310, Johor, Malaysia.
   [Salouti, Mojtaba] Islamic Azad Univ, Zanjan Branch, Biol Res Ctr, Zanjan, Iran.
   [Dabagh, Shadab] Univ Teknol Malaysia, Ibnu Sina Inst Fundamental Sci Studies, Johor Baharu 81310, Johor, Malaysia.
   [Marvibaigi, Mohsen; Amini, Neda] Univ Teknol Malaysia, Fac Biomed Engn, Johor Baharu 81310, Johor, Malaysia.
RP Idris, A (reprint author), Univ Teknol Malaysia, Fac Chem Engn, Dept Bioproc Engn, Johor Baharu 81310, Johor, Malaysia.
EM ani@cheme.utm.my
FU Universiti Teknologi Malaysia [Q. J130000.2524.06H09]
FX The authors would like to thank the Universiti Teknologi Malaysia for
   the financial support through Geran Universiti Penyelidikan (GUP)
   funding number Q. J130000.2524.06H09.
CR Alexiou C, 2000, CANCER RES, V60, P6641
   Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m
   Bean C.P., 1959, Journal of Applied Physics, V30, p120S, DOI 10.1063/1.2185850
   Berry CC, 2003, BIOMATERIALS, V24, P4551, DOI 10.1016/S0142-9612(03)00237-0
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Brusentsov NA, 2001, J MAGN MAGN MATER, V225, P113, DOI 10.1016/S0304-8853(00)01238-5
   Cheng FY, 2005, BIOMATERIALS, V26, P729, DOI 10.1016/j.biomaterials.2004.03.016
   Cheraghipour E, 2013, J MAGN MAGN MATER, V328, P91, DOI 10.1016/j.jmmm.2012.09.042
   Durgadas CV, 2012, BIOMATERIALS, V33, P6420, DOI 10.1016/j.biomaterials.2012.05.051
   Eghtedari M., 2008, NANO LETT, V9, P287
   Eghtedari M, 2009, NANO LETT, V9, P287, DOI 10.1021/nl802915q
   Flesch C, 2005, COLLOID SURFACE A, V262, P150, DOI 10.1016/j.colsurfa.2005.04.039
   Fura A, 2003, J PHARMACEUT BIOMED, V32, P513, DOI 10.1016/S0731-7085(03)00159-6
   Gokce G, 2004, RES VET SCI, V76, P121, DOI 10.1016/j.rvsc.2003.08.009
   Gref R, 2012, ADV DRUG DELIVER REV, V64, P316, DOI 10.1016/j.addr.2012.09.008
   Gruttner C, 2007, J MAGN MAGN MATER, V311, P181, DOI 10.1016/j.jmmm.2006.10.1151
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Habib AH, 2008, J APPL PHYS, V103, DOI 10.1063/1.2830975
   Hergt R, 2007, J MAGN MAGN MATER, V311, P187, DOI 10.1016/j.jmmm.2006.10.1156
   Herve K, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/46/465608
   Hilger I, 2004, EUR RADIOL, V14, P1124, DOI 10.1007/s00330-004-2257-9
   Hu FQ, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/24/245604
   Hu S, 2008, CLIN CANCER RES, V14, P6246, DOI 10.1158/1078-0432.CCR-07-5037
   Idris A, 2012, J IND ENG CHEM, V18, P1582, DOI 10.1016/j.jiec.2012.02.018
   Idris A, 2010, WATER RES, V44, P1683, DOI 10.1016/j.watres.2009.11.026
   Jayalekshmi AC, 2013, COLLOID SURFACE B, V101, P196, DOI 10.1016/j.colsurfb.2012.06.027
   Juang TY, 2014, MOLECULES, V19, P4997, DOI 10.3390/molecules19044997
   Lattuada M, 2007, J AM CHEM SOC, V129, P12878, DOI 10.1021/ja0740521
   de Freitas ERL, 2008, J NANOSCI NANOTECHNO, V8, P2385, DOI 10.1166/jnn.2008.275
   Liu C, 1999, SOIL SCI SOC AM J, V63, P65, DOI 10.2136/sssaj1999.03615995006300010011x
   Longmire M, 2008, NANOMEDICINE-UK, V3, P703, DOI 10.2217/17435889.3.5.703
   Lubbe AS, 1996, CANCER RES, V56, P4686
   Maiti D, 2013, CRYST GROWTH DES, V13, P3637, DOI 10.1021/cg400627c
   Mansour N, 2013, PHYS SCRIPTA, V87, DOI 10.1088/0031-8949/87/03/035701
   MASSART R, 1981, IEEE T MAGN, V17, P1247, DOI 10.1109/TMAG.1981.1061188
   Mehvar R, 2000, J CONTROL RELEASE, V69, P1, DOI 10.1016/S0168-3659(00)00302-3
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mukhopadhyay A., 2011, ACS APPL MATER INTER, V4, P142
   Munnier E, 2010, NANOPARTICLE RES, V13, P959
   Neuberger T, 2005, J MAGN MAGN MATER, V293, P483, DOI 10.1016/j.jmmm.2005.01.064
   Nigam S., 2010, J MAGN MAGN MATER, V323, P237
   Patel N, 1997, LANGMUIR, V13, P6485, DOI 10.1021/la970933h
   Patil MP, 2011, BRAZ J PHARM SCI, V47, P161, DOI 10.1590/S1984-82502011000100020
   Quaglia F, 2006, INT J PHARM, V324, P56, DOI 10.1016/j.ijpharm.2006.07.020
   Racuciu M, 2006, EUR PHYS J E, V21, P117, DOI 10.1140/epje/i2006-10051-y
   Reis E. F., 2006, MAT RES, V9, P185, DOI DOI 10.1590/S1516-14392006000200014
   Rouhana LL, 2007, LANGMUIR, V23, P12799, DOI 10.1021/la702151q
   Sadjadi MS, 2013, J NANO RES-SW, V21, P37, DOI 10.4028/www.scientific.net/JNanoR.21.37
   Saraswathy A, 2014, CARBOHYD POLYM, V101, P760, DOI 10.1016/j.carbpol.2013.10.015
   Shukla SK, 2013, INT J ELECTROCHEM SC, V8, P11711
   Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128
   Sun B, 2008, BIOMATERIALS, V29, P475, DOI 10.1016/j.biomaterials.2007.09.038
   Sun C, 2006, J BIOMED MATER RES A, V78A, P550, DOI 10.1002/jbm.a.30781
   Theivasanthi T., 2010, ARXIV10036068
   Tran T, 2007, BIOCONJUGATE CHEM, V18, P1956, DOI 10.1021/bc7002617
   Vayssieres L, 1998, J COLLOID INTERF SCI, V205, P205, DOI 10.1006/jcis.1998.5614
   Wang H, 2004, LANGMUIR, V20, P1877, DOI 10.1021/la035376f
   Wang TW, 2007, J BIOMED MATER RES A, V83A, P828, DOI 10.1002/jbm.a.31411
   Wilhelm C, 2008, SMALL, V4, P577, DOI 10.1002/smll.200700523
   Wu W, 2010, NANOSCALE RES LETT, V5, P1474, DOI 10.1007/s11671-010-9664-4
   Xie J, 2009, CURR MED CHEM, V16, P1278, DOI 10.2174/092986709787846604
   Xu CJ, 2004, J AM CHEM SOC, V126, P3392, DOI 10.1021/ja031776d
   Yu M, 2012, INT J MOL SCI, V13, P5554, DOI 10.3390/ijms13055554
   Zhang YF, 2008, CHEM RES CHINESE U, V24, P697
NR 64
TC 11
Z9 11
U1 2
U2 38
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
EI 1361-6528
J9 NANOTECHNOLOGY
JI Nanotechnology
PD MAR 11
PY 2016
VL 27
IS 10
AR 105601
DI 10.1088/0957-4484/27/10/105601
PG 13
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA DD3US
UT WOS:000369849200010
PM 26861770
DA 2018-10-19
ER

PT J
AU Chen, JN
   Suenaga, H
   Hogg, M
   Li, W
   Swain, M
   Li, Q
AF Chen, Junning
   Suenaga, Hanako
   Hogg, Michael
   Li, Wei
   Swain, Michael
   Li, Qing
TI Determination of oral mucosal Poisson's ratio and coefficient of
   friction from in-vivo contact pressure measurements
SO COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING
LA English
DT Article
DE oral mucosa; apparent Poisson's ratio; friction coefficient; in vivo
   contact pressure; hyperelastic finite element analysis; response surface
   method
ID 3-DIMENSIONAL FINITE-ELEMENT; RESIDUAL RIDGE RESORPTION;
   STRESS-ANALYSIS; PAIN THRESHOLD; DENTURE; BIOMECHANICS; TISSUE;
   OSSEOINTEGRATION; WETTABILITY; XEROSTOMIA
AB Despite their considerable importance to biomechanics, there are no existing methods available to directly measure apparent Poisson's ratio and friction coefficient of oral mucosa. This study aimed to develop an inverse procedure to determine these two biomechanical parameters by utilizing in vivo experiment of contact pressure between partial denture and beneath mucosa through nonlinear finite element (FE) analysis and surrogate response surface (RS) modelling technique. First, the in vivo denture-mucosa contact pressure was measured by a tactile electronic sensing sheet. Second, a 3D FE model was constructed based on the patient CT images. Third, a range of apparent Poisson's ratios and the coefficients of friction from literature was considered as the design variables in a series of FE runs for constructing a RS surrogate model. Finally, the discrepancy between computed in silico and measured in vivo results was minimized to identify the best matching Poisson's ratio and coefficient of friction. The established non-invasive methodology was demonstrated effective to identify such biomechanical parameters of oral mucosa and can be potentially used for determining the biomaterial properties of other soft biological tissues.
C1 [Chen, Junning; Hogg, Michael; Li, Wei; Li, Qing] Univ Sydney, Sch Aerosp Mech & Mechatron Engn, Sydney, NSW 2006, Australia.
   [Suenaga, Hanako] Tohoku Univ, Grad Sch Dent, Div Prevent Dent, Aoba Ku, Sendai, Miyagi 9808575, Japan.
   [Swain, Michael] Univ Sydney, Fac Dent, Sydney, NSW 2006, Australia.
RP Li, Q (reprint author), Univ Sydney, Sch Aerosp Mech & Mechatron Engn, Sydney, NSW 2006, Australia.
EM qing.li@sydney.edu.au
RI Swain, Michael/J-7266-2017; Li, Qing/B-3422-2009; Chen,
   Junning/F-5287-2016; Chen, Junning/J-4864-2018
OI Li, Qing/0000-0002-7930-2145; Chen, Junning/0000-0001-7121-0994; Chen,
   Junning/0000-0001-7121-0994
FU Australian Research Council (ARC); Australian Postgraduate Award (APA)
FX This work was supported by Australian Research Council (ARC) through the
   Discovery and Fellowship schemes. The first author is a recipient of
   Australian Postgraduate Award (APA) in his Ph. D. study.
CR Ahmad R, 2013, CLIN ORAL IMPLAN RES, V24, P1273, DOI 10.1111/j.1600-0501.2012.02566.x
   Bergomi M, 2011, J BIOMECH, V44, P34, DOI 10.1016/j.jbiomech.2010.08.019
   Braga IU, 2013, COMPUT METHOD BIOMEC, V16, P954, DOI 10.1080/10255842.2011.645227
   Chen JN, 2015, J BIOMECH, V48, P512, DOI 10.1016/j.jbiomech.2014.11.043
   Chen JN, 2013, J MECH BEHAV BIOMED, V20, P387, DOI 10.1016/j.jmbbm.2012.08.019
   Clason Christian, 2004, Computer Methods in Biomechanics and Biomedical Engineering, V7, P265, DOI 10.1080/10255840412331313590
   Field C, 2010, J BIOMECH, V43, P1771, DOI 10.1016/j.jbiomech.2010.02.016
   HART RT, 1992, J BIOMECH, V25, P261, DOI 10.1016/0021-9290(92)90025-V
   Igarashi Y, 1999, J ORAL REHABIL, V26, P111, DOI 10.1046/j.1365-2842.1999.00345.x
   Inoue K, 1985, Dent Mater J, V4, P47
   Isobe A, 2013, J PROSTHODONT RES, V57, P275, DOI 10.1016/j.jpor.2013.07.002
   Kanbara R, 2012, DENT MATER J, V31, P297, DOI 10.4012/dmj.2011-165
   Keenan KE, 2009, COMPUT METHOD BIOMEC, V12, P415, DOI 10.1080/10255840802654319
   Kishi M, 1972, SHIKWA GAKUHO, V72, P1043
   Klemetti E, 1996, J PROSTHET DENT, V75, P512, DOI 10.1016/S0022-3913(96)90455-2
   KORIOTH TWP, 1992, AM J PHYS ANTHROPOL, V88, P69, DOI 10.1002/ajpa.1330880107
   Kubo K, 2009, J PROSTHODONT RES, V53, P15, DOI 10.1016/j.jpor.2008.08.006
   KYDD WL, 1974, J PROSTHET DENT, V32, P493, DOI 10.1016/0022-3913(74)90003-1
   KYDD WL, 1982, J PROSTHET DENT, V47, P317, DOI 10.1016/0022-3913(82)90162-7
   Lacoste-Ferre MH, 2011, J MECH BEHAV BIOMED, V4, P269, DOI 10.1016/j.jmbbm.2010.10.005
   LESCH CA, 1989, J DENT RES, V68, P1345, DOI 10.1177/00220345890680091101
   Limbert Georges, 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P337, DOI 10.1080/10255840310001637572
   Ogawa T, 2003, J ORAL REHABIL, V30, P1062, DOI 10.1046/j.1365-2842.2003.01183.x
   Prinz JF, 2007, FOOD HYDROCOLLOID, V21, P402, DOI 10.1016/j.foodhyd.2006.05.005
   Ranc H, 2006, COLLOID SURFACE A, V276, P155, DOI 10.1016/j.colsurfa.2005.10.033
   Rashmikant US, 2012, J PROSTHET DENT, V108, P332, DOI 10.1016/S0022-3913(12)60188-7
   Rungsiyakull C, 2010, BIOMATERIALS, V31, P7196, DOI 10.1016/j.biomaterials.2010.05.077
   Satoh Y, 2000, J ORAL REHABIL, V27, P660, DOI 10.1046/j.1365-2842.2000.00566.x
   Sawada A, 2011, J DENT RES, V90, P590, DOI 10.1177/0022034510396881
   SCAPINO RP, 1967, J MORPHOL, V122, P89, DOI 10.1002/jmor.1051220203
   Sonune SJ, 2013, INT J PROSTHODONT RE, V2, P34, DOI [10.5005/jp-journals-10019-1044, DOI 10.5005/JP-JOURNALS-10019-1044]
   SQUIER C A, 1991, Critical Reviews in Oral Biology and Medicine, V2, P13
   Squier C A, 2001, J Natl Cancer Inst Monogr, P7
   Suenaga H, 2015, J DENT RES, V94, P738, DOI 10.1177/0022034515573271
   Tadepalli SC, 2011, J BIOMECH, V44, P2337, DOI 10.1016/j.jbiomech.2011.05.006
   Thelin WR, 2008, ORAL DIS, V14, P683, DOI 10.1111/j.1601-0825.2008.01486.x
   Turner M, 2008, J AM DENT ASSOC, V139, P146, DOI 10.14219/jada.archive.2008.0129
   Wakabayashi Noriyuki, 2013, J Dent Biomech, V4, p1758736013483298, DOI 10.1177/1758736013483298
   Wang HY, 2011, J PROSTHET DENT, V105, P338, DOI 10.1016/S0022-3913(11)60066-8
   Wang YC, 2002, INT J SOLIDS STRUCT, V39, P4825, DOI 10.1016/S0020-7683(02)00379-7
   Waters MGJ, 1999, J PROSTHET DENT, V81, P439, DOI 10.1016/S0022-3913(99)80011-0
   Wood SA, 2011, J BIOMECH, V44, P1831, DOI 10.1016/j.jbiomech.2011.03.022
   Wright PS, 2002, CLIN ORAL IMPLAN RES, V13, P169, DOI 10.1034/j.1600-0501.2002.130207.x
   Zmudzki J, 2012, J MECH MED BIOL, V12, DOI 10.1142/S021951941250087X
   Zmudzki J, 2012, ACTA BIOENG BIOMECH, V14, P67, DOI 10.5277/abb120309
NR 45
TC 4
Z9 4
U1 1
U2 22
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1025-5842
EI 1476-8259
J9 COMPUT METHOD BIOMEC
JI Comput. Methods Biomech. Biomed. Eng.
PD MAR 11
PY 2016
VL 19
IS 4
BP 357
EP 365
DI 10.1080/10255842.2015.1028925
PG 9
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical
SC Computer Science; Engineering
GA CY8IA
UT WOS:000366650800002
PM 26024011
DA 2018-10-19
ER

PT J
AU Schulte, C
   Rodighiero, S
   Cappelluti, MA
   Puricelli, L
   Maffioli, E
   Borghi, F
   Negri, A
   Sogne, E
   Galluzzi, M
   Piazzoni, C
   Tamplenizza, M
   Podesta, A
   Tedeschi, G
   Lenardi, C
   Milani, P
AF Schulte, Carsten
   Rodighiero, Simona
   Cappelluti, Martino Alfredo
   Puricelli, Luca
   Maffioli, Elisa
   Borghi, Francesca
   Negri, Armando
   Sogne, Elisa
   Galluzzi, Massimiliano
   Piazzoni, Claudio
   Tamplenizza, Margherita
   Podesta, Alessandro
   Tedeschi, Gabriella
   Lenardi, Cristina
   Milani, Paolo
TI Conversion of nanoscale topographical information of cluster-assembled
   zirconia surfaces into mechanotransductive events promotes neuronal
   differentiation
SO JOURNAL OF NANOBIOTECHNOLOGY
LA English
DT Article
DE Mechanotransduction; Focal adhesion; Biomaterial; Integrin; Atomic force
   microscopy; Biophysics; Cell adhesion; Proteomics
ID NERVE GROWTH-FACTOR; REGULATES NEURITE OUTGROWTH; STRESS FIBER
   ORGANIZATION; FOCAL ADHESION PROTEIN; NEURAL STEM-CELLS; MYOSIN-II;
   EXTRACELLULAR-MATRIX; INTEGRIN ACTIVATION; SIGNALING PATHWAYS; ACIDIC
   CALPONIN
AB Background: Thanks to mechanotransductive components cells are competent to perceive nanoscale topographical features of their environment and to convert the immanent information into corresponding physiological responses. Due to its complex configuration, unraveling the role of the extracellular matrix is particularly challenging. Cell substrates with simplified topographical cues, fabricated by top-down micro- and nanofabrication approaches, have been useful in order to identify basic principles. However, the underlying molecular mechanisms of this conversion remain only partially understood.
   Results: Here we present the results of a broad, systematic and quantitative approach aimed at understanding how the surface nanoscale information is converted into cell response providing a profound causal link between mechanotransductive events, proceeding from the cell/nanostructure interface to the nucleus. We produced nanostructured ZrO2 substrates with disordered yet controlled topographic features by the bottom-up technique supersonic cluster beam deposition, i.e. the assembling of zirconia nanoparticles from the gas phase on a flat substrate through a supersonic expansion. We used PC12 cells, a well-established model in the context of neuronal differentiation. We found that the cell/nanotopography interaction enforces a nanoscopic architecture of the adhesion regions that affects the focal adhesion dynamics and the cytoskeletal organization, which thereby modulates the general biomechanical properties by decreasing the rigidity of the cell. The mechanotransduction impacts furthermore on transcription factors relevant for neuronal differentiation (e.g. CREB), and eventually the protein expression profile. Detailed proteomic data validated the observed differentiation. In particular, the abundance of proteins that are involved in adhesome and/or cytoskeletal organization is striking, and their up- or downregulation is in line with their demonstrated functions in neuronal differentiation processes.
   Conclusion: Our work provides a deep insight into the molecular mechanotransductive mechanisms that realize the conversion of the nanoscale topographical information of SCBD-fabricated surfaces into cellular responses, in this case neuronal differentiation. The results lay a profound cell biological foundation indicating the strong potential of these surfaces in promoting neuronal differentiation events which could be exploited for the development of prospective research and/or biomedical applications. These applications could be e.g. tools to study mechanotransductive processes, improved neural interfaces and circuits, or cell culture devices supporting neurogenic processes.
C1 [Schulte, Carsten; Puricelli, Luca; Borghi, Francesca; Galluzzi, Massimiliano; Piazzoni, Claudio; Podesta, Alessandro; Lenardi, Cristina; Milani, Paolo] Univ Milan, Dipartimento Fis, CIMAINA, Via Celoria 16, I-20133 Milan, Italy.
   [Cappelluti, Martino Alfredo; Sogne, Elisa] SEMM European Sch Mol Med, Via Adamello 16, I-20139 Milan, Italy.
   [Maffioli, Elisa; Negri, Armando; Tedeschi, Gabriella] Univ Milan, DIVET, Via Celoria 10, I-20133 Milan, Italy.
   [Rodighiero, Simona; Cappelluti, Martino Alfredo; Maffioli, Elisa; Negri, Armando; Sogne, Elisa; Tamplenizza, Margherita; Tedeschi, Gabriella] Fdn Filarete, Via Ortles 22-4, I-20139 Milan, Italy.
RP Schulte, C; Milani, P (reprint author), Univ Milan, Dipartimento Fis, CIMAINA, Via Celoria 16, I-20133 Milan, Italy.
EM carsten.schulte@unimi.it; paolo.milani@mi.infn.it
RI Tedeschi, Gabriella/I-6247-2017; Piazzoni, Claudio/V-9080-2017; Schulte,
   Carsten/R-2370-2016; Galluzzi, Massimiliano/M-8854-2016; Lenardi,
   Cristina/J-5872-2012; Maffioli, Elisa/U-5511-2017; Negri,
   Armando/H-7914-2017; Podesta, Alessandro/E-6568-2010
OI Tedeschi, Gabriella/0000-0003-2082-6443; Piazzoni,
   Claudio/0000-0002-8052-8053; Schulte, Carsten/0000-0002-7554-5342;
   Galluzzi, Massimiliano/0000-0003-0404-4783; Lenardi,
   Cristina/0000-0002-5522-6803; Maffioli, Elisa/0000-0002-5539-1825;
   Negri, Armando/0000-0002-8401-7437; Podesta,
   Alessandro/0000-0002-4169-6679
FU Italian Ministry of University and Research, MIUR, through the "National
   Funding for Basic Research" (FIRB) [FIRB RBA-P11AYN]; European project
   FutureNanoNeeds "Framework to respond to regulatory needs of future
   nanomaterials and markets" [FP7-NMP-2013-LARGE-7]
FX This work has been supported by the Italian Ministry of University and
   Research, MIUR, through the "National Funding for Basic Research" (FIRB)
   with a project entitled "Oxides at the nanoscale: functionalities and
   applications" (FIRB RBA-P11AYN) and by the European project
   FutureNanoNeeds "Framework to respond to regulatory needs of future
   nanomaterials and markets" (FP7-NMP-2013-LARGE-7). COST Action TD1002 is
   acknowledged for providing a stimulating scientific environment for the
   discussion of AFM-based nanomechanics of cells and soft matter. We are
   very grateful for the work of Andrea Notarnicola and Davide Alessandro
   Martella who provided a valuable contribution for some of the cell
   biological experiments and their quantifications. We are also thankful
   for the help of Massimiliano Garre from the Imaging Unit of IFOM (The
   FIRC Institute of Molecular Oncology) in the TIRF microscopy
   experiments.
CR Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002
   Argenzio E, 2014, J CELL SCI, V127, P5189, DOI 10.1242/jcs.150623
   Barabasi A.L., 1995, FRACTAL CONCEPTS SUR, DOI [10.1017/CBO9780511599798, DOI 10.1017/CB09780511599798, 10.1017/CB09780511599798]
   Barnat M, 2010, J NEUROSCI, V30, P7804, DOI 10.1523/JNEUROSCI.0372-10.2010
   Betz T, 2011, P NATL ACAD SCI USA, V108, P13420, DOI 10.1073/pnas.1106145108
   Brunetti V, 2010, P NATL ACAD SCI USA, V107, P6264, DOI 10.1073/pnas.0914456107
   Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003
   Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Chen WQ, 2014, NANO TODAY, V9, P759, DOI 10.1016/j.nantod.2014.12.002
   Chevallier J, 2009, FEBS LETT, V583, P1096, DOI 10.1016/j.febslet.2009.03.012
   Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   Chua JS, 2014, BIOMATERIALS, V35, P7750, DOI 10.1016/j.biomaterials.2014.06.008
   Ciobanasu C, 2013, EUR J CELL BIOL, V92, P339, DOI 10.1016/j.ejcb.2013.10.009
   Cohan CS, 2001, CELL MOTIL CYTOSKEL, V48, P109, DOI 10.1002/1097-0169(200102)48:2<109::AID-CM1002>3.0.CO;2-G
   Coutts AS, 2003, J CELL SCI, V116, P897, DOI 10.1242/jcs.00278
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Cramer H., 1945, MATH METHODS STAT
   Dalby MJ, 2014, NAT MATER, V13, P558, DOI [10.1038/NMAT3980, 10.1038/nmat3980]
   Deerinck TJ, 2010, NCMIR METHODS FOR 3D
   Diz-Munoz A, 2013, TRENDS CELL BIOL, V23, P47, DOI 10.1016/j.tcb.2012.09.006
   Elkhatib N, 2014, CURR BIOL, V24, P1492, DOI 10.1016/j.cub.2014.05.023
   Ferhat L, 2001, J CELL SCI, V114, P3899
   Ferraris GMS, 2014, EMBO J, V33, P2458, DOI 10.15252/embj.201387611
   Flynn Kevin C, 2013, Bioarchitecture, V3, P86
   Foley JD, 2005, BIOMATERIALS, V26, P3639, DOI 10.1016/j.biomaterials.2004.09.048
   Franze K, 2013, ANNU REV BIOMED ENG, V15, P227, DOI 10.1146/annurev-bioeng-071811-150045
   Fu XQ, 2013, J NEUROSCI, V33, P709, DOI 10.1523/JNEUROSCI.4603-12.2013
   Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153
   Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036
   Gasiorowski JZ, 2013, ANNU REV BIOMED ENG, V15, P155, DOI 10.1146/annurev-bioeng-071811-150021
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Geiger T, 2012, CURR OPIN CELL BIOL, V24, P562, DOI 10.1016/j.ceb.2012.05.004
   Griffith E, 2005, CELL MOTIL CYTOSKEL, V60, P140, DOI 10.1002/cm.20052
   Guo JY, 2010, CYTOSKELETON, V67, P431, DOI 10.1002/cm.20455
   Head BP, 2014, BBA-BIOMEMBRANES, V1838, P532, DOI 10.1016/j.bbamem.2013.07.018
   Horzum U, 2014, METHODSX, V1, P56, DOI 10.1016/j.mex.2014.06.004
   Huang JH, 2009, NANO LETT, V9, P1111, DOI 10.1021/nl803548b
   Humphries JD, 2015, TRENDS CELL BIOL, V25, P388, DOI 10.1016/j.tcb.2015.02.008
   Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551
   Impey S, 2004, CELL, V119, P1041, DOI 10.1016/S0092-8674(04)01159-6
   Indrieri M, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3553499
   Iskratsch T, 2014, NAT REV MOL CELL BIO, V15, P825, DOI 10.1038/nrm3903
   Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574
   Joo E, 2007, DEV CELL, V13, P677, DOI 10.1016/j.devcel.2007.09.001
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y
   Kotov NA, 2009, ADV MATER, V21, P3970, DOI 10.1002/adma.200801984
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   LEE NH, 1995, P NATL ACAD SCI USA, V92, P8303, DOI 10.1073/pnas.92.18.8303
   Liu Y, 2014, NANO LETT, V14, P5539, DOI 10.1021/nl501912g
   Loudon RR, 2006, J NEUROBIOL, V66, P847, DOI 10.1002/neu.20258
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Mendes PM, 2013, CHEM SOC REV, V42, P9207, DOI 10.1039/c3cs60198f
   Merz K, 2011, EUR J NEUROSCI, V33, P1078, DOI 10.1111/j.1460-9568.2011.07606.x
   Meyer CJ, 2000, NAT CELL BIOL, V2, P666
   Migliorini E, 2011, BIOTECHNOL BIOENG, V108, P2736, DOI 10.1002/bit.23232
   Mingorance-Le Meur A, 2009, EMBO J, V28, P248, DOI 10.1038/emboj.2008.265
   Miyamoto S, 1996, J CELL BIOL, V135, P1633, DOI 10.1083/jcb.135.6.1633
   Murphy WL, 2014, NAT MATER, V13, P547, DOI [10.1038/NMAT3937, 10.1038/nmat3937]
   Myers JP, 2011, DEV NEUROBIOL, V71, P901, DOI 10.1002/dneu.20931
   O'Toole M, 2015, BIOPHYS J, V108, P1027, DOI 10.1016/j.bpj.2015.01.021
   Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007
   Park I, 2011, BIOCHEM J, V434, P171, DOI 10.1042/BJ20101473
   Plantier M, 1999, EUR J NEUROSCI, V11, P2801, DOI 10.1046/j.1460-9568.1999.00702.x
   Podesta A, 2015, J APPL PHYS, V118, DOI 10.1063/1.4937549
   Puricelli L, 2015, REV SCI INSTRUM, V86, DOI 10.1063/1.4915896
   Rami G, 2006, HIPPOCAMPUS, V16, P183, DOI 10.1002/hipo.20145
   Riccio A, 2010, NAT NEUROSCI, V13, P1330, DOI 10.1038/nn.2671
   Rocca DL, 2013, NEURON, V79, P293, DOI 10.1016/j.neuron.2013.05.003
   Sakurai M, 2006, J CELL SCI, V119, P162, DOI 10.1242/jcs.02716
   Santiago-Medina M, 2013, J CELL SCI, V126, P1122, DOI 10.1242/jcs.112607
   Schaefer AW, 2008, DEV CELL, V15, P146, DOI 10.1016/j.devcel.2008.05.003
   Schense JC, 2000, J BIOL CHEM, V275, P6813, DOI 10.1074/jbc.275.10.6813
   Schlienger S, 2015, CELL SIGNAL, V27, P403, DOI 10.1016/j.cellsig.2014.11.032
   Schulte C, 2016, EUR J CELL BIOL, V95, P1, DOI 10.1016/j.ejcb.2015.10.002
   Schulte C, 2010, TRAFFIC, V11, P1304, DOI 10.1111/j.1600-0854.2010.01095.x
   Schvartzman M, 2011, NANO LETT, V11, P1306, DOI 10.1021/nl104378f
   Scopelliti PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011862
   Singh AV, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/47/475101
   SPIEGELMAN BM, 1979, CELL, V16, P253, DOI 10.1016/0092-8674(79)90003-5
   Storr SJ, 2011, NAT REV CANCER, V11, P364, DOI 10.1038/nrc3050
   Sukharev S, 2012, J CELL SCI, V125, P3075, DOI 10.1242/jcs.092353
   Sun YB, 2014, NAT MATER, V13, P599, DOI [10.1038/NMAT3945, 10.1038/nmat3945]
   Tamplenizza M, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-35
   Tigyi G, 1996, J NEUROCHEM, V66, P537
   Tong ZX, 2015, EMBO J, V34, P987, DOI 10.15252/embj.201490756
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   van Kesteren RE, 2006, J NEUROSCI, V26, P152, DOI 10.1523/JNEUROSCI.4164-05.2006
   Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552
   Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594
   Wegner K, 2006, J PHYS D APPL PHYS, V39, pR439, DOI 10.1088/0022-3727/39/22/R02
   Westerink RHS, 2008, ACTA PHYSIOL, V192, P273, DOI 10.1111/j.1748-1716.2007.01805.x
   WINDER SJ, 1992, BIOCHEM J, V288, P733, DOI 10.1042/bj2880733
   Winograd-Katz SE, 2014, NAT REV MOL CELL BIO, V15, P273, DOI 10.1038/nrm3769
   Woo S, 2006, J NEUROSCI, V26, P1418, DOI 10.1523/JNEUROSCI.4209-05.2006
   Yamaguchi Y, 2001, J BIOL CHEM, V276, P18977, DOI 10.1074/jbc.M100254200
   Yang K, 2014, ACS NANO, V8, P7809, DOI 10.1021/nn501182f
   Yim EKF, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt132
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
   Yudin D, 2009, J CELL SCI, V122, P587, DOI 10.1242/jcs.015289
   Zhang J, 2009, SCIENCE, V325, P1250, DOI 10.1126/science.1174921
NR 103
TC 13
Z9 14
U1 0
U2 23
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1477-3155
J9 J NANOBIOTECHNOL
JI J. Nanobiotechnol.
PD MAR 9
PY 2016
VL 14
AR 18
DI 10.1186/s12951-016-0171-3
PG 24
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA DG9JH
UT WOS:000372398100002
PM 26955876
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Wassenaar, JW
   Gaetani, R
   Garcia, JJ
   Braden, RL
   Luo, CG
   Huang, D
   DeMaria, AN
   Omens, JH
   Christman, KL
AF Wassenaar, Jean W.
   Gaetani, Roberto
   Garcia, Julian J.
   Braden, Rebecca L.
   Luo, Colin G.
   Huang, Diane
   DeMaria, Anthony N.
   Omens, Jeffrey H.
   Christman, Karen L.
TI Evidence for Mechanisms Underlying the Functional Benefits of a
   Myocardial Matrix Hydrogel for Post-MI Treatment
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article
DE biomaterial; extracellular matrix; heart failure; infarction; microarray
ID CARDIAC STEM-CELLS; HEART REGENERATION; GENE-EXPRESSION; ADULT HEART;
   MAST-CELLS; IN-VIVO; INFARCTION; REPAIR; BIOMATERIALS; RESPONSES
AB BACKGROUND There is increasing need for better therapies to prevent the development of heart failure after myocardial infarction (MI). An injectable hydrogel derived from decellularized porcine ventricular myocardium has been shown to halt the post-infarction progression of negative left ventricular remodeling and decline in cardiac function in both small and large animal models.
   OBJECTIVES This study sought to elucidate the tissue-level mechanisms underlying the therapeutic benefits of myocardial matrix injection.
   METHODS Myocardial matrix or saline was injected into infarcted myocardium 1 week after ischemia-reperfusion in Sprague-Dawley rats. Cardiac function was evaluated by magnetic resonance imaging and hemodynamic measurements at 5 weeks after injection. Whole transcriptome microarrays were performed on RNA isolated from the infarct at 3 days and 1 week after injection. Quantitative polymerase chain reaction and histologic quantification confirmed expression of key genes and their activation in altered pathways.
   RESULTS Principal component analysis of the transcriptomes showed that samples collected from myocardial matrix-injected infarcts are distinct and cluster separately from saline-injected control subjects. Pathway analysis indicated that these differences are due to changes in several tissue processes that may contribute to improved cardiac healing after MI. Matrix-injected infarcted myocardium exhibits an altered inflammatory response, reduced cardiomyocyte apoptosis, enhanced infarct neovascularization, diminished cardiac hypertrophy and fibrosis, altered metabolic enzyme expression, increased cardiac transcription factor expression, and progenitor cell recruitment, along with improvements in global cardiac function and hemodynamics.
   CONCLUSIONS These results indicate that the myocardial matrix alters several key pathways after MI creating a pro-regenerative environment, further demonstrating its promise as a potential post-MI therapy. (C) 2016 by the American College of Cardiology Foundation.
C1 [Wassenaar, Jean W.; Gaetani, Roberto; Garcia, Julian J.; Braden, Rebecca L.; Omens, Jeffrey H.; Christman, Karen L.] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA.
   [Wassenaar, Jean W.; Gaetani, Roberto; Garcia, Julian J.; Braden, Rebecca L.; Christman, Karen L.] Univ Calif San Diego, Sanford Consortium Regenerat Med, La Jolla, CA 92093 USA.
   [Luo, Colin G.; Huang, Diane; DeMaria, Anthony N.; Omens, Jeffrey H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
RP Christman, KL (reprint author), Univ Calif San Diego, Dept Bioengn, 2880 Torrey Pines Scen Dr, La Jolla, CA 92037 USA.
EM christman@eng.ucsd.edu
FU National Institutes of Health National Heart, Lung, and Blood Institute
   [1R01HL113468]; California Institute for Regenerative Medicine; American
   Heart Association; University of California, San Diego Medical Scientist
   Training Program [T32 GM007198-40]
FX This research was funded in part by the National Institutes of Health
   National Heart, Lung, and Blood Institute (1R01HL113468). Ms. Wassenaar
   was supported by predoctoral fellowships from the California Institute
   for Regenerative Medicine and the American Heart Association, as well as
   the University of California, San Diego Medical Scientist Training
   Program T32 GM007198-40. Dr. DeMaria is a scientific advisory board
   member of Ventrix, Inc. Dr. Christman is a co-founder, board member,
   consultant, and holds equity interest in Ventrix, Inc. All other authors
   have reported that they have no relationships relevant to the contents
   of this paper disclose.
CR Akhmedov AT, 2012, HEART FAIL REV, V18, P815
   Aminzadeh MA, 2015, EUR HEART J, V36, P751, DOI 10.1093/eurheartj/ehu196
   Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI 10.1172/JCI72181
   Azakie A, 2006, J THORAC CARDIOV SUR, V132, P1262, DOI 10.1016/j.jtcvs.2006.08.005
   Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018
   Burt RK, 2012, CIRC RES, V111, P1286, DOI 10.1161/CIRCRESAHA.111.262584
   Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1
   Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080
   Delewi R, 2013, HEART, V99, P225, DOI 10.1136/heartjnl-2012-302230
   Duncan J, 2012, TRANSLATIONAL CARDIO, P83
   Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039
   Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5
   French KM, 2012, ACTA BIOMATER, V8, P4357, DOI 10.1016/j.actbio.2012.07.033
   Furtado MB, 2014, CIRC RES, V114, P1422, DOI 10.1161/CIRCRESAHA.114.302530
   Huang JH, 2009, P NATL ACAD SCI USA, V106, P18734, DOI 10.1073/pnas.0910749106
   Jameel MN, 2010, AM J PHYSIOL-HEART C, V298, pH1348, DOI 10.1152/ajpheart.01100.2009
   Jin H, 2001, CIRCULATION, V103, P736
   Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255
   Lachtermacher S, 2012, STEM CELL REV REP, V8, P251, DOI 10.1007/s12015-011-9282-2
   Laurencin C.T., 2012, SCI TRANSL MED, V4, P160
   Lee SH, 2000, NEW ENGL J MED, V342, P626, DOI 10.1056/NEJM200003023420904
   Leri A, 2011, CIRC RES, V109, P941, DOI 10.1161/CIRCRESAHA.111.243154
   Marin-Garcia J, 2011, SIGNALING IN THE HEART, P155, DOI 10.1007/978-1-4419-9461-5_9
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   NEELY JR, 1974, ANNU REV PHYSIOL, V36, P413, DOI 10.1146/annurev.ph.36.030174.002213
   Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4
   Palojoki E, 2001, AM J PHYSIOL-HEART C, V280, pH2726
   Pavo N, 2014, BIOMATERIALS, V35, P3541, DOI 10.1016/j.biomaterials.2013.12.071
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Shen T, 2011, J CLIN INVEST, V121, P4640, DOI 10.1172/JCI59472
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Somasundaram P, 2005, J PATHOL, V205, P102, DOI 10.1002/path.1690
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Toko H, 2002, J BIOL CHEM, V277, P24735, DOI 10.1074/jbc.M107669200
   Ungerleider JL, 2014, STEM CELL TRANSL MED, V3, P1090, DOI 10.5966/sctm.2014-0049
   van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309
   Virag JI, 2003, AM J PATHOL, V163, P2433, DOI 10.1016/S0002-9440(10)63598-5
   Wang ZV, 2014, J CARDIOVASC PHARM, V63, P302, DOI 10.1097/FJC.0000000000000054
   Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619
NR 42
TC 20
Z9 21
U1 1
U2 34
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
EI 1558-3597
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD MAR 8
PY 2016
VL 67
IS 9
BP 1074
EP 1086
DI 10.1016/j.jacc.2015.12.035
PG 13
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DE9DV
UT WOS:000370936800011
PM 26940929
OA Green Accepted, Bronze
DA 2018-10-19
ER

PT J
AU Costa, KD
AF Costa, Kevin D.
TI Decellularized Scaffold Hydrogel Materials for MI Treatment Could "The
   Matrix" Really Be the Future?
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Editorial Material
DE biomaterial; extracellular matrix; heart failure; infarction; tissue
   engineering
ID HEART; MYOCARDIUM; INFARCTION; DISEASE; IMPACT; MODEL
C1 [Costa, Kevin D.] Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, One Gustave L Levy Pl,Box 1030, New York, NY 10029 USA.
RP Costa, KD (reprint author), Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, One Gustave L Levy Pl,Box 1030, New York, NY 10029 USA.
EM kevin.costa@mssm.edu
CR Delewi R, 2014, EUR HEART J, V35, P989, DOI 10.1093/eurheartj/eht372
   Johnson TD, 2016, PROTEOM CLIN APPL, V10, P75, DOI 10.1002/prca.201500048
   Lee RJ, 2015, INT J CARDIOL, V199, P18, DOI 10.1016/j.ijcard.2015.06.111
   Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350
   Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818
   Sanchez PL, 2015, BIOMATERIALS, V61, P279, DOI 10.1016/j.biomaterials.2015.04.056
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Sultana N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9701
   Turnbull IC, 2014, FASEB J, V28, P644, DOI 10.1096/fj.13-228007
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wassenaar JW, 2016, J AM COLL CARDIOL, V67, P1074, DOI 10.1016/j.jacc.2015.12.035
   Wei K, 2015, NATURE, V525, P479, DOI 10.1038/nature15372
NR 13
TC 2
Z9 2
U1 0
U2 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
EI 1558-3597
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD MAR 8
PY 2016
VL 67
IS 9
BP 1087
EP 1090
DI 10.1016/j.jacc.2016.01.006
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DE9DV
UT WOS:000370936800012
PM 26940930
OA Bronze
DA 2018-10-19
ER

PT J
AU Chen, H
   Ji, XR
   Zhang, Q
   Tian, XZ
   Zhang, BX
   Tang, PF
AF Chen, Hua
   Ji, Xin-Ran
   Zhang, Qun
   Tian, Xue-Zhong
   Zhang, Bo-Xun
   Tang, Pei-Fu
TI Effects of Calcium Sulfate Combined with Platelet-rich Plasma on
   Restoration of Long Bone Defect in Rabbits
SO CHINESE MEDICAL JOURNAL
LA English
DT Article
DE Bone Restoration; Calcium Sulfate; Long Bone Defect; Platelet-rich
   Plasma
ID MORPHOGENETIC PROTEIN-2; GRAFT; REGENERATION; ENHANCEMENT; BIOMATERIAL;
   SCAFFOLDS; REPAIR
AB +/- Background: The treatment for long bone defects has been a hot topic in the field of regenerative medicine. This study aimed to evaluate the therapeutic effects of calcium sulfate (CS) combined with platelet-rich plasma (PRP) on long bone defect restoration.
   Methods: A radial bone defect model was constructed through an osteotomy using New Zealand rabbits. The rabbits were randomly divided into four groups (n = 10 in each group): a CS combined with PRP (CS-PRP) group, a CS group, a PRP group, and a positive (recombinant human bone morphogenetic protein-2) control group. PRP was prepared from autologous blood using a two-step centrifugation process. CS-PRP was obtained by mixing hemihydrate CS with PRP. Radiographs and histologic micrographs were generated. The percentage of bone regenerated bone area in each rabbit was calculated at 10 weeks. One-way analysis of variance was performed in this study.
   Results: The radiographs and histologic micrographs showed bone restoration in the CS-PRP and positive control groups, while nonunion was observed in the CS and PRP groups. The percentages of bone regenerated bone area in the CS-PRP (84.60 +/- 2.87%) and positive control (52.21 +/- 4.53%) groups were significantly greater than those in the CS group (12.34 +/- 2.17%) and PRP group (16.52 +/- 4.22%) (P < 0.001). In addition, the bone strength of CS-PRP group (43.10 +/- 4.10%) was significantly greater than that of the CS group (20.10 +/- 3.70%) or PRP group (25.10 +/- 2.10%) (P < 0.001).
   Conclusion: CS-PRP functions as an effective treatment for long bone defects through stimulating bone regeneration and enhancing new bone strength.
C1 [Chen, Hua; Ji, Xin-Ran; Zhang, Qun; Zhang, Bo-Xun; Tang, Pei-Fu] Chinese Peoples Liberat Army Gen Hosp, Dept Orthopaed, Beijing 100038, Peoples R China.
   [Tian, Xue-Zhong] Peoples Hosp Tianjin, Dept Orthopaed, Tianjin 300131, Peoples R China.
RP Tang, PF (reprint author), Chinese Peoples Liberat Army Gen Hosp, Dept Orthopaed, Beijing 100038, Peoples R China.
EM tangpf301@163.com
CR Bateman J, 2005, J PERIODONTOL, V76, P1833, DOI 10.1902/jop.2005.76.11.1833
   Borrelli J, 2003, CLIN ORTHOP RELAT R, P245, DOI 10.1097/01.blo.0000069893.31220.6f
   Chen TL, 2014, J CRANIOFAC SURG, V25, P215, DOI 10.1097/SCS.0000000000000420
   Cui X, 2008, J CRANIOFAC SURG, V19, P459, DOI 10.1097/SCS.0b013e31815ca034
   [崔旭 CUI Xu], 2009, [中华医学杂志, National Medical Journal of China], V89, P777
   Durmuslar MC, 2014, ACTA ODONTOL SCAND, V72, P948, DOI 10.3109/00016357.2014.926023
   Intini G, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-13
   Kutkut A, 2012, J PERIODONTOL, V83, P401, DOI 10.1902/jop.2011.110237
   Luca L, 2011, J BIOMED MATER RES A, V96A, P66, DOI 10.1002/jbm.a.32957
   Lyons F, 2012, J BONE JOINT SURG BR, V94, P162
   Marx R E, 2001, Implant Dent, V10, P225
   Sanchez AR, 2003, INT J ORAL MAX IMPL, V18, P93
   Shanmugarajan S, 2007, J CHILD NEUROL, V22, P967, DOI 10.1177/0883073807305664
   Shi B, 2006, INT J ORAL MAXILLOF, V22, P656
   Simson J, 2013, J ORTHOP RES, V31, P392, DOI 10.1002/jor.22247
   Tadokoro M, 2012, J TISSUE ENG REGEN M, V6, P253, DOI 10.1002/term.427
   Thomas MV, 2009, J BIOMED MATER RES B, V88B, P597, DOI 10.1002/jbm.b.31269
   Wang ML, 2008, SPINE J, V8, P340, DOI 10.1016/j.spinee.2007.06.003
   Wojtowicz AM, 2010, BIOMATERIALS, V31, P2574, DOI 10.1016/j.biomaterials.2009.12.008
   Zhang M, 2014, ARTIF ORGANS, V38, P493, DOI 10.1111/aor.12208
NR 20
TC 3
Z9 4
U1 0
U2 12
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0366-6999
J9 CHINESE MED J-PEKING
JI Chin. Med. J.
PD MAR 5
PY 2016
VL 129
IS 5
BP 557
EP 561
DI 10.4103/0366-6999.176981
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA DG7WF
UT WOS:000372293700009
PM 26904990
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Li, RC
   Zhang, XT
   Zhang, QY
   Liu, HH
   Rong, JH
   Tu, M
   Zeng, R
   Zhao, JH
AF Li, Ruicong
   Zhang, Xiaoting
   Zhang, Qiuyu
   Liu, Huahua
   Rong, Jianhua
   Tu, Mei
   Zeng, Rong
   Zhao, Jianhao
TI beta-cyclodextrin-conjugated hyaluronan hydrogel as a potential drug
   sustained delivery carrier for wound healing
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biomaterial; crosslinking; drug delivery systems; gels; polysaccharides
ID ACID HYDROGELS; CONTROLLED-RELEASE; NETWORKS; DEGRADATION; REGENERATION;
   MECHANISMS; BEHAVIORS; COMPLEXES; COMPOSITE; CELLULOSE
AB In order to develop a potential drug sustained delivery carrier suitable for wound healing, a series of beta-cyclodextrin conjugated hyaluronan hydrogels (beta-CD-HA) with adjustable crosslink densities were synthesized and characterized, meanwhile the delivery kinetics and mechanism of diclofenac as a model anti-inflammatory drug from these hydrogels were investigated. By controlling the feeding molar ratio of beta-CD/HA, a beta-CD substitution degree of 4.65% was obtained by H-1-NMR analysis. The incorporation of beta-CD modification had little effect on the internal porous structure, water swelling ratio, and rheological property of HA hydrogel, which however were influenced by the crosslink density. Although the crosslink density had an influence on the drug loading and release profile by altering the water swelling property, the interaction between beta-CD and drug was the primary factor for the high loading capacity and long-term sustained delivery of diclofenac. The semiempirical equation fit showed that the release of diclofenac from HA-based hydrogels followed a pseudo-Fickian diffusion mechanism. By the aid of beta-CD and controlled crosslink density, a beta-CD-HA hydrogel with a diclofenac sustained delivery period of over 28 days and desirable physicochemical properties was achieved, which will be a promising drug sustained delivery carrier for wound healing. (C) 2015 Wiley Periodicals, Inc.
C1 [Li, Ruicong; Zhang, Xiaoting; Zhang, Qiuyu; Liu, Huahua; Rong, Jianhua; Tu, Mei; Zeng, Rong; Zhao, Jianhao] Jinan Univ, Coll Sci & Technol, Dept Mat Sci & Engn, Guangzhou 510632, Guangdong, Peoples R China.
   [Rong, Jianhua; Tu, Mei; Zeng, Rong; Zhao, Jianhao] Minist Educ, Engn Res Ctr Artificial Organs & Mat, Guangzhou 510632, Guangdong, Peoples R China.
RP Zhao, JH (reprint author), Jinan Univ, Coll Sci & Technol, Dept Mat Sci & Engn, Guangzhou 510632, Guangdong, Peoples R China.
EM jhzhao@jnu.edu.cn
FU National Natural Science Foundation of China [30900296, 51173070,
   21344001]; Science and Technology Planning Project of Guangdong Province
   of China [2015A010105017, 2015A020214014]; National Undergraduate
   Training Programs for Innovation and Entrepreneurship [201510559007,
   1055915021, CX15020, CX15028, 15123001]
FX The authors are thankful to the financial support from the National
   Natural Science Foundation of China (No. 30900296, 51173070, 21344001),
   Science and Technology Planning Project of Guangdong Province of China
   (No. 2015A010105017, 2015A020214014) and National Undergraduate Training
   Programs for Innovation and Entrepreneurship (No. 201510559007,
   1055915021, CX15020, CX15028, 15123001).
CR Antunes BP, 2015, CARBOHYD POLYM, V130, P104, DOI 10.1016/j.carbpol.2015.04.072
   Borzacchiello A., 2015, BIOMED RES INT, V2015
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Chen MC, 2009, BIOMATERIALS, V30, P2102, DOI 10.1016/j.biomaterials.2008.12.047
   Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Dahlmann J, 2013, BIOMATERIALS, V34, P940, DOI 10.1016/j.biomaterials.2012.10.008
   Dang QF, 2011, CARBOHYD POLYM, V83, P171, DOI 10.1016/j.carbpol.2010.07.038
   Das S, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40318
   Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701
   Flory P. J, 1953, PRINCIPLES POLYM CHE
   Flynn TC, 2015, DERMATOL SURG, V41, pS143, DOI 10.1097/01.DSS.0000452647.14389.a7
   Gharib R, 2015, CARBOHYD POLYM, V129, P175, DOI 10.1016/j.carbpol.2015.04.048
   Gopalan SM, 2003, BIOTECHNOL BIOENG, V81, P578, DOI 10.1002/bit.10506
   Gupta A, 2013, J APPL POLYM SCI, V128, P4031, DOI 10.1002/app.38594
   Hahn SK, 2004, J BIOMAT SCI-POLYM E, V15, P1111, DOI 10.1163/1568562041753115
   Jeon O, 2007, CARBOHYD POLYM, V70, P251, DOI 10.1016/j.carbpol.2007.04.002
   Kim IL, 2011, BIOMATERIALS, V32, P8771, DOI 10.1016/j.biomaterials.2011.08.073
   Korhonen M, 2001, INT J PHARM, V221, P187, DOI 10.1016/S0378-5173(01)00675-5
   Li NN, 2014, MAT SCI ENG C-MATER, V36, P287, DOI 10.1016/j.msec.2013.12.025
   Liu YY, 2005, BIOMATERIALS, V26, P6367, DOI 10.1016/j.biomaterials.2005.04.011
   Loftsson T, 2007, INT J PHARM, V329, P1, DOI 10.1016/j.ijpharm.2006.10.044
   Lou C. H., 2015, MAT SCI ENG C, V46, P316
   Lou Y., 2000, J CONTROL RELEASE, V69, P169
   Luo CH, 2014, MAT SCI ENG C-MATER, V36, P301, DOI 10.1016/j.msec.2013.12.021
   Marsano E, 2000, POLYMER, V41, P7691, DOI 10.1016/S0032-3861(00)00142-7
   Menke NB, 2007, CLIN DERMATOL, V25, P19, DOI 10.1016/j.clindermatol.2006.12.005
   Metters A T, 1999, Biomed Sci Instrum, V35, P33
   Peng K, 2010, SOFT MATTER, V6, P85, DOI 10.1039/b914166a
   PETTER RC, 1990, J AM CHEM SOC, V112, P3860, DOI 10.1021/ja00166a021
   Rizzi SC, 2006, BIOMACROMOLECULES, V7, P3019, DOI 10.1021/bm060504a
   Rodriguez-Tenreiro C, 2007, EUR J PHARM BIOPHARM, V66, P55, DOI 10.1016/j.ejpb.2006.09.003
   Rodriguez-Tenreiro C., 2006, J PHARM RES, V23, P121, DOI DOI 10.1007/S11095-005-8924-Y
   Rodriguez-Vita J, 2010, CYTOKINE GROWTH F R, V21, P61, DOI 10.1016/j.cytogfr.2009.11.006
   dos Santos JFR, 2009, BIOMATERIALS, V30, P1348, DOI [10.1016/j.biomaterials.2008.11.016, 10.1016/j.biomaterials.2008:11.016]
   Roy S., 2013, DISORDER LOCALIZED I, P173
   Sahiner N, 2008, J BIOMAT SCI-POLYM E, V19, P223, DOI 10.1163/156856208783432462
   Schneider HJ, 1998, CHEM REV, V98, P1755, DOI 10.1021/cr970019t
   Stella VJ, 1999, ADV DRUG DELIVER REV, V36, P3, DOI 10.1016/S0169-409X(98)00052-0
   Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c
   Tan HP, 2009, BIOMATERIALS, V30, P6844, DOI 10.1016/j.biomaterials.2009.08.058
   Tang WL, 2013, J APPL POLYM SCI, V127, P2803, DOI 10.1002/app.37607
   UEKAMA K, 1994, DRUG TARG D, V3, P411
   Zainuddin J. J., 2002, J BIOMAT SCI-POLYM E, V13, P1007
   Zhang YL, 2002, J BIOMED MATER RES, V59, P318, DOI 10.1002/jbm.1248
   Zhao JH, 2011, CARBOHYD POLYM, V86, P806, DOI 10.1016/j.carbpol.2011.05.026
NR 46
TC 1
Z9 1
U1 4
U2 84
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD MAR 5
PY 2016
VL 133
IS 9
AR 43072
DI 10.1002/app.43072
PG 8
WC Polymer Science
SC Polymer Science
GA DA5NQ
UT WOS:000367850200016
DA 2018-10-19
ER

PT J
AU Harvey, VL
   Egerton, VM
   Chamberlain, AT
   Manning, PL
   Buckley, M
AF Harvey, Virginia L.
   Egerton, Victoria M.
   Chamberlain, Andrew T.
   Manning, Phillip L.
   Buckley, Michael
TI Collagen Fingerprinting: A New Screening Technique for Radiocarbon
   Dating Ancient Bone
SO PLOS ONE
LA English
DT Article
ID ARCHAEOLOGICAL BONE; SPECIES IDENTIFICATION; PRESERVATION; PRETREATMENT;
   INDICATORS; SURVIVAL; SITES; AMS
AB Collagen is the dominant organic component of bone and is intimately locked within the hydroxyapatite structure of this ubiquitous biomaterial that dominates archaeological and palaeontological assemblages. Radiocarbon analysis of extracted collagen is one of the most common approaches to dating bone from late Pleistocene or Holocene deposits, but dating is relatively expensive compared to other biochemical techniques. Numerous analytical methods have previously been investigated for the purpose of screening out samples that are unlikely to yield reliable dates including histological analysis, UV-stimulated fluorescence and, most commonly, the measurement of percentage nitrogen (% N) and ratio of carbon to nitrogen (C:N). Here we propose the use of collagen fingerprinting (also known as Zooarchaeology by Mass Spectrometry, or ZooMS, when applied to species identification) as an alternative screening method for radiocarbon dating, due to its ability to provide information on collagen presence and quality, alongside species identification. The method was tested on a series of sub-fossil bone specimens from cave systems on Cayman Brac (Cayman Islands), chosen due to the observable range in diagenetic alteration, and in particular, the extent of mineralisation. Six C-14 dates, of 18 initial attempts, were obtained from remains of extinct hutia, Capromys sp. (Rodentia; Capromyidae), recovered from five distinct caves on Cayman Brac, and ranging from 393 +/- 25 to 1588 +/- 26 radiocarbon years before present (yr BP). All of the bone samples that yielded radiocarbon dates generated excellent collagen fingerprints, and conversely those that gave poor fingerprints also failed dating. Additionally, two successfully fingerprinted bone samples were screened out from a set of 81. Both subsequently generated C-14 dates, demonstrating successful utilisation of ZooMS as an alternative screening mechanism to identify bone samples that are suitable for C-14 analysis.
C1 [Harvey, Virginia L.; Egerton, Victoria M.; Manning, Phillip L.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England.
   [Egerton, Victoria M.; Manning, Phillip L.] Coll Charleston, Dept Geol & Environm Geosci, 66 George St, Charleston, SC 29424 USA.
   [Chamberlain, Andrew T.; Buckley, Michael] Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England.
RP Buckley, M (reprint author), Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England.
EM m.buckley@manchester.ac.uk
RI Manning, Phillip/F-9966-2011; Chamberlain, Andrew/F-2118-2018
OI Manning, Phillip/0000-0002-7161-6246; Buckley,
   Michael/0000-0002-4166-8213; Harvey, Virginia/0000-0003-0796-8287
FU NERC New Investigator research grant [NE/K000799/1]; NERC fellowship
   [NE/H015132/1]; Royal Society [UF120473]; Science and Technology
   Facilities Council [ST/M001814/1]; Natural Environment Research Council;
   Science and Technology Facilities Council (STFC); Natural Environment
   Research Council [NE/K000799/1, NE/H015132/1]
FX This work was supported by NERC New Investigator research grant
   (NE/K000799/1), NERC fellowship (NE/H015132/1) and Royal Society
   (UF120473) fellowship funding to MB; Science and Technology Facilities
   Council (ST/M001814/1) fellowship funding to PM.; Sincere thanks go to
   Andrew Kitchener (National Museums Scotland) for help in the acquisition
   of the reference sample. Our many thanks also go to Oxford Radiocarbon
   Accelerator Unit (ORAU) and the University of Manchester's Faculty of
   Life Sciences Biomolecular Analysis core facility for access to
   instrumentation. We thank the editor and two anonymous reviewers for
   their useful comments on earlier versions of the manuscript. We also
   thank the Natural Environment Research Council, the Royal Society, and
   Science and Technology Facilities Council (STFC) for providing funding
   to make this research possible.
CR Aitken M. J., 2014, SCI BASED DATING ARC
   Brock F, 2013, RADIOCARBON, V55, P445, DOI 10.1017/S0033822200057581
   Brock F, 2007, EH RES DEP REP SER, V30, P2007
   Brock F, 2012, RADIOCARBON, V54, P879, DOI 10.1017/S0033822200047524
   Bronk Ramsey C., 2008, ARCHAEOMETRY, V50, P249, DOI DOI 10.1111/J.1475-4754.2008.00394.X)
   Bronk Ramsey C., 2002, ARCHAEOMETRY, V44, P1, DOI DOI 10.1111/J.1475-4754.2002.TB01101.X
   Buckley M, 2014, J ARCHAEOL SCI, V41, P631, DOI 10.1016/j.jas.2013.08.021
   Buckley M, 2016, RAPID COMMUNICATIONS, V30, P1
   Buckley M., 2011, ANTIQUA, V1, P1, DOI DOI 10.4081/ANTIQUA.2011.E1
   Buckley M, 2008, J ARCHAEOL SCI, V35, P1756, DOI 10.1016/j.jas.2007.11.022
   Buckley M, 2009, RAPID COMMUN MASS SP, V23, P3843, DOI 10.1002/rcm.4316
   Buckley M, 2011, ARCHAEOL ANTHROP SCI, V3, P271, DOI 10.1007/s12520-011-0066-z
   Buckley M, 2010, J ARCHAEOL SCI, V37, P13, DOI 10.1016/j.jas.2009.08.020
   Chiu TC, 2007, QUATERNARY SCI REV, V26, P18, DOI 10.1016/j.quascirev.2006.06.015
   Collins MJ, 2002, ARCHAEOMETRY, V44, P383, DOI 10.1111/1475-4754.t01-1-00071
   Davalos Liliana M., 2012, P157
   GOODFRIEND GA, 1983, GEOLOGY, V11, P575, DOI 10.1130/0091-7613(1983)11<575:LATPOR>2.0.CO;2
   Halcrow SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098462
   Hedges REM, 2002, ARCHAEOMETRY, V44, P319, DOI 10.1111/1475-4754.00064
   HEDGES REM, 1992, RADIOCARBON, V34, P279
   Hoke N, 2011, PALAEOGEOGR PALAEOCL, V310, P23, DOI 10.1016/j.palaeo.2011.03.021
   Holmes KM, 2005, J ARCHAEOL SCI, V32, P157, DOI 10.1016/j.jas.2004.06.002
   Jans MME, 2002, ARCHAEOMETRY, V44, P343, DOI 10.1111/1475-4754.t01-1-00067
   Marom A, 2012, P NATL ACAD SCI USA, V109, P6878, DOI 10.1073/pnas.1116328109
   Morgan GS, 1994, MONOGRAPHIAE BIOL, P465
   Pestle WJ, 2012, J ARCHAEOL SCI, V39, P2079, DOI 10.1016/j.jas.2012.03.008
   Ramsey CB, 2013, RADIOCARBON, V55, P2021
   Ramsey CB, 2004, RADIOCARBON, V46, P17
   Ramsey CB, 2004, RADIOCARBON, V46, P155
   Rybczynski N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2516
   Steadman DW, 2005, P NATL ACAD SCI USA, V102, P11763, DOI 10.1073/pnas.0502777102
   STEADMAN DW, 1985, P BIOL SOC WASH, V98, P544
   Turner-Walker G, 2002, INT J OSTEOARCHAEOL, V12, P407, DOI 10.1002/oa.642
   van der Sluis LG, 2014, PALAEOGEOGR PALAEOCL, V416, P80, DOI 10.1016/j.palaeo.2014.06.003
   Van Klinken GJ, 1999, J ARCHAEOL SCI, V26, P687, DOI 10.1006/jasc.1998.0385
NR 35
TC 13
Z9 13
U1 1
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 3
PY 2016
VL 11
IS 3
AR e0150650
DI 10.1371/journal.pone.0150650
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DG0EB
UT WOS:000371735200128
PM 26938469
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Choudhury, M
   Talukdar, B
   Dass, NN
   Baruah, KC
   Devi, D
AF Choudhury, Manasee
   Talukdar, Bijit
   Dass, Narendra Nath
   Baruah, Kanak Chandra
   Devi, Dipali
TI Impact of BSA and casein on chemical modification of muga silk fiber
SO JOURNAL OF THE TEXTILE INSTITUTE
LA English
DT Article
DE graft copolymerization; muga silk fiber; BSA; casein; 2; 2'
   azobisisobutyronitrile (AIBN)
ID METHYL-METHACRYLATE MMA; GRAFT-COPOLYMERIZATION; PHYSICAL-PROPERTIES;
   VINYL MONOMERS; REDOX SYSTEM; FIBROIN; FILMS; ACID; METHYLMETHACRYLATE;
   POLYMERIZATION
AB The study reports on the effects of bovine serum albumin and casein on grafting of muga (Antheraea assamensis Helfer) silk fibers using initiator 2,2' azobisisobutyronitrile. FTIR studies confirm the chemical binding of the proteins onto muga fibers through shifting of the major amide bonds, accredited to grafting. Scanning electron microscopy imaging reveals rugged morphology of the grafted fibers, due to the imprints of granular proteins. Tensile strength of the fibers increases with the augmentation in grafting percent. The grafted fibers showed no loss in weight after chemical resistance measurement indicating stable bond formation between the proteins and the fibers. Moreover, the water retention capacity and dynamic contact angle study of grafted fibers suggest better hydrophobicity. Thus, the use of such eco-friendly grafting agents for enhancing the strength and stability of silk fiber proves to be more beneficial than to other chemical grafting agents in producing efficient and environment-friendly silk for various applications in textile and other biomaterial fields.
C1 [Choudhury, Manasee; Talukdar, Bijit; Devi, Dipali] Inst Adv Study Sci & Technol, Div Life Sci, Seribiotech Unit, Gauhati, India.
   [Dass, Narendra Nath] Inst Adv Study Sci & Technol, Div Phys Sci, Gauhati, India.
   [Baruah, Kanak Chandra] Forens Sci Lab, Shillong, Meghalaya, India.
RP Devi, D (reprint author), Inst Adv Study Sci & Technol, Div Life Sci, Seribiotech Unit, Gauhati, India.
EM dipali.devi@gmail.com
FU Department of Science and Technology, Ministry of Science and Technology
   [IASST/PF/2012-13/2145-2153]
FX This work was supported by the Department of Science and Technology,
   Ministry of Science and Technology [grant number
   IASST/PF/2012-13/2145-2153].
CR Das A, 2001, J APPL POLYM SCI, V81, P2633, DOI 10.1002/app.1707
   Das A, 2000, BIORESOURCE TECHNOL, V74, P213, DOI 10.1016/S0960-8524(00)00020-1
   Das AM, 2010, INDIAN J FIBRE TEXT, V35, P107
   Deka H, 2012, J POLYM MATER, V29, P37
   Devi D, 2011, J TEXT I, V102, P527, DOI 10.1080/00405000.2010.498172
   Dong QZ, 2000, J APPL POLYM SCI, V77, P2543
   Dutta S., 2012, GLOBAL J BIOSCIENCE, V2, P229
   Dutta S, 2013, BIOPOLYMERS, V99, P326, DOI 10.1002/bip.22168
   Freddi G, 1997, J POLYM SCI POL PHYS, V35, P841, DOI 10.1002/(SICI)1099-0488(19970415)35:5<841::AID-POLB13>3.0.CO;2-A
   Freddi G, 1996, J SOC DYERS COLOUR, V112, P191
   Freddi G, 2003, J BIOTECHNOL, V106, P101, DOI 10.1016/j.jbiotec.2003.09.006
   Freddi G., 1996, POLYM MAT ENCY, V10, P7734
   Gu F., 2009, FOOD CHEM, V120, P505
   HAFIZ SAA, 1995, J APPL POLYM SCI, V55, P997, DOI 10.1002/app.1995.070550704
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Huang P, 2010, J NANOMATER, V2010, P6
   Kawahara Y, 1999, J MACROMOL SCI PHYS, VB38, P471, DOI 10.1080/00222349908212445
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   Kweon HY, 2000, POLYMER, V41, P7361, DOI 10.1016/S0032-3861(00)00100-2
   Liu X, 2012, ANALYST, V137, P4552, DOI 10.1039/c2an35700c
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Mandal BB, 2008, BIOTECHNOL BIOENG, V100, P1237, DOI 10.1002/bit.21835
   MISHRA MK, 1982, J APPL POLYM SCI, V27, P2403, DOI 10.1002/app.1982.070270710
   Nguyen T. T., 2010, J CHEM, V48, P637
   Ojah R, 2006, BIORESOURCE TECHNOL, V97, P1529, DOI 10.1016/j.biortech.2005.06.009
   Peng Q, 2006, J APPL POLYM SCI, V100, P1299, DOI 10.1002/app.23408
   Perez-Rigueiro J, 2000, J APPL POLYM SCI, V75, P1270, DOI 10.1002/(SICI)1097-4628(20000307)75:10<1270::AID-APP8>3.3.CO;2-3
   Perez-Rigueiro J, 2002, J APPL POLYM SCI, V84, P1431, DOI 10.1002/app.10366
   Prachayawarakorn J., 2005, J SCI TECHNOL, V27, P1233
   SAMAL RK, 1983, J APPL POLYM SCI, V28, P1311, DOI 10.1002/app.1983.070280405
   SAMAL S, 1984, J APPL POLYM SCI, V29, P2007, DOI 10.1002/app.1984.070290609
   Sheikh M. R. K., 2006, J APPL SCI, V6, P1954
   Shimizu M., 2000, STRUCTURE SILK YARN, P7
   Song Y, 2006, POLYM INT, V55, P1350, DOI 10.1002/pi.2093
   Taghizadeh M. T., 2001, SCI ISLAMIC REPUBLIC, V12, P333
   TSUKADA M, 1988, J POLYM SCI POL PHYS, V26, P949, DOI 10.1002/polb.1988.090260418
   TSUKADA M, 1992, J APPL POLYM SCI, V44, P2203, DOI 10.1002/app.1992.070441217
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Zhao J., 2007, J MACROMOLECULAR SCI, V44, P299
NR 40
TC 1
Z9 1
U1 4
U2 27
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0040-5000
EI 1754-2340
J9 J TEXT I
JI J. Text. Inst.
PD MAR 3
PY 2016
VL 107
IS 3
BP 346
EP 354
DI 10.1080/00405000.2015.1034926
PG 9
WC Materials Science, Textiles
SC Materials Science
GA DA6FZ
UT WOS:000367899300008
DA 2018-10-19
ER

PT J
AU Jia, XT
   Wang, CY
   Zhao, C
   Ge, Y
   Wallace, GG
AF Jia, Xiaoteng
   Wang, Caiyun
   Zhao, Chen
   Ge, Yu
   Wallace, Gordon G.
TI Toward Biodegradable Mg-Air Bioelectric Batteries Composed of Silk
   Fibroin-Polypyrrole Film
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID BOMBYX-MORI; BIOMEDICAL APPLICATIONS; CONDUCTING POLYMERS; DEVICES;
   BIOMATERIAL; ELECTRONICS; NANOPARTICLES; CYTOTOXICITY; STIMULATION;
   REDUCTION
AB Biodegradable active implantable devices can be used to diagnose and/or treat disease and eventually disappear without surgical removal. If an "external" energy source is required for effective operation then a biocompatible and biodegradable battery would be ideal. In this study, a partially biodegradable Mg-air bioelectric battery (biobattery) is demonstrated using a silk fibroin-polypyrrole (SF-PPy) film cathode coupled with bioresorbable Mg alloy anode in phosphate buffered saline (PBS) electrolyte. PPy is chemically coated onto one side of the silk substrate. SF-PPy film shows a conductivity of approximate to 1.1 S cm(-1) and a mild catalytic activity toward oxygen reduction. It degrades in a concentrated buffered protease XIV solution, with a weight loss of 82% after 15 d. The assembled Mg-air biobattery exhibits a discharge capacity up to 3.79 mA h cm(-2) at a current of 10 mu A cm(-2) at room temperature, offering a specific energy density of approximate to 4.70 mW h cm(-2). This novel partially biodegradable battery provides another step along the route to biodegradable batteries.
C1 [Jia, Xiaoteng; Wang, Caiyun; Zhao, Chen; Ge, Yu; Wallace, Gordon G.] Univ Wollongong, Intelligent Polymer Res Inst, ARC Ctr Excellence Electromat Sci, AIIM Facil, Innovat Campus, Wollongong, NSW 2522, Australia.
RP Wang, CY; Wallace, GG (reprint author), Univ Wollongong, Intelligent Polymer Res Inst, ARC Ctr Excellence Electromat Sci, AIIM Facil, Innovat Campus, Wollongong, NSW 2522, Australia.
EM caiyun@uow.edu.au; gwallace@uow.edu.au
RI Wallace, Gordon/H-1123-2011; Wang, Caiyun/A-2938-2013
OI Wallace, Gordon/0000-0002-0381-7273; Wang, Caiyun/0000-0001-9539-2155;
   Zhao, Chen/0000-0001-9848-4418
FU Australian Research Council Centre of Excellence [CE 140100012]; ARC
   [FL110100196]
FX Funding from the Australian Research Council Centre of Excellence Scheme
   (Project Number CE 140100012) is gratefully acknowledged. G.G.W. is
   grateful to the ARC for support under the Australian Laureate Fellowship
   scheme (FL110100196). The authors would like to thank the Australian
   National Nanofabrication Facility-Materials node (ANFF) and the UoW
   Electron Microscopy Centre for equipment use.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   Balint R, 2014, ACTA BIOMATER, V10, P2341, DOI 10.1016/j.actbio.2014.02.015
   Bettinger CJ, 2010, ADV MATER, V22, P651, DOI 10.1002/adma.200902322
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   DAVIDSON RG, 1995, SYNTHETIC MET, V72, P121, DOI 10.1016/0379-6779(94)02332-S
   Gordijo CR, 2010, ADV FUNCT MATER, V20, P1404, DOI 10.1002/adfm.200901581
   Guo BL, 2013, PROG POLYM SCI, V38, P1263, DOI 10.1016/j.progpolymsci.2013.06.003
   Ha SW, 2005, BIOMACROMOLECULES, V6, P1722, DOI 10.1021/bm050010y
   Hu WW, 2014, MAT SCI ENG C-MATER, V37, P28, DOI 10.1016/j.msec.2013.12.019
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Hwang SW, 2014, ADV MATER, V26, P1992, DOI 10.1002/adma.201304821
   Hwang SW, 2012, SCIENCE, V337, P1640, DOI 10.1126/science.1226325
   Irimia-Vladu M, 2014, CHEM SOC REV, V43, P588, DOI 10.1039/c3cs60235d
   Jeong YS, 2011, BIOMATERIALS, V32, P7217, DOI 10.1016/j.biomaterials.2011.06.020
   Jia XT, 2014, ACS APPL MATER INTER, V6, P21110, DOI 10.1021/am505985z
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Khomenko VG, 2005, ELECTROCHIM ACTA, V50, P1675, DOI 10.1016/j.electacta.2004.10.024
   Kim DH, 2012, P NATL ACAD SCI USA, V109, P19910, DOI 10.1073/pnas.1205923109
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/nmat2745, 10.1038/NMAT2745]
   Kim S, 2011, BIOMATERIALS, V32, P2342, DOI 10.1016/j.biomaterials.2010.11.080
   Kim YJ, 2013, P NATL ACAD SCI USA, V110, P20912, DOI 10.1073/pnas.1314345110
   Kim YJ, 2013, J MATER CHEM B, V1, P3781, DOI 10.1039/c3tb20183j
   Kong Y, 2012, SYNTHETIC MET, V162, P584, DOI 10.1016/j.synthmet.2012.01.021
   Lee Y, 2013, IEEE J SOLID-ST CIRC, V48, P229, DOI 10.1109/JSSC.2012.2221233
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   LI YF, 1989, SYNTHETIC MET, V28, pC127
   Liu YC, 2000, SYNTHETIC MET, V113, P203, DOI 10.1016/S0379-6779(00)00188-0
   Lu QA, 2011, BIOMACROMOLECULES, V12, P1080, DOI 10.1021/bm101422j
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Macdonald JR, 2005, SOLID STATE IONICS, V176, P1961, DOI 10.1016/j.ssi.2004.05.035
   MILLER DL, 1992, J ELECTROCHEM SOC, V139, P967, DOI 10.1149/1.2069376
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Monti P, 1998, J RAMAN SPECTROSC, V29, P297, DOI 10.1002/(SICI)1097-4555(199804)29:4<297::AID-JRS240>3.0.CO;2-G
   Moravej M, 2011, INT J MOL SCI, V12, P4250, DOI 10.3390/ijms12074250
   Nguyen HT, 2014, J BIOMED MATER RES A, V102, P2554, DOI 10.1002/jbm.a.34925
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Romero IS, 2014, ADV FUNCT MATER, V24, P3866, DOI 10.1002/adfm.201303292
   Romero IS, 2013, ACS APPL MATER INTER, V5, P553, DOI 10.1021/am301844c
   Shi GX, 2004, BIOMATERIALS, V25, P2477, DOI 10.1016/j.biomaterials.2003.09.032
   Sohail MR, 2007, J AM COLL CARDIOL, V49, P1851, DOI 10.1016/j.jacc.2007.01.072
   Sokolov A, 2012, J BIOMED MATER RES A, V100A, P1142, DOI 10.1002/jbm.a.34054
   Tao H, 2014, P NATL ACAD SCI USA, V111, P17385, DOI 10.1073/pnas.1407743111
   Tao H, 2012, ADV MATER, V24, P2824, DOI 10.1002/adma.201104477
   Tsang M, 2014, J MICROELECTROMECH S, V23, P1281, DOI 10.1109/JMEMS.2014.2360201
   Vaitkuviene A, 2013, J HAZARD MATER, V250, P167, DOI 10.1016/j.jhazmat.2013.01.038
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang CY, 2011, ADV MATER, V23, P3580, DOI 10.1002/adma.201101067
   Wei X, 2008, FRONT ENERGY POWER E, V2, P1, DOI DOI 10.1007/S11708-008-0016-3
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
   Wu A, 2007, SYNTHETIC MET, V157, P303, DOI 10.1016/j.synthmet.2007.03.008
   Xu LZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4329
   Yang Y, 2012, ADV ENERGY MATER, V2, P266, DOI 10.1002/aenm.201100449
   Yin L, 2014, ADV MATER, V26, P3879, DOI 10.1002/adma.201306304
   Zhang TR, 2014, MATER HORIZONS, V1, P196, DOI 10.1039/c3mh00059a
NR 56
TC 21
Z9 21
U1 17
U2 133
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD MAR 2
PY 2016
VL 26
IS 9
BP 1454
EP 1462
DI 10.1002/adfm.201503498
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA DG6FR
UT WOS:000372179100017
OA Bronze
DA 2018-10-19
ER

PT J
AU Yazici, H
   O'Neill, MB
   Kacar, T
   Wilson, BR
   Oren, EE
   Sarikaya, M
   Tamerler, C
AF Yazici, Hilal
   O'Neill, Mary B.
   Kacar, Turgay
   Wilson, Brandon R.
   Oren, E. Emre
   Sarikaya, Mehmet
   Tamerler, Candan
TI Engineered Chimeric Peptides as Antimicrobial Surface Coating Agents
   toward Infection-Free Implants
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE chimeric peptides; antimicrobial peptide (AMP); titanium binding
   peptides (TiBP); surface functionalization; infection; modular peptides
   and peptide-based implant coatings
ID MESENCHYMAL STEM-CELLS; BINDING PEPTIDES; MOLECULAR BIOMIMETICS;
   ANTIBIOTIC-RESISTANCE; CATIONIC PEPTIDES; BIOFILM FORMATION; SENSING
   SYSTEM; TITANIUM; IMMOBILIZATION; BIOMATERIALS
AB Prevention of bacterial colonization and consequent biofilm formation remains a major challenge in implantable medical devices. Implant-associated infections are not only a major cause of implant failures but also their conventional treatment with antibiotics brings further complications due to the escalation in multidrug resistance to a variety of bacterial species. Owing to their unique properties, antimicrobial peptides (AMPs) have gained significant attention as effective agents to combat colonization of microorganisms. These peptides have been shown to exhibit a wide spectrum of activities with specificity to a target cell while having a low tendency for developing bacterial resistance. Engineering biomaterial surfaces that feature AMP properties, therefore, offer a promising approach to prevent implant infections. Here, we engineered a chimeric peptide with bifunctionality that both forms a robust solid-surface coating while presenting antimicrobial property. The individual domains of the chimeric peptides were evaluated for their solid-binding kinetics to titanium substrate as well as for their antimicrobial properties in solution. The antimicrobial efficacy of the chimeric peptide on the implant material was evaluated in vitro against infection by a variety of bacteria, including Streptococcus mutans, Staphylococcus. epidermidis, and Escherichia coli, which are commonly found in oral and orthopedic implant related surgeries. Our results demonstrate significant improvement in reducing bacterial colonization onto titanium surfaces below the detectable limit. Engineered chimeric peptides with freely displayed antimicrobial domains could be a potential solution for developing infection-free surfaces by engineering implant interfaces with highly reduced bacterial colonization property.
C1 [Yazici, Hilal; O'Neill, Mary B.; Kacar, Turgay; Wilson, Brandon R.; Oren, E. Emre; Sarikaya, Mehmet; Tamerler, Candan] Univ Washington, Genetically Engn Mat Sci & Engn Ctr, Dept Mat Sci & Engn, Seattle, WA 98195 USA.
   [Yazici, Hilal; Kacar, Turgay] Istanbul Tech Univ, Dept Mol Biol & Genet, Mol Biol Biotechnol & Genet Ctr, TR-34469 Istanbul, Turkey.
   [Oren, E. Emre] TOBB Univ Econ & Technol, Dept Biomed Engn, TR-06560 Ankara, Turkey.
   [Tamerler, Candan] Univ Kansas, Bioengn Res Ctr, Dept Mech Engn, Lawrence, KS 66045 USA.
RP Tamerler, C (reprint author), Dept Mech Engn, Bioengn Res Ctr, 1530 W,15th St,Learned Hall, Lawrence, KS 66047 USA.
EM ctamerler@ku.edu
OI Tamerler, Candan/0000-0002-1960-2218; Oren, Ersin
   Emre/0000-0001-5902-083X
FU NIH-NIAMS [AR062249-03]; NIH- NIDCR through University of Kansas and
   University of Washington [R01DE025476-01]; NSF-MRSEC Program through the
   University of Washington GEMSEC [DMR-0520567]
FX This research was supported by NIH-NIAMS, AR062249-03, and NIH- NIDCR
   R01DE025476-01 through University of Kansas and University of Washington
   (C.T.) and by NSF-MRSEC Program, DMR-0520567, through the University of
   Washington GEMSEC (C.T., H.Y., M.B.O., T.K, B.R.W., E.E.O., and M.S.).
CR Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006
   Chen HB, 2008, LANGMUIR, V24, P6852, DOI 10.1021/la800314p
   Costa F, 2014, ACTA BIOMATER, V10, P3513, DOI 10.1016/j.actbio.2014.02.028
   Costa F, 2011, ACTA BIOMATER, V7, P1431, DOI 10.1016/j.actbio.2010.11.005
   Cubellis MV, 2005, PROTEINS, V58, P880, DOI 10.1002/prot.20327
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Donatan S, 2012, J R SOC INTERFACE, V9, P2688, DOI 10.1098/rsif.2012.0060
   Donatan S, 2009, MAT SCI ENG C-BIO S, V29, P14, DOI 10.1016/j.msec.2008.05.003
   Fang Y, 2008, J MATER CHEM, V18, P3871, DOI 10.1039/b806797j
   Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000
   Fukuta M, 2014, COLLOID SURFACE B, V118, P25, DOI 10.1016/j.colsurfb.2014.03.024
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Godoy-Gallardo M, 2014, ACTA BIOMATER, V10, P3522, DOI 10.1016/j.actbio.2014.03.026
   Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267
   Hayashi T, 2009, LANGMUIR, V25, P10901, DOI 10.1021/la901242q
   HAYNIE SL, 1995, ANTIMICROB AGENTS CH, V39, P301, DOI 10.1128/AAC.39.2.301
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Hilpert K, 2009, CHEM BIOL, V16, P58, DOI 10.1016/j.chembiol.2008.11.006
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Kacar T, 2009, ADV MATER, V21, P295, DOI 10.1002/adma.200801877
   Kazemzadeh-Narbat M, 2013, BIOMATERIALS, V34, P5969, DOI 10.1016/j.biomaterials.2013.04.036
   Kazemzadeh-Narbat M, 2012, J BIOMED MATER RES B, V100B, P1344, DOI 10.1002/jbm.b.32701
   Khatayevich D, 2010, ACTA BIOMATER, V6, P4634, DOI 10.1016/j.actbio.2010.06.004
   Krasnodembskaya A, 2010, STEM CELLS, V28, P2229, DOI 10.1002/stem.544
   Kraus D, 2012, J CELL PHYSIOL, V227, P994, DOI 10.1002/jcp.22808
   Lee JW, 2011, STEM CELLS, V29, P913, DOI 10.1002/stem.643
   Li M, 2007, MOL MICROBIOL, V66, P1136, DOI 10.1111/j.1365-2958.2007.05986.x
   Li M, 2007, P NATL ACAD SCI USA, V104, P9469, DOI 10.1073/pnas.0702159104
   Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789
   Ma MH, 2012, J BIOMED MATER RES A, V100A, P278, DOI 10.1002/jbm.a.33251
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Muszanska AK, 2014, BIOMACROMOLECULES, V15, P2019, DOI 10.1021/bm500168s
   Onaizi SA, 2011, BIOTECHNOL ADV, V29, P67, DOI 10.1016/j.biotechadv.2010.08.012
   Oren EE, 2005, NANO LETT, V5, P415, DOI 10.1021/nl048425x
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023
   Sanghvi AB, 2005, NAT MATER, V4, P496, DOI 10.1038/nmat1397
   Sano KI, 2005, LANGMUIR, V21, P3090, DOI 10.1021/la047428m
   Sano KI, 2003, J AM CHEM SOC, V125, P14234, DOI 10.1021/ja038414q
   Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964
   Seker UOS, 2007, LANGMUIR, V23, P7895, DOI 10.1021/la700446g
   So CR, 2012, ACS NANO, V6, P1648, DOI 10.1021/nn204631x
   Tamerler C, 2006, SMALL, V2, P1372, DOI 10.1002/smll.200600070
   Tamerler C, 2010, BIOPOLYMERS, V94, P78, DOI 10.1002/bip.21368
   Tamerler C, 2009, ACS NANO, V3, P1606, DOI 10.1021/nn900720g
   Tan XW, 2014, ANTIMICROB AGENTS CH, V58, P5229, DOI 10.1128/AAC.02859-14
   van 't Hof W, 2001, BIOL CHEM, V382, P597, DOI 10.1515/BC.2001.072
   Yazici H, 2013, ACTA BIOMATER, V9, P5341, DOI 10.1016/j.actbio.2012.11.004
   Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
   Zhang L, 2014, ACS APPL MATER INTER, V6, P17323, DOI 10.1021/am5045604
   Zhang ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013985
   Zhao LZ, 2011, BIOMATERIALS, V32, P5706, DOI 10.1016/j.biomaterials.2011.04.040
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
NR 59
TC 25
Z9 27
U1 9
U2 102
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAR 2
PY 2016
VL 8
IS 8
BP 5070
EP 5081
DI 10.1021/acsami.5b03697
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DF6GJ
UT WOS:000371453600004
PM 26795060
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Naves, AF
   Motay, M
   Merindol, R
   Davi, CP
   Felix, O
   Catalani, LH
   Decher, G
AF Naves, Alliny F.
   Motay, Marvin
   Merindol, Remi
   Davi, Christiane P.
   Felix, Olivier
   Catalani, Luiz H.
   Decher, Gero
TI Layer-by-Layer assembled growth factor reservoirs for steering the
   response of 3T3-cells
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Layer-by-layer assembly; Polyelectrolyte multilayers; Heparin; Chitosan;
   Acidic fibroblast growth factor (aFGF); Basic fibroblast growth factor
   (bFGF); Controlled release
ID CONTROLLED-RELEASE; MULTILAYER FILMS; FIBROBLAST; SURFACES; CHITOSAN
AB Layer-by-Layer (LbL) assemblies of heparin (Hep) and chitosan (Chi) were prepared for use as reservoirs for acidic and basic fibroblast growth factors (aFGFs and bFGFs, respectively). The effects of the architecture and composition of the reservoirs on the viability and proliferation of NIH-3T3 fibroblast cells were studied under starvation conditions. The reservoir stability was monitored by ellipsometry. The aFGF and bFGF loadings were determined using a dissipation-enhanced quartz crystal microbalance (QCM-D). Stability and release assays were performed in a phosphate buffer at physiological conditions. The results demonstrated that the amount of aFGF and bFGF loaded into and released from LbL reservoirs composed of 3 and 6 layer pairs could be controlled. Cell culture assays in low serum culture medium (LSCM) demonstrated that incorporating very small amounts of aFGF and bFGF into the (Hep/Chi)(n) multilayers significantly improved the proliferation of the NIH-3T3 fibroblasts. The cells did not proliferate on (Hep/Chi)(n) assemblies prepared in the absence of FGF under identical conditions. The LbL reservoirs were highly effective for the long-term storage (up to 9 months) of aFGF and bFGF. This work demonstrates the potential of LbL reservoirs for use as biomaterial coatings. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Naves, Alliny F.; Motay, Marvin; Merindol, Remi; Davi, Christiane P.; Felix, Olivier; Decher, Gero] CNRS, Inst Charles Sadron, 23 Rue Loess, F-67034 Strasbourg, France.
   [Naves, Alliny F.; Motay, Marvin; Merindol, Remi; Decher, Gero] Univ Strasbourg, Fac Chem, 1 Rue Blaise Pascal, F-67008 Strasbourg, France.
   [Davi, Christiane P.] Univ Fed ABC, CCNH, Rua Santa Adelia 166, BR-09210170 Santo Andre, Brazil.
   [Naves, Alliny F.; Catalani, Luiz H.] Univ Sao Paulo, Inst Quim, Dept Quim Fundamental, Av Prof Lineu Prestes 748,CP 26077, BR-05513970 Sao Paulo, Brazil.
   [Decher, Gero] Int Ctr Frontier Res Chem, 8 Allee Gaspard Monge, F-67083 Strasbourg, France.
RP Naves, AF (reprint author), CNRS, Inst Charles Sadron, 23 Rue Loess, F-67034 Strasbourg, France.; Decher, G (reprint author), Univ Strasbourg, Fac Chem, 1 Rue Blaise Pascal, F-67008 Strasbourg, France.; Naves, AF (reprint author), Univ Sao Paulo, Inst Quim, Dept Quim Fundamental, Av Prof Lineu Prestes 748,CP 26077, BR-05513970 Sao Paulo, Brazil.
EM alliny@iq.usp.br; decher@ics-cnrs.unistra.fr
RI Decher, Gero/E-7665-2011
OI Decher, Gero/0000-0002-7976-8818; Merindol, Remi/0000-0003-4193-7097
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   Brazil [201407/2011-6]
FX This work was partly funded by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq, grant for fellowship 201407/2011-6),
   Brazil. Facilities were provided by CNRS-ICS.
CR ARMELIN HA, 1973, P NATL ACAD SCI USA, V70, P2702, DOI 10.1073/pnas.70.9.2702
   BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X
   Brunot C, 2007, BIOMATERIALS, V28, P632, DOI 10.1016/j.biomaterials.2006.09.026
   CLARKE MSF, 1993, J CELL SCI, V106, P121
   Cock L. J., 2010, BIOMACROMOLECULES, V11, P1002
   CUEVAS P, 1988, BIOCHEM BIOPH RES CO, V156, P611, DOI 10.1016/S0006-291X(88)80887-8
   DECHER G, 1991, MAKROMOL CHEM-M SYMP, V46, P321, DOI 10.1002/masy.19910460145
   Decher G., 2002, MULTILAYER THIN FILM, V1
   Go DP, 2011, BIOMACROMOLECULES, V12, P1494, DOI 10.1021/bm1014574
   Gong YH, 2007, ACTA BIOMATER, V3, P677, DOI 10.1016/j.actbio.2007.04.007
   GOSPODAROWICZ D, 1974, P NATL ACAD SCI USA, V71, P4584, DOI 10.1073/pnas.71.11.4584
   GOSPODAROWICZ D, 1974, NATURE, V249, P123, DOI 10.1038/249123a0
   Gribova V, 2012, CHEM MATER, V24, P854, DOI 10.1021/cm2032459
   Hsu BB, 2014, BIOMACROMOLECULES, V15, P2049, DOI 10.1021/bm5001839
   Itoh Y, 2008, BIOMACROMOLECULES, V9, P2202, DOI 10.1021/bm800321w
   LEE K, 2011, R SOC INTERFACE, V8, P153, DOI DOI 10.1098/RSIF.2010.0223
   Lin Y, 2008, J APPL POLYM SCI, V109, P530, DOI 10.1002/app.28174
   Liu ZM, 2009, J MATER SCI-MATER M, V20, P2317, DOI 10.1007/s10856-009-3806-1
   Macdonald ML, 2011, BIOMATERIALS, V32, P1446, DOI 10.1016/j.biomaterials.2010.10.052
   Macdonald ML, 2010, BIOMACROMOLECULES, V11, P2053, DOI 10.1021/bm100413w
   Mao ZW, 2005, BIOCONJUGATE CHEM, V16, P1316, DOI 10.1021/bc049755b
   Nakahara T, 2003, TISSUE ENG, V9, P153, DOI 10.1089/107632703762687636
   Ornitz DM, 2001, GENOME BIOL, V2
   Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Volpato FZ, 2012, ACTA BIOMATER, V8, P1551, DOI 10.1016/j.actbio.2011.12.023
   YAMAGUCHI TP, 1995, CURR OPIN GENET DEV, V5, P485, DOI 10.1016/0959-437X(95)90053-J
   Zhu AP, 2005, BIOMACROMOLECULES, V6, P2607, DOI 10.1021/bm050328q
NR 30
TC 6
Z9 6
U1 2
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAR 1
PY 2016
VL 139
BP 79
EP 86
DI 10.1016/j.colsurfb.2015.11.019
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA EE5ZK
UT WOS:000389687900010
PM 26700236
DA 2018-10-19
ER

PT J
AU Lin, S
   Chen, MX
   Jiang, HY
   Fan, LP
   Sun, BB
   Yu, F
   Yang, XX
   Lou, XX
   He, CL
   Wang, HS
AF Lin, Si
   Chen, Mengxia
   Jiang, Huayue
   Fan, Linpeng
   Sun, Binbin
   Yu, Fan
   Yang, Xingxing
   Lou, Xiangxin
   He, Chuanglong
   Wang, Hongsheng
TI Green electrospun grape seed extract-loaded silk fibroin nanofibrous
   mats with excellent cytocompatibility and antioxidant effect
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Grape seed extract; Silk fibroin; Green electrospinning; Antioxidation
ID SKIN CARE APPLICATION; IN-VITRO; OXIDATIVE DAMAGE; CARCINOMA CELLS;
   SCAFFOLDS; PROANTHOCYANIDINS; BIOMATERIAL; PROTECTS; MATRICES; GROWTH
AB Silk fibroin (SF) from Bombyx mori has an excellent biocompatibility and thus be widely applied in the biomedical field. Recently, various SF-based composite nanofibers have been developed for more demanding applications. Additionally, grape seed extract (GSE) has been demonstrated to be powerful on antioxidation. In the present study, we dedicate to fabricate a GSE-loaded SF/polyethylene oxide (PEO) composite nanofiber by green electrospinning. Our results indicated the successful loading of GSE into the SF/PEO composite nanofibers. The introduction of GSE did not affect the morphology of the SF/PEO nanofibers and GSE can be released from the nanofibers with a sustained manner. Furthermore, comparing with the raw SF/PEO nanofibrous mats, the GSE-loaded SF/PEO nanofibrous mats significantly enhanced the proliferation of the skin fibroblasts and also protected them against the damage from tert-butyl hydroperoxide-induced oxidative stress. All these findings suggest a promising potential of this novel GSE-loaded SF/PEO composite nanofibrous mats applied in skin care, tissue regeneration and wound healing. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Lin, Si; Chen, Mengxia; Jiang, Huayue; Fan, Linpeng; Sun, Binbin; Yu, Fan; Yang, Xingxing; Lou, Xiangxin; He, Chuanglong; Wang, Hongsheng] Donghua Univ, Coll Chem Chem Engn & Biotechnol, 2999 North Renmin Rd, Shanghai 201620, Peoples R China.
   [Lou, Xiangxin; He, Chuanglong; Wang, Hongsheng] Donghua Univ, Minist Educ, Key Lab Text Sci & Technol, Shanghai 201620, Peoples R China.
RP Wang, HS (reprint author), Donghua Univ, Coll Chem Chem Engn & Biotechnol, 2999 North Renmin Rd, Shanghai 201620, Peoples R China.
EM whs@dhu.edu.cn
RI He, Chuanglong/C-2976-2011
OI He, Chuanglong/0000-0001-8330-8542
FU Natural Science Foundation of Shanghai [12ZR1400300]; Scientific
   Research Foundation for the Returned Overseas Chinese Scholars, State
   Education Ministry; 111 project [B07024]
FX This research was supported by the Natural Science Foundation of
   Shanghai (12ZR1400300), the Scientific Research Foundation for the
   Returned Overseas Chinese Scholars, State Education Ministry (To Dr.
   Hongsheng Wang) and 111 project (B07024).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bagchi D, 1998, GEN PHARMACOL, V30, P771, DOI 10.1016/S0306-3623(97)00332-7
   Bagchi D, 1997, RES COMMUN MOL PATH, V95, P179
   Balu M, 2005, NEUROSCI LETT, V383, P295, DOI 10.1016/j.neulet.2005.04.042
   Cha BG, 2014, BIOPOLYMERS, V101, P307, DOI 10.1002/bip.22359
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Dailhankar A., 2005, INDIAN J BIOTECHNOL, V4, P115
   Draelos ZD, 2000, CURR PROBL DERM-US, V12, P235, DOI 10.1016/S1040-0486(00)80007-1
   Fan LP, 2014, COLLOID SURFACE B, V117, P14, DOI 10.1016/j.colsurfb.2013.12.030
   Fan LP, 2012, RSC ADV, V2, P4110, DOI 10.1039/c2ra20302b
   Fan LP, 2012, J BIOMAT SCI-POLYM E, V23, P497, DOI 10.1163/092050610X552771
   Gotoh Y, 2004, BIOMATERIALS, V25, P1131, DOI 10.1016/S0142-9612(03)00633-1
   Guo HF, 2012, COLLOID SURFACE B, V96, P29, DOI 10.1016/j.colsurfb.2012.03.014
   Hu YY, 2015, MOLECULES, V20, P6443, DOI 10.3390/molecules20046443
   Huang C, 2011, COLLOID SURFACE B, V82, P307, DOI 10.1016/j.colsurfb.2010.09.002
   Huh YS, 2004, BIOTECHNOL BIOPROC E, V9, P471, DOI 10.1007/BF02933488
   Jose RR, 2012, J MATER SCI-MATER M, V23, P2679, DOI 10.1007/s10856-012-4739-7
   Kaur M, 2006, CLIN CANCER RES, V12, P6194, DOI 10.1158/1078-0432.CCR-06-1465
   Kim KH, 2005, J BIOTECHNOL, V120, P327, DOI 10.1016/j.jbiotec.2005.06.033
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   LEE JH, 1990, BIOMATERIALS, V11, P455, DOI 10.1016/0142-9612(90)90058-X
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Mandic AI, 2008, INT J FOOD PROP, V11, P713, DOI 10.1080/10942910701584260
   Mantena SK, 2006, CARCINOGENESIS, V27, P1682, DOI 10.1093/carcin/bgl030
   Mohansrinivasan V, 2015, BRAZ ARCH BIOL TECHN, V58, P540, DOI [10.1590/S1516-8913201500076, 10.1590/s1516-8913201500076]
   Ricci G, 2004, BRIT J DERMATOL, V150, P127, DOI 10.1111/j.1365-2133.2004.05705.x
   Rodriguez KJ, 2013, J DERMATOL SCI, V72, P304, DOI 10.1016/j.jdermsci.2013.08.004
   Roh DH, 2006, J MATER SCI-MATER M, V17, P547, DOI 10.1007/s10856-006-8938-y
   Saffari Y, 2004, LIFE SCI, V74, P1513, DOI 10.1016/j.lfs.2003.08.019
   Sheng XY, 2013, INT J BIOL MACROMOL, V56, P49, DOI 10.1016/j.ijbiomac.2013.01.029
   Sobajo C., 2008, OPEN ACCESS J PLASTI, V8, P438
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Vasconcelos A, 2012, ACTA BIOMATER, V8, P3049, DOI 10.1016/j.actbio.2012.04.035
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   YOSHIMIZU H, 1990, J APPL POLYM SCI, V40, P127, DOI 10.1002/app.1990.070400111
   Zhang KH, 2011, POLYM DEGRAD STABIL, V96, P2266, DOI 10.1016/j.polymdegradstab.2011.08.011
   Zhang KH, 2010, J BIOMED MATER RES A, V95A, P870, DOI 10.1002/jbm.a.32895
NR 37
TC 5
Z9 5
U1 11
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAR 1
PY 2016
VL 139
BP 156
EP 163
DI 10.1016/j.colsurfb.2015.12.001
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA EE5ZK
UT WOS:000389687900020
PM 26707696
DA 2018-10-19
ER

PT J
AU Cui, Z
   Yang, BF
   Li, RK
AF Cui, Zhi
   Yang, Baofeng
   Li, Ren-Ke
TI Application of Biomaterials in Cardiac Repair and Regeneration
SO ENGINEERING
LA English
DT Review
DE Myocardial infarction; Heart regeneration; Biomaterial; Tissue
   engineering; Stem cell
ID ACUTE MYOCARDIAL-INFARCTION; MESENCHYMAL STEM-CELLS; IMPLANTABLE
   CARDIOVERTER-DEFIBRILLATOR; RADIOFREQUENCY CATHETER ABLATION; ASSEMBLING
   PEPTIDE NANOFIBERS; PROMOTES ENDOGENOUS REPAIR;
   AMERICAN-HEART-ASSOCIATION; FREE-WALL RUPTURE; TEAM-BASED CARE;
   BIOMEDICAL APPLICATIONS
AB Cardiovascular disease is a leading cause of death throughout the world. The demand for new therapeutic interventions is increasing. Although pharmacological and surgical interventions dramatically improve the quality of life of cardiovascular disease patients, cheaper and less invasive approaches are always preferable. Biomaterials, both natural and synthetic, exhibit great potential in cardiac repair and regeneration, either as a carrier for drug delivery or as an extracellular matrix substitute scaffold. In this review, we discuss the current treatment options for several cardiovascular diseases, as well as types of biomaterials that have been investigated as potential therapeutic interventions for said diseases. We especially highlight investigations into the possible use of conductive polymers for correcting ischemic heart disease-induced conduction abnormalities, and the generation of biological pacemakers to improve the conduction pathway in heart block. (C) 2016 THE AUTHORS. Published by Elsevier LTD on behalf of Chinese Academy of Engineering and Higher Education Press Limited Company. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Cui, Zhi; Li, Ren-Ke] Univ Toronto, Inst Med Sci, Toronto, ON M5G 2M9, Canada.
   [Cui, Zhi; Li, Ren-Ke] Univ Toronto, Dept Surg, Div Cardiovasc Surg, Toronto, ON M5G 2M9, Canada.
   [Yang, Baofeng] Harbin Med Univ, Coll Pharm, Dept Pharmacol, Harbin 150001, Peoples R China.
   [Cui, Zhi; Li, Ren-Ke] Univ Hlth Network, Toronto Gen Res Inst, Div Cardiovasc Surg, Toronto, ON M5G 1L7, Canada.
RP Li, RK (reprint author), Univ Toronto, Inst Med Sci, Toronto, ON M5G 2M9, Canada.; Li, RK (reprint author), Univ Toronto, Dept Surg, Div Cardiovasc Surg, Toronto, ON M5G 2M9, Canada.; Li, RK (reprint author), Univ Hlth Network, Toronto Gen Res Inst, Div Cardiovasc Surg, Toronto, ON M5G 1L7, Canada.
EM renkeli@uhnres.utoronto.ca
OI Li, Ren-Ke/0000-0002-2584-060X
CR Akhyari P, 2002, CIRCULATION, V106, pI137, DOI 10.1161/01.cir.0000032893.55215.fc
   ALTEKIN RE, 2011, J CARDIOL CASES, V3, pE68
   Anitha A, 2014, PROG POLYM SCI, V39, P1644, DOI 10.1016/j.progpolymsci.2014.02.008
   Anker SD, 2015, EUR HEART J, V36, P2297, DOI 10.1093/eurheartj/ehv259
   Balint R, 2014, ACTA BIOMATER, V10, P2341, DOI 10.1016/j.actbio.2014.02.015
   Banypersad SM, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000364
   Barold SS, 2006, J INTERV CARD ELECTR, V17, P139, DOI 10.1007/s10840-006-9065-x
   Barold SS, 2001, MAYO CLIN PROC, V76, P44, DOI 10.4065/76.1.44
   Belhassen B, 2011, EUROPACE, V13, P1009, DOI 10.1093/europace/eur056
   Benito B, 2012, REV ESP CARDIOL, V65, P939, DOI [10.1016/j.recesp.2012.03.027, 10.1016/j.rec.2012.03.022]
   Berul Charles I, 2003, Expert Rev Cardiovasc Ther, V1, P165, DOI 10.1586/14779072.1.2.165
   Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019
   Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0
   Boopathy AV, 2014, METHODS MOL BIOL, V1141, P159, DOI 10.1007/978-1-4939-0363-4_10
   Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150
   Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054
   Chang MG, 2006, CIRCULATION, V113, P1832, DOI 10.1161/CIRCULATIONAHA.105.593038
   Chang MY, 2013, J CONTROL RELEASE, V170, P287, DOI 10.1016/j.jconrel.2013.04.022
   Chen ZM, 2005, LANCET, V366, P1622
   Cheng K, 2012, J AM COLL CARDIOL, V59, P256, DOI 10.1016/j.jacc.2011.10.858
   Chi NH, 2013, CARBOHYD POLYM, V92, P591, DOI 10.1016/j.carbpol.2012.09.012
   Cho HC, 2010, CIRC RES, V106, P674, DOI 10.1161/CIRCRESAHA.109.212936
   Cho Sung Woo, 2010, Korean Circ J, V40, P94, DOI 10.4070/kcj.2010.40.2.94
   Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523
   Creaser JW, 2015, HEART FAIL CLIN, V11, P379, DOI 10.1016/j.hfc.2015.03.004
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   de Zwaan C, 2001, NETH HEART J, V9, P30
   Deng BY, 2015, J BIOMED MATER RES A, V103, P907, DOI 10.1002/jbm.a.35232
   Dorian P, 2010, CIRCULATION, V122, P2645, DOI 10.1161/CIRCULATIONAHA.109.924225
   Finsterer J, 2008, CAN J CARDIOL, V24, P786, DOI 10.1016/S0828-282X(08)70686-X
   Frederick JR, 2010, CIRCULATION, V122, pS107, DOI [10.1161/C1RCULATIONAHA.109.930404, 10.1161/CIRCULATIONAHA.109.930404]
   French KM, 2016, ADV DRUG DELIVER REV, V96, P40, DOI 10.1016/j.addr.2015.04.023
   Gelmi A, 2015, PROC SPIE, V9430, DOI 10.1117/12.2084165
   George PM, 2005, BIOMATERIALS, V26, P3511, DOI 10.1016/j.biomaterials.2004.09.037
   Ghuran AV, 2001, BRIT MED BULL, V59, P193, DOI 10.1093/bmb/59.1.193
   Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80
   Goldenberg I, 2010, CIRCULATION, V122, P1265, DOI 10.1161/CIRCULATIONAHA.110.940148
   Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Guiseppi-Elie A, 2010, BIOMATERIALS, V31, P2701, DOI 10.1016/j.biomaterials.2009.12.052
   Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321
   Heidenreich P, 2015, HEART FAIL CLIN, V11, P349, DOI 10.1016/j.hfc.2015.03.001
   Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749
   Hreybe H, 2009, CLIN CARDIOL, V32, P274, DOI 10.1002/clc.20357
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Iemura J, 2001, ANN THORAC SURG, V71, P201, DOI 10.1016/S0003-4975(00)02211-6
   Issa Z, 2008, CLIN ARRHYTHMOLOGY E, P127
   Ivashchenko CY, 2013, AM J PHYSIOL-HEART C, V305, pH913, DOI 10.1152/ajpheart.00819.2012
   Kai D, 2011, J BIOMED MATER RES A, V99A, P376, DOI 10.1002/jbm.a.33200
   Katritsis DG, 2005, CATHETER CARDIO INTE, V65, P321, DOI 10.1002/ccd.20406
   Khan IA, 2002, AM J MED, V112, P58, DOI 10.1016/S0002-9343(01)01011-7
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   Lakshmanan R, 2013, MACROMOL BIOSCI, V13, P1119, DOI 10.1002/mabi.201300223
   Lam MT, 2012, EXPERT REV CARDIOVAS, V10, P1039, DOI [10.1586/erc.12.99, 10.1586/ERC.12.99]
   Lampert R, 2002, CIRCULATION, V106, P1800, DOI 10.1161/01.CIR.0000031733.51374.C1
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Larsen PM, 2015, HEART FAIL CLIN, V11, P359, DOI 10.1016/j.hfc.2015.03.002
   Laske TG, 2005, CURR CLIN ONCOL, P123
   Lee JC, 2009, CIRCULATION, V120, P1550, DOI 10.1161/CIRCULATIONAHA.109.872911
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Liu ZQ, 2012, BIOMATERIALS, V33, P3093, DOI 10.1016/j.biomaterials.2011.12.044
   Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667
   Lundin V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018624
   Macia E, 2009, CIRCULATION, V119, P1814, DOI 10.1161/CIRCULATIONAHA.108.779900
   Mann DL, 2016, EUR J HEART FAIL, V18, P314, DOI 10.1002/ejhf.449
   Martins AM, 2014, BIOMACROMOLECULES, V15, P635, DOI 10.1021/bm401679q
   Masumoto H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06716
   McDevitt TC, 2003, J BIOMED MATER RES A, V66A, P586, DOI 10.1002/jbm.a.10504
   Menasche P, 2008, CIRCULATION, V117, P1189, DOI 10.1161/CIRCULATIONAHA.107.734103
   Menasche P, 2007, PROG CARDIOVASC DIS, V50, P7, DOI 10.1016/j.pcad.2007.02.002
   Meng XL, 2013, J BIOMED MATER RES A, V101, P1095, DOI 10.1002/jbm.a.34400
   Mihardja SS, 2008, BIOMATERIALS, V29, P4205, DOI 10.1016/j.biomaterials.2008.07.021
   Miklas JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072956
   Miller JS, 2000, CHEMPHYSCHEM, V1, P229, DOI 10.1002/1439-7641(20001215)1:4<229::AID-CPHC229>3.0.CO;2-J
   Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007
   Mukherjee S, 2011, ADV FUNCT MATER, V21, P2291, DOI 10.1002/adfm.201002434
   Munshi NV, 2014, SCIENCE, V345, P268, DOI 10.1126/science.1257976
   Myerburg RJ, 2012, CIRCULATION, V125, P1043, DOI 10.1161/CIRCULATIONAHA.111.023846
   Nakashima T, 2014, AM J PHYSIOL-HEART C, V306, pH1324, DOI 10.1152/ajpheart.00653.2013
   NOAKES TD, 1983, CIRCULATION, V67, P24, DOI 10.1161/01.CIR.67.1.24
   *NORW MULT STUD GR, 1981, NEW ENGL J MED, V304, P801
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84
   Okonogi Taichi, 2013, J Invasive Cardiol, V25, pE186
   Pascual-Gil S, 2015, J CONTROL RELEASE, V203, P23, DOI 10.1016/j.jconrel.2015.02.009
   Prestwich GD, 2011, J CONTROL RELEASE, V155, P193, DOI 10.1016/j.jconrel.2011.04.007
   Proulx MK, 2011, J BIOMED MATER RES A, V96A, P301, DOI 10.1002/jbm.a.32978
   Public Health Agency of Canada, 2014, EC BURD ILLN CAN 200
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   RARDON DP, 1995, CARDIAC ELECTROPHYSI, P485
   Reis LA, 2016, J TISSUE ENG REGEN M, V10, P11, DOI 10.1002/term.1944
   Rivers TJ, 2002, ADV FUNCT MATER, V12, P33, DOI 10.1002/1616-3028(20020101)12:1<33::AID-ADFM33>3.0.CO;2-E
   Rosen AB, 2007, STEM CELLS, V25, P2128, DOI 10.1634/stemcells.2006-0722
   Rosen MR, 2011, NAT REV CARDIOL, V8, P656, DOI 10.1038/nrcardio.2011.120
   Rosen MR, 2008, CIRC-ARRHYTHMIA ELEC, V1, P54, DOI 10.1161/CIRCEP.108.764621
   Roughley P, 2006, BIOMATERIALS, V27, P388, DOI 10.1016/j.biomaterials.2005.06.037
   Ruvinov E, 2016, ADV DRUG DELIVER REV, V96, P54, DOI 10.1016/j.addr.2015.04.021
   Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388
   Schaffer MS, 1996, CIRCULATION, V94, P3214, DOI 10.1161/01.CIR.94.12.3214
   Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800
   Segers VFM, 2011, CIRC RES, V109, P910, DOI 10.1161/CIRCRESAHA.111.249052
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Serpooshan V, 2013, BIOMATERIALS, V34, P9048, DOI 10.1016/j.biomaterials.2013.08.017
   Shen DL, 2011, BIOMATERIALS, V32, P9290, DOI 10.1016/j.biomaterials.2011.08.057
   Siminiak T, 2004, AM HEART J, V148, P531, DOI 10.1016/j.ahj.2004.03.043
   Singh SM, 2015, EUR HEART J, V36, P976, DOI 10.1093/eurheartj/ehu357
   Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209
   Song KD, 2010, J MATER SCI-MATER M, V21, P2835, DOI 10.1007/s10856-010-4131-4
   Stevenson WG, 2011, CIRCULATION, V124, pE411, DOI 10.1161/CIRCULATIONAHA.111.064816
   Suarez SL, 2015, ACTA BIOMATER, V26, P13, DOI 10.1016/j.actbio.2015.08.004
   Tandon N, 2009, NAT PROTOC, V4, P155, DOI 10.1038/nprot.2008.183
   Terashima M, 2008, AM J CARDIOL, V101, P419, DOI 10.1016/j.amjcard.2007.09.086
   Tokunaga M, 2010, J MOL CELL CARDIOL, V49, P972, DOI 10.1016/j.yjmcc.2010.09.015
   Ungerleider JL, 2014, STEM CELL TRANSL MED, V3, P1090, DOI 10.5966/sctm.2014-0049
   Vogler J, 2012, REV ESP CARDIOL, V65, P656, DOI [10.1016/j.recesp.2012.01.025, 10.1016/j.rec.2012.01.027]
   Williams AR, 2013, CIRCULATION, V127, P213, DOI 10.1161/CIRCULATIONAHA.112.131110
   Witte KKA, 2006, J CARD FAIL, V12, P199, DOI 10.1016/j.cardfail.2005.12.003
   Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9
   Yousuf O, 2015, CIRC RES, V116, P2020, DOI 10.1161/CIRCRESAHA.116.304555
   Zammaretti P, 2004, CURR OPIN BIOTECH, V15, P430, DOI 10.1016/j.copbio.2004.08.007
   Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237
   Zhang L, 2010, MACROMOL BIOSCI, V10, P1456, DOI 10.1002/mabi.201000176
   Zhou J, 2014, SCI REP-UK, V4, DOI 10.1038/srep03733
   Zimmermann WH, 2004, BIOMATERIALS, V25, P1639, DOI 10.1016/S0142-9612(03)00521-0
NR 126
TC 10
Z9 10
U1 5
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2095-8099
EI 2096-0026
J9 ENGINEERING-PRC
JI Engineering
PD MAR
PY 2016
VL 2
IS 1
BP 141
EP 148
DI 10.1016/J.ENG.2016.01.028
PG 8
WC Engineering, Multidisciplinary
SC Engineering
GA EE1PV
UT WOS:000389355500032
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Tamm, I
   Heinamaki, J
   Laidmae, I
   Rammo, L
   Paaver, U
   Ingebrigtsen, SG
   Skalko-Basnet, N
   Halenius, A
   Yliruusi, J
   Pitkanen, P
   Alakurtti, S
   Kogermann, K
AF Tamm, Ingrid
   Heinamaki, Jyrki
   Laidmae, Ivo
   Rammo, Liisi
   Paaver, Urve
   Ingebrigtsen, Sveinung G.
   Skalko-Basnet, Natasa
   Halenius, Anna
   Yliruusi, Jouko
   Pitkanen, Pauliina
   Alakurtti, Sami
   Kogermann, Karin
TI Development of Suberin Fatty Acids and Chloramphenicol-Loaded
   Antimicrobial Electrospun Nanofibrous Mats Intended for Wound Therapy
SO JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE suberin fatty acids; electrospun nanofibers; nonwoven nanomats;
   antimicrobial agent/drug; nanotechnology; physical characterization;
   solvent evaporation; polymeric drug carrier; polymeric biomaterials;
   wound therapy
ID PHOTO-CROSS-LINKING; POLYMER NANOFIBERS; DELIVERY-SYSTEM;
   IMAGE-ANALYSIS; HYDROGELS; PVP; BIOSYNTHESIS; TECHNOLOGIES;
   BIOPOLYESTER; RELEASE
AB Suberin fatty acids (SFAs) isolated from outer birch bark were investigated as an antimicrobial agent and biomaterial in nanofibrous mats intended for wound treatment. Electrospinning (ES) was used in preparing the composite nonwoven nanomats containing chloramphenicol (CAM; as a primary antimicrobial drug), SFAs, and polyvinylpyrrolidone (as a carrier polymer for ES). The X-ray powder diffraction, differential scanning calorimetry, scanning electron microscopy, atomic force microscopy, and texture analysis were used for the physicochemical and mechanical characterization of the nanomats. ES produced nanofibrous mats with uniform structure and with an average fiber diameter ranging from 370 to 425 nm. Microcrystalline SFAs and crystalline CAM were found to undergo a solid-state transformation during ES processing. The ES process caused also the loss of CAM in the final nanofibers. In the texture analysis, the SFAs containing nanofibers exhibited significantly higher maximum detachment force to an isolated pig skin (p < 0.05) than that obtained with the reference nanofibers. CAM exists in an amorphous form in the nanofibers which needs to be taken into account in controlling the physical storage stability. In conclusion, homogeneous composite nanofibrous mats for wound healing can be electrospun from the ternary mixture(s) of CAM, SFAs, and polyvinylpyrrolidone. (C) 2016 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.
C1 [Tamm, Ingrid; Heinamaki, Jyrki; Laidmae, Ivo; Rammo, Liisi; Paaver, Urve; Kogermann, Karin] Univ Tartu, Inst Pharm, Fac Med, EE-50411 Tartu, Estonia.
   [Laidmae, Ivo] Univ Tartu, Fac Med, Dept Immunol, Inst Biomed & Translat Med, EE-50411 Tartu, Estonia.
   [Ingebrigtsen, Sveinung G.; Skalko-Basnet, Natasa] Arctic Univ Norway, Univ Tromso, Fac Hlth Sci, Drug Transport & Delivery Res Grp,Dept Pharm, N-9037 Tromso, Norway.
   [Halenius, Anna; Yliruusi, Jouko] Univ Helsinki, Fac Pharm, Dept Pharmaceut Chem & Technol, Helsinki, Finland.
   [Pitkanen, Pauliina; Alakurtti, Sami] VTT Tech Res Ctr Finland Ltd, FI-02044 Espoo, Finland.
   [Kogermann, Karin] Univ Tartu, Fac Sci & Technol, Inst Technol, EE-50411 Tartu, Estonia.
RP Kogermann, K (reprint author), Univ Tartu, Inst Pharm, Fac Med, EE-50411 Tartu, Estonia.; Kogermann, K (reprint author), Univ Tartu, Fac Sci & Technol, Inst Technol, EE-50411 Tartu, Estonia.
EM karin.kogermann@ut.ee
RI Skalko-Basnet, Natasa/A-4117-2012
OI Skalko-Basnet, Natasa/0000-0002-4301-2840; Ingebrigtsen,
   Sveinung/0000-0002-3500-3055
FU European Social Fund's Doctoral Studies and Internationalization
   Programme DoRa and GREASE Woodwisdom-ERANET [40375/11]; ETF grant
   [ETF7980, IUT-34-18]
FX This study was supported by the European Social Fund's Doctoral Studies
   and Internationalization Programme DoRa and GREASE Woodwisdom-ERANET
   (Tekes decision 40375/11). The work is part of the ETF grant project no.
   ETF7980 and IUT-34-18 project. Mr. J. Aruvali is kindly acknowledged for
   performing the XRPD analysis. A. Meos and A. Simasko are thanked for
   conducting the HPLC and GC analyses and discussing the article.
CR Adediran GO, 2003, SCI FOCUS, V3, P112
   Andrady AL, 2008, SCI TECHNOLOGY POLYM, P146
   Arcangelo VP, 2013, PHARMACOTHERAPEUTICS
   Archana D, 2013, CARBOHYD POLYM, V95, P530, DOI 10.1016/j.carbpol.2013.03.034
   Bertoncelj V, 2014, EUR J PHARM BIOPHARM, V88, P64, DOI 10.1016/j.ejpb.2014.06.001
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Boateng JS, 2008, J PHARM SCI, V99, P4215
   Buhler V, 2005, POLYVINYLPYRROLIDONE, P254
   Cordeiro N, 2000, IND CROP PROD, V11, P63, DOI 10.1016/S0926-6690(99)00037-0
   Cui WG, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/1/014108
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   EKMAN R, 1983, HOLZFORSCHUNG, V37, P205, DOI 10.1515/hfsg.1983.37.4.205
   Franke R, 2007, CURR OPIN PLANT BIOL, V10, P252, DOI 10.1016/j.pbi.2007.04.004
   Gordon V, 2015, INT J PHARMACEUT, V478, P172, DOI 10.1016/j.ijpharm.2014.11.038
   Graca J, 2007, MACROMOL BIOSCI, V7, P128, DOI 10.1002/mabi.200600218
   Heinamaki J, 2015, INT J PHARMACEUT, V489, P91, DOI 10.1016/j.ijpharm.2015.04.066
   Hofer R, 2008, J EXP BOT, V59, P2347, DOI 10.1093/jxb/ern101
   Huang C, 2011, COLLOID SURFACE B, V82, P307, DOI 10.1016/j.colsurfb.2010.09.002
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Hurler J, 2012, BURNS PREVENTION CAU, P39
   Hurler J, 2013, BIOMED RES INT, V101, P3906
   Hurler J, 2012, J PHARM SCI-US, V101, P3906, DOI 10.1002/jps.23260
   Hurler Julia, 2012, J Funct Biomater, V3, P37, DOI 10.3390/jfb3010037
   Kalhapure RS, 2015, J PHARM SCI-US, V104, P872, DOI 10.1002/jps.24298
   Lacin NT, 2014, INT J BIOL MACROMOL, V67, P22, DOI 10.1016/j.ijbiomac.2014.03.003
   LEHR HA, 1992, ARTERIOSCLER THROMB, V12, P824, DOI 10.1161/01.ATV.12.7.824
   Leung V, 2011, POLYM ADVAN TECHNOL, V22, P350, DOI 10.1002/pat.1813
   Lopergolo LC, 2003, POLYMER, V44, P6217, DOI 10.1016/S0032-3861(03)00686-4
   Lu P, 2008, RECENT PAT NANOTECH, V2, P169, DOI 10.2174/187221008786369688
   Lulai EC, 1998, PHYSIOL MOL PLANT P, V53, P209, DOI 10.1006/pmpp.1998.0179
   Martin L, 2002, J CONTROL RELEASE, V80, P87, DOI 10.1016/S0168-3659(02)00005-6
   Martineau L, 2006, BURNS, V32, P172, DOI 10.1016/j.burns.2005.08.012
   Mayet N, 2014, J PHARM SCI-US, V103, P2211, DOI 10.1002/jps.24068
   Meinel AJ, 2012, EUR J PHARM BIOPHARM, V81, P1, DOI 10.1016/j.ejpb.2012.01.016
   Nagy ZK, 2012, J PHARM SCI-US, V101, P322, DOI 10.1002/jps.22731
   Paaver U, 2014, BIOMED RES INT, DOI 10.1155/2014/789765
   Pelipenko J, 2015, INT J PHARMACEUT, V484, P57, DOI 10.1016/j.ijpharm.2015.02.043
   Pelipenko J, 2013, EUR J PHARM BIOPHARM, V84, P401, DOI 10.1016/j.ejpb.2012.09.009
   Pelipenko J, 2015, EUR J PHARM SCI, V66, P29, DOI 10.1016/j.ejps.2014.09.022
   Pillay V, 2013, J NANOMATER, DOI 10.1155/2013/789289
   Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003
   Rang H., 2012, RANG DALES PHARM, P237
   Rasekh M, 2014, INT J PHARMACEUT, V473, P95, DOI 10.1016/j.ijpharm.2014.06.059
   Rowe R.C., 2009, HDB PHARM EXCIPIENTS, p[581, 663, 685]
   Said SS, 2011, EUR J PHARM BIOPHARM, V79, P108, DOI 10.1016/j.ejpb.2011.03.002
   Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Self S, 2015, INT J PHARMACEUT, V478, P390, DOI 10.1016/j.ijpharm.2014.11.045
   Sionkowska A, 2008, POLYM DEGRAD STABIL, V88, P261
   Stalling SS, 2009, ACTA BIOMATER, V5, P1911, DOI 10.1016/j.actbio.2009.02.020
   Subbiah T, 2005, J APPL POLYM SCI, V96, P557, DOI 10.1002/app.21481
   Vasita R, 2006, INT J NANOMED, V1, P15, DOI 10.2147/nano.2006.1.1.15
   Verreck G, 2003, PHARMACEUT RES, V20, P810, DOI 10.1023/A:1023450006281
   Wang YZ, 2010, J PHARM SCI-US, V99, P4805, DOI 10.1002/jps.22189
   Xie ZW, 2013, ACTA BIOMATER, V9, P9351, DOI 10.1016/j.actbio.2013.07.030
   Xu XM, 2010, BIOMACROMOLECULES, V11, P2283, DOI 10.1021/bm1003509
   Zhang YZ, 2005, J MATER SCI-MATER M, V16, P933, DOI 10.1007/s10856-005-4428-x
   Zhou FL, 2008, POLYM INT, V57, P837, DOI 10.1002/pi.2395
NR 58
TC 6
Z9 6
U1 3
U2 20
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-3549
EI 1520-6017
J9 J PHARM SCI-US
JI J. Pharm. Sci.
PD MAR
PY 2016
VL 105
IS 3
BP 1239
EP 1247
DI 10.1016/j.xphs.2015.12.025
PG 9
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA DT8TT
UT WOS:000381769100027
PM 26886306
DA 2018-10-19
ER

PT J
AU Sandomirsky, BP
   Repin, NV
   Mikhailova, IP
   Manchenko, AA
AF Sandomirsky, Boris P.
   Repin, Nikolay V.
   Mikhailova, Irina P.
   Manchenko, Anna A.
TI Application of cryoirradiation-modified xenopericardium for building
   bladder wall defect
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE beta(-)-radiation; Devitalization; Low temperatures; Porcine
   pericardium; Tissue grafts; Xenotransplantation
ID AORTIC-VALVE LEAFLETS; MECHANICAL-PROPERTIES; IMMUNE-RESPONSE;
   IRRADIATION; PERICARDIUM; XENOTRANSPLANTATION
AB Introduction: The project goal was to study special aspects of biointegration and the functional efficiency of the modified xenopericardium on the experimental model in vivo. Xenopericardium devitalization was performed using low temperatures and ionizing radiation (beta(-)-radiation) in an original manner.
   Methods: In rabbits, a urinary bladder (UB) wall defect was repaired through tissue replacement. Observation period: up to 1 year. After implantation, tissue reaction and biomaterial structure changes were studied using light and electron microscopy. Dynamic ultrasound diagnostics were performed.
   Results: After surgery all animals displayed normal physiological activity. No cases of material rejection or post-operative period complications were detected. At all stages the xenopericardium preserved structural integrity and served as a skeleton for forming an adequate UB wall. Small peripheral areas were exposed to lysis. After 3 months the collagen structure of the graft was rearranged and mucous membrane epithelization appeared. Folding was already formed and invasion of narrow SMC panniculi was registered within deeper layers. After 6 months the inner surface of the UB wall consisted of normal mucosa, lined by fully formed epithelium. By the 7th month an almost solid muscular sheet was formed in the lower layers.
   Conclusions: Modified pericardium tissue with the given physical and mechanical properties was sustainable and able to endure the work load in an aggressive environment. It causes minimal inflammatory response, has a potential for cellular repopulation in vivo, stimulates formation of fibrous tissue, and embedded and restored cellular integrity and UB storage function.
C1 [Sandomirsky, Boris P.; Mikhailova, Irina P.; Manchenko, Anna A.] NAS Ukraine, Inst Problems Cryobiol & Cryomed, Dept Expt Cryomed, 23 Pereyaslavskaya St, UA-61015 Kharkov, Ukraine.
   [Repin, Nikolay V.] NAS Ukraine, Inst Problems Cryobiol & Cryomed, Dept Cryomorphol, UA-61015 Kharkov, Ukraine.
RP Manchenko, AA (reprint author), NAS Ukraine, Inst Problems Cryobiol & Cryomed, Dept Expt Cryomed, 23 Pereyaslavskaya St, UA-61015 Kharkov, Ukraine.
EM anna.gorlenko@gmail.com
OI Sandomirsky, Boris/0000-0002-2440-1971
CR [Anonymous], 2002, TC198 INT ORG STAND
   Ansaloni L, 2007, J INVEST SURG, V20, P237, DOI 10.1080/08941930701481296
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Byzov DV, 2010, BIOTECHNOLOGIA ACTA, V3, P75
   Byzov DV, 2012, CURRENT PROBLEMS CRY, P623
   Byzov DV, 2011, PROBL CRYOBIOL CRYOM, V21, P137
   GRANT RA, 1970, J CELL SCI, V7, P387
   Hilkin AM, 1976, COLLAGEN ITS APPL ME
   Manchenko AA, 2015, CECRM 2015, P92
   Manchenko AA, 2014, FREEZ BIOL TIM 50 AN, P76
   McGregor CGA, 2011, J THORAC CARDIOV SUR, V141, P269, DOI 10.1016/j.jtcvs.2010.08.064
   Mikhailova IP, 2015, CRYO2015 ANN M SOC C, P48
   MIKHAILOVA IP, 2015, PROBL CRYOBIOL CRYOM, V25, P311
   Mikhailova I, 2014, PERIOD BIOL, V116, P105
   Ota T, 2007, ANN THORAC SURG, V83, P1501, DOI 10.1016/j.athoracsur.2006.11.083
   Platt JL, 1996, CURR OPIN IMMUNOL, V8, P721, DOI 10.1016/S0952-7915(96)80091-4
   REPIN NV, 2015, PROBL CRYOBIOL CRYOM, V25, P246
   Sandomirsky BP, Ukraine patent, Patent No. [68379 IPC A61L27/00 A01N1/02, 68379]
   Seto A, 2009, CLIN ORTHOP RELAT R, V467, P2994, DOI 10.1007/s11999-009-0934-3
   Sevastjanov VI, 2011, BIOCOMPATIBLE MAT
   Teebken OE, 2002, EUR J VASC ENDOVASC, V23, P475, DOI 10.1006/ejvs.2002.1654
   Weakley B., 1975, ELECT MICROSCOPY BEG
NR 22
TC 0
Z9 0
U1 0
U2 2
PU WICHTIG PUBLISHING
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
EI 1724-6040
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD MAR
PY 2016
VL 39
IS 3
BP 121
EP 127
DI 10.5301/ijao.5000491
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA DR3HE
UT WOS:000379792900004
PM 27102693
DA 2018-10-19
ER

PT J
AU Soardi, CM
   del Amo, FSL
   Galindo-Moreno, P
   Catena, A
   Zaffe, D
   Wang, HL
AF Soardi, Carlo Maria
   del Amo, Fernando Suarez-Lopez
   Galindo-Moreno, Pablo
   Catena, Andres
   Zaffe, Davide
   Wang, Hom-Lay
TI Reliability of Cone Beam Computed Tomography in Determining Mineralized
   Tissue in Augmented Sinuses
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE bone allograft; cone beam computed tomography; maxillary sinus
   augmentation; microradiographs
ID FLOOR AUGMENTATION; BONE ALLOGRAFT; MICRORADIOGRAPHY; HISTOMORPHOMETRY;
   DENSITY; SIZE
AB Purpose: The aim of this study was to analyze cone beam computed tomography (CBCT) densitometries of maxillary sinuses augmented with human bone allograft. In addition, previously obtained microradiographic specimens were used to verify the diagnostic potential of CBCT. Materials and Methods: A two-stage protocol was conducted in 21 consecutive patients, all with a crestal bone height < 2 mm. Mineralized human bone allograft particles were used to augment sinuses using a lateral window approach. A succession of CBCT scans of the maxilla were taken before surgery, immediately after sinus augmentation, and 6, 10, and 18 months after implant placement. Using virtual probes, CBCT images taken at 6, 8, and 10 mm from the crestal surface were processed with medical imaging software and expressed as gray level (GL). Results: A total of 24 sinus augmentation procedures were performed in 21 patients. The average values of CBCT-GL ranged from 571 to 654, presenting the maximum value at 8 mm immediately after implant placement and the minimum value at 6 mm after 10 months. Furthermore, it was found that the graft mineral content decreased over time, completely disappearing between 10 and 11 months. Conclusion: CBCT and the medical imaging software employed for imaging visualization are reliable tools to study biomaterial behavior after sinus augmentation procedures. In addition, results from this study demonstrate that a complete resorption of human bone allograft is possible. Due to the limited sample size, further clinical and morphometric studies are needed.
C1 [del Amo, Fernando Suarez-Lopez; Wang, Hom-Lay] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI USA.
   [Galindo-Moreno, Pablo] Univ Granada, Dept Oral Surg & Implantol, Granada, Spain.
   [Catena, Andres] Univ Granada, Sch Psychol, Dept Expt Psychol, Granada, Spain.
   [Zaffe, Davide] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Via Pozzo 71, I-41124 Modena, MO, Italy.
RP Zaffe, D (reprint author), Univ Modena & Reggio Emilia, Dipartimento Sci Biomed Metab & Neurosci, Sez Morfol Umana, Via Pozzo 71, I-41124 Modena, MO, Italy.
EM davide.zaffe@unimore.it
RI Galindo-Moreno, Pablo/F-5567-2015; Catena, Andres/I-2159-2015
OI Galindo-Moreno, Pablo/0000-0002-6614-6470; Catena,
   Andres/0000-0002-0775-5751; Suarez Lopez del Amo,
   Fernando/0000-0002-0416-7380
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Arisan V, 2013, CLIN IMPLANT DENT R, V15, P893, DOI 10.1111/j.1708-8208.2011.00436.x
   Benavides E, 2012, IMPLANT DENT, V21, P78, DOI 10.1097/ID.0b013e31824885b5
   Boivin G, 2002, CALCIFIED TISSUE INT, V70, P503, DOI 10.1007/s00223-001-2048-0
   Chan HL, 2010, IMPLANT DENT, V19, P288, DOI 10.1097/ID.0b013e3181e59ebd
   Ekfeldt A, 2001, CLIN ORAL IMPLAN RES, V12, P462, DOI 10.1034/j.1600-0501.2001.120505.x
   Froum SJ, 2006, INT J PERIODONT REST, V26, P543
   Goldstein SA, 2002, ANN NY ACAD SCI, V961, P183, DOI 10.1111/j.1749-6632.2002.tb03079.x
   Gonzalez-Garcia R., 2012, CLIN ORAL IMPLAN RES, DOI [10.1111/j.1600-0501.2011.02390.x, DOI 10.1111/J.1600-0501.2011.02390.X]
   Hatano N, 2004, CLIN ORAL IMPLAN RES, V15, P339, DOI 10.1111/j.1600-0501.2004.00996.x
   JAFFIN RA, 1991, J PERIODONTOL, V62, P2, DOI 10.1902/jop.1991.62.1.2
   Misch C E, 1989, Dent Today, V8, P39
   Monje A, 2014, CLIN ORAL IMPLAN RES, V25, P723, DOI 10.1111/clr.12133
   Nolff MC, 2010, J CRANIO MAXILL SURG, V38, P38, DOI 10.1016/j.jcms.2009.07.010
   Puri KS, 2009, J POSTGRAD MED, V55, P131, DOI 10.4103/0022-3859.52846
   Rickert D, 2012, INT J ORAL MAX SURG, V41, P160, DOI 10.1016/j.ijom.2011.10.001
   Schultze-Mosgau S, 2001, BRIT J ORAL MAX SURG, V39, P439, DOI 10.1054/bjom.2001.0617
   SISSONS HA, 1960, XRAY MICROSCOPY XRAY, P199
   Soardi CM, 2014, CLIN IMPLANT DENT R, V16, P557, DOI 10.1111/cid.12016
   Soardi CM, 2011, CLIN ORAL IMPLAN RES, V22, P560, DOI 10.1111/j.1600-0501.2010.02034.x
   Todisco M, 2005, INT J ORAL MAX IMPL, V20, P898
   Vercellotti T, 2001, INT J PERIODONT REST, V21, P561
NR 22
TC 2
Z9 2
U1 1
U2 3
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
EI 1942-4434
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD MAR-APR
PY 2016
VL 31
IS 2
BP 352
EP 358
DI 10.11607/jomi.4111
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DP8IT
UT WOS:000378742400015
PM 27004281
OA Bronze
DA 2018-10-19
ER

PT J
AU Di Stefano, DA
   Gastaldi, G
   Vinci, R
   Polizzi, EM
   Cinci, L
   Pieri, L
   Gherlone, E
AF Di Stefano, Danilo Alessio
   Gastaldi, Giorgio
   Vinci, Raffaele
   Polizzi, Elisabetta Maria
   Cinci, Lorenzo
   Pieri, Laura
   Gherlone, Enrico
TI Bone Formation Following Sinus Augmentation with an Equine-Derived Bone
   Graft: A Retrospective Histologic and Histomorphometric Study with
   36-Month Follow-up
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE biomaterial; bone remodeling; sinus augmentation; xenograft
ID BETA-TRICALCIUM PHOSPHATE; ANORGANIC BOVINE BONE; VERTICAL RIDGE
   AUGMENTATION; HUMAN OSTEOCLAST FORMATION; AUTOGENOUS BONE; BIO-OSS;
   MORPHOGENETIC PROTEIN; FLOOR AUGMENTATION; PORCINE BONE; CASE SERIES
AB Purpose: The aim of this study was to investigate bone formation over time following maxillary sinus augmentation with an enzyme-deantigenic, bone collagen-preserving equine bone graft by retrospective assessment of histomorphometric data. Materials and Methods: Records of patients with atrophic ridges who underwent maxillary sinus augmentation with the enzyme-deantigenic equine bone graft and two-step implant placement between 3 and 12 months after the sinus-augmentation surgery were assessed retrospectively. The histomorphometric data were clustered in three classes according to time of collection from the augmentation surgery and analyzed to assess newly formed bone deposition and residual biomaterial degradation rates. Data concerning the 36-month clinical follow-up were also assessed. Results: Records of 77 patients and 115 biopsy specimens were retrieved, and histomorphometric data were clustered (3 to 5 months, n = 33; 6 to 8 months, n = 57; 9 to 12 months, n = 25). Mean minimum atrophic ridge thickness was 4.9 +/- 0.5 mm (range, 4.0 to 7.1 mm). The amount of newly formed bone and residual biomaterial did not significantly differ among the three clusters. Qualitative analysis showed a denser trabecular structure in late (> 8 months) samples. At the 36-month clinical follow-up, no differences were found among the implant success rates in the three groups, according to the Albrektsson and Zarb criteria for success. The overall implant success rate was 98.3%. Conclusion: Based upon this retrospective human study of 77 patients with 4 to 7 mm of residual bone, when enzyme-deantigenic equine bone is used for sinus augmentation, new bone formation occurs at an early time (< 3 months) after the grafting, and implant placement can be safely carried out as soon as 3 to 5 months after the augmentation surgery.
C1 [Di Stefano, Danilo Alessio; Gastaldi, Giorgio; Vinci, Raffaele; Polizzi, Elisabetta Maria; Gherlone, Enrico] Univ Vita Salute San Raffaele, Sch Dent, Milan, Italy.
   [Di Stefano, Danilo Alessio; Gastaldi, Giorgio; Vinci, Raffaele; Polizzi, Elisabetta Maria; Gherlone, Enrico] IRCCS San Raffaele, Milan, Italy.
   [Cinci, Lorenzo] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth Neuro, Pharmacol & Toxicol Sect, Florence, Italy.
   [Pieri, Laura] Univ Florence, Interdept Forens Med Sect, Dept Hlth Sci, Florence, Italy.
RP Di Stefano, DA (reprint author), Via Matteo Civitali 40, I-20148 Milan, Italy.
EM distefano@centrocivitali.it
RI Gherlone, Enrico/M-7376-2016
OI vinci, raffaele/0000-0001-9541-9303
CR Aerssens J, 1998, ENDOCRINOLOGY, V139, P663, DOI 10.1210/en.139.2.663
   Albrektsson T, 1998, INT J PROSTHODONT, V11, P517
   Artese L, 2011, IMPLANT DENT, V20, P383, DOI 10.1097/ID.0b013e3182310b3d
   Avila G, 2010, J PERIODONTOL, V81, P1041, DOI 10.1902/jop.2010.090686
   Baldini N, 2011, DENT MATER, V27, P61, DOI 10.1016/j.dental.2010.10.017
   Barone A, 2013, INT J PERIODONT REST, V33, P795, DOI 10.11607/prd.1690
   Benke D, 2001, BIOMATERIALS, V22, P1005, DOI 10.1016/S0142-9612(00)00323-9
   Benlidayi ME, 2009, INT J ORAL MAX IMPL, V24, P704
   Blokhuis TJ, 2000, J TRAUMA, V48, P179, DOI 10.1097/00005373-200001000-00037
   Bou-Gharios G, 2008, PRINCIPLES OF BONE BIOLOGY, VOL 1, 3RD EDITION, P285, DOI 10.1016/B978-0-12-373884-4.00034-3
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Browaeys H, 2007, CLIN IMPLANT DENT R, V9, P166, DOI 10.1111/j.1708-8208.2007.00050
   Busenlechner D, 2009, CLIN ORAL IMPLAN RES, V20, P1078, DOI 10.1111/j.1600-0501.2009.01733.x
   Buser D, 1994, Quintessence Int, V25, P679
   Buser D, 1999, PERIODONTOL 2000, V19, P151, DOI 10.1111/j.1600-0757.1999.tb00153.x
   Butz F, 2011, INT J ORAL MAX IMPL, V26, P1317
   De Angelis N, 2011, INT J PERIODONT REST, V31, P383
   Di Stefano D A, 2012, Minerva Stomatol, V61, P477
   Di Stefano DA, 2015, INT J ORAL MAX IMPL, V30, P1161, DOI 10.11607/jomi.4057
   Di Stefano DA, 2009, CLIN IMPLANT DENT R, V11, P90, DOI 10.1111/j.1708-8208.2008.00104.x
   Esposito M, 2014, COCHRANE DB SYST REV, V5
   Esposito M, 2009, COCHRANE DB SYST REV, V7, DOI DOI 10.1002/14651858.CD003607.PUB4
   Felice P, 2013, EUR J ORAL IMPLANTOL, V6, P153
   Felice P, 2013, INT J PERIODONT REST, V33, P159, DOI 10.11607/prd.1098
   Galindo-Moreno P, 2013, CLIN IMPLANT DENT R, V15, P858, DOI 10.1111/j.1708-8208.2012.00445.x
   Galindo-Moreno P, 2012, IMPLANT DENT, V21, P433, DOI 10.1097/ID.0b013e3182691959
   GREEN J, 1995, AM J PHYSIOL-CELL PH, V268, pC1090
   Helfrich MH, 1996, BONE, V19, P317, DOI 10.1016/S8756-3282(96)00223-2
   Iezzi G, 2012, CLIN ORAL IMPLAN RES, V23, P1369, DOI 10.1111/j.1600-0501.2011.02308.x
   Jensen SS, 2009, INT J ORAL MAX IMPL, V24, P218
   Jensen SS, 2006, CLIN ORAL IMPLAN RES, V17, P237, DOI 10.1111/j.1600-0501.2005.01257.x
   Jensen T, 2012, CLIN ORAL IMPLAN RES, V23, P902, DOI 10.1111/j.1600-0501.2011.02245.x
   Kolerman Roni, 2012, Int J Periodontics Restorative Dent, V32, pe21
   Lambert F, 2013, INT J ORAL MAX IMPL, V28, P393, DOI 10.11607/jomi.2332
   Lindgren C, 2012, INT J ORAL MAX IMPL, V27, P1151
   Liu Gang, 2004, Chin J Traumatol, V7, P358
   Ludovichetti M, 2011, INT J PERIODONT REST, V31, P401
   Mangano C, 2007, INT J ORAL MAX IMPL, V22, P980
   MARINO AA, 1970, NATURE, V226, P652, DOI 10.1038/226652a0
   Misch C E, 1987, Int J Oral Implantol, V4, P49
   Misch CM, 2011, ORAL MAXIL SURG CLIN, V23, P229, DOI 10.1016/j.coms.2011.01.003
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Nevins M, 2013, INT J PERIODONT REST, V33, P483, DOI 10.11607/prd.1728
   Nkenke E, 2004, INT J ORAL MAX SURG, V33, P157, DOI 10.1054/ijom.2003.0465
   Nkenke E, 2001, CLIN ORAL IMPLAN RES, V12, P495, DOI 10.1034/j.1600-0501.2001.120510.x
   PARALKAR VM, 1990, J BIOL CHEM, V265, P17281
   Perrotti V, 2009, CLIN ORAL IMPLAN RES, V20, P17, DOI 10.1111/j.1600-0501.2008.01608.x
   Perrotti V, 2009, J BIOMED MATER RES A, V90A, P238, DOI 10.1002/jbm.a.32079
   Pistilli R, 2013, IMPLANT DENT, V22, P8, DOI 10.1097/ID.0b013e3182777239
   Regazzoni C, 2001, BIOCHEM BIOPH RES CO, V283, P316, DOI 10.1006/bbrc.2001.4813
   Rickert D, 2012, INT J ORAL MAX SURG, V41, P160, DOI 10.1016/j.ijom.2011.10.001
   SAMPATH TK, 1981, P NATL ACAD SCI-BIOL, V78, P7599, DOI 10.1073/pnas.78.12.7599
   Santini S, 2011, MINERVA CHIR, V66, P63
   Scarano A, 2007, IMPLANT DENT, V16, P195, DOI 10.1097/ID.0b013e3180587ad8
   Scarano A, 2011, CLIN IMPLANT DENT R, V13, P13, DOI 10.1111/j.1708-8208.2009.00176.x
   Schlegel KA, 2007, ORAL SURG ORAL MED O, V104, pE15, DOI 10.1016/j.tripleo.2007.04.021
   Shanbhag S, 2014, INT J ORAL MAX IMPL, V29, P881, DOI 10.11607/jomi.3472
   Simunek A, 2008, INT J ORAL MAX IMPL, V23, P935
   Stievano D, 2008, Minerva Chir, V63, P79
   Szabo G, 2001, INT J ORAL MAX IMPL, V16, P681
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   Tete S, 2013, EUR J HISTOCHEM, V57, P60, DOI 10.4081/ejh.2013.e10
   Tete S, 2014, J CRANIOFAC SURG, V25, P835, DOI 10.1097/SCS.0000000000000679
   Tosta M, 2013, CLIN ORAL IMPLAN RES, V24, P866, DOI 10.1111/j.1600-0501.2011.02384.x
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Zitzmann NU, 1997, INT J ORAL MAX IMPL, V12, P844
NR 66
TC 3
Z9 3
U1 0
U2 5
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
EI 1942-4434
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD MAR-APR
PY 2016
VL 31
IS 2
BP 406
EP 412
DI 10.11607/jomi.4373
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DP8IT
UT WOS:000378742400022
PM 27004287
OA Bronze
DA 2018-10-19
ER

PT J
AU Ghanaati, S
   Kovacs, A
   Barbeck, M
   Lorenz, J
   Teiler, A
   Sadeghi, N
   Kirkpatrick, CJ
   Sader, R
AF Ghanaati, Shahram
   Kovacs, Adorjan
   Barbeck, Mike
   Lorenz, Jonas
   Teiler, Anna
   Sadeghi, Nader
   Kirkpatrick, Charles James
   Sader, Robert
TI Bilayered, non-cross-linked collagen matrix for regeneration of facial
   defects after skin cancer removal: a new perspective for
   biomaterial-based tissue reconstruction
SO JOURNAL OF CELL COMMUNICATION AND SIGNALING
LA English
DT Article
DE Inflammation; BCC; Skin cancer; Flaps; Mucograft; Soft tissue
   regeneration; Facial plastic surgery
ID GINGIVAL RECESSION DEFECTS; CORONALLY ADVANCED FLAP; MATRICELLULAR
   PROTEINS; INFRABONY DEFECTS; CLINICAL-TRIAL; MODULATORS; GRAFT
AB Classically skin defects are covered by split thickness skin grafts or by means of local or regional skin flaps. In the presented case series for the first time a bilayered, noncrossed-linked collagen matrix has been used in an off-label fashion in order to reconstruct facial skin defects following different types of skin cancer resection. The material is of porcine origin and consists of a spongy and a compact layer. The ratio of the two layers is 1: 3 in favour of the spongy layer. The aim of the study was to investigate the potential of this matrix for skin regeneration as an alternative to the standard techniques of skin grafts or flaps. Six patients between 39 and 83 years old were included in the study based on a therapeutic trial. The collagen matrix was used in seven defects involving the nose, eyelid, forehead-and posterior scalp regions, and ranging from 1,2 to 6 cm in diameter. Two different head and neck surgeons at two different institutions performed the operations. Each used a different technique in covering the wound following surgery, i.e. with and without a latex-based sheet under the pressure dressing. In three cases cylindrical biopsies were taken after 14 days. In all cases the biomaterial application was performed without any complication and no adverse effects were observed. Clinically, the collagen matrix contributed to a tension-free skin regeneration, independent of the wound dressing used. The newly regenerated skin showed strong similarity to the adjacent normal tissue both in quality and colour. Histological analysis indicated that the spongy layer replaced the defective connective tissue, by providing stepwise integration into the surrounding implantation bed, while the compact layer was infiltrated by mononuclear cells and contributed to its epithelialization by means of a "conductive" process from the surrounding epithelial cells. The clinical and histological data demonstrate that the collagen bilayered matrix used in this series contributes to a "Guided-Integrative-Regeneration-Process", which still needs to be further understood. The biomimetic nature of this material seems to contribute to physiological matrix remodelling, which probably involves other matricellular proteins essential for soft tissue regeneration. A deeper understanding of the mechanism, involved in the tissue integration of this material and its contribution to soft tissue regeneration based on the direct and indirect effect of matricellular proteins could open new therapeutic avenues for biomaterial-based soft tissue regeneration as an alternative to traditional flap-based plastic surgery.
C1 [Ghanaati, Shahram; Barbeck, Mike; Lorenz, Jonas; Teiler, Anna; Kirkpatrick, Charles James; Sader, Robert] Goethe Univ Frankfurt, Med Ctr, Dept Oral Cranio Maxillofacial & Facial Plast Sur, FORM Lab, D-60054 Frankfurt, Germany.
   [Sadeghi, Nader] George Washington Univ, Head & Neck Surg Oncol, Washington, DC USA.
RP Ghanaati, S (reprint author), Goethe Univ Frankfurt, Med Ctr, Dept Oral Cranio Maxillofacial & Facial Plast Sur, FORM Lab, D-60054 Frankfurt, Germany.
EM shahram.ghanaati@kgu.de
OI Barbeck, Mike/0000-0002-3001-1347
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Barbeck M, 2015, J ORAL IMPLANTOL, V41, pE267, DOI 10.1563/aaid-joi-D-14-00155
   Barbeck M, 2015, J ORAL IMPLANTOL, V41, pE238, DOI 10.1563/aaid-joi-D-14-00274
   Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7
   Cardaropoli D, 2012, J PERIODONTOL, V83, P321, DOI 10.1902/jop.2011.110215
   Eickholz P, 2007, J PERIODONTOL, V78, P37, DOI 10.1902/jop.2007.060097
   Emre Y, 2014, SEMIN IMMUNOPATHOL, V36, P253, DOI 10.1007/s00281-014-0420-1
   Ghanaati S, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015010
   Ghanaati S, 2012, ACTA BIOMATER, V8, P3061, DOI 10.1016/j.actbio.2012.04.041
   GOTTLOW J, 1984, J CLIN PERIODONTOL, V11, P494, DOI 10.1111/j.1600-051X.1984.tb00901.x
   Herford AS, 2010, J ORAL MAXIL SURG, V68, P1463, DOI 10.1016/j.joms.2010.02.054
   Jepsen K, 2013, J CLIN PERIODONTOL, V40, P82, DOI 10.1111/jcpe.12019
   Kyriakides TR, 2003, THROMB HAEMOSTASIS, V90, P986, DOI 10.1160/TH03-06-0399
   Lorenz J, 2015, J ORAL IMPLANTOL, V41, pE257, DOI [10.1563/aaid-joi-D-14-00273, 10.1563/AAID-JOI-D-14-00273]
   Morris AH, 2014, MATRIX BIOL, V37, P183, DOI 10.1016/j.matbio.2014.03.002
   Pretzl B, 2008, J PERIODONTOL, V79, P1491, DOI [10.1902/jop.2008.070571, 10.1902/jop.2008.070571 ]
   Rogers-Vizena CR, 2015, PLAST RECONSTR SURG, V135, p895E, DOI 10.1097/PRS.0000000000001146
   Sameem M, 2012, PLAST RECONSTR SURG, V130, p67E, DOI 10.1097/PRS.0b013e318254b19f
   Sandu K, 2012, EUR ARCH OTO-RHINO-L, V269, P1261, DOI 10.1007/s00405-011-1754-0
   Sanz M, 2009, J CLIN PERIODONTOL, V36, P868, DOI 10.1111/j.1600-051X.2009.01460.x
   Schmitt C. M., 2015, CLIN ORAL IMPLAN RES, P1
   Schmitt CM, 2013, J PERIODONTOL, V84, P914, DOI 10.1902/jop.2012.120084
   Willershausen I, 2014, J APPL ORAL SCI, V22, P29, DOI 10.1590/1678-775720130316
   Zhang FQ, 2015, J BIOL CHEM, V290, P8232, DOI 10.1074/jbc.M114.623074
   Zhao MX, 2012, J PLAST RECONSTR AES, V65, P1634, DOI 10.1016/j.bjps.2012.07.017
NR 25
TC 2
Z9 2
U1 0
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1873-9601
EI 1873-961X
J9 J CELL COMMUN SIGNAL
JI J. Cell Commun. Signal
PD MAR
PY 2016
VL 10
IS 1
BP 3
EP 15
DI 10.1007/s12079-015-0313-7
PG 13
WC Cell Biology
SC Cell Biology
GA DO3RO
UT WOS:000377699100002
PM 26660939
OA Other Gold, Green Published
DA 2018-10-19
ER

PT J
AU Souza, MR
   Reyes, KM
   Oliveira, NTC
   Kuromoto, NK
   Marino, CEB
AF Souza, M. R.
   Reyes, K. M.
   Oliveira, N. T. C.
   Kuromoto, N. K.
   Marino, C. E. B.
TI Bioactivity of self-organized TiO2 nanotubes used as surface treatment
   on Ti biomaterials
SO MATERIALS RESEARCH EXPRESS
LA English
DT Article
DE TiO2 nanotubes; electrochemical stability; bioactivity; Brazilian MRS
ID BIOMEDICAL APPLICATIONS; TITANIUM NANOTUBES; METALLIC MATERIALS;
   BIOCOMPATIBILITY; COATINGS; IMPLANTS; BEHAVIOR; TI6AL4V; ALLOY
AB Titanium and its alloys are widely used as implants due to their excellent mechanical properties, corrosion resistance and biocompatibility. TiO2 nanotubes have been studied as surface treatment to increase the specific area and to improve osseointegration. However, the thermodynamic stability and bioactivity of these nanostructures must be evaluated. The objective of this research was to obtain nanotubes oxides on Ti6Al4V alloy and to analyze the electrochemical stability in physiological solution at 37 degrees C and the bioactive response of the biomaterial. The nanotubes were obtained by potentiostatic anodization. The morphology of the oxides was evaluated by scanning electron microscopy. The chemical characterization was analyzed by energy dispersive spectroscopy and x-ray photoelectron spectroscopy techniques. The electrochemical stability was analyzed by open circuit potential (OCP) and the bioactivity by biomimetic test in a simulated body fluid (SBF) solution. The OCP of the nanotubes oxides was shown to be more noble and stable than the compacted oxides. The biomaterial covered with theses oxides showed sealing by Ca and P after 30 d immersion in artificial blood. And after 15 d of immersion in SBF, the hydroxyapatite could be seen on the non-sealed nanotubes. TiO2 nanotube layers could improve the superficial chemical stability and also the osseointegration process.
C1 [Souza, M. R.; Reyes, K. M.; Kuromoto, N. K.; Marino, C. E. B.] Univ Fed Parana, Programa Posgrad Engn & Ciencia Mat PIPE, BR-80060000 Curitiba, Parana, Brazil.
   [Oliveira, N. T. C.] Univ Fed Sao Carlos, Dept Mat Engn, BR-13560 Sao Carlos, SP, Brazil.
   [Kuromoto, N. K.] Univ Fed Parana, Dept Fis, BR-80060000 Curitiba, Parana, Brazil.
   [Marino, C. E. B.] Univ Fed Parana, Dept Engn Mech, Lab Biomat & Eletroquim, BR-80060000 Curitiba, Parana, Brazil.
RP Reyes, KM (reprint author), Univ Fed Parana, Programa Posgrad Engn & Ciencia Mat PIPE, BR-80060000 Curitiba, Parana, Brazil.
EM mariana.rossi.souza@gmail.com; kareleiva@gmail.com; ntco@yahoo.com;
   kuromoto@fisica.ufpr.br; claudiamarino@ufpr.br
RI MARINO, CLAUDIA/H-8169-2017
OI MARINO, CLAUDIA/0000-0003-2660-4577
FU CAPES; CNPq [301434/2013-1]
FX The authors are grateful to CAPES for their financial support, to
   CCDM-UFSCAR and CME-UFPR for the SEM analyses and to LSI-UFPR for the
   XPS analysis. Finally, we thank the CNPq productivity fellowship from
   Claudia Eliana Bruno Marino (grant number 301434/2013-1).
CR Bauer S, 2006, ELECTROCHEM COMMUN, V8, P1321, DOI 10.1016/j.elecom.2006.05.030
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Chiang CY, 2009, DENT MATER, V25, P1022, DOI 10.1016/j.dental.2009.03.001
   Goodman SB, 2013, BIOMATERIALS, V34, P3174, DOI 10.1016/j.biomaterials.2013.01.074
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Holzapfel BM, 2013, ADV DRUG DELIVER REV, V65, P581, DOI 10.1016/j.addr.2012.07.009
   Karpagavalli R, 2007, J BIOMED MATER RES A, V83A, P1087, DOI 10.1002/jbm.a.31447
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Marino CEB, 2004, THIN SOLID FILMS, V468, P109, DOI 10.1016/j.tsf.2004.05.006
   Mohan L, 2015, ELECTROCHIM ACTA, V155, P411, DOI 10.1016/j.electacta.2014.12.032
   Mor GK, 2006, SOL ENERG MAT SOL C, V90, P2011, DOI 10.1016/j.solmat.2006.04.007
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Niinomi M, 2007, MATER SCI FORUM, V539-543, P193, DOI 10.4028/www.scientific.net/MSF.539-543.193
   Parcharoen Y, 2014, APPL SURF SCI, V311, P54, DOI 10.1016/j.apsusc.2014.04.207
   Pisarek M, 2012, BIOMEDICAL ENG TECHN
   RATNER BD, 2004, INTRO MAT MED
   Roy P, 2011, ANGEW CHEM INT EDIT, V50, P2904, DOI 10.1002/anie.201001374
   Shirdar MR, 2015, VACUUM, V122, P82, DOI 10.1016/j.vacuum.2015.09.008
   Souza M R, 2014, REV MAT, V19, P53
   Tsuchiya H, 2006, J BIOMED MATER RES A, V77A, P534, DOI 10.1002/jbm.a.30677
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Xie JH, 2008, J MATER RES, V23, P768, DOI 10.1557/JMR.2008.0089
   Yang SG, 2006, APPL CATAL A-GEN, V301, P284, DOI 10.1016/j.apcata.2005.12.016
   Yang WE, 2010, THIN SOLID FILMS, V518, P7545, DOI 10.1016/j.tsf.2010.05.045
   Zhang F, 2009, BIOMED MATER, V4
   Zhong ZY, 2015, MAT SCI ENG C-MATER, V49, P251, DOI 10.1016/j.msec.2015.01.020
NR 26
TC 3
Z9 3
U1 1
U2 22
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 2053-1591
J9 MATER RES EXPRESS
JI Mater. Res. Express
PD MAR
PY 2016
VL 3
IS 3
AR UNSP 035401
DI 10.1088/2053-1591/3/3/035401
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA DO5GH
UT WOS:000377811100023
DA 2018-10-19
ER

PT J
AU Feng, C
   Lv, XG
   Zhu, WD
   Lu, WL
   Peng, XF
   Zhang, XR
AF Feng, Chao
   Lv, Xiang-Guo
   Zhu, Wei-Dong
   Lu, Wen-Long
   Peng, Xu-Feng
   Zhang, Xin-Ru
TI VEGF-Loaded Nanoparticle-Modified Bacterial Cellulose Combined with
   Multiple Cells in Tissue-Engineered Bladder
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Bladder Reconstruction; Vascularization; Nanoparticle; Bacterial
   Cellulose
ID SMALL-INTESTINAL SUBMUCOSA; ACELLULAR MATRIX; PORCINE MODEL;
   AUGMENTATION; REGENERATION; GROWTH; RECONSTRUCTION; CYSTOPLASTY;
   UROTHELIUM; CONSTRUCTS
AB The aim of this study is to assess the properties of a VEGF-loaded nanoparticle-modified bacterial cellulose scaffold and evaluate its feasibility for bladder reconstruction. The bacterial cellulose and the VEGF-nanoparticle was manufactured according to standard technique. After combining the BC with VEGF-nanoparticles, the scanning electronic microscopy, MTT assay, mechanical test, and controlled release test were performed. The keratinocytes and lingual muscle cells were seeded onto these scaffolds for bladder reconstruction (study group). Meanwhile, the cell seeded unmodified BC scaffolds were used as control group. The SEM showed the 3D network form in those scaffolds, which the VEGF nanoparticles attached to the surfaces of fibers. The biochemical and physical assessments showed excellent properties of scaffold. The ELISA test exhibited that VEGF loaded scaffold could release VEGF for at least 4 weeks. Three months after implantation, the study group showed an intact bladder, while mild defection was noticed in the control group. The urodynamic results suggested that the bladder capacity and compliance were better in the study group. In histological examination, thicker epithelial layers, better-organized muscle bundles and denser microvasculature existed in the study group. The VEGF-nanoparticle loaded BC scaffolds had excellent characters, which could be an alternative biomaterial for bladder reconstruction.
C1 [Feng, Chao; Lv, Xiang-Guo; Zhu, Wei-Dong; Lu, Wen-Long; Peng, Xu-Feng; Zhang, Xin-Ru] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Urol, Shanghai 200233, Peoples R China.
RP Zhang, XR (reprint author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Urol, Shanghai 200233, Peoples R China.
CR Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Ajalloueian F, 2014, BIOMATERIALS, V35, P5741, DOI 10.1016/j.biomaterials.2014.04.002
   Andersson J, 2010, J BIOMED MATER RES A, V94A, P1124, DOI 10.1002/jbm.a.32784
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Azzarello J, 2009, J TISSUE ENG REGEN M, V3, P579, DOI 10.1002/term.199
   Brown AL, 2002, BIOMATERIALS, V23, P2179, DOI 10.1016/S0142-9612(01)00350-7
   El-Taji OMS, 2015, ONCOL LETT, V10, P3, DOI 10.3892/ol.2015.3161
   Jiang XC, 2015, ANN BIOMED ENG, V43, P2577, DOI 10.1007/s10439-015-1284-9
   Kaefer M, 1998, J UROLOGY, V160, P2187, DOI 10.1016/S0022-5347(01)62290-0
   Kanematsu A, 2004, BIOMATERIALS, V25, P4513, DOI 10.1016/j.biomaterials.2003.11.035
   Kikuno N, 2009, BJU INT, V103, P1424, DOI 10.1111/j.1464-410X.2008.08129.x
   Kropp BP, 1996, J UROLOGY, V156, P599, DOI 10.1016/S0022-5347(01)65761-6
   Kropp BP, 1998, WORLD J UROL, V16, P262, DOI 10.1007/s003450050064
   Li Z, 2015, CELLULOSE, V22, P373, DOI 10.1007/s10570-014-0487-9
   Lin HK, 2015, ADV DRUG DELIVER REV, V82-83, P47, DOI 10.1016/j.addr.2014.11.020
   Merguerian PA, 2000, BJU INT, V85, P894, DOI 10.1046/j.1464-410x.2000.00513.x
   Olyveira G. M., 2014, J BIOMATER TISS ENG, V24, P600
   Osborn SL, 2014, STEM CELL TRANSL MED, V3, P610, DOI 10.5966/sctm.2013-0131
   Polykandriotis E, 2007, J CELL MOL MED, V11, P6, DOI 10.1111/j.1582-4934.2007.00012.x
   Post MJ, 2013, REGEN MED, V8, P759, DOI 10.2217/rme.13.74
   Reddy PP, 2000, J UROLOGY, V164, P936, DOI 10.1016/S0022-5347(05)67221-7
   Sanchavanakit N, 2006, BIOTECHNOL PROGR, V22, P1194, DOI 10.1021/bp060035o
   Sievert KD, 2000, WORLD J UROL, V18, P19, DOI 10.1007/s003450050004
   Wippermann J, 2009, EUR J VASC ENDOVASC, V37, P592, DOI 10.1016/j.ejvs.2009.01.007
   Xiong QW, 2015, TISSUE ENG PT A, V21, P45, DOI [10.1089/ten.tea.2013.0671, 10.1089/ten.TEA.2013.0671]
   YAMANAKA S, 1989, J MATER SCI, V24, P3141, DOI 10.1007/BF01139032
   Zhang F, 2014, J UROLOGY, V192, P544, DOI 10.1016/j.juro.2014.01.116
   Zhang YY, 2006, BJU INT, V98, P1100, DOI 10.1111/j.1464-410X.2006.06447.x
   Zhou L., 2015, PLOS ONE, V10
   Zhu WD, 2011, UROLOGE, V50, P1420, DOI 10.1007/s00120-011-2627-2
NR 30
TC 0
Z9 0
U1 5
U2 17
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD MAR
PY 2016
VL 6
IS 3
BP 216
EP 223
DI 10.1166/jbt.2016.1434
PG 8
WC Cell & Tissue Engineering
SC Cell Biology
GA DM5WG
UT WOS:000376420500006
DA 2018-10-19
ER

PT J
AU Vuong, BX
   Hiep, DT
AF Bui Xuan Vuong
   Dang Tan Hiep
TI In vitro studies of bioglass material by X-ray diffraction and
   solid-state MAS-NMR
SO GLASS PHYSICS AND CHEMISTRY
LA English
DT Article
DE bioactive glass; bioactivity; hydroxyapatite; P-31 MAS-NMR; Si-29
   MAS-NMR
ID NUCLEAR-MAGNETIC-RESONANCE; BIOACTIVE GLASSES; P-31; SPECTROSCOPY;
   PHOSPHATE; SI-29; NA-23
AB Bioactive glass 46S6 has been elaborated by melting method at high temperature. "In vitro" experiments of 46S6 glass were carried out by soaking in a simulated body fluid for different times. The kinetics of chemical reactivity and the bioactivity of this biomaterial was investigated by X-ray diffraction and elucidated by using an original structural analysis method based on solid-state MAS-NMR. After in vitro assays, X-ray diffraction confirmed the high bioactivity of bioglass 46S6. The Si-29 MAS-NMR spectra showed the emergence of two new species: Q (Si) (3) (OH) Q (Si) (4) and which are characteristic of the dissolution of vitreous network of 46S6 glass while the P-31 MAS-NMR spectra highlighted the formation of new component attributed to hydroxycarbonate apatite. The bioglass 46S6 have presented the rapid formation of a biological active hydroxycarbonate apatite layer after soaking in simulated body fluid fluid.
C1 [Bui Xuan Vuong] Ton Duc Thang Univ, Dept Management Sci & Technol Dev, Ho Chi Minh City, Vietnam.
   [Bui Xuan Vuong] Ton Duc Thang Univ, Fac Appl Sci, Ho Chi Minh City, Vietnam.
   [Dang Tan Hiep] Ho Chi Minh City Univ Food Ind, Fac Chem Engn, Ho Chi Minh City, Vietnam.
RP Vuong, BX (reprint author), Ton Duc Thang Univ, Dept Management Sci & Technol Dev, Ho Chi Minh City, Vietnam.; Vuong, BX (reprint author), Ton Duc Thang Univ, Fac Appl Sci, Ho Chi Minh City, Vietnam.
EM buixuanvuong@tdt.edu.vn
CR Angelopoulou A, 2008, J NON-CRYST SOLIDS, V354, P333, DOI 10.1016/j.jnoncrysol.2007.08.091
   AUE WP, 1984, BIOCHEMISTRY-US, V23, P6110, DOI 10.1021/bi00320a032
   BELTON PS, 1988, J PHYS CHEM SOLIDS, V49, P21, DOI 10.1016/0022-3697(88)90129-1
   Diaz A, 2006, ACTA BIOMATER, V2, P173, DOI 10.1016/j.actbio.2005.12.006
   Dietrich E., 2008, J BIOMED MATER RES A, V88, P1087
   Elgayar I, 2005, J NON-CRYST SOLIDS, V351, P173, DOI 10.1016/j.jnoncrysol.2004.07.067
   Gunawidjaja PN, 2010, J PHYS CHEM C, V114, P19345, DOI 10.1021/jp105408c
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HINEDI ZR, 1992, J COLLOID INTERF SCI, V152, P141, DOI 10.1016/0021-9797(92)90015-E
   Karlsson K. H., 1991, J NONCRYST SOLIDS, V12, P129
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Lin KSK, 2005, CHEM MATER, V17, P4493, DOI 10.1021/cm0505654c
   LOCKYER MWG, 1995, J NON-CRYST SOLIDS, V188, P207, DOI 10.1016/0022-3093(95)00188-3
   Massiot D, 2002, MAGN RESON CHEM, V40, P70, DOI 10.1002/mrc.984
   OESTRIKE R, 1987, GEOCHIM COSMOCHIM AC, V51, P2199, DOI 10.1016/0016-7037(87)90269-9
   Oudadesse H, 2011, APPL SURF SCI, V257, P8587, DOI 10.1016/j.apsusc.2011.05.022
   Smith M. E., 2002, MULTINUCLEAR SOLID S
NR 18
TC 0
Z9 0
U1 1
U2 11
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 1087-6596
EI 1608-313X
J9 GLASS PHYS CHEM+
JI Glass Phys. Chem.
PD MAR
PY 2016
VL 42
IS 2
BP 188
EP 193
DI 10.1134/S108765961602005X
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA DM3OR
UT WOS:000376256300011
DA 2018-10-19
ER

PT J
AU Bita, AI
   Antoniac, A
   Cotrut, C
   Vasile, E
   Ciuca, I
   Niculescu, M
   Antoniac, I
AF Bita, A. I.
   Antoniac, A.
   Cotrut, C.
   Vasile, E.
   Ciuca, I.
   Niculescu, M.
   Antoniac, I.
TI In vitro Degradation and Corrosion Evaluation of Mg-Ca Alloys for
   Biomedical Applications
SO JOURNAL OF OPTOELECTRONICS AND ADVANCED MATERIALS
LA English
DT Article
DE Magnesium alloys; Corrosion rate; Biomedical; Degradation; Surface
ID MAGNESIUM ALLOYS; BONE
AB The ability to adjust degradation rate of magnesium alloys is critical for the successful development of new biodegradable trauma implants. The aim of this study was to evaluate the biodegradability of an Mg0.8Ca alloy in different simulated biological medium by immersion tests and corrosion resistance testing using electrochemical measurements. The degradation of the experimental magnesium alloy was investigated by immersion tests in two different simulated medium (Simulated Body Fluid-SBF and Dulbecco's Modified Eagle Medium-DMEM) for 3, 5, 7 and 10 days at 37 degrees C. The evaluation of corrosion resistance was performed using electrochemical measurements in the same simulated mediums for 1 hour, at 37 degrees C. The surface morphology of the experimental sample after both tests was investigated using scanning electron microscopy - SEM. The experimental results showed that the experimental magnesium alloy Mg0.8Ca appear to be a promising biomaterial for biodegradable trauma implants but their biodegradation rate must be improved using different techniques like coatings.
C1 [Bita, A. I.; Antoniac, A.; Cotrut, C.; Ciuca, I.; Antoniac, I.] Univ Politehn Bucuresti, Fac Mat Sci & Engn, St Splaiul Independentei 313,Sect 6, Bucharest, Romania.
   [Vasile, E.] Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, St Gh Polizu 1-7,Sect 1, Bucharest, Romania.
   [Niculescu, M.] Colentina Clin Hosp, Dept Orthopaed & Trauma 1, St Stefan Cel Mare 19-21,Sect 2, Bucharest, Romania.
RP Niculescu, M (reprint author), Colentina Clin Hosp, Dept Orthopaed & Trauma 1, St Stefan Cel Mare 19-21,Sect 2, Bucharest, Romania.
EM mariusniculescu1961@gmail.com
RI Cotrut, Mihai Cosmin/G-4505-2011; Antoniac, Iulian/D-4802-2014
OI Cotrut, Mihai Cosmin/0000-0002-8991-7485; Antoniac,
   Iulian/0000-0003-0112-3494
FU Sectoral Operational Programme Human Resources Development of the
   Ministry of European Funds [POSDRU/159/1.5/S/132397]; UEFISCDI - PN II -
   Partnerships in priority areas [271/2014]; EU [POSCCE-A2-O2.2.1-2013-1/,
   638/12.c03.2014, cod SMIS-CSrNR 48652]
FX The work has been funded by the Sectoral Operational Programme Human
   Resources Development 2007-2013 of the Ministry of European Funds
   through the Financial Agreement POSDRU/159/1.5/S/132397 and the UEFISCDI
   - PN II - Partnerships in priority areas, Contract No. 271/2014. The SEM
   analyses on samples were possible due to EU-funding grant
   POSCCE-A2-O2.2.1-2013-1/ Priority direction 2, Project
   No.638/12.c03.2014, cod SMIS-CSrNR 48652.
CR Bakhsheshi-Rad HR, 2015, VACUUM, V119, P95, DOI 10.1016/j.vacuum.2015.04.039
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Kirkland NT, 2010, CORROS SCI, V52, P287, DOI 10.1016/j.corsci.2009.09.033
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Salahshoor M, 2012, MATERIALS, V5, P135, DOI 10.3390/ma5010135
   Sanchez AHM, 2015, ACTA BIOMATER, V13, P16, DOI 10.1016/j.actbio.2014.11.048
   Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Waizy H, 2013, J MATER SCI, V48, P39, DOI 10.1007/s10853-012-6572-2
NR 10
TC 2
Z9 2
U1 1
U2 8
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1454-4164
EI 1841-7132
J9 J OPTOELECTRON ADV M
JI J. Optoelectron. Adv. Mater.
PD MAR-APR
PY 2016
VL 18
IS 3-4
BP 394
EP 398
PG 5
WC Materials Science, Multidisciplinary; Optics; Physics, Applied
SC Materials Science; Optics; Physics
GA DL9LM
UT WOS:000375964800029
DA 2018-10-19
ER

PT J
AU Salehipour, M
   Mohammadian, R
   Malekahmadi, A
   Hosseinzadeh, M
   Yadollahi, M
   Natami, M
   Mohammadian, M
AF Salehipour, Mehdi
   Mohammadian, Reza
   Malekahmadi, Amir
   Hosseinzadeh, Massood
   Yadollahi, Mahnaz
   Natami, Mohammad
   Mohammadian, Mahsa
TI Renal capsule for augmentation cystoplasty in canine model: a favorable
   biomaterial?
SO INTERNATIONAL BRAZ J UROL
LA English
DT Article
DE Urinary Bladder; Dogs; Biocompatible Materials
ID SMALL-INTESTINAL SUBMUCOSA; BLADDER AUGMENTATION; CLINICAL-EXPERIENCE
AB Purpose: To evaluate effectiveness of canine renal capsule for augmentation cystoplasty.
   Materials and Methods: Ten adult dogs participated in this study. After induction of anesthesia each animal underwent bed side urodynamic study, bladder capacity and bladder pressure was recorded. Then via mid line incision abdominal cavity was entered, right kidney was identified and its capsule was dissected. Bladder augmentation was done by anastomosing the renal capsule to the bladder. After 6 months bed side urodynamic study was performed again and changes in bladder volume and pressure were recorded. Then the animals were sacrificed and the augmented bladders were sent for histopathology evaluation.
   Results: Mean maximum anatomic bladder capacity before cystoplasty was 334.00 +/- 11.40cc which increased to 488.00 +/- 14.83cc post-operatively (p=0.039). Mean anatomic bladder pressure before cystoplasty was 19.00 +/- 1.58cmH2O which decreased to 12.60 +/- 1.14cmH(2)O post-operatively (p=0.039). Histopathology evaluation revealed epithelialization of the renal capsule with urothelium without evidence of fibrosis, collagen deposits or contracture.
   Conclusions: Our data shows that renal capsule is a favorable biomaterial for bladder augmentation in a canine model.
C1 [Salehipour, Mehdi; Mohammadian, Reza; Malekahmadi, Amir; Natami, Mohammad; Mohammadian, Mahsa] Shiraz Univ Med Sci, Dept Urol, Shiraz, Iran.
   [Hosseinzadeh, Massood] Shiraz Univ Med Sci, Dept Pathol, Shiraz, Iran.
   [Yadollahi, Mahnaz] Shiraz Univ Med Sci, Trauma Res Ctr, Shiraz, Iran.
RP Salehipour, M (reprint author), Shiraz Univ Med Sci, Faghihi Hosp, Shiraz, Iran.
EM salehipour@sums.ac.ir
RI salehipour, mehdi/U-5423-2017; hosseinzadeh, massood/C-5216-2018
OI salehipour, mehdi/0000-0003-3882-0234; hosseinzadeh,
   massood/0000-0003-0531-0457
CR Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052
   [Anonymous], 2009, WHEC PRACT B CLIN MA
   [Anonymous], 1996, GUIDE CARE USE LAB A
   Barrett D M, 1984, Semin Urol, V2, P167
   CARTWRIGHT PC, 1989, J UROLOGY, V142, P505, DOI 10.1016/S0022-5347(17)38798-0
   CHURCHILL BM, 1993, J UROLOGY, V150, P716, DOI 10.1016/S0022-5347(17)35596-9
   Elbahnasy AM, 1998, J UROLOGY, V159, P628, DOI 10.1016/S0022-5347(01)63690-5
   Greenwell TJ, 2001, BJU INT, V88, P511, DOI 10.1046/j.1464-4096.2001.001206
   Greenwell TJ, 2001, UROLOGY, V58, P660, DOI 10.1016/S0090-4295(01)01363-2
   Higuchi TT, 2010, J UROLOGY, V84, P2492
   Hodjati H, 2013, UROLOGY, V81
   KHOURY JM, 1990, WORLD J UROL, V8, P203, DOI 10.1007/BF01580021
   Mikulicz V, 1889, ZENTRALBL CHIR, V20, P641
   NEUHOF H, 1917, SURG GYNECOL OBSTET, V24, P383
   Nurse DE, 1996, BRIT J UROL, V77, P684, DOI 10.1046/j.1464-410X.1996.97311.x
   Park HC, 2010, AM J PHYSIOL-RENAL, V298, pF1254, DOI 10.1152/ajprenal.00406.2009
   Paterson RF, 2002, J UROLOGY, V168, P2253, DOI 10.1097/01.ju.0000024629.58795.43
   Snow B W, 1992, Contemp Urol, V4, P41
   Swami KS, 1998, BRIT J UROL, V81, P68
   THOMPSON IM, 1969, J UROLOGY, V101, P487, DOI 10.1016/S0022-5347(17)62369-3
   Tizzoni G, 1888, CENTRALBL F CHIR, V15, P921
   Wang DS, 2007, BJU INT, V99, P628, DOI 10.1111/j.1464-410X.2006.06662.x
NR 22
TC 0
Z9 0
U1 0
U2 6
PU BRAZILIAN SOC UROL
PI RIO DE JANEIRO
PA RUA BAMBINA, 153, RIO DE JANEIRO, 2251-050, BRAZIL
SN 1677-5538
EI 1677-6119
J9 INT BRAZ J UROL
JI Int. Braz J Urol
PD MAR-APR
PY 2016
VL 42
IS 2
BP 383
EP 388
DI 10.1590/S1677-5538.IBJU.2014.0680
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA DL4KQ
UT WOS:000375604900029
PM 27256195
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Dursun, CK
   Dursun, E
   Eratalay, K
   Orhan, K
   Tatar, I
   Baris, E
   Tozum, TF
AF Dursun, Ceyda Kanli
   Dursun, Erhan
   Eratalay, Kenan
   Orhan, Kaan
   Tatar, Ilkan
   Baris, Emre
   Toezuem, Tolga Fikret
TI Effect of Porous Titanium Granules on Bone Regeneration and Primary
   Stability in Maxillary Sinus: A Human Clinical, Histomorphometric, and
   Microcomputed Tomography Analyses
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Bone density; dental implant; maxillary sinus floor elevation;
   microcomputed tomography; stability
ID ANORGANIC BOVINE BONE; FLOOR AUGMENTATION; AUTOGENOUS BONE; DENTAL
   IMPLANTS; HISTOLOGIC EVALUATION; MINERAL DENSITY; BIO-OSS; GRAFT;
   BIOMATERIAL; PLACEMENT
AB The aim of this randomized controlled study was to comparatively analyze the new bone (NB), residual bone, and graft-bone association in bone biopsies retrieved from augmented maxillary sinus sites by histomorphometry and microcomputed tomography (MicroCT) in a split-mouth model to test the efficacy of porous titanium granules (PTG) in maxillary sinus augmentation. Fifteen patients were included in the study and each patient was treated with bilateral sinus augmentation procedure using xenograft (equine origine, granule size 1000-2000 mu m) and xenograft (1g) + PTG (granule size 700-1000 mu m, pore size >50 mu m) (1g), respectively. After a mean of 8.4 months, 30 bone biopsies were retrieved from the implant sites for three-dimensional MicroCT and two-dimensional histomorphometric analyses. Bone volume and vital NB percentages were calculated. Immediate after core biopsy, implants having standard dimensions were placed and implant stability quotient values were recorded at baseline and 3 months follow-up. There were no significant differences between groups according to residual bone height, residual bone width, implant dimensions, and implant stability quotient values (baseline and 3 months). According to MicroCT and two-dimensional histomorphometric analyses, the volume of newly formed bone was 57.05% and 52.67%, and 56.5% and 55.08% for xenograft + PTG and xenograft groups, respectively. No statistically significant differences found between groups according to NB percentages and higher Hounsfield unit values were found for xenograft + PTG group. The findings of the current study supports that PTG, which is a porous, permanent nonresorbable bone substitute, may have a beneficial osteoconductive effect on mechanical strength of NB in augmented maxillary sinus.
C1 [Dursun, Ceyda Kanli; Dursun, Erhan; Eratalay, Kenan] Hacettepe Univ, Fac Dent, Dept Periodontol, Ankara, Turkey.
   [Orhan, Kaan] Ankara Univ, Fac Dent, Dept Dentomaxillofacial Radiol, TR-06100 Ankara, Turkey.
   [Tatar, Ilkan] Hacettepe Univ, Fac Med, Dept Anat, Ankara, Turkey.
   [Baris, Emre] Gazi Univ, Fac Dent, Dept Oral Pathol, Ankara, Turkey.
   [Toezuem, Tolga Fikret] Univ Illinois, Coll Dent, Dept Dept Periodont, Chicago, IL USA.
RP Dursun, CK (reprint author), Univ Illinois, Dept Periodont, Coll Dent, Chicago, IL USA.
EM ttozum@uic.edu
RI Bayram, Cem/D-7403-2013
OI Bayram, Cem/0000-0001-8717-4668; Orhan, Kaan/0000-0001-6768-0176
FU Hacettepe University, Scientific Research Projects Coordination Unit,
   Ankara, Turkey [011D10201003]
FX This study is supported by Hacettepe University, Scientific Research
   Projects Coordination Unit, Grant Number: 011D10201003, Ankara, Turkey.
CR BOYNE PJ, 1980, J ORAL SURG, V38, P613
   Butz F, 2011, INT J ORAL MAX IMPL, V26, P1317
   Bystedt H, 2009, CLIN IMPLANT DENT R, V11, P101, DOI 10.1111/j.1708-8208.2008.00100.x
   Chackartchi T, 2011, CLIN ORAL IMPLAN RES, V22, P473, DOI 10.1111/j.1600-0501.2010.02032.x
   Del Fabbro M, 2004, INT J PERIODONT REST, V24, P565
   Galindo-Moreno P, 2010, CLIN ORAL IMPLAN RES, V21, P122, DOI 10.1111/j.1600-0501.2009.01814.x
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635
   Handschel Jorg, 2009, Head Face Med, V5, P12, DOI 10.1186/1746-160X-5-12
   Hatano N, 2004, CLIN ORAL IMPLAN RES, V15, P339, DOI 10.1111/j.1600-0501.2004.00996.x
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Huang HL, 2012, CLIN ORAL IMPLAN RES, V23, P1098, DOI 10.1111/j.1600-0501.2011.02273.x
   Jensen OT, 1998, INT J ORAL MAX IMPL, V13, P11
   Jensen T, 2012, CLIN ORAL IMPLAN RES, V23, P263, DOI 10.1111/j.1600-0501.2011.02168.x
   John HD, 2004, INT J ORAL MAX IMPL, V19, P199
   Lambert F, 2013, CLIN IMPLANT DENT R, V15, P412, DOI 10.1111/j.1708-8208.2011.00374.x
   Lee CYS, 2011, IMPLANT DENT, V20, P202, DOI 10.1097/ID.0b013e318211f72e
   Orsini G, 2006, J PERIODONTOL, V77, P1984, DOI 10.1902/jop.2006.060181
   Ostman PO, 2008, INT J ORAL MAX IMPL, V23, P315
   Peleg M, 1998, J PERIODONTOL, V69, P1397, DOI 10.1902/jop.1998.69.12.1397
   Sabetrasekh R, 2011, J BIOMATER APPL, V25, P559, DOI 10.1177/0885328209354925
   Santagata M, 2010, J ORAL IMPLANTOL, V36, P485, DOI 10.1563/AAID-JOI-D-09-00105
   Sbordone L, 2009, INT J ORAL MAX SURG, V38, P1059, DOI 10.1016/j.ijom.2009.06.024
   Schlegel KA, 2003, INT J ORAL MAX IMPL, V18, P53
   Schmitt CM, 2015, CLIN ORAL IMPLAN RES, V26, P1043, DOI 10.1111/clr.12396
   Sennerby L, 2008, PERIODONTOL 2000, V47, P51, DOI 10.1111/j.1600-0757.2008.00267.x
   Sharan A, 2008, INT J ORAL MAX IMPL, V23, P48
   SMILER D G, 1987, Journal of Oral Implantology, V13, P239
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   Tozum TF, 2010, J ORAL REHABIL, V37, P217, DOI 10.1111/j.1365-2842.2009.02038.x
   Valentini P, 2003, INT J ORAL MAX IMPL, V18, P556
   Velich N, 2004, J CRANIOFAC SURG, V15, P38, DOI 10.1097/00001665-200401000-00013
   Verket A, 2014, CLIN ORAL IMPLAN RES, V25, pE100, DOI 10.1111/clr.12070
   Verket A, 2013, INT J ORAL MAX IMPL, V28, P721, DOI 10.11607/jomi.2853
   Wallace SS, 2005, INT J PERIODONT REST, V25, P551
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   Wohlfahrt JC, 2010, CLIN ORAL IMPLAN RES, V21, P165, DOI 10.1111/j.1600-0501.2009.01813.x
   Xavier SP, 2015, CLIN ORAL IMPLAN RES, V26, P1080, DOI 10.1111/clr.12404
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 39
TC 9
Z9 9
U1 2
U2 9
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD MAR
PY 2016
VL 27
IS 2
BP 391
EP 397
DI 10.1097/SCS.0000000000002421
PG 7
WC Surgery
SC Surgery
GA DK2RD
UT WOS:000374761200073
PM 26872278
DA 2018-10-19
ER

PT J
AU Ferreira, ACRD
   Munoz, XMJP
   Okamoto, R
   Pellizer, EP
   Garcia, IR
AF Rezende de Moraes Ferreira, Ana Carulina
   Johanna Palacio Munoz, Xiomara Monica
   Okamoto, Roberta
   Pellizer, Eduardo Piza
   Garcia, Idelmo Rangel, Jr.
TI Postoperative Complications in Craniomaxillofacial Reconstruction With
   Medpor
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Bone reconstruction; Medpor; postoperative complication
ID POROUS POLYETHYLENE IMPLANTS; FRACTURES; OUTCOMES; SURGERY
AB Bone reconstruction in craniofacial surgery is a challenge for surgeons, who most commonly adopt the autogenous bone grafting and alloplastic implants in such procedures. Among the alloplastic materials, the high-density porous polyethylene is highlighted-Medpor (Medpor, Porex Surgical Inc, Newman, GA), considered to be pure polyethylene, with only 1 manufacturing process and standard pore size. The purpose of the current study has been to present through a review of literature and the types of complications derived from the use of Medpor in craniomaxillo-facial bone surgery. A specific and sensitive database was initially created via PubMed, focusing on studies published in English peer-reviewed journals between 2004 and 2014, including case reports, experimental studies in humans, and prospective and retrospective studies. Forty articles were found at PubMed database. After analyzing their abstracts, 19 were selected, totaling 1453 patients and 121 complications, being the most commonly reported diplopia with 56 patients and infection with 6 patients. Most of the complications reported in the articles used for the development of the current review are not directly related to the use of the Medpor implant. The only complications directly related to the use of this biomaterial were cases of infection.
C1 [Rezende de Moraes Ferreira, Ana Carulina; Johanna Palacio Munoz, Xiomara Monica] Sao Paulo State Univ, Sao Paulo, Brazil.
   [Okamoto, Roberta] State Univ Sao Paulo UNESP, Coll Dent, Sao Paulo, Brazil.
   [Pellizer, Eduardo Piza; Garcia, Idelmo Rangel, Jr.] State Univ Sao Paulo UNESP, Coll Dent, Dept Dent Mat & Prosthodont, Sao Paulo, Brazil.
RP Ferreira, ACRD (reprint author), Sao Paulo State Univ, Rua Jose Bonifacio,1193 Vila Mendonca, BR-16015050 Aracatuba, SP, Brazil.
EM caru_moraes@hotmail.com
OI Okamoto, Roberta/0000-0002-6773-6966
CR Chambless LB, 2012, J CRANIO MAXILL SURG, V40, pE28, DOI 10.1016/j.jcms.2011.01.016
   Han DH, 2011, J CRANIOFAC SURG, V22, P1422, DOI 10.1097/SCS.0b013e31821cc2b5
   Heliotis M, 2007, PLAST RECONSTR SURG, V120, P1740, DOI 10.1097/01.prs.0000291404.03478.ff
   Hwang K, 2009, J CRANIOFAC SURG, V20, P1218, DOI 10.1097/SCS.0b013e3181acde01
   Kyung H, 2013, J CRANIOFAC SURG, V24, P1781, DOI 10.1097/SCS.0b013e3182a21076
   Lee S, 2005, ARCH OTOLARYNGOL, V131, P446, DOI 10.1001/archotol.131.5.446
   Lin AY, 2012, J CRANIOFAC SURG, V23, P67, DOI 10.1097/SCS.0b013e318240c876
   Nahai FR, 2012, FACIAL PLAST SURG, V28, P34, DOI 10.1055/s-0032-1305788
   Naik MN, 2007, OPHTHAL PLAST RECONS, V23, P463, DOI 10.1097/IOP.0b013e318158ec8e
   Nocini PF, 2009, PLAST RECONSTR SURG, V123, P670, DOI 10.1097/PRS.0b013e318196b958
   Ozturk S, 2005, J CRANIOFAC SURG, V16, P973, DOI 10.1097/01.scs.0000179744.91165.3a
   Rapidis AD, 2006, J ORAL MAXIL SURG, V64, P12, DOI 10.1016/j.joms.2005.09.007
   Wajih WAS, 2011, J ORAL MAXIL SURG, V69, P1740, DOI 10.1016/j.joms.2010.07.053
   Wang JC, 2012, J CRANIOFAC SURG, V23, P1404, DOI 10.1097/SCS.0b013e31825e3aeb
   Wang M, 2012, J CRANIOFAC SURG, V23, P44, DOI 10.1097/SCS.0b013e318240c83e
   Wang ST, 2008, ORAL SURG ORAL MED O, V106, P324, DOI 10.1016/j.tripleo.2007.12.022
   Xiao Jin-gang, 2007, Hua Xi Kou Qiang Yi Xue Za Zhi, V25, P67
   Xu JJ, 2009, J CRANIOFAC SURG, V20, P918, DOI 10.1097/SCS.0b013e3181a2d728
   Ye J, 2006, INVEST OPHTH VIS SCI, V47, P509, DOI 10.1167/iovs.05-0816
NR 19
TC 1
Z9 1
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD MAR
PY 2016
VL 27
IS 2
BP 425
EP 428
DI 10.1097/SCS.0000000000002325
PG 4
WC Surgery
SC Surgery
GA DK2RD
UT WOS:000374761200080
PM 26963299
DA 2018-10-19
ER

PT J
AU Pigache, P
   Anavekar, N
   Raoul, G
   Ferri, J
AF Pigache, Penelope
   Anavekar, Namrata
   Raoul, Gwenael
   Ferri, Joel
TI Maxillary Reconstruction for Sinus Lift Complications With Oro-Antral
   Fistula: The Le Fort I Approach
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Biomaterial; calvarial bone; maxillary reconstruction; oro-antral
   fistula; sinus lift complications
ID RETROSPECTIVE EVALUATION; ENDOSSEOUS IMPLANTS; OROANTRAL FISTULA;
   AUTOGENOUS BONE; CLOSURE; REPAIR
AB Although sinus lift procedures are reliable, some complications can lead to serious maxillary sequelae, including the development of oro-antral fistula (OAF). Maxillary reconstruction in such patients presents a challenge owing to sinus floor alterations, graft remnants, chronic infection, and morbidity from the original sinus lift approach. The current study describes our technique of maxillary reconstruction using a Le Fort 1 approach following major sinus lift complications with associated residual OAF. This technique provides excellent access for sinus curettage, OAF closure, and osseous reconstruction. It allowed a successful rehabilitation in our patients, with no implant loss and good functional and esthetic results.
C1 [Pigache, Penelope; Anavekar, Namrata; Raoul, Gwenael; Ferri, Joel] Lille Univ Hosp, Oral & Maxillofacial Dept, Lille, France.
RP Pigache, P (reprint author), Ctr Hosp Reg Univ Lille, Lille, France.
EM penelope.pigache@gmail.com
CR Abuabara A, 2006, INT J ORAL MAX SURG, V35, P155, DOI 10.1016/j.ijom.2005.04.024
   Ahmed MS, 2011, ORAL SURG ORAL MED O, V111, P8
   Anavi Y, 2003, ORAL SURG ORAL MED O, V96, P527, DOI 10.1016/S1079-2104(03)00470-0
   Anavi Y, 2008, ORAL SURG ORAL MED O, V106, P34, DOI 10.1016/j.tripleo.2007.09.021
   Anzalone JV, 2010, J ORAL IMPLANTOL, V36, P231, DOI 10.1563/AAID-JOI-D-09-00026
   Cawood JI, 2006, INT J ORAL MAX SURG, V35, P195, DOI 10.1016/j.ijom.2005.09.008
   Ferri J, 2010, REV STOMATOL CHIR, V111, P63, DOI 10.1016/j.stomax.2009.09.013
   Ferri J, 2008, HEAD FACE MED, V16, P4
   Goga D, 2000, Rev Stomatol Chir Maxillofac, V101, P303
   Lee BK, 2008, ORAL SURG ORAL MED O, V105, P707, DOI 10.1016/j.tripleo.2007.09.020
   Vazquez JCM, 2014, J ORAL MAXIL SURG, V72, P892, DOI 10.1016/j.joms.2013.11.023
   Nkenke E, 2009, CLIN ORAL IMPLAN RES, V20, P124, DOI 10.1111/j.1600-0501.2009.01776.x
   Nolan PJ, 2014, J ORAL MAXIL SURG, V72, P47, DOI 10.1016/j.joms.2013.07.020
   Papa F, 2005, BRIT J ORAL MAX SURG, V43, P309, DOI 10.1016/j.bjoms.2004.08.027
   PROCTOR B, 1969, LARYNGOSCOPE, V79, P822, DOI 10.1288/00005537-196905000-00005
   Raghoebar GM, 2001, CLIN ORAL IMPLAN RES, V12, P279, DOI 10.1034/j.1600-0501.2001.012003279.x
   SAILER HF, 1989, J CRANIO MAXILL SURG, V17, P299, DOI 10.1016/S1010-5182(89)80057-5
   Soehardi A, 2015, INT J ORAL MAX SURG, V44, P97, DOI 10.1016/j.ijom.2014.06.002
   Watzak G, 2005, J ORAL MAXIL SURG, V63, P1288, DOI 10.1016/j.joms.2005.05.299
   Zijderveld SA, 2008, J ORAL MAXIL SURG, V66, P1426, DOI [10.1016/j.joms.2008.01.027, 10.1016/j.jams.2008.01.027]
NR 20
TC 1
Z9 1
U1 1
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD MAR
PY 2016
VL 27
IS 2
BP 464
EP 468
DI 10.1097/SCS.0000000000002383
PG 5
WC Surgery
SC Surgery
GA DK2RD
UT WOS:000374761200089
PM 26825748
DA 2018-10-19
ER

PT J
AU Elangovan, S
   Prakasam, S
   Gajendrareddy, P
   Allareddy, V
AF Elangovan, Satheesh
   Prakasam, Sivaraman
   Gajendrareddy, Praveen
   Allareddy, Veerasathpurush
TI A RISK OF BIAS ASSESSMENT OF RANDOMIZED CONTROLLED TRIALS (RCTS) ON
   PERIODONTAL REGENERATION PUBLISHED IN 2013
SO JOURNAL OF EVIDENCE-BASED DENTAL PRACTICE
LA English
DT Article
DE Randomized controlled trial; Evidence based dentistry; Bias
ID CONTROLLED CLINICAL-TRIAL; EVIDENCE-BASED DENTISTRY; LOCAL-DRUG
   DELIVERY; SYSTEMATIC REVIEWS; QUALITY ASSESSMENT; SURGERY; DEFECTS; GEL;
   SMOKERS
AB Objective
   The objective of this assessment isto evaluate the degree of risk of bias in randomized controlled trials published in 2013 and focusing on periodontal regeneration.
   Methods
   Three reviewers searched and selected the trials based on pre-defined inclusion criteria. Predictor variables [number of authors, primary objective of the study, biomaterial employed, follow-up time periods, split mouth study (yes/no), journal, year of publication, country, scale (single/multi-center) and nature of funding] were extracted and risk of bias assessment using Cochrane risk of bias tool were performed independently by the three reviewers.
   Results
   Seventeen RCTs were included in this assessment. The risk of bias in RCTs published in 2013 with a focus in periodontal regeneration varied significantly with only in less than 30% of the included trials, the overall risk of bias was found to be low, while 41% oftrials were designated to have a higherdegree of bias. Specifically, when looking at the domains assessed, 70% of the included trials reported an accepted method of sequence generation, blinding (whenever possible), completeness of outcome data or avoided selective outcome reporting. Meanwhile, only 47% of the included trials reported some form of allocation concealment.
   Conclusion
   In this assessment, of the included 17 trials, slightly more than 40% of them had a high risk of bias, underscoring the importance of careful appraisal of trials before implementing the study interventions in clinical practice and the need for more detailed analyses.
C1 [Prakasam, Sivaraman; Allareddy, Veerasathpurush] Univ Iowa, Coll Dent, Dept Periodont, Iowa City, IA 52242 USA.
   [Elangovan, Satheesh] Oregon Hlth & Sci Univ, Sch Dent, Dept Periodont, Portland, OR 97239 USA.
   [Gajendrareddy, Praveen] Univ Illinois, Dept Periodont, Chicago, IL 60612 USA.
RP Allareddy, V (reprint author), Univ Iowa, Coll Dent, Dept Periodont, Iowa City, IA 52242 USA.
EM Veerasathpurush-Allareddy@uiowa.edu
CR Cairo F, 2012, J CLIN PERIODONTOL, V39, P81, DOI 10.1111/j.1600-051X.2011.01839.x
   Chalmers TC, 1983, NEW ENGL J MED, V309, P1359
   Chambrone L, 2010, J CLIN PERIODONTOL, V37, P1110, DOI 10.1111/j.1600-051X.2010.01634.x
   Elangovan S, 2013, J PERIODONTOL, V84, P758, DOI 10.1902/jop.2012.120317
   Elangovan S, 2013, J PERIODONTOL, V84, P176, DOI 10.1902/jop.2012.120021
   Faggion CM, 2012, J PERIODONTOL, V83, P1251, DOI 10.1902/jop.2012.110609
   Farina R, 2013, CLIN ORAL INVEST, V17, P1573, DOI 10.1007/s00784-012-0838-6
   Forni F, 2013, BLOOD TRANSFUS-ITALY, V11, P102, DOI 10.2450/2012.0007-12
   Higgins JP, 2011, COCHRANE COLLABORATI, DOI DOI 10.1002/9780470712184
   Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928
   Ismail AI, 2004, J AM DENT ASSOC, V135, P78, DOI 10.14219/jada.archive.2004.0024
   Kelly JT, 2013, J AM DENT ASSOC, V144, P371, DOI 10.14219/jada.archive.2013.0130
   Marshall TA, 2014, J DENT EDUC, V78, P359
   Pihlstrom BL, 2012, PERIODONTOL 2000, V59, P14, DOI 10.1111/j.1600-0757.2011.00439.x
   Pradeep AR, 2013, J PERIODONTOL, V84, P307, DOI 10.1902/jop.2012.110729
   Rao NS, 2013, AUST DENT J, V58, P156, DOI 10.1111/adj.12042
   Rao NS, 2013, J PERIODONTOL, V84, P1165, DOI 10.1902/jop.2012.120298
   Savovic Jelena, 2014, Syst Rev, V3, P37, DOI 10.1186/2046-4053-3-37
   Sjogren P, 2002, J CLIN PERIODONTOL, V29, P1112, DOI 10.1034/j.1600-051X.2002.291211.x
   Vere J, 2011, CLIN ORAL IMPLAN RES, V22, P1338, DOI 10.1111/j.1600-0501.2010.02124.x
NR 20
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1532-3382
EI 1532-3390
J9 J EVID-BASED DENT PR
JI J. Evid.-Based Dent. Pract.
PD MAR
PY 2016
VL 16
IS 1
BP 30
EP 40
DI 10.1016/j.jebdp.2015.03.016
PG 11
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DL6FO
UT WOS:000375735300004
PM 27132553
DA 2018-10-19
ER

PT J
AU Valente, FL
   Reis, ECC
   Sepulveda, RV
   Ochoa, CCR
   Santos, LC
   Corsini, CM
   Borges, APB
AF Valente, F. L.
   Reis, E. C. C.
   Sepulveda, R. V.
   Ochoa, C. C. R.
   Santos, L. C.
   Corsini, C. M.
   Borges, A. P. B.
TI Hydroxyapatite, polycaprolactone and alendronate composites for bone
   regeneration in rabbits' olecranon: histological features
SO ARQUIVO BRASILEIRO DE MEDICINA VETERINARIA E ZOOTECNIA
LA English
DT Article
DE bone regeneration; biocompatibility; biomaterial
ID IN-VIVO; DEFECT
C1 [Valente, F. L.; Reis, E. C. C.; Sepulveda, R. V.; Ochoa, C. C. R.; Santos, L. C.; Corsini, C. M.; Borges, A. P. B.] Univ Fed Vicosa, Vicosa, MG, Brazil.
RP Borges, APB (reprint author), Univ Fed Vicosa, Vicosa, MG, Brazil.
EM andrea@ufv.br
OI Borges, Andrea Pacheco Batista/0000-0002-7489-3847
FU FAPEMIG; CNPq; CAPES
FX The authors thank the agencies FAPEMIG, CNPq and CAPES for financial
   support and JHS Laboratorio Quimico Ltda. for providing the material for
   research.
CR Borges APB, 2000, ARQ BRAS MED VET ZOO, V52, P616, DOI 10.1590/S0102-09352000000600011
   Carlo EC, 2009, ARQ BRAS MED VET ZOO, V61, P844, DOI 10.1590/S0102-09352009000400011
   Fabbri P, 2010, J MATER SCI-MATER M, V21, P343, DOI 10.1007/s10856-009-3839-5
   FERNANDES R.G., 2004, REV ODONTOL UNESP, V33, P123
   Jakobsen T, 2007, J ORTHOP RES, V25, P432, DOI 10.1002/jor.20276
   Lam CXF, 2009, J BIOMED MATER RES A, V90A, P906, DOI 10.1002/jbm.a.32052
   MacNeill SR, 1999, J CLIN PERIODONTOL, V26, P239, DOI 10.1034/j.1600-051X.1999.260407.x
   Mitsak AG, 2011, TISSUE ENG PT A, V17, P1831, DOI [10.1089/ten.TEA.2010.0560, 10.1089/ten.tea.2010.0560]
   Perez-Lopez FR, 2004, MATURITAS, V48, P179, DOI 10.1016/j.maturitas.2003.12.006
   Somford MP, 2009, INT J RHEUMATOL, DOI 10.1155/2009/253432
   Vital CC, 2006, ARQ BRAS MED VET ZOO, V58, P175, DOI 10.1590/S0102-09352006000200005
   Woolf AD, 2012, BEST PRACT RES CL RH, V26, P183, DOI 10.1016/j.berh.2012.03.005
NR 12
TC 2
Z9 2
U1 3
U2 13
PU ARQUIVO BRASILEIRO MEDICINA VETERINARIA ZOOTECNIA
PI MINAS GERAIS
PA FEDERAL MINAS GERAIS CAIXA POSTAL 567-BELO HORIZ, MINAS GERAIS, BRAZIL
SN 0102-0935
EI 1678-4162
J9 ARQ BRAS MED VET ZOO
JI Arq. Bras. Med. Vet. Zootec.
PD MAR-APR
PY 2016
VL 68
IS 2
BP 543
EP 547
DI 10.1590/1678-4162-8343
PG 5
WC Veterinary Sciences
SC Veterinary Sciences
GA DK3PZ
UT WOS:000374830900036
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Wang, P
   Deng, C
   Yuan, JG
   Yu, YY
   Cui, L
   Su, MT
   Wang, Q
   Fan, XR
AF Wang, Ping
   Deng, Chao
   Yuan, Jiugang
   Yu, Yuanyuan
   Cui, Li
   Su, Mengting
   Wang, Qiang
   Fan, Xuerong
TI Preparation of antibacterial silk fibroin membranes via
   tyrosinase-catalyzed coupling of epsilon-polylysine
SO BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
LA English
DT Article
DE epsilon-polylysine; enzymatic functionalization; silk fibroin membrane;
   TNBS; tyrosinase
ID CROSS-LINKING; PEPTIDES; PROTEINS; CHITOSAN; OXIDATION; TEXTILES
AB Silk fibroins have good biocompatibility and could be used to form a variety of regenerated functional biomaterials. In this study, enzymatic oxidization of silk fibroins with tyrosinase (TYR) was carried out, followed by coupling of epsilon-polylysine (epsilon-PLL) for improving antibacterial ability of the fibroin-based biomaterial. Trinitrobenzene sulfonic acid (TNBS) was selectively used to incubate with silk fibroins prior to TYR treatment, aiming at preventing the self-crosslinking of silk fibroins during enzymatic oxidation. The results indicated that tyrosine residues in silk fibroins could be converted to reactive dioxyphenylalanine and o-quinone residues TYR successively. TNBS pretreatment inhibited the self-crosslinks of silk fibroins and promoted the successive coupling of epsilon-PLL to fibroin proteins with high graft yield. The combined use of TNBS, TYR, and epsilon-PLL treatments endowed fibroin membrane with satisfactory antibacterial ability against Staphylococcus aureus, and the obtained durability was also acceptable. The changes in surface potential and amine acid composition for the fibroin membranes verified the favorable actions of the combined treatment. The present method could be potentially utilized for enzymatic functionalization of various fibroin-based biomaterials. (C) 2015 International Union of Biochemistry and Molecular Biology, Inc.
C1 [Wang, Ping; Yuan, Jiugang; Yu, Yuanyuan; Cui, Li; Su, Mengting; Wang, Qiang; Fan, Xuerong] Jiangnan Univ, Minist Educ, Key Lab Sci & Technol Ecotext, 1800 Lihu Ave, Wuxi 214122, Peoples R China.
   [Deng, Chao] Jiangnan Univ, Wuxi Med Sch, Wuxi 214122, Peoples R China.
RP Fan, XR (reprint author), Jiangnan Univ, Minist Educ, Key Lab Sci & Technol Ecotext, 1800 Lihu Ave, Wuxi 214122, Peoples R China.
EM wxfxr@163.com
FU National Natural Science Funds [51373071]; Program for New Century
   Excellent Talents in University [NCET-12-0883]; Fundamental Research
   Funds for the Central Universities [JUSRP51312B]
FX This work was financially supported by the National Natural Science
   Funds (51373071), the Program for New Century Excellent Talents in
   University (NCET-12-0883), and the Fundamental Research Funds for the
   Central Universities (JUSRP51312B). The authors have declared no
   conflict of interest.
CR Anghileri A, 2007, J BIOTECHNOL, V127, P508, DOI 10.1016/j.jbiotec.2006.07.021
   Bai LQ, 2008, APPL SURF SCI, V254, P2988, DOI 10.1016/j.apsusc.2007.10.049
   Chadeau E, 2010, FOOD CONTROL, V21, P505, DOI 10.1016/j.foodcont.2009.07.013
   Dehshahri A, 2009, BIOMATERIALS, V30, P4187, DOI 10.1016/j.biomaterials.2009.04.036
   Freddi G, 2006, J BIOTECHNOL, V125, P281, DOI 10.1016/j.jbiotec.2006.03.003
   Friedman M, 2004, J AGR FOOD CHEM, V52, P385, DOI 10.1021/jf030490p
   Gao Y, 2008, TEXT RES J, V78, P60, DOI 10.1177/0040517507082332
   Haemers S, 2003, BIOMACROMOLECULES, V4, P632, DOI 10.1021/bm025707n
   Hu X, 2007, THERMOCHIM ACTA, V461, P137, DOI 10.1016/j.tca.2006.12.011
   Jia SR, 2010, FOOD SCI BIOTECHNOL, V19, P361, DOI 10.1007/s10068-010-0051-9
   Jus S, 2008, ENZYME MICROB TECH, V42, P535, DOI 10.1016/j.enzmictec.2008.02.012
   Kang GD, 2004, FIBER POLYM, V5, P234, DOI 10.1007/BF02903006
   Kuboe Y, 2004, BIOMACROMOLECULES, V5, P348, DOI 10.1021/bm034363d
   Li GH, 2012, MAT SCI ENG C-MATER, V32, P627, DOI 10.1016/j.msec.2011.12.013
   Liu TL, 2010, J ZHEJIANG UNIV-SC B, V11, P10, DOI 10.1631/jzus.B0900163
   Mattinen ML, 2008, J BIOTECHNOL, V133, P395, DOI 10.1016/j.biotec.2007.10.009
   Rodriguez C, 2014, CATAL TODAY, V230, P41, DOI 10.1016/j.cattod.2013.12.023
   Sampaio S, 2005, J BIOTECHNOL, V116, P21, DOI 10.1016/j.jbiotec.2004.10.003
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Sionkowska A., 2011, POLYM DEGRAD STABIL, V96, P23
   Son K., CHEM ENG J, V239, P284
   Vasconcelos A, 2012, ACTA BIOMATER, V8, P3049, DOI 10.1016/j.actbio.2012.04.035
   Wang P, 2013, ENG LIFE SCI, V13, P102, DOI 10.1002/elsc.201200015
   Yoshida T, 2003, APPL MICROBIOL BIOT, V62, P21, DOI 10.1007/s00253-003-1312-9
NR 24
TC 4
Z9 4
U1 8
U2 31
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-4513
EI 1470-8744
J9 BIOTECHNOL APPL BIOC
JI Biotechnol. Appl. Biochem.
PD MAR-APR
PY 2016
VL 63
IS 2
BP 163
EP 169
DI 10.1002/bab.1365
PG 7
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA DK3VA
UT WOS:000374844300002
PM 25757371
DA 2018-10-19
ER

PT J
AU Aljawish, A
   Muniglia, L
   Chevalot, I
AF Aljawish, Abdulhadi
   Muniglia, Lionel
   Chevalot, Isabelle
TI Growth of human mesenchymal stem cells (MSCs) on films of enzymatically
   modified chitosan
SO BIOTECHNOLOGY PROGRESS
LA English
DT Article
DE enzymatic modification; chitosan films; ABTS; cell adhesion; mesenchymal
   stem cells
ID SELF-ASSEMBLED MONOLAYERS; IN-VITRO; FERULIC ACID; DYNAMIC COMPRESSION;
   PROTEIN ADSORPTION; CULTIVATION SYSTEM; EXPANSION; SCAFFOLDS;
   BIOCOMPATIBILITY; DIFFERENTIATION
AB Mesenchymal stem cells (MSCs) are known to be an attractive cell source for tissue engineering and regenerative medicine. One of the main limiting steps for clinical use or biotechnological purposes is the expansion step. The research of compatible biomaterials for MSCs expansion is recently regarded as an attractive topic. The aim of this study was to create new functional biomaterial for MSCs expansion by evaluating the impact of chitosan derivative films modified by enzymatic approach. First, chitosan particles were enzymatically modified with ferulic acid (FA) or ethyl ferulate (EF) under an eco-friendly procedure. Then, films of chitosan and its modified derivatives were prepared and evaluated by physicochemical and biological properties. Results showed that the enzymatic grafting of FA or EF onto chitosan significantly increased hydrophobic and antioxidant properties of chitosan films. The MSCs cell viability on chitosan derivative films also increased depending on the film thickness and the quantity of grafted phenols. Furthermore, the cytotoxicity test showed the absence of toxic effect of chitosan derivative films towards MSCs cells. Cell morphology showed a well attached and spread phenotype of MSCs cells on chitosan derivative films. On the other hand, due to the higher phenol content of FA-chitosan films, their hydrophobic, antioxidant properties and cell adhesion were improved in comparison with those of EF-chitosan films. Finally, this enzymatic process can be considered as a promising process to favor MSCs cell growth as well as to create useful biomaterials for biomedical applications especially for tissue engineering. (c) 2016 American Institute of Chemical Engineers Biotechnol. Prog., 32:491-500, 2016
C1 [Aljawish, Abdulhadi; Muniglia, Lionel] Univ Lorraine, Lab Ingn Biomol LIBio, TSA40602, F-54518 Vandoeuvre Les Nancy, France.
   [Chevalot, Isabelle] Univ Lorraine, Lab React & Genie Proc, TSA40602, LRGP,CNRS,UMR 7274, F-54518 Vandoeuvre Les Nancy, France.
RP Chevalot, I (reprint author), Univ Lorraine, Lab React & Genie Proc, TSA40602, LRGP,CNRS,UMR 7274, F-54518 Vandoeuvre Les Nancy, France.
EM isabelle.chevalot@univ-lorraine.fr
FU Forest Ecosystems, Agricultural Resources, Food and Bioprocess (EFABA)
   program, Lorraine University, France
FX The authors gratefully acknowledge financial support from Forest
   Ecosystems, Agricultural Resources, Food and Bioprocess (EFABA) program,
   Lorraine University, France.
CR Aljawish A, 2015, J MOL CATAL B-ENZYM, V112, P25, DOI 10.1016/j.molcatb.2014.10.014
   Aljawish A, 2014, PROCESS BIOCHEM, V49, P863, DOI 10.1016/j.procbio.2014.02.001
   Aljawish A, 2014, FOOD CHEM, V161, P279, DOI 10.1016/j.foodchem.2014.03.076
   Aljawish A, 2012, CARBOHYD POLYM, V87, P537, DOI 10.1016/j.carbpol.2011.08.016
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Berry CC, 2004, BIOMATERIALS, V25, P5781, DOI 10.1016/j.biomaterials.2004.01.029
   Bettini R, 2008, EUR J PHARM BIOPHARM, V68, P74, DOI 10.1016/j.ejpb.2007.03.026
   Bhardwaj N, 2011, CARBOHYD POLYM, V85, P325, DOI 10.1016/j.carbpol.2011.02.027
   Boo L, 2011, J MATER SCI-MATER M, V22, P1343, DOI 10.1007/s10856-011-4294-7
   Bozic M, 2012, CARBOHYD POLYM, V87, P2388, DOI 10.1016/j.carbpol.2011.11.006
   Breyner NM, 2010, CELLS TISSUES ORGANS, V191, P119, DOI 10.1159/000231472
   Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469
   Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197
   Chang J, 2012, CELL PROLIFERAT, V45, P430, DOI 10.1111/j.1365-2184.2012.00836.x
   Chen CH, 2007, J APPL POLYM SCI, V105, P1086, DOI 10.1002/app.26257
   Chen XG, 2006, BIOCHEM ENG J, V27, P269, DOI 10.1016/j.bej.2005.08.021
   Choi KM, 2008, J BIOSCI BIOENG, V105, P586, DOI 10.1263/jbb.105.586
   Custodio C, 2014, J TISSUE ENG REGEN M, V8, P160
   Ebert R, 2006, STEM CELLS, V24, P1226, DOI 10.1634/stemcells.2005-0117
   Ferrari C, 2014, APPL BIOCHEM BIOTECH, V172, P1004, DOI 10.1007/s12010-013-0586-3
   Ferrari C, 2012, BIOTECHNOL PROGR, V28, P780, DOI 10.1002/btpr.1527
   Ferruti P, 1998, MACROMOL CHEM PHYSIC, V199, P2565, DOI 10.1002/(SICI)1521-3935(19981101)199:11<2565::AID-MACP2565>3.0.CO;2-G
   Fluri DA, 2012, NAT METHODS, V9, P509, DOI [10.1038/NMETH.1939, 10.1038/nmeth.1939]
   Fortier LA, 2005, VET SURG, V34, P415, DOI 10.1111/j.1532-950X.2005.00063.x
   Frauenschuh S, 2007, BIOTECHNOL PROGR, V23, P187, DOI 10.1021/bp060155w
   Gao J, 2007, P I MECH ENG H, V221, P441, DOI 10.1243/09544119JEIM257
   Godara P, 2008, J CHEM TECHNOL BIOT, V83, P408, DOI 10.1002/jctb.1918
   Helder MN, 2007, TISSUE ENG, V13, P1799, DOI 10.1089/ten.2006.0165
   Holmes C. A., 2011, J BIOMED MATER RES A, V100A, P518
   Hozumi K, 2010, BIOMATERIALS, V31, P3237, DOI 10.1016/j.biomaterials.2010.01.043
   Hsieh CY, 2007, CARBOHYD POLYM, V67, P124, DOI 10.1016/j.carbpol.2006.05.002
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Kanatt SR, 2008, FOOD CHEM, V107, P845, DOI 10.1016/j.foodchem.2007.08.088
   Kanski J, 2002, J NUTR BIOCHEM, V13, P273, DOI 10.1016/S0955-2863(01)00215-7
   Lai GJ, 2014, CARBOHYD POLYM, V111, P288, DOI 10.1016/j.carbpol.2014.04.094
   Li JJ, 2010, J BIOMED MATER RES B, V95B, P308, DOI 10.1002/jbm.b.31715
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Liu HN, 2008, ACTA BIOMATER, V4, P1472, DOI 10.1016/j.actbio.2008.02.025
   Liu JY, 2004, WOUND REPAIR REGEN, V12, P148, DOI 10.1111/j.1067-1927.2004.012205.x
   Maher S, 2006, BIOCHEM PHARMACOL, V71, P1289, DOI 10.1016/j.bcp.2006.01.012
   Malda J, 2003, BIOMATERIALS, V24, P5153, DOI 10.1016/S0142-9612(03)00428-9
   Maurstad G, 2007, BIOMACROMOLECULES, V8, P1124, DOI 10.1021/bm0610119
   Medrado GCB, 2006, BIOMED MATER, V1, P155, DOI 10.1088/1748-6041/1/3/010
   Mochizuki M, 2003, FASEB J, V17, P875, DOI 10.1096/fj.02-0564fje
   Mustafa R, 2005, FOOD RES INT, V38, P995, DOI 10.1016/j.foodres.2005.02.019
   Muzzarelli RAA, 2011, CARBOHYD POLYM, V83, P1433, DOI 10.1016/j.carbpol.2010.10.044
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V77, P1, DOI 10.1016/j.carbpol.2009.01.016
   Neamnark A, 2007, CARBOHYD POLYM, V68, P166, DOI 10.1016/j.carbpol.2006.07.024
   Nenadis N, 2003, J AGR FOOD CHEM, V51, P1874, DOI 10.1021/jf0261452
   Phuc PV, 2012, CELL TISSUE BANK, V13, P341, DOI 10.1007/s10561-011-9262-4
   Ragetly GR, 2010, ACTA BIOMATER, V6, P1430, DOI 10.1016/j.actbio.2009.10.040
   Ralph J, 1998, J AGR FOOD CHEM, V46, P2531, DOI 10.1021/jf980123r
   Ratner BD, 1979, J POLYM SCI POLYM S, V66, P363
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Sart S, 2009, J BIOTECHNOL, V139, P291, DOI 10.1016/j.jbiotec.2008.12.011
   Schop D, 2008, J TISSUE ENG REGEN M, V2, P126, DOI 10.1002/term.73
   Singleton VL, 1999, METHOD ENZYMOL, V299, P152
   Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341
   Toworfe GK, 2009, J TISSUE ENG REGEN M, V3, P26, DOI 10.1002/term.131
   Tsai WB, 2013, J TAIWAN INST CHEM E, V44, P1, DOI 10.1016/j.jtice.2012.09.003
   Tsai WB, 2012, CARBOHYD POLYM, V89, P379, DOI 10.1016/j.carbpol.2012.03.017
   Uygun BE, 2010, ACTA BIOMATER, V6, P2126, DOI 10.1016/j.actbio.2009.11.018
   VIENKEN J, 1995, ARTIF ORGANS, V19, P398, DOI 10.1111/j.1525-1594.1995.tb02349.x
   Wang PY, 2009, J BIOMED MATER RES B, V91B, P143, DOI 10.1002/jbm.b.31384
   Wang PY, 2009, J BIOMATER APPL, V23, P347, DOI 10.1177/0885328208093684
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   WESTERGREN I, 1993, ACTA PHYSIOL SCAND, V149, P99, DOI 10.1111/j.1748-1716.1993.tb09597.x
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
   Yang JL, 2011, J BIOMAT SCI-POLYM E, V22, P919, DOI 10.1163/092050610X496396
   Yue JH, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-0906-3
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
   Zhao GF, 2015, STEM CELL RES THER, V6, P31
   Zhuang PY, 2012, INT J BIOL MACROMOL, V50, P658, DOI 10.1016/j.ijbiomac.2012.01.026
NR 73
TC 5
Z9 5
U1 2
U2 21
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 8756-7938
EI 1520-6033
J9 BIOTECHNOL PROGR
JI Biotechnol. Prog.
PD MAR-APR
PY 2016
VL 32
IS 2
BP 491
EP 500
DI 10.1002/btpr.2216
PG 10
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA DK2VG
UT WOS:000374771900027
PM 26701830
DA 2018-10-19
ER

PT J
AU Naikoo, GA
   Thomas, M
   Ganaie, MA
   Sheikh, MUD
   Bano, M
   Hassan, IU
   Khan, F
AF Naikoo, Gowhar Ahmad
   Thomas, Molly
   Ganaie, Mohd. Anis
   Sheikh, Mehraj Ud Din
   Bano, Mustri
   Hassan, Israr Ul
   Khan, Farid
TI Hierarchically macroporous silver monoliths using Pluronic F127: Facile
   synthesis, characterization and its application as an efficient
   biomaterial for pathogens
SO JOURNAL OF SAUDI CHEMICAL SOCIETY
LA English
DT Article
DE Macroporous; Biomaterials; Pathogens; Pluronic F127
ID ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ESCHERICHIA-COLI;
   CATALYTIC PERFORMANCE; GOLD NANOPARTICLES; GREEN SYNTHESIS;
   NANOCOMPOSITES; IRRADIATION; PARTICLES; OXIDE
AB Herein we report the facile synthesis of three dimensional macroporous (MP) silver monoliths serving as intelligent biomaterials against Gram negative (Escherichia coli, Salmonella typhimurium) and Gram positive (Bacillus subtilis) bacteria with more efficacy against Gram negative bacteria. The macroporous silver monoliths were examined by Fourier transform infra red (FTIR) spectroscopy, thermogravimetric analysis (TGA), X-ray diffraction (XRD) study, field emission scanning electron microscopy (FESEM), energy dispersion X-ray spectroscopy analysis (EDX) and Brunauer-Emmet-Teller (BET) adsorption technique. From the antibacterial activity results, it was concluded that macroporous silver monoliths can serve as efficient disinfection agents. The enhanced antibacterial properties of macroporous silver monoliths was possibly due to high surface free energy of the surface Ag+ atoms leading to cell membrane damage followed by cell death. (C) 2015 King Saud University. Production and hosting by Elsevier B.V.
C1 [Naikoo, Gowhar Ahmad; Thomas, Molly; Sheikh, Mehraj Ud Din; Bano, Mustri; Khan, Farid] Dr Hari Singh Gour Vishwavidyalaya, Dept Chem, Nanomat Discovery Lab, Sagar 470003, MP, India.
   [Ganaie, Mohd. Anis] Univ Fed Sergipe, Lab Flavor & Chromatog Anal, BR-49000000 Sao Cristovao, Brazil.
   [Naikoo, Gowhar Ahmad; Hassan, Israr Ul] Dhofar Univ, Dept Math & Sci, Coll Arts & Appl Sci, Salalah, Oman.
RP Naikoo, GA (reprint author), Dr Hari Singh Gour Vishwavidyalaya, Dept Chem, Nanomat Discovery Lab, Sagar 470003, MP, India.
EM gowhar@du.edu.om; faridkhan58@yahoo.com
RI THOMAS, MOLLY/C-9457-2017; BANO, MUSTRI/R-1739-2017
OI THOMAS, MOLLY/0000-0002-4723-5427; BANO, MUSTRI/0000-0003-3993-9763;
   Naikoo, Gowhar/0000-0003-2276-6878; KHAN, FARID/0000-0002-6511-6050
FU UGC New Delhi through Central University Fellowship (CUF); UGC; National
   Council for Scientific and Technological Development, Brazil
FX GAN and MUDS acknowledge UGC New Delhi for financial assistance through
   Central University Fellowship (CUF) and MT acknowledges UGC for Rajiv
   Gandhi National Fellowship (RGNF). MAG is thankful to National Council
   for Scientific and Technological Development, Brazil for providing Post
   doctorate fellowship (Science without Border) and Department of Zoology,
   Dr. Hari Singh Gour University, Sagar, for antibacterial activities.
   Authors also acknowledge Head, Department of Chemistry, and
   Sophisticated Instrument Centre (SIC) Dr. Hari Singh Gour Central
   University, Sagar, for providing the necessary facilities to carry out
   this research work.
CR Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078
   Aymonier C, 2002, CHEM COMMUN, P3018, DOI 10.1039/b208575e
   Banerjee M, 2011, NANOSCALE, V3, P5120, DOI 10.1039/c1nr10703h
   Cho KH, 2005, ELECTROCHIM ACTA, V51, P956, DOI 10.1016/j.electacta.2005.04.071
   Cullity B. D., 1956, ELEMENTS XRAY DIFFRA
   Danilczuk M, 2006, SPECTROCHIM ACTA A, V63, P189, DOI 10.1016/j.saa.2005.05.002
   Dar RA, 2015, ELECTROCHIM ACTA, V163, P196, DOI 10.1016/j.electacta.2015.02.123
   Holt KB, 2005, BIOCHEMISTRY-US, V44, P13214, DOI 10.1021/bi0508542
   John R, 2009, CHALCOGENIDE LETT, V6, P535
   Khan F, 2007, SOLID STATE SCI, V9, P27, DOI 10.1016/j.solidstatesciences.2006.11.002
   Khan F, 2009, J PHYS CHEM C, V113, P19871, DOI 10.1021/jp9076068
   Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001
   Kim KJ, 2009, BIOMETALS, V22, P235, DOI 10.1007/s10534-008-9159-2
   Kumar VS, 2004, J MOL CATAL A-CHEM, V223, P313, DOI 10.1016/j.molcata.2003.09.047
   Liu YX, 2012, NANOSCALE, V4, P2317, DOI 10.1039/c2nr12046a
   Mallick K, 2004, J MATER SCI, V39, P4459, DOI 10.1023/B:JMSC.0000034138.80116.50
   Martinez-Castanon GA, 2008, J NANOPART RES, V10, P1343, DOI 10.1007/s11051-008-9428-6
   Melaiye A, 2005, J AM CHEM SOC, V127, P2285, DOI 10.1021/ja040226s
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Naiko GA, 2014, J MATER CHEM A, V2, P11792, DOI 10.1039/c3ta14977c
   Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06
   Perelshtein I, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/24/245705
   Petrochenko P.E., 2013, BIOMATTER, DOI e25528-1-e25528-7
   Raveendran P, 2003, J AM CHEM SOC, V125, P13940, DOI 10.1021/ja029267j
   Rodriguez-Sanchez L, 2000, J PHYS CHEM B, V104, P9683, DOI 10.1021/jp001761r
   Shameli K, 2010, INT J NANOMED, V5, P1067, DOI 10.2147/IJN.S15033
   Shameli K, 2010, INT J NANOMED, V5, P875, DOI 10.2147/IJN.S13632
   Shrivastava S, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/22/225103
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Subhankari I., 2013, WORLD J NANOSCI TECH, V2, P10, DOI DOI 10.5829/ID0SI.WJNST.2013.2.1.21133
   Sun FQ, 2005, ADV MATER, V17, P2872, DOI 10.1002/adma.200500936
   Theivasanthi A. M., 2010, ARCH PHYS RES, V1, P112
   Thomas V, 2007, J COLLOID INTERF SCI, V315, P389, DOI 10.1016/j.jcis.2007.06.068
   Walsh D, 2003, NAT MATER, V2, P386, DOI 10.1038/nmat903
   Wei YC, 2012, J CATAL, V287, P13, DOI 10.1016/j.jcat.2011.11.006
   Wei YC, 2011, ENERG ENVIRON SCI, V4, P2959, DOI 10.1039/c0ee00813c
   Xia BY, 2012, ANGEW CHEM INT EDIT, V51, P7213, DOI 10.1002/anie.201201553
   Yan J, 2010, J POWER SOURCES, V195, P3041, DOI 10.1016/j.jpowsour.2009.11.028
   Yin HB, 2004, MATER CHEM PHYS, V83, P66, DOI 10.1016/j.matchemphys.2003.09.006
   Zhang C, 2013, CRYSTENGCOMM, V15, P3965, DOI 10.1039/c3ce00053b
   Zhang HL, 2012, J COLLOID INTERF SCI, V380, P16, DOI 10.1016/j.jcis.2012.04.059
   Zhou L, 2012, ANGEW CHEM INT EDIT, V51, P239, DOI 10.1002/anie.201106998
NR 42
TC 2
Z9 2
U1 2
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1319-6103
EI 2212-4640
J9 J SAUDI CHEM SOC
JI J. Saudi Chem. Soc.
PD MAR
PY 2016
VL 20
IS 2
BP 237
EP 244
DI 10.1016/j.jscs.2015.12.002
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA DK4OT
UT WOS:000374898700015
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Ho, KN
   Salamanca, E
   Chang, KC
   Shih, TC
   Chang, YC
   Huang, HM
   Teng, NC
   Lin, CT
   Feng, SW
   Chang, WJ
AF Ho, Ko-Ning
   Salamanca, Eisner
   Chang, Kuo-Chi
   Shih, Tsai-Chin
   Chang, Yu-Chi
   Huang, Haw-Ming
   Teng, Nai-Chia
   Lin, Che-Tong
   Feng, Sheng-Wei
   Chang, Wei-Jen
TI A Novel HA/beta-TCP-Collagen Composite Enhanced New Bone Formation for
   Dental Extraction Socket Preservation in Beagle Dogs
SO MATERIALS
LA English
DT Article
DE hydroxyapatite; beta-tricalcium phosphate; composite; collagen;
   allograft; socket preservation; animal study
ID ALVEOLAR RIDGE PRESERVATION; TOOTH EXTRACTION; TRICALCIUM PHOSPHATE;
   CALCIUM-PHOSPHATE; BIOCERAMIC IMPLANTS; SCAFFOLDS; GROWTH; BIOMATERIALS;
   REGENERATION; METAANALYSIS
AB Past studies in humans have demonstrated horizontal and vertical bone loss after six months following tooth extraction. Many biomaterials have been developed to preserve bone volume after tooth extraction. Type I collagen serves as an excellent delivery system for growth factors and promotes angiogenesis. Calcium phosphate ceramics have also been investigated because their mineral chemistry resembles human bone. The aim of this study was to compare the performance of a novel bioresorbable purified fibrillar collagen and hydroxyapatite/-tricalcium phosphate (HA/-TCP) ceramic composite versus collagen alone and a bovine xenograft-collagen composite in beagles. Collagen plugs, bovine graft-collagen composite and HA/-TCP-collagen composite were implanted into the left and right first, second and third mandibular premolars, and the fourth molar was left empty for natural healing. In total, 20 male beagle dogs were used, and quantitative and histological analyses of the extraction ridge was done. The smallest width reduction was 19.09% +/- 8.81% with the HA/-TCP-collagen composite at Week 8, accompanied by new bone formation at Weeks 4 and 8. The HA/-TCP-collagen composite performed well, as a new osteoconductive and biomimetic composite biomaterial, for socket bone preservation after tooth extraction.
C1 [Ho, Ko-Ning; Salamanca, Eisner; Shih, Tsai-Chin; Chang, Yu-Chi; Teng, Nai-Chia; Lin, Che-Tong; Feng, Sheng-Wei; Chang, Wei-Jen] Taipei Med Univ, Coll Oral Med, Sch Dent, Taipei 110, Taiwan.
   [Chang, Kuo-Chi] Natl Taipei Univ Technol, Dept Chem Engn & Biotechnol, Taipei 106, Taiwan.
   [Huang, Haw-Ming] Taipei Med Univ, Coll Oral Med, Grad Inst Biomed Mat & Tissue Engn, Taipei 110, Taiwan.
   [Teng, Nai-Chia; Lin, Che-Tong] Taipei Med Univ Hosp, Dept Dent, Taipei 110, Taiwan.
   [Chang, Wei-Jen] Taipei Med Univ, Shuang Ho Hosp, Dept Dent, New Taipei 235, Taiwan.
RP Chang, WJ (reprint author), Taipei Med Univ, Coll Oral Med, Sch Dent, Taipei 110, Taiwan.; Chang, WJ (reprint author), Taipei Med Univ, Shuang Ho Hosp, Dept Dent, New Taipei 235, Taiwan.
EM d204097003@tmu.edu.tw; eisnergab@hotmail.com; hu2637@yahoo.com.tw;
   newdent.clinic@msa.hinet.net; ivytainan@hotmail.com; hhm@tmu.edu.tw;
   dianaten@tmu.edu.tw; chetong@tmu.edu.tw; b8702070@tmu.edu.tw;
   cweijen1@tmu.edu.tw
FU Taipei Medical University [99-TMU-IAC-021]
FX This study has been founded by the grant from Taipei Medical University
   99-TMU-IAC-021. Authors would like to thank Enago (www.enago.tw) for the
   English language review.
CR Albee FH, 1920, ANN SURG, V71, P32
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Avila-Ortiz G, 2014, J DENT RES, V93, P950, DOI 10.1177/0022034514541127
   BAUER TW, 2000, CLIN ORTHOP RELAT R, V371, P10, DOI DOI 10.1097/00003086-200002000-00003
   Behnia H, 2013, OR SURG OR MED OR PA, V115, pE7, DOI 10.1016/j.oooo.2011.09.034
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Cardaropoli G, 2003, J CLIN PERIODONTOL, V30, P809, DOI 10.1034/j.1600-051X.2003.00366.x
   De Risi V, 2015, CLIN ORAL IMPLAN RES, V26, P50, DOI 10.1111/clr.12288
   Santis R, 2013, POLYM COMPOSITE, V34, P1413, DOI 10.1002/pc.22446
   De Santis R, 2015, J BIOMED NANOTECHNOL, V11, P1236, DOI 10.1166/jbn.2015.2065
   DENISSEN HW, 1979, J PROSTHET DENT, V42, P551, DOI 10.1016/0022-3913(79)90253-1
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Dorozhkin SV, 2009, MATERIALS, V2, P399, DOI 10.3390/ma2020399
   Ebrahimi M, 2012, J BIOMED MATER RES A, V100A, P2260, DOI 10.1002/jbm.a.34160
   Fickl S, 2008, J CLIN PERIODONTOL, V35, P356, DOI 10.1111/j.1600-051X.2008.01209.x
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Habibovic P, 2008, BIOMATERIALS, V29, P944, DOI 10.1016/j.biomaterials.2007.10.023
   Habibovic P, 2007, J TISSUE ENG REGEN M, V1, P25, DOI 10.1002/term.5
   Han T, 1984, J West Soc Periodontol Periodontal Abstr, V32, P88
   Hoffmann O, 2008, J PERIODONTOL, V79, P1355, DOI 10.1902/jop.2008.070502 
   John A, 2003, J BIOMATER APPL, V18, P63, DOI 10.1177/088532803032826
   Khan SN, 2000, ORTHOP CLIN N AM, V31, P389, DOI 10.1016/S0030-5898(05)70158-9
   Kondo N, 2005, BIOMATERIALS, V26, P5600, DOI 10.1016/j.biomaterials.2005.02.026
   Lassus J, 1998, CLIN ORTHOP RELAT R, P7
   LeGeros R Z, 1988, Adv Dent Res, V2, P164
   LEGEROS RZ, 2002, CLIN ORTHOP RELAT R, V395, P81, DOI DOI 10.1097/00003086-200202000-00009
   Li JF, 2010, MAT SCI ENG C-MATER, V30, P1272, DOI 10.1016/j.msec.2010.07.011
   Mahesh L, 2015, J ORAL IMPLANTOL, V41, P178, DOI 10.1563/AAID-JOI-D-13-00025
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   Molly L, 2008, J PERIODONTOL, V79, P1108, DOI [10.1902/jop.2008.070476, 10.1902/jop.2008.070476 ]
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1
   NERY EB, 1975, J PERIODONTOL, V46, P328, DOI 10.1902/jop.1975.46.6.328
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   Patricio T, 2014, RAPID PROTOTYPING J, V20, P145, DOI 10.1108/RPJ-04-2012-0037
   Pietrokovski J, 2007, INT J ORAL MAXILLOF, V16, P141, DOI DOI 10.1111/J.1532-849X.2007.00165.X
   Pinho Marcia N, 2006, Implant Dent, V15, P53, DOI 10.1097/01.id.0000202596.18254.e1
   Rodriguez A, 2003, J ORAL MAXIL SURG, V61, P157, DOI 10.1053/joms.2003.50041
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   Schropp L, 2003, INT J ORAL MAX IMPL, V18, P189
   Susin C, 2013, PERIODONTOL 2000, V62, P232, DOI 10.1111/prd.12003
   Trombelli L, 2008, J CLIN PERIODONTOL, V35, P630, DOI 10.1111/j.1600-051X.2008.01246.x
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
   Weiner S, 1999, J STRUCT BIOL, V126, P241, DOI 10.1006/jsbi.1999.4107
NR 44
TC 1
Z9 1
U1 1
U2 15
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAR
PY 2016
VL 9
IS 3
AR 191
DI 10.3390/ma9030191
PG 15
WC Materials Science, Multidisciplinary
SC Materials Science
GA DI9ER
UT WOS:000373805400038
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Cioata, R
   Balan, A
   Antohe, ME
   Savin, C
   Ignat, G
   Basno, A
AF Cioata, Radu
   Balan, Adriana
   Antohe, Magda Ecaterina
   Savin, Carmen
   Ignat, Gabriela
   Basno, Alexandru
TI Researches Regarding New Biomaterials Involved in Sports Mouthguard
SO MATERIALE PLASTICE
LA English
DT Article
DE sports mouthguard; siliconic biomaterials; mathematical analysis;
   antimicrobian effect
ID MECHANICAL-PROPERTIES; SILICA; ABSORPTION; COMPOSITE; BEHAVIOR
AB The aim of this study is to individualize from the structural point of view the silicon materials which lay at the basis of the manufacturing the oral mouth guards in full accordance to the features of the subject who is going to benefit from these devices, a highly important role belonging to the maxillary architecture and the occlusion type. Choosing the election biomaterial for the oral protection gear was done based on mathematical modelling using the Abaqus Standard system, with the aim of evaluating the tensions transmitted at the jaw level by different types of biomaterials which are embedded in the structure of these devices. The biomaterial represents an alternative favorable for the oral protection gear given the degree of elasticity and the possibility of including an antiseptic material, such as Eugenol, important features which individualize it.
C1 [Cioata, Radu; Balan, Adriana; Antohe, Magda Ecaterina; Savin, Carmen; Basno, Alexandru] Grigore T Popa Univ Med & Pharm, Fac Dent Med, 16 Piata Natiunii Str, Iasi 70015, Romania.
   [Ignat, Gabriela] Ion Ionescu de la Brad Univ Agr Sci & Vet Med Ias, 3 M Sadoveanu Alley, Iasi 700490, Romania.
RP Antohe, ME (reprint author), Grigore T Popa Univ Med & Pharm, Fac Dent Med, 16 Piata Natiunii Str, Iasi 70015, Romania.
EM magda.antohe@yahoo.com
CR Alexandru M, 2011, POLYM ENG SCI, V51, P78, DOI 10.1002/pen.21781
   Alexandru M, 2009, HIGH PERFORM POLYM, V21, P379, DOI 10.1177/0954008308094327
   ARANGUREN MI, 1994, RUBBER CHEM TECHNOL, V67, P820, DOI 10.5254/1.3538713
   Brunauer S, 1940, J AM CHEM SOC, V62, P1723, DOI 10.1021/ja01864a025
   Cazacu M, 2008, POLYM INT, V57, P1067, DOI 10.1002/pi.2451
   Cazacu M, 2011, DYES PIGMENTS, V90, P106, DOI 10.1016/j.dyepig.2010.12.012
   Cazacu M, 2009, J COMPOS MATER, V43, P2045, DOI 10.1177/0021998309340447
   Chowdhury RU, 2014, DENT MATER J, V33, P551, DOI 10.4012/dmj.2014-061
   COOPER S.L., 2004, BIOMATERIALS SCIENCE
   FAZAL R., 2014, DENT TRAUMATOL, V30, P193
   GUIU A., 2001, POLYM SCI SER B, V39, P3843
   Hurduc N, 2008, SILICON BASED POLYMERS: ADVANCES IN SYNTHESIS AND SUPRAMOLECULAR ORGANIZATION, P65, DOI 10.1007/978-1-4020-8528-4_6
   Jandt KD, 2009, DENT MATER, V25, P1001, DOI 10.1016/j.dental.2009.02.009
   Moleavin I, 2011, CENT EUR J CHEM, V9, P1117, DOI 10.2478/s11532-011-0102-y
   Ona M, 2010, DENT MATER J, V29, P336, DOI 10.4012/dmj.2009-096
   Picu CR, 2012, MATER PLAST, V49, P133
   PLAZEK DJ, 1971, J POLYM SCI A2, V9, P209, DOI 10.1002/pol.1971.160090202
   Reza F, 2014, DENT TRAUMATOL, V30, P193, DOI 10.1111/edt.12068
   ROLAND CM, 1991, MACROMOLECULES, V24, P5315, DOI 10.1021/ma00019a016
   Stan F, 2011, MATER PLAST, V48, P1
   Vlad A, 2008, EUR POLYM J, V44, P2668, DOI 10.1016/j.eurpolymj.2008.05.014
NR 21
TC 13
Z9 13
U1 1
U2 9
PU CHIMINFORM DATA S A
PI BUCHAREST
PA CALEA PLEVNEI NR 139, SECTOR 6, BUCHAREST R-77131, ROMANIA
SN 0025-5289
J9 MATER PLAST
JI Mater. Plast.
PD MAR
PY 2016
VL 53
IS 1
BP 147
EP 149
PG 3
WC Materials Science, Multidisciplinary
SC Materials Science
GA DJ1MI
UT WOS:000373966500034
DA 2018-10-19
ER

PT J
AU Cara-Fuentes, M
   Machuca-Ariza, J
   Ruiz-Martos, A
   Ramos-Robles, MC
   Martinez-Lara, I
AF Cara-Fuentes, Manuel
   Machuca-Ariza, Jesus
   Ruiz-Martos, Alberto
   Ramos-Robles, Ma-Carmen
   Martinez-Lara, Ildefonso
TI Long-term outcome of dental implants after maxillary augmentation with
   and without bone grafting
SO MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL
LA English
DT Article
DE Bone formation; sinus membrane elevation; maxillary sinus; bone grafting
ID SINUS MEMBRANE ELEVATION; POSTERIOR MAXILLA; FLOOR AUGMENTATION;
   CLINICAL REPORT; BOVINE BONE; PLACEMENT; INTEGRATION; IMMEDIATE;
   SURVIVAL; LIFT
AB Background: This study aims to evaluate the technique of sinus bone reformation, which consists of elevating the sinus membrane and placement the implant without bone graft, compared with the widely-used technique involving raising the maxillary sinus and grafting, using animal hydroxyapatite as the filler, while simultaneously fixing the implants.
   Material and Methods: This is a retrospective study on two groups of patients who underwent elevation of the sinus membrane and simultaneous placement of the implant. The grafting technique was applied to one group, while the other had no graft. An alveolar ridge height of 4 to 7 mm was necessary. Radiological control was undertaken at 6 months and one year post-prosthetic loading. In each group 38 implants were placed.
   Results: No significant behavioural differences were observed in the implants according to the Albrektsson success criteria. Implant failure was observed in 2 implants from the bone grafting group (success rate 93%) and in 1 implant from the reformation group (success rate 97%). In this group, bone formation was observed on both sides of each implant, the bone gain was measured using image management software (2.7 +/- 0.9mm mesial and 2.6 +/- 0.9mm distal). There was no correlation between mesial and distal bone gain and implant's length.
   Conclusions: The results indicate that bone reformation is a valid technique in cases involving atrophy of the posterior maxilla. Primary stability, maintenance of space by the implant, and the formation of a blood clot are crucial in this technique in order to achieve bone formation around the implant. It is an alternative to the conventional technique of sinus lift with filling material, and has several advantages over this procedure, including a lower infection risk, as it does not involve a biomaterial, reduced cost, a simpler technique, and better acceptance by the patient.
C1 [Ramos-Robles, Ma-Carmen] Sch Dent, Dept Oral Med, Granada, Spain.
   [Martinez-Lara, Ildefonso] Sch Dent, Hlth Sci, Granada, Spain.
RP Cara-Fuentes, M (reprint author), Avda Europa 177, La Mojonera, Almeria, Spain.
EM manolocaraf@gmail.com
CR Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11
   Blomqvist J E, 1996, Int J Oral Maxillofac Implants, V11, P512
   Chen TW, 2007, J ORAL MAXIL SURG, V65, P2324, DOI 10.1016/j.joms.2007.06.649
   Cricchio G, 2014, CLIN IMPLANT DENT R, V16, P609, DOI 10.1111/cid.12035
   Cricchio G, 2011, CLIN ORAL IMPLAN RES, V22, P1200, DOI 10.1111/j.1600-0501.2010.02096.x
   Del Fabbro M, 2008, EUR J ORAL SCI, V116, P497, DOI 10.1111/j.1600-0722.2008.00571.x
   Gabbert O, 2009, J CLIN PERIODONTOL, V36, P177, DOI 10.1111/j.1600-051X.2008.01357.x
   Gurtner GC, 2007, ANNU REV MED, V58, P299, DOI 10.1146/annurev.med.58.085405.095329
   Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635
   Hatano N, 2007, CLIN IMPLANT DENT R, V9, P150, DOI 10.1111/j.1708-8208.2007.00043.x
   Jensen OT, 1998, INT J ORAL MAX IMPL, V13, P11
   Jeong SM, 2009, ORAL SURG ORAL MED O, V107, P364, DOI 10.1016/j.tripleo.2008.05.032
   Johansson LA, 2012, CLIN IMPLANT DENT R, V14, P575, DOI 10.1111/j.1708-8208.2010.00293.x
   Lundgren S, 2008, PERIODONTOL 2000, V47, P193, DOI 10.1111/j.1600-0757.2008.00264.x
   Lundgren Stefan, 2003, Clin Implant Dent Relat Res, V5, P78, DOI 10.1111/j.1708-8208.2003.tb00187.x
   Lundgren Stefan, 2004, Clin Implant Dent Relat Res, V6, P165, DOI 10.1111/j.1708-8208.2004.tb00217.x
   Mardinger O, 2007, ORAL SURG ORAL MED O, V103, P180, DOI 10.1016/j.tripleo.2006.03.008
   Misch C E, 1987, Int J Oral Implantol, V4, P49
   Palma VC, 2006, CLIN IMPLANT DENT R, V8, P11, DOI 10.2310/6480.2005.00026
   SMILER D G, 1992, Dental Clinics of North America, V36, P151
   Sohn DS, 2008, IMPLANT DENT, V17, P321, DOI 10.1097/ID.0b013e318182f01b
   Sohn DS, 2011, IMPLANT DENT, V20, P389, DOI 10.1097/ID.0b013e31822f7a70
   Sohn DS, 2010, J ORAL MAXIL SURG, V68, P1327, DOI 10.1016/j.joms.2010.02.014
   Srouji S, 2009, CALCIFIED TISSUE INT, V84, P138, DOI 10.1007/s00223-008-9202-x
   Tawil G, 2001, INT J ORAL MAX IMPL, V16, P713
   Thor A, 2007, J ORAL MAXIL SURG, V65, P64, DOI 10.1016/j.joms.2006.10.047
   Valentini P, 2003, INT J ORAL MAX IMPL, V18, P556
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   Zitzmann NU, 1998, ORAL SURG ORAL MED O, V85, P8, DOI 10.1016/S1079-2104(98)90391-2
NR 29
TC 12
Z9 12
U1 0
U2 6
PU MEDICINA ORAL S L
PI VALENCIA
PA CALLE DANIEL BALACIART N 4 PTA 17, VALENCIA, 46020, SPAIN
SN 1698-6946
J9 MED ORAL PATOL ORAL
JI Med. Oral Patol. Oral Cir. Bucal
PD MAR
PY 2016
VL 21
IS 2
BP E229
EP E235
AR 21055
DI 10.4317/medoral.21055
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DJ1AM
UT WOS:000373935500015
PM 26827071
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Kim, K
   Wagner, WR
AF Kim, Kang
   Wagner, William R.
TI Non-invasive and Non-destructive Characterization of Tissue Engineered
   Constructs Using Ultrasound Imaging Technologies: A Review
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Review
DE Ultrasound imaging; Noninvasive; Nondestructive; Multi-modality; Tissue
   scaffolds; Regeneration
ID SCANNING ACOUSTIC MICROSCOPY; ORAL MUCOSAL TISSUES; IN-VIVO;
   PHOTOACOUSTIC MICROSCOPY; RADIATION FORCE; HEMODIALYSIS ACCESS; ELASTIC
   PROPERTIES; VIRTUAL HISTOLOGY; SPECKLE TRACKING; VASCULAR GRAFTS
AB With the rapid expansion of biomaterial development and coupled efforts to translate such advances toward the clinic, non-invasive and non-destructive imaging tools to evaluate implants in situ in a timely manner are critically needed. The required multi-level information is comprehensive, including structural, mechanical, and biological changes such as scaffold degradation, mechanical strength, cell infiltration, extracellular matrix formation and vascularization to name a few. With its inherent advantages of non-invasiveness and non-destructiveness, ultrasound imaging can be an ideal tool for both preclinical and clinical uses. In this review, currently available ultrasound imaging technologies that have been applied in vitro and in vivo for tissue engineering and regenerative medicine are discussed and some new emerging ultrasound technologies and multi-modality approaches utilizing ultrasound are introduced.
C1 [Kim, Kang] Univ Pittsburgh, Sch Med, Dept Med, Ctr Ultrasound Mol Imaging & Therapeut, Pittsburgh, PA 15213 USA.
   [Kim, Kang] Univ Pittsburgh, Med Ctr, Inst Heart & Vasc, Pittsburgh, PA 15213 USA.
   [Kim, Kang; Wagner, William R.] Univ Pittsburgh, Sch Engn, Dept Bioengn, Pittsburgh, PA 15213 USA.
   [Wagner, William R.] Univ Pittsburgh, Sch Engn, Dept Surg, Pittsburgh, PA 15213 USA.
   [Kim, Kang; Wagner, William R.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Kim, Kang; Wagner, William R.] UPMC, Pittsburgh, PA 15219 USA.
RP Kim, K (reprint author), Univ Pittsburgh, Sch Med, Dept Med, Ctr Ultrasound Mol Imaging & Therapeut, Pittsburgh, PA 15213 USA.
EM kangkim@upmc.edu
FU NIH [R21EB013353]
FX This work was supported by NIH R21EB013353.
CR Allen RA, 2014, BIOMATERIALS, V35, P165, DOI 10.1016/j.biomaterials.2013.09.081
   Appel AA, 2013, BIOMATERIALS, V34, P6615, DOI 10.1016/j.biomaterials.2013.05.033
   Assmann A, 2012, J SURG RES, V176, P367, DOI 10.1016/j.jss.2011.10.009
   Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425
   Bilgen M, 1996, J ACOUST SOC AM, V99, P3212, DOI 10.1121/1.414865
   Cai X, 2013, MATER TODAY, V16, P67, DOI 10.1016/j.mattod.2013.03.007
   Cai X, 2013, TISSUE ENG PART C-ME, V19, P196, DOI [10.1089/ten.tec.2012.0326, 10.1089/ten.TEC.2012.0326]
   Chung E, 2013, INT J NANOMED, V8, P325, DOI 10.2147/IJN.S36711
   Cicciu M, 2014, J CRANIOFAC SURG, V25, P860, DOI 10.1097/SCS.0000000000000830
   Cohn NA, 2000, IEEE T ULTRASON FERR, V47, P956, DOI 10.1109/58.852079
   Cox B, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.6.061202
   Dahl SLM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001426
   Deffieux T, 2009, IEEE T MED IMAGING, V28, P313, DOI 10.1109/TMI.2008.925077
   Dutta D, 2013, ULTRASOUND MED BIOL, V39, P2103, DOI 10.1016/j.ultrasmedbio.2013.04.023
   Emelianov SY, 2009, PHYS TODAY, V62, P34, DOI 10.1063/1.3141939
   Fatemi M, 1999, P NATL ACAD SCI USA, V96, P6603, DOI 10.1073/pnas.96.12.6603
   Feleppa EJ, 2008, CANCER BIOMARK, V4, P201, DOI 10.3233/CBM-2008-44-504
   Fite BZ, 2011, TISSUE ENG PART C-ME, V17, P495, DOI 10.1089/ten.tec.2010.0368
   Gao L, 1996, ULTRASOUND MED BIOL, V22, P959, DOI 10.1016/S0301-5629(96)00120-2
   Gessner RC, 2013, BIOMATERIALS, V34, P9341, DOI 10.1016/j.biomaterials.2013.08.033
   GOLUB RM, 1993, J ULTRAS MED, V12, P601
   Gudur MSR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085749
   Hall TJ, 2003, ULTRASOUND MED BIOL, V29, P427, DOI 10.1016/S0301-5629(02)00733-0
   Herford Alan S, 2007, J Calif Dent Assoc, V35, P335
   Herford AS, 2012, INT J ORAL MAX IMPL, V27, P1351
   Hibino N, 2012, J THORAC CARDIOV SUR, V143, P696, DOI 10.1016/j.jtcvs.2011.06.046
   Kang KT, 2011, BLOOD, V118, P6718, DOI 10.1182/blood-2011-08-375188
   Kawamura M, 2012, CIRCULATION, V126, pS29, DOI 10.1161/CIRCULATIONAHA.111.084343
   Kim K, 2008, ACTA BIOMATER, V4, P783, DOI 10.1016/j.actbio.2008.02.010
   Kim K, 2008, ULTRASOUND MED BIOL, V34, P902, DOI 10.1016/j.ultrasmedbio.2007.11.020
   Kim S, 2011, BIOMED OPT EXPRESS, V2, P2540, DOI 10.1364/BOE.2.002540
   Konofagou E, 1998, ULTRASOUND MED BIOL, V24, P1183, DOI 10.1016/S0301-5629(98)00109-4
   Kreitz S, 2011, TISSUE ENG PART C-ME, V17, P1021, DOI [10.1089/ten.TEC.2010.0669, 10.1089/ten.tec.2010.0669]
   Kumar VA, 2013, ACTA BIOMATER, V9, P8067, DOI 10.1016/j.actbio.2013.05.024
   Lee IS, 2013, CARDIOVASC ULTRASOUN, V11, DOI 10.1186/1476-7120-11-25
   Lee WK, 2003, J BIOMED MATER RES A, V67A, P1087, DOI 10.1002/jbm.a.10570
   Lerner R. M., 1988, Acoustical Imaging. Vol.19. Proceedings of the 16th International Symposium, P317
   Lizzi FL, 1997, INT J IMAG SYST TECH, V8, P3, DOI 10.1002/(SICI)1098-1098(1997)8:1<3::AID-IMA2>3.0.CO;2-E
   Lubinski MA, 1999, IEEE T ULTRASON FERR, V46, P82, DOI 10.1109/58.741427
   Luke GP, 2012, ANN BIOMED ENG, V40, P422, DOI 10.1007/s10439-011-0449-4
   Lyshchik A, 2007, RADIOLOGY, V243, P258, DOI 10.1148/radiol.2431052032
   Martinez-Diaz S, 2010, AM J SPORT MED, V38, P509, DOI 10.1177/0363546509352448
   Matsumura G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035760
   Maurice RL, 2007, ULTRASOUND MED BIOL, V33, P1199, DOI 10.1016/j.ultrasmedbio.2007.01.018
   McAleavey S, 2009, ULTRASONIC IMAGING, V31, P217, DOI 10.1177/016173460903100401
   McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8
   Mercado KP, 2014, ANN BIOMED ENG, V42, P1292, DOI 10.1007/s10439-014-0994-8
   Nair A, 2002, CIRCULATION, V106, P2200, DOI 10.1161/01.CIR.0000035654.18341.5E
   Nam SY, 2015, TISSUE ENG PART B-RE, V21, P88, DOI [10.1089/ten.TEB.2014.0180, 10.1089/ten.teb.2014.0180]
   Nam SY, 2012, OPT LETT, V37, P4708, DOI 10.1364/OL.37.004708
   Nam SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037267
   Nasu K, 2006, J AM COLL CARDIOL, V47, P2405, DOI 10.1016/j.jacc.2006.02.044
   Neumayer L, 2004, NEW ENGL J MED, V350, P1819, DOI 10.1056/NEJMoa040093
   Nguyen MM, 2014, IEEE INT ULTRA SYM, P325, DOI 10.1109/ULTSYM.2014.0080
   Nightingale K, 2003, ULTRASOUND MED BIOL, V29, P1715, DOI 10.1016/j.ultrasmedbio.2003.08.008
   Nightingale K, 2002, ULTRASOUND MED BIOL, V28, P227, DOI 10.1016/S0301-5629(01)00499-9
   Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/NMETH.1483, 10.1038/nmeth.1483]
   O'Brien FJ, 2011, MATER TODAY, V14, P88, DOI 10.1016/S1369-7021(11)70058-X
   ODONNELL M, 1994, IEEE T ULTRASON FERR, V41, P314, DOI 10.1109/58.285465
   OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W
   Pan D, 2011, FASEB J, V25, P875, DOI 10.1096/fj.10-171728
   Park DW, 2014, BIOMATERIALS, V35, P7851, DOI 10.1016/j.biomaterials.2014.05.088
   Perk G, 2007, J AM SOC ECHOCARDIOG, V20, P234, DOI 10.1016/j.echo.2006.08.023
   Quint C, 2012, J VASC SURG, V55, P790, DOI 10.1016/j.jvs.2011.07.098
   Ribbers H, 2007, ULTRASOUND MED BIOL, V33, P530, DOI 10.1016/j.ultrasmedbio.2006.09.009
   Rice MA, 2009, ACTA BIOMATER, V5, P152, DOI 10.1016/j.actbio.2008.07.036
   Ricles LM, 2011, INT J NANOMED, V6, P407, DOI 10.2147/IJN.S16354
   Rouze NC, 2010, IEEE T ULTRASON FERR, V57, P2662, DOI 10.1109/TUFFC.2010.1740
   Rubin JM, 2006, J ULTRAS MED, V25, P1179, DOI 10.7863/jum.2006.25.9.1179
   Sarvazyan AP, 1998, ULTRASOUND MED BIOL, V24, P1419, DOI 10.1016/S0301-5629(98)00110-0
   SKOVORODA AR, 1994, IEEE T ULTRASON FERR, V41, P302, DOI 10.1109/58.285463
   Sun Y, 2012, TISSUE ENG PART C-ME, V18, P215, DOI [10.1089/ten.tec.2011.0343, 10.1089/ten.TEC.2011.0343]
   Talukdar Y, 2014, TISSUE ENG PART C-ME, V20, P440, DOI [10.1089/ten.tec.2013.0203, 10.1089/ten.TEC.2013.0203]
   Tanaka Y, 2012, J BIOSCI BIOENG, V113, P252, DOI 10.1016/j.jbiosc.2011.10.011
   Tayalia P, 2009, ADV MATER, V21, P3269, DOI 10.1002/adma.200900241
   Tillman BW, 2012, J VASC SURG, V56, P783, DOI 10.1016/j.jvs.2012.02.030
   Tsuji W, 2013, J ARTIF ORGANS, V16, P110, DOI 10.1007/s10047-012-0670-4
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210
   Weber M, 2014, TISSUE ENG PART C-ME, V20, P265, DOI [10.1089/ten.TEC.2013.0258, 10.1089/ten.tec.2013.0258]
   Wells PNT, 2006, PHYS MED BIOL, V51, pR83, DOI 10.1088/0031-9155/51/13/R06
   Weyhe D, 2007, WORLD J SURG, V31, P234, DOI 10.1007/s00268-006-0123-4
   Winterroth F, 2013, TISSUE ENG PART C-ME, V19, P345, DOI [10.1089/ten.tec.2012.0467, 10.1089/ten.TEC.2012.0467]
   Winterroth F, 2011, ULTRASOUND MED BIOL, V37, P1734, DOI 10.1016/j.ultrasmedbio.2011.06.010
   Wu W, 2012, NAT MED, V18, P1148, DOI 10.1038/nm.2821
   Wystrychowski W, 2014, J VASC SURG, V60, P1353, DOI 10.1016/j.jvs.2013.08.018
   Yoshikawa M, 2008, KEY ENG MATER, V361-363, P1185, DOI 10.4028/www.scientific.net/KEM.361-363.1185
   Yu J, 2013, BIOMATERIALS, V34, P2701, DOI 10.1016/j.biomaterials.2013.01.036
   Zhang Y, 2011, ANGEW CHEM INT EDIT, V50, P7359, DOI 10.1002/anie.201101659
   Zhang Y, 2010, BIOMATERIALS, V31, P8651, DOI 10.1016/j.biomaterials.2010.07.089
   Zhang YS, 2014, ANGEW CHEM INT EDIT, V53, P184, DOI 10.1002/anie.201306282
NR 91
TC 3
Z9 3
U1 3
U2 32
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAR
PY 2016
VL 44
IS 3
BP 621
EP 635
DI 10.1007/s10439-015-1495-0
PG 15
WC Engineering, Biomedical
SC Engineering
GA DI8HK
UT WOS:000373741900002
PM 26518412
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Zhang, YS
   Wang, LV
   Xia, YN
AF Zhang, Yu Shrike
   Wang, Lihong V.
   Xia, Younan
TI Seeing Through the Surface: Non-invasive Characterization of
   Biomaterial-Tissue Interactions Using Photoacoustic Microscopy
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Photoacoustic microscopy; Biomedical imaging; Tissue engineering;
   Regenerative medicine; Non-invasive
ID IN-VIVO; ENGINEERING SCAFFOLDS; REGENERATIVE MEDICINE; FLUORESCENT
   PROTEINS; OXYGEN-SATURATION; GOLD NANOCAGES; TOMOGRAPHY; RESOLUTION;
   VITRO; DEGRADATION
AB At the intersection of life sciences, materials science, engineering, and medicine, regenerative medicine stands out as a rapidly progressing field that aims at retaining, restoring, or augmenting tissue/organ functions to promote the human welfare. While the field has witnessed tremendous advancements over the past few decades, it still faces many challenges. For example, it has been difficult to visualize, monitor, and assess the functions of the engineered tissue/organ constructs, particularly when three-dimensional scaffolds are involved. Conventional approaches based on histology are invasive and therefore only convey end-point assays. The development of volumetric imaging techniques such as confocal and ultrasonic imaging has enabled direct observation of intact constructs without the need of sectioning. However, the capability of these techniques is often limited in terms of penetration depth and contrast. In comparison, the recently developed photoacoustic microscopy (PAM) has allowed us to address these issues by integrating optical and ultrasonic imaging to greatly reduce the effect of tissue scattering of photons with one-way ultrasound detection while retaining the high optical absorption contrast. PAM has been successfully applied to a number of studies, such as observation of cell distribution, monitoring of vascularization, and interrogation of biomaterial degradation. In this review article, we highlight recent progress in non-invasive and volumetric characterization of biomaterial-tissue interactions using PAM. We also discuss challenges ahead and envision future directions.
C1 [Zhang, Yu Shrike] Harvard Univ, Brigham & Womens Hosp, Sch Med, Biomat Innovat Res Ctr,Dept Med, Boston, MA 02115 USA.
   [Zhang, Yu Shrike] MIT, Harvard Div Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Zhang, Yu Shrike] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
   [Wang, Lihong V.] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.
   [Xia, Younan] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Xia, Younan] Emory Univ, Atlanta, GA 30332 USA.
   [Xia, Younan] Georgia Inst Technol, Sch Chem & Biomol Engn, Sch Chem & Biochem, Atlanta, GA 30332 USA.
RP Wang, LV (reprint author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.; Xia, YN (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.; Xia, YN (reprint author), Emory Univ, Atlanta, GA 30332 USA.
EM lhwang@wustl.edu; younan.xia@bme.gatech.edu
RI Xia, Younan/E-8499-2011
OI Wang, Lihong/0000-0001-9783-4383
FU Georgia Institute of Technology; NIH [DP1 OD000798, R01 AR060820]
FX This work was supported in part by startup funds from the Georgia
   Institute of Technology and NIH Grants DP1 OD000798 (NIH Director's
   Pioneer Award) and R01 AR060820. The authors would like to thank Dr. Yu
   Wang and Dr. Li Li for their assistance in OR-PAM-FCM and OR-PAM-OCT
   imaging of melanoma cell-scaffold interactions.
CR Allen TJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.6.061209
   [Anonymous], 2005, DISC COL GUID MULT A
   Appel A, 2011, TISSUE ENG PART B-RE, V17, P321, DOI [10.1089/ten.teb.2011.0230, 10.1089/ten.TEB.2011.0230]
   Appel AA, 2013, BIOMATERIALS, V34, P6615, DOI 10.1016/j.biomaterials.2013.05.033
   Artzi N, 2011, NAT MATER, V10, P704, DOI [10.1038/nmat3095, 10.1038/NMAT3095]
   Bae H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003688
   Beard P, 2011, INTERFACE FOCUS, V1, P602, DOI 10.1098/rsfs.2011.0028
   Brunker J, 2012, J ACOUST SOC AM, V132, P1780, DOI 10.1121/1.4739458
   Cai X, 2013, MATER TODAY, V16, P67, DOI 10.1016/j.mattod.2013.03.007
   Cai X, 2013, TISSUE ENG PART C-ME, V19, P196, DOI [10.1089/ten.tec.2012.0326, 10.1089/ten.TEC.2012.0326]
   Cai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043999
   Cai X, 2012, TISSUE ENG PART C-ME, V18, P310, DOI [10.1089/ten.tec.2011.0519, 10.1089/ten.TEC.2011.0519]
   Chatni M. R., 2012, J BIOMED OPT, V17
   Chen F, 2015, SCIENCE, V347, P543, DOI 10.1126/science.1260088
   Cho EC, 2009, J PHYS CHEM C, V113, P9023, DOI 10.1021/jp903343p
   Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107
   Del Guerra A, 2007, NUCL INSTRUM METH A, V583, P119, DOI 10.1016/j.nima.2007.08.187
   DURNIN J, 1988, OPT LETT, V13, P79, DOI 10.1364/OL.13.000079
   Favazza CP, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3528661
   Fernandez-Lopez C, 2015, ACS APPL MATER INTER, V7, P12530, DOI 10.1021/am5087209
   Filonov GS, 2012, ANGEW CHEM INT EDIT, V51, P1448, DOI 10.1002/anie.201107026
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Gottschalk S, 2015, J CEREBR BLOOD F MET, V35, P531, DOI 10.1038/jcbfm.2014.249
   HORWITZ JP, 1964, J MED CHEM, V7, P574, DOI 10.1021/jm00334a044
   Hu S, 2011, OPT LETT, V36, P1134, DOI 10.1364/OL.36.001134
   Jansen K, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.2.026006
   Jathoul AP, 2015, NAT PHOTONICS, V9, P239, DOI [10.1038/NPHOTON.2015.22, 10.1038/nphoton.2015.22]
   Kim C, 2010, CHEM REV, V110, P2756, DOI 10.1021/cr900266s
   Kim K, 2008, ACTA BIOMATER, V4, P783, DOI 10.1016/j.actbio.2008.02.010
   KORNER A, 1982, SCIENCE, V217, P1163, DOI 10.1126/science.6810464
   Kruger RA, 2010, MED PHYS, V37, P6096, DOI 10.1118/1.3497677
   Krumholz A, 2014, SCI REP-UK, V4, DOI 10.1038/srep03939
   Krumholz A, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3606568
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laufer J, 2013, BIOMED OPT EXPRESS, V4, P2477, DOI 10.1364/BOE.4.002477
   Li L, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717531
   Li L, 2008, J INNOV OPT HEAL SCI, V1, P207, DOI 10.1142/S1793545808000212
   Li L, 2009, OPT EXPRESS, V17, P16450, DOI 10.1364/OE.17.016450
   Li ML, 2006, OPT LETT, V31, P474, DOI 10.1364/OL.31.000474
   Liao CK, 2004, OPT LETT, V29, P2506, DOI 10.1364/OL.29.002506
   Liu Y, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.12.126014
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   MANSOUR SL, 1990, P NATL ACAD SCI USA, V87, P7688, DOI 10.1073/pnas.87.19.7688
   Nam SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037267
   Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/NMETH.1483, 10.1038/nmeth.1483]
   Ntziachristos V, 2010, CHEM REV, V110, P2783, DOI 10.1021/cr9002566
   O'Donnell M, 2013, ANN BIOMED ENG, V41, P2237, DOI 10.1007/s10439-013-0901-8
   Peptan IA, 2006, TISSUE ENG, V12, P843, DOI 10.1089/ten.2006.12.843
   Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107
   Rajian JR, 2013, J PHYS CHEM LETT, V4, P3211, DOI 10.1021/jz401638e
   Razansky D, 2009, NAT PHOTONICS, V3, P412, DOI 10.1038/NPHOTON.2009.98
   SEIDLER E, 1991, PROG HISTOCHEM CYTOC, V24, P1
   Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819
   Song KH, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2818045
   Song Yi, 2013, J Pathol Inform, V4, pS7, DOI 10.4103/2153-3539.109864
   Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034
   Talukdar Y, 2014, TISSUE ENG PART C-ME, V20, P440, DOI [10.1089/ten.tec.2013.0203, 10.1089/ten.TEC.2013.0203]
   Taruttis A, 2015, NAT PHOTONICS, V9, P219, DOI 10.1038/nphoton.2015.29
   Wang B, 2012, OPT LETT, V37, P1244, DOI 10.1364/OL.37.001244
   WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F
   Wang LD, 2013, P NATL ACAD SCI USA, V110, P5759, DOI [10.1073/pnas.1215578110, 10.1073/pnas.121578110]
   Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210
   Wang LV, 2009, NAT PHOTONICS, V3, P503, DOI 10.1038/NPHOTON.2009.157
   Wang P, 2014, SCI REP-UK, V4, DOI 10.1038/srep06889
   Wang XD, 2003, NAT BIOTECHNOL, V21, P803, DOI 10.1038/nbt839
   Wang Y, 2011, OPT LETT, V36, P1029, DOI 10.1364/OL.36.001029
   Wang Y, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3525643
   Xia YN, 2011, ACCOUNTS CHEM RES, V44, P914, DOI 10.1021/ar200061q
   Yao J., 2011, J BIOMED OPT, V16
   Yao JJ, 2013, LASER PHOTONICS REV, V7, P758, DOI 10.1002/lpor.201200060
   Yuste R, 2005, NAT METHODS, V2, P902, DOI 10.1038/nmeth1205-902
   Zhang C, 2010, OPT LETT, V35, P3195, DOI 10.1364/OL.35.003195
   Zhang HF, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2435697
   Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220
   Zhang Y, 2011, ANGEW CHEM INT EDIT, V50, P7359, DOI 10.1002/anie.201101659
   Zhang Y, 2010, BIOMATERIALS, V31, P8651, DOI 10.1016/j.biomaterials.2010.07.089
   Zhang YS, 2015, NANOMEDICINE-UK, V10, P689, DOI [10.2217/NNM.15.10, 10.2217/nnm.15.10]
   Zhang YS, 2014, ANGEW CHEM INT EDIT, V53, P8099, DOI 10.1002/anie.201403812
   Zhang YS, 2014, ANGEW CHEM INT EDIT, V53, P184, DOI 10.1002/anie.201306282
   Zhang YS, 2013, SOFT MATTER, V9, P9747, DOI 10.1039/c3sm52063c
   Zhang YS, 2013, THERANOSTICS, V3, P532, DOI 10.7150/thno.5369
NR 81
TC 5
Z9 5
U1 5
U2 40
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAR
PY 2016
VL 44
IS 3
BP 649
EP 666
DI 10.1007/s10439-015-1485-2
PG 18
WC Engineering, Biomedical
SC Engineering
GA DI8HK
UT WOS:000373741900004
PM 26471785
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Ozturk, MS
   Chen, CW
   Ji, R
   Zhao, LL
   Nguyen, BNB
   Fisher, JP
   Chen, Y
   Intes, X
AF Ozturk, Mehmet S.
   Chen, Chao-Wei
   Ji, Robin
   Zhao, Lingling
   Nguyen, Bao-Ngoc B.
   Fisher, John P.
   Chen, Yu
   Intes, Xavier
TI Mesoscopic Fluorescence Molecular Tomography for Evaluating Engineered
   Tissues
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Laminar optical tomography (LOT); Fluorescence laminar optical
   tomography (FLOT); Mesoscopic fluorescence molecular tomography (MFMT);
   Tissue engineering; Non-destructive imaging; Bioprinting; Optical
   imaging; In vivo imaging
ID LAMINAR OPTICAL TOMOGRAPHY; TUBULAR PERFUSION SYSTEM; MONTE-CARLO
   METHODS; COHERENCE TOMOGRAPHY; IMAGE-RECONSTRUCTION; TURBID MEDIA;
   PHOTON MIGRATION; SCAFFOLDS; ALGINATE; MICROSCOPY
AB Optimization of regenerative medicine strategies includes the design of biomaterials, development of cell-seeding methods, and control of cell-biomaterial interactions within the engineered tissues. Among these steps, one paramount challenge is to non-destructively image the engineered tissues in their entirety to assess structure, function, and molecular expression. It is especially important to be able to enable cell phenotyping and monitor the distribution andmigration of cells throughout the bulk scaffold. Advanced fluorescence microscopic techniques are commonly employed to perform such tasks; however, they are limited to superficial examination of tissue constructs. Therefore, the field of tissue engineering and regenerative medicine would greatly benefit from the development of molecular imaging techniques which are capable of non-destructive imaging of three-dimensional cellular distribution and maturation within a tissue-engineered scaffold beyond the limited depth of current microscopic techniques. In this review, we focus on an emerging depth-resolved optical mesoscopic imaging technique, termed laminar optical tomography (LOT) or mesoscopic fluorescence molecular tomography (MFMT), which enables longitudinal imaging of cellular distribution in thick tissue engineering constructs at depths of a fewmillimeters and with relatively high resolution. The physical principle, image formation, and instrumentation of LOT/MFMT systems are introduced. Representative applications in tissue engineering include imaging the distribution of human mesenchymal stemcells embedded in hydrogels, imaging of bioprinted tissues, and in vivo applications.
C1 [Ozturk, Mehmet S.; Ji, Robin; Zhao, Lingling; Intes, Xavier] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
   [Chen, Chao-Wei; Nguyen, Bao-Ngoc B.; Fisher, John P.; Chen, Yu] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
RP Chen, Y (reprint author), Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
EM yuchen@umd.edu; intesx@rpi.edu
FU NIH [R01 EB014946-01A1]; NSF [CBET-1263455]
FX This work is supported by the NIH R01 EB014946-01A1 (YC) and NSF
   CBET-1263455 (XI).
CR Abou-Elkacem L, 2012, EUR RADIOL, V22, P1955, DOI 10.1007/s00330-012-2462-x
   Alerstam E, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3041496
   Arridge SR, 2009, INVERSE PROBL, V25, DOI 10.1088/0266-5611/25/12/123010
   Arridge SR, 1997, PHILOS T R SOC B, V352, P717, DOI 10.1098/rstb.1997.0054
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Bjorn S, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3560631
   Bjorn S, 2010, OPT EXPRESS, V18, P8422, DOI 10.1364/OE.18.008422
   Burgess SA, 2008, OPT LETT, V33, P2710, DOI 10.1364/OL.33.002710
   Chartrand R, 2007, IEEE SIGNAL PROC LET, V14, P707, DOI 10.1109/LSP.2007.898300
   Chen CW, 2011, J INNOV OPT HEAL SCI, V4, P309, DOI 10.1142/S1793545811001435
   Chen J, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.10.106009
   Chen J, 2011, MED PHYS, V38, P5788, DOI 10.1118/1.3641827
   Chen J, 2011, BIOMED OPT EXPRESS, V2, P871, DOI 10.1364/BOE.2.000871
   Chen Y, 2010, IEEE J SEL TOP QUANT, V16, P755, DOI 10.1109/JSTQE.2009.2037723
   Crilly RJ, 1997, APPL OPTICS, V36, P6513, DOI 10.1364/AO.36.006513
   Derby B, 2012, SCIENCE, V338, P921, DOI 10.1126/science.1226340
   Dunn A, 2000, OPT LETT, V25, P1777, DOI 10.1364/OL.25.001777
   Endoh R, 2008, OPT REV, V15, P51, DOI 10.1007/s10043-008-0009-9
   Fang QQ, 2009, OPT EXPRESS, V17, P20178, DOI 10.1364/OE.17.020178
   Gardner AR, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.6.065003
   Georgakoudi I, 2008, TISSUE ENG PART B-RE, V14, P321, DOI 10.1089/ten.teb.2008.0248
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Guillotin B, 2011, TRENDS BIOTECHNOL, V29, P183, DOI 10.1016/j.tibtech.2010.12.008
   Hayakawa CK, 2001, OPT LETT, V26, P1335, DOI 10.1364/OL.26.001335
   Hillman EMC, 2007, OPT EXPRESS, V15, P17827, DOI 10.1364/OE.15.017827
   Hillman EMC, 2007, NEUROIMAGE, V35, P89, DOI 10.1016/j.neuroimage.2006.11.032
   Hillman EMC, 2009, LASER PHOTONICS REV, V3, P159, DOI 10.1002/lpor.200810031
   Hillman EMC, 2004, OPT LETT, V29, P1650, DOI 10.1364/OL.29.001650
   Hoover EE, 2013, NAT PHOTONICS, V7, P93, DOI [10.1038/nphoton.2013.361, 10.1038/nphoton.2012.361]
   Intes X, 2002, PHYS MED BIOL, V47, pN1, DOI 10.1088/0031-9155/47/1/401
   Intes X, 2003, MED PHYS, V30, P1039, DOI 10.1118/1.1573791
   Jacques SL, 2013, PHYS MED BIOL, V58, pR37, DOI 10.1088/0031-9155/58/11/R37
   Jaedicke V, 2013, BIOMED OPT EXPRESS, V4, P2945, DOI 10.1364/BOE.4.002945
   KELLER JB, 1976, AM MATH MON, V83, P107, DOI 10.2307/2976988
   Kobat D, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3646209
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Morgner U, 2000, OPT LETT, V25, P111, DOI 10.1364/OL.25.000111
   Muldoon TJ, 2012, BIOMED OPT EXPRESS, V3, P1701, DOI 10.1364/BOE.3.001701
   Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958
   Ouakli N, 2010, OPT EXPRESS, V18, P10068, DOI 10.1364/OE.18.010068
   Ozturk MS, 2014, ACAD RADIOL, V21, P271, DOI 10.1016/j.acra.2013.11.009
   Ozturk MS, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.10.100501
   Pawley J. B., 2006, HDB BIOL CONFOCAL MI
   Pian Q., 2014, CURR MOL IMAGING, V3, P72
   Pogue BW, 1999, APPL OPTICS, V38, P2950, DOI 10.1364/AO.38.002950
   Pogue BW, 1999, OPT EXPRESS, V4, P270, DOI 10.1364/OE.4.000270
   Robles FE, 2011, NAT PHOTONICS, V5, P744, DOI 10.1038/nphoton.2011.257
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   So PTC, 1998, OPT EXPRESS, V3, P339, DOI 10.1364/OE.3.000339
   Suzen M, 2010, OPT EXPRESS, V18, P23676, DOI 10.1364/OE.18.023676
   Tan W, 2004, TISSUE ENG, V10, P1747, DOI 10.1089/ten.2004.10.1747
   Tan W, 2007, MICROSC RES TECHNIQ, V70, P361, DOI 10.1002/jemt.20420
   Tan W, 2006, OPT EXPRESS, V14, P7159, DOI 10.1364/OE.14.007159
   Tanbakuchi AA, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3194131
   Tay BCM, 2013, MICROW OPT TECHN LET, V55, P2587, DOI 10.1002/mop.27926
   Thevenot P, 2008, TISSUE ENG PART C-ME, V14, P319, DOI 10.1089/ten.tec.2008.0221
   Tikhonov A. N., 1995, NUMERICAL METHODS SO
   Ueng SWN, 2007, J ORTHOP RES, V25, P62, DOI 10.1002/jor.20286
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Venugopal V, 2012, CURR MED IMAGING REV, V8, P244, DOI 10.2174/157340512803759884
   Vroom JM, 1999, APPL ENVIRON MICROB, V65, P3502
   Wang L, 2003, BIOMATERIALS, V24, P3475, DOI 10.1016/S0142-9612(03)00167-4
   Wang LV, 2007, BIOMEDICAL OPTICS PR
   Yang FG, 2015, IEEE T BIO-MED ENG, V62, P248, DOI 10.1109/TBME.2014.2347284
   Yang Y, 2006, PHYS MED BIOL, V51, P1649, DOI 10.1088/0031-9155/51/7/001
   Yeatts AB, 2011, TISSUE ENG PART C-ME, V17, P337, DOI [10.1089/ten.tec.2010.0172, 10.1089/ten.TEC.2010.0172]
   Yeatts AB, 2011, TISSUE ENG PART C-ME, V17, P1171, DOI 10.1089/ten.tec.2011.0263
   YODH A, 1995, PHYS TODAY, V48, P34, DOI 10.1063/1.881445
   Yuan BH, 2009, J INNOV OPT HEAL SCI, V2, P149, DOI 10.1142/S1793545809000486
   Yuan BH, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3117204
   Yuan SA, 2009, OPT LETT, V34, P1615, DOI 10.1364/OL.34.001615
   Zhao LL, 2014, OPT LETT, V39, P4156, DOI 10.1364/OL.39.004156
   Zhao LL, 2012, BIOMATERIALS, V33, P5325, DOI 10.1016/j.biomaterials.2012.04.004
   Zhu CG, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.5.050902
   Zhu WW, 1997, J OPT SOC AM A, V14, P799, DOI 10.1364/JOSAA.14.000799
NR 76
TC 17
Z9 18
U1 1
U2 14
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAR
PY 2016
VL 44
IS 3
BP 667
EP 679
DI 10.1007/s10439-015-1511-4
PG 13
WC Engineering, Biomedical
SC Engineering
GA DI8HK
UT WOS:000373741900005
PM 26645079
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Zhou, J
   Hu, WJ
   Tang, LP
AF Zhou, Jun
   Hu, Wenjing
   Tang, Liping
TI Non-invasive Characterization of Immune Responses to Biomedical Implants
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Biomaterials; Optical imaging probes; In vivo biocompatibility
ID BIORESORBABLE STENT MATERIALS; ACUTE INFLAMMATORY RESPONSES;
   FOREIGN-BODY REACTIONS; SMOOTH-MUSCLE-CELLS; RAT C6 GLIOMA; IN-VIVO;
   FLUORESCENT NANOSENSORS; ACTIVATED MACROPHAGES; RHEUMATOID-ARTHRITIS;
   CHEMOTACTIC PEPTIDE
AB Biomedical implants play an important role in today's clinical practice. Unfortunately, biomedical implant-mediated host responses may lead to implant failure. Thus, all implants are tested for tissue compatibility prior to clinical trials. For that, after implantation in animals for different periods of time, the implants and surrounding tissues are isolated for histological analyses. Unfortunately, histological evaluation methods are labor intensive, time consuming, expensive and do not produce quantitative outcomes. With the advent of in vivo imaging technology, many imaging methods have been developed for evaluating biomedical implant-associated immune responses. In this review, we summarize the recent progress in the use of in vivo real-time imaging techniques for assessing acute phase foreign body reactions, including fibrin deposition, inflammatory cell recruitment and responses surrounding biomaterial implants. These new technologies may serve as powerful tools to characterize tissue compatibility of medical implants.
C1 [Zhou, Jun; Tang, Liping] Univ Texas Arlington, Dept Bioengn, POB 19138, Arlington, TX 76019 USA.
   [Hu, Wenjing] Progenitec Inc, 1917 Parktree Dr, Arlington, TX 76001 USA.
   [Tang, Liping] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung 807, Taiwan.
RP Tang, LP (reprint author), Univ Texas Arlington, Dept Bioengn, POB 19138, Arlington, TX 76019 USA.
EM ltang@uta.edu
CR Adams WP, 2006, PLAST RECONSTR SURG, V117, P1214, DOI 10.1097/01.prs.0000208306.79104.18
   Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P6698, DOI 10.1073/pnas.0303859101
   ALTIERI DC, 1988, J CELL BIOL, V107, P1893, DOI 10.1083/jcb.107.5.1893
   Alves NM, 2010, SMALL, V6, P2208, DOI 10.1002/smll.201000233
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Andreev OA, 2007, P NATL ACAD SCI USA, V104, P7893, DOI 10.1073/pnas.0702439104
   Babich JW, 1997, J NUCL MED, V38, P1316
   Baker DW, 2014, ACTA BIOMATER, V10, P2945, DOI 10.1016/j.actbio.2014.04.001
   Bartsch I, 2014, ACTA BIOMATER, V10, P34, DOI 10.1016/j.actbio.2013.08.047
   Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009
   Botnar RM, 2004, CIRCULATION, V109, P2023, DOI 10.1161/01.CIR.000012703450006.C0
   Bouloux GF, 2009, J ORAL MAXIL SURG, V67, P2497, DOI 10.1016/j.joms.2009.04.103
   Brasuel M, 2001, ANAL CHEM, V73, P2221, DOI 10.1021/ac0012041
   Bratlie KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010032
   Brown BN, 2012, ACTA BIOMATER, V8, P2871, DOI 10.1016/j.actbio.2012.03.005
   Cai T, 2012, NANOMED-NANOTECHNOL, V8, P1301, DOI 10.1016/j.nano.2012.02.002
   Carmoa VAS, 2008, NUCL MED COMMUN, V29, P33, DOI 10.1097/MNM.0b013e3282f1bc0d
   Chen Wei-Tsung, 2004, Mol Imaging, V3, P159, DOI 10.1162/1535350042380290
   Chen WT, 2005, ARTHRITIS RES THER, V7, pR310, DOI 10.1186/ar1483
   Chen ZW, 2015, BIOMATERIALS, V39, P15, DOI 10.1016/j.biomaterials.2014.10.066
   Chi C, 2014, THERANOSTICS, V4, P1072, DOI 10.7150/thno.9899
   Clark HA, 1999, ANAL CHEM, V71, P4837, DOI 10.1021/ac990630n
   Conus S, 2008, BIOCHEM PHARMACOL, V76, P1374, DOI 10.1016/j.bcp.2008.07.041
   Daghighi S, 2014, EUR CELLS MATER, V27, P26, DOI 10.22203/eCM.v027a03
   De Backer D, 2003, Minerva Anestesiol, V69, P281
   de Chermont QL, 2007, P NATL ACAD SCI USA, V104, P9266, DOI 10.1073/pnas.0702427104
   Derian CK, 1996, BIOCHEMISTRY-US, V35, P1265, DOI 10.1021/bi952087k
   Dinjaski N, 2014, ACTA BIOMATER, V10, P2935, DOI 10.1016/j.actbio.2014.03.005
   Duo J, 2011, ANAL BIOANAL CHEM, V399, P783, DOI 10.1007/s00216-010-4333-0
   Fehr M, 2002, P NATL ACAD SCI USA, V99, P9846, DOI 10.1073/pnas.142089199
   FISCHMAN AJ, 1991, J NUCL MED, V32, P483
   Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007
   Freeman TA, 2009, FIBROGENESIS TISSUE, V2, DOI 10.1186/1755-1536-2-5
   Gerstner AOH, 2004, CYTOM PART A, V59A, P210, DOI 10.1002/cyto.a.20054
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Greenhalgh DG, 1998, INT J BIOCHEM CELL B, V30, P1019, DOI 10.1016/S1357-2725(98)00058-2
   Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886
   Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776
   Hayes EM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00537
   Hilgenbrink AR, 2005, J PHARM SCI-US, V94, P2135, DOI 10.1002/jps.20457
   Hoemann CD, 2010, AM J SPORT MED, V38, P1845, DOI 10.1177/0363546510369547
   Ji J, 2000, ANAL CHEM, V72, P3497, DOI 10.1021/ac000080p
   JOSEFSSON E, 1992, CELL IMMUNOL, V142, P67, DOI 10.1016/0008-8749(92)90269-U
   LANGUINO LR, 1993, CELL, V73, P1423, DOI 10.1016/0092-8674(93)90367-Y
   Lee D, 2007, NAT MATER, V6, P765, DOI 10.1038/nmat1983
   Lee DW, 2008, INT J NANOMED, V3, P471
   Lefer AM, 1998, CIRCULATION, V98, P1322, DOI 10.1161/01.CIR.98.13.1322
   Lidgren L, 2008, J BONE JOINT SURG BR, V90B, P7, DOI 10.1302/0301-620X.90B1.19823
   Lindner JR, 2000, CIRCULATION, V102, P2745, DOI 10.1161/01.CIR.102.22.2745
   Liu WE, 2011, BIOMATERIALS, V32, P1796, DOI 10.1016/j.biomaterials.2010.11.029
   Liu ZL, 2011, NUCL MED BIOL, V38, P795, DOI 10.1016/j.nucmedbio.2011.02.012
   LOIKE JD, 1991, P NATL ACAD SCI USA, V88, P1044, DOI 10.1073/pnas.88.3.1044
   Low PS, 2008, ACCOUNTS CHEM RES, V41, P120, DOI 10.1021/ar7000815
   Lu YJ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3304
   Mainnemare A, 2004, J DENT RES, V83, P823, DOI 10.1177/154405910408301101
   Marshall Milton V, 2010, Open Surg Oncol J, V2, P12
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   Martinez-Pomares L, 2003, J LEUKOCYTE BIOL, V73, P604, DOI 10.1189/jlb.0902450
   McCarthy JR, 2009, BIOCONJUGATE CHEM, V20, P1251, DOI 10.1021/bc9001163
   McNamara KP, 2001, ANAL CHEM, V73, P3240, DOI 10.1021/ac0102314
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Mou X, 2010, BIOMATERIALS, V31, P4530, DOI 10.1016/j.biomaterials.2010.02.016
   Nguyen KT, 2004, J BIOMED MATER RES A, V69A, P513, DOI 10.1002/jbm.a.30020
   Nguyen KT, 2004, BIOMATERIALS, V25, P5333, DOI 10.1016/j.biomaterials.2003.12.033
   Okusanya O. T., 2015, J THORAC CARDIOVASC, V150
   Overoye-Chan K, 2008, J AM CHEM SOC, V130, P6025, DOI 10.1021/ja800834y
   Panizzi P, 2009, J AM CHEM SOC, V131, P15739, DOI 10.1021/ja903922u
   Park MVDZ, 2011, BIOMATERIALS, V32, P9810, DOI 10.1016/j.biomaterials.2011.08.085
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P381, DOI 10.1002/jbm.a.30907
   Paulos CM, 2004, ADV DRUG DELIVER REV, V56, P1205, DOI 10.1016/j.addr.2004.01.012
   PEREZ RL, 1995, J IMMUNOL, V154, P1879
   Piemonti L, 2010, ADV EXP MED BIOL, V654, P725, DOI 10.1007/978-90-481-3271-3_32
   Puig-Kroger A, 2009, CANCER RES, V69, P9395, DOI 10.1158/0008-5472.CAN-09-2050
   Reeh PW, 1996, PROG BRAIN RES, V113, P143, DOI 10.1016/S0079-6123(08)61085-7
   Requena L, 2011, J AM ACAD DERMATOL, V64, P1, DOI 10.1016/j.jaad.2010.02.064
   Roda A, 2005, ANAL CHIM ACTA, V541, P25, DOI 10.1016/j.aca.2004.11.083
   Sabaliauskas NA, 2006, METHODS, V39, P246, DOI 10.1016/j.ymeth.2006.03.001
   Sailes FC, 2010, ANN PLAS SURG, V64, P696, DOI 10.1097/SAP.0b013e3181dc8409
   Santos E, 2010, ADV EXP MED BIOL, V670, P5
   Schreml S, 2012, EXP DERMATOL, V21, P951, DOI 10.1111/exd.12042
   Schreml S, 2011, P NATL ACAD SCI USA, V108, P2432, DOI 10.1073/pnas.1006945108
   Sevick-Muraca EM, 2008, RADIOLOGY, V246, P734, DOI 10.1148/radiol.2463070962
   Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887
   STEEN KH, 1995, J NEUROSCI, V15, P3982
   Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272
   Suri S, 2015, J BIOMED MATER RES A, V103, P76, DOI 10.1002/jbm.a.35162
   SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841
   Szaba FM, 2002, BLOOD, V99, P1053, DOI 10.1182/blood.V99.3.1053
   Tan MQ, 2004, J MATER CHEM, V14, P2896, DOI 10.1039/b407535h
   Tang EN, 2014, J BIOMED NANOTECHNOL, V10, P856, DOI 10.1166/jbn.2014.1852
   Tang LP, 2005, EXPERT REV MED DEVIC, V2, P493, DOI 10.1586/17434440.2.4.493
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1999, MOL MED, V5, P351, DOI 10.1007/BF03402124
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   THAKUR ML, 1979, CIRCULATION, V60, P297, DOI 10.1161/01.CIR.60.2.297
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   Tsai YT, 2014, ADV HEALTHC MATER, V3, P221, DOI 10.1002/adhm.201200365
   Tsai YT, 2014, BIOMATERIALS, V35, P2089, DOI 10.1016/j.biomaterials.2013.11.040
   Turk MJ, 2002, ARTHRITIS RHEUM, V46, P1947, DOI 10.1002/art.10405
   Turk MJ, 2004, CANCER LETT, V213, P165, DOI 10.1016/j.canlet.2003.12.028
   von Grote EC, 2011, MOL BIOSYST, V7, P150, DOI 10.1039/c0mb00059k
   Wang L, 2005, NANO LETT, V5, P37, DOI 10.1021/nl048417g
   Weng H, 2004, J BIOMAT SCI-POLYM E, V15, P1167, DOI 10.1163/1568562041753106
   Whiteman M, 2008, BIOCHEM BIOPH RES CO, V371, P50, DOI 10.1016/j.bbrc.2008.03.153
   Xiao L, 2010, BIOORG MED CHEM LETT, V20, P3515, DOI 10.1016/j.bmcl.2010.04.136
   Xu H, 2001, ANAL CHEM, V73, P4124, DOI 10.1021/ac0102718
   Yamamoto K, 1996, J CLIN INVEST, V97, P2440, DOI 10.1172/JCI118691
   Ye QS, 2010, BIOMATERIALS, V31, P9192, DOI 10.1016/j.biomaterials.2010.08.049
   Yu DG, 2012, INT J NANOMED, V7, P5725, DOI [10.2147/IJN.S37455, 10.2147/IJN.S29961]
   Zdolsek J, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-31
   Zhou J, 2008, BIOMACROMOLECULES, V9, P142, DOI 10.1021/bm700918d
   Zhou J, 2012, FREE RADICAL BIO MED, V52, P218, DOI 10.1016/j.freeradbiomed.2011.10.452
   Zhou J, 2011, BIOMATERIALS, V32, P9383, DOI 10.1016/j.biomaterials.2011.08.064
   Zhuang HM, 2002, SEMIN NUCL MED, V32, P47, DOI 10.1053/snuc.2002.29278
NR 116
TC 2
Z9 2
U1 4
U2 25
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAR
PY 2016
VL 44
IS 3
BP 693
EP 704
DI 10.1007/s10439-015-1470-9
PG 12
WC Engineering, Biomedical
SC Engineering
GA DI8HK
UT WOS:000373741900007
PM 26438448
DA 2018-10-19
ER

PT J
AU Stukel, JM
   Goss, M
   Zhou, HY
   Zhou, WD
   Willits, RK
   Exner, AA
AF Stukel, Jessica M.
   Goss, Monika
   Zhou, Haoyan
   Zhou, Wenda
   Willits, Rebecca Kuntz
   Exner, Agata A.
TI Development of a High-Throughput Ultrasound Technique for the Analysis
   of Tissue Engineering Constructs
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Ultrasound; Imaging; Tissue engineering; Scaffold; Hydrogel;
   Poly(ethylene glycol); Collagen
ID RAY COMPUTED-TOMOGRAPHY; LOCAL-DRUG RELEASE; IN-VITRO; SCAFFOLD
   DEGRADATION; STEM-CELLS; COLLAGEN; VIVO; GELS; PROLIFERATION; EVOLUTION
AB Development of hydrogel-based tissue engineering constructs is growing at a rapid rate, yet translation to patient use has been sluggish. Years of costly preclinical tests are required to predict clinical performance and safety of these devices. The tests are invasive, destructive to the samples and, in many cases, are not representative of the ultimate in vivo scenario. Biomedical imaging has the potential to facilitate biomaterial development by enabling longitudinal noninvasive device characterization directly in situ. Among the various available imaging modalities, ultrasound stands out as an excellent candidate due to low cost, wide availability, and a favorable safety profile. The overall goal of this work was to demonstrate the utility of clinical ultrasound in longitudinal characterization of 3D hydrogel matrices supporting cell growth. Specifically, we developed a quantitative technique using clinical B-mode ultrasound to differentiate collagen content and fibroblast density within poly(ethylene glycol) (PEG) hydrogels and validated it in an in vitro phantom environment. By manipulating the hydrogel gelation, differences in ultrasound signal intensity were found between gels with collagen fibers and those with non-fiber forming collagen, indicating that the technique was sensitive to the configuration of the protein. At a collagen density of 2.5 mg/mL collagen, fiber forming collagen had a significantly increased signal intensity of 14.90 +/- 2.58 x 10(-5) a. u. compared to non-fiber forming intensity at 2.74 +/- 0.36 x 10(-5) a. u. Additionally, differences in intensity were found between living and fixed fibroblasts, with an increased signal intensity detected in living cells (5.00 +/- 0.80 x 10(-5) a. u. in 1 day live cells compared to 2.26 +/- 0.39 x 10(-5) a. u. in fixed cells at a concentration of 1 x 10(6) cells/mL in gels containing collagen). Overall, there was a linear correlation > 0.90 for ultrasound intensity with increasing cell density. Results demonstrate the feasibility of using clinical ultrasound for characterization of PEG-based hydrogels in a tissue-mimicking phantom. The approach is clinically-relevant and could, with further validation, be utilized to nondestructively monitor in vivo performance of implanted tissue engineering scaffolds over time in preclinical and clinical settings.
C1 [Stukel, Jessica M.; Zhou, Wenda; Willits, Rebecca Kuntz] Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA.
   [Goss, Monika; Zhou, Haoyan; Exner, Agata A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Exner, Agata A.] Case Western Reserve Univ, Dept Radiol, Cleveland, OH 44106 USA.
RP Willits, RK (reprint author), Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA.
EM js217@zips.uakron.edu; monika.goss@case.edu; haoyan.zhou@case.edu;
   wz20@zips.uakron.edu; willits@uakron.edu; agata.exner@case.edu
OI Exner, Agata/0000-0003-3913-7066; Willits, Rebecca/0000-0002-1866-6789
FU National Institute of Biomedical Imaging and Bioengineering of the
   National Institutes of Health [R01EB016960]; Margaret F. Donovan
   Endowment for Women in Engineering
FX This study was supported by the National Institute of Biomedical Imaging
   and Bioengineering of the National Institutes of Health (R01EB016960 to
   AAE) and the Margaret F. Donovan Endowment for Women in Engineering
   (RKW). The content is solely the responsibility of the authors and does
   not necessarily represent the official views of the National Institutes
   of Health.
CR Aldrich JE, 2007, CRIT CARE MED, V35, pS131, DOI 10.1097/OCM.000020624.99430.22
   Artym Vira V, 2010, Curr Protoc Cell Biol, VChapter 10, DOI 10.1002/0471143030.cb1018s48
   BERLINER LJ, 1985, SCIENCE, V227, P517
   Bott K, 2010, BIOMATERIALS, V31, P8454, DOI 10.1016/j.biomaterials.2010.07.046
   Brightman AO, 2000, BIOPOLYMERS, V54, P222
   Bushberg J. T., 2002, ESSENTIAL PHYS MED I, P473
   Buxton AN, 2007, TISSUE ENG, V13, P2549, DOI 10.1089/ten.2007.0075
   CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062
   Chen Y, 2012, J NANOMATER, DOI 10.1155/2012/939821
   Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002
   Cunha C, 2011, INT J NANOMED, V6, P943, DOI 10.2147/IJN.S17292
   Czarnota G. J., 2010, IMAG MED, V2, P17
   Czarnota GJ, 1999, BRIT J CANCER, V81, P520, DOI 10.1038/sj.bjc.6690724
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   du Toit LC, 2014, PHARM RES-DORDR, V31, P607, DOI 10.1007/s11095-013-1184-3
   Gudur MSR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085749
   Guldberg RE, 2008, BIOMATERIALS, V29, P3757, DOI 10.1016/j.biomaterials.2008.06.018
   Han QQ, 2015, TISSUE ENG PT A, V21, P2156, DOI [10.1089/ten.tea.2014.0484, 10.1089/ten.TEA.2014.0484]
   Ho ST, 2006, BIOMATERIALS, V27, P1362, DOI 10.1016/j.biomaterials.2005.08.035
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Jensen T, 2015, BIOMATERIALS, V57, P133, DOI 10.1016/j.biomaterials.2015.04.004
   Kempe S, 2010, EUR J PHARM BIOPHARM, V74, P102, DOI 10.1016/j.ejpb.2009.06.008
   Kim HN, 2012, BIOMATERIALS, V33, P8782, DOI 10.1016/j.biomaterials.2012.08.038
   Kim K, 2008, ACTA BIOMATER, V4, P783, DOI 10.1016/j.actbio.2008.02.010
   Kim SH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01198
   Kreitz S, 2011, TISSUE ENG PART C-ME, V17, P1021, DOI [10.1089/ten.TEC.2010.0669, 10.1089/ten.tec.2010.0669]
   Lysaght MJ, 1998, TISSUE ENG, V4, P231, DOI 10.1089/ten.1998.4.231
   Ma D, 2013, NATURE, V495, P187, DOI 10.1038/nature11971
   Mercado KP, 2015, TISSUE ENG PART C-ME, V21, P671, DOI [10.1089/ten.TEC.2014.0527, 10.1089/ten.tec.2014.0527]
   Mercado KP, 2014, ANN BIOMED ENG, V42, P1292, DOI 10.1007/s10439-014-0994-8
   Perrin S, 2014, NATURE, V507, P423, DOI 10.1038/507423a
   Ribeiro VP, 2016, J BIOMED MATER RES B, V104, P496, DOI 10.1002/jbm.b.33400
   Rice MA, 2009, ACTA BIOMATER, V5, P152, DOI 10.1016/j.actbio.2008.07.036
   Salinas CN, 2008, J TISSUE ENG REGEN M, V2, P296, DOI 10.1002/term.95
   Sancho-Tello M, 2015, INT J ARTIF ORGANS, V38, P210, DOI 10.5301/ijao.5000404
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   SILVER FH, 1980, J BIOL CHEM, V255, P9427
   Skornia SL, 2007, J APPL BIOMATER BIOM, V5, P176
   Solorio L, 2010, J CONTROL RELEASE, V143, P183, DOI 10.1016/j.jconrel.2010.01.001
   Szymanski-Exner A, 2003, J PHARM SCI, V92, P289, DOI 10.1002/jps.10295
   Szymanski-Exner A, 2002, J CONTROL RELEASE, V83, P415, DOI 10.1016/S0168-3659(02)00216-X
   Uyanik I, 2013, LECT NOTES COMPUT SC, V7945, P466, DOI 10.1007/978-3-642-38899-6_55
   Willits RK, 2004, J BIOMAT SCI-POLYM E, V15, P1521, DOI 10.1163/1568562042459698
   You JO, 2015, BIOMATERIALS, V57, P22, DOI 10.1016/j.biomaterials.2015.04.011
   Zhou H., 2014, CURR DRUG TARGETS, V6, P672
NR 45
TC 1
Z9 1
U1 1
U2 20
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAR
PY 2016
VL 44
IS 3
BP 793
EP 802
DI 10.1007/s10439-015-1507-0
PG 10
WC Engineering, Biomedical
SC Engineering
GA DI8HK
UT WOS:000373741900014
PM 26577255
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Hodde, J
   Hiles, M
AF Hodde, Jason
   Hiles, Michael
TI Transforming surgery through biomaterial template technology
SO BRITISH JOURNAL OF HOSPITAL MEDICINE
LA English
DT Article
ID SMALL-INTESTINAL SUBMUCOSA; OF-THE-LITERATURE; EXTRACELLULAR-MATRIX;
   ANTIGEN REMOVAL; HOST RESPONSE; SCAFFOLD; GRAFTS; MODULATION; REPAIR;
   MODEL
AB Templates inserted into surgical wounds strongly influence the healing responses in humans. The science of these templates, in the form of extracellular matrix biomaterials, is rapidly evolving and improving as the natural interactions with the body become better understood.
C1 [Hodde, Jason] Cook Biotech Inc, Med Sci, W Lafayette, IN USA.
   [Hiles, Michael] Cook Biotech Inc, Res & Dev, 1425 Innovat Pl, W Lafayette, IN 47906 USA.
   [Hiles, Michael] Purdue Univ, Biomed Engn, W Lafayette, IN 47907 USA.
RP Hiles, M (reprint author), Cook Biotech Inc, Res & Dev, 1425 Innovat Pl, W Lafayette, IN 47906 USA.; Hiles, M (reprint author), Purdue Univ, Biomed Engn, W Lafayette, IN 47907 USA.
EM mhiles@CookBiotech.com
CR Alberts B, 2002, MOL BIOL CELL
   Bejjani GK, 2007, J NEUROSURG, V106, P1028, DOI 10.3171/jns.2007.106.6.1028
   Belcarz A, 2009, J BIOMED MATER RES B, V89B, P102, DOI 10.1002/jbm.b.31192
   Berlanga-Acosta J, 2013, BIOMED RES INT, DOI 10.1155/2013/256043
   Bissell M J, 1987, Prog Clin Biol Res, V249, P251
   Boehler RM, 2011, BIOTECHNIQUES, V51, P239, DOI 10.2144/000113754
   Brown BN, 2014, TRANSL RES, V163, P268, DOI 10.1016/j.trsl.2013.11.003
   Bryan N, 2012, CLIN BIOCHEM, V45, P672, DOI 10.1016/j.clinbiochem.2012.02.026
   Bryan N, 2015, J APPL BIOMATER FUNC, V13, P35, DOI 10.5301/jabfm.5000172
   Chan BP, 2008, EUR SPINE J, V4, P467
   Cheresh DA, 2008, ONCOGENE, V27, P6285, DOI 10.1038/onc.2008.304
   Chin LK, 2012, J BIOMED MATER RES A, V100A, P786, DOI 10.1002/jbm.a.34025
   Cintron JR, 2013, TECH COLOPROCTOL, V17, P187, DOI 10.1007/s10151-012-0897-3
   Cissell DD, 2014, J BIOMECH, V47, P1987, DOI 10.1016/j.jbiomech.2013.10.041
   Druecke D, 2004, WOUND REPAIR REGEN, V12, P518, DOI 10.1111/j.1067-1927.2004.012504.x
   Ebrecht M, 2004, PSYCHONEUROENDOCRINO, V29, P798, DOI 10.1016/S0306-4530(03)00144-6
   Engeland CG, 2009, BRAIN BEHAV IMMUN, V23, P629, DOI 10.1016/j.bbi.2008.12.001
   Gigliobianco G, 2015, BIOMED RES INT, DOI 10.1155/2015/968087
   Hiles M, 2005, INT SURG, V90, pS13
   Hiles M, 2006, INT UROGYNECOL J, V17, pS39, DOI 10.1007/s00192-006-0104-z
   Hiles M, 2009, SURG INNOV, V16, P26, DOI 10.1177/1553350609331397
   Hodde J, 2007, J MATER SCI-MATER M, V18, P545, DOI 10.1007/s10856-007-2301-9
   Holubec T, 2015, J CARDIAC SURG, V30, P145, DOI 10.1111/jocs.12494
   Jiang WW, 2016, J PEDIATR SURG, V51, P368, DOI 10.1016/j.jpedsurg.2015.08.005
   Jones C, 2011, ANN ROY COLL SURG, V93, P504, DOI 10.1308/147870811X13137608455136
   Jung MK, 2011, ALCOHOL CLIN EXP RES, V35, P392, DOI 10.1111/j.1530-0277.2010.01356.x
   Liang R, 2006, J ORTHOP RES, V24, P811, DOI 10.1002/jor.20080
   Mauney JR, 2015, ADV DRUG DELIVER REV, V82-83, P77, DOI 10.1016/j.addr.2014.10.016
   McDade JK, 2013, ACTA BIOMATER, V9, P7191, DOI 10.1016/j.actbio.2013.02.021
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   NALEBUFF EA, 1990, J HAND SURG-BRIT EUR, V15B, P395, DOI 10.1016/0266-7681(90)90078-I
   Nihsen Edith S, 2008, Adv Skin Wound Care, V21, P479, DOI 10.1097/01.ASW.0000323561.14144.19
   O'Donnell TF, 2006, J VASC SURG, V44, P1118, DOI 10.1016/j.jvs.2006.08.004
   Scully BB, 2016, J BIOMED MATER RES B, V104, P1713, DOI 10.1002/jbm.b.33484
   Seymour PE, 2008, ARCH FACIAL PLAST S, V10, P30, DOI 10.1001/archfacial.2007.17
   Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852
   Tam H, 2015, BIOMATERIALS, V66, P83, DOI 10.1016/j.biomaterials.2015.07.011
   Theocharis AD, 2016, ADV DRUG DELIVER REV, V97, P4, DOI 10.1016/j.addr.2015.11.001
   Trabuco EC, 2007, INT UROGYNECOL J, V18, P555, DOI 10.1007/s00192-006-0288-2
   Wang M, 2013, EMERGING TRENDS CELL, P485
   Wong ML, 2014, ACTA BIOMATER, V10, P1806, DOI 10.1016/j.actbio.2014.01.028
   Zhang J, 2011, BIOMATERIALS, V32, P7086, DOI 10.1016/j.biomaterials.2011.06.016
   Zhao HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111846
NR 43
TC 1
Z9 1
U1 0
U2 1
PU MA HEALTHCARE LTD
PI LONDON
PA ST JUDES CHURCH, DULWICH ROAD, LONDON SE24 0PB, ENGLAND
SN 1750-8460
EI 1759-7390
J9 BRIT J HOSP MED
JI Br. J. Hosp. Med.
PD MAR
PY 2016
VL 77
IS 3
BP 162
EP 166
DI 10.12968/hmed.2016.77.3.162
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA DI5QS
UT WOS:000373554300027
PM 26961446
DA 2018-10-19
ER

PT J
AU Deing, A
   Ebel, T
   Willumeit-Romer, R
   Luthringer, BJC
AF Deing, Axel
   Ebel, Thomas
   Willumeit-Roemer, Regine
   Luthringer, Berengere J. C.
TI Comparison of the Influence of Phospholipid-Coated Porous Ti-6Al-4V
   Material on the Osteosarcoma Cell Line Saos-2 and Primary Human Bone
   Derived Cells
SO METALS
LA English
DT Article
DE Ti-6Al-4V; biomaterial; phospholipid; implant; gene expression;
   immunocytochemistry; biomimetic coating; porous
ID HUMAN CORTICAL BONE; MECHANICAL-PROPERTIES; HUMAN OSTEOBLASTS; PCR DATA;
   IN-VIVO; TITANIUM; DIFFERENTIATION; SURFACE; ALLOYS; GROWTH
AB Biomaterial surface functionalization remains of great interest in the promotion of cell osteogenic induction. Previous studies highlighted the positive effects of porous Ti-6Al-4V and phospholipid coating on osteoblast differentiation and bone remodeling. Therefore, the first objective of this study was to evaluate the potential synergistic effects of material porosity and phospholipid coating. Primary human osteoblasts and Saos-2 cells were cultured on different Ti-6Al-4V specimens (mirror-like polished or porous specimens) and were coated or not with 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE) for three weeks or five weeks. Selected gene expressions (e.g., classical bone markers: alkaline phosphatase, osteocalcin, osteoprotegerin (OPG), receptor activator of nuclear factor kappa-beta ligand (RANKL) and runt-related transcription factor 2) were estimated in vitro. Furthermore, the expressions of osteocalcin and osteopontin were examined via fluorescent microscopy at five weeks (immunocytochemistry). Consequently, it was observed that phospholipid coating potentiates preferences for low and high porosities in Saos-2 and primary cells, respectively, at the gene and protein levels. Additionally, RANKL and OPG exhibited different gene expression patterns; primary cells showed dramatically increased RANKL expression, whereas OPG expression was decreased in the presence of POPE. A synergistic effect of increased porosity and phospholipid coating was observed in primary osteoblasts in bone remodeling. This study showed the advantage of primary cells over the standard bone cell model.
C1 [Deing, Axel; Ebel, Thomas; Willumeit-Roemer, Regine; Luthringer, Berengere J. C.] Helmholtz Zentrum Geesthacht, Inst Mat Res, Div Metall Biomat, D-21502 Geesthacht, Germany.
RP Luthringer, BJC (reprint author), Helmholtz Zentrum Geesthacht, Inst Mat Res, Div Metall Biomat, D-21502 Geesthacht, Germany.
EM meseus@gmx.de; thomas.ebel@hzg.de; regine.willumeit@hzg.de;
   berengere.luthringer@hzg.de
RI Willumeit, Regine/I-8029-2013; Luthringer, Berengere/G-9039-2017
OI Willumeit, Regine/0000-0002-6004-6946; Luthringer,
   Berengere/0000-0002-8248-6715
CR Alvarez K, 2009, MATERIALS, V2, P790, DOI 10.3390/ma2030790
   [Anonymous], 2014, ORTHOPEDIC DEVICES M
   Aubin J E, 2001, Rev Endocr Metab Disord, V2, P81, DOI 10.1023/A:1010011209064
   Bandyopadhyay A, 2010, ACTA BIOMATER, V6, P1640, DOI 10.1016/j.actbio.2009.11.011
   Burmester Anna, 2014, Biomatter, V4, pe967616, DOI 10.4161/21592527.2014.967616
   Camolezi FL, 2002, INT J BIOCHEM CELL B, V34, P1091, DOI 10.1016/S1357-2725(02)00029-8
   Crockett JC, 2011, J CELL SCI, V124, P991, DOI 10.1242/jcs.063032
   Da Silva Jorge H., 2008, THESIS U MINHO BRAGA
   Deing A., 2014, INT J BIOMATER, V2014
   EANES ED, 1992, BONE MINER, V17, P269, DOI 10.1016/0169-6009(92)90749-4
   Emoto K, 2005, J BIOL CHEM, V280, P37901, DOI 10.1074/jbc.M504282200
   Faria P.E., 2008, CLIN IMPLANT DENT R, V12, P72
   Franceschi RT, 2009, CELLS TISSUES ORGANS, V189, P144, DOI 10.1159/000151747
   Gallagher JA, 2003, METH MOLEC MED, V80, P3
   Gartland A, 2012, METHODS MOL BIOL, V806, P337, DOI 10.1007/978-1-61779-367-7_22
   Golub M, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-21
   Gross TS, 2005, J BONE MINER RES, V20, P250, DOI 10.1359/JBMR.041004
   Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19
   ISHIHARA K, 1992, BIOMATERIALS, V13, P145, DOI 10.1016/0142-9612(92)90062-S
   Kawana F, 2003, J ELECTRON MICROSC, V52, P515, DOI 10.1093/jmicro/52.6.515
   Kemper A., 2007, P 20 INT TECHN C ENH
   Kitazawa R, 2008, J CELL BIOCHEM, V105, P1289, DOI 10.1002/jcb.21929
   Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958
   Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8
   Krishna OD, 2005, BIOMATERIALS, V26, P7115, DOI 10.1016/j.biomaterials.2005.05.023
   Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896
   Lee T, 2002, BIOMECH MODEL MECHAN, V1, P165, DOI 10.1007/s10237-002-0015-y
   Letellier SR, 1998, BBA-GEN SUBJECTS, V1380, P31, DOI 10.1016/S0304-4165(97)00121-9
   Li JP, 2007, BIOMATERIALS, V28, P2810, DOI 10.1016/j.biomaterials.2007.02.020
   Lidington EA, 1999, TRANSPL IMMUNOL, V7, P239, DOI 10.1016/S0966-3274(99)80008-2
   Liu F, 2003, J CELL SCI, V116, P1787, DOI 10.1242/jcs.00376
   Lu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050378
   Luthringer BJC, 2014, J MATER SCI-MATER M, V25, P2561, DOI 10.1007/s10856-014-5263-8
   Marom R, 2005, J CELL PHYSIOL, V202, P41, DOI 10.1002/jcp.20109
   Maruyama Z, 2007, DEV DYNAM, V236, P1876, DOI 10.1002/dvdy.21187
   Matassi F, 2013, CLIN CASES MINER BON, V10, P111, DOI 10.11138/ccmbm/2013.10.2.111
   Millan JL, 2006, DYNAMICS BONE CARTIL, P153
   Niinomi M, 2010, EXPERT REV MED DEVIC, V7, P481, DOI [10.1586/erd.10.16, 10.1586/ERD.10.16]
   NIYIBIZI C, 1989, CONNECT TISSUE RES, V20, P247, DOI 10.3109/03008208909023894
   Okulov IV, 2013, MAT SCI ENG C-MATER, V33, P4795, DOI 10.1016/j.msec.2013.07.042
   Pautke C, 2004, ANTICANCER RES, V24, P3743
   Pei XB, 2012, J MATER SCI-MATER M, V23, P2717, DOI 10.1007/s10856-012-4724-1
   Ponader S., 2009, J BIOMED MATER RES A, V92, P56
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Santin M, 2006, J R SOC INTERFACE, V3, P277, DOI 10.1098/rsif.2005.0088
   Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6
   Schulz M.C., 2013, J MATER SCI-MATER M, V25, P247
   Spoerke ED, 2005, ACTA BIOMATER, V1, P523, DOI 10.1016/j.actbio.2005.04.005
   Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Surmenev RA, 2014, ACTA BIOMATER, V10, P557, DOI 10.1016/j.actbio.2013.10.036
   Tan XW, 2012, J BIOMED MATER RES B, V100B, P2090, DOI 10.1002/jbm.b.32774
   Thorfve A, 2014, ACTA BIOMATER, V10, P1451, DOI 10.1016/j.actbio.2013.12.012
   Turner CH, 2001, CALCIFIED TISSUE INT, V69, P373, DOI 10.1007/s00223-001-1006-1
   Van der Stok J, 2013, J ORTHOP RES, V31, P792, DOI 10.1002/jor.22293
   van Tuyl LHD, 2010, ANN RHEUM DIS, V69, P1623, DOI 10.1136/ard.2009.121764
   Wang XF, 2013, MOL MED REP, V7, P1169, DOI 10.3892/mmr.2013.1335
   Willumeit R, 2007, J MATER SCI-MATER M, V18, P367, DOI 10.1007/s10856-006-0702-9
   Willumeit R, 2007, EUR CELLS MATER, V13, P11, DOI 10.22203/eCM.v013a02
   Wooley PH, 2004, GENE THER, V11, P402, DOI 10.1038/sj.gt.3302202
   WUTHIER RE, 1975, BIOCHIM BIOPHYS ACTA, V409, P128, DOI 10.1016/0005-2760(75)90087-9
   YOON HS, 1976, J BIOMECH, V9, P459, DOI 10.1016/0021-9290(76)90089-0
   ZACHOWSKI A, 1993, BIOCHEM J, V294, P1
NR 63
TC 1
Z9 1
U1 0
U2 12
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 2075-4701
J9 METALS-BASEL
JI Metals
PD MAR
PY 2016
VL 6
IS 3
DI 10.3390/met6030066
PG 16
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA DI6NR
UT WOS:000373616800019
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Lee, SE
   Cha, SR
   Jang, NK
   Kim, SY
   Kim, EY
   Song, JE
   Park, CH
   Khang, G
AF Lee, Seon Eui
   Cha, Se Rom
   Jang, Na Keum
   Kim, Su Young
   Kim, Eun Young
   Song, Jeong Eun
   Park, Chan Hum
   Khang, Gilson
TI Effect of Degumming Time of Silk Films on Growth of Corneal Endothelial
   Cells for Tissue Engineered Endothelialized Neo-Corneas
SO POLYMER-KOREA
LA English
DT Article
DE silk; sericine; film; degumming time; corneal endothelial cells
ID INFLAMMATORY RESPONSES; FIBROIN MEMBRANE; IN-VIVO; BIOMATERIAL;
   KERATOPLASTY; SCAFFOLDS
AB Silk is a biodegradable natural polymer with low immunological rejection after transplantation. As well, silk can be manufactured in various forms and adjusted to the thickness of several micrometers depending on the manufacturing method. Silk shows high transparency in the form of film, high water and oxygen permeability. However, studies have cited some drawbacks of silk, such as inflammatory response due to presence of silk protein (sericin) and its another disadvantage of silk requires a long period of time to decomposition after transplantation. In this study, silk films with various degumming time (0, 20, 40 and 60 min) were fabricated in order to evaluate the effect of sericin in learns of biocompatibility, inflammatory responses, etc. The experiments such as the contact angle, cell viability and inflammatory factor expression using RT-PCR were performed. Corneal endothelial cells were seeded on silk films and examined to evaluate the degree of adhesion in films, cell's proliferation and specific mRNA expression. This study showed degumming time of silk film fabrication which is a factor for growth of corneal endothelial cells.
C1 [Lee, Seon Eui; Cha, Se Rom; Jang, Na Keum; Kim, Su Young; Kim, Eun Young; Song, Jeong Eun; Khang, Gilson] Chonbuk Natl Univ, Dept BIN Fus Tech, 567 Baekje Daero, Jeonju 54898, South Korea.
   [Lee, Seon Eui; Cha, Se Rom; Jang, Na Keum; Kim, Su Young; Kim, Eun Young; Song, Jeong Eun; Khang, Gilson] Chonbuk Natl Univ, Dept PolymerNanoSci Tech, 567 Baekje Daero, Jeonju 54898, South Korea.
   [Park, Chan Hum] Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, 1-1 Okcheon, Chunchon 24253, Gangwon, South Korea.
RP Khang, G (reprint author), Chonbuk Natl Univ, Dept BIN Fus Tech, 567 Baekje Daero, Jeonju 54898, South Korea.; Khang, G (reprint author), Chonbuk Natl Univ, Dept PolymerNanoSci Tech, 567 Baekje Daero, Jeonju 54898, South Korea.
EM gskang@jbnu.ac.kr
RI song, jeong eun/P-9106-2015
OI song, jeong eun/0000-0001-6879-7616
FU Brain Korea 21 PLUS Project, the Bio & Medical Technology Development
   Program of the National Research Foundation (NRF) - Korean government
   (MEST) [NRF-2012M3A9C6050204]
FX This research was supported by Brain Korea 21 PLUS Project, the Bio &
   Medical Technology Development Program of the National Research
   Foundation (NRF) funded by the Korean government (MEST)
   (NRF-2012M3A9C6050204).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   BARFORT P, 1974, EXP EYE RES, V19, P11, DOI 10.1016/0014-4835(74)90067-0
   Bhattacharjee M, 2013, BIOMATERIALS, V34, P8161, DOI 10.1016/j.biomaterials.2013.07.018
   Cho S. A., 2014, INT J TISSUE REG, V5, P46
   Ha YY, 2014, MACROMOL RES, V22, P1018, DOI 10.1007/s13233-014-2138-2
   Hatou S, 2009, CURR EYE RES, V34, P347, DOI 10.1080/02713680902829624
   Ho MP, 2012, APPL SURF SCI, V258, P3948, DOI 10.1016/j.apsusc.2011.12.068
   Hu E. P. X., 2013, MACROMOL BIOSCI, V13, P3
   Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4
   Kim E. Y., 2014, INT J TISSUE REG, V5, P3
   Kim EY, 2015, MACROMOL RES, V23, P189, DOI 10.1007/s13233-015-3027-z
   Kim HL, 2011, POLYM-KOREA, V35, P7
   Kim MK, 2014, POLYM-KOREA, V38, P98, DOI 10.7317/pk.2014.38.1.98
   Koizumi N, 2007, INVEST OPHTH VIS SCI, V48, P4519, DOI 10.1167/iovs.07-0567
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Lee J. H., 2013, INT J TISSUE REG, V4, P2
   Lee M, 2014, MACROMOL RES, V22, P746, DOI 10.1007/s13233-014-2096-8
   Lee S.E., 2014, INT J TISSUE REGEN, V5, P103
   Lee S. J., 2014, POLYM-KOREA, V38, P3
   Lee Y, 2012, TISSUE ENG PT A, V18, P1967, DOI [10.1089/ten.tea.2012.0001, 10.1089/ten.TEA.2012.0001]
   Madden PW, 2011, BIOMATERIALS, V32, P4076, DOI 10.1016/j.biomaterials.2010.12.034
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Oh H, 2011, MACROMOL RES, V19, P266, DOI 10.1007/s13233-011-0301-6
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Park S. W., 2015, INT J TISSUE REG, V6, P9
   Price FW, 2006, J CATARACT REFR SURG, V32, P411, DOI 10.1016/j.jcrs.2005.12.078
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   SLINGSBY JG, 1981, ARCH OPHTHALMOL-CHIC, V99, P1041
   Terry MA, 2003, OPHTHALMOLOGY, V110, P755, DOI 10.1016/S0161-6420(02)01939-5
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang TJ, 2012, COLLOID SURFACE B, V90, P236, DOI 10.1016/j.colsurfb.2011.10.043
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wu WC, 2007, CURR EYE RES, V32, P199, DOI 10.1080/02713680601174165
   Yoon H, 2014, MACROMOL RES, V22, P297, DOI 10.1007/s13233-014-2037-6
NR 37
TC 1
Z9 1
U1 2
U2 12
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 0379-153X
J9 POLYM-KOREA
JI Polym.-Korea
PD MAR
PY 2016
VL 40
IS 2
BP 181
EP 187
DI 10.7317/pk.2016.40.2.181
PG 7
WC Polymer Science
SC Polymer Science
GA DI5QT
UT WOS:000373554400004
DA 2018-10-19
ER

PT J
AU Kuppusamy, S
   Thavamani, P
   Megharaj, M
   Venkateswarlu, K
   Lee, YB
   Naidu, R
AF Kuppusamy, Saranya
   Thavamani, Palanisami
   Megharaj, Mallavarapu
   Venkateswarlu, Kadiyala
   Lee, Yong Bok
   Naidu, Ravi
TI Potential of Melaleuca diosmifolia leaf as a low-cost adsorbent for
   hexavalent chromium removal from contaminated water bodies
SO PROCESS SAFETY AND ENVIRONMENTAL PROTECTION
LA English
DT Article
DE Melaleuca diosmifolia; Forest biomass; Biosorption; Chromium(VI)
   reduction; Kinetic model; Wastewater treatment
ID ADSORPTION-COUPLED REDUCTION; AQUEOUS-SOLUTIONS; WASTE-WATER; CR(VI)
   REMOVAL; BIOMASS; BIOSORPTION; INDUSTRIAL; EVIDENCES; PEEL
AB The present study describes for the first time the utilization of dried twigs of Melaleuca diosmifolia, fallen off from the plant, to detoxify and remove hexavalent chromium or Cr(VI) from aqueous systems. Initial characterization by gas chromatography revealed that the selected biomaterial is one of the natural sources of eucalyptol. It constituted high concentrations of reducing compounds (iron, phenols and flavonoids). Batch studies revealed that the biosorbent (5 g L-1) was able to remove 97-99.9% of 250 mg L-1 Cr(VI) at wide-ranging pH (2-10) and temperature (24-48 degrees C). Adsorption kinetics was well described using the pseudo second -order kinetic model, while the equilibrium adsorption data were interpreted in terms of the Langmuir isotherm model. The monolayer adsorption capacity was 62.5 mg g(-1). Both inductively coupled plasma optical emission spectrometry and liquid chromatography analyses of the aqueous and solid phases revealed that the mechanism of Cr(VI) removal was `adsorption-coupled reduction'. Scanning electron microscope, infrared spectroscopy and X-ray diffraction analyses of the biosorbent before and after adsorption also confirmed that both adsorption and reduction of Cr(VI) to Cr(III) followed by complexation onto functional groups of the active surface contributed to the removal of Cr(VI) from aqueous solution. The selected biomaterial effectively (99.9%) removed Cr(VI) in lake and sea water samples, highlighting its potential for remediating Cr(VI) in real environmental conditions. (C) 2016 The Institution of Chemical Engineers. Published by Elsevier B.V. All rights reserved.
C1 [Kuppusamy, Saranya; Lee, Yong Bok] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju 660701, South Korea.
   [Kuppusamy, Saranya; Megharaj, Mallavarapu; Naidu, Ravi] Univ S Australia, CERAR, Mawson Lakes, SA 5095, Australia.
   [Kuppusamy, Saranya; Thavamani, Palanisami; Megharaj, Mallavarapu; Naidu, Ravi] CRC CARE, POB 486, Salisbury South, SA 5106, Australia.
   [Thavamani, Palanisami; Megharaj, Mallavarapu; Naidu, Ravi] Univ Newcastle, Fac Sci & Informat Technol, GCER, Callaghan, NSW 2308, Australia.
   [Venkateswarlu, Kadiyala] Sri Krishnadevaraya Univ, Dept Microbiol, Anantapur 515055, Andhra Pradesh, India.
RP Kuppusamy, S (reprint author), Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju 660701, South Korea.
EM saran.miles2go@gmail.com
RI Mallavarapu, Megharaj/D-3408-2011; Kuppusamy, Saranya/L-3912-2017
OI Mallavarapu, Megharaj/0000-0002-6230-518X; Kuppusamy,
   Saranya/0000-0002-6271-7475; Lee, Yong Bok/0000-0002-7651-4556
FU Australian Government; University of South Australia (UniSA);
   Cooperative Research Centre for Contamination Assessment and Remediation
   of the Environment (CRC CARE); CRC CARE
FX SK thanks the Australian Government, University of South Australia
   (UniSA) and Cooperative Research Centre for Contamination Assessment and
   Remediation of the Environment (CRC CARE) for the International
   Postgraduate Research Scholarship (IPRS), and CRC CARE for top-up
   fellowship during PhD.
CR Acharya J, 2009, CHEM ENG J, V150, P25, DOI 10.1016/j.cej.2008.11.035
   Atar N, 2012, CHEM ENG J, V192, P1, DOI 10.1016/j.cej.2012.03.067
   Augustin S., 2000, J NUTR, V130, P2073
   Babu BV, 2008, ADSORPTION, V14, P85, DOI 10.1007/s10450-007-9057-x
   BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0
   Colak F, 2013, J IND ENG CHEM, V19, P863, DOI 10.1016/j.jiec.2012.11.001
   Deng SB, 2005, ENVIRON SCI TECHNOL, V39, P8490, DOI 10.1021/es050697u
   El Nemr A, 2009, J HAZARD MATER, V161, P132, DOI 10.1016/j.jhazmat.2008.03.093
   Gao H, 2008, J HAZARD MATER, V150, P446, DOI 10.1016/j.jhazmat.2007.04.126
   Garg UK, 2009, DESALINATION, V249, P475, DOI 10.1016/j.desal.2008.10.025
   Ho YS, 1998, PROCESS SAF ENVIRON, V76, P332, DOI 10.1205/095758298529696
   Hu ZH, 2003, SEP PURIF TECHNOL, V31, P13, DOI 10.1016/S1383-5866(02)00149-1
   Jain M, 2009, J HAZARD MATER, V162, P365, DOI 10.1016/j.jhazmat.2008.05.048
   Khomdram S. D., 2011, Notulae Scientia Biologicae, V3, P108
   Kuppusamy S, 2015, ENVIRON TECHNOL INNO, V4, P17, DOI 10.1016/j.eti.2015.04.001
   Kuppusamy S, 2016, REV ENVIRON CONTAM T, V236, P117, DOI 10.1007/978-3-319-20013-2_2
   Kuppusamy S, 2016, REV ENVIRON CONTAM T, V236, P1, DOI 10.1007/978-3-319-20013-2_1
   Lopez-Garcia M, 2013, BIORESOURCE TECHNOL, V139, P181, DOI 10.1016/j.biortech.2013.04.044
   Luo P, 2011, IND ENG CHEM RES, V50, P10246, DOI 10.1021/ie200951n
   Malkoc E, 2006, J HAZARD MATER, V137, P899, DOI 10.1016/j.jhazmat.2006.03.004
   Mallampati R, 2012, RSC ADV, V2, P9914, DOI 10.1039/c2ra21108d
   MASON B, 1949, J GEOL, V57, P62, DOI 10.1086/625575
   Memon JR, 2009, COLLOID SURFACE B, V70, P232, DOI 10.1016/j.colsurfb.2008.12.032
   Mohanty K, 2006, CHEM ENG J, V117, P71, DOI 10.1016/j.cej.2005.11.018
   Moulton MC, 2010, NANOSCALE, V2, P763, DOI 10.1039/c0nr00046a
   Moure A, 2001, FOOD CHEM, V72, P145, DOI 10.1016/S0308-8146(00)00223-5
   Nadagouda MN, 2010, GREEN CHEM, V12, P114, DOI 10.1039/b921203p
   Ncibi MC, 2007, J HAZARD MATER, V139, P280, DOI 10.1016/j.jhazmat.2006.06.029
   OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307
   Park D, 2007, CHEMOSPHERE, V70, P298, DOI 10.1016/j.chemosphere.2007.06.007
   Rao RAK, 2010, J HAZARD MATER, V181, P405, DOI 10.1016/j.jhazmat.2010.05.025
   Saha B, 2010, COORDIN CHEM REV, V254, P2959, DOI 10.1016/j.ccr.2010.06.005
   Saha R, 2011, J COORD CHEM, V64, P1782, DOI 10.1080/00958972.2011.583646
   Sarkar B, 2010, J HAZARD MATER, V183, P87, DOI 10.1016/j.jhazmat.2010.06.110
   SHARMA DC, 1994, BIORESOURCE TECHNOL, V47, P257, DOI 10.1016/0960-8524(94)90189-9
   SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144
   Sreenivas KM, 2014, J ENVIRON CHEM ENG, V2, P455, DOI 10.1016/j.jece.2014.01.017
   Suksabye P, 2007, J HAZARD MATER, V141, P637, DOI 10.1016/j.jhazmat.2006.07.018
   Wang JL, 2009, BIOTECHNOL ADV, V27, P195, DOI 10.1016/j.biotechadv.2008.11.002
   Weng CH, 2008, J HAZARD MATER, V155, P65, DOI 10.1016/j.jhazmat.2007.11.029
   Xie AJ, 2014, NEW J CHEM, V38, P777, DOI 10.1039/c3nj01013a
   Yani S, 2014, FUEL, V133, P341, DOI 10.1016/j.fuel.2014.05.030
   Zhang YZ, 2011, MACROMOLECULES, V44, P683, DOI 10.1021/ma102492c
NR 43
TC 23
Z9 23
U1 4
U2 19
PU INST CHEMICAL ENGINEERS
PI RUGBY
PA 165-189 RAILWAY TERRACE, DAVIS BLDG, RUGBY CV21 3HQ, ENGLAND
SN 0957-5820
EI 1744-3598
J9 PROCESS SAF ENVIRON
JI Process Saf. Environ. Protect.
PD MAR
PY 2016
VL 100
BP 173
EP 182
DI 10.1016/j.psep.2016.01.009
PG 10
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA DI5KV
UT WOS:000373538700016
DA 2018-10-19
ER

PT J
AU Lee, S
   Yun, S
   Park, KI
   Jang, JH
AF Lee, Slgirim
   Yun, Seokhwan
   Park, Kook In
   Jang, Jae-Hyung
TI Sliding Fibers: Slidable, Injectable, and Gel-like Electrospun
   Nanofibers as Versatile Cell Carriers
SO ACS NANO
LA English
DT Article
DE electrospun nanofibers; injectable nanofibers; minimally invasive cell
   delivery; ECM-like nanofibers; human neural stem cells; stroke
ID CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; EXTRACELLULAR-MATRIX;
   CONTROLLED-RELEASE; SCAFFOLDS; DELIVERY; MODEL;
   POLY(EPSILON-CAPROLACTONE); NEUROPROTECTION; NANOPARTICLES
AB Designing biomaterial systems that can mimic fibrous, natural extracellular matrix is crucial for enhancing the efficacy of various therapeutic tools. Herein, a smart technology of three-dimensional electrospun fibers that can be injected in a minimally invasive manner was developed. Open surgery is currently the only route of administration of conventional electrospun fibers into the body. Coordinating electrospun fibers with a lubricating hydrogel produced fibrous constructs referred to as slidable, injectable, and gel-like (SLIDING) fibers. These SLIDING fibers could pass smoothly through a catheter and fill any cavity while maintaining their fibrous morphology. Their injectable features were derived from their distinctive theological characteristics, which were presumably caused by the combinatorial effects of mobile electrospun fibers and lubricating hydrogels. The resulting injectable fibers fostered a highly favorable environment for human neural stem cell (hNSC) proliferation and neurosphere formation within the fibrous structures without compromising hNSC viability. SLIDING fibers demonstrated superior performance as cell carriers in animal stroke models subjected to the middle cerebral artery occlusion (MCAO) stroke model. In this model, SLIDING fiber application extended the survival rate of administered hNSCs by blocking microglial infiltration at the early, acute inflammatory stage. The development of SLIDING fibers will increase the clinical significance of fiber-based scaffolds in many biomedical fields and will broaden their applicability.
C1 [Lee, Slgirim; Jang, Jae-Hyung] Yonsei Univ, Dept Chem & Biomol Engn, 50 Yonsei Ro, Seoul 03722, South Korea.
   [Yun, Seokhwan; Park, Kook In] Yonsei Univ, Coll Med, Dept Pediat, 50 Yonsei Ro, Seoul 03722, South Korea.
RP Jang, JH (reprint author), Yonsei Univ, Dept Chem & Biomol Engn, 50 Yonsei Ro, Seoul 03722, South Korea.; Park, KI (reprint author), Yonsei Univ, Coll Med, Dept Pediat, 50 Yonsei Ro, Seoul 03722, South Korea.
EM kipark@yuhs.ac; j-jang@yonsei.ac.kr
FU National Research Foundation of Korea (NRF) - Korea government (MSIP)
   [NRF-2015R1A2A2A03003553, NRF-2007-0056558]; Korea Health Technology R&D
   Project through the Korea Health Industry Development Institute (KHIDI);
   Ministry of Health & Welfare, Republic of Korea [HI14C1564]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (MSIP) (No.
   NRF-2015R1A2A2A03003553, and NRF-2007-0056558). This research was
   additionally supported by a grant of the Korea Health Technology R&D
   Project through the Korea Health Industry Development Institute (KHIDI),
   funded by the Ministry of Health & Welfare, Republic of Korea (Grant
   Number: HI14C1564).
CR Blakeney BA, 2011, BIOMATERIALS, V32, P1583, DOI 10.1016/j.biomaterials.2010.10.056
   Bonino CA, 2012, SMALL, V8, P1928, DOI 10.1002/smll.201101791
   Chen ML, 2012, ACS NANO, V6, P4835, DOI 10.1021/nn300106t
   Chew SY, 2007, ADV FUNCT MATER, V17, P1288, DOI 10.1002/adfm.200600441
   Chin SJ, 2015, POLYMER, V58, P209, DOI 10.1016/j.polymer.2014.12.034
   Cirillo V, 2014, BIOMATERIALS, V35, P8970, DOI 10.1016/j.biomaterials.2014.07.010
   De Feo D, 2012, CURR OPIN NEUROL, V25, P322, DOI 10.1097/WCO.0b013e328352ec45
   Fedoseyeva EV, 2002, J IMMUNOL, V169, P1168, DOI 10.4049/jimmunol.169.3.1168
   Fon D, 2014, BIOMATERIALS, V35, P2692, DOI 10.1016/j.biomaterials.2013.12.016
   Gallego R, 2014, POLYMERS-BASEL, V6, P1929, DOI 10.3390/polym6071929
   Gullberg D, 1995, INT J DEV BIOL, V39, P845
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Gupta P, 2003, POLYMER, V44, P6353, DOI 10.1016/S0032-3861(03)00616-5
   Jiao YP, 2006, J APPL POLYM SCI, V101, P1515, DOI 10.1002/app.22291
   Jin G, 2015, ANGEW CHEM INT EDIT, V54, P7587, DOI 10.1002/anie.201502177
   Jin G, 2014, BIOMED MICRODEVICES, V16, P793, DOI 10.1007/s10544-014-9883-z
   Kim H, 2014, MAT SCI ENG C-MATER, V40, P324, DOI 10.1016/j.msec.2014.04.012
   Kim YT, 2006, EXP NEUROL, V199, P222, DOI 10.1016/j.expneurol.2006.03.015
   Kobsa S, 2013, BIOMATERIALS, V34, P3891, DOI 10.1016/j.biomaterials.2013.02.016
   Latchney Sarah E, 2012, Eur J Neurodegener Dis, V1, P335
   Lee S, 2013, NAT PROTOC, V8, P771, DOI 10.1038/nprot.2013.039
   Lee S, 2014, ACS APPL MATER INTER, V6, P1082, DOI 10.1021/am404627r
   Lee S, 2011, ACTA BIOMATER, V7, P3868, DOI 10.1016/j.actbio.2011.06.035
   Li XR, 2015, ADV HEALTHC MATER, V4, P1869, DOI 10.1002/adhm.201500271
   LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84
   Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908
   Nakaya-Yaegashi K, 2008, J RHEOL, V52, P359, DOI 10.1122/1.2828645
   Nisbet DR, 2009, BIOMATERIALS, V30, P4573, DOI 10.1016/j.biomaterials.2009.05.011
   Pham QP, 2006, BIOMACROMOLECULES, V7, P2796, DOI 10.1021/bm060680j
   Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889
   Rammensee S, 2006, APPL PHYS A-MATER, V82, P261, DOI 10.1007/s00339-005-3431-x
   Ravichandran R, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/38/385102
   Schneider BL, 2003, MOL THER, V7, P506, DOI 10.1016/S1525-0016(03)00055-8
   Shah U, 2010, ACTA BIOMATER, V6, P3029, DOI 10.1016/j.actbio.2010.02.041
   Sollich P, 1998, PHYS REV E, V58, P738, DOI 10.1103/PhysRevE.58.738
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Subramanian G, 2015, MAT SCI ENG C-MATER, V51, P16, DOI 10.1016/j.msec.2015.02.030
   Taipale J, 1997, FASEB J, V11, P51
   Vag J, 2007, J CELL PHYSIOL, V212, P416, DOI 10.1002/jcp.21035
   Vaquette C, 2011, ACTA BIOMATER, V7, P2544, DOI 10.1016/j.actbio.2011.02.036
   Wallner EI, 1998, AM J PHYSIOL-RENAL, V275, pF467, DOI 10.1152/ajprenal.1998.275.4.F467
   Wang TY, 2012, BIOMATERIALS, V33, P9188, DOI 10.1016/j.biomaterials.2012.09.013
   Weightman AP, 2014, BIOMATERIALS, V35, P3756, DOI 10.1016/j.biomaterials.2014.01.022
   Won YY, 1999, SCIENCE, V283, P960, DOI 10.1126/science.283.5404.960
   Yang WX, 2013, ACTA BIOMATER, V9, P4505, DOI 10.1016/j.actbio.2012.10.003
   Zhang H, 2013, BIOMATERIALS, V34, P2202, DOI 10.1016/j.biomaterials.2012.12.005
   Zhang Z, 2014, SOFT MATTER, V10, P5965, DOI 10.1039/c4sm00716f
   Zong XH, 2003, POLYMER, V44, P4959, DOI 10.1016/S0032-3861(03)00464-6
   Zoppe JO, 2009, ACS APPL MATER INTER, V1, P1996, DOI 10.1021/am9003705
NR 49
TC 9
Z9 9
U1 10
U2 70
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD MAR
PY 2016
VL 10
IS 3
BP 3282
EP 3294
DI 10.1021/acsnano.5b06605
PG 13
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA DH5TR
UT WOS:000372855400029
PM 26885937
DA 2018-10-19
ER

PT J
AU Di Luca, A
   Longoni, A
   Criscenti, G
   Lorenzo-Moldero, I
   Klein-Gunnewiek, M
   Vancso, J
   van Blitterswijk, C
   Mota, C
   Moroni, L
AF Di Luca, Andrea
   Longoni, Alessia
   Criscenti, Giuseppe
   Lorenzo-Moldero, Ivan
   Klein-Gunnewiek, Michel
   Vancso, Julius
   van Blitterswijk, Clemens
   Mota, Carlos
   Moroni, Lorenzo
TI Surface energy and stiffness discrete gradients in additive manufactured
   scaffolds for osteochondral regeneration
SO BIOFABRICATION
LA English
DT Article
DE additive manufacturing; gradients; 3D scaffolds; stem cells;
   biomaterials
ID MESENCHYMAL STEM-CELLS; ARTICULAR-CARTILAGE REPAIR; BONE-MARROW;
   IN-VITRO; SUBCHONDRAL BONE; GENE-EXPRESSION; DIFFERENTIATION; MATRIX;
   FATE; MECHANISMS
AB Swift progress in biofabrication technologies has enabled unprecedented advances in the application of developmental biology design criteria in three-dimensional scaffolds for regenerative medicine. Considering that tissues and organs in the human body develop following specific physico-chemical gradients, in this study, we hypothesized that additive manufacturing (AM) technologies would significantly aid in the construction of 3D scaffolds encompassing such gradients. Specifically, we considered surface energy and stiffness gradients and analyzed their effect on adult bone marrow derived mesenchymal stem cell differentiation into skeletal lineages. Discrete step-wise macroscopic gradients were obtained by sequentially depositing different biodegradable biomaterials in the AM process, namely poly(lactic acid) (PLA), polycaprolactone (PCL), and poly(ethylene oxide terephthalate)/poly(butylene terephthalate) (PEOT/PBT) copolymers. At the bulk level, PEOT/PBT homogeneous scaffolds supported a higher alkaline phosphatase (ALP) activity compared to PCL, PLA, and gradient scaffolds, respectively. All homogeneous biomaterial scaffolds supported also a significantly higher amount of glycosaminoglycans (GAGs) production compared to discrete gradient scaffolds. Interestingly, the analysis of the different material compartments revealed a specific contribution of PCL, PLA, and PEOT/PBT to surface energy gradients. Whereas PEOT/PBT regions were associated to significantly higher ALP activity, PLA regions correlated with significantly higher GAG production. These results show that cell activity could be influenced by the specific spatial distribution of different biomaterial chemistries in a 3D scaffold and that engineering surface energy discrete gradients could be considered as an appealing criterion to design scaffolds for osteochondral regeneration.
C1 [Di Luca, Andrea; Longoni, Alessia; Criscenti, Giuseppe; van Blitterswijk, Clemens; Moroni, Lorenzo] Univ Twente, Tissue Regenerat Dept, Drienerlolaan 5, NL-7522 NB Enschede, Netherlands.
   [Criscenti, Giuseppe] Univ Pisa, Fac Engn, Res Ctr E Piaggio, Pisa, Italy.
   [Klein-Gunnewiek, Michel; Vancso, Julius] Univ Twente, Mat Sci & Technol Polymers Grp, Drienerlolaan 5, NL-7522 NB Enschede, Netherlands.
   [Lorenzo-Moldero, Ivan; van Blitterswijk, Clemens; Mota, Carlos; Moroni, Lorenzo] Maastricht Univ, MERLN Inst Technol Inspired Regenerat Med, Complex Tissue Regenerat Grp, Univ Singel 40, NL-6229 ER Maastricht, Netherlands.
RP Moroni, L (reprint author), Univ Twente, Tissue Regenerat Dept, Drienerlolaan 5, NL-7522 NB Enschede, Netherlands.; Moroni, L (reprint author), Maastricht Univ, MERLN Inst Technol Inspired Regenerat Med, Complex Tissue Regenerat Grp, Univ Singel 40, NL-6229 ER Maastricht, Netherlands.
EM l.moroni@maastrichtuniversity.nl
OI Moroni, Lorenzo/0000-0003-1298-6025; Mota, Carlos/0000-0001-5935-6245
FU Dutch Technology Foundation STW [11135]; Dutch Province of Limburg; NCRR
   of the NIH [P40RR017447]
FX This project was funded by the Dutch Technology Foundation STW (Grant
   number 11135). This project/research has been also made possible with
   the support of the Dutch Province of Limburg. Some of the materials used
   in this work were provided by the Texas A&M Health Science Center
   College of Medicine Institute for Regenerative Medicine at Scott & White
   through a grant from NCRR of the NIH (Grant #P40RR017447).
CR Abdallah BM, 2008, GENE THER, V15, P109, DOI 10.1038/sj.gt.3303067
   Athanasiou KA, 2000, TISSUE ENG, V6, P361, DOI 10.1089/107632700418083
   Bara JJ, 2014, STEM CELLS, V32, P1713, DOI 10.1002/stem.1649
   Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   Bartha Lajos, 2013, Eur J Orthop Surg Traumatol, V23, P81, DOI 10.1007/s00590-011-0907-6
   BRYNDA E, 1990, J COLLOID INTERF SCI, V139, P374, DOI 10.1016/0021-9797(90)90111-Z
   Buckwalter JA, 1994, J AM ACAD ORTHOP SUR, V2, P192
   Chatterjee K, 2010, BIOMATERIALS, V31, P5051, DOI 10.1016/j.biomaterials.2010.03.024
   Chen JN, 2011, BIOMATERIALS, V32, P4793, DOI 10.1016/j.biomaterials.2011.03.041
   Claase MB, 2003, BIOMACROMOLECULES, V4, P57, DOI 10.1021/bm0256045
   de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3
   Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3
   DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306
   Ding CM, 2013, BIOMATERIALS, V34, P6706, DOI 10.1016/j.biomaterials.2013.05.038
   Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137
   Emans PJ, 2013, J TISSUE ENG REGEN M, V7, P751, DOI 10.1002/term.1477
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Even-Ram S, 2006, CELL, V126, P645, DOI 10.1016/j.cell.2006.08.008
   Eyre D, 2002, ARTHRITIS RES, P4
   Ferguson VL, 2003, J ANAT, V203, P191, DOI 10.1046/j.1469-7580.2003.00193.x
   Ge ZG, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/021001
   Ghazavi MT, 1997, J BONE JOINT SURG BR, V79B, P1008, DOI 10.1302/0301-620X.79B6.7534
   Grogan SP, 2013, ARTHRITIS RHEUM-US, V65, P418, DOI 10.1002/art.37760
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Hendrikson WJ, 2015, RSC ADV, V5, P54510, DOI 10.1039/c5ra08048g
   Heymer A, 2009, J TISSUE ENG REGEN M, V3, P389, DOI 10.1002/term.175
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Johnson K, 2012, SCIENCE, V336, P717, DOI 10.1126/science.1215157
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Knychala J, 2013, ANN BIOMED ENG, V41, P917, DOI 10.1007/s10439-013-0748-z
   Langenbach F, 2013, STEM CELL RES THER, V4, DOI 10.1186/1757-6512-4-117
   Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200
   Levingstone TJ, 2014, ACTA BIOMATER, V10, P1996, DOI 10.1016/j.actbio.2014.01.005
   Liu XD, 2014, J BIOMED MATER RES B, V102, P1407, DOI 10.1002/jbm.b.33119
   Lu HX, 2012, BIOMATERIALS, V33, P6140, DOI 10.1016/j.biomaterials.2012.05.038
   MacQueen L, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0179
   Malladi P, 2006, AM J PHYSIOL-CELL PH, V290, pC1139, DOI 10.1152/ajpcell.00415.2005
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   MOW VC, 1991, J BIOMECH ENG-T ASME, V113, P198, DOI 10.1115/1.2891235
   Muller Sandra, 2010, Open Orthop J, V4, P111, DOI 10.2174/1874325001004020111
   Nishimura R, 2012, J BIOCHEM, V151, P247, DOI 10.1093/jb/mvs004
   Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019
   Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068
   Re'em T, 2012, ACTA BIOMATER, V8, P3283, DOI 10.1016/j.actbio.2012.05.014
   Reichert JC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003720
   Richardson J B, 2008, BR MED B, P77
   Salerno A, 2012, MATER LETT, V82, P137, DOI 10.1016/j.matlet.2012.05.072
   Slivka MA, 2001, TISSUE ENG, V7, P767, DOI 10.1089/107632701753337717
   TAMADA Y, 1993, J COLLOID INTERF SCI, V155, P334, DOI 10.1006/jcis.1993.1044
   Wei JH, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045002
   Woodfield Cavb T B F, 2005, TISSUE ENG, V11, P1297
   Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/NMAT3889, 10.1038/nmat3889]
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   ZANETTI NC, 1984, J CELL BIOL, V99, P115, DOI 10.1083/jcb.99.1.115
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
   Zemel A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194110
NR 58
TC 5
Z9 7
U1 5
U2 61
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1758-5082
EI 1758-5090
J9 BIOFABRICATION
JI Biofabrication
PD MAR
PY 2016
VL 8
IS 1
AR 015014
DI 10.1088/1758-5090/8/1/015014
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DI1WZ
UT WOS:000373289000018
PM 26924824
DA 2018-10-19
ER

PT J
AU Kusamori, K
   Katsumi, H
   Sakai, R
   Hayashi, R
   Hirai, Y
   Tanaka, Y
   Hitomi, K
   Quan, Y
   Kamiyama, F
   Yamada, K
   Sumida, S
   Kishi, K
   Hashiba, K
   Sakane, T
   Yamamoto, A
AF Kusamori, Kosuke
   Katsumi, Hidemasa
   Sakai, Ryota
   Hayashi, Rie
   Hirai, Yuka
   Tanaka, Yutaro
   Hitomi, Kaori
   Quan, Ying-shu
   Kamiyama, Fumio
   Yamada, Keigo
   Sumida, Shun-ichiro
   Kishi, Kazumasa
   Hashiba, Katsunori
   Sakane, Toshiyasu
   Yamamoto, Akira
TI Development of a drug-coated microneedle array and its application for
   transdermal delivery of interferon alpha
SO BIOFABRICATION
LA English
DT Article
DE antitumor effect; interferon alpha; microneedle arrays; transdermal drug
   delivery
ID HEPATITIS-C; CELL-PROLIFERATION; HYALURONIC-ACID; IN-VIVO; THERAPY;
   RESPONSES; SKIN; PHARMACOKINETICS; CARCINOMA; INNATE
AB Interferon alpha (IFN alpha) is one of the most famous drugs for the treatment of chronic hepatitis C and various types of human malignancy. Protein drugs, including IFN alpha, are generally administered by subcutaneous or intramuscular injection due to their poor permeability and low stability in the bloodstream or gastrointestinal tract. Therefore, in the present study, novel IFN alpha-coated polyvinyl alcohol-based microneedle arrays (IFN alpha-MNs) were fabricated for the transdermal delivery of IFN alpha without the painful injection. IFN alpha was rapidly released from MNs in phosphate buffered solution and these MNs presented piercing ability in the rat skin. Slight erythema and irritation were observed when MNs were applied to the rat skin, but these skin damages completely disappeared within 24 h after removing the IFN alpha-MNs. Furthermore, the pharmacokinetic parameters of IFN alpha-MNs were similar to those of IFN alpha subcutaneous administration. Finally, IFN alpha-MNs showed a significant antitumor effect in tumor bearing mice similar to that of IFN alpha subcutaneous administration. These results indicate that IFN alpha-MNs are a useful biomaterial tool for protein drug therapy and can improve the quality of life in patients by avoidance of painful injections.
C1 [Kusamori, Kosuke; Katsumi, Hidemasa; Sakai, Ryota; Hayashi, Rie; Hirai, Yuka; Tanaka, Yutaro; Hitomi, Kaori; Quan, Ying-shu; Sakane, Toshiyasu; Yamamoto, Akira] Kyoto Pharmaceut Univ, Dept Biopharmaceut, Yamashina Ku, Kyoto 6078414, Japan.
   [Quan, Ying-shu; Kamiyama, Fumio] CosMED Pharmaceut Co Ltd, Minami Ku, Kyoto 6018014, Japan.
   [Yamada, Keigo; Sumida, Shun-ichiro; Kishi, Kazumasa; Hashiba, Katsunori] Otsuka Pharmaceut Co Ltd, 224-18 Ebisuno Hiraishi, Kawaguchi, Tokushima 7710182, Japan.
RP Katsumi, H (reprint author), Kyoto Pharmaceut Univ, Dept Biopharmaceut, Yamashina Ku, Kyoto 6078414, Japan.
EM hkatsumi@mb.kyoto-phu.ac.jp
FU Mochida Memorial Foundation for Medical and Pharmaceutical Research
FX This work was supported in part by a grant from the Mochida Memorial
   Foundation for Medical and Pharmaceutical Research.
CR Bariya SH, 2012, J PHARM PHARMACOL, V64, P11, DOI 10.1111/j.2042-7158.2011.01369.x
   Bashir SJ, 2001, SKIN RES TECHNOL, V7, P40, DOI 10.1034/j.1600-0846.2001.007001040.x
   Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749
   Bos JD, 2000, EXP DERMATOL, V9, P165, DOI 10.1034/j.1600-0625.2000.009003165.x
   BRILLANTI S, 1994, GASTROENTEROLOGY, V107, P812, DOI 10.1016/0016-5085(94)90131-7
   Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159
   Gomaa YA, 2010, TOXICOL IN VITRO, V24, P1971, DOI 10.1016/j.tiv.2010.08.012
   Hoffmann HH, 2015, TRENDS IMMUNOL, V36, P124, DOI 10.1016/j.it.2015.01.004
   Ikeda K, 1999, HEPATOLOGY, V29, P1124, DOI 10.1002/hep.510290439
   Imran M, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-299
   Indermun S, 2014, J CONTROL RELEASE, V185, P130, DOI 10.1016/j.jconrel.2014.04.052
   Jain A, 2014, CRIT REV THER DRUG, V31, P219, DOI 10.1615/CritRevTherDrugCarrierSyst.2014008126
   JANIK P, 1975, CANCER RES, V35, P3698
   Kalia YN, 2000, PHARMACEUT RES, V17, P1148, DOI 10.1023/A:1026474200575
   Kalluri H, 2011, AAPS J, V13, P473, DOI 10.1208/s12248-011-9288-3
   Katsumi H, 2012, J PHARM SCI-US, V101, P3230, DOI 10.1002/jps.23136
   Krejcova D, 2009, GEN PHYSIOL BIOPHYS, V28, P294, DOI 10.4149/gpb_2009_03_294
   Kusamori K, 2010, J BONE MINER RES, V25, P2306, DOI 10.1002/jbmr.147
   Lim JYH, 2014, CANCER IMMUNOL IMMUN, V63, P259, DOI 10.1007/s00262-013-1506-7
   Liu S, 2014, EUR J PHARM BIOPHARM, V86, P267, DOI 10.1016/j.ejpb.2013.10.001
   Liu S, 2012, J CONTROL RELEASE, V161, P933, DOI 10.1016/j.jconrel.2012.05.030
   Liu X, 2012, CURR CANCER DRUG TAR, V12, P561, DOI 10.2174/156800912800673293
   Micco L, 2013, J HEPATOL, V58, P225, DOI 10.1016/j.jhep.2012.09.029
   Naik A., 2000, PHARM SCI TECHNOL TO, V3, P318, DOI DOI 10.1016/S1461-5347(00)00295-9
   Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604
   RADWANSKI E, 1987, J CLIN PHARMACOL, V27, P432, DOI 10.1002/j.1552-4604.1987.tb03044.x
   Pierre MBR, 2014, CURR DRUG TARGETS, V15, P281
   Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x
   Thomas HC, 1999, HEPATOLOGY, V29, P1333, DOI 10.1002/hep.510290453
   Wu D, 2015, BIOL PHARM BULL, V38, P365, DOI 10.1248/bpb.b14-00502
   YAMAOKA K, 1978, J PHARMACOKINET BIOP, V6, P547, DOI 10.1007/BF01062109
   YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879, DOI 10.1248/bpb1978.4.879
   Yan GA, 2010, INT J PHARMACEUT, V391, P7, DOI 10.1016/j.ijpharm.2010.02.007
   Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06
NR 34
TC 7
Z9 9
U1 4
U2 45
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1758-5082
EI 1758-5090
J9 BIOFABRICATION
JI Biofabrication
PD MAR
PY 2016
VL 8
IS 1
AR 015006
DI 10.1088/1758-5090/8/1/015006
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DI1WZ
UT WOS:000373289000010
PM 26756832
DA 2018-10-19
ER

PT J
AU Nagasawa, M
   Cooper, LF
   Ogino, Y
   Mendonca, D
   Liang, R
   Yang, S
   Mendonca, G
   Uoshima, K
AF Nagasawa, M.
   Cooper, L. F.
   Ogino, Y.
   Mendonca, D.
   Liang, R.
   Yang, S.
   Mendonca, G.
   Uoshima, K.
TI Topography Influences Adherent Cell Regulation of Osteoclastogenesis
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE biomaterial; dental implant; osteoblast; osteoclast; osseointegration;
   tissue engineering
ID TITANIUM IMPLANTS; BONE INTEGRATION; RAT MAXILLA; OSSEOINTEGRATION;
   NANOTOPOGRAPHY; OSTEOGENESIS; EXPRESSION; RESPONSES; SURFACES; MICRON
AB The importance of osteoclast-mediated bone resorption in the process of osseointegration has not been widely considered. In this study, cell culture was used to investigate the hypothesis that the function of implant-adherent bone marrow stromal cells (BMSCs) in osteoclastogenesis is influenced by surface topography. BMSCs isolated from femur and tibia of Sprague-Dawley rats were seeded onto 3 types of titanium surfaces (smooth, micro, and nano) and a control surface (tissue culture plastic) with or without osteogenic supplements. After 3 to 14 d, conditioned medium (CM) was collected. Subsequently, rat bone marrow-derived macrophages (BMMs) were cultured in media supplemented with soluble receptor activator of NF-kappa B ligand (RANKL) and macrophage colony-stimulating factor (M-CSF) as well as BMSC CM from each of the 4 surfaces. Gene expression levels of soluble RANKL, osteoprotegerin, tumor necrosis factor a, and M-CSF in cultured BMSCs at different time points were measured by real-time polymerase chain reaction. The number of differentiated osteoclastic cells was determined after tartrate-resistant acid phosphatase staining. Analysis of variance and t test were used for statistical analysis. The expression of prominent osteoclast-promoting factors tumor necrosis factor a and M-CSF was increased by BMSCs cultured on both micro-and nanoscale titanium topographies (P < 0.01). BMSC CM contained a heat-labile factor that increased BMMs osteoclastogenesis. CM from both micro-and nanoscale surface-adherent BMSCs increased the osteoclast number (P < 0.01). Difference in surface topography altered BMSC phenotype and influenced BMM osteoclastogenesis. Local signaling by implant-adherent cells at the implant-bone interface may indirectly control osteoclastogenesis and bone accrual around endosseous implants.
C1 [Nagasawa, M.; Cooper, L. F.; Liang, R.] Univ N Carolina, Sch Dent, Bone Biol & Implant Therapy Lab, 4610 Koury Oral Hlth Sci Bldg CB 7450, Chapel Hill, NC 27599 USA.
   [Nagasawa, M.; Uoshima, K.] Niigata Univ, Grad Sch Med & Dent Sci, Div Bioprosthodont, Niigata, Japan.
   [Ogino, Y.] Kyushu Univ, Dept Oral Rehabil, Fukuoka 812, Japan.
   [Mendonca, D.; Mendonca, G.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Div Prosthodont, Ann Arbor, MI 48109 USA.
   [Yang, S.] Chongqing Med Univ, Coll Stomatol, Chongqing, Peoples R China.
RP Cooper, LF (reprint author), Univ N Carolina, Sch Dent, Bone Biol & Implant Therapy Lab, 4610 Koury Oral Hlth Sci Bldg CB 7450, Chapel Hill, NC 27599 USA.
EM Lyndon_Cooper@unc.edu
OI Cooper, Lyndon/0000-0002-6577-781X
FU UNC DENTSPLY PDPA
FX This work was financially supported by UNC DENTSPLY PDPA. The authors
   thank Dr. Yujin Aoyagi for his assistance with the titanium surface
   analysis. The authors declare no potential conflicts of interest with
   respect to the authorship and/or publication of this article.
CR Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023
   Bosshardt DD, 2011, CLIN ORAL IMPLAN RES, V22, P357, DOI 10.1111/j.1600-0501.2010.02107.x
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Dalby Matthew J, 2007, Curr Stem Cell Res Ther, V2, P129, DOI 10.2174/157488807780599220
   Fujii N, 1998, J PERIODONTOL, V69, P485, DOI 10.1902/jop.1998.69.4.485
   Futami T, 2000, J PERIODONTOL, V71, P287, DOI 10.1902/jop.2000.71.2.287
   Galli C, 2013, CLIN ORAL IMPLAN RES, V24, P921, DOI 10.1111/j.1600-0501.2012.02488.x
   Kang H, 2010, P NATL ACAD SCI USA, V107, P12901, DOI 10.1073/pnas.1001499107
   Kitaura H, 2013, CLIN DEV IMMUNOL, V2013
   Klokkevold PR, 2007, INT J ORAL MAX IMPL, V22, P173
   Kupcova SH., 2013, BIOCHIMIE, V95, P2196, DOI DOI 10.1016/J.BIOCHI.2013.07.015
   Lossdorfer S, 2004, J BIOMED MATER RES A, V70A, P361, DOI 10.1002/jbm.a.30025
   Luo E, 2012, ACTA BIOMATER, V8, P734, DOI 10.1016/j.actbio.2011.10.029
   Masuda T, 1997, INT J ORAL MAX IMPL, V12, P472
   Matsubara R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047930
   Mendonca G, 2008, BIOMATERIALS, V29, P3822, DOI 10.1016/j.biomaterials.2008.05.012
   Mendonca G, 2010, J BIOMED MATER RES A, V94A, P169, DOI 10.1002/jbm.a.32701
   Minkin C, 1999, Adv Dent Res, V13, P49
   Nakano N, 2010, NEUROSCI LETT, V483, P57, DOI 10.1016/j.neulet.2010.07.062
   Ogawa T, 2003, INT J ORAL MAX IMPL, V18, P200
   Ogino Y, 2016, J CELL PHYSIOL, V231, P568, DOI 10.1002/jcp.25100
   Ogle Orrett E, 2015, Dent Clin North Am, V59, P505, DOI 10.1016/j.cden.2014.12.003
   Oshita K, 2011, ARTHRITIS RHEUM-US, V63, P1658, DOI 10.1002/art.30309
   Palmquist A, 2013, CLIN IMPLANT DENT R, V15, P96, DOI 10.1111/j.1708-8208.2011.00361.x
   Passeri G, 2010, CLIN ORAL IMPLAN RES, V21, P756, DOI 10.1111/j.1600-0501.2009.01906.x
   Schwartz Z, 2009, BIOMATERIALS, V30, P3390, DOI 10.1016/j.biomaterials.2009.03.047
   Shalabi MM, 2006, J DENT RES, V85, P496, DOI 10.1177/154405910608500603
   Shibata Y, 2015, J PROSTHODONT RES, V59, P20, DOI 10.1016/j.jpor.2014.11.007
   Souza PPC, 2013, IMMUNOL INVEST, V42, P555, DOI 10.3109/08820139.2013.822766
   Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102
   Thakral G. K., 2014, J CLIN DIAGN RES, V8, pZE07
   Thalji Ghadeer, 2014, Int J Oral Maxillofac Implants, V29, pe171, DOI 10.11607/jomi.te55
   Thalji G, 2013, INT J ORAL MAX IMPL, V28, pE521, DOI 10.11607/jomi.te33
   Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024
NR 34
TC 4
Z9 4
U1 2
U2 18
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD MAR
PY 2016
VL 95
IS 3
BP 319
EP 326
DI 10.1177/0022034515616760
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DH8YJ
UT WOS:000373082500010
PM 26553885
DA 2018-10-19
ER

PT J
AU Sheikh, FA
   Ju, HW
   Moon, BM
   Lee, OJ
   Kim, JH
   Park, HJ
   Kim, DW
   Kim, DK
   Jang, JE
   Khang, G
   Park, CH
AF Sheikh, Faheem A.
   Ju, Hyung Woo
   Moon, Bo Mi
   Lee, Ok Joo
   Kim, Jung-Ho
   Park, Hyun Jung
   Kim, Dong Wook
   Kim, Dong-Kyu
   Jang, Ji Eun
   Khang, Gilson
   Park, Chan Hum
TI Hybrid scaffolds based on PLGA and silk for bone tissue engineering
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE silk; PLGA; osteoblasts; hard tissue; hydrophilic; cell viability
ID POLY(LACTIC-CO-GLYCOLIC ACID); HYDROXYAPATITE NANOPARTICLES;
   MECHANICAL-PROPERTIES; FIBROIN SCAFFOLDS; GROWTH-FACTOR; BIOMATERIALS;
   FABRICATION; COMPOSITES; NANOFIBERS; MORPHOLOGY
AB Porous silk scaffolds, which are considered to be natural polymers, cannot be used alone because they have a long degradation rate, which makes it difficult for them to be replaced by the surrounding tissue. Scaffolds composed of synthetic polymers, such as PLGA, have a short degradation rate, lack hydrophilicity and their release of toxic by-products makes them difficult to use. The present investigations aimed to study hybrid scaffolds fabricated from PLGA, silk and hydroxyapatite nanoparticles (Hap NPs) for optimized bone tissue engineering. The results from variable-pressure field emission scanning electron microscopy (VP-FE-SEM), equipped with EDS, confirmed that the fabricated scaffolds had a porous architecture, and the location of each component present in the scaffolds was examined. Contact angle measurements confirmed that the introduction of silk and HAp NPs helped to change the hydrophobic nature of PLGA to hydrophilic, which is the main constraint for PLGA used as a biomaterial. Thermo-gravimetric analysis (TGA) and FT-IR spectroscopy confirmed thermal decomposition and different vibrations caused in functional groups of compounds used to fabricate the scaffolds, which reflected improvement in their mechanical properties. After culturing osteoblasts for 1, 7 and 14 days in the presence of scaffolds, their viability was checked by MTT assay. The fluorescent microscopy results revealed that the introduction of silk and HAp NPs had a favourable impact on the infiltration of osteoblasts. In vivo experiments were conducted by implanting scaffolds in rat calvariae for 4 weeks. Histological examinations and micro-CT scans from these experiments revealed beneficial attributes offered by silk fibroin and HAp NPs to PLGA-based scaffolds for bone induction. Copyright (C) 2015 John Wiley & Sons, Ltd.
C1 [Sheikh, Faheem A.; Ju, Hyung Woo; Moon, Bo Mi; Lee, Ok Joo; Kim, Jung-Ho; Park, Hyun Jung; Kim, Dong Wook; Kim, Dong-Kyu; Park, Chan Hum] Hallym Univ, Coll Med, Nanobio Regenerat Med Inst, Chunchon, South Korea.
   [Kim, Dong-Kyu; Park, Chan Hum] Hallym Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Chunchon 200704, South Korea.
   [Jang, Ji Eun; Khang, Gilson] Chonbuk Natl Univ, Polymer Fus Res Ctr, Jeonju 561756, South Korea.
RP Park, CH (reprint author), Hallym Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Chunchon 200704, South Korea.
EM hlpch@paran.com
RI Park, Chan Hum/C-6848-2016; Sheikh, Faheem/Q-9166-2018
OI Sheikh, Faheem/0000-0003-0942-4398; Kim, Dong-Kyu/0000-0003-4917-0177
FU Hallym University Research Fund; Bio-industry Technology Development,
   Ministry for Food, Agriculture, Forestry and Fisheries, Republic of
   Korea [112007-05-3-SB010]
FX This research was supported by Hallym University Research Fund and the
   Bio-industry Technology Development, Ministry for Food, Agriculture,
   Forestry and Fisheries, Republic of Korea (Grant Nos 112007-05-3-SB010).
   The authors are grateful to Dr Ju-Suk Nam at Hallym University for the
   gift of osteoblasts, and to Cell and Gene Biotechnology, Korea, for
   providing hydroxyapatite nanoparticles. The authors are grateful to the
   Korean Basic Science Institute, Chuncheon branch, for providing
   facilities to perform VP-FE-SEM investigations.
CR Arrington E D, 1996, Clin Orthop Relat Res, P300, DOI 10.1097/00003086-199608000-00037
   ASKEW MJ, 1990, J BIOMED MATER RES, V24, P573, DOI 10.1002/jbm.820240504
   Barakat NAM, 2008, MAT SCI ENG C-BIO S, V28, P1381, DOI 10.1016/j.msec.2008.03.003
   Baroli B, 2009, J PHARM SCI-US, V98, P1317, DOI 10.1002/jps.21528
   Choi JS, 2013, TISSUE ENG PT A, V19, P329, DOI [10.1089/ten.tea.2011.0738, 10.1089/ten.TEA.2011.0738]
   Costa DO, 2013, BIOMATERIALS, V34, P7215, DOI 10.1016/j.biomaterials.2013.06.014
   Cuddihy MJ, 2008, TISSUE ENG PT A, V14, P1639, DOI 10.1089/ten.tea.2007.0142
   Dang MH, 1996, J ENVIRON POLYM DEGR, V4, P197, DOI 10.1007/BF02067453
   Dimitriou R., 2011, BMC MED, V9, P1
   Ebrahimian-Hosseinabadi M, 2011, J MATER SCI TECHNOL, V27, P1105, DOI 10.1016/S1005-0302(12)60004-8
   Farokhi M, 2014, MAT SCI ENG C-MATER, V35, P401, DOI 10.1016/j.msec.2013.11.023
   GAZDAG AR, 1995, J AM ACAD ORTHOP SUR, V3, P1, DOI DOI 10.5435/00124635-199501000-00001
   Hsieh WC, 2007, COLLOID SURFACE B, V57, P250, DOI 10.1016/j.colsurfb.2007.02.004
   Ju HW, 2014, J BIOMED MATER RES A, V102, P2713, DOI 10.1002/jbm.a.34947
   Kim HY, 2017, J TISSUE ENG REGEN M, V11, P44, DOI 10.1002/term.1856
   Lanao RPF, 2013, TISSUE ENG PART B-RE, V19, P380, DOI [10.1089/ten.teb.2012.0443, 10.1089/ten.TEB.2012.0443]
   Li C, 2012, J BIOMAT SCI-POLYM E, V23, P405, DOI 10.1163/092050610X551970
   Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15
   Magdalena S, 2008, BIOMED NANOTECHNOL, V4, P349
   Mura S, 2011, INT J NANOMED, V6, P2591, DOI 10.2147/IJN.S24552
   Ng KS, 2009, IFMBE PROC, V23, P1381
   Pan Z, 2012, INTERFACE FOCUS, V2, P366, DOI 10.1098/rsfs.2011.0123
   Pommer A, 2002, J BONE JOINT SURG AM, V84A, P1162, DOI 10.2106/00004623-200207000-00011
   Popp JR, 2011, J TISSUE ENG REGEN M, V5, P780, DOI 10.1002/term.376
   Roohani-Esfahani SI, 2010, BIOMATERIALS, V31, P5498, DOI 10.1016/j.biomaterials.2010.03.058
   Rubert M, 2012, BIOINTERPHASES, V18, P1253
   Saithna A, 2010, INJURY, V41, P128, DOI 10.1016/j.injury.2009.01.001
   SALAMA R, 1978, J BONE JOINT SURG BR, V60, P111
   Sheikh FA, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-303
   Sheikh FA, 2011, J BIOMATER TISS ENG, V1, P194, DOI 10.1166/jbt.2011.1017
   Sheikh FA, 2010, MACROMOL RES, V18, P59, DOI 10.1007/s13233-009-0111-2
   Shepperd JAN, 2005, J BONE JOINT SURG BR, V87B, P1046, DOI 10.1302/0301-620X.87B8.16692
   SOUCACOS PN, 2008, INJURY S2, V39, pS1
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Tigli RS, 2011, J BIOMED MATER RES A, V96A, P21, DOI 10.1002/jbm.a.32949
   Wang W, 2010, BIOMATERIALS, V31, P5953, DOI 10.1016/j.biomaterials.2010.04.029
   Wenk E, 2009, BIOMATERIALS, V30, P2571, DOI 10.1016/j.biomaterials.2008.12.073
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 39
TC 15
Z9 15
U1 3
U2 42
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD MAR
PY 2016
VL 10
IS 3
BP 209
EP 221
DI 10.1002/term.1989
PG 13
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA DH6RV
UT WOS:000372920000011
PM 25628059
DA 2018-10-19
ER

PT J
AU Shin, HY
   Frechette, DM
   Rohner, N
   Zhang, XY
   Puleo, DA
   Bjursten, LM
AF Shin, Hainsworth Y.
   Frechette, Danielle M.
   Rohner, Nathan
   Zhang, Xiaoyan
   Puleo, David A.
   Bjursten, Lars M.
TI Dependence of macrophage superoxide release on the pulse amplitude of an
   applied pressure regime: a potential factor at the soft tissue-implant
   interface
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE mechanotransduction; macrophage; pressure; cell adhesion; superoxide;
   tissue-implant interface
ID PROMYELOCYTIC LEUKEMIA-CELLS; IN-VITRO; HUMAN MONOCYTE/MACROPHAGES;
   EXTRACELLULAR PRESSURE; HYDROSTATIC-PRESSURE; CYTOKINE PRODUCTION;
   CYCLIC PRESSURE; NADPH OXIDASE; PROPOSED ROLE; PHAGOCYTOSIS
AB Failure of soft tissue implants has been largely attributed to the influence of biomaterial surface properties on the foreign body response, but some implant complications, e.g. macrophage accumulation and necrosis, are still not effectively addressed with surface treatments to minimize deleterious biomaterial effects. We explored an alternative explanation for implant failure, linking biocompatibility with implant micromotion-induced pressure fluctuations at the tissue-biomaterial interface. For this purpose, we used a custom in vitro system to characterize the effects of pressure fluctuations on the activity of macrophages, the predominant cells at a healing implant site. Initially, we quantified superoxide production by HL60-derived macrophage-like cells under several different pressure regimes with means of 5-40mmHg, amplitudes of 0-15mmHg and frequencies of 0-1.5 Hz. All pressure regimes tested elicited significantly (p < 0.05) reduced superoxide production by macrophage-like cells relative to parallel controls. Notably, pressure-sensitive reductions in superoxide release correlated (r(2) = 0.74; p < 0.01) only with pulse pressures. Based on the connection between superoxide production and cell viability, we also explored the influence of cyclic pressure on macrophage numbers and death. Compared to controls, adherent macrophage-like cells exposed to 7.5/2.5 mmHg cyclic pressures for 6 h exhibited significantly (p < 0.01) reduced cell numbers, independent of cell death. A similar effect was observed for cells treated with 10 U/ml superoxide dismutase. Collectively, our results suggest that pressure pulses are a putative regulator of macrophage adhesion via a superoxide-related effect. Pressure fluctuations, e.g. due to implant micromotion, may, therefore, potentially modulate macrophage-dependent wound healing. Copyright (C) 2013 John Wiley & Sons, Ltd.
C1 [Shin, Hainsworth Y.; Frechette, Danielle M.; Rohner, Nathan; Zhang, Xiaoyan; Puleo, David A.] Univ Kentucky, Ctr Biomed Engn, Lexington, KY USA.
   [Bjursten, Lars M.] Lund Univ, Clin Sci, Malmo, Sweden.
RP Shin, HY (reprint author), Univ Kentucky, Ctr Biomed Engn, Wenner Gren Res Lab, Lexington, KY 40506 USA.
EM hy.shin@uky.edu
FU University of Kentucky Research Support Fund; National Science
   Foundation Research Experiences for Undergraduates; American Heart
   Association Beginning-Grant-Aid; NSF-Kentucky EPSCoR Bioengineering
   Initiative grant
FX This study was supported by the University of Kentucky Research Support
   Fund (to H.Y.S.), an American Heart Association Beginning-Grant-Aid (to
   H.Y.S.), a National Science Foundation Research Experiences for
   Undergraduates (to D.M.F. and N.R.; PI, K. W. Anderson) and an
   NSF-Kentucky EPSCoR Bioengineering Initiative grant (to X.Z.; PIs, J.
   Connelly and R. Andrews). We thank Dr S. Lai-Fook and Dr E. Bruce of the
   Center for Biomedical Engineering, University of Kentucky, for their
   technical and material assistance with setting up the pressure system.
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 1999, J MATER SCI-MATER M, V10, P579, DOI 10.1023/A:1008976531592
   Andrade J D, 1973, Med Instrum, V7, P110
   AUKLAND K, 1993, PHYSIOL REV, V73, P1
   Baskin DS, 2003, TOXICOL SCI, V74, P361, DOI 10.1093/toxsci/kfg126
   Bauer G, 2002, PROSTAG LEUKOTR ESS, V66, P41, DOI 10.1054/plef.2001.0332
   Beriault DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031320
   Bertram P, 1997, LANGENBECK ARCH CHIR, V382, P291, DOI 10.1007/s004230050069
   Bhalla S, 2009, AM J SURG, V198, P611, DOI 10.1016/j.amjsurg.2009.07.006
   Boutonnat J, 1999, CELL PROLIFERAT, V32, P203, DOI 10.1046/j.1365-2184.1999.3240203.x
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Bryers JD, 2012, BIOTECHNOL BIOENG, V109, P1898, DOI 10.1002/bit.24559
   Cathcart MK, 2004, ARTERIOSCL THROM VAS, V24, P23, DOI 10.1161/01.ATV.0000097769.47306.12
   COLLINS SJ, 1987, BLOOD, V70, P1233
   Crowther JE, 2004, J IMMUNOL, V172, P6866, DOI 10.4049/jimmunol.172.11.6866
   Evans CE, 2008, ATHEROSCLEROSIS, V197, P596, DOI 10.1016/j.atherosclerosis.2007.08.027
   Ferrier GM, 2000, J BONE JOINT SURG BR, V82B, P755, DOI 10.1302/0301-620X.82B5.9561
   Fleming AJ, 2003, TISSUE ENG, V9, P1023, DOI 10.1089/107632703322495664
   Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189
   Fujishiro T, 2004, J BIOMED MATER RES A, V68A, P531, DOI 10.1002/jbm.a..20098
   GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001
   GUYTON AC, 1996, TXB MED PHYSL
   HARRIS P, 1985, J LEUKOCYTE BIOL, V37, P407
   Helton Kristen L, 2011, J Diabetes Sci Technol, V5, P632
   HICKSTEIN DD, 1987, J IMMUNOL, V138, P513
   Hilborn J, 2007, J TISSUE ENG REGEN M, V1, P110, DOI 10.1002/term.4
   Hunt JA, 1997, J BIOMED MATER RES, V36, P542
   Ko JK, 2011, J BIOL CHEM, V286, P9038, DOI 10.1074/jbc.M110.198457
   Laurila JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005786
   Matheson LA, 2006, J BIOMED MATER RES A, V76A, P52, DOI 10.1002/jbm.a.30448
   MATLAGA BF, 1976, J BIOMED MATER RES, V10, P391, DOI 10.1002/jbm.820100308
   MCCARTHY KF, 1988, TOXICOL LETT, V43, P219, DOI 10.1016/0378-4274(88)90030-6
   McEvoy A, 2002, BONE, V30, P171
   Miguel L, 2011, J IMMUNOL, V186, P3505, DOI 10.4049/jimmunol.1002980
   MOREHEAD JM, 1994, OTOLARYNG CLIN N AM, V27, P195
   Paquay YCGJ, 1996, BIOMATERIALS, V17, P1251, DOI 10.1016/0142-9612(96)84946-5
   Park JB, 2003, EXP MOL MED, V35, P325, DOI 10.1038/emm.2003.44
   Patel RP, 2000, FREE RADICAL BIO MED, V28, P1780, DOI 10.1016/S0891-5849(00)00235-5
   Pugin J, 1998, AM J PHYSIOL-LUNG C, V275, pL1040, DOI 10.1152/ajplung.1998.275.6.L1040
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Ratner BD, 2011, J CARDIOVASC TRANSL, V4, P523, DOI 10.1007/s12265-011-9287-x
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   Rhodes NP, 1997, J BIOMED MATER RES, V37, P481, DOI 10.1002/(SICI)1097-4636(19971215)37:4<481::AID-JBM6>3.0.CO;2-H
   Rosengren A, 1999, J BIOMED MATER RES, V46, P458, DOI 10.1002/(SICI)1097-4636(19990915)46:4<458::AID-JBM3>3.0.CO;2-I
   Rosengren A, 2002, IEEE T BIO-MED ENG, V49, P392, DOI 10.1109/10.991167
   ROVERA G, 1979, P NATL ACAD SCI USA, V76, P2779, DOI 10.1073/pnas.76.6.2779
   Sakamoto H, 2001, CIRCULATION, V104, P109, DOI 10.1161/hc2701.091070
   Sampathkumar K, 2003, J BONE JOINT SURG BR, V85B, P288, DOI 10.1302/0301-620X.85B2.13211
   Schaser KD, 2003, LANGENBECK ARCH SURG, V388, P323, DOI 10.1007/s00423-003-0411-5
   Shin HY, 2012, TISSUE ENG PT A, V18, P2590, DOI [10.1089/ten.tea.2011.0588, 10.1089/ten.TEA.2011.0588]
   Shiratsuch H, 2005, AM J SURG, V190, P757, DOI 10.1016/j.amjsurg.2005.07.016
   Shiratsuchi H, 2005, AM J PHYSIOL-CELL PH, V288, pC1083, DOI 10.1152/ajpcell.00543.2004
   Shiratsuchi H, 2004, AM J PHYSIOL-CELL PH, V286, pC1358, DOI 10.1152/ajpcell.00553.2003
   Shiratsuchi H, 2007, J CELL BIOCHEM, V102, P353, DOI 10.1002/jcb.21295
   SKARLATOS S, 1994, J PHYSIOL-LONDON, V481, P743, DOI 10.1113/jphysiol.1994.sp020478
   Stromberg DD, 1977, MICROCIRCULATION
   Sven K, 2007, ADV PHYSIOL EDUC, V31, P116, DOI 10.1152/advan.00084.2006
   Takahashi H, 2010, J CONTROL RELEASE, V147, P400, DOI 10.1016/j.jconrel.2010.08.019
   Vendrov AE, 2007, ARTERIOSCL THROM VAS, V27, P2714, DOI 10.1161/ATVBAHA.107.152629
   Victor VM, 1998, MOL CELL BIOCHEM, V189, P25, DOI 10.1023/A:1006891926301
   Yang PY, 2009, MOL CANCER THER, V8, P2319, DOI 10.1158/1535-7163.MCT-08-1085
   Yasui K, 2006, INFLAMM RES, V55, P359, DOI 10.1007/s00011-006-5195-y
   Yokoyama Y, 2009, BLOOD, V113, P6584, DOI 10.1182/blood-2008-06-160838
NR 65
TC 1
Z9 1
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD MAR
PY 2016
VL 10
IS 3
BP E227
EP E238
DI 10.1002/term.1789
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA DH6RV
UT WOS:000372920000008
PM 23881832
DA 2018-10-19
ER

PT J
AU Viateau, V
   Manassero, M
   Sensebe, L
   Langonne, A
   Marchat, D
   Logeart-Avramoglou, D
   Petite, H
   Bensidhoum, M
AF Viateau, Veronique
   Manassero, Mathieu
   Sensebe, Luc
   Langonne, Alain
   Marchat, David
   Logeart-Avramoglou, Delphine
   Petite, Herve
   Bensidhoum, Morad
TI Comparative study of the osteogenic ability of four different ceramic
   constructs in an ectopic large animal model
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE bone tissue engineering; bone formation; mesenchymal stem cells; ceramic
   scaffolds; osteogenesis; scaffold resorption; osteoconduction
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; LONG-BONE DEFECTS;
   STABILIZED TRICALCIUM PHOSPHATE; CRITICAL-SIZE DEFECTS; IN-VIVO; TISSUE;
   SHEEP; RECONSTRUCTION; REGENERATION
AB Tissue-engineered constructs combining bone marrow mesenchymal stem cells with biodegradable osteoconductive scaffolds are very promising for repairing large segmental bone defects. Synchronizing and controlling the balance between scaffold-material resorption and new bone tissue formation are crucial aspects for the success of bone tissue engineering. The purpose of the present study was to determine, and compare, the osteogenic potential of ceramic scaffolds with different resorbability. Four clinically relevant granular biomaterial scaffolds (specifically, Porites coral, Acropora coral, beta-tricalcium phosphate and banked bone) with or without autologous bone marrow stromal cells were implanted in the ectopic, subcutaneous-pouch sheep model. Scaffold material resorption and new bone formation were assessed eight weeks after implantation. New bone formation was only detected when the biomaterial constructs tested contained MSCs. New bone formation was higher in the Porites coral and Acropora coral than in either the beta-tricalcium phosphate or the banked bone constructs; furthermore, there was a direct correlation between scaffold resorption and bone formation. The results of the present study provide evidence that, among the biomaterials tested, coral scaffolds containing MSCs promoted the best new bone formation in the present study. Copyright (C) 2013 John Wiley & Sons, Ltd.
C1 [Viateau, Veronique; Manassero, Mathieu; Logeart-Avramoglou, Delphine; Petite, Herve; Bensidhoum, Morad] Univ Paris 07, PRES Paris Cite, UMR CNRS 7052 B2OA, Lab Bioengn & Biomech Bone Articulat, Paris, France.
   [Sensebe, Luc; Langonne, Alain] CNRS UPS EFS, UMR5273, Etablissement Francais Sang Ctr Atlantique, Tours, France.
   [Viateau, Veronique; Manassero, Mathieu] Ecole Natl Vet Alfort, Maisons Alfort, France.
   [Marchat, David] Ecole Natl Super Mines, CIS, F-42023 St Etienne, France.
RP Bensidhoum, M (reprint author), Univ Paris Diderot, UMR CNRS 7052, Lab Bioingn & Biomacan Osteo Articulaires B2OA, 10 Ave Verdun, F-75010 Paris, France.
EM morad.bensidhoum@paris7.jussieu.fr
RI Petite, Herve/E-3478-2016
OI Petite, Herve/0000-0003-1694-5060; Bensidhoum,
   Morad/0000-0002-6621-6010; Manassero, Mathieu/0000-0003-1267-5120;
   Logeart-Avramoglou, Delphine/0000-0002-2052-9425
FU Delegation a la Recherche Clinique de l'Assistance Publique des Hopitaux
   de Paris; Centre National de Recherche Scientifique; ANR therabone
FX The authors thank Dr N. Guillemin (for her kind assistance with this
   study), Prof. R. Bizios (for her valuable comments on the manuscript),
   Biocoral, Inc., (for donating the coral scaffolds), Biobank, Inc., (for
   donating the banked bone) and Valentin Myrtil (for excellent technical
   support). We also acknowledge financial support from la Delegation a la
   Recherche Clinique de l'Assistance Publique des Hopitaux de Paris, from
   Centre National de Recherche Scientifique, and from ANR therabone.
CR Arinzeh TL, 2003, J BONE JOINT SURG AM, V85A, P1927, DOI 10.2106/00004623-200310000-00010
   Arinzeh TL, 2005, BIOMATERIALS, V26, P3631, DOI 10.1016/j.biomaterials.2004.09.035
   Bensaid W, 2005, TISSUE ENG, V11, P814, DOI 10.1089/ten.2005.11.814
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Cancedda R, 2003, STEM CELLS, V21, P610, DOI 10.1634/stemcells.21-5-610
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198
   Catros S, 2009, J ORTHOP RES, V27, P155, DOI 10.1002/jor.20738
   Chai YC, 2012, ACTA BIOMATER, V8, P3876, DOI 10.1016/j.actbio.2012.07.002
   DEBOER HH, 1989, J BONE JOINT SURG BR, V71, P374
   Eniwumide JO, 2007, EUR CELLS MATER, V14, P30, DOI 10.22203/eCM.v014a03
   Fouillard L, 2003, LEUKEMIA, V17, P474, DOI 10.1038/sj.leu.2402786
   Frayssinet P, 1998, BIOMATERIALS, V19, P2247, DOI 10.1016/S0142-9612(98)00124-0
   FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381
   FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009
   FRIEDLAENDER GE, 1991, J BONE JOINT SURG AM, V73A, P1119, DOI 10.2106/00004623-199173080-00001
   GUILLEMIN G, 1989, J BIOMED MATER RES, V23, P765, DOI 10.1002/jbm.820230708
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   HAN CS, 1992, J BONE JOINT SURG AM, V74A, P1441, DOI 10.2106/00004623-199274100-00002
   Kamitakahara M, 2008, J BIOMATER APPL, V23, P197, DOI 10.1177/0885328208096798
   Kitamura M, 2004, J MATER SCI-MATER M, V15, P1153, DOI 10.1023/B:JMSM.0000046399.40310.47
   Klaue K, 2009, INJURY, V40, pS95, DOI 10.1016/j.injury.2009.10.043
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   Kruyt MC, 2007, BIOMATERIALS, V28, P1798, DOI 10.1016/j.biomaterials.2006.11.038
   Liu GP, 2008, J MATER SCI-MATER M, V19, P2367, DOI 10.1007/s10856-007-3348-3
   Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x
   Marcacci M, 1999, CALCIFIED TISSUE INT, V64, P83, DOI 10.1007/s002239900583
   Masquelet A C, 2000, Ann Chir Plast Esthet, V45, P346
   Mastrogiacomo M, 2007, BIOMATERIALS, V28, P1376, DOI 10.1016/j.biomaterials.2006.10.001
   Mastrogiacomo M, 2006, TISSUE ENG, V12, P1261, DOI 10.1089/ten.2006.12.1261
   MAY JW, 1989, J BONE JOINT SURG AM, V71A, P1422, DOI 10.2106/00004623-198971090-00027
   Nair MB, 2010, TISSUE ENG PT A, V16, P385, DOI [10.1089/ten.tea.2009.0207, 10.1089/ten.TEA.2009.0207]
   Neildez-Nguyen TMA, 2002, NAT BIOTECHNOL, V20, P467, DOI 10.1038/nbt0502-467
   Olivier V, 2004, DRUG DISCOV TODAY, V9, P803, DOI 10.1016/S1359-6446(04)03222-2
   Papadimitropoulos A, 2007, BIOTECHNOL BIOENG, V98, P271, DOI 10.1002/bit.21418
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   van der Pol U, 2010, ACTA BIOMATER, V6, P3755, DOI 10.1016/j.actbio.2010.03.028
   Viateau V, 2006, VET SURG, V35, P445, DOI 10.1111/j.1532-950X.2006.00173.x
   Viateau V, 2007, J ORTHOP RES, V25, P741, DOI 10.1002/jor.20352
   Viateau V, 2010, ORTHOP CLIN N AM, V41, P49, DOI 10.1016/j.ocl.2009.07.010
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P7, DOI 10.1023/A:1026792615665
   Yuan HP, 2010, P NATL ACAD SCI USA, V107, P13614, DOI 10.1073/pnas.1003600107
NR 43
TC 11
Z9 11
U1 1
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD MAR
PY 2016
VL 10
IS 3
BP E177
EP E187
DI 10.1002/term.1782
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA DH6RV
UT WOS:000372920000003
PM 23784976
DA 2018-10-19
ER

PT J
AU Liow, SS
   Dou, QQ
   Kai, D
   Karim, AA
   Zhang, KY
   Xu, FJ
   Loh, XJ
AF Liow, Sing Shy
   Dou, Qingqing
   Kai, Dan
   Karim, Anis Abdul
   Zhang, Kangyi
   Xu, Fujian
   Loh, Xian Jun
TI Thermogels: In Situ Gelling Biomaterial
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Review
DE injectable hydrogels; thermosensitive polymers; LCST; sol-gel transition
ID COPOLYMER AQUEOUS-SOLUTIONS; MESENCHYMAL STEM-CELLS; TRANSFER RADICAL
   POLYMERIZATION; PLGA-PEG-PLGA; PHYSIOLOGICALLY RELEVANT CONDITIONS;
   BIODEGRADABLE BLOCK-COPOLYMERS; CONTROLLED-RELEASE FORMULATION; LOW
   GELATION CONCENTRATIONS; PHASE-TRANSITION BEHAVIOR; THERMAL GEL DEPOT
AB In situ gel delivery systems are preferred over conventional systems due to sustained and prolonged release action of therapeutic payload onto the targeted site. Thermogel, a form of in situ gel-forming polymeric formulation, undergoes sol gel transition after administration into the body. At room temperature, the system is an aqueous polymer solution that easily entraps therapeutic payload by mixing. Upon injection, the higher physiological temperature causes gelation in situ because of the presence of thermosensitive polymers. The gel degrades gradually over time, allowing sustained release of therapeutics localized to the site of interest. This minimizes systemic toxicity and improved efficacy of drug release to the targeted site. Thermogel properties can be easily altered for specific applications via substitution and modification of components in diblock and triblock copolymer systems. The feasibility of fine-tuning allows modifications to biodegradability, biocompatibility, biological functionalization, mechanical properties, and drug release profile. This review summarized recent development in thermogel research with a focus on synthesis and self-assembly mechanisms, gel biodegradability, and applications for drug delivery, cell encapsulation and tissue engineering. This review also assessed inadequacy of material properties as a stand-alone factor on therapeutic action efficacy in human trials, with a focus on OncoGel, an experimental thermogel that demonstrated excellent individual or synergistic drug delivery system in preclinical trials but lacked therapeutic impact in human trials. Detailed analysis from all aspects must be considered during technology development for a successful thermogel platform in drug delivery and tissue engineering.
C1 [Liow, Sing Shy; Dou, Qingqing; Kai, Dan; Karim, Anis Abdul; Zhang, Kangyi; Loh, Xian Jun] Inst Mat Res & Engn, 2 Fusionopolis Way,08-03 Innovis, Singapore 138634, Singapore.
   [Xu, Fujian] Beijing Univ Chem Technol, Coll Mat Sci & Engn, Minist Educ, Key Lab Carbon Fiber & Funct Polymers, Beijing 100029, Peoples R China.
   [Xu, Fujian] Beijing Univ Chem Technol, Beijing Lab Biomed Mat, Beijing 100029, Peoples R China.
   [Loh, Xian Jun] Natl Univ Singapore, Dept Mat Sci & Engn, 9 Engn Dr 1, Singapore 117576, Singapore.
   [Loh, Xian Jun] Singapore Eye Res Inst, 11 Third Hosp Ave, Singapore 168751, Singapore.
RP Loh, XJ (reprint author), Inst Mat Res & Engn, 2 Fusionopolis Way,08-03 Innovis, Singapore 138634, Singapore.; Loh, XJ (reprint author), Natl Univ Singapore, Dept Mat Sci & Engn, 9 Engn Dr 1, Singapore 117576, Singapore.; Loh, XJ (reprint author), Singapore Eye Res Inst, 11 Third Hosp Ave, Singapore 168751, Singapore.
EM lohxj@irnre.a-star.edu.sg
RI Xu, Fu-Jian/U-8024-2017; Zhang, Kangyi/R-3448-2017
OI Loh, Xian Jun/0000-0001-8118-6502
FU A*STAR Personal Care Grant [1325400026]
FX The authors express gratitude to the A*STAR Personal Care Grant (Project
   1325400026) for support of this project, Ms. Lally Owh for providing
   professional art work and proofreading, and Dr. Tan Mein Jin for
   proof-reading.
CR Abdul Karim Anis, 2015, Soft Matter, V11, P5425, DOI 10.1039/c5sm00665a
   Appel EA, 2012, CHEM COMMUN, V48, P9843, DOI 10.1039/c2cc35131e
   Appel EA, 2012, CHEM SOC REV, V41, P6195, DOI 10.1039/c2cs35264h
   Bae SJ, 2005, MACROMOLECULES, V38, P5260, DOI 10.1021/ma050489m
   Bagley CA, 2007, J NEUROSURG-SPINE, V7, P194, DOI 10.3171/SPI-07/08/194
   Barreiro-Iglesias R, 2004, J CONTROL RELEASE, V97, P537, DOI 10.1016/j.jconrel.2004.04.007
   Boffito M, 2015, J BIOMED MATER RES A, V103, P1276, DOI 10.1002/jbm.a.35253
   Boustta M, 2014, J CONTROL RELEASE, V174, P1, DOI 10.1016/j.jconrel.2013.10.040
   BURKERSRODA F, 2002, BIOMATERIALS, V23, P4221, DOI DOI 10.1016/S0142-9612(02)00170-9
   Cha Y., 1997, US Patent, Patent No. 5702717
   Chang GT, 2011, J CONTROL RELEASE, V156, P21, DOI 10.1016/j.jconrel.2011.07.008
   Chang GT, 2009, POLYMER, V50, P6111, DOI 10.1016/j.polymer.2009.10.036
   Chen CF, 2010, POLYM INT, V59, P1428, DOI 10.1002/pi.2886
   Chen L, 2015, MACROMOLECULES, V48, P3662, DOI 10.1021/acs.macromol.5b00168
   Chen L, 2014, MACROMOLECULES, V47, P5895, DOI 10.1021/ma501110p
   Chen YS, 2013, BIOMATERIALS, V34, P7328, DOI 10.1016/j.biomaterials.2013.06.017
   Cheng YH, 2013, CARBOHYD POLYM, V92, P1512, DOI 10.1016/j.carbpol.2012.10.074
   Cho JH, 2004, BIOMATERIALS, V25, P5743, DOI 10.1016/j.biomaterials.2004.01.051
   Choi B., 2015, SITU GELLING POLYM, P5
   Choi BG, 2011, SOFT MATTER, V7, P456, DOI 10.1039/c0sm00611d
   Choi BG, 2010, BIOMATERIALS, V31, P9266, DOI 10.1016/j.biomaterials.2010.08.067
   Choi S, 2004, PHARM RES, V21, P827, DOI 10.1023/B:PHAM.0000026435.27086.94
   Choi YY, 2008, SOFT MATTER, V4, P2383, DOI 10.1039/b809116a
   Ci TY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05473
   Ci TY, 2013, BIOMATER SCI-UK, V1, P1235, DOI 10.1039/c3bm60152h
   Ci TY, 2013, POLYM CHEM-UK, V4, P3245, DOI 10.1039/c3py00118k
   Cui HT, 2014, BIOMACROMOLECULES, V15, P1115, DOI 10.1021/bm4018963
   DeWitt J. M., 2011, GASTROINTESTINAL E S, V73, pAB136
   Diao BS, 2014, RSC ADV, V4, P42996, DOI 10.1039/c4ra08673b
   Dou QQ, 2014, ADV HEALTHC MATER, V3, P977, DOI 10.1002/adhm.201300627
   DuValla GA, 2009, ANTI-CANCER DRUG, V20, P89, DOI 10.1097/CAD.0b013e3283222c12
   Elstad NL, 2009, ADV DRUG DELIVER REV, V61, P785, DOI 10.1016/j.addr.2009.04.010
   EUSTACE DJ, 1988, J APPL POLYM SCI, V35, P707, DOI 10.1002/app.1988.070350311
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Garbern JC, 2011, BIOMATERIALS, V32, P2407, DOI 10.1016/j.biomaterials.2010.11.075
   Garripelli VK, 2011, ACTA BIOMATER, V7, P1984, DOI 10.1016/j.actbio.2011.02.005
   Ge ZS, 2011, LANGMUIR, V27, P1143, DOI 10.1021/la1048166
   Gok B, 2009, NEUROSURGERY, V65, P193, DOI 10.1227/01.NEU.0000345948.54008.82
   Gong CY, 2009, INT J PHARM, V365, P89, DOI 10.1016/j.ijpharm.2008.08.027
   GOPFERICH A, 1993, MACROMOLECULES, V26, P4105, DOI 10.1021/ma00068a006
   Gopferich A, 1997, MACROMOLECULES, V30, P2598, DOI 10.1021/ma961627y
   Graham PD, 1999, J CONTROL RELEASE, V58, P233, DOI 10.1016/S0168-3659(98)00158-8
   He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005
   Huang LF, 2014, NEURAL REGEN RES, V9, P1371, DOI 10.4103/1673-5374.137590
   Hwang MJ, 2005, BIOMACROMOLECULES, V6, P885, DOI 10.1021/bm049347a
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Jeong B, 2000, J BIOMED MATER RES, V50, P171, DOI 10.1002/(SICI)1097-4636(200005)50:2<171::AID-JBM11>3.0.CO;2-F
   Jeong B, 2000, J CONTROL RELEASE, V63, P155, DOI 10.1016/S0168-3659(99)00194-7
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jeong Y, 2009, J CONTROL RELEASE, V137, P25, DOI 10.1016/j.jconrel.2009.03.008
   Joo MK, 2007, MACROMOLECULES, V40, P5111, DOI 10.1021/ma070008u
   Ju CY, 2013, J PHARM SCI-US, V102, P2707, DOI 10.1002/jps.23649
   Kai D, 2015, ACS SUSTAIN CHEM ENG, V3, P2160, DOI 10.1021/acssuschemeng.5b00405
   Kai D, 2014, ACTA BIOMATER, V10, P2727, DOI 10.1016/j.actbio.2014.02.030
   Kai D, 2013, J MATER CHEM B, V1, P2305, DOI 10.1039/c3tb00151b
   Kai D, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/9/095705
   Kai D, 2011, J BIOMED MATER RES A, V99A, P376, DOI 10.1002/jbm.a.33200
   Kai D, 2011, J BIOMED MATER RES B, V98B, P379, DOI 10.1002/jbm.b.31862
   Kim DH, 2010, MACROMOL RES, V18, P387, DOI 10.1007/s13233-010-0405-4
   Kim SJ, 2014, ACS APPL MATER INTER, V6, P17034, DOI 10.1021/am504652y
   Kim YS, 2010, BIOMACROMOLECULES, V11, P981, DOI 10.1021/bm901455p
   Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025
   Ko DY, 2013, PROG POLYM SCI, V38, P672, DOI 10.1016/j.progpolymsci.2012.08.002
   Kwon JS, 2013, J MATER CHEM B, V1, P3314, DOI 10.1039/c3tb20105h
   Kwon JS, 2009, J CONTROL RELEASE, V138, P168, DOI 10.1016/j.jconrel.2009.05.023
   Lei KW, 2015, CHEM COMMUN, V51, P6080, DOI 10.1039/c5cc00049a
   Li CM, 2005, BIOMACROMOLECULES, V6, P994, DOI 10.1021/bm049331k
   Li J, 2003, MACROMOLECULES, V36, P2661, DOI 10.1021/ma025725x
   Li JJ, 2013, BIOMATERIALS, V34, P9071, DOI 10.1016/j.biomaterials.2013.08.031
   Li K, 2013, BIOMATERIALS, V34, P2834, DOI 10.1016/j.biomaterials.2013.01.013
   Li X., 2016, J SPINAL DISORDERS T, V1
   Li X, 2014, BIOMATERIALS, V35, P5679, DOI 10.1016/j.biomaterials.2014.03.067
   Li ZQ, 2012, ACTA BIOMATER, V8, P3586, DOI 10.1016/j.actbio.2012.06.024
   Li ZQ, 2012, BIOMACROMOLECULES, V13, P1956, DOI 10.1021/bm300574j
   Li ZQ, 2011, BIOMATERIALS, V32, P3220, DOI 10.1016/j.biomaterials.2011.01.050
   Lin YC, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024102
   Linghu E, 2005, ENDOSCOPY, V37, P1140, DOI 10.1055/s-870224
   Liu M, 2015, PROG POLYM SCI, V48, P111, DOI 10.1016/j.progpolymsci.2015.03.001
   Loh XJ, 2008, POLYMER, V49, P5084, DOI 10.1016/j.polymer.2008.08.061
   Loh XJ, 2008, BIOMATERIALS, V29, P3185, DOI 10.1016/j.biomaterials.2008.04.015
   Loh XJ, 2008, BIOMATERIALS, V29, P2164, DOI 10.1016/j.biomaterials.2008.01.016
   Loh XJ, 2007, EXPERT OPIN THER PAT, V17, P965, DOI 10.1517/13543776.17.8.965
   Loh XJ, 2007, BIOMATERIALS, V28, P4113, DOI 10.1016/j.biomaterials.2007.05-016
   Loh XJ, 2007, BIOMACROMOLECULES, V8, P585, DOI 10.1021/bm0607933
   Loh XJ, 2012, J MATER CHEM, V22, P21249, DOI 10.1039/c2jm33777k
   Loh XJ, 2010, MACROMOL SY, V296, P161, DOI 10.1002/masy.201051024
   Loh XJ, 2009, J PHYS CHEM B, V113, P11822, DOI 10.1021/jp903984r
   Loh XJ, 2009, MACROMOLECULES, V42, P194, DOI 10.1021/ma8019865
   Loh XJ, 2006, BIOMATERIALS, V27, P1841, DOI 10.1016/j.biomaterials.2005.10.038
   Low ZW, 2015, RSC ADV, V5, P57678, DOI 10.1039/c5ra09926a
   Lutz JF, 2008, J POLYM SCI POL CHEM, V46, P3459, DOI 10.1002/pola.22706
   Lutz JF, 2006, J AM CHEM SOC, V128, P13046, DOI 10.1021/ja065324n
   Lutz JF, 2006, MACROMOLECULES, V39, P893, DOI 10.1021/ma0517042
   Ma HW, 2004, ADV MATER, V16, P338, DOI 10.1002/adma.200305830
   Martin BC, 2008, J NEURAL ENG, V5, P221, DOI 10.1088/1741-2560/5/2/013
   Martin L, 2015, POLYM CHEM-UK, V6, P4875, DOI 10.1039/c5py00478k
   Matthes K, 2007, GASTROINTEST ENDOSC, V65, P448, DOI 10.1016/j.gie.2006.06.030
   Matyjaszewski K, 2012, MACROMOLECULES, V45, P4015, DOI 10.1021/ma3001719
   Mei-Chun L., 2014, BIOMED MATER, V9
   Mekhail Tarek M, 2002, Expert Opin Pharmacother, V3, P755
   Mirahmadi F, 2013, MAT SCI ENG C-MATER, V33, P4786, DOI 10.1016/j.msec.2013.07.043
   Moon HJ, 2012, CHEM SOC REV, V41, P4860, DOI 10.1039/c2cs35078e
   Moon HJ, 2011, BIOMACROMOLECULES, V12, P1234, DOI 10.1021/bm101518c
   Moreno E, 2014, INT J PHARMACEUT, V459, P1, DOI 10.1016/j.ijpharm.2013.11.030
   Nguyen VPN, 2011, SOFT MATTER, V7, P2150, DOI 10.1039/c0sm00764a
   Ning JY, 2013, REACT FUNCT POLYM, V73, P969, DOI 10.1016/j.reactfunctpolym.2012.11.005
   Nisbet DR, 2010, TISSUE ENG PT A, V16, P2833, DOI 10.1089/ten.TEA.2009.0677
   Nsereko S, 2002, BIOMATERIALS, V23, P2723, DOI 10.1016/S0142-9612(02)00005-4
   Park KM, 2008, MACROMOL RES, V16, P517, DOI 10.1007/BF03218553
   Park KM, 2009, ACTA BIOMATER, V5, P1956, DOI 10.1016/j.actbio.2009.01.040
   Park MH, 2014, ADV HEALTHC MATER, V3, P1782, DOI 10.1002/adhm.201400140
   Park MH, 2012, ADV FUNCT MATER, V22, P5118, DOI 10.1002/adfm.201201722
   Park MH, 2012, ACCOUNTS CHEM RES, V45, P424, DOI 10.1021/ar200162j
   Patel M., 2015, ADV HEALTHC MATER, V4, P1565
   Potta T, 2011, POLYM DEGRAD STABIL, V96, P1261, DOI 10.1016/j.polymdegradstab.2011.04.010
   Prasad A., 2015, IN SITU GELLING POLY, P215
   Rathi R. C., 2000, U.S. Patent, Patent No. [6004573 A, 6004573]
   Rothstein SN, 2009, BIOMATERIALS, V30, P1657, DOI 10.1016/j.biomaterials.2008.12.002
   ROWINSKY EK, 1993, SEMIN ONCOL, V20, P1
   Roy D, 2013, CHEM SOC REV, V42, P7214, DOI 10.1039/c3cs35499g
   SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   Shachaf Y, 2010, BIOMATERIALS, V31, P2836, DOI 10.1016/j.biomaterials.2009.12.050
   Shen WJ, 2015, BIOMACROMOLECULES, V16, P105, DOI 10.1021/bm501220a
   Shim WS, 2006, BIOMATERIALS, V27, P5178, DOI 10.1016/j.biomaterials.2006.05.038
   Shimada N, 2014, RSC ADV, V4, P52346, DOI 10.1039/c4ra10612a
   Shimada N, 2011, BIOMACROMOLECULES, V12, P3418, DOI 10.1021/bm2010752
   Soga O, 2004, BIOMACROMOLECULES, V5, P818, DOI 10.1021/bm049955q
   Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409
   Sun KH, 2006, BIOMACROMOLECULES, V7, P2871, DOI 10.1021/bm060512r
   Tate MC, 2001, BIOMATERIALS, V22, P1113, DOI 10.1016/S0142-9612(00)00348-3
   Thakur RRS, 2014, J CONTROL RELEASE, V176, P8, DOI 10.1016/j.jconrel.2013.12.020
   TISHLER RB, 1992, INT J RADIAT ONCOL, V22, P613, DOI 10.1016/0360-3016(92)90888-O
   TISHLER RB, 1992, CANCER RES, V52, P3495
   Torres AJ, 2011, BIOTECHNOL PROGR, V27, P1478, DOI 10.1002/btpr.665
   Tseng TC, 2015, ADV MATER, V27, P3518, DOI 10.1002/adma.201500762
   Tyler B, 2010, J NEUROSURG, V113, P210, DOI 10.3171/2009.11.JNS08162
   Tyler BM, 2012, J NEUROSURG-SPINE, V16, P93, DOI 10.3171/2011.9.SPINE11435
   Vancoillie G, 2014, PROG POLYM SCI, V39, P1074, DOI 10.1016/j.progpolymsci.2014.02.005
   Vellimana AK, 2013, J NEURO-ONCOL, V111, P229, DOI 10.1007/s11060-012-1014-1
   Vukelja SJ, 2007, ANTI-CANCER DRUG, V18, P283, DOI 10.1097/CAD.0b013e328011a51d
   Wan WB, 2015, J MATER CHEM B, V3, P1990, DOI 10.1039/c4tb01394h
   Wang T, 2009, EUR J HEART FAIL, V11, P14, DOI 10.1093/eurjhf/hfn009
   Ward MA, 2011, POLYMERS-BASEL, V3, P1215, DOI 10.3390/polym3031215
   Wei G, 2002, J CONTROL RELEASE, V83, P65, DOI 10.1016/S0168-3659(02)00175-X
   Williams R, 2013, EXPERT OPIN INV DRUG, V22, P9, DOI 10.1517/13543784.2013.739605
   Wu J, 2011, BIOMATERIALS, V32, P579, DOI 10.1016/j.biomaterials.2010.08.098
   Wu WQ, 2014, MOL PHARMACEUT, V11, P3378, DOI 10.1021/mp500019p
   Xia Y, 2015, EXP BIOL MED, V240, P593, DOI 10.1177/1535370214560957
   Ye HY, 2015, RSC ADV, V5, P48720, DOI 10.1039/c5ra08222f
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yu L, 2008, INT J PHARM, V348, P95, DOI 10.1016/j.ijpharm.2007.07.026
   Yu L, 2007, J POLYM SCI POL CHEM, V45, P1122, DOI 10.1002/pola.21876
   Yu L, 2014, BIOMATER SCI-UK, V2, P1100, DOI 10.1039/c4bm00029c
   Yu L, 2013, J PHARM SCI-US, V102, P4140, DOI 10.1002/jps.23735
   Yu L, 2013, BIOMATER SCI-UK, V1, P411, DOI 10.1039/c2bm00159d
   Yu L, 2012, MACROMOL RES, V20, P234, DOI 10.1007/s13233-012-0049-7
   Yu L, 2010, BIOMACROMOLECULES, V11, P2169, DOI 10.1021/bm100549q
   Yu L, 2009, BIOMACROMOLECULES, V10, P1547, DOI 10.1021/bm900145g
   Yun EJ, 2012, BIOMACROMOLECULES, V13, P1106, DOI 10.1021/bm2018596
   Zentner GM, 2001, J CONTROL RELEASE, V72, P203, DOI 10.1016/S0168-3659(01)00276-0
   Zhang H, 2008, MACROMOLECULES, V41, P6493, DOI 10.1021/ma7026484
   Zhang L, 2015, ACTA BIOMATER, V23, P271, DOI 10.1016/j.actbio.2015.05.005
   Zhang LS, 2007, J POLYM SCI POL CHEM, V45, P2617, DOI 10.1002/pola.22019
   Zhang Z, 2012, J BIOMED MATER RES B, V100B, P1599, DOI 10.1002/jbm.b.32728
   Zhang Z, 2011, BIOMATERIALS, V32, P4725, DOI 10.1016/j.biomaterials.2011.03.046
   Zhang Z, 2010, BIOMATERIALS, V31, P7873, DOI 10.1016/j.biomaterials.2010.07.014
   Zhou YM, 2007, LANGMUIR, V23, P13076, DOI 10.1021/la702548h
   Zhu WW, 2006, J BIOMED MATER RES B, V77B, P135, DOI 10.1002/jbm.b.30412
NR 171
TC 62
Z9 62
U1 39
U2 263
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD MAR
PY 2016
VL 2
IS 3
BP 295
EP 316
DI 10.1021/acsbiomaterials.5b00515
PG 22
WC Materials Science, Biomaterials
SC Materials Science
GA DG9IM
UT WOS:000372396000002
DA 2018-10-19
ER

PT J
AU Floros, MC
   Bortolatto, JF
   Oliveira, OB
   Salvador, SL
   Narine, SS
AF Floros, Michael C.
   Bortolatto, Janaina F.
   Oliveira, Osmir B.
   Salvador, Sergio L.
   Narine, Suresh S.
TI Antimicrobial Activity of Amphiphilic Triazole-Linked Polymers Derived
   from Renewable Sources
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article
DE biomimetic; antimicrobial polymer; amphiphilic; renewable; click
   chemistry; biomaterial
ID INDWELLING VASCULAR CATHETERS; ANTIBIOTIC-RESISTANCE;
   STAPHYLOCOCCUS-AUREUS; PATHOGENIC BACTERIA; ESCHERICHIA-COLI;
   MOLECULAR-WEIGHT; SATELLITE GROUPS; FATTY-ACIDS; IN-VITRO; SURFACES
AB Conventional engineered polymers are strong, stable, and can interact desirably within the human body in implants and medical devices. However, bacterial colonization of medical devices and implants constructed from these materials results in numerous hospital acquired infections (HAI) and deaths each year. Polytriazole based plastics containing triazole rings and fatty acid derivatives have been synthesized from biological sources without catalysts or solvents. In this study, three amphiphilic polytriazoles with varying triazole density and hydrophilic/hydrophobic segments demonstrated broad spectrum, contact antimicrobial properties against both Gram positive and negative bacteria. SEM analysis of bacteria killed by these polymers evidence membrane damage, indicating that these polymers act by direct contact with bacterial membranes. Surface hydrophobicity of these polymers increased with increasing triazole group density, which also improved the antimicrobial efficacy. This work demonstrates that amphiphilic polytriazoles have antimicrobial properties and that future utilization of triazole modified polymers may produce self-sterilizing materials which resist bacterial contamination and formation of antibiotic resistant organisms, ideal characteristics for medically relevant biomaterials.
C1 [Floros, Michael C.; Narine, Suresh S.] Trent Univ, Trent Ctr Biomat Res, Dept Phys & Astron, Peterborough, ON K9J 7B8, Canada.
   [Floros, Michael C.; Narine, Suresh S.] Trent Univ, Trent Ctr Biomat Res, Dept Chem, Peterborough, ON K9J 7B8, Canada.
   [Bortolatto, Janaina F.; Oliveira, Osmir B.] Univ Estadual Paulista, UNESP, Araraquara Sch Dent, Dept Restorat Dent, Araraquara, SP, Brazil.
   [Salvador, Sergio L.] Univ Sao Paulo, Dept Clin Anal, Sch Pharmaceut Sci, BR-14049 Ribeirao Preto, SP, Brazil.
RP Narine, SS (reprint author), Trent Univ, Trent Ctr Biomat Res, Dept Phys & Astron, Peterborough, ON K9J 7B8, Canada.; Narine, SS (reprint author), Trent Univ, Trent Ctr Biomat Res, Dept Chem, Peterborough, ON K9J 7B8, Canada.
EM sureshnarine@trentu.ca
RI Oliveira Junior, Osmir/C-2693-2016; Floros, Michael/O-9198-2016
OI Oliveira Junior, Osmir/0000-0002-2153-9887; Floros,
   Michael/0000-0001-9539-0782; Salvador, Sergio Luiz/0000-0002-4867-7294
FU Elevance Renewable Sciences; NSERC; Grain Farmers of Ontario; GPA-EDC;
   CAPES/DFATD; Industry Canada; Trent University
FX We thank Marina Del Arco for her technical assistance with the
   preparation of microbiological samples. The financial support from
   Elevance Renewable Sciences, NSERC, Grain Farmers of Ontario, GPA-EDC,
   CAPES/DFATD, Industry Canada, and Trent University is gratefully
   acknowledged.
CR ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   Afonin S, 2014, BBA-BIOMEMBRANES, V1838, P2260, DOI 10.1016/j.bbamem.2014.03.017
   Agalave SG, 2011, CHEM-ASIAN J, V6, P2696, DOI 10.1002/asia.201100432
   Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009
   Alexandridis P., 2000, AMPHIPHILIC BLOCK CO
   Bera S, 2012, MOLECULES, V17, P9129, DOI 10.3390/molecules17089129
   Bera S, 2010, BIOORG MED CHEM LETT, V20, P3031, DOI 10.1016/j.bmcl.2010.03.116
   Bossche H. V., 1984, PESTIC SCI, V15, P188
   Bouloussa O, 2008, CHEM COMMUN, P951, DOI 10.1039/b716026g
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   BUTCHER GW, 1976, J GEN MICROBIOL, V94, P290, DOI 10.1099/00221287-94-2-290
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Carlet J, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-11
   CHAMBERLAIN NR, 1991, INFECT IMMUN, V59, P4332
   Chen CZS, 2000, BIOMACROMOLECULES, V1, P473, DOI 10.1021/bm0055495
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   Dallmann A, 2011, CHEM-EUR J, V17, P14714, DOI 10.1002/chem.201102979
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Dennison SR, 2005, PROTEIN PEPTIDE LETT, V12, P31, DOI 10.2174/0929866053406084
   DYE ES, 1981, INFECT IMMUN, V32, P98
   El-Sagheer AH, 2011, P NATL ACAD SCI USA, V108, P11338, DOI 10.1073/pnas.1101519108
   Feng L, 2002, ADV MATER, V14, P1857, DOI 10.1002/adma.200290020
   Feng L., 2003, ANGEW CHEM, V115, P824, DOI DOI 10.1002/ANGE.200390181
   Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3
   Floros MC, 2014, BIOMED RES INT, DOI 10.1155/2014/792901
   Fulmer PA, 2011, ACS APPL MATER INTER, V3, P2878, DOI 10.1021/am2005465
   GOODRICH MS, 1991, ENVIRON TOXICOL CHEM, V10, P509, DOI 10.1897/1552-8618(1991)10[509:AALTOW]2.0.CO;2
   Gottenbos B, 2002, BIOMATERIALS, V23, P1417, DOI 10.1016/S0142-9612(01)00263-0
   Guggenbichler JP, 2011, GMS HYG INFECT CONTR, V6, DOI 10.3205/dgkh000175
   Haldar J, 2006, P NATL ACAD SCI USA, V103, P17667, DOI 10.1073/pnas.0608803103
   Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267
   HAYNIE SL, 1995, ANTIMICROB AGENTS CH, V39, P301, DOI 10.1128/AAC.39.2.301
   Huang CM, 2011, BIOMATERIALS, V32, P214, DOI 10.1016/j.biomaterials.2010.08.076
   KANAI K, 1979, JPN J MED SCI BIOL, V32, P135, DOI 10.7883/yoken1952.32.135
   KANAZAWA A, 1993, J POLYM SCI POL CHEM, V31, P1441, DOI 10.1002/pola.1993.080310611
   KATO K, 1978, INFECT IMMUN, V19, P12
   Kenawy ER, 2007, BIOMACROMOLECULES, V8, P1359, DOI 10.1021/bm061150q
   Kugler R, 2005, MICROBIOL-SGM, V151, P1341, DOI 10.1099/mic.0.27526-0
   Kuroda K, 2005, J AM CHEM SOC, V127, P4128, DOI 10.1021/ja044205+
   Kurt P, 2007, LANGMUIR, V23, P4719, DOI 10.1021/la063718m
   Le Droumaguet C, 2010, CHEM SOC REV, V39, P1233, DOI 10.1039/b901975h
   Leung E, 2011, B WORLD HEALTH ORGAN, V89, P390, DOI 10.2471/BLT.11.088435
   Li P, 2011, NAT MATER, V10, P149, DOI [10.1038/nmat2915, 10.1038/NMAT2915]
   LINDSTEDT M, 1990, ANTIMICROB AGENTS CH, V34, P1949, DOI 10.1128/AAC.34.10.1949
   Liu XM, 2004, BIOMATERIALS, V25, P1929, DOI 10.1016/j.biomaterials.2003.08.023
   Lynch SV, 2007, ANTIMICROB AGENTS CH, V51, P3650, DOI 10.1128/AAC.00601-07
   Mah TF, 2003, NATURE, V426, P306, DOI 10.1038/nature02122
   Maki DG, 2006, MAYO CLIN PROC, V81, P1159, DOI 10.4065/81.9.1159
   Miao SD, 2014, ACTA BIOMATER, V10, P1692, DOI 10.1016/j.actbio.2013.08.040
   Milovic NM, 2005, BIOTECHNOL BIOENG, V90, P715, DOI 10.1002/bit.20454
   Munoz-Bonilla A, 2012, PROG POLYM SCI, V37, P281, DOI 10.1016/j.progpolymsci.2011.08.005
   Nathan C, 2014, NEW ENGL J MED, V371, P1761, DOI 10.1056/NEJMp1408040
   PASSERINI L, 1992, CRIT CARE MED, V20, P665, DOI 10.1097/00003246-199205000-00020
   Pye AD, 2009, J HOSP INFECT, V72, P104, DOI 10.1016/j.jhin.2009.02.010
   RAAD II, 1992, CLIN INFECT DIS, V15, P197, DOI 10.1093/clinids/15.2.197
   Roberts DW, 2003, QSAR COMB SCI, V22, P220, DOI 10.1002/qsar.200390015
   Rostovtsev V. V., 2002, ANGEW CHEM, V114, P2708, DOI DOI 10.1002/1521-3757(20020715)114:14<2708::AID-ANGE2708>3.0.CO;2-0
   Russell TP, 2002, SCIENCE, V297, P964, DOI 10.1126/science.1075997
   Sambhy V, 2008, LANGMUIR, V24, P7549, DOI 10.1021/la800858z
   Schlegel A, 2011, J CONTROL RELEASE, V152, P393, DOI 10.1016/j.jconrel.2011.03.031
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Siedenbiedel F, 2012, POLYMERS-BASEL, V4, P46, DOI 10.3390/polym4010046
   Tew GN, 2002, P NATL ACAD SCI USA, V99, P5110, DOI 10.1073/pnas.082046199
   Thiyagarajan D, 2014, CHEM COMMUN, V50, P7434, DOI 10.1039/c4cc02354d
   Tikhonov VE, 2006, CARBOHYD POLYM, V64, P66, DOI 10.1016/j.carbpol.2005.10.021
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Timofeeva L, 2011, APPL MICROBIOL BIOT, V89, P475, DOI 10.1007/s00253-010-2920-9
   Trautner BW, 2004, ARCH INTERN MED, V164, P842, DOI 10.1001/archinte.164.8.842
   Vial F, 2007, SOFT MATTER, V3, P75, DOI 10.1039/b613003h
   Waschinski CJ, 2008, BIOMACROMOLECULES, V9, P1764, DOI 10.1021/bm7013944
   Waschinski CJ, 2004, MACROMOL BIOSCI, V5, P149, DOI 10.1002/mabi.200400169
   Weston DP, 2009, J ENVIRON QUAL, V38, P238, DOI 10.2134/jeq2008.0109
   Wilkins M C, 1993, Respir Care, V38, P1155
   Williams CK, 2008, POLYM REV, V48, P1, DOI 10.1080/15583720701834133
   Wiradharma N, 2011, BIOMATERIALS, V32, P2204, DOI 10.1016/j.biomaterials.2010.11.054
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020
NR 77
TC 8
Z9 8
U1 0
U2 18
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD MAR
PY 2016
VL 2
IS 3
BP 336
EP 343
DI 10.1021/acsbiomaterials.5b00412
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA DG9IM
UT WOS:000372396000005
DA 2018-10-19
ER

PT J
AU Nickels, JD
   Atkinson, J
   Papp-Szabo, E
   Stanley, C
   Diallo, SO
   Perticaroli, S
   Baylis, B
   Mahon, P
   Ehlers, G
   Katsaras, J
   Dutcher, JR
AF Nickels, Jonathan D.
   Atkinson, John
   Papp-Szabo, Erzsebet
   Stanley, Christopher
   Diallo, Souleymane O.
   Perticaroli, Stefania
   Baylis, Benjamin
   Mahon, Perry
   Ehlers, Georg
   Katsaras, John
   Dutcher, John R.
TI Structure and Hydration of Highly-Branched, Monodisperse Phytoglycogen
   Nanoparticles
SO BIOMACROMOLECULES
LA English
DT Article
ID WATER-PROTEIN FLUCTUATIONS; NEUTRON-SCATTERING; AQUEOUS-SOLUTIONS;
   LIGHT-SCATTERING; DIELECTRIC-RELAXATION; BIOLOGICAL-MEMBRANES; PHYSICAL
   CONSTRAINTS; GLYCOGEN STRUCTURE; SUPERCOOLED WATER; TIME SCALES
AB Phytoglycogen is a naturally occurring polysaccharide nano particle made up of extensively branched glucose monomers. It has a number of unusual and advantageous properties, such as high water retention, low viscosity, and high stability in water, which make this biomaterial a promising candidate for a wide variety of applications. In this study, we have characterized the structure and hydration of aqueous dispersions of phytoglycogen nanoparticles using neutron scattering. Small angle neutron scattering results suggest that the phytoglycogen nanoparticles behave similar to hard sphere colloids and are hydrated by a large number of water molecules (each nanoparticle contains between 250% and 285% of its mass in water). This suggests that phytoglycogen is an ideal sample in which to study the dynamics of hydration water. To this end, we used quasielastic neutron scattering (QENS) to provide an independent and consistent measure of the hydration number, and to estimate the retardation factor (or degree of water slow-down) for hydration wafer translational motions. These data demonstrate a length-scale dependence in the measured retardation factors that clarifies the origin of discrepancies between retardation factor values reported for hydration water using different experimental techniques. The present approach can be generalized to other systems containing nanoconfined water.
C1 [Nickels, Jonathan D.; Katsaras, John] Oak Ridge Natl Lab, Joint Inst Neutron Sci, Oak Ridge, TN 37831 USA.
   [Nickels, Jonathan D.; Katsaras, John] Univ Tennessee, Dept Phys, Knoxville, TN 37996 USA.
   [Atkinson, John; Papp-Szabo, Erzsebet; Perticaroli, Stefania; Baylis, Benjamin; Mahon, Perry; Dutcher, John R.] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada.
   [Nickels, Jonathan D.; Stanley, Christopher; Katsaras, John] Oak Ridge Natl Lab, Biol & Soft Matter Div, Oak Ridge, TN 37831 USA.
   [Diallo, Souleymane O.] Oak Ridge Natl Lab, Chem & Engn Mat Div, Oak Ridge, TN 37831 USA.
   [Ehlers, Georg] Oak Ridge Natl Lab, Quantum Condensed Matter Div, POB 2008, Oak Ridge, TN 37831 USA.
RP Dutcher, JR (reprint author), Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada.
EM dutcher@uoguelph.ca
RI Ehlers, Georg/B-5412-2008; Nickels, Jonathan/I-1913-2012
OI Ehlers, Georg/0000-0003-3513-508X; Nickels,
   Jonathan/0000-0001-8351-7846; Stanley, Christopher/0000-0002-4226-7710;
   Katsaras, John/0000-0002-8937-4177
FU Ontario Ministry of Agriculture (OMAF); Natural Sciences and Engineering
   Research Council (NSERC) of Canada; Senior Canada Research Chair in Soft
   Matter and Biological Physics; U.S. DOE BES through EPSCoR
   [DE-FG02-08ER46528]; US DOE [DE-AC05-00OR22725]
FX The authors would like to thank Phil Whiting, Anton Korenevski, and
   Michael Grossutti for discussions that have greatly benefitted this
   work. Mirexus Biotechnologies, Inc. generously supplied the monodisperse
   phytoglycogen nano particles. This work was funded by grants from the
   Ontario Ministry of Agriculture (OMAF) and the Natural Sciences and
   Engineering Research Council (NSERC) of Canada (J.R.D.). J.R.D. is the
   recipient of a Senior Canada Research Chair in Soft Matter and
   Biological Physics. J.D.N. is partially supported by the U.S. DOE BES
   through EPSCoR Grant No. DE-FG02-08ER46528. J.K. is supported through
   the Scientific User Facilities Division of the DOE Office of Basic
   Energy Sciences under US DOE Contract No. DE-AC05-00OR22725. Facilities
   as the Spallation Neutron Source are managed by UT-Battelle, LLC under
   US DOE Contract No. DE-AC05-00OR22725.
CR Arnold O, 2014, NUCL INSTRUM METH A, V764, P156, DOI 10.1016/j.nima.2014.07.029
   Azuah RT, 2009, J RES NATL INST STAN, V114, P341, DOI 10.6028/jres.114.025
   Ballauff M, 2004, ANGEW CHEM INT EDIT, V43, P2998, DOI 10.1002/anie.200300602
   BELLISSENTFUNEL MC, 1992, J PHYS I, V2, P995
   Ben Ishai P, 2013, J PHYS CHEM B, V117, P7724, DOI 10.1021/jp4030415
   Boris D, 1996, MACROMOLECULES, V29, P7251, DOI 10.1021/ma960397k
   Chiavazzo E., 2014, NAT COMMUN, V5, P1
   Denisov VP, 1996, FARADAY DISCUSS, V103, P227, DOI 10.1039/fd9960300227
   Ehlers G, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3626935
   Halle B, 2004, PHILOS T R SOC B, V359, P1207, DOI 10.1098/rstb.2004.1499
   Huang L, 2011, CARBOHYD POLYM, V83, P1665, DOI 10.1016/j.carbpol.2010.10.030
   Kajiura H, 2010, CARBOHYD RES, V345, P817, DOI 10.1016/j.carres.2010.01.013
   LESCANEC RL, 1990, MACROMOLECULES, V23, P2280, DOI 10.1021/ma00210a026
   Li TP, 2007, J AM CHEM SOC, V129, P3376, DOI 10.1021/ja0685957
   Liu AJ, 1998, NATURE, V396, P21, DOI 10.1038/23819
   Lupi L, 2012, J PHYS CHEM B, V116, P14760, DOI 10.1021/jp3079869
   Mamontov E, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3626214
   MANNERS DJ, 1991, CARBOHYD POLYM, V16, P37, DOI 10.1016/0144-8617(91)90071-J
   MANSFIELD ML, 1993, MACROMOLECULES, V26, P4262, DOI 10.1021/ma00068a029
   MASHIMO S, 1987, J PHYS CHEM-US, V91, P6337, DOI 10.1021/j100309a005
   Mattea C, 2008, BIOPHYS J, V95, P2951, DOI 10.1529/biophysj.108.135194
   Melendez R, 1997, J MOL EVOL, V45, P446, DOI 10.1007/PL00006249
   Melendez R, 1998, BIOPHYS J, V75, P106, DOI 10.1016/S0006-3495(98)77498-3
   Melendez R, 1999, BIOPHYS J, V77, P1327, DOI 10.1016/S0006-3495(99)76982-1
   NAGELE G, 1993, PHYS REV E, V47, P2562, DOI 10.1103/PhysRevE.47.2562
   Nickels JD, 2015, MEMBRANE HYDRATION, P45, DOI DOI 10.1007/978-3-319-19060-0_3
   Nickels JD, 2012, BIOPHYS J, V103, P1566, DOI 10.1016/j.bpj.2012.08.046
   Oleinikova A, 2005, J PHYS CHEM B, V109, P1988, DOI 10.1021/jp045903j
   Pal SK, 2002, J PHYS CHEM B, V106, P12376, DOI 10.1021/jp0213506
   Pal SK, 2002, P NATL ACAD SCI USA, V99, P1763, DOI 10.1073/pnas.042697899
   Paolantoni M, 2009, J PHYS CHEM B, V113, P7874, DOI 10.1021/jp9004983
   Paolantoni M., 2007, J CHEM PHYS, V127
   PEDERSEN JS, 1994, J APPL CRYSTALLOGR, V27, P595, DOI 10.1107/S0021889893013810
   PERCUS JK, 1958, PHYS REV, V110, P1, DOI 10.1103/PhysRev.110.1
   Perticaroli S, 2015, J PHYS CHEM LETT, V6, P4018, DOI 10.1021/acs.jpclett.5b01890
   Perticaroli S, 2013, J PHYS CHEM B, V117, P7729, DOI 10.1021/jp403665w
   Perticaroli S, 2010, J PHYS CHEM B, V114, P8262, DOI 10.1021/jp101896f
   Petrache HI, 1997, BIOPHYS J, V72, P2237, DOI 10.1016/S0006-3495(97)78867-2
   Powell PO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121337
   Putaux JL, 2006, BIOMACROMOLECULES, V7, P1720, DOI 10.1021/bm050988v
   Qvist J, 2008, J AM CHEM SOC, V130, P10345, DOI 10.1021/ja802668w
   Qvist J, 2009, FARADAY DISCUSS, V141, P131, DOI 10.1039/b806194g
   Santucci SC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.225701
   Sasisanker P, 2008, CHEMPHYSCHEM, V9, P2802, DOI 10.1002/cphc.200800508
   Sears V. F, 1992, NEUTRON NEWS, V3, P26, DOI [10.1080/10448639208218770, DOI 10.1080/10448639208218770]
   Suzuki T, 2003, J CHEM PHYS, V119, P10133, DOI 10.1063/1.1619953
   Takata H, 2009, CARBOHYD RES, V344, P654, DOI 10.1016/j.carres.2009.01.008
   Toppozini L., 2012, ISRN BIOPHYS, V2012, P1
   Toppozini L, 2015, SOFT MATTER, V11, P8354, DOI 10.1039/c5sm01713k
   Torre R, 2004, NATURE, V428, P296, DOI 10.1038/nature02409
   Trappe V, 2001, NATURE, V411, P772, DOI 10.1038/35081021
   VINEYARD GH, 1958, PHYS REV, V110, P999, DOI 10.1103/PhysRev.110.999
   Weik M, 2005, BIOPHYS J, V89, P3639, DOI 10.1529/biophysj.104.055749
   Wong KS, 2003, J CEREAL SCI, V37, P139, DOI 10.1006/jcrs.2002.0485
   Wood K, 2007, P NATL ACAD SCI USA, V104, P18049, DOI 10.1073/pnas.0706566104
   YUN SH, 1993, CARBOHYD RES, V243, P307, DOI 10.1016/0008-6215(93)87035-Q
   Zanotti JM, 1999, PHYS REV E, V59, P3084, DOI 10.1103/PhysRevE.59.3084
   Zhang LY, 2007, P NATL ACAD SCI USA, V104, P18461, DOI 10.1073/pnas.0707647104
   Zhang LY, 2009, J AM CHEM SOC, V131, P10677, DOI 10.1021/ja902918p
   Zhao JK, 2010, J APPL CRYSTALLOGR, V43, P1068, DOI 10.1107/S002188981002217X
   Zook TC, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.015502
NR 61
TC 9
Z9 9
U1 8
U2 39
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAR
PY 2016
VL 17
IS 3
BP 735
EP 743
DI 10.1021/acs.biomac.5b01393
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA DG9GW
UT WOS:000372391800004
PM 26866896
DA 2018-10-19
ER

PT J
AU Xu, SJ
   Mu, JS
   Zhang, JQ
   Ping, B
AF Xu Shijun
   Mu Junsheng
   Zhang Jianqun
   Bo Ping
TI Invitro three-dimensional coculturing
   poly3-hydroxybutyrate-co-3-hydroxyhexanoate with mouse-induced
   pluripotent stem cells for myocardial patch application
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Vitamin C; mouse-induced pluripotent stem cells; cardiomyocytes; induced
   differentiation; poly3-hydroxybutyrate-co-3-hydroxyhexanoate film;
   myocardial patch
ID DIFFERENTIATION; SCAFFOLDS; REPAIR
AB Identifying a suitable polymeric biomaterial for myocardial patch repair following myocardial infarction, cerebral infarction, and cartilage injury is essential. This study aimed to investigate the effect of the novel polymer material, poly3-hydroxybutyrate-co-3-hydroxyhexanoate, on the adhesion, proliferation, and differentiation of mouse-induced pluripotent stem cells invitro. Mouse-induced pluripotent stem cells were isolated, expanded, and cultured on either two-dimensional or three-dimensional poly3-hydroxybutyrate-co-3-hydroxyhexanoate films (membranes were perforated to imitate three-dimensional space). Following attachment onto the films, mouse-induced pluripotent stem cell morphology was visualized using scanning electron microscopy. Cell vitality was detected using the Cell Counting Kit-8 assay and cell proliferation was observed using fluorescent 4',6-diamidino-2-phenylindole (DAPI) staining. Mouse-induced pluripotent stem cells were induced into cardiomyocytes by differentiation medium containing vitamin C. A control group in the absence of an inducer was included. Mouse-induced pluripotent stem cell survival and differentiation were observed using immunofluorescence and flow cytometry, respectively. Mouse-induced pluripotent stem cells growth, proliferation, and differentiation were observed on both two-dimensional and three-dimensional poly3-hydroxybutyrate-co-3-hydroxyhexanoate films. Vitamin C markedly improved the efficiency of mouse-induced pluripotent stem cells differentiation into cardiomyocytes on poly3-hydroxybutyrate-co-3-hydroxyhexanoate films. Three-dimensional culture was better at promoting mouse-induced pluripotent stem cell proliferation and differentiation compared with two-dimensional culture.
C1 [Xu Shijun; Mu Junsheng; Zhang Jianqun; Bo Ping] Capital Med Univ, Affiliated Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Cardiac Surg, Beijing 100029, Peoples R China.
RP Mu, JS (reprint author), Capital Med Univ, Anzhen Hosp, Dept Cardiac Surg, Beijing 100029, Peoples R China.
EM wesleymu@hotmail.com
FU Chaoyang District, Beijing Science and Technology Program [SF1417];
   Capital Medical University student technological innovation program
   [XSKY2015192]; Beijing Anzhen Hospital Science Research Fund [15P11]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: 2014
   Chaoyang District, Beijing Science and Technology Program (SF1417); 2015
   Capital Medical University student technological innovation program
   (XSKY2015192); 2015 Beijing Anzhen Hospital Science Research Fund
   (15P11).
CR Al Kindi AH, 2011, EUR J CARDIO-THORAC, V39, P241, DOI 10.1016/j.ejcts.2010.03.066
   Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3
   Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Dong Y, 2010, BIOMATERIALS, V31, P8921, DOI 10.1016/j.biomaterials.2010.08.001
   Jain K, 2014, METHODS MOL BIOL, V1194, P247, DOI 10.1007/978-1-4939-1215-5_13
   Li X, 2013, PLOS ONE, V8
   Li XL, 2015, J BIOMED MATER RES A, V103, P1169, DOI 10.1002/jbm.a.35265
   Lu Haixia, 2012, Sheng Wu Gong Cheng Xue Bao, V28, P1216
   Matar AA, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-440
   Murry CE, 2006, J AM COLL CARDIOL, V47, P1777, DOI 10.1016/j.jacc.2006.02.002
   Nelson TJ, 2009, CIRCULATION, V120, P408, DOI 10.1161/CIRCULATIONAHA.109.865154
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Wu Q, 2009, ARTIF CELL BLOOD SUB, V37, P1, DOI 10.1080/10731190802664429
   Wu Song, 2008, Sheng Wu Gong Cheng Xue Bao, V24, P610, DOI 10.1016/S1872-2075(08)60030-8
   Yu Haiying, 2009, J Orthop Surg Res, V4, P5, DOI 10.1186/1749-799X-4-5
   Zhao K, 2003, BIOMATERIALS, V24, P1041, DOI 10.1016/S0142-9612(02)00426-X
NR 17
TC 1
Z9 2
U1 1
U2 6
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAR
PY 2016
VL 30
IS 8
BP 1273
EP 1282
DI 10.1177/0885328215612115
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DH3WR
UT WOS:000372718000012
PM 26873635
DA 2018-10-19
ER

PT J
AU Zhang, XB
   Wang, Q
   Ba, ZX
   Wang, ZZ
   Xue, YJ
AF Zhang, Xiaobo
   Wang, Qian
   Ba, Zhixin
   Wang, Zhangzhong
   Xue, Yajun
TI Improved Corrosion Resistance of As-Extruded GZ51K Biomagnesium Alloy
   with High Mechanical Properties by Aging Treatment
SO JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE
LA English
DT Article
DE aging treatment; biomaterial; corrosion; LPSO; magnesium alloy;
   mechanical property
ID ZN-ZR ALLOYS; MAGNESIUM ALLOYS; BIOMEDICAL APPLICATIONS; BIOCORROSION
   BEHAVIOR; MG; MICROSTRUCTURE; IMPLANTS; BIOMATERIALS; STENTS
AB Effects of aging treatment on microstructure, mechanical properties, and corrosion behavior of the as-extruded Mg-5Gd-1Zn-0.6Zr (GZ51K, wt.%) alloy were investigated. Microstructure was observed by optical microscopy and scanning electron microscopy, mechanical properties were tested on a tensile test machine and a microhardness tester, and corrosion behavior was evaluated by mass loss and polarization tests. It is found that most of equiaxed alpha-Mg grains have long-period stacking ordered (LPSO) structure, and some of them have no LPSO structure. Long-elongated grains are formed in the as-extruded alloy due to partial recrystallization and disappear after being aged at 200 and 220 A degrees C. The as-extruded alloy exhibits both high-yield strength and high ductility. The mechanical properties of the alloy are not apparently enhanced, but the corrosion resistance is significantly improved after aging treatment. Moreover, the alloy with LPSO structure presents uniform corrosion mode in simulated body fluid. The GZ51K alloy with high mechanical properties and uniform corrosion behavior is worthy to be further investigated for biomedical applications.
C1 [Zhang, Xiaobo; Wang, Qian; Ba, Zhixin; Wang, Zhangzhong; Xue, Yajun] Nanjing Inst Technol, Sch Mat Sci & Engn, Nanjing 211167, Jiangsu, Peoples R China.
   [Zhang, Xiaobo; Wang, Qian; Ba, Zhixin; Wang, Zhangzhong; Xue, Yajun] Jiangsu Key Lab Adv Struct Mat & Applicat Technol, Nanjing 211167, Jiangsu, Peoples R China.
RP Zhang, XB (reprint author), Nanjing Inst Technol, Sch Mat Sci & Engn, Nanjing 211167, Jiangsu, Peoples R China.; Zhang, XB (reprint author), Jiangsu Key Lab Adv Struct Mat & Applicat Technol, Nanjing 211167, Jiangsu, Peoples R China.
EM xbxbzhang2003@163.com
FU National Natural Science Foundation of China [51301089]; Natural Science
   Foundation of Jiangsu Province [BK20130745]; Jiangsu Key Laboratory of
   Advanced Structural Materials and Application Technology [ASMA201503];
   Qing Lan Project of Jiangsu Province
FX This project was supported by the National Natural Science Foundation of
   China (51301089), the Natural Science Foundation of Jiangsu Province
   (BK20130745), the Opening Project of Jiangsu Key Laboratory of Advanced
   Structural Materials and Application Technology (ASMA201503), and the
   Qing Lan Project of Jiangsu Province.
CR Atrens A, 2011, MATER SCI ENG B-ADV, V176, P1609, DOI 10.1016/j.mseb.2010.12.017
   Chen K, 2015, CORROS REV, V33, P101, DOI 10.1515/corrrev-2015-0007
   Chen YJ, 2014, ACTA BIOMATER, V10, P4561, DOI 10.1016/j.actbio.2014.07.005
   Du H, 2011, MATER CHEM PHYS, V125, P568, DOI 10.1016/j.matchemphys.2010.10.015
   Gao HY, 2015, MATER LETT, V146, P30, DOI 10.1016/j.matlet.2015.01.136
   Jeong YS, 2014, CORROS SCI, V82, P392, DOI 10.1016/j.corsci.2014.01.041
   Kirkland NT, 2012, CORROS ENG SCI TECHN, V47, P322, DOI 10.1179/1743278212Y.0000000034
   Kirkland NT, 2012, ACTA BIOMATER, V8, P925, DOI 10.1016/j.actbio.2011.11.014
   Li H, 2014, MATER DESIGN, V58, P43, DOI 10.1016/j.matdes.2014.01.031
   Li T, 2015, J MATER SCI TECHNOL, V31, P744, DOI 10.1016/j.jmst.2015.02.001
   Li X, 2015, BIOMATERIALS, V49, P135, DOI 10.1016/j.biomaterials.2015.01.060
   Liu F, 2015, MAT SCI ENG C-MATER, V48, P400, DOI 10.1016/j.msec.2014.12.024
   Liu K, 2010, MATER DESIGN, V31, P210, DOI 10.1016/j.matdes.2009.06.030
   Lu FM, 2014, MAT SCI ENG A-STRUCT, V594, P330, DOI 10.1016/j.msea.2013.11.081
   Manivannan S, 2015, J MATER ENG PERFORM, V24, P1649, DOI 10.1007/s11665-015-1432-2
   Manivasagam G, 2014, MATER SCI TECH-LOND, V30, P515, DOI 10.1179/1743284713Y.0000000500
   Qin H, 2015, BIOMATERIALS, V53, P211, DOI 10.1016/j.biomaterials.2015.02.096
   Shao XH, 2010, ACTA MATER, V58, P4760, DOI 10.1016/j.actamat.2010.05.012
   Wang ZH, 2014, PROG NAT SCI-MATER, V24, P423, DOI 10.1016/j.pnsc.2014.08.008
   Wu YJ, 2009, J MATER RES, V24, P3596, DOI 10.1557/JMR.2009.0425
   Zhang JS, 2013, MAT SCI ENG A-STRUCT, V585, P268, DOI 10.1016/j.msea.2013.07.049
   Zhang L., 2015, MAT SCI TECHNOL, V31, P1088
   Zhang XB, 2015, MATER SCI TECH-LOND, V31, P866, DOI 10.1179/1743284714Y.0000000661
   Zhang XB, 2014, MATER TECHNOL, V29, P179, DOI 10.1179/1753555714Y.0000000129
   Zhang XB, 2013, MATER TECHNOL, V28, P155, DOI 10.1179/1753555712Y.0000000048
   Zhang XB, 2014, T NONFERR METAL SOC, V24, P3797, DOI 10.1016/S1003-6326(14)63535-4
   Zhang XB, 2015, MATER LETT, V138, P212, DOI 10.1016/j.matlet.2014.09.133
   Zhang XB, 2014, CORROS SCI, V88, P1, DOI 10.1016/j.corsci.2014.07.004
   Zhang XB, 2014, ACTA METALL SIN, V50, P979
   Zhao CY, 2015, MATER DESIGN, V70, P60, DOI 10.1016/j.matdes.2014.12.041
   Zheng YF, 2014, MAT SCI ENG R, V77, P1, DOI 10.1016/j.mser.2014.01.001
   Zhou JC, 2014, J MATER ENG PERFORM, V23, P181, DOI 10.1007/s11665-013-0751-4
NR 32
TC 9
Z9 9
U1 2
U2 33
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-9495
EI 1544-1024
J9 J MATER ENG PERFORM
JI J. Mater. Eng. Perform.
PD MAR
PY 2016
VL 25
IS 3
BP 719
EP 725
DI 10.1007/s11665-016-1941-7
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA DG8CD
UT WOS:000372309100001
DA 2018-10-19
ER

PT J
AU Wise, SG
   Liu, HJ
   Yeo, GC
   Michael, PL
   Chan, AHP
   Ngo, AKY
   Bilek, MMM
   Bao, SS
   Weiss, AS
AF Wise, Steven G.
   Liu, Hongjuan
   Yeo, Giselle C.
   Michael, Praveesuda L.
   Chan, Alex H. P.
   Ngo, Alan K. Y.
   Bilek, Marcela M. M.
   Bao, Shisan
   Weiss, Anthony S.
TI Blended Polyurethane and Tropoelastin as a Novel Class of Biologically
   Interactive Elastomer
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID TISSUE ENGINEERING APPLICATIONS; RECOMBINANT HUMAN TROPOELASTIN; IN-VIVO
   BIOSTABILITY; VASCULAR GRAFT; MECHANICAL-PROPERTIES; PORE-SIZE;
   SCAFFOLDS; ELASTIN; COLLAGEN; REGION
AB Polyurethanes are versatile elastomers but suffer from biological limitations such as poor control over cell attachment and the associated disadvantages of increased fibrosis. We address this problem by presenting a novel strategy that retains elasticity while modulating biological performance. We describe a new biomaterial that comprises a blend of synthetic and natural elastomers: the biostable polyurethane Elast-Eon and the recombinant human tropoelastin protein. We demonstrate that the hybrid constructs yield a class of coblended elastomers with unique physical properties. Hybrid constructs displayed higher elasticity and linear stress-strain responses over more than threefold strain. The hybrid materials showed increased overall porosity and swelling in comparison to polyurethane alone, facilitating enhanced cellular interactions. In vitro, human dermal fibroblasts showed enhanced proliferation, while in vivo, following subcutaneous implantation in mice, hybrid scaffolds displayed a reduced fibrotic response and tunable degradation rate. To our knowledge, this is the first example of a blend of synthetic and natural elastomers and is a promising approach for generating tailored bioactive scaffolds for tissue repair.
C1 [Wise, Steven G.; Michael, Praveesuda L.; Chan, Alex H. P.] Heart Res Inst, Sydney, NSW, Australia.
   [Wise, Steven G.; Liu, Hongjuan; Michael, Praveesuda L.; Chan, Alex H. P.; Bao, Shisan] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.
   [Wise, Steven G.; Yeo, Giselle C.; Ngo, Alan K. Y.; Weiss, Anthony S.] Univ Sydney, Sch Mol Biosci, Charles Perkins Ctr D17, Sydney, NSW 2006, Australia.
   [Liu, Hongjuan; Bao, Shisan] Univ Sydney, Discipline Pathol, Sydney, NSW 2006, Australia.
   [Liu, Hongjuan; Bao, Shisan] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia.
   [Liu, Hongjuan; Yeo, Giselle C.; Bao, Shisan; Weiss, Anthony S.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.
   [Liu, Hongjuan; Bao, Shisan; Weiss, Anthony S.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia.
   [Bilek, Marcela M. M.] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia.
RP Weiss, AS (reprint author), Univ Sydney, Sch Mol Biosci, Charles Perkins Ctr D17, Sydney, NSW 2006, Australia.
EM tony.weiss@sydney.edu.au
RI Wise, Steven/G-2630-2018
OI Wise, Steven/0000-0001-7964-819X; Yeo, Giselle/0000-0001-6071-8899;
   Bilek, Marcela/0000-0003-3363-2664; Chan, Alex Ho
   Pang/0000-0002-1244-7673; WEISS, ANTHONY/0000-0002-8106-4836
FU Australian Research Council; National Institutes of Health [EB014283];
   Sydney Medical School, University of Sydney
FX The authors acknowledge funding from the Australian Research Council
   (M.M.M.B., A.S.W., and S.B.) and National Institutes of Health
   (EB014283; A.S.W.). A.S.W. is the Scientific Founder of Elastagen Pty
   Ltd. They also acknowledge a postgraduate scholarship from The Sydney
   Medical School, University of Sydney (H.L.). The authors declare no
   conflict of interest in this work. They also acknowledge the facilities
   as well as scientific and technical assistance at the Australian Centre
   for Microscopy and Microanalysis.
CR Ajalloueian F, 2014, BIOMATERIALS, V35, P5741, DOI 10.1016/j.biomaterials.2014.04.002
   Almine JF, 2010, CHEM SOC REV, V39, P3371, DOI 10.1039/b919452p
   Bax DV, 2014, BIOMATERIALS, V35, P6797, DOI 10.1016/j.biomaterials.2014.04.082
   Bax DV, 2009, J BIOL CHEM, V284, P28616, DOI 10.1074/jbc.M109.017525
   Bernacca GM, 2002, BIOMATERIALS, V23, P45, DOI 10.1016/S0142-9612(01)00077-1
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Collins TJ, 2007, BIOTECHNIQUES, V43, P25
   Detta N, 2010, J MATER SCI-MATER M, V21, P1761, DOI 10.1007/s10856-010-4006-8
   Gunatillake PA, 2000, J APPL POLYM SCI, V76, P2026, DOI 10.1002/(SICI)1097-4628(20000628)76:14<2026::AID-APP5>3.0.CO;2-X
   Gunatillake PA, 2003, AUST J CHEM, V56, P545, DOI 10.1071/CH02168
   Heo DN, 2013, J BIOMED NANOTECHNOL, V9, P511, DOI 10.1166/jbn.2013.1509
   Jia L, 2014, J BIOMATER APPL, V29, P364, DOI 10.1177/0885328214529002
   Klumpp D, 2012, J BIOMED MATER RES A, V100A, P2302, DOI 10.1002/jbm.a.34172
   Lee BK, 2012, BIOMATERIALS, V33, P9027, DOI 10.1016/j.biomaterials.2012.09.008
   Lee P, 2014, J BIOL CHEM, V289, P1467, DOI 10.1074/jbc.M113.518381
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Liu HJ, 2014, BIOMATERIALS, V35, P5138, DOI 10.1016/j.biomaterials.2014.03.024
   Loh QL, 2013, TISSUE ENG PART B-RE, V19, P485, DOI [10.1089/ten.TEB.2012.0437, 10.1089/ten.teb.2012.0437]
   Lowery JL, 2010, BIOMATERIALS, V31, P491, DOI 10.1016/j.biomaterials.2009.09.072
   Machula H, 2014, ADV WOUND CARE, V3, P367, DOI 10.1089/wound.2013.0513
   McKenna KA, 2012, ACTA BIOMATER, V8, P225, DOI 10.1016/j.actbio.2011.08.001
   Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055
   Nivison-Smith L, 2010, ACTA BIOMATER, V6, P354, DOI 10.1016/j.actbio.2009.08.011
   Padsalgikar A, 2015, J BIOMED MATER RES B, V103, P159, DOI 10.1002/jbm.b.33161
   Rnjak-Kovacina J, 2012, ACTA BIOMATER, V8, P3714, DOI 10.1016/j.actbio.2012.06.032
   Rnjak-Kovacina J, 2011, BIOMATERIALS, V32, P6729, DOI 10.1016/j.biomaterials.2011.05.065
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Simmons A, 2004, BIOMATERIALS, V25, P4887, DOI 10.1016/j.biomaterials.2004.01.004
   Simmons A, 2008, BIOMATERIALS, V29, P2987, DOI 10.1016/j.biomaterials.2008.04.007
   Sridhar R, 2015, CHEM SOC REV, V44, P790, DOI 10.1039/c4cs00226a
   Stefanovic IS, 2015, J BIOMED MATER RES A, V103, P1459, DOI 10.1002/jbm.a.35285
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Tavakoli NN, 2012, INT J MOL MED, V30, P545, DOI 10.3892/ijmm.2012.1034
   Wakelin EA, 2015, ACS APPL MATER INTER, V7, P23029, DOI 10.1021/acsami.5b06395
   Waterhouse A, 2010, BIOMATERIALS, V31, P8332, DOI 10.1016/j.biomaterials.2010.07.062
   Wise SG, 2014, ACTA BIOMATER, V10, P1532, DOI 10.1016/j.actbio.2013.08.003
   Wise SG, 2011, ACTA BIOMATER, V7, P295, DOI 10.1016/j.actbio.2010.07.022
   Wong CS, 2013, J MATER SCI-MATER M, V24, P1865, DOI 10.1007/s10856-013-4937-y
   Yeo GC, 2014, J BIOL CHEM, V289, P34815, DOI 10.1074/jbc.M114.606772
   Yeo GC, 2012, P NATL ACAD SCI USA, V109, P2878, DOI 10.1073/pnas.1111615108
   Yuan HH, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/4/045004
NR 41
TC 5
Z9 5
U1 4
U2 23
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAR 1
PY 2016
VL 22
IS 5-6
BP 524
EP 533
DI 10.1089/ten.tea.2015.0409
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA DH0FL
UT WOS:000372457800014
PM 26857114
OA Green Published
DA 2018-10-19
ER

PT J
AU Pereira, RC
   Carneiro, JDS
   Borges, SV
   Assis, OBG
   Alvarenga, GL
AF Pereira, Rafaela Correa
   Souza Carneiro, Joao de Deus
   Borges, Soraia Vilela
   Garrido Assis, Odilio Benedito
   Alvarenga, Gabriela Lara
TI Preparation and Characterization of Nanocomposites from Whey Protein
   Concentrate Activated with Lycopene
SO JOURNAL OF FOOD SCIENCE
LA English
DT Article
DE carotenoids; nanotechnology; packaging
ID IMPROVE BARRIER PROPERTIES; EDIBLE FILMS; SOLUBILITY; MODEL; PH
AB The production and characterization of nanocomposites based on whey protein concentrate (WPC) and montmorilonite (MMT) incorporated with lycopene as a functional substance is presented and discussed as an alternative biomaterial for potential uses in foodstuff applications. A full factorial design with varying levels of MMT (0% and 2% in w/w) and lycopene (0%, 6%, and 12% in w/w) was used. Color, light transmission, film transparency, moisture, density, solubility, water vapor permeability, and antioxidant activity of the resulting materials were evaluated. Results indicated that lycopene and MMT nanoparticles were successfully included in WPC films using the casting/evaporation method. Inclusion of 2% w/w of MMT in the polymeric matrix significantly improved barrier property against water vapor. Lycopene, besides its good red coloring ability, provided to the films antioxidant activity and UV-vis light protection. These findings open a new perspective for the use of materials for bioactive packaging applications.
C1 [Pereira, Rafaela Correa; Souza Carneiro, Joao de Deus; Borges, Soraia Vilela; Alvarenga, Gabriela Lara] Univ Fed Lavras, Dept Food Sci, Lavras, MG, Brazil.
   [Garrido Assis, Odilio Benedito] Embrapa Instrumentat CNPDIA, Sao Carlos, SP, Brazil.
RP Pereira, RC (reprint author), Univ Fed Lavras, Dept Food Sci, Lavras, MG, Brazil.
EM rafacpereira@gmail.com
RI AgroNano, Rede/F-5675-2017
OI Alvarenga, Gabriela/0000-0002-3061-1801
CR Akhtar MJ, 2012, CARBOHYD POLYM, V89, P1150, DOI 10.1016/j.carbpol.2012.03.088
   AMERICAN SOCIETY STANDARD TESTING AND MATERIALS (ASTM), 1994, D64494 ASTM
   [Anonymous], 2003, E39803 ASTM
   [Anonymous], 2000, D61800 ASTM
   Azevedo VM, 2015, FOOD HYDROCOLLOID, V48, P179, DOI 10.1016/j.foodhyd.2015.02.014
   Azevedo VM, 2014, REV I LAT CANDIDO TO, V69, P36
   Bourbon AI, 2011, J FOOD ENG, V106, P111, DOI 10.1016/j.jfoodeng.2011.03.024
   Cinelli P, 2014, POLYM DEGRAD STABIL, V108, P151, DOI 10.1016/j.polymdegradstab.2014.07.007
   Dias MV, 2014, FOOD CHEM, V165, P323, DOI 10.1016/j.foodchem.2014.05.120
   Domenek S, 2013, J POLYM ENVIRON, V21, P692, DOI 10.1007/s10924-013-0570-6
   Fu LJ, 2014, INTL ENDOCRINOL, V2014, P1
   Gajowik Aneta, 2014, Rocz Panstw Zakl Hig, V65, P263
   Garcia MA, 2000, J FOOD SCI, V65, P941, DOI 10.1111/j.1365-2621.2000.tb09397.x
   Giroux HJ, 2013, DAIRY SCI TECHNOL, V93, P241, DOI 10.1007/s13594-013-0119-4
   Gounga ME, 2007, J FOOD ENG, V83, P521, DOI 10.1016/j.jfoodeng.2007.04.008
   Gutierrez M, 2012, CARBOHYD POLYM, V87, P1495
   Li YX, 2011, FOOD HYDROCOLLOID, V25, P1098, DOI 10.1016/j.foodhyd.2010.10.006
   Lopez-Rubio A, 2006, TRENDS FOOD SCI TECH, V17, P567, DOI 10.1016/j.tifs.2006.04.012
   Mittal V, 2009, MATERIALS, V2, P992, DOI 10.3390/ma2030992
   Park SI, 2004, J AGR FOOD CHEM, V52, P1933, DOI 10.1021/jf034612p
   Perez LM, 2014, FOOD CONTROL, V37, P298
   Perez-Gago MB, 1999, J FOOD SCI, V64, P1034, DOI 10.1111/j.1365-2621.1999.tb12276.x
   Ramos OL, 2013, FOOD HYDROCOLLOID, V30, P110, DOI 10.1016/j.foodhyd.2012.05.001
   Rodrigues-Amaya DB, 2008, FONTES BRASILEIRAS C
   Sahin K, 2015, ARCH BIOCHEM BIOPHYS, V572, P36, DOI 10.1016/j.abb.2015.01.006
   Shiku Y, 2003, FISHERIES SCI, V69, P1026, DOI 10.1046/j.1444-2906.2003.00722.x
   Siripatrawan U, 2010, FOOD HYDROCOLLOID, V24, P770, DOI 10.1016/j.foodhyd.2010.04.003
   Sothornvit R, 2010, LWT-FOOD SCI TECHNOL, V43, P279, DOI 10.1016/j.lwt.2009.08.010
   Souza BWS, 2009, FOOD HYDROCOLLOID, V23, P2110, DOI 10.1016/j.foodhyd.2009.03.021
   Stice CP, 2015, ARCH BIOCHEM BIOPHYS, V572, P81, DOI 10.1016/j.abb.2015.01.004
   Wakai M, 2015, FOOD HYDROCOLLOID, V43, P612, DOI 10.1016/j.foodhyd.2014.07.022
NR 31
TC 4
Z9 4
U1 3
U2 19
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-1147
EI 1750-3841
J9 J FOOD SCI
JI J. Food Sci.
PD MAR
PY 2016
VL 81
IS 3
BP E637
EP E642
DI 10.1111/1750-3841.13234
PG 6
WC Food Science & Technology
SC Food Science & Technology
GA DG5VW
UT WOS:000372148400011
PM 26814439
DA 2018-10-19
ER

PT J
AU Krawczyk, N
   Fehm, T
   Banys-Paluchowski, M
   Janni, W
   Schramm, A
AF Krawczyk, Natalia
   Fehm, Tanja
   Banys-Paluchowski, Malgorzata
   Janni, Wolfgang
   Schramm, Annelle
TI Liquid Biopsy in Metastasized Breast Cancer as Basis for Treatment
   Decisions
SO ONCOLOGY RESEARCH AND TREATMENT
LA English
DT Review
DE Circulating tumor cells; Circulating tumor DNA; Metastatic breast
   cancer; Liquid biopsy
ID CIRCULATING TUMOR-CELLS; POOLED ANALYSIS; ESR1 MUTATIONS; NUCLEIC-ACIDS;
   DNA; SURVIVAL; DISEASE; CHEMOTHERAPY; THERAPY; MARKERS
AB According to current guidelines, the additional biopsy of breast cancer metastases to analyze the receptor status for phenotype assessment is recommended. However, due to clinical difficulties in performing biopsies of metastatic lesions, the phenotype of the primary tumor most often determines the treatment decisions in metastatic breast cancer. Liquid biopsy allows the analysis of several circulating biomarkers like circulating tumor cells (CTCs) or circulating tumor DNA (ctDNA) in peripheral blood samples of cancer patients. Thus, it is an elegant and easily practicable technique that delivers information on the current disease status. Determination of the CTC phenotype regarding the hormone receptor and human epidermal growth factor receptor 2 (HER2) status might replace additional tissue biopsy for planning further therapy strategies. Liquid biopsy is a crucial step towards a more individualized cancer therapy. In contrast to the conventional concept of tissue biopsy, it offers an easy, less invasive acquisition of biomaterial. In addition, it allows multiple repetitions and real-time monitoring of metastasized disease in the clinical routine. However, the clinical utility of liquid biopsy still needs to be evaluated. (C) 2016 S. Karger GmbH, Freiburg
C1 [Krawczyk, Natalia; Fehm, Tanja; Banys-Paluchowski, Malgorzata] Univ Dusseldorf, Dept Obstet & Gynecol, Moorenstr 5, D-40225 Dusseldorf, Germany.
   [Janni, Wolfgang; Schramm, Annelle] Univ Ulm, Dept Obstet & Gynecol, D-89069 Ulm, Germany.
RP Krawczyk, N (reprint author), Univ Dusseldorf, Dept Obstet & Gynecol, Moorenstr 5, D-40225 Dusseldorf, Germany.
EM natalia_krawczyk@yahoo.de
CR Amir E, 2012, CANCER TREAT REV, V38, P708, DOI 10.1016/j.ctrv.2011.11.006
   Babayan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075038
   Bernhard H, 2008, CANCER IMMUNOL IMMUN, V57, P271, DOI 10.1007/s00262-007-0355-7
   Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094
   Bidard FC, 2014, LANCET ONCOL, V15, P406, DOI 10.1016/S1470-2045(14)70069-5
   Bidard FC, 2013, CANCER METAST REV, V32, P179, DOI 10.1007/s10555-012-9398-0
   Bozionellou V, 2004, CLIN CANCER RES, V10, P8185, DOI 10.1158/1078-0432.CCR-03-0094
   Budd GT, 2006, CLIN CANCER RES, V12, P6403, DOI 10.1158/1078-0432.CCR-05-1769
   Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140
   Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766
   Dawson SJ, 2013, NEW ENGL J MED, V369, P93, DOI 10.1056/NEJMc1306040
   Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011
   Fasching PA, 2015, GEBURTSH FRAUENHEILK, V75, P41, DOI 10.1055/s-0034-1396215
   Fehm T, 2005, CYTOTHERAPY, V7, P171, DOI 10.1080/14653240510027082
   Fehm T, 2010, BREAST CANCER RES TR, V124, P403, DOI 10.1007/s10549-010-1163-x
   Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205
   Giordano A, 2012, ANN ONCOL, V23, P1144, DOI 10.1093/annonc/mdr434
   Giuliano M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2907
   Guttery DS, 2015, CLIN CHEM, V61, P974, DOI 10.1373/clinchem.2015.238717
   Hayes DF, 2006, CLIN CANCER RES, V12, P4218, DOI 10.1158/1078-0432.CCR-05-2821
   Heidary M, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0421-y
   Heitzer E, 2013, CANCER RES, V73, P2965, DOI 10.1158/0008-5472.CAN-12-4140
   Hepp PG, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.541
   Kalinsky K, 2015, CLIN TRANSL ONCOL, V17, P539, DOI 10.1007/s12094-015-1275-1
   Kasimir-Bauer S, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3099
   Krawczyk N, 2014, BIOMED RES INT, DOI 10.1155/2014/415721
   Ma MW, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.09.29
   Madic J, 2015, INT J CANCER, V136, P2158, DOI 10.1002/ijc.29265
   Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065
   Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375
   Pantel K, 2013, CANCER RES, V73, P6384, DOI 10.1158/0008-5472.CAN-13-2030
   Pestrin M, 2009, BREAST CANCER RES TR, V118, P523, DOI 10.1007/s10549-009-0461-7
   Pierga JY, 2008, CLIN CANCER RES, V14, P7004, DOI 10.1158/1078-0432.CCR-08-0030
   Rack B, 2012, ARCH GYNECOL OBSTET, V285, P485, DOI 10.1007/s00404-011-1954-2
   Rothe F, 2014, ANN ONCOL, V25, P1959, DOI 10.1093/annonc/mdu288
   Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066
   Sefrioui D, 2015, INT J CANCER, V137, P2513, DOI 10.1002/ijc.29612
   Singh N, 2015, CANCER INVEST, V33, P78, DOI 10.3109/07357907.2014.1001894
   Smerage JB, 2014, J CLIN ONCOL, V32, P3483, DOI 10.1200/JCO.2014.56.2561
   Spindler KLG, 2014, INT J CANCER, V135, P2984, DOI 10.1002/ijc.28946
   Wallwiener M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1423-6
   Wallwiener M, 2013, BREAST CANCER RES TR, V137, P503, DOI 10.1007/s10549-012-2382-0
   Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600
   Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670
NR 44
TC 3
Z9 3
U1 0
U2 10
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 2296-5270
EI 2296-5262
J9 ONCOL RES TREAT
JI Oncol. Res. Treat.
PD MAR
PY 2016
VL 39
IS 3
BP 112
EP 116
DI 10.1159/000444605
PG 5
WC Oncology
SC Oncology
GA DG3EO
UT WOS:000371952500003
PM 27031542
DA 2018-10-19
ER

PT J
AU Singh, C
   Ali, MA
   Sumana, G
AF Singh, Chandan
   Ali, Md Azahar
   Sumana, Gajjala
TI Green Synthesis of Graphene Based Biomaterial Using Fenugreek Seeds for
   Lipid Detection
SO ACS SUSTAINABLE CHEMISTRY & ENGINEERING
LA English
DT Article
DE Green chemistry; Graphene oxide; Palladium nanoparticles; Biosensors;
   Lipid detection; Fenugreek seeds; Sustainability
ID GRAPHITE OXIDE; AMPEROMETRIC BIOSENSOR; CHEMICAL-REDUCTION;
   RAMAN-SPECTRA; NANOPARTICLES; SHEETS; FILMS; ELECTRON; TRANSPARENT;
   NANOSHEETS
AB A novel, green, and sustainable route has been introduced for biosynthesis of a palladium nanoparticles (PdNPs) anchored reduced graphene oxide (rGO) platform for protein conjugation and detection of triglycerides. Fenugreek seeds (FS) were utilized for the simultaneous green reduction of Pd salt and graphene oxide (GO), which also act as a stabilizing and decorating agent for in situ grown PdNPs on rGO sheets. The well dispersed, homogeneous, and biologically reduced PdNPs having an average size of 3.5 nm on the rGO sheets are electrophoretically deposited on an indium tin oxide (ITO) glass substrate. The biosynthesized Pd-rGO sheets were characterized using spectroscopic and electrochemical techniques and further utilized for co-immobilization of lipase and glycerol dehydrogenase (LIP-GLDH) enzymes using EDC-NHS coupling chemistry. The LIP-GLDH conjugated Pd-rGO platform was used for electrochemical detection of triglycerides. The green and nontoxic approach offers enhanced stability of the fabricated biosensor as phytochemical (present in FS extract) residues available on the surface of Pd-rGO nanocomposite might have prevented the loss in the structure of the immobilized biomolecules/enzymes by providing a biocompatible coating. The fabricated Pd-rGO-based biosensor shows a wide detection range of 25-400 mg dL(-1) with an excellent sensitivity of 1.3 mu A mg(-1) dLcm(-1).
C1 [Singh, Chandan; Ali, Md Azahar; Sumana, Gajjala] CSIR Natl Phys Lab, Biomed Instrumentat Sect, Dr KS Krishnan Marg, New Delhi 110012, India.
   [Singh, Chandan] CSIR Natl Phys Lab, Acad Sci & Innovat Res AcSIR, Dr KS Krisnan Marg, New Delhi 110012, India.
RP Sumana, G (reprint author), CSIR Natl Phys Lab, Biomed Instrumentat Sect, Dr KS Krishnan Marg, New Delhi 110012, India.
EM sumanagajjala@gmail.com
RI Ali, Md Azahar/B-5573-2017
OI Ali, Md Azahar/0000-0001-5752-8808; Ali, Md Azahar/0000-0002-4583-2818
FU CSIR [ESC-0103]
FX We thank Director CSIR-NPL, New Delhi, India, for the facilities. We are
   thankful to Dr. A. M. Biradar for his consistent support and
   encouragement. The authors are thankful to Prof. B. D. Malhotra from
   Delhi Technological University for his sincere guidance. C.S. and
   Md.A.A. are thankful to CSIR for the award of Senior Research
   Fellowships. The authors are thankful to Dr. Ved V. Agrawal, Dr. Bhanu
   Pratap Singh, and Dr. Vidyanand Singh for AFM, Raman, and HR-TEM
   studies, respectively. We acknowledge the financial support received
   from CSIR (ESC-0103).
CR Afonso CAM, 2005, GREEN SEPARATION PROCESSES: FUNDAMENTALS AND APPLICATIONS, P1, DOI 10.1002/3527606602
   Albrecht MA, 2006, GREEN CHEM, V8, P417, DOI 10.1039/b517131h
   Ambrosi A, 2011, CHEM-EUR J, V17, P10763, DOI 10.1002/chem.201101117
   Anastas P, 2010, CHEM SOC REV, V39, P301, DOI 10.1039/b918763b
   Aswathy A. S., 2012, SPECTROCHIM ACTA A, V97, P1
   Becerril HA, 2008, ACS NANO, V2, P463, DOI 10.1021/nn700375n
   Berger C, 2004, J PHYS CHEM B, V108, P19912, DOI 10.1021/jp040650f
   Cancado LG, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2196057
   Chan KT, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235430
   Chua CK, 2014, CHEM SOC REV, V43, P291, DOI 10.1039/c3cs60303b
   Dhand C, 2009, ELECTROCHEM COMMUN, V11, P1482, DOI 10.1016/j.elecom.2009.05.034
   Djakovitch L., 2008, NANOPARTICLES CATALY
   Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g
   Eda G, 2008, NAT NANOTECHNOL, V3, P270, DOI 10.1038/nnano.2008.83
   Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095
   Ferrari AC, 2007, SOLID STATE COMMUN, V143, P47, DOI 10.1016/j.ssc.2007.03.052
   Gilje S, 2007, NANO LETT, V7, P3394, DOI 10.1021/nl0717715
   Gomez-Navarro C, 2007, NANO LETT, V7, P3499, DOI 10.1021/nl072090c
   Goncalves G, 2009, CHEM MATER, V21, P4796, DOI 10.1021/cm901052s
   Iravani S, 2011, GREEN CHEM, V13, P2638, DOI 10.1039/c1gc15386b
   Kang SJ, 2007, NAT NANOTECHNOL, V2, P230, DOI 10.1038/nnano.2007.77
   Katsnelson MI, 2006, NAT PHYS, V2, P620, DOI 10.1038/nphys384
   Khomyakov PA, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.195425
   Kirchhoff MM, 2005, RESOUR CONSERV RECY, V44, P237, DOI 10.1016/j.resconrec.2005.01.003
   Kudin KN, 2008, NANO LETT, V8, P36, DOI 10.1021/nl071822y
   Kuila T, 2012, CARBON, V50, P914, DOI 10.1016/j.carbon.2011.09.053
   Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451
   Liao WY, 2008, ANALYST, V133, P1757, DOI 10.1039/b801703d
   Lu GH, 2009, NANO RES, V2, P192, DOI 10.1007/s12274-009-9017-8
   Mann D, 2003, NANO LETT, V3, P1541, DOI 10.1021/nl034700o
   Marcano DC, 2010, ACS NANO, V4, P4806, DOI 10.1021/nn1006368
   Martins MVA, 2014, PHYS CHEM CHEM PHYS, V16, P17426, DOI 10.1039/c4cp00452c
   Mastalir A, 2008, CATAL LETT, V124, P34, DOI 10.1007/s10562-008-9503-8
   Minakshi CSP, 2008, SENSOR ACTUAT B-CHEM, V133, P251, DOI 10.1016/j.snb.2008.02.036
   Muszynski R, 2008, J PHYS CHEM C, V112, P5263, DOI 10.1021/jp800977b
   Narang J, 2011, INT J BIOL MACROMOL, V49, P707, DOI 10.1016/j.ijbiomac.2011.07.001
   Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233
   Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896
   Paredes JI, 2009, LANGMUIR, V25, P5957, DOI 10.1021/la804216z
   Pumera M, 2010, CHEM SOC REV, V39, P4146, DOI 10.1039/c002690p
   Pumera M, 2009, CHEM REC, V9, P211, DOI 10.1002/tcr.200900008
   Pundir CS, 2010, CLIN BIOCHEM, V43, P467, DOI 10.1016/j.clinbiochem.2009.12.003
   Ramamurthy C, 2013, BIOPROC BIOSYST ENG, V36, P1131, DOI 10.1007/s00449-012-0867-1
   Robinson JT, 2008, NANO LETT, V8, P3137, DOI 10.1021/nl8013007
   Sanderson K, 2011, NATURE, V469, P18, DOI 10.1038/469018a
   Schedin F, 2007, NAT MATER, V6, P652, DOI 10.1038/nmat1967
   Schniepp HC, 2006, J PHYS CHEM B, V110, P8535, DOI 10.1021/jp060936f
   Shin HJ, 2009, ADV FUNCT MATER, V19, P1987, DOI 10.1002/adfm.200900167
   Si YC, 2008, CHEM MATER, V20, P6792, DOI 10.1021/cm801356a
   Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034
   Suganya T. R., 2014, INT J CHEMTECH RES, V6, P2156
   Tang LH, 2009, ADV FUNCT MATER, V19, P2782, DOI 10.1002/adfm.200900377
   Thakur S, 2012, CARBON, V50, P5331, DOI 10.1016/j.carbon.2012.07.023
   Wang X, 2008, NANO LETT, V8, P323, DOI 10.1021/nl072838r
   Wang Y, 2011, ACS APPL MATER INTER, V3, P1127, DOI 10.1021/am1012613
   Watt-Smith M. J., 2008, J PHYS D, V41
   Wu ZS, 2009, ADV MATER, V21, P1756, DOI 10.1002/adma.200802560
   Xiang JL, 2011, ACS APPL MATER INTER, V3, P1325, DOI 10.1021/am200126x
   Yang X, 2010, J NANOPART RES, V12, P1589, DOI 10.1007/s11051-009-9675-1
   Yonezawa T, 2001, LANGMUIR, V17, P4701, DOI 10.1021/la0101954
   Zan R, 2011, NANO LETT, V11, P1087, DOI 10.1021/nl103980h
   Zhang JL, 2010, CHEM COMMUN, V46, P1112, DOI 10.1039/b917705a
NR 62
TC 8
Z9 8
U1 5
U2 57
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2168-0485
J9 ACS SUSTAIN CHEM ENG
JI ACS Sustain. Chem. Eng.
PD MAR
PY 2016
VL 4
IS 3
BP 871
EP 880
DI 10.1021/acssuschemeng.5b00923
PG 10
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY;
   Engineering, Chemical
SC Chemistry; Science & Technology - Other Topics; Engineering
GA DG0LD
UT WOS:000371755400031
DA 2018-10-19
ER

PT J
AU Panzella, L
   Cerruti, P
   Ambrogi, V
   Agustin-Salazar, S
   D'Errico, G
   Carfagna, C
   Goya, L
   Ramos, S
   Martin, MA
   Napolitano, A
   d'Ischia, M
AF Panzella, Lucia
   Cerruti, Pierfrancesco
   Ambrogi, Veronica
   Agustin-Salazar, Sarai
   D'Errico, Gerardino
   Carfagna, Cosimo
   Goya, Luis
   Ramos, Sonia
   Martin, Maria A.
   Napolitano, Alessandra
   d'Ischia, Marco
TI A Superior All-Natural Antioxidant Biomaterial from Spent Coffee Grounds
   for Polymer Stabilization, Cell Protection, and Food Lipid Preservation
SO ACS SUSTAINABLE CHEMISTRY & ENGINEERING
LA English
DT Article
DE Spent coffee grounds; Polyethylene; Antioxidant; HepG2 cells; Lipid
   peroxidation inhibition
ID POLYUNSATURATED FATTY-ACIDS; SCAVENGING PROPERTIES; VALUABLE SOURCE;
   OXIDATION; FILMS; ASSAY; POLY(3-HYDROXYBUTYRATE); STABILITY; STRESS;
   HEALTH
AB Treatment with boiling 6 M HCl increases up to 30 times the intrinsic antioxidant potency of spent coffee grounds, leading to a versatile multifunctional material (hydrolyzed spent coffee grounds, HSCG). Spectral and morphological analyses suggest that the remarkable potentiation of the antioxidant activity is due to efficient removal of the hydrolyzable components, mainly carbohydrates, making the polyphenol-rich component available for interaction with free radicals and oxidizing species. HSCG efficiently protects hepatocarcinoma (HepG2) cells from oxidative stress-induced injury and delays lipid peroxidation in fish and soybean oils. Moreover, films made of polyethylene/2% HSCG blends display greater stability to thermal and photo-oxidative degradation. HSCG may thus represent an easily accessible and sustainable alternative to currently available biomaterials with intrinsic antioxidant properties for biomedical, industrial, and technological applications.
C1 [Panzella, Lucia; D'Errico, Gerardino; Napolitano, Alessandra; d'Ischia, Marco] Univ Naples Federico II, Dept Chem Sci, Via Cintia 4, I-80126 Naples, Italy.
   [Cerruti, Pierfrancesco; Agustin-Salazar, Sarai; Carfagna, Cosimo] CNR, IPCB, Via Campi Flegrei 34, I-80078 Pozzuoli, Italy.
   [Ambrogi, Veronica; Carfagna, Cosimo] Univ Naples Federico II, Dept Chem Mat & Prod Engn, Piazzale Tecchio 80, I-80125 Naples, Italy.
   [D'Errico, Gerardino] CSGI Consorzio Sviluppo Sistemi Grande Interfase, Florence, Italy.
   [Goya, Luis; Ramos, Sonia; Martin, Maria A.] CSIC, ICTAN, Dept Metab & Nutr, Jose Antonio Novais 10, Madrid 28040, Spain.
RP Panzella, L (reprint author), Univ Naples Federico II, Dept Chem Sci, Via Cintia 4, I-80126 Naples, Italy.
EM panzella@unina.it
RI Martin, Maria Angeles/C-5768-2014; Napolitano, Alessandra/E-9761-2011;
   Ramos, Sonia/K-4594-2012
OI Martin, Maria Angeles/0000-0001-8173-4521; Ramos,
   Sonia/0000-0003-2649-2616; Cerruti, Pierfrancesco/0000-0003-0822-2866;
   AGUSTIN-SALAZAR, SARAI/0000-0002-8529-5965
FU Italian MIUR (PRIN PROxi project)
FX This work was partially supported by grants from Italian MIUR (PRIN
   2010-2011 PROxi project).
CR Agustin-Salazar S, 2014, ACS SUSTAIN CHEM ENG, V2, P1534, DOI 10.1021/sc5002337
   Ambrogi V, 2011, POLYM DEGRAD STABIL, V96, P2152, DOI 10.1016/j.polymdegradstab.2011.09.015
   Ambrogi V, 2014, BIOMACROMOLECULES, V15, P302, DOI 10.1021/bm4015478
   Angelini S, 2014, INT J BIOL MACROMOL, V71, P163, DOI 10.1016/j.ijbiomac.2014.07.038
   Auriemma M, 2015, EUR POLYM J, V63, P123, DOI 10.1016/j.eurpolymj.2014.12.021
   Ballesteros LF, 2014, FOOD BIOPROCESS TECH, V7, P3493, DOI 10.1007/s11947-014-1349-z
   Granado-Serrano AB, 2007, J AGR FOOD CHEM, V55, P2020, DOI 10.1021/jf062556x
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   Bravo J, 2013, FOOD CHEM TOXICOL, V60, P397, DOI 10.1016/j.fct.2013.08.002
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Campos-Vega R, 2015, TRENDS FOOD SCI TECH, V45, P24, DOI 10.1016/j.tifs.2015.04.012
   Cao SL, 2012, RSC ADV, V2, P10925, DOI 10.1039/c2ra22045h
   Lopez MDC, 2013, J AGR FOOD CHEM, V61, P8462, DOI 10.1021/jf402670a
   Cerruti P, 2009, POLYM DEGRAD STABIL, V94, P2095, DOI 10.1016/j.polymdegradstab.2009.07.023
   Cesareo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048849
   Cruz R, 2012, J AGR FOOD CHEM, V60, P7777, DOI 10.1021/jf3018854
   Fan LH, 2014, CARBOHYD POLYM, V112, P32, DOI 10.1016/j.carbpol.2014.05.056
   FRANKEL EN, 1984, PROG LIPID RES, V23, P197, DOI 10.1016/0163-7827(84)90011-0
   Gokmen V, 2009, TRENDS FOOD SCI TECH, V20, P278, DOI 10.1016/j.tifs.2009.03.010
   Gonzalez-Centeno MR, 2013, J AGR FOOD CHEM, V61, P11579, DOI 10.1021/jf403168k
   Goupy P, 2003, J AGR FOOD CHEM, V51, P615, DOI 10.1021/jf025938l
   Goya L, 2007, MOL NUTR FOOD RES, V51, P536, DOI 10.1002/mnfr.200600228
   Huber GM, 2009, FOOD CHEM, V117, P290, DOI 10.1016/j.foodchem.2009.04.007
   Jimenez-Zamora A, 2015, LWT-FOOD SCI TECHNOL, V61, P12, DOI 10.1016/j.lwt.2014.11.031
   Kaldstrom M, 2014, GREEN CHEM, V16, P2454, DOI 10.1039/c4gc00168k
   Kanner J, 2007, MOL NUTR FOOD RES, V51, P1094, DOI 10.1002/mnfr.200600303
   Kim E, 2011, BIOMACROMOLECULES, V12, P880, DOI 10.1021/bm101499a
   Kim E, 2010, ADV FUNCT MATER, V20, P2683, DOI 10.1002/adfm.200902428
   Li JB, 2007, BIORESOURCE TECHNOL, V98, P3061, DOI 10.1016/j.biortech.2006.10.018
   Liu QL, 2013, ACS APPL MATER INTER, V5, P11101, DOI 10.1021/am4033372
   Low JH, 2015, IND CROP PROD, V69, P456, DOI 10.1016/j.indcrop.2015.03.001
   Ma MG, 2012, BIORESOURCE TECHNOL, V114, P677, DOI 10.1016/j.biortech.2012.03.048
   MARCOCCI L, 1994, BIOCHEM BIOPH RES CO, V201, P748, DOI 10.1006/bbrc.1994.1764
   Monente C, 2015, J FUNCT FOODS, V12, P365, DOI 10.1016/j.jff.2014.12.006
   Moreira ASP, 2012, FOOD FUNCT, V3, P903, DOI 10.1039/c2fo30048f
   Mostert AB, 2013, J PHYS CHEM B, V117, P4965, DOI 10.1021/jp401615e
   Mussatto SI, 2011, FOOD BIOPROCESS TECH, V4, P661, DOI 10.1007/s11947-011-0565-z
   Nand AV, 2013, J FOOD ENG, V116, P422, DOI 10.1016/j.jfoodeng.2012.11.023
   NOUROOZZADEH J, 1995, J AGR FOOD CHEM, V43, P17, DOI 10.1021/jf00049a005
   Olejar KJ, 2014, CELLULOSE, V21, P4545, DOI 10.1007/s10570-014-0447-4
   Panzella L, 2013, ANGEW CHEM INT EDIT, V52, P12684, DOI 10.1002/anie.201305747
   Panzella L, 2013, J AGR FOOD CHEM, V61, P1710, DOI 10.1021/jf302690c
   Panzella L, 2012, J AGR FOOD CHEM, V60, P8895, DOI 10.1021/jf2053096
   Persico P, 2012, INT J BIOL MACROMOL, V51, P1151, DOI 10.1016/j.ijbiomac.2012.08.036
   Pisoschi AM, 2015, EUR J MED CHEM, V97, P55, DOI 10.1016/j.ejmech.2015.04.040
   Ribeiro JS, 2010, J FOOD QUALITY, V33, P212, DOI 10.1111/j.1745-4557.2010.00309.x
   Sadeghifar H, 2015, ACS SUSTAIN CHEM ENG, V3, P349, DOI 10.1021/sc500756n
   Serini S, 2011, CHEM RES TOXICOL, V24, P2093, DOI 10.1021/tx200314p
   Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Sturgeon MR, 2014, ACS SUSTAIN CHEM ENG, V2, P472, DOI 10.1021/sc400384w
   Vardon DR, 2013, ACS SUSTAIN CHEM ENG, V1, P1286, DOI 10.1021/sc400145w
   Wang H, 2008, FOOD CHEM, V106, P888, DOI 10.1016/j.foodchem.2007.05.068
   Wattamwar PP, 2012, ACTA BIOMATER, V8, P2529, DOI 10.1016/j.actbio.2012.03.022
   Williams SR, 2009, BIOMACROMOLECULES, V10, P155, DOI 10.1021/bm801058j
   Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017
   Xu C, 2013, ANAL CHIM ACTA, V793, P53, DOI 10.1016/j.aca.2013.07.027
   Yang J, 2014, BIOMACROMOLECULES, V15, P3942, DOI 10.1021/bm5010004
   Yordanov ND, 1999, J RADIOANAL NUCL CH, V240, P619, DOI 10.1007/BF02349422
   Zuorro A, 2012, J CLEAN PROD, V34, P49, DOI 10.1016/j.jclepro.2011.12.003
NR 60
TC 10
Z9 10
U1 1
U2 35
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2168-0485
J9 ACS SUSTAIN CHEM ENG
JI ACS Sustain. Chem. Eng.
PD MAR
PY 2016
VL 4
IS 3
BP 1169
EP 1179
DI 10.1021/acssuschemeng.5b01234
PG 11
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY;
   Engineering, Chemical
SC Chemistry; Science & Technology - Other Topics; Engineering
GA DG0LD
UT WOS:000371755400066
DA 2018-10-19
ER

PT J
AU Andorko, JI
   Hess, KL
   Pineault, KG
   Jewell, CM
AF Andorko, James I.
   Hess, Krystina L.
   Pineault, Kevin G.
   Jewell, Christopher M.
TI Intrinsic immunogenicity of rapidly-degradable polymers evolves during
   degradation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Poly(beta-amino esters); Dendritic cell; Vaccine; Microparticle and
   nanoparticie; Immune response and inflammation
ID DENDRITIC CELL MATURATION; GENE DELIVERY; POLY(BETA-AMINO ESTERS);
   CATIONIC POLYMER; VACCINE DELIVERY; PLASMID DNA; IN-VITRO;
   NANOPARTICLES; HYALURONAN; ACTIVATION
AB Recent studies reveal many biomaterial vaccine carriers are able to activate immunostimulatory pathways, even in the absence of other immune signals. How the changing properties of polymers during biodegradation impact this intrinsic immunogenicity is not well studied, yet this information could contribute to rational design of degradable vaccine carriers that help direct immune response. We use degradable poly(beta-amino esters) (PBAEs) to explore intrinsic immunogenicity as a function of the degree of polymer degradation and polymer form (e.g., soluble, particles). PBAE particles condensed by electrostatic interaction to mimic a common vaccine approach strongly activate dendritic cells, drive antigen presentation, and enhance T cell proliferation in the presence of antigen. Polymer molecular weight strongly influences these effects, with maximum stimulation at short degradation times - corresponding to high molecular weight - and waning levels as degradation continues. In contrast, free polymer is immunologically inert. In mice, PBAE particles increase the numbers and activation state of cells in lymph nodes. Mechanistic studies reveal that this evolving immunogenicity occurs as the physicochemical properties and concentration of particles change during polymer degradation. This work confirms the immunological profile of degradable, synthetic polymers can evolve over time and creates an opportunity to leverage this feature in new vaccines.
   Statement of Significance
   Degradable polymers are increasingly important in vaccination, but how the inherent immunogenicity of polymers changes during degradation is poorly understood. Using common rapidly-degradable vaccine carriers, we show that the activation of immune cells - even in the absence of other adjuvants - depends on polymer form (e.g., free, particulate) and the extent of degradation. These changing characteristics alter the physicochemical properties (e.g., charge, size, molecular weight) of polymer particles, driving changes in immunogenicity. Our results are important as many common biomaterials (e.g., PLGA) are now known to exhibit immune activity that alters how vaccines are processed. Thus, the results of this study could contribute to more rational design of biomaterial carriers that also actively direct the properties of responses generated by vaccines. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd.
C1 [Andorko, James I.; Hess, Krystina L.; Pineault, Kevin G.; Jewell, Christopher M.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Jewell, Christopher M.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.
   [Jewell, Christopher M.] Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD USA.
RP Jewell, CM (reprint author), Fischell Dept Bioengn, 2212 Jeong H Kim Engn Bldg, College Pk, MD 20742 USA.
EM cmjewell@umd.edu
OI Jewell, Christopher/0000-0002-6668-6928
FU NSF CAREER Award [1351688]; NIH Grant [T32 AI089621]; American
   Association of Pharmaceutical Scientists; Department of Defense SMART
   Award; Damon Runyon Foundation [DRR3415]; Alliance for Cancer Gene
   Therapy [15051543]; Melanoma Research Alliance [348963]
FX This work was supported by NSF CAREER Award # 1351688. J.I. A. is a
   trainee on NIH Grant # T32 AI089621 and a Graduate Research Fellow
   supported by the American Association of Pharmaceutical Scientists.
   K.L.H. is a Graduate Research Fellow supported by a Department of
   Defense SMART Award. C.M.J. is a Damon Runyon-Rachleff Innovator
   supported by the Damon Runyon Foundation # DRR3415, a Young Investigator
   supported by the Alliance for Cancer Gene Therapy # 15051543, and a
   Young Investigator supported by the Melanoma Research Alliance # 348963.
CR Abensee JEB, 2008, SEMIN IMMUNOL, V20, P101, DOI 10.1016/j.smim.2007.10.013
   Akinc A, 2003, J AM CHEM SOC, V125, P5316, DOI 10.1021/ja034429c
   Andorko J. I., 2014, AAPS J, P1
   Andorko JI, 2014, JOVE-J VIS EXP, DOI 10.3791/50984
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Bechler SL, 2012, BIOMACROMOLECULES, V13, P1523, DOI 10.1021/bm300234q
   Bechler SL, 2012, BIOMACROMOLECULES, V13, P542, DOI 10.1021/bm2016338
   Bechler SL, 2011, J POLYM SCI POL CHEM, V49, P1572, DOI 10.1002/pola.24578
   Bishop CJ, 2013, J AM CHEM SOC, V135, P6951, DOI 10.1021/ja4002376
   Da Silva CA, 2009, J IMMUNOL, V182, P3573, DOI 10.4049/jimmunol.0802113
   Demento SL, 2009, VACCINE, V27, P3013, DOI 10.1016/j.vaccine.2009.03.034
   DeMuth PC, 2012, ACS NANO, V6, P8041, DOI 10.1021/nn302639r
   Gallorini S, 2007, J IMMUNOL, V179, P8208, DOI 10.4049/jimmunol.179.12.8208
   Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017
   Green JJ, 2008, ACCOUNTS CHEM RES, V41, P749, DOI 10.1021/ar7002336
   Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111
   Grewal IS, 1996, IMMUNOL REV, V153, P85, DOI 10.1111/j.1600-065X.1996.tb00921.x
   Guerrero-Cazares H, 2014, ACS NANO, V8, P5141, DOI 10.1021/nn501197v
   Irvine DJ, 2013, NAT MATER, V12, P978, DOI [10.1038/NMAT3775, 10.1038/nmat3775]
   Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359
   Jewell CM, 2008, ADV DRUG DELIVER REV, V60, P979, DOI 10.1016/j.addr.2008.02.010
   Jewell CM, 2011, P NATL ACAD SCI USA, V108, P15745, DOI 10.1073/pnas.1105200108
   Jewell CM, 2005, J CONTROL RELEASE, V106, P214, DOI 10.1016/j.jconrel.2005.04.014
   Jones CH, 2015, BIOMATERIALS, V37, P333, DOI 10.1016/j.biomaterials.2014.10.037
   Keeney M, 2013, ACS NANO, V7, P7241, DOI 10.1021/nn402657d
   Kozielski KL, 2014, ACS NANO, V8, P3232, DOI 10.1021/nn500704t
   Little SR, 2005, J CONTROL RELEASE, V107, P449, DOI 10.1016/j.jconrel.2005.04.022
   Little SR, 2004, P NATL ACAD SCI USA, V101, P9534, DOI 10.1079/pnas.0403549101
   Lynn DM, 2000, J AM CHEM SOC, V122, P10761, DOI 10.1021/ja0015388
   Lynn DM, 2001, ANGEW CHEM INT EDIT, V40, P1707, DOI 10.1002/1521-3773(20010504)40:9<1707::AID-ANIE17070>3.3.CO;2-6
   Maitra R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002438
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059
   Moyano DF, 2012, J AM CHEM SOC, V134, P3965, DOI 10.1021/ja2108905
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   Nguyen DN, 2009, ADV MATER, V21, P847, DOI 10.1002/adma.200801478
   Park J, 2012, ACTA BIOMATER, V8, P3606, DOI 10.1016/j.actbio.2012.06.006
   Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272
   Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372
   Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106
   Su XF, 2011, MOL PHARMACEUT, V8, P774, DOI 10.1021/mp100390w
   Sunshine JC, 2014, BIOMATERIALS, V35, P269, DOI 10.1016/j.biomaterials.2013.09.050
   Sunshine JC, 2012, MOL PHARMACEUT, V9, P3375, DOI 10.1021/mp3004176
   Swartz M. A., 2012, SCI TRANSL MED, V4
   Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858
   Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863
   Tesar BM, 2006, AM J TRANSPLANT, V6, P2622, DOI 10.1111/j.1600-6143.2006.01537.x
   VanGool SW, 1996, IMMUNOL REV, V153, P47
   Zhang JT, 2007, LANGMUIR, V23, P11139, DOI 10.1021/la702021s
NR 50
TC 25
Z9 26
U1 1
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 1
PY 2016
VL 32
BP 24
EP 34
DI 10.1016/j.actbio.2015.12.026
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF8ZF
UT WOS:000371649100003
PM 26708710
OA Green Accepted, Other Gold
DA 2018-10-19
ER

PT J
AU Zhang, JY
   Li, M
   Kang, ET
   Neoh, KG
AF Zhang, Jieyu
   Li, Min
   Kang, En-Tang
   Neoh, Koon Gee
TI Electrical stimulation of adipose-derived mesenchymal stem cells in
   conductive scaffolds and the roles of voltage-gated ion channels
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Electrical stimulation; Polypyrrole; Adipose-derived mesenchymal stem
   cells; Polycaprolactone scaffold; Voltage-gated ion channels
ID IN-VITRO; OSTEOGENIC DIFFERENTIATION; BONE REGENERATION; BIOMATERIAL
   SCAFFOLDS; POLYPYRROLE FILMS; CALCIUM-CHANNEL; STROMAL CELLS; NA+
   CHANNELS; TISSUE; PROLIFERATION
AB Since electrical stimulation (ES) can significantly accelerate bone healing, a conductive scaffold that can deliver ES locally at the defect site is desirable for bone defect therapy. Herein, an electrically conductive scaffold was prepared via incorporation of polypyrrole (PPY) in a polycaprolactone (PCL) template scaffold. In vitro tests with mouse osteoblasts indicate that the PPY/PCL scaffold has good biocompatibility, and is suitable for use as an ES substrate. When human adipose-derived mesenchymal stem cells (AD-MSCs) were cultured in the PPY/PCL scaffold and subjected to 200 mu A of direct current for 4 h per day for 21 days, the amount of calcium deposited was 100% higher than that without ES. When these cells were subjected to ES together with blockers of voltage-gated calcium (Ca-v(2+)), sodium (Na-v(+)), potassium (K-v(+)), or chloride (Cl-v(-)) channels, the ES-induced enhancement of AD-MSCs' functions was reduced with Na-v(+), K-v(+), or Cl-v(-) blockers and completely nullified with Cev(2+) blocker. These results indicate that ion fluxes through these channels activated by ES induce different cascades of reactions in the cells, which subsequently regulate AD-MSCs' functions, and Cav(2+) plays a more critical role than the other three channels. Our results further the current understanding of the mechanisms by which ES regulates stem cells' behavior, and also showed that the conductive PPY/PCL scaffold with application of ES has good potential in bone defect therapy.
   Statement of Significance In this work, an electrically conductive and biocompatible scaffold was prepared by incorporating polypyrrole in a polycaprolactone template scaffold. Application of 200 A direct current for 4 h per day to human adipose derived-mesenchymal stem cells cultured on this scaffold promoted migration of these cells into the inner region of the scaffold and enhanced their osteogenic differentiation. The roles of voltage-gated ion channels (Ca-v(2+), Na-v(+), K-v(+), and Cl-v(-)) in osteogenic differentiation stimulated by the electric current were investigated. The results from these experiments further the current understanding of the mechanisms by which electrical stimulation regulates stem cells' behavior, and also show that the polypyr role-polycaprolactone scaffold with application of electrical stimulation has good potential in bone defect therapy. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Zhang, Jieyu; Kang, En-Tang; Neoh, Koon Gee] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Kent Ridge 117576, Singapore.
   [Li, Min; Kang, En-Tang; Neoh, Koon Gee] Natl Univ Singapore, Dept Chem & Biomol Engn, Kent Ridge 117576, Singapore.
RP Neoh, KG (reprint author), Blk E5,4 Engn Dr 4,02-34, Singapore 117576, Singapore.
EM zhangjieyu@u.nus.edu; chelim@nus.edu.sg; cheket@nus.edu.sg;
   chenkg@nus.edu.sg
OI Neoh, Koon Gee/0000-0002-2700-1914; Kang, En-Tang/0000-0003-0599-7834
FU National Medical Research Council of Singapore [NMRC EDG09-nov024]
FX This work was financially supported by the National Medical Research
   Council of Singapore (Grant number NMRC EDG09-nov024). We thank Dr.
   Yaw-Chyn Lim from Department of Physiology, National University of
   Singapore, for providing us the cell culture facilities.
CR Aronin CEP, 2008, ACTA BIOMATER, V4, P1187, DOI 10.1016/j.actbio.2008.02.029
   Bai XW, 2007, AM J PHYSIOL-CELL PH, V293, pC1539, DOI 10.1152/ajpcell.00089.2007
   Banu SK, 2008, ENDOCRINOLOGY, V149, P219, DOI 10.1210/en.2007-1087
   Benders KEM, 2013, TRENDS BIOTECHNOL, V31, P169, DOI 10.1016/j.tibtech.2012.12.004
   Bergh JJ, 2004, ENDOCRINOLOGY, V145, P426, DOI 10.1210/en.2003-0319
   Bjorninen M, 2014, ANN BIOMED ENG, V42, P1889, DOI 10.1007/s10439-014-1023-7
   Boiko N, 2013, J BIOL CHEM, V288, P9418, DOI 10.1074/jbc.M112.449413
   Bose S, 2012, TRENDS BIOTECHNOL, V30, P546, DOI 10.1016/j.tibtech.2012.07.005
   Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66
   Diykov D, 2013, INVERTEBR NEUROSCI, V13, P57, DOI 10.1007/s10158-012-0143-8
   Fassina L, 2010, J BIOMED MATER RES A, V93A, P1272, DOI 10.1002/jbm.a.32620
   Filardo G, 2013, AM J SPORT MED, V41, P1786, DOI 10.1177/0363546513490658
   Gabriel S, 2007, CHEM MATER, V19, P2364, DOI 10.1021/cm062450h
   Galar P, 2013, INT J ELECTROCHEM SC, V8, P57
   Goldstein C, 2010, J ORTHOP TRAUMA, V24, pS62, DOI 10.1097/BOT.0b013e3181cdde1b
   Hammerick KE, 2010, BIOCHEM BIOPH RES CO, V397, P12, DOI 10.1016/j.bbrc.2010.05.003
   Hardy JG, 2013, CURR OPIN BIOTECH, V24, P847, DOI 10.1016/j.copbio.2013.03.011
   Hess R, 2012, BIOMATERIALS, V33, P8975, DOI 10.1016/j.biomaterials.2012.08.056
   Holzwarth JM, 2011, BIOMATERIALS, V32, P9622, DOI 10.1016/j.biomaterials.2011.09.009
   Hong S, 2011, CARBOHYD POLYM, V83, P940, DOI 10.1016/j.carbpol.2010.09.002
   Hu CL, 2006, NEUROPHARMACOLOGY, V51, P737, DOI 10.1016/j.neuropharm.2006.05.013
   Hu WW, 2014, MAT SCI ENG C-MATER, V37, P28, DOI 10.1016/j.msec.2013.12.019
   Isaacson BM, 2010, J BIOMED MATER RES A, V95A, P1270, DOI 10.1002/jbm.a.32905
   Jansen JHW, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-188
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kawai T, 2014, TISSUE ENG PT A, V20, P1336, DOI [10.1089/ten.tea.2013.0508, 10.1089/ten.TEA.2013.0508]
   Kempen DHR, 2009, BIOMATERIALS, V30, P2816, DOI 10.1016/j.biomaterials.2009.01.031
   Khatib L, 2004, FASEB J, V18, P1903, DOI 10.1096/fj.04-1814fje
   Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014
   Koori K, 2014, CELL TISSUE RES, V357, P707, DOI 10.1007/s00441-014-1918-5
   Lefebvre M, 2006, APPL PROBABILITY STA
   Lian Kai, 2013, Biomatter, V3, DOI 10.4161/biom.27250
   Lin YH, 2011, LIFE SCI, V89, P886, DOI 10.1016/j.lfs.2011.09.011
   Liu AR, 2012, THIN SOLID FILMS, V520, P6307, DOI 10.1016/j.tsf.2012.06.039
   Meng SY, 2013, BIOELECTROMAGNETICS, V34, P189, DOI 10.1002/bem.21766
   Mycielska ME, 2004, J CELL SCI, V117, P1631, DOI 10.1242/jcs.01125
   Olsen ML, 2003, J NEUROSCI, V23, P5572
   Pappalardo LW, 2014, GLIA, V62, P1162, DOI 10.1002/glia.22671
   Pelto J, 2013, TISSUE ENG PT A, V19, P882, DOI [10.1089/ten.TEA.2012.0111, 10.1089/ten.tea.2012.0111]
   Pereira C, 2015, BIOMATERIALS, V56, P36, DOI 10.1016/j.biomaterials.2015.03.054
   Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637
   Radford R, 2012, AM J PHYSIOL-RENAL, V302, pF905, DOI 10.1152/ajprenal.00427.2011
   Russell TA, 2008, J BONE JOINT SURG AM, V90A, P2057, DOI 10.2106/JBJS.G.01191
   Saadoun S, 2011, J NEUROL NEUROSUR PS, V82, P3
   Shao SJ, 2011, BIOMATERIALS, V32, P2821, DOI 10.1016/j.biomaterials.2011.01.051
   Shi ZL, 2009, BIOMACROMOLECULES, V10, P1603, DOI 10.1021/bm900203w
   Shrestha B, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt480
   Sun WJ, 2010, J NEUROPHYSIOL, V103, P469, DOI 10.1152/jn.00154.2009
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Wu WKK, 2008, MOL CELL BIOCHEM, V308, P219, DOI 10.1007/s11010-007-9631-2
   Xiao YH, 2012, J MATER CHEM, V22, P8076, DOI 10.1039/c2jm30601h
   Yang SY, 2005, J BIOL CHEM, V280, P27130, DOI 10.1074/jbc.M501625200
   Zayzafoon M, 2006, J CELL BIOCHEM, V97, P56, DOI 10.1002/jcb.20675
   Zhang JY, 2013, BIOTECHNOL BIOENG, V110, P1466, DOI 10.1002/bit.24796
   Zhang X, 2003, LANGMUIR, V19, P10703, DOI 10.1021/la034893v
   Zheng LQ, 2011, BIOMATERIALS, V32, P7053, DOI [10.1016/j.biomaterials.2011.06.094, 10.1016/j.biomaterials.2011.06.004]
   Zheng XF, 2011, J MATER SCI-MATER M, V22, P693, DOI 10.1007/s10856-011-4248-0
   Zhu HB, 2011, BIOMATERIALS, V32, P4744, DOI 10.1016/j.biomaterials.2011.03.030
   Zuk PA, 2010, MOL BIOL CELL, V21, P1783, DOI 10.1091/mbc.E09-07-0589
NR 59
TC 24
Z9 24
U1 7
U2 93
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 1
PY 2016
VL 32
BP 46
EP 56
DI 10.1016/j.actbio.2015.12.024
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF8ZF
UT WOS:000371649100005
PM 26703122
DA 2018-10-19
ER

PT J
AU Patel, A
   Mukundan, S
   Wang, WH
   Karumuri, A
   Sant, V
   Mukhopadhyay, SM
   Sant, S
AF Patel, Akhil
   Mukundan, Shilpaa
   Wang, Wenhu
   Karumuri, Anil
   Sant, Vinayak
   Mukhopadhyay, Sharmila M.
   Sant, Shilpa
TI Carbon-based hierarchical scaffolds for myoblast differentiation:
   Synergy between nano-functionalization and alignment
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Carbon nanotubes; Multiscale hierarchy; Myogenesis; Carbon-based
   scaffolds; Alignment; Interconnected microporous structure; C2C12;
   Nano-roughness
ID SKELETAL-MUSCLE TISSUE; MESENCHYMAL STEM-CELLS; IN-VITRO; NANOTUBES;
   FABRICATION; COMPOSITE; CONSTRUCTS; SURFACES; ADHESION; CULTURE
AB While several scaffolds have been proposed for skeletal muscle regeneration, multiscale hierarchical scaffolds with the complexity of extracellular matrix (ECM) haven't been engineered successfully. By precise control over nano- and microscale features, comprehensive understanding of the effect of multiple factors on skeletal muscle regeneration can be derived. In this study, we engineered carbon-based scaffolds with hierarchical nano- and microscale architecture with controlled physico-chemical properties. More specifically, we built multiscale hierarchy by growing carbon nanotube (CNT) carpets on two types of scaffolds, namely, interconnected microporous carbon foams and aligned carbon fiber mats. Nanostructured CNT carpets offered fine control over nano-roughness and wettability facilitating myoblast adhesion, growth and differentiation into myocytes. However, microporous foam architecture failed to promote their fusion into multinucleated myotubes. On the other hand, aligned fibrous architecture stimulated formation of multinucleated myotubes. Most importantly, nanostructured CNT carpets interfaced with microscale aligned fibrous architecture significantly enhanced myocyte fusion into multinucleated mature myotubes highlighting synergy between nanoscale surface features and micro-/macroscale aligned fibrous architecture in the process of myogenesis.
   Statement of Significance
   Due to limited regenerative potential of skeletal muscle, strategies stimulating regeneration of functional muscles are important. These strategies are aimed at promoting differentiation of progenitor cells (myoblasts) into multinucleated myotubes, a key initial step in functional muscle regeneration. Recent tissue engineering approaches utilize various scaffolds ranging from decellularized matrices to aligned biomaterial scaffolds. Although, majority of them have focused on nano- or microscale organization, a systematic approach to build the multiscale hierarchy into these scaffolds is lacking. Here, we engineered multiscale hierarchy into carbon-based materials and demonstrated that the nanoscale features govern the differentiation of individual myoblasts into myocytes whereas microscale alignment cues orchestrate fusion of multiple myocytes into multinucleated myotubes underlining the importance of multiscale hierarchy in enhancing coordinated tissue regeneration. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Patel, Akhil; Mukundan, Shilpaa; Sant, Vinayak; Sant, Shilpa] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA.
   [Mukundan, Shilpaa; Wang, Wenhu; Mukhopadhyay, Sharmila M.] Wright State Univ, Ctr Nanoscale Multifunct Mat, Mech & Mat Engn, Dayton, OH 45324 USA.
   [Sant, Shilpa] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA 15261 USA.
   [Sant, Shilpa] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
RP Sant, S (reprint author), 3501 Terrace St,527 Salk Hall, Pittsburgh, PA 15261 USA.
EM shs149@pitt.edu
OI Patel, Akhil/0000-0001-8915-8995; Sant, Shilpa/0000-0002-2017-9584
FU Department of Pharmaceutical Sciences at University of Pittsburgh;
   NSF-CBET [1449582]; WSU PhD program; Ohio Board of Regents
FX The authors thank Dr. Donna B. Stolz, Center for Biologic Imaging (CBI),
   University of Pittsburgh for access to the electron microscopy facility.
   SS acknowledges funding support from start-up funds from the Department
   of Pharmaceutical Sciences at University of Pittsburgh. Mukhopadhyay
   group acknowledges financial support from NSF-CBET (1449582), WSU PhD
   program, and Ohio Board of Regents. We also thank Ultramet and Hexcel
   for generous supplies of carbon foam and fiber mats, respectively.
CR Ahadian S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04271
   [Anonymous], 2011, US BUR LAB STAT REP
   Bennett DB, 2014, J BONE JOINT SURG AM, V96A, P2062, DOI 10.2106/JBJS.M.01542
   Chen JY, 2008, J AM CHEM SOC, V130, P16778, DOI 10.1021/ja805570f
   Chen MC, 2013, ACTA BIOMATER, V9, P5562, DOI 10.1016/j.actbio.2012.10.024
   Chinn J. A., 1995, BIOMEDICAL ENG HDB, P1597
   Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031
   Clark P, 1997, EXP CELL RES, V230, P275, DOI 10.1006/excr.1996.3429
   Clark P, 2002, INT J BIOCHEM CELL B, V34, P816, DOI 10.1016/S1357-2725(01)00180-7
   Depan D, 2014, BIOMATER SCI-UK, V2, P1727, DOI 10.1039/c4bm00168k
   Duffy RM, 2014, WIRES NANOMED NANOBI, V6, P178, DOI 10.1002/wnan.1254
   El-Ayoubi R, 2008, TISSUE ENG PT A, V14, P1037, DOI [10.1089/ten.tea.2006.0418, 10.1089/tea.2006.0418]
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Evans DJR, 1999, DEV GENES EVOL, V209, P438, DOI 10.1007/s004270050275
   Ferlin KM, 2013, MICRO AND NANOTECHNOLOGIES IN ENGINEERING STEM CELLS AND TISSUES, P159
   Gaharwar AK, 2015, BIOFABRICATION, V7, DOI 10.1088/1758-5090/7/1/015001
   Gaharwar AK, 2013, ADV MATER, V25, P3329, DOI 10.1002/adma.201300584
   Hall JE, 2011, GUYTON HALL TXB MED
   Hinds S, 2011, BIOMATERIALS, V32, P3575, DOI 10.1016/j.biomaterials.2011.01.062
   Hwang CM, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/035003
   Karumuri AK, 2015, APPL SURF SCI, V327, P122, DOI [10.1016/j.apsusc.2014.11.154, 10.1016/j.apsusc.2014.10.154]
   Kerativitayanan P., 2015, ADV HEALTHCARE MAT
   Lacerda L, 2006, ADV DRUG DELIVER REV, V58, P1460, DOI 10.1016/j.addr.2006.09.015
   Lam MT, 2009, BIOMATERIALS, V30, P1150, DOI 10.1016/j.biomaterials.2008.11.014
   Li N., 2013, SCI REP, V3
   McKeon-Fischer KD, 2011, J BIOMED MATER RES A, V99A, P493, DOI 10.1002/jbm.a.33116
   Meng J, 2006, J BIOMED MATER RES A, V79A, P298, DOI 10.1002/jbm.a.30787
   Montesano S, 2013, ISRN TISSUE ENGINEER, V2013, P8
   Mukhopadhyay SM, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/36/365301
   Mukhopadhyay SM, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/19/195503
   Mukundan S, 2015, EUR POLYM J, V68, P21, DOI 10.1016/j.eurpolymj.2015.04.026
   Osses N, 2002, AM J PHYSIOL-CELL PH, V282, pC383, DOI 10.1152/ajpcell.00322.2001
   Papenburg BJ, 2010, SOFT MATTER, V6, P4377, DOI 10.1039/b927207k
   Park H, 2011, BIOMATERIALS, V32, P1856, DOI 10.1016/j.biomaterials.2010.11.032
   Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   Sant S., 2012, TISSUE ANALOGS ASSEM, P471
   Sant S, 2013, ACTA BIOMATER, V9, P5963, DOI 10.1016/j.actbio.2012.11.014
   Shin SR, 2013, ACS NANO, V7, P2369, DOI 10.1021/nn305559j
   Sirivisoot S, 2011, INT J NANOMED, V6, P2483, DOI 10.2147/IJN.S24073
   Spinks GM, 2006, ADV MATER, V18, P637, DOI 10.1002/adma.200502366
   TAMADA Y, 1993, J COLLOID INTERF SCI, V155, P334, DOI 10.1006/jcis.1993.1044
   Tong ZX, 2011, TISSUE ENG PT A, V17, P2773, DOI [10.1089/ten.tea.2011.0219, 10.1089/ten.TEA.2011.0219]
   VANDERVEN PFM, 1992, CELL TISSUE RES, V270, P189, DOI 10.1007/BF00381893
   Vilquin J T, 2005, Acta Myol, V24, P119
   Wang H., 2015, ADV COLLOID INTERFAC
   Xu AX, 2015, MAT SCI ENG C-MATER, V48, P592, DOI 10.1016/j.msec.2014.12.061
   Zhang XY, 2012, TOXICOL RES-UK, V1, P62, DOI 10.1039/c2tx20006f
NR 48
TC 10
Z9 11
U1 7
U2 49
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 1
PY 2016
VL 32
BP 77
EP 88
DI 10.1016/j.actbio.2016.01.004
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF8ZF
UT WOS:000371649100008
PM 26768231
OA Other Gold
DA 2018-10-19
ER

PT J
AU Levingstone, TJ
   Thompson, E
   Matsiko, A
   Schepens, A
   Gleeson, JP
   O'Brien, FJ
AF Levingstone, Tanya J.
   Thompson, Emmet
   Matsiko, Amos
   Schepens, Alexander
   Gleeson, John P.
   O'Brien, Fergal J.
TI Multi-layered collagen-based scaffolds for osteochondral defect repair
   in rabbits
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Cartilage; Osteochondral; Tissue engineering; Collagen; In vivo
ID ARTICULAR-CARTILAGE REPAIR; AUTOLOGOUS CHONDROCYTE TRANSPLANTATION;
   SIMULTANEOUS REGENERATION; TISSUE REGENERATION; BARRIER PRINCIPLE;
   TRABECULAR BONE; CELL-ADHESION; ANIMAL-MODELS; GAG SCAFFOLDS; II
   COLLAGEN
AB Introduction: Identification of a suitable treatment for osteochondral repair presents a major challenge due to existing limitations and an urgent clinical need remains for an off-the-shelf, low cost, one-step approach. A biomimetic approach, where the biomaterial itself encourages cellular infiltration from the underlying bone marrow and provides physical and chemical cues to direct these cells to regenerate the damaged tissue, provides a potential solution. To meet this need, a multi-layer collagen-based osteochondral defect repair scaffold has been developed in our group.
   Aim: The objective of this study was to assess the in vivo response to this scaffold and determine its ability to direct regenerative responses in each layer in order to repair osteochondral tissue in a critical-sized defect in a rabbit knee.
   Methods: Multi-layer scaffolds, consisting of a bone layer composed of type I collagen (bovine source) and hydroxyapatite (HA), an intermediate layer composed of type I and type II collagen and HA; and a superficial layer composed of type I and type II collagen (porcine source) and hyaluronic acid (HyA), were implanted into critical size (3 x 5 mm) osteochondral defects created in the medial femoral condyle of the knee joint of New Zealand white rabbits and compared to an empty control group. Repair was assessed macroscopically, histologically and using micro-CT analysis at 12 weeks post implantation.
   Results: Analysis of repair tissue demonstrated an enhanced macroscopic appearance in the multi-layer scaffold group compared to the empty group. In addition, diffuse host cellular infiltration in the scaffold group resulted in tissue regeneration with a zonal organisation, with repair of the subchondral bone, formation of an overlying cartilaginous layer and evidence of an intermediate tidemark.
   Conclusion: These results demonstrate the potential of this biomimetic multi-layered scaffold to support and guide the host reparative response in the treatment of osteochondral defects.
   Statement of Significance
   Osteochondral defects, involving cartilage and the underlying subchondral bone, frequently occur in young active patients due to disease or injury. While some treatment options are available, success is limited and patients often eventually require joint replacement. To address this clinical need, a multi-layer collagen-based osteochondral defect repair scaffold designed to direct host-stem cell mediated tissue formation within each region, has been developed in our group. The present study investigates the in vivo response to this scaffold in a critical-sized defect in a rabbit knee. Results shows the scaffolds ability to guide the host reparative response leading to tissue regeneration with a zonal organisation, repair of the subchondral bone, formation of an overlying cartilaginous layer and evidence of an intermediate tidemark. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Levingstone, Tanya J.; Thompson, Emmet; Matsiko, Amos; Gleeson, John P.; O'Brien, Fergal J.] Royal Coll Surgeons Ireland, Dept Anat, Tissue Engn Res Grp, 123 St Stephens Green, Dublin 2, Ireland.
   [Levingstone, Tanya J.; Thompson, Emmet; Matsiko, Amos; Gleeson, John P.; O'Brien, Fergal J.] Trinity Coll Dublin, Trin Ctr Bioengn, Dublin 2, Ireland.
   [Levingstone, Tanya J.; Thompson, Emmet; Matsiko, Amos; Gleeson, John P.; O'Brien, Fergal J.] Royal Coll Surgeons Ireland, Adv Mat & Bioengn Res AMBER Ctr, Dublin 2, Ireland.
   [Levingstone, Tanya J.; Thompson, Emmet; Matsiko, Amos; Gleeson, John P.; O'Brien, Fergal J.] Trinity Coll Dublin, Dublin 2, Ireland.
   [Schepens, Alexander] AZ Sint Lucas Hosp, Dept Orthopaed Surg, Ghent, Belgium.
   [Gleeson, John P.] Dublin City Univ, Invent Ctr, SurgaColl Technol Ltd, Dublin 9, Ireland.
RP O'Brien, FJ (reprint author), Royal Coll Surgeons Ireland, Dept Anat, 123 St Stephens Green, Dublin 2, Ireland.
EM fjobrien@rcsi.ie
RI O'Brien, Fergal/F-9485-2011
OI O'Brien, Fergal/0000-0003-2030-8005; Levingstone,
   Tanya/0000-0002-9751-2314
FU Enterprise Ireland Proof of Concept Award [PC/2007/331];
   Commercialisation Fund Technology Development Award [CFTD/2009/0104];
   Science Foundation Ireland (SFI)/Health Research Board (HRB)
   Translational Research Award [TRA/2011/19]
FX The authors acknowledge Enterprise Ireland Proof of Concept Award
   (PC/2007/331) and Commercialisation Fund Technology Development Award
   (CFTD/2009/0104) and Science Foundation Ireland (SFI)/Health Research
   Board (HRB) Translational Research Award (TRA/2011/19) for funding.
CR Abarrategi A, 2010, J BIOMED MATER RES A, V95A, P1132, DOI 10.1002/jbm.a.32912
   ASTM, 2010, STAND GUID IN VIV AS
   Benazzo F, 2008, J ORTHOP RES, V26, P631, DOI 10.1002/jor.20530
   Brittberg M., 2010, AM J SPORTS MED, V38, P259
   Chang CH, 2006, BIOMATERIALS, V27, P1876, DOI 10.1016/j.biomaterials.2005.10.014
   Chang KY, 2010, J BIOMED MATER RES A, V92A, P712, DOI 10.1002/jbm.a.32198
   Chen JN, 2011, BIOMATERIALS, V32, P4793, DOI 10.1016/j.biomaterials.2011.03.041
   Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI [10.1089/ten.teb.2009.0452, 10.1089/ten.TEB.2009.0452]
   Chu CR, 1997, CLIN ORTHOP RELAT R, P220
   Coburn JM, 2012, P NATL ACAD SCI USA, V109, P10012, DOI 10.1073/pnas.1121605109
   Cook JL, 2014, BONE JOINT RES, V3, P89, DOI 10.1302/2046-3758.34.2000238
   De Franceschi L, 2005, J BIOMED MATER RES A, V75A, P612, DOI 10.1002/jbm.a.30471
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Getgood A, 2012, CARTILAGE, V3, P351, DOI 10.1177/1947603512444597
   Getgood AMJ, 2012, KNEE, V19, P422, DOI 10.1016/j.knee.2011.03.011
   Gleeson JP, 2010, EUR CELLS MATER, V20, P218
   Gleeson J. P., 2009, Patent, Patent No. [WO2010/084481, 2010084481]
   Gudas R, 2012, AM J SPORT MED, V40, P2499, DOI 10.1177/0363546512458763
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1078, DOI 10.1002/jbm.a.32387
   Henderson IJP, 2005, KNEE, V12, P435, DOI 10.1016/j.knee.2005.04.003
   Hunziker EB, 2003, OSTEOARTHR CARTILAGE, V11, P320, DOI 10.1016/S1063-4584(03)00031-1
   Hunziker EB, 2001, CLIN ORTHOP RELAT R, pS182
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jeon JE, 2014, ANAT REC, V297, P26, DOI 10.1002/ar.22795
   Karamichos D, 2006, J BIOMED MATER RES A, V78A, P407, DOI 10.1002/jbm.a.30814
   Keeney M, 2009, TISSUE ENG PART B-RE, V15, P55, DOI 10.1089/ten.teb.2008.0388
   Kon E, 2013, BONE JOINT RES, V2, P18, DOI 10.1302/2046-3758.22.2000092
   Lahm A, 2006, ARCH ORTHOP TRAUM SU, V126, P582, DOI 10.1007/s00402-005-0077-2
   Levingstone TJ, 2014, ACTA BIOMATER, V10, P1996, DOI 10.1016/j.actbio.2014.01.005
   Lyons FG, 2014, CLIN ORTHOP RELAT R, V472, P1318, DOI 10.1007/s11999-013-3438-0
   Maehara H, 2010, J ORTHOP RES, V28, P677, DOI 10.1002/jor.21032
   Mainil-Varlet P, 2010, AM J SPORT MED, V38, P880, DOI 10.1177/0363546509359068
   Matsiko A, 2012, J MECH BEHAV BIOMED, V11, P41, DOI 10.1016/j.jmbbm.2011.11.012
   Minas T, 2009, AM J SPORT MED, V37, P902, DOI 10.1177/0363546508330137
   Mohan N, 2011, TISSUE ENG PT A, V17, P2845, DOI 10.1089/ten.tea.2011.0135
   Mrosek EH, 2006, OSTEOARTHR CARTILAGE, V14, P171, DOI 10.1016/j.joca.2005.08.004
   Murphy CM, 2014, ACTA BIOMATER, V10, P2250, DOI 10.1016/j.actbio.2014.01.016
   Nukavarapu SP, 2013, BIOTECHNOL ADV, V31, P706, DOI 10.1016/j.biotechadv.2012.11.004
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Panics G, 2012, CARTILAGE, V3, p25S, DOI 10.1177/1947603511408286
   Peterson L, 2000, Clin Orthop Relat Res, P212, DOI 10.1097/00003086-200005000-00020
   Ragetly G, 2010, ACTA BIOMATER, V6, P3988, DOI 10.1016/j.actbio.2010.05.016
   Re'em T, 2012, ACTA BIOMATER, V8, P3283, DOI 10.1016/j.actbio.2012.05.014
   Reyes R., 2014, J TISSUE ENG REGEN M, V6, P521
   Schaefer D, 2002, ARTHRITIS RHEUM, V46, P2524, DOI 10.1002/art.10493
   Scotti C, 2010, BIOMATERIALS, V31, P2252, DOI 10.1016/j.biomaterials.2009.11.110
   Tassani S, 2014, J MICROSC-OXFORD, V256, P75, DOI 10.1111/jmi.12159
   Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978
   Vines JB, 2012, ACTA BIOMATER, V8, P4053, DOI 10.1016/j.actbio.2012.07.024
   Wakitani S, 1998, TISSUE ENG, V4, P429, DOI 10.1089/ten.1998.4.429
   Wang FY, 2009, J STRUCT BIOL, V168, P359, DOI 10.1016/j.jsb.2009.08.010
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P761, DOI 10.1023/A:1013957431372
NR 53
TC 35
Z9 37
U1 10
U2 83
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 1
PY 2016
VL 32
BP 149
EP 160
DI 10.1016/j.actbio.2015.12.034
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF8ZF
UT WOS:000371649100015
PM 26724503
DA 2018-10-19
ER

PT J
AU Ferlin, KM
   Prendergast, ME
   Miller, ML
   Kaplan, DS
   Fisher, JP
AF Ferlin, Kimberly M.
   Prendergast, Margaret E.
   Miller, Makenzie L.
   Kaplan, David S.
   Fisher, John P.
TI Influence of 3D printed porous architecture on mesenchymal stem cell
   enrichment and differentiation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE 3D printing; Biomaterial; Mesenchymal stem cell; Differentiation;
   Scaffold architecture
ID MARROW STROMAL CELLS; POLY(PROPYLENE FUMARATE); PORE-SIZE; SCAFFOLDS;
   BIOMATERIALS; REGENERATION; CULTURE; DESIGN; PERMEABILITY; LINEAGES
AB The interactions between cells and an underlying biomaterial are important for the promotion of cell adhesion, proliferation, and function. Mesenchymal stem cells (MSCs) have great clinical potential as they are an adult stem cell population capable of multilineage differentiation. The relationship between MSC behavior and several material properties including substrate stiffness and pore size are well investigated, but there has been little research on the influence of porous architecture in a three-dimensional scaffold with a well-controlled architecture. Here, we investigate the impact of two different three-dimensionally printed, pore geometries on the enrichment and differentiation of MSCs. 3D printed scaffolds with ordered cubic pore geometry were supportive of MSC enrichment from unprocessed bone marrow, resulting in cell surface marker expression that was comparable to typical adhesion to tissue culture polystyrene, the gold standard for MSC culture. Results also show that scaffolds fabricated with ordered cubic pores significantly increase the gene expression of MSCs undergoing adipogenesis and chondrogenesis, when compared to scaffolds with ordered cylindrical pores. However, at the protein expression level, these differences were modest. For MSCs undergoing osteogenesis, gene expression results suggest that cylindrical pores may initially increase early osteogenic marker expression, while protein level expression at later timepoints is increased for scaffolds with ordered cubic pores. Taken together, these results suggest that 3D printed scaffolds with ordered cubic pores could be a suitable culture system for single-step MSC enrichment and differentiation.
   Statement of Significance
   Mesenchymal stem cells (MSCs) have great therapeutic potential, as they are capable of multilineage differentiation. MSC behavior, including lineage commitment, may be influenced by biomaterial properties including substrate stiffness and pore size. With three-dimensional (3D) printing, we can investigate these relationships in 3D culture systems. Here, we fabricated scaffolds with two different well controlled pore geometries, and investigated the impact on MSC enrichment and differentiation. Results show that scaffolds with ordered cubic pore geometry were supportive of both MSC enrichment from unprocessed bone marrow as well as MSC differentiation, resulting in increased gene expression during adipogenesis and chondrogenesis. These results suggest that 3D printed scaffolds with ordered cubic pores could be a suitable culture system for single-step MSC enrichment and differentiation. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Ferlin, Kimberly M.; Prendergast, Margaret E.; Miller, Makenzie L.; Fisher, John P.] Univ Maryland, Fischell Dept Bioengn, 3238 Jeong H Kim Engn Bldg, College Pk, MD 20742 USA.
   [Kaplan, David S.] US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD USA.
RP Fisher, JP (reprint author), Univ Maryland, Fischell Dept Bioengn, 3238 Jeong H Kim Engn Bldg, College Pk, MD 20742 USA.
EM jpfisher@umd.edu
OI Prendergast, Margaret/0000-0002-2534-5385
FU National Science Foundation/Food and Drug Administration
   Scholar-in-Residence Program [CBET 1238398]
FX Research reported in this publication was supported by the National
   Science Foundation/Food and Drug Administration Scholar-in-Residence
   Program (CBET 1238398). The authors wish to thank Dr. Srinidhi Nagaraja
   for his technical assistance obtaining and analyzing the results of mu
   CT and Dr. Girish Kumar for his technical assistance with the flow
   cytometry experiments.
CR Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x
   Bara JJ, 2014, STEM CELLS, V32, P1713, DOI 10.1002/stem.1649
   Bracaglia LG, 2014, TISSUE ENG PT A, V20, P2807, DOI [10.1089/ten.tea.2014.0516, 10.1089/ten.TEA.2014.0516]
   Campos DFD, 2015, TISSUE ENG PT A, V21, P740, DOI [10.1089/ten.TEA.2014.0231, 10.1089/ten.tea.2014.0231]
   Castro NJ, 2015, CELL MOL BIOENG, V8, P416, DOI 10.1007/s12195-015-0389-4
   Dean D, 2012, VIRTUAL PHYS PROTOTY, V7, P13, DOI 10.1080/17452759.2012.673152
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   dos Santos F, 2011, TISSUE ENG PART C-ME, V17, P1201, DOI 10.1089/ten.tec.2011.0255
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Ferlin KM, 2014, MOL PHARMACEUT, V11, P2172, DOI 10.1021/mp500062n
   Fisher JP, 2002, J BIOMED MATER RES, V59, P547, DOI 10.1002/jbm.1268
   Fisher JP, 2002, BIOMATERIALS, V23, P4333, DOI 10.1016/S0142-9612(02)00178-3
   Goh TKP, 2013, BIORESEARCH OPEN ACC, V2, P84, DOI 10.1089/biores.2013.0001
   Hervy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092120
   Huri PY, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/4/045003
   Jeong CG, 2010, TISSUE ENG PT A, V16, P3759, DOI [10.1089/ten.tea.2010.0103, 10.1089/ten.TEA.2010.0103]
   Jeong CG, 2011, ACTA BIOMATER, V7, P505, DOI 10.1016/j.actbio.2010.08.027
   Kasper FK, 2009, NAT PROTOC, V4, P518, DOI 10.1038/nprot.2009.24
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kim K, 2011, BIOMATERIALS, V32, P3750, DOI 10.1016/j.biomaterials.2011.01.016
   Lane SW, 2014, NAT BIOTECHNOL, V32, P795, DOI 10.1038/nbt.2978
   Lee J, 2013, BIOMATERIALS, V34, P8140, DOI 10.1016/j.biomaterials.2013.07.074
   Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020
   Lipowiecki M, 2014, J BIOMED MATER RES A, V102, P4127, DOI 10.1002/jbm.a.35084
   Lv FJ, 2014, STEM CELLS, V32, P1408, DOI 10.1002/stem.1681
   Mareschi K, 2012, STEM CELLS INT, DOI 10.1155/2012/920581
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Papadimitropoulos A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102359
   Phipps MC, 2012, BIOMATERIALS, V33, P524, DOI 10.1016/j.biomaterials.2011.09.080
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Wang M.O., 2015, TISSUE ENG A
   Wang MO, 2015, ADV MATER, V27, P138, DOI 10.1002/adma.201403943
   Wang MO, 2013, BIOMACROMOLECULES, V14, P1321, DOI 10.1021/bm301962f
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Yang Z, 2011, METHODS MOL BIOL, V698, P353, DOI 10.1007/978-1-60761-999-4_26
   Yeatts AB, 2011, TISSUE ENG PART C-ME, V17, P337, DOI [10.1089/ten.tec.2010.0172, 10.1089/ten.TEC.2010.0172]
   Zhang Q, 2014, ACTA BIOMATER, V10, P2005, DOI 10.1016/j.actbio.2013.12.042
   Zhang WJ, 2015, MAT SCI ENG C-MATER, V46, P10, DOI 10.1016/j.msec.2014.09.042
NR 38
TC 13
Z9 14
U1 1
U2 60
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 1
PY 2016
VL 32
BP 161
EP 169
DI 10.1016/j.actbio.2016.01.007
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF8ZF
UT WOS:000371649100016
PM 26773464
OA Other Gold
DA 2018-10-19
ER

PT J
AU Silva, SS
   Oliveira, NM
   Oliveira, MB
   da Costa, DPS
   Naskar, D
   Mano, JF
   Kundu, SC
   Reis, RL
AF Silva, Simone S.
   Oliveira, Nuno M.
   Oliveira, Mariana B.
   Soares da Costa, Diana P.
   Naskar, Deboki
   Mano, Joao F.
   Kundu, Subhas C.
   Reis, Rui L.
TI Fabrication and characterization of Eri silk fibers-based sponges for
   biomedical application
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Eri; Samia ricini; Ionic liquids; Genipin; Cartilage regeneration;
   Fibroin
ID CROSS-LINKING; VISCOELASTIC PROPERTIES; IONIC LIQUIDS; NON-MULBERRY;
   FIBROIN; GENIPIN; SCAFFOLDS; HYDROGELS; BIOMATERIAL; CRYSTALLINITY
AB Cocoon-derived semi-domesticated Ed silk fibers still lack exploitation for tissue engineering applications due to their poor solubility using conventional methods. The present work explores the ability to process cocoon fibers of non-mulberry Ed silk (Samia/Philosamia ricini) into sponges through a green approach using ionic liquid (IL) - 1-buthyl-imidazolium acetate as a solvent. The formation of beta-sheet structures during Eri silk/IL gelation was acquired by exposing the Ed silk/IL gels to a saturated atmosphere composed of two different solvents: (i) isopropanol/ethanol (physical stabilization) and (ii) genipin, a natural crosslinker, dissolved in ethanol (chemical crosslinking). The sponges were then obtained by freeze-drying. This approach promotes the formation of both stable and ordered non-crosslinked Eri silk fibroin matrices. Moreover, genipin-crosslinked silk fibroin sponges presenting high height recovery capacity after compression, high swelling degree and suitable mechanical properties for tissue engineering applications were produced. The incorporation of a model drug - ibuprofen - and the corresponding release study from the loaded sponges demonstrated the potential of using these matrices as effective drug delivery systems. The assessment of the biological performance of ATDC5 chondrocyte-like cells in contact with the developed sponges showed the promotion of cell adhesion and proliferation, as well as extracellular matrix production within 2 weeks of culture. Sponges' intrinsic properties and biological findings open up their potential use for biomedical applications.
   Statement of Significance
   This work addresses the preparation and characterization of non-mulberry cocoon-derived Ed silk sponges. The insolubility of cocoons-derived non-mulberry silkworms impairs their processability and applications in the healthcare field. We used a green approach with ionic liquids to overcome the lack solubility of such silk fibers. The formation of beta-sheet structures into Ed-based sponges was physically and chemically induced. The sponges were obtained by freeze-drying. The developed structures exhibited flexibility to adapt and recover their shapes upon application and subsequent removal of load, high swelling degree, ability to load an anti-inflammatory drug and to promote its sustained release. They promoted in vitro cellular adhesion, proliferation and extracellular matrix production of a chondrocyte-like cell line, opening up their potential application for biomedical applications. (C) 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Silva, Simone S.; Oliveira, Nuno M.; Oliveira, Mariana B.; Soares da Costa, Diana P.; Mano, Joao F.; Reis, Rui L.] Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, Avepk,Parque Ciencia & Tecnol, P-4806017 Barco Gmr, Portugal.
   [Silva, Simone S.; Oliveira, Nuno M.; Oliveira, Mariana B.; Soares da Costa, Diana P.; Mano, Joao F.; Reis, Rui L.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.
   [Naskar, Deboki; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Silva, SS (reprint author), Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, Avepk,Parque Ciencia & Tecnol, P-4806017 Barco Gmr, Portugal.; Kundu, SC (reprint author), Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
EM simonesilva@dep.uminho.pt; Kundu@hijli.iitkgp.ernet.in
RI Group, 3Bs/E-4374-2012; Mano, Joao/A-4418-2009; Reis, Rui
   L./A-8938-2008; Soares da Costa, Diana/C-3217-2011; Oliveira,
   Mariana/H-6933-2017; Oliveira, Nuno/K-8917-2016
OI Group, 3Bs/0000-0002-5195-3456; Mano, Joao/0000-0002-2342-3765; Reis,
   Rui L./0000-0002-4295-6129; Soares da Costa, Diana/0000-0002-1870-6904;
   Oliveira, Mariana/0000-0002-6104-6075; Oliveira,
   Nuno/0000-0002-2326-2404; Kundu, Subhas C./0000-0002-7170-2291; Silva,
   Simone/0000-0003-4268-9419
FU Portuguese Foundation for Science and Technology - FCT
   [SFRH/BPD/45307/2008, SFRH/BPD/85790/2012, SFRH/BD/71396/2010,
   SFRH/BD/73172/2010]; "Fundo Social Europeu" - FSE; Programa Diferencial
   de Potencial Humano POPH; European Union [REGPOT-CT2012-316331-POLARIS];
   Fundacao para a Ciencia e Tecnologia (FCT) [ENIGMA -
   PTDC/EQU-EPR/121491/2010]; Department of Biotechnology; Indian Council
   of Medical Research, Govt of India
FX The authors SSS, DSC, MBO, NMO acknowledge financial support from
   Portuguese Foundation for Science and Technology - FCT (Grants
   SFRH/BPD/45307/2008, SFRH/BPD/85790/2012, SFRH/BD/71396/2010 and
   SFRH/BD/73172/2010, respectively), "Fundo Social Europeu" - FSE, and
   "Programa Diferencial de Potencial Humano POPH". This work is also
   financially supported by the European Union Seventh Framework Programme
   (FP7/2007-2013) under grant agreement no REGPOT-CT2012-316331-POLARIS
   and from Fundacao para a Ciencia e Tecnologia (FCT) through the project
   ENIGMA - PTDC/EQU-EPR/121491/2010. The laboratory work of SCK is
   supported by Department of Biotechnology and Indian Council of Medical
   Research, Govt of India. SCK and RLR acknowledge their short visits
   either Institutes. SCK is also grateful to 3 Bs Research Group-
   Biomaterials, Biodegradables and Biomimetics, University of Minho,
   Portugal for providing facilities during his short visit.
CR Almeida LR, 2013, ACTA BIOMATER, V9, P8167, DOI 10.1016/j.actbio.2013.05.019
   Andiyappan M, 2013, INT J MATER RES, V104, P498, DOI 10.3139/146.110888
   Anthony J. L., 2003, IONIC LIQUIDS SYNTHE, P41, DOI 10.1002/3527600701.ch3
   Aydin HM, 2009, J TISSUE ENG REGEN M, V3, P470, DOI 10.1002/term.187
   Babu KM, 2013, WOODHEAD PUBL SER TE, P56, DOI 10.1533/9781782421580.56
   Bhardwaj N, 2012, BIOMATERIALS, V33, P2848, DOI 10.1016/j.biomaterials.2011.12.028
   BHAT NV, 1980, J APPL POLYM SCI, V25, P921, DOI 10.1002/app.1980.070250518
   BRODT M, 1995, REV SCI INSTRUM, V66, P5292, DOI 10.1063/1.1146101
   Carballido A., 2004, INT J PHARMACEUT, V279, P33
   Costa AMS, 2014, LANGMUIR, V30, P4535, DOI 10.1021/la500286v
   Deng X, 2012, SCIENCE, V335, P67, DOI 10.1126/science.1207115
   Dong YX, 2015, EUR J PHARM BIOPHARM, V91, P82, DOI 10.1016/j.ejpb.2015.01.018
   Dutta S, 2013, BIOPOLYMERS, V99, P326, DOI 10.1002/bip.22168
   Elliott WH, 2015, ACS APPL MATER INTER, V7, P12099, DOI 10.1021/acsami.5b02308
   Friedman M, 2004, J AGR FOOD CHEM, V52, P385, DOI 10.1021/jf030490p
   Fulcher GR, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-61
   Goujon N, 2013, J APPL POLYM SCI, V128, P4411, DOI 10.1002/app.38666
   Goujon N, 2012, CHEM COMMUN, V48, P1278, DOI 10.1039/c2cc17143k
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Kafienah W, 2004, BIOPOLYMER METHODS T, P217
   Kar S, 2013, TISSUE ENG REGEN MED, V10, P200, DOI 10.1007/s13770-012-0008-6
   Kundu B., 2013, BIOMED MAT, V8
   Kundu SC, 2012, BIOPOLYMERS, V97, P455, DOI 10.1002/bip.22024
   Li MZ, 2001, J APPL POLYM SCI, V79, P2192, DOI 10.1002/1097-4628(20010321)79:12<2192::AID-APP1027>3.0.CO;2-0
   Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Mathew AP, 2013, MACROMOL BIOSCI, V13, P289, DOI 10.1002/mabi.201200317
   Mi FL, 2000, J POLYM SCI POL CHEM, V38, P2804, DOI 10.1002/1099-0518(20000801)38:15<2804::AID-POLA210>3.0.CO;2-Y
   Muthumanickkam A, 2013, IRAN POLYM J, V22, P143, DOI 10.1007/s13726-012-0113-3
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V77, P1, DOI 10.1016/j.carbpol.2009.01.016
   Nakazawa Y, 2003, PROTEIN SCI, V12, P666, DOI 10.1110/ps.0239203
   Pal S, 2013, MACROMOL BIOSCI, V13, P1020, DOI 10.1002/mabi.201300013
   Phillips DM, 2004, J AM CHEM SOC, V126, P14350, DOI 10.1021/ja046079f
   Popa EG, 2013, SOFT MATTER, V9, P875, DOI 10.1039/c2sm26846a
   Rajkhowa R, 2011, J APPL POLYM SCI, V119, P1339, DOI 10.1002/app.31981
   Rial-Hermida MI, 2014, ACTA BIOMATER, V10, P4314, DOI 10.1016/j.actbio.2014.06.009
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Saha S., 2013, PLOS ONE, V8
   Silva M., 2010, TISSUE ENG PART B-RE, V16, P331
   Silva S. S., 2011, COMPREHENSIVE BIOMAT, P187
   Silva SS, 2008, BIOMACROMOLECULES, V9, P2764, DOI 10.1021/bm800874q
   Silva SS, 2013, GREEN CHEM, V15, P3252, DOI 10.1039/c3gc41060a
   Silva SS, 2013, ACTA BIOMATER, V9, P8972, DOI 10.1016/j.actbio.2013.06.044
   Silva SS, 2012, GREEN CHEM, V14, P1463, DOI 10.1039/c2gc16535j
   Silva SS, 2011, ACTA BIOMATER, V7, P1166, DOI 10.1016/j.actbio.2010.09.041
   Silva-Correia J, 2013, J BIOMED MATER RES A, V101, P3438, DOI 10.1002/jbm.a.34650
   Sosnowski S, 2006, MACROMOL BIOSCI, V6, P425, DOI 10.1002/mabi.200600003
   Sun W., 2014, J TISSUE ENG REGEN M
   Sung HW, 2000, J BIOMED MATER RES, V52, P77, DOI 10.1002/1097-4636(200010)52:1<77::AID-JBM10>3.0.CO;2-6
   Talukdar S, 2013, ADV FUNCT MATER, V23, P5249, DOI 10.1002/adfm.201300312
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Woodfield TBF, 2005, TISSUE ENG, V11, P1297, DOI 10.1089/ten.2005.11.1297
   You RC, 2014, POLYM DEGRAD STABIL, V109, P226, DOI 10.1016/j.polymdegradstab.2014.07.029
   Yuan Y, 2007, CARBOHYD POLYM, V68, P561, DOI 10.1016/j.carbpol.2006.10.023
NR 56
TC 13
Z9 13
U1 8
U2 90
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 1
PY 2016
VL 32
BP 178
EP 189
DI 10.1016/j.actbio.2016.01.003
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF8ZF
UT WOS:000371649100018
PM 26766632
DA 2018-10-19
ER

PT J
AU Kruppke, B
   Farack, J
   Wagner, AS
   Beckmann, S
   Heinemann, C
   Glenske, K
   Rossler, S
   Wiesmann, HP
   Wenisch, S
   Hanke, T
AF Kruppke, Benjamin
   Farack, Jana
   Wagner, Alena-Svenja
   Beckmann, Sarah
   Heinemann, Christiane
   Glenske, Kristina
   Roessler, Sina
   Wiesmann, Hans-Peter
   Wenisch, Sabine
   Hanke, Thomas
TI Gelatine modified monetite as a bone substitute material: An in vitro
   assessment of bone biocompatibility
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Bone; Biocompatibility; Gelatine; Bone marrow stromal cells; Osteoclast;
   Biomimetic material
ID EXTRACELLULAR CALCIUM; STROMAL CELLS; SCAFFOLDS; HYDROXYAPATITE;
   BRUSHITE; PROLIFERATION; MONOCYTES; GRANULES; CALVARIA; CEMENT
AB Calcium phosphate phases are increasingly used for bone tissue substitution, and the load bearing properties of these inherently brittle biomaterials are increased by inclusion of organic components. Monetite prepared using mineralization of gelatine pre-structured through phosphate leads to a significantly increased biaxial strength and indirect tensile strength compared to gelatine-free monetite. Besides the mechanical properties, degradation in physiological solutions and osteoblast and osteoclast cell response were investigated. Human bone marrow stromal cells (hBMSCs) showed considerably higher proliferation rates on the gelatine modified monetite than on polystyrene reference material in calcium-free as well as standard cell culture medium (alpha -MEM). Osteogenic differentiation on the material was comparable to polystyrene in both medium types. Osteoclast-like cells derived from monocytes were able to actively resorb the biomaterial. Osteoblastic differentiation and perhaps even more important the cellular resorption of the biomaterial indicate that it can be actively involved in the bone remodeling process. Thus the behavior of osteoblasts and osteoclasts as well as the adequate degradation and mechanical properties are strong indicators for bone biocompatibility, although in vivo studies are still required to prove this.
   Statement of Significance
   New and unique? A low temperature precipitationprocessforcalcium anhydrous hydrogen phosphateallows for the first time to produce monolithic compact composites of monetite and gelatine. The composite is degradable and resorbable. To prove that, the question arises: what is bone biocompatibility?
   The reaction of both mayor cell types of bone represents this biocompatibility. Therefore, human bone marrow stromal cells were seeded revealing the materials pro-osteogenic properties. Monocyte cultivation, becoming recently focus of interest, revealed the capability of the biomaterial to be actively resorbed by derived osteoclast-like cells.
   Not new but necessary ismechanical characterization, which is often only investigated as uniaxial property. Here, a biaxial method is applied, to characterize the materials properties closer to its application loads. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Kruppke, Benjamin; Farack, Jana; Beckmann, Sarah; Heinemann, Christiane; Roessler, Sina; Wiesmann, Hans-Peter; Hanke, Thomas] Tech Univ Dresden, Max Bergmann Ctr Biomat, D-01069 Dresden, Germany.
   [Kruppke, Benjamin; Farack, Jana; Beckmann, Sarah; Heinemann, Christiane; Roessler, Sina; Wiesmann, Hans-Peter; Hanke, Thomas] Tech Univ Dresden, Inst Mat Sci, D-01069 Dresden, Germany.
   [Wagner, Alena-Svenja; Glenske, Kristina; Wenisch, Sabine] Univ Giessen, Inst Vet Anat Histol & Embryol, Small Anim Clin, Dept Vet Clin Sci, D-35392 Giessen, Germany.
RP Kruppke, B (reprint author), Max Bergmann Zentrum Biomat, Budapester Str 27, D-01069 Dresden, Germany.
EM Benjamin.Kruppke@tu-dresden.de
OI Kruppke, Benjamin/0000-0002-0659-0238
FU Deutsche Forschungsgemeinschaft (DFG Collaborative Research Centre) [TRR
   79/SP M3]
FX The authors are grateful to Prof. Hartmut Worch<SUP>1</SUP> for giving
   the inspiring impulse for developing this material, to Axel
   Mensch<SUP>1</SUP> for XRD investigations and to Anne Hild<SUP>2</SUP>
   for her support in TEM sample preparation and for taking TEM images. We
   gratefully acknowledge the Deutsche Forschungsgemeinschaft (DFG
   Collaborative Research Centre TRR 79/SP M3) for financial support. We
   thank Prof. M. Bornhauser and co-workers (Medical Clinic I, University
   Hospital Carl Gustav Carus, Dresden) for providing hBMSC.
CR ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110
   BERRIDGE MJ, 1995, BIOESSAYS, V17, P491, DOI 10.1002/bies.950170605
   Borger A, 2002, J EUR CERAM SOC, V22, P1425, DOI 10.1016/S0955-2219(01)00458-7
   Da Silva MHP, 2001, SURF COAT TECH, V137, P270
   Detsch R., 2014, J TISSUE ENG REGEN M
   Dorozhkin SV, 2002, ANGEW CHEM, V114, P3260
   DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167
   Galea LG, 2008, BIOMATERIALS, V29, P3400, DOI 10.1016/j.biomaterials.2008.04.041
   Gonzalez-Vazquez A, 2014, ACTA BIOMATER, V10, P2824, DOI 10.1016/j.actbio.2014.02.004
   GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011
   Gustavsson J, 2013, J TISSUE ENG REGEN M, V7, P609, DOI 10.1002/term.550
   Gustavsson J, 2012, J MATER SCI-MATER M, V23, P2509, DOI 10.1007/s10856-012-4705-4
   Gustavsson J, 2011, ACTA BIOMATER, V7, P4242, DOI 10.1016/j.actbio.2011.07.016
   Habel B, 1998, EUR BIOPHYS J BIOPHY, V27, P411, DOI 10.1007/s002490050149
   Haema K, 2014, RADIAT PHYS CHEM, V103, P126, DOI 10.1016/j.radphyschem.2014.05.056
   Heinemann C., 2011, EUR CELL MAT
   Heinemann C, 2009, BIOMACROMOLECULES, V10, P1305, DOI 10.1021/bm900172m
   Heinemann S, 2013, ACTA BIOMATER, V9, P6199, DOI 10.1016/j.actbio.2012.12.017
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hoyer B, 2012, BIOMACROMOLECULES, V13, P1059, DOI 10.1021/bm201776r
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Jones J. R., 2001, MAT SCI TECHNOL
   Jung GY, 2010, J MATER SCI-MATER M, V21, P1649, DOI 10.1007/s10856-010-4011-y
   Jung HJ, 2015, BONE, V76, P88, DOI 10.1016/j.bone.2015.03.014
   KANATANI M, 1991, BIOCHEM BIOPH RES CO, V181, P1425, DOI 10.1016/0006-291X(91)92098-5
   Klammert U, 2009, ACTA BIOMATER, V5, P727, DOI 10.1016/j.actbio.2008.08.019
   Kollmann T, 2010, CHEM MATER, V22, P5137, DOI 10.1021/cm101755j
   Malafaya PB, 2009, ACTA BIOMATER, V5, P644, DOI 10.1016/j.actbio.2008.09.017
   Narayan RJ, 2010, PHILOS T R SOC A, V368, P1831, DOI 10.1098/rsta.2010.0001
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   SCHILLING AF, 2006, EUR J TRAUMA, V32, P107
   Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789
   Schumacher M, 2013, ACTA BIOMATER, V9, P7536, DOI 10.1016/j.actbio.2013.03.014
   Sivakumar GR, 1998, CRYST RES TECHNOL, V33, P197, DOI 10.1002/(SICI)1521-4079(1998)33:2<197::AID-CRAT197>3.0.CO;2-K
   SUGIMOTO T, 1993, J BONE MINER RES, V8, P1445
   Tamimi F, 2012, ACTA BIOMATER, V8, P474, DOI 10.1016/j.actbio.2011.08.005
   Tamimi F, 2010, BIOMATERIALS, V31, P2762, DOI 10.1016/j.biomaterials.2009.12.039
   Tamimi F, 2009, BIOMATERIALS, V30, P6318, DOI 10.1016/j.biomaterials.2009.07.049
   Tamimi F, 2008, J BIOMED MATER RES A, V87A, P980, DOI 10.1002/jbm.a.31842
   Tas AC, 2009, J AM CERAM SOC, V92, P2907, DOI 10.1111/j.1551-2916.2009.03351.x
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Williams D, 2014, CAMB TEXT BIOMED ENG, P1
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
NR 43
TC 10
Z9 10
U1 2
U2 48
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 1
PY 2016
VL 32
BP 275
EP 285
DI 10.1016/j.actbio.2015.12.035
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF8ZF
UT WOS:000371649100027
PM 26732518
DA 2018-10-19
ER

PT J
AU Biesiekierski, A
   Lin, JX
   Li, YC
   Ping, DH
   Yamabe-Mitarai, Y
   Wen, CE
AF Biesiekierski, Arne
   Lin, Jixing
   Li, Yuncang
   Ping, Dehai
   Yamabe-Mitarai, Yoko
   Wen, Cuie
TI Investigations into Ti-(Nb,Ta)-Fe alloys for biomedical applications
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Titanium; Orthopedic biomaterials; Admissible strain; Microstructure;
   High strength
ID CORROSION BEHAVIOR; TITANIUM-ALLOYS; MECHANICAL-PROPERTIES; IMPLANT
   MATERIALS; BONE TISSUE; TI; NB; MICROSTRUCTURE; DEFORMATION; ELEMENTS
AB In this study, a Ti-(Ta,Nb)-Fe system was investigated with aims toward the development of high strength, biocompatible titanium alloy suitable for the development of porous orthopedic biomaterials with minimal processing. Notable findings include yield strengths of 740, 1250 and 1360 MPa for the Ti-12Nb-5Fe, Ti-7Ta-5Fe and Ti-10Ta-4Fe alloys, respectively, with elastic moduli comparable to existing Ti-alloys, yielding admissible strains of 0.9 +/- 0.3, 12 +/- 0.2 and 1.13 +/- 0.02% for the Ti-12Nb-5Fe, Ti-7Ta-5Fe and Ti-10Ta-4Fe alloys, respectively; more than twice that of human bone. Observed microstructure varied significantly depending on alloy; near pure beta-phase was seen in Ti-12Nb-5Fe, beta with some omega precipitation in Ti-10Ta-4Fe, and a duplex alpha + beta structure was observed throughout the Ti-7Ta-5Fe. In addition to suitable mechanical parameters, all investigated alloys exhibited promising corrosion potentials on the order of -0.24 V SCE, equalling that seen for a C.P.-Ti control at -0.25 V SCE, and substantially more noble than that seen for Ti-6A1-4V. Electrochemical corrosion rates of 0.5-3 mu m/year were likewise seen to agree well with that measured for C.P.-Ti. Further, no statistically significant difference could be seen between any of the alloys relative to a C.P.-Ti control regards to cell proliferation, as investigated via MTS assay and confocal microscopy. As such, the combination of high admissible strain and low corrosion indicate all investigated alloys show significant promise as potential porous biomaterials while in the as-cast state, with the Ti-10Ta-4Fe alloy identified as the most promising composition investigated.
   Statement of Significance
   The findings of this paper are of significance to the field of metallic biomaterials as they detail the development of alloys of satisfactory biocompatibility and electrochemical behaviour, that furthermore display exceptional mechanical properties. Notably, both extremely high compressive yield strengths and admissible strains, up to 1.36 GPa and 1.2% respectively, are reported, exceeding or rivalling that seen in traditional alloys such as Ti-6A1-4V, which typically displays compressive yield strengths and admissible strains on the order of 895 MPa and 0.81% respectively, as well as modem alloys such as Gum Metal or TNZT. That this is achieved in the absence of thermomechanical processing represents a significant and novel outcome of substantial benefit for application as a porous biomaterial. (C) 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Biesiekierski, Arne; Wen, Cuie] Swinburne Univ Technol, Fac Sci Engn & Technol, Hawthorn, Vic 3122, Australia.
   [Lin, Jixing] Zhejiang Ind & Trade Vocat Coll, Dept Mat Engn, Wenzhou 325003, Zhejiang, Peoples R China.
   [Lin, Jixing] Jilin Univ, Coll Mat Sci & Engn, Changchun 130025, Jilin, Peoples R China.
   [Li, Yuncang; Wen, Cuie] RMIT Univ, Dept Aerosp Mech & Mfg Engn, Melbourne, Vic 3000, Australia.
   [Ping, Dehai; Yamabe-Mitarai, Yoko] Natl Inst Mat Sci, Sengen 1-2-1, Tsukuba, Ibaraki 3050047, Japan.
RP Wen, CE (reprint author), RMIT Univ, Dept Aerosp Mech & Mfg Engn, Melbourne, Vic 3000, Australia.
EM cuie.wen@rmit.edu.au
RI Li, Yuncang/I-5832-2012
OI Li, Yuncang/0000-0003-4290-4772; Wen, Cuie/0000-0001-8008-3536
FU National Health and Medical Research Council (NHMRC) [GNT1087290]
FX The authors acknowledge financial support for this research by the
   National Health and Medical Research Council (NHMRC) through grant
   GNT1087290.
CR American Society for Testing Materials, 2014, G314 ASTM
   [Anonymous], 2010, G102892010 ASTM
   [Anonymous], 2009, E909 ASTM
   Assis S.L.d., 2006, ELECTROCHIM ACTA, V51, P1815, DOI DOI 10.1016/J.ELECTACTA.2005.02.121
   Bai Y, 2013, MAT SCI ENG C-MATER, V33, P2159, DOI 10.1016/j.msec.2013.01.036
   Bayraktar HH, 2004, J BIOMECH, V37, P27, DOI 10.1016/S0021-9290(03)00257-4
   Beyersmann D, 2008, ARCH TOXICOL, V82, P493, DOI 10.1007/s00204-008-0313-y
   Biesiekierski A, 2014, MATER DESIGN, V59, P303, DOI 10.1016/j.matdes.2014.02.058
   Boyer R., 1994, MAT PROPERTIES HDB T
   Choubey A, 2004, J ALLOY COMPD, V381, P288, DOI 10.1016/j.jallcom.2004.03.096
   Cremasco A, 2011, MATER DESIGN, V32, P2387, DOI 10.1016/j.matdes.2010.11.012
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   DENTON AR, 1991, PHYS REV A, V43, P3161, DOI 10.1103/PhysRevA.43.3161
   Donachie M. J., 2000, TITANIUM TECHNICAL G
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   Gepreel MAH, 2013, J MECH BEHAV BIOMED, V20, P407, DOI 10.1016/j.jmbbm.2012.11.014
   Gibson L. G., 1997, CELLULAR SOLIDS STRU
   Goodhew P., 2014, ELECT MICROSCOPY ANA
   Hao YL, 2007, ACTA BIOMATER, V3, P277, DOI 10.1016/j.actbio.2006.11.002
   HEAD WC, 1995, CLIN ORTHOP RELAT R, P85
   Hinoshita K., 2006, SCRIPTA MATER, V55, P477
   Ikeda M, 2009, MATER TRANS, V50, P2737, DOI 10.2320/matertrans.MA200902
   Jayaraman M, 2004, BIOMATERIALS, V25, P625, DOI 10.1016/S0142-9612(03)00571-4
   Kent D, 2012, APPL PHYS A-MATER, V107, P835, DOI 10.1007/s00339-012-6778-9
   Kraus W, 1996, J APPL CRYSTALLOGR, V29, P301, DOI 10.1107/S0021889895014920
   Kuroda D, 2005, MATER TRANS, V46, P3015, DOI 10.2320/matertrans.46.3015
   Kuroda D, 2005, MAT SCI ENG C-BIO S, V25, P312, DOI 10.1016/j.msec.2005.04.004
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Lavos-Valereto I. C., 2002, Journal of Biomedical Materials Research, V63, P664, DOI 10.1002/jbm.10351
   Li Y, 2010, J DENT RES, V89, P493, DOI 10.1177/0022034510363675
   Li YC, 2012, ACTA BIOMATER, V8, P3177, DOI 10.1016/j.actbio.2012.04.028
   Lima P., 2011, HUM EXP TOXICOL, P1435
   Lopes ESN, 2011, MATER CHARACT, V62, P673, DOI 10.1016/j.matchar.2011.04.015
   Mantani Y, 2004, MATER TRANS, V45, P1629, DOI 10.2320/matertrans.45.1629
   Narayan RJ, 2012, ASM HDB, V23
   Niinomi M, 2012, ACTA BIOMATER, V8, P3888, DOI 10.1016/j.actbio.2012.06.037
   Nunez M., 2007, TRENDS ELECTROCHEMIS
   Ohmori Y, 2001, MAT SCI ENG A-STRUCT, V312, P182, DOI 10.1016/S0921-5093(00)01891-8
   Ozan S, 2015, ACTA BIOMATER, V20, P176, DOI 10.1016/j.actbio.2015.03.023
   Ping DH, 2014, ACTA METALL SIN-ENGL, V27, P1, DOI 10.1007/s40195-013-0014-2
   POURBAIX M, 1984, BIOMATERIALS, V5, P122, DOI 10.1016/0142-9612(84)90046-2
   RODAN SB, 1987, CANCER RES, V47, P4961
   Saito T, 2003, SCIENCE, V300, P464, DOI 10.1126/science.1081957
   SEMLITSCH M, 1985, BIOMED TECH, V30, P334, DOI 10.1515/bmte.1985.30.12.334
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   Wang J, 2014, INT J PLASTICITY, V61, P17, DOI 10.1016/j.ijplas.2014.05.005
   Wang K. K., 1996, MED APPL TITANIUM IT, P76
   Wen CE, 2002, J MATER RES, V17, P2633, DOI 10.1557/JMR.2002.0382
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
   Withey EA, 2010, ACTA MATER, V58, P2652, DOI 10.1016/j.actamat.2009.12.052
   Yamamoto A, 1998, J BIOMED MATER RES, V39, P331, DOI 10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E
   ZALUSKI L, 1993, J MATER RES, V8, P3059, DOI 10.1557/JMR.1993.3059
   Zywicki P, 2015, MET MATER INT, V21, P617, DOI 10.1007/s12540-015-4593-5
NR 53
TC 18
Z9 19
U1 7
U2 61
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR 1
PY 2016
VL 32
BP 336
EP 347
DI 10.1016/j.actbio.2015.12.010
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF8ZF
UT WOS:000371649100032
PM 26689463
DA 2018-10-19
ER

PT J
AU Cheng, LY
   Sun, XM
   Zhao, X
   Wang, L
   Yu, J
   Pan, GQ
   Li, B
   Yang, HL
   Zhang, YG
   Cui, WG
AF Cheng, Liying
   Sun, Xiaoming
   Zhao, Xin
   Wang, Lan
   Yu, Jia
   Pan, Guoqing
   Li, Bin
   Yang, Huilin
   Zhang, Yuguang
   Cui, Wenguo
TI Surface biofunctional drug-loaded electrospun fibrous scaffolds for
   comprehensive repairing hypertrophic scars
SO BIOMATERIALS
LA English
DT Article
DE Electrospun scaffold; Poly (dopamine); Biofunctionalization;
   Drug-loading; Hypertrophic scar
ID INFLAMMATION RESPONSES; IMMOBILIZATION; POLYDOPAMINE; MEMBRANES; GROWTH;
   POLYMER; SKIN; CYTOCOMPATIBILITY; REGENERATION; FABRICATION
AB Incorporation of bioactive drugs and biofunctionalization of polyester fibrous scaffolds are essential means to improve their bio-functions and histocompatibility for regenerative medicine. However, it is still a challenge to biofunctionalize such drug carriers via traditional biochemical methods while maintaining their properties without changes in drug activity and loading ratio. Here, we demonstrated a facile approach for biofunctionalization of PLGA fibrous scaffolds with various molecules (i.e., PEG polymer, RGD peptide and bFGF growth factor for cell repellent, adhesion and proliferation, respectively) via mussel-Inspired poly(dopamine) (PDA) coating in aqueous solution. By virtue of the mild and efficient nature of this approach, the drug-loaded PLGA fibers could be easily biofunctionalized and showed negligible effects on the scaffold properties, especially drug activity and loading ratio. Further, in vivo study showed that, a ginsenoside-Rg3-loaded fibrous scaffold functionalized with bFGF growth factor could not only promote the early -stage wound healing in rabbit ear wounds (bio-signal from bFGF), but also inhibit later -stage hypertrophic scars formation (release of Rg3 drug). Therefore, the mussel -inspired method for bio-modification provides a facile and effective strategy to combine drug and bio-function in one system, thus facilitating a synergistic effect of drug -therapy and bio-signal when such biomaterial is used for regenerative medicine. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Cheng, Liying; Sun, Xiaoming; Zhang, Yuguang] Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Dept Plast & Reconstruct Surg, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China.
   [Wang, Lan; Yu, Jia; Pan, Guoqing; Li, Bin; Yang, Huilin; Cui, Wenguo] Soochow Univ, Inst Orthoped, Affiliated Hosp 1, Dept Orthoped, 708 Renmin Rd, Suzhou 215006, Jiangsu, Peoples R China.
   [Zhao, Xin] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Biomed Engn,Dept Med, Cambridge, MA 02139 USA.
RP Zhang, YG (reprint author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Sch Med, Dept Plast & Reconstruct Surg, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China.; Cui, WG (reprint author), Soochow Univ, Inst Orthoped, Affiliated Hosp 1, Dept Orthoped, 708 Renmin Rd, Suzhou 215006, Jiangsu, Peoples R China.
EM zhangyg18@126.com; wgcui80@hotmail.com
RI Li, Bin/B-7802-2012; Zhao, Xin/P-2741-2017; Pan, Guoqing/E-1445-2014
OI Zhao, Xin/0000-0002-9521-7768; Pan, Guoqing/0000-0001-5187-796X
FU National Natural Science Foundation of China [51373112, 81372073];
   Jiangsu Provincial Special Program of Medical Science [BL2012004];
   Jiangsu Provincial Clinical Orthopedic Center; Priority Academic Program
   Development of Jiangsu Higher Education Institutions (PAPD)
FX This work was supported in part by National Natural Science Foundation
   of China (51373112 and 81372073), Jiangsu Provincial Special Program of
   Medical Science (BL2012004), Jiangsu Provincial Clinical Orthopedic
   Center, the Priority Academic Program Development of Jiangsu Higher
   Education Institutions (PAPD).
CR Alster TS, 2003, AM J CLIN DERMATOL, V4, P235, DOI 10.2165/00128071-200304040-00003
   Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n
   Cheng LY, 2013, ACTA BIOMATER, V9, P9461, DOI 10.1016/j.actbio.2013.07.040
   Cheng Q, 2013, TISSUE ENG PT A, V19, P1188, DOI [10.1089/ten.tea.2011.0725, 10.1089/ten.TEA.2011.0725]
   Cui WG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068771
   Della Vecchia NF, 2013, ADV FUNCT MATER, V23, P1331, DOI 10.1002/adfm.201202127
   Ham HO, 2011, ANGEW CHEM INT EDIT, V50, P732, DOI 10.1002/anie.201005001
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   Huang ZM, 2006, J BIOMED MATER RES A, V77A, P169, DOI 10.1002/jbm.a.30564
   Jiang JH, 2010, J MEMBRANE SCI, V364, P194, DOI 10.1016/j.memsci.2010.08.017
   Kang K, 2011, BIOMATERIALS, V32, P6374, DOI 10.1016/j.biomaterials.2011.05.028
   Karp JM, 2007, LAB CHIP, V7, P786, DOI 10.1039/b705085m
   Ko E, 2013, BIOMACROMOLECULES, V14, P3202, DOI 10.1021/bm4008343
   Ku SH, 2010, BIOMATERIALS, V31, P9431, DOI 10.1016/j.biomaterials.2010.08.071
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222
   Lu L, 2012, J BIOMED MATER RES A, V100A, P2421, DOI 10.1002/jbm.a.34143
   Ma ZW, 2005, BIOMATERIALS, V26, P2527, DOI 10.1016/j.biomaterials.2004.07.026
   Morris DE, 1997, PLAST RECONSTR SURG, V100, P674, DOI 10.1097/00006534-199709000-00021
   Pashuck ET, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002717
   Pridgen EM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007049
   Ren YH, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-63
   Sankar D, 2014, TISSUE ENG PT A, V20, P1689, DOI [10.1089/ten.tea.2013.0569, 10.1089/ten.TEA.2013.0569]
   Shi HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059966
   Son SR, 2013, J BIOMED MATER RES B, V101B, P1095, DOI 10.1002/jbm.b.32923
   Sun XM, 2014, J MATER CHEM B, V2, P3636, DOI 10.1039/c3tb21814g
   Sun XM, 2014, COLLOID SURFACE B, V115, P61, DOI 10.1016/j.colsurfb.2013.11.030
   Swartjes JJTM, 2013, ADV FUNCT MATER, V23, P2843, DOI 10.1002/adfm.201202927
   Wu LL, 2010, J BIOMED MATER RES A, V92A, P563, DOI 10.1002/jbm.a.32393
   Xie DC, 2013, J BIOMED MATER RES A, V101, P2005, DOI 10.1002/jbm.a.34508
   Xu DW, 2013, COLLOID SURFACE B, V110, P225, DOI 10.1016/j.colsurfb.2013.04.050
   Xu WJ, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014104
   Yang SH, 2011, J AM CHEM SOC, V133, P2795, DOI 10.1021/ja1100189
   Yang Y, 2011, BIOMATERIALS, V32, P4243, DOI 10.1016/j.biomaterials.2011.02.042
   Yoo HS, 2009, ADV DRUG DELIVER REV, V61, P1033, DOI 10.1016/j.addr.2009.07.007
   Zhang M, 2014, ADV FUNCT MATER, V24, P978, DOI 10.1002/adfm.201302359
   Zhu HG, 2002, J BIOMED MATER RES, V62, P532, DOI 10.1002/jbm.10313
   Zhu LP, 2011, COLLOID SURFACE B, V86, P111, DOI 10.1016/j.colsurfb.2011.03.027
NR 38
TC 27
Z9 27
U1 14
U2 156
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2016
VL 83
BP 169
EP 181
DI 10.1016/j.biomaterials.2016.01.002
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF9AD
UT WOS:000371651700014
PM 26774564
DA 2018-10-19
ER

PT J
AU Yoshizumi, T
   Zhu, Y
   Jiang, HB
   D'Amore, A
   Sakaguchi, H
   Tchao, J
   Tobita, K
   Wagner, WR
AF Yoshizumi, Tomo
   Zhu, Yang
   Jiang, Hongbin
   D'Amore, Antonio
   Sakaguchi, Hirokazu
   Tchao, Jason
   Tobita, Kimimasa
   Wagner, William R.
TI Timing effect of intramyocardial hydrogel injection for positively
   impacting left ventricular remodeling after myocardial infarction
SO BIOMATERIALS
LA English
DT Article
DE Cardiac tissue engineering; Injectable materials; Myocardial infarction;
   Hydrogel; Intervention timing
ID BIODEGRADABLE CARDIAC PATCH; ASSOCIATION TASK-FORCE;
   EXTRACELLULAR-MATRIX; INJECTABLE HYDROGEL; PRACTICE GUIDELINES; CHITOSAN
   HYDROGEL; AMERICAN-COLLEGE; ANGIOTENSIN-II; HEART-FAILURE; THERAPY
AB Intramyocardial injection of various injectable hydrogel materials has shown benefit in positively impacting the course of left ventricular (LV) remodeling after myocardial infarction (MI). However, since LV remodeling is a complex, time dependent process, the most efficacious time of hydrogel injection is not clear. In this study, we injected a relatively stiff, thermoresponsive and bioabsorbable hydrogel in rat hearts at 3 different time points - immediately after MI (IM), 3 d post -MI (3D), and 2 w post -MI (2W), corresponding to the beginnings of the necrotic, fibrotic and chronic remodeling phases. The employed left anterior descending coronary artery ligation model showed expected infarction responses including functional loss, inflammation and fibrosis with distinct time dependent patterns. Changes in LV geometry and contractile function were followed by longitudinal echocardiography for 10 w post -MI. While all injection times positively affected LV function and wall thickness, the 3D group gave better functional outcomes than the other injection times and also exhibited more local vascularization and less inflammatory markers than the earlier injection time. The results indicate an important role for injection timing in the increasingly explored concept of post -MI biomaterial injection therapy and suggest that for hydrogels with mechanical support as primary function, injection at the beginning of the fibrotic phase may provide improved outcomes. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Yoshizumi, Tomo; Zhu, Yang; Jiang, Hongbin; D'Amore, Antonio; Sakaguchi, Hirokazu; Tobita, Kimimasa; Wagner, William R.] Univ Pittsburgh, McGowan Inst Regenerat Med, 450 Technol Dr, Pittsburgh, PA 15219 USA.
   [Zhu, Yang; Tobita, Kimimasa; Wagner, William R.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
   [Tchao, Jason; Tobita, Kimimasa] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA 15219 USA.
   [Wagner, William R.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15219 USA.
   [Wagner, William R.] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15219 USA.
RP Wagner, WR (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, 450 Technol Dr, Pittsburgh, PA 15219 USA.
EM wagnerwr@upmc.edu
RI D'Amore, Antonio/E-7111-2012
OI D'Amore, Antonio/0000-0002-3151-3170; Zhu, Yang/0000-0002-7384-607X
FU National Institutes of Health [R01 HL105911]
FX This study was supported by the National Institutes of Health (grant R01
   HL105911). The authors thank Deanna Rhoads and Lori Walton for their
   excellent help with tissue histological assessment and Neil Turner for
   technical assistance.
CR Akhmedov AT, 2013, HEART FAIL REV, V18, P815, DOI 10.1007/s10741-012-9348-5
   Baum J, 2011, J CARDIOVASC PHARM, V57, P376, DOI 10.1097/FJC.0b013e3182116e39
   Blackburn NJR, 2015, BIOMATERIALS, V39, P182, DOI 10.1016/j.biomaterials.2014.11.004
   Bodiga S, 2011, CARDIOVASC RES, V91, P151, DOI 10.1093/cvr/cvr036
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Cittadini A, 2011, EUR J HEART FAIL, V13, P1264, DOI 10.1093/eurjhf/hfr143
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Dorsey SM, 2015, BIOMATERIALS, V69, P65, DOI 10.1016/j.biomaterials.2015.08.011
   Eckhouse SR, 2014, SCI TRANSL MED, V6, P223
   Fihn SD, 2012, CIRCULATION, V126, pE354, DOI 10.1161/CIR.0b013e318277d6a0
   Fujimoto KL, 2007, J AM COLL CARDIOL, V49, P2292, DOI 10.1016/j.jacc.2007.02.050
   Fujimoto KL, 2012, J CARD FAIL, V18, P585, DOI 10.1016/j.cardfail.2012.05.006
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Fujita M, 2005, J SURG RES, V126, P27, DOI 10.1016/j.jss.2004.12.025
   GUPTA KB, 1994, CIRCULATION, V89, P2315, DOI 10.1161/01.CIR.89.5.2315
   Hashizume R, 2013, BIOMATERIALS, V34, P7353, DOI 10.1016/j.biomaterials.2013.06.020
   Haudek SB, 2010, J MOL CELL CARDIOL, V49, P499, DOI 10.1016/j.yjmcc.2010.05.005
   Holmes JW, 2005, ANNU REV BIOMED ENG, V7, P223, DOI 10.1146/annurev.bioeng.7.060804.100453
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Jugdutt B.I., 2013, CARDIAC REMODELING M
   Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49
   Kadner K, 2012, BIOMATERIALS, V33, P2060, DOI 10.1016/j.biomaterials.2011.11.031
   Lahera V, 2011, AM J HYPERTENS, V24, P1059, DOI 10.1038/ajh.2011.142
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lin YD, 2010, CIRCULATION, V122, pS132, DOI 10.1161/CIRCULATIONAHA.110.939512
   Ma ZW, 2010, BIOMACROMOLECULES, V11, P1873, DOI 10.1021/bm1004299
   Mallory GK, 1939, AM HEART J, V18, P647
   Nelson DM, 2014, BIOMACROMOLECULES, V15, P1, DOI 10.1021/bm4010639
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6
   Okada M, 2010, BIOMATERIALS, V31, P7678, DOI 10.1016/j.biomaterials.2010.06.056
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Rane AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021571
   Ravi S, 2012, BIOMATERIALS, V33, P7736, DOI 10.1016/j.biomaterials.2012.07.010
   REIMER KA, 1979, CIRCULATION, V60, P866, DOI 10.1161/01.CIR.60.4.866
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981
   Tous E, 2011, BIOMACROMOLECULES, V12, P4127, DOI 10.1021/bm201198x
   Tous E, 2011, J CARDIOVASC TRANSL, V4, P528, DOI 10.1007/s12265-011-9291-1
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wang HB, 2014, BIOMATERIALS, V35, P3986, DOI 10.1016/j.biomaterials.2014.01.021
   Wang HB, 2010, J HEART LUNG TRANSPL, V29, P881, DOI 10.1016/j.healun.2010.03.016
   Wu J, 2011, BIOMATERIALS, V32, P579, DOI 10.1016/j.biomaterials.2010.08.098
   Yoon SJ, 2009, J BIOMED MATER RES B, V91B, P163, DOI 10.1002/jbm.b.31386
   Zhu Y, 2015, BIOMATERIALS, V53, P484, DOI 10.1016/j.biomaterials.2015.02.100
NR 46
TC 13
Z9 13
U1 4
U2 40
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2016
VL 83
BP 182
EP 193
DI 10.1016/j.biomaterials.2015.12.002
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF9AD
UT WOS:000371651700015
PM 26774561
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Li, WA
   Lu, BY
   Gu, L
   Choi, Y
   Kim, J
   Mooney, DJ
AF Li, Weiwei Aileen
   Lu, Beverly Ying
   Gu, Luo
   Choi, Youngjin
   Kim, Jaeyun
   Mooney, David J.
TI The effect of surface modification of mesoporous silica micro-rod
   scaffold on immune cell activation and infiltration
SO BIOMATERIALS
LA English
DT Article
DE Mesoporous silica; Poly(ethylene glycol); RGD; Acute inflammation;
   Inflammasome
ID COMPLEMENT ACTIVATION; NALP3 INFLAMMASOME; NLRP3 INFLAMMASOME; ADAPTIVE
   IMMUNITY; DENDRITIC CELLS; IN-VIVO; PROTEIN ADSORPTION;
   SUPPRESSOR-CELLS; NANOPARTICLES; HYDROGELS
AB Biomaterial scaffold based vaccines show significant potential in generating potent antigen -specific immunity. However, the role of the scaffold surface chemistry in initiating and modulating the immune response is not well understood. In this study, a mesoporous silica micro -rod (MSR) scaffold was modified with PEG, PEG-RGD and PEG-RDG groups. PEG modification significantly enhanced BMDC activation marker up-regulation and IL-113 production in vitro, and innate immune cell infiltration in vivo. PEG-RGD MSRs and PEG-RDG MSRs displayed decreased inflammation compared to PEG MSRs, and the effect was not RGD specific. Finally, the NIrp3 inflammasome was found to be necessary for MSR stimulated IL-113 production in vitro and played a key role in regulating immune cell infiltration in vivo. These findings suggest that simply modulating the surface chemistry of a scaffold can regulate its immune cell infiltration profile and have implications for the design and development of new material based vaccines. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Li, Weiwei Aileen; Lu, Beverly Ying; Gu, Luo; Mooney, David J.] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Li, Weiwei Aileen; Lu, Beverly Ying; Gu, Luo; Mooney, David J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
   [Choi, Youngjin; Kim, Jaeyun] Sungkyunkwan Univ, Sch Chem Engn, Suwon 440746, South Korea.
RP Mooney, DJ (reprint author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
EM mooneyd@seas.harvard.edu
OI Gu, Luo/0000-0002-9813-7202; Li, Aileen/0000-0002-1056-5932
FU National Institute of Health [R01 EB015498]; Wyss Institute for
   Biologically Inspired Engineering; Found Animals Foundation [D1213-W13];
   National Science Foundation Graduate Research Fellowship
FX This work was funded by the National Institute of Health (R01 EB015498),
   the Wyss Institute for Biologically Inspired Engineering, the Found
   Animals Foundation (D1213-W13), and the National Science Foundation
   Graduate Research Fellowship. The authors would like to thank Kyle
   Vining for his help with the endotoxin assay, Dr. Kate Fitzgerald, Dr.
   Kenneth Rock and Dr. Jiann-Jyh Lai from the University of Massachusetts
   Medical School for helping with the Nlrp3<SUP>-/-</SUP> mice, and
   Professor Allan Hoffman at the University of Washington for his helpful
   discussions about the manuscript.
CR Acharya AP, 2010, BIOMATERIALS, V31, P7444, DOI 10.1016/j.biomaterials.2010.06.025
   Ali OA, 2013, ADV FUNCT MATER, V23, P4621, DOI 10.1002/adfm.201203859
   Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359
   Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
   Arima Y, 2008, BIOMATERIALS, V29, P551, DOI 10.1016/j.biomaterials.2007.10.015
   Arima Y, 2009, ACS APPL MATER INTER, V1, P2400, DOI 10.1021/am9005463
   Armstrong JK, 2007, CANCER-AM CANCER SOC, V110, P103, DOI 10.1002/cncr.22739
   Bauernfeind F, 2012, J IMMUNOL, V189, P4175, DOI 10.4049/jimmunol.1201516
   Bradley AJ, 2001, TRANSFUSION, V41, P1225, DOI 10.1046/j.1537-2995.2001.41101225.x
   Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999
   Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113
   Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105
   Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1016/jem.20062602
   Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995
   Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544
   Eisenbarth SC, 2009, EMBO MOL MED, V1, P92, DOI 10.1002/emmm.200900014
   Garratty G, 2004, TRANSFUS MED REV, V18, P245, DOI 10.1016/j.tmrv.2004.06.005
   Godin B, 2010, J BIOMED MATER RES A, V94A, P1236, DOI 10.1002/jbm.a.32807
   Guarda G, 2011, J IMMUNOL, V186, P2529, DOI 10.4049/jimmunol.1002720
   Hamada I, 2008, MOL IMMUNOL, V46, P225, DOI 10.1016/j.molimm.2008.08.276
   Hao NJ, 2012, J NANOSCI NANOTECHNO, V12, P6346, DOI 10.1166/jnn.2012.6199
   Hershfield MS, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4500
   Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631
   INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693
   Irvine DJ, 2013, NAT MATER, V12, P978, DOI [10.1038/NMAT3775, 10.1038/nmat3775]
   Kidane A, 1999, J BIOMED MATER RES, V48, P640, DOI 10.1002/(SICI)1097-4636(1999)48:5<640::AID-JBM7>3.3.CO;2-O
   Kim J, 2015, NAT BIOTECHNOL, V33, P64, DOI 10.1038/nbt.3071
   Kolla RV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001044
   Li WA, 2013, CURR OPIN IMMUNOL, V25, P238, DOI 10.1016/j.coi.2012.12.008
   Lin YS, 2011, J AM CHEM SOC, V133, P20444, DOI 10.1021/ja208567v
   Lynn AD, 2011, J BIOMED MATER RES A, V96A, P621, DOI 10.1002/jbm.a.33015
   Lynn AD, 2011, ACTA BIOMATER, V7, P123, DOI 10.1016/j.actbio.2010.07.033
   Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595
   Mamaeva V, 2013, ADV DRUG DELIVER REV, V65, P689, DOI 10.1016/j.addr.2012.07.018
   Moghimi SM, 2010, J CONTROL RELEASE, V146, P175, DOI 10.1016/j.jconrel.2010.04.003
   Morishige T, 2010, BIOMATERIALS, V31, P6833, DOI 10.1016/j.biomaterials.2010.05.036
   Mosqueira VCF, 2001, BIOMATERIALS, V22, P2967, DOI 10.1016/S0142-9612(01)00043-6
   Niidome T, 2006, J CONTROL RELEASE, V114, P343, DOI 10.1016/j.jconrel.2006.06.017
   Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   RICHTER AW, 1983, INT ARCH ALLER A IMM, V70, P124, DOI 10.1159/000233309
   Salvador-Morales C, 2009, BIOMATERIALS, V30, P2231, DOI 10.1016/j.biomaterials.2009.01.005
   Schmidt DR, 2007, J BIOMED MATER RES A, V83A, P617, DOI 10.1002/jbm.a.31270
   Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106
   Sun BB, 2013, ACS NANO, V7, P10834, DOI 10.1021/nn404211j
   Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004
   Swartzlander MD, 2015, BIOMATERIALS, V41, P26, DOI 10.1016/j.biomaterials.2014.11.026
   Tobio M, 1998, PHARMACEUT RES, V15, P270, DOI 10.1023/A:1011922819926
   van der Eijk AA, 2006, NEW ENGL J MED, V354, P1323, DOI 10.1056/NEJMc052880
   van Deventer HW, 2010, CANCER RES, V70, P10161, DOI 10.1158/0008-5472.CAN-10-1921
   VandeVondele S, 2003, BIOTECHNOL BIOENG, V82, P784, DOI 10.1002/bit.10625
   Wattendorf U, 2008, J PHARM SCI-US, V97, P4655, DOI 10.1002/jps.21350
   Zhang P, 2015, P NATL ACAD SCI USA, V112, P12046, DOI 10.1073/pnas.1512465112
NR 53
TC 20
Z9 21
U1 3
U2 70
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2016
VL 83
BP 249
EP 256
DI 10.1016/j.biomaterials.2016.01.026
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF9AD
UT WOS:000371651700020
PM 26784009
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Crowley, C
   KlanritB, P
   Butler, CR
   Varanou, A
   Plate, M
   Hynds, RE
   Chambers, RC
   Seifalian, AM
   Birchall, MA
   Janes, SM
AF Crowley, Claire
   KlanritB, Poramate
   Butler, Colin R.
   Varanou, Aikaterini
   Plate, Manuela
   Hynds, Robert E.
   Chambers, Rachel C.
   Seifalian, Alexander M.
   Birchall, Martin A.
   Janes, Sam M.
TI Surface modification of a POSS-nanocomposite material to enhance
   cellular integration of a synthetic bioscaffold
SO BIOMATERIALS
LA English
DT Article
DE Tissue engineering; Biocompatible materials; Porosity; Nanocomposites;
   Re-epithelialization; Trachea
ID ENGINEERED TRACHEAL REPLACEMENT; BYPASS GRAFT; IN-VITRO; SCAFFOLDS;
   BIOMATERIALS; SIZE; ENDOTHELIALIZATION; HEMOCOMPATIBILITY;
   VASCULARIZATION; TRANSPLANTATION
AB Polyhedral oligomeric silsesquioxane poly(carbonate-urea) urethane (POSS-PCU) is a versatile nano composite biomaterial with growing applications as a bioscaffold for tissue engineering. Integration of synthetic implants with host tissue can be problematic but could be improved by topographical modifications. We describe optimization of POSS-PCU by dispersion of porogens (sodium bicarbonate (NaHCO3), sodium chloride (NaCI) and sucrose) onto the material surface, with the principle aim of increasing surface porosity, thus providing additional opportunities for improved cellular and vascular ingrowth. We assess the effect of the porogens on the material's mechanical strength, surface chemistry, wettability and cytocompatibilty. Surface porosity was characterized by scanning electron microscopy (SEM). There was no alteration in surface chemistry and wettability and only modest changes in mechanical properties were detected. The size of porogens correlated well with the porosity of the construct produced and larger porogens improved interconnectivity of spaces within constructs. Using primary human bronchial epithelial cells (HBECs) we demonstrate moderate in vitro cytocompatibility for all surface modifications; however, larger pores resulted in cellular aggregation. These cells were able to differentiate on POSS-PCU scaffolds. Implantation of the scaffold in vivo demonstrated that'larger pore sizes favor cellular integration and vascular ingrowth. These experiments demonstrate that surface modification with large porogens can improve POSS-PCU nanocomposite scaffold integration and suggest the need to strike a balance between the non -porous surfaces required for epithelial coverage and the porous structure required for integration and vascularization of synthetic scaffolds in future construct design. (C) 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
C1 [Crowley, Claire; Butler, Colin R.; Varanou, Aikaterini; Plate, Manuela; Hynds, Robert E.; Janes, Sam M.] UCL, UCL Resp, Lungs Living Res Ctr, 5 Univ St, London WC1E 6JF, England.
   [Crowley, Claire; KlanritB, Poramate; Seifalian, Alexander M.] Royal Free London NHS Fdn Trust Hosp, Div Surg & Intervent Sci, UCL Ctr Nanotechnol & Regenerat Med, London, England.
   [Crowley, Claire; KlanritB, Poramate; Seifalian, Alexander M.; Birchall, Martin A.] UCL, London WC1E 6JF, England.
   [Plate, Manuela; Chambers, Rachel C.] UCL, Ctr Inflammat & Tissue Repair, UCL Resp, London WC1E 6JF, England.
   [Birchall, Martin A.] Royal Natl Throat Nose & Ear Hosp, UCL Ear Inst, Grays Inn Rd, London WC1X 8DA, England.
RP Janes, SM (reprint author), UCL, UCL Resp, Lungs Living Res Ctr, 5 Univ St, London WC1E 6JF, England.; Birchall, MA (reprint author), Royal Natl Throat Nose & Ear Hosp, 330 Grays Inn Rd, London WC1X 8DA, England.
EM m.birchall@ucl.ac.uk; s.janes@ucl.ac.uk
OI Klanrit, Poramate/0000-0003-0209-3901; Chambers,
   Rachel/0000-0003-1370-9417; Hynds, Robert/0000-0002-2170-8791; Plate,
   Manuela/0000-0002-9957-0681
FU Rosetrees Trust; UCLH Charitable foundation; Great Ormond Street
   Hospital Charity; Wellcome Clinical Training Fellowship; Department of
   Health's NIHR Biomedical Research Centre's funding scheme; UCL ECMC;
   GOSH Charity [V1202]; MRC Regenvox grant [G1001539]; Biotechnology and
   Biological Sciences Research Council [1179376]; Medical Research Council
   [MR/K026453/1, G1001539]; National Institute for Health Research
   [NF-SI-0513-10089]; Rosetrees Trust [M35-F1-CD1]
FX S.M.J. is a Wellcome Senior Fellow in Clinical Science (WT091730AIA;
   WT107963AIA) and is supported by the Rosetrees Trust and UCLH Charitable
   foundation. C.C. was funded by the Great Ormond Street Hospital Charity.
   C.R.B. received a Wellcome Clinical Training Fellowship. This work was
   partially undertaken at UCLH/UCL/GOSH who received a proportion of
   funding from the Department of Health's NIHR Biomedical Research
   Centre's funding scheme, the UCL ECMC (S.M.J.) and GOSH Charity (V1202).
   This work was supported by the MRC Regenvox grant (G1001539, S.M.J.,
   A.M.S., and M.A.B.).
CR Abouna GM, 2008, TRANSPL P, V40, P34, DOI 10.1016/j.transproceed.2007.11.067
   Ahmed M, 2014, BIOMATERIALS, V35, P9033, DOI 10.1016/j.biomaterials.2014.07.008
   Ahmed M, 2013, J BIOMED MATER RES B, V101, P1182, DOI 10.1002/jbm.b.32928
   Ahmed M, 2011, ACTA BIOMATER, V7, P3857, DOI 10.1016/j.actbio.2011.06.051
   Ahmed M, 2010, IEEE ENG MED BIO, P251, DOI 10.1109/IEMBS.2010.5627472
   Anzlovar A, 2011, EXPRESS POLYM LETT, V5, P604, DOI 10.3144/expresspolymlett.2011.59
   Atala A., 2012, SCI TRANSL MED, V4
   Badylak SF, 2012, LANCET, V379, P943, DOI 10.1016/S0140-6736(12)60073-7
   Bland E, 2013, J TISSUE ENG REGEN M, V7, P505, DOI 10.1002/term.540
   Chaloupka K, 2011, BIOTECHNOL APPL BIOC, V58, P363, DOI 10.1002/bab.53
   Chawla R, 2014, J SURG RES, V188, P361, DOI 10.1016/j.jss.2014.01.006
   Chong DST, 2015, EUR J VASC ENDOVASC, V49, P335, DOI 10.1016/j.ejvs.2014.12.008
   Crowley C, 2015, J TISSUE ENG REGEN M, V9, P357, DOI 10.1002/term.1847
   de Mel A, 2009, BIO-MED MATER ENG, V19, P317, DOI 10.3233/BME-2009-0597
   Derby B, 2012, SCIENCE, V338, P921, DOI 10.1126/science.1226340
   Dhandayuthapani B., 2011, INT J POLYM SCI, V2011, P19, DOI DOI 10.1155/2011/290602
   Doss AE, 2007, ASAIO J, V53, P631, DOI 10.1097/MAT.0b013e318145ba13
   Elliott MJ, 2012, LANCET, V380, P994, DOI 10.1016/S0140-6736(12)60737-5
   Forch R, 2007, CHEM VAPOR DEPOS, V13, P280, DOI 10.1002/cvde.200604035
   Fulcher M Leslie, 2013, Methods Mol Biol, V945, P109, DOI 10.1007/978-1-62703-125-7_8
   Hamilton NJ, 2015, AM J TRANSPLANT, V15, P2750, DOI 10.1111/ajt.13318
   Hamilton N, 2014, LARYNGOSCOPE, V124, P961, DOI 10.1002/lary.24469
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7
   Kannan RY, 2006, BIOMATERIALS, V27, P1971, DOI 10.1016/j.biomaterials.2005.10.006
   Ker EDP, 2011, BIOMATERIALS, V32, P8097, DOI 10.1016/j.biomaterials.2011.07.025
   Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836
   Loh QL, 2013, TISSUE ENG PART B-RE, V19, P485, DOI [10.1089/ten.TEB.2012.0437, 10.1089/ten.teb.2012.0437]
   Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Nayyer L, 2014, NANOMED-NANOTECHNOL, V10, P235, DOI 10.1016/j.nano.2013.06.006
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   Oseni A, 2012, J TISSUE ENG REGEN M, V6, P757, DOI 10.1002/term.487
   Pageau SC, 2011, BIOMATERIALS, V32, P7169, DOI 10.1016/j.biomaterials.2011.06.017
   Park JH, 2015, BIOMATERIALS, V62, P106, DOI 10.1016/j.biomaterials.2015.05.008
   Rahmani B, 2012, J BIOMECH, V45, P1205, DOI 10.1016/j.jbiomech.2012.01.046
   Ren X, 2014, PFLUG ARCH EUR J PHY, V466, P1847, DOI 10.1007/s00424-014-1504-4
   Solouk A, 2015, MAT SCI ENG C-MATER, V46, P400, DOI 10.1016/j.msec.2014.10.065
   Story BJ, 1998, INT J ORAL MAX IMPL, V13, P749
   Tan A., 2013, BIOINTERPHASES, P8
   Tan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077112
   Totonelli G, 2012, WORLD J GASTROENTERO, V18, P6900, DOI 10.3748/wjg.v18.i47.6900
   VOLLENBERG PHT, 1989, POLYMER, V30, P1663, DOI 10.1016/0032-3861(89)90327-3
   Wu J, 2009, POLYM REV, V49, P25, DOI 10.1080/15583720802656237
NR 45
TC 15
Z9 15
U1 2
U2 71
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2016
VL 83
BP 283
EP 293
DI 10.1016/j.biomaterials.2016.01.005
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF9AD
UT WOS:000371651700023
PM 26790147
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Mandal, A
   Farhan, MK
   Sastry, TP
AF Mandal, Abhishek
   Farhan, Md. Katheem
   Sastry, Thotapalli Parvathaleswara
TI Effect of reinforced Al2O3 nanoparticles on collagen nanobiocomposite
   from chrome-containing leather waste for biomedical applications
SO CLEAN TECHNOLOGIES AND ENVIRONMENTAL POLICY
LA English
DT Article
DE Chrome leather waste; Al2O3; Collagen; Nanobiocomposite; Biomaterial
ID CAPPED SILVER NANOPARTICLES; SCAFFOLDS; CHITOSAN; ACID
AB The present study aims at developing nanobiocomposite from collagen extracted from solid biowaste, chrome-containing leather waste having aluminium oxide nanoparticles as reinforcement for value-added products. The extracted collagen was confirmed using sodium dodecyl sulphate-poly(acrylamide) gel electrophoresis technique, while Fourier-transform infrared spectroscopy and scanning electron microscopy were used to study the physicochemical and morphological properties of the prepared composites. Enhanced thermal stability and increase in denaturation temperature from 39 to 43 A degrees C with the increase in aluminium oxide content from 2 to 10 % in the composites were confirmed by differential scanning calorimetry and thermogravimetric analyses. Improved mechanical properties such as tensile, tear and flexural strength for the nanobiocomposites (NBCs) were also obtained. Moreover, decrease in water uptake from 475 to 285 % with the increase in aluminium oxide nanoparticles is attributed to the reduced porosity and their weak interaction with collagen that reduces the hydrophilicity of the NBCs. The above results indicate that the collagen-based NBCs present a simple, clean and easy route for effective recycling and recovery of biowaste that could find use in hip prosthesis and has the potential to be used in other biomedical applications.
C1 [Mandal, Abhishek] VIT Univ, Ctr Nanobiotechnol, Vellore 632014, Tamil Nadu, India.
   [Mandal, Abhishek; Farhan, Md. Katheem; Sastry, Thotapalli Parvathaleswara] Cent Leather Res Inst, Council Sci & Ind Res, Bioprod Lab, Chennai 600020, Tamil Nadu, India.
RP Sastry, TP (reprint author), Cent Leather Res Inst, Council Sci & Ind Res, Bioprod Lab, Chennai 600020, Tamil Nadu, India.
EM sastrytp@hotmail.com
CR Balaji S, 2012, POLYM ADVAN TECHNOL, V23, P500, DOI 10.1002/pat.1905
   Cao Y, 2004, ADV MATER, V16, P1189, DOI 10.1002/adma.200400028
   Cao Y, 2006, ADV MATER, V18, P1838, DOI 10.1002/adma.200600334
   Chen Z, 2014, INT J POLYM MATER, V63, P65
   CLESCERI LS, 1989, STANDARD METHODS EXA
   Geoprincy G, 2012, INT J PHARM PHARM SC, V4, P544
   GEORGE A, 1991, BIOCHEMISTRY-US, V30, P2372, DOI 10.1021/bi00223a011
   Gurusala NK, 2015, CLEAN TECHNOL ENVIR, V17, P681, DOI 10.1007/s10098-014-0825-5
   Hsieh WC, 2007, COLLOID SURFACE B, V57, P250, DOI 10.1016/j.colsurfb.2007.02.004
   Kalyanaraman C, 2013, CLEAN TECHNOL ENVIR, V15, P633, DOI 10.1007/s10098-012-0551-9
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Mandal A, 2013, BBA-GEN SUBJECTS, V1830, P4628, DOI 10.1016/j.bbagen.2013.05.018
   Mandal A, 2012, COLLOID SURFACE B, V90, P191, DOI 10.1016/j.colsurfb.2011.10.021
   Mandal A., 2010, BIOL ENG, V2, P63
   Mandal A, 2015, J MATER CHEM B, V3, P3032, DOI 10.1039/c4tb02124j
   Mandal A, 2015, RSC ADV, V5, P15763, DOI 10.1039/c4ra09694k
   Mandal A, 2014, PHYS CHEM CHEM PHYS, V16, P20175, DOI 10.1039/c4cp02554g
   Marousek J, 2015, POLICY, DOI [10.1007/s10098-015-0941-x, DOI 10.1007/S10098-015-0941-X]
   Mitra T, 2013, INT J POLYM MATER PO, V62, P572, DOI 10.1080/00914037.2013.769161
   Rajeshwari A, 2014, J LUMIN, V145, P859, DOI 10.1016/j.jlumin.2013.08.073
   Ramamurthy G, 2014, CLEAN TECHNOL ENVIR, V16, P647, DOI 10.1007/s10098-013-0651-1
   Ramamurthy G, 2015, ACS SUSTAIN CHEM ENG, V3, P1348, DOI 10.1021/acssuschemeng.5b00071
   Rao J. R., 2004, Clean Technologies and Environmental Policy, V6, P243, DOI 10.1007/s10098-003-0240-9
   Sankar S, 2008, INT J BIOL MACROMOL, V42, P6, DOI 10.1016/j.ijbiomac.2007.08.003
   Seggiani M, 2014, CLEAN TECHNOL ENVIR, V16, P1795, DOI 10.1007/s10098-014-0722-y
   Senthil R, 2015, CLEAN TECHNOL ENVIR, V17, P1535, DOI 10.1007/s10098-014-0881-x
   Senthil R, 2015, CLEAN TECHNOL ENVIR, V17, P187, DOI 10.1007/s10098-014-0776-x
   Senthilvelan T, 2012, CLEAN TECHNOL ENVIR, V14, P889, DOI 10.1007/s10098-012-0458-5
   Thamaraiselvi T. V., 2004, TRENDS BIOMATER ARTI, V18, P9
NR 29
TC 1
Z9 1
U1 2
U2 23
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1618-954X
EI 1618-9558
J9 CLEAN TECHNOL ENVIR
JI Clean Technol. Environ. Policy
PD MAR
PY 2016
VL 18
IS 3
BP 765
EP 773
DI 10.1007/s10098-015-1045-3
PG 9
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Engineering, Environmental;
   Environmental Sciences
SC Science & Technology - Other Topics; Engineering; Environmental Sciences
   & Ecology
GA DF8TI
UT WOS:000371631800012
DA 2018-10-19
ER

PT J
AU Siddiqi, A
   Milne, T
   Cullinan, MP
   Seymour, GJ
AF Siddiqi, Allauddin
   Milne, Trudy
   Cullinan, Mary P.
   Seymour, Gregory J.
TI Analysis of P.gingivalis, T.forsythia and S.aureus levels in edentulous
   mouths prior to and 6months after placement of one-piece zirconia and
   titanium implants
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biofilm; edentulous patients; one-piece implant; Porphyromonas
   gingivalis; qRT-PCR; Staphylococcus aureus; Tannerella forsythia
ID ORAL MUCOUS-MEMBRANES; POLYMERASE-CHAIN-REACTION; PERIODONTAL PATHOGENS;
   IN-VITRO; BACTERIAL-COLONIZATION; STAPHYLOCOCCUS-AUREUS; SURFACES; PCR;
   EXTRACTION; MICROBIOTA
AB BackgroundIt has been suggested that completely edentulous patients harbour fewer periodontopathic bacteria compared with dentate patients, due to the removal of the subgingival periodontal environment. However, reappearance of certain microbes has been reported after the placement of implants in these patients.
   AimThe aim of this study was to determine whether the periodontopathic bacteria Porphyromonas gingivalis and Tannerella forsythia, as well as the non-periodontopathic bacterium, Staphylococcus aureus, emerged in edentulous patients 6months after placement of one-piece zirconia and titanium implants.
   Materials and methodsTwenty-six patients were included in the study (titanium=13, zirconia=13). Microbial samples were collected from the tongue prior to implant placement and 6months after implant placement from both the tongue and from around the implants. A qRT-PCR assay using SYBR green/ROX chemistry was used for the detection and quantification of rgp, nuc and karilysin single-copy gene of P.gingivalis, T.forsythia and S.aureus, respectively. Positive controls used in the study were pure bacterial gDNA purified from cultures of P.gingivalis and S.aureus, a cloned sequence of the karilysin gene for T.forsythia, a plaque sample positive for P.gingivalis and T.forsythia, and nasal gDNA for S.aureus.
   ResultsThe results show that prior to implant placement, all three bacterial species were below the lower limit of quantification in all edentulous patients. The samples collected from the tongue and around the implants remained below the lower limit of quantification for each of the three species. However, all positive controls used in the study were detectable in the samples. qPCR standard curves showed correlation coefficients >0.97 and efficiencies >94.5% (slope range -3.19 to -3.46) for each of the SYBR green PCR assays.
   ConclusionThe results of this study indicate that the tested organisms did not emerge 6months after implant placement irrespective of the nature of the implant biomaterial. A further follow-up of at least 2years post-implantation of these patients is suggested to determine whether there are any changes in the oral microbiota and whether such changes are associated with the development of peri-implant disease.
C1 [Siddiqi, Allauddin] Univ Otago, Oral Implantol Res Grp, Sir John Walsh Res Inst, Fac Dent, Dunedin 9054, New Zealand.
   [Milne, Trudy; Cullinan, Mary P.; Seymour, Gregory J.] Univ Otago, Fac Dent, Sir John Walsh Res Inst, POB 647, Dunedin 9054, New Zealand.
RP Siddiqi, A (reprint author), Univ Otago, Fac Dent, Sir John Walsh Res Inst, POB 647, Dunedin 9054, New Zealand.
EM siddiqidr@gmail.com
RI Milne, Trudy/G-2630-2011
OI SIDDIQI, ALLAUDDIN/0000-0001-5528-9153; Cullinan,
   Mary/0000-0002-0423-1581; Seymour, Gregory/0000-0001-7595-5651
CR Alarcon B, 2006, J APPL MICROBIOL, V100, P352, DOI 10.1111/j.1365-2672.2005.02768.x
   Albertini M., 2014, CLIN ORAL IMPLANTS R, V26, P937
   Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009
   BRAKSTAD OG, 1992, J CLIN MICROBIOL, V30, P1654
   Carlen A, 2001, BIOMATERIALS, V22, P481, DOI 10.1016/S0142-9612(00)00204-0
   Cortelli JR, 2008, J PERIODONTOL, V79, P1962, DOI [10.1902/jop.2008.080092, 10.1902/jop.2008.080092 ]
   Danser MM, 1997, J PERIODONTOL, V68, P209, DOI 10.1902/jop.1997.68.3.209
   DANSER MM, 1994, J CLIN PERIODONTOL, V21, P484, DOI 10.1111/j.1600-051X.1994.tb00412.x
   DANSER MM, 1995, J CLIN PERIODONTOL, V22, P854, DOI 10.1111/j.1600-051X.1995.tb01784.x
   Devides SL, 2006, INT J ORAL MAX IMPL, V21, P262
   dosNascimento C., 2014, CLIN ORAL IMPLAN RES, V25, P337
   Egawa M, 2013, DENT MATER J, V32, P101, DOI 10.4012/dmj.2012-156
   Groessner-Schreiber B, 2004, EUR J ORAL SCI, V112, P516, DOI 10.1111/j.1600-0722.2004.00171.x
   Groner-Schreiber B., 2009, CLIN ORAL IMPLAN RES, V20, P817
   Haffajee AD, 1998, J CLIN PERIODONTOL, V25, P346, DOI 10.1111/j.1600-051X.1998.tb02454.x
   Harris LG, 2006, J BIOMED MATER RES A, V78A, P50, DOI 10.1002/jbm.a.30611
   Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986
   Heitz-Mayfield LJA, 2010, PERIODONTOL 2000, V53, P167, DOI 10.1111/j.1600-0757.2010.00348.x
   Karim AY, 2010, BIOL CHEM, V391, P105, DOI 10.1515/BC.2010.009
   Koar M., 2010, INT J ORAL MAXILLOF, V25, P690
   Leonhardt, 1999, CLIN ORAL IMPLAN RES, V10, P339
   Mombelli A, 1987, Oral Microbiol Immunol, V2, P145, DOI 10.1111/j.1399-302X.1987.tb00298.x
   Mombelli A, 1993, Adv Dent Res, V7, P202
   Morillo JM, 2004, J CLIN PERIODONTOL, V31, P1054, DOI 10.1111/j.1600-051X.2004.00608.x
   Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257
   Quirynen M, 2005, CLIN ORAL IMPLAN RES, V16, P277, DOI 10.1111/j.1600-0501.2005.01127.x
   Quirynen M, 1992, Clin Oral Implants Res, V3, P104, DOI 10.1034/j.1600-0501.1992.030302.x
   Quirynen M, 2011, J CLIN PERIODONTOL, V38, P581, DOI 10.1111/j.1600-051X.2011.01728.x
   RAMS TE, 1990, ORAL MICROBIOL IMMUN, V5, P29, DOI 10.1111/j.1399-302X.1990.tb00222.x
   Rimondini L, 2002, INT J ORAL MAX IMPL, V17, P793
   Sachdeo Amit, 2008, J Prosthodont, V17, P348, DOI 10.1111/j.1532-849X.2008.00301.x
   Salvi GE, 2008, CLIN ORAL IMPLAN RES, V19, P242, DOI 10.1111/j.1600-0501.2007.01470.x
   Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292
   Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x
   Tesmer M, 2009, J PERIODONTOL, V80, P1991, DOI 10.1902/jop.2009.090178
   Teughels W, 2006, CLIN ORAL IMPLAN RES, V17, P68, DOI 10.1111/j.1600-0501.2006.01353.x
   VansAssche N., 2009, J CLIN PERIODONTOL, V36, P1043
   VansBrakel R., 2011, CLIN ORAL IMPLAN RES, V22, P571
   Yasui M, 2012, GERODONTOLOGY, V29, pE494, DOI 10.1111/j.1741-2358.2011.00506.x
NR 39
TC 2
Z9 2
U1 4
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD MAR
PY 2016
VL 27
IS 3
BP 288
EP 294
DI 10.1111/clr.12536
PG 7
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA DF6ST
UT WOS:000371487800004
PM 25529603
DA 2018-10-19
ER

PT J
AU Mustafa, A
   Lung, CYK
   Mustafa, NS
   Mustafa, BA
   Kashmoola, MA
   Zwahlen, RA
   Matinlinna, JP
AF Mustafa, Ammar
   Lung, Christie Y. K.
   Mustafa, Nazih S.
   Mustafa, Besma A.
   Kashmoola, Muhannad A.
   Zwahlen, Roger A.
   Matinlinna, Jukka P.
TI EPA-coated titanium implants promote osteoconduction in white New
   Zealand rabbits
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE biomaterials; dental implant; fatty acid; implant coatings; surface
   chemistry; titanium
ID POLYUNSATURATED FATTY-ACIDS; EICOSAPENTAENOIC ACID; DENTAL IMPLANTS;
   SURFACE; BONE; OSSEOINTEGRATION; COATINGS; BIOMATERIAL; HEALTH; SILANE
AB ObjectivesTo investigate the effect of eicosapentaenoic acid (EPA)-coated Ti implants on osteoconduction in white New Zealand rabbit mandibles.
   Material and methodsSandblasted and cleansed planar titanium specimens with a size of 5x5x1mm were coated on one side with 0.25 vol% eicosapentaenoic acid (EPA). The other side of the specimens was kept highly polished (the control side). These specimens were inserted in rabbit mandibles. Twelve rabbits were randomly assigned into three study groups (n=4). The rabbits were sacrificed at 4, 8, and 12weeks. The harvested specimens with the implants were assessed for new bone formation on both sides of the implant using CBCT, conventional radiographs, and the biaxial pullout test. The results were statistically analyzed by a nonparametric Kruskal-Wallis test and Friedman's test as multiple comparisons and by Brunner-Langer nonparametric mixed model approach (R Software).
   ResultsA significant osteoconductive bone formation was found on the EPA-coated Ti implant surface (P<0.05) at 8weeks when compared to the polished surface (control). Biaxial pullout test results showed a significant difference (P<0.05) after 8 and 12weeks with a maximum force of 243.8N, compared to 143.25N after 4week.
   ConclusionEPA implant coating promoted osteoconduction on the Ti implant surfaces, enhancing the anchorage of the implant to the surrounding bone in white New Zealand rabbits.
C1 [Mustafa, Ammar; Lung, Christie Y. K.; Matinlinna, Jukka P.] Univ Hong Kong, Fac Dent, Dent Mat Sci, Hong Kong, Hong Kong, Peoples R China.
   [Mustafa, Ammar; Lung, Christie Y. K.; Matinlinna, Jukka P.] Int Islamic Univ Malaysia, Dent Mat Sci, Kulliyyah Dent, Kuantan, Malaysia.
   [Mustafa, Ammar] ISF Med Unit, POB 12430, Doha, Qatar.
   [Mustafa, Nazih S.; Mustafa, Besma A.; Kashmoola, Muhannad A.] Int Islamic Univ Malaysia, Kulliyyah Dent, Kuantan, Malaysia.
   [Zwahlen, Roger A.] Univ Hong Kong, Fac Dent, Oral & Maxillofacial Surg, Hong Kong, Hong Kong, Peoples R China.
RP Mustafa, A (reprint author), Univ Hong Kong, Fac Dent, Dent Mat Sci, Hong Kong, Hong Kong, Peoples R China.; Mustafa, A (reprint author), ISF Med Unit, POB 12430, Doha, Qatar.
EM drammar71@gmail.com
FU Research Management Center, International Islamic University Malaysia
   (IIUM) [11-067-0545]
FX The authors would like to acknowledge the Research Management Center,
   International Islamic University Malaysia (IIUM) for the generous fund
   for this research project (EDW B, 11-067-0545), and The Faculty of
   Science (IIUM) for the animals experiment. The authors would also like
   to thank Dr. Zohaib Khorshid for his kind assistance in performing the
   statistical analyses.
CR ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P347
   Albrektsson T, 1986, Int J Oral Maxillofac Implants, V1, P11
   Albrektsson T, 1998, J ORAL MAXIL SURG, V56, P1312, DOI 10.1016/S0278-2391(98)90616-4
   Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Babcock T, 2000, NUTRITION, V16, P1116, DOI 10.1016/S0899-9007(00)00392-0
   Barradas AMC, 2012, BIOMATERIALS, V33, P5696, DOI 10.1016/j.biomaterials.2012.04.021
   Barradas AMC, 2011, EUR CELLS MATER, V21, P407, DOI 10.22203/eCM.v021a31
   Ben-Nissan B, 2013, SURF COAT TECH, V233, P39, DOI 10.1016/j.surfcoat.2012.11.020
   Calder PC, 1997, ANN NUTR METAB, V41, P203, DOI 10.1159/000177997
   Cheng ZP, 2012, OR SURG OR MED OR PA, V113, pE48, DOI 10.1016/j.tripleo.2011.07.008
   Choi AH, 2013, J DENT RES, V92, P853, DOI 10.1177/0022034513497754
   Cochran DL, 2002, CLIN ORAL IMPLAN RES, V13, P144, DOI 10.1034/j.1600-0501.2002.130204.x
   Damsgaard CT, 2012, PEDIATR RES, V71, P713, DOI 10.1038/pr.2012.28
   Guo CY, 2012, J ADHES SCI TECHNOL, V26, P189, DOI 10.1163/016942411X569390
   Hanisch O, 1997, J PERIODONTOL, V68, P59, DOI 10.1902/jop.1997.68.1.59
   Jaatinen JJP, 2011, ACTA ORTHOP, V82, P499, DOI 10.3109/17453674.2011.579522
   JAFFIN RA, 1991, J PERIODONTOL, V62, P2, DOI 10.1902/jop.1991.62.1.2
   Junker R, 2009, CLIN ORAL IMPLAN RES, V20, P185, DOI 10.1111/j.1600-0501.2009.01777.x
   Kelly O, 2003, BRIT J NUTR, V90, P743, DOI 10.1079/BJN2003951
   Khang W, 2001, J PERIODONTOL, V72, P1384, DOI 10.1902/jop.2001.72.10.1384
   Kruger MC, 2005, PROSTAG LEUKOTR ESS, V73, P327, DOI 10.1016/j.plefa.2005.08.001
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   LIN H, 1992, J BIOMED MATER RES, V26, P7
   Lind M, 1998, ACTA ORTHOP SCAND, V69, P2
   Mallineni S. K., 2012, J INVESTIGATIVE CLIN, V4, P9
   Matinlinna JP, 2006, J DENT, V34, P740, DOI 10.1016/j.jdent.2006.01.008
   Matinlinna JP, 2013, CLIN ORAL IMPLAN RES, V24, P688, DOI 10.1111/j.1600-0501.2012.02504.x
   Murphy RA, 2011, BRIT J CANCER, V105, P1469, DOI 10.1038/bjc.2011.391
   National Research Council, 2011, GUID CAR US LAB AN
   Nettleton JA, 1995, OMEGA 3 FATTY ACIDS
   Norowski PA, 2009, J BIOMED MATER RES B, V88B, P530, DOI 10.1002/jbm.b.31152
   Petzold C, 2008, J MATER CHEM, V18, P5502, DOI 10.1039/b811932e
   Petzold C, 2011, J BIOMED MATER RES A, V96A, P83, DOI 10.1002/jbm.a.32960
   Pjetursson BE, 2007, CLIN ORAL IMPLAN RES, V18, P97, DOI 10.1111/j.1600-0501.2007.01439.x
   RAISZ LG, 1989, PROSTAG OTH LIPID M, V37, P615, DOI 10.1016/0090-6980(89)90076-2
   Ronold HJ, 2002, BIOMATERIALS, V23, P2201, DOI 10.1016/S0142-9612(01)00353-2
   Sethi S, 1996, J LAB CLIN MED, V128, P27, DOI 10.1016/S0022-2143(96)90111-0
   Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248
   THOMAS KA, 1987, J BIOMED MATER RES, V21, P1395, DOI 10.1002/jbm.820211205
   Trisi P, 1999, INT J ORAL MAX IMPL, V14, P689
   Villard N, 2015, CLIN ORAL IMPLAN RES, V26, P332, DOI 10.1111/clr.12338
   Wagner W. C., 1992, J ORAL IMPLANTOL, V18, P31
   Watkins BA, 2001, EXP BIOL MED, V226, P485
   Wennerberg A, 1998, CLIN ORAL IMPLAN RES, V9, P11, DOI 10.1034/j.1600-0501.1998.090102.x
   Zhao SF, 2013, CLIN ORAL IMPLAN RES, V24, P34, DOI 10.1111/j.1600-0501.2011.02362.x
NR 45
TC 0
Z9 0
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD MAR
PY 2016
VL 27
IS 3
BP 303
EP 309
DI 10.1111/clr.12525
PG 7
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA DF6ST
UT WOS:000371487800006
PM 25393376
OA Green Published
DA 2018-10-19
ER

PT J
AU Papanas, N
   Demetzos, C
   Pippa, N
   Maltezos, E
   Tentolouris, N
AF Papanas, Nikolaos
   Demetzos, Costas
   Pippa, Natassa
   Maltezos, Efstratios
   Tentolouris, Nicholas
TI Efficacy of a New Heparan Sulfate Mimetic Dressing in the Healing of
   Foot and Lower Extremity Ulcerations in Type 2 Diabetes: A Case Series
SO INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS
LA English
DT Article
DE biomimetic scaffold; diabetic foot; dressing; hydration; tissue
   engineering; ulceration
ID ANKLE-BRACHIAL INDEX; SURGICAL-TREATMENT; GROWTH-FACTORS; INFECTIONS;
   ISCHEMIA; ULCERS; AMPUTATIONS; PREVALENCE; PRESSURE; OTR4120
AB A novel heparan sulfate glycosaminoglycan mimetic product for local application to promote wound healing (CACIPLIQ) has recently become available. It is a biophysical therapeutic product comprising a polysaccharide as an innovative biomaterial to accomplish mechanical tissue engineering and skin regeneration in the site of ulceration. We present a series of 12 patients with type 2 diabetes (4 men and 8 women; age 53-87 years; diabetes duration 8-25 years) having chronic resistance to therapy for foot and lower extremity ulcerations. CACIPLIQ was locally applied twice per week after careful debridement. Complete ulcer healing was accomplished in all patients after a mean treatment duration of 4.92 months (range = 2-12 months). The product was very well tolerated. In conclusion, these results, although preliminary, are encouraging and suggest adequate efficacy and safety of the new product in difficult-to-heal foot and lower extremity ulcerations in type 2 diabetes.
C1 [Papanas, Nikolaos; Maltezos, Efstratios] Democritus Univ Thrace, Alexandroupolis, Greece.
   [Demetzos, Costas; Pippa, Natassa; Tentolouris, Nicholas] Univ Athens, Athens 11528, Greece.
RP Papanas, N (reprint author), Ctr Diabet, Dept Internal Med 2, Diabet Foot Clin, G Kondyli 22c, Alexandroupolis 68132, Greece.
EM papanasnikos@yahoo.gr
OI DEMETZOS, COSTAS/0000-0001-9771-4314; Maltezos,
   Efstratios/0000-0002-5827-2661; Pippa, Natassa/0000-0002-1197-9010
FU Asta-Zeneca; GSK; Novo Nordisk; Novartis; Sanofi-Aventis; TrigoCare
   International; Eli-Lilly; Galenica; Pfizer; MSD; Astra-Zeneca; Wyeth;
   Bayer
FX The author(s) declared the following potential conflicts of interest
   with respect to the research, authorship, and/or publication of this
   article: Nikolaos Papanas has been an advisory board member of TrigoCare
   International, Astra-Zeneca, Boehringer Ingelheim, MSD, Novo Nordisk,
   and Pfizer; has participated in sponsored studies by Asta-Zeneca, GSK,
   Novo Nordisk, Novartis, and Sanofi-Aventis; has received honoraria as a
   speaker for Astra-Zeneca, Boehringer Ingelheim, Eli-Lilly, ELPEN, MSD,
   Mylan, Novo Nordisk, Pfizer, and Sanofi-Aventis; and attended
   conferences sponsored by TrigoCare International, Eli-Lilly, Galenica,
   Novo Nordisk, Pfizer, and Sanofi-Aventis. Nicholas Tentolouris has been
   an advisory board member of TrigoCare International; has participated in
   sponsored studies by Sanofi-Aventis, Eli-Lilly, MSD, Pfizer, Novo
   Nordisk, and Novartis; has received honoraria as a speaker for
   Astra-Zeneca, Eli-Lilly, Novo Nordisk, Novartis, and MSD; has received
   research support by Sanofi-Aventis and Novartis; and has attended
   conferences sponsored by Novo Nordisk, Sanofi-Aventis, Astra-Zeneca,
   MSD, and Novartis. Efstratios Maltezos has participated in sponsored
   studies by Asta-Zeneca, GSK, Novo Nordisk, Novartis and Sanofi-Aventis;
   and attended conferences sponsored by Wyeth, Pfizer, and Bayer. The
   other authors have no conflicts of interest to report.
CR Aragon-Sanchez J, 2013, INT J LOW EXTR WOUND, V12, P146, DOI 10.1177/1534734613486155
   Aragon-Sanchez J, 2011, INT J LOW EXTR WOUND, V10, P207, DOI 10.1177/1534734611426364
   Aragon-Sanchez J, 2011, INT J LOW EXTR WOUND, V10, P33, DOI 10.1177/1534734611400259
   Demetriou M, 2013, INT J LOW EXTR WOUND, V12, P87, DOI 10.1177/1534734613481975
   Demetzos C, 2015, AAPS PHARMSCITECH, V16, P491, DOI 10.1208/s12249-015-0321-1
   Desgranges P, 2011, J WOUND TECHNOL, V13, P1
   Edmonds M, 2009, INT J LOW EXTR WOUND, V8, P62, DOI 10.1177/1534734609337930
   Franco D, 2013, BIOMATERIALS, V34, P1488, DOI 10.1016/j.biomaterials.2012.10.007
   Georgakarakos E, 2013, ANGIOLOGY, V64, P583, DOI 10.1177/0003319712465172
   Georgakarakos E, 2013, INT J LOW EXTR WOUND, V12, P138, DOI 10.1177/1534734613483769
   Georgakarakos E, 2013, INT J LOW EXTR WOUND, V12, P167, DOI 10.1177/1534734613483768
   Gouveri E, 2011, WORLD J DIABETES, V2, P59, DOI 10.4239/wjd.v2.i5.59
   Kakagia DD, 2007, J DIABETES COMPLICAT, V21, P387, DOI 10.1016/j.jdiacomp.2007.03.006
   Kundu B, 2012, BIOMATERIALS, V33, P7456, DOI 10.1016/j.biomaterials.2012.06.091
   Mikroulis D, 2007, CURR VASC PHARMACOL, V5, P195
   Panagopoulos P, 2015, INT J LOW EXTR WOUND, V14, P87, DOI 10.1177/1534734614566937
   Papanas N, 2007, INT ANGIOL, V26, P253
   Papanas N, 2007, Int J Low Extrem Wounds, V6, P37, DOI 10.1177/1534734606298416
   Papanas N, 2015, INT J LOW EXTR WOUND, V14, P106, DOI 10.1177/1534734615592313
   Papanas N, 2012, CURR DIABETES REV, V8, P209, DOI 10.2174/157339912800563963
   Papanas N, 2011, VASA, V40, P267, DOI 10.1024/0301-1526/a000114
   Papanas N, 2011, INT J LOW EXTR WOUND, V10, P4, DOI 10.1177/1534734611400255
   Papanas N, 2013, INT J LOW EXTR WOUND, V12, P83, DOI 10.1177/1534734613490507
   Papanas N, 2010, DRUG SAFETY, V33, P455, DOI 10.2165/11534570-000000000-00000
   Prompers L, 2007, DIABETOLOGIA, V50, P18, DOI 10.1007/s00125-006-0491-1
   Skoutas D, 2009, INT J LOW EXTR WOUND, V8, P69, DOI 10.1177/1534734609334808
   Tiaka EK, 2012, ANGIOLOGY, V63, P302, DOI 10.1177/0003319711416804
   Tong M, 2012, DIABETES, V61, P2633, DOI 10.2337/db11-1329
   Tong M, 2011, WOUND REPAIR REGEN, V19, P505, DOI 10.1111/j.1524-475X.2011.00704.x
   Tong M, 2009, WOUND REPAIR REGEN, V17, P840, DOI 10.1111/j.1524-475X.2009.00548.x
   YOUNG MJ, 1993, DIABETOLOGIA, V36, P150, DOI 10.1007/BF00400697
NR 31
TC 6
Z9 6
U1 0
U2 13
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1534-7346
EI 1552-6941
J9 INT J LOW EXTR WOUND
JI Int. J. Low. Extrem. Wounds
PD MAR
PY 2016
VL 15
IS 1
BP 63
EP 67
DI 10.1177/1534734616629302
PG 5
WC Dermatology; Surgery
SC Dermatology; Surgery
GA DF9QY
UT WOS:000371697400011
PM 26933115
DA 2018-10-19
ER

PT J
AU Zhang, Q
   Du, Y
   Jing, LJ
   Liang, XL
   Li, YQ
   Li, XF
   Dai, ZF
   Tian, J
AF Zhang, Qian
   Du, Yang
   Jing, Lijia
   Liang, Xiaolong
   Li, Yaqian
   Li, Xiaofeng
   Dai, Zhifei
   Tian, Jie
TI Infra Red Dye and Endostar Loaded Poly Lactic Acid Nano Particles as a
   Novel Theranostic Nanomedicine for Breast Cancer
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Endostar; Poly Lactic Acid (PLA); Zoledronic Acid (ZA); Breast Cancer;
   Nanoparticle; Molecular Imaging
ID TUMOR-ASSOCIATED MACROPHAGES; RECOMBINANT HUMAN ENDOSTATIN;
   BIODEGRADABLE NANOPARTICLES; DRUG-DELIVERY; PROGRESSION; METASTASIS;
   THERAPY; PHARMACOKINETICS; ANGIOGENESIS; CELLS
AB Endostar, a novel recombinant human endostatin, has been proven to inhibit tumor angiogenesis and is utilized as an anticancer drug. While free drugs can display limited efficacy, nanoscaled anticancer drugs have been fabricated and proven to possess superior therapeutic effects. Poly(lactic acid) (PLA) is a FDA-approved biomaterial displaying excellent biocompatibility and low toxicity. In this study, Endostar-loaded PLA nanoparticles (EPNPs) were first prepared, and a near-infrared (NIR) dye, IRDye 800CW, was conjugated to the surface for detecting nanoparticle biodistribution through fluorescence molecular imaging (FMI) using an orthotopic breast tumor mouse model. The antitumor efficacy of EPNPs was examined using bioluminescence imaging (BLI) and immunohistology. To further improve the antitumor effects, we combined EPNPs with zoledronic acid monohydrate (ZA), which is known to decrease the tumor-associated macrophages (TAM) and inhibit tumor progression. We found that EPNPs decreased human umbilical vein endothelial cell (HUVEC) viability by inhibiting tumor growth gene expression more significantly than free Endostar in vitro. In vivo, EPNPs displayed better tumor growth inhibitory effects compared with free Endostar, and the combination of EPNPs with ZA exhibited more significant antitumor effects. As confirmed by CD31 and CD11b immunohistochemistry, the combination of EPNPs and ZA showed synergistic effects in reducing tumor angiogenesis and TAM accumulation in tumor regions. Taken together, this study presents a novel and effective form of nanoscaled Endostar for the treatment of breast cancer that displays synergistic antitumor effects in combination with ZA.
C1 [Zhang, Qian; Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Xian 710071, Peoples R China.
   [Zhang, Qian; Tian, Jie] Minist Educ, Engn Res Ctr Mol & Neuro Imaging, Beijing, Peoples R China.
   [Zhang, Qian; Du, Yang; Li, Yaqian; Tian, Jie] Chinese Acad Sci, Inst Automat, Key Lab Mol Imaging, Beijing 100190, Peoples R China.
   [Jing, Lijia] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150001, Peoples R China.
   [Liang, Xiaolong; Dai, Zhifei] Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100871, Peoples R China.
   [Li, Yaqian] Harbin Univ Sci & Technol, Harbin 150080, Peoples R China.
   [Li, Xiaofeng] Univ Louisville, Sch Med, Dept Diagnost Radiol, Louisville, KY 40208 USA.
   [Li, Xiaofeng] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10065 USA.
RP Tian, J (reprint author), Xidian Univ, Sch Life Sci & Technol, Xian 710071, Peoples R China.; Tian, J (reprint author), Minist Educ, Engn Res Ctr Mol & Neuro Imaging, Beijing, Peoples R China.; Tian, J (reprint author), Chinese Acad Sci, Inst Automat, Key Lab Mol Imaging, Beijing 100190, Peoples R China.; Dai, ZF (reprint author), Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100871, Peoples R China.
EM zhifei.dai@pku.edu.cn; tian@ieee.org
RI Dai, Zhifei/B-1812-2012; Tian, Jie/H-1190-2011
FU Program of the National Basic Research and Development Program of China
   (973) [2011CB707702, 2014CB748600]; National Natural Science Foundation
   of China [81090272, 81227901]; National Key Technology Support Program
   [2012BAI23B06]; State Key laboratory of Management and Control for
   Complex Systems [Y3S9021F30]
FX This work was supported by the Program of the National Basic Research
   and Development Program of China (973) under Grant Nos. 2011CB707702 and
   2014CB748600, the National Natural Science Foundation of China under
   Grant Nos. 81090272 and 81227901 and the National Key Technology Support
   Program under Grant No. 2012BAI23B06. This work was also supported in
   part by the State Key laboratory of Management and Control for Complex
   Systems under Grant No. Y3S9021F30.
CR Acharya S, 2011, ADV DRUG DELIVER REV, V63, P170, DOI 10.1016/j.addr.2010.10.008
   Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154
   Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027
   Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007
   Coscia M, 2010, J CELL MOL MED, V14, P2803, DOI 10.1111/j.1582-4934.2009.00926.x
   DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134
   Fenlon D., 2012, EUR J ONCOL NURS, V17, P311
   Folkman J, 2006, EXP CELL RES, V312, P594, DOI 10.1016/j.yexcr.2005.11.015
   Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087
   Greish K, 2010, METHODS MOL BIOL, V624, P25, DOI 10.1007/978-1-60761-609-2_3
   Jia Y, 2011, EUR J GYNAECOL ONCOL, V32, P316
   Kadam RS, 2012, DRUG METAB DISPOS, V40, P1380, DOI 10.1124/dmd.112.044925
   Kircher MF, 2012, NAT MED, V18, P829, DOI 10.1038/nm.2721
   Ling Y, 2007, BIOCHEM BIOPH RES CO, V361, P79, DOI 10.1016/j.bbrc.2007.06.155
   Malam Y, 2009, TRENDS PHARMACOL SCI, V30, P592, DOI 10.1016/j.tips.2009.08.004
   Metcalf S, 2011, FUTURE ONCOL, V7, P1325, DOI [10.2217/FON.11.113, 10.2217/fon.11.113]
   O'Neal DP, 2004, CANCER LETT, V209, P171, DOI 10.1016/j.canlet.2004.02.004
   Ottewell PD, 2012, BREAST CANCER RES TR, V133, P523, DOI 10.1007/s10549-011-1782-x
   Panyam J, 2012, ADV DRUG DELIVER REV, V64, P61, DOI 10.1016/j.addr.2012.09.023
   Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256
   Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014
   Roelofs AJ, 2006, CLIN CANCER RES, V12, p6222S, DOI 10.1158/1078-0432.CCR-06-0843
   Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4
   Stresing V, 2007, CANCER LETT, V257, P16, DOI 10.1016/j.canlet.2007.07.007
   Vicioso L, 2006, AM J CLIN PATHOL, V125, P111, DOI 10.1309/0864AF2U3LGPCF3J
   WEIDNER N, 1992, J NATL CANCER I, V84, P1875, DOI 10.1093/jnci/84.24.1875
   Weissleder R, 2006, SCIENCE, V312, P1168, DOI 10.1126/science.1125949
   Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917
   Wittig R, 2014, NANOMEDICINE-UK, V9, P971, DOI [10.2217/NNM.13.62, 10.2217/nnm.13.62]
   Youlden DR, 2012, CANCER EPIDEMIOL, V36, P237, DOI 10.1016/j.canep.2012.02.007
   Zhang W, 2010, CLIN CANCER RES, V16, P3420, DOI 10.1158/1078-0432.CCR-09-2904
   Zou P, 2013, MOL PHARMACEUT, V10, P1977, DOI 10.1021/mp4000019
   Zucker D, 2012, J CONTROL RELEASE, V160, P281, DOI 10.1016/j.jconrel.2011.10.003
NR 33
TC 5
Z9 6
U1 2
U2 41
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
EI 1550-7041
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD MAR
PY 2016
VL 12
IS 3
BP 491
EP 502
DI 10.1166/jbn.2016.2022
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA DF6FJ
UT WOS:000371451000007
PM 27280247
DA 2018-10-19
ER

PT J
AU Schaller, B
   Saulacic, N
   Imwinkelried, T
   Beck, S
   Liu, EWY
   Gralla, J
   Nakahara, K
   Hofstetter, W
   Iizuka, T
AF Schaller, Benoit
   Saulacic, Nikola
   Imwinkelried, Thomas
   Beck, Stefan
   Liu, Edwin Wei Yang
   Gralla, Jan
   Nakahara, Ken
   Hofstetter, Willy
   Iizuka, Tateyuki
TI In vivo degradation of magnesium plate/screw osteosynthesis implant
   systems: Soft and hard tissue response in a calvarial model in miniature
   pigs
SO JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
LA English
DT Article
DE Biomaterial; Magnesium; Osteosynthesis; Implant; Degradation
ID CRANIOMAXILLOFACIAL SURGERY; RABBIT MODEL; ALLOYS; CORROSION; BONE;
   VITRO; SCREWS; PLATES; BIOCOMPATIBILITY; BIOMATERIALS
AB Biodegradable magnesium plate/screw osteosynthesis systems were implanted on the frontal bone of adult miniature pigs. The chosen implant geometries were based on existing titanium systems used for the treatment of facial fractures. The aim of this study was to evaluate the in vivo degradation and tissue response of the magnesium alloy WE43 with and without a plasma electrolytic surface coating. Of 14 animals, 6 received magnesium implants with surface modification (coated), 6 without surface modification (uncoated), and 2 titanium implants. Radiological examination of the skull was performed at 1, 4, and 8 weeks post-implantation. After euthanasia at 12 and 24 weeks, X-ray, computed tomography, and microfocus computed tomography analyses and histological and histomorphological examinations of the bone/implant blocks were performed. The results showed a good tolerance of the plate/screw system without wound healing disturbance. In the radiological examination, gas pocket formation was found mainly around the uncoated plates 4 weeks after surgery. The micro-CT and histological analyses showed significantly lower corrosion rates and increased bone density and bone implant contact area around the coated screws compared to the uncoated screws at both endpoints. This study shows promising results for the further development of coated magnesium implants for the osteosynthesis of the facial skeleton. (C) 2016 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.
C1 [Schaller, Benoit; Saulacic, Nikola; Nakahara, Ken; Iizuka, Tateyuki] Univ Hosp Bern, Inselspital, Dept Craniomaxillofacial Surg, CH-3010 Bern, Switzerland.
   [Schaller, Benoit; Saulacic, Nikola; Gralla, Jan; Nakahara, Ken; Iizuka, Tateyuki] Univ Bern, CH-3010 Bern, Switzerland.
   [Schaller, Benoit; Liu, Edwin Wei Yang] Natl Dent Ctr Singapore, Singapore 168938, Singapore.
   [Imwinkelried, Thomas] RMS Fdn, Bischmattstr 12, CH-2544 Bettlach, Switzerland.
   [Beck, Stefan] Synthes Biomat, Eimattstr 3, CH-4436 Oberdorf, Switzerland.
   [Gralla, Jan] Univ Hosp Bern, Dept Intervent & Diagnost Neuroradiol, CH-3010 Bern, Switzerland.
   [Hofstetter, Willy] Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland.
RP Schaller, B (reprint author), Univ Hosp Bern, Inselspital, Dept Craniomaxillofacial Surg, CH-3010 Bern, Switzerland.; Schaller, B (reprint author), Univ Bern, CH-3010 Bern, Switzerland.; Schaller, B (reprint author), Natl Dent Ctr Singapore, Singapore 168938, Singapore.
EM benoit.schaller@ndcs.com.sg
OI Hofstetter, Wilhelm/0000-0003-0126-8423; Schaller,
   Benoit/0000-0002-6861-2340
CR Al-Samman T, 2011, MAT SCI ENG A-STRUCT, V528, P3809, DOI 10.1016/j.msea.2011.01.080
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   BERGSMA JE, 1995, BIOMATERIALS, V16, P267, DOI 10.1016/0142-9612(95)93253-A
   Birbilis N, 2011, CORROS SCI, V53, P168, DOI 10.1016/j.corsci.2010.09.013
   Castellania C., 2010, ACTA BIOMATER, V7, P432
   Chaya A, 2015, ACTA BIOMATER, V18, P262, DOI 10.1016/j.actbio.2015.02.010
   Chaya A, 2015, J ORAL MAXIL SURG, V73, P295, DOI 10.1016/j.joms.2014.09.007
   Cui W, 2013, ACTA BIOMATER, V9, P8650, DOI 10.1016/j.actbio.2013.06.031
   Feyerabend F, 2015, ACTA BIOMATER, V25, P384, DOI 10.1016/j.actbio.2015.07.029
   Gephart MGH, 2013, CHILD NERV SYST, V29, P297, DOI 10.1007/s00381-012-1938-y
   Gunde P, 2010, J BIOMED MATER RES A, V92A, P409, DOI 10.1002/jbm.a.32350
   Guzman R, 2011, NEUROSURGERY, V68, P68, DOI 10.1227/NEU.0b013e31820780cd
   Han P, 2015, BIOMATERIALS, V64, P57, DOI 10.1016/j.biomaterials.2015.06.031
   Hort N, 2010, ACTA BIOMATER, V6, P1714, DOI 10.1016/j.actbio.2009.09.010
   Imwinkelried T, 2013, ACTA BIOMATER, V9, P8643, DOI 10.1016/j.actbio.2012.08.047
   Janning C, 2010, ACTA BIOMATER, V6, P1861, DOI 10.1016/j.actbio.2009.12.037
   Jung O, 2015, ACTA BIOMATER, V23, P354, DOI 10.1016/j.actbio.2015.06.005
   Keim S, 2011, J BIOMED MATER RES B, V96B, P84, DOI 10.1002/jbm.b.31742
   Kraus T, 2012, ACTA BIOMATER, V8, P1230, DOI 10.1016/j.actbio.2011.11.008
   Kuhlmann J, 2013, ACTA BIOMATER, V9, P8714, DOI 10.1016/j.actbio.2012.10.008
   Lambotte A., 1932, B MEM SOC NAT CHIR, V28, P1325
   Marukawa E., 2015, J BIOMED MAT RES B
   Rettig R, 2008, J BIOMED MATER RES A, V85A, P167, DOI 10.1002/jbm.a.31550
   Rossig C, 2015, ACTA BIOMATER, V25, P369, DOI 10.1016/j.actbio.2015.07.025
   Sanchez MAH, 2015, ACTA BIOMATER, V13, P16
   Schumann P, 2013, PATHOBIOLOGY, V80, P211, DOI 10.1159/000348328
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Suuronen R, 2004, BIO-MED MATER ENG, V14, P517
   Thomann M, 2010, J BIOMED MATER RES A, V93A, P1609, DOI 10.1002/jbm.a.32639
   Thoren H, 2008, J ORAL MAXIL SURG, V66, P1901, DOI 10.1016/j.joms.2008.03.009
   Tschegg EK, 2011, J MECH BEHAV BIOMED, V4, P766, DOI 10.1016/j.jmbbm.2010.08.004
   Verbrugge J., 1934, PRESSE MED, V23, P460
   Waizy H, 2013, J BIOMATER APPL, V28, P667
   Wang S, 2007, ORAL DIS, V13, P530, DOI 10.1111/j.1601-0825.2006.01337.x
   Willumeit R, 2013, ACTA BIOMATER, V9, P8722, DOI 10.1016/j.actbio.2013.02.042
   Windhagen H, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-62
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2008, J BIOMED MATER RES A, V86A, P1041, DOI 10.1002/jbm.a.31713
   Zartner P, 2005, CATHETER CARDIO INTE, V66, P590, DOI 10.1002/ccd.20520
NR 40
TC 14
Z9 14
U1 2
U2 28
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 1010-5182
EI 1878-4119
J9 J CRANIO MAXILL SURG
JI J. Cranio-MaxilloFac. Surg.
PD MAR
PY 2016
VL 44
IS 3
BP 309
EP 317
DI 10.1016/j.jcms.2015.12.009
PG 9
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA DF7PU
UT WOS:000371550900011
PM 26805919
DA 2018-10-19
ER

PT J
AU Tietsch, V
   Alencastre, J
   Witte, H
   Torres, FG
AF Tietsch, V.
   Alencastre, J.
   Witte, H.
   Torres, F. G.
TI Exploring the shock response of spider webs
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Spider silk; Spider orb-web; Vibration; Dynamic behavior
ID ORB-WEAVING SPIDERS; MECHANICAL-PROPERTIES; SILK; PREY; BIOMATERIAL;
   THREADS; INSECT; MODEL
AB Spider orb-webs are designed to allow for quick energy absorption as well as the constraint of drastic oscillations occurring upon prey impact. Studies on spider silk illustrate its impressive mechanical properties and its capacity to be used as technical fibers in composite materials. Models have previously been used to study the mechanical properties of different silk fibers, but not the behavior of the spider web as a whole. Full spider webs have been impacted by a projectile and the transverse displacement was measured by means of a laser interferometer. The damping and stiffness of the entire webs were quantified considering the orb-web as a single-degree-of-freedom (SDOF) system. The amplitude, the period duration, and the energy dissipation of the oscillations have also been reported from the experiments. The analysis of the energy dissipation confirmed that the webs of orb-web spiders are optimized for the capture of a single or few large prey, rather than several small prey. The experiments also confirmed that the overall stiffness of the web displayed a non-linear behavior. Such non-linearity was also observed in the damping characteristics of the webs studied. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Tietsch, V.; Witte, H.] Tech Univ Ilmenau, FachgebietBiomechatron, Max Planck Ring 12, D-98693 Ilmenau, Germany.
   [Alencastre, J.; Torres, F. G.] Pontificia Univ Catolica Peru, Dept Mech Engn, Av Univ 1801, Lima 32, Peru.
RP Alencastre, J; Torres, FG (reprint author), Pontificia Univ Catolica Peru, Dept Mech Engn, Av Univ 1801, Lima 32, Peru.
EM jalenca@pucp.edu.pe; fgtorres@pucp.pe
OI Torres, Fernando G./0000-0002-3123-266X
FU Pontificia Universidad Catolica del Peru [VRI-165]
FX F.T. and J.A. would like to acknowledge the Vice-Rectorate of Research
   of the Pontificia Universidad Catolica del Peru for financial support
   (VRI-165).
CR Alam MS, 2007, MECH MATER, V39, P145, DOI 10.1016/j.mechmat.2006.04.005
   Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.2755/jcmm010.003.18
   Bai JM, 2006, BIOMED MICRODEVICES, V8, P317, DOI 10.1007/s10544-006-9820-x
   Barrows WM, 1915, BIOL BULL-US, V29, P316, DOI 10.2307/1536407
   Blackledge TA, 2005, J EXP BIOL, V208, P1937, DOI 10.1242/jeb.01597
   Blackledge TA, 2006, J EXP BIOL, V209, P3131, DOI 10.1242/jeb.02327
   Chen Q, 1996, J VIB ACOUST, V118, P252, DOI 10.1115/1.2889656
   CRAIG CL, 1985, J THEOR BIOL, V115, P201, DOI 10.1016/S0022-5193(85)80096-5
   DENNY M, 1976, J EXP BIOL, V65, P483
   Du N, 2011, ADV FUNCT MATER, V21, P772, DOI 10.1002/adfm.201001397
   Elices M, 2009, BIOMACROMOLECULES, V10, P1904, DOI 10.1021/bm900312c
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Kelly SP, 2011, ZOOLOGY, V114, P233, DOI 10.1016/j.zool.2011.02.001
   LIN LH, 1995, NATURE, V373, P146, DOI 10.1038/373146a0
   PARRY DA, 1965, J EXP BIOL, V43, P185
   Perez-Rigueiro J, 2010, INT J BIOL MACROMOL, V46, P555, DOI 10.1016/j.ijbiomac.2010.03.013
   Porter D, 2005, EUR PHYS J E, V16, P199, DOI 10.1140/epje/e2005-00021-2
   Sensenig A, 2010, J EVOLUTION BIOL, V23, P1839, DOI 10.1111/j.1420-9101.2010.02048.x
   Sensenig AT, 2013, J EXP BIOL, V216, P3388, DOI 10.1242/jeb.085571
   Sensenig AT, 2012, J R SOC INTERFACE, V9, P1880, DOI 10.1098/rsif.2011.0851
   TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018
   Torres FG, 2014, MAT SCI ENG C-MATER, V34, P341, DOI 10.1016/j.msec.2013.09.030
   Torres FG, 2013, MAT SCI ENG C-MATER, V33, P1432, DOI 10.1016/j.msec.2012.12.047
   Venner S, 2005, P ROY SOC B-BIOL SCI, V272, P1587, DOI 10.1098/rspb.2005.3114
NR 24
TC 4
Z9 4
U1 2
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD MAR
PY 2016
VL 56
BP 1
EP 5
DI 10.1016/j.jmbbm.2015.11.007
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DF7RB
UT WOS:000371554200001
PM 26651062
DA 2018-10-19
ER

PT J
AU Rodriguez, AL
   Wang, TY
   Bruggeman, KF
   Li, R
   Williams, RJ
   Parish, CL
   Nisbet, DR
AF Rodriguez, Alexandra L.
   Wang, Ting-Yi
   Bruggeman, Kiara F.
   Li, Rui
   Williams, Richard J.
   Parish, Clare L.
   Nisbet, David R.
TI Tailoring minimalist self-assembling peptides for localized viral vector
   gene delivery
SO NANO RESEARCH
LA English
DT Article
DE viral vectors; gene therapy; self-assembling peptides; biomaterials
ID NEURAL PROGENITOR CELLS; STEM-CELLS; IN-VIVO; PARKINSONIAN MICE;
   SCAFFOLDS; THERAPY; HYDROGELS; DIFFERENTIATION; ADENOVIRUS; REPAIR
AB Viral vector gene delivery is a promising technique for the therapeutic administration of proteins to damaged tissue for the improvement of regeneration outcomes in various disease settings including brain and spinal cord injury, as well as autoimmune diseases. Though promising results have been demonstrated, limitations of viral vectors, including spread of the virus to distant sites, neutralization by the host immune system, and low transduction efficiencies have stimulated the investigation of biomaterials as gene delivery vehicles for improved protein expression at an injury site. Here, we show how Nfluorenylmethyloxycarbonyl (Fmoc) self-assembling peptide (SAP) hydrogels, designed for tissue-specific central nervous system (CNS) applications via incorporation of the laminin peptide sequence isoleucine-lysine-valine-alanine-valine (IKVAV), are effective as biocompatible, localized viral vector gene delivery vehicles in vivo. Through the addition of a C-terminal lysine (K) residue, we show that increased electrostatic interactions, provided by the additional amine side chain, allow effective immobilization of lentiviral vector particles, thereby limiting their activity exclusively to the site of injection and enabling focal gene delivery in vivo in a tissue-specific manner. When the C-terminal lysine was absent, no difference was observed between the number of transfected cells, the volume of tissue transfected, or the transfection efficiency with and without the Fmoc-SAP. Importantly, immobilization of the virus only affected transfection cell number and volume, with no impact observed on transfection efficiency. This hydrogel allows the sustained and targeted delivery of growth factors post injury. We have established Fmoc-SAPs as a versatile platform for enhanced biomaterial design for a range of tissue engineering applications.
C1 [Rodriguez, Alexandra L.; Bruggeman, Kiara F.; Nisbet, David R.] Australian Natl Univ, Res Sch Engn, Canberra, ACT 2601, Australia.
   [Wang, Ting-Yi; Parish, Clare L.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia.
   [Li, Rui] Deakin Univ, Ctr Chem & Biotechnol, Waurn Ponds, Vic 3217, Australia.
   [Williams, Richard J.] RMIT Univ, Res Inst, Sch Aerosp Mech & Mfg Engn & Hlth Innovat, Melbourne, Vic 3001, Australia.
RP Nisbet, DR (reprint author), Australian Natl Univ, Res Sch Engn, Canberra, ACT 2601, Australia.; Parish, CL (reprint author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia.
EM clare.parish@florey.edu.au; david.nisbet@anu.edu.au
OI Nisbet, David/0000-0002-1343-0769; Wang, Ting-Yi/0000-0001-7722-8087;
   Parish, Clare/0000-0001-8212-9884
FU Centre for Advanced Microscopy (CAM) through the Australian Microscopy
   and Microanalysis Research Facility (AMMRF); National Health and Medical
   Research Council, Australia (NHMRC) [APP1050684]; Australian Research
   Council (ARC) [DP130103131]; Australian Postgraduate Award; Alfred
   Deakin Research Fellowship; Viertel charitable Foundation, Australia;
   ARC Australian Postdoctoral Fellowship; Victorian Government's
   Operational Infrastructure Support Grant
FX Access to the facilities of the Centre for Advanced Microscopy (CAM)
   with funding through the Australian Microscopy and Microanalysis
   Research Facility (AMMRF) is gratefully acknowledged. We acknowledge
   NanoScope-Scientific Graphics and Illustration for kindly designing the
   virus immobilization schematic in Fig. 3. We would also like to thank
   Conor Horgan, Francesca Maclean and Anitha Parnneerselvan for thorough
   proof reading. Funding for this research was obtained from the National
   Health and Medical Research Council, Australia (NHMRC, No. APP1050684),
   and the Australian Research Council (ARC, No. DP130103131). A. L. R. was
   supported by an Australian Postgraduate Award; R. J. W. was funded via
   an Alfred Deakin Research Fellowship; C. L. P. was supported by Senior
   Medical Research Fellowship provided by the Viertel charitable
   Foundation, Australia; D. R. N. was supported by an ARC Australian
   Postdoctoral Fellowship, followed by an NHMRC Career Development
   Fellowship. The Florey Institute of Neuroscience and Mental Health
   acknowledges the support from the Victorian Government's Operational
   Infrastructure Support Grant.
CR Alexi T, 2000, PROG NEUROBIOL, V60, P409, DOI 10.1016/S0301-0082(99)00032-5
   Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004
   Bjorklund A, 2000, BRAIN RES, V886, P82, DOI 10.1016/S0006-8993(00)02915-2
   Bye CR, 2012, EXP NEUROL, V236, P58, DOI 10.1016/j.expneurol.2012.04.002
   ChoiLundberg DL, 1997, SCIENCE, V275, P838, DOI 10.1126/science.275.5301.838
   Geral Claire, 2013, Pharmaceutics, V5, P127, DOI 10.3390/pharmaceutics5010127
   Gersbach CA, 2007, BIOMATERIALS, V28, P5121, DOI 10.1016/j.biomaterials.2007.07.047
   Horne MK, 2010, STEM CELLS DEV, V19, P843, DOI 10.1089/scd.2009.0158
   Jang JH, 2011, MOL THER, V19, P1407, DOI 10.1038/mt.2011.111
   Kauhausen J, 2013, J PHYSIOL-LONDON, V591, P77, DOI 10.1113/jphysiol.2012.243063
   Kidd ME, 2012, J CONTROL RELEASE, V157, P80, DOI 10.1016/j.jconrel.2011.08.036
   Kim TG, 2012, ADV FUNCT MATER, V22, P2446, DOI 10.1002/adfm.201103083
   Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742
   Kreppel F, 2008, MOL THER, V16, P16, DOI 10.1038/sj.mt.6300321
   Lee GK, 2005, BIOTECHNOL BIOENG, V92, P24, DOI 10.1002/bit.20562
   Lentz TB, 2012, NEUROBIOL DIS, V48, P179, DOI 10.1016/j.nbd.2011.09.014
   Levenberg S, 2005, TISSUE ENG, V11, P506, DOI 10.1089/ten.2005.11.506
   Li R, 2015, RSC ADV, V5, P301, DOI 10.1039/c4ra13266a
   Matthews CB, 1999, GENE THER, V6, P1558, DOI 10.1038/sj.gt.3300978
   Modepalli VN, 2014, BIOPOLYMERS, V102, P197, DOI 10.1002/bip.22469
   Nisbet DR, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-011-0002-x
   Oliveira SLB, 2013, CYTOM PART A, V83A, P76, DOI 10.1002/cyto.a.22161
   Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685
   Rey-Rico A, 2015, ACTA BIOMATER, V18, P118, DOI 10.1016/j.actbio.2015.02.013
   Rodriguez AL, 2014, J MATER CHEM B, V2, P7771, DOI 10.1039/c4tb01391c
   Rodriguez A. L., 2012, STEM CELLS CANC STEM, V4, P97
   Rodriguez AL, 2013, SOFT MATTER, V9, P3915, DOI 10.1039/c3sm27758e
   Schek RM, 2004, MOL THER, V9, P130, DOI 10.1016/j.ymthe.2003.10.002
   Shin SJ, 2010, BIOMATERIALS, V31, P4353, DOI 10.1016/j.biomaterials.2010.02.013
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Smith AM, 2008, ADV MATER, V20, P37, DOI 10.1002/adma.200701221
   Turner P, 2007, BIOTECHNOL PROGR, V23, P423, DOI 10.1021/bp0600177
   Wang K, 2015, ADV FUNCT MATER, V25, P3380, DOI 10.1002/adfm.201403921
   Wang TY, 2012, BIOMATERIALS, V33, P9188, DOI 10.1016/j.biomaterials.2012.09.013
   Wei GB, 2008, ADV FUNCT MATER, V18, P3568, DOI 10.1002/adfm.200800662
   Wu EC, 2012, ADV FUNCT MATER, V22, P456, DOI 10.1002/adfm.201101905
   Zhou M, 2009, BIOMATERIALS, V30, P2523, DOI 10.1016/j.biomaterials.2009.01.010
NR 37
TC 11
Z9 12
U1 4
U2 31
PU TSINGHUA UNIV PRESS
PI BEIJING
PA TSINGHUA UNIV, RM A703, XUEYAN BLDG, BEIJING, 10084, PEOPLES R CHINA
SN 1998-0124
EI 1998-0000
J9 NANO RES
JI Nano Res.
PD MAR
PY 2016
VL 9
IS 3
BP 674
EP 684
DI 10.1007/s12274-015-0946-0
PG 11
WC Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science,
   Multidisciplinary; Physics, Applied
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA DG1AI
UT WOS:000371797000008
DA 2018-10-19
ER

PT J
AU Li, WY
   Zheng, YF
   Zhao, XH
   Ge, YJ
   Chen, T
   Liu, YS
   Zhou, YS
AF Li, Wenyue
   Zheng, Yunfei
   Zhao, Xianghui
   Ge, Yanjun
   Chen, Tong
   Liu, Yunsong
   Zhou, Yongsheng
TI Osteoinductive Effects of Free and Immobilized Bone Forming Peptide-1 on
   Human Adipose-Derived Stem Cells
SO PLOS ONE
LA English
DT Article
ID MORPHOGENETIC PROTEINS; IN-VITRO; TISSUE; REGENERATION; MARROW;
   DEGRADATION; INDUCTION; SCAFFOLDS; PRODOMAIN; ADHESION
AB Most synthetic polymeric materials currently used for bone tissue engineering lack specific signals through which cells can identify and interact with the surface, resulting in incompatibility and compromised osteogenic activity. Soluble inductive factors also have issues including a short half-live in vivo. Bone forming peptide-1 is a truncated peptide from the immature form of bone morphogenetic protein-7 (BMP-7) that displays higher osteogenic activity than full-length, mature BMP-7. In this study, we used a mussel-inspired immobilization strategy mediated by polymerization of dopamine to introduce recently discovered stimulators of bone forming peptide-1 (BFP-1) onto the surface of poly-lactic-co-glycolic acid (PLGA) substrate to form a biomaterial that overcomes these challenges. Human adipose-derived stem cells (hASCs), being abundant and easy accessible, were used to test the osteogenic activity of BFP-1 and the novel biomaterial. Under osteoinductive conditions, cells treated with both BFP-1 alone and BFP-1-coated biomaterials displayed elevated expression of the osteogenic markers alkaline phosphatase (ALP), osteocalcin (OC), and RUNX2. Furthermore, hASCs associated with poly-dopamine-assisted BFP-1-immobilized PLGA (pDA-BFP-1-PLGA) scaffolds promoted in vivo bone formation in nude mice. Our novel materials may hold great promise for future bone tissue engineering applications.
C1 [Li, Wenyue; Zhao, Xianghui; Ge, Yanjun; Chen, Tong; Liu, Yunsong; Zhou, Yongsheng] Peking Univ, Dept Prosthodont, Sch & Hosp Stomatol, Beijing 100871, Peoples R China.
   [Zheng, Yunfei] Peking Univ, Dept Oral & Maxillofacial Surg, Sch & Hosp Stomatol, Beijing 100871, Peoples R China.
   [Zhou, Yongsheng] Peking Univ, Natl Engn Lab Digital & Mat Technol Stomatol, Sch & Hosp Stomatol, Beijing 100871, Peoples R China.
RP Liu, YS; Zhou, YS (reprint author), Peking Univ, Dept Prosthodont, Sch & Hosp Stomatol, Beijing 100871, Peoples R China.; Zhou, YS (reprint author), Peking Univ, Natl Engn Lab Digital & Mat Technol Stomatol, Sch & Hosp Stomatol, Beijing 100871, Peoples R China.
EM kqliuyunsong@163.com; kqzhouysh@hsc.pku.edu.cn
FU National Natural Science Foundation of China [2011/81170937,
   2013/81400484]; Ministry of Education of China [NCET-11-0026]
FX This work was supported by the National Natural Science Foundation of
   China (2011/81170937 to YZhou, 2013/81400484 to YG),
   (http://www.nsfc.gov.cn/Portal0/default152.htm) and the Program for New
   Century Excellent Talents in University from Ministry of Education of
   China (NCET-11-0026 to YZhou),
   (http://www.moe.edu.cn/publicfiles/business/htmlfiles/moe/A16/index.html
   ). The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Al-Nbaheen M, 2013, STEM CELL REV REP, V9, P32, DOI 10.1007/s12015-012-9365-8
   Ball V, 2012, J COLLOID INTERF SCI, V386, P366, DOI 10.1016/j.jcis.2012.07.030
   Balmayor ER, 2015, ADV DRUG DELIVER REV, V94, P13, DOI 10.1016/j.addr.2015.04.022
   BANG G, 1967, ARCH SURG-CHICAGO, V94, P781
   Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890
   Chrastil J, 2013, SPINE, V38, pE1020, DOI 10.1097/BRS.0b013e3182982f8e
   De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150
   Dick A, 2000, DEVELOPMENT, V127, P343
   Dormer NH, 2013, MAT SCI ENG C-MATER, V33, P4343, DOI 10.1016/j.msec.2013.06.026
   Ducy P, 2000, KIDNEY INT, V57, P2207, DOI 10.1046/j.1523-1755.2000.00081.x
   Gao X, 2015, INT J NANOMED, V10, P7109, DOI 10.2147/IJN.S94045
   Garcia-Gareta E, 2015, BONE, V81, P112, DOI 10.1016/j.bone.2015.07.007
   Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0
   Kim HK, 2012, BIOMATERIALS, V33, P7057, DOI 10.1016/j.biomaterials.2012.06.036
   Ko E, 2013, BIOMACROMOLECULES, V14, P3202, DOI 10.1021/bm4008343
   Ku SH, 2010, BIOMATERIALS, V31, P2535, DOI 10.1016/j.biomaterials.2009.12.020
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee JS, 2014, MACROMOL BIOSCI, V14, P1181, DOI 10.1002/mabi.201400052
   Lee YJ, 2013, BIOMATERIALS, V34, P5059, DOI 10.1016/j.biomaterials.2013.03.051
   Liu YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056002
   Lo KWH, 2012, ADV DRUG DELIVER REV, V64, P1277, DOI 10.1016/j.addr.2012.03.014
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Lv LW, 2015, BIOMATERIALS, V39, P193, DOI 10.1016/j.biomaterials.2014.11.002
   Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076
   Peroni D, 2008, EXP CELL RES, V314, P603, DOI 10.1016/j.yexcr.2007.10.007
   Poh CK, 2010, BIOMATERIALS, V31, P1578, DOI 10.1016/j.biomaterials.2009.11.042
   Puetzer JL, 2010, TISSUE ENG PART B-RE, V16, P435, DOI [10.1089/ten.teb.2009.0705, 10.1089/ten.TEB.2009.0705]
   Roach P, 2010, SURF SCI REP, V65, P145, DOI 10.1016/j.surfrep.2010.07.001
   Ronziere MC, 2010, BIO-MED MATER ENG, V20, P145, DOI 10.3233/BME-2010-0626
   Sena P, 2012, HISTOL HISTOPATHOL, V27, P485, DOI 10.14670/HH-27.485
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Ventre M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0687
   Yan J, 2015, CELL MOL BIOENG, V8, P151, DOI 10.1007/s12195-014-0364-5
   Yang K, 2012, BIOMATERIALS, V33, P6952, DOI 10.1016/j.biomaterials.2012.06.067
   Yin WN, 2014, J MATER CHEM B, V2, P8434, DOI 10.1039/c4tb01548g
   Zhang H, 2014, BIOMATERIALS, V35, P711, DOI 10.1016/j.biomaterials.2013.10.017
NR 36
TC 5
Z9 5
U1 2
U2 20
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 1
PY 2016
VL 11
IS 3
AR e0150294
DI 10.1371/journal.pone.0150294
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DF5ZW
UT WOS:000371434500126
PM 26930062
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Peric, D
   Bartley, PA
   Davis, L
   Uzer, AU
   Gurer, C
AF Peric, Dunja
   Bartley, Paul A.
   Davis, Lawrence
   Uzer, Ali Ulvi
   Gurer, Cahit
TI Assessment of sand stabilization potential of a plant-derived biomass
SO SCIENCE AND ENGINEERING OF COMPOSITE MATERIALS
LA English
DT Article
DE biomaterial; coproduct; sand; shear strength; stability; unpaved roads
AB Lignin is a coproduct of biofuel and paper industries, which exhibits binding qualities when mixed with water. Lignin is an ideal candidate for a sustainable stabilization of unpaved roads. To this end, an experimental program was devised and carried out to quantify effects of lignin on compaction and early age shear strength behaviors of sand. Samples were prepared by mixing a particular type of coproduct called calcium lignosulfonate (CaL) with sand and water. Based on the extensive analyses of six series of strength tests, it was found that a normalized cohesion increased with an increasing normalized areas ratio. Normalizations were carried out by dividing the cohesion and area ratio by gravimetric CaL content whereby the area ratio was obtained by dividing the portion of the cross-sectional area occupied with lignosulfonate-water (CaL-W) paste by the total cross-sectional area. While the increase in the normalized cohesion eventually leveled out, the cohesion peaked at 6% of CaL. Thus, sand-CaL-water (S-CaL-W) mixes sustained larger shear stresses than dry sand for a range of normal stresses below the limiting normal stress. Consequently, the early age behavior indicates that adding CaL-W to sand is clearly beneficial in the near-surface applications in dry sand.
C1 [Gurer, Cahit] Afyon Kocatepe Univ, Fac Engn, Dept Civil Engn, ANS Campus, TR-03200 Afyon, Turkey.
   [Peric, Dunja] Kansas State Univ, Coll Engn, Dept Civil Engn, Manhattan, KS 66506 USA.
   [Bartley, Paul A.] Union Pacific Railroad, Denver, CO 80221 USA.
   [Davis, Lawrence] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA.
   [Uzer, Ali Ulvi] Selcuk Univ, Tech Sci Coll, Dept Construct, TR-42075 Konya, Turkey.
RP Gurer, C (reprint author), Afyon Kocatepe Univ, Fac Engn, Dept Civil Engn, ANS Campus, TR-03200 Afyon, Turkey.
EM cgurer@aku.edu.tr
RI Peric, Dunja/G-6411-2016
OI Peric, Dunja/0000-0002-8385-4487
CR Adams JW, 1988, ENV EFFECTS APPL LIG
   [Anonymous], D2487 ASTM
   [Anonymous], 2006, ANN BOOK ASTM STAND
   Bartley PA, 2009, THESIS KANSAS STATE
   Ceylan H, 2010, J T RES BOARD, V2186, P130
   DCN Digital Media, 2011, DAILY COMMERCIA 1018
   Fox C, 2006, THESIS U IDAHO
   Gopalakrishnan R, 2010, TR582 IHRB IOW STAT
   Kestler M. A., 2009, STABILIZATION SELECT
   Lignotech Borregaard, 2008, NORL POWD PROD DESCR
   Ragauskas A, 2011, BASICS KRAFT PULPING
   Santoni R. L., 2002, TRANSPORT RES REC, V1787, P61
   Stapanian M. A., 1986, INT J ENVIRON STUD, V27, P45
   Surdahl R, 2008, FEDERAL HIGHWAY ADM
   Surdahl R, 2005, FEDERAL HIGHWAY ADM
   Wang HJ, 2005, J ENVIRON SCI-CHINA, V17, P650
   Woll JH, 2008, FHWACFLTD08005
NR 17
TC 3
Z9 3
U1 0
U2 4
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0792-1233
EI 2191-0359
J9 SCI ENG COMPOS MATER
JI Sci. Eng. Compos. Mater.
PD MAR
PY 2016
VL 23
IS 2
BP 227
EP 236
DI 10.1515/secm-2014-0061
PG 10
WC Materials Science, Composites
SC Materials Science
GA DG2EH
UT WOS:000371878600011
DA 2018-10-19
ER

PT J
AU Jozala, AF
   de Lencastre-Novaes, LC
   Lopes, AM
   Santos-Ebinuma, VD
   Mazzola, PG
   Pessoa, A
   Grotto, D
   Gerenutti, M
   Chaud, MV
AF Jozala, Angela Faustino
   de Lencastre-Novaes, Leticia Celia
   Lopes, Andre Moreni
   Santos-Ebinuma, Valeria de Carvalho
   Mazzola, Priscila Gava
   Pessoa-, Adalberto, Jr.
   Grotto, Denise
   Gerenutti, Marli
   Chaud, Marco Vinicius
TI Bacterial nanocellulose production and application: a 10-year overview
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Review
DE Bacterial nanocellulose; Biopolymers; Biomaterial; Bioprocess;
   Bioproducts; Fermentation process; Gluconacetobacter xylinus
ID DIFFERENT CARBON-SOURCES; GLUCONACETOBACTER-XYLINUS; CELLULOSE
   PRODUCTION; MICROBIAL CELLULOSE; ACETOBACTER-XYLINUM; AGITATED CULTURE;
   WASTE-WATER; COMPOSITES; DELIVERY; NANOPARTICLES
AB Production of bacterial nanocellulose (BNC) is becoming increasingly popular owing to its environmentally friendly properties. Based on this benefit of BNC production, researchers have also begun to examine the capacity for cellulose production through microbial hosts. Indeed, several research groups have developed processes for BNC production, and many studies have been published to date, with the goal of developing methods for large-scale production. During BNC bioproduction, the culture medium represents approximately 30 % of the total cost. Therefore, one important and challenging aspect of the fermentation process is identification of a new cost-effective culture medium that can facilitate the production of high yields within short periods of time, thereby improving BNC production and permitting application of BNC in the biotechnological, medical, pharmaceutical, and food industries. In this review, we addressed different aspects of BNC production, including types of fermentation processes and culture media, with the aim of demonstrating the importance of these parameters.
C1 [Jozala, Angela Faustino; Grotto, Denise; Gerenutti, Marli; Chaud, Marco Vinicius] Univ Sorocaba UNISO, Dept Technol & Environm Proc, Sorocaba, SP, Brazil.
   [de Lencastre-Novaes, Leticia Celia; Mazzola, Priscila Gava] Univ Campinas UNICAMP, Fac Pharmaceut Sci, Campinas, SP, Brazil.
   [Lopes, Andre Moreni; Pessoa-, Adalberto, Jr.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Biochem & Pharmaceut Technol, Sao Paulo, Brazil.
   [Santos-Ebinuma, Valeria de Carvalho] Univ Estadual Paulista UNESP, Sch Pharmaceut Sci, Dept Bioproc & Biotechnol, Araraquara, SP, Brazil.
RP Jozala, AF (reprint author), Univ Sorocaba UNISO, Dept Technol & Environm Proc, Sorocaba, SP, Brazil.
EM angela.jozala@prof.uniso.br
RI Lopes, Andre/E-9058-2013; Jozala, Angela/D-2373-2013; Pessoa-Junior,
   Adalberto/B-7963-2012; C. Santos-Ebinuma, Valeria/J-3659-2014
OI Lopes, Andre/0000-0002-3570-2470; Jozala, Angela/0000-0002-3763-5451;
   Pessoa-Junior, Adalberto/0000-0002-5268-8690; Santos-Ebinuma,
   Valeria/0000-0002-6666-6695
FU Coordination for Higher Level Graduate Improvements (CAPES/Brazil);
   National Council for Scientific and Technological Development
   (CNPq/Brazil); State of Sao Paulo Research Foundation (FAPESP/Brazil)
   [2009/14897-7, 2013/08617-7]
FX The authors received grants from the Coordination for Higher Level
   Graduate Improvements (CAPES/Brazil), National Council for Scientific
   and Technological Development (CNPq/Brazil), and State of Sao Paulo
   Research Foundation (FAPESP/Brazil, process numbers 2009/14897-7 and
   2013/08617-7).
CR Akhlaghi SP, 2013, CELLULOSE, V20, P1747, DOI 10.1007/s10570-013-9954-y
   Almeida IF, 2014, EUR J PHARM BIOPHARM, V86, P332, DOI 10.1016/j.ejpb.2013.08.008
   Ashjaran A, 2013, J TEXT I, V104, P121, DOI 10.1080/00405000.2012.703796
   Backdahl H, 2011, MAT SCI ENG C-MATER, V31, P14, DOI 10.1016/j.msec.2010.07.010
   Basmaji P, 2014, J BIOMATER TISS ENG, V4, P59, DOI 10.1166/jbt.2014.1133
   Basta AH, 2009, J APPL MICROBIOL, V107, P2098, DOI 10.1111/j.1365-2672.2009.04467.x
   Cacicedo ML, 2015, J APPL BIOMED, V13, P239, DOI 10.1016/j.jab.2015.03.004
   Cai Z, 2010, CELLULOSE, V17, P83, DOI 10.1007/s10570-009-9362-5
   Cakar F, 2014, CARBOHYD POLYM, V106, P7, DOI 10.1016/j.carbpol.2014.01.103
   Chawla PR, 2009, FOOD TECHNOL BIOTECH, V47, P107
   Conley K, 2016, CARBOHYD POLYM, V135, P285, DOI 10.1016/j.carbpol.2015.08.029
   Czaja W, 2004, CELLULOSE, V11, P403, DOI 10.1023/B:CELL.0000046412.11983.61
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   de Azeredo HMC, 2013, TRENDS FOOD SCI TECH, V30, P56, DOI 10.1016/j.tifs.2012.11.006
   de Olyveira GM, 2013, J BIOMATER TISS ENG, V3, P227, DOI 10.1166/jbt.2013.1079
   Donini IAN, 2010, ECLET QUIM, V35, P165, DOI [DOI 10.1590/S0100-46702010000400021, 10.1590/50100-46702010000400021]
   Fu LN, 2013, CARBOHYD POLYM, V92, P1432, DOI 10.1016/j.carbpol.2012.10.071
   Gomes FP, 2013, BIOMASS BIOENERG, V55, P205, DOI 10.1016/j.biombioe.2013.02.004
   Hu WL, 2014, CARBOHYD POLYM, V101, P1043, DOI 10.1016/j.carbpol.2013.09.102
   Hu Y, 2010, LETT APPL MICROBIOL, V51, P109, DOI 10.1111/j.1472-765X.2010.02866.x
   Huang C, 2016, CARBOHYD POLYM, V136, P198, DOI 10.1016/j.carbpol.2015.09.043
   Jeon S, 2014, CURR APPL PHYS, V14, P1621, DOI 10.1016/j.cap.2014.07.010
   Jozala AF, 2015, APPL MICROBIOL BIOT, V99, P1181, DOI 10.1007/s00253-014-6232-3
   Jung HI, 2010, APPL BIOCHEM BIOTECH, V162, P486, DOI 10.1007/s12010-009-8759-9
   Keshk S, 2006, ENZYME MICROB TECH, V40, P4, DOI 10.1016/j.enzmictec.2006.07.037
   Keshk S.M., 2014, J BIOPROCESS BIOTECH, V4, P150, DOI DOI 10.4172/2155-9821.1000150
   Kim SS, 2017, SAUDI J BIOL SCI, V24, P314, DOI 10.1016/j.sjbs.2015.09.031
   Kiziltas EE, 2015, CARBOHYD POLYM, V129, P148, DOI 10.1016/j.carbpol.2015.04.039
   Kiziltas EE, 2015, CARBOHYD POLYM, V124, P131, DOI 10.1016/j.carbpol.2015.01.036
   Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273
   Kralisch D, 2010, BIOTECHNOL BIOENG, V105, P740, DOI 10.1002/bit.22579
   Krystynowicz A, 2002, J IND MICROBIOL BIOT, V29, P189, DOI 10.1038/sj.jim.7000303
   Kuo CH, 2016, FOOD HYDROCOLLOID, V53, P98, DOI 10.1016/j.foodhyd.2014.12.034
   Kurosumi A, 2009, CARBOHYD POLYM, V76, P333, DOI 10.1016/j.carbpol.2008.11.009
   Lee KY, 2014, MACROMOL BIOSCI, V14, P10, DOI 10.1002/mabi.201300298
   Li Z, 2015, CARBOHYD POLYM, V120, P115, DOI 10.1016/j.carbpol.2014.11.061
   Lin DH, 2014, BIORESOURCE TECHNOL, V151, P113, DOI 10.1016/j.biortech.2013.10.052
   Lin N, 2014, EUR POLYM J, V59, P302, DOI 10.1016/j.eurpolymj.2014.07.025
   Lu ZG, 2011, WORLD J MICROB BIOT, V27, P2281, DOI 10.1007/s11274-011-0692-8
   Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002
   Martinez-Sanz M, 2016, J APPL POLYM SCI, V133, DOI 10.1002/app.42486
   Mautner A, 2015, REACT FUNCT POLYM, V86, P209, DOI 10.1016/j.reactfunctpolym.2014.09.014
   Mikkelsen D, 2009, J APPL MICROBIOL, V107, P576, DOI 10.1111/j.1365-2672.2009.04226.x
   Mohammadkazemi F, 2015, CARBOHYD POLYM, V117, P518, DOI 10.1016/j.carbpol.2014.10.008
   Muller A, 2013, J PHARM SCI-US, V102, P579, DOI 10.1002/jps.23385
   Nimeskern L, 2013, J MECH BEHAV BIOMED, V22, P12, DOI 10.1016/j.jmbbm.2013.03.005
   Numata Y, 2015, INT J PHARMACEUT, V486, P217, DOI 10.1016/j.ijpharm.2015.03.068
   Numata Y, 2015, MAT SCI ENG C-MATER, V47, P57, DOI 10.1016/j.msec.2014.11.026
   Barud HGO, 2015, CARBOHYD POLYM, V128, P41, DOI 10.1016/j.carbpol.2015.04.007
   Padmanaban S, 2015, 3 BIOTECH, V5, P1067, DOI 10.1007/s13205-015-0308-3
   Rajwade JM, 2015, APPL MICROBIOL BIOT, V99, P2491, DOI 10.1007/s00253-015-6426-3
   Rehim SA, 2014, HAND CLIN, V30, P239, DOI 10.1016/j.hcl.2014.02.001
   Ruka DR, 2012, CARBOHYD POLYM, V89, P613, DOI 10.1016/j.carbpol.2012.03.059
   Santos-Ebinuma VC, 2013, BIOTECHNOL PROGR, V29, P778, DOI 10.1002/btpr.1720
   SCHRAMM M, 1954, J GEN MICROBIOL, V11, P123, DOI 10.1099/00221287-11-1-123
   Shah N, 2013, CARBOHYD POLYM, V98, P1585, DOI 10.1016/j.carbpol.2013.08.018
   Shi ZJ, 2014, FOOD HYDROCOLLOID, V35, P539, DOI 10.1016/j.foodhyd.2013.07.012
   Tanskul S, 2013, CARBOHYD POLYM, V92, P421, DOI 10.1016/j.carbpol.2012.09.017
   Thompson DN, 2001, APPL BIOCHEM BIOTECH, V91-3, P503, DOI 10.1385/ABAB:91-93:1-9:503
   Trovatti E, 2011, CARBOHYD POLYM, V86, P1417, DOI 10.1016/j.carbpol.2011.06.046
   Tyagi N, 2016, J CLEAN PROD, V112, P71, DOI 10.1016/j.jclepro.2015.07.054
   Wu JM, 2012, CARBOHYD POLYM, V90, P116, DOI 10.1016/j.carbpol.2012.05.003
   Wu SC, 2015, J BIOSCI BIOENG, V120, P444, DOI 10.1016/j.jbiosc.2015.02.018
   Zhang S, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-62
NR 64
TC 35
Z9 36
U1 17
U2 157
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0175-7598
EI 1432-0614
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
PD MAR
PY 2016
VL 100
IS 5
BP 2063
EP 2072
DI 10.1007/s00253-015-7243-4
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DF3KT
UT WOS:000371243500003
PM 26743657
DA 2018-10-19
ER

PT J
AU Aminabadi, NA
   Huang, B
   Samiei, M
   Agheli, S
   Jamali, Z
   Shirazi, S
AF Aminabadi, N. A.
   Huang, B.
   Samiei, M.
   Agheli, S.
   Jamali, Z.
   Shirazi, Sajjad
TI A Randomized Trial Using 3Mixtatin Compared to MTA in Primary Molars
   with Inflammatory Root Resorption: A Novel Endodontic Biomaterial
SO JOURNAL OF CLINICAL PEDIATRIC DENTISTRY
LA English
DT Article
DE 3Mix; Primary teeth; Regenerative treatment; Root resorption
ID MINERAL TRIOXIDE AGGREGATE; FURCAL PERFORATION; PERMANENT TEETH;
   DENTAL-PULP; CASE SERIES; IN-VITRO; SIMVASTATIN; REPAIR; RATS;
   DIFFERENTIATION
AB Objectives: Novel methods for preserving prima?), teeth can help to maintain their developmental, esthetic, and functional capabilities. The aim of this study was to assess the success of the repair of bony defects, caused by pre-treatment perforations; with a mixture of three antibiotics combined with simvastatin (3Mixtatin) compared to MTA in hopeless primary molars. Study design: In this randomized clinical trial, 80 teeth from 65 healthy children aged 3-6 years with interradicular or periapical root resorption and/or perforation in primary molars were treated either with 3Mixtatin or MTA before conventional pulpectomy and restoration. The subjects were followed up clinically and radiographically for 4, 6, 12 and 24 months after pulp treatment to evaluate and compare the healing process. The data were compared using chi-square test at a significance level of 0.05. Results: By the end of 24 months in 3Mixtatin group, 31 (96.8%) teeth revealed no clinical signs or symptoms with arrested resorption progress in radiographs. In MTA group, clinical signs and symptoms including pain, mobility and sinus tract were observed in 18 (48.6%) teeth with cessation of root/interradicular radiolucency in 7 (18.9%) teeth without bone repair. Conclusions: Radiographic and clinical healing occurred more successfully following 3Mixtatin treatment compared to treatment with MTA, it may lead to a paradigm shift in the pulpal treatment of primary teeth in the future.
C1 [Aminabadi, N. A.] Tabriz Univ Med Sci, Dept Pediat Dent, Fac Dent, Daneshgah St,Golgasht St, Tabriz, Iran.
   [Huang, B.] Charles Sturt Univ, Dept Pediat Dent, Sch Dent & Hlth Sci, Bathurst, NSW 2795, Australia.
   [Samiei, M.] Tabriz Univ Med Sci, Fac Dent, Dept Endodont, Tabriz, Iran.
   [Agheli, S.] Tabriz Univ Med Sci, Fac Dent, Dept Paediat Dent, Tabriz, Iran.
   [Jamali, Z.] Tabriz Univ Med Sci, Fac Dent, Dept Oral Sci, Tabriz, Iran.
   [Shirazi, Sajjad] Tabriz Univ Med Sci, Dent & Periodontal Res Ctr, Fac Dent, Tabriz, Iran.
RP Aminabadi, NA (reprint author), Tabriz Univ Med Sci, Dept Pediat Dent, Fac Dent, Daneshgah St,Golgasht St, Tabriz, Iran.
EM aslaminabadi@Gmail.com
RI jamali, zahra/F-6325-2017; Asl Aminabadi, Naser/F-6669-2017; Shirazi,
   Sajjad/L-7133-2017; Huang, Boyen/I-7768-2014; aminabadi,
   naser/L-5731-2017
OI jamali, zahra/0000-0002-9214-0574; Asl Aminabadi,
   Naser/0000-0002-6624-4994; Shirazi, Sajjad/0000-0002-3996-6772; Huang,
   Boyen/0000-0002-1246-7447; aminabadi, naser/0000-0002-6624-4994
CR American Academy of Pediatric Dentistry, 2013, PEDIAT DENT, V35, P235
   ANDO N, 1990, INT ENDOD J, V23, P20, DOI 10.1111/j.1365-2591.1990.tb00798.x
   Ayukawa Y, 2004, CLIN ORAL IMPLAN RES, V15, P346, DOI 10.1111/j.1600-0501.2004.01015.x
   Ayukawa Y, 2009, ORAL SURG ORAL MED O, V107, P336, DOI 10.1016/j.tripleo.2008.07.013
   Barriesbi-Nusair KM, 2006, J ENDODONT, V32, P731, DOI 10.1016/j.joen.2005.12.008
   Bodem O, 2004, Int J Paediatr Dent, V14, P376, DOI 10.1111/j.1365-263X.2004.00547.x
   Cordeiro MMR, 2011, INT J PAEDIATR DENT, V21, P361, DOI 10.1111/j.1365-263X.2011.01132.x
   Dandashi Moutaz B., 1993, Pediatric Dentistry, V15, P254
   Dombrecht EJ, 2007, CLIN EXP RHEUMATOL, V25, P534
   FORD TRP, 1995, ORAL SURG ORAL MED O, V79, P756
   HOSHINO E, 1992, INT ENDOD J, V25, P2, DOI 10.1111/j.1365-2591.1992.tb00941.x
   Jepsen S, 1997, J ENDODONT, V23, P378, DOI 10.1016/S0099-2399(97)80187-2
   Jung IY, 2008, J ENDODONT, V34, P876, DOI 10.1016/j.joen.2008.03.023
   Kamada A, 2005, J ORAL TISSUE ENG, V3, P169
   Maciel-Oliveira N, 2011, ORAL SURG ORAL MED O, V112, P170, DOI 10.1016/j.tripleo.2010.08.027
   Maroto M, 2007, AM J DENT, V20, P283
   Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946
   NAKASHIMA M, 1989, ENDOD DENT TRAUMATOL, V5, P279
   Nakashima M, 2005, J ENDODONT, V31, P711, DOI 10.1097/01.don.0000164138.49923.e5
   Nakornchai S, 2010, INT J PAEDIATR DENT, V20, P214, DOI 10.1111/j.1365-263X.2010.01044.x
   Ng FK, 2008, EUR ARCH PAEDIATR DE, V9, P58, DOI 10.1007/BF03262612
   Okamoto Y, 2009, J ENDODONT, V35, P367, DOI 10.1016/j.joen.2008.11.024
   Oliveira Thais M, 2008, J Dent Child (Chic), V75, P188
   Oxlund H, 2001, CALCIFIED TISSUE INT, V69, P299, DOI 10.1007/s00223-001-2027-5
   Pace R, 2008, J ENDODONT, V34, P1130, DOI 10.1016/i.joen.2008.05.019
   RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022
   Roberts HW, 2008, DENT MATER, V24, P149, DOI 10.1016/j.dental.2007.04.007
   Sakoda K, 2006, J DENT RES, V85, P520, DOI 10.1177/154405910608500608
   SATO T, 1992, Microbial Ecology in Health and Disease, V5, P171
   Seto H, 2008, J PERIODONTAL RES, V43, P261, DOI 10.1111/j.1600-0765.2007.01024.x
   Silveira CMM, 2008, J CAN DENT ASSOC, V74, P729
   Takushige T, 2004, INT ENDOD J, V37, P132, DOI 10.1111/j.0143-2885.2004.00771.x
   Takushige T, 2009, J LSTR THER, V8, P3
   Tavassoli-Hojjati S, 2014, PEDIAT DENT, V36, P23
   Torabinejad M, 1999, J ENDODONT, V25, P197, DOI 10.1016/S0099-2399(99)80142-3
   Unal Gul Celik, 2010, Eur J Dent, V4, P475
   Yokoyama T, 2004, ATHEROSCLEROSIS, V174, P253, DOI 10.1016/j.atherosclerosis.2004.01.039
   Yoshinari M, 2006, BIOMED RES-TOKYO, V27, P29, DOI 10.2220/biomedres.27.29
NR 38
TC 5
Z9 5
U1 1
U2 18
PU JOURNAL PEDODONTICS INC
PI BIRMINGHAM
PA 5724 HIGHWAY 280 EAST, BIRMINGHAM, AL 35242 USA
SN 1053-4628
EI 1557-5268
J9 J CLIN PEDIATR DENT
JI J. Clin. Pediatr. Dent.
PD SPR
PY 2016
VL 40
IS 2
BP 95
EP 102
DI 10.17796/1053-4628-40.2.95
PG 8
WC Dentistry, Oral Surgery & Medicine; Pediatrics
SC Dentistry, Oral Surgery & Medicine; Pediatrics
GA DF6DJ
UT WOS:000371445800001
PM 26950808
DA 2018-10-19
ER

PT J
AU Tang, QZ
   Desai, TA
AF Tang, Qizhi
   Desai, Tejal A.
TI Approaching a cure for type 1 diabetes
SO NATURE MEDICINE
LA English
DT Editorial Material
ID EMBRYONIC STEM-CELLS; IN-VITRO; BETA-CELLS
AB A study has demonstrated that transplanting human embryonic stem cell derived, insulin-producing cells shielded in capsules made with an optimized biomaterial can achieve long-term cure of diabetes in mice without the need for any immunosuppression.
C1 [Tang, Qizhi] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA.
   [Desai, Tejal A.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.
RP Tang, QZ (reprint author), Univ Calif San Francisco, Dept Surg, San Francisco, CA USA.
EM Qizhi.Tang@ucsf.edu
CR Andersson Trojer M., 2013, J CHEM, V2013
   Bratlie KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010032
   D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259
   Jacobs-Tulleneers-Thevissen D, 2013, DIABETOLOGIA, V56, P1605, DOI 10.1007/s00125-013-2906-0
   Khosravi-Maharlooei M, 2015, EUR J ENDOCRINOL, V173, pR165, DOI 10.1530/EJE-15-0094
   Naujok O, 2011, MOL THER, V19, P1759, DOI 10.1038/mt.2011.165
   Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040
   Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033
   Russ HA, 2015, EMBO J, V34, P1759, DOI 10.15252/embj.201591058
   Scharp DW, 2014, ADV DRUG DELIVER REV, V67-68, P35, DOI 10.1016/j.addr.2013.07.018
   Vegas A.J., 2016, NAT BIOTECHNOL, V34, P306
   Vegas AJ, 2016, NAT MED, V22, P306, DOI 10.1038/nm.4030
NR 12
TC 1
Z9 1
U1 2
U2 14
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD MAR
PY 2016
VL 22
IS 3
BP 236
EP 237
DI 10.1038/nm.4060
PG 2
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA DF6DC
UT WOS:000371445100009
PM 26937617
DA 2018-10-19
ER

PT J
AU Trzeciak, T
   Richter, M
   Suchorska, W
   Augustyniak, E
   Lach, M
   Kaczmarek, M
   Kaczmarczyk, J
AF Trzeciak, Tomasz
   Richter, Magdalena
   Suchorska, Wiktoria
   Augustyniak, Ewelina
   Lach, Michal
   Kaczmarek, Malgorzata
   Kaczmarczyk, Jacek
TI Application of cell and biomaterial-based tissue engineering methods in
   the treatment of cartilage, menisci and ligament injuries
SO INTERNATIONAL ORTHOPAEDICS
LA English
DT Review
DE Biodegradation; Biocompatible; Cartilage tissue engineering; Collagen;
   Fibrin; Scaffold; Silk
ID MESENCHYMAL STEM-CELLS; ANTERIOR CRUCIATE LIGAMENT; AUTOLOGOUS
   CHONDROCYTE IMPLANTATION; ARTICULAR-CARTILAGE; BONE-MARROW; IN-VIVO;
   OSTEOCHONDRAL DEFECTS; COLLAGEN MENISCUS; GENE-EXPRESSION; CHONDROGENIC
   DIFFERENTIATION
AB Over 20 years ago it was realized that the traditional methods of the treatment of injuries to joint components: cartilage, menisci and ligaments, did not give satisfactory results and so there is a need of employing novel, more effective therapeutic techniques. Recent advances in molecular biology, biotechnology and polymer science have led to both the experimental and clinical application of various cell types, adapting their culture conditions in order to ensure a directed differentiation of the cells into a desired cell type, and employing non-toxic and non-immunogenic biomaterial in the treatment of knee joint injuries. In the present review the current state of knowledge regarding novel cell sources, in vitro conditions of cell culture and major important biomaterials, both natural and synthetic, used in cartilage, meniscus and ligament repair by tissue engineering techniques are described, and the assets and drawbacks of their clinical application are critically evaluated.
C1 [Trzeciak, Tomasz; Richter, Magdalena; Kaczmarek, Malgorzata; Kaczmarczyk, Jacek] Poznan Univ Med Sci, Dept Orthoped & Traumatol, 28 Czerwca 1956,135-147, PL-61545 Poznan, Poland.
   [Suchorska, Wiktoria; Augustyniak, Ewelina; Lach, Michal] Greater Poland Canc Ctr, Radiobiol Lab, Garbary 15, PL-61688 Poznan, Poland.
   [Augustyniak, Ewelina; Lach, Michal] Med Univ Warsaw, Postgrad Sch Mol Med, Zwirki & Wigury 61, PL-02091 Warsaw, Poland.
RP Trzeciak, T (reprint author), Poznan Univ Med Sci, Dept Orthoped & Traumatol, 28 Czerwca 1956,135-147, PL-61545 Poznan, Poland.
EM doktortrzeciak@gmail.com
OI Lach, Michal/0000-0002-3615-3768; Suchorska,
   Wiktoria/0000-0003-4742-2465
FU National Science Centre [2012/07/E/NZ3/01819]
FX This work was supported by the National Science Centre [grant number
   2012/07/E/NZ3/01819].
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Akmal M, 2006, J BONE JOINT SURG BR, V88B, P544, DOI 10.1302/0301-620X.88B4.16498
   Alegre-Aguaron E, 2012, CELLS TISSUES ORGANS, V196, P231, DOI 10.1159/000334400
   An YH, 2000, BIOMATERIALS, V21, P2635, DOI 10.1016/S0142-9612(00)00132-0
   Angele P, 2008, J BIOMED MATER RES A, V85A, P445, DOI 10.1002/jbm.a.31480
   Armentano I, 2013, PROG POLYM SCI, V38, P1720, DOI 10.1016/j.progpolymsci.2013.05.010
   Augustyniak E, 2015, INT ORTHOP, V39, P995, DOI 10.1007/s00264-014-2619-0
   Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Bentley G, 2003, J BONE JOINT SURG BR, V85B, P223, DOI 10.1302/0301-620X.85B2.13543
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Brahimi-Horn MC, 2007, FEBS LETT, V581, P3582, DOI 10.1016/j.febsict.2007.06.018
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Buda R, 2010, J BONE JOINT SURG AM, V92A, P2, DOI 10.2106/JBJS.J.00813
   Cherry ABC, 2013, ANNU REV MED, V64, P277, DOI 10.1146/annurev-med-050311-163324
   Cooper JA, 2006, BIOMATERIALS, V27, P2747, DOI 10.1016/j.biomaterials.2005.12.013
   Cui L, 2009, BIOMATERIALS, V30, P2683, DOI 10.1016/j.biomaterials.2009.01.045
   Deng J, 2013, J MATER SCI-MATER M, V24, P2037, DOI 10.1007/s10856-013-4944-z
   Diekman BO, 2012, P NATL ACAD SCI USA, V109, P19172, DOI 10.1073/pnas.1210422109
   Doppalapudi S, 2014, POLYM ADVAN TECHNOL, V25, P427, DOI 10.1002/pat.3305
   Dos Santos F, 2010, J CELL PHYSIOL, V223, P27, DOI 10.1002/jcp.21987
   Esposito AR, 2013, BIORESEARCH OPEN ACC, V2, P138, DOI 10.1089/biores.2012.0293
   Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027
   Fan HB, 2008, BIOMATERIALS, V29, P3324, DOI 10.1016/j.biomaterials.2008.04.012
   Fan HB, 2009, BIOMATERIALS, V30, P4967, DOI 10.1016/j.biomaterials.2009.05.048
   Foldager CB, 2011, ACTA ORTHOP, V82, P234, DOI 10.3109/17453674.2011.566135
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Garlotta D, 2001, J POLYM ENVIRON, V9, P63, DOI 10.1023/A:1020200822435
   Ge ZG, 2005, CELL TRANSPLANT, V14, P573, DOI 10.3727/000000005783982819
   Gierloff M, 2014, CLIN ORAL INVEST, V18, P247, DOI 10.1007/s00784-013-0956-9
   Gong GC, 2010, J CELL PHYSIOL, V224, P664, DOI 10.1002/jcp.22166
   Grassi A, 2014, INT ORTHOP, V38, P1945, DOI 10.1007/s00264-014-2408-9
   Grigolo B, 2005, BIOMATERIALS, V26, P5668, DOI 10.1016/j.biomaterials.2005.02.030
   HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
   Hoben GM, 2009, STEM CELLS DEV, V18, P283, DOI 10.1089/scd.2008.0024
   Hoffmann A, 2006, REGEN MED, V1, P563, DOI 10.2217/17460751.1.4.563
   Ikeda R, 2009, INT ORTHOP, V33, P821, DOI 10.1007/s00264-008-0532-0
   Iwasa J, 2009, KNEE SURG SPORT TR A, V17, P561, DOI 10.1007/s00167-008-0663-2
   Izuta Y, 2005, KNEE, V12, P217, DOI 10.1016/j.knee.2001.06.001
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kang SW, 2006, J BIOMED MATER RES A, V77A, P659, DOI 10.1002/jbm.a.30579
   King JA, 2007, CURR OPIN CHEM BIOL, V11, P394, DOI 10.1016/j.cbpa.2007.05.034
   Koga H, 2008, CELL TISSUE RES, V333, P207, DOI 10.1007/s00441-008-0633-5
   Kon E, 2012, TISSUE ENG PT A, V18, P1573, DOI [10.1089/ten.tea.2011.0572, 10.1089/ten.TEA.2011.0572]
   Kreuz PC, 2011, AM J SPORT MED, V39, P1697, DOI 10.1177/0363546511403279
   LAURENT TC, 1992, FASEB J, V6, P2397
   Lebourg M, 2013, J BIOMED MATER RES A, V101, P518, DOI 10.1002/jbm.a.34349
   Legnani C, 2010, INT ORTHOP, V34, P465, DOI 10.1007/s00264-010-0963-2
   Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020
   Lien SM, 2009, MAT SCI ENG C-BIO S, V29, P315, DOI 10.1016/j.msec.2008.07.017
   Liu HF, 2008, BIOMATERIALS, V29, P1443, DOI 10.1016/j.biomaterials.2007.11.023
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mandal BB, 2011, TISSUE ENG PT A, V17, P2749, DOI [10.1089/ten.tea.2011.0031, 10.1089/ten.TEA.2011.0031]
   Mandal BB, 2011, BIOMATERIALS, V32, P639, DOI 10.1016/j.biomaterials.2010.08.115
   Marsano A, 2007, OSTEOARTHR CARTILAGE, V15, P48, DOI 10.1016/j.joca.2006.06.009
   Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001
   Martinek V, 2006, ARCH ORTHOP TRAUM SU, V126, P228, DOI 10.1007/s00402-005-0025-1
   McCullen SD, 2012, TISSUE ENG PT A, V18, P2073, DOI [10.1089/ten.tea.2011.0606, 10.1089/ten.TEA.2011.0606]
   Meinel L, 2012, ADV DRUG DELIVER REV, V64, P1111, DOI 10.1016/j.addr.2012.03.016
   Moran CJ, 2014, INT ORTHOP, V38, P1937, DOI 10.1007/s00264-014-2426-7
   Moutos FT, 2010, TISSUE ENG PT A, V16, P1291, DOI [10.1089/ten.tea.2009.0480, 10.1089/ten.TEA.2009.0480]
   Murdoch AD, 2007, STEM CELLS, V25, P2786, DOI 10.1634/stemcells.2007-0374
   Nerurkar NL, 2011, BIOMATERIALS, V32, P461, DOI 10.1016/j.biomaterials.2010.09.015
   Niemeyer P, 2014, INT ORTHOP, V38, P2065, DOI 10.1007/s00264-014-2368-0
   Nishimoto H, 2012, INT ORTHOP, V36, P2379, DOI 10.1007/s00264-012-1660-0
   Oldershaw RA, 2012, INT J EXP PATHOL, V93, P389, DOI 10.1111/j.1365-2613.2012.00837.x
   Oldershaw RA, 2010, NAT BIOTECHNOL, V28, P1221, DOI 10.1038/nbt.1683
   Pabbruwe MB, 2010, BIOMATERIALS, V31, P2583, DOI 10.1016/j.biomaterials.2009.12.023
   Pecina M, 2014, INT ORTHOP, V38, P1757, DOI 10.1007/s00264-014-2477-9
   Pei M, 2009, DIFFERENTIATION, V78, P260, DOI 10.1016/j.diff.2009.08.001
   Peretti GM, 2004, AM J SPORT MED, V32, P146, DOI 10.1177/0095399703258790
   Placzek MR, 2009, J R SOC INTERFACE, V6, P209, DOI 10.1098/rsif.2008.0442
   Rodkey WG, 1999, CLIN ORTHOP RELAT R, pS281
   Rodkey WG, 2008, J BONE JOINT SURG AM, V90A, P1413, DOI 10.2106/JBJS.G.00656
   Rodolfa K, 2007, DIFFERENTIATION, V75, P577, DOI 10.1111/j.1432-0436.2007.00213.x
   Rodrigues CAV, 2011, BIOTECHNOL ADV, V29, P815, DOI 10.1016/j.biotechadv.2011.06.009
   Saha S, 2013, CELL TISSUE RES, V352, P495, DOI 10.1007/s00441-013-1586-x
   Sarem M, 2013, MAT SCI ENG C-MATER, V33, P4777, DOI 10.1016/j.msec.2013.07.036
   Schop D, 2010, J TISSUE ENG REGEN M, V4, P131, DOI 10.1002/term.224
   Scotti C, 2009, KNEE SURG SPORT TR A, V17, P645, DOI 10.1007/s00167-009-0745-9
   Scotti C, 2013, EUR CELLS MATER, V26, P150, DOI 10.22203/eCM.v026a11
   Serra M, 2010, J BIOTECHNOL, V148, P208, DOI 10.1016/j.jbiotec.2010.06.015
   Setton LA, 1999, CLIN ORTHOP RELAT R, pS254, DOI 10.1097/00003086-199910001-00025
   Shafiee A, 2011, J BIOMED MATER RES A, V99A, P467, DOI 10.1002/jbm.a.33206
   Shen BJ, 2010, J CELL BIOCHEM, V109, P406, DOI 10.1002/jcb.22412
   Solchaga LA, 2005, OSTEOARTHR CARTILAGE, V13, P297, DOI 10.1016/j.joca.2004.12.016
   SOMMERLATH KG, 1991, INT ORTHOP, V15, P347
   Steck E, 2010, TISSUE ENG PT A, V16, P3697, DOI [10.1089/ten.tea.2009.0817, 10.1089/ten.TEA.2009.0817]
   Stokes DG, 2001, BIOCHEM J, V360, P461, DOI 10.1042/0264-6021:3600461
   Stolzing A, 2006, FREE RADICAL BIO MED, V41, P326, DOI 10.1016/j.freeradbiomed.2006.04.018
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tarng YW, 2012, INT ORTHOP, V36, P863, DOI 10.1007/s00264-011-1291-x
   Tay LX, 2012, AM J SPORT MED, V40, P83, DOI 10.1177/0363546511420819
   Toh WS, 2011, STEM CELL REV REP, V7, P544, DOI 10.1007/s12015-010-9222-6
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vinardell T, 2012, TISSUE ENG PT A, V18, P1161, DOI [10.1089/ten.TEA.2011.0544, 10.1089/ten.tea.2011.0544]
   Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005
   Wakitani S, 2007, J TISSUE ENG REGEN M, V1, P74, DOI 10.1002/term.8
   Wang N, 2014, INT ORTHOP, V38, P1105, DOI 10.1007/s00264-013-2194-9
   Weinand C, 2006, AM J SPORT MED, V34, P1779, DOI 10.1177/0363546506290666
   Wu SC, 2013, J APPL PHYSIOL, V114, P1610, DOI 10.1152/japplphysiol.01132.2012
   Xing Q, 2010, ACTA BIOMATER, V6, P2132, DOI 10.1016/j.actbio.2009.12.036
   Yoo HS, 2005, BIOMATERIALS, V26, P1925, DOI 10.1016/j.biomaterials.2004.06.021
   Yoo JJ, 2011, J BIOMED MATER RES A, V99A, P102, DOI 10.1002/jbm.a.33168
   Yuan T, 2014, J BIOMED MATER RES B, V102, P337, DOI 10.1002/jbm.b.33011
   Zaslav K, 2009, AM J SPORT MED, V37, P42, DOI 10.1177/0363546508322897
   Zellner J, 2013, J BIOMED MATER RES B, V101, P1133, DOI 10.1002/jbm.b.32922
   Zellner J, 2010, J BIOMED MATER RES A, V94A, P1150, DOI 10.1002/jbm.a.32796
   Zhao W, 2013, J CHEM TECHNOL BIOT, V88, P327, DOI 10.1002/jctb.3970
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 110
TC 12
Z9 14
U1 3
U2 66
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0341-2695
EI 1432-5195
J9 INT ORTHOP
JI Int. Orthop.
PD MAR
PY 2016
VL 40
IS 3
BP 615
EP 624
DI 10.1007/s00264-015-3099-6
PG 10
WC Orthopedics
SC Orthopedics
GA DF1FM
UT WOS:000371084600027
PM 26762517
OA Other Gold
DA 2018-10-19
ER

PT J
AU Brix, M
   Kaipel, M
   Kellner, R
   Schreiner, M
   Apprich, S
   Boszotta, H
   Windhager, R
   Domayer, S
   Trattnig, S
AF Brix, Martin
   Kaipel, Martin
   Kellner, Richard
   Schreiner, Markus
   Apprich, Sebastian
   Boszotta, Harald
   Windhager, Reinhard
   Domayer, Stephan
   Trattnig, Siegfried
TI Successful osteoconduction but limited cartilage tissue quality
   following osteochondral repair by a cell-free multilayered
   nano-composite scaffold at the knee
SO INTERNATIONAL ORTHOPAEDICS
LA English
DT Article
DE Osteochondral lesions; Knee; Osteochondral repair; Scaffold
ID T2 RELAXATION-TIME; ARTICULAR-CARTILAGE; SUBCHONDRAL BONE; REGENERATION;
   LESIONS; TRANSPLANTATION; BIOMATERIAL; MOCART; MRI
AB Introduction The treatment of larger osteochondral lesions in the knee is still a clinical challenge. One promising strategy to overcome this problem could be surgical repair by using a cell-free multilayered nano-composite scaffold.
   Method In this prospective cohort study eight consecutive patients which suffered from a single osteochondral lesion (>= 1.5 cm(2)) on the femoral condyle were enrolled. The repair potential of the implant was assessed by using MRI based biochemical MR sequences (T2 mapping) as well as semi-quantitative morphological analyses (MOCART score) at 18 months after the surgery. The clinical outcome was determined at six, 12, 18, and 24 month follow ups by using IKDC, Tegner-Lysholm, and Cincinnati knee scores.
   Results Seven out of eight patients showed a complete integration of the scaffold into the border zone and five out of eight patients excellent or good subchondral ossification of the implant at 18 months following implantation. The surface of the repair tissue was found to be intact in all eight patients. T2 mapping data and the zonal T2 index significantly differed in the repair tissue compared to the healthy control cartilage (P < 0.001) which indicates a limited quality of the repair cartilage. The clinical outcome scores consistently improved during the follow up period without reaching statistical significance.
   Conclusions Osteochondral repair by implanting the MaioRegenA (R) scaffold provides a successful osteoconduction and filling of the cartilage defect. However there is evidence for a limited repair cartilage tissue quality at 18 months after the surgery.
C1 [Brix, Martin; Schreiner, Markus; Domayer, Stephan; Trattnig, Siegfried] Med Univ Vienna, Ctr Excellence High Field Magnet Resonance MR, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.
   [Kaipel, Martin; Kellner, Richard; Boszotta, Harald] Barmherzige Bruder Hosp, Dept Orthopaed & Trauma Surg, Johannes von Gott Pl 1, A-7000 Eisenstadt, Austria.
   [Apprich, Sebastian; Windhager, Reinhard] Med Univ Vienna, Dept Orthopaed, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.
RP Kaipel, M (reprint author), Barmherzige Bruder Hosp, Dept Orthopaed & Trauma Surg, Johannes von Gott Pl 1, A-7000 Eisenstadt, Austria.
EM martin.kaipel@ortho-sued.at
CR Baum T, 2013, OSTEOARTHR CARTILAGE, V21, P1474, DOI 10.1016/j.joca.2013.07.012
   Bentley G, 2013, INJURY, V44, pS3, DOI 10.1016/S0020-1383(13)70003-2
   Berruto M, 2014, AM J SPORT MED, V42, P1607, DOI 10.1177/0363546514530292
   Chahal J, 2013, ARTHROSCOPY, V29, P575, DOI 10.1016/j.arthro.2012.12.002
   Christensen BB, 2015, KNEE SURG SPORTS TRA, V18
   Filardo G, 2014, KNEE SURG SPORT TR A, V22, P1337, DOI 10.1007/s00167-013-2813-4
   Filardo G, 2013, AM J SPORT MED, V41, P1786, DOI 10.1177/0363546513490658
   Glaser C, 2005, RADIOL CLIN N AM, V43, P641, DOI 10.1016/j.rcl.2005.02.007
   Gomoll AH, 2010, KNEE SURG SPORT TR A, V18, P434, DOI 10.1007/s00167-010-1072-x
   Kon E, 2010, J TISSUE ENG REGEN M, V4, P300, DOI 10.1002/term.243
   Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014
   Kon E, 2014, AM J SPORT MED, V42, P158, DOI 10.1177/0363546513505434
   Kon E, 2010, J ORTHOP RES, V28, P116, DOI 10.1002/jor.20958
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lusse S, 2000, MAGN RESON IMAGING, V18, P423, DOI 10.1016/S0730-725X(99)00144-7
   Marcacci M, 2013, INJURY, V44, pS11, DOI 10.1016/S0020-1383(13)70004-4
   Marlovits S, 2006, EUR J RADIOL, V57, P16, DOI 10.1016/j.ejrad.2005.08.007
   Marlovits S, 2004, EUR J RADIOL, V52, P310, DOI 10.1016/j.ejrad.2004.03.014
   McCormick F, 2014, ARTHROSCOPY, V30, P222, DOI 10.1016/j.arthro.2013.11.001
   McCoy B, 2012, J KNEE SURG, V25, P99, DOI 10.1055/s-0032-1322508
   Oussedik S, 2015, ARTHROSCOPY, V31, P732, DOI 10.1016/j.arthro.2014.11.023
   Recht MP, 2005, AM J ROENTGENOL, V185, P899, DOI 10.2214/AJR.05.0099
   Trattnig S, 2007, EUR RADIOL, V17, P103, DOI 10.1007/s00330-006-0333-z
   Trattnig S, 2015, OSTEOARTHR CARTILAGE, V23, P2224, DOI 10.1016/j.joca.2015.07.007
   Welsch GH, 2008, RADIOLOGY, V247, P154, DOI 10.1148/radiol.2471070688
NR 25
TC 9
Z9 9
U1 1
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0341-2695
EI 1432-5195
J9 INT ORTHOP
JI Int. Orthop.
PD MAR
PY 2016
VL 40
IS 3
BP 625
EP 632
DI 10.1007/s00264-016-3118-2
PG 8
WC Orthopedics
SC Orthopedics
GA DF1FM
UT WOS:000371084600028
PM 26803322
DA 2018-10-19
ER

PT J
AU Rath, A
   Mathesan, S
   Ghosh, P
AF Rath, Amrita
   Mathesan, Santhosh
   Ghosh, Pijush
TI Nanomechanical characterization and molecular mechanism study of
   nanoparticle reinforced and cross-linked chitosan biopolymer
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Biomaterials; Chitosan; Nanomechanical; Nanoindentation; NanoDMA;
   Nanoscratch
ID VISCOELASTIC PROPERTIES; NANOCOMPOSITE FILMS; ELASTIC-MODULUS;
   NANOINDENTATION; INDENTATION; SCAFFOLDS; DYNAMICS; BEHAVIOR; HARDNESS
AB Chitosan (CS) is a biomaterial that offers many sophisticated and innovative applications in the biomedical field owing to its excellent characteristics of biodegradability, biocompatibility and non-toxicity. However, very low mechanical properties of chitosan polymer impose restriction on its further development. Cross-linking and nanoparticle reinforcement are the two possible methods to improve the mechanical properties of chitosan films. In this research, these two methods are adopted individually by using tripolyphosphate as cross linker and nano-hydroxyapatite as particle reinforcement. The nanomechanical characterizations under static loading conditions are performed on these modified chitosan films. It is observed that nanoparticle reinforcement provided necessary mechanical properties such as ductility and modulus. The mechanisms involved in improvement of mechanical properties due to particle reinforcement are studied by molecular dynamics (MD). Further, improvement in mechanical properties due to combination of particle reinforcement and cross linking agent with chitosan is investigated. The stress relaxation behavior for all these types of films is characterized under dynamic loading conditions using dynamic mechanical analysis (nanoDMA) experiment. A viscoelastic solid like response is observed for all types of film with modulus relaxing by 3-6% of its initial value. A suitable generalized Maxwell model is fitted with the obtained viscoelastic response of these films. The response to nano-scratch behavior is also studied for particle reinforced composite films. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Rath, Amrita; Mathesan, Santhosh; Ghosh, Pijush] Indian Inst Technol, Dept Appl Mech, Madras 600036, Tamil Nadu, India.
RP Ghosh, P (reprint author), Indian Inst Technol, Dept Appl Mech, Madras 600036, Tamil Nadu, India.
EM pijush@iitm.ac.in
OI MATHESAN, SANTHOSH/0000-0001-6726-4033; ghosh,
   pijush/0000-0002-6077-6498
CR Albanna MZ, 2013, J MECH BEHAV BIOMED, V20, P217, DOI 10.1016/j.jmbbm.2012.09.012
   Aryaei A, 2012, J MECH BEHAV BIOMED, V5, P82, DOI 10.1016/j.jmbbm.2011.08.006
   Bassik N, 2010, J AM CHEM SOC, V132, P16314, DOI 10.1021/ja106218s
   Bi L, 2011, J MATER SCI-MATER M, V22, P51, DOI 10.1007/s10856-010-4177-3
   Cunha R.A., 2012, COMPLEX WORLD POLYSA, P232
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   Diez-Pascual AM, 2015, PROG MATER SCI, V67, P1, DOI 10.1016/j.pmatsci.2014.06.002
   Feng XM, 2014, COMPOS SCI TECHNOL, V93, P76, DOI 10.1016/j.compscitech.2013.11.016
   Fernandes R, 2009, MATER TODAY, V12, P14, DOI 10.1016/S1369-7021(09)70272-X
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Jayasuriya A.G., 2009, BIOMED MATER, V4, P1
   Khanna R., 2007, ACTA BIOMATER, V7, P1173
   Kikuchi N, 2000, SURF COAT TECH, V126, P131, DOI 10.1016/S0257-8972(99)00670-2
   Lalov IG, 2000, WATER RES, V34, P1503, DOI 10.1016/S0043-1354(99)00291-2
   Lei C., 2002, COMPOS SCI TECHNOL, V62, P1327
   Magdalena G.D., 2011, PCACD, V16, P15
   Martinez-Camacho AP, 2010, CARBOHYD POLYM, V82, P305, DOI 10.1016/j.carbpol.2010.04.069
   Mathesan S., 2015, MAT SCI ENG C, V2015
   Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2
   Odegard GM, 2005, EXP MECH, V45, P130, DOI 10.1177/0014485105052320
   Okuyama K, 2000, CARBOHYD POLYM, V41, P237, DOI 10.1016/S0144-8617(99)00142-3
   Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039
   Randall CL, 2012, TRENDS BIOTECHNOL, V30, P138, DOI 10.1016/j.tibtech.2011.06.013
   Ratakonda S, 2012, ACTA BIOMATER, V8, P1566, DOI 10.1016/j.actbio.2011.12.013
   Rodrigues Susana, 2012, J Funct Biomater, V3, P615, DOI 10.3390/jfb3030615
   Schiffman JD, 2007, BIOMACROMOLECULES, V8, P594, DOI 10.1021/bm060804s
   Silva J.A.L.D.A., 2006, J POLYM SCI B, V45, P1907
   Subramani S, 2007, COMPOS SCI TECHNOL, V67, P1561, DOI 10.1016/j.compscitech.2006.07.011
   Swetha M, 2010, INT J BIOL MACROMOL, V47, P1, DOI 10.1016/j.ijbiomac.2010.03.015
   Taylor P., 2011, CRIT REV FOOD SCI NU, V51, P872
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Wu TF, 2014, J MECH BEHAV BIOMED, V32, P279, DOI 10.1016/j.jmbbm.2014.01.014
   Yahyaei H, 2013, TRIBOL INT, V57, P147, DOI 10.1016/j.triboint.2012.08.004
   Yao CK, 2012, APPL SURF SCI, V262, P218, DOI 10.1016/j.apsusc.2012.05.128
   Young R.J., 2011, INTRO POLYM, P255
NR 37
TC 6
Z9 6
U1 4
U2 50
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD MAR
PY 2016
VL 55
BP 42
EP 52
DI 10.1016/j.jmbbm.2015.10.005
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DE8LD
UT WOS:000370886600005
PM 26540519
DA 2018-10-19
ER

PT J
AU de Viteri, VS
   Barandika, G
   Bayon, R
   Fernandez, X
   Ciarsolo, I
   Igartua, A
   Tanoira, RP
   Moreno, JE
   Conchita, JP
AF Saenz de Viteri, Virginia
   Barandika, Gotzone
   Bayon, Raquel
   Fernandez, Xana
   Ciarsolo, Inigo
   Igartua, Amaya
   Perez Tanoira, Ramon
   Esteban Moreno, Jaime
   Perez-Jorge Peremarch, Conchita
TI Development of Ti-C-N coatings with improved tribological behavior and
   antibacterial properties
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Ti-C-N; Tribocorrosion; Fretting; Silver; Bacterial adhesion
ID CARBON-FILMS; STAPHYLOCOCCUS-AUREUS; BIOMATERIAL SURFACES; BIOFILM
   DEVELOPMENT; BACTERIAL ADHESION; ION-IMPLANTATION; WOUND-INFECTION; DLC
   COATINGS; TRIBOCORROSION; TITANIUM
AB In artificial metallic joint implants, the failure is provoked by two effects in most of the cases: mass loss and wear debris removed due to tribological-corrosive effects on the implant alloy, and infections due to the presence of bacteria. In this work, several Ti-C-N corrosion and wear protective coatings were developed by Physical Vapour Deposition technology, and deposited on Ti6Al4V alloy. In order to provide the implant antibacterial properties, an additional silver top coating has been deposited. Tribological behavior was characterized through tribocorrosion and fretting tests. On the other hand, wettability tests were performed to study the grade of hydrophilicity/hydrophobia. Additionally, antibacterial properties were evaluated by means of bacterial adhesion tests. As a result of these characterization studies, the coating with the best performance was selected. The as coated material includes excellent protection against tribocorrosion and fretting effects (in relation to the uncoated one) and the silver layer has been confirmed to exhibit antibacterial properties. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Saenz de Viteri, Virginia; Bayon, Raquel; Fernandez, Xana; Ciarsolo, Inigo; Igartua, Amaya] IK4 Tekniker, Pk Teknol,C Inaki Goenaga 5, Eibar 20600, Gipuzkoa, Spain.
   [Barandika, Gotzone] Univ Basque Country, Dept Quim Inorgan, UPV EHU, Fac Ciencia & Tecnol, Apdo 644, Bilbao 48080, Spain.
   [Perez Tanoira, Ramon; Esteban Moreno, Jaime; Perez-Jorge Peremarch, Conchita] IIS Fdn Jimenez Diaz, Dept Clin Microbiol, Ave Reyes Catolicos 2, Madrid 28040, Spain.
RP de Viteri, VS (reprint author), IK4 Tekniker, Pk Teknol,C Inaki Goenaga 5, Eibar 20600, Gipuzkoa, Spain.
EM virginia.saenzdeviteri@tekniker.es
RI Barandika, Gotzone/N-2157-2014; Perez Tanoira, Ramon/K-4898-2014
OI Barandika, Gotzone/0000-0002-6771-6586; Perez Tanoira,
   Ramon/0000-0002-9816-3208
FU Spanish Government [CSD2008-00023]; Basque Country Government
FX The authors acknowledge FUNCOAT CONSOLIDER Project, financed by the
   Spanish Government, under contract CSD2008-00023 and to the Basque
   Country Government for the financing of EMAITEK project.
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Arslan E, 2012, PROG ORG COAT, V74, P768, DOI 10.1016/j.porgcoat.2011.10.023
   Atiyeh BS, 2007, BURNS, V33, P139, DOI 10.1016/j.burns.2006.06.010
   Baba K, 2013, VACUUM, V89, P179, DOI 10.1016/j.vacuum.2012.04.015
   Bayon R., 2011, THESIS U BASQUE COUN
   Bendavid A, 2007, DIAM RELAT MATER, V16, P1616, DOI 10.1016/j.diamond.2007.02.006
   Bhushan B, 1991, HDB TRIBOLOGY MAT CO
   Billi F, 2010, J BIOMECH, V43, P1310, DOI 10.1016/j.jbiomech.2010.01.015
   Boulos L, 1999, J MICROBIOL METH, V37, P77, DOI 10.1016/S0167-7012(99)00048-2
   Brodner W, 1997, J BONE JOINT SURG BR, V79B, P316, DOI 10.1302/0301-620X.79B2.7326
   Celis J.-P., 2012, TESTING TRIBOCORROSI
   Cheng Y, 2006, SURF COAT TECH, V200, P4543, DOI 10.1016/j.surfcoat.2005.03.039
   Cordero J, 1996, INJURY, V27, P34
   Cordero-Ampuero J, 2007, ACTA ORTHOP, V78, P511, DOI 10.1080/17453670710014167
   Currier JH, 2005, J BIOMECH, V38, P367, DOI 10.1016/j.jbiomech.2004.02.016
   Diomidis N, 2010, WEAR, V269, P93, DOI 10.1016/j.wear.2010.03.010
   Edwards C, 2008, J BONE JOINT SURG BR, V90B, P770, DOI 10.1302/0301-620X.90B6.20194
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   Esteban J., 2014, MICROBIOLOGY SURG IN, P41
   Esteban J, 2008, J CLIN MICROBIOL, V46, P488, DOI 10.1128/JCM.01762-07
   Esteban J, 2010, ACTA ORTHOP, V81, P674, DOI 10.3109/17453674.2010.537810
   GAMER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI DOI 10.1016/0196-6553(88)90053-3
   Gordon O, 2010, ANTIMICROB AGENTS CH, V54, P4208, DOI 10.1128/AAC.01830-09
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Guggenbichler J. P., 2011, GMS KRANKENHHYG INTE, V6, P18, DOI DOI 10.3205/DGKH000175
   Hallab N, 2000, BIOMATERIALS, V21, P1301, DOI 10.1016/S0142-9612(99)00235-5
   Harris LG, 2006, INJURY, V37, P3, DOI 10.1016/j.injury.2006.04.003
   Hodgson AWE, 2002, ELECTROCHIM ACTA, V47, P1913, DOI 10.1016/S0013-4686(02)00029-4
   Iwabuchi A, 2007, WEAR, V263, P492, DOI 10.1016/j.wear.2007.01.102
   Kaestner P, 2001, SURF COAT TECH, V142, P928, DOI 10.1016/S0257-8972(01)01214-2
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Kinnari TJ, 2008, J BIOMED MATER RES A, V86A, P760, DOI 10.1002/jbm.a.31643
   Landolt D, 2004, WEAR, V256, P517, DOI 10.1016/S0043-1648(03)00561-1
   Liu C., 2011, SURF COAT TECH, V414, P164
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Marciano FR, 2011, VACUUM, V85, P662, DOI 10.1016/j.vacuum.2010.07.017
   MARTINU L, 1992, THIN SOLID FILMS, V208, P42, DOI 10.1016/0040-6090(92)90945-8
   Medina O, 2012, DIAM RELAT MATER, V22, P77, DOI 10.1016/j.diamond.2011.12.022
   Mischler S, 2008, TRIBOL INT, V41, P573, DOI 10.1016/j.triboint.2007.11.003
   Mischler S, 2001, WEAR, V248, P211, DOI 10.1016/S0043-1648(00)00559-7
   Perez-Jorge C, 2012, J BIOMED MATER RES A, V100A, P1696, DOI 10.1002/jbm.a.34118
   Perez-Tanoira R, 2012, J BIOMED MATER RES A, V100A, P1521, DOI 10.1002/jbm.a.34090
   Perez-Tanoira R, 2014, SURG INFECT, V15, P90, DOI 10.1089/sur.2013.032
   Ponthiaux P, 2013, WOODH PUBL SER BIOM, V60, P372, DOI 10.1533/9780857098603.3.372
   RAVEH A, 1992, SURF COAT TECH, V53, P275, DOI 10.1016/0257-8972(92)90386-O
   Rochford ETJ, 2012, CLIN MICROBIOL INFEC, V18, P1162, DOI 10.1111/j.1469-0691.2012.04002.x
   Rogers SD, 1997, J BONE JOINT SURG BR, V79B, P311, DOI 10.1302/0301-620X.79B2.7192
   de Viteri VS, 2012, J INORG BIOCHEM, V117, P359, DOI 10.1016/j.jinorgbio.2012.09.012
   Sargeant A, 2007, MATER DESIGN, V28, P155, DOI 10.1016/j.matdes.2005.05.018
   Secinti KD, 2011, J CLIN NEUROSCI, V18, P391, DOI 10.1016/j.jocn.2010.06.022
   Sharkey P.F., 2001, CLIN ORTHOP RELAT R, V404, P7
   Sheeja D, 2001, SURF COAT TECH, V146, P410, DOI 10.1016/S0257-8972(01)01425-6
   Singhai M, 2012, J GLOB INFECT DIS, V4, P193, DOI 10.4103/0974-777X.103896
   Sinnett-Jones PE, 2005, WEAR, V259, P898, DOI 10.1016/j.wear.2005.02.045
   Snyders R, 2007, PLASMA PROCESS POLYM, V4, pS640, DOI 10.1002/ppap.200731601
   Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x
   Vieira AC, 2006, WEAR, V261, P994, DOI 10.1016/j.wear.2006.03.031
   Vitu T, 2014, SURF COAT TECH, V258, P734, DOI 10.1016/j.surfcoat.2014.08.003
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wang PF, 2013, SURF COAT TECH, V221, P163, DOI 10.1016/j.surfcoat.2013.01.045
   Yildiz F, 2008, SURF COAT TECH, V202, P2471, DOI 10.1016/j.surfcoat.2007.08.004
   Zhecheva A, 2005, SURF COAT TECH, V200, P2192, DOI 10.1016/j.surfcoat.2004.07.115
   Zhou H, 2008, DIAM RELAT MATER, V17, P1416, DOI 10.1016/j.diamond.2008.01.047
NR 63
TC 11
Z9 11
U1 3
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD MAR
PY 2016
VL 55
BP 75
EP 86
DI 10.1016/j.jmbbm.2015.10.020
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DE8LD
UT WOS:000370886600008
DA 2018-10-19
ER

PT J
AU Minuth, WW
   Denk, L
AF Minuth, Will W.
   Denk, Lucia
TI Bridging the gap between traditional cell cultures and bioreactors
   applied in regenerative medicine: practical experiences with the
   MINUSHEET perfusion culture system
SO CYTOTECHNOLOGY
LA English
DT Review
DE Cell culture; Perfusion culture; 3D culture; Tissue carrier; Bioreactor;
   Tissue engineering; Biomaterial testing; Biomedicine
ID DENTIN BARRIER TEST; IN-VITRO MODEL; TEXTILE CHITOSAN SCAFFOLDS; MARROW
   STROMAL CELLS; LONG-TERM CULTURE; ELECTROSPUN POLYMER SCAFFOLDS;
   DEPENDENT NEURONAL PLASTICITY; TISSUE-ENGINEERED CARTILAGE;
   RETINAL-PIGMENT EPITHELIUM; COLLECTING DUCT EPITHELIA
AB To meet specific requirements of developing tissues urgently needed in tissue engineering, biomaterial research and drug toxicity testing, a versatile perfusion culture system was developed. First an individual biomaterial is selected and then mounted in a MINUSHEETA (R) tissue carrier. After sterilization the assembly is transferred by fine forceps to a 24 well culture plate for seeding cells or mounting tissue on it. To support spatial (3D) development a carrier can be placed in various types of perfusion culture containers. In the basic version a constant flow of culture medium provides contained tissue with always fresh nutrition and respiratory gas. For example, epithelia can be transferred to a gradient container, where they are exposed to different fluids at the luminal and basal side. To observe development of tissue under the microscope, in a different type of container a transparent lid and base are integrated. Finally, stem/progenitor cells are incubated in a container filled by an artificial interstitium to support spatial development. In the past years the described system was applied in numerous own and external investigations. To present an actual overview of resulting experimental data, the present paper was written.
C1 [Minuth, Will W.; Denk, Lucia] Univ Regensburg, Mol & Cellular Anat, Univ St 31, D-93053 Regensburg, Germany.
RP Minuth, WW (reprint author), Univ Regensburg, Mol & Cellular Anat, Univ St 31, D-93053 Regensburg, Germany.
EM will.minuth@vkl.uni-regensburg.de
FU Institute of Molecular and Cellular Anatomy, University of Regensburg
FX The authors thank the Institute of Molecular and Cellular Anatomy,
   University of Regensburg for financial support and technical assistance
   to write this article.
CR Aberle T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086740
   AIGNER J, 1994, EPITHELIAL CELL BIOL, V3, P70
   Aigner J, 1995, EPITHELIAL CELL BIOL, V4, P121
   Anders JO, 2009, J BONE JOINT SURG BR, V91B, P409, DOI 10.1302/0301-620X.91B3.20869
   Astasov-Frauenhoffer M, 2012, FEMS MICROBIOL LETT, V337, P31, DOI 10.1111/1574-6968.12007
   Bakowsky U, 2005, ADHESION CURRENT RES, P157
   Bernhardt A, 2008, J MATER SCI-MATER M, V19, P269, DOI 10.1007/s10856-006-0059-0
   Bernhardt A, 2011, J TISSUE ENG REGEN M, V5, P444, DOI 10.1002/term.331
   Bitterle E, 2006, CHEMOSPHERE, V65, P1784, DOI 10.1016/j.chemosphere.2006.04.035
   Blattmann A, 2008, BIOMATERIALS, V29, P2749, DOI 10.1016/j.biomaterials.2008.03.019
   Blochl A, 1996, J BIOL CHEM, V271, P21100
   Bruggeman LA, 2012, CELL MOL BIOENG, V5, P194, DOI 10.1007/s12195-012-0221-3
   Bucheler M, 2003, DNA CELL BIOL, V22, P549, DOI 10.1089/104454903322405446
   BUJIA J, 1994, LARYNGO RHINO OTOL, V73, P577, DOI 10.1055/s-2007-997199
   BUJIA J, 1995, ACTA OTO-LARYNGOL, V115, P307, DOI 10.3109/00016489509139316
   Campos Doris M, 2013, Biomatter, V3, DOI 10.4161/biom.24922
   Camps J, 2002, CONNECT TISSUE RES, V43, P396, DOI 10.1080/03008200290001069
   Canossa M, 1997, P NATL ACAD SCI USA, V94, P13279, DOI 10.1073/pnas.94.24.13279
   Capitan Guarnizo A, 2002, ACTA OTORRINOLARINGO, V53, P631
   Constantinescu R, 2007, J NEURAL TRANSM-SUPP, P17
   da Silva HM, 2010, COLLOID SURFACE B, V75, P349, DOI 10.1016/j.colsurfb.2009.09.009
   da Silva JMF, 2014, CLIN ORAL INVEST, V18, P607, DOI 10.1007/s00784-013-1000-9
   Dankers PYW, 2011, BIOMATERIALS, V32, P723, DOI 10.1016/j.biomaterials.2010.09.020
   Dankers PYW, 2010, MACROMOL BIOSCI, V10, P1345, DOI 10.1002/mabi.201000146
   Demirci M, 2008, DENT MATER, V24, P362, DOI 10.1016/j.dental.2007.06.009
   Detsch R, 2008, J MATER SCI-MATER M, V19, P1491, DOI 10.1007/s10856-007-3297-x
   Dimova S, 2005, INT J PHARMACEUT, V292, P157, DOI 10.1016/j.ijpharm.2004.11.030
   Dithmer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089150
   Dreesmann L, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034119
   Du Y, 2008, BIOMATERIALS, V29, P290, DOI 10.1016/j.biomaterials.2007.09.016
   Duda GN, 2004, J BIOMED MATER RES B, V68B, P21, DOI 10.1002/jbm.b.10075
   Duda GN, 2000, J BIOMED MATER RES, V53, P673, DOI 10.1002/1097-4636(2000)53:6<673::AID-JBM9>3.0.CO;2-V
   Farack J, 2011, MATER SCI ENG B-ADV, V176, P1767, DOI 10.1016/j.mseb.2011.06.004
   Fiegel HC, 2004, TISSUE ENG, V10, P165, DOI 10.1089/107632704322791817
   Framme C, 2002, OPHTHALMOLOGICA, V216, P320, DOI 10.1159/000066184
   Frerich B, 2008, INT J ORAL MAX SURG, V37, P459, DOI 10.1016/j.ijom.2008.01.014
   Frerich Bernhard, 2006, Head Face Med, V2, P26, DOI 10.1186/1746-160X-2-26
   Fuss M, 2000, ANN ANAT, V182, P303
   Galler K, 2005, J ENDODONT, V31, P396, DOI 10.1097/01.don.0000145428.26880.e5
   Gelinsky M, 2004, MATERIALWISS WERKST, V35, P229, DOI 10.1002/mawe.200400732
   Gille J, 2005, TISSUE CELL, V37, P339, DOI 10.1016/j.tice.2005.05.004
   Glashauser A, 2011, J TISSUE SCI ENG, V2, P105
   Glaum R, 2010, J BIOMED MATER RES A, V93A, P704, DOI 10.1002/jbm.a.32575
   Glaum Ricarda, 2013, Methods Mol Biol, V946, P423, DOI 10.1007/978-1-62703-128-8_27
   Griesbeck O, 1999, MICROSC RES TECHNIQ, V45, P262, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<262::AID-JEMT10>3.0.CO;2-K
   Gueven N, 1996, EUR RESPIR J, V9, P968, DOI 10.1183/09031936.96.09050968
   Hagedorn GM, 2009, J PHYSIOL PHARMACOL, V60, P25
   Haisch A, 2002, EUR ARCH OTO-RHINO-L, V259, P316, DOI 10.1007/s00405-002-0446-1
   Hamilton RD, 2007, J ANAT, V211, P707, DOI 10.1111/j.1469-7580.2007.00812.x
   Hamilton RD, 2011, METHODS MOL BIOL, V686, P401, DOI 10.1007/978-1-60761-938-3_20
   Hammer M, 2008, GRAEF ARCH CLIN EXP, V246, P979, DOI 10.1007/s00417-008-0789-4
   Hayashi M, 2009, MOL CELL BIOCHEM, V322, P1, DOI 10.1007/s11010-008-9934-y
   Heber S, 2007, TISSUE ENG, V13, P281, DOI 10.1089/ten.2006.0199
   Heinemann C, 2010, EUR CELLS MATER, V19, P96, DOI 10.22203/eCM.v019a10
   Heinemann C, 2008, BIOMACROMOLECULES, V9, P2913, DOI 10.1021/bm800693d
   Heinemann C, 2009, BIOMACROMOLECULES, V10, P1305, DOI 10.1021/bm900172m
   HERTER P, 1993, J MICROSC-OXFORD, V171, P107, DOI 10.1111/j.1365-2818.1993.tb03364.x
   Hoener MC, 2000, EUR J NEUROSCI, V12, P3096, DOI 10.1046/j.1460-9568.2000.00190.x
   Hu Kanghong, 2007, Biotechnology Journal, V2, P992, DOI 10.1002/biot.200700009
   Jian GE, 2007, FRONT MED-PRC, V1, P6
   Kalamarz-Kubiak H, 2011, J NEUROSCI METH, V199, P56, DOI 10.1016/j.jneumeth.2011.04.035
   Kim HS, 2013, INT J ORAL SCI, V5, P26, DOI 10.1038/ijos.2013.11
   Kim MJ, 2013, CLIN ORAL INVEST, V17, P1489, DOI 10.1007/s00784-012-0840-z
   Klettner A, 2014, GRAEF ARCH CLIN EXP, V252, P1593, DOI 10.1007/s00417-014-2719-y
   Klettner A, 2013, MOL VIS, V19, P281
   Klettner A, 2009, GRAEF ARCH CLIN EXP, V247, P1487, DOI 10.1007/s00417-009-1139-x
   Klettner AK, 2012, GRAEF ARCH CLIN EXP, V250, P33, DOI 10.1007/s00417-011-1776-8
   Klettner AK, 2009, GRAEF ARCH CLIN EXP, V247, P1601, DOI 10.1007/s00417-009-1136-0
   Kloth S, 1998, IN VITRO CELL DEV-AN, V34, P515
   KLOTH S, 1994, EUR J CELL BIOL, V63, P84
   Kloth S, 2000, TOXICOL IN VITRO, V14, P265, DOI 10.1016/S0887-2333(00)00010-2
   KLOTH S, 1995, FASEB J, V9, P963
   Kloth S, 1998, KIDNEY INT, V53, P970, DOI 10.1111/j.1523-1755.1998.00854.x
   Kloth S, 2000, MICROVASC RES, V59, P190, DOI 10.1006/mvre.1999.2214
   Kloth S, 1999, BIOFORUM INT, V3, P70
   Kobuch K, 2008, EXP EYE RES, V86, P661, DOI 10.1016/j.exer.2008.01.011
   Korsuwannawong Suwanna, 2012, Eur J Dent, V6, P408
   Kreklau B, 1999, BIOMATERIALS, V20, P1743, DOI 10.1016/S0142-9612(99)00061-7
   Kremer M, 2001, LANGENBECK ARCH SURG, V386, P357, DOI 10.1007/s004230100227
   Lauer G, 2009, FUNDAMENTALS TISSUE, V27.6, P375
   Lehmann P, 1997, Mund Kiefer Gesichtschir, V1, P26
   Leukers B, 2005, J MATER SCI-MATER M, V16, P1121, DOI 10.1007/s10856-005-4716-5
   Leukers B, 2005, MATERIALWISS WERKST, V36, P781, DOI 10.1002/mawe.200500968
   Maier KL, 2008, INHAL TOXICOL, V20, P319, DOI [10.1080/08958370701866313, 10.1080/08958370701866313 ]
   da Silva HM, 2010, COLLOID SURFACE B, V80, P138, DOI 10.1016/j.colsurfb.2010.05.040
   Masungi C, 2004, J PHARM SCI-US, V93, P2507, DOI 10.1002/jps.20149
   Masungi C, 2009, PHARMAZIE, V64, P36, DOI 10.1691/ph.2008.8592
   Mateescu Mihaela, 2012, Biomatter, V2, P103, DOI 10.4161/biom.21377
   Miess C, 2010, ANN BIOMED ENG, V38, P2197, DOI 10.1007/s10439-010-0006-6
   Minuth W.W., 2010, J TISSUE SCI ENG, V1, P101
   Minuth W.W., 2013, TRANSPLANT TECHNOL, V1, P2
   Minuth W.W., 2013, INT J STEM CELL RES, V1, P202
   Minuth WW, 2007, CENT EUR J BIOL, V2, P307, DOI 10.2478/s11535-007-0030-1
   Minuth WW, 2007, BIOMATERIALS, V28, P4418, DOI 10.1016/j.biomaterials.2007.06.031
   Minuth WW, 2014, INT J MOL SCI, V15, P23240, DOI 10.3390/ijms151223240
   Minuth WW, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-34
   Minuth WW, 2012, J BIOMED MATER RES A, V100A, P1115, DOI 10.1002/jbm.a.34039
   Minuth WW, 2010, MATERIALS, V3, P2369, DOI 10.3390/ma3042369
   Minuth WW, 2010, ADV DRUG DELIVER REV, V62, P841, DOI 10.1016/j.addr.2010.01.004
   Minuth WW, 2009, LANGMUIR, V25, P4621, DOI 10.1021/la803858q
   MINUTH WW, 1990, CYTOTECHNOLOGY, V4, P181, DOI 10.1007/BF00365099
   MINUTH WW, 1992, KIDNEY INT, V41, P215, DOI 10.1038/ki.1992.30
   Minuth WW, 2005, BIO-MED MATER ENG, V15, P51
   Minuth WW, 2005, BIOMATERIALS, V26, P6588, DOI 10.1016/j.biomaterials.2005.04.029
   Minuth WW, 2003, MED KLIN, V98, P31
   Minuth WW, 2004, CELL PHYSIOL BIOCHEM, V14, P387, DOI 10.1159/000080348
   Minuth WW, 2004, TISSUE ENG, V10, P285, DOI 10.1089/107632704322791925
   MINUTH WW, 1993, KIDNEY INT, V44, P537, DOI 10.1038/ki.1993.278
   MINUTH WW, 1992, EUR J CELL BIOL, V57, P132
   Minuth WW, 2001, J BIOMAT SCI-POLYM E, V12, P353, DOI 10.1163/156856201750180861
   Minuth WW, 1997, EXP NEPHROL, V5, P414
   Minuth WW, 1997, PEDIATR NEPHROL, V11, P140, DOI 10.1007/s004670050245
   MINUTH WW, 1994, IN VITRO CELL DEV-AN, V30A, P12
   Minuth WW, 1999, EXP NEPHROL, V7, P394
   Minuth WW, 2008, J EPITHEL BIOL PHARM, V1, P24
   Minuth WW, 2010, STEM CELL ENG PRINCI, P321
   Minuth WW, 2009, J EPITHELIAL BIOL PH, V2, P1
   Minuth WW, 2008, TRANSPLANTATIONSMEDI, V20, P47
   Minuth WW, 1990, Patent No. [DE-PS 3923279, 3923279]
   Miura Y, 2013, INVEST OPHTH VIS SCI, V54, P3366, DOI 10.1167/iovs.13-11808
   Miura Y, 2010, OPHTHAL RES, V43, P122, DOI 10.1159/000252979
   Mollet BB, 2014, J MATER CHEM B, V2, P2483, DOI 10.1039/c3tb21516d
   Nandkumar MA, 2015, CELL BIOL INT, V39, P272, DOI 10.1002/cbin.10389
   Prem Caroline, 2000, Methods in Cell Science, V22, P125, DOI 10.1023/A:1009826424171
   Quadbeck P, 2010, PM2010 WORLD C PM BI, V4, P747
   Ramsauer M, 1998, J CEREBR BLOOD F MET, V18, P1270, DOI 10.1097/00004647-199811000-00014
   Rath SN, 2012, J CELL MOL MED, V16, P2350, DOI 10.1111/j.1582-4934.2012.01545.x
   Reischl J, 1999, CELL TISSUE RES, V296, P371, DOI 10.1007/s004410051297
   Risbud MV, 2002, TRENDS BIOTECHNOL, V20, P351, DOI 10.1016/S0167-7799(02)02016-4
   Roessger A, 2009, BIOMATERIALS, V30, P3723, DOI 10.1016/j.biomaterials.2009.03.041
   Ropke E, 2007, LARYNGO RHINO OTOL, V86, P37
   Rothamel D, 2004, CLIN ORAL IMPLAN RES, V15, P443, DOI 10.1111/j.1600-0501.2004.01039.x
   Rotter N, 1998, J BIOMED MATER RES, V42, P347, DOI 10.1002/(SICI)1097-4636(19981205)42:3<347::AID-JBM2>3.0.CO;2-J
   Rotter N, 1999, J MATER SCI-MATER M, V10, P689, DOI 10.1023/A:1008912514271
   Ruder C, 2012, CLIN HEMORHEOL MICRO, V50, P101, DOI 10.3233/CH-2011-1447
   Saikia P, 2006, INVEST OPHTH VIS SCI, V47, P4998, DOI 10.1167/05-1665
   Schiessl IM, 2013, AM J PHYSIOL-RENAL, V305, pF1139, DOI 10.1152/ajprenal.00259.2013
   Schmalz G, 1996, J ENDODONT, V22, P249, DOI 10.1016/S0099-2399(06)80142-1
   Schmalz G, 1999, J ENDODONT, V25, P24, DOI 10.1016/S0099-2399(99)80394-X
   Schmalz G, 2002, J ENDODONT, V28, P188, DOI 10.1097/00004770-200203000-00011
   Schmalz G, 2001, J ENDODONT, V27, P96, DOI 10.1097/00004770-200102000-00009
   Schneider T, 2012, CLIN HEMORHEOL MICRO, V52, P325, DOI 10.3233/CH-2012-1608
   Schneider T, 2011, MACROMOL SYMP, V309-310, P28, DOI 10.1002/masy.201100057
   Schultz O, 1997, ARTHRITIS RHEUM, V40, P1420, DOI 10.1002/art.1780400809
   Schumacher K, 2002, CELL PHYSIOL BIOCHEM, V12, P63, DOI 10.1159/000063782
   Schumacher K, 2002, BIOMATERIALS, V23, P805, DOI 10.1016/S0142-9612(01)00186-7
   Schumacher K, 1999, IN VITRO CELL DEV-AN, V35, P465
   Schumacher K, 2007, TISSUE ENG, V13, P197, DOI 10.1089/ten.2006.0046
   Seitz S, 2007, TISSUE ENG, V13, P1059, DOI 10.1089/ten.2006.0334
   Sengun A, 2011, ORAL SURG ORAL MED O, V112, pE83, DOI 10.1016/j.tripleo.2011.02.023
   Shearer H, 2006, TISSUE ENG, V12, P2717, DOI 10.1089/ten.2006.12.2717
   Sittinger M, 1997, INT J ARTIF ORGANS, V20, P57
   SITTINGER M, 1994, BIOMATERIALS, V15, P451, DOI 10.1016/0142-9612(94)90224-0
   Sittinger M, 1996, BIOMATERIALS, V17, P237, DOI 10.1016/0142-9612(96)85561-X
   Spiegel D, 2002, GRAEF ARCH CLIN EXP, V240, P111, DOI 10.1007/s00417-001-0407-1
   Steiner P, 1997, DIFFERENTIATION, V62, P193
   Steinhagen J, 2010, TISSUE CELL, V42, P151, DOI 10.1016/j.tice.2010.03.003
   Sternberg K, 2004, UROLOGE A, V43, P1200, DOI 10.1007/s00120-004-0688-1
   Steuer H, 2005, INVEST OPHTH VIS SCI, V46, P1047, DOI 10.1167/iovs.04-0925
   Steuer H, 2004, BRAIN RES PROTOC, V13, P26, DOI 10.1016/j.brainresprot.2003.12.002
   Strehl R, 2004, TISSUE ENG, V10, P1196, DOI 10.1089/1076327041887853
   Tiemann U, 2005, PROSTAG OTH LIPID M, V76, P35, DOI 10.1016/j.prostaglandins.2004.10.006
   Tippe A, 2002, J AEROSOL SCI, V33, P207, DOI 10.1016/S0021-8502(01)00158-6
   Treumer F, 2012, EXP EYE RES, V97, P63, DOI 10.1016/j.exer.2012.02.011
   Uemura T, 2003, BIOMATERIALS, V24, P2277, DOI 10.1016/S0142-9612(03)00039-5
   Ulker H, 2013, HUM EXP TOXICOL, V33, P949
   Ulker Hayriye Esra, 2009, Eur J Dent, V3, P120
   Ulker HE, 2013, BIOMED RES INT, V2013
   Vajrabhaya LO, 2009, ORAL SURG ORAL MED O, V107, pE86, DOI 10.1016/j.tripleo.2008.11.008
   Volkmer E, 2008, TISSUE ENG PT A, V14, P1331, DOI 10.1089/ten.tea.2007.0231
   Volkmer E, 2012, J MATER SCI-MATER M, V23, P2793, DOI 10.1007/s10856-012-4725-0
   Wang YC, 2003, TISSUE ENG, V9, P1205, DOI 10.1089/10763270360728116
   Wei FL, 2013, STEM CELLS DEV, V22, P1752, DOI 10.1089/scd.2012.0688
   Wu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093012
   Xia L, 2009, BIOMATERIALS, V30, P5927, DOI 10.1016/j.biomaterials.2009.07.022
   Yamagishi K, 2006, ANAL BIOCHEM, V354, P15, DOI 10.1016/j.ab.2006.03.031
   Yeatts AB, 2011, BONE, V48, P171, DOI 10.1016/j.bone.2010.09.138
   Yue S, 2011, ACTA BIOMATER, V7, P2637, DOI 10.1016/j.actbio.2011.02.009
   Zheng WM, 2007, BIOL REPROD, V76, P1091, DOI 10.1095/biolreprod.106.057877
NR 179
TC 1
Z9 1
U1 0
U2 27
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-9069
EI 1573-0778
J9 CYTOTECHNOLOGY
JI Cytotechnology
PD MAR
PY 2016
VL 68
IS 2
BP 179
EP 196
DI 10.1007/s10616-015-9873-x
PG 18
WC Biotechnology & Applied Microbiology; Cell Biology
SC Biotechnology & Applied Microbiology; Cell Biology
GA DE1AW
UT WOS:000370359200001
PM 25894791
OA Green Published
DA 2018-10-19
ER

PT J
AU Cui, GH
   Shao, SJ
   Yang, JJ
   Liu, JR
   Guo, HD
AF Cui, Guo-hong
   Shao, Shui-jin
   Yang, Jia-jun
   Liu, Jian-ren
   Guo, Hai-dong
TI Designer Self-Assemble Peptides Maximize the Therapeutic Benefits of
   Neural Stem Cell Transplantation for Alzheimer's Disease via Enhancing
   Neuron Differentiation and Paracrine Action
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article
DE Alzheimer's disease; Neural stem cell; Transplantation; Self-assembling
   peptide; Differentiation
ID SPINAL-CORD-INJURY; AMYLOID BETA-PEPTIDE; PRECURSOR CELLS; GENE-THERAPY;
   MOUSE MODEL; RAT MODEL; NEUROGENESIS; MEMBRANE; ADHESION; PROLIFERATION
AB The neuropathological hallmarks of Alzheimer's disease (AD) include the presence of extracellular amyloid-beta peptide (A beta) in the form of amyloid plaques and neuronal loss. Neural stem cell (NSC) is being scrutinized as a promising cell replacement therapy for various neurodegenerative diseases. However, the unfavorable niche at the site of degenerative disease is hostile to the survival and differentiation of transplanted cells. Here, we undertook in vitro and in vivo works to examine whether a designer self-assemble peptide (DSP), which contains one functional domain Tyr-Ile-Gly-Ser-Arg (YIGSR) derived from laminin, promotes the survival and neuronal differentiation of NSC and behavioral improvement. We found that DSP could undergo spontaneous assembly into well-ordered nanofibers, and it not only facilitated the cell viability in normal culture condition, but also decreased the number of apoptotic cells induced by A beta in vitro. NSC seeded in DSP showed much more neuronal differentiation than that seeded in self-assemble peptide (SP) or alone. In the AD model, NSC transplantation in DSP-treated AD rats demonstrated much more obvious cognitive rescue with restoration of learning/memory function compared with NSC transplantation in SP, NSC alone, or DSP alone treated ones. Interestingly, DSP enhanced the survival and neuronal differentiation of transplanted NSC. Apoptosis levels in the CA1 region and A beta level in the hippocampus were significantly decreased in the group of NSC transplantation in DSP. Moreover, synaptic function, indicated by the expression of pre-synaptic protein synapsin-1, was restored and the secretion of anti-inflammatory and neurotrophic factors were increased, such as IL-10, brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF), and insulin-like growth factor 1 (IGF-1), while the expression of pro-inflammatory factors were decreased, such as TNF-alpha and IL-1 beta. These data firstly unveiled that the biomaterial DSP can maximize the therapeutic benefits of NSC transplantation for AD through improving the survival and differentiation of transplanted stem cells and promoting the effects of neuroprotection, anti-neuroinflammatory and paracrine action. Our results may have important clinical implications for the design of future NSC-based strategies using the biomaterials for various neurodegenerative diseases including AD.
C1 [Cui, Guo-hong; Liu, Jian-ren] Shanghai Jiao Tong Univ, Dept Neurol, Shanghai Peoples Hosp 9, Sch Med, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.
   [Cui, Guo-hong; Yang, Jia-jun] Shanghai 6 Peoples Hosp, Dept Neurol, Sch Med, 639 Zhizaoju Rd, Shanghai 200233, Peoples R China.
   [Shao, Shui-jin; Guo, Hai-dong] Shanghai Univ Tradit Chinese Med, Sch Basic Med, Dept Anat, 1200 Cailun Rd, Shanghai 201203, Peoples R China.
RP Liu, JR (reprint author), Shanghai Jiao Tong Univ, Dept Neurol, Shanghai Peoples Hosp 9, Sch Med, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.; Guo, HD (reprint author), Shanghai Univ Tradit Chinese Med, Sch Basic Med, Dept Anat, 1200 Cailun Rd, Shanghai 201203, Peoples R China.
EM liujr021@vip.163.com; hdguo8@hotmail.com
FU National Natural Science Foundation of China [31400838, 81102670];
   Program of Shanghai No. 9 People's Hospital [2013A05]; Shanghai Jiaotong
   University Biomedical Engineering Crossover Project [YG2011MS12];
   Shanghai Municipal Natural Science Foundation [13ZR1431100]
FX This work was supported by grants from National Natural Science
   Foundation of China (31400838 and 81102670), Program of Shanghai No. 9
   People's Hospital (2013A05), Shanghai Jiaotong University Biomedical
   Engineering Crossover Project (YG2011MS12), and Shanghai Municipal
   Natural Science Foundation (13ZR1431100).
CR Arimoto T, 2007, NEUROBIOL AGING, V28, P894, DOI 10.1016/j.neurobiolaging.2006.04.011
   Aumailley M, 1998, J ANAT, V193, P1, DOI 10.1046/j.1469-7580.1998.19310001.x
   Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106
   Brustle O, 1996, CURR OPIN NEUROBIOL, V6, P688, DOI 10.1016/S0959-4388(96)80104-8
   Burgos-Ramos E, 2008, NEUROSCIENCE, V154, P1458, DOI 10.1016/j.neuroscience.2008.04.036
   Carta MG, 2002, PSYCHOTHER PSYCHOSOM, V71, P233, DOI 10.1159/000063649
   Choi H, 2013, STEM CELLS DEV, V22, P2112, DOI 10.1089/scd.2012.0604
   Cigognini D, 2014, J BIOMED NANOTECHNOL, V10, P309, DOI 10.1166/jbn.2014.1759
   Ebert AD, 2008, EXP NEUROL, V209, P213, DOI 10.1016/j.expneurol.2007.09.022
   Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039
   Gelain F, 2012, NANOSCALE, V4, P2946, DOI 10.1039/c2nr30220a
   GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004
   GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330
   Guo HD, 2011, TISSUE ENG PT A, V17, P45, DOI [10.1089/ten.tea.2010.0124, 10.1089/ten.TEA.2010.0124]
   Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016
   Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x
   Haughey NJ, 2002, NEUROMOL MED, V1, P125, DOI 10.1385/NMM:1:2:125
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Inestrosa NC, 2005, EXP CELL RES, V304, P91, DOI 10.1016/j.yexcr.2004.09.032
   Jackson Graham A, 2014, Nurs Times, V110, P24
   KATZMAN R, 1986, NEW ENGL J MED, V314, P964, DOI 10.1056/NEJM198604103141506
   Klafki HW, 2006, BRAIN, V129, P2840, DOI 10.1093/brain/awl280
   Li QQ, 2014, J BIOMED MATER RES A, V102, P1991, DOI 10.1002/jbm.a.34876
   Li YC, 2013, COLLOID SURFACE B, V102, P53, DOI 10.1016/j.colsurfb.2012.08.054
   Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2
   Malinin NL, 2005, P NATL ACAD SCI USA, V102, P3058, DOI 10.1073/pnas.0408237102
   Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621
   Muller FJ, 2006, NAT REV NEUROSCI, V7, P75, DOI 10.1038/nrn1829
   Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491
   Musial A, 2007, CURR MED CHEM, V14, P2654, DOI 10.2174/092986707782023217
   Pannese E, 2011, BRAIN STRUCT FUNCT, V216, P85, DOI 10.1007/s00429-011-0308-y
   Park D, 2012, EXP NEUROL, V234, P521, DOI 10.1016/j.expneurol.2011.12.040
   Patel S, 2007, NANO LETT, V7, P2122, DOI 10.1021/nl071182z
   Paxinos G., 1997, RAT BRAIN STEREOTAXI
   Perry EK, 2012, NEUROBIOL DIS, V47, P155, DOI 10.1016/j.nbd.2012.03.033
   Porayette P, 2009, J BIOL CHEM, V284, P23806, DOI 10.1074/jbc.M109.026328
   Rodriguez JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002935
   Rozemuller Annemieke J. M., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P223, DOI 10.2174/1568007054038229
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069
   Stephan A, 2005, GENES BRAIN BEHAV, V4, P157, DOI 10.1111/j.1601-183X.2004.00113.x
   Stephan A, 2001, J NEUROSCI, V21, P5703
   Tian XQ, 2012, INT J NEUROSCI, V122, P563, DOI 10.3109/00207454.2012.690797
   Tong YW, 2001, BIOMATERIALS, V22, P1029, DOI 10.1016/S0142-9612(00)00338-0
   Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239
   Wei Z, 2008, NEUROPHARMACOLOGY, V54, P721, DOI 10.1016/j.neuropharm.2007.12.006
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zhang W, 2014, J NEUROSCI RES, V92, P185, DOI 10.1002/jnr.23299
   Zhou ZG, 2009, EXP NEUROL, V220, P183, DOI 10.1016/j.expneurol.2009.08.018
NR 50
TC 7
Z9 9
U1 0
U2 32
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD MAR
PY 2016
VL 53
IS 2
BP 1108
EP 1123
DI 10.1007/s12035-014-9069-y
PG 16
WC Neurosciences
SC Neurosciences & Neurology
GA DD8OS
UT WOS:000370187100025
PM 25586060
OA Other Gold, Green Published
DA 2018-10-19
ER

PT J
AU Usprech, J
   Chen, WLK
   Simmons, CA
AF Usprech, Jenna
   Chen, Wen Li Kelly
   Simmons, Craig A.
TI Heart valve regeneration: the need for systems approaches
SO WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; VALVULAR INTERSTITIAL-CELLS; AORTIC-VALVE;
   EXTRACELLULAR-MATRIX; IN-VITRO; GROWTH-FACTOR; PULSATILE BIOREACTOR;
   CURRENT CHALLENGES; PROGENITOR CELLS; 1ST EXPERIENCES
AB Tissue-engineered heart valves are promising alternatives to address the limitations of current valve replacements, particularly for growing children. Current heart valve tissue engineering strategies involve the selection of biomaterial scaffolds, cell types, and often in vitro culture conditions aimed at regenerating a valve for implantation and subsequent maturation in vivo. However, identifying optimal combinations of cell sources, biomaterials, and/or bioreactor conditions to produce functional, durable valve tissue remains a challenge. Despite some short-term success in animal models, attempts to recapitulate aspects of the native heart valve environment based on best guesses' of a limited number of regulatory factors have not proven effective. Better outcomes for valve tissue regeneration will likely require a systems-level understanding of the relationships between multiple interacting regulatory factors and their effects on cell function and tissue formation. Until recently, conventional culture methods have not allowed for multiple design parameters to be considered at once. Emerging microtechnologies are well suited to systematically probe multiple inputs, in combination, in high throughput and with great precision. When combined with statistical and network systems analyses, these microtechnologies have excellent potential to define multivariate signal-response relationships and reveal key regulatory pathways for robust functional tissue regeneration. WIREs Syst Biol Med 2016, 8:169-182. doi: 10.1002/wsbm.1329 For further resources related to this article, please visit the .
C1 [Usprech, Jenna; Chen, Wen Li Kelly; Simmons, Craig A.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
   [Simmons, Craig A.] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON, Canada.
RP Simmons, CA (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.; Simmons, CA (reprint author), Univ Toronto, Dept Mech & Ind Engn, Toronto, ON, Canada.
EM c.simmons@utoronto.ca
RI Simmons, Craig/A-5880-2008
OI Simmons, Craig/0000-0001-7729-1772
CR Aikawa E, 2006, CIRCULATION, V113, P1344, DOI 10.1161/CIRCULATIONAHA.105.591768
   Alavi SH, 2015, ANN THORAC SURG, V99, P2183, DOI 10.1016/j.athoracsur.2015.02.058
   Anderson SB, 2011, BIOMATERIALS, V32, P3564, DOI 10.1016/j.biomaterials.2011.01.064
   Appleton AJE, 2009, TISSUE ENG PT A, V15, P3889, DOI [10.1089/ten.tea.2009.0031, 10.1089/ten.TEA.2009.0031]
   Balachandran K, 2009, AM J PHYSIOL-HEART C, V296, pH756, DOI 10.1152/ajpheart.00900.2008
   Balguid A, 2007, TISSUE ENG, V13, P1501, DOI 10.1089/ten.2006.0279
   Balguid A, 2009, CIRCULATION, V119, P290, DOI 10.1161/CIRCULATIONAHA.107.749853
   Benton JA, 2009, TISSUE ENG PT A, V15, P3221, DOI [10.1089/ten.tea.2008.0545, 10.1089/ten.TEA.2008.0545]
   Benton JA, 2009, BIOMATERIALS, V30, P6593, DOI 10.1016/j.biomaterials.2009.08.031
   Bloch O, 2011, TISSUE ENG PT A, V17, P2399, DOI [10.1089/ten.tea.2011.0046, 10.1089/ten.TEA.2011.0046]
   Boerboom RA, 2008, ANN BIOMED ENG, V36, P244, DOI 10.1007/s10439-007-9413-8
   Butcher JT, 2011, ADV DRUG DELIVER REV, V63, P242, DOI 10.1016/j.addr.2011.01.008
   Butcher JT, 2004, ARTERIOSCL THROM VAS, V24, P1429, DOI 10.1161/01.ATV.0000130462.50769.5a
   Chen JH, 2011, ARTERIOSCL THROM VAS, V31, P590, DOI 10.1161/ATVBAHA.110.220061
   Chen JH, 2009, AM J PATHOL, V174, P1109, DOI 10.2353/ajpath.2009.080750
   Chester AH, 2007, PHILOS T R SOC B, V362, P1437, DOI 10.1098/rstb.2007.2126
   Colazzo F, 2011, BIOMATERIALS, V32, P119, DOI 10.1016/j.biomaterials.2010.09.003
   Cosgrove BD, 2008, CELL MOL BIOENG, V1, P33, DOI 10.1007/s12195-008-0007-9
   Cushing MC, 2008, FASEB J, V22, P1769, DOI 10.1096/fj.07-087627
   Cushing MC, 2007, BIOMATERIALS, V28, P3378, DOI 10.1016/j.biomaterials.2007.04.005
   Del Gaudio C, 2008, ANN I SUPER SANITA, V44, P178
   Dolatshahi-Pirouz A, 2014, SCI REP-UK, V4, DOI 10.1038/srep03896
   Dor Y, 2003, ANAT REC PART A, V271A, P202, DOI 10.1002/ar.a.10026
   Dreger SA, 2002, J HEART VALVE DIS, V11, P875
   Driessen-Mol A, 2014, J AM COLL CARDIOL, V63, P1320, DOI 10.1016/j.jacc.2013.09.082
   Duan B, 2014, ACTA BIOMATER, V10, P1836, DOI 10.1016/j.actbio.2013.12.005
   Duan B, 2015, TISSUE ENG PART C-ME, V21, P1
   Dube J, 2014, ACTA BIOMATER, V10, P3563, DOI 10.1016/j.actbio.2014.04.033
   Eckert CE, 2011, ANN BIOMED ENG, V39, P205, DOI 10.1007/s10439-010-0162-8
   El Oakley R, 2008, CIRCULATION, V117, P253, DOI 10.1161/CIRCULATIONAHA.107.736819
   Emmert MY, 2012, JACC-CARDIOVASC INTE, V5, P874, DOI 10.1016/j.jcin.2012.04.010
   Engelmayr GC, 2003, BIOMATERIALS, V24, P2523, DOI 10.1016/S0142-9612(03)00051-6
   Engelmayr GC, 2008, ANN BIOMED ENG, V36, P700, DOI 10.1007/s10439-008-9447-6
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Esch EW, 2015, NAT REV DRUG DISCOV, V14, P248, DOI 10.1038/nrd4539
   Eslami M, 2014, J BIOMATER APPL, V29, P399, DOI 10.1177/0885328214530589
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Flanagan TC, 2006, BIOMATERIALS, V27, P2233, DOI 10.1016/j.biomaterials.2005.10.031
   Flanagan TC, 2009, TISSUE ENG PART A, V15, P2966
   Frank BS, 2012, J SURG RES, V174, P39, DOI 10.1016/j.jss.2010.11.911
   Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]
   Gould ST, 2013, CIRC RES, V113, P186, DOI 10.1161/CIRCRESAHA.112.300154
   Gould ST, 2012, ACTA BIOMATER, V8, P3201, DOI 10.1016/j.actbio.2012.05.009
   Hinton RB, 2011, ANNU REV PHYSIOL, V73, P29, DOI 10.1146/annurev-physiol-012110-142145
   Hoerstrup SP, 2000, CIRCULATION, V102, P44
   Hoerstrup SP, 2000, TISSUE ENG, V6, P75, DOI 10.1089/107632700320919
   Hoerstrup SP, 2002, CIRCULATION S1, V106
   Huang SD, 2007, HEART VESSELS, V22, P116, DOI 10.1007/s00380-006-0940-2
   Iwamoto R, 2006, CELL STRUCT FUNCT, V31, P1, DOI 10.1247/csf.31.1
   Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598
   Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041
   Kalfa D, 2010, BIOMATERIALS, V31, P4056, DOI 10.1016/j.biomaterials.2010.01.135
   Kloxin AM, 2010, BIOMATERIALS, V31, P1, DOI 10.1016/j.biomaterials.2009.09.025
   L'Heureux N, 1998, FASEB J, V12, P47
   Larouche Danielle, 2009, V482, P233, DOI 10.1007/978-1-59745-060-7_15
   Lau KS, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001393
   Liu HJ, 2016, ACTA BIOMATER, V34, P113, DOI 10.1016/j.actbio.2015.11.054
   Lueders C, 2014, EUR J CARDIO-THORAC, V46, P593, DOI 10.1093/ejcts/ezt510
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ma T, 2009, BIOTECHNOL PROGR, V25, P32, DOI [10.1021/bp.128, 10.1002/btpr.128]
   Majore I, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-6
   Masoumi N, 2014, BIOMATERIALS, V35, P7774, DOI 10.1016/j.biomaterials.2014.04.039
   Masters KS, 2005, BIOMATERIALS, V26, P2517, DOI 10.1016/j.biomaterials.2004.07.018
   Masters KS, 2010, J BIOMED MATER RES A, V94, P1620
   Merryman WD, 2007, TISSUE ENG, V13, P2281, DOI 10.1089/ten.2006.0324
   Mol A, 2005, ANN BIOMED ENG, V33, P1778, DOI 10.1007/s10439-005-8025-4
   Mol A, 2009, EXPERT REV MED DEVIC, V6, P259, DOI [10.1586/erd.09.12, 10.1586/ERD.09.12]
   Moraes C, 2013, INTEGR BIOL-UK, V5, P673, DOI 10.1039/c3ib20254b
   Moraes C, 2010, LAB CHIP, V10, P227, DOI 10.1039/b914460a
   Morsi YS, 2007, J ARTIF ORGANS, V10, P109, DOI 10.1007/s10047-006-0369-5
   Myken PSU, 2009, J THORAC CARDIOV SUR, V137, P76, DOI 10.1016/j.jtcvs.2008.05.068
   Narine K, 2006, TISSUE ENG, V12, P2707, DOI 10.1089/ten.2006.12.2707
   Pho M, 2008, AM J PHYSIOL-HEART C, V294, pH1767, DOI 10.1152/ajpheart.01305.2007
   Rabkin-Aikawa E, 2005, ADV BIOCHEM ENG BIOT, V94, P141, DOI 10.1007/b100003
   Rajamannan NM, 2011, CIRCULATION, V124, P1783, DOI 10.1161/CIRCULATIONAHA.110.006767
   Ramaswamy S, 2010, BIOMATERIALS, V31, P1114, DOI 10.1016/j.biomaterials.2009.10.019
   Rodriguez KJ, 2009, J BIOMED MATER RES A, V90A, P1043, DOI 10.1002/jbm.a.32187
   Rothenburger M, 2002, ASAIO J, V48, P586, DOI 10.1097/01.MAT.0000033637.90113.1E
   Rubbens MP, 2009, TISSUE ENG PT A, V15, P999, DOI 10.1089/ten.tea.2007.0396
   Sacks MS, 2007, PHILOS T R SOC B, V362, P1369, DOI 10.1098/rstb.2007.2122
   Sacks MS, 2009, ANNU REV BIOMED ENG, V11, P289, DOI 10.1146/annurev-bioeng-061008-124903
   Sacks MS, 2009, J BIOMECH, V42, P1804, DOI 10.1016/j.jbiomech.2009.05.015
   Sales VL, 2007, CIRCULATION, V116, pI55, DOI 10.1161/CIRCULATIONAHA.106.6806637
   Sant S, 2011, J TISSUE ENG REGEN M, V5, P283, DOI 10.1002/term.313
   Sarugaser R, 2009, PLOS ONE, V4, P1
   Schmidt D, 2007, PHILOS T R SOC B, V362, P1505, DOI 10.1098/rstb.2007.2131
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   Shi YL, 2002, BIOMED SCI INSTRUM, V38, P35
   Sider K. L., 2011, INT J INFLAM, V2011, P18, DOI DOI 10.4061/2011/364310
   Simpson DL, 2014, ANN THORAC SURG, V98, P947, DOI 10.1016/j.athoracsur.2014.04.075
   Sodian R, 2006, ANN THORAC SURG, V81, P2207, DOI 10.1016/j.athoracsur.2005.12.073
   Sodian R, 2002, ASAIO J, V48, P12, DOI 10.1097/00002480-200201000-00004
   Sodian R, 2000, ASAIO J, V46, P107, DOI 10.1097/00002480-200001000-00025
   Sodian R, 2000, TISSUE ENG, V6, P183, DOI 10.1089/107632700320793
   Stock UA, 2000, J THORAC CARDIOV SUR, V119, P732, DOI 10.1016/S0022-5223(00)70008-0
   Stradins P, 2004, EUR J CARDIO-THORAC, V26, P634, DOI 10.1016/j.ejcts.2004.05.043
   Sutherland FWH, 2005, CIRCULATION, V111, P2783, DOI 10.1161/CIRCULATIONAHA.104.498378
   Syedain Z., 2011, CARDIOVASC ENG TECHN, V2, P101, DOI DOI 10.1007/S13239-011-0039-5>[ACCESSED
   Syedain ZH, 2013, TISSUE ENG PT A, V19, P759, DOI [10.1089/ten.tea.2012.0365, 10.1089/ten.TEA.2012.0365]
   Syedain ZH, 2009, BIOMATERIALS, V30, P4078, DOI 10.1016/j.biomaterials.2009.04.027
   Taylor PM, 2007, PHILOS T R SOC B, V362, P1313, DOI 10.1098/rstb.2007.2117
   Tedder ME, 2009, TISSUE ENG PART A, V15, P1258
   Theodoris CV, 2015, CELL, V160, P1072, DOI 10.1016/j.cell.2015.02.035
   Tseng H, 2013, ANN BIOMED ENG, V41, P398, DOI 10.1007/s10439-012-0666-5
   Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395
   van Vlimmeren MAA, 2010, J APPL PHYSIOL, V109, P1483, DOI 10.1152/japplphysiol.00571.2010
   Vis PWR, 2011, EUR J CARDIO-THORAC, V39, P8, DOI 10.1016/j.ejcts.2010.05.032
   Waxman AS, 2012, J VET CARDIOL, V14, P211, DOI 10.1016/j.jvc.2012.02.006
   Weber B, 2011, EUR HEART J, V32, P2830, DOI 10.1093/eurheartj/ehr059
   Winer JP, 2009, TISSUE ENG PT A, V15, P147, DOI 10.1089/ten.tea.2007.0388
   Yip CYY, 2009, ARTERIOSCL THROM VAS, V29, P936, DOI 10.1161/ATVBAHA.108.182394
   Zund G, 1997, EUR J CARDIO-THORAC, V11, P493, DOI 10.1016/S1010-7940(96)01005-6
NR 113
TC 9
Z9 9
U1 2
U2 13
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1939-5094
EI 1939-005X
J9 WIRES SYST BIOL MED
JI Wiley Interdiscip. Rev.-Syst. Biol
PD MAR-APR
PY 2016
VL 8
IS 2
BP 169
EP 182
DI 10.1002/wsbm.1329
PG 14
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DE5BB
UT WOS:000370644400005
PM 26862013
DA 2018-10-19
ER

PT J
AU Miron, RJ
   Bosshardt, DD
AF Miron, Richard J.
   Bosshardt, Dieter D.
TI OsteoMacs: Key players around bone biomaterials
SO BIOMATERIALS
LA English
DT Review
DE Macrophage; Bone regeneration; Osteoimmunology; Biomaterial integration;
   Tissue response; Multi-nucleated giant cells; OsteoMacs; Foreign body
   cells
ID BIPHASIC CALCIUM-PHOSPHATE; GIANT-CELL FORMATION; ALTERNATIVELY
   ACTIVATED MACROPHAGES; BETA-TRICALCIUM PHOSPHATE; FOREIGN-BODY REACTION;
   MONONUCLEAR PHAGOCYTE SYSTEM; TISSUE-RESIDENT MACROPHAGES; TITANIUM
   SURFACE-TOPOGRAPHY; TRANSFORMING-GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA
AB Osteal macrophages (OsteoMacs) are a special subtype of macrophage residing in bony tissues. Interesting findings from basic research have pointed to their vast and substantial roles in bone biology by demonstrating their key function in bone formation and remodeling. Despite these essential findings, much less information is available concerning their response to a variety of biomaterials used for bone regeneration with the majority of investigation primarily focused on their role during the foreign body reaction. With respect to biomaterials, it is well known that cells derived from the monocyte/macrophage lineage are one of the first cell types in contact with implanted biomaterials. Here they demonstrate extremely plastic phenotypes with the ability to differentiate towards classical M1 or M2 macrophages, or subsequently fuse into osteoclasts or multinucleated giant cells (MNGCs). These MNGCs have previously been characterized as foreign body giant cells and associated with biomaterial rejection, however more recently their phenotypes have been implicated with wound healing and tissue regeneration by studies demonstrating their expression of key M2 markers around biomaterials. With such contrasting hypotheses, it becomes essential to better understand their roles to improve the development of osteo-compatible and osteo-promotive biomaterials. This review article expresses the necessity to further study OsteoMacs and MNGCs to understand their function in bone biomaterial tissue integration including dental/orthopedic implants and bone grafting materials. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Miron, Richard J.; Bosshardt, Dieter D.] Univ Bern, Dept Oral Surg & Stomatol, Dept Periodontol, Freiburgstrasse 7, CH-3010 Bern, Switzerland.
RP Miron, RJ (reprint author), Univ Bern, Oral Cell Biol, CH-3010 Bern, Switzerland.; Bosshardt, DD (reprint author), Univ Bern, Oral Histol, CH-3010 Bern, Switzerland.
EM richard.miron@zmk.unibe.ch; dieter.bosshardt@zmk.unibe.ch
RI Bosshardt, Dieter/C-9442-2012
CR Albrektsson T, 2014, CLIN IMPLANT DENT R, V16, P155, DOI 10.1111/cid.12142
   Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354
   Alfarsi MA, 2014, J BIOMED MATER RES A, V102, P60, DOI 10.1002/jbm.a.34666
   Ambarus CA, 2012, J IMMUNOL METHODS, V375, P196, DOI 10.1016/j.jim.2011.10.013
   Anderson CF, 2002, J ENDOTOXIN RES, V8, P477, DOI 10.1179/096805102125001118
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2007, BIOMATERIALS, V28, P5114, DOI [10.1016/j.biomaterials.2007.07.010, 10.1016/j.biornaterials.2007.07.010]
   Anderson JM, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5423-5
   Arron JR, 2000, NATURE, V408, P535, DOI 10.1038/35046196
   ASSOIAN RK, 1987, P NATL ACAD SCI USA, V84, P6020, DOI 10.1073/pnas.84.17.6020
   Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883
   AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013
   Balce DR, 2011, BLOOD, V118, P4199, DOI 10.1182/blood-2011-01-328906
   Barth KA, 2013, J BIOMED MATER RES A, V101, P2679, DOI 10.1002/jbm.a.34562
   Benahmed M, 1996, BIOMATERIALS, V17, P2173, DOI 10.1016/0142-9612(96)00046-4
   Benahmed M, 1997, J BIOMED MATER RES, V34, P115, DOI 10.1002/(SICI)1097-4636(199701)34:1<115::AID-JBM15>3.0.CO;2-J
   Biswas SK, 2012, IMMUNOL RES, V53, P11, DOI 10.1007/s12026-012-8291-9
   Blom AB, 2004, OSTEOARTHR CARTILAGE, V12, P627, DOI 10.1016/j.joca.2004.03.003
   Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320
   Bonifer C, 2008, FRONT BIOSCI-LANDMRK, V13, P549, DOI 10.2741/2700
   BOURQUE WT, 1993, INT J DEV BIOL, V37, P573
   Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658
   Brinkmann J, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0034-x
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2009, CURR OPIN HEMATOL, V16, P53, DOI 10.1097/MOH.0b013e32831ac52e
   Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97
   Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442
   Buser D, 2013, J DENT RES, V92, p176S, DOI 10.1177/0022034513504949
   Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010
   CECCHINI MG, 1994, DEVELOPMENT, V120, P1357
   Champagne CM, 2002, BONE, V30, P26, DOI 10.1016/S8756-3282(01)00638-X
   Chang DT, 2008, J BIOMED MATER RES A, V87A, P676, DOI 10.1002/jbm.a.31630
   Chang DT, 2009, J BIOMED MATER RES A, V89A, P490, DOI 10.1002/jbm.a.31981
   Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232
   Chappuis V, 2013, J DENT RES, V92, p195S, DOI 10.1177/0022034513506713
   Chappuis V., 2015, CLIN IMPLANT DENT RE
   Chehroudi B, 2010, J BIOMED MATER RES A, V93A, P724, DOI 10.1002/jbm.a.32587
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Chen ZT, 2015, BIOMATERIALS, V61, P126, DOI 10.1016/j.biomaterials.2015.04.044
   Chen ZT, 2014, BIOMATERIALS, V35, P1507, DOI 10.1016/j.biomaterials.2013.11.014
   Chen ZT, 2014, BIOMATERIALS, V35, P8553, DOI 10.1016/j.biomaterials.2014.06.038
   Chistiakov DA, 2015, J CELL MOL MED, V19, P1163, DOI 10.1111/jcmm.12591
   Chistiakov DA, 2015, INT J CARDIOL, V184, P436, DOI 10.1016/j.ijcard.2015.03.055
   Cho SW, 2014, P NATL ACAD SCI USA, V111, P1545, DOI 10.1073/pnas.1315153111
   Curran JM, 2005, BIOMATERIALS, V26, P5313, DOI [10.1016/j.biomaterials.2005.01.065, 10.1016/.jbiomaterials.2005.01.065]
   Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111
   Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236
   Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705
   Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877
   Davison NL, 2015, EUR CELLS MATER, V29, P314, DOI 10.22203/eCM.v029a24
   Davison NL, 2014, EUR CELLS MATER, V27, P281, DOI 10.22203/eCM.v027a20
   Davison N.L., 2014, EUR CELLS MATER, V27, P96
   Davison NL, 2014, BIOMATERIALS, V35, P7441, DOI 10.1016/j.biomaterials.2014.05.048
   Davison NL, 2014, BIOMATERIALS, V35, P5088, DOI 10.1016/j.biomaterials.2014.03.013
   DeFife KM, 1999, J HISTOCHEM CYTOCHEM, V47, P65, DOI 10.1177/002215549904700107
   Drake MT, 2015, CLIN THER, V37, P1837, DOI 10.1016/j.clinthera.2015.06.006
   Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249
   Egli RJ, 2011, ADV ENG MATER, V13, pB102, DOI 10.1002/adem.201080037
   Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7
   Favus M.J., 1996, PRIMER METABOLIC BON, V37, P553
   Fellah BH, 2007, J MATER SCI-MATER M, V18, P287, DOI 10.1007/s10856-006-0691-8
   Fellah BH, 2010, J BIOMED MATER RES A, V93A, P1588, DOI 10.1002/jbm.a.32663
   Fleetwood AJ, 2009, J LEUKOCYTE BIOL, V86, P411, DOI 10.1189/jlb.1108702
   Gamblin AL, 2014, BIOMATERIALS, V35, P9660, DOI 10.1016/j.biomaterials.2014.08.018
   Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435
   Ghrebi S, 2013, J BIOMED MATER RES A, V101, P2118, DOI 10.1002/jbm.a.34509
   Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671
   Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756
   Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Gratchev A, 2008, J IMMUNOL, V180, P6553, DOI 10.4049/jimmunol.180.10.6553
   Gundra UM, 2014, BLOOD, V123, pE110, DOI 10.1182/blood-2013-08-520619
   Hamlet S, 2012, CLIN ORAL IMPLAN RES, V23, P584, DOI 10.1111/j.1600-0501.2011.02325.x
   Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004
   HATTNER R, 1965, NATURE, V206, P489, DOI 10.1038/206489a0
   Haynes DR, 2001, RHEUMATOLOGY, V40, P623, DOI 10.1093/rheumatology/40.6.623
   Haynes DR, 1997, J BONE JOINT SURG BR, V79B, P988, DOI 10.1302/0301-620X.79B6.7832
   Hefti T, 2010, BIOMATERIALS, V31, P7321, DOI 10.1016/j.biomaterials.2010.06.009
   Heinemann DEH, 2000, IMMUNOBIOLOGY, V202, P68, DOI 10.1016/S0171-2985(00)80054-6
   Heinemann DEH, 2000, J BONE JOINT SURG BR, V82B, P283, DOI 10.1302/0301-620X.82B2.9730
   Helming L, 2007, IMMUNOBIOLOGY, V212, P785, DOI 10.1016/j.imbio.2007.09.012
   Helming L, 2007, EUR J IMMUNOL, V37, P33, DOI 10.1002/eji.200636788
   Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005
   Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533
   Heymann Felix, 2009, Inflammation & Allergy Drug Targets, V8, P307
   Hodge JM, 2004, J BONE MINER RES, V19, P190, DOI 10.1359/JBMR.0301232
   HUME DA, 1984, J CELL SCI, V66, P189
   Hume DA, 2006, CURR OPIN IMMUNOL, V18, P49, DOI 10.1016/j.coi.2005.11.008
   Hume DA, 2002, J LEUKOCYTE BIOL, V72, P621
   Ingham E, 2005, BIOMATERIALS, V26, P1271, DOI 10.1016/j.biomaterials.2004.04.035
   Itoh K, 2003, J IMMUNOL, V170, P3688, DOI 10.4049/jimmunol.170.7.3688
   James CG, 2005, MOL BIOL CELL, V16, P5316, DOI 10.1091/mbc.E05-01-0084
   JANSEN A, 1992, KIDNEY INT, V42, P1107, DOI 10.1038/ki.1992.394
   Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999
   Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   Jensen SS, 2014, J PERIODONTOL, V85, P1549, DOI 10.1902/jop.2014.140182
   Jensen SS, 2007, CLIN ORAL IMPLAN RES, V18, P752, DOI 10.1111/j.1600-0501.2007.01417.x
   Jilka RL, 2007, J BONE MINER RES, V22, P1492, DOI 10.1359/JBMR.070518
   Jimi E, 1999, EXP CELL RES, V247, P84, DOI 10.1006/excr.1998.4320
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Jude EB, 1999, DIABETOLOGIA, V42, P748, DOI 10.1007/s001250051224
   Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004
   Kaneko M, 2001, RHEUMATOLOGY, V40, P247, DOI 10.1093/rheumatology/40.3.247
   Katsuyama E, 2015, J BIOL CHEM, V290, P716, DOI 10.1074/jbc.M114.568360
   Kikuchi T, 2001, J IMMUNOL, V166, P3574, DOI 10.4049/jimmunol.166.5.3574
   Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275
   Kong YY, 1999, NATURE, V397, P315
   Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990
   KREUTZ M, 1993, BLOOD, V82, P1300
   Kronstrom M, 2000, J CLIN PERIODONTOL, V27, P875, DOI 10.1034/j.1600-051x.2000.027012875.x
   Kuwana M, 2003, J LEUKOCYTE BIOL, V74, P833, DOI 10.1189/jlb.0403170
   Kweon H, 2014, BIOMATERIALS, V35, P8576, DOI 10.1016/j.biomaterials.2014.06.050
   Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787
   Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253
   Lay G, 2007, J PATHOL, V211, P76, DOI 10.1002/path.2092
   Lean JM, 2000, BONE, V27, P29, DOI 10.1016/S8756-3282(00)00306-9
   Lemaire I, 2006, J IMMUNOL, V177, P7257, DOI 10.4049/jimmunol.177.10.7257
   Lessner SM, 2002, AM J PATHOL, V160, P2145, DOI 10.1016/S0002-9440(10)61163-7
   Lipford GB, 1997, EUR J IMMUNOL, V27, P3420, DOI 10.1002/eji.1830271242
   Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540
   Louis CA, 1999, AM J PHYSIOL-REG I, V276, pR237
   Lu J, 2015, ACTA BIOMATER, V16, P223, DOI 10.1016/j.actbio.2015.01.036
   Ma QL, 2014, BIOMATERIALS, V35, P9853, DOI 10.1016/j.biomaterials.2014.08.025
   MacLauchlan S, 2009, J LEUKOCYTE BIOL, V85, P617, DOI 10.1189/jlb.1008588
   Makihira S, 2007, DENT MATER J, V26, P739, DOI 10.4012/dmj.26.739
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004
   Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13
   Maruyama K, 2006, J BONE MINER METAB, V24, P454, DOI 10.1007/s00774-006-0708-x
   Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027
   McNally AK, 2005, EXP MOL PATHOL, V79, P126, DOI 10.1016/j.yexmp.2005.06.008
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   McNally AK, 2007, J BIOMED MATER RES A, V82A, P568, DOI 10.1002/bjm.a.31161
   McNally AK, 2015, J BIOMED MATER RES A, V103, P1380, DOI 10.1002/jbm.a.35280
   McNally AK, 2011, EXP MOL PATHOL, V91, P673, DOI 10.1016/j.yexmp.2011.06.012
   Menzies FM, 2010, CLIN EXP IMMUNOL, V160, P369, DOI 10.1111/j.1365-2249.2009.04086.x
   Milleret V, 2011, EUR CELLS MATER, V21, P430, DOI 10.22203/eCM.v021a32
   Mills CD, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00059
   Mirza R, 2011, CYTOKINE, V56, P256, DOI 10.1016/j.cyto.2011.06.016
   MODOLELL M, 1995, EUR J IMMUNOL, V25, P1101, DOI 10.1002/eji.1830250436
   Moreira AP, 2011, J INTERF CYTOK RES, V31, P485, DOI 10.1089/jir.2011.0027
   Moreno JL, 2007, J LEUKOCYTE BIOL, V82, P1542, DOI 10.1189/jlb.0107058
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   Munder M, 2005, BLOOD, V105, P2549, DOI 10.1182/blood-2004-07-2521
   Mundy GR, 2006, CELL, V126, P441, DOI 10.1016/j.cell.2006.07.015
   Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008
   Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409
   Mylonas KJ, 2009, J IMMUNOL, V182, P3084, DOI 10.4049/jimmunol.0803463
   Nich C, 2013, J BIOMED MATER RES A, V101, P3033, DOI 10.1002/jbm.a.34599
   Novak ML, 2013, J LEUKOCYTE BIOL, V93, P875, DOI 10.1189/jlb.1012512
   Oh J, 2012, J BIOL CHEM, V287, P11629, DOI 10.1074/jbc.M111.338673
   Olmsted-Davis EA, 2003, P NATL ACAD SCI USA, V100, P15877, DOI 10.1073/pnas.2632959100
   Parfitt AM, 2001, J BONE MINER RES, V16, P1583, DOI 10.1359/jbmr.2001.16.9.1583
   PASSLICK B, 1989, BLOOD, V74, P2527
   Pettit AR, 2008, BONE, V43, P976, DOI 10.1016/j.bone.2008.08.128
   Raes G, 2005, J LEUKOCYTE BIOL, V77, P321, DOI 10.1189/jlb.0304212
   Raggatt LJ, 2014, AM J PATHOL, V184, P3192, DOI 10.1016/j.ajpath.2014.08.017
   Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087
   Rao AJ, 2012, ACTA BIOMATER, V8, P2815, DOI 10.1016/j.actbio.2012.03.042
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Reyes-Botella C, 2000, J PERIODONTOL, V71, P614, DOI 10.1902/jop.2000.71.4.614
   Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150
   Rice JM, 2003, CALCIFIED TISSUE INT, V72, P726, DOI 10.1007/s00223-002-2045-y
   Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258
   RODAN GA, 1981, CALCIFIED TISSUE INT, V33, P349, DOI 10.1007/BF02409454
   Rodriguez A, 2009, J BIOMED MATER RES A, V90A, P106, DOI 10.1002/jbm.a.32050
   Roma-Lavisse C, 2015, DIABETES VASC DIS RE, V12, P279, DOI 10.1177/1479164115582351
   Ruiz C, 2003, CELL PHYSIOL BIOCHEM, V13, P309, DOI 10.1159/000074546
   Rutschman R, 2001, J IMMUNOL, V166, P2173, DOI 10.4049/jimmunol.166.4.2173
   SANDBERG M, 1988, DEVELOPMENT, V102, P461
   Saulacic N, 2012, EUR CELLS MATER, V23, P273, DOI 10.22203/eCM.v023a21
   SAULACIC N, 2012, EUR CELLS MATER, V23, P86
   Saulacic N, 2014, CLIN IMPLANT DENT R, V16, P313, DOI 10.1111/cid.12070
   Schneemann M, 2002, NAT IMMUNOL, V3, P102, DOI 10.1038/ni0202-102a
   Schneemann M, 2007, J LEUKOCYTE BIOL, V81, P579, DOI 10.1189/jlb.1106702
   Scislowska-Czarnecka A, 2012, TISSUE CELL, V44, P391, DOI 10.1016/j.tice.2012.08.002
   Selander KS, 1996, MOL PHARMACOL, V50, P1127
   Shearer JD, 1997, AM J PHYSIOL-ENDOC M, V272, pE181
   Shioi A, 2002, CIRC RES, V91, P9, DOI 10.1161/01.RES.0000026421.61398.F2
   Shirey KA, 2014, MUCOSAL IMMUNOL, V7, P549, DOI 10.1038/mi.2013.71
   Shirey KA, 2010, MUCOSAL IMMUNOL, V3, P291, DOI 10.1038/mi.2010.6
   Shirey KA, 2008, J IMMUNOL, V181, P4159, DOI 10.4049/jimmunol.181.6.4159
   Shiwaku Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132903
   Silva SN, 2003, J BIOMED MATER RES A, V65A, P475, DOI 10.1002/jbm.a.10544
   Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3
   Song EW, 2000, CELL IMMUNOL, V204, P19, DOI 10.1006/cimm.2000.1687
   Sparwasser T, 1997, EUR J IMMUNOL, V27, P1671, DOI 10.1002/eji.1830270712
   Spencer M, 2010, AM J PHYSIOL-ENDOC M, V299, pE1016, DOI 10.1152/ajpendo.00329.2010
   Stacey KJ, 1996, J IMMUNOL, V157, P2116
   Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342
   Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272
   Stout RD, 2009, J LEUKOCYTE BIOL, V86, P1105, DOI 10.1189/jlb.0209073
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   SUDA T, 1992, ENDOCR REV, V13, P66, DOI 10.1210/er.13.1.66
   Swier V. J., 2015, HISTOL HISTOPATHOL, P11652, DOI DOI 10.14670/HH-11-652
   Swirski FK, 2006, P NATL ACAD SCI USA, V103, P10340, DOI 10.1073/pnas.0604260103
   Takahashi F, 2004, LUNG, V182, P173
   Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a
   Takebe J, 2003, J BIOMED MATER RES A, V64A, P207, DOI 10.1002/jbm.a.10275
   Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477
   Tan KS, 2006, BIOMATERIALS, V27, P5170, DOI 10.1016/j.biomaterials.2006.05.002
   Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816
   Teitelbaum SL, 2005, J CLIN ENDOCR METAB, V90, P2466, DOI 10.1210/jc.2005-0338
   Thalji Ghadeer, 2014, Int J Oral Maxillofac Implants, V29, pe171, DOI 10.11607/jomi.te55
   Thalji GN, 2014, CLIN ORAL IMPLAN RES, V25, P1273, DOI 10.1111/clr.12266
   Theurl I, 2005, BIOMETALS, V18, P359, DOI 10.1007/s10534-005-3710-1
   Tintut Y, 2002, CIRCULATION, V105, P650, DOI 10.1161/hc0502.102969
   Trindade R., 2014, CLIN IMPLANT DENT RE
   Trindade R, 2015, ORAL MAXIL SURG CLIN, V27, P175, DOI 10.1016/j.coms.2015.01.004
   Valles G, 2008, BIOMATERIALS, V29, P2326, DOI 10.1016/j.biomaterials.2008.02.011
   van Holten J, 2005, ANN RHEUM DIS, V64, P1780, DOI 10.1136/ard.2005.040477
   van Lent PLEM, 2004, ARTHRITIS RHEUM, V50, P103, DOI 10.1002/art.11422
   Van Wesenbeeck L, 2002, P NATL ACAD SCI USA, V99, P14303, DOI 10.1073/pnas.202332999
   VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415
   Vasconcelos DP, 2015, BIOMATERIALS, V37, P116, DOI 10.1016/j.biomaterials.2014.10.035
   Vi L, 2015, J BONE MINER RES, V30, P1090, DOI 10.1002/jbmr.2422
   Vignery A, 2005, J EXP MED, V202, P337, DOI 10.1084/jem.20051123
   Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376
   Wehling-Henricks M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010763
   WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828
   WiktorJedrzejczak W, 1996, PHYSIOL REV, V76, P927
   Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534
   Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034
   Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354
   Xia ZD, 2006, BIOMATERIALS, V27, P4557, DOI 10.1016/j.biomaterials.2006.04.030
   Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006
   Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050615
   Yamada S, 1997, J BIOMED MATER RES, V37, P346, DOI 10.1002/(SICI)1097-4636(19971205)37:3<346::AID-JBM5>3.0.CO;2-L
   Yang SY, 2007, J ORTHOP RES, V25, P603, DOI 10.1002/jor.20342
   Yu G, 2006, J BIOL CHEM, V281, P10222, DOI 10.1074/jbc.M510320200
   Yu G, 2003, J BIOL CHEM, V278, P47209, DOI 10.1074/jbc.M306659200
   Zhang WJ, 2011, J IMMUNOL, V187, P1764, DOI 10.4049/jimmunol.1002315
   Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012
   Ziegler-Heitbrock L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00023
NR 238
TC 45
Z9 49
U1 14
U2 104
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2016
VL 82
BP 1
EP 19
DI 10.1016/j.biomaterials.2015.12.017
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DD7KS
UT WOS:000370103900001
PM 26735169
DA 2018-10-19
ER

PT J
AU Izadifar, Z
   Honaramooz, A
   Wiebe, S
   Belev, G
   Chen, XB
   Chapman, D
AF Izadifar, Zohreh
   Honaramooz, Ali
   Wiebe, Sheldon
   Belev, George
   Chen, Xiongbiao
   Chapman, Dean
TI Low-dose phase-based X-ray imaging techniques for in situ soft tissue
   engineering assessments
SO BIOMATERIALS
LA English
DT Article
DE Cartilage tissue engineering; Non-invasive imaging; Biomaterials
   characterization; Phase-based X-ray imaging; Synchrotron imaging;
   Imaging radiation dose; Biomaterial scaffolds
ID CONTRAST-COMPUTED-TOMOGRAPHY; SYNCHROTRON-RADIATION;
   ARTICULAR-CARTILAGE; CANINE MODEL; SCAFFOLDS; RETRIEVAL; VISUALIZATION;
   OPTIMIZATION; CELLS; CT
AB In tissue engineering, non-invasive imaging of biomaterial scaffolds and tissues in living systems is essential to longitudinal animal studies for assessments without interrupting the repair process. Conventional X-ray imaging is inadequate for use in soft tissue engineering due to the limited absorption difference between the soft tissue and biomaterial scaffolds. X-ray phase-based imaging techniques that derive contrast from refraction or phase effects rather than absorption can provide the necessary contrast to see low-density biomaterial scaffolds and tissues in large living systems. This paper explores and compares three synchrotron phase-based X-ray imaging techniques computed tomography (CT) diffraction enhanced imaging (DEI), -analyzer based imaging (ABI), and-phase contrast imaging (PCI)-for visualization and characterization of low-density biomaterial scaffolds and tissues in situ for non-invasive soft tissue engineering assessments. Intact pig joints implanted with polycaprolactone scaffolds were used as the model to assess and compare the imaging techniques in terms of different qualitative and quantitative criteria. For long-term in vivo live animal imaging, different strategies for reducing the imaging radiation dose and scan time reduced number of CT projections, region of interest, and low resolution imaging were examined with the presented phase-based imaging techniques. The results demonstrated promising capabilities of the phase-based techniques for visualization of biomaterial scaffolds and soft tissues in situ. The low-dose imaging strategies were illustrated effective for reducing the radiation dose to levels appropriate for live animal imaging. The comparison among the imaging techniques suggested that CT-DEI has the highest efficiency in retaining image contrast at considerably low radiation doses. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Izadifar, Zohreh; Chen, Xiongbiao; Chapman, Dean] Univ Saskatchewan, Coll Engn, Div Biomed Engn, Saskatoon, SK S7N 5A9, Canada.
   [Honaramooz, Ali] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Biomed Sci, Saskatoon, SK S7N 5B4, Canada.
   [Wiebe, Sheldon] Royal Univ Hosp, Dept Med Imaging, Saskatoon, SK S7N 0W8, Canada.
   [Belev, George; Chapman, Dean] Canadian Light Source, Saskatoon, SK S7N 2V3, Canada.
   [Chen, Xiongbiao] Univ Saskatchewan, Coll Engn, Dept Mech Engn, Saskatoon, SK S7N 5A9, Canada.
   [Chapman, Dean] Univ Saskatchewan, Coll Med, Dept Anat & Cell Biol, Saskatoon, SK S7N 5E5, Canada.
RP Izadifar, Z (reprint author), Univ Saskatchewan, 57 Campus Dr, Saskatoon, SK S7N 5A9, Canada.
EM zohreh.izadifar@usask.ca
RI Chapman, Dean/I-6168-2013
OI Chapman, Dean/0000-0001-6590-4156
FU University of Saskatchewan (U of S) Dean's Scholarship; Saskatchewan
   Health Research Foundation [SHRF] [2784]; Natural Sciences and
   Engineering Research Council of Canada [NSERC] [RGPIN-2014-05648];
   Canada Foundation for Innovation; NSERC; U of S; Government of
   Saskatchewan; Western Economic Diversification Canada; National Research
   Council (NRC) Canada; Canadian Institutes of Health Research; Canadian
   Institutes of Health Research Training grant in Health Research Using
   Synchrotron Techniques (CIHR-THRUST)
FX The authors acknowledge the University of Saskatchewan (U of S) Dean's
   Scholarship and the funding for the present study from the Saskatchewan
   Health Research Foundation [SHRF Reference # 2784] and the Natural
   Sciences and Engineering Research Council of Canada [NSERC
   RGPIN-2014-05648]. Images presented in this paper were captured at the
   Canadian Light Source, which is supported by the Canada Foundation for
   Innovation, NSERC, U of S, Government of Saskatchewan, Western Economic
   Diversification Canada, National Research Council (NRC) Canada, and the
   Canadian Institutes of Health Research. Zohreh Izadifar is a Fellow in
   the Canadian Institutes of Health Research Training grant in Health
   Research Using Synchrotron Techniques (CIHR-THRUST).
CR Appel AA, 2015, BIOTECHNOL BIOENG, V112, P612, DOI 10.1002/bit.25467
   Appel AA, 2012, TISSUE ENG PART C-ME, V18, P859, DOI [10.1089/ten.tec.2012.0123, 10.1089/ten.TEC.2012.0123]
   BARENDSEN GW, 1982, INT J RADIAT ONCOL, V8, P1981, DOI 10.1016/0360-3016(82)90459-X
   Bartels M., 2013, CONE BEAM XRAY PHASE
   Chang CH, 2005, BIOMED ENG-APP BAS C, V17, P61, DOI 10.4015/S101623720500010X
   Chapman D, 1997, PHYS MED BIOL, V42, P2015, DOI 10.1088/0031-9155/42/11/001
   Chen RC, 2012, J SYNCHROTRON RADIAT, V19, P836, DOI 10.1107/S0909049512029731
   Chinga G, 2007, NORD PULP PAP RES J, V22, P441
   Cloetens P, 1999, APPL PHYS LETT, V75, P2912, DOI 10.1063/1.125225
   Coan P, 2010, PHYS MED BIOL, V55, P7649, DOI 10.1088/0031-9155/55/24/017
   Diemoz PC, 2015, J SYNCHROTRON RADIAT, V22, P1072, DOI 10.1107/S1600577515008978
   Dreossi D, 2008, EUR J RADIOL, V68, pS58, DOI 10.1016/j.ejrad.2008.04.038
   EMAMI B, 1991, INT J RADIAT ONCOL, V21, P109, DOI 10.1016/0360-3016(91)90171-Y
   Grandl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097101
   Gureyev T. E., 2011, ADV COMPUTATIONAL ME, V8141
   Gureyev TE, 2004, APPL OPTICS, V43, P2418, DOI 10.1364/AO.43.002418
   Hagen CK, 2014, MED PHYS, V41, DOI 10.1118/1.4884297
   Hagen CK, 2014, OPT EXPRESS, V22, P7989, DOI 10.1364/OE.22.007989
   Herzen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083369
   Hetterich H, 2013, Z MED PHYS, V23, P194, DOI 10.1016/j.zemedi.2012.12.001
   Horng A, 2014, INVEST RADIOL, V49, P627, DOI 10.1097/RLI.0000000000000063
   Huang S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09418
   International Commission on Radiological Protection, 2007, ANN ICRP, V37, P1, DOI [DOI 10.1016/J.ICRP.2007.10.003, 10.1016/j.icrp.2007.10.003]
   Izadifar Z, 2014, TISSUE ENG PART C-ME, V20, P140, DOI [10.1089/ten.tec.2013.0138, 10.1089/ten.TEC.2013.0138]
   Kotecha M, 2013, TISSUE ENG PART B-RE, V19, P470, DOI [10.1089/ten.TEB.2012.0755, 10.1089/ten.teb.2012.0755]
   Kwack KS, 2008, ACTA RADIOL, V49, P65, DOI 10.1080/02841850701552934
   Langer M, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P210, DOI 10.1109/ISBI.2012.6235521
   Lewis RA, 2004, PHYS MED BIOL, V49, P3573, DOI 10.1088/0031-9155/49/16/005
   Lewis RA, 2003, BRIT J RADIOL, V76, P301, DOI 10.1529/bjr/32889803
   Li J, 2009, OSTEOARTHR CARTILAGE, V17, P1193, DOI 10.1016/j.joca.2009.03.005
   Lin XJ, 2015, PHYS MED BIOL, V60, P1655, DOI 10.1088/0031-9155/60/4/1655
   Luan XJ, 2014, P NATL ACAD SCI USA, V111, P12930, DOI 10.1073/pnas.1406414111
   lzadifar Z., 2015, DATA BRIEF IN PRESS
   Mirone A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114325
   Mollenhauer J, 2002, OSTEOARTHR CARTILAGE, V10, P163, DOI 10.1053/joca.2001.0496
   MOMOSE A, 1995, MED PHYS, V22, P375, DOI 10.1118/1.597472
   Momose A, 1996, NAT MED, V2, P473, DOI 10.1038/nm0496-473
   Muehleman C, 2006, OSTEOARTHR CARTILAGE, V14, P882, DOI 10.1016/j.joca.2006.02.011
   Muehleman C, 2004, OSTEOARTHR CARTILAGE, V12, P97, DOI 10.1016/j.joca.2003.10.001
   Muehleman C, 2002, ANN M ORTH RES SOC D
   Nesterets YI, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2038107
   Noel PB, 2013, Z MED PHYS, V23, P204, DOI 10.1016/j.zemedi.2013.02.006
   Nugent KA, 1996, PHYS REV LETT, V77, P2961, DOI 10.1103/PhysRevLett.77.2961
   Olubamiji AD, 2014, TISSUE ENG PART B-RE, V20, P503, DOI [10.1089/ten.teb.2013.0493, 10.1089/ten.TEB.2013.0493]
   Pacile S, 2015, BIOMED OPT EXPRESS, V6, P3099, DOI 10.1364/BOE.6.003099
   Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x
   Pelliccia D, 2015, PHYS MED BIOL, V60, P3065, DOI 10.1088/0031-9155/60/8/3065
   Quai E, 2013, RADIOL MED, V118, P89, DOI 10.1007/s11547-012-0847-1
   Radiological Society of North America (RSNA), 2015, RAD DOS XRAY CT EX
   Ren YQ, 2011, OPT EXPRESS, V19, P4170, DOI 10.1364/OE.19.004170
   Rubin P., 1972, 6 ANN SAN FRANC CANC
   Sarapata A, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4898052
   Sarapata A, 2014, MED PHYS, V41, DOI 10.1118/1.4860275
   Snigirev A, 1995, REV SCI INSTRUM, V66, P5486, DOI 10.1063/1.1146073
   STEEL GG, 1987, RADIOTHER ONCOL, V9, P299
   Suortti P, 2003, PHYS MED BIOL, V48, pR1, DOI 10.1088/0031-9155/48/13/201
   Szafraniec MB, 2014, PHYS MED BIOL, V59, DOI 10.1088/0031-9155/59/5/N1
   United States Nuclear Regulatory Commission (U. S. NRC), 2015, SHALL DOS EQ SDE
   Wang ZT, 2013, PHYS MED BIOL, V58, P6815, DOI 10.1088/0031-9155/58/19/6815
   Wrixon AD, 2008, J RADIOL PROT, V28, P161, DOI 10.1088/0952-4746/28/2/R02
   Wu XZ, 2005, OPT LETT, V30, P379, DOI 10.1364/OL.30.000379
   Wysokinski TW, 2007, NUCL INSTRUM METH A, V582, P73, DOI 10.1016/j.nima.2007.08.087
   Wysokinski TW, 2015, NUCL INSTRUM METH A, V775, P1, DOI 10.1016/j.nima.2014.11.088
   Zehbe R, 2010, ACTA BIOMATER, V6, P2097, DOI 10.1016/j.actbio.2009.11.020
   Zehbe R, 2007, INT J MATER RES, V98, P562, DOI 10.3139/146.101509
   Zehbe R, 2010, J R SOC INTERFACE, V7, P49, DOI 10.1098/rsif.2008.0539
   Zhang Lu, 2011, Open Med Inform J, V5, P19, DOI 10.2174/1874431101105010019
   Zhou T., 2013, J PHYS C SER IOP PUB
   Zhu N, 2011, TISSUE ENG PART C-ME, V17, P1071, DOI 10.1089/ten.tec.2011.0102
NR 69
TC 11
Z9 11
U1 0
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2016
VL 82
BP 151
EP 167
DI 10.1016/j.biomaterials.2015.11.044
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DD7KS
UT WOS:000370103900012
PM 26761779
DA 2018-10-19
ER

PT J
AU Inzana, JA
   Schwarz, EM
   Kates, SL
   Awad, HA
AF Inzana, Jason A.
   Schwarz, Edward M.
   Kates, Stephen L.
   Awad, Hani A.
TI Biomaterials approaches to treating implant-associated osteomyelitis
SO BIOMATERIALS
LA English
DT Review
DE Biomaterials; Osteomyelitis; Staphylococcus aureus; Antibiotics; Drug
   delivery
ID RESISTANT STAPHYLOCOCCUS-AUREUS; GENTAMICIN-PMMA-BEADS; ACRYLIC
   BONE-CEMENT; POSITRON-EMISSION-TOMOGRAPHY; PROSTHETIC-JOINT INFECTIONS;
   ANTIBIOTIC DELIVERY-SYSTEM; FOREIGN-BODY INFECTION; IN-VITRO;
   DRUG-DELIVERY; CALCIUM-PHOSPHATE
AB Orthopaedic devices are the most common surgical devices associated with implant-related infections and Staphylococcus aureus (S. aureus) is the most common causative pathogen in chronic bone infections (osteomyelitis). Treatment of these chronic bone infections often involves combinations of antibiotics given systemically and locally to the affected site via a biomaterial spacer. The gold standard biomaterial for local antibiotic delivery against osteomyelitis, poly(methyl methacrylate) (PMMA) bone cement, bears many limitations. Such shortcomings include limited antibiotic release, incompatibility with many antimicrobial agents, and the need for follow-up surgeries to remove the non-biodegradable cement before surgical reconstruction of the lost bone. Therefore, extensive research pursuits are targeting alternative, biodegradable materials to replace PMMA in osteomyelitis applications.
   Herein, we provide an overview of the primary clinical treatment strategies and emerging biodegradable materials that may be employed for management of implant-related osteomyelitis. We performed a systematic review of experimental biomaterials systems that have been evaluated for treating established S. aureus osteomyelitis in an animal model. Many experimental biomaterials were not decisively more efficacious for infection management than PMMA when delivering the same antibiotic. However, alternative biomaterials have reduced the number of follow-up surgeries, enhanced the antimicrobial efficacy by delivering agents that are incompatible with PMMA, and regenerated bone in an infected defect. Understanding the advantages, limitations, and potential for clinical translation of each biomaterial, along with the conditions under which it was evaluated (e.g. animal model), is critical for surgeons and researchers to navigate the plethora of options for local antibiotic delivery. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Inzana, Jason A.] AO Res Inst Davos, Clavadelerstr 8, CH-7270 Davos, Switzerland.
   [Inzana, Jason A.; Schwarz, Edward M.; Kates, Stephen L.; Awad, Hani A.] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, 601 Elmwood Ave,Box 665, Rochester, NY 14642 USA.
   [Inzana, Jason A.; Schwarz, Edward M.; Awad, Hani A.] Univ Rochester, Dept Biomed Engn, 207 Robert B Goergen Hall, Rochester, NY 14642 USA.
   [Schwarz, Edward M.; Kates, Stephen L.; Awad, Hani A.] Univ Rochester, Med Ctr, Dept Orthoped, 601 Elmwood Ave, Rochester, NY 14642 USA.
RP Inzana, JA (reprint author), AO Res Inst Davos, Clavadelerstr 8, CH-7270 Davos, Switzerland.
EM jason.inzana@aofoundation.org
FU AOTrauma Research- Clinical Priority Program on Bone Infection; National
   Institutes of Health (NIH) [P30 AR061307]; Whitaker International
   Program post-doctoral scholarship; National Science Foundation (NSF)
   [DGE-1419118]
FX This research was supported by the AOTrauma Research- Clinical Priority
   Program on Bone Infection and the National Institutes of Health (NIH P30
   AR061307). Jason Inzana was supported in part by a Whitaker
   International Program post-doctoral scholarship and a National Science
   Foundation graduate research fellowship (NSF Award DGE-1419118). The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of AOTrauma, NIH, NSF, or the
   Whitaker International Program.
CR Abou Neel EA, 2013, ADV DRUG DELIVER REV, V65, P429, DOI 10.1016/j.addr.2012.08.010
   Ahola Niina, 2012, Biomatter, V2, P213, DOI 10.4161/biom.22793
   Alvarez H, 2008, J BIOMED MATER RES B, V85B, P93, DOI 10.1002/jbm.b.30921
   Amador G, 2010, ANTIMICROB AGENTS CH, V54, P950, DOI 10.1128/AAC.00434-09
   Ambrose CG, 2004, CLIN ORTHOP RELAT R, P293, DOI 10.1097/01.blo.0000126303.41711.a2
   Amin TJ, 2012, J BONE JOINT SURG AM, V94A, P1946, DOI 10.2106/JBJS.L.00014
   Arciola CR, 2005, FEMS MICROBIOL LETT, V246, P81, DOI 10.1016/j.femsle.2005.03.035
   Basu S, 2009, SEMIN NUCL MED, V39, P36, DOI 10.1053/j.semnuclmed.2008.08.004
   BECKER PL, 1994, J ORTHOPAED RES, V12, P737, DOI 10.1002/jor.1100120517
   BEECHING NJ, 1986, J ANTIMICROB CHEMOTH, V17, P173, DOI 10.1093/jac/17.2.173
   Beenken KE, 2014, J BIOMATER APPL, V29, P514, DOI 10.1177/0885328214535452
   Bettin D, 2009, J BONE JOINT SURG BR, V91-B, P311
   Beuerlein MJS, 2010, J ORTHOP TRAUMA, V24, pS46, DOI 10.1097/BOT.0b013e3181cec48e
   Bosse MJ, 2005, J BONE JOINT SURG AM, V87A, P1343, DOI 10.2106/JBJS.D.02649
   Brin YS, 2008, J CONTROL RELEASE, V131, P121, DOI 10.1016/j.jconrel.2008.07.022
   Brown Kate V, 2010, J Surg Orthop Adv, V19, P18
   BUCHHOLZ HW, 1970, CHIRURG, V41, P511
   Calhoun JH, 1997, CLIN ORTHOP RELAT R, P206
   Calhoun JH, 2005, INFECT DIS CLIN N AM, V19, P765, DOI 10.1016/j.idc.2005.07.009
   CALHOUN JH, 1993, CLIN ORTHOP RELAT R, P23
   Cevher E, 2007, J MICROENCAPSUL, V24, P577, DOI 10.1080/02652040701472584
   Cevher E, 2006, INT J PHARM, V317, P127, DOI 10.1016/j.ijpharm.2006.03.014
   Chen LB, 2007, J BIOMED MATER RES B, V83B, P589, DOI 10.1002/jbm.b.30832
   Chen XQ, 2005, J ORTHOP RES, V23, P816, DOI 10.1016/j.orthres.2005.01.009
   Ciampolini J, 2000, POSTGRAD MED J, V76, P479, DOI 10.1136/pmj.76.898.479
   CORNELL CN, 1993, J ORTHOPAED RES, V11, P619, DOI 10.1002/jor.1100110502
   Darouiche RO, 2007, J BONE JOINT SURG AM, V89A, P792, DOI 10.2106/JBJS.F.00414
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Ding H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085472
   Drago L, 2014, CLIN ORTHOP RELAT R, V472, P3311, DOI 10.1007/s11999-014-3558-1
   Duewelhenke N, 2007, ANTIMICROB AGENTS CH, V51, P54, DOI 10.1128/AAC.00729-05
   EI-Kamel A. H., 2007, DRUG DELIV, V14, P349
   Ethell MT, 2000, VET SURG, V29, P375, DOI 10.1053/jvet.2000.7535
   Faber C, 2005, ANTIMICROB AGENTS CH, V49, P2438, DOI 10.1128/AAC.49.6.2438-2444.2005
   Ferguson JY, 2014, BONE JOINT J, V96B, P829, DOI 10.1302/0301-620X.96B6.32756
   Fitzpatrick F, 2005, CLIN MICROBIOL INFEC, V11, P967, DOI 10.1111/j.1469-0691.2005.01274.x
   Fleiter N, 2014, BONE JOINT RES, V3, P223, DOI 10.1302/2046-3758.37.2000301
   Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161
   Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000
   Garcia LG, 2013, J ANTIMICROB CHEMOTH, V68, P1455, DOI 10.1093/jac/dkt072
   Garvin K, 2005, CLIN ORTHOP RELAT R, P105, DOI 10.1097/01.blo.0000175720.99118.fe
   GARVIN KL, 1994, J BONE JOINT SURG AM, V76A, P1500, DOI 10.2106/00004623-199410000-00009
   Giavaresi G, 2012, J MATER SCI-MATER M, V23, P1247, DOI 10.1007/s10856-012-4585-7
   Giavaresi G, 2012, J ORTHOP RES, V30, P348, DOI 10.1002/jor.21531
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Gogia Jaspaul S, 2009, Semin Plast Surg, V23, P100, DOI 10.1055/s-0029-1214162
   GRISTINA AG, 1991, ORTHOP CLIN N AM, V22, P363
   Gu YX, 2012, ACTA BIOMATER, V8, P424, DOI 10.1016/j.actbio.2011.08.006
   Guelcher SA, 2011, J ORTHOP TRAUMA, V25, P477, DOI 10.1097/BOT.0b013e31821f624c
   Huntimer L, 2013, ADV HEALTHC MATER, V2, P369, DOI 10.1002/adhm.201200181
   Inzana JA, 2015, EUR CELLS MATER, V30, P232, DOI 10.22203/eCM.v030a16
   Inzana JA, 2015, BONE, V72, P128, DOI 10.1016/j.bone.2014.11.019
   Itokazu M, 1998, Bull Hosp Jt Dis, V57, P125
   Jaeblon T, 2010, J AM ACAD ORTHOP SUR, V18, P297, DOI 10.5435/00124635-201005000-00006
   Jain JP, 2008, J BIOMED MATER RES A, V84A, P740, DOI 10.1002/jbm.a.31456
   Jain JP, 2005, J CONTROL RELEASE, V103, P541, DOI 10.1016/j.jconrel.2004.12.021
   Jia WT, 2010, ACTA BIOMATER, V6, P812, DOI 10.1016/j.actbio.2009.09.011
   Jiang JL, 2012, INFLAMM RES, V61, P207, DOI 10.1007/s00011-011-0402-x
   Joosten U, 2005, BIOMATERIALS, V26, P5251, DOI 10.1016/j.biomaterials.2005.01.001
   Joosten U, 2004, BIOMATERIALS, V25, P4287, DOI 10.1016/j.biomaterials.2003.10.083
   Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5
   KLEMM K, 1979, ZBL CHIR, V104, P934
   Knaepler H, 2012, INT J SURG, V10, pS15, DOI 10.1016/j.ijsu.2012.05.020
   Koort JK, 2005, ANTIMICROB AGENTS CH, V49, P1502, DOI 10.1128/AAC.49.4.1502-1508.2005
   Koort JK, 2004, J NUCL MED, V45, P1406
   KUBOTA R, 1992, J NUCL MED, V33, P1972
   Kundu B, 2011, J MATER SCI-MATER M, V22, P705, DOI 10.1007/s10856-010-4221-3
   Kurien T, 2013, BONE JOINT J, V95B, P583, DOI 10.1302/0301-620X.95B5.30286
   LAURENCIN CT, 1993, J ORTHOPAED RES, V11, P256, DOI 10.1002/jor.1100110213
   Le Ray AM, 2005, ANTIMICROB AGENTS CH, V49, P3025, DOI 10.1128/AAC.49.7.3025-3027.2005
   Letsch R, 1993, Aktuelle Traumatol, V23, P324
   Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5
   Li B, 2010, J CONTROL RELEASE, V145, P221, DOI 10.1016/j.jconrel.2010.04.002
   Lora-Tamayo J, 2013, CLIN INFECT DIS, V56, P182, DOI 10.1093/cid/cis746
   Mader JT, 2002, CLIN ORTHOP RELAT R, P58, DOI 10.1097/01.blo.0000030070.92399.4d
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   Mariconda M, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-193
   Masquelet AC, 2010, ORTHOP CLIN N AM, V41, P27, DOI 10.1016/j.ocl.2009.07.011
   Mckee MD, 2010, J ORTHOP TRAUMA, V24, P483, DOI 10.1097/BOT.0b013e3181df91d9
   McLaren AC, 2004, CLIN ORTHOP RELAT R, P25, DOI 10.1097/01.blo.0000143556.41472.2a
   McLaren AC, 2007, CLIN ORTHOP RELAT R, P60, DOI 10.1097/BLO.0b013e3181123e90
   Mendel V, 2005, ARCH ORTHOP TRAUM SU, V125, P363, DOI 10.1007/s00402-004-0774-2
   Mihailescu R, 2014, ANTIMICROB AGENTS CH, V58, P2547, DOI 10.1128/AAC.02420-12
   Molina-Manso D, 2012, INT J ANTIMICROB AG, V40, P252, DOI 10.1016/j.ijantimicag.2012.05.013
   Moojen DJF, 2008, J ARTHROPLASTY, V23, P1152, DOI 10.1016/j.arth.2007.08.020
   Moreau JL, 2009, J BIOMED MATER RES A, V91A, P605, DOI 10.1002/jbm.a.32248
   Murray CK, 2008, J TRAUMA, V64, pS239, DOI 10.1097/TA.0b013e318163cd14
   Nelson CL, 1997, J ORTHOPAED RES, V15, P249, DOI 10.1002/jor.1100150214
   NELSON CL, 1993, CLIN ORTHOP RELAT R, P96
   Nishitani K, 2015, J ORTHOP RES, V33, P1311, DOI 10.1002/jor.22907
   NORDEN CW, 1970, J INFECT DIS, V122, P410, DOI 10.1093/infdis/122.5.410
   NORDEN CW, 1980, BRIT J EXP PATHOL, V61, P451
   O'Hara P, 2000, PHARMACEUT RES, V17, P955, DOI 10.1023/A:1007527204887
   Orhan Z, 2006, J BONE JOINT SURG BR, V88B, P270, DOI 10.1302/0301-620X.88B2.16328
   Orhan Z, 2010, ARCH ORTHOP TRAUM SU, V130, P135, DOI 10.1007/s00402-009-0886-9
   Otto M, 2013, ANNU REV MED, V64, P175, DOI 10.1146/annurev-med-042711-140023
   Overstreet D, 2015, CLIN ORTHOP RELAT R, V473, P337, DOI 10.1007/s11999-014-3935-9
   PATZAKIS MJ, 1993, CLIN ORTHOP RELAT R, P112
   Pelissier P, 2004, J ORTHOPAED RES, V22, P73, DOI 10.1016/S0736-0266(03)00165-7
   Penner MJ, 1996, J ARTHROPLASTY, V11, P939, DOI 10.1016/S0883-5403(96)80135-5
   Perez R. A., 2012, J TISSUE ENG, V3, DOI DOI 10.1177/2041731412439555
   Perez RA, 2013, J MATER SCI-MATER M, V24, P381, DOI 10.1007/s10856-012-4799-8
   Raafat D, 2008, APPL ENVIRON MICROB, V74, P3764, DOI 10.1128/AEM.00453-08
   Rani SA, 2007, J BACTERIOL, V189, P4223, DOI 10.1128/JB.00107-07
   Rasyid HN, 2009, ACTA ORTHOP, V80, P508, DOI 10.3109/17453670903389782
   Rathbone CR, 2011, J ORTHOP RES, V29, P1070, DOI 10.1002/jor.21343
   Reizner W, 2014, EUR CELLS MATER, V27, P196, DOI 10.22203/eCM.v027a15
   RISSING JP, 1985, INFECT IMMUN, V49, P141
   Romano CL, 2014, BONE JOINT J, V96B, P845, DOI 10.1302/0301-620X.96B6.33014
   Scheman L, 1941, J AMER MED ASSOC, V117, P1525, DOI 10.1001/jama.1941.02820440033008
   Schmolders J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-144
   Shaikh AA, 2014, CLIN ORTHOP RELAT R, V472, P2201, DOI 10.1007/s11999-014-3545-6
   Shanks RMQ, 2005, INFECT IMMUN, V73, P4596, DOI 10.1128/IAI.73.8.4596-4606.2005
   Shi PJ, 2010, J BIOMED MATER RES A, V93A, P1020, DOI 10.1002/jbm.a.32598
   Shirtliff ME, 2002, CLIN ORTHOP RELAT R, P239
   Sia IG, 2006, BEST PRACT RES CL RH, V20, P1065, DOI 10.1016/j.berh.2006.08.014
   Smeltzer MS, 1997, J ORTHOPAED RES, V15, P414, DOI 10.1002/jor.1100150314
   Smith JK, 2013, CLIN ORTHOP RELAT R, V471, P3158, DOI 10.1007/s11999-013-2988-5
   Solberg BD, 1999, J ORTHOP TRAUMA, V13, P102, DOI 10.1097/00005131-199902000-00006
   Spellberg B, 2012, CLIN INFECT DIS, V54, P393, DOI 10.1093/cid/cir842
   Stinner DJ, 2010, J ORTHOP TRAUMA, V24, P592, DOI 10.1097/BOT.0b013e3181ed296c
   Sugawara Y, 1999, EUR J NUCL MED, V26, P333, DOI 10.1007/s002590050395
   Takigami I, 2010, ARCH ORTHOP TRAUM SU, V130, P1221, DOI 10.1007/s00402-009-0991-9
   Tamimi F, 2008, ACTA BIOMATER, V4, P1315, DOI 10.1016/j.actbio.2008.04.003
   Tan HL, 2013, INT J MOL SCI, V14, P1854, DOI 10.3390/ijms14011854
   Tang HJ, 2013, ANTIMICROB AGENTS CH, V57, P5717, DOI 10.1128/AAC.01236-13
   ter Boo GJA, 2015, BIOMATERIALS, V52, P113, DOI 10.1016/j.biomaterials.2015.02.020
   Thein-Han W, 2011, TISSUE ENG PT A, V17, P2943, DOI 10.1089/ten.tea.2010.0674
   Tofuku K, 2012, EUR SPINE J, V21, P2027, DOI 10.1007/s00586-012-2435-4
   Trampuz A, 2006, INJURY, V37, P59, DOI 10.1016/j.injury.2006.04.010
   Trampuz A, 2006, CURR OPIN INFECT DIS, V19, P349, DOI 10.1097/01.qco.0000235161.85925.e8
   Tsiolis P, 2011, SURG INFECT, V12, P131, DOI 10.1089/sur.2010.050
   van de Belt H, 2000, ACTA ORTHOP SCAND, V71, P625, DOI 10.1080/000164700317362280
   Vergidis P, 2011, ANTIMICROB AGENTS CH, V55, P1182, DOI 10.1128/AAC.00740-10
   WacholDrewek Z, 1996, BIOMATERIALS, V17, P1733, DOI 10.1016/0142-9612(96)87654-X
   Waeiss RA, 2014, J ORAL MAXIL SURG, V72, P1310, DOI 10.1016/j.joms.2014.01.007
   Walenkamp GHIM, 1998, ACTA ORTHOP SCAND, V69, P518, DOI 10.3109/17453679808997790
   Webb JCJ, 2007, J BONE JOINT SURG BR, V89B, P851, DOI 10.1302/0301-620X.89B7.19148
   Winkler H, 2008, J BONE JOINT SURG BR, V90B, P1580, DOI 10.1302/0301-620X.90B12.20742
   Xing JC, 2013, TISSUE ENG PT A, V19, P255, DOI [10.1089/ten.TEA.2012.0262, 10.1089/ten.tea.2012.0262]
   Yagmurlu MF, 1999, J BIOMED MATER RES, V46, P494
   Yu BG, 1996, J CONTROL RELEASE, V39, P65, DOI 10.1016/0168-3659(95)00139-5
   Yun HC, 2008, J TRAUMA, V64, pS163, DOI 10.1097/TA.0b013e318160868c
   Zelken J, 2007, CLIN ORTHOP RELAT R, P190, DOI 10.1097/BLO.0b013e3180ca9521
   Zhang X, 2010, BIOMATERIALS, V31, P5865, DOI 10.1016/j.biomaterials.2010.04.005
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
   Zuluaga AF, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-8
NR 148
TC 45
Z9 46
U1 6
U2 125
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2016
VL 81
BP 58
EP 71
DI 10.1016/j.biomaterials.2015.12.012
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DD7KQ
UT WOS:000370103700006
PM 26724454
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Rosato, A
   Catalano, A
   Carocci, A
   Carrieri, A
   Carone, A
   Caggiano, G
   Franchini, C
   Corbo, F
   Montagna, MT
AF Rosato, Antonio
   Catalano, Alessia
   Carocci, Alessia
   Carrieri, Antonio
   Carone, Addolorata
   Caggiano, Giuseppina
   Franchini, Carlo
   Corbo, Filomena
   Montagna, Maria Teresa
TI In vitro interactions between anidulafungin and nonsteroidal
   anti-inflammatory drugs on biofilms of Candida spp.
SO BIOORGANIC & MEDICINAL CHEMISTRY
LA English
DT Article
DE Biofilm; Non-steroidal anti-inflammatory drugs (NSAIDs); Anidulafungin;
   XTT; Synergism; Candida species
ID ANTIFUNGAL AGENTS; ALBICANS BIOFILMS; FUNGAL-INFECTIONS; AMPHOTERICIN-B;
   RESISTANCE; ECHINOCANDINS; FLUCONAZOLE; SUSCEPTIBILITY; COMBINATION;
   PROSTAGLANDINS
AB Candida spp. are responsible for many biomaterial-related infections; they give rise to infective pathologies typically associated with biofilm formation. We recently reported that the echinocandin anidulafungin (ANF) showed a strong in vitro activity against both planktonic and biofilms cells. Herein, we report the antifungal activities of ANF alone and in association with some non-steroidal anti-inflammatory drugs (NSAIDs) against nine Candida strain biofilms: four Candida albicans, two Candida glabrata and three Candida guilliermondii. The activity of ANF was assessed using an in vitro microbiological model relevant for clinical practice. ANF proved oneself to be active against biofilms cells, and a clear-cut synergism was found against Candida species biofilms when ANF was used in combination with three NSAIDs: aspirin, diclofenac, ibuprofen. The positive synergism against Candida spp. of ANF in association with aspirin or the other NSAIDs proved to be a very effective antifungal treatment (FICI <0.5). These results may provide the starting point for new combination therapies of ANF with NSAIDs against Candida biofilm pathologies. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Rosato, Antonio; Catalano, Alessia; Carocci, Alessia; Carrieri, Antonio; Carone, Addolorata; Franchini, Carlo; Corbo, Filomena] Univ Bari, Dept Pharm Drug Sci, Bari, Italy.
   [Caggiano, Giuseppina; Montagna, Maria Teresa] Univ Bari, Hyg Sect, Dept Biomed Sci & Human Oncol, Bari, Italy.
   [Catalano, Alessia; Carocci, Alessia] Univ Bari Aldo Moro, Dipartimento Farm Sci Farmaco, Via E Orabona 4, I-70125 Bari, Italy.
RP Catalano, A; Carocci, A (reprint author), Univ Bari, Dept Pharm Drug Sci, Bari, Italy.; Catalano, A; Carocci, A (reprint author), Univ Bari Aldo Moro, Dipartimento Farm Sci Farmaco, Via E Orabona 4, I-70125 Bari, Italy.
EM alessia.catalano@uniba.it; alessia.carocci@uniba.it
OI Carrieri, Antonio/0000-0002-7725-6667; Montagna, Maria
   Teresa/0000-0002-2958-5458
FU Pfizer s.r.l. Italy
FX This study was supported by an unrestricted grant from Pfizer s.r.l.
   Italy.
CR Alem MAS, 2005, J MED MICROBIOL, V54, P1001, DOI 10.1099/jmm.0.46172-0
   Alem MAS, 2004, ANTIMICROB AGENTS CH, V48, P41, DOI 10.1128/AAC.48.1.41-47.2004
   Ashraf A, 2015, AM J MICROBIOL RES, V3, P1
   Bachmann SP, 2002, ANTIMICROB AGENTS CH, V46, P3591, DOI 10.1128/AAC.46.11.3591-3596.2002
   Bink A., 2011, The Open Mycology Journal, V5, P29, DOI 10.2174/1874437001105010029
   Bink A., 2012, J INFECT DIS, V1, P790
   Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7
   Cappelletty D, 2007, PHARMACOTHERAPY, V27, P369, DOI 10.1592/phco.27.3.369
   Catalano A, 2013, EUR J MED CHEM, V64, P357, DOI 10.1016/j.ejmech.2013.03.064
   Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001
   Cocuaud C, 2005, J ANTIMICROB CHEMOTH, V56, P507, DOI 10.1093/jac/dki269
   COX GM, 1993, CURR OPIN INFECT DIS, V6, P422
   d'Enfert C, 2006, CURR DRUG TARGETS, V7, P465, DOI 10.2174/138945006776359458
   de Quadros AU, 2011, FOLIA MICROBIOL, V56, P349, DOI 10.1007/s12223-011-0049-6
   Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1
   Erb-Downward JR, 2007, INFECT IMMUN, V75, P3498, DOI 10.1128/IAI.00232-07
   Ferreira J. A. G., 2004, ANTIMICROB AGENTS CH, V53, P4377
   Georgopapadakou NH, 2001, EXPERT OPIN INV DRUG, V10, P269, DOI 10.1517/13543784.10.2.269
   Ghalehnoo ZR, 2010, MICROB PATHOGENESIS, V48, P110, DOI 10.1016/j.micpath.2009.12.003
   Harriott M. M., 2011, THESIS
   Hawser SP, 1998, J CLIN MICROBIOL, V36, P1450
   Jacobson MJ, 2008, ANTIMICROB AGENTS CH, V52, P2242, DOI 10.1128/AAC.00211-08
   Kim R, 2007, EXPERT OPIN PHARMACO, V8, P1479, DOI 10.1517/14656566.8.10.1479
   Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004
   Kuhn DM, 2002, ANTIMICROB AGENTS CH, V46, P1773, DOI 10.1128/AAC.46.6.1773-1780.2002
   Kuhn Duncan M, 2004, Curr Opin Investig Drugs, V5, P186
   Lewis RE, 2002, J ANTIMICROB CHEMOTH, V49, P345, DOI 10.1093/jac/49.2.345
   Liu SY, 2014, INT J ANTIMICROB AG, V43, P395, DOI 10.1016/j.ijantimicag.2013.12.009
   Mishra Nagendra Nath, 2007, Acta Microbiologica et Immunologica Hungarica, V54, P201, DOI 10.1556/AMicr.54.2007.3.1
   Mukherjee PK, 2003, INFECT IMMUN, V71, P4333, DOI 10.1128/IAI.71.84333-4340.2003
   Mukherjee PK, 2004, DRUG RESIST UPDATE, V7, P301, DOI 10.1016/j.drup.2004.09.002
   Nett JE, 2014, EXPERT REV ANTI-INFE, V12, P375, DOI 10.1586/14787210.2014.885838
   Noverr MC, 2002, INFECT IMMUN, V70, P400, DOI 10.1128/IAI.70.1.400-402.2002
   Noverr MC, 2001, INFECT IMMUN, V69, P2957, DOI 10.1128/IAI.69.5.2957-2963.2001
   Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689
   PFALLER M, 1989, EUR J CLIN MICROBIOL, V8, P564, DOI 10.1007/BF01967483
   Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06
   Pfaller MA, 2011, ANTIMICROB AGENTS CH, V55, P561, DOI 10.1128/AAC.01079-10
   Pina-Vaz C, 2000, J MED MICROBIOL, V49, P831, DOI 10.1099/0022-1317-49-9-831
   Ramage G, 2001, Am Clin Lab, V20, P42
   Rosato A, 2013, J ANTIBIOT, V66, P701, DOI 10.1038/ja.2013.83
   Rosato A, 2012, MED CHEM, V8, P690, DOI 10.2174/157340612801216184
   Silva S, 2012, FEMS MICROBIOL REV, V36, P288, DOI 10.1111/j.1574-6976.2011.00278.x
   Simitsopoulou M, 2013, ANTIMICROB AGENTS CH, V57, P2562, DOI 10.1128/AAC.02541-12
   Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6
NR 45
TC 6
Z9 7
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-0896
EI 1464-3391
J9 BIOORGAN MED CHEM
JI Bioorg. Med. Chem.
PD MAR 1
PY 2016
VL 24
IS 5
BP 1002
EP 1005
DI 10.1016/j.bmc.2016.01.026
PG 4
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry,
   Organic
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry
GA DD5UH
UT WOS:000369989500009
PM 26833243
DA 2018-10-19
ER

PT J
AU Mosbahi, S
   Oudadesse, H
   Wers, E
   Trigui, M
   Lefeuvre, B
   Roiland, C
   Elfeki, H
   Elfeki, A
   Rebai, T
   Keskes, H
AF Mosbahi, Siwar
   Oudadesse, Hassane
   Wers, Eric
   Trigui, Moez
   Lefeuvre, Bertrand
   Roiland, Claire
   Elfeki, Hafed
   Elfeki, Abdelfatteh
   Rebai, Tareq
   Keskes, Hassib
TI Study of bioactive glass ceramic for use as bone biomaterial in vivo:
   Investigation by nuclear magnetic resonance and histology
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Porous glass ceramic; Nuclear magnetic resonance; Crystalline structure;
   Cells attachment
ID ALKALINE-PHOSPHATASE ACTIVITY; ZINC-DEFICIENCY; VITRO; IMPLANTS;
   APATITE; RATS; METABOLISM; BIOGLASS; CELLS; ZN
AB The performance of the porous glass ceramic doped with 10 wt% Zinc and 2 wt% TiN (46S6-10Zn), in the restoration of critical diaphyseal bone defect, was evaluated by several physicochemical methods and histological studies. The critical defect in rabbits was created and then filled with 46S6-10Zn. At different periods after implementation, animals were sacrificed. Samples were harvested for exploration. The nuclear magnetic resonance (MAS-NMR) of P-31 and Si-29 illustrates the progressive degradation of 46S6-10Zn in favor to of the formation and the development of biological apatite. Therefore, after one month of implementation, MAS-NMR Si-29 proves the presence of Q(2) (25%), Q(3) (73%) and Q(4) (2%). However, after six months, the disappearance of all these species was revealed and characterized by the 46S6-10Zn dissolution. Besides, MAS-NMR P-31 demonstrates the presence of Q(C)(0) (4%), Q(HA)(0) (55%) and Q(a)(0) (41%) after one month. Nevertheless, six months later, we observe the presence of Q(HA)(0) (80%) and Q(a)(0) (20%). Histological study demonstrates an intimate contact of 46S6-10Zn surrounding bone after one month of implantation. However, after four months, mature bone matrix became calcified and the implanted 46S6-10Zn began to be degraded. Moreover, nine months later, 46S6-10Zn was nearly resorbed and replaced by a calcified tissue in the periphery and an osteoid tissue in the middle of bone defects. (C) 2015 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Mosbahi, Siwar; Oudadesse, Hassane; Wers, Eric; Lefeuvre, Bertrand; Roiland, Claire] Univ Rennes 1, UMR CNRS 6226, Campus Beaulieu, F-35042 Rennes, France.
   [Mosbahi, Siwar; Trigui, Moez; Rebai, Tareq; Keskes, Hassib] Sfax Fac Med, Onhopaed & Traumatol Lab, Sfax, Tunisia.
   [Elfeki, Hafed] Sfax Fac Sci, Sci Mat & Environm Lab, Sfax, Tunisia.
   [Elfeki, Abdelfatteh] Sfax Fac Sci, Dept Life Sci, Anim Ecophys Lab, Sfax, Tunisia.
RP Oudadesse, H (reprint author), Univ Rennes 1, UMR CNRS 6226, Campus Beaulieu, F-35042 Rennes, France.
EM hassane.oudadesse@univ-rennes1.fr
OI roiland, claire/0000-0001-9587-1340
FU CNRST, Rabat, Morroco
FX The authors would like to acknowledge Francis GOUTTE-FANGEAS and Loic
   JOANNY(CMEBA, University of Rennes 1), for their help and their
   contribution during this work, and radiotherapy service in Sfax for
   their help for the sterilization of materials. Also, they would like to
   thank Professor A. Barroug from University of Cadi Ayyad, Marrakech,
   Morroco. This work concerns a part of our FINCOME program and
   collaboration supported by CNRST, Rabat, Morroco.
CR ANDERSSON OH, 1990, J NON-CRYST SOLIDS, V119, P290, DOI 10.1016/0022-3093(90)90301-2
   Bignon A, 2003, J MATER SCI-MATER M, V14, P1089, DOI 10.1023/B:JMSM.0000004006.90399.b4
   Bui XV, 2010, J AUST CERAM SOC, V46, P24
   Classen Hans-Georg, 2011, Med Monatsschr Pharm, V34, P87
   Dietrich E., 2009, BIOMED MAT RES A, V10, P1002
   Erol M, 2010, CHEM ENG TECHNOL, V33, P1066, DOI 10.1002/ceat.200900495
   Fetner A E, 1994, Compendium, V15, P935
   Garip S, 2010, J PHARMACEUT BIOMED, V52, P580, DOI 10.1016/j.jpba.2010.01.044
   Grussaute H, 2000, J NON-CRYST SOLIDS, V263, P312, DOI 10.1016/S0022-3093(99)00643-2
   Hall SL, 1999, CALCIFIED TISSUE INT, V64, P163, DOI 10.1007/s002239900597
   Hench LL, 2000, MATER RES INNOV, V3, P313, DOI 10.1007/s100190000055
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   HSIEH HS, 1980, J NUTR, V110, P1581
   Ishikawa K, 2002, BIOMATERIALS, V23, P423, DOI 10.1016/S0142-9612(01)00121-1
   Kourkoumelis N, 2010, THESCIENTIFICWORLDJO, V10, P402, DOI 10.1100/tsw.2010.43
   LI PJ, 1994, J BIOMED MATER RES, V28, P7, DOI 10.1002/jbm.820280103
   MCCARTHY TJ, 1992, J CLIN PHARM THER, V17, P51, DOI 10.1111/j.1365-2710.1992.tb01265.x
   OGINO M, 1980, J BIOMED MATER RES, V14, P55, DOI 10.1002/jbm.820140107
   Ohtsubo S, 2003, HISTOL HISTOPATHOL, V18, P153, DOI 10.14670/HH-18.153
   ONER G, 1984, ENDOCRINOLOGY, V114, P1860, DOI 10.1210/endo-114-5-1860
   Otsuki B, 2006, BIOMATERIALS, V27, P5892, DOI 10.1016/j.biomaterials.2006.08.013
   Oudadesse H, 2011, APPL SURF SCI, V257, P8587, DOI 10.1016/j.apsusc.2011.05.022
   Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X
   Singh K, 2010, J MECH SCI TECHNOL, V24, P1661, DOI 10.1007/s12206-010-0524-z
   Solomons NW, 1998, NUTR REV, V56, P27
   Toworfe GK, 2009, J TISSUE ENG REGEN M, V3, P26, DOI 10.1002/term.131
   Wers E. ., 2014, ELABORATION BIOMATER
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   YAMAGUCHI M, 1986, BIOCHEM PHARMACOL, V35, P773, DOI 10.1016/0006-2952(86)90245-5
   YAMAGUCHI M, 1987, BIOCHEM PHARMACOL, V36, P4007, DOI 10.1016/0006-2952(87)90471-0
   YAMAGUCHI M, 1986, RES EXP MED, V186, P337, DOI 10.1007/BF01852099
NR 34
TC 1
Z9 1
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD MAR
PY 2016
VL 42
IS 4
BP 4827
EP 4836
DI 10.1016/j.ceramint.2015.11.168
PG 10
WC Materials Science, Ceramics
SC Materials Science
GA DC8HM
UT WOS:000369460500025
DA 2018-10-19
ER

PT J
AU Brandes, C
   Tague, ACM
   Kroll, S
   Treccani, L
   Rezwan, K
AF Brandes, Christoph
   Tague, Armelle Cathy Megne
   Kroll, Stephen
   Treccani, Laura
   Rezwan, Kurosch
TI Gel casting of large area micro- and sub-micropatterned thin ceramic
   tapes
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Gel casting; Flexible ceramic tape; Micropatterning; High-precision
   pattern-contour; 3D-surface profilometry
ID FLEXURAL STRENGTH; SODIUM ALGINATE; SURFACES; ZIRCONIA; HYDROXYAPATITE;
   FABRICATION; GELATION; ALUMINA; ARRAYS; BIOCERAMICS
AB In this study an easy-to-use ceramic processing technique based on temperature-controlled ionotropic gelation of alginate is presented. This method is the breakthrough for simultaneously large scale tape casting and high quality patterning of thin ceramic tapes Alumina powder (d(50) = 205 nm) is used to cast flexible and on demand shapeable tapes. Compared to conventional ceramic micropatterning, ionotropic gelation combines complexity of the patterned structure over large-scale areas, a high pattern resolution down to sub-pm regime (similar to 400 nm) and tape thickness below 300 mu m. Obtained green and sintered (1350 degrees C) micro- and sub-micropatterns are characterized by SEM and quantitative 3D-profilometry focusing on both, pattern quality and pattern aspect ratio. The results show that reproducible thin ceramic tapes featuring positive and negative patterns maintain their aspect ratios after demolding, drying and sintering. This processing route represents a versatile tool for designing tailored ceramics for e.g. microelectromechanical engineered systems, biomaterial or microfluidic applications. (C) 2015 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Brandes, Christoph; Tague, Armelle Cathy Megne; Kroll, Stephen; Treccani, Laura; Rezwan, Kurosch] Univ Bremen, Adv Ceram, Biologischen Garten 2, D-28359 Bremen, Germany.
   [Kroll, Stephen; Rezwan, Kurosch] Univ Bremen, MAPEX Ctr Mat & Proc, Biologischen Garten 2, D-28359 Bremen, Germany.
RP Treccani, L (reprint author), Univ Bremen, Adv Ceram, Biologischen Garten 2, D-28359 Bremen, Germany.
EM treccani@uni-bremen.de
RI Treccani, Laura/R-1725-2016; Rezwan, Kurosch/K-9451-2013
OI Treccani, Laura/0000-0001-5365-9827; Rezwan, Kurosch/0000-0002-7318-1119
FU European Research Council within the BiocerEng [205509]
FX We thank the European Research Council for financial support within the
   BiocerEng, Project No. 205509.
CR Abdulbari HA, 2013, J IND ENG CHEM, V19, P27, DOI 10.1016/j.jiec.2012.07.023
   [Anonymous], 2010, 4287 DIN EN ISO
   Berger J, 2011, APPL SURF SCI, V257, P3081, DOI 10.1016/j.apsusc.2010.10.120
   Bernardo E, 2014, CERAM INT, V40, P1029, DOI 10.1016/j.ceramint.2013.06.100
   Bertazzo S, 2010, LANGMUIR, V26, P3364, DOI 10.1021/la903140k
   Brandes C, 2014, J AM CERAM SOC, V97, P1393, DOI 10.1111/jace.12877
   Chen B, 2013, J AM CERAM SOC, V96, P73, DOI 10.1111/jace.12069
   Danzer R, 2014, J EUR CERAM SOC, V34, P3435, DOI 10.1016/j.jeurceramsoc.2014.04.026
   de Abajo FJG, 2007, REV MOD PHYS, V79, P1267, DOI 10.1103/RevModPhys.79.1267
   Diao CL, 2014, CERAM INT, V40, P13827, DOI 10.1016/j.ceramint.2014.05.099
   Donthu SK, 2005, J APPL PHYS, V98, DOI 10.1063/1.1949712
   Holthaus MG, 2012, J MATER PROCESS TECH, V212, P614, DOI 10.1016/j.jmatprotec.2011.06.007
   Holthaus MG, 2011, J EUR CERAM SOC, V31, P2809, DOI 10.1016/j.jeurceramsoc.2011.07.020
   Holthaus MG, 2010, J AM CERAM SOC, V93, P2574, DOI 10.1111/j.1551-2916.2010.03902.x
   HOTZA D, 1995, MAT SCI ENG A-STRUCT, V202, P206, DOI 10.1016/0921-5093(95)09785-6
   Hozumi A, 2011, MATER CHEM PHYS, V129, P464, DOI 10.1016/j.matchemphys.2011.04.048
   Nieto MI, 2014, ADV ENG MATER, V16, P637, DOI 10.1002/adem.201400076
   Jagdheesh R, 2014, LANGMUIR, V30, P12067, DOI 10.1021/la5033527
   Jimenez J, 2004, ANNU REV FLUID MECH, V36, P173, DOI 10.1146/annurev.fluid.36.050802.122103
   Kristoffersson A, 1997, J EUR CERAM SOC, V17, P289, DOI 10.1016/S0955-2219(96)00143-4
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lewis JA, 2000, J AM CERAM SOC, V83, P2341
   Li F, 2014, J ALLOY COMPD, V614, P394, DOI 10.1016/j.jallcom.2014.06.117
   Lin DM, 2014, SCIENCE, V345, P298, DOI 10.1126/science.1253213
   Liu YT, 2013, COLLOID SURFACE B, V106, P37, DOI 10.1016/j.colsurfb.2013.01.023
   Liu Y, 2014, J MEMBRANE SCI, V467, P100, DOI 10.1016/j.memsci.2014.05.020
   Nadeem D, 2013, J BIOMED MATER RES A, V101, P3247, DOI 10.1002/jbm.a.34622
   Ohashi N, 2007, J ELECTROCHEM SOC, V154, pD82, DOI 10.1149/1.2402991
   Ritzhaupt-Kleissl H.J., 2008, MICROENGINEERING MET, P421
   Roy T, 2014, CERAM INT, V40, P2381, DOI 10.1016/j.ceramint.2013.08.009
   Ruschel VC, 2014, J PROSTHET DENT, V112, P903, DOI 10.1016/j.prosdent.2014.04.003
   Santacruz I, 2002, MATER RES BULL, V37, P671, DOI 10.1016/S0025-5408(02)00686-4
   Selimovic A, 2014, ANALYST, V139, P5686, DOI 10.1039/c4an01062k
   Shan XC, 2009, MICROSYST TECHNOL, V15, P1319, DOI 10.1007/s00542-008-0739-4
   Souza ROA, 2013, J MECH BEHAV BIOMED, V26, P155, DOI 10.1016/j.jmbbm.2013.04.018
   Stefanic M, 2014, J MATER SCI-MATER M, V25, P2333, DOI 10.1007/s10856-014-5246-9
   Su B, 2012, J EUR CERAM SOC, V32, P3345, DOI 10.1016/j.jeurceramsoc.2012.04.009
   Su B, 2002, J MATER SCI, V37, P3123, DOI 10.1023/A:1016198009368
   Thampi VVA, 2014, CERAM INT, V40, P14355, DOI 10.1016/j.ceramint.2014.06.027
   Treccani L, 2009, ADV ENG MATER, V11, pB61, DOI 10.1002/adem.200800372
   Vasconcellos FD, 2014, ACS PHOTONICS, V1, P489, DOI 10.1021/ph400149m
   Wang X, 2002, CERAM INT, V28, P865, DOI 10.1016/S0272-8842(02)00066-4
   Xie ZP, 2001, J MATER SCI LETT, V20, P1255, DOI 10.1023/A:1010943427450
   Zapata-Solvas E, 2014, J EUR CERAM SOC, V34, P3535, DOI 10.1016/j.jeurceramsoc.2014.06.004
   Zhang X, 2013, APPL SURF SCI, V287, P329, DOI 10.1016/j.apsusc.2013.09.151
NR 45
TC 2
Z9 2
U1 6
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD MAR
PY 2016
VL 42
IS 4
BP 5036
EP 5044
DI 10.1016/j.ceramint.2015.12.015
PG 9
WC Materials Science, Ceramics
SC Materials Science
GA DC8HM
UT WOS:000369460500049
DA 2018-10-19
ER

PT J
AU Ajioka, I
AF Ajioka, Itsuki
TI Biomaterial-engineering and neurobiological approaches for regenerating
   the injured cerebral cortex
SO REGENERATIVE THERAPY
LA English
DT Review
DE Cerebral cortex; Regeneration; Cell cycle; Biomaterials
ID NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; ADULT MAMMALIAN BRAIN; MARROW
   STROMAL CELLS; RETINOBLASTOMA PROTEIN; HORIZONTAL INTERNEURONS;
   ALZHEIMERS-DISEASE; CORTICAL-NEURONS; TRANSPLANTATION; NEUROGENESIS
AB The cerebral cortex is responsible for higher functions of the central nervous system (CNS), such as movement, sensation, and cognition. When the cerebral cortex is severely injured, these functions are irreversibly impaired. Although recent neurobiological studies reveal that the cortex has the potential for regeneration, therapies for functional recovery face some technological obstacles. Biomaterials have been used to evoke regenerative potential and promote regeneration in several tissues, including the CNS. This review presents a brief overview of new therapeutic strategies for cortical regeneration from the perspectives of neurobiology and biomaterial engineering, and discusses a promising technology for evoking the regenerative potential of the cerebral cortex. (c) 2016, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V.
C1 [Ajioka, Itsuki] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, 1-5-45 Yushima, Tokyo 1138510, Japan.
   [Ajioka, Itsuki] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan.
RP Ajioka, I (reprint author), Tokyo Med & Dent Univ, Ctr Brain Integrat Res, 1-5-45 Yushima, Tokyo 1138510, Japan.
EM iajioka@ams.kuramae.ne.jp
FU Ministry of Education, Culture, Sports, Science and Technology (MEXT)
   [26106711]; Terumo Life Science Foundation
FX This work was supported by a Grant-in-Aid for Scientific Research from
   the Ministry of Education, Culture, Sports, Science and Technology
   (MEXT) (26106711) and by the Terumo Life Science Foundation.
CR Ajioka I, 2007, CELL, V131, P378, DOI 10.1016/j.cell.2007.09.036
   Ajioka I, 2015, TISSUE ENG PT A, V21, P193, DOI [10.1089/ten.tea.2014.0080, 10.1089/ten.TEA.2014.0080]
   Ajioka I, 2014, DEV GROWTH DIFFER, V56, P324, DOI 10.1111/dgd.12127
   Ajioka I, 2011, BIOMATERIALS, V32, P5765, DOI 10.1016/j.biomaterials.2011.04.062
   Andrusiak MG, 2012, J NEUROSCI, V32, P14809, DOI 10.1523/JNEUROSCI.1912-12.2012
   Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747
   Assawachananont J, 2014, STEM CELL REP, V2, P662, DOI 10.1016/j.stemcr.2014.03.011
   Bible E, 2009, BIOMATERIALS, V30, P2985, DOI 10.1016/j.biomaterials.2009.02.012
   Biswas SC, 2007, J NEUROSCI, V27, P893, DOI 10.1523/JNEUROSCI.3524-06.2007
   Borlongan CV, 1998, EXP NEUROL, V149, P310, DOI 10.1006/exnr.1997.6730
   Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399
   CAJAL SRY, 1913, ESTUDIOS DEGENERACIO
   Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005
   Cheng TY, 2013, BIOMATERIALS, V34, P2005, DOI 10.1016/j.biomaterials.2012.11.043
   Deguchi K, 2006, J CEREBR BLOOD F MET, V26, P1263, DOI 10.1038/sj.jcbfm.9600275
   Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941
   El-Khodor BF, 2003, EXP NEUROL, V179, P17, DOI 10.1006/exnr.2002.8047
   Elias PZ, 2012, J NEUROSCI METH, V209, P199, DOI 10.1016/j.jneumeth.2012.06.003
   Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305
   Faiz M, 2008, MOL CELL NEUROSCI, V38, P170, DOI 10.1016/j.mcn.2008.02.002
   Ferguson KL, 2002, EMBO J, V21, P3337, DOI 10.1093/emboj/cdf338
   Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124
   Hoglinger GU, 2007, P NATL ACAD SCI USA, V104, P3585, DOI 10.1073/pnas.0611671104
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   Huang KF, 2012, BIOMATERIALS, V33, P2067, DOI 10.1016/j.biomaterials.2011.11.040
   Jensen MB, 2013, J STROKE CEREBROVASC, V22, P304, DOI 10.1016/j.jstrokecerebrovasdis.2011.09.008
   Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3
   Jin KL, 2010, J CEREBR BLOOD F MET, V30, P534, DOI 10.1038/jcbfm.2009.219
   Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101
   Kohwi M, 2013, NAT REV NEUROSCI, V14, P823, DOI 10.1038/nrn3618
   Kojima T, 2010, STEM CELLS, V28, P545, DOI 10.1002/stem.306
   Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711
   Kreuzberg M, 2010, EXP NEUROL, V226, P90, DOI 10.1016/j.expneurol.2010.08.006
   Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600
   Kuan CY, 2004, J NEUROSCI, V24, P10763, DOI 10.1523/JNEUROSCI.3883-04.2004
   Kuhn HG, 1996, J NEUROSCI, V16, P2027
   LABBE R, 1983, SCIENCE, V221, P470, DOI 10.1126/science.6683427
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Le Magueresse C, 2012, CEREB CORTEX, V22, P2285, DOI 10.1093/cercor/bhr302
   LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174
   MACKLIS JD, 1993, J NEUROSCI, V13, P3848
   MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161
   MacPherson D, 2003, MOL CELL BIOL, V23, P1044, DOI 10.1128/MCB.23.3.1044-1053.2003
   MCCONNELL SK, 1988, J NEUROSCI, V8, P945
   McEvoy J, 2011, CANCER CELL, V20, P260, DOI 10.1016/j.ccr.2011.07.005
   Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106
   Mohamad O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064160
   Nguyen MD, 2003, J NEUROSCI, V23, P2131
   Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384
   Oshikawa M, 2013, DEVELOPMENT, V140, P2310, DOI 10.1242/dev.095653
   Osuga H, 2000, P NATL ACAD SCI USA, V97, P10254, DOI 10.1073/pnas.170144197
   Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997
   Pittenger MF, 2011, SCIENCE, V143, P143
   Ratner B. D., 2012, BIOMATERIALS SCI INT
   Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   Saha B, 2013, STEM CELL RES, V11, P965, DOI 10.1016/j.scr.2013.06.006
   Silva ART, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099897
   Thored P, 2007, STROKE, V38, P3032, DOI 10.1161/STROKEAHA.107.488445
   WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2
   Williams D., 1986, P CONSC EUR SOC BIOM, V4, P414
   Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006
   Yang Y, 2001, J NEUROSCI, V21, P2661, DOI 10.1523/JNEUROSCI.21-08-02661.2001
   Yu Y, 2012, NEUROCHEM RES, V37, P503, DOI 10.1007/s11064-011-0636-6
   Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733
   Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129
NR 68
TC 2
Z9 2
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3204
J9 REGEN THER
JI Regen. Ther.
PD MAR
PY 2016
VL 3
SI SI
BP 63
EP 67
DI 10.1016/j.reth.2016.02.002
PG 5
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA FR1NM
UT WOS:000418834300010
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Abdal-hay, A
   Hussein, KH
   Casettari, L
   Khalil, KA
   Hamdy, AS
AF Abdal-hay, Abdalla
   Hussein, Kamal Hany
   Casettari, Luca
   Khalil, Khalil Abdelrazek
   Hamdy, Abdel Salam
TI Fabrication of novel high performance ductile poly(lactic acid)
   nanofiber scaffold coated with poly(vinyl alcohol) for tissue
   engineering applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Poly lactic acid; Poly vinyl alcohol; Tissue regeneration; Hydrothermal
   deposition; Nanofiber scaffolds; Cytocompatibility; Biodegradable
   synthetic polymers
ID ELECTROSPUN NYLON-6 NANOFIBERS; MECHANICAL-PROPERTIES; SURFACE
   MODIFICATION; BONE REGENERATION; BLENDS; PLA; HYDROXYAPATITE; MEMBRANE;
   POLYMERS; MATRIX
AB Poly(lactic acid) (PLA) nanofiber scaffold has received increasing interest as a promising material for potential application in the field of regenerative medicine. However, the low hydrophilicity and poor ductility restrict its practical application. Integration of hydrophilic elastic polymer onto the surface of the nanofiber scaffold may help to overcome the drawbacks of PLA material. Herein, we successfully optimized the parameters for in situ deposition of poly(vinyl alcohol), (PVA) onto post-electrospun PLA nanofibers using a simple hydrothermal approach. Our results showed that the average fiber diameter of coated nanofiber mat is about 1265 +/- 222 nm, which is remarkably higher than its pristine counterpart (650 +/- 180 nm). The hydrophilicity of PIA nanofiber scaffold coated with a PVA thin layer improved dramatically (36.11 +/- 1.5 degrees) compared to that of pristine PLA (119.7 +/- 1.5 degrees) scaffold. The mechanical testing showed that the PLA nanofiber scaffold could be converted from rigid to ductile with enhanced tensile strength, due to maximizing the hydrogen bond interaction during the heat treatment and in the presence of PVA. Cytocompatibility performance of the pristine and coated PLA fibers with PVA was observed through an in vitro experiment based on cell attachment and the MTT assay by EA.hy926 human endothelial cells. The cytocompatibility results showed that human cells induced more favorable attachment and proliferation behavior on hydrophilic PLA composite scaffold than that of pristine PLA. Hence, PVA coating resulted in an increase in initial human cell attachment and proliferation. We believe that the novel PVA-coated PLA nanofiber scaffold developed in this study, could be a promising high performance biomaterial in regeneration medicine. (C) 2015 Published by Elsevier B.V.
C1 [Abdal-hay, Abdalla] South Valley Univ, Fac Engn, Dept Engn Mat & Mech Design, Qena 83523, Egypt.
   [Hussein, Kamal Hany] Kangwon Natl Univ, Stem Cell Inst, Chunchon 200701, Gangwon, South Korea.
   [Hussein, Kamal Hany] Kangwon Natl Univ, Coll Vet Med, Chunchon 200701, Gangwon, South Korea.
   [Casettari, Luca] Univ Urbino, Dept Biomol Sci, Piazza Rinascimento 6, I-61029 Urbino, PU, Italy.
   [Khalil, Khalil Abdelrazek] King Saud Univ, Coll Engn, Dept Mech Engn, Riyadh 11421, Saudi Arabia.
   [Khalil, Khalil Abdelrazek] Aswan Univ, Fac Energy Engn, Dept Mech Engn, Aswan, Egypt.
   [Hamdy, Abdel Salam] Univ Texas Rio Grande Valley, Coll Engn & Comp Sci, Dept Mfg & Ind Engn, 1201 West Univ Dr, Edinburg, TX 78541 USA.
RP Abdal-hay, A (reprint author), South Valley Univ, Fac Engn, Dept Engn Mat & Mech Design, Qena 83523, Egypt.; Khalil, KA (reprint author), King Saud Univ, Coll Engn, Dept Mech Engn, POB 800, Riyadh 11421, Saudi Arabia.
EM abda_55@jbnu.ac.kr
RI Casettari, Luca/G-8518-2015
OI Casettari, Luca/0000-0001-6907-8904; Abdal-hay,
   Abdalla/0000-0001-6307-6027
FU Deanship of Scientific Research at King Saud University [RG 1435-001]
FX The authors would like to extend their sincere appreciation to the
   Deanship of Scientific Research at King Saud University for funding this
   Research Group NO. (RG 1435-001).
CR Abdal-hay A., 2013, COLLOID SURF A, P37
   Abdal-Hay A, 2014, MATER LETT, V137, P378, DOI 10.1016/j.matlet.2014.09.034
   Abdal-hay A, 2014, CERAM INT, V40, P4995, DOI 10.1016/j.ceramint.2013.08.057
   Abdal-hay A, 2013, CHEM ENG J, V228, P708, DOI 10.1016/j.cej.2013.05.022
   Abdal-hay A, 2013, EUR POLYM J, V49, P1314, DOI 10.1016/j.eurpolymj.2013.02.004
   Abdal-haya A, 2013, COLLOID SURFACE B, V102, P635, DOI 10.1016/j.colsurfb.2012.09.017
   Asran A., 2010, BIOMACROMOLECULES, P3413
   Chen BK, 2010, POLYMER, V51, P4667, DOI 10.1016/j.polymer.2010.08.028
   Cohn D, 2005, BIOMATERIALS, V26, P2297, DOI 10.1016/j.biomaterials.2004.07.052
   Cossement D, 2006, APPL SURF SCI, V252, P6636, DOI 10.1016/j.apsusc.2006.02.225
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   Franco RA, 2014, POLYM ADVAN TECHNOL, V25, P55, DOI 10.1002/pat.3205
   Grumezescu V, 2014, APPL SURF SCI, V302, P262, DOI 10.1016/j.apsusc.2013.09.081
   Jeong SI, 2004, BIOMATERIALS, V25, P5939, DOI 10.1016/j.biomaterials.2004.01.057
   Jorda-Vilaplana A, 2014, EUR POLYM J, V58, P23, DOI 10.1016/j.eurpolymj.2014.06.002
   Jung YH, 2005, MACROMOL RES, V13, P385, DOI 10.1007/BF03218470
   Kang S., 2001, MACROMOLECULES, P4542
   Kasuga T, 2001, BIOMATERIALS, V22, P19, DOI 10.1016/S0142-9612(00)00091-0
   Leiggener CS, 2006, BIOMATERIALS, V27, P202, DOI 10.1016/j.biomaterials.2005.05.068
   Li J, 2008, APPL SURF SCI, V255, P494, DOI 10.1016/j.apsusc.2008.06.067
   Liu CB, 2007, COLLOID SURFACE A, V302, P430, DOI 10.1016/j.colsurfa.2007.03.006
   Liu X, 1997, J ENVIRON POLYM DEGR, V5, P225
   Ma GP, 2010, POLYM ADVAN TECHNOL, V21, P189, DOI 10.1002/pat.1415
   Martin O, 2001, POLYMER, V42, P6209, DOI 10.1016/S0032-3861(01)00086-6
   Meneghello G, 2009, J MEMBRANE SCI, V344, P55, DOI 10.1016/j.memsci.2009.07.034
   MIKOS AG, 1989, POLYMER, V30, P84, DOI 10.1016/0032-3861(89)90387-X
   Nisbet DR, 2009, COLLOID SURFACE B, V71, pCP1, DOI 10.1016/j.colsurfb.2009.01.022
   Norton AB, 2014, FOOD HYDROCOLLOID, V42, P373, DOI 10.1016/j.foodhyd.2014.05.001
   Nuttelman CR, 2002, BIOMATERIALS, V23, P3617, DOI 10.1016/S0142-9612(02)00093-5
   Oh SH, 2003, BIOMATERIALS, V24, P4011, DOI 10.1016/S0142-9612(03)00284-9
   Papkov D, 2013, ACS NANO, V7, P3324, DOI 10.1021/nn400028p
   Pi PH, 2013, APPL SURF SCI, V273, P184, DOI 10.1016/j.apsusc.2013.02.011
   Pitarresi G, 2012, J BIOMED MATER RES A, V100A, P1565, DOI 10.1002/jbm.a.34095
   Qazi TH, 2014, BIOMATERIALS, V35, P9068, DOI 10.1016/j.biomaterials.2014.07.020
   Ribeiro C, 2011, SCI TECHNOL ADV MAT, V12, DOI 10.1088/1468-6996/12/1/015001
   Rogina A, 2014, APPL SURF SCI, V296, P221, DOI 10.1016/j.apsusc.2014.01.098
   Sarapirom S, 2014, APPL SURF SCI, V310, P42, DOI 10.1016/j.apsusc.2014.03.141
   SCHMITT EA, 1994, MACROMOLECULES, V27, P743, DOI 10.1021/ma00081a019
   Shuai X, 2001, J APPL POLYM SCI, V81, P762, DOI 10.1002/app.1493
   Tsuji H, 2001, J APPL POLYM SCI, V81, P2151, DOI 10.1002/app.1651
   Yang DZ, 2007, CARBOHYD POLYM, V69, P538, DOI 10.1016/j.carbpol.2007.01.008
   You Y, 2006, MATER LETT, V60, P1331, DOI 10.1016/j.matlet.2005.11.022
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 43
TC 22
Z9 22
U1 8
U2 147
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2016
VL 60
BP 143
EP 150
DI 10.1016/j.msec.2015.11.024
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA DC4QF
UT WOS:000369204700018
PM 26706517
DA 2018-10-19
ER

PT J
AU Hedayati, R
   Sadighi, M
   Mohammadi-Aghdam, M
   Zadpoor, AA
AF Hedayati, R.
   Sadighi, M.
   Mohammadi-Aghdam, M.
   Zadpoor, A. A.
TI Mechanical properties of regular porous biomaterials made from truncated
   cube repeating unit cells: Analytical solutions and computational models
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Porous biomaterials; Mechanical behavior; Analytical; Lattice structure
ID LATTICE CELLULAR STRUCTURES; LINEAR ELASTIC BEHAVIOR; FINITE-ELEMENT;
   TISSUE-GROWTH; BONE TISSUE; TITANIUM; GEOMETRY; FOAMS; MICROSTRUCTURE;
   ARTHROPLASTY
AB Additive manufacturing (AM) has enabled fabrication of open-cell porous biomaterials based on repeating unit cells. The micro-architecture of the porous biomaterials and, thus, their physical properties could then be precisely controlled. Due to their many favorable properties, porous biomaterials manufactured using AM are considered as promising candidates for bone substitution as well as for several other applications in orthopedic surgery. The mechanical properties of such porous structures including static and fatigue properties are shown to be strongly dependent on the type of the repeating unit cell based on which the porous biomaterial is built. In this paper, we study the mechanical properties of porous biomaterials made from a relatively new unit cell, namely truncated cube. We present analytical solutions that relate the dimensions of the repeating unit cell to the elastic modulus, Poisson's ratio, yield stress, and buckling load of those porous structures. We also performed finite element modeling to predict the mechanical properties of the porous structures. The analytical solution and computational results were found to be in agreement with each other. The mechanical properties estimated using both the analytical and computational techniques were somewhat higher than the experimental data reported in one of our recent studies on selective laser melted Ti-6Al-4V porous biomaterials. In addition to porosity, the elastic modulus and Poisson's ratio of the porous structures were found to be strongly dependent on the ratio of the length of the inclined struts to that of the uninclined (i.e. vertical or horizontal) struts, a, in the truncated cube unit cell. The geometry of the truncated cube unit cell approaches the octahedral and cube unit cells when a respectively approaches zero and infinity. Consistent with those geometrical observations, the analytical solutions presented in this study approached those of the octahedral and cube unit cells when a approached respectively 0 and infinity. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Hedayati, R.; Sadighi, M.; Mohammadi-Aghdam, M.] Amirkabir Univ Technol, Tehran Polytech, Dept Mech Engn, Hafez Ave, Tehran, Iran.
   [Hedayati, R.; Zadpoor, A. A.] Delft Univ Technol, Fac Mech Maritime & Mat Engn, Dept Biomech Engn, Mekelweg 2, NL-2628 CD Delft, Netherlands.
RP Hedayati, R (reprint author), Amirkabir Univ Technol, Tehran Polytech, Dept Mech Engn, Hafez Ave, Tehran, Iran.
EM rezahedayati@gmail.com
RI Hedayati, Reza/F-8806-2014; Zadpoor, Amir A/A-8510-2008; Aghdam,
   M./I-5723-2018
OI Hedayati, Reza/0000-0002-4806-3970; Aghdam, M./0000-0003-3403-0307;
   Zadpoor, Amir Abbas/0000-0003-3234-2112
CR Ahmadi SM, 2014, J MECH BEHAV BIOMED, V34, P106, DOI 10.1016/j.jmbbm.2014.02.003
   Ahmadi SM, 2015, MATERIALS, V8, P1871, DOI 10.3390/ma8041871
   Babaee S, 2012, ACTA MATER, V60, P2873, DOI 10.1016/j.actamat.2012.01.052
   Bauer TW, 1999, SKELETAL RADIOL, V28, P483, DOI 10.1007/s002560050552
   Bayraktar HH, 2004, J BIOMECH, V37, P27, DOI 10.1016/S0021-9290(03)00257-4
   Bidan CM, 2013, ADV HEALTHC MATER, V2, P186, DOI 10.1002/adhm.201200159
   Bidan CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036336
   Bitsche R, 2005, SPACE FILLING POLYHE
   Borleffs M.S., 2012, FINITE ELEMENT MODEL
   Buffel B, 2014, INT J SOLIDS STRUCT, V51, P3461, DOI 10.1016/j.ijsolstr.2014.06.017
   Campoli G, 2013, MATER DESIGN, V49, P957, DOI 10.1016/j.matdes.2013.01.071
   Cansizoglu O, 2008, MAT SCI ENG A-STRUCT, V492, P468, DOI 10.1016/j.msea.2008.04.002
   Gibson L. G., 1997, CELLULAR SOLIDS STRU
   Hasan MA, 2010, ADV MAT SCI ENG, V2010
   Hedayati R, 2017, APPL MATH MODEL, V46, P408, DOI 10.1016/j.apm.2017.01.076
   Hedayati R, 2016, INT J MECH SCI, V106, P19, DOI 10.1016/j.ijmecsci.2015.11.033
   Hedayati R, 2016, INT J FATIGUE, V84, P67, DOI 10.1016/j.ijfatigue.2015.11.017
   Hedayati R, 2016, MATER DESIGN, V89, P9, DOI 10.1016/j.matdes.2015.09.052
   Hedayati R, 2016, J MECH BEHAV BIOMED, V53, P272, DOI 10.1016/j.jmbbm.2015.07.013
   Hedayati R., 2015, COMPARISON OF ELASTI
   Heinl P, 2008, ADV ENG MATER, V10, P882, DOI 10.1002/adem.200800137
   Hou C., 2013, NUMERICAL EXPT CRASH
   Joshi MG, 2000, J BIOMECH, V33, P1655, DOI 10.1016/S0021-9290(00)00110-X
   Karachalios T, 2004, J ARTHROPLASTY, V19, P469, DOI 10.1016/j.arth.2003.12.081
   Kim A, 2006, MODEL SIMUL MATER SC, V14, P933, DOI 10.1088/0965-0393/14/6/004
   Kraynik AM, 1996, J COLLOID INTERF SCI, V181, P511, DOI 10.1006/jcis.1996.0408
   Labeas GN, 2010, STRAIN, V46, P195
   Luxner MH, 2009, ACTA BIOMATER, V5, P381, DOI 10.1016/j.actbio.2008.07.025
   Marciniak Z., 1967, INT J MECH SCI, V9, DOI [DOI 10.1016/0020-7403(67)90066-5, 10.1016/0020-7403(67)90066-5]
   Mills NJ, 2009, INT J SOLIDS STRUCT, V46, P677, DOI 10.1016/j.ijsolstr.2008.09.012
   Mullen L, 2009, J BIOMED MATER RES B, V89B, P325, DOI 10.1002/jbm.b.31219
   Murr LE, 2011, J MECH BEHAV BIOMED, V4, P1396, DOI 10.1016/j.jmbbm.2011.05.010
   Niendorf T, 2014, METALL MATER TRANS B, V45, P1181, DOI 10.1007/s11663-014-0086-z
   Parthasarathy J, 2010, J MECH BEHAV BIOMED, V3, P249, DOI 10.1016/j.jmbbm.2009.10.006
   Ptochos E, 2012, STRAIN, V48, P415, DOI 10.1111/j.1475-1305.2012.00837.x
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Rumpler M, 2008, J R SOC INTERFACE, V5, P1173, DOI 10.1098/rsif.2008.0064
   Senthilkumar S., 2014, WALAILAK J SCI TECHN, V11, pi
   Shulmeister V, 1998, MECH MATER, V30, P125, DOI 10.1016/S0167-6636(98)00033-7
   Smith M, 2013, INT J MECH SCI, V67, P28, DOI 10.1016/j.ijmecsci.2012.12.004
   Sun J., 2012, ADV MECH ENG, V2012
   Van Bael S, 2012, ACTA BIOMATER, V8, P2824, DOI 10.1016/j.actbio.2012.04.001
   Vigliotti A, 2012, COMPUT METHOD APPL M, V229, P27, DOI 10.1016/j.cma.2012.03.018
   Warren WE, 1997, J APPL MECH-T ASME, V64, P787, DOI 10.1115/1.2788983
   Yavari SA, 2014, J MECH BEHAV BIOMED, V36, P109, DOI 10.1016/j.jmbbm.2014.04.010
   Yavari SA, 2014, APPL SURF SCI, V290, P287, DOI 10.1016/j.apsusc.2013.11.069
   Yavari SA, 2014, BIOMATERIALS, V35, P6172, DOI 10.1016/j.biomaterials.2014.04.054
   Zadpoor AA, 2015, BIOMATER SCI-UK, V3, P231, DOI 10.1039/c4bm00291a
   Zadpoor AA, 2008, J MATER PROCESS TECH, V200, P288, DOI 10.1016/j.jmatprotec.2007,09.049
   Zheng XY, 2014, SCIENCE, V344, P1373, DOI 10.1126/science.1252291
   Zysset PK, 1999, J BIOMECH, V32, P1005, DOI 10.1016/S0021-9290(99)00111-6
NR 51
TC 29
Z9 29
U1 5
U2 60
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2016
VL 60
BP 163
EP 183
DI 10.1016/j.msec.2015.11.001
PG 21
WC Materials Science, Biomaterials
SC Materials Science
GA DC4QF
UT WOS:000369204700021
PM 26706520
DA 2018-10-19
ER

PT J
AU Kose, C
   Kacar, R
   Zorba, AP
   Bagirova, M
   Allahverdiyev, AM
AF Kose, Ceyhun
   Kacar, Ramazan
   Zorba, Asli Pinar
   Bagirova, Melahat
   Allahverdiyev, Adil M.
TI The effect of CO2 laser beam welded AISI 316L austenitic stainless steel
   on the viability of fibroblast cells, in vitro
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Laser beam welding; Austenitic stainless steel; L929 fibroblast cell;
   Viability; Tukey test
ID SIMULATED BODY-FLUIDS; MECHANICAL-PROPERTIES; CORROSION BEHAVIOR;
   ORTHOPEDIC IMPLANTS; LASER; SURFACE; NITROGEN; MICROSTRUCTURE;
   CYTOTOXICITY
AB It has been determined by the literature research that there is no clinical study on the in vivo and in vitro interaction of the cells with the laser beam welded joints of AISI 316L biomaterial. It is used as a prosthesis and implant material and that has adequate mechanical properties and corrosion resistance characteristics. Therefore, the interaction of the CO2 laser beam welded samples and samples of the base metal of AISI 316L austenitic stainless steel with L929 fibroblast cells as an element of connective tissue under in vitro conditions has been studied. To study the effect of the base metal and the laser welded test specimens on the viability of the fibroblast cells that act as an element of connective tissues in the body, they were kept in DMEMF-12 medium for 7, 14, 28 days and 18 months. The viability study was experimentally studied using the MTF method for 7, 14, 28 days. In addition, the direct interaction of the fibroblast cells seeded on 6 different plates with the samples was examined with an inverted microscope. The MIT cell viability experiment was repeated on the cells that were in contact with the samples. The statistical relationship was analyzed using a Tukey test for the variance with the GraphPad statistics software. The data regarding metallic ion release were identified with the ICP-MS method after the laser welded and main material samples were kept in cell culture medium for 18 months.
   The cell viability of the laser welded sample has been detected to be higher than that of the base metal and the control based on 7th day data. However, the laser welded sample's viability of the fibroblast cells has diminished by time during the test period of 14 and 28 days and base metal shows better viability when compared to the laser welded samples. On the other hand, the base metal and the laser welded sample show better cell viability effect when compared to the control group. According to the ICP-MS results of the main material and laser welded samples which were kept in the cell culture medium for 18 months, it was determined that the Fe, Ni and Cr ion concentration released to the cell culture medium from the laser welded test sample was less than that of the main material. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Kose, Ceyhun] Gaziosmanpasa Univ, Dept Mech Engn, Fac Nat Sci & Engn, TR-60150 Tokat, Turkey.
   [Kacar, Ramazan] Karabuk Univ, Fac Technol, Dept Mfg Engn, TR-78050 Karabuk, Turkey.
   [Zorba, Asli Pinar] Yildiz Tekn Univ, Dept Bioengn Cell Culture & Tissue Engn, Grad Sch Nat & Appl Sci, Istanbul, Turkey.
   [Bagirova, Melahat; Allahverdiyev, Adil M.] Yildiz Tekn Univ, Dept Bioengn Cell Culture & Tissue Engn, Istanbul, Turkey.
RP Kose, C (reprint author), Gaziosmanpasa Univ, Dept Mech Engn, Fac Nat Sci & Engn, TR-60150 Tokat, Turkey.
EM ceyhun.kose@gop.edu.tr; rkacar@karabuk.edu.tr; aslipinarzorba@gmail.com;
   mbagir@yildiz.edu.tr; adil@yildiz.edu.tr
RI Zorba, Asli Pinar/L-6429-2018
OI KOSE, CEYHUN/0000-0002-3907-2226
CR Lopez DA, 2008, J MATER SCI-MATER M, V19, P2137, DOI 10.1007/s10856-007-3138-y
   Alexandra Moisa Bogdan, 2010, Advances in Control, Chemical Engineering, Civil Engineering and Mechanical Engineering. European Conference of Chemical Engineering (ECCE 2010). European Conference of Civil Engineering (ECCIE 2010) European Conference of Mechanical Engineering (ECME 2010). European Conference of Control (ECC 2010), P159
   Balasubramanian K R, 2008, Advances in Production Engineering & Management, V3, P93
   Balla VK, 2013, MAT SCI ENG C-MATER, V33, P4594, DOI 10.1016/j.msec.2013.07.015
   Beddoes J, 1999, INTRO STAINLESS STEE
   Bordji K, 1996, BIOMATERIALS, V17, P491, DOI 10.1016/0142-9612(96)82723-2
   CALLISTER WD, 1994, MAT SCI ENG INTRO
   Celik O., 2009, INT ADV TECHN S KAR
   Chukkan JR, 2015, J MATER PROCESS TECH, V219, P48, DOI 10.1016/j.jmatprotec.2014.12.008
   Dadfar M, 2007, MATER LETT, V61, P2343, DOI 10.1016/j.matlet.2006.09.008
   Davis J. R., 1994, ASM SPECIALITY HDB S
   Duley W. W., 1983, LASER PROCESSING ANA
   Eliades T, 2004, AM J ORTHOD DENTOFAC, V125, P24, DOI 10.1016/j.ajodo.2003.09.009
   Faghihi S, 2012, TISSUE CELL, V44, P365, DOI 10.1016/j.tice.2012.06.002
   Fan X, 2009, T NONFERR METAL SOC, V19, P347, DOI 10.1016/S1003-6326(08)60276-9
   Fini M, 2003, BIOMATERIALS, V24, P4929, DOI 10.1016/S0142-9612(03)00416-2
   Gopi D, 2014, COLLOID SURFACE B, V114, P234, DOI 10.1016/j.colsurfb.2013.10.011
   Hallab N, 2001, J BONE JOINT SURG AM, V83A, P428, DOI 10.2106/00004623-200103000-00017
   Hansen D.C., 2008, METAL CORROSION HUMA, P31
   HI Y., 2006, J BIOMED MATER RES A, V76, P835
   Kenar H, 2013, COLLOID SURFACE B, V108, P305, DOI 10.1016/j.colsurfb.2013.02.039
   Kose C, 2015, J FAC ENG ARCHIT GAZ, V30, P225
   Kose C, 2014, MATER TEST, V56, P779, DOI 10.3139/120.110632
   Kose C, 2014, MATER DESIGN, V64, P221, DOI 10.1016/j.matdes.2014.07.044
   Kou S, 2003, WELDING METALLURGY
   Kuroda D, 2002, MATER TRANS, V43, P3100, DOI 10.2320/matertrans.43.3100
   Kuroda D., 2008, MAT T, V49, P2844
   Kwok CT, 2006, J MATER PROCESS TECH, V176, P168, DOI 10.1016/j.jmatprotec.2006.03.128
   Lee WS, 2003, MATER TRANS, V44, P2637, DOI 10.2320/matertrans.44.2637
   LIM IAL, 2004, MURJ, V11, P33
   Lippold J.C, 2005, WELDING METALLURGY W
   Lo KH, 2009, MAT SCI ENG R, V65, P39, DOI 10.1016/j.mser.2009.03.001
   Ma TC, 2012, J MATER SCI TECHNOL, V28, P647, DOI 10.1016/S1005-0302(12)60111-X
   Manivasagam G., 2010, RECENT PAT CORROS SC, V2, P40, DOI [10.2174/1877610801002010040, DOI 10.2174/1877610801002010040]
   Moravej M, 2011, INT J MOL SCI, V12, P4250, DOI 10.3390/ijms12074250
   Murphy BP, 2003, ANN BIOMED ENG, V31, P686, DOI 10.1114/1.1569268
   Nie FL, 2011, DENT MATER, V27, P677, DOI 10.1016/j.dental.2011.03.009
   Oberringer M, 2013, MAT SCI ENG C-MATER, V33, P901, DOI 10.1016/j.msec.2012.11.018
   Oh KT, 2004, J BIOMED MATER RES B, V69B, P183, DOI 10.1002/jbm.b.30002
   Ozdemir KG, 2009, J BIOMED MATER RES B, V90B, P82, DOI 10.1002/jbm.b.31256
   Pan HA, 2013, BIOMATERIALS, V34, P841, DOI 10.1016/j.biomaterials.2012.09.078
   Reclaru L, 2010, TIMISOARA MED J, V60, P86
   Ruggiero A, 2011, OPT LASER TECHNOL, V43, P82, DOI 10.1016/j.optlastec.2010.05.008
   Salahinejad E., 2013, PLOS ONE, V8, P1
   Samanta SK, 2008, J MATER ENG PERFORM, V17, P908, DOI 10.1007/s11665-008-9235-3
   Sasaki M., 2012, SCI TECHNOL ADV MAT, V13, P1
   Tang YC, 2006, ACTA BIOMATER, V2, P709, DOI 10.1016/j.actbio.2006.06.003
   Terada Maysa, 2006, Mat. Res., V9, P281, DOI 10.1590/S1516-14392006000300007
   Turk R., 2007, MAT GEOENVIRON, V54, P471
   Ventrella A., 2010, J MATER PROCESS TECH, V2010, P1838
   Wan P, 2012, MAT SCI ENG C-MATER, V32, P510, DOI 10.1016/j.msec.2011.12.002
   Zambon A, 2006, MAT SCI ENG A-STRUCT, V424, P117, DOI 10.1016/j.msea.2006.03.003
NR 52
TC 5
Z9 5
U1 0
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2016
VL 60
BP 211
EP 218
DI 10.1016/j.msec.2015.11.035
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA DC4QF
UT WOS:000369204700025
PM 26706524
DA 2018-10-19
ER

PT J
AU Huang, QL
   Liu, XJ
   Elkhooly, TA
   Zhang, RR
   Yang, X
   Shen, ZJ
   Feng, QL
AF Huang, Qianli
   Liu, Xujie
   Elkhooly, Tarek A.
   Zhang, Ranran
   Yang, Xing
   Shen, Zhijian
   Feng, Qingling
TI Preparation and characterization of TiO2/silicate hierarchical coating
   on titanium surface for biomedical applications
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Micro-arc oxidation; Hydrothermal treatment; Titanium implant; Surface
   topography; Surface chemistry; Calcium silicate hydrate
ID CALCIUM SILICATE; IN-VITRO; HYDROXYAPATITE COATINGS; FORMING ABILITY;
   CELL RESPONSE; PURE TITANIUM; IMPLANTS; BONE; OXIDATION; MINERALIZATION
AB In the current work, TiO2/silicate hierarchical coatings with various nanostructure morphologies were successfully prepared on titanium substrates through micro-arc oxidation (MAO) and subsequent hydrothermal treatment (FIT). Moreover, the nucleation mechanism and growth behavior of the nanostructures, hydrophilicity, protein adsorption and apatite-inducing ability of various coatings were also explored. The novel TiO2/silicate hierarchical coatings comprised calcium silicate hydrate (CSH) as an outer-layer and TiO2 matrix as an inner-layer.According to the morphological features, the nanostructures were classified as nanorod, nanoplate and nanoleaf. The morphology, degree of crystallinity and crystalline phases of CSH nanostructures could be controlled by optimizing the HT conditions. The nucleation of CSH nanostructures is caused by release and re-precipitation mechanism. The TiO2/CSH hierarchical coatings exhibited some enhanced physical and biological performances compared to MAO-fabricated coating. The improvement of the hydrophilicity, fibronectin adsorption and apatite-inducing ability was found to be morphological dependent according to the following trend: nanoleaf coating > nanoplate coating > nanorod coating > MAO coating. The results indicate that the tuning of physical and morphological properties of nanostructures coated on biomaterial surface could significantly influence the hydrophilicity, protein adsorption and in vitro bioactivity of biomaterial. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Huang, Qianli; Liu, Xujie; Elkhooly, Tarek A.; Zhang, Ranran; Yang, Xing; Shen, Zhijian; Feng, Qingling] Tsinghua Univ, Sch Mat Sci & Engn, State Key Lab New Ceram & Fine Proc, Beijing 100084, Peoples R China.
   [Liu, Xujie] Tsinghua Univ, Grad Sch Shenzhen, Shenzhen 518055, Peoples R China.
   [Feng, Qingling] Tsinghua Univ, Sch Mat Sci & Engn, Minist Educ China, Key Lab Adv Mat, Beijing 100084, Peoples R China.
   [Elkhooly, Tarek A.] Natl Res Ctr, Inorgan Chem Ind Div, Biomat Dept, Cairo 12622, Egypt.
RP Feng, QL (reprint author), Tsinghua Univ, Sch Mat Sci & Engn, Beijing 100084, Peoples R China.
EM biomater@mail.tsinghua.edu.cn
OI Liu, Xujie/0000-0001-8713-4287
FU National Natural Science Foundation of China [51361130032, 51472139];
   Doctor Subject Foundation of the Ministry of Education of China
   [20120002130002]
FX The authors are grateful for the financial support from the National
   Natural Science Foundation of China (51361130032, 51472139) and Doctor
   Subject Foundation of the Ministry of Education of China
   (20120002130002).
CR ATHANASOU NA, 1992, J BONE JOINT SURG BR, V74, P57
   Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009
   Della Valle C., 2012, J APPL BIOMATER FUNC, V11, pe106
   Diamanti MV, 2011, J APPL BIOMATER BIOM, V9, P55, DOI 10.5301/JABB.2011.7429
   Dou YD, 2012, ACTA BIOMATER, V8, P4139, DOI 10.1016/j.actbio.2012.07.009
   Gittens RA, 2014, ACTA BIOMATER
   Gittens RA, 2014, ACTA BIOMATER, V10, P2907, DOI 10.1016/j.actbio.2014.03.032
   Gittens RA, 2013, ACTA BIOMATER, V9, P6268, DOI 10.1016/j.actbio.2012.12.002
   Guan JJ, 2015, BIOMATERIALS, V55, P1, DOI 10.1016/j.biomaterials.2015.03.029
   Han G, 2015, MAT SCI ENG C-MATER, V47, P376, DOI 10.1016/j.msec.2014.11.021
   Hu HJ, 2013, COLLOID SURFACE B, V101, P83, DOI 10.1016/j.colsurfb.2012.06.021
   Huang Q., 2015, COLLOIDS SURF B
   Huang QL, 2015, CERAM INT, V41, P4452, DOI 10.1016/j.ceramint.2014.11.137
   Jeon H, 2014, J BIOMED MATER RES B, V102, P1580, DOI 10.1002/jbm.b.33158
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kollath VO, 2013, J EUR CERAM SOC, V33, P2715, DOI 10.1016/j.jeurceramsoc.2013.04.030
   Kubo K, 2009, BIOMATERIALS, V30, P5319, DOI 10.1016/j.biomaterials.2009.06.021
   Kung KC, 2012, J ALLOY COMPD, V515, P68, DOI 10.1016/j.jallcom.2011.11.050
   Lakstein D, 2009, ACTA BIOMATER, V5, P2258, DOI 10.1016/j.actbio.2009.01.033
   Laurindo CAH, 2014, MAT SCI ENG C-MATER, V37, P223, DOI 10.1016/j.msec.2014.01.006
   Lee JH, 1997, BIOMATERIALS, V18, P351, DOI 10.1016/S0142-9612(96)00128-7
   Li HY, 2014, BIOMATERIALS, V35, P3803, DOI 10.1016/j.biomaterials.2014.01.039
   Lin KL, 2007, ACTA BIOMATER, V3, P271, DOI 10.1016/j.actbio.2006.11.003
   Liu PS, 2014, ACS APPL MATER INTER, V6, P7141, DOI 10.1021/am501967y
   Liu PS, 2013, BIOMATERIALS, V34, P2442, DOI 10.1016/j.biomaterials.2012.12.029
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Mager MD, 2011, NAT CHEM, V3, P582, DOI [10.1038/NCHEM.1090, 10.1038/nchem.1090]
   Mansur AAP, 2010, MAT SCI ENG C-MATER, V30, P288, DOI 10.1016/j.msec.2009.11.004
   MIYAKE M, 1990, J AM CERAM SOC, V73, P3524, DOI 10.1111/j.1151-2916.1990.tb06491.x
   Mosher DF, 2006, ARTERIOSCL THROM VAS, V26, P1193, DOI 10.1161/01.ATV.0000223342.15969.7a
   Necula BS, 2013, APPL SURF SCI, V273, P310, DOI 10.1016/j.apsusc.2013.02.036
   Ni SY, 2007, J BIOMED MATER RES B, V80B, P174, DOI 10.1002/jbm.b.30582
   Nikkhah M, 2012, BIOMATERIALS, V33, P5230, DOI 10.1016/j.biomaterials.2012.03.079
   Rani VVD, 2012, ACTA BIOMATER, V8, P1976, DOI 10.1016/j.actbio.2012.01.021
   Rani VVD, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/19/195101
   Roy M, 2011, SURF COAT TECH, V205, P2785, DOI 10.1016/j.surfcoat.2010.10.042
   STEVULA L, 1983, CEMENT CONCRETE RES, V13, P684, DOI 10.1016/0008-8846(83)90058-3
   Sul YT, 2005, BIOMATERIALS, V26, P6720, DOI 10.1016/j.biomaterials.2005.04.058
   Sun MC, 2014, COLLOID SURFACE B, V122, P134, DOI 10.1016/j.colsurfb.2014.06.041
   Surmeneva MA, 2013, RSC ADV, V3, P11240, DOI 10.1039/c3ra40446c
   Tsui YC, 1998, BIOMATERIALS, V19, P2015, DOI 10.1016/S0142-9612(98)00103-3
   Vidal G, 2013, ACTA BIOMATER, V9, P4935, DOI 10.1016/j.actbio.2012.09.003
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wang C., 2015, J MAT CHEM B
   Wang HY, 2014, APPL SURF SCI, V292, P204, DOI 10.1016/j.apsusc.2013.11.115
   Wang XH, 2015, COLLOID SURFACE B, V126, P358, DOI 10.1016/j.colsurfb.2014.11.044
   Wang YM, 2014, APPL SURF SCI, V299, P58, DOI 10.1016/j.apsusc.2014.01.185
   Wu J, 2013, SMALL, V9, P2911, DOI 10.1002/smll.201300097
   Zhang W, 2008, APPL SURF SCI, V254, P5216, DOI 10.1016/j.apsusc.2008.02.047
   Zhou JH, 2014, INT J NANOMED, V9, P1243, DOI 10.2147/IJN.S58236
   Zhou JH, 2013, APPL SURF SCI, V286, P384, DOI 10.1016/j.apsusc.2013.09.097
   Zhou R, 2014, ACS APPL MATER INTER, V6, P4797, DOI 10.1021/am405680d
NR 52
TC 12
Z9 12
U1 4
U2 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2016
VL 60
BP 308
EP 316
DI 10.1016/j.msec.2015.11.056
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA DC4QF
UT WOS:000369204700036
PM 26706535
DA 2018-10-19
ER

PT J
AU Mareci, D
   Bolat, G
   Izquierdo, J
   Crimu, C
   Munteanu, C
   Antoniac, I
   Souto, RM
AF Mareci, D.
   Bolat, G.
   Izquierdo, J.
   Crimu, C.
   Munteanu, C.
   Antoniac, I.
   Souto, R. M.
TI Electrochemical characteristics of bioresorbable binary MgCa alloys in
   Ringer's solution: Revealing the impact of local pH distributions during
   in-vitro dissolution
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE MgCa alloys; Corrosion resistance; Electrochemical characterization;
   EIS; SECM; XRD; SEM; Local pH distributions
ID BIODEGRADABLE MAGNESIUM IMPLANTS; BIOMEDICAL APPLICATIONS; METALLIC
   BIOMATERIALS; CORROSION BEHAVIOR; SR ALLOYS; TI ALLOY; MICROSCOPY;
   CALCIUM; BONE; DEGRADATION
AB Biodegradable magnesium-calcium (MgCa) alloy is a very attractive biomaterial. Two MgCa alloys below the solid solubility of Ca were considered, as to solely investigate the effect of Ca content on the behavior of magnesium and the pH changes associated to metal dissolution. X-ray diffraction analysis and optical microscopy showed that both Mg-0.63Ca and Mg-0.89Ca alloys were solely composed of alpha(Mg) phase. Degradation characteristics and electro-chemical characterization of MgCa alloys were investigated during exposure to Ringer's solution at 37 degrees C by electro-chemical impedance spectroscopy and scanning electrochemical microscopy. The impedance behavior showed both capacitive and inductive features that are related to the alloy charge transfer reaction and the relaxation of the absorbed corrosion compounds, and can be described in terms of an equivalent circuit. Scanning electron microscopy (SEM) was employed to view the surface morphology of the MgCa samples after 1 week immersion in Ringer's solution showing extensive precipitation of corrosion products, whereas the substrate shows evidence of a non-uniform corrosion process. Energy dispersive analysis showed that the precipitates contained oxygen, calcium, magnesium and chlorine, and the Mg:Ca ratios were smaller than in the alloys. Scanning electrochemical microscopy (SECM) was used to visualize local pH changes associated to these physicochemical processes with high spatial resolution. The occurrence of pH variations in excess of 3 units between anodic and cathodic half-cell reactions was monitored in situ. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Mareci, D.; Bolat, G.] Gheorghe Asachi Tech Univ Iasi, Fac Chem Engn & Environm Protect, Bd Mangeron 71, Iasi 700050, Romania.
   [Izquierdo, J.; Souto, R. M.] Univ La Laguna, Dept Chem, POB 456, E-38200 San Cristobal la Laguna, Tenerife, Spain.
   [Crimu, C.; Munteanu, C.] Gheorghe Asachi Tech Univ Iasi, Fac Mech Engn, Iasi 700050, Romania.
   [Antoniac, I.; Souto, R. M.] Politehn Bucharest, Fac Mat Sci & Engn, Bucharest 060042, Romania.
RP Mareci, D (reprint author), Gheorghe Asachi Tech Univ Iasi, Fac Chem Engn & Environm Protect, Bd Mangeron 71, Iasi 700050, Romania.; Souto, RM (reprint author), Univ La Laguna, Dept Chem, E-38200 Tenerife, Canary Islands, Spain.
EM danmareci@yahoo.com; rsouto@ull.es
RI Antoniac, Iulian/D-4802-2014
OI Antoniac, Iulian/0000-0003-0112-3494; Izquierdo Perez,
   Javier/0000-0003-3287-9403; Mareci, Daniel/0000-0002-5859-1996; Souto,
   Ricardo M./0000-0001-9429-5513
FU Romanian National Authority for Scientific Research (CNCS-UEFISCDI)
   [PN-II-ID-PCE-2011-3-0218]; Spanish Ministry of Economy and
   Competitiveness; European Regional Development Fund [CTQ2012-36787]
FX The authors are grateful for the HPT deformed MgCa alloys supplied by
   Professor Koichi Tsuchiya, and PhD students Fanqiang Meng and Baozhen
   Jiang from the Graduate School of Pure and Applied Sciences, University
   of Tsukuba, Japan. The work was supported by grants from the Romanian
   National Authority for Scientific Research (CNCS-UEFISCDI, project
   number PN-II-ID-PCE-2011-3-0218), and from the Spanish Ministry of
   Economy and Competitiveness and the European Regional Development Fund
   (Project No. CTQ2012-36787).
CR [Anonymous], 1999, G190 ASTM
   Brar HS, 2012, J MECH BEHAV BIOMED, V7, P87, DOI 10.1016/j.jmbbm.2011.07.018
   Chen J, 2008, ELECTROCHEM COMMUN, V10, P577, DOI 10.1016/j.elecom.2008.01.027
   Cheng J, 2013, J MATER SCI TECHNOL, V29, P619, DOI 10.1016/j.jmst.2013.03.019
   Ciurescu G, 2012, INT J ELECTROCHEM SC, V7, P7404
   Ding YF, 2014, J MATER CHEM B, V2, P1912, DOI 10.1039/c3tb21746a
   Grobner J., 2001, MAT DESIGN APPROACHE
   Gu XN, 2012, ACTA BIOMATER, V8, P2360, DOI 10.1016/j.actbio.2012.02.018
   Gu XN, 2010, BIOMATERIALS, V31, P1093, DOI 10.1016/j.biomaterials.2009.11.015
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   HOLLOSI M, 1994, P NATL ACAD SCI USA, V91, P4902, DOI 10.1073/pnas.91.11.4902
   Huang JJ, 2007, RARE METAL MAT ENG, V36, P1102
   Ilich JZ, 2000, J AM COLL NUTR, V19, P715, DOI 10.1080/07315724.2000.10718070
   Izquierdo J, 2014, APPL SURF SCI, V313, P259, DOI 10.1016/j.apsusc.2014.05.201
   Izquierdo J, 2013, ELECTROCHIM ACTA, V87, P283, DOI 10.1016/j.electacta.2012.09.029
   Izquierdo J, 2011, ELECTROCHIM ACTA, V56, P8846, DOI 10.1016/j.electacta.2011.07.076
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Kirkland NT, 2010, J BIOMED MATER RES B, V95B, P91, DOI 10.1002/jbm.b.31687
   lacoban S., 2015, METALL MATER TRANS B, V46, P1011
   Li YC, 2012, ACTA BIOMATER, V8, P3177, DOI 10.1016/j.actbio.2012.04.028
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liu CL, 2010, CORROS SCI, V52, P3341, DOI 10.1016/j.corsci.2010.06.003
   Liu XB, 2011, ELECTROCHIM ACTA, V56, P2582, DOI 10.1016/j.electacta.2010.12.030
   Nagels J, 2003, J SHOULDER ELB SURG, V12, P35, DOI 10.1067/mse.2003.22
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Pust SE, 2007, J ELECTROCHEM SOC, V154, pC508, DOI 10.1149/1.2754080
   Pust SE, 2007, ADV MATER, V19, P878, DOI 10.1002/adma.200601446
   Rad HRB, 2012, MATER DESIGN, V33, P88, DOI 10.1016/j.matdes.2011.06.057
   Rao S, 1997, MAT SCI ENG C-BIO S, V4, P311, DOI 10.1016/S0928-4931(97)00016-7
   Rosalbino F, 2010, J MATER SCI-MATER M, V21, P1091, DOI 10.1007/s10856-009-3956-1
   Rosemann P, 2013, MATER CORROS, V64, P714, DOI 10.1002/maco.201206590
   Salahshoor M, 2012, MATERIALS, V5, P135, DOI 10.3390/ma5010135
   Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2
   Shaw BA., 2003, ASM HDB A, P692
   Shi ZM, 2010, CORROS SCI, V52, P579, DOI 10.1016/j.corsci.2009.10.016
   Song GL, 2005, ADV ENG MATER, V7, P563, DOI 10.1002/adem.200500013
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Souto R.M., 2012, CURRENT MICROSCOPY C, P1407
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Sun Y, 2012, MATER DESIGN, V34, P58, DOI 10.1016/j.matdes.2011.07.058
   Thomas S, 2015, CURR OPIN SOLID ST M, V19, P85, DOI 10.1016/j.cossms.2014.09.005
   Thomas S, 2015, CORROSION-US, V71, P171, DOI 10.5006/1483
   Tie D, 2014, MATER CORROS, V65, P569, DOI 10.1002/maco.201206903
   Von Der Hoh N., 2007, ADV ENG MATER, V11, pB47
   Wang H, 2007, ADV ENG MATER, V9, P967, DOI 10.1002/adem.200700200
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Wolf Federica I., 2003, Molecular Aspects of Medicine, V24, P3, DOI 10.1016/S0098-2997(02)00087-0
   Xue DC, 2011, MAT SCI ENG C-MATER, V31, P215, DOI 10.1016/j.msec.2010.08.019
   Zakiyuddin A, 2015, J ALLOY COMPD, V629, P274, DOI 10.1016/j.jallcom.2014.12.181
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
NR 52
TC 17
Z9 17
U1 4
U2 38
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2016
VL 60
BP 402
EP 410
DI 10.1016/j.msec.2015.11.069
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA DC4QF
UT WOS:000369204700047
PM 26706546
DA 2018-10-19
ER

PT J
AU Baino, F
   Ferraris, S
   Miola, M
   Perero, S
   Verne, E
   Coggiola, A
   Dolcino, D
   Ferraris, M
AF Baino, Francesco
   Ferraris, Sara
   Miola, Marta
   Perero, Sergio
   Verne, Enrica
   Coggiola, Andrea
   Dolcino, Daniela
   Ferraris, Monica
TI Novel antibacterial ocular prostheses: Proof of concept and
   physico-chemical characterization
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Ophthalmic biomaterial; Coating; Silver; Sputtering; Antibacterial
ID POROUS ORBITAL IMPLANTS; ESCHERICHIA-COLI; IN-VITRO;
   STAPHYLOCOCCUS-AUREUS; SILVER RESISTANCE; BACTERIAL; BIOMATERIALS;
   ENUCLEATION; INFECTION; TOXICITY
AB Discouraging bacterial colonization of ocular biomaterials and implants is a significant challenge in ophthalmology as infections often lead to the need for secondary surgery, with associated risks and additional stress to patients. In this work we demonstrate for the first time the feasibility of an innovative antibacterial ocular prosthesis produced by depositing a silver nanocluster/silica composite layer on the poly(methyl methacrylate) implant surface via radio-frequency sputtering. Tape test performed according to relevant ASTM standard provided a preliminary evidence of the mechanical stability and good adhesion of the coating to the substrate (absence of macroscopic damage after tape removal). Coating integrity was maintained after prolonged soaking in aqueous medium (1 month). The antibacterial effect of the coating, associated to silver ion release upon contact with aqueous fluid, was confirmed by the in vitro formation of a 5-mm inhibition halo test against Staphylococcus aureus that is one of the most common bacteria involved in ocular infections. The approach proposed in the present study for facing implant-related ocular infections can have a significant impact in the field of ophthalmic biomaterials, suggesting a valuable alternative to the administration of antibiotics that may become ineffective due to bacterial resistance. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Baino, Francesco; Ferraris, Sara; Miola, Marta; Perero, Sergio; Verne, Enrica; Ferraris, Monica] Politecn Torino, Appl Sci & Technol Dept, Inst Mat Phys & Engn, Corso Duca Abruzzi 24, Turin, Italy.
   [Coggiola, Andrea; Dolcino, Daniela] St Antonio & Biagio & Cesare Arrigo Natl Hosp, Ophthalmol Ward, Via Venezia 16, Alessandria, Italy.
RP Baino, F (reprint author), Politecn Torino, Appl Sci & Technol Dept, Inst Mat Phys & Engn, Corso Duca Abruzzi 24, Turin, Italy.
EM francesco.baino@polito.it
OI Verne, Enrica/0000-0002-8649-4739; Baino, Francesco/0000-0001-8860-0497
FU Regione Piemonte (Italy) (Regional Project "NABLA" - Nanostructured
   Antibacterial Layers); EC [262209]
FX This work was partially supported by the Regione Piemonte (Italy)
   (Regional Project "NABLA" - Nanostructured Antibacterial Layers) and by
   the EC-funded Project NASLA-FP7-SME-2010-1 (Project no. 262209).
CR [Anonymous], 2006, M2A9 NCCLS
   ASTM-American Society for Testing and Materials, 2009, D3359 ASTM
   Badilla J, 2008, OPHTHAL PLAST RECONS, V24, P287, DOI 10.1097/IOP.0b013e318177ebc7
   Baino F., 2012, Rivestimenti e Trattamenti Superficiali per Impartire Proprieta Antibatteriche a Dispositivi per Oftalmoplastica, Patent No. [IT0001412705, 0001412705]
   Baino F, 2015, J BIOMED MATER RES A, V103, P1259, DOI 10.1002/jbm.a.35260
   Baino F, 2014, ACTA BIOMATER, V10, P3372, DOI 10.1016/j.actbio.2014.05.017
   Baino F, 2014, ACTA BIOMATER, V10, P1064, DOI 10.1016/j.actbio.2013.12.014
   Balagna C, 2013, ENG MATER, P225, DOI 10.1007/978-3-642-40322-4_10
   BERGER TJ, 1976, ANTIMICROB AGENTS CH, V9, P357, DOI 10.1128/AAC.9.2.357
   Biederman H, 2000, VACUUM, V59, P594, DOI 10.1016/S0042-207X(00)00321-3
   Chalasani R, 2007, SURV OPHTHALMOL, V52, P145, DOI 10.1016/j.survophthal.2006.12.007
   Chuang CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042437
   Chuo JY, 2009, OPHTHALMOLOGY, V116, P349, DOI 10.1016/j.ophtha.2008.09.022
   Falagas ME, 2005, CLIN MICROBIOL INFEC, V11, P3, DOI 10.1111/j.1469-0691.2004.01014.x
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Ferraris M, 2012, IOP CONF SER-MAT SCI, V40, DOI 10.1088/1757-899X/40/1/012037
   Ferraris M, 2010, MATER CHEM PHYS, V120, P123, DOI 10.1016/j.matchemphys.2009.10.034
   Ferraris S, 2014, APPL SURF SCI, V317, P131, DOI 10.1016/j.apsusc.2014.07.196
   Gupta A, 1998, APPL ENVIRON MICROB, V64, P5042
   Haase A., 2011, J PHYS C SER, V304, DOI DOI 10.1088/1742-6596/304/1/012030
   Hau SC, 2009, CORNEA, V28, P703, DOI 10.1097/ICO.0b013e31818f9724
   Heidenau F, 2005, J MATER SCI-MATER M, V16, P883, DOI 10.1007/s10856-005-4422-3
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Jordan DR, 2007, OPHTHAL PLAST RECONS, V23, P413, DOI 10.1097/IOP.0b013e318137a600
   Jordan DR, 2006, OPHTHAL PLAST RECONS, V22, P66, DOI 10.1097/01.iop.0000197018.44245.7e
   Jun M.S., 2008, US Patent, Patent No. [US2008/0262612A1, 20080262612]
   Jung WK, 2008, APPL ENVIRON MICROB, V74, P2171, DOI 10.1128/AEM.02001-07
   Karshoglu S, 2006, OPHTHAL PLAST RECONS, V22, P461, DOI 10.1097/01.iop.0000248156.41020.94
   Kawata K, 2009, ENVIRON SCI TECHNOL, V43, P6046, DOI 10.1021/es900754q
   Kelly PJ, 2000, VACUUM, V56, P159, DOI 10.1016/S0042-207X(99)00189-X
   Mawn LA, 2001, CAN J OPHTHALMOL, V36, P245, DOI 10.1016/S0008-4182(01)80017-X
   Miola M, 2014, APPL SURF SCI, V313, P107, DOI 10.1016/j.apsusc.2014.05.151
   Moshfeghi DM, 2000, SURV OPHTHALMOL, V44, P277, DOI 10.1016/S0039-6257(99)00112-5
   Muzio G., 2015, HERNIA IN PRESS
   Sandeman SR, 2003, BIOMATERIALS, V24, P4729, DOI 10.1016/S0142-9612(03)00370-3
   Sant SB, 2007, ACTA BIOMATER, V3, P341, DOI 10.1016/j.actbio.2006.10.008
   Silver S, 2003, FEMS MICROBIOL REV, V27, P341, DOI 10.1016/S0168-6445(03)00047-0
   Stephens P., 2014, BBC NEWS HLTH   0430
   Tan XW, 2012, J MATER SCI-MATER M, V23, P1063, DOI 10.1007/s10856-012-4578-6
   Tan XW, 2011, INVEST OPHTH VIS SCI, V52, P21, DOI 10.1167/iovs.10-6186
   Wang HB, 2008, SURF ENG, V24, P70, DOI 10.1179/174329408X277493
   Yang JW, 2011, ORBIT, V30, P77, DOI 10.3109/01676830.2010.538123
   You JR, 2003, JPN J OPHTHALMOL, V47, P512, DOI 10.1016/S0021-5155(03)00137-0
   You SJ, 2002, J KOREAN OPHTHALMOL, V43, P1553
   Yun HS, 2011, ACTA BIOMATER, V7, P2651, DOI 10.1016/j.actbio.2011.02.014
NR 45
TC 5
Z9 5
U1 1
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2016
VL 60
BP 467
EP 474
DI 10.1016/j.msec.2015.11.075
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA DC4QF
UT WOS:000369204700054
PM 26706553
DA 2018-10-19
ER

PT J
AU Choudhury, AJ
   Gogoi, D
   Kandimalla, R
   Kalita, S
   Chaudhari, YB
   Khan, MR
   Kotoky, J
   Chutia, J
AF Choudhury, Arup Jyoti
   Gogoi, Dolly
   Kandimalla, Raghuram
   Kalita, Sanjeeb
   Chaudhari, Yogesh B.
   Khan, Mojibur R.
   Kotoky, Jibon
   Chutia, Joyanti
TI Penicillin impregnation on oxygen plasma surface functionalized
   chitosan/Antheraea assama silk fibroin: Studies of antibacterial
   activity and antithrombogenic property
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Oxygen plasma; Chitosan; Antheraea assama silk fibroin; Antibiotic drug;
   Antithrombogenic property; Antimicrobial
ID DRUG-RELEASE; POLYMERS; NANOPARTICLES
AB Low temperature plasma can effectively tailor the surface properties of natural polymeric biomaterials according to the need for various biomedical applications. Non-mulberry silk, Antheraea assama silk fibroin (AASF) is a natural polymer having excellent biocompatibility and mechanical strength yet unlike mulberry silk, Bombyx mori silk fibroin, has drawn less interest in biomedical research. In the quest for developing as potential biomaterial, surface functionalization of plasma induced chitosan (Cs) grafted AASF ((AASF/O-2-C-S)(g)/O-2) yarn is carried out using oxygen (O-2) plasma. The (AASF/O-2-C-S)(g)/O-2 yarn exhibits enhanced antithrombogenic property as well as antimicrobial activity against Gram positive (Bacillus subtilis) and Gram negative (Escherichia coli) bacteria as compared to AASF yarn. Moreover, impregnation of antibiotic drug (penicillin G sodium salt, PEN) on (AASF/O-2-C-S)(g)/O-2 yarn further improves the observed properties. In-vitro hemolysis assay reveals that O-2 plasma treatment and subsequent impregnation of PEN do not affect the hemocompatibility of AASF yarn. The present research findings demonstrate that plasma induced grafting of Cs followed by penicillin impregnation could significantly improve the potential applicability of AASF in the field of surgical research. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Choudhury, Arup Jyoti] Tezpur Univ, Dept Phys, Sonitpur 784028, Assam, India.
   [Gogoi, Dolly; Chutia, Joyanti] Inst Adv Study Sci & Technol, Div Phys Sci, Gauhati 781035, Assam, India.
   [Kandimalla, Raghuram; Kalita, Sanjeeb; Kotoky, Jibon] Inst Adv Study Sci & Technol, Drug Discovery Lab, Gauhati 781035, Assam, India.
   [Chaudhari, Yogesh B.; Khan, Mojibur R.] Inst Adv Study Sci & Technol, Mol Biol & Microbial Biotechnol Lab, Gauhati 781035, Assam, India.
RP Choudhury, AJ (reprint author), Tezpur Univ, Dept Phys, Sonitpur 784028, Assam, India.
EM arupjchoudhury@gmail.com
OI Kandimalla, Raghuram/0000-0002-9202-4071
FU Department of Science and Technology (DST), Government of India
   (DST/INSPIRE Faculty Award) [2014/DST/INSPIRE/04/2014/001621]
FX One of the authors, Arup Jyoti Choudhury would like to thank the
   Department of Science and Technology (DST), Government of India
   (DST/INSPIRE Faculty Award/2014/DST/INSPIRE/04/2014/001621) for
   providing the financial support through DST Inspire faculty scheme in
   carrying out this research work.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Amiji MM, 1998, COLLOID SURFACE B, V10, P263, DOI 10.1016/S0927-7765(98)00005-8
   Brugnerotto J, 2001, POLYMER, V42, P3569, DOI 10.1016/S0032-3861(00)00713-8
   Chang S. J., 2007, J MED BIOL ENG, V27, P41
   Choudhury AJ, 2016, SURGERY, V159, P539, DOI 10.1016/j.surg.2015.07.022
   Gogoi D, 2012, PLASMA CHEM PLASMA P, V32, P1293, DOI 10.1007/s11090-012-9410-z
   Gogoi D, 2014, BIOPOLYMERS, V101, P355, DOI 10.1002/bip.22369
   Gu ZP, 2013, INT J BIOL MACROMOL, V58, P121, DOI 10.1016/j.ijbiomac.2013.03.059
   Kalita S, 2015, INT J NANOMED, V10, P2971, DOI 10.2147/IJN.S75023
   Lee KY, 1998, J BIOMAT SCI-POLYM E, V9, P905, DOI 10.1163/156856298X00235
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   Maji TK, 1996, J APPL POLYM SCI, V62, P595
   Mohanty P. K., 1998, TROPICAL TASAR CULTU
   Morent R, 2011, PLASMA PROCESS POLYM, V8, P171, DOI 10.1002/ppap.201000153
   Oehr C, 2003, NUCL INSTRUM METH B, V208, P40, DOI 10.1016/S0168-583X(03)00650-5
   Oeveren W.V., 2002, ARTIF ORGANS, V26, P506
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Pavia D. L., 2008, INTRO SPECTROSCOPY
   Peng Q., 2006, J APPL POLYM SCI, V1002, P1299
   PEPPAS NA, 1985, PHARM ACTA HELV, V60, P110
   SAUER BB, 1990, LANGMUIR, V6, P1002, DOI 10.1021/la00095a020
   Singhal JP, 2002, BIOMATERIALS, V23, P1139, DOI 10.1016/S0142-9612(01)00228-9
   Sionkowska A, 2013, J MOL LIQ, V178, P5, DOI 10.1016/j.molliq.2012.10.042
   Snyder K.C., 2011, APPL SURG PHARM PHAR
   Wang H.S., 2005, BIODEGRADABLE SUSTAI, P391
   Wang Y., 2009, BIOMED MATER, V4
   WARWICKER JO, 1956, T FARADAY SOC, V52, P554, DOI 10.1039/tf9565200554
   Yoshida S, 2013, SURF COAT TECH, V233, P99, DOI 10.1016/j.surfcoat.2013.02.042
   Zhang DR, 2006, NANOTECHNOLOGY, V17, P5821, DOI 10.1088/0957-4484/17/23/018
   Zhang JL, 2010, MAR DRUGS, V8, P1962, DOI 10.3390/md8071962
NR 30
TC 13
Z9 13
U1 2
U2 44
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2016
VL 60
BP 475
EP 484
DI 10.1016/j.msec.2015.11.070
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA DC4QF
UT WOS:000369204700055
PM 26706554
DA 2018-10-19
ER

PT J
AU Skolucka-Szary, K
   Ramiega, A
   Piaskowska, W
   Janicki, B
   Grala, M
   Rieske, P
   Bartczak, Z
   Piaskowski, S
AF Skolucka-Szary, Karolina
   Ramiega, Aleksandra
   Piaskowska, Wanda
   Janicki, Bartosz
   Grala, Magdalena
   Rieske, Piotr
   Bartczak, Zbigniew
   Piaskowski, Sylwester
TI Synthesis and physicochemical characterization of chitin dihexanoate - A
   new biocompatible chitin derivative - In comparison to chitin dibutyrate
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biopolymers; Polysaccharides; Chitin; Esterification; Biomaterial
ID DIFFERENTIAL SCANNING CALORIMETRY; CHITOSAN; WATER; DIBUTYRYLCHITIN;
   PART; IDENTIFICATION; SOLUBILITY; SPONGES
AB Chitin dihexanoate (DHCH) is the novel biocompatible and technologically friendly highly substituted chitin diester. Here we described optimization of DHCH and chitin dibutyrate (dibutyryl chitin, DBC) synthesis conditions (temperature and reaction time) to obtain desired polymers with high reaction yield, high substitution degree (close to 2) and appropriately high molecular weights. A two-step procedure, employing acidic anhydrides (hexanoic or butyric anhydride) as the acylation agent and methanesulfonic acid both as the catalyst and the reaction medium, was applied. Chemical structures of DBC and DHCH were confirmed by NMR (H-1 and C-13) and IR investigations. Mechanical properties, thermogravimetric analysis, differential scanning calorimetry and biocompatibility (Neutral red uptake assay, Skin Sensitization and Irritation Tests) were assessed. Both polymers proved highly biocompatible (non-cytotoxic in vitro, non-irritating and non-allergic to skin) and soluble in several organic solvents (dimethylformamide, N,N-dimethylacetamide, dimethyl sulfoxide, acetone, ethanol and others). It is worth emphasizing that DHCH and DBC can be easily processed by solvent casting method and the salt leaching method, what gives the opportunity to prepare highly porous structures, which can be further successfully applied as the material for wound dressings and scaffolds for tissue engineering. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Skolucka-Szary, Karolina; Ramiega, Aleksandra; Piaskowska, Wanda; Rieske, Piotr; Piaskowski, Sylwester] Celther Poland Sp Zoo, Dept Res & Dev, Ul Ostrzykowizna 14A, PL-05170 Zakroczym, Poland.
   [Janicki, Bartosz] Silesian Tech Univ, Dept Phys Chem & Technol Polymers, Fac Chem, Ul M Strzody 9, PL-44100 Gliwice, Poland.
   [Grala, Magdalena; Bartczak, Zbigniew] Polish Acad Sci, Ctr Mol & Macromol Studies, Sienkiewicza 112, PL-90363 Lodz, Poland.
RP Skolucka-Szary, K (reprint author), Celther Polska Sp Zoo, PL-05170 Zakroczym, Poland.
EM karolina.skolucka@celther.com
RI Rieske, Piotr/M-4821-2015
OI Rieske, Piotr/0000-0002-2970-0970; Bartczak,
   Zbigniew/0000-0003-0514-9106
FU Polish Agency for Enterprise Development Grant [POIG.01.04.00-10-020/10]
FX This Study was sponsored by Polish Agency for Enterprise Development
   Grant No. POIG.01.04.00-10-020/10.
CR Almond A, 2003, GLYCOBIOLOGY, V13, P255, DOI 10.1093/glycob/cwg031
   Anitha A, 2014, PROG POLYM SCI, V39, P1644, DOI 10.1016/j.progpolymsci.2014.02.008
   [Anonymous], 2012, 10993102011 PNEN ISO
   AUSTIN PR, 1981, SCIENCE, V212, P749, DOI 10.1126/science.7221561
   Baxter A, 1992, J BIOL MACROMOL, V14, P166
   Bhatt LR, 2011, CARBOHYD RES, V346, P691, DOI 10.1016/j.carres.2011.01.033
   Blasinska A, 2004, FIBRES TEXT EAST EUR, V12, P51
   Bo M, 2012, INT J BIOL MACROMOL, V51, P129, DOI 10.1016/j.ijbiomac.2012.04.016
   Brunner E, 2009, ANGEW CHEM INT EDIT, V48, P9724, DOI 10.1002/anie.200905028
   Capozza R. C., 1976, US Patent, Patent No. 3988411
   Capozza RC, 1976, US Patent, Patent No. [3989535, 3,989,535]
   Chen BQ, 2004, CARBOHYD POLYM, V58, P65, DOI 10.1016/j.carbpol.2004.06.030
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   DOMSZY JG, 1985, MAKROMOL CHEM, V186, P1671
   Draczynski Z, 2011, J APPL POLYM SCI, V122, P175, DOI 10.1002/app.34031
   Dutta PK, 2004, J SCI IND RES INDIA, V63, P20
   EDWARD JT, 1955, CHEM IND-LONDON, P1102
   Ehrlich H, 2010, INT J BIOL MACROMOL, V47, P141, DOI 10.1016/j.ijbiomac.2010.05.009
   Ehrlich H, 2007, J EXP ZOOL PART B, V308B, P347, DOI 10.1002/jez.b.21156
   Ehrlich H, 2013, J MATER CHEM B, V1, P5092, DOI 10.1039/c3tb20676a
   Ehrlich H, 2013, J STRUCT BIOL, V183, P474, DOI 10.1016/j.jsb.2013.06.015
   Ehrlich H, 2010, INT GEOL REV, V52, P661, DOI 10.1080/00206811003679521
   Grzesiak E., 2011, Sposob otrzymywania estrow chityny, Patent No. [PL 389421(A1), 389421]
   Guinesi LS., 2006, THERMOCHIM ACTA, V444, P8128
   Hu XW, 2007, CARBOHYD POLYM, V70, P451, DOI 10.1016/j.carbpol.2007.05.002
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Jindal D.K., 2013, INT J ADV PHARM SCI, V4, P1177
   KAIFU K, 1981, POLYM J, V13, P241, DOI 10.1295/polymj.13.241
   Kaya M., 2014, FOOD BIOPHYS
   Kaya M, 2014, INT J BIOL MACROMOL, V65, P553, DOI 10.1016/j.ijbiomac.2014.02.010
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kittur FS, 2002, CARBOHYD POLYM, V49, P185, DOI 10.1016/S0144-8617(01)00320-4
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Kurita K, 2001, PROG POLYM SCI, V26, P1921, DOI 10.1016/S0079-6700(01)00007-7
   Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709
   MUZZARELLI RAA, 1983, CARBOHYD POLYM, V3, P53
   Paulino AT, 2006, CARBOHYD POLYM, V64, P98, DOI 10.1016/j.carbpol.2005.10.032
   Percot A, 2003, BIOMACROMOLECULES, V4, P12, DOI 10.1021/bm025602k
   Pillai CKS, 2009, PROG POLYM SCI, V34, P641, DOI 10.1016/j.progpolymsci.2009.04.001
   RATTO J, 1995, POLYMER, V36, P2915, DOI 10.1016/0032-3861(95)94340-Y
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Rutherford III F. A., 1978, P 1 INT C CHIT CHIT, P182
   Rutkowska-Olma E., 2006, Sposob otrzymywania dibutyrylochityny, Patent No. [PL 370755, 370755]
   Saravanan D., 2011, ARCH APPL SCI RES, V3, P342
   SCHLEDE E, 1995, CONTACT DERMATITIS, V32, P1, DOI 10.1111/j.1600-0536.1995.tb00830.x
   Schoukens G, 2009, INT J CLOTH SCI TECH, V21, P93, DOI 10.1108/09556220910933817
   Skolucka-Szary K, 2015, MAT SCI ENG C-MATER, V55, P50, DOI 10.1016/j.msec.2015.05.051
   Szosland L, 1996, J BIOACT COMPAT POL, V11, P61, DOI 10.1177/088391159601100105
   Szosland L, 2001, FIBRES TEXT EAST EUR, V9, P54
   Szosland L., 2001, PROGR CHEM APPL CHIT, V7, P33
   Szosland L., 2003, FIBRES TEXT EAST EUR, V9, P49
   Szumielewicz J., 2003, PROGR CHEM APPL CHIT, VIX, P41
   Tamura H., 2004, ADV CHITIN SCI, P94
   TERBOJEVICH M, 1988, CARBOHYD RES, V180, P73, DOI 10.1016/0008-6215(88)80065-X
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Van de Velde K, 2004, CARBOHYD POLYM, V58, P409, DOI 10.1016/j.carbpol.2004.08.004
   Vikhoreva GA, 1999, FIBRE CHEM+, V31, P274, DOI 10.1007/BF02358332
   Vincendon M., 1985, CHITIN NATURE TECHNO, P343
   Wysokowski M, 2015, POLYMERS-BASEL, V7, P235, DOI 10.3390/polym7020235
   Yang BY, 2009, CARBOHYD RES, V344, P336, DOI 10.1016/j.carres.2008.11.006
NR 60
TC 4
Z9 4
U1 5
U2 53
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2016
VL 60
BP 489
EP 502
DI 10.1016/j.msec.2015.11.078
PG 14
WC Materials Science, Biomaterials
SC Materials Science
GA DC4QF
UT WOS:000369204700057
PM 26706556
DA 2018-10-19
ER

PT J
AU Li, HF
   Cong, Y
   Zheng, YF
   Cui, LS
AF Li, Huafang
   Cong, Ying
   Zheng, Yufeng
   Cui, Lishan
TI In vitro investigation of NiTiW shape memory alloy as potential
   biomaterial with enhanced radiopacity
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Metals and alloys; Shape memory alloys (SMAs); Phase transformation;
   Radiopacity; Corrosion behavior; Biomaterials
ID BIOMEDICAL APPLICATIONS; STENTS
AB In the present study, a novel kind of NiTiW shape memory alloy with chemical composition of Ni43.5Ti45.5W11 (at.%) has been successfully developed with excellent X-ray radiopacity by the introduction of pure W precipitates into the NiTi matrix phase. Its microstructure, X-ray radiopacity, mechanical properties, corrosion resistance in simulated body fluid, hemocompatibility and in vitro cytocompatibility were systematically investigated. The typical microstructural feature of NiTiW alloy at room temperature was tiny pure W particles randomly distributing in the NiTi matrix phase. The presence of W precipitates was found to result in enhanced radiopacity and microhardness of NiTiW alloy in comparison to that of NiTi binary alloy. NiTiW alloy exhibits excellent shape memory effect, and a maximum shape recovery ratio of about 30% was obtained with a total prestrain of 8% for the NiTiW alloy sample. In the electrochemical test, NiTiW alloy, presented an excellent corrosion resistance in simulated body fluid, comparable to that of NiTi alloy. Hemocompatibility tests indicated that the NiTiW alloy has quite low hemolysis (lower than 0.5%) and the adherent platelet showed round shape without pseudo pod. Besides, in vitro cell viability tests demonstrated that the cell viability is all above 90%, and the cells spread well on the NiTiW alloy, having polygon or spindle healthy morphology. The hemocompatibility tests, in vitro cell viability tests and morphology observation indicated that the NiTiW shape memory alloys have excellent bio-compatibility. The excellent X-ray radiopacity makes the NiTiW alloys show obvious advantages in orthopedic, stomatological, neurological and cardiovascular domains where radiopacity is quite important factor in order to guarantee successful implantation. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Li, Huafang; Zheng, Yufeng] Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.
   [Li, Huafang; Zheng, Yufeng] Peking Univ, Coll Engn, Dept Mat Sci & Engn, Beijing 100871, Peoples R China.
   [Cong, Ying] Peking Univ, Phys Specialty YuanPei Coll, Beijing 100871, Peoples R China.
   [Cui, Lishan] China Univ Petr, State Key Lab Heavy Oil Proc, Beijing 102249, Peoples R China.
   [Cui, Lishan] China Univ Petr, Dept Mat Sci & Engn, Beijing 102249, Peoples R China.
RP Zheng, YF (reprint author), Peking Univ, Coll Engn, Dept Mat Sci & Engn, Beijing 100871, Peoples R China.
EM yfzheng@pku.edu.cn
RI Zheng, Yufeng/A-4146-2010; Li, Huafang/D-5486-2013
OI Zheng, Yufeng/0000-0002-7402-9979; 
FU National Basic Research Program of China (973 Program) [2012CB619102,
   2012CB619100]; National Science Fund for Distinguished Young Scholars
   [51225101]; National Natural Science Foundation of China [51431002,
   31170909]; NSFC/RGC Joint Research Scheme [51361165101]; Beijing
   Municipal Science and Technology Project [Z141100002814008]
FX This work was supported by the National Basic Research Program of China
   (973 Program) (grant No. 2012CB619102 and 2012CB619100), the National
   Science Fund for Distinguished Young Scholars (grant No. 51225101), the
   National Natural Science Foundation of China (grant No. 51431002 and
   31170909), the NSFC/RGC Joint Research Scheme (grant No. 51361165101),
   and Beijing Municipal Science and Technology Project (grant No.
   Z141100002814008).
CR Ebrahimi N, 2007, AM J NEURORADIOL, V28, P823
   El Feninat F, 2002, ADV ENG MATER, V4, P91, DOI 10.1002/1527-2648(200203)4:3<91::AID-ADEM91>3.0.CO;2-B
   Goodman S., 1983, SCANNING ELECT MIC 1, P279
   Gu S, 2006, DENT MATER, V22, P765, DOI 10.1016/j.dental.2005.11.004
   Hsieh SF, 2005, J ALLOY COMPD, V387, P121, DOI 10.1016/j.jallcom.2004.06.026
   Kumari PNS, 2008, MATER LETT, V62, P305, DOI 10.1016/j.matlet.2007.05.013
   Pelton B.L, 2001, SMST 2000 P INT C SH, P109
   Peuster M, 2003, BIOMATERIALS, V24, P4057, DOI 10.1016/S0142-9612(03)00274-6
   Rossi P, 1996, EUR RADIOL, V6, P741
   Steegmuller R, 2008, SMST 2006: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON SHAPE MEMORY AND SUPERELASTIC TECHNOLOGIES, P227, DOI 10.1361/cp2006smst227
   Stoeckel D, 2004, EUR RADIOL, V14, P292, DOI 10.1007/s00330-003-2022-5
   Wang S., 2014, SCR MAT
   Yan XJ, 2011, MATER LETT, V65, P2934, DOI 10.1016/j.matlet.2011.06.040
   Zhu K, 2012, CLIN BIOCHEM, V45, P936, DOI 10.1016/j.clinbiochem.2012.05.006
NR 14
TC 4
Z9 4
U1 2
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2016
VL 60
BP 554
EP 559
DI 10.1016/j.msec.2015.12.006
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA DC4QF
UT WOS:000369204700064
PM 26706563
DA 2018-10-19
ER

PT J
AU Schukur, L
   Geering, B
   Fussenegger, M
AF Schukur, Lina
   Geering, Barbara
   Fussenegger, Martin
TI Human whole-blood culture system for ex vivo characterization of
   designer-cell function
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE alginate; inflammatory disorder; personalized medicine; primary cells;
   synthetic biology; tumor necrosis factor
ID CYTOKINE PRODUCTION; MONONUCLEAR-CELLS; RHEUMATOID-ARTHRITIS; TNF-ALPHA;
   RESPONSES; ACTIVATION; APOPTOSIS; LIPOPOLYSACCHARIDE; STIMULATION;
   IMMUNOLOGY
AB Encapsulated designer cells implanted into mice are currently used to validate the efficacy of therapeutic gene networks for the diagnosis and treatment of various human diseases in preclinical research. Because many human conditions cannot be adequately replicated by animal models, complementary and alternative procedures to test future treatment strategies are required. Here we describe a novel approach utilizing an ex vivo human whole-blood culture system to validate synthetic biology-inspired designer cell-based treatment strategies. The viability and functionality of transgenic mammalian designer cells co-cultured with primary human immune cells were characterized. We demonstrated that transgenic mammalian designer cells required adequate insulation from the human blood microenvironment to maintain viability and functionality. The biomaterial alginate-(poly-l-lysine)-alginate used to encapsulate the transgenic designer cells did neither affect the viability of primary granulocytes and lymphocytes nor the functionality of lymphocytes. Additionally, alginate-encapsulated transgenic designer cells remained responsive to the release of the pro-inflammatory cytokine tumor necrosis factor (TNF) from the whole-blood culture upon exposure to bacterial lipopolysaccharide (LPS). TNF diffused into the alginate capsules, bound to the specific TNF receptors on the transgenic designer cells' surface and triggered the expression of the reporter gene SEAP (human placental secreted alkaline phosphatase) that was rewired to the TNF-specific signaling cascade. Human whole-blood culture systems can therefore be considered as valuable complementary assays to animal models for the validation of synthetic circuits in genetically modified mammalian cells and may speed up preclinical research in a world of personalized medicine. Biotechnol. Bioeng. 2016;113: 588-597. (c) 2015 Wiley Periodicals, Inc.
C1 [Schukur, Lina; Geering, Barbara; Fussenegger, Martin] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland.
   [Fussenegger, Martin] Univ Basel, Fac Sci, Basel, Switzerland.
RP Fussenegger, M (reprint author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland.
EM fussenegger@bsse.ethz.ch
FU European Research Council (ERC) [321381]; National Center of Competence
   in Research (NCCR) Molecular Systems Engineering
FX We thank Katrin Roessger for providing plasmid pKR32, Sandra Leber and
   Samuel Huerlemann for technical support, Aizhan Tastanova for assistance
   in collecting blood samples and all of the blood donors who participated
   in this study. This work was supported by a European Research Council
   (ERC) advanced grant (No. 321381) and in part by the National Center of
   Competence in Research (NCCR) Molecular Systems Engineering.
CR Auslander D, 2014, MOL CELL, V55, P397, DOI 10.1016/j.molcel.2014.06.007
   Auslander D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5408
   Boehler RM, 2011, BIOTECHNIQUES, V51, P239, DOI 10.2144/000113754
   Damsgaard CT, 2009, J IMMUNOL METHODS, V340, P95, DOI 10.1016/j.jim.2008.10.005
   Geering B, 2015, TRENDS BIOTECHNOL, V33, P65, DOI 10.1016/j.tibtech.2014.10.006
   Geering B, 2011, BLOOD, V117, P5953, DOI 10.1182/blood-2010-11-322206
   Godoy-Ramirez K, 2004, J IMMUNOL METHODS, V292, P1, DOI 10.1016/j.jim.204.04.028
   Hodge G, 2000, CYTOKINE, V12, P1763, DOI 10.1006/cyto.2000.0790
   Ingulli E, 2010, PEDIATR NEPHROL, V25, P61, DOI 10.1007/s00467-008-1020-x
   Jacobs-Tulleneers-Thevissen D, 2013, DIABETOLOGIA, V56, P1605, DOI 10.1007/s00125-013-2906-0
   Kaminska T, 2001, ARCH IMMUNOL THER EX, V49, P439
   Louis E, 1998, CLIN EXP IMMUNOL, V113, P401
   Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3
   Mak IWY, 2014, AM J TRANSL RES, V6, P114
   Mallone R, 2011, CLIN EXP IMMUNOL, V163, P33, DOI 10.1111/j.1365-2249.2010.04272.x
   McFarlane SM, 2002, FEBS LETT, V515, P119, DOI 10.1016/S0014-5793(02)02450-X
   McNamee JP, 2005, CYTOKINE, V31, P161, DOI 10.1016/j.cyto.2005.05.001
   Mikolajczyk TP, 2009, IMMUNOLOGY, V128, P103, DOI 10.1111/j.1365-2567.2009.03087.x
   OLIVER JC, 1993, LYMPHOKINE CYTOK RES, V12, P115
   Orive G, 2006, BIOMATERIALS, V27, P3691, DOI 10.1016/j.biomaterials.2006.02.048
   Paredes Juarez Genaro Alberto, 2014, Front Bioeng Biotechnol, V2, P26, DOI 10.3389/fbioe.2014.00026
   PAULY JL, 1973, J LAB CLIN MED, V82, P500
   Rossger K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3825
   Rossger K, 2013, P NATL ACAD SCI USA, V110, P18150, DOI 10.1073/pnas.1312414110
   Schmidt JJ, 2008, J BIOMED MATER RES A, V87A, P1113, DOI 10.1002/jbm.a.32287
   Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110
   Sottong PR, 2000, CLIN DIAGN LAB IMMUN, V7, P307, DOI 10.1128/CDLI.7.2.307-311.2000
   Swaak AJG, 1997, ANN RHEUM DIS, V56, P693, DOI 10.1136/ard.56.11.693
   Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9
   Wallis RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030479
   Weir RE, 1999, CLIN EXP IMMUNOL, V116, P263
   WILSON BMG, 1991, J IMMUNOL METHODS, V139, P233, DOI 10.1016/0022-1759(91)90193-J
   YACHIE A, 1990, PEDIATR RES, V27, P227, DOI 10.1203/00006450-199003000-00005
   Yaqoob P, 1999, CYTOKINE, V11, P600, DOI 10.1006/cyto.1998.0471
   Ye HF, 2011, SCIENCE, V332, P1565, DOI 10.1126/science.1203535
   Zakharyan R, 2014, WORLD J BIOL PSYCHIA, V15, P174, DOI 10.3109/15622975.2013.830774
   ZANGERLE PF, 1992, CYTOKINE, V4, P568, DOI 10.1016/1043-4666(92)90021-I
NR 37
TC 6
Z9 6
U1 0
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
EI 1097-0290
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD MAR
PY 2016
VL 113
IS 3
BP 588
EP 597
DI 10.1002/bit.25828
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DC1YT
UT WOS:000369015100014
PM 26348251
DA 2018-10-19
ER

PT J
AU Ghimire, N
   Foss, BL
   Sun, YY
   Deng, Y
AF Ghimire, Niranjan
   Foss, Berit L.
   Sun, Yuyu
   Deng, Ying
TI Interactions among osteoblastic cells, Staphylococcus aureus, and
   chitosan-immobilized titanium implants in a postoperative coculture
   system: An in vitro study
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bacteria-related infection (BRI); postoperative; sensitivity;
   osteogenic; antifouling
ID SURGICAL-SITE INFECTIONS; ORTHOPEDIC-SURGERY; ANTIBIOTIC-RESISTANCE;
   BIOFILM FORMATION; SURFACES; HIP; ARTHROPLASTY; EPIDERMIDIS; JOINT; BONE
AB Biomaterial-related infections (BRIs) have become a major challenge in the field of orthopedic implants. In this study, we delved into the problem of BRI and attempted to reduce the possibility of BRI incidence via surface modification of titanium (Ti) with chitosan (SA-CS-Ti). To comprehensively evaluate the anti-infection potential of SA-CS-Ti, we first constructed a postoperative infection (POI) model with varying concentrations of bacteria (10(2)CFU/sample and 10(4)CFU/sample) and a constant number of SaOS-2 cells (10(5)/sample). Then, we biologically characterized the interactions between the SaOS-2 cells, bacteria, and different Ti implants using the POI model. The results from the osteoblastic cell and bacterial attachment tests demonstrated that the SA-CS-Ti surfaces exhibit superior osteogenic behavior relative to other Ti surfaces studied while showing significant anti-infective activities in the POI model with a low infection ratio (bacteria: cell ratio of 0.001:1) 30min after infection. Additionally, the SA-CS-Ti surfaces showed significantly reduced (p<0.05) bacteria proliferation compared to the control Ti surfaces (UN-Ti), demonstrating their antifouling property. The significantly increased (p<0.05) sensitivity of Staphylococcus. aureus adhered to the SA-CS-Ti surfaces against cefazolin (1mg/L treatment) and gentamicin (10mg/L and 100mg/L treatment) in the coculture system augmented potential of SA-CS-Ti to be used as orthopedic implants. (c) 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 586-594, 2016.
C1 [Ghimire, Niranjan; Foss, Berit L.; Deng, Ying] Univ S Dakota, Dept Biomed Engn, 4800 North Career Ave, Sioux Falls, SD 57107 USA.
   [Sun, Yuyu] Univ Massachusetts, Dept Chem, One Univ Ave, Lowell, MA 01854 USA.
RP Deng, Y (reprint author), Univ S Dakota, Dept Biomed Engn, 4800 North Career Ave, Sioux Falls, SD 57107 USA.; Sun, YY (reprint author), Univ Massachusetts, Dept Chem, One Univ Ave, Lowell, MA 01854 USA.
EM Yuyu_sun@uml.edu; Ying.deng@usd.edu
FU National Institute of Arthritis and Musculoskeletal and Skin Diseases of
   the National Institutes of Health [R21AR065625]
FX Contract grant sponsor: National Institute of Arthritis and
   Musculoskeletal and Skin Diseases of the National Institutes of Health;
   contract grant number: R21AR065625
CR Adachi K, 2007, J ORTHOP SCI, V12, P178, DOI 10.1007/s00776-006-1102-1
   American Academy of Orthopaedic Surgeons, 2004, REC US INTR ANT PROP, V2015
   Amorena B, 1999, J ANTIMICROB CHEMOTH, V44, P43, DOI 10.1093/jac/44.1.43
   BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   Berbari EF, 2012, INFECT CONT HOSP EP, V33, P774, DOI 10.1086/666641
   Blomgren G, 1981, Acta Orthop Scand Suppl, V187, P1
   Bowler PG, 2013, J HOSP INFECT, V83, P232, DOI 10.1016/j.jhin.2012.11.018
   Burgers R, 2010, CLIN ORAL IMPLAN RES, V21, P156, DOI 10.1111/j.1600-0501.2009.01815.x
   Bumgardner JD, 2007, IMPLANT DENT, V16, P66, DOI 10.1097/ID.0b013e3180312011
   Carlson RP, 2008, J BIOMAT SCI-POLYM E, V19, P1035, DOI 10.1163/156856208784909372
   CHARNLEY J, 1969, BRIT J SURG, V56, P641, DOI 10.1002/bjs.1800560902
   CRAIG WA, 1992, ANTIMICROB AGENTS CH, V36, P2577, DOI 10.1128/AAC.36.12.2577
   Dexter SJ, 2001, J BIOMED MATER RES, V56, P222, DOI 10.1002/1097-4636(200108)56:2<222::AID-JBM1087>3.0.CO;2-L
   Dworkin J, 2010, NAT REV MICROBIOL, V8, P890, DOI 10.1038/nrmicro2453
   Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001
   FIELDS MT, 1993, ANTIMICROB AGENTS CH, V37, P203, DOI 10.1128/AAC.37.2.203
   Ghimire N, 2014, COLLOID SURFACE B, V122, P126, DOI 10.1016/j.colsurfb.2014.06.060
   Greene AH, 2008, CLIN ORTHOP RELAT R, V466, P1699, DOI 10.1007/s11999-008-0269-5
   Greene LR, 2012, AM J INFECT CONTROL, V40, P384, DOI 10.1016/j.ajic.2011.05.011
   GRISTINA AG, 1989, MED PROG TECHNOL, V14, P205
   Hanberger H, 1990, Scand J Infect Dis Suppl, V74, P118
   Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011
   Kasiakou SK, 2005, LANCET INFECT DIS, V5, P581, DOI 10.1016/S1473-3099(05)70218-8
   KIRBY WMM, 1973, J INFECT DIS, V128, pS341, DOI 10.1093/infdis/128.Supplement_2.S341
   Klokkevold PR, 1997, CLIN ORAL IMPLAN RES, V8, P442, DOI 10.1034/j.1600-0501.1997.080601.x
   Knobben BAS, 2006, J HOSP INFECT, V62, P174, DOI 10.1016/j.jhin.2005.08.007
   Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049
   Kurtz SM, 2008, J ARTHROPLASTY, V23, P984, DOI 10.1016/j.arth.2007.10.017
   MAHAN J, 1991, ORTHOPEDICS, V14, P305
   NAYLOR PT, 1990, CLIN ORTHOP RELAT R, P126
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   Peersman G, 2001, CLIN ORTHOP RELAT R, P15
   Phillips JE, 2006, J BONE JOINT SURG BR, V88B, P943, DOI 10.1302/0301-620X.88B7.17150
   Pier-Francesco A, 2006, CLIN ORAL IMPLAN RES, V17, P633, DOI 10.1111/j.1600-0501.2006.01274.x
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Renoud P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039367
   Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046
   Sidhu P. K., 2014, Journal of Veterinary Science and Technology, V5, P199
   Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196
   Subbiahdoss G, 2010, MICROBIOL-SGM, V156, P3073, DOI 10.1099/mic.0.040378-0
   Tang H, 2010, ACTA BIOMATER, V6, P2562, DOI 10.1016/j.actbio.2010.01.002
   Trampuz A, 2006, DRUGS, V66, P1089, DOI 10.2165/00003495-200666080-00005
   Trampuz A, 2006, CURR OPIN INFECT DIS, V19, P349, DOI 10.1097/01.qco.0000235161.85925.e8
   Tsukayama DT, 1996, J BONE JOINT SURG AM, V78A, P512, DOI 10.2106/00004623-199604000-00005
   Turnidge J, 2003, INFECT DIS CLIN N AM, V17, P503, DOI 10.1016/S0891-5520(03)00057-6
   Webb LXGE, 1993, T ORTHOP RES SOC, V18, P455
   Whitehouse JD, 2002, INFECT CONT HOSP EP, V23, P183, DOI 10.1086/502033
   WONG M, 1995, J BIOMED MATER RES, V29, P1567, DOI 10.1002/jbm.820291213
   Yao C, 2009, J BIOMED MATER RES B, V91B, P587, DOI 10.1002/jbm.b.31433
   Zeller V, 2009, ANTIMICROB AGENTS CH, V53, P883, DOI 10.1128/AAC.00389-08
NR 50
TC 2
Z9 2
U1 2
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2016
VL 104
IS 3
BP 586
EP 594
DI 10.1002/jbm.a.35597
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DC4AB
UT WOS:000369160800002
PM 26488154
DA 2018-10-19
ER

PT J
AU Campoccia, D
   Testoni, F
   Ravaioli, S
   Cangini, I
   Maso, A
   Speziale, P
   Montanaro, L
   Visai, L
   Arciola, CR
AF Campoccia, Davide
   Testoni, Francesca
   Ravaioli, Stefano
   Cangini, Ilaria
   Maso, Alessandra
   Speziale, Pietro
   Montanaro, Lucio
   Visai, Livia
   Arciola, Carla Renata
TI Orthopedic implant infections: Incompetence of Staphylococcus
   epidermidis, Staphylococcus lugdunensis, and Enterococcus faecalis to
   invade osteoblasts
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE implant infections; osteomyelitis; internalization; bone; osteoblasts;
   MG63 cells; Staphylococcus aureus; Staphylococcus epidermidis;
   Staphylococcus lugdunensis; Enterococcus faecalis; ribotyping; molecular
   epidemiology
ID MAMMARY EPITHELIAL-CELLS; EXTRACELLULAR ADHERENCE PROTEIN;
   ENDOTHELIAL-CELLS; BACTERIAL INTERNALIZATION; ANTIBIOTIC-RESISTANCE;
   BIOFILM FORMATION; ICA LOCUS; AUREUS; INVASION; EXPRESSION
AB Septic failure is still the major complication of prosthetic implants. Entering host cells, bacteria hide from host immune defenses, shelter from extracellular antibiotics, and cause chronic infection. Staphylococcus aureus, the leading etiologic agent of orthopedic implant infections, is able to enter bone cells and induce osteoblast apoptosis, osteoclast recruitment, and highly destructive osteomyelitis. Staphylococcus epidermidis, Staphylococcus lugdunensis, and Enterococcus faecalis are opportunistic pathogens causative of implant-related infections. This study investigated the ability to internalize into osteoblastic MG63 cells of 22 S. epidermidis, 9 S. lugdunensis, and 21 E. faecalis clinical isolates from orthopedic implant infections. Isolates were categorized in clusters by ribotyping. Internalization assay was carried out by means of a microtiter plate-based method. S. epidermidis, S. lugdunensis, and E. faecalis strains turned out incompetent to enter osteoblasts, exhibiting negligible internalization into MG63 cells, nearly three orders of magnitude lower than that of S. aureus. Osteoblast invasion does not appear as a pathogenetic mechanism utilized by S. epidermidis, S. lugdunensis, or E. faecalis for infecting orthopedic implants. Moreover, it can be inferred that intracellularly active antimicrobials should not be necessary against implant infections caused by the three bacterial species. Finally, implications with the uptake of biomaterial microparticles by nonphagocytic cells are enlightened. (c) 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 788-801, 2016.
C1 [Campoccia, Davide; Testoni, Francesca; Ravaioli, Stefano; Cangini, Ilaria; Montanaro, Lucio; Arciola, Carla Renata] Rizzoli Orthoped Inst, Res Unit Implant Infect, Bologna, Italy.
   [Testoni, Francesca; Ravaioli, Stefano; Cangini, Ilaria; Montanaro, Lucio; Arciola, Carla Renata] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy.
   [Maso, Alessandra] Rizzoli Orthoped Inst, Musculoskeletal Tissue Bank, Microbiol Anal Sect, Bologna, Italy.
   [Speziale, Pietro] Univ Pavia, Biochem Unit, Dept Mol Med, Via Palestro 3, I-27100 Pavia, Italy.
   [Visai, Livia] Univ Pavia, INSTM UdR Pavia, Ctr Tissue Engn CIT, Dept Mol Med, Via Palestro 3, I-27100 Pavia, Italy.
   [Visai, Livia] Salvatore Maugeri Fdn, Nanotechnol Lab, Dept Occupat Med Ergon & Disabil, Pavia, Italy.
RP Arciola, CR (reprint author), Rizzoli Orthoped Inst, Res Unit Implant Infect, Bologna, Italy.; Arciola, CR (reprint author), Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy.
EM carlarenata.arciola@ior.it
RI Campoccia, Davide/K-5348-2018
OI Campoccia, Davide/0000-0002-3336-0219
FU "5 per mille" grants for Health Research to the Rizzoli Orthopedic
   Institute of Bologna
FX Contract grant sponsor: "5 per mille" grants for Health Research to the
   Rizzoli Orthopedic Institute of Bologna
CR Almeida RA, 2007, J VET PHARMACOL THER, V30, P151, DOI 10.1111/j.1365-2885.2007.00830.x
   Almeida RA, 2001, MICROB PATHOGENESIS, V31, P205, DOI 10.1006/mpat.2001.0465
   Arciola CR, 2008, BIOMATERIALS, V29, P580, DOI 10.1016/j.biomaterials.2007.10.008
   Arciola CR, 2007, BIOMATERIALS, V28, P3987, DOI 10.1016/j.biomaterials.2007.05.013
   Arciola CR, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00007
   Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031
   Arciola CR, 2004, BIOMATERIALS, V25, P4117, DOI 10.1016/j.biomaterials.2003.11.027
   Arciola CR, 2002, J BIOMED MATER RES, V59, P557, DOI 10.1002/jbm.10006
   Bartlett AH, 2010, PEDIATR INFECT DIS J, V29, P860, DOI 10.1097/INF.0b013e3181ef2477
   Bur S, 2013, J INVEST DERMATOL, V133, P2004, DOI 10.1038/jid.2013.87
   Carnpoccia D, 2009, J BIOMED MATER RES A, V88A, P664, DOI 10.1002/jbm.a.32090
   Claro T, 2013, MICROBIOL-SGM, V159, P147, DOI 10.1099/mic.0.063016-0
   Ellington JK, 2006, J ORTHOP RES, V24, P87, DOI 10.1002/jor.20003
   Frank KL, 2008, CLIN MICROBIOL REV, V21, P111, DOI 10.1128/CMR.00036-07
   Frank KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130187
   Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105
   Haggar A, 2003, INFECT IMMUN, V71, P2310, DOI 10.1128/IAI.71.5.2310-2317.2003
   Hirschhausen N, 2010, CELL MICROBIOL, V12, P1746, DOI 10.1111/j.1462-5822.2010.01506.x
   Hudson MC, 1995, MICROB PATHOGENESIS, V19, P409, DOI 10.1006/mpat.1995.0075
   Hussain M, 2015, INT J MED MICROBIOL, V305, P129, DOI 10.1016/j.ijmm.2014.11.010
   Hyvonen P, 2009, J DAIRY RES, V76, P144, DOI 10.1017/S0022029908003774
   Izard T, 2006, J CELL BIOL, V175, P465, DOI 10.1083/jcb.200605091
   Khalil H, 2007, MICROBES INFECT, V9, P460, DOI 10.1016/j.micinf.2007.01.002
   Kuhbacher A, 2014, METHODS MOL BIOL, V1157, P167, DOI 10.1007/978-1-4939-0703-8_14
   Kumar JK, 2008, APPL MICROBIOL BIOT, V80, P555, DOI 10.1007/s00253-008-1579-y
   LAPENTA D, 1994, P NATL ACAD SCI USA, V91, P12115, DOI 10.1073/pnas.91.25.12115
   Lione VOF, 2005, INT J MOL MED, V15, P153
   McCarthy H, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00001
   Millan D, 2013, MICROB PATHOGENESIS, V57, P62, DOI 10.1016/j.micpath.2012.11.007
   Nagata E, 2011, MOL ORAL MICROBIOL, V26, P78, DOI 10.1111/j.2041-1014.2010.00597.x
   Osano E, 2003, TOXICOL IN VITRO, V17, P41, DOI 10.1016/S0887-2333(02)00127-3
   Oviedo-Boyso J, 2009, FEMS MICROBIOL LETT, V292, P92, DOI 10.1111/j.1574-6968.2008.01469.x
   Patino T, 2012, INT J NANOMED, V7, P5671, DOI 10.2147/IJN.S34635
   Pils S, 2006, J MICROBIOL METH, V65, P301, DOI 10.1016/j.mimet.2005.08.013
   Ravaioli S, 2012, INT J ARTIF ORGANS, V35, P742, DOI 10.5301/ijao.5000142
   Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x
   Solomon EB, 2005, J FOOD PROTECT, V68, P870, DOI 10.4315/0362-028X-68.4.870
   Soong G, 2011, J BIOL CHEM, V286, P35891, DOI 10.1074/jbc.M111.295386
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Szabados F, 2011, FEMS MICROBIOL LETT, V324, P48, DOI 10.1111/j.1574-6968.2011.02382.x
   Tang HJ, 2011, INT J ANTIMICROB AG, V38, P46, DOI 10.1016/j.ijantimicag.2011.02.013
   Testoni F, 2011, INT J ARTIF ORGANS, V34, P789, DOI 10.5301/ijao.5000058
   Valour F, 2015, ANTIMICROB AGENTS CH, V59, P2029, DOI 10.1128/AAC.04359-14
   Valour F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067240
   Veiga E, 2006, TRENDS CELL BIOL, V16, P499, DOI 10.1016/j.tcb.2006.08.005
   Von Eiff C, 2006, INT J ARTIF ORGANS, V29, P360
   Wang JH, 2013, J MICROBIOL, V51, P644, DOI 10.1007/s12275-013-3040-x
   Wells CL, 2000, INFECT IMMUN, V68, P7190, DOI 10.1128/IAI.68.12.7190-7194.2000
   WILSON CB, 1982, SEMIN PERINATOL, V6, P205
   YAO L, 1995, INFECT IMMUN, V63, P1835
   Zauner W, 2001, J CONTROL RELEASE, V71, P39, DOI 10.1016/S0168-3659(00)00358-8
NR 51
TC 7
Z9 8
U1 0
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2016
VL 104
IS 3
BP 788
EP 801
DI 10.1002/jbm.a.35564
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DC4AB
UT WOS:000369160800023
PM 26378773
DA 2018-10-19
ER

PT J
AU Aibibu, D
   Hild, M
   Woltje, M
   Cherif, C
AF Aibibu, Dilbar
   Hild, Martin
   Woeltje, Michael
   Cherif, Chokri
TI Textile cell-free scaffolds for in situ tissue engineering applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ACID-COLLAGEN TUBE; BIODEGRADABLE POLYMER SCAFFOLDS; PERIPHERAL-NERVE
   REGENERATION; ANTERIOR CRUCIATE LIGAMENT; ROTATOR CUFF REPAIR;
   3-DIMENSIONAL POROUS SCAFFOLDS; REINFORCED FASCIA PATCH; SPIDER SILK
   PROTEINS; POLYGLYCOLIC ACID; CROSS-LINKING
AB In this article, the benefits offered by micro-fibrous scaffold architectures fabricated by textile manufacturing techniques are discussed: How can established and novel fiber-processing techniques be exploited in order to generate templates matching the demands of the target cell niche? The problems related to the development of biomaterial fibers (especially from nature-derived materials) ready for textile manufacturing are addressed. Attention is also paid on how biological cues may be incorporated into micro-fibrous scaffold architectures by hybrid manufacturing approaches (e.g. nanofiber or hydrogel functionalization). After a critical review of exemplary recent research works on cell-free fiber based scaffolds for in situ TE, including clinical studies, we conclude that in order to make use of the whole range of favors which may be provided by engineered fibrous scaffold systems, there are four main issues which need to be addressed: (1) Logical combination of manufacturing techniques and materials. (2) Biomaterial fiber development. (3) Adaption of textile manufacturing techniques to the demands of scaffolds for regenerative medicine. (4) Incorporation of biological cues (e.g. stem cell homing factors).
C1 [Aibibu, Dilbar; Hild, Martin; Woeltje, Michael; Cherif, Chokri] Tech Univ Dresden, Fak Maschinenwesen, Inst Text Maschinen & Text Hochleistungswerkstoff, D-01062 Dresden, Germany.
RP Aibibu, D (reprint author), Tech Univ Dresden, Fak Maschinenwesen, Inst Text Maschinen & Text Hochleistungswerkstoff, D-01062 Dresden, Germany.
EM dilibaier.aibibu@tu-dresden.de
RI Cherif, Chokri/R-8818-2016
OI Cherif, Chokri/0000-0003-3835-0420
CR Abbushi A, 2008, SPINE, V33, P1527, DOI 10.1097/BRS.0b013e3181788760
   Aberg M, 2009, J PLAST RECONSTR AES, V62, P1503, DOI 10.1016/j.bjps.2008.06.041
   Abounaim MD, 2012, TEXT RES J, V82, P288, DOI 10.1177/0040517511426609
   Ahn H, 2014, J MECH BEHAV BIOMED, V34, P37, DOI 10.1016/j.jmbbm.2014.01.004
   Akbarzadeh R, 2014, J BIOMED MATER RES B, V102, P1304, DOI 10.1002/jbm.b.33101
   Albanna MZ, 2013, J MECH BEHAV BIOMED, V20, P217, DOI 10.1016/j.jmbbm.2012.09.012
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Anitha A, 2014, PROG POLYM SCI, V39, P1644, DOI 10.1016/j.progpolymsci.2014.02.008
   Anitua E, 2010, ADV DRUG DELIVER REV, V62, P741, DOI 10.1016/j.addr.2010.01.001
   Ansar M, 2011, COMPOS STRUCT, V93, P1947, DOI 10.1016/j.compstruct.2011.03.010
   Asti A, 2014, INT J ARTIF ORGANS, V37, P187, DOI [10.5301/ijao.5000307, 10.530/ijao.5000307]
   Aurora A, 2011, J BIOMED MATER RES A, V99A, P221, DOI 10.1002/jbm.a.33179
   Baker AR, 2012, CLIN ORTHOP RELAT R, V470, P2513, DOI 10.1007/s11999-012-2348-x
   Balasubramanian P, 2013, ADV POLYM SCI, V251, P173, DOI 10.1007/12_2012_176
   Behera BK, 2009, J IND TEXT, V38, P205, DOI 10.1177/1528083708091251
   Bell JHA, 2012, TISSUE ENG PART B-RE, V18, P116, DOI [10.1089/ten.teb.2011.0498, 10.1089/ten.TEB.2011.0498]
   Bettahalli NMS, 2011, ACTA BIOMATER, V7, P3312, DOI 10.1016/j.actbio.2011.06.012
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Bilisik K, 2013, TEXT RES J, V83, P1414, DOI 10.1177/0040517512450766
   Bini TB, 2004, J BIOMED MATER RES A, V68A, P286, DOI 10.1002/jbm.a.20050
   Braghirolli DI, 2014, DRUG DISCOV TODAY, V19, P743, DOI 10.1016/j.drudis.2014.03.024
   Bramfeldt H, 2010, CURR MED CHEM, V17, P3944, DOI 10.2174/092986710793205327
   Brunger JM, 2014, P NATL ACAD SCI USA, V111, pE798, DOI 10.1073/pnas.1321744111
   Bueno EM, 2009, NAT REV RHEUMATOL, V5, P685, DOI 10.1038/nrrheum.2009.228
   Burdick JA, 2011, BIOMATERIALS FOR TIS
   CAVALLARO JF, 1994, BIOTECHNOL BIOENG, V44, P146, DOI 10.1002/bit.260440121
   Caves JM, 2010, J BIOMED MATER RES B, V93B, P24, DOI 10.1002/jbm.b.31555
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Chen FM, 2011, BIOMATERIALS, V32, P3189, DOI 10.1016/j.biomaterials.2010.12.032
   Cheng XG, 2008, BIOMATERIALS, V29, P3278, DOI 10.1016/j.biomaterials.2008.04.028
   Cherif C, 2011, TEXTILE WERKSTOFFE L
   Chung DE, 2014, FIBER POLYM, V15, P153, DOI 10.1007/s12221-014-0153-8
   Cooper JA, 2007, P NATL ACAD SCI USA, V104, P3049, DOI 10.1073/pnas.0608837104
   Dalton PD, 2013, BIOMATER SCI-UK, V1, P171, DOI 10.1039/c2bm00039c
   De Visscher G, 2012, ACTA BIOMATER, V8, P1330, DOI 10.1016/j.actbio.2011.09.016
   Delgado LM, 2015, TISSUE ENG PART B-RE, V21, P298, DOI [10.1089/ten.teb.2014.0290, 10.1089/ten.TEB.2014.0290]
   Derwin KA, 2009, J BONE JOINT SURG AM, V91A, P1159, DOI 10.2106/JBJS.H.00775
   Desorme M, 2013, CARBOHYD POLYM, V98, P50, DOI 10.1016/j.carbpol.2013.04.070
   Donoghoe N, 2007, MICROSURG, V27, P595, DOI 10.1002/micr.20408
   Efe T, 2012, KNEE SURG SPORT TR A, V20, P1911, DOI 10.1007/s00167-011-1777-5
   Elsabee MZ, 2012, MAT SCI ENG C-MATER, V32, P1711, DOI 10.1016/j.msec.2012.05.009
   Enea D, 2013, KNEE SURG SPORT TR A, V21, P1783, DOI 10.1007/s00167-012-2102-7
   Enea D, 2011, J MATER SCI-MATER M, V22, P1569, DOI 10.1007/s10856-011-4336-1
   Erggelet C, 2007, BIOMATERIALS, V28, P5570, DOI 10.1016/j.biomaterials.2007.09.005
   Fang Q, 2009, MAT SCI ENG C-BIO S, V29, P1527, DOI 10.1016/j.msec.2008.12.007
   Fioretta ES, 2012, MACROMOL BIOSCI, V12, P577, DOI 10.1002/mabi.201100315
   Funakoshi T, 2006, J SHOULDER ELB SURG, V15, P112, DOI 10.1016/j.jse.2005.05.012
   Gavenis K, 2010, ARTIF ORGANS, V34, P79, DOI 10.1111/j.1525-1594.2009.00776.x
   Giannitelli SM, 2014, ACTA BIOMATER, V10, P580, DOI 10.1016/j.actbio.2013.10.024
   Glass KA, 2014, BIOMATERIALS, V35, P5921, DOI 10.1016/j.biomaterials.2014.03.073
   Gloy YS, 2013, ANN BIOMED ENG, V41, P1950, DOI 10.1007/s10439-013-0806-6
   Gokarneshan N, 2012, J IND TEXT, V42, P52, DOI 10.1177/1528083711426021
   Gomez G, 2006, J CRANIOFAC SURG, V17, P935
   Goonoo N, 2014, J BIOMED NANOTECHNOL, V10, P2173, DOI 10.1166/jbn.2014.1885
   Gotterbarm T, 2006, BIOMATERIALS, V27, P3387, DOI 10.1016/j.biomaterials.2006.01.041
   Guan JJ, 2015, RSC ADV, V5, P36175, DOI 10.1039/c5ra01487e
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   He JX, 2014, POLYM INT, V63, P1288, DOI 10.1002/pi.4672
   He NF, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40404
   Hibino N, 2010, J THORAC CARDIOV SUR, V139, P431, DOI 10.1016/j.jtcvs.2009.09.057
   Hild M, 2014, TEXT RES J, V84, P1084, DOI 10.1177/0040517513515315
   Hild M, 2014, COMPOS INTERFACE, V21, P301, DOI 10.1080/15685543.2014.852016
   Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6
   Hollister SJ, 2009, ADV MATER, V21, P3330, DOI 10.1002/adma.200802977
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Honkanen PB, 2010, J HAND SURG-EUR VOL, V35E, P746, DOI 10.1177/1753193410375777
   Honkanen PB, 2003, TISSUE ENG, V9, P957, DOI 10.1089/107632703322495600
   Hoogenkamp HR, 2014, TISSUE ENG PART C-ME, V20, P423, DOI [10.1089/ten.TEC.2013.0485, 10.1089/ten.tec.2013.0485]
   Hou QP, 2003, BIOMATERIALS, V24, P1937, DOI 10.1016/S0142-9612(02)00562-8
   Hsia Y, 2012, JOVE-J VIS EXP, DOI 10.3791/4191
   Hutmacher DW, 2007, J CELL MOL MED, V11, P654, DOI 10.1111/j.1582-4934.2007.00078.x
   Ichihara S, 2009, TISSUE ENG PART C-ME, V15, P387, DOI 10.1089/ten.tec.2008.0508
   Inada Y, 2005, PAIN, V117, P251, DOI 10.1016/j.pain.2005.05.033
   Inada Y, 2004, NEUROSURGERY, V55, P640, DOI 10.1227/01.NEU.0000134388.86603.11
   Inada Yuji, 2007, Neurosurgery, V61, pE1105
   Ingavle GC, 2014, TISSUE ENG PART B-RE, V20, P277, DOI [10.1089/ten.TEB.2013.0276, 10.1089/ten.teb.2013.0276]
   Inui Atsuyuki, 2011, Sports Med Arthrosc Rehabil Ther Technol, V3, P29, DOI 10.1186/1758-2555-3-29
   Inui A, 2010, INT ORTHOP, V34, P1327, DOI 10.1007/s00264-009-0917-8
   Ittah S, 2006, BIOMACROMOLECULES, V7, P1790, DOI 10.1021/bm060120k
   Iwai S, 2005, ANN THORAC SURG, V80, P1821, DOI 10.1016/j.athoracsur.2005.03.139
   Iwai S, 2004, J THORAC CARDIOV SUR, V128, P472, DOI 10.1016/j.jtcvs.2004.04.013
   Iwasaki N, 2011, POLYMERS-BASEL, V3, P100, DOI 10.3390/polym3010100
   Jakob F, 2012, CELL TISSUE RES, V347, P725, DOI 10.1007/s00441-011-1237-z
   Janicki P, 2012, DEUT Z SPORTMED, V63, P30, DOI 10.5960/dzsm.2011.064
   Jassal M, 2013, TEXT RES J, V83, P1999, DOI 10.1177/0040517513481870
   Jayakumar R, 2011, CHITOSAN BIOMATERIAL
   Johannsen O, 1932, Z VER DTSCH ING, V76, P710
   Jun Y, 2014, LAB CHIP, V14, P2145, DOI 10.1039/c3lc51414e
   Kamiya R, 2000, COMPOS SCI TECHNOL, V60, P33, DOI 10.1016/S0266-3538(99)00093-7
   Kasahara Y, 2008, J BIOMED MATER RES A, V86A, P127, DOI 10.1002/jbm.a.31259
   Kasoju N, 2012, ADV HEALTHC MATER, V1, P393, DOI 10.1002/adhm.201200097
   Kasoju N, 2009, J TISSUE ENG REGEN M, V3, P539, DOI 10.1002/term.196
   KATO YP, 1989, BIOMATERIALS, V10, P38, DOI 10.1016/0142-9612(89)90007-0
   Kew SJ, 2012, ACTA BIOMATER, V8, P3723, DOI 10.1016/j.actbio.2012.06.018
   Kew SJ, 2011, ACTA BIOMATER, V7, P3237, DOI 10.1016/j.actbio.2011.06.002
   Ki CS, 2007, J APPL POLYM SCI, V105, P1605, DOI 10.1002/app.26176
   Kimura Y, 2008, TISSUE ENG PT C-METH, V14, P47, DOI 10.1089/tec.2007.0286
   Kiyotani T, 1996, BRAIN RES, V740, P66, DOI 10.1016/S0006-8993(96)00848-7
   Ko IK, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.118
   Ko YG, 2013, COMPOS SCI TECHNOL, V79, P77, DOI 10.1016/j.compscitech.2013.02.016
   Koufaki N, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/4/045004
   Koyanagi Ryo, 2010, Journal of Insect Biotechnology and Sericology, V79, P27
   Kumar RS, 2014, TEXTILES IND APPL
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lansman S, 2006, J CRANIOFAC SURG, V17, P1121
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lee BR, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3576903
   Leong NL, 2014, J BIOMED MATER RES A, V102, P1614, DOI 10.1002/jbm.a.34820
   Li L, 2012, J MATER CHEM, V22, P8585, DOI 10.1039/c2jm30555k
   Li S, 2014, WIRES SYST BIOL MED, V6, P61, DOI 10.1002/wsbm.1246
   Li XM, 2014, J BIOMED MATER RES A, V102, P1580, DOI 10.1002/jbm.a.34801
   Li XM, 2014, J BIOMED MATER RES A, V102, P1092, DOI 10.1002/jbm.a.34774
   Li ZH, 2013, FRONT MATER SCI, V7, P237, DOI 10.1007/s11706-013-0214-8
   Liao CJ, 2002, J BIOMED MATER RES, V59, P676, DOI 10.1002/jbm.10030
   Liao IC, 2013, ADV FUNCT MATER, V23, P5833, DOI 10.1002/adfm.201300483
   Ling SJ, 2012, MATER LETT, V81, P13, DOI 10.1016/j.matlet.2012.04.136
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   MacGillivray JD, 2006, J SHOULDER ELB SURG, V15, P639, DOI 10.1016/j.jse.2005.11.009
   Maleki H, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41388
   Mandal BB, 2010, ACTA BIOMATER, V6, P360, DOI 10.1016/j.actbio.2009.08.035
   Matsumoto K, 2000, BRAIN RES, V868, P315, DOI 10.1016/S0006-8993(00)02207-1
   Matsumura G, 2003, BIOMATERIALS, V24, P2303, DOI 10.1016/S0142-9612(03)00043-7
   Matsumura G, 2013, BIOMATERIALS, V34, P6422, DOI 10.1016/j.biomaterials.2013.05.037
   Matsumura G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035760
   McCarron JA, 2010, J SHOULDER ELB SURG, V19, P688, DOI 10.1016/j.jse.2009.12.008
   McCullen SD, 2010, J MATER CHEM, V20, P8776, DOI 10.1039/c0jm01443e
   McNeil SE, 2011, CURR DRUG DELIV, V8, P448
   Meier C, 2011, BIOMACROMOLECULES, V12, P3453, DOI 10.1021/bm2005752
   Meyer M, 2010, MAT SCI ENG C-MATER, V30, P1266, DOI 10.1016/j.msec.2010.07.005
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Mukherjee DP, 2009, J BIOMED MATER RES B, V88B, P92, DOI 10.1002/jbm.b.31155
   Murphy WL, 2002, TISSUE ENG, V8, P43, DOI 10.1089/107632702753503045
   Nakamura T, 2004, BRAIN RES, V1027, P18, DOI 10.1016/j.brainres.2004.08.040
   Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R
   Nam YS, 1999, BIOMATERIALS, V20, P1783, DOI 10.1016/S0142-9612(99)00073-3
   Navissano M, 2005, MICROSURG, V25, P268, DOI 10.1002/micr.20128
   Ogulata RT, 2012, J TEXT I, V103, P654, DOI 10.1080/00405000.2011.597567
   Oliveira JT, 2011, J BIOMAT SCI-POLYM E, V22, P773, DOI 10.1163/092050610X494604
   Ozipek B, 2014, WOODHEAD PUBL SER TE, P174, DOI 10.1533/9780857099174.2.174
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Pasquinelli G, 2008, J ANAT, V213, P520, DOI 10.1111/j.1469-7580.2008.00974.x
   Pati F, 2012, J MATER SCI-MATER M, V23, P1085, DOI 10.1007/s10856-012-4559-9
   Peniston SJ, 2012, J BIOMED MATER RES B, V100B, P1922, DOI 10.1002/jbm.b.32759
   Pins GD, 1997, BIOPHYS J, V73, P2164, DOI 10.1016/S0006-3495(97)78247-X
   Piri N, 2013, E-POLYMERS, V13
   Pohl G, 2009, TEXTILES CONSTRUCTIO
   Puppi D, 2014, J BIOMED MATER RES B, V102, P1562, DOI 10.1002/jbm.b.33144
   Qian L, 2011, J CHEM TECHNOL BIOT, V86, P172, DOI 10.1002/jctb.2495
   Qiu WG, 2009, BIOMACROMOLECULES, V10, P602, DOI 10.1021/bm801296r
   Quigley AF, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/1/016008
   Rampichova M, 2010, PHYSIOL RES, V59, P773
   Rawal A, 2014, WOODHEAD PUBL SER TE, P75, DOI 10.1533/9780857099174.2.75
   Ribba L, 2014, J BIOMED NANOTECHNOL, V10, P3508, DOI 10.1166/jbn.2014.2046
   Riva R, 2011, ADV POLYM SCI, V244, P19, DOI 10.1007/12_2011_137
   Salerno A, 2009, J MATER SCI-MATER M, V20, P2043, DOI 10.1007/s10856-009-3767-4
   Schacht K, 2014, CURR OPIN BIOTECH, V29, P62, DOI 10.1016/j.copbio.2014.02.015
   Schafer-Nolte F, 2014, ANN SURG, V259, P781, DOI 10.1097/SLA.0b013e3182917677
   Seib FP, 2013, ISR J CHEM, V53, P756, DOI 10.1002/ijch.201300083
   Sengupta D, 2014, ANN BIOMED ENG, V42, P1537, DOI 10.1007/s10439-014-1022-8
   Shen WL, 2010, BIOMATERIALS, V31, P7239, DOI 10.1016/j.biomaterials.2010.05.040
   Shepherd DV, 2015, APL MATER, V3, DOI 10.1063/1.4900887
   Shepherd JH, 2013, J BIOMED MATER RES A, V101, P176, DOI 10.1002/jbm.a.34317
   Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y
   Starritt NE, 2011, LARYNGOSCOPE, V121, P1614, DOI 10.1002/lary.21868
   Takahashi H, 2009, ANN THORAC SURG, V88, P1269, DOI 10.1016/j.athoracsur.2009.04.087
   Tamayol A, 2013, BIOTECHNOL ADV, V31, P669, DOI 10.1016/j.biotechadv.2012.11.007
   Tian LL, 2015, REGEN BIOMATER, V2, P31, DOI 10.1093/rb/rbu017
   Tiihonen R, 2012, SCAND J SURG, V101, P265, DOI 10.1177/145749691210100408
   Tiihonen RP, 2012, J PLAST SURG HAND SU, V46, P113, DOI 10.3109/2000656X.2012.669202
   Toba T, 2001, J BIOMED MATER RES, V58, P622, DOI 10.1002/jbm.1061
   Torikai K, 2008, J THORAC CARDIOV SUR, V136, P37, DOI 10.1016/j.jtcvs.2007.06.039
   Toskas G, 2013, AUTEX RES J, V13, P134, DOI 10.2478/v10304-012-0041-5
   Trachtenberg JE, 2013, ISR J CHEM, V53, P646, DOI 10.1002/ijch.201300051
   Tuin SA, 2014, J BIOMED MATER RES A, V102, P3311, DOI 10.1002/jbm.a.35002
   Uquillas JA, 2012, J MECH BEHAV BIOMED, V15, P176, DOI 10.1016/j.jmbbm.2012.06.012
   Urita Y, 2008, PEDIATR SURG INT, V24, P1041, DOI 10.1007/s00383-008-2212-y
   Vleggeert-Lankamp CLAM, 2007, J BIOMED MATER RES A, V80A, P965, DOI 10.1002/jbm.a.30941
   Wan ACA, 2004, MACROMOLECULES, V37, P7019, DOI 10.1021/ma0498868
   Wang LM, 2009, TISSUE ENG PT A, V15, P1009, DOI 10.1089/ten.tea.2008.0012
   Wang XG, 2013, ACTA BIOMATER, V9, P7822, DOI 10.1016/j.actbio.2013.04.017
   Wang XG, 2012, J MECH BEHAV BIOMED, V8, P204, DOI 10.1016/j.jmbbm.2012.01.001
   Wang XG, 2011, J MECH BEHAV BIOMED, V4, P922, DOI 10.1016/j.jmbbm.2011.04.009
   Waris E, 2008, BIOMATERIALS, V29, P683, DOI 10.1016/j.biomaterials.2007.10.037
   Weber M, 2014, TISSUE ENG PART C-ME, V20, P265, DOI [10.1089/ten.TEC.2013.0258, 10.1089/ten.tec.2013.0258]
   Weisman S, 2010, BIOMATERIALS, V31, P2695, DOI 10.1016/j.biomaterials.2009.12.021
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
   Williams DF, 2014, TISSUE ENG PT A, V20, P1129, DOI 10.1089/ten.tea.2013.0769
   Wintermantel E, 1996, BIOMATERIALS, V17, P83, DOI 10.1016/0142-9612(96)85753-X
   Wong CS, 2012, TEXT RES J, V82, P1371, DOI 10.1177/0040517512439915
   Woodruff MA, 2012, MATER TODAY, V15, P430, DOI 10.1016/S1369-7021(12)70194-3
   Wulfhorst B, 2006, TEXTILE TECHNOLOGY
   Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107
   Xu HL, 2014, LANGMUIR, V30, P8461, DOI 10.1021/la500768b
   Xu LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050227
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
   Yamane S, 2007, J BIOMED MATER RES A, V81A, P586, DOI 10.1002/jbm.a.31095
   Yan JP, 2010, BIOMACROMOLECULES, V11, P1, DOI 10.1021/bm900840h
   Yan WX, 2014, J APPL POLYM SCI, V131, DOI [10.1002/app.40852, 10.1002/APP.40852]
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Yeoman MS, 2010, BIOMATERIALS, V31, P8484, DOI 10.1016/j.biomaterials.2010.07.033
   Yokota T, 2008, J THORAC CARDIOV SUR, V136, P900, DOI 10.1016/j.jtcvs.2008.02.058
   Yokoya S, 2008, AM J SPORT MED, V36, P1298, DOI 10.1177/0363546508314416
   Yoshitani M, 2007, J THORAC CARDIOV SUR, V133, P726, DOI 10.1016/j.jtcvs.2006.08.089
   You CG, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-125
   Younesi M, 2014, ADV FUNCT MATER, V24, P5762, DOI 10.1002/adfm.201400828
   Yudin VE, 2014, CARBOHYD POLYM, V108, P176, DOI 10.1016/j.carbpol.2014.02.090
   Zeugolis DI, 2008, J BIOMED MATER RES B, V85B, P343, DOI 10.1002/jbm.b.30952
   Zeugolis DI, 2008, J APPL POLYM SCI, V108, P2886, DOI 10.1002/app.27208
   Zeugolis DI, 2008, J BIOMED MATER RES A, V86A, P892, DOI 10.1002/jbm.a.31694
   Zeugolis DI, 2009, J BIOMED MATER RES A, V89A, P895, DOI 10.1002/jbm.a.32031
   Zhang CC, 2012, BIOMACROMOLECULES, V13, P2148, DOI 10.1021/bm300541g
   Zhou H, 2014, CHINESE J POLYM SCI, V32, P29, DOI 10.1007/s10118-014-1368-2
   Zhu MF, 2015, BIOMATERIALS, V61, P85, DOI 10.1016/j.biomaterials.2015.05.024
NR 213
TC 5
Z9 6
U1 2
U2 74
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAR
PY 2016
VL 27
IS 3
AR 63
DI 10.1007/s10856-015-5656-3
PG 20
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA DB7WQ
UT WOS:000368728100021
PM 26800694
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Lotfi, M
   Bagherzadeh, R
   Naderi-Meshkin, H
   Mahdipour, E
   Mafinezhad, A
   Sadeghnia, HR
   Esmaily, H
   Maleki, M
   Hasssanzadeh, H
   Ghayaour-Mobarhan, M
   Bidkhori, HR
   Bahrami, AR
AF Lotfi, Marzieh
   Bagherzadeh, Roohollah
   Naderi-Meshkin, Hojjat
   Mahdipour, Elahe
   Mafinezhad, Asghar
   Sadeghnia, Hamid Reza
   Esmaily, Habibollah
   Maleki, Masoud
   Hasssanzadeh, Halimeh
   Ghayaour-Mobarhan, Majid
   Bidkhori, Hamid Reza
   Bahrami, Ahmad Reza
TI Hybrid Chitosan-beta-Glycerol Phosphate-Gelatin Nano-/Micro Fibrous
   Scaffolds with Suitable Mechanical and Biological Properties for Tissue
   Engineering
SO BIOPOLYMERS
LA English
DT Article
DE regenerative medicine; chitosan; gelatin; tissue engineering;
   biocompatible scaffold
ID MESENCHYMAL STEM-CELLS; NORMAL HUMAN KERATINOCYTES; PORE
   STRUCTURE-ANALYSIS; CROSS-LINKING; NANOFIBERS; SKIN; DIFFERENTIATION;
   PREDICTION; REPAIR
AB Scaffold-based tissue engineering is considered as a promising approach in the regenerative medicine. Graft instability of collagen, by causing poor mechanical properties and rapid degradation, and their hard handling remains major challenges to be addressed. In this research, a composite structured nano-/microfibrous scaffold, made from a mixture of chitosan-beta-glycerol phosphate-gelatin (chitosan-GP-gelatin) using a standard electrospinning setup was developed. Gelatin-acid acetic and chitosan beta-glycerol phosphate-HCL solutions were prepared at ratios of 30/70, 50/50, 70/30 (w/w) and their mechanical and biological properties were engineered. Furthermore, the pore structure of the fabricated nanofibrous scaffolds was investigated and predicted using a theoretical model. Higher gelatin concentrations in the polymer blend resulted in significant increase in mean pore size and its distribution. Interaction between the scaffold and the contained cells was also monitored and compared in the test and control groups. Scaffolds with higher chitosan concentrations showed higher rate of cell attachment with better proliferation property, compared with gelatin-only scaffolds. The fabricated scaffolds, unlike many other natural polymers, also exhibit non-toxic and biodegradable properties in the grafted tissues. In conclusion, the data clearly showed that the fabricated biomaterial is a biologically compatible scaffold with potential to serve as a proper platform for retaining the cultured cells for further application in cell-based tissue engineering, especially in wound healing practices. These results suggested the potential of using mesoporous composite chitosan-GP-gelatin fibrous scaffolds for engineering three-dimensional tissues with different inherent cell characteristics. (C) 2015 Wiley Periodicals, Inc.
C1 [Lotfi, Marzieh] Mashhad Univ Med Sci, Dept Modern Sci, Mashhad, Iran.
   [Lotfi, Marzieh] Mashhad Univ Med Sci, Technol Sch Med, Mashhad, Iran.
   [Bagherzadeh, Roohollah] Amirkabir Univ Technol, Adv Text Mat & Technol Res Inst ATMT, Text Engn Dept, Tehran, Iran.
   [Naderi-Meshkin, Hojjat; Hasssanzadeh, Halimeh; Bidkhori, Hamid Reza; Bahrami, Ahmad Reza] Iranian Acad Ctr Educ Culture & Res ACECR, Stem Cell & Regenerat Med Res Grp, Khorasan Razavi Branch, Mashhad, Iran.
   [Mahdipour, Elahe] Mashhad Univ Med Sci, Sch Med, Dept Med Biotechnol, Mashhad, Iran.
   [Mafinezhad, Asghar] Mashhad Univ Med Sci, Dept Pathol, Shahid Kamyab Emdadi Hosp, Mashhad, Iran.
   [Sadeghnia, Hamid Reza] Mashhad Univ Med Sci, Sch Med, Neurocognit Res Ctr, Mashhad, Iran.
   [Esmaily, Habibollah] Mashhad Univ Med Sci, Sch Hlth, Dept Biostat & Epidemiol, Mashhad, Iran.
   [Maleki, Masoud] Mashhad Univ Med Sci, Sch Med, Cutaneous Leishmaniasis Res Ctr, Mashhad, Iran.
   [Ghayaour-Mobarhan, Majid] Mashhad Univ Med, Sch Med, Biochem Nutr Res Ctr, Mashhad, Iran.
   [Bahrami, Ahmad Reza] Ferdowsi Univ Mashhad, Inst Biotechnol, Cell & Mol Biotechnol Res Grp, Mashhad, Iran.
RP Bahrami, AR (reprint author), Iranian Acad Ctr Educ Culture & Res ACECR, Stem Cell & Regenerat Med Res Grp, Khorasan Razavi Branch, Mashhad, Iran.
EM ghayourm@mums.ac.ir; Ar-Bahrami@um.ac.ir
RI Bagherzadeh, Roohollah/B-7077-2014
OI Bagherzadeh, Roohollah/0000-0001-8297-5343; Esmaily,
   Habibollah/0000-0003-4139-546X
FU Mashhad University of Medical Sciences; Iranian Academic Center for
   Education, Culture and Research (ACECR), Khorasan Razavi Branch, Mashhad
FX The results described in this paper were part of a Ph.D. student
   (Marzieh Loth) thesis (thesis # A-543). This research project was
   supported by Mashhad University of Medical Sciences and Iranian Academic
   Center for Education, Culture and Research (ACECR), Khorasan Razavi
   Branch, Mashhad.
CR Alli A, 2006, EUR POLYM J, V42, P3024, DOI 10.1016/j.eurpolymj.2006.07.012
   Bagherzadeh R, 2014, J IND TEXT, V43, P483, DOI 10.1177/1528083712463400
   Bagherzadeh R, 2014, J IND TEXT, V43, P496, DOI 10.1177/1528083712463414
   Bagherzadeh R, 2014, J BIOMED MATER RES A, V102, P903, DOI 10.1002/jbm.a.34736
   Bagherzadeh R, 2013, J BIOMED MATER RES A, V101, P2107, DOI 10.1002/jbm.a.34487
   Bagherzadeh R, 2013, J BIOMED MATER RES A, V101, P765, DOI 10.1002/jbm.a.34379
   Bagherzadeh R, 2012, TEXT RES J, V82, P70, DOI 10.1177/0040517511420766
   Chen ZG, 2010, ACTA BIOMATER, V6, P372, DOI 10.1016/j.actbio.2009.07.024
   Chenite A, 2001, CARBOHYD POLYM, V46, P39, DOI 10.1016/S0144-8617(00)00281-2
   Dhandayuthapani B, 2010, J BIOMED MATER RES B, V94B, P264, DOI 10.1002/jbm.b.31651
   Dubsky M, 2012, J MATER SCI-MATER M, V23, P931, DOI 10.1007/s10856-012-4577-7
   Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Hoemann CD, 2007, OSTEOARTHR CARTILAGE, V15, P78, DOI 10.1016/j.joca.2006.06.015
   Jana S., 2012, DESIGNING CHITOSAN B
   Jin GR, 2011, ACTA BIOMATER, V7, P3113, DOI 10.1016/j.actbio.2011.04.017
   Knaul JZ, 1999, J POLYM SCI POL PHYS, V37, P1079, DOI 10.1002/(SICI)1099-0488(19990601)37:11<1079::AID-POLB4>3.0.CO;2-O
   Ko FK, 2014, INTRODUCTION TO NANOFIBER MATERIALS, P1, DOI 10.1017/CBO9781139021333
   Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002
   Lao LH, 2011, J MATER SCI-MATER M, V22, P1873, DOI 10.1007/s10856-011-4374-8
   Lee F, 2013, ACTA BIOMATER, V9, P5143, DOI 10.1016/j.actbio.2012.08.036
   Liu P, 2008, ARTIF ORGANS, V32, P925, DOI 10.1111/j.1525-1594.2008.00654.x
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maharlooei MK, 2011, DIABETES RES CLIN PR, V93, P228, DOI 10.1016/j.diabres.2011.04.018
   Maxson S, 2012, STEM CELL TRANSL MED, V1, P142, DOI 10.5966/sctm.2011-0018
   Min BM, 2004, CARBOHYD POLYM, V57, P285, DOI 10.1016/j.carbpol.2004.05.007
   Nalwa H. S., 2005, HDB NANOSTRUCTURED B
   Nguyen TBL, 2012, J BIOMATER APPL, V27, P255, DOI 10.1177/0885328211401932
   Patel M, 2008, PEDIATR RES, V63, P497, DOI 10.1203/01.PDR.0b013e318165eb3e
   Qian YF, 2011, J BIOMAT SCI-POLYM E, V22, P1099, DOI 10.1163/092050610X499447
   Quint C., 2009, TISSUE ENG REGEN MED, P950
   Ratanavaraporn J, 2006, J METALS MAT MINERAL, V16, P31
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   Schiffman JD, 2007, BIOMACROMOLECULES, V8, P594, DOI 10.1021/bm060804s
   Tchemtchoua VT, 2011, BIOMACROMOLECULES, V12, P3194, DOI 10.1021/bm200680q
   Telci D., 2013, STEM CELLS WOUND HEA, P1751
   Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226
   Xiumei M., 1997, ACTA POLYM SIN, V1, P222
   Zhan J., 2013, J RES UPDATE POLITIC, V1, P59
NR 39
TC 8
Z9 8
U1 2
U2 57
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3525
EI 1097-0282
J9 BIOPOLYMERS
JI Biopolymers
PD MAR
PY 2016
VL 105
IS 3
BP 163
EP 175
DI 10.1002/bip.22764
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA DB0GZ
UT WOS:000368187900004
PM 26566174
DA 2018-10-19
ER

PT J
AU Ribeiro, AM
   Flores-Sahagun, THS
   Paredes, RC
AF Ribeiro, Andreza M.
   Flores-Sahagun, Thais H. S.
   Paredes, Ramon C.
TI A perspective on molybdenum biocompatibility and antimicrobial activity
   for applications in implants
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Review
ID TI-MO ALLOYS; TI-10MO EXPERIMENTAL ALLOY; POROUS TI-7.5MO ALLOY;
   SHAPE-MEMORY ALLOY; IN-VIVO EFFICACY; BIOMEDICAL APPLICATIONS;
   MECHANICAL-PROPERTIES; CORROSION-RESISTANCE; SURFACE MODIFICATION;
   TITANIUM-ALLOYS
AB The use of biomaterials has become routine in dentistry, reconstructive surgery of the locomotor system, treatment of congenital, traumatic and tumor situations, and knee or hip arthroplasty. The main issue related to metal biomaterials is the systemic release of metal ions and the related biological risks. When placed in contact with a living organism, they must meet a set of criteria: they must be biocompatible and biofunctional, as well as have the ability to produce a specific biological response at the surface, leading to the formation of a bond between the material and the receiving tissue and a surface texture which allows cell adhesion and bone growth; they must also provide adequate structure and mechanical strength, without causing adverse reactions in the surrounding physiological environment; they must not cause oncogenic effects; they must be easy to manipulate during surgery; and they must be amenable to visible imaging and sterilization. The ability to use biomaterials is linked to the degree of biocompatibility and biofunctionality which in turn, are dependent on their physicochemical and mechanical properties, macroscopic and microscopic configuration, and the biological environment where they are deployed. Metal alloys, particularly stainless steel, cobalt, molybdenum, chromium alloys, and titanium-based alloys find wide application in orthopedics for making joint replacement prostheses, systems for external or internal fixation of bone fractures, surgical correction of degenerative conditions, or in the composition of staples, screws, and wires. Any synthetic biomaterial can replace or restore the function of body tissues while maintaining a continuous or intermittent contact with the fluid. When in contact with the fluid, it is essential that materials be biocompatible, so they do not produce adverse biological responses or induce systemic effects. Thus, they must not be toxic, carcinogenic, mutagenic, or antigenic. Bioactive materials with antibacterial properties are also of significant medical interest. Materials exhibiting good antimicrobial activity that minimize the formation of biofilm without the risk of promoting the development of resistant microorganisms are desirable. In this respect, this review briefly summarizes the recent successes of this metal as a biocompatible material with antibacterial activity for biomedical applications.
C1 [Ribeiro, Andreza M.; Flores-Sahagun, Thais H. S.; Paredes, Ramon C.] Univ Fed Parana, Engn & Mat Sci, BR-80060000 Curitiba, Parana, Brazil.
RP Ribeiro, AM (reprint author), Univ Fed Parana, Engn & Mat Sci, BR-80060000 Curitiba, Parana, Brazil.
EM ribeiroandreza@yahoo.com.br
RI Ribeiro, Andreza/I-8400-2012
OI Ribeiro, Andreza/0000-0003-3002-7362
FU National Council for Scientific and Technological Research (CNPq)
   [310272/2014-92]
FX We thank the National Council for Scientific and Technological Research
   for the research Grant (CNPq, process 310272/2014-92).
CR Akiyama H, 2013, J ORTHOP SCI, V18, P29, DOI 10.1007/s00776-012-0298-5
   Al-Zain Y, 2010, ACTA MATER, V58, P4212, DOI 10.1016/j.actamat.2010.04.013
   Almeida Filho Ed, 2007, QUIM NOVA, V30, P1129, DOI [10.1590/S0100-40422007000500034, DOI 10.1590/S0100-40422007000500034]
   Alves APR, 2004, MAT SCI ENG C-BIO S, V24, P693, DOI 10.1016/j.msec.2004.08.013
   Rezende MCRA, 2007, J MATER SCI-MATER M, V18, P149, DOI 10.1007/s10856-006-0674-9
   Anderson JM, 2006, BIOMATERIALS SILVER
   [Anonymous], 2013, F181313A ASTM INT
   [Anonymous], 2013, F56200A ASTM INT
   [Anonymous], 2000, F56300A ASTM INT
   [Anonymous], 2008, F105808 ASTM INT
   [Anonymous], 2014, F96114A ASTM INT
   [Anonymous], 2012, F7512A ASTM INT
   [Anonymous], 2011, F153711A
   [Anonymous], 2011, F79911A ASTM INT
   [Anonymous], 2008, F961A ASTM INT
   [Anonymous], F68814A ASTM INT
   [Anonymous], F74507A ASTM INT
   [Anonymous], 2014, F96108A ASTM INT
   Arciola CR, 2008, BIOMATERIALS, V29, P580, DOI 10.1016/j.biomaterials.2007.10.008
   Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031
   Arruebo M, 2010, EXPERT OPIN DRUG DEL, V7, P589, DOI 10.1517/17425241003671544
   Bago JR, 2013, TISSUE ENG PT A, V19, P593, DOI [10.1089/ten.tea.2012.0073, 10.1089/ten.TEA.2012.0073]
   Balas F, 2007, J MATER SCI-MATER M, V18, P1167, DOI 10.1007/s10856-007-0130-5
   BESSHO K, 1995, J BIOMED MATER RES, V29, P901, DOI 10.1002/jbm.820290716
   Bitar M, 2012, EUR CELLS MATER, V23, P333
   Borcard F, 2012, J MED CHEM, V55, P7988, DOI 10.1021/jm301092r
   BUNDY KJ, 1980, J BIOMED MATER RES, V14, P653, DOI 10.1002/jbm.820140511
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Chai YW, 2009, ACTA MATER, V57, P4054, DOI 10.1016/j.actamat.2009.04.051
   Chang YY, 2014, SURF COAT TECH, V259, P193, DOI 10.1016/j.surfcoat.2014.03.061
   Cheng CH, 2009, J ALLOY COMPD, V484, P524, DOI 10.1016/j.jallcom.2009.04.148
   Chu CL, 2005, J BIOMED MATER RES A, V75A, P595, DOI 10.1002/jbm.a.30465
   Chu PK, 2006, NUCL INSTRUM METH B, V242, P1, DOI 10.1016/j.nimb.2005.08.015
   Coraca DC, 2008, J MATER SCI-MATER M, V19, P2699, DOI 10.1007/s10856-008-3397-2
   Darouiche RO, 2007, J BONE JOINT SURG AM, V89A, P792, DOI 10.2106/JBJS.F.00414
   DeHoff PH, 1998, J BIOMED MATER RES, V41, P614, DOI 10.1002/(SICI)1097-4636(19980915)41:4<614::AID-JBM14>3.0.CO;2-E
   EVANS EJ, 1986, BIOMATERIALS, V7, P25, DOI 10.1016/0142-9612(86)90084-0
   Fisher L, 2014, BIOFOULING, V30, P911, DOI 10.1080/08927014.2014.939959
   Flores-Sahagun JH, 2011, Patent No. [1107210- 5, 11072105]
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gonzalez-Chomon C, 2012, EUR J PHARM BIOPHARM, V82, P383, DOI 10.1016/j.ejpb.2012.07.007
   Gordin DM, 2005, MATER LETT, V59, P2936, DOI 10.1016/j.matlet.2004.09.063
   Gordin DM, 2004, J MATER SCI-MATER M, V15, P885, DOI 10.1023/B:JMSM.0000036276.32211.31
   Guggenbichler J. P., 2011, GMS KRANKENHHYG INTE, V6, P18, DOI DOI 10.3205/DGKH000175
   Gunatillake P, 2006, BIOTECHNOL ANN REV, V12, P301, DOI 10.1016/S1387-2656(06)12009-8
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Hacking SA, 2012, J NEUROSCI METH, V211, P237, DOI 10.1016/j.jneumeth.2012.09.002
   Hao YL, 2007, ACTA BIOMATER, V3, P277, DOI 10.1016/j.actbio.2006.11.002
   Harding JL, 2014, TRENDS BIOTECHNOL, V32, P140, DOI 10.1016/j.tibtech.2013.12.004
   He FP, 2012, J BIOMED MATER RES A, V100A, P3239, DOI 10.1002/jbm.a.34265
   Ho WF, 2008, J ALLOY COMPD, V464, P580, DOI 10.1016/j.jallcom.2007.10.054
   Ho WF, 2012, MAT SCI ENG C-MATER, V32, P517, DOI 10.1016/j.msec.2011.12.003
   Ho WF, 2010, MAT SCI ENG C-MATER, V30, P904, DOI 10.1016/j.msec.2010.04.006
   Ho WF, 2009, SURF COAT TECH, V203, P3142, DOI 10.1016/j.surfcoat.2009.03.042
   Ho WF, 2008, J MED BIOL ENG, V28, P47
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Hsu HC, 2013, MAT SCI ENG A-STRUCT, V568, P1, DOI 10.1016/j.msea.2013.01.002
   Hsu HC, 2013, MATER DESIGN, V47, P21, DOI 10.1016/j.matdes.2012.12.043
   Hsu HC, 2013, J MATER SCI-MATER M, V24, P645, DOI 10.1007/s10856-012-4843-8
   Iijima D, 2003, BIOMATERIALS, V24, P1519, DOI 10.1016/S0142-9612(02)00533-1
   Jeong KJ, 2011, THER DELIV, V2, P737, DOI 10.4155/TDE.11.54
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   Joyce TJ, 2011, TRIBOL INT, V44, P513, DOI 10.1016/j.triboint.2010.04.007
   Kent D, 2010, MAT SCI ENG A-STRUCT, V527, P2246, DOI 10.1016/j.msea.2009.11.059
   Khalid A. Q., 2014, AFR J MICROBIOL RES, V8, P1080, DOI [10.5897/AJMR2013.5893, DOI 10.5897/AJMR2013.5893]
   Kokubo T, 2004, Med J Malaysia, V59 Suppl B, P91
   Krishnamoorthy K, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/31/315101
   Krishnamoorthy K, 2013, COLLOID SURFACE B, V112, P521, DOI 10.1016/j.colsurfb.2013.08.026
   Kumar S, 2008, J DENT, V36, P500, DOI 10.1016/j.jdent.2008.03.007
   Lemons J. E., 1996, MED APPL TITANIUM IT
   Li XM, 2008, BIOMATERIALS, V29, P3306, DOI 10.1016/j.biomaterials.2008.04.039
   Li YH, 2009, J ALLOY COMPD, V485, P215, DOI 10.1016/j.jallcom.2009.06.003
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Mansouri MD, 2008, CLIN MICROBIOL INFEC, V14, P190, DOI 10.1111/j.1469-0691.2007.01894.x
   MARCUS P, 1994, CORROS SCI, V36, P2155, DOI 10.1016/0010-938X(94)90013-2
   Mardare CC, 2014, ACS COMB SCI, V16, P631, DOI 10.1021/co5000536
   Marti A, 2000, INJURY, V31, P18, DOI [10.1016/S0020-1383(00)80018-2), DOI 10.1016/S0020-1383(00)80018-2]
   MCKELLOP HA, 1990, J BIOMED MATER RES, V24, P1413, DOI 10.1002/jbm.820241102
   MERRITT K, 1992, J BIOMED MATER RES, V26, P1503, DOI 10.1002/jbm.820261109
   Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/FMB.11.117, 10.2217/fmb.11.117]
   Murphy SV, 2013, BIOESSAYS, V35, P163, DOI 10.1002/bies.201200062
   Naderi H, 2011, J BIOMATER APPL, V26, P383, DOI 10.1177/0885328211408946
   Nadim James H, 2003, BIOMATERIALS ORTHOPE
   Niinomi M., 2003, Science and Technology of Advanced Materials, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Nordberg GF, 2015, HDB TOXICOLOGY METAL
   Okazaki Y, 1998, MAT SCI ENG A-STRUCT, V243, P250, DOI 10.1016/S0921-5093(97)00809-5
   Oliveira A, 2015, REV BRASILEIRA APLIC, V34, P66, DOI 10.17563/rbav.v34i2.994
   Oliveira NTC, 2009, ACTA BIOMATER, V5, P399, DOI 10.1016/j.actbio.2008.07.010
   Oliveira NTC, 2013, ELECTROCHEM COMMUN, V35, P139, DOI 10.1016/j.elecom.2013.08.019
   Oudadesse H, 2008, APPL SURF SCI, V255, P593, DOI 10.1016/j.apsusc.2008.06.086
   Page JM, 2012, ACTA BIOMATER, V8, P4405, DOI 10.1016/j.actbio.2012.07.037
   Paital SR, 2009, MAT SCI ENG R, V66, P1, DOI 10.1016/j.mser.2009.05.001
   Patel N. R., 2012, INT J EMERGING TECHN, V2, P91
   Patterson JT, 2012, REGEN MED, V7, P409, DOI [10.2217/RME.12.12, 10.2217/rme.12.12]
   Peckitt NS, 1999, BRIT J ORAL MAX SURG, V37, P353, DOI 10.1054/bjom.1999.0070
   PILLIAR RM, 1987, J BIOMED MATER RES-A, V21, P1
   PILLIAR RM, 1991, BIOMATERIALS, V12, P95, DOI 10.1016/0142-9612(91)90185-D
   Porter JR, 2009, BIOTECHNOL PROGR, V25, P1539, DOI 10.1002/btpr.246
   Qureshi N, 2015, APPL NANOSCI, V5, P331, DOI 10.1007/s13204-014-0322-5
   Randelli F, 2012, J ARTHROPLASTY, V27, P186, DOI 10.1016/j.arth.2011.04.015
   Ratner B. D., 2012, BIOMATERIALS SCI INT
   Ravaioli S, 2012, INT J ARTIF ORGANS, V35, P742, DOI 10.5301/ijao.5000142
   Ribeiro A, 2012, J R SOC INTERFACE, V9, P2059, DOI 10.1098/rsif.2012.0102
   Ribeiro A, 2012, CARBOHYD POLYM, V88, P977, DOI 10.1016/j.carbpol.2012.01.053
   Ribeiro A, 2011, J MEMBRANE SCI, V383, P60, DOI 10.1016/j.memsci.2011.08.030
   RIEU J, 1992, MATER SCI TECH-LOND, V8, P589, DOI 10.1179/mst.1992.8.7.589
   Rondelli G, 2002, BIOMATERIALS, V23, P639, DOI 10.1016/S0142-9612(01)00142-9
   Ross R.B., 1992, METALLIC MAT SPECIFI
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   San Roman J, 2004, BIODEGRADABLE SYSTEM
   Shafaei S, 2013, SURF INNOV, V1, P202, DOI 10.1680/si.13.00021
   Shalabi MM, 2007, J MATER SCI-MATER M, V18, P2033, DOI 10.1007/s10856-007-3160-0
   Shields J, 2013, INT MOLYBDENUM ASS
   Silva GA, 2007, J TISSUE ENG REGEN M, V1, P97, DOI 10.1002/term.1
   Temenoff J.S., 2008, BIOMATERIALS INTERSE
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   Torricelli P, 2004, INT J ARTIF ORGANS, V27, P658
   Torricelli Paola, 2000, Artificial Cells Blood Substitutes and Immobilization Biotechnology, V28, P181, DOI 10.3109/10731190009118580
   Trentani L, 2002, BIOMATERIALS, V23, P2863, DOI 10.1016/S0142-9612(01)00413-6
   Turnlund JR, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P731, DOI 10.1016/B978-012369413-3/50089-6
   Vallet-Regi M, 2011, ADV MATER, V23, P5177, DOI 10.1002/adma.201101586
   Wan YZ, 2007, VACUUM, V81, P1114, DOI 10.1016/j.vacuum.2006.12.011
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Whitcombe MJ, 2011, CHEM SOC REV, V40, P1547, DOI 10.1039/c0cs00049c
   Widmer AF, 2001, CLIN INFECT DIS, V33, pS94, DOI 10.1086/321863
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Yasuyuki M, 2010, BIOFOULING, V26, P851, DOI 10.1080/08927014.2010.527000
   Yeo A, 2010, J BIOMED MATER RES A, V92A, P311, DOI 10.1002/jbm.a.32366
   Young S, 2008, TISSUE ENG PT B-REV, V14, P295, DOI 10.1089/ten.teb.2008.0153
   Yu S, 2011, COLLOID SURFACE B, V85, P103, DOI 10.1016/j.colsurfb.2011.02.025
   Yu Z, 2009, MAT SCI ENG A-STRUCT, V513-14, P233, DOI 10.1016/j.msea.2009.01.077
   Yu ZT, 2009, T TECH PUBL
   Zaffe D, 2005, MICRON, V36, P583, DOI 10.1016/j.micron.2005.05.008
   Zardiackas LD, 1996, MED APPL TITANIUM IT, V60
   Zhao X, 2011, WOODHEAD PUBL MATER, P1, DOI 10.1533/9780857092939
   Zhentao Y., 2006, MAT SCI ENG A-STRUCT, V438-440, P391, DOI DOI 10.1016/J.MSEA.2005.12.079
   Zhou SF, 2014, J TISSUE ENG REGEN M, V8, P620, DOI 10.1002/term.1558
   Zhou YL, 2011, J ALLOY COMPD, V509, P6267, DOI 10.1016/j.jallcom.2011.03.045
   Zollfrank C, 2012, MAT SCI ENG C-MATER, V32, P47, DOI 10.1016/j.msec.2011.09.010
NR 143
TC 13
Z9 13
U1 2
U2 79
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
EI 1573-4803
J9 J MATER SCI
JI J. Mater. Sci.
PD MAR
PY 2016
VL 51
IS 6
BP 2806
EP 2816
DI 10.1007/s10853-015-9664-y
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA DA3FE
UT WOS:000367681300003
DA 2018-10-19
ER

PT J
AU Li, G
   Li, F
   Zheng, ZZ
   Luo, TT
   Liu, J
   Wu, JB
   Wang, XQ
   Kaplan, DL
AF Li, Gang
   Li, Fei
   Zheng, Zhaozhu
   Luo, Tingting
   Liu, Jian
   Wu, Jianbing
   Wang, Xiaoqin
   Kaplan, David L.
TI Silk microfiber-reinforced silk composite scaffolds: fabrication,
   mechanical properties, and cytocompatibility
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Article
ID SPIDER SILK; FIBROIN; FIBERS; BIOMATERIALS; HYDROGEL; REPAIR; FILMS
AB Mechanical reinforcement of silk membranes by embedding silk microfibers was studied. Silk microfibers of 10-600 mu m long were prepared by hydrolyzing degummed silk fibers in alkali solution. The silk microfibers were mixed with silk fibroin solution (continuous phase) at various ratios to fabricate silk microfiber-reinforced composite scaffolds (SMCSs). The morphology, mechanical properties, structural characteristics, biodegradation, and cytotoxicity of the composites were investigated. Silk microfiber-reinforced membranes with 1 wt% of microfibers displayed the most homogeneous distribution of microfibers in the membrane matrix. The tensile strength and elongation at break were 10.5 +/- A 2.7 MPa and 56.7 +/- A 7.8 %, respectively, comparable to human meniscus tissue. The presence of silk microfibers did not significantly impact the secondary structure and crystallization of SMCSs. Proteolytic degradation in vitro using protease XIV showed that the 1 % silk microfiber-reinforced membranes lost 90 % weight after 5 days, a longer time frame than plain silk membrane controls. The viability of human fibroblasts (Hs 865.Sk) on the SMCSs demonstrated no cytotoxicity. SMCSs may be useful as biomaterial systems as tissue substitutes where mechanical strength is critical for functional performance.
C1 [Li, Gang; Li, Fei; Zheng, Zhaozhu; Luo, Tingting; Liu, Jian; Wu, Jianbing; Wang, Xiaoqin; Kaplan, David L.] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Wang, Xiaoqin; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Wang, XQ (reprint author), Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
EM wangxiaoqin@suda.edu.cn; david.kaplan@tufts.edu
FU National Natural Science Foundation of China (NSFC) [51273138]; National
   Institutes of Health [P41 EB002520]; State Key Laboratory for
   Modification of Chemical Fibers and Polymer Materials, Donghua
   University [LK1421]; Natural Science Foundation of Jiangsu Province
   [BK20150372]
FX This work was funded by the National Natural Science Foundation of China
   (NSFC, 51273138) and the National Institutes of Health (P41 EB002520).
   We would like to thank the support of State Key Laboratory for
   Modification of Chemical Fibers and Polymer Materials, Donghua
   University (LK1421) and Natural Science Foundation of Jiangsu Province
   (BK20150372).
CR Asha S, 2012, FIBER POLYM, V13, P224
   Chao PHG, 2010, J BIOMED MATER RES B, V95B, P84, DOI 10.1002/jbm.b.31686
   Eli Nnaemeka, 2011, Ortop Traumatol Rehabil, V13, P319
   Gloria A, 2010, J APPL BIOMATER BIOM, V9, P151
   Hu X, 2008, MACROMOLECULES, V41, P3939, DOI 10.1021/ma071551d
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Hu X, 2009, MACROMOLECULES, V42, P2079, DOI 10.1021/ma802481p
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kharlampieva E, 2010, ADV FUNCT MATER, V20, P840, DOI 10.1002/adfm.200901774
   Kim HJ, 2007, MACROMOL BIOSCI, V7, P643, DOI 10.1002/mabi.200700030
   Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g
   Li CM, 2015, ACTA BIOMATER, V11, P222, DOI 10.1016/j.actbio.2014.08.009
   Li G, 2015, MACROMOL BIOSCI, V15, P1125, DOI 10.1002/mabi.201400502
   Li G, 2015, ADV HEALTHC MATER, V4, P1134, DOI 10.1002/adhm.201500002
   Li G, 2013, BIOMATERIALS, V34, P9451, DOI 10.1016/j.biomaterials.2013.08.055
   Li G, 2014, J BIOMED MATER RES A, V102, P982, DOI 10.1002/jbm.a.34759
   Li JS, 2015, ACS APPL MATER INTER, V7, P3871, DOI 10.1021/am508498u
   Lu Q, 2010, MACROMOL BIOSCI, V10, P289, DOI 10.1002/mabi.200900258
   Lu S, 2009, BIOMACROMOLECULES, V11, P143
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Mandal BB, 2011, BIOMATERIALS, V32, P639, DOI 10.1016/j.biomaterials.2010.08.115
   Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207
   Pendleton M, 2006, GRANA, V45, P71, DOI 10.1080/00173130500520479
   Rizvi GM, 2008, J VINYL ADDIT TECHN, V14, P39, DOI 10.1002/vnl.20135
   Schafer-Nolte F, 2014, ANN SURG, V259, P781, DOI 10.1097/SLA.0b013e3182917677
   Shchepelina O, 2011, ADV MATER, V23, P4655, DOI 10.1002/adma.201102234
   Taddei P, 2006, BIOMACROMOLECULES, V7, P259, DOI 10.1021/bm0506290
   Thwe MM, 2002, COMPOS PART A-APPL S, V33, P43, DOI 10.1016/S1359-835X(01)00071-9
   TISSAKHT M, 1995, J BIOMECH, V28, P411, DOI 10.1016/0021-9290(94)00081-E
   Tungjitpornkull S, 2007, J THERMOPLAST COMPOS, V20, P535, DOI 10.1177/0892705707084541
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Xie RJ, 2013, ADV MATER RES-SWITZ, V796, P126, DOI 10.4028/www.scientific.net/AMR.796.126
   Xu X, 2008, J MATER PROCESS TECH, V198, P168, DOI 10.1016/j.jmatprotec.2007.06.087
   Yang G, 2002, J MEMBRANE SCI, V210, P379, DOI 10.1016/S0376-7388(02)00419-2
   Yang MY, 2014, ACS APPL MATER INTER, V6, P13782, DOI 10.1021/am503214g
   Yodmuang S, 2015, ACTA BIOMATER, V11, P27, DOI 10.1016/j.actbio.2014.09.032
   Yuan QQ, 2010, POLYMER, V51, P4843, DOI 10.1016/j.polymer.2010.08.042
   Zhao Z, 2014, POWDER TECHNOL, V268, P118, DOI 10.1016/j.powtec.2014.07.029
   Zuo B, 2006, J MATER SCI, V41, P3357, DOI 10.1007/s10853-005-5384-z
NR 40
TC 10
Z9 11
U1 10
U2 120
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
EI 1573-4803
J9 J MATER SCI
JI J. Mater. Sci.
PD MAR
PY 2016
VL 51
IS 6
BP 3025
EP 3035
DI 10.1007/s10853-015-9613-9
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA DA3FE
UT WOS:000367681300024
DA 2018-10-19
ER

PT J
AU Kang, MO
   Tang, LP
   Gao, J
AF Kang, Mingon
   Tang, Liping
   Gao, Jean
TI Computational modeling of phagocyte transmigration for foreign body
   responses to subcutaneous biomaterial implants in mice
SO BMC BIOINFORMATICS
LA English
DT Article
DE Computational modeling; Foreign body responses; Phagocyte
   transmigration; Parameter estimation
ID ACUTE INFLAMMATORY RESPONSES; FIBRINOGEN ADSORPTION; TISSUE RESPONSES;
   MAST-CELLS
AB Background: Computational modeling and simulation play an important role in analyzing the behavior of complex biological systems in response to the implantation of biomedical devices. Quantitative computational modeling discloses the nature of foreign body responses. Such understanding will shed insight on the cause of foreign body responses, which will lead to improved biomaterial design and will reduce foreign body reactions. One of the major obstacles in computational modeling is to build a mathematical model that represents the biological system and to quantitatively define the model parameters.
   Results: In this paper, we considered quantitative inter connections and logical relationships among diverse proteins and cells, which have been reported in biological experiments and literature. Based on the established biological discovery, we have built a mathematical model while unveiling the key components that contribute to biomaterial-mediated inflammatory responses. For the parameter estimation of the mathematical model, we proposed a global optimization algorithm, called Discrete Selection Levenberg-Marquardt (DSLM). This is an extension of Levenberg-Marquardt (LM) algorithm which is a gradient-based local optimization algorithm. The proposed DSLM suggests a new approach for the selection of optimal parameters in the discrete space with fast computational convergence.
   Conclusions: The computational modeling not only provides critical clues to recognize current knowledge of fibrosis development but also enables the prediction of yet-to-be observed biological phenomena.
C1 [Kang, Mingon; Gao, Jean] Univ Texas Arlington, Dept Comp Sci & Engn, 500 UTA Blvd, Arlington, TX 76019 USA.
   [Tang, Liping] Univ Texas Arlington, Dept Bioengn, 500 UTA Blvd, Arlington, TX 76019 USA.
RP Gao, J (reprint author), Univ Texas Arlington, Dept Comp Sci & Engn, 500 UTA Blvd, Arlington, TX 76019 USA.
EM gao@uta.edu
FU NIH [R01EB00727]
FX This research was supported by NIH under grant R01EB00727.
CR Arfken G., 1985, MATH METHODS PHYS, P428
   Bonnans JF, 2006, NUMERICAL OPTIMIZATI
   Carlos D, 2006, EUR J IMMUNOL, V36, P1494, DOI 10.1002/eji.200535464
   CHRISTENSON L, 1989, J BIOMED MATER RES, V23, P705, DOI 10.1002/jbm.820230704
   Goldberg D. E., 1989, OPTIMIZATION MACHINE
   Kang M, 2010, BIOINF BIOM BIBM 201, P609
   Kenneth Ward W, 2008, J Diabetes Sci Technol, V2, P768
   KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671
   Levenberg K., 1944, Quarterly of Applied Mathematics, V2, P164
   MADSEN K, 2004, TECHNICAL REPORT
   MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030
   Nielsen HB, 1999, TECHNICAL REPORT
   Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530
   Pinter J, 2002, HDB GLOBAL OPTIMIZAT, V62
   Rolfe B., 2011, REGENERATIVE MED TIS
   Su Jianzhong, 2011, Open Access Bioinformatics, V2011, P19
   Su JZ, 2011, INT J COMPUT MATH, V88, P610, DOI 10.1080/00207161003640035
   Tang LP, 1999, MOL MED, V5, P351, DOI 10.1007/BF03402124
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Tang LP, 1998, J BIOMED MATER RES, V42, P156, DOI 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.3.CO;2-E
   Tang LP, 2002, J BIOMED MATER RES, V62, P471, DOI 10.1002/jbm.10271
   Thevenot PT, 2011, BIOMATERIALS, V32, P8394, DOI 10.1016/j.biomaterials.2011.07.084
   Xue J, 2008, BIOINFORMATICS BIOEN, P1
   Yamasaki S, 2005, CHEM IMMUNOL ALLERGY, V87, P22
   Yang JC, 2013, J IMMUNOL METHODS, V397, P37, DOI 10.1016/j.jim.2013.08.013
   Zdolsek J, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-31
NR 26
TC 3
Z9 3
U1 2
U2 12
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2105
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PD FEB 29
PY 2016
VL 17
AR 111
DI 10.1186/s12859-016-0947-3
PG 13
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA DE9ID
UT WOS:000370949300003
PM 26927968
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Maattanen, A
   Ihalainen, P
   Torngren, B
   Rosqvist, E
   Pesonen, M
   Peltonen, J
AF Maattanen, Anni
   Ihalainen, Petri
   Torngren, Bjorn
   Rosqvist, Emil
   Pesonen, Markus
   Peltonen, Jouko
TI Hierarchically structured self-supported latex films for flexible and
   semi-transparent electronics
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Transparent conducting electrodes; Thin film; 3D surface topography;
   Latex; Evaporated gold
ID CELL-CULTURE; PROTEIN ADSORPTION; GOLD-FILMS; ALIGNMENT; SURFACES;
   TITANIUM; PAPER; TOPOGRAPHY; SUBSTRATE; STIFFNESS
AB Different length scale alterations in topography, surface texture, and symmetry are known to evoke diverse cell behavior, including adhesion, orientation, motility, cytoskeletal condensation, and modulation of intracellular signaling pathways. In this work, self-supported latex films with well-defined isotropic/anisotropic surface features and hierarchical morphologies were fabricated by a peel-off process from different template surfaces. In addition, the latex films were used as substrates for evaporated ultrathin gold films with nominal thicknesses of 10 and 20 nm. Optical properties and topography of the samples were characterized using UV-vis spectroscopy and Atomic Force Microscopy (AFM) measurements, respectively. The latex films showed high-level transmittance of visible light, enabling the fabrication of semi-transparent gold electrodes. Electrochemical impedance spectroscopy (EIS) measurements were carried out for a number of days to investigate the long-term stability of the electrodes. The effect of 1-octadecanethiol (ODT) and HS(CH2)(11)OH (MuOH) thiolation and protein (human serum albumin, HSA) adsorption on the impedance and capacitance was studied. In addition, cyclic voltammetry ( CV) measurements were carried out to determine active medicinal components, i.e., caffeic acid with interesting biological activities and poorly water-soluble anti-inflammatory drug, piroxicam. The results show that the fabrication procedure presented in this study enables the formation of platforms with hierarchical morphologies for multimodal (optical and electrical) real-time monitoring of length-scale-dependent biomaterial-surface interactions. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Maattanen, Anni; Ihalainen, Petri; Torngren, Bjorn; Rosqvist, Emil; Peltonen, Jouko] Abo Akad Univ, Ctr Funct Mat, Fac Sci & Engn, Phys Chem Lab, Porthaninkatu 3, SF-20500 Turku, Finland.
   [Pesonen, Markus] Abo Akad Univ, Ctr Funct Mat, Fac Sci & Engn, Phys, Porthaninkatu 3, SF-20500 Turku, Finland.
RP Maattanen, A (reprint author), Abo Akad Univ, Ctr Funct Mat, Fac Sci & Engn, Phys Chem Lab, Porthaninkatu 3, SF-20500 Turku, Finland.
EM anni.maattanen@abo.fi; petri.ihalainen@abo.fi; bjorn.torngren@abo.fi;
   emil.rosqvist@abo.fi; markus.pesonen@abo.fi; jouko.peltonen@abo.fi
FU Abo Akademi University Endowment; Graduate School at Abo Akademi
   University
FX The author M. P. thankfully acknowledges the financial support from the
   Abo Akademi University Endowment. The author A. M. thankfully
   acknowledges the Graduate School at Abo Akademi University for the
   granted research scholarship.
CR Asadpour-Zeynali K, 2010, CENT EUR J CHEM, V8, P155, DOI 10.2478/s11532-009-0122-z
   Bao LR, 2002, J VAC SCI TECHNOL B, V20, P2881, DOI 10.1116/1.1526355
   Beier JP, 2010, HANDCHIR MIKROCHIR P, V42, P342, DOI 10.1055/s-0030-1252044
   Catheline A, 2015, J MATER RES, V30, P2009, DOI 10.1557/jmr.2015.166
   Choi CK, 2008, SENSORS-BASEL, V8, P3257, DOI 10.3390/s8053257
   Choi JS, 2014, BIOTECHNOL BIOPROC E, V19, P269, DOI 10.1007/s12257-013-0740-3
   Chung KK, 2007, BIOINTERPHASES, V2, P89, DOI 10.1116/1.2751405
   Deppe H, 2005, LASER MED SCI, V19, P229, DOI 10.1007/s10103-005-0327-0
   DeRosa ME, 2014, J APPL POLYM SCI, V131, DOI [10.1002/APP.40181, 10.1002/app.40181]
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Evans ND, 2009, EUR CELLS MATER, V18, P1
   Fernandez JG, 2008, J BIOMED MATER RES A, V85A, P242, DOI 10.1002/jbm.a.31561
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Galli C, 2001, SURF SCI, V474, pL180, DOI 10.1016/S0039-6028(00)01054-2
   Giacomelli C, 2002, J BRAZIL CHEM SOC, V13, P332, DOI 10.1590/S0103-50532002000300007
   Greiner AM, 2012, MACROMOL BIOSCI, V12, P1301, DOI 10.1002/mabi.201200132
   Grieshaber D, 2008, SENSORS-BASEL, V8, P1400, DOI 10.3390/s8031400
   Harms J, 2001, BIOSENS BIOELECTRON, V16, P169, DOI 10.1016/S0956-5663(00)00145-7
   Hassanin H, 2012, LAB CHIP, V12, P4160, DOI 10.1039/c2lc40512a
   Ihalainen P, 2015, APPL SURF SCI, V329, P321, DOI 10.1016/j.apsusc.2014.12.156
   Ihalainen P, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/9/094009
   Ihalainen P, 2013, BBA-GEN SUBJECTS, V1830, P4391, DOI 10.1016/j.bbagen.2012.09.007
   Ihalainen P, 2013, BIOSENSORS-BASEL, V3, P1, DOI 10.3390/bios3010001
   Juvonen H, 2015, COLLOID SURFACE B, V136, P527, DOI 10.1016/j.colsurfb.2015.09.061
   Juvonen H, 2014, COLLOID SURFACE B, V118, P261, DOI 10.1016/j.colsurfb.2014.03.050
   Juvonen H, 2013, ACTA BIOMATER, V9, P6704, DOI 10.1016/j.actbio.2013.01.033
   Kalyuzhny G, 2000, J PHYS CHEM B, V104, P8238, DOI 10.1021/jp0010785
   Le X, 2013, INT J BIOMATER, DOI 10.1155/2013/782549
   Leach R., 2013, CHARACTERISATION ARE
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Li JM, 2008, J BIOMED MATER RES A, V87A, P392, DOI 10.1002/jbm.a.31814
   Li YH, 2014, BIOTECHNOL ADV, V32, P347, DOI 10.1016/j.biotechadv.2013.11.007
   Liu RM, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-79
   Lukaski Henry C, 2012, J Diabetes Sci Technol, V6, P209
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maattanen A, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0032-0
   Morariu MD, 2003, NAT MATER, V2, P48, DOI 10.1038/nmat789
   NORRMAN S, 1978, PHYS REV B, V18, P674, DOI 10.1103/PhysRevB.18.674
   Ortiz R, 2014, MAT SCI ENG C-MATER, V37, P241, DOI 10.1016/j.msec.2013.12.039
   Pfleging W, 2007, APPL SURF SCI, V253, P9177, DOI 10.1016/j.apsusc.2007.05.047
   Sarfraz J., 2014, SENSOR ACTUAT B-CHEM, V173, P868
   Schrader J, 2011, HEPATOLOGY, V53, P1192, DOI 10.1002/hep.24108
   Strakosas X, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41735
   Sun JY, 2013, RSC ADV, V3, P14862, DOI 10.1039/c3ra41096j
   Vieira MJ, 2003, BIOFOULING, V19, P215, DOI 10.1080/08927010310000100800
   Wang XZ, 2010, IEEE J SEL TOP QUANT, V16, P1685, DOI 10.1109/JSTQE.2010.2049004
   Wanunu M, 2004, J AM CHEM SOC, V126, P5569, DOI 10.1021/ja0396448
   Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193
   Xie L, 2012, IEEE ENG MED BIO, P5026, DOI 10.1109/EMBC.2012.6347122
   Yoshinari M, 2002, METALL MATER TRANS A, V33, P511, DOI 10.1007/s11661-002-0113-6
   Zhang JF, 2011, OPT EXPRESS, V19, P23279, DOI 10.1364/OE.19.023279
NR 51
TC 1
Z9 1
U1 5
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD FEB 28
PY 2016
VL 364
BP 37
EP 44
DI 10.1016/j.apsusc.2015.12.088
PG 8
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA DD5IW
UT WOS:000369957800006
DA 2018-10-19
ER

PT J
AU Jenkins, SI
   Weinberg, D
   al-Shakli, AF
   Fernandes, AR
   Yiu, HHP
   Telling, ND
   Roach, P
   Chari, DM
AF Jenkins, Stuart I.
   Weinberg, Daniel
   al-Shakli, Arwa F.
   Fernandes, Alinda R.
   Yiu, Humphrey H. P.
   Telling, Neil D.
   Roach, Paul
   Chari, Divya M.
TI 'Stealth' nanoparticles evade neural immune cells but also evade major
   brain cell populations: Implications for PEG-based neurotherapeutics
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Astrocytes; Microglia; Oligodendrocyte precursor cells; Neural stem
   cells; Targeting; Corona
ID IRON-OXIDE NANOPARTICLES; CENTRAL-NERVOUS-SYSTEM; PEGYLATED
   POLYCYANOACRYLATE NANOPARTICLES; POLYETHYLENE-GLYCOL; DRUG-DELIVERY;
   PROTEIN CORONA; MAGNETIC NANOPARTICLES; CARBOXYMETHYL DEXTRAN;
   THERAPEUTIC AGENTS; GOLD NANOPARTICLES
AB Surface engineering to control cell behavior is of high interest across the chemical engineering, drug delivery and biomaterial communities. Defined chemical strategies are necessary to tailor nanoscale protein interactions/adsorption, enabling control of cell behaviors for development of novel therapeutic strategies. Nanoparticle-based therapies benefit from such strategies but particle targeting to sites of neurological injury remains challenging due to circulatory immune clearance. As a strategy to overcome this barrier, the use of stealth coatings can reduce immune clearance and prolong circulatory times, thereby enhancing therapeutic capacity. Polyethylene glycol (PEG) is the most widely-used stealth coating and facilitates particle accumulation in the brain. However, once within the brain, the mode of handling of PEGylated particles by the resident immune cells of the brain itself (the 'microglia') is unknown. This is a critical question as it is well established that microglia avidly sequester nanoparticles, limiting their bioavailability and posing a major translational barrier. If PEGylation can be proved to promote evasion of microglia, then this information will be of high value in developing tailored nanoparticle-based therapies for neurological applications. Here, we have conducted the first comparative study of uptake of PEGylated particles by all the major (immune and non-immune) brain cell types. We prove for the first time that PEGylated nanoparticles evade major brain cell populations - a phenomenon which will enhance extracellular bioavailability. We demonstrate changes in protein coronas around these particles within biological media, and discuss how surface chemistry presentation may affect this process and subsequent cellular interactions. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Jenkins, Stuart I.; Weinberg, Daniel; al-Shakli, Arwa F.; Fernandes, Alinda R.; Telling, Neil D.; Roach, Paul; Chari, Divya M.] Keele Univ, Inst Sci & Technol Med, Keele ST5 5BG, Staffs, England.
   [Yiu, Humphrey H. P.] Heriot Watt Univ, Chem Engn, Sch Engn & Phys Sci, Edinburgh EH14 4AS, Midlothian, Scotland.
RP Chari, DM (reprint author), Keele Univ, Inst Sci & Technol Med, Sch Med, David Weatherall Bldg, Keele ST5 5BG, Staffs, England.
EM s.i.jenkins@keele.ac.uk; weinberg@hotmail.co.uk;
   a.f.j.al-shakli@keele.ac.uk; a.fernandes@keele.ac.uk; H.H.Yiu@hw.ac.uk;
   n.d.telling@keele.ac.uk; p.roach@keele.ac.uk; d.chari@keele.ac.uk
OI Jenkins, Stuart/0000-0002-9857-957X
FU Engineering and Physical Sciences Research Council (EPSRC; UK)
   Engineering Tissue Engineering and Regenerative Medicine (E-TERM)
   Landscape Fellowship [EP/I017801/1]; Biotechnology and Biological
   Sciences Research Council [BB/J017590/1, BB/F013884/1]; Engineering and
   Physical Sciences Research Council [EP/I017801/1, 1119377]
FX We thank R Fricker and M Gates for access to z stack microscopy
   facilities (Keele University). SJ is funded by an Engineering and
   Physical Sciences Research Council (EPSRC; UK) Engineering Tissue
   Engineering and Regenerative Medicine (E-TERM) Landscape Fellowship
   (EP/I017801/1).
CR ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3578
   Adams CF, 2013, NANOMED-NANOTECHNOL, V9, P737, DOI 10.1016/j.nano.2013.05.014
   Arora Wahajuddin S., 2012, INT J NANOMED, V7, P3445, DOI DOI 10.2147/IJN.S30320
   Begley DJ, 2004, PHARMACOL THERAPEUT, V104, P29, DOI 10.1016/j.pharmthera.2004.08.001
   Brandenberger C, 2010, SMALL, V6, P1669, DOI 10.1002/smll.201000528
   Brigger I, 2002, J PHARMACOL EXP THER, V303, P928, DOI 10.1124/jpet.102.039669
   Calvo P, 2001, PHARMACEUT RES, V18, P1157, DOI 10.1023/A:1010931127745
   Calvo P, 2002, EUR J NEUROSCI, V15, P1317, DOI 10.1046/j.1460-9568.2002.01967.x
   Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104
   Cheng Y, 2014, ADV DRUG DELIVER REV, V66, P42, DOI 10.1016/j.addr.2013.09.006
   Cole AJ, 2011, BIOMATERIALS, V32, P6291, DOI 10.1016/j.biomaterials.2011.05.024
   De Bock M, 2014, FEBS LETT, V588, P1259, DOI 10.1016/j.febslet.2014.02.060
   Dobrovolskaia MA, 2008, MOL PHARMACEUT, V5, P487, DOI 10.1021/mp800032f
   Dobrovolskaia MA, 2014, NANOMED-NANOTECHNOL, V10, P1453, DOI 10.1016/j.nano.2014.01.009
   Fernandes AR, 2014, INTEGR BIOL-UK, V6, P855, DOI 10.1039/c4ib00085d
   Fleige G, 2001, NEOPLASIA, V3, P489, DOI 10.1038/sj.neo.7900176
   Gao XH, 2013, PHARM RES-DORDR, V30, P2538, DOI 10.1007/s11095-013-1004-9
   Garcia KP, 2014, SMALL, V10, P2516, DOI 10.1002/smll.201303540
   Gref R, 2000, COLLOID SURFACE B, V18, P301, DOI 10.1016/S0927-7765(99)00156-3
   Guo HY, 2015, CARBOHYD POLYM, V118, P209, DOI 10.1016/j.carbpol.2014.10.076
   Hirsch V, 2013, NANOSCALE, V5, P3723, DOI 10.1039/c2nr33134a
   Hong RL, 1999, CLIN CANCER RES, V5, P3645
   Jain TK, 2008, BIOMATERIALS, V29, P4012, DOI 10.1016/j.biomaterials.2008.07.004
   Jarjour AA, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002107
   Jenkins S.I., 2014, NANOMED-NANOTECHNOL, V11, P77
   Jenkins Stuart I, 2014, Mol Cell Ther, V2, P23, DOI 10.1186/2052-8426-2-23
   Jenkins SI, 2013, NANOMEDICINE-UK, V8, P951, DOI [10.2217/NNM.12.145, 10.2217/nnm.12.145]
   Jenkins SI, 2011, ACS NANO, V5, P6527, DOI 10.1021/nn2018717
   Kang JS, 2009, EXPERT OPIN EMERG DR, V14, P363, DOI 10.1517/14728210902907847
   Kim HR, 2007, BIOMACROMOLECULES, V8, P793, DOI 10.1021/bm060711a
   Koyama T, 2012, J CONTROL RELEASE, V159, P413, DOI 10.1016/j.jconrel.2012.01.023
   Krol S, 2012, J CONTROL RELEASE, V164, P145, DOI 10.1016/j.jconrel.2012.04.044
   Lee S, 2006, DIABETOLOGIA, V49, P1608, DOI 10.1007/s00125-006-0234-3
   Lehner R, 2013, NANOMED-NANOTECHNOL, V9, P742, DOI 10.1016/j.nano.2013.01.012
   Barran-Berdon AL, 2013, LANGMUIR, V29, P6485, DOI 10.1021/la401192x
   Lu CC, 2012, J MATER CHEM, V22, P19806, DOI 10.1039/c2jm34327d
   Lundqvist M, 2011, ACS NANO, V5, P7503, DOI 10.1021/nn202458g
   Lynch I, 2007, ADV COLLOID INTERFAC, V134-35, P167, DOI 10.1016/j.cis.2007.04.021
   Maeda H, 2003, INT IMMUNOPHARMACOL, V3, P319, DOI 10.1016/S1567-5769(02)00271-0
   Mahon E, 2012, J CONTROL RELEASE, V161, P164, DOI 10.1016/j.jconrel.2012.04.009
   Maldiney T, 2011, ACS NANO, V5, P854, DOI 10.1021/nn101937h
   MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890
   Mehvar R, 2000, J CONTROL RELEASE, V69, P1, DOI 10.1016/S0168-3659(00)00302-3
   Misra A, 2003, J PHARM PHARM SCI, V6, P252
   Nance E.A., 2013, SCI TRANSL MED, V4
   Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240
   Nielsen PA, 2011, DRUG DISCOV TODAY, V16, P472, DOI 10.1016/j.drudis.2011.04.004
   Ning SH, 2011, SOFT MATTER, V7, P9394, DOI 10.1039/c1sm05814b
   Pickard MR, 2011, TISSUE ENG PART C-ME, V17, P89, DOI [10.1089/ten.tec.2010.0170, 10.1089/ten.TEC.2010.0170]
   Pickard MR, 2010, INT J MOL SCI, V11, P967, DOI 10.3390/ijms11030967
   Pires LR, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1224
   Pozzi D, 2014, NANOSCALE, V6, P2782, DOI 10.1039/c3nr05559k
   Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722
   Rittchen S, 2015, BIOMATERIALS, V56, P78, DOI 10.1016/j.biomaterials.2015.03.044
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Rogers M.-L., 2014, FRONT MOL NEUROSCI, V7, P1
   Safi M, 2011, BIOMATERIALS, V32, P9353, DOI 10.1016/j.biomaterials.2011.08.048
   Santi DV, 2012, P NATL ACAD SCI USA, V109, P6211, DOI 10.1073/pnas.1117147109
   Schroeder U, 1998, PEPTIDES, V19, P777, DOI 10.1016/S0196-9781(97)00474-9
   Serrano-Perez MC, 2015, GLIA, V63, P987, DOI 10.1002/glia.22797
   Sosnovik DE, 2012, CIRC-CARDIOVASC IMAG, V5, P551, DOI 10.1161/CIRCIMAGING.112.978932
   Struckhoff AP, 2013, METHODS MOL BIOL, V1078, P119, DOI 10.1007/978-1-62703-640-5_10
   Sun ZZ, 2013, INT J NANOMED, V8, P961, DOI 10.2147/IJN.S39048
   Vllasaliu D, 2014, EXPERT OPIN DRUG DEL, V11, P139, DOI 10.1517/17425247.2014.866651
   Wachs FP, 2003, LAB INVEST, V83, P949, DOI 10.1097/01.LAB.0000075556.74231.A5
   Walczyk D, 2010, J AM CHEM SOC, V132, P5761, DOI 10.1021/ja910675v
   Walkey CD, 2012, CHEM SOC REV, V41, P2780, DOI 10.1039/c1cs15233e
   Wiley DT, 2013, P NATL ACAD SCI USA, V110, P8662, DOI 10.1073/pnas.1307152110
   Wohlfart S, 2012, J CONTROL RELEASE, V161, P264, DOI 10.1016/j.jconrel.2011.08.017
   Yiu HHP, 2012, PHARM RES-DORDR, V29, P1328, DOI 10.1007/s11095-011-0632-1
   Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400
NR 71
TC 11
Z9 11
U1 2
U2 59
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD FEB 28
PY 2016
VL 224
BP 136
EP 145
DI 10.1016/j.jconrel.2016.01.013
PG 10
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA DD1NT
UT WOS:000369689100013
PM 26780172
DA 2018-10-19
ER

PT J
AU Staufer, O
   Weber, S
   Bengtson, CP
   Bading, H
   Spatz, JP
   Rustom, A
AF Staufer, Oskar
   Weber, Sebastian
   Bengtson, C. Peter
   Bading, Hilmar
   Spatz, Joachim P.
   Rustom, Amin
TI Functional fusion of living systems with synthetic electrode interfaces
SO BEILSTEIN JOURNAL OF NANOTECHNOLOGY
LA English
DT Article
DE biointerface; biosensor; energy harvesting; nanoelectrodes; Physarum
   polycephalum
ID NANOWIRE CELL PENETRATION; PHYSARUM-POLYCEPHALUM; MICROPLASMODIA;
   MEMBRANE
AB The functional fusion of "living" biomaterial (such as cells) with synthetic systems has developed into a principal ambition for various scientific disciplines. In particular, emerging fields such as bionics and nanomedicine integrate advanced nanomaterials with biomolecules, cells and organisms in order to develop novel strategies for applications, including energy production or real-time diagnostics utilizing biomolecular machineries "perfected" during billion years of evolution. To date, hardware-wetware interfaces that sample or modulate bioelectric potentials, such as neuroprostheses or implantable energy harvesters, are mostly based on microelectrodes brought into the closest possible contact with the targeted cells. Recently, the possibility of using electrochemical gradients of the inner ear for technical applications was demonstrated using implanted electrodes, where 1.12 nW of electrical power was harvested from the guinea pig endocochlear potential for up to 5 h (Mercier, P.; Lysaght, A.; Bandyopadhyay, S.; Chandrakasan, A.; Stankovic, K. Nat. Biotech. 2012, 30, 1240-1243). More recent approaches employ nanowires (NWs) able to penetrate the cellular membrane and to record extra-and intracellular electrical signals, in some cases with subcellular resolution (Spira, M.; Hai, A. Nat. Nano. 2013, 8, 83-94). Such techniques include nanoelectric scaffolds containing free-standing silicon NWs (Robinson, J. T.; Jorgolli, M.; Shalek, A. K.; Yoon, M. H.; Gertner, R. S.; Park, H. Nat Nanotechnol. 2012, 10, 180-184) or NW field-effect transistors (Qing, Q.; Jiang, Z.; Xu, L.; Gao, R.; Mai, L.; Lieber, C. Nat. Nano. 2013, 9, 142-147), vertically aligned gallium phosphide NWs (Hallstrom, W.; Martensson, T.; Prinz, C.; Gustavsson, P.; Montelius, L.; Samuelson, L.; Kanje, M. Nano Lett. 2007, 7, 2960-2965) or individually contacted, electrically active carbon nanofibers. The latter of these approaches is capable of recording electrical responses from oxidative events occurring in intercellular regions of neuronal cultures (Zhang, D.; Rand, E.; Marsh, M.; Andrews, R.; Lee, K.; Meyyappan, M.; Koehne, J. Mol. Neurobiol. 2013, 48, 380-385). Employing monocrystalline gold, nanoelectrode interfaces, we have now achieved stable, functional access to the electrochemical machinery of individual Physarum polycephalum slime mold cells. We demonstrate the "symbionic" union, allowing for electrophysiological measurements, functioning as autonomous sensors and capable of producing nanowatts of electric power. This represents a further step towards the future development of groundbreaking, cell-based technologies, such as bionic sensory systems or miniaturized energy sources to power various devices, or even "intelligent implants", constantly refueled by their surrounding nutrients.
C1 [Staufer, Oskar; Weber, Sebastian; Spatz, Joachim P.; Rustom, Amin] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Heisenbergstr 3, D-70569 Stuttgart, Germany.
   [Staufer, Oskar] German Canc Res Ctr, DKFZ Life Sci Lab, Neuenheimer Feld 581, D-69120 Heidelberg, Germany.
   [Staufer, Oskar] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Bachelor Program Mol Biotechnol, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.
   [Bengtson, C. Peter; Bading, Hilmar] Heidelberg Univ, Interdisciplinary Ctr Neurosci IZN, Dept Neurobiol, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.
   [Spatz, Joachim P.; Rustom, Amin] Heidelberg Univ, Dept Biophys Chem, Neuenheimer Feld 253, D-69120 Heidelberg, Germany.
RP Rustom, A (reprint author), Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, Heisenbergstr 3, D-70569 Stuttgart, Germany.; Rustom, A (reprint author), Heidelberg Univ, Dept Biophys Chem, Neuenheimer Feld 253, D-69120 Heidelberg, Germany.
EM amin.rustom@urz.uni-heidelberg.de
RI Spatz, Joachim/A-1107-2017
OI Spatz, Joachim/0000-0003-3419-9807; Bengtson, C
   Peter/0000-0002-8245-3323
FU Max-Planck Society; Baden-Wurttemberg Stiftung ("Funktionelle
   Nanostrukturen IV")
FX We would like to thank It4ip Belgium for providing us with track-etched
   PC filter membranes with custom parameters, Sigrid Riese for cell
   culture and experimental support, Andrea Hellwig for support with SEM
   and TEM measurements, and Gunther Meinusch for help with electronics.
   This study was supported by the Max-Planck Society and the
   Baden-Wurttemberg Stiftung ("Funktionelle Nanostrukturen IV").
CR BAR-ZEEV MICHA, 1960, ENT EXPTL ET APPL, V3, P251
   Fendyur Anna, 2012, Front Neuroeng, V5, P21, DOI 10.3389/fneng.2012.00021
   FINGERLE J, 1982, J MEMBRANE BIOL, V68, P67, DOI 10.1007/BF01872255
   KURODA H, 1989, BIOCHIM BIOPHYS ACTA, V987, P154, DOI 10.1016/0005-2736(89)90538-5
   Latty T, 2015, J EXP BIOL, V218, P1175, DOI 10.1242/jeb.116533
   MEYER R, 1979, CELL BIOL INT REP, V3, P321, DOI 10.1016/S0309-1651(79)80002-8
   Nakagaki T, 2000, NATURE, V407, P470, DOI 10.1038/35035159
   Saigusa T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018101
   Schneckenburger M, 2012, SMALL, V8, P3396, DOI 10.1002/smll.201200963
   Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4
   Spira ME, 2013, NAT NANOTECHNOL, V8, P83, DOI [10.1038/NNANO.2012.265, 10.1038/nnano.2012.265]
   Tero A, 2010, SCIENCE, V327, P439, DOI 10.1126/science.1177894
   Tichy H, 2010, J NEUROPHYSIOL, V103, P3274, DOI 10.1152/jn.01043.2009
   UEDA T, 1975, J GEN PHYSIOL, V65, P223, DOI 10.1085/jgp.65.2.223
   Xie X, 2015, ACS NANO, V9, P11667, DOI 10.1021/acsnano.5b05498
   Xie X, 2013, NANO LETT, V13, P6002, DOI 10.1021/nl403201a
   Xu AM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4613
NR 17
TC 1
Z9 1
U1 3
U2 34
PU BEILSTEIN-INSTITUT
PI FRANKFURT AM MAIN
PA TRAKEHNER STRASSE 7-9, FRANKFURT AM MAIN, 60487, GERMANY
SN 2190-4286
J9 BEILSTEIN J NANOTECH
JI Beilstein J. Nanotechnol.
PD FEB 26
PY 2016
VL 7
BP 296
EP 301
DI 10.3762/bjnano.7.27
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA DF3AZ
UT WOS:000371217400001
PM 26977386
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Sato, YT
   Umezaki, K
   Sawada, S
   Mukai, S
   Sasaki, Y
   Harada, N
   Shiku, H
   Akiyoshi, K
AF Sato, Yuko T.
   Umezaki, Kaori
   Sawada, Shinichi
   Mukai, Sada-atsu
   Sasaki, Yoshihiro
   Harada, Naozumi
   Shiku, Hiroshi
   Akiyoshi, Kazunari
TI Engineering hybrid exosomes by membrane fusion with liposomes
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DRUG-DELIVERY SYSTEMS; ENERGY-TRANSFER; EXTRACELLULAR VESICLES;
   UNILAMELLAR VESICLES; IN-VITRO; CELLS; SIRNA; CRYOPRESERVATION;
   EFFICIENCY; INJECTION
AB Exosomes are a valuable biomaterial for the development of novel nanocarriers as functionally advanced drug delivery systems. To control and modify the performance of exosomal nanocarriers, we developed hybrid exosomes by fusing their membranes with liposomes using the freeze- thaw method. Exosomes embedded with a specific membrane protein isolated from genetically modified cells were fused with various liposomes, confirming that membrane engineering methods can be combined with genetic modification techniques. Cellular uptake studies performed using the hybrid exosomes revealed that the interactions between the developed exosomes and cells could be modified by changing the lipid composition or the properties of the exogenous lipids. These results suggest that the membraneengineering approach reported here offers a new strategy for developing rationally designed exosomes as hybrid nanocarriers for use in advanced drug delivery systems.
C1 [Sato, Yuko T.; Umezaki, Kaori; Sawada, Shinichi; Mukai, Sada-atsu; Akiyoshi, Kazunari] Kyoto Univ Katsura, JST ERATO, Akiyoshi Bionanotransporter Project, Nishikyo Ku, Kyoto 6158510, Japan.
   [Sawada, Shinichi; Mukai, Sada-atsu; Sasaki, Yoshihiro; Akiyoshi, Kazunari] Kyoto Univ Katsura, Dept Polymer Chem, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan.
   [Harada, Naozumi; Shiku, Hiroshi] Mie Univ, Dept Immunogene Therapy, Grad Sch Med, Tsu, Mie 5148507, Japan.
RP Akiyoshi, K (reprint author), Kyoto Univ Katsura, JST ERATO, Akiyoshi Bionanotransporter Project, Nishikyo Ku, Kyoto 6158510, Japan.; Akiyoshi, K (reprint author), Kyoto Univ Katsura, Dept Polymer Chem, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan.
EM akiyoshi@bio.polym.kyoto-u.ac.jp
FU Exploratory Research for Advanced Technology division of the Japan
   Science and Technology Agency (JSTERATO)
FX We wish to thank S. Ikeda of Kyoto University for preparing the
   exosomes. This work was supported by the Exploratory Research for
   Advanced Technology division of the Japan Science and Technology Agency
   (JSTERATO).
CR ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3578
   Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037
   Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807
   Banizs AB, 2014, INT J NANOMED, V9, P4223, DOI 10.2147/IJN.S64267
   BLUME G, 1990, BIOCHIM BIOPHYS ACTA, V1029, P91, DOI 10.1016/0005-2736(90)90440-Y
   Cooper JM, 2014, MOVEMENT DISORD, V29, P1476, DOI 10.1002/mds.25978
   Costa AP, 2014, PHARM RES-DORDR, V31, P97, DOI 10.1007/s11095-013-1135-z
   Duzgunes N, 2003, METHOD ENZYMOL, V372, P260
   Jia SD, 2014, EXPERT REV MOL DIAGN, V14, P307, DOI 10.1586/14737159.2014.893828
   Johnsen KB, 2014, BBA-REV CANCER, V1846, P75, DOI 10.1016/j.bbcan.2014.04.005
   Kanada M., 2015, P NATL ACAD SCI USA, pE1433
   Kooijmans SAA, 2013, J CONTROL RELEASE, V172, P229, DOI 10.1016/j.jconrel.2013.08.014
   Lee JK, 1997, BIOCHEMISTRY-US, V36, P421, DOI 10.1021/bi9622332
   Lee J, 2015, NANO LETT, V15, P2938, DOI 10.1021/nl5047494
   MACDONALD RC, 1994, BBA-BIOMEMBRANES, V1191, P362, DOI 10.1016/0005-2736(94)90187-2
   MACDONALD RI, 1987, J BIOL CHEM, V262, P10392
   MACDONALD RI, 1983, BIOCHIM BIOPHYS ACTA, V735, P243, DOI 10.1016/0005-2736(83)90299-7
   Matsuoka T, 2015, WORLD J CLIN CASES, V3, P42, DOI 10.12998/wjcc.v3.i1.42
   MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0
   Mineo M, 2012, ANGIOGENESIS, V15, P33, DOI 10.1007/s10456-011-9241-1
   Montecalvo A., 2011, BLOOD, V119, P756
   Moritani Y, 2010, FEBS J, V277, P3343, DOI 10.1111/j.1742-4658.2010.07736.x
   Mukai K, 2002, GENE THER, V9, P879, DOI 10.1038/sj.gt.3301707
   Mulcahy L. A., 2014, J EXTRACELL VESICLES, V3, P1, DOI DOI 10.3402/JEV.V3.24641
   Nagata Y, 1997, J IMMUNOL, V159, P1336
   Ohno S-I, 2012, MOL THER, DOI [10.1038/mt.2012.180, DOI 10.1038/MT.2012.180]
   OKU N, 1983, BIOCHEMISTRY-US, V22, P855, DOI 10.1021/bi00273a023
   Parolini I, 2009, J BIOL CHEM, V284, P34211, DOI 10.1074/jbc.M109.041152
   PICK U, 1981, ARCH BIOCHEM BIOPHYS, V212, P186, DOI 10.1016/0003-9861(81)90358-1
   Properzi F, 2013, BIOMARK MED, V7, P769, DOI 10.2217/bmm.13.63
   RUDOLPH AS, 1985, CRYOBIOLOGY, V22, P367, DOI 10.1016/0011-2240(85)90184-1
   Shtam TA, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-88
   Siow LF, 2007, CRYOBIOLOGY, V55, P210, DOI 10.1016/j.cryobiol.2007.08.002
   STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023
   Takahashi Y, 2013, J BIOTECHNOL, V165, P77, DOI 10.1016/j.jbiotec.2013.03.013
   TALSMA H, 1991, INT J PHARM, V77, P119, DOI 10.1016/0378-5173(91)90309-C
   Tian T, 2014, J BIOL CHEM, V289, P22258, DOI 10.1074/jbc.M114.588046
   Tian T, 2013, J CELL PHYSIOL, V228, P1487, DOI 10.1002/jcp.24304
   Tian YH, 2014, BIOMATERIALS, V35, P2383, DOI 10.1016/j.biomaterials.2013.11.083
   Trier S, 2011, SOFT MATTER, V7, P9027, DOI 10.1039/c1sm05818e
   Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596
   van der Meel R, 2014, J CONTROL RELEASE, V195, P72, DOI 10.1016/j.jconrel.2014.07.049
   Wahlgren J, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks463
NR 43
TC 39
Z9 41
U1 4
U2 50
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 25
PY 2016
VL 6
AR 21933
DI 10.1038/srep21933
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DE7DA
UT WOS:000370793200001
PM 26911358
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Ricapito, NG
   Ghobril, C
   Zhang, H
   Grinstaff, MW
   Putnam, D
AF Ricapito, Nicole G.
   Ghobril, Cynthia
   Zhang, Heng
   Grinstaff, Mark W.
   Putnam, David
TI Synthetic Biomaterials from Metabolically Derived Synthons
SO CHEMICAL REVIEWS
LA English
DT Review
ID RING-OPENING POLYMERIZATION; KETAL-PROTECTED DIHYDROXYACETONE;
   CONTROLLED DRUG-DELIVERY; NUCLEIC-ACID DELIVERY; CELL LUNG-CANCER;
   CARBOHYDRATE-CONTAINING POLYCATIONS; TISSUE ENGINEERING APPLICATIONS;
   5-MEMBERED CYCLIC CARBONATE; POLY-AMIDO-SACCHARIDES; ONE-STEP SYNTHESIS
AB The utility of metabolic synthons as the building blocks for new biomaterials is based on the early application and success of hydroxy acid based polyesters as degradable sutures and controlled drug delivery matrices. The sheer number of potential monomers derived from the metabolome (e.g., lactic acid, dihydroxyacetone, glycerol, fumarate) gives rise to almost limitless biomaterial structural possibilities, functionality, and performance characteristics, as well as opportunities for the synthesis of new polymers. This review describes recent advances in new chemistries, as well as the inventive use of traditional chemistries, toward the design and synthesis of new polymers. Specific polymeric biomaterials can be prepared for use in varied medical applications (e.g., drug delivery, tissue engineering, wound repair, etc.) through judicious selection of the monomer and backbone linkage.
C1 [Ricapito, Nicole G.; Putnam, David] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.
   [Ghobril, Cynthia; Zhang, Heng; Grinstaff, Mark W.] Boston Univ, Dept Chem, 590 Commonwealth Ave, Boston, MA 02215 USA.
   [Grinstaff, Mark W.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
   [Grinstaff, Mark W.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.
   [Putnam, David] Cornell Univ, Meinig Sch Biomed Engn, Ithaca, NY 14853 USA.
RP Putnam, D (reprint author), Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.; Grinstaff, MW (reprint author), Boston Univ, Dept Chem, 590 Commonwealth Ave, Boston, MA 02215 USA.; Grinstaff, MW (reprint author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.; Grinstaff, MW (reprint author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.; Putnam, D (reprint author), Cornell Univ, Meinig Sch Biomed Engn, Ithaca, NY 14853 USA.
EM mgrin@bu.edu; dap43@cornell.edu
RI Zhang, Heng/L-9010-2015
FU Cornell Center for Materials Research; Cornell Center for Advanced
   Technology, Boston University; Coulter Foundation; Pew Foundation;
   National Science Foundation; National Institutes of Health
FX The authors would like to thank the Cornell Center for Materials
   Research, the Cornell Center for Advanced Technology, Boston University,
   the Coulter Foundation, the Pew Foundation, the National Science
   Foundation, and National Institutes of Health (R01, R21, R56, and T32
   mechanisms) for support of our research and educational programs.
CR Abele S, 1998, HELV CHIM ACTA, V81, P2141, DOI 10.1002/(SICI)1522-2675(19981216)81:12<2141::AID-HLCA2141>3.0.CO;2-5
   AJIOKA M, 1995, J ENVIRON POLYM DEGR, V3, P225, DOI 10.1007/BF02068677
   AKAR A, 1989, MAKROMOL CHEM-RAPID, V10, P127
   ALDER RW, 1994, POLYMER, V35, P5765, DOI 10.1016/S0032-3861(05)80054-0
   ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   Appelhans D, 2015, CHEM SOC REV, V44, P3968, DOI 10.1039/c4cs00339j
   Arima Y, 2007, J MATER CHEM, V17, P4079, DOI 10.1039/b708099a
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Avseenko NV, 2001, ANAL CHEM, V73, P6047, DOI 10.1021/ac010460q
   Azechi M, 2013, J POLYM SCI POL CHEM, V51, P1651, DOI 10.1002/pola.26538
   Bajpai AK, 2008, PROG POLYM SCI, V33, P1088, DOI 10.1016/j.progpolymsci.2008.07.005
   Baker MI, 2012, J BIOMED MATER RES B, V100B, P1451, DOI 10.1002/jbm.b.32694
   Bao HM, 2012, MICROCHIM ACTA, V179, P291, DOI 10.1007/s00604-012-0896-0
   Billiet T, 2012, BIOMATERIALS, V33, P6020, DOI 10.1016/j.biomaterials.2012.04.050
   Bonvalot S, 2009, J CLIN ONCOL, V27, P31, DOI 10.1200/JCO.2008.18.0802
   Bouten PJM, 2014, PROG POLYM SCI, V39, P1375, DOI 10.1016/j.progpolymsci.2014.02.001
   Brandl F, 2007, BIOMATERIALS, V28, P134, DOI 10.1016/j.biomaterials.2006.09.017
   Bugnicourt E, 2014, EXPRESS POLYM LETT, V8, P791, DOI 10.3144/expresspolymlett.2014.82
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Calderon M, 2010, ADV MATER, V22, P190, DOI 10.1002/adma.200902144
   Carnahan MA, 2006, MACROMOLECULES, V39, P609, DOI 10.1021/ma0518407
   Carnahan MA, 2002, J AM CHEM SOC, V124, P5291, DOI 10.1021/ja025576y
   Carnahan MA, 2001, MACROMOLECULES, V34, P7648, DOI 10.1021/ma010848n
   Carnahan MA, 2001, J AM CHEM SOC, V123, P2905, DOI 10.1021/ja005726+
   Carnali JO, 2012, IND ENG CHEM RES, V51, P15573, DOI 10.1021/ie301929w
   CESAROTTI E, 1993, HELV CHIM ACTA, V76, P2344, DOI 10.1002/hlca.19930760620
   Chang CY, 2011, CARBOHYD POLYM, V84, P40, DOI 10.1016/j.carbpol.2010.12.023
   Chen LG, 2005, POLYMER, V46, P6274, DOI 10.1016/j.polymer.2005.05.041
   Cheng JJ, 2001, MACROMOLECULES, V34, P5169, DOI 10.1021/ma010386d
   Cheng YY, 2011, CHEM SOC REV, V40, P2673, DOI 10.1039/c0cs00097c
   Choi JS, 2000, J AM CHEM SOC, V122, P474, DOI 10.1021/ja9931473
   Choi JS, 1999, BIOCONJUGATE CHEM, V10, P62, DOI 10.1021/bc9800668
   Cohen CT, 2005, J AM CHEM SOC, V127, P10869, DOI 10.1021/ja051744l
   Cui W, 2012, CHEM-ASIAN J, V7, P127, DOI 10.1002/asia.201100425
   Dandu R, 2009, POLYMER, V50, P366, DOI 10.1016/j.polymer.2008.11.047
   Dane EL, 2014, CHEM SCI, V5, P551, DOI [10.1039/c3sc52777h, 10.1039/C3SC52777H]
   Dane EL, 2013, ACS MACRO LETT, V2, P887, DOI 10.1021/mz400394r
   Dane EL, 2012, J AM CHEM SOC, V134, P16255, DOI 10.1021/ja305900r
   Darensbourg DJ, 2007, CHEM REV, V107, P2388, DOI 10.1021/cr068363q
   Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064
   DAVIS L, 1973, BIOORG CHEM, V2, P197, DOI 10.1016/0045-2068(73)90023-0
   Degoricija L, 2007, INVEST OPHTH VIS SCI, V48, P2037, DOI 10.1167/iovs.06-0957
   Deming TJ, 2007, PROG POLYM SCI, V32, P858, DOI 10.1016/j.progpolymsci.2007.05.010
   Deming TJ, 2016, CHEM REV, V116, P786, DOI 10.1021/acs.chemrev.5b00292
   Deming TJ, 2013, ADV POLYM SCI, V262, P1, DOI 10.1007/12_2013_234
   Deming TJ, 1997, J AM CHEM SOC, V119, P2759, DOI 10.1021/ja962625w
   Deming TJ, 1999, MACROMOLECULES, V32, P4500, DOI 10.1021/ma9902899
   Denkewalter R. G., 1981, US Patent No, Patent No. [4(289):872, 4289872, 4, 289, 872]
   Denyer SP, 1995, INT BIODETER BIODEGR, V36, P227, DOI 10.1016/0964-8305(96)00015-7
   Do JY, 2005, POLYM ADVAN TECHNOL, V16, P221, DOI 10.1002/pat.554
   Do JY, 2005, MACROMOL CHEM PHYSIC, V206, P1326, DOI 10.1002/macp.200400547
   Dorgan JR, 2001, MACROMOL SYMP, V175, P55, DOI 10.1002/1521-3900(200110)175:1<55::AID-MASY55>3.0.CO;2-K
   Duan L, 2007, BIOCHEM BIOPH RES CO, V354, P357, DOI 10.1016/j.bbrc.2006.12.223
   Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b
   Edwards DA, 1997, SCIENCE, V276, P1868, DOI 10.1126/science.276.5320.1868
   Erdmann L, 2000, BIOMATERIALS, V21, P1941, DOI 10.1016/S0142-9612(00)00073-9
   Erni B, 2006, CELL MOL LIFE SCI, V63, P890, DOI 10.1007/s00018-005-5518-0
   Ernst B, 2009, NAT REV DRUG DISCOV, V8, P661, DOI 10.1038/nrd2852
   ERTEL SI, 1994, J BIOMED MATER RES, V28, P919, DOI 10.1002/jbm.820280811
   Esfand R, 2001, DRUG DISCOV TODAY, V6, P427, DOI 10.1016/S1359-6446(01)01757-3
   Fang X, 2015, CHEM COMMUN, V51, P1185, DOI 10.1039/c4cc07909d
   Feng J, 2012, PROG POLYM SCI, V37, P211, DOI 10.1016/j.progpolymsci.2011.07.008
   Ferroni EL, 1999, J ORG CHEM, V64, P4943, DOI 10.1021/jo9823902
   Fesq H, 2001, DERMATOLOGY, V203, P241, DOI 10.1159/000051757
   FLORY PJ, 1952, J AM CHEM SOC, V74, P2718, DOI 10.1021/ja01131a008
   FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43
   Frechet JMJ, 1995, REACT FUNCT POLYM, V26, P127, DOI 10.1016/1381-5148(95)00010-D
   Fu JM, 2004, J AM ACAD DERMATOL, V50, P706, DOI 10.1016/j.jaad.2003.12.006
   Gao C, 2004, PROG POLYM SCI, V29, P183, DOI 10.1016/j.progpolymsci.2003.12.002
   GARSON LR, 1969, CAN J CHEMISTRY, V47, P1249, DOI 10.1139/v69-205
   Geschwind J, 2013, MACROMOLECULES, V46, P3280, DOI 10.1021/ma400090m
   Ghobril C, 2015, CHEM SOC REV, V44, P1820, DOI 10.1039/c4cs00332b
   Ghobril C, 2014, ACS MACRO LETT, V3, P359, DOI 10.1021/mz5000703
   Ghobril C, 2013, ANGEW CHEM INT EDIT, V52, P14070, DOI 10.1002/anie.201308007
   Girelli AM, 2007, SENSOR ACTUAT B-CHEM, V121, P515, DOI 10.1016/j.snb.2006.04.076
   Godula K, 2009, ANGEW CHEM INT EDIT, V48, P4973, DOI 10.1002/anie.200805756
   GOLDMAN L, 1960, J INVEST DERMATOL, V35, P161, DOI 10.1038/jid.1960.100
   GOLDSTEIN SA, 1987, J BIOMECH, V20, P1055, DOI 10.1016/0021-9290(87)90023-6
   Gollwitzer H, 2005, J ORTHOP RES, V23, P802, DOI 10.1016/j.orthres.2005.02.003
   Grayson SM, 2001, CHEM REV, V101, P3819, DOI 10.1021/cr990116h
   GRAZI E, 1962, BIOCHEM BIOPH RES CO, V9, P38, DOI 10.1016/0006-291X(62)90083-9
   Greenberg James A, 2009, Rev Obstet Gynecol, V2, P146
   Grinstaff MW, 2008, J POLYM SCI POL CHEM, V46, P383, DOI 10.1002/pola.22525
   Grinstaff MW, 2007, BIOMATERIALS, V28, P5205, DOI 10.1016/j.biomaterials.2007.08.041
   Grinstaff MW, 2002, CHEM-EUR J, V8, P2838, DOI 10.1002/1521-3765(20020703)8:13<2838::AID-CHEM2838>3.0.CO;2-I
   Groot W., 2010, POLYLACTIC ACID SYNT, P1
   Gross RA, 2001, CHEM REV, V101, P2097, DOI 10.1021/cr0002590
   Guerin W, 2014, POLYM CHEM-UK, V5, P1229, DOI 10.1039/c3py00955f
   Gupta AP, 2007, EUR POLYM J, V43, P4053, DOI 10.1016/j.eurpolymj.2007.06.045
   Haag R, 2000, J AM CHEM SOC, V122, P2954, DOI 10.1021/ja994363e
   Haba O, 2005, MACROMOLECULES, V38, P3562, DOI 10.1021/ma0476745
   Haddleton DM, 1996, J CHEM SOC PERK T 1, P649, DOI 10.1039/p19960000649
   HARPOLE DH, 1995, CANCER-AM CANCER SOC, V76, P787, DOI 10.1002/1097-0142(19950901)76:5<787::AID-CNCR2820760512>3.0.CO;2-Q
   HAWKER CJ, 1991, J AM CHEM SOC, V113, P4583, DOI 10.1021/ja00012a030
   Hawker CJ, 1996, MACROMOLECULES, V29, P3831, DOI 10.1021/ma951909i
   HAWKER CJ, 1992, J CHEM SOC PERK T 1, P2459, DOI 10.1039/p19920002459
   HAWKER CJ, 1992, J AM CHEM SOC, V114, P8405, DOI 10.1021/ja00048a009
   Helou M, 2011, POLYM CHEM-UK, V2, P2789, DOI 10.1039/c1py00405k
   Helou M, 2010, CHEM-EUR J, V16, P13805, DOI 10.1002/chem.201001111
   Henderson PW, 2010, J BIOMED MATER RES A, V93A, P776, DOI 10.1002/jbm.a.32586
   Hilf J, 2014, POLYM CHEM-UK, V5, P814, DOI 10.1039/c3py00977g
   HODGE JE, 1953, J AGR FOOD CHEM, V1, P928, DOI 10.1021/jf60015a004
   Hu J, 2006, MACROMOLECULES, V39, P6789, DOI 10.1021/ma0612834
   Ingle NP, 2011, TRENDS BIOTECHNOL, V29, P443, DOI 10.1016/j.tibtech.2011.04.012
   James HP, 2014, ACTA PHARM SIN B, V4, P120, DOI 10.1016/j.apsb.2014.02.005
   Jia J, 1997, PROTEIN SCI, V6, P119
   Jia Y, 2015, CHEM REV, V115, P1597, DOI 10.1021/cr400559g
   Jia Y, 2011, CHEM COMMUN, V47, P1175, DOI 10.1039/c0cc03578e
   Jiang T, 2013, COLLOID SURFACE B, V111, P542, DOI 10.1016/j.colsurfb.2013.06.054
   Jin HB, 2012, CHEM SOC REV, V41, P5986, DOI 10.1039/c2cs35130g
   Johnson J. A., 1994, MAILLARD REACTIONS C, P114
   Jung K, 2008, SPECTROCHIM ACTA A, V69, P1423, DOI 10.1016/j.saa.2007.09.029
   JUNG SH, 1994, J ORG CHEM, V59, P7182, DOI 10.1021/jo00102a060
   Kang PC, 2005, J CATARACT REFR SURG, V31, P1208, DOI 10.1016/j.jcrs.2004.10.067
   Karakousis CP, 1996, ANN SURG ONCOL, V3, P150, DOI 10.1007/BF02305794
   Kasper FK, 2009, NAT PROTOC, V4, P518, DOI 10.1038/nprot.2009.24
   Ke XY, 2014, POLYM CHEM-UK, V5, P2621, DOI 10.1039/c3py01784b
   Kiessling LL, 2013, CHEM SOC REV, V42, P4476, DOI 10.1039/c3cs60097a
   Kim JG, 2012, MACROMOLECULES, V45, P7878, DOI 10.1021/ma301137q
   Kim JG, 2011, MACROMOLECULES, V44, P1110, DOI 10.1021/ma102585a
   Kim J, 2012, TISSUE ENG PT A, V18, P1132, DOI [10.1089/ten.tea.2011.0582, 10.1089/ten.TEA.2011.0582]
   Kirker KR, 2002, BIOMATERIALS, V23, P3661, DOI 10.1016/S0142-9612(02)00100-X
   Kohane DS, 2008, PEDIATR RES, V63, P487, DOI 10.1203/01.pdr.0000305937.26105.e7
   Kokabi M, 2007, EUR POLYM J, V43, P773, DOI 10.1016/j.eurpolymj.2006.11.030
   KOST J, 1991, ADV DRUG DELIVER REV, V6, P19
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Kricheldorf HR, 2006, ANGEW CHEM INT EDIT, V45, P5752, DOI 10.1002/anie.200600693
   KRICHELDORF HR, 1995, MACROMOLECULES, V28, P2118, DOI 10.1021/ma00111a003
   Krsko P, 2005, MATER TODAY, V8, P36, DOI 10.1016/S1369-7021(05)71223-2
   Kumar A, 2003, MACROMOLECULES, V36, P8219, DOI 10.1021/ma0351827
   Kumar A, 1996, MACROMOLECULES, V29, P2524, DOI 10.1021/ma950948r
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Kumar MNVR, 2001, DRUG DEV IND PHARM, V27, P1
   Kumar R, 2002, IND CROP PROD, V16, P155, DOI 10.1016/S0926-6690(02)00007-9
   Kumar R, 2002, MACROMOLECULES, V35, P6835, DOI 10.1021/ma020041a
   Kwon D. Y., 2012, J BIOMED SCI ENG, V05, P208
   Kwon Y, 2012, ACS CATAL, V2, P759, DOI 10.1021/cs200599g
   Ladmiral V, 2004, EUR POLYM J, V40, P431, DOI 10.1016/j.eurpolymj.2003.10.019
   Langowska K, 2014, J MATER CHEM B, V2, P4684, DOI 10.1039/c4tb00277f
   Lao UL, 2007, BIOMACROMOLECULES, V8, P3736, DOI 10.1021/bm700662n
   Lapcik L, 1998, CHEM REV, V98, P2663, DOI 10.1021/cr941199z
   Lee ALZ, 2015, BIOMACROMOLECULES, V16, P465, DOI 10.1021/bm5015206
   Lee ALZ, 2014, ADV FUNCT MATER, V24, P1538, DOI 10.1002/adfm.201301307
   Lee KW, 2007, BIOMACROMOLECULES, V8, P1077, DOI 10.1021/bm060834v
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lehnert T, 2009, EJSO-EUR J SURG ONC, V35, P986, DOI 10.1016/j.ejso.2008.11.003
   Lentini P. J, 1999, U.S. Patent, Patent No. [5,885,557, 5885557]
   Leuchs H, 1906, BER DTSCH CHEM GES, V39, P857, DOI 10.1002/cber.190603901133
   Lewitus D, 2011, ACTA BIOMATER, V7, P2483, DOI 10.1016/j.actbio.2011.02.027
   LINDE F, 1992, J BIOMECH, V25, P359, DOI 10.1016/0021-9290(92)90255-Y
   Liu R, 2012, ANN SURG ONCOL, V19, P199, DOI 10.1245/s10434-011-1871-4
   Liu R, 2010, ANN SURG ONCOL, V17, P1203, DOI 10.1245/s10434-009-0856-z
   Liu YM, 2010, BIOMACROMOLECULES, V11, P316, DOI 10.1021/bm9008233
   Liu YM, 2005, J AM CHEM SOC, V127, P3004, DOI 10.1021/ja0436446
   Liu YM, 2004, J AM CHEM SOC, V126, P7422, DOI 10.1021/ja049831l
   Lo CT, 2010, BIOMATERIALS, V31, P3631, DOI 10.1016/j.biomaterials.2010.01.048
   Lo MC, 2015, BIOMED MICRODEVICES, V17, DOI 10.1007/s10544-015-9927-z
   Lu H, 2007, J AM CHEM SOC, V129, P14114, DOI 10.1021/ja074961q
   Lu SX, 1999, J CONTROL RELEASE, V57, P291, DOI 10.1016/S0168-3659(98)00125-4
   Lu XB, 2004, ANGEW CHEM INT EDIT, V43, P3574, DOI 10.1002/anie.200453998
   Lu XB, 2012, CHEM SOC REV, V41, P1462, DOI 10.1039/c1cs15142h
   Lukaszczyk J, 2000, MACROMOL RAPID COMM, V21, P754, DOI 10.1002/1521-3927(20000701)21:11<754::AID-MARC754>3.0.CO;2-O
   Lukaszczyk J, 2001, MACROMOL BIOSCI, V1, P282
   Luman NR, 2004, PURE APPL CHEM, V76, P1375, DOI 10.1351/pac200476071375
   Luman NR, 2003, CHEM-EUR J, V9, P5618, DOI 10.1002/chem.2003051
   Lv L, 2015, METAB ENG, V29, P160, DOI 10.1016/j.ymben.2015.03.013
   MacBeath G, 2000, SCIENCE, V289, P1760
   Macdermot H E, 1925, Can Med Assoc J, V15, P412
   Magno MHR, 2010, J MATER CHEM, V20, P8885, DOI 10.1039/c0jm00868k
   Maillard LC, 1912, CR HEBD ACAD SCI, V154, P66
   Majoral JP, 1999, CHEM REV, V99, P845, DOI 10.1021/cr970414j
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   Marques ME, 2013, APPL SURF SCI, V275, P347, DOI 10.1016/j.apsusc.2012.12.099
   MARTINI N, 1992, ANN THORAC SURG, V54, P460, DOI 10.1016/0003-4975(92)90435-7
   Martins SIFS, 2000, TRENDS FOOD SCI TECH, V11, P364, DOI 10.1016/S0924-2244(01)00022-X
   Masood F, 2013, J MATER SCI-MATER M, V24, P1927, DOI 10.1007/s10856-013-4946-x
   Mccoy CP, 2007, BIOCONJUGATE CHEM, V18, P209, DOI 10.1021/bc060238y
   Medina SH, 2009, CHEM REV, V109, P3141, DOI 10.1021/cr900174j
   Meyers SR, 2008, J AM CHEM SOC, V130, P14444, DOI 10.1021/ja806912a
   Mikami K, 2013, J AM CHEM SOC, V135, P6826, DOI 10.1021/ja402319m
   Mintzer MA, 2011, CHEM SOC REV, V40, P173, DOI 10.1039/b901839p
   Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c
   Miura Y, 2007, J POLYM SCI POL CHEM, V45, P5031, DOI 10.1002/pola.22369
   Miura Y, 2016, CHEM REV, V116, P1673, DOI 10.1021/acs.chemrev.5b00247
   Mohanty AK, 2002, J POLYM ENVIRON, V10, P19, DOI 10.1023/A:1021013921916
   Moon SI, 2000, J POLYM SCI POL CHEM, V38, P1673, DOI 10.1002/(SICI)1099-0518(20000501)38:9<1673::AID-POLA33>3.0.CO;2-T
   Morgan MT, 2006, CANCER RES, V66, P11913, DOI 10.1158/0008-5472.CAN-06-2066
   Morgan MT, 2005, CHEM COMMUN, P4309, DOI 10.1039/b502411k
   Morgan MT, 2003, J AM CHEM SOC, V125, P15485, DOI 10.1021/ja0347383
   Mowery P, 2004, CHEM BIOL, V11, P725, DOI 10.1016/j.chembiol.2004.03.027
   Mulhaupt R, 2013, MACROMOL CHEM PHYS, V214, P159, DOI 10.1002/macp.201200439
   Nakano K, 2006, ANGEW CHEM INT EDIT, V45, P7274, DOI 10.1002/anie.200603132
   Namazi H, 2005, BIOMATERIALS, V26, P1175, DOI 10.1016/j.biomaterials.2004.04.014
   Namazi H, 2003, EUR POLYM J, V39, P1491, DOI 10.1016/S0014-3057(02)00385-3
   Newkome GR, 1999, CHEM REV, V99, P1689, DOI 10.1021/cr9800659
   Nguyen BC, 2003, J INVEST DERMATOL, V120, P655, DOI 10.1046/j.1523-1747.2003.12089.x
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Niknahad H, 2002, TOXICOL LETT, V132, P95, DOI 10.1016/S0378-4274(02)00016-4
   Nuyken O, 2013, POLYMERS-BASEL, V5, P361, DOI 10.3390/polym5020361
   O'Leary RE, 2014, J AM ACAD DERMATOL, V70, P562, DOI 10.1016/j.jaad.2013.11.004
   Oelker AM, 2008, J MATER CHEM, V18, P2521, DOI 10.1039/b719791h
   Oh EJ, 2010, J CONTROL RELEASE, V141, P2, DOI 10.1016/j.jconrel.2009.09.010
   Ohsaki M, 2002, BIOCONJUGATE CHEM, V13, P510, DOI 10.1021/bc015525a
   Owen RM, 2002, ORG LETT, V4, P2293, DOI 10.1021/ol0259239
   Pagoto S, 2012, SHEDDING LIGHT INDOO, P165
   Painter RM, 2010, ANGEW CHEM INT EDIT, V49, P9456, DOI 10.1002/anie.201004063
   Parzuchowski PG, 2008, MACROMOLECULES, V41, P3859, DOI 10.1021/ma8000912
   Parzuchowski PG, 2006, MACROMOLECULES, V39, P7181, DOI 10.1021/ma061488c
   Pearson DM, 2011, ADV SYNTH CATAL, V353, P3007, DOI 10.1002/adsc.201100240
   Peng YL, 2008, MACROMOLECULES, V41, P3455, DOI 10.1021/ma7025836
   Peng YF, 2014, BIOMACROMOLECULES, V15, P4214, DOI 10.1021/bm501255j
   Petersen AB, 2004, MUTAT RES-GEN TOX EN, V560, P173, DOI 10.1016/j.mrgentox.2004.03.002
   Pratt C. W., 2008, FUNDAMENTALS BIOCH L
   PULAPURA S, 1992, BIOPOLYMERS, V32, P411, DOI 10.1002/bip.360320418
   Putnam D., 2008, U.S. Patent, Patent No. [WO2008101173, 02008101173]
   Putnam D. A., 2010, <IT>US Patent</IT>, Patent No. 7659420
   QUINTANA RP, 1970, J ECON ENTOMOL, V63, P1128, DOI 10.1093/jee/63.4.1128
   QUINTANA RP, 1969, CAN J CHEMISTRY, V47, P853, DOI 10.1139/v69-135
   Rabinowitch IM, 1925, CAN MED ASSOC J, V15, P374
   Rabinowitch IM, 1925, CAN MED ASSOC J, V15, P520
   Rabinowitch IM, 1925, J BIOL CHEM, V65, P55
   Rajatanavin N, 2008, INT J DERMATOL, V47, P402, DOI 10.1111/j.1365-4632.2008.03356.x
   Ranganathan D, 1997, TETRAHEDRON LETT, V38, P1265, DOI 10.1016/S0040-4039(97)00054-3
   Ranganathan D, 2000, BIOPOLYMERS, V54, P289, DOI 10.1002/1097-0282(20001005)54:4<289::AID-BIP60>3.0.CO;2-7
   Ray WC, 2003, MACROMOLECULES, V36, P3557, DOI 10.1021/ma025872v
   Reineke TM, 2005, MRS BULL, V30, P635, DOI 10.1557/mrs2005.189
   Reineke TM, 2003, BIOCONJUGATE CHEM, V14, P255, DOI 10.1021/bc025593c
   Ren KF, 2006, BIOCONJUGATE CHEM, V17, P77, DOI 10.1021/bc050264g
   Reul R, 2009, BIOMATERIALS, V30, P5815, DOI 10.1016/j.biomaterials.2009.06.057
   REYNOLDS SJ, 1971, BIOCHEM J, V122, P285, DOI 10.1042/bj1220285
   Rinaudo M, 2008, POLYM INT, V57, P397, DOI 10.1002/pi.2378
   Ringer AI, 1914, J BIOL CHEM, V18, P233
   Rojas R, 2009, J POLYM SCI POL CHEM, V47, P49, DOI 10.1002/pola.23119
   Rokicki G, 2000, PROG POLYM SCI, V25, P259, DOI 10.1016/S0079-6700(00)00006-X
   Rokicki G, 2005, GREEN CHEM, V7, P529, DOI 10.1039/b501597a
   Sahoo B, 2005, ORG LETT, V7, P3857, DOI 10.1021/ol050942e
   Saito H, 2007, J BIOACT COMPAT POL, V22, P589, DOI 10.1177/0883911507084653
   Sakthivel T, 1998, PHARMACEUT RES, V15, P776, DOI 10.1023/A:1011935406664
   Sanner T., 2010, SCCS134710, P1
   Schmitt E. E., 1967, U. S. Patent, Patent No. [3,297,033, 3297033]
   Scholl M, 2009, PROG POLYM SCI, V34, P24, DOI 10.1016/j.progpolymsci.2008.09.001
   Schweizer D, 2013, BIOMACROMOLECULES, V14, P75, DOI 10.1021/bm301352x
   Seebach D, 1996, ANGEW CHEM INT EDIT, V35, P2795, DOI 10.1002/anie.199627951
   Seebach D, 1996, HELV CHIM ACTA, V79, P913, DOI 10.1002/hlca.19960790402
   Shinno K, 1997, MACROMOLECULES, V30, P6438, DOI 10.1021/ma9704323
   Simon J, 2012, MACROMOLECULES, V45, P9275, DOI 10.1021/ma302311h
   Singer JW, 2005, J CONTROL RELEASE, V109, P120, DOI 10.1016/j.jconrel.2005.09.033
   Sisson AL, 2010, SOFT MATTER, V6, P4968, DOI 10.1039/c0sm00149j
   Slepokura K, 2004, CARBOHYD RES, V339, P1995, DOI 10.1016/j.carres.2004.05.020
   Snell KD, 2015, CURR OPIN BIOTECH, V32, P68, DOI 10.1016/j.copbio.2014.11.005
   Sontjens SHM, 2006, BIOMACROMOLECULES, V7, P310, DOI 10.1021/bm050663e
   Spain SG, 2011, POLYM CHEM-UK, V2, P60, DOI 10.1039/c0py00149j
   Srinivasachari S, 2006, J AM CHEM SOC, V128, P8176, DOI 10.1021/ja0585580
   STANKO RT, 1990, J APPL PHYSIOL, V69, P1651
   Stern R, 2008, CHEM REV, V108, P5061, DOI 10.1021/cr078240l
   Stevens DM, 2015, POLYM CHEM-UK, V6, P1096, DOI 10.1039/c4py00986j
   Stidham SE, 2014, J AM CHEM SOC, V136, P9544, DOI 10.1021/ja5036804
   Strain HH, 1934, J AM CHEM SOC, V56, P2649, DOI 10.1021/ja01327a034
   Sudesh K, 2008, CLEAN-SOIL AIR WATER, V36, P433, DOI 10.1002/clen.200700183
   Sugimura H, 2007, ANN THORAC SURG, V83, P409, DOI 10.1016/j.athoracsur.2006.08.046
   Sun JW, 2004, J ORG CHEM, V69, P8932, DOI 10.1021/jo0486239
   Sun LL, 2014, J BIOMED MATER RES A, V102, P3446, DOI 10.1002/jbm.a.35008
   Sunder A, 1999, MACROMOLECULES, V32, P4240, DOI 10.1021/ma990090w
   Tang SZ, 2006, TETRAHEDRON LETT, V47, P7671, DOI 10.1016/j.tetlet.2006.08.110
   Taori VP, 2011, BIOMACROMOLECULES, V12, P2055, DOI 10.1021/bm101537f
   Taylor CR, 1999, ARCH DERMATOL, V135, P540, DOI 10.1001/archderm.135.5.540
   Teles H, 2010, J CONTROL RELEASE, V147, P298, DOI 10.1016/j.jconrel.2010.07.098
   Tian Y, 2006, BIOMACROMOLECULES, V7, P2539, DOI 10.1021/bm0604121
   Ting SRS, 2010, POLYM CHEM-UK, V1, P1392, DOI 10.1039/c0py00141d
   Treiser MD, 2007, BIOTECHNIQUES, V43, P361, DOI 10.2144/000112533
   Turner BB, 1933, J PHARMACOL EXP THER, V48, P445
   TURNER SR, 1993, MACROMOLECULES, V26, P4617, DOI 10.1021/ma00069a031
   Twibanire JDK, 2014, POLYMERS-BASEL, V6, P179, DOI 10.3390/polym6010179
   Twibanire JDK, 2012, POLYMERS-BASEL, V4, P794, DOI 10.3390/polym4010794
   Twyman LJ, 1998, J CHEM RES-S, P758, DOI 10.1039/a805918g
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   Vaisocherova H, 2008, ANAL CHEM, V80, P7894, DOI 10.1021/ac8015888
   van Boekel MAJS, 2001, NAHRUNG, V45, P150, DOI 10.1002/1521-3803(20010601)45:3<150::AID-FOOD150>3.0.CO;2-9
   Vazquez-Dorbatt V, 2012, CHEMBIOCHEM, V13, P2478, DOI 10.1002/cbic.201200480
   Velazquez AJ, 2004, ARCH OPHTHALMOL-CHIC, V122, P867, DOI 10.1001/archopht.122.6.867
   Wang DL, 2015, CHEM SOC REV, V44, P4023, DOI 10.1039/c4cs00229f
   Wang LS, 2014, POLYM BULL, V71, P47, DOI 10.1007/s00289-013-1044-7
   Wang LS, 2013, POLYM SCI SER B+, V55, P604, DOI 10.1134/S1560090413080101
   Wang LS, 2013, POLYM-PLAST TECHNOL, V52, P1063, DOI 10.1080/03602559.2013.769582
   Wang LS, 2013, MACROMOL CHEM PHYS, V214, P458, DOI 10.1002/macp.201200525
   Wang LS, 2005, CHINESE CHEM LETT, V16, P572
   Wang LS, 2004, MACROMOL RAPID COMM, V25, P959, DOI 10.1002/marc.200300319
   Wang XL, 2002, J POLYM SCI POL CHEM, V40, P70, DOI 10.1002/pola.10088
   Wathier M, 2004, J AM CHEM SOC, V126, P12744, DOI 10.1021/ja045870l
   Weiser JR, 2013, ACTA BIOMATER, V9, P8245, DOI 10.1016/j.actbio.2013.05.020
   Weiser JR, 2012, ANAL BIOCHEM, V430, P116, DOI 10.1016/j.ab.2012.08.009
   Weiser JR, 2011, BIOMACROMOLECULES, V12, P977, DOI 10.1021/bm101342p
   Weldon CB, 2012, J CONTROL RELEASE, V161, P903, DOI 10.1016/j.jconrel.2012.05.021
   Wilms D, 2010, ACCOUNTS CHEM RES, V43, P129, DOI 10.1021/ar900158p
   WITTGENSTEIN E, 1960, SCIENCE, V132, P894, DOI 10.1126/science.132.3431.894
   WITTGENSTEIN E, 1961, J INVEST DERMATOL, V36, P283, DOI 10.1038/jid.1961.46
   Wolinsky JB, 2008, ADV DRUG DELIVER REV, V60, P1037, DOI 10.1016/j.addr.2008.02.012
   Wolinsky JB, 2007, MACROMOLECULES, V40, P7065, DOI 10.1021/ma071276v
   Wolinsky JB, 2012, BIOMACROMOLECULES, V13, P406, DOI 10.1021/bm201443m
   Wolinsky JB, 2010, J CONTROL RELEASE, V144, P280, DOI 10.1016/j.jconrel.2010.02.022
   WOOLEY KL, 1994, POLYM J, V26, P187, DOI 10.1295/polymj.26.187
   Wright JC, 2012, ADV DEL SCI TECHNOL, P11, DOI 10.1007/978-1-4614-0554-2_2
   Wu GP, 2011, J AM CHEM SOC, V133, P15191, DOI 10.1021/ja206425j
   Wu Q, 2009, ARTIF CELL BLOOD SUB, V37, P1, DOI 10.1080/10731190802664429
   Wu X, 2014, MACROMOLECULES, V47, P492, DOI 10.1021/ma401899h
   Wu XM, 2014, ACS NANO, V8, P153, DOI 10.1021/nn4054107
   Xu CY, 2005, BIOMACROMOLECULES, V6, P1739, DOI 10.1021/bm0500171f
   Xu JW, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.39822
   Xu JW, 2011, CHEM-ASIAN J, V6, P2730, DOI 10.1002/asia.201100411
   Xue L, 2013, BIOMACROMOLECULES, V14, P3903, DOI 10.1021/bm401026n
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P2127, DOI 10.1016/0142-9612(96)00008-7
   Yu ME, 1998, MACROMOLECULES, V31, P4739, DOI 10.1021/ma980268z
   Yu XH, 2005, MACROMOLECULES, V38, P6244, DOI 10.1021/ma048839c
   Zagar E, 2011, PROG POLYM SCI, V36, P53, DOI 10.1016/j.progpolymsci.2010.08.004
   Zawaneh PN, 2006, BIOMACROMOLECULES, V7, P3245, DOI 10.1021/bm0605457
   Zawaneh PN, 2010, P NATL ACAD SCI USA, V107, P11014, DOI 10.1073/pnas.0811529107
   Zelikin AN, 2006, BIOMACROMOLECULES, V7, P3239, DOI 10.1021/bm060544e
   Zelikin AN, 2005, MACROMOLECULES, V38, P5532, DOI 10.1021/ma050049v
   Zhang H, 2014, MACROMOL RAPID COMM, V35, P1906, DOI 10.1002/marc.201400389
   Zhang H, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.39893
   Zhang H, 2013, J AM CHEM SOC, V135, P6806, DOI 10.1021/ja402558m
   Zhang XL, 2010, PROG ORG COAT, V69, P295, DOI 10.1016/j.porgcoat.2010.08.007
   Zhang XL, 2011, POLYM INT, V60, P153, DOI 10.1002/pi.2930
   Zhang XQ, 2011, ACS NANO, V5, P6962, DOI 10.1021/nn201446c
   Zhou CHC, 2008, CHEM SOC REV, V37, P527, DOI 10.1039/b707343g
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
   Zhu Q, 2013, RSC ADV, V3, P2071, DOI 10.1039/c2ra22210h
NR 329
TC 29
Z9 29
U1 8
U2 84
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2665
EI 1520-6890
J9 CHEM REV
JI Chem. Rev.
PD FEB 24
PY 2016
VL 116
IS 4
SI SI
BP 2664
EP 2704
DI 10.1021/acs.chemrev.5b00465
PG 41
WC Chemistry, Multidisciplinary
SC Chemistry
GA DF1NH
UT WOS:000371106000020
PM 26821863
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Hazra, S
   Nandi, S
   Naskar, D
   Guha, R
   Chowdhury, S
   Pradhan, N
   Kundu, SC
   Konar, A
AF Hazra, Sarbani
   Nandi, Sudip
   Naskar, Deboki
   Guha, Rajdeep
   Chowdhury, Sushovan
   Pradhan, Nirparaj
   Kundu, Subhas C.
   Konar, Aditya
TI Non-mulberry Silk Fibroin Biomaterial for Corneal Regeneration
SO SCIENTIFIC REPORTS
LA English
DT Article
ID POSTERIOR CAPSULAR OPACIFICATION; EXPANDED EX-VIVO; STEM-CELLS;
   EPITHELIAL-CELLS; AMNIOTIC MEMBRANE; LIMBAL EPITHELIUM; PROTEIN FIBROIN;
   OCULAR SURFACE; RAT MODEL; TRANSPLANTATION
AB Purpose: Successful repair of a damaged corneal surface is a great challenge and may require the use of a scaffold that supports cell growth and differentiation. Amniotic membrane is currently used for this purpose, in spite of its limitations. A thin transparent silk fibroin film from non-mulberry Antheraea mylitta (Am) has been developed which offers to be a promising alternative. The silk scaffolds provide sufficient rigidity for easy handling, the scaffolds support the sprouting, migration, attachment and growth of epithelial cells and keratocytes from rat corneal explants; the cells form a cell sheet, preserve their phenotypes, express cytokeratin3 and vimentin respectively. The films also support growth of limbal stem cell evidenced by expression of ABCG2. The cell growth on the silk film and the amniotic membrane is comparable. The implanted film within the rabbit cornea remains transparent, stable. The clinical examination as well as histology shows absence of any inflammatory response or neovascularization. The corneal surface integrity is maintained; tear formation, intraocular pressure and electroretinography of implanted eyes show no adverse changes. The silk fibroin film from non-mulberry silk worms may be a worthy candidate for use as a corneal scaffold.
C1 [Hazra, Sarbani; Pradhan, Nirparaj] West Bengal Univ Anim & Fishery Sci, Dept Vet Surg & Radiol, Kolkata 700037, W Bengal, India.
   [Nandi, Sudip; Guha, Rajdeep; Chowdhury, Sushovan; Konar, Aditya] CSIR Indian Inst Chem Biol, Kolkata 700032, W Bengal, India.
   [Naskar, Deboki; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Hazra, S (reprint author), West Bengal Univ Anim & Fishery Sci, Dept Vet Surg & Radiol, Kolkata 700037, W Bengal, India.; Konar, A (reprint author), CSIR Indian Inst Chem Biol, Kolkata 700032, W Bengal, India.
EM shazrakon@yahoo.co.in; adityakonar@yahoo.com
OI Kundu, Subhas C./0000-0002-7170-2291
FU Department of Biotechnology, Govt. of India [BT/PR12304/TDS/121/2/2014];
   CSIR, Govt. of India
FX This work is supported by Department of Biotechnology, Govt. of India
   BT/PR12304/TDS/121/2/2014 and CSIR, Govt. of India. We acknowledge West
   Bengal University of Animal & Fishery Sciences, CSIR-Indian Institute of
   Chemical Biology and IIT, Kharagpur for providing facilities.
CR Acharya C, 2009, ACTA BIOMATER, V5, P429, DOI 10.1016/j.actbio.2008.07.003
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   ARAND M, 1992, ANAL BIOCHEM, V207, P73, DOI 10.1016/0003-2697(92)90502-X
   Bray LJ, 2012, BIOMATERIALS, V33, P3529, DOI 10.1016/j.biomaterials.2012.01.045
   Bray LJ, 2011, BIOMATERIALS, V32, P5086, DOI 10.1016/j.biomaterials.2011.03.068
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   CHEN JJY, 1991, INVEST OPHTH VIS SCI, V32, P2219
   Chung YG, 2014, BIOMATERIALS, V35, P7452, DOI 10.1016/j.biomaterials.2014.05.044
   Du LQ, 2011, ARTIF ORGANS, V35, P691, DOI 10.1111/j.1525-1594.2010.01174.x
   Fagerholm P., 2010, TRANSL MED, V2, P46, DOI DOI 10.1126/SCITRANSLMED.3001022
   Ge Z, 2012, INT J ORAL MAX SURG, V41, P673, DOI 10.1016/j.ijom.2011.11.016
   George KA, 2013, MAT SCI ENG C-MATER, V33, P668, DOI 10.1016/j.msec.2012.10.016
   Gil ES, 2010, BIOMATERIALS, V31, P8953, DOI 10.1016/j.biomaterials.2010.08.017
   Gruchenberg K, 2015, KNEE SURG SPORT TR A, V23, P2218, DOI 10.1007/s00167-014-3009-2
   Guha R, 2013, NANOMEDICINE-UK, V8, P1415, DOI [10.2217/NNM.12.175, 10.2217/nnm.12.175]
   Han B, 2002, CORNEA, V21, P505, DOI 10.1097/01.ICO.0000016343.19018.1D
   Harkin DG, 2011, BIOMATERIALS, V32, P2445, DOI 10.1016/j.biomaterials.2010.12.041
   Hazra S, 2012, MOL VIS, V18, P1701
   Higa K, 2010, J BIOMAT SCI-POLYM E, V22, P2261
   Hogerheyde TA, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/2/025016
   Ke QC, 2011, J TISSUE ENG REGEN M, V5, P138, DOI 10.1002/term.298
   Kim HS, 2004, EXP EYE RES, V79, P41, DOI 10.1016/j.exer.2004.02.015
   Koizumi N, 2000, CORNEA, V19, P65, DOI 10.1097/00003226-200001000-00013
   Kundu SC, 2012, BIOPOLYMERS, V97, P455, DOI 10.1002/bip.22024
   Liu JB, 2012, INVEST OPHTH VIS SCI, V53, P4130, DOI 10.1167/iovs.12-9876
   Mandal BB, 2008, BIOTECHNOL BIOENG, V99, P1482, DOI 10.1002/bit.21699
   Nishida K, 2004, TRANSPLANTATION, V77, P379, DOI 10.1097/01.TP.0000110320.45678.30
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Omoto M, 2009, INVEST OPHTH VIS SCI, V50, P2109, DOI 10.1167/iovs.08-2262
   Paranthan RR, 2011, MOL VIS, V17, P1901
   Parker S. T., 2009, ADV MATER, V21, P1
   PATEL S, 1995, J REFRACT SURG, V11, P100
   Patra C, 2012, BIOMATERIALS, V33, P2673, DOI 10.1016/j.biomaterials.2011.12.036
   Rama P, 2001, TRANSPLANTATION, V72, P1478, DOI 10.1097/00007890-200111150-00002
   Saghizadeh M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079632
   Shang K, 2013, TRANSL VIS SCI TECHN, V2, DOI 10.1167/tvst.2.3.2
   Shen Y, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/1/015015
   Shimazaki J, 2002, OPHTHALMOLOGY, V109, P1285, DOI 10.1016/S0161-6420(02)01089-8
   Talukdar S, 2013, ADV FUNCT MATER, V23, P5249, DOI 10.1002/adfm.201300312
   Talukdar S, 2012, ADV FUNCT MATER, V22, P4778, DOI 10.1002/adfm.201200375
   Talukdar S, 2011, BIOMATERIALS, V32, P8927, DOI 10.1016/j.biomaterials.2011.08.027
   Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202
   Tseng Scheffer C G, 2004, Ocul Surf, V2, P177
   Uebersax L, 2013, EUR J PHARM BIOPHARM, V85, P107, DOI 10.1016/j.ejpb.2013.05.008
   van Essen TH, 2013, INVEST OPHTH VIS SCI, V54, P3224, DOI 10.1167/iovs.13-11799
   Wang LQ, 2015, J BIOMED MATER RES B, V103, P204, DOI 10.1002/jbm.b.33192
   Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214
   Wu J, 2014, BIOMATERIALS, V35, P3744, DOI 10.1016/j.biomaterials.2013.12.078
   Zhou Y., 2011, CORNEA, V3, P73
NR 49
TC 10
Z9 11
U1 1
U2 25
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 24
PY 2016
VL 6
AR 21840
DI 10.1038/srep21840
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DE5PE
UT WOS:000370682700001
PM 26908015
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Ma, HS
   Jiang, CA
   Zhai, D
   Luo, YX
   Chen, Y
   Lv, F
   Yi, ZF
   Deng, Y
   Wang, JW
   Chang, J
   Wu, CT
AF Ma, Hongshi
   Jiang, Chuan
   Zhai, Dong
   Luo, Yongxiang
   Chen, Yu
   Lv, Fang
   Yi, Zhengfang
   Deng, Yuan
   Wang, Jinwu
   Chang, Jiang
   Wu, Chengtie
TI A Bifunctional Biomaterial with Photothermal Effect forTumor Therapy and
   Bone Regeneration
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
DE 3D printing; bifunctional; bone regeneration; scaffolds; photothermal
   therapy
ID NANO-GRAPHENE OXIDE; CARBON NANOTUBES; CANCER-THERAPY; IN-VITRO;
   BIOMEDICAL APPLICATIONS; MOS2 NANOSHEETS; STEM-CELLS; NANOPARTICLES;
   DIFFERENTIATION; CHALLENGES
AB Malignant bone tumor is one of the major bone diseases. The treatment of such a bone disease typically requires the removal of bone tumor and regeneration of tumor-initiated bone defects simultaneously. To address this issue, it is required that implanted biomaterials should combine the bifunctions of both therapy and regeneration. In this work, a bifunctional graphene oxide (GO)-modified -tricalcium phosphate (GO-TCP) composite scaffold combining a high photothermal effect with significantly improved bone-forming ability is prepared by 3D-printing and surface-modification strategies. The prepared GO-TCP scaffolds exhibit excellent photothermal effects under the irradiation of 808 nm near infrared laser (NIR) even at an ultralow power density of 0.36 W cm(-2), while no photothermal effects are observed for pure -TCP scaffolds. The photothermal temperature of GO-TCP scaffolds can be effectively modulated in the range of 40-90 degrees C by controlling the used GO concentrations, surface-modification times, and power densities of NIR. The distinct photothermal effect of GO-TCP scaffolds induces more than 90% of cell death for osteosarcoma cells (MG-63) in vitro, and further effectively inhibits tumor growth in mice. Meanwhile, the prepared GO-TCP scaffolds possess the improved capability to stimulate the osteogenic differentiation of rabbit bone mesenchymal stem cells (rBMSCs) by upregulating bone-related gene expression, and significantly promote new bone formation in the bone defects of rabbits as compared to pure -TCP scaffolds. These results successfully demonstrate that the prepared GO-TCP scaffolds have bifunctional properties of photothermal therapy and bone regeneration, which is believed to pave the way to design and fabricate novel implanting biomaterials in combination of therapy and regeneration functions.
C1 [Ma, Hongshi; Zhai, Dong; Luo, Yongxiang; Chen, Yu; Chang, Jiang; Wu, Chengtie] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
   [Wang, Jinwu; Chang, Jiang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp Affiated 9, Shanghai Key Lab Orthopaed Implant,Dept Orthopaed, Shanghai 200011, Peoples R China.
   [Lv, Fang; Yi, Zhengfang] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China.
   [Lv, Fang; Yi, Zhengfang] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China.
   [Deng, Yuan; Wang, Jinwu] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China.
RP Chang, J; Wu, CT (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.; Chang, J (reprint author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp Affiated 9, Shanghai Key Lab Orthopaed Implant,Dept Orthopaed, Shanghai 200011, Peoples R China.
EM jchang@mail.sic.ac.cn; chengtiewu@mail.sic.ac.cn
RI Chen, Yu/N-8463-2015
OI Chen, Yu/0000-0002-8206-3325
FU Recruitment Program of Global Young Talent, China; National High
   Technology Research and Development Program of China (863 Program)
   [SS2015AA020302]; Natural Science Foundation of China [31370963,
   81190132, 81171707]; Program of Shanghai Outstanding Academic Leaders
   [15XD1503900]; Key Research Program of Chinese Academy of Sciences
   [KGZD-EW-T06]; joint research project for Shanghai Municipal Significant
   Diseases [2013ZYJB0501]
FX This study was funded by the Recruitment Program of Global Young Talent,
   China (Dr. Wu), the National High Technology Research and Development
   Program of China (863 Program, Grant No. SS2015AA020302), Natural
   Science Foundation of China (Grant Nos. 31370963, 81190132, and
   81171707), Program of Shanghai Outstanding Academic Leaders (Grant No.
   15XD1503900), Key Research Program of Chinese Academy of Sciences (Grant
   No. KGZD-EW-T06), and joint research project for Shanghai Municipal
   Significant Diseases (Grant No. 2013ZYJB0501).
CR Alford AI, 2006, BONE, V38, P749, DOI 10.1016/j.bone.2005.11.017
   Andronescu E, 2010, J MATER SCI-MATER M, V21, P2237, DOI 10.1007/s10856-010-4076-7
   Bai J, 2014, BIOMATERIALS, V35, P5805, DOI 10.1016/j.biomaterials.2014.04.008
   Bernhardt A, 2009, J TISSUE ENG REGEN M, V3, P54, DOI 10.1002/term.134
   Bitounis D, 2013, ADV MATER, V25, P2258, DOI 10.1002/adma.201203700
   Chen GY, 2012, BIOMATERIALS, V33, P418, DOI 10.1016/j.biomaterials.2011.09.071
   Chen JY, 2007, NANO LETT, V7, P1318, DOI 10.1021/nl070345g
   Chen SC, 2013, WORLD J PEDIATR, V9, P9, DOI 10.1007/s12519-013-0404-6
   Cheng L, 2014, CHEM REV, V114, P10869, DOI 10.1021/cr400532z
   [程亮 Cheng Liang], 2014, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V41, P18
   Cheng L, 2013, ADV FUNCT MATER, V23, P5893, DOI 10.1002/adfm.201301045
   Coleman R. E., 1997, CANCER, V80, P8
   Dong JJ, 2013, INT J NANOMED, V8, P1317, DOI 10.2147/IJN.S42862
   Du L, 2012, CHINESE MED J-PEKING, V125, P4022, DOI 10.3760/cma.j.issn.0366-6999.2012.22.021
   Feng LZ, 2011, NANOMEDICINE-UK, V6, P317, DOI 10.2217/NNM.10.158
   Goncalves G, 2013, ADV HEALTHC MATER, V2, P1072, DOI 10.1002/adhm.201300023
   Hong J, 2012, ACS NANO, V6, P81, DOI 10.1021/nn202607r
   Huang Xiaohua, 2006, J AM CHEM SOC, V128, P2115
   Ivaska KK, 2004, J BIOL CHEM, V279, P18361, DOI 10.1074/jbc.M314324200
   Jaque D, 2014, NANOSCALE, V6, P9494, DOI 10.1039/c4nr00708e
   Kim J, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/3/035010
   Kirui DK, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/10/105105
   La WG, 2013, SMALL, V9, DOI 10.1002/smll.201300571
   Lee C, 2010, PHOTOCHEM PHOTOBIOL, V86, P981, DOI 10.1111/j.1751-1097.2010.00731.x
   Lee WC, 2011, ACS NANO, V5, P7334, DOI 10.1021/nn202190c
   Li D, 2008, SCIENCE, V320, P1170, DOI 10.1126/science.1158180
   Li JL, 2008, ADV MATER, V20, P3866, DOI 10.1002/adma.200800941
   Liu T, 2015, ACS NANO, V9, P950, DOI 10.1021/nn506757x
   Liu T, 2014, ADV MATER, V26, P3433, DOI 10.1002/adma.201305256
   Liu XW, 2011, BIOMATERIALS, V32, P144, DOI 10.1016/j.biomaterials.2010.08.096
   Luetke A, 2014, CANCER TREAT REV, V40, P523, DOI 10.1016/j.ctrv.2013.11.006
   Markovic ZM, 2011, BIOMATERIALS, V32, P1121, DOI 10.1016/j.biomaterials.2010.10.030
   Meijer TWH, 2012, CLIN CANCER RES, V18, P5585, DOI 10.1158/1078-0432.CCR-12-0858
   Moon HK, 2009, ACS NANO, V3, P3707, DOI 10.1021/nn900904h
   Nikfarjam M, 2005, ANTICANCER RES, V25, P1413
   Orecchioni M, 2015, THERANOSTICS, V5, P710, DOI 10.7150/thno.11387
   Park SY, 2011, ADV MATER, V23, pH263, DOI 10.1002/adma.201101503
   Prosecka E, 2015, J BIOMED MATER RES A, V103, P671, DOI 10.1002/jbm.a.35216
   Robinson JT, 2011, J AM CHEM SOC, V133, P6825, DOI 10.1021/ja2010175
   Sahu A, 2013, BIOMATERIALS, V34, P6239, DOI 10.1016/j.biomaterials.2013.04.066
   Saito K, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.115409
   Shi XZ, 2013, BIOMATERIALS, V34, P4786, DOI 10.1016/j.biomaterials.2013.03.023
   Su SS, 2013, BIOMATERIALS, V34, P3523, DOI 10.1016/j.biomaterials.2013.01.083
   Thakor AS, 2013, CA-CANCER J CLIN, V63, P395, DOI 10.3322/caac.21199
   Verron E, 2014, DRUG DISCOV TODAY, V19, P1419, DOI 10.1016/j.drudis.2014.04.004
   Wang C, 2014, ADV MATER, V26, P8154, DOI 10.1002/adma.201402996
   Wang SG, 2015, BIOMATERIALS, V39, P206, DOI 10.1016/j.biomaterials.2014.11.009
   Wang YH, 2013, BIOMATERIALS, V34, P7715, DOI 10.1016/j.biomaterials.2013.06.045
   Wolf AM, 2004, BIOCHEM BIOPH RES CO, V323, P630, DOI 10.1016/j.bbrc.2004.08.145
   Yang K, 2013, BIOMATERIALS, V34, P2787, DOI 10.1016/j.biomaterials.2013.01.001
   Yang K, 2013, CHEM SOC REV, V42, P530, DOI 10.1039/c2cs35342c
   Yang K, 2012, ADV MATER, V24, P5586, DOI 10.1002/adma.201202625
   Yang K, 2012, ADV MATER, V24, P1868, DOI 10.1002/adma.201104964
   Yang K, 2010, NANO LETT, V10, P3318, DOI 10.1021/nl100996u
   Young JK, 2012, ANN BIOMED ENG, V40, P438, DOI 10.1007/s10439-011-0472-5
   Zha ZB, 2013, ADV MATER, V25, P777, DOI 10.1002/adma.201202211
   Zhang Y, 2012, NANOSCALE, V4, P3833, DOI 10.1039/c2nr31040f
NR 57
TC 46
Z9 47
U1 48
U2 398
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD FEB 23
PY 2016
VL 26
IS 8
BP 1197
EP 1208
DI 10.1002/adfm.201504142
PG 12
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA DF1DG
UT WOS:000371078100006
DA 2018-10-19
ER

PT J
AU Kawabe, S
   Seki, M
   Tabata, H
AF Kawabe, Shunsuke
   Seki, Munetoshi
   Tabata, Hitoshi
TI Evaluation of hydration in a water-soluble polymer by terahertz
   spectroscopy
SO APPLIED PHYSICS LETTERS
LA English
DT Article
ID TOTAL-REFLECTION SPECTROSCOPY; RELAXATION; BIOCOMPATIBILITY; ABSORPTION;
   DYNAMICS; STATE
AB In this study, we have evaluated the hydration properties of water-soluble polymers by terahertz spectroscopy. In particular, we focused on polyvinylpyrrolidone which has potential use for a wide range of applications as a biomaterial. The dielectric loss of samples obtained by the terahertz spectroscopy was found to strongly depend on the molecular weight of the polymers and the density of the solution. We revealed that the hydration number per monomer depends on the molecular weight of the polymer. It is also deduced that the hydration number is affected by the conformation of the polymer in the solution. (C) 2016 AIP Publishing LLC.
C1 [Kawabe, Shunsuke; Seki, Munetoshi; Tabata, Hitoshi] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
RP Seki, M (reprint author), Univ Tokyo, Grad Sch Engn, Dept Bioengn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
EM m-seki@ee.t.u-tokyo.ac.jp
FU JSPS Core-to-Core Program, A. Advanced Research Networks
FX We would like to acknowledge Advantest Co. for the opportunity to use
   the TAS7500 system in this work. This work was supported by the JSPS
   Core-to-Core Program, A. Advanced Research Networks.
CR Arikawa T, 2008, CHEM PHYS LETT, V457, P12, DOI 10.1016/j.cplett.2008.03.062
   Born B, 2009, J INFRARED MILLIM TE, V30, P1245, DOI 10.1007/s10762-009-9514-6
   Bye JW, 2014, J PHYS CHEM A, V118, P83, DOI 10.1021/jp407410g
   Choi DH, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4764304
   Elashmawi IS, 2012, CURR APPL PHYS, V12, P141, DOI 10.1016/j.cap.2011.05.011
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Hishida M, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/28/284113
   Hishida M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.158102
   Jones DS, 2005, BIOMATERIALS, V26, P2013, DOI 10.1016/j.biomaterials.2004.06.001
   Kawabe S, 2014, J APPL PHYS, V115, DOI 10.1063/1.4870954
   Kawaguchi S, 2010, PHYS CHEM CHEM PHYS, V12, P10255, DOI 10.1039/b927397b
   Matvejev V, 2012, J PHYS CHEM B, V116, P14071, DOI 10.1021/jp305356d
   Moller U, 2009, J OPT SOC AM B, V26, pA113, DOI 10.1364/JOSAB.26.00A113
   Murakami H, 2012, CHEM PHYS LETT, V519-20, P105, DOI 10.1016/j.cplett.2011.11.029
   Nagai M, 2006, INT J INFRARED MILLI, V27, P505, DOI 10.1007/s10762-006-9098-3
   Nibali VC, 2014, J AM CHEM SOC, V136, P12800, DOI 10.1021/ja504441h
   Ronne C, 1999, PHYS REV LETT, V82, P2888, DOI 10.1103/PhysRevLett.82.2888
   Shiraga K, 2013, FOOD CHEM, V140, P315, DOI 10.1016/j.foodchem.2013.02.066
   Tielrooij KJ, 2010, SCIENCE, V328, P1006, DOI 10.1126/science.1183512
   Tielrooij KJ, 2009, BIOPHYS J, V97, P2484, DOI 10.1016/j.bpj.2009.08.024
   Yada H, 2008, CHEM PHYS LETT, V464, P166, DOI 10.1016/j.cplett.2008.09.015
   Yada H, 2009, CHEM PHYS LETT, V473, P279, DOI 10.1016/j.cplett.2009.03.075
   Zhang JY, 2002, TISSUE ENG, V8, P771, DOI 10.1089/10763270260424132
NR 23
TC 1
Z9 1
U1 2
U2 22
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0003-6951
EI 1077-3118
J9 APPL PHYS LETT
JI Appl. Phys. Lett.
PD FEB 22
PY 2016
VL 108
IS 8
AR 081103
DI 10.1063/1.4942411
PG 3
WC Physics, Applied
SC Physics
GA DH8PO
UT WOS:000373057000003
DA 2018-10-19
ER

PT J
AU Cao, HL
   Qin, H
   Zhao, YC
   Jin, GD
   Lu, T
   Meng, FH
   Zhang, XL
   Liu, XY
AF Cao, Huiliang
   Qin, Hui
   Zhao, Yaochao
   Jin, Guodong
   Lu, Tao
   Meng, Fanhao
   Zhang, Xianlong
   Liu, Xuanyong
TI Nano-thick calcium oxide armed titanium: boosts bone cells against
   methicillin-resistant Staphylococcus aureus
SO SCIENTIFIC REPORTS
LA English
DT Article
ID FOREIGN-BODY INFECTION; ION-IMPLANTATION; MODEL; PATHOGENESIS;
   MECHANISMS; ADHESION
AB Since the use of systemic antibiotics for preventing acute biomaterial-associated infections (BAIs) may build up bacterial resistance and result in huge medical costs and unpredictable mortality, new precaution strategies are required. Here, it demonstrated that titanium armed with a nano-thick calcium oxide layer was effective on averting methicillin-resistant Staphylococcus aureus (MRSA) infections in rabbits. The calcium oxide layer was constructed by, firstly, injecting of metallic calcium into titanium via a plasma immersion ion implantation process, and then transforming the outer most surface into oxide by exposing to the atmosphere. Although the calcium oxide armed titanium had a relative low reduction rate (similar to 74%) in growth of MRSA in vitro, it could markedly promote the osteogenic differentiation of bone marrow stem cells (BMSCs), restore local bone integration against the challenge of MRSA, and decrease the incidence of MRSA infection with a rate of 100% (compared to the titanium control). This study demonstrated for the first time that calcium, as one of the major elements in a human body, could be engineered to avert MRSA infections, which is promising as a safe precaution of disinfection for implantable biomedical devices.
C1 [Cao, Huiliang; Jin, Guodong; Lu, Tao; Meng, Fanhao; Liu, Xuanyong] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
   [Qin, Hui; Zhao, Yaochao; Zhang, Xianlong] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Orthoped, Shanghai 200233, Peoples R China.
RP Liu, XY (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.; Zhang, XL (reprint author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Orthoped, Shanghai 200233, Peoples R China.
EM zhangxianl197826@163.com; xyliu@mail.sic.ac.cn
RI Liu, Xuanyong/J-2609-2018; Cao, Huiliang/V-1999-2017
OI Cao, Huiliang/0000-0002-5209-4497
FU National Basic Research Program of China (973 Program) [2012CB933600];
   National Natural Science Foundation of China [31370962]; Shanghai
   Committee of Science and Technology [14XD1403900]; Shanghai Rising-Star
   Program [15QA1404100]; Youth Innovation Promotion Association CAS
   [2015204]; Open Research Fund of State Key Laboratory of Bioelectronics,
   Southeast University
FX This work was supported by the National Basic Research Program of China
   (973 Program, 2012CB933600), National Natural Science Foundation of
   China (31370962), Shanghai Committee of Science and Technology
   (14XD1403900), Shanghai Rising-Star Program (15QA1404100), Youth
   Innovation Promotion Association CAS (2015204), and the Open Research
   Fund of State Key Laboratory of Bioelectronics, Southeast University.
CR Akiyama H, 1999, J DERMATOL SCI, V22, P62, DOI 10.1016/S0923-1811(99)00064-X
   Andrews JM, 2009, J ANTIMICROB CHEMOTH, V64, P454, DOI 10.1093/jac/dkp244
   Bae YS, 2011, MOL CELLS, V32, P491, DOI 10.1007/s10059-011-0276-3
   Bourre L, 2002, J PHOTOCH PHOTOBIO B, V67, P23, DOI 10.1016/S1011-1344(02)00279-8
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Campoccia D, 2013, BIOMATERIALS, V34, P8018, DOI 10.1016/j.biomaterials.2013.07.048
   Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x
   Ehrlich GD, 2005, CLIN ORTHOP RELAT R, P59, DOI 10.1097/01.blo.0000175125.60214.a4
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gonzalez-Vazquez A, 2014, ACTA BIOMATER, V10, P2824, DOI 10.1016/j.actbio.2014.02.004
   Grainger DW, 2013, BIOMATERIALS, V34, P9237, DOI 10.1016/j.biomaterials.2013.08.043
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hanawa T, 1997, J BIOMED MATER RES, V36, P131, DOI 10.1002/(SICI)1097-4636(199707)36:1<131::AID-JBM16>3.0.CO;2-L
   Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660
   Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032
   Jinno T, 2004, J ARTHROPLASTY, V19, P102, DOI 10.1016/j.arth.2003.10.001
   Kang SN, 2014, TISSUE ENG REGEN MED, V11, P39, DOI 10.1007/s13770-013-1104-y
   Kiernan JA, 2008, HISTOLOGICAL HISTOCH
   Krupa D, 2001, BIOMATERIALS, V22, P2139, DOI 10.1016/S0142-9612(00)00405-1
   Mohammadi Z, 2012, Chonnam Med J, V48, P133, DOI 10.4068/cmj.2012.48.3.133
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Moya JS, 2011, ADV ENG MATER, V13, pB256, DOI 10.1002/adem.201080133
   Naseem R, 2009, J MOL BIOL, V391, P42, DOI 10.1016/j.jmb.2009.05.064
   Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785
   Nayab SN, 2007, BIOMATERIALS, V28, P38, DOI 10.1016/j.biomaterials.2006.08.032
   Nayab SN, 2005, BIOMATERIALS, V26, P4717, DOI 10.1016/j.biomaterials.2004.11.044
   RAMACHANDRAN VS, 1964, NATURE, V201, P288, DOI 10.1038/201288a0
   Razzell W, 2013, CURR BIOL, V23, P424, DOI 10.1016/j.cub.2013.01.058
   Rosch JW, 2008, MOL MICROBIOL, V70, P435, DOI 10.1111/j.1365-2958.2008.06425.x
   Shen H, 2014, CHINESE MED J-PEKING, V127, P2748, DOI 10.3760/cma.j.issn.0366-6999.20140423
   Shen YH, 2012, J MATER CHEM, V22, P8662, DOI 10.1039/c2jm16141a
   Siqueira JF, 1999, INT ENDOD J, V32, P361, DOI 10.1046/j.1365-2591.1999.00275.x
   SOUTHWOOD RT, 1985, J BONE JOINT SURG BR, V67, P229
   Trampuz A, 2006, INJURY, V37, P59, DOI 10.1016/j.injury.2006.04.010
   van Oosten M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3584
   Vianna Morgana Eli, 2009, Braz. Dent. J., V20, P382, DOI 10.1590/S0103-64402009000500005
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
   Zimmerli W, 2011, SEMIN IMMUNOPATHOL, V33, P295, DOI 10.1007/s00281-011-0275-7
NR 43
TC 6
Z9 6
U1 2
U2 31
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 22
PY 2016
VL 6
AR 21761
DI 10.1038/srep21761
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DE3FR
UT WOS:000370513300001
PM 26899567
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Burkhardt, MA
   Waser, J
   Milleret, V
   Gerber, I
   Emmert, MY
   Foolen, J
   Hoerstrup, SP
   Schlottig, F
   Vogel, V
AF Burkhardt, Melanie A.
   Waser, Jasmin
   Milleret, Vincent
   Gerber, Isabel
   Emmert, Maximilian Y.
   Foolen, Jasper
   Hoerstrup, Simon P.
   Schlottig, Falko
   Vogel, Viola
TI Synergistic interactions of blood-borne immune cells, fibroblasts and
   extracellular matrix drive repair in an in vitro peri-implant wound
   healing model
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MESENCHYMAL STROMAL CELLS; FIBRONECTIN-FIBRIN MATRIX; COLD-INSOLUBLE
   GLOBULIN; MYOFIBROBLAST DIFFERENTIATION; MACROPHAGE PHENOTYPE; DENTAL
   IMPLANTS; CROSS-LINKING; BONE REPAIR; TITANIUM; SURFACE
AB Low correlations of cell culture data with clinical outcomes pose major medical challenges with costly consequences. While the majority of biomaterials are tested using in vitro cell monocultures, the importance of synergistic interactions between different cell types on paracrine signalling has recently been highlighted. In this proof-of-concept study, we asked whether the first contact of surfaces with whole human blood could steer the tissue healing response. This hypothesis was tested using alkali-treatment of rough titanium (Ti) surfaces since they have clinically been shown to improve early implant integration and stability, yet blood-free in vitro cell cultures poorly correlated with in vivo tissue healing. We show that alkali-treatment, compared to native Ti surfaces, increased blood clot thickness, including platelet adhesion. Strikingly, blood clots with entrapped blood cells in synergistic interactions with fibroblasts, but not fibroblasts alone, upregulated the secretion of major factors associated with fast healing. This includes matrix metalloproteinases (MMPs) to break down extracellular matrix and the growth factor VEGF, known for its angiogenic potential. Consequently, in vitro test platforms, which consider whole blood-implant interactions, might be superior in predicting wound healing in response to biomaterial properties.
C1 [Burkhardt, Melanie A.; Gerber, Isabel; Foolen, Jasper; Vogel, Viola] Swiss Fed Inst Technol, Lab Appl Mechanobiol, Dept Hlth Sci & Technol, CH-8093 Zurich, Switzerland.
   [Waser, Jasmin; Schlottig, Falko] Thommen Med AG, CH-2540 Grenchen, Switzerland.
   [Milleret, Vincent] Univ Zurich Hosp, Lab Cell & Tissue Engn, Dept Obstet, CH-8091 Zurich, Switzerland.
   [Emmert, Maximilian Y.; Hoerstrup, Simon P.] Swiss Ctr Regenerat Med, CH-8091 Zurich, Switzerland.
   [Schlottig, Falko] Univ Appl Sci Northwestern Switzerland, Sch Life Sci, CH-4132 Muttenz, Switzerland.
RP Vogel, V (reprint author), Swiss Fed Inst Technol, Lab Appl Mechanobiol, Dept Hlth Sci & Technol, CH-8093 Zurich, Switzerland.
EM viola.vogel@hest.ethz.ch
RI Vogel, Viola/O-8025-2015
OI Vogel, Viola/0000-0003-2898-7671
FU Scientific Center for Optical and Electron Microscopy ScopeM of ETH
   Zurich; ERC Advanced Grant of the European Research Council [233157];
   Swiss National Science Foundation (SNF) [310030B-133122]; SwissTransMed
   [33/2013]; European Union Seventh Framework Programme (FP7)
   [PIEF-GA-2013-628585]
FX The authors gratefully acknowledge Thommen Medical AG for providing SBA
   Ti surfaces and the Scientific Center for Optical and Electron
   Microscopy ScopeM of ETH Zurich for support. We thank Chantel Spencer
   for helping with ELISA assays, Dr. Thomas Hefti for giving input on
   experimental plans and Daniela Ortiz Franyuti for drawing Figure 7. The
   authors acknowledge funding from the ERC Advanced Grant of the European
   Research Council, Contract No. 233157 (V.V.), the Swiss National Science
   Foundation (SNF, Contract No. 310030B-133122) (V.V.), the SwissTransMed
   33/2013 (LifeMatrix) (V.V.). The research leading to these results has
   received funding from the European Union Seventh Framework Programme
   (FP7/2007-2013) under grant agreement no. PIEF-GA-2013-628585 (J.F.).
CR Al Mustafa M, 2015, CLIN ORAL IMPLAN RES, V26, P15, DOI 10.1111/clr.12294
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Arvidsson S, 2007, BIOMATERIALS, V28, P1346, DOI 10.1016/j.biomaterials.2006.11.005
   Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217
   Bae SE, 2012, BIOMACROMOLECULES, V13, P2811, DOI 10.1021/bm300791h
   Ballotta V, 2014, BIOMATERIALS, V35, P9100, DOI 10.1016/j.biomaterials.2014.07.042
   Bar-Or A, 2003, BRAIN, V126, P2738, DOI 10.1093/brain/awg285
   Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001
   Bratton DL, 2011, TRENDS IMMUNOL, V32, P350, DOI 10.1016/j.it.2011.04.009
   Buser D, 2004, J DENT RES, V83, P529, DOI 10.1177/154405910408300704
   Calvo-Guirado JL, 2010, CLIN ORAL IMPLAN RES, V21, P308, DOI 10.1111/j.1600-0501.2009.01841.x
   Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6
   Chen WJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4472
   Cooper LF, 2000, J PROSTHET DENT, V84, P522, DOI 10.1067/mpr.2000.111966
   Corbett SA, 1996, BLOOD, V88, P158
   Corbett SA, 1997, J BIOL CHEM, V272, P24999, DOI 10.1074/jbc.272.40.24999
   Daley JM, 2005, J IMMUNOL, V174, P2265, DOI 10.4049/jimmunol.174.4.2265
   Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047
   Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   GRINNELL F, 1980, CELL, V19, P517, DOI 10.1016/0092-8674(80)90526-7
   GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Held U, 2013, HEAD FACE MED, V9, DOI 10.1186/1746-160X-9-37
   Hempel U, 2013, CLIN ORAL IMPLAN RES, V24, P174, DOI 10.1111/j.1600-0501.2011.02328.x
   Herter JM, 2014, THROMB HAEMOSTASIS, V12, P1764, DOI DOI 10.1111/JTH.12730
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Kopf BS, 2015, ACTA BIOMATER, V19, P180, DOI 10.1016/j.actbio.2015.03.022
   Laurens N, 2006, J THROMB HAEMOST, V4, P932, DOI 10.1111/j.1538-7836.2006.01861.x
   Lichtnekert J, 2013, CURR OPIN PHARMACOL, V13, P555, DOI 10.1016/j.coph.2013.05.013
   Lindemann S, 2001, J CELL BIOL, V154, P485, DOI 10.1083/jcb.200105058
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Meszaros AJ, 1999, J LEUKOCYTE BIOL, V65, P35
   Midgley AC, 2013, J BIOL CHEM, V288, P14824, DOI 10.1074/jbc.M113.451336
   Milleret V, 2012, ACTA BIOMATER, V8, P4349, DOI 10.1016/j.actbio.2012.07.032
   Milleret V, 2011, EUR CELLS MATER, V21, P430, DOI 10.22203/eCM.v021a32
   Mirastschijski U, 2010, WOUND REPAIR REGEN, V18, P223, DOI 10.1111/j.1524-475X.2010.00574.x
   MOSHER DF, 1975, J BIOL CHEM, V250, P6614
   Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898
   Nurden AT, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2947
   Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418
   Peters T, 2005, EMBO J, V24, P3400, DOI 10.1038/sj.emboj.7600809
   Phelps EA, 2010, CURR OPIN BIOTECH, V21, P704, DOI 10.1016/j.copbio.2010.06.005
   Saran U, 2014, ARCH BIOCHEM BIOPHYS, V561, P109, DOI 10.1016/j.abb.2014.07.006
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schwarz F, 2009, J BIOMED MATER RES B, V88B, P544, DOI 10.1002/jbm.b.31233
   Shiu HT, 2014, TISSUE ENG PART B-RE, V20, P697, DOI [10.1089/ten.teb.2013.0709, 10.1089/ten.TEB.2013.0709]
   Stadlinger B, 2012, BRIT J ORAL MAX SURG, V50, P74, DOI 10.1016/j.bjoms.2010.11.013
   Stadlinger B, 2009, J CLIN PERIODONTOL, V36, P882, DOI 10.1111/j.1600-051X.2009.01466.x
   Stanford CM, 2010, INT J MOL SCI, V11, P354, DOI 10.3390/ijms11010354
   Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x
   Tugulu S, 2010, J MATER SCI-MATER M, V21, P2751, DOI 10.1007/s10856-010-4138-x
   Turbill P, 1996, BIOMATERIALS, V17, P1279, DOI 10.1016/0142-9612(96)88673-X
   Vasak C, 2014, CLIN ORAL IMPLAN RES, V25, P1378, DOI 10.1111/clr.12277
   Willenborg S, 2012, BLOOD, V120, P613, DOI 10.1182/blood-2012-01-403386
   Zarbock A, 2007, BLOOD REV, V21, P99, DOI 10.1016/j.blre.2006.06.001
   Zhang Y, 2014, MATRIX BIOL, V40, P62, DOI 10.1016/j.matbio.2014.09.001
NR 60
TC 5
Z9 5
U1 0
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 17
PY 2016
VL 6
AR 21071
DI 10.1038/srep21071
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DE1HW
UT WOS:000370378800001
PM 26883175
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Chiatti, F
   Delle Piane, M
   Ugliengo, P
   Corno, M
AF Chiatti, Fabio
   Delle Piane, Massimo
   Ugliengo, Piero
   Corno, Marta
TI Water at hydroxyapatite surfaces: the effect of coverage and surface
   termination as investigated by all-electron B3LYP-D* simulations
SO THEORETICAL CHEMISTRY ACCOUNTS
LA English
DT Article
DE Hydroxyapatite; Periodic modeling; Biomaterial; Water adsorption;
   B3LYP-D*; CRYSTAL14; Surface properties
ID DIFFERENTIAL SCANNING CALORIMETER; MOLECULAR-DYNAMICS; PHASE-TRANSITION;
   GLYCINE ADSORPTION; CATIONIC SITES; CRYSTAL-GROWTH; CITRIC-ACID;
   AB-INITIO; DENSITY; B3LYP
AB Hydroxyapatite [HA, Ca-10(PO4)(6)(OH)(2)], the main constituent of bones and teeth enamels, is a widely studied and employed biomaterial. Its applications span from dental to orthopedic implants, including bone tissue engineering scaffolds, coating, filler and many others. Previous theoretical and experimental studies have already characterized the physical-chemical foundations of water adsorption on a number of HA surfaces, an essential step in the mechanism of biomaterial integration. Here, we extend such knowledge by simulating, at a hybrid DFT level of theory, different HA surface terminations, both stoichiometric and non-stoichiometric, as free and in interaction with water. Such a goal is achieved at an unprecedented accuracy, with a large all-electron basis set and including dispersion forces contributions. The calculated results are then compared with experimental micro-calorimetric data, showing a good agreement in the loading trend of the (010) surfaces. More generally, this theoretical approach is confirmed to be an efficient tool to analyze these biomaterials, giving the possibility to investigate the HA behavior toward more complex molecules, from amino acids to collagen, at the here-presented level of theory, to shed some light on the complex biomineralization process of human bones and teeth.
C1 [Chiatti, Fabio; Delle Piane, Massimo; Ugliengo, Piero; Corno, Marta] Univ Turin, Dipartimento Chim, Via P Giuria 7, I-10125 Turin, Italy.
   [Chiatti, Fabio; Delle Piane, Massimo; Ugliengo, Piero; Corno, Marta] NIS Nanostruct Interfaces & Surfaces Ctr, Via P Giuria 7, I-10125 Turin, Italy.
RP Corno, M (reprint author), Univ Turin, Dipartimento Chim, Via P Giuria 7, I-10125 Turin, Italy.; Corno, M (reprint author), NIS Nanostruct Interfaces & Surfaces Ctr, Via P Giuria 7, I-10125 Turin, Italy.
EM marta.corno@unito.it
RI Corno, Marta/I-4310-2012; ugliengo, piero/H-6373-2015; Delle Piane,
   Massimo/K-5153-2012
OI Corno, Marta/0000-0001-7248-2705; ugliengo, piero/0000-0001-8886-9832;
   Delle Piane, Massimo/0000-0001-8522-9047
CR Almora-Barrios N, 2012, CRYST GROWTH DES, V12, P756, DOI 10.1021/cg201092s
   Astala R, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.075427
   BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913
   Bertinetti L, 2007, J PHYS CHEM C, V111, P4027, DOI 10.1021/jp066040s
   Bolis V, 2012, PHILOS T R SOC A, V370, P1313, DOI 10.1098/rsta.2011.0273
   BOYS SF, 1970, MOL PHYS, V19, P553, DOI 10.1080/00268977000101561
   Bystrov VS, 2013, FERROELECTRICS, V449, P94, DOI 10.1080/00150193.2013.822774
   Canepa P, 2011, PHYS CHEM CHEM PHYS, V13, P1099, DOI 10.1039/c0cp01143f
   CATTI M, 1991, J PHYS-CONDENS MAT, V3, P4151, DOI 10.1088/0953-8984/3/23/004
   Chiatti F, 2013, J PHYS CHEM C, V117, P25526, DOI 10.1021/jp4086574
   Chiatti F, 2012, J PHYS CHEM C, V116, P6108, DOI 10.1021/jp212595d
   Civalleri B, 2008, CRYSTENGCOMM, V10, P405, DOI 10.1039/b715018k
   Cora F, 2004, STRUCT BOND, V113, P171, DOI 10.1007/b97944
   Corno M, 2014, ENCY NANOTECHNOL, P1
   Corno M, 2007, EUR J MINERAL, V19, P757, DOI 10.1127/0935-1221/2007/0019-1764
   Corno M, 2006, PHYS CHEM CHEM PHYS, V8, P2464, DOI 10.1039/b602419j
   Corno M, 2011, BIOMATERIALS - PHYSICS AND CHEMISTRY, P275
   Corno M, 2010, PHYS CHEM CHEM PHYS, V12, P6309, DOI 10.1039/c002146f
   Corno M, 2009, LANGMUIR, V25, P2188, DOI 10.1021/la803253k
   Currey JD, 2005, SCIENCE, V309, P253, DOI 10.1126/science.1113954
   de Leeuw NH, 2007, CRYSTENGCOMM, V9, P1178, DOI 10.1039/b710974a
   Dovesi IL, 2014, CRYSTAL14 USERS MANU
   Dovesi R, 2014, INT J QUANTUM CHEM, V114, P1287, DOI 10.1002/qua.24658
   Filgueiras MRT, 2006, J CRYST GROWTH, V294, P60, DOI 10.1016/j.jcrysgro.2006.05.077
   FLETCHER R, 1970, COMPUT J, V13, P317, DOI 10.1093/comjnl/13.3.317
   Hernandez SER, 2015, PHYS CHEM CHEM PHYS, V17, P22377, DOI 10.1039/c5cp02630j
   Hochrein O, 2005, CHEM MATER, V17, P1978, DOI 10.1021/cm0401903
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Jimenez-Izal E, 2012, J PHYS CHEM C, V116, P14561, DOI 10.1021/jp304473p
   Kato K, 2015, CHEM PHYS LETT, V629, P58, DOI 10.1016/j.cplett.2015.03.057
   Katti DR, 2015, MAT SCI ENG C-MATER, V46, P207, DOI 10.1016/j.msec.2014.07.057
   KUKURA M, 1972, J PHYS CHEM-US, V76, P900, DOI 10.1021/j100650a019
   Lang SB, 2013, SCI REP-UK, V3, DOI 10.1038/srep02215
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   Lemaire T, 2015, J BIOMECH, V48, P3066, DOI 10.1016/j.jbiomech.2015.07.025
   MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188
   Mugnaioli E, 2014, CHEM-EUR J, V20, P6849, DOI 10.1002/chem.201402275
   Ospina CA, 2012, COLLOID SURFACE B, V89, P15, DOI 10.1016/j.colsurfb.2011.08.016
   Pascale F, 2004, J COMPUT CHEM, V25, P888, DOI 10.1002/jcc.20019
   Peccati F, 2014, J PHYS CHEM C, V118, P1364, DOI 10.1021/jp4108415
   Ratner B. D., 2013, BIOMATERIALS SCI
   Rimola A, 2011, J PHYS CHEM LETT, V2, P1390, DOI 10.1021/jz200457x
   Rimola A, 2009, PHYS CHEM CHEM PHYS, V11, P9005, DOI 10.1039/b913311a
   Roosen AR, 1998, COMP MATER SCI, V11, P16, DOI 10.1016/S0927-0256(97)00167-5
   Rulis P, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.245410
   Sakhno Y, 2015, J PHYS CHEM C, V119, P5928, DOI 10.1021/jp510492m
   Sakhno Y, 2010, J PHYS CHEM C, V114, P16640, DOI 10.1021/jp105971s
   Sato K, 2002, J AM CERAM SOC, V85, P3054
   SCHAFER A, 1992, J CHEM PHYS, V97, P2571, DOI 10.1063/1.463096
   SHANNO DF, 1970, MATH COMPUT, V24, P657, DOI 10.2307/2004841
   Slepko A, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4813828
   SUDA H, 1995, J PHYS CHEM-US, V99, P6752, DOI 10.1021/j100017a068
   Suetsugu Y, 2002, J MATER SCI-MATER M, V13, P767, DOI 10.1023/A:1016170924138
   Takahashi H, 2001, THERMOCHIM ACTA, V371, P53, DOI 10.1016/S0040-6031(01)00431-2
   Tao JH, 2015, LANGMUIR, V31, P10451, DOI 10.1021/acs.langmuir.5b02549
   Tao JH, 2015, P NATL ACAD SCI USA, V112, P326, DOI 10.1073/pnas.1404481112
   Tarini M, 2006, IEEE T VIS COMPUT GR, V12, P1237, DOI 10.1109/TVCG.2006.115
   UGLIENGO P, 1993, Z KRISTALLOGR, V207, P9, DOI 10.1524/zkri.1993.207.Part-1.9
   Wang ZQ, 2015, J MATER CHEM B, V3, P9157, DOI 10.1039/c5tb01036e
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Wierzbicki A, 2000, J MOL STRUC-THEOCHEM, V529, P73, DOI 10.1016/S0166-1280(00)00534-0
   Wu F, 2015, CRYST GROWTH DES, V15, P2452, DOI 10.1021/acs.cgd.5b00231
   Zahn D, 2003, PHYS CHEM CHEM PHYS, V5, P4004, DOI 10.1039/b306358e
   Zeglinski J, 2014, SURF SCI, V623, P55, DOI 10.1016/j.susc.2014.01.008
   Zhao WL, 2014, LANGMUIR, V30, P13283, DOI 10.1021/la503158p
NR 65
TC 12
Z9 12
U1 4
U2 58
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1432-881X
EI 1432-2234
J9 THEOR CHEM ACC
JI Theor. Chem. Acc.
PD FEB 16
PY 2016
VL 135
IS 3
AR 54
DI 10.1007/s00214-016-1818-8
PG 15
WC Chemistry, Physical
SC Chemistry
GA DH2TT
UT WOS:000372640100001
DA 2018-10-19
ER

PT J
AU Lawrence, H
   Mawdesley, AE
   Holland, JP
   Kirby, JA
   Deehan, DJ
   Tyson-Capper, AJ
AF Lawrence, Helen
   Mawdesley, Amy Elizabeth
   Holland, James Patrick
   Kirby, John Andrew
   Deehan, David John
   Tyson-Capper, Alison Jane
TI Targeting Toll-like receptor 4 prevents cobalt-mediated inflammation
SO ONCOTARGET
LA English
DT Article
DE cobalt; metal-on-metal; antibody; TLR4; inflammation; Immunology and
   Microbiology Section; Immune response; Immunity
ID HIP-ARTHROPLASTY; REPLACEMENT
AB Cobalt-chrome alloy is a widely used biomaterial in joint replacements, dental implants and spinal rods. Although it is an effective and biocompatible material, adverse reactions to metal debris (ARMD) have arisen in a minority of patients, particularly in those with metal-on-metal bearing hip replacements. There is currently no treatment for ARMD and once progressive, early revision surgery of the implant is necessary. Therapeutic agents to prevent, halt or reverse ARMD would therefore be advantageous.
   Cobalt ions activate Toll-like receptor 4 (TLR4), an innate immune receptor responsible for inflammatory responses to bacterial lipopolysaccharide (LPS) resulting in the production of pro-inflammatory cytokines and chemokines. We hypothesised that anti-TLR4 neutralising antibodies, reported to inhibit TLR4-mediated inflammation, could prevent the inflammatory response to cobalt ions in an in vitro macrophage cell culture model.
   This study shows that a monoclonal anti-TLR4 antibody inhibited cobalt-mediated increases in pro-inflammatory IL8, CCL20 and IL1A expression, as well as IL-8 secretion. In contrast, a polyclonal antibody did not prevent the effect of cobalt ions on either IL-8 or IL1A expression, although it did have a small effect on the CCL20 response. Interestingly, both antibodies inhibited cobalt-mediated neutrophil migration although the greater effect was observed with the monoclonal antibody.
   In summary our data shows that a monoclonal anti-TLR4 antibody can inhibit cobalt-mediated inflammatory responses while a polyclonal antibody only inhibits the effect of specific cytokines. Anti-TLR4 antibodies have therapeutic potential in ARMD although careful antibody design is required to ensure that the LPS response is preserved.
C1 [Lawrence, Helen; Mawdesley, Amy Elizabeth; Kirby, John Andrew; Deehan, David John; Tyson-Capper, Alison Jane] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Holland, James Patrick; Deehan, David John] Freeman Rd Hosp, Musculoskeletal Serv, Newcastle Upon Tyne, Tyne & Wear, England.
RP Tyson-Capper, AJ (reprint author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM alison.tyson-capper@ncl.ac.uk
FU Newcastle NIHR Biomedical Research Centre; DePuy Synthes Ltd.
FX HL is supported by a studentship from the Newcastle NIHR Biomedical
   Research Centre and DePuy Synthes Ltd.
CR AAOS, 2012, CURR MET ON MET HIP
   Daniel J, 2012, J BONE JOINT SURG AM, V94A, P86, DOI 10.2106/JBJS.J.01612
   de Steiger RN, 2010, ACTA ORTHOP, V81, P72, DOI 10.3109/17453671003667176
   DRANSFIELD I, 1994, J IMMUNOL, V153, P1254
   Ekaney ML, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0543-8
   Grammatopoulos G, 2009, J BONE JOINT SURG BR, V91B, P1019, DOI 10.1302/0301-620X.91B8.22562
   Jiang X, 2015, J ORTHOPAEDIC RES
   Langton DJ, 2010, J BONE JOINT SURG BR, V92B, P38, DOI 10.1302/0301-620X.92B1.22770
   Lawrence H, 2014, BONE JOINT J B, V69B, P1172
   Lima CX, 2015, PLOS ONE, V10
   Monnet E, 2015, ANN RHEUMATIC DIS
   Pajarinen J, 2015, J BIOMED MATER RES A, V103, P1339, DOI 10.1002/jbm.a.35278
   Perino G, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-39
   Potnis PA, 2013, CELL IMMUNOL, V282, P53, DOI 10.1016/j.cellimm.2013.04.003
   Powers-Freeling L, 2015, NATL JOINT REGISTRY
   Raghavan B, 2012, EMBO REP, V13, P1109, DOI 10.1038/embor.2012.155
   Tyson-Capper AJ, 2013, ANN RHEUM DIS, V72, P460, DOI 10.1136/annrheumdis-2012-202468
   Watters TS, 2010, AM J CLIN PATHOL, V134, P886, DOI 10.1309/AJCPLTNEUAH8XI4W
NR 18
TC 4
Z9 4
U1 1
U2 8
PU IMPACT JOURNALS LLC
PI ALBANY
PA 6211 TIPTON HOUSE, STE 6, ALBANY, NY 12203 USA
SN 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD FEB 16
PY 2016
VL 7
IS 7
BP 7578
EP 7585
DI 10.18632/oncotarget.7105
PG 8
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA DE0PD
UT WOS:000370325900018
PM 26840091
OA Other Gold, Green Published
DA 2018-10-19
ER

PT J
AU Masoom, H
   Courtier-Murias, D
   Farooq, H
   Soong, R
   Kelleher, BP
   Zhang, C
   Maas, WE
   Fey, M
   Kumar, R
   Monette, M
   Stronks, HJ
   Simpson, MJ
   Simpson, AJ
AF Masoom, Hussain
   Courtier-Murias, Denis
   Farooq, Hashim
   Soong, Ronald
   Kelleher, Brian P.
   Zhang, Chao
   Maas, Werner E.
   Fey, Michael
   Kumar, Rajeev
   Monette, Martine
   Stronks, Henry J.
   Simpson, Myrna J.
   Simpson, Andre J.
TI Soil Organic Matter in Its Native State: Unravelling the Most Complex
   Biomaterial on Earth
SO ENVIRONMENTAL SCIENCE & TECHNOLOGY
LA English
DT Article
ID POLYCYCLIC AROMATIC-HYDROCARBONS; HUMIC SUBSTANCES; NMR-SPECTROSCOPY;
   MINERAL SURFACES; CARBON SEQUESTRATION; MOLECULAR-STRUCTURE; SORPTION;
   MODEL; STABILIZATION; LIGNIN
AB Since the isolation of soil organic matter in 1786, tens of thousands of publications have searched for its structure. Nuclear magnetic resonance (NMR) spectroscopy has played a critical role in defining soil organic matter but traditional approaches remove key information such as the distribution of components at the soil water interface and conformational information. Here a novel form of NMR with capabilities to study all physical phases termed Comprehensive Multiphase NMR, is applied to analyze soil in its natural swollen-state. The key structural components in soil organic matter are identified to be largely composed of macro molecular inputs from degrading biomass. Polar lipid heads and carbohydrates dominate the soil water interface while lignin and microbes are arranged in a more hydrophobic interior. Lignin domains cannot be penetrated by aqueous solvents even at extreme pH indicating they are the most hydrophobic environment in soil and are ideal for sequestering hydrophobic contaminants. Here, for the first time, a complete range of physical states of a whole soil can be studied. This provides a more detailed understanding of soil organic matter at the molecular level itself key to develop the most efficient soil remediation and agricultural techniques, and better predict carbon sequestration and climate change.
C1 [Masoom, Hussain; Courtier-Murias, Denis; Farooq, Hashim; Soong, Ronald; Zhang, Chao; Simpson, Myrna J.; Simpson, Andre J.] Univ Toronto, Dept Chem, Toronto, ON M1C 1A4, Canada.
   [Kelleher, Brian P.] Dublin City Univ, Sch Chem Sci, Dublin 9, Ireland.
   [Maas, Werner E.; Fey, Michael] Bruker BioSpin Corp, Billerica, MA 01821 USA.
   [Kumar, Rajeev; Monette, Martine; Stronks, Henry J.] Bruker BioSpin Canada, Milton, ON L9T 1Y6, Canada.
RP Simpson, AJ (reprint author), Univ Toronto, Dept Chem, Toronto, ON M1C 1A4, Canada.
EM andre.simpson@utoronto.ca
OI Simpson, Myrna/0000-0002-8084-411X; Courtier-Murias,
   Denis/0000-0001-8023-738X
FU Natural Sciences and Engineering Research Council of Canada (NSERC);
   Ontario Graduate Scholarship; NSERC; Canada Foundation for Innovation
   (CFI); Ministry of Research and Innovation (MRI); Krembil Foundation;
   Government of Ontario; Irish EPA
FX H.M. thanks the Natural Sciences and Engineering Research Council of
   Canada (NSERC) for a postgraduate doctoral award and the Ontario
   Graduate Scholarship for funding. A.J.S. thanks NSERC, (Strategic and
   Discovery Programs), the Canada Foundation for Innovation (CFI), and the
   Ministry of Research and Innovation (MRI) and Krembil Foundation for
   providing funding. A.J.S. also thanks the Government of Ontario for an
   Early Researcher Award. B.K thanks the Irish EPA for funding through the
   STRIVE programme.
CR Alexander M, 2000, ENVIRON SCI TECHNOL, V34, P4259, DOI 10.1021/es001069+
   Almendros G, 1998, SOIL BIOL BIOCHEM, V30, P755, DOI 10.1016/S0038-0717(97)00175-2
   Almendros G, 1996, ORG GEOCHEM, V24, P651, DOI 10.1016/0146-6380(96)00056-3
   BAEK SO, 1991, WATER AIR SOIL POLL, V60, P279, DOI 10.1007/BF00282628
   Baldock JA, 2000, ORG GEOCHEM, V31, P697, DOI 10.1016/S0146-6380(00)00049-8
   Baldock JA, 1997, AUST J SOIL RES, V35, P1061, DOI 10.1071/S97004
   Brady NC, 2007, NATURE PROPERTIES SO
   Brown RB, 2008, J R SOC INTERFACE, V5, pS131, DOI 10.1098/rsif.2008.0009.focus
   Chefetz B, 2003, ENVIRON TOXICOL CHEM, V22, P2492, DOI 10.1897/02-461
   Clemente JS, 2013, ORG GEOCHEM, V58, P1, DOI 10.1016/j.orggeochem.2013.02.007
   Clemente JS, 2011, ORG GEOCHEM, V42, P1169, DOI 10.1016/j.orggeochem.2011.08.010
   Conte P, 1997, GEODERMA, V80, P339, DOI 10.1016/S0016-7061(97)00059-1
   Conte P, 2008, ANAL SCI, V24, P1183, DOI 10.2116/analsci.24.1183
   Courtier-Murias D, 2013, AGR ECOSYST ENVIRON, V171, P9, DOI 10.1016/j.agee.2013.03.010
   Courtier-Murias D, 2012, J MAGN RESON, V217, P61, DOI 10.1016/j.jmr.2012.02.009
   DAVID NA, 1972, ANNU REV PHARMACOLOG, V12, P353, DOI 10.1146/annurev.pa.12.040172.002033
   Derenne S, 2014, CR GEOSCI, V346, P53, DOI 10.1016/j.crte.2014.02.005
   Emery EF, 2001, ENVIRON SCI TECHNOL, V35, P2973, DOI 10.1021/es9911566
   Feng XJ, 2005, ORG GEOCHEM, V36, P1553, DOI 10.1016/j.orggeochem.2005.06.008
   Heberer T, 2002, TOXICOL LETT, V131, P5, DOI 10.1016/S0378-4274(02)00041-3
   Heim A, 2007, EUR J SOIL SCI, V58, P599, DOI 10.1111/j.1365-2389.2006.00848.x
   Heim A, 2007, ORG GEOCHEM, V38, P2001, DOI 10.1016/j.orggeochem.2007.08.009
   Hertkorn N, 2007, ANAL BIOANAL CHEM, V389, P1311, DOI 10.1007/s00216-007-1577-4
   JENKINSON DS, 1991, NATURE, V351, P304, DOI 10.1038/351304a0
   Johnson MD, 2001, ENVIRON SCI TECHNOL, V35, P1680, DOI 10.1021/es001390s
   Kaiser J, 2004, SCIENCE, V304, P1616, DOI 10.1126/science.304.5677.1616
   Kanicky JR, 2002, J COLLOID INTERF SCI, V256, P201, DOI 10.1006/jcis.2001.8009
   Kelleher BP, 2006, ENVIRON SCI TECHNOL, V40, P4605, DOI 10.1021/es0608085
   Kim J, 2004, SCIENCE, V303, P830, DOI 10.1126/science.1093245
   KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S
   Kleber M, 2007, BIOGEOCHEMISTRY, V85, P9, DOI 10.1007/s10533-007-9103-5
   KOGELKNABNER I, 1994, ORG GEOCHEM, V21, P1219, DOI 10.1016/0146-6380(94)90165-1
   Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j
   Lal R, 2007, SOIL SCI, V172, P943, DOI 10.1097/ss.0b013e31815cc498
   Lower SK, 2001, SCIENCE, V292, P1360, DOI 10.1126/science.1059567
   Maas WE, 1999, J MAGN RESON, V141, P29, DOI 10.1006/jmre.1999.1892
   Masoom H, 2013, ENVIRON TOXICOL CHEM, V32, P129, DOI 10.1002/etc.2028
   Okx JP, 1996, ENVIRON SCI POLLUT R, V3, P229, DOI 10.1007/BF02986966
   Perminova IV, 1999, ENVIRON SCI TECHNOL, V33, P3781, DOI 10.1021/es990056x
   Plaza C, 2013, SOIL BIOL BIOCHEM, V57, P124, DOI 10.1016/j.soilbio.2012.07.026
   Poirier N, 2000, ORG GEOCHEM, V31, P813, DOI 10.1016/S0146-6380(00)00067-X
   SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407
   SCHULTEN HR, 1993, NATURWISSENSCHAFTEN, V80, P29, DOI 10.1007/BF01139754
   Semple KT, 2003, EUR J SOIL SCI, V54, P809, DOI [10.1046/j.1351-0754.2003.0564.x, 10.1046/j.1365-2389.2003.00564.x]
   Shirzadi A, 2008, ENVIRON SCI TECHNOL, V42, P5514, DOI 10.1021/es800115b
   Simpson AJ, 2001, ENVIRON SCI TECHNOL, V35, P3321, DOI 10.1021/es010607v
   Simpson AJ, 2007, ENVIRON SCI TECHNOL, V41, P8070, DOI 10.1021/es071217x
   Simpson AJ, 2007, ENVIRON SCI TECHNOL, V41, P876, DOI 10.1021/es061576c
   Simpson AJ, 2011, PROG NUCL MAG RES SP, V58, P97, DOI 10.1016/j.pnmrs.2010.09.001
   Song XY, 2013, SCI TOTAL ENVIRON, V458, P319, DOI 10.1016/j.scitotenv.2013.04.052
   STEVENSON F J, 1994, HUMUS CHEM GENESIS C
   Sun K, 2008, ENVIRON SCI TECHNOL, V42, P1961, DOI 10.1021/es7024627
   Sutton R, 2005, ENVIRON SCI TECHNOL, V39, P9009, DOI 10.1021/es050778q
   Xing BS, 1996, ENVIRON SCI TECHNOL, V30, P2432, DOI 10.1021/es950350z
   Young IM, 2004, SCIENCE, V304, P1634, DOI 10.1126/science.1097394
NR 55
TC 9
Z9 9
U1 6
U2 80
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0013-936X
EI 1520-5851
J9 ENVIRON SCI TECHNOL
JI Environ. Sci. Technol.
PD FEB 16
PY 2016
VL 50
IS 4
BP 1670
EP 1680
DI 10.1021/acs.est.5b03410
PG 11
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA DE2JS
UT WOS:000370454200006
PM 26783947
DA 2018-10-19
ER

PT J
AU Mahmoud, AA
   Salama, AH
AF Mahmoud, Azza A.
   Salama, Alaa H.
TI Norfloxacin-loaded collagen/chitosan scaffolds for skin reconstruction:
   Preparation, evaluation and in-vivo wound healing assessment
SO EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE Chitosan; Collagen; Scaffold; Wound healing; Terahertz imaging
ID CHITOSAN SPONGE SCAFFOLD; EXTRACELLULAR-MATRIX; ANTIBACTERIAL ACTIVITY;
   MECHANICAL-PROPERTIES; THERAPEUTIC-EFFICACY; MEDICAL APPLICATIONS;
   ARTIFICIAL SKIN; COLLAGEN SPONGE; DIABETIC-RATS; FIBROBLASTS
AB Biomaterial scaffolds are versatile tools as drug carrier for treatment of wounds. A series of norfloxacin-loaded scaffolds were synthesized for treatment of wounds by combining collagen with two different types of chitosan using freeze-drying technique. Subsequently, scaffolds were screened in terms of morphology, water absorption and retention capacity, biodegradation, ex-vivo bioadhesive strength, in-vitro drug release biological compatibility, X-ray diffractometry, differential scanning calorimetry as well as in-vivo evaluation. The results indicate that the scaffold mechanical strength is dependent on the type of used chitosan. The prepared scaffolds contained interconnected porous architecture. The scaffolds had highwater uptake and retention capacity with extended biodegradation rate. Scaffolds prepared with chitosan HCl showed superior bioadhesive strength compared to those prepared with low molecular weight chitosan. All scaffolds showed almost 100% drug release within 24 h. As identified by the terahertz pulsed imaging measurements, there is single scaffold area with the same concentration. After 28 days of wound dressing with selected norfoloxacin-loaded or unloaded collagen/chitosan scaffolds in Albino rats, it was found that the tissue regeneration time was fast compared to non-treated wounds. Furthermore, the drug-loaded scaffolds showed normal structure of an intact epidermal layer as well as the underlying dermis as revealed by histopathological studies. The obtained results suggest that the investigated norfloxacin-loaded collagen/chitosan scaffold is a potential candidate for skin regeneration application. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Mahmoud, Azza A.; Salama, Alaa H.] Natl Res Ctr, Dept Pharmaceut Technol, Cairo, Egypt.
   [Mahmoud, Azza A.] Future Univ Egypt, Fac Pharmaceut Sci & Pharmaceut Ind, Dept Pharmaceut & Pharmaceut Technol, Cairo, Egypt.
RP Salama, AH (reprint author), Natl Res Ctr, Dept Pharmaceut Technol, Cairo, Egypt.
RI Mahmoud, Azza/S-1502-2016
OI Salama, Alaa/0000-0003-0028-2645; Mahmoud, Azza/0000-0002-4716-7524
CR Anisha BS, 2013, CARBOHYD POLYM, V92, P1470, DOI 10.1016/j.carbpol.2012.10.058
   [Anonymous], 2000, F163595 ASTM INT
   Cho YW, 1999, BIOMATERIALS, V20, P2139, DOI 10.1016/S0142-9612(99)00116-7
   CHVAPIL M, 1977, J BIOMED MATER RES, V11, P721, DOI 10.1002/jbm.820110508
   COOPER DR, 1966, BIOCHEM J, V98, P655, DOI 10.1042/bj0980655
   Croisier F, 2013, EUR POLYM J, V49, P780, DOI 10.1016/j.eurpolymj.2012.12.009
   De Lima MSP, 2009, CARBOHYD RES, V344, P1709, DOI 10.1016/j.carres.2009.05.024
   Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406
   Dua K., 2010, EPLASTY, V10
   Dutta PK, 2011, ADV POLYM SCI, V244, P45, DOI 10.1007/12_2011_112
   Emmerson AM, 2003, J ANTIMICROB CHEMOTH, V51, P13, DOI 10.1093/jac/dkg208
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Han F, 2014, INT J PHARMACEUT, V476, P124, DOI 10.1016/j.ijpharm.2014.09.036
   He X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104323
   Huang MH, 2008, INT J PHARM, V346, P38, DOI 10.1016/j.ijpharm.2007.06.021
   Jayakumar GC, 2014, RSC ADV, V4, P42846, DOI 10.1039/c4ra07683d
   Jayakumar R, 2011, BIOTECHNOL ADV, V29, P322, DOI 10.1016/j.biotechadv.2011.01.005
   Kane J.B., 1996, BIOMATERIALS SCI INT
   Kane J.B., 1996, BURN DRESSINGS
   KHAN KA, 1972, PHARM ACTA HELV, V47, P594
   Kim JY, 2014, OPT EXPRESS, V22, P1735, DOI 10.1364/OE.22.001735
   Kim MN, 2005, J APPL POLYM SCI, V96, P936, DOI 10.1002/app.21543
   Kirk J.F, 2013, BIOMATTER, V3
   KLEINMAN HK, 1987, ANAL BIOCHEM, V166, P1, DOI 10.1016/0003-2697(87)90538-0
   Koide T, 1997, Dent Mater J, V16, P1
   Kozen BG, 2008, ACAD EMERG MED, V15, P74, DOI 10.1111/j.1553-2712.2007.00009.x
   Lan Y, 2014, ACTA BIOMATER, V10, P3167, DOI 10.1016/j.actbio.2014.03.029
   Lee JE, 2004, BIOMATERIALS, V25, P4163, DOI 10.1016/j.biomaterials.2003.10.057
   Lee JE, 2001, YONSEI MED J, V42, P172, DOI 10.3349/ymj.2001.42.2.172
   Lee WF, 2001, J APPL POLYM SCI, V82, P2487, DOI 10.1002/app.2099
   Li CQ, 2010, J MATER SCI-MATER M, V21, P741, DOI 10.1007/s10856-009-3871-5
   Li JL, 2003, BIOMATERIALS, V24, P2317, DOI 10.1016/S0142-9612(03)00048-6
   Lockhart LK, 2001, THROMB HAEMOSTASIS, V85, P882
   Ma JB, 2001, BIOMATERIALS, V22, P331, DOI 10.1016/S0142-9612(00)00188-5
   Madison KC, 2003, J INVEST DERMATOL, V121, P231, DOI 10.1046/j.1523-1747.2003.12359.x
   Malipeddi V.R., 2006, J BURNS WOUNDS, V5
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   O'Meara S., 1999, HEALTH TECHNOL ASSES, V4, P1
   Portieri A, 2011, PHARM MANUFACTURING
   Pusateri AE, 2003, J TRAUMA, V54, P177, DOI 10.1097/01.TA.0000032512.04647.C6
   Rao KP, 1995, J BIOMAT SCI-POLYM E, V7, P623
   Saito A, 2012, ACTA BIOMATER, V8, P2932, DOI 10.1016/j.actbio.2012.04.019
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Senel S, 2004, ADV DRUG DELIVER REV, V56, P1467, DOI 10.1016/j.addr.2004.02.007
   Shen YC, 2008, IEEE J SEL TOP QUANT, V14, P407, DOI [10.1109/JSTQE.2007.911309, 10.1109/.2007.JSTQE.911309]
   Synytsya A, 2009, BIOMACROMOLECULES, V10, P1067, DOI 10.1021/bm8011715
   Tangsadthakun C, 2007, J BIOMAT SCI-POLYM E, V18, P147, DOI 10.1163/156856207779116694
   Taravel MN, 1996, BIOMATERIALS, V17, P451, DOI 10.1016/0142-9612(96)89663-3
   TARAVEL MN, 1995, BIOMATERIALS, V16, P865, DOI 10.1016/0142-9612(95)94149-F
   Thomas AM, 2013, J CONTROL RELEASE, V170, P421, DOI 10.1016/j.jconrel.2013.06.013
   Ti DD, 2015, TISSUE ENG PT A, V21, P541, DOI [10.1089/ten.tea.2013.0750, 10.1089/ten.TEA.2013.0750]
   Tomihata K, 1997, J BIOMED MATER RES, V37, P243
   Tsai GJ, 1999, J FOOD PROTECT, V62, P239, DOI 10.4315/0362-028X-62.3.239
   Ueno H, 2001, BIOMATERIALS, V22, P2125, DOI 10.1016/S0142-9612(00)00401-4
   Van Bambeke F, 2005, CLIN MICROBIOL INFEC, V11, P256, DOI 10.1111/j.1469-0691.2005.01131.x
   Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074508
   Wang W, 2008, LIFE SCI, V82, P190, DOI 10.1016/j.lfs.2007.11.009
   WEISS SJ, 1989, NEW ENGL J MED, V320, P365
   YANNAS IV, 1990, ANGEW CHEM INT EDIT, V29, P20, DOI 10.1002/anie.199000201
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
NR 60
TC 27
Z9 28
U1 3
U2 78
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-0987
EI 1879-0720
J9 EUR J PHARM SCI
JI Eur. J. Pharm. Sci.
PD FEB 15
PY 2016
VL 83
BP 155
EP 165
DI 10.1016/j.ejps.2015.12.026
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DD8OU
UT WOS:000370187300018
PM 26733072
DA 2018-10-19
ER

PT J
AU Vilas, V
   Philip, D
   Mathew, J
AF Vilas, Vidya
   Philip, Daizy
   Mathew, Joseph
TI Facile one-pot synthesis of crystalline palladium nanoparticles with
   exceptional catalytic and antiradical activities
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Biomaterials; Nanostructures; Electron microscopy; Fourier transform
   infrared spectroscopy
ID RAPID GREEN SYNTHESIS; SILVER NANOPARTICLES; METHYL RED; REDUCTION;
   EXTRACT; PD; IRRADIATION; ORANGE; LEAVES; DYES
AB It is for the first time that the essential oils of medicinal plants are used for the synthesis of palladium nanoparticles, one of the rarest and precious transition metals known to mankind. In the present study, leaf essential oil of Coleus aromaticus and Myristica fragrans is used as the bioreductant. The appearance of an absorption continuum in the UV-vis spectrum indicates the formation of palladium nanoparticles. The effect of varying quantities of biomaterial on the synthesis of nanopalladium is studied. TEM micrographs disclose the formation of clusters of well dispersed nanospheroids of size similar to 2.8 nm. Sharp peaks in the XRD are indexed to Bragg reflections from planes corresponding to face centred cubic crystalline structure. FTIR spectral analyses reveal the participation of terpenoids and phenolic ether derivatives in reduction and capping. The synthesized nanoparticles exhibit significantly high catalytic efficiency in degrading a broad spectrum of organic pollutants including methyl red, methyl orange, eriochrome black T, methylene blue, rhodamine B, ortho-, meta- and para-nitrophenols. The reduction reactions are observed to obey pseudo first order kinetics. Antioxidant potential of the as synthesized palladium nanoparticles is portrayed through DPPH assay, nitric oxide and hydroxyl radical scavenging activities and reducing power activity. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Vilas, Vidya; Philip, Daizy] Mar Ivanios Coll, Dept Phys, Thiruvananthapuram 695015, Kerala, India.
   [Vilas, Vidya; Mathew, Joseph] Mar Ivanios Coll, Dept Chem, Thiruvananthapuram 695015, Kerala, India.
RP Philip, D (reprint author), Mar Ivanios Coll, Dept Phys, Thiruvananthapuram 695015, Kerala, India.
EM daizyp@rediffmail.com
FU Kerala State Council for Science, Technology and Environment,
   Thiruvananthapuram
FX Vidya Vilas thanks Kerala State Council for Science, Technology and
   Environment, Thiruvananthapuram for a research fellowship. The authors
   further acknowledge NIIST, Thiruvananthapuram for the TEM imaging.
CR ARBELOA IL, 1981, CHEM PHYS LETT, V79, P347, DOI 10.1016/0009-2614(81)80219-9
   Astruc D, 2007, INORG CHEM, V46, P1884, DOI 10.1021/ic062183h
   Azad UP, 2011, J NANOPART RES, V13, P3951, DOI 10.1007/s11051-011-0317-z
   Baruwati B, 2009, CHEMSUSCHEM, V2, P1041, DOI 10.1002/cssc.200900220
   Coates J., 2000, ENCY ANAL CHEM, V12, P10815, DOI DOI 10.1002/9780470027318.A5606
   Del Nero J, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1860372
   HAMED MMA, 1994, DYES PIGMENTS, V26, P297, DOI 10.1016/0143-7208(94)80043-X
   Hussein M. A., 2011, International Journal of Phytomedicine, V3, P459
   Hwang CG, 2008, J IND ENG CHEM, V14, P864, DOI 10.1016/j.jiec.2008.05.010
   Joseph S, 2015, MATER SCI ENG B-ADV, V195, P90, DOI 10.1016/j.mseb.2015.02.007
   Khalwar N. H., 2014, INT J MET, V2014, P1
   Krikunova N., 2011, CHEM CHEM TECH, V5, P161
   Kumar KM, 2013, SPECTROCHIM ACTA A, V102, P128, DOI 10.1016/j.saa.2012.10.015
   Masoud MS, 2001, SPECTROCHIM ACTA A, V57, P977, DOI 10.1016/S1386-1425(00)00416-9
   Miyajima M, 2000, BIOCHEM BIOPH RES CO, V275, P752, DOI 10.1006/bbrc.2000.3367
   Molaie R., 2012, P 4 INT C NAN, P12
   Muniyappan N, 2014, PROCESS BIOCHEM, V49, P1054, DOI 10.1016/j.procbio.2014.03.015
   Rastogi L, 2011, MATER CHEM PHYS, V129, P558, DOI 10.1016/j.matchemphys.2011.04.068
   Raut RW, 2013, ADV MAT LETT, V4, P650, DOI DOI 10.5185/amlett.2012.11470
   Saha M., 2012, ADV NANOPART, V1, P61
   Sathishkumar M, 2009, J HAZARD MATER, V171, P400, DOI 10.1016/j.jhazmat.2009.06.014
   Sathishkumar M., 2009, INT J MAT SCI, V4, P11
   Shen XS, 2009, CHINESE J CHEM PHYS, V22, P440, DOI 10.1088/1674-0068/22/04/440-446
   Sheny DS, 2012, SPECTROCHIM ACTA A, V91, P35, DOI 10.1016/j.saa.2012.01.063
   Sinha T, 2015, J MOL LIQ, V201, P113, DOI 10.1016/j.molliq.2014.09.031
   Subramanian R., 2013, SPRING PLUS, V2, P1
   TAWARAH KM, 1991, DYES PIGMENTS, V17, P203, DOI 10.1016/0143-7208(91)80027-7
   Venkatesham M., 2014, APP NANOSCI, V5, P315
   Vilas V, 2014, J MOL LIQ, V200, P390, DOI 10.1016/j.molliq.2014.11.002
   Xiong YJ, 2005, NANO LETT, V5, P1237, DOI 10.1021/nl0508826
   Yilmaz M, 2011, MATER CHEM PHYS, V130, P1195, DOI 10.1016/j.matchemphys.2011.08.068
   Zhao MQ, 1999, ANGEW CHEM INT EDIT, V38, P364, DOI 10.1002/(SICI)1521-3773(19990201)38:3<364::AID-ANIE364>3.0.CO;2-L
NR 32
TC 4
Z9 4
U1 2
U2 29
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
EI 1879-3312
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD FEB 15
PY 2016
VL 170
BP 1
EP 11
DI 10.1016/j.matchemphys.2015.12.011
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA DC8ML
UT WOS:000369473600001
DA 2018-10-19
ER

PT J
AU Nishikawa, H
   Hasegawa, T
   Miyake, A
   Tashiro, Y
   Hashimoto, Y
   Blank, DHA
   Rijnders, G
AF Nishikawa, Hiroaki
   Hasegawa, Tsukasa
   Miyake, Akiko
   Tashiro, Yuichiro
   Hashimoto, Yoshiya
   Blank, Daveh H. A.
   Rijnders, Guus
TI Relationship between the Ca/P ratio of hydroxyapatite thin films and the
   spatial energy distribution of the ablation laser in pulsed laser
   deposition
SO MATERIALS LETTERS
LA English
DT Article
DE Pulsed laser deposition; Hydroxyapatite; Laser spot size; Ca/P ratio;
   Biomaterial
ID CALCIUM-PHOSPHATE COATINGS; BEAM SPUTTER-DEPOSITION; HYDROXYL-APATITE;
   TITANIUM; IMPLANTS; SURFACE
AB Variation of the Ca/P ratio in hydroxyapatite (Ca-10(PO4)(6)(OH)(2)) thin films was studied in relation to the spot size of the ablation laser for two different spatial energy distributions in pulsed laser deposition. One energy distribution is the defocus method with a raw distribution and the other is the projection method without the weak portion at the edges of the ablation laser spot. A Ca/P ratio closer to that of stoichiometry was obtained with the larger spot sizes for both methods, and with the projection method compared to the defocus method. It is considered that a more uniform spatial energy distribution of the ablation laser improves the Ca/P ratio. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Nishikawa, Hiroaki] Kinki Univ, Fac Biol Oriented Sci & Technol, Wakayama 6496493, Japan.
   [Hasegawa, Tsukasa] Kinki Univ, Grad Sch Biol Oriented Sci & Technol, Wakayama 6496493, Japan.
   [Miyake, Akiko; Tashiro, Yuichiro] Osaka Dent Univ, Dept Removable Prosthodont & Occlus, Hirakata, Osaka 5731121, Japan.
   [Hashimoto, Yoshiya] Osaka Dent Univ, Dept Biomat, Hirakata, Osaka 5731121, Japan.
   [Blank, Daveh H. A.; Rijnders, Guus] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands.
RP Nishikawa, H (reprint author), Kinki Univ, Fac Biol Oriented Sci & Technol, 930 Nishi Mitani, Wakayama 6496493, Japan.
EM nishik32@waka.kindai.ac.jp
OI Nishikawa, Hiroaki/0000-0001-7753-3866
FU Strategic Research Foundation Grant-aided Project for Private
   Universities from the Ministry of Education, Culture, Sports, Science,
   and Technology, Japan [S1311045]; Project Research of the Faculty of
   Biology-Oriented Science and Technology, Kinki University [14-I-3]
FX This work was supported in part by a grant from the Strategic Research
   Foundation Grant-aided Project for Private Universities from the
   Ministry of Education, Culture, Sports, Science, and Technology, Japan,
   2013-2017 (No. S1311045) and a grant from the Project Research of the
   Faculty of Biology-Oriented Science and Technology, Kinki University,
   2015-2016 (No. 14-I-3).
CR Ektessabi AM, 1995, THIN SOLID FILMS, V270, P335, DOI 10.1016/0040-6090(95)06714-0
   GEESINK RGT, 1987, CLIN ORTHOP RELAT R, P147
   Hontsu S, 1996, JPN J APPL PHYS 2, V35, pL1208
   Kekkonen V, 2011, J EUR OPT SOC-RAPID, V6, DOI 10.2971/jeos.2011.11013s
   KLEIN CPAT, 1991, J BIOMED MATER RES, V25, P53, DOI 10.1002/jbm.820250105
   MCPHERSON R, 1995, J MATER SCI-MATER M, V6, P327, DOI 10.1007/BF00120300
   Nishikawa H., 2015, T MAT RES SOC JPN, V40, P111
   Nishikawa H, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.088001
   Ohnishi T, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2146069
   Okazaki M, 1979, J Osaka Univ Dent Sch, V19, P87
   ONG JL, 1992, BIOMATERIALS, V13, P249, DOI 10.1016/0142-9612(92)90192-Q
   Sakoishi Y, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.115501
   Song JH, 2008, ADV MATER, V20, P2528, DOI 10.1002/adma.200701919
   Stoch A, 2001, J MOL STRUCT, V596, P191, DOI 10.1016/S0022-2860(01)00716-5
   Tyunina M, 2000, J APPL PHYS, V87, P8132, DOI 10.1063/1.373508
   WOLKE JGC, 1994, J BIOMED MATER RES, V28, P1477, DOI 10.1002/jbm.820281213
   YAMASHITA K, 1994, J AM CERAM SOC, V77, P2401, DOI 10.1111/j.1151-2916.1994.tb04611.x
   Yan WQ, 1997, BIOMATERIALS, V18, P1185, DOI 10.1016/S0142-9612(97)00057-4
   Yoshinari M, 1997, J BIOMED MATER RES, V37, P60, DOI 10.1002/(SICI)1097-4636(199710)37:1<60::AID-JBM8>3.0.CO;2-H
   Zeng H, 1999, BIOMATERIALS, V20, P443, DOI 10.1016/S0142-9612(98)00190-2
NR 20
TC 12
Z9 12
U1 2
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD FEB 15
PY 2016
VL 165
BP 95
EP 98
DI 10.1016/j.matlet.2015.11.115
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA CZ6UM
UT WOS:000367236500024
DA 2018-10-19
ER

PT J
AU Christo, SN
   Diener, KR
   Manavis, J
   Grimbaldeston, MA
   Bachhuka, A
   Vasilev, K
   Hayball, JD
AF Christo, Susan N.
   Diener, Kerrilyn R.
   Manavis, Jim
   Grimbaldeston, Michele A.
   Bachhuka, Akash
   Vasilev, Krasimir
   Hayball, John D.
TI Inflammasome components ASC and AIM2 modulate the acute phase of
   biomaterial implant-induced foreign body responses
SO SCIENTIFIC REPORTS
LA English
DT Article
ID POLY(ETHYLENE GLYCOL)-BASED HYDROGELS; MESENCHYMAL PROGENITOR CELLS;
   VIVO HOST RESPONSE; MAST-CELLS; NLRP3 INFLAMMASOME; IN-VIVO; PRODUCE
   INTERLEUKIN-13; MURINE MACROPHAGES; NALP3 INFLAMMASOME; HUMAN
   CHONDROCYTES
AB Detailing the inflammatory mechanisms of biomaterial-implant induced foreign body responses (FBR) has implications for revealing targetable pathways that may reduce leukocyte activation and fibrotic encapsulation of the implant. We have adapted a model of poly(methylmethacrylate) (PMMA) bead injection to perform an assessment of the mechanistic role of the ASC-dependent inflammasome in this process. We first demonstrate that ASC(-/-) mice subjected to PMMA bead injections had reduced cell infiltration and altered collagen deposition, suggesting a role for the inflammasome in the FBR. We next investigated the NLRP3 and AIM2 sensors because of their known contributions in recognising damaged and apoptotic cells. We found that NLRP3 was dispensable for the fibrotic encapsulation; however AIM2 expression influenced leukocyte infiltration and controlled collagen deposition, suggesting a previously unexplored link between AIM2 and biomaterial-induced FBR.
C1 [Christo, Susan N.; Diener, Kerrilyn R.; Hayball, John D.] Univ S Australia, Sch Pharm & Med Sci, Sansom Inst, Expt Therapeut Lab, Adelaide, SA 5000, Australia.
   [Christo, Susan N.; Diener, Kerrilyn R.; Hayball, John D.] Univ S Australia, Sch Pharm & Med Sci, Hanson Inst, Adelaide, SA 5000, Australia.
   [Diener, Kerrilyn R.; Hayball, John D.] Univ Adelaide, Sch Paediat & Reprod Hlth, Robinson Res Inst, Adelaide, SA 5005, Australia.
   [Manavis, Jim] SA Pathol, Ctr Neurol Dis, Adelaide, SA 5000, Australia.
   [Grimbaldeston, Michele A.] Univ S Australia, Ctr Canc Biol, Adelaide, SA 5000, Australia.
   [Grimbaldeston, Michele A.] SA Pathol, Adelaide, SA 5000, Australia.
   [Bachhuka, Akash; Vasilev, Krasimir] Univ S Australia, Mawson Inst, Adelaide, SA 5095, Australia.
   [Hayball, John D.] Univ Adelaide, Sch Med, Adelaide, SA 5005, Australia.
RP Hayball, JD (reprint author), Univ S Australia, Sch Pharm & Med Sci, Sansom Inst, Expt Therapeut Lab, Adelaide, SA 5000, Australia.; Hayball, JD (reprint author), Univ S Australia, Sch Pharm & Med Sci, Hanson Inst, Adelaide, SA 5000, Australia.
EM john.hayball@unisa.edu.au
RI Hayball, John/F-4137-2013
OI Hayball, John/0000-0002-3089-4506
CR Almeida CR, 2012, J R SOC INTERFACE, V9, P261, DOI 10.1098/rsif.2011.0357
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363
   Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104
   Blaney Davidson EN, 2006, ANN RHEUM DIS, V65, P1414, DOI DOI 10.1136/ARD.2005.045971
   Blaney DE, 2005, ARTHRITIS RES THER, V7, pR1338, DOI DOI 10.1186/AR1833
   Branzk N, 2014, NAT IMMUNOL, V15, P1017, DOI 10.1038/ni.2987
   Brunette RL, 2012, J EXP MED, V209, P1969, DOI 10.1084/jem.20121960
   Bujor AM, 2008, J INVEST DERMATOL, V128, P1906, DOI 10.1038/jid.2008.39
   BURD PR, 1995, J EXP MED, V181, P1373, DOI 10.1084/jem.181.4.1373
   Castro PR, 2012, MICROVASC RES, V84, P9, DOI 10.1016/j.mvr.2012.04.003
   CHRISTENSON L, 1991, J BIOMED MATER RES, V25, P1119, DOI 10.1002/jbm.820250906
   Cui Hang, 2012, J Signal Transduct, V2012, P646354, DOI 10.1155/2012/646354
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995
   Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Garcia-Romo GS, 2011, SCI TRANSL MED, V3, P20, DOI DOI 10.1126/SCITRANSLMED.3001201
   Gilfillan AM, 2011, CRIT REV IMMUNOL, V31, P475, DOI 10.1615/CritRevImmunol.v31.i6.30
   GOLDRING MB, 1988, J CLIN INVEST, V82, P2026, DOI 10.1172/JCI113823
   Hamilton RF, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0043-7
   Hari A, 2014, SCI REP-UK, V4, DOI 10.1038/srep07281
   Hwang SG, 2007, IUBMB LIFE, V59, P90, DOI 10.1080/15216540701245022
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kanbe N, 1999, INT ARCH ALLERGY IMM, V119, P138, DOI 10.1159/000024189
   Kawakita K, 2012, OSTEOARTHR CARTILAGE, V20, P1603, DOI 10.1016/j.joca.2012.08.022
   Kersse K, 2011, CYTOKINE GROWTH F R, V22, P257, DOI 10.1016/j.cytogfr.2011.09.003
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Lande R., 2011, SCI TRANSL MED, V3, P19
   Lee HH, 2013, SCI REP-UK, V3, DOI 10.1038/srep02683
   Li TF, 2005, FRONT BIOSCI, V10, P681, DOI 10.2741/1563
   Lu A., 2014, FEBS J, V282, P435
   Lynn AD, 2011, ACTA BIOMATER, V7, P123, DOI 10.1016/j.actbio.2010.07.033
   Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Malik AF, 2011, P NATL ACAD SCI USA, V108, P20095, DOI 10.1073/pnas.1105152108
   Man SM, 2015, CELL, V162, P45, DOI 10.1016/j.cell.2015.06.001
   Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3
   Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016
   Nelson CE, 2014, ADV MATER, V26, P607, DOI 10.1002/adma.201303520
   Ng G, 2008, IMMUNITY, V29, P807, DOI 10.1016/j.immuni.2008.09.013
   Oviedo-Socarras T, 2014, MICROVASC RES, V93, P23, DOI 10.1016/j.mvr.2014.02.011
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Puolakkainen P, 2003, AM J PATHOL, V162, P627, DOI 10.1016/S0002-9440(10)63856-4
   Qiao Y, 2012, FEBS LETT, V586, P1022, DOI 10.1016/j.febslet.2012.02.045
   Rezzani R, 2004, ARCH HISTOL CYTOL, V67, P211, DOI 10.1679/aohc.67.211
   Rujitanaroj PO, 2013, ACTA BIOMATER, V9, P4513, DOI 10.1016/j.actbio.2012.09.029
   Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200
   Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   van der Kraan PM, 1998, OSTEOARTHR CARTILAGE, V6, P417, DOI 10.1053/joca.1998.0145
   Wilson JE, 2015, NAT MED, V21, P906, DOI 10.1038/nm.3908
   Winter M, 2011, NANOTOXICOLOGY, V5, P326, DOI 10.3109/17435390.2010.506957
   Yang EJ, 2012, BIOMATERIALS, V33, P6858, DOI 10.1016/j.biomaterials.2012.06.016
   Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 56
TC 4
Z9 5
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 10
PY 2016
VL 6
AR 20635
DI 10.1038/srep20635
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DD2HC
UT WOS:000369742300001
PM 26860464
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Powell, LC
   Khan, S
   Chinga-Carrasco, G
   Wright, CJ
   Hill, KE
   Thomas, DW
AF Powell, Lydia C.
   Khan, Saira
   Chinga-Carrasco, Gary
   Wright, Chris J.
   Hill, Katja E.
   Thomas, David W.
TI An investigation of Pseudomonas aeruginosa biofilm growth on novel
   nanocellulose fibre dressings
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Nanocellulose; Biofilm; Pseudomonas aeniginosa; Atomic force microscopy;
   Characterisation
ID MICROFIBRILLATED CELLULOSE; WOUND DRESSINGS; RAW-MATERIALS; TRANSPARENT;
   NANOFIBRILS; MICROSCOPY; OXIDATION; HYDROGELS; ULCERS; FILMS
AB Nanocellulose from wood is a novel biomaterial, which is highly fibrillated at the nanoscale. This affords the material a number of advantages, including self-assembly, biodegradability and the ability to absorb and retain moisture, which highlights its potential usefulness in clinical wound-dressing applications. In these in vitro studies, the wound pathogen Pseudomonas aeruginosa PAO1 was used to assess the ability of two nanocellulose materials to impair bacterial growth (<48 h). The two nanocelluloses had a relatively small fraction of residual fibres (<4%) and thus a large fraction of nanofibrils (widths <20 nm). Scanning electron microscopy and confocal laser scanning microscopy imaging demonstrated impaired biofilm growth on the nanocellulose films and increased cell death when compared to a commercial control wound dressing, Aquacel (R). Nanocellulose suspensions inhibited bacterial growth, whilst UV-vis spectrophotometry and laser profilometry also revealed the ability of nanocellulose to form smooth, translucent films. Atomic force microscopy studies of the surface properties of nanocellulose demonstrated that PAO1 exhibited markedly contrasting morphology when grown on the nanocellulose film surfaces compared to an Aquacel (R) control dressing (p <0.05). This study highlights the potential utility of these biodegradable materials, from a renewable source, for wound dressing applications in the prevention and treatment of biofilm development. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Powell, Lydia C.; Khan, Saira; Hill, Katja E.; Thomas, David W.] Cardiff Univ, Sch Dent, Coll Biomed & Life Sci, Adv Therapies Grp, Cardiff CF14 4XY, S Glam, Wales.
   [Powell, Lydia C.; Wright, Chris J.] Univ Swansea, Coll Engn, Ctr NanoHlth, Syst & Proc Engn Ctr, Swansea SA2 8PP, W Glam, Wales.
   [Chinga-Carrasco, Gary] Paper & Fibre Res Inst PFI, NO-7491 Trondheim, Norway.
RP Chinga-Carrasco, G (reprint author), Paper & Fibre Res Inst PFI, NO-7491 Trondheim, Norway.
EM gary.chinga.carrasco@pfi.no
RI Chinga-Carrasco, Gary/J-1661-2014
OI Chinga-Carrasco, Gary/0000-0002-6183-2017; Wright,
   Chris/0000-0003-2375-8159
FU Research Council of Norway [219733]
FX This work has been funded by the Research Council of Norway through the
   NANO2021 program, Grant no. 219733 - NanoHeal: Bio-compatible cellulose
   nanostructures for advanced wound healing applications.
CR Alexandrescu L, 2013, CELLULOSE, V20, P1765, DOI 10.1007/s10570-013-9948-9
   Alila S, 2013, IND CROP PROD, V41, P250, DOI 10.1016/j.indcrop.2012.04.028
   Andresen M, 2007, BIOMACROMOLECULES, V8, P2149, DOI 10.1021/bm070304e
   Anghel I, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-12
   Atiyeh BS, 2007, BURNS, V33, P139, DOI 10.1016/j.burns.2006.06.010
   Bjarnsholt T, 2008, WOUND REPAIR REGEN, V16, P2, DOI 10.1111/j.1524-475X.2007.00283.x
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Chinga-Carrasco G, 2014, J BIOMATER APPL, V29, P423, DOI 10.1177/0885328214531511
   Chinga-Carrasco G, 2014, MICRON, V56, P80, DOI 10.1016/j.micron.2013.09.002
   Chinga-Carrasco G, 2013, MICRON, V48, P42, DOI 10.1016/j.micron.2013.02.005
   Chinga-Carrasco G, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-192
   Chinga-Carrasco G, 2011, MICROSC MICROANAL, V17, P563, DOI 10.1017/S1431927611000444
   Davies CE, 2004, J CLIN MICROBIOL, V42, P3549, DOI 10.1128/JCM.42.8.3549-3557.2004
   Dong S., 2012, NANO LIFE, V3
   Dufresne A, 2013, MATER TODAY, V16, P220, DOI 10.1016/j.mattod.2013.06.004
   Fukuzumi H, 2013, CARBOHYD POLYM, V93, P172, DOI 10.1016/j.carbpol.2012.04.069
   Fukuzumi H, 2009, BIOMACROMOLECULES, V10, P162, DOI 10.1021/bm801065u
   Gjodsbol Kristine, 2006, Int Wound J, V3, P225, DOI 10.1111/j.1742-481X.2006.00159.x
   Gottrup F, 2004, AM J SURG, V187, p38S, DOI 10.1016/S0002-9610(03)00303-9
   Hill KE, 2010, J ANTIMICROB CHEMOTH, V65, P1195, DOI 10.1093/jac/dkq105
   James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x
   Jonoobi M, 2012, IND CROP PROD, V40, P232, DOI 10.1016/j.indcrop.2012.03.018
   Jorfi M, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.41719
   Josefsson G, 2015, RSC ADV, V5, P58091, DOI 10.1039/c5ra04016g
   Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273
   Kokabi M, 2007, EUR POLYM J, V43, P773, DOI 10.1016/j.eurpolymj.2006.11.030
   Liimatainen H, 2012, BIOMACROMOLECULES, V13, P1592, DOI 10.1021/bm300319m
   Lin N, 2014, EUR POLYM J, V59, P302, DOI 10.1016/j.eurpolymj.2014.07.025
   Newman GR, 2006, BIOMATERIALS, V27, P1129, DOI 10.1016/j.biomaterials.2005.07.046
   Nogi M, 2009, ADV MATER, V21, P1595, DOI 10.1002/adma.200803174
   Oh YJ, 2009, ULTRAMICROSCOPY, V109, P874, DOI 10.1016/j.ultramic.2009.03.042
   Parr GR, 2002, J PROSTHET DENT, V88, P139, DOI 10.1067/mpr.2002.127399
   Rees A, 2015, BIOMED RES INT, DOI 10.1155/2015/925757
   Sai P, 2000, BURNS, V26, P54
   Saito T, 2013, BIOMACROMOLECULES, V14, P248, DOI 10.1021/bm301674e
   Saito T, 2009, BIOMACROMOLECULES, V10, P1992, DOI 10.1021/bm900414t
   Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x
   Steinberger RE, 2002, MICROBIAL ECOL, V43, P416, DOI 10.1007/s00248-001-1063-z
   Syverud K, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-626
   Syverud K, 2011, CARBOHYD POLYM, V84, P1033, DOI 10.1016/j.carbpol.2010.12.066
   Tran PL, 2009, APPL ENVIRON MICROB, V75, P3586, DOI 10.1128/AEM.02683-08
   Transparency Market Research, 2013, WOUND DRESS MARK GLO
   Vartiainen J, 2011, CELLULOSE, V18, P775, DOI 10.1007/s10570-011-9501-7
   Veves A, 2002, ARCH SURG-CHICAGO, V137, P822, DOI 10.1001/archsurg.137.7.822
   Wagberg L, 2008, LANGMUIR, V24, P784, DOI 10.1021/la702481v
   Walker M, 2003, BIOMATERIALS, V24, P883, DOI 10.1016/S0142-9612(02)00414-3
   Wright CJ, 2010, SCANNING, V32, P134, DOI 10.1002/sca.20193
NR 47
TC 15
Z9 16
U1 2
U2 63
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD FEB 10
PY 2016
VL 137
BP 191
EP 197
DI 10.1016/j.carbpol.2015.10.024
PG 7
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA CZ2MB
UT WOS:000366938200022
PM 26686120
DA 2018-10-19
ER

PT J
AU Pinto, FCM
   De-Oliveira, ACAX
   De-Carvalho, RR
   Gomes-Carneiro, MR
   Coelho, DR
   Lima, SVC
   Paumgartten, FJR
   Aguiar, JLA
AF Morono Pinto, Flavia Cristina
   De-Oliveira, Ana Cecilia A. X.
   De-Carvalho, Rosangela R.
   Gomes-Carneiro, Maria Regina
   Coelho, Deise R.
   Lima, Salvador Vilar C.
   Paumgartten, Francisco Jose R.
   Aguiar, Jose Lamartine A.
TI Acute toxicity, cytotoxicity, genotoxicity and antigenotoxic effects of
   a cellulosic exopolysaccharide obtained from sugarcane molasses
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Antigenotoxicity; Bacterial Cellulose; Biomaterial; Cytotoxicity;
   Exopolysaccharide; Genotoxicity
ID RABBITS; BIOPOLYMER; MODEL
AB The acute toxicity, cytotoxicity, genotoxicity and antigenotoxic effects of BC were studied. Cytotoxicity of BC was evaluated in cultured C3A hepatoma cells (HepG2/C3A) using a lactate dehydrogenase (LDH) activity assay. Acute toxicity was tested in adults Wistar rats treated with a single dose of BC. The genotoxicity of BC was evaluated in vivo by the micronucleus assay. BC (0.33-170 tig/mL) added to C3A cell culture medium caused no elevation in LDH release over the background level recorded in untreated cell wells. The treatment with the BC in a single oral dose (2000 mg/kg body weight) caused no deaths or signs of toxicity. BC attenuated CP-induced and inhibition the incidence of MNPCE (female: 46.94%; male: 22.7%) and increased the ratio of PCE/NCE (female: 46.10%; male: 35.25%). There was no alteration in the LDH release in the wells where C3A cells were treated with increasing concentrations of BC compared to the wells where the cells received the cell culture medium only (background of approximately 20% cell death), indicated that in the dose range tested BC was not cytotoxic. BC was not cytotoxic, genotoxic or acutely toxic. BC attenuated CP-induced genotoxic and myelotoxic effects. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Morono Pinto, Flavia Cristina; Lima, Salvador Vilar C.; Aguiar, Jose Lamartine A.] Univ Fed Pernambuco, UFPE, Ctr Hlth Sci, Ctr Expt Surg,Dept Surg, Recife, PE, Brazil.
   [De-Oliveira, Ana Cecilia A. X.; De-Carvalho, Rosangela R.; Gomes-Carneiro, Maria Regina; Coelho, Deise R.; Paumgartten, Francisco Jose R.] Fiocruz MS, Oswaldo Cruz Fdn, Natl Sch Publ Hlth, Lab Environm Toxicol, BR-21045900 Rio De Janeiro, Brazil.
RP Pinto, FCM (reprint author), Rua Futuro 551-201, Recife, PE, Brazil.
EM fcmorone@gmail.com
OI Pinto, Flavia/0000-0003-2038-9984
FU Brazil's Science, Technology, and Innovation Ministry (MCTI): FINEP
   (Financier of Studies and Projects); CNPq (National Counsel of
   Technological and Scientific Development).
FX This study was supported by Brazil's Science, Technology, and Innovation
   Ministry (MCTI): FINEP (Financier of Studies and Projects) and CNPq
   (National Counsel of Technological and Scientific Development).
CR Castro CMMB, 2004, AN FAC MED U FED PER, V49, P119
   Chagas H. M., 2005, ANN INT BRAZILIAN J, V30, P43
   Coelho MCOC, 2002, ACTA CIR BRAS, V17, P1
   Cordeiro-Barbosa FD, 2012, ARQ BRAS OFTALMOL, V75, P267, DOI 10.1590/S0004-27492012000400010
   Albuquerque Paulo Cezar Vidal Carneiro de, 2011, Rev. bras. ortop., V46, P577, DOI [10.1016/S2255-4971(15)30415-8, 10.1590/S0102-36162011000500016]
   Pita PCD, 2015, ACTA CIR BRAS, V30, P296, DOI 10.1590/S0102-865020150040000009
   FDA, 2000, TOX PRINC SAF ASS FO
   FDA, 1994, GUID IND DET TOX REP
   Teixeira FMF, 2014, ACTA CIR BRAS, V29, P231, DOI 10.1590/S0102-86502014000400003
   Fragoso AS, 2014, J MATER SCI-MATER M, V25, P229, DOI 10.1007/s10856-013-5056-5
   Goncalves R., 2006, ANN I BRAZ J UROL S2, V32, P41
   Krishna G, 2000, MUTAT RES-FUND MOL M, V455, P155, DOI 10.1016/S0027-5107(00)00117-2
   Kublbeck J., 2011, MOL PHARM, V5, P2424
   Lee KY, 2014, MACROMOL BIOSCI, V14, P10, DOI 10.1002/mabi.201300298
   Lima S. V. C., 2015, UROLOGY, V85, pe1
   Lima S. V. C., 2015, UROLOGY, V85, P1520
   Lucena M. T, 2015, J MATER SCI-MATER M, V26, P82
   Lucena RG, 2005, INT BRAZ J UROL, V30, P105
   Naik P, 2013, ENVIRON TOXICOL PHAR, V36, P135, DOI 10.1016/j.etap.2013.03.004
   OECD, 2001, 423 OECD
   OECD, 2013, 474 OECD
   Paterson-Beedle M, 2000, CARBOHYD POLYM, V42, P375, DOI 10.1016/S0144-8617(99)00179-4
   Martins AGS, 2013, INT BRAZ J UROL, V39, P408, DOI 10.1590/S1677-5538.IBJU.2013.03.15
   Silva DB, 2006, AN FM U FED PERNAMB, V51, P45
   WATERS MD, 1990, MUTAT RES, V238, P57, DOI 10.1016/0165-1110(90)90039-E
NR 25
TC 9
Z9 10
U1 1
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD FEB 10
PY 2016
VL 137
BP 556
EP 560
DI 10.1016/j.carbpol.2015.10.071
PG 5
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA CZ2MB
UT WOS:000366938200065
PM 26686163
OA Bronze
DA 2018-10-19
ER

PT J
AU Zhang, S
   Tang, YG
   Vlahovic, B
AF Zhang, Shu
   Tang, Yongan
   Vlahovic, Branislav
TI A Review on Preparation and Applications of Silver-Containing Nanofibers
SO NANOSCALE RESEARCH LETTERS
LA English
DT Review
DE Silver nanoparticle; Biomaterial; Polymer nanofiber; Electrospinning
ID GRAM-NEGATIVE BACTERIA; ANTIBACTERIAL ACTIVITY; LASER-ABLATION; METAL
   NANOPARTICLES; PHOTOCHEMICAL-SYNTHESIS; PATHOGENIC BACTERIA; ANTIFUNGAL
   ACTIVITY; GOLD NANOPARTICLES; SIZE; PARTICLES
AB Silver-containing nanofibers are of great interest recently because of the dual benefits from silver particles and nanofibers. Silver nanoparticles are extensively used for biomedical applications due to the antibacterial and antiviral properties. In addition, silver nanoparticles can excite resonance effect of light trapping when pairing with dielectric materials, such as polymer. Comparing to the traditional fabrics, polymer nanofibers can provide larger number of reaction sites and higher permeability contributed to their high surface-to-volume ratio and high porosity. By embedding the silver nanoparticles into polymer nanofiber matrix, the composite is promising candidates for biomaterials, photovoltaic materials, and catalysts. This work demonstrates and evaluates the methods employed to synthesize silver nanoparticle-containing nanofibers and their potential applications.
C1 [Zhang, Shu; Tang, Yongan; Vlahovic, Branislav] North Carolina Cent Univ, Dept Math & Phys, Durham, NC 27707 USA.
RP Tang, YG (reprint author), North Carolina Cent Univ, Dept Math & Phys, Durham, NC 27707 USA.
EM tangy@nccu.edu
OI Tang, Yongan/0000-0001-9312-1378
FU NSF [HRD-1345219, DMR-1523617]; NASA [NNX09AV07A]; ARO
   [W911NF-13-1-0165]; XSEDE [TG-DMR130018, TG-PHY140023]
FX This work was supported in part by NSF: HRD-1345219, NSF: DMR-1523617,
   NASA: NNX09AV07A, ARO: W911NF-13-1-0165, and XSEDE grant: TG-DMR130018
   and TG-PHY140023.
CR Abou El-Nour KMM, 2010, ARAB J CHEM, V3, P135, DOI 10.1016/j.arabjc.2010.04.008
   Ahmad A, 2003, NANOTECHNOLOGY, V14, P824, DOI 10.1088/0957-4484/14/7/323
   Ahmadi TS, 1996, SCIENCE, V272, P1924, DOI 10.1126/science.272.5270.1924
   Bai J, 2007, MATER CHEM PHYS, V106, P412, DOI 10.1016/j.matchemphys.2007.06.021
   Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937
   BIRRINGER R, 1989, MAT SCI ENG A-STRUCT, V117, P33, DOI 10.1016/0921-5093(89)90083-X
   Bu YY, 2013, RSC ADV, V3, P24118, DOI 10.1039/c3ra44047h
   Callegari A, 2003, NANO LETT, V3, P1565, DOI 10.1021/nl034757a
   Chen JY, 2014, PLASMON ENHANCED POL, P1
   Chou KS, 2005, MATER CHEM PHYS, V94, P429, DOI 10.1016/j.mathchemphys.2005.05.029
   Chou KS, 2004, MATER CHEM PHYS, V83, P82, DOI 10.1016/j.matchemphys.2003.09.026
   CREIGHTON JA, 1979, J CHEM SOC FARAD T 2, V75, P790, DOI 10.1039/f29797500790
   Daoud WA, 2005, SURF SCI, V599, P69, DOI 10.1016/j.susc.2005.09.038
   Duran N, 2011, APPL MICROBIOL BIOT, V90, P1609, DOI 10.1007/s00253-011-3249-8
   Duran N, 2010, J BRAZIL CHEM SOC, V21, P949, DOI 10.1590/S0103-50532010000600002
   Esteban-Cubillo A, 2006, J MATER SCI, V41, P5208, DOI 10.1007/s10853-006-0432-x
   FOJTIK A, 1993, BER BUNSEN PHYS CHEM, V97, P252
   Fraser A.N., 1932, Canadian Journal of Research, V7, P133
   Ghule K, 2006, GREEN CHEM, V8, P1034, DOI 10.1039/b605623g
   Goia DV, 1998, NEW J CHEM, V22, P1203, DOI 10.1039/a709236i
   Gong P, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/28/285604
   Gonzalez-Castillo JR, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-1105-y
   Guo YM, 2005, CHEM J CHINESE U, V26, P209
   Guzman M, 2012, NANOMED-NANOTECHNOL, V8, P37, DOI 10.1016/j.nano.2011.05.007
   He SY, 2007, MATER LETT, V61, P3984, DOI 10.1016/j.matlet.2007.01.018
   Henglein A, 1999, J PHYS CHEM B, V103, P9533, DOI 10.1021/jp9925334
   Henglein A, 1998, CHEM MATER, V10, P444, DOI 10.1021/cm970613j
   Hennebel T, 2009, TRENDS BIOTECHNOL, V27, P90, DOI 10.1016/j.tibtech.2008.11.002
   Horiuchi Y, 2009, J MATER CHEM, V19, P6745, DOI 10.1039/b910474g
   Huang CJ, 2006, J APPL POLYM SCI, V100, P1457, DOI 10.1002/app.23576
   Huang HH, 1996, LANGMUIR, V12, P909, DOI 10.1021/la950435d
   Ingle A, 2008, CURR NANOSCI, V4, P141, DOI 10.2174/157341308784340804
   Jain P, 2005, BIOTECHNOL BIOENG, V90, P59, DOI 10.1002/bit.20368
   Jo YK, 2009, PLANT DIS, V93, P1037, DOI 10.1094/PDIS-93-10-1037
   Kamyshny A, 2010, PREPARATION STABILIZ, V147
   Kasprowicz MJ, 2010, CAN J MICROBIOL, V56, P247, DOI [10.1139/W10-012, 10.1139/w10-012]
   Kim JS, 2014, NANOMED-NANOTECHNOL, V10, P1119, DOI 10.1016/j.nano.2014.04.007
   Kim KJ, 2009, BIOMETALS, V22, P235, DOI 10.1007/s10534-008-9159-2
   Klasen HJ, 2000, BURNS, V30, P1
   Kumar A, 2008, NAT MATER, V7, P236, DOI 10.1038/nmat2099
   Lara HH, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-30
   Lara Humberto H., 2010, Journal of Nanobiotechnology, V8, P1, DOI 10.1186/1477-3155-8-1
   Lee D, 2005, LANGMUIR, V21, P9651, DOI 10.1021/la0513306
   Li L, 2015, NANOTECHNOLOGY, V26, P44
   Liu X, 2010, J BIOMED MATER RES A, V94A, P499, DOI 10.1002/jbm.a.32718
   Mafune F, 2000, J PHYS CHEM B, V104, P9111, DOI 10.1021/jp001336y
   Makhluf S, 2005, ADV FUNCT MATER, V15, P1708, DOI 10.1002/adfm.200500029
   Mallick K, 2004, J MATER SCI, V39, P4459, DOI 10.1023/B:JMSC.0000034138.80116.50
   Manea F, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-331
   Martinez-Castanon GA, 2008, J NANOPART RES, V10, P1343, DOI 10.1007/s11051-008-9428-6
   Marun F, 2000, J PHYS CHEM B, V104, P8333
   Mayer AB, 2002, POLYM J, V32, P15
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Naik RR, 2002, NAT MATER, V1, P169, DOI 10.1038/nmat758
   Nangia Y, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3141519
   NEDDERSEN J, 1993, APPL SPECTROSC, V47, P1959, DOI 10.1366/0003702934066460
   Ocwieja M, 2014, ADV COLLOID INTERFAC, V7, P1
   Oliveira MM, 2005, J COLLOID INTERF SCI, V292, P429, DOI 10.1016/j.jcis.2005.05.068
   Palza H, 2015, INT J MOL SCI, V16, P2099, DOI 10.3390/ijms16012099
   Panacek A, 2009, BIOMATERIALS, V30, P6333, DOI 10.1016/j.biomaterials.2009.07.065
   Parikh RY, 2008, CHEMBIOCHEM, V9, P1415, DOI 10.1002/cbic.200700592
   Pietrobon B, 2008, CHEM MATER, V20, P5186, DOI 10.1021/cm800926u
   Prochazka M, 1997, ANAL CHEM, V69, P5103, DOI 10.1021/ac970683+
   Pyatenko A, 2004, APPL PHYS A-MATER, V79, P803, DOI 10.1007/s00339-004-2841-5
   Pyatenko A, 2010, SILVER NANOPARTICLES, P121
   Qi LF, 2004, CARBOHYD RES, V339, P2693, DOI 10.1016/j.carres.2004.09.007
   Rodriguez-Leon E, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-318
   Salehi-Khojin A, 2013, J PHYS CHEM C, V117, P1627, DOI 10.1021/jp310509z
   Selvakannan PR, 2004, LANGMUIR, V20, P7825, DOI 10.1021/la049258j
   Shi Q, 2011, EUR POLYM J, V47, P1402, DOI 10.1016/j.eurpolymj.2011.04.002
   Shi Q, 2011, J MATER CHEM, V21, P10330, DOI 10.1039/c1jm11492a
   Shi YL, 2009, MATER LETT, V63, P2698, DOI 10.1016/j.matlet.2009.09.046
   Sivaraman SK, 1997, CURR SCI, V7, P1055
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Sui ZM, 2005, CHEM LETT, V34, P100, DOI 10.1246/cl.2005.100
   Tang YA, 2011, NANOSCALE RES LETT, V6, P1, DOI 10.1186/1556-276X-6-394
   Tolaymat TM, 2010, SCI TOTAL ENVIRON, V408, P999, DOI 10.1016/j.scitotenv.2009.11.003
   Wright JB, 1999, AM J INFECT CONTROL, V27, P344, DOI 10.1016/S0196-6553(99)70055-6
   Yoosaf K, 2007, J PHYS CHEM C, V111, P12839, DOI 10.1021/jp073923q
   Zhai HJ, 2006, J NANOSCI NANOTECHNO, V6, P1968, DOI 10.1166/jnn.2006.320
   Zhang S, 2009, MATER DESIGN, V30, P3659, DOI 10.1016/j.matdes.2009.02.017
   Zielinska A, 2009, PROCEDIA CHEM, V1, P1560, DOI 10.1016/j.proche.2009.11.004
NR 82
TC 15
Z9 15
U1 6
U2 307
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1556-276X
J9 NANOSCALE RES LETT
JI Nanoscale Res. Lett.
PD FEB 9
PY 2016
VL 11
AR 80
DI 10.1186/s11671-016-1286-z
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA EH4NR
UT WOS:000391748400004
PM 26858162
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Jiang, XC
   Lin, HW
   Jiang, DP
   Xu, GF
   Fang, XL
   He, L
   Xu, MS
   Tang, BQ
   Wang, ZY
   Cui, DX
   Chen, F
   Geng, HQ
AF Jiang, Xincheng
   Lin, Houwei
   Jiang, Dapeng
   Xu, Guofeng
   Fang, Xiaoliang
   He, Lei
   Xu, Maosheng
   Tang, Bingqiang
   Wang, Zhiyong
   Cui, Daxiang
   Chen, Fang
   Geng, Hongquan
TI Co-delivery of VEGF and bFGF via a PLGA nanoparticle-modified BAM for
   effective contracture inhibition of regenerated bladder tissue in
   rabbits
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ACELLULAR MATRIX GRAFT; SMALL-INTESTINAL SUBMUCOSA; ENDOTHELIAL
   GROWTH-FACTOR; LOWER URINARY-TRACT; FUNCTIONAL-EVALUATION; MICROVESSEL
   DENSITY; SUSTAINED-RELEASE; RAT BLADDER; MODEL; AUGMENTATION
AB Graft contracture is a common problem associated with the regeneration processes of tissue-engineered bladders. Currently, most strategies used for incorporating bioactive molecules into biomaterial designs do not work during all phases of tissue regeneration. In this study, we used a growth factor-PLGA nanoparticle thermo-sensitive gel system (i.e., BAM with incorporated VEGF and bFGF-loaded PLGA nanoparticles and mixed with a hydrophilic gel) to promote bladder tissue regeneration in a rabbit model. At 4 and 12 weeks after surgery, contracture rate assessment and histological examination were conducted to evaluate bladder tissue regeneration. The results indicated that the functional composite scaffold continuously and effectively released VEGF and bFGF and promoted bladder reconstruction with a significant decrease in graft contracture. In addition, the number and arrangement of regenerated urothelial cells and smooth muscle cells as well as microvascular density and maturity were improved in the VEGF/bFGF nanoparticle group compared with the single factor VEGF or bFGF nanoparticle group and BAM alone. The nanoparticle thermo-sensitive gel system, which exhibited favourable performance, may effectively inhibit graft contracture and promote bladder tissue regeneration in rabbits.
C1 [Jiang, Xincheng; Lin, Houwei; Jiang, Dapeng; Xu, Guofeng; Fang, Xiaoliang; He, Lei; Xu, Maosheng; Tang, Bingqiang; Geng, Hongquan] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Pediat Urol, Shanghai 200030, Peoples R China.
   [Wang, Zhiyong] Shanghai Inst Pharmaceut Ind, Shanghai, Peoples R China.
   [Cui, Daxiang] Shanghai Jiao Tong Univ, Inst Micronano Sci & Technol, Dept Bionano Sci & Engn, Key Lab Thin Film & Microfabricat,Minist Educ, Shanghai 200030, Peoples R China.
   [Chen, Fang] Shanghai Jiao Tong Univ, Sch Med, Childrens Hosp Affiliated, Dept Urol, Shanghai 200030, Peoples R China.
RP Geng, HQ (reprint author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Pediat Urol, Shanghai 200030, Peoples R China.
EM ghongquan@hotmail.com
FU National Natural Science Foundation of China [81170639]
FX This research was supported by a grant from the National Natural Science
   Foundation of China (No. 81170639). We thank Dr. Zhixiang Wu (Xinhua
   Hospital, Shanghai Jiao Tong University School of Medicine, China) for
   assistance with the in vitro studies.
CR Ashley RA, 2010, BJU INT, V105, P1462, DOI 10.1111/j.1464-410X.2009.08965.x
   Biers SM, 2012, BJU INT, V109, P1280, DOI 10.1111/j.1464-410X.2011.10650.x
   Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005
   Brown AL, 2002, BIOMATERIALS, V23, P2179, DOI 10.1016/S0142-9612(01)00350-7
   Cartwright L, 2006, J BIOMED MATER RES A, V77A, P390, DOI 10.1002/jbm.a.30648
   Castellan M, 2012, J UROLOGY, V187, P1823, DOI 10.1016/j.juro.2011.12.105
   Cayan S, 2002, J UROLOGY, V168, P798, DOI 10.1016/S0022-5347(05)64746-5
   Chen BSS, 2009, INT J ARTIF ORGANS, V32, P159
   Chen W, 2014, TISSUE ENG PT A, V20, P2234, DOI [10.1089/ten.tea.2013.0730, 10.1089/ten.TEA.2013.0730]
   Chun SY, 2007, BIOMATERIALS, V28, P4251, DOI 10.1016/j.biomaterials.2007.05.020
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Dahms SE, 1998, BRIT J UROL, V82, P411
   Geng HQ, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-312
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Kajbafzadeh AM, 2007, J SURG RES, V139, P189, DOI 10.1016/j.jss.2006.11.003
   Kanematsu A, 2003, J UROLOGY, V170, P1633, DOI 10.1097/01.ju.0000084021.51099.8a
   Kanematsu A, 2007, INT J UROL, V14, P673, DOI 10.1111/j.1442-2042.2007.01768.x
   Kikuno N, 2009, BJU INT, V103, P1424, DOI 10.1111/j.1464-410X.2008.08129.x
   Kispal Z, 2011, BJU INT, V108, P282, DOI 10.1111/j.1464-410X.2010.09862.x
   Liao X., 2010, NANO BIOMED ENG, V2, P133
   Lin HK, 2014, TISSUE ENG PART B-RE, V20, P73, DOI 10.1089/ten.TEB.2013.0126
   Loai Y, 2010, J BIOMED MATER RES A, V94A, P1205, DOI 10.1002/jbm.a.32777
   Mataveli FD, 2009, GROWTH FACTORS, V27, P22, DOI 10.1080/08977190802574765
   Mondalek FG, 2010, J BIOMED MATER RES A, V94A, P712, DOI 10.1002/jbm.a.32748
   Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0
   Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004
   Rosario DJ, 2008, REGEN MED, V3, P145, DOI 10.2217/17460751.3.2.145
   Roth CC, 2011, BJU INT, V108, P148, DOI 10.1111/j.1464-410X.2010.09757.x
   Singh M, 2008, TISSUE ENG PART B-RE, V14, P341, DOI 10.1089/ten.teb.2008.0304
   Song LJ, 2014, TISSUE ENG PART B-RE, V20, P163, DOI [10.1089/ten.teb.2013.0103, 10.1089/ten.TEB.2013.0103]
   Uzzan B, 2004, CANCER RES, V64, P2941, DOI 10.1158/0008-5472.CAN-03-1957
   Weidner N, 2008, METHOD ENZYMOL, V444, P305, DOI 10.1016/S0076-6879(08)02814-0
   Youssif M, 2005, UROLOGY, V66, P201, DOI 10.1016/j.urology.2005.01.054
   Zhou LH, 2013, TISSUE ENG PT A, V19, P264, DOI [10.1089/ten.tea.2011.0609, 10.1089/ten.TEA.2011.0609]
   Zhu WD, 2010, WORLD J UROL, V28, P493, DOI 10.1007/s00345-010-0508-8
NR 35
TC 10
Z9 11
U1 4
U2 23
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 8
PY 2016
VL 6
AR 20784
DI 10.1038/srep20784
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DC8TV
UT WOS:000369493500001
PM 26854200
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Sacks, MS
   Zhang, W
   Wognum, S
AF Sacks, Michael S.
   Zhang, Will
   Wognum, Silvia
TI A novel fibre-ensemble level constitutive model for exogenous
   cross-linked collagenous tissues
SO INTERFACE FOCUS
LA English
DT Article
DE collagenous tissues; cross-linking; constitutive model
ID VALVE ANTERIOR LEAFLET; TENSILE VISCOELASTIC PROPERTIES; BOVINE
   PERICARDIAL XENOGRAFT; FINITE-ELEMENT IMPLEMENTATION; BIAXIAL
   MECHANICAL-BEHAVIOR; BIOPROSTHETIC HEART-VALVES; PLANAR SOFT-TISSUES;
   HETEROGRAFT BIOMATERIALS; CONNECTIVE TISSUES; STRESS-RELAXATION
AB Exogenous cross-linking of soft collagenous tissues is a common method for biomaterial development and medical therapies. To enable improved applications through computational methods, physically realistic constitutive models are required. Yet, despite decades of research, development and clinical use, no such model exists. In this study, we develop the first rigorous full structural model (i.e. explicitly incorporating various features of the collagen fibre architecture) for exogenously cross-linked soft tissues. This was made possible, in-part, with the use of native to cross-linked matched experimental datasets and an extension to the collagenous structural constitutive model so that the uncross-linked collagen fibre responses could be mapped to the cross-linked configuration. This allowed us to separate the effects of cross-linking from kinematic changes induced in the cross-linking process, which in turn allowed the non-fibrous tissue matrix component and the interaction effects to be identified. It was determined that the matrix could be modelled as an isotropic material using a modified Yeoh model. The most novel findings of this study were that: (i) the effective collagen fibre modulus was unaffected by cross-linking and (ii) fibre-ensemble interactions played a large role in stress development, often dominating the total tissue response (depending on the stress component and loading path considered). An important utility of the present model is its ability to separate the effects of exogenous cross-linking on the fibres from changes due to the matrix. Applications of this approach include the utilization in the design of novel chemical treatments to produce specific mechanical responses and the study of fatigue damage in bioprosthetic heart valve biomaterials.
C1 [Sacks, Michael S.; Zhang, Will] Univ Texas Austin, Dept Biomed Engn, Inst Computat Engn & Sci, Ctr Cardiovasc Simulat, 201 East 24th St,POB 5-236,Stop C0200, Austin, TX 78712 USA.
   [Wognum, Silvia] Eindhoven Univ Technol, Dept Biomed Engn, POB 513, NL-5600 MB Eindhoven, Netherlands.
RP Sacks, MS (reprint author), Univ Texas Austin, Dept Biomed Engn, Inst Computat Engn & Sci, Ctr Cardiovasc Simulat, 201 East 24th St,POB 5-236,Stop C0200, Austin, TX 78712 USA.
EM msacks@ices.utexas.edu
OI Zhang, Will/0000-0003-1986-6253
FU NIH [R01 HL108330]
FX This study was supported by NIH grant no. R01 HL108330.
CR Alferiev I, 2003, J BIOMED MATER RES A, V66A, P385, DOI 10.1002/jbm.a.10896
   Barber J E, 1999, Biomed Sci Instrum, V35, P29
   Bini A, 1999, ARTERIOSCL THROM VAS, V19, P1852, DOI 10.1161/01.ATV.19.8.1852
   Buehler MJ, 2006, J MATER RES, V21, P1947, DOI 10.1557/JMR.2006.0236
   Cavalcante FSA, 2005, J APPL PHYSIOL, V98, P672, DOI 10.1152/japplphysiol.00619.2004
   CHEUNG DT, 1983, J BIOL CHEM, V258, P7774
   CHEUNG DT, 1982, CONNECT TISSUE RES, V10, P187, DOI 10.3109/03008208209034418
   CHEUNG DT, 1982, CONNECT TISSUE RES, V10, P201, DOI 10.3109/03008208209034419
   CHEUNG DT, 1985, CONNECT TISSUE RES, V13, P109, DOI 10.3109/03008208509152389
   CHEUNG DT, 1990, CONNECT TISSUE RES, V25, P27, DOI 10.3109/03008209009009810
   Coughlin MF, 1996, J APPL PHYSIOL, V80, P1880
   Eckert CE, 2013, ACTA BIOMATER, V9, P4653, DOI 10.1016/j.actbio.2012.09.031
   Eppell SJ, 2006, J ROY SOC INTERFACE, V3, P117, DOI 10.1098/rsif.2005.0100
   Fan R, 2014, J BIOMECH, V47, P2043, DOI 10.1016/j.jbiomech.2014.03.014
   Fata B, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026457
   Garikipati K, 2008, J MECH PHYS SOLIDS, V56, P1693, DOI 10.1016/j.jmps.2007.07.005
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   GENDLER E, 1984, J BIOMED MATER RES, V18, P727, DOI 10.1002/jbm.820180703
   Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0
   Grashow JS, 2006, ANN BIOMED ENG, V34, P1509, DOI 10.1007/s10439-006-9183-8
   Grashow JS, 2006, ANN BIOMED ENG, V34, P315, DOI [10.1007/s10439-005-9027-y, 10.1007/s10439-005-9027-v]
   Holzapfel GA, 2000, NONLINEAR SOLID MECH
   Kojic M, 1998, COMPUT MECH, V21, P189, DOI 10.1007/s004660050294
   LANIR Y, 1994, J APPL MECH-T ASME, V61, P695, DOI 10.1115/1.2901516
   LANIR Y, 1983, J BIOMECH, V16, P1, DOI 10.1016/0021-9290(83)90041-6
   LANIR Y, 1979, J BIOMECH, V12, P423, DOI 10.1016/0021-9290(79)90027-7
   Lee CH, 2015, BIOPHYS J, V108, P2074, DOI 10.1016/j.bpj.2015.03.019
   LEE JM, 1989, J BIOMED MATER RES, V23, P457, DOI 10.1002/jbm.820230502
   LEE JM, 1989, J BIOMED MATER RES, V23, P477, DOI 10.1002/jbm.820230503
   LEE JM, 1989, J BIOMED MATER RES, V23, P491, DOI 10.1002/jbm.820230504
   LEE JM, 1994, AM SOC TEST MATER, V1173, P19, DOI 10.1520/STP18091S
   Lee TC, 2001, J BIOMECH, V34, P203, DOI 10.1016/S0021-9290(00)00187-1
   Liao J, 2005, ACTA BIOMATER, V1, P45, DOI 10.1016/j.actbio.2004.09.007
   Liao J, 2004, ANN BIOMED ENG, V32, P977, DOI 10.1023/B:ABME.0000032460.97278.e9
   Liao J, 2007, J BIOMECH ENG-T ASME, V129, P78, DOI 10.1115/1.2401186
   Merodio J, 2006, INT J NONLINEAR MECH, V41, P556, DOI [10.1016/j.ijnonlinmec.2006.02.001, 10.1016/j.ijnonlinmec.2006.11.002]
   Mirnajafi A, 2005, BIOMATERIALS, V26, P795, DOI 10.1016/j.biomaterials.2004.03.004
   NAIMARK WA, 1992, AM J PHYSIOL, V263, pH1095
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   Nimni ME., 1988, COLLAGEN VOLUME II B
   PARRY DAD, 1988, BIOPHYS CHEM, V29, P195, DOI 10.1016/0301-4622(88)87039-X
   PETRUSKA JA, 1964, P NATL ACAD SCI USA, V51, P871, DOI 10.1073/pnas.51.5.871
   Sacks MS, 2006, EXPERT REV MED DEVIC, V3, P817, DOI 10.1586/17434440.3.6.817
   Sacks MS, 2009, J BIOMECH, V42, P1804, DOI 10.1016/j.jbiomech.2009.05.015
   Sacks MS, 1998, ANN BIOMED ENG, V26, P892, DOI 10.1114/1.135
   Sacks MS, 2000, COMPUT MECH, V26, P243, DOI 10.1007/s004660000175
   Sacks MS, 2003, ANNU REV BIOMED ENG, V5, P251, DOI 10.1146/annurev.bioeng.5.011303.120714
   Sacks MS, 2003, J BIOMECH ENG-T ASME, V125, P280, DOI 10.1115/1.1544508
   Sacks MS, 1999, CALCIFICATION INDEPE
   Sasaki N, 1996, J BIOMECH, V29, P1131, DOI 10.1016/0021-9290(96)00024-3
   Sasaki N, 1996, J BIOMECH, V29, P655, DOI 10.1016/0021-9290(95)00110-7
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   Schoen FJ, 2005, CARDIOVASC PATHOL, V14, P189, DOI 10.1016/j.carpath.2005.03.005
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   Schoen FJ, 2001, CARDIOVASC PATHOL, P629
   Sellaro TL, 2007, J BIOMED MATER RES A, V80A, P194, DOI 10.1002/jbm.a.30871
   Shen ZL, 2008, BIOPHYS J, V95, P3956, DOI 10.1529/biophysj.107.124602
   Stella JA, 2007, J BIOMECH, V40, P3169, DOI 10.1016/j.jbiomech.2007.04.001
   Sun W, 2005, BIOMECH MODEL MECHAN, V4, P190, DOI 10.1007/s10237-005-0075-x
   Sun W, 2004, J BIOMED MATER RES A, V69A, P658, DOI 10.1002/jbm.a.30031
   Sun W, 2003, J BIOMECH ENG-T ASME, V125, P372, DOI 10.1115/1.1572518
   Sun W, 2005, J BIOMECH ENG-T ASME, V127, P905, DOI 10.1115/1.2049337
   Vesely I, 2001, J HEART VALVE DIS, V10, P471
   Wells S. M., 2000, T 6 WORLD BIOM C KAM, V2, P794
   Wells SM, 2005, BIOMATERIALS, V26, P2611, DOI 10.1016/j.biomaterials.2004.06.046
   Wells SM, 2002, BIOMATERIALS, V23, P2389, DOI 10.1016/S0142-9612(01)00375-1
   Wells SM, 1999, ASME ADV BIOENG, V43, P91
   Yang L, 2008, BIOMATERIALS, V29, P955, DOI 10.1016/j.biomaterials.2007.10.058
   Yang L, 2007, J BIOMED MATER RES A, V82A, P160, DOI 10.1002/jbm.a.31127
   Zhang W., J MECH BEHA IN PRESS
   Zhang W, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029266
NR 71
TC 9
Z9 9
U1 0
U2 4
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 2042-8898
EI 2042-8901
J9 INTERFACE FOCUS
JI Interface Focus
PD FEB 6
PY 2016
VL 6
IS 1
AR 20150090
DI 10.1098/rsfs.2015.0090
PG 15
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA DG4TM
UT WOS:000372065600016
PM 26855761
OA Green Published, Bronze
DA 2018-10-19
ER

EF